PT	AU	BA	BE	GP	AF	BF	CA	TI	SO	SE	BS	LA	DT	CT	CY	CL	SP	HO	DE	ID	AB	C1	C3	RP	EM	RI	OI	FU	FP	FX	CR	NR	TC	Z9	U1	U2	PU	PI	PA	SN	EI	BN	J9	JI	PD	PY	VL	IS	PN	SU	SI	MA	BP	EP	AR	DI	DL	D2	EA	PG	WC	WE	SC	GA	PM	OA	HC	HP	DA	UT
J	Kwon, SE; Chapman, ER				Kwon, Sung E.; Chapman, Edwin R.			Glycosylation Is Dispensable for Sorting of Synaptotagmin 1 but Is Critical for Targeting of SV2 and Synaptophysin to Recycling Synaptic Vesicles	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MEMBRANE-PROTEINS; NEUROTRANSMITTER RELEASE; HIPPOCAMPAL-NEURONS; TRANSMITTER RELEASE; N-GLYCOSYLATION; TRAFFICKING; ENDOCYTOSIS; CELLS; LOCALIZATION; TRANSMISSION	Glycosylation is a major form of post-translational modification of synaptic vesicle membrane proteins. For example, the three major synaptic vesicle glycoproteins, synaptotagmin 1, synaptophysin, and SV2, represent similar to 30% of the total copy number of vesicle proteins. Previous studies suggested that glycosylation is required for the vesicular targeting of synaptotagmin 1, but the role of glycosylation of synaptophysin and SV2 has not been explored in detail. In this study, we analyzed all glycosylation sites on synaptotagmin 1, synaptophysin, and SV2A via mutagenesis and optical imaging of pHluorin-tagged proteins in cultured neurons from knock-out mice lacking each protein. Surprisingly, these experiments revealed that glycosylation is completely dispensable for the sorting of synaptotagmin 1 to SVs whereas the N-glycans on SV2A are only partially dispensable. In contrast, N-glycan addition is essential for the synaptic localization and function of synaptophysin. Thus, glycosylation plays distinct roles in the trafficking of each of the three major synaptic vesicle glycoproteins.	[Kwon, Sung E.; Chapman, Edwin R.] Univ Wisconsin, Dept Neurosci, Howard Hughes Med Inst, Madison, WI 53706 USA	Howard Hughes Medical Institute; University of Wisconsin System; University of Wisconsin Madison	Chapman, ER (corresponding author), 1300 Univ Ave,SMI 203, Madison, WI 53706 USA.	chapman@wisc.edu		Chapman, Edwin/0000-0001-9787-8140	National Institutes of Health Grant [MH 61876]; Epilepsy Foundation predoctoral fellowship; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH061876] Funding Source: NIH RePORTER	National Institutes of Health Grant(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Epilepsy Foundation predoctoral fellowship; NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))	This study was supported, in whole or in part, by National Institutes of Health Grant MH 61876.; Supported by an Epilepsy Foundation predoctoral fellowship.	Bonanomi D, 2006, PROG NEUROBIOL, V80, P177, DOI 10.1016/j.pneurobio.2006.09.002; Chang WP, 2009, J NEUROSCI, V29, P883, DOI 10.1523/JNEUROSCI.4521-08.2009; Daly C, 2000, P NATL ACAD SCI USA, V97, P6120, DOI 10.1073/pnas.97.11.6120; Dean C, 2009, NAT NEUROSCI, V12, P767, DOI 10.1038/nn.2315; Dong M, 2006, SCIENCE, V312, P592, DOI 10.1126/science.1123654; Dong M, 2008, MOL BIOL CELL, V19, P5226, DOI 10.1091/mbc.E08-07-0765; Duffield A, 2008, INT REV CEL MOL BIO, V270, P145, DOI 10.1016/S1937-6448(08)01404-4; ESHKIND LG, 1995, CELL TISSUE RES, V282, P423, DOI 10.1007/s004410050493; Fernandez-Alfonso T, 2006, NEURON, V51, P179, DOI 10.1016/j.neuron.2006.06.008; GEPPERT M, 1994, CELL, V79, P717, DOI 10.1016/0092-8674(94)90556-8; Granseth B, 2006, NEURON, V51, P773, DOI 10.1016/j.neuron.2006.08.029; Haas KF, 2008, BBA-GENE REGUL MECH, V1779, P495, DOI 10.1016/j.bbagrm.2007.12.010; Han WP, 2004, NEURON, V41, P85, DOI 10.1016/S0896-6273(03)00820-1; Hannah MJ, 1999, ANNU REV CELL DEV BI, V15, P733, DOI 10.1146/annurev.cellbio.15.1.733; Hui EF, 2009, CELL, V138, P709, DOI 10.1016/j.cell.2009.05.049; Janz R, 1999, NEUROSCIENCE, V94, P1279, DOI 10.1016/S0306-4522(99)00370-X; Janz R, 1999, NEURON, V24, P1003, DOI 10.1016/S0896-6273(00)81046-6; Jiang M, 2006, NAT PROTOC, V1, P695, DOI 10.1038/nprot.2006.86; Kanno E., 2007, J NEUROSCI RES; Kanno E, 2008, J NEUROSCI RES, V86, P1036, DOI 10.1002/jnr.21568; Kittler JT, 2003, CURR OPIN NEUROBIOL, V13, P341, DOI 10.1016/S0959-4388(03)00064-3; Kwon SE, 2011, NEURON, V70, P847, DOI 10.1016/j.neuron.2011.04.001; LEUBE RE, 1989, CELL, V59, P433, DOI 10.1016/0092-8674(89)90028-7; Liu HS, 2009, J NEUROSCI, V29, P7395, DOI 10.1523/JNEUROSCI.1341-09.2009; Miesenbock G, 1998, NATURE, V394, P192, DOI 10.1038/28190; Nishiki T, 2004, J NEUROSCI, V24, P6127, DOI 10.1523/JNEUROSCI.1563-04.2004; Nowack A, 2010, AM J PHYSIOL-CELL PH, V299, pC960, DOI 10.1152/ajpcell.00259.2010; Sampo B, 2003, NEURON, V37, P611, DOI 10.1016/S0896-6273(03)00058-8; Takamori S, 2006, CELL, V127, P831, DOI 10.1016/j.cell.2006.10.030; Vagin O, 2009, AM J PHYSIOL-RENAL, V296, pF459, DOI 10.1152/ajprenal.90340.2008; Wienisch M, 2006, NAT NEUROSCI, V9, P1019, DOI 10.1038/nn1739; Yao J, 2012, NAT NEUROSCI, V15, P243, DOI 10.1038/nn.3013	32	29	32	1	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	OCT 12	2012	287	42					35658	35668		10.1074/jbc.M112.398883	http://dx.doi.org/10.1074/jbc.M112.398883			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	022OF	22908222	Green Published, hybrid			2022-12-25	WOS:000309968000077
J	Corbiere, V; Pottier, G; Bonkain, F; Schepers, K; Verscheure, V; Lecher, S; Doherty, TM; Locht, C; Mascart, F				Corbiere, Veronique; Pottier, Gaelle; Bonkain, Florence; Schepers, Kinda; Verscheure, Virginie; Lecher, Sophie; Doherty, T. Mark; Locht, Camille; Mascart, Francoise			Risk Stratification of Latent Tuberculosis Defined by Combined Interferon Gamma Release Assays	PLOS ONE			English	Article							HEPARIN-BINDING-HEMAGGLUTININ; TBNET CONSENSUS STATEMENT; ACTIVE TUBERCULOSIS; T-CELL; IMMUNE-RESPONSES; DIALYSIS PATIENTS; PREDICTIVE-VALUE; INFECTION; ANTIGEN; INTERVENTION	Background: Most individuals infected with Mycobacterium tuberculosis develop latent tuberculosis infection (LTBI). Some may progress to active disease and would benefit from preventive treatment yet no means currently exists to predict who will reactivate. Here, we provide an approach to stratify LTBI based on IFN-gamma responses to two antigens, the recombinant Early-Secreted Antigen Target-6 (rESAT-6) and the latency antigen Heparin-Binding Haemagglutinin (HBHA). Methods: We retrospectively analyzed results from in-house IFN-gamma-release assays with HBHA (HBHA-IGRA) and rESAT-6 (rESAT-6-IGRA) performed during a 12-year period on serial blood samples (3 to 9) collected from 23 LTBI subjects in a low-TB incidence country. Both the kinetics of the absolute IFN-gamma concentrations secreted in response to each antigen and the dynamics of HBHA/rESAT-6-induced IFN-gamma concentrations ratios were examined. Results: This analysis allowed the identification among the LTBI subjects of three major groups. Group A featured stable HBHA and rESAT-6-IGRA profiles with an HBHA/rESAT-6 ratio persistently higher than 1, and with high HBHA-and usually negative rESAT-6-IGRA responses throughout the study. Group B had changing HBHA/rESAT-6 ratios fluctuating from 0.0001 to 10,000, with both HBHA and rESAT-6 responses varying over time at least once during the follow-up. Group C was characterized by a progressive disappearance of all responses. Conclusions: By combining the measures of IFN-gamma concentrations secreted in response to an early and a latency antigens, LTBI subjects can be stratified into different risk groups. We propose that disappearing responses indicate cure, that persistent responses to HBHA with HBHA/rESAT-6 ratios >= 1 represent stable LTBI subjects, whereas subjects with ratios varying from >= 1 to <1 should be closely monitored as they may represent the highest-risk group, as illustrated by a case report, and should therefore be prioritized for preventive treatment.	[Corbiere, Veronique; Pottier, Gaelle; Verscheure, Virginie; Mascart, Francoise] Univ Libre Bruxelles ULB Brussels, Lab Vaccinol & Mucosal Immun, Brussels, Belgium; [Bonkain, Florence] Univ Libre Bruxelles ULB Brussels, Hop Erasme, Dept Nephrol, Brussels, Belgium; [Schepers, Kinda] Univ Libre Bruxelles ULB Brussels, Hop Erasme, Immunodeficiency Unit, Brussels, Belgium; [Lecher, Sophie; Locht, Camille] INSERM, U1019, F-59045 Lille, France; [Lecher, Sophie; Locht, Camille] Inst Pasteur, Ctr Immunol & Biol Parasitaire, CNRS, UMR8204, F-59019 Lille, France; [Lecher, Sophie; Locht, Camille] Univ Lille Nord France, Inst Pasteur Lille, Lille, France; [Lecher, Sophie; Locht, Camille] Ctr Infect & Immun Lille, Lille, France; [Doherty, T. Mark] Statens Serum Inst, Dept TB Immunol, DK-2300 Copenhagen, Denmark; [Mascart, Francoise] Univ Libre Bruxelles ULB Brussels, Hop Erasme, Immunobiol Clin, Brussels, Belgium	Universite Libre de Bruxelles; Universite Libre de Bruxelles; Institut National de la Sante et de la Recherche Medicale (Inserm); Universite de Lille - ISITE; Universite de Lille; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); Le Reseau International des Instituts Pasteur (RIIP); Universite de Lille - ISITE; Institut Pasteur Lille; Universite de Lille; Le Reseau International des Instituts Pasteur (RIIP); Universite de Lille - ISITE; Institut Pasteur Lille; Universite de Lille; Universite de Lille - ISITE; Universite de Lille; Statens Serum Institut; Universite Libre de Bruxelles	Corbiere, V (corresponding author), Univ Libre Bruxelles ULB Brussels, Lab Vaccinol & Mucosal Immun, Brussels, Belgium.	fmascart@ulb.ac.be		Bonkain, Florence/0000-0002-6643-1300; Locht, Camille/0000-0001-7295-7336	E.C. FP6 program TB-VAC (An integrated project for the design and testing of vaccine candidates against tuberculosis: identification, development, and clinical studies) [LSHP-CT-2003-503367]; FP7 program NEWTB-VAC (Discovery and preclinical development of new generation tuberculosis vaccines) [HEALTH-2009-2.3.2-2]; Region de Bruxelles Capitale	E.C. FP6 program TB-VAC (An integrated project for the design and testing of vaccine candidates against tuberculosis: identification, development, and clinical studies); FP7 program NEWTB-VAC (Discovery and preclinical development of new generation tuberculosis vaccines); Region de Bruxelles Capitale	This work is supported by the E.C. FP6 program TB-VAC (An integrated project for the design and testing of vaccine candidates against tuberculosis: identification, development, and clinical studies)(LSHP-CT-2003-503367), FP7 program NEWTB-VAC (Discovery and preclinical development of new generation tuberculosis vaccines)(HEALTH-2009-2.3.2-2), and the "Region de Bruxelles Capitale". The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andersen P, 2007, TRENDS MOL MED, V13, P175, DOI 10.1016/j.molmed.2007.03.004; Barry CE, 2009, NAT REV MICROBIOL, V7, P845, DOI 10.1038/nrmicro2236; Cardona PJ, 2009, INFECTION, V37, P80, DOI 10.1007/s15010-008-8087-y; Cengiz K, 1996, NEPHRON, V73, P421; Chou KJ, 2001, NEPHRON, V88, P138, DOI 10.1159/000045974; Delogu G, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018315; Diel R, 2011, AM J RESP CRIT CARE, V183, P88, DOI 10.1164/rccm.201006-0974OC; Doherty TM, 2002, J CLIN MICROBIOL, V40, P704, DOI 10.1128/JCM.40.2.704-706.2002; Dye C, 2010, SCIENCE, V328, P856, DOI 10.1126/science.1185449; Goletti D, 2010, EUR RESPIR J, V36, P135, DOI 10.1183/09031936.00140009; Harari A, 2011, NAT MED, V17, P372, DOI 10.1038/nm.2299; Hougardy JM, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000926; Hougardy JM, 2007, AM J RESP CRIT CARE, V176, P409, DOI 10.1164/rccm.200701-084OC; Lawn SD, 2011, CLIN DEV IMMUNOL, DOI 10.1155/2011/980594; Leyten EMS, 2007, CLIN VACCINE IMMUNOL, V14, P880, DOI 10.1128/CVI.00132-07; Lin May Young, 2008, Endocrine Metabolic & Immune Disorders-Drug Targets, V8, P15, DOI 10.2174/187153008783928398; Mack U, 2009, EUR RESPIR J, V33, P956, DOI 10.1183/09031936.00120908; Masungi C, 2002, J INFECT DIS, V185, P513, DOI 10.1086/338833; Menozzi FD, 2006, MICROBES INFECT, V8, P1, DOI 10.1016/j.micinf.2005.03.023; Moore DAJ, 2002, EMERG INFECT DIS, V8, P77, DOI 10.3201/eid0801.010017; Pai M, 2008, ANN INTERN MED, V149, P177, DOI 10.7326/0003-4819-149-3-200808050-00241; Pai M, 2010, NAT REV MICROBIOL, V8, P242, DOI 10.1038/nrmicro2236-c1; Parra M, 2004, INFECT IMMUN, V72, P6799, DOI 10.1128/IAI.72.12.6799-6805.2004; Place S, 2010, AM J RESP CRIT CARE, V182, P848, DOI 10.1164/rccm.201001-0083OC; Rangaka MX, 2012, LANCET INFECT DIS, V12, P45, DOI 10.1016/S1473-3099(11)70210-9; Rouanet Carine, 2010, Expert Rev Respir Med, V4, P339, DOI 10.1586/ers.10.25; Rouanet C, 2009, MICROBES INFECT, V11, P995, DOI 10.1016/j.micinf.2009.07.005; Segall L, 2010, CLIN J AM SOC NEPHRO, V5, P1114, DOI 10.2215/CJN.09231209; Solovic I, 2010, EUR RESPIR J, V36, P1185, DOI 10.1183/09031936.00028510; Temmerman S, 2004, NAT MED, V10, P935, DOI 10.1038/nm1090; Temmerman ST, 2005, J INFECT DIS, V192, P226, DOI 10.1086/430930; Wallis RS, 2010, LANCET, V375, P1920, DOI 10.1016/S0140-6736(10)60359-5; WILKINSON D, 2000, COCHRANE DB SYST REV, V4; Young DB, 2009, TRENDS MICROBIOL, V17, P183, DOI 10.1016/j.tim.2009.02.005	34	49	50	1	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 17	2012	7	8							e43285	10.1371/journal.pone.0043285	http://dx.doi.org/10.1371/journal.pone.0043285			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	996DG	22912846	Green Published, Green Submitted, gold			2022-12-25	WOS:000308063700075
J	El Hamidieh, A; Grammatikakis, N; Patsavoudi, E				El Hamidieh, Avraam; Grammatikakis, Nicholas; Patsavoudi, Evangelia			Cell Surface Cdc37 Participates in Extracellular HSP90 Mediated Cancer Cell Invasion	PLOS ONE			English	Article							MONOCLONAL-ANTIBODY 4C5; DEVELOPING NERVOUS-SYSTEM; KINASE-TARGETING SUBUNIT; MOLECULAR CHAPERONE; P50(CDC37); HSP90-ALPHA; METASTASIS; ONCOGENE; PATHWAYS; MOTILITY	Cdc37 is a 50 kDa molecular chaperone which targets intrinsically unstable protein kinases to the molecular chaperone HSP90. It is also an over-expressed oncoprotein that mediates carcinogenesis and maintenance of the malignant phenotype by stabilizing the compromised structures of mutant and/or over-expressed oncogenic kinases. Here we report that Cdc37 is not restricted intracellularly but instead it is also present on the surface of MDA-MB-453 and MDA-MB-231 human breast cancer cells, where it is shown to participate in cancer cell motility processes. Furthermore, we demonstrate using an anti-Cdc37 cell impermeable antibody, that similarly to its intracellular counterpart, this surface pool of Cdc37 specifically interacts with HSP90 as well as the kinase receptors HER2 and EGFR on the cell surface, probably acting as a co-factor in HSP90's extracellular chaperoning activities. Finally, we show that functional inhibition of surface HSP90 using mAb 4C5, a cell impermeable monoclonal antibody against this protein, leads not only to disruption of the Cdc37/HSP90 complex but also to inhibition of the Cdc37/ErbB receptors complexes. These results support an essential role for surface Cdc37 in concert with HSP90 on the cell surface during cancer cell invasion processes and strengthen the therapeutic potential of mAb 4C5 for the treatment of cancer.	[El Hamidieh, Avraam; Patsavoudi, Evangelia] Hellenic Pasteur Inst, Dept Biochem, Athens, Greece; [Grammatikakis, Nicholas] Natl Ctr Sci Res Demokritos, Inst Biol, Athens, Greece; [Patsavoudi, Evangelia] Technol Educ Inst Athens, Dept Biomed Instrumentat Technol, Athens, Greece	National Centre of Scientific Research "Demokritos"; University of West Attica	El Hamidieh, A (corresponding author), Hellenic Pasteur Inst, Dept Biochem, Athens, Greece.	epatsavoudi@pasteur.gr			Hellenic Pasteur Institute	Hellenic Pasteur Institute	AEH received a fellowship from the Hellenic Pasteur Institute. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bagatell R, 2004, MOL CANCER THER, V3, P1021; Calderwood SK, 2006, TRENDS BIOCHEM SCI, V31, P164, DOI 10.1016/j.tibs.2006.01.006; Casas S, 2003, CANCER GENET CYTOGEN, V146, P89, DOI 10.1016/S0165-4608(03)00102-X; Cheng CF, 2011, J CLIN INVEST, V121, P4348, DOI 10.1172/JCI46475; Eustace BK, 2004, CELL CYCLE, V3, P1098; Eustace BK, 2004, NAT CELL BIOL, V6, P507, DOI 10.1038/ncb1131; Feo F, 2006, BBA-REV CANCER, V1765, P126, DOI 10.1016/j.bbcan.2005.08.007; Grammatikakis N, 1999, MOL CELL BIOL, V19, P1661; Gray PJ, 2008, NAT REV CANCER, V8, P491, DOI 10.1038/nrc2420; Gray PJ, 2007, CANCER RES, V67, P11942, DOI 10.1158/0008-5472.CAN-07-3162; Hartson SD, 2000, BIOCHEMISTRY-US, V39, P7631, DOI 10.1021/bi000315r; Katayama Y, 2004, INT J ONCOL, V25, P579; Kimura Y, 1997, GENE DEV, V11, P1775, DOI 10.1101/gad.11.14.1775; Matei D, 2007, J BIOL CHEM, V282, P445, DOI 10.1074/jbc.M607012200; Meintanis S, 2001, GLIA, V34, P39, DOI 10.1002/glia.1038; Neckers L, 2002, TRENDS MOL MED, V8, pS55, DOI 10.1016/S1471-4914(02)02316-X; PATSAVOUDI E, 1991, J NEUROCHEM, V56, P782, DOI 10.1111/j.1471-4159.1991.tb01992.x; Pearl LH, 2005, CURR OPIN GENET DEV, V15, P55, DOI 10.1016/j.gde.2004.12.011; Picard D, 2002, CELL MOL LIFE SCI, V59, P1640, DOI 10.1007/PL00012491; Pratt WB, 2003, EXP BIOL MED, V228, P111, DOI 10.1177/153537020322800201; Roe SM, 2004, CELL, V116, P87, DOI 10.1016/S0092-8674(03)01027-4; Sidera K, 2004, J BIOL CHEM, V279, P45379, DOI 10.1074/jbc.M405486200; Sidera K, 2008, J BIOL CHEM, V283, P2031, DOI 10.1074/jbc.M701803200; Siligardi G, 2002, J BIOL CHEM, V277, P20151, DOI 10.1074/jbc.M201287200; Silverstein AM, 1998, J BIOL CHEM, V273, P20090, DOI 10.1074/jbc.273.32.20090; Sims JD, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018848; Smith JR, 2009, CELL CYCLE, V8, P362, DOI 10.4161/cc.8.3.7531; Stellas D, 2007, CLIN CANCER RES, V13, P1831, DOI 10.1158/1078-0432.CCR-06-1585; Stellas D, 2010, BMC CELL BIOL, V11, DOI 10.1186/1471-2121-11-51; Stepanova L, 1996, GENE DEV, V10, P1491, DOI 10.1101/gad.10.12.1491; Stepanova L, 1997, METHOD ENZYMOL, V283, P220; Stepanova L, 2000, MOL CELL BIOL, V20, P4462, DOI 10.1128/MCB.20.12.4462-4473.2000; THOMAIDOU D, 1993, NEUROSCIENCE, V53, P813, DOI 10.1016/0306-4522(93)90626-Q; Thompson MA, 2005, HUM PATHOL, V36, P494, DOI 10.1016/j.humpath.2005.03.004; Tsutsumi S, 2007, CANCER SCI, V98, P1536, DOI 10.1111/j.1349-7006.2007.00561.x; Vaughan CK, 2006, MOL CELL, V23, P697, DOI 10.1016/j.molcel.2006.07.016; Walsh N, 2011, CANCER LETT, V306, P180, DOI 10.1016/j.canlet.2011.03.004; Whitesell L, 2005, NAT REV CANCER, V5, P761, DOI 10.1038/nrc1716	38	29	29	1	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 17	2012	7	8							e42722	10.1371/journal.pone.0042722	http://dx.doi.org/10.1371/journal.pone.0042722			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	996DG	22912728	gold, Green Submitted, Green Published			2022-12-25	WOS:000308063700019
J	Gutknecht, L; Araragi, N; Merker, S; Waider, J; Sommerlandt, FMJ; Mlinar, B; Baccini, G; Mayer, U; Proft, F; Hamon, M; Schmitt, AG; Corradetti, R; Lanfumey, L; Lesch, KP				Gutknecht, Lise; Araragi, Naozumi; Merker, Soeren; Waider, Jonas; Sommerlandt, Frank M. J.; Mlinar, Boris; Baccini, Gilda; Mayer, Ute; Proft, Florian; Hamon, Michel; Schmitt, Angelika G.; Corradetti, Renato; Lanfumey, Laurence; Lesch, Klaus-Peter			Impacts of Brain Serotonin Deficiency following Tph2 Inactivation on Development and Raphe Neuron Serotonergic Specification	PLOS ONE			English	Article							KNOCK-OUT MICE; ENERGY-EXPENDITURE; LOCOMOTOR-ACTIVITY; 5-HT TRANSPORTER; ANXIETY-LIKE; RECEPTORS; BEHAVIOR; TRYPTOPHAN; NUCLEUS; LACKING	Brain serotonin (5-HT) is implicated in a wide range of functions from basic physiological mechanisms to complex behaviors, including neuropsychiatric conditions, as well as in developmental processes. Increasing evidence links 5-HT signaling alterations during development to emotional dysregulation and psychopathology in adult age. To further analyze the importance of brain 5-HT in somatic and brain development and function, and more specifically differentiation and specification of the serotonergic system itself, we generated a mouse model with brain-specific 5-HT deficiency resulting from a genetically driven constitutive inactivation of neuronal tryptophan hydroxylase-2 (Tph2). Tph2 inactivation (Tph2-/-) resulted in brain 5-HT deficiency leading to growth retardation and persistent leanness, whereas a sex- and age-dependent increase in body weight was observed in Tph2+/- mice. The conserved expression pattern of the 5-HT neuron-specific markers (except Tph2 and 5-HT) demonstrates that brain 5-HT synthesis is not a prerequisite for the proliferation, differentiation and survival of raphe neurons subjected to the developmental program of serotonergic specification. Furthermore, although these neurons are unable to synthesize 5-HT from the precursor tryptophan, they still display electrophysiological properties characteristic of 5-HT neurons. Moreover, 5-HT deficiency induces an up-regulation of 5-HT1A and 5-HT1B receptors across brain regions as well as a reduction of norepinephrine concentrations accompanied by a reduced number of noradrenergic neurons. Together, our results characterize developmental, neurochemical, neurobiological and electrophysiological consequences of brain-specific 5-HT deficiency, reveal a dual dose-dependent role of 5-HT in body weight regulation and show that differentiation of serotonergic neuron phenotype is independent from endogenous 5-HT synthesis.	[Gutknecht, Lise; Araragi, Naozumi; Merker, Soeren; Waider, Jonas; Sommerlandt, Frank M. J.; Mayer, Ute; Schmitt, Angelika G.; Lesch, Klaus-Peter] Univ Wurzburg, Dept Psychiat Psychosomat & Psychotherapy, Lab Translat Neurosci, Wurzburg, Germany; [Mlinar, Boris; Baccini, Gilda; Corradetti, Renato] Univ Florence, Dept Preclin & Clin Pharmacol, Florence, Italy; [Hamon, Michel; Lanfumey, Laurence] Natl Inst Hlth & Med Res, INSERM U894, Med Fac Pierre & Marie Curie, Ctr Psychiat & Neurosci, Paris, France	University of Wurzburg; University of Florence; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Sorbonne Universite; Universite Paris Cite	Gutknecht, L (corresponding author), Univ Montpellier I, Inst Funct Genom, Natl Ctr Sci Res CNRS UMR 5203, INSERM U661,Dept Neurobiol, Montpellier, France.	Gutknecht.Lise@yahoo.fr; kplesch@mail.uni-wuerzburg.de	Corradetti, Renato/A-1604-2008; Lesch, Klaus-Peter/J-4906-2013; Lanfumey, Laurence/F-7695-2013; Lanfumey, Laurence/P-3037-2017; Mlinar, Boris/A-7034-2008	Corradetti, Renato/0000-0002-2588-0484; Lesch, Klaus-Peter/0000-0001-8348-153X; Mlinar, Boris/0000-0001-9082-0827	German research foundation (DFG) [SFB 581, SFB TRR 58, KFO 125]; IZKF [N-162]; European Community [NEWMOOD LSHM-CT-2003-503474]	German research foundation (DFG)(German Research Foundation (DFG)); IZKF; European Community(European Commission)	This study was supported by the German research foundation (DFG) (SFB 581, SFB TRR 58, KFO 125), IZKF (N-162) and the European Community (NEWMOOD LSHM-CT-2003-503474). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alenina N, 2009, P NATL ACAD SCI USA, V106, P10332, DOI 10.1073/pnas.0810793106; Audero E, 2008, SCIENCE, V321, P130, DOI 10.1126/science.1157871; Beaulieu JM, 2008, P NATL ACAD SCI USA, V105, P1333, DOI 10.1073/pnas.0711496105; Bonnin A, 2011, NATURE, V472, P347, DOI 10.1038/nature09972; BRADY LS, 1992, BRAIN RES, V572, P117, DOI 10.1016/0006-8993(92)90459-M; BROSS R, 1995, AM J CLIN NUTR, V61, P1020, DOI 10.1093/ajcn/61.5.1020; Compan V, 1998, BRAIN RES, V795, P264, DOI 10.1016/S0006-8993(98)00316-3; Conductier G, 2005, NEUROPSYCHOPHARMACOL, V30, P1056, DOI 10.1038/sj.npp.1300662; Cote F, 2003, P NATL ACAD SCI USA, V100, P13525, DOI 10.1073/pnas.2233056100; Cote F, 2007, P NATL ACAD SCI USA, V104, P329, DOI 10.1073/pnas.0606722104; CURZON G, 1990, ANN NY ACAD SCI, V600, P521; Daubert EA, 2010, TRENDS NEUROSCI, V33, P424, DOI 10.1016/j.tins.2010.05.005; Ding YQ, 2003, NAT NEUROSCI, V6, P933, DOI 10.1038/nn1104; Drevets WC, 2007, NUCL MED BIOL, V34, P865, DOI 10.1016/j.nucmedbio.2007.06.008; Erritzoe D, 2010, NEUROIMAGE, V52, P284, DOI 10.1016/j.neuroimage.2010.03.086; Evrard A, 2002, EUR J NEUROSCI, V15, P841, DOI 10.1046/j.1460-9568.2002.01917.x; Fabre V, 2000, EUR J NEUROSCI, V12, P2299, DOI 10.1046/j.1460-9568.2000.00126.x; GALLAGER DW, 1976, NEUROPHARMACOLOGY, V15, P149, DOI 10.1016/0028-3908(76)90023-X; Gaspar P, 2003, NAT REV NEUROSCI, V4, P1002, DOI 10.1038/nrn1256; Gross C, 2004, NAT REV NEUROSCI, V5, P545, DOI 10.1038/nrn1429; Gutknecht L, 2008, J NEURAL TRANSM, V115, P1127, DOI 10.1007/s00702-008-0096-6; Gutknecht L, 2009, EUR NEUROPSYCHOPHARM, V19, P266, DOI 10.1016/j.euroneuro.2008.12.005; Heiming RS, 2009, FRONT BEHAV NEUROSCI, V3, DOI 10.3389/neuro.08.026.2009; Hendricks TJ, 2003, NEURON, V37, P233, DOI 10.1016/S0896-6273(02)01167-4; Jacobsen JP, 2011, MOL PSYCHIAT; Jean A, 2007, P NATL ACAD SCI USA, V104, P16335, DOI 10.1073/pnas.0701471104; Kiyasova V, 2011, J NEUROSCI, V31, P2756, DOI 10.1523/JNEUROSCI.4080-10.2011; Lanoir J, 2006, J COMP NEUROL, V495, P607, DOI 10.1002/cne.20916; Leibowitz SF, 1998, BIOL PSYCHIAT, V44, P851, DOI 10.1016/S0006-3223(98)00186-3; Lesch KP, 2004, INT J NEUROPSYCHOPH, V7, P381, DOI 10.1017/S1461145704004845; Li Q, 2000, J NEUROSCI, V20, P7888; Meguid MM, 2000, NUTRITION, V16, P843, DOI 10.1016/S0899-9007(00)00449-4; Mlinar B, 2005, NEUROREPORT, V16, P1351, DOI 10.1097/01.wnr.0000175249.25535.bf; Mongeau R, 1997, BRAIN RES REV, V23, P145, DOI 10.1016/S0165-0173(96)00017-3; Murphy DL, 2008, NAT REV NEUROSCI, V9, P85, DOI 10.1038/nrn2284; Pudovkina OL, 2002, EUR J PHARMACOL, V445, P37, DOI 10.1016/S0014-2999(02)01663-1; Savelieva KV, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003301; Savitz J, 2009, PROG NEUROBIOL, V88, P17, DOI 10.1016/j.pneurobio.2009.01.009; Simpson KL, 2011, P NATL ACAD SCI USA, V108, P18465, DOI 10.1073/pnas.1109353108; Song NN, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0015998; Srinivasan S, 2008, CELL METAB, V7, P533, DOI 10.1016/j.cmet.2008.04.012; Sziray N, 2010, BEHAV BRAIN RES, V209, P93, DOI 10.1016/j.bbr.2010.01.019; Uceyler N, 2010, INT J OBESITY, V34, P701, DOI 10.1038/ijo.2009.289; Walther DJ, 2003, SCIENCE, V299, P76, DOI 10.1126/science.1078197; Yadav VK, 2009, CELL, V138, P976, DOI 10.1016/j.cell.2009.06.051; Zhao ZQ, 2006, J NEUROSCI, V26, P12781, DOI 10.1523/JNEUROSCI.4143-06.2006	46	77	80	1	28	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 17	2012	7	8							e43157	10.1371/journal.pone.0043157	http://dx.doi.org/10.1371/journal.pone.0043157			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	996DG	22912815	gold, Green Published, Green Submitted			2022-12-25	WOS:000308063700051
J	Kozuka-Hata, H; Nasu-Nishimura, Y; Koyama-Nasu, R; Ao-Kondo, H; Tsumoto, K; Akiyama, T; Oyama, M				Kozuka-Hata, Hiroko; Nasu-Nishimura, Yukiko; Koyama-Nasu, Ryo; Ao-Kondo, Hiroko; Tsumoto, Kouhei; Akiyama, Tetsu; Oyama, Masaaki			Phosphoproteome of Human Glioblastoma Initiating Cells Reveals Novel Signaling Regulators Encoded by the Transcriptome	PLOS ONE			English	Article							CANCER STEM-CELLS; PHOSPHORYLATION DYNAMICS; C-TRAP; PROTEOMICS; BRAIN; DIFFERENTIATION; IDENTIFICATION; NETWORKS; KINASES; CULTURE	Background: Glioblastoma is one of the most aggressive tumors with poor prognosis. Although various studies have been performed so far, there are not effective treatments for patients with glioblastoma. Methodology/Principal Findings: In order to systematically elucidate the aberrant signaling machinery activated in this malignant brain tumor, we investigated phosphoproteome dynamics of glioblastoma initiating cells using high-resolution nanoflow LC-MS/MS system in combination with SILAC technology. Through phosphopeptide enrichment by titanium dioxide beads, a total of 6,073 phosphopeptides from 2,282 phosphorylated proteins were identified based on the two peptide fragmentation methodologies of collision induced dissociation and higher-energy C-trap dissociation. The SILAC-based quantification described 516 up-regulated and 275 down-regulated phosphorylation sites upon epidermal growth factor stimulation, including the comprehensive status of the phosphorylation sites on stem cell markers such as nestin. Very intriguingly, our in-depth phosphoproteome analysis led to identification of novel phosphorylated molecules encoded by the undefined sequence regions of the human transcripts, one of which was regulated upon external stimulation in human glioblastoma initiating cells. Conclusions/Significance: Our result unveils an expanded diversity of the regulatory phosphoproteome defined by the human transcriptome.	[Kozuka-Hata, Hiroko; Ao-Kondo, Hiroko; Tsumoto, Kouhei; Oyama, Masaaki] Univ Tokyo, Inst Med Sci, Med Prote Lab, Minato Ku, Tokyo, Japan; [Nasu-Nishimura, Yukiko; Koyama-Nasu, Ryo; Akiyama, Tetsu] Univ Tokyo, Lab Mol & Genet Informat, Inst Mol & Cellular Biosci, Bunkyo Ku, Tokyo, Japan	University of Tokyo; University of Tokyo	Kozuka-Hata, H (corresponding author), Univ Tokyo, Inst Med Sci, Med Prote Lab, Minato Ku, Tokyo, Japan.	moyama@ims.u-tokyo.ac.jp		Oyama, Masaaki/0000-0001-6478-3735; Kozuka-Hata, Hiroko/0000-0002-9286-6594	Cell Innovation Program, Ministry of Education, Culture, Sports, Science and Technology of Japan	Cell Innovation Program, Ministry of Education, Culture, Sports, Science and Technology of Japan	This work was supported by Cell Innovation Program, Ministry of Education, Culture, Sports, Science and Technology of Japan. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aebersold R, 2003, NATURE, V422, P198, DOI 10.1038/nature01511; Aguirre A, 2010, NATURE, V467, P323, DOI 10.1038/nature09347; Bao SD, 2006, NATURE, V444, P756, DOI 10.1038/nature05236; Bianco P, 2001, NATURE, V414, P118, DOI 10.1038/35102181; Blume-Jensen P, 2001, NATURE, V411, P355, DOI 10.1038/35077225; Brill LM, 2009, CELL STEM CELL, V5, P204, DOI 10.1016/j.stem.2009.06.002; Cho RW, 2008, CURR OPIN GENET DEV, V18, P48, DOI 10.1016/j.gde.2008.01.017; Dai L, 2010, J PROTEOME RES, V9, P3394, DOI 10.1021/pr100231m; Dennis G, 2003, GENOME BIOL, V4, DOI 10.1186/gb-2003-4-9-r60; Diehn M, 2009, NATURE, V458, P780, DOI 10.1038/nature07733; Gangloff YG, 2004, MOL CELL BIOL, V24, P9508, DOI 10.1128/MCB.24.21.9508-9516.2004; Huang PH, 2007, P NATL ACAD SCI USA, V104, P12867, DOI 10.1073/pnas.0705158104; Huang Z, 2010, PROTEIN CELL, V1, P638, DOI 10.1007/s13238-010-0078-y; HUNTER T, 1995, CELL, V80, P225, DOI 10.1016/0092-8674(95)90405-0; Hunter T, 2000, CELL, V100, P113, DOI 10.1016/S0092-8674(00)81688-8; Lee J, 2006, CANCER CELL, V9, P391, DOI 10.1016/j.ccr.2006.03.030; Legler JM, 1999, JNCI-J NATL CANCER I, V91, P1382, DOI 10.1093/jnci/91.16.1382; Liu G., 2006, MOL CANC; Maher EA, 2001, GENE DEV, V15, P1311, DOI 10.1101/gad.891601; Mani SA, 2008, CELL, V133, P704, DOI 10.1016/j.cell.2008.03.027; Mann M, 2006, NAT REV MOL CELL BIO, V7, P952, DOI 10.1038/nrm2067; Murakami M, 2004, MOL CELL BIOL, V24, P6710, DOI 10.1128/mcb.24.15.6710-6718.2004; Nilsson CL, 2010, J PROTEOME RES, V9, P430, DOI 10.1021/pr9007927; Olsen JV, 2007, NAT METHODS, V4, P709, DOI 10.1038/NMETH1060; Olsen JV, 2006, CELL, V127, P635, DOI 10.1016/j.cell.2006.09.026; Olsen JV, 2005, MOL CELL PROTEOMICS, V4, P2010, DOI 10.1074/mcp.T500030-MCP200; Ong SE, 2002, MOL CELL PROTEOMICS, V1, P376, DOI 10.1074/mcp.M200025-MCP200; Pawson T, 2003, SCIENCE, V300, P445, DOI 10.1126/science.1083653; Peri S, 2003, GENOME RES, V13, P2363, DOI 10.1101/gr.1680803; Pollard SM, 2009, CELL STEM CELL, V4, P568, DOI 10.1016/j.stem.2009.03.014; Reya T, 2001, NATURE, V414, P105, DOI 10.1038/35102167; Rigbolt KTG, 2011, SCI SIGNAL, V4, DOI 10.1126/scisignal.2001570; Schlessinger J, 2000, CELL, V103, P211, DOI 10.1016/j.cell.2010.06.011; Singh SK, 2003, CANCER RES, V63, P5821; Singh SK, 2004, NATURE, V432, P396, DOI 10.1038/nature03128; Son MJ, 2009, CELL STEM CELL, V4, P440, DOI 10.1016/j.stem.2009.03.003; Van Hoof D, 2009, CELL STEM CELL, V5, P214, DOI 10.1016/j.stem.2009.05.021; Wang XJ, 2005, NEW ENGL J MED, V353, P1224, DOI 10.1056/NEJMoa051931; Xu N, 2009, CELL, V137, P647, DOI 10.1016/j.cell.2009.02.038; Zou JA, 2011, WORLD J GASTROENTERO, V17, P1276, DOI 10.3748/wjg.v17.i10.1276	40	27	27	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 17	2012	7	8							e43398	10.1371/journal.pone.0043398	http://dx.doi.org/10.1371/journal.pone.0043398			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	996DG	22912867	gold, Green Published, Green Submitted			2022-12-25	WOS:000308063700095
J	McDaniel, LD; Young, EC; Ritchie, KB; Paul, JH				McDaniel, Lauren D.; Young, Elizabeth C.; Ritchie, Kimberly B.; Paul, John H.			Environmental Factors Influencing Gene Transfer Agent (GTA) Mediated Transduction in the Subtropical Ocean	PLOS ONE			English	Article							MARINE-BACTERIA; POPULATIONS; BACTERIOPHAGES; ENUMERATION; EXPRESSION	Microbial genomic sequence analyses have indicated widespread horizontal gene transfer (HGT). However, an adequate mechanism accounting for the ubiquity of HGT has been lacking. Recently, high frequencies of interspecific gene transfer have been documented, catalyzed by Gene Transfer Agents (GTAs) of marine alpha-Proteobacteria. It has been proposed that the presence of bacterial genes in highly purified viral metagenomes may be due to GTAs. However, factors influencing GTA-mediated gene transfer in the environment have not yet been determined. Several genomically sequenced strains containing complete GTA sequences similar to Rhodobacter capsulatus (RcGTA, type strain) were screened to ascertain if they produced putative GTAs, and at what abundance. Five of nine marine strains screened to date spontaneously produced virus-like particles (VLP's) in stationary phase. Three of these strains have demonstrated gene transfer activity, two of which were documented by this lab. These two strains Roseovarius nubinhibens ISM and Nitratireductor 44B9s, were utilized to produce GTAs designated RnGTA and NrGTA and gene transfer activity was verified in culture. Cell-free preparations of purified RnGTA and NrGTA particles from marked donor strains were incubated with natural microbial assemblages to determine the level of GTA-mediated gene transfer. In conjunction, several ambient environmental parameters were measured including lysogeny indicated by prophage induction. GTA production in culture systems indicated that approximately half of the strains produced GTA-like particles and maximal GTA counts ranged from 10-30% of host abundance. Modeling of GTA-mediated gene transfer frequencies in natural samples, along with other measured environmental variables, indicated a strong relationship between GTA mediated gene transfer and the combined factors of salinity, multiplicity of infection (MOI) and ambient bacterial abundance. These results indicate that GTA-mediated HGT in the marine environment with the strains examined is favored during times of elevated bacterial and GTA abundance as well as in areas of higher salinity.	[McDaniel, Lauren D.; Young, Elizabeth C.; Paul, John H.] Univ S Florida, Coll Marine Sci, St Petersburg, FL 33701 USA; [Ritchie, Kimberly B.] Mote Marine Lab, Sarasota, FL 34236 USA	State University System of Florida; University of South Florida; Mote Marine Laboratory & Aquarium	McDaniel, LD (corresponding author), Univ S Florida, Coll Marine Sci, St Petersburg, FL 33701 USA.	mcdaniel@marine.usf.edu			U.S. National Science Foundation, Microbial Interactions and Processes (NSF-MIP) [EF 0801593]; State of Florida Mote "Protect Our Reefs" (POR) License Plate Grant [MML197-656]; Florida Institute of Oceanography	U.S. National Science Foundation, Microbial Interactions and Processes (NSF-MIP)(National Science Foundation (NSF)); State of Florida Mote "Protect Our Reefs" (POR) License Plate Grant; Florida Institute of Oceanography	Funding was provided by U.S. National Science Foundation, Microbial Interactions and Processes (NSF-MIP) grant, award number EF 0801593 to JHP and LM; a grant from the State of Florida Mote "Protect Our Reefs" (POR) License Plate Grant MML197-656to KBR and JHP; and a Florida Institute of Oceanography Shiptime award to JHP. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ANDERSON B, 1994, MOL MICROBIOL, V13, P67, DOI 10.1111/j.1365-2958.1994.tb00402.x; Bertani G, 1999, J BACTERIOL, V181, P2992, DOI 10.1128/JB.181.10.2992-3002.1999; Biers EJ, 2008, APPL ENVIRON MICROB, V74, P2933, DOI 10.1128/AEM.02129-07; Brussaard Corina P. D., 2009, V501, P97, DOI 10.1007/978-1-60327-164-6_11; Eiserling F, 1999, J GEN VIROL, V80, P3305, DOI 10.1099/0022-1317-80-12-3305; Fu YY, 2010, AQUAT MICROB ECOL, V59, P283, DOI 10.3354/ame01398; Huang S, 2011, VIROLOGY J, P8; Kristensen DM, 2010, TRENDS MICROBIOL, V18, P11, DOI 10.1016/j.tim.2009.11.003; Lan RT, 1996, MOL BIOL EVOL, V13, P47, DOI 10.1093/oxfordjournals.molbev.a025569; Lang AS, 2007, TRENDS MICROBIOL, V15, P54, DOI 10.1016/j.tim.2006.12.001; Lang AS, 2010, NUCLEIC ACIDS MOL BI, V25, P15, DOI 10.1007/978-3-642-12617-8_2; Lang AS, 2000, P NATL ACAD SCI USA, V97, P859, DOI 10.1073/pnas.97.2.859; Lang AS, 2002, J MOL EVOL, V55, P534, DOI 10.1007/s00239-002-2348-7; Long A, 2008, ISME J, V2, P132, DOI 10.1038/ismej.2007.102; MARRS B, 1974, P NATL ACAD SCI USA, V71, P971, DOI 10.1073/pnas.71.3.971; Matson EG, 2005, J BACTERIOL, V187, P5885, DOI 10.1128/JB.187.17.5885-5892.2005; MAZODIER P, 1985, NUCLEIC ACIDS RES, V13, P195, DOI 10.1093/nar/13.1.195; McDaniel L, 2012, PLOS ONE IN PRESS; McDaniel LD, 2010, SCIENCE, V330, P50, DOI 10.1126/science.1192243; Patel A, 2007, NAT PROTOC, V2, P269, DOI 10.1038/nprot.2007.6; Paul JH, 2008, ISME J, V2, P579, DOI 10.1038/ismej.2008.35; Paul John H., 1999, Journal of Molecular Microbiology and Biotechnology, V1, P45; RAPP BJ, 1987, P NATL ACAD SCI USA, V84, P9128, DOI 10.1073/pnas.84.24.9128; Ritchie K.B., 2011, BENEFICIAL MICROORGA, P139, DOI DOI 10.1007/978-3-642-21680-0_9; Sambrook J, 2001, MOL CLONING LAB MANU; Thomas CM, 2005, NAT REV MICROBIOL, V3, P711, DOI 10.1038/nrmicro1234; Vicente M, 2008, ENVIRON MICROBIOL, V10, P1663, DOI 10.1111/j.1462-2920.2008.01635.x; Williams HG, 1997, MOL MAR BIOL BIOTECH, V6, P238; Young EC, 2012, APPL ENV MICRO UNPUB; Zhao YL, 2010, APPL ENVIRON MICROB, V76, P589, DOI 10.1128/AEM.01450-09; Zhao YL, 2009, ISME J, V3, P364, DOI 10.1038/ismej.2008.115; Zobell CE, 1941, J MAR RES, V4, P42	32	15	15	1	30	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 15	2012	7	8							e43506	10.1371/journal.pone.0043506	http://dx.doi.org/10.1371/journal.pone.0043506			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	993AG	22905268	gold, Green Published, Green Submitted			2022-12-25	WOS:000307823600077
J	Jaillet, J; Genty, M; Cambefort, J; Rouault, JD; Auge-Gouillou, C				Jaillet, Jerome; Genty, Murielle; Cambefort, Jeanne; Rouault, Jacques-Deric; Auge-Gouillou, Corinne			Regulation of Mariner Transposition: The Peculiar Case of Mos1	PLOS ONE			English	Article							TRANSPOSABLE ELEMENT MARINER; RECENT HORIZONTAL TRANSFER; SYNAPTIC COMPLEX; GERM-LINE; IN-VITRO; DROSOPHILA; EVOLUTION; BINDING; ARCHITECTURE; CELLS	Background: Mariner elements represent the most successful family of autonomous DNA transposons, being present in various plant and animal genomes, including humans. The introduction and co-evolution of mariners within host genomes imply a strict regulation of the transposon activity. Biochemical data accumulated during the past decade have led to a convergent picture of the transposition cycle of mariner elements, suggesting that mariner transposition does not rely on host-specific factors. This model does not account for differences of transposition efficiency in human cells between mariners. We thus wondered whether apparent similarities in transposition cycle could hide differences in the intrinsic parameters that control mariner transposition. Principal Findings: We find that Mos1 transposase concentrations in excess to the Mos1 ends prevent the paired-end complex assembly. However, we observe that Mos1 transposition is not impaired by transposase high concentration, dismissing the idea that transposase over production plays an obligatory role in the down-regulation of mariner transposition. Our main finding is that the paired-end complex is formed in a cooperative way, regardless of the transposase concentration. We also show that an element framed by two identical ITRs (Inverted Terminal Repeats) is more efficient in driving transposition than an element framed by two different ITRs (i.e. the natural Mos1 copy), the latter being more sensitive to transposase concentration variations. Finally, we show that the current Mos1 ITRs correspond to the ancestral ones. Conclusions: We provide new insights on intrinsic properties supporting the self-regulation of the Mos1 element. These properties (transposase specific activity, aggregation, ITR sequences, transposase concentration/transposon copy number ratio.) could have played a role in the dynamics of host-genomes invasion by Mos1, accounting (at least in part) for the current low copy number of Mos1 within host genomes.	[Jaillet, Jerome; Genty, Murielle; Cambefort, Jeanne; Auge-Gouillou, Corinne] Univ Tours, EA 6306, Tours, France; [Rouault, Jacques-Deric] CNRS, Lab Evolut Genomes & Speciat, UPR9034, Gif Sur Yvette, France; [Rouault, Jacques-Deric] Univ Paris 11, Orsay, France	Universite de Tours; Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Universite Paris Saclay; UDICE-French Research Universities; Universite Paris Saclay	Jaillet, J (corresponding author), Univ Tours, EA 6306, Parc Grandmont, Tours, France.	auge@univ-tours.fr	GOUILLOU, Corinne AUGE/T-2346-2018	GOUILLOU, Corinne AUGE/0000-0002-3340-5560	Universite Francois Rabelais (Tours); Centre National de la Recherche Scientifique (CNRS); Ministere de l'Education Nationale, de la Recherche et de la Technologie; Agence Nationale de la recherche (ANR project Elegineer) [ANR 2010 BLAN 1618 02]	Universite Francois Rabelais (Tours); Centre National de la Recherche Scientifique (CNRS)(Centre National de la Recherche Scientifique (CNRS)); Ministere de l'Education Nationale, de la Recherche et de la Technologie; Agence Nationale de la recherche (ANR project Elegineer)(French National Research Agency (ANR))	This research was supported by grants from the Universite Francois Rabelais (Tours), the Centre National de la Recherche Scientifique (CNRS), the Ministere de l'Education Nationale, de la Recherche et de la Technologie and from the Agence Nationale de la recherche (ANR project Elegineer, # ANR 2010 BLAN 1618 02). This work was sustained by the GIS mariner of the french CNRS. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Auge-Gouillou C, 2005, J MOL BIOL, V351, P117, DOI 10.1016/j.jmb.2005.05.019; Auge-Gouillou C, 2005, MOL CELL BIOL, V25, P2861, DOI 10.1128/MCB.25.7.2861-2870.2005; Auge-Gouillou C, 2001, MOL GENET GENOMICS, V265, P51, DOI 10.1007/s004380000385; BEACHY PA, 1993, MOL CELL BIOL, V13, P6941, DOI 10.1128/MCB.13.11.6941; Bessereau JL, 2001, NATURE, V413, P70, DOI 10.1038/35092567; Bouuaert CC, 2011, MOL CELL BIOL, V31, P317, DOI 10.1128/MCB.01066-10; Bouuaert CC, 2010, NUCLEIC ACIDS RES, V38, P190, DOI 10.1093/nar/gkp891; Brunet F, 1999, J MOL EVOL, V49, P760, DOI 10.1007/PL00006598; Butler MG, 2006, GENETICA, V127, P351, DOI 10.1007/s10709-006-6250-x; Carpentier G, 2011, J MOL BIOL, V405, P892, DOI 10.1016/j.jmb.2010.11.032; Casteret S, 2009, MOL GENET GENOMICS, V282, P531, DOI 10.1007/s00438-009-0484-0; CRENES G, 2010, MOSL GENETICA, V138, P509, DOI DOI 10.1007/S10709-009-9387-6; Crenes G, 2009, MOL GENET GENOMICS, V281, P315, DOI 10.1007/s00438-008-0414-6; Crooks GE, 2004, GENOME RES, V14, P1188, DOI 10.1101/gr.849004; Dawson A, 2003, MOL CELL, V11, P225, DOI 10.1016/S1097-2765(02)00798-0; Fischer SEJ, 2001, P NATL ACAD SCI USA, V98, P6759, DOI 10.1073/pnas.121569298; Germon S, 2009, GENETICA, V137, P265, DOI 10.1007/s10709-009-9375-x; Gueiros FJ, 1997, SCIENCE, V276, P1716, DOI 10.1126/science.276.5319.1716; Hartl DL, 1997, TRENDS GENET, V13, P197, DOI 10.1016/S0168-9525(97)01087-1; Kazazian HH, 2004, SCIENCE, V303, P1626, DOI 10.1126/science.1089670; Lampe DJ, 2003, MOL BIOL EVOL, V20, P554, DOI 10.1093/molbev/msg069; Lampe DJ, 1998, GENETICS, V149, P179; Lipkow K, 2004, MOL CELL BIOL, V24, P8301, DOI 10.1128/MCB.24.18.8301-8311.2004; Liu N, 2004, INSECT MOL BIOL, V13, P443, DOI 10.1111/j.0962-1075.2004.00500.x; Lohe AR, 1996, MOL BIOL EVOL, V13, P549, DOI 10.1093/oxfordjournals.molbev.a025615; MARUYAMA K, 1991, J MOL EVOL, V33, P514, DOI 10.1007/BF02102804; MARUYAMA K, 1991, GENETICS, V128, P319; Ogura K, 2003, GENETICA, V119, P229, DOI 10.1023/B:GENE.0000003602.98863.67; Plasterk RHA, 1999, TRENDS GENET, V15, P326, DOI 10.1016/S0168-9525(99)01777-1; Richardson JM, 2009, CELL, V138, P1096, DOI 10.1016/j.cell.2009.07.012; ROBERTSON HM, 1995, MOL BIOL EVOL, V12, P850; Rouault JD, 2009, GENE, V448, P227, DOI 10.1016/j.gene.2009.08.009; Sinzelle L, 2008, BMC MOL BIOL, V9, DOI 10.1186/1471-2199-9-106; Tosi LRO, 2000, NUCLEIC ACIDS RES, V28, P784, DOI 10.1093/nar/28.3.784; Wang W, 2000, INSECT MOL BIOL, V9, P145, DOI 10.1046/j.1365-2583.2000.00172.x; Wu SCY, 2006, P NATL ACAD SCI USA, V103, P15008, DOI 10.1073/pnas.0606979103; Zhang L, 2001, NUCLEIC ACIDS RES, V29, P3566, DOI 10.1093/nar/29.17.3566	37	12	14	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 14	2012	7	8							e43365	10.1371/journal.pone.0043365	http://dx.doi.org/10.1371/journal.pone.0043365			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	988OQ	22905263	Green Published, gold, Green Submitted			2022-12-25	WOS:000307500800081
J	Rodriguez-Sanchez, AJ; Tsotsos, JK				Rodriguez-Sanchez, Antonio J.; Tsotsos, John K.			The Roles of Endstopped and Curvature Tuned Computations in a Hierarchical Representation of 2D Shape	PLOS ONE			English	Article							CAT STRIATE CORTEX; VISUAL-CORTEX; OBJECT RECOGNITION; RECEPTIVE-FIELDS; AREA V4; FUNCTIONAL ARCHITECTURE; INFEROTEMPORAL CORTEX; NEURAL MECHANISMS; MODEL; SELECTIVITY	That shape is important for perception has been known for almost a thousand years (thanks to Alhazen in 1083) and has been a subject of study ever since by scientists and phylosophers (such as Descartes, Helmholtz or the Gestalt psychologists). Shapes are important object descriptors. If there was any remote doubt regarding the importance of shape, recent experiments have shown that intermediate areas of primate visual cortex such as V2, V4 and TEO are involved in analyzing shape features such as corners and curvatures. The primate brain appears to perform a wide variety of complex tasks by means of simple operations. These operations are applied across several layers of neurons, representing increasingly complex, abstract intermediate processing stages. Recently, new models have attempted to emulate the human visual system. However, the role of intermediate representations in the visual cortex and their importance have not been adequately studied in computational modeling. This paper proposes a model of shape-selective neurons whose shape-selectivity is achieved through intermediate layers of visual representation not previously fully explored. We hypothesize that hypercomplex - also known as endstopped - neurons play a critical role to achieve shape selectivity and show how shape-selective neurons may be modeled by integrating endstopping and curvature computations. This model - a representational and computational system for the detection of 2-dimensional object silhouettes that we term 2DSIL - provides a highly accurate fit with neural data and replicates responses from neurons in area V4 with an average of 83% accuracy. We successfully test a biologically plausible hypothesis on how to connect early representations based on Gabor or Difference of Gaussian filters and later representations closer to object categories without the need of a learning phase as in most recent models.	[Rodriguez-Sanchez, Antonio J.] Univ Innsbruck, A-6020 Innsbruck, Austria; [Tsotsos, John K.] York Univ, Ctr Vis Res, Toronto, ON M3J 2R7, Canada; [Tsotsos, John K.] York Univ, Dept Comp Sci & Engn, Toronto, ON M3J 2R7, Canada	University of Innsbruck; York University - Canada; York University - Canada	Rodriguez-Sanchez, AJ (corresponding author), Univ Innsbruck, A-6020 Innsbruck, Austria.	Antonio.Rodriguez-Sanchez@uibk.ac.at	Tsotsos, John/N-1131-2019	Tsotsos, John/0000-0002-8621-9147	Natural Sciences and Engineering Research Council of Canada [4557-2009]; Teledyne Scientific Company, Durham, North Carolina [BOU546385]; Canada Research Chair in Computational Vision; York University from Teledyne; Teledyne Scientific Company, Durham, North Carolina	Natural Sciences and Engineering Research Council of Canada(Natural Sciences and Engineering Research Council of Canada (NSERC)CGIAR); Teledyne Scientific Company, Durham, North Carolina; Canada Research Chair in Computational Vision; York University from Teledyne; Teledyne Scientific Company, Durham, North Carolina	The authors are grateful for research support from the Natural Sciences and Engineering Research Council of Canada through a grant to JKT (4557-2009) and the Teledyne Scientific Company, Durham, North Carolina, through a contract to JKT (BOU546385). JKT holds the Canada Research Chair in Computational Vision which also supported this work. JKT is not an employee of Teledyne - he was PI on a contract to York University from Teledyne. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; The authors have the following competing interest to declare. This study was partly funded by the Teledyne Scientific Company, Durham, North Carolina. There are no patents, products in development or marketed products to declare. This does not alter the authors' adherence to all the PLoS ONE policies on sharing data and materials, as detailed online in the guide for authors.	Amit Y, 2003, VISION RES, V43, P2073, DOI 10.1016/S0042-6989(03)00306-7; Amit Y, 2000, NEURAL COMPUT, V12, P1141, DOI 10.1162/089976600300015538; BISHOP PO, 1980, J NEUROPHYSIOL, V43, P1266, DOI 10.1152/jn.1980.43.5.1266; BOUSSAOUD D, 1991, J COMP NEUROL, V306, P554, DOI 10.1002/cne.903060403; Brincat SL, 2004, NAT NEUROSCI, V7, P880, DOI 10.1038/nn1278; Cadieu C, 2007, J NEUROPHYSIOL, V98, P1733, DOI 10.1152/jn.01265.2006; Cajal S. R., 1888, REV TRIM HISTOL NORM, V1, P33; Craft E, 2007, J NEUROPHYSIOL, V97, P4310, DOI 10.1152/jn.00203.2007; DESIMONE R, 1995, ANNU REV NEUROSCI, V18, P193, DOI 10.1146/annurev.ne.18.030195.001205; DOBBINS A, 1989, VISION RES, V29, P1371, DOI 10.1016/0042-6989(89)90193-4; DOBBINS A, 1987, NATURE, V329, P438, DOI 10.1038/329438a0; Dobbins A, 1992, THESIS MCGILL U; FUKUSHIMA K, 1980, BIOL CYBERN, V36, P193, DOI 10.1007/BF00344251; Fukushima K, 1983, IEEE T SYSTEMS MAN C, P13; GALLANT JL, 1993, SCIENCE, V259, P100, DOI 10.1126/science.8418487; Geman S, 2006, J PHYSIOL-PARIS, V100, P212, DOI 10.1016/j.jphysparis.2007.01.001; GROSSBERG S, 1971, P NATL ACAD SCI USA, V68, P828, DOI 10.1073/pnas.68.4.828; Grossberg S, 1975, Int Rev Neurobiol, V18, P263, DOI 10.1016/S0074-7742(08)60037-9; GROSSBERG S, 1970, J THEOR BIOL, V27, P291, DOI 10.1016/0022-5193(70)90143-8; GROSSBERG S, 1968, P NATL ACAD SCI USA, V59, P368, DOI 10.1073/pnas.59.2.368; HAWKEN MJ, 1987, PROC R SOC SER B-BIO, V231, P251, DOI 10.1098/rspb.1987.0044; Hegde J, 2000, J NEUROSCI, V20, part. no.; Heitger F., 1993, [1993] Proceedings Fourth International Conference on Computer Vision, P32, DOI 10.1109/ICCV.1993.378238; Heitger F, 1998, IMAGE VISION COMPUT, V16, P407, DOI 10.1016/S0262-8856(97)00083-8; HEITGER F, 1992, VISION RES, V32, P963, DOI 10.1016/0042-6989(92)90039-L; HUBEL DH, 1968, J PHYSIOL-LONDON, V195, P215, DOI 10.1113/jphysiol.1968.sp008455; HUBEL DH, 1962, J PHYSIOL-LONDON, V160, P106, DOI 10.1113/jphysiol.1962.sp006837; HUBEL DH, 1959, J PHYSIOL-LONDON, V148, P574, DOI 10.1113/jphysiol.1959.sp006308; Ito M, 2004, J NEUROSCI, V24, P3313, DOI 10.1523/JNEUROSCI.4364-03.2004; Jones EG, 2007, BRAIN RES REV, V55, P248, DOI 10.1016/j.brainresrev.2007.06.001; KATO H, 1978, J NEUROPHYSIOL, V41, P1071, DOI 10.1152/jn.1978.41.5.1071; LeCun Y, 1989, NEURAL COMPUT, V1, P541, DOI 10.1162/neco.1989.1.4.541; Lecun Y, 1998, P IEEE, V86, P2278, DOI 10.1109/5.726791; MARCELJA S, 1980, J OPT SOC AM, V70, P1297, DOI 10.1364/JOSA.70.001297; MARR D, 1980, PROC R SOC SER B-BIO, V207, P187, DOI 10.1098/rspb.1980.0020; Marr D., 1982, VISION COMPUTATIONAL; Martinez-Trujillo JC, 2005, NEUROREPORT, V16, P435, DOI 10.1097/00001756-200504040-00004; Meese TS, 2002, VISION RES, V42, P1073, DOI 10.1016/S0042-6989(02)00058-5; ORBAN GA, 1979, J NEUROPHYSIOL, V42, P818, DOI 10.1152/jn.1979.42.3.818; ORBAN GA, 1979, J NEUROPHYSIOL, V42, P833, DOI 10.1152/jn.1979.42.3.833; Pasupathy A, 1999, J NEUROPHYSIOL, V82, P2490, DOI 10.1152/jn.1999.82.5.2490; Pasupathy A, 2001, J NEUROPHYSIOL, V86, P2505, DOI 10.1152/jn.2001.86.5.2505; Pasupathy A, 2002, NAT NEUROSCI, V5, P1332, DOI 10.1038/nn972; Ramon y Cajal S., 1904, TRAB LAB INVEST BIOL, V3, P9; Ramon y Cajal S, 1894, P R SOC LOND, V55, P444, DOI DOI 10.1098/RSPL.1894.0063; Rao RPN, 1999, NAT NEUROSCI, V2, P79, DOI 10.1038/4580; Rao RPN, 1997, NEURAL COMPUT, V9, P721, DOI 10.1162/neco.1997.9.4.721; Riesenhuber M, 2002, CURR OPIN NEUROBIOL, V12, P162, DOI 10.1016/S0959-4388(02)00304-5; Riesenhuber M, 1999, NAT NEUROSCI, V2, P1019, DOI 10.1038/14819; Riesenhuber M, 2000, NAT NEUROSCI, V3, P1199, DOI 10.1038/81479; Rodriguez-Sanchez A. J., 2011, 2011 IEEE Conference on Computer Vision and Pattern Recognition (CVPR), P4321, DOI 10.1109/CVPR.2011.5995671; Rodriguez-Sanchez AJ, 2007, INT J NEURAL SYST, V17, P275, DOI 10.1142/S0129065707001135; Rumelhart D., 1986, PARALLEL DISTRIBUTED; Serre T, 2005, PROC CVPR IEEE, P994; Serre T, 2007, IEEE T PATTERN ANAL, V29, P411, DOI 10.1109/TPAMI.2007.56; SPITZER H, 1985, J NEUROPHYSIOL, V53, P1266, DOI 10.1152/jn.1985.53.5.1266; Suzuki N, 2004, BIOSYSTEMS, V76, P33, DOI 10.1016/j.biosystems.2004.05.004; Tanaka K, 1996, ANNU REV NEUROSCI, V19, P109, DOI 10.1146/annurev.ne.19.030196.000545; Treue S, 1996, VISUAL NEUROSCI, V13, P797, DOI 10.1017/S095252380000866X; Tsotsos J. K., 2011, COMPUTATIONAL PERSPE, DOI DOI 10.7551/MITPRESS/9780262015417.001.0001; TSOTSOS JK, 1995, ARTIF INTELL, V78, P507, DOI 10.1016/0004-3702(95)00025-9; Tsotsos JK, 2005, COMPUT VIS IMAGE UND, V100, P3, DOI 10.1016/j.cviu.2004.10.011; VONDERHEYDT R, 1984, SCIENCE, V224, P1260, DOI 10.1126/science.6539501; Wallis G, 1997, PROG NEUROBIOL, V51, P167, DOI 10.1016/S0301-0082(96)00054-8; Willmore BDB, 2010, J NEUROSCI, V30, P2102, DOI 10.1523/JNEUROSCI.4099-09.2010; Zhou H, 2000, J NEUROSCI, V20, P6594, DOI 10.1523/JNEUROSCI.20-17-06594.2000; Zucker S., 1981, P 7 INT C ART INT AU, P1102	67	40	41	1	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 9	2012	7	8							e42058	10.1371/journal.pone.0042058	http://dx.doi.org/10.1371/journal.pone.0042058			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	986WZ	22912683	Green Submitted, Green Published, gold			2022-12-25	WOS:000307378500010
J	Toxopeus, CM; Maurits, NM; Valsan, G; Conway, BA; Leenders, KL; de Jong, BM				Toxopeus, Carolien M.; Maurits, Natasha M.; Valsan, Gopal; Conway, Bernard A.; Leenders, Klaus L.; de Jong, Bauke M.			Cerebral Activations Related to Ballistic, Stepwise Interrupted and Gradually Modulated Movements in Parkinson Patients	PLOS ONE			English	Article							BASAL GANGLIA CIRCUITS; MOTOR CONTROL; FUNCTIONAL-ANATOMY; RHESUS-MONKEY; ARM MOVEMENTS; DISEASE; INHIBITION; CEREBELLUM; BRAIN; CUES	Patients with Parkinson's disease (PD) experience impaired initiation and inhibition of movements such as difficulty to start/stop walking. At single-joint level this is accompanied by reduced inhibition of antagonist muscle activity. While normal basal ganglia (BG) contributions to motor control include selecting appropriate muscles by inhibiting others, it is unclear how PD-related changes in BG function cause impaired movement initiation and inhibition at single-joint level. To further elucidate these changes we studied 4 right-hand movement tasks with fMRI, by dissociating activations related to abrupt movement initiation, inhibition and gradual movement modulation. Initiation and inhibition were inferred from ballistic and stepwise interrupted movement, respectively, while smooth wrist circumduction enabled the assessment of gradually modulated movement. Task-related activations were compared between PD patients (N = 12) and healthy subjects (N = 18). In healthy subjects, movement initiation was characterized by antero-ventral striatum, substantia nigra (SN) and premotor activations while inhibition was dominated by subthalamic nucleus (STN) and pallidal activations, in line with the known role of these areas in simple movement. Gradual movement mainly involved antero-dorsal putamen and pallidum. Compared to healthy subjects, patients showed reduced striatal/SN and increased pallidal activation for initiation, whereas for inhibition STN activation was reduced and striatal-thalamo-cortical activation increased. For gradual movement patients showed reduced pallidal and increased thalamo-cortical activation. We conclude that PD-related changes during movement initiation fit the (rather static) model of alterations in direct and indirect BG pathways. Reduced STN activation and regional cortical increased activation in PD during inhibition and gradual movement modulation are better explained by a dynamic model that also takes into account enhanced responsiveness to external stimuli in this disease and the effects of hyper-fluctuating cortical inputs to the striatum and STN in particular.	[Toxopeus, Carolien M.; Maurits, Natasha M.; Leenders, Klaus L.; de Jong, Bauke M.] Univ Groningen, Univ Med Ctr Groningen, Dept Neurol, Groningen, Netherlands; [Valsan, Gopal; Conway, Bernard A.] Univ Strathclyde, Bioengn Unit, Glasgow, Lanark, Scotland	University of Groningen; University of Strathclyde	Toxopeus, CM (corresponding author), Univ Groningen, Univ Med Ctr Groningen, Dept Neurol, Groningen, Netherlands.	c.m.toxopeus@umcg.nl	Conway, Bernard/A-9625-2016	Conway, Bernard/0000-0002-0069-0131; Maurits, Natasha/0000-0001-6231-7044; de Jong, Bauke M./0000-0002-6568-5739	International Parkinson Foundation	International Parkinson Foundation	This study was sponsored with a grant from the International Parkinson Foundation, grant title: "Initiation and Inhibition of Movement in patients with Parkinson's disease: New Insights Using a Direct Coupling Between Movement, Muscle and Brain Activity". The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALBIN RL, 1989, TRENDS NEUROSCI, V12, P366, DOI 10.1016/0166-2236(89)90074-X; ALEXANDER GE, 1990, PROG BRAIN RES, V85, P119; ALEXANDER GE, 1990, TRENDS NEUROSCI, V13, P266, DOI 10.1016/0166-2236(90)90107-L; Amick MM, 2006, NEUROPSYCHOLOGIA, V44, P339, DOI 10.1016/j.neuropsychologia.2005.06.002; ANNETT M, 1970, BRIT J PSYCHOL, V61, P303, DOI 10.1111/j.2044-8295.1970.tb01248.x; Aron AR, 2006, J NEUROSCI, V26, P2424, DOI 10.1523/JNEUROSCI.4682-05.2006; BENECKE R, 1987, J NEUROL NEUROSUR PS, V50, P296, DOI 10.1136/jnnp.50.3.296; Berardelli A, 1996, BRAIN, V119, P661, DOI 10.1093/brain/119.2.661; BERARDELLI A, 1986, J NEUROL NEUROSUR PS, V49, P1273, DOI 10.1136/jnnp.49.11.1273; Berardelli A, 2001, BRAIN, V124, P2131, DOI 10.1093/brain/124.11.2131; Beudel M, 2008, NEUROREPORT, V19, P1055, DOI 10.1097/WNR.0b013e328303b7b9; Boecker H, 2008, NEUROIMAGE, V39, P1356, DOI 10.1016/j.neuroimage.2007.09.069; Bostan AC, 2010, NEUROPSYCHOL REV, V20, P261, DOI 10.1007/s11065-010-9143-9; Castiello U, 2009, NEUROPSYCHOLOGIA, V47, P835, DOI 10.1016/j.neuropsychologia.2008.12.016; Cerminara NL, 2005, PROG BRAIN RES, V148, P213, DOI 10.1016/S0079-6123(04)48018-2; Coxon JP, 2009, J COGNITIVE NEUROSCI, V21, P1193, DOI 10.1162/jocn.2009.21081; Crossman AR, 2000, J ANAT, V196, P519, DOI 10.1046/j.1469-7580.2000.19640519.x; de Jong BM, 2007, BRAIN RES, V1132, P139, DOI 10.1016/j.brainres.2006.11.017; de Jong BM, 1999, COGNITIVE BRAIN RES, V8, P45, DOI 10.1016/S0926-6410(99)00005-1; DeLong M, 2009, PARKINSONISM RELAT D, V15, pS237, DOI 10.1016/S1353-8020(09)70822-3; DeLong MR, 2007, ARCH NEUROL-CHICAGO, V64, P20, DOI 10.1001/archneur.64.1.20; DELONG MR, 1990, TRENDS NEUROSCI, V13, P281, DOI 10.1016/0166-2236(90)90110-V; den Ouden HEM, 2010, J NEUROSCI, V30, P3210, DOI 10.1523/JNEUROSCI.4458-09.2010; Donovan S, 2011, PARKINSONISM RELAT D, V17, P240, DOI 10.1016/j.parkreldis.2010.08.010; Dounskaia N, 2005, EXP BRAIN RES, V164, P311, DOI 10.1007/s00221-005-2251-8; Draganski B, 2008, J NEUROSCI, V28, P7143, DOI 10.1523/JNEUROSCI.1486-08.2008; EBERSBACH G, 1994, NEUROPSYCHOLOGIA, V32, P799, DOI 10.1016/0028-3932(94)90018-3; EIDELBERG D, 1994, J CEREBR BLOOD F MET, V14, P783, DOI 10.1038/jcbfm.1994.99; Fahn S., 1987, RECENT DEV PARKINSON, V2, P153; Frank MJ, 2007, SCIENCE, V318, P1309, DOI 10.1126/science.1146157; FREEMAN JS, 1993, J NEUROL NEUROSUR PS, V56, P1078, DOI 10.1136/jnnp.56.10.1078; FRISTON KJ, 1991, J CEREBR BLOOD F MET, V11, P690, DOI 10.1038/jcbfm.1991.122; Gauggel S, 2004, J NEUROL NEUROSUR PS, V75, P539; Giladi N, 2001, ADV NEUROL, V87, P191; Gowen E, 2007, NEUROIMAGE, V36, P396, DOI 10.1016/j.neuroimage.2007.03.005; Grillner S, 2005, TRENDS NEUROSCI, V28, P364, DOI 10.1016/j.tins.2005.05.004; Groenewegen Henk J., 2003, Neural Plasticity, V10, P107, DOI 10.1155/NP.2003.107; Hauber W, 1998, PROG NEUROBIOL, V56, P507, DOI 10.1016/S0301-0082(98)00041-0; Hirano S, 2009, MOVEMENT DISORD, V24, pS725, DOI 10.1002/mds.22541; HOEHN MM, 1967, NEUROLOGY, V17, P427, DOI 10.1212/WNL.17.5.427; Hoffman DS, 1999, J NEUROPHYSIOL, V81, P319, DOI 10.1152/jn.1999.81.1.319; HORE J, 1980, EXP BRAIN RES, V39, P217; JAHANSHAHI M, 1995, BRAIN, V118, P913, DOI 10.1093/brain/118.4.913; Jahanshahi M, 2006, J NEUROSCI, V26, P12266, DOI 10.1523/JNEUROSCI.2540-06.2006; Jahfari S, 2011, J NEUROSCI, V31, P6891, DOI 10.1523/JNEUROSCI.5253-10.2011; Jiang Y, 2006, CLIN REHABIL, V20, P36, DOI 10.1191/0269215506cr925oa; Josephs KA, 2006, ARCH NEUROL-CHICAGO, V63, P354, DOI 10.1001/archneur.63.3.354; Joti P, 2007, EXP BRAIN RES, V177, P447, DOI 10.1007/s00221-006-0687-0; Jueptner M, 1998, BRAIN, V121, P1437, DOI 10.1093/brain/121.8.1437; KALASKA JF, 1992, SCIENCE, V255, P1517, DOI 10.1126/science.1549781; Kaneda K, 2002, J NEUROPHYSIOL, V88, P1420, DOI 10.1152/jn.2002.88.3.1420; KEMP JM, 1970, BRAIN, V93, P525, DOI 10.1093/brain/93.3.525; Knill DC, 2005, J VISION, V5, P103, DOI 10.1167/5.2.2; Kreitzer AC, 2008, NEURON, V60, P543, DOI 10.1016/j.neuron.2008.11.005; Kropotov JD, 1999, INT J PSYCHOPHYSIOL, V31, P197, DOI 10.1016/S0167-8760(98)00051-8; Leh SE, 2007, NEUROSCI LETT, V419, P113, DOI 10.1016/j.neulet.2007.04.049; Lehericy S, 2006, CEREB CORTEX, V16, P149, DOI 10.1093/cercor/bhi089; Lemon RN, 2008, ANNU REV NEUROSCI, V31, P195, DOI 10.1146/annurev.neuro.31.060407.125547; Lewis GN, 2000, BRAIN, V123, P2077, DOI 10.1093/brain/123.10.2077; Luzzi S, 2011, J NEUROL NEUROSURG P; Ma YL, 2007, J CEREBR BLOOD F MET, V27, P597, DOI 10.1038/sj.jcbfm.9600358; MARSDEN CD, 1994, J NEUROL NEUROSUR PS, V57, P672, DOI 10.1136/jnnp.57.6.672; Matell MS, 2000, BIOESSAYS, V22, P94, DOI 10.1002/(SICI)1521-1878(200001)22:1<94::AID-BIES14>3.0.CO;2-E; Meunier S, 2000, BRAIN, V123, P1017, DOI 10.1093/brain/123.5.1017; Miall RC, 2001, NAT NEUROSCI, V4, P638, DOI 10.1038/88465; Middleton FA, 2000, BRAIN RES REV, V31, P236, DOI 10.1016/S0165-0173(99)00040-5; Mink J W, 1993, Curr Opin Neurobiol, V3, P950, DOI 10.1016/0959-4388(93)90167-W; MINK JW, 1991, J NEUROPHYSIOL, V65, P330, DOI 10.1152/jn.1991.65.2.330; Mink JW, 1996, PROG NEUROBIOL, V50, P381, DOI 10.1016/S0301-0082(96)00042-1; Mink JW, 2003, ARCH NEUROL-CHICAGO, V60, P1365, DOI 10.1001/archneur.60.10.1365; Nambu A, 2005, J NEUROL, V252, P1, DOI 10.1007/s00415-005-4002-y; Nambu A, 2002, NEUROSCI RES, V43, P111, DOI 10.1016/S0168-0102(02)00027-5; Obeso JA, 2008, ANN NEUROL, V64, pS30, DOI 10.1002/ana.21481; Ohyama T, 2003, TRENDS NEUROSCI, V26, P222, DOI 10.1016/S0166-2236(03)00054-7; PLAYFORD ED, 1992, ANN NEUROL, V32, P151, DOI 10.1002/ana.410320206; Praamstra P, 1998, BRAIN, V121, P167, DOI 10.1093/brain/121.1.167; Raptis H, 2010, J PHYSIOL-LONDON, V588, P1551, DOI 10.1113/jphysiol.2009.186858; Rascol O, 1997, BRAIN, V120, P103, DOI 10.1093/brain/120.1.103; Redgrave P, 2010, NAT REV NEUROSCI, V11, P760, DOI 10.1038/nrn2915; ROMO R, 1992, EXP BRAIN RES, V91, P396, DOI 10.1007/BF00227836; Rorden C, 2007, J COGNITIVE NEUROSCI, V19, P1081, DOI 10.1162/jocn.2007.19.7.1081; ROTHWELL JC, 2003, HAND CLIN N, V1, P417; Rubchinsky LL, 2003, P NATL ACAD SCI USA, V100, P14427, DOI 10.1073/pnas.2036283100; Sabatini U, 2000, BRAIN, V123, P394, DOI 10.1093/brain/123.2.394; Samuel M, 1997, BRAIN, V120, P963, DOI 10.1093/brain/120.6.963; Schieber MH, 2004, J APPL PHYSIOL, V96, P2293, DOI 10.1152/japplphysiol.01063.2003; SELEMON LD, 1988, J NEUROSCI, V8, P4049; Shires J, 2010, CURR OPIN NEUROBIOL, V20, P717, DOI 10.1016/j.conb.2010.08.008; Sporns O, 2011, ANN NY ACAD SCI, V1224, P109, DOI 10.1111/j.1749-6632.2010.05888.x; Teune LK, 2010, MOVEMENT DISORD, V25, P2395, DOI 10.1002/mds.23291; Toxopeus CM, 2007, NEUROREPORT, V18, P1557, DOI 10.1097/WNR.0b013e3282efa0a2; Toxopeus CM, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024572; Turner RS, 1997, J NEUROPHYSIOL, V77, P1051, DOI 10.1152/jn.1997.77.3.1051; WISE SP, 1988, SCIENCE, V242, P736, DOI 10.1126/science.3187520; Worsley KJ, 1996, HUM BRAIN MAPP, V4, P58, DOI 10.1002/(SICI)1097-0193(1996)4:1<58::AID-HBM4>3.0.CO;2-O; YETERIAN EH, 1995, J COMP NEUROL, V352, P436, DOI 10.1002/cne.903520309; YETERIAN EH, 1978, BRAIN RES, V139, P43, DOI 10.1016/0006-8993(78)90059-8; Yu H, 2007, NEUROIMAGE, V35, P222, DOI 10.1016/j.neuroimage.2006.11.047; Zatsiorsky VM, 2008, J MOTOR BEHAV, V40, P446, DOI 10.3200/JMBR.40.5.446-476	99	7	8	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 23	2012	7	7							e41042	10.1371/journal.pone.0041042	http://dx.doi.org/10.1371/journal.pone.0041042			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	977TM	22911738	Green Accepted, Green Published, Green Submitted, gold			2022-12-25	WOS:000306687700036
J	Geiss-Liebisch, S; Rooijakkers, SHM; Beczala, A; Sanchez-Carballo, P; Kruszynska, K; Repp, C; Sakinc, T; Vinogradov, E; Holst, O; Huebner, J; Theilacker, C				Geiss-Liebisch, Stefan; Rooijakkers, Suzan H. M.; Beczala, Agnieszka; Sanchez-Carballo, Patricia; Kruszynska, Karolina; Repp, Christian; Sakinc, Tuerkan; Vinogradov, Evgeny; Holst, Otto; Huebner, Johannes; Theilacker, Christian			Secondary Cell Wall Polymers of Enterococcus faecalis Are Critical for Resistance to Complement Activation via Mannose-binding Lectin	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							GROUP-D STREPTOCOCCI; PATTERN-RECOGNITION MOLECULE; STAPHYLOCOCCUS-AUREUS; VANCOMYCIN-RESISTANT; LIPOTEICHOIC ACID; TEICHOIC-ACIDS; GENE-CLUSTER; RISK-FACTORS; L-FICOLIN; INFECTION	The complement system is part of our first line of defense against invading pathogens. The strategies used by Enterococcus faecalis to evade recognition by human complement are incompletely understood. In this study, we identified an insertional mutant of the wall teichoic acid (WTA) synthesis gene tagB in E. faecalis V583 that exhibited an increased susceptibility to complement-mediated killing by neutrophils. Further analysis revealed that increased killing of the mutant was due to a higher rate of phagocytosis by neutrophils, which correlated with higher C3b deposition on the bacterial surface. Our studies indicated that complement activation via the lectin pathway was much stronger on the tagB mutant compared with wild type. In concordance, we found an increased binding of the key lectin pathway components mannose-binding lectin and mannose-binding lectin-associated serine protease-2 (MASP-2) on the mutant. To understand the mechanism of lectin pathway inhibition by E. faecalis, we purified and characterized cell wall carbohydrates of E. faecalis wild type and V583 Delta tagB. NMR analysis revealed that the mutant strain lacked two WTAs with a repeating unit of -> 6)[alpha-L-Rhap-(1 -> 3)]beta-D-GalpNAc-(1 -> 5)-Rbo-1-P and -> 6) beta-D-Glcp-(1 -> 3) [alpha-D-Glcp-(1 -> 4)]-beta-D-Gal-pNAc-(1 -> 5)-Rbo-1-P ->, respectively (Rbo, ribitol). In addition, compositional changes in the enterococcal rhamnopolysaccharide were noticed. Our study indicates that in E. faecalis, modification of peptidoglycan by secondary cell wall polymers is critical to evade recognition by the complement system.	[Geiss-Liebisch, Stefan; Theilacker, Christian] Univ Med Ctr Freiburg, Ctr Chron Immunodeficiency, D-79106 Freiburg, Germany; [Rooijakkers, Suzan H. M.] Univ Med Ctr Utrecht G04 614, Dept Med Microbiol, NL-3584 CX Utrecht, Netherlands; [Beczala, Agnieszka; Sanchez-Carballo, Patricia; Holst, Otto] Leibniz Ctr Med & Biosci, Res Ctr Borstel, Div Struct Biochem, D-23845 Borstel, Germany; [Kruszynska, Karolina; Repp, Christian; Sakinc, Tuerkan; Huebner, Johannes; Theilacker, Christian] Univ Med Ctr Freiburg, Ctr Infect Dis & Travel Med, D-79106 Freiburg, Germany; [Vinogradov, Evgeny] Natl Res Council Canada, Inst Biol Sci, Ottawa, ON K1A 0R6, Canada; [Huebner, Johannes] Univ Munich, Dr von Hauner Childrens Hosp, Div Pediat Infect Dis, D-80337 Munich, Germany	University of Freiburg; Forschungszentrum Borstel; University of Freiburg; National Research Council Canada; University of Munich	Huebner, J (corresponding author), Univ Munich, Dr von Hauner Childrens Hosp, Div Pediat Infect Dis, Lindwurmstr 4, D-80337 Munich, Germany.	johannes.huebner@med.uni-muenchen.de		Theilacker, Christian/0000-0003-0821-9202; Huebner, Johannes/0000-0003-1232-4646; Sanchez Carballo, Patricia M./0000-0003-1061-7023; Vinogradov, Evgeny/0000-0002-5364-1376	German Federal Ministry of Education and Research [BMBF 01 EO 0803]; ERA-Net PathoGenoMics; Netherlands Organization of Scientific Research	German Federal Ministry of Education and Research(Federal Ministry of Education & Research (BMBF)); ERA-Net PathoGenoMics; Netherlands Organization of Scientific Research(Netherlands Organization for Scientific Research (NWO))	This work was supported by the German Federal Ministry of Education and Research (BMBF 01 EO 0803). This work was also supported by the German grant (0313933) from the 1st call of the ERA-Net PathoGenoMics, a European program for cooperation and coordination of genome sequencing and functional genomics of human-pathogenic microorganisms.; Supported by a Vidi grant from the Netherlands Organization of Scientific Research.	ARDUINO RC, 1994, INFECT IMMUN, V62, P5587, DOI 10.1128/IAI.62.12.5587-5594.1994; BLEIWEIS AS, 1967, J BACTERIOL, V94, P1381, DOI 10.1128/JB.94.5.1381-1387.1967; Bychowska A, 2011, CARBOHYD RES, V346, P2816, DOI 10.1016/j.carres.2011.09.026; CIUCANU I, 1984, CARBOHYD RES, V131, P209, DOI 10.1016/0008-6215(84)85242-8; DiazGranados CA, 2005, J INFECT DIS, V191, P588, DOI 10.1086/427512; ELLIOTT SD, 1959, NATURE, V184, P1342, DOI 10.1038/1841342a0; ELLIOTT SD, 1960, J EXP MED, V111, P621, DOI 10.1084/jem.111.5.621; Garred P, 2010, J INNATE IMMUN, V2, P3, DOI 10.1159/000242419; Ghanem G, 2007, INFECT CONT HOSP EP, V28, P1054, DOI 10.1086/519932; Gjelstrup LC, 2012, J IMMUNOL, V188, P1292, DOI 10.4049/jimmunol.1103012; Gros P, 2008, NAT REV IMMUNOL, V8, P48, DOI 10.1038/nri2231; Hancock LE, 2002, P NATL ACAD SCI USA, V99, P1574, DOI 10.1073/pnas.032448299; Haseley SR, 1997, EUR J BIOCHEM, V244, P761, DOI 10.1111/j.1432-1033.1997.00761.x; Hummelshoj T, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0038196; Ip WKE, 2009, IMMUNOL REV, V230, P9, DOI 10.1111/j.1600-065X.2009.00789.x; Kemper C, 2010, ANNU REV IMMUNOL, V28, P131, DOI 10.1146/annurev-immunol-030409-101250; Krarup A, 2004, J BIOL CHEM, V279, P47513, DOI 10.1074/jbc.M407161200; Lecours MP, 2011, J INFECT DIS, V204, P919, DOI 10.1093/infdis/jir415; Leendertse M, 2010, J INFECT DIS, V201, P544, DOI 10.1086/650341; Ma YG, 2004, J BIOL CHEM, V279, P25307, DOI 10.1074/jbc.M400701200; Mohamed JA, 2004, INFECT IMMUN, V72, P3658, DOI 10.1128/IAI.72.6.3658-3663.2004; Mullighan CG, 2008, BLOOD, V112, P2120, DOI 10.1182/blood-2007-07-100222; Nadesalingam J, 2005, J IMMUNOL, V175, P1785, DOI 10.4049/jimmunol.175.3.1785; Neuhaus FC, 2003, MICROBIOL MOL BIOL R, V67, P686, DOI 10.1128/MMBR.67.4.686-723.2003; Park KH, 2010, J BIOL CHEM, V285, P27167, DOI 10.1074/jbc.M110.141309; Park Soornin, 2008, V427, P3, DOI 10.1007/978-1-59745-273-1_1; Peel T, 2012, CLIN MICROBIOL INFEC, V18, P388, DOI 10.1111/j.1469-0691.2011.03591.x; Polotsky VY, 1996, INFECT IMMUN, V64, P380, DOI 10.1128/IAI.64.1.380-383.1996; Ricklin D, 2010, NAT IMMUNOL, V11, P785, DOI 10.1038/ni.1923; Rigottier-Gois L, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0029023; Rooijakkers SHM, 2005, NAT IMMUNOL, V6, P920, DOI 10.1038/ni1235; Schlapbach LJ, 2010, CLIN INFECT DIS, V51, P153, DOI 10.1086/653531; Serruto D, 2010, NAT REV MICROBIOL, V8, P393, DOI 10.1038/nrmicro2366; Silhavy TJ, 2010, CSH PERSPECT BIOL, V2, DOI 10.1101/cshperspect.a000414; Swoboda JG, 2010, CHEMBIOCHEM, V11, P35, DOI 10.1002/cbic.200900557; Teng F, 2002, INFECT IMMUN, V70, P2010, DOI 10.1128/IAI.70.4.2010-2015.2002; Teng F, 2009, INFECT IMMUN, V77, P3759, DOI 10.1128/IAI.00149-09; Theilacker C, 2009, INFECTION, V37, P540, DOI 10.1007/s15010-009-9023-5; Theilacker C, 2006, INFECT IMMUN, V74, P5703, DOI 10.1128/IAI.00570-06; Theilacker C, 2012, J INFECT DIS, V205, P1076, DOI 10.1093/infdis/jis022; Theilacker C, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017839; Thurlow LR, 2009, INFECT IMMUN, V77, P5551, DOI 10.1128/IAI.00576-09; Vekemans M, 2007, CLIN INFECT DIS, V44, P1593, DOI 10.1086/518171; Vincent JL, 2009, JAMA-J AM MED ASSOC, V302, P2323, DOI 10.1001/jama.2009.1754; Vollmer W, 2008, FEMS MICROBIOL REV, V32, P287, DOI 10.1111/j.1574-6976.2007.00088.x; Weidenmaier C, 2008, NAT REV MICROBIOL, V6, P276, DOI 10.1038/nrmicro1861; Worthley DL, 2009, CLIN INFECT DIS, V48, P410, DOI 10.1086/596313; Xu Y, 2000, INFECT IMMUN, V68, P815, DOI 10.1128/IAI.68.2.815-823.2000; Zeng J, 2004, J CLIN MICROBIOL, V42, P1149, DOI 10.1128/JCM.42.3.1149-1154.2004	49	28	29	0	16	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 2	2012	287	45								10.1074/jbc.M112.358283	http://dx.doi.org/10.1074/jbc.M112.358283			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	031LP	22908219	Green Published, hybrid			2022-12-25	WOS:000310642200016
J	Chaurasia, P; Sen, R; Pandita, TK; Bhaumik, SR				Chaurasia, Priyasri; Sen, Rwik; Pandita, Tej K.; Bhaumik, Sukesh R.			Preferential Repair of DNA Double-strand Break at the Active Gene in Vivo	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							RNA-POLYMERASE-II; TRANSCRIPTION-COUPLED REPAIR; BASE EXCISION-REPAIR; HUMAN CSB GENE; SACCHAROMYCES-CEREVISIAE; MOLECULAR-MECHANISMS; PYRIMIDINE DIMERS; INO80 COMPLEX; PHO5 PROMOTER; YEAST RAD26	Previous studies have demonstrated transcription-coupled nucleotide/base excision repair. We report here for the first time that DNA double-strand break (DSB) repair is also coupled to transcription. We generated a yeast strain by introducing a homing (Ho) endonuclease cut site followed by a nucleotide sequence for multiple Myc epitopes at the 3' end of the coding sequence of a highly active gene, ADH1. This yeast strain also contains the Ho cut site at the nearly silent or poorly active mating type alpha (MAT alpha) locus and expresses Ho endonuclease under the galactose-inducible GAL1 promoter. Using this strain, DSBs were generated at the ADH1 and MAT alpha loci in galactose-containing growth medium that induced HO expression. Subsequently, yeast cells were transferred to dextrose-containing growth medium to stop HO expression, and the DSB repair was monitored at the ADH1 and MAT alpha loci by PCR, using the primer pairs flanking the Ho cut sites. Our results revealed a faster DSB repair at the highly active ADH1 than that at the nearly silent MAT alpha locus, hence implicating a transcription-coupled DSB repair at the active gene in vivo. Subsequently, we extended this study to another gene, PHO5 (carrying the Ho cut site at its coding sequence), under transcriptionally active and inactive growth conditions. We found a fast DSB repair at the active PHO5 gene in comparison to its inactive state. Collectively, our results demonstrate a preferential DSB repair at the active gene, thus supporting transcription-coupled DSB repair in living cells.	[Chaurasia, Priyasri; Sen, Rwik; Bhaumik, Sukesh R.] So Illinois Univ, Sch Med, Dept Biochem & Mol Biol, Carbondale, IL 62901 USA; [Pandita, Tej K.] Univ Texas SW Med Ctr Dallas, Dept Radiat Oncol, Dallas, TX 75390 USA	Southern Illinois University System; Southern Illinois University; University of Texas System; University of Texas Southwestern Medical Center Dallas	Bhaumik, SR (corresponding author), So Illinois Univ, Sch Med, Dept Biochem & Mol Biol, Carbondale, IL 62901 USA.	sbhaumik@siumed.edu	Pandita, Tej K/AAM-9188-2020	Sen, Rwik/0000-0003-2853-2378	National Institutes of Health Grant [1R15GM088798-01]; American Heart Association [10GRNT4300059]; Mallinckrodt Foundation grant; Excellence in Academic Medicine (EAM) the Southern Illinois University School of Medicine;  [R01 CA123232];  [R01 CA129537];  [R01 CA154320]; NATIONAL CANCER INSTITUTE [R01CA154320, R01CA129537, R01CA123232] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R15GM088798] Funding Source: NIH RePORTER	National Institutes of Health Grant(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); American Heart Association(American Heart Association); Mallinckrodt Foundation grant; Excellence in Academic Medicine (EAM) the Southern Illinois University School of Medicine; ; ; ; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grant 1R15GM088798-01 (to S. R. B.), American Heart Association Grant-in-Aid 10GRNT4300059 (Greater Midwest Affiliate), a Mallinckrodt Foundation grant, and Excellence in Academic Medicine (EAM) grants of the Southern Illinois University School of Medicine. This work was also supported by Grants R01 CA123232, R01 CA129537, and R01 CA154320 (to T. K. P.).	Adkins MW, 2007, MOL CELL BIOL, V27, P6372, DOI 10.1128/MCB.00981-07; Ausubel F. M., 2001, CURRENT PROTOCOLS MO; Banerjee D, 2011, J BIOL CHEM, V286, P6006, DOI 10.1074/jbc.M110.198796; Barbaric S, 2007, J BIOL CHEM, V282, P27610, DOI 10.1074/jbc.M700623200; Bhaumik SR, 2004, GENE DEV, V18, P333, DOI 10.1101/gad.1148404; Bhaumik SR, 2003, METHOD ENZYMOL, V370, P445; Bhaumik SR, 2002, MOL CELL BIOL, V22, P7365, DOI 10.1128/MCB.22.21.7365-7371.2002; Bhaumik SR, 2001, GENE DEV, V15, P1935, DOI 10.1101/gad.911401; BOHR VA, 1985, CELL, V40, P359, DOI 10.1016/0092-8674(85)90150-3; Bucheli M, 2004, MOL MICROBIOL, V52, P1653, DOI 10.1111/j.1365-2958.2004.04081.x; CHRISTIANS FC, 1992, MUTAT RES, V274, P93, DOI 10.1016/0921-8777(92)90056-9; Citterio E, 2000, MOL CELL BIOL, V20, P7643, DOI 10.1128/MCB.20.20.7643-7653.2000; Conaway JW, 2000, TRENDS BIOCHEM SCI, V25, P375, DOI 10.1016/S0968-0004(00)01615-7; Conaway RC, 2009, TRENDS BIOCHEM SCI, V34, P71, DOI 10.1016/j.tibs.2008.10.010; Cromie GA, 2001, MOL CELL, V8, P1163, DOI 10.1016/S1097-2765(01)00419-1; Feuerhahn S, 2008, TRENDS GENET, V24, P467, DOI 10.1016/j.tig.2008.07.003; Friedberg EC, 2006, DNA REPAIR, V5, P986, DOI 10.1016/j.dnarep.2006.05.005; Hanawalt PC, 2008, NAT REV MOL CELL BIO, V9, P958, DOI 10.1038/nrm2549; HARTWELL LH, 1989, SCIENCE, V246, P629, DOI 10.1126/science.2683079; HARTWELL LH, 1992, CANCER-AM CANCER SOC, V69, P2615, DOI 10.1002/1097-0142(19920515)69:10<2615::AID-CNCR2820691036>3.0.CO;2-1; He Y, 2012, MOL MICROBIOL, V83, P395, DOI 10.1111/j.1365-2958.2011.07941.x; Holstege FCP, 1998, CELL, V95, P717, DOI 10.1016/S0092-8674(00)81641-4; Jiang CZ, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-10-r109; Kanaar R, 1998, TRENDS CELL BIOL, V8, P483, DOI 10.1016/S0962-8924(98)01383-X; Klaunig JE, 2010, TOXICOL PATHOL, V38, P96, DOI 10.1177/0192623309356453; Klopf E, 2009, MOL CELL BIOL, V29, P4994, DOI 10.1128/MCB.01858-08; Larsen E, 2004, DNA REPAIR, V3, P1457, DOI 10.1016/j.dnarep.2004.06.008; Lau WTW, 1998, GENETICS, V150, P1349; Leadon SA, 2000, COLD SPRING HARB SYM, V65, P561, DOI 10.1101/sqb.2000.65.561; Lee JS, 2007, CELL, V131, P1084, DOI 10.1016/j.cell.2007.09.046; Lee KB, 2002, P NATL ACAD SCI USA, V99, P4239, DOI 10.1073/pnas.072068399; Lee SK, 2002, MOL CELL BIOL, V22, P4383, DOI 10.1128/MCB.22.12.4383-4389.2002; Lee SK, 2001, MOL CELL BIOL, V21, P8651, DOI 10.1128/MCB.21.24.8651-8656.2001; Li XY, 2000, SCIENCE, V288, P1242, DOI 10.1126/science.288.5469.1242; Ljungman M, 1996, ONCOGENE, V13, P823; Longtine MS, 1998, YEAST, V14, P953, DOI 10.1002/(SICI)1097-0061(199807)14:10<953::AID-YEA293>3.3.CO;2-L; Malik S., 2012, BIOCHEMISTR IN PRESS; Malik S, 2008, J BIOL CHEM, V283, P6897, DOI 10.1074/jbc.M707649200; Malik S, 2012, NUCLEIC ACIDS RES, V40, P3348, DOI 10.1093/nar/gkr1244; Malik S, 2010, NUCLEIC ACIDS RES, V38, P1461, DOI 10.1093/nar/gkp1147; MELLON I, 1987, CELL, V51, P241, DOI 10.1016/0092-8674(87)90151-6; Moore JK, 1996, MOL CELL BIOL, V16, P2164, DOI 10.1128/mcb.16.5.2164; Morrison AJ, 2004, CELL, V119, P767, DOI 10.1016/j.cell.2004.11.037; Mortensen UH, 2009, CURR BIOL, V19, pR676, DOI 10.1016/j.cub.2009.06.001; Nyberg KA, 2002, ANNU REV GENET, V36, P617, DOI 10.1146/annurev.genet.36.060402.113540; Pandita TK, 2009, NUCLEIC ACIDS RES, V37, P1363, DOI 10.1093/nar/gkn1071; PANDITA TK, 1992, RADIAT RES, V131, P214, DOI 10.2307/3578443; PETERSON CL, 1991, CELL, V64, P1135, DOI 10.1016/0092-8674(91)90268-4; Richardson C, 2004, DNA REPAIR, V3, P1149, DOI 10.1016/j.dnarep.2004.05.007; Sancar A, 2004, ANNU REV BIOCHEM, V73, P39, DOI 10.1146/annurev.biochem.73.011303.073723; Scott SP, 2006, J CELL BIOCHEM, V99, P1463, DOI 10.1002/jcb.21067; SEEBERG E, 1995, TRENDS BIOCHEM SCI, V20, P391, DOI 10.1016/S0968-0004(00)89086-6; Selby CP, 1997, P NATL ACAD SCI USA, V94, P11205, DOI 10.1073/pnas.94.21.11205; Shukla A, 2006, MOL CELL BIOL, V26, P3339, DOI 10.1128/MCB.26.9.3339-3352.2006; SIKORSKI RS, 1989, GENETICS, V122, P19; Sikorski TW, 2011, MOL CELL, V44, P397, DOI 10.1016/j.molcel.2011.09.013; Sims RJ, 2004, CURR OPIN CELL BIOL, V16, P263, DOI 10.1016/j.ceb.2004.04.004; SMERDON MJ, 1990, CELL, V61, P675, DOI 10.1016/0092-8674(90)90479-X; SWEDER KS, 1993, SCIENCE, V262, P439, DOI 10.1126/science.8211165; SWEDER KS, 1992, P NATL ACAD SCI USA, V89, P10696, DOI 10.1073/pnas.89.22.10696; Tornaletti S, 2009, CELL MOL LIFE SCI, V66, P1010, DOI 10.1007/s00018-009-8738-x; Tsukuda T, 2005, NATURE, V438, P379, DOI 10.1038/nature04148; Tsutakawa SE, 2000, COLD SPRING HARB SYM, V65, P201, DOI 10.1101/sqb.2000.65.201; van Attikum H, 2004, CELL, V119, P777, DOI 10.1016/j.cell.2004.11.033; YAMAIZUMI M, 1994, ONCOGENE, V9, P2775	65	21	21	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 19	2012	287	43					36414	36422		10.1074/jbc.M112.364661	http://dx.doi.org/10.1074/jbc.M112.364661			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	027PA	22910905	Green Published, hybrid			2022-12-25	WOS:000310364000061
J	Coincon, M; Wang, WJ; Sygusch, J; Seah, SYK				Coincon, Mathieu; Wang, Weijun; Sygusch, Jurgen; Seah, Stephen Y. K.			Crystal Structure of Reaction Intermediates in Pyruvate Class II Aldolase SUBSTRATE CLEAVAGE, ENOLATE STABILIZATION, AND SUBSTRATE SPECIFICITY	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ACTIVE-SITE; MICROBIAL ALDOLASES; MOLECULAR-BASIS; MECHANISM; RIBONUCLEASE-T1; CONVERGENT; CATALYSIS; RESIDUES; COMPLEX; VALUES	Crystal structures of divalent metal-dependent pyruvate aldolase, HpaI, in complex with substrate and cleavage products were determined to 1.8-2.0 angstrom resolution. The enzyme substrate complex with 4-hydroxy-2-ketoheptane-1,7-dioate indicates that water molecule W2 bound to the divalent metal ion initiates C3-C4 bond cleavage. The binding mode of the aldehyde donor delineated a solvent-filled capacious binding locus lined with predominantly hydrophobic residues. The absence of direct interactions with the aldehyde aliphatic carbons accounts for the broad specificity and lack of stereospecific control by the enzyme. Enzymatic complex structures formed with keto acceptors, pyruvate, and 2-ketobutyrate revealed bidentate interaction with the divalent metal ion by C1-carboxyl and C2-carbonyl oxygens and water molecule W4 that is within close contact of the C3 carbon. Arg(70) assumes a multivalent role through its guanidinium moiety interacting with all active site enzymatic species: C2 oxygen in substrate, pyruvate, and ketobutyrate; substrate C4 hydroxyl; aldehyde C1 oxygen; and W4. The multiple interactions made by Arg(70) stabilize the negatively charged C4 oxygen following proton abstraction, the aldehyde alignment in aldol condensation, and the pyruvate enolate upon aldol cleavage as well as support proton exchange at C3. This role is corroborated by loss of aldol cleavage ability and pyruvate C3 proton exchange activity and by a 730-fold increase in the dissociation constant toward the pyruvate enolate analog oxalate in the R70A mutant. Based on the crystal structures, a mechanism is proposed involving the two enzyme-bound water molecules, W2 and W4, in acid/base catalysis that facilitates reversible aldol cleavage. The same reaction mechanism promotes decarboxylation of oxaloacetate.	[Coincon, Mathieu; Sygusch, Jurgen] Univ Montreal, Dept Biochem, Stn Ctr Ville, Montreal, PQ H3C 3J7, Canada; [Wang, Weijun; Seah, Stephen Y. K.] Univ Guelph, Dept Mol & Cellular Biol, Guelph, ON N1G 2W1, Canada	Universite de Montreal; University of Guelph	Sygusch, J (corresponding author), Univ Montreal, Dept Biochem, Stn Ctr Ville, CP6128, Montreal, PQ H3C 3J7, Canada.	jurgen.sygusch@umontreal.ca; sseah@uoguelph.ca		wang, weijun/0000-0001-9283-5619; Sygusch, Jurgen/0000-0002-6629-2128	National Science and Engineering Research Council of Canada; Canadian Institutes for Health Research; United States Department of Energy, Division of Materials Sciences, and Division of Chemical Sciences [DE-AC02-98CH10886]	National Science and Engineering Research Council of Canada(Natural Sciences and Engineering Research Council of Canada (NSERC)); Canadian Institutes for Health Research(Canadian Institutes of Health Research (CIHR)); United States Department of Energy, Division of Materials Sciences, and Division of Chemical Sciences(United States Department of Energy (DOE))	This work was supported by discovery grants from the National Science and Engineering Research Council of Canada (to S.S. and J.S.) and by a grant from the Canadian Institutes for Health Research (to J.S.).; Work was carried out in part at the National Synchrotron Light Source, Brookhaven National Laboratory, which is supported by the United States Department of Energy, Division of Materials Sciences, and Division of Chemical Sciences under Contract DE-AC02-98CH10886.	Adams PD, 2002, ACTA CRYSTALLOGR D, V58, P1948, DOI 10.1107/S0907444902016657; Baker NA, 2001, P NATL ACAD SCI USA, V98, P10037, DOI 10.1073/pnas.181342398; Baker P, 2011, BIOCHEMISTRY-US, V50, P3559, DOI 10.1021/bi101947g; BASHFORD D, 1990, BIOCHEMISTRY-US, V29, P10219, DOI 10.1021/bi00496a010; Blom NS, 1996, NAT STRUCT BIOL, V3, P856, DOI 10.1038/nsb1096-856; Cooper SJ, 1996, STRUCTURE, V4, P1303, DOI 10.1016/S0969-2126(96)00138-4; Cornish-Bowden A., 1995, ANAL ENZYME KINETIC; de Carvalho LPS, 2006, BIOCHEMISTRY-US, V45, P8988, DOI 10.1021/bi0606602; DeLano WL, 2004, PYMOL MOL GRAPHICS S; Diaz E, 2001, MICROBIOL MOL BIOL R, V65, P523, DOI 10.1128/MMBR.65.4.523-569.2001; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Eswar Narayanan, 2008, V426, P145, DOI 10.1007/978-1-60327-058-8_8; Fish D. C., 1966, METHOD ENZYMOL, V9, P529; Fu ZJ, 2006, J BIOL CHEM, V281, P7526, DOI 10.1074/jbc.M506880200; Hernaez MJ, 2002, APPL ENVIRON MICROB, V68, P4841, DOI 10.1128/AEM.68.10.4841-4846.2002; Herzberg O, 1996, P NATL ACAD SCI USA, V93, P2652, DOI 10.1073/pnas.93.7.2652; Herzberg O, 2002, BIOCHEMISTRY-US, V41, P780, DOI 10.1021/bi011799+; Holm L, 2000, BIOINFORMATICS, V16, P566, DOI 10.1093/bioinformatics/16.6.566; Izard T, 2000, EMBO J, V19, P3849, DOI 10.1093/emboj/19.15.3849; Joerger AC, 2000, BIOCHEMISTRY-US, V39, P6033, DOI 10.1021/bi9927686; Kabsch W, 2010, ACTA CRYSTALLOGR D, V66, P125, DOI 10.1107/S0907444909047337; Kroemer M, 2003, BIOCHEMISTRY-US, V42, P10560, DOI 10.1021/bi0349266; Liu T, 1997, PROTEIN SCI, V6, P1937, DOI 10.1002/pro.5560060914; Lovell SC, 2003, PROTEINS, V50, P437, DOI 10.1002/prot.10286; Luchinat C., 1994, BIOINORGANIC BIOCH, P41; LUMRY R, 1951, J AM CHEM SOC, V73, P4330, DOI 10.1021/ja01153a090; Manjasetty BA, 2003, P NATL ACAD SCI USA, V100, P6992, DOI 10.1073/pnas.1236794100; MCNUTT M, 1990, BIOCHEMISTRY-US, V29, P7572, DOI 10.1021/bi00485a005; MOCK WL, 1988, J BIOL CHEM, V263, P8635; Narayanan BC, 2008, BIOCHEMISTRY-US, V47, P167, DOI 10.1021/bi701954p; O'Leary M. H., 1992, MECH CATALYSIS, P239; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Praznikar J, 2009, ACTA CRYSTALLOGR D, V65, P921, DOI 10.1107/S0907444909021933; QUINN DM, 1991, ENZYME MECH ISOTOPE, P73; Rea D, 2008, BIOCHEMISTRY-US, V47, P9955, DOI 10.1021/bi800943g; Rea D, 2007, J MOL BIOL, V373, P866, DOI 10.1016/j.jmb.2007.06.048; Samland AK, 2006, APPL MICROBIOL BIOT, V71, P253, DOI 10.1007/s00253-006-0422-6; STEYAERT J, 1990, BIOCHEMISTRY-US, V29, P9064, DOI 10.1021/bi00490a025; Takayama S, 1997, ANNU REV MICROBIOL, V51, P285, DOI 10.1146/annurev.micro.51.1.285; Teplyakov A, 2006, P NATL ACAD SCI USA, V103, P16218, DOI 10.1073/pnas.0607587103; Vaguine AA, 1999, ACTA CRYSTALLOGR D, V55, P191, DOI 10.1107/S0907444998006684; Wang WJ, 2008, FEBS LETT, V582, P3385, DOI 10.1016/j.febslet.2008.08.032; Wang WJ, 2010, J BIOL CHEM, V285, P36608, DOI 10.1074/jbc.M110.159509; Wang WJ, 2010, BIOCHEMISTRY-US, V49, P3774, DOI 10.1021/bi100251u; Wang WJ, 2005, BIOCHEMISTRY-US, V44, P9447, DOI 10.1021/bi050607y; Zheng YQ, 2002, J COORD CHEM, V55, P1249, DOI 10.1080/0095897021000036262	46	20	20	0	17	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 19	2012	287	43					36208	36221		10.1074/jbc.M112.400705	http://dx.doi.org/10.1074/jbc.M112.400705			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	027PA	22908224	Green Published, hybrid			2022-12-25	WOS:000310364000042
J	Khurana, S; Chakraborty, S; Zhao, X; Liu, Y; Guan, DY; Lam, M; Huang, W; Yang, SC; Kao, HY				Khurana, Simran; Chakraborty, Sharmistha; Zhao, Xuan; Liu, Yu; Guan, Dongyin; Lam, Minh; Huang, Wei; Yang, Sichun; Kao, Hung-Ying			Identification of a Novel LXXLL Motif in alpha-Actinin 4-spliced Isoform That Is Critical for Its Interaction with Estrogen Receptor alpha and Co-activators	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							NUCLEAR RECEPTOR; ACETYLATION; BINDING; PROTEINS; SUPERFAMILY; SPECIFICITY; COMPLEX; SRC-1; GENE	alpha-Actinins (ACTNs) are a family of proteins cross-linking actin filaments that maintain cytoskeletal organization and cell motility. Recently, it has also become clear that ACTN4 can function in the nucleus. In this report, we found that ACTN4 (full length) and its spliced isoform ACTN4 (Iso) possess an unusual LXXLL nuclear receptor interacting motif. Both ACTN4 (full length) and ACTN4 (Iso) potentiate basal transcription activity and directly interact with estrogen receptor alpha, although ACTN4 (Iso) binds ER alpha more strongly. We have also found that both ACTN4 (full length) and ACTN4 (Iso) interact with the ligand-independent and the ligand-dependent activation domains of estrogen receptor alpha. Although ACTN4 (Iso) interacts efficiently with transcriptional co-activators such as p300/CBP-associated factor (PCAF) and steroid receptor co-activator 1 (SRC-1), the full length ACTN4 protein either does not or does so weakly. More importantly, the flanking sequences of the LXXLL motif are important not only for interacting with nuclear receptors but also for the association with co-activators. Taken together, we have identified a novel extended LXXLL motif that is critical for interactions with both receptors and co-activators. This motif functions more efficiently in a spliced isoform of ACTN4 than it does in the full-length protein.	[Khurana, Simran; Chakraborty, Sharmistha; Zhao, Xuan; Liu, Yu; Guan, Dongyin; Kao, Hung-Ying] Case Western Reserve Univ, Dept Biochem, Cleveland, OH 44106 USA; [Huang, Wei; Yang, Sichun] Case Western Reserve Univ, Sch Med, Ctr Prote, Cleveland, OH 44106 USA; [Huang, Wei; Yang, Sichun] Case Western Reserve Univ, Sch Med, Dept Pharmacol, Cleveland, OH 44106 USA; [Lam, Minh] Case Western Reserve Univ, Ctr Comprehens Canc, Cleveland, OH 44106 USA; [Lam, Minh] Univ Hosp Cleveland, Res Inst, Cleveland, OH 44106 USA	Case Western Reserve University; Case Western Reserve University; Case Western Reserve University; Case Western Reserve University; University Hospitals of Cleveland	Kao, HY (corresponding author), Case Western Reserve Univ, Dept Biochem, Cleveland, OH 44106 USA.	hxk43@cwru.edu	Yang, Sichun/B-1608-2008; Huang, Wei/O-2035-2016	Yang, Sichun/0000-0002-1726-0576; Huang, Wei/0000-0003-2097-8148	National Institutes of Health [RO1 DK078965, HL093269, P30 CA43703-12]; American Cancer Society-Institutional Research Grant [ACS IRG-91-022-15]; NATIONAL CANCER INSTITUTE [P30CA043703] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL093269] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK078965] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); American Cancer Society-Institutional Research Grant(American Cancer Society); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported, in whole or in part, by National Institutes of Health Grants RO1 DK078965 and HL093269 (to H.-Y.K.) and P30 CA43703-12. This work was also supported by American Cancer Society-Institutional Research Grant ACS IRG-91-022-15 (to S.Y.).	Aoyagi S, 2008, MOL CELL BIOL, V28, P30, DOI 10.1128/MCB.01158-07; Bannister AJ, 2000, CELL MOL LIFE SCI, V57, P1184, DOI 10.1007/PL00000758; BEATO M, 1995, CELL, V83, P851, DOI 10.1016/0092-8674(95)90201-5; BROOKS BR, 1983, J COMPUT CHEM, V4, P187, DOI 10.1002/jcc.540040211; Chakraborty S, 2006, J BIOL CHEM, V281, P35070, DOI 10.1074/jbc.M602474200; Chang CY, 1999, MOL CELL BIOL, V19, P8226; Darimont BD, 1998, GENE DEV, V12, P3343, DOI 10.1101/gad.12.21.3343; Djinovic-Carugo K, 2002, FEBS LETT, V513, P119, DOI 10.1016/S0014-5793(01)03304-X; Djinovic-Carugo K, 1999, CELL, V98, P537, DOI 10.1016/S0092-8674(00)81981-9; Francis GA, 2003, ANNU REV PHYSIOL, V65, P261, DOI 10.1146/annurev.physiol.65.092101.142528; Gehin M, 2002, MOL CELL BIOL, V22, P5923, DOI 10.1128/MCB.22.16.5923-5937.2002; Glass CK, 2000, GENE DEV, V14, P121; Glozak MA, 2005, GENE, V363, P15, DOI 10.1016/j.gene.2005.09.010; Heery DM, 1997, NATURE, V387, P733, DOI 10.1038/42750; Heinlein CA, 2002, ENDOCR REV, V23, P175, DOI 10.1210/er.23.2.175; Honda K, 1998, J CELL BIOL, V140, P1383, DOI 10.1083/jcb.140.6.1383; Jeong KW, 2009, J BIOL CHEM, V284, P29298, DOI 10.1074/jbc.M109.037010; Kao HY, 2000, GENE DEV, V14, P55; Khurana S, 2011, J BIOL CHEM, V286, P1850, DOI 10.1074/jbc.M110.162107; Lee YH, 2004, MOL CELL BIOL, V24, P2103, DOI 10.1128/MCB.24.5.2103-2117.2004; MANGELSDORF DJ, 1995, CELL, V83, P835, DOI 10.1016/0092-8674(95)90199-X; McInerney EM, 1998, GENE DEV, V12, P3357, DOI 10.1101/gad.12.21.3357; Nolte RT, 1998, NATURE, V395, P137, DOI 10.1038/25931; Olave IA, 2002, ANNU REV BIOCHEM, V71, P755, DOI 10.1146/annurev.biochem.71.110601.135507; Otey CA, 2004, CELL MOTIL CYTOSKEL, V58, P104, DOI 10.1002/cm.20007; Perissi V, 2005, NAT REV MOL CELL BIO, V6, P542, DOI 10.1038/nrm1680; Rando OJ, 2002, P NATL ACAD SCI USA, V99, P2824, DOI 10.1073/pnas.032662899; Shapovalov MV, 2007, PROTEINS, V66, P279, DOI 10.1002/prot.21150; Shen XT, 2003, MOL CELL, V12, P147, DOI 10.1016/S1097-2765(03)00264-8; Shiau AK, 1998, CELL, V95, P927, DOI 10.1016/S0092-8674(00)81717-1; Soutoglou E, 2000, MOL CELL, V5, P745, DOI 10.1016/S1097-2765(00)80253-1; Sterner DE, 2000, MICROBIOL MOL BIOL R, V64, P435, DOI 10.1128/MMBR.64.2.435-459.2000; Thomas M, 2004, J BIOL CHEM, V279, P8389, DOI 10.1074/jbc.M311761200; TSAI MJ, 1994, ANNU REV BIOCHEM, V63, P451, DOI 10.1146/annurev.biochem.63.1.451; Wolf IM, 2008, J CELL BIOCHEM, V104, P1580, DOI 10.1002/jcb.21755; Xu JM, 2000, P NATL ACAD SCI USA, V97, P6379, DOI 10.1073/pnas.120166297; Xu JM, 1998, SCIENCE, V279, P1922, DOI 10.1126/science.279.5358.1922; Yang XJ, 2004, BIOESSAYS, V26, P1076, DOI 10.1002/bies.20104	38	22	23	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 12	2012	287	42					35418	35429		10.1074/jbc.M112.401364	http://dx.doi.org/10.1074/jbc.M112.401364			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	022OF	22908231	Green Published, hybrid			2022-12-25	WOS:000309968000049
J	Carroll, ME; Zlebnik, NE; Anker, JJ; Kosten, TR; Orson, FM; Shen, XY; Kinsey, B; Parks, RJ; Gao, Y; Brimijoin, S				Carroll, Marilyn E.; Zlebnik, Natalie E.; Anker, Justin J.; Kosten, Thomas R.; Orson, Frank M.; Shen, Xiaoyun; Kinsey, Berma; Parks, Robin J.; Gao, Yang; Brimijoin, Stephen			Combined Cocaine Hydrolase Gene Transfer and Anti-Cocaine Vaccine Synergistically Block Cocaine-Induced Locomotion	PLOS ONE			English	Article							HUMAN SERUM BUTYRYLCHOLINESTERASE; DEPENDENT ADENOVIRAL VECTORS; CARDIOVASCULAR-RESPONSES; MONOCLONAL-ANTIBODY; IMMUNE-RESPONSE; ACUTE TOXICITY; DRUG-ABUSE; IN-VIVO; RATS; MICE	Mice and rats were tested for reduced sensitivity to cocaine-induced hyper-locomotion after pretreatment with anti-cocaine antibody or cocaine hydrolase (CocH) derived from human butyrylcholinesterase (BChE). In Balb/c mice, direct i.p. injection of CocH protein (1 mg/kg) had no effect on spontaneous locomotion, but it suppressed responses to i.p. cocaine up to 80 mg/kg. When CocH was injected i.p. along with a murine cocaine antiserum that also did not affect spontaneous locomotion, there was no response to any cocaine dose. This suppression of locomotor activity required active enzyme, as it was lost after pretreatment with iso-OMPA, a selective BChE inhibitor. Comparable results were obtained in rats that developed high levels of CocH by gene transfer with helper-dependent adenoviral vector, and/or high levels of anti-cocaine antibody by vaccination with norcocaine hapten conjugated to keyhole limpet hemocyanin (KLH). After these treatments, rats were subjected to a locomotor sensitization paradigm involving a "training phase" with an initial i.p. saline injection on day 1 followed by 8 days of repeated cocaine injections (10 mg/kg, i.p.). A 15-day rest period then ensued, followed by a final "challenge" cocaine injection. As in mice, the individual treatment interventions reduced cocaine-stimulated hyperactivity to a modest extent, while combined treatment produced a greater reduction during all phases of testing compared to control rats (with only saline pretreatment). Overall, the present results strongly support the view that anti-cocaine vaccine and cocaine hydrolase vector treatments together provide enhanced protection against the stimulatory actions of cocaine in rodents. A similar combination therapy in human cocaine users might provide a robust therapy to help maintain abstinence.	[Carroll, Marilyn E.; Zlebnik, Natalie E.; Anker, Justin J.] Univ Minnesota, Dept Psychiat, Minneapolis, MN 55455 USA; [Kosten, Thomas R.; Orson, Frank M.; Shen, Xiaoyun; Kinsey, Berma] Baylor Coll Med, Dept Med, Houston, TX 77030 USA; [Kosten, Thomas R.; Orson, Frank M.; Shen, Xiaoyun; Kinsey, Berma] Baylor Coll Med, Dept Psychiat & Neurosci, Houston, TX 77030 USA; [Kosten, Thomas R.; Orson, Frank M.; Shen, Xiaoyun; Kinsey, Berma] Baylor Coll Med, Dept Pathol & Immunol, Houston, TX 77030 USA; [Kosten, Thomas R.; Orson, Frank M.; Shen, Xiaoyun; Kinsey, Berma] Vet Adm Med Ctr, Houston, TX 77211 USA; [Parks, Robin J.] Ottawa Hosp Res Inst, Regenerat Med Program, Ottawa, ON, Canada; [Gao, Yang; Brimijoin, Stephen] Mayo Clin, Dept Mol Pharmacol & Expt Therapeut, Rochester, MN USA	University of Minnesota System; University of Minnesota Twin Cities; Baylor College of Medicine; Baylor College of Medicine; Baylor College of Medicine; Baylor College of Medicine; US Department of Veterans Affairs; Veterans Health Administration (VHA); University of Ottawa; Ottawa Hospital Research Institute; Mayo Clinic	Carroll, ME (corresponding author), Univ Minnesota, Dept Psychiat, Minneapolis, MN 55455 USA.	Brimijoin@mayo.edu	Kosten, Thomas/AAI-5998-2021; Anker, Justin J/H-4748-2019	Anker, Justin J/0000-0002-2115-5170	National Institute on Drug Abuse [DP1 DA031340, R01 DA023979, R01 DA023979 S1, K05 DA015267, R01 DA030338]; Department of Veterans Affairs; NATIONAL INSTITUTE ON DRUG ABUSE [R01DA023979, R01DA030338, DP1DA031340, K05DA015267] Funding Source: NIH RePORTER	National Institute on Drug Abuse(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission); Department of Veterans Affairs(US Department of Veterans Affairs); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission)	This research was supported by grants from the National Institute on Drug Abuse [DP1 DA031340, R01 DA023979, R01 DA023979 S1 (SB, MEC subcontractor) and K05 DA015267 (MEC), R01 DA030338 (FO)] and the Department of Veterans Affairs. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anker JJ, 2011, BIOL PSYCHIAT; Brimijoin S, 2002, ANAL BIOCHEM, V309, P200, DOI 10.1016/S0003-2697(02)00238-5; Brimijoin S, 2008, NEUROPSYCHOPHARMACOL, V33, P2715, DOI 10.1038/sj.npp.1301666; Brunetti-Pierri N, 2004, HUM GENE THER, V15, P35, DOI 10.1089/10430340460732445; CARRERA MRA, 1995, NATURE, V378, P727, DOI 10.1038/378727a0; CHOU TC, 1984, ADV ENZYME REGUL, V22, P27, DOI 10.1016/0065-2571(84)90007-4; Collins GT, 2012, NEUROPSYCHOPHARMACOL, V37, P1092, DOI 10.1038/npp.2011.226; Collins GT, 2009, J PHARMACOL EXP THER, V331, P445, DOI 10.1124/jpet.108.150029; Cooper ZD, 2006, MOL PHARMACOL, V70, P1885, DOI 10.1124/mol.106.025999; Ferrario CR, 2010, NEUROPSYCHOPHARMACOL, V35, P818, DOI 10.1038/npp.2009.190; Gao Y, 2005, MOL PHARMACOL, V67, P204, DOI 10.1124/mol.104.006924; Gao Y, 2004, J PHARMACOL EXP THER, V310, P1046, DOI 10.1124/jpet.104.068122; Gao Y, 2008, CHEM-BIOL INTERACT, V175, P83, DOI 10.1016/j.cbi.2008.04.024; Gao Y, 2010, CHEM-BIOL INTERACT, V187, P421, DOI 10.1016/j.cbi.2010.02.036; Gao Y, 2009, J PHARMACOL EXP THER, V330, P449, DOI 10.1124/jpet.109.152231; Gorelick DA, 1997, DRUG ALCOHOL DEPEN, V48, P159, DOI 10.1016/S0376-8716(97)00119-1; HICKS MJ, 2011, MOL THER; JOHNSON CD, 1975, ANAL BIOCHEM, V64, P229, DOI 10.1016/0003-2697(75)90423-6; Kantak KM, 2003, EXPERT OPIN PHARMACO, V4, P213; Kantak KM, 2001, PSYCHOPHARMACOLOGY, V153, P334, DOI 10.1007/s002130000555; Kantak KN, 2000, PSYCHOPHARMACOLOGY, V148, P251, DOI 10.1007/s002130050049; Kim IH, 2001, P NATL ACAD SCI USA, V98, P13282, DOI 10.1073/pnas.241506298; Kinsey BM, 2010, DRUG FUTURE, V35, P301, DOI 10.1358/dof.2010.035.04.1474292; Koetzner L, 2002, DRUG METAB DISPOS, V30, P716, DOI 10.1124/dmd.30.6.716; Kosten T, 2005, PHARMACOL THERAPEUT, V108, P76, DOI 10.1016/j.pharmthera.2005.06.009; Kosten TR, 2002, VACCINE, V20, P1196, DOI 10.1016/S0264-410X(01)00425-X; LeSage MG, 2006, AAPS J, V8, pE65, DOI 10.1208/aapsj080108; Li YL, 2004, EUR J NEUROSCI, V20, P1647, DOI 10.1111/j.1460-9568.2004.03612.x; Mane VP, 2006, GENE THER, V13, P1272, DOI 10.1038/sj.gt.3302792; Manno CS, 2006, NAT MED, V12, P342, DOI 10.1038/nm1358; Martell BA, 2005, BIOL PSYCHIAT, V58, P158, DOI 10.1016/j.biopsych.2005.04.032; Martell BA, 2009, ARCH GEN PSYCHIAT, V66, P1116, DOI 10.1001/archgenpsychiatry.2009.128; Muruve DA, 2004, HUM GENE THER, V15, P1157, DOI 10.1089/hum.2004.15.1157; Muruve DA, 2004, J VIROL, V78, P5966, DOI 10.1128/JVI.78.11.5966-5972.2004; National Research Council, 2011, GUID CAR US LAB AN, P8; Norman AB, 2009, J PHARMACOL EXP THER, V328, P873, DOI 10.1124/jpet.108.146407; Norman AB, 2007, J PHARMACOL EXP THER, V320, P145, DOI 10.1124/jpet.106.111781; Orson FM, 2009, HUM VACCIN, V5; Orson FM, 2008, ANN NY ACAD SCI, V1141, P257, DOI 10.1196/annals.1441.027; Orson Frank M, 2007, Curr Psychiatry Rep, V9, P381, DOI 10.1007/s11920-007-0049-z; Orson FM, 2009, HUM VACCINES, V5, P194, DOI 10.4161/hv.5.4.7457; Pan YM, 2005, P NATL ACAD SCI USA, V102, P16656, DOI 10.1073/pnas.0507332102; Pan YM, 2008, J AM CHEM SOC, V130, P5140, DOI 10.1021/ja077972s; Pan YM, 2007, J AM CHEM SOC, V129, P13537, DOI 10.1021/ja073724k; Parks RJ, 1996, P NATL ACAD SCI USA, V93, P13565, DOI 10.1073/pnas.93.24.13565; Raper SE, 2003, MOL GENET METAB, V80, P148, DOI 10.1016/j.ymgme.2003.08.016; Riday TT, 2012, NEUROPHARMACOLOGY, V62, P1858, DOI 10.1016/j.neuropharm.2011.12.011; Robinson TE, 2003, ANNU REV PSYCHOL, V54, P25, DOI 10.1146/annurev.psych.54.101601.145237; Saxena A, 2005, CHEM-BIOL INTERACT, V157, P199, DOI 10.1016/j.cbi.2005.10.028; Saxena A, 2011, BIOCHEM PHARMACOL, V81, P164, DOI 10.1016/j.bcp.2010.09.007; Sun H, 2002, MOL PHARMACOL, V62, P220, DOI 10.1124/mol.62.2.220; Sun H, 2001, J BIOL CHEM, V276, P9330, DOI 10.1074/jbc.M006676200; Vezina P, 2004, NEUROSCI BIOBEHAV R, V27, P827, DOI 10.1016/j.neubiorev.2003.11.001; Weber A, 2011, VOX SANG, V100, P285, DOI 10.1111/j.1423-0410.2010.01415.x; Wee S, 2012, NEUROPSYCHOPHARMACOL, V37, P1083, DOI 10.1038/npp.2011.200; Xue L, 2011, MOL PHARMACOL, V79, P290, DOI 10.1124/mol.110.068494; Yang WC, 2010, CHEM-BIOL INTERACT, V187, P148, DOI 10.1016/j.cbi.2010.01.004; Zhou S.J., 2011, PSYCHOPHARMACOLOGY B	58	23	23	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 17	2012	7	8							e43536	10.1371/journal.pone.0043536	http://dx.doi.org/10.1371/journal.pone.0043536			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	996DG	22912888	Green Published, Green Submitted, gold			2022-12-25	WOS:000308063700116
J	Hoffmann, J; Rabezanahary, H; Randriamarotia, M; Ratsimbasoa, A; Najjar, J; Vernet, G; Contamin, B; Paranhos-Baccala, G				Hoffmann, Jonathan; Rabezanahary, Henintsoa; Randriamarotia, Martin; Ratsimbasoa, Arsene; Najjar, Josette; Vernet, Guy; Contamin, Benedicte; Paranhos-Baccala, Glaucia			Viral and Atypical Bacterial Etiology of Acute Respiratory Infections in Children under 5 Years Old Living in a Rural Tropical Area of Madagascar	PLOS ONE			English	Article							COMMUNITY-ACQUIRED PNEUMONIA; RHINOVIRUS GENOTYPE; PATHOGENS; VIRUSES; PCR	Background: In Madagascar, very little is known about the etiology and prevalence of acute respiratory infections (ARIs) in a rural tropical area. Recent data are needed to determine the viral and atypical bacterial etiologies in children with defined clinical manifestations of ARIs. Methods: During one year, we conducted a prospective study on ARIs in children between 2 to 59 months in the community hospital of Ampasimanjeva, located in the south-east of Madagascar. Respiratory samples were analyzed by multiplex real-time RT-PCR, including 18 viruses and 2 atypical bacteria. The various episodes of ARI were grouped into four clinical manifestations with well-documented diagnosis: "Community Acquired Pneumonia"(CAP, group I), "Other acute lower respiratory infections (Other ALRIs, group II)", "Upper respiratory tract infections with cough (URTIs with cough, group III)" and "Upper respiratory tract infections without cough (URTIs without cough, group IV)". Results: 295 children were included in the study between February 2010 and February 2011. Viruses and/or atypical bacteria respiratory pathogens were detected in 74.6% of samples, the rate of co-infection was 27.3%. Human rhinovirus (HRV; 20.5%), metapneumovirus (HMPV A/B, 13.8%), coronaviruses (HCoV, 12.5%), parainfluenza virus (HPIV, 11.8%) and respiratory syncytial virus A and B (RSV A/B, 11.8%) were the most detected. HRV was predominantly single detected (23.8%) in all the clinical groups while HMPV A/B (23.9%) was mainly related to CAP (group I), HPIV (17.3%) to the "Other ALRIs" (group II), RSV A/B (19.5%) predominated in the group "URTIs with cough" (group III) and Adenovirus (HAdV, 17.8%) was mainly detected in the "without cough" (group IV). Interpretation: This study describes for the first time the etiology of respiratory infections in febrile children under 5 years in a malaria rural area of Madagascar and highlights the role of respiratory viruses in a well clinically defined population of ARIs.	[Hoffmann, Jonathan; Rabezanahary, Henintsoa; Contamin, Benedicte] CICM, Fac Med, Antananarivo, Madagascar; [Hoffmann, Jonathan; Ratsimbasoa, Arsene; Contamin, Benedicte] Fdn Merieux, Antananarivo, Madagascar; [Randriamarotia, Martin] FMA, Ampasimanjeva, Madagascar; [Ratsimbasoa, Arsene] Minist Sante Publ, Antanananarivo, Madagascar; [Najjar, Josette; Vernet, Guy; Paranhos-Baccala, Glaucia] SFR BioSci Gerland Lyon Sud, UMS3444, US8, Emerging Pathogens Lab,Fdn Merieux, Lyon, France	Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB)	Hoffmann, J (corresponding author), CICM, Fac Med, Antananarivo, Madagascar.	glaucia.baccala@fondation-merieux.org	Ratsimbasoa, Arsene/AAE-9306-2020	HOFFMANN, JONATHAN/0000-0002-2400-8862	Fondation Merieux; NGO Reggio Terzo Mundo through European Union; Government of Monaco's cooperation	Fondation Merieux; NGO Reggio Terzo Mundo through European Union; Government of Monaco's cooperation	This project was jointly funded by Fondation Merieux, the NGO Reggio Terzo Mundo (through funding from the European Union) and Government of Monaco's cooperation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allander T, 2005, P NATL ACAD SCI USA, V102, P12891, DOI 10.1073/pnas.0504666102; Amexo M, 2004, LANCET, V364, P1896, DOI 10.1016/S0140-6736(04)17446-1; Bezerra PGM, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018928; Blic J, 2009, FLAMMARION MED SCI, P69; Broberg E, 2011, J CLIN VIROL, V51, P79, DOI 10.1016/j.jcv.2011.01.018; Brownlee JW, 2008, CURR OPIN PEDIATR, V20, P67, DOI 10.1097/MOP.0b013e3282f41cb6; Caliendo AM, 2011, CLIN INFECT DIS, V52, pS326, DOI 10.1093/cid/cir047; Cevey-Macherel M, 2009, EUR J PEDIATR, V168, P1429, DOI 10.1007/s00431-009-0943-y; Do Anh Ha Lien, 2011, PLoS One, V6, pe18176, DOI 10.1371/journal.pone.0018176; Garcia Ramos E, 1991, Rev Latinoam Microbiol, V33, P109; Honkinen M, 2012, CLIN MICROBIOL INFEC, V18, P300, DOI 10.1111/j.1469-0691.2011.03603.x; Jartti T, 2008, PEDIATR INFECT DIS J, V27, P1103, DOI 10.1097/INF.0b013e31817e695d; Kaiser L, 2006, AM J RESP CRIT CARE, V174, P1392, DOI 10.1164/rccm.200604-489OC; Kumar S, 2008, J CLIN MICROBIOL, V46, P3063, DOI 10.1128/JCM.00625-08; Lamson D, 2006, J INFECT DIS, V194, P1398, DOI 10.1086/508551; Mackay IM, 2008, J CLIN VIROL, V42, P297, DOI 10.1016/j.jcv.2008.04.002; McCracken GH, 2000, PEDIATR INFECT DIS J, V19, P924, DOI 10.1097/00006454-200009000-00036; Mermond S, 2012, CLIN INFECT DIS, V54, pS180, DOI 10.1093/cid/cir1070; Nascimento-Carvalho CM, 2011, INFLUENZA OTHER RESP, V5, P285, DOI 10.1111/j.1750-2659.2011.00206.x; O'Brien KL, 2000, CLIN INFECT DIS, V30, P784, DOI 10.1086/313772; ONUAIDS, 2010, UNAIDS REP GLOB AIDS; PALMA S. CAMILO, 2005, Rev. chil. infectol., V22, P247; Papadopoulos NG, 2000, J INFECT DIS, V181, P1875, DOI 10.1086/315513; Pavia AT, 2011, CLIN INFECT DIS, V52, pS284, DOI 10.1093/cid/cir043; Razanajatovo NH, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017579; Renwick N, 2007, J INFECT DIS, V196, P1754, DOI 10.1086/524312; Richard N, 2008, PEDIATR INFECT DIS J, V27, P213, DOI 10.1097/INF.0b013e31815b4935; Ruuskanen O, 2011, LANCET, V377, P1264, DOI 10.1016/S0140-6736(10)61459-6; SAIKKU P, 1993, AM J TROP MED HYG, V49, P88, DOI 10.4269/ajtmh.1993.49.88; Tapparel C, 2009, J CLIN VIROL, V45, P157, DOI 10.1016/j.jcv.2009.03.014; Tsolia MN, 2004, CLIN INFECT DIS, V39, P681, DOI 10.1086/422996; van den Hoogen BG, 2001, NAT MED, V7, P719, DOI 10.1038/89098; van der Hoek L, 2010, J CLIN VIROL, V48, P104, DOI 10.1016/j.jcv.2010.02.023; *WHO, 2008, GLOB ACT PLAN PREV C; Williams BG, 2002, LANCET INFECT DIS, V2, P25, DOI 10.1016/S1473-3099(01)00170-0; Woo PCY, 2005, J VIROL, V79, P884, DOI 10.1128/JVI.79.2.884-895.2005; World Health Organization, 2012, AC RESP INF CHILDR	37	36	42	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 17	2012	7	8							e43666	10.1371/journal.pone.0043666	http://dx.doi.org/10.1371/journal.pone.0043666			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	996DG	22912897	Green Published, gold			2022-12-25	WOS:000308063700125
J	Murray, LB; Lau, YKI; Yu, Q				Murray, Lucas B.; Lau, Ying-Ka Ingar; Yu, Qin			Merlin Is a Negative Regulator of Human Melanoma Growth	PLOS ONE			English	Article							TUMOR-SUPPRESSOR MERLIN; CELL CONTACT INHIBITION; ORGAN SIZE CONTROL; HIPPO PATHWAY; METASTATIC MELANOMA; YAP ONCOPROTEIN; PROTEIN YAP; CANCER; GENE; PROLIFERATION	Merlin is encoded by the neurofibromatosis type 2 (NF2) gene and is a member of the Band 4.1 protein family. This protein acts as a linker that connects cell surface proteins to the actin cytoskeleton. Defects caused by mutations of the NF2 gene give rise to NF2 disease, which is generally characterized by the formation of bilateral vestibular schwannomas and, to a lesser extent, meningiomas and ependymomas. In addition to these tumor types, NF2 is mutated and/or merlin expression is reduced or lost in numerous non-NF2 associated tumors, including melanoma. However, the role of merlin in human melanoma growth and the mechanism underlying its effect are currently unknown. In the present study, we show that merlin knockdown enhances melanoma cell proliferation, migration, and invasion in vitro and that decreased merlin expression promotes subcutaneous melanoma growth in immunocompromised mice. Concordantly, we find that increased expression of merlin in a metastatic melanoma cell line reduced their in vitro migration and proliferation, and diminished their ability to grow in an anchorage independent manner. Increased merlin expression also inhibits in vivo growth of these melanoma cells. Lastly, we demonstrate that higher merlin levels in human melanoma cells promote the H2O2-induced activation of MST1/2 Ser/Thr kinases, which are known tumor suppressors in the Hippo signaling pathway. Taken together, these results provide for the first time evidence that merlin negatively regulates human melanoma growth, and that loss of merlin, or impaired merlin function, results in an opposite effect. In addition, we show that increased merlin expression leads to enhanced activation of the MTS1/2 kinases, implying the potential roles of MST1/2 in mediating the anti-melanoma effects of merlin.	[Murray, Lucas B.; Lau, Ying-Ka Ingar; Yu, Qin] Mt Sinai Sch Med, Dept Oncol Sci, New York, NY USA	Icahn School of Medicine at Mount Sinai	Murray, LB (corresponding author), Mt Sinai Sch Med, Dept Oncol Sci, New York, NY USA.	qin.yu@mssm.edu			 [R01CA135158]; NATIONAL CANCER INSTITUTE [R01CA150355, R01CA135158] Funding Source: NIH RePORTER	; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported by R01CA135158. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alfthan K, 2004, J BIOL CHEM, V279, P18559, DOI 10.1074/jbc.M313916200; Bai Y, 2007, ONCOGENE, V26, P836, DOI 10.1038/sj.onc.1209849; BIANCHI AB, 1994, NAT GENET, V6, P185, DOI 10.1038/ng0294-185; Brose MS, 2002, CANCER RES, V62, P6997; Brunckhorst MK, 2010, CANCER RES, V70, P7283, DOI 10.1158/0008-5472.CAN-09-4125; Chan EH, 2005, ONCOGENE, V24, P2076, DOI 10.1038/sj.onc.1208445; Chapman PB, 2011, NEW ENGL J MED, V364, P2507, DOI 10.1056/NEJMoa1103782; Chapman PB, 1999, J CLIN ONCOL, V17, P2745, DOI 10.1200/JCO.1999.17.9.2745; Curto M, 2007, J CELL BIOL, V177, P893, DOI 10.1083/jcb.200703010; Davies H, 2002, NATURE, V417, P949, DOI 10.1038/nature00766; EVANS DGR, 1992, Q J MED, V84, P603; Flaherty KT, 2010, NEW ENGL J MED, V363, P809, DOI 10.1056/NEJMoa1002011; Fraenzer JT, 2003, INT J ONCOL, V23, P1493; Galcheva-Gargova Z, 2008, INT J ONCOL, V32, P1237; Garbe C, 2011, ONCOLOGIST, V16, P5, DOI 10.1634/theoncologist.2010-0190; Gutmann DH, 1997, NEUROLOGY, V49, P267, DOI 10.1212/WNL.49.1.267; Hamaratoglu F, 2006, NAT CELL BIOL, V8, P27, DOI 10.1038/ncb1339; Horiguchi A, 2008, PROSTATE, V68, P975, DOI 10.1002/pros.20760; Houshmandi SS, 2009, MOL CELL BIOL, V29, P1472, DOI 10.1128/MCB.01392-08; Hu SS, 2009, ARCH DERMATOL, V145, P1369, DOI 10.1001/archdermatol.2009.302; Kissil JL, 2003, MOL CELL, V12, P841, DOI 10.1016/S1097-2765(03)00382-4; Kissil JL, 2002, J BIOL CHEM, V277, P10394, DOI 10.1074/jbc.M200083200; Lallemand D, 2003, GENE DEV, V17, P1090, DOI 10.1101/gad.1054603; Lallemand D, 2009, ONCOGENE, V28, P854, DOI 10.1038/onc.2008.427; Lau YKI, 2008, CANCER RES, V68, P5733, DOI 10.1158/0008-5472.CAN-08-0190; Lehtinen MK, 2006, CELL, V125, P987, DOI 10.1016/j.cell.2006.03.046; Lu L, 2010, P NATL ACAD SCI USA, V107, P1437, DOI 10.1073/pnas.0911427107; LUIKART SD, 1984, J CLIN ONCOL, V2, P164, DOI 10.1200/JCO.1984.2.3.164; Madhunapantula SV, 2009, PIGM CELL MELANOMA R, V22, P400, DOI 10.1111/j.1755-148X.2009.00585.x; McCartney BM, 2000, DEVELOPMENT, V127, P1315; Morrison H, 2001, GENE DEV, V15, P968, DOI 10.1101/gad.189601; Morrow KA, 2011, J BIOL CHEM, V286, P40376, DOI 10.1074/jbc.M111.250035; Oka T, 2008, J BIOL CHEM, V283, P27534, DOI 10.1074/jbc.M804380200; Radu M, 2009, CURR BIOL, V19, pR421, DOI 10.1016/j.cub.2009.04.022; ROULEAU GA, 1993, NATURE, V363, P515, DOI 10.1038/363515a0; Satyamoorthy K, 1997, MELANOMA RES, V7, pS35; Song H, 2010, P NATL ACAD SCI USA, V107, P1431, DOI 10.1073/pnas.0911409107; Stamenkovic I, 2010, CURR PROTEIN PEPT SC, V11, P471, DOI 10.2174/138920310791824011; Tang XL, 2007, NAT CELL BIOL, V9, P1199, DOI 10.1038/ncb1641; Thurneysen C, 2009, LUNG CANCER, V64, P140, DOI 10.1016/j.lungcan.2008.08.014; Trofatter J A, 1993, Cell, V75, P826; Ura S, 2007, MOL CELL BIOL, V27, P5514, DOI 10.1128/MCB.00199-07; Weatherhead SC, 2007, BRIT J DERMATOL, V156, P72, DOI 10.1111/j.1365-2133.2006.07570.x; Xu Y, 2010, CANCER RES, V70, P2455, DOI 10.1158/0008-5472.CAN-09-2505; Xu ZP, 2011, HEPATO-GASTROENTEROL, V58, P1611, DOI 10.5754/hge10669; Zeng Q, 2008, CANCER CELL, V13, P188, DOI 10.1016/j.ccr.2008.02.011; Zhang JM, 2009, NAT CELL BIOL, V11, P1444, DOI 10.1038/ncb1993; Zhang NL, 2010, DEV CELL, V19, P27, DOI 10.1016/j.devcel.2010.06.015; Zhao B, 2007, GENE DEV, V21, P2747, DOI 10.1101/gad.1602907; Zhou DW, 2011, P NATL ACAD SCI USA, V108, pE1312, DOI 10.1073/pnas.1110428108; Zhou DW, 2009, CANCER CELL, V16, P425, DOI 10.1016/j.ccr.2009.09.026	51	26	26	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 17	2012	7	8							e43295	10.1371/journal.pone.0043295	http://dx.doi.org/10.1371/journal.pone.0043295			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	996DG	22912849	Green Published, Green Submitted, gold			2022-12-25	WOS:000308063700077
J	Sun, J; Sun, QH; Brown, MF; Dudgeon, C; Chandler, J; Xu, X; Shu, YQ; Zhang, L; Yu, J				Sun, Jing; Sun, Quanhong; Brown, Matthew F.; Dudgeon, Crissy; Chandler, Julie; Xu, Xiang; Shu, Yongqian; Zhang, Lin; Yu, Jian			The Multi-Targeted Kinase Inhibitor Sunitinib Induces Apoptosis in Colon Cancer Cells via PUMA	PLOS ONE			English	Article							COLORECTAL-CANCER; BH3-ONLY PROTEINS; TUMOR-CELLS; P53; GROWTH; MECHANISMS; INDUCTION; RESPONSES; PATHWAYS; STAT3	Constitutive activation of pro-survival kinases has become a promising target of small molecules with an increasing interest in developing multi-targeted agents. The mechanisms underlying the responsiveness to most agents targeting cancer specific survival pathways are still poorly understood but critical for their clinical application. In this study, we found that sunitinib, a small molecule inhibitor of multiple tyrosine kinases including VEGFRs and PDGFRs induces apoptosis and inhibits cell growth in colon cancer cells in cell culture and xenograft models via the BH3-only protein PUMA. Sunitinib treatment induced PUMA transcription via the AKT/FoxO3a axis. PUMA, BH3 mimetics, or 5-Flurourical sensitized colon cancer cells to sunitinib-induced apoptosis. Furthermore, PUMA was induced by sunitinib treatment in xenograft tumors, and deficiency in PUMA significantly suppressed the anti-tumor effects of sunitinib. Our study suggests that PUMA-mediated apoptosis is important for the therapeutic responses to sunitinib, and activation of the mitochondrial pathway by BH3 mimetics or PUMA manipulation may be useful for improving the antitumor activity of sunitinib. Modulation of PUMA and selective Bcl-2 family members might be potential biomarkers for predicting sunitinib responses.	[Sun, Jing; Sun, Quanhong; Brown, Matthew F.; Dudgeon, Crissy; Chandler, Julie; Zhang, Lin; Yu, Jian] Univ Pittsburgh, Pittsburgh Canc Inst, Pittsburgh, PA 15260 USA; [Sun, Jing; Sun, Quanhong; Brown, Matthew F.; Dudgeon, Crissy; Chandler, Julie; Zhang, Lin; Yu, Jian] Univ Pittsburgh, Sch Med, Dept Pathol, Pittsburgh, PA USA; [Sun, Jing; Sun, Quanhong; Brown, Matthew F.; Dudgeon, Crissy; Chandler, Julie; Zhang, Lin; Yu, Jian] Univ Pittsburgh, Sch Med, Dept Pharmacol & Chem Biol, Pittsburgh, PA USA; [Sun, Jing; Shu, Yongqian] Nanjing Med Univ, Affiliated Hosp 1, Dept Med Oncol, Nanjing, Jiangsu, Peoples R China; [Xu, Xiang] Third Mil Med Univ, Inst Surg Res, Chongqing, Peoples R China; [Xu, Xiang] Third Mil Med Univ, Daping Hosp, Chongqing, Peoples R China	Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Magee-Womens Research Institute; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Nanjing Medical University; Army Medical University; Army Medical University	Sun, J (corresponding author), Univ Pittsburgh, Pittsburgh Canc Inst, Pittsburgh, PA 15260 USA.	yuj2@upmc.edu	Zhang, Lin/A-7389-2009; Shu, Yongqian/ABD-5698-2021; xu, xiang/L-2579-2014; Yu, Jian/A-8301-2009	Zhang, Lin/0000-0003-0018-3903; Yu, Jian/0000-0002-4021-1000; Dudgeon, Crissy/0000-0001-9010-2569; xu, xiang/0000-0002-1026-2210	National Institutes of Health (NIH) [CA129829, CA106348, CA121105]; American Cancer Society [RGS-10-124-01-CCE, RSG-07-156-01-CNE]; FAMRI; National Natural Science Foundation of China [30772549];  [P30CA047904]; NATIONAL CANCER INSTITUTE [P30CA047904, R01CA129829, R01CA106348, R01CA172136, R01CA121105] Funding Source: NIH RePORTER	National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); American Cancer Society(American Cancer Society); FAMRI; National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); ; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work is supported by National Institutes of Health (NIH) grant CA129829, American Cancer Society grant RGS-10-124-01-CCE and FAMRI (J. Yu), and by NIH grants CA106348, CA121105 and American Cancer Society grant RSG-07-156-01-CNE (L. Zhang). This project used the UPCI shared facilities that were supported in part by award P30CA047904. J. Sun and Y. Shu are supported in part by National Natural Science Foundation of China Grants 30772549. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adams JM, 2007, ONCOGENE, V26, P1324, DOI 10.1038/sj.onc.1210220; Arena S, 2008, CELL CYCLE, V7, P1560, DOI 10.4161/cc.7.11.6031; Bunz F, 1999, J CLIN INVEST, V104, P263, DOI 10.1172/JCI6863; Burkitt K, 2009, MOL CANCER THER, V8, P1148, DOI 10.1158/1535-7163.MCT-08-0944; Mena AC, 2010, ANTI-CANCER DRUG, V21, pS3, DOI 10.1097/01.cad.0000361534.44052.c5; Chonghaile TN, 2011, SCIENCE, V334, P1129, DOI 10.1126/science.1206727; Deng J, 2007, CANCER CELL, V12, P171, DOI 10.1016/j.ccr.2007.07.001; Dudgeon C, 2010, MOL CANCER THER, V9, P2893, DOI 10.1158/1535-7163.MCT-10-0635; Faber AC, 2009, P NATL ACAD SCI USA, V106, P19503, DOI 10.1073/pnas.0905056106; Faivre S, 2007, NAT REV DRUG DISCOV, V6, P734, DOI 10.1038/nrd2380; Fesik SW, 2005, NAT REV CANCER, V5, P876, DOI 10.1038/nrc1736; Hait WN, 2009, CANCER RES, V69, P1263, DOI 10.1158/0008-5472.CAN-08-3836; Hanahan D, 2011, CELL, V144, P646, DOI 10.1016/j.cell.2011.02.013; Huang D, 2010, CANCER RES, V70, P1053, DOI 10.1158/0008-5472.CAN-09-3722; Jeffers JR, 2003, CANCER CELL, V4, P321, DOI 10.1016/S1535-6108(03)00244-7; Jemal A, 2009, CA-CANCER J CLIN, V59, P225, DOI 10.3322/caac.20006; Johnson KD, 2002, METHODS, V26, P27, DOI 10.1016/S1046-2023(02)00005-1; Johnstone RW, 2002, CELL, V108, P153, DOI 10.1016/S0092-8674(02)00625-6; Labi V, 2006, CELL DEATH DIFFER, V13, P1325, DOI 10.1038/sj.cdd.4401940; Leibowitz BJ, 2011, MOL CANCER RES, V9, P616, DOI 10.1158/1541-7786.MCR-11-0052; Ming LH, 2008, CARCINOGENESIS, V29, P1878, DOI 10.1093/carcin/bgn150; Ming L, 2006, J BIOL CHEM, V281, P16034, DOI 10.1074/jbc.M513587200; Naik E, 2011, J EXP MED, V208, P1351, DOI 10.1084/jem.20100951; Nakano K, 2001, MOL CELL, V7, P683, DOI 10.1016/S1097-2765(01)00214-3; Pinon JD, 2008, ONCOGENE, V27, pS41, DOI 10.1038/onc.2009.42; Qiu W, 2009, CANCER RES, V69, P4999, DOI 10.1158/0008-5472.CAN-09-0262; Rolff J, 2009, J ONCOL, V2009, DOI 10.1155/2009/814140; Saltz LB, 2007, J CLIN ONCOL, V25, P4793, DOI 10.1200/JCO.2007.12.8637; Sun Q, 2009, ONCOGENE, V28, P2348, DOI 10.1038/onc.2009.108; Sun Q, 2011, CLIN CANC RES; Sun Q, 2007, MOL CANCER THER, V6, P3180, DOI 10.1158/1535-7163.MCT-07-0265; Takezawa K, 2011, CLIN CANCER RES, V17, P2140, DOI 10.1158/1078-0432.CCR-10-2798; Villunger A, 2003, SCIENCE, V302, P1036, DOI 10.1126/science.1090072; Vogelstein B, 2004, NAT MED, V10, P789, DOI 10.1038/nm1087; Wang P, 2009, CELL DEATH DIFFER, V16, P1192, DOI 10.1038/cdd.2009.51; Wang P, 2007, P NATL ACAD SCI USA, V104, P4054, DOI 10.1073/pnas.0700020104; Xin H, 2009, CANCER RES, V69, P2506, DOI 10.1158/0008-5472.CAN-08-4323; Yang F, 2010, MOL CANCER RES, V8, P35, DOI 10.1158/1541-7786.MCR-09-0220; You H, 2006, J EXP MED, V203, P1657, DOI 10.1084/jem.20060353; Yu J, 2007, ONCOGENE, V26, P4189, DOI 10.1038/sj.onc.1210196; Yu J, 2001, MOL CELL, V7, P673, DOI 10.1016/S1097-2765(01)00213-1; Yu J, 1999, P NATL ACAD SCI USA, V96, P14517, DOI 10.1073/pnas.96.25.14517; Yu J, 2006, CLIN CANCER RES, V12, P2928, DOI 10.1158/1078-0432.CCR-05-2429; Yu J, 2004, CURR OPIN ONCOL, V16, P19, DOI 10.1097/00001622-200401000-00005; Yu J, 2008, ONCOGENE, V27, pS71, DOI 10.1038/onc.2009.45; Yu J, 2003, P NATL ACAD SCI USA, V100, P1931, DOI 10.1073/pnas.2627984100; Zhang JM, 2009, NAT REV CANCER, V9, P28, DOI 10.1038/nrc2559; Zhang L, 2007, DRUG RESIST UPDATE, V10, P207, DOI 10.1016/j.drup.2007.08.002	48	36	38	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 17	2012	7	8							e43158	10.1371/journal.pone.0043158	http://dx.doi.org/10.1371/journal.pone.0043158			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	996DG	22912816	Green Published, gold, Green Submitted, Green Accepted			2022-12-25	WOS:000308063700052
J	Ueta, M; Tokunaga, K; Sotozono, C; Sawai, H; Tamiya, G; Inatomi, T; Kinoshita, S				Ueta, Mayumi; Tokunaga, Katsushi; Sotozono, Chie; Sawai, Hiromi; Tamiya, Gen; Inatomi, Tsutomu; Kinoshita, Shigeru			HLA-A*0206 with TLR3 Polymorphisms Exerts More than Additive Effects in Stevens-Johnson Syndrome with Severe Ocular Surface Complications	PLOS ONE			English	Article							TOXIC EPIDERMAL NECROLYSIS; ERYTHEMA MULTIFORME; GENE POLYMORPHISMS; JAPANESE PATIENTS; ASSOCIATION; MANIFESTATIONS; CHILDREN; RISK	Background: Stevens-Johnson syndrome (SJS) is an acute inflammatory vesiculobullous reaction of the skin and mucosa, often including the ocular surface, and toxic epidermal necrolysis (TEN) occurs with its progression. Although SJS/TEN is thought to be initiated by certain types of medication coupled with possible infection. In the present study we examined the multiplicative interaction(s) between HLA-A*0206 and 7 Toll-like receptor 3 (TLR3) Single-nucleotide polymorphisms (SNPs) in patients with SJS/TEN. Principal Findings: We analyzed the genotypes for HLA-A and 7 TLR3 SNPs in 110 Japanese SJS/TEN patients with severe ocular complications and 206 healthy volunteers to examine the interactions between the two loci. We found that HLA-A*0206 exhibited a high odds ratio for SJS/TEN (carrier frequency: OR = 5.1; gene frequency: OR = 4.0) and that there was a strong association with TLR3 rs.5743312T/T SNP (OR = 7.4), TLR3 rs.3775296T/T SNP (OR = 5.8), TLR3 rs.6822014G/G SNP (OR = 4.8), TLR3 rs.3775290A/A SNP (OR = 2.9), TLR3 rs.7668666A/A SNP (OR = 2.7), TLR3 rs.4861699G/G SNP (OR = 2.3), and TLR3 rs.11732384G/G SNP (OR = 1.9). There was strong linkage disequilibrium (LD) between rs.3775296 and rs.5743312 and between rs.7668666 and rs.3775290. The results of interaction analysis showed that the pair, HLA-A*0206 and TLR3 SNP rs3775296T/T, which exhibited strong LD with TLR3 rs.5743312, exerted more than additive effects (OR = 47.7). The other pairs, HLA-A*0206 and TLR3 rs.3775290A/A SNP (OR = 11.4) which was in strong LD with TLR3 rs7668666A/A SNP, and TLR3 rs4861699G/G SNP (OR = 7.6) revealed additive effects. Moreover, the combination HLA-A*0206 and TLR3 rs3775296T/T was stronger than the TLR3 rs6822014G/G and TLR3 rs3775290A/A pair, which reflected the interactions within the TLR3 gene alone. Significance: By interaction analysis, HLA-A*0206 and TLR3 SNP rs3775296T/T, which were in strong LD with TLR3 SNP rs5743312T/T, manifested more than additive effects that were stronger than the interactions within the TLR3 gene alone. Therefore, multiplicative interactions of HLA-A and TLR3 gene might be required for the onset of SJS/TEN with ocular complications.	[Ueta, Mayumi; Sotozono, Chie; Inatomi, Tsutomu; Kinoshita, Shigeru] Kyoto Prefectural Univ Med, Dept Ophthalmol, Kyoto, Japan; [Ueta, Mayumi] Doshisha Univ, Fac Life & Med Sci, Res Ctr Inflammat & Regenerat Med, Kyoto 602, Japan; [Tokunaga, Katsushi; Sawai, Hiromi] Univ Tokyo, Dept Human Genet, Grad Sch Med, Tokyo, Japan; [Tamiya, Gen] Yamagata Univ, Adv Mol Epidemiol Res Inst, Fac Medcine, Yamagata 990, Japan	Kyoto Prefectural University of Medicine; Doshisha University; University of Tokyo; Yamagata University	Ueta, M (corresponding author), Kyoto Prefectural Univ Med, Dept Ophthalmol, Kyoto, Japan.	mueta@koto.kpu-m.ac.jp		Tamiya, Gen/0000-0002-0597-415X	Japanese Ministry of Health, Labour and Welfare; Japanese Ministry of Education, Culture, Sports, Science and Technology; Kyoto Foundation for the Promotion of Medical Science; Intramural Research Fund of Kyoto Prefectural University of Medicine; Grants-in-Aid for Scientific Research [22133008] Funding Source: KAKEN	Japanese Ministry of Health, Labour and Welfare(Ministry of Health, Labour and Welfare, Japan); Japanese Ministry of Education, Culture, Sports, Science and Technology(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Kyoto Foundation for the Promotion of Medical Science(Kyoto Foundation for the Promotion of Medical Science); Intramural Research Fund of Kyoto Prefectural University of Medicine; Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was supported in part by grants-in-aid for scientific research from the Japanese Ministry of Health, Labour and Welfare, the Japanese Ministry of Education, Culture, Sports, Science and Technology, a research grant from the Kyoto Foundation for the Promotion of Medical Science, and the Intramural Research Fund of Kyoto Prefectural University of Medicine. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Auquier-Dunant A, 2002, ARCH DERMATOL, V138, P1019, DOI 10.1001/archderm.138.8.1019; Di Pascuale MA, 2005, OPHTHALMOLOGY, V112, P904, DOI 10.1016/j.ophtha.2004.11.035; Forman R, 2002, DRUG SAFETY, V25, P965, DOI 10.2165/00002018-200225130-00006; Kaniwa N, 2010, EPILEPSIA, V51, P2461, DOI 10.1111/j.1528-1167.2010.02766.x; Kawai T, 2007, SEMIN IMMUNOL, V19, P24, DOI 10.1016/j.smim.2006.12.004; Leaute-Labreze C, 2000, ARCH DIS CHILD, V83, P347, DOI 10.1136/adc.83.4.347; MONDINO BJ, 1982, ARCH OPHTHALMOL-CHIC, V100, P1453; POWER WJ, 1995, OPHTHALMOLOGY, V102, P1669; ROUJEAU JC, 1995, NEW ENGL J MED, V333, P1600, DOI 10.1056/NEJM199512143332404; Sotozono C, 2007, OPHTHALMOLOGY, V114, P1294, DOI 10.1016/j.ophtha.2006.10.029; Sotozono C, 2009, OPHTHALMOLOGY, V116, P685, DOI 10.1016/j.ophtha.2008.12.048; Stevens AM, 1922, AM J DIS CHILD, V24, P526, DOI 10.1001/archpedi.1922.04120120077005; Ueta M, 2008, BRIT J OPHTHALMOL, V92, P989, DOI 10.1136/bjo.2007.136796; Ueta M, J ALLERGY C IN PRESS; Ueta M, 2008, MOL VIS, V14, P550; Ueta M, 2008, INVEST OPHTH VIS SCI, V49, P1809, DOI 10.1167/iovs.07-1401; Ueta M, 2007, J ALLERGY CLIN IMMUN, V120, P1457, DOI 10.1016/j.jaci.2007.07.048; Ueta M, 2007, BRIT J OPHTHALMOL, V91, P962, DOI 10.1136/bjo.2006.113449; Ueta M, 2007, AM J OPHTHALMOL, V143, P367, DOI 10.1016/j.ajo.2006.09.029; Ueta M, 2010, J ALLERGY CLIN IMMUN, V126, P1218, DOI 10.1016/j.jaci.2010.08.007; Ueta M, 2010, BRAIN RES BULL, V81, P219, DOI 10.1016/j.brainresbull.2009.10.001; Wolf R, 2005, CLIN DERMATOL, V23, P171, DOI 10.1016/j.clindermatol.2004.06.012; YETIV JZ, 1980, SOUTH MED J, V73, P599, DOI 10.1097/00007611-198005000-00015	23	30	32	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 17	2012	7	8							e43650	10.1371/journal.pone.0043650	http://dx.doi.org/10.1371/journal.pone.0043650			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	996DG	22912896	Green Submitted, gold, Green Published			2022-12-25	WOS:000308063700124
J	Gomez-Marin, A; Partoune, N; Stephens, GJ; Louis, M				Gomez-Marin, Alex; Partoune, Nicolas; Stephens, Greg J.; Louis, Matthieu			Automated Tracking of Animal Posture and Movement during Exploration and Sensory Orientation Behaviors	PLOS ONE			English	Article							DROSOPHILA LARVA; DECISION-MAKING; LIGHT-AVOIDANCE; HIGH-RESOLUTION; MACHINE VISION; CHEMOTAXIS; MECHANISMS; ELEGANS; SYSTEM; STRATEGIES	Background: The nervous functions of an organism are primarily reflected in the behavior it is capable of. Measuring behavior quantitatively, at high-resolution and in an automated fashion provides valuable information about the underlying neural circuit computation. Accordingly, computer-vision applications for animal tracking are becoming a key complementary toolkit to genetic, molecular and electrophysiological characterization in systems neuroscience. Methodology/Principal Findings: We present Sensory Orientation Software ( SOS) to measure behavior and infer sensory experience correlates. SOS is a simple and versatile system to track body posture and motion of single animals in two-dimensional environments. In the presence of a sensory landscape, tracking the trajectory of the animal's sensors and its postural evolution provides a quantitative framework to study sensorimotor integration. To illustrate the utility of SOS, we examine the orientation behavior of fruit fly larvae in response to odor, temperature and light gradients. We show that SOS is suitable to carry out high-resolution behavioral tracking for a wide range of organisms including flatworms, fishes and mice. Conclusions/Significance: Our work contributes to the growing repertoire of behavioral analysis tools for collecting rich and fine-grained data to draw and test hypothesis about the functioning of the nervous system. By providing open-access to our code and documenting the software design, we aim to encourage the adaptation of SOS by a wide community of non-specialists to their particular model organism and questions of interest.	[Gomez-Marin, Alex; Partoune, Nicolas; Louis, Matthieu] Ctr Genom Regulat, European Mol Biol Lab, Ctr Genom Regulat Syst Biol Unit, Barcelona, Spain; [Gomez-Marin, Alex; Partoune, Nicolas; Louis, Matthieu] Univ Pompeu Fabra, Barcelona, Spain; [Partoune, Nicolas] Univ Liege, Dept Elect Engn & Comp Sci, B-4000 Sart Tilman Par Liege, Belgium; [Stephens, Greg J.] Princeton Univ, Joseph Henry Labs, Phys & Lewis Sigler Inst Integrat Genom, Princeton, NJ 08544 USA	Barcelona Institute of Science & Technology; Pompeu Fabra University; Centre de Regulacio Genomica (CRG); European Molecular Biology Laboratory (EMBL); Pompeu Fabra University; University of Liege; Princeton University	Gomez-Marin, A (corresponding author), Ctr Genom Regulat, European Mol Biol Lab, Ctr Genom Regulat Syst Biol Unit, Barcelona, Spain.	agomezmarin@gmail.com; matthieu.louis@crg.eu	Louis, Matthieu/J-5566-2015; Gomez Marin, Alejandro/M-6408-2015	Louis, Matthieu/0000-0002-2267-0262; Stephens, Greg/0000-0003-3135-3514; Gomez Marin, Alejandro/0000-0003-2764-2583	Juan de la Cierva program from the Spanish Ministry of Science and Innovation; ERASMUS scholarship; University of Liege; National Science Foundation [PHY-0650617, IIS-0613435]; National Institutes of Health [P50 GM071508]; Swartz Foundation; Spanish Ministry of Science and Innovation [BFU2008-00362, BFU2009-07757-E/BMC]; European Molecular Biology Laboratory/Center for Genomic Regulation Systems Biology Program; Marie Curie Reintegration Grant [PIRG02-GA-2007-224791]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P50GM071508] Funding Source: NIH RePORTER	Juan de la Cierva program from the Spanish Ministry of Science and Innovation(Ministry of Science and Innovation, Spain (MICINN)); ERASMUS scholarship; University of Liege(University of Liege); National Science Foundation(National Science Foundation (NSF)); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Swartz Foundation; Spanish Ministry of Science and Innovation(Ministry of Science and Innovation, Spain (MICINN)Spanish Government); European Molecular Biology Laboratory/Center for Genomic Regulation Systems Biology Program; Marie Curie Reintegration Grant(European Commission); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	AGM is supported by the Juan de la Cierva program from the Spanish Ministry of Science and Innovation. NP was funded through an ERASMUS scholarship granted by the University of Liege. GJS is supported in part by grants PHY-0650617 and IIS-0613435 from the National Science Foundation, by grant P50 GM071508 from the National Institutes of Health, and by the Swartz Foundation. ML acknowledges funding from the Spanish Ministry of Science and Innovation (BFU2008-00362 and BFU2009-07757-E/BMC), the European Molecular Biology Laboratory/Center for Genomic Regulation Systems Biology Program and a Marie Curie Reintegration Grant (PIRG02-GA-2007-224791). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ACEVESPINA FO, 1979, SCIENCE, V206, P93, DOI 10.1126/science.206.4414.93; Baek JH, 2002, J NEUROSCI METH, V118, P9, DOI 10.1016/S0165-0270(02)00117-6; BERG HC, 1972, NATURE, V239, P500, DOI 10.1038/239500a0; Branson K, 2009, NAT METHODS, V6, P451, DOI [10.1038/nmeth.1328, 10.1038/NMETH.1328]; Busto M, 1999, J NEUROSCI, V19, P3337; Carde RT, 2008, J CHEM ECOL, V34, P854, DOI 10.1007/s10886-008-9484-5; Cobb M, 1999, BIOL REV, V74, P425, DOI 10.1017/S0006323199005393; Crespo JE, 2011, J INSECT PHYSIOL, V57, P191, DOI 10.1016/j.jinsphys.2010.11.010; Drai D, 2001, NEUROSCI BIOBEHAV R, V25, P409, DOI 10.1016/S0149-7634(01)00022-7; Faumont S, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024666; Fishilevich E, 2005, CURR BIOL, V15, P2086, DOI 10.1016/j.cub.2005.11.016; Fraenkel GS, 1961, ORIENTATION ANIMALS; Garrity PA, 2010, GENE DEV, V24, P2365, DOI 10.1101/gad.1953710; Gerber B, 2007, CHEM SENSES, V32, P65, DOI 10.1093/chemse/bjl030; Gershow M, 2012, NAT METHODS, V9, P290, DOI [10.1038/NMETH.1853, 10.1038/nmeth.1853]; Gilestro GF, 2009, BIOINFORMATICS, V25, P1466, DOI 10.1093/bioinformatics/btp237; Gomez-Marin A, 2012, CURR OPIN NEUROBIOL, V22, P208, DOI 10.1016/j.conb.2011.11.008; Gomez-Marin A, 2011, NAT COMMUN, V2, DOI 10.1038/ncomms1455; Gomez-Marin A, 2010, FRONT CELL NEUROSCI, V4, DOI 10.3389/fncel.2010.00006; Hassan J, 2000, BEHAV GENET, V30, P59, DOI 10.1023/A:1002090627601; Huang KM, 2006, J NEUROSCI METH, V158, P323, DOI 10.1016/j.jneumeth.2006.06.007; Huston SJ, 2011, CURR OPIN NEUROBIOL, V21, P527, DOI 10.1016/j.conb.2011.05.030; Iino Y, 2009, J NEUROSCI, V29, P5370, DOI 10.1523/JNEUROSCI.3633-08.2009; Inoue T, 2004, ZOOL SCI, V21, P275, DOI 10.2108/zsj.21.275; Jekely G, 2008, NATURE, V456, P395, DOI 10.1038/nature07590; Kane E, SENSORIMOTOR B UNPUB; Keene AC, 2011, J NEUROSCI, V31, P6527, DOI 10.1523/JNEUROSCI.6165-10.2011; Khurana S, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015259; Kohlhoff KJ, 2011, INTEGR BIOL-UK, V3, P755, DOI 10.1039/c0ib00149j; Leifer AM, 2011, NAT METHODS, V8, P147, DOI 10.1038/NMETH.1554; Leshner A, 2011, P NATL ACAD SCI USA, V108, P15537, DOI 10.1073/pnas.1010653108; Lockery SR, 2011, CURR OPIN NEUROBIOL; Lott GK, 2010, GVISION SCI VIDEO IM; Louis M, 2008, NAT NEUROSCI, V11, P187, DOI 10.1038/nn2031; Luo LJ, 2010, J NEUROSCI, V30, P4261, DOI 10.1523/JNEUROSCI.4090-09.2010; Min TL, 2009, NAT METHODS, V6, P831, DOI [10.1038/NMETH.1380, 10.1038/nmeth.1380]; MONTE P, 1989, BEHAV GENET, V19, P267, DOI 10.1007/BF01065910; Orgogozo V, 2006, GENETICS, V173, P197, DOI 10.1534/genetics.105.054098; Pierce-Shimomura JT, 1999, J NEUROSCI, V19, P9557; Ramot D, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002208; SAWIN FP, 1994, J INSECT BEHAV, V7, P553, DOI 10.1007/BF02025449; Scantlebury N, 2007, BEHAV GENET, V37, P513, DOI 10.1007/s10519-007-9146-3; Sprecher SG, 2008, NATURE, V454, P533, DOI 10.1038/nature07062; Stephens GJ, 2008, PLOS COMPUT BIOL, V4, DOI 10.1371/journal.pcbi.1000028; Stephens GJ, 2011, P NATL ACAD SCI USA, V108, P15565, DOI 10.1073/pnas.1010868108; Straw AD, 2011, J R SOC INTERFACE, V8, P395, DOI 10.1098/rsif.2010.0230; Swierczek NA, 2011, NAT METHODS, V8, P592, DOI [10.1038/NMETH.1625, 10.1038/nmeth.1625]; Webster DR, 2009, ANNU REV FLUID MECH, V41, P73, DOI 10.1146/annurev.fluid.010908.165240; Xiang Y, 2010, NATURE, V468, P921, DOI 10.1038/nature09576	49	64	65	2	51	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 9	2012	7	8							e41642	10.1371/journal.pone.0041642	http://dx.doi.org/10.1371/journal.pone.0041642			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	986WZ	22912674	gold, Green Published, Green Submitted			2022-12-25	WOS:000307378500007
J	Foersch, S; Heimann, A; Ayyad, A; Spoden, GA; Florin, L; Mpoukouvalas, K; Kiesslich, R; Kempski, O; Goetz, M; Charalampaki, P				Foersch, Sebastian; Heimann, Axel; Ayyad, Ali; Spoden, Gilles A.; Florin, Luise; Mpoukouvalas, Konstantin; Kiesslich, Ralf; Kempski, Oliver; Goetz, Martin; Charalampaki, Patra			Confocal Laser Endomicroscopy for Diagnosis and Histomorphologic Imaging of Brain Tumors In Vivo	PLOS ONE			English	Article							GLIOBLASTOMA-MULTIFORME; 5-AMINOLEVULINIC ACID; COLORECTAL-CANCER; MALIGNANT GLIOMA; MICROSCOPY; RESECTION; NEUROSURGERY; LAPAROSCOPY; SURVIVAL; SURGERY	Early detection and evaluation of brain tumors during surgery is crucial for accurate resection. Currently cryosections during surgery are regularly performed. Confocal laser endomicroscopy (CLE) is a novel technique permitting in vivo histologic imaging with miniaturized endoscopic probes at excellent resolution. Aim of the current study was to evaluate CLE for in vivo diagnosis in different types and models of intracranial neoplasia. In vivo histomorphology of healthy brains and two different C6 glioma cell line allografts was evaluated in rats. One cell line expressed EYFP, the other cell line was used for staining with fluorescent dyes (fluorescein, acriflavine, FITC-dextran and Indocyanine green). To evaluate future application in patients, fresh surgical resection specimen of human intracranial tumors (n = 15) were examined (glioblastoma multiforme, meningioma, craniopharyngioma, acoustic neurinoma, brain metastasis, medulloblastoma, epidermoid tumor). Healthy brain tissue adjacent to the samples served as control. CLE yielded high-quality histomorphology of normal brain tissue and tumors. Different fluorescent agents revealed distinct aspects of tissue and cell structure (nuclear pattern, axonal pathways, hemorrhages). CLE discrimination of neoplastic from healthy brain tissue was easy to perform based on tissue and cellular architecture and resemblance with histopathology was excellent. Confocal laser endomicroscopy allows immediate in vivo imaging of normal and neoplastic brain tissue at high resolution. The technology might be transferred to scientific and clinical application in neurosurgery and neuropathology. It may become helpful to screen for tumor free margins and to improve the surgical resection of malignant brain tumors, and opens the door to in vivo molecular imaging of tumors and other neurologic disorders.	[Foersch, Sebastian; Kiesslich, Ralf; Goetz, Martin] Univ Med Ctr, Med Clin 1, Mainz, Germany; [Heimann, Axel; Kempski, Oliver; Charalampaki, Patra] Univ Med Ctr, Inst Neurosurg Pathophysiol, Mainz, Germany; [Ayyad, Ali] Univ Med Ctr, Dept Neurosurg, Mainz, Germany; [Charalampaki, Patra] Med Univ Graz, Dept Neurosurg, Graz, Austria; [Spoden, Gilles A.; Florin, Luise] Univ Med Ctr, Dept Med Microbiol & Hyg, Mainz, Germany; [Mpoukouvalas, Konstantin] Inst Microtechnol Mainz, Mainz, Germany	Johannes Gutenberg University of Mainz; Johannes Gutenberg University of Mainz; Johannes Gutenberg University of Mainz; Medical University of Graz; Johannes Gutenberg University of Mainz	Foersch, S (corresponding author), Univ Med Ctr, Med Clin 1, Mainz, Germany.	kempski@nc-patho.klinik.uni-mainz.de	Ralf Kiesslich, Dr./AAK-9313-2021	Heimann, Axel/0000-0003-2510-3228	German Federal Ministry of Education and Research [16SV5069]; Boehringer-Ingelheim-Foundation; Professional Association of German Internists; Olympus Europe Foundation	German Federal Ministry of Education and Research(Federal Ministry of Education & Research (BMBF)); Boehringer-Ingelheim-Foundation(Boehringer Ingelheim); Professional Association of German Internists; Olympus Europe Foundation	This work was supported by a governmental grant from the German Federal Ministry of Education and Research (No. 16SV5069) to OK. SF received scholarships from the Boehringer-Ingelheim-Foundation, the Professional Association of German Internists and a grant from the Olympus Europe Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Becker V, 2007, GASTROINTEST ENDOSC, V66, P1001, DOI 10.1016/j.gie.2007.04.015; Buckner JC, 2003, SEMIN ONCOL, V30, P10, DOI 10.1053/j.seminoncol.2003.11.031; Callovini GM, 2008, MINIM INVAS NEUROSUR, V51, P109, DOI 10.1055/s-2008-1058096; Deinert K, 2007, ENDOSCOPY, V39, P366, DOI 10.1055/s-2007-966217; Dunbar KB, 2009, GASTROINTEST ENDOSC, V70, P645, DOI 10.1016/j.gie.2009.02.009; Eschbacher J, 2012, J NEUROSURG, V116, P854, DOI 10.3171/2011.12.JNS11696; Field P, 2001, J NEUROSURG, V94, P545, DOI 10.3171/jns.2001.94.4.0545; Foersch S, 2010, GUT, V59, P1046, DOI 10.1136/gut.2009.202986; Goetz M, 2008, EUR SURG RES, V41, P290, DOI 10.1159/000148242; Goetz M, 2007, ENDOSCOPY, V39, P350, DOI 10.1055/s-2007-966262; Goetz M, 2008, J HEPATOL, V48, P91, DOI 10.1016/j.jhep.2007.07.029; Goetz M, 2010, J HEPATOL, V53, P84, DOI 10.1016/j.jhep.2010.01.039; Goetz M, 2010, GASTROENTEROLOGY, V138, P435, DOI 10.1053/j.gastro.2009.10.032; Goetz M, 2009, GASTROINTEST ENDOSC, V70, P959, DOI 10.1016/j.gie.2009.04.016; Gunther U, 2008, GUT, V57, P1331; Hale SL, 2011, TOXICOL PATHOL, V39, P52, DOI 10.1177/0192623310394213; Hammoud MA, 1996, J NEURO-ONCOL, V27, P65, DOI 10.1007/BF00146086; Hsiung PL, 2008, NAT MED, V14, P454, DOI 10.1038/nm1692; Kiesslich R, 2004, GASTROENTEROLOGY, V127, P706, DOI 10.1053/j.gastro.2004.06.050; Kiesslich R, 2007, GASTROENTEROLOGY, V133, P742, DOI 10.1053/j.gastro.2007.07.037; Knauer SK, 2006, EMBO REP, V7, P1259, DOI 10.1038/sj.embor.7400824; Krizova A, 2011, AM J SURG PATHOL, V35, P115, DOI 10.1097/PAS.0b013e31820273dc; Lacroix M, 2001, J NEUROSURG, V95, P190, DOI 10.3171/jns.2001.95.2.0190; Martirosyan NL, 2011, J NEUROSURG, V115, P1131, DOI 10.3171/2011.8.JNS11559; Sanai N, 2008, NEUROSURGERY, V62, P753, DOI 10.1227/01.neu.0000318159.21731.cf; Sankar T, 2010, NEUROSURGERY, V66, P410, DOI 10.1227/01.NEU.0000365772.66324.6F; Schlosser HG, 2010, CENT EUR NEUROSURG, V71, P13, DOI 10.1055/s-0029-1237735; Stummer W, 2006, LANCET ONCOL, V7, P392, DOI 10.1016/S1470-2045(06)70665-9; Stummer W, 1998, J PHOTOCH PHOTOBIO B, V45, P160, DOI 10.1016/S1011-1344(98)00176-6; Stummer W, 2000, J NEUROSURG, V93, P1003, DOI 10.3171/jns.2000.93.6.1003; Stummer W, 2011, ACTA NEUROCHIR, V153, P1211, DOI 10.1007/s00701-011-1001-x; Suh JH, 2010, NEW ENGL J MED, V362, P1119, DOI 10.1056/NEJMct0806951; Tanaka Y, 2009, J NEUROSURG, V110, P163, DOI 10.3171/2008.4.17569; Van Meir EG, 2010, CA-CANCER J CLIN, V60, P166, DOI 10.3322/caac.20069; Waldner MJ, 2010, J EXP MED, V207, P2855, DOI 10.1084/jem.20100438; Wiesner C, 2011, BJU INT, V107, P399, DOI 10.1111/j.1464-410X.2010.09540.x	36	56	60	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 24	2012	7	7							e41760	10.1371/journal.pone.0041760	http://dx.doi.org/10.1371/journal.pone.0041760			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	978NX	22911853	Green Published, gold			2022-12-25	WOS:000306751300071
J	Wang, CY; Zhu, Z; Xu, Q; Xu, AQ; Fang, XQ; Song, LZ; Li, WX; Xiong, P; Xu, WB				Wang, Changyin; Zhu, Zhen; Xu, Qing; Xu, Aiqiang; Fang, Xueqiang; Song, Lizhi; Li, Weixiu; Xiong, Ping; Xu, Wenbo			Rubella Epidemics and Genotypic Distribution of the Rubella Virus in Shandong Province, China, in 1999-2010	PLOS ONE			English	Article							PHYLOGENETIC ANALYSIS; PREVENTION	Background: The rubella vaccine was introduced into the immunization program in 1995 in the Shandong province, China. A series of different rubella vaccination strategies were implemented at different stages of measles control in Shandong province. Methodology/Principal Findings: The average reported incidence rate of rubella cases remained at a low level in Shandong province after 1999. However, rubella epidemics occurred repeatedly in 2001/2002, 2006, and 2008/2009. The age of the onset of rubella cases gradually increased during 1999-2010, which showed that most cases were found among the 10 years old in 1999 and among the 17 years old in 2010. Phylogenetic analysis was performed and a phylogenetic tree was constructed based on the World Health Organization standard sequence window for rubella virus isolates. All rubella viruses isolated in Shandong province were divided into 4 genotypes: 1E, 1F, 2A, and 2B. Genotype 1E viruses accounted for the majority (79%) of all these viruses. The similarity of nucleotide and amino acid sequences among genotype 1E viruses was 98.2-100% and 99.1-100%, respectively. All Shandong genotype 1E strains, differed from international genotype 1E strains, belonged to cluster 1 and interdigitated with the viruses from other provinces in mainland China. The effective number of infections indicated by a Bayesian skyline plot remained constant from 2001 to 2009. Conclusions/Significance: The gradual shift of disease burden to an older age group occurred after a rubella-containing vaccine was introduced into the childhood immunization schedule in 1995 in Shandong province. Four genotypes, including 1E, 1F, 2A, and 2B, were found in Shandong province during 2000-2009. Genotype 1E, rather than genotype 1F, became the predominant genotype circulating in Shandong province from 2001. All Shandong genotype 1E viruses belong to the genotype 1E/cluster 1; they have constantly circulated, and co-evolved and co-circulated, with those from other provinces.	[Wang, Changyin; Xu, Qing; Xu, Aiqiang; Fang, Xueqiang; Song, Lizhi; Li, Weixiu; Xiong, Ping] Shandong Ctr Dis Control & Prevent, Shandong Prov Key Lab Infect Dis Control & Preven, Jinan, Peoples R China; [Zhu, Zhen; Xu, Wenbo] Chinese Ctr Dis Control & Prevent, Natl Inst Viral Dis Control & Prevent, WHO WPRO Reg Reference Measles Rubella Lab, Beijing, Peoples R China	Chinese Center for Disease Control & Prevention; National Institute for Viral Disease Control & Prevention, Chinese Center for Disease Control & Prevention	Wang, CY (corresponding author), Shandong Ctr Dis Control & Prevent, Shandong Prov Key Lab Infect Dis Control & Preven, Jingshi Rd, Jinan, Peoples R China.	aqxuepi@163.com; wenbo_xu1@yahoo.com.cn		ll, li/0000-0001-9925-3021	Key Research Plan on Medicine from the Health Department of Shandong province in China [2009HD014]; National Natural Science Foundation of China [81101244]; National Infectious Diseases Surveillance Program [2012ZX10004201, 2008ZX10004-008, 2009ZX10004-201, 2009ZX10004-202]; WHO Measles Regional Reference Laboratory funding [WPCHN1002802]	Key Research Plan on Medicine from the Health Department of Shandong province in China; National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); National Infectious Diseases Surveillance Program; WHO Measles Regional Reference Laboratory funding	This work was supported by the Key Research Plan on Medicine from the Health Department of Shandong province in China (2009HD014), the National Natural Science Foundation of China (project no. 81101244), the National Infectious Diseases Surveillance Program (2012ZX10004201, 2008ZX10004-008, 2009ZX10004-201, and 2009ZX10004-202), and WHO Measles Regional Reference Laboratory funding (WPCHN1002802). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abernathy ES, 2011, J INFECT DIS, V204, pS524, DOI 10.1093/infdis/jir099; Adam O, 2010, CLIN MICROBIOL INFEC, V16, P678, DOI 10.1111/j.1469-0691.2009.02966.x; [Anonymous], 2007, Wkly Epidemiol Rec, V82, P216; [Anonymous], 2011, Wkly Epidemiol Rec, V86, P301; [Anonymous], 2005, Wkly Epidemiol Rec, V80, P126; [Anonymous], 2000, Wkly Epidemiol Rec, V75, P290; [Anonymous], 2006, Wkly Epidemiol Rec, V81, P474; Castillo-Solorzano C, 2003, J INFECT DIS, V187, pS146, DOI 10.1086/368034; Chen MH, 2007, PERSP MED V, V15, P1, DOI 10.1016/S0168-7069(06)15001-6; COOPER LZ, 1985, REV INFECT DIS, V7, pS2; Drummond AJ, 2005, MOL BIOL EVOL, V22, P1185, DOI [10.1093/molbev/msi103, 10.1093/molbev/mss075]; FREY TK, 1994, ADV VIRUS RES, V44, P69, DOI 10.1016/S0065-3527(08)60328-0; HAN YR, 1985, REV INFECT DIS, V7, pS79; Hubschen JM, 2007, J GEN VIROL, V88, P1960, DOI 10.1099/vir.0.82580-0; Jin L, 2007, J MED VIROL, V79, P1017, DOI 10.1002/jmv.20847; Lee JY, 2000, CLIN MICROBIOL REV, V13, P571, DOI 10.1128/CMR.13.4.571-587.2000; Reef SE, 2011, J INFECT DIS, V204, pS24, DOI 10.1093/infdis/jir155; Song XQ, 2007, PREVENTIVE MED TRIBU, V7, P577; Tamura K, 2007, MOL BIOL EVOL, V24, P1596, DOI 10.1093/molbev/msm092; Vauloup-Fellous C, 2010, J CLIN MICROBIOL, V48, P2530, DOI 10.1128/JCM.00181-10; Vynnycky E, 2003, VACCINE, V21, P2708, DOI 10.1016/S0264-410X(03)00229-9; World Health Organization, 2005, Wkly Epidemiol Rec, V80, P141; World Health Organization, 2000, Weekly Epidemiological Record, V75, P161; Xu Aiqiang, 2003, Journal of Infectious Diseases, V187, pS258, DOI 10.1086/368044; Zheng DP, 2003, EMERG INFECT DIS, V9, P1523; Zheng DP, 2003, J INFECT DIS, V187, P1587, DOI 10.1086/374972; Zhu Z, 2007, J CLIN MICROBIOL, V45, P2847, DOI 10.1128/JCM.00289-07; Zhu Z, 2012, J CLIN MICROBIOL, V50, P353, DOI 10.1128/JCM.01264-11; Zhu Z, 2010, J CLIN MICROBIOL, V48, P1775, DOI 10.1128/JCM.02055-09	29	11	14	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 24	2012	7	7							e42013	10.1371/journal.pone.0042013	http://dx.doi.org/10.1371/journal.pone.0042013			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	978NX	22911874	Green Published, Green Submitted, gold			2022-12-25	WOS:000306751300090
J	Gillis, LD; Lewis, SM				Gillis, L. D.; Lewis, S. M.			Decreased eIF3e/Int6 expression causes epithelial-to-mesenchymal transition in breast epithelial cells	ONCOGENE			English	Article						migration; metastasis; breast cancer; Snail1; Zeb2; translation initiation	MAMMARY-TUMOR VIRUS; TRANSLATION INITIATION; GENE-EXPRESSION; MIR-200 FAMILY; SNAIL; INT6; TRANSCRIPTION; PHOSPHORYLATION; PROGRESSION; INT6/EIF3E	eIF3e/Int6 is a component of the multi-subunit eIF3 complex, which binds directly to the 40S ribosome to facilitate ribosome recruitment to mRNA and hence protein synthesis. Reduced expression of eIF3e/Int6 has been found in up to 37% of human breast cancers, and expression of a truncated mutant version of the mouse eIF3e/Int6 protein leads to malignant transformation of normal mammary cells. These findings suggest that eIF3e/Int6 is a tumor suppressor; however, a recent study has reported that a reduction of eIF3e/Int6 expression in breast cancer cells leads to reduced translation of oncogenes, suggesting that eIF3e/Int6 may in fact have an oncogenic role in breast cancer. To gain a better understanding of the role of eIF3e/Int6 in breast cancer, we have examined the effects of decreased eIF3e/Int6 expression in an immortalized breast epithelial cell line, MCF-10A. Surprisingly, we find that decreased expression of eIF3e/Int6 causes breast epithelial cells to undergo epithelial-to-mesenchymal transition (EMT). We show that EMT induced by a decrease in eIF3e/Int6 expression imparts invasive and migratory properties to breast epithelial cells, suggesting that regulation of EMT by eIF3e/Int6 may have an important role in breast cancer metastasis. Furthermore, we show that reduced eIF3e/Int6 expression in breast epithelial cells causes a specific increase in the expression of the key EMT regulators Snail1 and Zeb2, which occurs at both the transcriptional and post-transcriptional levels. Together, our data indicate a novel role of eIF3e/Int6 in the regulation of EMT in breast epithelial cells and support a tumor suppressor role of eIF3e/Int6.	[Gillis, L. D.; Lewis, S. M.] Hotel Dieu Pavil, Atlantic Canc Res Inst, Moncton, NB E1C 8X3, Canada; [Lewis, S. M.] Dalhousie Univ, Dept Microbiol & Immunol, Halifax, NS, Canada; [Lewis, S. M.] Univ New Brunswick, Dept Biol, St John, NB E2L 4L5, Canada	Dalhousie University; University of New Brunswick	Lewis, SM (corresponding author), Hotel Dieu Pavil, Atlantic Canc Res Inst, 35 Providence St, Moncton, NB E1C 8X3, Canada.	stephenl@canceratl.ca	Lewis, Stephen/E-5533-2010	Lewis, Stephen/0000-0001-9537-5822	Canadian Breast Cancer Foundation-Atlantic Chapter; Canadian Institutes of Health Research-Regional [RSH-108667]	Canadian Breast Cancer Foundation-Atlantic Chapter; Canadian Institutes of Health Research-Regional	We thank Dr Craig McCormick for the generous gift of the retroviral transduction system used in this study, Dr Anirban Ghosh for advice on confocal immunofluorescence microscopy and Dr Martin Holcik for critical comments on the manuscript. This research was supported by a grant to SML from the Canadian Breast Cancer Foundation-Atlantic Chapter. SML is a Senior Scientist of the Beatrice Hunter Cancer Research Institute and a Canadian Institutes of Health Research-Regional Partnerships Program New Investigator (RSH-108667).	Ansieau S, 2008, CANCER CELL, V14, P79, DOI 10.1016/j.ccr.2008.06.005; Bandyopadhyay A, 2000, MOL BIOL CELL, V11, P4005, DOI 10.1091/mbc.11.11.4005; Barbera MJ, 2004, ONCOGENE, V23, P7345, DOI 10.1038/sj.onc.1207990; Barrallo-Gimeno A, 2005, DEVELOPMENT, V132, P3151, DOI 10.1242/dev.01907; Beltran M, 2008, GENE DEV, V22, P756, DOI 10.1101/gad.455708; Bustin SA, 2000, J MOL ENDOCRINOL, V25, P169, DOI 10.1677/jme.0.0250169; Chaudhury A, 2010, NAT CELL BIOL, V12, P286, DOI 10.1038/ncb2029; Chiluiza D, 2011, J BIOL CHEM, V286, P31288, DOI 10.1074/jbc.M111.267294; Debnath J, 2003, METHODS, V30, P256, DOI 10.1016/S1046-2023(03)00032-X; Evdokimova V, 2009, CELL CYCLE, V8, P2901, DOI 10.4161/cc.8.18.9537; Evdokimova V, 2009, CANCER CELL, V15, P402, DOI 10.1016/j.ccr.2009.03.017; Gregory PA, 2008, NAT CELL BIOL, V10, P593, DOI 10.1038/ncb1722; Grzmil M, 2010, ONCOGENE, V29, P4080, DOI 10.1038/onc.2010.152; Hanahan D, 2011, CELL, V144, P646, DOI 10.1016/j.cell.2011.02.013; Jechlinger M, 2003, ONCOGENE, V22, P7155, DOI 10.1038/sj.onc.1206887; Kalluri R, 2009, J CLIN INVEST, V119, P1420, DOI 10.1172/JCI39104; Korpal M, 2008, J BIOL CHEM, V283, P14910, DOI 10.1074/jbc.C800074200; KOZAK M, 1986, P NATL ACAD SCI USA, V83, P2850, DOI 10.1073/pnas.83.9.2850; Kurrey NK, 2009, STEM CELLS, V27, P2059, DOI 10.1002/stem.154; LeFebvre AK, 2006, J BIOL CHEM, V281, P22917, DOI 10.1074/jbc.M605418200; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Luo DC, 2011, MOL CANCER RES, V9, P234, DOI 10.1158/1541-7786.MCR-10-0214; Mack DL, 2007, BREAST CANCER RES, V9, DOI 10.1186/bcr1742; MARCHETTI A, 1995, J VIROL, V69, P1932, DOI 10.1128/JVI.69.3.1932-1938.1995; Marchetti A, 2001, INT J ONCOL, V18, P175; Morris C, 2005, ONCOGENE, V24, P1203, DOI 10.1038/sj.onc.1208268; Morris C, 2007, EMBO REP, V8, P596, DOI 10.1038/sj.embor.7400955; PAINE TM, 1992, INT J CANCER, V50, P463, DOI 10.1002/ijc.2910500323; Petz M, 2007, NUCLEIC ACIDS RES, V35, P2473, DOI 10.1093/nar/gkm096; Rasmussen SB, 2001, ONCOGENE, V20, P5291, DOI 10.1038/sj.onc.1204624; Raun R, MRNA FORMATION FUNCT, P305; SOULE HD, 1990, CANCER RES, V50, P6075; Suo J, 2011, ONCOGENE, V30, P724, DOI 10.1038/onc.2010.445; Thiery JP, 2009, CELL, V139, P871, DOI 10.1016/j.cell.2009.11.007; Yen HCS, 2003, CELL, V112, P207, DOI 10.1016/S0092-8674(03)00043-6; Zeisberg M, 2009, J CLIN INVEST, V119, P1429, DOI 10.1172/JCI36183; Zhao TT, 2009, CELL DEATH DIFFER, V16, P244, DOI 10.1038/cdd.2008.146; Zhou BHP, 2004, NAT CELL BIOL, V6, P931, DOI 10.1038/ncb1173; Zhou CS, 2005, BMC BIOL, V3, DOI 10.1186/1741-7007-3-14; Zhou M, 2008, P NATL ACAD SCI USA, V105, P18139, DOI 10.1073/pnas.0801313105	40	25	25	0	5	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	AUG 1	2013	32	31					3598	3605		10.1038/onc.2012.371	http://dx.doi.org/10.1038/onc.2012.371			8	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	194MW	22907435				2022-12-25	WOS:000322638400004
J	Tanaka, T; Yamaguchi, J; Shoji, K; Nangaku, M				Tanaka, Tetsuhiro; Yamaguchi, Junna; Shoji, Kumi; Nangaku, Masaomi			Anthracycline Inhibits Recruitment of Hypoxia-inducible Transcription Factors and Suppresses Tumor Cell Migration and Cardiac Angiogenic Response in the Host	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							LYSYL OXIDASE; CANCER; EXPRESSION; CARCINOMA; BINDING; MODEL; HIF; HIF-2-ALPHA; HIF-1-ALPHA; METASTASIS	Anthracycline chemotherapeutic agents of the topoisomerase inhibitor family are widely used for the treatment of various tumors. Although targeted tumor tissues are generally situated in a hypoxic environment, the connection between efficacy of anthracycline agents and cellular hypoxia response has not been investigated in depth. Here, we report that doxorubicin (DXR) impairs the transcriptional response of the hypoxia-inducible factor (HIF) by inhibiting the binding of the HIF heterodimer to the consensus - RCGTG-enhancer element. This pleiotropic effect retarded migration of von Hippel-Lindau (VHL)-defective renal cell carcinoma and that of VHL-competent renal cell carcinoma in hypoxia. This effect was accompanied by a coordinated down-regulation of HIF target lysyl oxidase (LOX) family members LOX, LOX-like2 (LOXL2), and LOXL4. Furthermore, DXR suppressed HIF target genes in tumor xenografts, inhibited cardiac induction of HIF targets in rats with acute anemia, and impaired the angiogenic response in the isoproterenol-induced heart failure model, which may account for the clinical fragility of doxorubicin cardiomyopathy. Collectively, these findings highlight the impaired hypoxia response by anthracycline agents affecting both tumors and organs of the cancer host and offer a promising opportunity to develop HIF inhibitors using DXR as a chemical template.	[Tanaka, Tetsuhiro] Univ Tokyo, Div Hlth Serv Promot, Tokyo 1138655, Japan; [Tanaka, Tetsuhiro; Yamaguchi, Junna; Shoji, Kumi; Nangaku, Masaomi] Univ Tokyo, Sch Med, Div Nephrol & Endocrinol, Bunkyo Ku, Tokyo 1138655, Japan	University of Tokyo; University of Tokyo	Tanaka, T (corresponding author), Univ Tokyo, Div Hlth Serv Promot, Tokyo 1138655, Japan.	tetsu-tky@umin.ac.jp; mnangaku-tky@umin.ac.jp			Japan Society for the Promotion of Science [24390213, 22790781]; Takeda Science Foundation	Japan Society for the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); Takeda Science Foundation(Takeda Science Foundation (TSF))	This work was supported by Grants-in-aid for Scientific Research 24390213 (to M. N.) and 22790781 (to T. T.) from the Japan Society for the Promotion of Science and a research grant from the Takeda Science Foundation (to T. T.).	Aebersold DM, 2001, CANCER RES, V61, P2911; Bernhardt WM, 2009, P NATL ACAD SCI USA, V106, P21276, DOI 10.1073/pnas.0903978106; Brizel DM, 1997, INT J RADIAT ONCOL, V38, P285, DOI 10.1016/S0360-3016(97)00101-6; Dang EV, 2011, CELL, V146, P772, DOI 10.1016/j.cell.2011.07.033; Erler JT, 2006, NATURE, V440, P1222, DOI 10.1038/nature04695; Fu LP, 2011, CANCER RES, V71, P6848, DOI 10.1158/0008-5472.CAN-11-1745; Grimm D, 1998, CARDIOVASC RES, V37, P91, DOI 10.1016/S0008-6363(97)00212-5; HOCKEL M, 1993, RADIOTHER ONCOL, V26, P45, DOI 10.1016/0167-8140(93)90025-4; Hollosi P, 2009, INT J CANCER, V125, P318, DOI 10.1002/ijc.24308; Hu CJ, 2007, MOL BIOL CELL, V18, P4528, DOI 10.1091/mbc.E06-05-0419; Huang LE, 2008, CELL DEATH DIFFER, V15, P672, DOI 10.1038/sj.cdd.4402302; Kaelin WG, 2008, MOL CELL, V30, P393, DOI 10.1016/j.molcel.2008.04.009; Kondo K, 2003, PLOS BIOL, V1, P439, DOI 10.1371/journal.pbio.0000083; Kondo K, 2002, CANCER CELL, V1, P237, DOI 10.1016/S1535-6108(02)00043-0; Koshiji M, 2004, EMBO J, V23, P1949, DOI 10.1038/sj.emboj.7600196; Kung AL, 2000, NAT MED, V6, P1335, DOI 10.1038/82146; Lee K, 2009, P NATL ACAD SCI USA, V106, P2353, DOI 10.1073/pnas.0812801106; Liang CC, 2007, NAT PROTOC, V2, P329, DOI 10.1038/nprot.2007.30; Liao D, 2007, CANCER RES, V67, P563, DOI 10.1158/0008-5472.CAN-06-2701; Longley DB, 2005, J PATHOL, V205, P275, DOI 10.1002/path.1706; Maranchie JK, 2002, CANCER CELL, V1, P247, DOI 10.1016/S1535-6108(02)00044-2; Maynard MA, 2003, J BIOL CHEM, V278, P11032, DOI 10.1074/jbc.M208681200; McGuire J, 2001, J BIOL CHEM, V276, P41841, DOI 10.1074/jbc.M105607200; Mole DR, 2009, J BIOL CHEM, V284, P16767, DOI 10.1074/jbc.M901790200; Nordsmark M, 1996, RADIOTHER ONCOL, V41, P31, DOI 10.1016/S0167-8140(96)91811-3; Oh MK, 2011, J BIOL CHEM, V286, P8857, DOI 10.1074/jbc.M110.150557; Quesada AJ, 2005, CELL DEATH DIFFER, V12, P649, DOI 10.1038/sj.cdd.4401615; Sano M, 2007, NATURE, V446, P444, DOI 10.1038/nature05602; Schietke R, 2010, J BIOL CHEM, V285, P6658, DOI 10.1074/jbc.M109.042424; Spagnuolo RD, 2011, BRIT J PHARMACOL, V163, P299, DOI 10.1111/j.1476-5381.2011.01208.x; Tanaka T, 2004, AM J PATHOL, V165, P1979, DOI 10.1016/S0002-9440(10)63249-X; Turner KJ, 2002, CANCER RES, V62, P2957; Wong CCL, 2011, P NATL ACAD SCI USA, V108, P16369, DOI 10.1073/pnas.1113483108	33	32	33	0	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 12	2012	287	42					34866	34882		10.1074/jbc.M112.374587	http://dx.doi.org/10.1074/jbc.M112.374587			17	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	022OF	22908232	hybrid, Green Published			2022-12-25	WOS:000309968000001
J	Meisel, E; Dvir, M; Haitin, Y; Giladi, M; Peretz, A; Attali, B				Meisel, Eshcar; Dvir, Meidan; Haitin, Yoni; Giladi, Moshe; Peretz, Asher; Attali, Bernard			KCNQ1 Channels Do Not Undergo Concerted but Sequential Gating Transitions in Both the Absence and the Presence of KCNE1 Protein	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							POTASSIUM CHANNELS; VOLTAGE SENSOR; WILD-TYPE; KVLQT1; MUTATIONS; SUBUNITS; FORM; COOPERATIVITY; INACTIVATION; ACTIVATION	The co-assembly of KCNQ1 with KCNE1 produces I-KS, a K+ current, crucial for the repolarization of the cardiac action potential. Mutations in these channel subunits lead to life-threatening cardiac arrhythmias. However, very little is known about the gating mechanisms underlying KCNQ1 channel activation. Shaker channels have provided a powerful tool to establish the basic gating mechanisms of voltage-dependent K+ channels, implying prior independent movement of all four voltage sensor domains (VSDs) followed by channel opening via a last concerted cooperative transition. To determine the nature of KCNQ1 channel gating, we performed a thermodynamic mutant cycle analysis by constructing a concatenated tetrameric KCNQ1 channel and by introducing separately a gain and a loss of function mutation, R231W and R243W, respectively, into the S4 helix of the VSD of one, two, three, and four subunits. The R231W mutation destabilizes channel closure and produces constitutively open channels, whereas the R243W mutation disrupts channel opening solely in the presence of KCNE1 by right-shifting the voltage dependence of activation. The linearity of the relationship between the shift in the voltage dependence of activation and the number of mutated subunits points to an independence of VSD movements, with each subunit incrementally contributing to channel gating. Contrary to Shaker channels, our work indicates that KCNQ1 channels do not experience a late cooperative concerted opening transition. Our data suggest that KCNQ1 channels in both the absence and the presence of KCNE1 undergo sequential gating transitions leading to channel opening even before all VSDs have moved.	[Meisel, Eshcar; Dvir, Meidan; Haitin, Yoni; Giladi, Moshe; Peretz, Asher; Attali, Bernard] Tel Aviv Univ, Sackler Fac Med, Dept Physiol & Pharmacol, IL-69978 Tel Aviv, Israel	Tel Aviv University; Sackler Faculty of Medicine	Attali, B (corresponding author), Tel Aviv Univ, Sackler Fac Med, Dept Physiol & Pharmacol, IL-69978 Tel Aviv, Israel.	battali@post.tau.ac.il	Haitin, Yoni/AAQ-4571-2021	Haitin, Yoni/0000-0002-1648-6792; Giladi, Moshe/0000-0002-8589-6920	Deutsch-Israelische Projektkooperation (DIP) fund (Deutsche Forschungsgemeinschaft); Israel Science Foundation (ISF) [488/09]	Deutsch-Israelische Projektkooperation (DIP) fund (Deutsche Forschungsgemeinschaft)(German Research Foundation (DFG)); Israel Science Foundation (ISF)(Israel Science Foundation)	This work was supported by the Deutsch-Israelische Projektkooperation (DIP) fund (Deutsche Forschungsgemeinschaft) and the Israel Science Foundation (ISF Grant 488/09).	Abbott GW, 1998, Q REV BIOPHYS, V31, P357, DOI 10.1017/S0033583599003467; Barhanin J, 1996, NATURE, V384, P78, DOI 10.1038/384078a0; Bartos DC, 2011, HEART RHYTHM, V8, P48, DOI 10.1016/j.hrthm.2010.09.010; Franqueza L, 1999, J BIOL CHEM, V274, P21063, DOI 10.1074/jbc.274.30.21063; Gagnon DG, 2010, J GEN PHYSIOL, V136, P555, DOI 10.1085/jgp.201010487; Gagnon DG, 2009, J GEN PHYSIOL, V133, P467, DOI 10.1085/jgp.200810082; Haitin Y, 2008, J PHYSIOL-LONDON, V586, P1803, DOI 10.1113/jphysiol.2007.149187; Haitin Y, 2009, EMBO J, V28, P1994, DOI 10.1038/emboj.2009.157; Hernandez CC, 2008, J PHYSIOL-LONDON, V586, P1811, DOI 10.1113/jphysiol.2007.148304; HODGKIN AL, 1952, J PHYSIOL-LONDON, V117, P500, DOI 10.1113/jphysiol.1952.sp004764; Horn R, 2000, J GEN PHYSIOL, V116, P461, DOI 10.1085/jgp.116.3.461; HOROVITZ A, 1990, J MOL BIOL, V214, P613, DOI 10.1016/0022-2836(90)90275-Q; ISACOFF EY, 1990, NATURE, V345, P530, DOI 10.1038/345530a0; Jentsch TJ, 2000, NAT REV NEUROSCI, V1, P21, DOI 10.1038/35036198; KAVANAUGH MP, 1992, NEURON, V8, P493, DOI 10.1016/0896-6273(92)90277-K; Ledwell JL, 1999, J GEN PHYSIOL, V113, P389, DOI 10.1085/jgp.113.3.389; Long SB, 2005, SCIENCE, V309, P897, DOI 10.1126/science.1116269; Long SB, 2005, SCIENCE, V309, P903, DOI 10.1126/science.1116270; Ma LJ, 2011, BIOPHYS J, V100, P885, DOI 10.1016/j.bpj.2010.12.3726; Melman YF, 2002, TRENDS CARDIOVAS MED, V12, P182, DOI 10.1016/S1050-1738(02)00158-5; Miceli F, 2008, BIOPHYS J, V95, P2254, DOI 10.1529/biophysj.107.128371; Miceli F, 2009, CHANNELS, V3, P274; Mohammad-Panah R, 1999, AM J HUM GENET, V64, P1015, DOI 10.1086/302346; Morin TJ, 2008, J BIOL CHEM, V283, P25105, DOI 10.1074/jbc.R800033200; Nakajo K, 2010, P NATL ACAD SCI USA, V107, P18862, DOI 10.1073/pnas.1010354107; Osteen JD, 2012, P NATL ACAD SCI USA, V109, P7103, DOI 10.1073/pnas.1201582109; Osteen JD, 2010, P NATL ACAD SCI USA, V107, P22710, DOI 10.1073/pnas.1016300108; Panaghie G, 2007, J GEN PHYSIOL, V129, P121, DOI 10.1085/jgp.200609612; Pathak M, 2005, J GEN PHYSIOL, V125, P57, DOI 10.1085/jgp.200409197; Peroz D, 2008, J PHYSIOL-LONDON, V586, P1785, DOI 10.1113/jphysiol.2007.148254; Pusch M, 1998, BIOPHYS J, V75, P785, DOI 10.1016/S0006-3495(98)77568-X; Robbins J, 2001, PHARMACOL THERAPEUT, V90, P1, DOI 10.1016/S0163-7258(01)00116-4; Sadovsky E, 2007, P NATL ACAD SCI USA, V104, P19813, DOI 10.1073/pnas.0708120104; Sanguinetti MC, 1996, NATURE, V384, P80, DOI 10.1038/384080a0; Schoppa NE, 1998, J GEN PHYSIOL, V111, P313, DOI 10.1085/jgp.111.2.313; Sesti F, 1998, J GEN PHYSIOL, V112, P651, DOI 10.1085/jgp.112.6.651; Shamgar L, 2006, CIRC RES, V98, P1055, DOI 10.1161/01.RES.0000218979.40770.69; Shamgar L, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001943; Splawski I, 1998, GENOMICS, V51, P86, DOI 10.1006/geno.1998.5361; Tristani-Firouzi M, 1998, J PHYSIOL-LONDON, V510, P37, DOI 10.1111/j.1469-7793.1998.037bz.x; TYTGAT J, 1992, NATURE, V359, P420, DOI 10.1038/359420a0; WANG KW, 1995, NEURON, V14, P1303, DOI 10.1016/0896-6273(95)90277-5; Wang WY, 1998, J BIOL CHEM, V273, P34069, DOI 10.1074/jbc.273.51.34069; Wiener R, 2008, J BIOL CHEM, V283, P5815, DOI 10.1074/jbc.M707541200; Wu D, 2010, BIOPHYS J, V99, P3599, DOI 10.1016/j.bpj.2010.10.018; Yang YS, 1998, J GEN PHYSIOL, V112, P665, DOI 10.1085/jgp.112.6.665; Yang YS, 1997, J GEN PHYSIOL, V109, P779, DOI 10.1085/jgp.109.6.779; Yellen G, 2002, NATURE, V419, P35, DOI 10.1038/nature00978; Yifrach O, 2002, CELL, V111, P231, DOI 10.1016/S0092-8674(02)01013-9; Yifrach O, 2009, METHOD ENZYMOL, V466, P179, DOI 10.1016/S0076-6879(09)66008-0; ZAGOTTA WN, 1994, J GEN PHYSIOL, V103, P321, DOI 10.1085/jgp.103.2.321; Zandany N, 2008, P NATL ACAD SCI USA, V105, P11697, DOI 10.1073/pnas.0804104105	52	23	24	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 5	2012	287	41					34212	34224		10.1074/jbc.M112.364901	http://dx.doi.org/10.1074/jbc.M112.364901			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	018IS	22908235	Green Published, hybrid			2022-12-25	WOS:000309654200026
J	Barchi, L; Lanteri, S; Portis, E; Vale, G; Volante, A; Pulcini, L; Ciriaci, T; Acciarri, N; Barbierato, V; Toppino, L; Rotino, GL				Barchi, Lorenzo; Lanteri, Sergio; Portis, Ezio; Vale, Giampiero; Volante, Andrea; Pulcini, Laura; Ciriaci, Tommaso; Acciarri, Nazareno; Barbierato, Valeria; Toppino, Laura; Rotino, Giuseppe Leonardo			A RAD Tag Derived Marker Based Eggplant Linkage Map and the Location of QTLs Determining Anthocyanin Pigmentation	PLOS ONE			English	Article							QUANTITATIVE TRAIT LOCI; SOLANUM-MELONGENA L.; MOLECULAR ANALYSIS; HIGH-RESOLUTION; FRUIT-SHAPE; TUBEROSUM L; COLOR LOCI; A-LOCUS; TOMATO; RESISTANCE	Both inter-and intra-specific maps have been developed in eggplant (Solanum melongena L.). The former benefit from an enhanced frequency of marker polymorphism, but their relevance to marker-assisted crop breeding is limited. Combining the restriction-site associated DNA strategy with high throughput sequencing has facilitated the discovery of a large number of functional single nucleotide polymorphism (SNP) markers discriminating between the two eggplant mapping population parental lines '305E40' and '67/3'. A set of 347 de novo SNPs, together with 84 anchoring markers, were applied to the F-2 mapping population bred from the cross '305E40' x '67/3' to construct a linkage map. In all, 415 of the 431 markers were assembled into twelve major and one minor linkage group, spanning 1,390 cM, and the inclusion of established markers allowed each linkage group to be assigned to one of the 12 eggplant chromosomes. The map was then used to discover the genetic basis of seven traits associated with anthocyanin content. Each of the traits proved to be controlled by between one and six quantitative trait loci (QTL), of which at least one was a major QTL. Exploitation of syntenic relationships between the eggplant and tomato genomes facilitated the identification of potential candidate genes for the eggplant QTLs related to anthocyanin accumulation. The intra-specific linkage map should have utility for elucidating the genetic basis of other phenotypic traits in eggplant.	[Barchi, Lorenzo; Lanteri, Sergio; Portis, Ezio] Univ Turin, DIVAPRA Plant Genet & Breeding, Turin, Italy; [Vale, Giampiero; Volante, Andrea] CRA GPG Genom Res Ctr, Fiorenzuola Darda, Piacenza, Italy; [Vale, Giampiero] CRA RIS, Rice Res Unit, Vercelli, Italy; [Pulcini, Laura; Ciriaci, Tommaso; Acciarri, Nazareno] CRA ORA Res Unit Vegetable Crops, Monsampolo Del Tronto, Ascoli Piceno, Italy; [Barbierato, Valeria; Toppino, Laura; Rotino, Giuseppe Leonardo] CRA ORL Res Unit Vegetable Crops, Lodi, Italy	University of Turin	Barchi, L (corresponding author), Univ Turin, DIVAPRA Plant Genet & Breeding, Turin, Italy.	ezio.portis@unito.it	BARCHI, Lorenzo/ABC-4206-2020; Volante, Andrea/ADB-8436-2022; Valè, Giampiero/ABF-1492-2020; Lanteri, Sergio/P-4902-2015	BARCHI, Lorenzo/0000-0001-6414-4239; Valè, Giampiero/0000-0003-2158-9726; Lanteri, Sergio/0000-0003-3012-8710; volante, andrea/0000-0002-0463-5375; PORTIS, Ezio/0000-0002-1548-6096; PULCINI, LAURA/0000-0002-8335-4108; Toppino, Laura/0000-0002-8664-1233; Acciarri, Nazzareno/0000-0002-0892-5994	Italian Ministry of Agricultural Alimentary and Forest Politics	Italian Ministry of Agricultural Alimentary and Forest Politics	This research was partially supported by the Italian Ministry of Agricultural Alimentary and Forest Politics in the framework of "PROM", "ESPLORA" and "AGRONANOTECH" projects. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Al-Sane KO, 2011, PLANT BIOSYST, V145, P436, DOI 10.1080/11263504.2010.548914; Arumuganathan K., 1991, PLANT MOL BIOL REP, V9, P208, DOI [10.1007/BF02672069, DOI 10.1007/BF02672069]; Barbierato V, 2011, P JOINT M AGI SIBV S; Barchi L, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-304; Barchi L, 2010, GENOME, V53, P805, DOI [10.1139/g10-073, 10.1139/G10-073]; BERNATZKY R, 1986, GENETICS, V112, P887; Borovsky Y, 2004, THEOR APPL GENET, V109, P23, DOI 10.1007/s00122-004-1625-9; Bovy A, 2007, METABOLOMICS, V3, P399, DOI 10.1007/s11306-007-0074-2; Broman KW, 2003, BIOINFORMATICS, V19, P889, DOI 10.1093/bioinformatics/btg112; Chaim AB, 2003, THEOR APPL GENET, V106, P889, DOI 10.1007/s00122-002-1132-9; Chalker-Scott L, 1999, PHOTOCHEM PHOTOBIOL, V70, P1, DOI 10.1111/j.1751-1097.1999.tb01944.x; CHURCHILL GA, 1994, GENETICS, V138, P963; Collard BCY, 2005, EUPHYTICA, V142, P169, DOI 10.1007/s10681-005-1681-5; De Jong WS, 2004, THEOR APPL GENET, V108, P423, DOI 10.1007/s00122-003-1455-1; DEVICENTE MC, 1993, GENETICS, V134, P585; DIXON RA, 1995, PLANT CELL, V7, P1085, DOI 10.1105/tpc.7.7.1085; Doganlar S, 2002, GENETICS, V161, P1697; Doganlar S, 2002, GENETICS, V161, P1713; Frary A, 2005, THEOR APPL GENET, V111, P291, DOI 10.1007/s00122-005-2023-7; Fukuoka H, 2012, THEOR APPL GENET, V125, P47, DOI 10.1007/s00122-012-1815-9; Gonzali S, 2009, TRENDS PLANT SCI, V14, P237, DOI 10.1016/j.tplants.2009.02.001; Gould K. S., 2006, Flavonoids: chemistry, biochemistry and applications, P397; Hernandez I, 2009, TRENDS PLANT SCI, V14, P125, DOI 10.1016/j.tplants.2008.12.003; JANSEN RC, 1994, GENETICS, V138, P871; JANSEN RC, 1994, GENETICS, V136, P1447; JANSEN RC, 1993, GENETICS, V135, P205; Koes R, 2005, TRENDS PLANT SCI, V10, P236, DOI 10.1016/j.tplants.2005.03.002; Kosambi D. D., 1944, ANN EUGENICS, V12, P172; LANDER ES, 1989, GENETICS, V121, P185; Li Z, 2001, THEOR APPL GENET, V103, P1167, DOI 10.1007/s001220100672; Lindhout P, 2002, EUPHYTICA, V124, P217, DOI 10.1023/A:1015686601404; Miller MR, 2007, GENOME RES, V17, P240, DOI 10.1101/gr.5681207; Miyatake K, 2012, THEOR APPL GENET, V124, P1403, DOI 10.1007/s00122-012-1796-8; Nunome T, 2003, PLANT BREEDING, V122, P256, DOI 10.1046/j.1439-0523.2003.00816.x; Nunome T, 2001, BREEDING SCI, V51, P19, DOI 10.1270/jsbbs.51.19; Nunome T, 2009, THEOR APPL GENET, V119, P1143, DOI 10.1007/s00122-009-1116-0; Peters DJ, 2002, PLANT J, V32, P701, DOI 10.1046/j.1365-313X.2002.01458.x; Pilet-Nayel ML, 2002, THEOR APPL GENET, V106, P28, DOI 10.1007/s00122-002-0985-2; Polignano G, 2010, GENET RESOUR CROP EV, V57, P171, DOI 10.1007/s10722-009-9459-6; Prohens J, 2012, EUPHYTICA, V186, P517, DOI 10.1007/s10681-012-0652-x; Quattrocchio F, 1999, PLANT CELL, V11, P1433, DOI 10.1105/tpc.11.8.1433; Rizza F, 2002, PLANT CELL REP, V20, P1022, DOI 10.1007/s00299-001-0429-5; Stagel A, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-357; TANKSLEY SD, 1992, GENETICS, V132, P1141; TATEBE T., 1939, Idengahu Zasshi = Japanese Journal of Genetics, V15, P261, DOI 10.1266/jjg.15.261; Team RDC, 2009, R LANG ENV STAT COMP; TIGCHELAAR EC, 1968, GENETICS, V60, P475; Toppino L, 2010, ADV GENETICS BREEDIN, P241; Toppino L, 2008, MOL BREEDING, V22, P237, DOI 10.1007/s11032-008-9170-x; Van Ooijen J.W., 2004, MAPQTL 6 SOFTWARE MA; Van Ooijen JW, 2006, JOINMAP 40 SOFTWARE; VANECK HJ, 1994, HEREDITY, V73, P410, DOI 10.1038/hdy.1994.189; VANECK HJ, 1993, THEOR APPL GENET, V86, P295, DOI 10.1007/BF00222091; VANECK HJ, 1994, GENETICS, V137, P303; Vilanova S, 2012, MOL BREEDING, V30, P647, DOI 10.1007/s11032-011-9650-2; Voorrips RE, 2002, J HERED, V93, P77, DOI 10.1093/jhered/93.1.77; Wittwer CT, 2003, CLIN CHEM, V49, P853, DOI 10.1373/49.6.853; Wu FN, 2006, GENETICS, V174, P1407, DOI 10.1534/genetics.106.062455; Wu FN, 2009, THEOR APPL GENET, V118, P1279, DOI 10.1007/s00122-009-0980-y; Wu FN, 2009, THEOR APPL GENET, V118, P927, DOI 10.1007/s00122-008-0950-9	60	92	101	2	88	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 17	2012	7	8							e43740	10.1371/journal.pone.0043740	http://dx.doi.org/10.1371/journal.pone.0043740			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	996DG	22912903	Green Published, Green Submitted, gold			2022-12-25	WOS:000308063700131
J	Esposito, E; Impellizzeri, D; Mazzon, E; Paterniti, I; Cuzzocrea, S				Esposito, Emanuela; Impellizzeri, Daniela; Mazzon, Emanuela; Paterniti, Irene; Cuzzocrea, Salvatore			Neuroprotective Activities of Palmitoylethanolamide in an Animal Model of Parkinson's Disease	PLOS ONE			English	Article							PROLIFERATOR-ACTIVATED RECEPTOR; SPINAL-CORD-INJURY; ACUTE-INFLAMMATION; NITRIC-OXIDE; PPAR-ALPHA; MPTP MODEL; IN-VITRO; NEURONS; MINOCYCLINE; THERAPY	The biochemical and cellular changes that occur following treatment with 1-methyl-4-phenyl-1,2,3,6-tetrahyropyridine (MPTP) are remarkably similar to that seen in idiopathic Parkinson's disease (PD). PD is characterized by the degeneration of dopaminergic nigrostriatal neurons, which results in disabling motor disturbances. Activation of glial cells and the consequent neuroinflammatory response is increasingly recognized as a prominent neuropathological feature of PD. There is currently no effective disease-modifying therapy. Targeting the signaling pathways in glial cells responsible for neuroinflammation represents a promising new therapeutic approach designed to preserve remaining neurons in PD. Chronic treatment with palmitoylethanolamide (PEA, 10 mg/kg, i.p.), initiated 24 hr after MPTP injection (20 mg/kg), protected against MPTP-induced loss of tyrosine hydroxylase positive neurons in the substantia nigra pars compacta. Treatment with PEA reduced MPTP-induced microglial activation, the number of GFAP-positive astrocytes and S100 beta overexpression, and protected against the alterations of microtubule-associated protein 2a,b-, dopamine transporter-, nNOS-positive cells in the substantia nigra. Furthermore, chronic PEA reversed MPTP-associated motor deficits, as revealed by the analysis of forepaw step width and percentage of faults. Genetic ablation of peroxisome proliferator activated receptor (PPAR)-alpha in PPAR-alpha KO mice exacerbated MPTP systemic toxicity, while PEA-induced neuroprotection seemed be partially PPAR alpha-dependent. The effects of PEA on molecules typically involved in apoptotic pathways were also analyzed. Our results indicate that PEA protects against MPTP-induced neurotoxicity and the ensuing functional deficits even when administered once the insult has been initiated.	[Esposito, Emanuela; Impellizzeri, Daniela; Mazzon, Emanuela; Paterniti, Irene; Cuzzocrea, Salvatore] Univ Messina, Sch Med, Dept Clin & Expt Med & Pharmacol, Messina, Italy; [Mazzon, Emanuela] IRCCS Ctr Neurolesi Bonino Pulejo, Messina, Italy	University of Messina; IRCCS Bonino Pulejo	Esposito, E (corresponding author), Univ Messina, Sch Med, Dept Clin & Expt Med & Pharmacol, Messina, Italy.	salvator@unime.it	Mazzon, Emanuela/AAL-4334-2020	Impellizzeri, Daniela/0000-0001-9492-3161; mazzon, emanuela/0000-0002-5073-717X; Cuzzocrea, Salvatore/0000-0001-6131-3690; Esposito, Emanuela/0000-0002-2663-6387	Programma Operativo Nazionale "Ricerca e Competitivita" (PON RC) [01_02512]	Programma Operativo Nazionale "Ricerca e Competitivita" (PON RC)	This study was supported by Programma Operativo Nazionale "Ricerca e Competitivita 2007-2013" (PON R&C) 01_02512. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Antzoulatos E, 2011, PARKINSONS DIS-US, V2011, DOI 10.4061/2011/138471; Araki T, 2001, BRAIN RES, V918, P176, DOI 10.1016/S0006-8993(01)02944-4; Bar-Peled O, 1999, J NEUROSCI RES, V55, P542, DOI 10.1002/(SICI)1097-4547(19990301)55:5<542::AID-JNR2>3.0.CO;2-7; Barcia C, 2004, GLIA, V46, P402, DOI 10.1002/glia.20015; Brundula V, 2002, BRAIN, V125, P1297, DOI 10.1093/brain/awf133; Costa B, 2002, BRIT J PHARMACOL, V137, P413, DOI 10.1038/sj.bjp.0704900; Cullingford TE, 1998, J NEUROCHEM, V70, P1366; Cuzzocrea S, 2001, PHARMACOL REV, V53, P135; Dauer W, 2003, NEURON, V39, P889, DOI 10.1016/S0896-6273(03)00568-3; De Filippis D, 2008, J NEUROENDOCRINOL, V20, P20, DOI 10.1111/j.1365-2826.2008.01674.x; Dehmer T, 2004, J NEUROCHEM, V88, P494, DOI 10.1046/j.1471-4159.2003.02210.x; Duan WZ, 1999, J NEUROSCI RES, V57, P195, DOI 10.1002/(SICI)1097-4547(19990715)57:2&lt;195::AID-JNR5&gt;3.0.CO;2-P; Esposito E, 2005, ENDOCRINOLOGY, V146, P3301, DOI 10.1210/en.2005-0375; Esposito E, 2011, BRAIN BEHAV IMMUN, V25, P1099, DOI 10.1016/j.bbi.2011.02.006; Esposito E, 2010, PPAR RES, V2010, DOI 10.1155/2010/917312; Fleming SM, 2011, MOL CELL NEUROSCI, V46, P597, DOI 10.1016/j.mcn.2010.12.011; Fleming SM, 2004, J NEUROSCI, V24, P9434, DOI 10.1523/JNEUROSCI.3080-04.2004; Fu J, 2005, NEUROPHARMACOLOGY, V48, P1147, DOI 10.1016/j.neuropharm.2005.02.013; Galan-Rodriguez B, 2009, NEUROPHARMACOLOGY, V56, P653, DOI 10.1016/j.neuropharm.2008.11.006; Gao HM, 2003, FASEB J, V17, DOI 10.1096/fj.03-0109fje; Genovese T, 2008, J PHARMACOL EXP THER, V326, P12, DOI 10.1124/jpet.108.136903; Hald A, 2005, EXP NEUROL, V193, P279, DOI 10.1016/j.expneurol.2005.01.013; Halliday GM, 2011, MOVEMENT DISORD, V26, P6, DOI 10.1002/mds.23455; Hansen HS, 2010, EXP NEUROL, V224, P48, DOI 10.1016/j.expneurol.2010.03.022; Hirsch EC, 2003, ANN NY ACAD SCI, V991, P214; Imamura N, 2003, NEUROSCI RES, V46, P289, DOI 10.1016/S0168-0102(03)00065-8; Inoue Ikuo, 2003, J Atheroscler Thromb, V10, P99; KAINU T, 1994, NEUROREPORT, V5, P2481, DOI 10.1097/00001756-199412000-00019; Kidd P M, 2000, Altern Med Rev, V5, P502; Koch M, 2011, NEUROTOX RES, V19, P330, DOI 10.1007/s12640-010-9166-2; Kreisler A, 2007, BRAIN RES, V1135, P77, DOI 10.1016/j.brainres.2006.12.011; Lambert DM, 2002, CURR MED CHEM, V9, P663, DOI 10.2174/0929867023370707; Lo Verme J, 2005, MOL PHARMACOL, V67, P15, DOI 10.1124/mol.104.006353; Marchetti B, 2005, TRENDS PHARMACOL SCI, V26, P517, DOI 10.1016/j.tips.2005.08.007; McGeer PL, 2008, MOVEMENT DISORD, V23, P474, DOI 10.1002/mds.21751; MCGEER PL, 2002, SCI AGING KNOWLEDGE, pRE3; Melis M, 2008, J NEUROSCI, V28, P13985, DOI 10.1523/JNEUROSCI.3221-08.2008; Moreno S, 2004, NEUROSCIENCE, V123, P131, DOI 10.1016/j.neuroscience.2003.08.064; Nesic-Taylor O, 2005, J NEUROSCI RES, V79, P628, DOI 10.1002/jnr.20400; Obata T, 2006, J NEURAL TRANSM, V113, P1131, DOI 10.1007/s00702-005-0415-0; Ouchi Y, 2005, ANN NEUROL, V57, P168, DOI 10.1002/ana.20338; Raso GM, 2011, J NEUROENDOCRINOL, V23, P591, DOI 10.1111/j.1365-2826.2011.02152.x; Roberts RA, 1998, CARCINOGENESIS, V19, P43, DOI 10.1093/carcin/19.1.43; Rogers J, 2007, INT REV NEUROBIOL, V82, P235, DOI 10.1016/S0074-7742(07)82012-5; Sasso O, 2011, PAIN; Schulz JB, 2004, CELL TISSUE RES, V318, P135, DOI 10.1007/s00441-004-0954-y; Scuderi C, 2011, J CELL MOL MED, DOI 10.111141582-4934.2011.01267.x; SHEA TB, 1994, BIOTECHNIQUES, V16, P1126; Takahashi H, 2005, PARKINSONISM RELAT D, V11, pS31, DOI 10.1016/j.parkreldis.2005.02.011; TIPTON KF, 1993, J NEUROCHEM, V61, P1191, DOI 10.1111/j.1471-4159.1993.tb13610.x; Wells JEA, 2003, BRAIN, V126, P1628, DOI 10.1093/brain/awg178; WHITE NJ, 1982, LANCET, V2, P99; Yrjanheikki J, 1999, P NATL ACAD SCI USA, V96, P13496, DOI 10.1073/pnas.96.23.13496	53	114	116	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 17	2012	7	8							e41880	10.1371/journal.pone.0041880	http://dx.doi.org/10.1371/journal.pone.0041880			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	996DG	22912680	Green Published, Green Submitted, gold			2022-12-25	WOS:000308063700008
J	Han, XJ; Lu, MZ; Chen, YC; Zhan, ZY; Cui, QQ; Wang, YD				Han, Xiaojiao; Lu, Mengzhu; Chen, Yicun; Zhan, Zhiyong; Cui, Qinqin; Wang, Yangdong			Selection of Reliable Reference Genes for Gene Expression Studies Using Real-Time PCR in Tung Tree during Seed Development	PLOS ONE			English	Article							NORMALIZING RNA EXPRESSION; CANDIDATE REFERENCE GENES; QUANTITATIVE RT-PCR; HOUSEKEEPING GENES; INTERNAL CONTROL; VALIDATION; QUANTIFICATION; EVOLUTION	Quantitative real-time PCR (RT-qPCR) has become an accurate and widely used technique to analyze expression levels of selected genes. It is very necessary to select appropriate reference genes for gene expression normalization. In the present study, we assessed the expression stability of 11 reference genes including eight traditional housekeeping genes and three novel genes in different tissues/organs and developing seeds from four cultivars of tung tree. All 11 reference genes showed a wide range of Ct values in all samples, indicating that they differently expressed. Three softwares - geNorm, NormFinder and BestKeeper - were used to determine the stability of these references except for ALB (2S albumin), which presented a little divergence. The results from the three softwares showed that ACT7 (Actin7a), UBQ (Ubiquitin), GAPDH (glyceraldehyde-3-phosphate dehydrogenase) and EF1 alpha (elongation factor 1-alpha) were the most stable reference genes across all of the tested tung samples and tung developing seeds, while ALB (2S albumin) was unsuitable as internal controls. ACT7, EF1 beta (elongation factor1-beta), GAPDH and TEF1 (transcription elongation factor 1) were the top four choices for different tissues/organs whereas LCR69 did not favor normalization of RT-qPCR in these tissues/organs. Meanwhile, the expression profiles of FAD2 and FADX were realized using stable reference genes. The relative quantification of the FAD2 and FADX genes varied according to the internal controls and the number of internal controls. The results further proved the importance of the choice of reference genes in the tung tree. These stable reference genes will be employed in normalization and quantification of transcript levels in future expression studies of tung genes.	[Han, Xiaojiao; Lu, Mengzhu; Chen, Yicun; Wang, Yangdong] Chinese Acad Forestry, State Key Lab Tree Genet & Breeding, Beijing, Peoples R China; [Han, Xiaojiao; Chen, Yicun; Zhan, Zhiyong; Cui, Qinqin; Wang, Yangdong] Chinese Acad Forestry, Res Inst Subtrop Forestry, Fuyang, Peoples R China; [Lu, Mengzhu] Chinese Acad Forestry, Res Inst Forestry, Beijing, Peoples R China	Chinese Academy of Forestry; State Key Laboratory of Tree Genetics & Breeding, CAF; Chinese Academy of Forestry; Research Institute of Subtropical Forestry, CAF; Chinese Academy of Forestry; Research Institute of Forestry, CAF	Han, XJ (corresponding author), Chinese Acad Forestry, State Key Lab Tree Genet & Breeding, Beijing, Peoples R China.	wyd11111@126.com	Lu, Meng-Zhu/AAN-9710-2020	Han, Xiaojiao/0000-0001-6082-7569	State Forestry Administration Foundation of China [2009-4-23]	State Forestry Administration Foundation of China	The work presented here was supported by the State Forestry Administration Foundation of China (2009-4-23).	Andersen CL, 2004, CANCER RES, V64, P5245, DOI 10.1158/0008-5472.CAN-04-0496; Banda M, 2008, MUTAT RES-GEN TOX EN, V649, P126, DOI 10.1016/j.mrgentox.2007.08.005; Basa B, 2009, FUNCT PLANT BIOL, V36, P1079, DOI 10.1071/FP09073; Brown K., 2005, WILDL WEEDS, V9, P4; Bustin SA, 2005, J MOL ENDOCRINOL, V34, P597, DOI 10.1677/jme.1.01755; Bustin SA, 2002, J MOL ENDOCRINOL, V29, DOI 10.1677/jme.0.0290023; Chen X, 2010, ANAL BIOCHEM, V405, P138, DOI 10.1016/j.ab.2010.05.032; Chen YC, 2010, IND CROP PROD, V32, P684, DOI 10.1016/j.indcrop.2010.06.009; Czechowski T, 2005, PLANT PHYSIOL, V139, P5, DOI 10.1104/pp.105.063743; De Ketelaere A, 2006, J DAIRY SCI, V89, P4066, DOI 10.3168/jds.S0022-0302(06)72450-X; Demidenko NV, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019434; Dheda K, 2004, BIOTECHNIQUES, V37, P112, DOI 10.2144/04371RR03; Dyer JM, 2002, PLANT PHYSIOL, V130, P2027, DOI 10.1104/pp.102.010835; Dyer JM, 2008, PHYSIOL PLANTARUM, V132, P11, DOI 10.1111/j.1399-3054.2007.01021.x; Fang JX, 1998, TUNG OIL TREES CHINA, P104; Fernandez P, 2011, PLANT CELL REP, V30, P63, DOI 10.1007/s00299-010-0944-3; Gutierrez L, 2008, PLANT BIOTECHNOL J, V6, P609, DOI 10.1111/j.1467-7652.2008.00346.x; Hochstrasser M, 2000, NAT CELL BIOL, V2, pE153, DOI 10.1038/35019643; Huggett J, 2005, GENES IMMUN, V6, P279, DOI 10.1038/sj.gene.6364190; Jain M, 2006, BIOCHEM BIOPH RES CO, V345, P646, DOI 10.1016/j.bbrc.2006.04.140; Jian B, 2008, BMC MOL BIOL, V9, DOI 10.1186/1471-2199-9-59; Kim BR, 2003, BIOTECHNOL LETT, V25, P1869, DOI 10.1023/A:1026298032009; Kuijk EW, 2007, BMC DEV BIOL, V7, DOI 10.1186/1471-213X-7-58; Kumar V, 2011, AUST J CROP SCI, V5, P1455; Lovdal T, 2009, ANAL BIOCHEM, V387, P238, DOI 10.1016/j.ab.2009.01.024; Luo HL, 2010, ANAL BIOCHEM, V404, P100, DOI 10.1016/j.ab.2010.05.002; Mafra V, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0031263; Maroufi A, 2010, BMC MOL BIOL, V11, DOI 10.1186/1471-2199-11-15; Martin RC, 2008, CROP SCI, V48, P1881, DOI 10.2135/cropsci2007.10.0597; Nicot N, 2005, J EXP BOT, V56, P2907, DOI 10.1093/jxb/eri285; Nolan T, 2006, NAT PROTOC, V1, P1559, DOI 10.1038/nprot.2006.236; Pastor S, 2011, 1337 U NEW ORL; Pfaffl MW, 2004, BIOTECHNOL LETT, V26, P509, DOI 10.1023/B:BILE.0000019559.84305.47; Phillips MA, 2009, PLANT MOL BIOL REP, V27, P407, DOI 10.1007/s11105-008-0072-1; Qi JN, 2010, PLANT MOL BIOL REP, V28, P597, DOI 10.1007/s11105-010-0185-1; Radonic A, 2004, BIOCHEM BIOPH RES CO, V313, P856, DOI 10.1016/j.bbrc.2003.11.177; Reid KE, 2006, BMC PLANT BIOL, V6, DOI 10.1186/1471-2229-6-27; Remans T, 2008, PLANTA, V227, P1343, DOI 10.1007/s00425-008-0706-4; Shang Q, 2010, BIORESOURCE TECHNOL, V101, P826, DOI 10.1016/j.biortech.2009.08.047; Shockey JM, 2006, PLANT CELL, V18, P2294, DOI 10.1105/tpc.106.043695; Sonntag N.O.V., 1979, BAILEYS IND OIL FAT, V1, P289; Thanamongkollit N, 2008, MODIFICATION TUNG OI; Udvardi MK, 2008, PLANT CELL, V20, P1736, DOI 10.1105/tpc.108.061143; Vandesompele J, 2002, GENOME BIOL, V3, DOI 10.1186/gb-2002-3-7-research0034; Wan HJ, 2010, ANAL BIOCHEM, V399, P257, DOI 10.1016/j.ab.2009.12.008	45	84	96	1	39	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 17	2012	7	8							e43084	10.1371/journal.pone.0043084	http://dx.doi.org/10.1371/journal.pone.0043084			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	996DG	22912794	gold, Green Submitted, Green Published			2022-12-25	WOS:000308063700039
J	Kwak, KJ; Jung, HJ; Lee, KH; Kim, YS; Kim, WY; Ahn, SJ; Kang, H				Kwak, Kyung Jin; Jung, Hyun Ju; Lee, Kwang Ho; Kim, Young Soon; Kim, Won Yong; Ahn, Sung Ju; Kang, Hunseung			The Minor Spliceosomal Protein U11/U12-31K Is an RNA Chaperone Crucial for U12 Intron Splicing and the Development of Dicot and Monocot Plants	PLOS ONE			English	Article							ESCHERICHIA-COLI; U12-TYPE INTRONS; U12-DEPENDENT INTRONS; ARABIDOPSIS-THALIANA; U11-59K PROTEIN; U4ATAC SNRNA; CSPA-FAMILY; DOMAIN; COMPONENT; DISORDER	U12 intron-specific spliceosomes contain U11 and U12 small nuclear ribonucleoproteins and mediate the removal of U12 introns from precursor-mRNAs. Among the several proteins unique to the U12-type spliceosomes, an Arabidopsis thaliana AtU11/U12-31K protein has been shown to be indispensible for proper U12 intron splicing and for normal growth and development of Arabidopsis plants. Here, we assessed the functional roles of the rice (Oryza sativa) OsU11/U12-31K protein in U12 intron splicing and development of plants. The U11/U12-31K transcripts were abundantly expressed in the shoot apical meristems (SAMs) of Arabidopsis and rice. Ectopic expression of OsU11/U12-31K in AtU11/U12-31K-defecient Arabidopsis mutant complemented the incorrect U12 intron splicing and abnormal development phenotypes of the Arabidopsis mutant plants. Impaired cell division activity in the SAMs and inflorescence stems observed in the AtU11/U12-31K-deficient mutant was completely recovered to normal by the expression of OsU11/U12-31K. Similar to Arabidopsis AtU11/U12-31K, rice OsU11/U12-31K was determined to harbor RNA chaperone activity. Collectively, the present findings provide evidence for the emerging idea that the U11/U12-31K protein is an indispensible RNA chaperone that functions in U12 intron splicing and is necessary for normal development of monocotyledonous plants as well as dicotyledonous plants.	[Kwak, Kyung Jin; Jung, Hyun Ju; Kim, Won Yong; Kang, Hunseung] Chonnam Natl Univ, Coll Agr & Life Sci, Dept Plant Biotechnol, Kwangju, South Korea; [Kwak, Kyung Jin; Jung, Hyun Ju; Kim, Won Yong; Kang, Hunseung] Chonnam Natl Univ, Coll Agr & Life Sci, Kumho Life Sci Lab, Kwangju, South Korea; [Lee, Kwang Ho] Chonnam Natl Univ, Coll Agr & Life Sci, Dept Wood Sci & Landscape Architecture, Kwangju, South Korea; [Kim, Young Soon; Ahn, Sung Ju] Chonnam Natl Univ, Coll Agr & Life Sci, Bioenergy Res Ctr, Kwangju, South Korea; [Ahn, Sung Ju] Chonnam Natl Univ, Coll Agr & Life Sci, Dept Bioenergy Sci & Technol, Kwangju, South Korea	Chonnam National University; Chonnam National University; Chonnam National University; Chonnam National University; Chonnam National University	Kwak, KJ (corresponding author), Chonnam Natl Univ, Coll Agr & Life Sci, Dept Plant Biotechnol, Kwangju, South Korea.	hskang@jnu.ac.kr	Kang, Hunseung/AAE-9912-2020	Kim, Wonyong/0000-0002-9094-8908	Mid-career Researcher Program through the National Research Foundation (NRF) of Korea [2011-0017357]; Ministry of Education, Science and Technology (MEST); Next-Generation BioGreen 21 Program (SSAC), Rural Development Administration, Republic of Korea [PJ00803701]; Priority Research Centers Program through the NRF of Korea [2011-0018393]; MEST	Mid-career Researcher Program through the National Research Foundation (NRF) of Korea(National Research Foundation of Korea); Ministry of Education, Science and Technology (MEST)(Ministry of Education, Science & Technology (MEST), Republic of Korea); Next-Generation BioGreen 21 Program (SSAC), Rural Development Administration, Republic of Korea; Priority Research Centers Program through the NRF of Korea(National Research Foundation of Korea); MEST(Ministry of Education, Science & Technology (MEST), Republic of Korea)	This work was supported in part by the Mid-career Researcher Program (2011-0017357) through the National Research Foundation (NRF) of Korea grant funded by the Ministry of Education, Science and Technology (MEST), by a grant from the Next-Generation BioGreen 21 Program (SSAC, PJ00803701), Rural Development Administration, Republic of Korea, and by Priority Research Centers Program (2011-0018393) through the NRF of Korea funded by the MEST. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alioto TS, 2007, NUCLEIC ACIDS RES, V35, pD110, DOI 10.1093/nar/gkl796; Bae WH, 2000, P NATL ACAD SCI USA, V97, P7784, DOI 10.1073/pnas.97.14.7784; Bassil E, 2011, PLANT CELL, V23, P224, DOI 10.1105/tpc.110.079426; Bechtold N, 1998, METH MOL B, V82, P259; Benecke H, 2005, EMBO J, V24, P3057, DOI 10.1038/sj.emboj.7600765; Burge CB, 1998, MOL CELL, V2, P773, DOI 10.1016/S1097-2765(00)80292-0; Chang WC, 2007, NUCLEIC ACIDS RES, V35, P1833, DOI 10.1093/nar/gkm026; Edery P, 2011, SCIENCE, V332, P240, DOI 10.1126/science.1202205; Frilander MJ, 1999, GENE DEV, V13, P851, DOI 10.1101/gad.13.7.851; He HL, 2011, SCIENCE, V332, P238, DOI 10.1126/science.1200587; Hirose T, 2004, P NATL ACAD SCI USA, V101, P17976, DOI 10.1073/pnas.0408435102; Jiang WN, 1997, J BIOL CHEM, V272, P196; Kim JS, 2007, NUCLEIC ACIDS RES, V35, P506, DOI 10.1093/nar/gkl1076; Kim WY, 2010, PLANT CELL, V22, P3951, DOI 10.1105/tpc.110.079103; Konig H, 2007, CELL, V131, P718, DOI 10.1016/j.cell.2007.09.043; Lahmy S, 2007, PLANT J, V50, P615, DOI 10.1111/j.1365-313X.2007.03072.x; Levine A, 2001, NUCLEIC ACIDS RES, V29, P4006, DOI 10.1093/nar/29.19.4006; Lin CF, 2010, BMC EVOL BIOL, V10, DOI 10.1186/1471-2148-10-47; Lopez MD, 2008, NUCLEIC ACIDS RES, V36, P3001, DOI 10.1093/nar/gkn142; Lorkovic ZJ, 2005, RNA, V11, P1095, DOI 10.1261/rna.2440305; Lorkovic ZJ, 2004, J BIOL CHEM, V279, P33890, DOI 10.1074/jbc.M400270200; Otake LR, 2002, MOL CELL, V9, P439, DOI 10.1016/S1097-2765(02)00441-0; Phadtare S, 2002, J BIOL CHEM, V277, P7239, DOI 10.1074/jbc.M111496200; Rajkowitsch L, 2007, RNA BIOL, V4, P118, DOI 10.4161/rna.4.3.5445; Milla MA, 2006, PLANT MOL BIOL, V61, P13, DOI 10.1007/s11103-005-5798-7; Russell AG, 2006, NATURE, V443, P863, DOI 10.1038/nature05228; Schneider C, 2002, MOL CELL BIOL, V22, P3219, DOI 10.1128/MCB.22.10.3219-3229.2002; Sikand K, 2011, NUCLEIC ACIDS RES, V39, P8531, DOI 10.1093/nar/gkr530; Tompa P, 2010, BIOCHEM CELL BIOL, V88, P167, DOI [10.1139/O09-163, 10.1139/o09-163]; Tsukagoshi H, 2007, P NATL ACAD SCI USA, V104, P2543, DOI 10.1073/pnas.0607940104; Turunen JJ, 2008, MOL CELL BIOL, V28, P3548, DOI 10.1128/MCB.01928-07; WASSARMAN KM, 1992, MOL CELL BIOL, V12, P1276, DOI 10.1128/MCB.12.3.1276; Will CL, 2005, BIOL CHEM, V386, P713, DOI 10.1515/BC.2005.084; Will CL, 2004, RNA, V10, P929, DOI 10.1261/rna.7320604; Xia B, 2001, MOL MICROBIOL, V40, P179, DOI 10.1046/j.1365-2958.2001.02372.x; Zhu W, 2003, NUCLEIC ACIDS RES, V31, P4561, DOI 10.1093/nar/gkg492	36	15	16	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 17	2012	7	8							e43707	10.1371/journal.pone.0043707	http://dx.doi.org/10.1371/journal.pone.0043707			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	996DG	22912901	gold, Green Published, Green Submitted			2022-12-25	WOS:000308063700129
J	Sugiyama, T; Sugioka-Sugiyama, R; Hada, K; Niwa, R				Sugiyama, Tomoyasu; Sugioka-Sugiyama, Rie; Hada, Kazumasa; Niwa, Ryusuke			Rhn1, a Nuclear Protein, Is Required for Suppression of Meiotic mRNAs in Mitotically Dividing Fission Yeast	PLOS ONE			English	Article							PROMOTES TRANSCRIPTION TERMINATION; SCHIZOSACCHAROMYCES-POMBE; POLYMERASE-II; C-ELEGANS; SACCHAROMYCES-CEREVISIAE; CAENORHABDITIS-ELEGANS; SELECTIVE ELIMINATION; DHP1(+) GENE; MEIOSIS; INTERFERENCE	In the fission yeast Schizosaccharomyces pombe, many meiotic mRNAs are transcribed during mitosis and meiosis and selectively eliminated in mitotic cells. However, this pathway for mRNA decay, called the determinant of selective removal (DSR)-Mmi1 system, targets only some of the numerous meiotic mRNAs that are transcribed in mitotic cells. Here we describe Rhn1, a nuclear protein involved in meiotic mRNA suppression in vegetative fission yeast. Rhn1 is homologous to budding yeast Rtt103 and localizes to one or a few discrete nuclear dots in growing vegetative cells. Rhn1 colocalizes with a pre-mRNA 3'-end processing factor, Pcf11, and with the 5'-3' exoribonuclease, Dhp1; moreover, Rhn1 coimmunoprecipitates with Pcf11. Loss of rhn1 results in elevated sensitivity to high temperature, to thiabendazole (TBZ), and to UV. Interestingly, meiotic mRNAs-including moa1(+), mcp5(+), and mug96(+)-accumulate in mitotic rhn1 Delta cells. Accumulation of meiotic mRNAs also occurs in strains lacking Lsk1, a kinase that phosphorylates serine 2 (Ser-2) in the C-terminal domain (CTD) of RNA polymerase II (Pol II), and in strains lacking Sen1, an ATP-dependent 5'-3' RNA/DNA helicase: notably, both Lsk1 and Sen1 have been implicated in termination of Pol II-dependent transcription. Furthermore, RNAi knockdown of cids-2, a Caenorhabditis elegans ortholog of rhn1(+), leads to elevated expression of a germline-specific gene, pgl-1, in somatic cells. These results indicate that Rhn1 contributes to the suppression of meiotic mRNAs in vegetative fission yeast and that the mechanism by which Rhn1 downregulates germline-specific transcripts may be conserved in unicellular and multicellular organisms.	[Sugiyama, Tomoyasu; Sugioka-Sugiyama, Rie; Hada, Kazumasa; Niwa, Ryusuke] Univ Tsukuba, Grad Sch Life & Environm Sci, Tsukuba, Ibaraki, Japan; [Sugiyama, Tomoyasu; Sugioka-Sugiyama, Rie; Hada, Kazumasa; Niwa, Ryusuke] Univ Tsukuba, Initiat Promot Young Scientists Independent Res, Tsukuba, Ibaraki, Japan; [Sugiyama, Tomoyasu] Japan Sci & Technol Agcy JST, Precursory Res Embryon Sci & Technol PRESTO, Kawaguchi, Saitama, Japan	University of Tsukuba; University of Tsukuba; Japan Science & Technology Agency (JST)	Sugiyama, T (corresponding author), Univ Tsukuba, Grad Sch Life & Environm Sci, Tsukuba, Ibaraki, Japan.	sugiyamt@biol.tsukuba.ac.jp		Sugiyama, Tomoyasu/0000-0001-5704-6606	Japanese Government; Japan Society for the Promotion of Science [22687013]; Nakajima Foundation	Japanese Government; Japan Society for the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); Nakajima Foundation	This work was supported by the Japanese Government's Special Coordination Funds for Promoting Science and Technology (to T.S. and R.N.), by a Grant-in-Aid for Young Scientists (A) (22687013) from the Japan Society for the Promotion of Science (to T.S.), and a research grant from the Nakajima Foundation (to T.S.). T.S. was a JST PRESTO researcher. The funders had no role in study design, data collection, data analysis, preparation of the manuscript, or the decision to publish.	ALLSHIRE RC, 1994, CELL, V76, P157, DOI 10.1016/0092-8674(94)90180-5; Bahler J, 1998, YEAST, V14, P943, DOI 10.1002/(SICI)1097-0061(199807)14:10<943::AID-YEA292>3.0.CO;2-Y; BEANAN MJ, 1992, DEVELOPMENT, V116, P755; Bond CS, 2009, J CELL BIOL, V186, P637, DOI 10.1083/jcb.200906113; BRENNER S, 1974, GENETICS, V77, P71; Buratowski S, 2005, CURR OPIN CELL BIOL, V17, P257, DOI 10.1016/j.ceb.2005.04.003; Cheeks RJ, 2004, CURR BIOL, V14, P851, DOI 10.1016/j.cub.2004.05.022; Chen HM, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0029917; Chen HM, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0026804; Chikashige Y, 2006, CELL, V125, P59, DOI 10.1016/j.cell.2006.01.048; Coudreuse D, 2010, CURR BIOL, V20, P1053, DOI 10.1016/j.cub.2010.04.054; Cui MX, 2008, P NATL ACAD SCI USA, V105, P16665, DOI 10.1073/pnas.0807104105; Curran SP, 2009, NATURE, V459, P1079, DOI 10.1038/nature08106; Garneau NL, 2007, NAT REV MOL CELL BIO, V8, P113, DOI 10.1038/nrm2104; Harigaya Y, 2006, NATURE, V442, P45, DOI 10.1038/nature04881; Houseley J, 2009, CELL, V136, P763, DOI 10.1016/j.cell.2009.01.019; Kim HD, 1999, BIOCHEMISTRY-US, V38, P14697, DOI 10.1021/bi991470c; Kim M, 2004, NATURE, V432, P517, DOI 10.1038/nature03041; Lamond AI, 2003, NAT REV MOL CELL BIO, V4, P605, DOI 10.1038/nrm1172; Li J, 2008, PLOS BIOL, V6, P1870, DOI 10.1371/journal.pbio.0060233; Licatalosi DD, 2002, MOL CELL, V9, P1101, DOI 10.1016/S1097-2765(02)00518-X; Mata J, 2002, NAT GENET, V32, P143, DOI 10.1038/ng951; Matera AG, 2009, DEV CELL, V17, P639, DOI 10.1016/j.devcel.2009.10.017; Matsuyama A, 2006, NAT BIOTECHNOL, V24, P841, DOI 10.1038/nbt1222; McPheeters DS, 2009, NAT STRUCT MOL BIOL, V16, P255, DOI 10.1038/nsmb.1556; MORENO S, 1991, METHOD ENZYMOL, V194, P795; Ogawa H, 2004, BIOCHEM BIOPH RES CO, V320, P218, DOI 10.1016/j.bbrc.2004.05.161; Saberianfar R, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024694; Scholes DT, 2001, GENETICS, V159, P1449; Schwer B, 2011, MOL CELL, V43, P311, DOI 10.1016/j.molcel.2011.05.024; Shaner NC, 2004, NAT BIOTECHNOL, V22, P1567, DOI 10.1038/nbt1037; Shobuike T, 2001, NUCLEIC ACIDS RES, V29, P1326, DOI 10.1093/nar/29.6.1326; Spector DL, 2001, J CELL SCI, V114, P2891; St-Andre O, 2010, J BIOL CHEM, V285, P27859, DOI 10.1074/jbc.M110.150748; SUGANO S, 1994, MOL GEN GENET, V243, P1, DOI 10.1007/BF00283869; SUGIMOTO A, 1991, GENE DEV, V5, P1990, DOI 10.1101/gad.5.11.1990; Sugiyama T, 2011, EMBO J, V30, P1027, DOI 10.1038/emboj.2011.32; Sukegawa Y, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1002387; Timmons L, 1998, NATURE, V395, P854, DOI 10.1038/27579; Unhavaithaya Y, 2002, CELL, V111, P991, DOI 10.1016/S0092-8674(02)01202-3; Updike DL, 2009, GENETICS, V183, P1397, DOI 10.1534/genetics.109.110171; Wang D, 2005, NATURE, V436, P593, DOI 10.1038/nature04010; West S, 2004, NATURE, V432, P522, DOI 10.1038/nature03035; Yamamoto M, 2010, P JPN ACAD B-PHYS, V86, P788, DOI 10.2183/pjab.86.788; Yamanaka S, 2010, EMBO J, V29, P2173, DOI 10.1038/emboj.2010.108; Yamashita A, 2012, OPEN BIOL, V2, DOI 10.1098/rsob.120014; Zhao R, 2009, CURR OPIN GENET DEV, V19, P172, DOI 10.1016/j.gde.2009.02.007	47	12	14	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 17	2012	7	8							e42962	10.1371/journal.pone.0042962	http://dx.doi.org/10.1371/journal.pone.0042962			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	996DG	22912768	Green Published, gold, Green Submitted			2022-12-25	WOS:000308063700031
J	Proust, R; Bertoglio, J; Gesbert, F				Proust, Richard; Bertoglio, Jacques; Gesbert, Franck			The Adaptor Protein SAP Directly Associates with CD3 zeta Chain and Regulates T Cell Receptor Signaling	PLOS ONE			English	Article							LINKED LYMPHOPROLIFERATIVE-DISEASE; SYNDROME GENE-PRODUCT; ZETA-CHAIN; SH2 DOMAIN; TYROSINE KINASE; ENCODING GENE; XLP SYNDROME; ACTIVATION; SLAM; TRANSDUCTION	Mutations altering the gene encoding the SLAM associated protein (SAP) are responsible for the X-linked lymphoproliferative disease or XLP1. Its absence is correlated with a defective NKT cells development, a decrease in B cell functions and a reduced T cells and NK cells cytotoxic activities, thus leading to an immunodeficiency syndrome. SAP is a small 128 amino-acid long protein that is almost exclusively composed of an SH2 domain. It has been shown to interact with the CD150/SLAM family of receptors, and in a non-canonical manner with SH3 containing proteins such as Fyn, beta PIX, PKC theta and Nck1. It would thus play the role of a minimal adaptor protein. It has been shown that SAP plays an important function in the activation of T cells through its interaction with the SLAM family of receptors. Therefore SAP defective T cells display a reduced activation of signaling events downstream of the TCR-CD3 complex triggering. In the present work, we evidence that SAP is a direct interactor of the CD3 zeta chain. This direct interaction occurs through the first ITAM of CD3 zeta, proximal to the membrane. Additionally, we show that, in the context of the TCR-CD3 signaling, an Sh-RNA mediated silencing of SAP is responsible for a decrease of several canonical T cell signaling pathways including Erk, Akt and PLC gamma 1 and to a reduced induction of IL-2 and IL-4 mRNA. Altogether, we show that SAP plays a central function in the T cell activation processes through a direct association with the CD3 complex.	[Proust, Richard; Gesbert, Franck] Univ Paris 11, Hop Paul Brousse, INSERM, UMR S1004, Villejuif, France; [Bertoglio, Jacques] Inst Gustave Roussy, INSERM, UMR S749, F-94805 Villejuif, France	Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Paul-Brousse - APHP; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Saclay; Institut National de la Sante et de la Recherche Medicale (Inserm); UNICANCER; Gustave Roussy	Proust, R (corresponding author), Univ Paris 11, Hop Paul Brousse, INSERM, UMR S1004, Villejuif, France.	franck.gesbert@u-psud.fr		Gesbert, Franck/0000-0002-5800-8385	INSERM; La Ligue Nationale contre le Cancer; association Nouvelles Recherches Biomedicales (NRB)-Vaincre le cancer; universite Paris-Sud; Ministere de l'Enseignement Superieur et de la Recherche; Association pour la Recherche contre le Cancer	INSERM(Institut National de la Sante et de la Recherche Medicale (Inserm)European Commission); La Ligue Nationale contre le Cancer(Ligue nationale contre le cancer); association Nouvelles Recherches Biomedicales (NRB)-Vaincre le cancer; universite Paris-Sud; Ministere de l'Enseignement Superieur et de la Recherche(Estonian Research CouncilEuropean Commission); Association pour la Recherche contre le Cancer(Fondation ARC pour la Recherche sur le Cancer)	This work was supported by INSERM, La Ligue Nationale contre le Cancer (equipe labellisee to JB), association Nouvelles Recherches Biomedicales (NRB)-Vaincre le cancer and universite Paris-Sud (FG and RP). RP received a doctoral fellowship from the Ministere de l'Enseignement Superieur et de la Recherche. RP is funded by the Association pour la Recherche contre le Cancer (aide individuelle) and received the prize Challenge Nathalie from the NRB. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abraham RT, 2004, NAT REV IMMUNOL, V4, P301, DOI 10.1038/nri1330; Al-Alem U, 2005, BLOOD, V106, P2069, DOI 10.1182/blood-2004-07-2731; Ansel KM, 2006, ANNU REV IMMUNOL, V24, P607, DOI 10.1146/annurev.immunol.23.021704.115821; Ardouin L, 1999, IMMUNITY, V10, P409, DOI 10.1016/S1074-7613(00)80041-2; Astoul E, 2001, TRENDS IMMUNOL, V22, P490, DOI 10.1016/S1471-4906(01)01973-1; Baldanzi G, 2011, J IMMUNOL, V187, P5941, DOI 10.4049/jimmunol.1002476; Bida AT, 2011, MOL IMMUNOL, V48, P1149, DOI 10.1016/j.molimm.2011.02.008; Cannons JL, 2010, J IMMUNOL, V185, P2819, DOI 10.4049/jimmunol.0902182; CHAN AC, 1991, P NATL ACAD SCI USA, V88, P9166, DOI 10.1073/pnas.88.20.9166; CHAN AC, 1992, CELL, V71, P649, DOI 10.1016/0092-8674(92)90598-7; Chung B, 2005, J IMMUNOL, V174, P3153, DOI 10.4049/jimmunol.174.6.3153; Coffey AJ, 1998, NAT GENET, V20, P129, DOI 10.1038/2424; da Silva FP, 2008, TRENDS IMMUNOL, V29, P366, DOI 10.1016/j.it.2008.05.001; Detre C, 2010, SEMIN IMMUNOPATHOL, V32, P157, DOI 10.1007/s00281-009-0193-0; Gesbert F, 1998, J BIOL CHEM, V273, P18273, DOI 10.1074/jbc.273.29.18273; Gu CP, 2006, P NATL ACAD SCI USA, V103, P14447, DOI 10.1073/pnas.0606624103; Haughn L, 1998, J EXP MED, V188, P1575, DOI 10.1084/jem.188.9.1575; Houtman JCD, 2005, J IMMUNOL, V175, P2449, DOI 10.4049/jimmunol.175.4.2449; Hwang PM, 2002, EMBO J, V21, P314, DOI 10.1093/emboj/21.3.314; IRVING BA, 1991, CELL, V64, P891, DOI 10.1016/0092-8674(91)90314-O; IRVING BA, 1993, J EXP MED, V177, P1093, DOI 10.1084/jem.177.4.1093; KOLANUS W, 1993, CELL, V74, P171, DOI 10.1016/0092-8674(93)90304-9; Latour S, 2003, NAT CELL BIOL, V5, P149, DOI 10.1038/ncb919; Li CJ, 2008, CELL SIGNAL, V20, P1960, DOI 10.1016/j.cellsig.2008.07.004; Li CJ, 2009, CELL SIGNAL, V21, P111, DOI 10.1016/j.cellsig.2008.09.014; Li SC, 1999, CURR BIOL, V9, P1355, DOI 10.1016/S0960-9822(00)80080-9; Li-Weber M, 2002, EUR J IMMUNOL, V32, P3587, DOI 10.1002/1521-4141(200212)32:12<3587::AID-IMMU3587>3.0.CO;2-E; Ma CS, 2007, ANNU REV IMMUNOL, V25, P337, DOI 10.1146/annurev.immunol.25.022106.141651; Morra M, 2001, ANNU REV IMMUNOL, V19, P657, DOI 10.1146/annurev.immunol.19.1.657; Murphy MA, 1998, MOL CELL BIOL, V18, P4872, DOI 10.1128/MCB.18.8.4872; Nakamura H, 2001, J IMMUNOL, V167, P2657, DOI 10.4049/jimmunol.167.5.2657; Nichols KE, 1998, P NATL ACAD SCI USA, V95, P13765, DOI 10.1073/pnas.95.23.13765; Nichols KE, 2005, NAT MED, V11, P340, DOI 10.1038/nm1189; Ostrakhovitch EA, 2009, CELL SIGNAL, V21, P540, DOI 10.1016/j.cellsig.2008.12.006; Pasquier B, 2005, J EXP MED, V201, P695, DOI 10.1084/jem.20042432; PURTILO D T, 1975, Lancet, V1, P935; REIF K, 1993, J BIOL CHEM, V268, P10780; Romero X, 2004, TISSUE ANTIGENS, V64, P132, DOI 10.1111/j.1399-0039.2004.00247.x; Sanzone S, 2003, J BIOL CHEM, V278, P29593, DOI 10.1074/jbc.M300565200; Sayos J, 1998, NATURE, V395, P462, DOI 10.1038/26683; Schwartzberg PL, 2009, NAT REV IMMUNOL, V9, P39, DOI 10.1038/nri2456; SECRIST JP, 1991, J BIOL CHEM, V266, P12135; SECRIST JP, 1993, J BIOL CHEM, V268, P5886; Shlapatska LM, 2001, J IMMUNOL, V166, P5480, DOI 10.4049/jimmunol.166.9.5480; Smith-Garvin JE, 2009, ANNU REV IMMUNOL, V27, P591, DOI 10.1146/annurev.immunol.021908.132706; Snow AL, 2009, J CLIN INVEST, V119, P2976, DOI 10.1172/JCI39518; Veillette A, 2009, IMMUNOL REV, V232, P229, DOI 10.1111/j.1600-065X.2009.00824.x; Waterman PM, 2010, FEBS LETT, V584, P4878, DOI 10.1016/j.febslet.2010.09.029; WEGENER AMK, 1992, CELL, V68, P83, DOI 10.1016/0092-8674(92)90208-T; Weiss A, 1991, Semin Immunol, V3, P313; Zhang WG, 1998, CELL, V92, P83, DOI 10.1016/S0092-8674(00)80901-0	51	21	23	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 13	2012	7	8							e43200	10.1371/journal.pone.0043200	http://dx.doi.org/10.1371/journal.pone.0043200			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	988OJ	22912825	Green Published, Green Submitted, gold			2022-12-25	WOS:000307500100070
J	Sysa-Shah, P; Xu, Y; Guo, X; Belmonte, F; Kang, B; Bedja, D; Pin, S; Tsuchiya, N; Gabrielson, K				Sysa-Shah, Polina; Xu, Yi; Guo, Xin; Belmonte, Frances; Kang, Byunghak; Bedja, Djahida; Pin, Scott; Tsuchiya, Noriko; Gabrielson, Kathleen			Cardiac-Specific Over-Expression of Epidermal Growth Factor Receptor 2 (ErbB2) Induces Pro-Survival Pathways and Hypertrophic Cardiomyopathy in Mice	PLOS ONE			English	Article							PROTEIN-SYNTHESIS; UP-REGULATION; MOUSE MODEL; HEART; KINASE; ACTIVATION; NEUREGULIN; MUTATION; STIMULATION; DYSFUNCTION	Background: Emerging evidence shows that ErbB2 signaling has a critical role in cardiomyocyte physiology, based mainly on findings that blocking ErbB2 for cancer therapy is toxic to cardiac cells. However, consequences of high levels of ErbB2 activity in the heart have not been previously explored. Methodology/Principal Findings: We investigated consequences of cardiac-restricted over-expression of ErbB2 in two novel lines of transgenic mice. Both lines develop striking concentric cardiac hypertrophy, without heart failure or decreased life span. ErbB2 transgenic mice display electrocardiographic characteristics similar to those found in patients with Hypertrophic Cardiomyopathy, with susceptibility to adrenergic-induced arrhythmias. The hypertrophic hearts, which are 2-3 times larger than those of control littermates, express increased atrial natriuretic peptide and b-myosin heavy chain mRNA, consistent with a hypertrophic phenotype. Cardiomyocytes in these hearts are significantly larger than wild type cardiomyocytes, with enlarged nuclei and distinctive myocardial disarray. Interestingly, the over-expression of ErbB2 induces a concurrent up-regulation of multiple proteins associated with this signaling pathway, including EGFR, ErbB3, ErbB4, PI3K subunits p110 and p85, bcl-2 and multiple protective heat shock proteins. Additionally, ErbB2 up-regulation leads to an anti-apoptotic shift in the ratio of bcl-xS/xL in the heart. Finally, ErbB2 over-expression results in increased activation of the translation machinery involving S6, 4E-BP1 and eIF4E. The dependence of this hypertrophic phenotype on ErbB family signaling is confirmed by reduction in heart mass and cardiomyocyte size, and inactivation of pro-hypertrophic signaling in transgenic animals treated with the ErbB1/2 inhibitor, lapatinib. Conclusions/Significance: These studies are the first to demonstrate that increased ErbB2 over-expression in the heart can activate protective signaling pathways and induce a phenotype consistent with Hypertrophic Cardiomyopathy. Furthermore, our work suggests that in the situation where ErbB2 signaling contributes to cardiac hypertrophy, inhibition of this pathway may reverse this process.	[Sysa-Shah, Polina; Xu, Yi; Guo, Xin; Belmonte, Frances; Kang, Byunghak; Bedja, Djahida; Pin, Scott; Tsuchiya, Noriko; Gabrielson, Kathleen] Johns Hopkins Univ, Sch Med, Dept Mol & Comparat Pathobiol, Baltimore, MD 21218 USA; [Tsuchiya, Noriko] Shionogi & Co Ltd, Drug Dev Res Labs, Osaka, Japan	Johns Hopkins University; Shionogi & Company Limited	Sysa-Shah, P (corresponding author), Johns Hopkins Univ, Sch Med, Dept Mol & Comparat Pathobiol, Baltimore, MD 21218 USA.	kgabriel@jhmi.edu			NIH [RO1 HL088649]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL088649] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [T32ES007141] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS))	This work was supported by NIH grant RO1 HL088649. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abraham TP, 2009, CARDIOVASC RES, V82, P84, DOI 10.1093/cvr/cvp016; Baselga J, 2001, EUR J CANCER, V37, pS18, DOI 10.1016/S0959-8049(00)00404-4; Baselga J, 1996, J CLIN ONCOL, V14, P737, DOI 10.1200/JCO.1996.14.3.737; Behr TM, 2001, NEW ENGL J MED, V345, P995; Bersell K, 2009, CELL, V138, P257, DOI 10.1016/j.cell.2009.04.060; Boluyt MO, 2004, CARDIOVASC DRUG THER, V18, P257, DOI 10.1023/B:CARD.0000041245.61136.56; Boluyt MO, 1997, CIRC RES, V81, P176, DOI 10.1161/01.RES.81.2.176; Camenisch TD, 2002, NAT MED, V8, P850, DOI 10.1038/nm742; Ciampi Q, 2002, J AM COLL CARDIOL, V40, P278, DOI 10.1016/S0735-1097(02)01950-2; Crone SA, 2002, NAT MED, V8, P459, DOI 10.1038/nm0502-459; Daugherty A., 2009, JOVE, P2, DOI [10.3791/1291, DOI 10.3791/1291]; de Bakker JMT, 2006, J CARDIOVASC ELECTR, V17, P567, DOI 10.1111/j.1540-8167.2006.00367.x; Di Mauro S, 2007, Acta Myol, V26, P79; Doggen K, 2009, J MOL CELL CARDIOL, V46, P33, DOI 10.1016/j.yjmcc.2008.10.010; EFTHIMIOU J, 1986, POSTGRAD MED J, V62, P285, DOI 10.1136/pgmj.62.726.285; Emanuel SL, 2008, MOL PHARMACOL, V73, P338, DOI 10.1124/mol.107.041236; Esparis-Ogando A, 1999, BIOCHEM J, V344, P339, DOI 10.1042/0264-6021:3440339; Fenton TR, 2011, INT J BIOCHEM CELL B, V43, P47, DOI 10.1016/j.biocel.2010.09.018; Fineschi V, 2005, INT J CARDIOL, V99, P277, DOI 10.1016/j.ijcard.2004.01.022; Forsha D, 2011, GENET MED, V13, P625, DOI 10.1097/GIM.0b013e3182142966; Gabrielson K, 2007, CANCER RES, V67, P1436, DOI 10.1158/0008-5472.CAN-06-3721; Georgakopoulos D, 1999, NAT MED, V5, P327, DOI 10.1038/6549; Gollob MH, 2001, NEW ENGL J MED, V344, P1823, DOI 10.1056/NEJM200106143442403; Gorlick R, 2009, PEDIATR BLOOD CANCER, V53, P594, DOI 10.1002/pbc.21989; Grazette LP, 2004, J AM COLL CARDIOL, V44, P2231, DOI 10.1016/j.jacc.2004.08.066; Hershberger RE, 2009, CIRC-HEART FAIL, V2, P253, DOI 10.1161/CIRCHEARTFAILURE.108.817346; Ho Carolyn Y, 2010, Heart Fail Clin, V6, P141, DOI 10.1016/j.hfc.2009.12.001; Horie T, 2010, CARDIOVASC RES, V87, P656, DOI 10.1093/cvr/cvq148; Jimenez J, 2011, AM J PHYSIOL-HEART C, V300, pH627, DOI 10.1152/ajpheart.00247.2010; Knollmann BC, 2001, J BIOL CHEM, V276, P10039, DOI 10.1074/jbc.M006745200; LEE KF, 1995, NATURE, V378, P394, DOI 10.1038/378394a0; Martens UM, 2009, SMALL MOL ONCOLOGY; Matsui T, 2002, J BIOL CHEM, V277, P22896, DOI 10.1074/jbc.M200347200; McConnell BK, 2001, CIRC RES, V88, P383; McKeage K, 2002, DRUGS, V62, P209, DOI 10.2165/00003495-200262010-00008; McMullen JR, 2004, J BIOL CHEM, V279, P4782, DOI 10.1074/jbc.M310405200; McMullen JR, 2003, P NATL ACAD SCI USA, V100, P12355, DOI 10.1073/pnas.1934654100; Muthuchamy M, 1999, CIRC RES, V85, P47; Negro A, 2004, RECENT PROG HORM RES, V59, P1, DOI 10.1210/rp.59.1.1; Okin PM, 2002, J AM COLL CARDIOL, V40, P1395, DOI 10.1016/S0735-1097(02)02171-X; Olayioye MA, 2000, EMBO J, V19, P3159, DOI 10.1093/emboj/19.13.3159; Olayioye MA, 1998, MOL CELL BIOL, V18, P5042, DOI 10.1128/MCB.18.9.5042; Olayioye MA, 1999, J BIOL CHEM, V274, P17209, DOI 10.1074/jbc.274.24.17209; Oliveira SMJ, 2003, J MOL CELL CARDIOL, V35, P1251, DOI 10.1016/S0022-2828(03)00237-2; Ozcelik C, 2002, P NATL ACAD SCI USA, V99, P8880, DOI 10.1073/pnas.122249299; PAUSE A, 1994, NATURE, V371, P762, DOI 10.1038/371762a0; Perik PJ, 2007, EUR J HEART FAIL, V9, P173, DOI 10.1016/j.ejheart.2006.05.010; Prabhakar R, 2003, MOL CELL BIOCHEM, V251, P33, DOI 10.1023/A:1025409227350; Prasad SVN, 2009, J BIOL CHEM, V284, P27487, DOI 10.1074/jbc.M109.036541; Reiss K, 1996, P NATL ACAD SCI USA, V93, P8630, DOI 10.1073/pnas.93.16.8630; Ripplinger CM, 2007, CIRC RES, V101, P1049, DOI 10.1161/CIRCRESAHA.107.161240; Rohrbach S, 1999, CIRCULATION, V100, P407, DOI 10.1161/01.CIR.100.4.407; Rohrbach S, 2005, BASIC RES CARDIOL, V100, P240, DOI 10.1007/s00395-005-0514-4; Rohrbach S, 2005, J MOL CELL CARDIOL, V38, P485, DOI 10.1016/j.yjmcc.2004.12.013; ROMHILT DW, 1968, AM HEART J, V75, P752, DOI 10.1016/0002-8703(68)90035-5; SADOSHIMA J, 1995, CIRC RES, V77, P1040, DOI 10.1161/01.RES.77.6.1040; SAHN DJ, 1978, CIRCULATION, V58, P1072, DOI 10.1161/01.CIR.58.6.1072; Sakamoto M, 2006, CIRC RES, V99, P1411, DOI 10.1161/01.RES.0000252345.80198.97; Shioi T, 2000, EMBO J, V19, P2537, DOI 10.1093/emboj/19.11.2537; Shioi T, 2002, MOL CELL BIOL, V22, P2799, DOI 10.1128/MCB.22.8.2799-2809.2002; Shiojima I, 2005, J CLIN INVEST, V115, P2108, DOI 10.1172/JCI24682; Sweeney C, 2000, ONCOGENE, V19, P5568, DOI 10.1038/sj.onc.1203913; Sweeney C, 2001, J BIOL CHEM, V276, P22685, DOI 10.1074/jbc.M100602200; Taniyama Yoshiaki, 2005, J Mol Cell Cardiol, V38, P375, DOI 10.1016/j.yjmcc.2004.12.002; Tidcombe H, 2003, P NATL ACAD SCI USA, V100, P8281, DOI 10.1073/pnas.1436402100; Uray I. P., 2001, Journal of Heart and Lung Transplantation, V20, P210, DOI 10.1016/S1053-2498(00)00454-X; Uzzaman M, 2000, CIRC RES, V86, P871, DOI 10.1161/01.RES.86.8.871; Varnava AM, 2001, CIRCULATION, V104, P1380, DOI 10.1161/hc3701.095952; Wang SC, 2004, CANCER CELL, V6, P251, DOI 10.1016/j.ccr.2004.07.012; Wolf CM, 2005, P NATL ACAD SCI USA, V102, P18123, DOI 10.1073/pnas.0509145102; Yang Z, 2010, CIRC-CARDIOVASC GENE, V3, P129, DOI 10.1161/CIRCGENETICS.109.901785; Yarden Y, 2001, NAT REV MOL CELL BIO, V2, P127, DOI 10.1038/35052073; YOKOYAMA A, 1987, BRIT HEART J, V57, P296; Zhao YH, 2009, ONCOGENE, V28, P3689, DOI 10.1038/onc.2009.229	74	39	39	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 9	2012	7	8							e42805	10.1371/journal.pone.0042805	http://dx.doi.org/10.1371/journal.pone.0042805			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	986WZ	22912742	Green Published, gold			2022-12-25	WOS:000307378500027
J	Ackermann, M; Clement-Ziza, M; Michaelson, JJ; Beyer, A				Ackermann, Marit; Clement-Ziza, Mathieu; Michaelson, Jacob J.; Beyer, Andreas			Teamwork: Improved eQTL Mapping Using Combinations of Machine Learning Methods	PLOS ONE			English	Article							QUANTITATIVE TRAIT LOCI; STATISTICAL-METHODS; SELECTION; EPISTASIS	Expression quantitative trait loci (eQTL) mapping is a widely used technique to uncover regulatory relationships between genes. A range of methodologies have been developed to map links between expression traits and genotypes. The DREAM (Dialogue on Reverse Engineering Assessments and Methods) initiative is a community project to objectively assess the relative performance of different computational approaches for solving specific systems biology problems. The goal of one of the DREAM5 challenges was to reverse-engineer genetic interaction networks from synthetic genetic variation and gene expression data, which simulates the problem of eQTL mapping. In this framework, we proposed an approach whose originality resides in the use of a combination of existing machine learning algorithms (committee). Although it was not the best performer, this method was by far the most precise on average. After the competition, we continued in this direction by evaluating other committees using the DREAM5 data and developed a method that relies on Random Forests and LASSO. It achieved a much higher average precision than the DREAM best performer at the cost of slightly lower average sensitivity.	[Ackermann, Marit; Clement-Ziza, Mathieu; Michaelson, Jacob J.; Beyer, Andreas] Tech Univ Dresden, Ctr Biotechnol, D-01062 Dresden, Germany; [Beyer, Andreas] Ctr Regenerat Therapy Dresden, Dresden, Germany	Technische Universitat Dresden	Ackermann, M (corresponding author), Tech Univ Dresden, Ctr Biotechnol, D-01062 Dresden, Germany.	andreas.beyer@biotec.tu-dresden.de	Beyer, Andreas/AAQ-5519-2020; Clément-Ziza, Mathieu/J-4146-2012; Beyer, Andreas/A-3352-2009	Beyer, Andreas/0000-0002-3891-2123; Clément-Ziza, Mathieu/0000-0003-2763-249X; Beyer, Andreas/0000-0002-3891-2123; Michaelson, Jacob/0000-0001-9713-0992	Klaus Tschira Foundation; CRTD Seed Grant [043 261581]; European Union [FP7-223539, FP7-200720]	Klaus Tschira Foundation; CRTD Seed Grant; European Union(European Commission)	This work was funded by the Klaus Tschira Foundation http://www.klaus-tschira-stiftung.de/english/index.html, a CRTD Seed Grant (Grant ID 043 261581) http://www.crt-dresden.de/, and the European Union FP7 projects PhenOxiGEn (Grant ID FP7-223539) http://www.phenoxigen.eu/and EuroSyStem (Grant ID FP7-200720) http://www.eurosystemproject.eu/.]jmm 6/21/2012. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Breiman L., 2001, Machine Learning, V45, P5, DOI 10.1023/A:1010933404324; Broman KW, 2002, J R STAT SOC B, V64, P641, DOI 10.1111/1467-9868.00354; Cookson W, 2009, NAT REV GENET, V10, P184, DOI 10.1038/nrg2537; Cordell HJ, 2002, HUM MOL GENET, V11, P2463, DOI 10.1093/hmg/11.20.2463; Davis J, 2006, P 23 INT C MACH LEAR, P233, DOI [DOI 10.1145/1143844.1143874, 10.1145/1143844.1143874]; Dietterich TG, 2000, LECT NOTES COMPUT SC, V1857, P1, DOI 10.1007/3-540-45014-9_1; Drummond C., 2000, P 17 INT C MACH LEAR, P239; Efron B, 2004, ANN STAT, V32, P407, DOI 10.1214/009053604000000067; Friedman J., 2001, ELEMENTS STAT LEARNI, DOI DOI 10.1007/978-0-387-84858-7; Goadrich M, 2004, LECT NOTES ARTIF INT, V3194, P98; HANLEY JA, 1982, RADIOLOGY, V143, P29, DOI 10.1148/radiology.143.1.7063747; Huang GJ, 2009, GENOME RES, V19, P1133, DOI 10.1101/gr.088120.108; Kempermann G, 2006, P NATL ACAD SCI USA, V103, P780, DOI 10.1073/pnas.0510291103; Kendziorski CM, 2006, BIOMETRICS, V62, P19, DOI 10.1111/j.1541-0420.2005.00437.x; Lee SI, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000358; Loguercio S, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013920; Marbach D, 2009, ANN NY ACAD SCI, V1158, P102, DOI 10.1111/j.1749-6632.2008.03945.x; Michaelson JJ, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-502; Michaelson JJ, 2009, METHODS, V48, P265, DOI 10.1016/j.ymeth.2009.03.004; Norel R, 2011, MOL SYST BIOL, V7, DOI 10.1038/msb.2011.70; Obuchowski NA, 2005, AM J ROENTGENOL, V184, P364, DOI 10.2214/ajr.184.2.01840364; Petretto E, 2006, PLOS GENET, V2, P1625, DOI 10.1371/journal.pgen.0020172; Phillips PC, 2008, NAT REV GENET, V9, P855, DOI 10.1038/nrg2452; Pinna A, 2011, BIOINFORMATICS, V27, P2459, DOI 10.1093/bioinformatics/btr407; Prill RJ, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009202; Provost F., 1997, Proceedings of the Third International Conference on Knowledge Discovery and Data Mining, P43; R Core Team, 2021, R LANG ENV STAT COMP; Stolovitzky G, 2009, ANN NY ACAD SCI, V1158, P159, DOI 10.1111/j.1749-6632.2009.04497.x; Suthram S, 2008, MOL SYST BIOL, V4, DOI 10.1038/msb.2008.4; Tibshirani R, 1996, J ROY STAT SOC B MET, V58, P267, DOI 10.1111/j.2517-6161.1996.tb02080.x; Veyrieras JB, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000214; Vignes M, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0029165; Yilmaz E, 2006, ESTIMATING AVERAGE P, P102, DOI DOI 10.1145/1183614.1183633; Zhu J, 2008, NAT GENET, V40, P854, DOI 10.1038/ng.167; Zou H, 2005, J R STAT SOC B, V67, P301, DOI 10.1111/j.1467-9868.2005.00503.x	35	12	13	4	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 24	2012	7	7							e40916	10.1371/journal.pone.0040916	http://dx.doi.org/10.1371/journal.pone.0040916			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	978NX	22911718	gold, Green Published, Green Submitted			2022-12-25	WOS:000306751300017
J	Hernandez, DG; Nalls, MA; Ylikotila, P; Keller, M; Hardy, JA; Majamaa, K; Singleton, AB				Hernandez, Dena G.; Nalls, Michael A.; Ylikotila, Pauli; Keller, Margaux; Hardy, John A.; Majamaa, Kari; Singleton, Andrew B.			Genome Wide Assessment of Young Onset Parkinson's Disease from Finland	PLOS ONE			English	Article							HEXANUCLEOTIDE REPEAT; FAMILIAL AGGREGATION; ASSOCIATION; VARIANTS; C9ORF72; LOCI	In the current study we undertook a series of experiments to test the hypothesis that a monogenic cause of disease may be detectable within a cohort of Finnish young onset Parkinson's disease patients. In the first instance we performed standard genome wide association analyses, and subsequent risk profile analysis. In addition we performed a series of analyses that involved testing measures of global relatedness within the cases compared to controls, searching for excess homozygosity in the cases, and examining the cases for signs of excess local genomic relatedness using a sliding window approach. This work suggested that the previously identified common, low risk alleles, and the risk models associated with these alleles, were generalizable to the Finnish Parkinson's disease population. However, we found no evidence that would suggest a single common high penetrance mutation exists in this cohort of young onset patients.	[Hernandez, Dena G.; Nalls, Michael A.; Keller, Margaux; Singleton, Andrew B.] NIA, Neurogenet Lab, NIH, Bethesda, MD 20892 USA; [Ylikotila, Pauli] Turku Univ Hosp, Dept Neurol, FIN-20520 Turku, Finland; [Hardy, John A.] UCL Inst Neurol, Reta Lilla Weston Labs, London, England; [Hardy, John A.] UCL Inst Neurol, Dept Mol Neurosci, London, England; [Majamaa, Kari] Univ Oulu, Inst Clin Med, Dept Neurol, Oulu, Finland	National Institutes of Health (NIH) - USA; NIH National Institute on Aging (NIA); University of Turku; University of London; University College London; University of London; University College London; University of Oulu	Hernandez, DG (corresponding author), NIA, Neurogenet Lab, NIH, Bethesda, MD 20892 USA.	singleta@mail.nih.gov	Hardy, John/C-2451-2009; Majamaa, Kari/A-1344-2012; Singleton, Andrew B/C-3010-2009	Hardy, John/0000-0002-3122-0423; Majamaa, Kari/0000-0002-9070-3791	Michael J. Fox Foundation for Parkinson's Disease Research through the Rapid Response Innovation Award program; Intramural Research Program of the National Institute on Aging; National Institutes of Health; Department of Health and Human Services [Z01 AG000949-06]; Academy of Finland [127764]; Finnish Parkinson Foundation; MRC [G0701075] Funding Source: UKRI; Alzheimers Research UK [ART-PPG2011A-14] Funding Source: researchfish; Medical Research Council [G0701075] Funding Source: researchfish; Parkinson&quot;s UK [G-0907] Funding Source: researchfish; NATIONAL INSTITUTE ON AGING [ZIAAG000949, Z01AG000949] Funding Source: NIH RePORTER	Michael J. Fox Foundation for Parkinson's Disease Research through the Rapid Response Innovation Award program; Intramural Research Program of the National Institute on Aging(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Department of Health and Human Services; Academy of Finland(Academy of Finland); Finnish Parkinson Foundation; MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Alzheimers Research UK(Alzheimer&apos;s Research UK (ARUK)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); Parkinson&quot;s UK(Parkinson&apos;s UK); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	This work was supported by a grant from the Michael J. Fox Foundation for Parkinson's Disease Research through the 2009 Rapid Response Innovation Award program. This work was also supported by the Intramural Research Program of the National Institute on Aging, National Institutes of Health, Department of Health and Human Services; project Z01 AG000949-06. This work was supported by grants from the Academy of Finland (project number 127764) and The Finnish Parkinson Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Autere JM, 2000, J NEUROL NEUROSUR PS, V69, P107, DOI 10.1136/jnnp.69.1.107; DeJesus-Hernandez M, 2011, NEURON, V72, P245, DOI 10.1016/j.neuron.2011.09.011; Do CB, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1002141; Gibbs JR, 2006, PLOS GENET, V2, P1511, DOI 10.1371/journal.pgen.0020150; Hardy J, 2009, NEW ENGL J MED, V360, P1759, DOI 10.1056/NEJMra0808700; Laaksovirta H, 2010, LANCET NEUROL, V9, P978, DOI 10.1016/S1474-4422(10)70184-8; Li Y, 2009, ANNU REV GENOM HUM G, V10, P387, DOI 10.1146/annurev.genom.9.081307.164242; Moilanen JS, 2001, HUM GENET, V108, P184; Nalls MA, 2011, LANCET, V377, P641, DOI 10.1016/S0140-6736(10)62345-8; Nalls MA, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000415; Pankratz N, 2009, HUM GENET, V124, P593, DOI 10.1007/s00439-008-0582-9; Payami H, 2002, ARCH NEUROL-CHICAGO, V59, P848, DOI 10.1001/archneur.59.5.848; Plagnol V, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1002142; Renton AE, 2011, NEURON, V72, P257, DOI 10.1016/j.neuron.2011.09.010; Ripatti S, 2010, LANCET, V376, P1393, DOI 10.1016/S0140-6736(10)61267-6; Saad M, 2011, HUM MOL GENET, V20, P615, DOI 10.1093/hmg/ddq497; Satake W, 2009, NAT GENET, V41, P1303, DOI 10.1038/ng.485; Simon-Sanchez J, 2009, NAT GENET, V41, P1308, DOI 10.1038/ng.487; Singleton A, 2011, HUM MOL GENET, V20, pR158, DOI 10.1093/hmg/ddr358; Skol AD, 2006, NAT GENET, V38, P209, DOI 10.1038/ng1706	20	23	23	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 24	2012	7	7							e41859	10.1371/journal.pone.0041859	http://dx.doi.org/10.1371/journal.pone.0041859			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	978NX	22911860	Green Submitted, Green Published, gold			2022-12-25	WOS:000306751300078
J	Vinogradov, AE				Vinogradov, Alexander E.			Human More Complex than Mouse at Cellular Level	PLOS ONE			English	Article							GENE-EXPRESSION	The family of transcription factors with the C2H2 zinc finger domain is expanding in the evolution of vertebrates, reaching its highest numbers in the mammals. The question arises: whether an increased amount of these transcription factors is related to embryogenesis, nervous system, pathology or more of them are expressed in individual cells? Among mammals, the primates have a more complex anatomical structure than the rodents (e. g., brain). In this work, I show that a greater number of C2H2-ZFgenes are expressed in the human cells than in the mouse cells. The effect is especially pronounced for C2H2-ZF genes accompanied with the KRAB domain. The relative difference between the numbers of C2H2-ZF(-KRAB) genes in the human and mouse cellular transcriptomes even exceeds their difference in the genomes (i.e. a greater subset of existing in the genome genes is expressed in the human cellular transcriptomes compared to the mouse transcriptomes). The evolutionary turnover of C2H2-ZF(-KRAB) genes acts in the direction of the revealed phenomenon, i.e. gene duplication and loss enhances the difference in the relative number of C2H2-ZF(-KRAB) genes between human and mouse cellular transcriptomes. A higher amount of these genes is expressed in the brain and embryonic cells (compared with other tissues), whereas a lower amount - in the cancer cells. It is specifically the C2H2-ZF transcription factors whose repertoire is poorer in the cancer and richer in the brain (other transcription factors taken together do not show this trend). These facts suggest that increase of anatomical complexity is accompanied by a more complex intracellular regulation involving these transcription factors. Malignization is associated with simplification of this regulation. These results agree with the known fact that human cells are more resistant to oncogenic transformation than mouse cells. The list of C2H2-ZF genes whose suppression might be involved in malignization is provided.	Russian Acad Sci, Inst Cytol, St Petersburg 194064, Russia	Russian Academy of Sciences; St. Petersburg Scientific Centre of the Russian Academy of Sciences; Institute of Cytology RAS	Vinogradov, AE (corresponding author), Russian Acad Sci, Inst Cytol, St Petersburg 194064, Russia.	aevin@mail.cytspb.rssi.ru	Vinogradov, Alexander E/GZA-4008-2022; Vinogradov, Alexander E/R-3923-2016	Vinogradov, Alexander E/0000-0001-5540-8896; 	Russian Foundation for Basic Research (RFBR)	Russian Foundation for Basic Research (RFBR)(Russian Foundation for Basic Research (RFBR))	This work was supported by the Russian Foundation for Basic Research (RFBR). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bateman A, 2004, NUCLEIC ACIDS RES, V32, pD138, DOI [10.1093/nar/gkt1223, 10.1093/nar/gkp985, 10.1093/nar/gkr1065]; Blake JA, 2012, NUCLEIC ACIDS RES, V40, pD559, DOI 10.1093/nar/gkr1028; Clark DA, 2001, NATURE, V411, P189, DOI 10.1038/35075564; Demetrius Lloyd, 2005, EMBO Rep, V6 Spec No, pS39; Feldmesser E, 2006, BMC GENOMICS, V7, DOI 10.1186/1471-2164-7-121; Go Y, 2008, MOL BIOL EVOL, V25, P1897, DOI 10.1093/molbev/msn135; Groner AC, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1000869; Hunter S, 2012, NUCLEIC ACIDS RES, V40, pD306, DOI 10.1093/nar/gkr948; Lorenz P, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-206; Meylan S, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-378; Nowick K, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021553; Pearson William, 2004, Curr Protoc Bioinformatics, VChapter 3, DOI 10.1002/0471250953.bi0309s04; Pontius JU, 2003, NCBI HDB, V1, P1; Rangarajan A, 2004, CANCER CELL, V6, P171, DOI 10.1016/j.ccr.2004.07.009; Rangarajan A, 2003, NAT REV CANCER, V3, P952, DOI 10.1038/nrc1235; Sayers EW, 2012, NUCLEIC ACIDS RES, V40, pD13, DOI [10.1093/nar/gkr1184, 10.1093/nar/gks1189, 10.1093/nar/gky1069]; Schwanhausser B, 2011, NATURE, V473, P337, DOI 10.1038/nature10098; Soares Marcelo Bento, 2009, V533, P109, DOI 10.1007/978-1-60327-136-3_6; Vaquerizas JM, 2009, NAT REV GENET, V10, P252, DOI 10.1038/nrg2538; Vinogradov AE, 2007, NUCLEIC ACIDS RES, V35, P6350, DOI 10.1093/nar/gkm723; Vinogradov AE, 2010, P ROY SOC B-BIOL SCI, V277, P1403, DOI 10.1098/rspb.2009.1865	21	8	9	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 24	2012	7	7							e41753	10.1371/journal.pone.0041753	http://dx.doi.org/10.1371/journal.pone.0041753			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	978NX	22911852	Green Published, gold, Green Submitted			2022-12-25	WOS:000306751300070
J	Wang, DS; Wang, ZQ; Zhang, L; Qiu, MZ; Luo, HY; Ren, C; Zhang, DS; Wang, FH; Li, YH; Xu, RH				Wang, De-shen; Wang, Zhi-qiang; Zhang, Le; Qiu, Miao-zhen; Luo, Hui-yan; Ren, Chao; Zhang, Dong-sheng; Wang, Feng-hua; Li, Yu-hong; Xu, Rui-hua			Are Risk Factors Associated with Outcomes in Pancreatic Cancer?	PLOS ONE			English	Article							ABO BLOOD-GROUP; HEPATITIS-B-VIRUS; BODY-MASS INDEX; METABOLIC SYNDROME; GROUP ALLELES; COHORT; INFECTION; INFLAMMATION; MALIGNANCY; SURVIVAL	Background: The development of pancreatic cancer is a process in which genes interact with environmental factors. We performed this study to determine the effects of the ABO blood group, obesity, diabetes mellitus, metabolic syndrome (MetS), smoking, alcohol consumption and hepatitis B viral (HBV) infection on patient survival. Methods: A total of 488 patients with pancreatic cancer were evaluated. Result: Patients who presented as chronic carriers of HBV infection were younger at disease onset (p = 0.001) and more predominantly male (p = 0.020) than those never exposed to HBV. Patients with MetS had later disease staging (p = 0.000) and a lower degree of pathological differentiation (p = 0.008) than those without MetS. In a univariate analysis, the ABO blood group, smoking and alcohol consumption were not associated with overall survival. HBsAg-positivity and elevated fasting plasma glucose were significantly associated with unfavorable survival though not in the multivariate analysis. The presence of MetS (HR: 1.541, 95% CI: 1.095-2.169, p = 0.013), age >= 65, an elevated CA19-9 baseline level, TNM staging, the type of surgery, the degree of differentiation and chemotherapy were independently associated with overall survival. Conclusion: We report, for the first time, that patients with chronic HBV infection may represent a special subtype of pancreatic cancer, who have a younger age of disease onset and male dominancy. Patients with MetS had later disease staging and a poorer histological grade. Patients with MetS demonstrated significantly poorer survival.	[Wang, De-shen; Wang, Zhi-qiang; Zhang, Le; Qiu, Miao-zhen; Luo, Hui-yan; Ren, Chao; Zhang, Dong-sheng; Wang, Feng-hua; Li, Yu-hong; Xu, Rui-hua] Sun Yat Sen Univ, Ctr Canc, Dept Med Oncol, State Key Lab Oncol S China, Guangzhou 510275, Guangdong, Peoples R China	Sun Yat Sen University	Wang, DS (corresponding author), Sun Yat Sen Univ, Ctr Canc, Dept Med Oncol, State Key Lab Oncol S China, Guangzhou 510275, Guangdong, Peoples R China.	xurh@sysucc.org.cn	Xu, Rui-Hua/AAW-4766-2021; 骆, 卉妍/GWR-3383-2022; xu, rui/GRX-5734-2022; Li, yu/HHZ-5236-2022; li, Yu/HCI-9086-2022; li, yu/HGL-9518-2022	Xu, Rui-Hua/0000-0001-9771-8534; 骆, 卉妍/0000-0001-6312-9299; 	National Natural Science Foundation of China [30672408]; Guangzhou Bureau of Science and Technology [2006Z3-E0041]; Sun Yat-sen University 985 Program Initiation Fund (China)	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Guangzhou Bureau of Science and Technology; Sun Yat-sen University 985 Program Initiation Fund (China)	This work was supported by the National Natural Science Foundation of China grant 30672408(http://www.nsfc.gov.cn/), Guangzhou Bureau of Science and Technology grant 2006Z3-E0041 (http://gdsf.gdstc.gov.cn/) and Sun Yat-sen University 985 Program Initiation Fund (China)(http://www.sysu.edu.cn/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amundadottir L, 2009, NAT GENET, V41, P986, DOI 10.1038/ng.429; Bao B, 2012, CANC PREV RES PHILA; Ben QW, 2011, INT J CANCER, V128, P1179, DOI 10.1002/ijc.25426; Chae YK, 2011, CANCER INVEST, V29, P585, DOI 10.3109/07357907.2011.616252; Chang CH, 2011, J CLIN ONCOL, V29, P3001, DOI 10.1200/JCO.2011.35.1908; Cleeman JI, 2001, JAMA-J AM MED ASSOC, V285, P2486, DOI 10.1001/jama.285.19.2486; Dandona M, 2010, JNCI-J NATL CANCER I, V102, P135, DOI 10.1093/jnci/djp447; Devaraj S, 2004, ENDOCRIN METAB CLIN, V33, P431, DOI 10.1016/j.ecl.2004.03.008; Fantuzzi G, 2005, J ALLERGY CLIN IMMUN, V115, P911, DOI 10.1016/j.jaci.2005.02.023; Felini M, 2011, ANN EPIDEMIOL, V21, P755, DOI 10.1016/j.annepidem.2011.07.001; Feng Y, 2008, J CLIN ONCOL, V26; FUJIOKA S, 1987, METABOLISM, V36, P54, DOI 10.1016/0026-0495(87)90063-1; Gapstur SM, 2011, ARCH INTERN MED, V171, P444, DOI 10.1001/archinternmed.2010.536; Geraci JM, 2006, J CLIN ONCOL, V24, p333S; Grivennikov SI, 2010, CELL, V140, P883, DOI 10.1016/j.cell.2010.01.025; Hakomori S, 2001, ADV EXP MED BIOL, V491, P369; Hakomori S, 1999, BBA-GEN SUBJECTS, V1473, P247, DOI 10.1016/S0304-4165(99)00183-X; HAKOMORI SI, 1989, ADV CANCER RES, V52, P257; Hassan MM, 2008, J CLIN ONCOL, V26, P4557, DOI 10.1200/JCO.2008.17.3526; Healy L, 2011, COLORECTAL DIS; Hezel AF, 2006, GENE DEV, V20, P1218, DOI 10.1101/gad.1415606; Iloeje UH, 2010, LIVER INT, V30, P423, DOI 10.1111/j.1478-3231.2009.02147.x; Jee SH, 2005, JAMA-J AM MED ASSOC, V293, P194, DOI 10.1001/jama.293.2.194; Jemal A, 2011, CA-CANCER J CLIN, V61, P134, DOI [10.3322/caac.20115, 10.3322/caac.20107]; Johansen D, 2010, CANCER EPIDEM BIOMAR, V19, P2307, DOI 10.1158/1055-9965.EPI-10-0234; Lemieux I, 2001, ARTERIOSCL THROM VAS, V21, P961, DOI 10.1161/01.ATV.21.6.961; Li DH, 2011, CANCER-AM CANCER SOC, V117, P2863, DOI 10.1002/cncr.25858; Li DH, 2009, JAMA-J AM MED ASSOC, V301, P2553, DOI 10.1001/jama.2009.886; Magruder JT, 2011, PANCREAS, V40, P339, DOI 10.1097/MPA.0b013e318209e05d; McWilliams RR, 2010, CANCER, V116, P203, DOI [10.1002/cncr.24697, 10.1002/cncr.25465]; McWilliams RR, 2005, CANCER, V104, P388, DOI 10.1002/cncr.21166; Moore T, 2008, CANCER PREV RES, V1, P65, DOI 10.1158/1940-6207.CAPR-08-0022; Nakamura K, 2011, JPN J CLIN ONCOL, V41, P225, DOI 10.1093/jjco/hyq185; Olefsky JM, 2010, ANNU REV PHYSIOL, V72, P219, DOI 10.1146/annurev-physiol-021909-135846; Olowokure OO, 2010, J CLIN ONCOL, V28, P4114; Raimondi S, 2009, NAT REV GASTRO HEPAT, V6, P699, DOI 10.1038/nrgastro.2009.177; Rosato V, 2011, METABOLISM, V60, P1372, DOI 10.1016/j.metabol.2011.03.005; Russo A, 2008, EUR J CANCER, V44, P293, DOI 10.1016/j.ejca.2007.11.005; Shama MA, 2010, J CLIN ONCOL, V28, P4117, DOI DOI 10.1200/JCO.2010.28.15_SUPPL.4117; Shan T, 2011, EUR J PHARMACOL, V665, P1, DOI 10.1016/j.ejphar.2011.04.055; Stocks T, 2009, PLOS MED, V6, DOI 10.1371/journal.pmed.1000201; Suganuma M, 1999, CANCER RES, V59, P4516; Tang HW, 2011, CANCER EPIDEM BIOMAR, V20, P779, DOI 10.1158/1055-9965.EPI-10-0845; Trikudanathan G, 2011, J PANCREAS, V12, P26; Wang DS, 2012, INT J CANCER, V131, P461, DOI 10.1002/ijc.26376; Wang W, 2011, PANCREATOLOGY, V11, P16, DOI 10.1159/000322982; Welzel TM, 2011, HEPATOLOGY, V54, P463, DOI 10.1002/hep.24397; Wolpin BM, 2010, CANCER EPIDEM BIOMAR, V19, P3140, DOI 10.1158/1055-9965.EPI-10-0751; Wolpin BM, 2010, CANCER RES, V70, P1015, DOI 10.1158/0008-5472.CAN-09-2993; Wolpin BM, 2009, J NATL CANCER I, V101, P424, DOI 10.1093/jnci/djp020	50	35	35	1	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 24	2012	7	7							e41984	10.1371/journal.pone.0041984	http://dx.doi.org/10.1371/journal.pone.0041984			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	978NX	22911869	Green Submitted, Green Published, gold			2022-12-25	WOS:000306751300086
J	Featherstone, RE; Phillips, JM; Thieu, T; Ehrlichman, RS; Halene, TB; Leiser, SC; Christian, E; Johnson, E; Lerman, C; Siegel, SJ				Featherstone, Robert E.; Phillips, Jennifer M.; Thieu, Tony; Ehrlichman, Richard S.; Halene, Tobias B.; Leiser, Steven C.; Christian, Edward; Johnson, Edwin; Lerman, Caryn; Siegel, Steven J.			Nicotine Receptor Subtype-Specific Effects on Auditory Evoked Oscillations and Potentials	PLOS ONE			English	Article							EVENT-RELATED POTENTIALS; GAMMA-BAND RESPONSES; ACETYLCHOLINE-RECEPTOR; PHARMACOLOGICAL CHARACTERIZATION; NEUROPHYSIOLOGICAL EVIDENCE; INDUCED ENHANCEMENT; GATING DEFICITS; MICE; SCHIZOPHRENIA; MOUSE	Background: Individuals with schizophrenia show increased smoking rates which may be due to a beneficial effect of nicotine on cognition and information processing. Decreased amplitude of the P50 and N100 auditory event-related potentials (ERPs) is observed in patients. Both measures show normalization following administration of nicotine. Recent studies identified an association between deficits in auditory evoked gamma oscillations and impaired information processing in schizophrenia, and there is evidence that nicotine normalizes gamma oscillations. Although the role of nicotine receptor subtypes in augmentation of ERPs has received some attention, less is known about how these receptor subtypes regulate the effect of nicotine on evoked gamma activity. Methodology/Principal Findings: We examined the effects of nicotine, the alpha 7 nicotine receptor antagonist methyllycaconitine (MLA) the alpha 4 beta 4/alpha 4 beta 2 nicotine receptor antagonist dihydro-beta-erythroidine (DH beta E), and the alpha 4 beta 2 agonist AZD3480 on P20 and N40 amplitude as well as baseline and event-related gamma oscillations in mice, using electrodes in hippocampal CA3. Nicotine increased P20 amplitude, while DHbE blocked nicotine-induced enhancements in P20 amplitude. Conversely, MLA did not alter P20 amplitude either when presented alone or with nicotine. Administration of the alpha 4 beta 2 specific agonist AZD3480 did not alter any aspect of P20 response, suggesting that DHbE blocks the effects of nicotine through a non-alpha 4 beta 2 receptor specific mechanism. Nicotine and AZD3480 reduced N40 amplitude, which was blocked by both DHbE and MLA. Finally, nicotine significantly increased event-related gamma, as did AZD3480, while DHbE but not MLA blocked the effect of nicotine on event-related gamma. Conclusions/Significance: These results support findings showing that nicotine-induced augmentation of P20 amplitude occurs via a DHbE sensitive mechanism, but suggests that this does not occur through activation of alpha 4 beta 2 receptors. Event-related gamma is strongly influenced by activation of alpha 4 beta 2, but not a7, receptor subtypes, while disruption of N40 amplitude requires the activation of multiple receptor subtypes.	[Featherstone, Robert E.; Thieu, Tony; Ehrlichman, Richard S.; Halene, Tobias B.; Lerman, Caryn; Siegel, Steven J.] Univ Penn, Dept Psychiat, Philadelphia, PA 19104 USA; [Phillips, Jennifer M.] Mt St Marys Univ, Dept Psychol, Emmitsburg, MD USA; [Leiser, Steven C.; Christian, Edward; Johnson, Edwin] AstraZeneca, Wilmington, DE USA	University of Pennsylvania; AstraZeneca	Featherstone, RE (corresponding author), Univ Penn, Dept Psychiat, Philadelphia, PA 19104 USA.	siegels@upenn.edu	Lerman, Caryn/AHC-5180-2022	Leiser, Steven/0000-0002-4680-2012; Siegel, Steven/0000-0001-8058-9713	National Cancer Institute [P50-CA/DA-084718]; National Institute of Drug Abuse [R01DA023210]; AstraZeneca; NuPathe; Merck; Glaxo SmithKline; Novartis; Pfizer; NATIONAL CANCER INSTITUTE [P50CA084718] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DRUG ABUSE [R01DA023210] Funding Source: NIH RePORTER	National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); National Institute of Drug Abuse(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)); AstraZeneca(AstraZeneca); NuPathe; Merck(Merck & Company); Glaxo SmithKline(GlaxoSmithKline); Novartis(Novartis); Pfizer(Pfizer); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission)	This work was supported by P50-CA/DA-084718, (National Cancer Institute and National Institute of Drug Abuse, Caryn Lerman, PI) and R01DA023210 (National Institute of Drug Abuse, Steven Siegel, PI). No additional external funding received for this study.; The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. We have the following interests. Steven Leiser, Edward Christian and Edwin Johnson are former employees of AstraZeneca who provided a pilot grant for this study. Steven Siegel has been a consultant and/or has received grant support from the following companies that develop and/or market medications: NuPathe, AstraZeneca, and Merck, all unrelated to the current manuscript. Caryn Lerman has been a consultant and/or has received grant support from the following companies that develop and/or market smoking cessation medications: AstraZeneca, Glaxo SmithKline, Novartis and Pfizer, all unrelated to the current manuscript. AstraZeneca supplied AZD3480 for use in this study. There are no other patents, products in development or other marketed products to declare. This does not alter our adherence to all the PLoS ONE policies on sharing data and materials, as detailed online in the guide for authors.	Adler LE, 1998, SCHIZOPHRENIA BULL, V24, P189, DOI 10.1093/oxfordjournals.schbul.a033320; ADLER LE, 1982, BIOL PSYCHIAT, V17, P639; ADLER LE, 1993, AM J PSYCHIAT, V150, P1856; Amann LC, 2008, BEHAV NEUROSCI, V122, P982, DOI 10.1037/a0012995; Basar E, 2001, INT J PSYCHOPHYSIOL, V39, P241, DOI 10.1016/S0167-8760(00)00145-8; BasarEroglu C, 1996, INT J PSYCHOPHYSIOL, V24, P101, DOI 10.1016/S0167-8760(96)00051-7; Benchenane K, 2011, CURR OPIN NEUROBIOL, V21, P475, DOI 10.1016/j.conb.2011.01.004; BOUTROS N, 1993, PSYCHIAT RES, V47, P243, DOI 10.1016/0165-1781(93)90082-R; BOUTROS NN, 1991, CLIN ELECTROENCEPHAL, V22, P40, DOI 10.1177/155005949102200109; ChavezNoriega LE, 1997, J PHARMACOL EXP THER, V280, P346; Connolly PM, 2003, BRAIN RES, V992, P85, DOI 10.1016/j.brainres.2003.08.035; Connolly PM, 2004, NEUROCHEM RES, V29, P1179, DOI 10.1023/B:NERE.0000023605.68408.fb; Crawford HJ, 2002, NEUROSCI LETT, V317, P151, DOI 10.1016/S0304-3940(01)02454-5; Damaj MI, 1999, J PHARMACOL EXP THER, V291, P1284; Davis JA, 2006, PSYCHOPHARMACOLOGY, V184, P345, DOI 10.1007/s00213-005-0047-y; De Biasi M, 2011, ANNU REV NEUROSCI, V34, P105, DOI 10.1146/annurev-neuro-061010-113734; Delorme A, 2004, J NEUROSCI METH, V134, P9, DOI 10.1016/j.jneumeth.2003.10.009; Demiralp T, 1996, INT J NEUROSCI, V84, P1, DOI 10.3109/00207459608987246; Demiralp T, 2007, INT J PSYCHOPHYSIOL, V64, P24, DOI 10.1016/j.ijpsycho.2006.07.005; Dunbar G, 2007, PSYCHOPHARMACOLOGY, V191, P919, DOI 10.1007/s00213-006-0675-x; Ehrlichman RS, 2008, J COGNITIVE NEUROSCI, V20, P1403, DOI 10.1162/jocn.2008.20097; FREEDMAN R, 1983, BIOL PSYCHIAT, V18, P537; Gandal MJ, 2011, NEUROPHARMACOLOGY; Gatto GJ, 2004, CNS DRUG REV, V10, P147; Gommans J, 2000, NEUROPHARMACOLOGY, V39, P2840, DOI 10.1016/S0028-3908(00)00130-1; Griffith JM, 1998, BIOL PSYCHIAT, V44, P98, DOI 10.1016/S0006-3223(97)00362-4; Hajos M, 2005, J PHARMACOL EXP THER, V312, P1213, DOI 10.1124/jpet.104.076968; Hashimoto K, 2005, PSYCHOPHARMACOLOGY, V183, P13, DOI 10.1007/s00213-005-0142-0; Herrmann CS, 2005, CLIN NEUROPHYSIOL, V116, P2719, DOI 10.1016/j.clinph.2005.07.007; Lewis DA, 2005, NAT REV NEUROSCI, V6, P312, DOI 10.1038/nrn1648; Lippiello P, 2006, J MOL NEUROSCI, V30, P19, DOI 10.1385/JMN:30:1:19; Maxwell CR, 2004, NEUROPSYCHOPHARMACOL, V29, P739, DOI 10.1038/sj.npp.1300376; Maxwell CR, 2004, NEUROSCIENCE, V129, P101, DOI 10.1016/j.neuroscience.2004.07.038; Maxwell CR, 2006, NEUROPSYCHOPHARMACOL, V31, P897, DOI 10.1038/sj.npp.1300879; Maxwell CR, 2006, J PHARMACOL EXP THER, V316, P315, DOI 10.1124/jpet.105.091199; Metzger KL, 2007, BIOL PSYCHIAT, V61, P23, DOI 10.1016/j.biopsych.2005.12.011; Olincy A, 2006, ARCH GEN PSYCHIAT, V63, P630, DOI 10.1001/archpsyc.63.6.630; PANTEV C, 1991, ACTA OTO-LARYNGOL, P106; Pantev C, 1991, ACTA OTO-LARYNGOL, V491, P115; Patterson F, 2009, BIOL PSYCHIAT, V65, P144, DOI 10.1016/j.biopsych.2008.08.028; PETERSEN DR, 1984, DRUG METAB DISPOS, V12, P725; Phillips JM, 2007, NEUROSCIENCE, V144, P1314, DOI 10.1016/j.neuroscience.2006.11.003; Rudnick ND, 2010, NICOTINE TOB RES, V12, P589, DOI 10.1093/ntr/ntq049; Rudnick N, 2009, PSYCHOPHARMACOLOGY, V202, P745, DOI 10.1007/s00213-008-1358-6; Siegel S, 2003, NEUROPSYCHOPHARMACOL, V28, P675, DOI 10.1038/sj.npp.1300087; Siegel SJ, 2005, NEUROSCIENCE, V133, P729, DOI 10.1016/j.neuroscience.2005.03.027; Stegelmeier BL, 2003, J ANIM SCI, V81, P1237; Stevens KE, 1998, PSYCHOPHARMACOLOGY, V136, P320, DOI 10.1007/s002130050573; TUREK JW, 1995, J NEUROSCI METH, V61, P113, DOI 10.1016/0165-0270(95)00032-P; Uhlhaas PJ, 2010, NAT REV NEUROSCI, V11, P100, DOI 10.1038/nrn2774; Umbricht D, 2004, BRAIN RES, V1019, P189, DOI 10.1016/j.brainres.2004.05.097; Walters CL, 2006, PSYCHOPHARMACOLOGY, V184, P339, DOI 10.1007/s00213-005-0295-x; Wildeboer KM, 2008, BRAIN RES, V1224, P29, DOI 10.1016/j.brainres.2008.06.007	53	16	16	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 20	2012	7	7							e39775	10.1371/journal.pone.0039775	http://dx.doi.org/10.1371/journal.pone.0039775			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	977GL	22911690	Green Published, gold, Green Submitted			2022-12-25	WOS:000306644600009
J	Macdonald, TA; Burd, BJ; van Roodselaar, A				Macdonald, Tara A.; Burd, Brenda J.; van Roodselaar, Albert			Size Structure of Marine Soft-Bottom Macrobenthic Communities across Natural Habitat Gradients: Implications for Productivity and Ecosystem Function	PLOS ONE			English	Article							TRAWLING DISTURBANCE; BRISSOPSIS LYRIFERA; TROPHIC STRUCTURE; BIOMASS SPECTRA; ORGANIC-CARBON; SEDIMENT; STRAIT; ABUNDANCE; GEORGIA; INVERTEBRATES	Size distributions of biotic assemblages are important modifiers of productivity and function in marine sediments. We investigated the distribution of proportional organic biomass among logarithmic size classes (2(-6) J to 2(16) J) in the soft-bottom macrofaunal communities of the Strait of Georgia, Salish Sea on the west coast of Canada. The study examines how size structure is influenced by 3 fundamental habitat descriptors: depth, sediment percent fines, and organic flux (modified by quality). These habitat variables are uncorrelated in this hydrographically diverse area, thus we examine their effects in combination and separately. Cluster analyses and cumulative biomass size spectra reveal clear and significant responses to each separate habitat variable. When combined, habitat factors result in three distinct assemblages: (1) communities with a high proportion of biomass in small organisms, typical of shallow areas (, 10 m) with coarse sediments (<10% fines) and low accumulation of organic material (<3.0 g C/m(2)/yr/delta N-15); (2) communities with high proportion of biomass in the largest organisms found in the Strait, typical of deep, fine sediments with high modified organic flux (>3 g C/m(2)/yr/delta 15N) from the Fraser River; and (3) communities with biomass dominated by moderately large organisms, but lacking the smallest and largest size classes, typical of deep, fine sediments experiencing low modified organic flux (<3.0 gC/m(2)/yr/delta N-15). The remaining assemblages had intermediate habitat types and size structures. Sediment percent fines and flux appear to elicit threshold responses in size structure, whereas depth has the most linear influence on community size structure. The ecological implications of size structure in the Strait of Georgia relative to environmental conditions, secondary production and sediment bioturbation are discussed.	[Macdonald, Tara A.; Burd, Brenda J.] Inst Ocean Sci, Dept Fisheries & Oceans, Sidney, BC V8L 4B2, Canada; [Macdonald, Tara A.] Biol Environm Serv, Victoria, BC, Canada; [Burd, Brenda J.] Ecostat Res Ltd, N Saanich, BC, Canada; [van Roodselaar, Albert] Metro Vancouver, Burnaby, BC, Canada	Fisheries & Oceans Canada	Macdonald, TA (corresponding author), Inst Ocean Sci, Dept Fisheries & Oceans, Sidney, BC V8L 4B2, Canada.	tara@biologica.bc.ca			Metro Vancouver	Metro Vancouver	This work is part of the Strait of Georgia Ambient Monitoring Program, which is a collaborative research program with two partners: Fisheries and Oceans Canada and Metro Vancouver (formerly the Greater Vancouver Regional District). Metro Vancouver supplied the funding for this research. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amaro T, 2010, BIOGEOSCIENCES, V7, P2419, DOI 10.5194/bg-7-2419-2010; Austen MC, 1998, J EXP MAR BIOL ECOL, V222, P219, DOI 10.1016/S0022-0981(97)00146-9; BOUDREAU PR, 1991, J THEOR BIOL, V152, P329, DOI 10.1016/S0022-5193(05)80198-5; Braeckman U, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018078; BRAY JR, 1957, ECOL MONOGR, V27, P326, DOI 10.2307/1942268; BREY T, 1988, J EXP MAR BIOL ECOL, V117, P271, DOI 10.1016/0022-0981(88)90062-7; Brey T., 2001, POPULATION DYNAMICS; Bromley R.G., 1990, TRACE FOSSILS BIOL T; Burd B. J., 2009, Canadian Technical Report of Fisheries and Aquatic Sciences, V2859, pV; Burd BJ, 2008, MAR ENVIRON RES, V66, pS3, DOI 10.1016/j.marenvres.2008.09.004; Burd BJ, 2008, MAR ENVIRON RES, V66, pS62, DOI 10.1016/j.marenvres.2008.08.009; Burd BJ, 2012, PLOS ONE IN PRESS; Clarke K.R., 2006, PRIMER E V6 USER MAN; CLARKE KR, 1993, MAR ECOL PROG SER, V92, P205, DOI 10.3354/meps092205; Clarke KR., 2001, CHANGE MARINE COMMUN, V2; Cusson M, 2005, MAR ECOL PROG SER, V297, P1, DOI 10.3354/meps297001; Dashtgard SE, 2008, PALAEOGEOGR PALAEOCL, V257, P224, DOI 10.1016/j.palaeo.2007.10.024; Duplisea DE, 1999, MAR ECOL PROG SER, V177, P73, DOI 10.3354/meps177073; Duplisea DE, 2000, LIMNOL OCEANOGR, V45, P558, DOI 10.4319/lo.2000.45.3.0558; Duplisea DE, 2002, CAN J FISH AQUAT SCI, V59, P1785, DOI 10.1139/F02-148; Gaston GR, 1996, ESTUARIES, V19, P674, DOI 10.2307/1352527; GORDON K, 1997, THESIS U BRIT COLUMB; GRAY JS, 1982, NETH J SEA RES, V16, P424, DOI 10.1016/0077-7579(82)90048-5; GRAY JS, 1989, BIOL J LINN SOC, V37, P19, DOI 10.1111/j.1095-8312.1989.tb02003.x; Hill PR, 2008, MAR ENVIRON RES, V66, pS39, DOI 10.1016/j.marenvres.2008.09.003; Isaaks E.H., 1989, APPL GEOSTATISTICS; Jennings S, 1998, ADV MAR BIOL, V34, P201, DOI 10.1016/S0065-2881(08)60212-6; Jennings S, 2001, MAR ECOL PROG SER, V213, P127, DOI 10.3354/meps213127; Johannessen SC, 2012, MAR POLLUT BULL, V64, P675, DOI 10.1016/j.marpolbul.2012.01.026; Johannessen SC, 2008, MAR ENVIRON RES, V66, pS1, DOI 10.1016/j.marenvres.2008.10.001; Johannessen SC, 2005, ENVIRON SCI TECHNOL, V39, P4361, DOI 10.1021/es040535i; Johannessen SC, 2003, ESTUAR COAST SHELF S, V56, P845, DOI 10.1016/S0272-7714(02)00303-7; Kristensen K, 1999, BIOGEOCHEMISTRY, V45, P147, DOI 10.1007/BF01106779; Levinton J, 1995, BIOTURBATORS ECOSYST, P29; Lin L., 2000, BIOMETRICS, V56, P324, DOI [10.1111/j.0006-341X.2000.00324.x, DOI 10.1111/J.0006-341X.2000.00324.X]; Macdonald RW, 2008, MAR ENVIRON RES, V66, pS87, DOI 10.1016/j.marenvres.2008.08.001; Macdonald T.A., 2010, CAN TECH REP FISH AQ, V2874, P63; Macdonald TA, 2012, MAR ECOL PROG SER, V445, P129, DOI 10.3354/meps09478; Masson D, 2002, ESTUAR COAST SHELF S, V54, P115, DOI 10.1006/ecss.2001.0833; Needham HR, 2011, ECOSYSTEMS, V14, P1096, DOI 10.1007/s10021-011-9468-0; NEMEC AFL, 1988, CAN J FISH AQUAT SCI, V45, P965, DOI 10.1139/f88-118; Pearson T.H., 1978, Oceanography and Marine Biology an Annual Review, V16, P229; PLATT T, 1977, HELGOLAND WISS MEER, V30, P575, DOI 10.1007/BF02207862; Queiros AM, 2006, J EXP MAR BIOL ECOL, V335, P91, DOI 10.1016/j.jembe.2006.03.001; ROMEROWETZEL MB, 1991, MEERESFORSCHUNG, V33, P247; Saiz-Salinas JI, 1999, MAR ECOL PROG SER, V178, P221, DOI 10.3354/meps178221; Sakamaki T, 2009, MAR FRESHWATER RES, V60, P160, DOI 10.1071/MF08173; Sakamaki T, 2007, ESTUAR COAST SHELF S, V73, P781, DOI 10.1016/j.ecss.2007.03.019; SCHWINGHAMER P, 1981, CAN J FISH AQUAT SCI, V38, P1255, DOI 10.1139/f81-167; SCHWINGHAMER P, 1983, MAR ECOL PROG SER, V13, P151, DOI 10.3354/meps013151; Sneath P.H.A., 1973, NUMERICAL TAXONOMY; SNELGROVE PVR, 1994, OCEANOGR MAR BIOL, V32, P111; SPRULES WG, 1986, CAN J FISH AQUAT SCI, V43, P1789, DOI 10.1139/f86-222; Vanaverbeke J, 2003, MAR ECOL PROG SER, V249, P157, DOI 10.3354/meps249157; Vopel K, 2007, MAR ECOL PROG SER, V333, P161, DOI 10.3354/meps333161; WACASEY JW, 1987, MAR ECOL PROG SER, V39, P243, DOI 10.3354/meps039243; WARWICK RM, 1984, OECOLOGIA, V61, P32, DOI 10.1007/BF00379085; WARWICK RM, 1994, MAR BIOL, V118, P739, DOI 10.1007/BF00347523; WESTON DP, 1990, MAR ECOL PROG SER, V61, P233, DOI 10.3354/meps061233; Wethey DS, 2008, J MAR RES, V66, P255, DOI 10.1357/002224008785837121; Wetzel MA, 2005, HELGOLAND MAR RES, V59, P206, DOI 10.1007/s10152-005-0220-z; Widdicombe S, 2004, MAR ECOL PROG SER, V275, P1, DOI 10.3354/meps275001; Widdicombe S, 2000, HYDROBIOLOGIA, V440, P369, DOI 10.1023/A:1004120621842; Widdicombe S, 1998, J EXP MAR BIOL ECOL, V228, P241, DOI 10.1016/S0022-0981(98)00032-X; WIGLEY RL, 1964, LIMNOL OCEANOGR, V9, P485, DOI 10.4319/lo.1964.9.4.0485; Wlodarska-Kowalczuk M, 2005, MAR ECOL PROG SER, V303, P31, DOI 10.3354/meps303031; Yvon-Durocher G, 2011, GLOBAL CHANGE BIOL, V17, P1681, DOI 10.1111/j.1365-2486.2010.02321.x	67	13	13	2	53	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 20	2012	7	7							e40071	10.1371/journal.pone.0040071	http://dx.doi.org/10.1371/journal.pone.0040071			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	977GL	22911694	Green Published, gold, Green Submitted			2022-12-25	WOS:000306644600013
J	Stucki, D; Malla, B; Hostettler, S; Huna, T; Feldmann, J; Yeboah-Manu, D; Borrell, S; Fenner, L; Comas, I; Coscolla, M; Gagneux, S				Stucki, David; Malla, Bijaya; Hostettler, Simon; Huna, Thembela; Feldmann, Julia; Yeboah-Manu, Dorothy; Borrell, Sonia; Fenner, Lukas; Comas, Inaki; Coscolla, Mireia; Gagneux, Sebastien			Two New Rapid SNP-Typing Methods for Classifying Mycobacterium tuberculosis Complex into the Main Phylogenetic Lineages	PLOS ONE			English	Article							SINGLE-NUCLEOTIDE POLYMORPHISMS; LARGE SEQUENCE POLYMORPHISMS; REAL-TIME PCR; STRAIN DIFFERENTIATION; BEIJING GENOTYPE; MULTIPLEX ASSAY; GENOME; IDENTIFICATION; RESISTANCE; DIVERSITY	There is increasing evidence that strain variation in Mycobacterium tuberculosis complex (MTBC) might influence the outcome of tuberculosis infection and disease. To assess genotype-phenotype associations, phylogenetically robust molecular markers and appropriate genotyping tools are required. Most current genotyping methods for MTBC are based on mobile or repetitive DNA elements. Because these elements are prone to convergent evolution, the corresponding genotyping techniques are suboptimal for phylogenetic studies and strain classification. By contrast, single nucleotide polymorphisms (SNP) are ideal markers for classifying MTBC into phylogenetic lineages, as they exhibit very low degrees of homoplasy. In this study, we developed two complementary SNP-based genotyping methods to classify strains into the six main human-associated lineages of MTBC, the "Beijing" sublineage, and the clade comprising Mycobacterium bovis and Mycobacterium caprae. Phylogenetically informative SNPs were obtained from 22 MTBC whole-genome sequences. The first assay, referred to as MOL-PCR, is a ligation-dependent PCR with signal detection by fluorescent microspheres and a Luminex flow cytometer, which simultaneously interrogates eight SNPs. The second assay is based on six individual TaqMan real-time PCR assays for singleplex SNP-typing. We compared MOL-PCR and TaqMan results in two panels of clinical MTBC isolates. Both methods agreed fully when assigning 36 well-characterized strains into the main phylogenetic lineages. The sensitivity in allele-calling was 98.6% and 98.8% for MOL-PCR and TaqMan, respectively. Typing of an additional panel of 78 unknown clinical isolates revealed 99.2% and 100% sensitivity in allele-calling, respectively, and 100% agreement in lineage assignment between both methods. While MOL-PCR and TaqMan are both highly sensitive and specific, MOL-PCR is ideal for classification of isolates with no previous information, whereas TaqMan is faster for confirmation. Furthermore, both methods are rapid, flexible and comparably inexpensive.	[Stucki, David; Malla, Bijaya; Hostettler, Simon; Feldmann, Julia; Borrell, Sonia; Coscolla, Mireia; Gagneux, Sebastien] Swiss Trop & Publ Hlth Inst, Basel, Switzerland; [Stucki, David; Malla, Bijaya; Hostettler, Simon; Feldmann, Julia; Borrell, Sonia; Coscolla, Mireia; Gagneux, Sebastien] Univ Basel, Basel, Switzerland; [Huna, Thembela] Natl Inst Med Res, Div Mycobacterial Res, Med Res Council, London NW7 1AA, England; [Yeboah-Manu, Dorothy] Univ Ghana, Noguchi Mem Inst Med Res, Legon, Ghana; [Fenner, Lukas] Univ Bern, Inst Social & Prevent Med, Bern, Switzerland; [Comas, Inaki] Ctr Publ Hlth Res, Genom & Hlth Unit, Valencia, Spain; [Comas, Inaki] CIBER Epidemiol & Salud Publ, Madrid, Spain	University of Basel; Swiss Tropical & Public Health Institute; University of Basel; MRC National Institute for Medical Research; UK Research & Innovation (UKRI); Medical Research Council UK (MRC); University of Ghana; University of Bern; CIBER - Centro de Investigacion Biomedica en Red; CIBERESP	Stucki, D (corresponding author), Swiss Trop & Publ Hlth Inst, Basel, Switzerland.	Sebastien.Gagneux@unibas.ch	Comas, Iñaki/F-1185-2011; Comas, Iñaki/AAA-1155-2019; Coscolla, Mireia/ABD-7942-2021; Gagneux, Sebastien/ABE-7909-2020; Yeboah-Manu, Dorothy/A-1933-2016	Comas, Iñaki/0000-0001-5504-9408; Comas, Iñaki/0000-0001-5504-9408; Fenner, Lukas/0000-0003-3309-4835; Gagneux, Sebastien/0000-0001-7783-9048; Stucki, David/0000-0003-0131-9980; Coscolla, Mireia/0000-0003-0752-0538; Yeboah-Manu, Dorothy/0000-0002-1663-6287	Swiss National Science Foundation [PP00A-119205]; National Institutes of Health [AI090928, HHSN266200700022C]; Leverhulme-Royal Society Africa Award [AA080019]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI090928] Funding Source: NIH RePORTER	Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Leverhulme-Royal Society Africa Award; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported by the Swiss National Science Foundation (grant number PP00A-119205), the National Institutes of Health (AI090928 and HHSN266200700022C), and the Leverhulme-Royal Society Africa Award (AA080019). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abadia E, 2010, INFECT GENET EVOL, V10, P1066, DOI 10.1016/j.meegid.2010.07.006; Allix-Beguec C, 2008, J CLIN MICROBIOL, V46, P2692, DOI 10.1128/JCM.00540-08; Baker L, 2004, EMERG INFECT DIS, V10, P1568, DOI 10.3201/eid1009.040046; Ben Shabat M, 2010, J CLIN MICROBIOL, V48, P2909, DOI 10.1128/JCM.00699-10; Bentley SD, 2012, PLOS NEGLECT TROP D, V6, DOI 10.1371/journal.pntd.0001552; Bergal IL, 2008, J CLIN MICROBIOL, V46, P689, DOI 10.1128/JCM.01821-07; Bouakaze C, 2011, J CLIN MICROBIOL, V49, P3292, DOI 10.1128/JCM.00744-11; Bouakaze C, 2010, J CLIN MICROBIOL, V48, P1758, DOI 10.1128/JCM.02255-09; Caws M, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.1000034; Caws M, 2006, J CLIN MICROBIOL, V44, P3934, DOI 10.1128/JCM.01181-06; Click ES, 2012, CLIN INFECT DIS, V54, P211, DOI 10.1093/cid/cir788; Clotilde LM, 2011, J FOOD PROTECT, V74, P373, DOI 10.4315/0362-028X.JFP-10-344; Cole ST, 1998, NATURE, V393, P537, DOI 10.1038/31159; Comas I, 2010, NAT GENET, V42, P498, DOI 10.1038/ng.590; Comas I, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007815; Coscolla Mireilla, 2010, Drug Discov Today Dis Mech, V7, pe43, DOI 10.1016/j.ddmec.2010.09.004; Cowan LS, 2004, J CLIN MICROBIOL, V42, P474, DOI 10.1128/JCM.42.1.474-477.2004; de Jong BC, 2008, J INFECT DIS, V198, P1037, DOI 10.1086/591504; de Jong BC, 2010, PLOS NEGLECT TROP D, V4, DOI 10.1371/journal.pntd.0000744; de los Monteros LEE, 1998, J CLIN MICROBIOL, V36, P239, DOI 10.1128/JCM.36.1.239-242.1998; Demay C, 2012, INFECT GENET EVOL, V12, P755, DOI 10.1016/j.meegid.2012.02.004; Deshpande A, 2010, J MICROBIOL METH, V80, P155, DOI 10.1016/j.mimet.2009.12.001; Dunbar SA, 2006, CLIN CHIM ACTA, V363, P71, DOI 10.1016/j.cccn.2005.06.023; Fenner L, 2012, J CLIN MICROBIOL, V50, P388, DOI 10.1128/JCM.05392-11; Fenner L, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024737; Filliol I, 2003, J CLIN MICROBIOL, V41, P1963, DOI 10.1128/JCM.41.5.1963-1970.2003; Filliol I, 2006, J BACTERIOL, V188, P759, DOI 10.1128/JB.188.2.759-772.2006; Flores L, 2007, J CLIN MICROBIOL, V45, P3393, DOI 10.1128/JCM.00828-07; Gagneux S, 2006, P NATL ACAD SCI USA, V103, P2869, DOI 10.1073/pnas.0511240103; GROENEN PMA, 1993, MOL MICROBIOL, V10, P1057, DOI 10.1111/j.1365-2958.1993.tb00976.x; Gutacker MM, 2006, J INFECT DIS, V193, P121, DOI 10.1086/498574; Halse TA, 2011, J CLIN MICROBIOL, V49, P2562, DOI 10.1128/JCM.00467-11; Hershberg R, 2008, PLOS BIOL, V6, P2658, DOI 10.1371/journal.pbio.0060311; HOLLAND PM, 1991, P NATL ACAD SCI USA, V88, P7276, DOI 10.1073/pnas.88.16.7276; Homolka S, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1000988; Kaderali L, 2003, NUCLEIC ACIDS RES, V31, P1796, DOI 10.1093/nar/gkg267; Kamerbeek J, 1997, J CLIN MICROBIOL, V35, P907, DOI 10.1128/JCM.35.4.907-914.1997; Kato-Maeda M, 2011, INT J TUBERC LUNG D, V15, P131; Kato-Maeda M, 2011, FUTURE MICROBIOL, V6, P203, DOI 10.2217/FMB.10.165; Keim P, 2004, INFECT GENET EVOL, V4, P205, DOI 10.1016/j.meegid.2004.02.005; Kim S, 2007, ANNU REV BIOMED ENG, V9, P289, DOI 10.1146/annurev.bioeng.9.060906.152037; Lee SH, 2004, THEOR APPL GENET, V110, P167, DOI 10.1007/s00122-004-1827-1; Maddison WP, 2009, MESQUITE MODULAR SYS; McEvoy CRE, 2007, TUBERCULOSIS, V87, P393, DOI 10.1016/j.tube.2007.05.010; Mestre O, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016020; Milner DA, 2012, MALARIA J, V11, DOI 10.1186/1475-2875-11-35; Nicol MP, 2008, T ROY SOC TROP MED H, V102, P955, DOI 10.1016/j.trstmh.2008.03.025; Nuebel U, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0032698; Okonechnikov K, 2012, BIOINFORMATICS, V28, P1166, DOI 10.1093/bioinformatics/bts091; Parwati I, 2010, LANCET INFECT DIS, V10, P103, DOI 10.1016/S1473-3099(09)70330-5; Pearson T, 2004, P NATL ACAD SCI USA, V101, P13536, DOI 10.1073/pnas.0403844101; Portevin D, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1001307; Sassetti CM, 2003, P NATL ACAD SCI USA, V100, P12989, DOI 10.1073/pnas.2134250100; Sassetti CM, 2003, MOL MICROBIOL, V48, P77, DOI 10.1046/j.1365-2958.2003.03425.x; Schouten JP, 2002, NUCLEIC ACIDS RES, V30, DOI 10.1093/nar/gnf056; Schurch AC, 2012, INFECT GENET EVOL, V12, P602, DOI 10.1016/j.meegid.2011.08.032; Schurch AC, 2010, J CLIN MICROBIOL, V48, P3403, DOI 10.1128/JCM.00370-10; Smith NH, 2009, NAT REV MICROBIOL, V7, P537, DOI 10.1038/nrmicro2165; Song JA, 2010, ADV EXP MED BIOL, V680, P455, DOI 10.1007/978-1-4419-5913-3_51; Sreevatsan S, 1997, P NATL ACAD SCI USA, V94, P9869, DOI 10.1073/pnas.94.18.9869; Supply P, 2000, MOL MICROBIOL, V36, P762, DOI 10.1046/j.1365-2958.2000.01905.x; Supply P, 2006, J CLIN MICROBIOL, V44, P4498, DOI 10.1128/JCM.01392-06; Tamura K, 2011, MOL BIOL EVOL, V28, P2731, DOI 10.1093/molbev/msr121; Thwaites G, 2008, J CLIN MICROBIOL, V46, P1363, DOI 10.1128/JCM.02180-07; Tsolaki AG, 2004, P NATL ACAD SCI USA, V101, P4865, DOI 10.1073/pnas.0305634101; Vallone PM, 2004, BIOTECHNIQUES, V37, P226, DOI 10.2144/04372ST03; VANEMBDEN JDA, 1993, J CLIN MICROBIOL, V31, P406, DOI 10.1128/JCM.31.2.406-409.1993; Wang L, 2007, ADV EXP MED BIOL, V593, P105; Yeboah-Manu D, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021906; Yesilkaya H, 2006, J CLIN MICROBIOL, V44, P3826, DOI 10.1128/JCM.00225-06; Zhi Jizu, 2010, BMC Res Notes, V3, P137, DOI 10.1186/1756-0500-3-137; Zhi JZ, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-407	72	91	92	0	24	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 20	2012	7	7							e41253	10.1371/journal.pone.0041253	http://dx.doi.org/10.1371/journal.pone.0041253			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	977GL	22911768	Green Published, Green Submitted, gold, Green Accepted			2022-12-25	WOS:000306644600062
J	Mariante, RM; Nobrega, A; Martins, RAP; Areal, RB; Bellio, M; Linden, R				Mariante, Rafael M.; Nobrega, Alberto; Martins, Rodrigo A. P.; Areal, Romulo B.; Bellio, Maria; Linden, Rafael			Neuroimmunoendocrine Regulation of the Prion Protein in Neutrophils	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							OXIDATIVE STRESS; EXPRESSION; RECEPTOR; CELLS; ACTIVATION; NEURODEGENERATION; PROLIFERATION; PHAGOCYTOSIS; APOPTOSIS; TOXICITY	The prion protein (PrPC) is a cell surface protein expressed mainly in the nervous system. In addition to the role of its abnormal conformer in transmissible spongiform encephalopathies, normal PrPC may be implicated in other degenerative conditions often associated with inflammation. PrPC is also present in cells of hematopoietic origin, including T cells, dendritic cells, and macrophages, and it has been shown to modulate their functions. Here, we investigated the impact of inflammation and stress on the expression and function of PrPC in neutrophils, a cell type critically involved in both acute and chronic inflammation. We found that systemic injection of LPS induced transcription and translation of PrPC in mouse neutrophils. Up-regulation of PrPC was dependent on the serum content of TGF-beta and glucocorticoids (GC), which, in turn, are contingent on the activation of the hypothalamic-pituitary-adrenal axis in response to systemic inflammation. GC and TGF-beta, either alone or in combination, directly up-regulated PrPC in neutrophils, and accordingly, the blockade of GC receptors in vivo curtailed the LPS-induced increase in the content of PrPC. Moreover, GC also mediated up-regulation of PrPC in neutrophils following noninflammatory restraint stress. Finally, neutrophils with up-regulated PrPC presented enhanced peroxide-dependent cytotoxicity to endothelial cells. The data demonstrate a novel interplay of the nervous, endocrine, and immune systems upon both the expression and function of PrPC in neutrophils, which may have a broad impact upon the physiology and pathology of various organs and systems.	[Linden, Rafael] John Simon Guggenheim Fdn, New York, NY USA; [Mariante, Rafael M.; Linden, Rafael] Univ Fed Rio de Janeiro, Inst Biophys, BR-21941902 Rio De Janeiro, Brazil; [Nobrega, Alberto; Areal, Romulo B.; Bellio, Maria] Univ Fed Rio de Janeiro, Inst Microbiol, BR-21941902 Rio De Janeiro, Brazil; [Martins, Rodrigo A. P.] Univ Fed Rio de Janeiro, Inst Biomed Sci, BR-21941902 Rio De Janeiro, Brazil	Universidade Federal do Rio de Janeiro; Universidade Federal do Rio de Janeiro; Universidade Federal do Rio de Janeiro	Mariante, RM (corresponding author), Univ Fed Rio de Janeiro, Inst Biofis, Ctr Ciencias Saude, Bloco G,Cidade Univ, BR-21941902 Rio de Janeiro, Brazil.	rafaelmariante@gmail.com; rlinden@biof.ufrj.br	Nobrega, Alberto/U-1161-2019; Mariante, Rafael/A-2971-2015; Linden, Rafael/F-2275-2011; Martins, Rodrigo/W-7604-2019; Mariante, Rafael/AAM-6010-2021; Bellio, Maria/N-8525-2018; Martins, Rodrigo A. P./A-4701-2010	Mariante, Rafael/0000-0001-8024-9612; Linden, Rafael/0000-0003-3287-336X; Martins, Rodrigo/0000-0002-8420-6991; Mariante, Rafael/0000-0001-8024-9612; Bellio, Maria/0000-0002-3360-2740; Martins, Rodrigo A. P./0000-0002-8420-6991; Nobrega, Alberto/0000-0002-9840-0103; Braga Areal, Romulo/0000-0001-9531-0092	Conselho Nacional de Desenvolvimento Cientifico e Tecnologico; Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior; Fundacao de Amparo a Pesquisa do Estado do Rio de Janeiro; Financiadora de Estudos e Projetos; Fundacao de Amparo a Pesquisa do Estado de Sao Paulo; International Brain Research Organization; International Retinal Research Foundation; Programa de Apoio a Nucleos de Excelencia; Rio de Janeiro Postdoctoral Support Program	Conselho Nacional de Desenvolvimento Cientifico e Tecnologico(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior(Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES)); Fundacao de Amparo a Pesquisa do Estado do Rio de Janeiro(Fundacao Carlos Chagas Filho de Amparo a Pesquisa do Estado do Rio De Janeiro (FAPERJ)); Financiadora de Estudos e Projetos(Financiadora de Inovacao e Pesquisa (Finep)); Fundacao de Amparo a Pesquisa do Estado de Sao Paulo(Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP)); International Brain Research Organization; International Retinal Research Foundation; Programa de Apoio a Nucleos de Excelencia; Rio de Janeiro Postdoctoral Support Program	This work was supported in part by grants from Conselho Nacional de Desenvolvimento Cientifico e Tecnologico, Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior, Fundacao de Amparo a Pesquisa do Estado do Rio de Janeiro, Financiadora de Estudos e Projetos, Fundacao de Amparo a Pesquisa do Estado de Sao Paulo, International Brain Research Organization, International Retinal Research Foundation, and Programa de Apoio a Nucleos de Excelencia.; Recipient of a postdoctoral fellowship from Rio de Janeiro Postdoctoral Support Program. To whom correspondence may be addressed: Instituto de Biofisica da UFRJ, Centro de Ciencias da Saude, Bloco G, Cidade Universitaria, 21941-902, Rio de Janeiro, Brasil. Tel.: 55-21-25626553; Fax: 55-21-22808193; E-mail: rafaelmariante@gmail.com.	Albus C, 2010, ANN MED, V42, P487, DOI 10.3109/07853890.2010.515605; Ballerini C, 2006, J IMMUNOL, V176, P7254, DOI 10.4049/jimmunol.176.12.7254; Beishuizen A, 2003, J ENDOTOXIN RES, V9, P3, DOI 10.1179/096805103125001298; Borregaard N, 2010, IMMUNITY, V33, P657, DOI 10.1016/j.immuni.2010.11.011; Brown DR, 2005, FOLIA NEUROPATHOL, V43, P229; Butcher SK, 2004, AGING CELL, V3, P151, DOI 10.1111/j.1474-9728.2004.00103.x; Buynitsky T, 2009, NEUROSCI BIOBEHAV R, V33, P1089, DOI 10.1016/j.neubiorev.2009.05.004; Calella AM, 2010, EMBO MOL MED, V2, P306, DOI 10.1002/emmm.201000082; CASHMAN NR, 1990, CELL, V61, P185, DOI 10.1016/0092-8674(90)90225-4; Cohen S, 2003, BRAIN BEHAV IMMUN, V17, P407, DOI 10.1016/S0889-1591(03)00110-7; COX G, 1995, J IMMUNOL, V154, P4719; de Almeida CJG, 2005, J LEUKOCYTE BIOL, V77, P238, DOI 10.1189/jlb.1103531; Dejana E, 2009, DEV CELL, V16, P209, DOI 10.1016/j.devcel.2009.01.004; Durig J, 2000, BRIT J HAEMATOL, V108, P488, DOI 10.1046/j.1365-2141.2000.01881.x; Fischer S, 2005, EUR J CELL BIOL, V84, P687, DOI 10.1016/j.ejcb.2005.03.002; Graner E, 2000, MOL BRAIN RES, V76, P85, DOI 10.1016/S0169-328X(99)00334-4; Gunther EC, 2010, J MOL MED, V88, P331, DOI 10.1007/s00109-009-0568-7; Isaacs JD, 2006, CLIN EXP IMMUNOL, V146, P1, DOI 10.1111/j.1365-2249.2006.03194.x; Jensen K, 2006, BMC GENOMICS, V7, DOI 10.1186/1471-2164-7-224; Kagi D, 1999, J IMMUNOL, V162, P4598; Kellett KAB, 2009, PRION, V3, P190, DOI 10.4161/pri.3.4.9980; Kessels HW, 2010, NATURE, V466, pE3, DOI 10.1038/nature09217; Khanfer Riyad, 2010, Psychosom Med, V72, P636, DOI 10.1097/PSY.0b013e3181e7fae8; Kuczius T, 2011, J CELL BIOCHEM, V112, P954, DOI 10.1002/jcb.23012; Kumar P, 2009, EXPERT REV MOL MED, V11, DOI 10.1017/S1462399409001112; Lauren J, 2009, NATURE, V457, P1128, DOI 10.1038/nature07761; Lee HS, 2004, MICROVASC RES, V68, P231, DOI 10.1016/j.mvr.2004.07.005; LICURSI PC, 1972, INFECT IMMUN, V6, P370, DOI 10.1128/IAI.6.3.370-376.1972; LILES WC, 1995, BLOOD, V86, P3181; Linden R, 2008, PHYSIOL REV, V88, P673, DOI 10.1152/physrev.00007.2007; Linden R, 2012, CELL MOL LIFE SCI, V69, P1105, DOI 10.1007/s00018-011-0847-7; Mallucci GR, 2009, PRION, V3, P195, DOI 10.4161/pri.3.4.9981; MANSON JC, 1994, MOL NEUROBIOL, V8, P121, DOI 10.1007/BF02780662; Martins RAP, 2006, EUR J NEUROSCI, V24, P969, DOI 10.1111/j.1460-9568.2006.04966.x; Martins VR, 2010, CURR ISSUES MOL BIOL, V12, P63; Mattei V, 2004, FEBS LETT, V560, P14, DOI 10.1016/S0014-5793(04)00029-8; McGregor BA, 2009, BRAIN BEHAV IMMUN, V23, P159, DOI 10.1016/j.bbi.2008.08.002; MIRAGLIOTTA G, 1990, ACTA VIROL, V34, P517; Nair A, 2006, J NEUROIMMUNOL, V171, P72, DOI 10.1016/j.jneuroim.2005.09.012; NALBANDIAN RM, 1983, CLIN IMMUNOL IMMUNOP, V28, P155, DOI 10.1016/0090-1229(83)90150-2; Paar C, 2007, EUR J CELL BIOL, V86, P253, DOI 10.1016/j.ejcb.2007.03.001; Perry VH, 2010, ACTA NEUROPATHOL, V120, P277, DOI 10.1007/s00401-010-0722-x; PFEFFER K, 1993, CELL, V73, P457, DOI 10.1016/0092-8674(93)90134-C; Polymenidou M, 2012, J EXP MED, V209, P889, DOI 10.1084/jem.20120741; Prusiner SB, 1998, P NATL ACAD SCI USA, V95, P13363, DOI 10.1073/pnas.95.23.13363; Rangel A, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007592; Repetto G, 2008, NAT PROTOC, V3, P1125, DOI 10.1038/nprot.2008.75; Sales N, 2002, EUR J NEUROSCI, V15, P1163, DOI 10.1046/j.1460-9568.2002.01953.x; Satoh J, 1998, J NEUROPATH EXP NEUR, V57, P131, DOI 10.1097/00005072-199802000-00004; Sauer H, 2003, FREE RADICAL BIO MED, V35, P586, DOI 10.1016/S0891-5849(03)00360-5; Scali C, 2002, NEUROBIOL AGING, V23, P523, DOI 10.1016/S0197-4580(01)00346-3; Scholz M, 2007, MED RES REV, V27, P401, DOI 10.1002/med.20064; Segel GB, 2011, J LEUKOCYTE BIOL, V89, P359, DOI 10.1189/jlb.0910538; Silva MT, 2010, J LEUKOCYTE BIOL, V87, P93, DOI 10.1189/jlb.0809549; Simard M, 2009, CURR PSYCHIAT REP, V11, P41, DOI 10.1007/s11920-009-0007-z; Smith ELP, 2002, BRAIN BEHAV IMMUN, V16, P140, DOI 10.1006/brbi.2001.0629; Splettstoesser WD, 2002, MICROSC RES TECHNIQ, V57, P441, DOI 10.1002/jemt.10098; Steele AD, 2009, PRION, V3, P240, DOI 10.4161/pri.3.4.10135; Trottier MD, 2008, P NATL ACAD SCI USA, V105, P2028, DOI 10.1073/pnas.0712003105; Vere CC, 2009, WORLD J GASTROENTERO, V15, P2980, DOI 10.3748/wjg.15.2980; Vitte J, 2004, J CLIN IMMUNOL, V24, P683, DOI 10.1007/s10875-004-6243-4; WEISSMANN C, 1993, BRIT MED BULL, V49, P995, DOI 10.1093/oxfordjournals.bmb.a072658; Westergard L, 2007, BBA-MOL BASIS DIS, V1772, P629, DOI 10.1016/j.bbadis.2007.02.011; Wright RJ, 2005, CURR OPIN ALLERGY CL, V5, P23, DOI 10.1097/00130832-200502000-00006; Zhang CC, 2006, P NATL ACAD SCI USA, V103, P2184, DOI 10.1073/pnas.0510577103	65	22	22	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 12	2012	287	42					35506	35515		10.1074/jbc.M112.394924	http://dx.doi.org/10.1074/jbc.M112.394924			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	022OF	22910907	hybrid, Green Published			2022-12-25	WOS:000309968000059
J	Bakker, D; Smits, WK; Kuijper, EJ; Corver, J				Bakker, Dennis; Smits, Wiep Klaas; Kuijper, Ed J.; Corver, Jeroen			TcdC Does Not Significantly Repress Toxin Expression in Clostridium difficile 630 Delta Erm	PLOS ONE			English	Article							ESCHERICHIA-COLI; NORTH-AMERICA; SIGMA-FACTOR; RT-PCR; DISEASE; STRAIN; GENE; INFECTION; GENOME; PATHOGENICITY	In the past decade, Clostridium difficile has emerged as an important gut pathogen. Symptoms of C. difficile infection range from mild diarrhea to pseudomembranous colitis, sometimes resulting in colectomy or death. The main virulence factors of C. difficile are toxin A and toxin B. Besides the genes encoding these toxins (tcdA and tcdB), the pathogenicity locus (PaLoc) also contains genes encoding a sigma factor (tcdR) and a putative anti-sigma factor (tcdC). The important role of TcdR as a sigma factor for toxin expression is undisputed, whereas the role of TcdC as an anti-sigma factor, inhibiting toxin expression, is currently the subject of debate. To clarify the role of TcdC in toxin expression, we generated an isogenic ClosTron-based mutant of tcdC in Clostridium difficile strain 630 Delta Erm (CT::tcdC) and determined the transcription levels of the PaLoc genes and the expression levels of the toxins in the wild type strain and the tcdC mutant strain. We found only minor differences in transcription levels of the PaLoc genes between the wild type and CT:: tcdC strains and total toxin levels did not significantly differ either. These results suggest that in C. difficile 630 Delta erm TcdC is not a major regulator of toxin expression under the conditions tested.	[Bakker, Dennis; Smits, Wiep Klaas; Kuijper, Ed J.; Corver, Jeroen] Leiden Univ, Med Ctr, Ctr Infect Dis, Dept Med Microbiol, NL-2300 RA Leiden, Netherlands	Leiden University; Leiden University Medical Center (LUMC); Leiden University - Excl LUMC	Bakker, D (corresponding author), Leiden Univ, Med Ctr, Ctr Infect Dis, Dept Med Microbiol, NL-2300 RA Leiden, Netherlands.	j.corver@lumc.nl	Smits, Wiep Klaas/A-8366-2008; Kuijper, ed/AAB-7853-2022	Smits, Wiep Klaas/0000-0002-7409-2847; Kuijper, ed/0000-0001-5726-2405; Corver, Jeroen/0000-0002-9262-5475	Netherlands Organization for Health, Research and Development (NWO-ZOnMW) [016.116.043]; Gisela Thier fellowship (LUMC); European Union [Health-F3-2008-223585]	Netherlands Organization for Health, Research and Development (NWO-ZOnMW)(Netherlands Organization for Scientific Research (NWO)Netherlands Organization for Health Research and Development); Gisela Thier fellowship (LUMC); European Union(European Commission)	W.K. Smits was supported by Veni grant 016.116.043 from The Netherlands Organization for Health, Research and Development (NWO-ZOnMW) and a Gisela Thier fellowship (LUMC). This study was supported by the European Union (HYPERDIFF-The Physiological Basis of Hypervirulence in Clostridium difficile: a Prerequisite for Effective Infection Control; Health-F3-2008-223585). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bauer MP, 2011, LANCET, V377, P63, DOI 10.1016/S0140-6736(10)61266-4; Carter GP, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002317; Cartman ST, 2012, APPL ENVIRON MICROB, V78, P4683, DOI 10.1128/AEM.00249-12; Curry SR, 2007, J CLIN MICROBIOL, V45, P215, DOI 10.1128/JCM.01599-06; Dawson LF, 2011, BMC MICROBIOL, V11, DOI 10.1186/1471-2180-11-86; DECKERSHEBESTREIT G, 1986, EUR J BIOCHEM, V161, P225, DOI 10.1111/j.1432-1033.1986.tb10146.x; Dupuy B, 1998, MOL MICROBIOL, V27, P107, DOI 10.1046/j.1365-2958.1998.00663.x; GARNIER T, 1986, J BACTERIOL, V168, P1189, DOI 10.1128/jb.168.3.1189-1196.1986; Goorhuis A, 2007, CLIN INFECT DIS, V45, P695, DOI 10.1086/520984; Goorhuis A, 2008, CLIN INFECT DIS, V47, P1162, DOI 10.1086/592257; Govind R, 2006, J BACTERIOL, V188, P3716, DOI 10.1128/JB.188.10.3716-3720.2006; Graeber K, 2011, PLANT CELL, V23, P2045, DOI 10.1105/tpc.111.084103; Heap JT, 2007, J MICROBIOL METH, V70, P452, DOI 10.1016/j.mimet.2007.05.021; Heap JT, 2010, J MICROBIOL METH, V80, P49, DOI 10.1016/j.mimet.2009.10.018; Ho TD, 2011, INFECT IMMUN, V79, P3229, DOI 10.1128/IAI.00019-11; Hundsberger T, 1997, EUR J BIOCHEM, V244, P735, DOI 10.1111/j.1432-1033.1997.t01-1-00735.x; Hussain HA, 2005, J MED MICROBIOL, V54, P137, DOI 10.1099/jmm.0.45790-0; Just I, 2005, REV PHYSIOL BIOCH P, V152, P23, DOI 10.1007/s10254-004-0033-5; Karlsson S, 2000, INFECT IMMUN, V68, P5881, DOI 10.1128/IAI.68.10.5881-5888.2000; Knetsch CW, 2012, INFECT GENET EVOL, V12, P1577, DOI 10.1016/j.meegid.2012.06.003; Kuehne SA, 2010, NATURE, V467, P711, DOI 10.1038/nature09397; Kuijper EJ, 2006, CLIN MICROBIOL INFEC, V12, P2, DOI 10.1111/j.1469-0691.2006.01580.x; Kuijper E.J., 2008, EURO SURVEILL, V13; Loo VG, 2005, NEW ENGL J MED, V353, P2442, DOI 10.1056/NEJMoa051639; LYERLY DM, 1983, J CLIN MICROBIOL, V17, P72, DOI 10.1128/JCM.17.1.72-78.1983; Lyras D, 2009, NATURE, V458, P1176, DOI 10.1038/nature07822; Mani N, 2002, J BACTERIOL, V184, P5971, DOI 10.1128/JB.184.21.5971-5978.2002; Mani N, 2001, P NATL ACAD SCI USA, V98, P5844, DOI 10.1073/pnas.101126598; Matamouros S, 2007, MOL MICROBIOL, V64, P1274, DOI 10.1111/j.1365-2958.2007.05739.x; Merrigan M, 2010, J BACTERIOL, V192, P4904, DOI 10.1128/JB.00445-10; Metcalf D, 2010, ANAEROBE, V16, P439, DOI 10.1016/j.anaerobe.2010.06.007; Murray R, 2009, BMC INFECT DIS, V9, DOI 10.1186/1471-2334-9-103; O'Connor JR, 2009, GASTROENTEROLOGY, V136, P1913, DOI 10.1053/j.gastro.2009.02.073; Paltansing S, 2007, CLIN MICROBIOL INFEC, V13, P1058, DOI 10.1111/j.1469-0691.2007.01793.x; Pepin J, 2004, CAN MED ASSOC J, V171, P466, DOI 10.1503/cmaj.1041104; Pfaffl MW, 2001, NUCLEIC ACIDS RES, V29, DOI 10.1093/nar/29.9.e45; Purdy D, 2002, MOL MICROBIOL, V46, P439, DOI 10.1046/j.1365-2958.2002.03134.x; Sebaihia M, 2006, NAT GENET, V38, P779, DOI 10.1038/ng1830; Snijder EJ, 2003, J MOL BIOL, V331, P991, DOI 10.1016/S0022-2836(03)00865-9; Tan KS, 2001, J MED MICROBIOL, V50, P613, DOI 10.1099/0022-1317-50-7-613; Vohra P, 2011, MICROBIOL-SGM, V157, P1343, DOI 10.1099/mic.0.046243-0; Voth DE, 2005, CLIN MICROBIOL REV, V18, P247, DOI 10.1128/CMR.18.2.247-263.2005; Warny M, 2005, LANCET, V366, P1079, DOI 10.1016/S0140-6736(05)67420-X; Wilcox MH, 2009, CLOSTRIDIUM DIFFICLE; WREN BW, 1987, J CLIN MICROBIOL, V25, P2402, DOI 10.1128/JCM.25.12.2402-2404.1987	45	52	54	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 17	2012	7	8							e43247	10.1371/journal.pone.0043247	http://dx.doi.org/10.1371/journal.pone.0043247			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	996DG	22912837	Green Published, Green Submitted, gold			2022-12-25	WOS:000308063700067
J	Feng, B; Dong, TT; Wang, LL; Zhou, HM; Zhao, HC; Dong, F; Zheng, MH				Feng, Bo; Dong, Tao Tao; Wang, Lin Lin; Zhou, Hou Min; Zhao, Hong Chao; Dong, Feng; Zheng, Min Hua			Colorectal Cancer Migration and Invasion Initiated by microRNA-106a	PLOS ONE			English	Article							TGF-BETA; TUMOR-METASTASIS; CELL-GROWTH; EXPRESSION; RECEPTOR; GENE; CARCINOMA; TARGET; ADENOCARCINOMA; INHIBITION	MicroRNAs have been implicated in the regulation of several cellular signaling pathways of colorectal cancer (CRC) cells. Although emerging evidence proves that microRNA (miR)-106a is expressed highly in primary tumor and stool samples of CRC patients; whether or not miR-106a mediates cancer metastasis is unknown. We show here that miR-106a is highly expressed in metastatic CRC cells, and regulates cancer cell migration and invasion positively in vitro and in vivo. These phenotypes do not involve confounding influences on cancer cell proliferation. MiR-106a inhibits the expression of transforming growth factor-beta receptor 2 (TGFBR2), leading to increased CRC cell migration and invasion. Importantly, miR-106a expression levels in primary CRCs are correlated with clinical cancer progression. These observations indicate that miR-106a inhibits the anti-metastatic target directly and results in CRC cell migration and invasion.	[Feng, Bo; Zhou, Hou Min; Zhao, Hong Chao; Dong, Feng; Zheng, Min Hua] Shanghai Jiao Tong Univ, Sch Med, Ruijin Hosp, Dept Surg, Shanghai 200030, Peoples R China; [Feng, Bo; Zhou, Hou Min; Zhao, Hong Chao; Zheng, Min Hua] Shanghai Inst Digest Surg, Shanghai, Peoples R China; [Feng, Bo; Zhou, Hou Min; Zhao, Hong Chao; Zheng, Min Hua] Shanghai Minimally Invas Surg Ctr, Shanghai, Peoples R China; [Dong, Tao Tao] Shandong Univ, Qilu Hosp, Dept Obstet & Gynecol, Jinan 250100, Shandong, Peoples R China; [Wang, Lin Lin] Shanghai Jiao Tong Univ, Sch Med, Shanghai Childrens Hosp, Shanghai Inst Med Genet, Shanghai 200030, Peoples R China	Shanghai Jiao Tong University; Shandong University; Shanghai Jiao Tong University	Feng, B (corresponding author), Shanghai Jiao Tong Univ, Sch Med, Ruijin Hosp, Dept Surg, Shanghai 200030, Peoples R China.	dfsnake@yahoo.cn; fengbo2022@163.com	wang, lin/HHM-2225-2022					Bartel DP, 2009, CELL, V136, P215, DOI 10.1016/j.cell.2009.01.002; Batlle E, 2000, NAT CELL BIOL, V2, P84, DOI 10.1038/35000034; Bolos V, 2003, J CELL SCI, V116, P499, DOI 10.1242/jcs.00224; Borczuk AC, 2011, CANCER RES, V71, P6665, DOI 10.1158/0008-5472.CAN-11-1590; Calin GA, 2004, P NATL ACAD SCI USA, V101, P2999, DOI 10.1073/pnas.0307323101; Calin GA, 2006, NAT REV CANCER, V6, P857, DOI 10.1038/nrc1997; Chen CZ, 2004, SCIENCE, V303, P83, DOI 10.1126/science.1091903; Cheng AM, 2005, NUCLEIC ACIDS RES, V33, P1290, DOI 10.1093/nar/gki200; Cheng N, 2008, MOL CANCER RES, V6, P1521, DOI 10.1158/1541-7786.MCR-07-2203; Dews M, 2010, CANCER RES, V70, P8233, DOI 10.1158/0008-5472.CAN-10-2412; Diaz R, 2008, GENE CHROMOSOME CANC, V47, P794, DOI 10.1002/gcc.20580; Dong TT, 2011, ANN SURG ONCOL, V18, P1797, DOI 10.1245/s10434-011-1561-2; Edge SB, 2010, ANN SURG ONCOL, V17, P1471, DOI 10.1245/s10434-010-0985-4; Fidler IJ, 2003, NAT REV CANCER, V3, P453, DOI 10.1038/nrc1098; Grimson A, 2007, MOL CELL, V27, P91, DOI 10.1016/j.molcel.2007.06.017; Gupta GP, 2006, CELL, V127, P679, DOI 10.1016/j.cell.2006.11.001; Hartwell KA, 2006, P NATL ACAD SCI USA, V103, P18969, DOI 10.1073/pnas.0608636103; He L, 2005, NATURE, V435, P828, DOI 10.1038/nature03552; Hirai Y, 2004, AM J OBSTET GYNECOL, V191, P1173, DOI 10.1016/j.ajog.2004.04.015; Johnson SM, 2005, CELL, V120, P635, DOI 10.1016/j.cell.2005.01.014; Krek A, 2005, NAT GENET, V37, P495, DOI 10.1038/ng1536; Link A, 2010, CANCER EPIDEM BIOMAR, V19, P1766, DOI 10.1158/1055-9965.EPI-10-0027; Lu J, 2005, NATURE, V435, P834, DOI 10.1038/nature03702; MacKay SLD, 1998, ANN SURG, V227, P781, DOI 10.1097/00000658-199806000-00001; Mamiya T, 2010, LAB INVEST, V90, P1339, DOI 10.1038/labinvest.2010.105; Mani SA, 2007, P NATL ACAD SCI USA, V104, P10069, DOI 10.1073/pnas.0703900104; Meister G, 2004, RNA, V10, P544, DOI 10.1261/rna.5235104; Roldo C, 2006, J CLIN ONCOL, V24, P4677, DOI 10.1200/JCO.2005.05.5194; Sathyanarayana UG, 2004, CANCER RES, V64, P1425, DOI 10.1158/0008-5472.CAN-03-0701; Sayan AE, 2012, ONCOGENE, V31, P1493, DOI 10.1038/onc.2011.336; Schetter AJ, 2008, JAMA-J AM MED ASSOC, V299, P425, DOI 10.1001/jama.299.4.425; Siegel PM, 2003, NAT REV CANCER, V3, P807, DOI 10.1038/nrc1208; Spaderna S, 2008, CANCER RES, V68, P537, DOI 10.1158/0008-5472.CAN-07-5682; Stewart SA, 2003, RNA, V9, P493, DOI 10.1261/rna.2192803; Tan AR, 2009, BREAST CANCER RES TR, V115, P453, DOI 10.1007/s10549-008-0184-1; Ventura A, 2009, CELL, V136, P586, DOI 10.1016/j.cell.2009.02.005; Yang J, 2004, CELL, V117, P927, DOI 10.1016/j.cell.2004.06.006	37	72	80	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 17	2012	7	8							e43452	10.1371/journal.pone.0043452	http://dx.doi.org/10.1371/journal.pone.0043452			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	996DG	22912877	Green Published, Green Submitted, gold			2022-12-25	WOS:000308063700105
J	Jensen, SMR; Schmitz, A; Pedersen, FS; Kjems, J; Bramsen, JB				Jensen, Stig Molgaard Rask; Schmitz, Alexander; Pedersen, Finn Skou; Kjems, Jorgen; Bramsen, Jesper Bertram			Functional Selection of shRNA Loops from Randomized Retroviral Libraries	PLOS ONE			English	Article							DOUBLE-STRANDED-RNA; NUCLEAR EXPORT; INTERFERING RNAS; GENE; SEQUENCE; BINDING; HAIRPIN; MOTIFS; SYSTEM; PACT	Gene silencing by RNA interference (RNAi) can be achieved by the ectopic expression of tailored short hairpin RNAs (shRNAs) which after export to the cytoplasm are processed by Dicer and incorporated into the RNA induced silencing complex (RISC). Design rules for shRNAs have been the focus of several studies, but only a few reports have turned the attention to the sequence of the loop-region. In this work we selected high-functional and low-functional shRNA loops from retroviral hairpin-loop-libraries in an RNAi reporter assay. The procedure revealed a very significant and stem sequence-dependent effect of the loop on shRNA function and although neither strong consensus loop sequence nor structural motifs could be identified, a preferred loop sequence (5'-UGUGCUU-3') was found to support robust knock down with little stem sequence dependency. These findings will serve as a guide for designing shRNAs with improved knock down capacity.	[Jensen, Stig Molgaard Rask; Schmitz, Alexander; Pedersen, Finn Skou; Kjems, Jorgen; Bramsen, Jesper Bertram] Aarhus Univ, Dept Mol Biol & Genet, Aarhus, Denmark; [Kjems, Jorgen; Bramsen, Jesper Bertram] Aarhus Univ, Interdisciplinary Nanosci Ctr iNANO, Aarhus, Denmark	Aarhus University; Aarhus University	Jensen, SMR (corresponding author), Aarhus Univ, Dept Mol Biol & Genet, Aarhus, Denmark.	jk@mb.au.dk	Kjems, Jorgen/I-3490-2016; Jensen, Stig/H-2126-2019	Kjems, Jorgen/0000-0003-4128-9317; Jensen, Stig/0000-0002-4256-3202	RIGHT EU consortium [LSHB-CT-2004-005276]; SIROCCO EU consortium [LSHG-CT-2006-037900]; Danish Technical Research Council; Danish Strategic Research Council; Lundbeck Foundation through the LUNA Nanomedicine Center, Denmark	RIGHT EU consortium; SIROCCO EU consortium; Danish Technical Research Council; Danish Strategic Research Council(Danske Strategiske Forskningsrad (DSF)); Lundbeck Foundation through the LUNA Nanomedicine Center, Denmark	This work was supported by the RIGHT EU consortium (no. LSHB-CT-2004-005276), the SIROCCO EU consortium (LSHG-CT-2006-037900), the Danish Technical Research Council, the Danish Strategic Research Council and the Lundbeck Foundation through the LUNA Nanomedicine Center, Denmark. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Boden D, 2004, NUCLEIC ACIDS RES, V32, P1154, DOI 10.1093/nar/gkh278; Bohnsack MT, 2004, RNA, V10, P185, DOI 10.1261/rna.5167604; Boudreau RL, 2008, RNA, V14, P1834, DOI 10.1261/rna.1062908; Brummelkamp TR, 2002, SCIENCE, V296, P550, DOI 10.1126/science.1068999; Chendrimada TP, 2005, NATURE, V436, P740, DOI 10.1038/nature03868; Crooks GE, 2004, GENOME RES, V14, P1188, DOI 10.1101/gr.849004; Fire A, 1998, NATURE, V391, P806, DOI 10.1038/35888; Frilander MJ, 2001, MOL CELL, V7, P217, DOI 10.1016/S1097-2765(01)00169-1; Gregory RI, 2005, CELL, V123, P631, DOI 10.1016/j.cell.2005.10.022; Gupta V, 2003, VIROLOGY, V315, P283, DOI 10.1016/S0042-6822(03)00589-0; Harborth J, 2003, ANTISENSE NUCLEIC A, V13, P83, DOI 10.1089/108729003321629638; Hochsmann M, 2004, IEEE ACM T COMPUT BI, V1, P53, DOI 10.1109/TCBB.2004.11; Lagos-Quintana M, 2001, SCIENCE, V294, P853, DOI 10.1126/science.1064921; Lau NC, 2001, SCIENCE, V294, P858, DOI 10.1126/science.1065062; Lee RC, 2001, SCIENCE, V294, P862, DOI 10.1126/science.1065329; Lee Y, 2006, EMBO J, V25, P522, DOI 10.1038/sj.emboj.7600942; Leontis NB, 2001, RNA, V7, P499, DOI 10.1017/S1355838201002515; Leontis NB, 2006, CURR OPIN STRUC BIOL, V16, P279, DOI 10.1016/j.sbi.2006.05.009; Lescoute A, 2005, NUCLEIC ACIDS RES, V33, P2395, DOI 10.1093/nar/gki535; Lund E, 2004, SCIENCE, V303, P95, DOI 10.1126/science.1090599; Mathews DH, 1999, J MOL BIOL, V288, P911, DOI 10.1006/jmbi.1999.2700; Miyagishi M, 2004, J GENE MED, V6, P715, DOI 10.1002/jgm.556; Morita S, 2000, GENE THER, V7, P1063, DOI 10.1038/sj.gt.3301206; Novina CD, 2002, NAT MED, V8, P681, DOI 10.1038/nm725; Peters GA, 2001, MOL CELL BIOL, V21, P1908, DOI 10.1128/MCB.21.6.1908-1920.2001; Rana TM, 2007, NAT REV MOL CELL BIO, V8, P23, DOI 10.1038/nrm2085; Schopman NC, ANTIVIRAL RES, V86, P204; Schopman NCT, 2010, ANTIVIR RES, V86, P204, DOI 10.1016/j.antiviral.2010.02.320; Taxman DJ, 2006, BMC BIOTECHNOL, V6, DOI 10.1186/1472-6750-6-7; Tian B, 2004, NAT REV MOL CELL BIO, V5, P1013, DOI 10.1038/nrm1528; Vlassov AV, 2007, OLIGONUCLEOTIDES, V17, P223, DOI 10.1089/oli.2006.0069; Watanabe T, 2008, NATURE, V453, P539, DOI 10.1038/nature06908; WIGLER M, 1977, CELL, V11, P223, DOI 10.1016/0092-8674(77)90333-6; Wu HH, 2001, EMBO J, V20, P7240, DOI 10.1093/emboj/20.24.7240; Zeng Y, 2005, EMBO J, V24, P138, DOI 10.1038/sj.emboj.7600491; Zeng Y, 2004, NUCLEIC ACIDS RES, V32, P4776, DOI 10.1093/nar/gkh824; Zuker M, 2003, NUCLEIC ACIDS RES, V31, P3406, DOI 10.1093/nar/gkg595	37	6	7	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 17	2012	7	8							e43095	10.1371/journal.pone.0043095	http://dx.doi.org/10.1371/journal.pone.0043095			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	996DG	22912797	Green Published, Green Submitted, gold			2022-12-25	WOS:000308063700040
J	Loitfelder, M; Filippi, M; Rocca, M; Valsasina, P; Ropele, S; Jehna, M; Fuchs, S; Schmidt, R; Neuper, C; Fazekas, F; Enzinger, C				Loitfelder, Marisa; Filippi, Massimo; Rocca, Mara; Valsasina, Paola; Ropele, Stefan; Jehna, Margit; Fuchs, Siegrid; Schmidt, Reinhold; Neuper, Christa; Fazekas, Franz; Enzinger, Christian			Abnormalities of Resting State Functional Connectivity Are Related to Sustained Attention Deficits in MS	PLOS ONE			English	Article							COMPENSATORY CORTICAL ACTIVATION; MULTIPLE-SCLEROSIS; COGNITIVE IMPAIRMENT; DEFAULT-MODE; FMRI DATA; BRAIN; FREQUENCY; FLUCTUATIONS; DYSFUNCTION; MEMORY	Objectives: Resting state (RS) functional MRI recently identified default network abnormalities related to cognitive impairment in MS. fMRI can also be used to map functional connectivity (FC) while the brain is at rest and not adhered to a specific task. Given the importance of the anterior cingulate cortex (ACC) for higher executive functioning in MS, we here used the ACC as seed-point to test for differences and similarities in RS-FC related to sustained attention between MS patients and controls. Design: Block-design rest phases of 3 Tesla fMRI data were analyzed to assess RS-FC in 31 patients (10 clinically isolated syndromes, 16 relapsing-remitting, 5 secondary progressive MS) and 31 age-and gender matched healthy controls (HC). Participants underwent extensive cognitive testing. Observations: In both groups, signal changes in several brain areas demonstrated significant correlation with RS-activity in the ACC. These comprised the posterior cingulate cortex (PCC), insular cortices, the right caudate, right middle temporal gyrus, angular gyri, the right hippocampus, and the cerebellum. Compared to HC, patients showed increased FC between the ACC and the left angular gyrus, left PCC, and right postcentral gyrus. Better cognitive performance in the patients was associated with increased FC to the cerebellum, middle temporal gyrus, occipital pole, and the angular gyrus. Conclusion: We provide evidence for adaptive changes in RS-FC in MS patients compared to HC in a sustained attention network. These results extend and partly mirror findings of task-related fMRI, suggesting FC may increase our understanding of cognitive dysfunction in MS.	[Loitfelder, Marisa; Ropele, Stefan; Jehna, Margit; Fuchs, Siegrid; Schmidt, Reinhold; Fazekas, Franz; Enzinger, Christian] Med Univ Graz, Dept Neurol, Graz, Austria; [Filippi, Massimo; Rocca, Mara; Valsasina, Paola] Inst Sci, Neuroimaging Res Unit, Inst Expt Neurol, Milan, Italy; [Filippi, Massimo; Rocca, Mara; Valsasina, Paola] Univ Vita Salute San Raffaele, Osped San Raffaele, Milan, Italy; [Loitfelder, Marisa; Jehna, Margit; Neuper, Christa] Karl Franzens Univ Graz, Inst Psychol, Graz, Austria; [Enzinger, Christian] Med Univ Graz, Dept Radiol, Neuroradiol Sect, Graz, Austria	Medical University of Graz; Vita-Salute San Raffaele University; IRCCS Ospedale San Raffaele; University of Graz; Medical University of Graz	Loitfelder, M (corresponding author), Med Univ Graz, Dept Neurol, Graz, Austria.	chris.enzinger@medunigraz.at	Valsasina, Paola/K-5820-2016; Filippi, Massimo/K-1755-2018; Rocca, Maria Assunta/K-1619-2018; Jehna, Margit/M-9873-2017; Schmidt, Reinhold/E-1137-2014	Valsasina, Paola/0000-0001-5390-2655; Filippi, Massimo/0000-0002-5485-0479; Rocca, Maria Assunta/0000-0003-2358-4320; Jehna, Margit/0000-0003-3376-7753	Sanofi Aventis; Bayer Schering Pharma; Biogen-Dompe; Genmab A/S; Merck Serono; Teva Pharmaceutical Industries Ltd.; Fondazione Italiana Sclerosi Multipla; Biogen-Idec; Teva-Aventis; Merck-Serono; Bayer-Schering	Sanofi Aventis(Sanofi-Aventis); Bayer Schering Pharma(Bayer AG); Biogen-Dompe(Biogen); Genmab A/S(Genmab); Merck Serono(Merck & Company); Teva Pharmaceutical Industries Ltd.(Teva Pharmaceutical Industries); Fondazione Italiana Sclerosi Multipla(Fondazione Italiana Sclerosi Multipla (FISM)); Biogen-Idec(Biogen); Teva-Aventis(Teva Pharmaceutical Industries); Merck-Serono(Merck & Company); Bayer-Schering(Bayer AG)	Marisa Loitfelder received unrestricted research funds from Sanofi Aventis. Massimo Filippi serves on scientific advisory boards for Teva Pharmaceutical Industries Ltd. and Genmab A/S and has received funding for travel from Bayer Schering Pharma, Biogen-Dompe, Genmab A/S, Merck Serono, and Teva Pharmaceutical Industries Ltd. Massimo Filippi also serves as a consultant to Bayer Schering Pharma, Biogen-Dompe, Genmab A/S, Merck Serono, Pepgen Corporation, and Teva Pharmaceutical Industries Ltd. and serves on speakers' bureaus for Bayer Schering Pharma, Biogen-Dompe, Genmab A/S, Merck Serono, and Teva Pharmaceutical Industries Ltd. He also receives research support from Bayer Schering Pharma, Biogen-Dompe, Genmab A/S, Merck Serono, Teva Pharmaceutical Industries Ltd., and Fondazione Italiana Sclerosi Multipla, and serves on editorial boards of the American Journal of Neuroradiology, BMC Musculoskeletal Disorders, Clinical Neurology and Neurosurgery, Erciyes Medical Journal, Journal of Neuroimaging, Journal of Neurovirology, Magnetic Resonance Imaging, Multiple Sclerosis, Neurological Sciences, and Lancet Neurology. Maria Rocca has served as consultant to Bayer Schering Pharma and received speakers' bureaus for Biogen-Dompe. Paola Valsasina reports no disclosures. Stefan Ropele reports no disclosures. Margit Jehna reports no disclosures. Siegrid Fuchs serves on scientific advisory boards for Bayer Schering, Biogen Idec, Merck Serono, Novartis and Teva Pharmaceutical Industries Ltd./Sanofi Aventis and has received speaker honoraria from Biogen Idec, Merck Serono, and Sanofi-Aventis. Reinhold Schmidt has received consulting fees or honoraria from Pfizer, Novartis, Janssen, Lundbeck and Merz. Christa Neuper reports no disclosures. Franz Fazekas serves on scientific advisory boards for Bayer Schering, Biogen Idec, Merck Serono, Novartis and Teva Pharmaceutical Industries Ltd./Sanofi Aventis and serves on the editorial boards of Cerebrovascular Diseases, Multiple Sclerosis, the Polish Journal of Neurology and Neurosurgery, Stroke, Therapeutic Advances in Neurological Disorders, and the Swiss Archives of Neurology and Psychiatry. Franz Fazekas has received speaker honoraria from Biogen Idec, Merck Serono, Novartis and Sanofi-Aventis. Christian Enzinger has received travel grants and speaking honoraria from Biogen-Idec, Teva-Aventis, Merck-Serono, Bayer-Schering and unrestricted research grants from Teva-Aventis and Merck-Serono. This does not alter the authors' adherence to all the PLoS ONE policies on sharing data and materials.	Audoin B, 2005, MAGN RESON MATER PHY, V18, P96, DOI 10.1007/s10334-004-0098-9; Audoin B, 2003, HUM BRAIN MAPP, V20, P51, DOI 10.1002/hbm.10128; BISWAL B, 1995, MAGNET RESON MED, V34, P537, DOI 10.1002/mrm.1910340409; Bush G, 2000, TRENDS COGN SCI, V4, P215, DOI 10.1016/S1364-6613(00)01483-2; Cabeza R, 2000, J COGNITIVE NEUROSCI, V12, P1, DOI 10.1162/08989290051137585; Chang CH, 2003, MULT SCLER J, V9, P160, DOI 10.1191/1352458503ms885oa; Chiaravalloti ND, 2008, LANCET NEUROL, V7, P1139, DOI 10.1016/S1474-4422(08)70259-X; Cordes D, 2000, AM J NEURORADIOL, V21, P1636; Dineen RA, 2009, BRAIN, V132, P239, DOI 10.1093/brain/awn275; Duong MVA, 2005, J CEREBR BLOOD F MET, V25, P1245, DOI 10.1038/sj.jcbfm.9600122; Eryilmaz H, 2011, NEUROIMAGE, V54, P2481, DOI 10.1016/j.neuroimage.2010.10.021; Fair DA, 2007, NEUROIMAGE, V35, P396, DOI 10.1016/j.neuroimage.2006.11.051; Filippi M, 2010, NEUROLOGY, V75, P2121, DOI 10.1212/WNL.0b013e318200d768; Fischer JS, 1999, MULT SCLER J, V5, P244, DOI 10.1177/135245859900500409; FORMAN SD, 1995, MAGNET RESON MED, V33, P636, DOI 10.1002/mrm.1910330508; Fransson P, 2005, HUM BRAIN MAPP, V26, P15, DOI 10.1002/hbm.20113; Hayter AL, 2007, NEUROIMAGE, V36, P943, DOI 10.1016/j.neuroimage.2007.03.011; Kalkers NF, 2000, NEUROLOGY, V54, P1233, DOI 10.1212/WNL.54.6.1233; KURTZKE JF, 1983, NEUROLOGY, V33, P1444, DOI 10.1212/WNL.33.11.1444; Lazeron RHC, 2003, J NEUROL SCI, V213, P29, DOI 10.1016/S0022-510X(03)00144-8; Lesage E, 2010, BEHAV NEUROL, V23, P39, DOI [10.1155/2010/482139, 10.3233/BEN-2010-0267]; Loitfelder M, 2011, NEUROLOGY, V76, P526, DOI 10.1212/WNL.0b013e31820b75cf; Lowe MJ, 2002, RADIOLOGY, V224, P184, DOI 10.1148/radiol.2241011005; Lowe MJ, 2000, NEUROIMAGE, V12, P582, DOI 10.1006/nimg.2000.0654; Lowe MJ, 1995, MAGNETIC RESONANCE M, V29, P537; Lowe MJ, 1995, MAGNETIC RESONANCE M, V29, P818; Lowe MJ, 1995, MAGNETIC RESONANCE M, V29, P541; Mainero C, 2004, NEUROIMAGE, V21, P858, DOI 10.1016/j.neuroimage.2003.10.004; Maldjian JA, 2003, NEUROIMAGE, V19, P1233, DOI 10.1016/S1053-8119(03)00169-1; Morrow SA, 2010, MULT SCLER J, V16, P1385, DOI 10.1177/1352458510378021; OLDFIELD RC, 1971, NEUROPSYCHOLOGIA, V9, P97, DOI 10.1016/0028-3932(71)90067-4; Patti F, 2010, NEUROL SCI, V31, P265, DOI 10.1007/s10072-010-0438-7; Polman CH, 2005, ANN NEUROL, V58, P840, DOI 10.1002/ana.20703; RAO SM, 1991, NEUROLOGY, V41, P685, DOI 10.1212/WNL.41.5.685; RAO SM, 1986, J CLIN EXP NEUROPSYC, V8, P503, DOI 10.1080/01688638608405173; ROBINSON AL, 1980, J CONSULT CLIN PSYCH, V48, P605, DOI 10.1037/0022-006X.48.5.605; Rocca MA, 2010, NEUROLOGY, V74, P1252, DOI 10.1212/WNL.0b013e3181d9ed91; Staffen W, 2002, BRAIN, V125, P1275, DOI 10.1093/brain/awf125; Sumowski JF, 2010, NEUROLOGY, V74, P1942, DOI 10.1212/WNL.0b013e3181e396be; Valentino P, 2009, MULT SCLER J, V15, P854, DOI 10.1177/1352458509104589; Valsasina P, 2011, EUR J NEUROSCI, V33, P1256, DOI 10.1111/j.1460-9568.2011.07623.x; Zhao JZ, 2011, NEUROSCI LETT, V487, P27, DOI 10.1016/j.neulet.2010.09.067	42	44	45	2	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 17	2012	7	8							e42862	10.1371/journal.pone.0042862	http://dx.doi.org/10.1371/journal.pone.0042862			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	996DG	22912754	Green Published, Green Submitted, gold			2022-12-25	WOS:000308063700026
J	Wei, K; Sun, ZH; Zhu, SF; Guo, WL; Sheng, PC; Wang, ZM; Zhao, CL; Zhao, QY; Zhu, RL				Wei, Kai; Sun, Zhenhong; Zhu, Shufen; Guo, Wenlong; Sheng, Pengcheng; Wang, Zunmin; Zhao, Changliang; Zhao, Qingyou; Zhu, Ruiliang			Probable Congenital Transmission of Reticuloendotheliosis Virus Caused by Vaccination with Contaminated Vaccines	PLOS ONE			English	Article							AVIAN-LEUKOSIS-VIRUS; VERTICAL TRANSMISSION; SUBGROUP J; CHICKENS; INFECTION; GENOME; STRAIN	Contaminated vaccine is one unexpected and potential origin of virus infection. In order to investigate the most likely cause of disease in a broiler breeder company of Shandong Province, all 17 batches of live-virus vaccines used in the affected flocks and 478 tissue samples were tested by dot-blot hybridization, nested PCR, and IFA. The results suggested the outbreak of disease was most probably due to the vaccination of REV-contaminated MD-CVI988/Rispens vaccines and ND-LaSota+IB-H120 vaccines. Furthermore, the REV was probably transmitted to the commercial chickens through congenital transmission.	[Wei, Kai; Sun, Zhenhong; Zhu, Shufen; Guo, Wenlong; Sheng, Pengcheng; Wang, Zunmin; Zhao, Changliang; Zhao, Qingyou; Zhu, Ruiliang] Shandong Agr Univ, Coll Anim Sci & Technol, Key Lab Biol Prod, Tai An, Shandong, Peoples R China	Shandong Agricultural University	Wei, K (corresponding author), Shandong Agr Univ, Coll Anim Sci & Technol, Key Lab Biol Prod, Tai An, Shandong, Peoples R China.	zhurl@sdau.edu.cn			National Natural Science Foundation of China [30972183, 30740077]; Special Fund Research of Public Welfare Industries of Ministry of Agriculture [200803019]; Science and Technology Development Plan of Shandong Province [2012GNC11020]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Special Fund Research of Public Welfare Industries of Ministry of Agriculture; Science and Technology Development Plan of Shandong Province	This work was supported by National Natural Science Foundation of China (30972183, 30740077), Special Fund Research of Public Welfare Industries of Ministry of Agriculture (200803019), and Science and Technology Development Plan of Shandong Province (2012GNC11020). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Awad AM, 2010, POULTRY SCI, V89, P2389, DOI 10.3382/ps.2010-00899; Barbosa T, 2007, VIRUS RES, V124, P68, DOI 10.1016/j.virusres.2006.10.002; Biswas SK, 2011, VET ITAL, V47, P147; Bohls RL, 2006, VIRUS RES, V119, P187, DOI 10.1016/j.virusres.2006.01.011; Cheng Z, 2011, ISR J VET MED, V66, P34; Cui ZZ, 2010, VIRUS GENES, V40, P236, DOI 10.1007/s11262-009-0437-z; Cui ZZ, 2009, AVIAN PATHOL, V38, P443, DOI 10.1080/03079450903349188; Davidson I, 2008, J GEN VIROL, V89, P2456, DOI 10.1099/vir.0.2008/001313-0; Davidson T, 2005, J MED ENTOMOL, V42, P128, DOI 10.1603/0022-2585(2005)042[0128:ICTHTO]2.0.CO;2; Diao XiuGuo, 2008, Agricultural Sciences in China, V7, P1387, DOI 10.1016/S1671-2927(08)60189-3; Fadly AM, 1997, AVIAN DIS, V41, P695, DOI 10.2307/1592163; Hatai H, 2009, J VET DIAGN INVEST, V21, P519, DOI 10.1177/104063870902100415; Hauck R, 2009, AVIAN DIS, V53, P211, DOI 10.1637/8452-081908-Reg.1; JACKSON CAW, 1977, AUST VET J, V53, P457, DOI 10.1111/j.1751-0813.1977.tb05509.x; KAWAMURA H, 1976, NATL I ANIM HEALTH Q, V16, P135; Mays JK, 2010, AVIAN PATHOL, V39, P383, DOI 10.1080/03079457.2010.510828; MOTHA MXJ, 1987, AVIAN PATHOL, V16, P141, DOI 10.1080/03079458708436359; Ni Nan, 2008, Weishengwu Xuebao, V48, P514; Pastoret PP, 2010, BIOLOGICALS, V38, P332, DOI 10.1016/j.biologicals.2010.02.015; Sun SH, 2009, AVIAN PATHOL, V38, P31, DOI 10.1080/03079450802607504; WITTER RL, 1989, AVIAN DIS, V33, P226, DOI 10.2307/1590836; YUASA N, 1976, NATL I ANIM HEALTH Q, V16, P141; Yue H., 2010, CHINA POULTRY, V32, P27; Zheng YS, 2007, J VET MED SCI, V69, P213, DOI 10.1292/jvms.69.213	24	34	39	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 17	2012	7	8							e43422	10.1371/journal.pone.0043422	http://dx.doi.org/10.1371/journal.pone.0043422			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	996DG	22912872	Green Submitted, Green Published, gold			2022-12-25	WOS:000308063700100
J	Chan, VBS; Li, CY; Lane, AC; Wang, YC; Lu, XW; Shih, KM; Zhang, T; Thiyagarajan, V				Chan, Vera Bin San; Li, Chaoyi; Lane, Ackley Charles; Wang, Yanchun; Lu, Xingwen; Shih, Kaimin; Zhang, Tong; Thiyagarajan, Vengatesen			CO2-Driven Ocean Acidification Alters and Weakens Integrity of the Calcareous Tubes Produced by the Serpulid Tubeworm, Hydroides elegans	PLOS ONE			English	Article							AMORPHOUS CALCIUM-CARBONATE; LARVAL DEVELOPMENT; SHELL DISSOLUTION; COASTAL ZONE; CALCIFICATION; SALINITY; SEAWATER; MECHANISMS; OYSTERS; DIOXIDE	As a consequence of anthropogenic CO2-driven ocean acidification (OA), coastal waters are becoming increasingly challenging for calcifiers due to reductions in saturation states of calcium carbonate (CaCO3) minerals. The response of calcification rate is one of the most frequently investigated symptoms of OA. However, OA may also result in poor quality calcareous products through impaired calcification processes despite there being no observed change in calcification rate. The mineralogy and ultrastructure of the calcareous products under OA conditions may be altered, resulting in changes to the mechanical properties of calcified structures. Here, the warm water biofouling tubeworm, Hydroides elegans, was reared from larva to early juvenile stage at the aragonite saturation state (Omega(A)) for the current pCO(2) level (ambient) and those predicted for the years 2050, 2100 and 2300. Composition, ultrastructure and mechanical strength of the calcareous tubes produced by those early juvenile tubeworms were examined using X-ray diffraction (XRD), Fourier transform infrared spectroscopy (FT-IR), scanning electron microscopy (SEM) and nanoindentation. Juvenile tubes were composed primarily of the highly soluble CaCO3 mineral form, aragonite. Tubes produced in seawater with aragonite saturation states near or below one had significantly higher proportions of the crystalline precursor, amorphous calcium carbonate (ACC) and the calcite/aragonite ratio dramatically increased. These alterations in tube mineralogy resulted in a holistic deterioration of the tube hardness and elasticity. Thus, in conditions where Omega(A) is near or below one, the aragonite-producing juvenile tubeworms may no longer be able to maintain the integrity of their calcification products, and may result in reduced survivorship due to the weakened tube protection.	[Chan, Vera Bin San; Li, Chaoyi; Lane, Ackley Charles; Thiyagarajan, Vengatesen] Univ Hong Kong, Swire Inst Marine Sci, Pokfulam, Hong Kong, Peoples R China; [Chan, Vera Bin San; Li, Chaoyi; Lane, Ackley Charles; Thiyagarajan, Vengatesen] Univ Hong Kong, Sch Biol Sci, Pokfulam, Hong Kong, Peoples R China; [Wang, Yanchun; Lu, Xingwen; Shih, Kaimin; Zhang, Tong] Univ Hong Kong, Dept Civil Engn, Pokfulam, Hong Kong, Peoples R China	University of Hong Kong; University of Hong Kong; University of Hong Kong	Chan, VBS (corresponding author), Univ Hong Kong, Swire Inst Marine Sci, Pokfulam, Hong Kong, Peoples R China.	rajan@hku.hk	Zhang, Tong/HGC-1090-2022; Shih, Kaimin/N-8512-2017; 張彤, Tong Zhang/C-6786-2008	Shih, Kaimin/0000-0002-6461-3207; Zhang, Tong/0000-0003-1148-4322; Thiyagarajan, Vengatesen/0000-0002-2062-4799; Chan, Bin San/0000-0003-3935-2700	Research Grants Council, Hong Kong [778309M]	Research Grants Council, Hong Kong(Hong Kong Research Grants Council)	This study was supported by a research grant from the Research Grants Council, Hong Kong (no. 778309M). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Addadi L, 2003, ADV MATER, V15, P959, DOI 10.1002/adma.200300381; Albright R, 2011, POPULATION, V12, P15; Allemand D, 2011, COROL CALCIFICATION; Allison N, 2011, CHEM GEOL, V289, P171, DOI 10.1016/j.chemgeo.2011.08.001; Andersson AJ, 2008, MAR ECOL PROG SER, V373, P265, DOI 10.3354/meps07639; [Anonymous], 2009, BIOGEOSCI DISCUSS, DOI DOI 10.5194/BGD-6-3109-2009; Auzoux-Bordenave S, 2010, J STRUCT BIOL, V171, P277, DOI 10.1016/j.jsb.2010.05.012; Beniash E, 1997, P ROY SOC B-BIOL SCI, V264, P461, DOI 10.1098/rspb.1997.0066; Beniash E, 2010, MAR ECOL PROG SER, V419, P95, DOI 10.3354/meps08841; Bentov S, 2010, J STRUCT BIOL, V171, P207, DOI 10.1016/j.jsb.2010.04.007; Bish DL, 1989, REV MINERAL, V73, P20; Borges AV, 2010, LIMNOL OCEANOGR, V55, P346, DOI 10.4319/lo.2010.55.1.0346; BRADSHAW AL, 1988, MAR CHEM, V23, P69, DOI 10.1016/0304-4203(88)90023-0; Byrne M, 2011, OCEANOGR MAR BIOL, V49, P1; Cai WJ, 2011, NAT GEOSCI, V4, P766, DOI [10.1038/ngeo1297, 10.1038/NGEO1297]; Caldeira K, 2005, J GEOPHYS RES-OCEANS, V110, DOI 10.1029/2004JC002671; Checkley DM, 2009, SCIENCE, V324, P1683, DOI 10.1126/science.1169806; Cigliano M, 2010, MAR BIOL, V157, P2489, DOI 10.1007/s00227-010-1513-6; Cleroux C, 2008, PALEOCEANOGRAPHY, V23, DOI 10.1029/2007PA001505; Cohen AL, 2009, GEOCHEM GEOPHY GEOSY, V10, DOI 10.1029/2009GC002411; Comeau S, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011362; Dai MH, 2008, CONT SHELF RES, V28, P1416, DOI 10.1016/j.csr.2007.04.018; Dekens PS, 2008, GEOCHEM GEOPHY GEOSY, V9, DOI 10.1029/2007GC001931; Dickinson GH, 2012, J EXP BIOL, V215, P29, DOI 10.1242/jeb.061481; DODD J. ROBERT, 1967, J PALEONTOL, V41, P1313; Doney SC, 2009, ANNU REV MAR SCI, V1, P169, DOI 10.1146/annurev.marine.010908.163834; Duenas-Bohorquez A, 2009, MAR MICROPALEONTOL, V73, P178, DOI 10.1016/j.marmicro.2009.09.002; Dykstra MJ, 1993, MANUAL APPL TECHNIQU; Fabry VJ, 2009, OCEANOGRAPHY, V22, P160, DOI 10.5670/oceanog.2009.105; Feely RA, 2009, GEOPHYS MONOGR SER, V183, P175, DOI 10.1029/2005GM000337; Feng QL, 2000, MAT SCI ENG C-BIO S, V11, P19, DOI 10.1016/S0928-4931(00)00138-7; Gaylord B, 2011, J EXP BIOL, V214, P2586, DOI 10.1242/jeb.055939; Green MA, 2004, LIMNOL OCEANOGR, V49, P727, DOI 10.4319/lo.2004.49.3.0727; Hadfield MG, 2001, AM ZOOL, V41, P1123, DOI 10.1668/0003-1569(2001)041[1123:MCAMAC]2.0.CO;2; HE MY, 1991, J AM CERAM SOC, V74, P767, DOI 10.1111/j.1151-2916.1991.tb06922.x; Heinemann A, 2012, GEOCHEM GEOPHY GEOSY, V13, DOI 10.1029/2011GC003790; Hofmann GE, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0028983; Hofmann GE, 2010, ANNU REV PHYSIOL, V72, P127, DOI 10.1146/annurev-physiol-021909-135900; Howarth R, 2011, FRONT ECOL ENVIRON, V9, P18, DOI 10.1890/100008; Jacob DE, 2008, GEOCHIM COSMOCHIM AC, V72, P5401, DOI 10.1016/j.gca.2008.08.019; Kurihara H, 2008, MAR ECOL PROG SER, V373, P275, DOI 10.3354/meps07802; Lane A, MAR BIOL IN PRESS; Larson AC., 1994, J APPL CRYSTALLOGR, V34, P210, DOI DOI 10.1107/S0021889801002242; Li W, 2012, MAR POLLUT BULL, V64, P699, DOI 10.1016/j.marpolbul.2012.01.033; MacDonald J, 2010, MAR BIOL, V157, P2087, DOI 10.1007/s00227-010-1476-7; Marshall DJ, 2008, MAR ENVIRON RES, V66, P422, DOI 10.1016/j.marenvres.2008.07.003; McClintock JB, 2011, J GEOL, V119, P457, DOI 10.1086/660890; McClintock JB, 2009, ANTARCT SCI, V21, P449, DOI 10.1017/S0954102009990198; Medakovic D, 1997, MAR BIOL, V129, P615, DOI 10.1007/s002270050204; Melzner F, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024223; Merkel C, 2009, J STRUCT BIOL, V168, P396, DOI 10.1016/j.jsb.2009.08.014; Millero FJ, 2006, MAR CHEM, V100, P80, DOI 10.1016/j.marchem.2005.12.001; Mount AS, 2004, SCIENCE, V304, P297, DOI 10.1126/science.1090506; MUCCI A, 1983, AM J SCI, V283, P780, DOI 10.2475/ajs.283.7.780; Nedved BT, 2009, SPRINGER SER BIOFILM, V4, P203, DOI 10.1007/7142_2008_15; Nienhuis S, 2010, P ROY SOC B-BIOL SCI, V277, P2553, DOI 10.1098/rspb.2010.0206; PALMER AR, 1992, P NATL ACAD SCI USA, V89, P1379, DOI 10.1073/pnas.89.4.1379; Parmigiani JP, 2006, J MECH PHYS SOLIDS, V54, P266, DOI 10.1016/j.jmps.2005.09.002; Pechenik JA, 2007, BIOL BULL-US, V212, P151, DOI 10.2307/25066592; Perez-Huerta A, 2008, MINERAL MAG, V72, P563, DOI 10.1180/minmag.2008.072.2.563; Pierrot D., 2006, ORNLCDIAC105A US DEP, DOI [10.3334/CDIAC/otg.CO2SYS_XLS_CDIAC105a, DOI 10.3334/CDIAC/OTG.CO2SYS_XLS_CDIAC105A]; Portner HO, 2008, MAR ECOL PROG SER, V373, P203, DOI 10.3354/meps07768; Politi Y, 2008, P NATL ACAD SCI USA, V105, P17362, DOI 10.1073/pnas.0806604105; Qiu JW, 1997, MAR ECOL PROG SER, V152, P79, DOI 10.3354/meps152079; Raz S, 2003, ADV FUNCT MATER, V13, P480, DOI 10.1002/adfm.200304285; Riebesell U., 2011, GUIDE BEST PRACTICES, DOI DOI 10.2777/58454; Ries JB, 2004, GEOLOGY, V32, P981, DOI 10.1130/G20851.1; Ries JB, 2011, J EXP MAR BIOL ECOL, V403, P54, DOI 10.1016/j.jembe.2011.04.006; Rodolfo-Metalpa R, 2011, NAT CLIM CHANGE, V1, P308, DOI 10.1038/NCLIMATE1200; Sheppard Brennand H, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011372; SIKES CS, 1986, BIOL BULL, V170, P494, DOI 10.2307/1541857; Simkiss K, 1989, BIOMINERALIZATION CE; Snyder R, 1989, REV MINERAL, V101, P20; STENZEL HB, 1964, SCIENCE, V145, P155, DOI 10.1126/science.145.3628.155; Stumpp M, 2011, COMP BIOCHEM PHYS A, V160, P320, DOI 10.1016/j.cbpa.2011.06.023; Sumitomo T, 2011, J STRUCT BIOL, V174, P31, DOI 10.1016/j.jsb.2011.01.001; Talmage SC, 2010, P NATL ACAD SCI USA, V107, P17246, DOI 10.1073/pnas.0913804107; Tanur AE, 2010, J STRUCT BIOL, V169, P145, DOI 10.1016/j.jsb.2009.09.008; Taylor PD, 2010, J STRUCT BIOL, V171, P402, DOI 10.1016/j.jsb.2010.05.010; Twitchett R.J., 2009, BIOGEOSCIENCES DISCU, V6, P2267, DOI [DOI 10.5194/BGD-6-2267-2009, 10.5194/bgd-6-2267-2009]; Vinn O, 2008, PALAEONTOLOGY, V51, P295, DOI 10.1111/j.1475-4983.2008.00763.x; Vinn O, 2011, CARNETS GEOL, P137, DOI 10.4267/2042/43896; Vinn O, 2008, ZOOL J LINN SOC-LOND, V154, P633, DOI 10.1111/j.1096-3642.2008.00421.x; Waldbusser GG, 2011, ESTUAR COAST, V34, P221, DOI 10.1007/s12237-010-9307-0; Watson SA, 2009, J SHELLFISH RES, V28, P431, DOI 10.2983/035.028.0302; Weiner S, 1997, J MATER CHEM, V7, P689, DOI 10.1039/a604512j; Weiner S, 2008, J STRUCT BIOL, V163, P229, DOI 10.1016/j.jsb.2008.02.001; Weiss IM, 2002, J EXP ZOOL, V293, P478, DOI 10.1002/jez.90004; Welladsen HM, 2010, MOLLUSCAN RES, V30, P125; WHEELER AP, 1984, AM ZOOL, V24, P933; Wood HL, 2008, P ROY SOC B-BIOL SCI, V275, P1767, DOI 10.1098/rspb.2008.0343; Yang W, 2011, J MATER SCI TECHNOL, V27, P139, DOI 10.1016/S1005-0302(11)60039-X; Zeebe RE, 2008, SCIENCE, V321, P51, DOI 10.1126/science.1159124; Zhu ZH, 2006, MICRON, V37, P35, DOI 10.1016/j.micron.2005.07.001	94	53	56	2	67	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 13	2012	7	8							e42718	10.1371/journal.pone.0042718	http://dx.doi.org/10.1371/journal.pone.0042718			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	988OJ	22912726	Green Published, Green Submitted, gold			2022-12-25	WOS:000307500100024
J	Chen, N; Hong, FL; Wang, HH; Yuan, QH; Ma, WY; Gao, XN; Shi, R; Zhang, RJ; Sun, CS; Wang, SB				Chen, Nan; Hong, Fu-Lin; Wang, Hai-Hong; Yuan, Qi-Hang; Ma, Wan-Yan; Gao, Xu-Na; Shi, Rui; Zhang, Rui-Juan; Sun, Chang-Sheng; Wang, Sheng-Bin			Modified Recombinant Proteins Can Be Exported via the Sec Pathway in Escherichia coli	PLOS ONE			English	Article							ACETYL-COA CARBOXYLASE; ACYL CARRIER PROTEIN; BACTERIAL CYTOPLASMIC MEMBRANE; POSTTRANSLATIONAL MODIFICATION; DOMAIN; EXPRESSION; BIOTINYLATION; TRANSLOCATION; BIOSYNTHESIS; PURIFICATION	The correct folding of a protein is a pre-requirement for its proper posttranslational modification. The Escherichia coli Sec pathway, in which preproteins, in an unfolded, translocation-competent state, are rapidly secreted across the cytoplasmic membrane, is commonly assumed to be unfavorable for their modification in the cytosol. Whether posttranslationally modified recombinant preproteins can be efficiently transported via the Sec pathway, however, remains unclear. ACP and BCCP domain (BCCP87) are carrier proteins that can be converted into active phosphopantetheinylated ACP (holo-ACP) and biotinylated-BCCP (holo-BCCP) by AcpS and BirA, respectively. In the present study, we show that, when ACP or BCCP87 is fused to the C-terminus of secretory protein YebF or MBP, the resulting fusion protein preYebF-ACP, preYebF-BCCP87, preMBP-ACP or preMBP-BCCP87 can be modified and then secreted. Our data demonstrate that posttranslational modification of preYebF-ACP, preYebF-BCCP87 preMBP-ACP and preMBP-BCCP87 can take place in the cytosol prior to translocation, and the Sec machinery accommodates these previously modified fusion proteins. High levels of active holo-ACP and holo-BCCP87 are achieved when AcpS or BirA is co-expressed, especially when sodium azide is used to retard their translocation across the inner membrane. Our results also provide an alternative to achieve a high level of modified recombinant proteins expressed extracellularly.	[Chen, Nan; Hong, Fu-Lin; Wang, Hai-Hong; Yuan, Qi-Hang; Ma, Wan-Yan; Gao, Xu-Na; Shi, Rui; Zhang, Rui-Juan; Sun, Chang-Sheng; Wang, Sheng-Bin] S China Agr Univ, Coll Life Sci, Guangzhou, Guangdong, Peoples R China	South China Agricultural University	Chen, N (corresponding author), S China Agr Univ, Coll Life Sci, Guangzhou, Guangdong, Peoples R China.	swwl@scau.edu.cn			Chinese National Nature Science Foundation [30470994, 30671424]	Chinese National Nature Science Foundation(National Natural Science Foundation of China (NSFC))	This study was supported by the Chinese National Nature Science Foundation (30470994 and 30671424). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Borgese N, 2009, EMBO REP, V10, P337, DOI 10.1038/embor.2009.48; Chapman-Smith A, 1999, J BIOL CHEM, V274, P1449, DOI 10.1074/jbc.274.3.1449; ChapmanSmith A, 1997, J BIOL CHEM, V272, P26017, DOI 10.1074/jbc.272.41.26017; CHAPMANSMITH A, 1994, BIOCHEM J, V302, P881, DOI 10.1042/bj3020881; COLLIER DN, 1988, CELL, V53, P273, DOI 10.1016/0092-8674(88)90389-3; Cronan JE, 2001, J BIOL CHEM, V276, P37355, DOI 10.1074/jbc.M106353200; Cronan JE, 2009, METHOD ENZYMOL, V459, P395, DOI 10.1016/S0076-6879(09)04617-5; Driessen AJM, 2008, ANNU REV BIOCHEM, V77, P643, DOI 10.1146/annurev.biochem.77.061606.160747; Filenko NA, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016299; Fisher AC, 2008, MICROB BIOTECHNOL, V1, P403, DOI 10.1111/j.1751-7915.2008.00041.x; Flugel RS, 2000, J BIOL CHEM, V275, P959, DOI 10.1074/jbc.275.2.959; Garcia-Estrada C, 2008, BIOCHEM J, V415, P317, DOI 10.1042/BJ20080369; Gravel RA, 2005, J NUTR BIOCHEM, V16, P428, DOI 10.1016/j.jnutbio.2005.03.020; Hansen EH, 2009, APPL ENVIRON MICROB, V75, P2765, DOI 10.1128/AEM.02681-08; HORTON RM, 1989, GENE, V77, P61, DOI 10.1016/0378-1119(89)90359-4; Ingaranno M, 2011, J BIOL CHEM, V286, P13071, DOI 10.1074/jbc.M110.183624; JACKOWSKI S, 1983, J BIOL CHEM, V258, P5186; Kay Brian K., 2009, V498, P185, DOI 10.1007/978-1-59745-196-3_13; Keating DH, 1996, J BACTERIOL, V178, P2662, DOI 10.1128/jb.178.9.2662-2667.1996; Keating DH, 1996, J BIOL CHEM, V271, P15905, DOI 10.1074/jbc.271.27.15905; Kotzsch A, 2011, PROTEIN SCI, V20, P597, DOI 10.1002/pro.593; Li SY, 2006, J BIOTECHNOL, V122, P412, DOI 10.1016/j.jbiotec.2005.09.011; Maeda Y, 2010, APPL ENVIRON MICROB, V76, P5785, DOI 10.1128/AEM.00916-10; Matos CFRO, 2008, EMBO J, V27, P2055, DOI 10.1038/emboj.2008.132; Natale P, 2008, BBA-BIOMEMBRANES, V1778, P1735, DOI 10.1016/j.bbamem.2007.07.015; Neumann H, 2008, NAT CHEM BIOL, V4, P232, DOI 10.1038/nchembio.73; Ni Y, 2009, BIOTECHNOL LETT, V31, P1661, DOI 10.1007/s10529-009-0077-3; Nomen N, 2007, J MOL BIOL, V372, P422, DOI 10.1016/j.jmb.2007.07.003; OLIVER DB, 1990, P NATL ACAD SCI USA, V87, P8227, DOI 10.1073/pnas.87.21.8227; Qian ZG, 2008, BIOTECHNOL BIOENG, V101, P587, DOI 10.1002/bit.21898; REED KE, 1991, J BIOL CHEM, V266, P11425; ROCK CO, 1981, J BIOL CHEM, V256, P2669; Saitoh Hisato, 2009, V497, P211, DOI 10.1007/978-1-59745-566-4_14; SAMOLS D, 1988, J BIOL CHEM, V263, P6461; Shields JA, 2010, CHEMBIOCHEM, V11, P248, DOI 10.1002/cbic.200900565; Skillman KM, 2005, MOL MICROBIOL, V58, P945, DOI 10.1111/j.1365-2958.2005.04885.x; Sugase K, 2008, PROTEIN EXPRES PURIF, V57, P108, DOI 10.1016/j.pep.2007.10.018; Sun CS, 2012, PROTEIN EXPRES PURIF, V82, P226, DOI 10.1016/j.pep.2012.01.005; Terai T, 2011, CHEM BIOL, V18, P1261, DOI 10.1016/j.chembiol.2011.09.007; Tropea Joseph E., 2009, V498, P297, DOI 10.1007/978-1-59745-196-3_19; Witze ES, 2007, NAT METHODS, V4, P798, DOI 10.1038/nmeth1100; Yoon Sung Ho, 2010, Recent Pat Biotechnol, V4, P23, DOI 10.2174/187220810790069550; Zhang GJ, 2006, NAT BIOTECHNOL, V24, P100, DOI 10.1038/nbt1174	43	5	7	2	32	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 13	2012	7	8							e42519	10.1371/journal.pone.0042519	http://dx.doi.org/10.1371/journal.pone.0042519			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	988OJ	22912705	Green Published, Green Submitted, gold			2022-12-25	WOS:000307500100014
J	Esapa, CT; Head, RA; Jeyabalan, J; Evans, H; Hough, TA; Cheeseman, MT; McNally, EG; Carr, AJ; Thomas, GP; Brown, MA; Croucher, PI; Brown, SDM; Cox, RD; Thakker, RV				Esapa, Christopher T.; Head, Rosie A.; Jeyabalan, Jeshmi; Evans, Holly; Hough, Tertius A.; Cheeseman, Michael T.; McNally, Eugene G.; Carr, Andrew J.; Thomas, Gethin P.; Brown, Matthew A.; Croucher, Peter I.; Brown, Steve D. M.; Cox, Roger D.; Thakker, Rajesh V.			A Mouse with an N-Ethyl-N-Nitrosourea (ENU) Induced Trp589Arg Galnt3 Mutation Represents a Model for Hyperphosphataemic Familial Tumoural Calcinosis	PLOS ONE			English	Article							HOMOZYGOUS MISSENSE MUTATION; ALPHA-D-GALACTOSAMINE; INTACT FIBROBLAST-GROWTH-FACTOR-23; TARGETED INACTIVATION; GENE LEADS; PHOSPHATE; FGF23; HYPERCALCIURIA; GLYCOSYLATION; METABOLISM	Mutations of UDP-N-acetyl-alpha-D-galactosamine polypeptide N-acetyl galactosaminyl transferase 3 (GALNT3) result in familial tumoural calcinosis (FTC) and the hyperostosis-hyperphosphataemia syndrome (HHS), which are autosomal recessive disorders characterised by soft-tissue calcification and hyperphosphataemia. To facilitate in vivo studies of these heritable disorders of phosphate homeostasis, we embarked on establishing a mouse model by assessing progeny of mice treated with the chemical mutagen N-ethyl-N-nitrosourea (ENU), and identified a mutant mouse, TCAL, with autosomal recessive inheritance of ectopic calcification, which involved multiple tissues, and hyperphosphataemia; the phenotype was designated TCAL and the locus, Tcal. TCAL males were infertile with loss of Sertoli cells and spermatozoa, and increased testicular apoptosis. Genetic mapping localized Tcal to chromosome 2 (62.64-71.11 Mb) which contained the Galnt3. DNA sequence analysis identified a Galnt3 missense mutation (Trp589Arg) in TCAL mice. Transient transfection of wild-type and mutant Galnt3-enhanced green fluorescent protein (EGFP) constructs in COS-7 cells revealed endoplasmic reticulum retention of the Trp589Arg mutant and Western blot analysis of kidney homogenates demonstrated defective glycosylation of Galnt3 in Tcal/Tcal mice. Tcal/Tcal mice had normal plasma calcium and parathyroid hormone concentrations; decreased alkaline phosphatase activity and intact Fgf23 concentrations; and elevation of circulating 1,25-dihydroxyvitamin D. Quantitative reverse transcriptase-PCR (qRT-PCR) revealed that Tcal/Tcal mice had increased expression of Galnt3 and Fgf23 in bone, but that renal expression of Klotho, 25-hydroxyvitamin D-1 alpha-hydroxylase (Cyp27b1), and the sodium-phosphate co-transporters type-IIa and -IIc was similar to that in wild-type mice. Thus, TCAL mice have the phenotypic features of FTC and HHS, and provide a model for these disorders of phosphate metabolism.	[Esapa, Christopher T.; Head, Rosie A.; Jeyabalan, Jeshmi; Thakker, Rajesh V.] Univ Oxford, Nuffield Dept Clin Med, Acad Endocrine Unit, Oxford Ctr Diabet Endocrinol & Metab,Churchill Ho, Oxford, England; [Evans, Holly; Croucher, Peter I.] Univ Sheffield, Dept Human Metab, Mellanby Ctr Bone Res, Sheffield, S Yorkshire, England; [McNally, Eugene G.] Univ Oxford, Dept Radiol, Nuffield Orthopaed Ctr, Oxford OX1 2JD, England; [Carr, Andrew J.] Univ Oxford, Nuffield Dept Orthopaed Rheumatol & Musculoskelet, NIHR Biomed Res Unit, Oxford OX1 2JD, England; [Thomas, Gethin P.; Brown, Matthew A.] Univ Queensland, Princess Alexandra Hosp, Diamantina Inst, Brisbane, Qld 4072, Australia; [Croucher, Peter I.] Garvan Inst Med Res, Sydney, NSW, Australia	University of Oxford; University of Sheffield; Nuffield Orthopaedic Centre; University of Oxford; University of Oxford; University of Queensland; Garvan Institute of Medical Research	Esapa, CT (corresponding author), Univ Oxford, Nuffield Dept Clin Med, Acad Endocrine Unit, Oxford Ctr Diabet Endocrinol & Metab,Churchill Ho, Oxford, England.	rajesh.thakker@ndm.ox.ac.uk	Thomas, Gethin P/A-3624-2011; Brown, Matthew A/E-5749-2010	Brown, Matthew A/0000-0003-0538-8211; Thomas, Gethin/0000-0001-9081-3686; Cox, Roger/0000-0001-7170-5014; Croucher, Peter/0000-0002-7102-2413; Thakker, Rajesh/0000-0002-1438-3220	Medical Research Council UK [G0600702/1, G9825289, G1000467]; European Union [FP7-200800]; Ernest Heine Family Foundation; Lions Senior Medical Research Fellowship; BBSRC [BBS/E/D/20251969] Funding Source: UKRI; MRC [MC_U142684172, MC_U142684175, MC_U142661184, MC_UP_1502/1, G9825289, G0600702, G1000467, MC_U142670371] Funding Source: UKRI; Biotechnology and Biological Sciences Research Council [BBS/E/D/20251969] Funding Source: researchfish; Medical Research Council [G1000467, MC_U142684172, MC_UP_1502/1, G0600702, MC_U142684175, MC_U142670371, MC_U142661184, G9825289] Funding Source: researchfish	Medical Research Council UK(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); European Union(European Commission); Ernest Heine Family Foundation; Lions Senior Medical Research Fellowship; BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	This work was supported by the Medical Research Council UK [grant numbers G0600702/1, G9825289 and G1000467]; and European Union Framework 7 [grant number FP7-200800, TREAT-OA]. PIC is supported by the Ernest Heine Family Foundation and Mrs Janice Gibson. GPT was supported by a Lions Senior Medical Research Fellowship. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Acevedo-Arozena A, 2008, ANNU REV GENOM HUM G, V9, P49, DOI 10.1146/annurev.genom.9.081307.164224; Araya K, 2005, J CLIN ENDOCR METAB, V90, P5523, DOI 10.1210/jc.2005-0301; Barbieri AM, 2007, J HUM GENET, V52, P464, DOI 10.1007/s10038-007-0126-5; Beck L, 1998, P NATL ACAD SCI USA, V95, P5372, DOI 10.1073/pnas.95.9.5372; Benet-Pages A, 2005, HUM MOL GENET, V14, P385, DOI 10.1093/hmg/ddi034; Bennett EP, 1996, J BIOL CHEM, V271, P17006, DOI 10.1074/jbc.271.29.17006; Campagnoli MF, 2006, J CLIN PATHOL, V59, P440, DOI 10.1136/jcp.2005.026369; Carmichael KD, 2009, J BONE JOINT SURG AM, V91A, P664, DOI 10.2106/JBJS.G.01512; Chefetz I, 2005, HUM GENET, V118, P261, DOI 10.1007/s00439-005-0026-8; Chefetz I, 2009, BBA-MOL BASIS DIS, V1792, P847, DOI 10.1016/j.bbadis.2008.10.008; Chefetz I, 2009, BBA-MOL BASIS DIS, V1792, P61, DOI 10.1016/j.bbadis.2008.09.016; Church C, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000599; Clausen H, 1996, GLYCOBIOLOGY, V6, P635, DOI 10.1093/glycob/6.6.635; Dardenne O, 2001, ENDOCRINOLOGY, V142, P3135, DOI 10.1210/en.142.7.3135; Di Marco GS, 2008, AM J PHYSIOL-RENAL, V294, pF1381, DOI 10.1152/ajprenal.00003.2008; Dumitrescu CE, 2009, OSTEOPOROSIS INT, V20, P1273, DOI 10.1007/s00198-008-0775-z; Duncan EL, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1001372; Esapa CT, 2007, HUM MOL GENET, V16, P327, DOI 10.1093/hmg/ddl472; Esapa CT, 2012, J BONE MINER RES, V27, P413, DOI 10.1002/jbmr.547; Frishberg Y, 2005, J MOL MED, V83, P33, DOI 10.1007/s00109-004-0610-8; Frishberg Y, 2007, J BONE MINER RES, V22, P235, DOI 10.1359/JBMR.061105; Fukumoto S, 2008, INTERNAL MED, V47, P337, DOI 10.2169/internalmedicine.47.0730; Garringer HJ, 2007, AM J MED GENET A, V143A, P2390, DOI 10.1002/ajmg.a.31947; Garringer HJ, 2006, J CLIN ENDOCR METAB, V91, P4037, DOI 10.1210/jc.2006-0305; Gok F, 2009, ACTA ORTHOP, V80, P131, DOI 10.1080/17453670902807482; Hannan FM, 2008, EUR J ENDOCRINOL, V158, P265, DOI 10.1530/EJE-07-0485; Hannan FM, 2008, NAT CLIN PRACT ENDOC, V4, P53, DOI 10.1038/ncpendmet0718; Heath DJ, 2009, J BONE MINER RES, V24, P425, DOI 10.1359/JBMR.081104; Hough TA, 2004, P NATL ACAD SCI USA, V101, P13566, DOI 10.1073/pnas.0405516101; Ichikawa S, 2005, J CLIN ENDOCR METAB, V90, P2420, DOI 10.1210/jc.2004-2302; Ichikawa S, 2007, J CLIN INVEST, V117, P2684, DOI 10.1172/JCI31330; Ichikawa S, 2007, J CLIN ENDOCR METAB, V92, P1943, DOI 10.1210/jc.2006-1825; Ichikawa S, 2006, J CLIN ENDOCR METAB, V91, P4472, DOI 10.1210/jc.2006-1247; Ichikawa S, 2011, ENDOCRINOLOGY, V152, P4504, DOI 10.1210/en.2011-1137; Ichikawa S, 2010, AM J MED GENET A, V152A, P896, DOI 10.1002/ajmg.a.33337; Ichikawa S, 2009, ENDOCRINOLOGY, V150, P2543, DOI 10.1210/en.2008-0877; Joseph L, 2010, SKELETAL RADIOL, V39, P63, DOI 10.1007/s00256-009-0808-5; Kato K, 2006, J BIOL CHEM, V281, P18370, DOI 10.1074/jbc.M602469200; Keays DA, 2006, MAMM GENOME, V17, P230, DOI 10.1007/s00335-005-0101-4; Kuroo M, 1997, NATURE, V390, P45, DOI 10.1038/36285; Laleye A, 2008, GENET COUNSEL, V19, P183; Lorenz-Depiereux B, 2006, AM J HUM GENET, V78, P193, DOI 10.1086/499410; Meleti Z, 2000, BONE, V27, P359, DOI 10.1016/S8756-3282(00)00346-X; Nesbit MA, 2004, J BIOL CHEM, V279, P22624, DOI 10.1074/jbc.M401797200; Olauson H, 2008, EUR J ENDOCRINOL, V158, P929, DOI 10.1530/EJE-08-0011; Olsen KM, 2006, RADIOGRAPHICS, V26, P871, DOI 10.1148/rg.263055099; Pakasa NM, 1997, HISTOPATHOLOGY, V31, P18, DOI 10.1046/j.1365-2559.1997.6050831.x; Quwailid MM, 2004, MAMM GENOME, V15, P585, DOI 10.1007/s00335-004-2379-z; RUTENBER E, 1991, PROTEINS, V10, P260, DOI 10.1002/prot.340100310; Shaw N, 2008, TUMORAL CALCINOSIS D; Shimada T, 2004, J CLIN INVEST, V113, P561, DOI 10.1172/JCI200419081; Specktor P, 2006, J HUM GENET, V51, P487, DOI 10.1007/s10038-006-0377-6; Stechman MJ, 2010, LAB ANIM-UK, V44, P218, DOI 10.1258/la.2010.009128; Stubbs J, 2007, SEMIN DIALYSIS, V20, P302, DOI 10.1111/j.1525-139X.2007.00308.x; Ten Hagen KG, 2003, GLYCOBIOLOGY, V13, p1R, DOI 10.1093/glycob/cwg007; Topaz O, 2004, NAT GENET, V36, P579, DOI 10.1038/ng1358; Urakawa I, 2006, NATURE, V444, P770, DOI 10.1038/nature05315; Wang PF, 2008, MOL CELL BIOL, V28, P2930, DOI 10.1128/MCB.00654-07; Williams SE, 2009, HUM MOL GENET; Yancovitch A, 2011, J BONE MINER METAB	60	17	17	0	29	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 13	2012	7	8							e43205	10.1371/journal.pone.0043205	http://dx.doi.org/10.1371/journal.pone.0043205			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	988OJ	22912827	Green Submitted, Green Published, gold, Green Accepted			2022-12-25	WOS:000307500100071
J	Vinkers, CH; van Oorschot, R; Nielsen, EO; Cook, JM; Hansen, HH; Groenink, L; Olivier, B; Mirza, NR				Vinkers, Christiaan H.; van Oorschot, Ruud; Nielsen, Elsebet O.; Cook, James M.; Hansen, Henrik H.; Groenink, Lucianne; Olivier, Berend; Mirza, Naheed R.			GABA(A) Receptor alpha Subunits Differentially Contribute to Diazepam Tolerance after Chronic Treatment	PLOS ONE			English	Article							GAMMA-AMINOBUTYRIC-ACID; STRESS-INDUCED HYPERTHERMIA; MESSENGER-RNA LEVELS; ELEVATED PLUS-MAZE; IN-SITU; SELECTIVE AGONIST; EXPRESSION; MOUSE; ANXIETY; BENZODIAZEPINES	Background: Within the GABA(A)-receptor field, two important questions are what molecular mechanisms underlie benzodiazepine tolerance, and whether tolerance can be ascribed to certain GABA(A)-receptor subtypes. Methods: We investigated tolerance to acute anxiolytic, hypothermic and sedative effects of diazepam in mice exposed for 28-days to non-selective/selective GABA(A)-receptor positive allosteric modulators: diazepam (non-selective), bretazenil (partial non-selective), zolpidem (alpha(1) selective) and TPA023 (alpha(2/3) selective). In-vivo binding studies with [H-3]flumazenil confirmed compounds occupied CNS GABA(A) receptors. Results: Chronic diazepam treatment resulted in tolerance to diazepam's acute anxiolytic, hypothermic and sedative effects. In mice treated chronically with bretazenil, tolerance to diazepam's anxiolytic and hypothermic, but not sedative, effects was seen. Chronic zolpidem treatment resulted in tolerance to diazepam's hypothermic effect, but partial anxiolytic tolerance and no sedative tolerance. Chronic TPA023 treatment did not result in tolerance to diazepam's hypothermic, anxiolytic or sedative effects. Conclusions: Our data indicate that: (i) GABA(A)-alpha(2)/alpha(3) subtype selective drugs might not induce tolerance; (ii) in rodents quantitative and temporal variations in tolerance development occur dependent on the endpoint assessed, consistent with clinical experience with benzodiazepines (e. g., differential tolerance to antiepileptic and anxiolytic actions); (iii) tolerance to diazepam's sedative actions needs concomitant activation of GABA(A)-alpha(1)/GABA(A)-alpha(5) receptors. Regarding mechanism, in-situ hybridization studies indicated no gross changes in expression levels of GABA(A) alpha(1), alpha(2) or alpha(5) subunit mRNA in hippocampus or cortex. Since selective chronic activation of either GABA(A) alpha(2), or alpha(3) receptors does not engender tolerance development, subtype-selective GABA(A) drugs might constitute a promising class of novel drugs.	[Vinkers, Christiaan H.; van Oorschot, Ruud; Groenink, Lucianne; Olivier, Berend] Univ Utrecht, Div Pharmacol, Utrecht Inst Pharmaceut Sci, Utrecht, Netherlands; [Vinkers, Christiaan H.] Univ Med Ctr Utrecht, Rudolf Magnus Inst Neurosci, Dept Psychiat, Utrecht, Netherlands; [Nielsen, Elsebet O.; Hansen, Henrik H.; Mirza, Naheed R.] NeuroSearch AS, NsDiscovery, Ballerup, Denmark; [Cook, James M.] Univ Wisconsin, Dept Chem & Biochem, Milwaukee, WI 53201 USA; [Hansen, Henrik H.] Gubra ApS, Horsholm, Denmark; [Olivier, Berend] Yale Univ, Sch Med, Dept Psychiat, New Haven, CT USA; [Mirza, Naheed R.] Aniona ApS, Ballerup, Denmark	Utrecht University; Utrecht University; Utrecht University Medical Center; University of Wisconsin System; University of Wisconsin Milwaukee; Yale University	Vinkers, CH (corresponding author), Univ Utrecht, Div Pharmacol, Utrecht Inst Pharmaceut Sci, Utrecht, Netherlands.	c.h.vinkers@uu.nl	Groenink, Lucianne/O-6588-2016; Vinkers, Christiaan/AAV-1720-2020	Groenink, Lucianne/0000-0002-4971-7796; Vinkers, Christiaan/0000-0003-3698-0744	National Institute for Mental Health [MH-046851]; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH046851] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS076517] Funding Source: NIH RePORTER	National Institute for Mental Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This work was supported in part by MH-046851 (National Institute for Mental Health) (JMC). No additional external funding was received for this study. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ali NJ, 2001, J NEUROCHEM, V79, P1100, DOI 10.1046/j.1471-4159.2001.00664.x; Allison C, 2006, NEUROPSYCHOPHARMACOL, V31, P602, DOI 10.1038/sj.npp.1300800; Arnot MI, 2001, J NEUROSCI RES, V64, P617, DOI 10.1002/jnr.1115.abs; Atack JR, 2009, ADV PHARMACOL, V57, P137, DOI 10.1016/S1054-3589(08)57004-9; Atack JR, 2006, J PHARMACOL EXP THER, V316, P410, DOI 10.1124/jpet.105.089920; Atack JR, 1999, NEUROPSYCHOPHARMACOL, V20, P255, DOI 10.1016/S0893-133X(98)00052-9; Ator NA, 2010, J PHARMACOL EXP THER, V332, P4, DOI 10.1124/jpet.109.158303; Auta J, 2008, NEUROPHARMACOLOGY, V55, P148, DOI 10.1016/j.neuropharm.2008.05.002; Bateson AN, 2002, CURR PHARM DESIGN, V8, P5, DOI 10.2174/1381612023396681; Bosman LWJ, 2002, J PHYSIOL-LONDON, V545, P169, DOI 10.1113/jphysiol.2002.026534; Bouwknecht J. Adriaan, 2002, Behavioural Brain Research, V136, P489, DOI 10.1016/S0166-4328(02)00200-0; Bouwknecht JA, 2004, EUR J PHARMACOL, V494, P35, DOI 10.1016/j.ejphar.2004.04.036; Carling RW, 2005, J MED CHEM, V48, P7089, DOI 10.1021/jm058034a; de Hass SL, 2007, J PSYCHOPHARMACOL, V21, P374, DOI 10.1177/0269881106072343; Di Lio A, 2011, NEUROPHARMACOLOGY, V60, P626, DOI 10.1016/j.neuropharm.2010.11.026; Fahey JM, 2006, BRAIN RES, V1118, P13, DOI 10.1016/j.brainres.2006.08.017; Fahey JM, 1999, J PSYCHOPHARMACOL, V13, P211, DOI 10.1177/026988119901300301; Gill KM, 2011, NEUROPSYCHOPHARMACOL, V36, P1903, DOI 10.1038/npp.2011.76; Groenink L, 2009, CURRENT PROTOCOLS PH, VS45, P51611; HAEFELY W, 1990, TRENDS PHARMACOL SCI, V11, P452, DOI 10.1016/0165-6147(90)90126-S; Heldt SA, 2007, NEUROSCIENCE, V150, P370, DOI 10.1016/j.neuroscience.2007.09.008; HENINGER C, 1990, J MOL NEUROSCI, V2, P101, DOI 10.1007/BF02876917; Holmes A, 2003, EUR J PHARMACOL, V459, P221, DOI 10.1016/S0014-2999(02)02874-1; Holt RA, 1997, EUR J PHARMACOL, V329, P129, DOI 10.1016/S0014-2999(97)00168-4; Huopaniemi L, 2004, J NEUROCHEM, V88, P1059, DOI 10.1046/j.1471-4159.2003.02216.x; Hutchinson MA, 1996, PROG NEUROBIOL, V49, P73, DOI 10.1016/S0301-0082(96)00011-1; Impagnatiello F, 1996, MOL PHARMACOL, V49, P822; KANG I, 1991, BRIT J PHARMACOL, V103, P1285, DOI 10.1111/j.1476-5381.1991.tb09781.x; Knabl J, 2008, NATURE, V451, P330, DOI 10.1038/nature06493; LARSEN PJ, 1993, J NEUROSCI, V13, P1138; McKernan RM, 2000, NAT NEUROSCI, V3, P587, DOI 10.1038/75761; Mirza NR, 2010, DRUG NEWS PERSPECT, V23, P351, DOI 10.1358/dnp.2010.23.6.1489909; Mirza NR, 2006, J PHARMACOL EXP THER, V316, P1378, DOI 10.1124/jpet.105.094474; Mirza NR, 2006, J PHARMACOL EXP THER, V316, P1291, DOI 10.1124/jpet.105.094003; Paxinos G, 2004, MOUSE BRAIN STEREOTA; PERSOHN E, 1992, J COMP NEUROL, V326, P193, DOI 10.1002/cne.903260204; Pesold C, 1997, NEUROSCIENCE, V79, P477, DOI 10.1016/S0306-4522(96)00609-4; Primus RJ, 1996, J PHARMACOL EXP THER, V276, P882; PUIA G, 1992, P NATL ACAD SCI USA, V89, P3620, DOI 10.1073/pnas.89.8.3620; RamseyWilliams VA, 1996, MOL BRAIN RES, V43, P132, DOI 10.1016/S0169-328X(96)00166-0; Reagan-Shaw S, 2008, FASEB J, V22, P659, DOI 10.1096/fj.07-9574LSF; RODGERS RJ, 1993, PSYCHOPHARMACOLOGY, V113, P237, DOI 10.1007/BF02245704; Rowlett JK, 2005, P NATL ACAD SCI USA, V102, P915, DOI 10.1073/pnas.0405621102; Rudolph U, 2004, ANNU REV PHARMACOL, V44, P475, DOI 10.1146/annurev.pharmtox.44.101802.121429; Rudolph U, 2006, CURR OPIN PHARMACOL, V6, P18, DOI 10.1016/j.coph.2005.10.003; Rudolph U, 1999, NATURE, V401, P796, DOI 10.1038/44579; Sanger DJ, 1999, PHARMACOL BIOCHEM BE, V64, P269, DOI 10.1016/S0091-3057(99)00081-7; Savic MM, 2008, NEUROPSYCHOPHARMACOL, V33, P332, DOI 10.1038/sj.npp.1301403; Sieghart W., 2002, Current Topics in Medicinal Chemistry, V2, P795, DOI 10.2174/1568026023393507; SIEGHART W, 1995, PHARMACOL REV, V47, P181; Tietz EI, 1999, NEUROSCIENCE, V91, P327, DOI 10.1016/S0306-4522(98)00516-8; TIETZ EI, 1993, J MOL NEUROSCI, V4, P277, DOI 10.1007/BF02821559; Uusi-Oukari M, 2010, PHARMACOL REV, V62, P97, DOI 10.1124/pr.109.002063; van Rijnsoever C, 2004, J NEUROSCI, V24, P6785, DOI 10.1523/JNEUROSCI.1067-04.2004; VanderHeyden JAM, 1997, PHYSIOL BEHAV, V62, P463, DOI 10.1016/S0031-9384(97)00157-1; Vinkers CH, 2010, OPEN PHARM J, V4, P1; Vinkers CH, 2008, EUR J PHARMACOL, V585, P407, DOI 10.1016/j.ejphar.2008.02.097; Vinkers CH, 2012, ADV PHARMACOL SCI, V2012, DOI 10.1155/2012/416864; Vinkers CH, 2010, PSYCHOPHARMACOLOGY, V211, P123, DOI 10.1007/s00213-010-1895-7; Vinkers CH, 2009, PSYCHOPHARMACOLOGY, V204, P299, DOI 10.1007/s00213-009-1460-4; Wafford KA, 2005, CURR OPIN PHARMACOL, V5, P47, DOI 10.1016/j.coph.2004.08.006; WU YX, 1994, J MOL NEUROSCI, V5, P105, DOI 10.1007/BF02736752; ZHAO TJ, 1994, MOL PHARMACOL, V45, P657	63	26	26	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 13	2012	7	8							e43054	10.1371/journal.pone.0043054	http://dx.doi.org/10.1371/journal.pone.0043054			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	988OJ	22912786	Green Published, Green Submitted, gold			2022-12-25	WOS:000307500100058
J	Wang, SH; Yuan, Y; Xia, WQ; Li, FF; Huang, Y; Zhou, Y; Guo, YJ				Wang, Shaohua; Yuan, Yang; Xia, Wenqing; Li, Fengfei; Huang, Yan; Zhou, Yi; Guo, Yijing			Neuronal Apoptosis and Synaptic Density in the Dentate Gyrus of Ischemic Rats' Response to Chronic Mild Stress and the Effects of Notch Signaling	PLOS ONE			English	Article							FOCAL CEREBRAL-ISCHEMIA; HIPPOCAMPAL NEUROGENESIS; ADULT NEUROGENESIS; GRANULE CELLS; EXPRESSION; PROTEOLYSIS; DEPRESSION; PLASTICITY; BRAIN; MODEL	Our previous research highlighted an inconsistency with Notch1 signaling-related compensatory neurogenesis after chronic mild stress (CMS) in rodents suffering from cerebral ischemia, which continue to display post-stroke depressive symptoms. Here, we hypothesize that CMS aggrandized ischemia-related apoptosis injury and worsened synaptic integrity via gamma secretase-meditated Notch1 signaling. Adult rats were exposed to a CMS paradigm after left middle cerebral artery occlusion (MCAO). Open-field and sucrose consumption testing were employed to assess depression-like behavior. Gene expression of pro-apoptotic Bax, anti-apoptotic Bcl-2, and synaptic density-related synaptophysin were measured by western blotting and real-time PCR on Day 28 after MCAO surgery. CMS induced depressive behaviors in ischemic rats, which was accompanied by an elevation in Bax/bcl-2 ratio, TUNEL staining in neurons and reduced synaptophysin expression in the dentate gyrus. These collective effects were reversed by the gamma-secretase inhibitor DAPT (N-[N-(3,5-difluorophenacetyl-L-alanyl)]-S-phenyl-glycine t-butyl ester). We found that post-stroke stressors made neurons in the dentate gyrus vulnerable to apoptosis, which supports a putative role for Notch signaling in neural integrity, potentially in newborn cells' synaptic deficit with regard to preexisting cells. These findings suggest that post-stroke depression therapeutically benefits from blocking gamma secretase mediated Notch signaling, and whether this signaling pathway could be a therapeutic target needs to be further investigated.	[Wang, Shaohua; Yuan, Yang; Xia, Wenqing; Li, Fengfei; Huang, Yan; Zhou, Yi] Southeast Univ, Affiliated ZhongDa Hosp, Dept Endocrinol, Nanjing, Jiangsu, Peoples R China; [Guo, Yijing] Southeast Univ, Affiliated ZhongDa Hosp, Dept Neurol, Nanjing, Jiangsu, Peoples R China	Southeast University - China; Southeast University - China	Guo, YJ (corresponding author), Southeast Univ, Affiliated ZhongDa Hosp, Dept Neurol, Nanjing, Jiangsu, Peoples R China.	janegyj@yahoo.com.cn			National Nature Science Foundation of China [30870870, 81070638, 81070916]; Nature Science Foundation of JiangSu Province [BK2011601]; Social Development Project of JiangSu Province [SBE201170735]	National Nature Science Foundation of China(National Natural Science Foundation of China (NSFC)); Nature Science Foundation of JiangSu Province(Natural Science Foundation of Jiangsu Province); Social Development Project of JiangSu Province	This work was partially supported by the National Nature Science Foundation of China (No. 30870870, Wang SH), (No. 81070638, Wang SH) and (No. 81070916, Guo YJ). We would like to express our heartfelt gratitude to the staff of the Department of Neurology, Medical School of Southeast University, for their valuable assistance.; This work was partially supported by the foundations shown as follows: the National Nature Science Foundation of China (No. 30870870, SH Wang), (No. 81070638, SH Wang) and (No. 81070916, YJ Guo), Nature Science Foundation of JiangSu Province (No. BK2011601, Y Yuan), Social Development Project of JiangSu Province (No. SBE201170735, SH Wang). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abrous DN, 2005, PHYSIOL REV, V85, P523, DOI 10.1152/physrev.00055.2003; Adams JM, 1998, SCIENCE, V281, P1322, DOI 10.1126/science.281.5381.1322; Barinaga M, 1998, SCIENCE, V281, P1302, DOI 10.1126/science.281.5381.1302; Bercovich B, 1997, J BIOL CHEM, V272, P9002; Cameron HA, 2001, J COMP NEUROL, V435, P406, DOI 10.1002/cne.1040; Carlen M, 2002, CURR BIOL, V12, P606, DOI 10.1016/S0960-9822(02)00771-6; Choi DW, 1996, CURR OPIN NEUROBIOL, V6, P667, DOI 10.1016/S0959-4388(96)80101-2; Costa RM, 2005, TRENDS NEUROSCI, V28, P429, DOI 10.1016/j.tins.2005.05.003; Dranovsky A, 2006, BIOL PSYCHIAT, V59, P1136, DOI 10.1016/j.biopsych.2006.03.082; Gainotti G, 2003, BRAIN, V126, P792, DOI 10.1093/brain/awg092; Gainotti G, 1999, BRIT J PSYCHIAT, V175, P163, DOI 10.1192/bjp.175.2.163; Guo YJ, 2009, PROG NEURO-PSYCHOPH, V33, P688, DOI 10.1016/j.pnpbp.2009.03.022; Hama S, 2011, PSYCHOGERIATRICS, V11, P68, DOI 10.1111/j.1479-8301.2011.00358.x; Hastings NB, 1999, J COMP NEUROL, V413, P146, DOI 10.1002/(SICI)1096-9861(19991011)413:1<146::AID-CNE10>3.0.CO;2-B; House A, 1996, J NEUROPSYCH CLIN N, V8, P453; Jacobs BL, 2000, MOL PSYCHIATR, V5, P262, DOI 10.1038/sj.mp.4000712; Jin KL, 2001, P NATL ACAD SCI USA, V98, P4710, DOI 10.1073/pnas.081011098; KAPLAN MS, 1977, SCIENCE, V197, P1092, DOI 10.1126/science.887941; Kempermann G, 2003, BIOL PSYCHIAT, V54, P499, DOI 10.1016/S0006-3223(03)00319-6; Kuida K, 1996, NATURE, V384, P368, DOI 10.1038/384368a0; Liu JL, 1998, J NEUROSCI, V18, P7768; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Lledo PM, 2006, NAT REV NEUROSCI, V7, P179, DOI 10.1038/nrn1867; LONGA EZ, 1989, STROKE, V20, P84, DOI 10.1161/01.STR.20.1.84; MacManus JP, 1997, J CEREBR BLOOD F MET, V17, P815, DOI 10.1038/aj.jcbfm.9590266; Markakis EA, 1999, J COMP NEUROL, V406, P449; Renolleau S, 1998, STROKE, V29, P1454, DOI 10.1161/01.STR.29.7.1454; Santarelli L, 2003, SCIENCE, V301, P805, DOI 10.1126/science.1083328; Selkoe D, 2003, ANNU REV NEUROSCI, V26, P565, DOI 10.1146/annurev.neuro.26.041002.131334; SLOVITER RS, 1993, J COMP NEUROL, V330, P324, DOI 10.1002/cne.903300304; STANFIELD BB, 1988, EXP BRAIN RES, V72, P399; Stroemer RP, 1998, J CEREBR BLOOD F MET, V18, P833, DOI 10.1097/00004647-199808000-00003; Villa PG, 1998, J CELL SCI, V111, P713; Wang S, 2000, J NEUROBIOL, V42, P248, DOI 10.1002/(SICI)1097-4695(20000205)42:2<248::AID-NEU8>3.3.CO;2-A; Wang SH, 2009, J PSYCHOPHARMACOL, V23, P295, DOI 10.1177/0269881108089814; Wang SH, 2008, BEHAV BRAIN RES, V189, P9, DOI 10.1016/j.bbr.2007.11.028; WOOLLEY CS, 1991, BRAIN RES, V554, P312, DOI 10.1016/0006-8993(91)90207-C; Yoon K, 2005, NAT NEUROSCI, V8, P709, DOI 10.1038/nn1475; Zhu DY, 2003, J NEUROSCI, V23, P223	39	30	34	0	22	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 9	2012	7	8							e42828	10.1371/journal.pone.0042828	http://dx.doi.org/10.1371/journal.pone.0042828			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	986WZ	22912748	gold, Green Published, Green Submitted			2022-12-25	WOS:000307378500029
J	Feine, I; Pinkas, I; Salomon, Y; Scherz, A				Feine, Ilan; Pinkas, Iddo; Salomon, Yoram; Scherz, Avigdor			Local Oxidative Stress Expansion through Endothelial Cells - A Key Role for Gap Junction Intercellular Communication	PLOS ONE			English	Article							REACTIVE OXYGEN; NITRIC-OXIDE; CONNEXIN43 EXPRESSION; PHOTODYNAMIC THERAPY; HYDROGEN-PEROXIDE; DEATH; PROPAGATION; APOPTOSIS; RESPONSES; PEROXYNITRITE	Background: Major circulation pathologies are initiated by oxidative insult expansion from a few injured endothelial cells to distal sites; this possibly involves mechanisms that are important to understanding circulation physiology and designing therapeutic management of myocardial pathologies. We tested the hypothesis that a localized oxidative insult of endothelial cells (ECs) propagates through gap junction inter-cellular communication (GJIC). Methodology/Principal Findings: Cultures comprising the bEnd.3 cell line, that have been established and recognized as suitable for examining communication among ECs, were used to study the propagation of a localized oxidative insult to remote cells. Spatially confined near infrared illumination of parental or genetically modified bEnd.3 cultures, pretreated with the photosensitizer WST11, generated O-2 center dot(-) and center dot OH radicals in the illuminated cells. Time-lapse fluorescence microscopy, utilizing various markers, and other methods, were used to monitor the response of non-illuminated bystander and remote cells. Functional GJIC among ECs was shown to be mandatory for oxidative insult propagation, comprising denovo generation of reactive oxygen and nitrogen species (ROS and RNS, respectively), activation and nuclear translocation of c-Jun N-terminal kinase, followed by massive apoptosis in all bystander cells adjacent to the primarily injured ECs. The oxidative insult propagated through GJIC for many hours, over hundreds of microns from the primary photogeneration site. This wave is shown to be limited by intracellular ROS scavenging, chemical GJIC inhibition or genetic manipulation of connexin 43 (a key component of GJIC). Conclusion/Significance: Localized oxidative insults propagate through GJIC between ECs, while stimulating de-novo generation of ROS and RNS in bystander cells, thereby driving the insult's expansion.	[Feine, Ilan; Scherz, Avigdor] Weizmann Inst Sci, Dept Plant Sci, IL-76100 Rehovot, Israel; [Feine, Ilan; Salomon, Yoram] Weizmann Inst Sci, Dept Regulat Biol, IL-76100 Rehovot, Israel; [Pinkas, Iddo] Weizmann Inst Sci, Dept Chem Res Support, IL-76100 Rehovot, Israel	Weizmann Institute of Science; Weizmann Institute of Science; Weizmann Institute of Science	Feine, I (corresponding author), Weizmann Inst Sci, Dept Plant Sci, IL-76100 Rehovot, Israel.	Avigdor.Scherz@weizmann.ac.il	Pinkas, Iddo/I-7970-2019	Pinkas, Iddo/0000-0001-7434-9844	The Susan Komen Foundation for the Cure [BCTR0707388]; Women's Health Research Center", Weizmann Institute of Science	The Susan Komen Foundation for the Cure; Women's Health Research Center", Weizmann Institute of Science	This research is funded by grant # BCTR0707388 from 'The Susan Komen Foundation for the Cure', a non-profit organization and the "Women's Health Research Center", Weizmann Institute of Science. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abramoff MD, 2004, BIOPHOTONICS INT, V11, P36, DOI DOI 10.1117/1.3589100; Aikawa R, 1997, J CLIN INVEST, V100, P1813, DOI 10.1172/JCI119709; Ashur I, 2009, J PHYS CHEM A, V113, P8027, DOI 10.1021/jp900580e; Azzam EI, 2003, ONCOGENE, V22, P7050, DOI 10.1038/sj.onc.1206961; Bagher P, 2011, ACTA PHYSIOL, V202, P271, DOI 10.1111/j.1748-1716.2010.02244.x; Banaz-Yasar F, 2005, CELL COMMUN ADHES, V12, P249, DOI 10.1080/15419060500514101; Belousov VV, 2006, NAT METHODS, V3, P281, DOI 10.1038/NMETH866; Bogdan C, 2000, CURR OPIN IMMUNOL, V12, P64, DOI 10.1016/S0952-7915(99)00052-7; Brandis A, 2005, PHOTOCHEM PHOTOBIOL, V81, P983, DOI 10.1562/2004-12-01-RA-389R1.1; Cai H, 2000, CIRC RES, V87, P840, DOI 10.1161/01.RES.87.10.840; Cai H, 2005, CIRC RES, V96, P818, DOI 10.1161/01.RES.0000163631.07205.fb; Carpenter AE, 2006, GENOME BIOL, V7, DOI 10.1186/gb-2006-7-10-r100; Chakraborty A, 2009, RADIAT RES, V172, P74, DOI 10.1667/RR1669.1; De Maio A, 2002, J CELL PHYSIOL, V191, P269, DOI 10.1002/jcp.10108; Decrock E, 2009, CELL DEATH DIFFER, V16, P524, DOI 10.1038/cdd.2008.196; Decrock E, 2009, CELL DEATH DIFFER, V16, P151, DOI 10.1038/cdd.2008.138; Dou L, 2007, J THROMB HAEMOST, V5, P1302, DOI 10.1111/j.1538-7836.2007.02540.x; Figueroa XF, 2009, ANTIOXID REDOX SIGN, V11, P251, DOI 10.1089/ars.2008.2117; Forman LJ, 1998, NEUROCHEM RES, V23, P141, DOI 10.1023/A:1022468522564; Fuks Z, 2005, CANCER CELL, V8, P89, DOI 10.1016/j.ccr.2005.07.014; Garcia-Dorado D, 2004, CARDIOVASC RES, V61, P386, DOI 10.1016/j.cardiores.2003.11.039; Garcia-Dorado D, 2000, NEWS PHYSIOL SCI, V15, P326; GARLANDA C, 1994, P NATL ACAD SCI USA, V91, P7291, DOI 10.1073/pnas.91.15.7291; Gatti R, 1998, J HISTOCHEM CYTOCHEM, V46, P895, DOI 10.1177/002215549804600804; Goldberg GS, 1998, EXP CELL RES, V239, P82, DOI 10.1006/excr.1997.3872; GOTTLIEB RA, 1994, J CLIN INVEST, V94, P1621, DOI 10.1172/JCI117504; Gross S, 2003, NAT MED, V9, P1327, DOI 10.1038/nm940; Hammond S, 2011, EUR J PHARMACOL, V668, P225, DOI 10.1016/j.ejphar.2011.06.050; Hensley K, 2000, FREE RADICAL BIO MED, V28, P1456, DOI 10.1016/S0891-5849(00)00252-5; Higgins GC, 2010, J ALZHEIMERS DIS, V20, pS453, DOI 10.3233/JAD-2010-100321; Hunter AW, 2005, MOL BIOL CELL, V16, P5686, DOI 10.1091/mbc.E05-08-0737; Irani K, 2000, CIRC RES, V87, P179, DOI 10.1161/01.RES.87.3.179; Kamata H, 2005, CELL, V120, P649, DOI 10.1016/j.cell.2004.12.041; Kavdia M, 2006, ANTIOXID REDOX SIGN, V8, P1103, DOI 10.1089/ars.2006.8.1103; Kojda G, 1999, CARDIOVASC RES, V42, P206, DOI 10.1016/S0008-6363(98)00315-0; Kwak BR, 2005, CELL COMMUN ADHES, V12, P261, DOI 10.1080/15419060500514119; Kwak BR, 2001, MOL BIOL CELL, V12, P831, DOI 10.1091/mbc.12.4.831; Lin JHC, 1998, NAT NEUROSCI, V1, P494, DOI 10.1038/2210; Lyon AR, 2010, J MOL CELL CARDIOL, V49, P565, DOI 10.1016/j.yjmcc.2010.07.002; Madamanchi NR, 2005, ARTERIOSCL THROM VAS, V25, P950, DOI 10.1161/01.ATV.0000161050.77646.68; Mao XL, 2004, ONCOGENE, V23, P5632, DOI 10.1038/sj.onc.1207756; Matsumura T, 1997, J IMMUNOL, V158, P3408; Mayer M, 2010, NATURE, V467, P617, DOI 10.1038/nature09376; McLaughlin R, 2001, IRISH J MED SCI, V170, P132, DOI 10.1007/BF03168827; Meems H, 2009, BLOOD, V114, P3938, DOI 10.1182/blood-2009-01-197707; Mesnil M, 2000, CANCER RES, V60, P3989; Miller G, 2009, SCI SIGNAL, V2, DOI 10.1126/scisignal.2000448; MONTESANO R, 1990, CELL, V62, P435, DOI 10.1016/0092-8674(90)90009-4; Morre DM, 2000, J EXP BIOL, V203, P1513; Mulders ACM, 2006, ARTERIOSCL THROM VAS, V26, P2043, DOI 10.1161/01.ATV.0000237569.95046.b9; Myhre O, 2003, BIOCHEM PHARMACOL, V65, P1575, DOI 10.1016/S0006-2952(03)00083-2; Opal SM, 2000, CRIT CARE MED, V28, pS77, DOI 10.1097/00003246-200009001-00017; Pacher P, 2007, PHYSIOL REV, V87, P315, DOI 10.1152/physrev.00029.2006; Papaharalambus CA, 2007, TRENDS CARDIOVAS MED, V17, P48, DOI 10.1016/j.tcm.2006.11.005; Parola M, 1998, J CLIN INVEST, V102, P1942, DOI 10.1172/JCI1413; Pepper MS, 1997, TUMOUR ANGIOGENESIS, P309; Pimentel DR, 2001, CIRC RES, V89, P453, DOI 10.1161/hh1701.096615; Posen Y, 2005, J CELL SCI, V118, P1957, DOI 10.1242/jcs.02323; Pries AR, 2010, NAT REV CANCER, V10, P587, DOI 10.1038/nrc2895; Ravichandran KS, 2010, J EXP MED, V207, P1807, DOI 10.1084/jem.20101157; Rozental R, 2001, METH MOL B, V154, P447; Rubio N, 2009, PHOTOCH PHOTOBIO SCI, V8, P457, DOI 10.1039/b815343d; Ruiz-Gines JA, 2000, J CARDIOVASC PHARM, V35, P109, DOI 10.1097/00005344-200001000-00014; SAEZ JC, 1989, P NATL ACAD SCI USA, V86, P2708, DOI 10.1073/pnas.86.8.2708; Savill J, 2000, NATURE, V407, P784, DOI 10.1038/35037722; Shaul Yoav D, 2004, Methods Mol Biol, V250, P113; Shen HM, 2006, FREE RADICAL BIO MED, V40, P928, DOI 10.1016/j.freeradbiomed.2005.10.056; Simon HU, 2000, APOPTOSIS, V5, P415, DOI 10.1023/A:1009616228304; Touyz RM, 2004, HISTOCHEM CELL BIOL, V122, P339, DOI 10.1007/s00418-004-0696-7; Trosko JE, 2000, METHODS, V20, P245, DOI 10.1006/meth.1999.0941; Wardman P, 2007, FREE RADICAL BIO MED, V43, P995, DOI 10.1016/j.freeradbiomed.2007.06.026; Wolfle SE, 2009, CARDIOVASC RES, V82, P476, DOI 10.1093/cvr/cvp060; Wong HL, 2009, SCI SIGNAL, V2, DOI 10.1126/scisignal.290pe60; Yakes FM, 1997, P NATL ACAD SCI USA, V94, P514, DOI 10.1073/pnas.94.2.514; Zitvogel L, 2010, CELL, V140, P798, DOI 10.1016/j.cell.2010.02.015	75	33	36	0	23	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 23	2012	7	7							e41633	10.1371/journal.pone.0041633	http://dx.doi.org/10.1371/journal.pone.0041633			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	977TM	22911831	gold, Green Published, Green Submitted			2022-12-25	WOS:000306687700130
J	Kim, ST; Adair-Kirk, TL; Senior, RM; Miner, JH				Kim, Sung Tae; Adair-Kirk, Tracy L.; Senior, Robert M.; Miner, Jeffrey H.			Functional Consequences of Cell Type-Restricted Expression of Laminin alpha 5 in Mouse Placental Labyrinth and Kidney Glomerular Capillaries	PLOS ONE			English	Article							MUTANT MICE; BASEMENT-MEMBRANE; CHAIN; MORPHOGENESIS; LAMININ-ALPHA-5; ABNORMALITIES; LOCALIZATION; MATURATION; MIGRATION; DELETION	The labyrinth is the highly vascularized part of the rodent placenta that allows efficient transfer of gases, nutrients, wastes, and other molecules between the maternal and embryonic circulations. These two blood compartments are separated by blastocyst-derived trophoblasts and endothelial cells with an intervening basement membrane that contains laminin and other typical basement membrane components. Previously we reported that the labyrinth of laminin alpha 5 knockout (LM alpha 5-/-) embryos exhibits reduced vascularization and detachment of endothelial cells from the basement membrane, which normally contains LM alpha 5. As very little is known about the origin of this vascular basement membrane, we investigated the cellular requirements for LM alpha 5 expression in the mouse placental labyrinth. By fluorescence-activated cell sorting and RTPCR we confirmed that both endothelial cells and trophoblasts normally express LM alpha 5. Using Cre-loxP technology and doxycycline-mediated gene expression, we generated genetically mosaic placentas in which either the trophoblasts or the endothelial cells, but not both, expressed LM alpha 5. We found that the overall architecture of the labyrinth was normal as long as one of these two cell types expressed LM alpha 5, even if it was transgene-derived human laminin alpha 5. These results suggest that laminin trimers containing alpha 5 that are synthesized and secreted by endothelium or by trophoblasts are capable of integrating into the basement membrane and promoting normal vascularization of the placenta. Additional studies showed that endothelium-expressed human LM alpha 5 can support vascularization of the kidney glomerulus, consistent with previous studies using a tissue grafting approach.	[Kim, Sung Tae; Miner, Jeffrey H.] Washington Univ, Sch Med, Div Renal, St Louis, MO 63110 USA; [Adair-Kirk, Tracy L.; Senior, Robert M.] Washington Univ, Sch Med, Div Pulm & Crit Care Med, St Louis, MO 63110 USA; [Senior, Robert M.; Miner, Jeffrey H.] Washington Univ, Sch Med, Dept Cell Biol & Physiol, St Louis, MO 63110 USA	Washington University (WUSTL); Washington University (WUSTL); Washington University (WUSTL)	Kim, ST (corresponding author), Washington Univ, Sch Med, Div Renal, St Louis, MO 63110 USA.	minerj@wustl.edu			National Institutes of Health [R01GM060432, R01DK078314, P01HL029594]; Washington University George M. O'Brien Center for Kidney Disease Research [NIH P30DK079333]; Washington University Department of Otolaryngology, Research Center for Auditory and Visual Studies [NIH P30DC004665]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [P01HL029594] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P30DK079333, R01DK078314] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM060432] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS [P30DC004665] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Washington University George M. O'Brien Center for Kidney Disease Research; Washington University Department of Otolaryngology, Research Center for Auditory and Visual Studies; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD))	These studies were supported by grants from the National Institutes of Health (R01GM060432 and R01DK078314 to JHM; P01HL029594 to RMS). Imaging and transgenic mouse studies were supported by the Washington University George M. O'Brien Center for Kidney Disease Research (NIH P30DK079333) and by the Washington University Department of Otolaryngology, Research Center for Auditory and Visual Studies (NIH P30DC004665). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abrahamson DR, 2007, J AM SOC NEPHROL, V18, P2285, DOI 10.1681/ASN.2007020207; Belteki G, 2005, NUCLEIC ACIDS RES, V33, DOI 10.1093/nar/gni051; Carter AM, 2007, PLACENTA, V28, pS41, DOI 10.1016/j.placenta.2006.11.002; Coles EG, 2006, DEV BIOL, V289, P218, DOI 10.1016/j.ydbio.2005.10.031; ENGVALL E, 1986, J CELL BIOL, V103, P2457, DOI 10.1083/jcb.103.6.2457; Fukumoto S, 2006, J BIOL CHEM, V281, P5008, DOI 10.1074/jbc.M509295200; Gao J, 2008, GENE DEV, V22, P2111, DOI 10.1101/gad.1689908; Goldberg S, 2010, J AM SOC NEPHROL, V21, P579, DOI 10.1681/ASN.2009091004; Hallmann R, 2005, PHYSIOL REV, V85, P979, DOI 10.1152/physrev.00014.2004; Hayashi S, 2002, MECH DEVELOP, V119, pS97, DOI 10.1016/S0925-4773(03)00099-6; Jarad G, 2006, J CLIN INVEST, V116, P2272, DOI 10.1172/JCI28414; Kikkawa Y, 2006, DEV BIOL, V296, P265, DOI 10.1016/j.ydbio.2006.04.463; Koni PA, 2001, J EXP MED, V193, P741, DOI 10.1084/jem.193.6.741; Korhonen M, 2001, J HISTOCHEM CYTOCHEM, V49, P313, DOI 10.1177/002215540104900305; Mahoney ZX, 2008, J CELL SCI, V121, P2493, DOI 10.1242/jcs.025528; Miner JH, 2006, DEVELOPMENT, V133, P967, DOI 10.1242/dev.02270; Miner JH, 2004, ANNU REV CELL DEV BI, V20, P255, DOI 10.1146/annurev.cellbio.20.010403.094555; MINER JH, 1995, J BIOL CHEM, V270, P28523, DOI 10.1074/jbc.270.48.28523; Miner JH, 2000, DEV BIOL, V217, P278, DOI 10.1006/dbio.1999.9546; Miner JH, 1997, J CELL BIOL, V137, P685, DOI 10.1083/jcb.137.3.685; Miner JH, 1998, J CELL BIOL, V143, P1713, DOI 10.1083/jcb.143.6.1713; Miyagoe Y, 1997, FEBS LETT, V415, P33, DOI 10.1016/S0014-5793(97)01007-7; Nguyen NM, 2002, DEV BIOL, V246, P231, DOI 10.1006/dbio.2002.0658; Nguyet NM, 2005, DEV BIOL, V282, P111, DOI 10.1016/j.ydbio.2005.02.031; NOAKES PG, 1995, NATURE, V374, P258, DOI 10.1038/374258a0; Patton BL, 1997, J CELL BIOL, V139, P1507, DOI 10.1083/jcb.139.6.1507; Rebustini IT, 2007, DEV BIOL, V308, P15, DOI 10.1016/j.ydbio.2007.04.031; Shaut CAE, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000073; Simmons DG, 2008, DEVELOPMENT, V135, P2083, DOI 10.1242/dev.020099; St John PL, 2001, KIDNEY INT, V60, P1037, DOI 10.1046/j.1523-1755.2001.0600031037.x; Steenhard BM, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023926; Thyboll J, 2002, MOL CELL BIOL, V22, P1194, DOI 10.1128/MCB.22.4.1194-1202.2002; Tiger CF, 1997, J BIOL CHEM, V272, P28590, DOI 10.1074/jbc.272.45.28590; Wang JM, 2006, J BIOL CHEM, V281, P213, DOI 10.1074/jbc.M505061200; Watson ED, 2005, PHYSIOLOGY, V20, P180, DOI 10.1152/physiol.00001.2005; Wulff C, 2003, REPRODUCTION, V126, P569, DOI 10.1530/rep.0.1260569	36	11	11	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 20	2012	7	7							e41348	10.1371/journal.pone.0041348	http://dx.doi.org/10.1371/journal.pone.0041348			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	977GL	22911783	Green Published, gold, Green Submitted			2022-12-25	WOS:000306644600073
J	Whiston, E; Wise, HZ; Sharpton, TJ; Jui, G; Cole, GT; Taylor, JW				Whiston, Emily; Wise, Hua Zhang; Sharpton, Thomas J.; Jui, Ginger; Cole, Garry T.; Taylor, John W.			Comparative Transcriptomics of the Saprobic and Parasitic Growth Phases in Coccidioides pp	PLOS ONE			English	Article							HISTOPLASMA-CAPSULATUM; FUNGAL PATHOGEN; POSADASII CONTRIBUTES; CANDIDA-ALBICANS; IMMITIS; VIRULENCE; GENE; EXPRESSION; PROTEIN; ALPHA-(1,3)-GLUCAN	Coccidioides immitis and C. posadasii, the causative agents of coccidioidomycosis, are dimorphic fungal pathogens, which grow as hyphae in the saprobic phase in the environment and as spherules in the parasitic phase in the mammalian host. In this study, we use comparative transcriptomics to identify gene expression differences between the saprobic and parasitic growth phases. We prepared Illumina mRNA sequencing libraries for saprobic-phase hyphae and parasitic-phase spherules in vitro for C. immitis isolate RS and C. posadasii isolate C735 in biological triplicate. Of 9,910 total predicted genes in Coccidioides, we observed 1,298 genes up-regulated in the saprobic phase of both C. immitis and C. posadasii and 1,880 genes up-regulated in the parasitic phase of both species. Comparing the saprobic and parasitic growth phases, we observed considerable differential expression of cell surface-associated genes, particularly chitin-related genes. We also observed differential expression of several virulence factors previously identified in Coccidioides and other dimorphic fungal pathogens. These included alpha (1,3) glucan synthase, SOWgp, and several genes in the urease pathway. Furthermore, we observed differential expression in many genes predicted to be under positive selection in two recent Coccidioides comparative genomics studies. These results highlight a number of genes that may be crucial to dimorphic phase-switching and virulence in Coccidioides. These observations will impact priorities for future genetics-based studies in Coccidioides and provide context for studies in other fungal pathogens.	[Whiston, Emily; Jui, Ginger; Taylor, John W.] Univ Calif Berkeley, Dept Plant & Microbial Biol, Berkeley, CA 94720 USA; [Wise, Hua Zhang; Cole, Garry T.] Univ Texas San Antonio, Dept Biol, San Antonio, TX USA; [Sharpton, Thomas J.] Univ Calif San Francisco, J David Gladstone Inst, San Francisco, CA 94143 USA	University of California System; University of California Berkeley; University of Texas System; University of Texas at San Antonio (UTSA); University of California System; University of California San Francisco; The J David Gladstone Institutes	Whiston, E (corresponding author), Univ Calif Berkeley, Dept Plant & Microbial Biol, Berkeley, CA 94720 USA.	whiston@berkeley.edu	Pacific-Southwest, RCE/B-6155-2009	Sharpton, Thomas/0000-0002-5996-7764	National Institutes of Health [NIH-NIAID 1R01AI070891, NIH-U54-AI65359]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI070891, U54AI065359] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	The authors received funding from the National Institutes of Health with grants NIH-NIAID 1R01AI070891 and NIH-U54-AI65359. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ampel NM, 2010, MYCOPATHOLOGIA, V169, P425, DOI 10.1007/s11046-010-9285-6; ANDERS S, 2010, GENOME BIOL, V11; Ashburner M, 2000, NAT GENET, V25, P25, DOI 10.1038/75556; Bayram OS, 2010, LAEA CONTROL VELVET; Bendtsen JD, 2004, J MOL BIOL, V340, P783, DOI 10.1016/j.jmb.2004.05.028; Benjamini Y., 1995, J R STAT SOC, V57, P289, DOI [10.1111/j.2517-6161.1995.tb02031.x, DOI 10.1111/J.2517-6161.1995.TB02031.X]; Blow MJ, 2008, GENOME RES, V18, P1347, DOI 10.1101/gr.076091.108; Borchers AT, 2010, AUTOIMMUN REV, V10, P94, DOI 10.1016/j.autrev.2010.08.010; Bray N, 2003, GENOME RES, V13, P97, DOI 10.1101/gr.789803; Castillo-Davis CI, 2003, BIOINFORMATICS, V19, P891, DOI 10.1093/bioinformatics/btg114; Center for Disease Control, 2010, CDC COCC GEN INF NCZ; Chanda A, 2009, P NATL ACAD SCI USA, V106, P19533, DOI 10.1073/pnas.0907416106; Cole GT., 1985, FUNGAL DIMORPHISM, P281, DOI [10.1007/978-1-4684-4982-2_12, DOI 10.1007/978-1-4684-4982-2_12]; Delgado N, 2003, INFECT IMMUN, V71, P3010, DOI 10.1128/IAI.71.6.3010-3019.2003; DEWEY C, 2006, WHOLE GENOME ALIGNME; Dewey Colin N., 2007, V395, P221; Dixon DM, 2001, J APPL MICROBIOL, V91, P602, DOI 10.1046/j.1365-2672.2001.01496.x; Fisher BT, 2010, PEDIATR INFECT DIS J, V29, P243, DOI 10.1097/INF.0b013e3181bcfd7f; Fisher MC, 2002, MYCOLOGIA, V94, P73, DOI 10.2307/3761847; Fisher MC, 2000, J CLIN MICROBIOL, V38, P807, DOI 10.1128/JCM.38.2.807-813.2000; Grumbt M, 2011, FEMS MICROBIOL LETT, V320, P79, DOI 10.1111/j.1574-6968.2011.02276.x; Guevara-Olvera L, 2000, GENE, V242, P437, DOI 10.1016/S0378-1119(99)00496-5; Hashizume K, 2009, MOL BIOL CELL, V20, P4673, DOI 10.1091/mbc.E09-02-0172; Hector RF, 2011, INT J ENV RES PUB HE, V8, P1150, DOI 10.3390/ijerph8041150; Herr RA, 2007, INFECT IMMUN, V75, P5777, DOI 10.1128/IAI.00807-07; HOGAN LH, 1994, INFECT IMMUN, V62, P3543, DOI 10.1128/IAI.62.8.3543-3546.1994; Huang GH, 2006, P NATL ACAD SCI USA, V103, P12813, DOI 10.1073/pnas.0605270103; Hung CY, 2005, INFECT IMMUN, V73, P6689, DOI 10.1128/IAI.73.10.6689-6703.2005; Hung CY, 2000, INFECT IMMUN, V68, P584, DOI 10.1128/IAI.68.2.584-593.2000; Hung CY, 2002, INFECT IMMUN, V70, P3443, DOI 10.1128/IAI.70.7.3443-3456.2002; Jedd G, 2000, NAT CELL BIOL, V2, P226, DOI 10.1038/35008652; Johannesson H, 2006, FUNGAL GENET BIOL, V43, P545, DOI 10.1016/j.fgb.2006.02.003; Johannesson H, 2005, GENETICS, V171, P109, DOI 10.1534/genetics.105.040923; KIRKLAND TN, 1991, INFECT IMMUN, V59, P3952, DOI 10.1128/IAI.59.11.3952-3961.1991; Klein BS, 2007, CURR OPIN MICROBIOL, V10, P314, DOI 10.1016/j.mib.2007.04.002; KLIMPEL KR, 1988, INFECT IMMUN, V56, P2997, DOI 10.1128/IAI.56.11.2997-3000.1988; LEVINE HB, 1961, J IMMUNOL, V87, P218; Martin R, 2011, INT J MED MICROBIOL, V301, P417, DOI 10.1016/j.ijmm.2011.04.009; Maubon D, 2006, FUNGAL GENET BIOL, V43, P366, DOI 10.1016/j.fgb.2006.01.006; Mirbod-Donovan F, 2006, INFECT IMMUN, V74, P504, DOI 10.1128/IAI.74.1.504-515.2006; Mulder HJ, 2004, MOL GENET GENOMICS, V271, P130, DOI 10.1007/s00438-003-0965-5; Neafsey DE, 2010, GENOME RES, V20, P938, DOI 10.1101/gr.103911.109; Nemecek JC, 2006, SCIENCE, V312, P583, DOI 10.1126/science.1124105; Nguyen VQ, 2008, P NATL ACAD SCI USA, V105, P4880, DOI 10.1073/pnas.0710448105; Nunes LR, 2005, EUKARYOT CELL, V4, P2115, DOI 10.1128/EC.4.12.2115-2128.2005; Rappleye CA, 2004, MOL MICROBIOL, V53, P153, DOI 10.1111/j.1365-2958.2004.04131.x; Rappleye CA, 2007, P NATL ACAD SCI USA, V104, P1366, DOI 10.1073/pnas.0609848104; Rappleye CA, 2006, ANNU REV MICROBIOL, V60, P281, DOI 10.1146/annurev.micro.59.030804.121055; Ruiz-Herrera J., 2003, Current Drug Targets - Infectious Disorders, V3, P77, DOI 10.2174/1568005033342064; SANBLAS G, 1977, INFECT IMMUN, V15, P343, DOI 10.1128/IAI.15.2.343-346.1977; Sharpton TJ, 2009, GENOME RES, V19, P1722, DOI 10.1101/gr.087551.108; Smit A, 1996, REPEATMASKER OPEN 30; Sudhof TC, 2009, MEMBRANE FUSION GRAP; Tan KC, 2009, MOL PLANT PATHOL, V10, P703, DOI [10.1111/J.1364-3703.2009.00565.X, 10.1111/j.1364-3703.2009.00565.x]; Taylor JW, 2003, CURR OPIN MICROBIOL, V6, P351, DOI 10.1016/S1369-5274(03)00088-2; Tenney K, 2000, FUNGAL GENET BIOL, V31, P205, DOI 10.1006/fgbi.2000.1230; Trapnell C, 2009, BIOINFORMATICS, V25, P1105, DOI 10.1093/bioinformatics/btp120; Viriyakosol S., 2005, INFECT IMMUN, V73, P1553; Webster RH, 2008, P NATL ACAD SCI USA, V105, P14573, DOI 10.1073/pnas.0806221105; Wu X, 2001, MOL GENET GENOMICS, V265, P622, DOI 10.1007/s004380100455; WYCKOFF EE, 1995, GENE, V161, P107, DOI 10.1016/0378-1119(95)00250-A; Zaragoza O, 2010, PLOS PATHOG, V6, P18	62	50	50	1	28	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 20	2012	7	7							e41034	10.1371/journal.pone.0041034	http://dx.doi.org/10.1371/journal.pone.0041034			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	977GL	22911737	Green Submitted, gold, Green Published			2022-12-25	WOS:000306644600041
J	Kalari, S; Jung, M; Kernstine, KH; Takahashi, T; Pfeifer, GP				Kalari, S.; Jung, M.; Kernstine, K. H.; Takahashi, T.; Pfeifer, G. P.			The DNA methylation landscape of small cell lung cancer suggests a differentiation defect of neuroendocrine cells	ONCOGENE			English	Article						DNA methylation; small cell lung cancer; differentiation; epigenetics	TUMOR-SUPPRESSOR GENE; CPG ISLAND; EPIGENETIC INACTIVATION; MOLECULAR-GENETICS; EXPRESSION; FAMILY; IDENTIFICATION; AMPLIFICATION; HYPERMETHYLATION; NEUROBLASTOMA	Small cell lung cancer (SCLC) is a disease characterized by aggressive clinical behavior and lack of effective therapy. Owing to its tendency for early dissemination, only a third of patients have limited-stage disease at the time of diagnosis. SCLC is thought to derive from pulmonary neuroendocrine cells. Although several molecular abnormalities in SCLC have been described, there are relatively few studies on epigenetic alterations in this type of tumor. Here, we have used methylation profiling with the methylated-CpG island recovery assay in combination with microarrays and conducted the first genome-scale analysis of methylation changes that occur in primary SCLC and SCLC cell lines. Among the hundreds of tumor-specifically methylated genes discovered, we identified 73 gene targets that are methylated in >77% of primary SCLC tumors, most of which have never been linked to aberrant methylation in tumors. These methylated targets have potential for biomarker development for early detection and therapeutic management of SCLC. SCLC cell lines had a greater number of hypermethylated genes than primary tumors. Gene ontology analysis indicated a significant enrichment of methylated genes functioning as transcription factors and in processes of neuronal differentiation. Motif analysis of tumor-specific methylated regions identified enrichment of binding sites for several neural cell fate-specifying transcription factors including NEUROD1, HAND1, ZNF423 and REST. We hypothesize that two potential mechanisms, loss of cell fate-determining transcription factors by methylation of their promoters and functional inactivation of their corresponding genomic-binding sites by DNA methylation, can promote a differentiation defect of neuroendocrine cells thus enhancing the ability of tumor progenitor cells to transition toward SCLC.	[Kalari, S.; Jung, M.; Pfeifer, G. P.] City Hope Natl Med Ctr, Beckman Res Inst, Dept Canc Biol, Duarte, CA 91010 USA; [Kernstine, K. H.] City Hope Natl Med Ctr, Beckman Res Inst, Dept Surg, Duarte, CA 91010 USA; [Takahashi, T.] Nagoya Univ, Grad Sch Med, Div Mol Carcinogenesis, Nagoya, Aichi 4648601, Japan	City of Hope; Beckman Research Institute of City of Hope; City of Hope; Beckman Research Institute of City of Hope; Nagoya University	Pfeifer, GP (corresponding author), City Hope Natl Med Ctr, Beckman Res Inst, Dept Canc Biol, Duarte, CA 91010 USA.	gpfeifer@coh.org	Takahashi, Takashi/I-7262-2014	Takahashi, Takashi/0000-0003-0615-7001	National Institutes of Health grant [CA084469]; NATIONAL CANCER INSTITUTE [R01CA084469] Funding Source: NIH RePORTER	National Institutes of Health grant(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	We thank Steven Bates for culturing SCLC cell lines. This work was supported by the National Institutes of Health grant CA084469 to GPP and by generous funds from an anonymous donor.	Burbee DG, 2001, JNCI-J NATL CANCER I, V93, P691, DOI 10.1093/jnci/93.9.691; Coulson JM, 2005, CURR BIOL, V15, pR665, DOI 10.1016/j.cub.2005.08.032; Coulson JM, 2000, CANCER RES, V60, P1840; Dammann R, 2000, NAT GENET, V25, P315, DOI 10.1038/77083; Dammann R, 2001, ONCOGENE, V20, P3563, DOI 10.1038/sj.onc.1204469; Fischer B, 2007, CANCER TREAT REV, V33, P391, DOI 10.1016/j.ctrv.2007.01.006; Govindan R, 2006, J CLIN ONCOL, V24, P4539, DOI 10.1200/JCO.2005.04.4859; Hahn MA, 2008, CANCER RES, V68, P10280, DOI 10.1158/0008-5472.CAN-08-1957; Hanahan D, 2011, CELL, V144, P646, DOI 10.1016/j.cell.2011.02.013; Heinz S, 2010, MOL CELL, V38, P576, DOI 10.1016/j.molcel.2010.05.004; Holzel M, 2010, CELL, V142, P218, DOI 10.1016/j.cell.2010.06.004; Huang DW, 2009, NAT PROTOC, V4, P44, DOI 10.1038/nprot.2008.211; Huang DW, 2009, NUCLEIC ACIDS RES, V37, P1, DOI 10.1093/nar/gkn923; Huang SD, 2009, CANCER CELL, V15, P328, DOI 10.1016/j.ccr.2009.02.023; JOHNSON BE, 1987, J CLIN INVEST, V79, P1629, DOI 10.1172/JCI112999; Kalari S, 2010, ADV GENET, V70, P277, DOI [10.1016/B978-0-12-380866-0.60010-1, 10.1016/S0065-2660(10)70010-9]; Kondo Y, 2008, NAT GENET, V40, P741, DOI 10.1038/ng.159; Kreisler A, 2010, ONCOGENE, V29, P5828, DOI 10.1038/onc.2010.321; Laird PW, 2003, NAT REV CANCER, V3, P253, DOI 10.1038/nrc1045; Lee NH, 2007, HYPERTENSION, V50, P1126, DOI 10.1161/HYPERTENSIONAHA.107.093138; Lerman MI, 2000, CANCER RES, V60, P6116; Linhart C, 2008, GENOME RES, V18, P1180, DOI 10.1101/gr.076117.108; LITTLE CD, 1983, NATURE, V306, P194, DOI 10.1038/306194a0; Majumder S, 2006, CELL CYCLE, V5, P1929, DOI 10.4161/cc.5.17.2982; Maunakea AK, 2010, NATURE, V466, P253, DOI 10.1038/nature09165; Modi S, 2000, ONCOGENE, V19, P4632, DOI 10.1038/sj.onc.1203815; Neptune ER, 2008, J BIOL CHEM, V283, P21160, DOI 10.1074/jbc.M708692200; Park KS, 2011, CELL CYCLE, V10, P2806, DOI 10.4161/cc.10.16.17012; Piper M, 2010, J NEUROSCI, V30, P9127, DOI 10.1523/JNEUROSCI.6167-09.2010; Quinlan AR, 2010, BIOINFORMATICS, V26, P841, DOI 10.1093/bioinformatics/btq033; Qureshi IA, 2010, CELL CYCLE, V9, P4477, DOI 10.4161/cc.9.22.13973; Rauch T, 2007, P NATL ACAD SCI USA, V104, P5527, DOI 10.1073/pnas.0701059104; Rauch TA, 2008, P NATL ACAD SCI USA, V105, P252, DOI 10.1073/pnas.0710735105; Rauch TA, 2010, METHODS, V52, P213, DOI 10.1016/j.ymeth.2010.03.004; Rauch Tibor A., 2009, V507, P65, DOI 10.1007/978-1-59745-522-0_6; Rauch TA, 2009, P NATL ACAD SCI USA, V106, P671, DOI 10.1073/pnas.0812399106; Reinert T, 2011, CLIN CANCER RES, V17, P5582, DOI 10.1158/1078-0432.CCR-10-2659; Rodriguez J, 2008, P NATL ACAD SCI USA, V105, P19809, DOI 10.1073/pnas.0810133105; Sato M, 2007, J THORAC ONCOL, V2, P327, DOI 10.1097/01.JTO.0000263718.69320.4c; Sattler M, 2003, SEMIN ONCOL, V30, P57, DOI 10.1053/sonc.2003.50019; Sekido Y, 2003, ANNU REV MED, V54, P73, DOI 10.1146/annurev.med.54.101601.152202; Smith LT, 2006, P NATL ACAD SCI USA, V103, P982, DOI 10.1073/pnas.0510171102; Stadler MB, 2011, NATURE, V480, P490, DOI 10.1038/nature10716; Sunaga N, 2004, CANCER RES, V64, P4277, DOI 10.1158/0008-5472.CAN-03-3941; SUTHERLAND K, 2011, TLS TIMES LIT S 0422, P19; Suzuki MM, 2008, NAT REV GENET, V9, P465, DOI 10.1038/nrg2341; TAKAHASHI T, 1989, CANCER RES, V49, P2683; Takeshima H, 2009, GENOME RES, V19, P1974, DOI 10.1101/gr.093310.109; Toedling J, 2007, BMC BIOINFORMATICS, V8, DOI 10.1186/1471-2105-8-221; Tommasi S, 2009, BREAST CANCER RES, V11, DOI 10.1186/bcr2233; Ushijima T, 2005, NAT REV CANCER, V5, P223, DOI 10.1038/nrc1571; Warming S, 2006, MOL CELL BIOL, V26, P6913, DOI 10.1128/MCB.02255-05; Wistuba II, 2001, SEMIN ONCOL, V28, P3, DOI 10.1053/sonc.2001.25738; Wu XW, 2010, CANCER RES, V70, P2718, DOI 10.1158/0008-5472.CAN-09-3631; Xiong ZG, 1997, NUCLEIC ACIDS RES, V25, P2532, DOI 10.1093/nar/25.12.2532	55	48	48	0	17	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	JUL 25	2013	32	30					3559	3568		10.1038/onc.2012.362	http://dx.doi.org/10.1038/onc.2012.362			10	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	188UQ	22907430	Green Accepted			2022-12-25	WOS:000322220800009
J	Rao, V; Guan, B; Mutton, LN; Bieberich, CJ				Rao, Varsha; Guan, Bin; Mutton, Laura N.; Bieberich, Charles J.			Proline-mediated Proteasomal Degradation of the Prostate-specific Tumor Suppressor NKX3.1	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							UBIQUITIN-INDEPENDENT DEGRADATION; INTRAEPITHELIAL NEOPLASIA; TAT PROTEIN; EXPRESSION; INHIBITORS; INTERACTS; BINDING; DOMAIN; RICH; ATP	Reduced expression of the homeodomain transcription factor NKX3.1 is associated with prostate cancer initiation and progression. NKX3.1 turnover requires post-translational modifications including phosphorylation and ubiquitination. Here, we demonstrate the existence of a non-canonical mechanism for NKX3.1 turnover that does not require ubiquitination. Using a structure-function approach, we have determined that the conserved, C-terminal 21-amino acid domain of NKX3.1 (C21) is required for this novel ubiquitin-independent degradation mechanism. Addition of C21 decreased half-life of enhanced green fluorescence protein (EGFP) by 5-fold, demonstrating that C21 constitutes a portable degron. Point mutational analyses of C21 revealed that a conserved proline residue (Pro-221) is central to degron activity, and mutation to alanine (P221A) increased NKX3.1 half-life >2-fold. Proteasome inhibition and in vivo ubiquitination analyses indicated that degron activity is ubiquitin-independent. Evaluating degron activity in the context of a ubiquitination-resistant, lysine-null NKX3.1 mutant (NKX3.1(KO)) confirmed that P221A mutation conferred additional stability to NKX3.1. Treatment of prostate cancer cell lines with a C21-based peptide specifically increased the level of NKX3.1, suggesting that treatment with degron mimetics may be a viable approach for NKX3.1 restoration.	[Rao, Varsha; Guan, Bin; Mutton, Laura N.; Bieberich, Charles J.] Univ Maryland Baltimore Cty, Dept Biol Sci, Baltimore, MD 21250 USA	University System of Maryland; University of Maryland Baltimore County	Bieberich, CJ (corresponding author), Univ Maryland Baltimore Cty, Dept Biol Sci, 1000 Hilltop Circle, Baltimore, MD 21250 USA.	bieberic@umbc.edu		Guan, Bin/0000-0001-5986-5189; Bieberich, Charles/0000-0002-9208-5077	Congressionally Directed Medical Research Prostate Cancer Program [W81XWH-07-1-0232]	Congressionally Directed Medical Research Prostate Cancer Program	This work was supported by Grant W81XWH-07-1-0232 from the Congressionally Directed Medical Research Prostate Cancer Program (to C. J. B.).	Abdulkadir SA, 2002, MOL CELL BIOL, V22, P1495, DOI 10.1128/MCB.22.5.1495-1503.2002; Acquaviva C, 2001, ONCOGENE, V20, P7563, DOI 10.1038/sj.onc.1204880; Adams J, 2004, CANCER INVEST, V22, P304, DOI 10.1081/CNV-120030218; Bess KL, 2003, BIOCHEM J, V374, P667, DOI 10.1042/BJ20030769; Bethel CR, 2007, PROSTATE, V67, P1740, DOI 10.1002/pros.20579; Bethel CR, 2006, CANCER RES, V66, P10683, DOI 10.1158/0008-5472.CAN-06-0963; Bhatia-Gaur R, 1999, GENE DEV, V13, P966, DOI 10.1101/gad.13.8.966; Bowen C, 2000, CANCER RES, V60, P6111; Chen H, 2005, J CELL BIOCHEM, V94, P168, DOI 10.1002/jcb.20297; Chen H, 2002, CANCER RES, V62, P338; Corallini F, 2008, J LEUKOCYTE BIOL, V84, P651, DOI 10.1189/jlb.0408222; De Marzo AM, 2007, NAT REV CANCER, V7, P256, DOI 10.1038/nrc2090; DOHMEN RJ, 1994, SCIENCE, V263, P1273, DOI 10.1126/science.8122109; Ferrara P, 2003, ONCOGENE, V22, P1461, DOI 10.1038/sj.onc.1206266; FRANKEL AD, 1988, CELL, V55, P1189, DOI 10.1016/0092-8674(88)90263-2; Gaczynska M, 2003, BIOCHEMISTRY-US, V42, P8663, DOI 10.1021/bi034784f; Guan B, 2008, J BIOL CHEM, V283, P4834, DOI 10.1074/jbc.M708630200; He WW, 1997, GENOMICS, V43, P69, DOI 10.1006/geno.1997.4715; Herbst A, 2004, ONCOGENE, V23, P3863, DOI 10.1038/sj.onc.1207492; HERSHKO A, 1980, P NATL ACAD SCI-BIOL, V77, P1783, DOI 10.1073/pnas.77.4.1783; Hershko A, 2005, CELL DEATH DIFFER, V12, P1191, DOI 10.1038/sj.cdd.4401702; HERSHKO A, 1979, P NATL ACAD SCI USA, V76, P3107, DOI 10.1073/pnas.76.7.3107; Hoeller D, 2006, NAT REV CANCER, V6, P776, DOI 10.1038/nrc1994; Hori T, 2010, CANCER LETT, V287, P98, DOI 10.1016/j.canlet.2009.06.002; Hwang J, 2011, BBA-REV CANCER, V1816, P147, DOI 10.1016/j.bbcan.2011.05.005; Iwata T, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009427; Jin JP, 2003, GENE DEV, V17, P3062, DOI 10.1101/gad.1157503; Jin YT, 2003, EMBO J, V22, P6365, DOI 10.1093/emboj/cdg600; Kaelin WG, 2005, ANNU REV BIOCHEM, V74, P115, DOI 10.1146/annurev.biochem.74.082803.133142; Kalejta RF, 2003, P NATL ACAD SCI USA, V100, P3263, DOI 10.1073/pnas.0538058100; Kane RC, 2003, ONCOLOGIST, V8, P508, DOI 10.1634/theoncologist.8-6-508; Kanelis V, 2000, J BIOMOL NMR, V16, P253, DOI 10.1023/A:1008355012528; Kay BK, 2000, FASEB J, V14, P231, DOI 10.1096/fasebj.14.2.231; Kim MJ, 2002, CANCER RES, V62, P2999; Lei QY, 2006, CANCER CELL, V9, P367, DOI 10.1016/j.ccr.2006.03.031; Lewis MD, 2004, ONCOGENE, V23, P2315, DOI 10.1038/sj.onc.1207384; Li X, 2006, MOL CELL BIOL, V26, P3008, DOI 10.1128/MCB.26.8.3008-3017.2006; Mack PC, 2003, LUNG CANCER, V41, pS89, DOI 10.1016/S0169-5002(03)00149-1; Magee JA, 2003, CANCER CELL, V3, P273, DOI 10.1016/S1535-6108(03)00047-3; Markowski MC, 2008, CANCER RES, V68, P6896, DOI 10.1158/0008-5472.CAN-08-0578; Melo SP, 2011, J BIOL CHEM, V286, P36559, DOI 10.1074/jbc.M111.274258; Moehler T, 2011, RECENT RESULTS CANC, V183, P239, DOI 10.1007/978-3-540-85772-3_11; Orlicky S, 2003, CELL, V112, P243, DOI 10.1016/S0092-8674(03)00034-5; Papandreou CN, 2004, CANCER RES, V64, P5036, DOI 10.1158/0008-5472.CAN-03-2707; Patel S, 2008, EXPERT OPIN INV DRUG, V17, P1865, DOI 10.1517/13543780802493366 ; Prescott JL, 1998, PROSTATE, V35, P71, DOI 10.1002/(SICI)1097-0045(19980401)35:1<71::AID-PROS10>3.0.CO;2-H; Sciavolino PJ, 1997, DEV DYNAM, V209, P127, DOI 10.1002/(SICI)1097-0177(199705)209:1<127::AID-AJA12>3.0.CO;2-Z; Sdek P, 2005, MOL CELL, V20, P699, DOI 10.1016/j.molcel.2005.10.017; Sen N, 2007, J VIROL, V81, P4323, DOI 10.1128/JVI.02279-06; Tahmatzopoulos A, 2004, AKTUEL UROL, V35, P491, DOI 10.1055/s-2004-830048; Tovar C, 2011, MOL CANCER, V10, DOI 10.1186/1476-4598-10-49; Tulchin N, 2010, AM J PATHOL, V176, P1203, DOI 10.2353/ajpath.2010.081063; Vassilev LT, 2004, CELL CYCLE, V3, P419; Vives E, 1997, J BIOL CHEM, V272, P16010, DOI 10.1074/jbc.272.25.16010; Wadia JS, 2005, ADV DRUG DELIVER REV, V57, P579, DOI 10.1016/j.addr.2004.10.005; WILKINSON KD, 1980, J BIOL CHEM, V255, P7529; Wu G, 2006, J BIOTECHNOL, V124, P496, DOI 10.1016/j.jbiotec.2006.01.015; Yan YT, 2000, MOL CELL BIOL, V20, P661, DOI 10.1128/MCB.20.2.661-671.2000; Ye X, 2004, J BIOL CHEM, V279, P50110, DOI 10.1074/jbc.M409226200; Ying HQ, 2006, CELL CYCLE, V5, P506, DOI 10.4161/cc.5.5.2515; Zhang HY, 2008, CANCER RES, V68, P8770, DOI 10.1158/0008-5472.CAN-08-1912	61	9	10	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 19	2012	287	43					36331	36340		10.1074/jbc.M112.352823	http://dx.doi.org/10.1074/jbc.M112.352823			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	027PA	22910912	Green Published, hybrid			2022-12-25	WOS:000310364000054
J	Denisova, OV; Kakkola, L; Feng, L; Stenman, J; Nagaraj, A; Lampe, J; Yadav, B; Aittokallio, T; Kaukinen, P; Ahola, T; Kuivanen, S; Vapalahti, O; Kantele, A; Tynell, J; Julkunen, I; Kallio-Kokko, H; Paavilainen, H; Hukkanen, V; Elliott, RM; De Brabander, JK; Saelens, X; Kainov, DE				Denisova, Oxana V.; Kakkola, Laura; Feng, Lin; Stenman, Jakob; Nagaraj, Ashwini; Lampe, Johanna; Yadav, Bhagwan; Aittokallio, Tero; Kaukinen, Pasi; Ahola, Tero; Kuivanen, Suvi; Vapalahti, Olli; Kantele, Anu; Tynell, Janne; Julkunen, Ilkka; Kallio-Kokko, Hannimari; Paavilainen, Henrik; Hukkanen, Veijo; Elliott, Richard M.; De Brabander, Jef K.; Saelens, Xavier; Kainov, Denis E.			Obatoclax, Saliphenylhalamide, and Gemcitabine Inhibit Influenza A Virus Infection	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							APOPTOSIS; CELLS; NUCLEOSIDE; EXPRESSION; PROTEINS; AGENTS; MCL-1	Influenza A viruses (IAVs) infect humans and cause significant morbidity and mortality. Different treatment options have been developed; however, these were insufficient during recent IAV outbreaks. Here, we conducted a targeted chemical screen in human nonmalignant cells to validate known and search for novel host-directed antivirals. The screen validated saliphenylhalamide (SaliPhe) and identified two novel anti-IAV agents, obatoclax and gemcitabine. Further experiments demonstrated that Mcl-1 (target of obatoclax) provides a novel host target for IAV treatment. Moreover, we showed that obatoclax and SaliPhe inhibited IAV uptake and gemcitabine suppressed viral RNA transcription and replication. These compounds possess broad spectrum antiviral activity, although their antiviral efficacies were virus-, cell type-, and species-specific. Altogether, our results suggest that phase II obatoclax, investigational SaliPhe, and FDA/EMEA-approved gemcitabine represent potent antiviral agents.	[Denisova, Oxana V.; Kakkola, Laura; Stenman, Jakob; Nagaraj, Ashwini; Lampe, Johanna; Yadav, Bhagwan; Aittokallio, Tero; Kainov, Denis E.] FIMM, Inst Mol Med Finland, FI-00290 Helsinki, Finland; [Feng, Lin; Stenman, Jakob] Minerva Fdn, Inst Med Res, FI-00290 Helsinki, Finland; [Kaukinen, Pasi; Ahola, Tero] Inst Biotechnol, FI-00290 Helsinki, Finland; [Kuivanen, Suvi; Vapalahti, Olli] Haartman Inst, FI-00290 Helsinki, Finland; [Vapalahti, Olli; Kantele, Anu] Helsinki Univ Hosp Lab, FI-00290 Helsinki, Finland; [Tynell, Janne; Julkunen, Ilkka] Natl Inst Hlth & Welf, FI-00290 Helsinki, Finland; [Kallio-Kokko, Hannimari] Inst Clin Med, FI-00290 Helsinki, Finland; [Paavilainen, Henrik; Hukkanen, Veijo] Univ Turku, Dept Virol, FI-20520 Turku, Finland; [Elliott, Richard M.] Univ St Andrews, Ctr Biomol Sci, St Andrews KY16 9ST, Fife, Scotland; [De Brabander, Jef K.] Univ Texas SW Med Ctr Dallas, Dept Biochem, Dallas, TX 75390 USA; [Saelens, Xavier] VIB, Dept Mol Biomed Res, B-9000 Ghent, Belgium; [Saelens, Xavier] Univ Ghent, Dept Biomed Mol Biol, B-9000 Ghent, Belgium	Finland National Institute for Health & Welfare; University of Turku; University of St Andrews; University of Texas System; University of Texas Southwestern Medical Center Dallas; Flanders Institute for Biotechnology (VIB); Ghent University	Kainov, DE (corresponding author), Inst Mol Med Finland FIMM, Tukholmankatu 8, Helsinki 00290, Finland.	denis.kainov@helsinki.fi	Kantele, Anu/AAS-4131-2021; Denisova, Oxana/AAY-9569-2021; Denisova, Oxana V/I-6471-2012; kainov, denis/I-5526-2019; Denisova, Oxana/M-4328-2019; Yadav, Bhagwan/M-2921-2015; Saelens, Xavier/N-5728-2015; Aittokallio, Tero/B-6583-2009; Denisova, Oxana/X-1906-2019	Kantele, Anu/0000-0002-0004-1000; kainov, denis/0000-0001-7716-6955; Denisova, Oxana/0000-0002-7041-3842; Yadav, Bhagwan/0000-0002-3502-9335; Aittokallio, Tero/0000-0002-0886-9769; Stenman, Jakob/0000-0001-9543-3957; Julkunen, Ilkka/0000-0003-0165-2564; Tynell, Janne/0000-0001-6930-5230; , Xavier/0000-0002-3861-6965; Vapalahti, Olli/0000-0003-2270-6824	National Institutes of Health [CA90349, CA95471]; Jane and Aatos Erkko Foundation; Centre for International Mobility (CIMO); Academy of Finland [138644, 255852]; Robert A. Welch Foundation [I-1422]; NATIONAL CANCER INSTITUTE [R01CA090349, P01CA095471] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Jane and Aatos Erkko Foundation; Centre for International Mobility (CIMO); Academy of Finland(Academy of Finland); Robert A. Welch Foundation(The Welch Foundation); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported, in whole or in part, by National Institutes of Health Grants CA90349 and CA95471. This work was also supported by the Jane and Aatos Erkko Foundation, Centre for International Mobility (CIMO), the Academy of Finland Grants 138644 and 255852, and Robert A. Welch Foundation Grant I-1422.	Bajwa N, 2012, EXPERT OPIN THER PAT, V22, P37, DOI 10.1517/13543776.2012.644274; Chase G, 2008, VIROLOGY, V377, P431, DOI 10.1016/j.virol.2008.04.040; Chen KF, 2012, CANCER LETT, V321, P27, DOI 10.1016/j.canlet.2012.03.023; Dudek SE, 2010, J VIROL, V84, P9439, DOI 10.1128/JVI.00533-10; Feng L, 2012, BIOTECHNIQUES, V52, P263, DOI 10.2144/0000113842; Gesto DS, 2012, CURR MED CHEM, V19, P1076; Gu J, 2007, LANCET, V370, P1137, DOI 10.1016/S0140-6736(07)61515-3; Guse K, 2010, J VIROL, V84, P856, DOI 10.1128/JVI.00692-09; Heikkila O, 2009, J GEN VIROL, V90, P197, DOI 10.1099/vir.0.004838-0; Jiang XR, 1999, NAT GENET, V21, P111, DOI 10.1038/5056; Koskela HLM, 2012, NEW ENGL J MED, V366, P1905, DOI 10.1056/NEJMoa1114885; Kurtz J, 1996, LANCET, V348, P901, DOI 10.1016/S0140-6736(05)64783-6; Lebreton S, 2008, BIOORG MED CHEM LETT, V18, P5879, DOI 10.1016/j.bmcl.2008.07.003; Lietzen N, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1001340; Meneghesso S, 2012, ANTIVIR RES, V94, P35, DOI 10.1016/j.antiviral.2012.01.007; Michaelis M, 2009, INVEST OPHTH VIS SCI, V50, P5419, DOI 10.1167/iovs.09-3752; Muller KH, 2012, TRENDS PHARMACOL SCI, V33, P89, DOI 10.1016/j.tips.2011.10.004; Muller KH, 2011, BRIT J PHARMACOL, V164, P344, DOI 10.1111/j.1476-5381.2011.01346.x; Nguyen M, 2007, P NATL ACAD SCI USA, V104, P19512, DOI 10.1073/pnas.0709443104; Qin A, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0034132; Rosebeck S, 2011, VIROLOGY, V417, P293, DOI 10.1016/j.virol.2011.06.010; Sane J, 2012, J INFECT DIS, V206, P407, DOI 10.1093/infdis/jis358; Schneider J, 2009, J VIROL, V83, P701, DOI 10.1128/JVI.01858-08; SCHWARZ AJF, 1962, AM J DIS CHILD, V103, P386, DOI 10.1001/archpedi.1962.02080020398042; Shi XH, 2009, J GEN VIROL, V90, P297, DOI 10.1099/vir.0.007567-0; Spuul P, 2011, J VIROL, V85, P4739, DOI 10.1128/JVI.00085-11; Venticinque L, 2010, MOL CANCER, V9, DOI 10.1186/1476-4598-9-37; Wang WB, 2011, J IMMUNOL, V187, P2578, DOI 10.4049/jimmunol.1004128; Weinheimer V.K., 2012, J INFECT DI IN PRESS	29	67	69	0	12	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 12	2012	287	42					35324	35332		10.1074/jbc.M112.392142	http://dx.doi.org/10.1074/jbc.M112.392142			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	022OF	22910914	Green Published, hybrid			2022-12-25	WOS:000309968000041
J	Hurd, TR; Collins, Y; Abakumova, I; Chouchani, ET; Baranowski, B; Fearnley, IM; Prime, TA; Murphy, MP; James, AM				Hurd, Thomas R.; Collins, Yvonne; Abakumova, Irina; Chouchani, Edward T.; Baranowski, Bartlomiej; Fearnley, Ian M.; Prime, Tracy A.; Murphy, Michael P.; James, Andrew M.			Inactivation of Pyruvate Dehydrogenase Kinase 2 by Mitochondrial Reactive Oxygen Species	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SIGNAL-TRANSDUCTION; OXIDATIVE STRESS; COMPLEX; SUPEROXIDE; PYRUVATE-DEHYDROGENASE-KINASE-2; PHOSPHORYLATION; PHOSPHATASE; ACTIVATION; MECHANISMS; H2O2	Reactive oxygen species are byproducts of mitochondrial respiration and thus potential regulators of mitochondrial function. Pyruvate dehydrogenase kinase 2 (PDHK2) inhibits the pyruvate dehydrogenase complex, thereby regulating entry of carbohydrates into the tricarboxylic acid (TCA) cycle. Here we show that PDHK2 activity is inhibited by low levels of hydrogen peroxide (H2O2) generated by the respiratory chain. This occurs via reversible oxidation of cysteine residues 45 and 392 on PDHK2 and results in increased pyruvate dehydrogenase complex activity. H2O2 derives from superoxide (O-2((center dot) over bar)), and we show that conditions that inhibit PDHK2 also inactivate the TCA cycle enzyme, aconitase. These findings suggest that under conditions of high mitochondrial O-2((center dot) over bar) production, such as may occur under nutrient excess and low ATP demand, the increase in O-2(<(center dot)over bar)> and H2O2 may provide feedback signals to modulate mitochondrial metabolism.	[Hurd, Thomas R.; Collins, Yvonne; Abakumova, Irina; Chouchani, Edward T.; Baranowski, Bartlomiej; Fearnley, Ian M.; Prime, Tracy A.; Murphy, Michael P.; James, Andrew M.] MRC, Mitochondrial Biol Unit, Cambridge CB2 0XY, England		Murphy, MP (corresponding author), MRC, Mitochondrial Biol Unit, Wellcome Trust MRC Bldg,Hills Rd, Cambridge CB2 0XY, England.	mpm@mrc-mbu.cam.ac.uk	Abakumova, Irina V/A-9712-2016; James, Andrew M/A-2639-2015; Murphy, Michael P/C-2120-2009; Chouchani, Edward/A-1733-2014	James, Andrew M/0000-0002-0515-9649; Murphy, Michael P/0000-0003-1115-9618; Chouchani, Edward/0000-0002-9203-8094	Medical Research Council (United Kingdom); MRC [MC_U105663142] Funding Source: UKRI; Medical Research Council [MC_U105663142] Funding Source: researchfish	Medical Research Council (United Kingdom)(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	This work was supported by the Medical Research Council (United Kingdom).	Bowker-Kinley MM, 1998, BIOCHEM J, V329, P191, DOI 10.1042/bj3290191; Cocheme HM, 2008, J BIOL CHEM, V283, P1786, DOI 10.1074/jbc.M708597200; Cox AG, 2008, FREE RADICAL BIO MED, V44, P1001, DOI 10.1016/j.freeradbiomed.2007.11.017; D'Autreaux B, 2007, NAT REV MOL CELL BIO, V8, P813, DOI 10.1038/nrm2256; Green T, 2008, J BIOL CHEM, V283, P15789, DOI 10.1074/jbc.M800311200; HAUSLADEN A, 1994, J BIOL CHEM, V269, P29405; Hoehn KL, 2009, P NATL ACAD SCI USA, V106, P17787, DOI 10.1073/pnas.0902380106; Hurd TR, 2007, J BIOL CHEM, V282, P22040, DOI 10.1074/jbc.M703591200; James AM, 2012, TRENDS ENDOCRIN MET, V23, P429, DOI 10.1016/j.tem.2012.06.008; Janssen-Heininger YMW, 2008, FREE RADICAL BIO MED, V45, P1, DOI 10.1016/j.freeradbiomed.2008.03.011; Kato M, 2005, EMBO J, V24, P1763, DOI 10.1038/sj.emboj.7600663; Knoechel TR, 2006, BIOCHEMISTRY-US, V45, P402, DOI 10.1021/bi051402s; Li J, 2009, J BIOL CHEM, V284, P34458, DOI 10.1074/jbc.M109.065557; LI YB, 1995, NAT GENET, V11, P376, DOI 10.1038/ng1295-376; Makmura L, 2001, ANTIOXID REDOX SIGN, V3, P1105, DOI 10.1089/152308601317203611; Murphy MP, 2009, BIOCHEM J, V417, P1, DOI 10.1042/BJ20081386; Patel MS, 2006, BIOCHEM SOC T, V34, P217, DOI 10.1042/BST0340217; POPOV KM, 1994, J BIOL CHEM, V269, P29720; POPP DA, 1980, J BIOL CHEM, V255, P7540; RANDLE PJ, 1995, P NUTR SOC, V54, P317, DOI 10.1079/PNS19950057; Rardin MJ, 2009, ANAL BIOCHEM, V389, P157, DOI 10.1016/j.ab.2009.03.040; Rhee SG, 2006, SCIENCE, V312, P1882, DOI 10.1126/science.1130481; Roche TE, 2001, PROG NUCLEIC ACID RE, V70, P33, DOI 10.1016/S0079-6603(01)70013-X; Rodriguez-Cuenca S, 2010, FREE RADICAL BIO MED, V48, P161, DOI 10.1016/j.freeradbiomed.2009.10.039; Steussy CN, 2001, J BIOL CHEM, V276, P37443, DOI 10.1074/jbc.M104285200; SUNDARESAN M, 1995, SCIENCE, V270, P296, DOI 10.1126/science.270.5234.296; THOR H, 1982, J BIOL CHEM, V257, P2419; Veal EA, 2007, MOL CELL, V26, P1, DOI 10.1016/j.molcel.2007.03.016; WHITEHOUSE S, 1974, BIOCHEM J, V141, P761, DOI 10.1042/bj1410761; Wynn RM, 2008, J BIOL CHEM, V283, P25305, DOI 10.1074/jbc.M802249200; YEAMAN SJ, 1978, BIOCHEMISTRY-US, V17, P2364, DOI 10.1021/bi00605a017	31	37	40	0	17	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 12	2012	287	42					35153	35160		10.1074/jbc.M112.400002	http://dx.doi.org/10.1074/jbc.M112.400002			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	022OF	22910903	Green Published, hybrid			2022-12-25	WOS:000309968000025
J	Haferkamp, B; Zhang, HH; Lin, YT; Yeap, XY; Bunce, A; Sharp, J; Xiang, JL				Haferkamp, Bonnie; Zhang, Honghong; Lin, Yuting; Yeap, Xinyi; Bunce, Alex; Sharp, Juanita; Xiang, Jialing			Bax Delta 2 Is a Novel Bax Isoform Unique to Microsatellite Unstable Tumors	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							TARGET GENE-MUTATIONS; PROGRAMMED CELL-DEATH; BCL-2 FAMILY-MEMBERS; COLON-CANCER; FRAMESHIFT MUTATIONS; MUTATOR PHENOTYPE; POOR-PROGNOSIS; CYTOCHROME-C; PROTEIN BAX; IN-VIVO	The pro-death Bcl-2 family protein and tumor suppressor Bax is frequently mutated in tumors with microsatellite instability (MSI). The mutation often results in a "Bax negative" phenotype and therefore is generally thought to be beneficial to the development of the tumor. Here, we report the identification of a novel Bax isoform, Bax Delta 2, which is unique to microsatellite unstable tumors. Bax Delta 2 is generated by a unique combination of a microsatellite deletion in Bax exon 3 and alternative splicing of Bax exon 2. Consistently, Bax Delta 2 is only detected in MSI cell lines and primary tumors. Bax Delta 2 is a potent cell death inducer but does not directly target mitochondria. In addition, Bax Delta 2 sensitizes certain MSI tumor cells to a subset of chemotherapeutic agents, such as adriamycin. Thus, our data provide evidence that mutation and alternative splicing of tumor suppressors such as Bax are not always beneficial to tumor development but can be detrimental instead.	[Xiang, Jialing] IIT, Dept Biol & Chem Sci, Chicago, IL 60616 USA; [Sharp, Juanita] Chicago State Univ, Chicago, IL 60628 USA	Illinois Institute of Technology; Chicago State University	Xiang, JL (corresponding author), IIT, Dept Biol & Chem Sci, 3101 S Dearborn St, Chicago, IL 60616 USA.	xiang@iit.edu			National Institutes of Health [CA128114]; NATIONAL CANCER INSTITUTE [R01CA128114] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported, in whole or in part, by National Institutes of Health Grant CA128114 (to J. X.).	Annis MG, 2005, EMBO J, V24, P2096, DOI 10.1038/sj.emboj.7600675; APTE SS, 1995, GENOMICS, V26, P592, DOI 10.1016/0888-7543(95)80180-T; Baldwin E. L., 2005, Current Medicinal Chemistry - Anti-Cancer Agents, V5, P363, DOI 10.2174/1568011054222364; Barbara JT, 2006, INT J CANCER, V118, P2509, DOI 10.1002/ijc.21710; Cartron PF, 2003, J BIOL CHEM, V278, P11633, DOI 10.1074/jbc.M208955200; Cartron PF, 2002, HUM MOL GENET, V11, P675, DOI 10.1093/hmg/11.6.675; Cartron PF, 2005, J BIOL CHEM, V280, P10587, DOI 10.1074/jbc.M409714200; Chlopkiewicz Bozena, 2002, Acta Pol Pharm, V59, P115; Duval A, 2002, CANCER RES, V62, P2447; El-Bchiri J, 2005, HUM MOL GENET, V14, P2435, DOI 10.1093/hmg/ddi245; Elliott B, 2001, MOL CELL BIOL, V21, P2671, DOI 10.1128/MCB.21.8.2671-2682.2001; Falchetti M, 2008, HUM PATHOL, V39, P925, DOI 10.1016/j.humpath.2007.10.024; Fallik D, 2003, CANCER RES, V63, P5738; Fu NY, 2009, MOL CELL, V33, P15, DOI 10.1016/j.molcel.2008.11.025; Gavathiotis E, 2008, NATURE, V455, P1076, DOI 10.1038/nature07396; Goel A, 2003, CANCER RES, V63, P1608; Goping IS, 1998, J CELL BIOL, V143, P207, DOI 10.1083/jcb.143.1.207; Habraken Y, 1996, CURR BIOL, V6, P1185, DOI 10.1016/S0960-9822(02)70686-6; Hofland KF, 2005, CLIN CANCER RES, V11, P3915, DOI 10.1158/1078-0432.CCR-04-2343; Hussain AR, 2008, MOL CANCER THER, V7, P3318, DOI 10.1158/1535-7163.MCT-08-0541; Jeong SH, 2008, JPN J CLIN ONCOL, V38, P661, DOI 10.1093/jjco/hyn089; Jurgensmeier JM, 1998, P NATL ACAD SCI USA, V95, P4997, DOI 10.1073/pnas.95.9.4997; Kawaguchi M, 2009, INT J ONCOL, V35, P977, DOI 10.3892/ijo_00000411; Kohler T, 2002, LEUKEMIA, V16, P22, DOI 10.1038/sj.leu.2402340; Korsmeyer SJ, 1999, CANCER RES, V59, p1693S; KRAJEWSKI S, 1995, CANCER RES, V55, P4471; Kuismanen SA, 2002, AM J PATHOL, V160, P1953, DOI 10.1016/S0002-9440(10)61144-3; Lalier L, 2007, APOPTOSIS, V12, P887, DOI 10.1007/s10495-007-0749-1; Liu FT, 2008, BLOOD, V111, P2797, DOI 10.1182/blood-2007-08-110445; Mrozek A, 2003, CELL DEATH DIFFER, V10, P461, DOI 10.1038/sj.cdd.4401193; Nithipongvanitch R, 2007, J HISTOCHEM CYTOCHEM, V55, P629, DOI 10.1369/jhc.6A7146.2007; Olejniczak SH, 2008, CLIN CANCER RES, V14, P1550, DOI 10.1158/1078-0432.CCR-07-1255; OLTVAI ZN, 1993, CELL, V74, P609, DOI 10.1016/0092-8674(93)90509-O; Rampino N, 1997, SCIENCE, V275, P967, DOI 10.1126/science.275.5302.967; Sani MA, 2009, BBA-BIOMEMBRANES, V1788, P623, DOI 10.1016/j.bbamem.2008.12.014; Schmitt E, 2000, BIOCHEM BIOPH RES CO, V270, P868, DOI 10.1006/bbrc.2000.2537; Schwartz S, 1999, CANCER RES, V59, P2995; Scorrano L, 2003, BIOCHEM BIOPH RES CO, V304, P437, DOI 10.1016/S0006-291X(03)00615-6; SEDLAK TW, 1995, P NATL ACAD SCI USA, V92, P7834, DOI 10.1073/pnas.92.17.7834; Shima K, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025062; Sun XD, 2006, PROSTATE, V66, P660, DOI 10.1002/pros.20390; Tamm I, 2002, CANCER GENE THER, V9, P641, DOI 10.1038/sj.cgt.7700480; Thomas AL, 1999, CELL DEATH DIFFER, V6, P97, DOI 10.1038/sj.cdd.4400474; Wei MC, 2001, SCIENCE, V292, P727, DOI 10.1126/science.1059108; Williams DS, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0016012; Wolter KG, 1997, J CELL BIOL, V139, P1281, DOI 10.1083/jcb.139.5.1281; Xiang JL, 1996, P NATL ACAD SCI USA, V93, P14559, DOI 10.1073/pnas.93.25.14559; Yeh ETH, 2004, CIRCULATION, V109, P3122, DOI 10.1161/01.CIR.0000133187.74800.B9; Yin X M, 1995, Curr Top Microbiol Immunol, V194, P331; YIN XM, 1994, NATURE, V369, P321, DOI 10.1038/369321a0; Zha HB, 1996, J BIOL CHEM, V271, P7440, DOI 10.1074/jbc.271.13.7440; Zhang L, 2000, SCIENCE, V290, P989, DOI 10.1126/science.290.5493.989; Zhou M, 1998, J BIOL CHEM, V273, P11930, DOI 10.1074/jbc.273.19.11930	53	19	19	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 5	2012	287	41					34722	34729		10.1074/jbc.M112.374785	http://dx.doi.org/10.1074/jbc.M112.374785			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	018IS	22910913	Green Published, hybrid			2022-12-25	WOS:000309654200072
J	Arase, F; Nishitani, H; Egusa, M; Nishimoto, N; Sakurai, S; Sakamoto, N; Kaminaka, H				Arase, Fumi; Nishitani, Hiroko; Egusa, Mayumi; Nishimoto, Nami; Sakurai, Sumiko; Sakamoto, Naho; Kaminaka, Hironori			IAA8 Involved in Lateral Root Formation Interacts with the TIR1 Auxin Receptor and ARF Transcription Factors in Arabidopsis	PLOS ONE			English	Article							BOX PROTEIN TIR1; AUX/IAA GENES; DOMAIN-II; CELL-DEATH; EXPRESSION; FAMILY; DEGRADATION; ENCODES; IDENTIFICATION; LOCALIZATION	The expression of auxin-responsive genes is regulated by the TIR1/AFB auxin receptor-dependent degradation of Aux/IAA transcriptional repressors, which interact with auxin-responsive factors (ARFs). Most of the 29 Aux/IAA genes present in Arabidopsis have not been functionally characterized to date. IAA8 appears to have a distinct function from the other Aux/IAA genes, due to its unique transcriptional response to auxin and the stability of its encoded protein. In this study, we characterized the function of Arabidopsis IAA8 in various developmental processes governed by auxin and in the transcriptional regulation of the auxin response. Transgenic plants expressing estrogen-inducible IAA8 (XVE::IAA8) exhibited significantly fewer lateral roots than the wild type, and an IAA8 loss-of-function mutant exhibited significantly more. Ectopic overexpression of IAA8 resulted in abnormal gravitropism. The strong induction of early auxin-responsive marker genes by auxin treatment was delayed by IAA8 overexpression. GFP-fusion analysis revealed that IAA8 localized not only to the nucleus, but, in contrast to other Aux/IAAs, also to the cytosol. Furthermore, we demonstrated that IAA8 interacts with TIR1, in an auxin-dependent fashion, and with ARF proteins, both in yeast and in planta. Taken together, our results show that IAA8 is involved in lateral root formation, and that this process is regulated through the interaction with the TIR1 auxin receptor and ARF transcription factors in the nucleus.	[Arase, Fumi; Nishitani, Hiroko; Egusa, Mayumi; Nishimoto, Nami; Sakurai, Sumiko; Sakamoto, Naho; Kaminaka, Hironori] Tottori Univ, Fac Agr, Plant Mol Biol Lab, Tottori 680, Japan	Tottori University	Arase, F (corresponding author), Tottori Univ, Fac Agr, Plant Mol Biol Lab, Tottori 680, Japan.	kaminaka@muses.tottori-u.ac.jp	Kaminaka, Hironori/AAD-9894-2020	Kaminaka, Hironori/0000-0002-3685-8688	NIBB Cooperative Research Program [7-342, 8-101, 9-102]; Japanese Ministry of Education, Sports, Culture, Science and Technology [1685101, 23770045]; Saneyoshi Scholarship Foundation; Sumitomo Foundation; Inamori Foundation	NIBB Cooperative Research Program; Japanese Ministry of Education, Sports, Culture, Science and Technology(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Saneyoshi Scholarship Foundation; Sumitomo Foundation; Inamori Foundation	This work was carried out partially under the NIBB Cooperative Research Program (7-342, 8-101, 9-102), and supported in part by a Grant-in-Aid for Scientific Research of Priority Areas on 'Organelle Differentiation as the Strategy for Environmental Adaptation in Plants' (no. 1685101) and a Grant-in-Aid for Young Scientists (B) (no. 23770045) from the Japanese Ministry of Education, Sports, Culture, Science and Technology, Saneyoshi Scholarship Foundation, Sumitomo Foundation, and Inamori Foundation to H. K. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ABEL S, 1995, J MOL BIOL, V251, P533, DOI 10.1006/jmbi.1995.0454; ABEL S, 1995, PLANT J, V8, P87, DOI 10.1046/j.1365-313X.1995.08010087.x; ABEL S, 1994, P NATL ACAD SCI USA, V91, P326, DOI 10.1073/pnas.91.1.326; Causier B, 2012, PLANT PHYSIOL, V158, P423, DOI 10.1104/pp.111.186999; Clough SJ, 1998, PLANT J, V16, P735, DOI 10.1046/j.1365-313x.1998.00343.x; Coll NS, 2011, CELL DEATH DIFFER, V18, P1247, DOI 10.1038/cdd.2011.37; Del Bianco M, 2011, CSH PERSPECT BIOL, V3, DOI 10.1101/cshperspect.a001578; Dharmasiri N, 2005, DEV CELL, V9, P109, DOI 10.1016/j.devcel.2005.05.014; Dharmasiri N, 2005, NATURE, V435, P441, DOI 10.1038/nature03543; Dreher KA, 2006, PLANT CELL, V18, P699, DOI 10.1105/tpc.105.039172; Fukaki H, 2002, PLANT J, V29, P153, DOI 10.1046/j.0960-7412.2001.01201.x; Gray WM, 2001, NATURE, V414, P271, DOI 10.1038/35104500; Gray WM, 1999, GENE DEV, V13, P1678, DOI 10.1101/gad.13.13.1678; Greenham K, 2011, CURR BIOL, V21, P520, DOI 10.1016/j.cub.2011.02.029; Groover AT, 2003, PLANT MOL BIOL, V51, P427, DOI 10.1023/A:1022039815537; Hamann T, 2002, GENE DEV, V16, P1610, DOI 10.1101/gad.229402; Hardtke CS, 2004, DEVELOPMENT, V131, P1089, DOI 10.1242/dev.00925; Holt BF, 2005, SCIENCE, V309, P929, DOI 10.1126/science.1109977; Kaminaka H, 2006, EMBO J, V25, P4400, DOI 10.1038/sj.emboj.7601312; Karimi M, 2002, TRENDS PLANT SCI, V7, P193, DOI 10.1016/S1360-1385(02)02251-3; Kawai J, 2003, GENOME RES, V13, P1488, DOI 10.1101/gr.914203; Kazan K, 2009, TRENDS PLANT SCI, V14, P373, DOI 10.1016/j.tplants.2009.04.005; Kepinski S, 2005, NATURE, V435, P446, DOI 10.1038/nature03542; Kieffer M, 2010, CURR OPIN PLANT BIOL, V13, P12, DOI 10.1016/j.pbi.2009.10.006; Kim J, 1997, P NATL ACAD SCI USA, V94, P11786, DOI 10.1073/pnas.94.22.11786; Koroleva OA, 2005, PLANT J, V41, P162, DOI 10.1111/j.1365-313X.2004.02281.x; Lee YJ, 2001, PLANT CELL, V13, P2175, DOI 10.1105/tpc.13.10.2175; Li JF, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027364; Maraschin FD, 2009, PLANT J, V59, P100, DOI 10.1111/j.1365-313X.2009.03854.x; Momonoi K, 2009, PLANT J, V59, P437, DOI 10.1111/j.1365-313X.2009.03879.x; Muto H, 2007, PLANT PHYSIOL, V144, P187, DOI 10.1104/pp.107.096628; Nagpal P, 2000, PLANT PHYSIOL, V123, P563, DOI 10.1104/pp.123.2.563; Nakamura S, 2010, BIOSCI BIOTECH BIOCH, V74, P1315, DOI 10.1271/bbb.100184; Ouellet F, 2001, PLANT CELL, V13, P829, DOI 10.1105/tpc.13.4.829; Overvoorde PJ, 2005, PLANT CELL, V17, P3282, DOI 10.1105/tpc.105.036723; Padmanabhan MS, 2006, MOL PLANT MICROBE IN, V19, P864, DOI 10.1094/MPMI-19-0864; Park JY, 2002, PLANT J, V32, P669, DOI 10.1046/j.1365-313X.2002.01459.x; Parry G, 2009, P NATL ACAD SCI USA, V106, P22540, DOI 10.1073/pnas.0911967106; Prigge MJ, 2010, CURR BIOL, V20, P1907, DOI 10.1016/j.cub.2010.08.050; Rademacher EH, 2011, PLANT J, V68, P597, DOI 10.1111/j.1365-313X.2011.04710.x; Ramos JA, 2001, PLANT CELL, V13, P2349, DOI 10.1105/tpc.13.10.2349; Reed JW, 2001, TRENDS PLANT SCI, V6, P420, DOI 10.1016/S1360-1385(01)02042-8; Rouse D, 1998, SCIENCE, V279, P1371, DOI 10.1126/science.279.5355.1371; Sato A, 2008, PHYSIOL PLANTARUM, V133, P397, DOI 10.1111/j.1399-3054.2008.01055.x; Shen CJ, 2010, J EXP BOT, V61, P3971, DOI 10.1093/jxb/erq208; Singh T, 2009, PLANT J, V60, P488, DOI 10.1111/j.1365-313X.2009.03970.x; Szemenyei H, 2008, SCIENCE, V319, P1384, DOI 10.1126/science.1151461; Tan X, 2007, NATURE, V446, P640, DOI 10.1038/nature05731; Tatematsu K, 2004, PLANT CELL, V16, P379, DOI 10.1105/tpc.018630; Tian Q, 2002, PLANT CELL, V14, P301, DOI 10.1105/tpc.010283; Tian Q, 1999, DEVELOPMENT, V126, P711; Tiwari SB, 2004, PLANT CELL, V16, P533, DOI 10.1105/tpc.017384; Tiwari SB, 2003, PLANT CELL, V15, P533, DOI 10.1105/tpc.008417; Uehara T, 2008, PLANT CELL PHYSIOL, V49, P1025, DOI 10.1093/pcp/pcn079; Wang H, 2005, PLANT CELL, V17, P2676, DOI 10.1105/tpc.105.033415; Yamada K, 2003, SCIENCE, V302, P842, DOI 10.1126/science.1088305; Yoo SD, 2007, NAT PROTOC, V2, P1565, DOI 10.1038/nprot.2007.199; Zuo JR, 2000, PLANT J, V24, P265, DOI 10.1046/j.1365-313x.2000.00868.x	58	46	63	2	59	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 17	2012	7	8							e43414	10.1371/journal.pone.0043414	http://dx.doi.org/10.1371/journal.pone.0043414			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	996DG	22912871	gold, Green Published, Green Submitted			2022-12-25	WOS:000308063700099
J	Chen, JM; Uplekar, S; Gordon, SV; Cole, ST				Chen, Jeffrey M.; Uplekar, Swapna; Gordon, Stephen V.; Cole, Stewart T.			A Point Mutation in cycA Partially Contributes to the D-cycloserine Resistance Trait of Mycobacterium bovis BCG Vaccine Strains	PLOS ONE			English	Article							D-ALANINE RACEMASE; TUBERCULOSIS; SMEGMATIS; MUTANTS; TRANSFORMATION; POLYMORPHISMS; EFFICACY; SEQUENCE; IMPACT; GROWTH	In mycobacteria, CycA a D-serine, L-and D-alanine, and glycine transporter also functions in the uptake of D-cycloserine, an important second-line anti-tubercular drug. A single nucleotide polymorphism identified in the cycA gene of BCG was hypothesized to contribute to the increased resistance of Mycobacterium bovis bacillus Calmette-Guerin (BCG) to D-cycloserine compared to wild-type Mycobacterium tuberculosis or Mycobacterium bovis. Working along these lines, a merodiploid strain of BCG expressing Mycobacterium tuberculosis CycA was generated and found to exhibit increased susceptibility to D-cycloserine albeit not to the same extent as wild-type Mycobacterium tuberculosis or Mycobacterium bovis. In addition, recombinant Mycobacterium smegmatis strains expressing either Mycobacterium tuberculosis or Mycobacterium bovis CycA but not BCG CycA were rendered more susceptible to D-cycloserine. These findings support the notion that CycA-mediated uptake in BCG is impaired as a result of a single nucleotide polymorphism; however, the partial contribution of this impairment to D-cycloserine resistance suggests the involvement of additional genetic lesions in this phenotype.	[Chen, Jeffrey M.; Uplekar, Swapna; Cole, Stewart T.] Ecole Polytech Fed Lausanne, Global Hlth Inst, Lausanne, Switzerland; [Gordon, Stephen V.] Univ Coll Dublin, Sch Vet Med, Dublin 2, Ireland; [Gordon, Stephen V.] Univ Coll Dublin, Conway Inst, Dublin 2, Ireland; [Gordon, Stephen V.] Univ Coll Dublin, Sch Biomol & Biomed Sci, Dublin 2, Ireland; [Gordon, Stephen V.] Univ Coll Dublin, Sch Med, Dublin 2, Ireland; [Gordon, Stephen V.] Univ Coll Dublin, Sch Med Sci, Dublin 2, Ireland	Swiss Federal Institutes of Technology Domain; Ecole Polytechnique Federale de Lausanne; University College Dublin; University College Dublin; University College Dublin; University College Dublin; University College Dublin	Chen, JM (corresponding author), Ecole Polytech Fed Lausanne, Global Hlth Inst, Lausanne, Switzerland.	jeffrey.chen@epfl.ch		Chen, Jeffrey/0000-0001-8431-3802; Gordon, Stephen/0000-0002-4833-5542	Canadian Thoracic Society/Canadian Lung Association; Canadian Institutes of Health Research; SystemsX.ch	Canadian Thoracic Society/Canadian Lung Association; Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR)); SystemsX.ch	JMC is a recipient of fellowships from the Canadian Thoracic Society/Canadian Lung Association and the Canadian Institutes of Health Research. This work was supported by SystemsX.ch. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2008, TUBERCULOSIS EDINB, V88, P100; Bange F.-C., 1999, Tubercle and Lung Disease, V79, P171, DOI 10.1054/tuld.1998.0201; Behr MA, 1999, SCIENCE, V284, P1520, DOI 10.1126/science.284.5419.1520; Belanger AE, 2000, J BACTERIOL, V182, P6854, DOI 10.1128/JB.182.23.6854-6856.2000; Brosch R, 2007, P NATL ACAD SCI USA, V104, P5596, DOI 10.1073/pnas.0700869104; Bruning JB, 2011, ANTIMICROB AGENTS CH, V55, P291, DOI 10.1128/AAC.00558-10; Bryson K, 2005, NUCLEIC ACIDS RES, V33, pW36, DOI 10.1093/nar/gki410; Caceres NE, 1997, J BACTERIOL, V179, P5046, DOI 10.1128/jb.179.16.5046-5055.1997; Caminero JA, 2010, LANCET INFECT DIS, V10, P621, DOI 10.1016/S1473-3099(10)70139-0; Chacon O, 2002, ANTIMICROB AGENTS CH, V46, P47, DOI 10.1128/AAC.46.2.47-54.2002; Chen JM, 2007, VACCINE, V25, P8114, DOI 10.1016/j.vaccine.2007.09.041; Chen JM, 2003, INFECT IMMUN, V71, P708, DOI 10.1128/IAI.71.2.708-716.2003; Cole ST, 1998, NATURE, V393, P537, DOI 10.1038/31159; CORPET F, 1988, NUCLEIC ACIDS RES, V16, P10881, DOI 10.1093/nar/16.22.10881; Danilchanka O, 2008, ANTIMICROB AGENTS CH, V52, P2503, DOI 10.1128/AAC.00298-08; DAVID HL, 1971, APPL MICROBIOL, V21, P888, DOI 10.1128/AEM.21.5.888-892.1971; DONNELLYWU MK, 1993, MOL MICROBIOL, V7, P407, DOI 10.1111/j.1365-2958.1993.tb01132.x; Durek C, 2000, EUR UROL, V37, P21, DOI 10.1159/000052378; Feher T, 2006, MUTAT RES-FUND MOL M, V595, P184, DOI 10.1016/j.mrfmmm.2005.11.004; Feng ZY, 2003, ANTIMICROB AGENTS CH, V47, P283, DOI 10.1128/AAC.47.1.283-291.2003; GOH KS, 1991, RES MICROBIOL, V142, P659, DOI 10.1016/0923-2508(91)90079-P; GRIFFITH ME, 1992, ANTIMICROB AGENTS CH, V36, P2398, DOI 10.1128/AAC.36.11.2398; Halouska S, 2007, J PROTEOME RES, V6, P4608, DOI 10.1021/pr0704332; Leung AS, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-413; Lew JM, 2011, TUBERCULOSIS, V91, P1, DOI 10.1016/j.tube.2010.09.008; Mostowy S, 2003, VACCINE, V21, P4270, DOI 10.1016/S0264-410X(03)00484-5; Pelayo MCG, 2009, INFECT IMMUN, V77, P2230, DOI 10.1128/IAI.01099-08; Peteroy M, 2000, ANTIMICROB AGENTS CH, V44, P1701, DOI 10.1128/AAC.44.6.1701-1704.2000; Pym AS, 2002, MOL MICROBIOL, V46, P709, DOI 10.1046/j.1365-2958.2002.03237.x; Saier MH, 2009, NUCLEIC ACIDS RES, V37, pD274, DOI 10.1093/nar/gkn862; Sassetti CM, 2003, MOL MICROBIOL, V48, P77, DOI 10.1046/j.1365-2958.2003.03425.x; Siroy A, 2008, J BIOL CHEM, V283, P17827, DOI 10.1074/jbc.M800866200; Spyropoulos IC, 2004, BIOINFORMATICS, V20, P3258, DOI 10.1093/bioinformatics/bth358; Tusnady GE, 2001, BIOINFORMATICS, V17, P849, DOI 10.1093/bioinformatics/17.9.849; Wang F, 2010, ANTIMICROB AGENTS CH, V54, P3776, DOI 10.1128/AAC.00453-10; Wards BJ, 1996, FEMS MICROBIOL LETT, V145, P101, DOI 10.1016/0378-1097(96)00394-1	36	23	26	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 17	2012	7	8							e43467	10.1371/journal.pone.0043467	http://dx.doi.org/10.1371/journal.pone.0043467			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	996DG	22912881	Green Published, Green Submitted, gold			2022-12-25	WOS:000308063700109
J	Gakuya, F; Ombui, J; Heukelbach, J; Maingi, N; Muchemi, G; Ogara, W; Mijele, D; Alasaad, S				Gakuya, Francis; Ombui, Jackson; Heukelbach, Jorg; Maingi, Ndichu; Muchemi, Gerald; Ogara, William; Mijele, Domnic; Alasaad, Samer			Knowledge of Mange among Masai Pastoralists in Kenya	PLOS ONE			English	Article							SARCOPTES-SCABIEI; GENETIC-STRUCTURE; WILD ANIMALS; MITE; EPIDEMIOLOGY; IVERMECTIN; ACARI	Background: Pastoralists in low-income countries usually live in close proximity to their animals and thus represent an important repository of information about livestock disease. Since wild and domestic animals often mix freely whilst grazing, pastoralists are also able to observe first-hand the diseases that are present in wildlife and as such are key informants in disease outbreaks in sylvatic animals. We report here the findings of the first study of the knowledge and role of Masai pastoralists in mange in wildlife and livestock in Masai Mara, Kenya. Methodology/Principal Findings: In this paper we describe the knowledge of mange accrued by 56 Masai pastoralists in Kenya and how they respond to it in both wildlife and livestock. In total, 52 (93%) pastoralists had a clear idea of the clinical appearance of mange, 13 (23%) understood its aetiology and 37 (66%) knew that mites were the causal agent. Thirty-nine (69%) believed that mange cross-infection between domestic and wild animals occurs, while 48 (85%) had observed mange in domestic animals including sheep (77%), goats (57%), dogs (24%) and cattle (14%). The pastoralists had also observed wild animals infected with mange, above all lions (19%), gazelles (14%), cheetahs (12%) and wildebeests (2%). In 68% of cases Masai pastoralists treat mange infection or apply control measures, most commonly via the topical use of acaricides (29%) and/or the reporting of the outbreak to the veterinary authorities (21%). In the period 2007-2011, Kenya Wildlife Service received 24 warnings of 59 wild animals with mange-like lesions from the Masai Mara pastoralist community. The reported species were cheetah, lion, wild dog, Thomson's gazelle and wildebeest. Conclusion: Masai pastoralists have good knowledge of mange epidemiology and treatment. Their observations and the treatments they apply are valuable in the control of this disease in both wild and domestic animals.	[Gakuya, Francis; Mijele, Domnic] Kenya Wildlife Serv, Dept Vet & Capture Serv, Nairobi, Kenya; [Ombui, Jackson; Muchemi, Gerald; Ogara, William] Univ Nairobi, Dept Publ Hlth Pharmacol & Toxicol, Nairobi, Kenya; [Heukelbach, Jorg] Univ Fed Ceara, Sch Med, Dept Community Hlth, Fortaleza, Ceara, Brazil; [Maingi, Ndichu] Univ Nairobi, Dept Pathol & Microbiol, Nairobi, Kenya; [Alasaad, Samer] CSIC, Estn Biol Donana, E-41080 Seville, Spain; [Alasaad, Samer] Univ Zurich, Inst Evolutionary Biol & Environm Studies IEU, Zurich, Switzerland	University of Nairobi; Universidade Federal do Ceara; University of Nairobi; Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Estacion Biologica de Donana (EBD); University of Zurich	Gakuya, F (corresponding author), Kenya Wildlife Serv, Dept Vet & Capture Serv, Nairobi, Kenya.	sameralasaad@hotmail.com	Angelone, Samer/G-4727-2013	Angelone, Samer/0000-0003-0868-7276; Heukelbach, Jorg/0000-0002-7845-5510	Kenya Wildlife Service; Projecto de Excelencia (Junta de Andalucia, Spain); Juan de la Cierva Grant	Kenya Wildlife Service; Projecto de Excelencia (Junta de Andalucia, Spain)(Junta de Andalucia); Juan de la Cierva Grant	The research was supported by Kenya Wildlife Service, Projecto de Excelencia (Junta de Andalucia, Spain) and Juan de la Cierva Grant. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alasaad S, 2008, PARASITOL RES, V104, P101, DOI 10.1007/s00436-008-1165-3; Alasaad S, 2009, PARASITOL RES, V104, P723, DOI 10.1007/s00436-009-1333-0; Alasaad S, 2009, VET PARASITOL, V159, P181, DOI 10.1016/j.vetpar.2008.10.001; Alasaad S, 2011, VET PARASITOL; Alasaad S, 2012, FORENSIC SCI MED PAT, V8, P280, DOI 10.1007/s12024-011-9268-z; Alasaad S, 2011, PARASITE VECTOR, V4, DOI 10.1186/1756-3305-4-151; Alasaad S, 2011, INT J INFECT DIS, V15, pE294, DOI 10.1016/j.ijid.2011.01.012; [Anonymous], 1989, SMALL ANIMAL DERMATO; ARLIAN LG, 1989, ANNU REV ENTOMOL, V34, P139, DOI 10.1146/annurev.en.34.010189.001035; Blood D. C., 1989, VET MED TXB DIS CATT, P1094; Bornstein Set, 2001, P107, DOI 10.1002/9780470377000.ch5; Bradberry Sally M, 2005, Toxicol Rev, V24, P93, DOI 10.2165/00139709-200524020-00003; Currie BJ, 2004, CLIN INFECT DIS, V39, pE8, DOI 10.1086/421776; Dagleish MP, 2007, J WILDLIFE DIS, V43, P512, DOI 10.7589/0090-3558-43.3.512; Fain A., 1968, ACTA ZOOL PATHOL ANT, V47, P1; Gakuya F, 2012, PARASITOLOGY, V139, P1587, DOI 10.1017/S0031182012000935; Gakuya F, 2011, PARASITE VECTOR, V4, DOI 10.1186/1756-3305-4-193; Heukelbach J, 2004, B WORLD HEALTH ORGAN, V82, P563; Heukelbach J, 2006, LANCET, V367, P1767, DOI 10.1016/S0140-6736(06)68772-2; Kahn CM, 2005, MERCK VET MANUAL, V9th, P742; Leon-Vizcaino L, 2001, J WILDLIFE DIS, V37, P775, DOI 10.7589/0090-3558-37.4.775; Mugera G. M., 1979, DIS CATTLE TROPICAL, P296; Munang'andu HM, 2010, BMC VET RES, V6, DOI 10.1186/1746-6148-6-29; Mwanzia Jacob M., 1995, P105; Ngoru B., 2002, CHEETAH ACINONYX JUB; Obasanjo OO, 2001, INFECT CONT HOSP EP, V22, P13, DOI 10.1086/501818; Pence DB, 2002, REV SCI TECH OIE, V21, P385, DOI 10.20506/rst.21.2.1335; Polley L, 2005, INT J PARASITOL, V35, P1279, DOI 10.1016/j.ijpara.2005.07.003; Rasero R, 2010, BIOL CONSERV, V143, P1269, DOI 10.1016/j.biocon.2010.03.001; Sanders A, 2000, MED VET ENTOMOL, V14, P131, DOI 10.1046/j.1365-2915.2000.00223.x; Sanderson H, 2007, AQUAT TOXICOL, V85, P229, DOI 10.1016/j.aquatox.2007.08.011; Serrano E, 2011, EPIDEMIOL INFECT, V139, P1626, DOI 10.1017/S0950268811000951; Soulsbury CD, 2007, MAMMAL REV, V37, P278, DOI 10.1111/j.1365-2907.2007.00101.x; Walton SF, 2004, ADV PARASIT, V57, P309, DOI 10.1016/S0065-308X(04)57005-7; Walton SF, 1999, AM J TROP MED HYG, V61, P542, DOI 10.4269/ajtmh.1999.61.542; Walton SF, 1997, MOL BIOCHEM PARASIT, V85, P187, DOI 10.1016/S0166-6851(96)02825-3; Walton SF, 2004, INT J PARASITOL, V34, P839, DOI 10.1016/j.ijpara.2004.04.002; Zahler M, 1999, INT J PARASITOL, V29, P759, DOI 10.1016/S0020-7519(99)00034-X	38	14	14	1	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 17	2012	7	8							e43342	10.1371/journal.pone.0043342	http://dx.doi.org/10.1371/journal.pone.0043342			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	996DG	22912858	Green Submitted, Green Published, gold			2022-12-25	WOS:000308063700086
J	Garg, P; Borel, C; Sharp, AJ				Garg, Paras; Borel, Christelle; Sharp, Andrew J.			Detection of Parent-of-Origin Specific Expression Quantitative Trait Loci by Cis-Association Analysis of Gene Expression in Trios	PLOS ONE			English	Article							BIPOLAR AFFECTIVE-DISORDER; GENOME-WIDE ASSOCIATION; POPULATION; TRANSMISSION; PATTERNS	Parent-of-origin (PofO) effects, such as imprinting are a phenomenon in which homologous chromosomes exhibit differential gene expression and epigenetic modifications according to their parental origin. Such non-Mendelian inheritance patterns are generally ignored by conventional association studies, as these tests consider the maternal and paternal alleles as equivalent. To identify regulatory regions that show PofO effects on gene expression (imprinted expression Quantitative Trait Loci, ieQTLs), here we have developed a novel method in which we associate SNP genotypes of defined parental origin with gene expression levels. We applied this method to study 59 HapMap phase II parent-offspring trios. By analyzing mother/father/child trios, rules of Mendelian inheritance allowed the parental origin to be defined for similar to 95% of SNPs in each child. We used 680,475 informative SNPs and corresponding expression data for 92,167 probe sets from Affymetrix GeneChip Human Exon 1.0 ST arrays and performed four independent cis-association analyses with the expression level of RefSeq genes within 1 Mb using PLINK. Independent analyses of maternal and paternal genotypes identified two significant cis-ieQTLs (p<10(-7)) at which expression of genes SFT2D2 and SRRT associated exclusively with maternally inherited SNPs rs3753292 and rs6945374, respectively. 28 additional suggestive cis-associations with only maternal or paternal SNPs were found at a lower stringency threshold of p<10(-6), including associations with two known imprinted genes PEG10 and TRAPPC9, demonstrating the efficacy of our method. Furthermore, comparison of our method that utilizes independent analyses of maternal and paternal genotypes with the Likelihood Ratio Test (LRT) showed it to be more effective for detecting imprinting effects than the LRT. Our method represents a novel approach that can identify imprinted regulatory elements that control gene expression, suggesting novel PofO effects in the human genome.	[Garg, Paras; Borel, Christelle; Sharp, Andrew J.] Mt Sinai Sch Med, Dept Genet & Genom Sci, New York, NY USA	Icahn School of Medicine at Mount Sinai	Garg, P (corresponding author), Mt Sinai Sch Med, Dept Genet & Genom Sci, New York, NY USA.	andrew.sharp@mssm.edu	borel, christelle/AAC-9645-2019		Fondation Jerome Lejeune	Fondation Jerome Lejeune	This work was supported by a grant from the Fondation Jerome Lejeune to AJS (www.fondationlejeune.org/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bell JT, 2011, GENOME BIOL, V12, DOI 10.1186/gb-2011-12-1-r10; Belonogova NM, 2010, EUR J HUM GENET, V18, P379, DOI 10.1038/ejhg.2009.167; Benyamin B, 2009, PHARMACOGENOMICS, V10, P181, DOI 10.2217/14622416.10.2.181; Carroll WD, 2005, PEDIAT ALLERG IMM-UK, V16, P32, DOI 10.1111/j.1399-3038.2005.00249.x; Duggal P, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-516; Franks S, 2001, HUM REPROD UPDATE, V7, P405, DOI 10.1093/humupd/7.4.405; Frazer KA, 2007, NATURE, V449, P851, DOI 10.1038/nature06258; Frost JM, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013556; Gardner RJ, 2000, HUM MOL GENET, V9, P589, DOI 10.1093/hmg/9.4.589; Gerrits A, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000692; Gertz J, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1002228; Gregg C, 2010, SCIENCE, V329, P682, DOI 10.1126/science.1190831; Kong A, 2009, NATURE, V462, P868, DOI 10.1038/nature08625; Kornberg JR, 2000, J AFFECT DISORDERS, V59, P183, DOI 10.1016/S0165-0327(99)00151-2; Lau JCY, 2004, NUCLEIC ACIDS RES, V32, P3376, DOI 10.1093/nar/gkh671; MCMAHON FJ, 1995, AM J HUM GENET, V56, P1277; Montgomery SB, 2010, NATURE, V464, P773, DOI 10.1038/nature08903; Morison IM, 2005, TRENDS GENET, V21, P457, DOI 10.1016/j.tig.2005.06.008; Nica AC, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1002003; NICHOLLS RD, 1989, NATURE, V342, P281, DOI 10.1038/342281a0; Nicolae DL, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1000888; Oudejans CBM, 2004, MOL HUM REPROD, V10, P589, DOI 10.1093/molehr/gah080; Pickrell JK, 2010, NATURE, V464, P768, DOI 10.1038/nature08872; Pollard KS, 2008, HUM GENET, V122, P625, DOI 10.1007/s00439-007-0440-1; Purcell S, 2007, AM J HUM GENET, V81, P559, DOI 10.1086/519795; REIK W, 1995, HUM MOL GENET, V4, P2379, DOI 10.1093/hmg/4.12.2379; Spencer CCA, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000477; Stranger BE, 2007, NAT GENET, V39, P1217, DOI 10.1038/ng2142; Stranger BE, 2007, SCIENCE, V315, P848, DOI 10.1126/science.1136678; Stranger BE, 2005, PLOS GENET, V1, P695, DOI 10.1371/journal.pgen.0010078; Suazo J, 2010, AM J MED GENET A, V152A, P2011, DOI 10.1002/ajmg.a.33528; Sull JW, 2008, GENET EPIDEMIOL, V32, P505, DOI 10.1002/gepi.20323; Sull JW, 2009, HUM GENET, V126, P385, DOI 10.1007/s00439-009-0680-3; Wallace C, 2010, NAT GENET, V42, P68, DOI 10.1038/ng.493; Weinberg CR, 1998, AM J HUM GENET, V62, P969, DOI 10.1086/301802; Zeft A, 2008, CLIN RHEUMATOL, V27, P241, DOI 10.1007/s10067-007-0778-8; Zhang W, 2009, HUM GENET, V125, P81, DOI 10.1007/s00439-008-0601-x	37	10	10	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 17	2012	7	8							e41695	10.1371/journal.pone.0041695	http://dx.doi.org/10.1371/journal.pone.0041695			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	996DG	22912676	Green Submitted, Green Published, gold			2022-12-25	WOS:000308063700006
J	Huang, T; Jiang, M; Kong, XY; Cai, YD				Huang, Tao; Jiang, Min; Kong, Xiangyin; Cai, Yu-Dong			Dysfunctions Associated with Methylation, MicroRNA Expression and Gene Expression in Lung Cancer	PLOS ONE			English	Article							SOMATIC MUTATIONS; SYSTEMS BIOLOGY; NONSMALL; PROFILES; TARGETS; CELLS; ADENOCARCINOMA; EGFR; ACTIVATION; PREDICTION	Integrating high-throughput data obtained from different molecular levels is essential for understanding the mechanisms of complex diseases such as cancer. In this study, we integrated the methylation, microRNA and mRNA data from lung cancer tissues and normal lung tissues using functional gene sets. For each Gene Ontology (GO) term, three sets were defined: the methylation set, the microRNA set and the mRNA set. The discriminating ability of each gene set was represented by the Matthews correlation coefficient (MCC), as evaluated by leave-one-out cross-validation (LOOCV). Next, the MCCs in the methylation sets, the microRNA sets and the mRNA sets were ranked. By comparing the MCC ranks of methylation, microRNA and mRNA for each GO term, we classified the GO sets into six groups and identified the dysfunctional methylation, microRNA and mRNA gene sets in lung cancer. Our results provide a systematic view of the functional alterations during tumorigenesis that may help to elucidate the mechanisms of lung cancer and lead to improved treatments for patients.	[Cai, Yu-Dong] Shanghai Univ, Inst Syst Biol, Shanghai, Peoples R China; [Huang, Tao] Chinese Acad Sci, Shanghai Inst Biol Sci, Key Lab Syst Biol, Shanghai, Peoples R China; [Huang, Tao] Shanghai Ctr Bioinformat Technol, Shanghai, Peoples R China; [Jiang, Min; Kong, Xiangyin] Chinese Acad Sci, Inst Hlth Sci, Shanghai Inst Biol Sci, Shanghai, Peoples R China; [Jiang, Min; Kong, Xiangyin] Shanghai Jiao Tong Univ, Sch Med, Shanghai 200030, Peoples R China; [Jiang, Min; Kong, Xiangyin] Shanghai Jiao Tong Univ, Ruijin Hosp, State Key Lab Med Genom, Shanghai 200030, Peoples R China	Shanghai University; Chinese Academy of Sciences; Shanghai Institutes for Biological Sciences, CAS; Chinese Academy of Sciences; Chinese Academy of Sciences; Shanghai Institutes for Biological Sciences, CAS; Shanghai Jiao Tong University; Chinese Academy of Sciences; Shanghai Jiao Tong University	Huang, T (corresponding author), Mt Sinai Sch Med, Dept Genet & Genom Sci, New York, NY 10029 USA.	xykong@sibs.ac.cn; cai_yud@yahoo.com.cn		cai, yudong/0000-0001-5664-7979	National Basic Research Program of China [2011CB510102, 2011CB510101, 2011CB910200, 2010CB912702]; National Natural Science Foundation of China [90913009]; Research Program of the Chinese Academy of Sciences [KSCX2-EW-R-04]; Innovation Program of the Shanghai Municipal Education Commission [12ZZ087]	National Basic Research Program of China(National Basic Research Program of China); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Research Program of the Chinese Academy of Sciences; Innovation Program of the Shanghai Municipal Education Commission(Innovation Program of Shanghai Municipal Education Commission)	This work was supported by grants from the National Basic Research Program of China (2011CB510102, 2011CB510101, 2011CB910200 and 2010CB912702), the National Natural Science Foundation of China (90913009), Research Program of the Chinese Academy of Sciences (KSCX2-EW-R-04) and the Innovation Program of the Shanghai Municipal Education Commission (12ZZ087). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akavia UD, 2010, CELL, V143, P1005, DOI 10.1016/j.cell.2010.11.013; Ashburner M, 2000, NAT GENET, V25, P25, DOI 10.1038/75556; Babbar N, 2006, J BIOL CHEM, V281, P24182, DOI 10.1074/jbc.M601871200; Bandi N, 2009, CANCER RES, V69, P5553, DOI 10.1158/0008-5472.CAN-08-4277; Bastide K, 2009, LUNG CANCER, V63, P348, DOI 10.1016/j.lungcan.2008.06.007; Belinsky SA, 2004, NAT REV CANCER, V4, P707, DOI 10.1038/nrc1432; Betel D, 2008, NUCLEIC ACIDS RES, V36, pD149, DOI 10.1093/nar/gkm995; Cai Y., 2011, AMINO ACIDS; Ceppi P, 2010, MOL CANCER RES, V8, P1207, DOI 10.1158/1541-7786.MCR-10-0052; Chari R, 2010, BMC SYST BIOL, V4, DOI 10.1186/1752-0509-4-67; Chari R, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-422; Chin LJ, 2008, CANCER RES, V68, P8535, DOI 10.1158/0008-5472.CAN-08-2129; Chitale D, 2009, ONCOGENE, V28, P2773, DOI 10.1038/onc.2009.135; Cho WCS, 2009, EUR J CANCER, V45, P2197, DOI 10.1016/j.ejca.2009.04.039; Chou RH, 2011, BIOCHEM BIOPH RES CO, V409, P442, DOI 10.1016/j.bbrc.2011.05.022; Christensen BC, 2009, CANCER RES, V69, P6315, DOI 10.1158/0008-5472.CAN-09-1073; Dacic S, 2010, MODERN PATHOL, V23, P1577, DOI 10.1038/modpathol.2010.152; Davies H, 2005, CANCER RES, V65, P7591, DOI 10.1158/0008-5472.CAN-05-1855; De Jong WK, 2009, ANTICANCER RES, V29, P363; Ding L, 2008, NATURE, V455, P1069, DOI 10.1038/nature07423; Fabbri M, 2007, P NATL ACAD SCI USA, V104, P15805, DOI 10.1073/pnas.0707628104; Friedman RC, 2009, GENOME RES, V19, P92, DOI 10.1101/gr.082701.108; Fruh M, 2011, LUNG CANCER, V72, P265, DOI 10.1016/j.lungcan.2011.02.020; Garofalo M, 2008, ONCOGENE, V27, P3845, DOI 10.1038/onc.2008.6; Greenman C, 2007, NATURE, V446, P153, DOI 10.1038/nature05610; Gregorc V, 2003, LUNG CANCER, V42, P275, DOI 10.1016/j.lungcan.2003.07.003; Griffiths-Jones S, 2006, NUCLEIC ACIDS RES, V34, pD140, DOI 10.1093/nar/gkj112; Hornberg JJ, 2006, BIOSYSTEMS, V83, P81, DOI 10.1016/j.biosystems.2005.05.014; Huang T, 2011, CROSSTISSUE COEXPRES; Huang T, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017291; Huang T, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016036; Huang T, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0034460; Huang T, 2012, BIOCHIMIE, V94, P1017, DOI 10.1016/j.biochi.2011.12.024; Huang T, 2012, PROTEIN CELL, V3, P38, DOI 10.1007/s13238-011-1130-2; Huang T, 2011, NEUROCOMPUTING, V74, P3677, DOI 10.1016/j.neucom.2011.07.019; Huang T, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025297; Huang T, 2011, OMICS, V15, P665, DOI 10.1089/omi.2011.0034; Huang T, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022940; Huang T, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011900; Huang T, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010972; Huang T, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0008126; Huang T, 2008, J TRANSL MED, V6, DOI 10.1186/1479-5876-6-44; Hurteau GJ, 2007, CANCER RES, V67, P7972, DOI 10.1158/0008-5472.CAN-07-1058; Jiang Lili, 2009, Zhongguo Fei Ai Za Zhi, V12, P1069, DOI 10.3779/j.issn.1009-3419.2009.10.03; Jiang Lili, 2009, Zhongguo Fei Ai Za Zhi, V12, P951, DOI 10.3779/j.issn.1009-3419.2009.09.002; Jo UH, 2008, BMC CANCER, V9, DOI 10.1186/1471-2407-8-359; Katsuda K, 2002, ONCOGENE, V21, P2108, DOI 10.1038/sj.onc.1205272; Kreeger PK, 2010, CARCINOGENESIS, V31, P2, DOI 10.1093/carcin/bgp261; Krek A, 2005, NAT GENET, V37, P495, DOI 10.1038/ng1536; Lee JH, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021300; Liu L, 2011, CANCER-AM CANCER SOC, V117, P5172, DOI 10.1002/cncr.26154; Oda K, 2005, MOL SYST BIOL, V1, DOI 10.1038/msb4100014; Peng J, 2010, ANN APPL STAT, V4, P53, DOI 10.1214/09-AOAS271; Ponomareva A A, 2011, Mol Biol (Mosk), V45, P203; Reinmuth N, 2008, LUNG CANCER, V62, P193, DOI 10.1016/j.lungcan.2008.03.011; Rikova K, 2007, CELL, V131, P1190, DOI 10.1016/j.cell.2007.11.025; Sanchez-Palencia A, 2010, INT J CANC; Sasaki H, 2009, J CANCER RES CLIN, V135, P313, DOI 10.1007/s00432-008-0464-5; Selamat SA, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021443; Sethupathy P, 2006, RNA, V12, P192, DOI 10.1261/rna.2239606; Tan X, 2011, CLIN CANC RES; Tellez CS, 2011, CANCER RES, V71, P3087, DOI 10.1158/0008-5472.CAN-10-3035; Toyooka S, 2011, GEN THORAC CARDIOVAS, V59, P527, DOI 10.1007/s11748-010-0743-3; Voortman J, 2010, CANCER RES, V70, P8288, DOI 10.1158/0008-5472.CAN-10-1348; Wang GF, 2008, FEBS LETT, V582, P3663, DOI 10.1016/j.febslet.2008.09.051; Wang SZE, 2006, CANCER CELL, V10, P25, DOI 10.1016/j.ccr.2006.05.023; Wang XW, 2008, BIOINFORMATICS, V24, P325, DOI 10.1093/bioinformatics/btm595; Warburton D, 2010, CURR TOP DEV BIOL, V90, P73, DOI 10.1016/S0070-2153(10)90003-3; Watanabe K, 2012, INT J CANCER, V130, P2580, DOI 10.1002/ijc.26254; Webster RJ, 2009, J BIOL CHEM, V284, P5731, DOI 10.1074/jbc.M804280200; Weiss J, 2010, SCI TRANSL MED, V2, DOI 10.1126/scitranslmed.3001451; Wesche J, 2011, BIOCHEM J, V437, P199, DOI 10.1042/BJ20101603; Xiang X, 2011, ONCOGENE, V30, P3440, DOI 10.1038/onc.2011.54; Yanaihara N, 2006, CANCER CELL, V9, P189, DOI 10.1016/j.ccr.2006.01.025; Yu SL, 2008, CANCER CELL, V13, P48, DOI 10.1016/j.ccr.2007.12.008; Zimmer S, 2009, J CANCER RES CLIN, V135, P723, DOI 10.1007/s00432-008-0509-9	76	15	15	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 17	2012	7	8							e43441	10.1371/journal.pone.0043441	http://dx.doi.org/10.1371/journal.pone.0043441			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	996DG	22912875	Green Published, Green Submitted, gold			2022-12-25	WOS:000308063700103
J	Maciotta, S; Meregalli, M; Cassinelli, L; Parolini, D; Farini, A; Del Fraro, G; Gandolfi, F; Forcato, M; Ferrari, S; Gabellini, D; Bicciato, S; Cossu, G; Torrente, Y				Maciotta, Simona; Meregalli, Mirella; Cassinelli, Letizia; Parolini, Daniele; Farini, Andrea; Del Fraro, Giulia; Gandolfi, Francesco; Forcato, Mattia; Ferrari, Sergio; Gabellini, Davide; Bicciato, Silvio; Cossu, Giulio; Torrente, Yvan			Hmgb3 Is Regulated by MicroRNA-206 during Muscle Regeneration	PLOS ONE			English	Article							DUCHENNE MUSCULAR-DYSTROPHY; EXPRESSION; DIFFERENTIATION; PATTERNS; MIR-206; MATURATION; SIGNATURE; MODELS; INJURY; MEMBER	Background: MicroRNAs (miRNAs) have been recently involved in most of human diseases as targets for potential strategies to rescue the pathological phenotype. Since the skeletal muscle is a spread-wide highly differentiated and organized tissue, rescue of severely compromised muscle still remains distant from nowadays. For this reason, we aimed to identify a subset of miRNAs major involved in muscle remodelling and regeneration by analysing the miRNA-profile of single fibres isolated from dystrophic muscle, which was here considered as a model of chronic damage. Methodology/Principal Findings: The miRNA-signature associated to regenerating (newly formed) and remodelling (resting) fibres was investigated in animal models of muscular dystrophies and acute damage, in order to distinguish which miRNAs are primary related to muscle regeneration. In this study we identify fourteen miRNAs associated to dystrophic fibres responsible for muscle regeneration and remodelling, and confirm over-expression of the previously identified regeneration-associated myomiR-206. In particular, a functional binding site for myomiR-206 was identified and validated in the 3'untranslated region (3'UTR) of an X-linked member of a family of sequence independent chromatin-binding proteins (Hmgb3) that is preferentially expressed in hematopoietic stem cells. During regeneration of single muscle fibres, Hmgb3 messenger RNA (mRNA) and protein expression was gradually reduced, concurrent with the up-regulation of miR-206. Conclusion/Significance: Our results elucidate a negative feedback circuit in which myomiR-206 represses Hmgb3 expression to modulate the regeneration of single muscle fibres after acute and chronic muscle damage. These findings suggest that myomiR-206 may be a potential therapeutic target in muscle diseases.	[Maciotta, Simona; Meregalli, Mirella; Cassinelli, Letizia; Parolini, Daniele; Farini, Andrea; Del Fraro, Giulia; Torrente, Yvan] Univ Milan, Stem Cell Lab, Dept Pathophysiol & Transplantat, Fdn IRCCS Ca Granda Osped Maggiore Policlin,Ctr D, Milan, Italy; [Gandolfi, Francesco; Forcato, Mattia; Ferrari, Sergio; Bicciato, Silvio] Univ Modena & Reggio Emilia, Dipartimento Sci Biomed, Modena, Italy; [Gabellini, Davide] Ist Sci San Raffaele, Dulbecco Telethon Inst, I-20132 Milan, Italy; [Gabellini, Davide] Ist Sci San Raffaele, Div Regenerat Med, I-20132 Milan, Italy; [Cossu, Giulio] UCL, Dept Cell & Dev Biol, London, England	IRCCS Ca Granda Ospedale Maggiore Policlinico; University of Milan; Universita di Modena e Reggio Emilia; Fondazione Telethon; Dulbecco Telethon Institute (DTI); Vita-Salute San Raffaele University; IRCCS Ospedale San Raffaele; Vita-Salute San Raffaele University; IRCCS Ospedale San Raffaele; University of London; University College London	Maciotta, S (corresponding author), Univ Milan, Stem Cell Lab, Dept Pathophysiol & Transplantat, Fdn IRCCS Ca Granda Osped Maggiore Policlin,Ctr D, Milan, Italy.	yvan.torrente@unimi.it	Gabellini, Davide/I-4551-2018; Forcato, Mattia/B-7733-2015; BICCIATO, Silvio/J-4466-2019; Ferrari, Sergio/A-1110-2010; Bicciato, Silvio/C-9825-2009; TORRENTE, YVAN/A-2964-2015	Gabellini, Davide/0000-0002-3811-4121; Forcato, Mattia/0000-0002-7383-6576; BICCIATO, Silvio/0000-0002-1944-7078; Ferrari, Sergio/0000-0002-4822-2521; Bicciato, Silvio/0000-0002-1944-7078; TORRENTE, YVAN/0000-0002-2705-3984; Meregalli, Mirella/0000-0002-5151-607X; Cossu, Giulio/0000-0001-5863-9593; Farini, Andrea/0000-0002-8514-4921	Association Monegasque contre les Myopathies (AMM); EU [223098]; Associazione La Nostra Famiglia Fondo DMD Gli Amici di Emanuele; Associazione Amici del Centro Dino Ferrari; Fondazione Telethon Funding Source: Custom	Association Monegasque contre les Myopathies (AMM); EU(European Commission); Associazione La Nostra Famiglia Fondo DMD Gli Amici di Emanuele; Associazione Amici del Centro Dino Ferrari; Fondazione Telethon(Fondazione Telethon)	This work was supported in part by grants from the Association Monegasque contre les Myopathies (AMM), EU's Framework programme 7 Optistem 223098, the Associazione La Nostra Famiglia Fondo DMD Gli Amici di Emanuele, and by the Associazione Amici del Centro Dino Ferrari. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anderson C, 2006, NUCLEIC ACIDS RES, V34, P5863, DOI 10.1093/nar/gkl743; Bae S, 2009, CELL TISSUE RES, V335, P565, DOI 10.1007/s00441-008-0729-y; Banks GB, 2008, CURR TOP DEV BIOL, V84, P431, DOI 10.1016/S0070-2153(08)00609-1; Bartel DP, 2004, CELL, V116, P281, DOI 10.1016/S0092-8674(04)00045-5; BISCHOFF R, 1986, DEV BIOL, V115, P129, DOI 10.1016/0012-1606(86)90234-4; BONILLA E, 1988, CELL, V54, P447, DOI 10.1016/0092-8674(88)90065-7; Cacchiarelli D, 2011, EMBO REP, V12, P136, DOI 10.1038/embor.2010.208; Cacchiarelli D, 2010, CELL METAB, V12, P341, DOI 10.1016/j.cmet.2010.07.008; Cardinali B, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007607; Chen TS, 2010, NUCLEIC ACIDS RES, V38, P215, DOI 10.1093/nar/gkp857; Creuzet S, 1998, EXP CELL RES, V243, P241, DOI 10.1006/excr.1998.4100; Crist CG, 2009, P NATL ACAD SCI USA, V106, P13383, DOI 10.1073/pnas.0900210106; DALBIS A, 1988, EUR J BIOCHEM, V174, P103, DOI 10.1111/j.1432-1033.1988.tb14068.x; Danieli-Betto D, 2005, AM J PHYSIOL-REG I, V289, pR1328, DOI 10.1152/ajpregu.00673.2004; Dey BK, 2011, MOL CELL BIOL, V31, P203, DOI 10.1128/MCB.01009-10; Duclos F, 1998, J CELL BIOL, V142, P1461, DOI 10.1083/jcb.142.6.1461; Eisenberg I, 2007, P NATL ACAD SCI USA, V104, P17016, DOI 10.1073/pnas.0708115104; Eisenberg I, 2009, J CELL MOL MED, V13, P2, DOI 10.1111/j.1582-4934.2008.00524.x; Emery AEH, 2002, LANCET, V359, P687, DOI 10.1016/S0140-6736(02)07815-7; Gabellini D, 2006, NATURE, V439, P973, DOI 10.1038/nature04422; Garry DJ, 2000, P NATL ACAD SCI USA, V97, P5416, DOI 10.1073/pnas.100501197; Greco S, 2009, FASEB J, V23, P3335, DOI 10.1096/fj.08-128579; Grist CG, 2010, CELL METAB, V12, P425, DOI 10.1016/j.cmet.2010.10.007; Grounds MD, 2008, CELL MOL LIFE SCI, V65, P1621, DOI 10.1007/s00018-008-7574-8; Hawke TJ, 2001, J APPL PHYSIOL, V91, P534, DOI 10.1152/jappl.2001.91.2.534; HOFFMAN EP, 1987, CELL, V51, P919, DOI 10.1016/0092-8674(87)90579-4; Kim HK, 2006, J CELL BIOL, V174, P677, DOI 10.1083/jcb.200603008; Kurek JB, 1997, MUSCLE NERVE, V20, P815; Lee EJ, 2008, RNA, V14, P35, DOI 10.1261/rna.804508; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Lu H, 2010, CARDIOVASC RES, V86, P410, DOI 10.1093/cvr/cvq010; Malumbres R, 2009, BLOOD, V113, P3754, DOI 10.1182/blood-2008-10-184077; Manzur AY, 2009, POSTGRAD MED J, V85, P622, DOI 10.1136/jnnp.2008.158329; Matkovich SJ, 2009, CIRCULATION, V119, P1263, DOI 10.1161/CIRCULATIONAHA.108.813576; McCarthy JJ, 2007, J APPL PHYSIOL, V102, P306, DOI 10.1152/japplphysiol.00932.2006; McCarthy JJ, 2011, EXERC SPORT SCI REV, V39, P150, DOI 10.1097/JES.0b013e31821c01e1; McCarthy JJ, 2008, BBA-GENE REGUL MECH, V1779, P682, DOI 10.1016/j.bbagrm.2008.03.001; Nemeth MJ, 2003, BLOOD, V102, P1298, DOI 10.1182/blood-2002-11-3541; Nie Y, 2011, INT J BIOL SCI, V7, P762, DOI 10.7150/ijbs.7.762; Nielsen S, 2010, J PHYSIOL-LONDON, V588, P4029, DOI 10.1113/jphysiol.2010.189860; Petrof BJ, 1998, MOL CELL BIOCHEM, V179, P111, DOI 10.1023/A:1006812004945; Rosenberg MI, 2006, J CELL BIOL, V175, P77, DOI 10.1083/jcb.200603039; Schoolmeesters A, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005605; Singh SK, 2008, FEBS J, V275, P4929, DOI 10.1111/j.1742-4658.2008.06624.x; STEDMAN HH, 1991, NATURE, V352, P536, DOI 10.1038/352536a0; Subramanian S, 2008, ONCOGENE, V27, P2015, DOI 10.1038/sj.onc.1210836; Sun M, 2009, AM J PHYSIOL-CELL PH, V301, pC21; Tanaka Shingo, 2011, J Mol Signal, V6, P12, DOI 10.1186/1750-2187-6-12; Thum T, 2008, NATURE, V456, P980, DOI 10.1038/nature07511; Vaccari T, 1998, GENOMICS, V49, P247, DOI 10.1006/geno.1998.5214; Vainzof M, 2008, J MOL NEUROSCI, V34, P241, DOI 10.1007/s12031-007-9023-9; WATKINS SC, 1988, NATURE, V333, P863, DOI 10.1038/333863a0; Wells D J, 2005, Acta Myol, V24, P172; Yuasa K, 2008, CELL STRUCT FUNCT, V33, P163, DOI 10.1247/csf.08022	54	30	30	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 17	2012	7	8							e43464	10.1371/journal.pone.0043464	http://dx.doi.org/10.1371/journal.pone.0043464			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	996DG	22912879	Green Published, gold, Green Submitted			2022-12-25	WOS:000308063700107
J	Pope, MD; Asthagiri, AR				Pope, Melissa D.; Asthagiri, Anand R.			Short-Lived, Transitory Cell-Cell Interactions Foster Migration-Dependent Aggregation	PLOS ONE			English	Article							MAMMARY EPITHELIAL-CELL; EPIDERMAL-GROWTH-FACTOR; ADHESION; EXPRESSION; MOTILITY; CADHERIN; MORPHOGENESIS; ORGANIZATION; MORPHOLOGY; MECHANISM	During embryonic development, motile cells aggregate into cohesive groups, which give rise to tissues and organs. The role of cell migration in regulating aggregation is unclear. The current paradigm for aggregation is based on an equilibrium model of differential cell adhesivity to neighboring cells versus the underlying substratum. In many biological contexts, however, dynamics is critical. Here, we provide evidence that multicellular aggregation dynamics involves both local adhesive interactions and transport by cell migration. Using time-lapse video microscopy, we quantified the duration of cell-cell contacts among migrating cells that collided and adhered to another cell. This lifetime of cell-cell interactions exhibited a monotonic decreasing dependence on substratum adhesivity. Parallel quantitative measurements of cell migration speed revealed that across the tested range of adhesive substrata, the mean time needed for cells to migrate and encounter another cell was greater than the mean adhesion lifetime, suggesting that aggregation dynamics may depend on cell motility instead of the local differential adhesivity of cells. Consistent with this hypothesis, aggregate size exhibited a biphasic dependence on substratum adhesivity, matching the trend we observed for cell migration speed. Our findings suggest a new role for cell motility, alongside differential adhesion, in regulating developmental aggregation events and motivate new design principles for tuning aggregation dynamics in tissue engineering applications.	[Pope, Melissa D.] Univ Colorado, Dept Chem & Biol Engn, Boulder, CO 80309 USA; [Asthagiri, Anand R.] Northeastern Univ, Dept Chem Engn, Boston, MA 02115 USA	University of Colorado System; University of Colorado Boulder; Northeastern University	Pope, MD (corresponding author), Univ Colorado, Dept Chem & Biol Engn, Boulder, CO 80309 USA.	anand@cell-engineering.org			National Institutes of Health (NIH) [R01-CA138899]; Jacobs Institute for Molecular Engineering for Medicine; National Science Foundation; NIH [NIH/NRSA5T32GM07616Z]; NATIONAL CANCER INSTITUTE [R01CA138899] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM007616] Funding Source: NIH RePORTER	National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Jacobs Institute for Molecular Engineering for Medicine; National Science Foundation(National Science Foundation (NSF)); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by the National Institutes of Health (NIH) grant R01-CA138899 and the Jacobs Institute for Molecular Engineering for Medicine. MP was supported by a National Science Foundation Graduate Research Fellowship and an NIH Molecular Cell Biology Training Grant (NIH/NRSA5T32GM07616Z). The funders had no role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bergin E, 2000, AM J PHYSIOL-RENAL, V278, pF758, DOI 10.1152/ajprenal.2000.278.5.F758; CLARK RAF, 1990, J INVEST DERMATOL, V94, pS128, DOI 10.1111/1523-1747.ep12876104; de Rooij J, 2005, J CELL BIOL, V171, P153, DOI 10.1083/jcb.200506152; DICKINSON RB, 1993, AICHE J, V39, P1995, DOI 10.1002/aic.690391210; Gumbiner BM, 1996, CELL, V84, P345, DOI 10.1016/S0092-8674(00)81279-9; Hanahan D, 2000, CELL, V100, P57, DOI 10.1016/S0092-8674(00)81683-9; Hartsock A, 2008, BBA-BIOMEMBRANES, V1778, P660, DOI 10.1016/j.bbamem.2007.07.012; Hofmann C, 2007, GASTROENTEROLOGY, V132, P587, DOI 10.1053/j.gastro.2006.11.017; Kass L, 2007, INT J BIOCHEM CELL B, V39, P1987, DOI 10.1016/j.biocel.2007.06.025; Kim JH, 2009, P NATL ACAD SCI USA, V106, P11149, DOI 10.1073/pnas.0812651106; LI Y, 1994, IN VITRO CELL DEV-AN, V30A, P105; LIN MY, 1989, NATURE, V339, P360, DOI 10.1038/339360a0; Luther MJ, 2005, AM J PHYSIOL-ENDOC M, V288, pE502, DOI 10.1152/ajpendo.00424.2004; Maheshwari G, 2001, J CELL BIOL, V155, P1123, DOI 10.1083/jcb.200109060; Mori H, 2009, P NATL ACAD SCI USA, V106, P14890, DOI 10.1073/pnas.0901269106; OBERLENDER SA, 1994, DEVELOPMENT, V120, P177; Palecek SP, 1997, NATURE, V385, P537, DOI 10.1038/385537a0; Pandis S. N., 2006, ATMOSPHERIC CHEM PHY; Pope MD, 2008, CELL ADHES MIGR, V2, P110, DOI 10.4161/cam.2.2.6218; Powers MJ, 1997, BIOTECHNOL BIOENG, V53, P415, DOI 10.1002/(SICI)1097-0290(19970220)53:4<415::AID-BIT10>3.3.CO;2-3; Reinhart-King CA, 2008, BIOPHYS J, V95, P6044, DOI 10.1529/biophysj.107.127662; Ridley AJ, 2003, SCIENCE, V302, P1704, DOI 10.1126/science.1092053; Runyan RB, 2005, MOL B INT U, P40; Ryan PL, 2001, P NATL ACAD SCI USA, V98, P4323, DOI 10.1073/pnas.071615398; Stefanelli A., 1961, ACTA EMBRYOL MORPHOL, V4, P47; Steinberg MS, 2007, CURR OPIN GENET DEV, V17, P281, DOI 10.1016/j.gde.2007.05.002; Steinberg MS, 1997, J CELL PHYSIOL, V173, P135, DOI 10.1002/(SICI)1097-4652(199711)173:2<135::AID-JCP10>3.3.CO;2-Y; STEINBERG MS, 1962, P NATL ACAD SCI USA, V48, P1769, DOI 10.1073/pnas.48.10.1769; SUNG KLP, 1986, SCIENCE, V234, P1405, DOI 10.1126/science.3491426; TOWNES PL, 1955, J EXP ZOOL, V128, P53, DOI 10.1002/jez.1401280105; Umeda T, 2004, J THEOR BIOL, V226, P215, DOI 10.1016/j.jtbi.2003.08.016; Walmod PS, 2001, METH MOL B, V161, P59; Wang YX, 2006, P NATL ACAD SCI USA, V103, P1774, DOI 10.1073/pnas.0510774103; Williams CM, 2008, CANCER RES, V68, P3185, DOI 10.1158/0008-5472.CAN-07-2673	34	5	5	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 17	2012	7	8							e43237	10.1371/journal.pone.0043237	http://dx.doi.org/10.1371/journal.pone.0043237			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	996DG	22912835	Green Published, gold, Green Submitted			2022-12-25	WOS:000308063700065
J	Wang, GZ; Meng, K; Luo, HY; Wang, YR; Huang, HQ; Shi, PJ; Yang, PL; Zhang, ZF; Yao, B				Wang, Guozeng; Meng, Kun; Luo, Huiying; Wang, Yaru; Huang, Huoqing; Shi, Pengjun; Yang, Peilong; Zhang, Zhifang; Yao, Bin			Phylogenetic Diversity and Environment-Specific Distributions of Glycosyl Hydrolase Family 10 Xylanases in Geographically Distant Soils	PLOS ONE			English	Article							GENE; DISCOVERY; BIODIVERSITY; EXPRESSION; SEQUENCES; COMMUNITY; PROGRAM; CLUSTER; CLONING; FUNGI	Background: Xylan is one of the most abundant biopolymers on Earth. Its degradation is mediated primarily by microbial xylanase in nature. To explore the diversity and distribution patterns of xylanase genes in soils, samples of five soil types with different physicochemical characters were analyzed. Methodology/Principal Findings: Partial xylanase genes of glycoside hydrolase ( GH) family 10 were recovered following direct DNA extraction from soil, PCR amplification and cloning. Combined with our previous study, a total of 1084 gene fragments were obtained, representing 366 OTUs. More than half of the OTUs were novel ( identities of <65% with known xylanases) and had no close relatives based on phylogenetic analyses. Xylanase genes from all the soil environments were mainly distributed in Bacteroidetes, Proteobacteria, Acidobacteria, Firmicutes, Actinobacteria, Dictyoglomi and some fungi. Although identical sequences were found in several sites, habitat-specific patterns appeared to be important, and geochemical factors such as pH and oxygen content significantly influenced the compositions of xylan-degrading microbial communities. Conclusion/Significance: These results provide insight into the GH 10 xylanases in various soil environments and reveal that xylan-degrading microbial communities are environment specific with diverse and abundant populations.	[Wang, Guozeng; Meng, Kun; Luo, Huiying; Wang, Yaru; Huang, Huoqing; Shi, Pengjun; Yang, Peilong; Yao, Bin] Chinese Acad Agr Sci, Feed Res Inst, Minist Agr, Key Lab Feed Biotechnol, Beijing 100193, Peoples R China; [Wang, Guozeng; Zhang, Zhifang] Chinese Acad Agr Sci, Biotechnol Res Inst, Beijing 100193, Peoples R China	Chinese Academy of Agricultural Sciences; Feed Research Institute, CAAS; Ministry of Agriculture & Rural Affairs; Chinese Academy of Agricultural Sciences; Biotechnology Research Institute, CAAS	Wang, GZ (corresponding author), Chinese Acad Agr Sci, Feed Res Inst, Minist Agr, Key Lab Feed Biotechnol, Beijing 100193, Peoples R China.	zhifangzhang@yahoo.com; binyao@caas.net.cn		Wang, Guozeng/0000-0001-6547-0490	key program of Transgenic Plant Breeding [2008ZX08003-002]; China Modern Agriculture Research System [CARS-42]	key program of Transgenic Plant Breeding; China Modern Agriculture Research System	This work was supported by the key program of Transgenic Plant Breeding (2008ZX08003-002) and the China Modern Agriculture Research System (CARS-42). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BASTAWDE KB, 1992, WORLD J MICROB BIOT, V8, P353, DOI 10.1007/BF01198746; Bentley SD, 2008, J BACTERIOL, V190, P2150, DOI 10.1128/JB.01598-07; Biely P, 1997, J BIOTECHNOL, V57, P151, DOI 10.1016/S0168-1656(97)00096-5; Brady SF, 2007, NAT PROTOC, V2, P1297, DOI 10.1038/nprot.2007.195; Collins T, 2005, FEMS MICROBIOL REV, V29, P3, DOI 10.1016/j.femsre.2004.06.005; Cowan D, 2005, TRENDS BIOTECHNOL, V23, P321, DOI 10.1016/j.tibtech.2005.04.001; Damon C, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0028967; Daniel R, 2005, NAT REV MICROBIOL, V3, P470, DOI 10.1038/nrmicro1160; Daniel R, 2004, CURR OPIN BIOTECH, V15, P199, DOI 10.1016/j.copbio.2004.04.005; Dodd D, 2009, J BACTERIOL, V191, P3328, DOI 10.1128/JB.01628-08; Downes J, 2006, INT J SYST EVOL MICR, V56, P609, DOI 10.1099/ijs.0.63888-0; Flint HJ, 1997, BBA-PROTEIN STRUCT M, V1337, P161, DOI 10.1016/S0167-4838(96)00213-0; GIBBS MD, 1995, APPL ENVIRON MICROB, V61, P4403, DOI 10.1128/AEM.61.12.4403-4408.1995; Gilbert JA, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003042; Haegeman A, 2009, MOL PLANT PATHOL, V10, P389, DOI [10.1111/J.1364-3703.2009.00539.X, 10.1111/j.1364-3703.2009.00539.x]; Hattenschwiler S, 2011, CR BIOL, V334, P393, DOI 10.1016/j.crvi.2011.03.001; Hattenschwiler S, 2005, ANNU REV ECOL EVOL S, V36, P191, DOI 10.1146/annurev.ecolsys.36.112904.151932; HENRISSAT B, 1989, GENE, V81, P83, DOI 10.1016/0378-1119(89)90339-9; Hess M, 2011, SCIENCE, V331, P463, DOI 10.1126/science.1200387; Hopkins DW, 2010, SOIL MICROBIOLOGY AND SUSTAINABLE CROP PRODUCTION, P59, DOI 10.1007/978-90-481-9479-7_3; Hu Y, 2008, APPL MICROBIOL BIOT, V80, P823, DOI 10.1007/s00253-008-1636-6; JACKSON M. L., 1958, Soil Chemical Analysis.; Jeffries TW, 1996, CURR OPIN BIOTECH, V7, P337, DOI 10.1016/S0958-1669(96)80041-3; Kulkarni N, 1999, FEMS MICROBIOL REV, V23, P411, DOI 10.1111/j.1574-6976.1999.tb00407.x; LeCleir GR, 2004, APPL ENVIRON MICROB, V70, P6977, DOI 10.1128/AEM.70.12.6977-6983.2004; Lejon DPH, 2007, FEMS MICROBIOL ECOL, V61, P424, DOI 10.1111/j.1574-6941.2007.00365.x; Li WZ, 2006, BIOINFORMATICS, V22, P1658, DOI 10.1093/bioinformatics/btl158; Liang YT, 2011, ISME J, V5, P403, DOI 10.1038/ismej.2010.142; Lipson DA, 2004, APPL ENVIRON MICROB, V70, P2867, DOI 10.1128/AEM.70.5.2867-2879.2004; Lozupone C, 2005, APPL ENVIRON MICROB, V71, P8228, DOI 10.1128/AEM.71.12.8228-8235.2005; Ludwig W, 2004, NUCLEIC ACIDS RES, V32, P1363, DOI 10.1093/nar/gkh293; Luo HY, 2010, APPL MICROBIOL BIOT, V86, P1829, DOI 10.1007/s00253-009-2410-0; MILLWARDSADLER SJ, 1995, BIOCHEM J, V312, P39, DOI 10.1042/bj3120039; Nielsen UN, 2011, EUR J SOIL SCI, V62, P105, DOI 10.1111/j.1365-2389.2010.01314.x; Polizeli MLTM, 2005, APPL MICROBIOL BIOT, V67, P577, DOI 10.1007/s00253-005-1904-7; Ricard G, 2006, BMC GENOMICS, V7, DOI 10.1186/1471-2164-7-22; Saleh-Lakha S, 2005, J MICROBIOL METH, V63, P1, DOI 10.1016/j.mimet.2005.03.007; Schloss PD, 2005, APPL ENVIRON MICROB, V71, P1501, DOI 10.1128/AEM.71.3.1501-1506.2005; Solomon V, 2007, ACTA CRYSTALLOGR D, V63, P845, DOI 10.1107/S0907444907024845; Sunna A, 2003, EXTREMOPHILES, V7, P63, DOI 10.1007/s00792-002-0296-1; Sunna A, 1997, CRIT REV BIOTECHNOL, V17, P39, DOI 10.3109/07388559709146606; Tamura K, 2007, MOL BIOL EVOL, V24, P1596, DOI 10.1093/molbev/msm092; THOMSON JA, 1993, FEMS MICROBIOL LETT, V104, P65, DOI 10.1111/j.1574-6968.1993.tb05864.x; Urich T, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002527; Wang GZ, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016731; Wang GZ, 2010, APPL MICROBIOL BIOT, V87, P1383, DOI 10.1007/s00253-010-2564-9; Warnecke F, 2007, NATURE, V450, P560, DOI 10.1038/nature06269; White JR, 2008, BIOINFORMATICS, V24, P462, DOI 10.1093/bioinformatics/btm632	48	18	18	4	28	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 17	2012	7	8							e43480	10.1371/journal.pone.0043480	http://dx.doi.org/10.1371/journal.pone.0043480			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	996DG	22912883	Green Submitted, gold, Green Published			2022-12-25	WOS:000308063700111
J	Guirola, M; Perez-Rafael, S; Capdevila, M; Palacios, O; Atrian, S				Guirola, Maria; Perez-Rafael, Silvia; Capdevila, Merce; Palacios, Oscar; Atrian, Silvia			Metal Dealing at the Origin of the Chordata Phylum: The Metallothionein System and Metal Overload Response in Amphioxus	PLOS ONE			English	Article							BINDING ABILITIES; MESSENGER-RNA; EVOLUTION; FEATURES; ZINC; DIFFERENTIATION; SPECIFICITY; CADMIUM(II); EXPRESSION; SEQUENCE	Non-vertebrate chordates, specifically amphioxus, are considered of the utmost interest for gaining insight into the evolutionary trends, i.e. differentiation and specialization, of gene/protein systems. In this work, MTs (metallothioneins), the most important metal binding proteins, are characterized for the first time in the cephalochordate subphylum at both gene and protein level, together with the main features defining the amphioxus response to cadmium and copper overload. Two MT genes (BfMT1 and BfMT2) have been identified in a contiguous region of the genome, as well as several ARE (antioxidant response element) and MRE (metal response element) located upstream the transcribed region. Their corresponding cDNAs exhibit identical sequence in the two lancelet species (B. floridae and B. lanceolatum), BfMT2 cDNA resulting from an alternative splicing event. BfMT1 is a polyvalent metal binding peptide that coordinates any of the studied metal ions (Zn, Cd or Cu) rendering complexes stable enough to last in physiological environments, which is fully concordant with the constitutive expression of its gene, and therefore, with a metal homeostasis housekeeping role. On the contrary, BfMT2 exhibits a clear ability to coordinate Cd(II) ions, while it is absolutely unable to fold into stable Cu (I) complexes, even as mixed species. This identifies it as an essential detoxification agent, which is consequently only induced in emergency situations. The cephalochordate MTs are not directly related to vertebrate MTs, neither by gene structure, protein similarity nor metal-binding behavior of the encoded peptides. The closest relative is the echinoderm MT, which confirm proposed phylogenetic relationships between these two groups. The current findings support the existence in most organisms of two types of MTs as for their metal binding preferences, devoted to different biological functions: multivalent MTs for housekeeping roles, and specialized MTs that evolve either as Cd-thioneins or Cu-thioneins, according to the ecophysiological needs of each kind of organisms.	[Guirola, Maria; Atrian, Silvia] Univ Barcelona, Fac Biol, Dept Genet, Barcelona, Spain; [Perez-Rafael, Silvia; Capdevila, Merce; Palacios, Oscar] Univ Autonoma Barcelona, Dept Quim, Fac Ciencies, E-08193 Barcelona, Spain	University of Barcelona; Autonomous University of Barcelona	Guirola, M (corresponding author), Univ Barcelona, Fac Biol, Dept Genet, Barcelona, Spain.	satrian@ub.edu	Guirola, Maria/AAA-8752-2019; Capdevila, Mercè/ABG-4588-2020; Guirola, Maria/N-3734-2015; Palacios, Òscar/AAJ-3492-2021; Capdevila, Mercè/F-5374-2015; Palacios, Oscar/C-8974-2009	Guirola, Maria/0000-0003-1381-4567; Capdevila, Mercè/0000-0002-2246-0994; Guirola, Maria/0000-0003-1381-4567; Palacios, Òscar/0000-0002-2987-7303; Capdevila, Mercè/0000-0002-2246-0994; Palacios, Oscar/0000-0002-2987-7303	Spanish "Ministerio de Ciencia e Innovacion" (MICINN) [BIO2009-12513-C02-01, BIO2009-12513-C02-02]; European Union; "Ministerio de Asuntos Exteriores-Agencia Espanola de Cooperacion Internacional para el Desarrollo" (MAE-AECID) fellowship	Spanish "Ministerio de Ciencia e Innovacion" (MICINN)(Ministry of Science and Innovation, Spain (MICINN)Spanish Government); European Union(European Commission); "Ministerio de Asuntos Exteriores-Agencia Espanola de Cooperacion Internacional para el Desarrollo" (MAE-AECID) fellowship	This work was supported by the Spanish "Ministerio de Ciencia e Innovacion" (MICINN) grants BIO2009-12513-C02-01 to Silvia Atrian and BIO2009-12513-C02-02 to Merce Capdevila. These coordinated projects were co-financed by the European Union, through the "Fondo Europeo de Desarrollo Regional" (FEDER) program. The authors from the Universitat de Barcelona and the Universitat Autonoma de Barcelona are members of the 2009SGR-1457 "Grup de Recerca de la Generalitat de Catalunya". Maria Guirola is recipient of an "Ministerio de Asuntos Exteriores-Agencia Espanola de Cooperacion Internacional para el Desarrollo" (MAE-AECID) fellowship for PhD studies in Spain. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andrews GK, 1996, J NUTR, V126, pS1317, DOI 10.1093/jn/126.suppl_4.1317S; Barsyte D, 2001, FASEB J, V15, P627, DOI 10.1096/fj.99-0966com; Binz PA, 1999, METALLOTHIONEIN IV, P7; Bofill R, 1999, J INORG BIOCHEM, V73, P57, DOI 10.1016/S0162-0134(98)10091-0; Bofill R, 2009, FEBS J, V276, P7040, DOI 10.1111/j.1742-4658.2009.07417.x; Bofill R, 2009, METALLOMICS, V1, P229, DOI 10.1039/b904953c; BONGERS J, 1988, ANAL CHEM, V60, P2683, DOI 10.1021/ac00175a008; Canestro C, 2003, GENOME BIOL, V4, DOI 10.1186/gb-2003-4-3-208; Canestro C, 2012, BRIEF FUNCT GENOMICS, V11, P131, DOI 10.1093/bfgp/els010; Capdevila M, 2005, ANGEW CHEM INT EDIT, V44, P4618, DOI 10.1002/anie.200501183; Capdevila M, 2012, COORDIN CHEM REV, V256, P46, DOI 10.1016/j.ccr.2011.07.006; Capdevila M, 1997, CELL MOL LIFE SCI, V53, P681, DOI 10.1007/s000180050088; Capdevila M, 2011, J BIOL INORG CHEM, V16, P977, DOI 10.1007/s00775-011-0798-3; Cohen M, 1900, BIOL EFFECTS HEAVY M, P19; Cols N, 1997, J INORG BIOCHEM, V68, P157, DOI 10.1016/S0162-0134(97)00085-8; Delsuc F, 2006, NATURE, V439, P965, DOI 10.1038/nature04336; Domenech J, 2007, J BIOL INORG CHEM, V12, P867, DOI 10.1007/s00775-007-0241-y; FELSENSTEIN J, 1985, EVOLUTION, V39, P783, DOI 10.1111/j.1558-5646.1985.tb00420.x; Felsenstein J., 2002, PHYLIP PHYLOGENETIC; Ferre F, 2006, NUCLEIC ACIDS RES, V1, P82; Franchi N, 2011, J EXP ZOOL PART A, V315A, P90, DOI 10.1002/jez.653; Guo An-Yuan, 2007, Yichuan, V29, P1023, DOI 10.1360/yc-007-1023; Henikoff JG, 2000, ELECTROPHORESIS, V21, P1700, DOI 10.1002/(SICI)1522-2683(20000501)21:9<1700::AID-ELPS1700>3.3.CO;2-M; Hockner M, 2011, BIOMETALS, V24, P1079, DOI 10.1007/s10534-011-9466-x; KIMURA M, 1980, J MOL EVOL, V16, P111, DOI 10.1007/BF01731581; Lippi M, 2008, BIOINFORMATICS, V24, P2094, DOI 10.1093/bioinformatics/btn371; Magrane M, 2011, DATABASE-OXFORD, DOI 10.1093/database/bar009; MULLER JP, 1993, DNA CELL BIOL, V12, P341, DOI 10.1089/dna.1993.12.341; Nam DH, 2007, COMP BIOCHEM PHYS C, V145, P295, DOI 10.1016/j.cbpc.2006.10.012; Notredame C, 2000, J MOL BIOL, V302, P205, DOI 10.1006/jmbi.2000.4042; Orihuela R, 2010, CHEM-EUR J, V16, P12363, DOI 10.1002/chem.201001125; Oulion S, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0036554; Pagani A, 2007, MOL MICROBIOL, V63, P256, DOI 10.1111/j.1365-2958.2006.05510.x; Pagani MA, 2007, MOL MICROBIOL, V65, P521, DOI 10.1111/j.1365-2958.2007.05807.x; Palacios O, 2011, BMC BIOL, V9, DOI 10.1186/1741-7007-9-4; Perez-Rafael S, 2012, METALLOMICS, V4, P342, DOI 10.1039/c2mt00182a; Perez-Rafael S, 2012, J INORG BIOCHEM, V108, P84, DOI 10.1016/j.jinorgbio.2011.11.025; Putnam NH, 2008, NATURE, V453, P1064, DOI 10.1038/nature06967; Riggio M, 2003, MOL REPROD DEV, V66, P374, DOI 10.1002/mrd.10365; Schubert M, 2006, TRENDS ECOL EVOL, V21, P269, DOI 10.1016/j.tree.2006.01.009; Sigel A., 2009, METAL IONS LIFE SCI, V5; Sigrist CJA, 2010, NUCLEIC ACIDS RES, V38, pD161, DOI 10.1093/nar/gkp885; Tio L, 2004, J BIOL CHEM, V279, P24403, DOI 10.1074/jbc.M401346200; Valls M, 2001, J BIOL CHEM, V276, P32835, DOI 10.1074/jbc.M102151200; Vasak M, 2000, CURR OPIN CHEM BIOL, V4, P177, DOI 10.1016/S1367-5931(00)00082-X; Vasak M, 2011, J BIOL INORG CHEM, V16, P1067, DOI 10.1007/s00775-011-0799-2; Vergani Laura, 2009, V5, P199, DOI 10.1039/9781847558992-00199; Villarreal L, 2006, FEBS J, V273, P523, DOI 10.1111/j.1742-4658.2005.05086.x; Yu JK, 2008, DEV GENES EVOL, V218, P723, DOI 10.1007/s00427-008-0228-x; Zdobnov EM, 2002, BIOINFORMATICS, V18, P368, DOI 10.1093/bioinformatics/18.2.368; Zeitoun-Ghandour S, 2010, FEBS J, V277, P2531, DOI 10.1111/j.1742-4658.2010.07667.x	51	12	13	0	24	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 14	2012	7	8							e43299	10.1371/journal.pone.0043299	http://dx.doi.org/10.1371/journal.pone.0043299			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	988OQ	22905252	Green Submitted, Green Published, gold			2022-12-25	WOS:000307500800074
J	Morrison, GJ; Ganesan, R; Qin, ZX; Aswad, DW				Morrison, Gareth J.; Ganesan, Ranjani; Qin, Zhenxia; Aswad, Dana W.			Considerations in the Identification of Endogenous Substrates for Protein L-Isoaspartyl Methyltransferase: The Case of Synuclein	PLOS ONE			English	Article							CARBOXYL METHYLTRANSFERASE; O-METHYLTRANSFERASE; REPAIR ENZYME; ASPARTYL RESIDUES; DAMAGED PROTEINS; HISTONE H2B; DEAMIDATION; METHYLATION; MICE; PEPTIDES	Protein L-isoaspartyl methyltransferase (PIMT) repairs abnormal isoaspartyl peptide bonds in age-damaged proteins. It has been reported that synuclein, a protein implicated in neurodegenerative diseases, is a major target of PIMT in mouse brain. To extend this finding and explore its possible relevance to neurodegenerative diseases, we attempted to determine the stoichiometry of isoaspartate accumulation in synuclein in vivo and in vitro. Brain proteins from PIMT knockout mice were separated by 2D electrophoresis followed by on-blot [H-3]-methylation to label isoaspartyl proteins, and by immunoblotting to confirm the coincident presence of synuclein. On-blot H-3-methylation revealed numerous isoaspartyl proteins, but no signal in the position of synuclein. This finding was corroborated by immunoprecipitation of synuclein followed by on-blot H-3-methylation. To assess the propensity of synuclein to form isoaspartyl sites in vitro, samples of recombinant mouse and human alpha-synucleins were aged for two weeks by incubation at pH 7.5 and 37 degrees C. The stoichiometries of isoaspartate accumulation were extremely low at 0.02 and 0.07 mol of isoaspartate per mol of protein respectively. Using a simple mathematical model based on the first order kinetics of isoaspartyl protein methyl ester hydrolysis, we ascribe the discrepancy between our results and the previous report to methodological limitations of the latter stemming from an inherent, and somewhat counterintuitive, relationship between the propensity of proteins to form isoaspartyl sites and the instability of the H-3-methyl esters used to tag them. The results presented here indicate that synuclein is not a major target of PIMT in vivo, and emphasize the need to minimize methyl ester hydrolysis when using methylation to assess the abundance of isoaspartyl sites in proteins.	[Morrison, Gareth J.; Ganesan, Ranjani; Qin, Zhenxia; Aswad, Dana W.] Univ Calif Irvine, Dept Mol Biol & Biochem, Irvine, CA 92717 USA	University of California System; University of California Irvine	Morrison, GJ (corresponding author), Univ Calif Irvine, Dept Mol Biol & Biochem, Irvine, CA 92717 USA.	dwaswad@uci.edu			National Institutes of Health [NS-17269]; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS017269] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This work was funded by National Institutes of Health grant NS-17269 to Dana W. Aswad. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alfaro JF, 2008, ANAL CHEM, V80, P3882, DOI 10.1021/ac800251q; ASWAD DW, 1984, J BIOL CHEM, V259, P714; AXELROD J, 1965, SCIENCE, V150, P892, DOI 10.1126/science.150.3698.892; BRENNAN TV, 1994, J BIOL CHEM, V269, P24586; Clarke S, 2003, AGEING RES REV, V2, P263, DOI 10.1016/S1568-1637(03)00011-4; Diepold K, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0030295; DILIBERTO EJ, 1976, J NEUROCHEM, V26, P1159, DOI 10.1111/j.1471-4159.1976.tb07001.x; Doyle HA, 2007, AUTOIMMUNITY, V40, P131, DOI 10.1080/08916930601165180; Furuchi T, 2010, CHEM BIODIVERS, V7, P1337, DOI 10.1002/cbdv.200900273; GALLETTI P, 1988, BIOCHEMISTRY-US, V27, P1752, DOI 10.1021/bi00405a055; GEIGER T, 1987, J BIOL CHEM, V262, P785; Ikegaya Y, 2001, HIPPOCAMPUS, V11, P287, DOI 10.1002/hipo.1043; JOHNSON BA, 1987, J BIOL CHEM, V262, P12283; JOHNSON BA, 1993, J BIOL CHEM, V268, P6174; JOHNSON BA, 1987, J BIOL CHEM, V262, P5622; JOHNSON BA, 1985, BIOCHEMISTRY-US, V24, P2581, DOI 10.1021/bi00331a028; JOHNSON BA, 1989, ARCH BIOCHEM BIOPHYS, V268, P276, DOI 10.1016/0003-9861(89)90589-4; JOHNSON BA, 1989, J BIOL CHEM, V264, P14262; Khoury MK, 2010, ANAL BIOCHEM, V397, P129, DOI 10.1016/j.ab.2009.09.041; Kim E, 1997, P NATL ACAD SCI USA, V94, P6132, DOI 10.1073/pnas.94.12.6132; Kim E, 1999, J BIOL CHEM, V274, P20671, DOI 10.1074/jbc.274.29.20671; Lees JE, 1999, ELECTROPHORESIS, V20, P2139, DOI 10.1002/(SICI)1522-2683(19990701)20:10<2139::AID-ELPS2139>3.0.CO;2-R; Lindner H, 2001, EXP GERONTOL, V36, P1551, DOI 10.1016/S0531-5565(01)00140-1; LINDQUIST JA, 1994, J PROTEIN CHEM, V13, P553, DOI 10.1007/BF01901537; Liu M, 2012, ANAL CHEM, V84, P1056, DOI 10.1021/ac202652z; Mamula MJ, 1999, J BIOL CHEM, V274, P22321, DOI 10.1074/jbc.274.32.22321; MCFADDEN PN, 1987, P NATL ACAD SCI USA, V84, P2595, DOI 10.1073/pnas.84.9.2595; MURRAY ED, 1984, J BIOL CHEM, V259, P722; Reissner KJ, 2006, J BIOL CHEM, V281, P8389, DOI 10.1074/jbc.M510716200; Reissner KJ, 2003, CELL MOL LIFE SCI, V60, P1281, DOI 10.1007/s00018-003-2287-5; Robinson NE, 2004, J PEPT RES, V63, P426, DOI 10.1111/j.1399-3011.2004.00151.x; Robinson NE, 2009, PROTEIN SCI, V18, P1766, DOI 10.1002/pro.183; Shimizu T, 2005, BIOL PHARM BULL, V28, P1590, DOI 10.1248/bpb.28.1590; Vigneswara V, 2006, J BIOL CHEM, V281, P32619, DOI 10.1074/jbc.M605421200; Vitali R, 2004, BEHAV BRAIN RES, V153, P129, DOI 10.1016/j.bbr.2003.11.007; Volkin DB, 1997, MOL BIOTECHNOL, V8, P105, DOI 10.1007/BF02752255; Yamamoto A, 1998, J NEUROSCI, V18, P2063; Young AL, 2001, J BIOL CHEM, V276, P37161, DOI 10.1074/jbc.M106682200; Young GW, 2005, J BIOL CHEM, V280, P26094, DOI 10.1074/jbc.M503624200; Zhu JX, 2007, ANAL BIOCHEM, V364, P1, DOI 10.1016/j.ab.2007.02.013; Zhu JX, 2006, J BIOL CHEM, V281, P33802, DOI 10.1074/jbc.M606958200	41	8	8	1	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 14	2012	7	8							e43288	10.1371/journal.pone.0043288	http://dx.doi.org/10.1371/journal.pone.0043288			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	988OQ	22905247	Green Published, gold			2022-12-25	WOS:000307500800072
J	Lei, XY; Ou, T; Zhang, QY				Lei, Xiao-Ying; Ou, Tong; Zhang, Qi-Ya			Rana grylio Virus (RGV) 50L Is Associated with Viral Matrix and Exhibited Two Distribution Patterns	PLOS ONE			English	Article							MAJOR CAPSID PROTEIN; FISH CELL-LINE; FAMILY IRIDOVIRIDAE; SEQUENCE-ANALYSIS; GENE; EXPRESSION; DNA; MORPHOGENESIS; REPLICATION; TRANSPORT	Background: The complete genome of Rana grylio virus (RGV) was sequenced and analyzed recently, which revealed that RGV 50L had homologues in many iridoviruses with different identities; however, the characteristics and functions of 50L have not been studied yet. Methodology/Principal Findings: We cloned and characterized RGV50L, and revealed 50L functions in virus assembly and gene regulation. 50L encoded a 499-amino acid structural protein of about 85 kDa in molecular weight and contained a nuclear localization signal (NLS) and a helix-extension-helix motif. Drug inhibition assay demonstrated that 50L was an immediate-early (IE) gene. Immuno-fluorescence assay revealed that 50L appeared early and persisted in RGV-infected cells following two distribution patterns. One pattern was that 50L exhibited a cytoplasm-nucleus-viromatrix distribution pattern, and mutagenesis of the NLS motif revealed that localization of 50L in the nucleus was NLS-dependent; the other was that 50L co-localized with viral matrix which plays important roles in virus assembly and the life circle of viruses. Conclusion/Significance: RGV 50L is a novel iridovirus IE gene encoded structural protein which plays important roles in virus assembly.	[Lei, Xiao-Ying; Ou, Tong; Zhang, Qi-Ya] Chinese Acad Sci, Grad Sch, Inst Hydrobiol, State Key Lab Freshwater Ecol & Biotechnol, Wuhan, Peoples R China	Chinese Academy of Sciences; Institute of Hydrobiology, CAS	Lei, XY (corresponding author), Chinese Acad Sci, Grad Sch, Inst Hydrobiol, State Key Lab Freshwater Ecol & Biotechnol, Wuhan, Peoples R China.	zhangqy@ihb.ac.cn			National Major Basic Research Program [2010CB126303, 2009CB118704]; Knowledge Innovation Program of the Chinese Academy of Sciences [KSCX2-EW-Z-3]; National Key Technologies R & D Program of China [2012BAD25B00]; National Natural Science Foundation of China [31072239]; FEBL [Y15B121F01]	National Major Basic Research Program(National Basic Research Program of China); Knowledge Innovation Program of the Chinese Academy of Sciences(Chinese Academy of SciencesKnowledge Innovation Program of the Chinese Academy of Sciences); National Key Technologies R & D Program of China(National Key Technology R&D Program); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); FEBL	This work was funded by National Major Basic Research Program (2010CB126303, 2009CB118704), Knowledge Innovation Program of the Chinese Academy of Sciences (KSCX2-EW-Z-3), National Key Technologies R & D Program of China (2012BAD25B00), National Natural Science Foundation of China (31072239), and the FEBL research grant (Y15B121F01). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahn JS, 2003, J BIOL CHEM, V278, P29121, DOI 10.1074/jbc.M302314200; Andres G, 2002, J VIROL, V76, P2654, DOI 10.1128/JVI.76.6.2654-2666.2002; Aravind L, 2000, TRENDS BIOCHEM SCI, V25, P112, DOI 10.1016/S0968-0004(99)01537-6; Capul AA, 2007, J VIROL, V81, P9451, DOI 10.1128/JVI.00499-07; Castillo JP, 2002, GENE, V290, P19, DOI 10.1016/S0378-1119(02)00566-8; Chen ZY, 2008, VET IMMUNOL IMMUNOP, V123, P266, DOI 10.1016/j.vetimm.2008.02.011; Chen ZY, 2012, VET MICROBIOL, V157, P264, DOI 10.1016/j.vetmic.2011.12.025; Chinchar VG, 2009, CURR TOP MICROBIOL, V328, P123; Chinchar VG, 2011, VIRUSES-BASEL, V3, P1959, DOI 10.3390/v3101959; Combet C, 2000, TRENDS BIOCHEM SCI, V25, P147, DOI 10.1016/S0968-0004(99)01540-6; DEVAUCHELLE G, 1985, CURR TOP MICROBIOL, V116, P1; Du CS, 2004, VIRUS RES, V101, P119, DOI 10.1016/j.virusres.2003.12.034; Eaton HE, 2007, VIROL J, V4, DOI 10.1186/1743-422X-4-11; Gorlich D, 1999, ANNU REV CELL DEV BI, V15, P607, DOI 10.1146/annurev.cellbio.15.1.607; Gui JF, 2012, CHINESE SCI BULL, V57, P1751, DOI 10.1007/s11434-012-5213-0; He LB, 2012, VIRUS RES, V163, P66, DOI 10.1016/j.virusres.2011.08.012; Heckman KL, 2007, NAT PROTOC, V2, P924, DOI 10.1038/nprot.2007.132; Huang XH, 2006, J VIROL METHODS, V133, P117, DOI 10.1016/j.jviromet.2005.10.029; Huang YH, 2007, APOPTOSIS, V12, P1569, DOI 10.1007/s10495-007-0089-1; Jancovich J.K., 2011, VIRUS TAXONOMY 9 REP, P193; Kaothien P, 2005, PLANT J, V42, P492, DOI 10.1111/j.1365-313X.2005.02388.x; Ke F, 2009, MOL BIOL REP, V36, P1651, DOI 10.1007/s11033-008-9365-6; Kim YS, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010308; la Cour T, 2004, PROTEIN ENG DES SEL, V17, P527, DOI 10.1093/protein/gzh062; Lei XY, 2012, FISH PHYSIOL BIOCHEM, V38, P1175, DOI 10.1007/s10695-012-9603-7; Lei XY, 2012, ARCH VIROL IN PRESS; Liu YL, 2012, VIRUS RES; Lua DT, 2005, J VIROL, V79, P15151, DOI 10.1128/JVI.79.24.15151-15164.2005; Mao J, 1996, VIROLOGY, V216, P431, DOI 10.1006/viro.1996.0080; Miller D, 2011, VIRUSES-BASEL, V3, P2351, DOI 10.3390/v3112351; Moroianu J, 1999, J CELL BIOCHEM, P76; Nigg EA, 1997, NATURE, V386, P779, DOI 10.1038/386779a0; Novoa RR, 2005, BIOL CELL, V97, P147, DOI 10.1042/BC20040058; Robinson AR, 2011, J VIROL, V85, P8940, DOI 10.1128/JVI.00569-11; Rost B, 2004, NUCLEIC ACIDS RES, V32, pW321, DOI 10.1093/nar/gkh377; Sample R, 2007, VIROLOGY, V358, P311, DOI 10.1016/j.virol.2006.07.009; Song WJ, 2006, MOL CELL PROTEOMICS, V5, P256, DOI 10.1074/mcp.M500149-MCP200; Su D, 2012, EPIGENETICS-US, V7, P146, DOI 10.4161/epi.7.2.18907; Sun W, 2006, BIOCHEM BIOPH RES CO, V351, P44, DOI 10.1016/j.bbrc.2006.09.169; Suzan-Monti M, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000328; Topol LZ, 2000, J BIOL CHEM, V275, P8785, DOI 10.1074/jbc.275.12.8785; Whitley DS, 2011, DEV COMP IMMUNOL, V35, P937, DOI 10.1016/j.dci.2010.12.002; Williams T, 2005, ADV VIRUS RES, V65, P173, DOI 10.1016/S0065-3527(05)65006-3; Xia LQ, 2010, VIRUS RES, V147, P30, DOI 10.1016/j.virusres.2009.09.015; Xia LQ, 2009, ARCH VIROL, V154, P1409, DOI 10.1007/s00705-009-0457-y; Yan XD, 2009, J MOL BIOL, V385, P1287, DOI 10.1016/j.jmb.2008.11.002; Zanta MA, 1999, P NATL ACAD SCI USA, V96, P91, DOI 10.1073/pnas.96.1.91; Zhang QiYa, 1996, Acta Hydrobiologica Sinica, V20, P390; Zhang QY, 1999, AQUACULTURE, V175, P185, DOI 10.1016/S0044-8486(99)00041-1; Zhang QY, 2006, AQUACULTURE, V251, P1, DOI 10.1016/j.aquaculture.2005.05.012; Zhang QY, 2001, DIS AQUAT ORGAN, V48, P27, DOI 10.3354/dao048027; Zhao Z, 2008, J GEN VIROL, V89, P1866, DOI 10.1099/vir.0.2008/000810-0; Zhao Z, 2007, VIRUS RES, V123, P128, DOI 10.1016/j.virusres.2006.08.007; Zhao Z, 2009, VIRUS GENES, V38, P345, DOI 10.1007/s11262-008-0318-x	54	15	18	1	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 13	2012	7	8							e43033	10.1371/journal.pone.0043033	http://dx.doi.org/10.1371/journal.pone.0043033			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	988OJ	22912781	Green Submitted, Green Published, gold			2022-12-25	WOS:000307500100055
J	Ruiz-Rodriguez, M; Valdivia, E; Martin-Vivaldi, M; Martin-Platero, AM; Martinez-Bueno, M; Mendez, M; Peralta-Sanchez, JM; Soler, JJ				Ruiz-Rodriguez, Magdalena; Valdivia, Eva; Martin-Vivaldi, Manuel; Martin-Platero, Antonio M.; Martinez-Bueno, Manuel; Mendez, Maria; Peralta-Sanchez, Juan M.; Soler, Juan J.			Antimicrobial Activity and Genetic Profile of Enteroccoci Isolated from Hoopoes Uropygial Gland	PLOS ONE			English	Article							ANTIBIOTIC-PRODUCING BACTERIA; LACTIC-ACID BACTERIA; STREPTOCOCCUS-FAECALIS; SYMBIOTIC BACTERIA; UPUPA-EPOPS; SUBSTANCES; EVOLUTION; DEFENSE; EMBRYOS; FUNGUS	Symbiotic microorganisms may be directly transferred from parents to offspring or acquired from a particular environment that animals may be able to select. If benefits for hosts vary among microbial strains, natural selection may favour hosts holding the most beneficial one. Enterococci symbionts living in the hoopoe (Upupa epops) uropygial gland are able to synthesise bacteriocins (antimicrobial peptides that inhibit the growth of competitor bacteria). We explored variability in genetic profile (through RAPD-PCR analyses) and antimicrobial properties (by performing antagonistic tests against ten bacterial indicator strains) of the different isolates obtained from the uropygial glands of hoopoe females and nestlings. We found that the genetic profile of bacterial isolates was related to antimicrobial activity, as well as to individual host identity and the nest from which samples were obtained. This association suggest that variation in the inhibitory capacity of Enterococci symbionts should be under selection.	[Ruiz-Rodriguez, Magdalena; Soler, Juan J.] CSIC, Dept Ecol Func & Evolut, Estn Expt Zonas Aridas, Almeria, Spain; [Ruiz-Rodriguez, Magdalena; Valdivia, Eva; Martin-Vivaldi, Manuel; Martin-Platero, Antonio M.; Martinez-Bueno, Manuel; Peralta-Sanchez, Juan M.; Soler, Juan J.] Univ Granada, CSIC, Grp Coevoluc, Unidad Asociada, Granada, Spain; [Valdivia, Eva; Martinez-Bueno, Manuel; Peralta-Sanchez, Juan M.] Univ Granada, Dept Microbiol, Granada, Spain; [Martin-Vivaldi, Manuel] Univ Granada, Dept Biol Anim, Granada, Spain; [Mendez, Maria] CSIC, Dept Biol Conservac, Estn Biol Donana, E-41080 Seville, Spain	Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Estacion Experimental de Zonas Aridas (EEZA); Consejo Superior de Investigaciones Cientificas (CSIC); University of Granada; University of Granada; University of Granada; Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Estacion Biologica de Donana (EBD)	Ruiz-Rodriguez, M (corresponding author), CSIC, Dept Ecol Func & Evolut, Estn Expt Zonas Aridas, Almeria, Spain.	magda@eeza.csic.es	Ruiz-Rodríguez, Magdalena/D-4226-2014; Martin-Platero, Antonio M/H-3201-2018; Martínez-Bueno, Manuel/N-7021-2016; Ruiz-Rodríguez, Magdalena/AAZ-6384-2021; Valdivia, Eva/R-9978-2018; Peralta-Sanchez, Juan M/L-3159-2017; Soler, J. J./H-2363-2011; Martín-Vivaldi, Manuel/F-8256-2016; Martínez, Manuel Martín-Vivaldi/AAJ-6736-2021	Ruiz-Rodríguez, Magdalena/0000-0002-4202-5180; Martin-Platero, Antonio M/0000-0003-2822-4885; Martínez-Bueno, Manuel/0000-0002-1488-5642; Ruiz-Rodríguez, Magdalena/0000-0002-4202-5180; Valdivia, Eva/0000-0002-9429-9634; Peralta-Sanchez, Juan M/0000-0003-4648-7988; Soler, J. J./0000-0003-2990-1489; Martín-Vivaldi, Manuel/0000-0002-5432-425X; Martínez, Manuel Martín-Vivaldi/0000-0002-5432-425X	FEDER founds [CGL2010-19233-C03-01, CGL2010-19233-C03-03]; Junta de Andalucia [P09-RNM-4557]; Ministerio de Ciencia e Innovacion (Spanish National Government)	FEDER founds(European Commission); Junta de Andalucia(Junta de Andalucia); Ministerio de Ciencia e Innovacion (Spanish National Government)	This work was financed by Ministerio de Ciencia e Innovacion (Spanish National Government) and FEDER founds (projects CGL2010-19233-C03-01, and CGL2010-19233-C03-03), and Junta de Andalucia (P09-RNM-4557). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abriouel F, 2005, SYST APPL MICROBIOL, V28, P383, DOI 10.1016/j.syapm.2005.01.007; ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1016/S0022-2836(05)80360-2; Banning JL, 2008, OECOLOGIA, V156, P423, DOI 10.1007/s00442-008-1002-5; Bisson IA, 2007, MICROB ECOL, V54, P65, DOI 10.1007/s00248-006-9173-2; Currie CR, 1999, NATURE, V398, P701, DOI 10.1038/19519; Devriese LA, 1993, J APPL BACTERIOL, V33, P14; Douglas AE, 1998, HEREDITY, V81, P599, DOI 10.1038/sj.hdy.6884550; Gardner A, 2004, P ROY SOC B-BIOL SCI, V271, P1529, DOI 10.1098/rspb.2004.2756; GILTURNES MS, 1992, BIOL BULL, V182, P105, DOI 10.2307/1542184; GILTURNES MS, 1989, SCIENCE, V246, P116, DOI 10.1126/science.2781297; GRATIA A, 1946, CR SOC BIOL, V140, P1032; Koch AM, 2004, P NATL ACAD SCI USA, V101, P2369, DOI 10.1073/pnas.0306441101; Lindquist N, 2005, P ROY SOC B-BIOL SCI, V272, P1209, DOI 10.1098/rspb.2005.3082; Martin-Platero AM, 2007, ANAL BIOCHEM, V366, P102, DOI 10.1016/j.ab.2007.03.010; Martin-Platero AM, 2006, APPL ENVIRON MICROB, V72, P4245, DOI 10.1128/AEM.02940-05; Martin-Vivaldi M, 2006, J AVIAN BIOL, V37, P467, DOI 10.1111/j.0908-8857.2006.03660.x; Martin-Vivaldi M, 2010, P ROY SOC B-BIOL SCI, V277, P123, DOI 10.1098/rspb.2009.1377; McGarigal K., 2000, MULTIVARIATE STAT WI; Oliver KM, 2003, P NATL ACAD SCI USA, V100, P1803, DOI 10.1073/pnas.0335320100; Price P. W., 1980, EVOLUTIONARY BIOL PA; Rajchard J, 2010, VET MED-CZECH, V55, P413, DOI 10.17221/2981-VETMED; Riley MA, 2002, ANNU REV MICROBIOL, V56, P117, DOI 10.1146/annurev.micro.56.012302.161024; Rossetti L, 2005, J MICROBIOL METH, V63, P135, DOI 10.1016/j.mimet.2005.03.001; Ruiz-Rodriguez M, 2009, J EXP BIOL, V212, P3621, DOI 10.1242/jeb.031336; Saikkonen K, 1998, ANNU REV ECOL SYST, V29, P319, DOI 10.1146/annurev.ecolsys.29.1.319; SCHLEIFER KH, 1984, INT J SYST BACTERIOL, V34, P31, DOI 10.1099/00207713-34-1-31; Shawkey MD, 2003, J AVIAN BIOL, V34, P345, DOI 10.1111/j.0908-8857.2003.03193.x; Shnit-Orland M, 2009, FEMS MICROBIOL ECOL, V67, P371, DOI 10.1111/j.1574-6941.2008.00644.x; Soler JJ, 2008, FUNCT ECOL, V22, P864, DOI 10.1111/j.1365-2435.2008.01448.x; Soler Juan Jose, 2010, Open Ornithology Journal, V3, P93, DOI 10.2174/1874453201003010093; Todorov SD, 2006, BIOLOGIA, V61, P269, DOI 10.2478/s11756-006-0049-1; WILLIAMS JGK, 1990, NUCLEIC ACIDS RES, V18, P6531, DOI 10.1093/nar/18.22.6531; Wolf JB, 1998, TRENDS ECOL EVOL, V13, P64, DOI 10.1016/S0169-5347(97)01233-0; YAGI Y, 1980, J BACTERIOL, V143, P966, DOI 10.1128/JB.143.2.966-970.1980	34	26	26	0	27	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 24	2012	7	7							e41843	10.1371/journal.pone.0041843	http://dx.doi.org/10.1371/journal.pone.0041843			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	978NX	22911858	Green Published, gold			2022-12-25	WOS:000306751300077
J	Viginier, B; Dolmazon, C; Lantier, I; Lantier, F; Archer, F; Leroux, C; Terzian, C				Viginier, Barbara; Dolmazon, Christine; Lantier, Isabelle; Lantier, Frederic; Archer, Fabienne; Leroux, Caroline; Terzian, Christophe			Copy Number Variation and Differential Expression of a Protective Endogenous Retrovirus in Sheep	PLOS ONE			English	Article							MURINE LEUKEMIA-VIRUS; JAAGSIEKTE SHEEP; IN-VITRO; LUNG-CANCER; JSRV; GAG; RESTRICTION; GENE	The Jaagsiekte sheep retrovirus exJSRV and its endogenous counterpart enJSRV co-exist in sheep. exJSRV, a betaretrovirus, is the etiological agent of ovine pulmonary adenocarcinoma, and it has been demonstrated in vitro that an enJSRV Gag variant bearing the R-to-W amino acid change at position 21 was able to block exJSRV budding from the cells, providing a potential protective role for the host. In this work, we developed a fast mutation detection assay based on the oligo ligation assay (OLA) that permits the quantification of the relative proportions of the R21 and W21 Gag variants present in individual genomes and in cDNA obtained from normal and exJSRV-induced lung tumors. We have shown that the W21/R21 ratio is variable within and between breeds. We also describe for the first time that putative protecting enJSRV variants were expressed in alveolar type II cells (AECII), the major target of exJSRV.	[Viginier, Barbara; Dolmazon, Christine; Archer, Fabienne; Leroux, Caroline; Terzian, Christophe] Univ Lyon 1, Retrovirus & Pathol Comparee INRA UMR754, F-69365 Lyon, France; [Viginier, Barbara; Terzian, Christophe] Ecole Prat Hautes Etud, Paris, France; [Lantier, Isabelle; Lantier, Frederic] INRA Ctr Tours, Nouzilly, France	INRAE; UDICE-French Research Universities; Universite Claude Bernard Lyon 1; UDICE-French Research Universities; PSL Research University Paris; Ecole Pratique des Hautes Etudes (EPHE); INRAE	Viginier, B (corresponding author), Univ Lyon 1, Retrovirus & Pathol Comparee INRA UMR754, F-69365 Lyon, France.	christophe.terzian@univ-lyon1.fr	Archer, Fabienne/E-9371-2010	Archer, Fabienne/0000-0002-8175-866X; leroux, caroline/0000-0002-7923-3127; Lantier, Frederic/0000-0001-5896-330X	Institut National de la Recherche Agronomique; Ecole Pratique des Hautes Etudes; Agence National Recherche "Genomobile''; Fondation Innovation en Infectiologie	Institut National de la Recherche Agronomique; Ecole Pratique des Hautes Etudes; Agence National Recherche "Genomobile''(French National Research Agency (ANR)); Fondation Innovation en Infectiologie	This work was supported by Institut National de la Recherche Agronomique, Ecole Pratique des Hautes Etudes, Agence National Recherche "Genomobile'' and Fondation Innovation en Infectiologie. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Archer F, 2007, AM J RESP CELL MOL, V36, P534, DOI 10.1165/rcmb.2006-0285OC; Armezzani A, 2011, J VIROL, V85, P7118, DOI 10.1128/JVI.00407-11; Arnaud F, 2007, PLOS PATHOG, V3, P1716, DOI 10.1371/journal.ppat.0030170; Black LR, 2010, J VIROL, V84, P6564, DOI 10.1128/JVI.00210-10; Carlson J, 2003, J VIROL, V77, P9662, DOI 10.1128/JVI.77.17.9662-9668.2003; Hallwirth C, 2005, VIRUS GENES, V30, P59, DOI 10.1007/s11262-004-4582-0; IKEDA H, 1989, J VIROL, V63, P5405, DOI 10.1128/JVI.63.12.5405-5412.1989; Jern P, 2008, ANNU REV GENET, V42, P709, DOI 10.1146/annurev.genet.42.110807.091501; LANDEGREN U, 1988, SCIENCE, V241, P1077, DOI 10.1126/science.3413476; Leroux C, 2007, VET RES, V38, P211, DOI 10.1051/vetres:2006060; Murcia PR, 2007, J VIROL, V81, P1762, DOI 10.1128/JVI.01859-06; Palmarini M, 2000, J VIROL, V74, P8065, DOI 10.1128/JVI.74.17.8065-8076.2000; Palmarini M, 1999, J VIROL, V73, P6964, DOI 10.1128/JVI.73.8.6964-6972.1999; PRYCIAK PM, 1992, J VIROL, V66, P5959, DOI 10.1128/JVI.66.10.5959-5966.1992; Wang Y, 2010, TRANSGENIC RES, V19, P775, DOI 10.1007/s11248-009-9355-z	15	11	11	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 24	2012	7	7							e41965	10.1371/journal.pone.0041965	http://dx.doi.org/10.1371/journal.pone.0041965			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	978NX	22911867	Green Submitted, Green Published, gold			2022-12-25	WOS:000306751300084
J	Guo, W; Li, YH; Liang, W; Wong, S; Apovian, C; Kirkland, JL; Corkey, BE				Guo, Wen; Li, Yahui; Liang, Wentao; Wong, Siu; Apovian, Caroline; Kirkland, James L.; Corkey, Barbara E.			Beta-Mecaptoethanol Suppresses Inflammation and Induces Adipogenic Differentiation in 3T3-F442A Murine Preadipocytes	PLOS ONE			English	Article							NF-KAPPA-B; ACTIVATED RECEPTOR-GAMMA; NECROSIS-FACTOR-ALPHA; ADIPOCYTE DIFFERENTIATION; GENE-EXPRESSION; PPAR-GAMMA; DIETARY 2-MERCAPTOETHANOL; OXIDATIVE STRESS; NORMAL-WEIGHT; REDOX STATUS	Preadipocytes are present in adipose tissues throughout adult life that can proliferate and differentiate into mature adipocytes in response to environmental cues. Abnormal increase in adipocyte number or size leads to fat tissue expansion. However, it is now recognized that adipocyte hypertrophy is a greater risk factor for metabolic syndrome whereas fat tissue that continues to produce newer and smaller fat cells through preadipocyte differentiation is "metabolically healthy". Because adipocyte hypertrophy is often associated with increased oxidant stress and low grade inflammation, both are linked to disturbed cellular redox, we tested how preadipocyte differentiation may be regulated by beta-mercaptoethanol (BME), a pharmacological redox regulator and radical scavenger, using murine 3T3-F442A preadipocytes as the cell model. Effects of BME on adipogenesis were measured by microphotography, real-time PCR, and Western analysis. Our data demonstrated that preadipocyte differentiation could be regulated by extracellular BME. At an optimal concentration, BME enhanced expression of adipogenic gene markers and lipid accumulation. This effect was associated with BME-mediated down-regulation of inflammatory cytokine expression during early differentiation. BME also attenuated TNFalpha-induced activation of NFkappaB in differentiating preadipocytes and partially restored TNFalpha-mediated suppression on adipogenesis. Using a non-adipogenic HEK293 cell line transfected with luciferase reporter genes, we demonstrated that BME reduced basal and TNFalpha-induced NFkappaB activity and increased basal and ciglitazone-induced PPARgamma activity; both may contribute to the pro-adipogenic effect of BME in differentiating F442A preadipocytes.	[Guo, Wen; Li, Yahui; Liang, Wentao; Wong, Siu; Apovian, Caroline; Corkey, Barbara E.] Boston Univ, Sch Med, Dept Med, Boston, MA 02118 USA; [Kirkland, James L.] Mayo Clin, Robert & Arlene Kogod Ctr Aging, Rochester, MN USA	Boston University; Mayo Clinic	Guo, W (corresponding author), Boston Univ, Sch Med, Dept Med, Boston, MA 02118 USA.	wguo@bu.edu	Kirkland, James/F-9159-2016	Guo, Wen/0000-0002-4474-2837; Apovian, Caroline/0000-0002-8029-1922; Liang, Wentao/0000-0002-0609-6280	National Institutes of Health [AG013925, DK56690, AG037859]; Department of Medicine Bridge Fund; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P30DK050456, R01DK056690] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [R01AG013925, R21AG037859, R37AG013925] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Department of Medicine Bridge Fund; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	This work is supported by National Institutes of Health funding AG013925 (JLK), DK56690 (BEC, WG), AG037859 (WG) and the Department of Medicine Bridge Fund (WG). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abe D, 2010, BIOFACTORS, V36, P52, DOI 10.1002/biof.70; Abeydeera LR, 1998, THERIOGENOLOGY, V50, P747, DOI 10.1016/S0093-691X(98)00180-0; Antonopoulos Alexios S, 2011, Recent Pat Cardiovasc Drug Discov, V6, P78; Basseri S, 2009, J LIPID RES, V50, P2486, DOI 10.1194/jlr.M900216-JLR200; Berg AH, 2004, AM J PHYSIOL-ENDOC M, V287, pE1178, DOI 10.1152/ajpendo.00002.2004; Beyer I, 2012, CURR OPIN CLIN NUTR, V15, P12, DOI 10.1097/MCO.0b013e32834dd297; Bird SD, 2011, CELL BIOL INT, V35, P857, DOI 10.1042/CBI20100593; Blanquicett C, 2010, FREE RADICAL BIO MED, V48, P1618, DOI 10.1016/j.freeradbiomed.2010.03.007; BRIDGEMAN MME, 1994, THORAX, V49, P670, DOI 10.1136/thx.49.7.670; Briggs DB, 2009, BIOCHEMISTRY-US, V48, P12345, DOI 10.1021/bi9015555; Brodsky M, 2010, J INFLAMM-LOND, V7, DOI 10.1186/1476-9255-7-3; Cheong R, 2008, MOL SYST BIOL, V4, DOI 10.1038/msb.2008.30; Chiarugi P, 2010, EXPERT OPIN THER TAR, V14, P193, DOI 10.1517/14728220903530712; Cho KJ, 2003, J BIOL CHEM, V278, P34823, DOI 10.1074/jbc.M210747200; Cho S, 1998, BIOCHEM BIOPH RES CO, V253, P104, DOI 10.1006/bbrc.1998.9697; Chung SW, 2000, J BIOL CHEM, V275, P32681, DOI 10.1074/jbc.M002577200; Click RE, 2010, VIRULENCE, V1, P509, DOI 10.4161/viru.1.6.13803; Click RE, 2010, VIRULENCE, V1, P516, DOI 10.4161/viru.1.6.13805; Coskun H, 2010, J THEOR BIOL, V265, P87, DOI 10.1016/j.jtbi.2010.03.047; Cristancho AG, 2011, NAT REV MOL CELL BIO, V12, P722, DOI 10.1038/nrm3198; Diaz-Velasquez CE, 2008, J CELL BIOCHEM, V105, P147, DOI 10.1002/jcb.21810; Elbrecht A, 1999, J BIOL CHEM, V274, P7913, DOI 10.1074/jbc.274.12.7913; Finck BN, 2000, AM J PHYSIOL-REG I, V278, pR537, DOI 10.1152/ajpregu.2000.278.2.R537; Finck BN, 1998, ENDOCRINOLOGY, V139, P2278, DOI 10.1210/en.139.5.2278; Fink T, 2011, METHODS MOL BIOL, V698, P243, DOI 10.1007/978-1-60761-999-4_19; Fisette PL, 2003, J BIOL CHEM, V278, P46252, DOI 10.1074/jbc.M306587200; Fukuyama R, 2007, MOL CARCINOGEN, V46, P402, DOI 10.1002/mc.20288; GREEN H, 1976, CELL, V7, P105, DOI 10.1016/0092-8674(76)90260-9; GREEN H, 1979, J CELL PHYSIOL, V101, P169, DOI 10.1002/jcp.1041010119; Gummersbach C, 2009, DIFFERENTIATION, V77, P115, DOI 10.1016/j.diff.2008.09.009; Gustafson B, 2009, AM J PHYSIOL-ENDOC M, V297, pE999, DOI 10.1152/ajpendo.00377.2009; HEIDRICK ML, 1984, MECH AGEING DEV, V27, P341, DOI 10.1016/0047-6374(84)90057-5; Higa A, 2012, CELL SIGNAL, V24, P1548, DOI 10.1016/j.cellsig.2012.03.011; HOTAMISLIGIL GS, 1993, SCIENCE, V259, P87, DOI 10.1126/science.7678183; Imhoff BR, 2011, CELL MOL BIOL LETT, V16, P149, DOI 10.2478/s11658-010-0042-0; Imhoff BR, 2010, DIFFERENTIATION, V80, P31, DOI 10.1016/j.diff.2010.04.005; Jiang CY, 1998, NATURE, V391, P82, DOI 10.1038/34184; Kalupahana NS, 2012, MOL ASPECTS MED, V33, P26, DOI 10.1016/j.mam.2011.10.011; Kamata H, 1999, CELL SIGNAL, V11, P1, DOI 10.1016/S0898-6568(98)00037-0; Kaur S, 2008, BRIT J DERMATOL, V159, P1364, DOI 10.1111/j.1365-2133.2008.08759.x; Kil IS, 2008, BIOCHEM BIOPH RES CO, V373, P169, DOI 10.1016/j.bbrc.2008.06.007; Kirkland JL, 2002, EXP GERONTOL, V37, P757, DOI 10.1016/S0531-5565(02)00014-1; Kobayashi H, 2009, AM J PHYSIOL-ENDOC M, V296, pE1326, DOI 10.1152/ajpendo.90921.2008; Koutnikova H, 2001, ANN MED, V33, P556, DOI 10.3109/07853890108995966; Lechpammer S, 2005, EXP HEMATOL, V33, P1201, DOI 10.1016/j.exphem.2005.06.026; Lee H, 2009, J BIOL CHEM, V284, P10601, DOI 10.1074/jbc.M808742200; Lee JH, 2007, INT J MOL MED, V20, P59; Lee OH, 2010, BIOFACTORS, V36, P459, DOI 10.1002/biof.119; Lijnen HR, 2011, J PHARMACOL EXP THER, V337, P457, DOI 10.1124/jpet.110.178046; Lin YC, 2012, FREE RADICAL BIO MED, V52, P1844, DOI 10.1016/j.freeradbiomed.2012.02.028; MACDOUGALD OA, 1995, CURR BIOL, V5, P618, DOI 10.1016/S0960-9822(95)00125-4; MACDOUGALD OA, 1995, ANNU REV BIOCHEM, V64, P345, DOI 10.1146/annurev.bi.64.070195.002021; Mandrup S, 1997, P NATL ACAD SCI USA, V94, P4300, DOI 10.1073/pnas.94.9.4300; Moghe SS, 2012, J MED FOOD, V15, P448, DOI 10.1089/jmf.2011.0234; Moon MK, 2012, APPL PHYSL NUTR META; O'Connell J, 2011, J CLIN ENDOCR METAB, V96, pE680, DOI 10.1210/jc.2010-2026; Park HT, 2012, CLIN ENDOCRINOL, V76, P59, DOI 10.1111/j.1365-2265.2011.04141.x; Prins JB, 1997, CLIN SCI, V92, P3, DOI 10.1042/cs0920003; Qanungo S, 2007, J BIOL CHEM, V282, P18427, DOI 10.1074/jbc.M610934200; Rahman I, 2004, BIOCHEM PHARMACOL, V68, P1255, DOI 10.1016/j.bcp.2004.05.042; Relic B, 2009, LAB INVEST, V89, P811, DOI 10.1038/labinvest.2009.41; Ricote M, 1998, P NATL ACAD SCI USA, V95, P7614, DOI 10.1073/pnas.95.13.7614; Rosen ED, 2000, ANNU REV CELL DEV BI, V16, P145, DOI 10.1146/annurev.cellbio.16.1.145; Samuni Y, 2010, FREE RADICAL BIO MED, V49, P667, DOI 10.1016/j.freeradbiomed.2010.05.028; Siersbaek R, 2010, FEBS LETT, V584, P3242, DOI 10.1016/j.febslet.2010.06.010; Simone RE, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019652; Singh Sarvjeet, 2006, Anti-Cancer Agents in Medicinal Chemistry, V6, P259, DOI 10.2174/187152006776930918; Spangenburg EE, 2011, J BIOMED BIOTECHNOL, DOI 10.1155/2011/598358; Sun K, 2011, J CLIN INVEST, V121, P2094, DOI 10.1172/JCI45887; Sundar IK, 2010, METHOD ENZYMOL, V474, P213, DOI 10.1016/S0076-6879(10)74013-1; Tchkonia T, 2010, AGING CELL, V9, P667, DOI 10.1111/j.1474-9726.2010.00608.x; TONTONOZ P, 1994, GENE DEV, V8, P1224, DOI 10.1101/gad.8.10.1224; Vallespi MG, 2004, INT IMMUNOPHARMACOL, V4, P1343, DOI 10.1016/j.intimp.2004.05.019; van Tienen FHJ, 2011, INT J OBESITY, V35, P1154, DOI 10.1038/ijo.2010.275; Vigilanza P, 2011, J CELL PHYSIOL, V226, P2016, DOI 10.1002/jcp.22542; Vincent HK, 2009, METABOLISM, V58, P254, DOI 10.1016/j.metabol.2008.09.022; Zembron-Lacny A, 2010, PHYSIOL RES, V59, P239, DOI 10.33549/physiolres.931774; Zhou QG, 2010, J CELL PHYSIOL, V225, P42, DOI 10.1002/jcp.22189	78	11	11	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 23	2012	7	7							e40958	10.1371/journal.pone.0040958	http://dx.doi.org/10.1371/journal.pone.0040958			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	977TM	22911724	Green Submitted, gold, Green Published			2022-12-25	WOS:000306687700028
J	English, AK; Chauvenet, ALM; Safi, K; Pettorelli, N				English, Annie K.; Chauvenet, Alienor L. M.; Safi, Kamran; Pettorelli, Nathalie			Reassessing the Determinants of Breeding Synchrony in Ungulates	PLOS ONE			English	Article							ROE DEER FAWNS; CLIMATE-CHANGE; BIRTH SYNCHRONY; REPRODUCTIVE SYNCHRONY; ECOLOGICAL RESPONSES; PRIMARY PRODUCTIVITY; GESTATION LENGTH; RED DEER; PATTERNS; POPULATION	Predicting the consequences of climate change is a major challenge in ecology and wildlife management. While the impact of changes in climatic conditions on distribution ranges has been documented for many organisms, the consequences of changes in resource dynamics for species' overall performance have seldom been investigated. This study addresses this gap by identifying the factors shaping the reproductive synchrony of ungulates. In temporally-variable environments, reproductive phenology of individuals is a key determinant of fitness, with the timing of reproduction affecting their reproductive output and future performance. We used a satellite-based index of resource availability to explore how the level of seasonality and inter-annual variability in resource dynamics affect birth season length of ungulate populations. Contrary to what was previously thought, we found that both the degree of seasonal fluctuation in resource dynamics and inter-annual changes in resource availability influence the degree of birth synchrony within wild ungulate populations. Our results highlight how conclusions from previous interspecific analyses, which did not consider the existence of shared life-history among species, should be treated with caution. They also support the existence of a multi-faceted link between temporal variation in resource availability and breeding synchrony in terrestrial mammals, and increase our understanding of the mechanisms shaping reproductive synchrony in large herbivores, thus enhancing our ability to predict the potential impacts of climate change on biodiversity.	[English, Annie K.; Chauvenet, Alienor L. M.] Univ London Imperial Coll Sci Technol & Med, Dept Biol, Ascot SL5 7PY, Berks, England; [English, Annie K.; Chauvenet, Alienor L. M.; Pettorelli, Nathalie] Zool Soc London, Inst Zool, London NW1 4RY, England; [Safi, Kamran] Max Planck Inst Ornithol, Radolfzell am Bodensee, Germany	Imperial College London; Zoological Society of London; Max Planck Society	Pettorelli, N (corresponding author), Univ London Imperial Coll Sci Technol & Med, Dept Biol, Silwood Pk, Ascot SL5 7PY, Berks, England.	Nathalie.Pettorelli@ioz.ac.uk	Chauvenet, Alienor/A-7952-2011; Chauvenet, Alienor/L-9135-2015; Pettorelli, Nathalie/AAW-8438-2021; Safi, Kamran/B-2079-2008	Chauvenet, Alienor/0000-0002-3743-7375; Chauvenet, Alienor/0000-0002-3743-7375; Safi, Kamran/0000-0002-8418-6759				Asher GW, 2011, ANIM REPROD SCI, V124, P170, DOI 10.1016/j.anireprosci.2010.08.026; Asher G W, 2007, Soc Reprod Fertil Suppl, V64, P255; BELL G, 1980, AM NAT, V116, P45, DOI 10.1086/283611; BERGER J, 1992, ECOLOGY, V73, P323, DOI 10.2307/1938743; Berteaux D, 2006, CLIM RES, V32, P151, DOI 10.3354/cr032151; Bininda-Emonds ORP, 2007, NATURE, V446, P507, DOI 10.1038/nature05634; Birgersson B, 1997, BEHAV ECOL, V8, P493, DOI 10.1093/beheco/8.5.493; BIRKHEAD TR, 1993, BIOL J LINN SOC, V50, P295, DOI 10.1111/j.1095-8312.1993.tb00933.x; Bivand R., 2020, SPDEP SPATIAL DEPEND; Blomberg SP, 2003, EVOLUTION, V57, P717, DOI 10.1111/j.0014-3820.2003.tb00285.x; Bowyer RT, 1998, J MAMMAL, V79, P1332, DOI 10.2307/1383025; BOYCE MS, 1979, AM NAT, V114, P569, DOI 10.1086/283503; Bradshaw WE, 2007, ANNU REV ECOL EVOL S, V38, P1, DOI 10.1146/annurev.ecolsys.37.091305.110115; Burnham K.P., 2002, MODEL SELECTION MULT, DOI 10.1007/b97636; Burthe S, 2011, J ANIM ECOL, V1865, P1365; Butler MA, 2004, AM NAT, V164, P683, DOI 10.1086/426002; COLWELL RK, 1974, ECOLOGY, V55, P1148, DOI 10.2307/1940366; Darling F.F., 1938, BIRD FLOCKS BREEDING; Di Bitetti MS, 2000, AM J PRIMATOL, V50, P109, DOI 10.1002/(SICI)1098-2345(200002)50:2<109::AID-AJP2>3.3.CO;2-N; Dormann CF, 2007, ECOGRAPHY, V30, P609, DOI 10.1111/j.2007.0906-7590.05171.x; Durant JM, 2005, ECOL LETT, V8, P952, DOI 10.1111/j.1461-0248.2005.00798.x; Ejsmond MJ, 2010, AM NAT, V175, P551, DOI 10.1086/651589; ESRI, 2009, ARCGIS VERS 9 3 1; ESTES R D, 1976, East African Wildlife Journal, V14, P135; FAIRBANKS WS, 1993, J MAMMAL, V74, P129, DOI 10.2307/1381911; FELSENSTEIN J, 1985, AM NAT, V125, P1, DOI 10.1086/284325; Foden W., 2008, 2008 REV IUCN RED LI, P77, DOI DOI 10.1128/AEM.01630-08; Freckleton RP, 2000, FUNCT ECOL, V14, P129, DOI 10.1046/j.1365-2435.2000.00400.x; Freckleton RP, 2002, AM NAT, V160, P712, DOI 10.1086/343873; Garel M, 2009, AM NAT, V173, P89, DOI 10.1086/593359; GARLAND T, 1992, SYST BIOL, V41, P18, DOI 10.2307/2992503; Garonna I, 2009, ENVIRON CONSERV, V36, P253, DOI 10.1017/S0376892909990208; Gordon IJ, 2003, FOREST ECOL MANAG, V181, P13, DOI 10.1016/S0378-1127(03)00124-5; GRAFEN A, 1989, PHILOS T R SOC B, V326, P119, DOI 10.1098/rstb.1989.0106; Hansen TF, 1996, EVOLUTION, V50, P1404, DOI 10.1111/j.1558-5646.1996.tb03914.x; Hansen TF, 2008, EVOLUTION, V62, P1965, DOI 10.1111/j.1558-5646.2008.00412.x; Harmon L, 2009, GEIGER ANAL EVOLUTIO; Harvey P.H., 1991, COMP METHOD EVOLUTIO; Hodge SJ, 2011, BIOL LETTERS, V7, P54, DOI 10.1098/rsbl.2010.0555; HOFMANN R R, 1972, Mammalia, V36, P226, DOI 10.1515/mamm.1972.36.2.226; HUETE A R, 1988, Remote Sensing of Environment, V25, P295; Huffman B, 2011, UNGULATES WORLD; Hunt G, 2006, PALEOBIOLOGY, V32, P578, DOI 10.1666/05070.1; IMS RA, 1990, AM NAT, V136, P485, DOI 10.1086/285109; IMS RA, 1990, TRENDS ECOL EVOL, V5, P135, DOI 10.1016/0169-5347(90)90218-3; Intergovernmental Panel on Climate Change, 2022, CLIM CHANG 2022 IMP, P1; IUCN and UNEP-WCMC, 2010, WORLD DAT PROT AR WD; Jarnemo A, 2004, CAN J ZOOL, V82, P416, DOI 10.1139/z04-011; Jeong SJ, 2011, GLOBAL CHANGE BIOL, V17, P2385, DOI 10.1111/j.1365-2486.2011.02397.x; Kerr JT, 2003, TRENDS ECOL EVOL, V18, P299, DOI 10.1016/S0169-5347(03)00071-5; Kingdon J., 1997, KINGDOM FIELD GUIDE; Loe LE, 2005, J ANIM ECOL, V74, P579, DOI 10.1111/j.1365-2656.2005.00987.x; MacDonald D, 2009, ENCY MAMMALS; Markon Carl J., 1995, Polar Record, V31, P179; Markon CJ, 2002, INT J REMOTE SENS, V23, P4571, DOI 10.1080/01431160110113926; Martins EP, 1997, AM NAT, V149, P646, DOI 10.1086/286013; Meehl GA, 2005, SCIENCE, V307, P1769, DOI 10.1126/science.1106663; Menzel A, 2006, GLOBAL CHANGE BIOL, V12, P1969, DOI 10.1111/j.1365-2486.2006.01193.x; Mysterud A, 2003, N ATLANTIC OSCILLATI, P235; Oftedal O.T., 1985, P215; Pagel M, 1999, NATURE, V401, P877, DOI 10.1038/44766; Panzacchi M, 2008, CAN J ZOOL, V86, P116, DOI 10.1139/Z07-120; Parmesan C, 2003, NATURE, V421, P37, DOI 10.1038/nature01286; Pettorelli N, 2005, TRENDS ECOL EVOL, V20, P503, DOI 10.1016/j.tree.2005.05.011; Pettorelli N, 2011, CLIM RES, V46, P15, DOI 10.3354/cr00936; Post E, 1999, J WILDLIFE MANAGE, V63, P335, DOI 10.2307/3802517; RACHLOW JL, 1991, J MAMMAL, V72, P487, DOI 10.2307/1382131; Reznick D, 2002, ECOLOGY, V83, P1509, DOI 10.2307/3071970; Rohlf FJ, 2001, EVOLUTION, V55, P2143; Rowell JE, 2009, THERIOGENOLOGY, V72, P190, DOI 10.1016/j.theriogenology.2009.01.022; RUTBERG AT, 1987, AM NAT, V130, P692, DOI 10.1086/284739; RUTBERG AT, 1984, J MAMMAL, V65, P418, DOI 10.2307/1381088; Ryan SJ, 2007, BEHAV ECOL, V18, P635, DOI 10.1093/beheco/arm028; Saino N, 2011, P ROY SOC B-BIOL SCI, V278, P835, DOI 10.1098/rspb.2010.1778; Sato T, 2008, ZOOL SCI, V25, P766, DOI 10.2108/zsj.25.766; Scott IC, 2008, ANIM REPROD SCI, V109, P206, DOI 10.1016/j.anireprosci.2007.11.025; SEKULIC R, 1978, E AFR WILDL J, V16, P177; Sheehy DP, 1996, J RANGE MANAGE, V49, P16, DOI 10.2307/4002719; Sigouin D, 1997, ALCES N AM, V33, P85; Sinclair ARE, 2000, ECOLOGY, V81, P2100, DOI 10.1890/0012-9658(2000)081[2100:WDPASO]2.0.CO;2; Stenseth NC, 2002, SCIENCE, V297, P1292, DOI 10.1126/science.1071281; Testa JW, 2002, J MAMMAL, V83, P699, DOI 10.1644/1545-1542(2002)083<0699:DPONIS>2.0.CO;2; Tucker CJ, 2005, INT J REMOTE SENS, V26, P4485, DOI 10.1080/01431160500168686; Visser ME, 2003, P ROY SOC B-BIOL SCI, V270, P367, DOI 10.1098/rspb.2002.2244; Visser ME, 2005, P ROY SOC B-BIOL SCI, V272, P2561, DOI 10.1098/rspb.2005.3356; Walker EP, 1975, MAMMALS WORLD; Walther GR, 2002, NATURE, V416, P389, DOI 10.1038/416389a; Wilson DE, 2011, HOOFED MAMMALS, V2	88	512	518	0	73	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 20	2012	7	7							e41444	10.1371/journal.pone.0041444	http://dx.doi.org/10.1371/journal.pone.0041444			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	977GL	22911793	Green Submitted, Green Published, gold			2022-12-25	WOS:000306644600078
J	Qi, RF; Xu, Q; Zhang, LJH; Zhong, J; Zheng, G; Wu, SY; Zhang, ZQ; Liao, W; Zhong, Y; Ni, L; Jiao, Q; Zhang, ZJ; Liu, YJ; Lu, GM				Qi, Rongfeng; Xu, Qiang; Zhang, Long Jiang; Zhong, Jianhui; Zheng, Gang; Wu, Shengyong; Zhang, Zhiqiang; Liao, Wei; Zhong, Yuan; Ni, Ling; Jiao, Qing; Zhang, Zongjun; Liu, Yijun; Lu, Guangming			Structural and Functional Abnormalities of Default Mode Network in Minimal Hepatic Encephalopathy: A Study Combining DTI and fMRI	PLOS ONE			English	Article							RESTING-STATE NETWORKS; BRAIN NETWORKS; CEREBRAL EDEMA; CONNECTIVITY; CIRRHOSIS; ARCHITECTURE; COMPONENTS; DIAGNOSIS; DISEASE; NUMBER	Background and Purpose: Live failure can cause brain edema and aberrant brain function in cirrhotic patients. In particular, decreased functional connectivity within the brain default-mode network (DMN) has been recently reported in overt hepatic encephalopathy (HE) patients. However, so far, little is known about the connectivity among the DMN in the minimal HE (MHE), the mildest form of HE. Here, we combined diffusion tensor imaging (DTI) and resting-state functional MRI (rs-fMRI) to test our hypothesis that both structural and functional connectivity within the DMN were disturbed in MHE. Materials and Methods: Twenty MHE patients and 20 healthy controls participated in the study. We explored the changes of structural (path length, tracts count, fractional anisotropy [FA] and mean diffusivity [MD] derived from DTI tractography) and functional (temporal correlation coefficient derived from rs-fMRI) connectivity of the DMN in MHE patients. Pearson correlation analysis was performed between the structural/functional indices and venous blood ammonia levels/neuropsychological tests scores of patients. All thresholds were set at P<0.05, Bonferroni corrected. Results: Compared to the healthy controls, MHE patients showed both decreased FA and increased MD in the tract connecting the posterior cingulate cortex/precuneus (PCC/PCUN) to left parahippocampal gyrus (PHG), and decreased functional connectivity between the PCC/PCUN and left PHG, and medial prefrontal cortex (MPFC). MD values of the tract connecting PCC/PCUN to the left PHG positively correlated to the ammonia levels, the temporal correlation coefficients between the PCC/PCUN and the MPFC showed positive correlation to the digital symbol tests scores of patients. Conclusion: MHE patients have both disturbed structural and functional connectivity within the DMN. The decreased functional connectivity was also detected between some regions without abnormal structural connectivity, suggesting that the former may be more sensitive in detecting the early abnormalities of MHE. This study extends our understanding of the pathophysiology of MHE.	[Qi, Rongfeng; Zhang, Long Jiang; Zheng, Gang; Zhang, Zhiqiang; Zhong, Yuan; Ni, Ling; Jiao, Qing; Zhang, Zongjun; Lu, Guangming] Nanjing Univ, Jinling Hosp, Sch Clin, Dept Med Imaging,Med Coll, Nanjing 210008, Jiangsu, Peoples R China; [Xu, Qiang] Univ Elect Sci & Technol China, Sch Life Sci & Technol, Key Lab NeuroInformat, Minist Educ, Chengdu 610054, Sichuan Provinc, Peoples R China; [Wu, Shengyong] Med Imaging Inst Tianjin, Tianjin, Peoples R China; [Zhong, Jianhui] Zhejiang Univ, Dept Biomed Engn, Hangzhou 310027, Zhejiang, Peoples R China	Nanjing University; University of Electronic Science & Technology of China; Zhejiang University	Qi, RF (corresponding author), Nanjing Univ, Jinling Hosp, Sch Clin, Dept Med Imaging,Med Coll, Nanjing 210008, Jiangsu, Peoples R China.	kevinzhanglongjiang@yahoo.com.cn; cjr.luguangming@vip.163.com	Wu, Shawn/J-8611-2014	Wu, Shawn/0000-0003-3432-9819; Xu, Qiang/0000-0002-7739-7515	Natural Scientific Foundation of China [30700194, 81101039, 30800264, 30971019]; Chinese key grant [BWS11J063, 10z026]	Natural Scientific Foundation of China(National Natural Science Foundation of China (NSFC)); Chinese key grant	This work was supported by the grants from the Natural Scientific Foundation of China [Grant No. 30700194 for LJZ, Grant No. 81101039 for GZ, Grant No. 30800264 for Zhiqiang Zhang, and Grant No. 30971019 for QJ], and Chinese key grant for GL (Grant Nos. BWS11J063 and 10z026). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bai F, 2012, CORTEX, V48, P604, DOI 10.1016/j.cortex.2011.02.011; Broyd SJ, 2009, NEUROSCI BIOBEHAV R, V33, P279, DOI 10.1016/j.neubiorev.2008.09.002; Bullmore ET, 2009, NAT REV NEUROSCI, V10, P186, DOI 10.1038/nrn2575; Catani M, 2008, CORTEX, V44, P1105, DOI 10.1016/j.cortex.2008.05.004; Chavarria L, 2011, AM J NEURORADIOL, V32, P1510, DOI 10.3174/ajnr.A2533; Chen B, 2008, MAGN RESON IMAGING, V26, P103, DOI 10.1016/j.mri.2007.05.003; Chen HJ, 2011, EUR J RADIOL; Chen HJ, 2012, NEUROSCI LETT, V507, P5, DOI 10.1016/j.neulet.2011.11.033; Damoiseaux JS, 2009, BRAIN STRUCT FUNCT, V213, P525, DOI 10.1007/s00429-009-0208-6; Duarte-Carvajalino JM, 2012, NEUROIMAGE, V59, P3784, DOI 10.1016/j.neuroimage.2011.10.096; Ferenci P, 2002, HEPATOLOGY, V35, P716, DOI 10.1053/jhep.2002.31250; Fox MD, 2005, P NATL ACAD SCI USA, V102, P9673, DOI 10.1073/pnas.0504136102; Goel A, 2010, LIVER INT, V30, P1143, DOI 10.1111/j.1478-3231.2010.02289.x; Greicius MD, 2004, P NATL ACAD SCI USA, V101, P4637, DOI 10.1073/pnas.0308627101; Greicius MD, 2009, CEREB CORTEX, V19, P72, DOI 10.1093/cercor/bhn059; Groeneweg M, 1998, HEPATOLOGY, V28, P45, DOI 10.1002/hep.510280108; Honey CJ, 2009, P NATL ACAD SCI USA, V106, P2035, DOI 10.1073/pnas.0811168106; Jafri MJ, 2008, NEUROIMAGE, V39, P1666, DOI 10.1016/j.neuroimage.2007.11.001; Kaiser M, 2006, PLOS COMPUT BIOL, V2, P805, DOI 10.1371/journal.pcbi.0020095; Kale RA, 2006, HEPATOLOGY, V43, P698, DOI 10.1002/hep.21114; Kumar R, 2008, J MAGN RESON IMAGING, V27, P1061, DOI 10.1002/jmri.21342; Le Bihan D, 2003, NAT REV NEUROSCI, V4, P469, DOI 10.1038/nrn1119; Le Bihan D, 2001, J MAGN RESON IMAGING, V13, P534, DOI 10.1002/jmri.1076; Liao W, 2011, HUM BRAIN MAPP, V32, P883, DOI 10.1002/hbm.21076; Liao W, 2010, NEUROIMAGE, V52, P1549, DOI 10.1016/j.neuroimage.2010.05.010; Mantini D, 2007, P NATL ACAD SCI USA, V104, P13170, DOI 10.1073/pnas.0700668104; Mardini H, 2011, J HEPATOL, V54, P1154, DOI 10.1016/j.jhep.2010.09.030; Miese F, 2006, AM J NEURORADIOL, V27, P1019; Miller EK, 2001, ANNU REV NEUROSCI, V24, P167, DOI 10.1146/annurev.neuro.24.1.167; Ortiz M, 2005, J HEPATOL, V42, pS45, DOI 10.1016/j.jhep.2004.11.028; Poveda MJ, 2010, NEUROIMAGE, V52, P481, DOI 10.1016/j.neuroimage.2010.04.260; Prasad S, 2007, HEPATOLOGY, V45, P549, DOI 10.1002/hep.21533; PUGH RNH, 1973, BRIT J SURG, V60, P646, DOI 10.1002/bjs.1800600817; Qi RF, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0037400; Qi RF, 2012, RADIOLOGY, V264, P187, DOI 10.1148/radiol.12111429; Raichle ME, 2001, P NATL ACAD SCI USA, V98, P676, DOI 10.1073/pnas.98.2.676; Ralchle ME, 2007, NEUROIMAGE, V37, P1083, DOI 10.1016/j.neuroimage.2007.02.041; Sidhu SS, 2011, AM J GASTROENTEROL, V106, P307, DOI 10.1038/ajg.2010.455; Smith SM, 2004, NEUROIMAGE, V23, pS208, DOI 10.1016/j.neuroimage.2004.07.051; van den Heuvel M, 2008, J NEUROSCI, V28, P10844, DOI 10.1523/JNEUROSCI.2964-08.2008; van den Heuvel MP, 2009, HUM BRAIN MAPP, V30, P3127, DOI 10.1002/hbm.20737; Wang K, 2007, HUM BRAIN MAPP, V28, P967, DOI 10.1002/hbm.20324; Weissenborn K, 1998, J HEPATOL, V28, P646, DOI 10.1016/S0168-8278(98)80289-4; Weissenborn K, 2001, J HEPATOL, V34, P768, DOI 10.1016/S0168-8278(01)00026-5; Zhang DY, 2010, NAT REV NEUROL, V6, P15, DOI 10.1038/nrneurol.2009.198; Zhang LJ, 2012, HUM BRAIN MAPP, V33, P1384, DOI 10.1002/hbm.21295; Zhang ZQ, 2011, BRAIN, V134, P2912, DOI 10.1093/brain/awr223	48	48	54	1	27	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 20	2012	7	7							e41376	10.1371/journal.pone.0041376	http://dx.doi.org/10.1371/journal.pone.0041376			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	977GL	22911787	Green Published, Green Submitted, gold			2022-12-25	WOS:000306644600076
J	Chen, XL; Zhang, J; Zhang, M; Liu, S; Yan, WS; Jung, JH; Chen, XB				Chen, Xiangling; Zhang, Jin; Zhang, Min; Liu, Shou; Yan, Wensheng; Jung, JinHyuk; Chen, Xinbin			Serine 123 Phosphorylation Modulates p21 Protein Stability and Activity by Suppressing Ubiquitin-independent Proteasomal Degradation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							NUCLEOTIDE EXCISION-REPAIR; CYCLIN-DEPENDENT KINASES; DNA-REPLICATION; P53; P21(CIP1); P21(WAF1/CIP1); INHIBITION; EXPRESSION; BINDING; PROLIFERATION	The cyclin-dependent kinase inhibitor p21(Waf1/Cip1) is a major regulator of the cell cycle and plays an important role in many cellular processes, including differentiation, stress response, apoptosis, and tumorigenesis. We previously cloned the gene encoding dog p21 and found that unlike its human ortholog, dog p21 is expressed as two isoforms, one high molecular mass band of 23 kDa and one low molecular mass band of 19 kDa. In the current study, we found that the high molecular mass band is phosphorylated, whereas the low molecular mass band is hypophosphorylated. Moreover, by generating multiple mutants of dog p21, we found that serine 123 and proline 124, which form a consensus site for proline-directed phosphorylation, are required for expression of the high molecular mass p21 isoform through phosphorylation at serine 123. Most importantly, we showed that serine 123 phosphorylation inhibits ubiquitin-independent proteasomal degradation of p21 protein and subsequently, prolongs p21 protein half-life and enhances the ability of p21 to suppress cell proliferation. Taken together, these data reveal that serine 123 phosphorylation modulates p21 protein stability and activity by suppressing ubiquitin-independent proteasomal degradation.	[Chen, Xiangling; Zhang, Jin; Zhang, Min; Liu, Shou; Yan, Wensheng; Jung, JinHyuk; Chen, Xinbin] Univ Calif Davis, Comparat Oncol Lab, Davis, CA 95616 USA	University of California System; University of California Davis	Zhang, J (corresponding author), Univ Calif Davis, Comparat Oncol Lab, Davis, CA 95616 USA.	jinzhang@ucdavis.edu; xbchen@ucdavis.edu	liu, shou/C-5406-2015		National Institutes of Health [R01 CA076069, R01 CA102188]; NATIONAL CANCER INSTITUTE [P30CA093373, R01CA102188, R01CA076069] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported, in whole or in part, by National Institutes of Health Grants R01 CA076069 and R01 CA102188.	Amador V, 2007, MOL CELL, V27, P462, DOI 10.1016/j.molcel.2007.06.013; Bornstein G, 2003, J BIOL CHEM, V278, P25752, DOI 10.1074/jbc.M301774200; Brugarolas J, 1998, J CELL BIOL, V141, P503, DOI 10.1083/jcb.141.2.503; Chen JJ, 1996, P NATL ACAD SCI USA, V93, P11597, DOI 10.1073/pnas.93.21.11597; CHOWDARY DR, 1994, MOL CELL BIOL, V14, P1997, DOI 10.1128/MCB.14.3.1997; Dash BC, 2005, MOL CELL BIOL, V25, P3364, DOI 10.1128/MCB.25.8.3364-3387.2005; DENG CX, 1995, CELL, V82, P675, DOI 10.1016/0092-8674(95)90039-X; Dohn M, 2001, ONCOGENE, V20, P3193, DOI 10.1038/sj.onc.1204427; DULIC V, 1993, P NATL ACAD SCI USA, V90, P11034, DOI 10.1073/pnas.90.23.11034; ELDEIRY WS, 1994, CANCER RES, V54, P1169; ELDEIRY WS, 1993, CELL, V75, P817, DOI 10.1016/0092-8674(93)90500-P; ELDEIRY WS, 1995, CANCER RES, V55, P2910; Erhardt JA, 1998, J BIOL CHEM, V273, P23517, DOI 10.1074/jbc.273.36.23517; Franklin DS, 2000, MOL CELL BIOL, V20, P6147, DOI 10.1128/MCB.20.16.6147-6158.2000; Gartel AL, 1999, EXP CELL RES, V246, P280, DOI 10.1006/excr.1998.4319; GU Y, 1993, NATURE, V366, P707, DOI 10.1038/366707a0; Harms KL, 2007, CANCER RES, V67, P3145, DOI 10.1158/0008-5472.CAN-06-4397; HARPER JW, 1995, MOL BIOL CELL, V6, P387, DOI 10.1091/mbc.6.4.387; Ji C, 1997, ONCOGENE, V15, P2749, DOI 10.1038/sj.onc.1201441; Jin YT, 2003, EMBO J, V22, P6365, DOI 10.1093/emboj/cdg600; Jung YS, 2010, CELL SIGNAL, V22, P1003, DOI 10.1016/j.cellsig.2010.01.013; Kashiwagi M, 2000, ONCOGENE, V19, P6334, DOI 10.1038/sj.onc.1204028; Kim GY, 2002, J BIOL CHEM, V277, P29792, DOI 10.1074/jbc.M201299200; Kim Y, 2008, GENE DEV, V22, P2507, DOI 10.1101/gad.1703708; Li Y, 2002, J BIOL CHEM, V277, P11352, DOI 10.1074/jbc.M109062200; Martin-Caballero J, 2001, CANCER RES, V61, P6234; Oku T, 1998, GENES CELLS, V3, P357, DOI 10.1046/j.1365-2443.1998.00199.x; PAN ZQ, 1995, J BIOL CHEM, V270, P22008, DOI 10.1074/jbc.270.37.22008; PODUST VN, 1995, BIOCHEMISTRY-US, V34, P8869, DOI 10.1021/bi00027a039; Rossig L, 2002, J BIOL CHEM, V277, P9684, DOI 10.1074/jbc.M106157200; Sherr CJ, 1999, GENE DEV, V13, P1501, DOI 10.1101/gad.13.12.1501; Shivji MKK, 1998, ONCOGENE, V17, P2827, DOI 10.1038/sj.onc.1202352; Suzuki A, 2000, CELL DEATH DIFFER, V7, P721, DOI 10.1038/sj.cdd.4400706; Touitou R, 2001, EMBO J, V20, P2367, DOI 10.1093/emboj/20.10.2367; WAGA S, 1994, NATURE, V369, P574, DOI 10.1038/369574a0; Wang ZP, 2010, INT J BIOCHEM CELL B, V42, P1030, DOI 10.1016/j.biocel.2010.03.012; Warbrick E, 1997, ONCOGENE, V14, P2313, DOI 10.1038/sj.onc.1201072; XIONG Y, 1993, NATURE, V366, P701, DOI 10.1038/366701a0; Zhang J, 2011, GENE DEV, V25, P1528, DOI 10.1101/gad.2069311; Zhang Jin, 2008, Curr Mol Med, V8, P845, DOI 10.2174/156652408786733748; Zhang J, 2009, MOL CANCER RES, V7, P67, DOI 10.1158/1541-7786.MCR-08-0347; Zhang Z, 2004, J BIOL CHEM, V279, P16000, DOI 10.1074/jbc.M312264200	42	5	5	0	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 5	2012	287	41					34410	34418		10.1074/jbc.M112.384990	http://dx.doi.org/10.1074/jbc.M112.384990			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	018IS	22908227	Green Published, hybrid			2022-12-25	WOS:000309654200043
J	Braun, KR; DeWispelaere, AM; Bressler, SL; Fukai, N; Kenagy, RD; Chen, LH; Clowes, AW; Kinsella, MG				Braun, Kathleen R.; DeWispelaere, Allison M.; Bressler, Steven L.; Fukai, Nozomi; Kenagy, Richard D.; Chen, Lihua; Clowes, Alexander W.; Kinsella, Michael G.			Inhibition of PDGF-B Induction and Cell Growth by Syndecan-1 Involves the Ubiquitin and SUMO-1 Ligase, Topors	PLOS ONE			English	Article							TOPOISOMERASE-I-BINDING; HEPARAN-SULFATE PROTEOGLYCAN; RING FINGER PROTEIN; CYTOPLASMIC DOMAIN; PDZ PROTEIN; TYROSINE PHOSPHORYLATION; NUCLEAR-LOCALIZATION; SURFACE; GENE; SUPPRESSION	Syndecans are receptors for soluble ligands, including heparin-binding growth factors, and matrix proteins. However, intracellular targets of syndecan-1 (Sdc-1)-mediated signaling are not fully understood. A yeast two-hybrid protein interaction screening of a mouse embryo library identified the ubiquitin and SUMO-1 E3 ligase, Topors, as a novel ligand of the Sdc-1 cytoplasmic domain (S1CD), a finding confirmed by ligand blotting and co-precipitation with Sdc-1 from cell lysates. Deletion mutagenesis identified an 18-amino acid sequence of Topors required for the interaction with the S1CD. By immunohistochemistry, Topors and Sdc-1 co-localized near the cell periphery in normal murine mammary gland (NMuMG) cells in vitro and in mouse embryonic epithelia in vivo. Finally, siRNA-mediated knockdown of Topors demonstrated that Topors is a growth promoter for murine arterial smooth muscle cells and is required for the inhibitory effect of Sdc-1 on cell growth and platelet-derived growth factor-B induction. These data suggest a novel mechanism for the inhibitory effects of Sdc-1 on cell growth that involves the interaction between the cytoplasmic domain of Sdc-1 and the SUMO-1 E3 ligase, Topors.	[Braun, Kathleen R.; DeWispelaere, Allison M.; Bressler, Steven L.; Kinsella, Michael G.] Virginia Mason, Benaroya Res Inst, Seattle, WA 98101 USA; [Fukai, Nozomi; Kenagy, Richard D.; Chen, Lihua; Clowes, Alexander W.] Univ Washington, Dept Surg, Seattle, WA 98195 USA	Benaroya Research Institute; Virginia Mason Medical Center; University of Washington; University of Washington Seattle	Braun, KR (corresponding author), Virginia Mason, Benaroya Res Inst, Seattle, WA 98101 USA.	mkinsella@benaroyaresearch.org		Kenagy, Richard/0000-0002-2021-5565	American Heart Association [0355478Z]; Pacific Mountain Affiliate of the American Heart Association; National Institutes of Health (NIH) [HL52459, HL30946]; USAMRAA/DOD [W81XWH-07-01-0246]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL030946, R37HL052459, R01HL052459, R01HL092928] Funding Source: NIH RePORTER	American Heart Association(American Heart Association); Pacific Mountain Affiliate of the American Heart Association(American Heart Association); National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); USAMRAA/DOD; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported by American Heart Association Grant-in-Aid 0355478Z (Dr. Kinsella); Pacific Mountain Affiliate of the American Heart Association (Dr. Fukai) www.heart.org; National Institutes of Health (NIH) grants HL52459 and HL30946 (Dr. Clowes) grants.nih.gov; USAMRAA/DOD grant W81XWH-07-01-0246 (Dr. Kinsella). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adams JC, 2001, J CELL BIOL, V152, P1169, DOI 10.1083/jcb.152.6.1169; ASUNDI VK, 1995, J BIOL CHEM, V270, P26404, DOI 10.1074/jbc.270.44.26404; BACIU PC, 1995, MOL BIOL CELL, V6, P1503, DOI 10.1091/mbc.6.11.1503; Baciu PC, 2000, J CELL SCI, V113, P315; Beauvais DeannaLee M, 2004, Reprod Biol Endocrinol, V2, P3, DOI 10.1186/1477-7827-2-3; Bernfield M, 1999, ANNU REV BIOCHEM, V68, P729, DOI 10.1146/annurev.biochem.68.1.729; BJERRUM OJ, 1989, J CHROMATOGR, V470, P351, DOI 10.1016/S0021-9673(01)83563-9; Bowne SJ, 2008, MOL VIS, V14, P922; BREEDEN L, 1985, COLD SPRING HARB SYM, V50, P643, DOI 10.1101/SQB.1985.050.01.078; Bressler SL, 1996, HUM MOL GENET, V5, P1589, DOI 10.1093/hmg/5.10.1589; Brockstedt U, 2002, EXP CELL RES, V274, P235, DOI 10.1006/excr.2002.5477; Carey DJ, 1996, J BIOL CHEM, V271, P15253, DOI 10.1074/jbc.271.25.15253; CAREY DJ, 1994, J CELL BIOL, V124, P161, DOI 10.1083/jcb.124.1.161; Chakarova CF, 2007, AM J HUM GENET, V81, P1098, DOI 10.1086/521953; Chakarova CF, 2011, HUM MOL GENET, V20, P975, DOI 10.1093/hmg/ddq543; Chen LG, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004947; Chen P, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006565; CHIEN CT, 1991, P NATL ACAD SCI USA, V88, P9578, DOI 10.1073/pnas.88.21.9578; DAVID G, 1993, FASEB J, V7, P1023, DOI 10.1096/fasebj.7.11.8370471; Fukai N, 2009, ARTERIOSCL THROM VAS, V29, P1356, DOI 10.1161/ATVBAHA.109.190132; Fuki IV, 2000, BIOCHEM J, V351, P607, DOI 10.1042/0264-6021:3510607; Fuki IV, 1997, J CLIN INVEST, V100, P1611, DOI 10.1172/JCI119685; Gao YH, 2000, J CELL PHYSIOL, V184, P373, DOI 10.1002/1097-4652(200009)184:3<373::AID-JCP12>3.0.CO;2-I; Grootjans JJ, 1997, P NATL ACAD SCI USA, V94, P13683, DOI 10.1073/pnas.94.25.13683; Guan B, 2008, J BIOL CHEM, V283, P4834, DOI 10.1074/jbc.M708630200; Haluska P, 1999, NUCLEIC ACIDS RES, V27, P2538, DOI 10.1093/nar/27.12.2538; Hayashida K, 2008, J BIOL CHEM, V283, P35435, DOI 10.1074/jbc.M804172200; Hsia E, 2003, J CELL BIOCHEM, V88, P1214, DOI 10.1002/jcb.10470; Hsueh YP, 1998, J CELL BIOL, V142, P139, DOI 10.1083/jcb.142.1.139; Hu YP, 2010, NEOPLASIA, V12, P826, DOI 10.1593/neo.10586; ISHIHARA M, 1986, J BIOL CHEM, V261, P3575; JALKANEN M, 1991, BIOCHEM SOC T, V19, P1069, DOI 10.1042/bst0191069; KATO M, 1995, MOL BIOL CELL, V6, P559, DOI 10.1091/mbc.6.5.559; Kikuno K, 1998, BIOCHEM BIOPH RES CO, V253, P519, DOI 10.1006/bbrc.1998.9782; Kinnunen T, 1998, J BIOL CHEM, V273, P10702, DOI 10.1074/jbc.273.17.10702; Kovalszky I, 1998, MOL CELL BIOCHEM, V183, P11, DOI 10.1023/A:1006898920637; Koyama N, 1996, AM J PATHOL, V148, P749; Lambaerts K, 2009, CURR OPIN CELL BIOL, V21, P662, DOI 10.1016/j.ceb.2009.05.002; Lemos TA, 2006, CELL BIOCHEM BIOPHYS, V44, P463, DOI 10.1385/CBB:44:3:463; LEPPA S, 1991, CELL REGUL, V2, P1; Lin L, 2005, ONCOGENE, V24, P3385, DOI 10.1038/sj.onc.1208554; Maniatis T, 1982, MOL CLONING LABORATO, P433; MIETTINEN HM, 1994, MOL BIOL CELL, V5, P1325, DOI 10.1091/mbc.5.12.1325; O'Connell MP, 2009, J BIOL CHEM, V284, P28704, DOI 10.1074/jbc.M109.028498; Oh ES, 1997, J BIOL CHEM, V272, P11805, DOI 10.1074/jbc.272.18.11805; Oh ES, 1997, J BIOL CHEM, V272, P8133, DOI 10.1074/jbc.272.13.8133; Ojeh N, 2008, J CELL SCI, V121, P2705, DOI 10.1242/jcs.025643; Ott VL, 1998, J BIOL CHEM, V273, P35291, DOI 10.1074/jbc.273.52.35291; Oyanagi H, 2004, LUNG CANCER, V46, P21, DOI 10.1016/j.lungcan.2004.03.009; POLSON A, 1990, IMMUNOL INVEST, V19, P253; Pungaliya P, 2007, J PROTEOME RES, V6, P3918, DOI 10.1021/pr0703674; Rajendra R, 2004, J BIOL CHEM, V279, P36440, DOI 10.1074/jbc.C400300200; RAPRAEGER A, 1986, J CELL BIOL, V103, P2683, DOI 10.1083/jcb.103.6.2683; Rasheed ZA, 2002, EXP CELL RES, V277, P152, DOI 10.1006/excr.2002.5550; Rauch BH, 2005, J BIOL CHEM, V280, P17507, DOI 10.1074/jbc.M410848200; Reiland J, 1996, BIOCHEM J, V319, P39, DOI 10.1042/bj3190039; Richardson TP, 2001, J CELL SCI, V114, P1613; Ridgway LD, 2011, EXP THER MED, V2, P229, DOI 10.3892/etm.2010.189; SAIKI RK, 1985, SCIENCE, V230, P1350, DOI 10.1126/science.2999980; Saleem A, 2004, ONCOGENE, V23, P5293, DOI 10.1038/sj.onc.1207700; Secombe J, 2004, J BIOL CHEM, V279, P17126, DOI 10.1074/jbc.M310097200; Shinbo YM, 2005, INT J ONCOL, V26, P641; Stenmark H, 2009, NAT REV MOL CELL BIO, V10, P513, DOI 10.1038/nrm2728; Sun RJ, 2009, BIOCHEM J, V419, P457, DOI 10.1042/BJ20080515; VOJTEK AB, 1993, CELL, V74, P205, DOI 10.1016/0092-8674(93)90307-C; Volk R, 1999, J BIOL CHEM, V274, P24417, DOI 10.1074/jbc.274.34.24417; Weger S, 2003, EXP CELL RES, V290, P13, DOI 10.1016/S0014-4827(03)00292-1; WOODS A, 1994, MOL BIOL CELL, V5, P183, DOI 10.1091/mbc.5.2.183; Yang XM, 2009, J BIOL CHEM, V284, P28775, DOI 10.1074/jbc.M109.017681; Yao Z, 2007, EMBO J, V26, P1068, DOI 10.1038/sj.emboj.7601571; Zhou R, 1999, GENE, V235, P93, DOI 10.1016/S0378-1119(99)00203-6; Zimmermann P, 2001, MOL BIOL CELL, V12, P339, DOI 10.1091/mbc.12.2.339; Zong F, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007346	73	5	6	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 17	2012	7	8							e43701	10.1371/journal.pone.0043701	http://dx.doi.org/10.1371/journal.pone.0043701			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	996DG	22912899	Green Published, gold, Green Submitted			2022-12-25	WOS:000308063700127
J	Fu, YY; Nergard, JC; Barnette, NK; Wang, YL; Chai, KX; Chen, LM				Fu, Ya-Yuan; Nergard, Jennifer C.; Barnette, Nicole K.; Wang, Yan-Ling; Chai, Karl X.; Chen, Li-Mei			Proteasome Inhibition Augments Cigarette Smoke-Induced GM-CSF Expression in Trophoblast Cells via the Epidermal Growth Factor Receptor	PLOS ONE			English	Article							COLONY-STIMULATING FACTOR; NF-KAPPA-B; MATERNAL SMOKING; TOBACCO USE; PREECLAMPSIA; PREGNANCY; WOMEN; ACTIVATION; PLACENTA; MICE	Maternal cigarette smoking has adverse effects on pregnancy outcomes. The granulocyte-macrophage colony-stimulating factor (GM-CSF) is an essential cytokine for a normal pregnancy. We investigated the impact of cigarette smoke extract (CSE) on GM-CSF expression in human cytotrophoblast cells and suggested a cellular mechanism underlying the CSE-induced GM-CSF expression. An immortalized normal human trophoblast cell line (B6Tert-1) was treated with CSE. The viability and proliferation of the CSE-treated B6Tert-1 cells were evaluated, and the expression of GM-CSF in these cells was quantified at the mRNA and the protein levels by means of reverse-transcription and quantitative polymerase chain reaction (RT-qPCR); and enzyme-linked immunosorbent assay (ELISA), respectively. Human trophoblast cells treated with CSE had an increased expression of GM-CSF at both the mRNA and the protein levels. The CSE-induced GM-CSF expression was synergistically enhanced by the addition of the proteasome inhibitor MG-132, but inhibited by AG-1478, an inhibitor of the epidermal growth factor receptor (EGFR) kinase. Furthermore, CSE treatment increased the phosphorylation of the extracellular-signal regulated kinases (ERK1/2) in the trophoblast cells. The expression of other growth factors such as heparin-binding epidermal growth factor-like growth factor (HB-EGF) and vascular endothelial growth factor (VEGF) was also evaluated. Our data suggested that cigarette smoking and proteasome inhibition synergistically up-regulate GM-CSF cytokine expression by activating the EGFR signaling pathway.	[Fu, Ya-Yuan; Wang, Yan-Ling] Chinese Acad Sci, Inst Zool, State Key Lab Reprod Biol, Beijing, Peoples R China; [Nergard, Jennifer C.; Barnette, Nicole K.; Chai, Karl X.; Chen, Li-Mei] Univ Cent Florida, Burnett Sch Biomed Sci, Coll Med, Orlando, FL 32816 USA	Chinese Academy of Sciences; Institute of Zoology, CAS; State University System of Florida; University of Central Florida	Fu, YY (corresponding author), Chinese Acad Sci, Inst Zool, State Key Lab Reprod Biol, Beijing, Peoples R China.	lchen@mail.ucf.edu			Florida Department of Health [06NIR-03, 10KT-1]	Florida Department of Health	This work was supported by the Florida Department of Health James & Esther King Biomedical Research Program grants 06NIR-03 to LMC and 10KT-1 (Project 5) to KXC. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Belo L, 2003, HYPERTENS PREGNANCY, V22, P129, DOI 10.1081/PRG-120021059; BENOWITZ NL, 1988, CLIN PHARMACOL THER, V44, P23, DOI 10.1038/clpt.1988.107; BENOWITZ NL, 1982, CLIN PHARMACOL THER, V32, P758, DOI 10.1038/clpt.1982.233; Bernhard D, 2003, FASEB J, V17, P2302, DOI 10.1096/fj.03-0312fje; Chaouat G, 1990, J REPROD FERTIL, V89, P4474; Chen GQ, 2002, SCIENCE, V296, P1634, DOI 10.1126/science.1071924; Chen LM, 2001, J BIOL CHEM, V276, P21434, DOI 10.1074/jbc.M011423200; Chen MQ, 2007, BBA-MOL CELL RES, V1773, P1133, DOI 10.1016/j.bbamcr.2007.04.013; CLARK SC, 1987, SCIENCE, V236, P1229, DOI 10.1126/science.3296190; Cnattingius S, 1997, AM J OBSTET GYNECOL, V177, P156, DOI 10.1016/S0002-9378(97)70455-1; de Haas J H, 1975, Eur J Obstet Gynecol Reprod Biol, V5, P283, DOI 10.1016/0028-2243(75)90038-6; Dolcet X, 2006, J BIOL CHEM, V281, P22118, DOI 10.1074/jbc.M601350200; DUFFUS GM, 1968, LANCET, V1, P994; England L, 2007, FRONT BIOSCI-LANDMRK, V12, P2471, DOI 10.2741/2248; Gangl K, 2009, ALLERGY, V64, P398, DOI 10.1111/j.1398-9995.2008.01861.x; GARCIALLORET MI, 1994, EXP CELL RES, V214, P46, DOI 10.1006/excr.1994.1232; Gratacos E, 1998, OBSTET GYNECOL, V92, P849, DOI 10.1016/S0029-7844(98)00300-7; GREER IA, 1994, OBSTET GYNECOL, V84, P937; Hamilton JA, 2004, GROWTH FACTORS, V22, P225, DOI 10.1080/08977190412331279881; Hass R, 2003, PLACENTA, V24, P979, DOI 10.1016/S0143-4004(03)00174-7; Hayashi M, 2004, AM J OBSTET GYNECOL, V190, P456, DOI 10.1016/j.ajog.2003.07.032; Hayden MS, 2004, GENE DEV, V18, P2195, DOI 10.1101/gad.1228704; Hoffmann D, 2001, CHEM RES TOXICOL, V14, P767, DOI 10.1021/tx000260u; Horta BL, 1997, PAEDIATR PERINAT EP, V11, P140, DOI 10.1046/j.1365-3016.1997.d01-17.x; Jiang BB, 2004, J BIOL CHEM, V279, P1323, DOI 10.1074/jbc.M307521200; JOKHI PP, 1994, HUM REPROD, V9, P1660, DOI 10.1093/oxfordjournals.humrep.a138769; Jonsson Y, 2006, J REPROD IMMUNOL, V70, P83, DOI 10.1016/j.jri.2005.10.007; Khan EM, 2008, FASEB J, V22, P910, DOI 10.1096/fj.06-7729com; KLONOFFCOHEN H, 1993, OBSTET GYNECOL, V81, P541; Mascia F, 2010, J INVEST DERMATOL, V130, P682, DOI 10.1038/jid.2009.336; Masubuchi T, 1998, AM J PATHOL, V153, P1903, DOI 10.1016/S0002-9440(10)65704-5; Rajakumar A, 2008, PLACENTA, V29, P290, DOI 10.1016/j.placenta.2007.11.015; Rezvani K, 2007, J NEUROSCI, V27, P10508, DOI 10.1523/JNEUROSCI.3353-07.2007; Roberts JM, 2002, PLACENTA, V23, P359, DOI 10.1053/plac.2002.0819; Robertson SA, 1999, BIOL REPROD, V60, P251, DOI 10.1095/biolreprod60.2.251; Saccani S, 2004, J EXP MED, V200, P107, DOI 10.1084/jem.20040196; Salafia C, 1999, PLACENTA, V20, P273, DOI 10.1053/plac.1998.0378; Savion S, 2002, REPRODUCTION, V123, P399, DOI 10.1530/reprod/123.3.399; SCHRECK R, 1990, MOL CELL BIOL, V10, P1281, DOI 10.1128/MCB.10.3.1281; Seymour JF, 1997, BLOOD, V90, P3037, DOI 10.1182/blood.V90.8.3037; Shibata T, 2002, IMMUNOL CELL BIOL, V80, P226, DOI 10.1046/j.1440-1711.2002.01079.x; Shiverick KT, 1999, PLACENTA, V20, P265, DOI 10.1053/plac.1998.0377; Sjoblom C, 2005, ENDOCRINOLOGY, V146, P2142, DOI 10.1210/en.2004-1260; TARTAKOVSKY B, 1991, DEV BIOL, V146, P345, DOI 10.1016/0012-1606(91)90236-V; Wang HJ, 2001, AM J RESP CELL MOL, V25, P772, DOI 10.1165/ajrcmb.25.6.4458; Wang Y, 2006, MOL HUM REPROD, V12, P451, DOI 10.1093/molehr/gal054; Wikstrom AK, 2010, HYPERTENSION, V55, P1254, DOI 10.1161/HYPERTENSIONAHA.109.147082; Wu WKK, 2010, AUTOPHAGY, V6, P228, DOI 10.4161/auto.6.2.11042; Zdravkovic T, 2005, PLACENTA, V26, pS81, DOI 10.1016/j.placenta.2005.02.003; Zhang HQ, 2012, FREE RADICAL BIO MED, V52, P1437, DOI 10.1016/j.freeradbiomed.2012.01.024	50	7	7	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 17	2012	7	8							e43042	10.1371/journal.pone.0043042	http://dx.doi.org/10.1371/journal.pone.0043042			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	996DG	22912784	Green Published, gold			2022-12-25	WOS:000308063700033
J	Le Bigot, N; Grosjean, M				Le Bigot, Nathalie; Grosjean, Marc			Effects of Handedness on Visual Sensitivity in Perihand Space	PLOS ONE			English	Article							REACTION-TIME; RIGHT-HANDERS; ATTENTION	Recent studies have shown that changes in visual processing in perihand space are limited to the area around the right hand, at least in right-handers. One explanation for these findings is that perception is altered at locations where action is more likely to occur. To test this notion, we asked both right- and left-handers to perform an unspeeded visual discrimination task under four hand-position configurations: Left hand, right hand, both hands, or no hands near the display. Compared to the no-hands (control) condition, visual sensitivity (d') was higher in the dominant-hand condition for right-handers and higher in the dominant- as well as the non-dominant hand condition for left-handers. When both hands were near the display, sensitivity was similar to that in the dominant- hand condition for right-handers and to that in the non-dominant hand condition for left-handers. This shows that performance differed between the two handedness groups when their non-dominant hand was near the display (both alone and accompanied by their dominant hand). Thus, the pattern for left-handers did not correspond to a mirror image of the pattern for right-handers. In line with studies on bimanual action control, visual processing in perihand space seems to be determined by the different ways in which left- and right-handers use their hands.	[Le Bigot, Nathalie; Grosjean, Marc] Leibniz Res Ctr Working Environm & Human Factors, Dortmund, Germany	Dortmund University of Technology; Leibniz Institut for Arbeitsforschung an der TU Dortmund (IFADO)	Le Bigot, N (corresponding author), Leibniz Res Ctr Working Environm & Human Factors, Dortmund, Germany.	lebigot@ifado.de			Deutsche Forschungsgemeinschaft [Ja 747/5-1]	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG))	This research was supported by the Deutsche Forschungsgemeinschaft (Grant Ja 747/5-1). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abrams RA, 2008, COGNITION, V107, P1035, DOI 10.1016/j.cognition.2007.09.006; Bridgeman B, 2011, PHYS LIFE REV, V8, P73, DOI 10.1016/j.plrev.2011.01.002; Buckingham G, 2011, CORTEX, V47, P432, DOI 10.1016/j.cortex.2009.11.003; Cosman JD, 2010, PSYCHOL SCI, V21, P1254, DOI 10.1177/0956797610380697; Cousineau D, 2005, TUTOR QUANT METHODS, V1, P42, DOI 10.20982/tqmp.01.1.p042; COWEY A, 1974, EXP BRAIN RES, V21, P447; Davoli CC, 2010, MEM COGNITION, V38, P555, DOI 10.3758/MC.38.5.555; Dufour A, 2008, EXP BRAIN RES, V190, P91, DOI 10.1007/s00221-008-1453-2; EGLY R, 1994, J EXP PSYCHOL GEN, V123, P161, DOI 10.1037/0096-3445.123.2.161; Franz EA, 2004, J MOTOR BEHAV, V36, P71, DOI 10.3200/JMBR.36.1.71-81; Goble DJ, 2008, NEUROSCI BIOBEHAV R, V32, P598, DOI 10.1016/j.neubiorev.2007.10.006; Gonzalez CLR, 2007, EXP BRAIN RES, V182, P275, DOI 10.1007/s00221-007-1090-1; Graziano MSA, 2002, NEURON, V34, P841, DOI 10.1016/S0896-6273(02)00698-0; Knoblich G., 2006, HUMAN BODY PERCEPTIO; KORNBLUM S, 1990, PSYCHOL REV, V97, P253, DOI 10.1037/0033-295X.97.2.253; Leek MR, 2001, PERCEPT PSYCHOPHYS, V63, P1279, DOI 10.3758/BF03194543; Lloyd DM, 2010, BRAIN COGNITION, V73, P102, DOI 10.1016/j.bandc.2010.03.006; Macmillan N. A., 1991, DETECTION THEORY USE; Moore CM, 1998, PSYCHOL SCI, V9, P104, DOI 10.1111/1467-9280.00019; Moore CM, 1998, J EXP PSYCHOL HUMAN, V24, P1296, DOI 10.1037/0096-1523.24.4.1296; OLDFIELD RC, 1971, NEUROPSYCHOLOGIA, V9, P97, DOI 10.1016/0028-3932(71)90067-4; POSNER MI, 1987, NEUROPSYCHOLOGIA, V25, P135, DOI 10.1016/0028-3932(87)90049-2; Prinzmetal W, 2005, J EXP PSYCHOL GEN, V134, P73, DOI 10.1037/0096-3445.134.1.73; Reed CL, 2010, ATTEN PERCEPT PSYCHO, V72, P236, DOI 10.3758/APP.72.1.236; Reed CL, 2006, J EXP PSYCHOL HUMAN, V32, P166, DOI 10.1037/0096-1523.32.1.166; Sainburg RL, 2002, EXP BRAIN RES, V142, P241, DOI 10.1007/s00221-001-0913-8; SANTEE JL, 1982, J EXP PSYCHOL HUMAN, V8, P489, DOI 10.1037/0096-1523.8.4.489; Shen YC, 2005, J MOTOR BEHAV, V37, P3, DOI 10.3200/JMBR.37.1.3-9; Tseng P, 2011, EXP BRAIN RES, V209, P257, DOI 10.1007/s00221-011-2544-z; Wandell B.A., 1995, FDN VISION	30	27	27	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 17	2012	7	8							e43150	10.1371/journal.pone.0043150	http://dx.doi.org/10.1371/journal.pone.0043150			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	996DG	22912813	Green Published, gold, Green Submitted			2022-12-25	WOS:000308063700050
J	Salgado, A; Oliver, ALS; Matia-Gonzalez, AM; Sotelo, J; Zarco-Fernandez, S; Munoz-Olivas, R; Camara, C; Rodriguez-Gabriel, MA				Salgado, Alejandro; Lopez-Serrano Oliver, Ana; Matia-Gonzalez, Ana M.; Sotelo, Jael; Zarco-Fernandez, Sonia; Munoz-Olivas, Riansares; Camara, Carmen; Rodriguez-Gabriel, Miguel A.			Response to Arsenate Treatment in Schizosaccharomyces pombe and the Role of Its Arsenate Reductase Activity	PLOS ONE			English	Article							DNA-REPAIR PROCESSES; CELL-CYCLE CONTROL; PROTEIN-KINASE; FISSION YEAST; ARSENITE; METABOLITES; TOLERANCE; PATHWAY; MITOSIS; WATER	Arsenic toxicity has been studied for a long time due to its effects in humans. Although epidemiological studies have demonstrated multiple effects in human physiology, there are many open questions about the cellular targets and the mechanisms of response to arsenic. Using the fission yeast Schizosaccharomyces pombe as model system, we have been able to demonstrate a strong activation of the MAPK Spc1/Sty1 in response to arsenate. This activation is dependent on Wis1 activation and Pyp2 phosphatase inactivation. Using arsenic speciation analysis we have also demonstrated the previously unknown capacity of S. pombe cells to reduce As (V) to As (III). Genetic analysis of several fission yeast mutants point towards the cell cycle phosphatase Cdc25 as a possible candidate to carry out this arsenate reductase activity. We propose that arsenate reduction and intracellular accumulation of arsenite are the key mechanisms of arsenate tolerance in fission yeast.	[Salgado, Alejandro; Matia-Gonzalez, Ana M.; Sotelo, Jael; Rodriguez-Gabriel, Miguel A.] Univ Autonoma Madrid, CSIC, Ctr Biol Mol Severo Ochoa, Madrid, Spain; [Lopez-Serrano Oliver, Ana; Zarco-Fernandez, Sonia; Munoz-Olivas, Riansares; Camara, Carmen] Univ Complutense Madrid, Fac CC Quim, Dept Quim Analit, Madrid, Spain	Autonomous University of Madrid; Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Centro de Biologia Molecular Severo Ochoa (CBM); Complutense University of Madrid	Salgado, A (corresponding author), Univ Autonoma Madrid, CSIC, Ctr Biol Mol Severo Ochoa, Madrid, Spain.	marodriguez@cbm.uam.es	Gonzalez, Ana M. Matia/N-3371-2019; Muñoz-Olivas, Riansares/K-4491-2014; Rodriguez-Gabriel, Miguel/L-2425-2013	Gonzalez, Ana M. Matia/0000-0002-8127-4219; Muñoz-Olivas, Riansares/0000-0003-4385-9520; Rodriguez-Gabriel, Miguel/0000-0002-6855-5286; Salgado, Alejandro/0000-0002-9582-3135	Spanish Science and Innovation Ministry [CTQ2008-01031/BQU, BFU2006/01767, BFU2009/09116]; Madrid government; Spanish Ministry of Science and Innovation	Spanish Science and Innovation Ministry(Ministry of Science and Innovation, Spain (MICINN)Spanish Government); Madrid government; Spanish Ministry of Science and Innovation(Ministry of Science and Innovation, Spain (MICINN)Spanish Government)	This work has been supported by Projects CTQ2008-01031/BQU from Spanish Science and Innovation Ministry. JS was supported by Madrid government and AMMG by Spanish Ministry of Science and Innovation. This research was supported by grants awarded to MARG by the Spanish Science and Innovation Ministry (BFU2006/01767 and BFU2009/09116). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahmad SA, 2001, ENVIRON HEALTH PERSP, V109, P629, DOI 10.2307/3455038; Bhattacharjee H, 2010, BIOCHEMISTRY-US, V49, P802, DOI 10.1021/bi9019127; Chakraborti D, 2003, ENVIRON HEALTH PERSP, V111, P1194, DOI 10.1289/ehp.5966; Chakraborti D, 2002, TALANTA, V58, P3, DOI 10.1016/S0039-9140(02)00270-9; Clemens S, 1999, EMBO J, V18, P3325, DOI 10.1093/emboj/18.12.3325; Ellis DR, 2006, PLANT PHYSIOL, V141, P1544, DOI 10.1104/pp.106.084079; Hartwig A, 2002, ENVIRON HEALTH PERSP, V110, P797, DOI 10.1289/ehp.02110s5797; Hartwig A, 2003, TOXICOLOGY, V193, P161, DOI 10.1016/j.tox.2003.08.004; Lyne R, 2003, BMC GENOMICS, V4, DOI 10.1186/1471-2164-4-27; Matia-Gonzalez AM, 2011, YEAST, V28, P9, DOI 10.1002/yea.1816; MORENO S, 1989, CELL, V58, P361, DOI 10.1016/0092-8674(89)90850-7; Mukhopadhyay R, 1998, FEMS MICROBIOL LETT, V168, P127, DOI 10.1016/S0378-1097(98)00430-3; Ohi R, 1999, CURR OPIN CELL BIOL, V11, P267, DOI 10.1016/S0955-0674(99)80036-2; Oremland RS, 2003, SCIENCE, V300, P939, DOI 10.1126/science.1081903; Rodriguez-Gabriel MA, 2005, EUKARYOT CELL, V4, P1396, DOI 10.1128/EC.4.8.1396-1402.2005; Sanz E, 2005, J CHROMATOGR A, V1097, P1, DOI 10.1016/j.chroma.2005.08.012; Schwerdtle T, 2003, DNA REPAIR, V2, P1449, DOI 10.1016/j.dnarep.2003.09.001; Schwerdtle T, 2003, CARCINOGENESIS, V24, P967, DOI 10.1093/carcin/bgg018; Shiozaki K, 1997, METHOD ENZYMOL, V283, P506; Sotelo J, 2006, EUKARYOT CELL, V5, P1826, DOI 10.1128/EC.00225-06; Tsai SL, 2009, CURR OPIN BIOTECH, V20, P659, DOI 10.1016/j.copbio.2009.09.013; Wasserman GA, 2004, ENVIRON HEALTH PERSP, V112, P1329, DOI 10.1289/ehp.6964; Wysocki R, 2003, BIOCHEM BIOPH RES CO, V304, P293, DOI 10.1016/S0006-291X(03)00584-9; Zhou Y, 2004, J BIOL CHEM, V279, P37445, DOI 10.1074/jbc.M404383200	24	5	5	0	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 17	2012	7	8							e43208	10.1371/journal.pone.0043208	http://dx.doi.org/10.1371/journal.pone.0043208			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	996DG	22912829	Green Submitted, Green Published, gold			2022-12-25	WOS:000308063700061
J	Tong, RJ; Purser, A; Unnithan, V; Guinan, J				Tong, Ruiju; Purser, Autun; Unnithan, Vikram; Guinan, Janine			Multivariate Statistical Analysis of Distribution of Deep-Water Gorgonian Corals in Relation to Seabed Topography on the Norwegian Margin	PLOS ONE			English	Article							LOPHELIA-PERTUSA SCLERACTINIA; PREDICTING SUITABLE HABITAT; FOOD-SUPPLY MECHANISMS; ROCKALL TROUGH MARGIN; CONTINENTAL MARGINS; NE ATLANTIC; PRIMNOA-RESEDAEFORMIS; REEF; GROWTH; BANK	Investigating the relationship between deep-water coral distribution and seabed topography is important for understanding the terrain habitat selection of these species and for the development of predictive habitat models. In this study, the distribution of the deep-water gorgonians, Paragorgia arborea and Primnoa resedaeformis, in relation to terrain variables at multiple scales of 30 m, 90 m and 170 m were investigated at Rost Reef, Traena Reef and Sotbakken Reef on the Norwegian margin, with Ecological Niche Factor Analysis applied. To date, there have been few published studies investigating this aspect of gorgonian distribution. A similar correlation between the distribution of P. arborea and P. resedaeformis and each particular terrain variable was found at each study site, but the strength of the correlation between each variable and distribution differed by reef. The terrain variables of bathymetric position index (BPI) and curvature at analysis scales of 90 m or 170 m were most strongly linked to the distribution of both species at the three geographically distinct study sites. Both gorgonian species tended to inhabit local topographic highs across all three sites, particularly at Sotbakken Reef and Traena Reef, with both species observed almost exclusively on such topographic highs. The tendency for observed P. arborea to inhabit ridge crests at Rost Reef was much greater than was indicated for P. resedaeformis. This investigation identifies the terrain variables which most closely correlate with distribution of these two gorgonian species, and analyzes their terrain habitat selection; further development of predictive habitat models may be considered essential for effective management of these species.	[Tong, Ruiju; Purser, Autun; Unnithan, Vikram] Univ Bremen, D-28359 Bremen, Germany; [Guinan, Janine] Geol Survey Ireland, INFOMAR, Marine & Geophys Programme, Dublin, Ireland	University of Bremen	Tong, RJ (corresponding author), Univ Bremen, D-28359 Bremen, Germany.	r.tong@jacobs-university.de	Unnithan, Vikram/I-2441-2013	Unnithan, Vikram/0000-0002-4656-3824; Purser, Autun/0000-0001-5427-0151	China Scholarship Council; ESSReS (Earth System Science Research School); European Community [226354]	China Scholarship Council(China Scholarship Council); ESSReS (Earth System Science Research School); European Community(European Commission)	This work was funded by a scholarship from China Scholarship Council, and a scholarship prolongation from ESSReS (Earth System Science Research School) to R. Tong. Additional funding to A. Purser was provided through the European Community's Seventh Framework programme (FP7/2007-2013) under the HERMIONE (Hotspot Ecosystem Research and Man's Impact ON European Seas) project, grant agreement no. 226354. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Albani M, 2004, INT J GEOGR INF SCI, V18, P577, DOI 10.1080/13658810410001701987; Andrews AH, 2002, HYDROBIOLOGIA, V471, P101, DOI 10.1023/A:1016501320206; Basille M, 2008, ECOL MODEL, V211, P233, DOI 10.1016/j.ecolmodel.2007.09.006; Bryan TL, 2007, MAR ECOL PROG SER, V330, P113, DOI 10.3354/meps330113; Bryan TL, 2006, DEEP-SEA RES PT I, V53, P1865, DOI 10.1016/j.dsr.2006.09.006; Buhl-Mortensen L, 2005, ERLANGEN EARTH C SER, P849, DOI 10.1007/3-540-27673-4_44; Buhl-Mortensen L, 2010, MAR ECOL-EVOL PERSP, V31, P21, DOI 10.1111/j.1439-0485.2010.00359.x; Buhl-Mortensen P, 2009, ICES J MAR SCI, V66, P2026, DOI 10.1093/icesjms/fsp200; Carlier A, 2009, MAR ECOL PROG SER, V397, P125, DOI 10.3354/meps08361; Davies AJ, 2008, DEEP-SEA RES PT I, V55, P1048, DOI 10.1016/j.dsr.2008.04.010; Davies AJ, 2007, BIOL CONSERV, V138, P299, DOI 10.1016/j.biocon.2007.05.011; Davies AJ, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018483; Davies AJ, 2009, LIMNOL OCEANOGR, V54, P620, DOI 10.4319/lo.2009.54.2.0620; de Haas H, 2009, FACIES, V55, P1, DOI 10.1007/s10347-008-0157-1; Dodds LA, 2009, MAR ECOL PROG SER, V397, P113, DOI 10.3354/meps08143; Dolan MFJ, 2008, DEEP-SEA RES PT I, V55, P1564, DOI 10.1016/j.dsr.2008.06.010; Dolan MFJ, 2009, NORW J GEOL, V89, P17; Dorschel B, 2007, MAR GEOL, V244, P184, DOI 10.1016/j.margeo.2007.06.010; Duineveld GCA, 2004, MAR ECOL PROG SER, V277, P13, DOI 10.3354/meps277013; Duineveld GCA, 2007, B MAR SCI, V81, P449; Dullo WC, 2008, MAR ECOL PROG SER, V371, P165, DOI 10.3354/meps07623; Fossa J.H., 2004, PROTECTION MANAGEMEN; Fossa JH, 2005, ERLANGEN EARTH C SER, P359, DOI 10.1007/3-540-27673-4_18; Fossa Skjoldal H.R, 2010, HDB MARINE FISHERIES, P215; Freiwald A, 1999, SEDIMENT GEOL, V125, P1, DOI 10.1016/S0037-0738(98)00142-0; Freiwald A, 2002, FACIES, V47, P179, DOI 10.1007/BF02667712; GENIN A, 1986, NATURE, V322, P59, DOI 10.1038/322059a0; Guinan J, 2009, ECOL INFORM, V4, P83, DOI 10.1016/j.ecoinf.2009.01.004; Guinan J, 2009, MAR ECOL PROG SER, V375, P125, DOI 10.3354/meps07739; Heindel K, 2010, CONT SHELF RES, V30, P1814, DOI 10.1016/j.csr.2010.08.007; Hirzel AH, 2002, ECOLOGY, V83, P2027, DOI 10.1890/0012-9658(2002)083[2027:ENFAHT]2.0.CO;2; Howell KL, 2011, BIOL CONSERV, V144, P2656, DOI 10.1016/j.biocon.2011.07.025; Kiriakoulakis K, 2007, INT J EARTH SCI, V96, P159, DOI 10.1007/s00531-006-0078-6; Leverette TL, 2005, ERLANGEN EARTH C SER, P467, DOI 10.1007/3-540-27673-4_23; Lindberg B, 2007, INT J EARTH SCI, V96, P201, DOI 10.1007/s00531-005-0495-y; Mienis F, 2007, DEEP-SEA RES PT I, V54, P1655, DOI 10.1016/j.dsr.2007.05.013; Mienis F, 2009, DEEP-SEA RES PT I, V56, P1026, DOI 10.1016/j.dsr.2009.01.006; Moje A., 2011, EXPEDITION RES VESSE, P32; Mortensen P, 2005, MAR BIOL, V147, P775, DOI 10.1007/s00227-005-1604-y; Mortensen PB, 2009, NORW J GEOL, V89, P163; MORTENSEN PB, 1995, SARSIA, V80, P145, DOI 10.1080/00364827.1995.10413586; Mortensen PB, 2004, MAR BIOL, V144, P1223, DOI 10.1007/s00227-003-1280-8; Mortensen PB, 2001, OPHELIA, V54, P83, DOI 10.1080/00785236.2001.10409457; Murillo FJ, 2011, ICES J MAR SCI, V68, P319, DOI 10.1093/icesjms/fsq071; Orvik KA, 2001, DEEP-SEA RES PT I, V48, P937, DOI 10.1016/S0967-0637(00)00038-8; Ottesen D, 2008, QUATERNARY SCI REV, V27, P922, DOI 10.1016/j.quascirev.2008.01.014; Roberts J. M., 2009, COLD WATER CORALS BI, DOI [10.1017/CBO9780511581588, DOI 10.1017/CBO9780511581588]; Roberts JM, 2005, ERLANGEN EARTH C SER, P483, DOI 10.1007/3-540-27673-4_24; Roberts JM, 2003, MAR POLLUT BULL, V46, P7, DOI 10.1016/S0025-326X(02)00259-X; Rogers AD, 1999, INT REV HYDROBIOL, V84, P315; Ruggeberg A, 2011, MAR GEOL, V282, P5, DOI 10.1016/j.margeo.2010.05.009; Sherwood OA, 2009, CAN J FISH AQUAT SCI, V66, P142, DOI 10.1139/F08-195; TENDAL OS, 1992, SARSIA, V77, P213, DOI 10.1080/00364827.1992.10413506; Thiem O, 2006, J MARINE SYST, V60, P207, DOI 10.1016/j.jmarsys.2005.12.004; Thomsen L, 2000, DEEP-SEA RES PT I, V47, P1881, DOI 10.1016/S0967-0637(00)00003-0; THOMSEN L, 2002, OCEAN MARGIN SYSTEMS, P143; Tittensor DP, 2009, J BIOGEOGR, V36, P1111, DOI 10.1111/j.1365-2699.2008.02062.x; van Oevelen D, 2009, LIMNOL OCEANOGR, V54, P1829, DOI 10.4319/lo.2009.54.6.1829; Wagner H, 2011, J MARINE SYST, V85, P19, DOI 10.1016/j.jmarsys.2010.11.003; White M, 2005, ERLANGEN EARTH CONF, P503, DOI 10.1007/3-540-27673-4_25; White M, 2007, INT J EARTH SCI, V96, P1, DOI 10.1007/s00531-006-0099-1; Wilson MFJ, 2007, MAR GEOD, V30, P3, DOI 10.1080/01490410701295962	62	36	37	0	36	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 17	2012	7	8							e43534	10.1371/journal.pone.0043534	http://dx.doi.org/10.1371/journal.pone.0043534			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	996DG	22912887	gold, Green Submitted, Green Published, Green Accepted			2022-12-25	WOS:000308063700115
J	Jones, JE; Kroll, AJ; Giovanini, J; Duke, SD; Ellis, TM; Betts, MG				Jones, Jay E.; Kroll, Andrew J.; Giovanini, Jack; Duke, Steven D.; Ellis, Tana M.; Betts, Matthew G.			Avian Species Richness in Relation to Intensive Forest Management Practices in Early Seral Tree Plantations	PLOS ONE			English	Article							PACIFIC-NORTHWEST; DOUGLAS-FIR; COASTAL OREGON; BIRD ABUNDANCE; UNITED-STATES; VEGETATION; COMMUNITIES; LANDSCAPE; DIVERSITY; HABITAT	Background: Managers of landscapes dedicated to forest commodity production require information about how practices influence biological diversity. Individual species and communities may be threatened if management practices truncate or simplify forest age classes that are essential for reproduction and survival. For instance, the degradation and loss of complex diverse forest in young age classes have been associated with declines in forest-associated Neotropical migrant bird populations in the Pacific Northwest, USA. These declines may be exacerbated by intensive forest management practices that reduce hardwood and broadleaf shrub cover in order to promote growth of economically valuable tree species in plantations. Methodology and Principal Findings: We used a Bayesian hierarchical model to evaluate relationships between avian species richness and vegetation variables that reflect stand management intensity (primarily via herbicide application) on 212 tree plantations in the Coast Range, Oregon, USA. Specifically, we estimated the influence of broadleaf hardwood vegetation cover, which is reduced through herbicide applications, on bird species richness and individual species occupancy. Our model accounted for imperfect detection. We used average predictive comparisons to quantify the degree of association between vegetation variables and species richness. Both conifer and hardwood cover were positively associated with total species richness, suggesting that these components of forest stand composition may be important predictors of alpha diversity. Estimates of species richness were 35-80% lower when imperfect detection was ignored (depending on covariate values), a result that has critical implications for previous efforts that have examined relationships between forest composition and species richness. Conclusion and Significance: Our results revealed that individual and community responses were positively associated with both conifer and hardwood cover. In our system, patterns of bird community assembly appear to be associated with stand management strategies that retain or increase hardwood vegetation while simultaneously regenerating the conifer cover in commercial tree plantations.	[Jones, Jay E.; Giovanini, Jack; Duke, Steven D.] Weyerhaeuser NR, Stat Math & Operat Res, Washington, DC USA; [Kroll, Andrew J.] Weyerhaeuser NR, Timberlands Technol, Washington, DC USA; [Ellis, Tana M.; Betts, Matthew G.] Oregon State Univ, Dept Forest Ecosyst & Soc, Corvallis, OR 97331 USA	Oregon State University	Jones, JE (corresponding author), Weyerhaeuser NR, Stat Math & Operat Res, Fed Way, Washington, DC USA.	jay.jones@weyerhaeuser.com	Kroll, Andrew/ABB-3724-2020; Betts, Matthew G/Q-2978-2019	Kroll, Andrew/0000-0001-7747-830X; Betts, Matthew G/0000-0002-7100-2551	National Science Foundation [NSF-ARC-0941748]; United States Department of Agriculture Food and Research Initiative [AFRI-2009-04457]; National Council for Air and Stream Improvement; Directorate For Geosciences [0941748] Funding Source: National Science Foundation	National Science Foundation(National Science Foundation (NSF)); United States Department of Agriculture Food and Research Initiative; National Council for Air and Stream Improvement; Directorate For Geosciences(National Science Foundation (NSF)NSF - Directorate for Geosciences (GEO))	This work was partially supported by grants from the National Science Foundation (NSF-ARC-0941748), the United States Department of Agriculture Food and Research Initiative (AFRI-2009-04457), and the National Council for Air and Stream Improvement to M.G. Betts. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2010, R LANG ENV STAT COMP; Arnett EB, 2010, FOREST ECOL MANAG, V260, P1773, DOI 10.1016/j.foreco.2010.08.021; Berlik MM, 2002, J BIOGEOGR, V29, P1557, DOI 10.1046/j.1365-2699.2002.00768.x; Beschta RL, 2004, CONSERV BIOL, V18, P957, DOI 10.1111/j.1523-1739.2004.00495.x; Betts MG, 2010, ECOL APPL, V20, P2116, DOI 10.1890/09-1305.1; BIBBY CJ, 1987, ACTA OECOL-OEC GEN, V8, P103; Binkley CS, 2005, J FOREST, V103, P61; Bunnell Fred L., 1999, Environmental Reviews, V7, P97, DOI 10.1139/a99-010; Cam E, 2000, ECOL APPL, V10, P1196, DOI 10.2307/2641026; Carnus JM, 2006, J FOREST, V104, P65; CONNOR EF, 1979, ECOLOGY, V60, P1132, DOI 10.2307/1936961; DeGraaf RM, 2003, FOREST ECOL MANAG, V185, P179, DOI 10.1016/S0378-1127(03)00254-8; Dorazio RM, 2005, J AM STAT ASSOC, V100, P389, DOI 10.1198/016214505000000015; Ellis TM, 2012, CAN J FOREST RES, V42, P918, DOI [10.1139/x2012-035, 10.1139/X2012-035]; Ellis TM, 2011, FOREST ECOL MANAG, V261, P1372, DOI 10.1016/j.foreco.2011.01.018; ENOKSSON B, 1995, LANDSCAPE ECOL, V10, P267, DOI 10.1007/BF00128994; Etterson MA, 2009, ECOL APPL, V19, P2049, DOI 10.1890/08-1317.1; Flynn DFB, 2009, ECOL LETT, V12, P22, DOI 10.1111/j.1461-0248.2008.01255.x; Gelman A., 2004, BAYESIAN DATA ANAL; Gelman A, 2007, SOCIOL METHODOL, V37, P23, DOI 10.1111/j.1467-9531.2007.00181.x; Hagar JC, 2007, FOREST ECOL MANAG, V246, P108, DOI 10.1016/j.foreco.2007.03.054; HARRINGTON TB, 1995, FOREST ECOL MANAG, V76, P55, DOI 10.1016/0378-1127(95)03558-R; Harrington TB, 2005, PRODUCTIVITY W FORES, P27; Harvey CA, 2007, BIODIVERS CONSERV, V16, P2257, DOI 10.1007/s10531-007-9194-2; Hayes JP, 2005, J FOREST, V103, P83; HUTCHINSON GE, 1959, AM NAT, V93, P145, DOI 10.1086/282070; Jetz W, 2009, P ROY SOC B-BIOL SCI, V276, P269, DOI 10.1098/rspb.2008.1005; Kennedy RSH, 2005, BIOL CONSERV, V122, P363, DOI 10.1016/j.biocon.2004.07.022; Kissling WD, 2008, GLOBAL ECOL BIOGEOGR, V17, P327, DOI 10.1111/j.1466-8238.2007.00379.x; Kroll AJ, 2010, FOREST ECOL MANAG, V260, P1599, DOI 10.1016/j.foreco.2010.08.009; Lesak AA, 2011, REMOTE SENS ENVIRON, V115, P2823, DOI 10.1016/j.rse.2011.01.025; Lima SL, 2009, BIOL REV, V84, P485, DOI 10.1111/j.1469-185X.2009.00085.x; Linden DW, FOREST ECOL IN PRESS; Lindh BC, 2004, FOREST ECOL MANAG, V192, P285, DOI 10.1016/j.foreco.2004.01.018; Maas B, 2009, BIOL CONSERV, V142, P2665, DOI 10.1016/j.biocon.2009.06.018; MACARTHUR R, 1961, ECOLOGY, V42, P594, DOI 10.2307/1932254; MacKenzie DI, 2002, ECOLOGY, V83, P2248, DOI 10.1890/0012-9658(2002)083[2248:ESORWD]2.0.CO;2; Marshall MR, 2003, FOREST ECOL MANAG, V183, P127, DOI 10.1016/S0378-1127(03)00101-4; MARTIN TE, 1993, AM NAT, V141, P897, DOI 10.1086/285515; MARTIN TE, 1992, ECOLOGY AND CONSERVATION OF NEOTROPICAL MIGRANT LANDBIRDS, P455; MARTIN TE, 1987, ANNU REV ECOL SYST, V18, P453, DOI 10.1146/annurev.ecolsys.18.1.453; MORRISON ML, 1984, J WILDLIFE MANAGE, V48, P14, DOI 10.2307/3808449; Nagy LR, 2005, ECOLOGY, V86, P675, DOI 10.1890/04-0155; Najera A, 2010, CONSERV BIOL, V24, P319, DOI 10.1111/j.1523-1739.2009.01350.x; Oliver C.D., 1996, FOREST STAND DYNAMIC; Paquet JY, 2006, FOREST ECOL MANAG, V227, P59, DOI 10.1016/j.foreco.2006.02.009; Pearman PB, 2002, ECOL MONOGR, V72, P19, DOI 10.1890/0012-9615(2002)072[0019:TSOCSH]2.0.CO;2; Perrings C, 2010, SCIENCE, V330, P323, DOI 10.1126/science.1196431; Rahbek C, 1997, AM NAT, V149, P875, DOI 10.1086/286028; Ralph CJ, 1995, PSWGTR149 USDA FOR S; RICH TD, 2004, PARTNERS FLIGHT N AM; Russell RE, 2009, ECOL APPL, V19, P1253, DOI 10.1890/08-0910.1; Sauer J.R., 2008, N AM BREEDING BIRD S; Schieck J, 1997, CONDOR, V99, P179, DOI 10.2307/1370236; Spiegelhalter DJ, 2003, WINBUGS VERSION 1 4; Spies TA, 2007, ECOL APPL, V17, P5, DOI 10.1890/1051-0761(2007)017[0005:CEASEO]2.0.CO;2; Sturtz S, 2005, J STAT SOFTW, V12, P1, DOI 10.18637/jss.v012.i03; Swanson ME, 2011, FRONT ECOL ENVIRON, V9, P117, DOI 10.1890/090157; Tappeiner JC, 2001, CAN J FOREST RES, V31, P1629, DOI 10.1139/cjfr-31-9-1629; TERBORGH J, 1977, ECOLOGY, V58, P1007, DOI 10.2307/1936921; TERBORGH J, 1975, ECOLOGY, V56, P562, DOI 10.2307/1935491; van Dorp D, 1987, LANDSCAPE ECOL, V1, P59, DOI 10.1007/BF02275266; Vitousek PM, 1997, SCIENCE, V277, P494, DOI 10.1126/science.277.5325.494; WILLSON MF, 1974, ECOLOGY, V55, P1017, DOI 10.2307/1940352; Zipkin EF, 2010, BIOL CONSERV, V143, P479, DOI 10.1016/j.biocon.2009.11.016; Zipkin EF, 2009, J APPL ECOL, V46, P815, DOI 10.1111/j.1365-2664.2009.01664.x	66	22	22	0	49	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 15	2012	7	8							e43290	10.1371/journal.pone.0043290	http://dx.doi.org/10.1371/journal.pone.0043290			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	993AG	22905249	Green Published, gold			2022-12-25	WOS:000307823600065
J	Kinoshita, SM; Krutzik, PO; Nolan, GP				Kinoshita, Shigemi M.; Krutzik, Peter O.; Nolan, Garry P.			COP9 Signalosome Component JAB1/CSN5 Is Necessary for T Cell Signaling through LFA-1 and HIV-1 Replication	PLOS ONE			English	Article							HUMAN-IMMUNODEFICIENCY-VIRUS; ADHESION RECEPTOR LFA-1; TRANSCRIPTION FACTORS; PEPTIDE LIBRARIES; TYPE-1 INFECTION; NUCLEAR FACTOR; ACTIVATION; EXPRESSION; INHIBITORS; INTERACTS	To determine critical host factors involved in HIV-1 replication, a dominant effector genetics approach was developed to reveal signaling pathways on which HIV-1 depends for replication. A large library of short peptide aptamers was expressed via retroviral delivery in T cells. Peptides that interfered with T cell activation-dependent processes that might support HIV-1 replication were identified. One of the selected peptides altered signaling, lead to a difference in T cell activation status, and inhibited HIV-1 replication. The target of the peptide was JAB1/CSN5, a component of the signalosome complex. JAB1 expression overcame the inhibition of HIV-1 replication in the presence of peptide and also promoted HIV-1 replication in activated primary CD4(+) T cells. This peptide blocked physiological release of JAB1 from the accessory T cell surface protein LFA-1, downstream AP-1 dependent events, NFAT activation, and HIV-1 replication. Thus, genetic selection for intracellular aptamer inhibitors of host cell processes proximal to signals at the immunological synapse of T cells can define unique mechanisms important to HIV-1 replication.	[Kinoshita, Shigemi M.] Osaka Univ, Grad Sch Frontier Biosci, Lab Immune Regulat, Suita, Osaka, Japan; [Kinoshita, Shigemi M.] Thomas Jefferson Univ, Dept Pathol Anat & Cell Biol, Philadelphia, PA 19107 USA; [Krutzik, Peter O.; Nolan, Garry P.] Stanford Univ, Sch Med, Dept Mol Pharmacol, Stanford, CA 94305 USA; [Nolan, Garry P.] Stanford Univ, Dept Microbiol & Immunol, Sch Med, Stanford, CA 94305 USA	Osaka University; Jefferson University; Stanford University; Stanford University	Kinoshita, SM (corresponding author), Osaka Univ, Grad Sch Frontier Biosci, Lab Immune Regulat, Suita, Osaka, Japan.	shigemik@biken.osaka-u.ac.jp	Nolan, Garry/AAE-7903-2019	Nolan, Garry/0000-0002-8862-9043	National Institutes of Health [AI56920]; Ministry of Education, Culture, Sports, Science and Technology, Japan; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI056920] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Ministry of Education, Culture, Sports, Science and Technology, Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported by National Institutes of Health grant AI56920 and a grant-in-aid from the 21st Century COE Program of the Ministry of Education, Culture, Sports, Science and Technology, Japan. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bech-Otschir D, 2001, EMBO J, V20, P1630, DOI 10.1093/emboj/20.7.1630; Bianchi E, 2000, NATURE, V404, P617, DOI 10.1038/35007098; Bogoyevitch MA, 2008, BBA-PROTEINS PROTEOM, V1784, P76, DOI 10.1016/j.bbapap.2007.09.013; Chauchereau A, 2000, J BIOL CHEM, V275, P8540, DOI 10.1074/jbc.275.12.8540; Claret FX, 1996, NATURE, V383, P453, DOI 10.1038/383453a0; Cope GA, 2002, SCIENCE, V298, P608, DOI 10.1126/science.1075901; Dechend R, 1999, ONCOGENE, V18, P3316, DOI 10.1038/sj.onc.1202717; Deng XW, 2000, TRENDS GENET, V16, P202, DOI 10.1016/S0168-9525(00)01982-X; DUSTIN ML, 1989, COLD SPRING HARB SYM, V54, P753; Fortin JF, 1997, J VIROL, V71, P3588, DOI 10.1128/JVI.71.5.3588-3596.1997; FUJITA T, 1992, GENE DEV, V6, P775, DOI 10.1101/gad.6.5.775; Grakoui A, 1999, SCIENCE, V285, P221, DOI 10.1126/science.285.5425.221; Han ZN, 2001, J CLIN INVEST, V108, P73, DOI 10.1172/JCI12466; HARPER JW, 1993, CELL, V75, P805; HILDRETH JEK, 1989, SCIENCE, V244, P1075, DOI 10.1126/science.2543075; Hioe CE, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023202; Hioe CE, 1998, AIDS RES HUM RETROV, V14, pS247; Hioe CE, 2001, J VIROL, V75, P1077, DOI 10.1128/JVI.75.2.1077-1082.2001; Hogg N, 2011, NAT REV IMMUNOL, V11, P416, DOI 10.1038/nri2986; Kinoshita S, 1997, IMMUNITY, V6, P235, DOI 10.1016/S1074-7613(00)80326-X; Kinoshita S, 1998, CELL, V95, P595, DOI 10.1016/S0092-8674(00)81630-X; Kinoshita SM, 2008, P NATL ACAD SCI USA, V105, P15022, DOI 10.1073/pnas.0807269105; Kinsella TM, 2002, J BIOL CHEM, V277, P37512, DOI 10.1074/jbc.M206162200; Kleemann R, 2000, NATURE, V408, P211, DOI 10.1038/35041591; Macian F, 1999, MOL CELL BIOL, V19, P3645, DOI 10.1128/mcb.19.5.3645; Macian F, 2001, ONCOGENE, V20, P2476, DOI 10.1038/sj.onc.1204386; MARKOVITZ DM, 1990, P NATL ACAD SCI USA, V87, P9098, DOI 10.1073/pnas.87.23.9098; NABEL G, 1987, NATURE, V326, P711, DOI 10.1038/326711a0; Naumann M, 1999, J BIOL CHEM, V274, P35297, DOI 10.1074/jbc.274.50.35297; NOLAN GP, 1994, CELL, V77, P795, DOI 10.1016/0092-8674(94)90126-0; NORCROSS MA, 1984, ANN INST PASTEUR IMM, VD135, P113, DOI 10.1016/S0769-2625(84)81105-8; Nordgard O, 2001, BIOCHIMIE, V83, P969, DOI 10.1016/S0300-9084(01)01329-3; NORTHROP JP, 1994, NATURE, V369, P497, DOI 10.1038/369497a0; NORTHROP JP, 1993, J BIOL CHEM, V268, P2917; PAUL WE, 1994, CELL, V76, P241, DOI 10.1016/0092-8674(94)90332-8; Peelle B, 2001, CHEM BIOL, V8, P521, DOI 10.1016/S1074-5521(01)00031-X; Perez OD, 2003, NAT IMMUNOL, V4, P1083, DOI 10.1038/ni984; Rao A, 1997, ANNU REV IMMUNOL, V15, P707, DOI 10.1146/annurev.immunol.15.1.707; SCHMID RM, 1991, NATURE, V352, P733, DOI 10.1038/352733a0; Shackleford TJ, 2010, CELL DIV, V5, DOI 10.1186/1747-1028-5-26; SIEKEVITZ M, 1987, SCIENCE, V238, P1575, DOI 10.1126/science.2825351; SPINA CA, 1995, J VIROL, V69, P2977, DOI 10.1128/JVI.69.5.2977-2988.1995; Swift S., 1999, CURRENT PROTOCOL S31; Swingler S, 2003, NATURE, V424, P213, DOI 10.1038/nature01749; Tomoda K, 1999, NATURE, V398, P160, DOI 10.1038/18230; UNANUE ER, 1984, ANNU REV IMMUNOL, V2, P395, DOI 10.1146/annurev.iy.02.040184.002143; Vincenti MP, 2001, J CLIN INVEST, V108, P181; Wei N, 2008, TRENDS BIOCHEM SCI, V33, P592, DOI 10.1016/j.tibs.2008.09.004; Xu X, 2001, NAT GENET, V27, P23, DOI 10.1038/83717; ZACK JA, 1988, SCIENCE, V240, P1026, DOI 10.1126/science.2835813; ZAGURY D, 1986, SCIENCE, V231, P850, DOI 10.1126/science.2418502	51	6	6	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 24	2012	7	7							e41725	10.1371/journal.pone.0041725	http://dx.doi.org/10.1371/journal.pone.0041725			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	978NX	22911848	Green Published, Green Submitted, gold			2022-12-25	WOS:000306751300067
J	Liu, JH; Mak, TCP; Banigesh, A; Desai, K; Wang, R; Wu, LY				Liu, Jianghai; Mak, Timothy Chun-Ping; Banigesh, Ali; Desai, Kaushik; Wang, Rui; Wu, Lingyun			Aldolase B Knockdown Prevents High Glucose-Induced Methylglyoxal Overproduction and Cellular Dysfunction in Endothelial Cells	PLOS ONE			English	Article							GLYCATION END-PRODUCTS; SMOOTH-MUSCLE-CELLS; PROTEIN-KINASE-C; NF-KAPPA-B; DEPENDENT PATHWAY; ALDOSE REDUCTASE; OXIDATIVE STRESS; DIABETIC-RATS; GROWTH-FACTOR; NITRIC-OXIDE	We used cultured endothelial cells as a model to examine whether up-regulation of aldolase B and enhanced methylglyoxal (MG) formation play an important role in high glucose-induced overproduction of advanced glycosylation endproducts (AGEs), oxidative stress and cellular dysfunction. High glucose (25 mM) incubation up-regulated mRNA levels of aldose reductase (an enzyme converting glucose to fructose) and aldolase B (a key enzyme that catalyzes MG formation from fructose) and enhanced MG formation in human umbilical vein endothelial cells (HUVECs) and HUVEC-derived EA. hy926 cells. High glucose-increased MG production in EA. hy926 cells was completely prevented by siRNA knockdown of aldolase B, but unaffected by siRNA knockdown of aldolase A, an enzyme responsible for MG formation during glycolysis. In addition, inhibition of cytochrome P450 2E1 or semicarbazide-sensitive amine oxidase which produces MG during the metabolism of lipid and proteins, respectively, did not alter MG production. Both high glucose (25 mM) and MG (30, 100 mu M) increased the formation of N(epsilon)-carboxyethyl-lysine (CEL, a MG-induced AGE), oxidative stress (determined by the generation of oxidized DCF, H2O2, protein carbonyls and 8-oxo-dG), O-GlcNAc modification (product of the hexosamine pathway), membrane protein kinase C activity and nuclear translocation of NF-kappa B in EA. hy926 cells. However, the above metabolic and signaling alterations induced by high glucose were completely prevented by knockdown of aldolase B and partially by application of aminoguanidine (a MG scavenger) or alagebrium (an AGEs breaker). In conclusion, efficient inhibition of aldolase B can prevent high glucose-induced overproduction of MG and related cellular dysfunction in endothelial cells.	[Liu, Jianghai; Mak, Timothy Chun-Ping; Banigesh, Ali; Desai, Kaushik; Wu, Lingyun] Univ Saskatchewan, Dept Pharmacol, Coll Med, Saskatoon, SK S7N 0W0, Canada; [Wang, Rui] Lakehead Univ, Dept Biol, Thunder Bay, ON P7B 5E1, Canada; [Wu, Lingyun] Lakehead Univ, Dept Hlth Sci, Thunder Bay, ON P7B 5E1, Canada; [Wu, Lingyun] Thunder Bay Reg Res Inst, Thunder Bay, ON, Canada	University of Saskatchewan; Lakehead University; Lakehead University; Northern Ontario School of Medicine	Liu, JH (corresponding author), Univ Saskatchewan, Dept Pharmacol, Coll Med, Saskatoon, SK S7N 0W0, Canada.	lwu@lakeheadu.ca	Wang, Rui/C-7824-2012	Wang, Rui/0000-0003-3825-3620; Desai, Kaushik/0000-0001-9355-4528	Canadian Institutes of Health Research; Heart and Stroke Foundation of Saskatchewan; College of Medicine Graduate Scholarship from University of Saskatchewan	Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR)); Heart and Stroke Foundation of Saskatchewan; College of Medicine Graduate Scholarship from University of Saskatchewan	This work was supported by operating grants from the Canadian Institutes of Health Research and the Heart and Stroke Foundation of Saskatchewan to Dr. Wu. Mr. Jianghai Liu was supported by a College of Medicine Graduate Scholarship from the University of Saskatchewan. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Barnes PJ, 1997, NEW ENGL J MED, V336, P1066, DOI 10.1056/NEJM199704103361506; Bierhaus A, 1997, DIABETES, V46, P1481, DOI 10.2337/diabetes.46.9.1481; Brownlee M, 2001, NATURE, V414, P813, DOI 10.1038/414813a; Cai H, 2000, CIRC RES, V87, P840, DOI 10.1161/01.RES.87.10.840; Chang TJ, 2005, FREE RADICAL BIO MED, V38, P286, DOI 10.1016/j.freeradbiomed.2004.10.034; Chang TJ, 2011, FASEB J, V25, P1746, DOI 10.1096/fj.10-178053; Chung SSM, 2005, CURR DRUG TARGETS, V6, P475, DOI 10.2174/1389450054021891; COX TM, 1994, FASEB J, V8, P62, DOI 10.1096/fasebj.8.1.8299892; Desai Kaushik, 2007, Recent Pat Cardiovasc Drug Discov, V2, P89; Desai KM, 2010, CAN J PHYSIOL PHARM, V88, P273, DOI 10.1139/Y10-001; Dhar A, 2008, METABOLISM, V57, P1211, DOI 10.1016/j.metabol.2008.04.014; Dhar A, 2010, BRIT J PHARMACOL, V161, P1843, DOI 10.1111/j.1476-5381.2010.01017.x; Dhar A, 2009, J CHROMATOGR B, V877, P1093, DOI 10.1016/j.jchromb.2009.02.055; Du XL, 2001, J CLIN INVEST, V108, P1341, DOI 10.1172/JCI11235; EDGELL CJ, 1983, P NATL ACAD SCI-BIOL, V80, P3734, DOI 10.1073/pnas.80.12.3734; Goldin A, 2006, CIRCULATION, V114, P597, DOI 10.1161/CIRCULATIONAHA.106.621854; Han JY, 2005, CARDIOVASC DIABETOL, V4, DOI 10.1186/1475-2840-4-12; Hanssen KF, 1997, DIABETES, V46, pS101, DOI 10.2337/diab.46.2.S101; Ho FM, 2006, CELL SIGNAL, V18, P391, DOI 10.1016/j.cellsig.2005.05.009; Jia XM, 2006, FASEB J, V20, P1555, DOI 10.1096/fj.05-5478fje; Li Y, 2006, NATURE, V443, P234, DOI 10.1038/nature05107; Lim EJ, 2007, AM J PHYSIOL-HEART C, V293, pH3340, DOI 10.1152/ajpheart.00921.2007; Liu JH, 2011, CARDIOVASC RES, V92, P494, DOI 10.1093/cvr/cvr239; Maeda H, 2004, ANGEW CHEM INT EDIT, V43, P2389, DOI 10.1002/anie.200452381; Mamputu JC, 2002, J DIABETES COMPLICAT, V16, P284, DOI 10.1016/S1056-8727(01)00229-X; Morigi M, 1998, J CLIN INVEST, V101, P1905, DOI 10.1172/JCI656; Nishikawa T, 2000, NATURE, V404, P787, DOI 10.1038/35008121; NISHIZUKA Y, 1992, SCIENCE, V258, P607, DOI 10.1126/science.1411571; O'Connor RP, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011828; Park J, 2011, NEPHROL DIAL TRANSPL; Pfaffl MW, 2001, NUCLEIC ACIDS RES, V29, DOI 10.1093/nar/29.9.e45; PHILLIPS SA, 1993, BIOCHEM PHARMACOL, V46, P805, DOI 10.1016/0006-2952(93)90488-I; PHILLIPS SA, 1993, EUR J BIOCHEM, V212, P101, DOI 10.1111/j.1432-1033.1993.tb17638.x; Pieper GM, 1997, J CARDIOVASC PHARM, V30, P528, DOI 10.1097/00005344-199710000-00019; RICHARD JP, 1993, BIOCHEM SOC T, V21, P549, DOI 10.1042/bst0210549; Riederer I, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015339; Scalia R, 2007, DIABETES, V56, P1842, DOI 10.2337/db06-1198; Schalkwijk CG, 2005, CLIN SCI, V109, P143, DOI 10.1042/CS20050025; Shinohara M, 1998, J CLIN INVEST, V101, P1142, DOI 10.1172/JCI119885; Singh R, 2001, DIABETOLOGIA, V44, P129, DOI 10.1007/s001250051591; Thallas-Bonke V, 2004, DIABETES, V53, P2921, DOI 10.2337/diabetes.53.11.2921; Wang H, 2009, BIOCHEM PHARMACOL, V77, P1709, DOI 10.1016/j.bcp.2009.02.024; Wang XX, 2004, KIDNEY INT, V66, P2315, DOI 10.1111/j.1523-1755.2004.66034.x; Wautier JL, 1996, J CLIN INVEST, V97, P238, DOI 10.1172/JCI118397; Wu LY, 2002, HYPERTENSION, V39, P809, DOI 10.1161/hy0302.105207; Wu LY, 2005, CAN J PHYSIOL PHARM, V83, P63, DOI 10.1139/Y04-112; Yao D, 2007, J BIOL CHEM, V282, P31038, DOI 10.1074/jbc.M704703200; Yildiz G, 1998, BRIT J PHARMACOL, V124, P905, DOI 10.1038/sj.bjp.0701924	48	17	18	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 24	2012	7	7							e41495	10.1371/journal.pone.0041495	http://dx.doi.org/10.1371/journal.pone.0041495			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	978NX	22911800	gold, Green Published, Green Submitted			2022-12-25	WOS:000306751300048
J	Pant, A; Lee, II; Lu, ZX; Rueda, BR; Schink, J; Kim, JJ				Pant, Alok; Lee, Irene I.; Lu, Zhenxiao; Rueda, Bo R.; Schink, Julian; Kim, J. Julie			Inhibition of AKT with the Orally Active Allosteric AKT Inhibitor, MK-2206, Sensitizes Endometrial Cancer Cells to Progestin	PLOS ONE			English	Article							WELL-DIFFERENTIATED CARCINOMA; FORKHEAD TRANSCRIPTION FACTOR; GENE-EXPRESSION; RECEPTOR; PATHWAY; GROWTH; ADENOCARCINOMA; HYPERPLASIA; FERTILITY; THERAPY	Progestin resistance is a major obstacle to treating early stage, well-differentiated endometrial cancer as well as recurrent endometrial cancer. The mechanism behind the suboptimal response to progestin is not well understood. The PTEN tumor suppressor gene is frequently mutated in type I endometrial cancers and this mutation results in hyperactivation of the PI3K/AKT pathway. We hypothesized that increased activation of AKT promotes an inadequate response to progestins in endometrial cancer cells. Ishikawa cells stably transfected with progesterone receptor B (PRB23 cells) were treated with the AKT inhibitor, MK-2206, which effectively decreased levels of p(Ser473)-AKT in a dose-dependent (10 nM to 1 uM) and time-dependent manner (0.5 h to 24 h). MK-2206 inhibited levels of p(Thr308)-AKT and a downstream target, p(Thr246)-PRAS40, but did not change levels of p(Thr202/Tyr204) ERK or p(Thr13/Tyr185) SAPK/JNK, demonstrating specificity of MK-2206 for AKT. Additionally, MK-2206 treatment of PRB23 cells resulted in a significant increase in levels of progesterone receptor B (PRB) protein. Microarray analysis of PRB23 cells identified PDK4 as the most highly upregulated gene among 70 upregulated genes in response to R5020. Inhibition of AKT further upregulated progestin-mediated expression of PDK4 but did not affect another progestin-responsive gene, SGK1. Treatment of PRB23 cells with R5020 and MK-2206 independently decreased viability of cells while the combination of R5020 and MK-2206 caused the greatest decrease in cell viability. Furthermore, mice with xenografted tumors treated with MK-2206 alone or with progesterone alone exhibited modest reductions in their tumor volume. The largest decrease in tumor size was observed in the mice treated with both MK-2206 and progesterone; these tumors exhibited the least proliferation (Ki67) and the most apoptosis (cleaved caspase-3) of all the treatment groups. In summary, inhibition of AKT stabilizes the Progesterone Receptor B and augments progesterone response in endometrial cancer cells that have hyperactivated AKT.	[Pant, Alok; Schink, Julian] Northwestern Univ, Dept Obstet & Gynecol, Div Gynecol Oncol, Chicago, IL 60611 USA; [Lee, Irene I.; Lu, Zhenxiao; Kim, J. Julie] Northwestern Univ, Div Reprod Biol Res, Dept Obstet & Gynecol, Chicago, IL 60611 USA; [Rueda, Bo R.] Harvard Univ, Massachusetts Gen Hosp, Sch Med, Vincent Ctr Reprod Biol,Dept Obstet & Gynecol, Boston, MA USA	Northwestern University; Northwestern University; Harvard University; Harvard Medical School; Massachusetts General Hospital	Pant, A (corresponding author), Northwestern Univ, Dept Obstet & Gynecol, Div Gynecol Oncol, Chicago, IL 60611 USA.	j-kim4@northwestern.edu		Kim, J Julie/0000-0001-9834-8213; Lee, Irene/0000-0002-5749-9389	National Institutes of Health [R21 CA127674]; National Institutes of Health/National Cancer Institute [T32CA09560]; Malkin Scholars Program from the Robert H. Lurie Comprehensive Cancer Center of Northwestern University; NATIONAL CANCER INSTITUTE [R21CA127674, R01CA155513, T32CA009560] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Institutes of Health/National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); Malkin Scholars Program from the Robert H. Lurie Comprehensive Cancer Center of Northwestern University; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	National Institutes of Health R21 CA127674 (JJK), National Institutes of Health/National Cancer Institute training grant T32CA09560, and from the Malkin Scholars Program from the Robert H. Lurie Comprehensive Cancer Center of Northwestern University (IIL). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bolstad BM, 2003, BIOINFORMATICS, V19, P185, DOI 10.1093/bioinformatics/19.2.185; Bonnet S, 2007, CANCER CELL, V11, P37, DOI 10.1016/j.ccr.2006.10.020; Brazil DP, 2004, TRENDS BIOCHEM SCI, V29, P233, DOI 10.1016/j.tibs.2004.03.006; Carnero A, 2010, CURR PHARM DESIGN, V16, P34, DOI 10.2174/138161210789941865; Chen KF, 2011, J PHARMACOL EXP THER, V337, P155, DOI 10.1124/jpet.110.175786; Cheng Y, 2011, MOL CANC THERAPEUTIC; Chiva L, 2008, GYNECOL ONCOL, V111, pS101, DOI 10.1016/j.ygyno.2008.07.056; Dai D, 2002, CANCER RES, V62, P881; Dennis G, 2003, GENOME BIOL, V4, DOI 10.1186/gb-2003-4-9-r60; EHRLICH CE, 1988, AM J OBSTET GYNECOL, V158, P796, DOI 10.1016/0002-9378(88)90075-0; Erkanli S, 2010, INT J GYNECOL CANCER, V20, P1170, DOI 10.1111/IGC.0b013e3181e94f5a; Grassian AR, 2011, GENE DEV, V25, P1716, DOI 10.1101/gad.16771811; Gu CO, 2011, CANCER SCI, V102, P557, DOI 10.1111/j.1349-7006.2010.01829.x; Hecht JL, 2006, J CLIN ONCOL, V24, P4783, DOI 10.1200/JCO.2006.06.7173; Hirai H, 2010, MOL CANCER THER, V9, P1956, DOI 10.1158/1535-7163.MCT-09-1012; Jemal A, 2011, CA-CANCER J CLIN, V61, P133, DOI [10.3322/caac.20105, 10.3322/caac.20073]; Jin X, 2004, BRIT J CANCER, V91, P1808, DOI 10.1038/sj.bjc.6602214; KASTNER P, 1990, EMBO J, V9, P1603, DOI 10.1002/j.1460-2075.1990.tb08280.x; Kim JJ, 2010, SEMIN REPROD MED, V28, P81, DOI 10.1055/s-0029-1242998; Kim JJ, 2005, BIOL REPROD, V73, P833, DOI 10.1095/biolreprod.105.043182; Knowles JA, 2011, LARYNGOSCOPE, V121, P2359, DOI 10.1002/lary.22180; Kwon HS, 2004, DIABETES, V53, P899, DOI 10.2337/diabetes.53.4.899; Lewin SN, 2010, OBSTET GYNECOL, V116, P1141, DOI 10.1097/AOG.0b013e3181f39849; Liu RX, 2011, J CLIN ENDOCR METAB, V96, pE577, DOI 10.1210/jc.2010-2644; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Meng Jieru, 2010, PLoS One, V5, pe14124, DOI 10.1371/journal.pone.0014124; Montz FJ, 2002, AM J OBSTET GYNECOL, V186, P651, DOI 10.1067/mob.2002.122130; Neubauer Nikki L., 2011, Hormones & Cancer, V2, P170, DOI 10.1007/s12672-011-0065-7; Pal SK, 2010, EXPERT OPIN INV DRUG, V19, P1355, DOI 10.1517/13543784.2010.520701; Ramirez PT, 2004, GYNECOL ONCOL, V95, P133, DOI 10.1016/j.ygyno.2004.06.045; Randall TC, 1997, OBSTET GYNECOL, V90, P434, DOI 10.1016/S0029-7844(97)00297-4; Risinger JI, 1997, CANCER RES, V57, P4736; Smid-Koopman E, 2003, J SOC GYNECOL INVEST, V10, P49, DOI 10.1016/S1071-5576(02)00217-4; Smyth G.K., 2004, STAT APPL GENET MOL, V3, DOI DOI 10.2202/1544-6115.1027; Takano M, 2007, MOL ENDOCRINOL, V21, P2334, DOI 10.1210/me.2007-0058; Terakawa N, 2003, ENDOCR-RELAT CANCER, V10, P203, DOI 10.1677/erc.0.0100203; van der Horst PH, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0030840; Ward EC, 2008, ENDOCRINOLOGY, V149, P1942, DOI 10.1210/en.2007-0756; Wheeler DT, 2007, AM J SURG PATHOL, V31, P988, DOI 10.1097/PAS.0b013e31802d68ce; Yap TA, 2011, J CLIN ONCOLOGY OFFI	40	42	47	1	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 24	2012	7	7							e41593	10.1371/journal.pone.0041593	http://dx.doi.org/10.1371/journal.pone.0041593			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	978NX	22911820	Green Published, gold, Green Submitted			2022-12-25	WOS:000306751300056
J	Wei, CF; Hsu, ST; Deng, WL; Wen, YD; Huang, HC				Wei, Chia-Fong; Hsu, Shih-Tien; Deng, Wen-Ling; Wen, Yu-Der; Huang, Hsiou-Chen			Plant Innate Immunity Induced by Flagellin Suppresses the Hypersensitive Response in Non-Host Plants Elicited by Pseudomonas syringae pv. averrhoi	PLOS ONE			English	Article							III SECRETION SYSTEM; TOMATO; DEFENSE; ARABIDOPSIS; PERCEPTION; RESISTANCE; VIRULENCE; EFFECTORS; MOTILITY; GLYCINEA	A new pathogen, Pseudomonas syringae pv. averrhoi (Pav), which causes bacterial spot disease on carambola was identified in Taiwan in 1997. Many strains of this pathovar have been isolated from different locations and several varieties of hosts. Some of these strains, such as HL1, are nonmotile and elicit a strong hypersensitive response (HR) in nonhost tobacco leaves, while other strains, such as PA5, are motile and elicit a weak HR. Based on the image from a transmission electron microscope, the results showed that HL1 is flagellum-deficient and PA5 has normal flagella. Here we cloned and analyzed the fliC gene and glycosylation island from Pav HL1 and PA5. The amino acid sequences of FliC from HL1 and PA5 are identical to P. s. pvs. tabaci (Pta), glycinea and phaseolicola and share very high similarity with other pathovars of P. syringae. In contrast to the flagellin mutant Pta Delta fliC, PA5 Delta fliC grows as well as wild type in the host plant, but it elicits stronger HR than wild type does in non-host plants. Furthermore, the purified Pav flagellin, but not the divergent flagellin from Agrobacterium tumefaciens, is able to impair the HR induced by PA5 Delta fliC. PA5 Delta fgt1 possessing nonglycosylated flagella behaved as its wild type in both bacterial growth in host and HR elicitation. Flagellin was infiltrated into tobacco leaves either simultaneously with flagellum-deficient HL1 or prior to the inoculation of wild type HL1, and both treatments impaired the HR induced by HL1. Moreover, the HR elicited by PA5 and PA5 Delta fliC was enhanced by the addition of cycloheximide, suggesting that the flagellin is one of the PAMPs (pathogen-associated molecular patterns) contributed to induce the PAMP-triggered immunity (PTI). Taken together, the results shown in this study reveal that flagellin in Pav is capable of suppressing HR via PTI induction during an incompatible interaction.	[Wei, Chia-Fong; Huang, Hsiou-Chen] Natl Chung Hsing Univ, Grad Inst Biotechnol, Taichung 40227, Taiwan; [Hsu, Shih-Tien; Deng, Wen-Ling] Natl Chung Hsing Univ, Dept Plant Pathol, Taichung 40227, Taiwan; [Wen, Yu-Der] Natl Changhua Univ Educ, Dept Biol, Changhua, Taiwan	National Chung Hsing University; National Chung Hsing University; National Changhua University of Education	Wei, CF (corresponding author), Chang Gung Univ, Dept Med Biotechnol & Lab Sci, Tao Yuan, Taiwan.	hchuang@dragon.nchu.edu.tw			Interchange Association-Japan; NSC-Taiwan (National Science Council);  [NSC97-2317-B-005-001]	Interchange Association-Japan(Interchange Association, Japan); NSC-Taiwan (National Science Council); 	This work was supported by grant NSC97-2317-B-005-001 and the Ph.D. summer program financed by Interchange Association-Japan and NSC-Taiwan (National Science Council) (for C-FW). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abramovitch RB, 2006, NAT REV MOL CELL BIO, V7, P601, DOI 10.1038/nrm1984; Bahar O, 2011, MOL PLANT MICROBE IN, V24, P1040, DOI 10.1094/MPMI-02-11-0041; BAKER CJ, 1987, PHYTOPATHOLOGY, V77, P1268, DOI 10.1094/Phyto-77-1268; Bent AF, 2007, ANNU REV PHYTOPATHOL, V45, P399, DOI 10.1146/annurev.phyto.45.062806.094427; Boller T, 2009, ANNU REV PLANT BIOL, V60, P379, DOI 10.1146/annurev.arplant.57.032905.105346; Bozso Z, 1999, PHYSIOL MOL PLANT P, V55, P215, DOI 10.1006/pmpp.1999.0225; Buell CR, 2003, P NATL ACAD SCI USA, V100, P10181, DOI 10.1073/pnas.1731982100; Charkowski AO, 1998, J BACTERIOL, V180, P5211, DOI 10.1128/JB.180.19.5211-5217.1998; Crabill E, 2010, PLANT PHYSIOL, V154, P233, DOI 10.1104/pp.110.159723; DITTA G, 1980, P NATL ACAD SCI-BIOL, V77, P7347, DOI 10.1073/pnas.77.12.7347; Felix G, 1999, PLANT J, V18, P265, DOI 10.1046/j.1365-313X.1999.00265.x; Gomez-Gomez L, 2000, MOL CELL, V5, P1003, DOI 10.1016/S1097-2765(00)80265-8; Gomez-Gomez L, 1999, PLANT J, V18, P277, DOI 10.1046/j.1365-313X.1999.00451.x; Grant SR, 2006, ANNU REV MICROBIOL, V60, P425, DOI 10.1146/annurev.micro.60.080805.142251; Hanahan D, 1985, DNA CLONING PRACTICA; Harlow E., 1988, ANTIBODIES LAB MANUA; HATTERMANN DR, 1989, PHYTOPATHOLOGY, V79, P284, DOI 10.1094/Phyto-79-284; He P, 2004, PLANT J, V37, P589, DOI 10.1111/j.1365-313X.2003.01986.x; HUYNH TV, 1992, CIRC RES, V70, P508, DOI 10.1161/01.RES.70.3.508; Ichinose Yuki, 2003, Journal of General Plant Pathology, V69, P244, DOI 10.1007/s10327-003-0045-z; Ishiga Yasuhiro, 2005, Journal of General Plant Pathology, V71, P302, DOI 10.1007/s10327-005-0201-8; Jones JDG, 2006, NATURE, V444, P323, DOI 10.1038/nature05286; KING EO, 1954, J LAB CLIN MED, V44, P301; Klement Z, 2003, PEST MANAG SCI, V59, P465, DOI 10.1002/ps.694; Klement Z, 1999, J PHYTOPATHOL, V147, P467, DOI 10.1111/j.1439-0434.1999.tb03852.x; KOVACH ME, 1995, GENE, V166, P175, DOI 10.1016/0378-1119(95)00584-1; Kvitko BH, 2007, J BACTERIOL, V189, P8059, DOI 10.1128/JB.01146-07; Li XY, 2005, P NATL ACAD SCI USA, V102, P12990, DOI 10.1073/pnas.0502425102; Lin Y-C, 2006, THESIS NATL CHUNG HS; Lin YuanChuen, 2006, Plant Pathology Bulletin, V15, P139; Melotto M, 2006, CELL, V126, P969, DOI 10.1016/j.cell.2006.06.054; Naito K, 2008, MOL PLANT MICROBE IN, V21, P1165, DOI 10.1094/MPMI-21-9-1165; Navarro L, 2004, PLANT PHYSIOL, V135, P1113, DOI 10.1104/pp.103.036749; Newman MA, 2000, MOL PLANT PATHOL, V1, P25, DOI 10.1046/j.1364-3703.2000.00004.x; Nomura K, 2006, SCIENCE, V313, P220, DOI 10.1126/science.1129523; Oh HS, 2005, PLANT J, V44, P348, DOI 10.1111/j.1365-313X.2005.02529.x; Oh HS, 2010, MOL PLANT MICROBE IN, V23, P727, DOI 10.1094/MPMI-23-6-0727; Pallen MJ, 2005, TRENDS MICROBIOL, V13, P143, DOI 10.1016/j.tim.2005.02.008; PANOPOULOS NJ, 1974, PHYTOPATHOLOGY, V64, P1389, DOI 10.1094/Phyto-64-1389; Sambrook J, 2001, MOL CLONING LAB MANU; SCHAFER A, 1994, GENE, V145, P69, DOI 10.1016/0378-1119(94)90324-7; Shimizu R, 2003, MOL GENET GENOMICS, V269, P21, DOI 10.1007/s00438-003-0817-3; SIMON R, 1983, BIO-TECHNOL, V1, P784, DOI 10.1038/nbt1183-784; Taguchi F, 2003, PLANT CELL PHYSIOL, V44, P342, DOI 10.1093/pcp/pcg042; Taguchi F, 2006, CELL MICROBIOL, V8, P923, DOI 10.1111/j.1462-5822.2005.00674.x; Taguchi F, 2003, PLANT PHYSIOL BIOCH, V41, P165, DOI 10.1016/S0981-9428(02)00018-9; Taguchi F, 2009, PHYSIOL MOL PLANT P, V74, P11, DOI 10.1016/j.pmpp.2009.08.001; Takeuchi K, 2003, J BACTERIOL, V185, P6658, DOI 10.1128/JB.185.22.6658-6665.2003; Tans-Kersten J, 2001, J BACTERIOL, V183, P3597, DOI 10.1128/JB.183.12.3597-3605.2001; Torres MA, 2006, PLANT PHYSIOL, V141, P373, DOI 10.1104/pp.106.079467; TOTTEN PA, 1990, J BACTERIOL, V172, P7188, DOI 10.1128/jb.172.12.7188-7199.1990; Tsuda K, 2008, PLANT J, V53, P763, DOI 10.1111/j.1365-313X.2007.03369.x; Tsuda K, 2010, CURR OPIN PLANT BIOL, V13, P459, DOI 10.1016/j.pbi.2010.04.006; Tsuda K, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000772; TURNER JG, 1974, PHYTOPATHOLOGY, V64, P885, DOI 10.1094/Phyto-64-885; Wei CF, 2005, MOL MICROBIOL, V57, P520, DOI 10.1111/j.1365-2958.2005.04704.x; WILSON DR, 1993, CAN J MICROBIOL, V39, P451, DOI 10.1139/m93-066; YAMAGUCHI S, 1984, J GEN MICROBIOL, V130, P3339; Zipfel C, 2009, CURR OPIN PLANT BIOL, V12, P414, DOI 10.1016/j.pbi.2009.06.003	59	39	40	0	22	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 23	2012	7	7							e41056	10.1371/journal.pone.0041056	http://dx.doi.org/10.1371/journal.pone.0041056			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	977TM	22911741	Green Submitted, Green Published, gold			2022-12-25	WOS:000306687700038
J	Lerret, NM; Rogozinska, M; Jaramillo, A; Marzo, AL				Lerret, Nadine M.; Rogozinska, Magdalena; Jaramillo, Andres; Marzo, Amanda L.			Adoptive Transfer of Mammaglobin-A Epitope Specific CD8 T Cells Combined with a Single Low Dose of Total Body Irradiation Eradicates Breast Tumors	PLOS ONE			English	Article							POORLY IMMUNOGENIC TUMOR; IL-7 RECEPTOR-ALPHA; IN-VIVO; ANTITUMOR IMMUNITY; TRANSFER THERAPY; TRANSGENIC MICE; CENTRAL MEMORY; EFFECTOR; CANCER; LYMPHOCYTES	Adoptive T cell therapy has proven to be beneficial in a number of tumor systems by targeting the relevant tumor antigen. The tumor antigen targeted in our model is Mammaglobin-A, expressed by approximately 80% of human breast tumors. Here we evaluated the use of adoptively transferred Mammaglobin-A specific CD8 T cells in combination with low dose irradiation to induce breast tumor rejection and prevent relapse. We show Mammaglobin-A specific CD8 T cells generated by DNA vaccination with all epitopes (Mammaglobin-A2.1, A2.2, A2.4 and A2.6) and full-length DNA in vivo resulted in heterogeneous T cell populations consisting of both effector and central memory CD8 T cell subsets. Adoptive transfer of spleen cells from all Mammaglobin-A2 immunized mice into tumor-bearing SCID/beige mice induced tumor regression but this anti-tumor response was not sustained long-term. Additionally, we demonstrate that only the adoptive transfer of Mammaglobin-A2 specific CD8 T cells in combination with a single low dose of irradiation prevents tumors from recurring. More importantly we show that this single dose of irradiation results in the down regulation of the macrophage scavenger receptor 1 on dendritic cells within the tumor and reduces lipid uptake by tumor resident dendritic cells potentially enabling the dendritic cells to present tumor antigen more efficiently and aid in tumor clearance. These data reveal the potential for adoptive transfer combined with a single low dose of total body irradiation as a suitable therapy for the treatment of established breast tumors and the prevention of tumor recurrence.	[Lerret, Nadine M.; Rogozinska, Magdalena; Marzo, Amanda L.] Rush Univ, Med Ctr, Dept Immunol & Microbiol, Chicago, IL 60612 USA; [Jaramillo, Andres] Rush Univ, Med Ctr, Dept Pathol, Chicago, IL 60612 USA; [Jaramillo, Andres] Gift Hope Organ & Tissue Donor Network, Histocompatibil Lab, Itasca, IL USA	Rush University; Rush University	Lerret, NM (corresponding author), Rush Univ, Med Ctr, Dept Immunol & Microbiol, Chicago, IL 60612 USA.	Amanda_Marzo@rush.edu	Jaramillo, Andrés/AAG-8461-2020	Jaramillo, Andrés/0000-0002-0910-1460; Marzo, amanda/0000-0002-5839-0430	Susan G. Komen for the Cure [BCTR0600731]; Prevent Cancer Foundation; Brian Piccolo/Gavers Cancer Research Foundation; Rush UCR grant	Susan G. Komen for the Cure(Susan G. Komen Breast Cancer Foundation); Prevent Cancer Foundation; Brian Piccolo/Gavers Cancer Research Foundation; Rush UCR grant	This work was supported by the Susan G. Komen for the Cure (Grant# BCTR0600731; A. L. M. and A.J.), the Prevent Cancer Foundation (A.L.M. and A.J.), the Brian Piccolo/Gavers Cancer Research Foundation (A.L.M.), and a Rush UCR grant (A.L.M.). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bachmann MF, 2005, J IMMUNOL, V175, P4686, DOI 10.4049/jimmunol.175.7.4686; Beverley PC, 2008, NAT CLIN PRACT RHEUM, V4, P43, DOI 10.1038/ncprheum0671; Croft M, 2003, NAT REV IMMUNOL, V3, P609, DOI 10.1038/nri1148; Dudley ME, 2003, NAT REV CANCER, V3, P666, DOI 10.1038/nrc1167; Fallarino F, 2000, J IMMUNOL, V165, P5495, DOI 10.4049/jimmunol.165.10.5495; Gallez-Hawkins G, 2003, J VIROL, V77, P4457, DOI 10.1128/JVI.77.7.4457-4462.2003; Gattinoni L, 2005, J CLIN INVEST, V115, P1616, DOI 10.1172/JCI24480; Gattinoni L, 2005, J EXP MED, V202, P907, DOI 10.1084/jem.20050732; Hand TW, 2007, P NATL ACAD SCI USA, V104, P11730, DOI 10.1073/pnas.0705007104; Hendricks J, 2003, J EXP MED, V198, P1369, DOI 10.1084/jem.20030916; Herber DL, 2010, NAT MED, V16, P880, DOI 10.1038/nm.2172; Intlekofer AM, 2005, NAT IMMUNOL, V6, P1236, DOI 10.1038/ni1268; Jaramillo A, 2004, BREAST CANCER RES TR, V88, P29, DOI 10.1007/s10549-004-8918-1; Kaech SM, 2003, NAT IMMUNOL, V4, P1191, DOI 10.1038/ni1009; Klebanoff CA, 2005, P NATL ACAD SCI USA, V102, P9571, DOI 10.1073/pnas.0503726102; Knutson KL, 2005, CANCER IMMUNOL IMMUN, V54, P721, DOI 10.1007/s00262-004-0653-2; Lacey SF, 2011, BLOOD, V118, P2159, DOI 10.1182/blood-2011-04-349951; Marzo AL, 2000, J IMMUNOL, V165, P6047, DOI 10.4049/jimmunol.165.11.6047; Marzo AL, 2007, J IMMUNOL, V179, P36, DOI 10.4049/jimmunol.179.1.36; Masopust D, 2001, SCIENCE, V291, P2413, DOI 10.1126/science.1058867; Narayanan K, 2004, JNCI-J NATL CANCER I, V96, P1388, DOI 10.1093/jnci/djh261; Paulos CM, 2007, J CLIN INVEST, V117, P2197, DOI 10.1172/JCI32205; Paulos CM, 2007, CLIN CANCER RES, V13, P5280, DOI 10.1158/1078-0432.CCR-07-1378; Perret R, 2008, EUR J IMMUNOL, V38, P2886, DOI 10.1002/eji.200838483; Powell DJ, 2005, BLOOD, V105, P241, DOI 10.1182/blood-2004-06-2482; Sallusto F, 2004, ANNU REV IMMUNOL, V22, P745, DOI 10.1146/annurev.immunol.22.012703.104702; Sallusto F, 1999, NATURE, V401, P708, DOI 10.1038/44385; Schluns KS, 2000, NAT IMMUNOL, V1, P426, DOI 10.1038/80868; SHIRAI M, 1995, J IMMUNOL, V154, P2733; Sussman JJ, 2004, CANCER RES, V64, P9124, DOI 10.1158/0008-5472.CAN-03-0376; SUSSMAN JJ, 1994, ANN SURG ONCOL, V1, P296, DOI 10.1007/BF02303568; Thomas WD, 1998, J IMMUNOL, V161, P2195; VITIELLO A, 1991, J EXP MED, V173, P1007, DOI 10.1084/jem.173.4.1007; Watson MA, 1999, CANCER RES, V59, P3028; Weninger W, 2001, J EXP MED, V194, P953, DOI 10.1084/jem.194.7.953; Wong SBJ, 2008, J IMMUNOL, V180, P3122, DOI 10.4049/jimmunol.180.5.3122; Yee C, 2002, P NATL ACAD SCI USA, V99, P16168, DOI 10.1073/pnas.242600099; Zhang PS, 2007, CANCER RES, V67, P6468, DOI 10.1158/0008-5472.CAN-07-1264	38	7	8	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 20	2012	7	7							e41240	10.1371/journal.pone.0041240	http://dx.doi.org/10.1371/journal.pone.0041240			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	977GL	22911764	gold, Green Published, Green Submitted			2022-12-25	WOS:000306644600059
J	Ort, BS; Bantay, RM; Pantoja, NA; O'Grady, PM				Ort, Brian S.; Bantay, Roxanne M.; Pantoja, Norma A.; O'Grady, Patrick M.			Fungal Diversity Associated with Hawaiian Drosophila Host Plants	PLOS ONE			English	Article							NONPARAMETRIC-ESTIMATION; FOOD PREFERENCES; GENE-EXPRESSION; YOSEMITE REGION; YEAST; LARVAL; ORIGIN; COEVOLUTION; PHYLOGENY; COMMUNITY	Hawaiian Drosophila depend primarily, sometimes exclusively, on specific host plants for oviposition and larval development, and most specialize further on a particular decomposing part of that plant. Differences in fungal community between host plants and substrate types may establish the basis for host specificity in Hawaiian Drosophila. Fungi mediate decomposition, releasing plant micronutrients and volatiles that can indicate high quality substrates and serve as cues to stimulate oviposition. This study addresses major gaps in our knowledge by providing the first culture-free, DNA-based survey of fungal diversity associated with four ecologically important tree genera in the Hawaiian Islands. Three genera, Cheirodendron, Clermontia, and Pisonia, are important host plants for Drosophila. The fourth, Acacia, is not an important drosophilid host but is a dominant forest tree. We sampled fresh and rotting leaves from all four taxa, plus rotting stems from Clermontia and Pisonia. Based on sequences from the D1/D2 domain of the 26S rDNA gene, we identified by BLAST search representatives from 113 genera in 13 fungal classes. A total of 160 operational taxonomic units, defined on the basis of >= 97% genetic similarity, were identified in these samples, but sampling curves show this is an underestimate of the total fungal diversity present on these substrates. Shannon diversity indices ranged from 2.0 to 3.5 among the Hawaiian samples, a slight reduction compared to continental surveys. We detected very little sharing of fungal taxa among the substrates, and tests of community composition confirmed that the structure of the fungal community differed significantly among the substrates and host plants. Based on these results, we hypothesize that fungal community structure plays a central role in the establishment of host preference in the Hawaiian Drosophila radiation.	[Ort, Brian S.; Bantay, Roxanne M.; Pantoja, Norma A.; O'Grady, Patrick M.] Univ Calif Berkeley, Dept Environm Sci Policy & Management, Berkeley, CA 94720 USA	University of California System; University of California Berkeley	Ort, BS (corresponding author), Univ Calif Berkeley, Dept Environm Sci Policy & Management, Berkeley, CA 94720 USA.	ort@berkeley.edu	O'Grady, Patrick/J-3421-2019	O'Grady, Patrick/0000-0002-6075-8951	University of California, Berkeley; UC Berkeley's Sponsored Projects for Undergraduate Research (SPUR); UC Berkeley's Undergraduate Research Apprenticeship Program (URAP)	University of California, Berkeley(University of California System); UC Berkeley's Sponsored Projects for Undergraduate Research (SPUR); UC Berkeley's Undergraduate Research Apprenticeship Program (URAP)	This work was funded in part by University of California, Berkeley start up funds to PMO. Other funding was from UC Berkeley's Sponsored Projects for Undergraduate Research (SPUR) and Undergraduate Research Apprenticeship Program (URAP). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1016/S0022-2836(05)80360-2; Anagnostou C, 2010, ENTOMOL EXP APPL, V136, P1, DOI 10.1111/j.1570-7458.2010.00997.x; Anderson TM, 2004, AM NAT, V164, P709, DOI 10.1086/425372; Baker RH, 1997, SYST BIOL, V46, P654, DOI 10.2307/2413499; Barker J.S.F., 1982, ECOLOGICAL GENETICS; BARKER JSF, 1994, HEREDITY, V72, P384, DOI 10.1038/hdy.1994.55; Barker JSF, 1999, HEREDITAS, V130, P145, DOI 10.1111/j.1601-5223.1999.00145.x; Bronstein JL, 2006, NEW PHYTOL, V172, P412, DOI 10.1111/j.1469-8137.2006.01864.x; Buee M, 2009, NEW PHYTOL, V184, P449, DOI 10.1111/j.1469-8137.2009.03003.x; Chandler JA, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1002272; CHAO A, 1984, SCAND J STAT, V11, P265; Chao A, 2003, ENVIRON ECOL STAT, V10, P429, DOI 10.1023/A:1026096204727; COOPER DM, 1960, EVOLUTION, V14, P41, DOI 10.2307/2405921; Currie CR, 2006, SCIENCE, V311, P81, DOI 10.1126/science.1119744; Currie CR, 2003, SCIENCE, V299, P386, DOI 10.1126/science.1078155; DACUNHA AB, 1951, EVOLUTION, V5, P97, DOI 10.1111/j.1558-5646.1951.tb02766.x; DESALLE R, 1992, MOL BIOL EVOL, V9, P905; DOBZHANSKY T, 1956, ECOLOGY, V37, P544, DOI 10.2307/1930178; Ebbs ML, 2007, PFLUG ARCH EUR J PHY, V454, P735, DOI 10.1007/s00424-007-0246-y; EXCOFFIER L, 1992, GENETICS, V131, P479; Fellous S, 2010, MOL ECOL, V19, P1462, DOI 10.1111/j.1365-294X.2010.04567.x; Felsenstein J., 1989, CLADISTICS, V5, P164, DOI DOI 10.1111/J.1096-0031.1989.TB00562.X; Fierer N, 2007, APPL ENVIRON MICROB, V73, P7059, DOI 10.1128/AEM.00358-07; FOGLEMAN JC, 1982, OECOLOGIA, V52, P187, DOI 10.1007/BF00363835; FOGLEMAN JC, 1981, P NATL ACAD SCI-BIOL, V78, P4435, DOI 10.1073/pnas.78.7.4435; Fricke C, 2008, EVOLUTION, V62, P3170, DOI 10.1111/j.1558-5646.2008.00515.x; Haas BJ, 2011, GENOME RES, V21, P494, DOI 10.1101/gr.112730.110; Hallem EA, 2006, ANNU REV ENTOMOL, V51, P113, DOI 10.1146/annurev.ento.51.051705.113646; HEED W B, 1971, Taxon, V20, P115, DOI 10.2307/1218539; Heed WB, 1968, ECOLOGY HAWAIIAN DRO, P387; Janz N, 2006, BMC EVOL BIOL, V6, DOI 10.1186/1471-2148-6-4; KANESHIRO KY, 1973, AM NAT, V107, P766, DOI 10.1086/282874; Katoh K, 2005, NUCLEIC ACIDS RES, V33, P511, DOI 10.1093/nar/gki198; Kopp A, 2008, MOL BIOL EVOL, V25, P1081, DOI 10.1093/molbev/msn055; Kurtzman CP, 2006, TOP CURR GENET, V15, P29, DOI 10.1007/b106654; Kurtzman CP, 1997, J CLIN MICROBIOL, V35, P1216, DOI 10.1128/JCM.35.5.1216-1223.1997; Lachance MA, 2006, BIODIVERSITY AND ECOPHYSIOLOGY OF YEASTS, P1, DOI 10.1007/3-540-30985-3_1; LACHANCE MA, 1989, YEAST, V5, P501; Lachance MA, 2001, FEMS YEAST RES, V1, P1; Lapoint RT, 2011, MOL PHYLOGENET EVOL, V58, P492, DOI 10.1016/j.ympev.2010.12.015; LINDSAY SL, 1958, AM NAT, V92, P279, DOI 10.1086/282036; Lozupone C, 2005, APPL ENVIRON MICROB, V71, P8228, DOI 10.1128/AEM.71.12.8228-8235.2005; Machado CA, 2005, P NATL ACAD SCI USA, V102, P6558, DOI 10.1073/pnas.0501840102; MADDISON D. R., 2005, MACCLADE 4 ANAL PHYL; Magnacca KN, 2008, ZOOTAXA, P1; Magnacca KN, 2012, ZOOTAXA, P1; Markow T. A., 2006, DROSOPHILA GUIDE SPE; Markow TA, 2005, ANNU REV GENET, V39, P263, DOI 10.1146/annurev.genet.39.073003.112454; Mikheyev AS, 2007, MOL ECOL, V16, P209, DOI 10.1111/j.1365-294X.2006.03134.x; Miller M. A., 2010, GAT COMP ENV WORKSH, P1, DOI DOI 10.1109/GCE.2010.5676129; Moran NA, 2000, CURR OPIN MICROBIOL, V3, P270, DOI 10.1016/S1369-5274(00)00088-6; Northrop JH, 1917, J BIOL CHEM, V30, P0181; O'Brien HE, 2005, APPL ENVIRON MICROB, V71, P5544, DOI 10.1128/AEM.71.9.5544-5550.2005; O'Grady P, RAPIDLY EVO IN PRESS; O'Grady P.M., 2010, Bishop Museum Occasional Papers, V108, P1; O'Grady P, 2008, BIOL LETTERS, V4, P195, DOI 10.1098/rsbl.2007.0575; O'Grady PM, 2011, MOL PHYLOGENET EVOL, V58, P244, DOI 10.1016/j.ympev.2010.11.022; Pellmyr O, 2003, ANN MO BOT GARD, V90, P35, DOI 10.2307/3298524; PHAFF HJ, 1956, ECOLOGY, V37, P533, DOI 10.2307/1930176; Phaff HJ, 2000, INT J SYST EVOL MICR, V50, P1683, DOI 10.1099/00207713-50-4-1683; Remsen J, 2002, MOL PHYLOGENET EVOL, V24, P249, DOI 10.1016/S1055-7903(02)00226-9; Remsen J, 1998, MOL PHYLOGENET EVOL, V9, P225, DOI 10.1006/mpev.1997.0484; Roderick GK, 1998, MOL ECOL, V7, P519, DOI 10.1046/j.1365-294x.1998.00309.x; Schloss PD, 2008, ISME J, V2, P265, DOI 10.1038/ismej.2008.5; Schloss PD, 2009, APPL ENVIRON MICROB, V75, P7537, DOI 10.1128/AEM.01541-09; STARMER WT, 1982, EVOL BIOL, V14, P269; Starmer WT, 2003, FEMS YEAST RES, V3, P441, DOI 10.1016/S1567-1356(03)00056-4; STARMER WT, 1981, EVOLUTION, V35, P38, DOI 10.1111/j.1558-5646.1981.tb04856.x; STARMER WT, 1990, EVOL BIOL, V24, P253; Stewart CN, 1996, J EVOLUTION BIOL, V9, P153, DOI 10.1046/j.1420-9101.1996.9020153.x; Storey JD, 2004, J R STAT SOC B, V66, P187, DOI 10.1111/j.1467-9868.2004.00439.x; SWOFFORD DL, 2001, PHYLOGENETIC ANAL US; THOMAS RH, 1993, MOL BIOL EVOL, V10, P362; WAGNER RP, 1944, U TEXAS PUBL, V4445, P104; Weiblen GD, 2002, ANNU REV ENTOMOL, V47, P299, DOI 10.1146/annurev.ento.47.091201.145213; Werren John H, 2008, Nat Rev Microbiol, V6, P741, DOI 10.1038/nrmicro1969; Wisotsky Z, 2011, NAT NEUROSCI, V14, P1534, DOI 10.1038/nn.2944	77	13	13	0	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 20	2012	7	7							e40550	10.1371/journal.pone.0040550	http://dx.doi.org/10.1371/journal.pone.0040550			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	977GL	22911703	Green Published, Green Submitted, gold			2022-12-25	WOS:000306644600021
J	Wisniewski, MG; Mercado, E; Gramann, K; Makeig, S				Wisniewski, Matthew G.; Mercado, Eduardo, III; Gramann, Klaus; Makeig, Scott			Familiarity with Speech Affects Cortical Processing of Auditory Distance Cues and Increases Acuity	PLOS ONE			English	Article							PHASE PATTERNS; EEG DYNAMICS; PERCEPTION; DISCRIMINATION; INFORMATION; RESPONSES; SOUNDS; CORTEX	Several acoustic cues contribute to auditory distance estimation. Nonacoustic cues, including familiarity, may also play a role. We tested participants' ability to distinguish the distances of acoustically similar sounds that differed in familiarity. Participants were better able to judge the distances of familiar sounds. Electroencephalographic (EEG) recordings collected while participants performed this auditory distance judgment task revealed that several cortical regions responded in different ways depending on sound familiarity. Surprisingly, these differences were observed in auditory cortical regions as well as other cortical regions distributed throughout both hemispheres. These data suggest that learning about subtle, distance-dependent variations in complex speech sounds involves processing in a broad cortical network that contributes both to speech recognition and to how spatial information is extracted from speech.	[Wisniewski, Matthew G.; Mercado, Eduardo, III] SUNY Buffalo, Dept Psychol, Buffalo, NY 14260 USA; [Gramann, Klaus; Makeig, Scott] Univ Calif San Diego, Inst Neural Computat, Swartz Ctr Computat Neurosci, La Jolla, CA 92093 USA; [Gramann, Klaus] Univ Osnabruck, Inst Cognit Sci, Osnabruck, Germany	State University of New York (SUNY) System; State University of New York (SUNY) Buffalo; University of California System; University of California San Diego; University Osnabruck	Wisniewski, MG (corresponding author), SUNY Buffalo, Dept Psychol, Buffalo, NY 14260 USA.	mgw@buffalo.edu	Gramann, Klaus/AAD-7313-2019	Gramann, Klaus/0000-0003-2673-1832	NSF [SBE 0542013, SBE 0835976]; Office of Naval Research	NSF(National Science Foundation (NSF)); Office of Naval Research(Office of Naval Research)	This work was supported in part by NSF Grants SBE 0542013 to the Temporal Dynamics of Learning Center, SBE 0835976 to CELEST, a BRC grant from the Office of Naval Research (SM) and by a gift from The Swartz Foundation (Old Field NY). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	At A, 2011, NEUROPSYCHOLOGIA, V49, P2794, DOI 10.1016/j.neuropsychologia.2011.05.024; BERGER KW, 1964, J ACOUST SOC AM, V36, P1888, DOI 10.1121/1.1919287; Brungart DS, 2001, J ACOUST SOC AM, V110, P425, DOI 10.1121/1.1379730; BUZSAKI G, 1982, J EXP ANAL BEHAV, V37, P461, DOI 10.1901/jeab.1982.37-461; Cheyne HA, 2009, J ACOUST SOC AM, V126, P2052, DOI 10.1121/1.3205400; COLEMAN PD, 1963, PSYCHOL BULL, V60, P302, DOI 10.1037/h0045716; COLEMAN PD, 1962, J ACOUST SOC AM, V34, P345, DOI 10.1121/1.1928121; Delorme A, 2004, J NEUROSCI METH, V134, P9, DOI 10.1016/j.jneumeth.2003.10.009; Delorme A, 2011, COMPUT INTEL NEUROSC, V2011, DOI 10.1155/2011/130714; Downar J, 2002, J NEUROPHYSIOL, V87, P615, DOI 10.1152/jn.00636.2001; Hall DA, 2003, CURR BIOL, V13, pR91, DOI 10.1016/S0960-9822(03)00034-4; Hickok G, 2007, NAT REV NEUROSCI, V8, P393, DOI 10.1038/nrn2113; Howard MF, 2010, J NEUROPHYSIOL, V104, P2500, DOI 10.1152/jn.00251.2010; Jung TP, 2001, P IEEE, V89, P1107, DOI 10.1109/5.939827; Krause CM, 1999, BRAIN RES COGN GRAIN, V5, P295; Lerner Y, 2011, J NEUROSCI, V31, P2906, DOI 10.1523/JNEUROSCI.3684-10.2011; Liu EH, 2011, ATTEN PERCEPT PSYCHO, V73, P2624, DOI 10.3758/s13414-011-0190-y; Luo H, 2007, NEURON, V54, P1001, DOI 10.1016/j.neuron.2007.06.004; Makeig S, 2004, TRENDS COGN SCI, V8, P204, DOI 10.1016/j.tics.2004.03.008; Makeig S, 1997, P NATL ACAD SCI USA, V94, P10979, DOI 10.1073/pnas.94.20.10979; MAKEIG S, 1993, ELECTROEN CLIN NEURO, V86, P283, DOI 10.1016/0013-4694(93)90110-H; Mathiak K, 2003, NEUROREPORT, V14, P307, DOI 10.1097/01.wnr.0000059775.23521.fe; MCGREGOR P, 1985, PERCEPT MOTOR SKILL, V61, P1082, DOI 10.2466/pms.1985.61.3f.1082; Mills W, 1972, MODERN AUDITORY THEO; NACHSHON I, 1986, INT J PSYCHOL, V21, P617, DOI 10.1080/00207598608247609; Nasir SM, 2009, P NATL ACAD SCI USA, V106, P20470, DOI 10.1073/pnas.0907032106; Onton J, 2005, NEUROIMAGE, V27, P341, DOI 10.1016/j.neuroimage.2005.04.014; Onton J, 2006, PROG BRAIN RES, V159, P99, DOI 10.1016/S0079-6123(06)59007-7; Orr JM, 2009, CEREB CORTEX, V19, P703, DOI 10.1093/cercor/bhn119; Paquette C, 1997, CORTEX, V33, P689, DOI 10.1016/S0010-9452(08)70726-3; Seifritz E, 2002, CURR BIOL, V12, P2147, DOI 10.1016/S0960-9822(02)01356-8; SIMPSON WE, 1973, AM J PSYCHOL, V86, P151, DOI 10.2307/1421856; Talati A, 2005, J COGNITIVE NEUROSCI, V17, P981, DOI 10.1162/0898929054475226; Tzourio N, 1997, NEUROIMAGE, V5, P63, DOI 10.1006/nimg.1996.0252; Wu CT, 2007, BRAIN RES, V1134, P187, DOI 10.1016/j.brainres.2006.11.088; Zahorik P, 2002, J ACOUST SOC AM, V111, P1832, DOI 10.1121/1.1458027; Zahorik P, 2005, ACTA ACUST UNITED AC, V91, P409; Zahorik P, 2002, J ACOUST SOC AM, V112, P2110, DOI 10.1121/1.1506692	38	12	12	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 20	2012	7	7							e41025	10.1371/journal.pone.0041025	http://dx.doi.org/10.1371/journal.pone.0041025			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	977GL	22911734	Green Published, gold			2022-12-25	WOS:000306644600038
J	Lehmann, L; Ferrari, R; Vashisht, AA; Wohlschlegel, JA; Kurdistani, SK; Carey, M				Lehmann, Lynn; Ferrari, Roberto; Vashisht, Ajay A.; Wohlschlegel, James A.; Kurdistani, Siavash K.; Carey, Michael			Polycomb Repressive Complex 1 (PRC1) Disassembles RNA Polymerase II Preinitiation Complexes	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							H3 LYSINE-27 METHYLATION; VP16 ACTIVATION DOMAIN; METHYLTRANSFERASE ACTIVITY; CHROMATIN-STRUCTURE; GENE-EXPRESSION; HISTONE; MEDIATOR; CORE; DISTINCT; UBIQUITINATION	Despite the important role of Polycomb in genome-wide silencing, little is known of the specific biochemical mechanism by which it inactivates transcription. Here we address how recombinant Polycomb repressive complex 1 (PRC1) inhibits activated RNA polymerase II preinitiation complex (PIC) assembly using immobilized H3K27-methylated chromatin templates in vitro. Recombinant PRC1 inhibited transcription, but had little effect on binding of the activator as reported previously. In contrast, Mediator and the general transcription factors were blocked during assembly or dissociated from preassembled PICs. Importantly, among the PIC components, Tata Binding Protein (TBP) was the most resistant to eviction by PRC1. Immobilized template experiments using purified PRC1, transcription factor II D (TFIID), and Mediator indicate that PRC1 blocks the recruitment of Mediator, but not TFIID. We conclude that PRC1 functions to block or dissociate PICs by interfering with Mediator, but leaves TBP and perhaps TFIID intact, highlighting a specific mechanism for PRC1 transcriptional silencing. Analysis of published genome-wide datasets from mouse embryonic stem cells revealed that the Ring1b subunit of PRC1 and TBP co-enrich at developmental genes. Further, genes enriched for Ring1b and TBP are expressed at significantly lower levels than those enriched for Mediator, TBP, and Ring1b. Collectively, the data are consistent with a model in which PRC1 and TFIID could co-occupy genes poised for activation during development.	[Lehmann, Lynn; Ferrari, Roberto; Vashisht, Ajay A.; Wohlschlegel, James A.; Kurdistani, Siavash K.; Carey, Michael] Univ Calif Los Angeles, David Geffen Sch Med, Dept Biol Chem, Los Angeles, CA 90095 USA; [Lehmann, Lynn; Carey, Michael] Univ Calif Los Angeles, Inst Mol Biol, Los Angeles, CA 90095 USA	University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA; University of California System; University of California Los Angeles	Carey, M (corresponding author), Univ Calif Los Angeles, David Geffen Sch Med, Dept Biol Chem, Los Angeles, CA 90095 USA.	mcarey@mednet.ucla.edu	Ferrari, Roberto/O-8143-2015	Ferrari, Roberto/0000-0002-0453-0899; Kurdistani, Siavash/0000-0003-3295-3511	National Institutes of Health Grant [R01-GM074701]; California Institute for Regenerative Medicine Grant [RN1-00550-1]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM074701, R01GM089778] Funding Source: NIH RePORTER	National Institutes of Health Grant(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); California Institute for Regenerative Medicine Grant(California Institute for Regenerative Medicine); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grant R01-GM074701 (to M. C.).; Supported by California Institute for Regenerative Medicine Grant RN1-00550-1.	Berk AJ, 1998, COLD SPRING HARB SYM, V63, P243, DOI 10.1101/sqb.1998.63.243; Black JC, 2006, MOL CELL, V23, P809, DOI 10.1016/j.molcel.2006.07.018; Breiling A, 2001, NATURE, V412, P651, DOI 10.1038/35088090; Cao R, 2002, SCIENCE, V298, P1039, DOI 10.1126/science.1076997; Chao DM, 1996, NATURE, V380, P82, DOI 10.1038/380082a0; Chen X, 2005, SCIENCE, V310, P869, DOI 10.1126/science.1118101; Czermin B, 2002, CELL, V111, P185, DOI 10.1016/S0092-8674(02)00975-3; Dellino GI, 2004, MOL CELL, V13, P887, DOI 10.1016/S1097-2765(04)00128-5; DIGNAM JD, 1983, NUCLEIC ACIDS RES, V11, P1475, DOI 10.1093/nar/11.5.1475; Eadie W. T., 1971, STAT METHODS EXPT PH, P313; Endoh M, 2008, DEVELOPMENT, V135, P1513, DOI 10.1242/dev.014340; Eskeland R, 2010, MOL CELL, V38, P452, DOI 10.1016/j.molcel.2010.02.032; Ferrari R, 2012, GENOME RES, V22, P1212, DOI 10.1101/gr.132308.111; Fischle W, 2003, GENE DEV, V17, P1870, DOI 10.1101/gad.1110503; Francis NJ, 2004, SCIENCE, V306, P1574, DOI 10.1126/science.1100576; Francis NJ, 2001, MOL CELL, V8, P545, DOI 10.1016/S1097-2765(01)00316-1; GOODRICH JA, 1993, CELL, V75, P519, DOI 10.1016/0092-8674(93)90386-5; Hawkins RD, 2010, CELL STEM CELL, V6, P479, DOI 10.1016/j.stem.2010.03.018; Ikeda K, 1999, MOL CELL BIOL, V19, P855; Johnson KM, 2002, GENE DEV, V16, P1852, DOI 10.1101/gad.995702; Kagey MH, 2010, NATURE, V467, P430, DOI 10.1038/nature09380; King IFG, 2002, MOL CELL BIOL, V22, P7919, DOI 10.1128/MCB.22.22.7919-7928.2002; KOLESKE AJ, 1994, NATURE, V368, P466, DOI 10.1038/368466a0; Krebs AR, 2011, MOL CELL, V44, P410, DOI 10.1016/j.molcel.2011.08.037; Ku M, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000242; Langmead B, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-3-r25; Levine SS, 2002, MOL CELL BIOL, V22, P6070, DOI 10.1128/MCB.22.17.6070-6078.2002; LEWIS EB, 1978, NATURE, V276, P565, DOI 10.1038/276565a0; Lin J. J., 2012, CURR PROTOC MOL BIOL; Lin JJ, 2011, GENE DEV, V25, P2198, DOI 10.1101/gad.17554711; Luger K, 1997, J MOL BIOL, V272, P301, DOI 10.1006/jmbi.1997.1235; Min JR, 2003, GENE DEV, V17, P1823, DOI 10.1101/gad.269603; Muller J, 2002, CELL, V111, P197, DOI 10.1016/S0092-8674(02)00976-5; Ng J, 2000, MOL CELL BIOL, V20, P3069, DOI 10.1128/MCB.20.9.3069-3078.2000; Plath K, 2003, SCIENCE, V300, P131, DOI 10.1126/science.1084274; Sato S, 2003, J BIOL CHEM, V278, P49671, DOI 10.1074/jbc.C300444200; Saurin AJ, 2001, NATURE, V412, P655, DOI 10.1038/35088096; Shao ZH, 1999, CELL, V98, P37, DOI 10.1016/S0092-8674(00)80604-2; Simon JA, 2009, NAT REV MOL CELL BIO, V10, P697, DOI 10.1038/nrm2763; Simon MD, 2007, CELL, V128, P1003, DOI 10.1016/j.cell.2006.12.041; Smallwood A, 2008, NAT STRUCT MOL BIOL, V15, P318, DOI 10.1038/nsmb.1385; Steger DJ, 1997, METHODS, V12, P276, DOI 10.1006/meth.1997.0479; Stock JK, 2007, NAT CELL BIOL, V9, P1428, DOI 10.1038/ncb1663; Tantin D, 1996, METHOD ENZYMOL, V274, P133; Tavares L, 2012, CELL, V148, P664, DOI 10.1016/j.cell.2011.12.029; Thomas MC, 2006, CRIT REV BIOCHEM MOL, V41, P105, DOI 10.1080/10409230600648736; Uhlmann T, 2007, J BIOL CHEM, V282, P2163, DOI 10.1074/jbc.M608451200; Vermeulen M, 2007, CELL, V131, P58, DOI 10.1016/j.cell.2007.08.016; Wang HB, 2004, NATURE, V431, P873, DOI 10.1038/nature02985; Yang FJ, 2004, P NATL ACAD SCI USA, V101, P2339, DOI 10.1073/pnas.0308676100; ZHOU Q, 1992, GENE DEV, V6, P1964, DOI 10.1101/gad.6.10.1964	51	54	55	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 19	2012	287	43					35784	35794		10.1074/jbc.M112.397430	http://dx.doi.org/10.1074/jbc.M112.397430			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	027PA	22910904	Green Published, hybrid			2022-12-25	WOS:000310364000002
J	Bi, YQ; Tugume, AK; Valkonen, JPT				Bi, Yaqi; Tugume, Arthur K.; Valkonen, Jari P. T.			Small-RNA Deep Sequencing Reveals Arctium tomentosum as a Natural Host of Alstroemeria virus X and a New Putative Emaravirus	PLOS ONE			English	Article							COMPLETE NUCLEOTIDE-SEQUENCE; YELLOW-SPOT-VIRUS; SWEET-POTATO; MOSAIC-VIRUS; ERIOPHYID MITE; SORBUS-AUCUPARIA; WILD; MULTIPARTITE; EVOLUTION; PLANTS	Background: Arctium species (Asteraceae) are distributed worldwide and are used as food and rich sources of secondary metabolites for the pharmaceutical industry, e. g., against avian influenza virus. RNA silencing is an antiviral defense mechanism that detects and destroys virus-derived double-stranded RNA, resulting in accumulation of virus-derived small RNAs (21-24 nucleotides) that can be used for generic detection of viruses by small-RNA deep sequencing (SRDS). Methodology/Principal Findings: SRDS was used to detect viruses in the biennial wild plant species Arctium tomentosum (woolly burdock; family Asteraceae) displaying virus-like symptoms of vein yellowing and leaf mosaic in southern Finland. Assembly of the small-RNA reads resulted in contigs homologous to Alstroemeria virus X (AlsVX), a positive/single-stranded RNA virus of genus Potexvirus (family Alphaflexiviridae), or related to negative/single-stranded RNA viruses of the genus Emaravirus. The coat protein gene of AlsVX was 81% and 89% identical to the two AlsVX isolates from Japan and Norway, respectively. The deduced, partial nucleocapsid protein amino acid sequence of the emara-like virus was only 78% or less identical to reported emaraviruses and showed no variability among the virus isolates characterized. This virus-tentatively named as Woolly burdock yellow vein virus-was exclusively associated with yellow vein and leaf mosaic symptoms in woolly burdock, whereas AlsVX was detected in only one of the 52 plants tested. Conclusions/Significance: These results provide novel information about natural virus infections in Acrtium species and reveal woolly burdock as the first natural host of AlsVX besides Alstroemeria (family Alstroemeriaceae). Results also revealed a new virus related to the recently emerged Emaravirus genus and demonstrated applicability of SRDS to detect negative-strand RNA viruses. SRDS potentiates virus surveys of wild plants, a research area underrepresented in plant virology, and helps reveal natural reservoirs of viruses that cause yield losses in cultivated plants.	[Bi, Yaqi; Tugume, Arthur K.; Valkonen, Jari P. T.] Univ Helsinki, Dept Agr Sci, Helsinki, Finland	University of Helsinki	Bi, YQ (corresponding author), Univ Helsinki, Dept Agr Sci, Helsinki, Finland.	jari.valkonen@helsinki.fi		Tugume, Arthur/0000-0003-3689-6745; Valkonen, Jari/0000-0002-3704-9911	Academy of Finland [1253126]	Academy of Finland(Academy of Finland)	This study was supported by the Academy of Finland grant no. 1253126. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allen GC, 2006, NAT PROTOC, V1, P2320, DOI 10.1038/nprot.2006.384; Awano T, 2009, P NATL ACAD SCI USA, V106, P2794, DOI [10.1073/pnas.0812297106, 10.1073/pnas.0905845106]; Baulcombe D, 2004, NATURE, V431, P356, DOI 10.1038/nature02874; Bayer Randall J., 2001, Kew Bulletin, V56, P1013, DOI 10.2307/4119317; Bisnieks M, 2006, ACTA AGR SCAND B-S P, V56, P171, DOI 10.1080/09064710500297658; Brant V, 2006, J PLANT DIS PROTECT, P605; Caglayan K, 2010, PLANT DIS, V94, P1448, DOI 10.1094/PDIS-11-09-0771; Cooper I, 2006, ADV VIRUS RES, V67, P1, DOI 10.1016/S0065-3527(06)67001-2; Dees MW, 2007, THESIS NORWEGIAN U L; Deleris A, 2006, SCIENCE, V313, P68, DOI 10.1126/science.1128214; Dunoyer P, 2005, NAT GENET, V37, P1356, DOI 10.1038/ng1675; Elbeaino T, 2009, ARCH VIROL, V154, P1719, DOI 10.1007/s00705-009-0509-3; Elbeaino T, 2009, J GEN VIROL, V90, P1281, DOI 10.1099/vir.0.008649-0; FLOCK RA, 1955, PHYTOPATHOLOGY, V45, P52; Fuji S, 2005, ARCH VIROL, V150, P2377, DOI 10.1007/s00705-005-0574-1; Fuji S, 2004, ARCH VIROL, V149, P1843, DOI 10.1007/s00705-004-0344-5; Fuji Shin-ichi, 2007, Journal of General Plant Pathology, V73, P216, DOI 10.1007/s10327-007-0009-9; Gammelgard E, 2007, J GEN VIROL, V88, P2337, DOI 10.1099/vir.0.82928-0; Ghedin E, 2011, J INFECT DIS, V203, P168, DOI 10.1093/infdis/jiq040; Hagen C, 2011, ARCH VIROL, V156, P1209, DOI 10.1007/s00705-011-0979-y; Hayashi K, 2010, BIOL PHARM BULL, V33, P1199, DOI 10.1248/bpb.33.1199; HEILMEIER H, 1986, OECOLOGIA, V70, P466, DOI 10.1007/BF00379513; Hsu CL, 2011, PLANT DIS, V95, P735, DOI 10.1094/PDIS-05-10-0353; Isakov O, 2011, BIOINFORMATICS, V27, P2027, DOI 10.1093/bioinformatics/btr349; Jaiswal R, 2011, FOOD FUNCT, V2, P63, DOI 10.1039/c0fo00125b; Kallinen AK, 2009, PHYTOPATHOLOGY, V99, P344, DOI 10.1094/PHYTO-99-4-0344; Kendall DA, 1996, PLANT PATHOL, V45, P29, DOI 10.1046/j.1365-3059.1996.d01-98.x; KIMURA M, 1980, J MOL EVOL, V16, P111, DOI 10.1007/BF01731581; King A. M., 2012, VIRUS TAXONOMY CLASS; Kormelink R, 2011, VIRUS RES, V162, P184, DOI 10.1016/j.virusres.2011.09.028; Kreuze JF, 2009, VIROLOGY, V388, P1, DOI 10.1016/j.virol.2009.03.024; Kulkarni NK, 2002, PLANT DIS, V86, P1297, DOI 10.1094/PDIS.2002.86.12.1297; Laney AG, 2011, J GEN VIROL, V92, P1727, DOI 10.1099/vir.0.031146-0; Li H, 2008, GENOME RES, V18, P1851, DOI 10.1101/gr.078212.108; Luo H, 2011, ANN APPL BIOL, V159, P339, DOI 10.1111/j.1744-7348.2011.00496.x; Ma MJ, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024758; Margis R, 2006, FEBS LETT, V580, P2442, DOI 10.1016/j.febslet.2006.03.072; MATTHEWS REF, 1993, DIAGNOSIS PLANT VIRU; Matzke MA, 2005, NAT REV GENET, V6, P24, DOI 10.1038/nrg1500; McGavin WJ, 2012, J GEN VIROL, V93, P430, DOI 10.1099/vir.0.037937-0; Mielke N, 2007, J GEN VIROL, V88, P1337, DOI 10.1099/vir.0.82715-0; Mielke-Ehret N, 2010, ARCH VIROL, V155, P987, DOI 10.1007/s00705-010-0667-3; Mossberg B, 1997, NORDISKA FLORAN, P472; Pallett DW, 2010, J VIROL METHODS, V168, P223, DOI 10.1016/j.jviromet.2010.06.003; Pantaleo V, 2007, J VIROL, V81, P3797, DOI 10.1128/JVI.02383-06; Pantaleo V, 2010, VIROLOGY, V408, P49, DOI 10.1016/j.virol.2010.09.001; Qi XP, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004971; Qu F, 2010, MOL PLANT MICROBE IN, V23, P1248, DOI 10.1094/MPMI-06-10-0124; Rannali M, 2008, PLANT DIS, V92, P1313, DOI 10.1094/PDIS-92-9-1313; Rannali M, 2009, PLANT DIS, V93, P933, DOI 10.1094/PDIS-93-9-0933; SAITOU N, 1987, MOL BIOL EVOL, V4, P406, DOI 10.1093/oxfordjournals.molbev.a040454; Skare JM, 2006, VIROLOGY, V347, P343, DOI 10.1016/j.virol.2005.11.030; Smith EA, 2011, ENVIRON ENTOMOL, V40, P194, DOI 10.1603/EN10246; Tamura K, 2007, MOL BIOL EVOL, V24, P1596, DOI 10.1093/molbev/msm092; Tugume AK, 2008, PHYTOPATHOLOGY, V98, P640, DOI 10.1094/PHYTO-98-6-0640; Tugume AK, 2010, MOL ECOL, V19, P3139, DOI 10.1111/j.1365-294X.2010.04682.x; Tugume AK, 2010, J GEN VIROL, V91, P1092, DOI 10.1099/vir.0.016089-0; Valkonen JPT, 2010, PLANT DIS, V94, P921, DOI 10.1094/PDIS-94-7-0921B; Voinnet O, 2008, CURR OPIN PLANT BIOL, V11, P464, DOI 10.1016/j.pbi.2008.04.006; Walia JJ, 2009, PLANT DIS, V93, P4, DOI 10.1094/PDIS-93-1-0004; Wu QF, 2010, P NATL ACAD SCI USA, V107, P1606, DOI 10.1073/pnas.0911353107; Xie ZX, 2004, PLOS BIOL, V2, P642, DOI 10.1371/journal.pbio.0020104; Zerbino DR, 2008, GENOME RES, V18, P821, DOI 10.1101/gr.074492.107; Zhang Y, 2011, PHYTOPATHOLOGY, V101, P1081, DOI 10.1094/PHYTO-02-11-0034	64	32	34	0	37	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 17	2012	7	8							e42758	10.1371/journal.pone.0042758	http://dx.doi.org/10.1371/journal.pone.0042758			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	996DG	22912734	Green Published, Green Submitted, gold			2022-12-25	WOS:000308063700020
J	Chung, DWD; Ponts, N; Prudhomme, J; Rodrigues, EM; Le Roch, KG				Chung, Duk-Won D.; Ponts, Nadia; Prudhomme, Jacques; Rodrigues, Elisandra M.; Le Roch, Karine G.			Characterization of the Ubiquitylating Components of the Human Malaria Parasite's Protein Degradation Pathway	PLOS ONE			English	Article							PLASMODIUM-FALCIPARUM; ENDOPLASMIC-RETICULUM; UBIQUITIN-LIGASE; PROTEASOME; MEMBRANE; HOMOLOG; SYSTEM; ER; TRANSFORMATION; DISLOCATION	Ubiquitin-dependent protein degradation within malarial parasites is a burgeoning field of interest due to several encouraging reports of proteasome inhibitors that were able to confer antimalarial activity. Despite the growing interest in the Plasmodium proteasome system, relatively little investigation has been done to actually characterize the parasite degradation machinery. In this report, we provide an initial biological investigation of the ubiquitylating components of the endoplasmic reticulum-associated degradation (ERAD) system, which is a major pathway in targeting misfolded proteins from the ER to the cytosol for proteasome degradation. We are able to show that the ERAD system is essential for parasite survival and that the putative Plasmodium HRD1 (E3 ubiquitin ligase), UBC (E2 ubiquitin conjugating enzyme) and UBA1 (E1 ubiquitin activating enzyme) are able to mediate in vitro ubiquitylation. Furthermore, by using immunofluorescence, we report that Plasmodium HRD1 localizes to the ER membranes, while the Plasmodium UBC and UBA1 localize to the cytosol. In addition, our gene disruption experiments indicate that the Plasmodium HRD1 is likely essential. We have conducted an initial characterization of the ubiquitylating components of the Plasmodium ERAD system, a major pathway for protein degradation and parasite maintenance. In conjunction with promising proteasome inhibitor studies, we explore the possibility of targeting the Plasmodium ERAD system for future bottom-up drug development approaches.	[Chung, Duk-Won D.; Ponts, Nadia; Prudhomme, Jacques; Rodrigues, Elisandra M.; Le Roch, Karine G.] Univ Calif Riverside, Dept Cell Biol & Neurosci, Riverside, CA 92521 USA; [Ponts, Nadia] INRA, MycSA UR 1264, F-33883 Villenave Dornon, France	University of California System; University of California Riverside; INRAE	Chung, DWD (corresponding author), Univ Calif Riverside, Dept Cell Biol & Neurosci, Riverside, CA 92521 USA.	karine.leroch@ucr.edu	Rodrigues, Elisandra/K-5980-2012	Rodrigues, Elisandra/0000-0002-1609-2507	University of California, Riverside; Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES) [374808-1/2009]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI085077] Funding Source: NIH RePORTER	University of California, Riverside(University of California System); Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES)(Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This study was funded by the startup funds provided by the University of California, Riverside. Dr. Rodrigues was supported by a postdoctoral fellowship from the Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES, contract no. 374808-1/2009). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bagola K, 2011, BBA-BIOMEMBRANES, V1808, P925, DOI 10.1016/j.bbamem.2010.06.025; Bendtsen JD, 2004, J MOL BIOL, V340, P783, DOI 10.1016/j.jmb.2004.05.028; Carvalho P, 2006, CELL, V126, P361, DOI 10.1016/j.cell.2006.05.043; Certad G, 1999, EXP PARASITOL, V93, P123, DOI 10.1006/expr.1999.4442; Chung Duk-Won Doug, 2010, Infectious Disorders - Drug Targets, V10, P158; Cross BCS, 2009, J CELL SCI, V122, P4393, DOI 10.1242/jcs.054494; Deitsch KW, 2001, NUCLEIC ACIDS RES, V29, P850, DOI 10.1093/nar/29.3.850; Deshaies RJ, 2009, ANNU REV BIOCHEM, V78, P399, DOI 10.1146/annurev.biochem.78.101807.093809; Dick LR, 1996, J BIOL CHEM, V271, P7273, DOI 10.1074/jbc.271.13.7273; Edelmann MJ, 2011, EXPERT REV MOL MED, V13, DOI 10.1017/S1462399411002031; Edgar RC, 2004, NUCLEIC ACIDS RES, V32, P1792, DOI 10.1093/nar/gkh340; Fidock DA, 1997, P NATL ACAD SCI USA, V94, P10931, DOI 10.1073/pnas.94.20.10931; Garcia LS, 2010, CLIN LAB MED, V30, P93, DOI 10.1016/j.cll.2009.10.001; Gardner MJ, 2002, NATURE, V419, P498, DOI 10.1038/nature01097; Gardner RG, 2000, J CELL BIOL, V151, P69, DOI 10.1083/jcb.151.1.69; Hassink G, 2005, BIOCHEM J, V388, P647, DOI 10.1042/BJ20041241; Hempel F, 2010, MOL MICROBIOL, V76, P793, DOI 10.1111/j.1365-2958.2010.07142.x; Hershko A, 1998, ANNU REV BIOCHEM, V67, P425, DOI 10.1146/annurev.biochem.67.1.425; Hunter S, 2009, NUCLEIC ACIDS RES, V37, pD211, DOI 10.1093/nar/gkn785; Klemba M, 2005, MOL BIOCHEM PARASIT, V143, P183, DOI 10.1016/j.molbiopara.2005.05.015; Kreidenweiss A, 2008, MALARIA J, V7, DOI 10.1186/1475-2875-7-187; Laney JD, 1999, CELL, V97, P427, DOI 10.1016/S0092-8674(00)80752-7; Le Roch KG, 2003, SCIENCE, V301, P1503, DOI 10.1126/science.1087025; Li GD, 2000, INT J PARASITOL, V30, P729, DOI 10.1016/S0020-7519(00)00046-1; Lindenthal C, 2005, PARASITOLOGY, V131, P37, DOI 10.1017/S003118200500747X; Maier AG, 2006, MOL BIOCHEM PARASIT, V150, P118, DOI 10.1016/j.molbiopara.2006.06.014; McKibbin C, 2012, BIOCHEM J, V442, P639, DOI 10.1042/BJ20111220; Melen K, 2003, J MOL BIOL, V327, P735, DOI 10.1016/S0022-2836(03)00182-7; Melikova M, 2005, CELL BIOL INT; Mueller B, 2006, J CELL BIOL, V175, P261, DOI 10.1083/jcb.200605196; Pickart CM, 2004, CELL, V116, P181, DOI 10.1016/S0092-8674(03)01074-2; Ponts N, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002386; Prudhomme J, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002335; Ramasamy G, 2007, MOL BIOCHEM PARASIT, V152, P139, DOI 10.1016/j.molbiopara.2007.01.002; Reynolds Jennifer M, 2007, BMC Clin Pharmacol, V7, P13, DOI 10.1186/1472-6904-7-13; Saha MN, 2010, CANCER BIOL THER, V9, P936, DOI 10.4161/cbt.9.11.11882; Sato BK, 2009, MOL CELL, V34, P212, DOI 10.1016/j.molcel.2009.03.010; Smith MH, 2011, SCIENCE, V334, P1086, DOI 10.1126/science.1209235; Sommer MS, 2007, MOL BIOL EVOL, V24, P918, DOI 10.1093/molbev/msm008; Spork S, 2009, EUKARYOT CELL, V8, P1134, DOI 10.1128/EC.00083-09; St-Pierre P, 2012, J CELL SCI; Stagg HR, 2009, J CELL BIOL, V186, P685, DOI 10.1083/jcb.200906110; Tcherpakov M, 2009, J BIOL CHEM, V284, P12099, DOI 10.1074/jbc.M808222200; van Vugt M, 2011, FUTURE MICROBIOL, V6, P1485, DOI [10.2217/fmb.11.138, 10.2217/FMB.11.138]; Wenzel DM, 2012, BMC BIOL, V10, DOI 10.1186/1741-7007-10-24; Xie W, 2010, SEMIN CELL DEV BIOL, V21, P533, DOI 10.1016/j.semcdb.2010.02.007; Xu GW, 2010, BLOOD, V115, P2251, DOI 10.1182/blood-2009-07-231191; Yoo SJ, 1996, J BIOL CHEM, V271, P14035, DOI 10.1074/jbc.271.24.14035	48	24	25	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 17	2012	7	8							e43477	10.1371/journal.pone.0043477	http://dx.doi.org/10.1371/journal.pone.0043477			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	996DG	22912882	Green Published, Green Submitted, gold			2022-12-25	WOS:000308063700110
J	Hanlon, SM; Kerby, JL; Parris, MJ				Hanlon, Shane M.; Kerby, Jacob L.; Parris, Matthew J.			Unlikely Remedy: Fungicide Clears Infection from Pathogenic Fungus in Larval Southern Leopard Frogs (Lithobates sphenocephalus)	PLOS ONE			English	Article							CORTICOTROPIN-RELEASING HORMONE; BATRACHOCHYTRIUM-DENDROBATIDIS; METHYL THIOPHANATE; GENE-EXPRESSION; CHYTRID FUNGUS; THYROID-GLAND; CHYTRIDIOMYCOSIS; METAMORPHOSIS; STRESS; INSECTICIDE	Amphibians are often exposed to a wide variety of perturbations. Two of these, pesticides and pathogens, are linked to declines in both amphibian health and population viability. Many studies have examined the separate effects of such perturbations; however, few have examined the effects of simultaneous exposure of both to amphibians. In this study, we exposed larval southern leopard frog tadpoles (Lithobates sphenocephalus) to the chytrid fungus Batrachochytrium dendrobatidis and the fungicide thiophanate-methyl (TM) at 0.6 mg/L under laboratory conditions. The experiment was continued until all larvae completed metamorphosis or died. Overall, TM facilitated increases in tadpole mass and length. Additionally, individuals exposed to both TM and Bd were heavier and larger, compared to all other treatments. TM also cleared Bd in infected larvae. We conclude that TM affects larval anurans to facilitate growth and development while clearing Bd infection. Our findings highlight the need for more research into multiple perturbations, specifically pesticides and disease, to further promote amphibian heath.	[Hanlon, Shane M.; Parris, Matthew J.] Univ Memphis, Dept Biol Sci, Memphis, TN 38152 USA; [Kerby, Jacob L.] Univ S Dakota, Dept Biol, Vermillion, SD 57069 USA	University of Memphis; University of South Dakota	Hanlon, SM (corresponding author), Univ Memphis, Dept Biol Sci, Memphis, TN 38152 USA.	shanlon1@memphis.edu		Hanlon, Shane/0000-0002-4296-9069	NSF [MRI 0923419]	NSF(National Science Foundation (NSF))	Bd analyses were conducted on equipment supplied by NSF grant MRI 0923419. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALFORD RA, 1988, AM NAT, V131, P91, DOI 10.1086/284775; Belden LK, 2003, FUNCT ECOL, V17, P409, DOI 10.1046/j.1365-2435.2003.00746.x; BENDER J, 1994, FUTURE HARVEST PESTI; Berger L, 1998, P NATL ACAD SCI USA, V95, P9031, DOI 10.1073/pnas.95.15.9031; Bishop P, 2008, CROP SCI, V48, P1615, DOI 10.2135/cropsci2007.11.0635sc; Boone MD, 2003, OECOLOGIA, V137, P610, DOI 10.1007/s00442-003-1394-1; Boone MD, 2003, ECOL APPL, V13, P829, DOI 10.1890/1051-0761(2003)013[0829:IOAIHA]2.0.CO;2; Boone MD, 2002, ECOL APPL, V12, P307, DOI 10.1890/1051-0761(2002)012[0307:IOAIWC]2.0.CO;2; Boyle DG, 2004, DIS AQUAT ORGAN, V60, P141, DOI 10.3354/dao060141; Brande-Lavridsen N., 2010, OPEN ZOOLOGY J, V3, P7, DOI [DOI 10.2174/1874336601003010007, DOI 10.2174/1874336601003020007]; Capaldo A, 2006, COMP BIOCHEM PHYS C, V143, P86, DOI 10.1016/j.cbpc.2005.12.005; Cheek AO, 1999, ARCH ENVIRON CON TOX, V37, P70, DOI 10.1007/s002449900491; Clements W. H., 2002, COMMUNITY ECOTOXICOL; Colautti RI, 2004, ECOL LETT, V7, P721, DOI 10.1111/j.1461-0248.2004.00616.x; Collins J.P., 2009, EXTINCTION OUR TIMES; Crump D, 2002, ENVIRON HEALTH PERSP, V110, P1199, DOI 10.1289/ehp.021101199; Daszak P, 2003, DIVERS DISTRIB, V9, P141, DOI 10.1046/j.1472-4642.2003.00016.x; De Falco M, 2007, ARCH ENVIRON CON TOX, V53, P241, DOI 10.1007/s00244-006-0204-2; Denver RJ, 1997, HORM BEHAV, V31, P169, DOI 10.1006/hbeh.1997.1383; Denver RJ, 1999, ANN NY ACAD SCI, V897, P46, DOI 10.1111/j.1749-6632.1999.tb07877.x; Fellers GM, 2001, COPEIA, P945, DOI 10.1643/0045-8511(2001)001[0945:OCITMY]2.0.CO;2; Fort DJ, 2011, TOXICOL SCI, V121, P292, DOI 10.1093/toxsci/kfr069; Gahl MK, 2011, ECOL APPL, V21, P2521, DOI 10.1890/10-2319.1; Garner TWJ, 2009, OIKOS, V118, P783, DOI 10.1111/j.1600-0706.2008.17202.x; Gilliam R, 2006, 1291 US GEOL SURV, P172; Gosner K. L., 1960, Herpetologica, V16, P183; Hanlon SM, 2012, ARCH ENVIRON CON TOX, V63, P137, DOI 10.1007/s00244-011-9744-1; HAYES TB, 1995, J EXP ZOOL, V271, P103, DOI 10.1002/jez.1402710205; Hayes TB, 2006, ENVIRON HEALTH PERSP, V114, P40, DOI 10.1289/ehp.8051; Howe GE, 1998, ENVIRON TOXICOL CHEM, V17, P519, DOI [10.1002/etc.5620170324, 10.1897/1551-5028(1998)017&lt;0519:EOCSAL&gt;2.3.CO;2]; Huang HC, 2001, P NATL ACAD SCI USA, V98, P7348, DOI 10.1073/pnas.131198998; Hyatt AD, 2007, DIS AQUAT ORGAN, V73, P175, DOI 10.3354/dao073175; Johnson ML, 2003, EMERG INFECT DIS, V9, P922; Johnson ML, 2003, DIS AQUAT ORGAN, V57, P255, DOI 10.3354/dao057255; Jones DK, 2010, ENVIRON TOXICOL CHEM, V29, P2016, DOI 10.1002/etc.240; KIKUYAMA S, 1993, INT REV CYTOL, V145, P105, DOI 10.1016/S0074-7696(08)60426-X; LeNoir JS, 1999, ENVIRON TOXICOL CHEM, V18, P2715, DOI [10.1002/etc.5620181210, 10.1897/1551-5028(1999)018&lt;2715:STOCUP&gt;2.3.CO;2]; Longcore JE, 1999, MYCOLOGIA, V91, P219, DOI 10.2307/3761366; Martel A, 2011, MED MYCOL, V49, P143, DOI 10.3109/13693786.2010.508185; Matthews G. A, 1992, PESTICIDE APPL METHO, V2; McDiarmid R. W., 1999, TADPOLES BIOL ANURAN; NEWMAN RA, 1988, EVOLUTION, V42, P774, DOI 10.1111/j.1558-5646.1988.tb02495.x; Norris L. A., 1983, PW149 USDA FOR SERV; Parris MJ, 2004, ECOLOGY, V85, P3385, DOI 10.1890/04-0383; Parris MJ, 2006, CAN J ZOOL, V84, P58, DOI 10.1139/Z05-175; Parris MJ, 2004, COPEIA, P344, DOI 10.1643/CE-03-116R1; Payne NJ, 1998, CROP PROT, V17, P171, DOI 10.1016/S0261-2194(97)00092-6; Pessier AP, 1999, J VET DIAGN INVEST, V11, P194, DOI 10.1177/104063879901100219; Relyea RA, 2001, P NATL ACAD SCI USA, V98, P2491, DOI 10.1073/pnas.031076198; Relyea RA, 2008, ECOL APPL, V18, P1728, DOI 10.1890/08-0454.1; Rohr JR, 2009, OECOLOGIA, V159, P447, DOI 10.1007/s00442-008-1208-6; Rolland-Cachera MF, 2006, INT J OBESITY, V30, pS11, DOI 10.1038/sj.ijo.0803514; Rose CS, 2005, TRENDS ECOL EVOL, V20, P129, DOI 10.1016/j.tree.2005.01.005; Sadeh A, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0015602; Schmidt BR, 2009, AMPHIBIA-REPTILIA, V30, P313, DOI 10.1163/156853809788795245; Sciarrillo R, 2008, ARCH ENVIRON CON TOX, V55, P254, DOI 10.1007/s00244-007-9116-z; Semlitsch RD, 2000, OECOLOGIA, V125, P179, DOI 10.1007/s004420000443; Smith KG, 2007, DIS AQUAT ORGAN, V74, P159, DOI 10.3354/dao074159; Sparling DW, 2009, ENVIRON TOXICOL CHEM, V28, P1696, DOI 10.1897/08-336.1; Sparling DW, 2010, ECOTOXICOLOGY OF AMPHIBIANS AND REPTILES, SECOND EDITION, P1, DOI 10.1201/EBK1420064162; Steiner UK, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006160; Summermatter S, 2008, FASEB J, V22, P774, DOI 10.1096/fj.07-8972com; THOMAS TH, 1974, ANN APPL BIOL, V76, P237, DOI 10.1111/j.1744-7348.1974.tb07977.x; Van Buskirk J, 1998, BIOL J LINN SOC, V65, P301, DOI 10.1006/bijl.1998.0249; Veldhoen N, 2006, AQUAT TOXICOL, V80, P217, DOI 10.1016/j.aquatox.2006.08.010; Venesky MD, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024991; Venesky MD, 2009, ECOHEALTH, V6, P565, DOI 10.1007/s10393-009-0272-7; Venesky MD, 2010, J PARASITOL, V96, P552, DOI 10.1645/GE-2353.1; Vredenburg VT, 2010, P NATL ACAD SCI USA, V107, P9689, DOI 10.1073/pnas.0914111107; Webb R, 2005, DIS AQUAT ORGAN, V68, P89, DOI 10.3354/dao068089; Wilson GWT, 2008, MYCOLOGIA, V100, P548, DOI 10.3852/08-024R; Yoon CS, 2008, ENVIRON TOXICOL, V23, P131, DOI 10.1002/tox.20338	72	28	29	1	47	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 17	2012	7	8							e43573	10.1371/journal.pone.0043573	http://dx.doi.org/10.1371/journal.pone.0043573			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	996DG	22912890	Green Published, Green Submitted, gold			2022-12-25	WOS:000308063700118
J	Hu, J; Yao, HJ; Gan, F; Tokarski, A; Wang, YM				Hu, Jing; Yao, Hongjie; Gan, Fei; Tokarski, Anthony; Wang, Yanming			Interaction of OKL38 and p53 in Regulating Mitochondrial Structure and Function	PLOS ONE			English	Article							GROWTH INHIBITOR; EXPRESSION; GENE; ACTIVATION; MEDIATOR; CELLS; PHOSPHORYLATION; UBIQUITINATION; POLYMORPHISM; FISSION	The tumor suppressor p53 is a well-known transcription factor controlling the expression of its target genes involved in cell cycle and apoptosis. In addition, p53 also plays a direct proapoptotic role in mitochondria by regulating cytochrome c release. Recently, we identified a novel downstream target of p53, OKL38, which relocalizes from nucleus to mitochondria upon forced expression to induce apoptosis. However, the mechanism underlying OKL38 targeting to mitochondria and apoptosis induction remains unclear. Here, we found that OKL38 interacts with p53 to regulate mitochondria function. After DNA damage, OKL38 colocalizes with p53 to mitochondria in U2OS cells. Further, p53 and OKL38 are targeted to mitochondria in synergy: forced expression of OKL38 leads to p53 localization to mitochondria while the expression of a mitochondria enriched p53 polymorphic variant, p53(R72), leads to OKL38 enrichment in mitochondria. Biochemical analyses found that OKL38 and p53 interact in vivo and in vitro via multiple domains. In cell biological assays, multiple regions of OKL38 mediate its mitochondria localization and induce mitochondria morphology changes. OKL38 induces formation of megamitochondria and increases cellular levels of reactive oxygen species. Furthermore, OKL38 induces cytochrome c release upon incubation with mitochondria. Taken together, our studies suggest that OKL38 regulates mitochondria morphology and functions during apoptosis together with p53.	[Hu, Jing; Yao, Hongjie; Gan, Fei; Tokarski, Anthony; Wang, Yanming] Penn State Univ, Dept Biochem & Mol Biol, Ctr Eukaryot Gene Regulat, University Pk, PA 16802 USA	Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Pennsylvania State University - University Park	Hu, J (corresponding author), Penn State Univ, Dept Biochem & Mol Biol, Ctr Eukaryot Gene Regulat, University Pk, PA 16802 USA.	yuw12@psu.edu	Gan, Fei/I-8599-2017	Wang, Yanming/0000-0002-0710-043X	PSU; TSF seed grant award; NIH [CA136856]; NATIONAL CANCER INSTITUTE [R01CA136856] Funding Source: NIH RePORTER	PSU; TSF seed grant award; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	Research is supported in part by a startup fund from PSU, a TSF seed grant award, and NIH R01 grant CA136856 to YW. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. No additional external funding received for this study.	An W, 2004, CELL, V117, P735, DOI 10.1016/j.cell.2004.05.009; BECKMAN G, 1994, HUM HERED, V44, P266, DOI 10.1159/000154228; Brooks CL, 2004, CELL CYCLE, V3, P895; Brooks CL, 2003, CURR OPIN CELL BIOL, V15, P164, DOI 10.1016/S0955-0674(03)00003-6; Chipuk JE, 2004, SCIENCE, V303, P1010, DOI 10.1126/science.1092734; Dumont P, 2003, NAT GENET, V33, P357, DOI 10.1038/ng1093; ELDEIRY WS, 1993, CELL, V75, P817, DOI 10.1016/0092-8674(93)90500-P; Green DR, 2009, NATURE, V458, P1127, DOI 10.1038/nature07986; Han MK, 2008, CELL STEM CELL, V2, P241, DOI 10.1016/j.stem.2008.01.002; Hu WW, 2007, NATURE, V450, P721, DOI 10.1038/nature05993; Hu WW, 2007, CANCER RES, V67, P2757, DOI 10.1158/0008-5472.CAN-06-2656; Huang J, 2007, NATURE, V449, P105, DOI 10.1038/nature06092; Huynh H, 2001, ENDOCRINOLOGY, V142, P3607, DOI 10.1210/en.142.8.3607; Jeong SY, 2008, BMB REP, V41, P11, DOI 10.1146/annurev-genet-102108-134850; Jin Y, 2000, J CELL BIOL, V149, P1005, DOI 10.1083/jcb.149.5.1005; Kitayner M, 2006, MOL CELL, V22, P741, DOI 10.1016/j.molcel.2006.05.015; Laptenko O, 2006, CELL DEATH DIFFER, V13, P951, DOI 10.1038/sj.cdd.4401916; Leu JIJ, 2004, NAT CELL BIOL, V6, P443, DOI 10.1038/ncb1123; Li PX, 2008, MOL CELL BIOL, V28, P4745, DOI 10.1128/MCB.01747-07; Li RS, 2007, J LIPID RES, V48, P709, DOI 10.1194/jlr.M600501-JLR200; Li SD, 2012, P NATL ACAD SCI USA, V109, P185, DOI 10.1073/pnas.1118560109; Luo X, 1998, CELL, V94, P481, DOI 10.1016/S0092-8674(00)81589-5; Maiuri MC, 2009, CELL CYCLE, V8, P1571, DOI 10.4161/cc.8.10.8498; Mihara M, 2003, MOL CELL, V11, P577, DOI 10.1016/S1097-2765(03)00050-9; Murphy ME, 2004, CELL CYCLE, V3, P836; Nunnari J, 2012, CELL, V148, P1145, DOI 10.1016/j.cell.2012.02.035; Oda E, 2000, SCIENCE, V288, P1053, DOI 10.1126/science.288.5468.1053; Ong CK, 2007, ONCOGENE, V26, P1155, DOI 10.1038/sj.onc.1209896; Ong CK, 2004, J BIOL CHEM, V279, P743, DOI 10.1074/jbc.M308668200; Parone PA, 2006, MOL CELL BIOL, V26, P7397, DOI 10.1128/MCB.02282-05; Riley T, 2008, NAT REV MOL CELL BIO, V9, P402, DOI 10.1038/nrm2395; Romanoski CE, 2011, CIRC RES, V109, pE27, DOI 10.1161/CIRCRESAHA.111.241869; SELVAKUMARAN M, 1994, ONCOGENE, V9, P1791; Shieh SY, 1997, CELL, V91, P325, DOI 10.1016/S0092-8674(00)80416-X; Vogelstein B, 2000, NATURE, V408, P307, DOI 10.1038/35042675; Wakabayashi T, 2002, J CELL MOL MED, V6, P497, DOI 10.1111/j.1582-4934.2002.tb00452.x; Wang T, 2005, J BIOL CHEM, V280, P4374, DOI 10.1074/jbc.M408708200; Yao HJ, 2008, J BIOL CHEM, V283, P20060, DOI 10.1074/jbc.M802940200; Youle RJ, 2005, NAT REV MOL CELL BIO, V6, P657, DOI 10.1038/nrm1697	39	25	25	3	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 17	2012	7	8							e43362	10.1371/journal.pone.0043362	http://dx.doi.org/10.1371/journal.pone.0043362			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	996DG	22912861	Green Submitted, gold, Green Published			2022-12-25	WOS:000308063700089
J	Li, YZ; Naveed, H; Kachalo, S; Xu, LX; Liang, J				Li, Yingzi; Naveed, Hammad; Kachalo, Sema; Xu, Lisa X.; Liang, Jie			Mechanisms of Regulating Cell Topology in Proliferating Epithelia: Impact of Division Plane, Mechanical Forces, and Cell Memory	PLOS ONE			English	Article							SPINDLE ORIENTATION; PATTERN-FORMATION; MITOTIC SPINDLE; CANCER; SHAPE; MORPHOGENESIS; INVASION; POLARITY; MODEL; SIZE	Regulation of cell growth and cell division has a fundamental role in tissue formation, organ development, and cancer progression. Remarkable similarities in the topological distributions were found in a variety of proliferating epithelia in both animals and plants. At the same time, there are species with significantly varied frequency of hexagonal cells. Moreover, local topology has been shown to be disturbed on the boundary between proliferating and quiescent cells, where cells have fewer sides than natural proliferating epithelia. The mechanisms of regulating these topological changes remain poorly understood. In this study, we use a mechanical model to examine the effects of orientation of division plane, differential proliferation, and mechanical forces on animal epithelial cells. We find that regardless of orientation of division plane, our model can reproduce the commonly observed topological distributions of cells in natural proliferating animal epithelia with the consideration of cell rearrangements. In addition, with different schemes of division plane, we are able to generate different frequency of hexagonal cells, which is consistent with experimental observations. In proliferating cells interfacing quiescent cells, our results show that differential proliferation alone is insufficient to reproduce the local changes in cell topology. Rather, increased tension on the boundary, in conjunction with differential proliferation, can reproduce the observed topological changes. We conclude that both division plane orientation and mechanical forces play important roles in cell topology in animal proliferating epithelia. Moreover, cell memory is also essential for generating specific topological distributions.	[Li, Yingzi; Xu, Lisa X.] Shanghai Jiao Tong Univ, Sch Biomed Engn, Shanghai 200030, Peoples R China; [Li, Yingzi; Xu, Lisa X.] Shanghai Jiao Tong Univ, Med X Res Inst, Shanghai 200030, Peoples R China; [Li, Yingzi; Naveed, Hammad; Kachalo, Sema; Liang, Jie] Univ Illinois, Dept Bioengn, Chicago, IL USA; [Xu, Lisa X.; Liang, Jie] Shanghai Jiao Tong Univ, Shanghai Ctr Syst Biomed, Minist Educ, Shanghai 200030, Peoples R China	Shanghai Jiao Tong University; Shanghai Jiao Tong University; University of Illinois System; University of Illinois Chicago; University of Illinois Chicago Hospital; Shanghai Jiao Tong University	Li, YZ (corresponding author), Shanghai Jiao Tong Univ, Sch Biomed Engn, Shanghai 200030, Peoples R China.	jliang@uic.edu	Naveed, Hammad/N-8851-2013	Naveed, Hammad/0000-0002-1867-974X	National Institutes of Health [GM079804, GM086145]; National Science Foundation [DBI 1062328, DMS-0800257]; China Scholarship Council; Fulbright Fellowship; Higher Education Commission of Pakistan; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P50GM086145, R01GM079804] Funding Source: NIH RePORTER; Direct For Biological Sciences [1062328] Funding Source: National Science Foundation; Division Of Mathematical Sciences [0800257] Funding Source: National Science Foundation	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Science Foundation(National Science Foundation (NSF)); China Scholarship Council(China Scholarship Council); Fulbright Fellowship; Higher Education Commission of Pakistan(Higher Education Commission of Pakistan); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); Direct For Biological Sciences(National Science Foundation (NSF)NSF - Directorate for Biological Sciences (BIO)); Division Of Mathematical Sciences(National Science Foundation (NSF)NSF - Directorate for Mathematical & Physical Sciences (MPS))	This work is supported by National Institutes of Health Grants GM079804 and GM086145 (http://www.nih.gov), National Science Foundation Grant DBI 1062328 and DMS-0800257 (http://www.nsf.gov). Y.L. was supported by the China Scholarship Council. H.N. was supported by the Fulbright Fellowship and the Higher Education Commission of Pakistan. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aegerter-Wilmsen T, 2007, MECH DEVELOP, V124, P318, DOI 10.1016/j.mod.2006.12.005; Aegerter-Wilmsen T, 2010, DEVELOPMENT, V137, P499, DOI 10.1242/dev.041731; Affolter M, 2007, NAT REV GENET, V8, P663, DOI 10.1038/nrg2166; Aigouy B, 2010, CELL, V142, P773, DOI 10.1016/j.cell.2010.07.042; Anderson ARA, 2005, MATH MED BIOL, V22, P163, DOI 10.1093/imammb/dqi005; Axelrod JD, 2006, CELL, V126, P643, DOI 10.1016/j.cell.2006.07.018; Baena-Lopez LA, 2005, CURR BIOL, V15, P1640, DOI 10.1016/j.cub.2005.07.062; Besson S, 2011, P NATL ACAD SCI USA, V108, P6294, DOI 10.1073/pnas.1011866108; Bhowmick NA, 2004, NATURE, V432, P332, DOI 10.1038/nature03096; Brodland GW, 2002, J BIOMECH, V35, P673, DOI 10.1016/S0021-9290(02)00006-4; Burrill DR, 2010, CELL, V140, P13, DOI 10.1016/j.cell.2009.12.034; Cao YF, 2010, P NATL ACAD SCI USA, V107, P18445, DOI 10.1073/pnas.1001455107; Classen AK, 2005, DEV CELL, V9, P805, DOI 10.1016/j.devcel.2005.10.016; den Elzen N, 2009, MOL BIOL CELL, V20, P3740, DOI 10.1091/mbc.E09-01-0023; Dubertret B, 1998, PHYS REV E, V58, P6368, DOI 10.1103/PhysRevE.58.6368; Dubertret B, 1997, BIOPHYS J, V73, P38, DOI 10.1016/S0006-3495(97)78045-7; Dumais J, 2007, CURR OPIN PLANT BIOL, V10, P58, DOI 10.1016/j.pbi.2006.11.014; Farhadifar R, 2007, CURR BIOL, V17, P2095, DOI 10.1016/j.cub.2007.11.049; Feldman JL, 2007, PLOS BIOL, V5, P1284, DOI [10.1371/journal.pbio.0050149, 10.1371/journal.pbio.0050286]; Fleming ES, 2007, J HISTOCHEM CYTOCHEM, V55, P1173, DOI 10.1369/jhc.7A7234.2007; Gibson MC, 2006, NATURE, V442, P1038, DOI 10.1038/nature05014; Gibson WT, 2011, CELL, V144, P427, DOI 10.1016/j.cell.2010.12.035; Gibson WT, 2009, CURR TOP DEV BIOL, V89, P87, DOI 10.1016/S0070-2153(09)89004-2; Gong Y, 2004, NATURE, V430, P689, DOI 10.1038/nature02796; Hanahan D, 2000, CELL, V100, P57, DOI 10.1016/S0092-8674(00)81683-9; Hanahan D, 2011, CELL, V144, P646, DOI 10.1016/j.cell.2011.02.013; HONDA H, 1978, J THEOR BIOL, V72, P523, DOI 10.1016/0022-5193(78)90315-6; Hufnagel L, 2007, P NATL ACAD SCI USA, V104, P3835, DOI 10.1073/pnas.0607134104; Ingber DE, 2005, P NATL ACAD SCI USA, V102, P11571, DOI 10.1073/pnas.0505939102; Ingber DE, 2002, DIFFERENTIATION, V70, P547, DOI 10.1046/j.1432-0436.2002.700908.x; Ingber DE, 2003, J CELL SCI, V116, P1157, DOI 10.1242/jcs.00359; Jiao Y, 2011, PLOS COMPUT BIOL, V7, DOI 10.1371/journal.pcbi.1002314; KORN RW, 1973, NEW PHYTOL, V72, P1357, DOI 10.1111/j.1469-8137.1973.tb02114.x; Kumar S, 2009, CANCER METAST REV, V28, P113, DOI 10.1007/s10555-008-9173-4; Lewis FT, 1926, ANAT REC, V33, P331, DOI 10.1002/ar.1090330502; Lewis FT, 1928, ANAT REC, V38, P341, DOI 10.1002/ar.1090380305; Li YZ, 2011, IEEE ENG MED BIO, P178, DOI 10.1109/IEMBS.2011.6089923; Martinand-Mari C, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004202; Nagpal R, 2008, BIOESSAYS, V30, P260, DOI 10.1002/bies.20722; Naveed H, 2010, IEEE ENG MED BIO, P3808, DOI 10.1109/IEMBS.2010.5627601; Nienhaus U, 2009, MECH DEVELOP, V126, P942, DOI 10.1016/j.mod.2009.09.002; OSTER GF, 1987, J CELL SCI, P35; Patel AB, 2009, PLOS COMPUT BIOL, V5, DOI 10.1371/journal.pcbi.1000412; Sahlin P, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011750; Schwank G, 2010, CSH PERSPECT BIOL, V2, DOI 10.1101/cshperspect.a001669; Segalen M, 2009, SEMIN CELL DEV BIOL, V20, P972, DOI 10.1016/j.semcdb.2009.03.018; SHIMIZU H, 1995, DEV DYNAM, V204, P349, DOI 10.1002/aja.1002040402; Shraiman BI, 2005, P NATL ACAD SCI USA, V102, P3318, DOI 10.1073/pnas.0404782102; Staple DB, 2010, EUR PHYS J E, V33, P117, DOI 10.1140/epje/i2010-10677-0; Strauss B, 2006, DEVELOPMENT, V133, P3883, DOI 10.1242/dev.02578; Takeichi M, 1993, CURR OPIN CELL BIOL, V5, P806, DOI 10.1016/0955-0674(93)90029-P; Thery M, 2007, NATURE, V447, P493, DOI 10.1038/nature05786; Turner S, 2002, J THEOR BIOL, V216, P85, DOI 10.1006/jtbi.2001.2522; Wakatsuki T, 2000, BIOPHYS J, V79, P2353, DOI 10.1016/S0006-3495(00)76481-2; WELIKY M, 1990, DEVELOPMENT, V109, P373; Westermann S, 2003, NAT REV MOL CELL BIO, V4, P938, DOI 10.1038/nrm1260; Yarden Y, 2001, EUR J CANCER, V37, pS3; Zallen JA, 2004, J PHYS-CONDENS MAT, V16, pS5073, DOI 10.1088/0953-8984/16/44/005	58	20	21	1	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 17	2012	7	8							e43108	10.1371/journal.pone.0043108	http://dx.doi.org/10.1371/journal.pone.0043108			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	996DG	22912800	Green Published, gold, Green Submitted			2022-12-25	WOS:000308063700043
J	Maybeno, M; Redeker, A; Welten, SPM; Peters, B; Loughhead, SM; Schoenberger, SP; Sette, A; Arens, R				Maybeno, Matt; Redeker, Anke; Welten, Suzanne P. M.; Peters, Bjoern; Loughhead, Scott M.; Schoenberger, Stephen P.; Sette, Alessandro; Arens, Ramon			Polyfunctional CD4(+) T Cell Responses to Immunodominant Epitopes Correlate with Disease Activity of Virulent Salmonella	PLOS ONE			English	Article							SEROVAR TYPHIMURIUM INFECTION; INNATE IMMUNE ACTIVATION; COMPLETE GENOME SEQUENCE; MURINE HOST PROTECTION; TYPHOID-FEVER; VACCINE DEVELOPMENT; GLOBAL BURDEN; CUTTING EDGE; IFN-GAMMA; IN-VIVO	Salmonella enterica serovars are intracellular bacteria capable of causing typhoid fever and gastroenteritis of significant morbidity and mortality worldwide. Current prophylactic and therapeutic treatment is hampered by the emergence of multidrug-resistant (MDR) strains of Salmonella, and vaccines provide only temporal and partial protection in vaccinees. To develop more effective Salmonella vaccines, it is important to understand the development of protective adaptive immunity to virulent Salmonella. Here we report the identification of novel CD4(+) T cell peptide epitopes, which are conserved among Salmonella serovars. Immunization of Salmonella-infected mice with these peptide epitopes reduces the burden of Salmonella disease. Furthermore, we show that distinct polyfunctional (interferon-gamma(+), tumor necrosis factor(+), and interleukin-2(+)) Salmonella-specific CD4(+) T cell responses develop with respect to magnitude and kinetics. Moreover, we found that CD4(+) T cell responses against immunodominant epitopes are predictive for active Salmonella disease. Collectively, these data could contribute to improved diagnosis of Salmonella-related diseases and rational design of Salmonella vaccines.	[Maybeno, Matt; Peters, Bjoern; Sette, Alessandro] La Jolla Inst Allergy & Immunol, Div Vaccine Discovery, La Jolla, CA 92037 USA; [Loughhead, Scott M.; Schoenberger, Stephen P.] La Jolla Inst Allergy & Immunol, Cellular Immunol Lab, La Jolla, CA USA; [Redeker, Anke; Welten, Suzanne P. M.; Arens, Ramon] Leiden Univ, Dept Immunohematol & Blood Transfus, Med Ctr, Leiden, Netherlands	La Jolla Institute for Immunology; La Jolla Institute for Immunology; Leiden University; Leiden University Medical Center (LUMC); Leiden University - Excl LUMC	Maybeno, M (corresponding author), La Jolla Inst Allergy & Immunol, Div Vaccine Discovery, La Jolla, CA 92037 USA.	R.Arens@lumc.nl	Arens, Ramon/V-4010-2018; Redeker, Anke/A-1953-2019; Sette, Alessandro/AFO-8916-2022	Arens, Ramon/0000-0001-5058-4110; Redeker, Anke/0000-0002-5832-6332; Welten, Suzanne/0000-0002-8224-7984	Marie Curie Fellowship from the European Commission; U.S. National Institutes of Health	Marie Curie Fellowship from the European Commission; U.S. National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	This work was supported by a Marie Curie Fellowship from the European Commission to R. A. and by grants from the U.S. National Institutes of Health to A.S. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alaniz RC, 2006, J IMMUNOL, V177, P3983, DOI 10.4049/jimmunol.177.6.3983; [Anonymous], 2008, Wkly Epidemiol Rec, V83, P49; Ansong C, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004809; Arens R, 2008, J IMMUNOL, V180, P6472, DOI 10.4049/jimmunol.180.10.6472; Arens R, 2011, J VIROL, V85, P390, DOI 10.1128/JVI.01839-10; Becker D, 2006, NATURE, V440, P303, DOI 10.1038/nature04616; Bergman MA, 2005, INFECT IMMUN, V73, P7226, DOI 10.1128/IAI.73.11.7226-7235.2005; Bobat S, 2011, EUR J IMMUNOL, V41, P1606, DOI 10.1002/eji.201041089; Brien JD, 2008, J IMMUNOL, V181, P8568, DOI 10.4049/jimmunol.181.12.8568; Caccamo N, 2010, EUR J IMMUNOL, V40, P2211, DOI 10.1002/eji.201040455; Chen C, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017712; Cookson BT, 1997, J IMMUNOL, V158, P4310; Crump JA, 2004, B WORLD HEALTH ORGAN, V82, P346; Cummings LA, 2005, J IMMUNOL, V174, P7929, DOI 10.4049/jimmunol.174.12.7929; Darrah PA, 2007, NAT MED, V13, P843, DOI 10.1038/nm1592; ElNewihi HM, 1996, HEPATOLOGY, V24, P516, DOI 10.1002/hep.510240308; Francis KP, 1997, J BACTERIOL, V179, P4046, DOI 10.1128/jb.179.12.4046-4048.1997; Gonzalez-Quintela A, 2004, REV ESP ENFERM DIG, V96, P559; Harari A, 2006, IMMUNOL REV, V211, P236, DOI 10.1111/j.0105-2896.2006.00395.x; Harari A, 2011, NAT MED, V17, P372, DOI 10.1038/nm.2299; Hess J, 1996, J IMMUNOL, V156, P3321; Jackson A, 2010, J IMMUNOL, V185, P6198, DOI 10.4049/jimmunol.1001198; Jellison ER, 2005, J IMMUNOL, V174, P614, DOI 10.4049/jimmunol.174.2.614; Johanns TM, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1001043; JONES BD, 1994, J EXP MED, V180, P15, DOI 10.1084/jem.180.1.15; Jones BD, 1996, ANNU REV IMMUNOL, V14, P533, DOI 10.1146/annurev.immunol.14.1.533; Lee SJ, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002499; LORENTZ K, 1975, CLIN CHIM ACTA, V63, P271, DOI 10.1016/0009-8981(75)90047-9; Majowicz SE, 2010, CLIN INFECT DIS, V50, P882, DOI 10.1086/650733; McClelland M, 2001, NATURE, V413, P852, DOI 10.1038/35101614; McSorley SJ, 2000, J IMMUNOL, V164, P986, DOI 10.4049/jimmunol.164.2.986; Mittrucker HW, 2000, J IMMUNOL, V164, P1648, DOI 10.4049/jimmunol.164.4.1648; Mittrucker HW, 2002, INFECT IMMUN, V70, P199, DOI 10.1128/IAI.70.1.199-203.2002; Mittrucker HW, 2000, J LEUKOCYTE BIOL, V67, P457, DOI 10.1002/jlb.67.4.457; Monack DM, 2004, NAT REV MICROBIOL, V2, P747, DOI 10.1038/nrmicro955; Monack DM, 2004, J EXP MED, V199, P231, DOI 10.1084/jem.20031319; Moutaftsi M, 2007, J IMMUNOL, V178, P6814, DOI 10.4049/jimmunol.178.11.6814; Murphy KM, 2002, NAT REV IMMUNOL, V2, P933, DOI 10.1038/nri954; NAUCIEL C, 1990, J IMMUNOL, V145, P1265; Oseroff C, 2008, J IMMUNOL, V180, P7193, DOI 10.4049/jimmunol.180.11.7193; Parkhill J, 2001, NATURE, V413, P848, DOI 10.1038/35101607; Parry CM, 2002, NEW ENGL J MED, V347, P1770, DOI 10.1056/NEJMra020201; PAUL C, 1985, INFECT IMMUN, V48, P40, DOI 10.1128/IAI.48.1.40-43.1985; PAUL CC, 1988, INFECT IMMUN, V56, P2189, DOI 10.1128/IAI.56.8.2189-2192.1988; Perfetto SP, 2004, NAT REV IMMUNOL, V4, P648, DOI 10.1038/nri1416; Rabsch W, 2001, MICROBES INFECT, V3, P237, DOI 10.1016/S1286-4579(01)01375-2; RichterDahlfors A, 1997, J EXP MED, V186, P569, DOI 10.1084/jem.186.4.569; Robbins SH, 2003, J IMMUNOL, V170, P5876, DOI 10.4049/jimmunol.170.12.5876; Rollenhagen C, 2004, P NATL ACAD SCI USA, V101, P8739, DOI 10.1073/pnas.0401283101; Ross EA, 2011, J IMMUNOL, V187, P1553, DOI 10.4049/jimmunol.1000502; Santos RL, 2001, MICROBES INFECT, V3, P1335, DOI 10.1016/S1286-4579(01)01495-2; Scott P, 2004, IMMUNOL REV, V201, P318, DOI 10.1111/j.0105-2896.2004.00198.x; Seder RA, 2008, NAT REV IMMUNOL, V8, P247, DOI 10.1038/nri2274; Srinivasan A, 2007, J IMMUNOL, V178, P6342, DOI 10.4049/jimmunol.178.10.6342; Taylor PD, 1998, INFECT IMMUN, V66, P3208, DOI 10.1128/IAI.66.7.3208-3217.1998; Vidric M, 2006, INFECT IMMUN, V74, P1050, DOI 10.1128/IAI.74.2.1050-1061.2006; Voehringer D, 2002, BLOOD, V100, P3698, DOI 10.1182/blood-2002-02-0657; Walton SM, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002214; Walzl G, 2011, NAT REV IMMUNOL, V11, P343, DOI 10.1038/nri2960; Wang P, 2008, PLOS COMPUT BIOL, V4, DOI 10.1371/journal.pcbi.1000048; Yauch LE, 2010, J IMMUNOL, V185, P5405, DOI 10.4049/jimmunol.1001709; Zaki SA, 2011, J INFECT DEV COUNTR, V5, P324, DOI 10.3855/jidc.1405; Zhang Q, 2008, NUCLEIC ACIDS RES, V36, pW513, DOI 10.1093/nar/gkn254	63	20	22	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 17	2012	7	8							e43481	10.1371/journal.pone.0043481	http://dx.doi.org/10.1371/journal.pone.0043481			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	996DG	22912884	Green Published, gold, Green Submitted			2022-12-25	WOS:000308063700112
J	Qiao, HJ; Lin, CT; Ji, LQ; Jiang, ZG				Qiao, Huijie; Lin, Congtian; Ji, Liqiang; Jiang, Zhigang			mMWeb - An Online Platform for Employing Multiple Ecological Niche Modeling Algorithms	PLOS ONE			English	Article							SPECIES DISTRIBUTIONS; PREDICTIONS	Background: Predicting the ecological niche and potential habitat distribution of a given organism is one of the central domains of ecological and biogeographical research. A wide variety of modeling techniques have been developed for this purpose. In order to implement these models, the users must prepare a specific runtime environment for each model, learn how to use multiple model platforms, and prepare data in a different format each time. Additionally, often model results are difficult to interpret, and a standardized method for comparing model results across platforms does not exist. We developed a free and open source online platform, the multi-models web-based (mMWeb) platform, to address each of these problems, providing a novel environment in which the user can implement and compare multiple ecological niche model (ENM) algorithms. Methodology: mMWeb combines 18 existing ENMs and their corresponding algorithms and provides a uniform procedure for modeling the potential habitat niche of a species via a common web browser. mMWeb uses Java Native Interface (JNI), Java R Interface to combine the different ENMs and executes multiple tasks in parallel on a super computer. The cross-platform, user-friendly interface of mMWeb simplifies the process of building ENMs, providing an accessible and efficient environment from which to explore and compare different model algorithms.	[Qiao, Huijie; Lin, Congtian; Ji, Liqiang; Jiang, Zhigang] Chinese Acad Sci, Inst Zool, Key Lab Anim Ecol & Conservat Biol, Beijing, Peoples R China; [Qiao, Huijie] Chinese Acad Sci, Grad Univ, Beijing, Peoples R China	Chinese Academy of Sciences; Institute of Zoology, CAS; Chinese Academy of Sciences; University of Chinese Academy of Sciences, CAS	Qiao, HJ (corresponding author), Chinese Acad Sci, Inst Zool, Key Lab Anim Ecol & Conservat Biol, Beijing, Peoples R China.	jiangzg@ioz.ac.cn	Jiang, Zhigang/E-4598-2014	Jiang, Zhigang/0000-0003-2154-8588; Qiao, Huijie/0000-0002-5345-6234	National Natural Science Foundation of China [31100390]; Ministry of Science and Technology of People's Republic of China [2008BAC39B04]; Chinese Academy of Sciences [KSCX2-EW-Z-4]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Ministry of Science and Technology of People's Republic of China(Ministry of Science and Technology, China); Chinese Academy of Sciences(Chinese Academy of Sciences)	This study was supported by the National Natural Science Foundation of China (A New Method to Predict the Species Distributions, 31100390), the Science and Technology Supporting Project of Ministry of Science and Technology of People's Republic of China (2008BAC39B04), and the Key Program of Knowledge Innovation Program of the Chinese Academy of Sciences (KSCX2-EW-Z-4). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anderson RP, 2003, ECOL MODEL, V162, P211, DOI 10.1016/S0304-3800(02)00349-6; Austin M, 2007, ECOL MODEL, V200, P1, DOI 10.1016/j.ecolmodel.2006.07.005; BUSBY JR, 1986, AUST J ECOL, V11, P1, DOI 10.1111/j.1442-9993.1986.tb00912.x; Elith J, 2006, ECOGRAPHY, V29, P129, DOI 10.1111/j.2006.0906-7590.04596.x; Freeman EA, 2008, J STAT SOFTW, V23, P1; GDAL Development Team, 2011, GDAL GEOSP DAT ABSTR; GeoServer Development Team, 2011, GEOSERVER 2 1 3; Grenouillet G, 2011, ECOGRAPHY, V34, P9, DOI 10.1111/j.1600-0587.2010.06152.x; Guisan A, 2005, ECOL LETT, V8, P993, DOI 10.1111/j.1461-0248.2005.00792.x; Hall M., 2009, SIGKDD EXPLORATIONS, V11; Heikkinen RK, 2011, ECOGRAPHY; Hijmans RJ, 2005, INT J CLIMATOL, V25, P1965, DOI 10.1002/joc.1276; Hirzel AH, 2002, ECOLOGY, V83, P2027, DOI 10.1890/0012-9658(2002)083[2027:ENFAHT]2.0.CO;2; Mbogga MS, 2010, J APPL ECOL, V47, P731, DOI 10.1111/j.1365-2664.2010.01830.x; Miller J, 2010, GEOGR COMPASS, V4, P490, DOI 10.1111/j.1749-8198.2010.00351.x; Munoz MES, 2009, GEOINFORMATICA; OpenLayers Development Team, 2011, OPENLAYERS 2 0; Pearson RG, 2007, J BIOGEOGR, V34, P102, DOI 10.1111/j.1365-2699.2006.01594.x; Peterson AT, 2008, ECOL MODEL, V213, P63, DOI 10.1016/j.ecolmodel.2007.11.008; Peterson AT, 2007, ECOGRAPHY, V30, P550, DOI 10.1111/j.2007.0906-7590.05102.x; Peterson AT, 2006, EMERG INFECT DIS, V12, P1822; Phillips SJ, 2008, ECOGRAPHY, V31, P161, DOI 10.1111/j.0906-7590.2008.5203.x; Qiao HJ, 2010, THESIS GRADUATE U; R DEVELOPMENT CORE TEAM, 2011, R LANG ENV STAT COMP; Santana FS, 2006, 2006 WORLD C COMP AG; Soberon J, 2007, ECOL LETT, V10, P1115, DOI 10.1111/j.1461-0248.2007.01107.x; Soberon J, 2009, P NATL ACAD SCI USA, V106, P19644, DOI 10.1073/pnas.0901637106; Soberon Jorge, 2005, Biodiversity Informatics, V2, P1; Stockwell D, 1999, INT J GEOGR INF SCI, V13, P143, DOI 10.1080/136588199241391; Sutton T, 2007, OSGEO J; Syphard AD, 2009, ECOGRAPHY, V32, P907, DOI 10.1111/j.1600-0587.2009.05883.x; Thuiller W, 2010, R FORGE BIOMOD PROJE; Thuiller W, 2009, ECOGRAPHY, V32, P369, DOI 10.1111/j.1600-0587.2008.05742.x; Tsoar A, 2007, DIVERS DISTRIB, V13, P397, DOI 10.1111/j.1472-4642.2007.00346.x	34	7	12	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 17	2012	7	8							e43327	10.1371/journal.pone.0043327	http://dx.doi.org/10.1371/journal.pone.0043327			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	996DG	22912854	Green Submitted, gold, Green Published			2022-12-25	WOS:000308063700082
J	Rendon-Anaya, M; Delaye, L; Possani, LD; Herrera-Estrella, A				Rendon-Anaya, Martha; Delaye, Luis; Possani, Lourival D.; Herrera-Estrella, Alfredo			Global Transcriptome Analysis of the Scorpion Centruroides noxius: New Toxin Families and Evolutionary Insights from an Ancestral Scorpion Species	PLOS ONE			English	Article							NA+-CHANNELS; VENOM GLAND; BETA-KTX; PEPTIDES; SEQUENCE; ARACHNIDA; BLOCKER; IDENTIFICATION; PHYLOGENIES; COMPONENTS	Scorpion venoms have been studied for decades, leading to the identification of hundreds of different toxins with medical and pharmacological implications. However, little emphasis has been given to the description of these arthropods from cellular and evolutionary perspectives. In this report, we describe a transcriptomic analysis of the Mexican scorpion Centruroides noxius Hoffmann, performed with a pyrosequencing platform. Three independent sequencing experiments were carried out, each including three different cDNA libraries constructed from RNA extracted from the whole body of the scorpion after telson removal, and from the venom gland before and after venom extraction. Over three million reads were obtained and assembled in almost 19000 isogroups. Within the telson-specific sequences, 72 isogroups (0.4% of total unique transcripts) were found to be similar to toxins previously reported in other scorpion species, spiders and sea anemones. The annotation pipeline also revealed the presence of important elements of the small non-coding RNA processing machinery, as well as microRNA candidates. A phylogenomic analysis of concatenated essential genes evidenced differential evolution rates in this species, particularly in ribosomal proteins and proteasome components. Additionally, statistical comparison of transcript abundance before and after venom extraction showed that 3% and 2% of the assembled isogroups had higher expression levels in the active and replenishing gland, respectively. Thus, our sequencing and annotation strategies provide a general view of the cellular and molecular processes that take place in these arthropods, allowed the discovery of new pharmacological and biotechnological targets and uncovered several regulatory and metabolic responses behind the assembly of the scorpion venom. The results obtained in this report represent the first high-throughput study that thoroughly describes the universe of genes that are expressed in the scorpion Centruroides noxius Hoffmann, a highly relevant organism from medical and evolutionary perspectives.	[Rendon-Anaya, Martha; Herrera-Estrella, Alfredo] Ctr Invest & Estudios Avanzados CINVESTAV, Lab Nacl Genom Biodiversidad, Guanajuato, Mexico; [Delaye, Luis] Ctr Invest & Estudios Avanzados CINVESTAV, Dept Ingn Genet, Guanajuato, Mexico; [Rendon-Anaya, Martha; Possani, Lourival D.] Univ Nacl Autonoma Mexico, Inst Biotecnol, Dept Med Mol & Bioproc, Cuernavaca 62191, Morelos, Mexico	CINVESTAV - Centro de Investigacion y de Estudios Avanzados del Instituto Politecnico Nacional; CINVESTAV - Centro de Investigacion y de Estudios Avanzados del Instituto Politecnico Nacional; Universidad Nacional Autonoma de Mexico	Rendon-Anaya, M (corresponding author), Ctr Invest & Estudios Avanzados CINVESTAV, Lab Nacl Genom Biodiversidad, Guanajuato, Mexico.	possani@ibt.unam.mx; aherrera@langebio.cinvestav.mx	Arredondo, Luis José Delaye/A-9574-2015; Herrera-Estrella, Alfredo/F-3185-2011; Herrera-Estrella, Alfredo/J-8210-2019; Possani, Lourival D/J-2397-2013	Arredondo, Luis José Delaye/0000-0003-4193-2720; Herrera-Estrella, Alfredo/0000-0002-4589-6870; Herrera-Estrella, Alfredo/0000-0002-4589-6870; RENDON ANAYA, MARTHA/0000-0002-8047-223X	Direccion General del Personal Academico of National Autonomous University of Mexico (UNAM); Institute Bioclon S.A. de C.V.	Direccion General del Personal Academico of National Autonomous University of Mexico (UNAM); Institute Bioclon S.A. de C.V.	This work was partially supported by grant number IN204110 from Direccion General del Personal Academico of National Autonomous University of Mexico (UNAM) (http://www.unam.mx), and the support of Institute Bioclon S.A. de C.V. (http://www.bioclon.com.mx) to LDP. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aiken CT, 2011, MOL CELL PROTEOMICS, V10, DOI 10.1074/mcp.M110.006924; Auld KL, 2006, MOL CELL, V21, P861, DOI 10.1016/j.molcel.2006.02.020; Conde R, 2000, FEBS LETT, V471, P165, DOI 10.1016/S0014-5793(00)01384-3; Conesa A, 2005, BIOINFORMATICS, V21, P3674, DOI 10.1093/bioinformatics/bti610; Corona M, 2002, FEBS LETT, V532, P121, DOI 10.1016/S0014-5793(02)03652-9; D'Suze G, 2009, BIOCHIMIE, V91, P1010, DOI 10.1016/j.biochi.2009.05.005; Darriba D, 2011, BIOINFORMATICS, V27, P1164, DOI 10.1093/bioinformatics/btr088; Davila S, 2005, GENE, V360, P92, DOI 10.1016/j.gene.2005.06.008; de la Vega RCR, 2005, TOXICON, V46, P831, DOI 10.1016/j.toxicon.2005.09.006; del Rio-Portilla F, 2004, EUR J BIOCHEM, V271, P2504, DOI 10.1111/j.1432-1033.2004.04181.x; Diego-Garcia E, 2008, CELL MOL LIFE SCI, V65, P187, DOI 10.1007/s00018-007-7370-x; Diego-Garcia E, 2007, PEPTIDES, V28, P31, DOI 10.1016/j.peptides.2006.06.012; Dinger Marcel E., 2009, Briefings in Functional Genomics & Proteomics, V8, P407, DOI 10.1093/bfgp/elp038; Edgar RC, 2004, NUCLEIC ACIDS RES, V32, P1792, DOI 10.1093/nar/gkh340; Fet Victor, 2003, Euscorpius, V4, P1; Fletcher PL, 2010, J BIOL CHEM, V285, P7405, DOI 10.1074/jbc.M109.028365; Garcia-Valdes J, 2001, FEBS LETT, V505, P369, DOI 10.1016/S0014-5793(01)02791-0; Guindon S, 2010, SYST BIOL, V59, P307, DOI 10.1093/sysbio/syq010; Gurrola GB, 1999, FASEB J, V13, P953, DOI 10.1096/fasebj.13.8.953; Hansen KD, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000525; Huson DH, 2007, GENOME RES, V17, P377, DOI 10.1101/gr.5969107; Jacquier A, 2009, NAT REV GENET, V10, P833, DOI 10.1038/nrg2683; Jeffroy O, 2006, TRENDS GENET, V22, P225, DOI 10.1016/j.tig.2006.02.003; Jeyaprakash A, 2009, EXP APPL ACAROL, V47, P1, DOI 10.1007/s10493-008-9203-5; Kozminsky-Atias A, 2008, BMC EVOL BIOL, V8, DOI 10.1186/1471-2148-8-333; Larkin MA, 2007, BIOINFORMATICS, V23, P2947, DOI 10.1093/bioinformatics/btm404; Licea AF, 1996, TOXICON, V34, P843, DOI 10.1016/0041-0101(96)00043-8; Ma YB, 2010, PROTEOMICS, V10, P2471, DOI 10.1002/pmic.200900763; Ma YB, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-290; Malik S, 2009, J BIOL CHEM, V284, P35714, DOI 10.1074/jbc.M109.035709; Margulies M, 2005, NATURE, V437, P376, DOI 10.1038/nature03959; Mitra S, 2011, BMC BIOINFORMATICS, V12, DOI 10.1186/1471-2105-12-S1-S21; Morgenstern D, 2011, TOXICON, V57, P695, DOI 10.1016/j.toxicon.2011.02.001; Nieto AR, 1996, TOXICON, V34, P913, DOI 10.1016/0041-0101(96)00029-3; Nisani Z, 2007, COMP BIOCHEM PHYS A, V147, P509, DOI 10.1016/j.cbpa.2007.01.027; Pardo-Lopez L, 2002, FEBS LETT, V510, P45, DOI 10.1016/S0014-5793(01)03218-5; Pisani D, 2004, BMC BIOL, V2, DOI 10.1186/1741-7007-2-1; Possani LD, 1999, EUR J BIOCHEM, V264, P287, DOI 10.1046/j.1432-1327.1999.00625.x; Quintero-Hernandez V, 2011, TOXICON, V58, P644, DOI 10.1016/j.toxicon.2011.09.015; Ramirez-Dominguez ME, 2002, J EXP BIOL, V205, P869; Regier JC, 2010, NATURE, V463, P1079, DOI 10.1038/nature08742; Roeding F, 2009, MOL PHYLOGENET EVOL, V53, P826, DOI 10.1016/j.ympev.2009.08.014; Rudolf I, 2009, FOLIA MICROBIOL, V54, P419, DOI 10.1007/s12223-009-0059-9; Schwartz EF, 2007, BMC GENOMICS, V8, DOI 10.1186/1471-2164-8-119; Soleglad Michael E., 2003, Euscorpius, V11, P1; Soudani N, 2005, BBA-PROTEINS PROTEOM, V1747, P47, DOI 10.1016/j.bbapap.2004.09.020; Storey JD, 2004, J R STAT SOC B, V66, P187, DOI 10.1111/j.1467-9868.2004.00439.x; Talavera G, 2007, SYST BIOL, V56, P564, DOI 10.1080/10635150701472164; Trevisan-Silva D, 2010, BIOCHIMIE, V92, P21, DOI 10.1016/j.biochi.2009.10.003; Wang ET, 2008, NATURE, V456, P470, DOI 10.1038/nature07509; Wang H, 2011, J APPL MICROBIOL, V110, P1390, DOI 10.1111/j.1365-2672.2011.05001.x; Zhao RM, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-452	52	49	49	0	38	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 17	2012	7	8							e43331	10.1371/journal.pone.0043331	http://dx.doi.org/10.1371/journal.pone.0043331			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	996DG	22912855	Green Submitted, gold, Green Published			2022-12-25	WOS:000308063700083
J	Marks, LR; Clementi, EA; Hakansson, AP				Marks, Laura R.; Clementi, Emily A.; Hakansson, Anders P.			The Human Milk Protein-Lipid Complex HAMLET Sensitizes Bacterial Pathogens to Traditional Antimicrobial Agents	PLOS ONE			English	Article							PENICILLIN-RESISTANT PNEUMOCOCCI; CONJUGATE VACCINE FORMULATION; HUMAN ALPHA-LACTALBUMIN; STREPTOCOCCUS-PNEUMONIAE; OTITIS-MEDIA; BINDING PROTEINS; TUMOR-CELLS; MIDDLE-EAR; VANCOMYCIN TOLERANCE; EPITHELIAL-CELLS	The fight against antibiotic resistance is one of the most significant challenges to public health of our time. The inevitable development of resistance following the introduction of novel antibiotics has led to an urgent need for the development of new antibacterial drugs with new mechanisms of action that are not susceptible to existing resistance mechanisms. One such compound is HAMLET, a natural complex from human milk that kills Streptococcus pneumoniae (the pneumococcus) using a mechanism different from common antibiotics and is immune to resistance-development. In this study we show that sublethal concentrations of HAMLET potentiate the effect of common antibiotics (penicillins, macrolides, and aminoglycosides) against pneumococci. Using MIC assays and short-time killing assays we dramatically reduced the concentrations of antibiotics needed to kill pneumococci, especially for antibiotic-resistant strains that in the presence of HAMLET fell into the clinically sensitive range. Using a biofilm model in vitro and nasopharyngeal colonization in vivo, a combination of HAMLET and antibiotics completely eradicated both biofilms and colonization in mice of both antibiotic-sensitive and resistant strains, something each agent alone was unable to do. HAMLET-potentiation of antibiotics was partially due to increased accessibility of antibiotics to the bacteria, but relied more on calcium import and kinase activation, the same activation pathway HAMLET uses when killing pneumococci by itself. Finally, the sensitizing effect was not confined to species sensitive to HAMLET. The HAMLET-resistant respiratory species Acinetobacter baumanii and Moraxella catarrhalis were all sensitized to various classes of antibiotics in the presence of HAMLET, activating the same mechanism as in pneumococci. Combined these results suggest the presence of a conserved HAMLET-activated pathway that circumvents antibiotic resistance in bacteria. The ability to activate this pathway may extend the lifetime of the current treatment arsenal.	[Marks, Laura R.; Clementi, Emily A.; Hakansson, Anders P.] SUNY Buffalo, Dept Microbiol & Immunol, Buffalo, NY 14260 USA; [Hakansson, Anders P.] SUNY Buffalo, Witebsky Ctr Microbial Pathogenesis & Immunol, Buffalo, NY 14260 USA; [Hakansson, Anders P.] New York State Ctr Excellence Bioinformat & Life, Buffalo, NY USA	State University of New York (SUNY) System; State University of New York (SUNY) Buffalo; State University of New York (SUNY) System; State University of New York (SUNY) Buffalo	Marks, LR (corresponding author), SUNY Buffalo, Dept Microbiol & Immunol, Buffalo, NY 14260 USA.	andersh@buffalo.edu	Hakansson, Anders P/AAX-1225-2020; Hakansson, Anders/H-8190-2014	Hakansson, Anders P/0000-0002-2834-6009; Hakansson, Anders/0000-0002-2834-6009; Marks, Laura/0000-0002-5317-443X	Bill and Melinda Gates Foundation [53085]; JR Oishei Foundation; American Lung Association [RG-123721-N]; NIH (NIDCR) [F31DC011218]; NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS [F31DC011218] Funding Source: NIH RePORTER	Bill and Melinda Gates Foundation(Bill & Melinda Gates Foundation); JR Oishei Foundation; American Lung Association; NIH (NIDCR)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR)); NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD))	This work was supported by the Bill and Melinda Gates Foundation (Grant 53085), the JR Oishei Foundation, and The American Lung Association (Grant RG-123721-N) to APH, and NIH (NIDCR) fellowship F31DC011218 to EAC. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alanis AJ, 2005, ARCH MED RES, V36, P697, DOI 10.1016/j.arcmed.2005.06.009; ANDERSSON B, 1983, J EXP MED, V158, P559, DOI 10.1084/jem.158.2.559; ANIANSSON G, 1994, PEDIATR INFECT DIS J, V13, P183, DOI 10.1097/00006454-199403000-00003; Avery OT, 1944, J EXP MED, V79, P137, DOI 10.1084/jem.79.2.137; Bachrach VRG, 2003, ARCH PEDIAT ADOL MED, V157, P237, DOI 10.1001/archpedi.157.3.237; Bryce J, 2005, LANCET, V365, P1147, DOI 10.1016/S0140-6736(05)71877-8; Butler JC, 1999, CLIN INFECT DIS, V28, P730, DOI 10.1086/515220; Clardy J, 2006, NAT BIOTECHNOL, V24, P1541, DOI 10.1038/nbt1266; Clementi EA, 2012, J BIOL CHEM; Costerton JW, 1999, SCIENCE, V284, P1318, DOI 10.1126/science.284.5418.1318; Cottagnoud P, 2000, ANTIMICROB AGENTS CH, V44, P2179, DOI 10.1128/AAC.44.8.2179-2181.2000; Cottagnoud P, 2003, ANTIMICROB AGENTS CH, V47, P144, DOI 10.1128/AAC.47.1.144-147.2003; DarrasJoly C, 1996, ANTIMICROB AGENTS CH, V40, P2147, DOI 10.1128/AAC.40.9.2147; Drago L, 2011, J ANTIMICROB CHEMOTH, V66, P845, DOI 10.1093/jac/dkr016; Fischer W, 2004, CANCER RES, V64, P2105, DOI 10.1158/0008-5472.CAN-03-2661; Gee KR, 2001, ELECTROPHORESIS, V22, P960, DOI 10.1002/1522-2683()22:5<960::AID-ELPS960>3.0.CO;2-9; German JB, 2002, CURR OPIN CLIN NUTR, V5, P653, DOI 10.1097/00075197-200211000-00007; Ginsburg I, 2002, APMIS, V110, P753, DOI 10.1034/j.1600-0463.2002.1101101.x; GROSS ME, 1995, ANTIMICROB AGENTS CH, V39, P1166, DOI 10.1128/AAC.39.5.1166; HAKANSSON A, 1995, P NATL ACAD SCI USA, V92, P8064, DOI 10.1073/pnas.92.17.8064; Hakansson A, 2000, MOL MICROBIOL, V35, P589, DOI 10.1046/j.1365-2958.2000.01728.x; Hakansson AP, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017717; HAKENBECK R, 1991, J INFECT DIS, V164, P313, DOI 10.1093/infdis/164.2.313; HALL MJ, 1983, J ANTIMICROB CHEMOTH, V11, P427, DOI 10.1093/jac/11.5.427; Hall-Stoodley L, 2006, JAMA-J AM MED ASSOC, V296, P202, DOI 10.1001/jama.296.2.202; Hammerschmidt S, 2005, INFECT IMMUN, V73, P4653, DOI 10.1128/IAI.73.8.4653-4667.2005; Hancock REW, 2006, NAT BIOTECHNOL, V24, P1551, DOI 10.1038/nbt1267; Hanson Lars A, 2002, Semin Neonatol, V7, P275, DOI 10.1016/S1084-2756(02)90124-7; Harrison CJ, 2009, J ANTIMICROB CHEMOTH, V63, P511, DOI 10.1093/jac/dkn538; Hausdorff WP, 2000, CLIN INFECT DIS, V30, P122, DOI 10.1086/313609; Hausdorff WP, 2000, CLIN INFECT DIS, V30, P100, DOI 10.1086/313608; Havarstein LS, 2006, MOL MICROBIOL, V59, P1297, DOI 10.1111/j.1365-2958.2005.05021.x; Hoa M, 2009, ANN OTO RHINOL LARYN, V118, P292, DOI 10.1177/000348940911800410; Jain R, 2004, ANN PHARMACOTHER, V38, P1449, DOI 10.1345/aph.1D592; Johnsborg O, 2008, MOL MICROBIOL, V69, P245, DOI 10.1111/j.1365-2958.2008.06288.x; Joloba ML, 2001, CLIN INFECT DIS, V33, P1489, DOI 10.1086/323027; Kadurugamuwa JL, 1997, J ANTIMICROB CHEMOTH, V40, P615, DOI 10.1093/jac/40.5.615; Kuhn F, 2003, ANTIMICROB AGENTS CH, V47, P2487, DOI 10.1128/AAC.47.8.2487-2491.2003; Lepper PM, 2002, INTENS CARE MED, V28, P824, DOI 10.1007/s00134-002-1330-6; Levin BR, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000601; Lonnerdal B, 2004, ADV EXP MED BIOL, V554, P11; Magee AD, 2001, INFECT IMMUN, V69, P3755, DOI 10.1128/IAI.69.6.3755-3761.2001; Mah TFC, 2001, TRENDS MICROBIOL, V9, P34, DOI 10.1016/S0966-842X(00)01913-2; Marks L. R., 2012, INFECT IMMU IN PRESS; Marriott HM, 2008, CURR MOL MED, V8, P497, DOI 10.2174/156652408785747924; MARSHALL KJ, 1993, J CLIN MICROBIOL, V31, P1246, DOI 10.1128/JCM.31.5.1246-1250.1993; Mattie H, 2005, J ANTIMICROB CHEMOTH, V56, P154, DOI 10.1093/jac/dki176; MCDANIEL LS, 1987, J EXP MED, V165, P381, DOI 10.1084/jem.165.2.381; Mossberg AK, 2007, INT J CANCER, V121, P1352, DOI 10.1002/ijc.22810; Mossberg AK, 2010, J UROLOGY, V183, P1590, DOI 10.1016/j.juro.2009.12.008; Nau R, 2002, CLIN MICROBIOL REV, V15, P95, DOI 10.1128/CMR.15.1.95-110.2002; Novak R, 1999, NATURE, V399, P590, DOI 10.1038/21202; Reid SD, 2009, J INFECT DIS, V199, P786, DOI 10.1086/597042; Robertson GT, 2002, J BACTERIOL, V184, P6987, DOI 10.1128/JB.184.24.6987-7000.2002; Rudan I, 2008, B WORLD HEALTH ORGAN, V86, P408, DOI 10.2471/BLT.07.048769; Russo TA, 2010, INFECT IMMUN, V78, P3993, DOI 10.1128/IAI.00366-10; Sader HS, 1998, DIAGN MICR INFEC DIS, V32, P289, DOI 10.1016/S0732-8893(98)00124-2; Sanchez CJ, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1001044; Sanchez-Tatay D, 2008, CLIN MICROBIOL INFEC, V14, P797, DOI 10.1111/j.1469-0691.2008.02025.x; Sanderson AR, 2006, LARYNGOSCOPE, V116, P1121, DOI 10.1097/01.mlg.0000221954.05467.54; Schneider Aline Petter, 2007, J. bras. pneumol., V33, P454, DOI 10.1590/S1806-37132007000400016; Svensson M, 2000, P NATL ACAD SCI USA, V97, P4221, DOI 10.1073/pnas.97.8.4221; Svensson M, 1999, J BIOL CHEM, V274, P6388, DOI 10.1074/jbc.274.10.6388; TOMASZ A, 1975, P NATL ACAD SCI USA, V72, P4162, DOI 10.1073/pnas.72.10.4162; TUOMANEN E, 1985, J INFECT DIS, V151, P535, DOI 10.1093/infdis/151.3.535; Tuomanen E, 1999, CURR OPIN MICROBIOL, V2, P35, DOI 10.1016/S1369-5274(99)80006-X; Tyx RE, 2011, J BACTERIOL, V193, P3512, DOI 10.1128/JB.01410-10; Van Looveren M, 2004, CLIN MICROBIOL INFEC, V10, P684, DOI 10.1111/j.1469-0691.2004.00942.x; Varon E, 2010, CLIN MICROBIOL INFEC, V16, P401, DOI 10.1111/j.1469-0691.2010.03190.x; Zhao GS, 1999, ANTIMICROB AGENTS CH, V43, P1124, DOI 10.1128/AAC.43.5.1124	70	39	40	0	24	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 15	2012	7	8							e43514	10.1371/journal.pone.0043514	http://dx.doi.org/10.1371/journal.pone.0043514			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	993AG	22905269	Green Submitted, Green Published, gold			2022-12-25	WOS:000307823600078
J	Amaral, C; Borges, M; Melo, S; da Silva, ET; Correia-da-Silva, G; Teixeira, N				Amaral, Cristina; Borges, Margarida; Melo, Soraia; da Silva, Elisiario Tavares; Correia-da-Silva, Georgina; Teixeira, Natercia			Apoptosis and Autophagy in Breast Cancer Cells following Exemestane Treatment	PLOS ONE			English	Article							AROMATASE INHIBITORS; MEMBRANE PERMEABILIZATION; POSTMENOPAUSAL WOMEN; TAMOXIFEN-RESISTANT; TRIGGERS APOPTOSIS; CYCLE PROGRESSION; MODIFIED STEROIDS; CROSS-TALK; DEATH; MCF-7	Aromatase inhibitors (AIs), which block the conversion of androgens to estrogens, are used for hormone-dependent breast cancer treatment. Exemestane, a steroidal that belongs to the third-generation of AIs, is a mechanism-based inhibitor that binds covalently and irreversibly, inactivating and destabilizing aromatase. Since the biological effects of exemestane in breast cancer cells are not totally understood, its effects on cell viability, cell proliferation and mechanisms of cell death were studied in an ER-positive aromatase-overexpressing breast cancer cell line (MCF-7aro). The effects of 3-methyladenine (3-MA), an inhibitor of autophagy and of ZVAD-FMK, an apoptotic inhibitor, in exemestane treated cells were also investigated. Our results indicate that exemestane induces a strong inhibition in MCF-7aro cell proliferation in a dose-and time-dependent manner, promoting a significant cell cycle arrest in G(0)/G(1) or in G(2)/M phases after 3 and 6 days of treatment, respectively. This was accompanied by a decrease in cell viability due to activation of cell death by apoptosis, via mitochondrial pathway and the occurrence of autophagy. Inhibition of autophagy by the autophagic inhibitor, 3-MA, resulted in a reduction of cell viability and activation of caspases. All together the results obtained suggest that exemestane induced mitochondrial-mediated apoptosis and autophagy, which act as a pro-survival process regulating breast cancer cell apoptosis.	[Amaral, Cristina; Borges, Margarida; Melo, Soraia; Correia-da-Silva, Georgina; Teixeira, Natercia] Univ Porto, Biochem Lab, Dept Biol Sci, Fac Pharm, P-4100 Oporto, Portugal; [Amaral, Cristina; Borges, Margarida; Correia-da-Silva, Georgina; Teixeira, Natercia] Univ Porto, Inst Mol & Cell Biol IBMC, P-4100 Oporto, Portugal; [Melo, Soraia] Univ Coimbra, Dept Zool, Fac Sci & Technol, Coimbra, Portugal; [da Silva, Elisiario Tavares] Univ Coimbra, Ctr Pharmaceut Studies, Pharmaceut Chem Lab, Fac Pharm, Coimbra, Portugal	Universidade do Porto; Universidade do Porto; Universidade de Coimbra; Universidade de Coimbra	Amaral, C (corresponding author), Univ Porto, Biochem Lab, Dept Biol Sci, Fac Pharm, Rua Campo Alegre 823, P-4100 Oporto, Portugal.	natercia@ff.up.pt	da Silva, Elisiário José Tavares/A-1759-2014; borges, margarida/GWR-0803-2022; Amaral, Cristina/K-5850-2013; Correia-da-Silva, Georgina/K-4696-2013; Borges, Margarida/E-9021-2013; Teixeira, Natercia A/K-4663-2013	da Silva, Elisiário José Tavares/0000-0002-0390-3403; Amaral, Cristina/0000-0003-1594-2095; Correia-da-Silva, Georgina/0000-0001-5787-9018; Borges, Margarida/0000-0001-6035-4095; Teixeira, Natercia A/0000-0002-3664-1120; Melo, Soraia/0000-0002-0278-0827	Fundacao para a Ciencia e Tecnologia (FCT) [SFRH/BD/48190/2008]; FEDER Funds through the Operational Competitiveness Program-COMPETE; National Funds through FCT-Fundacao para a Ciencia e Tecnologia [FCOMP-01-0124-FEDER-020970 (PTDC/QUI-BIQ/120319/2010)]	Fundacao para a Ciencia e Tecnologia (FCT)(Portuguese Foundation for Science and TechnologyEuropean Commission); FEDER Funds through the Operational Competitiveness Program-COMPETE; National Funds through FCT-Fundacao para a Ciencia e Tecnologia	Cristina Amaral is a recipient of a PhD grant of Fundacao para a Ciencia e Tecnologia (FCT) (SFRH/BD/48190/2008). This work was funded by FEDER Funds through the Operational Competitiveness Program-COMPETE and by National Funds through FCT-Fundacao para a Ciencia e Tecnologia under the project FCOMP-01-0124-FEDER-020970 (PTDC/QUI-BIQ/120319/2010). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abedin MJ, 2007, CELL DEATH DIFFER, V14, P500, DOI 10.1038/sj.cdd.4402039; BERTHOIS Y, 1986, P NATL ACAD SCI USA, V83, P2496, DOI 10.1073/pnas.83.8.2496; Boya P, 2005, MOL CELL BIOL, V25, P1025, DOI 10.1128/MCB.25.3.1025-1040.2005; Cepa M, 2008, BIOL CHEM, V389, P1183, DOI 10.1515/BC.2008.134; Cepa M, 2008, BMC CELL BIOL, V9, DOI 10.1186/1471-2121-9-41; Cepa MMDS, 2005, J MED CHEM, V48, P6379, DOI 10.1021/jm050129p; Chen XP, 2010, FREE RADICAL RES, V44, P587, DOI 10.3109/10715761003709802; Chen YQ, 2010, CAN J PHYSIOL PHARM, V88, P285, DOI 10.1139/Y10-010; de Medina P, 2009, CELL DEATH DIFFER, V16, P1372, DOI 10.1038/cdd.2009.62; de Medina P, 2009, AUTOPHAGY, V5, P1066, DOI 10.4161/auto.5.7.9820; de Vries JF, 2007, APOPTOSIS, V12, P181, DOI 10.1007/s10495-006-0526-6; Deeks ED, 2009, DRUGS, V69, P889, DOI 10.2165/00003495-200969070-00007; Detre S, 1999, INT J CANCER, V81, P309, DOI 10.1002/(SICI)1097-0215(19990412)81:2<309::AID-IJC23>3.0.CO;2-S; Dewaele M, 2010, AUTOPHAGY, V6, P838, DOI 10.4161/auto.6.7.12113; DiPaola RS, 2002, CLIN CANCER RES, V8, P3311; Doisneau-Sixou SF, 2003, ENDOCR-RELAT CANCER, V10, P179, DOI 10.1677/erc.0.0100179; Dutta U, 2008, MED ONCOL, V25, P113, DOI 10.1007/s12032-007-9019-x; Eisenberg-Lerner A, 2009, CELL DEATH DIFFER, V16, P966, DOI 10.1038/cdd.2009.33; Eisenberg-Lerner A, 2009, APOPTOSIS, V14, P376, DOI 10.1007/s10495-008-0307-5; Fabian CJ, 2007, INT J CLIN PRACT, V61, P2051, DOI 10.1111/j.1742-1241.2007.01587.x; Ferreira CG, 2000, CANCER RES, V60, P7133; Gluck S, 2010, AM J CLIN ONCOL-CANC, V33, P314, DOI 10.1097/COC.0b013e31819fdf9b; Gozuacik D, 2004, ONCOGENE, V23, P2891, DOI 10.1038/sj.onc.1207521; Gross JM, 2003, CANCER METAST REV, V22, P327, DOI 10.1023/A:1023720928680; Hou W, 2010, AUTOPHAGY, V6, P891, DOI 10.4161/auto.6.7.13038; Itoh T, 2005, MOL CANCER RES, V3, P203; Kallio A, 2005, APOPTOSIS, V10, P1395, DOI 10.1007/s10495-005-2137-z; Kanematsu S, 2010, ANTICANCER RES, V30, P3381; Klionsky DJ, 2008, AUTOPHAGY, V4, P151, DOI 10.4161/auto.5338; Kroemer G, 2007, PHYSIOL REV, V87, P99, DOI 10.1152/physrev.00013.2006; Kurokawa H, 1999, ONCOL REP, V6, P33; KYPRIANOU N, 1991, CANCER RES, V51, P162; Lemasters JJ, 1998, GASTROENTEROLOGY, V115, P783, DOI 10.1016/S0016-5085(98)70160-X; Lemasters JJ, 2002, ANTIOXID REDOX SIGN, V4, P769, DOI 10.1089/152308602760598918; Lim KB, 2001, BREAST CANCER RES TR, V68, P127, DOI 10.1023/A:1011929222555; Lonning PE, 2009, EUR J CANCER, V45, P527, DOI 10.1016/j.ejca.2008.10.019; Macedo LF, 2009, ANN NY ACAD SCI, V1155, P162, DOI 10.1111/j.1749-6632.2008.03689.x; Madden DT, 2007, AUTOPHAGY, V3, P519; Masri S, 2008, CANCER RES, V68, P4910, DOI 10.1158/0008-5472.CAN-08-0303; Miller WR, 2008, ONCOLOGIST, V13, P829, DOI 10.1634/theoncologist.2008-0055; Nazarewicz RR, 2007, CANCER RES, V67, P1282, DOI 10.1158/0008-5472.CAN-06-3099; NICHOLSON RI, 1994, BREAST CANCER RES TR, V29, P117, DOI 10.1007/BF00666187; Paglin S, 2001, CANCER RES, V61, P439; Qadir MA, 2008, BREAST CANCER RES TR, V112, P389, DOI 10.1007/s10549-007-9873-4; Samaddar JS, 2008, MOL CANCER THER, V7, P2977, DOI 10.1158/1535-7163.MCT-08-0447; Sun WL, 2011, AUTOPHAGY, V7, P1035, DOI 10.4161/auto.7.9.16521; Sun XZ, 1997, J STEROID BIOCHEM, V63, P29, DOI 10.1016/S0960-0760(97)00068-X; Thiantanawat A, 2003, CANCER RES, V63, P8037; Truchet I, 2000, EXP CELL RES, V254, P241, DOI 10.1006/excr.1999.4756; Wang X, 2006, CANCER RES, V66, P10281, DOI 10.1158/0008-5472.CAN-06-2134; Yan CH, 2007, ACTA PHARMACOL SIN, V28, P540, DOI 10.1111/j.1745-7254.2007.00530.x; Zhivotovsky B, 2010, EXP CELL RES, V316, P1374, DOI 10.1016/j.yexcr.2010.02.037; ZHOU D, 1990, CANCER RES, V50, P6949	53	46	49	1	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 13	2012	7	8							e42398	10.1371/journal.pone.0042398	http://dx.doi.org/10.1371/journal.pone.0042398			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	988OJ	22912703	gold, Green Submitted, Green Published			2022-12-25	WOS:000307500100013
J	Ang, KC; Ngu, MS; Reid, KP; Teh, MS; Aida, ZS; Koh, DXR; Berg, A; Oppenheimer, S; Salleh, H; Clyde, MM; Md-Zain, BM; Canfield, VA; Cheng, KC				Ang, Khai C.; Ngu, Mee S.; Reid, Katherine P.; Teh, Mei S.; Aida, Zamzuraida S.; Koh, Danny X. R.; Berg, Arthur; Oppenheimer, Stephen; Salleh, Hood; Clyde, Mahani M.; Md-Zain, Badrul M.; Canfield, Victor A.; Cheng, Keith C.			Skin Color Variation in Orang Asli Tribes of Peninsular Malaysia	PLOS ONE			English	Article							PIGMENTATION; EVOLUTION; PREGNANCY; EUROPEANS; ANCESTRY; ERYTHEMA; SLC24A5; SLC45A2; ALLELE; HUMANS	Pigmentation is a readily scorable and quantitative human phenotype, making it an excellent model for studying multifactorial traits and diseases. Convergent human evolution from the ancestral state, darker skin, towards lighter skin colors involved divergent genetic mechanisms in people of European vs. East Asian ancestry. It is striking that the European mechanisms result in a 10-20-fold increase in skin cancer susceptibility while the East Asian mechanisms do not. Towards the mapping of genes that contribute to East Asian pigmentation there is need for one or more populations that are admixed for ancestral and East Asian ancestry, but with minimal European contribution. This requirement is fulfilled by the Senoi, one of three indigenous tribes of Peninsular Malaysia collectively known as the Orang Asli. The Senoi are thought to be an admixture of the Negrito, an ancestral dark-skinned population representing the second of three Orang Asli tribes, and regional Mongoloid populations of Indo-China such as the Proto-Malay, the third Orang Asli tribe. We have calculated skin reflectance-based melanin indices in 492 Orang Asli, which ranged from 28 (lightest) to 75 (darkest); both extremes were represented in the Senoi. Population averages were 56 for Negrito, 42 for Proto-Malay, and 46 for Senoi. The derived allele frequencies for SLC24A5 and SLC45A2 in the Senoi were 0.04 and 0.02, respectively, consistent with greater South Asian than European admixture. Females and individuals with the A111T mutation had significantly lighter skin (p = 0.001 and 0.0039, respectively). Individuals with these derived alleles were found across the spectrum of skin color, indicating an overriding effect of strong skin lightening alleles of East Asian origin. These results suggest that the Senoi are suitable for mapping East Asian skin color genes.	[Ang, Khai C.; Reid, Katherine P.; Cheng, Keith C.] Penn State Coll Med, Dept Expt Pathol, Hershey, PA USA; [Ang, Khai C.; Reid, Katherine P.; Cheng, Keith C.] Penn State Coll Med, Jake Gittlen Canc Res Fdn, Hershey, PA USA; [Ngu, Mee S.; Teh, Mei S.; Aida, Zamzuraida S.; Koh, Danny X. R.; Clyde, Mahani M.; Md-Zain, Badrul M.] Univ Kebangsaan Malaysia, Fac Sci & Technol, Sch Environm & Nat Resource Sci, Bangi 43600, Selangor, Malaysia; [Berg, Arthur] Penn State Coll Med, Dept Biostat & Bioinformat, Hershey, PA USA; [Oppenheimer, Stephen] Univ Oxford, Sch Anthropol & Museum Ethnog, Inst Cognit & Evolutionary Anthropol, Oxford, England; [Salleh, Hood] Univ Kebangsaan Malaysia, Acad Heritage Museum, Bangi 43600, Selangor, Malaysia; [Canfield, Victor A.] Penn State Coll Med, Dept Pharmacol, Hershey, PA USA	Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Penn State Health; Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Penn State Health; Universiti Kebangsaan Malaysia; Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Penn State Health; University of Oxford; Universiti Kebangsaan Malaysia; Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Penn State Health	Ang, KC (corresponding author), Penn State Coll Med, Dept Expt Pathol, Hershey, PA USA.	khaichung@gmail.com; kcheng76@gmail.com	teh, mei sze/N-5404-2017; Ang, Khai C./N-7956-2019	teh, mei sze/0000-0002-8020-3398; Ang, Khai C./0000-0001-7695-9953; Cheng, Keith/0000-0002-5350-5825; Berg, Arthur/0000-0002-4097-7348	National Institutes of Health [5R01 AR052535, 3R01 AR052535-03S1]; National Institute of Arthritis and Musculoskeletal and Skin Diseases; Jake Gittlen Cancer Research Foundation of the Penn State Cancer Institute; Universiti Kebangsaan Malaysia (UKM) [UKM-GUP-ASP-07-04-146, UKM-ST-08-FRGS0012-2010]; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R01AR052535] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Institute of Arthritis and Musculoskeletal and Skin Diseases(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); Jake Gittlen Cancer Research Foundation of the Penn State Cancer Institute; Universiti Kebangsaan Malaysia (UKM); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS))	This work was supported by National Institutes of Health grants 5R01 AR052535 and 3R01 AR052535-03S1 from the National Institute of Arthritis and Musculoskeletal and Skin Diseases to KCC, the Jake Gittlen Cancer Research Foundation of the Penn State Cancer Institute, and UKM-GUP-ASP-07-04-146 and UKM-ST-08-FRGS0012-2010 from Universiti Kebangsaan Malaysia (UKM) to BMMZ, MMC, KCA and HS. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alaluf S, 2002, PIGM CELL RES, V15, P119, DOI 10.1034/j.1600-0749.2002.1o072.x; Ang KC, 2011, GENET MOL RES, V10, P640, DOI 10.4238/vol10-2gmr1011; Ang KC, 2009, SISTEMATIK MOLEKUL O; Barsh GS, 2003, PLOS BIOL, V1, P19, DOI 10.1371/journal.pbio.0000027; Bonilla C, 2005, HUM GENET, V116, P402, DOI 10.1007/s00439-004-1251-2; Carey I, 1976, ADM ORANG ASLI, P283; DIFFEY BL, 1984, BRIT J DERMATOL, V111, P663, DOI 10.1111/j.1365-2133.1984.tb14149.x; FIX AG, 1995, AM ANTHROPOL, V97, P313, DOI 10.1525/aa.1995.97.2.02a00090; Frazer KA, 2007, NATURE, V449, P851, DOI 10.1038/nature06258; Fullerton A, 1996, CONTACT DERMATITIS, V35, P1, DOI 10.1111/j.1600-0536.1996.tb02258.x; HOLICK MF, 1981, J INVEST DERMATOL, V77, P51, DOI 10.1111/1523-1747.ep12479237; Hood S, 2006, PEOPLE TRADITION; Howlader N, 2012, SEER CANC STAT REV 1; Jablonski NG, 2000, J HUM EVOL, V39, P57, DOI 10.1006/jhev.2000.0403; JHEOA (Jabatan Hal Ehwal Orang Asli, 2002, KEH BUD PANT LAR OR; KOHLMEIRER L, 1995, ENDOCRIN METAB CLIN, V24, P15, DOI 10.1016/S0889-8529(18)30052-5; Lamason RL, 2005, SCIENCE, V310, P1782, DOI 10.1126/science.1116238; Lim LS, 2010, J BIOL SCI, V10, P71, DOI DOI 10.3923/jbs.2010.71.83; Longmire JL, 1988, GENOMICS, V2, P14, DOI 10.1016/0888-7543(88)90104-8; McEvoy B, 2006, HUM MOL GENET, V15, pR176, DOI 10.1093/hmg/ddl217; Miller CT, 2007, CELL, V131, P1179, DOI 10.1016/j.cell.2007.10.055; Nakayama K, 2002, J HUM GENET, V47, P92, DOI 10.1007/s100380200007; NICHOLAS C, 2002, INDIGENOUS POLITICS; Nicholas C, 2006, PEOPLES TRADITIONS E, P20; Norton HL, 2007, MOL BIOL EVOL, V24, P710, DOI 10.1093/molbev/msl203; Oppenheimer S., 2011, DYN HUM DIVERS CASE, V627, P81; Parra EJ, 2004, NAT GENET, V36, pS54, DOI 10.1038/ng1440; Qiu DM, 2006, JPN J CLIN ONCOL, V36, P533, DOI 10.1093/jjco/hyl085; Rees JL, 2003, ANNU REV GENET, V37, P67, DOI 10.1146/annurev.genet.37.110801.143233; Shriver MD, 2003, HUM GENET, V112, P387, DOI 10.1007/s00439-002-0896-y; Soejima M, 2007, INT J LEGAL MED, V121, P36, DOI 10.1007/s00414-006-0112-z; Sulem P, 2007, NAT GENET, V39, P1443, DOI 10.1038/ng.2007.13; WHITEHEAD M, 1981, BRIT MED J, V283, P10, DOI 10.1136/bmj.283.6283.10; Yuasa I, 2006, ANN HUM GENET, V70, P802, DOI 10.1111/j.1469-1809.2006.00261.x; Yuasa I, 2004, INT J LEGAL MED, V118, P364, DOI 10.1007/s00414-004-0490-z	35	17	18	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 13	2012	7	8							e42752	10.1371/journal.pone.0042752	http://dx.doi.org/10.1371/journal.pone.0042752			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	988OJ	22912732	Green Published, Green Submitted, gold			2022-12-25	WOS:000307500100027
J	Fujieda, Y; Ueno, S; Ogino, R; Kuroda, M; Jonsson, TJ; Guo, LN; Bamba, T; Fukusaki, E				Fujieda, Yusuke; Ueno, Shinya; Ogino, Ryoko; Kuroda, Mariko; Joensson, Thomas J.; Guo, Lining; Bamba, Takeshi; Fukusaki, Eiichiro			Metabolite Profiles Correlate Closely with Neurobehavioral Function in Experimental Spinal Cord Injury in Rats	PLOS ONE			English	Article							MAGNETIC-RESONANCE-SPECTROSCOPY; N-ACETYL-ASPARTATE; ORNITHINE-DECARBOXYLASE; MULTIPLE-SCLEROSIS; BRAIN ISCHEMIA; RECOVERY; DISEASE; ACETYLASPARTATE; METABOLOMICS; MAINTENANCE	Traumatic spinal cord injury (SCI) results in direct physical damage and the generation of local factors contributing to secondary pathogenesis. Untargeted metabolomic profiling was used to uncover metabolic changes and to identify relationships between metabolites and neurobehavioral functions in the spinal cord after injury in rats. In the early metabolic phase, neuronal signaling, stress, and inflammation-associated metabolites were strongly altered. A dynamic inflammatory response consisting of elevated levels of prostaglandin E2 and palmitoyl ethanolamide as well as pro- and anti-inflammatory polyunsaturated fatty acids was observed. N-acetyl-aspartyl-glutamate (NAAG) and N-acetyl-aspartate (NAA) were significantly decreased possibly reflecting neuronal cell death. A second metabolic phase was also seen, consistent with membrane remodeling and antioxidant defense response. These metabolomic changes were consistent with the pathology and progression of SCI. Several metabolites, including NAA, NAAG, and the omega-3 fatty acids docosapentaenoate and docosahexaenoate correlated greatly with the established Basso, Beattie and Bresnahan locomotive score (BBB score). Our findings suggest the possibility of a biochemical basis for BBB score and illustrate that metabolites may correlate with neurobehavior. In particular the NAA level in the spinal cord might provide a meaningful biomarker that could help to determine the degree of injury severity and prognosticate neurologic recovery.	[Fujieda, Yusuke; Bamba, Takeshi; Fukusaki, Eiichiro] Osaka Univ, Grad Sch Engn, Dept Biotechnol, Suita, Osaka, Japan; [Fujieda, Yusuke; Ueno, Shinya; Ogino, Ryoko; Kuroda, Mariko] Asubio Pharma Co Ltd, Kobe, Hyogo, Japan; [Joensson, Thomas J.; Guo, Lining] Metabolon Inc, Durham, NC USA	Osaka University; Asubio Pharma Co., Ltd.; Metabolon	Fujieda, Y (corresponding author), Osaka Univ, Grad Sch Engn, Dept Biotechnol, Suita, Osaka, Japan.	fujieda.yusuke.aw@asubio.co.jp; fukusaki@bio.eng.osaka-u.ac.jp						Abe T, 2005, EUR J NEUROSCI, V22, P1445, DOI 10.1111/j.1460-9568.2005.04340.x; BASSO DM, 1995, J NEUROTRAUM, V12, P1, DOI 10.1089/neu.1995.12.1; Bazan NG, 2006, CELL MOL NEUROBIOL, V26, P901, DOI 10.1007/s10571-006-9064-6; Blamire AM, 2007, MAGN RESON MED, V58, P880, DOI 10.1002/mrm.21382; Carmel JB, 2001, PHYSIOL GENOMICS, V7, P201, DOI 10.1152/physiolgenomics.00074.2001; DABNEY A, 2010, Q VALUE Q VALUE ESTI; Demougeot C, 2004, J NEUROCHEM, V90, P776, DOI 10.1111/j.1471-4159.2004.02583.x; DIENEL GA, 1984, J NEUROCHEM, V42, P1053, DOI 10.1111/j.1471-4159.1984.tb12710.x; Erschbamer M, 2011, EUR J NEUROSCI, V33, P678, DOI 10.1111/j.1460-9568.2010.07562.x; Evans AM, 2009, ANAL CHEM, V81, P6656, DOI 10.1021/ac901536h; FADEN AI, 1989, SCIENCE, V244, P798, DOI 10.1126/science.2567056; Falconer JC, 1996, J NEUROCHEM, V66, P717; Figueroa JD, 2012, J NEUROTRAUM, V29, P551, DOI 10.1089/neu.2011.2141; Fitch MT, 2008, EXP NEUROL, V209, P294, DOI 10.1016/j.expneurol.2007.05.014; Genovese T, 2008, J PHARMACOL EXP THER, V326, P12, DOI 10.1124/jpet.108.136903; Giroud M, 1996, NEUROL RES, V18, P241; Griffith HR, 2008, ALZ DIS ASSOC DIS, V22, P54, DOI 10.1097/WAD.0b013e3181611011; Hayashi S, 2009, BIOCHEM BIOPH RES CO, V386, P268, DOI 10.1016/j.bbrc.2009.06.041; Hulsebosch CE, 2002, ADV PHYSIOL EDUC, V26, P238, DOI 10.1152/advan.00039.2002; Kaddurah-Daouk R, 2008, ANNU REV PHARMACOL, V48, P653, DOI 10.1146/annurev.pharmtox.48.113006.094715; Kendi ATK, 2004, NEURORADIOLOGY, V46, P764, DOI 10.1007/s00234-004-1231-1; King VR, 2006, J NEUROSCI, V26, P4672, DOI 10.1523/JNEUROSCI.5539-05.2006; KWO S, 1989, Journal of Neurotrauma, V6, P13, DOI 10.1089/neu.1989.6.13; Lindon JC, 2007, FEBS J, V274, P1140, DOI 10.1111/j.1742-4658.2007.05673.x; Lubieniecka JM, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019247; Ma WY, 2010, NEUROBIOL AGING, V31, P1227, DOI 10.1016/j.neurobiolaging.2008.08.002; Marliani AF, 2007, MAGN RESON MED, V57, P160, DOI 10.1002/mrm.21113; Mautes AEM, 1999, NEUROSCI LETT, V264, P153, DOI 10.1016/S0304-3940(99)00197-4; McDonald JW, 2002, LANCET, V359, P417, DOI 10.1016/S0140-6736(02)07603-1; Pouw MH, 2009, SPINAL CORD, V47, P519, DOI 10.1038/sc.2008.176; Qian JC, 2010, J NEUROTRAUM, V27, P599, DOI 10.1089/neu.2009.1145; Resnick DK, 2004, NEUROREPORT, V15, P837, DOI 10.1097/00001756-200404090-00020; SAGER TN, 1995, J CEREBR BLOOD F MET, V15, P639, DOI 10.1038/jcbfm.1995.79; Schott JM, 2010, BRAIN, V133, P3315, DOI 10.1093/brain/awq208; Sha W, 2010, FASEB J, V24, P2962, DOI 10.1096/fj.09-154054; Storey JD, 2003, P NATL ACAD SCI USA, V100, P9440, DOI 10.1073/pnas.1530509100; Su HM, 2010, J NUTR BIOCHEM, V21, P364, DOI 10.1016/j.jnutbio.2009.11.003; Tator C H, 1996, J Spinal Cord Med, V19, P206; Tator CH, 1998, NEUROSURGERY, V42, P696, DOI 10.1097/00006123-199804000-00007; Vera-Portocarrero LP, 2002, BRAIN RES, V927, P104, DOI 10.1016/S0006-8993(01)03329-7; Wyndaele M, 2006, SPINAL CORD, V44, P523, DOI 10.1038/sj.sc.3101893; Yan XD, 2010, NEUROCHEM INT, V56, P971, DOI 10.1016/j.neuint.2010.04.007	42	18	19	2	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 13	2012	7	8							e43152	10.1371/journal.pone.0043152	http://dx.doi.org/10.1371/journal.pone.0043152			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	988OJ	22912814	Green Submitted, gold, Green Published			2022-12-25	WOS:000307500100068
J	Grandjean, J; D'Ostilio, K; Phillips, C; Balteau, E; Degueldre, C; Luxen, A; Maquet, P; Salmon, E; Collette, F				Grandjean, Julien; D'Ostilio, Kevin; Phillips, Christophe; Balteau, Evelyne; Degueldre, Christian; Luxen, Andre; Maquet, Pierre; Salmon, Eric; Collette, Fabienne			Modulation of Brain Activity during a Stroop Inhibitory Task by the Kind of Cognitive Control Required	PLOS ONE			English	Article							ANTERIOR CINGULATE CORTEX; WORKING-MEMORY CAPACITY; PREFRONTAL CORTEX; ATTENTIONAL CONTROL; CONTROL MECHANISMS; INTERFERENCE; CONFLICT; FACILITATION; METAANALYSIS; PERFORMANCE	This study used a proportion congruency manipulation in the Stroop task in order to investigate, at the behavioral and brain substrate levels, the predictions derived from the Dual Mechanisms of Control (DMC) account of two distinct modes of cognitive control depending on the task context. Three experimental conditions were created that varied the proportion congruency: mostly incongruent (MI), mostly congruent (MC), and mostly neutral (MN) contexts. A reactive control strategy, which corresponds to transient interference resolution processes after conflict detection, was expected for the rare conflicting stimuli in the MC context, and a proactive strategy, characterized by a sustained task-relevant focus prior to the occurrence of conflict, was expected in the MI context. Results at the behavioral level supported the proactive/reactive distinction, with the replication of the classic proportion congruent effect (i.e., less interference and facilitation effects in the MI context). fMRI data only partially supported our predictions. Whereas reactive control for incongruent trials in the MC context engaged the expected fronto-parietal network including dorsolateral prefrontal cortex (DLPFC) and anterior cingulate cortex, proactive control in the MI context was not associated with any sustained lateral prefrontal cortex activations, contrary to our hypothesis. Surprisingly, incongruent trials in the MI context elicited transient activation in common with incongruent trials in the MC context, especially in DLPFC, superior parietal lobe, and insula. This lack of sustained activity in MI is discussed in reference to the possible involvement of item-specific rather than list-wide mechanisms of control in the implementation of a high task-relevant focus.	[Grandjean, Julien; D'Ostilio, Kevin; Phillips, Christophe; Balteau, Evelyne; Degueldre, Christian; Luxen, Andre; Maquet, Pierre; Salmon, Eric; Collette, Fabienne] Univ Liege, Cyclotron Res Ctr, Liege, Belgium; [Grandjean, Julien; D'Ostilio, Kevin; Collette, Fabienne] Univ Liege, Dept Psychol Cognit & Behav, Liege, Belgium; [Phillips, Christophe] Univ Liege, Dept Elect Engn & Comp Sci, Liege, Belgium	University of Liege; University of Liege; University of Liege	Grandjean, J (corresponding author), Univ Liege, Cyclotron Res Ctr, Liege, Belgium.	f.collette@ulg.ac.be	Salmon, Eric/AAE-4901-2020; Phillips, Christophe/M-3025-2017	Salmon, Eric/0000-0003-2520-9241; , Pierre/0000-0003-3106-3357; Phillips, Christophe/0000-0002-4990-425X	National Fund for Scientific Research (Belgium)	National Fund for Scientific Research (Belgium)(Fonds de la Recherche Scientifique - FNRS)	The authors are supported by the National Fund for Scientific Research (Belgium; http://www1.frs-fnrs.be/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aarts E, 2011, J COGNITIVE NEUROSCI, V23, P716, DOI 10.1162/jocn.2010.21435; Belanger S, 2010, NEUROPSYCHOLOGIA, V48, P581, DOI 10.1016/j.neuropsychologia.2009.10.021; Blais C, 2007, PSYCHOL REV, V114, P1076, DOI 10.1037/0033-295X.114.4.1076; Blais C, 2010, J COGNITIVE NEUROSCI, V22, P2758, DOI 10.1162/jocn.2009.21365; Botvinick MM, 2004, TRENDS COGN SCI, V8, P539, DOI 10.1016/j.tics.2004.10.003; Botvinick MM, 2001, PSYCHOL REV, V108, P624, DOI 10.1037//0033-295X.108.3.624; Braver T. S., 2007, VARIATION WORKING ME, P76, DOI DOI 10.1093/ACPROF:OSO/9780195168648.003.0004; Braver TS, 2012, TRENDS COGN SCI, V16, P106, DOI 10.1016/j.tics.2011.12.010; Braver TS, 2009, P NATL ACAD SCI USA, V106, P7351, DOI 10.1073/pnas.0808187106; Brown TL, 2011, J EXP PSYCHOL HUMAN, V37, P85, DOI 10.1037/a0019252; Bugg JM, 2011, PSYCHON B REV, V18, P930, DOI 10.3758/s13423-011-0112-y; Bugg JM, 2011, J EXP PSYCHOL HUMAN, V37, P1595, DOI 10.1037/a0024670; Bugg JM, 2008, MEM COGNITION, V36, P1484, DOI 10.3758/MC.36.8.1484; Bunge SA, 2002, NEUROIMAGE, V17, P1562, DOI 10.1006/nimg.2002.1252; Carter CS, 2000, P NATL ACAD SCI USA, V97, P1944, DOI 10.1073/pnas.97.4.1944; COHEN JD, 1990, PSYCHOL REV, V97, P332, DOI 10.1037/0033-295X.97.3.332; De Pisapia N, 2006, NEUROCOMPUTING, V69, P1322, DOI 10.1016/j.neucom.2005.12.100; Deichmann R, 2004, NEUROIMAGE, V21, P757, DOI 10.1016/j.neuroimage.2003.09.062; Egner T, 2005, NEUROIMAGE, V24, P539, DOI 10.1016/j.neuroimage.2004.09.007; Fan J, 2003, NEUROIMAGE, V18, P42, DOI 10.1006/nimg.2002.1319; Floden D, 2011, J COGNITIVE NEUROSCI, V23, P867, DOI 10.1162/jocn.2010.21492; Goghari VM, 2009, BRAIN COGNITION, V71, P72, DOI 10.1016/j.bandc.2009.04.004; Hutchison KA, 2011, J EXP PSYCHOL LEARN, V37, P851, DOI 10.1037/a0023437; Jimura K, 2010, CEREB CORTEX, V20, P1420, DOI 10.1093/cercor/bhp206; Jimura K, 2010, P NATL ACAD SCI USA, V107, P8871, DOI 10.1073/pnas.1002007107; Kane MJ, 2003, J EXP PSYCHOL GEN, V132, P47, DOI 10.1037/0096-3445.132.1.47; Kerns JG, 2004, SCIENCE, V303, P1023, DOI 10.1126/science.1089910; Kurth F, 2010, BRAIN STRUCT FUNCT, V214, P519, DOI 10.1007/s00429-010-0255-z; Laird AR, 2005, HUM BRAIN MAPP, V25, P6, DOI 10.1002/hbm.20129; LINDSAY DS, 1994, J EXP PSYCHOL HUMAN, V20, P219, DOI 10.1037/0096-1523.20.2.219; Locke HS, 2008, COGN AFFECT BEHAV NE, V8, P99, DOI 10.3758/CABN.8.1.99; Logan GD, 1998, J EXP PSYCHOL HUMAN, V24, P978, DOI 10.1037/0096-1523.24.3.978; LOGAN GD, 1979, MEM COGNITION, V7, P166, DOI 10.3758/BF03197535; LOWE DG, 1982, CAN J PSYCHOL, V36, P684, DOI 10.1037/h0080661; MacDonald AW, 2000, SCIENCE, V288, P1835, DOI 10.1126/science.288.5472.1835; MACLEOD CM, 1988, J EXP PSYCHOL LEARN, V14, P126, DOI 10.1037/0278-7393.14.1.126; MacLeod CM, 2000, TRENDS COGN SCI, V4, P383, DOI 10.1016/S1364-6613(00)01530-8; MACLEOD CM, 1991, PSYCHOL BULL, V109, P163, DOI 10.1037/0033-2909.109.2.163; Menon V, 2010, BRAIN STRUCT FUNCT, V214, P655, DOI 10.1007/s00429-010-0262-0; Nee DE, 2007, COGN AFFECT BEHAV NE, V7, P1, DOI 10.3758/CABN.7.1.1; Nichols T, 2005, NEUROIMAGE, V25, P653, DOI 10.1016/j.neuroimage.2004.12.005; Paxton JL, 2008, CEREB CORTEX, V18, P1010, DOI 10.1093/cercor/bhm135; Ridderinkhof KR, 2011, WIRES COGN SCI, V2, P174, DOI 10.1002/wcs.99; Roberts KL, 2008, J COGNITIVE NEUROSCI, V20, P1063, DOI 10.1162/jocn.2008.20074; Rush BK, 2006, AGING NEUROPSYCHOL C, V13, P588, DOI 10.1080/13825580600680703; Savine AC, 2010, J NEUROSCI, V30, P10294, DOI 10.1523/JNEUROSCI.2052-10.2010; Stroop JR, 1935, J EXP PSYCHOL, V18, P643, DOI 10.1037/h0054651; Wager TD, 2005, NEUROIMAGE, V27, P323, DOI 10.1016/j.neuroimage.2005.01.054; Walsh BJ, 2011, J COGNITIVE NEUROSCI, V23, P2211, DOI 10.1162/jocn.2010.21595	49	44	46	2	22	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 24	2012	7	7							e41513	10.1371/journal.pone.0041513	http://dx.doi.org/10.1371/journal.pone.0041513			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	978NX	22911806	Green Published, Green Submitted, gold			2022-12-25	WOS:000306751300051
J	Patel, A; Zhu, YH; Kuzhikandathil, EV; Banks, WA; Siegel, A; Zalcman, SS				Patel, Ankur; Zhu, Youhua; Kuzhikandathil, Eldo V.; Banks, William A.; Siegel, Allan; Zalcman, Steven S.			Soluble Interleukin-6 Receptor Induces Motor Stereotypies and Co-Localizes with Gp130 in Regions Linked to Cortico-Striato-Thalamo-Cortical Circuits	PLOS ONE			English	Article							BETA-PROTEIN ANTIBODY; BLOOD-BRAIN-BARRIER; IL-6 RECEPTOR; CYTOKINE NETWORK; MOUSE MODEL; SCHIZOPHRENIA; AMPHETAMINE; ACTIVATION; COMPLEX; PASSAGE	Soluble cytokine receptors are normal constituents of body fluids that regulate peripheral cytokine and lymphoid activity and whose levels are increased in states of immune activation. Soluble interleukin-6 receptor (sIL-6R) levels positively correlate with disease progression in some autoimmune conditions and psychiatric disorders. Particularly strong links between levels of sIL-6R and the severity of psychotic symptoms occur in schizophrenia, raising the possibility that sIL-6R is involved in this disease. However, there is no evidence that peripheral sIL-6R induces relevant behavioral disturbances. We showed that single subcutaneous injections of sIL-6R (0-1 mu g), stimulated novelty stress-induced exploratory motor behaviors in male Balb/c mice within 20-40-min of injection. A progressive increase in vertical stereotypies was observed 40-80 min post injection, persisting for the remainder of the test session. Paralleling these stimulant-like effects, sIL-6R pretreatment significantly enhanced stereotypy scores following challenge with GBR 12909. We found that peripherally administered sIL-6R crossed the blood-brain barrier, localizing in brain regions associated with cortico-striatal-thalamo-cortical (CSTC) circuits, which are putative neuroanatomical substrates of disorders associated with repetitive stereotypies. Peripherally administered sIL-6R co-localized with gp130, a transmembrane protein involved in IL-6 trans-signaling, in the nucleus accumbens, caudate-putamen, motor and infralimbic cortices, and thalamic nuclei, but not with gp130 in the ventral tegmental area, substantia nigra, or sensorimotor cortex,. The results suggest that peripheral sIL-6R can act as a neuroimmune messenger, crossing the blood brain barrier (BBB) to selectively target CSTC circuits rich in IL-6 trans-signaling protein, and inducing repetitive stereotypies. As such sIL-6R may represent a novel therapeutic agent for relevant psychiatric disorders.	[Patel, Ankur; Siegel, Allan] Univ Med & Dent New Jersey, New Jersey Med Sch, Dept Neurol & Neurosci, Newark, NJ 07103 USA; [Zhu, Youhua; Zalcman, Steven S.] Univ Med & Dent New Jersey, New Jersey Med Sch, Dept Psychiat, Newark, NJ 07103 USA; [Kuzhikandathil, Eldo V.] Univ Med & Dent New Jersey, New Jersey Med Sch, Dept Physiol & Pharmacol, Newark, NJ 07103 USA; [Banks, William A.] Univ Washington, Vet Affairs Puget Sound Hlth Care Syst, Div Gerontol & Geriatr Med, Dept Med,Geriatr Res Educ & Clin Ctr, Seattle, WA 98195 USA	Rutgers State University New Brunswick; Rutgers State University Medical Center; Rutgers State University New Brunswick; Rutgers State University Medical Center; Rutgers State University New Brunswick; Rutgers State University Medical Center; Geriatric Research Education & Clinical Center; University of Washington; University of Washington Seattle; US Department of Veterans Affairs; Veterans Health Administration (VHA); Vet Affairs Puget Sound Health Care System	Patel, A (corresponding author), Univ Med & Dent New Jersey, New Jersey Med Sch, Dept Neurol & Neurosci, 185 S Orange Ave, Newark, NJ 07103 USA.	dr.ankur@yahoo.com	Banks, William A/K-1330-2017	Banks, William A/0000-0002-0496-3619	National Institutes of Health [R01 MH74689, T32 5A74309]; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH074689] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))	This work was supported by National Institutes of Health Grant R01 MH74689 (SSZ) and National Institutes of Health Training Fellowship T32 5A74309 (AP). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Banks WA, 2005, PEPTIDES, V26, P287, DOI 10.1016/j.peptides.2004.09.016; Banks WA, 2004, CURR PHARM DESIGN, V10, P1365, DOI 10.2174/1381612043384862; Banks WA, 2002, PEPTIDES, V23, P2223, DOI 10.1016/S0196-9781(02)00261-9; Banks WA, 2007, EXP NEUROL, V206, P248, DOI 10.1016/j.expneurol.2007.05.005; Barille S, 2000, EUR CYTOKINE NETW, V11, P546; CREESE I, 1972, NATURE-NEW BIOL, V238, P247, DOI 10.1038/newbio238247a0; Dayer JM, 2010, RHEUMATOLOGY, V49, P15, DOI 10.1093/rheumatology/kep329; DEBENEDETTI F, 1994, J CLIN INVEST, V93, P2114, DOI 10.1172/JCI117206; Hirota H, 1996, J EXP MED, V183, P2627, DOI 10.1084/jem.183.6.2627; Jones SA, 2001, FASEB J, V15, P43, DOI 10.1096/fj.99-1003rev; KISHIMOTO T, 1992, SCIENCE, V258, P593, DOI 10.1126/science.1411569; Lauta VM, 2003, CANCER, V97, P2440, DOI 10.1002/cncr.11072; Levine SJ, 2008, J BIOL CHEM, V283, P14177, DOI 10.1074/jbc.R700052200; Maes M, 1995, INTERLEUKIN 2 INTERL; Marz P, 1998, P NATL ACAD SCI USA, V95, P3251, DOI 10.1073/pnas.95.6.3251; Muller N, 2008, EUR ARCH PSY CLIN N, V258, P97, DOI 10.1007/s00406-008-2012-3; Muller N, 1997, NERVENARZT, V68, P11, DOI 10.1007/s001150050092; Muller N, 1996, GEBURTSH FRAUENHEILK, V56, pM82; Novick D, 2007, CYTOKINE GROWTH F R, V18, P525, DOI 10.1016/j.cytogfr.2007.06.024; Peter JC, 2010, J PHARMACOL EXP THER, V333, P478, DOI 10.1124/jpet.109.163279; Potvin S, 2008, BIOL PSYCHIAT, V63, P801, DOI 10.1016/j.biopsych.2007.09.024; ROSEJOHN S, 1994, BIOCHEM J, V300, P281, DOI 10.1042/bj3000281; Saka E, 2004, J NEUROSCI, V24, P7557, DOI 10.1523/JNEUROSCI.1072-04.2004; SCHOBITZ B, 1995, FASEB J, V9, P659, DOI 10.1096/fasebj.9.8.7768358; Wang JP, 1998, NEUROCHEM INT, V33, P143, DOI 10.1016/S0197-0186(98)00016-3; ZALCMAN S, 1994, BRAIN RES, V643, P40, DOI 10.1016/0006-8993(94)90006-X; Zalcman S, 1999, BRAIN RES, V847, P276, DOI 10.1016/S0006-8993(99)02063-6; Zalcman S, 1998, BRAIN RES, V811, P111, DOI 10.1016/S0006-8993(98)00904-4; Zalcman SS, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0036316; Zhang DH, 2012, BRAIN BEHAV IMMUN, V26, P521, DOI 10.1016/j.bbi.2012.01.005; Zhang PL, 2004, STEM CELLS, V22, P344, DOI 10.1634/stemcells.22-3-344	31	26	28	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 23	2012	7	7							e41623	10.1371/journal.pone.0041623	http://dx.doi.org/10.1371/journal.pone.0041623			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	977TM	22911828	Green Published, Green Submitted, gold			2022-12-25	WOS:000306687700127
J	Clokie, SJH; Lau, P; Kim, HH; Coon, SL; Klein, DC				Clokie, Samuel J. H.; Lau, Pierre; Kim, Hyun Hee; Coon, Steven L.; Klein, David C.			MicroRNAs in the Pineal Gland miR-483 REGULATES MELATONIN SYNTHESIS BY TARGETING ARYLALKYLAMINE N-ACETYLTRANSFERASE	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SEROTONIN N-ACETYLTRANSFERASE; MESSENGER-RNAS; MOUSE RETINA; EXPRESSION; RAT; GENES; IDENTIFICATION; RHYTHM; AANAT; DIFFERENTIATION	MicroRNAs (miRNAs) play a broad range of roles in biological regulation. In this study, rat pineal miRNAs were profiled for the first time, and their importance was evaluated by focusing on the main function of the pineal gland, melatonin synthesis. Massively parallel sequencing and related methods revealed the miRNA population is dominated by a small group of miRNAs as follows: similar to 75% is accounted for by 15 miRNAs; miR-182 represents 28%. In addition to miR-182, miR-183 and miR-96 are also highly enriched in the pineal gland, a distinctive pattern also found in the retina. This effort also identified previously unrecognized miRNAs and other small noncoding RNAs. Pineal miRNAs do not exhibit a marked night/day difference in abundance with few exceptions (e. g. 2-fold night/day differences in the abundance of miR-96 and miR-182); this contrasts sharply with the dynamic 24-h pattern that characterizes the pineal transcriptome. During development, the abundance of most pineal gland-enriched miRNAs increases; however, there is a marked decrease in at least one, miR-483. miR-483 is a likely regulator of melatonin synthesis, based on the following. It inhibits melatonin synthesis by pinealocytes in culture; it acts via predicted binding sites in the 3'-UTR of arylalkylamine N-acetyltransferase (Aanat) mRNA, the penultimate enzyme in melatonin synthesis, and it exhibits a developmental profile opposite to that of Aanat transcripts. Additionally, a miR-483 targeted antagonist increased melatonin synthesis in neonatal pinealocytes. These observations support the hypothesis that miR-483 suppresses Aanat mRNA levels during development and that the developmental decrease in miR-483 abundance promotes melatonin synthesis.	[Klein, David C.] Eunice Kennedy Shriver NICHD, Sect Neuroendocrinol, Program Dev Endocrinol & Genet, NIH, Bethesda, MD 20892 USA; [Lau, Pierre] Univ Louvain, Ctr Human Genet, B-3000 Louvain, Belgium; [Lau, Pierre] Univ Louvain, LIND, B-3000 Louvain, Belgium	National Institutes of Health (NIH) - USA; NIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)	Klein, DC (corresponding author), Eunice Kennedy Shriver NICHD, Sect Neuroendocrinol, Program Dev Endocrinol & Genet, NIH, Bldg 49,Rm 6A82, Bethesda, MD 20892 USA.	kleind@mail.nih.gov	Osada, Hiroyuki/N-4305-2014	Clokie, Samuel/0000-0002-0025-3652; Klein, David/0000-0002-1792-5806	National Institutes of Health Intramural Research Program, NICHD; Grants-in-Aid for Scientific Research [23790115] Funding Source: KAKEN; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [ZIAHD008836, ZIAHD008838] Funding Source: NIH RePORTER	National Institutes of Health Intramural Research Program, NICHD; Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI)); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD))	This work was supported, in whole or in part, by National Institutes of Health Intramural Research Program, NICHD.	Araki M, 2007, DEV NEUROBIOL, V67, P1641, DOI 10.1002/dneu.20534; Bagga S, 2005, CELL, V122, P553, DOI 10.1016/j.cell.2005.07.031; Bailey MJ, 2009, J BIOL CHEM, V284, P7606, DOI 10.1074/jbc.M808394200; Bartel DP, 2009, CELL, V136, P215, DOI 10.1016/j.cell.2009.01.002; Bernstein E, 2003, NAT GENET, V35, P215, DOI 10.1038/ng1253; Burroughs AM, 2010, GENOME RES, V20, P1398, DOI 10.1101/gr.106054.110; Cai XZ, 2004, RNA, V10, P1957, DOI 10.1261/rna.7135204; Candiani S, 2011, EVODEVO, V2, DOI 10.1186/2041-9139-2-15; Coon SL, 1996, GENOMICS, V34, P76, DOI 10.1006/geno.1996.0243; Damiani D, 2008, J NEUROSCI, V28, P4878, DOI 10.1523/JNEUROSCI.0828-08.2008; Elbashir SM, 2001, GENE DEV, V15, P188, DOI 10.1101/gad.862301; ELLISON N, 1972, J NEUROCHEM, V19, P1335, DOI 10.1111/j.1471-4159.1972.tb01458.x; Eriksson T, 2001, EXP CELL RES, V270, P88, DOI 10.1006/excr.2001.5336; Friedlander MR, 2008, NAT BIOTECHNOL, V26, P407, DOI 10.1038/nbt1394; Friedman RC, 2009, GENOME RES, V19, P92, DOI 10.1101/gr.082701.108; Fujita PA, 2011, NUCLEIC ACIDS RES, V39, pD876, DOI 10.1093/nar/gkq963; Hackenberg M, 2009, NUCLEIC ACIDS RES, V37, pW68, DOI 10.1093/nar/gkp347; Ho AK, 1996, MOL PHARMACOL, V49, P1104; Ho AK, 2010, J NEUROCHEM, V112, P321, DOI 10.1111/j.1471-4159.2009.06457.x; Kim JS, 2005, J BIOL CHEM, V280, P677, DOI 10.1074/jbc.M408438200; Klein DC, 2007, J BIOL CHEM, V282, P4233, DOI 10.1074/jbc.R600036200; Klein DC, 2006, CHRONOBIOL INT, V23, P5, DOI 10.1080/07420520500545839; Klein DC, 2004, J BIOL RHYTHM, V19, P264, DOI 10.1177/0748730404267340; Krol J, 2010, CELL, V141, P618, DOI 10.1016/j.cell.2010.03.039; Lagos-Quintana M, 2001, SCIENCE, V294, P853, DOI 10.1126/science.1064921; Landgraf P, 2007, CELL, V129, P1401, DOI 10.1016/j.cell.2007.04.040; Lee Rosalind, 2004, Cell, VS116, pS89, DOI 10.1016/S0092-8674(04)00035-2; Lee Y, 2004, EMBO J, V23, P4051, DOI 10.1038/sj.emboj.7600385; Li H, 2009, BIOINFORMATICS, V25, P2078, DOI 10.1093/bioinformatics/btp352; Li QS, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0026000; Miranda KC, 2006, CELL, V126, P1203, DOI 10.1016/j.cell.2006.07.031; Moller M, 2007, PROTEOMICS, V7, P2009, DOI 10.1002/pmic.200600963; Munoz EM, 2007, J NEUROCHEM, V102, P887, DOI 10.1111/j.1471-4159.2007.04605.x; Pall GS, 2008, NAT PROTOC, V3, P1077, DOI 10.1038/nprot.2008.67; PARFITT A, 1975, MOL PHARMACOL, V11, P241; Patterson EE, 2011, CANCER-AM CANCER SOC, V117, P1630, DOI 10.1002/cncr.25724; Peliciari-Garcia RA, 2010, LIFE SCI, V87, P169, DOI 10.1016/j.lfs.2010.06.005; Pfeffer M, 1998, NEUROSCI LETT, V248, P163, DOI 10.1016/S0304-3940(98)00356-5; Quinlan AR, 2010, BIOINFORMATICS, V26, P841, DOI 10.1093/bioinformatics/btq033; Rath MF, 2007, EXP EYE RES, V85, P65, DOI 10.1016/j.exer.2007.02.016; Rath MF, 2006, J NEUROCHEM, V97, P556, DOI 10.1111/j.1471-4159.2006.03773.x; Reiter Russel J., 2007, Critical Reviews in Oncogenesis, V13, P303; Ruby JG, 2007, NATURE, V448, P83, DOI 10.1038/nature05983; Schnall-Levin M, 2011, GENOME RES, V21, P1395, DOI 10.1101/gr.121210.111; Sempere LF, 2004, GENOME BIOL, V5, DOI 10.1186/gb-2004-5-3-r13; Shen JY, 2012, P NATL ACAD SCI USA, V109, P3540, DOI 10.1073/pnas.1119201109; SUGDEN D, 1983, J NEUROCHEM, V40, P1647, DOI 10.1111/j.1471-4159.1983.tb08138.x; Valoczi A, 2004, NUCLEIC ACIDS RES, V32, DOI 10.1093/nar/gnh171; Varani G, 2000, EMBO REP, V1, P18, DOI 10.1093/embo-reports/kvd001; Vermeulen A, 2007, RNA, V13, P723, DOI 10.1261/rna.448107; Wongchitrat P, 2011, NEUROENDOCRINOLOGY, V94, P75, DOI 10.1159/000327430; Xu SB, 2007, J BIOL CHEM, V282, P25053, DOI 10.1074/jbc.M700501200; Zhu QB, 2011, J BIOL CHEM, V286, P31749, DOI 10.1074/jbc.M111.259028; Zuker M, 2003, NUCLEIC ACIDS RES, V31, P3406, DOI 10.1093/nar/gkg595	54	55	86	1	14	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 20	2012	287	30					25312	25324		10.1074/jbc.M112.356733	http://dx.doi.org/10.1074/jbc.M112.356733			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	977IW	22908386	Green Published, hybrid			2022-12-25	WOS:000306651700039
J	Magadan, AH; Dupuis, ME; Villion, M; Moineau, S				Magadan, Alfonso H.; Dupuis, Marie-Eve; Villion, Manuela; Moineau, Sylvain			Cleavage of Phage DNA by the Streptococcus thermophilus CRISPR3-Cas System	PLOS ONE			English	Article							CRISPR/CAS SYSTEM; IMMUNE-SYSTEM; BACTERIA; BACTERIOPHAGES; RESISTANCE; SEQUENCES; DIVERSITY; EVOLUTION; RNA	Streptococcus thermophilus, similar to other Bacteria and Archaea, has developed defense mechanisms to protect cells against invasion by foreign nucleic acids, such as virus infections and plasmid transformations. One defense system recently described in these organisms is the CRISPR-Cas system (Clustered Regularly Interspaced Short Palindromic Repeats loci coupled to CRISPR-associated genes). Two S. thermophilus CRISPR-Cas systems, CRISPR1-Cas and CRISPR3-Cas, have been shown to actively block phage infection. The CRISPR1-Cas system interferes by cleaving foreign dsDNA entering the cell in a length-specific and orientation-dependant manner. Here, we show that the S. thermophilus CRISPR3-Cas system acts by cleaving phage dsDNA genomes at the same specific position inside the targeted protospacer as observed with the CRISPR1-Cas system. Only one cleavage site was observed in all tested strains. Moreover, we observed that the CRISPR1-Cas and CRISPR3-Cas systems are compatible and, when both systems are present within the same cell, provide increased resistance against phage infection by both cleaving the invading dsDNA. We also determined that overall phage resistance efficiency is correlated to the total number of newly acquired spacers in both CRISPR loci.	[Magadan, Alfonso H.; Dupuis, Marie-Eve; Villion, Manuela; Moineau, Sylvain] Univ Laval, Fac Sci & Genie, Grp Rech Ecol Buccale, Dept Biochim Microbiol & Bioinformat, Quebec City, PQ G1K 7P4, Canada; [Moineau, Sylvain] Univ Laval, Felix dHerelle Reference Ctr Bacterial Viruses, Quebec City, PQ G1K 7P4, Canada	Laval University; Laval University	Magadan, AH (corresponding author), Univ Laval, Fac Sci & Genie, Grp Rech Ecol Buccale, Dept Biochim Microbiol & Bioinformat, Quebec City, PQ G1K 7P4, Canada.	Sylvain.Moineau@bcm.ulaval.ca	Magadán, Alfonso Hernández/K-4455-2012; Moineau, Sylvain/I-7231-2019; Moineau, Sylvain/N-3578-2013; Magadan, Alfonso Hernandez/M-5994-2019	Magadán, Alfonso Hernández/0000-0003-2556-7890; Moineau, Sylvain/0000-0002-2832-5101; Magadan, Alfonso Hernandez/0000-0003-2556-7890	Natural Sciences and Engineering Research Council (NSERC) of Canada	Natural Sciences and Engineering Research Council (NSERC) of Canada(Natural Sciences and Engineering Research Council of Canada (NSERC))	S.M. acknowledges funding from the Natural Sciences and Engineering Research Council (NSERC) of Canada (Discovery program). S. M. holds a Tier 1 Canada Research Chair in Bacteriophages. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Al-Attar S, 2011, BIOL CHEM, V392, P277, DOI 10.1515/BC.2011.042; Barrangou R, 2007, SCIENCE, V315, P1709, DOI 10.1126/science.1138140; Bolotin A, 2004, NAT BIOTECHNOL, V22, P1554, DOI 10.1038/nbt1034; Delorme C, 2011, J BACTERIOL, V193, P5581, DOI 10.1128/JB.05404-11; Delorme C, 2010, APPL ENVIRON MICROB, V76, P451, DOI 10.1128/AEM.01018-09; Deltcheva E, 2011, NATURE, V471, P602, DOI 10.1038/nature09886; Deveau H, 2008, J BACTERIOL, V190, P1390, DOI 10.1128/JB.01412-07; Deveau H, 2010, ANNU REV MICROBIOL, V64, P475, DOI 10.1146/annurev.micro.112408.134123; Duplessis M, 2005, VIROLOGY, V340, P192, DOI 10.1016/j.virol.2005.05.033; Fortier LC, 2007, APPL ENVIRON MICROB, V73, P7358, DOI 10.1128/AEM.00582-07; Garneau JE, 2011, MICROB CELL FACT, V10, DOI 10.1186/1475-2859-10-S1-S20; Garneau JE, 2010, NATURE, V468, P67, DOI 10.1038/nature09523; Grissa I, 2007, BMC BIOINFORMATICS, V8, DOI 10.1186/1471-2105-8-172; Hale C, 2008, RNA, V14, P2572, DOI 10.1261/rna.1246808; Horvath P, 2008, J BACTERIOL, V190, P1401, DOI 10.1128/JB.01415-07; Horvath P, 2010, SCIENCE, V327, P167, DOI 10.1126/science.1179555; Khan MA, 2004, ENV BIOTECHNOLOGY AD, P349; Levesque C, 2005, APPL ENVIRON MICROB, V71, P4057, DOI 10.1128/AEM.71.7.4057-4068.2005; Makarova K, 2006, P NATL ACAD SCI USA, V103, P15611, DOI 10.1073/pnas.0607117103; Makarova KS, 2011, NAT REV MICROBIOL, V9, P467, DOI 10.1038/nrmicro2577; Mills S, 2010, J APPL MICROBIOL, V108, P945, DOI 10.1111/j.1365-2672.2009.04486.x; Mojica FJM, 2009, MICROBIOL-SGM, V155, P733, DOI 10.1099/mic.0.023960-0; Mojica FJM, 2005, J MOL EVOL, V60, P174, DOI 10.1007/s00239-004-0046-3; Sambrook J, 2001, MOL CLONING LAB MANU; Sapranauskas R, 2011, NUCLEIC ACIDS RES, V39, P9275, DOI 10.1093/nar/gkr606; Sun ZH, 2011, J BACTERIOL, V193, P793, DOI 10.1128/JB.01374-10; Wiedenheft B, 2012, NATURE, V482, P331, DOI 10.1038/nature10886	27	72	96	1	50	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 20	2012	7	7							e40913	10.1371/journal.pone.0040913	http://dx.doi.org/10.1371/journal.pone.0040913			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	977GL	22911717	gold, Green Published, Green Submitted			2022-12-25	WOS:000306644600028
J	Molesini, B; Pandolfini, T; Pii, Y; Korte, A; Spena, A				Molesini, Barbara; Pandolfini, Tiziana; Pii, Youry; Korte, Arthur; Spena, Angelo			Arabidopsis thaliana AUCSIA-1 Regulates Auxin Biology and Physically Interacts with a Kinesin-Related Protein	PLOS ONE			English	Article							PRECURSOR INDOLE-3-BUTYRIC ACID; CLATHRIN-DEPENDENT ENDOCYTOSIS; LATERAL ROOT DEVELOPMENT; GENE-EXPRESSION; FLAVIN MONOOXYGENASES; SIGNAL-TRANSDUCTION; ACTIN CYTOSKELETON; FRUIT-DEVELOPMENT; PLANT DEVELOPMENT; ABC TRANSPORTERS	Aucsia is a green plant gene family encoding 44-54 amino acids long miniproteins. The sequenced genomes of most land plants contain two Aucsia genes. RNA interference of both tomato (Solanum lycopersicum) Aucsia genes (SlAucsia-1 and SlAucsia-2) altered auxin sensitivity, auxin transport and distribution; it caused parthenocarpic development of the fruit and other auxin-related morphological changes. Here we present data showing that the Aucsia-1 gene of Arabidopsis thaliana alters, by itself, root auxin biology and that the AtAUCSIA-1 miniprotein physically interacts with a kinesin-related protein. The AtAucsia-1 gene is ubiquitously expressed, although its expression is higher in roots and inflorescences in comparison to stems and leaves. Two allelic mutants for AtAucsia-1 gene did not display visible root morphological alterations; however both basipetal and acropetal indole-3-acetic acid (IAA) root transport was reduced as compared with wild-type plants. The transcript steady state levels of the auxin efflux transporters ATP BINDING CASSETTE subfamily B (ABCB) ABCB1, ABCB4 and ABCB19 were reduced in ataucsia-1 plants. In ataucsia-1 mutant, lateral root growth showed an altered response to i) exogenous auxin, ii) an inhibitor of polar auxin transport and iii) ethylene. Overexpression of AtAucsia-1 inhibited primary root growth. In vitro and in vivo protein-protein interaction experiments showed that AtAUCSIA-1 interacts with a 185 amino acids long fragment belonging to a 2712 amino acids long protein of unknown function (At4g31570). Bioinformatics analysis indicates that the AtAUCSIA-1 interacting protein (AtAUCSIA-1IP) clusters with a group of CENP-E kinesin-related proteins. Gene ontology predictions for the two proteins are consistent with the hypothesis that the AtAUCSIA-1/AtAUCSIA-1IP complex is involved in the regulation of the cytoskeleton dynamics underlying auxin biology.	[Molesini, Barbara; Pandolfini, Tiziana; Pii, Youry; Spena, Angelo] Univ Verona, Dept Biotechnol, I-37100 Verona, Italy; [Korte, Arthur] WeihenstephanTech Univ Muenchen, Wissensch Zentrum, Freising Weihenstephan, Germany	University of Verona	Molesini, B (corresponding author), Univ Verona, Dept Biotechnol, I-37100 Verona, Italy.	angelo.spena@univr.it	Korte, Arthur/H-3190-2019; Pii, Youry/N-1151-2016	Korte, Arthur/0000-0003-0831-1463; Pii, Youry/0000-0002-1613-851X; MOLESINI, Barbara/0000-0002-4324-4908; Pandolfini, Tiziana/0000-0002-1658-2231	MIUR (Ministry for University and Research)	MIUR (Ministry for University and Research)(Ministry of Education, Universities and Research (MIUR))	Supported by a MIUR (Ministry for University and Research) grant to AS (from 2005 to 2007). No other financial support. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abas L, 2006, NAT CELL BIOL, V8, P249, DOI 10.1038/ncb1369; ABEL S, 1994, PLANT J, V5, P421, DOI 10.1111/j.1365-313X.1994.00421.x; Alonso JM, 2004, SCIENCE, V306, P1513, DOI 10.1126/science.1104812; Alonso JM, 2003, SCIENCE, V301, P653, DOI 10.1126/science.1086391; ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1016/S0022-2836(05)80360-2; Bandyopadhyay A, 2007, BIOCHEM SOC T, V35, P137, DOI 10.1042/BST0350137; Berg JS, 2001, MOL BIOL CELL, V12, P780, DOI 10.1091/mbc.12.4.780; Bhalerao RP, 2003, NAT CELL BIOL, V5, P939, DOI 10.1038/ncb1103-939; Blakeslee JJ, 2005, CURR OPIN PLANT BIOL, V8, P494, DOI 10.1016/j.pbi.2005.07.014; Blakeslee JJ, 2007, PLANT CELL, V19, P131, DOI 10.1105/tpc.106.040782; Bohn-Courseau I, 2010, CR BIOL, V333, P290, DOI 10.1016/j.crvi.2010.01.004; Bradford JR, 2010, PLANT J, V61, P713, DOI 10.1111/j.1365-313X.2009.04097.x; Calderon-Villalobos LI, 2010, CSH PERSPECT BIOL, V2, DOI 10.1101/cshperspect.a005546; Casimiro I, 2001, PLANT CELL, V13, P843, DOI 10.1105/tpc.13.4.843; Cecchetti V, 2008, PLANT CELL, V20, P1760, DOI 10.1105/tpc.107.057570; Cheng YF, 2006, GENE DEV, V20, P1790, DOI 10.1101/gad.1415106; Dhonukshe P, 2008, P NATL ACAD SCI USA, V105, P4489, DOI 10.1073/pnas.0711414105; Doherty GJ, 2009, ANNU REV BIOCHEM, V78, P857, DOI 10.1146/annurev.biochem.78.081307.110540; Fei HM, 2004, PLANTA, V219, P649, DOI 10.1007/s00425-004-1270-1; FIELDS S, 1994, TRENDS GENET, V10, P286, DOI 10.1016/0168-9525(90)90012-U; Freeling M, 2006, GENOME RES, V16, P805, DOI 10.1101/gr.3681406; Freeling M, 2009, ANNU REV PLANT BIOL, V60, P433, DOI 10.1146/annurev.arplant.043008.092122; Frey N, 2010, J EXP BOT, V61, P3423, DOI 10.1093/jxb/erq164; Friml J, 2004, SCIENCE, V306, P862, DOI 10.1126/science.1100618; Fuentes S, 2010, ANNU PLANT REV, V38, P107, DOI 10.1002/9781444314557.ch4; Fukaki H, 2009, PLANT MOL BIOL, V69, P437, DOI 10.1007/s11103-008-9417-2; Galvan-Ampudia CS, 2007, TRENDS PLANT SCI, V12, P541, DOI 10.1016/j.tplants.2007.10.004; Gao XW, 2008, MOL PLANT, V1, P899, DOI 10.1093/mp/ssn069; Garzon M, 2007, FEBS LETT, V581, P3189, DOI 10.1016/j.febslet.2007.06.005; Geisler M, 2005, PLANT J, V44, P179, DOI 10.1111/j.1365-313X.2005.02519.x; Geldner N, 2001, NATURE, V413, P425, DOI 10.1038/35096571; Geldner N, 2003, CELL, V112, P219, DOI 10.1016/S0092-8674(03)00003-5; Gil P, 2001, GENE DEV, V15, P1985, DOI 10.1101/gad.905201; Gupta Ramneek, 2002, Pac Symp Biocomput, P310; Gustafson FG, 1936, P NATL ACAD SCI USA, V22, P628, DOI 10.1073/pnas.22.11.628; Harrison BR, 2008, PLANT J, V53, P380, DOI 10.1111/j.1365-313X.2007.03351.x; Heisler MG, 2005, CURR BIOL, V15, P1899, DOI 10.1016/j.cub.2005.09.052; Ivanchenko MG, 2008, PLANT J, V55, P335, DOI 10.1111/j.1365-313X.2008.03528.x; Iwai S, 2004, J BIOL CHEM, V279, P4696, DOI 10.1074/jbc.M308022200; Kleine-Vehn J, 2008, CURR BIOL, V18, P526, DOI 10.1016/j.cub.2008.03.021; Kleine-Vehn J, 2006, PLANT CELL, V18, P3171, DOI 10.1105/tpc.106.042770; Knapp S, 2002, J EXP BOT, V53, P2001, DOI 10.1093/jxb/erf068; Komander D, 2009, BIOCHEM SOC T, V37, P937, DOI 10.1042/BST0370937; Kuriyama R, 2002, J CELL BIOL, V156, P783, DOI 10.1083/jcb.200109090; Lewis DR, 2009, NAT PROTOC, V4, P437, DOI 10.1038/nprot.2009.1; Leyser O, 2006, CURR BIOL, V16, pR424, DOI 10.1016/j.cub.2006.05.014; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Ljung K, 2005, PLANT CELL, V17, P1090, DOI 10.1105/tpc.104.029272; Ljung K, 2001, PLANT J, V28, P465, DOI 10.1046/j.1365-313X.2001.01173.x; Lobello G, 2000, J EXP BOT, V51, P1403, DOI 10.1093/jexbot/51.349.1403; Lynch M, 2000, GENETICS, V154, P459; Lynch M, 2002, SCIENCE, V297, P945, DOI 10.1126/science.1075472; Marsch-Martinez N, 2002, PLANT PHYSIOL, V129, P1544, DOI 10.1104/pp.003327; Martinez-Laborda A., 2009, ARABIDOPSIS FRUIT DE, P172; Molesini B, 2009, PLANT PHYSIOL, V149, P534, DOI 10.1104/pp.108.131367; Mravec J, 2009, NATURE, V459, P1136, DOI 10.1038/nature08066; Muller A, 1998, EMBO J, V17, P6903, DOI 10.1093/emboj/17.23.6903; Negi S, 2008, PLANT J, V55, P175, DOI 10.1111/j.1365-313X.2008.03495.x; Nick P, 2009, PLANT PHYSIOL, V151, P155, DOI 10.1104/pp.109.140111; Noh B, 2003, NATURE, V423, P999, DOI 10.1038/nature01716; Noh B, 2001, PLANT CELL, V13, P2441, DOI 10.1105/tpc.13.11.2441; Paciorek T, 2005, NATURE, V435, P1251, DOI 10.1038/nature03633; Pagnussat GC, 2009, SCIENCE, V324, P1684, DOI 10.1126/science.1167324; Pandey KN, 2009, FRONT BIOSCI-LANDMRK, V14, P5339, DOI 10.2741/3599; Peer WA, 2011, MOL PLANT, V4, P487, DOI 10.1093/mp/ssr034; Petrasek J, 2006, SCIENCE, V312, P914, DOI 10.1126/science.1123542; Petrasek J, 2009, DEVELOPMENT, V136, P2675, DOI 10.1242/dev.030353; Pii Y, 2007, BMC PLANT BIOL, V7, DOI 10.1186/1471-2229-7-21; Preuss ML, 2004, PLANT PHYSIOL, V136, P3945, DOI 10.1104/pp.104.052340; Rahman A, 2007, PLANT J, V50, P514, DOI 10.1111/j.1365-313X.2007.03068.x; Rashotte AM, 2000, PLANT PHYSIOL, V122, P481, DOI 10.1104/pp.122.2.481; Reed RC, 1998, PLANT PHYSIOL, V118, P1369, DOI 10.1104/pp.118.4.1369; Robert S, 2010, CELL, V143, P111, DOI 10.1016/j.cell.2010.09.027; Rotino GL, 1997, NAT BIOTECHNOL, V15, P1398, DOI 10.1038/nbt1297-1398; Ruegger M, 1998, GENE DEV, V12, P198, DOI 10.1101/gad.12.2.198; Ruzicka K, 2010, P NATL ACAD SCI USA, V107, P10749, DOI 10.1073/pnas.1005878107; Samaj J, 2004, PLANT PHYSIOL, V135, P1150, DOI 10.1104/pp.104.040683; SANCHEZBRAVO J, 1992, PLANT PHYSIOL, V100, P108, DOI 10.1104/pp.100.1.108; Sauer M, 2006, GENE DEV, V20, P2902, DOI 10.1101/gad.390806; Schliwa M, 2003, NATURE, V422, P759, DOI 10.1038/nature01601; Schulz B, 2006, FEBS LETT, V580, P1010, DOI 10.1016/j.febslet.2006.01.002; Shin R, 2007, PLANT CELL, V19, P2440, DOI 10.1105/tpc.107.050963; Stepanova AN, 2005, PLANT CELL, V17, P2230, DOI 10.1105/tpc.105.033365; Stepanova AN, 2007, PLANT CELL, V19, P2169, DOI 10.1105/tpc.107.052068; Strader LC, 2009, PLANT CELL, V21, P1992, DOI 10.1105/tpc.109.065821; Suetsugu N, 2010, P NATL ACAD SCI USA, V107, P8860, DOI 10.1073/pnas.0912773107; Terasaka K, 2005, PLANT CELL, V17, P2922, DOI 10.1105/tpc.105.035816; THOMPSON JD, 1994, NUCLEIC ACIDS RES, V22, P4673, DOI 10.1093/nar/22.22.4673; Titapiwatanakun B, 2009, PLANT J, V57, P27, DOI 10.1111/j.1365-313X.2008.03668.x; Titapiwatanakun B, 2009, J EXP BOT, V60, P1093, DOI 10.1093/jxb/ern240; Traub LM, 2007, J CELL SCI, V120, P543, DOI 10.1242/jcs.03385; Ulmasov T, 1997, PLANT CELL, V9, P1963, DOI 10.1105/tpc.9.11.1963; Walter M, 2004, PLANT J, V40, P428, DOI 10.1111/j.1365-313X.2004.02219.x; Wisniewska J, 2006, SCIENCE, V312, P883, DOI 10.1126/science.1121356; Woodward C, 2005, PLANT PHYSIOL, V139, P192, DOI 10.1104/pp.105.063495; Wu G, 2007, PLANT CELL, V19, P1826, DOI 10.1105/tpc.106.048777; Xu TD, 2010, CELL, V143, P99, DOI 10.1016/j.cell.2010.09.003; Zazimalova E, 2010, CSH PERSPECT BIOL, V2, DOI 10.1101/cshperspect.a001552; Zeidan Q, 2010, J CELL SCI, V123, P13, DOI 10.1242/jcs.053678; Zhang XR, 2006, NAT PROTOC, V1, P641, DOI 10.1038/nprot.2006.97; Zhao YD, 2001, SCIENCE, V291, P306, DOI 10.1126/science.291.5502.306; Zhao YD, 2010, ANNU REV PLANT BIOL, V61, P49, DOI 10.1146/annurev-arplant-042809-112308; Zourelidou M, 2009, DEVELOPMENT, V136, P627, DOI 10.1242/dev.028365	103	11	12	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 20	2012	7	7							e41327	10.1371/journal.pone.0041327	http://dx.doi.org/10.1371/journal.pone.0041327			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	977GL	22911780	Green Submitted, Green Published, gold			2022-12-25	WOS:000306644600071
J	Vadrot, N; Ghanem, S; Braut, F; Gavrilescu, L; Pilard, N; Mansouri, A; Moreau, R; Reyl-Desmars, F				Vadrot, Nathalie; Ghanem, Sarita; Braut, Francoise; Gavrilescu, Laura; Pilard, Nathalie; Mansouri, Abdellah; Moreau, Richard; Reyl-Desmars, Florence			Mitochondrial DNA Maintenance Is Regulated in Human Hepatoma Cells by Glycogen Synthase Kinase 3 beta and p53 in Response to Tumor Necrosis Factor alpha	PLOS ONE			English	Article							TRANSCRIPTION-FACTOR-A; BASE EXCISION-REPAIR; CANCER; KINASE-3-BETA; PROTEIN; INFLAMMATION; HEPATOCYTES; INDUCTION; APOPTOSIS; DEPLETION	During chronic liver inflammation, up-regulated Tumor Necrosis Factor alpha (TNF-alpha) targets hepatocytes and induces abnormal reactive oxygen species (ROS) production responsible for mitochondrial DNA (mtDNA) alterations. The serine/threonine Glycogen Synthase Kinase 3 beta (GSK3 beta) plays a pivotal role during inflammation but its involvement in the maintenance of mtDNA remains unknown. The aim of this study was to investigate its involvement in TNF-alpha induced mtDNA depletion and its interrelationship with p53 a protein known to maintain mtDNA copy numbers. Using quantitative polymerase chain reaction (qPCR) we found that at 30 min in human hepatoma HepG2 cells TNF-alpha induced 0.55 +/- 0.10 mtDNA lesions per 10 Kb and a 52.4 +/- 2.8% decrease in mtDNA content dependent on TNF-R1 receptor and ROS production. Both lesions and depletion returned to baseline from 1 to 6 h after TNF-alpha exposure. Luminol-amplified chemiluminescence (LAC) was used to measure the rapid (10 min) and transient TNF-alpha induced increase in ROS production (168 +/- 15%). A transient 8-oxo-dG level of 1.4 +/- 0.3 ng/mg DNA and repair of abasic sites were also measured by ELISA assays. Translocation of p53 to mitochondria was observed by Western Blot and co-immunoprecipitations showed that TNF-alpha induced p53 binding to GSK3 beta and mitochondrial transcription factor A (TFAM). In addition, mitochondrial D-loop immunoprecipitation (mtDIP) revealed that TNF-alpha induced p53 binding to the regulatory D-loop region of mtDNA. The knockdown of p53 by siRNAs, inhibition by the phosphoSer(15) p53 antibody or transfection of human mutant active GSK3 beta S9A pcDNA3 plasmid inhibited recovery of mtDNA content while blockade of GSK3 beta activity by SB216763 inhibitor or knockdown by siRNAs suppressed mtDNA depletion. This study is the first to report the involvement of GSK3 beta in TNF-alpha induced mtDNA depletion. We suggest that p53 binding to GSK3 beta, TFAM and D-loop could induce recovery of mtDNA content through mtDNA repair.	[Vadrot, Nathalie; Ghanem, Sarita; Gavrilescu, Laura; Pilard, Nathalie; Mansouri, Abdellah; Moreau, Richard; Reyl-Desmars, Florence] Univ Paris 07, Equipe Moreau, INSERM U773, Fac Med Bichat 10,CRB3, Paris, France; [Braut, Francoise] Univ Paris 07, Equipe El Benna, INSERM U773, Fac Med Bichat 10,CRB3, Paris, France	Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite	Vadrot, N (corresponding author), Univ Paris 07, Equipe Moreau, INSERM U773, Fac Med Bichat 10,CRB3, Paris, France.	florence.reyl-desmars@inserm.fr	Abdellah, Mansouri/B-3002-2017; Moreau, Richard/S-1300-2019; Moreau, Richard/N-2197-2017	Abdellah, Mansouri/0000-0003-3856-5771; Moreau, Richard/0000-0003-0862-403X; Moreau, Richard/0000-0003-0862-403X				Achanta G, 2005, EMBO J, V24, P3482, DOI 10.1038/sj.emboj.7600819; Appella E, 2000, PATHOL BIOL, V48, P227; Bakhanashvili M, 2008, CELL DEATH DIFFER, V15, P1865, DOI 10.1038/cdd.2008.122; Bijur GN, 2003, NEUROREPORT, V14, P2415, DOI 10.1097/00001756-200312190-00025; Bijur GN, 2003, J NEUROCHEM, V87, P1427, DOI 10.1046/j.1471-4159.2003.02113.x; Canugovi C, 2010, DNA REPAIR, V9, P1080, DOI 10.1016/j.dnarep.2010.07.009; Carew JS, 2003, LEUKEMIA, V17, P1437, DOI 10.1038/sj.leu.2403043; Chen DX, 2006, CANCER RES, V66, P3485, DOI 10.1158/0008-5472.CAN-05-4103; Chinnery PF, 2005, J HEPATOL, V43, P207, DOI 10.1016/j.jhep.2005.05.012; Choumar A, 2011, ANTIOXID REDOX SIGN, V15, P2837, DOI 10.1089/ars.2010.3713; Coant N, 2011, J HEPATOL, V55, P784, DOI 10.1016/j.jhep.2010.12.039; Cotgreave I A, 1997, Adv Pharmacol, V38, P205; de Souza-Pinto NC, 2004, ONCOGENE, V23, P6559, DOI 10.1038/sj.onc.1207874; de Souza-Pinto NC, 2001, CANCER RES, V61, P5378; Ekstrand MI, 2004, HUM MOL GENET, V13, P935, DOI 10.1093/hmg/ddh109; Farina AK, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004797; Gensler S, 2001, NUCLEIC ACIDS RES, V29, P3657, DOI 10.1093/nar/29.17.3657; Huang M, 2011, MOL PHARMACOL, V80, P40, DOI 10.1124/mol.110.070284; Hussain SP, 2007, INT J CANCER, V121, P2373, DOI 10.1002/ijc.23173; Jelkmann W, 1999, EXP HEMATOL, V27, P224, DOI 10.1016/S0301-472X(98)00054-X; Jope RS, 2007, NEUROCHEM RES, V32, P577, DOI 10.1007/s11064-006-9128-5; Kai Y, 2006, MITOCHONDRION, V6, P299, DOI 10.1016/j.mito.2006.10.002; Kang D, 2007, MITOCHONDRION, V7, P39, DOI 10.1016/j.mito.2006.11.017; Kobayashi H, 2001, J ANDROL, V22, P568; Kukat C, 2011, P NATL ACAD SCI USA, V108, P13534, DOI 10.1073/pnas.1109263108; Kulawiec M, 2009, J CARCINOGEN, V8, P1; Larosche I, 2010, J PHARMACOL EXP THER, V332, P886, DOI 10.1124/jpet.109.160879; Lasfer M, 2005, J HEPATOL, V42, P230, DOI 10.1016/j.jhep.2004.10.014; Lasfer M, 2006, FEBS LETT, V580, P2547, DOI 10.1016/j.febslet.2006.03.089; Lebedeva MA, 2009, BBA-BIOENERGETICS, V1787, P328, DOI 10.1016/j.bbabio.2009.01.004; Lim KS, 2005, ANN NY ACAD SCI, V1042, P210, DOI 10.1196/annals.1338.023; Liu B, 2008, FREE RADICAL BIO MED, V44, P1529, DOI 10.1016/j.freeradbiomed.2008.01.011; Meijer L, 2004, TRENDS PHARMACOL SCI, V25, P471, DOI 10.1016/j.tips.2004.07.006; Mottet D, 2003, J BIOL CHEM, V278, P31277, DOI 10.1074/jbc.M300763200; Nagakawa Y, 2005, HEPATOLOGY, V42, P208, DOI 10.1002/hep.20755; O'Dowd Y, 2004, BIOCHEM PHARMACOL, V68, P2003, DOI 10.1016/j.bcp.2004.06.023; Pessayre Dominique, 2010, Handb Exp Pharmacol, P311, DOI 10.1007/978-3-642-00663-0_11; Sadji-Ouatas Z, 2002, BIOCHEM J, V364, P881, DOI 10.1042/BJ20020349; Santos Janine H, 2006, Methods Mol Biol, V314, P183; Schwabe RF, 2006, AM J PHYSIOL-GASTR L, V290, pG583, DOI 10.1152/ajpgi.00422.2005; Shen HM, 2006, FASEB J, V20, P1589, DOI 10.1096/fj.05-5603rev; Shokolenko I, 2009, NUCLEIC ACIDS RES, V37, P2339; Staib F, 2005, CANCER RES, V65, P10255, DOI 10.1158/0008-5472.CAN-05-1714; STAMBOLIC V, 1994, BIOCHEM J, V303, P701, DOI 10.1042/bj3030701; Tazi KA, 2006, J HEPATOL, V45, P280, DOI 10.1016/j.jhep.2006.02.013; Van Houten B, 2006, DNA REPAIR, V5, P145, DOI 10.1016/j.dnarep.2005.03.002; Vaseva AV, 2009, BBA-BIOENERGETICS, V1787, P414, DOI 10.1016/j.bbabio.2008.10.005; Wajant H, 2003, CELL DEATH DIFFER, V10, P45, DOI 10.1038/sj.cdd.4401189; Wang W, 2008, CELL, V134, P279, DOI 10.1016/j.cell.2008.06.017; Wong TS, 2009, NUCLEIC ACIDS RES, V37, P568, DOI 10.1093/nar/gkn974; Yang ES, 2011, NEURO-ONCOLOGY, V13, P459, DOI 10.1093/neuonc/nor016; Yoshida Y, 2003, CANCER RES, V63, P3729; Yoshida Y, 2002, BIOCHEM BIOPH RES CO, V295, P945, DOI 10.1016/S0006-291X(02)00757-X	53	16	18	0	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 20	2012	7	7							e40879	10.1371/journal.pone.0040879	http://dx.doi.org/10.1371/journal.pone.0040879			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	977GL	22911714	Green Published, gold, Green Submitted			2022-12-25	WOS:000306644600025
J	Calvenzani, V; Testoni, B; Gusmaroli, G; Lorenzo, M; Gnesutta, N; Petroni, K; Mantovani, R; Tonelli, C				Calvenzani, Valentina; Testoni, Barbara; Gusmaroli, Giuliana; Lorenzo, Mariangela; Gnesutta, Nerina; Petroni, Katia; Mantovani, Roberto; Tonelli, Chiara			Interactions and CCAAT-Binding of Arabidopsis thaliana NF-Y Subunits	PLOS ONE			English	Article							TRANSCRIPTION FACTOR; LEAFY COTYLEDON1; EXPRESSION ANALYSIS; CRYSTAL-STRUCTURE; FACTOR CBF; IDENTIFICATION; COMPLEX; GENES; CONSTANS; DOMAINS	Background: NF-Y is a transcription factor that recognizes with high specificity and affinity the widespread CCAAT box promoter element. It is formed by three subunits: NF-YA and the NF-YB/NF-YC-heterodimer containing histone fold domains (HFDs). We previously identified a large NF-Y gene family in Arabidopsis thaliana, composed of 29 members, and characterized their expression patterns in various plant tissues. Methods: We used yeast Two-hybrids assays (Y2H), pull-down and Electrophoretic Mobility Shift Assay (EMSA) in vitro experiments with recombinant proteins to dissect AtNF-YB/AtNF-YC interactions and DNA-binding with different AtNF-YAs. Results: Consistent with robust conservation within HFDs, we show that heterodimerization is possible among all histone-like subunits, including the divergent and related LEC1/AtNF-YB9 and L1L/AtNF-YB6 required for embryo development. DNA-binding to a consensus CCAAT box was investigated with specific AtNF-YB/AtNF-YC combinations and observed with some, but not all AtNF-YA subunits. Conclusions: Our results highlight (i) the conserved heterodimerization capacity of AtNF-Y histone-like subunits, and (ii) the different affinities of AtNF-YAs for the CCAAT sequence. Because of the general expansion of NF-Y genes in plants, these results most likely apply to other species.	[Calvenzani, Valentina; Testoni, Barbara; Gusmaroli, Giuliana; Lorenzo, Mariangela; Gnesutta, Nerina; Petroni, Katia; Mantovani, Roberto; Tonelli, Chiara] Univ Milan, Dipartimento Biosci, Milan, Italy	University of Milan	Calvenzani, V (corresponding author), Univ Milan, Dipartimento Biosci, Milan, Italy.	mantor@unimi.it; chiara.tonelli@unimi.it	Petroni, Katia/K-1159-2018; Gnesutta, Nerina/I-5432-2015; Tonelli, Chiara/F-7969-2015; TESTONI, Barbara/F-3767-2017	Petroni, Katia/0000-0003-3318-0442; Gnesutta, Nerina/0000-0002-2465-8881; Tonelli, Chiara/0000-0002-9505-3118; TESTONI, Barbara/0000-0001-5588-5465	Progetto di Rilevante Interesse Nazionale (PRIN); European Research Area-Plant Genomics; Fondo Italiano Ricerca di Base (ERA-PG FIRB)	Progetto di Rilevante Interesse Nazionale (PRIN)(Ministry of Education, Universities and Research (MIUR)Research Projects of National Relevance (PRIN)); European Research Area-Plant Genomics; Fondo Italiano Ricerca di Base (ERA-PG FIRB)	This work was supported by a Progetto di Rilevante Interesse Nazionale (PRIN) grant to RM and by European Research Area-Plant Genomics, Fondo Italiano Ricerca di Base (ERA-PG FIRB) to CT. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alemanno L, 2008, PLANTA, V227, P853, DOI 10.1007/s00425-007-0662-4; Ben-Naim O, 2006, PLANT J, V46, P462, DOI 10.1111/j.1365-313X.2006.02706.x; Braybrook SA, 2008, TRENDS PLANT SCI, V13, P624, DOI 10.1016/j.tplants.2008.09.008; Cai XN, 2007, PLANT PHYSIOL, V145, P98, DOI 10.1104/pp.107.102079; Cao SH, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021805; Chen NZ, 2007, J BIOCHEM MOL BIOL, V40, P1083; Combier JP, 2006, GENE DEV, V20, P3084, DOI 10.1101/gad.402806; Coustry F, 1996, J BIOL CHEM, V271, P14485, DOI 10.1074/jbc.271.24.14485; di Silvio A, 1999, NUCLEIC ACIDS RES, V27, P2578; Diebold ML, 2011, J STRUCT BIOL, V175, P178, DOI 10.1016/j.jsb.2011.02.001; Dolfini D, 2012, CRIT REV BIOCHEM MOL, V47, P29, DOI 10.3109/10409238.2011.628970; Dolfini D, 2009, CELL CYCLE, V8, P4127, DOI 10.4161/cc.8.24.10240; FORSBURG SL, 1989, GENE DEV, V3, P1166, DOI 10.1101/gad.3.8.1166; Gaj MD, 2005, PLANTA, V222, P977, DOI 10.1007/s00425-005-0041-y; GIETZ D, 1992, NUCLEIC ACIDS RES, V20, P1425, DOI 10.1093/nar/20.6.1425; Gusmaroli G, 2001, GENE, V264, P173, DOI 10.1016/S0378-1119(01)00323-7; Gusmaroli G, 2002, GENE, V283, P41, DOI 10.1016/S0378-1119(01)00833-2; Hackenberg D, 2012, MOL PLANT, V5, P876, DOI 10.1093/mp/ssr107; Hartlepp KF, 2005, MOL CELL BIOL, V25, P9886, DOI 10.1128/MCB.25.22.9886-9896.2005; Ito Y, 2011, PLANT SCI, V181, P105, DOI 10.1016/j.plantsci.2011.04.009; James P, 1996, GENETICS, V144, P1425; Kamada K, 2001, CELL, V106, P71, DOI 10.1016/S0092-8674(01)00417-2; Kumimoto RW, 2008, PLANTA, V228, P709, DOI 10.1007/s00425-008-0773-6; Kumimoto RW, 2010, PLANT J, V63, P379, DOI 10.1111/j.1365-313X.2010.04247.x; Kwong RW, 2003, PLANT CELL, V15, P5, DOI 10.1105/tpc.006973; Lee HS, 2003, P NATL ACAD SCI USA, V100, P2152, DOI 10.1073/pnas.0437909100; Li CX, 2011, PLANT J, V67, P763, DOI 10.1111/j.1365-313X.2011.04630.x; Li WX, 2008, PLANT CELL, V20, P2238, DOI 10.1105/tpc.108.059444; LI XY, 1992, NUCLEIC ACIDS RES, V20, P1087, DOI 10.1093/nar/20.5.1087; Lotan T, 1998, CELL, V93, P1195, DOI 10.1016/S0092-8674(00)81463-4; Luger K, 1997, NATURE, V389, P251, DOI 10.1038/38444; MANTOVANI R, 1994, J BIOL CHEM, V269, P20340; Masiero S, 2002, J BIOL CHEM, V277, P26429, DOI 10.1074/jbc.M202546200; McNabb DS, 1997, MOL CELL BIOL, V17, P7008, DOI 10.1128/MCB.17.12.7008; Nelson DE, 2007, P NATL ACAD SCI USA, V104, P16450, DOI 10.1073/pnas.0707193104; Romier C, 2003, J BIOL CHEM, V278, P1336, DOI 10.1074/jbc.M209635200; Siefers N, 2009, PLANT PHYSIOL, V149, P625, DOI 10.1104/pp.108.130591; Sinha S, 1996, MOL CELL BIOL, V16, P328; Stephenson TJ, 2007, PLANT MOL BIOL, V65, P77, DOI 10.1007/s11103-007-9200-9; Thirumurugan T, 2008, MOL GENET GENOMICS, V279, P279, DOI 10.1007/s00438-007-0312-3; Warpeha KM, 2007, PLANT PHYSIOL, V143, P1590, DOI 10.1104/pp.106.089904; Wenkel S, 2006, PLANT CELL, V18, P2971, DOI 10.1105/tpc.106.043299; Xie ZY, 2008, MOL BIOL EVOL, V25, P1581, DOI 10.1093/molbev/msn105; XING YY, 1993, EMBO J, V12, P4647, DOI 10.1002/j.1460-2075.1993.tb06153.x; XING YY, 1994, P NATL ACAD SCI USA, V91, P3009, DOI 10.1073/pnas.91.8.3009; Yamamoto A, 2009, PLANT J, V58, P843, DOI 10.1111/j.1365-313X.2009.03817.x; Yang J, 2005, NEW PHYTOL, V165, P623, DOI 10.1111/j.1469-8137.2004.01260.x; Yazawa K, 2004, PLANT PHYSIOL BIOCH, V42, P215, DOI 10.1016/j.plaphy.2003.12.003; Yazawa K, 2007, J EXP BOT, V58, P3819, DOI 10.1093/jxb/erm238; Zemzoumi K, 1999, J MOL BIOL, V286, P327, DOI 10.1006/jmbi.1998.2496	50	54	61	0	43	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 17	2012	7	8							e42902	10.1371/journal.pone.0042902	http://dx.doi.org/10.1371/journal.pone.0042902			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	996DG	22912760	gold, Green Submitted, Green Published			2022-12-25	WOS:000308063700028
J	Alvarenga, JSC; Ligeiro, CM; Gontijo, CMF; Cortes, S; Campino, L; Vago, AR; Melo, MN				Campos Alvarenga, Janaina Sousa; Ligeiro, Carla Maia; Ferreira Gontijo, Celia Maria; Cortes, Sofia; Campino, Lenea; Vago, Annamaria Ravara; Melo, Maria Norma			KDNA Genetic Signatures Obtained by LSSP-PCR Analysis of Leishmania (Leishmania) infantum Isolated from the New and the Old World	PLOS ONE			English	Article							TRYPANOSOMA-CRUZI; VIANNIA BRAZILIENSIS; DONOVANI COMPLEX; ISOENZYMATIC ANALYSIS; SEQUENCE-ANALYSIS; GENUS LEISHMANIA; CHAGAS-DISEASE; STRAINS; IDENTIFICATION; POLYMORPHISM	Background: Visceral Leishmaniasis (VL) caused by species from the Leishmania donovani complex is the most severe form of the disease, lethal if untreated. VL caused by Leishmania infantum is a zoonosis with an increasing number of human cases and millions of dogs infected in the Old and the New World. In this study, L. infantum (syn. L. chagasi) strains were isolated from human and canine VL cases. The strains were obtained from endemic areas from Brazil and Portugal and their genetic polymorphism was ascertained using the LSSP-PCR (Low-Stringency Single Specific Primer PCR) technique for analyzing the kinetoplastid DNA (kDNA) minicircles hypervariable region. Principal Findings: KDNA genetic signatures obtained by minicircle LSSP-PCR analysis of forty L. infantum strains allowed the grouping of strains in several clades. Furthermore, LSSP-PCR profiles of L. infantum subpopulations were closely related to the host origin (human or canine). To our knowledge this is the first study which used this technique to compare genetic polymorphisms among strains of L. infantum originated from both the Old and the New World. Conclusions: LSSP-PCR profiles obtained by analysis of L. infantum kDNA hypervariable region of parasites isolated from human cases and infected dogs from Brazil and Portugal exhibited a genetic correlation among isolates originated from the same reservoir, human or canine. However, no association has been detected among the kDNA signatures and the geographical origin of L. infantum strains.	[Campos Alvarenga, Janaina Sousa; Melo, Maria Norma] Univ Fed Minas Gerais, Inst Ciencias Biol, Dept Parasitol, Belo Horizonte, MG, Brazil; [Ligeiro, Carla Maia; Vago, Annamaria Ravara] Univ Fed Minas Gerais, Inst Ciencias Biol, Dept Morfol, Belo Horizonte, MG, Brazil; [Ferreira Gontijo, Celia Maria] Fundacao Oswaldo Cruz, Ctr Pesquisas Rene Rachou, Belo Horizonte, MG, Brazil; [Cortes, Sofia; Campino, Lenea] Univ Nova Lisboa, Inst Higiene & Med Trop, Unidade Leishmanioses, P-1200 Lisbon, Portugal	Universidade Federal de Minas Gerais; Universidade Federal de Minas Gerais; Fundacao Oswaldo Cruz; Universidade Nova de Lisboa; Institute of Hygiene & Tropical Medicine - UNL	Alvarenga, JSC (corresponding author), Univ Fed Minas Gerais, Inst Ciencias Biol, Dept Parasitol, Belo Horizonte, MG, Brazil.	melo@icb.ufmg.br	Cortes, Sofia/I-2800-2012; Gontijo, Celia MF/AAU-7736-2020; Campino, Lenea/I-6375-2012	Cortes, Sofia/0000-0001-5850-6950; Gontijo, Celia MF/0000-0002-7034-535X; Campino, Lenea/0000-0003-4512-9660	European Community (EpiLeishNetSA) [015407]; Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq); Fundacao de Amparo a Pesquisa do Estado de Minas Gerais (FAPEMIG); Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES), Brazil; FAPEMIG, Brazil	European Community (EpiLeishNetSA); Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq)(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); Fundacao de Amparo a Pesquisa do Estado de Minas Gerais (FAPEMIG)(Fundacao de Amparo a Pesquisa do Estado de Minas Gerais (FAPEMIG)); Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES), Brazil(Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES)); FAPEMIG, Brazil(Fundacao de Amparo a Pesquisa do Estado de Minas Gerais (FAPEMIG))	For this study, the authors received financial support from the European Community (EpiLeishNetSA - Contract no 015407) and from Brazilian funding agencies Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq) and Fundacao de Amparo a Pesquisa do Estado de Minas Gerais (FAPEMIG). JSCA was supported by a PhD scholarship from the Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES), Brazil. CML was supported by an undergraduate scholarship from the FAPEMIG, Brazil. The funders had no role in the study design, the data collection and analysis, the decision to publish, or preparation of the manuscript.	Baptista C, 2009, EXP PARASITOL, V121, P317, DOI 10.1016/j.exppara.2008.12.006; Baptista-Fernandes T, 2007, COMP IMMUNOL MICROB, V30, P41, DOI 10.1016/j.cimid.2006.10.001; Barreto G, 1996, AM J HUM GENET, V58, P609; BEVERLEY SM, 1987, P NATL ACAD SCI USA, V84, P484, DOI 10.1073/pnas.84.2.484; Botilde Y, 2006, INFECT GENET EVOL, V6, P440, DOI 10.1016/j.meegid.2006.02.003; Brewster S, 2002, T R SOC TROP MED HYG, V96, pS55, DOI DOI 10.1016/S0035-9203(02)90052-0; Brito CMM, 2008, PARASITOL RES, V103, P1111, DOI 10.1007/s00436-008-1102-5; Bulle B, 2002, J CLIN MICROBIOL, V40, P3391, DOI 10.1128/JCM.40.9.3391-3397.2002; Burgos JM, 2007, INT J PARASITOL, V37, P1319, DOI 10.1016/j.ijpara.2007.04.015; Caiaffa Waleska Teixeira, 2005, Cad. Saúde Pública, V21, P958, DOI 10.1590/S0102-311X2005000300032; Campino L, 2006, TROP MED INT HEALTH, V11, P1708, DOI 10.1111/j.1365-3156.2006.01728.x; Chargui N, 2009, INT J PARASITOL, V39, P801, DOI 10.1016/j.ijpara.2008.11.016; Chicharro C., 2002, T R SOC TROP MED HYG, V96, P93; Cortes S, 2004, T ROY SOC TROP MED H, V98, P12, DOI 10.1016/S0035-9203(03)00002-6; Cortes S, 2011, ZOONOSES PUBLIC HLTH, V58, P234, DOI 10.1111/j.1863-2378.2010.01374.x; Cortes S, 2006, PARASITOL INT, V55, P277, DOI 10.1016/j.parint.2006.07.003; de Oliveira FS, 2010, DIAGN MICR INFEC DIS, V66, P361, DOI 10.1016/j.diagmicrobio.2009.11.004; Desjeux P, 2003, ANN TROP MED PARASIT, V97, P3, DOI 10.1179/000349803225002499; Ferreira GA, 2007, J PARASITOL, V93, P712, DOI 10.1645/GE-958R1.1; Ferroglio E, 2006, T ROY SOC TROP MED H, V100, P636, DOI 10.1016/j.trstmh.2005.09.008; Gallego M, 2001, ARCH DERMATOL, V137, P667; Garcia A. L., 2005, Infection Genetics and Evolution, V5, P109, DOI 10.1016/j.meegid.2004.07.003; Gomes MA, 1997, PARASITOLOGY, V114, P517; GOMES RF, 1995, EXP PARASITOL, V80, P681, DOI 10.1006/expr.1995.1084; Gontijo Célia Maria Ferreira, 2004, Rev. bras. epidemiol., V7, P338; Gontijo CMF, 2002, MEM I OSWALDO CRUZ, V97, P751, DOI 10.1590/S0074-02762002000500029; Hide M, 2008, T ROY SOC TROP MED H, V102, P105, DOI 10.1016/j.trstmh.2007.09.013; Junqueira ACV, 2005, TRENDS PARASITOL, V21, P270, DOI 10.1016/j.pt.2005.04.001; KILLICKKENDRICK R, 1980, ANN TROP MED PARASIT, V74, P563, DOI 10.1080/00034983.1980.11687385; Kuhls K, 2008, PLOS NEGLECT TROP D, V2, DOI 10.1371/journal.pntd.0000261; Kuhls K, 2007, MICROBES INFECT, V9, P334, DOI 10.1016/j.micinf.2006.12.009; Kuhls K, 2011, PLOS NEGLECT TROP D, V5, DOI 10.1371/journal.pntd.0001155; Lages-Silva E, 2006, J CLIN MICROBIOL, V44, P2167, DOI 10.1128/JCM.02124-05; Lukes J, 2007, P NATL ACAD SCI USA, V104, P9375, DOI 10.1073/pnas.0703678104; MACEDO AM, 1992, MOL BIOCHEM PARASIT, V53, P63, DOI 10.1016/0166-6851(92)90007-7; Maia C, 2009, J VECTOR DIS, V46, P268; Marquez DS, 2007, EXP PARASITOL, V117, P35, DOI 10.1016/j.exppara.2007.03.007; Mauricio IL, 1999, PARASITOLOGY, V119, P237, DOI 10.1017/S0031182099004710; Mauricio IL, 2000, PARASITOL TODAY, V16, P188, DOI 10.1016/S0169-4758(00)01637-9; Mauricio IL, 2001, PARASITOLOGY, V122, P393, DOI 10.1017/S0031182001007466; Mauricio IL, 2009, AIDS RES HUM RETRO S, V324, P187; Mejía Ana María, 2005, Biomed., V25, P76; MOMEN H, 1987, Memorias do Instituto Oswaldo Cruz, V82, P447, DOI 10.1590/S0074-02761987000300022; Morales MA, 2001, T ROY SOC TROP MED H, V95, P104, DOI 10.1016/S0035-9203(01)90352-9; Morales MA, 2002, J INFECT DIS, V185, P1533, DOI 10.1086/340219; Nasereddin A, 2009, VET PARASITOL, V161, P126, DOI 10.1016/j.vetpar.2008.12.003; Ochsenreither S, 2006, J CLIN MICROBIOL, V44, P495, DOI 10.1128/JCM.44.2.495-503.2006; PENA SDJ, 1994, P NATL ACAD SCI USA, V91, P1946, DOI 10.1073/pnas.91.5.1946; Pratlong F, 2004, J CLIN MICROBIOL, V42, P4077, DOI 10.1128/JCM.42.9.4077-4082.2004; Quaresma PF, 2009, ACTA TROP, V111, P289, DOI 10.1016/j.actatropica.2009.05.008; Reithinger R, 2007, J CLIN MICROBIOL, V45, P21, DOI 10.1128/JCM.02029-06; RIOUX JA, 1990, ANN PARASIT HUM COMP, V65, P111, DOI 10.1051/parasite/1990653111; Schantz PM, 2005, JAVMA-J AM VET MED A, V226, P1316, DOI 10.2460/javma.2005.226.1316; Schonian G, 1996, MOL BIOCHEM PARASIT, V77, P19, DOI 10.1016/0166-6851(96)02572-8; Simpson L, 2000, P NATL ACAD SCI USA, V97, P6986, DOI 10.1073/pnas.97.13.6986; Singh S, 2005, EXPERT REV MOL DIAGN, V5, P251, DOI 10.1586/14737159.5.2.251; SNEATH PHA, 1962, NATURE, V193, P855, DOI 10.1038/193855a0; Telleria J, 2006, EXP PARASITOL, V114, P279, DOI 10.1016/j.exppara.2006.04.005; THIEMANN OH, 1994, EMBO J, V13, P5689, DOI 10.1002/j.1460-2075.1994.tb06907.x; Toledo A, 2002, MOL BIOCHEM PARASIT, V119, P257, DOI 10.1016/S0166-6851(01)00424-8; Vago AR, 2000, AM J PATHOL, V156, P1805, DOI 10.1016/S0002-9440(10)65052-3; Vago AR, 1996, AM J PATHOL, V149, P2153; VANEYS GJJM, 1992, MOL BIOCHEM PARASIT, V51, P133, DOI 10.1016/0166-6851(92)90208-2; Zafra G, 2011, HUM PATHOL, V42, P1159, DOI 10.1016/j.humpath.2010.11.012; Zemanova E, 2004, AM J TROP MED HYG, V70, P613, DOI 10.4269/ajtmh.2004.70.613	65	8	8	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 17	2012	7	8							e43363	10.1371/journal.pone.0043363	http://dx.doi.org/10.1371/journal.pone.0043363			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	996DG	22912862	Green Published, Green Submitted, gold			2022-12-25	WOS:000308063700090
J	Fang, WG; St Leger, RJ				Fang, Weiguo; St Leger, Raymond J.			Enhanced UV Resistance and Improved Killing of Malaria Mosquitoes by Photolyase Transgenic Entomopathogenic Fungi	PLOS ONE			English	Article							BEAUVERIA-BASSIANA; METARHIZIUM-ANISOPLIAE; REPAIR; GENE; VIRULENCE; PHOTOPRODUCTS; INACTIVATION; PERSISTENCE; INCREASES; PROTEIN	The low survival of microbial pest control agents exposed to UV is the major environmental factor limiting their effectiveness. Using gene disruption we demonstrated that the insect pathogenic fungus Metarhizium robertsii uses photolyases to remove UV-induced cyclobutane pyrimidine dimers (CPD) and pyrimidine (6-4) photoproducts [(6-4) PPs] from its DNA. However, this photorepair is insufficient to fix CPD lesions and prevent the loss of viability caused by seven hours of solar radiation. Expression of a highly efficient archaeal (Halobacterium salinarum) CPD photolyase increased photorepair >30-fold in both M. robertsii and Beauveria bassiana. Consequently, transgenic strains were much more resistant to sunlight and retained virulence against the malaria vector Anopheles gambiae. In the field this will translate into much more efficient pest control over a longer time period. Conversely, our data shows that deleting native photolyase genes will strictly contain M. robertsii to areas protected from sunlight, alleviating safety concerns that transgenic hypervirulent Metarhizium spp will spread from mosquito traps or houses. The precision and malleability of the native and transgenic photolyases allows design of multiple pathogens with different strategies based on the environments in which they will be used.	[Fang, Weiguo] Zhejiang Univ, Coll Life Sci, Inst Microbiol, Hangzhou 310003, Zhejiang, Peoples R China; [St Leger, Raymond J.] Univ Maryland, Dept Entomol, College Pk, MD 20742 USA	Zhejiang University; University System of Maryland; University of Maryland College Park	Fang, WG (corresponding author), Zhejiang Univ, Coll Life Sci, Inst Microbiol, Hangzhou 310003, Zhejiang, Peoples R China.	wfang1@zju.edu.cn	St. Leger, Raymond/N-3219-2013; Fang, Weiguo/G-6680-2012	Fang, Weiguo/0000-0002-8431-8256	1000 Young Talents Program of China	1000 Young Talents Program of China	This work is supported by the "1000 Young Talents Program of China" to WF. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alejandre-Duran E, 2003, FUNGAL GENET BIOL, V40, P159, DOI 10.1016/S1087-1845(03)00089-6; Berrocal-Tito GM, 2007, EUKARYOT CELL, V6, P1682, DOI 10.1128/EC.00208-06; Bischoff JF, 2009, MYCOLOGIA, V101, P512, DOI 10.3852/07-202; Blanford S, 2005, SCIENCE, V308, P1638, DOI 10.1126/science.1108423; Chelico L, 2006, J APPL MICROBIOL, V100, P964, DOI 10.1111/j.1365-2672.2006.02844.x; Cline SD, 2003, NAT REV MOL CELL BIO, V4, P361, DOI 10.1038/nrm1101; COHEN E, 1991, J INVERTEBR PATHOL, V57, P343, DOI 10.1016/0022-2011(91)90138-G; Douki T, 2001, BIOCHEMISTRY-US, V40, P2495, DOI 10.1021/bi0022543; Edgington S, 2000, INT J PEST MANAGE, V46, P169, DOI 10.1080/096708700415490; Fan YH, 2012, NAT BIOTECHNOL, V30, P35, DOI 10.1038/nbt.2080; Fang WG, 2011, SCIENCE, V331, P1074, DOI 10.1126/science.1199115; Fang WG, 2009, J INVERTEBR PATHOL, V102, P155, DOI 10.1016/j.jip.2009.07.013; Fang W, 2009, FUNGAL GENET BIOL, V46, P277, DOI 10.1016/j.fgb.2008.12.001; Fang WG, 2004, J INVERTEBR PATHOL, V85, P18, DOI 10.1016/j.jip.2003.12.003; Fernandes EKK, 2007, J INVERTEBR PATHOL, V96, P237, DOI 10.1016/j.jip.2007.05.007; Gao QA, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1001264; Horton P, 1997, ISMB-97 - FIFTH INTERNATIONAL CONFERENCE ON INTELLIGENT SYSTEMS FOR MOLECULAR BIOLOGY, PROCEEDINGS, P147; IGNOFFO CM, 1977, ENVIRON ENTOMOL, V6, P411, DOI 10.1093/ee/6.3.411; Jans J, 2005, CURR BIOL, V15, P105, DOI 10.1016/j.cub.2005.01.001; Kaiser G, 2009, PLANTA, V230, P505, DOI 10.1007/s00425-009-0962-y; Lin LC, 2011, J MICROBIOL METH, V87, P241, DOI 10.1016/j.mimet.2011.07.018; Lwetoijera DW, 2010, PARASITE VECTOR, V3, DOI 10.1186/1756-3305-3-18; McCready S, 2003, BIOCHEM SOC T, V31, P694, DOI 10.1042/BST0310694; Nakajima S, 1998, NUCLEIC ACIDS RES, V26, P638, DOI 10.1093/nar/26.2.638; Pilz C, 2011, J APPL ENTOMOL, V135, P393, DOI 10.1111/j.1439-0418.2010.01566.x; PRIOR C, 1992, BIOLOGICAL CONTROL OF LOCUSTS AND GRASSHOPPERS, P159; Roberts DW, 2004, ADV APPL MICROBIOL, V54, P1, DOI 10.1016/S0065-2164(04)54001-7; SANCAR GB, 1985, J BACTERIOL, V161, P769, DOI 10.1128/JB.161.2.769-771.1985; Scholte EJ, 2005, SCIENCE, V308, P1641, DOI 10.1126/science.1108639; Shang YF, 2012, J INVERTEBR PATHOL, V109, P105, DOI 10.1016/j.jip.2011.10.004; Shimura M, 1999, FUNGAL GENET BIOL, V28, P12, DOI 10.1006/fgbi.1999.1158; Sinha RP, 2002, PHOTOCH PHOTOBIO SCI, V1, P225, DOI 10.1039/b201230h; Smits N, 1996, FEMS MICROBIOL ECOL, V21, P167, DOI 10.1016/S0168-6496(96)00052-9; StLeger RJ, 1996, P NATL ACAD SCI USA, V93, P6349, DOI 10.1073/pnas.93.13.6349; Thomas MB, 1997, PESTIC SCI, V49, P47, DOI 10.1002/(SICI)1096-9063(199701)49:1&lt;47::AID-PS471&gt;3.0.CO;2-O; Wang CS, 2007, NAT BIOTECHNOL, V25, P1455, DOI 10.1038/nbt1357; Yasui A, 1998, CONT CANC RES, P9	37	69	73	0	86	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 17	2012	7	8							e43069	10.1371/journal.pone.0043069	http://dx.doi.org/10.1371/journal.pone.0043069			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	996DG	22912789	gold, Green Submitted, Green Published			2022-12-25	WOS:000308063700036
J	Jia, YL; Jia, MH; Wang, XY; Liu, GJ				Jia, Yulin; Jia, Melissa H.; Wang, Xueyan; Liu, Guangjie			Indica and Japonica Crosses Resulting in Linkage Block and Recombination Suppression on Rice Chromosome 12	PLOS ONE			English	Article							BLAST RESISTANCE GENE; PI-TA; WILD-RICE; MOLECULAR CHARACTERIZATION; MAPPING POPULATION; CULTIVATED RICE; REGISTRATION; LOCUS; INSIGHTS; MARKERS	Understanding linkage block size and molecular mechanisms of recombination suppression is important for plant breeding. Previously large linkage blocks ranging from 14 megabases to 27 megabases were observed around the rice blast resistance gene Pi-ta in rice cultivars and backcross progeny involving an indica and japonica cross. In the present study, the same linkage block was further examined in 456 random recombinant individuals of rice involving 5 crosses ranging from F-2 to F-10 generation, with and without Pi-ta containing genomic indica regions with both indica and japonica germplasm. Simple sequence repeat markers spanning the entire chromosome 12 were used to detect recombination break points and to delimit physical size of linkage blocks. Large linkage blocks ranging from 4.1 megabases to 10 megabases were predicted from recombinant individuals involving genomic regions of indica and japonica. However, a significantly reduced block from less than 800 kb to 2.1megabases was identified from crosses of indica with indica rice regardless of the existence of Pi-ta. These findings suggest that crosses of indica and japonica rice have significant recombination suppression near the centromere on chromosome 12.	[Jia, Yulin; Jia, Melissa H.] ARS, Dale Bumpers Natl Rice Res Ctr, USDA, Stuttgart, AR USA; [Wang, Xueyan] China Jiliang Univ, Coll Life Sci, Dept Biol, Hangzhou, Zhejiang, Peoples R China; [Liu, Guangjie] Univ Arkansas, Rice Res & Extens Ctr, Stuttgart, AR USA	United States Department of Agriculture (USDA); China Jiliang University; University of Arkansas System; University of Arkansas Fayetteville	Jia, YL (corresponding author), ARS, Dale Bumpers Natl Rice Res Ctr, USDA, Stuttgart, AR USA.	Yulin.jia@ars.usda.gov	jia, yu/HHR-9047-2022; Jia, Yulin/T-8235-2019; Wang, Xueyan/N-1168-2017	Wang, Xueyan/0000-0002-5635-126X; Jia, Yulin/0000-0002-2132-0498	National Natural Science Foundation of China [31000847]; Science and Technology Department of Zhejiang Province [2011R10038]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Science and Technology Department of Zhejiang Province	Financial supports of National Natural Science Foundation of China (Grant No. 31000847) and of Science and Technology Department of Zhejiang Province (Grant No. 2011R10038) to XW are also acknowledged. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anderson LK, 2003, GENETICS, V165, P849; Ballini E, 2008, MOL PLANT MICROBE IN, V21, P859, DOI 10.1094/MPMI-21-7-0859; Beadle GW, 1932, P NATL ACAD SCI USA, V18, P160, DOI 10.1073/pnas.18.2.160; BOLLICH CN, 1985, CROP SCI, V25, P883, DOI 10.2135/cropsci1985.0011183X002500050038x; Bryan GT, 2000, PLANT CELL, V12, P2033, DOI 10.1105/tpc.12.11.2033; Chu QR, 2006, CROP SCI, V46, P1417, DOI 10.2135/cropsci2005.0199; Conaway-Bormans CA, 2003, THEOR APPL GENET, V107, P1014, DOI 10.1007/s00122-003-1338-5; Costanzo S, 2009, PLANT SCI, V177, P468, DOI 10.1016/j.plantsci.2009.07.012; Dai YT, 2010, FUNGAL GENET BIOL, V47, P973, DOI 10.1016/j.fgb.2010.08.003; Henikoff S, 2001, SCIENCE, V293, P1098, DOI 10.1126/science.1062939; Huang CL, 2008, GENETICS, V179, P1527, DOI 10.1534/genetics.108.089805; Jain M, 2004, BBA-GENE STRUCT EXPR, V1676, P182, DOI 10.1016/j.bbaexp.2003.11.012; Jain M, 2008, PLANT CELL REP, V27, P767, DOI 10.1007/s00299-007-0491-8; Jia Y, 2003, PLANT DIS, V87, P129, DOI 10.1094/PDIS.2003.87.2.129; Jia Y, 2000, EMBO J, V19, P4004, DOI 10.1093/emboj/19.15.4004; Jia Y, 2009, HEREDITY, V103, P333, DOI 10.1038/hdy.2009.95; Jia YL, 2004, EUPHYTICA, V138, P97, DOI 10.1023/B:EUPH.0000047079.42768.4d; Jia YL, 2004, PHYTOPATHOLOGY, V94, P296, DOI 10.1094/PHYTO.2004.94.3.296; Jia YL, 2002, CROP SCI, V42, P2145, DOI 10.2135/cropsci2002.2145; Jia Y, 2008, MOL PLANT MICROBE IN, V21, P396, DOI 10.1094/MPMI-21-4-0396; Jia YL, 2010, J PLANT REGIST, V4, P163, DOI 10.3198/jpr2009.04.0223crmp; Kovach MJ, 2007, TRENDS GENET, V23, P578, DOI 10.1016/j.tig.2007.08.012; LAMBIE EJ, 1986, GENETICS, V114, P769; Lee S, 2009, GENETICS, V183, P1315, DOI 10.1534/genetics.109.108266; Lee SB, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022312; Linscombe SD, 2000, CROP SCI, V40, P294, DOI 10.2135/cropsci2000.0007rcv; Liu GJ, 2008, EUPHYTICA, V159, P73, DOI 10.1007/s10681-007-9459-6; Londo JP, 2006, P NATL ACAD SCI USA, V103, P9578, DOI 10.1073/pnas.0603152103; Ma JX, 2007, TRENDS GENET, V23, P134, DOI 10.1016/j.tig.2007.01.004; MARCHETTI M, 1998, SALES MARK MANAG APR, P38; Mather K, 1939, GENETICS, V24, P413; Metkar SS, 2004, CURR SCI INDIA, V87, P353; MOLDENHAUER KAK, 1990, CROP SCI, V30, P747, DOI 10.2135/cropsci1990.0011183X003000030065x; Nakamura S, 1997, MOL GEN GENET, V254, P611, DOI 10.1007/s004380050459; NAVEIRA H, 1992, GENETICS, V130, P205; Orbach MJ, 2000, PLANT CELL, V12, P2019, DOI 10.1105/tpc.12.11.2019; Remington DL, 2001, P NATL ACAD SCI USA, V98, P11479, DOI 10.1073/pnas.201394398; Roychowdhury M., 2012, Acta Agronomica Sinica, V38, P381, DOI 10.3724/SP.J.1006.2012.00381; Rutger JN, 2005, CROP SCI, V45, P2671, DOI 10.2135/cropsci2005.0216; Tian ZX, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-142; Van Ooijen J.W., 2006, JOINMAP 4 0 SOFTWARE; Vaughan DA, 2008, PLANT SCI, V174, P394, DOI 10.1016/j.plantsci.2008.01.016; Wang X, 2008, PHYTOPATHOLOGY, V98, P1305, DOI 10.1094/PHYTO-98-12-1305; Wang X, 2010, PLANT BREEDING, V129, P491, DOI 10.1111/j.1439-0523.2009.01706.x; Xu X, 2012, NAT BIOTECHNOL, V30, P105, DOI 10.1038/nbt.2050; Yulin Jia, 2009, Frontiers of Agriculture in China, V3, P231, DOI 10.1007/s11703-009-0062-6; Zhao K, 2010, PLOS ONE, V5, DOI [10.1371/journal.pone.010780, DOI 10.1371/JOURNAL.PONE.010780]; Zhou EX, 2007, FUNGAL GENET BIOL, V44, P1024, DOI 10.1016/j.fgb.2007.02.003	48	17	17	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 17	2012	7	8							e43066	10.1371/journal.pone.0043066	http://dx.doi.org/10.1371/journal.pone.0043066			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	996DG	22912788	Green Submitted, Green Published, gold			2022-12-25	WOS:000308063700035
J	Kiefer, SM; Robbins, L; Rauchman, M				Kiefer, Susan M.; Robbins, Lynn; Rauchman, Michael			Conditional Expression of Wnt9b in Six2-Positive Cells Disrupts Stomach and Kidney Function	PLOS ONE			English	Article							NEPHRON PROGENITOR POPULATION; BETA-CATENIN GENE; DUODENOGASTRIC REFLUX; MOUSE; DISEASE; PROTEIN; MICE; DIFFERENTIATION; TRANSCRIPTION; INACTIVATION	During kidney development, canonical Wnt signaling activates differentiation, while the transcription factor Six2 maintains the progenitor pool. These opposing signals help to regulate nephron formation and ensure the full complement of nephrons are formed. Since these two factors control differing fates in kidney mesenchyme, we hypothesized that overexpression of Wnt9b in Six2-expressing cells would disrupt kidney formation and may alter cell differentiation decisions in other tissues. We created a transgenic mouse that conditionally expressed the canonical Wnt ligand in the developing kidney, Wnt9b. The transgene is activated by cre recombinase and expresses GFP. We first tested its biological activity using Hoxb7-cre and found that transgenic Wnt9b was capable of inducing differentiation genes and of rescuing kidney development in Wnt9b(-/-) homozygous deficient mice. In contrast, expression of Wnt9b in cells using Six2-cre caused gastrointestinal distress and severe renal failure in adult mice. Transgenic kidneys had numerous cystic tubules and elevated creatinine values (0.652 +/- 0.044) compared to wild-type mice (0.119 +/- 0.002). These animals also exhibited a malformed pyloric sphincter, duodenogastric reflux, and a transformation of the distal stomach into proximal fate. The gene expression changes observed for the Wnt9b:EGFP transgene were compared to a stabilized beta-catenin allele to determine that Wnt9b is activating the canonical Wnt pathway in the tissues analyzed. These results demonstrate that expression of Wnt9b in Six2-positive cells disrupts cell fate decisions in the kidney and the gastrointestinal tract.	[Kiefer, Susan M.; Robbins, Lynn; Rauchman, Michael] St Louis Univ, Dept Internal Med, St Louis, MO 63103 USA; [Kiefer, Susan M.; Rauchman, Michael] St Louis Univ, Dept Biochem & Mol Biol, St Louis, MO 63103 USA; [Kiefer, Susan M.; Robbins, Lynn; Rauchman, Michael] St Louis Univ, Div Nephrol, John Cochran Vet Affairs Med Ctr, St Louis, MO 63103 USA	Saint Louis University; Saint Louis University; Saint Louis University	Kiefer, SM (corresponding author), St Louis Univ, Dept Internal Med, St Louis, MO 63103 USA.	rauchman@slu.edu			National Institutes of Health [R01 DK067222]; American Heart Association [0840117N]; Saint Louis University; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK067222] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); American Heart Association(American Heart Association); Saint Louis University; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported by National Institutes of Health grant R01 DK067222 (http://nih.gov/) and the American Heart Association Established Investigator 0840117N (http://www.heart.org) to MR. SK was supported by a Saint Louis University Presidential Research Fund Award (www.slu.edu). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Boyle SC, 2011, DEVELOPMENT, V138, P4245, DOI 10.1242/dev.070433; Carroll TJ, 2005, DEV CELL, V9, P283, DOI 10.1016/j.devcel.2005.05.016; Clevers H, 2006, CELL, V127, P469, DOI 10.1016/j.cell.2006.10.018; Couillard M, 2009, DEV DYNAM, V238, P405, DOI 10.1002/dvdy.21841; Harada N, 1999, EMBO J, V18, P5931, DOI 10.1093/emboj/18.21.5931; Heller RS, 2002, DEV DYNAM, V225, P260, DOI 10.1002/dvdy.10157; Hermans D, 2003, EUR J PEDIATR, V162, P598, DOI 10.1007/s00431-003-1259-y; Jho EH, 2002, MOL CELL BIOL, V22, P1172, DOI 10.1128/MCB.22.4.1172-1183.2002; KARAM SM, 1992, ANAT RECORD, V232, P231, DOI 10.1002/ar.1092320208; Karner CM, 2011, DEVELOPMENT, V138, P1247, DOI 10.1242/dev.057646; Karner CM, 2009, NAT GENET, V41, P793, DOI 10.1038/ng.400; Kiefer SM, 2008, HUM MUTAT, V29, P1133, DOI 10.1002/humu.20759; Kiefer SM, 2010, DEVELOPMENT, V137, P3099, DOI 10.1242/dev.037812; Kim BM, 2005, DEV CELL, V8, P611, DOI 10.1016/j.devcel.2005.01.015; Kishimoto N, 2008, DEV CELL, V14, P954, DOI 10.1016/j.devcel.2008.03.010; Kobayashi A, 2008, CELL STEM CELL, V3, P169, DOI 10.1016/j.stem.2008.05.020; Kuure S, 2007, J AM SOC NEPHROL, V18, P1130, DOI 10.1681/ASN.2006111206; Lancaster MA, 2011, NAT CELL BIOL, V13, P700, DOI 10.1038/ncb2259; Lewandoski M, 1997, COLD SPRING HARB SYM, V62, P159; Li X, 2009, DEV DYNAM, V238, P3205, DOI 10.1002/dvdy.22134; Lin SL, 2010, P NATL ACAD SCI USA, V107, P4194, DOI 10.1073/pnas.0912228107; MacDonald BT, 2009, DEV CELL, V17, P9, DOI 10.1016/j.devcel.2009.06.016; Mugford JW, 2009, DEV BIOL, V333, P312, DOI 10.1016/j.ydbio.2009.06.043; Novak A, 2000, GENESIS, V28, P147, DOI 10.1002/1526-968X(200011/12)28:3/4<147::AID-GENE90>3.0.CO;2-G; Park JS, 2007, DEVELOPMENT, V134, P2533, DOI 10.1242/dev.006155; Patel V, 2009, CURR OPIN NEPHROL HY, V18, P99, DOI 10.1097/MNH.0b013e3283262ab0; Qian CN, 2005, J BIOL CHEM, V280, P3938, DOI 10.1074/jbc.M410697200; Saadi-Kheddouci S, 2001, ONCOGENE, V20, P5972, DOI 10.1038/sj.onc.1204825; Schmidt-Ott KM, 2007, DEVELOPMENT, V134, P3177, DOI 10.1242/dev.006544; Self M, 2006, EMBO J, V25, P5214, DOI 10.1038/sj.emboj.7601381; Self M, 2009, DEV BIOL, V334, P409, DOI 10.1016/j.ydbio.2009.07.039; Smith DM, 2000, DEVELOPMENT, V127, P3671; Surendran K, 2005, J AM SOC NEPHROL, V16, P2373, DOI 10.1681/ASN.2004110949; VAEZI MF, 1995, GASTROENTEROLOGY, V108, P1897, DOI 10.1016/0016-5085(95)90156-6; Vaezi MF, 1996, GASTROENTEROLOGY, V111, P1192, DOI 10.1053/gast.1996.v111.pm8898632; Zhao HT, 2004, DEV BIOL, V276, P403, DOI 10.1016/j.ydbio.2004.09.002	36	23	24	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 17	2012	7	8							e43098	10.1371/journal.pone.0043098	http://dx.doi.org/10.1371/journal.pone.0043098			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	996DG	22912798	Green Published, gold, Green Submitted			2022-12-25	WOS:000308063700041
J	Pontiroli, F; Dussurget, O; Zanoni, I; Urbano, M; Beretta, O; Granucci, F; Ricciardi-Castagnoli, P; Cossart, P; Foti, M				Pontiroli, Francesca; Dussurget, Olivier; Zanoni, Ivan; Urbano, Matteo; Beretta, Ottavio; Granucci, Francesca; Ricciardi-Castagnoli, Paola; Cossart, Pascale; Foti, Maria			The Timing of IFN beta Production Affects Early Innate Responses to Listeria monocytogenes and Determines the Overall Outcome of Lethal Infection	PLOS ONE			English	Article							CD8-ALPHA(+) DENDRITIC CELLS; I INTERFERON RECEPTOR; NATURAL-KILLER-CELLS; CD8(+) T-CELLS; BACTERIAL-INFECTION; IMMUNE-RESPONSES; ALPHA-BETA; MACROPHAGE ACTIVATION; MONOCLONAL-ANTIBODY; GAMMA-INTERFERON	Dendritic cells (DCs) and natural killer (NK) cells are essential components of the innate immunity and play a crucial role in the first phase of host defense against infections and tumors. Listeria monocytogenes (Lm) is an intracellular pathogen that colonizes the cytosol of eukaryotic cells. Recent findings have shown Lm specifically in splenic CD8a(+) DCs shortly after intravenous infection. We examined gene expression profiles of mouse DCs exposed to Lm to elucidate the molecular mechanisms underlying DCs interaction with Lm. Using a functional genomics approach, we found that Lm infection induced a cluster of late response genes including type I IFNs and interferon responsive genes (IRGs) in DCs. Type I INFs were produced at the maximal level only at 24 h post infection indicating that the regulation of IFNs in the context of Lm infection is delayed compared to the rapid response observed with viral pathogens. We showed that during Lm infection, IFN gamma production and cytotoxic activity were severely impaired in NK cells compared to E. coli infection. These defects were restored by providing an exogenous source of IFN beta during the initial phase of bacterial challenge. Moreover, when treated with IFN beta during early infection, NK cells were able to reduce bacterial titer in the spleen and significantly improve survival of infected mice. These findings show that the timing of IFN beta production is fundamental to the efficient control of the bacterium during the early innate phase of Lm infection.	[Pontiroli, Francesca; Zanoni, Ivan; Urbano, Matteo; Beretta, Ottavio; Granucci, Francesca; Foti, Maria] Univ Milano Bicocca, Dept Biotechnol & Biosci, Milan, Italy; [Beretta, Ottavio; Foti, Maria] Univ Milano Bicocca, Genopolis Consortium, Milan, Italy; [Dussurget, Olivier; Cossart, Pascale] Inst Pasteur, Unite Interact Bacteries Cellules, Paris, France; [Dussurget, Olivier; Cossart, Pascale] INSERM, U604, Paris, France; [Ricciardi-Castagnoli, Paola] Singapore Immunol Network, Singapore, Singapore; [Dussurget, Olivier; Cossart, Pascale] INRA, USC2020, Paris, France	University of Milano-Bicocca; University of Milano-Bicocca; Le Reseau International des Instituts Pasteur (RIIP); Institut Pasteur Paris; Institut National de la Sante et de la Recherche Medicale (Inserm); Agency for Science Technology & Research (A*STAR); A*STAR - Singapore Immunology Network (SIgN); INRAE	Pontiroli, F (corresponding author), Univ Milano Bicocca, Dept Biotechnol & Biosci, Milan, Italy.	maria.foti@unimib.it	Foti, Maria/AAB-9961-2022; GRANUCCI, Francesca/K-6150-2019	Dussurget, Olivier/0000-0001-9924-0837; granucci, francesca/0000-0002-7046-4914; Zanoni, Ivan/0000-0002-3423-7474; FOTI, MARIA/0000-0002-4481-1900	Italian Ministry of Education and Research (COFIN); European Union [TOLERAGE: HEALTH-F4-2008-202156, FIGHT-MG: Health-2009-242210]	Italian Ministry of Education and Research (COFIN)(Ministry of Education, Universities and Research (MIUR)); European Union(European Commission)	This work was supported by the Italian Ministry of Education and Research (COFIN 2009), by grants from the European Union FP7 Program (TOLERAGE: HEALTH-F4-2008-202156; FIGHT-MG: Health-2009-242210). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aoshi T, 2008, IMMUNITY, V29, P476, DOI 10.1016/j.immuni.2008.06.013; Aoshi T, 2009, EUR J IMMUNOL, V39, P417, DOI 10.1002/eji.200838718; Auerbuch V, 2004, J EXP MED, V200, P527, DOI 10.1084/jem.20040976; Berg RE, 2005, J IMMUNOL, V175, P1751, DOI 10.4049/jimmunol.175.3.1751; Bhardwaj V, 1998, J IMMUNOL, V160, P376; Biron CA, 2001, IMMUNITY, V14, P661, DOI 10.1016/S1074-7613(01)00154-6; Boneca IG, 2007, P NATL ACAD SCI USA, V104, P997, DOI 10.1073/pnas.0609672104; BORTOLUSSI R, 1991, PEDIATR RES, V29, P400, DOI 10.1203/00006450-199104000-00014; Brzoza-Lewis KL, 2012, CELL IMMUNOL, V273, P41, DOI 10.1016/j.cellimm.2011.11.008; Buchrieser C, 2007, MICROBES INFECT, V9, P1147, DOI 10.1016/j.micinf.2007.05.002; Campisi L, 2011, EUR J IMMUNOL, V41, P1594, DOI 10.1002/eji.201041036; Carrero JA, 2004, J EXP MED, V200, P535, DOI 10.1084/jem.20040769; Conlan JW, 1996, J MED MICROBIOL, V44, P295, DOI 10.1099/00222615-44-4-295; CONLAN JW, 1994, J EXP MED, V179, P259, DOI 10.1084/jem.179.1.259; Cossart P, 2008, MICROBES INFECT, V10, P1041, DOI 10.1016/j.micinf.2008.07.043; CZUPRYNSKI CJ, 1994, INFECT IMMUN, V62, P5161, DOI 10.1128/IAI.62.11.5161-5163.1994; Decker T, 2005, NAT REV IMMUNOL, V5, P675, DOI 10.1038/nri1684; Decker T, 2002, J CLIN INVEST, V109, P1271, DOI 10.1172/JCI200215770; DRANOFF G, 1993, P NATL ACAD SCI USA, V90, P3539, DOI 10.1073/pnas.90.8.3539; DUNN PL, 1991, INFECT IMMUN, V59, P2892, DOI 10.1128/IAI.59.9.2892-2900.1991; Edelson BT, 2012, ADV IMMUNOL, V113, P33, DOI 10.1016/B978-0-12-394590-7.00006-3; Edelson BT, 2011, IMMUNITY, V35, P236, DOI 10.1016/j.immuni.2011.06.012; Feng HP, 2005, J IMMUNOL, V175, P421, DOI 10.4049/jimmunol.175.1.421; Fischer MA, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002374; Fortineau N, 2000, RES MICROBIOL, V151, P353, DOI 10.1016/S0923-2508(00)00158-3; Granucci F, 2004, J EXP MED, V200, P287, DOI 10.1084/jem.20040370; Hauf N, 1997, P NATL ACAD SCI USA, V94, P9394, DOI 10.1073/pnas.94.17.9394; HAVELL EA, 1993, J INFECT DIS, V167, P1364, DOI 10.1093/infdis/167.6.1364; Hossain H, 2006, CURR OPIN IMMUNOL, V18, P422, DOI 10.1016/j.coi.2006.05.018; Humann J, 2010, J IMMUNOL, V184, P5172, DOI 10.4049/jimmunol.0903759; Irizarry RA, 2003, BIOSTATISTICS, V4, P249, DOI 10.1093/biostatistics/4.2.249; Jia T, 2009, J IMMUNOL, V183, P1271, DOI 10.4049/jimmunol.0900460; Jung S, 2002, IMMUNITY, V17, P211, DOI 10.1016/S1074-7613(02)00365-5; Kang SJ, 2008, IMMUNITY, V29, P819, DOI 10.1016/j.immuni.2008.09.017; Kapadia D, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019376; Leber JH, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.0040006; Leroy Q, 2009, CLIN MICROBIOL INFEC, V15, P114, DOI 10.1111/j.1469-0691.2008.02189.x; Lin KL, 2008, J IMMUNOL, V180, P2562, DOI 10.4049/jimmunol.180.4.2562; Liu Q, 2012, AM J PATHOL; McCaffrey RL, 2004, P NATL ACAD SCI USA, V101, P11386, DOI 10.1073/pnas.0403215101; Medzhitov R, 2012, SCIENCE, V335, P936, DOI 10.1126/science.1214935; Miller MB, 2009, CLIN MICROBIOL REV, V22, P611, DOI 10.1128/CMR.00019-09; Mitchell LM, 2011, CELL IMMUNOL, V268, P79, DOI 10.1016/j.cellimm.2011.03.001; Monroe KM, 2010, CELL MICROBIOL, V12, P881, DOI 10.1111/j.1462-5822.2010.01478.x; Moretta A, 2008, CELL DEATH DIFFER, V15, P226, DOI 10.1038/sj.cdd.4402170; Nagai T, 2003, J IMMUNOL, V171, P5233, DOI 10.4049/jimmunol.171.10.5233; NAKANE A, 1983, CELL IMMUNOL, V75, P283, DOI 10.1016/0008-8749(83)90326-X; Neuenhahn M, 2007, IMMUNOL LETT, V114, P66, DOI 10.1016/j.imlet.2007.09.007; Neuenhahn M, 2006, IMMUNITY, V25, P619, DOI 10.1016/j.immuni.2006.07.017; O'Connell RM, 2004, J EXP MED, V200, P437, DOI 10.1084/jem.20040712; O'Riordan M, 2002, P NATL ACAD SCI USA, V99, P13861, DOI 10.1073/pnas.202476699; Pamer EG, 2004, NAT REV IMMUNOL, V4, P812, DOI 10.1038/nri1461; Ray JCJ, 2008, J THEOR BIOL, V252, P24, DOI 10.1016/j.jtbi.2008.01.010; Rayamajhi M, 2010, J EXP MED, V207, P327, DOI 10.1084/jem.20091746; ROGERS HW, 1993, INFECT IMMUN, V61, P5090, DOI 10.1128/IAI.61.12.5090-5096.1993; Serbina NV, 2003, IMMUNITY, V19, P891, DOI 10.1016/S1074-7613(03)00330-3; Serbina NV, 2003, IMMUNITY, V19, P59, DOI 10.1016/S1074-7613(03)00171-7; Shahangian A, 2009, J CLIN INVEST, V119, P1910, DOI 10.1172/JCI35412; Stavru F, 2011, IMMUNOL REV, V240, P160, DOI 10.1111/j.1600-065X.2010.00993.x; Stetson DB, 2006, IMMUNITY, V25, P373, DOI 10.1016/j.immuni.2006.08.007; Stockinger S, 2004, J IMMUNOL, V173, P7416, DOI 10.4049/jimmunol.173.12.7416; Stockinger S, 2002, J IMMUNOL, V169, P6522, DOI 10.4049/jimmunol.169.11.6522; Stockinger S, 2008, IMMUNOBIOLOGY, V213, P889, DOI 10.1016/j.imbio.2008.07.020; Stockinger S, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000355; Tchatalbachev S, 2010, BMC MICROBIOL, V10, DOI 10.1186/1471-2180-10-275; Unanue ER, 1997, CURR OPIN IMMUNOL, V9, P35, DOI 10.1016/S0952-7915(97)80156-2; Westcott MM, 2010, INFECT IMMUN, V78, P2956, DOI 10.1128/IAI.01027-09; Winzler C, 1997, J EXP MED, V185, P317, DOI 10.1084/jem.185.2.317; Woodward JJ, 2010, SCIENCE, V328, P1703, DOI 10.1126/science.1189801; Zammit DJ, 2005, IMMUNITY, V22, P561, DOI 10.1016/j.immuni.2005.03.005; Zenewicz LA, 2007, MICROBES INFECT, V9, P1208, DOI 10.1016/j.micinf.2007.05.008	71	18	18	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 17	2012	7	8							e43455	10.1371/journal.pone.0043455	http://dx.doi.org/10.1371/journal.pone.0043455			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	996DG	22912878	Green Published, gold, Green Submitted			2022-12-25	WOS:000308063700106
J	Abo, R; Jenkins, GD; Wang, LW; Fridley, BL				Abo, Ryan; Jenkins, Gregory D.; Wang, Liewei; Fridley, Brooke L.			Identifying the Genetic Variation of Gene Expression Using Gene Sets: Application of Novel Gene Set eQTL Approach to PharmGKB and KEGG	PLOS ONE			English	Article							GENOME-WIDE ASSOCIATION; BIOLOGICAL PATHWAYS; VARIANTS; RISK; PHARMACOGENOMICS; GEMCITABINE; DISCOVERY; DISEASE; LOCI; SNPS	Genetic variation underlying the regulation of mRNA gene expression in humans may provide key insights into the molecular mechanisms of human traits and complex diseases. Current statistical methods to map genetic variation associated with mRNA gene expression have typically applied standard linkage and/or association methods; however, when genome-wide SNP and mRNA expression data are available performing all pair wise comparisons is computationally burdensome and may not provide optimal power to detect associations. Consideration of different approaches to account for the high dimensionality and multiple testing issues may provide increased efficiency and statistical power. Here we present a novel approach to model and test the association between genetic variation and mRNA gene expression levels in the context of gene sets (GSs) and pathways, referred to as gene set - expression quantitative trait loci analysis (GS-eQTL). The method uses GSs to initially group SNPs and mRNA expression, followed by the application of principal components analysis (PCA) to collapse the variation and reduce the dimensionality within the GSs. We applied GS-eQTL to assess the association between SNP and mRNA expression level data collected from a cell-based model system using PharmGKB and KEGG defined GSs. We observed a large number of significant GS-eQTL associations, in which the most significant associations arose between genetic variation and mRNA expression from the same GS. However, a number of associations involving genetic variation and mRNA expression from different GSs were also identified. Our proposed GS-eQTL method effectively addresses the multiple testing limitations in eQTL studies and provides biological context for SNP-expression associations.	[Abo, Ryan; Wang, Liewei] Mayo Clin, Dept Mol Pharmacol & Expt Therapeut, Div Clin Pharmacol, Rochester, MN 55905 USA; [Jenkins, Gregory D.; Fridley, Brooke L.] Mayo Clin, Dept Hlth Sci Res, Rochester, MN USA	Mayo Clinic; Mayo Clinic	Abo, R (corresponding author), Mayo Clin, Dept Mol Pharmacol & Expt Therapeut, Div Clin Pharmacol, Rochester, MN 55905 USA.	fridley.brooke@mayo.edu	Fridley, Brooke L/D-8315-2015	Fridley, Brooke L/0000-0001-7739-7956	National Institutes of Health (NIH) [GM61388, CA140879, GM86689, CA130828, CA138461, CA102701]; Minnesota Partnership; Mayo Foundation; NATIONAL CANCER INSTITUTE [K22CA130828, P50CA102701, P20CA102701, R21CA140879, R01CA138461] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R21GM086689, U01GM061388, U19GM061388] Funding Source: NIH RePORTER	National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Minnesota Partnership; Mayo Foundation; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This research was supported by the National Institutes of Health (NIH grants GM61388, CA140879, GM86689, CA130828, CA138461, CA102701), the Minnesota Partnership, and the Mayo Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allen HL, 2010, NATURE, V467, P832, DOI 10.1038/nature09410; Ashburner M, 2000, NAT GENET, V25, P25, DOI 10.1038/75556; Ballard DH, 2010, GENET EPIDEMIOL, V34, P201, DOI 10.1002/gepi.20448; Breitling R, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000232; Chai HS, 2009, BMC BIOINFORMATICS, V10, DOI 10.1186/1471-2105-10-102; Chen L, 2009, GENOMICS, V93, P501, DOI 10.1016/j.ygeno.2009.01.011; Chen LS, 2010, AM J HUM GENET, V86, P860, DOI 10.1016/j.ajhg.2010.04.014; Cheung VG, 2005, NATURE, V437, P1365, DOI 10.1038/nature04244; Cheung VG, 2009, NAT REV GENET, V10, P595, DOI 10.1038/nrg2630; Dimas AS, 2009, SCIENCE, V325, P1246, DOI 10.1126/science.1174148; Ding J, 2010, AM J HUM GENET, V87, P779, DOI 10.1016/j.ajhg.2010.10.024; Dixon AL, 2007, NAT GENET, V39, P1202, DOI 10.1038/ng2109; Duarte CW, 2011, GENETICS, V187, P955, DOI 10.1534/genetics.110.124685; Emilsson V, 2008, NATURE, V452, P423, DOI 10.1038/nature06758; Franke L, 2009, METHODS MOL BIOL, V573, P311, DOI 10.1007/978-1-60761-247-6_17; Fransen K, 2010, HUM MOL GENET, V19, P3482, DOI 10.1093/hmg/ddq264; Fridley BL, 2011, EUR J HUM GENET, V19, P837, DOI 10.1038/ejhg.2011.57; Gauderman WJ, 2007, GENET EPIDEMIOL, V31, P383, DOI 10.1002/gepi.20219; Goeman JJ, 2007, BIOINFORMATICS, V23, P980, DOI 10.1093/bioinformatics/btm051; Goring HHH, 2007, NAT GENET, V39, P1208, DOI 10.1038/ng2119; Grieve IC, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0004033; Jia PL, 2010, SCHIZOPHR RES, V122, P38, DOI 10.1016/j.schres.2010.07.001; Kanehisa M, 2000, NUCLEIC ACIDS RES, V28, P27, DOI 10.1093/nar/28.1.27; Klein T. E., 2001, Pharmacogenomics Journal, V1, P167; Lettice LA, 2002, P NATL ACAD SCI USA, V99, P7548, DOI 10.1073/pnas.112212199; Li J, 2005, HUM MOL GENET, V14, pR163, DOI 10.1093/hmg/ddi267; Li L, 2008, CANCER RES, V68, P7050, DOI 10.1158/0008-5472.CAN-08-0405; Li L, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007765; Li SY, 2011, STAT INTERFACE, V4, P389; Li SY, 2010, J BIOPHARM STAT, V20, P373, DOI 10.1080/10543400903572803; Loguercio S, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013920; Marchini J, 2010, NAT REV GENET, V11, P499, DOI 10.1038/nrg2796; Mardia K., 1979, MULTIVARIATE ANAL, V15, P518; Menashe I, 2010, CANCER RES, V70, P4453, DOI 10.1158/0008-5472.CAN-09-4502; Moffatt MF, 2007, NATURE, V448, P470, DOI 10.1038/nature06014; Monks SA, 2004, AM J HUM GENET, V75, P1094, DOI 10.1086/426461; Mootha VK, 2003, NAT GENET, V34, P267, DOI 10.1038/ng1180; Morley M, 2004, NATURE, V430, P743, DOI 10.1038/nature02797; Murphy A, 2010, HUM MOL GENET, V19, P4745, DOI 10.1093/hmg/ddq392; Myers AJ, 2007, NAT GENET, V39, P1494, DOI 10.1038/ng.2007.16; Nicolae DL, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1000888; Niu NF, 2010, GENOME RES, V20, P1482, DOI 10.1101/gr.107672.110; Nobrega MA, 2003, SCIENCE, V302, P413, DOI 10.1126/science.1088328; O'Dushlaine C, 2011, MOL PSYCHIATR, V16, P286, DOI 10.1038/mp.2010.7; Plenge RM, 2010, NAT GENET, V42, P281, DOI 10.1038/ng0410-281; Price AL, 2006, NAT GENET, V38, P904, DOI 10.1038/ng1847; Scholkopf B., 2002, LEARNING KERNELS; Sieberts SK, 2007, MAMM GENOME, V18, P389, DOI 10.1007/s00335-007-9040-6; Song S, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-502; Stranger BE, 2005, PLOS GENET, V1, P695, DOI 10.1371/journal.pgen.0010078; Subramanian A, 2005, P NATL ACAD SCI USA, V102, P15545, DOI 10.1073/pnas.0506580102; Suthram S, 2008, MOL SYST BIOL, V4, DOI 10.1038/msb.2008.4; Team RDC, 2010, R LANG ENV STAT COMP; Tomfohr J, 2005, BMC BIOINFORMATICS, V6, DOI 10.1186/1471-2105-6-225; Vapnik V., 1998, STAT LEARNING THEORY; Veyrieras JB, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000214; Wang K, 2010, NAT REV GENET, V11, P843, DOI 10.1038/nrg2884; Wu CL, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000070; Wu ZJ, 2004, J AM STAT ASSOC, V99, P909, DOI 10.1198/016214504000000683; Yekutieli D, 1999, J STAT PLAN INFER, V82, P171, DOI 10.1016/S0378-3758(99)00041-5	60	6	6	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 14	2012	7	8							e43301	10.1371/journal.pone.0043301	http://dx.doi.org/10.1371/journal.pone.0043301			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	988OQ	22905253	Green Published, Green Submitted, gold			2022-12-25	WOS:000307500800075
J	Bartee, E; Meacham, A; Wise, E; Cogle, CR; McFadden, G				Bartee, Eric; Meacham, Amy; Wise, Elizabeth; Cogle, Christopher R.; McFadden, Grant			Virotherapy Using Myxoma Virus Prevents Lethal Graft-versus-Host Disease following Xeno-Transplantation with Primary Human Hematopoietic Stem Cells	PLOS ONE			English	Article							T-CELLS; GVHD; STRATEGIES; LEUKEMIA; FAILURE	Graft-versus-host disease (GVHD) is a potentially lethal clinical complication arising from the transfer of alloreactive T lymphocytes into immunocompromised recipients. Despite conventional methods of T cell depletion, GVHD remains a major challenge in allogeneic hematopoietic cell transplant. Here, we demonstrate a novel method of preventing GVHD by ex vivo treatment of primary human hematopoietic cell sources with myxoma virus, a rabbit specific poxvirus currently under development for oncolytic virotherapy. This pretreatment dramatically increases post-transplant survival of immunocompromised mice injected with primary human bone marrow or peripheral blood cells and prevents the expansion of human CD3(+) lymphocytes in major recipient organs. Similar viral treatment also prevents human-human mixed alloreactive T lymphocyte reactions in vitro. Our data suggest that ex vivo virotherapy with myxoma virus can be a simple and effective method for preventing GVHD following infusion of hematopoietic products containing alloreactive T lymphocytes such as: allogeneic hematopoietic stem and progenitor cells, donor leukocyte infusions and blood transfusions.	[Bartee, Eric; McFadden, Grant] Univ Florida, Coll Med, Dept Mol Genet & Microbiol, Gainesville, FL 32603 USA; [Meacham, Amy; Wise, Elizabeth; Cogle, Christopher R.] Univ Florida, Coll Med, Dept Med, Div Hematol Oncol, Gainesville, FL USA	State University System of Florida; University of Florida; State University System of Florida; University of Florida	Bartee, E (corresponding author), Univ Florida, Coll Med, Dept Mol Genet & Microbiol, Gainesville, FL 32603 USA.	grantmcf@ufl.edu	Cogle, Christopher/H-1746-2016	Cogle, Christopher/0000-0001-5422-6863; McFadden, Grant/0000-0002-2556-3526; Bartee, Eric/0000-0003-1793-446X	National Institutes of Health, National Cancer Institute [R01 CA138541, R21 CA149869]; Florida Department of Health Bankhead Coley Research Program Team Science grant [1BT02]; Leukemia & Lymphoma Society; STOP! Children's Cancer, Inc; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [UL1TR000064] Funding Source: NIH RePORTER	National Institutes of Health, National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); Florida Department of Health Bankhead Coley Research Program Team Science grant; Leukemia & Lymphoma Society(Leukemia and Lymphoma Society); STOP! Children's Cancer, Inc; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS))	This study was supported by funding to GM from National Institutes of Health R01 CA138541 and R21 CA149869 from National Cancer Institute (www.nih.gov). GM and CRC are supported by the Florida Department of Health Bankhead Coley Research Program Team Science grant 1BT02 (http://floridabiomed.com/funding_bc.html). CRC is supported by a Scholar in Clinical Research Award from the Leukemia & Lymphoma Society (www.lss.org). EB is supported by STOP! Children's Cancer, Inc (http://www.stopchildrenscancer.org/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anwar Masood, 2003, J Ayub Med Coll Abbottabad, V15, P56; Bais S, 2011, ADV VIROL; Bartee E, 2012, BIOL BLOOD MARROW TR; Blazar BR, 1997, IMMUNOL REV, V157, P79, DOI 10.1111/j.1600-065X.1997.tb00976.x; Chahroudi A, 2005, J VIROL, V79, P10397, DOI 10.1128/JVI.79.16.10397-10407.2005; Chao N, 2012, BLOOD, V119, P1102, DOI 10.1182/blood-2011-12-395905; Chao NJ, 2008, BEST PRACT RES CL HA, V21, P93, DOI 10.1016/j.beha.2007.11.012; Choi SW, 2010, IMMUNOL ALLERGY CLIN, V30, P75, DOI 10.1016/j.iac.2009.10.001; Davies JK, 2011, JOVE-J VIS EXP, DOI 10.3791/2673; DELAIN M, 1993, LEUKEMIA LYMPHOMA, V11, P359, DOI 10.3109/10428199309067927; FENNER F, 1965, MYXOMATOSIS; Ferrara JLM, 2009, LANCET, V373, P1550, DOI 10.1016/S0140-6736(09)60237-3; Ito R, 2009, TRANSPLANTATION, V87, P1654, DOI 10.1097/TP.0b013e3181a5cb07; Johnston JB, 2003, J VIROL, V77, P5877, DOI 10.1128/JVI.77.10.5877-5888.2003; Kim M, 2009, LEUKEMIA, V23, P2313, DOI 10.1038/leu.2009.219; Li JM, 2009, IMMUNOTHERAPY-UK, V1, P599, DOI 10.2217/IMT.09.32; Madlambayan GJ, 2012, LEUKEMIA RES, V36, P619, DOI 10.1016/j.leukres.2012.01.020; Maeda Y, 2005, BLOOD, V105, P2023, DOI 10.1182/blood-2004-08-3036; MARTIN PJ, 1988, BONE MARROW TRANSPL, V3, P445; MOSS B, 2007, FIELDS VIROLOGY, P2849; Murphy WJ, 1999, CURR OPIN IMMUNOL, V11, P509, DOI 10.1016/S0952-7915(99)00002-3; O'Shaughnessy MJ, 2009, AM J TRANSPLANT, V9, P452, DOI 10.1111/j.1600-6143.2008.02533.x; Paczesny S, 2009, CURR OPIN HEMATOL, V16, P427, DOI 10.1097/MOH.0b013e3283319a6f; Pasquini MC, 2010, CURRENT USE OUTCOME; Rahman MM, 2010, CYTOKINE GROWTH F R, V21, P169, DOI 10.1016/j.cytogfr.2010.02.010; Socie G, 2009, BLOOD, V114, P4327, DOI 10.1182/blood-2009-06-204669; Stanford MM, 2007, EXPERT OPIN BIOL TH, V7, P1415, DOI 10.1517/14712598.7.9.1415; Ullman-Cullere MH, 1999, LAB ANIM SCI, V49, P319	28	14	16	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 14	2012	7	8							e43298	10.1371/journal.pone.0043298	http://dx.doi.org/10.1371/journal.pone.0043298			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	988OQ	22905251	gold, Green Submitted, Green Published			2022-12-25	WOS:000307500800073
J	Boechat, ND; Ogusku, MM; Boechat, AL; Sadahiro, A				Boechat, Narjara de Oliveira; Ogusku, Mauricio Morish; Boechat, Antonio Luiz; Sadahiro, Aya			Interaction between Smoking and HLA-DRB1*04 Gene Is Associated with a High Cardiovascular Risk in Brazilian Amazon Patients with Rheumatoid Arthritis	PLOS ONE			English	Article							SHARED EPITOPE; ISRAELI JEWS; HLA-DRB1; MORTALITY; DISEASE; CLASSIFICATION; ALLELES; SUSCEPTIBILITY; POLYMORPHISM; CRITERIA	Background: Rheumatoid Arthritis (RA) is an autoimmune disease characterized by chronic inflammation of the joints that affects approximately 1% of the population worldwide. The HLA-DRB1 gene locus plays a major role in genetic susceptibility to RA, a condition that has been associated with a high cardiovascular morbidity and mortality in many studies. Methodology/Principal Findings: The aim of this work was to investigate which types of HLA class II genes are associated with RA in patients from the Brazilian Amazon and their influence on high cardiovascular risk status in this population. For this purpose, a case-control study was carried out with a total of 350 non-Indian individuals made up of a cohort of 132 consecutive RA sufferers and 218 healthy controls. A chi(2) test showed that HLADRB1*04 (p<0.0016; OR = 1.89; 95% CI = 1.29-2.79) and HLADRB1*10 (p = 0.0377; OR = 3.81; 95% CI = 1.16-12.50) are the major HLA genes associated with susceptibility to RA. A logistic regression model also showed that the interaction between HLADRB1*04 (p = 0.027; OR = 6.02; 95% CI = 1.21-29.7), age (p = 0.0001; OR = 1.26; 95% CI = 1.13-1.39) and smoking (p = 0.0001; OR = 23.6; 95% CI = 4.25-32.1) is associated with a probability of a high cardiovascular risk status at an early age. Conclusions/Significance: The results of this study show for the first time that HLA class II type is associated with RA in Brazilian Amazon populations and that a specific interaction between the HLA-DRB1*04 gene and smoking is associated with a high cardiovascular risk status, as initially reported in the European population. This study therefore contributes to an understanding of gene-environment interactions in RA patients.	[Boechat, Narjara de Oliveira; Boechat, Antonio Luiz; Sadahiro, Aya] Univ Fed Amazonas, Programa Posgrad Imunol Basica & Aplicada, Inst Ciencias Biol, Manaus, Amazonas, Brazil; [Boechat, Narjara de Oliveira; Boechat, Antonio Luiz] Hosp Geral Adriano Jorge, Clin Artrite Reumatoide, Manaus, Amazonas, Brazil; [Ogusku, Mauricio Morish] INPA, Lab Micobacteriol, Manaus, Amazonas, Brazil	Universidade Federal de Amazonas; Institute Nacional de Pesquisas da Amazonia	Boechat, ND (corresponding author), Univ Fed Amazonas, Programa Posgrad Imunol Basica & Aplicada, Inst Ciencias Biol, Manaus, Amazonas, Brazil.	antonioluiz.boechat@gmail.com	Ogusku, Mauricio Morishi/G-3158-2012; Boechat, A.L./H-8484-2019; Boechat, Antonio Luiz/E-6464-2010	Boechat, A.L./0000-0001-5597-7343; Boechat, Antonio Luiz/0000-0001-5597-7343; Ogusku, Mauricio Morishi/0000-0003-0173-6266				ARNETT FC, 1988, ARTHRITIS RHEUM, V31, P315, DOI 10.1002/art.1780310302; Avina-Zubieta JA, 2008, ARTHRIT RHEUM-ARTHR, V59, P1690, DOI 10.1002/art.24092; Baka Z, 2009, ARTHRITIS RES THER, V11, DOI 10.1186/ar2751; Callegari-Jacques SM, 2003, AM J HUM BIOL, V15, P824, DOI 10.1002/ajhb.10217; Chang WW, 2010, RHEUMATOLOGY, V49, P652, DOI 10.1093/rheumatology/kep417; D'Agostino RB, 2008, CIRCULATION, V117, P743, DOI 10.1161/CIRCULATIONAHA.107.699579; del Rincon I, 2005, ARTHRITIS RHEUM-US, V52, P3413, DOI 10.1002/art.21397; del Rincon I, 2001, ARTHRITIS RHEUM-US, V44, P2737, DOI 10.1002/1529-0131(200112)44:12<2737::AID-ART460>3.0.CO;2-#; DEVRIES N, 1993, TISSUE ANTIGENS, V41, P26; du Montcel ST, 2005, ARTHRITIS RHEUM-US, V52, P1063, DOI 10.1002/art.20989; Farragher TM, 2008, ARTHRITIS RHEUM-US, V58, P359, DOI 10.1002/art.23149; FERRAZ MB, 1990, J RHEUMATOL, V17, P813; Fietta Pieranna, 2009, Acta Biomed, V80, P177; FRIES JF, 1980, ARTHRITIS RHEUM, V23, P137, DOI 10.1002/art.1780230202; Funovits J, 2010, ANN RHEUM DIS, V69, P1589, DOI 10.1136/ard.2010.130310; Gabriel SE, 1999, J RHEUMATOL, V26, P2475; Gabriel SE, 2003, ARTHRITIS RHEUM-US, V48, P54, DOI 10.1002/art.10705; GAO XJ, 1991, J RHEUMATOL, V18, P801; Gonzalez A, 2008, J RHEUMATOL, V35, P1009; Gonzalez A, 2007, ARTHRITIS RHEUM, V56, P3583, DOI 10.1002/art.22979; Gonzalez-Gay MA, 2005, SEMIN ARTHRITIS RHEU, V35, P8, DOI 10.1016/j.semarthrit.2005.03.004; Gonzalez-Gay MA, 2007, ARTHRIT RHEUM-ARTHR, V57, P125, DOI 10.1002/art.22482; Gonzalez-Juanatey C, 2003, AM J MED, V114, P647, DOI 10.1016/S0002-9343(03)00133-5; GUSTINCICH S, 1991, BIOTECHNIQUES, V11, P298; Hill JA, 2003, J IMMUNOL, V171, P538, DOI 10.4049/jimmunol.171.2.538; Hoeben A, 2004, PHARMACOL REV, V56, P549, DOI 10.1124/pr.56.4.3; Hot A, 2012, ANN RHEUMATIC DIS; Imboden JB, 2009, ANNU REV PATHOL-MECH, V4, P417, DOI 10.1146/annurev.pathol.4.110807.092254; Kallberg H, 2007, AM J HUM GENET, V80, P867, DOI 10.1086/516736; Ligeiro D, 2007, ANN RHEUM DIS, V66, P246, DOI 10.1136/ard.2005.051177; Louzada P, 2008, BRAZ J MED BIOL RES, V41, P493, DOI 10.1590/S0100-879X2008005000021; Marder W, 2011, ANN RHEUM DIS, V70, P1550, DOI 10.1136/ard.2010.148031; Mattey DL, 2007, ARTHRITIS RHEUM-US, V56, P1408, DOI 10.1002/art.22527; Newton JL, 2004, GENES IMMUN, V5, P151, DOI 10.1038/sj.gene.6364045; Palomino-Morales R, 2010, ARTHRITIS RES THER, V12, DOI 10.1186/ar2989; Peters MJL, 2010, ANN RHEUM DIS, V69, P325, DOI 10.1136/ard.2009.113696; Pollard L, 2005, CLIN EXP RHEUMATOL, V23, pS43; PREVOO MLL, 1995, ARTHRITIS RHEUM, V38, P44, DOI 10.1002/art.1780380107; Raychaudhuri S, 2010, CURR OPIN RHEUMATOL, V22, P109, DOI 10.1097/BOR.0b013e328336474d; Rodriguez-Rodriguez L, 2011, ARTHRITIS RES THER, V13, DOI 10.1186/ar3444; Rodriguez-Rodriguez L, 2011, ATHEROSCLEROSIS, V216, P125, DOI 10.1016/j.atherosclerosis.2010.10.052; Rojas-Villarraga A, 2008, SEMIN ARTHRITIS RHEU, V38, P71, DOI 10.1016/j.semarthrit.2008.01.019; Sokka T, 2010, ARTHRITIS RES THER, V12, DOI 10.1186/ar2951; Symmons DPM, 2011, NAT REV RHEUMATOL, V7, P399, DOI 10.1038/nrrheum.2011.75; Taneja V, 2008, J IMMUNOL, V181, P2869, DOI 10.4049/jimmunol.181.4.2869; Tobon GJ, 2010, J AUTOIMMUN, V35, P10, DOI 10.1016/j.jaut.2009.12.009; Ursum J, 2010, J RHEUMATOL, V37, P1431, DOI 10.3899/jrheum.090913; van der Horst-Bruinsma IE, 1999, HUM IMMUNOL, V60, P152, DOI 10.1016/S0198-8859(98)00101-3; YELAMOS J, 1993, ARTHRITIS RHEUM-US, V36, P811, DOI 10.1002/art.1780360611; Zanelli E, 2000, HUM IMMUNOL, V61, P1254, DOI 10.1016/S0198-8859(00)00185-3	50	8	8	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 13	2012	7	8							e41588	10.1371/journal.pone.0041588	http://dx.doi.org/10.1371/journal.pone.0041588			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	988OJ	22912672	gold, Green Published, Green Submitted			2022-12-25	WOS:000307500100005
J	Graham, SM; Holte, SE; Dragavon, JA; Ramko, KM; Mandaliya, KN; McClelland, RS; Peshu, NM; Sanders, EJ; Krieger, JN; Coombs, RW				Graham, Susan M.; Holte, Sarah E.; Dragavon, Joan A.; Ramko, Kelly M.; Mandaliya, Kishor N.; McClelland, R. Scott; Peshu, Norbert M.; Sanders, Eduard J.; Krieger, John N.; Coombs, Robert W.			HIV-1 RNA May Decline More Slowly in Semen than in Blood following Initiation of Efavirenz-Based Antiretroviral Therapy	PLOS ONE			English	Article							HIV-1-INFECTED MEN; DRUG CONCENTRATIONS; GENITAL-TRACT; COMPARTMENTS; PLASMA; TRANSMISSION; METAANALYSIS; PENETRATION; LAMIVUDINE; INFECTION	Objectives: Antiretroviral therapy (ART) decreases HIV-1 RNA levels in semen and reduces sexual transmission from HIV-1-infected men. Our objective was to study the time course and magnitude of seminal HIV-1 RNA decay after initiation of efavirenz-based ART among 13 antiretroviral-naive Kenyan men. Methods: HIV-1 RNA was quantified (lower limit of detection, 120 copies/mL) in blood and semen at baseline and over the first month of ART. Median log(10) HIV-1 RNA was compared at each time-point using Wilcoxon Signed Rank tests. Perelson's two-phase viral decay model and nonlinear random effects were used to compare decay rates in blood and semen. Results: Median baseline HIV-1 RNA was 4.40 log(10) copies/mL in blood (range, 3.20-5.08 log(10) copies/mL) and 3.69 log(10) copies/mL in semen (range, <2.08-4.90 log(10) copies/mL). The median reduction in HIV-1 RNA by day 28 was 1.90 log(10) copies/mL in blood (range, 0.56-2.68 log(10) copies/mL) and 1.36 log(10) copies/mL in semen (range, 0-2.66 log(10) copies/mL). ART led to a decrease from baseline by day 7 in blood and day 14 in semen (p = 0.005 and p = 0.006, respectively). The initial modeled decay rate was slower in semen than in blood (p = 0.06). There was no difference in second-phase decay rates between blood and semen. Conclusions: Efavirenz-based ART reduced HIV-1 RNA levels more slowly in semen than in blood. Although this difference was of borderline significance in this small study, our observations suggest that there is suboptimal suppression of seminal HIV-1 RNA for some men in the early weeks of treatment.	[Graham, Susan M.; McClelland, R. Scott; Coombs, Robert W.] Univ Washington, Dept Med, Seattle, WA 98195 USA; [Graham, Susan M.; McClelland, R. Scott; Krieger, John N.] Univ Washington, Dept Global Hlth, Seattle, WA 98195 USA; [Graham, Susan M.; McClelland, R. Scott] Univ Nairobi, Dept Med Microbiol, Nairobi, Kenya; [Graham, Susan M.; Ramko, Kelly M.; Peshu, Norbert M.; Sanders, Eduard J.] Kenya Govt Med Res Ctr, Ctr Geog Med & Res Coast, Kilifi, Kenya; [Holte, Sarah E.] Univ Washington, Dept Biostat, Seattle, WA 98195 USA; [Holte, Sarah E.] Fred Hutchinson Canc Res Ctr, Dept Biostat & Biomath, Seattle, WA 98104 USA; [Dragavon, Joan A.; Coombs, Robert W.] Univ Washington, Dept Lab Med, Seattle, WA 98195 USA; [Mandaliya, Kishor N.] PathCare Kenya, Mombasa, Kenya; [McClelland, R. Scott] Univ Washington, Dept Epidemiol, Seattle, WA 98195 USA; [Sanders, Eduard J.] Univ Oxford, Nuffield Dept Clin Med, Headington, England; [Krieger, John N.] Univ Washington, Dept Urol, Seattle, WA 98195 USA; [Krieger, John N.] VA Puget Sound Hlth Care Syst, Dept Urol, Seattle, WA USA	University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle; University of Nairobi; Kenya Medical Research Institute; University of Washington; University of Washington Seattle; Fred Hutchinson Cancer Center; University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle; University of Oxford; University of Washington; University of Washington Seattle; US Department of Veterans Affairs; Veterans Health Administration (VHA); Vet Affairs Puget Sound Health Care System	Graham, SM (corresponding author), Univ Washington, Dept Med, Seattle, WA 98195 USA.	grahamsm@u.washington.edu	Graham, Susan/W-6133-2019	Graham, Susan/0000-0001-7847-8686	National Institutes of Health (NIH) [R21 HD-055864, K23 AI-069990, R01 AI-055343, P30 AI027757]; University of Washington Center for AIDS Research (CFAR); NIH (NIAID); NIH (NCI); NIH (NIMH); NIH (NIDA); NIH (NICHD); NIH (NHLBI); NIH (NCCAM); Kenya Medical Research Institute (KEMRI); International AIDS Vaccine Initiative (IAVI); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [R21HD055864] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [P30AI027757, K23AI069990, R01AI055343] Funding Source: NIH RePORTER	National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); University of Washington Center for AIDS Research (CFAR); NIH (NIAID)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NIH (NCI)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NIH (NIMH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NIH (NIDA)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)); NIH (NICHD)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NIH (NHLBI)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NIH (NCCAM)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Complementary & Alternative Medicine); Kenya Medical Research Institute (KEMRI); International AIDS Vaccine Initiative (IAVI); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This study was supported by National Institutes of Health (NIH) grant R21 HD-055864. Dr. Graham was supported by NIH grant K23 AI-069990, and Dr. Holte was supported by NIH grant R01 AI-055343. Additional funding was provided by the University of Washington Center for AIDS Research (CFAR), an NIH funded program (P30 AI027757), which is supported by the following NIH Institutes and Centers (NIAID, NCI, NIMH, NIDA, NICHD, NHLBI, NCCAM). The funders had no role in study design, data collection and analysis, decision to publish, or prepartion of the manuscript.; We would like to thank the research staff who helped make this project a success, the Kenya Medical Research Institute (KEMRI) and the International AIDS Vaccine Initiative (IAVI) for support of E. Sanders and use of clinical space, the Coast Provincial General Hospital for provision of laboratory space, and the KEMRI Director for permission to publish. Special thanks go to the men who participated in this study.	Attia S, 2009, AIDS, V23, P1397, DOI 10.1097/QAD.0b013e32832b7dca; Baeten JM, 2011, SCI TRANSL MED, V3, DOI 10.1126/scitranslmed.3001888; Barroso PF, 2003, JAIDS-J ACQ IMM DEF, V32, P435, DOI 10.1097/00126334-200304010-00014; Calcagno A, 2010, ANTIMICROB AGENTS CH, V54, P2744, DOI 10.1128/AAC.00241-10; Cohen MS, 2011, 6 IAS C HIV PATH TRE; Cohen MS, 2011, NEW ENGL J MED, V365, P493, DOI [10.1056/NEJMoa1105243, 10.1056/NEJMoa1600693]; Craigo JK, 2004, AIDS RES HUM RETROV, V20, P1196, DOI 10.1089/aid.2004.20.1196; Donnell D, 2010, LANCET, V375, P2092, DOI 10.1016/S0140-6736(10)60705-2; Ghosn J, 2004, AIDS, V18, P1958, DOI 10.1097/00002030-200409240-00014; Graham SM, 2007, AIDS, V21, P501, DOI 10.1097/QAD.0b013e32801424bd; Graham SM, 2011, SEX TRANSM INFECT, V87, P232, DOI 10.1136/sti.2010.047118; Granich RM, 2009, LANCET, V373, P48, DOI 10.1016/S0140-6736(08)61697-9; Ivers LC, 2005, CLIN INFECT DIS, V41, P217, DOI 10.1086/431199; Leruez-Ville M, 2002, AIDS, V16, P486, DOI 10.1097/00002030-200202150-00023; Li CC, 2005, J CLIN MICROBIOL, V43, P3901, DOI 10.1128/JCM.43.8.3901-3905.2005; Lorello G, 2009, HIV MED, V10, P548, DOI 10.1111/j.1468-1293.2009.00725.x; Lowe SH, 2006, HIV CLIN TRIALS, V7, P285, DOI 10.1310/hct0706-285; Murray JM, 2007, AIDS, V21, P2315, DOI 10.1097/QAD.0b013e3282f12377; Pereira AS, 2002, J INFECT DIS, V186, P198, DOI 10.1086/341209; Perelson AS, 1997, NATURE, V387, P188, DOI 10.1038/387188a0; Pinheiro J, 2001, MIXED EFFECTS MODELS; Reddy YS, 2002, J INFECT DIS, V186, P1339, DOI 10.1086/344311; Shen CL, 2010, VIROLOGY, V401, P190, DOI 10.1016/j.virol.2010.01.033; Sheth PM, 2009, AIDS, V23, P2050, DOI 10.1097/QAD.0b013e3283303e04; Taylor S, 2001, AIDS, V15, P424, DOI 10.1097/00002030-200102160-00022; Taylor S, 2001, AIDS, V15, P2051, DOI 10.1097/00002030-200110190-00022; Taylor S, 2000, AIDS, V14, P1979, DOI 10.1097/00002030-200009080-00014; UNAIDS, 2010, GLOB REP UNAIDS REP; WHO, 2010, ANT THER HIV INF AD; Zuckerman RA, 2007, J INFECT DIS, V196, P1500, DOI 10.1086/522523	30	10	12	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 13	2012	7	8							e43086	10.1371/journal.pone.0043086	http://dx.doi.org/10.1371/journal.pone.0043086			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	988OJ	22912795	gold, Green Published, Green Submitted			2022-12-25	WOS:000307500100060
J	Heckman, MG; Soto-Ortolaza, AI; Diehl, NN; Carrasquillo, MM; Uitti, RJ; Wszolek, ZK; Graff-Radford, NR; Ross, OA				Heckman, Michael G.; Soto-Ortolaza, Alexandra I.; Diehl, Nancy N.; Carrasquillo, Minerva M.; Uitti, Ryan J.; Wszolek, Zbigniew K.; Graff-Radford, Neill R.; Ross, Owen A.			Evaluation of the Role of SNCA Variants in Survival without Neurological Disease	PLOS ONE			English	Article							ALPHA-SYNUCLEIN; GENETIC-DETERMINANTS; PARKINSONS-DISEASE; INCREASED RISK; ASSOCIATION; DEMENTIA	Background: A variety of definitions of successful aging have been proposed, many of which relate to longevity, freedom from disease and disability, or preservation of high physical and cognitive function. Many behavioral, biomedical, and psychological factors have been linked with these various measures of successful aging, however genetic predictors are less understood. Parkinson's disease (PD) is an age-related neurodegenerative disorder, and variants in the a-synuclein gene (SNCA) affect susceptibility to PD. This exploratory study examined whether SNCA variants may also promote successful aging as defined by survival without neurological disease. Methods: We utilized 769 controls without neurological disease (Mean age: 79 years, Range: 33-99 years) and examined the frequency of 20 different SNCA variants across age groups using logistic regression models. We also included 426 PD cases to assess the effect of these variants on PD risk. Results: There was a significant decline in the proportion of carriers of the minor allele of rs10014396 as age increased (P = 0.021), from 30% in controls younger than 60 to 14% in controls 90 years of age or older. Findings were similar for rs3775439, where the proportion of carriers of the minor allele declined from 32% in controls less than 60 years old to 19% in those 90 or older (P = 0.025). A number of SNCA variants, not including rs10014396 or rs3775439, were significantly associated with susceptibility to PD. Conclusions: In addition to its documented roles in PD and alpha-synucleinopathies, our results suggest that SNCA has a role in survival free of neurological disease. Acknowledging that our findings would not have withstood correction for multiple testing, validation in an independent series of aged neurologically normal controls is needed.	[Heckman, Michael G.; Diehl, Nancy N.] Mayo Clin, Biostat Unit, Jacksonville, FL 32224 USA; [Soto-Ortolaza, Alexandra I.; Carrasquillo, Minerva M.; Ross, Owen A.] Mayo Clin, Dept Neurosci, Jacksonville, FL 32224 USA; [Uitti, Ryan J.; Wszolek, Zbigniew K.; Graff-Radford, Neill R.] Mayo Clin, Dept Neurol, Jacksonville, FL 32224 USA	Mayo Clinic; Mayo Clinic; Mayo Clinic	Heckman, MG (corresponding author), Mayo Clin, Biostat Unit, Jacksonville, FL 32224 USA.	heckman.michael@mayo.edu	Ross, Owen/D-7573-2013; Wszolek, Zbigniew K./AAB-1431-2019	Ross, Owen/0000-0003-4813-756X	American Parkinson Disease Association; Morris K. Udall Parkinson's Disease Research Center of Excellence (NINDS) [NS072187]; Carl and Susan Bolch; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [P50NS072187] Funding Source: NIH RePORTER	American Parkinson Disease Association; Morris K. Udall Parkinson's Disease Research Center of Excellence (NINDS)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); Carl and Susan Bolch; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This work is funded, in part, by a research grant for the American Parkinson Disease Association, the Morris K. Udall Parkinson's Disease Research Center of Excellence (NINDS P50 #NS072187) and the family of Carl and Susan Bolch. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Al-Chalabi A, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007114; Christensen K, 2006, NAT REV GENET, V7, P436, DOI 10.1038/nrg1871; Dachsel JC, 2007, MOVEMENT DISORD, V22, P293, DOI 10.1002/mds.21223; de Lau LML, 2006, LANCET NEUROL, V5, P525, DOI 10.1016/S1474-4422(06)70471-9; Depp CA, 2006, AM J GERIAT PSYCHIAT, V14, P6, DOI 10.1097/01.JGP.0000192501.03069.bc; Depp Colin A, 2007, Curr Psychiatry Rep, V9, P7, DOI 10.1007/s11920-007-0003-0; Elbaz A, 2011, ANN NEUROL, V69, P778, DOI 10.1002/ana.22321; Gelb DJ, 1999, ARCH NEUROL-CHICAGO, V56, P33, DOI 10.1001/archneur.56.1.33; Glatt SJ, 2007, BIOL PSYCHIAT, V62, P282, DOI 10.1016/j.biopsych.2006.09.015; Graff-Radford NR, 2006, ALZ DIS ASSOC DIS, V20, P101, DOI 10.1097/01.wad.0000213813.35424.d2; HARMAN D, 1991, P NATL ACAD SCI USA, V88, P5360, DOI 10.1073/pnas.88.12.5360; Karasik D, 2005, J GERONTOL A-BIOL, V60, P574, DOI 10.1093/gerona/60.5.574; Kirkwood TBL, 1996, BIOESSAYS, V18, P1009, DOI 10.1002/bies.950181211; Mueller JC, 2005, ANN NEUROL, V57, P535, DOI 10.1002/ana.20438; Nishioka K, 2010, ARCH NEUROL-CHICAGO, V67, P970, DOI 10.1001/archneurol.2010.177; Polymeropoulos MH, 1997, SCIENCE, V276, P2045, DOI 10.1126/science.276.5321.2045; Postuma RB, 2009, PARKINSONISM RELAT D, V15, pS105, DOI 10.1016/S1353-8020(09)70793-X; Ross OA, 2006, IRISH J MED SCI, V175, P82, DOI 10.1007/BF03169012; Ross OA, 2008, ANN NEUROL, V63, P743, DOI 10.1002/ana.21380; Ross OA, 2007, MECH AGEING DEV, V128, P378, DOI 10.1016/j.mad.2007.04.002; Ross OA, 2011, MOVEMENT DISORD, V26, P2552, DOI 10.1002/mds.23909; Ross OA, 2010, ANN NEUROL, V67, P414, DOI 10.1002/ana.21786; ROWE JW, 1987, SCIENCE, V237, P143, DOI 10.1126/science.3299702; Rowe JW, 1997, GERONTOLOGIST, V37, P433, DOI 10.1093/geront/37.4.433; Scholz SW, 2009, ANN NEUROL, V65, P610, DOI 10.1002/ana.21685; Siepel A, 2005, GENOME RES, V15, P1034, DOI 10.1101/gr.3715005; Singleton AB, 2003, SCIENCE, V302, P841, DOI 10.1126/science.1090278; Spillantini MG, 1998, P NATL ACAD SCI USA, V95, P6469, DOI 10.1073/pnas.95.11.6469; Spillantini MG, 1997, NATURE, V388, P839, DOI 10.1038/42166; Stein JL, 2010, NEUROIMAGE, V51, P542, DOI 10.1016/j.neuroimage.2010.02.068; Trotta L, 2012, PARKINSONISM RELAT D, V18, P257, DOI 10.1016/j.parkreldis.2011.10.014; Walter S, 2011, NEUROBIOL AGING, V32, DOI 10.1016/j.neurobiolaging.2011.05.026; Wu SL, 2010, NEUROSCI LETT, V478, P61, DOI 10.1016/j.neulet.2010.04.063	33	6	6	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 13	2012	7	8							e42877	10.1371/journal.pone.0042877	http://dx.doi.org/10.1371/journal.pone.0042877			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	988OJ	22912757	Green Published, gold, Green Submitted			2022-12-25	WOS:000307500100040
J	Liu, B; Zhang, JL; Huang, C; Liu, H				Liu, Bei; Zhang, Jinglei; Huang, Chen; Liu, Hui			Dyskerin Overexpression in Human Hepatocellular Carcinoma Is Associated with Advanced Clinical Stage and Poor Patient Prognosis	PLOS ONE			English	Article							HUMAN BREAST-CANCER; RIBOSOMAL-RNA; TELOMERASE ACTIVITY; EXPRESSION; GENES; DKC1; CARCINOGENESIS; CLASSIFICATION; ACCUMULATION; TRANSLATION	Background: Dyskerin (encoded by the DKC1 gene) is an essential nucleolar protein involved in cell proliferation, where it is required for the pseudo-uridylation of ribosomal RNA (rRNA) molecules and the stabilization of the telomerase RNA component. Dyskerin expression has been reported to predict poor survival in some cancer patients. The aim of the present study was to analyze the expression of dyskerin in hepatocellular carcinoma (HCC) and to determine its correlation with clinicopathologic features, including the survival of patients with HCC. Methodology/Principal Findings: Dyskerin protein expression was detected by immunohistochemistry in paraffin sections of 252 HCC cases and 80 noncancerous liver tissues. The correlation was analyzed between dyskerin expression levels and clinicopathologic variables and prognosis. Dyskerin protein was significantly overexpressed in HCC tissues when compared to noncancerous liver tissue. Dyskerin overexpression was positively correlated with the hepatitis B surface antigen status, serum alpha-fetoprotein, and advanced clinical stage in HCC patients. A survival analysis indicated that HCC patients with higher dyskerin expression had a significantly shorter overall survival and 5-year survival time when compared to those with low expression. A multivariate analysis suggested that dyskerin overexpression was an independent factor for prognosis (hazard risk, 2.912; P = 0.007). Expression of DKC1 mRNA was measured by quantitative RT-PCR in 80 HCC and 50 noncancerous tissues. The relationship between DKC1, TERT, MKI67, and MYC mRNA expression in HCC tissues was also evaluated. DKC1 mRNA was significantly overexpressed in HCC tissues and showed a significant correlation with MKI67 and MYC mRNA but a weak correlation with TERT mRNA. Conclusions/Significance: Dyskerin overexpression in HCC patients was correlated with MYC and MKI67 expression and showed a possible involvement in the tumorigenic process. Dyskerin overexpression may be an unfavorable prognostic factor in patients with HCC.	[Liu, Bei] Wuhan Univ Sci & Technol, Affiliated Tianyou Hosp, Dept Pathol, Wuhan, Peoples R China; [Zhang, Jinglei; Liu, Hui] Second Mil Med Univ, Eastern Hepatobiliary Surg Hosp, Shanghai, Peoples R China; [Huang, Chen] Peking Univ, Hosp 3, Med Res Ctr, Beijing 100871, Peoples R China	Wuhan University of Science & Technology; Naval Medical University; Peking University	Liu, B (corresponding author), Wuhan Univ Sci & Technol, Affiliated Tianyou Hosp, Dept Pathol, Wuhan, Peoples R China.	candyhuang719@hotmail.com; happyehbh@163.com			Ministry of Science and Technology, China [010S2012ZR0058]; Shanghai Municipal Health Bureau [2008Y077]; Special Program for Military Medicine, China [2010JS15]	Ministry of Science and Technology, China(Ministry of Science and Technology, China); Shanghai Municipal Health Bureau; Special Program for Military Medicine, China	This study has been supported by International Science & Technology Cooperation Program of the Ministry of Science and Technology, China (No.010S2012ZR0058), the Fund of Shanghai Municipal Health Bureau (No.2008Y077), and Special Program for Military Medicine, China (No.2010JS15). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alawi F, 2010, MOL CARCINOG; Alawi F, 2007, BIOCHEM BIOPH RES CO, V362, P893, DOI 10.1016/j.bbrc.2007.08.071; Alawi F, 2011, MOL CARCINOGEN, V50, P334, DOI 10.1002/mc.20715; Alawi F, 2011, HEAD NECK-J SCI SPEC, V33, P1041, DOI 10.1002/hed.21579; Alawi F, 2010, CELL CYCLE, V9, P2467, DOI 10.4161/cc.9.12.11922; Angrisani A, 2011, BBA-GEN SUBJECTS, V1810, P1361, DOI 10.1016/j.bbagen.2011.07.012; Bellodi C, 2010, CANCER RES, V70, P6026, DOI 10.1158/0008-5472.CAN-09-4730; El-Serag HB, 2007, GASTROENTEROLOGY, V132, P2557, DOI 10.1053/j.gastro.2007.04.061; Filipowicz W, 2002, CURR OPIN CELL BIOL, V14, P319, DOI 10.1016/S0955-0674(02)00334-4; Gu BW, 2008, P NATL ACAD SCI USA, V105, P10173, DOI 10.1073/pnas.0803559105; Koskimaa HM, 2010, CANCER EPIDEM BIOMAR, V19, P2003, DOI 10.1158/1055-9965.EPI-09-0781; Lee JS, 2004, HEPATOLOGY, V40, P667, DOI 10.1002/hep.20375; Llovet JM, 1999, SEMIN LIVER DIS, V19, P329, DOI 10.1055/s-2007-1007122; McDonald SL, 2004, CANCER BIOL THER, V3, P110, DOI 10.4161/cbt.3.1.662; Mochizuki Y, 2004, P NATL ACAD SCI USA, V101, P10756, DOI 10.1073/pnas.0402560101; Montanaro L, 2006, J PATHOL, V210, P10, DOI 10.1002/path.2023; Montanaro L, 2008, CELL ONCOL, V30, P483, DOI 10.3233/CLO-2008-0436; Montanaro L, 2010, CANCER RES, V70, P4767, DOI 10.1158/0008-5472.CAN-09-4024; Ni JW, 1997, CELL, V89, P565, DOI 10.1016/S0092-8674(00)80238-X; Peng SY, 2004, INT J CANCER, V112, P44, DOI 10.1002/ijc.20279; Perz JF, 2006, J HEPATOL, V45, P529, DOI 10.1016/j.jhep.2006.05.013; Piva R, 2006, J CLIN INVEST, V116, P3171, DOI 10.1172/JCI29401; Poncet D, 2008, BLOOD, V111, P2388, DOI 10.1182/blood-2007-09-111245; Ruggero D, 2003, SCIENCE, V299, P259, DOI 10.1126/science.1079447; Sanyal AJ, 2010, ONCOLOGIST, V15, P14, DOI 10.1634/theoncologist.2010-S4-14; Schaner ME, 2003, MOL BIOL CELL, V14, P4376, DOI 10.1091/mbc.e03-05-0279; Scott MS, 2009, PLOS COMPUT BIOL, V5, DOI 10.1371/journal.pcbi.1000507; Sieron P, 2009, BRIT J CANCER, V101, P1410, DOI 10.1038/sj.bjc.6605299; Sobin, 2009, UICC TNM CLASSIFICAT; Turano M, 2008, ACTA ONCOL, V47, P1598, DOI 10.1080/02841860801898616; Westermann F, 2007, CLIN CANCER RES, V13, P4695, DOI 10.1158/1078-0432.CCR-06-2818; Witkowska A, 2010, INT J MOL MED, V25, P321, DOI 10.3892/ijmm_00000348	32	43	45	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 13	2012	7	8							e43147	10.1371/journal.pone.0043147	http://dx.doi.org/10.1371/journal.pone.0043147			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	988OJ	22912812	Green Published, Green Submitted, gold			2022-12-25	WOS:000307500100067
J	Sebald, J; Morettini, S; Podhraski, V; Lass-Florl, C; Lusser, A				Sebald, Johanna; Morettini, Stefano; Podhraski, Valerie; Lass-Floerl, Cornelia; Lusser, Alexandra			CHD1 Contributes to Intestinal Resistance against Infection by P. aeruginosa in Drosophila melanogaster	PLOS ONE			English	Article							GENOME-WIDE ANALYSIS; IMMUNE-RESPONSE; HOST-DEFENSE; BACTERIAL-INFECTION; ORAL INFECTION; CHROMATIN; GENE; RECOGNITION; IDENTIFICATION; TRANSCRIPTION	Drosophila SNF2-type ATPase CHD1 catalyzes the assembly and remodeling of nucleosomal arrays in vitro and is involved in H3.3 incorporation in viin vivo during early embryo development. Evidence for a role as transcriptional regulator comes from its colocalization with elongating RNA polymerase II as well as from studies of fly Hsp70 transcription. Here we used microarray analysis to identify target genes of CHD1. We found a fraction of genes that were misregulated in Chd1 mutants to be functionally linked to Drosophila immune and stress response. Infection experiments using different microbial species revealed defects in host defense in Chd1-deficient adults upon oral infection with P. aeruginosa but not upon septic injury, suggesting a so far unrecognized role for CHD1 in intestinal immunity. Further molecular analysis showed that gut-specific transcription of antimicrobial peptide genes was overactivated in the absence of infection in Chd1 mutant flies. Moreover, microbial colonization of the intestine was elevated in Chd1 mutants and oral infection resulted in strong enrichment of bacteria in the body cavity indicating increased microbial passage across intestinal epithelia. However, we did not detect enhanced epithelial damage or alterations of the intestinal stem cell population. Collectively, our data provide evidence that intestinal resistance against infection by P. aeruginosa in Drosophila is linked to maintaining proper balance of gut-microbe interactions and that the chromatin remodeler CHD1 is involved in regulating this aspect.	[Sebald, Johanna; Morettini, Stefano; Podhraski, Valerie; Lusser, Alexandra] Innsbruck Med Univ, Bioctr, Div Mol Biol, Innsbruck, Austria; [Lass-Floerl, Cornelia] Innsbruck Med Univ, Div Hyg & Med Microbiol, Innsbruck, Austria	Medical University of Innsbruck; Medical University of Innsbruck	Sebald, J (corresponding author), Innsbruck Med Univ, Bioctr, Div Mol Biol, Innsbruck, Austria.	alexandra.lusser@i-med.ac.at	Lass-Flörl, Cornelia/AAA-8449-2020	Lass-Florl, Cornelia/0000-0002-2946-7785; Lusser, Alexandra/0000-0002-2226-9081	Austrian Science Fund (FWF) [START Y275-B12]; Tyrolean Science Fund [TWF-2010-1-1002]; Austrian Science Fund (FWF) [Y 275] Funding Source: researchfish	Austrian Science Fund (FWF)(Austrian Science Fund (FWF)); Tyrolean Science Fund; Austrian Science Fund (FWF)(Austrian Science Fund (FWF))	This work was funded by the Austrian Science Fund (FWF; START Y275-B12 to A. L.) and the Tyrolean Science Fund (TWF-2010-1-1002 to V. P.). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aggarwal K, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.1000120; Apidianakis Y, 2009, P NATL ACAD SCI USA, V106, P20883, DOI 10.1073/pnas.0911797106; Bae YS, 2010, TRENDS IMMUNOL, V31, P278, DOI 10.1016/j.it.2010.05.003; Banaszynski LA, 2010, DEV CELL, V19, P662, DOI 10.1016/j.devcel.2010.10.014; Bannister AJ, 2011, CELL RES, V21, P381, DOI 10.1038/cr.2011.22; Bardin AJ, 2010, DEVELOPMENT, V137, P705, DOI 10.1242/dev.039404; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Bischoff V, 2006, PLOS PATHOG, V2, P139, DOI 10.1371/journal.ppat.0020014; Braun A, 1997, GENETICS, V147, P623; Braun A, 1998, P NATL ACAD SCI USA, V95, P14337, DOI 10.1073/pnas.95.24.14337; Brennan CA, 2004, ANNU REV IMMUNOL, V22, P457, DOI 10.1146/annurev.immunol.22.012703.104626; Buchon N, 2010, BMC BIOL, V8, DOI 10.1186/1741-7007-8-152; Buchon N, 2009, GENE DEV, V23, P2333, DOI 10.1101/gad.1827009; Buchon N, 2009, CELL HOST MICROBE, V5, P200, DOI 10.1016/j.chom.2009.01.003; Choe KM, 2002, SCIENCE, V296, P359, DOI 10.1126/science.1070216; Clapier CR, 2009, ANNU REV BIOCHEM, V78, P273, DOI 10.1146/annurev.biochem.77.062706.153223; De Gregorio E, 2001, P NATL ACAD SCI USA, V98, P12590, DOI 10.1073/pnas.221458698; Dionne MS, 2008, DIS MODEL MECH, V1, P43, DOI 10.1242/dmm.000307; Elrod-Erickson M, 2000, CURR BIOL, V10, P781, DOI 10.1016/S0960-9822(00)00569-8; Flaus A, 2006, NUCLEIC ACIDS RES, V34, P2887, DOI 10.1093/nar/gkl295; Gaspar-Maia A, 2009, NATURE, V460, P863, DOI 10.1038/nature08212; Gorski SM, 2003, CURR BIOL, V13, P358, DOI 10.1016/S0960-9822(03)00082-4; Gottar M, 2002, NATURE, V416, P640, DOI 10.1038/nature734; Hargreaves DC, 2011, CELL RES, V21, P396, DOI 10.1038/cr.2011.32; Hetru C, 2009, CSH PERSPECT BIOL, V1, DOI 10.1101/cshperspect.a000232; Jiang HQ, 2009, CELL, V137, P1343, DOI 10.1016/j.cell.2009.05.014; Kim M, 2006, P NATL ACAD SCI USA, V103, P16358, DOI 10.1073/pnas.0603238103; Kleino A, 2008, J IMMUNOL, V180, P5413, DOI 10.4049/jimmunol.180.8.5413; Konev AY, 2007, SCIENCE, V317, P1087, DOI 10.1126/science.1145339; Kugler SJ, 2011, GENETICS, V188, P127, DOI 10.1534/genetics.111.127795; Kwon SY, 2008, DEV BIOL, V316, P538, DOI 10.1016/j.ydbio.2008.01.033; Kwon SY, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000574; Lemaitre B, 1996, CELL, V86, P973, DOI 10.1016/S0092-8674(00)80172-5; Lemaitre B, 2007, ANNU REV IMMUNOL, V25, P697, DOI 10.1146/annurev.immunol.25.022106.141615; Levashina EA, 1998, J MOL BIOL, V278, P515, DOI 10.1006/jmbi.1998.1705; Lhocine N, 2008, CELL HOST MICROBE, V4, P147, DOI 10.1016/j.chom.2008.07.004; Liehl P, 2006, PLOS PATHOG, V2, P551, DOI 10.1371/journal.ppat.0020056; Limmer S, 2011, P NATL ACAD SCI USA, V108, P17378, DOI 10.1073/pnas.1114907108; Lin GN, 2008, NATURE, V455, P1119, DOI 10.1038/nature07329; Lusser A, 2005, NAT STRUCT MOL BIOL, V12, P160, DOI 10.1038/nsmb884; Marfella CGA, 2007, MUTAT RES-FUND MOL M, V618, P30, DOI 10.1016/j.mrfmmm.2006.07.012; Matova N, 2006, P NATL ACAD SCI USA, V103, P16424, DOI 10.1073/pnas.0605721103; Micchelli CA, 2006, NATURE, V439, P475, DOI 10.1038/nature04371; Morettini S, 2011, NUCLEIC ACIDS RES, V39, P3103, DOI 10.1093/nar/gkq1298; Natoli G, 2009, CSH PERSPECT BIOL, V1, DOI 10.1101/cshperspect.a000224; Ohlstein B, 2006, NATURE, V439, P470, DOI 10.1038/nature04333; Ohlstein B, 2007, SCIENCE, V315, P988, DOI 10.1126/science.1136606; Paredes JC, 2011, IMMUNITY, V35, P770, DOI 10.1016/j.immuni.2011.09.018; Petesch SJ, 2008, CELL, V134, P74, DOI 10.1016/j.cell.2008.05.029; Piatti P, 2011, INT J MOL SCI, V12, P6544, DOI 10.3390/ijms12106544; Podhraski V, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010120; Rainer J, 2006, NUCLEIC ACIDS RES, V34, pW498, DOI 10.1093/nar/gkl038; Ramet M, 2002, NATURE, V416, P644, DOI 10.1038/nature735; Ruhf ML, 2001, DEVELOPMENT, V128, P1429; Ryu JH, 2008, SCIENCE, V319, P777, DOI 10.1126/science.1149357; Ryu JH, 2010, DEV COMP IMMUNOL, V34, P369, DOI 10.1016/j.dci.2009.11.010; Senger K, 2006, P NATL ACAD SCI USA, V103, P15957, DOI 10.1073/pnas.0607608103; Sibley CD, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.1000184; Smale ST, 2010, CELL, V140, P833, DOI 10.1016/j.cell.2010.01.037; Stofanko M, 2008, GENETICS, V180, P253, DOI 10.1534/genetics.108.089094; Thevenon D, 2009, CELL HOST MICROBE, V6, P309, DOI 10.1016/j.chom.2009.09.007; Uvell H, 2007, TRENDS GENET, V23, P342, DOI 10.1016/j.tig.2007.05.003; Valanne S, 2011, J IMMUNOL, V186, P649, DOI 10.4049/jimmunol.1002302; Vodovar N, 2005, P NATL ACAD SCI USA, V102, P11414, DOI 10.1073/pnas.0502240102; Walker J, 2011, GENETICS, V187, P1067, DOI 10.1534/genetics.110.123893; Xi ZY, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-1; Zaidman-Remy A, 2006, IMMUNITY, V24, P463, DOI 10.1016/j.immuni.2006.02.012; Zaidman-Remy A, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017231	68	13	13	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 13	2012	7	8							e43144	10.1371/journal.pone.0043144	http://dx.doi.org/10.1371/journal.pone.0043144			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	988OJ	22912810	Green Published, gold, Green Submitted			2022-12-25	WOS:000307500100066
J	Simoes, GF; de Oliveira, ALR				Simoes, Gustavo Ferreira; Rodrigues de Oliveira, Alexandre Leite			Granulocyte-Colony Stimulating Factor Improves MDX Mouse Response to Peripheral Nerve Injury	PLOS ONE			English	Article							PROMOTES FUNCTIONAL RECOVERY; SPINAL-CORD-INJURY; DUCHENNE MUSCULAR-DYSTROPHY; SYNAPTIC PLASTICITY; IN-VITRO; UP-REGULATION; NEURONS; BRAIN; ASTROCYTES; CELLS	Background: G-CSF has been shown to increase neuronal survival, which may positively influence the spinal cord microenvironment during the course of muscular dystrophies. Methodology/Principal Findings: Male MDX mice that were six weeks of age received a left sciatic nerve transection and were treated with intraperitoneal injections of 200 mg/kg/day of G-CSF 7 days before and 7 days after the transection. The axotomy was performed after the cycles of muscular degeneration/regeneration, consistent with previous descriptions of this model of muscular dystrophy. C57BL/10 mice were used as control subjects. Seven days after the surgery, the animals were sacrificed and their lumbar spinal cords were processed for immunohistochemistry (anti-MHC I, anti-Synaptophysin, anti-GFAP and anti-IBA-1) and transmission electron microscopy. MHC I expression increased in both strains of mice after the axotomy. Nevertheless, the MDX mice displayed a significantly smaller MHC I upregulation than the control mice. Regarding GFAP expression, the MDX mice showed a stronger astrogliosis compared with the C57BL/10 mice across all groups. Both groups that were treated with G-CSF demonstrated preservation of synaptophysin expression compared with the untreated and placebo groups. The quantitative analysis of the ultrastructural level showed a preservation of the synaptic covering for the both groups that were treated with G-CSF and the axotomized groups showed a smaller loss of synaptic contact in relation to the treated groups after the lesion. Conclusions/Significance: The reduction of active inputs to the alpha-motoneurons and increased astrogliosis in the axotomized and control groups may be associated with the cycles of muscle degeneration/regeneration that occur postnatally. The G-CSF treated group showed a preservation of the spinal cord microenvironment after the lesion. Moreover, the increase of MHC I expression in the MDX mice that were treated with G-CSF may indicate that this drug performs an active role in regenerative potential after lesions.	[Simoes, Gustavo Ferreira; Rodrigues de Oliveira, Alexandre Leite] Univ Campinas UNICAMP, Inst Biol, Dept Struct & Funct Biol, Campinas, Brazil	Universidade de Sao Paulo; Universidade Estadual de Campinas	Simoes, GF (corresponding author), Univ Campinas UNICAMP, Inst Biol, Dept Struct & Funct Biol, Campinas, Brazil.	alroliv@unicamp.br	Oliveira, Alexandre L. R./C-4436-2012; Oliveira, Alexandre/AAI-6815-2020	Oliveira, Alexandre L. R./0000-0003-4224-4575; Oliveira, Alexandre/0000-0003-4224-4575; Simoes, Gustavo/0000-0001-5362-4085	Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES); Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq); Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP) [2009/06686-6, 2009/05565-0, 2012/14236-3]	Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES)(Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES)); Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq)(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP)(Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP))	This work was funded by grants from Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES), Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq) and Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP - 2009/06686-6, 2009/05565-0 and 2012/14236-3). ALRO receives a fellowship from CNPq. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aldskogius H, 1999, J NEUROSCI RES, V58, P33, DOI 10.1002/(SICI)1097-4547(19991001)58:1<33::AID-JNR5>3.3.CO;2-D; Anderson CM, 2000, GLIA, V32, P1; Barreto George, 2011, Central Nervous System Agents in Medicinal Chemistry, V11, P164; Barreto GE, 2011, NEUROSCI RES, V71, P107, DOI 10.1016/j.neures.2011.06.004; Batchelor PE, 2002, MOL CELL NEUROSCI, V21, P436, DOI 10.1006/mcne.2002.1185; BEGLEY CG, 1986, BLOOD, V68, P162; BULFIELD G, 1984, P NATL ACAD SCI-BIOL, V81, P1189, DOI 10.1073/pnas.81.4.1189; BURGESS AW, 1980, INT J CANCER, V26, P647, DOI 10.1002/ijc.2910260517; Carretta D, 2001, BRAIN RES, V895, P213, DOI 10.1016/S0006-8993(01)02108-4; Conradi S, 1969, Acta Physiol Scand Suppl, V332, P5; Cullheim S, 2007, BRAIN RES REV, V55, P89, DOI 10.1016/j.brainresrev.2007.03.012; Daoud F, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006574; del Zoppo GJ, 2009, NEUROSCIENCE, V158, P972, DOI 10.1016/j.neuroscience.2008.08.028; Dittgen T, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0029880; Dong F, 1997, LEUKEMIA, V11, P120, DOI 10.1038/sj.leu.2400537; Dringen R, 2000, EUR J BIOCHEM, V267, P4912, DOI 10.1046/j.1432-1327.2000.01597.x; Dringen R, 2000, PROG NEUROBIOL, V62, P649, DOI 10.1016/S0301-0082(99)00060-X; Emirandetti A, 2006, BRAIN RES, V1095, P35, DOI 10.1016/j.brainres.2006.04.021; GORGEN I, 1992, J IMMUNOL, V149, P918; Hanisch UK, 2007, NAT NEUROSCI, V10, P1387, DOI 10.1038/nn1997; Hartung T, 1998, Curr Opin Hematol, V5, P221, DOI 10.1097/00062752-199805000-00013; Heard SO, 1999, CRIT CARE MED, V27, P1019, DOI 10.1097/00003246-199905000-00051; Henriques A, 2010, BMC NEUROSCI, V11, DOI 10.1186/1471-2202-11-25; HOFFMAN EP, 1987, CELL, V51, P919, DOI 10.1016/0092-8674(87)90579-4; Hu B, 1997, INT J HEMATOL, V66, P179; Jung KH, 2006, NEUROSCI LETT, V394, P168, DOI 10.1016/j.neulet.2005.10.040; Kaur C, 2008, CURR NEUROVASC RES, V5, P71, DOI 10.2174/156720208783565645; Kawada H, 2006, CIRCULATION, V113, P701, DOI 10.1161/CIRCULATIONAHA.105.563668; Koda M, 2007, BRAIN RES, V1149, P223, DOI 10.1016/j.brainres.2007.02.058; KONISHI Y, 1993, BRAIN RES, V609, P29, DOI 10.1016/0006-8993(93)90850-M; Lagrota-Candido J, 2002, INT J EXP PATHOL, V83, P121, DOI 10.1046/j.1365-2613.2002.00221.x; Lee JS, 2012, SPINE, V37, P10, DOI 10.1097/BRS.0b013e31823b0440; Lee ST, 2005, BRAIN RES, V1058, P120, DOI 10.1016/j.brainres.2005.07.076; LEFAUCHEUR JP, 1995, ANAT REC, V242, P70, DOI 10.1002/ar.1092420109; LIDOV HGW, 1993, NEUROSCIENCE, V54, P167, DOI 10.1016/0306-4522(93)90392-S; LINDA H, 1992, EXP BRAIN RES, V91, P284; Lindenau J, 2000, GLIA, V29, P25, DOI 10.1002/(SICI)1098-1136(20000101)29:1<25::AID-GLIA3>3.0.CO;2-G; Luo J, 2009, ACTA NEUROCHIR, V151, P1483, DOI 10.1007/s00701-009-0402-6; Meuer K, 2006, J NEUROCHEM, V97, P675, DOI 10.1111/j.1471-4159.2006.03727.x; Nedergaard M, 2005, GLIA, V50, P281, DOI 10.1002/glia.20205; Nishio Y, 2007, J NEUROPATH EXP NEUR, V66, P724, DOI 10.1097/nen.0b013e3181257176; Nonaka I, 1998, LAB ANIM SCI, V48, P8; Ohki Y, 2005, FASEB J, V19, P2005, DOI 10.1096/fj.04-3496fje; Oliveira ALR, 2004, P NATL ACAD SCI USA, V101, P17843, DOI 10.1073/pnas.0408154101; Osada T, 2010, J NEUROSURG-SPINE, V13, P516, DOI 10.3171/2010.4.SPINE09973; Ouyang YB, 2007, J NEUROSCI, V27, P4253, DOI 10.1523/JNEUROSCI.0211-07.2007; PASTORET C, 1995, J NEUROL SCI, V129, P97, DOI 10.1016/0022-510X(94)00276-T; Pitzer C, 2008, BRAIN, V131, P3335, DOI 10.1093/brain/awn243; Ridet JL, 1997, TRENDS NEUROSCI, V20, P570, DOI 10.1016/S0166-2236(97)01139-9; RYDERCOOK AS, 1988, EMBO J, V7, P3017, DOI 10.1002/j.1460-2075.1988.tb03165.x; Sabha M, 2008, SYNAPSE, V62, P137, DOI 10.1002/syn.20475; Sanli AM, 2010, J CLIN NEUROSCI, V17, P1548, DOI 10.1016/j.jocn.2010.03.043; SBRICCOLI A, 1995, NEUROSCI LETT, V200, P53, DOI 10.1016/0304-3940(95)12079-J; Schabitz WR, 2003, STROKE, V34, P745, DOI 10.1161/01.STR.0000057814.70180.17; Schneider A, 2005, CELL CYCLE, V4, P1753, DOI 10.4161/cc.4.12.2213; Schneider A, 2006, BMC BIOL, V4, DOI 10.1186/1741-7007-4-36; SICINSKI P, 1989, SCIENCE, V244, P1578, DOI 10.1126/science.2662404; Simoes GF, 2010, NEUROPATH APPL NEURO, V36, P55, DOI 10.1111/j.1365-2990.2009.01033.x; Sims NR, 2004, J BIOENERG BIOMEMBR, V36, P329, DOI 10.1023/B:JOBB.0000041763.63958.e7; Solaroglu I, 2006, STROKE, V37, P1123, DOI 10.1161/01.STR.0000208205.26253.96; Squadrito F, 1997, BRIT J PHARMACOL, V120, P333, DOI 10.1038/sj.bjp.0700904; Streit WJ, 2005, BRAIN RES REV, V48, P234, DOI 10.1016/j.brainresrev.2004.12.013; Swanson RA, 2004, CURR MOL MED, V4, P193, DOI 10.2174/1566524043479185; Takagi Y, 2005, J PHARMACOL SCI, V99, P45, DOI 10.1254/jphs.FP0040966; TANABE Y, 1986, ACTA NEUROPATHOL, V69, P91, DOI 10.1007/BF00687043; Tanaka M, 2006, J NEUROPATH EXP NEUR, V65, P816, DOI 10.1097/01.jnen.0000232025.84238.e1; TORRES LFB, 1987, BRAIN, V110, P269, DOI 10.1093/brain/110.2.269; Walz W, 2000, NEUROCHEM INT, V36, P291, DOI 10.1016/S0197-0186(99)00137-0; Ward AC, 2007, FRONT BIOSCI-LANDMRK, V12, P608, DOI 10.2741/2086; WELTE K, 1985, P NATL ACAD SCI USA, V82, P1526, DOI 10.1073/pnas.82.5.1526; Wong BLY, 2002, J CHILD NEUROL, V17, P183, DOI 10.1177/088307380201700306; Zanon RG, 2006, EXP NEUROL, V200, P521, DOI 10.1016/j.expneurol.2006.03.004; Zavala F, 2002, J IMMUNOL, V168, P2011, DOI 10.4049/jimmunol.168.4.2011	73	4	4	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 13	2012	7	8							e42803	10.1371/journal.pone.0042803	http://dx.doi.org/10.1371/journal.pone.0042803			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	988OJ	22912741	Green Published, Green Submitted, gold			2022-12-25	WOS:000307500100033
J	Kolics, B; Acs, Z; Chobanov, DP; Orci, KM; Qiang, LS; Kovacs, B; Kondorosy, E; Decsi, K; Taller, J; Specziar, A; Orban, L; Muller, T				Kolics, Balazs; Acs, Zoltan; Chobanov, Dragan Petrov; Orci, Kirill Mark; Qiang, Lo Shun; Kovacs, Balazs; Kondorosy, Elod; Decsi, Kincso; Taller, Janos; Specziar, Andras; Orban, Laszlo; Mueller, Tamas			Re-Visiting Phylogenetic and Taxonomic Relationships in the Genus Saga (Insecta: Orthoptera)	PLOS ONE			English	Article							RAMMEI KALTENBACH; BUSH-CRICKETS; TETTIGONIIDAE; HYBRIDIZATION; CHROMOSOME; GENETICS; COMPLEX; REVEAL; SONG	Twelve of the 13 bushcricket species of the Saga genus are bisexuals and diploids, except the parthenogenetic and tetraploid bush cricket, Saga pedo. Despite a continuous research effort stretching through the 1900s, the taxonomic relationships of the Saga species are still disputed. In this study, our primary aim was to reveal natural relationships of the European Saga species and three of their Asian relatives, with special attention to the problematic taxonomy of two subspecies: S. campbelli campbelli and S. c. gracilis. Following a phylogenetic analysis of eight species, a comprehensive study was carried out on the above three taxa by using acoustic and morphometric approaches in parallel. Our phylogenetic data showed that European Saga species evolved from a monophyletic lineage. The geographical transitional species S. cappadocica was positioned between European and Asian lineages supporting the idea that the European Saga lineage originated phylogeographically from the Asian clade. The above results showed better agreement with the morphological data than with earlier ones based either on karyology or acoustic information only. After reviewing our data, we concluded that Saga pedo has most likely evolved from S. c. gracilis and not from S. rammei or S. ephippigera, as proposed by earlier studies. S. c. gracilis shares the same ITS2 haplotype with S. pedo, indicating that the latter could have evolved from populations of the former, probably through whole genome duplication. Based on acoustic and morphometric differences, we propose to elevate the two subspecies, S. campbelli campbelli and S. c. gracilis, to species level status, as Saga gracilis Kis 1962, and Saga campbelli Uvarov 1921. The present work sets the stage for future genetic and experimental investigations of Saginae and highlights the need for additional comprehensive analysis involving more Asian Saga species.	[Kolics, Balazs; Decsi, Kincso; Taller, Janos] Univ Pannonia, Dept Plant Sci & Biotechnol, Georgikon Fac, Keszthely, Hungary; [Chobanov, Dragan Petrov] Bulgarian Acad Sci, Inst Biodivers & Ecosyst Res, Sofia, Bulgaria; [Acs, Zoltan] Fitolab Ltd, Budapest, Hungary; [Orci, Kirill Mark] Eotvos Lorand Univ, Ecol Res Grp, Hungarian Acad Sci, Budapest, Hungary; [Orci, Kirill Mark] Hungarian Nat Hist Museum, Budapest, Hungary; [Qiang, Lo Shun; Orban, Laszlo] Natl Univ Singapore, Strateg Res Program, Temasek Life Sci Lab, Singapore 117548, Singapore; [Qiang, Lo Shun; Orban, Laszlo] Natl Univ Singapore, Dept Biol Sci, Singapore 117548, Singapore; [Kovacs, Balazs; Mueller, Tamas] Szent Istvan Univ, Dept Aquaculture, Fac Agr & Environm Sci, Godollo, Hungary; [Kovacs, Balazs] Szent Istvan Univ, Reg Univ Ctr Excellence Environm Ind Based Nat, Godollo, Hungary; [Kondorosy, Elod; Orban, Laszlo] Univ Pannonia, Dept Anim Sci & Anim Breeding, Georgikon Fac, Keszthely, Hungary; [Specziar, Andras] Hungarian Acad Sci, Balaton Limnol Inst, Ctr Ecol Res, Tihany, Hungary	University of Pannonia; Bulgarian Academy of Sciences; Eotvos Lorand University; Hungarian Academy of Sciences; National University of Singapore; National University of Singapore; Hungarian University of Agriculture & Life Sciences; Hungarian University of Agriculture & Life Sciences; University of Pannonia; Eotvos Lorand Research Network; Hungarian Academy of Sciences; Hungarian Centre for Ecological Research; Hungarian Balaton Limnological Research Institute	Kolics, B (corresponding author), Univ Pannonia, Dept Plant Sci & Biotechnol, Georgikon Fac, Keszthely, Hungary.	bkolics@gmail.com; laszlo@tll.org.sg; muller.tamas@mkk.szie.hu	Chobanov, Dragan/AAB-9475-2020; Taller, Janos/ABB-9586-2021; Kovács, Balázs/K-9372-2015; Specziár, András/N-5656-2019; Orbán, László/A-3030-2009	Kovács, Balázs/0000-0002-1090-1334; Specziár, András/0000-0001-6341-636X; Orbán, László/0000-0001-5435-5948; Muller, Tamas/0000-0002-0512-4315; Kondorosy, Elod/0000-0001-7162-0862; Orci, Kirill Mark/0000-0002-4076-6700; Chobanov, Dragan/0000-0002-1642-0363; Balazs, Kovacs/0000-0003-1753-5098	Bolyai Research Grant of the Hungarian Academy of Sciences; Ministry of Education, Youth and Science of Bulgaria [DO 02-259/08]; United Nations Development Programme [00058373 - PIMS 3728, RFP 79/2009]; European Social Fund through the Ministry of Education, Youth and Science of Bulgaria [BG051PO001-3.3.04/41]; Ministry of Science and Higher Education of Poland [57497 (2009-01-27)];  [TAMOP-4.2.2/B-10/1-2010-0025]	Bolyai Research Grant of the Hungarian Academy of Sciences; Ministry of Education, Youth and Science of Bulgaria; United Nations Development Programme; European Social Fund through the Ministry of Education, Youth and Science of Bulgaria; Ministry of Science and Higher Education of Poland(Ministry of Science and Higher Education, Poland); 	This work supported by Bolyai Research Grant of the Hungarian Academy of Sciences, grant no.: DO 02-259/08 of the Ministry of Education, Youth and Science of Bulgaria, the United Nations Development Programme grant 00058373 - PIMS 3728 (Ref. RFP 79/2009), BG051PO001-3.3.04/41 (European Social Fund through the Ministry of Education, Youth and Science of Bulgaria), grant 57497 (2009-01-27) of the Ministry of Science and Higher Education of Poland and a bilateral agreement between the Bulgarian and Polish Academies of Sciences. The article was made under the project TAMOP-4.2.2/B-10/1-2010-0025. IKR ZRt. provided a DNA extraction Kit. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Baur B, 2006, SAUTERELLES GRILLONS, P140; Burr M, 1923, T ROYAL ENTOMOLOGICA, V71, P110; Cabrero J, 2007, EUR SOC EV BIOL 11 C; Camacho JPM, 2000, PHILOS T R SOC B, V355, P163, DOI 10.1098/rstb.2000.0556; CANTRALL I J, 1972, Great Lakes Entomologist, V5, P103; Dutrillaux AM, 2009, EUR J ENTOMOL, V106, P477, DOI 10.14411/eje.2009.060; ELLIOTT NG, 1995, J FISH BIOL, V46, P202, DOI 10.1111/j.1095-8649.1995.tb05962.x; Ewing AW, 1989, ARTHROPOD BIOACOUSTI, P1; Goldsohmldt E., 1946, Nature London, V158, P587, DOI 10.1038/158587c0; Hall T.A., 1999, NUCL ACIDS S SERIES, V41, P95, DOI [DOI 10.1021/BK-1999-0734.CH008, citeulike-article-id:691774, 10.12691/ajmr-6-4-3]; Heller KG, 2006, CONT T ENT, P137; Heller KG, 1998, OKOLOGIE FORSCHUNG A, P1; Huang Renxin, 1986, Entomotaxonomia, V8, P290; Huelsenbeck JP, 2001, BIOINFORMATICS, V17, P754, DOI 10.1093/bioinformatics/17.8.754; INGRISCH S, 1991, Mitteilungen der Schweizerischen Entomologischen Gesellschaft, V64, P269; Kalmring K, 1997, ENTOMOL GEN, V21, P265; Kaltenbach A, 1970, ZOOL BEITR, P158; Kaltenbach A.P., 1990, P280; KALTENBACH ALFRED, 1967, BEITR ENTOMOL, V17, P3; Kis B., 1962, Annales Historico Naturales Musei Nationalis Hungarici, V54, P255; Kolics B, 2008, BIOLOGIA, V63, P254, DOI 10.2478/s11756-008-0028-9; Krauss H, 1878, SITZUNGSBERICHTE MN, V78, P506; Kumar, 2000, MOL EVOLUTION PHYLOG, P1; Larkin MA, 2007, BIOINFORMATICS, V23, P2947, DOI 10.1093/bioinformatics/btm404; Lehmann GUC, 2011, J ZOOL SYST EVOL RES, V49, P102, DOI 10.1111/j.1439-0469.2010.00588.x; Lemonnier-Darcemont M, 2007, ANN SOC ENTOMOL FR, V43, P249, DOI 10.1080/00379271.2007.10697518; Lemonnier-Darcemont Michele, 2009, Articulata, V24, P15; Lemonnier-Darcemont M, 2008, ANN SOC ENTOMOL FR, V44, P477, DOI 10.1080/00379271.2008.10697583; Lemonnier-Darcemont Michele, 2008, Biocosme Mesogeen, V25, P29; Matthey R, 1939, CR SOC BIOL, V132, P369; MATTHEY R., 1950, ARCH JULIUS KLAUS STIFT, V25, P44; MATTHEY ROBERT, 1948, REV SUISSE ZOOL, V55, P45; MATTHEY ROBERT, 1941, REV SUISSE ZOOL, V48, P91; Nylander J. A. A., 2004, MRMODELTEST V2; Orci KM, 2005, ZOOL ANZ, V244, P31, DOI 10.1016/j.jcz.2004.11.002; Panaram K, 2007, GENETICA, V130, P53, DOI 10.1007/s10709-006-0020-7; Ragge DR, 1998, SONGS GRASSHOPPERS C, P1; RAMME W., 1951, MITT ZOOL MUS BERLIN, V27, P1; Robinson DJ, 2002, ADV INSECT PHYSIOL, V29, P151, DOI 10.1016/S0065-2806(02)29003-7; Rokas A, 2003, MOL PHYLOGENET EVOL, V26, P36, DOI 10.1016/S1055-7903(02)00329-9; Saussure H, 1888, ANN SOC ENTOMOLOGIQU, V8, P127; SENAR JC, 1994, J AVIAN BIOL, V25, P50, DOI 10.2307/3677293; STOUTHAMER R, 1993, NATURE, V361, P66, DOI 10.1038/361066a0; Stumpner A, 2001, NATURWISSENSCHAFTEN, V88, P159, DOI 10.1007/s001140100223; Tamura K, 2007, MOL BIOL EVOL, V24, P1596, DOI 10.1093/molbev/msm092; Walker TJ, 2003, ANN ENTOMOL SOC AM, V96, P433, DOI 10.1603/0013-8746(2003)096[0433:TRCOTG]2.0.CO;2; Warchalowska-Sliwa E, 2007, CARYOLOGIA, V60, P29; Warchalowska-Sliwa E, 2009, EUR J ENTOMOL, V106, P1, DOI 10.14411/eje.2009.001; Werner F, 1905, MITTEILUNGEN NATURWI, V3, P1; WERREN JH, 1993, AM NAT, V142, P224, DOI 10.1086/285536; Willemse Fer, 2008, Articulata Beiheft, V13, P1	51	11	13	0	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 10	2012	7	8							e42229	10.1371/journal.pone.0042229	http://dx.doi.org/10.1371/journal.pone.0042229			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	986XO	22912691	Green Accepted, Green Published, Green Submitted, gold			2022-12-25	WOS:000307380900026
J	Zou, SR; Wu, F; Guo, CY; Song, J; Huang, CH; Zhu, ZN; Yu, HT; Guo, YF; Lu, X; Ruan, Y				Zou, Shurong; Wu, Fan; Guo, Changyi; Song, Jun; Huang, Cuihua; Zhu, Zhenni; Yu, Huiting; Guo, Yanfei; Lu, Xi; Ruan, Ye			Iodine Nutrition and the Prevalence of Thyroid Disease after Salt Iodization: A Cross-Sectional Survey in Shanghai, a Coastal Area in China	PLOS ONE			English	Article							NODULES; GOITER	Background: Both insufficient and excess iodine may produce thyroid disease. After salt iodization in China, the median urine iodine concentration (UIC) of children aged 8-10 years appeared adequate. However, it is unknown whether dietary changes due to rapid economic development in Shanghai have affected whole population iodine nutrition. Objective: To assess dietary iodine intake, UIC and the prevalence of thyroid disease in the general population of Shanghai. Design: A cross-sectional survey was conducted with general participants aged 5-69 years (n = 7,904) plus pregnant and lactating women (n = 380 each) selected by stratified multistage sampling. The iodine concentrations in their salt, drinking water and urine were measured. Daily iodine intake was estimated using the total diet study approach. Serum thyroid hormone concentrations and thyroid-related antibodies were measured and thyroid ultrasonography was performed. Results: The median iodine concentration in salt was 29.5 mg/kg, and 12.8 mu g/L in drinking water. Iodized salt, used by 95.3% of participants, contributed 63.5% of total dietary iodine. Estimated daily iodine intake was 225.96 mu g. The median UIC of general participants was 146.7 mu g/L; UIC <100 mu g/L (iodine insufficiency) was seen in 28.6%; UIC >300 mg/L (iodine excess) in 10.1%. Pregnant women had a median UIC of 135.9 mu g/L, with UIC <150 mu g/L in 55.4%. Thyroid nodules and subclinical hypothyroidism were found in 27.44% and 9.17%, respectively. Conclusions: According to published criteria, the current dietary iodine intake in Shanghai was generally sufficient and safe, but insufficient in pregnant women. Thyroid nodules and subclinical hypothyroidism were the commonest thyroid diseases identified.	[Zou, Shurong; Wu, Fan; Guo, Changyi; Song, Jun; Huang, Cuihua; Zhu, Zhenni] Shanghai Municipal Ctr Dis Control & Prevent, Dept Nutr Hyg, Shanghai, Peoples R China; [Yu, Huiting] Shanghai Municipal Ctr Dis Control & Prevent, Dept Hlth Stat, Shanghai, Peoples R China; [Guo, Yanfei] Shanghai Municipal Ctr Dis Control & Prevent, Dept Environm Hlth, Shanghai, Peoples R China; [Lu, Xi] Shanghai Municipal Ctr Dis Control & Prevent, Dept Sch Hlth, Shanghai, Peoples R China; [Ruan, Ye] Shanghai Municipal Ctr Dis Control & Prevent, Dept Diabet Mellitus Control & Prevent, Shanghai, Peoples R China	Shanghai Center for Disease Control & Prevention; Shanghai Center for Disease Control & Prevention; Shanghai Center for Disease Control & Prevention; Shanghai Center for Disease Control & Prevention; Shanghai Center for Disease Control & Prevention	Zou, SR (corresponding author), Shanghai Municipal Ctr Dis Control & Prevent, Dept Nutr Hyg, Shanghai, Peoples R China.	fanwu@scdc.sh.cn						[Anonymous], 2007, ASS IOD DEF DIS MON; [Anonymous], 2001, CHIN J ENDOCRINOL; BRANDER A, 1991, RADIOLOGY, V181, P683, DOI 10.1148/radiology.181.3.1947082; BRUNETON JN, 1994, J ULTRAS MED, V13, P87; Caldwell KL, 2011, THYROID, V21, P419, DOI 10.1089/thy.2010.0077; Canaris GJ, 2000, ARCH INTERN MED, V160, P526, DOI 10.1001/archinte.160.4.526; Chen JX, 2000, CHINA NATL IODINE DE, P27; Chen JX, 1997, CHINA NATL IODINE DE, P16; Chen X., 2003, CHINA NATL IODINE DE; Chen XY, 2002, CHINA NATL IODINE DE, P39; Dunn JT, 1998, J CLIN ENDOCR METAB, V83, P3398, DOI 10.1210/jc.83.10.3398; FAO/WHO/UNU, 2004, FAO FOOD NUTR TECH R, V1, P103; Gharib H, 1997, ENDOCRIN METAB CLIN, V26, P777, DOI 10.1016/S0889-8529(05)70282-6; HELSEL DR, 1990, ENVIRON SCI TECHNOL, V24, P1766, DOI 10.1021/es00082a001; Hollowell JG, 2002, J CLIN ENDOCR METAB, V87, P489, DOI 10.1210/jc.87.2.489; HULL OH, 1955, ARCH PATHOL, V59, P291; Leech JV, 1928, AM J PATHOL, V4, P481; Li QS, 2009, SERIES ULTRASOUND PH, P61; Liao EY, 2001, ENDOCRINOLOGY, P619; MATOVINOVIC J, 1965, J AMER MED ASSOC, V192, P234, DOI 10.1001/jama.1965.03080160054014; MORTENSEN JD, 1955, J CLIN ENDOCR METAB, V15, P1270, DOI 10.1210/jcem-15-10-1270; OERTEL J E, 1965, Med Ann Dist Columbia, V34, P75; Bonet-Manso MP, 2007, ENFERM CLIN, V17, P293; RALLISON ML, 1975, JAMA-J AM MED ASSOC, V233, P1069, DOI 10.1001/jama.233.10.1069; ROJESKI MT, 1985, NEW ENGL J MED, V313, P428, DOI 10.1056/NEJM198508153130707; Teng WP, 2003, FOREIGN MED SCI SEC, V23, P370; The Chinese Nutrition Society, 2000, CHIN DIET REF INT 20; Travers CA, 2006, MED J AUSTRALIA, V184, P617, DOI 10.5694/j.1326-5377.2006.tb00417.x; TROWBRIDGE FL, 1975, PEDIATRICS, V56, P82; TUNBRIDGE WMG, 1977, CLIN ENDOCRINOL, V7, P481, DOI 10.1111/j.1365-2265.1977.tb01340.x; US Environmental Protection Agency, 2006, DAT QUAL ASS STAT ME; VANDER JB, 1968, ANN INTERN MED, V69, P537, DOI 10.7326/0003-4819-69-3-537; WOESTYN J, 1985, BRIT J RADIOL, V58, P1179, DOI 10.1259/0007-1285-58-696-1179; World Health Organization, 2009, 72 WHO INT CLASS PAT, P5; Xiao DL, 2007, CHINA NATL IODINE DE, P43; [阎玉芹 Yan Yuqin], 2003, [中国地方病学杂志, Chinese Journal of Endemiology], V22, P141; Yang F, 2001, CHINESE J ENDOCRINOL, V17, P197	37	48	60	2	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 27	2012	7	7							e40718	10.1371/journal.pone.0040718	http://dx.doi.org/10.1371/journal.pone.0040718			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	981ER	22911705	Green Published, gold, Green Submitted			2022-12-25	WOS:000306950200028
J	Brandi, G; Tavolari, S; De Rosa, F; Di Girolamo, S; Agostini, V; Barbera, MA; Frega, G; Biasco, G				Brandi, Giovanni; Tavolari, Simona; De Rosa, Francesco; Di Girolamo, Stefania; Agostini, Valentina; Barbera, Maria Aurelia; Frega, Giorgio; Biasco, Guido			Antitumoral Efficacy of the Protease Inhibitor Gabexate Mesilate in Colon Cancer Cells Harbouring KRAS, BRAF and PIK3CA Mutations	PLOS ONE			English	Article							METASTATIC COLORECTAL-CANCER; CETUXIMAB RESISTANCE; TARGETED THERAPIES; GENE-MUTATIONS; GROWTH; ANGIOGENESIS; SIMVASTATIN; BIOMARKERS; APOPTOSIS; INVASION	The employment of anti-epidermal growth factor receptor (EGFR) antibodies represents a backbone of the therapeutic options for the treatment of metastatic colorectal cancer (mCRC). However, this therapy is poorly effective or ineffective in unselected patients. Mutations in KRAS, BRAF and PIK3CA genes have recently emerged as the best predictive factors of low/absent response to EGFR-targeted therapy. Due to the need for efficacious treatment options for mCRC patients bearing these mutations, in this short report we examined the antitumoral activity of the protease inhibitor gabexate mesilate, alone and in combination with the anti-EGFR monoclonal antibody cetuximab, in a panel of human CRC cell lines harbouring a different expression pattern of wild-type/mutated KRAS, BRAF and PIK3CA genes. Results obtained showed that gabexate mesilate significantly inhibited the growth, invasive potential and tumour-induced angiogenesis in all the CRC cells employed in this study (including those ones harbouring dual KRAS/PIK3CA or BRAF/PIK3CA mutation), while cetuximab affected these parameters only in CRC cells with KRAS, BRAF and PIK3CA wild-type. Notably, the antitumoral efficacy of gabexate mesilate and cetuximab in combination was found to be not superior than that observed with gabexate mesilate as single agent. Overall, these preliminary findings suggest that gabexate mesilate could represent a promising therapeutic option for mCRC patients, particularly for those harbouring KRAS, BRAF and PIK3CA mutations, either as mono-therapy or in addition to standard chemotherapy regimens. Further studies to better elucidate gabexate mesilate mechanism of action in CRC cells are therefore warranted.	[Brandi, Giovanni; De Rosa, Francesco; Di Girolamo, Stefania; Agostini, Valentina; Barbera, Maria Aurelia; Frega, Giorgio; Biasco, Guido] Univ Bologna, St Orsola Malpighi Hosp, L&A Seragnoli Dept Hematol & Oncol Sci, Bologna, Italy; [Brandi, Giovanni; Tavolari, Simona; Biasco, Guido] Univ Bologna, G Prodi Interdept Ctr Canc Res CIRC, Bologna, Italy; [Tavolari, Simona] Univ Bologna, St Orsola Malpighi Hosp, Ctr Appl Biomed Res CRBA, Bologna, Italy	IRCCS Azienda Ospedaliero-Universitaria di Bologna; University of Bologna; University of Bologna; IRCCS Azienda Ospedaliero-Universitaria di Bologna; University of Bologna	Brandi, G (corresponding author), Univ Bologna, St Orsola Malpighi Hosp, L&A Seragnoli Dept Hematol & Oncol Sci, Bologna, Italy.	giovanni.brandi@unibo.it	de Rosa, Francesco/AAC-5935-2022; Tavolari, Simona/K-3540-2018; Frega, Giorgio/W-8099-2019; Brandi, Giovanni/AAD-6327-2021; agostini, valentina/K-3945-2016	de Rosa, Francesco/0000-0003-0511-1298; Frega, Giorgio/0000-0001-9153-0557; Brandi, Giovanni/0000-0003-0013-2858; agostini, valentina/0000-0001-5540-2371; di girolamo, stefania/0000-0001-5156-7400				Albini A, 2007, NAT PROTOC, V2, P504, DOI 10.1038/nprot.2006.466; Allegra CJ, 2009, J CLIN ONCOL, V27, P2091, DOI 10.1200/JCO.2009.21.9170; Amado RG, 2008, J CLIN ONCOL, V26, P1626, DOI 10.1200/JCO.2007.14.7116; Barendsz-Janson AF, 1998, J VASC RES, V35, P109, DOI 10.1159/000025572; Brandi G, 2011, J NATL CANCER I, V103, P1278, DOI 10.1093/jnci/djr266; Chappell WH, 2011, ONCOTARGET, V2, P135, DOI 10.18632/oncotarget.240; De Mattos-Arruda L, 2011, CLIN COLORECTAL CANC, V10, P279, DOI 10.1016/j.clcc.2011.03.030; De Roock W, 2011, LANCET ONCOL, V12, P594, DOI 10.1016/S1470-2045(10)70209-6; De Roock W, 2010, LANCET ONCOL, V11, P753, DOI 10.1016/S1470-2045(10)70130-3; Jhawer M, 2008, CANCER RES, V68, P1953, DOI 10.1158/0008-5472.CAN-07-5659; Karapetis CS, 2008, NEW ENGL J MED, V359, P1757, DOI 10.1056/NEJMoa0804385; Lee J, 2011, JNCI-J NATL CANCER I, V103, P674, DOI 10.1093/jnci/djr070; Meyerhardt JA, 2005, NEW ENGL J MED, V352, P476, DOI 10.1056/NEJMra040958; Normanno N, 2009, NAT REV CLIN ONCOL, V6, P519, DOI 10.1038/nrclinonc.2009.111; OHTA N, 1986, INT J PHARM, V29, P137, DOI 10.1016/0378-5173(86)90111-0; Ozeki T, 2010, INT J CLIN EXP PATHO, V3, P710; Prenen H, 2010, CLIN CANCER RES, V16, P2921, DOI 10.1158/1078-0432.CCR-09-2029; Sartore-Bianchi A, 2009, CANCER RES, V69, P1851, DOI 10.1158/0008-5472.CAN-08-2466; Seta T, 2004, EUR J GASTROEN HEPAT, V16, P1287, DOI 10.1097/00042737-200412000-00009; Seta T, 2011, GASTROINTEST ENDOSC, V73, P700, DOI 10.1016/j.gie.2010.09.022; Siena S, 2009, JNCI-J NATL CANCER I, V101, P1308, DOI 10.1093/jnci/djp280; Simi L, 2008, AM J CLIN PATHOL, V130, P247, DOI 10.1309/LWDY1AXHXUULNVHQ; Soares R, 2004, MOL ENDOCRINOL, V18, P2333, DOI 10.1210/me.2003-0362; Takahashi H, 2007, DIGEST DIS SCI, V52, P2646, DOI 10.1007/s10620-006-9654-7; Van Cutsem E, 2010, ANN ONCOL, V21, pv93, DOI 10.1093/annonc/mdq222; Yoon WH, 2004, CLIN CANCER RES, V10, P4517, DOI 10.1158/1078-0432.CCR-04-0084	26	13	13	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 24	2012	7	7							e41347	10.1371/journal.pone.0041347	http://dx.doi.org/10.1371/journal.pone.0041347			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	978NX	22911782	Green Submitted, Green Published, gold			2022-12-25	WOS:000306751300033
J	Nielsen, R; Korneliussen, T; Albrechtsen, A; Li, YR; Wang, J				Nielsen, Rasmus; Korneliussen, Thorfinn; Albrechtsen, Anders; Li, Yingrui; Wang, Jun			SNP Calling, Genotype Calling, and Sample Allele Frequency Estimation from New-Generation Sequencing Data	PLOS ONE			English	Article							ASSOCIATION; INFERENCE; IMPUTATION; SITES	We present a statistical framework for estimation and application of sample allele frequency spectra from New-Generation Sequencing (NGS) data. In this method, we first estimate the allele frequency spectrum using maximum likelihood. In contrast to previous methods, the likelihood function is calculated using a dynamic programming algorithm and numerically optimized using analytical derivatives. We then use a Bayesian method for estimating the sample allele frequency in a single site, and show how the method can be used for genotype calling and SNP calling. We also show how the method can be extended to various other cases including cases with deviations from Hardy-Weinberg equilibrium. We evaluate the statistical properties of the methods using simulations and by application to a real data set.	[Nielsen, Rasmus; Li, Yingrui; Wang, Jun] BGI Shenzhen, Shenzhen, Peoples R China; [Nielsen, Rasmus] Univ Calif Berkeley, Dept Integrat Biol, Berkeley, CA 94720 USA; [Nielsen, Rasmus] Univ Calif Berkeley, Dept Stat, Berkeley, CA 94720 USA; [Nielsen, Rasmus; Korneliussen, Thorfinn; Albrechtsen, Anders; Wang, Jun] Univ Copenhagen, Dept Biol, Copenhagen, Denmark	Beijing Genomics Institute (BGI); University of California System; University of California Berkeley; University of California System; University of California Berkeley; University of Copenhagen	Nielsen, R (corresponding author), BGI Shenzhen, Shenzhen, Peoples R China.	rasmus_nielsen@berkeley.edu; wangj@genomics.org.cn	Korneliussen, Thorfinn Sand/ABB-7656-2021; Albrechtsen, Anders/K-4281-2013; Wang, Jun/A-7261-2013; Li, Yingrui/K-1064-2015; Korneliussen, Thorfinn Sand/F-6421-2014; Nielsen, Rasmus/D-4405-2009; Wang, Jun/C-8434-2016; Wang, Jun/B-9503-2016	Korneliussen, Thorfinn Sand/0000-0001-7576-5380; Albrechtsen, Anders/0000-0001-7306-031X; Korneliussen, Thorfinn Sand/0000-0001-7576-5380; Nielsen, Rasmus/0000-0003-0513-6591; Wang, Jun/0000-0002-8540-8931; Wang, Jun/0000-0002-2113-5874	United States National Institutes of Health [R01-HG003229]; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [R01HG003229] Funding Source: NIH RePORTER; Villum Fonden [00007171] Funding Source: researchfish	United States National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); Villum Fonden(Villum Fonden)	Funding was provided by United States National Institutes of Health grant R01-HG003229. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Altshuler D, 2010, NATURE, V467, P1061, DOI 10.1038/nature09534; Browning SR, 2007, AM J HUM GENET, V81, P1084, DOI 10.1086/521987; CASELLA G, 1985, AM STAT, V39, P83, DOI 10.2307/2682801; Dai JY, 2006, GENET EPIDEMIOL, V30, P690, DOI 10.1002/gepi.20180; Gibbons JG, 2009, MOL BIOL EVOL, V26, P2731, DOI 10.1093/molbev/msp188; Gravel S, 2011, P NATL ACAD SCI USA, V108, P11983, DOI 10.1073/pnas.1019276108; Gutenkunst RN, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000695; Harismendy O, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-3-r32; Hedges D, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0008232; Hellmann I, 2008, GENOME RES, V18, P1020, DOI 10.1101/gr.074187.107; Howie BN, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000529; Johnson PLF, 2008, MOL BIOL EVOL, V25, P199, DOI 10.1093/molbev/msm239; Johnson PLF, 2006, GENOME RES, V16, P1320, DOI 10.1101/gr.5431206; Keightley PD, 2011, GENETICS, V188, P931, DOI 10.1534/genetics.111.128355; Kim SY, 2011, BMC BIOINFORMATICS, V12, DOI 10.1186/1471-2105-12-231; Kim SY, 2010, GENET EPIDEMIOL, V34, P479, DOI 10.1002/gepi.20501; Le SQ, 2011, GENOME RES, V21, P952, DOI 10.1101/gr.113084.110; Li H, 2008, GENOME RES, V18, P1851, DOI 10.1101/gr.078212.108; Li H, 2011, BIOINFORMATICS, V27, P2987, DOI 10.1093/bioinformatics/btr509; Li RQ, 2010, NATURE, V463, P311, DOI 10.1038/nature08696; Li RQ, 2009, GENOME RES, V19, P1124, DOI 10.1101/gr.088013.108; Li YR, 2010, NAT GENET, V42, P969, DOI 10.1038/ng.680; Lynch M, 2008, MOL BIOL EVOL, V25, P2409, DOI 10.1093/molbev/msn185; Marchini J, 2007, NAT GENET, V39, P906, DOI 10.1038/ng2088; Martin ER, 2010, BIOINFORMATICS, V26, P2803, DOI 10.1093/bioinformatics/btq526; Minichiello MJ, 2006, AM J HUM GENET, V79, P910, DOI 10.1086/508901; Nordby J.J., 2000, DEAD RECKONING ART F; Schuster SC, 2008, NAT METHODS, V5, P16, DOI 10.1038/NMETH1156; TAJIMA F, 1989, GENETICS, V123, P585; Tucker T, 2009, AM J HUM GENET, V85, P142, DOI 10.1016/j.ajhg.2009.06.022; Voelkerding KV, 2009, CLIN CHEM, V55, P641, DOI 10.1373/clinchem.2008.112789; Wang Z, 2009, NAT REV GENET, V10, P57, DOI 10.1038/nrg2484; WATTERSON GA, 1975, THEOR POPUL BIOL, V7, P256, DOI 10.1016/0040-5809(75)90020-9; WEIR BS, 1984, EVOLUTION, V38, P1358, DOI [10.2307/2408641, 10.1111/j.1558-5646.1984.tb05657.x]; Yi X, 2010, SCIENCE, V329, P75, DOI 10.1126/science.1190371	35	222	226	1	69	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 24	2012	7	7							e37558	10.1371/journal.pone.0037558	http://dx.doi.org/10.1371/journal.pone.0037558			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	978NX	22911679	Green Published, gold			2022-12-25	WOS:000306751300001
J	Fu, Y; Lan, JC; Zhang, ZH; Hou, R; Wu, XH; Yang, DY; Zhang, RH; Zheng, WP; Nie, HM; Xie, Y; Yan, N; Yang, Z; Wang, CD; Luo, L; Liu, L; Gu, XB; Wang, SX; Peng, XR; Yang, GY				Fu, Yan; Lan, Jingchao; Zhang, Zhihe; Hou, Rong; Wu, Xuhang; Yang, Deying; Zhang, Runhui; Zheng, Wanpeng; Nie, Huaming; Xie, Yue; Yan, Ning; Yang, Zhi; Wang, Chengdong; Luo, Li; Liu, Li; Gu, Xiaobin; Wang, Shuxian; Peng, Xuerong; Yang, Guangyou			Novel Insights into the Transcriptome of Dirofilaria immitis	PLOS ONE			English	Article							PARASITIC NEMATODE; HAEMONCHUS-CONTORTUS; 2005 GUIDELINES; LIFE-CYCLE; GENES; WOLBACHIA; CANINE; COMPLEMENT; SYSTEM; ENDOSYMBIONT	Background: The heartworm Dirofilaria immitis is the causal agent of cardiopulmonary dirofilariosis in dogs and cats, and also infects a wide range of wild mammals as well as humans. One bottleneck for the design of fundamentally new intervention and management strategies against D. immitis may be the currently limited knowledge of fundamental molecular aspects of D. immitis. Methodology/Principal Findings: A next-generation sequencing platform combining computational approaches was employed to assess a global view of the heartworm transcriptome. A total of 20,810 unigenes (mean length = 1,270 bp) were assembled from 22.3 million clean reads. From these, 15,698 coding sequences (CDS) were inferred, and about 85% of the unigenes had orthologs/homologs in public databases. Comparative transcriptomic study uncovered 4,157 filarial-specific genes as well as 3,795 genes potentially involved in filarial-Wolbachia symbiosis. In addition, the potential intestine transcriptome of D. immitis (1,101 genes) was mined for the first time, which might help to discover 'hidden antigens'. Conclusions/Significance: This study provides novel insights into the transcriptome of D. immitis and sheds light on its molecular processes and survival mechanisms. Furthermore, it provides a platform to discover new vaccine candidates and potential targets for new drugs against dirofilariosis.	[Fu, Yan; Wu, Xuhang; Yang, Deying; Zhang, Runhui; Zheng, Wanpeng; Nie, Huaming; Xie, Yue; Yan, Ning; Gu, Xiaobin; Wang, Shuxian; Yang, Guangyou] Sichuan Agr Univ, Coll Vet Med, Dept Parasitol, Yaan, Peoples R China; [Lan, Jingchao; Zhang, Zhihe; Hou, Rong; Yang, Zhi; Wang, Chengdong; Luo, Li; Liu, Li] Chengdu Res Base Giant Panda Breeding, Sichuan Key Lab Conservat Biol Endangered Wildlif, State Key Lab China, Chengdu, Sichuan, Peoples R China; [Peng, Xuerong] Sichuan Agr Univ, Coll Life & Basic Sci, Dept Chem, Yaan, Peoples R China	Sichuan Agricultural University; Sichuan Agricultural University	Fu, Y (corresponding author), Sichuan Agr Univ, Coll Vet Med, Dept Parasitol, Yaan, Peoples R China.	guangyou1963@yahoo.com.cn			Research Fund for the Chengdu Giant Panda Breeding and Research Foundation [CPF-08005]; Changjiang Scholars and Innovative Research Team in University [IRT0848]	Research Fund for the Chengdu Giant Panda Breeding and Research Foundation; Changjiang Scholars and Innovative Research Team in University(Program for Changjiang Scholars & Innovative Research Team in University (PCSIRT))	This work was supported by Research Fund for the Chengdu Giant Panda Breeding and Research Foundation (Project No. CPF-08005) and Changjiang Scholars and Innovative Research Team in University (Project No. IRT0848). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abraham D., 1988, P29; ADDISS DG, 2004, AM J TROP MED HYG  S, V71, P12; Montoya-Alonso JA, 2010, PARASITOL RES, V107, P1265, DOI 10.1007/s00436-010-1987-7; Bandi C, 1998, P ROY SOC B-BIOL SCI, V265, P2407, DOI 10.1098/rspb.1998.0591; Bateman A, 2004, NUCLEIC ACIDS RES, V32, pD138, DOI [10.1093/nar/gkt1223, 10.1093/nar/gkp985, 10.1093/nar/gkr1065]; Bowman DD, 2009, GEORGIS PARASITOLOGY, P213; Buttner Dietrich W, 2003, Filaria J, V2, P10, DOI 10.1186/1475-2883-2-10; Canestri-Trotti G., 1997, Parassitologia (Rome), V39, P369; Cantacessi C, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023590; Cantacessi C, 2011, BIOTECHNOL ADV, V29, P261, DOI 10.1016/j.biotechadv.2010.11.005; Cantacessi C, 2010, INFECT GENET EVOL, V10, P1199, DOI 10.1016/j.meegid.2010.07.024; Cantacessi C, 2010, NUCLEIC ACIDS RES, V38, DOI 10.1093/nar/gkq667; Cantacessi C, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-266; Cantacessi C, 2010, PLOS NEGLECT TROP D, V4, DOI 10.1371/journal.pntd.0000684; Chirgwin SR, 2002, J PARASITOL, V88, P1248, DOI 10.1645/0022-3395(2002)088[1248:TFEWSI]2.0.CO;2; Choi YJ, 2011, PLOS NEGLECT TROP D, V5, DOI 10.1371/journal.pntd.0001409; Conesa A, 2005, BIOINFORMATICS, V21, P3674, DOI 10.1093/bioinformatics/bti610; De Ybanez MRR, 2006, VET REC, V158, P240, DOI 10.1136/vr.158.7.240; Elsworth B, 2011, INT J PARASITOL, V41, P881, DOI 10.1016/j.ijpara.2011.03.009; Foster J, 2005, PLOS BIOL, V3, P599, DOI 10.1371/journal.pbio.0030121; Friedrich T, 2004, BBA-BIOENERGETICS, V1608, P1, DOI 10.1016/j.bbabio.2003.10.002; Gamble KC, 1998, J ZOO WILDLIFE MED, V29, P50; Gasser RB, 2011, TOP COMPANION ANIM M, V26, P193, DOI 10.1053/j.tcam.2011.09.003; Genchi C, 2009, VET PARASITOL, V163, P286, DOI 10.1016/j.vetpar.2009.03.026; Grabherr MG, 2011, NAT BIOTECHNOL, V29, P644, DOI 10.1038/nbt.1883; HAMADA A, 1988, J CLIN INVEST, V82, P945, DOI 10.1172/JCI113702; HAMMERBERG B, 1985, TROPENMED PARASITOL, V36, pS5; Heider U, 2006, INT J MED MICROBIOL, V296, P287, DOI 10.1016/j.ijmm.2005.12.019; Hoch H, 2008, COMPENDIUM, V30, P133; Hunter S, 2009, NUCLEIC ACIDS RES, V37, pD211, DOI 10.1093/nar/gkn785; Kim MK, 2002, J KOREAN MED SCI, V17, P686, DOI 10.3346/jkms.2002.17.5.686; Liotta F, 2010, CURR OPIN INVEST DR, V11, P147; Mardis ER, 2008, TRENDS GENET, V24, P133, DOI 10.1016/j.tig.2007.12.007; Martin J, 2012, NUCLEIC ACIDS RES, V40, pD720, DOI 10.1093/nar/gkr1194; McCall JW, 2008, ADV PARASIT, V66, P193, DOI 10.1016/S0065-308X(08)00204-2; McGhee JD, 2007, DEV BIOL, V302, P627, DOI 10.1016/j.ydbio.2006.10.024; McGonigle S, 2001, INT J PARASITOL, V31, P1459, DOI 10.1016/S0020-7519(01)00272-7; McKay SJ, 2003, COLD SPRING HARB SYM, V68, P159, DOI 10.1101/sqb.2003.68.159; Morgan BP, 2005, IMMUNOL LETT, V97, P171, DOI 10.1016/j.imlet.2004.11.010; Mortazavi A, 2008, NAT METHODS, V5, P621, DOI 10.1038/nmeth.1226; Neiffer DL, 2002, J ZOO WILDLIFE MED, V33, P242, DOI 10.1638/1042-7260(2002)033[0242:MAWMDA]2.0.CO;2; Nelson CT, 2005, VET PARASITOL, V133, P255, DOI 10.1016/j.vetpar.2005.07.008; Nelson CT, 2005, VET PARASITOL, V133, P267, DOI 10.1016/j.vetpar.2005.07.009; Ogata H, 1999, NUCLEIC ACIDS RES, V27, P29, DOI 10.1093/nar/27.1.29; Otranto D, 2009, PARASITE VECTOR, V2, DOI 10.1186/1756-3305-2-S1-S2; Parkinson J, 2004, NAT GENET, V36, P1259, DOI 10.1038/ng1472; Pauli F, 2006, DEVELOPMENT, V133, P287, DOI 10.1242/dev.02185; Pertea G, 2003, BIOINFORMATICS, V19, P651, DOI 10.1093/bioinformatics/btg034; Polizopoulou ZS, 2000, VET REC, V146, P466, DOI 10.1136/vr.146.16.466; Riley SPD, 2004, J WILDLIFE DIS, V40, P11, DOI 10.7589/0090-3558-40.1.11; Rus H, 2005, IMMUNOL RES, V33, P103, DOI 10.1385/IR:33:2:103; Schuster SC, 2008, NAT METHODS, V5, P16, DOI 10.1038/NMETH1156; Scott AL, 2012, PARASITE IMMUNOL, V34, P121, DOI 10.1111/j.1365-3024.2011.01344.x; Sher A., 1988, MBL (Marine Biology Laboratory) Lectures in Biology, V9, P169; Shi CY, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-131; Simon F, 2009, TRENDS PARASITOL, V25, P404, DOI 10.1016/j.pt.2009.06.003; Slatko BE, 2010, SYMBIOSIS, V51, P55, DOI 10.1007/s13199-010-0067-1; STANIUNAS RJ, 1982, J PARASITOL, V68, P809, DOI 10.2307/3280987; Strubing U, 2010, INT J PARASITOL, V40, P1193, DOI 10.1016/j.ijpara.2010.03.004; TANAKA KI, 1993, VET RES COMMUN, V17, P109, DOI 10.1007/BF01839238; Tatusov RL, 2003, BMC BIOINFORMATICS, V4, DOI 10.1186/1471-2105-4-41; Theis JH, 2001, AM J TROP MED HYG, V64, P317, DOI 10.4269/ajtmh.2001.64.317; VANFLETEREN JR, 1994, MOL PHYLOGENET EVOL, V3, P92, DOI 10.1006/mpev.1994.1012; Wang JS, 2005, VET PARASITOL, V131, P261, DOI 10.1016/j.vetpar.2005.04.041; Wasmuth J, 2008, PLOS NEGLECT TROP D, V2, DOI 10.1371/journal.pntd.0000258; Wheat CW, 2011, METHODS MOL BIOL, V772, P129, DOI 10.1007/978-1-61779-228-1_7; Winter AD, 2012, BMC GENOMICS, V13, DOI 10.1186/1471-2164-13-4; Ye J, 2006, NUCLEIC ACIDS RES, V34, pW293, DOI 10.1093/nar/gkl031; Yin Y, 2008, PLOS NEGLECT TROP D, V2, DOI 10.1371/journal.pntd.0000269; Yin Y, 2006, INT J PARASITOL, V36, P829, DOI 10.1016/j.ijpara.2006.03.002; Young ND, 2010, BIOTECHNOL ADV, V28, P222, DOI 10.1016/j.biotechadv.2009.12.003	71	10	13	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 23	2012	7	7							e41639	10.1371/journal.pone.0041639	http://dx.doi.org/10.1371/journal.pone.0041639			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	977TM	22911833	Green Published, gold, Green Submitted			2022-12-25	WOS:000306687700131
J	Jung, J; Kim, HY; Kim, T; Shin, BH; Park, GS; Park, S; Chwae, YJ; Shin, HJ; Kim, K				Jung, Jaesung; Kim, Hee-Young; Kim, Taeyeung; Shin, Bo-Hye; Park, Gil-Soon; Park, Sun; Chwae, Yong-Joon; Shin, Ho-Joon; Kim, Kyongmin			C-Terminal Substitution of HBV Core Proteins with Those from DHBV Reveals That Arginine-Rich (167)RRRSQSPRR(175) Domain Is Critical for HBV Replication	PLOS ONE			English	Article							HEPATITIS-B-VIRUS; CAPSID PROTEIN; REVERSE TRANSCRIPTION; NUCLEAR-LOCALIZATION; NUCLEOTIDE-SEQUENCE; PHOSPHORYLATION; RNA; DUCK; ENCAPSIDATION; PARTICLES	To investigate the contributions of carboxyl-terminal nucleic acid binding domain of HBV core (C) protein for hepatitis B virus (HBV) replication, chimeric HBV C proteins were generated by substituting varying lengths of the carboxyl-terminus of duck hepatitis B virus (DHBV) C protein for the corresponding regions of HBV C protein. All chimeric C proteins formed core particles. A chimeric C protein with 221-262 amino acids of DHBV C protein, in place of 146-185 amino acids of the HBV C protein, supported HBV pregenomic RNA (pgRNA) encapsidation and DNA synthesis: 40% amino acid sequence identity or 45% homology in the nucleic-acid binding domain of HBV C protein was sufficient for pgRNA encapsidation and DNA synthesis, although we predominantly detected spliced DNA. A chimeric C protein with 221-241 and 251-262 amino acids of DHBV C, in place of HBV C 146-166 and 176-185 amino acids, respectively, could rescue full-length DNA synthesis. However, a reciprocal C chimera with 242-250 of DHBV C ((242)RAGSPLPRS(250)) introduced in place of 167-175 of HBV C ((167)RRRSQSPRR(175)) significantly decreased pgRNA encapsidation and DNA synthesis, and full-length DNA was not detected, demonstrating that the arginine-rich (167)RRRSQSPRR(175) domain may be critical for efficient viral replication. Five amino acids differing between viral species (underlined above) were tested for replication rescue; R169 and R175 were found to be important.	[Jung, Jaesung; Kim, Hee-Young; Kim, Taeyeung; Shin, Bo-Hye; Park, Gil-Soon; Park, Sun; Chwae, Yong-Joon; Shin, Ho-Joon; Kim, Kyongmin] Ajou Univ, Sch Med, Dept Microbiol, Suwon 441749, South Korea	Ajou University	Jung, J (corresponding author), Ajou Univ, Sch Med, Dept Microbiol, Suwon 441749, South Korea.	kimkm@ajou.ac.kr		Park, Sun/0000-0003-3254-4064; Kim, Kyongmin/0000-0001-9539-3051	Korea Research Foundation; Korean Government [KRF-2005-E00086, KRF-2006-E00017, KRF-2008-E00164]; Korean Ministry of Education	Korea Research Foundation(National Research Foundation of Korea); Korean Government(Korean Government); Korean Ministry of Education(Ministry of Education (MOE), Republic of Korea)	This work was supported by Korea Research Foundation Grants funded by the Korean Government (KRF-2005-E00086, KRF-2006-E00017, and KRF-2008-E00164). Jaesung Jung, Taeyeung Kim, and Bo-Hye Shin were supported by the BK21 program, Korean Ministry of Education. The authors thank Dr. William Mason (Fox Chase Cancer Center) for providing the DHBV construct. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BEAMES B, 1993, VIROLOGY, V194, P597, DOI 10.1006/viro.1993.1299; BERKOWITZ RD, 1995, J VIROL, V69, P6445, DOI 10.1128/JVI.69.10.6445-6456.1995; BIRNBAUM F, 1990, J VIROL, V64, P3319, DOI 10.1128/JVI.64.7.3319-3330.1990; Brechot C, 2004, GASTROENTEROLOGY, V127, pS56, DOI 10.1053/j.gastro.2004.09.016; Certo JL, 1999, J VIROL, V73, P9170, DOI 10.1128/JVI.73.11.9170-9177.1999; Chua PK, 2010, J VIROL, V84, P2340, DOI 10.1128/JVI.01666-09; Daub H, 2002, J VIROL, V76, P8124, DOI 10.1128/JVI.76.16.8124-8137.2002; Enomoto M, 2006, FEBS LETT, V580, P894, DOI 10.1016/j.febslet.2006.01.011; GALLINA A, 1989, J VIROL, V63, P4645, DOI 10.1128/JVI.63.11.4645-4652.1989; Gazina EV, 2000, J VIROL, V74, P4721, DOI 10.1128/JVI.74.10.4721-4728.2000; Gunther S, 1997, VIROLOGY, V238, P363, DOI 10.1006/viro.1997.8863; HATTON T, 1992, J VIROL, V66, P5232, DOI 10.1128/JVI.66.9.5232-5241.1992; HUANG JK, 1993, MOL CELL BIOL, V13, P7476, DOI 10.1128/MCB.13.12.7476; KANN M, 1994, J VIROL, V68, P7993, DOI 10.1128/JVI.68.12.7993-8000.1994; Kau JH, 1998, J VIROL, V72, P3796, DOI 10.1128/JVI.72.5.3796-3803.1998; Kaye JF, 1998, J VIROL, V72, P5877, DOI 10.1128/JVI.72.7.5877-5885.1998; KENNEY JM, 1995, STRUCTURE, V3, P1009, DOI 10.1016/S0969-2126(01)00237-4; Kim HY, 2004, VIROLOGY, V322, P22, DOI 10.1016/j.virol.2004.01.009; Kim KH, 2000, J VIROL, V74, P2663, DOI 10.1128/JVI.74.6.2663-2670.2000; Kock J, 2004, J VIROL, V78, P13812, DOI 10.1128/JVI.78.24.13812-13818.2004; Kock J, 1998, J VIROL, V72, P9116; KODAMA K, 1985, J VIROL, V56, P978, DOI 10.1128/JVI.56.3.978-986.1985; Konig S, 1998, J VIROL, V72, P4997; Lan YT, 1999, VIROLOGY, V259, P342, DOI 10.1006/viro.1999.9798; Le Pogam S, 2005, J VIROL, V79, P1871, DOI 10.1128/JVI.79.3.1871-1887.2005; Lewellyn EB, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017202; Lewellyn EB, 2011, J VIROL, V85, P1298, DOI 10.1128/JVI.01957-10; LIAO W, 1995, J VIROL, V69, P1025, DOI 10.1128/JVI.69.2.1025-1029.1995; MACHIDA A, 1991, J VIROL, V65, P6024, DOI 10.1128/JVI.65.11.6024-6030.1991; MANDART E, 1984, J VIROL, V49, P782, DOI 10.1128/JVI.49.3.782-792.1984; Melegari M, 2005, J VIROL, V79, P9810, DOI 10.1128/JVI.79.15.9810-9820.2005; Mueller-Hill K, 2002, J VIROL, V76, P4260, DOI 10.1128/JVI.76.9.4260-4266.2002; NASSAL M, 1992, J VIROL, V66, P4107, DOI 10.1128/JVI.66.7.4107-4116.1992; Newman M, 2003, J VIROL, V77, P12950, DOI 10.1128/JVI.77.24.12950-12960.2003; OKAMOTO H, 1990, J GEN VIROL, V71, P959, DOI 10.1099/0022-1317-71-4-959; Ostrow KM, 2004, J VIROL, V78, P8780, DOI 10.1128/JVI.78.16.8780-8787.2004; Ostrow KM, 2002, J VIROL, V76, P9087, DOI 10.1128/JVI.76.18.9087-9095.2002; Park GS, 2008, VIRUS RES, V136, P166, DOI 10.1016/j.virusres.2008.05.005; Perlman DH, 2005, P NATL ACAD SCI USA, V102, P9020, DOI 10.1073/pnas.0502138102; YEH CT, 1993, P NATL ACAD SCI USA, V90, P6459, DOI 10.1073/pnas.90.14.6459; YEH CT, 1991, J VIROL, V65, P2327, DOI 10.1128/JVI.65.5.2327-2331.1991; YU MS, 1994, J VIROL, V68, P2965, DOI 10.1128/JVI.68.5.2965-2969.1994; ZHOU S, 1992, P NATL ACAD SCI USA, V89, P10046, DOI 10.1073/pnas.89.21.10046; Ziermann R, 1996, VIROLOGY, V219, P350, DOI 10.1006/viro.1996.0260	44	11	11	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 20	2012	7	7							e41087	10.1371/journal.pone.0041087	http://dx.doi.org/10.1371/journal.pone.0041087			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	977GL	22911745	gold, Green Published, Green Submitted			2022-12-25	WOS:000306644600045
J	Carr, IM; Diggle, CP; Khan, K; Inglehearn, C; McKibbin, M; Bonthron, DT; Markham, AF; Anwar, R; Dobbie, A; Pena, SDJ; Ali, M				Carr, Ian M.; Diggle, Christine P.; Khan, Kamron; Inglehearn, Chris; McKibbin, Martin; Bonthron, David T.; Markham, Alexander F.; Anwar, Rashida; Dobbie, Angus; Pena, Sergio D. J.; Ali, Manir			Rapid Visualisation of Microarray Copy Number Data for the Detection of Structural Variations Linked to a Disease Phenotype	PLOS ONE			English	Article							COMPARATIVE GENOMIC HYBRIDIZATION; ACROSOME FORMATION; MALE-INFERTILITY; CANCER GENOME; PAX6 GENE; ANIRIDIA; GLOBOZOOSPERMIA; DELETIONS; MUTATION; ARRAYS	Whilst the majority of inherited diseases have been found to be caused by single base substitutions, small insertions or deletions (<1Kb), a significant proportion of genetic variability is due to copy number variation (CNV). The possible role of CNV in monogenic and complex diseases has recently attracted considerable interest. However, until the development of whole genome, oligonucleotide micro-arrays, designed specifically to detect the presence of copy number variation, it was not easy to screen an individual for the presence of unknown deletions or duplications with sizes below the level of sensitivity of optical microscopy (3-5 Mb). Now that currently available oligonucleotide micro-arrays have in excess of a million probes, the problem of copy number analysis has moved from one of data production to that of data analysis. We have developed CNViewer, to identify copy number variation that co-segregates with a disease phenotype in small nuclear families, from genome-wide oligonucleotide micro-array data. This freely available program should constitute a useful addition to the diagnostic armamentarium of clinical geneticists.	[Carr, Ian M.; Diggle, Christine P.; Khan, Kamron; Inglehearn, Chris; McKibbin, Martin; Bonthron, David T.; Markham, Alexander F.; Anwar, Rashida; Ali, Manir] Univ Leeds, Sch Med, Leeds LS2 9JT, W Yorkshire, England; [Markham, Alexander F.; Dobbie, Angus] St James Univ Hosp, Dept Clin Genet, Leeds, W Yorkshire, England; [McKibbin, Martin] St James Univ Hosp, Dept Ophthalmol, Leeds, W Yorkshire, England; [Pena, Sergio D. J.] Univ Fed Minas Gerais, Dept Biochem & Immunol, Belo Horizonte, MG, Brazil; [Pena, Sergio D. J.] GENE Nucleo Genet Med, Belo Horizonte, MG, Brazil	University of Leeds; Saint James's University Hospital; Saint James's University Hospital; Universidade Federal de Minas Gerais	Carr, IM (corresponding author), Univ Leeds, Sch Med, Leeds LS2 9JT, W Yorkshire, England.	i.m.carr@leeds.ac.uk	Inglehearn, Chris/GYD-9783-2022; Ali, Manir/ABE-5251-2020	Ali, Manir/0000-0003-3204-3788; Bonthron, David/0000-0001-8132-8179	Sir Jules Thorn Charitable Trust [09/JTA]; Engineering and Physical Sciences Research Council [FP/I000623/1]; Cancer Research UK [600130]; Conselho Nacional de Desenvolvimento Cientifico e Tecnologico of Brazil [472588/2004-5, 401983/2010-2]; Engineering and Physical Sciences Research Council [EP/I000623/1] Funding Source: researchfish; The Sir Jules Thorn Charitable Trust [09JTA] Funding Source: researchfish; EPSRC [EP/I000623/1] Funding Source: UKRI	Sir Jules Thorn Charitable Trust; Engineering and Physical Sciences Research Council(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC)); Cancer Research UK(Cancer Research UK); Conselho Nacional de Desenvolvimento Cientifico e Tecnologico of Brazil(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); Engineering and Physical Sciences Research Council(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC)); The Sir Jules Thorn Charitable Trust; EPSRC(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC))	Funding provided by the Sir Jules Thorn Charitable Trust (Grant 09/JTA), the Engineering and Physical Sciences Research Council (Grant FP/I000623/1), Cancer Research UK (Grant 600130) and Conselho Nacional de Desenvolvimento Cientifico e Tecnologico of Brazil (projects 472588/2004-5 and 401983/2010-2). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Altshuler D, 2010, NATURE, V467, P1061, DOI 10.1038/nature09534; Baross A, 2007, BMC BIOINFORMATICS, V8, DOI 10.1186/1471-2105-8-368; Bejjani BA, 2008, ANNU REV GENOM HUM G, V9, P71, DOI 10.1146/annurev.genom.9.081307.164207; Beroukhim R, 2010, NATURE, V463, P899, DOI 10.1038/nature08822; Bignell GR, 2010, NATURE, V463, P893, DOI 10.1038/nature08768; CHEUNG SW, 1977, CELL BIOL INT REP, V1, P255, DOI 10.1016/0309-1651(77)90050-9; Crolla JA, 2002, AM J HUM GENET, V71, P1138, DOI 10.1086/344396; Dam AHDM, 2007, AM J HUM GENET, V81, P813, DOI 10.1086/521314; Dellinger AE, 2010, NUCLEIC ACIDS RES, V38, DOI 10.1093/nar/gkq040; Diskin SJ, 2009, NATURE, V459, P987, DOI 10.1038/nature08035; Fan YS, 2007, HUM MUTAT, V28, P1124, DOI 10.1002/humu.20581; FANTES JA, 1992, AM J HUM GENET, V51, P1286; Forer L, 2010, BMC BIOINFORMATICS, V11, DOI 10.1186/1471-2105-11-318; Gonzaga-Jauregui C, 2012, ANNU REV MED, V63, P35, DOI 10.1146/annurev-med-051010-162644; Huang Jing, 2004, Human Genomics, V1, P287; JORDAN T, 1992, NAT GENET, V1, P328, DOI 10.1038/ng0892-328; Korn JM, 2008, NAT GENET, V40, P1253, DOI 10.1038/ng.237; Koscinski I, 2011, AM J HUM GENET, V88, P344, DOI 10.1016/j.ajhg.2011.01.018; Lauderdale J, 2000, P NATL ACAD SCI USA, V97, P13755, DOI 10.1073/pnas.240398797; McCarroll SA, 2008, NAT GENET, V40, P1166, DOI 10.1038/ng.238; Mills RE, 2011, NATURE, V470, P59, DOI 10.1038/nature09708; Nannya Y, 2005, CANCER RES, V65, P6071, DOI 10.1158/0008-5472.CAN-05-0465; Norton N, 2011, AM J HUM GENET, V88, P273, DOI 10.1016/j.ajhg.2011.01.016; Pinkel D, 1998, NAT GENET, V20, P207, DOI 10.1038/2524; Pinto D, 2010, NATURE, V466, P368, DOI 10.1038/nature09146; Schouten JP, 2002, NUCLEIC ACIDS RES, V30, DOI 10.1093/nar/gnf056; Wang DG, 1998, SCIENCE, V280, P1077, DOI 10.1126/science.280.5366.1077; Ware JS, 2012, HEART, V98, P276, DOI 10.1136/heartjnl-2011-300742; Xiao N, 2009, J CLIN INVEST, V119, P802, DOI 10.1172/JCI36230; Yao RJ, 2002, P NATL ACAD SCI USA, V99, P11211, DOI 10.1073/pnas.162027899; Zhao XJ, 2004, CANCER RES, V64, P3060, DOI 10.1158/0008-5472.CAN-03-3308	31	1	1	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 17	2012	7	8							e43466	10.1371/journal.pone.0043466	http://dx.doi.org/10.1371/journal.pone.0043466			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	996DG	22912880	Green Published, Green Submitted, gold			2022-12-25	WOS:000308063700108
J	Dewan, M; Kumar, A; Saxena, A; De, A; Mozumdar, S				Dewan, Manika; Kumar, Ajeet; Saxena, Amit; De, Arnab; Mozumdar, Subho			Biginelli Reaction Catalyzed by Copper Nanoparticles	PLOS ONE			English	Article							ONE-POT SYNTHESIS; IONIC LIQUIDS; EFFICIENT CATALYST; NI-NANOPARTICLES; DIHYDROPYRIMIDINONES; TETRAFLUOROBORATE; TEMPERATURE	We recently reported a novel synthesis of copper nanoparticles from copper sulphate utilizing the charge-compensatory effect of ionic liquid [bmim]BF4 and ethylene glycol. The nanoparticles were characterized and found to be stable for one year. Here we hypothesize that the stabilized nanoparticles should be able to catalyze one-pot multicomponent organic reactions. We show that the nanoparticles catalyzed Biginelli reaction at room temperature to give the product 3,4-dihydopyrimidinone (>90% yield in similar to 15 minutes) from aldehydes, beta-diketoester (ethylacetoacetate) and urea (or thiourea).). Remarkably, such high yields and rapid kinetics was found to be independent of the electronic density on the reactant aryl-aldehyde. This was probably because even the surface-active particles reacted faster in the presence of ionic liquid as compared to conventional methods. The heterocyclic dihydropyrimidinones (DHPMs) and their derivatives are widely used in natural and synthetic organic chemistry due to their wide spectrum of biological and therapeutic properties (resulting from their antibacterial, antiviral, antitumor and anti-inflammatory activities. Our method has an easy work-up procedure and the nanoparticles could be recycled with minimal loss of efficiency.	[Dewan, Manika; Kumar, Ajeet; Saxena, Amit; Mozumdar, Subho] Univ Delhi, Dept Chem, Delhi 110007, India; [De, Arnab] Columbia Univ, Med Ctr, Dept Microbiol & Immunol, New York, NY USA	University of Delhi; Columbia University	Dewan, M (corresponding author), Univ Delhi, Dept Chem, Delhi 110007, India.	subhoscom@yahoo.co.in						Ansari IA, 2005, TETRAHEDRON LETT, V46, P7507, DOI 10.1016/j.tetlet.2005.09.013; Antonietti M, 2004, ANGEW CHEM INT EDIT, V43, P4988, DOI 10.1002/anie.200460091; Choudhary VR, 2003, CATAL COMMUN, V4, P449, DOI 10.1016/S1566-7367(03)00111-0; Chu CD, 2007, CATAL COMMUN, V8, P1527, DOI 10.1016/j.catcom.2006.12.024; Dewan M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0029131; Dewan M, 2010, TETRAHEDRON LETT, V51, P6108, DOI 10.1016/j.tetlet.2010.09.052; Dhas NA, 1998, CHEM MATER, V10, P1446, DOI 10.1021/cm9708269; Germani R, 2007, TETRAHEDRON LETT, V48, P1767, DOI 10.1016/j.tetlet.2007.01.038; Ha SH, 2010, KOREAN J CHEM ENG, V27, P1360, DOI 10.1007/s11814-010-0386-1; Hallett JP, 2011, ROOM TEMPERATURE ION, P3508; Hanusek J, 2007, DYES PIGMENTS, V73, P326, DOI 10.1016/j.dyepig.2006.01.025; He YF, 2008, J PHOTOCH PHOTOBIO A, V197, P253, DOI 10.1016/j.jphotochem.2008.01.001; Holomb R, 2008, J RAMAN SPECTROSC, V39, P793, DOI 10.1002/jrs.1912; Jain SL, 2007, CATAL LETT, V115, P52, DOI 10.1007/s10562-007-9070-4; Jiang C, 2007, CHINESE CHEM LETT, V18, P647, DOI 10.1016/j.cclet.2007.04.002; Kachoosangi RT, 2009, ANAL CHEM, V81, P435, DOI 10.1021/ac801853r; Kamal A, 2007, CATAL COMMUN, V8, P1929, DOI 10.1016/j.catcom.2007.03.009; Kamavaram V, 2008, INT J THERM SCI, V47, P773, DOI 10.1016/j.ijthermalsci.2007.06.012; Kappe CO, 2000, EUR J MED CHEM, V35, P1043, DOI 10.1016/S0223-5234(00)01189-2; Khanna PK, 2007, MATER LETT, V61, P4711, DOI 10.1016/j.matlet.2007.03.014; Kim KS, 2005, KOREAN J CHEM ENG, V22, P717, DOI 10.1007/BF02705788; Kumar A, 2008, CATAL COMMUN, V10, P17, DOI 10.1016/j.catcom.2008.07.030; Kumar A, 2008, CATAL COMMUN, V9, P778, DOI 10.1016/j.catcom.2007.08.021; Kumar A, 2008, CATAL LETT, V122, P98, DOI 10.1007/s10562-007-9349-5; Kumar A, 2012, GREEN CHEM, V14, P1298, DOI 10.1039/c2gc35070j; Kumar A, 2011, TETRAHEDRON LETT, V52, P4835, DOI 10.1016/j.tetlet.2011.07.016; Kumar A, 2010, CATAL COMMUN, V11, P679, DOI 10.1016/j.catcom.2010.01.017; Liu CJ, 2009, MOLECULES, V14, P763, DOI 10.3390/molecules14020763; Liu X, 2006, TRIBOL LETT, V23, P191, DOI 10.1007/s11249-006-9050-7; Paczal A, 2007, MONATSH CHEM, V138, P1115, DOI 10.1007/s00706-007-0759-2; Pasunooti KK, 2011, TETRAHEDRON LETT, V52, P80, DOI 10.1016/j.tetlet.2010.10.150; PATIL AD, 1995, J ORG CHEM, V60, P1182, DOI 10.1021/jo00110a021; Redel E, 2008, CHEM COMMUN, P1789, DOI 10.1039/b718055a; Salavati-Niasari M, 2009, MATER LETT, V63, P441, DOI 10.1016/j.matlet.2008.11.023; Singh K, 2009, MINI-REV MED CHEM, V9, P95, DOI 10.2174/138955709787001686; Swadzba-Kwasny M, 2012, DALTON T, V41, P219, DOI 10.1039/c1dt11578b; Trohalaki S, 2005, QSAR COMB SCI, V24, P485, DOI 10.1002/qsar.200430927; Wang BG, 2011, NANOSCALE RES LETT, V6, DOI 10.1186/1556-276X-6-259; Wang L, 2007, SCI CHINA SER B, V50, P63, DOI 10.1007/s11426-007-0016-x; Welton T, 1999, CHEM REV, V99, P2071, DOI 10.1021/cr980032t; Welton T, 2004, COORDIN CHEM REV, V248, P2459, DOI 10.1016/j.ccr.2004.04.015; WIPF P, 1995, TETRAHEDRON LETT, V36, P7819, DOI 10.1016/0040-4039(95)01660-A; Zhang JD, 2010, J MATER CHEM, V20, P9798, DOI 10.1039/c0jm01970d; Zhang M, 2008, J DISPER SCI TECHNOL, V29, P508, DOI 10.1080/01932690701728734; Zhou Y, 2005, CURR NANOSCI, V1, P35, DOI 10.2174/1573413052953174; Zhu HT, 2005, NANOTECHNOLOGY, V16, P3079, DOI 10.1088/0957-4484/16/12/059; Zhu JM, 2007, J PHYS CHEM C, V111, P7629, DOI 10.1021/jp0711850	47	27	27	1	29	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 17	2012	7	8							e43078	10.1371/journal.pone.0043078	http://dx.doi.org/10.1371/journal.pone.0043078			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	996DG	22912792	Green Published, Green Submitted, gold			2022-12-25	WOS:000308063700038
J	Pripuzova, N; Wang, R; Tsai, S; Li, BJ; Hung, GC; Ptak, RG; Lo, SC				Pripuzova, Natalia; Wang, Richard; Tsai, Shien; Li, Bingjie; Hung, Guo-Chiuan; Ptak, Roger G.; Lo, Shyh-Ching			Development of Real-Time PCR Array for Simultaneous Detection of Eight Human Blood-Borne Viral Pathogens	PLOS ONE			English	Article							DISEASES (RAPID)-BIOACTIVE AMPLIFICATION; RELIABLE ASSAY PROTOCOL; B-VIRUS DNA; WEST-NILE-VIRUS; RAPID DETECTION; PROBING BAP; HIV TYPE-1; GROUP-O; IDENTIFICATION; QUANTIFICATION	Background: Real-time PCR array for rapid detection of multiple viral pathogens should be highly useful in cases where the sample volume and the time of testing are limited, i.e. in the eligibility testing of tissue and organ donors. Findings: We developed a real-time PCR array capable of simultaneously detecting eight human viral pathogens: human immunodeficiency virus types 1 and 2 (HIV-1 and -2), hepatitis B virus (HBV), hepatitis C virus (HCV), human T-cell leukemia virus-1 and -2 (HTLV-1 and -2), vaccinia virus (VACV) and West Nile virus (WNV). One hundred twenty (120) primers were designed using a combination of bioinformatics approaches, and, after experimental testing, 24 primer sets targeting eight viral pathogens were selected to set up the array with SYBR Green chemistry. The specificity and sensitivity of the virus-specific primer sets selected for the array were evaluated using analytical panels with known amounts of viruses spiked into human plasma. The array detected: 10 genome equivalents (geq)/ml of HIV-2 and HCV, 50 geq of HIV-1 (subtype B), HBV (genotype A) and WNV. It detected 100-1,000 geq/ml of plasma of HIV-1 subtypes (A - G), group N and CRF (AE and AG) isolates. Further evaluation with a panel consisting of 28 HIV-1 and HIV-2 clinical isolates revealed no cross-reactivity of HIV-1 or HIV-2 specific primers with another type of HIV. All 28 viral isolates were identified with specific primer sets targeting the most conserved genome areas. The PCR array correctly identified viral infections in a panel of 17 previously quantified clinical plasma samples positive for HIV-1, HCV or HBV at as low as several geq per PCR reaction. Conclusions: The viral array described here demonstrated adequate performance in the testing of donors' clinical samples. Further improvement in its sensitivity for the broad spectrum of HIV-1 subtypes is under development.	[Pripuzova, Natalia; Tsai, Shien; Li, Bingjie; Hung, Guo-Chiuan; Lo, Shyh-Ching] US FDA, Tissue Microbiol Lab, Div Cellular & Gene Therapies, Off Cellular Tissue & Gene Therapy,Ctr Biol Evalu, Bethesda, MD 20014 USA; [Wang, Richard] NIH, Dept Transfus Med, Warren Grant Magnuson Clin Ctr, Bethesda, MD 20892 USA; [Ptak, Roger G.] So Res Inst, Dept Infect Dis Res, Frederick, MD USA	US Food & Drug Administration (FDA); National Institutes of Health (NIH) - USA	Pripuzova, N (corresponding author), US FDA, Tissue Microbiol Lab, Div Cellular & Gene Therapies, Off Cellular Tissue & Gene Therapy,Ctr Biol Evalu, Bethesda, MD 20014 USA.	ShyhChing.Lo@fda.hhs.gov			CLINICAL CENTER [ZIACL002121] Funding Source: NIH RePORTER	CLINICAL CENTER		ABIMIKU AG, 1994, AIDS RES HUM RETROV, V10, P1581, DOI 10.1089/aid.1994.10.1581; Assal A, 2009, TRANSFUSION, V49, P289, DOI 10.1111/j.1537-2995.2008.01965.x; BEYL W, 1987, MUNCHEN MED WOCHEN, V129, P895; Brown BK, 2005, J VIROL, V79, P6089, DOI 10.1128/JVI.79.10.6089-6101.2005; Buonaguro L, 2007, J VIROL, V81, P10209, DOI 10.1128/JVI.00872-07; CANN AJ, 1990, J VIROL, V64, P4735, DOI 10.1128/JVI.64.10.4735-4742.1990; Cannon GA, 2010, J VIROL METHODS, V163, P17, DOI 10.1016/j.jviromet.2009.07.005; Chen EC, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002155; Daniel HDJ, 2009, INDIAN J MED MICROBI, V27, P111, DOI 10.4103/0255-0857.45362; Food and Drug Administration, 2005, FED REG, V69, P29785; GAO F, 1994, AIDS RES HUM RETROV, V10, P1359, DOI 10.1089/aid.1994.10.1359; Gueudin M, 2011, J CLIN MICROBIOL; Gueudin M, 2007, JAIDS-J ACQ IMM DEF, V44, P500, DOI 10.1097/QAI.0b013e31803260df; Gurtler L, 1988, INT C AIDS; Hsieh YC, 2005, J VIROL METHODS, V129, P75, DOI 10.1016/j.jviromet.2005.05.009; Ismail AM, 2011, J CLIN MICROBIOL, V49, P3215, DOI 10.1128/JCM.00915-11; Khodakov DA, 2008, BIOTECHNIQUES, V44, P241, DOI 10.2144/000112628; Kistler A, 2007, J INFECT DIS, V196, P817, DOI 10.1086/520816; Kodani M, 2011, J CLIN MICROBIOL, V49, P2175, DOI 10.1128/JCM.02270-10; KOYANAGI Y, 1987, SCIENCE, V236, P819, DOI 10.1126/science.3646751; Lanciotti RS, 2000, J CLIN MICROBIOL, V38, P4066, DOI 10.1128/JCM.38.11.4066-4071.2000; Lanier ER, 2010, ANTIMICROB AGENTS CH, V54, P2901, DOI 10.1128/AAC.00068-10; Lee S, 2006, J VIROL METHODS, V137, P287, DOI 10.1016/j.jviromet.2006.07.001; Leski TA, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006569; Li G, 2005, J GEN VIROL, V86, P2969, DOI 10.1099/vir.0.81331-0; Li SK, 2008, J VIROL METHODS, V149, P35, DOI 10.1016/j.jviromet.2007.12.021; Lin BC, 2004, J CLIN MICROBIOL, V42, P3232, DOI 10.1128/JCM.42.7.3232-3239.2004; Liu Y, 2007, J CLIN MICROBIOL, V45, P553, DOI 10.1128/JCM.00709-06; LOUSSERTAJAKA I, 1995, J VIROL, V69, P5640, DOI 10.1128/JVI.69.9.5640-5649.1995; Mallick TK, 2011, REPORTED INFECT HUMA; Motulsky H.J., 2012, INTUITIVE BIOSTATIST; OU CY, 1988, SCIENCE, V239, P295, DOI 10.1126/science.3336784; Owen SM, 1998, J VIROL, V72, P5425, DOI 10.1128/JVI.72.7.5425-5432.1998; Palacios G, 2007, EMERG INFECT DIS, V13, P73, DOI 10.3201/eid1301.060837; Papin JF, 2004, J CLIN MICROBIOL, V42, P1511, DOI 10.1128/JCM.42.4.1511-1518.2004; Phillippy AM, 2009, NUCLEIC ACIDS RES, V37, pW229, DOI 10.1093/nar/gkp286; SCHULZ TF, 1990, J VIROL, V64, P5177, DOI 10.1128/JVI.64.10.5177-5182.1990; Simon F, 1998, NAT MED, V4, P1032, DOI 10.1038/2017; Sire JM, 2011, JAIDS-J ACQ IMM DEF, V56, P239, DOI 10.1097/QAI.0b013e3182099891; Snijders PJF, 2005, METH MOLEC MED, V119, P101; Wang CY, 2008, VET MICROBIOL, V130, P28, DOI 10.1016/j.vetmic.2007.12.015; Wang Su, 2007, Cell and Tissue Banking, V8, P211, DOI 10.1007/s10561-007-9034-3; Whitehouse CA, 2010, APPL ENVIRON MICROB, V76, P1996, DOI 10.1128/AEM.01919-09	43	13	15	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 17	2012	7	8							e43246	10.1371/journal.pone.0043246	http://dx.doi.org/10.1371/journal.pone.0043246			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	996DG	22912836	Green Submitted, gold, Green Published			2022-12-25	WOS:000308063700066
J	Quintana, A; Morgan, PG; Kruse, SE; Palmiter, RD; Sedensky, MM				Quintana, Albert; Morgan, Philip G.; Kruse, Shane E.; Palmiter, Richard D.; Sedensky, Margaret M.			Altered Anesthetic Sensitivity of Mice Lacking Ndufs4, a Subunit of Mitochondrial Complex I	PLOS ONE			English	Article							AMINOBUTYRIC ACID(A) RECEPTORS; D-ASPARTATE RECEPTOR; CAENORHABDITIS-ELEGANS; VOLATILE-ANESTHETICS; GENERAL-ANESTHESIA; INHALED ANESTHETICS; RIGHTING REFLEX; ALZHEIMER MICE; LEIGH-SYNDROME; ISOFLURANE	Anesthetics are in routine use, yet the mechanisms underlying their function are incompletely understood. Studies in vitro demonstrate that both GABA(A) and NMDA receptors are modulated by anesthetics, but whole animal models have not supported the role of these receptors as sole effectors of general anesthesia. Findings in C. elegans and in children reveal that defects in mitochondrial complex I can cause hypersensitivity to volatile anesthetics. Here, we tested a knockout (KO) mouse with reduced complex I function due to inactivation of the Ndufs4 gene, which encodes one of the subunits of complex I. We tested these KO mice with two volatile and two non-volatile anesthetics. KO and wild-type (WT) mice were anesthetized with isoflurane, halothane, propofol or ketamine at post-natal (PN) days 23 to 27, and tested for loss of response to tail clamp (isoflurane and halothane) or loss of righting reflex (propofol and ketamine). KO mice were 2.5 - to 3-fold more sensitive to isoflurane and halothane than WT mice. KO mice were 2-fold more sensitive to propofol but resistant to ketamine. These changes in anesthetic sensitivity are the largest recorded in a mammal.	[Quintana, Albert; Kruse, Shane E.; Palmiter, Richard D.] Univ Washington, Howard Hughes Med Inst, Seattle, WA 98195 USA; [Quintana, Albert; Kruse, Shane E.; Palmiter, Richard D.] Univ Washington, Dept Biochem, Seattle, WA 98195 USA; [Morgan, Philip G.; Sedensky, Margaret M.] Univ Washington, Dept Anesthesiol & Pain Med, Seattle, WA 98195 USA; [Morgan, Philip G.; Sedensky, Margaret M.] Seattle Childrens Res Inst, Ctr Dev Therapeut, Seattle, WA USA	Howard Hughes Medical Institute; University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle; Seattle Children's Hospital	Quintana, A (corresponding author), Univ Washington, Howard Hughes Med Inst, Seattle, WA 98195 USA.	pgm4@uw.edu	Quintana, Albert/N-5544-2015; kruse, shane/L-8717-2014	Quintana, Albert/0000-0003-1674-7160; kruse, shane/0000-0001-6344-0650	Howard Hughes Medical Institute (HHMI); MICINN postdoctoral mobility program fellowship from the Spanish Ministerio de Ciencia e Innovacion; National Institutes of Health (NIH) [GM58881]; Mitochondrial Research Guild; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM058881] Funding Source: NIH RePORTER	Howard Hughes Medical Institute (HHMI)(Howard Hughes Medical Institute); MICINN postdoctoral mobility program fellowship from the Spanish Ministerio de Ciencia e Innovacion; National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Mitochondrial Research Guild; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	RDP and AQ were supported by the Howard Hughes Medical Institute (HHMI). AQ was a recipient of MICINN postdoctoral mobility program fellowship from the Spanish Ministerio de Ciencia e Innovacion. PGM and MMS were supported by National Institutes of Health (NIH) grant GM58881. These studies were also supported in part by the Mitochondrial Research Guild. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abulafia R, 2009, J NEUROSCI, V29, P7053, DOI 10.1523/JNEUROSCI.1357-08.2009; Alkire MT, 2007, ANESTHESIOLOGY, V107, P264, DOI 10.1097/01.anes.0000270741.33766.24; Alkire MT, 2009, ANESTHESIOLOGY, V110, P766, DOI 10.1097/ALN.0b013e31819c461c; Bianchi SL, 2010, ANESTH ANALG, V110, P427, DOI 10.1213/ANE.0b013e3181b5a292; Brown EN, 2010, NEW ENGL J MED, V363, P2638, DOI 10.1056/NEJMra0808281; Campagna JA, 2003, NEW ENGL J MED, V348, P2110, DOI 10.1056/NEJMra021261; Chen XD, 2009, J NEUROSCI, V29, P560, DOI 10.1523/JNEUROSCI.3481-08.2009; Eckel B, 2010, ANESTH ANALG, V110, P438, DOI 10.1213/ANE.0b013e3181b76383; Eger EI, 2006, ANESTH ANALG, V102, P1397, DOI 10.1213/01.ANE.0000219019.91281.51; Falk MJ, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006607; Forman SA, 2008, INT ANESTHESIOL CLIN, V46, P43, DOI 10.1097/AIA.0b013e3181755da5; Franks NP, 2006, BRIT J PHARMACOL, V147, pS72, DOI 10.1038/sj.bjp.0706441; FRANKS NP, 1994, NATURE, V367, P607, DOI 10.1038/367607a0; HARRIS RA, 1971, ARCH BIOCHEM BIOPHYS, V142, P435, DOI 10.1016/0003-9861(71)90507-8; Hartman PS, 2001, MECH AGEING DEV, V122, P1187, DOI 10.1016/S0047-6374(01)00259-7; Heurteaux C, 2004, EMBO J, V23, P2684, DOI 10.1038/sj.emboj.7600234; Hollmann MW, 2001, ANESTH ANALG, V92, P1182; Humphrey JA, 2002, HUM MOL GENET, V11, P1241, DOI 10.1093/hmg/11.10.1241; Jinks SL, 2008, ANESTHESIOLOGY, V108, P1016, DOI 10.1097/ALN.0b013e3181730297; Kayser EB, 1999, ANESTHESIOLOGY, V90, P545, DOI 10.1097/00000542-199902000-00031; Kayser EB, 2001, J BIOL CHEM, V276, P20551, DOI 10.1074/jbc.M011066200; Kilbride SM, 2008, J NEUROCHEM, V106, P826, DOI 10.1111/j.1471-4159.2008.05441.x; Kruse SE, 2008, CELL METAB, V7, P312, DOI 10.1016/j.cmet.2008.02.004; Kubo K, 2009, J PHARMACOL EXP THER, V329, P592, DOI 10.1124/jpet.109.151456; Liao M, 2005, ANESTH ANALG, V101, P412, DOI 10.1213/01.ANE.0000154196.86587.35; Liu HT, 2001, ANESTH ANALG, V92, P1173; MORGAN PG, 1994, ANESTHESIOLOGY, V81, P888, DOI 10.1097/00000542-199410000-00016; Morgan PG, 2002, ANESTHESIOLOGY, V96, P1268, DOI 10.1097/00000542-200205000-00036; MORGAN PG, 1990, P NATL ACAD SCI USA, V87, P2965, DOI 10.1073/pnas.87.8.2965; Petrenko AB, 2004, ANESTH ANALG, V99, P1136, DOI 10.1213/01.ANE.0000131729.54986.30; Quintana A, 2012, J CLIN INVE IN PRESS; Quintana A, 2012, J CLIN INVEST, V122, P2359, DOI 10.1172/JCI62923; Quintana A, 2010, P NATL ACAD SCI USA, V107, P10996, DOI 10.1073/pnas.1006214107; Scholvinck ML, 2008, NEUROIMAGE, V40, P1460, DOI 10.1016/j.neuroimage.2008.01.032; Singaram VK, 2011, CURR BIOL, V21, P2070, DOI 10.1016/j.cub.2011.10.042; Sonner JM, 2007, ANESTHESIOLOGY, V106, P107, DOI 10.1097/00000542-200701000-00019; Sonner JM, 1999, ANESTH ANALG, V89, P1030, DOI 10.1097/00000539-199910000-00039; Sonner JM, 2000, ANESTH ANALG, V91, P720, DOI 10.1213/00000539-200009000-00042; Suthammarak W, 2010, J BIOL CHEM, V285, P40724, DOI 10.1074/jbc.M110.159608; Suthammarak W, 2009, J BIOL CHEM, V284, P6425, DOI 10.1074/jbc.M805733200; WALKER JE, 1992, Q REV BIOPHYS, V25, P253, DOI 10.1017/S003358350000425X; WAUD DR, 1972, J PHARMACOL EXP THER, V183, P577; Werner DF, 2011, J PHARMACOL EXP THER, V336, P134, DOI 10.1124/jpet.110.170431; Xi J, 2004, J BIOL CHEM, V279, P19628, DOI 10.1074/jbc.M313864200; Zhang Y, 2004, ANESTH ANALG, V99, P85, DOI 10.1213/01.ANE.0000118108.64886.42	45	49	49	1	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 17	2012	7	8							e42904	10.1371/journal.pone.0042904	http://dx.doi.org/10.1371/journal.pone.0042904			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	996DG	22912761	Green Submitted, Green Published, gold			2022-12-25	WOS:000308063700029
J	Varamini, P; Mansfeld, FM; Blanchfield, JT; Wyse, BD; Smith, MT; Toth, I				Varamini, Pegah; Mansfeld, Friederike M.; Blanchfield, Joanne T.; Wyse, Bruce D.; Smith, Maree T.; Toth, Istvan			Lipo-Endomorphin-1 Derivatives with Systemic Activity against Neuropathic Pain without Producing Constipation	PLOS ONE			English	Article							BLOOD-BRAIN-BARRIER; OPIOID-PEPTIDES; CROSS-TOLERANCE; IN-VIVO; ENDOMORPHIN-1; MORPHINE; TRANSPORT; ANALOGS; POTENT; ANTINOCICEPTION	To enhance the drug-like properties of the endogenous opioid peptide endomorphin-1 (1 = Tyr-Pro-Trp-Phe-NH2), the N-terminus of the peptide was modified with 2-aminodecanoic acid, resulting in compound 3. Tyr in compound 1 was replaced with 2,6-dimethyltyrosine yielding compound 2. Derivative 2 was also substituted with 2-aminodecanoic acid producing compound, 4. Lipoamino acid-modified derivatives showed improved metabolic stability and membrane permeability while maintaining high m-opioid (MOP) receptor binding affinity and acting as a potent agonist. In vivo studies showed dose-dependent antinociceptive activity following intravenous (i.v.) administration of compounds 3 and 4 in a chronic constriction injury (CCI)-rat model of neuropathic pain with ED50 values of 1.22 (+/-0.93) and 0.99 (+/-0.89) mu mol/kg, respectively. Pre-treatment of animals with naloxone hydrochloride significantly attenuated the anti-neuropathic effects of compound 3, confirming the key role of opioid receptors in mediating antinociception. In contrast to morphine, no significant constipation was produced following i. v. administration of compound 3 at 16 mmol/kg. Furthermore, following chronic administration of equi-potent doses of compound 3 and morphine to rats, there was less antinociceptive tolerance for compound 3 compared with morphine.	[Varamini, Pegah; Mansfeld, Friederike M.; Blanchfield, Joanne T.; Toth, Istvan] Univ Queensland, Sch Chem & Mol Biosci, Brisbane, Qld, Australia; [Wyse, Bruce D.; Smith, Maree T.] Univ Queensland, Ctr Integrated Preclin Drug Dev, Brisbane, Qld, Australia; [Wyse, Bruce D.; Smith, Maree T.; Toth, Istvan] Univ Queensland, Sch Pharm, Brisbane, Qld, Australia	University of Queensland; University of Queensland; University of Queensland	Varamini, P (corresponding author), Univ Queensland, Sch Chem & Mol Biosci, Brisbane, Qld, Australia.	i.toth@uq.edu.au	Varamini, Pegah/N-6917-2015; Smith, Maree T/I-4005-2015; Blanchfield, Joanne T/C-1725-2014; Varamini, Pegah/ABB-2824-2020; Toth, Istvan/C-1965-2013	Varamini, Pegah/0000-0001-8658-9722; Smith, Maree T/0000-0003-2281-3734; Blanchfield, Joanne T/0000-0003-1338-7446; Varamini, Pegah/0000-0001-8658-9722; Toth, Istvan/0000-0002-4572-397X	International Postgraduate Research Scholarship (IPRS) at The University of Queensland; Queensland Government Smart State Research Facilities Fund; National Health and Medical Research Council [569855]	International Postgraduate Research Scholarship (IPRS) at The University of Queensland; Queensland Government Smart State Research Facilities Fund; National Health and Medical Research Council(National Health and Medical Research Council (NHMRC) of Australia)	PV was supported by an International Postgraduate Research Scholarship (IPRS) at The University of Queensland (www.uq.edu.au). This work was supported by infrastructure purchased with funds from the Queensland Government Smart State Research Facilities Fund (http://www.science.qld.gov.au), and by research funds from the National Health and Medical Research Council Development grant 569855 (http://www.nhmrc.gov.au). The funders had no role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alewood P, 1997, METHOD ENZYMOL, V289, P14; Allt G, 2000, BRAIN RES BULL, V52, P1, DOI 10.1016/S0361-9230(00)00230-6; BANKS WA, 1992, PEPTIDES, V13, P1289, DOI 10.1016/0196-9781(92)90037-4; BANKS WA, 1985, BRAIN RES BULL, V15, P287, DOI 10.1016/0361-9230(85)90153-4; Bennett Gary J, 2003, Curr Protoc Neurosci, VChapter 9, DOI 10.1002/0471142301.ns0914s22; Benyamin R, 2008, PAIN PHYSICIAN, V11, pS105; Blanchfield J, 2004, CURR MED CHEM, V11, P2375, DOI 10.2174/0929867043364621; Csullog E, 2001, PAIN, V94, P31, DOI 10.1016/S0304-3959(01)00338-4; DEY PK, 1976, BRIT J PHARMACOL, V58, P383, DOI 10.1111/j.1476-5381.1976.tb07715.x; Dworkin RH, 2007, PAIN, V132, P237, DOI 10.1016/j.pain.2007.08.033; Egleton RD, 1998, J PHARM SCI-US, V87, P1433, DOI 10.1021/js980062b; Gao YF, 2005, BIOORG MED CHEM LETT, V15, P1847, DOI 10.1016/j.bmcl.2005.02.021; Garberg P, 2005, TOXICOL IN VITRO, V19, P299, DOI 10.1016/j.tiv.2004.06.011; Gentilucci L, 2004, CURR TOP MED CHEM, V4, P19, DOI 10.2174/1568026043451663; Goldberg IE, 1998, J PHARMACOL EXP THER, V286, P1007; Harrison C, 1999, BRIT J PHARMACOL, V128, P472, DOI 10.1038/sj.bjp.0702798; Horvath G, 2000, PHARMACOL THERAPEUT, V88, P437, DOI 10.1016/S0163-7258(00)00100-5; Hung KC, 2002, EUR J PHARMACOL, V448, P169, DOI 10.1016/S0014-2999(02)01984-2; IdanpaanHeikkila JJ, 1997, J PHARMACOL EXP THER, V282, P1366; Jinsmaa Y, 2006, PHARMACOL BIOCHEM BE, V84, P252, DOI 10.1016/j.pbb.2006.05.005; Koda Y, 2008, BIOORGAN MED CHEM, V16, P6286, DOI 10.1016/j.bmc.2008.04.020; Labuz D, 2002, NEUROSCI LETT, V334, P127, DOI 10.1016/S0304-3940(02)01121-7; Gelman PL, 2010, SALUD MENT, V33, P179; Leon S., 2005, APPL BIOPHARMACEUTIC, V5th; Li TY, 2005, J MED CHEM, V48, P586, DOI 10.1021/jm049384k; Lundquist S, 2002, PHARMACEUT RES, V19, P976, DOI 10.1023/A:1016462205267; Nielsen CK, 2007, PAIN, V132, P289, DOI 10.1016/j.pain.2007.03.022; Perlikowska R, 2010, PEPTIDES, V31, P339, DOI 10.1016/j.peptides.2009.12.002; Przewlocki R, 2001, EUR J PHARMACOL, V429, P79, DOI 10.1016/S0014-2999(01)01308-5; RAPOPORT SI, 1980, SCIENCE, V207, P84, DOI 10.1126/science.7350645; Sambuy Y, 2005, CELL BIOL TOXICOL, V21, P1, DOI 10.1007/s10565-005-0085-6; SARIN VK, 1981, ANAL BIOCHEM, V117, P147, DOI 10.1016/0003-2697(81)90704-1; Smetanova Libuse, 2011, Acta Medica (Hradec Kralove), V54, P3; Soignier RD, 2000, LIFE SCI, V67, P907, DOI 10.1016/S0024-3205(00)00689-5; Soignier RD, 2004, NEUROSCI LETT, V366, P211, DOI 10.1016/j.neulet.2004.05.046; Spampinato S, 2003, EUR J PHARMACOL, V469, P89, DOI 10.1016/S0014-2999(03)01736-9; Thiel-Demby VE, 2009, MOL PHARMACEUT, V6, P11, DOI 10.1021/mp800122b; TOTH I, 1991, INT J PHARM, V68, P191, DOI 10.1016/0378-5173(91)90141-A; Treede RD, 2008, NEUROLOGY, V70, P1630, DOI 10.1212/01.wnl.0000282763.29778.59; Tsuji Akira, 2005, NeuroRx, V2, P54, DOI 10.1007/BF03206642; VOJKOVSKY T, 1995, PEPTIDE RES, V8, P236; Zadina JE, 1997, NATURE, V386, P499, DOI 10.1038/386499a0	42	32	32	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 17	2012	7	8							e41909	10.1371/journal.pone.0041909	http://dx.doi.org/10.1371/journal.pone.0041909			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	996DG	22912681	Green Published, Green Submitted, gold			2022-12-25	WOS:000308063700009
J	Hernadi, A; Anna, K; Turcsan, B; Topal, J				Hernadi, Anna; Kis, Anna; Turcsan, Borbala; Topal, Jozsef			Man's Underground Best Friend: Domestic Ferrets, Unlike the Wild Forms, Show Evidence of Dog-Like Social-Cognitive Skills	PLOS ONE			English	Article							HUMAN POINTING GESTURES; CANIS-FAMILIARIS; STRANGE SITUATION; MUSTELA-PUTORIUS; HUMANS; CUES; COMMUNICATION; ATTACHMENT; GAZE; RECOGNITION	Recent research has shown that dogs' possess surprisingly sophisticated human-like social communication skills compared to wolves or chimpanzees. The effects of domestication on the emergence of socio-cognitive skills, however, are still highly debated. One way to investigate this is to compare socialized individuals from closely related domestic and wild species. In the present study we tested domestic ferrets (Mustela furo) and compared their performance to a group of wild Mustela hybrids and to domestic dogs (Canis familiaris). We found that, in contrast to wild Mustela hybrids, both domestic ferrets and dogs tolerated eye-contact for a longer time when facing their owners versus the experimenter and they showed a preference in a two-way choice task towards their owners. Furthermore, domestic ferrets, unlike the wild hybrids, were able to follow human directional gestures (sustained touching; momentary pointing) and could reach the success rate of dogs. Our study provides the first evidence that domestic ferrets, in a certain sense, are more dog-like than their wild counterparts. These findings support the hypothesis that domestic species may share basic socio-cognitive skills that enable them to engage in effectively orchestrated social interactions with humans.	[Hernadi, Anna; Topal, Jozsef] Hungarian Acad Sci, Res Ctr Nat Sci, Inst Cognit Neurosci & Psychol, Budapest, Hungary; [Hernadi, Anna; Kis, Anna; Turcsan, Borbala] Eotvos Lorand Univ, Dept Ethol, Budapest, Hungary; [Kis, Anna] HAS ELTE Comparat Ethol Res Grp, Budapest, Hungary	Hungarian Academy of Sciences; Hungarian Research Centre for Natural Sciences; Eotvos Lorand University; MTA-ELTE Comparative Ethology Research Group	Hernadi, A (corresponding author), Hungarian Acad Sci, Res Ctr Nat Sci, Inst Cognit Neurosci & Psychol, Budapest, Hungary.	kisanna12@gmail.com	Turcsán, Borbála/I-7983-2018	Turcsán, Borbála/0000-0002-0197-5243; Kis, Anna/0000-0001-8728-4795	Hungarian Scientific Research Fund [K 84036, K 100695]; Hungarian Academy of Sciences [MTA 01 031]	Hungarian Scientific Research Fund(Orszagos Tudomanyos Kutatasi Alapprogramok (OTKA)); Hungarian Academy of Sciences(Hungarian Academy of Sciences)	This research was supported by the Hungarian Scientific Research Fund (K 84036, K 100695) and the Hungarian Academy of Sciences (MTA 01 031). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Archer J, 1997, EVOL HUM BEHAV, V18, P237, DOI 10.1016/S0162-3095(99)80001-4; Call J, 2003, J COMP PSYCHOL, V117, P257, DOI 10.1037/0735-7036.117.3.257; Gacsi M, 2005, DEV PSYCHOBIOL, V47, P111, DOI 10.1002/dev.20082; Gacsi M, 2004, ANIM COGN, V7, P144, DOI 10.1007/s10071-003-0205-8; Gacsi M, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006584; Gaunet F, 2010, ANIM COGN, V13, P311, DOI 10.1007/s10071-009-0279-z; Grossmann T, 2008, P ROY SOC B-BIOL SCI, V275, P2803, DOI 10.1098/rspb.2008.0986; Hare B, 2005, TRENDS COGN SCI, V9, P439, DOI 10.1016/j.tics.2005.07.003; Hare B, 2005, CURR BIOL, V15, P226, DOI 10.1016/j.cub.2005.01.040; Hare B, 2002, SCIENCE, V298, P1634, DOI 10.1126/science.1072702; Herman LM, 1999, J COMP PSYCHOL, V113, P347, DOI 10.1037/0735-7036.113.4.347; Ittyerah M, 2009, ANIM COGN, V12, P257, DOI 10.1007/s10071-008-0188-6; Kaminski J, 2005, ANIM BEHAV, V69, P11, DOI 10.1016/j.anbehav.2004.05.008; Kirchhofer KC, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0030913; Kumashiro M, 2002, CAH PSYCHOL COGN, V21, P3; Lode T, 1999, Z SAUGETIERKD, V64, P110; Lode T, 2008, CR BIOL, V331, P248, DOI 10.1016/j.crvi.2007.12.006; Maros K, 2008, ANIM COGN, V11, P457, DOI 10.1007/s10071-008-0136-5; Miklosi A, 2005, J COMP PSYCHOL, V119, P179, DOI 10.1037/0735-7036.119.2.179; Miklosi A, 2004, ANIM BEHAV, V67, P995, DOI 10.1016/j.anbehav.2003.10.008; Miklosi A, 2003, CURR BIOL, V13, P763, DOI 10.1016/S0960-9822(03)00263-X; Miklosi A, 2011, LEARN BEHAV, V39, P310, DOI 10.3758/s13420-011-0038-2; Mulcahy NJ, 2012, ANIM BEHAV, V83, P313, DOI 10.1016/j.anbehav.2011.11.019; Pongracz P, 2005, J COMP PSYCHOL, V119, P136, DOI 10.1037/0735-7036.119.2.136; Prato-Previde E, 2003, BEHAVIOUR, V140, P225, DOI 10.1163/156853903321671514; Price E.O., 2002, ANIMAL DOMESTICATION; Racca A, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0036076; Scheumann M, 2004, ANIM COGN, V7, P224, DOI 10.1007/s10071-004-0216-0; Soproni K, 2002, J COMP PSYCHOL, V116, P27, DOI 10.1037//0735-7036.116.1.27; THOMSON ALEXANDER P. D., 1951, JOUR HIST MED AND ALLIED SCI, V6, P471; Topal J, 2005, ANIM BEHAV, V70, P1367, DOI 10.1016/j.anbehav.2005.03.025; Topal J, 1998, J COMP PSYCHOL, V112, P219, DOI 10.1037/0735-7036.112.3.219; Udell MAR, 2011, LEARN BEHAV, V39, P289, DOI 10.3758/s13420-011-0034-6; Udell MAR, 2010, BIOL REV, V85, P327, DOI 10.1111/j.1469-185X.2009.00104.x; Vinke CM, 2012, APPL ANIM BEHAV SCI, V139, P155, DOI 10.1016/j.applanim.2012.03.016; Viranyi Z, 2004, BEHAV PROCESS, V66, P161, DOI 10.1016/j.beproc.2004.01.012	36	47	47	0	52	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 15	2012	7	8							e43267	10.1371/journal.pone.0043267	http://dx.doi.org/10.1371/journal.pone.0043267			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	993AG	22905244	Green Submitted, Green Published, gold, Green Accepted			2022-12-25	WOS:000307823600063
J	Wiehagen, KR; Corbo-Rodgers, E; Li, SR; Staub, ES; Hunter, CA; Morrisey, EE; Maltzman, JS				Wiehagen, Karla R.; Corbo-Rodgers, Evann; Li, Shanru; Staub, Elizabeth S.; Hunter, Christopher A.; Morrisey, Edward E.; Maltzman, Jonathan S.			Foxp4 Is Dispensable for T Cell Development, but Required for Robust Recall Responses	PLOS ONE			English	Article							ESSENTIAL TRANSCRIPTIONAL REGULATOR; TOXOPLASMA-GONDII; GENE-EXPRESSION; LUNG; INFLAMMATION; INHIBITION; DEPLETION; IMMUNITY; HELP; CD4+	Transcription factors regulate T cell fates at every stage of development and differentiation. Members of the Foxp family of forkhead transcription factors are essential for normal T lineage development; Foxp3 is required for T regulatory cell generation and function, and Foxp1 is necessary for generation and maintenance of naive T cells. Foxp4, an additional member of the Foxp family, is highly homologous to Foxp1 and has been shown to dimerize with other Foxp proteins. We report the initial characterization of Foxp4 in T lymphocytes. Foxp4 is expressed in both thymocytes and peripheral CD4(+) and CD8(+) T cells. We used a CD4Cre mediated approach to evaluate the cell autonomous role for Foxp4 in murine T lymphocytes. T cell development, peripheral cellularity and cell surface phenotype are normal in the absence of Foxp4. Furthermore, Foxp3(+) T regulatory cells develop normally in Foxp4 deficient animals and naive Foxp4 deficient CD4 T cells can differentiate to inducible T regulatory cells in vitro. In wild-type T cells, expression of Foxp4 increases following activation, but deletion of Foxp4 does not affect T cell proliferative responses or in vitro effector T cell differentiation. In vivo, despite effective control of Toxoplasma gondii and acute lymphocytic choriomeningitis virus infections, effector cytokine production during antigen specific recall responses are reduced in the absence of Foxp4. We conclude that Foxp4 is dispensable for T cell development, but necessary for normal T cell cytokine recall responses to antigen following pathogenic infection.	[Wiehagen, Karla R.; Corbo-Rodgers, Evann; Li, Shanru; Staub, Elizabeth S.; Morrisey, Edward E.; Maltzman, Jonathan S.] Univ Penn, Dept Med, Perelman Sch Med, Philadelphia, PA 19104 USA; [Hunter, Christopher A.] Univ Penn, Sch Vet Med, Dept Pathobiol, Philadelphia, PA 19104 USA	University of Pennsylvania; Pennsylvania Medicine; University of Pennsylvania	Wiehagen, KR (corresponding author), Univ Penn, Dept Med, Perelman Sch Med, Philadelphia, PA 19104 USA.	maltz@mail.med.upenn.edu		Maltzman, Jonathan/0000-0001-5722-269X	Barra Foundation; University of Pennsylvania; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL071589] Funding Source: NIH RePORTER	Barra Foundation; University of Pennsylvania; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This research was funded by the Barra Foundation and by institutional funds from the University of Pennsylvania. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ARAUJO FG, 1992, J IMMUNOL, V149, P3003; Bennett SRM, 1998, NATURE, V393, P478, DOI 10.1038/30996; Bettelli E, 2005, P NATL ACAD SCI USA, V102, P5138, DOI 10.1073/pnas.0501675102; Cai GF, 2000, INFECT IMMUN, V68, P6932, DOI 10.1128/IAI.68.12.6932-6938.2000; Carlsson P, 2002, DEV BIOL, V250, P1, DOI 10.1006/dbio.2002.0780; Casciotti L, 2002, INFECT IMMUN, V70, P434, DOI 10.1128/IAI.70.2.434-443.2002; Chokas AL, 2010, J BIOL CHEM, V285, P13304, DOI 10.1074/jbc.M109.088468; Denkers EY, 1999, MICROBES INFECT, V1, P699, DOI 10.1016/S1286-4579(99)80071-9; Du JG, 2008, J IMMUNOL, V180, P4785, DOI 10.4049/jimmunol.180.7.4785; Feng XM, 2011, NAT IMMUNOL, V12, P544, DOI 10.1038/ni.2034; Feng XM, 2010, BLOOD, V115, P510, DOI 10.1182/blood-2009-07-232694; GAZZINELLI R, 1992, J IMMUNOL, V149, P175; Hori S, 2003, SCIENCE, V299, P1057, DOI 10.1126/science.1079490; Hu H, 2006, NAT IMMUNOL, V7, P819, DOI 10.1038/ni1358; Kaufmann E, 1996, MECH DEVELOP, V57, P3, DOI 10.1016/0925-4773(96)00539-4; Lee PP, 2001, IMMUNITY, V15, P763, DOI 10.1016/S1074-7613(01)00227-8; Li B, 2007, INT IMMUNOL, V19, P825, DOI 10.1093/intimm/dxm043; Li B, 2006, IMMUNOL REV, V212, P99, DOI 10.1111/j.0105-2896.2006.00405.x; Li SR, 2012, DEVELOPMENT, V139, P2500, DOI 10.1242/dev.079699; Li SR, 2004, SCIENCE, V305, P1619, DOI 10.1126/science.1098674; Li SR, 2004, MOL CELL BIOL, V24, P809, DOI 10.1128/MCB.24.2.809-822.2004; Liu PT, 2003, GENOME RES, V13, P476, DOI 10.1101/gr.749203; MATLOUBIAN M, 1994, J VIROL, V68, P8056, DOI 10.1128/JVI.68.12.8056-8063.1994; Ono M, 2007, NATURE, V446, P685, DOI 10.1038/nature05673; Prilliman KR, 2002, J IMMUNOL, V169, P4094, DOI 10.4049/jimmunol.169.8.4094; Rudensky AY, 2011, IMMUNOL REV, V241, P260, DOI 10.1111/j.1600-065X.2011.01018.x; Sakaguchi S, 2006, IMMUNOL REV, V212, P8, DOI 10.1111/j.0105-2896.2006.00427.x; SANDER B, 1993, J IMMUNOL METHODS, V166, P201, DOI 10.1016/0022-1759(93)90361-A; SHARMA SD, 1983, J IMMUNOL, V131, P977; Shu WG, 2001, J BIOL CHEM, V276, P27488, DOI 10.1074/jbc.M100636200; Stumhofer JS, 2006, NAT IMMUNOL, V7, P937, DOI 10.1038/ni1376; Teufel A, 2003, BBA-GENE STRUCT EXPR, V1627, P147, DOI 10.1016/S0167-4781(03)00074-5; Wilson EH, 2005, J NEUROIMMUNOL, V165, P63, DOI 10.1016/j.jneuroim.2005.04.018; Wu YQ, 2006, CELL, V126, P375, DOI 10.1016/j.cell.2006.05.042; Yap GS, 1999, IMMUNOBIOLOGY, V201, P240, DOI 10.1016/S0171-2985(99)80064-3	35	22	23	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 13	2012	7	8							e42273	10.1371/journal.pone.0042273	http://dx.doi.org/10.1371/journal.pone.0042273			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	988OJ	22912696	Green Published, gold, Green Submitted			2022-12-25	WOS:000307500100010
J	Zhang, P; Liu, W; Zhu, CS; Yuan, XY; Li, DG; Gu, WJ; Ma, HM; Xie, X; Gao, TW				Zhang, Ping; Liu, Wei; Zhu, Cansheng; Yuan, Xiaoying; Li, Dongguang; Gu, Weijie; Ma, Huimin; Xie, Xin; Gao, Tianwen			Silencing of GPNMB by siRNA Inhibits the Formation of Melanosomes in Melanocytes in a MITF-Independent Fashion	PLOS ONE			English	Article							TRANSCRIPTION FACTOR MITF; MELANOMA PROTEIN-B; BETA-CATENIN; EXPRESSION; TYROSINASE; GLYCOPROTEIN; GENE; DIFFERENTIATION; IDENTIFICATION; OSTEOACTIVIN	Background: Melanosomes are specialized membrane-surrounded organelles, which are involved in the synthesis, storage and transport of melanin. Glycoprotein (transmembrane) non-metastatic melanoma protein b (GPNMB), a melanosome-specific structural protein, shares significant amino acid sequence homology with Pmel-17. Proteomic analysis demonstrated that GPNMB is present in all stages (I-IV) of melanosomes. However, little is known about the role of GPNMB in melanosomes. Methodology/Principal Findings: Using real-time quantitative PCR, Western blotting and immunofluorescence analysis, we demonstrated that the expression of GPNMB in PIG1 melanocytes was up-regulated by ultraviolet B (UVB) radiation. Transmission electron microscopy analysis showed that the total number of melanosomes in PIG1 melanocytes was sharply reduced by GPNMB-siRNA transfection. Simultaneously, the expression levels of tyrosinase (Tyr), tyrosinase related protein 1 (Trp1), Pmel17/gp100 and ocular albinism type 1 protein (OA1) were all significantly attenuated. But the expression of microphthalmia-associated transcription factor (MITF) was up-regulated. Intriguingly, in GPNMB silenced PIG1 melanocytes, UVB radiation sharply reduced MITF expression. Conclusion: Our present work revealed that the GPNMB was critical for the formation of melanosomes. And GPNMB expression down-regulation attenuated melanosome formation in a MITF-independent fashion.	[Zhang, Ping; Liu, Wei; Yuan, Xiaoying; Li, Dongguang; Gu, Weijie; Ma, Huimin] Gen Hosp AF, Dept Dermatol, Beijing, Peoples R China; [Zhang, Ping; Liu, Wei; Gao, Tianwen] Fourth Mil Med Univ, Xijing Hosp, Dept Dermatol, Xian 710032, Peoples R China; [Zhu, Cansheng] Shaanxi Prov Inst Endem Dis Control, Xian, Peoples R China; [Xie, Xin] Northwest Univ, Fac Life Sci, Reg Lab Tissue Engn, Xian, Peoples R China	Air Force Military Medical University; Northwest University Xi'an	Zhang, P (corresponding author), Gen Hosp AF, Dept Dermatol, Beijing, Peoples R China.	liuweilove5@gmail.com						Abdelmagid SM, 2008, EXP CELL RES, V314, P2334, DOI 10.1016/j.yexcr.2008.02.006; An SM, 2009, BMB REP, V42, P178, DOI 10.5483/BMBRep.2009.42.3.178; Anderson MG, 2002, NAT GENET, V30, P81, DOI 10.1038/ng794; Anghel SI, 2012, PIGMENT CELL MELANOM; Bachner Dietmar, 2002, Brain Res Gene Expr Patterns, V1, P159; Basrur V, 2003, J PROTEOME RES, V2, P69, DOI 10.1021/pr025562r; Berson JF, 2001, MOL BIOL CELL, V12, P3451, DOI 10.1091/mbc.12.11.3451; Chi A, 2006, J PROTEOME RES, V5, P3135, DOI 10.1021/pr060363j; Goodall J, 2008, CANCER RES, V68, P7788, DOI 10.1158/0008-5472.CAN-08-1053; Grabacka M, 2008, PIGM CELL MELANOMA R, V21, P388, DOI 10.1111/j.1755-148X.2008.00460.x; Haraszti T, 2011, PIGM CELL MELANOMA R, V24, P187, DOI 10.1111/j.1755-148X.2010.00788.x; Hoashi T, 2005, J BIOL CHEM, V280, P14006, DOI 10.1074/jbc.M413692200; Hoashi T, 2010, FASEB J, V24, P1616, DOI 10.1096/fj.09-151019; Hoashi T, 2010, FASEB J, V24, P916, DOI 10.1096/fj.09-140921; Hoek KS, 2008, PIGM CELL MELANOMA R, V21, P665, DOI 10.1111/j.1755-148X.2008.00505.x; Jacquemin P, 2001, BIOCHEM BIOPH RES CO, V285, P1200, DOI 10.1006/bbrc.2001.5294; Kim HJ, 2008, J COSMET SCI, V59, P117; Kuan CT, 2006, CLIN CANCER RES, V12, P1970, DOI 10.1158/1078-0432.CCR-05-2797; LePoole IC, 1997, IN VITRO CELL DEV-AN, V33, P42, DOI 10.1007/s11626-997-0021-6; Liu YQ, 2009, INVEST OPHTH VIS SCI, V50, P5080, DOI 10.1167/iovs.08-2911; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Loftus SK, 2009, PIGM CELL MELANOMA R, V22, P99, DOI 10.1111/j.1755-148X.2008.00518.x; Magina S, 2011, ARCH DERMATOL RES, V303, P201, DOI 10.1007/s00403-011-1126-z; Mizutani Y, 2010, ARCH DERMATOL RES, V302, P283, DOI 10.1007/s00403-009-1007-x; Nishioka E, 1999, MELANOMA RES, V9, P433, DOI 10.1097/00008390-199910000-00002; Okazawa M, 1998, J BIOL CHEM, V273, P12584, DOI 10.1074/jbc.273.20.12584; Olivares C, 2009, PIGM CELL MELANOMA R, V22, P750, DOI 10.1111/j.1755-148X.2009.00636.x; Owen TA, 2003, CRIT REV EUKAR GENE, V13, P205; Pierrat MJ, 2012, J BIOL CHEM, V287, P17996, DOI 10.1074/jbc.M112.358341; Ripoll VM, 2008, GENE, V413, P32, DOI 10.1016/j.gene.2008.01.014; Rose AAN, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012093; Ruoslahti E, 1996, ANNU REV CELL DEV BI, V12, P697, DOI 10.1146/annurev.cellbio.12.1.697; Saito H, 2003, PIGM CELL RES, V16, P261, DOI 10.1034/j.1600-0749.2003.00039.x; Sato S, 1997, ONCOGENE, V14, P3083, DOI 10.1038/sj.onc.1201298; Schepsky A, 2006, MOL CELL BIOL, V26, P8914, DOI 10.1128/MCB.02299-05; Sheng MHC, 2008, FEBS LETT, V582, P1451, DOI 10.1016/j.febslet.2008.03.030; Tadokoro T, 2005, J INVEST DERMATOL, V124, P1326, DOI 10.1111/j.0022-202X.2005.23760.x; Tomihari M, 2009, EXP DERMATOL, V18, P586, DOI 10.1111/j.1600-0625.2008.00830.x; Vachtenheim J, 2010, EXP DERMATOL, V19, P617, DOI 10.1111/j.1600-0625.2009.01053.x; Watabe H, 2004, J BIOL CHEM, V279, P7971, DOI 10.1074/jbc.M309714200; WETERMAN MAJ, 1995, INT J CANCER, V60, P73, DOI 10.1002/ijc.2910600111	41	33	42	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 13	2012	7	8							e42955	10.1371/journal.pone.0042955	http://dx.doi.org/10.1371/journal.pone.0042955			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	988OJ	22912767	gold, Green Submitted, Green Published			2022-12-25	WOS:000307500100046
J	Jansson, J; Wilson, DP				Jansson, James; Wilson, David P.			Projected Demographic Profile of People Living with HIV in Australia: Planning for an Older Generation	PLOS ONE			English	Article							IMMUNODEFICIENCY-VIRUS-INFECTION; MORTALITY; EPIDEMIC; DISEASE; RISK; HIV/AIDS; AIDS	Background: Advances in HIV antiretroviral therapy (ART) has reduced mortality in people living with HIV (PLHIV), resulting in an ageing population of PLHIV. Knowledge of demographic details such as age, geographical location and sex, will aid in the planning of training and resource allocation to effectively care for the future complex health needs of PLHIV. Methods: An agent-based, stochastic, geographical model was developed to determine the current and future demographic of PLHIV in Australia. Data and parameters were sourced from Australia's National HIV Registry and peer reviewed literature. Processes that were simulated include progression to AIDS, mortality and internal migration. Findings: The model estimates the mean age of PLHIV in Australia is increasing at a rate of 0.49 years each year. The expected proportion of PLHIV in over 55 years is estimated to increase from 25.3% in 2010 to 44.2% in 2020. Median age is lower in inner-city areas of the capital cities than in rural areas. The areas with the highest prevalence of HIV will continue to be capital cities; however, other areas will have greater percentage growth from 2010 to 2020. Conclusions: The age of the population of people living with HIV is expected to increase considerably in the future. As the population of PLHIV ages, specialist clinical training and resource provision in the aged care sector will also need to be addressed.	[Jansson, James; Wilson, David P.] Univ New S Wales, Kirby Inst, Sydney, NSW, Australia	University of New South Wales Sydney; Kirby Institute	Jansson, J (corresponding author), Univ New S Wales, Kirby Inst, Sydney, NSW, Australia.	dwilson@kirby.unsw.edu.au	Wilson, David P/G-4614-2013		National Association of People Living with HIV/AIDS; Australian Research Council [FT0991990, DP1093026]; Australian Government Department of Health and Ageing; University of New South Wales	National Association of People Living with HIV/AIDS; Australian Research Council(Australian Research Council); Australian Government Department of Health and Ageing(Australian GovernmentDepartment of Health & Ageing); University of New South Wales	This study was funded from the following sources: National Association of People Living with HIV/AIDS; Australian Research Council (FT0991990, DP1093026); the Australian Government Department of Health and Ageing; and the University of New South Wales. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Australian Bureau of Statistics (ABS), 2006, STAT GEOGR; Australian Institute of Health Welfare (AIHW), 2010, GRIM GEN REC INC MOR; Bica I, 2001, CLIN INFECT DIS, V32, P492, DOI 10.1086/318501; Biggar RJ, 2004, JAIDS-J ACQ IMM DEF, V36, P861, DOI 10.1097/00126334-200407010-00014; Cole JW, 2004, STROKE, V35, P51, DOI 10.1161/01.STR.0000105393.57853.11; Friis-Moller N, 2003, AIDS, V17, P1179, DOI 10.1097/00002030-200305230-00010; Grierson J, 2009, MONOGRAPH SERIES LAT, V74; Hallett TB, 2011, SEXUALLY TRANSMITTED; Hallett TB, 2009, EPIDEMICS-NETH, V1, P108, DOI 10.1016/j.epidem.2009.03.001; Hammer SM, 2006, JAMA-J AM MED ASSOC, V296, P827, DOI 10.1001/jama.296.7.827; Hull P, 2011, GAY COMMUNITY PERIOD; Justice Amy C, 2010, Curr HIV/AIDS Rep, V7, P69, DOI 10.1007/s11904-010-0041-9; Mallitt K-A, 2011, HIV INCIDENCE TRENDS; Mellors JW, 1997, ANN INTERN MED, V126, P946, DOI 10.7326/0003-4819-126-12-199706150-00003; Mills EJ, 2011, LANCET, V377, P1131, DOI 10.1016/S0140-6736(10)62180-0; Murray JM, 2009, SEX HEALTH, V6, P83, DOI 10.1071/SH08063; Nakhaee F, 2009, SEX HEALTH, V6, P129, DOI 10.1071/SH08007; National Centre in HIV Epidemiology and Clinical Research, 2010, HIV VIR HEP SEX TRAN; Negin J, 2011, LANCET, V378, P768, DOI 10.1016/S0140-6736(11)61373-1; Negin J, 2010, B WORLD HEALTH ORGAN, V88, P847, DOI 10.2471/BLT.10.076349; Palella FJ, 1998, NEW ENGL J MED, V338, P853, DOI 10.1056/NEJM199803263381301; STEWART RB, 1994, DRUG AGING, V4, P449, DOI 10.2165/00002512-199404060-00002; Teweldemedhin E, 2004, AGENT BASED MODELLIN, P154; Wyatt CM, 2007, AIDS, V21, P2101, DOI 10.1097/QAD.0b013e3282ef1bb4	24	29	29	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 9	2012	7	8							e38334	10.1371/journal.pone.0038334	http://dx.doi.org/10.1371/journal.pone.0038334			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	986WZ	22912660	Green Published, Green Submitted, gold			2022-12-25	WOS:000307378500001
J	Koike, MA; Lin, AJ; Pham, J; Nguyen, E; Yeh, JJ; Rahimian, R; Tromberg, BJ; Choi, B; Green, KN; LaFerla, FM				Koike, Maya A.; Lin, Alexander J.; Pham, Jonathan; Elaine Nguyen; Yeh, James J.; Rahimian, Rombod; Tromberg, Bruce J.; Choi, Bernard; Green, Kim N.; LaFerla, Frank M.			APP Knockout Mice Experience Acute Mortality as the Result of Ischemia	PLOS ONE			English	Article							AMYLOID PRECURSOR PROTEIN; GLOBAL CEREBRAL-ISCHEMIA; ALZHEIMERS-DISEASE; FAMILY-MEMBERS; BETA PEPTIDES; MODELS; BRAIN; TERRITORY; LACKING; ROLES	The incidence of Alzheimer's disease increases in people who have had an ischemic episode. Furthermore, APP expression is increased following ischemic or hypoxic conditions, as is the production of the A beta peptide. To address the question of why APP and A beta are increased in hypoxic and ischemic conditions we induced an ischemic episode in APP knockout mice (APP-/-) and BACE1 knockout mice (BACE-/-). We find that both APP-/- and BACE-/- mice have a dramatically increased risk of mortality as a result of cerebral ischemia. Furthermore, APP knockout mice have reduced cerebral blood flow in response to hypoxia, while wild-type mice maintain or increase cerebral blood flow to the same conditions. The transcription factor, serum response factor (SRF), and calcium-binding molecule, calsequestrin, both involved in vascular regulation, are significantly altered in the brains of APP-/- mice compared to wild type controls. These results show that APP regulates cerebral blood flow in response to hypoxia, and that it, and its cleavage fragments, are crucial for rapid adaptation to ischemic conditions.	[Koike, Maya A.; Lin, Alexander J.; Green, Kim N.; LaFerla, Frank M.] Univ Calif Irvine, Inst Memory Impairments & Neurol Disorders, Irvine, CA 92717 USA; [Lin, Alexander J.; Pham, Jonathan; Elaine Nguyen; Yeh, James J.; Rahimian, Rombod; Tromberg, Bruce J.; Choi, Bernard] Univ Calif Irvine, Beckman Laser Inst & Med Clin, Laser Microbeam & Med Program, Irvine, CA 92715 USA; [Lin, Alexander J.; Pham, Jonathan; Tromberg, Bruce J.; Choi, Bernard] Univ Calif Irvine, Dept Biomed Engn, Irvine, CA USA; [Choi, Bernard] Univ Calif Irvine, Edwards Lifesci Ctr Adv Cardiovasc Tech, Irvine, CA USA	University of California System; University of California Irvine; University of California System; University of California Irvine; University of California System; University of California Irvine; University of California System; University of California Irvine	Koike, MA (corresponding author), Univ Calif Irvine, Inst Memory Impairments & Neurol Disorders, Irvine, CA 92717 USA.	kngreen@uci.edu; laferla@uci.edu		Choi, Bernard/0000-0002-4380-8291	National Institutes of Health (NIH) [1F31NS063650-01A1, 1F30AG039949-01A1, K99AR054695]; LAMMP [P41-RR01192]; NIH/NIA [AG-021982]; Arnold and Mabel Beckman Foundation; NATIONAL CANCER INSTITUTE [P30CA062203] Funding Source: NIH RePORTER; NATIONAL CENTER FOR RESEARCH RESOURCES [P41RR001192] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [K99AR054695] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [F31NS063650] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [F30AG039949, R01AG021982] Funding Source: NIH RePORTER	National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); LAMMP; NIH/NIA(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); Arnold and Mabel Beckman Foundation; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	This work was supported in part by grants from the National Institutes of Health (NIH) 1F31NS063650-01A1 to MAK, 1F30AG039949-01A1 to AJL, K99AR054695 to MAK, LAMMP P41-RR01192 to BJT, NIH/NIA AG-021982 to FML and the Arnold and Mabel Beckman Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Baranova O, 2007, J NEUROSCI, V27, P6320, DOI 10.1523/JNEUROSCI.0449-07.2007; Boas DA, 2010, J BIOMED OPT, V15, DOI 10.1117/1.3285504; Chang J, 2003, CIRCULATION, V108, P407, DOI 10.1161/01.CIR.0000084502.02147.83; Chow N, 2007, P NATL ACAD SCI USA, V104, P823, DOI 10.1073/pnas.0608251104; Cuccia DJ, 2009, J BIOMED OPT, V14, DOI 10.1117/1.3088140; Fujii M, 1997, STROKE, V28, P1805, DOI 10.1161/01.STR.28.9.1805; GINSBERG MD, 1989, STROKE, V20, P1627, DOI 10.1161/01.STR.20.12.1627; Green KN, 2001, J NEUROCHEM, V77, P953, DOI 10.1046/j.1471-4159.2001.00338.x; HARDY JA, 1992, SCIENCE, V256, P184, DOI 10.1126/science.1566067; Heber S, 2000, J NEUROSCI, V20, P7951; Herms J, 2004, EMBO J, V23, P4106, DOI 10.1038/sj.emboj.7600390; Hitt BD, 2010, BACE1 MICE EXHIBIT S, P1; Hossmann KA, 1998, CARDIOVASC RES, V39, P106, DOI 10.1016/S0008-6363(98)00075-3; Howells DW, 2010, J CEREBR BLOOD F MET, V30, P1412, DOI 10.1038/jcbfm.2010.66; Hu XY, 2010, J NEUROSCI, V30, P8819, DOI 10.1523/JNEUROSCI.1334-10.2010; Jacobsen KT, 2009, CELL MOL LIFE SCI, V66, P2299, DOI 10.1007/s00018-009-0020-8; KAWAI K, 1992, J CEREBR BLOOD F MET, V12, P238, DOI 10.1038/jcbfm.1992.34; Koike MA, 2011, NEUROSCI LETT, V495, P55, DOI 10.1016/j.neulet.2011.03.034; KOIKE MA, 2010, AM J PATHOL; Mattson MP, 1997, PHYSIOL REV, V77, P1081, DOI 10.1152/physrev.1997.77.4.1081; Mazhar A, 2010, J BIOMED OPT, V15, DOI 10.1117/1.3523373; McColl BW, 2004, BRAIN RES, V997, P15, DOI 10.1016/j.brainres.2003.10.028; OLSEN TS, 1985, STROKE, V16, P459, DOI 10.1161/01.STR.16.3.459; Panahian N, 2001, CURR PROTOC TOXICOL; Pearson HA, 2006, J PHYSIOL-LONDON, V575, P5, DOI 10.1113/jphysiol.2006.111203; Ramirez-San-Juan JC, 2008, OPT EXPRESS, V16, P3197, DOI 10.1364/OE.16.003197; Roberds SL, 2001, HUM MOL GENET, V10, P1317, DOI 10.1093/hmg/10.12.1317; Schmued LC, 1997, BRAIN RES, V751, P37, DOI 10.1016/S0006-8993(96)01387-X; Takagi K, 2003, J NEUROSURG, V98, P50, DOI 10.3171/jns.2003.98.1.0050; TERRY RD, 1991, ANN NEUROL, V30, P572, DOI 10.1002/ana.410300410; Turner PR, 2003, PROG NEUROBIOL, V70, P1, DOI 10.1016/S0301-0082(03)00089-3; Von Koch CS, 1997, NEUROBIOL AGING, V18, P661, DOI 10.1016/S0197-4580(97)00151-6; Webster CM, 2009, NEUROBIOL DIS, V33, P301, DOI 10.1016/j.nbd.2008.11.001; Zetterberg H, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0028263; ZHENG H, 1995, CELL, V81, P525, DOI 10.1016/0092-8674(95)90073-X	35	31	33	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 9	2012	7	8							e42665	10.1371/journal.pone.0042665	http://dx.doi.org/10.1371/journal.pone.0042665			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	986WZ	22912719	Green Published, gold			2022-12-25	WOS:000307378500023
J	Liu, RJ; Wang, DY; Shi, Q; Fu, Q; Hizon, S; Xiang, YK				Liu, Ruijie; Wang, Dayong; Shi, Qian; Fu, Qin; Hizon, Steven; Xiang, Yang K.			Palmitoylation Regulates Intracellular Trafficking of beta(2) Adrenergic Receptor/Arrestin/Phosphodiesterase 4D Complexes in Cardiomyocytes	PLOS ONE			English	Article							HUMAN BETA-2-ADRENERGIC RECEPTOR; PROTEIN-COUPLED RECEPTORS; PDZ-BINDING MOTIF; BETA(2)-ADRENERGIC RECEPTOR; CARDIAC MYOCYTES; KINASE-A; PHOSPHORYLATION; DESENSITIZATION; INTERNALIZATION; DEGRADATION	beta(2) adrenergic receptor (beta(2)AR) is a prototypical G-protein coupled receptor that stimulates the classic cAMP-protein kinase A (PKA) signaling pathway. Recent studies indicate that the cAMP-PKA activities are spatiotemporally regulated in part due to dynamic association of beta(2)AR with phosphodiesterase 4D (PDE4D), a group of cAMP degradation enzymes. Here, we demonstrate that in cardiomyocytes, palmitoylation of beta(2)AR, the covalent acylation of cysteine residue 341, plays a critical role in shaping subcellular cAMP-PKA activities in cardiomyocytes via regulating beta(2)AR association with arrestin/PDE4D. Replacing cysteine 341 on beta(2)AR with alanine (C341A) leads to an impaired binding to beta arrestin 2. Surprisingly, the C341A mutant is able to internalize via an arrestin-independent pathway at saturated concentration of agonist stimulation; the internalization becomes caveolae-dependent and requires dynamin GTPase. However, the impaired binding to beta arrestin 2 also leads to an impaired recruitment of PDE4D to the C341A mutant. Thus, the mutant C341A beta(2)AR is transported alone from the plasma membrane to the endosome without recruiting PDE4D. This alteration leads to an enhanced cytoplasmic cAMP signal for PKA activation under beta(2)AR stimulation. Functionally, Mutation of the C341 residue or inhibition of palmitoylation modification of beta(2)AR enhances the receptor-induced PKA activities in the cytoplasm and increases in myocyte contraction rate. Our data reveal a novel function of palmitoylation in shaping subcellular cAMP-PKA signaling in cardiomyocytes via modulating the recruitment of b arrestin 2-PDE4D complexes to the agonist-stimulated beta(2)AR.	[Liu, Ruijie; Wang, Dayong; Shi, Qian; Fu, Qin; Hizon, Steven; Xiang, Yang K.] Univ Illinois, Dept Mol & Integrat Physiol, Urbana, IL USA; [Xiang, Yang K.] Univ Calif Davis, Dept Pharmacol, Davis, CA 95616 USA	University of Illinois System; University of Illinois Urbana-Champaign; University of California System; University of California Davis	Liu, RJ (corresponding author), Univ Illinois, Dept Mol & Integrat Physiol, Urbana, IL USA.	kevinyx@illinois.edu	; Fu, Qin/O-6960-2014	liu, ruijie/0000-0002-2468-0579; Fu, Qin/0000-0002-7954-7708; Shi, Qian/0000-0003-2634-9553; Wang, Dayong/0000-0002-2086-1663	NIH grant [HL082646]; American Heart Association grant [0635331N]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL082846] Funding Source: NIH RePORTER	NIH grant(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); American Heart Association grant(American Heart Association); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This study was supported by NIH grant HL082646 and American Heart Association grant 0635331N to YKX. The authors thank the members of the Xiang laboratory for critical reading and comments. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	De Arcangelis V, 2010, MOL PHARMACOL, V78, P340, DOI 10.1124/mol.110.064444; De Arcangelis V, 2009, J BIOL CHEM, V284, P33824, DOI 10.1074/jbc.M109.020388; Dessauer CW, 2009, MOL PHARMACOL, V76, P935, DOI 10.1124/mol.109.059345; Dipilato L, 2009, MOLECULAR BIOSYSTEMS; Dong XW, 2003, MOL CELL BIOL, V23, P6574, DOI 10.1128/MCB.23.18.6574-6584.2003; Flier J, 1996, NEW ENGL J MED, V334, P580, DOI 10.1056/NEJM199602293340907; Gonzalo S, 1998, MOL BIOL CELL, V9, P585, DOI 10.1091/mbc.9.3.585; Halls ML, 2010, EMBO J, V29, P2772, DOI 10.1038/emboj.2010.168; Hawtin SR, 2001, J BIOL CHEM, V276, P38139; Hiol A, 2003, J BIOL CHEM, V278, P19301, DOI 10.1074/jbc.M210123200; Kwiatkowska K, 2003, J CELL SCI, V116, P537, DOI 10.1242/jcs.00254; Liu RJ, 2009, J BIOL CHEM, V284, P32279, DOI 10.1074/jbc.M109.021428; Loisel TP, 1996, BIOCHEMISTRY-US, V35, P15923, DOI 10.1021/bi9611321; Malbon CC, 2007, CURR OPIN DRUG DISC, V10, P573; Mialet-Perez J, 2004, J BIOL CHEM, V279, P38603, DOI 10.1074/jbc.M403708200; MOFFETT S, 1993, EMBO J, V12, P349, DOI 10.1002/j.1460-2075.1993.tb05663.x; Moffett S, 1996, J BIOL CHEM, V271, P21490, DOI 10.1074/jbc.271.35.21490; Moffett S, 2001, J NEUROCHEM, V76, P269, DOI 10.1046/j.1471-4159.2001.00005.x; Mongillo M, 2004, CIRC RES, V95, P67, DOI 10.1161/01.RES.0000134629.84732.11; ODOWD BF, 1989, J BIOL CHEM, V264, P7564; Pleger ST, 2007, J CARD FAIL, V13, P401, DOI 10.1016/j.cardfail.2007.01.003; Plested CP, 2001, EXP PHYSIOL, V86, P303, DOI 10.1113/eph8602187; Rapacciuolo A, 2003, J BIOL CHEM, V278, P35403, DOI 10.1074/jbc.M305675200; RESH MD, 2006, SCI STKE, pRE14, DOI DOI 10.1126/STKE.3592006RE14; Richter W, 2005, BIOCHEM J, V388, P803, DOI 10.1042/BJ20050030; Richter W, 2008, EMBO J, V27, P384, DOI 10.1038/sj.emboj.7601968; Shenoy SK, 2008, J BIOL CHEM, V283, P22166, DOI 10.1074/jbc.M709668200; Soto D, 2009, CIRC RES, V104, P770, DOI 10.1161/CIRCRESAHA.108.187880; Swaminath G, 2004, J BIOL CHEM, V279, P686, DOI 10.1074/jbc.M310888200; Vaughan DJ, 2006, J BIOL CHEM, V281, P7684, DOI 10.1074/jbc.M500328200; Wang DY, 2011, J BIOL CHEM, V286, P31852, DOI 10.1074/jbc.M111.244335; Wang Y, 2008, J BIOL CHEM, V283, P1799, DOI 10.1074/jbc.M705747200; Xiang Y, 2005, P NATL ACAD SCI USA, V102, P909, DOI 10.1073/pnas.0405263102; Xiang Y, 2003, P NATL ACAD SCI USA, V100, P10776, DOI 10.1073/pnas.1831718100; Xiang Y, 2003, SCIENCE, V300, P1530, DOI 10.1126/science.1079206; Xiang Y, 2002, J BIOL CHEM, V277, P34280, DOI 10.1074/jbc.M201644200; Xiang Y, 2002, J BIOL CHEM, V277, P33783, DOI 10.1074/jbc.M204136200; Xie L, 2009, SCI SIGNAL, V2, DOI 10.1126/scisignal.2000444; Yudowski GA, 2009, MOL BIOL CELL, V20, P2774, DOI 10.1091/mbc.E08-08-0892; Zhang J, 1996, J BIOL CHEM, V271, P18302, DOI 10.1074/jbc.271.31.18302	40	21	21	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 9	2012	7	8							e42658	10.1371/journal.pone.0042658	http://dx.doi.org/10.1371/journal.pone.0042658			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	986WZ	22912718	Green Submitted, Green Published, gold			2022-12-25	WOS:000307378500022
J	Ray, S; Renu, D; Srivastava, R; Gollapalli, K; Taur, S; Jhaveri, T; Dhali, S; Chennareddy, S; Potla, A; Dikshit, JB; Srikanth, R; Gogtay, N; Thatte, U; Patankar, S; Srivastava, S				Ray, Sandipan; Renu, Durairaj; Srivastava, Rajneesh; Gollapalli, Kishore; Taur, Santosh; Jhaveri, Tulip; Dhali, Snigdha; Chennareddy, Srinivasarao; Potla, Ankit; Dikshit, Jyoti Bajpai; Srikanth, Rapole; Gogtay, Nithya; Thatte, Urmila; Patankar, Swati; Srivastava, Sanjeeva			Proteomic Investigation of Falciparum and Vivax Malaria for Identification of Surrogate Protein Markers	PLOS ONE			English	Article							PARTIAL LEAST-SQUARES; PLASMODIUM-FALCIPARUM; PLASMA PROTEOME; BIOMARKERS; HAPTOGLOBIN; ACTIVATION; DISCOVERY; INDICATOR; COMPONENT	This study was conducted to analyze alterations in the human serum proteome as a consequence of infection by malaria parasites Plasmodium falciparum and P. vivax to obtain mechanistic insights about disease pathogenesis, host immune response, and identification of potential protein markers. Serum samples from patients diagnosed with falciparum malaria (FM) (n = 20), vivax malaria (VM) (n = 17) and healthy controls (HC) (n = 20) were investigated using multiple proteomic techniques and results were validated by employing immunoassay-based approaches. Specificity of the identified malaria related serum markers was evaluated by means of analysis of leptospirosis as a febrile control (FC). Compared to HC, 30 and 31 differentially expressed and statistically significant (p<0.05) serum proteins were identified in FM and VM respectively, and almost half (46.2%) of these proteins were commonly modulated due to both of the plasmodial infections. 13 proteins were found to be differentially expressed in FM compared to VM. Functional pathway analysis involving the identified proteins revealed the modulation of different vital physiological pathways, including acute phase response signaling, chemokine and cytokine signaling, complement cascades and blood coagulation in malaria. A panel of identified proteins consists of six candidates; serum amyloid A, hemopexin, apolipoprotein E, haptoglobin, retinol-binding protein and apolipoprotein A-I was used to build statistical sample class prediction models. By employing PLS-DA and other classification methods the clinical phenotypic classes (FM, VM, FC and HC) were predicted with over 95% prediction accuracy. Individual performance of three classifier proteins; haptoglobin, apolipoprotein A-I and retinol-binding protein in diagnosis of malaria was analyzed using receiver operating characteristic (ROC) curves. The discrimination of FM, VM, FC and HC groups on the basis of differentially expressed serum proteins demonstrates the potential of this analytical approach for the detection of malaria as well as other human diseases.	[Ray, Sandipan; Srivastava, Rajneesh; Gollapalli, Kishore; Patankar, Swati; Srivastava, Sanjeeva] Indian Inst Technol, Wadhwani Res Ctr Biosci & Bioengn, Dept Biosci & Bioengn, Bombay 400076, Maharashtra, India; [Renu, Durairaj; Potla, Ankit; Dikshit, Jyoti Bajpai] Strand Life Sci Pvt Ltd, Bangalore, Karnataka, India; [Taur, Santosh; Jhaveri, Tulip; Gogtay, Nithya; Thatte, Urmila] Seth GS Med Coll, Dept Clin Pharmacol, Bombay, Maharashtra, India; [Taur, Santosh; Jhaveri, Tulip; Gogtay, Nithya; Thatte, Urmila] King Edward Mem Hosp, Bombay, Maharashtra, India; [Dhali, Snigdha; Srikanth, Rapole] Natl Ctr Cell Sci, Prote Lab, Pune, Maharashtra, India; [Chennareddy, Srinivasarao] Wipro GE Healthcare, Bombay, Maharashtra, India	Indian Institute of Technology System (IIT System); Indian Institute of Technology (IIT) - Bombay; Seth Gordhandas Sunderdas Medical College & King Edward Memorial Hospital; Seth Gordhandas Sunderdas Medical College & King Edward Memorial Hospital; Department of Biotechnology (DBT) India; National Centre for Cell Science, Pune (NCCS); General Electric	Ray, S (corresponding author), Indian Inst Technol, Wadhwani Res Ctr Biosci & Bioengn, Dept Biosci & Bioengn, Bombay 400076, Maharashtra, India.	sanjeeva@iitb.ac.in	Taur, Santosh/G-5538-2013; Jhaveri, Tulip/ABF-2963-2020; Srivastava, Rajneesh/F-6288-2012; RAY, SANDIPAN/AAQ-4064-2021	Taur, Santosh/0000-0002-6865-230X; Jhaveri, Tulip/0000-0002-8758-3696; Srivastava, Rajneesh/0000-0003-1093-2082; RAY, SANDIPAN/0000-0002-9960-5768; Gollapalli, Kishore/0000-0002-9546-2472	Board of Research in Nuclear Sciences (BRNS) DAE young scientist award [2009/20/37/4/BRNS]; Indian Institute of Technology (IIT) Bombay [09IRCC007]; IIT Bombay fellowship	Board of Research in Nuclear Sciences (BRNS) DAE young scientist award; Indian Institute of Technology (IIT) Bombay; IIT Bombay fellowship	This research was supported by Board of Research in Nuclear Sciences (BRNS) DAE young scientist award (2009/20/37/4/BRNS) and a start-up grant 09IRCC007 from the Indian Institute of Technology (IIT) Bombay to SS. SR is a senior research fellow (Ph.D student) supported by the IIT Bombay fellowship. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Acharya P, 2009, PROTEOM CLIN APPL, V3, P1314, DOI 10.1002/prca.200900090; Albuquerque LM, 2009, J PROTEOME RES, V8, P5431, DOI 10.1021/pr900236f; Armah HB, 2007, MALARIA J, V6, DOI 10.1186/1475-2875-6-147; Bahk YY, 2010, KOREAN J PARASITOL, V48, P203, DOI 10.3347/kjp.2010.48.3.203; Barker M, 2003, J CHEMOMETR, V17, P166, DOI 10.1002/cem.785; Bell D, 2006, NAT REV MICROBIOL, pS34, DOI [10.1038/nrmico1524, 10.1038/nrmicro1524]; Benjamini Y, 2000, J EDUC BEHAV STAT, V25, P60, DOI 10.2307/1165312; Boulesteix AL, 2007, BRIEF BIOINFORM, V8, P32, DOI 10.1093/bib/bb1016; Burges CJC, 1998, DATA MIN KNOWL DISC, V2, P121, DOI 10.1023/A:1009715923555; Chen JH, 2004, P NATL ACAD SCI USA, V101, P17039, DOI 10.1073/pnas.0407992101; Chen YY, 2005, ELECTROPHORESIS, V26, P2117, DOI 10.1002/elps.200410381; Crompton PD, 2010, P NATL ACAD SCI USA, V107, P6958, DOI 10.1073/pnas.1001323107; Delanghe JR, 2001, CLIN CHIM ACTA, V312, P13, DOI 10.1016/S0009-8981(01)00586-1; Fontaine A, 2012, PARASITOL RES, V110, P545, DOI 10.1007/s00436-011-2521-2; Francischetti IMB, 2008, TRENDS PARASITOL, V24, P258, DOI 10.1016/j.pt.2008.03.009; Gollapalli K, 2012, PROTEOMICS, V12, P2378, DOI 10.1002/pmic.201200002; Harrison T, 2003, SCIENCE, V301, P1734, DOI 10.1126/science.1089324; Huang DW, 2009, NAT PROTOC, V4, P44, DOI 10.1038/nprot.2008.211; Huang DW, 2009, NUCLEIC ACIDS RES, V37, P1, DOI 10.1093/nar/gkn923; Kappelle PJWH, 2011, ARCH MED RES, V42, P219, DOI 10.1016/j.arcmed.2011.05.002; Kassa FA, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0026495; Mishra SK, 2009, NAT REV NEUROL, V5, P189, DOI 10.1038/nrneurol.2009.23; Mockenhaupt FP, 2000, TROP MED INT HEALTH, V5, P167, DOI 10.1046/j.1365-3156.2000.00532.x; Olszewski KL, 2009, CELL HOST MICROBE, V5, P191, DOI 10.1016/j.chom.2009.01.004; Omenn GS, 2004, DIS MARKERS, V20, P131, DOI 10.1155/2004/579363; Pabon A, 2003, CLIN BIOCHEM, V36, P71, DOI 10.1016/S0009-9120(02)00423-X; PAYNE D, 1988, B WORLD HEALTH ORGAN, V66, P621; Perez-Enciso M, 2003, HUM GENET, V112, P581, DOI 10.1007/s00439-003-0921-9; PIED S, 1995, PARASITE, V2, P263, DOI 10.1051/parasite/1995023263; Price RN, 2007, AM J TROP MED HYG, V77, P79, DOI 10.4269/ajtmh.2007.77.79; Ray S, 2012, J PROTEOMICS, V75, P3063, DOI 10.1016/j.jprot.2011.10.018; Ray S, 2011, PROTEOMICS, V11, P2139, DOI 10.1002/pmic.201000460; ROUGEMONT A, 1988, LANCET, V2, P709; Rukmangadachar Lokesh A, 2011, Clin Proteomics, V8, P4, DOI 10.1186/1559-0275-8-4; Shevchenko A, 2006, NAT PROTOC, V1, P2856, DOI 10.1038/nprot.2006.468; Snow RW, 2005, NATURE, V434, P214, DOI 10.1038/nature03342; Srivastava R, 2012, J PROTEOMICS, V76, P56, DOI 10.1016/j.jprot.2012.04.007; STEEL DM, 1994, IMMUNOL TODAY, V15, P81, DOI 10.1016/0167-5699(94)90138-4; Taylor-Robinson Andrew W., 2000, Parasitology International, V48, P297, DOI 10.1016/S1383-5769(99)00029-X; Thomas PD, 2006, NUCLEIC ACIDS RES, V34, pW645, DOI 10.1093/nar/gkl229; Verhoeckx KCM, 2005, J PROTEOME RES, V4, P2015, DOI 10.1021/pr050183u; Wenisch C, 1997, CLIN IMMUNOL IMMUNOP, V85, P166, DOI 10.1006/clin.1997.4417; WHO, 2008, WHO LIST KNOWN COMM; WHO, 2008, WHO WORLD MAL REP; WOLD S, 1987, CHEMOMETR INTELL LAB, V2, P37, DOI 10.1016/0169-7439(87)80084-9; Wozniak MA, 2003, J MED GENET, V40, P348, DOI 10.1136/jmg.40.5.348; YERLY S, 1990, ACTA TROP, V47, P237, DOI 10.1016/0001-706X(90)90015-R	47	42	42	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 9	2012	7	8							e41751	10.1371/journal.pone.0041751	http://dx.doi.org/10.1371/journal.pone.0041751			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	986WZ	22912677	Green Published, Green Submitted, gold			2022-12-25	WOS:000307378500008
J	Tokusumi, Y; Tokusumi, T; Shoue, DA; Schulz, RA				Tokusumi, Yumiko; Tokusumi, Tsuyoshi; Shoue, Douglas A.; Schulz, Robert A.			Gene Regulatory Networks Controlling Hematopoietic Progenitor Niche Cell Production and Differentiation in the Drosophila Lymph Gland	PLOS ONE			English	Article							STEM-CELLS; SIGNALING CENTER; DUAL ROLE; MAINTENANCE; SIZE; MTOR; MELANOGASTER; QUIESCENCE; SUPPRESSOR; PATHWAY	Hematopoiesis occurs in two phases in Drosophila, with the first completed during embryogenesis and the second accomplished during larval development. The lymph gland serves as the venue for the final hematopoietic program, with this larval tissue well-studied as to its cellular organization and genetic regulation. While the medullary zone contains stem-like hematopoietic progenitors, the posterior signaling center (PSC) functions as a niche microenvironment essential for controlling the decision between progenitor maintenance versus cellular differentiation. In this report, we utilize a PSC-specific GAL4 driver and UAS-gene RNAi strains, to selectively knockdown individual gene functions in PSC cells. We assessed the effect of abrogating the function of 820 genes as to their requirement for niche cell production and differentiation. 100 genes were shown to be essential for normal niche development, with various loci placed into subgroups based on the functions of their encoded protein products and known genetic interactions. For members of three of these groups, we characterized loss-and gain-of-function phenotypes. Gene function knockdown of members of the BAP chromatin-remodeling complex resulted in niche cells that do not express the hedgehog (hh) gene and fail to differentiate filopodia believed important for Hh signaling from the niche to progenitors. Abrogating gene function of various members of the insulin-like growth factor and TOR signaling pathways resulted in anomalous PSC cell production, leading to a defective niche organization. Further analysis of the Pten, TSC1, and TSC2 tumor suppressor genes demonstrated their loss-of-function condition resulted in severely altered blood cell homeostasis, including the abundant production of lamellocytes, specialized hemocytes involved in innate immune responses. Together, this cell-specific RNAi knockdown survey and mutant phenotype analyses identified multiple genes and their regulatory networks required for the normal organization and function of the hematopoietic progenitor niche within the lymph gland.	[Tokusumi, Yumiko; Tokusumi, Tsuyoshi; Shoue, Douglas A.; Schulz, Robert A.] Univ Notre Dame, Dept Biol Sci, Notre Dame, IN 46556 USA	University of Notre Dame	Tokusumi, Y (corresponding author), Univ Notre Dame, Dept Biol Sci, Notre Dame, IN 46556 USA.	rschulz@nd.edu		Tokusumi, Tsuyoshi/0000-0001-9494-1888	National Institutes of Health (NIH) [HL071540]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL071540] Funding Source: NIH RePORTER	National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported by National Institutes of Health (NIH) HL071540. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Benmimoun B, 2012, DEVELOPMENT, V139, P1713, DOI 10.1242/dev.080259; Chen C, 2008, J EXP MED, V205, P2397, DOI 10.1084/jem.20081297; Crozatier M, 2004, PLOS BIOL, V2, P1107, DOI 10.1371/journal.pbio.0020196; Crozatier M, 2011, DIS MODEL MECH, V4, P439, DOI 10.1242/dmm.007351; Edgar BA, 2006, NAT REV GENET, V7, P907, DOI 10.1038/nrg1989; Gan B, 2009, CELL CYCLE, V8, P1003, DOI 10.4161/cc.8.7.8045; Gao HJ, 2009, MOL CELL BIOL, V29, P6086, DOI 10.1128/MCB.00244-09; Hombria JCG, 2005, DEV BIOL, V288, P420, DOI 10.1016/j.ydbio.2005.09.040; Jung SH, 2005, DEVELOPMENT, V132, P2521, DOI 10.1242/dev.01837; Junger Martin A, 2003, J Biol, V2, P20, DOI 10.1186/1475-4924-2-20; Kim DH, 2002, CELL, V110, P163, DOI 10.1016/S0092-8674(02)00808-5; Kohlmaier A, 2008, CURR OPIN CELL BIOL, V20, P699, DOI 10.1016/j.ceb.2008.10.002; Krzemien J, 2007, NATURE, V446, P325, DOI 10.1038/nature05650; Krzemien J, 2010, DEV BIOL, V346, P310, DOI 10.1016/j.ydbio.2010.08.003; Lanot R, 2001, DEV BIOL, V230, P243, DOI 10.1006/dbio.2000.0123; Lebestky T, 2003, GENE DEV, V17, P348, DOI 10.1101/gad.1052803; Lin HF, 2002, NAT REV GENET, V3, P931, DOI 10.1038/nrg952; Mandal L, 2007, NATURE, V446, P320, DOI 10.1038/nature05585; Martinez-Agosto JA, 2007, GENE DEV, V21, P3044, DOI 10.1101/gad.1602607; Minakhina S, 2010, DEVELOPMENT, V137, P27, DOI 10.1242/dev.043943; Mondal BC, 2011, CELL, V147, P1589, DOI 10.1016/j.cell.2011.11.041; Montagne J, 1999, SCIENCE, V285, P2126, DOI 10.1126/science.285.5436.2126; Morrison SJ, 2008, CELL, V132, P598, DOI 10.1016/j.cell.2008.01.038; Napolioni V, 2008, CURR GENOMICS, V9, P475, DOI 10.2174/138920208786241243; Oldham S, 2002, DEVELOPMENT, V129, P4103; Orkin SH, 2008, CELL, V132, P631, DOI 10.1016/j.cell.2008.01.025; Pennetier D, 2012, P NATL ACAD SCI USA, V109, P3389, DOI 10.1073/pnas.1109407109; Sarbassov DD, 2004, CURR BIOL, V14, P1296, DOI 10.1016/j.cub.2004.06.054; Shim J, 2012, NAT CELL BIOL, V14, P394, DOI 10.1038/ncb2453; Sinenko SA, 2012, EMBO REP, V13, P83, DOI 10.1038/embor.2011.223; Sinenko SA, 2009, DEV CELL, V16, P756, DOI 10.1016/j.devcel.2009.03.003; Sorrentino RP, 2007, DEV BIOL, V311, P311, DOI 10.1016/j.ydbio.2007.08.011; Terriente-Felix A, 2009, DEV BIOL, V329, P350, DOI 10.1016/j.ydbio.2009.03.010; Tokusumi T, 2011, DEVELOPMENT, V138, P3879, DOI 10.1242/dev.069336; Tokusumi T, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006429; Tokusumi T, 2009, GENESIS, V47, P771, DOI 10.1002/dvg.20561; Tokusumi Y, 2010, DEVELOPMENT, V137, P3561, DOI 10.1242/dev.053728; Vilmos P, 2004, DEV COMP IMMUNOL, V28, P555, DOI 10.1016/j.dci.2003.10.001; Yilmaz OH, 2006, NATURE, V441, P475, DOI 10.1038/nature04703; Yoo AS, 2009, CURR OPIN NEUROBIOL, V19, P120, DOI 10.1016/j.conb.2009.04.006; Zettervall CJ, 2004, P NATL ACAD SCI USA, V101, P14192, DOI 10.1073/pnas.0403789101; Zhang JW, 2006, NATURE, V441, P518, DOI 10.1038/nature04747	42	46	47	0	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 24	2012	7	7							e41604	10.1371/journal.pone.0041604	http://dx.doi.org/10.1371/journal.pone.0041604			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	978NX	22911822	Green Submitted, Green Published, gold			2022-12-25	WOS:000306751300057
J	Garcia-Martin, E; Martinez, C; Alonso-Navarro, H; Benito-Leon, J; Lorenzo-Betancor, O; Pastor, P; Lopez-Alburquerque, T; Samaranch, L; Lorenzo, E; Agundez, JAG; Jimenez-Jimenez, FJ				Garcia-Martin, Elena; Martinez, Carmen; Alonso-Navarro, Hortensia; Benito-Leon, Julian; Lorenzo-Betancor, Oswaldo; Pastor, Pau; Lopez-Alburquerque, Tomas; Samaranch, Lluis; Lorenzo, Elena; Agundez, Jose A. G.; Javier Jimenez-Jimenez, Felix			H1-MAPT and the Risk for Familial Essential Tremor	PLOS ONE			English	Article							HISTAMINE-N-METHYLTRANSFERASE; PARKINSONS-DISEASE; GENE; TAU; POLYMORPHISMS; ASSOCIATION; RECEPTOR; MAPT; METAANALYSIS; THR105ILE	The most frequent MAPT H1 haplotype is associated with the risk for developing progressive supranuclear palsy and other neurodegenerative diseases such as Parkinson's disease. A recent report suggests that the MAPT H1 is associated with the risk for developing essential tremor. We wanted to confirm this association in a different population. We analyzed the distribution of allelic and genotype frequencies of rs1052553, which is an H1/H2 SNP, in 200 subjects with familial ET and 291 healthy controls. rs1052553 genotype and allelic frequencies did not differ significantly between subjects with ET and controls and were unrelated with the age at onset of tremor or gender, and with the presence of head, voice, chin, and tongue tremor. Our study suggests that the MAPT H1 rs1052553 is not associated with the risk for developing familial ET in the Spanish population.	[Garcia-Martin, Elena] Univ Extremadura, Dept Biochem & Mol Biol, Caceres, Spain; [Martinez, Carmen] Univ Extremadura, Dept Pharmacol, Badajoz, Spain; [Alonso-Navarro, Hortensia; Javier Jimenez-Jimenez, Felix] Univ Alcala de Henares, Hosp Principe de Asturias, Dept Med Neurol, Madrid, Spain; [Alonso-Navarro, Hortensia] Hosp Univ Sureste, Neurol Sect, Madrid, Spain; [Benito-Leon, Julian] Univ Complutense, Dept Med, Hosp Doce de Octubre, Serv Neurol, E-28040 Madrid, Spain; [Benito-Leon, Julian; Pastor, Pau] Inst Salud Carlos III, Ctr Invest Biomed Red Enfermedades Neurodegenerat, Madrid, Spain; [Lorenzo-Betancor, Oswaldo; Pastor, Pau; Samaranch, Lluis; Lorenzo, Elena; Javier Jimenez-Jimenez, Felix] Univ Navarra, Ctr Appl Med Res, Neurogenet Lab, Div Neurosci, E-31080 Pamplona, Spain; [Lorenzo-Betancor, Oswaldo; Pastor, Pau] Univ Navarra, Sch Med, Dept Neurol, Univ Navarra Clin, E-31080 Pamplona, Spain; [Lopez-Alburquerque, Tomas] Hosp Univ Salamanca, Dept Neurol, Salamanca, Spain; [Agundez, Jose A. G.] Univ Extremadura, Dept Pharmacol, Caceres, Spain	Universidad de Extremadura; Universidad de Extremadura; Prince of Asturias University Hospital; Universidad de Alcala; Complutense University of Madrid; Hospital Universitario 12 de Octubre; CIBERNED; Instituto de Salud Carlos III; University of Navarra; University of Navarra; University of Salamanca; Universidad de Extremadura	Garcia-Martin, E (corresponding author), Univ Extremadura, Dept Biochem & Mol Biol, Caceres, Spain.	fjavier.jimenez@salud.madrid.org	Agúndez, José A. G./A-5503-2008; Samaranch, Lluis/AAU-8464-2021; Pastor, Pau/C-9834-2009; Lorenzo-Betancor, Oswaldo/J-2753-2019; Benito-León, Julián/AAA-1331-2019; García-Martin, Elena/H-9828-2016	Agúndez, José A. G./0000-0001-6895-9160; Pastor, Pau/0000-0002-7493-8777; Lorenzo-Betancor, Oswaldo/0000-0002-5607-8363; Benito-León, Julián/0000-0002-1769-4809; García-Martin, Elena/0000-0002-8094-046X; Samaranch, Lluis/0000-0001-8151-473X	Fondo de Investigacion Sanitaria, Instituto de Salud Carlos III, Madrid, Spain [PS09/00943, PS09/00469, RETICS RD07/0064/0016]; Junta de Extremadura, Merida, Spain [GR10068]; Spanish Ministry of Education and Science [SAF2006-10126]; "Union Tecnica de Empresas" project from the Centro de Investigaciones Medicas Aplicadas, Spain; FEDER	Fondo de Investigacion Sanitaria, Instituto de Salud Carlos III, Madrid, Spain(Instituto de Salud Carlos III); Junta de Extremadura, Merida, Spain; Spanish Ministry of Education and Science(Spanish Government); "Union Tecnica de Empresas" project from the Centro de Investigaciones Medicas Aplicadas, Spain; FEDER(European Commission)	This work was supported in part by Grants PS09/00943, PS09/00469 and RETICS RD07/0064/0016 from Fondo de Investigacion Sanitaria, Instituto de Salud Carlos III, Madrid, Spain and GR10068 from Junta de Extremadura, Merida, Spain, Grant to PP from the Spanish Ministry of Education and Science (SAF2006-10126: 2006-2009) and "Union Tecnica de Empresas" project from the Centro de Investigaciones Medicas Aplicadas, Spain. Partially financed with FEDER funds. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agundez JAG, 1997, AGE AGEING, V26, P147, DOI 10.1093/ageing/26.2.147; Alonso-Navarro H, 2008, TRATADO TRASTORNOS M, P833; Benito-Leon J, 2003, MOVEMENT DISORD, V18, P389, DOI 10.1002/mds.10376; Deng H, 2006, NEUROSCI LETT, V401, P16, DOI 10.1016/j.neulet.2006.02.066; Deuschl G, 1998, MOVEMENT DISORD, V13, P2, DOI 10.1002/mds.870131303; Elbaz A, 2011, ANN NEUROL, V69, P778, DOI 10.1002/ana.22321; Ezquerra M, 2011, NEUROBIOL AGING, V32, DOI 10.1016/j.neurobiolaging.2009.09.011; Fekete R, 2011, MOVEMENT DISORD, V26, P391, DOI 10.1002/mds.23512; Garcia-Martin E, 2010, EUR J NEUROL, V17, P879, DOI 10.1111/j.1468-1331.2009.02914.x; Garcia-Martin E, 2011, PHARMACOGENET GENOM, V21, P436, DOI 10.1097/FPC.0b013e328345bec0; Garcia-Martin E, 2011, J NEUROL, V258, P203, DOI 10.1007/s00415-010-5708-z; Garcia-Martin E, 2009, MOVEMENT DISORD, V24, P1910, DOI 10.1002/mds.22518; Hutton M, 1998, NATURE, V393, P702, DOI 10.1038/31508; Jimenez-Jimenez FJ, 2012, J NEUROL SCI, V317, P52, DOI 10.1016/j.jns.2012.02.030; Jimenez-Jimenez Felix Javier, 2012, Tremor Other Hyperkinet Mov (N Y), V2, DOI 10.7916/D8FN14Z6; Keeling BH, 2010, PARKINSONISM RELAT D, V16, P112, DOI 10.1016/j.parkreldis.2009.08.011; LaRoia H, 2011, NEUROEPIDEMIOLOGY, V37, P1, DOI 10.1159/000328866; Ledesma MC, 2008, NEUROMOL MED, V10, P356, DOI 10.1007/s12017-008-8040-3; Lorenz D, 2009, EUR J HUM GENET, V17, P766, DOI 10.1038/ejhg.2008.243; Mata IF, 2011, MOVEMENT DISORD, V26, P819, DOI 10.1002/mds.23642; Nalls MA, 2011, LANCET, V377, P641, DOI 10.1016/S0140-6736(10)62345-8; Pastor P, 2000, ANN NEUROL, V47, P242; Pastor P, 2001, ANN NEUROL, V49, P263, DOI 10.1002/1531-8249(20010201)49:2<263::AID-ANA50>3.0.CO;2-K; Rademakers R, 2005, HUM MOL GENET, V14, P3281, DOI 10.1093/hmg/ddi361; Stefansson H, 2009, NAT GENET, V41, P277, DOI 10.1038/ng.299; Thier S, 2011, EUR J NEUROL, V18, P1098, DOI 10.1111/j.1468-1331.2010.03308.x; Vilarino-Guell C, 2011, NEUROLOGY, V76, P670, DOI 10.1212/WNL.0b013e31820c30c1; Wider C, 2011, EUR J NEUROL, V18, P876, DOI 10.1111/j.1468-1331.2010.03297.x	28	15	15	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 23	2012	7	7							e41581	10.1371/journal.pone.0041581	http://dx.doi.org/10.1371/journal.pone.0041581			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	977TM	22911817	gold, Green Submitted, Green Published			2022-12-25	WOS:000306687700117
J	Rosenthal, DT; Zhang, J; Bao, LW; Zhu, L; Wu, ZF; Toy, K; Kleer, CG; Merajver, SD				Rosenthal, Devin T.; Zhang, Jie; Bao, Liwei; Zhu, Lian; Wu, Zhifen; Toy, Kathy; Kleer, Celina G.; Merajver, Sofia D.			RhoC Impacts the Metastatic Potential and Abundance of Breast Cancer Stem Cells	PLOS ONE			English	Article							ACTIN STRESS FIBERS; PROSPECTIVE IDENTIFICATION; ALDEHYDE DEHYDROGENASE; BINDING PROTEIN; GTPASE; GROWTH; CORRELATE	Cancer stem cells (CSCs) have been shown to promote tumorigenesis of many tumor types, including breast, although their relevance to cancer metastasis remains unclear. While subpopulations of CSCs required for metastasis have been identified, to date there are no known molecular regulators of breast CSC (BCSC) metastasis. Here we identify RhoC GTPase as an important regulator of BCSC metastasis, and present evidence suggesting that RhoC also modulates the frequency of BCSCs within a population. Using an orthotopic xenograft model of spontaneous metastasis we discover that RhoC is both necessary and sufficient to promote SUM149 and MCF-10A BCSC metastasis-often independent from primary tumor formation-and can even induce metastasis of non-BCSCs within these cell lines. The relationship between RhoC and BCSCs persists in breast cancer patients, as expression of RhoC and the BCSC marker ALDH1 are highly correlated in clinical specimens. These results suggest new avenues to combating the deadliest cells driving the most lethal stage of breast cancer progression.	[Rosenthal, Devin T.; Kleer, Celina G.; Merajver, Sofia D.] Univ Michigan, Mol & Cellular Biol Program, Ann Arbor, MI 48109 USA; [Toy, Kathy; Kleer, Celina G.] Univ Michigan, Dept Pathol, Ann Arbor, MI 48109 USA; [Kleer, Celina G.; Merajver, Sofia D.] Univ Michigan, Ctr Comprehens Canc, Ann Arbor, MI 48109 USA; [Rosenthal, Devin T.; Zhang, Jie; Bao, Liwei; Zhu, Lian; Wu, Zhifen; Merajver, Sofia D.] Univ Michigan, Dept Internal Med, Div Hematol & Oncol, Ann Arbor, MI 48109 USA	University of Michigan System; University of Michigan; University of Michigan System; University of Michigan; University of Michigan System; University of Michigan; University of Michigan System; University of Michigan	Rosenthal, DT (corresponding author), Tufts Univ, Dept Anat, Boston, MA 02111 USA.	smerajve@med.umich.edu			Department of Defense Breast Cancer Research Program through a Predoctoral Traineeship award [BC083262]; NIH Cellular and Molecular Biology Training Grant [T32-GM07315]; Burroughs Wellcome Fund; Breast Cancer Research Foundation; NATIONAL CANCER INSTITUTE [R01CA107469] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM007315] Funding Source: NIH RePORTER	Department of Defense Breast Cancer Research Program through a Predoctoral Traineeship award(United States Department of Defense); NIH Cellular and Molecular Biology Training Grant(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Burroughs Wellcome Fund(Burroughs Wellcome Fund); Breast Cancer Research Foundation; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by the Department of Defense Breast Cancer Research Program through a Predoctoral Traineeship award (BC083262) (D. T. R.), an NIH Cellular and Molecular Biology Training Grant (T32-GM07315) (D. T. R.), the Burroughs Wellcome Fund (S. D. M.), and the Breast Cancer Research Foundation (S. D. M.). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abramoff MD, 2004, BIOPHOTONICS INT, V11, P36, DOI DOI 10.1117/1.3589100; Al-Hajj M, 2003, P NATL ACAD SCI USA, V100, P3983, DOI 10.1073/pnas.0530291100; Charafe-Jauffret E, 2010, CLIN CANCER RES, V16, P45, DOI 10.1158/1078-0432.CCR-09-1630; Clark EA, 2000, NATURE, V406, P532, DOI 10.1038/35020106; Collins AT, 2005, CANCER RES, V65, P10946, DOI 10.1158/0008-5472.CAN-05-2018; Debnath J, 2005, NAT REV CANCER, V5, P675, DOI 10.1038/nrc1695; Dietrich KA, 2009, BIOL CHEM, V390, P1063, DOI 10.1515/BC.2009.110; Ginestier C, 2007, CELL STEM CELL, V1, P555, DOI 10.1016/j.stem.2007.08.014; Gupta PB, 2009, CELL, V138, P645, DOI 10.1016/j.cell.2009.06.034; Hakem A, 2005, GENE DEV, V19, P1974, DOI 10.1101/gad.1310805; Hermann PC, 2007, CELL STEM CELL, V1, P313, DOI 10.1016/j.stem.2007.06.002; Ikoma T, 2004, CLIN CANCER RES, V10, P1192, DOI 10.1158/1078-0432.CCR-03-0275; Islam M, 2009, MOL CANCER RES, V7, P1771, DOI 10.1158/1541-7786.MCR-08-0512; JONES RJ, 1995, BLOOD, V85, P2742, DOI 10.1182/blood.V85.10.2742.bloodjournal85102742; Kenny PA, 2007, MOL ONCOL, V1, P84, DOI 10.1016/j.molonc.2007.02.004; Kleer CG, 2005, BREAST CANCER RES TR, V93, P101, DOI 10.1007/s10549-005-4170-6; Korkaya H, 2008, ONCOGENE, V27, P6120, DOI 10.1038/onc.2008.207; Lee GY, 2007, NAT METHODS, V4, P359, DOI 10.1038/NMETH1015; Liu HP, 2010, P NATL ACAD SCI USA, V107, P18115, DOI 10.1073/pnas.1006732107; Liu R, 2007, NEW ENGL J MED, V356, P217, DOI 10.1056/NEJMoa063994; Mani SA, 2008, CELL, V133, P704, DOI 10.1016/j.cell.2008.03.027; McCabe A, 2005, JNCI-J NATL CANCER I, V97, P1808, DOI 10.1093/jnci/dji427; NOBES CD, 1995, CELL, V81, P53, DOI 10.1016/0092-8674(95)90370-4; Nocito A, 2001, INT J CANCER, V94, P1, DOI 10.1002/ijc.1385; Pang R, 2010, CELL STEM CELL, V6, P603, DOI 10.1016/j.stem.2010.04.001; Pavlidis N, 2012, LANCET; Reya T, 2001, NATURE, V414, P105, DOI 10.1038/35102167; RIDLEY AJ, 1992, CELL, V70, P389, DOI 10.1016/0092-8674(92)90163-7; Rosenthal DT, 2010, RHO GTPASES IN CANCER, P29, DOI 10.1007/978-1-4419-1111-7_2; Singh SK, 2003, CANCER RES, V63, P5821; van Golen KL, 1999, CLIN CANCER RES, V5, P2511; van Golen KL, 2000, CANCER RES, V60, P5832; Wheeler AP, 2004, EXP CELL RES, V301, P43, DOI 10.1016/j.yexcr.2004.08.012	33	56	57	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 23	2012	7	7							e40979	10.1371/journal.pone.0040979	http://dx.doi.org/10.1371/journal.pone.0040979			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	977TM	22911725	gold, Green Published, Green Submitted			2022-12-25	WOS:000306687700031
J	Wang, W; Zhang, X; Qin, JJ; Voruganti, S; Nag, SA; Wang, MH; Wang, H; Zhang, RW				Wang, Wei; Zhang, Xu; Qin, Jiang-Jiang; Voruganti, Sukesh; Nag, Subhasree Ashok; Wang, Ming-Hai; Wang, Hui; Zhang, Ruiwen			Natural Product Ginsenoside 25-OCH3-PPD Inhibits Breast Cancer Growth and Metastasis through Down-Regulating MDM2	PLOS ONE			English	Article							PROMOTES CELL MOTILITY; PROSTATE-CANCER; IN-VITRO; P53-MDM2 INTERACTION; ANTICANCER ACTIVITY; TUMOR-SUPPRESSOR; P53 PROTEIN; ACTIVATION; EXPRESSION; ONCOGENE	Although ginseng and related herbs have a long history of utility for various health benefits, their application in cancer therapy and underlying mechanisms of action are not fully understood. Our recent work has shown that 20(S)-25-methoxyl-dammarane-3 beta, 12 beta, 20-triol (25-OCH3-PPD), a newly identified ginsenoside from Panax notoginseng, exerts activities against a variety of cancer cells in vitro and in vivo. This study was designed to investigate its anti-breast cancer activity and the underlying mechanisms of action. We observed that 25-OCH3-PPD decreased the survival of breast cancer cells by induction of apoptosis and G1 phase arrest and inhibited the growth of breast cancer xenografts in vivo. We further demonstrated that, in a dose-and time-dependent manner, 25-OCH3-PPD inhibited MDM2 expression at both transcriptional and post-translational levels in human breast cancer cells with various p53 statuses (wild type and mutant). Moreover, 25-OCH3-PPD inhibited in vitro cell migration, reduced the expression of epithelial-to-mesenchymal transition (EMT) markers, and prevented in vivo metastasis of breast cancer. In summary, 25-OCH3-PPD is a potential therapeutic and anti-metastatic agent for human breast cancer through down-regulating MDM2. Further preclinical and clinical development of this agent is warranted.	[Wang, Wei; Zhang, Xu; Qin, Jiang-Jiang; Voruganti, Sukesh; Nag, Subhasree Ashok; Zhang, Ruiwen] Texas Tech Univ, Hlth Sci Ctr, Sch Pharm, Dept Pharmaceut Sci, Amarillo, TX USA; [Wang, Wei; Wang, Ming-Hai; Zhang, Ruiwen] Texas Tech Univ, Hlth Sci Ctr, Sch Pharm, Canc Biol Ctr, Amarillo, TX USA; [Wang, Ming-Hai] Texas Tech Univ, Hlth Sci Ctr, Sch Pharm, Dept Biomed Sci, Amarillo, TX USA; [Wang, Hui] Chinese Acad Sci, Shanghai Inst Biol Sci, Inst Nutr Sci, Shanghai, Peoples R China	Texas Tech University System; Texas Tech University; Texas Tech University Health Science Center; Texas Tech University Health Sciences Center Amarillo; Texas Tech University System; Texas Tech University; Texas Tech University Health Science Center; Texas Tech University Health Sciences Center Amarillo; Texas Tech University System; Texas Tech University; Texas Tech University Health Science Center; Texas Tech University Health Sciences Center Amarillo; Chinese Academy of Sciences; Shanghai Institutes for Biological Sciences, CAS	Wang, W (corresponding author), Texas Tech Univ, Hlth Sci Ctr, Sch Pharm, Dept Pharmaceut Sci, Amarillo, TX USA.	ruiwen.zhang@ttuhsc.edu	Qin, Jiangjiang/AAM-9553-2020; voruganti, sukesh/B-1524-2016; Nag, subhasree/T-1505-2019	Qin, Jiangjiang/0000-0002-8559-616X; voruganti, sukesh/0000-0003-2240-8114; Nag, subhasree/0000-0001-6933-4349	Susan G. Komen for the Cure [BCTR070731]; NIH [R01 CA112029, R01 CA121211, R01 CA91980]; One Hundred Talents Program, Chinese Academy of Sciences; National Nature Science Foundation [30870513, 31070680, 91029715, 81025017]; Ministry of Science and Technology of China [2007CB947100]; National Science and Technology Major Project "Key New Drug Creation and Manufacturing Program" [2009ZX09102-114, 2009ZX09301-011]; NATIONAL CANCER INSTITUTE [R01CA121211, R01CA112029, R01CA091980] Funding Source: NIH RePORTER	Susan G. Komen for the Cure(Susan G. Komen Breast Cancer Foundation); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); One Hundred Talents Program, Chinese Academy of Sciences; National Nature Science Foundation(National Natural Science Foundation of China (NSFC)); Ministry of Science and Technology of China(Ministry of Science and Technology, China); National Science and Technology Major Project "Key New Drug Creation and Manufacturing Program"; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work is mainly supported by a grant (BCTR070731) from Susan G. Komen for the Cure (to H.W. and R.Z.). R.Z. was also supported by NIH grants R01 CA112029 and R01 CA121211. M.W. was supported by NIH grant R01 CA91980. H.W. was supported by the One Hundred Talents Program, Chinese Academy of Sciences, grants from National Nature Science Foundation (30870513, 31070680, 91029715 and 81025017) and Ministry of Science and Technology of China (2007CB947100), and National Science and Technology Major Project "Key New Drug Creation and Manufacturing Program" (2009ZX09102-114, 2009ZX09301-011). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Araki S, 2010, J CLIN INVEST, V120, P290, DOI 10.1172/JCI39194; BARAK Y, 1993, EMBO J, V12, P461, DOI 10.1002/j.1460-2075.1993.tb05678.x; Bothner B, 2001, J MOL BIOL, V314, P263, DOI 10.1006/jmbi.2001.5110; CHEN CY, 1994, P NATL ACAD SCI USA, V91, P2684, DOI 10.1073/pnas.91.7.2684; Chen D, 2007, ONCOGENE, V26, P5029, DOI 10.1038/sj.onc.1210327; Chen JD, 1996, MOL CELL BIOL, V16, P2445; Chen LH, 2005, EMBO J, V24, P3411, DOI 10.1038/sj.emboj.7600812; Chene P, 2003, NAT REV CANCER, V3, P102, DOI 10.1038/nrc991; Christiansen JJ, 2006, CANCER RES, V66, P8319, DOI 10.1158/0008-5472.CAN-06-0410; Croce CM, 2008, NEW ENGL J MED, V358, P502, DOI 10.1056/NEJMra072367; DeSantis C, 2011, CA-CANCER J CLIN, V61, P409, DOI 10.3322/caac.20134; Hanahan D, 2011, CELL, V144, P646, DOI 10.1016/j.cell.2011.02.013; Haupt Y, 1997, NATURE, V387, P296, DOI 10.1038/387296a0; Helms Steve, 2004, Altern Med Rev, V9, P259; Issaeva N, 2004, NAT MED, V10, P1321, DOI 10.1038/nm1146; Iwakuma T, 2003, MOL CANCER RES, V1, P993; Jones SN, 1998, P NATL ACAD SCI USA, V95, P15608, DOI 10.1073/pnas.95.26.15608; Kamijo T, 1998, P NATL ACAD SCI USA, V95, P8292, DOI 10.1073/pnas.95.14.8292; Kubbutat MHG, 1997, NATURE, V387, P299, DOI 10.1038/387299a0; Levine AJ, 2009, NAT REV CANCER, V9, P749, DOI 10.1038/nrc2723; Li M, 2007, CANCER RES, V67, P1988, DOI 10.1158/0008-5472.CAN-06-3066; Liu G, 2006, MOL CELL BIOL, V26, P1398, DOI 10.1128/MCB.26.4.1398-1413.2006; MARTIN K, 1995, NATURE, V375, P691, DOI 10.1038/375691a0; MOMAND J, 1992, CELL, V69, P1237, DOI 10.1016/0092-8674(92)90644-R; Onel K, 2004, MOL CANCER RES, V2, P1; Pan Y, 1999, CANCER RES, V59, P2064; Peng YH, 2001, J BIOL CHEM, V276, P6874, DOI 10.1074/jbc.C000781200; Phelps M, 2003, CANCER RES, V63, P2616; Polanski R, 2010, FEBS LETT, V584, P4695, DOI 10.1016/j.febslet.2010.10.049; Rayburn E, 2005, CURR CANCER DRUG TAR, V5, P27, DOI 10.2174/1568009053332636; Ries S, 2000, CELL, V103, P321, DOI 10.1016/S0092-8674(00)00123-9; Vogelstein B, 2000, NATURE, V408, P307, DOI 10.1038/35042675; Wang W, 2008, BRIT J CANCER, V98, P792, DOI 10.1038/sj.bjc.6604227; Wang W, 2008, PROSTATE, V68, P809, DOI 10.1002/pros.20742; Wang W, 2007, CANCER CHEMOTH PHARM, V59, P589, DOI 10.1007/s00280-006-0300-z; Wang W, 2010, BREAST CANCER RES TR, V123, P321, DOI 10.1007/s10549-009-0638-0; Wang W, 2009, LUNG CANCER, V65, P306, DOI 10.1016/j.lungcan.2008.11.016; Wang W, 2009, CLIN CANCER RES, V15, P3511, DOI 10.1158/1078-0432.CCR-08-2689; Wang W, 2009, CANCER LETT, V278, P241, DOI 10.1016/j.canlet.2009.01.005; XIAO ZX, 1995, NATURE, V375, P694, DOI 10.1038/375694a0; Xu HX, 2010, J BIOL CHEM, V285, P18407, DOI 10.1074/jbc.M109.059568; Yang JY, 2006, MOL CELL BIOL, V26, P7269, DOI 10.1128/MCB.00172-06; Zhang RW, 2000, CURR PHARM DESIGN, V6, P393, DOI 10.2174/1381612003400911; Zhang Z, 2003, P NATL ACAD SCI USA, V100, P11636, DOI 10.1073/pnas.1934692100; Zhao Y, 2007, MED CHEM, V3, P51, DOI 10.2174/157340607779317508	45	62	68	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 23	2012	7	7							e41586	10.1371/journal.pone.0041586	http://dx.doi.org/10.1371/journal.pone.0041586			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	977TM	22911819	Green Published, Green Submitted, gold			2022-12-25	WOS:000306687700120
J	Saraon, P; Musrap, N; Cretu, D; Karagiannis, GS; Batruch, I; Smith, C; Drabovich, AP; Trudel, D; van der Kwast, T; Morrissey, C; Jarvi, KA; Diamandis, EP				Saraon, Punit; Musrap, Natasha; Cretu, Daniela; Karagiannis, George S.; Batruch, Ihor; Smith, Chris; Drabovich, Andrei P.; Trudel, Dominique; van der Kwast, Theodorus; Morrissey, Colm; Jarvi, Keith A.; Diamandis, Eleftherios P.			Proteomic Profiling of Androgen-independent Prostate Cancer Cell Lines Reveals a Role for Protein S during the Development of High Grade and Castration-resistant Prostate Cancer	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SIGNAL-TRANSDUCTION PATHWAYS; GROWTH-FACTOR-BETA; RECEPTOR; EXPRESSION; PROGRESSION; METASTASIS; GAS6; PROLIFERATION; HYPERPLASIA; ACTIVATION	Androgen deprivation constitutes the principal therapy for advanced and metastatic prostate cancers. However, this therapeutic intervention usually results in the transition to a more aggressive androgen-independent prostate cancer. The elucidation of molecular alterations during the progression to androgen independence is an integral step toward discovering more effective targeted therapies. With respect to identifying crucial mediators of this transition, we compared the proteomes of androgen-independent (PC3, DU145, PPC1, LNCaP-SF, and 22Rv1) and androgen-dependent (LNCaP and VCaP) and/or normal prostate epithelial (RWPE) cell lines using mass spectrometry. We identified more than 100 proteins that were differentially secreted in the androgen-independent cell lines. Of these, Protein S (PROS1) was elevated in the secretomes of all of the androgen-independent prostate cancer cell lines, with no detectable secretion in normal and androgen-dependent cell lines. Using quantitative PCR, we observed significantly higher (p < 0.05) tissue expression levels of PROS1 in prostate cancer samples, further indicating its importance in prostate cancer progression. Similarly, immunohistochemistry analysis revealed elevation of PROS1 in high grade prostate cancer (Gleason grade >= 8), and further elevation in castration-resistant metastatic prostate cancer lesions. We also observed its significant (p < 0.05) elevation in high grade prostate cancer seminal plasma samples. Taken together, these results show that PROS1 is elevated in high grade and castration-resistant prostate cancer and could serve as a potential biomarker of aggressive disease.	[Diamandis, Eleftherios P.] Mt Sinai Hosp, Joseph & Wolf Lebovic Ctr, Dept Pathol & Lab Med, Samuel Lunenfeld Res Inst, Toronto, ON M5T 3L9, Canada; [Saraon, Punit; Musrap, Natasha; Cretu, Daniela; Karagiannis, George S.; van der Kwast, Theodorus; Diamandis, Eleftherios P.] Univ Toronto, Dept Lab Med & Pathobiol, Toronto, ON M5S 1A8, Canada; [Trudel, Dominique; van der Kwast, Theodorus] Univ Toronto, Univ Hlth Network, Dept Pathol, Toronto, ON M5G 2C4, Canada; [Morrissey, Colm] Univ Washington, Dept Urol, Seattle, WA 98467 USA; [Jarvi, Keith A.] Mt Sinai Hosp, Dept Surg, Div Urol, Toronto, ON M5T 3L9, Canada; [Diamandis, Eleftherios P.] Univ Hlth Network, Dept Clin Biochem, Toronto, ON M5G 2C4, Canada	University of Toronto; University Toronto Affiliates; Sinai Health System Toronto; Lunenfeld Tanenbaum Research Institute; University of Toronto; University of Toronto; University Toronto Affiliates; University Health Network Toronto; University of Washington; University of Washington Seattle; University of Toronto; University Toronto Affiliates; Sinai Health System Toronto; Lunenfeld Tanenbaum Research Institute; University of Toronto; University Toronto Affiliates; University Health Network Toronto	Diamandis, EP (corresponding author), Mt Sinai Hosp, Joseph & Wolf Lebovic Ctr, Dept Pathol & Lab Med, Samuel Lunenfeld Res Inst, 60 Murray St,Box 32,Flr 6,Rm L6-201, Toronto, ON M5T 3L9, Canada.	ediamandis@mtsinai.on.ca	Trudel, Dominique/AAS-4455-2020; Drabovich, Andrei/E-9347-2012; Saraon, Punit/K-2639-2019	Drabovich, Andrei/0000-0003-3049-7145; Diamandis, Eleftherios/0000-0002-1589-820X; Trudel, Dominique/0000-0001-9820-1772; Van der Kwast, Theodorus/0000-0001-8640-5786	Ontario Graduate Scholarship; Scace Graduate Prostate Cancer Fellowship; Pacific Northwest Prostate Cancer SPORE [P50CA97186]; National Institutes of Health [PO1CA085859]; Richard M. Lucas Foundation; PO1 NIH; NATIONAL CANCER INSTITUTE [P50CA097186, P01CA085859] Funding Source: NIH RePORTER	Ontario Graduate Scholarship(Ontario Graduate Scholarship); Scace Graduate Prostate Cancer Fellowship; Pacific Northwest Prostate Cancer SPORE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Richard M. Lucas Foundation; PO1 NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	Supported by the Ontario Graduate Scholarship and the Scace Graduate Prostate Cancer Fellowship.; We acknowledge the support of the University Health Network Pathology Research Program for performing the immunohistochemistry experiments. We thank Apostolos Dimitromanolakis for assistance in analyzing the proteomics data and with statistical analysis. We also thank the patients and their families who were willing to participate in the Prostate Cancer Donor Program, for without them research of this nature would not be possible. We also acknowledge Lawrence True, Eva Corey, Celestia Higano, and Robert Vessella and the rapid autopsy teams in the Urology Department at the University of Washington. The donated material is the result of work supported by resources from the Pacific Northwest Prostate Cancer SPORE (P50CA97186), PO1 NIH, National Institutes of Health, Grant PO1CA085859, and the Richard M. Lucas Foundation.	Alaiya AA, 2011, INT J ONCOL, V38, P1047, DOI 10.3892/ijo.2011.937; Blanchere M, 2001, PROSTATE, V46, P311, DOI 10.1002/1097-0045(20010301)46:4<311::AID-PROS1038>3.0.CO;2-2; Blando JM, 2011, NEOPLASIA, V13, P254, DOI 10.1593/neo.101388; Cao J, 2008, J BIOL CHEM, V283, P6232, DOI 10.1074/jbc.M705759200; CHODAK GW, 1992, J UROLOGY, V147, P798, DOI 10.1016/S0022-5347(17)37389-5; Crawford ED, 2010, J CLIN ONCOL, V28, pE408, DOI 10.1200/JCO.2010.28.7664; Damon SE, 1998, ENDOCRINOLOGY, V139, P3456, DOI 10.1210/en.139.8.3456; Davis JS, 2011, MOL ENDOCRINOL, V25, P611, DOI 10.1210/me.2010-0312; Debes JD, 2004, NEW ENGL J MED, V351, P1488, DOI 10.1056/NEJMp048178; Deng YX, 2003, CANCER-AM CANCER SOC, V98, P2576, DOI 10.1002/cncr.11849; Denmeade SR, 2002, NAT REV CANCER, V2, P389, DOI 10.1038/nrc801; DEWINTER JAR, 1991, J HISTOCHEM CYTOCHEM, V39, P927, DOI 10.1177/39.7.1865110; Diamandis EP, 1998, TRENDS ENDOCRIN MET, V9, P310, DOI 10.1016/S1043-2760(98)00082-4; Drake RR, 2010, J PROTEOME RES, V9, P2109, DOI 10.1021/pr1001498; Edwards J, 2005, BJU INT, V95, P1327, DOI 10.1111/j.1464-410X.2005.05527.x; Edwards J, 2005, BJU INT, V95, P1320, DOI 10.1111/j.1464-410X.2005.05526.x; Gronberg H, 2003, LANCET, V361, P859, DOI 10.1016/S0140-6736(03)12713-4; Guo HA, 2011, MOL NEURODEGENER, V6, DOI 10.1186/1750-1326-6-13; Hafizi S, 2006, FEBS J, V273, P5231, DOI 10.1111/j.1742-4658.2006.05529.x; Hafizi S, 2006, CYTOKINE GROWTH F R, V17, P295, DOI 10.1016/j.cytogfr.2006.04.004; Hall MO, 2005, EXP EYE RES, V81, P581, DOI 10.1016/j.exer.2005.03.017; Jarvis GA, 1997, INT J CANCER, V71, P1049, DOI 10.1002/(SICI)1097-0215(19970611)71:6<1049::AID-IJC22>3.0.CO;2-7; Jennbacken K, 2010, ENDOCR-RELAT CANCER, V17, P469, DOI 10.1677/ERC-10-0015; Karagiannis GS, 2010, MOL ONCOL, V4, P496, DOI 10.1016/j.molonc.2010.09.001; Khan AP, 2010, MOL CELL PROTEOMICS, V9, P298, DOI 10.1074/mcp.M900159-MCP200; Kinkade CW, 2008, J CLIN INVEST, V118, P3051, DOI 10.1172/JCI34764; Latil A, 2003, INT J CANCER, V103, P306, DOI 10.1002/ijc.10821; Lemke G, 2008, NAT REV IMMUNOL, V8, P327, DOI 10.1038/nri2303; Miyake H, 2000, CANCER RES, V60, P3058; Recchia AG, 2009, INT J BIOCHEM CELL B, V41, P603, DOI 10.1016/j.biocel.2008.07.004; SADI MV, 1991, CANCER, V67, P3057, DOI 10.1002/1097-0142(19910615)67:12<3057::AID-CNCR2820671221>3.0.CO;2-S; Sainaghi PP, 2005, J CELL PHYSIOL, V204, P36, DOI 10.1002/jcp.20265; Saraon P, 2011, CLIN CHEM, V57, P1366, DOI 10.1373/clinchem.2011.165977; Sardana G, 2008, J PROTEOME RES, V7, P3329, DOI 10.1021/pr8003216; Sardana G, 2008, CLIN CHEM, V54, P1951, DOI 10.1373/clinchem.2008.110668; Shiozawa Y, 2010, NEOPLASIA, V12, P116, DOI 10.1593/neo.91384; Sierko E, 2010, THROMB RES, V125, pE71, DOI 10.1016/j.thromres.2009.09.011; Skvortsov S, 2011, J PROTEOME RES, V10, P259, DOI 10.1021/pr100921j; Suh J, 2004, J CELL BIOCHEM, V91, P100, DOI 10.1002/jcb.10729; Taddei ML, 2009, AM J PATHOL, V174, P1492, DOI 10.2353/ajpath.2009.080473; Trendel JA, 2008, J BIOMOL SCREEN, V13, P804, DOI 10.1177/1087057108321976; Tsui KH, 2008, ANTICANCER RES, V28, P1993; Tyson DR, 2008, ADV EXP MED BIOL, V630, P133; Vellaichamy A, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010936; WOLFF JM, 1995, EUR J CANCER, V31A, P339, DOI 10.1016/0959-8049(94)00446-C; Zhang FH, 2005, CLIN CANCER RES, V11, P4512, DOI 10.1158/1078-0432.CCR-04-2571; Zhang Y, 2012, INT J CANCER, V130, P200, DOI 10.1002/ijc.25993; Zhong ZH, 2010, J NEUROSCI, V30, P15521, DOI 10.1523/JNEUROSCI.4437-10.2010	48	49	50	0	11	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 5	2012	287	41					34019	34031		10.1074/jbc.M112.384438	http://dx.doi.org/10.1074/jbc.M112.384438			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	018IS	22908226	Green Published, hybrid			2022-12-25	WOS:000309654200009
J	Cruz-Barraza, JA; Carballo, JL; Rocha-Olivares, A; Ehrlich, H; Hog, M				Antonio Cruz-Barraza, Jose; Luis Carballo, Jose; Rocha-Olivares, Axayacatl; Ehrlich, Hermann; Hog, Martin			Integrative Taxonomy and Molecular Phylogeny of Genus Aplysina (Demospongiae: Verongida) from Mexican Pacific	PLOS ONE			English	Article							CHITIN-BASED SCAFFOLDS; PHYLUM PORIFERA; MARINE SPONGES; SPECIES IDENTIFICATION; GENETIC-VARIATION; DNA; CLASSIFICATION; MARKERS; MTDNA; RDNA	Integrative taxonomy provides a major approximation to species delimitation based on integration of different perspectives (e.g. morphology, biochemistry and DNA sequences). The aim of this study was to assess the relationships and boundaries among Eastern Pacific Aplysina species using morphological, biochemical and molecular data. For this, a collection of sponges of the genus Aplysina from the Mexican Pacific was studied on the basis of their morphological, chemical (chitin composition), and molecular markers (mitochondrial COI and nuclear ribosomal rDNA: ITS1-5.8-ITS2). Three morphological species were identified, two of which are new to science. A. clathrata sp. nov. is a yellow to yellow-reddish or -brownish sponge, characterized by external clathrate-like morphology; A. revillagigedi sp. nov. is a lemon yellow to green, cushion-shaped sometimes lobate sponge, characterized by conspicuous oscules, which are slightly elevated and usually linearly distributed on rims; and A. gerardogreeni a known species distributed along the Mexican Pacific coast. Chitin was identified as the main structural component within skeletons of the three species using FTIR, confirming that it is shared among Verongida sponges. Morphological differences were confirmed by DNA sequences from nuclear ITS1-5.8-ITS2. Mitochondrial COI sequences showed extremely low but diagnostic variability for Aplysina revillagigedi sp. nov., thus our results corroborate that COI has limited power for DNA-barcoding of sponges and should be complemented with other markers (e.g. rDNA). Phylogenetic analyses of Aplysina sequences from the Eastern Pacific and Caribbean, resolved two allopatric and reciprocally monophyletic groups for each region. Eastern Pacific species were grouped in general accordance with the taxonomic hypothesis based on morphological characters. An identification key of Eastern Pacific Aplysina species is presented. Our results constitute one of the first approximations to integrative taxonomy, phylogeny and evolutionary biogeography of Eastern Pacific marine sponges; an approach that will significantly contribute to our better understanding of their diversity and evolutionary history.	[Antonio Cruz-Barraza, Jose; Luis Carballo, Jose] UNAM, Unidad Acad Mazatlan, Inst Ciencias Mar & Limnol, Mazatlan Sinaloa, Mexico; [Rocha-Olivares, Axayacatl] CICESE, Dept Oceanog Biol, Ensenada, Baja California, Mexico; [Ehrlich, Hermann; Hog, Martin] Tech Univ Dresden, Inst Bioanalyt Chem, Dresden, Germany	Universidad Nacional Autonoma de Mexico; CICESE - Centro de Investigacion Cientifica y de Educacion Superior de Ensenada; Technische Universitat Dresden	Cruz-Barraza, JA (corresponding author), UNAM, Unidad Acad Mazatlan, Inst Ciencias Mar & Limnol, Mazatlan Sinaloa, Mexico.	joseantonio@ola.icmyl.unam.mx	Cruz-Barraza, José Antonio/AAD-8317-2020; Carballo, José Luis/C-3198-2018; Rocha-Olivares, Axayacatl/A-9832-2008; Ehrlich, Hermann/J-6698-2012; Ehrlich, Hermann/I-5481-2015	Carballo, José Luis/0000-0002-5146-7597; Rocha-Olivares, Axayacatl/0000-0002-2700-9086; Ehrlich, Hermann/0000-0003-3654-0810; Ehrlich, Hermann/0000-0003-4951-3555	CONACYT = Consejo Nacional de Ciencia y Tecnologia, SEP = Secretaria de Educacion Publica, SEMARNAT = Secretaria de medio ambiente y recursos naturales, PAPIT = Programa de Apoyo a Proyectos de Investigacion e Innovacion Tecnologica. [SEP-CONACYT-102239, SEMARNAT-CONACYT-23390, PAPIT-IT209311-3, IACOD-IB200711]; CICESE (Centro de Investigacion Cientifica y de Educacion superior de Ensenada); German Research Foundation [DFG EH 394/1-1]	CONACYT = Consejo Nacional de Ciencia y Tecnologia, SEP = Secretaria de Educacion Publica, SEMARNAT = Secretaria de medio ambiente y recursos naturales, PAPIT = Programa de Apoyo a Proyectos de Investigacion e Innovacion Tecnologica.; CICESE (Centro de Investigacion Cientifica y de Educacion superior de Ensenada)(Consejo Interinstitucional de Ciencia y Tecnologia (CICYT)); German Research Foundation(German Research Foundation (DFG))	This research has been supported by the projects SEP-CONACYT-102239, SEMARNAT-CONACYT-23390, PAPIT-IT209311-3 and IACOD-IB200711 (CONACYT = Consejo Nacional de Ciencia y Tecnologia, SEP = Secretaria de Educacion Publica, SEMARNAT = Secretaria de medio ambiente y recursos naturales, PAPIT = Programa de Apoyo a Proyectos de Investigacion e Innovacion Tecnologica, IACOD = Iniciativa de Apoyo complementario a la realizacion de Obras Determinadas). The first author received financial support from CICESE (Centro de Investigacion Cientifica y de Educacion superior de Ensenada) for an academical stay. Hermann Ehrlich received financial support from the German Research Foundation (DFG EH 394/1-1). No additional external funding received for this study. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Addis JS, 2005, ZOOL SCR, V34, P549, DOI 10.1111/j.1463-6409.2005.00211.x; Aljanabi SM, 1997, NUCLEIC ACIDS RES, V25, P4692, DOI 10.1093/nar/25.22.4692; Austin William C., 1996, Monographiae Biologicae, V75, P237; Bell JJ, 2008, ESTUAR COAST SHELF S, V79, P341, DOI 10.1016/j.ecss.2008.05.002; BERGQUIST PR, 1980, NEW ZEAL J ZOOL, V7, P443, DOI 10.1080/03014223.1980.11760680; Bergquist PR, 2002, SYSTEMA PORIFERA GUI, V1, P1081, DOI DOI 10.1007/978-1-4615-0747-5_108; Blanquer A, 2008, INVERTEBR SYST, V22, P489, DOI 10.1071/IS07004; BODEN N, 1985, INSECT BIOCHEM, V15, P19, DOI 10.1016/0020-1790(85)90039-3; Borchiellini C, 2004, MOL PHYLOGENET EVOL, V32, P823, DOI 10.1016/j.ympev.2004.02.021; Borchiellini C, 2001, J EVOLUTION BIOL, V14, P171, DOI 10.1046/j.1420-9101.2001.00244.x; Boury-Esnault N, 1997, SMITHSONIAN CONTRIBU, V596, P1, DOI DOI 10.5479/SI.00810282.596; Bowerbank JS, 1845, ANN LYC NAT HIST, VXVI, P400; Brunner E, 2009, J STRUCT BIOL, V168, P539, DOI 10.1016/j.jsb.2009.06.018; Brusca RC, 1975, CIENC MAR, V2, P37, DOI DOI 10.7773/CM.V2I2.290; Caballero-George CJ, 2010, CURR TRENDS BIOTECHN, V4, P881; Carballo JL, 1994, THESIS U SEVILLA ESP; Cardenas P, 2007, J MAR BIOL ASSOC UK, V87, P1511, DOI 10.1017/S0025315407058286; Cardenas P, 2010, ZOOL SCR, V39, P89, DOI 10.1111/j.1463-6409.2009.00402.x; Chombard C, 1998, SYST BIOL, V47, P351, DOI 10.1080/106351598260761; Clare EL, 2007, MOL ECOL NOTES, V7, P184, DOI 10.1111/j.1471-8286.2006.01657.x; Damm S, 2010, MOL ECOL, V19, P3881, DOI 10.1111/j.1365-294X.2010.04720.x; DAVIS JI, 1992, SYST BIOL, V41, P421, DOI 10.2307/2992584; Dayrat B, 2005, BIOL J LINN SOC, V85, P407, DOI 10.1111/j.1095-8312.2005.00503.x; DeLAUBENFELS M. W., 1930, STANFORD UNIV BULL SER 5, V5, P24; DeSalle R, 2005, PHILOS T R SOC B, V360, P1905, DOI 10.1098/rstb.2005.1722; Diaz M.C., 2005, Zootaxa, V1012, P1; Duran S, 2004, MOL ECOL, V13, P109, DOI 10.1046/j.1365-294X.2003.02022.x; Duran S, 2004, MAR BIOL, V144, P31, DOI 10.1007/s00227-003-1178-5; Duran S, 2006, MOL PHYLOGENET EVOL, V40, P292, DOI 10.1016/j.ympev.2006.02.018; Ehrlich H, 2010, INT J BIOL MACROMOL, V47, P132, DOI 10.1016/j.ijbiomac.2010.05.007; Ehrlich H, 2010, INT J BIOL MACROMOL, V47, P141, DOI 10.1016/j.ijbiomac.2010.05.009; Ehrlich H, 2007, J EXP ZOOL PART B, V308B, P347, DOI 10.1002/jez.b.21156; Ehrlich H, 2010, INT GEOL REV, V52, P661, DOI 10.1080/00206811003679521; Ehrlich H, 2010, CHEM MATER, V22, P1462, DOI 10.1021/cm9026607; Ereskovsky AV, 2011, ZOOTAXA, P5, DOI 10.11646/zootaxa.2768.1.2; Erpenbeck D, 2002, MAR BIOL, V141, P377, DOI 10.1007/s00227-002-0785-x; Erwin PM, 2007, INVERTEBR BIOL, V126, P220, DOI 10.1111/j.1744-7410.2007.00092.x; Ferri E, 2009, FRONT ZOOL, V6, DOI 10.1186/1742-9994-6-1; Folmer O., 1994, Molecular Marine Biology and Biotechnology, V3, P294; Garrone R, 1996, J MICROSC-OXFORD, V8, P581; Gomez Patricia, 1992, Anales del Instituto de Ciencias del Mar y Limnologia Universidad Nacional Autonoma de Mexico, V19, P175; Green G, 1977, ANALES I CIENCIAS MA, V4, P79; Hebert PDN, 2003, P ROY SOC B-BIOL SCI, V270, pS96, DOI 10.1098/rsbl.2003.0025; Heim Isabel, 2010, Zootaxa, V2422, P1; Heim Isabel, 2007, V28, P361; Hellberg ME, 2006, BMC EVOL BIOL, V6, DOI 10.1186/1471-2148-6-24; Hentschel U, 2001, FEMS MICROBIOL ECOL, V35, P305, DOI 10.1111/j.1574-6941.2001.tb00816.x; Hyatt A, 1875, MEMOIRS BOSTON SOC N, V2, P399; Kiebala M, 2010, PLOS ONE, V5, DOI [10.1371/journal.pone.0013102, 10.1371/journal.pone.0011875]; Klautau M, 1999, EVOLUTION, V53, P1414, DOI 10.1111/j.1558-5646.1999.tb05406.x; KREUTER MH, 1992, COMP BIOCHEM PHYS C, V101, P183, DOI 10.1016/0742-8413(92)90217-U; Lamarao FRM, 2010, J MAR BIOL ASSOC UK, V90, P845, DOI 10.1017/S0025315409991202; Laubenfels MW, 1948, A HANCOCK FDN PUBL O, V3; Lopez JV, 2002, J HERED, V93, P27, DOI 10.1093/jhered/93.1.27; Maldonado M, 1998, B MAR SCI, V63, P417; Maldonado M, 2009, BIOL J LINN SOC, V97, P427, DOI 10.1111/j.1095-8312.2009.01202.x; Manuel M, 2003, SYST BIOL, V52, P311, DOI 10.1080/10635150390196966; Nichols SA, 2005, J EXP MAR BIOL ECOL, V323, P1, DOI 10.1016/j.jembe.2005.02.012; Nichols SA, 2005, MOL PHYLOGENET EVOL, V34, P81, DOI 10.1016/j.ympev.2004.08.019; Olivella I, 1977, MISC ZOOL, V4, P4; Padial JM, 2010, FRONT ZOOL, V7, DOI 10.1186/1742-9994-7-16; Pfenninger M, 2007, MOL ECOL, V16, P1957, DOI 10.1111/j.1365-294X.2006.03136.x; Pinheiro Ulisses dos S., 2007, Zootaxa, V1609, P1; Pires AC, 2010, BIOTA NEOTROP, V10, P339, DOI 10.1590/S1676-06032010000200035; Posada D, 2008, MOL BIOL EVOL, V25, P1253, DOI 10.1093/molbev/msn083; Redmond NE, 2007, MOL PHYLOGENET EVOL, V43, P344, DOI 10.1016/j.ympev.2006.10.021; Ronquist F, 2003, BIOINFORMATICS, V19, P1572, DOI 10.1093/bioinformatics/btg180; Rubinoff D, 2005, SYST BIOL, V54, P952, DOI 10.1080/10635150500234674; Salcedo Martinez S., 1989, Anales del Instituto de Ciencias del Mar y Limnologia Universidad Nacional Autonoma de Mexico, V15, P73; Schmitt S, 2005, J MOL EVOL, V60, P327, DOI 10.1007/s00239-004-0162-0; Simpson T, 1984, CELL BIOL SPONGES; Tamura K, 2007, MOL BIOL EVOL, V24, P1596, DOI 10.1093/molbev/msm092; Thacker RW, 2003, MAR BIOL, V142, P643, DOI 10.1007/s00227-002-0971-x; van Oppen M.J.H., 2002, P131; van Soest RWM, 2011, WORLD PORIFERA DATA; Vences M, 2005, PHILOS T R SOC B, V360, P1859, DOI 10.1098/rstb.2005.1717; Weis B, 1996, BIOCHEM SYST ECOL, V24, P1, DOI 10.1016/0305-1978(95)00101-8; White T., 1990, PCR PROTOCOLS GUIDE, P315; Wiedenmayer F., 1977, Experientia Supplementum (Basel), V28, P1; Will KW, 2005, SYST BIOL, V54, P844, DOI 10.1080/10635150500354878; Worheide G, 2007, J MAR BIOL ASSOC UK, V87, P1629, DOI 10.1017/S0025315407058274; Worheide G, 2006, MAR BIOL, V148, P907, DOI 10.1007/s00227-005-0134-y; Worheide G, 2004, MOL PHYLOGENET EVOL, V33, P816, DOI 10.1016/j.ympev.2004.07.005; Wulff JL, 2006, CAN J ZOOL, V84, P146, DOI 10.1139/Z06-019	84	39	42	0	34	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 13	2012	7	8							e42049	10.1371/journal.pone.0042049	http://dx.doi.org/10.1371/journal.pone.0042049			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	988OJ	22912682	Green Submitted, Green Published, gold			2022-12-25	WOS:000307500100006
J	Mendez, N; Abarzua-Catalan, L; Vilches, N; Galdames, HA; Spichiger, C; Richter, HG; Valenzuela, GJ; Seron-Ferre, M; Torres-Farfan, C				Mendez, Natalia; Abarzua-Catalan, Lorena; Vilches, Nelson; Galdames, Hugo A.; Spichiger, Carlos; Richter, Hans G.; Valenzuela, Guillermo J.; Seron-Ferre, Maria; Torres-Farfan, Claudia			Timed Maternal Melatonin Treatment Reverses Circadian Disruption of the Fetal Adrenal Clock Imposed by Exposure to Constant Light	PLOS ONE			English	Article							FOR-GESTATIONAL-AGE; CORTISOL PRODUCTION; GENE-EXPRESSION; DIURNAL RHYTHM; TIMING SYSTEM; RAT; FETUS; GLAND; HYPERTENSION; PINEALECTOMY	Surprisingly, in our modern 24/7 society, there is scant information on the impact of developmental chronodisruption like the one experienced by shift worker pregnant women on fetal and postnatal physiology. There are important differences between the maternal and fetal circadian systems; for instance, the suprachiasmatic nucleus is the master clock in the mother but not in the fetus. Despite this, several tissues/organs display circadian oscillations in the fetus. Our hypothesis is that the maternal plasma melatonin rhythm drives the fetal circadian system, which in turn relies this information to other fetal tissues through corticosterone rhythmic signaling. The present data show that suppression of the maternal plasma melatonin circadian rhythm, secondary to exposure of pregnant rats to constant light along the second half of gestation, had several effects on fetal development. First, it induced intrauterine growth retardation. Second, in the fetal adrenal in vivo it markedly affected the mRNA expression level of clock genes and clock-controlled genes as well as it lowered the content and precluded the rhythm of corticosterone. Third, an altered in vitro fetal adrenal response to ACTH of both, corticosterone production and relative expression of clock genes and steroidogenic genes was observed. All these changes were reversed when the mother received a daily dose of melatonin during the subjective night; supporting a role of melatonin on overall fetal development and pointing to it as a 'time giver' for the fetal adrenal gland. Thus, the present results collectively support that the maternal circadian rhythm of melatonin is a key signal for the generation and/or synchronization of the circadian rhythms in the fetal adrenal gland. In turn, low levels and lack of a circadian rhythm of fetal corticosterone may be responsible of fetal growth restriction; potentially inducing long term effects in the offspring, possibility that warrants further research.	[Mendez, Natalia; Abarzua-Catalan, Lorena; Galdames, Hugo A.; Spichiger, Carlos; Richter, Hans G.; Torres-Farfan, Claudia] Univ Austral Chile, Inst Anat Histol & Patol, Valdivia, Chile; [Vilches, Nelson; Seron-Ferre, Maria] Univ Chile, Fac Med, Programa Fisiopatol, Inst Ciencias Biomed ICBM, Santiago 7, Chile; [Valenzuela, Guillermo J.] Arrowhead Reg Med Ctr, Dept Womens Hlth, Colton, CA USA	Universidad Austral de Chile; Universidad de Chile	Mendez, N (corresponding author), Univ Austral Chile, Inst Anat Histol & Patol, Valdivia, Chile.	claudia.torres@uach.cl	Richter, Hans/D-6273-2013	Richter, Hans/0000-0002-7224-9388; Abarzua Catalan, Lorena/0000-0003-4684-0649	Fondo Nacional de Desarrollo Cientifico y Tecnologico (FONDECYT) [1080649]; Commission Nacional de Investigacion Cientifica y Tecnologica (CONICYT), Chile	Fondo Nacional de Desarrollo Cientifico y Tecnologico (FONDECYT)(Comision Nacional de Investigacion Cientifica y Tecnologica (CONICYT)CONICYT FONDECYT); Commission Nacional de Investigacion Cientifica y Tecnologica (CONICYT), Chile(Comision Nacional de Investigacion Cientifica y Tecnologica (CONICYT))	This work was supported by Grant 1080649 from Fondo Nacional de Desarrollo Cientifico y Tecnologico (FONDECYT). Dr. Abarzua-Catalan was supported by a PhD-Fellowship from Commission Nacional de Investigacion Cientifica y Tecnologica (CONICYT), Chile. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abeysena C, 2009, AUST NZ J OBSTET GYN, V49, P382, DOI 10.1111/j.1479-828X.2009.01010.x; Balsalobre A, 2000, SCIENCE, V289, P2344, DOI 10.1126/science.289.5488.2344; Barker DJP, 2006, NAT CLIN PRACT NEPHR, V2, P700, DOI 10.1038/ncpneph0344; Bellavia SL, 2006, PHYSIOL BEHAV, V89, P342, DOI 10.1016/j.physbeh.2006.06.018; Bibeau K, 2010, AM J PHYSIOL-REG I, V298, pR899, DOI 10.1152/ajpregu.00238.2009; Campino C, 2011, HORM METAB RES, V43, P337, DOI 10.1055/s-0031-1271693; Chung S, 2011, ANN NY ACAD SCI, V1220, P71, DOI 10.1111/j.1749-6632.2010.05923.x; Croteau A, 2006, AM J PUBLIC HEALTH, V96, P846, DOI 10.2105/AJPH.2004.058552; DAVIS FC, 1988, AM J PHYSIOL, V255, pR439, DOI 10.1152/ajpregu.1988.255.3.R439; DEGUCHI T, 1975, P NATL ACAD SCI USA, V72, P2814, DOI 10.1073/pnas.72.7.2814; DEPRESBRUMMER P, 1995, AM J PHYSIOL-REG I, V268, pR1111, DOI 10.1152/ajpregu.1995.268.5.R1111; Fowden AL, 2006, PHYSIOLOGY, V21, P29, DOI 10.1152/physiol.00050.2005; Gozeri E, 2008, NEUROENDOCRINOL LETT, V29, P87; Hammer F, 2006, BEST PRACT RES CL EN, V20, P337, DOI 10.1016/j.beem.2006.07.001; HONMA S, 1984, ENDOCRINOLOGY, V114, P1791, DOI 10.1210/endo-114-5-1791; Jin LZ, 2004, J OCCUP ENVIRON MED, V46, P1144, DOI 10.1097/01.jom.0000145168.21614.21; Jud C, 2006, J BIOL RHYTHM, V21, P149, DOI [10.1177/0748730406286264, 10.1177/0748730405286264]; Kachi T, 2006, CHRONOBIOL INT, V23, P289, DOI 10.1080/07420520600588713; Kapoor A, 2006, J PHYSIOL-LONDON, V572, P31, DOI 10.1113/jphysiol.2006.105254; KENNAWAY DJ, 1992, J CLIN ENDOCR METAB, V75, P367, DOI 10.1210/jc.75.2.367; Kivimaki M, 2011, PLOS MED, V8, DOI 10.1371/journal.pmed.1001138; Knutsson A, 2003, OCCUP MED-OXFORD, V53, P103, DOI 10.1093/occmed/kqg048; LIGGINS GC, 1994, REPROD FERT DEVELOP, V6, P141, DOI 10.1071/RD9940141; MATSUMOTO T, 1991, AM J OBSTET GYNECOL, V165, P1777, DOI 10.1016/0002-9378(91)90032-M; MCMILLEN IC, 1989, J ENDOCRINOL, V120, P459, DOI 10.1677/joe.0.1200459; Nathanielsz PW, 2006, ILAR J, V47, P73, DOI 10.1093/ilar.47.1.73; Novakova M, 2010, J BIOL RHYTHM, V25, P350, DOI 10.1177/0748730410377967; NOWAK R, 1990, J ENDOCRINOL, V125, P97, DOI 10.1677/joe.0.1250097; NuessleinHildesheim B, 1996, AM J PHYSIOL-REG I, V271, pR1388, DOI 10.1152/ajpregu.1996.271.5.R1388; Okatani Y, 1998, J PINEAL RES, V25, P129, DOI 10.1111/j.1600-079X.1998.tb00550.x; Osmond C, 2000, ENVIRON HEALTH PERSP, V108, P545, DOI 10.1289/ehp.00108s3545; Oster H, 2006, CELL METAB, V4, P163, DOI 10.1016/j.cmet.2006.07.002; Pennell CE, 2009, EARLY LIFE ORIGINS OF HUMAN HEALTH AND DISEASE, P205, DOI 10.1159/000221166; Reiter RJ, 1998, PROG NEUROBIOL, V56, P359, DOI 10.1016/S0301-0082(98)00052-5; REPPERT SM, 1986, ENDOCRINOLOGY, V119, P1763, DOI 10.1210/endo-119-4-1763; Richter HG, 2008, ENDOCRINOLOGY, V149, P995, DOI 10.1210/en.2007-1009; Richter HG, 2004, BIOL RES, V37, P11, DOI 10.4067/S0716-97602004000100003; Schenker S, 1998, CLIN NUTR, V17, P159, DOI 10.1016/S0261-5614(98)80052-6; Schmittgen TD, 2008, NAT PROTOC, V3, P1101, DOI 10.1038/nprot.2008.73; Seron-Ferre M, 2004, PEDIATR RES, V55, P531; Seron-Ferre M, 2012, MOL CELL ENDOCRINOL, V349, P68, DOI 10.1016/j.mce.2011.07.039; Simonneaux V, 2011, ENDOCRINOLOGY, V152, P1734, DOI 10.1210/en.2011-0226; Son GH, 2011, FRONT NEUROENDOCRIN, V32, P451, DOI 10.1016/j.yfrne.2011.07.003; Son GH, 2008, P NATL ACAD SCI USA, V105, P20970, DOI 10.1073/pnas.0806962106; Torres-Farfan C, 2006, ENDOCRINOLOGY, V147, P4618, DOI 10.1210/en.2006-0628; Torres-Farfan C, 2004, J PHYSIOL-LONDON, V554, P841, DOI 10.1113/jphysiol.2003.056465; Torres-Farfan C, 2011, ENDOCRINOLOGY, V152, P1891, DOI 10.1210/en.2010-1260; Torres-Farfan C, 2009, ENDOCRINOLOGY, V150, P2717, DOI 10.1210/en.2008-1683; Torres-Farfan C, 2006, J PINEAL RES, V41, P58, DOI 10.1111/j.1600-079X.2006.00331.x; Valenzuela FJ, 2012, ENDOCRINOL DIABETES, V5, P6; Varcoe TJ, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018504; WALKER CD, 1986, ENDOCRINOLOGY, V118, P1445, DOI 10.1210/endo-118-4-1445; Witlin AG, 2002, BIOL REPROD, V67, P1025, DOI 10.1095/biolreprod.101.002196; Wotus C, 1998, ENDOCRINOLOGY, V139, P4397, DOI 10.1210/en.139.10.4397; YELLON SM, 1988, BIOL REPROD, V39, P1093, DOI 10.1095/biolreprod39.5.1093	55	80	87	0	22	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 13	2012	7	8							e42713	10.1371/journal.pone.0042713	http://dx.doi.org/10.1371/journal.pone.0042713			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	988OJ	22912724	Green Published, Green Submitted, gold			2022-12-25	WOS:000307500100022
J	Berhanu, WM; Hansmann, UHE				Berhanu, Workalemahu M.; Hansmann, Ulrich H. E.			Structure and Dynamics of Amyloid-beta Segmental Polymorphisms	PLOS ONE			English	Article							PARTICLE MESH EWALD; MOLECULAR-DYNAMICS; PROTEIN AGGREGATION; FORCE-FIELD; EARLY STEPS; FIBRILS; SIMULATIONS; STABILITY; PEPTIDE; A-BETA(1-40)	It is believed that amyloid-beta (A beta) aggregates play a role in the pathogenesis of Alzheimer's disease. A beta molecules form beta-sheet structures with multiple interaction sites. This polymorphism gives rise to differences in morphology, physicochemical property and level of cellular toxicity. We have investigated the conformational stability of various segmental polymorphisms using molecular dynamics simulations and find that the segmental polymorphic models of A beta retain a U-shaped architecture. Our results demonstrate the importance of inter-sheet side chain-side chain contacts, hydrophobic contacts among the strands (beta 1 and beta 2) and of salt bridges in stabilizing the aggregates. Residues in beta-sheet regions have smaller fluctuation while those at the edge and loop region are more mobile. The inter-peptide salt bridges between Asp23 and Lys28 are strong compared to intra-chain salt bridge and there is an exchange of the inter-chain salt-bridge with intra-chain salt bridge. As our results suggest that A beta exists under physiological conditions as an ensemble of distinct segmental polymorphs, it may be necessary to account in the development of therapeutics for Alzheimer's disease the differences in structural stability and aggregation behavior of the various A beta polymorphic forms.	[Berhanu, Workalemahu M.; Hansmann, Ulrich H. E.] Univ Oklahoma, Dept Chem & Biochem, Norman, OK 73019 USA	University of Oklahoma System; University of Oklahoma - Norman	Berhanu, WM (corresponding author), Univ Oklahoma, Dept Chem & Biochem, Norman, OK 73019 USA.	uhansmann@ou.edu	Hansmann, Ulrich/L-4597-2017	Hansmann, Ulrich/0000-0002-0700-4835	National Institutes of Health [GM62838]; Office of Science of the U.S. Department of Energy [DE-AC02-05CH11231]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM062838] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Office of Science of the U.S. Department of Energy(United States Department of Energy (DOE)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	The authors acknowledge support from the National Institutes of Health (grant number GM62838). This research used resources of the National Energy Research Scientific Computing Center, which is supported by the Office of Science of the U. S. Department of Energy under contract no. DE-AC02-05CH11231. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anand P, 2011, MOL SIMULAT, V37, P440, DOI 10.1080/08927022.2011.551879; Ashe KH, 2010, NEURON, V66, P631, DOI 10.1016/j.neuron.2010.04.031; Baumketner A, 2008, P NATL ACAD SCI USA, V105, P6027, DOI 10.1073/pnas.0708193105; Berhanu WM, 2012, BIOPOLYMERS, V98, P131, DOI 10.1002/bip.21731; Berhanu WM, 2011, BIOPOLYMERS, V95, P573, DOI 10.1002/bip.21611; Berhanu WM, 2012, J MOL MODEL, V18, P1129, DOI 10.1007/s00894-011-1123-3; Berhanu WM, 2012, J MOL MODEL, V18, P891, DOI 10.1007/s00894-011-1030-7; Berhanu WM, 2011, J MOL MODEL, V17, P2423, DOI 10.1007/s00894-010-0912-4; Berhanu WM, 2010, J MOL MODEL, V16, P1093, DOI 10.1007/s00894-009-0610-2; Berryman JT, 2011, BIOPHYS J, V100, P2234, DOI 10.1016/j.bpj.2011.02.060; Bussi G, 2007, J CHEM PHYS, V126, DOI 10.1063/1.2408420; Case DA, 2005, J COMPUT CHEM, V26, P1668, DOI 10.1002/jcc.20290; Chebaro Y, 2012, J PHYS CHEM B, V116, P8412, DOI 10.1021/jp2118778; Chebaro Y, 2009, PROTEINS, V75, P442, DOI 10.1002/prot.22254; Chiti F, 2006, ANNU REV BIOCHEM, V75, P333, DOI 10.1146/annurev.biochem.75.101304.123901; Colletier JP, 2011, P NATL ACAD SCI USA, V108, P16938, DOI 10.1073/pnas.1112600108; DARDEN T, 1993, J CHEM PHYS, V98, P10089, DOI 10.1063/1.464397; Dzubiella J, 2008, J AM CHEM SOC, V130, P14000, DOI 10.1021/ja805562g; Eisenberg D, 2012, CELL, V148, P1188, DOI 10.1016/j.cell.2012.02.022; ESSMANN U, 1995, J CHEM PHYS, V103, P8577, DOI 10.1063/1.470117; Fawzi NL, 2008, BIOPHYS J, V94, P2007, DOI 10.1529/biophysj.107.121467; Greenwald J, 2010, STRUCTURE, V18, P1244, DOI 10.1016/j.str.2010.08.009; Han M, 2011, J CHEM PHYS, V134, DOI 10.1063/1.3586804; Hardy J, 2002, SCIENCE, V297, P353, DOI 10.1126/science.1072994; Hess B, 2008, J CHEM THEORY COMPUT, V4, P116, DOI 10.1021/ct700200b; Homeyer N, 2012, MOL INFORM, V31, P114, DOI 10.1002/minf.201100135; Hornak V, 2006, PROTEINS, V65, P712, DOI 10.1002/prot.21123; Hu KN, 2011, BIOPHYS J, V101, P2242, DOI 10.1016/j.bpj.2011.09.051; Hu XY, 2009, P NATL ACAD SCI USA, V106, P20324, DOI 10.1073/pnas.0911281106; Huet A, 2006, BIOPHYS J, V91, P3829, DOI 10.1529/biophysj.106.090993; Humphrey W, 1996, J MOL GRAPH MODEL, V14, P33, DOI 10.1016/0263-7855(96)00018-5; JORGENSEN WL, 1983, J CHEM PHYS, V79, P926, DOI 10.1063/1.445869; KABSCH W, 1983, BIOPOLYMERS, V22, P2577, DOI 10.1002/bip.360221211; Knowles TP, 2007, SCIENCE, V318, P1900, DOI 10.1126/science.1150057; Laganowsky A, 2012, SCIENCE, V335, P1228, DOI 10.1126/science.1213151; Landau M, 2011, PLOS BIOL, V9, DOI 10.1371/journal.pbio.1001080; Lemkul JA, 2010, J PHYS CHEM B, V114, P1652, DOI 10.1021/jp9110794; Li MS, 2010, PHYS REV LETT, V105, DOI 10.1103/PhysRevLett.105.218101; Lindorff-Larsen K, 2010, PROTEINS, V78, P1950, DOI 10.1002/prot.22711; Luhrs T, 2005, P NATL ACAD SCI USA, V102, P17342, DOI 10.1073/pnas.0506723102; Ma BY, 2006, CURR OPIN CHEM BIOL, V10, P445, DOI 10.1016/j.cbpa.2006.08.018; Masman MF, 2009, J PHYS CHEM B, V113, P11710, DOI 10.1021/jp901057w; Meersman F, 2006, BBA-PROTEINS PROTEOM, V1764, P452, DOI 10.1016/j.bbapap.2005.10.021; Miller Y, 2010, CHEM REV, V110, P4820, DOI 10.1021/cr900377t; Miller Y, 2009, BIOPHYS J, V97, P1168, DOI 10.1016/j.bpj.2009.05.042; MIYAMOTO S, 1992, J COMPUT CHEM, V13, P952, DOI 10.1002/jcc.540130805; Nguyen PH, 2011, PHYS CHEM CHEM PHYS, V13, P9778, DOI 10.1039/c1cp20323a; Paravastu AK, 2009, P NATL ACAD SCI USA, V106, P7443, DOI 10.1073/pnas.0812033106; PARRINELLO M, 1981, J APPL PHYS, V52, P7182, DOI 10.1063/1.328693; Petkova AT, 2005, SCIENCE, V307, P262, DOI 10.1126/science.1105850; Petkova AT, 2006, BIOCHEMISTRY-US, V45, P498, DOI 10.1021/bi051952q; Qiang W, 2012, P NATL ACAD SCI USA, V109, P4443, DOI 10.1073/pnas.1111305109; Rojas A, 2010, J MOL BIOL, V404, P537, DOI 10.1016/j.jmb.2010.09.057; Sachse C, 2008, P NATL ACAD SCI USA, V105, P7462, DOI 10.1073/pnas.0712290105; Sawaya MR, 2007, NATURE, V447, P453, DOI 10.1038/nature05695; Schmidt M, 2009, P NATL ACAD SCI USA, V106, P19813, DOI 10.1073/pnas.0905007106; Takeda T, 2008, BIOPHYS J, V95, P1758, DOI 10.1529/biophysj.108.131698; Takeda T, 2007, J MOL BIOL, V368, P1202, DOI 10.1016/j.jmb.2007.02.066; Takeda T, 2009, BIOPHYS J, V96, P4428, DOI 10.1016/j.bpj.2009.03.015; Takeda T, 2009, BIOPHYS J, V96, P442, DOI 10.1016/j.bpj.2008.10.008; Tarus B, 2006, J AM CHEM SOC, V128, P16159, DOI 10.1021/ja064872y; Tycko R, 2009, BIOCHEMISTRY-US, V48, P6072, DOI 10.1021/bi9002666; Van der Spoel D, 2005, J COMPUT CHEM, V26, P1701, DOI 10.1002/jcc.20291; Vitagliano L, 2009, BIOPOLYMERS, V91, P1161, DOI 10.1002/bip.21182; Wei GH, 2007, PRION, V1, P3, DOI 10.4161/pri.1.1.3969; Wiltzius JJW, 2009, NAT STRUCT MOL BIOL, V16, P973, DOI 10.1038/nsmb.1643; Xue WF, 2010, PRION, V4, P20, DOI 10.4161/pri.4.1.11378; Zheng J, 2007, BIOPHYS J, V93, P3046, DOI 10.1529/biophysj.107.110700	68	58	58	0	24	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 24	2012	7	7							e41479	10.1371/journal.pone.0041479	http://dx.doi.org/10.1371/journal.pone.0041479			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	978NX	22911797	Green Published, gold, Green Submitted			2022-12-25	WOS:000306751300047
J	Pacheco, A; Twiss, JL				Pacheco, Almudena; Twiss, Jeffery L.			Localized IRES-Dependent Translation of ER Chaperone Protein mRNA in Sensory Axons	PLOS ONE			English	Article							RIBOSOMAL ENTRY SITE; INTERNAL INITIATION; MEDIATED TRANSLATION; SYMPATHETIC NEURONS; PERIPHERAL-NERVE; GROWTH CONES; ACTIN; PHOSPHORYLATION; TRANSPORT; REPERTOIRE	Transport of neuronal mRNAs into distal nerve terminals and growth cones allows axonal processes to generate proteins autonomous from the cell body. While the mechanisms for targeting mRNAs for transport into axons has received much attention, how specificity is provided to the localized translational apparatus remains largely unknown. In other cellular systems, protein synthesis can be regulated by both cap-dependent and cap-independent mechanisms. The possibility that these mechanisms are used by axons has not been tested. Here, we have used expression constructs encoding axonally targeted bicistronic reporter mRNAs to determine if sensory axons can translate mRNAs through cap-independent mechanisms. Our data show that the well-defined IRES element of encephalomyocarditis virus (EMCV) can drive internal translational initiation of a bicistronic reporter mRNA in distal DRG axons. To test the potential for cap-independent translation of cellular mRNAs, we asked if calreticulin or grp78/BiP mRNA 59UTRs might have IRES activity in axons. Only grp78/BiP mRNA 5'UTR showed clear IRES activity in axons when placed between the open reading frames of diffusion limited fluorescent reporters. Indeed, calreticulin's 5'UTR provided an excellent control for potential read through by ribosomes, since there was no evidence of internal initiation when this UTR was placed between reporter ORFs in a bicistronic mRNA. This study shows that axons have the capacity to translate through internal ribosome entry sites, but a simple binary choice between cap-dependent and cap-independent translation cannot explain the specificity for translation of individual mRNAs in distal axons.	[Pacheco, Almudena; Twiss, Jeffery L.] Drexel Univ, Dept Biol, Philadelphia, PA 19104 USA	Drexel University	Pacheco, A (corresponding author), Drexel Univ, Dept Biol, Philadelphia, PA 19104 USA.	jeff.twiss@drexel.edu			NIH [R01-NS041596]; Miriam and Sheldon F. Aldelson Medical Research Foundation; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS041596] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Miriam and Sheldon F. Aldelson Medical Research Foundation; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This work was supported by grants from NIH (R01-NS041596) and the Miriam and Sheldon F. Aldelson Medical Research Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aakalu G, 2001, NEURON, V30, P489, DOI 10.1016/S0896-6273(01)00295-1; Andreassi C, 2009, TRENDS CELL BIOL, V19, P465, DOI 10.1016/j.tcb.2009.06.001; Aschrafi A, 2008, J NEUROSCI, V28, P12581, DOI 10.1523/JNEUROSCI.3338-08.2008; Ben-Yaakov K, 2012, EMBO J, V31, P1350, DOI 10.1038/emboj.2011.494; Bochkov YA, 2006, BIOTECHNIQUES, V41, P283, DOI 10.2144/000112243; Borman AM, 1997, NUCLEIC ACIDS RES, V25, P925, DOI 10.1093/nar/25.5.925; Brostrom MA, 2003, CELL CALCIUM, V34, P345, DOI 10.1016/S0143-4160(03)00127-1; Dobson T, 2005, NUCLEIC ACIDS RES, V33, P2929, DOI 10.1093/nar/gki605; Donnelly CJ, 2011, EMBO J, V30, P4665, DOI 10.1038/emboj.2011.347; Donnelly CJ, 2010, TRAFFIC, V11, P1498, DOI 10.1111/j.1600-0854.2010.01118.x; Eng H, 1999, J NEUROSCI, V19, P1; Fitzgerald KD, 2009, BBA-GENE REGUL MECH, V1789, P518, DOI 10.1016/j.bbagrm.2009.07.004; Gale E.F., 1981, MOL BASIS ANTIBIOTIC, Vsecond; GROLLMAN AP, 1967, J BIOL CHEM, V242, P3226; Gromeier M, 1999, J VIROL, V73, P958, DOI 10.1128/JVI.73.2.958-964.1999; Gumy LF, 2011, RNA, V17, P85, DOI 10.1261/rna.2386111; Hanz S, 2003, NEURON, V40, P1095, DOI 10.1016/S0896-6273(03)00770-0; Hengst U, 2006, J NEUROSCI, V26, P5727, DOI 10.1523/JNEUROSCI.5229-05.2006; Huttelmaier S, 2005, NATURE, V438, P512, DOI 10.1038/nature04115; JANG SK, 1988, J VIROL, V62, P2636, DOI 10.1128/JVI.62.8.2636-2643.1988; Kim YK, 2002, BIOCHEM BIOPH RES CO, V297, P224, DOI 10.1016/S0006-291X(02)02154-X; Komar AA, 2011, CELL CYCLE, V10, P229, DOI 10.4161/cc.10.2.14472; Le Quesne JPC, 2010, J PATHOL, V220, P140, DOI 10.1002/path.2627; Lee SK, 2003, J CELL SCI, V116, P4467, DOI 10.1242/jcs.00745; Leung KM, 2006, NAT NEUROSCI, V9, P1247, DOI 10.1038/nn1775; Licursi M, 2011, GENE THER, V18, P631, DOI 10.1038/gt.2011.11; MACEJAK DG, 1991, NATURE, V353, P90, DOI 10.1038/353090a0; Martinez-Salas E, 2008, J GEN VIROL, V89, P611, DOI 10.1099/vir.0.83426-0; Murashov AK, 2007, FASEB J, V21, P656, DOI 10.1096/fj.06-6155com; Natera-Naranjo O, 2010, RNA, V16, P1516, DOI 10.1261/rna.1833310; Pacheco A, 2010, J BIOMED BIOTECHNOL, DOI 10.1155/2010/458927; PELLETIER J, 1988, NATURE, V334, P320, DOI 10.1038/334320a0; Perlson E, 2005, NEURON, V45, P715, DOI 10.1016/j.neuron.2005.01.023; Pestova TV, 2001, P NATL ACAD SCI USA, V98, P7029, DOI 10.1073/pnas.111145798; Pinkstaff JK, 2001, P NATL ACAD SCI USA, V98, P2770, DOI 10.1073/pnas.051623398; SARNOW P, 1989, P NATL ACAD SCI USA, V86, P5795, DOI 10.1073/pnas.86.15.5795; Sasaki Y, 2010, J NEUROSCI, V30, P9349, DOI 10.1523/JNEUROSCI.0499-10.2010; Sonenberg N, 2003, CURR OPIN STRUC BIOL, V13, P56, DOI 10.1016/S0959-440X(03)00009-5; Spriggs KA, 2005, CELL DEATH DIFFER, V12, P585, DOI 10.1038/sj.cdd.4401642; Spriggs KA, 2008, BIOL CELL, V100, P27, DOI 10.1042/BC20070098; Twiss JL, 2009, TRENDS CELL BIOL, V19, P236, DOI 10.1016/j.tcb.2009.02.007; Vuppalanchi D, 2012, MOL CELL NE IN PRESS; Vuppalanchi D, 2010, J BIOL CHEM, V285, P18025, DOI 10.1074/jbc.M109.061333; Walker BA, 2012, GENE THER; Wang WL, 2007, DEV NEUROBIOL, V67, P1166, DOI 10.1002/dneu.20511; Willis D, 2005, J NEUROSCI, V25, P778, DOI 10.1523/JNEUROSCI.4235-04.2005; Willis DE, 2007, J CELL BIOL, V178, P965, DOI 10.1083/jcb.200703209; Wu KY, 2005, NATURE, V436, P1020, DOI 10.1038/nature03885; Yao JQ, 2006, NAT NEUROSCI, V9, P1265, DOI 10.1038/nn1773; Yudin D, 2008, NEURON, V59, P241, DOI 10.1016/j.neuron.2008.05.029; Zivraj KH, 2010, J NEUROSCI, V30, P15464, DOI 10.1523/JNEUROSCI.1800-10.2010	51	11	11	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 24	2012	7	7							e40788	10.1371/journal.pone.0040788	http://dx.doi.org/10.1371/journal.pone.0040788			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	978NX	22911708	Green Published, Green Submitted, gold			2022-12-25	WOS:000306751300014
J	Sabol, I; Matovina, M; Si-Mohamed, A; Grce, M				Sabol, Ivan; Matovina, Mihaela; Si-Mohamed, Ali; Grce, Magdalena			Characterization and Whole Genome Analysis of Human Papillomavirus Type 16 E1-1374(boolean AND)63nt Variants	PLOS ONE			English	Article							CERVICAL INTRAEPITHELIAL NEOPLASIA; 16 E6 VARIANTS; HUMAN-PAPILLOMAVIRUS-16 E6; GENE-EXPRESSION; E1 GENE; PROTEIN; CODON; SEQUENCE; CANCER; E7	Background: The variation of the most common Human papillomavirus (HPV) type found in cervical cancer, the HPV16, has been extensively investigated in almost all viral genes. The E1 gene variation, however, has been rarely studied. The main objective of the present investigation was to analyze the variability of the E6 and E1 genes, focusing on the recently identified E1-1374(boolean AND)63nt variant. Methodology/Principal Findings: Variation within the E6 of 786 HPV16 positive cervical samples was analyzed using high-resolution melting, while the E1-1374(boolean AND)63nt duplication was assayed by PCR. Both techniques were supplemented with sequencing. The E1-1374(boolean AND)63nt duplication was linked with the E-G350 and the E-C109/G350 variants. In comparison to the referent HPV16, the E1-1374(boolean AND)63nt E-G350 variant was significantly associated with lower grade cervical lesions (p = 0.029), while the E1-1374(boolean AND)63nt E-C109/G350 variant was equally distributed between high and low grade lesions. The E1-1374(boolean AND)63nt variants were phylogenetically closest to E-G350 variant lineage (A2 sub-lineage based on full genome classification). The major differences between E1-1374(boolean AND)63nt variants were within the LCR and the E6 region. On the other hand, changes within the E1 region were the major differences from the A2 sub-lineage, which has been historically but inconclusively associated with high grade cervical disease. Thus, the shared variations cannot explain the particular association of the E1-1374(boolean AND)63nt variant with lower grade cervical lesions. Conclusions/Significance: The E1 region has been thus far considered to be well conserved among all HPVs and therefore uninteresting for variability studies. However, this study shows that the variations within the E1 region could possibly affect cervical disease, since the E1-1374(boolean AND)63nt E-G350 variant is significantly associated with lower grade cervical lesions, in comparison to the A1 and A2 sub-lineage variants. Furthermore, it appears that the silent variation 109T>C of the E-C109/G350 variant might have a significant role in the viral life cycle and warrants further study.	[Sabol, Ivan; Grce, Magdalena] Rudjer Boskovic Inst, Div Mol Med, Zagreb, Croatia; [Matovina, Mihaela] Univ Rijeka, Sch Med, Dept Microbiol & Parasitol, Rijeka, Croatia; [Si-Mohamed, Ali] Hop Europeen Georges Pompidou, Virol Lab, Paris, France	Rudjer Boskovic Institute; University of Rijeka; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Europeen Georges-Pompidou - APHP; UDICE-French Research Universities; Universite Paris Cite	Sabol, I (corresponding author), Rudjer Boskovic Inst, Div Mol Med, Zagreb, Croatia.	grce@irb.hr	Matovina, Mihaela/J-3834-2012; Matovina, Mihaela/P-7426-2019; Sabol, Ivan/B-7455-2012; GRCE, MAGDALENA/ABD-2768-2020	Matovina, Mihaela/0000-0001-7647-3339; Sabol, Ivan/0000-0002-5753-8528; Grce, Magdalena/0000-0001-6178-8418	Croatian Ministry of Science, Education and Sports [098-0982464-2510]	Croatian Ministry of Science, Education and Sports(Ministry of Science, Education and Sports, Republic of Croatia)	This work was supported by the Croatian Ministry of Science, Education and Sports grant no. 098-0982464-2510 (http://public.mzos.hr). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abbate EA, 2004, GENE DEV, V18, P1981, DOI 10.1101/gad.1220104; ANDROPHY EJ, 1987, EMBO J, V6, P989, DOI 10.1002/j.1460-2075.1987.tb04849.x; [Anonymous], 2007, MON EV CARC RISKS HU; Asadurian Y, 2007, J MED VIROL, V79, P1751, DOI 10.1002/jmv.20978; Bernard HU, 2006, INT J CANCER, V118, P1071, DOI 10.1002/ijc.21655; Bernard HU, 2002, ANTIVIR THER, V7, P219; Bhattacharjee B, 2006, GYNECOL ONCOL, V100, P372, DOI 10.1016/j.ygyno.2005.09.016; Bhattacharjee B, 2008, VIROLOGY, V377, P143, DOI 10.1016/j.virol.2008.04.007; Bogovac Z, 2011, ACTA DERMATOVEN ALP, V20, P135; Bontkes HJ, 1998, INT J CANCER, V78, P166, DOI 10.1002/(SICI)1097-0215(19981005)78:2<166::AID-IJC8>3.0.CO;2-X; Brady CS, 1999, J GEN VIROL, V80, P3233, DOI 10.1099/0022-1317-80-12-3233; Burk RD, 2003, CANCER RES, V63, P7215; Burk Robert D, 2011, Acta Dermatovenerol Alp Pannonica Adriat, V20, P113; Chakrabarti O, 2004, J VIROL, V78, P5934, DOI 10.1128/JVI.78.11.5934-5945.2004; CHEN GFT, 1990, NUCLEIC ACIDS RES, V18, P1465, DOI 10.1093/nar/18.6.1465; Chen ZG, 2005, J VIROL, V79, P7014, DOI 10.1128/JVI.79.11.7014-7023.2005; Chen ZG, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020183; Cid-Arregui A, 2003, J VIROL, V77, P4928, DOI 10.1128/JVI.77.8.4928-4937.2003; de Boer MA, 2004, GYNECOL ONCOL, V94, P488, DOI 10.1016/j.ygyno.2004.05.037; de Sanjose S, 2010, LANCET ONCOL, V11, P1048, DOI 10.1016/S1470-2045(10)70230-8; Enemark EJ, 2000, MOL CELL, V6, P149, DOI 10.1016/S1097-2765(00)00016-2; Enemark EJ, 2006, NATURE, V442, P270, DOI 10.1038/nature04943; FU CW, 1994, MOL GEN GENET, V243, P434, DOI 10.1007/BF00280474; Giannoudis A, 2001, J PATHOL, V193, P295, DOI 10.1002/1096-9896(2000)9999:9999&lt;::AID-PATH809&gt;3.0.CO;2-C; Grodzki M, 2006, CANCER EPIDEM BIOMAR, V15, P820, DOI 10.1158/1055-9965.EPI-05-0864; GRUNERT S, 1994, EMBO J, V13, P3618, DOI 10.1002/j.1460-2075.1994.tb06669.x; Hu XR, 2001, J PATHOL, V195, P307, DOI 10.1002/path.944; Hu XR, 1999, INT J CANCER, V83, P34, DOI 10.1002/(SICI)1097-0215(19990924)83:1<34::AID-IJC7>3.0.CO;2-Q; Hubert WG, 2005, J VIROL, V79, P5914, DOI 10.1128/JVI.79.10.5914-5922.2005; Huertas-Salgado A, 2011, VIROLOGY, V410, P201, DOI 10.1016/j.virol.2010.10.039; Kammer C, 2002, BRIT J CANCER, V86, P269, DOI 10.1038/sj.bjc.6600024; Kanodia S, 2007, CURR CANCER DRUG TAR, V7, P79, DOI 10.2174/156800907780006869; Karplus K, 2009, NUCLEIC ACIDS RES, V37, pW492, DOI 10.1093/nar/gkp403; Kelley LA, 2009, NAT PROTOC, V4, P363, DOI 10.1038/nprot.2009.2; Lee K, 2008, VIRUS RES, V131, P106, DOI 10.1016/j.virusres.2007.08.003; Lentz MR, 2006, VIROL J, V3, DOI 10.1186/1743-422X-3-13; LOOMAN AC, 1991, YEAST, V7, P157, DOI 10.1002/yea.320070209; Lurchachaiwong W, 2009, VIRUS GENES, V39, P30, DOI 10.1007/s11262-009-0363-0; Matovina M, 2009, GYNECOL ONCOL, V113, P120, DOI 10.1016/j.ygyno.2008.12.004; Milutin-Gagperov N, 2007, COLLEGIUM ANTROPOL, V31, P89; Munoz N, 2003, NEW ENGL J MED, V348, P518, DOI 10.1056/NEJMoa021641; Nindl I, 1999, INT J CANCER, V82, P203, DOI 10.1002/(SICI)1097-0215(19990719)82:2<203::AID-IJC9>3.0.CO;2-9; O'Connor M, 1995, HUMAN PAPILLOMAVIRUS, pIII21; Ortiz M, 2006, J CLIN MICROBIOL, V44, P1428, DOI 10.1128/JCM.44.4.1428-1434.2006; OVANINRAKIC A, 2003, GYNAECOL PERINATOL, V12, P148; Pettersen EF, 2004, J COMPUT CHEM, V25, P1605, DOI 10.1002/jcc.20084; Sabol I, 2008, J MED VIROL, V80, P2134, DOI 10.1002/jmv.21304; Sabol I, 2009, J VIROL METHODS, V162, P142, DOI 10.1016/j.jviromet.2009.07.029; Sailaja G, 1999, J GEN VIROL, V80, P1715, DOI 10.1099/0022-1317-80-7-1715; Smith B, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021375; Sotlar K, 2004, J CLIN MICROBIOL, V42, P3176, DOI 10.1128/JCM.42.7.3176-3184.2004; Sreekumar E, 2005, INT J IMMUNOGENET, V32, P355, DOI 10.1111/j.1744-313X.2005.00538.x; Stacey SN, 2000, J VIROL, V74, P7284, DOI 10.1128/JVI.74.16.7284-7297.2000; SVERDRUP F, 1997, HUMAN PAPILLOMAVIRUS, P37; Tamura K, 2011, MOL BIOL EVOL, V28, P2731, DOI 10.1093/molbev/msr121; van Duin M, 2000, J GEN VIROL, V81, P317, DOI 10.1099/0022-1317-81-2-317; Volkova OA, 2010, J BIOMOL STRUCT DYN, V27, P611, DOI 10.1080/07391102.2010.10508575; Wheeler CM, 1997, J CLIN MICROBIOL, V35, P11, DOI 10.1128/JCM.35.1.11-19.1997; Wilson VG, 2002, VIRUS GENES, V24, P275, DOI 10.1023/A:1015336817836; Wisniewska MB, 2007, J MOL BIOL, V371, P569, DOI 10.1016/j.jmb.2007.05.079; Yamada T, 1997, J VIROL, V71, P2463, DOI 10.1128/JVI.71.3.2463-2472.1997; Yasugi T, 1997, J VIROL, V71, P891, DOI 10.1128/JVI.71.2.891-899.1997; Zehbe I, 1998, LANCET, V352, P1441, DOI 10.1016/S0140-6736(05)61263-9; Zehbe I, 2001, INT J CANCER, V94, P711, DOI 10.1002/ijc.1520; Zehbe I, 1998, CANCER RES, V58, P829; Zehbe I, 2009, VIROLOGY, V383, P69, DOI 10.1016/j.virol.2008.09.036; Zhang Y, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-40; Zhao KN, 2003, VIRUS RES, V98, P95, DOI 10.1016/j.virusres.2003.08.019; Zhao KN, 2011, REV MED VIROL, V21, P397, DOI 10.1002/rmv.707; Zheng ZM, 2006, FRONT BIOSCI-LANDMRK, V11, P2286, DOI 10.2741/1971; Zouridis H, 2008, BIOPHYS J, V95, P1018, DOI 10.1529/biophysj.107.126128; Zuna RE, 2009, INT J CANCER, V125, P2609, DOI 10.1002/ijc.24706	72	11	12	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 24	2012	7	7							e41045	10.1371/journal.pone.0041045	http://dx.doi.org/10.1371/journal.pone.0041045			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	978NX	22911739	gold, Green Published, Green Submitted			2022-12-25	WOS:000306751300022
J	Preusse, M; Stastna, M; Freistuhler, H; Peeters, F				Preusse, Martina; Stastna, Marek; Freistuehler, Heinrich; Peeters, Frank			Intrinsic Breaking of Internal Solitary Waves in a Deep Lake	PLOS ONE			English	Article							INSTABILITIES; GENERATION; TURBULENCE	Based on simulations with the Dubreil-Jacotin-Long (DJL) equation, the limiting amplitude and the breaking mechanisms of internal solitary waves of depression (ISWs) are predicted for different background stratifications. These theoretical predictions are compared to the amplitude and the stability of the leading internal solitary waves of more than 200 trains of ISWs observed in the centre of a sub-basin of Lake Constance. The comparison of the model results with the field observations indicates that the simulated limiting amplitude of the ISWs provides an excellent prediction of the critical wave height above which ISWs break in the field. Shear instabilities and convective instabilities are each responsible for about half of the predicted wave breaking events. The data suggest the presence of core-like structures within the convectively unstable waves, but fully developed and stable cores were not observed. The lack of stable trapped cores in the field can be explained by the results from dynamic simulations of ISWs with trapped cores which demonstrate that even slight disturbances of the background stratification cause trapped cores to become unstable.	[Preusse, Martina; Peeters, Frank] Univ Konstanz, Limnol Inst, Constance, Germany; [Stastna, Marek] Univ Waterloo, Dept Appl Math, Waterloo, ON N2L 3G1, Canada; [Preusse, Martina; Freistuehler, Heinrich] Univ Konstanz, Dept Math & Stat, Constance, Germany	University of Konstanz; University of Waterloo; University of Konstanz	Preusse, M (corresponding author), Univ Konstanz, Limnol Inst, Constance, Germany.	martina.preusse@uni-konstanz.de		Stastna, Marek/0000-0003-1770-2044	German research association (DFG) [PE 701/4-1]; Natural Sciences and Engineering Research Council of Canada	German research association (DFG)(German Research Foundation (DFG)); Natural Sciences and Engineering Research Council of Canada(Natural Sciences and Engineering Research Council of Canada (NSERC)CGIAR)	This work was supported by the German research association (DFG, PE 701/4-1), and the Natural Sciences and Engineering Research Council of Canada (M.S.). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Barad MF, 2010, J FLUID MECH, V644, P61, DOI 10.1017/S0022112009992035; Boegman L, 2005, LIMNOL OCEANOGR, V50, P1620, DOI 10.4319/lo.2005.50.5.1620; Bourgault D, 2007, GEOPHYS RES LETT, V34, DOI 10.1029/2006GL028462; Carr M, 2008, PHYS FLUIDS, V20; Carr M, 2011, J FLUID MECH, V683, P263, DOI 10.1017/jfm.2011.261; de la Fuente A, 2010, J GEOPHYS RES-OCEANS, V115, DOI 10.1029/2009JC005839; Fructus D, 2009, J FLUID MECH, V620, P1, DOI 10.1017/S0022112008004898; Gloor M, 2000, J GEOPHYS RES-OCEANS, V105, P8629, DOI 10.1029/1999JC900303; Helfrich KR, 2010, NONLINEAR PROC GEOPH, V17, P303, DOI 10.5194/npg-17-303-2010; Imberger J, 1998, COAST ESTUAR STUD, V54, P1; King SE, 2011, J FLUID MECH, V666, P477, DOI 10.1017/S0022112010004301; Lamb KG, 2011, J PHYS OCEANOGR, V41, P67, DOI 10.1175/2010JPO4308.1; Lamb KG, 2003, J FLUID MECH, V478, P81, DOI 10.1017/S0022112002003269; Lamb KG, 2002, J FLUID MECH, V451, P109, DOI [10.1017/SO02211200100636X, 10.1017/S002211200100636X]; Lien RC, 2012, J PHYS OCEANOGR, V42, P511, DOI [10.1175/2011JP04578.1, 10.1175/2011JPO4578.1]; Lorke A, 2007, J GEOPHYS RES-OCEANS, V112, DOI 10.1029/2006JC004008; Moum JN, 2003, J PHYS OCEANOGR, V33, P2093, DOI 10.1175/1520-0485(2003)033<2093:SAGOTA>2.0.CO;2; Preusse M, 2012, J GEOPHYS RES-OCEANS, V117, DOI 10.1029/2011JC007403; Preusse M, 2010, LIMNOL OCEANOGR, V55, P2353, DOI 10.4319/lo.2010.55.6.2353; Scotti A, 2004, GEOPHYS RES LETT, V31, DOI 10.1029/2004GL021052; Soontiens N, 2010, PHYS FLUIDS, V22, DOI 10.1063/1.3521532; Stastna M, 2002, PHYS FLUIDS, V14, P2987, DOI 10.1063/1.1496510; Stastna M, 2008, J GEOPHYS RES-OCEANS, V113, DOI 10.1029/2007JC004711; van Haren H, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0032535; Wunsch C, 2004, ANNU REV FLUID MECH, V36, P281, DOI 10.1146/annurev.fluid.36.050802.122121	25	9	11	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 23	2012	7	7							e41674	10.1371/journal.pone.0041674	http://dx.doi.org/10.1371/journal.pone.0041674			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	977TM	22911842	Green Submitted, gold, Green Published			2022-12-25	WOS:000306687700138
J	Fenouille, N; Tichet, M; Dufies, M; Pottier, A; Mogha, A; Soo, JK; Rocchi, S; Mallavialle, A; Galibert, MD; Khammari, A; Lacour, JP; Ballotti, R; Deckert, M; Tartare-Deckert, S				Fenouille, Nina; Tichet, Melanie; Dufies, Maeva; Pottier, Anais; Mogha, Ariane; Soo, Julia K.; Rocchi, Stephane; Mallavialle, Aude; Galibert, Marie-Dominique; Khammari, Amir; Lacour, Jean-Philippe; Ballotti, Robert; Deckert, Marcel; Tartare-Deckert, Sophie			The Epithelial-Mesenchymal Transition (EMT) Regulatory Factor SLUG (SNAI2) Is a Downstream Target of SPARC and AKT in Promoting Melanoma Cell Invasion	PLOS ONE			English	Article							REPRESSES E-CADHERIN; TRANSCRIPTION FACTOR SLUG; MALIGNANT-MELANOMA; SIGNALING PATHWAY; EXPRESSION; KINASE; PROTEIN; GROWTH; TUMOR; PROGRESSION	During progression of melanoma, malignant melanocytes can be reprogrammed into mesenchymal-like cells through a process similar to epithelial-mesenchymal transition (EMT), which is associated with downregulation of the junctional protein E-cadherin and acquisition of a migratory phenotype. Recent evidence supports a role for SLUG, a transcriptional repressor of E-cadherin, as a melanocyte lineage transcription factor that predisposes to melanoma metastasis. However, the signals responsible for SLUG expression in melanoma are unclear and its role in the invasive phenotype is not fully elucidated. Here, we report that SLUG expression and activation is driven by SPARC (also known as osteonectin), a secreted extracellular matrix-associated factor that promotes EMT-like changes. Ectopic expression or knockdown of SPARC resulted in increased or reduced expression of SLUG, respectively. SLUG increase occurred concomitantly with SPARC-mediated downregulation of E-cadherin and P-cadherin, and induction of mesenchymal traits in human melanocytes and melanoma cells. Pharmacological blockade of PI3 kinase/AKT signaling impeded SPARC-induced SLUG levels and cell migration, whereas adenoviral introduction of constitutively active AKT allowed rescue of SLUG and migratory capabilities of SPARC knockdown cells. We also observed that pharmacological inhibition of oncogenic BRAF(V600E) using PLX4720 did not influence SLUG expression in melanoma cells harboring BRAF(V600E). Furthermore, SLUG is a bona fide transcriptional repressor of E-cadherin as well as a regulator of P-cadherin in melanoma cells and its knockdown attenuated invasive behavior and blocked SPARC-enhanced cell migration. Notably, inhibition of cell migration in SPARC-depleted cells was rescued by expression of a SLUG transgene. In freshly isolated metastatic melanoma cells, a positive association between SPARC and SLUG mRNA levels was also found. These findings reveal that autocrine SPARC maintains heightened SLUG expression in melanoma cells and indicate that SPARC may promote EMT-associated tumor invasion by supporting AKT-dependent upregulation of SLUG.	[Fenouille, Nina; Tichet, Melanie; Dufies, Maeva; Pottier, Anais; Rocchi, Stephane; Ballotti, Robert; Tartare-Deckert, Sophie] Ctr Mediterraneen Med Mol Biol & Pathol Melanocyt, INSERM, U1065, Nice, France; [Fenouille, Nina; Tichet, Melanie; Pottier, Anais; Mallavialle, Aude; Deckert, Marcel; Tartare-Deckert, Sophie] C3M, INSERM, U1065, Nice, France; [Fenouille, Nina; Tichet, Melanie; Dufies, Maeva; Pottier, Anais; Rocchi, Stephane; Mallavialle, Aude; Ballotti, Robert; Deckert, Marcel; Tartare-Deckert, Sophie] Univ Nice Sophia Antipolis, Fac Med, Inst Signalisat & Pathol IFR50, Nice, France; [Mogha, Ariane; Galibert, Marie-Dominique] Univ Rennes 1, CHU, CNRS UMR6290, Rennes, France; [Soo, Julia K.] Univ London, Div Biomed Sci, London, England; [Khammari, Amir] CHU Nantes, INSERM, Dept OncoDermatol, U892, F-44035 Nantes 01, France; [Rocchi, Stephane; Lacour, Jean-Philippe; Ballotti, Robert; Tartare-Deckert, Sophie] CHU Nice, Hop Archet, Serv Dermatol, Nice, France	Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Cote d'Azur; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Cote d'Azur; UDICE-French Research Universities; Universite Cote d'Azur; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); CHU Rennes; Universite de Rennes; University of London; Institut National de la Sante et de la Recherche Medicale (Inserm); Nantes Universite; CHU de Nantes; CHU Nice	Fenouille, N (corresponding author), Ctr Mediterraneen Med Mol Biol & Pathol Melanocyt, INSERM, U1065, Nice, France.	tartare@unice.fr	Deckert, Marcel/M-4998-2016; Fenouille, Nina/AAI-1027-2021; Deckert, Marcel/T-3566-2019; BALLOTTI, Robert/F-8825-2013; TARTARE-DECKERT, Sophie/P-6057-2015; Rocchi, Stephane/O-4152-2016	Deckert, Marcel/0000-0003-2094-559X; TARTARE-DECKERT, Sophie/0000-0001-8680-5720; Rocchi, Stephane/0000-0002-0943-1304; Tichet, Melanie/0000-0001-7128-4061; BALLOTTI, Robert/0000-0002-7322-4908; mallavialle, aude/0000-0002-9380-6788; Dufies, Maeva/0000-0003-1732-0388	Institut National de la Sante et de la Recherche Medicale (INSERM); Association pour la Recherche sur le Cancer (ARC); ARC; Contrat d'Interface Clinique, Service de Dermatologie, CHU de Nice	Institut National de la Sante et de la Recherche Medicale (INSERM)(Institut National de la Sante et de la Recherche Medicale (Inserm)); Association pour la Recherche sur le Cancer (ARC)(Fondation ARC pour la Recherche sur le Cancer); ARC(Australian Research Council); Contrat d'Interface Clinique, Service de Dermatologie, CHU de Nice	This work was supported by the Institut National de la Sante et de la Recherche Medicale (INSERM) and the Association pour la Recherche sur le Cancer (ARC). NF is a recipient of a doctoral fellowship from ARC. STD is a recipient of a Contrat d'Interface Clinique, Service de Dermatologie, CHU de Nice. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alvarez MJ, 2005, CANCER RES, V65, P5123, DOI 10.1158/0008-5472.CAN-04-1102; Arnold SA, 2009, J CELL COMMUN SIGNAL, V3, P255, DOI 10.1007/s12079-009-0072-4; Bailet O, 2009, CANCER RES, V69, P2748, DOI 10.1158/0008-5472.CAN-08-2690; Barrallo-Gimeno A, 2005, DEVELOPMENT, V132, P3151, DOI 10.1242/dev.01907; Bauer R, 2005, EXP CELL RES, V305, P418, DOI 10.1016/j.yexcr.2005.01.024; Bolos V, 2003, J CELL SCI, V116, P499, DOI 10.1242/jcs.00224; Chin L, 2006, GENE DEV, V20, P2149, DOI 10.1101/gad.1437206; Chin YR, 2009, CELL SIGNAL, V21, P470, DOI 10.1016/j.cellsig.2008.11.015; Clark CJ, 2008, J CELL BIOCHEM, V104, P721, DOI 10.1002/jcb.21688; Come C, 2006, CLIN CANCER RES, V12, P5395, DOI 10.1158/1078-0432.CCR-06-0478; Engelman JA, 2006, NAT REV GENET, V7, P606, DOI 10.1038/nrg1879; Fenouille N, 2011, ONCOGENE, V30, P4887, DOI 10.1038/onc.2011.198; Fenouille N, 2011, PIGM CELL MELANOMA R, V24, P219, DOI 10.1111/j.1755-148X.2010.00790.x; Fenouille N, 2010, CANCER RES, V70, P9659, DOI 10.1158/0008-5472.CAN-10-2034; Fleige S, 2006, BIOTECHNOL LETT, V28, P1601, DOI 10.1007/s10529-006-9127-2; Franci C, 2006, ONCOGENE, V25, P5134, DOI 10.1038/sj.onc.1209519; Gaggioli C, 2005, ONCOGENE, V24, P1423, DOI 10.1038/sj.onc.1208318; Grille SJ, 2003, CANCER RES, V63, P2172; Gupta PB, 2005, NAT GENET, V37, P1047, DOI 10.1038/ng1634; Hajra KM, 2002, CANCER RES, V62, P1613; Halaban R, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004563; Hoek K, 2004, CANCER RES, V64, P5270, DOI 10.1158/0008-5472.CAN-04-0731; Hsu MY, 2000, AM J PATHOL, V156, P1515, DOI 10.1016/S0002-9440(10)65023-7; Inoue A, 2002, CANCER CELL, V2, P279, DOI 10.1016/S1535-6108(02)00155-1; Kajita M, 2004, MOL CELL BIOL, V24, P7559, DOI 10.1128/MCB.24.17.7559-7566.2004; Koefinger P, 2011, PIGM CELL MELANOMA R, V24, P382, DOI 10.1111/j.1755-148X.2010.00807.x; Kuphal S, 2009, PIGM CELL MELANOMA R, V22, P296, DOI 10.1111/j.1755-148X.2009.00568.x; Ledda MF, 1997, NAT MED, V3, P171, DOI 10.1038/nm0297-171; LEDOUARIN NM, 1994, CURR OPIN GENET DEV, V4, P685, DOI 10.1016/0959-437X(94)90135-P; Miller AJ, 2006, NEW ENGL J MED, V355, P51, DOI 10.1056/NEJMra052166; Murakami M, 2010, MOL BIOL REP, V37, P1279, DOI 10.1007/s11033-009-9502-x; Nieto MA, 2002, NAT REV MOL CELL BIO, V3, P155, DOI 10.1038/nrm757; Olmeda D, 2008, ONCOGENE, V27, P4690, DOI 10.1038/onc.2008.118; Peinado H, 2007, NAT REV CANCER, V7, P415, DOI 10.1038/nrc2131; Perez-Losada J, 2003, ONCOGENE, V22, P4205, DOI 10.1038/sj.onc.1206467; Pla P, 2001, J CELL PHYSIOL, V189, P121, DOI 10.1002/jcp.10008; Robert G, 2006, CANCER RES, V66, P7516, DOI 10.1158/0008-5472.CAN-05-3189; Robertson GP, 2005, CANCER METAST REV, V24, P273, DOI 10.1007/s10555-005-1577-9; Rodriguez M, 2008, CANCER RES, V68, P7872, DOI 10.1158/0008-5472.CAN-08-0301; Sanchez-Martin M, 2002, HUM MOL GENET, V11, P3231, DOI 10.1093/hmg/11.25.3231; Sanchez-Martin MS, 2003, AM J MED GENET A, V122A, P125, DOI 10.1002/ajmg.a.20345; Satyamoorthy K, 2003, CANCER RES, V63, P756; Savagner P, 2005, J CELL PHYSIOL, V202, P858, DOI 10.1002/jcp.20188; Smalley KSM, 2006, MOL CANCER THER, V5, P1136, DOI 10.1158/1535-7163.MCT-06-0084; Smit DJ, 2007, INT J CANCER, V121, P2653, DOI 10.1002/ijc.23039; Soo JK, 2011, PIGM CELL MELANOMA R, V24, P490, DOI 10.1111/j.1755-148X.2011.00850.x; Thiery JP, 2009, CELL, V139, P871, DOI 10.1016/j.cell.2009.11.007; Tsai J, 2008, P NATL ACAD SCI USA, V105, P3041, DOI 10.1073/pnas.0711741105; Turner FE, 2006, J BIOL CHEM, V281, P21321, DOI 10.1074/jbc.M509731200; Van Marck V, 2011, INT J CANCER, V128, P1031, DOI 10.1002/ijc.25427; Vannini I, 2007, CELL ONCOL, V29, P279; Wang SP, 2009, NAT CELL BIOL, V11, P694, DOI 10.1038/ncb1875; Wels C, 2011, J INVEST DERMATOL, V131, P1877, DOI 10.1038/jid.2011.142; Wu WS, 2005, CELL, V123, P641, DOI 10.1016/j.cell.2005.09.029	54	145	150	0	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 20	2012	7	7							e40378	10.1371/journal.pone.0040378	http://dx.doi.org/10.1371/journal.pone.0040378			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	977GL	22911700	Green Published, gold, Green Submitted			2022-12-25	WOS:000306644600018
J	Murugan, R				Murugan, Rajamanickam			Theory on the Dynamics of Feedforward Loops in the Transcription Factor Networks	PLOS ONE			English	Article							STOCHASTIC GENE-EXPRESSION; SACCHAROMYCES-CEREVISIAE; ESCHERICHIA-COLI; RESPONSE-TIMES; FLUCTUATIONS; CELL	Feedforward loops (FFLs) consist of three genes which code for three different transcription factors A, B and C where B regulates C and A regulates both B and C. We develop a detailed model to describe the dynamical behavior of various types of coherent and incoherent FFLs in the transcription factor networks. We consider the deterministic and stochastic dynamics of both promoter-states and synthesis and degradation of mRNAs of various genes associated with FFL motifs. Detailed analysis shows that the response times of FFLs strongly dependent on the ratios (w(h) = gamma(pc)/gamma(ph) where h = a, b, c corresponding to genes A, B and C) between the lifetimes of mRNAs (1/gamma(mh)) of genes A, B and C and the protein of C (1/gamma(pc)). Under strong binding conditions we can categorize all the possible types of FFLs into groups I, II and III based on the dependence of the response times of FFLs on w(h). Group I that includes C1 and I1 type FFLs seem to be less sensitive to the changes in w(h). The coherent C1 type seems to be more robust against changes in other system parameters. We argue that this could be one of the reasons for the abundant nature of C1 type coherent FFLs.	Indian Inst Technol Madras, Dept Biotechnol, Madras, Tamil Nadu, India	Indian Institute of Technology System (IIT System); Indian Institute of Technology (IIT) - Madras	Murugan, R (corresponding author), Indian Inst Technol Madras, Dept Biotechnol, Madras, Tamil Nadu, India.	rmurugan@gmail.com	Murugan, Rajamanickam/A-9700-2008	Murugan, Rajamanickam/0000-0002-5454-3540				Alberts B, 1994, MOL BIOL CELL, P331; Alon U., 2006, INTRO SYSTEMS BIOL D, P41; Eichenberger P, 2004, PLOS BIOL, V2, P1664, DOI 10.1371/journal.pbio.0020328; Elkon R, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-259; Gardiner C W, 2004, HDB STOCHASTIC METHO; Gillespie DT, 2000, J CHEM PHYS, V113, P297, DOI 10.1063/1.481811; GILLESPIE DT, 1977, J PHYS CHEM-US, V81, P2340, DOI 10.1021/j100540a008; GOODSELL DS, 1991, TRENDS BIOCHEM SCI, V16, P203, DOI 10.1016/0968-0004(91)90083-8; Lee TI, 2002, SCIENCE, V298, P799, DOI 10.1126/science.1075090; Levin B, 2011, GENES X, P546; Lomholt MA, 2009, P NATL ACAD SCI USA, V106, P8204, DOI 10.1073/pnas.0903293106; Mangan S, 2006, J MOL BIOL, V356, P1073, DOI 10.1016/j.jmb.2005.12.003; Mangan S, 2003, P NATL ACAD SCI USA, V100, P11980, DOI 10.1073/pnas.2133841100; Mangan S, 2003, J MOL BIOL, V334, P197, DOI 10.1016/j.jmb.2003.09.049; Milo R, 2004, SCIENCE, V303, P1538, DOI 10.1126/science.1089167; Murugan R, 2007, PHYS REV E, V76, DOI 10.1103/PhysRevE.76.011901; Murugan R, 2010, BIOPHYS J, V99, P353, DOI 10.1016/j.bpj.2010.04.026; Murugan R, 2010, J PHYS A, V43; Murugan R, 2011, BIOPHYS J, V101, P1297, DOI 10.1016/j.bpj.2011.08.005; Neumann FR, 2007, J CELL BIOL, V179, P593, DOI 10.1083/jcb.200708054; Newman JRS, 2006, NATURE, V441, P840, DOI 10.1038/nature04785; Ptashne M, 1997, NATURE, V386, P569, DOI 10.1038/386569a0; Ptashne M, 2001, GENES SIGNALS, P60; Rosenfeld N, 2002, J MOL BIOL, V323, P785, DOI 10.1016/S0022-2836(02)00994-4; Shahrezaei V, 2008, P NATL ACAD SCI USA, V105, P17256, DOI 10.1073/pnas.0803850105; Shahrezaei V, 2008, MOL SYST BIOL, V4, DOI 10.1038/msb.2008.31; Shen-Orr SS, 2002, NAT GENET, V31, P64, DOI 10.1038/ng881; Wall ME, 2005, J MOL BIOL, V349, P501, DOI 10.1016/j.jmb.2005.04.022	28	14	14	1	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 20	2012	7	7							e41027	10.1371/journal.pone.0041027	http://dx.doi.org/10.1371/journal.pone.0041027			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	977GL	22911735	gold, Green Published, Green Submitted			2022-12-25	WOS:000306644600039
J	Steere, N; Chae, V; Burke, M; Li, FQ; Takemaru, KI; Kuriyama, R				Steere, Nathan; Chae, Vanessa; Burke, Michael; Li, Feng-Qian; Takemaru, Ken-Ichi; Kuriyama, Ryoko			A Wnt/beta-Catenin Pathway Antagonist Chibby Binds Cenexin at the Distal End of Mother Centrioles and Functions in Primary Cilia Formation	PLOS ONE			English	Article							BETA-CATENIN; EPITHELIAL-CELLS; AXIN LOCALIZES; BASAL BODY; CENTROSOME; COMPLEX; CYCLE; CILIOGENESIS; TRANSITION; COMPONENT	The mother centriole of the centrosome is distinguished from immature daughter centrioles by the presence of accessory structures (distal and subdistal appendages), which play an important role in the organization of the primary cilium in quiescent cells. Primary cilia serve as sensory organelles, thus have been implicated in mediating intracellular signal transduction pathways. Here we report that Chibby (Cby), a highly conserved antagonist of the Wnt/beta-catenin pathway, is a centriolar component specifically located at the distal end of the mother centriole and essential for assembly of the primary cilium. Cby appeared as a discrete dot in the middle of a ring-like structure revealed by staining with a distal appendage component of Cep164. Cby interacted with one of the appendage components, Cenexin (Cnx), which thereby abrogated the inhibitory effect of Cby on beta-catenin-mediated transcriptional activation in a dose-dependent manner. Cby and Cnx did not precisely align, as Cby was detected at a more distal position than Cnx. Cnx emerged earlier than Cby during the cell cycle and was required for recruitment of Cby to the mother centriole. However, Cby was dispensable for Cnx localization to the centriole. During massive centriogenesis in in vitro cultured mouse tracheal epithelial cells, Cby and Cnx were expressed in a similar pattern, which was coincident with the expression of Foxj1. Our results suggest that Cby plays an important role in organization of both primary and motile cilia in collaboration with Cnx.	[Steere, Nathan; Chae, Vanessa; Kuriyama, Ryoko] Univ Minnesota, Dept Genet Cell Biol & Dev, Minneapolis, MN 55455 USA; [Burke, Michael; Takemaru, Ken-Ichi] SUNY Stony Brook, Grad Program Genet, Stony Brook, NY 11794 USA; [Burke, Michael; Takemaru, Ken-Ichi] SUNY Stony Brook, Med Scientist Training Program, Stony Brook, NY 11794 USA; [Li, Feng-Qian; Takemaru, Ken-Ichi] SUNY Stony Brook, Dept Pharmacol Sci, Stony Brook, NY 11794 USA	University of Minnesota System; University of Minnesota Twin Cities; State University of New York (SUNY) System; State University of New York (SUNY) Stony Brook; State University of New York (SUNY) System; State University of New York (SUNY) Stony Brook; State University of New York (SUNY) System; State University of New York (SUNY) Stony Brook	Steere, N (corresponding author), Univ Minnesota, Dept Genet Cell Biol & Dev, Minneapolis, MN 55455 USA.	kuriy001@umn.edu			National Institutes of Health [GM55735, HL107493]; National Science Foundation [MCB1140033]; Minnesota Medical Foundation; American Heart Association [09GRNT2261212]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL107493, R56HL107493] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM055735, T32GM008444] Funding Source: NIH RePORTER; Direct For Biological Sciences [1140033] Funding Source: National Science Foundation	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Science Foundation(National Science Foundation (NSF)); Minnesota Medical Foundation; American Heart Association(American Heart Association); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); Direct For Biological Sciences(National Science Foundation (NSF)NSF - Directorate for Biological Sciences (BIO))	This work was supported by National Institutes of Health Grant Numbers GM55735 (Dr. Kuriyama) and HL107493 (Dr. Takemaru), National Science Foundation Grant Number MCB1140033 (Dr. Kuriyama), Minnesota Medical Foundation (Dr. Kuriyama), and American Heart Association Grant Number 09GRNT2261212 (Dr. Takemaru). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alexandrova EM, 2010, DEV DYNAM, V239, P261, DOI 10.1002/dvdy.22125; Alieva IB, 2004, CELL BIOL INT, V28, P139, DOI 10.1016/j.cellbi.2003.11.013; Bahmanyar S, 2008, GENE DEV, V22, P91, DOI 10.1101/gad.1596308; Chen JC, 1998, J CLIN INVEST, V102, P1077, DOI 10.1172/JCI4786; Corbit KC, 2008, NAT CELL BIOL, V10, P70, DOI 10.1038/ncb1670; Fumoto K, 2009, EMBO REP, V10, P606, DOI 10.1038/embor.2009.45; Gaillard CLB, 2011, MOL BIOL CELL, V22, P4549, DOI 10.1091/mbc.E11-05-0405; Garcia-Gonzalo FR, 2011, NAT GENET, V43, P776, DOI 10.1038/ng.891; Gerdes JM, 2007, NAT GENET, V39, P1350, DOI 10.1038/ng.2007.12; Goetz SC, 2010, NAT REV GENET, V11, P331, DOI 10.1038/nrg2774; Graser S, 2007, J CELL BIOL, V179, P321, DOI 10.1083/jcb.200707181; Greer YE, 2011, J CELL BIOL, V192, P993, DOI 10.1083/jcb.201011111; Huang P, 2007, ONCOGENE, V26, P4357, DOI 10.1038/sj.onc.1210217; Huang P, 2009, DEVELOPMENT, V136, P3089, DOI 10.1242/dev.041343; Ishikawa H, 2005, NAT CELL BIOL, V7, P517, DOI 10.1038/ncb1251; Itoh K, 2009, J CELL SCI, V122, P3791, DOI 10.1242/jcs.057067; Jakobsen L, 2011, EMBO J, V30, P1520, DOI 10.1038/emboj.2011.63; Kim SM, 2009, EXP CELL RES, V315, P943, DOI 10.1016/j.yexcr.2009.01.013; Kleylein-Sohn J, 2007, DEV CELL, V13, P190, DOI 10.1016/j.devcel.2007.07.002; Kobayashi T, 2011, J CELL BIOL, V193, P435, DOI 10.1083/jcb.201101005; Korinek V, 1997, SCIENCE, V275, P1784, DOI 10.1126/science.275.5307.1784; KURIYAMA R, 1981, J CELL BIOL, V91, P814, DOI 10.1083/jcb.91.3.814; Lancaster MA, 2011, NAT CELL BIOL, V13, P700, DOI 10.1038/ncb2259; LANGE BMH, 1995, J CELL BIOL, V130, P919, DOI 10.1083/jcb.130.4.919; Li FQ, 2008, J CELL BIOL, V181, P1141, DOI 10.1083/jcb.200709091; Li FQ, 2010, MOL BIOL CELL, V21, P311, DOI 10.1091/mbc.E09-05-0437; Louie RK, 2004, J CELL SCI, V117, P1117, DOI 10.1242/jcs.00939; Love D, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013600; Mogensen MM, 2000, J CELL SCI, V113, P3013; Nachury MV, 2010, ANNU REV CELL DEV BI, V26, P59, DOI 10.1146/annurev.cellbio.042308.113337; Nakagawa Y, 2001, MOL BIOL CELL, V12, P1687, DOI 10.1091/mbc.12.6.1687; Ocbina PJR, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006839; Ohta T, 2002, J CELL BIOL, V156, P87, DOI 10.1083/jcb.200108088; Park TJ, 2008, NAT GENET, V40, P871, DOI 10.1038/ng.104; Schmidt TI, 2009, CURR BIOL, V19, P1005, DOI 10.1016/j.cub.2009.05.016; Sillibourne JE, 2011, CYTOSKELETON, V68, P619, DOI 10.1002/cm.20536; Singla V, 2010, DEV CELL, V18, P410, DOI 10.1016/j.devcel.2009.12.022; SOROKIN SP, 1968, J CELL SCI, V3, P207; Soung NK, 2009, DEV CELL, V16, P539, DOI 10.1016/j.devcel.2009.02.004; Spektor A, 2007, CELL, V130, P678, DOI 10.1016/j.cell.2007.06.027; Takemaru KI, 2003, NATURE, V422, P905, DOI 10.1038/nature01570; Vladar EK, 2007, J CELL BIOL, V178, P31, DOI 10.1083/jcb.200703064; VOROBJEV IA, 1982, J CELL BIOL, V93, P938, DOI 10.1083/jcb.93.3.938; Voronina VA, 2009, J CELL BIOL, V181, P1141; Wakefield JG, 2003, J CELL SCI, V116, P637, DOI 10.1242/jcs.00273; Wallingford JB, 2011, GENE DEV, V25, P201, DOI 10.1101/gad.2008011; You YJ, 2002, AM J PHYSIOL-LUNG C, V283, pL1315, DOI 10.1152/ajplung.00169.2002	47	30	30	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 20	2012	7	7							e41077	10.1371/journal.pone.0041077	http://dx.doi.org/10.1371/journal.pone.0041077			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	977GL	22911743	Green Submitted, gold, Green Published			2022-12-25	WOS:000306644600043
J	Switt, AIM; den Bakker, HC; Cummings, CA; Rodriguez-Rivera, LD; Govoni, G; Raneiri, ML; Degoricija, L; Brown, S; Hoelzer, K; Peters, JE; Bolchacova, E; Furtado, MR; Wiedmann, M				Switt, Andrea I. Moreno; den Bakker, Henk C.; Cummings, Craig A.; Rodriguez-Rivera, Lorraine D.; Govoni, Gregory; Raneiri, Matthew L.; Degoricija, Lovorka; Brown, Stephanie; Hoelzer, Karin; Peters, Joseph E.; Bolchacova, Elena; Furtado, Manohar R.; Wiedmann, Martin			Identification and Characterization of Novel Salmonella Mobile Elements Involved in the Dissemination of Genes Linked to Virulence and Transmission	PLOS ONE			English	Article							RESTRICTION-MODIFICATION SYSTEMS; ENTERICA SEROVAR TYPHIMURIUM; COMPLETE GENOME SEQUENCE; TOXIN-ANTITOXIN SYSTEMS; ESCHERICHIA-COLI; ANTIMICROBIAL RESISTANCE; PATHOGENICITY ISLAND; UNITED-STATES; ANTIBIOTIC-RESISTANCE; CONJUGATIVE ELEMENTS	The genetic diversity represented by >2,500 different Salmonella serovars provides a yet largely uncharacterized reservoir of mobile elements that can contribute to the frequent emergence of new pathogenic strains of this important zoonotic pathogen. Currently, our understanding of Salmonella mobile elements is skewed by the fact that most studies have focused on highly virulent or common serovars. To gain a more global picture of mobile elements in Salmonella, we used prediction algorithms to screen for mobile elements in 16 sequenced Salmonella genomes representing serovars for which no prior genome scale mobile element data were available. From these results, selected mobile elements underwent further analyses in the form of validation studies, comparative analyses, and PCR-based population screens. Through this analysis we identified a novel plasmid that has two cointegrated replicons (IncI1-IncFIB); this plasmid type was found in four genomes representing different Salmonella serovars and contained a virulence gene array that had not been previously identified. A Salmonella Montevideo isolate contained an IncHI and an IncN2 plasmid, which both encoded antimicrobial resistance genes. We also identified two novel genomic islands (SGI2 and SGI3), and 42 prophages with mosaic architecture, seven of them harboring known virulence genes. Finally, we identified a novel integrative conjugative element (ICE) encoding a type IVb pilus operon in three non-typhoidal Salmonella serovars. Our analyses not only identified a considerable number of mobile elements that have not been previously reported in Salmonella, but also found evidence that these elements facilitate transfer of genes that were previously thought to be limited in their distribution among Salmonella serovars. The abundance of mobile elements encoding pathogenic properties may facilitate the emergence of strains with novel combinations of pathogenic traits.	[Switt, Andrea I. Moreno; den Bakker, Henk C.; Rodriguez-Rivera, Lorraine D.; Raneiri, Matthew L.; Brown, Stephanie; Hoelzer, Karin; Wiedmann, Martin] Cornell Univ, Dept Food Sci, Ithaca, NY 14853 USA; [Cummings, Craig A.; Govoni, Gregory; Degoricija, Lovorka; Bolchacova, Elena; Furtado, Manohar R.] Life Technol Corp, Foster City, CA USA; [Peters, Joseph E.] Cornell Univ, Dept Microbiol, Ithaca, NY 14853 USA	Cornell University; Thermo Fisher Scientific; Cornell University	Switt, AIM (corresponding author), Cornell Univ, Dept Food Sci, Ithaca, NY 14853 USA.	mw16@cornell.edu	Peters, Joseph/P-7130-2019; Wiedmann, Martin/A-9683-2008; Bakker, Henk den/AAF-8282-2020; den Bakker, Hendrik/A-8136-2010; Switt, Andrea I Moreno/B-3285-2017; Rodriguez-Rivera, Lorraine D/E-6098-2013	Peters, Joseph/0000-0001-8309-3297; Wiedmann, Martin/0000-0002-4168-5662; den Bakker, Hendrik/0000-0002-4086-1580; Switt, Andrea I Moreno/0000-0001-8231-9397; Rodriguez-Rivera, Lorraine D/0000-0002-0890-2274; Govoni, Gregory/0000-0002-4664-0834; Furtado, Manohar/0000-0001-6016-1357	USDA [2006-34459-16952, 2009-34459-19750, 2010-34459-20756]; Life Technologies Corporation	USDA(United States Department of Agriculture (USDA)); Life Technologies Corporation	This work was supported by USDA (http://www.csrees.usda.gov/fo/agriculturalandfoodresearchinitiativeafri.cfm) Special Research Grants 2006-34459-16952; 2009-34459-19750, and 2010-34459-20756 (to MW). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. In addition, Life Technologies Corporation partially funded this study by providing sequencing reagents and instruments and by compensating its employees (GG, CAC, LD, EB and MRF), who participated in study design, data collection and analysis, decision to publish, and preparation of the manuscript.	Aktories K, 2011, NAT REV MICROBIOL, V9, P487, DOI 10.1038/nrmicro2592; Aziz RK, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-75; Bishop AL, 2005, J BACTERIOL, V187, P2469, DOI 10.1128/JB.187.7.2469-2482.2005; Boquet P, 2000, MICROBES INFECT, V2, P837, DOI 10.1016/S1286-4579(00)90369-1; Brown JM, 2003, J BACTERIOL, V185, P6600, DOI 10.1128/JB.185.22.6600-6608.2003; Brussow H, 2004, MICROBIOL MOL BIOL R, V68, P560, DOI 10.1128/MMBR.68.3.560-602.2004; Bukowski M, 2011, ACTA BIOCHIM POL, V58, P1; Casjens S, 2003, MOL MICROBIOL, V49, P277, DOI 10.1046/j.1365-2958.2003.03580.x; Casjens SR, 2005, J BACTERIOL, V187, P1091, DOI 10.1128/JB.187.3.1091-1104.2005; [CDC] Center for Disease Control and Prevention, 2009, SALM ANN SUMM; Centers for Disease Control and Prevention, 2011, NAT ENT DIS SURV SAL; Chu C, 2012, CLIN MICROBIOL INFEC, V18, P47, DOI 10.1111/j.1469-0691.2011.03464.x; Chu CS, 2006, MICROBES INFECT, V8, P1931, DOI 10.1016/j.micinf.2005.12.026; Cirl C, 2008, NAT MED, V14, P399, DOI 10.1038/nm1734; Cogez V, 2002, EUR J BIOCHEM, V269, P2473, DOI 10.1046/j.1432-1033.2002.02907.x; Craig L, 2004, NAT REV MICROBIOL, V2, P363, DOI 10.1038/nrmicro885; Darling AE, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011147; Darling ACE, 2004, GENOME RES, V14, P1394, DOI 10.1101/gr.2289704; den Bakker HC, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-425; Deng W, 2003, J BACTERIOL, V185, P2330, DOI 10.1128/JB.185.7.2330-2337.2003; Didelot X, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1002191; Douard G, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015302; Doublet B, 2005, MOL MICROBIOL, V55, P1911, DOI 10.1111/j.1365-2958.2005.04520.x; Doublet B, 2004, ANTIMICROB AGENTS CH, V48, P3806, DOI 10.1128/AAC.48.10.3806-3812.2004; Doublet B, 2009, J ANTIMICROB CHEMOTH, V63, P282, DOI 10.1093/jac/dkn500; Doumith M, 2012, J ANTIMICROB CHEMOTH, V67, P878, DOI 10.1093/jac/dkr553; Ehrbar K, 2003, J BACTERIOL, V185, P6950, DOI 10.1128/JB.185.23.6950-6967.2003; Ehrbar Kristin, 2005, Infection Genetics and Evolution, V5, P1; Fernandez-Alarcon C, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023415; Figueroa-Bossi N, 1999, MOL MICROBIOL, V33, P167, DOI 10.1046/j.1365-2958.1999.01461.x; Folster JP, 2011, FOODBORNE PATHOG DIS, V8, P1289, DOI 10.1089/fpd.2011.0944; Fookes M, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002191; Fricke WF, 2009, APPL ENVIRON MICROB, V75, P5963, DOI 10.1128/AEM.00786-09; Fries M, 2007, EMBO J, V26, P3879, DOI 10.1038/sj.emboj.7601816; Furuta Y, 2010, NUCLEIC ACIDS RES, V38, P2428, DOI 10.1093/nar/gkp1226; Garcia-Fernandez A, 2009, J ANTIMICROB CHEMOTH, V63, P274, DOI 10.1093/jac/dkn470; Garcia-Fernandez A, 2008, J ANTIMICROB CHEMOTH, V61, P1229, DOI 10.1093/jac/dkn131; Gough NR, 2008, SCI SIGNAL, V1, pec129; Grimont P. A. D., 2007, ANTIGENIC FORMULAE S; Hall RM, 2010, FUTURE MICROBIOL, V5, P1525, DOI 10.2217/FMB.10.122; Hendrix RW, 2000, TRENDS MICROBIOL, V8, P504, DOI 10.1016/S0966-842X(00)01863-1; Herrero A, 2009, EUR J CLIN MICROBIOL, V28, P1087, DOI 10.1007/s10096-009-0753-1; Ho TD, 2002, J BACTERIOL, V184, P5234, DOI 10.1128/JB.184.19.5234-5239.2002; Holt KE, 2007, J BACTERIOL, V189, P4257, DOI 10.1128/JB.00232-07; Holt KE, 2011, PLOS NEGLECT TROP D, V5, DOI 10.1371/journal.pntd.0001245; Jacobsen A, 2011, MICROB ECOL, V62, P487, DOI 10.1007/s00248-011-9880-1; Jenal U, 2004, CURR OPIN MICROBIOL, V7, P185, DOI 10.1016/j.mib.2004.02.007; Johnson TJ, 2006, ANTIMICROB AGENTS CH, V50, P3929, DOI 10.1128/AAC.00569-06; Johnson TJ, 2011, PLASMID, V66, P144, DOI 10.1016/j.plasmid.2011.07.003; Johnson TJ, 2009, MICROBIOL MOL BIOL R, V73, P750, DOI 10.1128/MMBR.00015-09; Juhas M, 2009, FEMS MICROBIOL REV, V33, P376, DOI 10.1111/j.1574-6976.2008.00136.x; Kobayashi I, 2001, NUCLEIC ACIDS RES, V29, P3742, DOI 10.1093/nar/29.18.3742; KOMANO T, 1994, J MOL BIOL, V243, P6, DOI 10.1006/jmbi.1994.1625; Lee S, 2009, BMB REP, V42, P769, DOI 10.5483/BMBRep.2009.42.12.769; Lima-Mendez G, 2008, BIOINFORMATICS, V24, P863, DOI 10.1093/bioinformatics/btn043; McLaughlin LM, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000671; Mellmann A, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022751; Mirold S, 2001, J MOL BIOL, V312, P7, DOI 10.1006/jmbi.2001.4950; Morris C, 2003, MICROB PATHOGENESIS, V35, P279, DOI 10.1016/j.micpath.2003.08.001; Parkhill J, 2001, NATURE, V413, P848, DOI 10.1038/35101607; Parks AR, 2009, PLASMID, V61, P1, DOI 10.1016/j.plasmid.2008.09.008; Pickard D, 2003, J BACTERIOL, V185, P5055, DOI 10.1128/JB.185.17.5055-5065.2003; Pimenta AL, 2005, J BACTERIOL, V187, P7471, DOI 10.1128/JB.187.21.7471-7480.2005; Poirel L, 2011, ANTIMICROB AGENTS CH, V55, P4224, DOI 10.1128/AAC.00165-11; Roberts AP, 2008, PLASMID, V60, P167, DOI 10.1016/j.plasmid.2008.08.001; Romling U, 2002, RES MICROBIOL, V153, P205, DOI 10.1016/S0923-2508(02)01316-5; Rychlik I, 2006, VET MICROBIOL, V112, P1, DOI 10.1016/j.vetmic.2005.10.030; Sabbagh SC, 2010, FEMS MICROBIOL LETT, V305, P1, DOI 10.1111/j.1574-6968.2010.01904.x; Savard P, 2011, ANTIMICROB AGENTS CH, V55, P5957, DOI 10.1128/AAC.05719-11; Scallan E, 2011, EMERG INFECT DIS, V17, P16, DOI [10.3201/eid1701.P21101, 10.3201/eid1701.091101p2]; Seth-Smith HMB, 2012, J BACTERIOL, V194, P1494, DOI 10.1128/JB.06403-11; Seth-Smith HMB, 2008, J INFECT DEV COUNTR, V2, P267, DOI 10.3855/jidc.220; Sibley MH, 2004, NUCLEIC ACIDS RES, V32, P522, DOI 10.1093/nar/gkh194; Stamatakis A, 2006, BIOINFORMATICS, V22, P2688, DOI 10.1093/bioinformatics/btl446; Stanley TL, 2000, J BACTERIOL, V182, P4406, DOI 10.1128/JB.182.16.4406-4413.2000; Sulakvelidze Andrew M. Kropinski Alexander, 2007, V394, P133, DOI 10.1007/978-1-59745-512-1_9; Sullivan MJ, 2011, BIOINFORMATICS, V27, P1009, DOI 10.1093/bioinformatics/btr039; Takahashi H, 2011, PLASMID, V66, P112, DOI 10.1016/j.plasmid.2011.06.004; Townsend SM, 2001, INFECT IMMUN, V69, P2894, DOI 10.1128/IAI.69.5.2894-2901.2001; Tracz DM, 2006, J CLIN MICROBIOL, V44, P2007, DOI 10.1128/JCM.02630-05; Uchida I, 2009, MICROBIOL-SGM, V155, P3710, DOI 10.1099/mic.0.028399-0; van Asten AJAM, 2005, FEMS IMMUNOL MED MIC, V44, P251, DOI 10.1016/j.femsim.2005.02.002; Waack S, 2006, BMC BIOINFORMATICS, V7, DOI 10.1186/1471-2105-7-142; Wang XX, 2011, APPL ENVIRON MICROB, V77, P5577, DOI 10.1128/AEM.05068-11; Welch TJ, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000309; Wozniak RAF, 2010, NAT REV MICROBIOL, V8, P552, DOI 10.1038/nrmicro2382; Zhang XL, 2000, INFECT IMMUN, V68, P3067, DOI 10.1128/IAI.68.6.3067-3073.2000; Zou QH, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-729	88	39	39	0	23	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 20	2012	7	7							e41247	10.1371/journal.pone.0041247	http://dx.doi.org/10.1371/journal.pone.0041247			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	977GL	22911766	Green Submitted, Green Published, gold			2022-12-25	WOS:000306644600060
J	Yang, J; Bachrati, CZ; Hickson, ID; Brown, GW				Yang, Jay; Bachrati, Csanad Z.; Hickson, Ian D.; Brown, Grant W.			BLM and RMI1 Alleviate RPA Inhibition of TopoIII alpha Decatenase Activity	PLOS ONE			English	Article							REPLICATION PROTEIN-A; TOPOISOMERASE-III-ALPHA; BLOOMS-SYNDROME PROTEIN; STRANDED-DNA-BINDING; SUBSTRATE; HELICASE; PURIFICATION; BLAP75; WERNER	RPA is a single-stranded DNA binding protein that physically associates with the BLM complex. RPA stimulates BLM helicase activity as well as the double Holliday junction dissolution activity of the BLM-topoisomerase III alpha complex. We investigated the effect of RPA on the ssDNA decatenase activity of topoisomerase III alpha. We found that RPA and other ssDNA binding proteins inhibit decatenation by topoisomerase III alpha. Complex formation between BLM, TopoIII alpha, and RMI1 ablates inhibition of decatenation by ssDNA binding proteins. Together, these data indicate that inhibition by RPA does not involve species-specific interactions between RPA and BLM-TopoIII alpha-RMI1, which contrasts with RPA modulation of double Holliday junction dissolution. We propose that topoisomerase III alpha and RPA compete to bind to single-stranded regions of catenanes. Interactions with BLM and RMI1 enhance toposiomerase III alpha activity, promoting decatenation in the presence of RPA.	[Yang, Jay; Brown, Grant W.] Univ Toronto, Dept Biochem, Toronto, ON, Canada; [Yang, Jay; Brown, Grant W.] Univ Toronto, Donnelly Ctr Cellular & Biomol Res, Toronto, ON, Canada; [Bachrati, Csanad Z.; Hickson, Ian D.] Univ Oxford, John Radcliffe Hosp, Weatherall Inst Mol Med, Oxford OX3 9DU, England; [Hickson, Ian D.] Univ Copenhagen, Ctr Healthy Aging, Dept Cellular & Mol Med, Copenhagen, Denmark	University of Toronto; University of Toronto; University of Oxford; University of Copenhagen	Yang, J (corresponding author), Univ Toronto, Dept Biochem, Toronto, ON, Canada.	grant.brown@utoronto.ca	Bachrati, Csanad/ABF-2020-2021; Hickson, Ian/AAJ-7548-2020	Bachrati, Csanad/0000-0003-1703-5894; Brown, Grant/0000-0002-9002-5003; Hickson, Ian/0000-0002-0583-566X	Canadian Institutes of Health Research [MOP-79368]; Cancer Research UK; Bloom's Syndrome Foundation	Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR)); Cancer Research UK(Cancer Research UK); Bloom's Syndrome Foundation	This work was supported by Canadian Institutes of Health Research Grant MOP-79368 (to GWB), and by Cancer Research UK and the Bloom's Syndrome Foundation (to IDH and CZB). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bachrati CZ, 2006, NUCLEIC ACIDS RES, V34, P2269, DOI 10.1093/nar/gkl258; Bochkarev A, 2004, CURR OPIN STRUC BIOL, V14, P36, DOI 10.1016/j.sbi.2004.01.001; Brosh RM, 2000, J BIOL CHEM, V275, P23500, DOI 10.1074/jbc.M001557200; Cejka P, 2010, NAT STRUCT MOL BIOL, V17, P1377, DOI 10.1038/nsmb.1919; CHAGANTI RS, 1974, P NATL ACAD SCI USA, V71, P4508, DOI 10.1073/pnas.71.11.4508; Champoux JJ, 2001, ANNU REV BIOCHEM, V70, P369, DOI 10.1146/annurev.biochem.70.1.369; Chen CF, 2007, J BIOL CHEM, V282, P28971, DOI 10.1074/jbc.M705427200; Desai NA, 2003, FEMS MICROBIOL REV, V26, P457, DOI 10.1111/j.1574-6976.2003.tb00626.x; Doherty KM, 2005, J BIOL CHEM, V280, P29494, DOI 10.1074/jbc.M500653200; ELLIS NA, 1995, CELL, V83, P655, DOI 10.1016/0092-8674(95)90105-1; FAIRMAN MP, 1988, EMBO J, V7, P1211, DOI 10.1002/j.1460-2075.1988.tb02933.x; Garcia PL, 2004, NUCLEIC ACIDS RES, V32, P3771, DOI 10.1093/nar/gkh709; Goulaouic H, 1999, NUCLEIC ACIDS RES, V27, P2443, DOI 10.1093/nar/27.12.2443; Hickson ID, 2003, NAT REV CANCER, V3, P169, DOI 10.1038/nrc1012; Iftode C, 1999, CRIT REV BIOCHEM MOL, V34, P141, DOI 10.1080/10409239991209255; KIRKEGAARD K, 1985, J MOL BIOL, V185, P625, DOI 10.1016/0022-2836(85)90075-0; Liu Y, 2008, GENE DEV, V22, P2737, DOI 10.1101/gad.1732808; Machwe A, 2006, BMC MOL BIOL, V7, DOI 10.1186/1471-2199-7-1; Meetei AR, 2003, MOL CELL BIOL, V23, P3417, DOI 10.1128/MCB.23.10.3417-3426.2003; Mohaghegh P, 2001, NUCLEIC ACIDS RES, V29, P2843, DOI 10.1093/nar/29.13.2843; Plank JL, 2005, J BIOL CHEM, V280, P3564, DOI 10.1074/jbc.M411337200; Plank JL, 2006, P NATL ACAD SCI USA, V103, P11118, DOI 10.1073/pnas.0604873103; Raynard S, 2008, J BIOL CHEM, V283, P15701, DOI 10.1074/jbc.M802127200; Raynard S, 2006, J BIOL CHEM, V281, P13861, DOI 10.1074/jbc.C600051200; Sharma S, 2011, J NUCLEIC ACIDS, V2011, DOI 10.4061/2011/724215; Sikder D, 2001, J MOL BIOL, V306, P669, DOI 10.1006/jmbi.2000.4384; Wechsler T, 2011, NATURE, V471, P642, DOI 10.1038/nature09790; Wold MS, 1997, ANNU REV BIOCHEM, V66, P61, DOI 10.1146/annurev.biochem.66.1.61; WOLD MS, 1988, P NATL ACAD SCI USA, V85, P2523, DOI 10.1073/pnas.85.8.2523; Wu L, 2006, P NATL ACAD SCI USA, V103, P4068, DOI 10.1073/pnas.0508295103; Wu L, 2003, NATURE, V426, P870, DOI 10.1038/nature02253; Xu DY, 2008, GENE DEV, V22, P2843, DOI 10.1101/gad.1708608; Yang J, 2010, J BIOL CHEM, V285, P21426, DOI 10.1074/jbc.M110.123216; Yin JH, 2005, EMBO J, V24, P1465, DOI 10.1038/sj.emboj.7600622; Zou Y, 2006, J CELL PHYSIOL, V208, P267, DOI 10.1002/jcp.20622	35	5	5	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 20	2012	7	7							e41208	10.1371/journal.pone.0041208	http://dx.doi.org/10.1371/journal.pone.0041208			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	977GL	22911760	Green Submitted, Green Published, Green Accepted, gold			2022-12-25	WOS:000306644600056
J	Du, CW; Zhou, JM; Goyne, KW				Du Changwen; Zhou Jianmin; Goyne, Keith W.			Organic and Inorganic Carbon in Paddy Soil as Evaluated by Mid-Infrared Photoacoustic Spectroscopy	PLOS ONE			English	Article							MATTER; BIOGEOCHEMISTRY; PHOSPHORUS; EMISSIONS; METHANE; FOREST	Paddy soils are classified as wetlands which play a vital role in climatic change and food production. Soil carbon (C), especially soil organic C (SOC), in paddy soils has been received considerable attention as of recent. However, considerably less attention has been given to soil inorganic carbon (SIC) in paddy soils and the relationship between SOC and SIC at interface between soil and the atmosphere. The objective of this research was to investigate the utility of applying Fourier transform mid-infrared photoacoustic spectroscopy (FTIR-PAS) to explore SOC and SIC present near the surface (0-10 mu m) of paddy soils. The FTIR-PAS spectra revealed an unique absorption region in the wavenumber range of 1,350-1,500 cm(-1) that was dominated by C-O (carbonate) and C-H bending vibrations (organic materials), and these vibrations were used to represented SIC and SOC, respectively. A circular distribution between SIC and SOC on the surface of paddy soils was determined using principal component analysis (PCA), and the distribution showed no significant relationship with the age of paddy soil. However, SIC and SOC were negatively correlated, and higher SIC content was observed near the soil surface. This relationship suggests that SIC in soil surface plays important roles in the soil C dynamics.	[Du Changwen; Zhou Jianmin] Chinese Acad Sci, Inst Soil Sci, State Key Lab Soil & Sustainable Agr, Nanjing, Jiangsu, Peoples R China; [Goyne, Keith W.] Univ Missouri, Dept Soil Environm & Atmospher Sci, Columbia, MO USA	Chinese Academy of Sciences; Institute of Soil Science, CAS; University of Missouri System; University of Missouri Columbia	Du, CW (corresponding author), Chinese Acad Sci, Inst Soil Sci, State Key Lab Soil & Sustainable Agr, Nanjing, Jiangsu, Peoples R China.	chwdu@issas.ac.cn	Changwen, Du/E-5239-2013	Changwen, Du/0000-0002-9064-3581	National Natural Science Foundation of China [40871113]; Knowledge Innovation Program of the Chinese Academy of Sciences [KZCX2-YW-QN411]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Knowledge Innovation Program of the Chinese Academy of Sciences(Chinese Academy of SciencesKnowledge Innovation Program of the Chinese Academy of Sciences)	This research was supported by the National Natural Science Foundation of China (40871113) and the Knowledge Innovation Program of the Chinese Academy of Sciences (KZCX2-YW-QN411). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bellamy PH, 2005, NATURE, V437, P245, DOI 10.1038/nature04038; Calderon FJ, 2011, SOIL SCI SOC AM J, V75, P568, DOI 10.2136/sssaj2009.0375; Cao ZH, 2006, NATURWISSENSCHAFTEN, V93, P232, DOI 10.1007/s00114-006-0083-4; Davidson EA, 2006, NATURE, V440, P165, DOI 10.1038/nature04514; Davidson EA, 2000, NATURE, V408, P789, DOI 10.1038/35048672; Drapcho DL, 1997, APPL SPECTROSC, V51, P453, DOI 10.1366/0003702971940486; Du C, 2008, GEODERMA, V143, P85, DOI 10.1016/j.geoderma.2007.10.012; Du CW, 2007, CHINESE J ANAL CHEM, V35, P119; Du CW, 2007, APPL SPECTROSC, V61, P1063, DOI 10.1366/000370207782217743; Du CW, 2011, J PLANT NUTR SOIL SC, V174, P20, DOI 10.1002/jpln.200900281; Du CW, 2010, J SOIL SEDIMENT, V10, P855, DOI 10.1007/s11368-010-0225-3; Du CW, 2009, VIB SPECTROSC, V49, P32, DOI 10.1016/j.vibspec.2008.04.009; Ellerbrock RH, 2004, EUR J SOIL SCI, V55, P219, DOI 10.1046/j.1365-2389.2004.00593.x; Fang CM, 2005, NATURE, V433, P57, DOI 10.1038/nature03138; Fontaine S, 2004, ECOL LETT, V7, P314, DOI 10.1111/j.1461-0248.2004.00579.x; GELADI P, 1986, ANAL CHIM ACTA, V185, P1, DOI 10.1016/0003-2670(86)80028-9; Giardina CP, 2000, NATURE, V404, P858, DOI 10.1038/35009076; Gill RA, 2002, NATURE, V417, P279, DOI 10.1038/417279a; Goddard MA, 2009, SOIL SCI SOC AM J, V73, P989, DOI 10.2136/sssaj2008.0004; Griffiths P R., 2006, HDB VIBRATIONAL SPEC; Hirmas DR, 2010, GEODERMA, V154, P486, DOI 10.1016/j.geoderma.2009.05.005; Huang PM, 2005, PEDOBIOLOGIA, V49, P609, DOI 10.1016/j.pedobi.2005.06.006; Jones DL, 2006, SOIL BIOL BIOCHEM, V38, P991, DOI 10.1016/j.soilbio.2005.08.012; Kogel-Knabner I, 2010, GEODERMA, V157, P1, DOI 10.1016/j.geoderma.2010.03.009; Lal R, 2004, SCIENCE, V304, P1623, DOI 10.1126/science.1097396; Melillo JM, 2002, SCIENCE, V298, P2173, DOI 10.1126/science.1074153; Pan GX, 2004, GLOBAL CHANGE BIOL, V10, P79, DOI 10.1111/j.1365-2486.2003.00717.x; Paustian K, 2000, BIOGEOCHEMISTRY, V48, P147, DOI 10.1023/A:1006271331703; Redeker KR, 2000, SCIENCE, V290, P966, DOI 10.1126/science.290.5493.966; Tatzber M, 2010, APPL SPECTROSC, V64, P1167, DOI 10.1366/000370210792973460; Wang YG, 2010, SCI TOTAL ENVIRON, V408, P1925, DOI 10.1016/j.scitotenv.2010.01.015; Yan XY, 2005, GLOBAL CHANGE BIOL, V11, P1131, DOI 10.1111/j.1365-2486.2005.00976.x; Zhang WR, 2009, PROG ORG COAT, V65, P469, DOI 10.1016/j.porgcoat.2009.04.005; Zoltan B, 2011, APPL SPECTROSC REV, V46, P1, DOI 10.1080/05704928.2010.520178	34	6	6	2	65	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 17	2012	7	8							e43368	10.1371/journal.pone.0043368	http://dx.doi.org/10.1371/journal.pone.0043368			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	996DG	22912863	gold, Green Published, Green Submitted			2022-12-25	WOS:000308063700091
J	Cox, RF; Jenkinson, A; Pohl, K; O'Brien, FJ; Morgan, MP				Cox, Rachel F.; Jenkinson, Allan; Pohl, Kerstin; O'Brien, Fergal J.; Morgan, Maria P.			Osteomimicry of Mammary Adenocarcinoma Cells In Vitro; Increased Expression of Bone Matrix Proteins and Proliferation within a 3D Collagen Environment	PLOS ONE			English	Article							HUMAN BREAST-CANCER; MESENCHYMAL STEM-CELLS; OSTEOBLAST DIFFERENTIATION; GENE-EXPRESSION; GAG SCAFFOLDS; SIALOPROTEIN; MICROCALCIFICATIONS; MINERALIZATION; CALCIUM; BENIGN	Bone is the most common site of metastasis for breast cancer, however the reasons for this remain unclear. We hypothesise that under certain conditions mammary cells possess osteomimetic capabilities that may allow them to adapt to, and flourish within, the bone microenvironment. Mammary cells are known to calcify within breast tissue and we have recently reported a novel in vitro model of mammary mineralization using murine mammary adenocarcinoma 4T1 cells. In this study, the osteomimetic properties of the mammary adenocarcinoma cell line and the conditions required to induce mineralization were characterized extensively. It was found that exogenous organic phosphate and inorganic phosphate induce mineralization in a dose dependent manner in 4T1 cells. Ascorbic acid and dexamethasone alone have no effect. 4T1 cells also show enhanced mineralization in response to bone morphogenetic protein 2 in the presence of phosphate supplemented media. The expression of several bone matrix proteins were monitored throughout the process of mineralization and increased expression of collagen type 1 and bone sialoprotein were detected, as determined by real-time RT-PCR. In addition, we have shown for the first time that 3D collagen glycosaminoglycan scaffolds, bioengineered to represent the bone microenvironment, are capable of supporting the growth and mineralization of 4T1 adenocarcinoma cells. These 3D scaffolds represent a novel model system for the study of mammary mineralization and bone metastasis. This work demonstrates that mammary cells are capable of osteomimicry, which may ultimately contribute to their ability to preferentially metastasize to, survive within and colonize the bone microenvironment.	[Cox, Rachel F.; Jenkinson, Allan; Pohl, Kerstin; Morgan, Maria P.] Royal Coll Surgeons Ireland, Dept Mol & Cellular Therapeut, Dublin 2, Ireland; [O'Brien, Fergal J.] Royal Coll Surgeons Ireland, Dept Anat, Dublin 2, Ireland; [O'Brien, Fergal J.] Trinity Coll Dublin, Trinity Ctr Bioengn, Dublin, Ireland	Royal College of Surgeons - Ireland; Royal College of Surgeons - Ireland; Trinity College Dublin	Cox, RF (corresponding author), Royal Coll Surgeons Ireland, Dept Mol & Cellular Therapeut, Dublin 2, Ireland.	mmorgan@rcsi.ie	O'Brien, Fergal/F-9485-2011	O'Brien, Fergal/0000-0003-2030-8005; Morgan, Maria/0000-0002-7041-3949	Royal College of Surgeons in Ireland Research Committee grant	Royal College of Surgeons in Ireland Research Committee grant	This work was supported by a Royal College of Surgeons in Ireland Research Committee grant to Maria P. Morgan. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ASLAKSON CJ, 1992, CANCER RES, V52, P1399; BELLAHCENE A, 1995, AM J PATHOL, V146, P95; Bellahcene A, 1996, LAB INVEST, V75, P203; Bellahcene A, 1996, INT J CANCER, V69, P350; BELLAHCENE A, 1994, CANCER RES, V54, P2823; Bellahcene A, 1996, J BONE MINER RES, V11, P665; BUSING CM, 1981, VIRCHOWS ARCH A, V393, P307, DOI 10.1007/BF00430830; CHEN JK, 1992, J BONE MINER RES, V7, P987; CHUNG CH, 1992, CALCIFIED TISSUE INT, V51, P305, DOI 10.1007/BF00334492; Clement JH, 2005, INT J ONCOL, V27, P401; COLEMAN RE, 1987, BRIT J CANCER, V55, P61, DOI 10.1038/bjc.1987.13; Cox RF, 2012, BRIT J CANCER, V106, P525, DOI 10.1038/bjc.2011.583; Davies Simon R, 2008, J Exp Ther Oncol, V7, P327; FRAPPART L, 1984, HUM PATHOL, V15, P880, DOI 10.1016/S0046-8177(84)80150-1; Gulsun M, 2003, EUR J RADIOL, V47, P227, DOI 10.1016/S0720-048X(02)00181-X; Haka AS, 2002, CANCER RES, V62, P5375; Haugh MG, 2009, J BIOMED MATER RES A, V89A, P363, DOI 10.1002/jbm.a.31955; Hofvind S, 2011, ACTA RADIOL, V52, P481, DOI 10.1258/ar.2011.100357; Hosogane N, 2010, INT J BIOCHEM CELL B, V42, P1132, DOI 10.1016/j.biocel.2010.03.020; HUNTER GK, 1993, P NATL ACAD SCI USA, V90, P8562, DOI 10.1073/pnas.90.18.8562; Hutmacher DW, 2010, NAT MATER, V9, P90, DOI 10.1038/nmat2619; Jensen ED, 2010, BIOFACTORS, V36, P25, DOI 10.1002/biof.72; Jorgensen NR, 2004, STEROIDS, V69, P219, DOI 10.1016/j.steroids.2003.12.005; Kauppila S, 1998, J PATHOL, V186, P262, DOI 10.1002/(SICI)1096-9896(1998110)186:3<262::AID-PATH191>3.0.CO;2-3; Keogh MB, 2010, ACTA BIOMATER, V6, P4305, DOI 10.1016/j.actbio.2010.06.001; Keogh MB, 2010, CELL TISSUE RES, V340, P169, DOI 10.1007/s00441-010-0939-y; Kirsch T, 2006, CURR OPIN RHEUMATOL, V18, P174, DOI 10.1097/01.bor.0000209431.59226.46; Komori T, 2010, ADV EXP MED BIOL, V658, P43, DOI 10.1007/978-1-4419-1050-9_5; Landis W J, 1999, Gravit Space Biol Bull, V12, P15; Landis WJ, 2009, CELLS TISSUES ORGANS, V189, P20, DOI 10.1159/000151454; LEBOY PS, 1989, J BIOL CHEM, V264, P17281; Lee Jae-Mok, 2010, J Periodontal Implant Sci, V40, P39, DOI 10.5051/jpis.2010.40.1.39; Lian JB, 1997, ENDOCRINOLOGY, V138, P2117, DOI 10.1210/en.138.5.2117; Liu FB, 2010, BREAST CANCER RES TR, V122, P87, DOI 10.1007/s10549-009-0535-6; Morgan MP, 2001, MOL CARCINOGEN, V32, P111, DOI 10.1002/mc.1070; Nakashima K, 2002, CELL, V108, P17, DOI 10.1016/S0092-8674(01)00622-5; O'Brien FJ, 2005, BIOMATERIALS, V26, P433, DOI 10.1016/j.biomaterials.2004.02.052; O'Brien FJ, 2004, BIOMATERIALS, V25, P1077, DOI 10.1016/S0142-9612(03)00630-6; OWEN TA, 1990, J CELL PHYSIOL, V143, P420, DOI 10.1002/jcp.1041430304; RADI MJ, 1989, ARCH PATHOL LAB MED, V113, P1367; Soung DY, 2007, J BONE MINER RES, V22, P1260, DOI 10.1359/JBMR.070502; Spinella-Jaegle S, 2001, BONE, V29, P323, DOI 10.1016/S8756-3282(01)00580-4; Suzuki A, 2006, J BONE MINER RES, V21, P674, DOI 10.1359/JBMR.020603; Tierney CM, 2009, J BIOMED MATER RES A, V91A, P92, DOI 10.1002/jbm.a.32207; Wan XC, 2008, BIOCHEM BIOPH RES CO, V373, P488, DOI 10.1016/j.bbrc.2008.06.037; Yavorskyy A, 2010, BIOANALYSIS, V2, P189, DOI 10.4155/BIO.09.163; Yin YX, 2007, CHINESE MED J-PEKING, V120, P204, DOI 10.1097/00029330-200702010-00006	47	59	62	1	22	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 24	2012	7	7							e41679	10.1371/journal.pone.0041679	http://dx.doi.org/10.1371/journal.pone.0041679			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	978NX	22911843	Green Submitted, Green Published, gold			2022-12-25	WOS:000306751300064
J	Mihara, M; Hara, H; Hayashi, Y; Narushima, M; Yamamoto, T; Todokoro, T; Iida, T; Sawamoto, N; Araki, J; Kikuchi, K; Murai, N; Okitsu, T; Kisu, I; Koshima, I				Mihara, Makoto; Hara, Hisako; Hayashi, Yohei; Narushima, Mitsunaga; Yamamoto, Takumi; Todokoro, Takeshi; Iida, Takuya; Sawamoto, Naoya; Araki, Jun; Kikuchi, Kazuki; Murai, Noriyuki; Okitsu, Taro; Kisu, Iori; Koshima, Isao			Pathological Steps of Cancer-Related Lymphedema: Histological Changes in the Collecting Lymphatic Vessels after Lymphadenectomy	PLOS ONE			English	Article							SMOOTH-MUSCLE; FLUORESCENCE LYMPHOGRAPHY; CONSERVATIVE TREATMENT; INDOCYANINE GREEN; EXTREMITIES	Introduction: To date, an electron microscopy study of the collecting lymphatic vessels has not been conducted to examine the early stages of lymphedema. However, such histological studies could be useful for elucidating the mechanism of lymphedema onset. The aim of this study was to clarify the changes occurring in collecting lymphatic vessels after lymphadenectomy. Methods: The study was conducted on 114 specimens from 37 patients who developed lymphedema of the lower limbs after receiving surgical treatment for gynecologic cancers and who consulted the University of Tokyo Hospital and affiliated hospitals from April 2009 to March 2011. Lymphatic vessels that were not needed for lymphatico venous anastomosis surgery were trimmed and subsequently examined using electron microscopy and light microscopy. Results: Based on macroscopic findings, the histochemical changes in the collecting lymphatic vessels were defined as follows: normal, ectasis, contraction, and sclerosis type (NECST). In the ectasis type, an increase in endolymphatic pressure was accompanied by a flattening of the lymphatic vessel endothelial cells. In the contraction type, smooth muscle cells were transformed into synthetic cells and promoted the growth of collagen fibers. In the sclerosis type, fibrous elements accounted for the majority of the components, the lymphatic vessels lost their transport and concentrating abilities, and the lumen was either narrowed or completely obstructed. Concl usions: The increase in pressure inside the collecting lymphatic vessels after lymphadenectomy was accompanied by histological changes that began before the onset of lymphedema.	[Mihara, Makoto; Hara, Hisako; Hayashi, Yohei; Narushima, Mitsunaga; Yamamoto, Takumi; Todokoro, Takeshi; Iida, Takuya; Sawamoto, Naoya; Araki, Jun; Kikuchi, Kazuki; Koshima, Isao] Univ Tokyo, Dept Plast & Reconstruct Surg, Tokyo, Japan; [Murai, Noriyuki] Saiseikai Kawaguchi Gen Hosp, Dept Vasc Surg, Saitama, Japan; [Okitsu, Taro] Keio Univ, Dept Rehabil Med, Tokyo, Japan; [Kisu, Iori] Keio Univ, Sch Med, Dept Obstet & Gynecol, Tokyo 160, Japan	University of Tokyo; Keio University; Keio University	Mihara, M (corresponding author), Univ Tokyo, Dept Plast & Reconstruct Surg, Tokyo, Japan.	mihara@keiseigeka.name	Yamamoto, Takumi/Y-7658-2019; Sawamoto, Mitsuo/AAH-3955-2020	Hayashi, Yohei/0000-0003-3914-9999	Japanese funding program for next generation world-leading researchers (NEXT program) [LS039]	Japanese funding program for next generation world-leading researchers (NEXT program)	The grant was provided by a Japanese funding program for next generation world-leading researchers (NEXT program, LS039). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arkill KP, 2010, J ANAT, V216, P547, DOI 10.1111/j.1469-7580.2010.01215.x; Becker C, 2006, ANN SURG, V243, P313, DOI 10.1097/01.sla.0000201258.10304.16; Breiteneder-Geleff S, 1999, AM J PATHOL, V154, P385, DOI 10.1016/S0002-9440(10)65285-6; Campisi C, 2010, MICROSURG, V30, P256, DOI 10.1002/micr.20737; Danz B, 2005, EUR J DERMATOL, V15, P474; Davis-Dusenbery BN, 2011, ARTERIOSCL THROM VAS, V31, P2370, DOI 10.1161/ATVBAHA.111.226670; FOLDI E, 1985, ANGIOLOGY, V36, P171, DOI 10.1177/000331978503600306; Foldi E, 1998, CANCER, V83, P2833, DOI 10.1002/(SICI)1097-0142(19981215)83:12B+<2833::AID-CNCR35>3.0.CO;2-3; Jensen MR, 2010, CLIN PHYSIOL FUNCT I, V30, P389, DOI 10.1111/j.1475-097X.2010.00969.x; Koshima I, 1996, PLAST RECONSTR SURG, V97, P397, DOI 10.1097/00006534-199602000-00018; Koshima I, 2003, J RECONSTR MICROSURG, V19, P209; LEAK LV, 1968, J CELL BIOL, V36, P129, DOI 10.1083/jcb.36.1.129; Ogata F, 2010, JAPANESE J LYMPHOLOG, V33, P64; OHHASHI T, 1984, MICROVASC RES, V27, P71, DOI 10.1016/0026-2862(84)90042-6; OHTANI O, 1992, ARCH HISTOL CYTOL, V55, P429, DOI 10.1679/aohc.55.429; Quick CM, 2009, AM J PHYSIOL-HEART C, V296, pH662, DOI 10.1152/ajpheart.00322.2008; Rockson SG, 2001, AM J MED, V110, P288, DOI 10.1016/S0002-9343(00)00727-0; Roy P, 2004, EJSO-EUR J SURG ONC, V30, P982, DOI 10.1016/j.ejso.2004.07.027; Suami H, 2010, PLAST RECONSTR SURG, V126, P1853, DOI 10.1097/PRS.0b013e3181f44658; Szuba A, 2000, AM J MED, V109, P296, DOI 10.1016/S0002-9343(00)00503-9; Unno N, 2008, EUR J VASC ENDOVASC, V36, P230, DOI 10.1016/j.ejvs.2008.04.013; Unno N, 2007, J VASC SURG, V45, P1016, DOI 10.1016/j.jvs.2007.01.023; Unno N, 2010, J VASC SURG, V52, P946, DOI 10.1016/j.jvs.2010.04.067; von der Weid PY, 2004, INT J BIOCHEM CELL B, V36, P1147, DOI 10.1016/j.biocel.2003.12.008; Wagner S, 2011, VASA, V40, P271, DOI 10.1024/0301-1526/a000115	25	77	78	1	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 24	2012	7	7							e41126	10.1371/journal.pone.0041126	http://dx.doi.org/10.1371/journal.pone.0041126			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	978NX	22911751	Green Published, gold			2022-12-25	WOS:000306751300024
J	Kaufman, M; Corner, MA; Ziv, NE				Kaufman, Maya; Corner, Michael A.; Ziv, Noam E.			Long-term Relationships between Cholinergic Tone, Synchronous Bursting and Synaptic Remodeling	PLOS ONE			English	Article							SLEEP-WAKE CYCLE; CEREBRAL-CORTEX; NEOCORTICAL NEURONS; DEVELOPING NETWORKS; HZ OSCILLATION; SPINDLE BURSTS; IN-VITRO; PLASTICITY; DYNAMICS; RAT	Cholinergic neuromodulation plays key roles in the regulation of neuronal excitability, network activity, arousal, and behavior. On longer time scales, cholinergic systems play essential roles in cortical development, maturation, and plasticity. Presumably, these processes are associated with substantial synaptic remodeling, yet to date, long-term relationships between cholinergic tone and synaptic remodeling remain largely unknown. Here we used automated microscopy combined with multielectrode array recordings to study long-term relationships between cholinergic tone, excitatory synapse remodeling, and network activity characteristics in networks of cortical neurons grown on multielectrode array substrates. Experimental elevations of cholinergic tone led to the abrupt suppression of episodic synchronous bursting activity (but not of general activity), followed by a gradual growth of excitatory synapses over hours. Subsequent blockage of cholinergic receptors led to an immediate restoration of synchronous bursting and the gradual reversal of synaptic growth. Neither synaptic growth nor downsizing was governed by multiplicative scaling rules. Instead, these occurred in a subset of synapses, irrespective of initial synaptic size. Synaptic growth seemed to depend on intrinsic network activity, but not on the degree to which bursting was suppressed. Intriguingly, sustained elevations of cholinergic tone were associated with a gradual recovery of synchronous bursting but not with a reversal of synaptic growth. These findings show that cholinergic tone can strongly affect synaptic remodeling and synchronous bursting activity, but do not support a strict coupling between the two. Finally, the reemergence of synchronous bursting in the presence of elevated cholinergic tone indicates that the capacity of cholinergic neuromodulation to indefinitely suppress synchronous bursting might be inherently limited.	[Kaufman, Maya; Ziv, Noam E.] Lorry Lokey Ctr Life Sci & Engn, Dept Physiol & Biophys, Haifa, Israel; [Kaufman, Maya; Ziv, Noam E.] Lorry Lokey Ctr Life Sci & Engn, Rappaport Inst, Technion Fac Med, Haifa, Israel; [Kaufman, Maya; Ziv, Noam E.] Lorry Lokey Ctr Life Sci & Engn, Network Biol Res Labs, Haifa, Israel; [Corner, Michael A.] Netherlands Inst Brain Res, Amsterdam, Netherlands	Technion Israel Institute of Technology; Rappaport Faculty of Medicine; Royal Netherlands Academy of Arts & Sciences; Netherlands Institute for Neuroscience (NIN-KNAW)	Kaufman, M (corresponding author), Lorry Lokey Ctr Life Sci & Engn, Dept Physiol & Biophys, Haifa, Israel.	noamz@netvision.net.il	Ziv, Noam/ABA-6551-2020	Ziv, Noam/0000-0001-9197-326X	Israel Science Foundation [1780/07, 1038/09]	Israel Science Foundation(Israel Science Foundation)	This work was supported by grants from the Israel Science Foundation (1780/07; 1038/09). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amzica F, 2002, SLEEP MED REV, V6, P139, DOI 10.1053/smrv.2001.0181; Appelbaum L, 2010, NEURON, V68, P87, DOI 10.1016/j.neuron.2010.09.006; Baker RE, 2006, BRAIN RES, V1101, P29, DOI 10.1016/j.brainres.2006.05.028; BARNES CA, 1977, SCIENCE, V197, P91, DOI 10.1126/science.194313; Beggs JM, 2003, J NEUROSCI, V23, P11167; Ben-Ari Y, 2001, TRENDS NEUROSCI, V24, P353, DOI 10.1016/S0166-2236(00)01813-0; Birtoli B, 2004, J NEUROSCI, V24, P4935, DOI 10.1523/JNEUROSCI.0795-04.2004; Bresler T, 2001, MOL CELL NEUROSCI, V18, P149, DOI 10.1006/mcne.2001.1012; Buchanan KA, 2010, NEURON, V68, P948, DOI 10.1016/j.neuron.2010.11.018; Bushey D, 2011, SCIENCE, V332, P1576, DOI 10.1126/science.1202839; Cash SS, 2009, SCIENCE, V324, P1084, DOI 10.1126/science.1169626; Chiappalone M, 2010, P 7 INT M SUBSTR INT, P65; Chiappalone M, 2007, INT J NEURAL SYST, V17, P87, DOI 10.1142/S0129065707000968; Cohen D, 2009, J NEUROPHYSIOL, V101, P2077, DOI 10.1152/jn.91085.2008; Constantinople CM, 2011, NEURON, V69, P1061, DOI 10.1016/j.neuron.2011.02.040; Corner MA, 2005, PROG BRAIN RES, V147, P231, DOI 10.1016/S0079-6123(04)47018-6; Corner MA, 2008, NEUROSCI BIOBEHAV R, V32, P1569, DOI 10.1016/j.neubiorev.2008.06.008; Corner MA, 2008, BRAIN RES REV, V59, P221, DOI 10.1016/j.brainresrev.2008.08.001; Destexhe A, 1999, J NEUROSCI, V19, P4595, DOI 10.1523/jneurosci.19-11-04595.1999; Diekelmann S, 2010, NAT REV NEUROSCI, V11, P114, DOI 10.1038/nrn2762; Donlea JM, 2009, SCIENCE, V324, P105, DOI 10.1126/science.1166657; Eytan D, 2006, J NEUROSCI, V26, P8465, DOI 10.1523/JNEUROSCI.1627-06.2006; Fisher-Lavie A, 2011, J NEUROSCI, V31, P16770, DOI 10.1523/JNEUROSCI.3384-11.2011; Froemke RC, 2007, NATURE, V450, P425, DOI 10.1038/nature06289; Frohlich F, 2008, J NEUROSCI, V28, P1709, DOI 10.1523/JNEUROSCI.4263-07.2008; Garaschuk O, 2000, NAT NEUROSCI, V3, P452, DOI 10.1038/74823; Gilestro GF, 2009, SCIENCE, V324, P109, DOI 10.1126/science.1166673; Golshani P, 2009, J NEUROSCI, V29, P10890, DOI 10.1523/JNEUROSCI.2012-09.2009; Gray NW, 2006, PLOS BIOL, V4, P2065, DOI 10.1371/journal.pbio.0040370; Gu Q, 2002, NEUROSCIENCE, V111, P815, DOI 10.1016/S0306-4522(02)00026-X; Gu ZL, 2011, NEURON, V71, P155, DOI 10.1016/j.neuron.2011.04.026; Hanganu IL, 2007, J NEUROSCI, V27, P5694, DOI 10.1523/JNEUROSCI.5233-06.2007; Hanganu IL, 2009, CEREB CORTEX, V19, P89, DOI 10.1093/cercor/bhn061; Hasselmo ME, 2006, CURR OPIN NEUROBIOL, V16, P710, DOI 10.1016/j.conb.2006.09.002; Hill S, 2005, J NEUROPHYSIOL, V93, P1671, DOI 10.1152/jn.00915.2004; Hohmann CF, 1998, PERSPECT DEV NEUROBI, V5, P401; Holtmaat A, 2009, NAT REV NEUROSCI, V10, P647, DOI 10.1038/nrn2699; JASPER HH, 1971, SCIENCE, V172, P601, DOI 10.1126/science.172.3983.601; Johnson HA, 2007, J NEUROSCI, V27, P5915, DOI 10.1523/JNEUROSCI.0447-07.2007; Jones BE, 2005, TRENDS PHARMACOL SCI, V26, P578, DOI 10.1016/j.tips.2005.09.009; Keith D, 2008, FRONT MOL NEUROSCI, V1, DOI 10.3389/neuro.02.004.2008; Khazipov R, 2004, NATURE, V432, P758, DOI 10.1038/nature03132; Lante F, 2011, J NEUROSCI, V31, P3953, DOI 10.1523/JNEUROSCI.3210-10.2011; Lee MG, 2005, J NEUROSCI, V25, P4365, DOI 10.1523/JNEUROSCI.0178-05.2005; Liu ZW, 2010, J NEUROSCI, V30, P8671, DOI 10.1523/JNEUROSCI.1409-10.2010; Loewenstein Y, 2011, J NEUROSCI, V31, P9481, DOI 10.1523/JNEUROSCI.6130-10.2011; MAEDA E, 1995, J NEUROSCI, V15, P6834; Maret S, 2011, NAT NEUROSCI, V14, P1418, DOI 10.1038/nn.2934; MARROSU F, 1995, BRAIN RES, V671, P329, DOI 10.1016/0006-8993(94)01399-3; MCCORMICK DA, 1987, J PHYSIOL-LONDON, V392, P147, DOI 10.1113/jphysiol.1987.sp016774; METHERATE R, 1992, J NEUROSCI, V12, P4701; Minerbi A, 2009, PLOS BIOL, V7, DOI 10.1371/journal.pbio.1000136; Moore AR, 2011, J NEUROSCI, V31, P2391, DOI 10.1523/JNEUROSCI.3886-10.2011; Pasquale V, 2008, NEUROSCIENCE, V153, P1354, DOI 10.1016/j.neuroscience.2008.03.050; Platt B, 2011, BEHAV BRAIN RES, V221, P499, DOI 10.1016/j.bbr.2011.01.017; Pozo K, 2010, NEURON, V66, P337, DOI 10.1016/j.neuron.2010.04.028; Ramanathan D, 2009, J NEUROSCI, V29, P5992, DOI 10.1523/JNEUROSCI.0230-09.2009; Sanchez-Vives MV, 2000, NAT NEUROSCI, V3, P1027, DOI 10.1038/79848; Schatzle P, 2011, J PHYSIOL-LONDON, V589, P4353, DOI 10.1113/jphysiol.2010.204446; Segev R, 2002, PHYS REV LETT, V88, DOI 10.1103/PhysRevLett.88.118102; Seol GH, 2007, NEURON, V55, P919, DOI 10.1016/j.neuron.2007.08.013; Shaffery JP, 2009, CURRENT ADV SLEEP BI, P177; SIEGEL JM, 1988, BRAIN RES REV, V13, P213, DOI 10.1016/0165-0173(88)90007-0; STERIADE M, 1993, J NEUROSCI, V13, P3266; STERIADE M, 1993, J NEUROPHYSIOL, V70, P1385, DOI 10.1152/jn.1993.70.4.1385; Steriade M, 2001, J NEUROPHYSIOL, V85, P1969, DOI 10.1152/jn.2001.85.5.1969; STERIADE M, 1993, J NEUROSCI, V13, P3252, DOI 10.1523/jneurosci.13-08-03252.1993; Tateno T, 2005, NEUROSCIENCE, V134, P425, DOI 10.1016/j.neuroscience.2005.04.049; Timofeev I, 2001, P NATL ACAD SCI USA, V98, P1924, DOI 10.1073/pnas.041430398; Tononi G, 2006, SLEEP MED REV, V10, P49, DOI 10.1016/j.smrv.2005.05.002; Turrigiano GG, 2004, NAT REV NEUROSCI, V5, P97, DOI 10.1038/nrn1327; van Pelt J, 2004, IEEE T BIO-MED ENG, V51, P2051, DOI 10.1109/TBME.2004.827936; Volgushev M, 2006, J NEUROSCI, V26, P5665, DOI 10.1523/JNEUROSCI.0279-06.2006; Vyazovskiy VV, 2008, NAT NEUROSCI, V11, P200, DOI 10.1038/nn2035; Vyazovskiy VV, 2011, NATURE, V472, P443, DOI 10.1038/nature10009; Vyazovskiy VV, 2009, NEURON, V63, P865, DOI 10.1016/j.neuron.2009.08.024; Wagenaar DA, 2006, BMC NEUROSCI, V7, DOI 10.1186/1471-2202-7-11; Wagenaar DA, 2005, J NEUROSCI, V25, P680, DOI 10.1523/JNEUROSCI.4209-04.2005; Yang G, 2012, DEV NEUROBIOL, V72, P1391, DOI 10.1002/dneu.20996; Yasumatsu N, 2008, J NEUROSCI, V28, P13592, DOI 10.1523/JNEUROSCI.0603-08.2008	80	24	24	1	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 23	2012	7	7							e40980	10.1371/journal.pone.0040980	http://dx.doi.org/10.1371/journal.pone.0040980			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	977TM	22911726	Green Published, gold, Green Submitted			2022-12-25	WOS:000306687700032
J	Douarre, C; Sourbier, C; Dalla Rosa, I; Das, BB; Redon, CE; Zhang, HL; Neckers, L; Pommier, Y				Douarre, Celine; Sourbier, Carole; Dalla Rosa, Ilaria; Das, Benu Brata; Redon, Christophe E.; Zhang, Hongliang; Neckers, Len; Pommier, Yves			Mitochondrial Topoisomerase I is Critical for Mitochondrial Integrity and Cellular Energy Metabolism	PLOS ONE			English	Article							OXIDATIVE STRESS; GENE-EXPRESSION; DNA; BIOGENESIS; AUTOPHAGY; CANCER; CELLS; NUCLEAR; DISEASE; ATM	Background: Mitochondria contain their own DNA genome (mtDNA), as well as specific DNA replication and protein synthesis machineries. Relaxation of the circular, double-stranded mtDNA relies on the presence of topoisomerase activity. Three different topoisomerases have been identified in mitochondria: Top1mt, Top3 alpha and a truncated form of Top2 beta. Methodology/Principal Findings: The present study shows the importance of Top1mt in mitochondrial homeostasis. Here we show that Top1mt(-/-) murine embryonic fibroblasts (MEF) exhibit dysfunctional mitochondrial respiration, which leads decreased ATP production and compensation by increased glycolysis and fatty acid oxidation. ROS production in Top1mt(-/-) MEF cells is involved in nuclear DNA damage and induction of autophagy. Lack of Top1mt also triggers oxidative stress and DNA damage associated with lipid peroxidation and mitophagy in Top1mt(-/-) mice. Conclusion/Significance: Together, our data implicate Top1mt for mitochondrial integrity and energy metabolism. The compensation mechanism described here contributes to the survival of Top1mt(-/-) cells and mice despite alterations of mitochondrial functions and metabolism. Therefore, this study supports a novel model for cellular adaptation to mitochondrial damage.	[Douarre, Celine; Dalla Rosa, Ilaria; Das, Benu Brata; Redon, Christophe E.; Zhang, Hongliang] NCI, Mol Pharmacol Lab, NIH, Bethesda, MD 20892 USA; [Sourbier, Carole; Neckers, Len; Pommier, Yves] NCI, Urol Oncol Branch, NIH, Bethesda, MD 20892 USA	National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI)	Douarre, C (corresponding author), NCI, Mol Pharmacol Lab, NIH, Bethesda, MD 20892 USA.	celine.douarre@umontreal.ca	Das, Benu Brata/AAC-3452-2022; DAS, BENU BRATA BRATA/AAX-4347-2021	DAS, BENU BRATA BRATA/0000-0003-2519-7105; Dalla Rosa, Ilaria/0000-0003-4801-2396	Center for Cancer Research, Intramural Program of the U.S. National Cancer Institute, National Institutes of Health; NATIONAL CANCER INSTITUTE [ZIABC010683, ZIABC006161] Funding Source: NIH RePORTER	Center for Cancer Research, Intramural Program of the U.S. National Cancer Institute, National Institutes of Health; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This research was supported by the Center for Cancer Research, Intramural Program of the U.S. National Cancer Institute, National Institutes of Health. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bailey CM, 2010, BBA-PROTEINS PROTEOM, V1804, P1213, DOI 10.1016/j.bbapap.2010.01.007; Bakkenist CJ, 2003, NATURE, V421, P499, DOI 10.1038/nature01368; Barzilai A, 2004, DNA REPAIR, V3, P1109, DOI 10.1016/j.dnarep.2004.03.002; Bonawitz ND, 2006, MOL CELL, V24, P813, DOI 10.1016/j.molcel.2006.11.024; Bonner WM, 2008, NAT REV CANCER, V8, P957, DOI 10.1038/nrc2523; Brand MD, 2011, BIOCHEM J, V435, P297, DOI 10.1042/BJ20110162; Butow RA, 2004, MOL CELL, V14, P1, DOI 10.1016/S1097-2765(04)00179-0; Champoux JJ, 2001, ANNU REV BIOCHEM, V70, P369, DOI 10.1146/annurev.biochem.70.1.369; Christie DA, 2011, MOL CELL BIOL, V31, P3845, DOI 10.1128/MCB.05393-11; Da Cruz S, 2008, BBA-MOL CELL RES, V1783, P904, DOI 10.1016/j.bbamcr.2008.02.006; Eaton JS, 2007, J CLIN INVEST, V117, P2723, DOI 10.1172/JCI31604; Erol A, 2005, MED HYPOTHESES, V65, P525, DOI 10.1016/j.mehy.2005.03.022; ESTERBAUER H, 1991, FREE RADICAL BIO MED, V11, P81, DOI 10.1016/0891-5849(91)90192-6; Feldser D, 1999, CANCER RES, V59, P3915; Fernandez-Checa JC, 1998, BIOFACTORS, V8, P7, DOI 10.1002/biof.5520080102; Fu XA, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002009; Gomes LC, 2011, NAT CELL BIOL, V13, P589, DOI 10.1038/ncb2220; Gong BD, 1998, RADIAT RES, V150, P505, DOI 10.2307/3579866; Ichimura Y, 2000, NATURE, V408, P488, DOI 10.1038/35044114; Kabeya Y, 2000, EMBO J, V19, P5720, DOI 10.1093/emboj/19.21.5720; Kang DC, 2005, CURR MED CHEM, V12, P429, DOI 10.2174/0929867053363081; Kelly DP, 2004, GENE DEV, V18, P357, DOI 10.1101/gad.1177604; Kim I, 2007, ARCH BIOCHEM BIOPHYS, V462, P245, DOI 10.1016/j.abb.2007.03.034; Kluza J, 2004, ONCOGENE, V23, P7018, DOI 10.1038/sj.onc.1207936; Kondo Y, 2005, NAT REV CANCER, V5, P726, DOI 10.1038/nrc1692; Lee HC, 2002, J BIOMED SCI, V9, P517, DOI 10.1007/BF02254978; Lee HC, 2005, INT J BIOCHEM CELL B, V37, P822, DOI 10.1016/j.biocel.2004.09.010; Li F, 2005, MOL CELL BIOL, V25, P6225, DOI 10.1128/MCB.25.14.6225-6234.2005; Low RL, 2003, EUR J BIOCHEM, V270, P4173, DOI 10.1046/j.1432-1033.2003.03814.x; O'Neil RG, 2005, MOL IMAGING BIOL, V7, P388, DOI 10.1007/s11307-005-0011-6; Patel AJ, 1998, J NEUROSCI, V18, P3117; Pommier Y, 2006, NAT REV CANCER, V6, P789, DOI 10.1038/nrc1977; Rabinowitz JD, 2010, SCIENCE, V330, P1344, DOI 10.1126/science.1193497; Rambold AS, 2011, P NATL ACAD SCI USA, V108, P10190, DOI 10.1073/pnas.1107402108; Rendina AR, 2005, BIOCHEM J, V388, P895, DOI 10.1042/BJ20041963; Rinaldo P, 2002, ANNU REV PHYSIOL, V64, P477, DOI 10.1146/annurev.physiol.64.082201.154705; Sas K, 2007, J NEUROL SCI, V257, P221, DOI 10.1016/j.jns.2007.01.033; Scarpulla RC, 2002, BBA-GENE STRUCT EXPR, V1576, P1, DOI 10.1016/S0167-4781(02)00343-3; Scarpulla RC, 2008, PHYSIOL REV, V88, P611, DOI 10.1152/physrev.00025.2007; Schapira AHV, 2006, LANCET, V368, P70, DOI 10.1016/S0140-6736(06)68970-8; Scherz-Shouval R, 2007, EMBO J, V26, P1749, DOI 10.1038/sj.emboj.7601623; SEMENZA GL, 1994, J BIOL CHEM, V269, P23757; So SR, 2009, J CELL BIOL, V187, P977, DOI 10.1083/jcb.200906064; Tanaka T, 2006, CELL CYCLE, V5, P2671, DOI 10.4161/cc.5.22.3472; Tondera D, 2009, EMBO J, V28, P1589, DOI 10.1038/emboj.2009.89; VIRBASIUS JV, 1994, P NATL ACAD SCI USA, V91, P1309, DOI 10.1073/pnas.91.4.1309; Wallace DC, 2010, ENVIRON MOL MUTAGEN, V51, P440, DOI 10.1002/em.20586; Wang Y, 2002, P NATL ACAD SCI USA, V99, P12114, DOI 10.1073/pnas.192449499; WARBURG O, 1956, SCIENCE, V123, P309, DOI 10.1126/science.123.3191.309; Wu M, 2007, AM J PHYSIOL-CELL PH, V292, pC125, DOI 10.1152/ajpcell.00247.2006; Yorimitsu T, 2005, CELL DEATH DIFFER, V12, P1542, DOI 10.1038/sj.cdd.4401765; Zhang HL, 2004, NUCLEIC ACIDS RES, V32, P2087, DOI 10.1093/nar/gkh525; Zhang HL, 2001, P NATL ACAD SCI USA, V98, P10608, DOI 10.1073/pnas.191321998; Zhang HL, 2008, BIOCHEMISTRY-US, V47, P11196, DOI 10.1021/bi800774b; Zoppoli G, 2011, NUCLEIC ACIDS RES, V39, P6620, DOI 10.1093/nar/gkr208	55	71	73	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 20	2012	7	7							e41094	10.1371/journal.pone.0041094	http://dx.doi.org/10.1371/journal.pone.0041094			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	977GL	22911747	gold, Green Submitted, Green Published			2022-12-25	WOS:000306644600046
J	Elliott, EC; Cornell, SJ				Elliott, Elizabeth C.; Cornell, Stephen J.			Dispersal Polymorphism and the Speed of Biological Invasions	PLOS ONE			English	Article							CLIMATE-CHANGE; TRADE-OFFS; EVOLUTION; RANGE; POPULATIONS; DYNAMICS; SPREAD; RATES	The speed at which biological range expansions occur has important consequences for the conservation management of species experiencing climate change and for invasion by exotic organisms. Rates of dispersal and population growth are known to affect the speed of invasion, but little is known about the effect of having a community of dispersal phenotypes on the rate of range expansion. We use reaction-diffusion equations to model the invasion of a species with two dispersal phenotypes into a previously unoccupied landscape. These phenotypes differ in both their dispersal rate and population growth rate. We find that the presence of both phenotypes can result in faster range expansions than if only a single phenotype were present in the landscape. For biologically realistic parameters, the invasion can occur up to twice as fast as a result of this polymorphism. This has implications for predicting the speed of biological invasions, suggesting that speeds cannot just be predicted from looking at a single phenotype and that the full community of phenotypes needs to be taken into consideration.	[Elliott, Elizabeth C.; Cornell, Stephen J.] Univ Leeds, Inst Integrat & Comparat Biol, Leeds, W Yorkshire, England	University of Leeds	Elliott, EC (corresponding author), Univ Leeds, Inst Integrat & Comparat Biol, Leeds, W Yorkshire, England.	jhs5ece@leeds.ac.uk	Cornell, Stephen J/D-3955-2009		Natural Environment Research Council	Natural Environment Research Council(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC))	Elizabeth Elliott was supported by a Natural Environment Research Council studentship, funders website: www.nerc.ac.uk/. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Barton KA, 2012, P ROY SOC B-BIOL SCI, V279, P1194, DOI 10.1098/rspb.2011.1254; Bonte D, 2010, OIKOS, V119, P560, DOI 10.1111/j.1600-0706.2009.17943.x; Burton OJ, 2010, ECOL LETT, V13, P1210, DOI 10.1111/j.1461-0248.2010.01505.x; Chen IC, 2011, SCIENCE, V333, P1024, DOI 10.1126/science.1206432; Duckworth RA, 2008, AM NAT, V172, pS4, DOI 10.1086/588289; Ellner SP, 2012, THEOR POPUL BIOL, V82, P283, DOI 10.1016/j.tpb.2012.03.005; Fisher RA, 1937, ANN EUGENIC, V7, P355, DOI 10.1111/j.1469-1809.1937.tb02153.x; Garcia-Ramos G, 2002, EVOLUTION, V56, P661, DOI 10.1554/0014-3820(2002)056[0661:ESOSI]2.0.CO;2; Gienapp P, 2008, MOL ECOL, V17, P167, DOI 10.1111/j.1365-294X.2007.03413.x; Hanski I, 2006, J ANIM ECOL, V75, P91, DOI 10.1111/j.1365-2656.2005.01024.x; Hastings A, 2005, ECOL LETT, V8, P91, DOI 10.1111/j.1461-0248.2004.00687.x; Hickling R, 2006, GLOBAL CHANGE BIOL, V12, P450, DOI 10.1111/j.1365-2486.2006.01116.x; Hill JK, 2011, ANNU REV ENTOMOL, V56, P143, DOI 10.1146/annurev-ento-120709-144746; Hill JK, 1999, OECOLOGIA, V121, P165, DOI 10.1007/s004420050918; Hughes CL, 2003, P ROY SOC B-BIOL SCI, V270, pS147, DOI 10.1098/rsbl.2003.0049; Hughes CL, 2007, ECOL ENTOMOL, V32, P437, DOI 10.1111/j.1365-2311.2007.00890.x; Jansen VAA, 2007, EVOLUTION, V61, P2386, DOI 10.1111/j.1558-5646.2007.00201.x; Kubisch A, 2010, ECOLOGY, V91, P3094, DOI 10.1890/09-2022.1; MCPEEK MA, 1992, AM NAT, V140, P1010, DOI 10.1086/285453; Mustin K, 2009, OIKOS, V118, P131, DOI 10.1111/j.1600-0706.2008.17025.x; Ovaskainen O, 2006, THEOR POPUL BIOL, V69, P13, DOI 10.1016/j.tpb.2005.05.005; Parmesan C, 2003, NATURE, V421, P37, DOI 10.1038/nature01286; Phillips BL, 2009, BIOL LETTERS, V5, P802, DOI 10.1098/rsbl.2009.0367; Phillips BL, 2010, ECOLOGY, V91, P1617, DOI 10.1890/09-0910.1; Root TL, 2003, NATURE, V421, P57, DOI 10.1038/nature01333; Saastamoinen M, 2007, OECOLOGIA, V153, P569, DOI 10.1007/s00442-007-0772-5; Sakai AK, 2001, ANNU REV ECOL SYST, V32, P305, DOI 10.1146/annurev.ecolsys.32.081501.114037; Shine R, 2011, P NATL ACAD SCI USA, V108, P5708, DOI 10.1073/pnas.1018989108; Soetaert K, 2010, J STAT SOFTW, V33, P1, DOI 10.18637/jss.v033.i09; SORENSEN AE, 1978, NATURE, V276, P174, DOI 10.1038/276174a0; Travis JMJ, 2002, EVOL ECOL RES, V4, P1119; Travis JMJ, 2010, DIVERS DISTRIB, V16, P690, DOI 10.1111/j.1472-4642.2010.00674.x; Travis JMJ, 2009, J THEOR BIOL, V259, P151, DOI 10.1016/j.jtbi.2009.03.008; van Saarloos W, 2003, PHYS REP, V386, P29, DOI 10.1016/j.physrep.2003.08.001; Weinberger HF, 2007, J MATH BIOL, V55, P207, DOI 10.1007/s00285-007-0078-6; Weinberger HF, 2002, J MATH BIOL, V45, P183, DOI 10.1007/s002850200145; Zera AJ, 1997, ANNU REV ENTOMOL, V42, P207, DOI 10.1146/annurev.ento.42.1.207; Zhang BC, 2016, J BASIC MICROB, V56, P670, DOI 10.1002/jobm.201500751; Ziska LH, 2011, CLIMATIC CHANGE, V105, P13, DOI 10.1007/s10584-010-9879-5	39	24	24	2	50	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 20	2012	7	7							e40496	10.1371/journal.pone.0040496	http://dx.doi.org/10.1371/journal.pone.0040496			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	977GL	22911701	gold, Green Published, Green Submitted			2022-12-25	WOS:000306644600019
J	Sahebzadeh, N; Mardan, M; Ali, AM; Tan, SG; Adam, NA; Lau, WH				Sahebzadeh, Najmeh; Mardan, Makhdzir; Ali, Abdul Manaf; Tan, Soon Guan; Adam, Nur Azura; Lau, Wei Hong			Genetic Relatedness of Low Solitary Nests of Apis dorsata from Marang, Terengganu, Malaysia	PLOS ONE			English	Article							MELLIFERA; POPULATION; AGGREGATIONS; HYMENOPTERA; DISTANCES	Knowledge on the population of genetic structure and ecological behaviour of Apis dorsata from Peninsular Malaysia is needed for effective management and conservation of this species since unsustainable whole solitary low nest cutting for product harvesting is the current common practice here. The analysis of 15 single locus DNA microsatellite markers on samples from 20 solitary nests of A. dorsata showed that while these markers were polymorphic, high intracolonial relatedness existed. Furthermore, in general, slightly negative values of intercolony relatedness (R) among the nests of A. dorsata were found. However, positive values of mean intercolony relatedness were observed between 54 pairs of nests out of 190 possible combinations. The R values among nest pairs 3-4 and 3-5 was higher than 0.50 showing that their queens were half siblings, whereas nest pair 19-20 showed relatedness of 0.95 indicating that the same queen was sampled. The results that we obtained could not conclusively support the hypothesis of this study that the honey hunters in Marang district of Malaysia repeatedly harvest the same nest located at a different site and at a different time during the same honey harvesting season. However, our finding of an appreciable level of intercolonial relatedness between several pairs of nests in this pioneer study indicated that a comprehensive study with a larger sample size of solitary nests found throughout the region would be necessary to provide concrete proof for this novel idea.	[Sahebzadeh, Najmeh; Adam, Nur Azura; Lau, Wei Hong] Univ Putra Malaysia, Dept Plant Protect, Fac Agr, Serdang, Selangor, Malaysia; [Mardan, Makhdzir] Univ Putra Malaysia, Dept Agr Technol, Fac Agr, Serdang, Selangor, Malaysia; [Ali, Abdul Manaf] Univ Sultan Zainal Abidin, Fac Agr & Biotechnol, Dept Biotechnol, Kuala Terengganu, Terengganu, Malaysia; [Tan, Soon Guan] Univ Putra Malaysia, Fac Biotechnol & Biomol Sci, Dept Cell & Mol Biol, Serdang, Selangor, Malaysia	Universiti Putra Malaysia; Universiti Putra Malaysia; Universiti Sultan Zainal Abidin; Universiti Putra Malaysia	Sahebzadeh, N (corresponding author), Univ Putra Malaysia, Dept Plant Protect, Fac Agr, Serdang, Selangor, Malaysia.	najmeh.sahebzadeh@gmail.com	Sahebzadeh, Najmeh/ABA-3727-2021; Tan, S G/B-2448-2010; Tan, Soon Guan/V-1782-2019	Sahebzadeh, Najmeh/0000-0001-5736-1702; Tan, S G/0000-0001-9960-4493; Tan, Soon Guan/0000-0001-9960-4493	University Putra Malaysia via FRGS [07-04-10-819FR]	University Putra Malaysia via FRGS	University Putra Malaysia supported this research via FRGS grant (07-04-10-819FR). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], BIOGEOGRAPHY TAXONOM, DOI DOI 10.1007/978-3-642-72649-1; Cornuet JM, 1996, GENETICS, V144, P2001; Creste S, 2001, PLANT MOL BIOL REP, V19, P299, DOI 10.1007/BF02772828; ESTOUP A, 1995, GENETICS, V140, P679; GUO SW, 1992, BIOMETRICS, V48, P361, DOI 10.2307/2532296; HAMID A H, 1997, P INT C TROP BEES EN, P60; Hartl D., 2007, PRINCIPLES POPULATIO; Insuan S, 2007, BIOCHEM GENET, V45, P345, DOI 10.1007/s10528-007-9079-9; Kastberger G, 2000, APIDOLOGIE, V31, P727, DOI 10.1051/apido:2000157; Mardan M, 2007, BEES DEV, V83, P7; MARDAN MB, 1989, THESIS U GUELPH ONTA; Michalakis Y, 1996, GENETICS, V142, P1061; Norris AT, 1999, AQUACULTURE, V180, P247, DOI 10.1016/S0044-8486(99)00212-4; OLDROYD B, 1995, APIDOLOGIE, V26, P119, DOI 10.1051/apido:19950205; Oldroyd BP, 1996, ANN ENTOMOL SOC AM, V89, P276, DOI 10.1093/aesa/89.2.276; Oldroyd BP, 2000, INSECT SOC, V47, P94, DOI 10.1007/s000400050015; Oldroyd BP, 2006, ASIAN HONEY BEES BIO; Ott J., 2001, ANAL HUMAN GENETIC L; Paar J, 2004, J HERED, V95, P119, DOI 10.1093/jhered/esh026; Park S., 2008, EXCEL MICROSATELLITE; Peakall R, 2010, GENALEX 6 41 GENETIC; QUELLER DC, 1989, EVOLUTION, V43, P258, DOI 10.1111/j.1558-5646.1989.tb04226.x; RAYMOND M, 1995, J HERED, V86, P248, DOI 10.1093/oxfordjournals.jhered.a111573; RINDERER TE, 1994, J APICULT RES, V33, P171, DOI 10.1080/00218839.1994.11100866; Saberioon M. M., 2010, American Journal of Applied Sciences, V7, P252; Solignac M, 2003, MOL ECOL NOTES, V3, P307, DOI 10.1046/j.1471-8286.2003.00436.x; Takezaki N, 1996, GENETICS, V144, P389; Ting J, 2008, RES J ANIMAL SCI, V2, P178; WANG J, 2008, COLONY VERSION 2 0 1; WEIR BS, 1984, EVOLUTION, V38, P1358, DOI [10.2307/2408641, 10.1111/j.1558-5646.1984.tb05657.x]; Weir BS, 1990, GENETIC DATA ANAL ME, P222; Yong PL, 2007, EC VALUES HONEY BEES, P120	32	2	2	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 20	2012	7	7							e41020	10.1371/journal.pone.0041020	http://dx.doi.org/10.1371/journal.pone.0041020			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	977GL	22911733	gold, Green Submitted, Green Published			2022-12-25	WOS:000306644600037
J	Epis, MR; Giles, KM; Kalinowski, FC; Barker, A; Cohen, RJ; Leedman, PJ				Epis, Michael R.; Giles, Keith M.; Kalinowski, Felicity C.; Barker, Andrew; Cohen, Ronald J.; Leedman, Peter J.			Regulation of Expression of Deoxyhypusine Hydroxylase (DOHH), the Enzyme That Catalyzes the Activation of eIF5A, by miR-331-3p and miR-642-5p in Prostate Cancer Cells	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							P-GLYCOPROTEIN EXPRESSION; GENE-EXPRESSION; HYPUSINE FORMATION; PROTEIN-SYNTHESIS; GROWTH ARREST; UP-REGULATION; INITIATION; MICRORNAS; CYCLE; PROLIFERATION	The enzyme deoxyhypusine hydroxylase (DOHH) catalyzes the activation of eukaryotic translation initiation factor (eIF5A), a protein essential for cell growth. Using bioinformatic predictions and reporter gene assays, we have identified a 182-nt element within the DOHH 3'-untranslated region (3'-UTR) that contains a number of target sites for miR-331-3p and miR-642-5p. Quantitative RT-PCR studies demonstrated overexpression of DOHH mRNA and underexpression of miR-331-3p and miR-642-5p in several prostate cancer cell lines compared with normal prostate epithelial cells. Transient overexpression of miR-331-3p and/or miR-642-5p in DU145 prostate cancer cells reduced DOHH mRNA and protein expression and inhibited cell proliferation. We observed synergistic growth inhibition with the combination of miR-331-3p and miR-642-5p and mimosine, a pharmacological DOHH inhibitor. Finally, we identified a significant inverse relationship between the expression of miR-331-3p or miR-642-5p and DOHH in a cohort of human prostate cancer tissues. Our results suggest a novel role for miR-331-3p and miR-642-5p in the control of prostate cancer cell growth via the regulation of DOHH expression and eIF5A activity.	[Epis, Michael R.; Giles, Keith M.; Kalinowski, Felicity C.; Barker, Andrew; Leedman, Peter J.] Univ Western Australia, Med Res Ctr, Royal Perth Hosp, Perth, WA 6000, Australia; [Epis, Michael R.; Giles, Keith M.; Kalinowski, Felicity C.; Barker, Andrew; Leedman, Peter J.] Western Australian Inst Med Res, Lab Canc Med, Perth, WA 6000, Australia; [Cohen, Ronald J.] Uropath Pty Ltd, W Leederville, WA 6007, Australia; [Cohen, Ronald J.] Univ Western Australia, Sch Pathol & Lab Med, Nedlands, WA 6009, Australia; [Leedman, Peter J.] Univ Western Australia, Sch Med & Pharmacol, Nedlands, WA 6009, Australia	Royal Perth Hospital; University of Western Australia; University of Western Australia; University of Western Australia; University of Western Australia	Leedman, PJ (corresponding author), Level 6,MRF Bldg,Rear 50 Murray St, Perth, WA 6000, Australia.	peter.leedman@uwa.edu.au	Leedman, Peter J/O-4044-2014; Barker, Andrew/A-4289-2013	Kalinowski, Felicity/0000-0002-3923-8898	National Health and Medical Research Council of Australia; Prostate Cancer Foundation of Australia	National Health and Medical Research Council of Australia(National Health and Medical Research Council (NHMRC) of Australia); Prostate Cancer Foundation of Australia	This work was supported by the National Health and Medical Research Council of Australia and the Prostate Cancer Foundation of Australia.	Balabanov S, 2007, BLOOD, V109, P1701, DOI 10.1182/blood-2005-03-037648; Bartel DP, 2004, CELL, V116, P281, DOI 10.1016/S0092-8674(04)00045-5; BENNE R, 1978, J BIOL CHEM, V253, P3078; Bliss CI, 1939, ANN APPL BIOL, V26, P585, DOI 10.1111/j.1744-7348.1939.tb06990.x; Caraglia M., 2011, AMINO ACIDS; Chang HC, 2000, INT J ONCOL, V17, P659; Chen JF, 2006, NAT GENET, V38, P228, DOI 10.1038/ng1725; Chen KY, 1997, BIOL SIGNAL, V6, P105; Cheng AM, 2005, NUCLEIC ACIDS RES, V33, P1290, DOI 10.1093/nar/gki200; Chi SW, 2009, NATURE, V460, P479, DOI 10.1038/nature08170; Chung LC, 2012, AM J PHYSIOL-CELL PH, V302, pC676, DOI 10.1152/ajpcell.00180.2011; Cracchiolo BM, 2004, GYNECOL ONCOL, V94, P217, DOI 10.1016/j.ygyno.2004.03.018; Engelmann D, 2012, CANCER RES, V72, P571, DOI 10.1158/0008-5472.CAN-11-2575; Epis MR, 2011, J BIOL CHEM, V286, P41442, DOI 10.1074/jbc.M111.301481; Epis MR, 2009, J BIOL CHEM, V284, P24696, DOI 10.1074/jbc.M109.030098; Esquela-Kerscher A, 2006, NAT REV CANCER, V6, P259, DOI 10.1038/nrc1840; Giles KM, 2011, METHODS MOL BIOL, V676, P147, DOI 10.1007/978-1-60761-863-8_11; Grimson A, 2007, MOL CELL, V27, P91, DOI 10.1016/j.molcel.2007.06.017; Guan XY, 2004, CANCER RES, V64, P4197, DOI 10.1158/0008-5472.CAN-03-3747; Guo HL, 2010, NATURE, V466, P835, DOI 10.1038/nature09267; Guo XB, 2010, BIOCHEM BIOPH RES CO, V398, P1, DOI 10.1016/j.bbrc.2010.05.082; HANAUSKEABEL HM, 1994, BBA-MOL CELL RES, V1221, P115, DOI 10.1016/0167-4889(94)90003-5; HANAUSKEABEL HM, 1995, FEBS LETT, V366, P92, DOI 10.1016/0014-5793(95)00493-S; Hoque M, 2009, RETROVIROLOGY, V6, DOI 10.1186/1742-4690-6-90; Humphreys DT, 2005, P NATL ACAD SCI USA, V102, P16961, DOI 10.1073/pnas.0506482102; Jackson Richard J, 2007, Sci STKE, V2007, pre1, DOI 10.1126/stke.3672007re1; John B, 2004, PLOS BIOL, V2, P1862, DOI 10.1371/journal.pbio.0020363; Johnson SM, 2005, CELL, V120, P635, DOI 10.1016/j.cell.2005.01.014; Bueno MJ, 2011, BBA-MOL BASIS DIS, V1812, P592, DOI 10.1016/j.bbadis.2011.02.002; KANG HA, 1994, J BIOL CHEM, V269, P3934; KEMPER WM, 1976, ARCH BIOCHEM BIOPHYS, V174, P603, DOI 10.1016/0003-9861(76)90389-1; Krek A, 2005, NAT GENET, V37, P495, DOI 10.1038/ng1536; Kulp KS, 1996, TOXICOL APPL PHARM, V139, P356, DOI 10.1006/taap.1996.0176; Lee KH, 2009, ONCOGENE, V28, P3360, DOI 10.1038/onc.2009.192; Lewis BP, 2005, CELL, V120, P15, DOI 10.1016/j.cell.2004.12.035; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Maes OC, 2009, J CELL PHYSIOL, V221, P109, DOI 10.1002/jcp.21834; Maier B, 2010, J CLIN INVEST, V120, P2156, DOI 10.1172/JCI38924; Park JH, 2006, P NATL ACAD SCI USA, V103, P51, DOI 10.1073/pnas.0509348102; Park MH, 2010, AMINO ACIDS, V38, P491, DOI 10.1007/s00726-009-0408-7; PARK MH, 1993, BIOFACTORS, V4, P95; Park MH, 1997, BIOL SIGNAL, V6, P115; Preukschas M. H., 2011, 2011 EUR MULT CAN S1, V47, P157; Samuni Y, 2001, RADIAT RES, V155, P304, DOI 10.1667/0033-7587(2001)155[0304:RSOMCB]2.0.CO;2; Si ML, 2007, ONCOGENE, V26, P2799, DOI 10.1038/sj.onc.1210083; Takamizawa J, 2004, CANCER RES, V64, P3753, DOI 10.1158/0008-5472.CAN-04-0637; Volinia S, 2006, P NATL ACAD SCI USA, V103, P2257, DOI 10.1073/pnas.0510565103; Wang L, 2009, CANCER RES, V69, P9490, DOI 10.1158/0008-5472.CAN-09-2183; Wang L, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005878; Wartenberg M, 2002, BBA-MOL CELL RES, V1589, P49, DOI 10.1016/S0167-4889(01)00185-9; Webster RJ, 2009, J BIOL CHEM, V284, P5731, DOI 10.1074/jbc.M804280200; White NMA, 2012, BIOL CHEM, V393, P379, DOI 10.1515/hsz-2011-0246; Witkos TM, 2011, CURR MOL MED, V11, P93; Xie D, 2008, HUM PATHOL, V39, P80, DOI 10.1016/j.humpath.2007.05.011; Xu G, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015519; Zalatnai A, 2005, PATHOL ONCOL RES, V11, P164, DOI 10.1007/BF02893393; Zhang BH, 2007, DEV BIOL, V302, P1, DOI 10.1016/j.ydbio.2006.08.028	57	44	47	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 12	2012	287	42					35251	35259		10.1074/jbc.M112.374686	http://dx.doi.org/10.1074/jbc.M112.374686			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	022OF	22908221	Green Published, hybrid			2022-12-25	WOS:000309968000035
J	Guo, PC; Ma, JD; Jiang, YL; Wang, SJ; Bao, ZZ; Yu, XJ; Chen, YX; Zhou, CZ				Guo, Peng-Chao; Ma, Jin-Di; Jiang, Yong-Liang; Wang, Shu-Jie; Bao, Zhang-Zhi; Yu, Xiao-Jie; Chen, Yuxing; Zhou, Cong-Zhao			Structure of Yeast Sulfhydryl Oxidase Erv1 Reveals Electron Transfer of the Disulfide Relay System in the Mitochondrial Intermembrane Space	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SMALL TIM PROTEINS; LIVER-REGENERATION; SACCHAROMYCES-CEREVISIAE; RESPIRATORY-CHAIN; BOND FORMATION; CYTOCHROME-C; IN-VIVO; MIA40; IMPORT; AUGMENTOR	The disulfide relay system in the mitochondrial intermembrane space drives the import of proteins with twin CX9C or twin CX3C motifs by an oxidative folding mechanism. This process requires disulfide bond transfer from oxidized Mia40 to a substrate protein. Reduced Mia40 is reoxidized/regenerated by the FAD-linked sulfhydryl oxidase Erv1 (EC 1.8.3.2). Full-length Erv1 consists of a flexible N-terminal shuttle domain (NTD) and a conserved C-terminal core domain (CTD). Here, we present crystal structures at 2.0 angstrom resolution of the CTD and at 3.0 angstrom resolution of a C30S/C133S double mutant of full-length Erv1 (Erv1FL). Similar to previous homologous structures, the CTD exists as a homodimer, with each subunit consisting of a conserved four-helix bundle that accommodates the isoalloxazine ring of FAD and an additional single-turn helix. The structure of Erv1FL enabled us to identify, for the first time, the three-dimensional structure of the Erv1NTD, which is an amphipathic helix flanked by two flexible loops. This structure also represents an intermediate state of electron transfer from the NTD to the CTD of another subunit. Comparative structural analysis revealed that the four-helix bundle of the CTD forms a wide platform for the electron donor NTD. Moreover, computational simulation combined with multiple-sequence alignment suggested that the amphipathic helix close to the shuttle redox enter is critical for the recognition of Mia40, the upstream electron donor. These findings provide structural insights into electron transfer from Mia40 via the shuttle domain of one subunit of Erv1 to the CTD of another Erv1 subunit.	[Zhou, Cong-Zhao] Univ Sci & Technol China, Hefei Natl Lab Phys Sci Microscale, Hefei 230027, Anhui, Peoples R China; [Zhou, Cong-Zhao] Univ Sci & Technol China, Sch Life Sci, Hefei 230027, Anhui, Peoples R China	Chinese Academy of Sciences; University of Science & Technology of China, CAS; Chinese Academy of Sciences; University of Science & Technology of China, CAS	Zhou, CZ (corresponding author), Univ Sci & Technol China, Hefei Natl Lab Phys Sci Microscale, Hefei 230027, Anhui, Peoples R China.	zcz@ustc.edu.cn	yu, xiaojie/GSI-9676-2022; guo, peng/AAG-4052-2019; Guo, Peng/GWC-0572-2022; Zhou, Cong-Zhao/E-9174-2011; Chen, Yuxing/P-4156-2014	Zhou, Cong-Zhao/0000-0002-6881-7151; Chen, Yuxing/0000-0002-7560-1922; Jiang, YongLiang/0000-0001-5441-4936	Ministry of Science and Technology of China [2012CB911000]	Ministry of Science and Technology of China(Ministry of Science and Technology, China)	This work was supported by Ministry of Science and Technology of China Project 2012CB911000.	Allen S, 2005, J MOL BIOL, V353, P937, DOI 10.1016/j.jmb.2005.08.049; Ang SK, 2009, J BIOL CHEM, V284, P28754, DOI 10.1074/jbc.M109.021113; BAILEY S, 1994, ACTA CRYSTALLOGR D, V50, P760, DOI 10.1107/s0907444994003112; Banci L, 2011, P NATL ACAD SCI USA, V108, P4811, DOI 10.1073/pnas.1014542108; Banci L, 2010, P NATL ACAD SCI USA, V107, P20190, DOI 10.1073/pnas.1010095107; Banci L, 2009, NAT STRUCT MOL BIOL, V16, P198, DOI 10.1038/nsmb.1553; Beers J, 1997, J BIOL CHEM, V272, P33191, DOI 10.1074/jbc.272.52.33191; Bien M, 2010, MOL CELL, V37, P516, DOI 10.1016/j.molcel.2010.01.017; Bihlmaier K, 2007, J CELL BIOL, V179, P389, DOI 10.1083/jcb.200707123; Chacinska A, 2004, EMBO J, V23, P3735, DOI 10.1038/sj.emboj.7600389; Dabir DV, 2007, EMBO J, V26, P4801, DOI 10.1038/sj.emboj.7601909; Daithankar VN, 2010, BIOCHEMISTRY-US, V49, P6737, DOI 10.1021/bi100912m; Daithankar VN, 2009, BIOCHEMISTRY-US, V48, P4828, DOI 10.1021/bi900347v; de Vries SJ, 2006, PROTEINS, V63, P479, DOI 10.1002/prot.20842; De Vries SJ, 2010, NAT PROTOC, V5, P883, DOI 10.1038/nprot.2010.32; DeLano W.L., 2002, PYMOL MOL GRAPHICS S; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Endo T, 2010, ANTIOXID REDOX SIGN, V13, P1359, DOI 10.1089/ars.2010.3099; Fass D, 2008, BBA-MOL CELL RES, V1783, P557, DOI 10.1016/j.bbamcr.2007.11.009; Gross E, 2002, NAT STRUCT BIOL, V9, P61, DOI 10.1038/nsb740; Heaton D, 2000, J BIOL CHEM, V275, P37582, DOI 10.1074/jbc.M006639200; Hofhaus G, 2003, EUR J BIOCHEM, V270, P1528, DOI 10.1046/j.1432-1033.2003.03519.x; Janin J, 2008, Q REV BIOPHYS, V41, P133, DOI 10.1017/S0033583508004708; Kawano S, 2009, P NATL ACAD SCI USA, V106, P14403, DOI 10.1073/pnas.0901793106; Koehler CM, 2004, TRENDS BIOCHEM SCI, V29, P1, DOI 10.1016/j.tibs.2003.11.003; Lee JE, 2000, FEBS LETT, V477, P62, DOI 10.1016/S0014-5793(00)01767-1; Levitan A, 2004, J BIOL CHEM, V279, P20002, DOI 10.1074/jbc.M312877200; Lionaki E, 2010, ANTIOXID REDOX SIGN, V13, P1327, DOI 10.1089/ars.2010.3200; LISOWSKY T, 1994, CURR GENET, V26, P15, DOI 10.1007/BF00326299; Lisowsky T, 2001, DIGEST LIVER DIS, V33, P173, DOI 10.1016/S1590-8658(01)80074-8; Lovell SC, 2003, PROTEINS, V50, P437, DOI 10.1002/prot.10286; Lu H, 2004, J BIOL CHEM, V279, P18952, DOI 10.1074/jbc.M313045200; Lutz T, 2003, EMBO J, V22, P4400, DOI 10.1093/emboj/cdg421; Mesecke N, 2005, CELL, V121, P1059, DOI 10.1016/j.cell.2005.04.011; Murshudov GN, 1997, ACTA CRYSTALLOGR D, V53, P240, DOI 10.1107/S0907444996012255; Naoe M, 2004, J BIOL CHEM, V279, P47815, DOI 10.1074/jbc.M410272200; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Pagani M, 2000, J BIOL CHEM, V275, P23685, DOI 10.1074/jbc.M003061200; Riemer J, 2009, SCIENCE, V324, P1284, DOI 10.1126/science.1170653; Rissler M, 2005, J MOL BIOL, V353, P485, DOI 10.1016/j.jmb.2005.08.051; Rodriguez I, 2006, J VIROL, V80, P3157, DOI 10.1128/JVI.80.7.3157-3166.2006; Senkevich TG, 2000, P NATL ACAD SCI USA, V97, P12068, DOI 10.1073/pnas.210397997; Sideris DP, 2009, J CELL BIOL, V187, P1007, DOI 10.1083/jcb.200905134; Terziyska N, 2005, FEBS LETT, V579, P179, DOI 10.1016/j.febslet.2004.11.072; Vagin A, 1997, J APPL CRYSTALLOGR, V30, P1022, DOI 10.1107/S0021889897006766; Vitu E, 2006, J MOL BIOL, V362, P89, DOI 10.1016/j.jmb.2006.06.070; Wu CK, 2003, PROTEIN SCI, V12, P1109, DOI 10.1110/ps.0238103	47	24	24	0	14	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 12	2012	287	42					34961	34969		10.1074/jbc.M112.394759	http://dx.doi.org/10.1074/jbc.M112.394759			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	022OF	22910915	hybrid, Green Published			2022-12-25	WOS:000309968000009
J	Davis, MPA; Abreu-Goodger, C; van Dongen, S; Lu, D; Tate, PH; Bartonicek, N; Kutter, C; Liu, PT; Skarnes, WC; Enright, AJ; Dunham, I				Davis, Matthew P. A.; Abreu-Goodger, Cei; van Dongen, Stijn; Lu, Dong; Tate, Peri H.; Bartonicek, Nenad; Kutter, Claudia; Liu, Pentao; Skarnes, William C.; Enright, Anton J.; Dunham, Ian			Large-Scale Identification of MicroRNA Targets in Murine Dgcr8-Deficient Embryonic Stem Cell Lines	PLOS ONE			English	Article							RNA-INTERFERENCE; SELF-RENEWAL; MICROPROCESSOR COMPLEX; DROSHA-DGCR8 COMPLEX; MESSENGER-RNAS; GENOME-WIDE; C-ELEGANS; ES CELLS; EXPRESSION; MOUSE	Small RNAs such as microRNAs play important roles in embryonic stem cell maintenance and differentiation. A broad range of microRNAs is expressed in embryonic stem cells while only a fraction of their targets have been identified. We have performed large-scale identification of embryonic stem cell microRNA targets using a murine embryonic stem cell line deficient in the expression of Dgcr8. These cells are heavily depleted for microRNAs, allowing us to reintroduce specific microRNA duplexes and identify refined target sets. We used deep sequencing of small RNAs, mRNA expression profiling and bioinformatics analysis of microRNA seed matches in 3' UTRs to identify target transcripts. Consequently, we have identified a network of microRNAs that converge on the regulation of several important cellular pathways. Additionally, our experiments have revealed a novel candidate for Dgcr8-independent microRNA genesis and highlighted the challenges currently facing miRNA annotation.	[Davis, Matthew P. A.; Lu, Dong; Tate, Peri H.; Liu, Pentao; Skarnes, William C.] Wellcome Trust Sanger Inst, Hinxton, England; [Davis, Matthew P. A.; Abreu-Goodger, Cei; van Dongen, Stijn; Bartonicek, Nenad; Enright, Anton J.; Dunham, Ian] European Bioinformat Inst, European Mol Biol Lab, Hinxton, England; [Abreu-Goodger, Cei] CINVESTAV, Natl Lab Genom Biodivers Langebio, Guanajuato, Mexico; [Kutter, Claudia] Canc Res UK, Cambridge Res Inst, Li Ka Shing Ctr, Cambridge, England	Wellcome Trust Sanger Institute; European Molecular Biology Laboratory (EMBL); CINVESTAV - Centro de Investigacion y de Estudios Avanzados del Instituto Politecnico Nacional; Cancer Research UK; CRUK Cambridge Institute; University of Cambridge	Davis, MPA (corresponding author), Wellcome Trust Sanger Inst, Wellcome Trust Genome Campus, Hinxton, England.	dunham@ebi.ac.uk	Abreu-Goodger, Cei/A-1268-2010; Bartonicek, Nenad/B-6675-2016; Enright, Anton/F-3094-2011; Kutter, Claudia/HHD-1391-2022	Abreu-Goodger, Cei/0000-0001-8302-9893; Bartonicek, Nenad/0000-0003-2144-1887; Enright, Anton/0000-0002-6090-3100; Kutter, Claudia/0000-0002-8047-0058; Davis, Matthew/0000-0002-9909-3651; Dunham, Ian/0000-0003-2525-5598	Wellcome Trust; European Molecular Biology Laboratory European Bioinformatics Institute; Medical Research Council	Wellcome Trust(Wellcome Trust); European Molecular Biology Laboratory European Bioinformatics Institute; Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	This work was funded by the Wellcome Trust and the European Molecular Biology Laboratory European Bioinformatics Institute. MPD was partially supported by a Medical Research Council studentship. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adams DJ, 2005, GENOMICS, V86, P753, DOI 10.1016/j.ygeno.2005.08.003; Anokye-Danso F, 2011, CELL STEM CELL, V8, P376, DOI 10.1016/j.stem.2011.03.001; Babiarz JE, 2008, GENE DEV, V22, P2773, DOI 10.1101/gad.1705308; Baek D, 2008, NATURE, V455, P64, DOI 10.1038/nature07242; Bartel DP, 2009, CELL, V136, P215, DOI 10.1016/j.cell.2009.01.002; Calabrese JM, 2007, P NATL ACAD SCI USA, V104, P18097, DOI 10.1073/pnas.0709193104; Card DAG, 2008, MOL CELL BIOL, V28, P6426, DOI 10.1128/MCB.00359-08; Cerami EG, 2011, NUCLEIC ACIDS RES, V39, pD685, DOI 10.1093/nar/gkq1039; Chiang HR, 2010, GENE DEV, V24, P992, DOI 10.1101/gad.1884710; Conaway RC, 2011, CURR OPIN GENET DEV, V21, P225, DOI 10.1016/j.gde.2011.01.013; Denli AM, 2004, NATURE, V432, P231, DOI 10.1038/nature03049; Ender C, 2008, MOL CELL, V32, P519, DOI 10.1016/j.molcel.2008.10.017; Enright AJ, 2004, GENOME BIOL, V5; Friedman RC, 2009, GENOME RES, V19, P92, DOI 10.1101/gr.082701.108; Garzon R, 2010, NAT REV DRUG DISCOV, V9, P775, DOI 10.1038/nrd3179; Giraldez AJ, 2006, SCIENCE, V312, P75, DOI 10.1126/science.1122689; Gregory RI, 2004, NATURE, V432, P235, DOI 10.1038/nature03120; Grishok A, 2001, CELL, V106, P23, DOI 10.1016/S0092-8674(01)00431-7; Guo HL, 2010, NATURE, V466, P835, DOI 10.1038/nature09267; Han JJ, 2006, CELL, V125, P887, DOI 10.1016/j.cell.2006.03.043; Han JJ, 2004, GENE DEV, V18, P3016, DOI 10.1101/gad.1262504; Hanina SA, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1001163; He L, 2005, NATURE, V435, P828, DOI 10.1038/nature03552; Hutvagner G, 2001, SCIENCE, V293, P834, DOI 10.1126/science.1062961; Ivanovska I, 2008, MOL CELL BIOL, V28, P2167, DOI 10.1128/MCB.01977-07; Kagey MH, 2010, NATURE, V467, P430, DOI 10.1038/nature09380; Kanehisa M, 2010, NUCLEIC ACIDS RES, V38, pD355, DOI 10.1093/nar/gkp896; Kanellopoulou C, 2005, GENE DEV, V19, P489, DOI 10.1101/gad.1248505; Ketting RF, 2001, GENE DEV, V15, P2654, DOI 10.1101/gad.927801; Kim YK, 2009, NUCLEIC ACIDS RES, V37, P1672, DOI 10.1093/nar/gkp002; Kozomara A, 2011, NUCLEIC ACIDS RES, V39, pD152, DOI 10.1093/nar/gkq1027; Krebs AR, 2010, EMBO REP, V11, P541, DOI 10.1038/embor.2010.75; Lee Y, 2003, NATURE, V425, P415, DOI 10.1038/nature01957; Lerner M, 2011, CELL CYCLE GEORGETOW, V10; Leung AKL, 2011, NAT STRUCT MOL BIOL, V18, P1084, DOI 10.1038/nsmb0911-1084a; Lewis BP, 2003, CELL, V115, P787, DOI 10.1016/S0092-8674(03)01018-3; Lewis BP, 2005, CELL, V120, P15, DOI 10.1016/j.cell.2004.12.035; Lin SM, 2008, NUCLEIC ACIDS RES, V36, DOI 10.1093/nar/gkm1075; Lu D, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0040938; Malik S, 2010, NAT REV GENET, V11, P761, DOI 10.1038/nrg2901; Mallanna SK, 2010, DEV BIOL, V344, P16, DOI 10.1016/j.ydbio.2010.05.014; Maragkakis M, 2009, BMC BIOINFORMATICS, V10, DOI 10.1186/1471-2105-10-295; Melton C, 2010, NATURE, V463, P621, DOI 10.1038/nature08725; Miyoshi N, 2011, CELL STEM CELL, V8, P633, DOI 10.1016/j.stem.2011.05.001; Murchison EP, 2005, P NATL ACAD SCI USA, V102, P12135, DOI 10.1073/pnas.0505479102; Ning ZM, 2001, GENOME RES, V11, P1725, DOI 10.1101/gr.194201; Niwa H, 2000, NAT GENET, V24, P372, DOI 10.1038/74199; O'Donnell KA, 2005, NATURE, V435, P839, DOI 10.1038/nature03677; Palmer RD, 2010, CANCER RES, V70, P2911, DOI 10.1158/0008-5472.CAN-09-3301; Rybak A, 2009, NAT CELL BIOL, V11, P1411, DOI 10.1038/ncb1987; Schopman NCT, 2010, RNA BIOL, V7, P573, DOI [10.4161/rna.7.5.13141, 10.4161/rna.7.4.13141]; Selbach M, 2008, NATURE, V455, P58, DOI 10.1038/nature07228; Shiohama A, 2003, BIOCHEM BIOPH RES CO, V304, P184, DOI 10.1016/S0006-291X(03)00554-0; Sinkkonen L, 2008, NAT STRUCT MOL BIOL, V15, P259, DOI 10.1038/nsmb.1391; Skarnes WC, 2000, METHOD ENZYMOL, V328, P592, DOI 10.1016/S0076-6879(00)28420-6; Sridharan R, 2011, CELL STEM CELL, V8, P599, DOI 10.1016/j.stem.2011.05.009; Stryke D, 2003, NUCLEIC ACIDS RES, V31, P278, DOI 10.1093/nar/gkg064; Subramanian A, 2005, P NATL ACAD SCI USA, V102, P15545, DOI 10.1073/pnas.0506580102; Szymczak AL, 2004, NAT BIOTECHNOL, V22, P589, DOI 10.1038/nbt957; van Dongen S, 2008, NAT METHODS, V5, P1023, DOI 10.1038/nmeth.1267; Wang XW, 2008, BIOINFORMATICS, V24, P325, DOI 10.1093/bioinformatics/btm595; Wang YM, 2007, NAT GENET, V39, P380, DOI 10.1038/ng1969; Wang Y, 2008, NAT GENET, V40, P1478, DOI 10.1038/ng.250; Xu YF, 2010, J BIOL CHEM, V285, P34439, DOI 10.1074/jbc.M110.152306; Yang CS, 2011, RNA, V17, P1451, DOI 10.1261/rna.2664111	65	10	10	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 17	2012	7	8							e41762	10.1371/journal.pone.0041762	http://dx.doi.org/10.1371/journal.pone.0041762			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	996DG	22912678	Green Published, Green Submitted, gold			2022-12-25	WOS:000308063700007
J	Leprieur, F; Albouy, C; De Bortoli, J; Cowman, PF; Bellwood, DR; Mouillot, D				Leprieur, Fabien; Albouy, Camille; De Bortoli, Julien; Cowman, Peter F.; Bellwood, David R.; Mouillot, David			Quantifying Phylogenetic Beta Diversity: Distinguishing between 'True' Turnover of Lineages and Phylogenetic Diversity Gradients	PLOS ONE			English	Article							RICHNESS GRADIENTS; SPATIAL TURNOVER; NULL MODELS; EVOLUTIONARY; PATTERNS; BIODIVERSITY; CONSERVATION; DRIVERS; CLIMATE; CONSTRAINTS	The evolutionary dissimilarity between communities (phylogenetic beta diversity PBD) has been increasingly explored by ecologists and biogeographers to assess the relative roles of ecological and evolutionary processes in structuring natural communities. Among PBD measures, the PhyloSor and UniFrac indices have been widely used to assess the level of turnover of lineages over geographical and environmental gradients. However, these indices can be considered as 'broad-sense' measures of phylogenetic turnover as they incorporate different aspects of differences in evolutionary history between communities that may be attributable to phylogenetic diversity gradients. In the present study, we extend an additive partitioning framework proposed for compositional beta diversity to PBD. Specifically, we decomposed the PhyloSor and UniFrac indices into two separate components accounting for 'true' phylogenetic turnover and phylogenetic diversity gradients, respectively. We illustrated the relevance of this framework using simple theoretical and archetypal examples, as well as an empirical study based on coral reef fish communities. Overall, our results suggest that using PhyloSor and UniFrac may greatly over-estimate the level of spatial turnover of lineages if the two compared communities show contrasting levels of phylogenetic diversity. We therefore recommend that future studies use the 'true' phylogenetic turnover component of these indices when the studied communities encompass a large phylogenetic diversity gradient.	[Leprieur, Fabien; Albouy, Camille; De Bortoli, Julien; Mouillot, David] Univ Montpellier 2, Lab Ecol Syst Marins Cotiers, UMR 5119, Montpellier, France; [Cowman, Peter F.; Bellwood, David R.; Mouillot, David] James Cook Univ, Australian Res Council, Ctr Excellence Coral Reef Studies, Townsville, Qld 4811, Australia; [Cowman, Peter F.; Bellwood, David R.; Mouillot, David] James Cook Univ, Sch Marine & Trop Biol, Townsville, Qld 4811, Australia	Universite de Montpellier; James Cook University; James Cook University	Leprieur, F (corresponding author), Univ Montpellier 2, Lab Ecol Syst Marins Cotiers, UMR 5119, Montpellier, France.	fabien.leprieur@univ-montp2.fr	Cowman, Peter Francis/G-9998-2017; Leprieur, Fabien/ABA-4433-2020; albouy, camille/H-9317-2012; Leprieur, Fabien/C-4430-2008	Cowman, Peter Francis/0000-0001-5977-5327; albouy, camille/0000-0003-1629-2389; 	Marie Curie International Outgoing Fellowship (FISHECO) [IOF-GA-2009-236316]; Australian Research Council; FRB-CESAB project GASPAR	Marie Curie International Outgoing Fellowship (FISHECO)(European Commission); Australian Research Council(Australian Research Council); FRB-CESAB project GASPAR	D.M. was supported by a Marie Curie International Outgoing Fellowship (FISHECO) with agreement number IOF-GA-2009-236316. D. R. B. and P. F. C. were funded by the Australian Research Council. This study was partly supported by the FRB-CESAB project GASPAR. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andrew ME, 2012, GLOBAL ECOL BIOGEOGR, V21, P352, DOI 10.1111/j.1466-8238.2011.00676.x; Baselga A, 2012, GLOB ECOL B IN PRESS; Baselga A, 2007, ECOGRAPHY, V30, P838, DOI 10.1111/j.2007.0906-7590.05191.x; Baselga A, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0032341; Baselga A, 2010, GLOBAL ECOL BIOGEOGR, V19, P134, DOI 10.1111/j.1466-8238.2009.00490.x; Bellwood David R., 2002, P5, DOI 10.1016/B978-012615185-5/50003-7; Bellwood DR, 2005, ECOL LETT, V8, P643, DOI 10.1111/j.1461-0248.2005.00763.x; Bellwood DR, 2001, SCIENCE, V292, P1532, DOI 10.1126/science.1058635; Bortolussi N, 2006, BIOINFORMATICS, V22, P363, DOI 10.1093/bioinformatics/bti798; Bryant JA, 2008, P NATL ACAD SCI USA, V105, P11505, DOI 10.1073/pnas.0801920105; Cadotte MW, 2008, P NATL ACAD SCI USA, V105, P17012, DOI 10.1073/pnas.0805962105; Cadotte MW, 2010, DIVERS DISTRIB, V16, P376, DOI 10.1111/j.1472-4642.2010.00650.x; Cavender-Bares J, 2009, ECOL LETT, V12, P693, DOI 10.1111/j.1461-0248.2009.01314.x; Chase JM, 2011, ECOSPHERE, V2, DOI 10.1890/ES10-00117.1; Cowman PF, 2011, J EVOLUTION BIOL, V24, P2543, DOI 10.1111/j.1420-9101.2011.02391.x; Cunningham SA, 1995, EVOLUTION, V49, P1292, DOI 10.1111/j.1558-5646.1995.tb04460.x; Davies TJ, 2011, PHILOS T R SOC B, V366, P2414, DOI 10.1098/rstb.2011.0058; Faith DP, 2010, CURR OPIN ENV SUST, V2, P66, DOI 10.1016/j.cosust.2010.04.002; Faith DP, 2009, INT J MOL SCI, V10, P4723, DOI 10.3390/ijms10114723; FAITH DP, 1992, BIOL CONSERV, V61, P1, DOI 10.1016/0006-3207(92)91201-3; Feng G, 2012, CHINESE SCI BULL, V57, P623, DOI 10.1007/s11434-011-4869-1; Gaston KJ, 2007, P ROY SOC B-BIOL SCI, V274, P1567, DOI 10.1098/rspb.2007.0236; Gotelli N.J., 1996, NULL MODELS ECOLOGY, DOI DOI 10.1098/rspb.2014.0675; Graham CH, 2008, ECOL LETT, V11, P1265, DOI 10.1111/j.1461-0248.2008.01256.x; Graham CH, 2009, P NATL ACAD SCI USA, V106, P19673, DOI 10.1073/pnas.0901649106; Hortal J, 2011, ECOL LETT, V14, P741, DOI 10.1111/j.1461-0248.2011.01634.x; Ives AR, 2010, AM NAT, V176, pE128, DOI 10.1086/656486; Koleff P, 2003, J ANIM ECOL, V72, P367, DOI 10.1046/j.1365-2656.2003.00710.x; Kraft NJB, 2011, SCIENCE, V333, P1755, DOI 10.1126/science.1208584; Lennon JJ, 2001, J ANIM ECOL, V70, P966, DOI 10.1046/j.0021-8790.2001.00563.x; Leprieur F, 2011, ECOL LETT, V14, P325, DOI 10.1111/j.1461-0248.2011.01589.x; Leprieur F, 2009, J BIOGEOGR, V36, P1899, DOI 10.1111/j.1365-2699.2009.02107.x; Lozupone C, 2005, APPL ENVIRON MICROB, V71, P8228, DOI 10.1128/AEM.71.12.8228-8235.2005; McKnight MW, 2007, PLOS BIOL, V5, P2424, DOI 10.1371/journal.pbio.0050272; Mooers AO, 1997, Q REV BIOL, V72, P31, DOI 10.1086/419657; Morlon H, 2011, ECOL LETT, V14, P141, DOI 10.1111/j.1461-0248.2010.01563.x; Mouchet MA, 2011, BIOL LETTERS, V7, P205, DOI 10.1098/rsbl.2010.0769; Mouillot D, 2011, CURR BIOL, V21, P1044, DOI 10.1016/j.cub.2011.05.005; Mouquet N, 2012, BIOL REV IN PRESS; Nipperess DA, 2010, J VEG SCI, V21, P809, DOI 10.1111/j.1654-1103.2010.01192.x; O'Dea A, 2007, P NATL ACAD SCI USA, V104, P5501, DOI 10.1073/pnas.0610947104; Gomez JP, 2010, J ANIM ECOL, V79, P1181, DOI 10.1111/j.1365-2656.2010.01725.x; Parenti Paolo, 2011, Smithiana Bulletin, P29; Pommier T, 2012, BIOL LETT IN PRESS; Rodrigues ASL, 2002, BIOL CONSERV, V105, P103, DOI 10.1016/S0006-3207(01)00208-7; ROSEN DE, 1978, SYST ZOOL, V27, P159, DOI 10.2307/2412970; Schweiger O, 2008, OECOLOGIA, V157, P485, DOI 10.1007/s00442-008-1082-2; Stevens RD, 2011, P ROY SOC B-BIOL SCI, V278, P2528, DOI 10.1098/rspb.2010.2341; Svenning JC, 2011, J ANIM ECOL, V80, P393, DOI 10.1111/j.1365-2656.2010.01771.x; Swenson NG, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021264; Swenson NG, 2011, P ROY SOC B-BIOL SCI, V278, P877, DOI 10.1098/rspb.2010.1369; Swenson NG, 2012, ECOLOGY IN PRESS; Team R. D. C, 2011, R LANG ENV STAT COMP; Webb CO, 2002, ANNU REV ECOL SYST, V33, P475, DOI 10.1146/annurev.ecolsys.33.010802.150448; Yule GU, 1925, PHILOS T R SOC LON B, V213, P21, DOI 10.1098/rstb.1925.0002	55	149	152	9	119	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 17	2012	7	8							e42760	10.1371/journal.pone.0042760	http://dx.doi.org/10.1371/journal.pone.0042760			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	996DG	22912736	Green Published, Green Accepted, Green Submitted, gold			2022-12-25	WOS:000308063700021
J	Liu, LS; Cao, B; Aa, JY; Zheng, T; Shi, J; Li, MJ; Wang, XW; Zhao, CY; Xiao, WJ; Yu, XY; Sun, RB; Gu, RR; Zhou, J; Wu, L; Hao, G; Zhu, XX; Wang, GJ				Liu, Linsheng; Cao, Bei; Aa, Jiye; Zheng, Tian; Shi, Jian; Li, Mengjie; Wang, Xinwen; Zhao, Chunyan; Xiao, Wenjing; Yu, Xiaoyi; Sun, Runbin; Gu, Rongrong; Zhou, Jun; Wu, Liang; Hao, Gang; Zhu, Xuanxuan; Wang, Guangji			Prediction of the Pharmacokinetic Parameters of Triptolide in Rats Based on Endogenous Molecules in Pre-Dose Baseline Serum	PLOS ONE			English	Article							HUMAN METABOLIC PHENOTYPES; INDUCED HEPATOTOXICITY; PERSONALIZED MEDICINE; OXIDATIVE STRESS; GLUTATHIONE; MODULATION; TOXICITY; RELEASE; LIVER; FOOD	Background: Individual variances usually affect drug metabolism and disposition, and hence result in either ineffectiveness or toxicity of a drug. In addition to genetic polymorphism, the multiple confounding factors of lifestyles, such as dietary preferences, contribute partially to individual variances. However, the difficulty of quantifying individual diversity greatly challenges the realization of individualized drug therapy. This study aims at quantitative evaluating the association between individual variances and the pharmacokinetics. Methodology/Principal Findings: Molecules in pre-dose baseline serum were profiled using gas chromatography mass spectrometry to represent the individual variances of the model rats provided with high fat diets (HFD), routine chows and calorie restricted (CR) chows. Triptolide and its metabolites were determined using high performance liquid chromatography mass spectrometry. Metabonomic and pharmacokinetic data revealed that rats treated with the varied diets had distinctly different metabolic patterns and showed differential C-max values, AUC and drug metabolism after oral administration of triptolide. Rats with fatty chows had the lowest C-max and AUC values and the highest percentage of triptolide metabolic transformation, while rats with CR chows had the highest C-max and AUC values and the least percentage of triptolide transformation. Multivariate linear regression revealed that in baseline serum, the concentrations of creatinine and glutamic acid, which is the precursor of GSH, were linearly negatively correlated to C-max and AUC values. The glutamic acid and creatinine in baseline serum were suggested as the potential markers to represent individual diversity and as predictors of the disposal and pharmacokinetics of triptolide. Conclusions/Significance: These results highlight the robust potential of metabonomics in characterizing individual variances and identifying relevant markers that have the potential to facilitate individualized drug therapy.	[Liu, Linsheng; Cao, Bei; Aa, Jiye; Zheng, Tian; Shi, Jian; Li, Mengjie; Wang, Xinwen; Zhao, Chunyan; Xiao, Wenjing; Yu, Xiaoyi; Sun, Runbin; Gu, Rongrong; Zhou, Jun; Wu, Liang; Hao, Gang; Wang, Guangji] China Pharmaceut Univ, State Key Lab Nat Med, Key Lab Drug Metab & Pharmacokinet, Nanjing, Jiangsu, Peoples R China; [Zhu, Xuanxuan] Jiangsu Prov Hosp Tradit Chinese Med, Nanjing, Jiangsu, Peoples R China	China Pharmaceutical University; Nanjing University of Chinese Medicine	Liu, LS (corresponding author), China Pharmaceut Univ, State Key Lab Nat Med, Key Lab Drug Metab & Pharmacokinet, Nanjing, Jiangsu, Peoples R China.	jiye_2005@yahoo.com.cn; guangjiwang@hotmail.com	Shi, Jian/Y-9055-2019; li, mengjie/GRS-3931-2022; Wang, Xinwen/O-2885-2018; Shi, Jian/Q-1667-2018; liu, linsheng/AGF-5590-2022	Shi, Jian/0000-0003-2609-0094; Shi, Jian/0000-0003-2609-0094; liu, linsheng/0000-0001-5371-3109; Wang, Xinwen/0000-0001-8143-7017	National Natural Science Foundation of the People's Republic of China [81072692/H3110]; Project Program of State Key Laboratory of Natural Medicines, China Pharmaceutical University [JKGP201108-AJY]; National '973' Key Fundamental Program [2011CB505303, 2012CB517606]	National Natural Science Foundation of the People's Republic of China(National Natural Science Foundation of China (NSFC)); Project Program of State Key Laboratory of Natural Medicines, China Pharmaceutical University; National '973' Key Fundamental Program	This work was supported by the National Natural Science Foundation of the People's Republic of China (81072692/H3110), the Project Program of State Key Laboratory of Natural Medicines, China Pharmaceutical University (JKGP201108-AJY), and the National '973' Key Fundamental Program (2011CB505303, 2012CB517606). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	A J, 2005, ANAL CHEM, V77, P8086, DOI 10.1021/ac051211v; Aa JY, 2011, METABOLOMICS, V7, P217, DOI 10.1007/s11306-010-0241-8; Backshall A, 2011, CLIN CANCER RES, V17, P3019, DOI 10.1158/1078-0432.CCR-10-2474; Bernini P, 2009, J PROTEOME RES, V8, P4264, DOI 10.1021/pr900344m; Bronson SL, 2011, BEHAV BRAIN RES, V220, P55, DOI 10.1016/j.bbr.2010.12.040; Brown BL, 1995, TOXICOL LETT, V81, P39, DOI 10.1016/0378-4274(95)03407-2; Chen BJ, 2001, LEUKEMIA LYMPHOMA, V42, P253, DOI 10.3109/10428190109064582; Clayton TA, 2009, P NATL ACAD SCI USA, V106, P14728, DOI 10.1073/pnas.0904489106; Clayton TA, 2006, NATURE, V440, P1073, DOI 10.1038/nature04648; Frade J, 2008, J NEUROCHEM, V105, P1144, DOI 10.1111/j.1471-4159.2008.05216.x; Gao Q, 2010, NEPHROL DIAL TRANSPL, V25, P3539, DOI 10.1093/ndt/gfq245; Gowda GAN, 2010, BIOMARK MED, V4, P299, DOI [10.2217/bmm.10.6, 10.2217/BMM.10.6]; Heinzmann SS, 2012, J PROTEOME RES, V11, P643, DOI 10.1021/pr2005764; Hikim APS, 2000, J ANDROL, V21, P431; Huynh PN, 2000, J ANDROL, V21, P689; Jonsson P, 2005, ANAL CHEM, V77, P5635, DOI 10.1021/ac050601e; Lee D, 2011, CLIN THER, V33, P2038, DOI 10.1016/j.clinthera.2011.10.024; Li HL, 2010, CANCER LETT, V297, P198, DOI 10.1016/j.canlet.2010.05.012; Li J, 2011, HUM MOL GENET, V20, P528, DOI 10.1093/hmg/ddq498; Liu L, 2010, TOXICOLOGY, V271, P57, DOI 10.1016/j.tox.2010.03.004; Mei ZN, 2005, PHARMACOL RES, V51, P345, DOI 10.1016/j.phrs.2004.10.007; Noeman SA, 2011, DIABETOL METAB SYNDR, V3, DOI 10.1186/1758-5996-3-17; O'Sullivan A, 2011, AM J CLIN NUTR, V93, P314, DOI 10.3945/ajcn.110.000950; OGUMA T, 1991, ANTIMICROB AGENTS CH, V35, P1729, DOI 10.1128/AAC.35.9.1729; Persson M, 2006, EUR J NEUROSCI, V24, P1063, DOI 10.1111/j.1460-9568.2006.04974.x; Phapale PB, 2010, CLIN PHARMACOL THER, V87, P426, DOI 10.1038/clpt.2009.296; Santin K, 2011, BRAIN RES, V1421, P1, DOI 10.1016/j.brainres.2011.08.003; Shao F, 2007, BIOL PHARM BULL, V30, P702, DOI 10.1248/bpb.30.702; Spear BB, 2001, TRENDS MOL MED, V7, P201, DOI 10.1016/S1471-4914(01)01986-4; Stella C, 2006, J PROTEOME RES, V5, P2780, DOI 10.1021/pr060265y; Titov DV, 2011, NAT CHEM BIOL, V7, P182, DOI [10.1038/nchembio.522, 10.1038/NCHEMBIO.522]; Trygg J, 2007, J PROTEOME RES, V6, P469, DOI 10.1021/pr060594q; VANDESTRAAT R, 1987, BIOCHEM PHARMACOL, V36, P2065, DOI 10.1016/0006-2952(87)90132-8; WILLIAMS PEO, 1984, J ANTIMICROB CHEMOTH, V13, P191, DOI 10.1093/jac/13.2.191; Wilson ID, 2009, P NATL ACAD SCI USA, V106, P14187, DOI 10.1073/pnas.0907721106; Winnike JH, 2010, CLIN PHARMACOL THER, V88, P45, DOI 10.1038/clpt.2009.240; WOLD S, 1978, TECHNOMETRICS, V20, P397, DOI 10.2307/1267639; Xu LY, 2008, EUR J PHARM BIOPHARM, V70, P741, DOI 10.1016/j.ejpb.2008.07.017; Xue X, 2011, TOXICOL LETT, V205, P47, DOI 10.1016/j.toxlet.2011.05.003; Yan B, 2009, J APPL PHYSIOL, V106, P531, DOI 10.1152/japplphysiol.90816.2008; Yang SM, 2003, MOL CANCER THER, V2, P65; Yao JC, 2008, BIOL PHARM BULL, V31, P592, DOI 10.1248/bpb.31.592; YOO JSH, 1992, BIOCHEM PHARMACOL, V43, P2535, DOI 10.1016/0006-2952(92)90141-5; Zhang Y, 2010, J IMMUNOL, V184, P3866, DOI 10.4049/jimmunol.0903417; Zhou R, 2005, INT IMMUNOPHARMACOL, V5, P1895, DOI 10.1016/j.intimp.2005.06.009; Zhou SF, 2008, CURR DRUG METAB, V9, P738, DOI 10.2174/138920008786049302	46	12	17	1	44	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 17	2012	7	8							e43389	10.1371/journal.pone.0043389	http://dx.doi.org/10.1371/journal.pone.0043389			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	996DG	22912866	Green Published, Green Submitted, gold			2022-12-25	WOS:000308063700094
J	Schaefer, M; Heinze, HJ; Rotte, M				Schaefer, Michael; Heinze, Hans-Jochen; Rotte, Michael			Close to You: Embodied Simulation for Peripersonal Space in Primary Somatosensory Cortex	PLOS ONE			English	Article							TOUCH; ACTIVATIONS; EMPATHY; NEURONS; BODY; HAND; SI	Background: An increasing body of evidence has demonstrated that in contrast to the classic understanding the primary somatosensory cortex (SI) reflects merely seen touch (in the absence of any real touch on the own body). Based on these results it has been discussed that SI may play a role in understanding touch seen on other bodies. In order to further examine this understanding of observed touch, the current study aimed to test if mirror-like responses in SI are affected by the perspective of the seen touch. Thus, we presented touch on a hand and close to the hand either in first-person-perspective or in third-person-perspective. Principal Findings: Results of functional magnetic resonance imaging (fMRI) revealed stronger vicarious brain responses in SI/BA2 for touch seen in first-person-perspective. Surprisingly, the third-person viewpoint revealed activation in SI both when subjects viewed a hand being stimulated as well as when the space close to the hand was being touched. Conclusions/Significance: Based on these results we conclude that vicarious somatosensory responses in SI/BA2 are affected by the viewpoint of the seen hand. Furthermore, we argue that mirror-like responses in SI do not only reflect seen touch, but also the peripersonal space surrounding this body (in third-person-perspective). We discuss these findings with recent studies on mirror responses for action observation in peripersonal space.	[Schaefer, Michael; Heinze, Hans-Jochen; Rotte, Michael] Univ Magdeburg, Dept Neurol, D-39106 Magdeburg, Germany	Otto von Guericke University	Schaefer, M (corresponding author), Univ Magdeburg, Dept Neurol, D-39106 Magdeburg, Germany.	mischa@neuro2.med.uni-magdeburg.de			Deutsche Forschungsgemeinschaft [SCHA105/7-1]	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG))	MS was supported by the Deutsche Forschungsgemeinschaft (SCHA105/7-1). The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. No additional external funding was received for this study.	Avikainen S, 2002, NEUROIMAGE, V15, P640, DOI 10.1006/nimg.2001.1029; Bastiaansen JACJ, 2009, PHILOS T R SOC B, V364, P2391, DOI 10.1098/rstb.2009.0058; Blakemore SJ, 2005, BRAIN, V128, P1571, DOI 10.1093/brain/awh500; Bolognini N, 2011, CEREBRAL CO IN PRESS; Bremmer F, 2001, NEURON, V29, P287, DOI 10.1016/S0896-6273(01)00198-2; Buccino G, 2001, EUR J NEUROSCI, V13, P400, DOI 10.1046/j.1460-9568.2001.01385.x; Bufalari I, 2007, CEREB CORTEX, V17, P2553, DOI 10.1093/cercor/bhl161; Caggiano V, 2009, SCIENCE, V324, P403, DOI 10.1126/science.1166818; Carlsson K, 2000, J COGNITIVE NEUROSCI, V12, P691, DOI 10.1162/089892900562318; Ebisch SJ, 2008, J COGNITIVE NEUROSCI, V20, P1, DOI DOI 10.1162/J0CN.2008.20111; Ebisch SJH, 2011, J COGNITIVE NEUROSCI, V23, P1808, DOI 10.1162/jocn.2010.21551; Eickhoff SB, 2005, NEUROIMAGE, V25, P1325, DOI 10.1016/j.neuroimage.2004.12.034; Fogassi L, 1996, J NEUROPHYSIOL, V76, P141, DOI 10.1152/jn.1996.76.1.141; Galati G, 2001, EUR J NEUROSCI, V14, P737, DOI 10.1046/j.0953-816x.2001.01674.x; Gallace A, 2010, NEUROSCI BIOBEHAV R, V34, P246, DOI 10.1016/j.neubiorev.2008.10.004; Gazzola V, 2007, NEUROIMAGE, V35, P1674, DOI 10.1016/j.neuroimage.2007.02.003; Gazzola V, 2009, CEREB CORTEX, V19, P1239, DOI 10.1093/cercor/bhn181; Graziano MS, 1993, AIDS RES HUM RETRO S, V266, P1054; Graziano MSA, 2000, SCIENCE, V290, P1782, DOI 10.1126/science.290.5497.1782; Graziano MSA, 2002, P NATL ACAD SCI USA, V99, P11930, DOI 10.1073/pnas.172380399; Gross C.G., 1995, NEUROSCIENTIST, V1, P43, DOI [10.1177/107385849500100107, DOI 10.1177/107385849500100107]; Keysers C, 2004, NEURON, V42, P335, DOI 10.1016/S0896-6273(04)00156-4; Keysers C, 2010, NAT REV NEUROSCI, V11, P417, DOI 10.1038/nrn2833; Makin TR, 2007, J NEUROSCI, V27, P731, DOI 10.1523/JNEUROSCI.3653-06.2007; Mottonen R, 2005, NEUROIMAGE, V24, P731, DOI 10.1016/j.neuroimage.2004.10.011; OLDFIELD RC, 1971, NEUROPSYCHOLOGIA, V9, P97, DOI 10.1016/0028-3932(71)90067-4; Pihko E, 2010, EUR J NEUROSCI, V31, P1836, DOI 10.1111/j.1460-9568.2010.07192.x; Prinz W, 2006, CORTEX, V42, P515, DOI 10.1016/S0010-9452(08)70389-7; Rizzolatti G, 2001, NAT REV NEUROSCI, V2, P661, DOI 10.1038/35090060; Rizzolatti G, 2002, CURR OPIN NEUROBIOL, V12, P149, DOI 10.1016/S0959-4388(02)00308-2; Rossi S, 2002, CLIN NEUROPHYSIOL, V113, P16, DOI 10.1016/S1388-2457(01)00725-8; Saxe R, 2006, CEREB CORTEX, V16, P178, DOI 10.1093/cercor/bhi095; Schaefer M, 2009, HUM BRAIN MAPP, V30, P2722, DOI 10.1002/hbm.20701; Serino A, 2011, J COGNITIVE NEUROSCI, V23, P2956, DOI 10.1162/jocn_a_00006; Taylor-Clarke M, 2002, CURR BIOL, V12, P233, DOI 10.1016/S0960-9822(01)00681-9; Wood R, 2010, NEUROSCI LETT, V473, P28, DOI 10.1016/j.neulet.2010.02.012	36	12	13	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 17	2012	7	8							e42308	10.1371/journal.pone.0042308	http://dx.doi.org/10.1371/journal.pone.0042308			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	996DG	22912698	Green Published, Green Submitted, gold			2022-12-25	WOS:000308063700013
J	Sipos, B; Massingham, T; Stutz, AM; Goldman, N				Sipos, Botond; Massingham, Tim; Stuetz, Adrian M.; Goldman, Nick			An Improved Protocol for Sequencing of Repetitive Genomic Regions and Structural Variations Using Mutagenesis and Next Generation Sequencing	PLOS ONE			English	Article							EVOLUTION; ALGORITHMS; ALIGNMENT; REPEATS; VELVET; READS	The rise of Next Generation Sequencing (NGS) technologies has transformed de novo genome sequencing into an accessible research tool, but obtaining high quality eukaryotic genome assemblies remains a challenge, mostly due to the abundance of repetitive elements. These also make it difficult to study nucleotide polymorphism in repetitive regions, including certain types of structural variations. One solution proposed for resolving such regions is Sequence Assembly aided by Mutagenesis (SAM), which relies on the fact that introducing enough random mutations breaks the repetitive structure, making assembly possible. Sequencing many different mutated copies permits the sequence of the repetitive region to be inferred by consensus methods. However, this approach relies on molecular cloning in order to isolate and amplify individual mutant copies, making it hard to scale-up the approach for use in conjunction with high-throughput sequencing technologies. To address this problem, we propose NG-SAM, a modified version of the SAM protocol that relies on PCR and dilution steps only, coupled to a NGS workflow. NG-SAM therefore has the potential to be scaled-up, e. g. using emerging microfluidics technologies. We built a realistic simulation pipeline to study the feasibility of NG-SAM, and our results suggest that under appropriate experimental conditions the approach might be successfully put into practice. Moreover, our simulations suggest that NG-SAM is capable of reconstructing robustly a wide range of potential target sequences of varying lengths and repetitive structures.	[Sipos, Botond; Massingham, Tim; Goldman, Nick] European Bioinformat Inst EMBL EBI, Cambridge, England; [Stuetz, Adrian M.] European Mol Biol Lab, Genome Biol Res Unit, Heidelberg, Germany	European Molecular Biology Laboratory (EMBL); European Molecular Biology Laboratory (EMBL)	Sipos, B (corresponding author), European Bioinformat Inst EMBL EBI, Wellcome Trust Genome Campus, Cambridge, England.	sbotond@ebi.ac.uk		Goldman, Nick/0000-0001-8486-2211; Stuetz, Adrian/0000-0001-7650-3470; Sipos, Botond/0000-0002-9046-3302	European Molecular Biology Laboratory (EMBL) Interdisciplinary Postdoc (EIPOD) under Marie Curie Actions (COFUND, "COFUNDing of regional, national and international programmes")	European Molecular Biology Laboratory (EMBL) Interdisciplinary Postdoc (EIPOD) under Marie Curie Actions (COFUND, "COFUNDing of regional, national and international programmes")	BS was funded by a European Molecular Biology Laboratory (EMBL) Interdisciplinary Postdoc (EIPOD) under Marie Curie Actions (COFUND, "COFUNDing of regional, national and international programmes"). No additional external funding received for this study. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bailey JA, 2006, NAT REV GENET, V7, P552, DOI 10.1038/nrg1895; Blow N, 2009, NAT METHODS, V6, P539, DOI 10.1038/nmeth0709-539; Collins FS, 2004, NATURE, V431, P931, DOI 10.1038/nature03001; Edgar RC, 2004, BMC BIOINFORMATICS, V5, P1, DOI 10.1186/1471-2105-5-113; Flicek P, 2009, NAT METHODS, V6, pS6, DOI [10.1038/NMETH.1376, 10.1038/nmeth.1376]; Garber M, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-6-r60; Keith JM, 2004, BIOINFORMATICS, V20, P2401, DOI 10.1093/bioinformatics/bth258; Keith JM, 2004, NUCLEIC ACIDS RES, V32, DOI 10.1093/nar/gnh022; Keith JM, 2002, BIOINFORMATICS, V18, P1494, DOI 10.1093/bioinformatics/18.11.1494; Keith JM, 2007, PERSP BIOANAL, V2, P303, DOI 10.1016/S1871-0069(06)02010-6; Kocks C, 2005, CELL, V123, P335, DOI 10.1016/j.cell.2005.08.034; Liu SJ, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015778; Medvedev P, 2009, NAT METHODS, V6, pS13, DOI [10.1038/NMETH.1374, 10.1038/nmeth.1374]; Metzker ML, 2010, NAT REV GENET, V11, P31, DOI 10.1038/nrg2626; Meyer M., 2010, COLD SPRING HARB PRO; Miller JR, 2010, GENOMICS, V95, P315, DOI 10.1016/j.ygeno.2010.03.001; Mills RE, 2011, NATURE, V470, P59, DOI 10.1038/nature09708; Mitchelson KR, 2011, METHODS MOL BIOL, V687, P75, DOI 10.1007/978-1-60761-944-4_6; Nielsen R, 2011, NAT REV GENET, V12, P443, DOI 10.1038/nrg2986; Paszkiewicz K, 2010, BRIEF BIOINFORM, V11, P457, DOI 10.1093/bib/bbq020; Slater GS, 2005, BMC BIOINFORMATICS, V6, DOI 10.1186/1471-2105-6-31; Somogyi K, 2008, MOL BIOL EVOL, V25, P2337, DOI 10.1093/molbev/msn180; Stallard N, 2006, J ROY STAT SOC C-APP, V55, P15, DOI 10.1111/j.1467-9876.2005.00517.x; Tewhey R, 2009, NAT BIOTECHNOL, V27, P1025, DOI 10.1038/nbt.1583; Treangen T. J., 2011, NAT REV GENET; Waltemath D, 2011, PLOS COMPUT BIOL, V7, DOI 10.1371/journal.pcbi.1001122; Weiss G, 1997, NUCLEIC ACIDS RES, V25, P3082, DOI 10.1093/nar/25.15.3082; Wessler S, 2006, PNAS, V103, P1760; YANG ZB, 1994, J MOL EVOL, V39, P105; Zaccolo M, 1996, J MOL BIOL, V255, P589, DOI 10.1006/jmbi.1996.0049; Zerbino DR, 2008, GENOME RES, V18, P821, DOI 10.1101/gr.074492.107; Zerbino DR, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0008407; Zhang JZ, 2003, TRENDS ECOL EVOL, V18, P292, DOI 10.1016/S0169-5347(03)00033-8	33	6	16	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 17	2012	7	8							e43359	10.1371/journal.pone.0043359	http://dx.doi.org/10.1371/journal.pone.0043359			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	996DG	22912860	Green Published, Green Submitted, gold			2022-12-25	WOS:000308063700088
J	Kim, D; Yan, YT; Valencia, CA; Liu, RH				Kim, Dongwook; Yan, Yitang; Valencia, C. Alexander; Liu, Rihe			Heptameric Targeting Ligands against EGFR and HER2 with High Stability and Avidity	PLOS ONE			English	Article							SINGLE-CHAIN FV; ANTIGEN-BINDING; DOMAIN; ANTIBODIES; PEPTABODY; AFFINITY; ALPHA	Multivalency of targeting ligands provides significantly increased binding strength towards their molecular targets. Here, we report the development of a novel heptameric targeting system, with general applications, constructed by fusing a target-binding domain with the heptamerization domain of the Archaeal RNA binding protein Sm1 through a flexible hinge peptide. The previously reported affibody molecules against EGFR and HER2, Z(EGFR) and Z(HER2), were used as target binding moieties. The fusion molecules were highly expressed in E. coli as soluble proteins and efficiently self-assembled into multimeric targeting ligands with the heptamer as the predominant form. We demonstrated that the heptameric molecules were resistant to protease-mediated digestion or heat-and SDS-induced denaturation. Surface plasmon resonance (SPR) analysis showed that both heptameric Z(EGFR) and Z(HER2) ligands have a significantly enhanced binding strength to their target receptors with a nearly 100 to 1000 fold increase relative to the monomeric ligands. Cellular binding assays showed that heptameric ligands maintained their target-binding specificities similar to the monomeric forms towards their respective receptor. The non-toxic property of each heptameric ligand was demonstrated by the cell proliferation assay. In general,, the heptamerization strategy we describe here could be applied to the facile and efficient engineering of other protein domain- or short peptide-based affinity molecules to acquire significantly improved target-binding strengths with potential applications in the targeted delivery of various imaging or therapeutic agents..	[Kim, Dongwook; Yan, Yitang; Valencia, C. Alexander; Liu, Rihe] Univ N Carolina, Div Chem Biol & Med Chem, UNC Eshelman Sch Pharm, Chapel Hill, NC 27515 USA; [Kim, Dongwook; Yan, Yitang; Valencia, C. Alexander; Liu, Rihe] Univ N Carolina, Carolina Ctr Genome Sci, Chapel Hill, NC USA	University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina; University of North Carolina Chapel Hill	Kim, D (corresponding author), Univ N Carolina, Div Chem Biol & Med Chem, UNC Eshelman Sch Pharm, Chapel Hill, NC 27515 USA.	rliu@email.unc.edu	Ariel, Pablo/AGJ-4118-2022		National Cancer Institute [CA119343, CA151652]; NATIONAL CANCER INSTITUTE [P30CA016086, U54CA151652, U54CA119343] Funding Source: NIH RePORTER	National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported by grants from the National Cancer Institute to RL. (CA119343 and CA151652). The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Beck K, 1996, J MOL BIOL, V256, P909, DOI 10.1006/jmbi.1996.0137; Benhabbour SR, 2012, J CONTROL RELEASE, V158, P63, DOI 10.1016/j.jconrel.2011.10.013; BIRD RE, 1988, SCIENCE, V242, P423, DOI 10.1126/science.3140379; Bjorkelund H, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024739; Borsi L, 2003, BLOOD, V102, P4384, DOI 10.1182/blood-2003-04-1039; Burke P, 2001, MOL BIOL CELL, V12, P1897, DOI 10.1091/mbc.12.6.1897; CROTHERS DM, 1972, IMMUNOCHEMISTRY, V9, P341, DOI 10.1016/0019-2791(72)90097-3; Deyev SM, 2008, BIOESSAYS, V30, P904, DOI 10.1002/bies.20805; Duan J, 2007, BIOCHEMISTRY-US, V46, P12656, DOI 10.1021/bi701215e; Fattah OM, 2006, INT J CANCER, V119, P2455, DOI 10.1002/ijc.21541; Friedman M, 2008, J MOL BIOL, V376, P1388, DOI 10.1016/j.jmb.2007.12.060; Gostring L, 2010, INT J ONCOL, V36, P757, DOI 10.3892/ijo_00000551; Govindarajan S, 2012, BIOMATERIALS, V33, P2570, DOI 10.1016/j.biomaterials.2011.12.003; Ishida S, 2002, P NATL ACAD SCI USA, V99, P14298, DOI 10.1073/pnas.162491399; Kipriyanov SM, 1999, J MOL BIOL, V293, P41, DOI 10.1006/jmbi.1999.3156; Kubetzko S, 2006, J BIOL CHEM, V281, P35186, DOI 10.1074/jbc.M604127200; Leonard D, 2008, J CELL SCI, V121, P3445, DOI 10.1242/jcs.031484; Lyakhov I, 2010, CHEMBIOCHEM, V11, P345, DOI 10.1002/cbic.200900532; Nordberg E, 2010, INT J ONCOL, V36, P967, DOI 10.3892/ijo_00000576; Orlova A, 2006, CANCER RES, V66, P4339, DOI 10.1158/0008-5472.CAN-05-3521; PACK P, 1995, J MOL BIOL, V246, P28, DOI 10.1006/jmbi.1994.0062; Pluckthun A, 1997, IMMUNOTECHNOLOGY, V3, P83, DOI 10.1016/S1380-2933(97)00067-5; Stone E, 2007, J IMMUNOL METHODS, V318, P88, DOI 10.1016/j.jim.2006.10.006; Terskikh AV, 1997, P NATL ACAD SCI USA, V94, P1663, DOI 10.1073/pnas.94.5.1663; Toro I, 2002, J MOL BIOL, V320, P129, DOI 10.1016/S0022-2836(02)00406-0; Toro I, 2001, EMBO J, V20, P2293, DOI 10.1093/emboj/20.9.2293; Trejtnar F, 2002, Q J NUCL MED, V46, P181; YOKOTA T, 1992, CANCER RES, V52, P3402; Zhang JB, 2004, J MOL BIOL, V335, P49, DOI 10.1016/j.jmb.2003.09.034	29	7	9	1	23	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 9	2012	7	8							e43077	10.1371/journal.pone.0043077	http://dx.doi.org/10.1371/journal.pone.0043077			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	986WZ	22912791	Green Published, gold, Green Submitted			2022-12-25	WOS:000307378500038
J	Jeffery, JAL; Clements, ACA; Nguyen, YT; Nguyen, LH; Tran, SH; Le, NT; Vu, NS; Ryan, PA; Kay, BH				Jeffery, Jason A. L.; Clements, Archie C. A.; Nguyen, Yen Thi; Nguyen, Le Hoang; Tran, Son Hai; Le, Nghia Trung; Vu, Nam Sinh; Ryan, Peter A.; Kay, Brian H.			Water Level Flux in Household Containers in Vietnam - A Key Determinant of Aedes aegypti Population Dynamics	PLOS ONE			English	Article							DENGUE VECTOR; WOLBACHIA INFECTION; MODEL DEVELOPMENT; DIPTERA; SURVEILLANCE; TRANSMISSION; OVIPOSITION; IQUITOS; DISEASE; PERU	We examined changes in the abundance of immature Aedes aegypti at the household and water storage container level during the dry-season (June-July, 2008) in Tri Nguyen village, central Vietnam. We conducted quantitative immature mosquito surveys of 171 containers in the same 41 households, with replacement of samples, every two days during a 29-day period. We developed multi-level mixed effects regression models to investigate container and household variability in pupal abundance. The percentage of houses that were positive for I/II instars, III/IV instars and pupae during any one survey ranged from 19.5-43.9%, 48.8-75.6% and 17.1-53.7%, respectively. The mean numbers of Ae. aegypti pupae per house ranged between 1.9-12.6 over the study period. Estimates of absolute pupal abundance were highly variable over the 29-day period despite relatively stable weather conditions. Most variability in pupal abundance occurred at the container rather than the household level. A key determinant of Ae. aegypti production was the frequent filling of the containers with water, which caused asynchronous hatching of Ae. aegypti eggs and development of cohorts of immatures. We calculated the probability of the water volume of a large container (>500L) increasing or decreasing by >= 20% to be 0.05 and 0.07 per day, respectively, and for small containers (<500L) to be 0.11 and 0.13 per day, respectively. These human water-management behaviors are important determinants of Ae. aegypti production during the dry season. This has implications for choosing a suitable Wolbachia strain for release as it appears that prolonged egg desiccation does not occur in this village.	[Jeffery, Jason A. L.; Clements, Archie C. A.; Ryan, Peter A.; Kay, Brian H.] PO Royal Brisbane Hosp, Queensland Inst Med Res, Brisbane, Qld, Australia; [Clements, Archie C. A.] Univ Queensland, Infect Dis Epidemiol Unit, Sch Populat Hlth, Herston, Qld, Australia; [Nguyen, Yen Thi; Nguyen, Le Hoang; Tran, Son Hai] Natl Inst Hyg & Epidemiol, Hanoi, Vietnam; [Le, Nghia Trung] Inst Pasteur, Nha Trang, Vietnam; [Vu, Nam Sinh] Minist Hlth, Gen Dept Prevent Med & Environm Hlth, Hanoi, Vietnam	QIMR Berghofer Medical Research Institute; Royal Brisbane & Women's Hospital; University of Queensland; National Institute of Hygiene & Epidemiology (NIHE)	Jeffery, JAL (corresponding author), PO Royal Brisbane Hosp, Queensland Inst Med Res, Brisbane, Qld, Australia.	brian.kay@qimr.edu.au	Clements, Archie/ABD-1615-2020; Clements, Archie/D-9619-2013	Ryan, Peter/0000-0003-0674-4441	Bill and Melinda Gates Foundation "Grand Challenges in Global Health" [55]	Bill and Melinda Gates Foundation "Grand Challenges in Global Health"(Bill & Melinda Gates Foundation)	This study was funded by a grant from the Bill and Melinda Gates Foundation "Grand Challenges in Global Health" #55, administered by FNIH. The funders had no role in the study design, data collection and analysis, decision to publish, or preparation of this manuscript.	Barrera R, 2011, PLOS NEGLECT TROP D, V5, DOI 10.1371/journal.pntd.0001378; Beatty ME, 2011, AM J TROP MED HYG, V84, P473, DOI 10.4269/ajtmh.2011.10-0521; Chadee DD, 2004, B ENTOMOL RES, V94, P201, DOI 10.1079/BER2004297; Chaves LF, 2012, GLOBAL CHANGE BIOL, V18, P457, DOI 10.1111/j.1365-2486.2011.02522.x; Clements ACA, 2006, PARASITOLOGY, V133, P711, DOI 10.1017/S0031182006001181; FOCKS DA, 1993, J MED ENTOMOL, V30, P1003, DOI 10.1093/jmedent/30.6.1003; FOCKS DA, 1995, AM J TROP MED HYG, V53, P489, DOI 10.4269/ajtmh.1995.53.489; Getis A, 2003, AM J TROP MED HYG, V69, P494, DOI 10.4269/ajtmh.2003.69.494; Gubler DJ, 1997, DENGUE DENGUE HEMORR; Hoffmann AA, 2011, NATURE, V476, P454, DOI 10.1038/nature10356; Iturbe-Ormaetxe I, 2011, EMBO REP, V12, P508, DOI 10.1038/embor.2011.84; Jeffery JAL, 2009, PLOS NEGLECT TROP D, V3, DOI 10.1371/journal.pntd.0000552; Knox TB, 2007, J MED ENTOMOL, V44, P192, DOI 10.1603/0022-2585(2007)44[192:CEOQSM]2.0.CO;2; Knox TB, 2010, J MED ENTOMOL, V47, P748, DOI 10.1603/ME09297; Magori K, 2009, PLOS NEGLECT TROP D, V3, DOI 10.1371/journal.pntd.0000508; McMeniman CJ, 2010, PLOS NEGLECT TROP D, V4, DOI 10.1371/journal.pntd.0000748; McMeniman CJ, 2009, SCIENCE, V323, P141, DOI 10.1126/science.1165326; Moreira LA, 2009, CELL, V139, P1268, DOI 10.1016/j.cell.2009.11.042; Padmanabha H, 2010, ECOHEALTH, V7, P78, DOI 10.1007/s10393-010-0301-6; SOUTHWOOD T R E, 1972, Bulletin of the World Health Organization, V46, P211; Stoddard ST, 2009, PLOS NEGLECT TROP D, V3, DOI 10.1371/journal.pntd.0000481; Tran HP, 2010, INT HEALTH, V2, P136, DOI 10.1016/j.inhe.2009.12.007; TunLin W, 1995, AM J TROP MED HYG, V53, P595, DOI 10.4269/ajtmh.1995.53.595; Wong J, 2011, PLOS NEGLECT TROP D, V5, DOI 10.1371/journal.pntd.0001015; Wong J, 2011, J MED ENTOMOL, V48, P45, DOI 10.1603/ME10149	25	9	9	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 24	2012	7	7							e39067	10.1371/journal.pone.0039067	http://dx.doi.org/10.1371/journal.pone.0039067			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	978NX	22911683	Green Published, gold			2022-12-25	WOS:000306751300003
J	Guo, RN; Zheng, HZ; Huang, LQ; Zhou, Y; Zhang, X; Liang, CK; Lin, JY; He, JF; Zhang, JQ				Guo, Ru-ning; Zheng, Hui-zhen; Huang, Li-qun; Zhou, Yong; Zhang, Xin; Liang, Chan-kun; Lin, Jin-yan; He, Jian-feng; Zhang, Jin-qing			Epidemiologic and Economic Burden of Influenza in the Outpatient Setting: A Prospective Study in a Subtropical Area of China	PLOS ONE			English	Article							INFECTION	Objectives: To understand the incidence of outpatient influenza cases in a subtropical area of China and the associated economic burden on patients' families. Methods: A hospital-based prospective study was conducted in Zhuhai City during 2008-2009. All outpatient influenza-like illness (ILI) cases were identified in 28 sentinel hospitals. A representative sample of throat swabs from ILI cases were collected for virus isolation using Madin-Darby canine kidney cells. The incidence of outpatient influenza cases in Zhuhai was estimated on the basis of the number of influenza patients detected by the sentinel sites. A telephone survey on the direct costs associated with illness was conducted as a follow-up. Results: The incidence of influenza was estimated to be 4.1 per 1,000 population in 2008 and 19.2 per 1,000 population in 2009. Children aged < 5 years were the most-affected population, suffering from influenza at the highest rates (34.3 per 1,000 population in 2008 and 95.3 per 1,000 population in 2009). A high incidence of 29.2-40.9 per 1000 population was also seen in young people aged 5-24 years in 2009. ILI activity and influenza virus isolations adopted a consistent seasonal pattern, with a summer peak in July 2008 and the longest epidemic period lasting from July-December 2009. The medical costs per episode of influenza among urban patients were higher than those for rural patients. A total of $1.1 million in direct economic losses were estimated to be associated with outpatient influenza during 2008-2009 in Zhuhai community. Conclusions: Influenza attacks children aged < 5 years in greater proportions than children in other age groups. Seasonal influenza 2008 and Pandemic influenza A (H1N1) 2009 had different epidemiological and etiological characteristics. Direct costs (mostly medical costs) impose an enormous burden on the patient family. Vaccination strategies for high-risk groups need to be further strengthened.	[Guo, Ru-ning; Zheng, Hui-zhen; He, Jian-feng; Zhang, Jin-qing] Ctr Dis Control & Prevent, Inst Infect Dis Prevent & Control, Guangzhou, Guangdong, Peoples R China; [Huang, Li-qun; Zhou, Yong; Liang, Chan-kun] Zhuhai Municipal Ctr Dis Control & Prevent, Zhuhai, Peoples R China; [Zhang, Xin] Ctr Dis Control & Prevent, Inst Pathogen Microorganisms, Guangzhou, Guangdong, Peoples R China	Chinese Center for Disease Control & Prevention; Chinese Center for Disease Control & Prevention	Zheng, HZ (corresponding author), Ctr Dis Control & Prevent, Inst Infect Dis Prevent & Control, Guangzhou, Guangdong, Peoples R China.	zhzgdcdc@163.com			World Health Organization [WP/2008/CHN/02/CSR/PE 15.01]; Medical Research Foundation of Guangdong Province, China [A2007079]	World Health Organization(World Health Organization); Medical Research Foundation of Guangdong Province, China	The work was supported by grants from the World Health Organization (WP/2008/CHN/02/CSR/PE 15.01), and Medical Research Foundation of Guangdong Province, China (project number: A2007079). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Azziz-Baumgartner E, 2012, B WORLD HEALTH ORGAN, V90, P12, DOI 10.2471/BLT.11.090209; data S, 2010, STAT YB 2010; Dawood FS, 2010, J PEDIATR-US, V157, P808, DOI 10.1016/j.jpeds.2010.05.012; Esteban-Vasallo MD, 2012, EUR J PUBLIC HEALTH, V22, P792, DOI 10.1093/eurpub/ckr171; Grijalva CG, 2010, VACCINE, V29, P123, DOI 10.1016/j.vaccine.2010.08.072; Guo RN, 2011, PUBLIC HEALTH, V125, P389, DOI 10.1016/j.puhe.2011.03.004; Hardelid P, 2010, HEALTH TECHNOL ASSES, V14, P115, DOI 10.3310/hta14550-03; Kiro Amnon, 2008, Harefuah, V147, P960; Kyncl Jan, 2010, Klin Mikrobiol Infekc Lek, V16, P116; Li C, 2009, J SCH NURS, V25, p4S, DOI 10.1177/1059840508330066; Paget WJ, 2010, EUR J PEDIATR, V169, P997, DOI 10.1007/s00431-010-1164-0; Ru-ning G, 2008, CHIN J PUBLIC HLTH, V24, P843; Seligova J, 2011, CENT EUR J PUBL HEAL, V19, P20, DOI 10.21101/cejph.a3593; Shortridge K F, 1992, Semin Respir Infect, V7, P11; Silvennoinen H, 2011, PEDIATR INFECT DIS J, V30, pE24, DOI 10.1097/INF.0b013e3181fe37c8; Simmerman JM, 2009, PLOS ONE, V4, pA107, DOI 10.1371/journal.pone.0007776; Tao Z, 2011, CHIN HLTH EC, V30, P25; Turbelin C, 2009, EURO SURVEILL, V14; World Health Organization, 2004, WHO MAN ANIM INFL DI; Zheng H, 2010, MOD PREV MED, V2, P201	20	17	25	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 20	2012	7	7							e41403	10.1371/journal.pone.0041403	http://dx.doi.org/10.1371/journal.pone.0041403			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	977GL	22911789	Green Published, gold, Green Submitted			2022-12-25	WOS:000306644600077
J	Haurigot, V; Villacampa, P; Ribera, A; Bosch, A; Ramos, D; Ruberte, J; Bosch, F				Haurigot, Virginia; Villacampa, Pilar; Ribera, Albert; Bosch, Assumpcio; Ramos, David; Ruberte, Jesus; Bosch, Fatima			Long-Term Retinal PEDF Overexpression Prevents Neovascularization in a Murine Adult Model of Retinopathy	PLOS ONE			English	Article							ENDOTHELIAL GROWTH-FACTOR; EPITHELIUM-DERIVED FACTOR; MATRIX METALLOPROTEINASES; PIGMENTED EPITHELIUM; VISUAL FUNCTION; VITREOUS LEVELS; GENE-TRANSFER; FACTOR-I; EXPRESSION; VEGF	Neovascularization associated with diabetic retinopathy (DR) and other ocular disorders is a leading cause of visual impairment and adult-onset blindness. Currently available treatments are merely palliative and offer temporary solutions. Here, we tested the efficacy of antiangiogenic gene transfer in an animal model that mimics the chronic progression of human DR. Adeno-associated viral (AAV) vectors of serotype 2 coding for antiangiogenic Pigment Epithelium Derived Factor (PEDF) were injected in the vitreous of a 1.5 month-old transgenic model of retinopathy that develops progressive neovascularization. A single intravitreal injection led to long-term production of PEDF and to a striking inhibition of intravitreal neovascularization, normalization of retinal capillary density, and prevention of retinal detachment. This was parallel to a reduction in the intraocular levels of Vascular Endothelial Growth Factor (VEGF). Normalization of VEGF was consistent with a downregulation of downstream effectors of angiogenesis, such as the activity of Matrix Metalloproteinases (MMP) 2 and 9 and the content of Connective Tissue Growth Factor (CTGF). These results demonstrate long-term efficacy of AAV-mediated PEDF overexpression in counteracting retinal neovascularization in a relevant animal model, and provides evidence towards the use of this strategy to treat angiogenesis in DR and other chronic proliferative retinal disorders.	[Haurigot, Virginia; Villacampa, Pilar; Ribera, Albert; Bosch, Assumpcio; Ramos, David; Ruberte, Jesus; Bosch, Fatima] Univ Autonoma Barcelona, Ctr Anim Biotechnol & Gene Therapy, Sch Vet Med, Bellaterra, Spain; [Haurigot, Virginia; Villacampa, Pilar; Ribera, Albert; Bosch, Assumpcio; Bosch, Fatima] Univ Autonoma Barcelona, Dept Biochem & Mol Biol, Sch Vet Med, Bellaterra, Spain; [Haurigot, Virginia; Villacampa, Pilar; Ribera, Albert; Ruberte, Jesus; Bosch, Fatima] CIBER Diabet & Associated Metab Disorders CIBERDE, Barcelona, Spain; [Ramos, David; Ruberte, Jesus] Univ Autonoma Barcelona, Dept Anim Hlth & Anat, Sch Vet Med, Bellaterra, Spain	Autonomous University of Barcelona; Autonomous University of Barcelona; CIBER - Centro de Investigacion Biomedica en Red; CIBERDEM; Autonomous University of Barcelona	Haurigot, V (corresponding author), Univ Autonoma Barcelona, Ctr Anim Biotechnol & Gene Therapy, Sch Vet Med, Bellaterra, Spain.	fatima.bosch@uab.es	Bosch, Assumpcio/C-7593-2015; Villacampa, Pilar/B-1801-2019; Ribera, Albert/K-9744-2014; Ruberte, Jesus/AAS-9240-2021	Bosch, Assumpcio/0000-0002-7205-2796; Villacampa, Pilar/0000-0002-2860-7475; Ribera, Albert/0000-0002-7120-4276; BOSCH, FATIMA/0000-0002-7705-5515; Haurigot, Virginia A./0000-0002-9772-2565; RUBERTE, JESUS/0000-0003-1540-1432	Instituto de Salud Carlos III [PI 061417]; Generalitat de Catalunya, Spain [SGR224]; European Community [CLINIGENE LSHB-CT-2006-018933]; Fundacion Ramon Areces; Ministerio de Educacion y Ciencia; Ministerio de Ciencia y Tecnologia	Instituto de Salud Carlos III(Instituto de Salud Carlos IIIEuropean Commission); Generalitat de Catalunya, Spain(Generalitat de Catalunya); European Community(European Commission); Fundacion Ramon Areces; Ministerio de Educacion y Ciencia(Spanish Government); Ministerio de Ciencia y Tecnologia(Ministry of Science and Innovation, Spain (MICINN)Spanish Government)	This study was supported by grants from Instituto de Salud Carlos III (PI 061417) and Generalitat de Catalunya (2009 SGR224), Spain, and European Community (CLINIGENE LSHB-CT-2006-018933). PV and AR were recipients of predoctoral fellowships from Fundacion Ramon Areces and Ministerio de Educacion y Ciencia, respectively. AB was recipient of a Ramon y Cajal Program contract, from Ministerio de Ciencia y Tecnologia. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aiello LP, 1998, DIABETES CARE, V21, P143, DOI 10.2337/diacare.21.1.143; AIELLO LP, 1994, NEW ENGL J MED, V331, P1480, DOI 10.1056/NEJM199412013312203; Akache B, 2006, J VIROL, V80, P9831, DOI 10.1128/JVI.00878-06; Bainbridge JWB, 2008, NEW ENGL J MED, V358, P2231, DOI 10.1056/NEJMoa0802268; Barnstable CJ, 2004, PROG RETIN EYE RES, V23, P561, DOI 10.1016/j.preteyeres.2004.05.002; Bennett J, 1997, INVEST OPHTH VIS SCI, V38, P2857; Cai J, 2006, J BIOL CHEM, V281, P3604, DOI 10.1074/jbc.M507401200; Cao W, 2001, INVEST OPHTH VIS SCI, V42, P1646; Cayouette M, 1999, NEUROBIOL DIS, V6, P523, DOI 10.1006/nbdi.1999.0263; Chen LL, 2006, BIOCHEM BIOPH RES CO, V348, P1288, DOI 10.1016/j.bbrc.2006.07.188; Chen YH, 2009, NAT MED, V15, P1215, DOI 10.1038/nm.2025; Dawson DW, 1999, SCIENCE, V285, P245, DOI 10.1126/science.285.5425.245; Fletcher EL, 2010, DOC OPHTHALMOL, V120, P67, DOI 10.1007/s10633-009-9193-6; Fonsatti E, 2010, CARDIOVASC RES, V86, P12, DOI 10.1093/cvr/cvp332; Forsythe JA, 1996, MOL CELL BIOL, V16, P4604; Gao GP, 2002, P NATL ACAD SCI USA, V99, P11854, DOI 10.1073/pnas.182412299; Gariano RF, 2005, NATURE, V438, P960, DOI 10.1038/nature04482; GRANT M, 1986, DIABETES, V35, P416, DOI 10.2337/diabetes.35.4.416; Haurigot V, 2009, J BIOL CHEM, V284, P22961, DOI 10.1074/jbc.M109.014787; Hauswirth WW, 2008, HUM GENE THER, V19, P979, DOI 10.1089/hum.2008.107; Inokuchi N, 2001, CURR EYE RES, V23, P368, DOI 10.1076/ceyr.23.5.368.5441; Kozulin P, 2009, MOL VIS, V15, P45; Kuiper EJ, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002675; Laughner E, 2001, MOL CELL BIOL, V21, P3995, DOI 10.1128/MCB.21.12.3995-4004.2001; Lebherz C, 2008, J GENE MED, V10, P375, DOI 10.1002/jgm.1126; Maguire AM, 2008, NEW ENGL J MED, V358, P2240, DOI 10.1056/NEJMoa0802315; Manno CS, 2006, NAT MED, V12, P342, DOI 10.1038/nm1358; Mori K, 2002, INVEST OPHTH VIS SCI, V43, P1994; Nicholson BP, 2010, GRAEF ARCH CLIN EXP, V248, P915, DOI 10.1007/s00417-010-1315-z; Ogata N, 2002, AM J OPHTHALMOL, V134, P348, DOI 10.1016/S0002-9394(02)01568-4; Ohno-Matsui K, 2001, J CELL PHYSIOL, V189, P323, DOI 10.1002/jcp.10026; PIERCE EA, 1995, P NATL ACAD SCI USA, V92, P905, DOI 10.1073/pnas.92.3.905; Raisler BJ, 2002, P NATL ACAD SCI USA, V99, P8909, DOI 10.1073/pnas.122247299; Ruberte J, 2004, J CLIN INVEST, V113, P1149, DOI 10.1172/JCI200419478; Saint-Geniez M, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003554; Salzmann J, 2000, BRIT J OPHTHALMOL, V84, P1091, DOI 10.1136/bjo.84.10.1091; Singh V, 1998, MOL VIS, P4; SMITH LEH, 1994, INVEST OPHTH VIS SCI, V35, P101; Stieger K, 2009, MOL THER, V17, P516, DOI 10.1038/mt.2008.283; Summerford C, 1998, J VIROL, V72, P1438, DOI 10.1128/JVI.72.2.1438-1445.1998; Suzuma K, 2000, J BIOL CHEM, V275, P40725, DOI 10.1074/jbc.M006509200; TOMBRANTINK J, 1989, INVEST OPHTH VIS SCI, V30, P1700; Volpert OV, 2002, NAT MED, V8, P349, DOI 10.1038/nm0402-349; Wang H, 1998, CIRC RES, V83, P832, DOI 10.1161/01.RES.83.8.832; Wang JJ, 2006, DIABETES, V55, P1678, DOI 10.2337/db05-1448; Weber M, 2003, MOL THER, V7, P774, DOI 10.1016/S1525-0016(03)00098-4; Zhang SX, 2006, J MOL ENDOCRINOL, V37, P1, DOI 10.1677/jme.1.02008; Zhang SX, 2006, FASEB J, V20, P323, DOI 10.1096/fj.05-4313fje	48	46	54	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 20	2012	7	7							e41511	10.1371/journal.pone.0041511	http://dx.doi.org/10.1371/journal.pone.0041511			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	977GL	22911805	gold, Green Published, Green Submitted			2022-12-25	WOS:000306644600083
J	Selvaraj, S; Liu, K; Robinson, AM; Epstein, VA; Conley, DB; Kern, RC; Richter, CP				Selvaraj, Senthil; Liu, Kevin; Robinson, Alan M.; Epstein, Victoria A.; Conley, David B.; Kern, Robert C.; Richter, Claus-Peter			In Vivo Determination of Mouse Olfactory Mucus Cation Concentrations in Normal and Inflammatory States	PLOS ONE			English	Article							AIRWAY SURFACE LIQUID; ODOR IDENTIFICATION; K+; DISCRIMINATION; TRANSDUCTION; PATHOGENESIS; CHANNEL; PROTEIN; ANOSMIA; CILIA	Objective: Olfaction is impaired in chronic rhinosinusitis (CRS). The study has two aims: (1) to determine whether changes in cation concentration occur in the olfactory mucus of mice with CRS, which may affect chemo-electrical transduction, (2) and to examine whether these alterations are physiologically significant in humans. Study Design: Animal study in mice and translational study in humans. Methods: Inflammation was induced by sensitization and chronic exposure of 16 C57BL/6 mice to Aspergillus fumigatus. The control group included 16 untreated mice. Ion-selective microelectrodes were used to measure free cation concentrations in the olfactory mucus of 8 mice from each treatment group, while the remaining mice were sacrificed for histology. To validate the findings in the animal model, olfactory threshold was measured in 11 healthy human participants using Sniffin' Sticks before and after nasal irrigation with solutions that were composed of either of the cation concentrations. Results: In 8 mice, olfactory mucus of chronically inflamed mice had lower [Na+] (84.8 +/- 4.45 mM versus 93.73 +/- 3.06 mM, p = 0.02), and higher [K+] (7.2 +/- 0.65 mM versus 5.7 +/- 0.20 mM, p = 0.04) than controls. No difference existed in [Ca2+] (0.50 +/- 0.12 mM versus 0.54 +/- 0.06 mM, p = 0.39). In humans, rinsing with solutions replicating ion concentrations of the mouse mucosa with chronic inflammation caused a significant elevation in the median olfactory threshold (9.0 to 4.8, p = 0.003) but not with the control solution (8.3 to 7.8, p = 0.75). Conclusion: Chronic inflammation elevates potassium and lowers sodium ion concentration in mice olfactory mucus. Nasal irrigation with a corresponding solution induced olfactory threshold shift in humans.	[Selvaraj, Senthil; Liu, Kevin; Robinson, Alan M.; Epstein, Victoria A.; Conley, David B.; Kern, Robert C.; Richter, Claus-Peter] Northwestern Univ, Feinberg Sch Med, Dept Otolaryngol Head & Neck Surg, Chicago, IL 60611 USA; [Richter, Claus-Peter] Northwestern Univ, Dept Biomed Engn, Evanston, IL 60208 USA; [Richter, Claus-Peter] Northwestern Univ, Dept Commun Sci & Disorders, Hugh Knowles Ctr, Evanston, IL USA	Northwestern University; Feinberg School of Medicine; Northwestern University; Northwestern University	Selvaraj, S (corresponding author), Northwestern Univ, Feinberg Sch Med, Dept Otolaryngol Head & Neck Surg, Chicago, IL 60611 USA.	CRI529@northwestern.edu		Selvaraj, Senthil/0000-0001-8418-7623	Department of Otolaryngology-Head and Neck Surgery, Feinberg School of Medicine, Northwestern University; American Academy of Otolaryngic Allergy	Department of Otolaryngology-Head and Neck Surgery, Feinberg School of Medicine, Northwestern University; American Academy of Otolaryngic Allergy	This work was supported by the Department of Otolaryngology-Head and Neck Surgery, Feinberg School of Medicine, Northwestern University and the American Academy of Otolaryngic Allergy (V.A.E.). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Albrecht J, 2008, CHEM SENSES, V33, P461, DOI 10.1093/chemse/bjn013; Carr VM, 2012, CHEM SENSES; Dalton P, 2004, CURR ALLERGY ASTHM R, V4, P230, DOI 10.1007/s11882-004-0031-3; Dejima K, 2006, ARCH OTOLARYNGOL, V132, P1352, DOI 10.1001/archotol.132.12.1352; FRINGS S, 1991, J GEN PHYSIOL, V97, P725, DOI 10.1085/jgp.97.4.725; Gamel K, 2000, BIOPHYS J, V79, P2475, DOI 10.1016/S0006-3495(00)76490-3; GLEICH GJ, 1993, ANNU REV MED, V44, P85, DOI 10.1146/annurev.me.44.020193.000505; Gold GH, 1999, ANNU REV PHYSIOL, V61, P857, DOI 10.1146/annurev.physiol.61.1.857; Grubb BR, 2002, AM J PHYSIOL-CELL PH, V282, pC1423, DOI 10.1152/ajpcell.00612.2001; HISAMATSU K, 1990, J ALLERGY CLIN IMMUN, V86, P52, DOI 10.1016/S0091-6749(05)80123-X; Holmgren M, 2003, J GEN PHYSIOL, V121, P61, DOI 10.1085/jgp.20028722; Hull J, 1998, AM J RESP CRIT CARE, V157, P10, DOI 10.1164/ajrccm.157.1.9703045; Hummel T, 1997, CHEM SENSES, V22, P39, DOI 10.1093/chemse/22.1.39; Hussain I, 2001, CLIN EXP ALLERGY, V31, P1048, DOI 10.1046/j.1365-2222.2001.01129.x; JOSHI H, 1987, NEUROSCI LETT, V82, P321, DOI 10.1016/0304-3940(87)90276-X; Kern RC, 2000, LARYNGOSCOPE, V110, P1071, DOI 10.1097/00005537-200007000-00001; KLEENE SJ, 1993, J MEMBRANE BIOL, V131, P237, DOI 10.1007/BF02260112; Knowles MR, 1997, J CLIN INVEST, V100, P2588, DOI 10.1172/JCI119802; Kobal G., 1996, Rhinology (Utrecht), V34, P222; Kobal G, 2000, EUR ARCH OTO-RHINO-L, V257, P205, DOI 10.1007/s004050050223; Kozlova I, 2006, UPSALA J MED SCI, V111, P137, DOI 10.3109/2000-1967-016; Kozlova I, 2005, AM J PHYSIOL-LUNG C, V288, pL874, DOI 10.1152/ajplung.00303.2004; Kramer MF, 2006, AM J OTOLARYNG, V27, P190, DOI 10.1016/j.amjoto.2005.09.013; Kushnir NM, 2011, IMMUNOL ALLERGY CLIN, V31, P601, DOI 10.1016/j.iac.2011.05.008; Liu GX, 1998, ACTA PHARMACOL SIN, V19, P238; MARGOLIS FL, 1972, P NATL ACAD SCI USA, V69, P1221, DOI 10.1073/pnas.69.5.1221; Meyerholz DK, 2009, TOXICOL PATHOL, V37, P249, DOI 10.1177/0192623308329342; Namkung W, 2009, J BIOL CHEM, V284, P15916, DOI 10.1074/jbc.M808021200; Panagiotopoulos G, 2005, RHINOLOGY, V43, P130; Ponikau JU, 2005, CURR ALLERGY ASTHM R, V5, P472, DOI 10.1007/s11882-005-0028-6; Reisert J, 2003, J GEN PHYSIOL, V122, P349, DOI 10.1085/jgp.200308888; Robinson AM, 2003, NEUROREPORT, V14, P1891, DOI 10.1097/00001756-200310270-00002; Sauer G, 1999, HEARING RES, V129, P1, DOI 10.1016/S0378-5955(98)00230-5; Schild D, 1998, PHYSIOL REV, V78, P429, DOI 10.1152/physrev.1998.78.2.429; van de Rijn M, 1998, J ALLERGY CLIN IMMUN, V102, P65, DOI 10.1016/S0091-6749(98)70056-9; Wong ST, 2000, NEURON, V27, P487, DOI 10.1016/S0896-6273(00)00060-X; ZUFALL F, 1994, ANNU REV BIOPH BIOM, V23, P577, DOI 10.1146/annurev.bb.23.060194.003045	37	6	6	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 20	2012	7	7							e39600	10.1371/journal.pone.0039600	http://dx.doi.org/10.1371/journal.pone.0039600			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	977GL	22911687	Green Submitted, Green Published, gold			2022-12-25	WOS:000306644600006
J	Rollenhagen, M; Kuckuck, S; Ulm, C; Hartmann, M; Galuska, SP; Geyer, R; Geyer, H; Muhlenhoff, M				Rollenhagen, Manuela; Kuckuck, Sarah; Ulm, Christina; Hartmann, Maike; Galuska, Sebastian P.; Geyer, Rudolf; Geyer, Hildegard; Muehlenhoff, Martina			Polysialylation of the Synaptic Cell Adhesion Molecule 1 (SynCAM 1) Depends Exclusively on the Polysialyltransferase ST8SiaII in Vivo	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							POLYSIALIC ACID SYNTHESIS; POSTNATAL MOUSE-BRAIN; MONOCLONAL-ANTIBODIES; SOLUBLE ISOFORM; N-GLYCOSYLATION; OLFACTORY-BULB; III REPEAT; RAT-BRAIN; NCAM; STX	Polysialic acid is a unique carbohydrate polymer specifically attached to a limited number of glycoproteins. Among them is synaptic cell adhesion molecule 1 (SynCAM 1), a member of the immunoglobulin (Ig) superfamily composed of three extracellular Ig-like domains. Polysialylation of SynCAM 1 is cell type-specific and was exclusively found in NG2 cells, a class of multifunctional progenitor cells that form specialized synapses with neurons. Here, we studied the molecular requirements for SynCAM 1 polysialylation. Analysis of mice lacking one of the two polysialyltransferases, ST8SiaII or ST8SiaIV, revealed that polysialylation of SynCAM 1 is exclusively mediated by ST8SiaII throughout postnatal brain development. Alternative splicing of the three variable exons 8a, 8b, and 8c can theoretically give rise to eight transmembrane isoforms of SynCAM 1. We detected seven transcript variants in the developing mouse brain, including three variants containing exon 8c, which was so far regarded as a cryptic exon in mice. Polysialylation of SynCAM 1 was restricted to four isoforms in perinatal brain. However, cell culture experiments demonstrated that all transmembrane isoforms of SynCAM 1 can be polysialylated by ST8SiaII. Moreover, analysis of domain deletion constructs revealed that Ig1, which harbors the polysialylation site, is not sufficient as an acceptor for ST8SiaII. The minimal polypeptide required for polysialylation contained Ig1 and Ig2, suggesting an important role for Ig2 as a docking site for ST8SiaII.	[Rollenhagen, Manuela; Kuckuck, Sarah; Hartmann, Maike; Muehlenhoff, Martina] Hannover Med Sch, Inst Cellular Chem, D-30625 Hannover, Germany; [Ulm, Christina; Galuska, Sebastian P.; Geyer, Rudolf; Geyer, Hildegard] Univ Giessen, Inst Biochem, Fac Med, D-35392 Giessen, Germany	Hannover Medical School; Justus Liebig University Giessen	Muhlenhoff, M (corresponding author), Hannover Med Sch, Inst Cellular Chem, Carl Neuberg Str 1, D-30625 Hannover, Germany.	muehlenhoff.martina@mh-hannover.de			Deutsche Forschungsgemeinschaft [GE 527/5, MU 1774/3]	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG))	This work was supported by Deutsche Forschungsgemeinschaft Grants GE 527/5 (to H. G.) and MU 1774/3 (to M. M.).	Angata K, 1998, J BIOL CHEM, V273, P28524, DOI 10.1074/jbc.273.43.28524; Angata K, 2004, J BIOL CHEM, V279, P32603, DOI 10.1074/jbc.M403429200; Biederer T, 2006, GENOMICS, V87, P139, DOI 10.1016/j.ygeno.2005.08.017; Biederer T, 2002, SCIENCE, V297, P1525, DOI 10.1126/science.1072356; Busam RD, 2011, J BIOL CHEM, V286, P4511, DOI 10.1074/jbc.M110.174011; Close BE, 2003, J BIOL CHEM, V278, P30796, DOI 10.1074/jbc.M305390200; Close BE, 1998, J BIOL CHEM, V273, P34586, DOI 10.1074/jbc.273.51.34586; CREMER H, 1994, NATURE, V367, P455, DOI 10.1038/367455a0; CUNNINGHAM BA, 1987, SCIENCE, V236, P799, DOI 10.1126/science.3576199; Curreli S, 2007, J BIOL CHEM, V282, P30346, DOI 10.1074/jbc.M702965200; ECKHARDT M, 1995, NATURE, V373, P715, DOI 10.1038/373715a0; Eckhardt M, 2000, J NEUROSCI, V20, P5234, DOI 10.1523/JNEUROSCI.20-14-05234.2000; EDELMAN GM, 1982, P NATL ACAD SCI-BIOL, V79, P7036, DOI 10.1073/pnas.79.22.7036; FINNE J, 1983, BIOCHEM BIOPH RES CO, V112, P482, DOI 10.1016/0006-291X(83)91490-0; Fogel AI, 2007, J NEUROSCI, V27, P12516, DOI 10.1523/JNEUROSCI.2739-07.2007; Fogel AI, 2011, EMBO J, V30, P4728, DOI 10.1038/emboj.2011.336; Fogel AI, 2010, J BIOL CHEM, V285, P34864, DOI 10.1074/jbc.M110.120865; FROSCH M, 1985, P NATL ACAD SCI USA, V82, P1194, DOI 10.1073/pnas.82.4.1194; Fujimoto I, 2001, J BIOL CHEM, V276, P31745, DOI 10.1074/jbc.M104525200; Galuska SP, 2008, J BIOL CHEM, V283, P17, DOI 10.1074/jbc.M707024200; Galuska SP, 2006, J BIOL CHEM, V281, P31605, DOI 10.1074/jbc.M606516200; Galuska SP, 2010, P NATL ACAD SCI USA, V107, P10250, DOI 10.1073/pnas.0912103107; Hagiyama M, 2011, J IMMUNOL, V186, P5983, DOI 10.4049/jimmunol.1002244; Hagiyama M, 2009, AM J PATHOL, V174, P2278, DOI 10.2353/ajpath.2009.080743; Hildebrandt H, 1998, J NEUROCHEM, V71, P2339; Hildebrandt H, 2009, BRAIN, V132, P2831, DOI 10.1093/brain/awp117; Kojima N, 1996, J BIOL CHEM, V271, P19457, DOI 10.1074/jbc.271.32.19457; KOJIMA N, 1995, FEBS LETT, V373, P119, DOI 10.1016/0014-5793(95)01024-9; Koma Y, 2004, ONCOGENE, V23, P5687, DOI 10.1038/sj.onc.1207761; Li FG, 1996, J BIOL CHEM, V271, P6342, DOI 10.1074/jbc.271.11.6342; Li Q, 2007, NAT REV NEUROSCI, V8, P819, DOI 10.1038/nrn2237; Liedtke S, 2001, GLYCOBIOLOGY, V11, P373, DOI 10.1093/glycob/11.5.373; Mendiratta SS, 2006, J BIOL CHEM, V281, P36052, DOI 10.1074/jbc.M608073200; Mendiratta SS, 2005, J BIOL CHEM, V280, P32340, DOI 10.1074/jbc.M506217200; Muhlenhoff M, 2009, BIOL CHEM, V390, P567, DOI 10.1515/BC.2009.078; Muhlenhoff M, 2001, J BIOL CHEM, V276, P34066, DOI 10.1074/jbc.M101022200; Muhlenhoff M, 1996, EMBO J, V15, P6943, DOI 10.1002/j.1460-2075.1996.tb01086.x; Muhlenhoff M, 1996, CURR BIOL, V6, P1188, DOI 10.1016/S0960-9822(02)70687-8; Muotri AR, 2006, NATURE, V441, P1087, DOI 10.1038/nature04959; NELSON RW, 1995, J BIOL CHEM, V270, P17171, DOI 10.1074/jbc.270.29.17171; Nishiyama A, 2009, NAT REV NEUROSCI, V10, P9, DOI 10.1038/nrn2495; Oltmann-Norden I, 2008, J BIOL CHEM, V283, P1463, DOI 10.1074/jbc.M708463200; Ong E, 1998, GLYCOBIOLOGY, V8, P415, DOI 10.1093/glycob/8.4.415; Paukert M, 2006, CURR OPIN NEUROBIOL, V16, P515, DOI 10.1016/j.conb.2006.08.009; Robbins EM, 2010, NEURON, V68, P894, DOI 10.1016/j.neuron.2010.11.003; Rockle I, 2008, DEV NEUROBIOL, V68, P1170, DOI 10.1002/dneu.20649; ROSE MC, 1984, J BIOL CHEM, V259, P3167; ROTHBARD JB, 1982, J BIOL CHEM, V257, P1064; Rutishauser U, 2008, NAT REV NEUROSCI, V9, P26, DOI 10.1038/nrn2285; Sara Y, 2005, J NEUROSCI, V25, P260, DOI 10.1523/JNEUROSCI.3165-04.2005; Stagi M, 2010, P NATL ACAD SCI USA, V107, P7568, DOI 10.1073/pnas.0911798107; Stummeyer K, 2005, NAT STRUCT MOL BIOL, V12, P90, DOI 10.1038/nsmb874; Thomas LA, 2008, J COMP NEUROL, V510, P47, DOI 10.1002/cne.21773; Thompson MG, 2011, J BIOL CHEM, V286, P4525, DOI 10.1074/jbc.M110.200386; Trotter J, 2010, BRAIN RES REV, V63, P72, DOI 10.1016/j.brainresrev.2009.12.006; von der Ohe M, 2002, GLYCOBIOLOGY, V12, P47, DOI 10.1093/glycob/12.1.47; Weinhold B, 2005, J BIOL CHEM, V280, P42971, DOI 10.1074/jbc.M511097200; Windfuhr M, 2000, J BIOL CHEM, V275, P32861, DOI 10.1074/jbc.M003507200; Yabe U, 2003, J BIOL CHEM, V278, P13875, DOI 10.1074/jbc.M300458200; ZUBER C, 1992, J BIOL CHEM, V267, P9965	60	31	31	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 12	2012	287	42					35170	35180		10.1074/jbc.M112.375642	http://dx.doi.org/10.1074/jbc.M112.375642			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	022OF	22908220	hybrid, Green Published			2022-12-25	WOS:000309968000027
J	Dong, ZS; Danilevskaya, O; Abadie, T; Messina, C; Coles, N; Cooper, M				Dong, Zhanshan; Danilevskaya, Olga; Abadie, Tabare; Messina, Carlos; Coles, Nathan; Cooper, Mark			A Gene Regulatory Network Model for Floral Transition of the Shoot Apex in Maize and Its Dynamic Modeling	PLOS ONE			English	Article							VEGETATIVE PHASE-CHANGE; FLOWERING-TIME; ARABIDOPSIS-THALIANA; INFLORESCENCE ARCHITECTURE; PHOTOPERIOD SENSITIVITY; TRANSCRIPTION FACTOR; CIRCADIAN CLOCK; INBRED LINES; EXPRESSION; RICE	The transition from the vegetative to reproductive development is a critical event in the plant life cycle. The accurate prediction of flowering time in elite germplasm is important for decisions in maize breeding programs and best agronomic practices. The understanding of the genetic control of flowering time in maize has significantly advanced in the past decade. Through comparative genomics, mutant analysis, genetic analysis and QTL cloning, and transgenic approaches, more than 30 flowering time candidate genes in maize have been revealed and the relationships among these genes have been partially uncovered. Based on the knowledge of the flowering time candidate genes, a conceptual gene regulatory network model for the genetic control of flowering time in maize is proposed. To demonstrate the potential of the proposed gene regulatory network model, a first attempt was made to develop a dynamic gene network model to predict flowering time of maize genotypes varying for specific genes. The dynamic gene network model is composed of four genes and was built on the basis of gene expression dynamics of the two late flowering id1 and dlf1 mutants, the early flowering landrace Gaspe Flint and the temperate inbred B73. The model was evaluated against the phenotypic data of the id1 dlf1 double mutant and the ZMM4 overexpressed transgenic lines. The model provides a working example that leverages knowledge from model organisms for the utilization of maize genomic information to predict a whole plant trait phenotype, flowering time, of maize genotypes.	[Dong, Zhanshan; Danilevskaya, Olga; Abadie, Tabare; Messina, Carlos; Coles, Nathan; Cooper, Mark] DuPont Pioneer, Johnston, IA USA	DuPont; Pioneer Hi-Bred International, Inc.	Dong, ZS (corresponding author), DuPont Pioneer, Johnston, IA USA.	zhanshan.dong@pioneer.com	Cooper, Mark/AAG-8551-2019	Cooper, Mark/0000-0002-9418-3359; Coles, Nathan/0000-0002-2008-3283				Akutsu T, 1999, PAC S BIOC, P17, DOI [10.1142/9789814447300_0003, DOI 10.1142/9789814447300_0003]; Alvarez-Buylla ER, 2007, CURR OPIN PLANT BIOL, V10, P83, DOI 10.1016/j.pbi.2006.11.008; Amasino RM, 2010, PLANT PHYSIOL, V154, P516, DOI 10.1104/pp.110.161653; Andersen CH, 2004, TRENDS PLANT SCI, V9, P105, DOI 10.1016/j.tplants.2004.01.002; Andersen JR, 2005, THEOR APPL GENET, V111, P206, DOI 10.1007/s00122-005-1996-6; Aukerman MJ, 2003, PLANT CELL, V15, P2730, DOI 10.1105/tpc.016238; Benfey PN, 2008, SCIENCE, V320, P495, DOI 10.1126/science.1153716; Blazquez MA, 2000, J CELL SCI, V113, P3547; Bolduc N, 2009, PLANT CELL, V21, P1647, DOI 10.1105/tpc.109.068221; Bomblies K, 2003, DEVELOPMENT, V130, P2385, DOI 10.1242/dev.00457; Bomblies K, 2006, GENETICS, V172, P519, DOI 10.1534/genetics.105.048595; BONHOMME R, 1994, CROP SCI, V34, P156, DOI 10.2135/cropsci1994.0011183X003400010028x; Buckler ES, 2009, SCIENCE, V325, P714, DOI 10.1126/science.1174276; Camus-Kulandaivelu L, 2006, GENETICS, V172, P2449, DOI 10.1534/genetics.105.048603; Chardon F, 2004, GENETICS, V168, P2169, DOI 10.1534/genetics.104.032375; Cockram J, 2007, J EXP BOT, V58, P1231, DOI 10.1093/jxb/erm042; Colasanti J, 1998, CELL, V93, P593, DOI 10.1016/S0092-8674(00)81188-5; Colasanti J, 2009, PLANT PHYSIOL, V149, P56, DOI 10.1104/pp.108.130500; Colasanti Joseph, 2009, P41, DOI 10.1007/978-0-387-79418-1_3; Coles ND, 2010, GENETICS, V184, P799, DOI 10.1534/genetics.109.110304; Coneva V, 2007, J EXP BOT, V58, P3679, DOI 10.1093/jxb/erm217; Cooper Mark, 2002, In Silico Biology, V2, P151; Danilevskaya ON, 2008, PLANT PHYSIOL, V147, P2054, DOI 10.1104/pp.107.115261; Danilevskaya ON, 2008, PLANT PHYSIOL, V146, P250, DOI 10.1104/pp.107.109538; Danilevskaya ON, 2010, PLANT PHYSIOL, V153, P238, DOI 10.1104/pp.110.154211; Davidson E, 2002, AIDS RES HUM RETRO S, V295, P1670; Di Paolo EA, 2001, BIOSYSTEMS, V59, P185, DOI 10.1016/S0303-2647(01)00102-2; DIJKHUIS F. J., 1956, Euphytica, V5, P267; Ehrenreich IM, 2009, GENETICS, V183, P325, DOI 10.1534/genetics.109.105189; FERWERDA F. P., 1953, EUPHYTICA, V2, P127; Fornara F, 2010, CELL, V141, DOI 10.1016/j.cell.2010.04.024; Gaut BS, 1997, P NATL ACAD SCI USA, V94, P6809, DOI 10.1073/pnas.94.13.6809; Genoud T, 1999, TRENDS PLANT SCI, V4, P503, DOI 10.1016/S1360-1385(99)01498-3; Genoud T, 2001, PLANT PHYSIOL, V126, P1430, DOI 10.1104/pp.126.4.1430; Greenup A, 2009, ANN BOT-LONDON, V103, P1165, DOI 10.1093/aob/mcp063; Hammer G, 2006, TRENDS PLANT SCI, V11, P587, DOI 10.1016/j.tplants.2006.10.006; Hammer GL, 2010, J EXP BOT, V61, P2185, DOI 10.1093/jxb/erq095; Harmer SL, 2000, SCIENCE, V290, P2110, DOI 10.1126/science.290.5499.2110; Hayama R, 2003, NATURE, V422, P719, DOI 10.1038/nature01549; Hayama R, 2007, PLANT CELL, V19, P2988, DOI 10.1105/tpc.107.052480; Hayes KR, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012887; Heuer S, 2001, PLANT PHYSIOL, V127, P33, DOI 10.1104/pp.127.1.33; Higgins JA, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010065; Hung H-Y, 2012, P NATL ACAD SCI USA, P1; Izawa T, 2003, CURR OPIN PLANT BIOL, V6, P113, DOI 10.1016/S1369-5266(03)00014-1; Izawa T, 2002, GENE DEV, V16, P2006, DOI 10.1101/gad.999202; Jung C, 2009, TRENDS PLANT SCI, V14, P563, DOI 10.1016/j.tplants.2009.07.005; Jung JH, 2007, PLANT CELL, V19, P2736, DOI 10.1105/tpc.107.054528; Kauffman SA, 1993, ORIGINS ORDER SELF O, P734; Khan S, 2010, BMC PLANT BIOL, V10, DOI 10.1186/1471-2229-10-126; Koduru P, 2008, IEEE T EVOLUT COMPUT, V12, P572, DOI 10.1109/TEVC.2008.917202; Kong FJ, 2010, PLANT PHYSIOL, V154, P1220, DOI 10.1104/pp.110.160796; Ku LX, 2011, AGR SCI CHINA, V10, P18, DOI 10.1016/S1671-2927(11)60303-9; Lagercrantz U, 2009, J EXP BOT, V60, P2501, DOI 10.1093/jxb/erp139; Lauter N, 2005, P NATL ACAD SCI USA, V102, P9412, DOI 10.1073/pnas.0503927102; Lawit SJ, 2010, PLANT CELL PHYSIOL, V51, P1854, DOI 10.1093/pcp/pcq153; LEE I, 1994, PLANT CELL, V6, P75, DOI 10.1105/tpc.6.1.75; Liljegren SJ, 1999, PLANT CELL, V11, P1007, DOI 10.1105/tpc.11.6.1007; Liu C, 2009, DEVELOPMENT, V136, P3379, DOI 10.1242/dev.033076; Malcomber ST, 2006, ADV BOT RES, V44, P425, DOI 10.1016/S0065-2296(06)44011-8; Markelz NH, 2003, PLANT PHYSIOL, V133, P1578, DOI 10.1104/pp.103.029694; Matsubara K, 2008, PLANT PHYSIOL, V148, P1425, DOI 10.1104/pp.108.125542; McClung CR, 2010, BMC BIOL, V8, DOI 10.1186/1741-7007-8-55; McSteen P, 2000, TRENDS PLANT SCI, V5, P61, DOI 10.1016/S1360-1385(99)01541-1; Mena M, 1995, PLANT J, V8, P845, DOI 10.1046/j.1365-313X.1995.8060845.x; Mendoza L, 1998, J THEOR BIOL, V193, P307, DOI 10.1006/jtbi.1998.0701; Meng X, 2011, PLANT CELL, V23, P942, DOI 10.1105/tpc.110.081406; Messina CD, 2011, J EXP BOT, V62, P855, DOI 10.1093/jxb/erq329; Miller TA, 2008, PLANTA, V227, P1377, DOI 10.1007/s00425-008-0709-1; MOOSE SP, 1994, PLANT CELL, V6, P1343, DOI 10.1105/tpc.6.10.1343; Morishige DT, 2002, PLANT PHYSIOL, V130, P1614, DOI 10.1104/pp.012567; Murakami M, 2007, PLANT CELL PHYSIOL, V48, P110, DOI 10.1093/pcp/pcl043; Muszynski MG, 2006, PLANT PHYSIOL, V142, P1523, DOI 10.1104/pp.106.088815; NELDER JA, 1965, COMPUT J, V7, P308, DOI 10.1093/comjnl/7.4.308; Park SJ, 2008, PLANT J, V56, P1018, DOI 10.1111/j.1365-313X.2008.03667.x; Pastore JJ, 2011, DEVELOPMENT, V138, P3189, DOI 10.1242/dev.063073; Peng JR, 1999, NATURE, V400, P256, DOI 10.1038/22307; Poethig RS, 2010, PLANT PHYSIOL, V154, P541, DOI 10.1104/pp.110.161620; Press W, 1992, NUMERICAL RECIPES FO, P933; Ritchie J. T., 1986, CERES MAIZE SIMULATI, P1; Rosenthal WD, 1991, PREDICTING CROP PHEN, P29; Russell W, 1982, CROP SCI, V23, P847; Salvi S, 2002, PLANT MOL BIOL, V48, P601, DOI 10.1023/A:1014838024509; Salvi S, 2007, P NATL ACAD SCI USA, V104, P11376, DOI 10.1073/pnas.0704145104; Salvi S, 2009, MAYDICA, V54, P501; Samach A, 2000, BIOESSAYS, V22, P38, DOI 10.1002/(SICI)1521-1878(200001)22:1&lt;38::AID-BIES8&gt;3.0.CO;2-L; Sawa M, 2007, SCIENCE, V318, P261, DOI 10.1126/science.1146994; Sawa M, 2008, PLANT SIGNAL BEHAV, V3, P269, DOI 10.4161/psb.3.4.5219; Sawers RJH, 2004, PLANT PHYSIOL, V136, P2771, DOI 10.1104/pp.104.046417; Sawers RJH, 2002, PLANT PHYSIOL, V130, P155, DOI 10.1104/pp.006411; Schnable PS, 2009, SCIENCE, V326, P1112, DOI 10.1126/science.1178534; Sheehan MJ, 2004, GENETICS, V167, P1395, DOI 10.1534/genetics.103.026096; Sheehan MJ, 2007, PLANT J, V49, P338, DOI 10.1111/j.1365-313X.2006.02962.x; Simpson GG, 2002, SCIENCE, V296, P285, DOI 10.1126/science.296.5566.285; Song YH, 2010, CURR OPIN PLANT BIOL, V13, P594, DOI 10.1016/j.pbi.2010.05.004; Strable J, 2008, PLANT J, V56, P1045, DOI 10.1111/j.1365-313X.2008.03661.x; Tadege M, 2003, PLANT BIOTECHNOL J, V1, P361, DOI 10.1046/j.1467-7652.2003.00034.x; Takata N, 2010, BMC EVOL BIOL, V10, DOI 10.1186/1471-2148-10-126; Thornsberry JM, 2001, NAT GENET, V28, P286, DOI 10.1038/90135; Tsuji H, 2008, RICE, V1, P25, DOI 10.1007/s12284-008-9005-8; Turner A, 2005, SCIENCE, V310, P1031, DOI 10.1126/science.1117619; Van Esbroeck GA, 2008, MAYDICA, V53, P117; van Nocker S, 2000, PLANT MOL BIOL, V44, P107, DOI 10.1023/A:1006472929800; Vladutu C, 1999, GENETICS, V153, P993; Wang XT, 2011, PLANT CELL REP, V30, P1261, DOI 10.1007/s00299-011-1036-8; Welch SM, 2005, AUST J AGR RES, V56, P919, DOI 10.1071/AR05155; WESTERMAN JM, 1970, HEREDITY, V25, P609, DOI 10.1038/hdy.1970.66; Wigge PA, 2005, SCIENCE, V309, P1056, DOI 10.1126/science.1114358; Wilczek AM, 2009, SCIENCE, V323, P930, DOI 10.1126/science.1165826; Wong AYM, 2007, J EXP BOT, V58, P403, DOI 10.1093/jxb/erl206; Wu CY, 2008, P NATL ACAD SCI USA, V105, P12915, DOI 10.1073/pnas.0806019105; Wu G, 2006, DEVELOPMENT, V133, P3539, DOI 10.1242/dev.02521; Yang L, 2011, DEVELOPMENT, V138, P245, DOI 10.1242/dev.058578; Yin XY, 2010, J EXP BOT, V61, P2171, DOI 10.1093/jxb/erp375; Yuh CH, 1998, SCIENCE, V279, P1896, DOI 10.1126/science.279.5358.1896; Yuh CH, 2001, DEVELOPMENT, V128, P617; Zhang LF, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000716; Zhu QH, 2011, J EXP BOT, V62, P487, DOI 10.1093/jxb/erq295	118	69	78	0	59	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 17	2012	7	8							e43450	10.1371/journal.pone.0043450	http://dx.doi.org/10.1371/journal.pone.0043450			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	996DG	22912876	Green Submitted, Green Published, gold			2022-12-25	WOS:000308063700104
J	Poh, YC; Corrias, A; Cheng, N; Buist, ML				Poh, Yong Cheng; Corrias, Alberto; Cheng, Nicholas; Buist, Martin Lindsay			A Quantitative Model of Human Jejunal Smooth Muscle Cell Electrophysiology	PLOS ONE			English	Article							SLOW-WAVE ACTIVITY; MYENTERIC INTERSTITIAL-CELLS; ACTIVATED POTASSIUM CHANNELS; ELECTROGENIC SODIUM PUMP; MOUSE SMALL-INTESTINE; PACEMAKER ACTIVITY; NUMERICAL-SIMULATION; MATHEMATICAL-MODEL; CALCIUM-CHANNEL; CA2+ CHANNEL	Recently, a number of ion channel mutations have been identified in the smooth muscle cells of the human jejunum. Although these are potentially significant in understanding diseases that are currently of unknown etiology, no suitable computational cell model exists to evaluate the effects of such mutations. Here, therefore, a biophysically based single cell model of human jejunal smooth muscle electrophysiology is presented. The resulting cellular description is able to reproduce experimentally recorded slow wave activity and produces realistic responses to a number of perturbations, providing a solid platform on which the causes of intestinal myopathies can be investigated.	[Poh, Yong Cheng; Corrias, Alberto; Cheng, Nicholas; Buist, Martin Lindsay] Natl Univ Singapore, Dept Bioengn, Singapore 117548, Singapore; [Poh, Yong Cheng; Buist, Martin Lindsay] Natl Univ Singapore, NUS Grad Sch Integrat Sci & Engn, Ctr Life Sci CeLS, Singapore 117548, Singapore	National University of Singapore; National University of Singapore	Poh, YC (corresponding author), Natl Univ Singapore, Dept Bioengn, Singapore 117548, Singapore.	biebml@nus.edu.sg	Corrias, Alberto/H-5176-2011	Cheng, Nicholas/0000-0001-8227-6243; Corrias, Alberto/0000-0003-2156-713X	Ministry of Education Academic Research Fund [T13-0902-P02]	Ministry of Education Academic Research Fund	Funding support from the Ministry of Education Academic Research Fund (grant T13-0902-P02). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aliev RR, 2000, J THEOR BIOL, V204, P21, DOI 10.1006/jtbi.2000.1069; BENHAM CD, 1986, J PHYSIOL-LONDON, V371, P45, DOI 10.1113/jphysiol.1986.sp015961; Beyder A, 2010, J PHYSIOL-LONDON, V588, P4969, DOI 10.1113/jphysiol.2010.199034; Bielefeldt K, 1997, AM J PHYSIOL-GASTR L, V272, pG1439, DOI 10.1152/ajpgi.1997.272.6.G1439; Carl A, 1996, AM J PHYSIOL-CELL PH, V271, pC9, DOI 10.1152/ajpcell.1996.271.1.C9; CASTEELS R, 1971, J PHYSIOL-LONDON, V217, P297, DOI 10.1113/jphysiol.1971.sp009572; Cho WJ, 2005, AM J PHYSIOL-GASTR L, V288, pG571, DOI 10.1152/ajpgi.00222.2004; Clancy CE, 2002, CIRCULATION, V105, P1208, DOI 10.1161/hc1002.105183; Clancy CE, 1999, NATURE, V400, P566, DOI 10.1038/23034; Corrias A, 2008, AM J PHYSIOL-GASTR L, V294, pG989, DOI 10.1152/ajpgi.00528.2007; Corrias A, 2007, ANN BIOMED ENG, V35, P1595, DOI 10.1007/s10439-007-9324-8; Cox DH, 1997, J GEN PHYSIOL, V110, P257, DOI 10.1085/jgp.110.3.257; Duridanova DB, 1997, GEN PHYSIOL BIOPHYS, V16, P49; Faber GM, 2007, BIOPHYS J, V92, P1522, DOI 10.1529/biophysj.106.088807; FARRUGIA G, 1995, GASTROENTEROLOGY, V109, P707, DOI 10.1016/0016-5085(95)90377-1; FARRUGIA G, 1993, AM J PHYSIOL, V265, pG873, DOI 10.1152/ajpgi.1993.265.5.G873; Farrugia G, 1996, GASTROENTEROLOGY, V110, P1438, DOI 10.1053/gast.1996.v110.pm8613049; Farrugia G, 1999, ANNU REV PHYSIOL, V61, P45, DOI 10.1146/annurev.physiol.61.1.45; Farrugia G, 1999, GASTROENTEROLOGY, V117, P900, DOI 10.1016/S0016-5085(99)70349-5; Faville RA, 2009, BIOPHYS J, V96, P4834, DOI 10.1016/j.bpj.2009.03.058; Gallagher Tom K, 2009, Ann Surg Innov Res, V3, P4, DOI 10.1186/1750-1164-3-4; Gibbons SJ, 2009, J CELL MOL MED, V13, P4422, DOI 10.1111/j.1582-4934.2008.00623.x; HARA Y, 1986, J PHYSIOL-LONDON, V372, P501, DOI 10.1113/jphysiol.1986.sp016022; HODGKIN AL, 1952, J PHYSIOL-LONDON, V117, P500, DOI 10.1113/jphysiol.1952.sp004764; Holm AN, 2002, GASTROENTEROLOGY, V122, P178, DOI 10.1053/gast.2002.30346; Horowitz A, 1996, PHYSIOL REV, V76, P967, DOI 10.1152/physrev.1996.76.4.967; HUIZINGA JD, 1995, NATURE, V373, P347, DOI 10.1038/373347a0; Hwang SJ, 2009, J PHYSIOL-LONDON, V587, P4887, DOI 10.1113/jphysiol.2009.176198; Kao C., 2005, CELLULAR ASPECTS SMO; Kito Y, 2003, J PHYSIOL-LONDON, V553, P803, DOI 10.1113/jphysiol.2003.051334; Lee HT, 2007, GASTROENTEROLOGY, V132, P1852, DOI 10.1053/j.gastro.2007.02.049; Lim I, 2005, AM J PHYSIOL-GASTR L, V288, pG7, DOI 10.1152/ajpgi.00205.2004; Locke GR, 2006, AM J GASTROENTEROL, V101, P1299, DOI 10.1111/j.1572-0241.2006.00507.x; Lyford GL, 2002, AM J PHYSIOL-CELL PH, V283, pC1001, DOI 10.1152/ajpcell.00140.2002; MAGARIBUCHI T, 1973, JPN J PHYSIOL, V23, P25; Mazzone A, 2008, J BIOL CHEM, V283, P16537, DOI 10.1074/jbc.M801744200; Meera P, 1996, FEBS LETT, V382, P84, DOI 10.1016/0014-5793(96)00151-2; Miftakhov RN, 1996, BIOL CYBERN, V74, P455, DOI 10.1007/BF00206712; Miftakhov RN, 1999, J THEOR BIOL, V197, P89, DOI 10.1006/jtbi.1998.0859; MITRA R, 1985, SCIENCE, V229, P269, DOI 10.1126/science.2409600; Poh YC, 2012, J THEOR BIOL, V293, P41, DOI 10.1016/j.jtbi.2011.09.014; Saito YA, 2008, AM J PHYSL GASTROINT; Sakmann B., 1995, SINGLE CHANNEL RECOR; Sanders KM, 2006, ANNU REV PHYSIOL, V68, P307, DOI 10.1146/annurev.physiol.68.040504.094718; SINGER JJ, 1987, PFLUG ARCH EUR J PHY, V408, P98, DOI 10.1007/BF00581337; SKINNER FK, 1993, BIOPHYS CHEM, V45, P253, DOI 10.1016/0301-4622(93)80007-6; SMITH TK, 1987, AM J PHYSIOL, V252, pC215, DOI 10.1152/ajpcell.1987.252.2.C215; Strege PR, 2010, AM J PHYSIOL-GASTR L, V298, pG706, DOI 10.1152/ajpgi.00437.2009; Strege PR, 2003, AM J PHYSIOL-CELL PH, V284, pC60, DOI 10.1152/ajpcell.00532.2001; ten Tusscher KHWJ, 2004, AM J PHYSIOL-HEART C, V286, pH1573, DOI 10.1152/ajpheart.00794.2003; WARD SM, 1994, J PHYSIOL-LONDON, V480, P91, DOI 10.1113/jphysiol.1994.sp020343; YOSHINO M, 1988, PFLUG ARCH EUR J PHY, V411, P229, DOI 10.1007/BF00582322; Youm JB, 2006, PHILOS T R SOC A, V364, P1135, DOI 10.1098/rsta.2006.1759	53	14	14	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 17	2012	7	8							e42385	10.1371/journal.pone.0042385	http://dx.doi.org/10.1371/journal.pone.0042385			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	996DG	22912702	Green Submitted, Green Published, gold			2022-12-25	WOS:000308063700014
J	Siudeja, K; Grzeschik, NA; Rana, A; de Jong, J; Sibon, OCM				Siudeja, Katarzyna; Grzeschik, Nicola A.; Rana, Anil; de Jong, Jannie; Sibon, Ody C. M.			Cofilin/Twinstar Phosphorylation Levels Increase in Response to Impaired Coenzyme A Metabolism	PLOS ONE			English	Article							ACTIVATED PROTEIN-KINASE; BETA-TUBULIN ISOTYPE; ACTIN DEPOLYMERIZING FACTOR; LIM-KINASE; COFILIN PHOSPHORYLATION; NEURITE OUTGROWTH; DROSOPHILA HOMOLOG; RETINOIC ACID; RHO GTPASES; FUEL GAUGE	Coenzyme A (CoA) is a pantothenic acid-derived metabolite essential for many fundamental cellular processes including energy, lipid and amino acid metabolism. Pantothenate kinase (PANK), which catalyses the first step in the conversion of pantothenic acid to CoA, has been associated with a rare neurodegenerative disorder PKAN. However, the consequences of impaired PANK activity are poorly understood. Here we use Drosophila and human neuronal cell cultures to show how PANK deficiency leads to abnormalities in F-actin organization. Cells with reduced PANK activity are characterized by abnormally high levels of phosphorylated cofilin, a conserved actin filament severing protein. The increased levels of phospho-cofilin coincide with morphological changes of PANK-deficient Drosophila S2 cells and human neuronal SHSY-5Y cells. The latter exhibit also markedly reduced ability to form neurites in culture - a process that is strongly dependent on actin remodeling. Our results reveal a novel and conserved link between a metabolic biosynthesis pathway, and regulation of cellular actin dynamics.	[Siudeja, Katarzyna; Grzeschik, Nicola A.; Rana, Anil; de Jong, Jannie; Sibon, Ody C. M.] Univ Groningen, Univ Med Ctr Groningen, Dept Cell Biol Radiat & Stress Cell Biol, Groningen, Netherlands	University of Groningen	Siudeja, K (corresponding author), Univ Groningen, Univ Med Ctr Groningen, Dept Cell Biol Radiat & Stress Cell Biol, Groningen, Netherlands.	o.c.m.sibon@umcg.nl		Siudeja, Katarzyna/0000-0002-2522-7776; Sibon, Ody/0000-0002-6836-6063	Dutch organization for scientific research (NWO)	Dutch organization for scientific research (NWO)(Netherlands Organization for Scientific Research (NWO))	Dutch organization for scientific research (NWO) funded the described work in a VICI Grant to Ody Sibon. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Afshar K, 2001, GENETICS, V157, P1267; Arber S, 1998, NATURE, V393, P805, DOI 10.1038/31729; Bellenchi GC, 2007, GENE DEV, V21, P2347, DOI 10.1101/gad.434307; Bernstein BW, 2010, TRENDS CELL BIOL, V20, P187, DOI 10.1016/j.tcb.2010.01.001; Blair A, 2006, DEVELOPMENT, V133, P1789, DOI 10.1242/dev.02320; Blume C, 2007, J BIOL CHEM, V282, P4601, DOI 10.1074/jbc.M608866200; Bosveld F, 2008, HUM MOL GENET, V17, P2058, DOI 10.1093/hmg/ddn105; Bosveld Floris, 2008, BMC Res Notes, V1, P75, DOI 10.1186/1756-0500-1-75; Carlier MF, 1997, J CELL BIOL, V136, P1307, DOI 10.1083/jcb.136.6.1307; Clemens JC, 2000, P NATL ACAD SCI USA, V97, P6499, DOI 10.1073/pnas.110149597; Da Silva JS, 2002, NAT REV NEUROSCI, V3, P694, DOI 10.1038/nrn918; Dillon C, 2005, ANNU REV NEUROSCI, V28, P25, DOI 10.1146/annurev.neuro.28.061604.135757; Encinas M, 2000, J NEUROCHEM, V75, P991, DOI 10.1046/j.1471-4159.2000.0750991.x; Endo M, 2003, J NEUROSCI, V23, P2527; Endo M, 2007, J BIOL CHEM, V282, P13692, DOI 10.1074/jbc.M610873200; Fanarraga ML, 1999, EUR J NEUROSCI, V11, P517; FERREIRA A, 1992, J NEUROSCI RES, V32, P516, DOI 10.1002/jnr.490320407; Frangiskakis JM, 1996, CELL, V86, P59, DOI 10.1016/S0092-8674(00)80077-X; Ghillebert R, 2011, FEBS J, V278, P3978, DOI 10.1111/j.1742-4658.2011.08315.x; GUNSALUS KC, 1995, J CELL BIOL, V131, P1243, DOI 10.1083/jcb.131.5.1243; Hall A, 1998, SCIENCE, V279, P509, DOI 10.1126/science.279.5350.509; Hardie DG, 1997, EUR J BIOCHEM, V246, P259, DOI 10.1111/j.1432-1033.1997.00259.x; Hearle N, 2006, CLIN CANCER RES, V12, P3209, DOI 10.1158/1078-0432.CCR-06-0083; Jones RG, 2005, MOL CELL, V18, P283, DOI 10.1016/j.molcel.2005.03.027; Jovceva E, 2007, J CELL SCI, V120, P1888, DOI 10.1242/jcs.004366; Kiger A A, 2003, J Biol, V2, P27, DOI 10.1186/1475-4924-2-27; Kuhn TB, 2000, J NEUROBIOL, V44, P126, DOI 10.1002/1097-4695(200008)44:2<126::AID-NEU4>3.0.CO;2-Z; Lappalainen P, 1997, NATURE, V388, P78, DOI 10.1038/40418; Lee JH, 2007, NATURE, V447, P1017, DOI 10.1038/nature05828; LEE MK, 1990, CELL MOTIL CYTOSKEL, V17, P118, DOI 10.1002/cm.970170207; Leonardi R, 2005, PROG LIPID RES, V44, P125, DOI 10.1016/j.plipres.2005.04.001; Matthews BB, 1999, DNA CELL BIOL, V18, P435, DOI 10.1089/104454999315150; Meberg PJ, 1998, CELL MOTIL CYTOSKEL, V39, P172, DOI 10.1002/(SICI)1097-0169(1998)39:2<172::AID-CM8>3.0.CO;2-8; Meng YH, 2002, NEURON, V35, P121, DOI 10.1016/S0896-6273(02)00758-4; Miranda L, 2010, BIOCHEM BIOPH RES CO, V396, P656, DOI 10.1016/j.bbrc.2010.04.151; Narumiya S, 1997, FEBS LETT, V410, P68, DOI 10.1016/S0014-5793(97)00317-7; Newey SE, 2005, J NEUROBIOL, V64, P58, DOI 10.1002/neu.20153; Niwa R, 2002, CELL, V108, P233, DOI 10.1016/S0092-8674(01)00638-9; Ohashi K, 2000, BIOCHEM BIOPH RES CO, V276, P1178, DOI 10.1006/bbrc.2000.3599; Pham H, 2008, DEV BIOL, V318, P82, DOI 10.1016/j.ydbio.2008.03.006; Rana A, 2010, P NATL ACAD SCI USA, V107, P6988, DOI 10.1073/pnas.0912105107; RIDLEY AJ, 1992, CELL, V70, P401, DOI 10.1016/0092-8674(92)90164-8; RIDLEY AJ, 1992, CELL, V70, P389, DOI 10.1016/0092-8674(92)90163-7; Rogers SL, 2003, J CELL BIOL, V162, P1079, DOI 10.1083/jcb.200303023; ROSSINO P, 1991, CELL REGUL, V2, P1021, DOI 10.1091/mbc.2.12.1021; Rosso S, 2004, MOL BIOL CELL, V15, P3433, DOI 10.1091/mbc.E03-05-0328; Rust MB, 2010, EMBO J, V29, P1889, DOI 10.1038/emboj.2010.72; SMITH CL, 1994, J NEUROSCI, V14, P384; SMITH CL, 1994, J CELL BIOL, V127, P1407, DOI 10.1083/jcb.127.5.1407; Wu ZH, 2009, HUM MOL GENET, V18, P3659, DOI 10.1093/hmg/ddp314; Xu XJ, 2010, BMC CELL BIOL, V11, DOI 10.1186/1471-2121-11-77; Yang N, 1998, NATURE, V393, P809, DOI 10.1038/31735; Zhang YM, 2007, CHEM BIOL, V14, P291, DOI 10.1016/j.chembiol.2007.01.013; Zhou B, 2001, NAT GENET, V28, P345, DOI 10.1038/ng572	54	11	11	2	27	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 17	2012	7	8							e43145	10.1371/journal.pone.0043145	http://dx.doi.org/10.1371/journal.pone.0043145			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	996DG	22912811	Green Submitted, Green Published, gold			2022-12-25	WOS:000308063700049
J	Zgheib, C; Kurdi, M; Zouein, FA; Gunter, BW; Stanley, BA; Zgheib, J; Romero, DG; King, SB; Paolocci, N; Booz, GW				Zgheib, Carlos; Kurdi, Mazen; Zouein, Fouad A.; Gunter, Barak W.; Stanley, Brian A.; Zgheib, Joe; Romero, Damian G.; King, S. Bruce; Paolocci, Nazareno; Booz, George W.			Acyloxy Nitroso Compounds Inhibit LIF Signaling in Endothelial Cells and Cardiac Myocytes: Evidence That STAT3 Signaling Is Redox-Sensitive	PLOS ONE			English	Article							MONOCYTE CHEMOATTRACTANT PROTEIN-1; MYOCARDIAL-INFARCTION; S-GLUTATHIONYLATION; OXIDATIVE STRESS; TRANSGENIC MICE; SULFENIC ACID; JAK-STAT; ACTIVATION; OVEREXPRESSION; INFLAMMATION	We previously showed that oxidative stress inhibits leukemia inhibitory factor (LIF) signaling by targeting JAK1, and the catalytic domains of JAK 1 and 2 have a cysteine-based redox switch. Thus, we postulated that the NO sibling and thiophylic compound, nitroxyl (HNO), would inhibit LIF-induced JAK-STAT3 activation. Pretreatment of human microvascular endothelial cells (HMEC-1) or neonatal rat cardiomyocytes with the HNO donors Angeli's salt or nitrosocyclohexyl acetate (NCA) inhibited LIF-induced STAT3 activation. NCA pretreatment also blocked the induction of downstream inflammatory genes (e. g. intercellular adhesion molecule 1, CCAAT/enhancer binding protein delta). The related 1-nitrosocyclohexyl pivalate (NCP; not a nitroxyl donor) was equally effective in inhibiting STAT3 activation, suggesting that these compounds act as thiolate targeting electrophiles. The JAK1 redox switch is likely not a target of acyloxy nitroso compounds, as NCA had no effect on JAK1 catalytic activity and only modestly affected JAK1-induced phosphorylation of the LIF receptor. However, pretreatment of recombinant human STAT3 with NCA or NCP reduced labeling of free sulfhydryl residues. We show that NCP in the presence of diamide enhanced STAT3 glutathionylation and dimerization in adult mouse cardiac myocytes and altered STAT3 under non-reducing conditions. Finally, we show that monomeric STAT3 levels are decreased in the G alpha q model of heart failure in a redox-sensitive manner. Altogether, our evidence indicates that STAT3 has redox-sensitive cysteines that regulate its activation and are targeted by HNO donors and acyloxy nitroso compounds. These findings raise the possibility of new therapeutic strategies to target STAT3 signaling via a redox-dependent manner, particularly in the context of cardiac and non-cardiac diseases with prominent pro-inflammatory signaling.	[Zgheib, Carlos; Zouein, Fouad A.; Gunter, Barak W.; Booz, George W.] Univ Mississippi, Med Ctr, Dept Pharmacol, Jackson, MS 39216 USA; [Zgheib, Carlos; Zouein, Fouad A.; Gunter, Barak W.; Booz, George W.] Univ Mississippi, Med Ctr, Dept Toxicol, Sch Med, Jackson, MS 39216 USA; [Zgheib, Carlos; Zouein, Fouad A.; Gunter, Barak W.; Romero, Damian G.; Booz, George W.] Univ Mississippi, Med Ctr, Ctr Excellence Cardiovasc Renal Res, Jackson, MS 39216 USA; [Kurdi, Mazen] Lebanese Univ, Dept Chem & Biochem, Fac Sci, Hadath, Lebanon; [Stanley, Brian A.; Paolocci, Nazareno] Johns Hopkins Med Inst, Div Cardiol, Baltimore, MD 21205 USA; [Zgheib, Joe] Ctr Hosp Univ Nancy, Div Cardiol, Dept Med, Brabois, France; [Romero, Damian G.] Univ Mississippi, Med Ctr, Dept Biochem, Sch Med, Jackson, MS 39216 USA; [King, S. Bruce] Wake Forest Univ, Dept Chem, Winston Salem, NC 27109 USA; [Paolocci, Nazareno] Univ Perugia, Dept Clin Med, Sect Gen Pathol, I-06100 Perugia, Italy	University of Mississippi; University of Mississippi Medical Center; University of Mississippi; University of Mississippi Medical Center; University of Mississippi; University of Mississippi Medical Center; Lebanese University; Johns Hopkins University; Johns Hopkins Medicine; CHU de Nancy; University of Mississippi; University of Mississippi Medical Center; Wake Forest University; University of Perugia	Zgheib, C (corresponding author), Univ Mississippi, Med Ctr, Dept Pharmacol, Jackson, MS 39216 USA.	gbooz@umc.edu	paolocci, nazareno/A-7124-2009	Paolocci, Nazareno/0000-0001-7011-997X; Zouein, Fouad/0000-0003-4451-804X	Lebanese University [MK-02-2011]; Lebanese National Council for Scientific Research (CNRS) [05-10-09]; COMSTECH-TWAS [09-122 RG/PHA/AF/AC_C]; National Heart, Lung, and Blood Institute [R01HL088101-05, R01HL62198, R01HL091923-01]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL062198, R01HL091923, R01HL088101] Funding Source: NIH RePORTER	Lebanese University; Lebanese National Council for Scientific Research (CNRS)(Centre National de la Recherche Scientifique (CNRS)); COMSTECH-TWAS; National Heart, Lung, and Blood Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported by grants to MK from The Lebanese University (MK-02-2011), The Lebanese National Council for Scientific Research (CNRS; 05-10-09), and The COMSTECH-TWAS (09-122 RG/PHA/AF/AC_C); and grants from the National Heart, Lung, and Blood Institute to GWB (R01HL088101-05), SBK (R01HL62198), and NP (R01HL091923-01). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alturkmani HJ, 2012, J INORG BIO IN PRESS; Arany I, 2012, AM J PHYSIOL-RENAL, V302, pF722, DOI 10.1152/ajprenal.00338.2011; Boengler K, 2008, PHARMACOL THERAPEUT, V120, P172, DOI 10.1016/j.pharmthera.2008.08.002; Booz GW, 2003, BASIC RES CARDIOL, V98, P33, DOI 10.1007/s00395-003-0387-x; Brown DA, 2010, J MOL CELL CARDIOL, V48, P673, DOI 10.1016/j.yjmcc.2009.11.011; Butturini E, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020174; Claycomb WC, 1998, P NATL ACAD SCI USA, V95, P2979, DOI 10.1073/pnas.95.6.2979; Dalle-Donne I, 2009, TRENDS BIOCHEM SCI, V34, P85, DOI 10.1016/j.tibs.2008.11.002; DAngelo DD, 1997, P NATL ACAD SCI USA, V94, P8121, DOI 10.1073/pnas.94.15.8121; Fischer P, 2007, BASIC RES CARDIOL, V102, P393, DOI 10.1007/s00395-007-0674-z; Fritzenwanger M, 2006, CYTOKINE, V33, P46, DOI 10.1016/j.cyto.2005.11.016; Froehlich JP, 2008, BIOCHEMISTRY-US, V47, P13150, DOI 10.1021/bi801925p; Fujio Y, 2011, J PHARMACOL SCI, V117, P213, DOI 10.1254/jphs.11R05CR; Haghikia A, 2011, HEART FAIL REV, V16, P35, DOI 10.1007/s10741-010-9170-x; Hong HY, 2000, ELECTROPHORESIS, V21, P841, DOI 10.1002/(SICI)1522-2683(20000301)21:5<841::AID-ELPS841>3.3.CO;2-W; Kim YS, 2007, J CARDIOVASC PHARM, V50, P41, DOI 10.1097/FJC.0b013e31805559b9; Krishnamurthy P, 2009, CIRC RES, V104, pE9, DOI 10.1161/CIRCRESAHA.108.188243; Kurdi M, 2007, J CARDIOVASC PHARM, V50, P126, DOI 10.1097/FJC.0b013e318068dd49; Kurdi M, 2007, J CELL PHYSIOL, V212, P424, DOI 10.1002/jcp.21033; Kurdi M, 2009, AM J PHYSIOL-HEART C, V297, pH1545, DOI 10.1152/ajpheart.00032.2009; Li L, 2004, BIOCHEM BIOPH RES CO, V322, P1005, DOI 10.1016/j.bbrc.2004.08.014; Li L, 2010, CANCER RES, V70, P8222, DOI 10.1158/0008-5472.CAN-10-0894; Liu YC, 2007, LIFE SCI, V80, P1420, DOI 10.1016/j.lfs.2006.12.040; Miranda KM, 2005, J AM CHEM SOC, V127, P722, DOI 10.1021/ja045480z; Morimoto H, 2006, CIRC RES, V99, P891, DOI 10.1161/01.RES.0000246113.82111.2d; Paolocci N, 2003, P NATL ACAD SCI USA, V100, P5537, DOI 10.1073/pnas.0937302100; Paolocci N, 2001, P NATL ACAD SCI USA, V98, P10463, DOI 10.1073/pnas.181191198; Poole LB, 2004, ANNU REV PHARMACOL, V44, P325, DOI 10.1146/annurev.pharmtox.44.101802.121735; Qin FZ, 2010, CIRC-HEART FAIL, V3, P306, DOI 10.1161/CIRCHEARTFAILURE.109.864785; Rajasingh J, 2006, EXP CELL RES, V312, P2538, DOI 10.1016/j.yexcr.2006.04.010; Rehder DS, 2010, BIOCHEMISTRY-US, V49, P7748, DOI 10.1021/bi1008694; Seo YH, 2009, P NATL ACAD SCI USA, V106, P16163, DOI 10.1073/pnas.0903015106; Shoman ME, 2011, J MED CHEM, V54, P1059, DOI 10.1021/jm101432z; Silver JS, 2010, J LEUKOCYTE BIOL, V88, P1145, DOI 10.1189/jlb.0410217; Smith JK, 2012, FREE RADIC BIOL MED; Szczepanek K, 2012, MITOCHONDRION, V12, P180, DOI 10.1016/j.mito.2011.08.011; Taflin C, 2011, P NATL ACAD SCI USA, V108, P2891, DOI 10.1073/pnas.1011811108; Tocchetti CG, 2011, ANTIOXID REDOX SIGN, V14, P1687, DOI 10.1089/ars.2010.3859; Wang MJ, 2007, AM J PHYSIOL-HEART C, V293, pH2101, DOI 10.1152/ajpheart.00125.2007; Wang M, 2007, AM J PHYSIOL-ENDOC M, V293, pE872, DOI 10.1152/ajpendo.00251.2007; White SM, 2004, AM J PHYSIOL-HEART C, V286, pH823, DOI 10.1152/ajpheart.00986.2003; Wung BS, 2006, LIFE SCI, V78, P3035, DOI 10.1016/j.lfs.2005.12.013; Xie Y, 2009, ENDOCRINOLOGY, V150, P1122, DOI 10.1210/en.2008-1241; Zgheib C, 2012, J INTERF CYTOK RES, V32, P87, DOI 10.1089/jir.2011.0059	44	32	32	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 15	2012	7	8							e43313	10.1371/journal.pone.0043313	http://dx.doi.org/10.1371/journal.pone.0043313			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	993AG	22905257	Green Published, Green Submitted, gold			2022-12-25	WOS:000307823600068
J	Moffitt, KL; Malley, R; Lu, YJ				Moffitt, Kristin L.; Malley, Richard; Lu, Ying-Jie			Identification of Protective Pneumococcal T(H)17 Antigens from the Soluble Fraction of a Killed Whole Cell Vaccine	PLOS ONE			English	Article							STREPTOCOCCUS-PNEUMONIAE; INTRANASAL IMMUNIZATION; COLONIZATION; PROTEIN; DISEASE; IMMUNITY; SURFACE	Mucosal or parenteral immunization with a killed unencapsulated pneumococcal whole cell antigen (WCA) with an adjuvant protects mice from colonization by a T(H)17 CD4+ cell-mediated mechanism. Using preparative SDS gels, we separated the soluble proteins that compose the WCA in order to identify fractions that were immunogenic and protective. We screened these fractions for their ability to stimulate IL-17A secretion from splenocytes obtained from mice immunized with WCA and adjuvant. We identified 12 proteins within the stimulatory fractions by mass spectrometry; these proteins were then cloned, recombinantly expressed and purified using an Escherichia coli expression system. The ability of these proteins to induce IL-17A secretion was then evaluated by stimulation of mouse splenocytes. Of the four most stimulatory proteins, three were protective in a mouse pneumococcal serotype 6B colonization model. This work thus describes a method for identifying immunogenic proteins from the soluble fraction of pneumococcus and shows that several of the proteins identified protect mice from colonization when used as mucosal vaccines. We propose that, by providing protection against pneumococcal colonization, one or more of these proteins may serve as components of a multivalent pneumococcal vaccine.	[Moffitt, Kristin L.; Malley, Richard; Lu, Ying-Jie] Harvard Univ, Sch Med, Boston Childrens Hosp, Div Infect Dis, Boston, MA 02115 USA	Harvard University; Boston Children's Hospital; Harvard Medical School	Moffitt, KL (corresponding author), Harvard Univ, Sch Med, Boston Childrens Hosp, Div Infect Dis, Boston, MA 02115 USA.	kristin.moffitt@childrens.harvard.edu		Moffitt, Kristin/0000-0003-4581-7199	Pediatric Infectious Diseases Society; National Institutes of Health/National Institute of Allergy and Infectious Diseases (NIH/NIAID) [1K08AI095352-01]; Bill & Melinda Gates Foundation through the Grand Challenge Explorations program; Children's Hospital Technology Development grant; Translational Research Program at Children's Hospital Boston; NIH [R01 AI067737]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [K08AI095352, R01AI067737] Funding Source: NIH RePORTER	Pediatric Infectious Diseases Society; National Institutes of Health/National Institute of Allergy and Infectious Diseases (NIH/NIAID)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); Bill & Melinda Gates Foundation through the Grand Challenge Explorations program; Children's Hospital Technology Development grant; Translational Research Program at Children's Hospital Boston; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	KLM acknowledges support from a fellowship award from the Pediatric Infectious Diseases Society and from National Institutes of Health/National Institute of Allergy and Infectious Diseases (NIH/NIAID) grant 1K08AI095352-01. This work was supported by the Bill & Melinda Gates Foundation through the Grand Challenge Explorations program and Children's Hospital Technology Development grant (to YJL and RM). RM acknowledges support from the Translational Research Program at Children's Hospital Boston and NIH grant R01 AI067737. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ANDERSEN P, 1992, SCAND J IMMUNOL, V36, P823, DOI 10.1111/j.1365-3083.1992.tb03144.x; Basset A, 2007, INFECT IMMUN, V75, P5460, DOI 10.1128/IAI.00773-07; Centers for Disease Control and Prevention (CDC), 2005, MMWR Morb Mortal Wkly Rep, V54, P893; Giefing C, 2008, J EXP MED, V205, P117, DOI 10.1084/jem.20071168; Green BA, 2005, INFECT IMMUN, V73, P981, DOI 10.1128/IAI.73.2.981-989.2005; Hsu KK, 2010, PEDIATR INFECT DIS J, V29, P289, DOI 10.1097/INF.0b013e3181c15471; Isaacman DJ, 2010, INT J INFECT DIS, V14, pE197, DOI 10.1016/j.ijid.2009.05.010; Ling E, 2004, CLIN EXP IMMUNOL, V138, P290, DOI 10.1111/j.1365-2249.2004.02628.x; Lu YJ, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.1000159; Lu YJ, 2012, VACCINE, V30, P3405, DOI 10.1016/j.vaccine.2012.03.039; Lu YJ, 2010, VACCINE, V28, P7468, DOI 10.1016/j.vaccine.2010.09.031; Lu YJ, 2010, CLIN VACCINE IMMUNOL, V17, P1005, DOI 10.1128/CVI.00036-10; Lu YJ, 2009, INFECT IMMUN, V77, P2076, DOI 10.1128/IAI.01554-08; Malley R, 2005, P NATL ACAD SCI USA, V102, P4848, DOI 10.1073/pnas.0501254102; Malley R, 2001, INFECT IMMUN, V69, P4870, DOI 10.1128/IAI.69.8.4870-4873.2001; Medina M, 2008, INFECT IMMUN, V76, P2696, DOI 10.1128/IAI.00119-08; Moffitt KL, VACCINE IN PRESS; Moffitt KL, 2011, CURR OPIN IMMUNOL, V23, P407, DOI 10.1016/j.coi.2011.04.002; Moffitt KL, 2011, CELL HOST MICROBE, V9, P158, DOI 10.1016/j.chom.2011.01.007; O'Brien KL, 2009, LANCET, V374, P893, DOI 10.1016/S0140-6736(09)61204-6; Weinberger DM, 2011, LANCET, V378, P1962, DOI 10.1016/S0140-6736(10)62225-8; Wizemann TM, 2001, INFECT IMMUN, V69, P1593, DOI 10.1128/IAI.69.3.1593-1598.2001	22	33	35	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 14	2012	7	8							e43445	10.1371/journal.pone.0043445	http://dx.doi.org/10.1371/journal.pone.0043445			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	988OQ	22905267	Green Published, Green Submitted, gold			2022-12-25	WOS:000307500800083
J	Presicce, P; Moreno-Fernandez, ME; Rusie, LK; Fichtenbaum, C; Chougnet, CA				Presicce, Pietro; Moreno-Fernandez, Maria E.; Rusie, Laura K.; Fichtenbaum, Carl; Chougnet, Claire A.			In Vitro HIV Infection Impairs the Capacity of Myeloid Dendritic Cells to Induce Regulatory T Cells	PLOS ONE			English	Article							HUMAN-IMMUNODEFICIENCY-VIRUS; PERIPHERAL-BLOOD; TYPE-1; IMMATURE; EXPRESSION; FREQUENCY; ACCUMULATION; REPLICATION; SUPPRESSION; ACTIVATION	Myeloid dendritic cells (mDCs) are the antigen-presenting cells best capable of promoting peripheral induction of regulatory T cells (Tregs), and are among the first targets of HIV. It is thus important to understand whether HIV alters their capacity to promote Treg conversion. Monocyte-derived DCs (moDCs) from uninfected donors induced a Treg phenotype (CD25(+)FOXP3(+)) in autologous conventional T cells. These converted FOXP3(+) cells suppressed the proliferation of responder T cells similarly to circulating Tregs. In contrast, the capacity of moDCs to induce CD25 or FOXP3 was severely impaired by their in vitro infection with CCR5-utilizing virus. MoDC exposure to inactivated HIV was sufficient to impair FOXP3 induction. This DC defect was not dependent on IL-10, TGF-beta or other soluble factors, but was due to preferential killing of Tregs by HIV-exposed/ infected moDCs, through a caspase-dependent pathway. Importantly, similar results were obtained with circulating primary myeloid DCs. Upon infection in vitro, these mDCs also killed Treg through mechanisms at least partially caspase-dependent, leading to a significantly lower proportion of induced Tregs. Taken together, our data suggest that Treg induction may be defective when DCs are exposed to high levels of virus, such as during the acute phase of infection or in AIDS patients.	[Presicce, Pietro; Moreno-Fernandez, Maria E.; Rusie, Laura K.; Chougnet, Claire A.] Univ Cincinnati, Coll Med, Div Cellular & Mol Immunol, Cincinnati Childrens Hosp,Res Fdn, Cincinnati, OH 45221 USA; [Presicce, Pietro; Moreno-Fernandez, Maria E.; Rusie, Laura K.; Chougnet, Claire A.] Univ Cincinnati, Coll Med, Dept Pediat, Cincinnati, OH USA; [Fichtenbaum, Carl] Univ Cincinnati, Coll Med, Ctr Infect Dis, Cincinnati, OH USA	Cincinnati Children's Hospital Medical Center; Cincinnati Children's Hospital Research Foundation; University System of Ohio; University of Cincinnati; University System of Ohio; University of Cincinnati; University System of Ohio; University of Cincinnati	Presicce, P (corresponding author), Univ Cincinnati, Coll Med, Div Cellular & Mol Immunol, Cincinnati Childrens Hosp,Res Fdn, Cincinnati, OH 45221 USA.	claire.chougnet@cchmc.org	Presicce, Pietro/AAN-8719-2020	Presicce, Pietro/0000-0002-2690-1814; Fichtenbaum, Carl/0000-0002-6778-7253	Public Health Service [R01 AI068524]; University of Cincinnati Postdoctoral Fellow Research Grant; Center for Excellence in Molecular Hematology [1P30DK090971-01]; Digestive Health Center [AR47363]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI068524] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [P30AR047363] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P30DK090971] Funding Source: NIH RePORTER	Public Health Service(United States Department of Health & Human ServicesUnited States Public Health Service); University of Cincinnati Postdoctoral Fellow Research Grant; Center for Excellence in Molecular Hematology; Digestive Health Center; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported by Public Health Service Grant R01 AI068524 (to CAC) and University of Cincinnati Postdoctoral Fellow Research Grant 2010 (to PP). The authors acknowledge the support provided in part by the Center for Excellence in Molecular Hematology Grant 1P30DK090971-01 and Digestive Health Center Grant AR47363. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aandahl EM, 2004, J VIROL, V78, P2454, DOI 10.1128/JVI.78.5.2454-2459.2004; Baatar D, 2007, J IMMUNOL, V178, P4891, DOI 10.4049/jimmunol.178.8.4891; Bacchetta R, 2010, HAEMATOL-HEMATOL J, V95, P2134, DOI 10.3324/haematol.2010.025825; Bandera A, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010788; Banerjee DK, 2006, BLOOD, V108, P2655, DOI 10.1182/blood-2006-03-011353; Boasso A, 2007, BLOOD, V109, P3351, DOI 10.1182/blood-2006-07-034785; Brussel A, 2003, J VIROL, V77, P10119, DOI 10.1128/JVI.77.18.10119-10124.2003; Chase AJ, 2007, J VIROL, V81, P12748, DOI 10.1128/JVI.00841-07; Chen WJ, 2003, J EXP MED, V198, P1875, DOI 10.1084/jem.20030152; Chung DJ, 2009, BLOOD, V114, P555, DOI 10.1182/blood-2008-11-191197; Coates PTH, 2003, BLOOD, V102, P2513, DOI 10.1182/blood-2002-09-2929; de Lafaille MAC, 2004, J IMMUNOL, V173, P7259, DOI 10.4049/jimmunol.173.12.7259; de Lafaille MAC, 2009, IMMUNITY, V30, P626, DOI 10.1016/j.immuni.2009.05.002; Dhodapkar MV, 2001, J EXP MED, V193, P233, DOI 10.1084/jem.193.2.233; Donaghy H, 2003, BLOOD, V101, P4505, DOI 10.1182/blood-2002-10-3189; Epple HJ, 2006, BLOOD, V108, P3072, DOI 10.1182/blood-2006-04-016923; Fazekas de St Groth B, 2008, AIDS, V22, P671, DOI 10.1097/QAD.0b013e3282f466da; Friedline RH, 2009, J EXP MED, V206, P421, DOI 10.1084/jem.20081811; Gavin MA, 2006, P NATL ACAD SCI USA, V103, P6659, DOI 10.1073/pnas.0509484103; Goujon C, 2006, GENE THER, V13, P991, DOI 10.1038/sj.gt.3302753; Granelli-Piperno A, 1998, J VIROL, V72, P2733, DOI 10.1128/JVI.72.4.2733-2737.1998; Granelli-Piperno A, 2004, P NATL ACAD SCI USA, V101, P7669, DOI 10.1073/pnas.0402431101; Hardy AW, 2007, P NATL ACAD SCI USA, V104, P17453, DOI 10.1073/pnas.0707244104; Herbeuval JP, 2005, BLOOD, V106, P3524, DOI 10.1182/blood-2005-03-1243; Huang JH, 2012, RETROVIROLOGY, V9, DOI 10.1186/1742-4690-9-11; Izquierdo-Useros N, 2007, J VIROL, V81, P7559, DOI 10.1128/JVI.02572-06; Jonuleit H, 2000, J EXP MED, V192, P1213, DOI 10.1084/jem.192.9.1213; Kim BS, 2010, P NATL ACAD SCI USA, V107, P8742, DOI 10.1073/pnas.0911756107; KIMPTON J, 1992, J VIROL, V66, P2232, DOI 10.1128/JVI.66.4.2232-2239.1992; Kinter A, 2007, P NATL ACAD SCI USA, V104, P3390, DOI 10.1073/pnas.0611423104; Laguette N, 2011, NATURE, V474, P654, DOI 10.1038/nature10117; Lichtner M, 2004, AIDS RES HUM RETROV, V20, P175, DOI 10.1089/088922204773004897; Liu JU, 2009, J IMMUNOL, V182, P3855, DOI 10.4049/jimmunol.0803330; Lohr J, 2003, NAT IMMUNOL, V4, P664, DOI 10.1038/ni939; LORE K, 2002, 17 INT AIDS C MEX CI, V16, P683; Mahnke K, 2003, BLOOD, V101, P4862, DOI 10.1182/blood-2002-10-3229; Maloy KJ, 2003, J EXP MED, V197, P111, DOI 10.1084/jem.20021345; Manches O, 2008, J CLIN INVEST, V118, P3431, DOI 10.1172/JCI34823; MCILROY D, 1995, J VIROL, V69, P4737, DOI 10.1128/JVI.69.8.4737-4745.1995; Moreno-Fernandez ME, 2011, BLOOD, V117, P5372, DOI 10.1182/blood-2010-12-323162; Nikolova M, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002110; Nilsson J, 2006, BLOOD, V108, P3808, DOI 10.1182/blood-2006-05-021576; Patterson S, 2005, J IMMUNOL, V174, P8200, DOI 10.4049/jimmunol.174.12.8200; Piguet V, 2007, TRENDS IMMUNOL, V28, P503, DOI 10.1016/j.it.2007.07.010; Presicce P, 2011, 17 INT AIDS C MEX CI; Presicce P, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0028118; Rossio JL, 1998, J VIROL, V72, P7992, DOI 10.1128/JVI.72.10.7992-8001.1998; Sakaguchi S, 2001, IMMUNOL REV, V182, P18, DOI 10.1034/j.1600-065X.2001.1820102.x; Shaw JM, 2011, J VIROL, V85, P11422, DOI 10.1128/JVI.05608-11; Smed-Sorensen A, 2004, BLOOD, V104, P2810, DOI 10.1182/blood-2003-07-2314; Smed-Sorensen A, 2005, J VIROL, V79, P8861, DOI 10.1128/JVI.79.14.8861-8869.2005; Sugita S, 2011, INVEST OPHTH VIS SCI, V52, P2598, DOI 10.1167/iovs.10-6322; Verhasselt V, 2004, EUR J IMMUNOL, V34, P762, DOI 10.1002/eji.200324552; Vukmanovic-Stejic M, 2008, J CLIN INVEST, V118, P3639, DOI 10.1172/JCI35834; Vukmanovic-Stejic M, 2006, J CLIN INVEST, V116, P2423, DOI 10.1172/JCI28941; Wang J, 2009, J IMMUNOL, V183, P4119, DOI 10.4049/jimmunol.0901065; Wang L, 2008, P NATL ACAD SCI USA, V105, P9331, DOI 10.1073/pnas.0710441105; Wang R, 2009, P NATL ACAD SCI USA, V106, P13439, DOI 10.1073/pnas.0901965106; Wing K, 2008, SCIENCE, V322, P271, DOI 10.1126/science.1160062; zur Wiesch JS, 2011, J VIROL, V85, P1287, DOI 10.1128/JVI.01758-10	60	8	9	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 13	2012	7	8							e42802	10.1371/journal.pone.0042802	http://dx.doi.org/10.1371/journal.pone.0042802			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	988OJ	22912740	gold, Green Published, Green Submitted			2022-12-25	WOS:000307500100032
J	Gupta, S; Singh, R				Gupta, Saurabh; Singh, Raghvendra			Analysis of the Virus Dynamics Model Reveals That Early Treatment of HCV Infection May Lead to the Sustained Virological Response	PLOS ONE			English	Article							HEPATITIS-C-VIRUS; INTERFERON-ALPHA THERAPY; VIRAL DYNAMICS; HEPATOCELLULAR-CARCINOMA; RIBAVIRIN THERAPY; INITIAL TREATMENT; PLUS RIBAVIRIN; DRUG EFFICACY; IN-VIVO; CLEARANCE	Considerable progress has been made towards understanding hepatitis C virus, its pathogenesis and the effect of the drug therapy on the viral load, yet around 50% of patients do not achieve the sustained virological response (SVR) by the standard treatment. Although several personalized factors such as patients' age and weight may be important, by mathematical modeling we show that the time of the start of the therapy is a significant factor in determining the outcome. Toward this end, we first performed sensitivity analysis on the standard virus dynamics model. The analysis revealed four phases when the sensitivity of the infection to drug treatment differs. Further, we added a perturbation term in the model to simulate the drug treatment period and predict the outcome when the therapy is carried out during each of the four phases. The study shows that while the infection may be difficult to treat in the late phases, the therapy is likely to result in SVR if it is carried out in the first or second phase. Thus, development of newer and more sensitive screening methods is needed for the early detection of the infection. Moreover, the analysis predicts that the drug that blocks new infections is more effective than the drug that blocks the virus production.	[Gupta, Saurabh; Singh, Raghvendra] Indian Inst Technol, Dept Chem Engn, Kanpur 208016, Uttar Pradesh, India	Indian Institute of Technology System (IIT System); Indian Institute of Technology (IIT) - Kanpur	Gupta, S (corresponding author), Indian Inst Technol, Dept Chem Engn, Kanpur 208016, Uttar Pradesh, India.	raghvend@iitk.ac.in			Indian Institute of Technology Kanpur [IITK/CHE/20090282]	Indian Institute of Technology Kanpur	This work was supported by the Indian Institute of Technology Kanpur grant IITK/CHE/20090282 to RS. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alberti A, 1997, HEPATOLOGY, V26, pS137, DOI 10.1002/hep.510260724; Armstrong GL, 2006, ANN INTERN MED, V144, P705, DOI 10.7326/0003-4819-144-10-200605160-00004; BALLARDINI G, 1995, J CLIN INVEST, V95, P2067, DOI 10.1172/JCI117893; Bekkering F C, 2001, BMC Gastroenterol, V1, P14, DOI 10.1186/1471-230X-1-14; Bekkering FC, 2001, HEPATOLOGY, V33, P419, DOI 10.1053/jhep.2001.21552; Bonhoeffer S, 1997, P NATL ACAD SCI USA, V94, P6971, DOI 10.1073/pnas.94.13.6971; Chang M, 2003, AM J PATHOL, V163, P433, DOI 10.1016/S0002-9440(10)63673-5; Dahari H, 2007, J THEOR BIOL, V247, P371, DOI 10.1016/j.jtbi.2007.03.006; Dahari H, 2007, HEPATOLOGY, V46, P16, DOI 10.1002/hep.21657; Delang L, 2011, ANTIMICROB AGENTS CH, V55, P4103, DOI 10.1128/AAC.00294-11; Di Bisceglie AM, 1998, LANCET, V351, P351, DOI 10.1016/S0140-6736(97)07361-3; Dixit NM, 2004, ANTIVIR THER, V9, P237; Dixit NM, 2004, NATURE, V432, P922, DOI 10.1038/nature03153; Feld JJ, 2005, NATURE, V436, P967, DOI 10.1038/nature04082; Gao M, 2010, NATURE, V465, P96, DOI 10.1038/nature08960; Gerlach JT, 2003, GASTROENTEROLOGY, V125, P80, DOI 10.1016/S0016-5085(03)00668-1; Guedj J, 2010, J THEOR BIOL, V267, P330, DOI 10.1016/j.jtbi.2010.08.036; Herrmann E, 2003, HEPATOLOGY, V37, P1351, DOI 10.1053/jhep.2003.50218; Hezode C, 2009, NEW ENGL J MED, V360, P1839, DOI 10.1056/NEJMoa0807650; HO DD, 1995, NATURE, V373, P123, DOI 10.1038/373123a0; Kamal SM, 2006, GASTROENTEROLOGY, V130, P632, DOI 10.1053/j.gastro.2006.01.034; Lam NP, 1997, DIGEST DIS SCI, V42, P178, DOI 10.1023/A:1018865928308; Lam NP, 1997, HEPATOLOGY, V26, P226; Lauer GM, 2001, NEW ENGL J MED, V345, P41, DOI 10.1056/NEJM200107053450107; Licata A, 2003, J HEPATOL, V39, P1056, DOI 10.1016/S0168-8278(03)00461-6; Lopez-Labrador FX, 1999, HEPATOLOGY, V29, P897, DOI 10.1002/hep.510290306; Manns MP, 2001, LANCET, V358, P958, DOI 10.1016/S0140-6736(01)06102-5; MARTINOTPEIGNOUX M, 1995, HEPATOLOGY, V22, P1050, DOI 10.1016/0270-9139(95)90608-8; Matthews GV, 2009, CLIN INFECT DIS, V48, P650, DOI 10.1086/596770; McCown MF, 2008, ANTIMICROB AGENTS CH, V52, P1604, DOI 10.1128/AAC.01317-07; McHutchison JG, 1998, NEW ENGL J MED, V339, P1485, DOI 10.1056/NEJM199811193392101; McHutchison JG, 2010, NEW ENGL J MED, V362, P1292, DOI 10.1056/NEJMoa0908014; Moriya K, 1998, NAT MED, V4, P1065, DOI 10.1038/2053; Neumann AU, 2000, J INFECT DIS, V182, P28, DOI 10.1086/315661; Neumann AU, 1998, SCIENCE, V282, P103, DOI 10.1126/science.282.5386.103; Nowak MA, 1996, P NATL ACAD SCI USA, V93, P4398, DOI 10.1073/pnas.93.9.4398; Perelson AS, 1996, SCIENCE, V271, P1582, DOI 10.1126/science.271.5255.1582; Perelson AS, 1997, NATURE, V387, P188, DOI 10.1038/387188a0; Poynard T, 2000, HEPATOLOGY, V32, P1131, DOI 10.1053/jhep.2000.19347; Reluga TC, 2009, SIAM J APPL MATH, V69, P999, DOI 10.1137/080714579; SAITO I, 1990, P NATL ACAD SCI USA, V87, P6547, DOI 10.1073/pnas.87.17.6547; Santantonio T, 2005, J HEPATOL, V42, P329, DOI 10.1016/j.jhep.2004.11.021; Sentjens RE, 2002, EUR J GASTROEN HEPAT, V14, P833, DOI 10.1097/00042737-200208000-00004; Shiffman ML, 2004, GASTROENTEROLOGY, V126, P1015, DOI 10.1053/j.gastro.2004.01.014; Shiffman ML, 2004, GASTROENTEROLOGY, V126, P1947; Shirakawa H, 2008, HEPATOLOGY, V48, P1753, DOI 10.1002/hep.22543; Shiratori Y, 2000, ANN INTERN MED, V132, P517, DOI 10.7326/0003-4819-132-7-200004040-00002; Stafford MA, 2000, J THEOR BIOL, V203, P285, DOI 10.1006/jtbi.2000.1076; WEI XP, 1995, NATURE, V373, P117, DOI 10.1038/373117a0	49	5	5	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 24	2012	7	7							e41209	10.1371/journal.pone.0041209	http://dx.doi.org/10.1371/journal.pone.0041209			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	978NX	22911761	Green Published, gold, Green Submitted			2022-12-25	WOS:000306751300027
J	Yang, LL; Serada, S; Fujimoto, M; Terao, M; Kotobuki, Y; Kitaba, S; Matsui, S; Kudo, A; Naka, T; Murota, H; Katayama, I				Yang, Lingli; Serada, Satoshi; Fujimoto, Minoru; Terao, Mika; Kotobuki, Yorihisa; Kitaba, Shun; Matsui, Saki; Kudo, Akira; Naka, Tetsuji; Murota, Hiroyuki; Katayama, Ichiro			Periostin Facilitates Skin Sclerosis via PI3K/Akt Dependent Mechanism in a Mouse Model of Scleroderma	PLOS ONE			English	Article							GROWTH-FACTOR-BETA; MYOFIBROBLAST DIFFERENTIATION; MYOCARDIAL-INFARCTION; ANIMAL-MODEL; NULL MICE; FIBROSIS; FIBROBLASTS; EXPRESSION; PROTEIN; REPAIR	Objective: Periostin, a novel matricellular protein, is recently reported to play a crucial role in tissue remodeling and is highly expressed under fibrotic conditions. This study was undertaken to assess the role of periostin in scleroderma. Methods: Using skin from patients and healthy donors, the expression of periostin was assessed by immunohistochemistry and immunoblotting analyses. Furthermore, we investigated periostin (-/-) (PN-/-) and wild-type (WT) mice to elucidate the role of periostin in scleroderma. To induce murine cutaneous sclerosis, mice were subcutaneously injected with bleomycin, while untreated control groups were injected with phosphate-buffered saline. Bleomycin-induced fibrotic changes were compared in PN-/- and WT mice by histological analysis as well as by measurements of profibrotic cytokine and extracellular matrix protein expression levels in vivo and in vitro. To determine the downstream pathway involved in periostin signaling, receptor neutralizing antibody and signal transduction inhibitors were used in vitro. Results: Elevated expression of periostin was observed in the lesional skin of patients with scleroderma compared with healthy donors. Although WT mice showed marked cutaneous sclerosis with increased expression of periostin and increased numbers of myofibroblasts after bleomycin treatment, PN-/- mice showed resistance to these changes. In vitro, dermal fibroblasts from PN-/- mice showed reduced transcript expression of alpha smooth actin and procollagen type-I alpha 1 (Col1 alpha 1) induced by transforming growth factor beta 1 (TGF beta 1). Furthermore, recombinant mouse periostin directly induced Col1 alpha 1 expression in vitro, and this effect was inhibited by blocking the alpha v integrin-mediated PI3K/Akt signaling either with anti-alpha v functional blocking antibody or with the PI3K/Akt kinase inhibitor LY294002. Conclusion: Periostin plays an essential role in the pathogenesis of Bleomycin-induced scleroderma in mice. Periostin may represent a potential therapeutic target for human scleroderma.	[Yang, Lingli; Terao, Mika; Kotobuki, Yorihisa; Kitaba, Shun; Matsui, Saki; Murota, Hiroyuki; Katayama, Ichiro] Osaka Univ, Grad Sch Med, Dept Dermatol, Osaka, Japan; [Yang, Lingli; Serada, Satoshi; Fujimoto, Minoru; Kotobuki, Yorihisa; Naka, Tetsuji] Natl Inst Biomed Innovat, Lab Immune Signal, Osaka, Japan; [Kudo, Akira] Tokyo Inst Technol, Dept Biol Informat, Yokohama, Kanagawa 227, Japan	Osaka University; National Institute of Health Sciences - Japan; Tokyo Institute of Technology	Yang, LL (corresponding author), Osaka Univ, Grad Sch Med, Dept Dermatol, Osaka, Japan.	h-murota@derma.med.osaka-u.ac.jp	Kudo, Akira/C-7340-2015	Kudo, Akira/0000-0001-6289-3391; yi lang, pian shan/0000-0002-3270-1085; Naka, Tetsuji/0000-0002-1269-3997; Serada, Satoshi/0000-0001-6948-9009; Kotobuki, Yorihisa/0000-0002-6519-5000; FUJIMOTO, MINORU/0000-0002-6390-8863	Ministry of Health, Labour and Welfare of Japan; Grants-in-Aid for Scientific Research [22591101] Funding Source: KAKEN	Ministry of Health, Labour and Welfare of Japan(Ministry of Health, Labour and Welfare, Japan); Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This study was supported by a grant-in-aid for the Program for Promotion of Fundamental Studies in Health Sciences of the National Institute of Biomedical Innovation and Grant-in-Aid from the Ministry of Health, Labour and Welfare of Japan. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Baril P, 2007, ONCOGENE, V26, P2082, DOI 10.1038/sj.onc.1210009; BORDER WA, 1994, NEW ENGL J MED, V331, P1286; Chen CC, 2009, INT J BIOCHEM CELL B, V41, P771, DOI 10.1016/j.biocel.2008.07.025; DESMOULIERE A, 1993, J CELL BIOL, V122, P103, DOI 10.1083/jcb.122.1.103; Dorn GW, 2007, NEW ENGL J MED, V357, P1552, DOI 10.1056/NEJMcibr074816; Elliott CG, 2012, J CELL SCI, V125, P121, DOI 10.1242/jcs.087841; Gabrielli A, 2009, NEW ENGL J MED, V360, P1989, DOI 10.1056/NEJMra0806188; Gillan L, 2002, CANCER RES, V62, P5358; Gordon ED, 2012, CLIN EXP ALLERGY, V42, P144, DOI 10.1111/j.1365-2222.2011.03840.x; Hamilton DW, 2008, J CELL COMMUN SIGNAL, V2, P9, DOI 10.1007/s12079-008-0023-5; Horiuchi K, 1999, J BONE MINER RES, V14, P1239, DOI 10.1359/jbmr.1999.14.7.1239; Ikonomidis JS, 2005, AM J PHYSIOL-HEART C, V288, pH149, DOI 10.1152/ajpheart.00370.2004; Jun JI, 2010, NAT CELL BIOL, V12, P676, DOI 10.1038/ncb2070; Kii I, 2006, BIOCHEM BIOPH RES CO, V342, P766, DOI 10.1016/j.bbrc.2006.02.016; Kitaba S, 2011, AM J PATHOL; Kudo A, 2011, CELL MOL LIFE SCI, V68, P3201, DOI 10.1007/s00018-011-0784-5; Kuhn B, 2007, NAT MED, V13, P962, DOI 10.1038/nm1619; Larsen M, 2006, CURR OPIN CELL BIOL, V18, P463, DOI 10.1016/j.ceb.2006.08.009; Leask A, 2002, ARTHRITIS RHEUM-US, V46, P1857, DOI 10.1002/art.10333; Leask Andrew, 2009, Front Biosci (Elite Ed), V1, P115; Liu SX, 2011, ARTHRITIS RHEUM-US, V63, P239, DOI 10.1002/art.30074; Liu SX, 2009, ARTHRITIS RHEUM-US, V60, P2817, DOI 10.1002/art.24801; Lygoe KA, 2007, BIOL CELL, V99, P601, DOI 10.1042/BC20070008; McCann MR, 2011, ARTHRITIS RES THER, V13, DOI 10.1186/ar3226; Murota H, 2003, ARTHRITIS RHEUM, V48, P1117, DOI 10.1002/art.10896; Nishiyama T, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018410; Norris RA, 2008, ANN NY ACAD SCI, V1123, P30, DOI 10.1196/annals.1420.005; Norris RA, 2007, J CELL BIOCHEM, V101, P695, DOI 10.1002/jcb.21224; Norris RA, 2009, J CELL COMMUN SIGNAL, V3, P275, DOI 10.1007/s12079-009-0063-5; Oka T, 2007, CIRC RES, V101, P313, DOI 10.1161/CIRCRESAHA.107.149047; Oku E, 2008, INT J HEMATOL, V88, P57, DOI 10.1007/s12185-008-0095-2; Ontsuka K, 2012, EXP DERMATOL, V21, P331, DOI 10.1111/j.1600-0625.2012.01454.x; Ruan K, 2009, CELL MOL LIFE SCI, V66, P2219, DOI 10.1007/s00018-009-0013-7; Shi-Wen X, 2006, J BIOL CHEM, V281, P10715, DOI 10.1074/jbc.M511343200; Shimazaki M, 2008, J EXP MED, V205, P295, DOI 10.1084/jem.20071297; Shimazaki M, 2008, BIOCHEM BIOPH RES CO, V367, P736, DOI 10.1016/j.bbrc.2008.01.009; Sidhu SS, 2010, P NATL ACAD SCI USA, V107, P14170, DOI 10.1073/pnas.1009426107; Snider P, 2008, CIRC RES, V102, P752, DOI 10.1161/CIRCRESAHA.107.159517; Takayama G, 2006, J ALLERGY CLIN IMMUN, V118, P98, DOI 10.1016/j.jaci.2006.02.046; TAKESHITA S, 1993, BIOCHEM J, V294, P271, DOI 10.1042/bj2940271; Tanabe H, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012234; Terao M, 2011, J BIOL CHEM, V286, P28303, DOI 10.1074/jbc.M111.220376; Terao M, 2010, EXP DERMATOL, V19, P38, DOI 10.1111/j.1600-0625.2009.00973.x; Tilman G, 2007, MOL CANCER, V6, DOI 10.1186/1476-4598-6-80; Tkatchenko TV, 2009, PHYSIOL GENOMICS, V39, P160, DOI 10.1152/physiolgenomics.00078.2009; YAMAGUCHI Y, 1990, NATURE, V346, P281, DOI 10.1038/346281a0; Yamamoto T, 1999, J INVEST DERMATOL, V112, P456, DOI 10.1046/j.1523-1747.1999.00528.x; Yamamoto T, 2000, ARCH DERMATOL RES, V292, P535, DOI 10.1007/s004030000183; Zhou HM, 2010, J CELL COMMUN SIGNAL, V4, P99, DOI 10.1007/s12079-010-0090-2	49	75	77	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 24	2012	7	7							e41994	10.1371/journal.pone.0041994	http://dx.doi.org/10.1371/journal.pone.0041994			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	978NX	22911870	gold, Green Published, Green Submitted			2022-12-25	WOS:000306751300087
J	Biswas, R; Martinez, RE; Gohring, N; Schlag, M; Josten, M; Xia, GQ; Hegler, F; Gekeler, C; Gleske, AK; Gotz, F; Sahl, HG; Kappler, A; Peschel, A				Biswas, Raja; Martinez, Raul E.; Goehring, Nadine; Schlag, Martin; Josten, Michaele; Xia, Guoqing; Hegler, Florian; Gekeler, Cordula; Gleske, Anne-Kathrin; Goetz, Friedrich; Sahl, Hans-Georg; Kappler, Andreas; Peschel, Andreas			Proton-Binding Capacity of Staphylococcus aureus Wall Teichoic Acid and Its Role in Controlling Autolysin Activity	PLOS ONE			English	Article							CELL-WALL; BACILLUS-SUBTILIS; MEMBRANE; COLONIZATION; LOCALIZATION; OPERON	Wall teichoic acid (WTA) or related polyanionic cell wall glycopolymers are produced by most Gram-positive bacterial species and have been implicated in various cellular functions. WTA and the proton gradient across bacterial membranes are known to control the activity of autolysins but the molecular details of these interactions are poorly understood. We demonstrate that WTA contributes substantially to the proton-binding capacity of Staphylococcus aureus cell walls and controls autolysis largely via the major autolysin AtlA whose activity is known to decline at acidic pH values. Compounds that increase or decrease the activity of the respiratory chain, a main source of protons in the cell wall, modulated autolysis rates in WTA-producing cells but did not affect the augmented autolytic activity observed in a WTA-deficient mutant. We propose that WTA represents a cation-exchanger like mesh in the Gram-positive cell envelopes that is required for creating a locally acidified milieu to govern the pH-dependent activity of autolysins.	[Biswas, Raja; Goehring, Nadine; Schlag, Martin; Xia, Guoqing; Gekeler, Cordula; Gleske, Anne-Kathrin; Goetz, Friedrich; Peschel, Andreas] Univ Tubingen, Interfac Inst Microbiol & Infect Med, Tubingen, Germany; [Martinez, Raul E.; Hegler, Florian; Kappler, Andreas] Univ Tubingen, Ctr Appl Geosci, Tubingen, Germany; [Josten, Michaele; Sahl, Hans-Georg] Univ Bonn, Pharmaceut Microbiol Unit, IMMIP, Bonn, Germany	Eberhard Karls University of Tubingen; Eberhard Karls University of Tubingen; University of Bonn	Biswas, R (corresponding author), Univ Tubingen, Interfac Inst Microbiol & Infect Med, Tubingen, Germany.	andreas.peschel@uni-tuebingen.de	Xia, Guoqing/C-2365-2015; Kappler, Andreas/G-7221-2016	Xia, Guoqing/0000-0003-4492-9156; Kappler, Andreas/0000-0002-3558-9500; Gekeler, Cordula/0000-0001-9041-6672	German Research Foundation [TRR34, SFB766]; Bacteria Materials Interaction graduate programme of the University of Tubingen; Humboldt Foundation	German Research Foundation(German Research Foundation (DFG)); Bacteria Materials Interaction graduate programme of the University of Tubingen; Humboldt Foundation(Alexander von Humboldt Foundation)	This work was supported by the German Research Foundation grants TRR34 to A. P. and F. G. and SFB766 to A. P., G. X., and F. G.; by the Bacteria Materials Interaction graduate programme of the University of Tubingen to A. P. and A. K.; and by a fellowship from the Humboldt Foundation to R. M. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Atilano ML, 2010, P NATL ACAD SCI USA, V107, P18991, DOI 10.1073/pnas.1004304107; Bera A, 2007, J BACTERIOL, V189, P280, DOI 10.1128/JB.01221-06; BIERBAUM G, 1985, ARCH MICROBIOL, V141, P249, DOI 10.1007/BF00408067; BRUCKNER R, 1992, GENE, V122, P187, DOI 10.1016/0378-1119(92)90048-T; Calamita HG, 2002, MOL MICROBIOL, V44, P601, DOI 10.1046/j.1365-2958.2002.02872.x; Calamita HG, 2001, P NATL ACAD SCI USA, V98, P15260, DOI 10.1073/pnas.261483798; Campbell J, 2011, ACS CHEM BIOL, V6, P106, DOI 10.1021/cb100269f; Choudhury B, 2006, J BIOL CHEM, V281, P27932, DOI 10.1074/jbc.M605768200; Delmas C, 1997, GLYCOBIOLOGY, V7, P811, DOI 10.1093/glycob/7.6.811; Eugster MR, 2011, MOL MICROBIOL, V81, P1419, DOI 10.1111/j.1365-2958.2011.07774.x; Frankel MB, 2012, J BIOL CHEM, V287, P10460, DOI 10.1074/jbc.M111.336404; Gross M, 2001, INFECT IMMUN, V69, P3423, DOI 10.1128/IAI.69.5.3423-3426.2001; Heilmann C, 1997, MOL MICROBIOL, V24, P1013, DOI 10.1046/j.1365-2958.1997.4101774.x; HEPTINSTALL S, 1970, NATURE, V225, P519, DOI 10.1038/225519a0; JOLLIFFE LK, 1981, CELL, V25, P753, DOI 10.1016/0092-8674(81)90183-5; Kohler T, 2009, J BACTERIOL, V191, P4482, DOI 10.1128/JB.00221-09; Lutzner N, 2009, BIOCHEM BIOPH RES CO, V380, P554, DOI 10.1016/j.bbrc.2009.01.140; Martinez RE, 2002, J COLLOID INTERF SCI, V253, P130, DOI 10.1006/jcis.2002.8541; Park KH, 2010, J BIOL CHEM, V285, P27167, DOI 10.1074/jbc.M110.141309; Patton TG, 2006, MOL MICROBIOL, V59, P1395, DOI 10.1111/j.1365-2958.2006.05034.x; Penyige A, 2002, BIOCHEM BIOPH RES CO, V290, P1169, DOI 10.1006/bbrc.2001.6317; Peschel A, 1999, J BIOL CHEM, V274, P8405, DOI 10.1074/jbc.274.13.8405; Phoenix VR, 2002, APPL ENVIRON MICROB, V68, P4827, DOI 10.1128/AEM.68.10.4827-4834.2002; Price CE, 2010, BBA-MOL CELL RES, V1803, P748, DOI 10.1016/j.bbamcr.2010.01.019; Raafat D, 2008, APPL ENVIRON MICROB, V74, P3764, DOI 10.1128/AEM.00453-08; Reichmann NT, 2011, FEMS MICROBIOL LETT, V319, P97, DOI 10.1111/j.1574-6968.2011.02260.x; Rice KC, 2003, MOL MICROBIOL, V50, P729, DOI 10.1046/j.1365-2958.2003.t01-1-03720.x; Schirner K, 2009, EMBO J, V28, P830, DOI 10.1038/emboj.2009.25; Schlag M, 2010, MOL MICROBIOL, V75, P864, DOI 10.1111/j.1365-2958.2009.07007.x; Silhavy TJ, 2010, CSH PERSPECT BIOL, V2, DOI 10.1101/cshperspect.a000414; Soldo B, 1999, MOL MICROBIOL, V31, P795, DOI 10.1046/j.1365-2958.1999.01218.x; Swoboda JG, 2010, CHEMBIOCHEM, V11, P35, DOI 10.1002/cbic.200900557; Tamm LK, 1997, Q REV BIOPHYS, V30, P365, DOI 10.1017/S0033583597003375; Weidenmaier C, 2004, NAT MED, V10, P243, DOI 10.1038/nm991; Weidenmaier C, 2008, NAT REV MICROBIOL, V6, P276, DOI 10.1038/nrmicro1861; Xia GQ, 2011, J BACTERIOL, V193, P4006, DOI 10.1128/JB.01412-10; Xia GQ, 2010, J BIOL CHEM, V285, P13405, DOI 10.1074/jbc.M109.096172; Xia GQ, 2010, INT J MED MICROBIOL, V300, P148, DOI 10.1016/j.ijmm.2009.10.001; Yamamoto H, 2008, MOL MICROBIOL, V70, P297, DOI 10.1111/j.1365-2958.2008.06397.x; Zoll S, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1000807	40	60	60	0	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 23	2012	7	7							e41415	10.1371/journal.pone.0041415	http://dx.doi.org/10.1371/journal.pone.0041415			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	977TM	22911791	gold, Green Submitted, Green Published			2022-12-25	WOS:000306687700087
J	Buitrago-Perez, A; Hachimi, M; Duenas, M; Lloveras, B; Santos, A; Holguin, A; Duarte, B; Santiago, JL; Akgul, B; Rodriguez-Peralto, JL; Storey, A; Ribas, C; Larcher, F; del Rio, M; Paramio, JM; Garcia-Escudero, R				Buitrago-Perez, Agueda; Hachimi, Mariam; Duenas, Marta; Lloveras, Belen; Santos, Almudena; Holguin, Almudena; Duarte, Blanca; Santiago, Juan Luis; Akguel, Baki; Rodriguez-Peralto, Jose L.; Storey, Alan; Ribas, Catalina; Larcher, Fernando; del Rio, Marcela; Paramio, Jesus M.; Garcia-Escudero, Ramon			A Humanized Mouse Model of HPV-Associated Pathology Driven by E7 Expression	PLOS ONE			English	Article							HUMAN-PAPILLOMAVIRUS TYPE-16; SQUAMOUS-CELL CARCINOMA; RETINOBLASTOMA TUMOR-SUPPRESSOR; E6 PROTEINS; EPIDERMODYSPLASIA-VERRUCIFORMIS; CERVICAL-CARCINOMA; GENE-THERAPY; SKIN-CANCER; HIGH-RISK; DIFFERENTIATION	Human papillomavirus (HPV) is the causative agent of human cervical cancer and has been associated with oropharyngeal squamous cell carcinoma development. Although prophylactic vaccines have been developed, there is a need to develop new targeted therapies for individuals affected with malignant infected lesions in these locations, which must be tested in appropriate models. Cutaneous beta HPV types appear to be involved in skin carcinogenesis. Virus oncogenicity is partly achieved by inactivation of retinoblastoma protein family members by the viral E7 gene. Here we show that the E7 protein of cutaneous beta HPV5 binds pRb and promotes its degradation. In addition, we described an in vivo model of HPV-associated disease in which artificial human skin prepared using primary keratinocytes engineered to express the E7 protein is engrafted onto nude mice. Expression of E7 in the transplants was stably maintained for up to 6 months, inducing the appearance of lesions that, in the case of HPV16 E7, histologically resembled human anogenital lesions caused by oncogenic HPVs. Moreover, it was confirmed through biomarker expression analysis via immunodetection and/or quantitative PCR from mRNA and miRNA that the 16E7-modified engrafted skin shares molecular features with human HPV-associated pretumoral and tumoral lesions. Finally, our findings indicate a decrease of the in vitro capacity of HPV5 E7 to reduce pRb levels in vivo, possibly explaining the phenotypical differences when compared with 16E7-grafts. Our model seems to be a valuable platform for basic research into HPV oncogenesis and preclinical testing of HPV-associated antitumor therapies.	[Buitrago-Perez, Agueda; Hachimi, Mariam; Duenas, Marta; Paramio, Jesus M.; Garcia-Escudero, Ramon] CIEMAT, Mol Oncol Unit, E-28040 Madrid, Spain; [Lloveras, Belen] Hosp del Mar, Barcelona, Spain; [Santos, Almudena; Ribas, Catalina] Univ Autonoma Barcelona, CSIC UAM, Ctr Biol Mol Severo Ochoa, Madrid, Spain; [Santos, Almudena; Ribas, Catalina] Univ Autonoma Barcelona, CSIC UAM, Dept Biol Mol, Madrid, Spain; [Santos, Almudena; Ribas, Catalina] Inst Invest Sanitaria Princesa, Madrid, Spain; [Holguin, Almudena; del Rio, Marcela] CIEMAT, Div Biomed, Regenerat Med Unit, E-28040 Madrid, Spain; [Duarte, Blanca; Larcher, Fernando] CIEMAT, Div Biomed, Cutaneous Dis Modeling Unit, E-28040 Madrid, Spain; [Santiago, Juan Luis] Univ Castilla La Mancha, Hosp Gen Ciudad Real, Dept Dermatol, Ciudad Real, Spain; [Akguel, Baki] Univ Cologne, Inst Virol, D-50931 Cologne, Germany; [Rodriguez-Peralto, Jose L.] Univ Complutense, Hosp Univ Octubre 12, Dept Pathol, E-28040 Madrid, Spain; [Storey, Alan] Univ Complutense, Inst Invest Hosp Octubre i 12 12, Dept Pathol, E-28040 Madrid, Spain; Univ Oxford, John Radcliffe Hosp, Dept Oncol, Oxford OX3 9DU, England	Centro de Investigaciones Energeticas, Medioambientales Tecnologicas; Institut Hospital del Mar d'Investigacions Mediques (IMIM); Hospital del Mar; Autonomous University of Barcelona; Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Centro de Biologia Molecular Severo Ochoa (CBM); Autonomous University of Barcelona; Consejo Superior de Investigaciones Cientificas (CSIC); Centro de Investigaciones Energeticas, Medioambientales Tecnologicas; Centro de Investigaciones Energeticas, Medioambientales Tecnologicas; Universidad de Castilla-La Mancha; University of Cologne; Complutense University of Madrid; Hospital Universitario 12 de Octubre; Complutense University of Madrid; Hospital Universitario 12 de Octubre; University of Oxford	Buitrago-Perez, A (corresponding author), Hosp Univ La Paz, Hlth Res Inst IdiPAZ, Madrid, Spain.	jesusm.paramio@ciemat.es; ramon.garcia@ciemat.es	Paramio, Jesus M/M-8482-2014; Akgül, Baki/H-5629-2019; Garcia-Escudero, Ramon/A-2735-2012; DEL RIO, MARCELA/H-2796-2015; Larcher, Fernando/J-1527-2016	Paramio, Jesus M/0000-0001-7520-3177; Akgül, Baki/0000-0002-6564-9412; Garcia-Escudero, Ramon/0000-0001-5640-6542; DEL RIO, MARCELA/0000-0003-2910-7189; Larcher, Fernando/0000-0002-6771-3561; Hachimi, Mariam/0000-0002-0962-0850; Storey, Alan/0000-0003-2001-9772; Duenas, Marta/0000-0003-0857-9726; Rodriguez-Peralto, Jose Luis/0000-0002-6578-7153	Comunidad Autonoma de Madrid [Oncocycle S2006/BIO-0232]; Ministerio de Ciencia e Innovacion [ISCIII-RETIC RD06/0020, SAF2008-00121]; Fundacion Sandra Ibarra	Comunidad Autonoma de Madrid(Comunidad de Madrid); Ministerio de Ciencia e Innovacion(Ministry of Science and Innovation, Spain (MICINN)Instituto de Salud Carlos IIISpanish Government); Fundacion Sandra Ibarra	This work was supported by Comunidad Autonoma de Madrid (Oncocycle S2006/BIO-0232), by Ministerio de Ciencia e Innovacion (ISCIII-RETIC RD06/0020 and SAF2008-00121), and by Fundacion Sandra Ibarra. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Accardi R, 2006, EMBO REP, V7, P334, DOI 10.1038/sj.embor.7400615; Akgul B, 2006, J PATHOL, V208, P165, DOI 10.1002/path.1893; Akgul B, 2005, ARCH VIROL, V150, P145, DOI 10.1007/s00705-004-0398-4; Asgari MM, 2008, J INVEST DERMATOL, V128, P1409, DOI 10.1038/sj.jid.5701227; Azuma M, 2010, METHODS MOL BIOL, V623, P373, DOI 10.1007/978-1-60761-588-0_24; Bavinck JNB, 2010, CANCER RES, V70, P9777, DOI 10.1158/0008-5472.CAN-10-0352; Boyer SN, 1996, CANCER RES, V56, P4620; Buitrago-Perez A, 2009, CURR GENOMICS, V10, P26, DOI 10.2174/138920209787581235; Caldeira S, 2003, J VIROL, V77, P2195, DOI 10.1128/JVI.77.3.2195-2206.2003; Caldeira S, 2000, ONCOGENE, V19, P821, DOI 10.1038/sj.onc.1203375; CRUM CP, 1984, NEW ENGL J MED, V310, P880, DOI 10.1056/NEJM198404053101403; de Jong-Tieben LM, 2000, TRANSPLANTATION, V69, P44, DOI 10.1097/00007890-200001150-00009; de Koning MNC, 2009, J GEN VIROL, V90, P1611, DOI 10.1099/vir.0.010017-0; de Sanjose S, 2010, LANCET ONCOL, V11, P1048, DOI 10.1016/S1470-2045(10)70230-8; Del Rio M, 2002, HUM GENE THER, V13, P959, DOI 10.1089/10430340252939069; Di Nunzio F, 2008, MOL THER, V16, P1977, DOI 10.1038/mt.2008.204; Doorbar J, 2005, J CLIN VIROL, V32, pS7, DOI 10.1016/j.jcv.2004.12.006; Dubina M, 2009, AM J DERMATOPATH, V31, P561, DOI 10.1097/DAD.0b013e3181a58234; DURST M, 1983, P NATL ACAD SCI-BIOL, V80, P3812, DOI 10.1073/pnas.80.12.3812; DYSON N, 1989, SCIENCE, V243, P934, DOI 10.1126/science.2537532; Escamez MJ, 2008, J INVEST DERMATOL, V128, P1565, DOI 10.1038/sj.jid.5701217; Escamez MJ, 2004, J INVEST DERMATOL, V123, P1182, DOI 10.1111/j.0022-202X.2004.23473.x; Funk JO, 1997, GENE DEV, V11, P2090, DOI 10.1101/gad.11.16.2090; Gache Y, 2004, HUM GENE THER, V15, P921, DOI 10.1089/hum.2004.15.921; Gewirtzman A, 2008, CURR OPIN INFECT DIS, V21, P141, DOI 10.1097/QCO.0b013e3282f486c9; Ghavami S, 2009, J MED GENET, V46, P497, DOI 10.1136/jmg.2009.066944; Gonzalez SL, 2001, J VIROL, V75, P7583, DOI 10.1128/JVI.75.16.7583-7591.2001; Harper DM, 2006, LANCET, V367, P1247, DOI 10.1016/S0140-6736(06)68439-0; Helt AM, 2002, J VIROL, V76, P10559, DOI 10.1128/JVI.76.20.10559-10568.2002; Hui ABY, 2010, CLIN CANCER RES, V16, P1129, DOI 10.1158/1078-0432.CCR-09-2166; HUIBREGTSE JM, 1991, EMBO J, V10, P4129, DOI 10.1002/j.1460-2075.1991.tb04990.x; Iftner T, 2002, EMBO J, V21, P4741, DOI 10.1093/emboj/cdf443; Jackson S, 2000, GENE DEV, V14, P3065, DOI 10.1101/gad.182100; Jackson S, 2000, ONCOGENE, V19, P592, DOI 10.1038/sj.onc.1203339; Jian YC, 1998, ONCOGENE, V17, P2027, DOI 10.1038/sj.onc.1202142; Jones DL, 1997, VIROLOGY, V239, P97, DOI 10.1006/viro.1997.8851; Jones DL, 1997, GENE DEV, V11, P2101, DOI 10.1101/gad.11.16.2101; Karim R, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017848; Larcher F, 2001, FASEB J, V15, P1529, DOI 10.1096/fj.01-0082com; Lee JW, 2008, CLIN CANCER RES, V14, P2535, DOI 10.1158/1078-0432.CCR-07-1231; Leverrier S, 2007, APOPTOSIS, V12, P549, DOI 10.1007/s10495-006-0004-1; Llames Sara, 2006, Cell and Tissue Banking, V7, P47, DOI 10.1007/s10561-004-7253-4; Llames SG, 2004, TRANSPLANTATION, V77, P350, DOI 10.1097/01.TP.0000112381.80964.85; Lui WO, 2007, CANCER RES, V67, P6031, DOI 10.1158/0008-5472.CAN-06-0561; Martinez I, 2008, ONCOGENE, V27, P2575, DOI 10.1038/sj.onc.1210919; Martinez-Cruz AB, 2008, CANCER RES, V68, P683, DOI 10.1158/0008-5472.CAN-07-3049; Marur S, 2010, LANCET ONCOL, V11, P781, DOI 10.1016/S1470-2045(10)70017-6; MCCANCE DJ, 1988, P NATL ACAD SCI USA, V85, P7169, DOI 10.1073/pnas.85.19.7169; Meana A, 1998, BURNS, V24, P621, DOI 10.1016/S0305-4179(98)00107-7; Middleton K, 2003, J VIROL, V77, P10186, DOI 10.1128/JVI.77.19.10186-10201.2003; Moody CA, 2007, P NATL ACAD SCI USA, V104, P19541, DOI 10.1073/pnas.0707947104; Orth G, 2006, SEMIN IMMUNOL, V18, P362, DOI 10.1016/j.smim.2006.07.008; Pereira PM, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011780; Pfister Herbert, 2003, J Natl Cancer Inst Monogr, P52; Pyeon D, 2007, CANCER RES, V67, P4605, DOI 10.1158/0008-5472.CAN-06-3619; Ramqvist T, 2011, ANTICANCER RES, V31, P1515; Rheinwald JG., 1989, CELL GROWTH DIVISION, P81; Rhodes DR, 2007, NEOPLASIA, V9, P166, DOI 10.1593/neo.07112; Riley RR, 2003, CANCER RES, V63, P4862; Ruesch MN, 1998, VIROLOGY, V250, P19, DOI 10.1006/viro.1998.9359; Ruiz S, 2004, DEVELOPMENT, V131, P2737, DOI 10.1242/dev.01148; Santegoets LAM, 2007, INT J CANCER, V121, P759, DOI 10.1002/ijc.22769; Saydam O, 2009, MOL CELL BIOL, V29, P5923, DOI 10.1128/MCB.00332-09; Schaper ID, 2005, CANCER RES, V65, P1394, DOI 10.1158/0008-5472.CAN-04-3263; SCHMITT A, 1994, J VIROL, V68, P7051, DOI 10.1128/JVI.68.11.7051-7059.1994; Segrelles C, 2007, CANCER RES, V67, P10879, DOI 10.1158/0008-5472.CAN-07-2564; Selcuklu SD, 2009, BIOCHEM SOC T, V37, P918, DOI 10.1042/BST0370918; Sonkoly E, 2008, CLIN EXP DERMATOL, V33, P312, DOI 10.1111/j.1365-2230.2008.02804.x; STOLER MH, 1986, HUM PATHOL, V17, P1250, DOI 10.1016/S0046-8177(86)80569-X; Strati K, 2007, CANCER RES, V67, P11585, DOI 10.1158/0008-5472.CAN-07-3007; Taganov KD, 2006, P NATL ACAD SCI USA, V103, P12481, DOI 10.1073/pnas.0605298103; Underbrink MP, 2008, J VIROL, V82, P10408, DOI 10.1128/JVI.00902-08; Viarisio D, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002125; Wang X, 2008, PLOS ONE, V3, DOI [10.1371/journal.pone.0003839, 10.1371/journal.pone.0002557]; Xia HP, 2010, J BIOL CHEM, V285, P36995, DOI 10.1074/jbc.M110.133744; YAMASHITA T, 1993, ONCOGENE, V8, P2433; Yang SL, 1999, HUM GENE THER, V10, P123, DOI 10.1089/10430349950019255; Zehbe I, 1999, ONCOGENE, V18, P2201, DOI 10.1038/sj.onc.1202549; zur Hausen H, 2000, JNCI-J NATL CANCER I, V92, P690, DOI 10.1093/jnci/92.9.690	79	20	21	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 23	2012	7	7							e41743	10.1371/journal.pone.0041743	http://dx.doi.org/10.1371/journal.pone.0041743			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	977TM	22911850	Green Published, Green Submitted, Green Accepted, gold			2022-12-25	WOS:000306687700145
J	Andersen, LL; Clausen, T; Burr, H; Holtermann, A				Andersen, Lars L.; Clausen, Thomas; Burr, Hermann; Holtermann, Andreas			Threshold of Musculoskeletal Pain Intensity for Increased Risk of Long-Term Sickness Absence among Female Healthcare Workers in Eldercare	PLOS ONE			English	Article							LOW-BACK-PAIN; PROSPECTIVE COHORT; NECK-SHOULDER; FOLLOW-UP; PROGNOSTIC-FACTORS; POPULATION; QUESTIONNAIRE; DISABILITY; DISORDERS; EMPLOYEES	Purpose: Musculoskeletal disorders increase the risk for absenteeism and work disability. However, the threshold when musculoskeletal pain intensity significantly increases the risk of sickness absence among different occupations is unknown. This study estimates the risk for long-term sickness absence (LTSA) from different pain intensities in the low back, neck/shoulder and knees among female healthcare workers in eldercare. Methods: Prospective cohort study among 8,732 Danish female healthcare workers responding to a questionnaire in 20042005, and subsequently followed for one year in a national register of social transfer payments (DREAM). Using Cox regression hazard ratio (HR) analysis we modeled risk estimates of pain intensities on a scale from 0-9 (reference 0, where 0 is no pain and 9 is worst imaginable pain) in the low back, neck/shoulders and knees during the last three months for onset of LTSA (receiving sickness absence compensation for at least eight consecutive weeks) during one-year follow-up. Results: During follow-up, the 12-month prevalence of LTSA was 6.3%. With adjustment for age, BMI, smoking and leisure physical activity, the thresholds of pain intensities significantly increasing risk of LTSA for the low back (HR 1.44 [95% CI 1.07-1.93]), neck/shoulders (HR 1.47 [95% CI 1.10-1.96]) and knees (HR 1.43 [95% CI 1.06-1.93]) were 5, 4 and 3 (scale 0-9), respectively, referencing pain intensity of 0. Conclusion: The threshold of pain intensity significantly increasing the risk for LTSA among female healthcare workers varies across body regions, with knee pain having the lowest threshold. This knowledge may be used in the prevention of LTSA among health care workers.	[Andersen, Lars L.; Clausen, Thomas; Holtermann, Andreas] Natl Res Ctr Working Environm, Copenhagen O, Denmark; [Burr, Hermann] Fed Inst Occupat Safety & Hlth BAuA, Berlin, Germany	National Research Centre for the Working Environment	Andersen, LL (corresponding author), Natl Res Ctr Working Environm, Copenhagen O, Denmark.	LLA@NRCWE.DK	Andersen, Lars Louis/AAQ-4802-2020	Burr, Hermann/0000-0002-3864-6347; Andersen, Lars L./0000-0003-2777-8085	Danish Parliament	Danish Parliament	The study was supported by a grant from the Danish Parliament (SATS 2004). The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andersen LL, 2012, INT ARCH OCC ENV HEA, V85, P615, DOI 10.1007/s00420-011-0709-5; Andersen LL, 2011, OCCUP ENVIRON MED, V68, P590, DOI 10.1136/oem.2010.056259; [Anonymous], GUID NOT; Bergstrom G, 2007, OCCUP ENVIRON MED, V64, P279, DOI 10.1136/oem.2006.026583; Bevan S, 2009, FIT WORK MUSCULOSKEL, P1; Buchbinder R, 2001, BRIT MED J, V322, P1516, DOI 10.1136/bmj.322.7301.1516; Clausen T, 2012, J ADV NURS, V68, P127, DOI 10.1111/j.1365-2648.2011.05724.x; Eriksen W, 2004, OCCUP ENVIRON MED, V61, P398, DOI 10.1136/oem.2003.008482; Herin F, 2011, PAIN, V152, P2006, DOI 10.1016/j.pain.2011.04.018; Hjollund NH, 2007, SCAND J PUBLIC HEALT, V35, P497, DOI 10.1080/14034940701271882; Hogelund J, 2003, 0320 DAN NAT I SOC R; Hollmann S, 1999, SCAND J WORK ENV HEA, V25, P105, DOI 10.5271/sjweh.412; Holmberg SAC, 2006, BMC MUSCULOSKEL DIS, V7, DOI 10.1186/1471-2474-7-66; Holtermann A, 2010, BMC PUBLIC HEALTH, V10, DOI 10.1186/1471-2458-10-120; Holtermann A, 2010, SCAND J WORK ENV HEA, V36, P34, DOI 10.5271/sjweh.2883; Hoogendoorn WE, 1999, SCAND J WORK ENV HEA, V25, P387, DOI 10.5271/sjweh.451; Kaergaard A, 2000, PAIN, V86, P305, DOI 10.1016/S0304-3959(00)00261-X; Kivimaki M, 2003, BRIT MED J, V327, P364, DOI 10.1136/bmj.327.7411.364; Kuiper JI, 1999, INT J IND ERGONOM, V24, P389, DOI 10.1016/S0169-8141(99)00006-2; KUORINKA I, 1987, APPL ERGON, V18, P233, DOI 10.1016/0003-6870(87)90010-X; Lotters F, 2003, SCAND J WORK ENV HEA, V29, P431; Lund T, 2005, J OCCUP ENVIRON MED, V47, P1141, DOI 10.1097/01.jom.0000174301.80318.f2; Morken T, 2003, BMC MUSCULOSKEL DIS, V4, DOI 10.1186/1471-2474-4-21; Natvig B, 2002, SCAND J PUBLIC HEALT, V30, P288, DOI 10.1080/14034940210133951; Nyman T, 2007, EUR SPINE J, V16, P631, DOI 10.1007/s00586-006-0152-6; Pejtersen JH, 2010, SCAND J PUBLIC HEALT, V38, P8, DOI 10.1177/1403494809349858; Pincus T, 2008, J RHEUMATOL, V35, P1550; SALTIN B, 1968, CIRCULATION, V38, P1104, DOI 10.1161/01.CIR.38.6.1104; The Danish Data Protection Agency, 2008, STAND TERMS RES PROJ; Tubach F, 2002, J OCCUP ENVIRON MED, V44, P451, DOI 10.1097/00043764-200205000-00013; van den Heuvel SG, 2004, SCAND J WORK ENV HEA, V30, P459, DOI 10.5271/sjweh.835; Veale D J, 2008, Ir Med J, V101, P208; Waddell G., 2006, IS WORK GOOD YOUR HL; Waters T, 2006, ORTHOP NURS, V25, P380	34	78	78	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 20	2012	7	7							e41287	10.1371/journal.pone.0041287	http://dx.doi.org/10.1371/journal.pone.0041287			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	977GL	22911772	Green Submitted, Green Published, gold			2022-12-25	WOS:000306644600066
J	Feng, L; Zhou, X; Su, LX; Feng, D; Jia, YH; Xie, LX				Feng, Lin; Zhou, Xin; Su, Long-Xiang; Feng, Dan; Jia, Yan-Hong; Xie, Li-Xin			Clinical Significance of Soluble Hemoglobin Scavenger Receptor CD163 (sCD163) in Sepsis, a Prospective Study	PLOS ONE			English	Article							EPIDEMIOLOGY; DYSFUNCTION; EXPRESSION; COMMUNITY; SURVIVAL	Objective: We investigated serum soluble CD163 (sCD163) levels for use in the diagnosis, severity assessment, and prognosis of sepsis in the critical ill patients and compared sCD163 with other infection-related variables. Methods: During july 2010 and April 2011, serum was obtained from 102 sepsis patients (days 1, 3, 5, 7, and 10 after admission to an ICU) and 30 systemic inflammatory response syndrome (SIRS) patients with no sepsis diagnosed. Serum levels of sCD163, procalcitonon (PCT), and C reactive protein (CRP) were determined respectively. Sequential organ failure assessment (SOFA) scores for sepsis patients were also recorded. Then evaluated their roles in sepsis. Results: The sCD163 levels were 0.88(0.78-1.00) ug/mL for SIRS patients, 1.50(0.92-2.00) ug/mL for moderate sepsis patients, and 2.95(2.18-5.57) ug/mL for severe sepsis patients on day1. The areas under the ROC curves for sCD163, CRP, and PCT for the diagnosis of sepsis were, respectively, 0.856(95% CI: 0.791-0.921), 0.696(95% CI: 0.595-0.797), and 0.629(95% CI: 0.495-0.763), At the recommended cut-off 1.49 ug/mL for sCD163, the sensitivity is 74.0% with 93.3% specificity. Based on 28-day survivals, sCD163 levels in the surviving group stay constant, while they tended to gradually increase in the non-surviving group. The area under the ROC curve for sCD163 for sepsis prognosis was 0.706(95% CI 0.558-0.804). Levels of sCD163 with cut-off point >2.84 ug/mL have sensitivity of 55.8.0%, specificity 80.4%. Common risk factors for death and sCD163 were included in multivariate logistic regression analysis; the odds ratios (OR) for sCD163 and SOFA scores for sepsis prognosis were 1.173 and 1.396, respectively (P<0.05). Spearman rank correlation analysis showed that sCD163 was weakly, but positively correlated with CRP, PCT, and SOFA scores (0.2 < r < 0.4, P<0.0001), but not with leukocyte counts (r<0.2, P = 0.450). Conclusion: Serum sCD163 is superior to PCT and CRP for the diagnosis of sepsis and differentiate the severity of sepsis. sCD163 levels were more sensitive for dynamic evaluations of sepsis prognosis. Serum sCD163 and SOFA scores are prognostic factors for sepsis.	[Feng, Lin; Xie, Li-Xin] Chinese Peoples Liberat Army Gen Hosp, Hainan Branch, Dept Resp Med, Sanya, Hainan Province, Peoples R China; [Feng, Lin] Guangzhou Childrens Hosp, Dept Resp Med, Guangzhou, Guangdong, Peoples R China; [Zhou, Xin] Chinese Acad Med Sci, Canc Inst & Hosp, State Key Lab Mol Oncol, Beijing 100730, Peoples R China; [Zhou, Xin] Chinese Acad Med Sci, Canc Inst & Hosp, Dept Etiol & Carcinogenesis, Beijing 100730, Peoples R China; [Zhou, Xin] Peking Union Med Coll, Beijing 100021, Peoples R China; [Su, Long-Xiang; Jia, Yan-Hong; Xie, Li-Xin] Chinese Peoples Liberat Army Gen Hosp, Dept Resp Med, Beijing, Peoples R China; [Feng, Dan] Chinese Peoples Liberat Army Gen Hosp, Dept Med Stat, Beijing, Peoples R China	Chinese People's Liberation Army General Hospital; Chinese Academy of Medical Sciences - Peking Union Medical College; Cancer Institute & Hospital - CAMS; Chinese Academy of Medical Sciences - Peking Union Medical College; Cancer Institute & Hospital - CAMS; Chinese Academy of Medical Sciences - Peking Union Medical College; Peking Union Medical College; Chinese People's Liberation Army General Hospital; Chinese People's Liberation Army General Hospital	Feng, L (corresponding author), Chinese Peoples Liberat Army Gen Hosp, Hainan Branch, Dept Resp Med, Sanya, Hainan Province, Peoples R China.	fenglinkuaile@mail.nankai.edu.cn	Su, Longxiang/I-6788-2019; Xie, li/HGE-6052-2022	Su, Longxiang/0000-0002-0942-2870; 	Chinese National Science and Technology Pillar Program [2009BAI86B03]	Chinese National Science and Technology Pillar Program	This Study was supported by the Chinese National Science and Technology Pillar Program (NO: 2009BAI86B03). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abraham NG, 2006, CIRC RES, V99, P911, DOI 10.1161/01.RES.0000249616.10603.d6; Adrie C, 2005, J CRIT CARE, V20, P46, DOI 10.1016/j.jcrc.2004.10.005; Blanco J, 2008, CRIT CARE, V12, DOI 10.1186/cc7157; BONE RC, 1992, CHEST, V101, P1644, DOI 10.1378/chest.101.6.1644; Buechler C, 2000, J LEUKOCYTE BIOL, V67, P97, DOI 10.1002/jlb.67.1.97; Cheng BL, 2007, CRIT CARE MED, V35, P2538, DOI 10.1097/01.CCM.0000284492.30800.00; Davis BH, 2005, CYTOM PART B-CLIN CY, V63B, P16, DOI 10.1002/cyto.b.20031; Fabriek BO, 2009, BLOOD, V113, P887, DOI 10.1182/blood-2008-07-167064; Felbinger TW, 1999, NEW ENGL J MED, V341, P56; Gaini S, 2006, APMIS, V114, P103, DOI 10.1111/j.1600-0463.2006.apm_341.x; Kibe S, 2011, J ANTIMICROB CHEMOTH, V66, pII33, DOI 10.1093/jac/dkq523; Knudsen TB, 2005, CLIN MICROBIOL INFEC, V11, P730, DOI 10.1111/j.1469-0691.2005.01229.x; Larsen R, 2011, SCI TRANSL MED, V2, P51; Moller HJ, 2006, CRIT CARE MED, V34, P2561, DOI 10.1097/01.CCM.0000239120.32490.AB; PARRILLO JE, 1990, ANN INTERN MED, V113, P227, DOI 10.7326/0003-4819-113-3-227; Vincent JL, 2006, CRIT CARE MED, V34, P344, DOI 10.1097/01.CCM.0000194725.48928.3A	16	183	196	2	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 20	2012	7	7							e38400	10.1371/journal.pone.0038400	http://dx.doi.org/10.1371/journal.pone.0038400			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	977GL	22911680	gold, Green Submitted, Green Published			2022-12-25	WOS:000306644600002
J	Napoleon, C; Claquin, P				Napoleon, Camille; Claquin, Pascal			Multi-Parametric Relationships between PAM Measurements and Carbon Incorporation, an In Situ Approach	PLOS ONE			English	Article							PHOTOSYNTHETIC ELECTRON-TRANSPORT; MARINE-PHYTOPLANKTON; QUANTUM YIELD; OXYGEN EVOLUTION; FLUORESCENCE; LIGHT; TEMPERATURE; ECOSYSTEM; PSII; CHLAMYDOMONAS	Primary production (PP) in the English Channel was measured using C-13 uptake and compared to the electron transport rate (ETR) measured using PAM (pulse amplitude modulated fluorometer). The relationship between carbon incorporation (P-obs) and ETR was not linear but logarithmic. This result can be explained by alternative electron sinks at high irradiance which protect the phytoplankton from photoinhibition. A multi-parametric model was developed to estimate PP by ETR. This approach highlighted the importance of taking physicochemical parameters like incident light and nutrient concentrations into account. The variation in the ETR/P-obs ratio as a function of the light revealed different trends which were characterized by three parameters (R-max, the maximum value of ETR/P-obs; E-Rmax, the light intensity at which R-max is measured; c the initial slope of the curve). Based on the values of these three parameters, data were divided into six groups which were highly dependent on the seasons and on the physicochemical conditions. Using the multi-parametric model which we defined by P-obs and ETR measurements at low frequencies, the high frequency measurements of ETR enabled us to estimate the primary production capacity between November 2009 and December 2010 at high temporal and spatial scales.	[Napoleon, Camille; Claquin, Pascal] Univ Caen Basse Normandie, BIOMEA CNRS FRE3484, Caen, France; [Napoleon, Camille; Claquin, Pascal] CNRS INEE, BIOMEA FRE3484, Caen, France; [Napoleon, Camille] IFREMER, Lab Environm Ressources Normandie, Port En Bessin, France	Universite de Caen Normandie; Centre National de la Recherche Scientifique (CNRS); CNRS - Institute of Ecology & Environment (INEE); Ifremer	Napoleon, C (corresponding author), Univ Caen Basse Normandie, BIOMEA CNRS FRE3484, Caen, France.	pascal.claquin@unicaen.fr		Claquin, Pascal/0000-0002-5183-203X	European project Interreg 4a CHannel integrated Approach for marine Resource 3 (CHARM 3)	European project Interreg 4a CHannel integrated Approach for marine Resource 3 (CHARM 3)	This study was supported by the European project Interreg 4a CHannel integrated Approach for marine Resource 3 (CHARM 3). The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aminot A., 2007, DOSAGE AUTOMATIQUE N; Aminot A., 1983, MANUEL ANAL CHIMIQUE; BABIN M, 1993, LIMNOL OCEANOGR, V38, P154, DOI 10.4319/lo.1993.38.1.0154; Babin M, 2003, J GEOPHYS RES-OCEANS, V108, DOI 10.1029/2001JC000882; Babin M, 1996, DEEP-SEA RES PT I, V43, P1241, DOI 10.1016/0967-0637(96)00058-1; BABIN M, 1994, LIMNOL OCEANOGR, V39, P694, DOI 10.4319/lo.1994.39.3.0694; Barranguet C, 2000, MAR ECOL PROG SER, V204, P39, DOI 10.3354/meps204039; Behrenfeld MJ, 2004, J PHYCOL, V40, P4, DOI 10.1046/j.1529-8817.2004.03083.x; BIRMINGHAM BC, 1982, PLANT PHYSIOL, V69, P259, DOI 10.1104/pp.69.1.259; BURNS BD, 1987, J EXP MAR BIOL ECOL, V107, P75, DOI 10.1016/0022-0981(87)90125-0; Claquin P, 2004, EUR J PHYCOL, V39, P33, DOI 10.1080/0967026032000157165; Claquin P, 2010, ESTUAR COAST SHELF S, V86, P93, DOI 10.1016/j.ecss.2009.10.017; Cloern JE, 1996, REV GEOPHYS, V34, P127, DOI 10.1029/96RG00986; EILERS PHC, 1988, ECOL MODEL, V42, P199, DOI 10.1016/0304-3800(88)90057-9; Falkowski P.G., 1985, Internationale Vereinigung fuer Theoretische und Angewandte Limnologie Verhandlungen, V22, P2830; Falkowski P.G., 2007, AQUATIC PHOTOSYNTHES; Flameling IA, 1998, LIMNOL OCEANOGR, V43, P284, DOI 10.4319/lo.1998.43.2.0284; Gaxiola-Castro G, 1999, J PLANKTON RES, V21, P231, DOI 10.1093/plankt/21.2.231; Geel C, 1997, PHOTOSYNTH RES, V51, P61, DOI 10.1023/A:1005779112140; GENTY B, 1989, BIOCHIM BIOPHYS ACTA, V990, P87, DOI 10.1016/S0304-4165(89)80016-9; Grangere K, 2009, ESTUAR COAST SHELF S, V81, P169, DOI 10.1016/j.ecss.2008.10.009; HAMA T, 1983, MAR BIOL, V73, P31, DOI 10.1007/BF00396282; Hancke K, 2008, J PHYCOL, V44, P501, DOI 10.1111/j.1529-8817.2008.00487.x; Hartig P, 1998, MAR ECOL PROG SER, V166, P53, DOI 10.3354/meps166053; Johnsen G, 2007, J PHYCOL, V43, P1236, DOI 10.1111/j.1529-8817.2007.00422.x; Jouenne F, 2007, MAR BIOL, V151, P805, DOI 10.1007/s00227-006-0440-z; Juneau P, 2005, PHOTOCHEM PHOTOBIOL, V81, P649, DOI 10.1562/2005-01-13-RA-414.1; KOLBER Z, 1988, PLANT PHYSIOL, V88, P923, DOI 10.1104/pp.88.3.923; KOLBER Z, 1993, LIMNOL OCEANOGR, V38, P1646, DOI 10.4319/lo.1993.38.8.1646; Kromkamp JC, 2003, EUR J PHYCOL, V38, P103, DOI 10.1080/0967026031000094094; Lefebvre S, 2007, J PHOTOCH PHOTOBIO B, V86, P131, DOI 10.1016/j.jphotobiol.2006.08.012; Lippemeier S, 1999, J PLANKTON RES, V21, P269, DOI 10.1093/plankt/21.2.269; Lomas MW, 1999, LIMNOL OCEANOGR, V44, P556, DOI 10.4319/lo.1999.44.3.0556; Marchetti A, 2006, DEEP-SEA RES PT II, V53, P2131, DOI 10.1016/j.dsr2.2006.05.032; Masojidek J, 2001, J PLANKTON RES, V23, P57, DOI 10.1093/plankt/23.1.57; Morris EP, 2003, EUR J PHYCOL, V38, P133, DOI 10.1080/0967026031000085832; Napoleon C, 2012, J SEA RES, V69, P43, DOI 10.1016/j.seares.2012.01.005; NELSON NB, 1993, MAR ECOL PROG SER, V94, P217, DOI 10.3354/meps094217; Pannard A, 2008, ESTUAR COAST SHELF S, V80, P212, DOI 10.1016/j.ecss.2008.08.008; Parkhill JP, 2001, J PHYCOL, V37, P517, DOI 10.1046/j.1529-8817.2001.037004517.x; PAULY D, 1995, NATURE, V374, P255, DOI 10.1038/374255a0; PELTIER G, 1985, PLANT PHYSIOL, V79, P225, DOI 10.1104/pp.79.1.225; Platt T, 2008, REMOTE SENS ENVIRON, V112, P3437, DOI 10.1016/j.rse.2007.11.018; PREZELIN BB, 1986, MAR BIOL, V93, P1, DOI 10.1007/BF00428648; Raven JA, 2000, J MAR BIOL ASSOC UK, V80, P1, DOI 10.1017/S0025315499001526; Reynolds CS, 2006, ECOL BIODIVERS CONS, P1, DOI 10.2277/ 0521605199; SAVIDGE G, 1995, DEEP-SEA RES PT I, V42, P599, DOI 10.1016/0967-0637(95)00016-Y; Schaeffer BA, 2007, J PHYCOL, V43, P702, DOI 10.1111/j.1529-8817.2007.00377.x; SCHREIBER U, 1986, PHOTOSYNTH RES, V10, P51, DOI 10.1007/BF00024185; Tan SC, 2009, J GEOPHYS RES-BIOGEO, V114, DOI 10.1029/2008JG000854; WELSCHMEYER NA, 1994, LIMNOL OCEANOGR, V39, P1985, DOI 10.4319/lo.1994.39.8.1985; Wilhelm C, 2006, PROTIST, V157, P91, DOI 10.1016/j.protis.2006.02.003; Xue XP, 1996, PLANT PHYSIOL, V112, P1005, DOI 10.1104/pp.112.3.1005	53	28	29	2	38	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 20	2012	7	7							e40284	10.1371/journal.pone.0040284	http://dx.doi.org/10.1371/journal.pone.0040284			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	977GL	22911698	Green Published, gold			2022-12-25	WOS:000306644600016
J	Savin, C; Leclercq, A; Carniel, E				Savin, Cyril; Leclercq, Alexandre; Carniel, Elisabeth			Evaluation of a Single Procedure Allowing the Isolation of Enteropathogenic Yersinia along with Other Bacterial Enteropathogens from Human Stools	PLOS ONE			English	Article							SELECTIVE AGAR MEDIUM; ENTEROCOLITICA INFECTION; PSEUDOTUBERCULOSIS; ENRICHMENT; SEROTYPE-O3; RECOVERY; OUTBREAK; MEDIA; BROTH	Enteropathogenic Yersinia are among the most frequent agents of human diarrhea in temperate and cold countries. However, the incidence of yersiniosis is largely underestimated because of the peculiar growth characteristics of pathogenic Yersinia, which make their isolation from poly-contaminated samples difficult. The use of specific procedures for Yersinia isolation is required, but is expensive and time consuming, and therefore is not systematically performed in clinical pathology laboratories. A means to circumvent this problem would be to use a single procedure for the isolation of all bacterial enteropathogens. Since the Statens Serum Institut enteric medium (SSI) has been reported to allow the growth at 37 degrees C of most Gram-negative bacteria, including Yersinia, our study aimed at evaluating its performances for Yersinia isolation, as compared to the commonly used Yersinia-specific semi-selective Cefsulodin-Irgasan-Novobiocin medium (CIN) incubated at 28 degrees C. Our results show that Yersinia pseudotuberculosis growth was strongly inhibited on SSI at 37 degrees C, and therefore that this medium is not suitable for the isolation of this species. All Yersinia enterocolitica strains tested grew on SSI, while some non-pathogenic Yersinia species were inhibited. The morphology of Y. enterocolitica colonies on SSI allowed their differentiation from various other Gram-negative bacteria commonly isolated from stool samples. However, in artificially contaminated human stools, the recovery of Y. enterocolitica colonies on SSI at 37 degrees C was difficult and was 3 logs less sensitive than on CIN at 28 degrees C. Therefore, despite its limitations, the use of a specific procedure (CIN incubated at 28 degrees C) is still required for an efficient isolation of enteropathogenic Yersinia from stools.	[Savin, Cyril] Inst Pasteur, Yersinia Res Unit, Paris, France; Inst Pasteur, Natl Reference Lab, Paris, France	Le Reseau International des Instituts Pasteur (RIIP); Institut Pasteur Paris; Le Reseau International des Instituts Pasteur (RIIP); Institut Pasteur Paris	Savin, C (corresponding author), Inst Pasteur, Yersinia Res Unit, Paris, France.	cyril.savin@pasteur.fr	Alexandre, Leclercq Jean-Louis/H-2140-2018; Savin, Cyril/ABG-3807-2020	Alexandre, Leclercq Jean-Louis/0000-0003-3778-7313; Savin, Cyril/0000-0003-2659-3433	'Institut de Veille Sanitaire' (InVS), France	'Institut de Veille Sanitaire' (InVS), France	This work was funded in part by the 'Institut de Veille Sanitaire' (InVS), France. No additional external funding received for this study. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ackers ML, 2000, J INFECT DIS, V181, P1834, DOI 10.1086/315436; BERCOVIER H, 1984, CURR MICROBIOL, V10, P121, DOI 10.1007/BF01576770; BLACK RE, 1978, NEW ENGL J MED, V298, P76, DOI 10.1056/NEJM197801122980204; Blom M, 1999, J CLIN MICROBIOL, V37, P2312, DOI 10.1128/JCM.37.7.2312-2316.1999; Bottone EJ, 1997, CLIN MICROBIOL REV, V10, P257, DOI 10.1128/CMR.10.2.257; Bottone EJ, 1999, MICROBES INFECT, V1, P323, DOI 10.1016/S1286-4579(99)80028-8; Carniel E, 2006, PROKARYOTES: A HANDBOOK ON THE BIOLOGY OF BACTERIA, VOL 6, THIRD EDITION, P270, DOI 10.1007/0-387-30746-x_13; Denis M, 2011, J PATHOG, V2011, DOI 10.4061/2011/296275; DEZUTTER L, 1994, INT J FOOD MICROBIOL, V23, P231, DOI 10.1016/0168-1605(94)90057-4; European Food Safety Authority, 2011, EFSA Journal, V9, P2090; Fredriksson-Ahomaa M, 2003, CLIN MICROBIOL REV, V16, P220, DOI 10.1128/CMR.16.2.220-229.2003; FUKUSHIMA H, 1986, J CLIN MICROBIOL, V24, P116, DOI 10.1128/JCM.24.1.116-120.1986; FUKUSHIMA H, 1987, J CLIN MICROBIOL, V25, P1068, DOI 10.1128/JCM.25.6.1068-1073.1987; Gilliss Debra, 2011, Morbidity and Mortality Weekly Report, V60, P749; Hallanvuo S, 2006, J CLIN MICROBIOL, V44, P1077, DOI 10.1128/JCM.44.3.1077-1080.2006; HEAD CB, 1982, J CLIN MICROBIOL, V16, P615, DOI 10.1128/JCM.16.4.615-621.1982; HOOGKAMPKORSTANJE JAA, 1986, J INFECT DIS, V153, P138, DOI 10.1093/infdis/153.1.138; Jalava K, 2004, J CLIN MICROBIOL, V42, P2789, DOI 10.1128/JCM.42.6.2789-2791.2004; Jalava K, 2006, J INFECT DIS, V194, P1209, DOI 10.1086/508191; Jiang GC, 2000, J FOOD PROTECT, V63, P1483, DOI 10.4315/0362-028X-63.11.1483; LJUNGBERG P, 1995, EUR J CLIN MICROBIOL, V14, P804, DOI 10.1007/BF01690998; Long C, 2010, EMERG INFECT DIS, V16, P566, DOI 10.3201/eid1603.091106; MARKS MI, 1980, J PEDIATR-US, V96, P26, DOI 10.1016/S0022-3476(80)80318-0; Okwori AEJ, 2009, FOOD MICROBIOL, V26, P872, DOI 10.1016/j.fm.2009.06.001; SATO K, 1983, PEDIATR INFECT DIS J, V2, P123, DOI 10.1097/00006454-198303000-00011; Savin C, 2010, B EPID HEBD, V29, P307; Savin C, 2008, REV FRANCOPH LAB, V400, P49; SCHIEMANN DA, 1979, CAN J MICROBIOL, V25, P1298, DOI 10.1139/m79-205; Smirnova YY, 2004, EPIDEMIOLOGICAL FEAT; SOMOV GP, 1973, CONTRIB MICROBIOL IM, V2, P214; TSUBOKURA M, 1989, J CLIN MICROBIOL, V27, P790, DOI 10.1128/JCM.27.4.790-791.1989; VANNOYEN R, 1980, J CLIN MICROBIOL, V11, P127, DOI 10.1128/JCM.11.2.127-131.1980; VERHAEGEN J, 1991, CONTRIB TO MICROBIOL, V12, P11; WAUTERS G, 1988, APPL ENVIRON MICROB, V54, P851, DOI 10.1128/AEM.54.4.851-854.1988; WEAGANT SD, 1983, APPL ENVIRON MICROB, V45, P468, DOI 10.1128/AEM.45.2.468-471.1983; Weagant SD, 2008, J MICROBIOL METH, V72, P185, DOI 10.1016/j.mimet.2007.11.019; Weber P, 2003, B EPID HEBD, V8, P45; Zheng H, 2008, EUR J CLIN MICROBIOL, V27, P741, DOI 10.1007/s10096-008-0562-y	38	11	13	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 20	2012	7	7							e41176	10.1371/journal.pone.0041176	http://dx.doi.org/10.1371/journal.pone.0041176			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	977GL	22911756	Green Published, gold, Green Submitted			2022-12-25	WOS:000306644600052
J	de Leeuw, R; Flach, K; Toaldo, CB; Alexi, X; Canisius, S; Neefjes, J; Michalides, R; Zwart, W				de Leeuw, R.; Flach, K.; Toaldo, C. Bentin; Alexi, X.; Canisius, S.; Neefjes, J.; Michalides, R.; Zwart, W.			PKA phosphorylation redirects ER alpha to promoters of a unique gene set to induce tamoxifen resistance	ONCOGENE			English	Article						estrogen receptor; breast cancer; protein kinase A; tamoxifen resistance; myc; ChIP-seq	ESTROGEN-RECEPTOR-ALPHA; BREAST-CANCER; PROTEIN-KINASE; NUCLEAR P21-ACTIVATED-KINASE-1; SERINE 305; CHIP-SEQ; ACTIVATION; EXPRESSION; TRANSCRIPTION; GROWTH	Protein kinase A (PKA)-induced estrogen receptor alpha (ER alpha) phosphorylation at serine residue 305 (ER alpha S305-P) can induce tamoxifen (TAM) resistance in breast cancer. How this phospho-modification affects ER alpha specificity and translates into TAM resistance is unclear. Here, we show that S305-P modification of ER alpha reprograms the receptor, redirecting it to new transcriptional start sites, thus modulating the transcriptome. By altering the chromatin-binding pattern, Ser305 phosphorylation of ER alpha translates into a 26-gene expression classifier that identifies breast cancer patients with a poor disease outcome after TAM treatment. MYC-target genes and networks were significantly enriched in this gene classifier that includes a number of selective targets for ER alpha S305-P. The enhanced expression of MYC increased cell proliferation in the presence of TAM. We demonstrate that activation of the PKA signaling pathway alters the transcriptome by redirecting ERa to new transcriptional start sites, resulting in altered transcription and TAM resistance.	[de Leeuw, R.; Toaldo, C. Bentin; Neefjes, J.; Michalides, R.] Netherlands Canc Inst, Dept Cell Biol, NL-1066 CX Amsterdam, Netherlands; [Flach, K.; Alexi, X.; Canisius, S.; Zwart, W.] Netherlands Canc Inst, Dept Mol Pathol, NL-1066 CX Amsterdam, Netherlands; [Canisius, S.] Netherlands Canc Inst, Dept Mol Biol, NL-1066 CX Amsterdam, Netherlands	Netherlands Cancer Institute; Netherlands Cancer Institute; Netherlands Cancer Institute	Zwart, W (corresponding author), Netherlands Canc Inst, Dept Mol Pathol, Plesmanlaan 121, NL-1066 CX Amsterdam, Netherlands.	w.zwart@nki.nl	Neefjes, Jacques J.C./H-8780-2017	Neefjes, Jacques J.C./0000-0001-6763-2211; Zwart, Wilbert/0000-0002-9823-7289; de Leeuw, Renee/0000-0002-5550-7613	Top Institute Pharma; KWF Dutch Cancer Society Fellowship	Top Institute Pharma; KWF Dutch Cancer Society Fellowship	We thank the Central Microarray Facility of the Netherlands Cancer Institute for processing the microarray samples. RL is in part supported by Top Institute Pharma. WZ is supported by a KWF Dutch Cancer Society Fellowship.	Al-Dhaheri MH, 2007, MOL ENDOCRINOL, V21, P439, DOI 10.1210/me.2006-0059; Bossis I, 2004, ENDOCRINOLOGY, V145, P5452, DOI 10.1210/en.2004-0900; Bostner J, 2010, CLIN CANCER RES, V16, P1624, DOI 10.1158/1078-0432.CCR-09-1733; BOUSSIF O, 1995, P NATL ACAD SCI USA, V92, P7297, DOI 10.1073/pnas.92.16.7297; Buffa FM, 2011, CANCER RES, V71, P5635, DOI 10.1158/0008-5472.CAN-11-0489; Callero MA, 2011, INT J BREAST CANCER, V2011, DOI 10.4061/2011/923250; Carascossa S, 2010, GENE DEV, V24, P708, DOI 10.1101/gad.568410; Carroll JS, 2006, NAT GENET, V38, P1289, DOI 10.1038/ng1901; Carroll JS, 2005, CELL, V122, P33, DOI 10.1016/j.cell.2005.05.008; Chandra V, 2008, NATURE, V456, P350, DOI 10.1038/nature07413; Chen DS, 1999, MOL CELL BIOL, V19, P1002; de Leeuw R, 2011, INT J BREAST CANCER, V2011, DOI 10.4061/2011/232435; Dudek P, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001859; Fan P, 2007, CANCER RES, V67, P1352, DOI 10.1158/0008-5472.CAN-06-1020; Ferlay J, 2010, IARC CANCERBASE; Frietze S, 2008, CANCER RES, V68, P301, DOI 10.1158/0008-5472.CAN-07-1983; Fullwood MJ, 2009, NATURE, V462, P58, DOI 10.1038/nature08497; Gee JMW, 2001, INT J CANCER, V95, P247, DOI 10.1002/1097-0215(20010720)95:4<247::AID-IJC1042>3.0.CO;2-S; He HSHS, 2010, NAT GENET, V42, P343, DOI 10.1038/ng.545; Holm C, 2009, J PATHOL, V217, P372, DOI 10.1002/path.2455; Hurtado A, 2011, NAT GENET, V43, P27, DOI 10.1038/ng.730; Inoue A, 2004, J MOL ENDOCRINOL, V32, P649, DOI 10.1677/jme.0.0320649; Ji XW, 2006, NUCLEIC ACIDS RES, V34, pW551, DOI 10.1093/nar/gkl322; KATO S, 1995, SCIENCE, V270, P1491, DOI 10.1126/science.270.5241.1491; Kirkegaard T, 2005, J PATHOL, V207, P139, DOI 10.1002/path.1829; Kok M, 2011, BREAST CANCER RES TR, V125, P1, DOI 10.1007/s10549-010-0798-y; Krum SA, 2008, MOL ENDOCRINOL, V22, P2393, DOI 10.1210/me.2008-0100; Loi S, 2007, J CLIN ONCOL, V25, P1239, DOI 10.1200/JCO.2006.07.1522; Louie MC, 2010, MOL CANCER RES, V8, P343, DOI 10.1158/1541-7786.MCR-09-0395; Lupien M, 2010, GENE DEV, V24, P2219, DOI 10.1101/gad.1944810; Lupien M, 2009, MOL CELL BIOL, V29, P3413, DOI 10.1128/MCB.00020-09; Madak-Erdogan Z, 2012, TOXICOL SCI, V125, P401, DOI 10.1093/toxsci/kfr300; Madak-Erdogan Z, 2011, MOL CELL BIOL, V31, P226, DOI 10.1128/MCB.00821-10; Massarweh S, 2008, CANCER RES, V68, P826, DOI 10.1158/0008-5472.CAN-07-2707; Michalides R, 2004, CANCER CELL, V5, P597, DOI 10.1016/j.ccr.2004.05.016; Miller TW, 2011, CLIN CANCER RES, V17, P2024, DOI 10.1158/1078-0432.CCR-10-2567; Miller WR, 2002, ANN NY ACAD SCI, V968, P37, DOI 10.1111/j.1749-6632.2002.tb04325.x; Musgrove EA, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002987; Rayala SK, 2006, CANCER RES, V66, P1694, DOI 10.1158/0008-5472.CAN-05-2922; Rayala SK, 2006, CANCER RES, V66, P5985, DOI 10.1158/0008-5472.CAN-06-0978; REINER GCA, 1986, CANCER RES, V46, P1124; Riggins RB, 2007, CANCER LETT, V256, P1, DOI 10.1016/j.canlet.2007.03.016; Robertson JFR, 2004, CANCER TREAT REV, V30, P695, DOI 10.1016/j.ctrv.2004.04.003; Robinson JLL, 2011, EMBO J, V30, P3019, DOI 10.1038/emboj.2011.216; Schmidt D, 2009, METHODS, V48, P240, DOI 10.1016/j.ymeth.2009.03.001; Shiau AK, 1998, CELL, V95, P927, DOI 10.1016/S0092-8674(00)81717-1; Shou J, 2004, JNCI-J NATL CANCER I, V96, P926, DOI 10.1093/jnci/djh166; Skliris GP, 2009, BREAST CANCER RES TR, V118, P443, DOI 10.1007/s10549-008-0267-z; Skliris GP, 2010, ENDOCR-RELAT CANCER, V17, P589, DOI 10.1677/ERC-10-0030; Sorlie T, 2001, P NATL ACAD SCI USA, V98, P10869, DOI 10.1073/pnas.191367098; Suzuki T, 2007, ENDOCR-RELAT CANCER, V14, P279, DOI 10.1677/ERC-06-0005; Wang CY, 2011, MOL ENDOCRINOL, V25, P1527, DOI 10.1210/me.2011-1037; Welboren WJ, 2009, EMBO J, V28, P1418, DOI 10.1038/emboj.2009.88; Wu RC, 2004, MOL CELL, V15, P937, DOI 10.1016/j.molcel.2004.08.019; Yi P, 2008, MOL CELL, V29, P465, DOI 10.1016/j.molcel.2007.12.030; Zang CZ, 2009, BIOINFORMATICS, V25, P1952, DOI 10.1093/bioinformatics/btp340; Zhang Y, 2008, GENOME BIOL, V9, DOI 10.1186/gb-2008-9-9-r137; Zwart W, 2007, EMBO J, V26, P3534, DOI 10.1038/sj.emboj.7601791	58	28	28	0	12	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	JUL 25	2013	32	30					3543	3551		10.1038/onc.2012.361	http://dx.doi.org/10.1038/onc.2012.361			9	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	188UQ	22907427				2022-12-25	WOS:000322220800007
J	Gonzalez-Gonzalez, M; Munoz-Bellvis, L; Mackintosh, C; Fontanillo, C; Gutierrez, ML; Abad, MM; Bengoechea, O; Teodosio, C; Fonseca, E; Fuentes, M; De Las Rivas, J; Orfao, A; Sayagues, JM				Gonzalez-Gonzalez, Maria; Munoz-Bellvis, Luis; Mackintosh, Carlos; Fontanillo, Celia; Laura Gutierrez, M.; Mar Abad, M.; Bengoechea, Oscar; Teodosio, Cristina; Fonseca, Emilio; Fuentes, Manuel; De Las Rivas, Javier; Orfao, Alberto; Maria Sayagues, Jose			Prognostic Impact of del(17p) and del(22q) as Assessed by Interphase FISH in Sporadic Colorectal Carcinomas	PLOS ONE			English	Article							COMPARATIVE GENOMIC HYBRIDIZATION; LIVER METASTASIS; TUMOR-SUPPRESSOR; CHROMOSOME 22Q13; HUMAN BREAST; CANCER; ADENOCARCINOMA; INSTABILITY; PROGRESSION; EXPRESSION	Background: Most sporadic colorectal cancer (sCRC) deaths are caused by metastatic dissemination of the primary tumor. New advances in genetic profiling of sCRC suggest that the primary tumor may contain a cell population with metastatic potential. Here we compare the cytogenetic profile of primary tumors from liver metastatic versus non-metastatic sCRC. Methodology/Principal Findings: We prospectively analyzed the frequency of numerical/structural abnormalities of chromosomes 1, 7, 8, 13, 14, 17, 18, 20, and 22 by iFISH in 58 sCRC patients: thirty-one non-metastatic (54%) vs. 27 metastatic (46%) disease. From a total of 18 probes, significant differences emerged only for the 17p11.2 and 22q11.2 chromosomal regions. Patients with liver metastatic sCRC showed an increased frequency of del(17p11.2) (10% vs. 67%; p<.001) and del(22q11.2) (0% vs. 22%; p=.02) versusnon-metastatic cases. Multivariate analysis of prognostic factors for overall survival (OS) showed that the only clinical and cytogenetic parameters that had an independent adverse impact on patient outcome were the presence of del(17p) with a 17p11.2 breakpoint and del(22q11.2). Based on these two cytogenetic variables, patients were classified into three groups: low- (no adverse features), intermediate- (one adverse feature) and high-risk (two adverse features)-with significantly different OS rates at 5-years (p<.001): 92%, 53% and 0%, respectively. Conclusions/Significance: Our results unravel the potential implication of del(17p11.2) in sCRC patients with liver metastasis as this cytogenetic alteration appears to be intrinsically related to an increased metastatic potential and a poor outcome, providing additional prognostic information to that associated with other cytogenetic alterations such as del(22q11.2). Additional prospective studies in larger series of patients would be required to confirm the clinical utility of the new prognostic markers identified.	[Gonzalez-Gonzalez, Maria; Laura Gutierrez, M.; Teodosio, Cristina; Fuentes, Manuel; Orfao, Alberto; Maria Sayagues, Jose] Univ Salamanca, Hosp Univ Salamanca IBSAL, Dept Med, Serv Gen Citometria, E-37008 Salamanca, Spain; [Gonzalez-Gonzalez, Maria; Laura Gutierrez, M.; Teodosio, Cristina; Fuentes, Manuel; Orfao, Alberto; Maria Sayagues, Jose] Univ Salamanca, Hosp Univ Salamanca IBSAL, Ctr Invest Canc IBMCC CSIC USAL, E-37008 Salamanca, Spain; [Munoz-Bellvis, Luis] Hosp Univ Salamanca IBSAL, Dept Cirugia, Unidad Cirugia Hepatobiliopancreat, Salamanca, Spain; [Fontanillo, Celia; De Las Rivas, Javier] Univ Salamanca, Ctr Invest Canc IBMCC CSIC USAL, Grp Invest Bioinformat & Genom Func, E-37008 Salamanca, Spain; [Mar Abad, M.; Bengoechea, Oscar] Hosp Univ Salamanca IIBSAL, Dept Patol, Salamanca, Spain; [Fonseca, Emilio] Hosp Univ Salamanca IBSAL, Dept Oncol Med, Salamanca, Spain	University of Salamanca; Consejo Superior de Investigaciones Cientificas (CSIC); CSIC-USAL - Instituto de Biologia Molecular y Celular del Cancer de Salamanca (IBMCC); University of Salamanca; Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Centro de Investigacion del Cancer (CIC); CSIC-USAL - Instituto de Biologia Molecular y Celular del Cancer de Salamanca (IBMCC); University of Salamanca	Gonzalez-Gonzalez, M (corresponding author), Univ Salamanca, Hosp Univ Salamanca IBSAL, Dept Med, Serv Gen Citometria, E-37008 Salamanca, Spain.	orfao@usal.es; ppmari@usal.es	Muñoz-Bellvis, Luis/A-2245-2016; Gutiérrez, María Laura/AAY-9195-2020; De Las Rivas, Javier/G-5936-2014; Fuentes, Manuel/B-5957-2017; Orfao, Alberto/B-5801-2017; Gutiérrez, María Laura ML/J-4313-2016; Muñoz-Bellvis, Luis/AAU-7364-2021	Muñoz-Bellvis, Luis/0000-0002-7809-5201; Gutiérrez, María Laura/0000-0003-2997-6317; De Las Rivas, Javier/0000-0002-0984-9946; Fuentes, Manuel/0000-0002-7305-3766; Gutiérrez, María Laura ML/0000-0003-2997-6317; Muñoz-Bellvis, Luis/0000-0002-7809-5201; , Maria Gonzalez-Gonzalez/0000-0001-8115-1086; Mackintosh, Carlos/0000-0002-6786-9558; Teodosio, Cristina/0000-0002-2097-7199; Fontanillo, Celia/0000-0002-3631-7881	Consejeria de Sanidad, Junta de Castilla y Leon, Valladolid, Spain [SAN673/SA39/08, SAN/103/2011]; Fundacion Memoria de Don Samuel Solorzano Barruso, Salamanca, Spain; Caja de Burgos (Obra Social), Burgos, Spain; Grupo Excelencia de Castilla y Leon [GR37]; Red Tematica de Investigacion Cooperativa en Cancer (RTICC) from the Instituto de Salud Carlos III (ISCIII), Ministerio de Sanidad y Consumo, Madrid, Spain [PI12/02053-FIS, RD06/0020/0035-FEDER]; ISCIII, Ministerio de Ciencia e Innovacion, Madrid, Spain [CP05/00321, FI08/00721]; Caja de Burgos - Obra Social	Consejeria de Sanidad, Junta de Castilla y Leon, Valladolid, Spain(Junta de Castilla y Leon); Fundacion Memoria de Don Samuel Solorzano Barruso, Salamanca, Spain; Caja de Burgos (Obra Social), Burgos, Spain; Grupo Excelencia de Castilla y Leon; Red Tematica de Investigacion Cooperativa en Cancer (RTICC) from the Instituto de Salud Carlos III (ISCIII), Ministerio de Sanidad y Consumo, Madrid, Spain; ISCIII, Ministerio de Ciencia e Innovacion, Madrid, Spain(Instituto de Salud Carlos IIIMinistry of Science and Innovation, Spain (MICINN)Spanish Government); Caja de Burgos - Obra Social	This work has been partially supported by grants from the Consejeria de Sanidad, Junta de Castilla y Leon, Valladolid, Spain (SAN673/SA39/08 and SAN/103/2011), Fundacion Memoria de Don Samuel Solorzano Barruso, Salamanca, Spain, Caja de Burgos (Obra Social), Burgos, Spain, Grupo Excelencia de Castilla y Leon (GR37) and the Red Tematica de Investigacion Cooperativa en Cancer (RTICC) from the Instituto de Salud Carlos III (ISCIII), Ministerio de Sanidad y Consumo, Madrid, Spain (PI12/02053-FIS and RD06/0020/0035-FEDER). JM Sayagues and M Gonzalez are supported by grants (CP05/00321 and FI08/00721, respectively) from the ISCIII, Ministerio de Ciencia e Innovacion, Madrid, Spain.; The authors have the following competing interests: The study was partly funded by Caja de Burgos - Obra Social. This does not alter the authors' adherence to all the PLoS ONE policies on sharing data and materials, as detailed online in the guide for authors.	Al-Mulla F, 1999, GENE CHROMOSOME CANC, V24, P306, DOI 10.1002/(SICI)1098-2264(199904)24:4<306::AID-GCC3>3.0.CO;2-5; Arnold CN, 2005, CANCER-AM CANCER SOC, V104, P2035, DOI 10.1002/cncr.21462; Asghar U, 2010, CLIN COLORECTAL CANC, V9, P274, DOI 10.3816/CCC.2010.n.040; Ashktorab H, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0008879; Camps J, 2008, CANCER RES, V68, P1284, DOI 10.1158/0008-5472.CAN-07-2864; Castells A, 1999, GASTROENTEROLOGY, V117, P831, DOI 10.1016/S0016-5085(99)70341-0; Castells A, 2000, CANCER RES, V60, P2836; Chang SC, 2005, INT J ONCOL, V26, P65; Derks S, 2008, CARCINOGENESIS, V29, P434, DOI 10.1093/carcin/bgm270; Diep CB, 2003, J CLIN ONCOL, V21, P820, DOI 10.1200/JCO.2003.05.190; Garcia J, 2003, CYTOM PART B-CLIN CY, V51B, P14, DOI 10.1002/cyto.b.10006; Ghadimi BM, 2006, CELL ONCOL, V28, P273; Gurtner A, 2010, J BIOL CHEM, V285, P14160, DOI 10.1074/jbc.M109.094813; Hu XT, 2008, ONCOL REP, V19, P441; IINO H, 1994, CANCER, V73, P1324, DOI 10.1002/1097-0142(19940301)73:5<1324::AID-CNCR2820730503>3.0.CO;2-W; Jia M, 2010, PROTEOM CLIN APPL, V4, P816, DOI 10.1002/prca.201000006; KHINE K, 1994, CANCER, V73, P28, DOI 10.1002/1097-0142(19940101)73:1<28::AID-CNCR2820730107>3.0.CO;2-3; Kim DH, 2011, BLOOD, V117, P6906, DOI 10.1182/blood-2011-01-329797; Liu YL, 2010, J GASTROEN HEPATOL, V25, P1800, DOI 10.1111/j.1440-1746.2010.06352.x; Liu YL, 2012, CELL BIOCHEM BIOPHYS, V62, P229, DOI 10.1007/s12013-011-9287-0; Liu YL, 2011, J SURG ONCOL, V103, P283, DOI 10.1002/jso.21802; Losi L, 2004, ONCOL REP, V12, P1221; Mackintosh C, 2012, ONCOGENE, V31, P1287, DOI 10.1038/onc.2011.317; Maltzman T, 2001, GASTROENTEROLOGY, V121, P302, DOI 10.1053/gast.2001.26278; Sayagues JM, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013752; Sayagues JM, 2010, J PATHOL, V221, P308, DOI 10.1002/path.2712; Munoz-Bellvis L, 2012, MOD PATHOL; Paredes-Zaglul A, 1998, CLIN CANCER RES, V4, P879; Popat S, 2007, ANTICANCER RES, V27, P627; Poulogiannis G, 2010, J PATHOL, V220, P338, DOI 10.1002/path.2640; Re M, 2011, INT J IMMUNOPATH PH, V24, P603, DOI 10.1177/039463201102400306; Risio M, 2003, CANCER GENET CYTOGEN, V147, P44, DOI 10.1016/S0165-4608(03)00188-2; Sartore-Bianchi A, 2007, J CLIN ONCOL, V25, P3238, DOI 10.1200/JCO.2007.11.5956; Seicean R, 2011, HEPATO-GASTROENTEROL, V58, P1490, DOI 10.5754/hge11130; Sheffer M, 2009, P NATL ACAD SCI USA, V106, P7131, DOI 10.1073/pnas.0902232106; Sher RB, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023498; Syngal S, 1999, JAMA-J AM MED ASSOC, V282, P247, DOI 10.1001/jama.282.3.247; World Health Organization. WHO, 1981, INT HIST CLASS TUM V; YANA I, 1995, INT J CANCER, V60, P174, DOI 10.1002/ijc.2910600207; Yashiro M, 2010, BMC CANCER, V10, DOI 10.1186/1471-2407-10-303	40	12	14	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 17	2012	7	8							e42683	10.1371/journal.pone.0042683	http://dx.doi.org/10.1371/journal.pone.0042683			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	996DG	22912721	Green Submitted, gold, Green Published			2022-12-25	WOS:000308063700017
J	Tran, TP; Tu, HY; Liu, JX; Muelleman, RL; Li, YL				Tran, Thai P.; Tu, Huiyin; Liu, Jinxu; Muelleman, Robert L.; Li, Yu-Long			Mitochondria-Derived Superoxide Links to Tourniquet-Induced Apoptosis in Mouse Skeletal Muscle	PLOS ONE			English	Article							PERMEABILITY TRANSITION PORE; ISCHEMIA-REPERFUSION INJURY; CELL-DEATH; HEART-FAILURE; STEM-CELLS; COMPLEX-I; CONNEXIN-43; ISCHEMIA/REPERFUSION; CARDIOPROTECTION; NECROSIS	Our previous study has reported that superoxide mediates ischemia-reperfusion (IR)-induced necrosis in mouse skeletal muscle. However, it remains poorly understood whether IR induces apoptosis and what factors are involved in IR-induced apoptosis in skeletal muscle. Using a murine model of tourniquet-induced hindlimb IR, we investigated the relationship between mitochondrial dysfunction and apoptosis in skeletal muscle. Hindlimbs of C57/BL6 mice were subjected to 3 h ischemia and 4 h reperfusion via placement and release of a rubber tourniquet at the greater trochanter. Compared to sham treatment, tourniquet-induced IR significantly elevated mitochondria-derived superoxide production, activated opening of mitochondrial permeability transition pore (mPTP), and caused apoptosis in the gastrocnemius muscles. Pretreatment with a superoxide dismutase mimetic (tempol, 50 mg/kg) or a mitochondrial antioxidant (co-enzyme Q(10), 50 mg/kg) not only decreased mitochondria-derived superoxide production, but also inhibited mPTP opening and apoptosis in the IR gastrocnemius muscles. Additionally, an inhibitor of mPTP (cyclosporine A, 50 mg/kg) also inhibited both mPTP opening and apoptosis in the IR gastrocnemius muscles. These results suggest that mitochondria-derived superoxide overproduction triggers the mPTP opening and subsequently causes apoptosis in tourniquet-induced hindlimb IR.	[Tran, Thai P.; Tu, Huiyin; Liu, Jinxu; Muelleman, Robert L.; Li, Yu-Long] Univ Nebraska Med Ctr, Dept Emergency Med, Omaha, NE 68198 USA; [Li, Yu-Long] Univ Nebraska Med Ctr, Dept Cellular & Integrat Physiol, Omaha, NE USA	University of Nebraska System; University of Nebraska Medical Center; University of Nebraska System; University of Nebraska Medical Center	Tran, TP (corresponding author), Univ Nebraska Med Ctr, Dept Emergency Med, Omaha, NE 68198 USA.	yulongli@unmc.edu		, HUIYIN/0000-0002-1662-2088	National Heart, Lung, and Blood Institute [HL-098503]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL098503] Funding Source: NIH RePORTER	National Heart, Lung, and Blood Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	Support for this study was in part provided by a grant from National Heart, Lung, and Blood Institute (HL-098503) to Y-L. Li. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Baines CP, 2009, BASIC RES CARDIOL, V104, P181, DOI 10.1007/s00395-009-0004-8; Beekley AC, 2008, J TRAUMA, V64, pS28, DOI 10.1097/TA.0b013e318160937e; BELLAMY RF, 1984, MIL MED, V149, P55; Blaisdell FW, 2002, CARDIOVASC SURG, V10, P620, DOI 10.1016/S0967-2109(02)00070-4; Boengler K, 2006, HEART, V92, P1724, DOI 10.1136/hrt.2005.066878; Bopassa JC, 2006, CARDIOVASC RES, V69, P178, DOI 10.1016/j.cardiores.2005.07.014; BOVERIS A, 1973, BIOCHEM J, V134, P707, DOI 10.1042/bj1340707; Carey ME, 1996, J TRAUMA, V40, pS165, DOI 10.1097/00005373-199603001-00036; Cowled PA, 2001, EUR J VASC ENDOVASC, V21, P28, DOI 10.1053/ejvs.2000.1209; Crawford RS, 2007, AM J PHYSIOL-HEART C, V292, pH830, DOI 10.1152/ajpheart.00581.2006; Dalla Libera L, 1999, AM J PHYSIOL-CELL PH, V277, pC982, DOI 10.1152/ajpcell.1999.277.5.C982; Dalla Libera L, 2001, CIRCULATION, V103, P2195; Di Lisa F, 2007, HEART FAIL REV, V12, P249, DOI 10.1007/s10741-007-9028-z; Doyle GS, 2008, PREHOSP EMERG CARE, V12, P241, DOI 10.1080/10903120801907570; Green DR, 1998, SCIENCE, V281, P1309, DOI 10.1126/science.281.5381.1309; Halestrap AP, 2006, CIRC RES, V99, P10, DOI 10.1161/01.RES.0000233145.94073.b8; Halestrap AP, 2004, CARDIOVASC RES, V61, P372, DOI 10.1016/S0008-6363(03)00533-9; Honda HM, 2005, ANN NY ACAD SCI, V1047, P248, DOI 10.1196/annals.1341.022; Knight KR, 1999, INT J EXP PATHOL, V80, P169, DOI 10.1046/j.1365-2613.1999.00111.x; Kroemer G, 2003, CURR MED CHEM, V10, P1469, DOI 10.2174/0929867033457232; Kroemer G, 2000, NAT MED, V6, P513, DOI 10.1038/74994; Lambert AJ, 2008, FEBS LETT, V582, P1711, DOI 10.1016/j.febslet.2008.04.030; Lambert AJ, 2004, BIOCHEM J, V382, P511, DOI 10.1042/BJ20040485; Lee C, 2007, EMERG MED J, V24, P584, DOI 10.1136/emj.2007.046359; Lee YM, 2011, J CARDIOVASC PHARM, V58, P133, DOI 10.1097/FJC.0b013e31821a5078; Leung AWC, 2008, BBA-BIOENERGETICS, V1777, P946, DOI 10.1016/j.bbabio.2008.03.009; Li Y, 2011, BRAIN RES, V1382, P252, DOI 10.1016/j.brainres.2011.01.023; Li YL, 2007, CARDIOVASC RES, V75, P546, DOI 10.1016/j.cardiores.2007.04.006; Linkermann A, 2012, KIDNEY INT, V10; Lopez-Neblina F, 2005, J INVEST SURG, V18, P335, DOI 10.1080/08941930500328862; Lu G, 2012, REGEN MED, V7, P323, DOI [10.2217/RME.12.13, 10.2217/rme.12.13]; Lu G, 2012, ANTIOXID REDOX SIGN, V16, P217, DOI 10.1089/ars.2011.4112; Lu G, 2010, CARDIOVASC RES, V88, P277, DOI 10.1093/cvr/cvq293; Lu G, 2009, CIRCULATION, V119, P2587, DOI 10.1161/CIRCULATIONAHA.108.827691; Lv M, 2011, NEUROSCIENCE, V176, P162, DOI 10.1016/j.neuroscience.2010.11.066; Mabry RL, 2000, J TRAUMA, V49, P515, DOI 10.1097/00005373-200009000-00021; MAJNO G, 1995, AM J PATHOL, V146, P3; Matsuyama S, 2000, CELL DEATH DIFFER, V7, P1155, DOI 10.1038/sj.cdd.4400779; MATTOX KL, 1989, ANN SURG, V209, P698, DOI 10.1097/00000658-198906000-00007; Miles MV, 2007, MITOCHONDRION, V7, pS72, DOI 10.1016/j.mito.2007.02.012; Muller FL, 2004, J BIOL CHEM, V279, P49064, DOI 10.1074/jbc.M407715200; Murphy E, 2008, PHYSIOL REV, V88, P581, DOI 10.1152/physrev.00024.2007; Nicholson DW, 1999, CELL DEATH DIFFER, V6, P1028, DOI 10.1038/sj.cdd.4400598; Rodriguez-Sinovas A, 2006, CIRC RES, V99, P93, DOI 10.1161/01.RES.0000230315.56904.de; Rudiger HA, 2002, GASTROENTEROLOGY, V122, P202, DOI 10.1053/gast.2002.30304; SCHMITNEUERBURG KP, 1985, ACTA CHIR BELG, V85, P239; St-Pierre J, 2002, J BIOL CHEM, V277, P44784, DOI 10.1074/jbc.M207217200; Suzuki H, 1995, J CLIN INVEST, V96, P2892, DOI 10.1172/JCI118360; Tran TP, 2011, EUR J PHARMACOL, V650, P328, DOI 10.1016/j.ejphar.2010.10.037; Tu HY, 2012, J NEUROPHYSIOL, V107, P591, DOI 10.1152/jn.00754.2011; Van Cruchten S, 2002, ANAT HISTOL EMBRYOL, V31, P214, DOI 10.1046/j.1439-0264.2002.00398.x; Wang WZ, 2008, J ORTHOP RES, V26, P351, DOI 10.1002/jor.20493; Wang WZ, 2011, J SURG RES, V171, P175, DOI 10.1016/j.jss.2011.07.015; Weiss JN, 2003, CIRC RES, V93, P292, DOI 10.1161/01.RES.0000087542.26971.D4; Yao HP, 2007, CELL RES, V17, P565, DOI 10.1038/cr.2007.6; Yin JX, 2010, AM J PHYSIOL-CELL PH, V298, pC857, DOI 10.1152/ajpcell.00313.2009	56	32	33	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 17	2012	7	8							e43410	10.1371/journal.pone.0043410	http://dx.doi.org/10.1371/journal.pone.0043410			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	996DG	22912870	gold, Green Published, Green Submitted			2022-12-25	WOS:000308063700098
J	Yang, HJ; Wang, Y; Cheryan, VT; Wu, WJ; Cui, CQ; Polin, LA; Pass, HI; Dou, QP; Rishi, AK; Wali, A				Yang, Huanjie; Wang, Ying; Cheryan, Vino T.; Wu, Wenjuan; Cui, Cindy Qiuzhi; Polin, Lisa A.; Pass, Harvey I.; Dou, Q. Ping; Rishi, Arun K.; Wali, Anil			Withaferin A Inhibits the Proteasome Activity in Mesothelioma In Vitro and In Vivo	PLOS ONE			English	Article							APOPTOSIS-REGULATORY PROTEIN-1; MALIGNANT PLEURAL MESOTHELIOMA; COMPOUND WITHAFERIN; CANCER CELLS; KAPPA-B; GROWTH; TUMOR; CYCLE; RECEPTOR; MEDIATOR	The medicinal plant Withania somnifera has been used for over centuries in Indian Ayurvedic Medicine to treat a wide spectrum of disorders. Withaferin A (WA), a bioactive compound that is isolated from this plant, has anti-inflammatory, immuno-modulatory, anti-angiogenic, and anti-cancer properties. Here we investigated malignant pleural mesothelioma (MPM) suppressive effects of WA and the molecular mechanisms involved. WA inhibited growth of the murine as well as patient-derived MPM cells in part by decreasing the chymotryptic activity of the proteasome that resulted in increased levels of ubiquitinated proteins and pro-apoptotic proteasome target proteins (p21, Bax, I kappa B alpha). WA suppression of MPM growth also involved elevated apoptosis as evidenced by activation of pro-apoptotic p38 stress activated protein kinase (SAPK) and caspase-3, elevated levels of pro-apoptotic Bax protein and cleavage of poly-(ADP-ribose)-polymerase (PARP). Our studies including gene-array based analyses further revealed that WA suppressed a number of cell growth and metastasis-promoting genes including c-myc. WA treatments also stimulated expression of the cell cycle and apoptosis regulatory protein (CARP)-1/CCAR1, a novel transducer of cell growth signaling. Knock-down of CARP-1, on the other hand, interfered with MPM growth inhibitory effects of WA. Intra-peritoneal administration of 5 mg/kg WA daily inhibited growth of murine MPM cell-derived tumors in vivo in part by inhibiting proteasome activity and stimulating apoptosis. Together our in vitro and in vivo studies suggest that WA suppresses MPM growth by targeting multiple pathways that include blockage of proteasome activity and stimulation of apoptosis, and thus holds promise as an anti-MPM agent.	[Yang, Huanjie; Wang, Ying; Cui, Cindy Qiuzhi; Pass, Harvey I.; Dou, Q. Ping; Rishi, Arun K.; Wali, Anil] Wayne State Univ, Karmanos Canc Inst, Detroit, MI 48202 USA; [Cheryan, Vino T.; Wu, Wenjuan; Rishi, Arun K.; Wali, Anil] Wayne State Univ, John D Dingell VA Med Ctr, Detroit, MI USA; [Cheryan, Vino T.; Wu, Wenjuan; Polin, Lisa A.; Rishi, Arun K.] Wayne State Univ, Dept Oncol, Detroit, MI USA; [Dou, Q. Ping] Wayne State Univ, Dept Pathol, Detroit, MI 48202 USA; [Pass, Harvey I.] NYU, Ctr Canc, New York, NY USA; [Yang, Huanjie] Harbin Inst Technol, Dept Life Sci & Engn, Harbin 150006, Peoples R China	Barbara Ann Karmanos Cancer Institute; Wayne State University; Wayne State University; Wayne State University; Wayne State University; New York University; Harbin Institute of Technology	Yang, HJ (corresponding author), Wayne State Univ, Karmanos Canc Inst, Detroit, MI 48202 USA.	doup@karmanos.org; Rishia@Karmanos.org	Wu, wenjuan/GPX-6968-2022	Dou, Qingping/0000-0002-6465-1473; Pass, Harvey/0000-0003-3222-3471	Department of Veterans Affairs Merit Review; Mesothelioma Applied Research Foundation (MARF); National Cancer Institute [CA120009, CA112625]; National Cancer Institute at the National Institutes of Health (NCI/NIH) Cancer Center; NATIONAL CANCER INSTITUTE [R01CA120009, R03CA112625] Funding Source: NIH RePORTER	Department of Veterans Affairs Merit Review(US Department of Veterans Affairs); Mesothelioma Applied Research Foundation (MARF); National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); National Cancer Institute at the National Institutes of Health (NCI/NIH) Cancer Center; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported by the Department of Veterans Affairs Merit Review grants (AKR and AW), Mesothelioma Applied Research Foundation (MARF) support (AW), and National Cancer Institute Grants CA120009, CA112625 (QPD), and the National Cancer Institute at the National Institutes of Health (NCI/NIH) Cancer Center Support Grant to Karmanos Cancer Institute. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bargagna-Mohan P, 2007, CHEM BIOL, V14, P623, DOI 10.1016/j.chembiol.2007.04.010; Bhattacharya SK, 2002, PHYTOMEDICINE, V9, P167, DOI 10.1078/0944-7113-00089; CHOWDHURY K, 1975, BIOCHEM PHARMACOL, V24, P919, DOI 10.1016/0006-2952(75)90165-3; Devi P. Uma, 1996, Indian Journal of Experimental Biology, V34, P927; Dou Q Ping, 2003, Prog Cell Cycle Res, V5, P441; Falsey RR, 2006, NAT CHEM BIOL, V2, P33, DOI 10.1038/nchembio755; Gordon GJ, 2007, J PATHOL, V211, P439, DOI 10.1002/path.2120; Jolly C, 2000, JNCI-J NATL CANCER I, V92, P1564, DOI 10.1093/jnci/92.19.1564; Kalluri R, 2009, J CLIN INVEST, V119, P1420, DOI 10.1172/JCI39104; Kamp DW, 2009, TRANSL RES, V153, P143, DOI 10.1016/j.trsl.2009.01.004; Kim JH, 2008, MOL CELL, V31, P510, DOI 10.1016/j.molcel.2008.08.001; Lahat G, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010105; Malara N, 2008, CELL CYCLE, V7, P3235, DOI 10.4161/cc.7.20.6832; Malik F, 2007, APOPTOSIS, V12, P2115, DOI 10.1007/s10495-007-0129-x; Mohan Royce, 2004, Angiogenesis, V7, P115, DOI 10.1007/s10456-004-1026-3; Odaka M, 2001, CANCER RES, V61, P6201; Oh JH, 2008, EUR J PHARMACOL, V599, P11, DOI 10.1016/j.ejphar.2008.09.017; Pass HI, 2005, NEW ENGL J MED, V353, P1564, DOI 10.1056/NEJMoa051185; Peto J, 1999, BRIT J CANCER, V79, P666, DOI 10.1038/sj.bjc.6690105; Puliyappadamba VT, 2011, J BIOL CHEM, V286, P38000, DOI 10.1074/jbc.M111.222398; Rishi AK, 2006, J BIOL CHEM, V281, P13188, DOI 10.1074/jbc.M512279200; Rishi AK, 2003, J BIOL CHEM, V278, P33422, DOI 10.1074/jbc.M303173200; Smyth GK, 2005, STAT BIOL HEALTH, P397, DOI 10.1007/0-387-29362-0_23; Srinivasan S, 2007, CANCER RES, V67, P246, DOI 10.1158/0008-5472.CAN-06-2430; Stan SD, 2008, CANCER RES, V68, P7661, DOI 10.1158/0008-5472.CAN-08-1510; Su S, 2009, SEMIN THORAC CARDIOV, V21, P125, DOI 10.1053/j.semtcvs.2009.07.006; Suzuki E, 2007, CANCER RES, V67, P2351, DOI 10.1158/0008-5472.CAN-06-2389; Tarca AL, 2007, PLOS COMPUT BIOL, V3, P953, DOI 10.1371/journal.pcbi.0030116; Tsao AS, 2009, J CLIN ONCOL, V27, P2081, DOI 10.1200/JCO.2008.19.8523; Wang Y, 2011, MOL CELL BIOCHEM, V357, P83, DOI 10.1007/s11010-011-0878-2; Wang Y, 2010, CANCER CHEMOTH PHARM, V66, P455, DOI 10.1007/s00280-009-1181-8; Yang H, 2008, CURR PROTEIN PEPT SC, V9, P227, DOI 10.2174/138920308784533998; Yang HJ, 2007, MOL PHARMACOL, V71, P426, DOI 10.1124/mol.106.030015; Zhang LY, 2007, MOL CANCER THER, V6, P1661, DOI 10.1158/1535-7163.MCT-06-0653	34	36	38	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 17	2012	7	8							e41214	10.1371/journal.pone.0041214	http://dx.doi.org/10.1371/journal.pone.0041214			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	996DG	22912669	Green Published, gold, Green Submitted			2022-12-25	WOS:000308063700003
J	Grau, I; Ardanuy, C; Calatayud, L; Rolo, D; Domenech, A; Linares, J; Pallares, R				Grau, Imma; Ardanuy, Carmen; Calatayud, Laura; Rolo, Dora; Domenech, Arnau; Linares, Josefina; Pallares, Roman			Invasive Pneumococcal Disease in Healthy Adults: Increase of Empyema Associated with the Clonal-Type Sweden(1)-ST306	PLOS ONE			English	Article							STREPTOCOCCUS-PNEUMONIAE; CONJUGATE VACCINE; SEROTYPE REPLACEMENT; PENICILLIN; SUSCEPTIBILITY; EPIDEMIOLOGY; MORTALITY; BARCELONA; ERA	Background: Adult invasive pneumococcal disease (IPD) occurs mainly in the elderly and patients with co-morbidities. Little is known about the clinical characteristics, serotypes and genotypes causing IPD in healthy adults. Methods: We studied 745 culture-proven cases of IPD in adult patients aged 18-64 years (1996-2010). Patients were included in two groups: 1.) adults with co-morbidities, and 2.) healthy adults, who had no prior or coincident diagnosis of a chronic or immunosuppressive underlying disease. Microbiological studies included pneumococcal serotyping and genotyping. Results: Of 745 IPD episodes, 525 (70%) occurred in patients with co-morbidities and 220 (30%) in healthy adults. The healthy adults with IPD were often smokers (56%) or alcohol abusers (18%). As compared to patients with co-morbidities, the healthy adults had (P<0.05): younger age (43.5+/-13.1 vs. 48.7+/-11.3 years); higher proportions of women (45% vs. 24%), pneumonia with empyema (15% vs. 7%) and infection with non-PCV7 serotypes including serotypes 1 (25% vs. 5%), 7F (13% vs. 4%), and 5 (7% vs. 2%); and lower mortality (5% vs. 20%). Empyema was more frequently caused by serotype 1. No death occurred among 79 patients with serotype 1 IPD. There was an emergence of virulent clonal-types Sweden(1)-ST306 and Netherlands(7F)-ST191. The vaccine serotype coverage with the PCV13 was higher in healthy adults than in patients with co-morbidities: 82% and 56%, respectively, P<0.001. Conclusion: In this clinical study, one-third of adults with IPD had no underlying chronic or immunosuppressive diseases (healthy adults). They were often smokers and alcohol abusers, and frequently presents with pneumonia and empyema caused by virulent clones of non-PCV7 serotypes such as the Sweden(1)-ST306. Thus, implementing tobacco and alcohol abuse-cessation measures and a proper pneumococcal vaccination, such as PCV13 policy, in active smokers and alcohol abusers may diminish the burden of IPD in adults.	[Grau, Imma; Pallares, Roman] Univ Barcelona, Dept Infect Dis, Bellvitge Hosp, Idibell,Ciberes, Barcelona, Spain; [Ardanuy, Carmen; Calatayud, Laura; Rolo, Dora; Domenech, Arnau; Linares, Josefina] Univ Barcelona, Dept Microbiol, Bellvitge Hosp, Idibell,Ciberes, Barcelona, Spain	CIBER - Centro de Investigacion Biomedica en Red; CIBERES; Institut d'Investigacio Biomedica de Bellvitge (IDIBELL); Bellvitge University Hospital; University of Barcelona; CIBER - Centro de Investigacion Biomedica en Red; CIBERES; Institut d'Investigacio Biomedica de Bellvitge (IDIBELL); Bellvitge University Hospital; University of Barcelona	Grau, I (corresponding author), Univ Barcelona, Dept Infect Dis, Bellvitge Hosp, Idibell,Ciberes, Barcelona, Spain.	rpallares@ub.edu	PALLARES, Roman/B-5710-2008; Liñares, Josefina/N-9450-2014; Rolo, Dora/AAI-4326-2021; Rolo, Dora/G-4236-2015; Ardanuy, Carmen/C-4463-2015	PALLARES, Roman/0000-0003-3262-8508; Ardanuy, Carmen/0000-0003-0225-607X; Domenech, Arnau/0000-0002-0829-511X; Rolo, Dora/0000-0003-2704-8648; Rolo, Dora/0000-0003-4327-2279; Grau, Imma/0000-0002-3040-8184	Ministry of Health, Madrid, Spain [FIS-081922]; CIBER de Enfermedades Respiratorias [CIBERES - CB06/06/0037]; ISCIII - Instituto de Salud Carlos III, Ministry of Health, Madrid, Spain; FPU (Formacion Profesorado Universitario), Ministry of Education, Madrid, Spain	Ministry of Health, Madrid, Spain; CIBER de Enfermedades Respiratorias; ISCIII - Instituto de Salud Carlos III, Ministry of Health, Madrid, Spain; FPU (Formacion Profesorado Universitario), Ministry of Education, Madrid, Spain	This study was supported in part by a grant from the Ministry of Health (FIS-081922), Madrid, Spain, and by CIBER de Enfermedades Respiratorias (CIBERES - CB06/06/0037), an initiative of the ISCIII - Instituto de Salud Carlos III, Ministry of Health, Madrid, Spain. A. Domenech was supported by a grant from FPU (Formacion Profesorado Universitario), Ministry of Education, Madrid, Spain. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Advisory Committee on Immunization Practices, 2012, Ann Intern Med, V156, P211, DOI 10.7326/0003-4819-156-3-201202070-00388; Ardanuy C, 2009, CLIN INFECT DIS, V48, P57, DOI 10.1086/594125; Beall B, 2006, J CLIN MICROBIOL, V44, P999, DOI 10.1128/JCM.44.3.999-1017.2006; Bogaert D, 2004, LANCET INFECT DIS, V4, P144, DOI 10.1016/S1473-3099(04)00938-7; Brueggemann AB, 2004, J INFECT DIS, V190, P1203, DOI 10.1086/423820; Brueggemann AB, 2003, J CLIN MICROBIOL, V41, P4966, DOI 10.1128/JCM.41.11.4966-4970.2003; Burgos J, 2011, CLIN INFECT DIS, V53, P254, DOI 10.1093/cid/cir354; Clinical and Laboratory Standard Institute, 2009, M7A8 CLSINCCLS, V29; Clinical and Laboratory Standards Institute, 2011, M100S21 CLSI; de Lencastre H, 2002, J ANTIMICROB CHEMOTH, V50, P75, DOI 10.1093/jac/dkf511; Enright MC, 1998, MICROBIOL-UK, V144, P3049, DOI 10.1099/00221287-144-11-3049; Esteva C, 2011, CLIN MICROBIOL INFEC, V17, P1441, DOI 10.1111/j.1469-0691.2011.03526.x; Fenoll A, 2010, ANTIMICROB AGENTS CH, V54, P5387, DOI 10.1128/AAC.00217-10; Fiore MC, 2012, NEW ENGL J MED, V366, P1172, DOI 10.1056/NEJMp1115176; Gessner BD, 2010, BMC INFECT DIS, V10, DOI 10.1186/1471-2334-10-22; Grau I, 2005, ARCH INTERN MED, V165, P1533, DOI 10.1001/archinte.165.13.1533; Harboe ZB, 2009, PLOS MED, V6, DOI 10.1371/journal.pmed.1000081; Hausdorff WP, 2005, LANCET INFECT DIS, V5, P83, DOI 10.1016/S1473-3099(05)01280-6; Hsu HE, 2009, NEW ENGL J MED, V360, P244, DOI 10.1056/NEJMoa0800836; Huss A, 2009, CAN MED ASSOC J, V180, P48, DOI 10.1503/cmaj.080734; Klemets P, 2008, BMC INFECT DIS, V8, DOI 10.1186/1471-2334-8-96; Kyaw MH, 2005, J INFECT DIS, V192, P377, DOI 10.1086/431521; Marimon JM, 2009, CLIN MICROBIOL INFEC, V15, P875, DOI 10.1111/j.1469-0691.2009.02883.x; Marrie TJ, 2011, MEDICINE, V90, P171, DOI 10.1097/MD.0b013e31821a5a76; Miller E, 2011, LANCET INFECT DIS, V11, P760, DOI 10.1016/S1473-3099(11)70090-1; Munoz R, 1999, MOL MICROBIOL, V31, P703, DOI 10.1046/j.1365-2958.1999.01211.x; Musher DM, 2000, MEDICINE, V79, P210, DOI 10.1097/00005792-200007000-00002; Normark BH, 2001, J INFECT DIS, V184, P861, DOI 10.1086/323339; Nuorti JP, 2000, NEW ENGL J MED, V342, P681, DOI 10.1056/NEJM200003093421002; PALLARES R, 1995, NEW ENGL J MED, V333, P474, DOI 10.1056/NEJM199508243330802; Picazo J, 2011, PEDIATR INFECT DIS J, V30, P471, DOI 10.1097/INF.0b013e31820a418a; Ritchie ND, 2012, FUTURE MICROBIOL, V7, P33, DOI [10.2217/fmb.11.146, 10.2217/FMB.11.146]; Sa-Leao R, 2011, J CLIN MICROBIOL, V49, P1369, DOI 10.1128/JCM.01763-10; Sjostrom K, 2006, CLIN INFECT DIS, V42, P451, DOI 10.1086/499242; Smith KJ, 2012, JAMA-J AM MED ASSOC, V307, P804, DOI 10.1001/jama.2012.169; Weinberger DM, 2011, LANCET, V378, P1962, DOI 10.1016/S0140-6736(10)62225-8; Weinberger DM, 2010, CLIN INFECT DIS, V51, P692, DOI 10.1086/655828; Weinstein MP, 2009, CLIN INFECT DIS, V48, P1596, DOI 10.1086/598975; Whitney CG, 2003, NEW ENGL J MED, V348, P1737, DOI 10.1056/NEJMoa022823	39	31	31	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 13	2012	7	8							e42595	10.1371/journal.pone.0042595	http://dx.doi.org/10.1371/journal.pone.0042595			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	988OJ	22912711	Green Submitted, gold, Green Published			2022-12-25	WOS:000307500100016
J	Mutika, GN; Marin, C; Parker, AG; Boucias, DG; Vreysen, MJB; Abd-Alla, AMM				Mutika, Gratian N.; Marin, Carmen; Parker, Andrew G.; Boucias, Drion G.; Vreysen, Marc J. B.; Abd-Alla, Adly M. M.			Impact of Salivary Gland Hypertrophy Virus Infection on the Mating Success of Male Glossina pallidipes: Consequences for the Sterile Insect Technique	PLOS ONE			English	Article							MORSITANS-CENTRALIS DIPTERA; TSETSE-FLY; DNA VIRUS; ULTRASTRUCTURAL-CHANGES; FEMALE TSETSE; BEHAVIOR; POPULATIONS; RADIATION	Many species of tsetse flies are infected by a virus (GpSGHV) that causes salivary gland hypertrophy (SGH). Female Glossina pallidipes (Austen) with SGH symptoms (SGH+) have reduced fecundity and SGH+ male G. pallidipes are unable to inseminate female flies. Consequently, G. pallidipes laboratory colonies with a high prevalence of SGH have been difficult to maintain and have collapsed on several occasions. To assess the potential impact of the release of SGH+ sterile male G. pallidipes on the efficacy of an integrated control programme with a sterile insect technique (SIT) component, we examined the mating efficiency and behaviour of male G. pallidipes in field cages in relation to SGH prevalence. The results showed in a field cage setting a significantly reduced mating frequency of 19% for a male G. pallidipes population with a high prevalence of SGH (83%) compared to 38% for a male population with a low prevalence of SGH (7%). Premating period and mating duration did not vary significantly with SGH status. A high percentage (>80%) of females that had mated with SGH+ males had empty spermathecae. The remating frequency of female G. pallidipes was very low irrespective of the SGH status of the males in the first mating. These results indicate that a high prevalence of SGH+ in G. pallidipes not only affects colony stability and performance but, in view of their reduced mating propensity and competitiveness, releasing SGH+ sterile male G. pallidipes will reduce the efficiency of a sterile male release programme.	[Mutika, Gratian N.; Marin, Carmen; Parker, Andrew G.; Vreysen, Marc J. B.; Abd-Alla, Adly M. M.] Joint FAO IAEA Programme Nucl Techn Food & Agr, Insect Pest Control Lab, Vienna, Austria; [Boucias, Drion G.] Univ Florida, Dept Entomol & Nematol, Gainesville, FL 32611 USA	International Atomic Energy Agency; State University System of Florida; University of Florida	Mutika, GN (corresponding author), Joint FAO IAEA Programme Nucl Techn Food & Agr, Insect Pest Control Lab, Vienna, Austria.	a.m.m.abd-alla@iaea.org		ABD-ALLA, Adly/0000-0001-7540-4462; Parker, Andrew Gordon/0000-0001-8187-1278				Abd-Alla A, 2007, J VIROL METHODS, V139, P143, DOI 10.1016/j.jviromet.2006.09.018; Abd-Alla AMM, 2010, VIRUS RES, V150, P103, DOI 10.1016/j.virusres.2010.03.001; Abd-Alla AMM, 2009, VIRUS RES, V139, P48, DOI 10.1016/j.virusres.2008.10.006; Aksoy S, 2005, INSECT BIOCHEM MOLEC, V35, P691, DOI 10.1016/j.ibmb.2005.02.012; Bonomi A, 2011, PLOS NEGLECT TROP D, V5, DOI 10.1371/journal.pntd.0001190; Burand JP, 2006, ANN ENTOMOL SOC AM, V99, P969, DOI 10.1603/0013-8746(2006)99[969:MPAMBO]2.0.CO;2; Burand John P., 2009, Virologica Sinica, V24, P428, DOI 10.1007/s12250-009-3046-z; Burand JP, 2005, J INSECT SCI, V5, DOI 10.1093/jis/5.1.6; Calkins CO, 2005, STERILE INSECT TECHNIQUE: PRINCIPLES AND PRACTICE IN AREA-WIDE INTEGRATED PEST MANAGEMENT, P269, DOI 10.1007/1-4020-4051-2_10; CURTIS CF, 1968, J INSECT PHYSIOL, V14, P1365, DOI 10.1016/0022-1910(68)90172-8; DAME DA, 1968, B ENTOMOL RES, V58, P213, DOI 10.1017/S0007485300056789; Feldmann U, 1994, TECHNIQUES INSECT RE, P449; GILLOTT C, 1981, PHYSIOL ENTOMOL, V6, P269, DOI 10.1111/j.1365-3032.1981.tb00271.x; Glasgow JP, 1963, DISTRIBUTION ABUNDAN; Gooding R. H., 1997, The molecular biology of insect disease vectors: a methods manual., P41; Hendrichs J, 2005, STERILE INSECT TECHNIQUE: PRINCIPLES AND PRACTICE IN AREA-WIDE INTEGRATED PEST MANAGEMENT, P563, DOI 10.1007/1-4020-4051-2_22; Hendrichs J, 2002, FLA ENTOMOL, V85, P1, DOI 10.1653/0015-4040(2002)085[0001:MASITP]2.0.CO;2; JAENSON TGT, 1978, T ROY SOC TROP MED H, V72, P234, DOI 10.1016/0035-9203(78)90200-6; JAENSON TGT, 1986, ENTOMOL EXP APPL, V41, P265, DOI 10.1007/BF00221256; Jordan A, 1986, TRYPANOSOMIASIS CONT; Jordan A. M., 1958, Bulletin of Entomological Research London, V49, P35, DOI 10.1017/S0007485300053402; Jura WGZO, 1992, BIOL CONTROL, V2, P188, DOI 10.1016/1049-9644(92)90058-L; JURA WGZO, 1989, CURR MICROBIOL, V18, P1, DOI 10.1007/BF01568821; JURA WGZO, 1988, J INVERTEBR PATHOL, V52, P1, DOI 10.1016/0022-2011(88)90095-X; KOKWARO ED, 1990, J INVERTEBR PATHOL, V56, P337, DOI 10.1016/0022-2011(90)90120-U; Leak SGA., 1998, TSETSE BIOL ECOLOGY, DOI [10.1079/9780851993003.0000, DOI 10.1079/9780851993003.0000]; LEEGWATERVANDERLINDEN ME, 1984, ENTOMOL EXP APPL, V35, P283, DOI 10.1007/BF00369145; Lietze VU, 2011, ANNU REV ENTOMOL, V56, P63, DOI 10.1146/annurev-ento-120709-144841; Minitab Inc, 2000, MIN REL 13 32 MIN IN; Mutika GN, 2001, B ENTOMOL RES, V91, P281, DOI 10.1079/BER2001102; ODINDO MO, 1982, INSECT SCI APPL, V3, P59, DOI 10.1017/S1742758400001910; ODINDO MO, 1988, INSECT SCI APPL, V9, P399, DOI 10.1017/S1742758400006408; Pollock J.N., 1982, TRAINING MANUAL TSET, V1; Sang RC, 1996, J INVERTEBR PATHOL, V68, P253, DOI 10.1006/jipa.1996.0093; Sang RC, 1999, CURR MICROBIOL, V38, P349, DOI 10.1007/PL00006815; Sang RC, 1998, MEM I OSWALDO CRUZ, V93, P861, DOI 10.1590/S0074-02761998000600030; Sokal R. R., 2012, BIOMETRY; STEELMAN CD, 1976, ANNU REV ENTOMOL, V21, P155, DOI 10.1146/annurev.en.21.010176.001103; Thornhill R., 1983, pi; VANDERVLOEDT AMV, 1978, INT J APPL RADIAT IS, V29, P713, DOI 10.1016/0020-708X(78)90117-5; Vreysen M. J. B., 1992, Revue d'Elevage et de Medecine Veterinaire des Pays Tropicaux, V45, P303; *WHO, 2003, REP SCI WORK GROUP M	42	10	10	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 13	2012	7	8							e42188	10.1371/journal.pone.0042188	http://dx.doi.org/10.1371/journal.pone.0042188			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	988OJ	22912687	Green Published, gold, Green Submitted			2022-12-25	WOS:000307500100007
J	Vallve, JC; Serra, N; Zalba, G; Fortuno, A; Beloqui, O; Ferre, R; Ribalta, J; Masana, L				Vallve, Joan-Carles; Serra, Noemi; Zalba, Guillermo; Fortuno, Ana; Beloqui, Oscar; Ferre, Raimon; Ribalta, Josep; Masana, Lluis			Two Variants in the Fibulin2 Gene Are Associated with Lower Systolic Blood Pressure and Decreased Risk of Hypertension	PLOS ONE			English	Article							GENOME-WIDE ASSOCIATION; EXTRACELLULAR-MATRIX; PUBLIC-HEALTH; EXPRESSION; PREVENTION; MOUSE	Arterial stiffness is an important factor in hypertension. Fibulin 2 is an extracellular matrix scaffold protein involved in arterial stiffness and, hence, the fibulin 2 (FBLN2) gene may be a candidate for hypertension susceptibility. 4 single nucleotide polymorphisms (SNPs) of FBLN2 were evaluated in an association case-control study containing 447 hypertensive patients and 344 normotensive control subjects. The minor allele frequencies of rs3732666 and rs1061376 were significantly lower in hypertensives. The odds ratios (OR) for having the protective G (rs3732666) and T (rs1061376) alleles were 0.75 (95%CI: 0.58 to 0.96) and 0.83 (95%CI: 0.66 to 1.02), respectively. For rs3732666, the OR for hypertension in AG+GG subjects, compared with AA, was 0.71 (95%CI: 0.52 to 0.95). The protective genotype AG+GG was associated with significantly lower systolic blood pressure (SBP) [-3.6 mmHg (P = 0.048)]. There was a significant age interaction with rs3732666; the effect decreasing with increasing age. For rs1061376, TT subjects had an OR for hypertension of 0.53 (95%CI: 0.32 to 0.87) compared with CC subjects, with reduced SBP (-7.91 mmHg; P = 0.008) and diastolic BP (DBP) (-3.69 mmHg; P = 0.015). The presence of a G allele was an independent predictor of intima-media thickness (IMT); G carrier's having lower mean IMT (-0.037 mm, P = 0.027) compared with AA. Our results provide the first evidence for FBLN2 as a new gene associated with hypertension.	[Vallve, Joan-Carles; Serra, Noemi; Ferre, Raimon; Ribalta, Josep; Masana, Lluis] Univ Rovira & Virgili, Hosp St Joan, Fac Med URLA, IISPV,CIBERDEM, E-43201 Reus, Catalonia, Spain; [Zalba, Guillermo; Fortuno, Ana] Univ Navarra, Div Cardiovasc Sci, Ctr Appl Med Res, E-31080 Pamplona, Spain; [Beloqui, Oscar] Univ Navarra, Univ Clin, Dept Internal Med, E-31080 Pamplona, Spain	CIBER - Centro de Investigacion Biomedica en Red; CIBERDEM; Universitat Rovira i Virgili; Institut d'Investigacio Sanitaria Pere Virgili (IISPV); University of Navarra; University of Navarra	Vallve, JC (corresponding author), Univ Rovira & Virgili, Hosp St Joan, Fac Med URLA, IISPV,CIBERDEM, C St Llorenc 21, E-43201 Reus, Catalonia, Spain.	jc.vallve@urv.cat	Fortuño, Ana/C-6921-2017; Ribalta, Josep/AAD-4859-2020; MASANA, LUIS/M-7002-2019; Vallvé, Joan-Carles/T-6742-2019; ZALBA, GUILLERMO/AAB-6231-2019	Fortuño, Ana/0000-0002-0796-4879; Ribalta, Josep/0000-0002-8879-4719; MASANA, LUIS/0000-0002-0789-4954; Vallvé, Joan-Carles/0000-0001-8711-9618; ZALBA, GUILLERMO/0000-0003-4616-1523; Serra, Noemi/0000-0002-2277-351X	Instituto de Salud Carlos III [PI030786, PI10/02547]; Fondo Europeo de Desarrollo Regional (FEDER)	Instituto de Salud Carlos III(Instituto de Salud Carlos IIIEuropean Commission); Fondo Europeo de Desarrollo Regional (FEDER)(European Commission)	The study was funded by grants from The Instituto de Salud Carlos III (PI030786 and PI10/02547) (www.isciii.es) and from Fondo Europeo de Desarrollo Regional (FEDER) (europa.eu). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 1967, J AMER MED ASSOC, V202, P1028, DOI 10.1001/jama.1967.03130240070013; Appel LJ, 1997, NEW ENGL J MED, V336, P1117, DOI 10.1056/NEJM199704173361601; BRILLA CG, 1992, EUR HEART J, V13, P24, DOI 10.1093/eurheartj/13.suppl_D.24; Briones AM, 2010, CURR OPIN NEPHROL HY, V19, P187, DOI 10.1097/MNH.0b013e328335eec9; Chapman SL, 2010, ARTERIOSCL THROM VAS, V30, P68, DOI 10.1161/ATVBAHA.109.196725; DiBona GF, 2002, CURR OPIN NEPHROL HY, V11, P197, DOI 10.1097/00041552-200203000-00011; Dumler F, 2009, J RENAL NUTR, V19, P57, DOI 10.1053/j.jrn.2008.10.006; Eom TY, 2009, BIOL PSYCHIAT, V66, P494, DOI 10.1016/j.biopsych.2009.04.015; Fassler R, 1996, EXP CELL RES, V222, P111, DOI 10.1006/excr.1996.0014; Flamant M, 2007, HYPERTENSION, V50, P212, DOI 10.1161/HYPERTENSIONAHA.107.089631; Fritsche L, 2010, AM J PHYSL ENDOCRINO; Giroux MJ, 1998, P NATL ACAD SCI USA, V95, P6262, DOI 10.1073/pnas.95.11.6262; HAVLIK RJ, 1979, AM J EPIDEMIOL, V110, P304, DOI 10.1093/oxfordjournals.aje.a112815; Hermann Matthias, 2006, J Clin Hypertens (Greenwich), V8, P17, DOI 10.1111/j.1524-6175.2006.06032.x; Howard G, 2006, STROKE, V37, P1171, DOI 10.1161/01.STR.0000217222.09978.ce; Hultgardh-Nilsson A, 2007, CURR OPIN LIPIDOL, V18, P540, DOI 10.1097/MOL.0b013e3282ef77e9; Jones DW, 2004, HYPERTENSION, V43, P1, DOI 10.1161/01.HYP.0000110061.06674.ca; Kramer H, 2004, AM J HYPERTENS, V17, P963, DOI 10.1016/j.amjhyper.2004.06.001; Lacolley P, 2009, CARDIOVASC RES, V81, P637, DOI 10.1093/cvr/cvn353; Lawes CMM, 2008, LANCET, V371, P1513, DOI 10.1016/S0140-6736(08)60655-8; Lee HW, 2008, CURR DIABETES REP, V8, P208, DOI 10.1007/s11892-008-0036-8; Lemaire R, 2004, J INVEST DERMATOL, V123, P1063, DOI 10.1111/j.0022-202X.2004.23471.x; Lemarie CA, 2010, J MOL CELL CARDIOL, V48, P433, DOI 10.1016/j.yjmcc.2009.09.018; Levy D, 2009, NAT GENET, V41, P677, DOI 10.1038/ng.384; Lewington S, 2002, LANCET, V360, P1903, DOI 10.1016/S0140-6736(02)11911-8; Liu YF, 2005, NEW ENGL J MED, V352, P2294, DOI 10.1056/NEJMoa042480; London G M, 1997, Blood Press Suppl, V2, P48; Miosge N, 1996, HISTOCHEM J, V28, P109, DOI 10.1007/BF02331415; Newton-Cheh C, 2009, NAT GENET, V41, P666, DOI 10.1038/ng.361; Oeth P, 2009, METHODS MOL BIOL, V578, P307, DOI 10.1007/978-1-60327-411-1_20; Olin AI, 2001, J BIOL CHEM, V276, P1253, DOI 10.1074/jbc.M006783200; PAN TC, 1993, J CELL BIOL, V123, P1269, DOI 10.1083/jcb.123.5.1269; Payne RA, 2010, HYPERTENSION, V55, P9, DOI 10.1161/HYPERTENSIONAHA.107.090464; PROBSTFIELD JL, 1991, JAMA-J AM MED ASSOC, V265, P3255; Purcell S, 2003, BIOINFORMATICS, V19, P149, DOI 10.1093/bioinformatics/19.1.149; Rafiq S, 2010, J CARDIOVASC TRANSL, V3, P189, DOI 10.1007/s12265-010-9183-9; Reinhardt DP, 1996, J BIOL CHEM, V271, P19489, DOI 10.1074/jbc.271.32.19489; SASAKI T, 1995, J MOL BIOL, V254, P892, DOI 10.1006/jmbi.1995.0664; Schultheis M, 2007, CELL MOL NEUROBIOL, V27, P11, DOI 10.1007/s10571-006-9113-1; Sharma A. K., 2006, V1, P1; Sharma JN, 2009, CURR HYPERTENS REP, V11, P178, DOI 10.1007/s11906-009-0032-7; Sicot FX, 2008, MOL CELL BIOL, V28, P1061, DOI 10.1128/MCB.01876-07; STAMLER J, 1989, HYPERTENSION, V14, P570, DOI 10.1161/01.HYP.14.5.570; Stevens VJ, 2001, ANN INTERN MED, V134, P1, DOI 10.7326/0003-4819-134-1-200101020-00007; Strom A, 2006, CARDIOVASC RES, V69, P755, DOI 10.1016/j.cardiores.2005.12.001; Timpl R, 2003, NAT REV MOL CELL BIO, V4, P479, DOI 10.1038/nrm1130; Tobin MD, 2005, STAT MED, V24, P2911, DOI 10.1002/sim.2165; Touyz RM, 2000, CAN J CARDIOL, V16, P1137; Utani A, 1997, J BIOL CHEM, V272, P2814, DOI 10.1074/jbc.272.5.2814; Whelton PK, 2002, JAMA-J AM MED ASSOC, V288, P1882, DOI 10.1001/jama.288.15.1882; Yanagisawa H, 2010, INT J BIOCHEM CELL B, V42, P1084, DOI 10.1016/j.biocel.2010.03.009; Yi CH, 2007, AM J PATHOL, V170, P1535, DOI 10.2353/ajpath.2007.060478; Zalba G, 2005, ARTERIOSCL THROM VAS, V25, P1452, DOI 10.1161/01.ATV.0000168411.72483.08	53	5	5	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 13	2012	7	8							e43051	10.1371/journal.pone.0043051	http://dx.doi.org/10.1371/journal.pone.0043051			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	988OJ	22912785	Green Submitted, gold, Green Published			2022-12-25	WOS:000307500100057
J	Kuo, HC; Wang, TY; Hsu, HH; Lee, SH; Chen, YM; Tsai, TJ; Ou, MC; Ku, HT; Lee, GB; Chen, TY				Kuo, Hsiao-Che; Wang, Ting-Yu; Hsu, Hao-Hsuan; Lee, Szu-Hsien; Chen, Young-Mao; Tsai, Tieh-Jung; Ou, Ming-Chang; Ku, Hsiao-Tung; Lee, Gwo-Bin; Chen, Tzong-Yueh			An Automated Microfluidic Chip System for Detection of Piscine Nodavirus and Characterization of Its Potential Carrier in Grouper Farms	PLOS ONE			English	Article							NERVOUS NECROSIS VIRUS; LARVAL STRIPED JACK; EPINEPHELUS-COIOIDES; VERTICAL TRANSMISSION; PSEUDOCARANX-DENTEX; ATLANTIC HALIBUT; SEA BASS; BETANODAVIRUS; BROODFISH; FISH	Groupers of the Epinephelus spp. are an important aquaculture species of high economic value in the Asia Pacific region. They are susceptible to piscine nodavirus infection, which results in viral nervous necrosis disease. In this study, a rapid and sensitive automated microfluidic chip system was implemented for the detection of piscine nodavirus; this technology has the advantage of requiring small amounts of sample and has been developed and applied for managing grouper fish farms. Epidemiological investigations revealed an extremely high detection rate of piscine nodavirus (89% of fish samples) from 5 different locations in southern Taiwan. In addition, positive samples from the feces of fish-feeding birds indicated that the birds could be carrying the virus between fish farms. In the present study, we successfully introduced this advanced technology that combines engineering and biological approaches to aquaculture. In the future, we believe that this approach will improve fish farm management and aid in reducing the economic loss experienced by fish farmers due to widespread disease outbreaks.	[Kuo, Hsiao-Che; Wang, Ting-Yu; Hsu, Hao-Hsuan; Chen, Young-Mao; Tsai, Tieh-Jung; Ou, Ming-Chang; Chen, Tzong-Yueh] Natl Cheng Kung Univ, Inst Biotechnol, Mol Genet Lab, Tainan 70101, Taiwan; [Kuo, Hsiao-Che; Wang, Ting-Yu; Hsu, Hao-Hsuan; Chen, Young-Mao; Chen, Tzong-Yueh] Natl Cheng Kung Univ, Translat Ctr Marine Biotechnol, Tainan 70101, Taiwan; [Kuo, Hsiao-Che; Chen, Young-Mao; Chen, Tzong-Yueh] Natl Cheng Kung Univ, Agr Biotechnol Res Ctr, Tainan 70101, Taiwan; [Kuo, Hsiao-Che; Chen, Young-Mao; Chen, Tzong-Yueh] Natl Cheng Kung Univ, Univ Ctr Biosci & Biotechnol, Tainan 70101, Taiwan; [Kuo, Hsiao-Che; Chen, Young-Mao; Chen, Tzong-Yueh] Natl Cheng Kung Univ, Res Ctr Ocean Environm & Technol, Tainan 70101, Taiwan; [Lee, Szu-Hsien; Lee, Gwo-Bin] Natl Cheng Kung Univ, Inst Nanotechnol & Microsyst Engn, Tainan 70101, Taiwan; [Lee, Szu-Hsien; Lee, Gwo-Bin] Natl Cheng Kung Univ, Dept Engn Sci, Tainan 70101, Taiwan; [Ku, Hsiao-Tung] Taiwan Inst Econ Res, Res Div 1, Taipei, Taiwan; [Ku, Hsiao-Tung] Natl Sci Council, Off Energy Strategy Dev, Taipei, Taiwan; [Lee, Gwo-Bin] Natl Tsing Hua Univ, Dept Power Mech Engn, Hsinchu, Taiwan	National Cheng Kung University; National Cheng Kung University; National Cheng Kung University; National Cheng Kung University; National Cheng Kung University; National Cheng Kung University; National Cheng Kung University; National Tsing Hua University	Kuo, HC (corresponding author), Natl Cheng Kung Univ, Inst Biotechnol, Mol Genet Lab, Tainan 70101, Taiwan.	gwobin@pme.nthu.edu.tw; ibcty@mail.ncku.edu.tw	Lee, Gwo-Bin Vincent/D-3032-2012	Lee, Gwo-Bin Vincent/0000-0001-6910-9133	Fish Breeding Association Taiwan; Council of Agriculture, Taiwan [94AS-14.2.1-FA-F1, 96AS-14.2.1-BQ-B2[28], 97AS-14.2.1-BQ-B1[8]]	Fish Breeding Association Taiwan; Council of Agriculture, Taiwan	This work was supported by grants from Fish Breeding Association Taiwan and Council of Agriculture, Taiwan (94AS-14.2.1-FA-F1, 96AS-14.2.1-BQ-B2[28], and 97AS-14.2.1-BQ-B1[8]). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Breuil G, 2002, J FISH DIS, V25, P697, DOI 10.1046/j.1365-2761.2002.00406.x; Chen YM, 2006, FISH SHELLFISH IMMUN, V20, P58, DOI 10.1016/j.fsi.2005.04.001; Chi SC, 1999, J FISH DIS, V22, P173, DOI 10.1046/j.1365-2761.1999.00152.x; Frerichs GN, 2000, AQUACULTURE, V185, P13, DOI 10.1016/S0044-8486(99)00337-3; Huang FC, 2006, ELECTROPHORESIS, V27, P3297, DOI 10.1002/elps.200600458; Johansen R, 2004, J FISH DIS, V27, P327, DOI 10.1111/j.1365-2761.2004.00548.x; Kai YH, 2008, VACCINE, V26, P1450, DOI 10.1016/j.vaccine.2007.12.043; Kai YH, 2010, VACCINE, V28, P996, DOI 10.1016/j.vaccine.2009.10.132; KAMEI Y, 1987, FISH PATHOL, V22, P147, DOI 10.3147/jsfp.22.147; Kuo HC, 2011, J CLIN MICROBIOL, V49, P1090, DOI 10.1128/JCM.01016-10; Lee S. H., 2007, SOL STAT SENS ACT MI, P943; Lee YF, 2009, BIOSENS BIOELECTRON, V25, P745, DOI 10.1016/j.bios.2009.08.020; MORI KI, 1992, VIROLOGY, V187, P368, DOI 10.1016/0042-6822(92)90329-N; Munday BL, 2002, J FISH DIS, V25, P127, DOI 10.1046/j.1365-2761.2002.00350.x; Munday BL, 1997, WORLD J MICROB BIOT, V13, P375, DOI 10.1023/A:1018516014782; MUNDAY BL, 1994, AUST VET J, V71, P384, DOI 10.1111/j.1751-0813.1994.tb00937.x; Nerland AH, 2007, DIS AQUAT ORGAN, V73, P201, DOI 10.3354/dao073201; Ole BS, 2006, DIS AQUAT ORGAN, V71, P239; Ou MC, 2007, BIOCHEM BIOPH RES CO, V361, P634, DOI 10.1016/j.bbrc.2007.07.075; Sano M, 2011, FISH DIS DISORDERS, P198; Skliris GP, 2001, VIRUS RES, V75, P59, DOI 10.1016/S0168-1702(01)00225-8; Tanaka S, 1998, FISH PATHOL, V33, P31, DOI 10.3147/jsfp.33.31	22	11	11	0	25	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 9	2012	7	8							e42203	10.1371/journal.pone.0042203	http://dx.doi.org/10.1371/journal.pone.0042203			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	986WZ	22912690	Green Published, gold, Green Submitted			2022-12-25	WOS:000307378500012
J	Liemburg, EJ; van der Meer, L; Swart, M; Curcic-Blake, B; Bruggeman, R; Knegtering, H; Aleman, A				Liemburg, Edith J.; van der Meer, Lisette; Swart, Marte; Curcic-Blake, Branislava; Bruggeman, Richard; Knegtering, Henderikus; Aleman, Andre			Reduced Connectivity in the Self-Processing Network of Schizophrenia Patients with Poor Insight	PLOS ONE			English	Article							INDEPENDENT COMPONENT ANALYSIS; CORTICAL MIDLINE STRUCTURES; ANTERIOR CINGULATE CORTEX; RESTING-STATE NETWORKS; DEFAULT-MODE NETWORK; EVENT-RELATED FMRI; FUNCTIONAL CONNECTIVITY; 1ST-EPISODE SCHIZOPHRENIA; SOCIAL COGNITION; BIPOLAR DISORDER	Lack of insight (unawareness of illness) is a common and clinically relevant feature of schizophrenia. Reduced levels of self-referential processing have been proposed as a mechanism underlying poor insight. The default mode network (DMN) has been implicated as a key node in the circuit for self-referential processing. We hypothesized that during resting state the DMN network would show decreased connectivity in schizophrenia patients with poor insight compared to patients with good insight. Patients with schizophrenia were recruited from mental health care centers in the north of the Netherlands and categorized in groups having good insight (n = 25) or poor insight (n = 19). All subjects underwent a resting state fMRI scan. A healthy control group (n = 30) was used as a reference. Functional connectivity of the anterior and posterior part of the DMN, identified using Independent Component Analysis, was compared between groups. Patients with poor insight showed lower connectivity of the ACC within the anterior DMN component and precuneus within the posterior DMN component compared to patients with good insight. Connectivity between the anterior and posterior part of the DMN was lower in patients than controls, and qualitatively different between the good and poor insight patient groups. As predicted, subjects with poor insight in psychosis showed decreased connectivity in DMN regions implicated in self-referential processing, although this concerned only part of the network. This finding is compatible with theories implying a role of reduced self-referential processing as a mechanism contributing to poor insight.	[Liemburg, Edith J.; van der Meer, Lisette; Swart, Marte; Curcic-Blake, Branislava; Knegtering, Henderikus; Aleman, Andre] Univ Groningen, Dept Neurosci, Univ Med Ctr Groningen, Groningen, Netherlands; [Liemburg, Edith J.; van der Meer, Lisette; Swart, Marte; Curcic-Blake, Branislava; Knegtering, Henderikus; Aleman, Andre] Univ Groningen, BCN NeuroImaging Ctr, Groningen, Netherlands; [Liemburg, Edith J.; Knegtering, Henderikus] Univ Med Ctr Groningen, Rob Giel Res Ctr, NL-9713 AV Groningen, Netherlands; [van der Meer, Lisette; Swart, Marte; Bruggeman, Richard; Knegtering, Henderikus] Lentis, Ctr Mental Healthcare, Groningen, Netherlands; [Aleman, Andre] Univ Groningen, Dept Psychol, NL-9712 TS Groningen, Netherlands	University of Groningen; University of Groningen; University of Groningen; University of Groningen	Liemburg, EJ (corresponding author), Univ Groningen, Dept Neurosci, Univ Med Ctr Groningen, Groningen, Netherlands.	E.J.Liemburg@umcg.nl		Curcic-Blake, Branislava/0000-0003-0817-1894; Bruggeman, Richard/0000-0002-3238-8471	European Science Foundation European Young Investigators (EURYI) award (N.W.O.) [044035001]; Eli Lilly; Astra Zeneca; Janssen-Cilag; BMS	European Science Foundation European Young Investigators (EURYI) award (N.W.O.); Eli Lilly(Eli Lilly); Astra Zeneca(AstraZeneca); Janssen-Cilag(Johnson & JohnsonJohnson & Johnson USAJanssen Biotech Inc); BMS(Bristol-Myers Squibb)	This work was supported by the European Science Foundation European Young Investigators (EURYI) award (N.W.O. number 044035001) awarded to A.A. The website link: http://www.esf.org/activities/euryi.html. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; E.J. Liemburg, MSc reports no financial relationships with commercial interests. Dr. L. van der Meer reports no financial relationships with commercial interests. M. Swart, MSc reports no financial relationships with commercial interests. Dr. B. Curcic-Blake reports no financial relationships with commercial interests. Dr. R. Bruggeman reports no financial relationships with commercial interests. Dr. H. Knegtering is on the speakers list of Janssen-Cilag, BMS and Eli Lilly, and received unrestricted research grants from Eli Lilly, Astra Zeneca, Janssen-Cilag and BMS. These companies had no further role in the selection of literature and interpretation of data; in the writing of the review; and in the decision to submit the manuscript for publication. Dr. A. Aleman reports no financial relationships with commercial interests. Lentis Center for Mental Health Care is not a commercial organization, but a local public health care center without profit-making activities. Being an employee of Lentis does not alter those authors' adherence to all the PLoS ONE policies on sharing data and materials. The authors declare their adherence to all the PLoS ONE policies on sharing data and materials.	Allman JM, 2001, ANN NY ACAD SCI, V935, P107, DOI 10.1111/j.1749-6632.2001.tb03476.x; Antonius D, 2011, SCHIZOPHR RES, V128, P76, DOI 10.1016/j.schres.2011.02.020; ATKINSON R, 1961, J ABNORM SOC PSYCH, V62, P322, DOI 10.1037/h0049307; Bassett DS, 2008, J NEUROSCI, V28, P9239, DOI 10.1523/JNEUROSCI.1929-08.2008; Beckmann CF, 2005, PHILOS T R SOC B, V360, P1001, DOI 10.1098/rstb.2005.1634; Brune M, 2008, NEUROPSYCHOLOGIA, V46, P1992, DOI 10.1016/j.neuropsychologia.2008.01.023; Buckner RL, 2008, ANN NY ACAD SCI, V1124, P1, DOI 10.1196/annals.1440.011; Calhoun VD, 2001, HUM BRAIN MAPP, V14, P140, DOI 10.1002/hbm.1048; Carter CS, 2001, AM J PSYCHIAT, V158, P1423, DOI 10.1176/appi.ajp.158.9.1423; Cavanna AE, 2006, BRAIN, V129, P564, DOI 10.1093/brain/awl004; Cavanna AE, 2007, CNS SPECTRUMS, V12, P545, DOI 10.1017/S1092852900021295; Cole MW, 2011, BIOL PSYCHIAT, V70, P43, DOI 10.1016/j.biopsych.2011.02.010; Cooke MA, 2008, SCHIZOPHR RES, V103, P40, DOI 10.1016/j.schres.2008.04.022; David A. S, 2004, INSIGHT PSYCHOSIS AW; David A. S., 2004, INSIGHT PSYCHOSIS AW, P359; Dickerson FB, 1997, PSYCHIATR SERV, V48, P195; Drake RJ, 2003, SCHIZOPHR RES, V62, P165, DOI 10.1016/S0920-9964(02)00382-1; Flashman LA, 2004, INSIGHT PSYCHOSIS AW; Fox MD, 2007, NAT REV NEUROSCI, V8, P700, DOI 10.1038/nrn2201; Fransson P, 2006, NEUROPSYCHOLOGIA, V44, P2836, DOI 10.1016/j.neuropsychologia.2006.06.017; Frith C. D., 1995, COGNITIVE NEUROPSYCH; Frith CD, 1996, PSYCHOL MED, V26, P521, DOI 10.1017/S0033291700035601; Garrity AG, 2007, AM J PSYCHIAT, V164, P450, DOI 10.1176/appi.ajp.164.3.450; Giel R, 1996, SCAN 2 1 SCEDULES CL; Gusnard DA, 2001, NAT REV NEUROSCI, V2, P685, DOI 10.1038/35094500; Hill K, 2004, ACTA PSYCHIAT SCAND, V110, P243, DOI 10.1111/j.1600-0447.2004.00376.x; Himberg J, 2004, NEUROIMAGE, V22, P1214, DOI 10.1016/j.neuroimage.2004.03.027; Holt DJ, 2011, BIOL PSYCHIAT, V69, P415, DOI 10.1016/j.biopsych.2010.10.003; Jafri MJ, 2008, NEUROIMAGE, V39, P1666, DOI 10.1016/j.neuroimage.2007.11.001; Jang JH, 2011, SCHIZOPHR RES, V127, P58, DOI 10.1016/j.schres.2010.12.022; Johnson SC, 2002, BRAIN, V125, P1808, DOI 10.1093/brain/awf181; Kay S, 1987, SCHIZOPHR B, V13, P231; Kelley WM, 2002, J COGNITIVE NEUROSCI, V14, P785, DOI 10.1162/08989290260138672; Kemp R, 1996, BRIT J PSYCHIAT, V169, P444, DOI 10.1192/bjp.169.4.444; Kuhn S., 2011, SCHIZOPHR B; Lancaster JL, 2000, HUM BRAIN MAPP, V10, P120, DOI 10.1002/1097-0193(200007)10:3<120::AID-HBM30>3.0.CO;2-8; Li Y, 2006, P ISBI; Liu Y, 2008, BRAIN, V131, P945, DOI 10.1093/brain/awn018; Lui S, 2010, ARCH GEN PSYCHIAT, V67, P783, DOI 10.1001/archgenpsychiatry.2010.84; Lynall ME, 2010, J NEUROSCI, V30, P9477, DOI 10.1523/JNEUROSCI.0333-10.2010; Lysaker PH, 2005, ACTA PSYCHIAT SCAND, V112, P64, DOI 10.1111/j.1600-0447.2005.00514.x; Mannell MV, 2010, HUM BRAIN MAPP, V31, P424, DOI 10.1002/hbm.20876; Mintz AR, 2003, SCHIZOPHR RES, V61, P75, DOI 10.1016/S0920-9964(02)00316-X; Modinos G, 2011, NEUROPSYCHOLOGY, V25, P295, DOI 10.1037/a0021747; Morgan KD, 2010, BRIT J PSYCHIAT, V197, P141, DOI 10.1192/bjp.bp.109.070888; Nelson B, 2009, EARLY INTERV PSYCHIA, V3, P83, DOI 10.1111/j.1751-7893.2009.00112.x; Northoff G, 2004, TRENDS COGN SCI, V8, P102, DOI 10.1016/j.tics.2004.01.004; Northoff G, 2006, NEUROIMAGE, V31, P440, DOI 10.1016/j.neuroimage.2005.12.002; Ongur D, 2010, PSYCHIAT RES-NEUROIM, V183, P59, DOI 10.1016/j.pscychresns.2010.04.008; OLDFIELD RC, 1971, NEUROPSYCHOLOGIA, V9, P97, DOI 10.1016/0028-3932(71)90067-4; Orfei MD, 2012, SOC COGN AFFECT NEUR; Parellada M, 2011, SCHIZOPHRENIA BULL, V37, P38, DOI 10.1093/schbul/sbq109; Parnas J, 2003, COMPR PSYCHIAT, V44, P121, DOI 10.1053/comp.2003.50017; Philippi CL, 2012, J COGNITIVE NEUROSCI, V24, P475, DOI 10.1162/jocn_a_00138; Pinkham AE, 2003, AM J PSYCHIAT, V160, P815, DOI 10.1176/appi.ajp.160.5.815; Pinkham AE, 2008, SCHIZOPHRENIA BULL, V34, P688, DOI 10.1093/schbul/sbn031; Pyne JM, 2001, J NERV MENT DIS, V189, P146, DOI 10.1097/00005053-200103000-00002; Qin PM, 2011, NEUROIMAGE, V57, P1221, DOI 10.1016/j.neuroimage.2011.05.028; Raballo A, 2011, SCHIZOPHRENIA BULL, V37, P344, DOI 10.1093/schbul/sbp056; Raichle ME, 2005, J COMP NEUROL, V493, P167, DOI 10.1002/cne.20752; Raichle ME, 2001, P NATL ACAD SCI USA, V98, P676, DOI 10.1073/pnas.98.2.676; Ries ML, 2007, J INT NEUROPSYCH SOC, V13, P450, DOI 10.1017/S1355617707070488; Rotarska-Jagiela A, 2010, SCHIZOPHR RES, V117, P21, DOI 10.1016/j.schres.2010.01.001; Salomon R, 2011, J NEUROSCI, V31, P12972, DOI 10.1523/JNEUROSCI.2987-11.2011; Salvador Raymond, 2010, Front Neuroinform, V4, P115, DOI 10.3389/fninf.2010.00115; Sanz M, 1998, PSYCHOL MED, V28, P437, DOI 10.1017/S0033291797006296; Sass LA, 2003, SCHIZOPHRENIA BULL, V29, P427, DOI 10.1093/oxfordjournals.schbul.a007017; Schmitz TW, 2006, NEUROPSYCHOLOGIA, V44, P762, DOI 10.1016/j.neuropsychologia.2005.07.012; Schwartz RC, 1998, PSYCHIAT QUART, V69, P1, DOI 10.1023/A:1022141322657; Shad MU, 2006, PSYCHIAT RES-NEUROIM, V146, P35, DOI 10.1016/j.pscychresns.2005.11.001; Shad MU, 2004, NEUROIMAGE, V22, P1315, DOI 10.1016/j.neuroimage.2004.03.016; Shen H, 2010, NEUROIMAGE, V49, P3110, DOI 10.1016/j.neuroimage.2009.11.011; Skudlarski P, 2010, BIOL PSYCHIAT, V68, P61, DOI 10.1016/j.biopsych.2010.03.035; Smith SM, 2009, P NATL ACAD SCI USA, V106, P13040, DOI 10.1073/pnas.0905267106; Spreng RN, 2010, J COGNITIVE NEUROSCI, V22, P1112, DOI 10.1162/jocn.2009.21282; Startup M, 1997, SCHIZOPHR RES, V26, P203, DOI 10.1016/S0920-9964(97)00050-9; Stefanopoulou E, 2009, PSYCHIAT QUART, V80, P155, DOI 10.1007/s11126-009-9103-9; Summerlin JL., 1997, NEUROIMAGE, V5, pS633, DOI DOI 10.1002/(SICI)1097-0193(1997)5:4<238:AID-HBM6>3.0.C0;2-4; Tie YM, 2008, NEUROIMAGE, V42, P1214, DOI 10.1016/j.neuroimage.2008.05.028; van de Ven VG, 2004, HUM BRAIN MAPP, V22, P165, DOI 10.1002/hbm.20022; van den Heuvel MP, 2010, EUR NEUROPSYCHOPHARM, V20, P519, DOI 10.1016/j.euroneuro.2010.03.008; van der Meer L, 2010, NEUROSCI BIOBEHAV R, V34, P935, DOI 10.1016/j.neubiorev.2009.12.004; Verhage F., 1984, INTELLIGENTIE LEEFTI; Wang LA, 2011, SCHIZOPHR RES, V125, P136, DOI 10.1016/j.schres.2010.11.012; Whitfield-Gabrieli S, 2011, NEUROIMAGE, V55, P225, DOI 10.1016/j.neuroimage.2010.11.048; Wicker B, 2003, BRAIN RES REV, V43, P224, DOI 10.1016/j.brainresrev.2003.08.003; Wolf ND, 2011, J PSYCHIATR NEUROSCI, V36, P366, DOI 10.1503/jpn.110008; Woodward ND, 2011, SCHIZOPHR RES, V130, P86, DOI 10.1016/j.schres.2011.03.010; Yen CF, 2005, PSYCHIAT CLIN NEUROS, V59, P403, DOI 10.1111/j.1440-1819.2005.01392.x; Zhang DG, 2012, BRAIN IMAGING BEHAV, V6, P27, DOI 10.1007/s11682-011-9138-z	90	39	44	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 9	2012	7	8							e42707	10.1371/journal.pone.0042707	http://dx.doi.org/10.1371/journal.pone.0042707			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	986WZ	22912723	Green Submitted, Green Published, gold			2022-12-25	WOS:000307378500024
J	Walton, JC; Pyter, LM; Weil, ZM; Nelson, RJ				Walton, James C.; Pyter, Leah M.; Weil, Zachary M.; Nelson, Randy J.			Photoperiod Mediated Changes in Olfactory Bulb Neurogenesis and Olfactory Behavior in Male White-Footed Mice (Peromyscus leucopus)	PLOS ONE			English	Article							GONADAL HORMONE MODULATION; DENTATE GYRUS; ADULT MALE; HIPPOCAMPAL NEUROGENESIS; MICROTUS-PENNSYLVANICUS; REPRODUCTIVE RESPONSES; CELL-PROLIFERATION; MEADOW VOLES; NEURONS; DEATH	Brain plasticity, in relation to new adult mammalian neurons generated in the subgranular zone of the hippocampus, has been well described. However, the functional outcome of new adult olfactory neurons born in the subventricular zone of the lateral ventricles is not clearly defined, as manipulating neurogenesis through various methods has given inconsistent and conflicting results in lab mice. Several small rodent species, including Peromyscus leucopus, display seasonal (photoperiodic) brain plasticity in brain volume, hippocampal function, and hippocampus-dependent behaviors; plasticity in the olfactory system of photoperiodic rodents remains largely uninvestigated. We exposed adult male P. leucopus to long day lengths (LD) and short day lengths (SD) for 10 to 15 weeks and then examined olfactory bulb cell proliferation and survival using the thymidine analog BrdU, olfactory bulb granule cell morphology using Golgi-Cox staining, and behavioral investigation of same-sex conspecific urine. SD mice did not differ from LD counterparts in granular cell morphology of the dendrites or in dendritic spine density. Although there were no differences due to photoperiod in habituation to water odor, SD mice rapidly habituated to male urine, whereas LD mice did not. In addition, short day induced changes in olfactory behavior were associated with increased neurogenesis in the caudal plexiform and granule cell layers of the olfactory bulb, an area known to preferentially respond to water-soluble odorants. Taken together, these data demonstrate that photoperiod, without altering olfactory bulb neuronal morphology, alters olfactory bulb neurogenesis and olfactory behavior in Peromyscus leucopus.	[Walton, James C.; Pyter, Leah M.; Weil, Zachary M.; Nelson, Randy J.] Ohio State Univ, Wexner Med Ctr, Dept Neurosci, Columbus, OH 43210 USA	University System of Ohio; Ohio State University	Walton, JC (corresponding author), Ohio State Univ, Wexner Med Ctr, Dept Neurosci, Columbus, OH 43210 USA.	walton.315@osu.edu	Pyter, Leah/AFR-8698-2022; Weil, Zachary M/A-2439-2008; Weil, Zachary M/B-5003-2008; Walton, James C/F-7435-2010	Weil, Zachary M/0000-0003-3758-1809; Weil, Zachary M/0000-0003-3758-1809; Walton, James C/0000-0002-3049-1029; Pyter, Leah/0000-0001-8189-0663; Nelson, Randy/0000-0002-8194-4016	National Institutes of Health [R01MH057535]; National Research Service Award (NRSA) [MH73375]; NATIONAL INSTITUTE OF MENTAL HEALTH [F31MH073375, R01MH057535] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Research Service Award (NRSA)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))	This work was supported by National Institutes of Health R01MH057535 and National Research Service Award (NRSA) MH73375. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript	Bartkowska K, 2008, EUR J NEUROSCI, V27, P1710, DOI 10.1111/j.1460-9568.2008.06133.x; Borowski Z, 2010, NATURWISSENSCHAFTEN, V97, P487, DOI 10.1007/s00114-010-0663-1; Breton-Provencher V, 2009, J NEUROSCI, V29, P15245, DOI 10.1523/JNEUROSCI.3606-09.2009; Brown J, 2003, EUR J NEUROSCI, V17, P2042, DOI 10.1046/j.1460-9568.2003.02647.x; Buck LB, 2004, NUTR REV, V62, pS184, DOI 10.1111/j.1753-4887.2004.tb00097.x; CLANCY AN, 1986, BIOL REPROD, V35, P1202, DOI 10.1095/biolreprod35.5.1202; Deng W, 2010, NAT REV NEUROSCI, V11, P339, DOI 10.1038/nrn2822; FERKIN MH, 1992, PHYSIOL BEHAV, V51, P1087, DOI 10.1016/0031-9384(92)90098-M; Galea LAM, 2006, HIPPOCAMPUS, V16, P225, DOI 10.1002/hipo.20154; Galea LAM, 1999, NEUROSCIENCE, V89, P955, DOI 10.1016/S0306-4522(98)00345-5; Galea LAM, 2008, BRAIN RES REV, V57, P332, DOI 10.1016/j.brainresrev.2007.05.008; Goel N, 2004, CHRONOBIOL INT, V21, P691, DOI 10.1081/CBI-200025989; Heth G, 1996, PHYSIOL BEHAV, V60, P963; Huang LY, 1998, J NEUROBIOL, V36, P410, DOI 10.1002/(SICI)1097-4695(19980905)36:3<410::AID-NEU8>3.0.CO;2-Z; Institute of Laboratory Animal Resources (U.S.), 1996, GUID CAR US LAB AN, p[xii, 125]; Johnson BA, 2007, J COMP NEUROL, V502, P468, DOI 10.1002/cne.21322; Kageyama R, 2012, BEHAV BRAIN RES, V227, P459, DOI 10.1016/j.bbr.2011.04.038; King JA, 1968, BIOL PEROMYSCUS RODE, p[xiii, 593]; Lavenex P, 2000, EUR J NEUROSCI, V12, P643, DOI 10.1046/j.1460-9568.2000.00949.x; Lazarini F, 2011, TRENDS NEUROSCI, V34, P20, DOI 10.1016/j.tins.2010.09.006; Liu ZP, 2003, J COMP NEUROL, V459, P368, DOI 10.1002/cne.10664; Lledo PM, 2005, TRENDS NEUROSCI, V28, P248, DOI 10.1016/j.tins.2005.03.005; LYNCH GR, 1973, COMP BIOCHEM PHYSIOL, V44, P1373, DOI 10.1016/0300-9629(73)90277-6; Mandairon N, 2003, NEUROSCIENCE, V119, P507, DOI 10.1016/S0306-4522(03)00172-6; NELSON RJ, 1994, J PINEAL RES, V17, P123, DOI 10.1111/j.1600-079X.1994.tb00123.x; NELSON RJ, 1990, PHYSIOL BEHAV, V48, P403, DOI 10.1016/0031-9384(90)90335-2; Nelson RJ, 2010, PHOTOPERIODISM BIOL, pxiii; Nissant A, 2011, EUR J NEUROSCI, V33, P1069, DOI 10.1111/j.1460-9568.2011.07605.x; Ormerod BK, 2003, NEUROSCI LETT, V346, P25, DOI 10.1016/S0304-3940(03)00546-9; Peretto P, 1999, BRAIN RES BULL, V49, P221, DOI 10.1016/S0361-9230(99)00037-4; Perrot-Sinal T, 2000, PSYCHONEUROENDOCRINO, V25, P259, DOI 10.1016/S0306-4530(99)00054-2; PIEPER DR, 1984, BRAIN RES, V321, P183, DOI 10.1016/0006-8993(84)90699-1; PINCHING AJ, 1974, BRAIN RES, V82, P195, DOI 10.1016/0006-8993(74)90598-8; Prendergast BJ, 2009, BEHAV BRAIN RES, V198, P159, DOI 10.1016/j.bbr.2008.10.032; Pyter LM, 2005, J NEUROSCI, V25, P4521, DOI 10.1523/JNEUROSCI.0795-05.2005; Pyter LM, 2005, AM J PHYSIOL-REG I, V288, pR891, DOI 10.1152/ajpregu.00680.2004; Sahay A, 2011, NEURON, V70, P582, DOI 10.1016/j.neuron.2011.05.012; Sakamoto M, 2011, P NATL ACAD SCI USA, V108, P8479, DOI 10.1073/pnas.1018782108; Sawada M, 2011, J NEUROSCI, V31, P11587, DOI 10.1523/JNEUROSCI.0614-11.2011; Seguy M, 2005, PHYSIOL BEHAV, V84, P23, DOI 10.1016/j.physbeh.2004.10.019; Shingo T, 2003, SCIENCE, V299, P117, DOI 10.1126/science.1076647; Smith MT, 2001, HORM BEHAV, V39, P11, DOI 10.1006/hbeh.2000.1630; Valley MT, 2009, FRONT NEUROSCI-SWITZ, V3, DOI 10.3389/neuro.22.003.2009; VASSAR R, 1994, CELL, V79, P981, DOI 10.1016/0092-8674(94)90029-9; Wachowiak M, 2001, NEURON, V32, P723, DOI 10.1016/S0896-6273(01)00506-2; Walton JC, 2011, NEUROSCIENCE, V175, P127, DOI 10.1016/j.neuroscience.2010.12.004; Walton JC, 2011, FRONT NEUROENDOCRIN, V32, P303, DOI 10.1016/j.yfrne.2010.12.003; Whitman MC, 2009, PROG NEUROBIOL, V89, P162, DOI 10.1016/j.pneurobio.2009.07.003; Wilson DA, 2009, NEUROBIOL LEARN MEM, V92, P199, DOI 10.1016/j.nlm.2008.07.010; Winner B, 2002, EUR J NEUROSCI, V16, P1681, DOI 10.1046/j.1460-9568.2002.02238.x; WOLFF JO, 1986, J MAMMAL, V67, P409, DOI 10.2307/1380900	51	12	12	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 9	2012	7	8							e42743	10.1371/journal.pone.0042743	http://dx.doi.org/10.1371/journal.pone.0042743			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	986WZ	22912730	Green Published, gold			2022-12-25	WOS:000307378500026
J	Kitada, K; Nakano, D; Liu, Y; Fujisawa, Y; Hitomi, H; Shibayama, Y; Shibata, H; Nagai, Y; Mori, H; Masaki, T; Kobori, H; Nishiyama, A				Kitada, Kento; Nakano, Daisuke; Liu, Ya; Fujisawa, Yoshihide; Hitomi, Hirofumi; Shibayama, Yuki; Shibata, Hirotaka; Nagai, Yukiko; Mori, Hirohito; Masaki, Tsutomu; Kobori, Hiroyuki; Nishiyama, Akira			Oxidative Stress-Induced Glomerular Mineralocorticoid Receptor Activation Limits the Benefit of Salt Reduction in Dahl Salt-Sensitive Rats	PLOS ONE			English	Article							RENAL INJURY; INDUCED HYPERTENSION; BLOOD-PRESSURE; CARDIOVASCULAR-DISEASE; PODOCYTE INJURY; CALCIUM-CHANNEL; DIETARY SALT; RAC1 GTPASE; TIME-COURSE; ALDOSTERONE	Background: Mineralocorticoid receptor (MR) antagonists attenuate renal injury in salt-sensitive hypertensive rats with low plasma aldosterone levels. We hypothesized that oxidative stress causes MR activation in high-salt-fed Dahl salt-sensitive rats. Furthermore, we determined if MR activation persisted and induced renal injury, even after switching from a high- to a normal-salt diet. Methods and Findings: High-salt feeding for 4 weeks increased dihydroethidium fluorescence (DHE, an oxidant production marker), p22phox (a NADPH oxidase subunit) and serum and glucocorticoid-regulated kinase-1 (SGK1, an MR transcript) in glomeruli, compared with normal-salt feeding, and these changes persisted 4 weeks after salt withdrawal. Tempol treatment (0.5 mmol/L) during high-salt feeding abolished the changes in DHE fluorescence, p22phox and SGK1. Dietary salt reduction after a 4-week high-salt diet decreased both blood pressure and proteinuria, but was associated with significantly higher proteinuria than in normal control rats at 4 weeks after salt reduction. Administration of tempol during high-salt feeding, or eplerenone, an MR antagonist (100 mg/kg/day), started after salt reduction, recovered proteinuria to normal levels at 4 weeks after salt reduction. Paraquat, a reactive oxygen species generator, enhanced MR transcriptional activity in cultured rat mesangial cells and mouse podocytes. Conclusions: These results suggest that oxidative stress plays an important role in glomerular MR activation in Dahl salt-sensitive rats. Persistent MR activation even after reducing salt intake could limit the beneficial effects of salt restriction.	[Kitada, Kento; Nakano, Daisuke; Liu, Ya; Hitomi, Hirofumi; Shibayama, Yuki; Kobori, Hiroyuki; Nishiyama, Akira] Kagawa Univ, Dept Pharmacol, Takamatsu, Kagawa 760, Japan; [Fujisawa, Yoshihide; Nagai, Yukiko] Kagawa Univ, Life Sci Res Ctr, Takamatsu, Kagawa 760, Japan; [Shibata, Hirotaka] Keio Univ, Sch Med, Dept Internal Med, Tokyo, Japan; [Mori, Hirohito; Masaki, Tsutomu] Kagawa Univ, Dept Gastroenterol, Takamatsu, Kagawa 760, Japan	Kagawa University; Kagawa University; Keio University; Kagawa University	Kitada, K (corresponding author), Kagawa Univ, Dept Pharmacol, Takamatsu, Kagawa 760, Japan.	dnakano@med.kagawa-u.ac.jp	Hitomi, Hirofumi/ABA-2086-2021; Kobori, Hiroyuki/F-1994-2014	Kitada, Kento/0000-0002-6738-1253; Nishiyama, Akira/0000-0001-5971-820X; Kobori, Hiroyuki/0000-0001-5128-5059	Kagawa University Young Scientists; Ministry of Education, Culture, Sports, Science and Technology of Japan [23590303]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK072408] Funding Source: NIH RePORTER	Kagawa University Young Scientists; Ministry of Education, Culture, Sports, Science and Technology of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported in part by a grant-in-aid for the fund for Kagawa University Young Scientists 2011 to YN, scientific research from the Ministry of Education, Culture, Sports, Science and Technology of Japan to AN (23590303). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aleksandrova K, 2011, JAMA-J AM MED ASSOC, V306, P1083, DOI 10.1001/jama.2011.1291; [Anonymous], 1988, BMJ, V297, P319; Bayorh MA, 2006, CLIN EXP HYPERTENS, V28, P121, DOI 10.1080/10641960500468276; Bhargava A, 2004, TRENDS ENDOCRIN MET, V15, P147, DOI 10.1016/j.tem.2004.03.009; Bianchi S, 2005, AM J KIDNEY DIS, V46, P45, DOI 10.1053/j.ajkd.2005.03.007; Bomback AS, 2008, AM J KIDNEY DIS, V51, P199, DOI 10.1053/j.ajkd.2007.10.040; Du J, 2009, AM J PHYSIOL-RENAL, V297, pF802, DOI 10.1152/ajprenal.00197.2009; Fan YY, 2010, J HYPERTENS, V28, P1034, DOI 10.1097/HJH.0b013e328336ade3; FERGUSON RK, 1977, CLIN PHARMACOL THER, V21, P62; Flack JM, 2003, J AM COLL CARDIOL, V41, P1148, DOI 10.1016/S0735-1097(03)00054-8; Funder JW, 2007, HYPERTENSION, V50, P840, DOI 10.1161/HYPERTENSIONAHA.107.098012; Funder JW, 2009, HYPERTENSION, V53, P286, DOI 10.1161/HYPERTENSIONAHA.108.119966; Gertner RA, 2004, J AM SOC NEPHROL, V15, P558, DOI 10.1097/01.ASN.0000113244.37857.AC; Gomez-Sanchez EP, 2004, ENDOCRINOLOGY, V145, P4796, DOI 10.1210/en.2004-0295; Graudal NA, 1998, JAMA-J AM MED ASSOC, V279, P1383, DOI 10.1001/jama.279.17.1383; Halimi JM, 1995, J HYPERTENS, V13, P1801; He FJ, 2011, LANCET, V378, P380, DOI 10.1016/S0140-6736(11)61174-4; Hisaki R, 2005, AM J HYPERTENS, V18, P707, DOI 10.1016/j.amjhyper.2004.11.045; Hodge G, 2002, ACTA PHYSIOL SCAND, V174, P209, DOI 10.1046/j.1365-201x.2002.00937.x; Hood SJ, 2007, CIRCULATION, V116, P268, DOI 10.1161/CIRCULATIONAHA.107.690396; Ito K, 2010, J HYPERTENS, V28, P1449, DOI 10.1097/HJH.0b013e328338bb37; Kawarazaki H, 2010, NEPHROL DIAL TRANSPL, V25, P2879, DOI 10.1093/ndt/gfq197; Kimura S, 2005, J HYPERTENS, V23, P1887, DOI 10.1097/01.hjh.0000182523.29193.e3; Liu G, 2010, J HYPERTENS, V28, P536, DOI 10.1097/HJH.0b013e3283346b62; Meng SM, 2003, HYPERTENSION, V41, P1346, DOI 10.1161/01.HYP.0000070028.99408.E8; Mihailidou AS, 2009, HYPERTENSION, V54, P1306, DOI 10.1161/HYPERTENSIONAHA.109.136242; Mori T, 2008, J AM SOC NEPHROL, V19, P1472, DOI 10.1681/ASN.2007121271; Mori T, 2009, EUR J PHARMACOL, V623, P84, DOI 10.1016/j.ejphar.2009.09.005; Morizane S, 2012, ARTERIOSCL THROM VAS, V32, P1194, DOI 10.1161/ATVBAHA.111.242719; Nagai Y, 2005, J AM SOC NEPHROL, V16, P703, DOI 10.1681/ASN.2004080649; Nagase M, 2011, CURR DIABETES REV, V7, P8, DOI 10.2174/157339911794273919; Nagase M, 2010, CLIN EXP NEPHROL, V14, P303, DOI 10.1007/s10157-010-0298-8; Nagase M, 2006, HYPERTENSION, V47, P1084, DOI 10.1161/01.HYP.0000222003.28517.99; Nishimura M, 1999, AM J KIDNEY DIS, V33, P261, DOI 10.1016/S0272-6386(99)70298-2; Nishiyama A, 2005, HYPERTENSION, V45, P710, DOI 10.1161/01.HYP.0000154681.38944.9a; Nishiyama A, 2004, J AM SOC NEPHROL, V15, P306, DOI 10.1097/01.ASN.0000108523.02100.E0; Nishiyama A, 2010, J PHARMACOL EXP THER, V332, P1072, DOI 10.1124/jpet.109.158113; Oki K, 2011, CLIN EXP PHARM PHYSL; Quinkler M, 2005, CIRCULATION, V112, P1435, DOI 10.1161/CIRCULATIONAHA.105.539122; Rafiq K, 2011, J PHARMACOL SCI, V115, P1, DOI 10.1254/jphs.10R07CR; Rafiq K, 2011, J HYPERTENS, V29, P290, DOI 10.1097/HJH.0b013e32834103a9; Rebholz CM, 2011, JAMA-J AM MED ASSOC, V306, P1083, DOI 10.1001/jama.2011.1292; Rebholz CM, 2011, JAMA-J AM MED ASSOC, V306, P1086; Rickard AJ, 2007, ENDOCRINOLOGY, V148, P4829, DOI 10.1210/en.2007-0209; ROGACZ S, 1990, HYPERTENSION, V15, P376, DOI 10.1161/01.HYP.15.4.376; Shibata S, 2011, J CLIN INVEST, V121, P3233, DOI 10.1172/JCI43124; Shibata S, 2008, NAT MED, V14, P1370, DOI 10.1038/nm.1879; Stolarz-Skrzypek K, 2011, JAMA-J AM MED ASSOC, V305, P1777, DOI 10.1001/jama.2011.574; Adler Alma J, 2014, Cochrane Database Syst Rev, pCD009217, DOI [10.1002/14651858.CD009217, 10.1002/14651858.CD009217.pub3]; Taylor RS, 2011, AM J HYPERTENS, V24, P843, DOI 10.1038/ajh.2011.115; Tian N, 2005, HYPERTENSION, V45, P934, DOI 10.1161/01.HYP.0000160404.08866.5a; Tian N, 2007, AM J PHYSIOL-HEART C, V293, pH3388, DOI 10.1152/ajpheart.00981.2007; Udani SM, 2009, CURR HYPERTENS REP, V11, P368, DOI 10.1007/s11906-009-0061-2; Vallon V, 2005, AM J PHYSIOL-REG I, V289, pR395, DOI 10.1152/ajpregu.00731.2004; Yokota K, 2007, J BIOL CHEM, V282, P1998, DOI 10.1074/jbc.M607741200; Zhang MM, 2010, AM J NEPHROL, V31, P75, DOI 10.1159/000256665; Zhang MM, 2009, RENAL FAILURE, V31, P726, DOI 10.3109/08860220903134571; Zhou MS, 2004, HYPERTENSION, V44, P186, DOI 10.1161/01.HYP.0000136395.06810.cf; Zhou MS, 2003, HYPERTENSION, V42, P945, DOI 10.1161/01.HYP.0000094220.06020.C8	59	21	21	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 24	2012	7	7							e41896	10.1371/journal.pone.0041896	http://dx.doi.org/10.1371/journal.pone.0041896			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	978NX	22911865	Green Submitted, gold, Green Published			2022-12-25	WOS:000306751300082
J	Daley, SME; Kappell, AD; Carrick, MJ; Burnap, RL				Daley, Shawn M. E.; Kappell, Anthony D.; Carrick, Marla J.; Burnap, Robert L.			Regulation of the Cyanobacterial CO2-Concentrating Mechanism Involves Internal Sensing of NADP(+) and alpha-Ketogutarate Levels by Transcription Factor CcmR	PLOS ONE			English	Article							INORGANIC CARBON LIMITATION; CO2 CONCENTRATING MECHANISMS; SYNECHOCYSTIS SP PCC-6803; SURFACE-PLASMON RESONANCE; MOBILITY SHIFT ASSAY; NDH-1 COMPLEXES; BICARBONATE TRANSPORTER; SYNECHOCOCCUS PCC7942; GENE-PRODUCTS; ACTIVATION	Inorganic carbon is the major macronutrient required by organisms utilizing oxygenic photosynthesis for autotrophic growth. Aquatic photoautotrophic organisms are dependent upon a CO2 concentrating mechanism (CCM) to overcome the poor CO2-affinity of the major carbon-fixing enzyme, ribulose-bisphosphate carboxylase/oxygenase (Rubisco). The CCM involves the active transport of inorganic forms of carbon (C-i) into the cell to increase the CO2 concentration around the active site of Rubisco. It employs both bicarbonate transporters and redox-powered CO2-hydration enzymes coupled to membranous NDH-type electron transport complexes that collectively produce C-i concentrations up to a 1000-fold greater in the cytoplasm compared to the external environment. The CCM is regulated: a high affinity CCM comprised of multiple components is induced under limiting external C-i concentrations. The LysR-type transcriptional regulator CcmR has been shown to repress its own expression along with structural genes encoding high affinity C-i transporters distributed throughout the genome of Synechocystis sp. PCC 6803. While much has been learned about the structural genes of the CCM and the identity of the transcriptional regulators controlling their expression, little is known about the physiological signals that elicit the induction of the high affinity CCM. Here CcmR is studied to identify metabolites that modulate its transcriptional repressor activity. Using surface plasmon resonance (SPR) alpha-ketoglutarate (alpha-KG) and the oxidized form of nicotinamide adenine dinucleotide phosphate (NADP(+)) have been identified as the co-repressors of CcmR. Additionally, ribulose-1,5-bisphosphate (RuBP) and 2-phosphoglycolate (2-PG) have been confirmed as co-activators of CmpR which controls the expression of the ABC-type bicarbonate transporter.	[Daley, Shawn M. E.; Carrick, Marla J.; Burnap, Robert L.] Oklahoma State Univ, Dept Biochem & Mol Biol, Stillwater, OK 74078 USA	Oklahoma State University System; Oklahoma State University - Stillwater	Daley, SME (corresponding author), Oklahoma State Univ, Dept Biochem & Mol Biol, Stillwater, OK 74078 USA.	rob.burnap@okstate.edu			United States Department of Energy, Office of Basic Energy Sciences [DE-FG02-08ER15968]; Oklahoma State University Foundation	United States Department of Energy, Office of Basic Energy Sciences(United States Department of Energy (DOE)); Oklahoma State University Foundation	This work was supported by the United States Department of Energy, Office of Basic Energy Sciences, DE-FG02-08ER15968. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; The authors wish to thank: Dr. Hong Jin Hwang for his assistance with data analysis, editing, and experimental design; Prof. Aaron Kaplan for his suggestion of SPR for ligand molecule identification; Prof. Archie Portis for his kind gift of 2-PG (originally from Sigma); Steven Holland for assisting in the spectroscopic assays, Prof. Uday DeSilva for his kind gift of the Taq enzyme construct; and Dr. Drew Dangel and Prof. Robert Tabita for their assistance with EMSA buffers and protocols are gratefully acknowledged. MJC was gratefully supported by Wentz and Niblack undergraduate research scholarships through the Oklahoma State University Foundation.	Badger MR, 2002, FUNCT PLANT BIOL, V29, P161, DOI 10.1071/PP01213; Bundy BM, 2002, P NATL ACAD SCI USA, V99, P7693, DOI 10.1073/pnas.102605799; CHANCE B, 1964, P NATL ACAD SCI USA, V51, P1244, DOI 10.1073/pnas.51.6.1244; Eisenhut M, 2008, PLANT PHYSIOL, V148, P2109, DOI 10.1104/pp.108.129403; Engohang-Ndong J, 2004, MOL MICROBIOL, V51, P175, DOI 10.1046/j.1365-2958.2003.03809.x; Ezezika OC, 2007, J MOL BIOL, V367, P616, DOI 10.1016/j.jmb.2006.09.090; Figge RM, 2001, MOL MICROBIOL, V39, P455, DOI 10.1046/j.1365-2958.2001.02239.x; Galmozzi CV, 2007, MOL MICROBIOL, V65, P166, DOI 10.1111/j.1365-2958.2007.05773.x; Georg J, 2011, MICROBIOL MOL BIOL R, V75, P286, DOI 10.1128/MMBR.00032-10; Giordano M, 2005, ANNU REV PLANT BIOL, V56, P99, DOI 10.1146/annurev.arplant.56.032604.144052; Hackenberg C, 2009, PLANTA, V230, P625, DOI 10.1007/s00425-009-0972-9; Hanson TE, 2011, FUNCTIONAL GENOMICS, P225; Hisbergues M, 1999, FEBS LETT, V463, P216, DOI 10.1016/S0014-5793(99)01624-5; Jing D, 2004, ELECTROPHORESIS, V25, P2439, DOI 10.1002/elps.200405994; Jing D, 2003, PROTEOMICS, V3, P1172, DOI 10.1002/pmic.200300438; KAPLAN A, 1991, PLANT PHYSIOL, V97, P851, DOI 10.1104/pp.97.3.851; Kaplan A, 1999, ANNU REV PLANT PHYS, V50, P539, DOI 10.1146/annurev.arplant.50.1.539; Klughammer B, 1999, MOL MICROBIOL, V32, P1305, DOI 10.1046/j.1365-2958.1999.01457.x; Lee HM, 1999, J BACTERIOL, V181, P2697, DOI 10.1128/JB.181.9.2697-2702.1999; Lieman-Hurwitz J, 2009, ENVIRON MICROBIOL, V11, P927, DOI 10.1111/j.1462-2920.2008.01818.x; Maeda S, 2002, MOL MICROBIOL, V43, P425, DOI 10.1046/j.1365-2958.2002.02753.x; MARCUS Y, 1983, PLANT PHYSIOL, V71, P208, DOI 10.1104/pp.71.1.208; McGinn PJ, 2004, PLANT CELL ENVIRON, V27, P615, DOI 10.1111/j.1365-3040.2004.01175.x; McGinn PJ, 2003, PLANT PHYSIOL, V132, P218, DOI 10.1104/pp.102.019349; Mitschke J, 2011, P NATL ACAD SCI USA, V108, P2124, DOI 10.1073/pnas.1015154108; Momany C, 2012, MOL MICROBIOL, V83, P453, DOI 10.1111/j.1365-2958.2011.07960.x; Muro-Pastor MI, 2001, J BIOL CHEM, V276, P38320; Muro-Pastor MI, 2005, PHOTOSYNTH RES, V83, P135, DOI 10.1007/s11120-004-2082-7; Myszyka DG, 1999, J MOL RECOGNIT, V12, P279, DOI 10.1002/(SICI)1099-1352(199909/10)12:5<279::AID-JMR473>3.0.CO;2-3; Nishimura T, 2008, MOL MICROBIOL; Omata T, 1999, P NATL ACAD SCI USA, V96, P13571, DOI 10.1073/pnas.96.23.13571; Omata T, 2001, J BACTERIOL, V183, P1891, DOI 10.1128/JB.183.6.1891-1898.2001; Pattnaik P, 2005, APPL BIOCHEM BIOTECH, V126, P79, DOI 10.1385/ABAB:126:2:079; PLUTHERO FG, 1993, NUCLEIC ACIDS RES, V21, P4850, DOI 10.1093/nar/21.20.4850; Poulsen AK, 2008, BIOCHEMISTRY-US, V47, P7477, DOI 10.1021/bi800396e; Price GD, 2008, J EXP BOT, V59, P1441, DOI 10.1093/jxb/erm112; Price GD, 2004, P NATL ACAD SCI USA, V101, P18228, DOI 10.1073/pnas.0405211101; PRICE GD, 1989, PLANT PHYSIOL, V89, P37, DOI 10.1104/pp.89.1.37; Prommeenate P, 2004, J BIOL CHEM, V279, P28165, DOI 10.1074/jbc.M401107200; Sambrook J., 1989, MOL CLONING LAB MANU, V2; Schwarz D, 2011, PLANT PHYSIOL, V155, P1640, DOI 10.1104/pp.110.170225; Shibata M, 2002, J BIOL CHEM, V277, P18658, DOI 10.1074/jbc.M112468200; Shibata M, 2001, P NATL ACAD SCI USA, V98, P11789, DOI 10.1073/pnas.191258298; STANIER RY, 1977, ANNU REV MICROBIOL, V31, P225, DOI 10.1146/annurev.mi.31.100177.001301; Stockley PG, 1998, BIOSENS BIOELECTRON, V13, P637, DOI 10.1016/S0956-5663(98)00019-0; Takahashi H, 2008, J EXP BOT, V59, P3009, DOI 10.1093/jxb/ern157; Takahashi Y, 2004, MOL MICROBIOL, V52, P837, DOI 10.1111/j.1365-2958.2004.04021.x; Tamoi M, 2005, PLANT J, V42, P504, DOI 10.1111/j.1365-313X.2005.02391.x; Tyrrell PN, 1996, PLANT PHYSIOL, V112, P79, DOI 10.1104/pp.112.1.79; van Keulen G, 2003, J BACTERIOL, V185, P1245, DOI 10.1128/JB.185.4.1245-1252.2003; Wang H, 2004, J BIOL CHEM, V279, P1468, DOI 10.1074/jbc.M309106200; Woodger FJ, 2007, J BACTERIOL, V189, P3335, DOI 10.1128/JB.01745-06; Woodger FJ, 2005, PLANT PHYSIOL, V139, P1959, DOI 10.1104/pp.105.069146; Woodger FJ, 2003, PLANT PHYSIOL, V133, P2069, DOI 10.1104/pp.103.029728; Zhang PP, 2004, PLANT CELL, V16, P3326, DOI 10.1105/tpc.104.026526; Zhou XH, 2010, J MOL BIOL, V396, P1012, DOI 10.1016/j.jmb.2009.12.033	57	54	56	0	64	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 20	2012	7	7							e41286	10.1371/journal.pone.0041286	http://dx.doi.org/10.1371/journal.pone.0041286			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	977GL	22911771	gold, Green Published, Green Submitted			2022-12-25	WOS:000306644600065
J	Dombrowski, SU; Sniehotta, FF; Mackintosh, J; White, M; Rodgers, H; Thomson, RG; Murtagh, MJ; Ford, GA; Eccles, MP; Araujo-Soares, V				Dombrowski, Stephan U.; Sniehotta, Falko F.; Mackintosh, Joan; White, Martin; Rodgers, Helen; Thomson, Richard G.; Murtagh, Madeleine J.; Ford, Gary A.; Eccles, Martin P.; Araujo-Soares, Vera			Witness Response at Acute Onset of Stroke: A Qualitative Theory-Guided Study	PLOS ONE			English	Article							DELAY; SEEKING; HEALTH; CARE; INTERVENTIONS; ASSOCIATION; STATEMENT; SYMPTOMS; DECISION; BEHAVIOR	Background: Delay in calling emergency medical services following stroke limits access to early treatment that can reduce disability. Emergency medical services contact is mostly initiated by stroke witnesses (often relatives), rather than stroke patients. This study explored appraisal and behavioural factors that are potentially important in influencing witness behaviour in response to stroke. Methods and Findings: Semi-structured interviews with 26 stroke witnesses were transcribed and theory-guided content analysed was undertaken based on the Common Sense Self-Regulation Model (appraisal processes) and Theory Domains Framework (behavioural determinants). Response behaviours were often influenced by heuristics-guided appraisal (i.e. mental rules of thumb). Some witnesses described their responses to the situation as 'automatic' and 'instinctive', rather than products of deliberation. Potential behavioural influences included: environmental context and resources (e. g. time of day), social influence (e. g. prompts from patients) and beliefs about consequences (e. g. 999 accesses rapid help). Findings are based on retrospective accounts and need further verification in prospective studies. Conclusions: Witnesses play a key role in patient access to emergency medical services. Factors that potentially influence witnesses' responses to stroke were identified and could inform behavioural interventions and future research. Interventions might benefit from linking automatic/instinctive threat perceptions with deliberate appraisal of stroke symptoms, prompting action to call emergency medical services.	[Dombrowski, Stephan U.; Sniehotta, Falko F.; Mackintosh, Joan; White, Martin; Thomson, Richard G.; Murtagh, Madeleine J.; Eccles, Martin P.; Araujo-Soares, Vera] Newcastle Univ, Inst Hlth & Soc, Newcastle Upon Tyne NE1 7RU, Tyne & Wear, England; [Rodgers, Helen; Ford, Gary A.] Newcastle Univ, Inst Ageing & Hlth, Newcastle Upon Tyne NE1 7RU, Tyne & Wear, England; [Murtagh, Madeleine J.] Univ Leicester, Dept Hlth Sci, Leicester, Leics, England; [Ford, Gary A.] Newcastle Upon Tyne Hosp Natl Hlth Serv Fdn Trust, Royal Victoria Infirm, Acute Stroke Serv, Newcastle Upon Tyne, Tyne & Wear, England	Newcastle University - UK; Newcastle University - UK; University of Leicester; Newcastle University - UK; Newcastle Upon Tyne Hospitals NHS Foundation Trust	Dombrowski, SU (corresponding author), Newcastle Univ, Inst Hlth & Soc, Baddiley Clark Bldg, Newcastle Upon Tyne NE1 7RU, Tyne & Wear, England.	stephan.dombrowski@ncl.ac.uk	Eccles, Martin P/AAD-4029-2020; Araujo-Soares, Vera/ABF-8144-2021; Sniehotta, Falko/ABF-7131-2021; Ford, Gary/AAY-6405-2020; Rodgers, Helen/K-4358-2012; Araujo-Soares, Vera/F-1806-2015; Sniehotta, Falko F/C-5481-2008; Dombrowski, Stephan/I-2350-2013	Araujo-Soares, Vera/0000-0003-4044-2527; Sniehotta, Falko/0000-0003-1738-4269; Ford, Gary/0000-0001-8719-4968; Araujo-Soares, Vera/0000-0003-4044-2527; Sniehotta, Falko F/0000-0003-1738-4269; White, Martin/0000-0002-1861-6757; Dombrowski, Stephan U/0000-0001-9832-2777	National Institute of Health Research [RP-PG-0606-1241]; Medical Research Council [G0900686] Funding Source: researchfish; National Institute for Health Research [RP-PG-0606-1241, NF-SI-0507-10249] Funding Source: researchfish; MRC [G0900686] Funding Source: UKRI	National Institute of Health Research(National Institute for Health Research (NIHR)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); National Institute for Health Research(National Institute for Health Research (NIHR)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	The research formed part of a research programme to Develop And evaluate Services for Hyperacute stroke, funded by the National Institute of Health Research (grant number: RP-PG-0606-1241). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andersen BL, 1995, BRIT J SOCIAL PSYC 1, V34; Department of Health, 2009, STROK ACT FAST; Evenson KR, 2009, INT J STROKE, V4, P187, DOI 10.1111/j.1747-4949.2009.00276.x; Flynn D, 2011, CEREBROVASC DIS, V31, P77; Gigerenzer G, 2011, ANNU REV PSYCHOL, V62, P451, DOI 10.1146/annurev-psych-120709-145346; Handschu R, 2003, STROKE, V34, P1005, DOI 10.1161/01.STR.0000063366.98459.1F; Jones SP, INT J STROK IN PRESS; Jones SP, 2010, AGE AGEING, V39, P11, DOI 10.1093/ageing/afp196; Kleindorfer D, 2010, AM J EMERG MED, V28, P607, DOI 10.1016/j.ajem.2009.02.016; Leventhal H, 1998, PSYCHOL HEALTH, V13, P717, DOI 10.1080/08870449808407425; Leventhal H, 2007, HDB HLTH PSYCHOL AGI; Lowe R, 2011, BRIT J HEALTH PSYCH, V16, P862, DOI 10.1111/j.2044-8287.2011.02023.x; Michie S, 2005, QUAL SAF HEALTH CARE, V14, P26, DOI 10.1136/qshc.2004.011155; Michie S, 2004, PSYCHOL HEALTH, V19, P29, DOI 10.1080/0887044031000141199; Moser DK, 2006, CIRCULATION, V114, P168, DOI 10.1161/CIRCULATIONAHA.106.176040; Mosley I, 2007, STROKE, V38, P361, DOI 10.1161/01.STR.0000254528.17405.cc; Porteous G H, 1999, Prehosp Emerg Care, V3, P211; Prestwich A, 2005, PSYCHOL HEALTH, V20, P743, DOI 10.1080/14768320500183335; Redfern J, 2006, STROKE, V37, P2410, DOI 10.1161/01.STR.0000237097.00342.a9; Rosamond Wayne D, 2005, Prehosp Emerg Care, V9, P19, DOI 10.1080/10903120590891985; SAFER MA, 1979, MED CARE, V17, P11, DOI 10.1097/00005650-197901000-00002; Scott S, 2010, SOC PERSONAL PSYCHOL, V4, P531, DOI 10.1111/j.1751-9004.2010.00287.x; Sniehotta FF, 2009, BRIT J HEALTH PSYCH, V14, P261, DOI 10.1348/135910708X389042; Teuschl Y, 2010, INT J STROKE, V5, P187, DOI 10.1111/j.1747-4949.2010.00428.x; The Stroke Collaborative, 2008, GIV ME 5 STROK; Walter F, 2011, HLTH SERVICES RES PO; Weller D, 2012, BRIT J CANCER, V106, P1262, DOI 10.1038/bjc.2012.68	28	16	17	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 20	2012	7	7							e39852	10.1371/journal.pone.0039852	http://dx.doi.org/10.1371/journal.pone.0039852			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	977GL	22911691	Green Published, gold, Green Submitted			2022-12-25	WOS:000306644600010
J	Kim, DS; Lee, DR; Kim, HS; Yoo, JE; Jung, SJ; Lim, BY; Jang, J; Kang, HC; You, S; Hwang, DY; Leem, JW; Nam, TS; Cho, SR; Kim, DW				Kim, Dae-Sung; Lee, Dongjin R.; Kim, Han-Soo; Yoo, Jeong-Eun; Jung, Sung Jun; Lim, Bo Young; Jang, Jiho; Kang, Hoon-Chul; You, Seungkwon; Hwang, Dong-Youn; Leem, Joong Woo; Nam, Taick Sang; Cho, Sung-Rae; Kim, Dong-Wook			Highly Pure and Expandable PSA-NCAM-Positive Neural Precursors from Human ESC and iPSC-Derived Neural Rosettes	PLOS ONE			English	Article							LONG-TERM PROLIFERATION; EMBRYONIC STEM-CELLS; DOPAMINE NEURONS; LINEAGE SELECTION; POLYSIALIC ACID; DIFFERENTIATION; PLASTICITY; EXPRESSION	Homogeneous culture of neural precursor cells (NPCs) derived from human pluripotent stem cells (hPSCs) would provide a powerful tool for biomedical applications. However, previous efforts to expand mechanically dissected neural rosettes for cultivation of NPCs remain concerns regarding non-neural cell contamination. In addition, several attempts to purify NPCs using cell surface markers have not demonstrated the expansion capability of the sorted cells. In the present study, we show that polysialic acid-neural cell adhesion molecule (PSA-NCAM) is detected in neural rosette cells derived from hPSCs, and employ PSA-NCAM as a marker for purifying expandable primitive NPCs from the neural rosettes. PSA-NCAM-positive NPCs (termed hNPC(PSA-NCAM+)) were isolated from the heterogeneous cell population of mechanically harvested neural rosettes using magnetic-based cell sorting. The hNPC(PSA-NCAM+) extensively expressed neural markers such as Sox1, Sox2, Nestin, and Musashi-1 (80 similar to 98% of the total cells) and were propagated for multiple passages while retaining their primitive characteristics in our culture condition. Interestingly, PSA-NCAM-negative cells largely exhibited characteristics of neural crest cells. The hNPC(PSA-NCAM+) showed multipotency and responsiveness to instructive cues towards region-specific neuronal subtypes in vitro. When transplanted into the rat striatum, hNPC(PSA-NCAM+) differentiated into neurons, astrocytes, and oligodendrocytes without particular signs of tumorigenesis. Furthermore, Ki67-positive proliferating cells and non-neural lineage cells were rarely detected in the grafts of hNPC(PSA-NCAM+) compared to those of neural rosette cells. Our results suggest that PSA-NCAM-mediated cell isolation provides a highly expandable population of pure primitive NPCs from hPSCs that will lend themselves as a promising strategy for drug screening and cell therapy for neurodegenerative disorders.	[Kim, Dae-Sung; Lee, Dongjin R.; Yoo, Jeong-Eun; Lim, Bo Young; Jang, Jiho; Leem, Joong Woo; Nam, Taick Sang; Kim, Dong-Wook] Yonsei Univ, Coll Med, Dept Physiol, Seoul, South Korea; [Lee, Dongjin R.; Yoo, Jeong-Eun; Lim, Bo Young; Kim, Dong-Wook] Yonsei Univ, Coll Med, Brain Korea Project Med Sci 21, Seoul, South Korea; [Kim, Han-Soo] Yonsei Univ, Coll Med, Ctr Cell Therapy, Seoul, South Korea; [Kim, Han-Soo] Yonsei Univ, Coll Med, Dept Lab Med, Seoul, South Korea; [Jung, Sung Jun] Hanyang Univ, Coll Med, Dept Physiol, Seoul 133791, South Korea; [Kang, Hoon-Chul] Yonsei Univ, Coll Med, Severance Childrens Hosp, Dept Pediat,Div Pediat Neurol, Seoul, South Korea; [You, Seungkwon] Korea Univ, Coll Life Sci & Biotechnol, Seoul, South Korea; [Hwang, Dong-Youn] CHA Univ, Coll Med, CHA Stem Cell Inst, Seoul, South Korea; [Cho, Sung-Rae] Yonsei Univ, Coll Med, Dept & Res Inst Rehabil Med, Seoul, South Korea; [Kim, Dong-Wook] Yonsei Univ, Coll Med, Severance Biomed Res Inst, Seoul, South Korea	Yonsei University; Yonsei University Health System; Yonsei University; Yonsei University Health System; Yonsei University; Yonsei University Health System; Yonsei University; Yonsei University Health System; Hanyang University; Yonsei University; Yonsei University Health System; Korea University; Pochon Cha University; Yonsei University; Yonsei University Health System; Yonsei University; Yonsei University Health System	Kim, DS (corresponding author), Yonsei Univ, Coll Med, Dept Physiol, Seoul, South Korea.	dwkim2@yuhs.ac	Kim, Dae-Sung/H-1116-2015; Kang, Phil Jun/F-4716-2013; You, Seungkwon/H-3067-2015	Kim, Dae-Sung/0000-0002-3835-4803; Dong-Wook, Kim/0000-0002-5025-1532; Kang, Hoon-Chul/0000-0002-3659-8847; Cho, Sung-Rae/0000-0003-1429-2684; Leem, Joong/0000-0002-1605-2230	Stem Cell Research Center of the 21st Century Frontier Research Program [SC1110]; National Research Foundation [NRF 2010-0020408, 2010-0020353]; Ministry of Education, Science and Technology, Korea	Stem Cell Research Center of the 21st Century Frontier Research Program(Ministry of Education, Science & Technology (MEST), Republic of Korea); National Research Foundation; Ministry of Education, Science and Technology, Korea(Ministry of Education, Science & Technology (MEST), Republic of Korea)	This work was supported by a grant from the Stem Cell Research Center of the 21st Century Frontier Research Program (SC1110), National Research Foundation (NRF 2010-0020408 and 2010-0020353) funded by the Ministry of Education, Science and Technology, Korea. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Barraud P, 2007, J NEUROSCI RES, V85, P250, DOI 10.1002/jnr.21116; Bonfanti L, 2006, PROG NEUROBIOL, V80, P129, DOI 10.1016/j.pneurobio.2006.08.003; Carpenter MK, 2001, EXP NEUROL, V172, P383, DOI 10.1006/exnr.2001.7832; Chambers SM, 2009, NAT BIOTECHNOL, V27, P275, DOI 10.1038/nbt.1529; Colleoni S, 2010, EXP CELL RES, V316, P1148, DOI 10.1016/j.yexcr.2010.02.013; Conti L, 2005, PLOS BIOL, V3, P1594, DOI 10.1371/journal.pbio.0030283; Curchoe CL, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013890; Daadi MM, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001644; Elkabetz Y, 2008, GENE DEV, V22, P152, DOI 10.1101/gad.1616208; Friling S, 2009, P NATL ACAD SCI USA, V106, P7613, DOI 10.1073/pnas.0902396106; Gascon E, 2007, BRAIN RES REV, V56, P101, DOI 10.1016/j.brainresrev.2007.05.014; Hedlund E, 2007, STEM CELLS, V25, P1126, DOI 10.1634/stemcells.2006-0540; Hong S, 2008, J NEUROCHEM, V104, P316, DOI 10.1111/j.1471-4159.2007.04952.x; Hu BY, 2010, P NATL ACAD SCI USA, V107, P4335, DOI 10.1073/pnas.0910012107; Jong J, 2012, EXP MOL MED, V44, P202, DOI 10.3858/emm.2012.44.3.015; Kalyani A, 1997, DEV BIOL, V186, P202, DOI 10.1006/dbio.1997.8592; Kim DS, 2010, STEM CELL REV REP, V6, P270, DOI 10.1007/s12015-010-9138-1; Koch P, 2009, P NATL ACAD SCI USA, V106, P3225, DOI 10.1073/pnas.0808387106; Ladewig J, 2008, STEM CELLS, V26, P1705, DOI 10.1634/stemcells.2008-0007; Le Douarin NM, 2008, CELL CYCLE, V7, P1013, DOI 10.4161/cc.7.8.5641; Lee G, 2007, NAT BIOTECHNOL, V25, P1468, DOI 10.1038/nbt1365; MayerProschel M, 1997, NEURON, V19, P773, DOI 10.1016/S0896-6273(00)80960-5; Oh SK, 2005, STEM CELLS, V23, P605, DOI 10.1634/stemcells.2004-0297; Osafune K, 2008, NAT BIOTECHNOL, V26, P313, DOI 10.1038/nbt1383; Perrier AL, 2004, P NATL ACAD SCI USA, V101, P12543, DOI 10.1073/pnas.0404700101; Pruszak J, 2009, STEM CELLS, V27, P2928, DOI 10.1002/stem.211; Rutishauser U, 2008, NAT REV NEUROSCI, V9, P26, DOI 10.1038/nrn2285; Schmandt T, 2005, STEM CELLS DEV, V14, P55, DOI 10.1089/scd.2005.14.55; Shin SJ, 2006, STEM CELLS, V24, P125, DOI 10.1634/stemcells.2004-0150; Tabar V, 2005, NAT BIOTECHNOL, V23, P601, DOI 10.1038/nbt1088; Thomson JA, 1998, SCIENCE, V282, P1145, DOI 10.1126/science.282.5391.1145; Uchida N, 2000, P NATL ACAD SCI USA, V97, P14720, DOI 10.1073/pnas.97.26.14720; Wang S, 2010, J NEUROSCI, V30, P14635, DOI 10.1523/JNEUROSCI.1729-10.2010; Yuan SH, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017540; Zhang SC, 2001, NAT BIOTECHNOL, V19, P1129, DOI 10.1038/nbt1201-1129; Zola H, 2006, MOL MED, V12, P312, DOI 10.2119/2006-00081.Zola	36	48	54	0	23	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 20	2012	7	7							e39715	10.1371/journal.pone.0039715	http://dx.doi.org/10.1371/journal.pone.0039715			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	977GL	22911689	Green Published, gold, Green Submitted			2022-12-25	WOS:000306644600008
J	Mocroft, A; Neuhaus, J; Peters, L; Ryom, L; Bickel, M; Grint, D; Koirala, J; Szymczak, A; Lundgren, J; Ross, MJ; Wyatt, CM				Mocroft, Amanda; Neuhaus, Jacqueline; Peters, Lars; Ryom, Lene; Bickel, Markus; Grint, Daniel; Koirala, Janak; Szymczak, Aleksandra; Lundgren, Jens; Ross, Michael J.; Wyatt, Christina M.		INSIGHT SMART Study Grp; ESPRIT Study Grp	Hepatitis B and C Co-Infection Are Independent Predictors of Progressive Kidney Disease in HIV-Positive, Antiretroviral-Treated Adults	PLOS ONE			English	Article							GLOMERULAR-FILTRATION-RATE; INFECTED PATIENTS; MEMBRANOUS NEPHROPATHY; VIRUS COINFECTION; RISK-FACTORS; CIRRHOSIS; FIBROSIS; THERAPY; GLOMERULONEPHRITIS; ALBUMINURIA	Chronic kidney disease (CKD) is an important cause of morbidity and mortality in HIV-positive individuals. Hepatitis C (HCV) co-infection has been associated with increased risk of CKD, but prior studies lack information on potential mechanisms. We evaluated the association between HCV or hepatitis B (HBV) co-infection and progressive CKD among 3,441 antiretroviral-treated clinical trial participants. Progressive CKD was defined as the composite of end-stage renal disease, renal death, or significant glomerular filtration rate (eGFR) decline (25% decline to eGFR <60 mL/min/1.73 m(2) or 25% decline with a baseline <60). Generalized Estimating Equations were used to model the odds of progressive CKD. At baseline, 13.8% and 3.3% of participants were co-infected with HCV and HBV, respectively. Median eGFR was 111, and 3.7% developed progressive CKD. After adjustment, the odds of progressive CKD were increased in participants with HCV (OR 1.72, 95% CI 1.07-2.76) or HBV (OR 2.26, 95% CI 1.15-4.44). Participants with undetectable or low HCV-RNA had similar odds of progressive CKD as HCV seronegative participants, while participants with HCV-RNA >800,000 IU/ml had increased odds (OR 3.07; 95% CI 1.60-5.90). Interleukin-6, hyaluronic acid, and the FIB-4 hepatic fibrosis index were higher among participants who developed progressive CKD, but were no longer associated with progressive CKD after adjustment. Future studies should validate the relationship between HCV viremia and CKD.	[Mocroft, Amanda; Grint, Daniel] UCL, Sch Med, Res Dept Infect & Populat Hlth, London W1N 8AA, England; [Neuhaus, Jacqueline] Univ Minnesota, Sch Publ Hlth, Dept Biostat, Minneapolis, MN USA; [Peters, Lars; Ryom, Lene; Lundgren, Jens] Univ Copenhagen, Fac Hlth Sci, Copenhagen HIV Programme, Copenhagen, Denmark; [Bickel, Markus] JW Goethe Univ Clin, Dept Infect Dis, Frankfurt, Germany; [Koirala, Janak] So Illinois Univ, Sch Med, Dept Med, Div Infect Dis, Springfield, IL 62708 USA; [Szymczak, Aleksandra] Wroclaw Med Univ, Dept Infect Dis Liver Dis & Acquired Immunodefici, Wroclaw, Poland; [Lundgren, Jens] Rigshosp, Dept Infect Dis, Copenhagen Univ Hosp, DK-2100 Copenhagen, Denmark; [Ross, Michael J.; Wyatt, Christina M.] Mt Sinai Sch Med, Dept Med, Div Nephrol, New York, NY USA	University of London; University College London; UCL Medical School; University of Minnesota System; University of Minnesota Twin Cities; University of Copenhagen; Goethe University Frankfurt; Goethe University Frankfurt Hospital; Southern Illinois University System; Southern Illinois University; Wroclaw Medical University; Rigshospitalet; University of Copenhagen; Icahn School of Medicine at Mount Sinai	Mocroft, A (corresponding author), UCL, Sch Med, Res Dept Infect & Populat Hlth, Mortimer St, London W1N 8AA, England.	Christina.wyatt@mssm.edu	Lundgren, Jens/AAE-6876-2019; Szymczak, Aleksandra/ABD-3498-2021	Szymczak, Aleksandra/0000-0001-6695-2942; Lundgren, Jens/0000-0001-8901-7850; Grint, Daniel/0000-0001-8001-6544; Koirala, Janak/0000-0002-3608-474X	National Institutes of Health, National Institute of Allergy and Infectious Disease [U01AI042170, U01A1068641, U01AI46362, U01AI046957]; National Institute of Diabetes and Digestive and Kidney Diseases [K23DK077568]; Medical Research Council [MC_U122886352] Funding Source: researchfish; MRC [MC_U122886352] Funding Source: UKRI; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [U01AI046957, U01AI042170, U01AI046362] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [K23DK077568, R01DK078510] Funding Source: NIH RePORTER	National Institutes of Health, National Institute of Allergy and Infectious Disease(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); National Institute of Diabetes and Digestive and Kidney Diseases(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported by the National Institutes of Health, National Institute of Allergy and Infectious Disease, grants U01AI042170, U01A1068641, and U01AI46362 (SMART) and grant U01AI046957 (ESPRIT). The current analysis was also supported by the National Institute of Diabetes and Digestive and Kidney Diseases, grant K23DK077568 (CMW). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abrams D, 2009, NEW ENGL J MED, V361, P1548, DOI 10.1056/NEJMoa0903175; Butt AA, 2011, AM J KIDNEY DIS, V57, P396, DOI 10.1053/j.ajkd.2010.09.023; Cheng JT, 1999, J AM SOC NEPHROL, V10, P1566; Choi AI, 2010, CIRCULATION, V121, P651, DOI 10.1161/CIRCULATIONAHA.109.898585; CONJEEVARAM HS, 1995, GASTROENTEROLOGY, V109, P540, DOI 10.1016/0016-5085(95)90343-7; Di Biagio A, 2011, CLIN NEPHROL, V75, P518, DOI 10.5414/CNP75518; El-Sadr WM, 2006, NEW ENGL J MED, V355, P2283, DOI 10.1056/NEJMoa062360; George E, 2011, MEDICINE, V90, P289, DOI 10.1097/MD.0b013e31822f5915; Gupta SK, 2005, CLIN INFECT DIS, V40, P1559, DOI 10.1086/430257; Horio M, 2010, AM J KIDNEY DIS, V56, P32, DOI 10.1053/j.ajkd.2010.02.344; Huang JF, 2006, J INTERN MED, V260, P255, DOI 10.1111/j.1365-2796.2006.01686.x; Jotwani V, 2011, AM J KIDNEY DIS; LAI KN, 1991, NEW ENGL J MED, V324, P1457, DOI 10.1056/NEJM199105233242103; Lee JJ, 2010, AM J KIDNEY DIS, V56, P23, DOI 10.1053/j.ajkd.2010.01.015; Levey AS, 2009, ANN INTERN MED, V150, P604, DOI 10.7326/0003-4819-150-9-200905050-00006; Martin-Carbonero L, 2011, AIDS, V25, P73, DOI 10.1097/QAD.0b013e328340fde2; McGuire BM, 2006, ANN INTERN MED, V144, P735, DOI 10.7326/0003-4819-144-10-200605160-00007; Mocroft A, 2010, AIDS, V24, P1667, DOI 10.1097/QAD.0b013e328339fe53; Oberti F, 1997, GASTROENTEROLOGY, V113, P1609, DOI 10.1053/gast.1997.v113.pm9352863; Peters L, 2012, AIDS IN PRESS; Sorli ML, 2008, JAIDS-J ACQ IMM DEF, V48, P506, DOI 10.1097/QAI.0b013e31817bbecb; Stevens LA, 2011, KIDNEY INT, V79, P555, DOI 10.1038/ki.2010.462; System USRD, 2011, USRDS 2011 ANN DAT R; Szczech LA, 2004, KIDNEY INT, V66, P1145, DOI 10.1111/j.1523-1755.2004.00865.x; Tang S, 2005, KIDNEY INT, V68, P1750, DOI 10.1111/j.1523-1755.2005.00591.x; Tsui JI, 2006, J AM SOC NEPHROL, V17, P1168, DOI 10.1681/ASN.2005091006; Vallet-Pichard A, 2007, HEPATOLOGY, V46, P32, DOI 10.1002/hep.21669; Wai CT, 2003, HEPATOLOGY, V38, P518, DOI 10.1053/jhep.2003.50346; Wyatt CA, 2008, AIDS, V22, P1799, DOI 10.1097/QAD.0b013e32830e0152; Wyatt CM, 2011, ANTIVIR THER, V16, P591, DOI 10.3851/IMP1766	30	57	62	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 20	2012	7	7							e40245	10.1371/journal.pone.0040245	http://dx.doi.org/10.1371/journal.pone.0040245			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	977GL	22911697	Green Published, gold, Green Submitted			2022-12-25	WOS:000306644600015
J	Shull, AY; Latham-Schwark, A; Ramasamy, P; Leskoske, K; Oroian, D; Birtwistle, MR; Buckhaults, PJ				Shull, Austin Y.; Latham-Schwark, Alicia; Ramasamy, Poornema; Leskoske, Kristin; Oroian, Dora; Birtwistle, Marc R.; Buckhaults, Phillip J.			Novel Somatic Mutations to PI3K Pathway Genes in Metastatic Melanoma	PLOS ONE			English	Article							NEGATIVE FEEDBACK-AMPLIFIER; MST2 PATHWAY; HUMAN CANCER; BRAF; AKT; INHIBITION; (V600E)BRAF; MECHANISMS; RESISTANCE; APOPTOSIS	Background: BRAF(V600) inhibitors have offered a new gateway for better treatment of metastatic melanoma. However, the overall efficacy of BRAF(V600) inhibitors has been lower than expected in clinical trials, and many patients have shown resistance to the drug's effect. We hypothesized that somatic mutations in the Phosphoinositide 3-Kinase (PI3K) pathway, which promotes proliferation and survival, may coincide with BRAF(V600) mutations and contribute to chemotherapeutic resistance. Methods: We performed a somatic mutation profiling study using the 454 FLX pyrosequencing platform in order to identify candidate cancer genes within the MAPK and PI3K pathways of melanoma patients. Somatic mutations of theses candidate cancer genes were then confirmed using Sanger sequencing. Results: As expected, BRAF(V600) mutations were seen in 51% of the melanomas, whereas NRAS mutations were seen in 19% of the melanomas. However, PI3K pathway mutations, though more heterogeneous, were present in 41% of the melanoma, with PTEN being the highest mutated PI3K gene in melanomas (22%). Interestingly, several novel PI3K pathway mutations were discovered in MTOR, IRS4, PIK3R1, PIK3R4, PIK3R5, and NFKB1. PI3K pathway mutations co-occurred with BRAF(V600) mutations in 17% of the tumors and co-occurred with 9% of NRAS mutant tumors, implying cooperativity between these pathways in terms of melanoma progression. Conclusions: These novel PI3K pathway somatic mutations could provide alternative survival and proliferative pathways for metastatic melanoma cells. They therefore may be potential chemotherapeutic targets for melanoma patients who exhibit resistance to BRAF(V600) inhibitors.	[Shull, Austin Y.; Latham-Schwark, Alicia; Ramasamy, Poornema; Leskoske, Kristin; Oroian, Dora; Birtwistle, Marc R.; Buckhaults, Phillip J.] Georgia Hlth Sci Univ, Ctr Canc, Augusta, GA USA; [Latham-Schwark, Alicia] Med Univ S Carolina, Coll Med, Charleston, SC 29425 USA; [Leskoske, Kristin] Univ Calif Berkeley, Dept Mol & Cell Biol, Berkeley, CA 94720 USA	University System of Georgia; Augusta University; Medical University of South Carolina; University of California System; University of California Berkeley	Shull, AY (corresponding author), Georgia Hlth Sci Univ, Ctr Canc, Augusta, GA USA.	phillip.buckhaults@gmail.com		Birtwistle, Marc/0000-0002-0341-0705	NIH [3P20RR017698-07]; NATIONAL CENTER FOR RESEARCH RESOURCES [P20RR017698] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR))	Support for this project was provided by NIH grant # 3P20RR017698-07 Bench-to-bedside award. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alcala AM, 2012, CLIN CANCER RES, V18, P33, DOI 10.1158/1078-0432.CCR-11-0997; Andersen V, 2010, BMC CANCER, V10, DOI 10.1186/1471-2407-10-484; Atefi M, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0028973; Berger MF, 2012, NATURE, V485, P502, DOI 10.1038/nature11071; Birtwistle MR, 2011, CELL CYCLE, V10, P2069, DOI 10.4161/cc.10.13.16245; Bollag G, 2010, NATURE, V467, P596, DOI 10.1038/nature09454; Datta SR, 1997, CELL, V91, P231, DOI 10.1016/S0092-8674(00)80405-5; Davies H, 2002, NATURE, V417, P949, DOI 10.1038/nature00766; Deng W, 2012, PIGM CELL MELANOMA R, V25, DOI 10.1111/j.1755-148X.2011.00950.x; Dhomen N, 2009, HEMATOL ONCOL CLIN N, V23, P529, DOI 10.1016/j.hoc.2009.04.001; Eisen T, 2006, BRIT J CANCER, V95, P581, DOI 10.1038/sj.bjc.6603291; Flaherty KT, 2010, NEW ENGL J MED, V363, P809, DOI 10.1056/NEJMoa1002011; Forbes SA, 2011, NUCLEIC ACIDS RES, V39, pD945, DOI 10.1093/nar/gkq929; Gray-Schopfer V, 2007, NATURE, V445, P851, DOI 10.1038/nature05661; Greger J, 2012, MOL CANC THERAPEUTIC; Heidorn SJ, 2010, CELL, V140, P209, DOI 10.1016/j.cell.2009.12.040; Inamdar GS, 2010, BIOCHEM PHARMACOL, V80, P624, DOI 10.1016/j.bcp.2010.04.029; Ling J, 2012, CANC LETT; Martin D, 2011, CANCER CELL, V19, P805, DOI 10.1016/j.ccr.2011.05.005; Matallanas D, 2007, MOL CELL, V27, P962, DOI 10.1016/j.molcel.2007.08.008; Matallanas D, 2011, MOL CELL, V44, P893, DOI 10.1016/j.molcel.2011.10.016; Memmott RM, 2009, CELL SIGNAL, V21, P656, DOI 10.1016/j.cellsig.2009.01.004; Ogawara Y, 2002, J BIOL CHEM, V277, P21843, DOI 10.1074/jbc.M109745200; Palavalli LH, 2009, NAT GENET, V41, P518, DOI 10.1038/ng.340; Paraiso KHT, 2011, CANCER RES, V71, P2750, DOI 10.1158/0008-5472.CAN-10-2954; Pleasance ED, 2010, NATURE, V463, P191, DOI 10.1038/nature08658; Romano D, 2010, CANCER RES, V70, P1195, DOI 10.1158/0008-5472.CAN-09-3147; Samuels Y, 2006, CURR OPIN ONCOL, V18, P77, DOI 10.1097/01.cco.0000198021.99347.b9; Sanchez-Hernandez I, 2012, CANCER LETT, V314, P244, DOI 10.1016/j.canlet.2011.09.037; Shimizu T, 2012, CLIN CANC RES OFFICI; Sturm OE, 2010, SCI SIGNAL, V3, DOI 10.1126/scisignal.2001212; Thoresen SB, 2010, EXP CELL RES, V316, P3368, DOI 10.1016/j.yexcr.2010.07.008; Wang Y, 2007, CURR CANCER DRUG TAR, V7, P591, DOI 10.2174/156800907781662248; Wei XM, 2011, NAT GENET, V43, P442, DOI 10.1038/ng.810; Wu H, 2003, ONCOGENE, V22, P3113, DOI 10.1038/sj.onc.1206451; Xing F, 2012, ONCOGENE, V31, P446, DOI 10.1038/onc.2011.250	37	61	66	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 17	2012	7	8							e43369	10.1371/journal.pone.0043369	http://dx.doi.org/10.1371/journal.pone.0043369			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	996DG	22912864	Green Published, Green Submitted, gold			2022-12-25	WOS:000308063700092
J	Guo, HT; Xu, CX; Zhou, TL; Block, TM; Guo, JT				Guo, Haitao; Xu, Chunxiao; Zhou, Tianlun; Block, Timothy M.; Guo, Ju-Tao			Characterization of the Host Factors Required for Hepadnavirus Covalently Closed Circular (ccc) DNA Formation	PLOS ONE			English	Article							HEPATITIS-B-VIRUS; REVERSE TRANSCRIPTION; VIRAL-DNA; INFECTED LIVER; CELL-CULTURES; REPLICATION; GENOME; INTERMEDIATE; INTEGRATION; LAMIVUDINE	Synthesis of the covalently closed circular (ccc) DNA is a critical, but not well-understood step in the life cycle of hepadnaviruses. Our previous studies favor a model that removal of genome-linked viral DNA polymerase occurs in the cytoplasm and the resulting deproteinized relaxed circular DNA (DP-rcDNA) is subsequently transported into the nucleus and converted into cccDNA. In support of this model, our current study showed that deproteinization of viral double-stranded linear (dsl) DNA also took place in the cytoplasm. Furthermore, we demonstrated that Ku80, a component of non-homologous end joining DNA repair pathway, was essential for synthesis of cccDNA from dslDNA, but not rcDNA. In an attempt to identify additional host factors regulating cccDNA biosynthesis, we found that the DP-rcDNA was produced in all tested cell lines that supported DHBV DNA replication, but cccDNA was only synthesized in the cell lines that accumulated high levels of DP-rcDNA, except for NCI-H322M and MDBK cells, which failed to synthesize cccDNA despite of the existence of nuclear DP-rcDNA. The results thus imply that while removal of the genome-linked viral DNA polymerase is most likely catalyzed by viral or ubiquitous host function(s), nuclear factors required for the conversion of DP-rcDNA into cccDNA and/or its maintenance are deficient in the above two cell lines, which could be useful tools for identification of the elusive host factors essential for cccDNA biosynthesis or maintenance.	[Guo, Haitao; Xu, Chunxiao; Block, Timothy M.; Guo, Ju-Tao] Drexel Univ, Coll Med, Dept Microbiol & Immunol, Doylestown, PA USA; [Zhou, Tianlun; Block, Timothy M.] Hepatitis B Fdn, Inst Hepatitis & Virus Res, Doylestown, PA USA	Drexel University	Guo, HT (corresponding author), Drexel Univ, Coll Med, Dept Microbiol & Immunol, Doylestown, PA USA.	Haitao.Guo@drexelmed.edu; ju-tao.guo@drexelmed.edu			National Institutes of Health [AI094474]; Hepatitis B Foundation; Commonwealth of Pennsylvania; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI094474] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Hepatitis B Foundation; Commonwealth of Pennsylvania; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	The study was supported by National Institutes of Health (AI094474), Hepatitis B Foundation and appropriation from the Commonwealth of Pennsylvania. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Beck J, 2007, WORLD J GASTROENTERO, V13, P48, DOI 10.3748/wjg.v13.i1.48; Bill CA, 2004, P NATL ACAD SCI USA, V101, P11135, DOI 10.1073/pnas.0403925101; Gao WF, 2007, J VIROL, V81, P6164, DOI 10.1128/JVI.02721-06; GERLICH WH, 1980, J VIROL, V36, P787, DOI 10.1128/JVI.36.3.787-795.1980; GUIDOTTI LG, 1995, J VIROL, V69, P6158, DOI 10.1128/JVI.69.10.6158-6169.1995; Guo H, 2007, J VIROL, V81, P12472, DOI 10.1128/JVI.01123-07; Guo HT, 2010, J VIROL, V84, P387, DOI 10.1128/JVI.01921-09; Guo HT, 2005, J VIROL, V79, P2729, DOI 10.1128/JVI.79.5.2729-2742.2005; Guo JT, 2003, J VIROL, V77, P1885, DOI 10.1128/JVI.77.3.1885-1893.2003; Guo JT, 2007, ANTIVIR RES, V76, P232, DOI 10.1016/j.antiviral.2007.06.015; HIRT B, 1967, J MOL BIOL, V26, P365, DOI 10.1016/0022-2836(67)90307-5; Hsu HL, 2000, GENE DEV, V14, P2807, DOI 10.1101/gad.844000; Kann M, 2007, WORLD J GASTROENTERO, V13, P39, DOI 10.3748/wjg.v13.i1.39; Kock J, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1001082; Lai CL, 2002, GASTROENTEROLOGY, V123, P1831, DOI 10.1053/gast.2002.37058; Li HC, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1001162; Liaw YF, 2000, GASTROENTEROLOGY, V119, P172, DOI 10.1053/gast.2000.8559; LIEN JM, 1986, J VIROL, V57, P229, DOI 10.1128/JVI.57.1.229-236.1986; Liu N, 2003, P NATL ACAD SCI USA, V100, P1984, DOI 10.1073/pnas.0436218100; Marcellin P, 2003, NEW ENGL J MED, V348, P808, DOI 10.1056/NEJMoa020681; MOLNARKIMBER KL, 1983, J VIROL, V45, P165, DOI 10.1128/JVI.45.1.165-172.1983; NEWBOLD JE, 1995, J VIROL, V69, P3350, DOI 10.1128/JVI.69.6.3350-3357.1995; Rabe B, 2003, P NATL ACAD SCI USA, V100, P9849, DOI 10.1073/pnas.1730940100; Schmitz A, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1000741; Seeger C, 2000, MICROBIOL MOL BIOL R, V64, P51, DOI 10.1128/MMBR.64.1.51-68.2000; Sohn JA, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0008093; STAPRANS S, 1991, J VIROL, V65, P1255, DOI 10.1128/JVI.65.3.1255-1262.1991; SUMMERS J, 1990, J VIROL, V64, P2819, DOI 10.1128/JVI.64.6.2819-2824.1990; SUMMERS J, 1982, CELL, V29, P403, DOI 10.1016/0092-8674(82)90157-X; SUMMERS J, 1975, P NATL ACAD SCI USA, V72, P4597, DOI 10.1073/pnas.72.11.4597; Symington LS, 2011, ANNU REV GENET, V45, P247, DOI 10.1146/annurev-genet-110410-132435; TAVIS JE, 1994, J VIROL, V68, P3536, DOI 10.1128/JVI.68.6.3536-3543.1994; TUTTLEMAN JS, 1986, CELL, V47, P451, DOI 10.1016/0092-8674(86)90602-1; WANG GH, 1993, J VIROL, V67, P6507, DOI 10.1128/JVI.67.11.6507-6512.1993; WU TT, 1990, VIROLOGY, V175, P255, DOI 10.1016/0042-6822(90)90206-7; Xu CX, 2010, J VIROL, V84, P9332, DOI 10.1128/JVI.00918-10; YANG WG, 1995, J VIROL, V69, P4029, DOI 10.1128/JVI.69.7.4029-4036.1995; Yang WG, 1999, J VIROL, V73, P9710, DOI 10.1128/JVI.73.12.9710-9717.1999; Yang WG, 1996, J VIROL, V70, P4567, DOI 10.1128/JVI.70.7.4567-4575.1996; Zhou TL, 2006, ANTIVIR RES, V72, P116, DOI 10.1016/j.antiviral.2006.05.006; Zhu Y, 2001, J VIROL, V75, P311, DOI 10.1128/JVI.75.1.311-322.2001; Zoulim F, 2012, GUT, V61, P333, DOI 10.1136/gutjnl-2011-300937	42	43	47	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 13	2012	7	8							e43270	10.1371/journal.pone.0043270	http://dx.doi.org/10.1371/journal.pone.0043270			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	988OJ	22912842	Green Published, Green Submitted, gold			2022-12-25	WOS:000307500100075
J	Kim, HE; Kim, DG; Lee, KJ; Son, JG; Song, MY; Park, YM; Kim, JJ; Cho, SW; Chi, SG; Cheong, HS; Shin, HD; Lee, SW; Lee, JK				Kim, Hye-Eun; Kim, Dae-Ghon; Lee, Kyung Jin; Son, Jang Geun; Song, Min-Young; Park, Young-Mi; Kim, Jae-Jung; Cho, Sung-Won; Chi, Sung-Gil; Cheong, Hyun Sub; Shin, Hyoung Doo; Lee, Sang-Wook; Lee, Jong-Keuk			Frequent Amplification of CENPF, GMNN and CDK13 Genes in Hepatocellular Carcinomas	PLOS ONE			English	Article							MAMMARY EPITHELIAL-CELLS; COPY NUMBER ALTERATIONS; CANCER GENES; GEMININ; EXPRESSION; GENOME; DNA; ASSOCIATION; ABERRATIONS; PROTEIN	Genomic changes frequently occur in cancer cells during tumorigenesis from normal cells. Using the Illumina Human NS-12 single-nucleotide polymorphism (SNP) chip to screen for gene copy number changes in primary hepatocellular carcinomas (HCCs), we initially detected amplification of 35 genes from four genomic regions (1q21-41, 6p21.2-24.1, 7p13 and 8q13-23). By integrated screening of these genes for both DNA copy number and gene expression in HCC and colorectal cancer, we selected CENPF (centromere protein F/mitosin), GMNN (geminin, DNA replication inhibitor), CDK13 (cyclin-dependent kinase 13), and FAM82B (family with sequence similarity 82, member B) as common cancer genes. Each gene exhibited an amplification frequency of similar to 30% (range, 20-50%) in primary HCC (n = 57) and colorectal cancer (n = 12), as well as in a panel of human cancer cell lines (n = 70). Clonogenic and invasion assays of NIH3T3 cells transfected with each of the four amplified genes showed that CENPF, GMNN, and CDK13 were highly oncogenic whereas FAM82B was not. Interestingly, the oncogenic activity of these genes (excluding FAM82B) was highly correlated with gene-copy numbers in tumor samples (correlation coefficient, r>0.423), indicating that amplifications of CENPF, GMNN, and CDK13 genes are tightly linked and coincident in tumors. Furthermore, we confirmed that CDK13 gene copy number was significantly associated with clinical onset age in patients with HCC (P = 0.0037). Taken together, our results suggest that coincidently amplified CDK13, GMNN, and CENPF genes can play a role as common cancer-driver genes in human cancers.	[Kim, Hye-Eun; Lee, Kyung Jin; Son, Jang Geun; Song, Min-Young; Park, Young-Mi; Kim, Jae-Jung; Lee, Jong-Keuk] Univ Ulsan, Coll Med, Asan Inst Life Sci, Seoul, South Korea; [Kim, Dae-Ghon] Chonbuk Natl Univ, Med Sch & Hosp, Dept Internal Med, Chonju, Chonbuk, South Korea; [Cho, Sung-Won] Ajou Univ, Sch Med, Suwon 441749, South Korea; [Chi, Sung-Gil] Korea Univ, Sch Life Sci & Biotechnol, Seoul, South Korea; [Cheong, Hyun Sub; Shin, Hyoung Doo] SNP Genet, Seoul, South Korea; [Shin, Hyoung Doo] Sogang Univ, Dept Life Sci, Seoul, South Korea; [Lee, Sang-Wook] Univ Ulsan, Coll Med, Dept Radiat Oncol, Seoul, South Korea	University of Ulsan; Jeonbuk National University; Ajou University; Korea University; SNP Genetics; Sogang University; University of Ulsan	Kim, HE (corresponding author), Univ Ulsan, Coll Med, Asan Inst Life Sci, Seoul, South Korea.	cookie_jklee@hotmail.com			Ministry of Health & Welfare, Republic of Korea [0720200]; Asan Institute for Life Sciences, Seoul, Korea [2010-419]	Ministry of Health & Welfare, Republic of Korea(Ministry of Health & Welfare (MOHW), Republic of Korea); Asan Institute for Life Sciences, Seoul, Korea	This work was supported by a grant (#0720200) from the National R&D Program for Cancer Control, Ministry of Health & Welfare, Republic of Korea, and a grant (No. 2010-419) from the Asan Institute for Life Sciences, Seoul, Korea. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Albertson DG, 2003, NAT GENET, V34, P369, DOI 10.1038/ng1215; Albertson DG, 2006, TRENDS GENET, V22, P447, DOI 10.1016/j.tig.2006.06.007; Bae JS, 2008, BIOCHEM BIOPH RES CO, V373, P593, DOI 10.1016/j.bbrc.2008.06.083; Chen CF, 2010, HEPATOLOGY, V52, P1690, DOI 10.1002/hep.23847; Evans DM, 2008, EUR J HUM GENET, V16, P718, DOI 10.1038/sj.ejhg.5202011; Even Y, 2006, J CELL BIOCHEM, V99, P890, DOI 10.1002/jcb.20986; Feitelson MA, 2002, ONCOGENE, V21, P2593, DOI 10.1038/sj.onc.1205434; Gardner L, 2011, BREAST CANCER RES, V13, DOI 10.1186/bcr2884; Green BM, 2010, SCIENCE, V329, P943, DOI 10.1126/science.1190966; Huang WC, 2002, DNA CELL BIOL, V21, P707, DOI 10.1089/104454902760599681; Ku Ja-Lok, 2005, Cancer Res Treat, V37, P1, DOI 10.4143/crt.2005.37.1.1; LaFramboise T, 2009, NUCLEIC ACIDS RES, V37, P4181, DOI 10.1093/nar/gkp552; Lee JH, 1999, WORLD J GASTROENTERO, V5, P289; Lee KJ, 2006, FOOD CHEM TOXICOL, V44, P1890, DOI 10.1016/j.fct.2006.06.009; Liu WN, 2006, GENE CHROMOSOME CANC, V45, P1018, DOI 10.1002/gcc.20369; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Medina PP, 2009, HUM MOL GENET, V18, P1343, DOI 10.1093/hmg/ddp034; Montanari M, 2005, J CELL PHYSIOL, V202, P215, DOI 10.1002/jcp.20120; Nickerson DA, 1997, NUCLEIC ACIDS RES, V25, P2745, DOI 10.1093/nar/25.14.2745; O'Brien SL, 2007, INT J CANCER, V120, P1434, DOI 10.1002/ijc.22413; Oishi K, 2007, J CELL BIOL, V179, P1149, DOI 10.1083/jcb.200705108; PARK JG, 1995, INT J CANCER, V62, P276, DOI 10.1002/ijc.2910620308; Paterlini-Brechot P, 2003, ONCOGENE, V22, P3911, DOI 10.1038/sj.onc.1206492; Peiffer DA, 2006, GENOME RES, V16, P1136, DOI 10.1101/gr.5402306; Santarius T, 2010, NAT REV CANCER, V10, P59, DOI 10.1038/nrc2771; Stratton MR, 2009, NATURE, V458, P719, DOI 10.1038/nature07943; Thorgeirsson SS, 2002, NAT GENET, V31, P339, DOI 10.1038/ng0802-339; Zhu WG, 2009, CANCER RES, V69, P4870, DOI 10.1158/0008-5472.CAN-08-4559; Zhu WG, 2004, MOL CELL BIOL, V24, P7140, DOI 10.1128/MCB.24.16.7140-7150.2004	29	79	82	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 13	2012	7	8							e43223	10.1371/journal.pone.0043223	http://dx.doi.org/10.1371/journal.pone.0043223			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	988OJ	22912832	Green Submitted, Green Published, gold			2022-12-25	WOS:000307500100073
J	Sahraeian, SME; Yoon, BJ				Sahraeian, Sayed Mohammad Ebrahim; Yoon, Byung-Jun			A Network Synthesis Model for Generating Protein Interaction Network Families	PLOS ONE			English	Article							MOLECULAR INTERACTION DATABASE; GLOBAL ALIGNMENT; BIOLOGICAL NETWORKS; SYSTEMATIC IDENTIFICATION; EVOLUTION; DYNAMICS; GENOMES; SCALE; YEAST; TOOL	In this work, we introduce a novel network synthesis model that can generate families of evolutionarily related synthetic protein-protein interaction (PPI) networks. Given an ancestral network, the proposed model generates the network family according to a hypothetical phylogenetic tree, where the descendant networks are obtained through duplication and divergence of their ancestors, followed by network growth using network evolution models. We demonstrate that this network synthesis model can effectively create synthetic networks whose internal and cross-network properties closely resemble those of real PPI networks. The proposed model can serve as an effective framework for generating comprehensive benchmark datasets that can be used for reliable performance assessment of comparative network analysis algorithms. Using this model, we constructed a large-scale network alignment benchmark, called NAPAbench, and evaluated the performance of several representative network alignment algorithms. Our analysis clearly shows the relative performance of the leading network algorithms, with their respective advantages and disadvantages. The algorithm and source code of the network synthesis model and the network alignment benchmark NAPAbench are publicly available at http://www.ece.tamu.edu/bjyoon/NAPAbench/.	[Sahraeian, Sayed Mohammad Ebrahim; Yoon, Byung-Jun] Texas A&M Univ, Dept Elect & Comp Engn, College Stn, TX 77843 USA	Texas A&M University System; Texas A&M University College Station	Sahraeian, SME (corresponding author), Texas A&M Univ, Dept Elect & Comp Engn, College Stn, TX 77843 USA.	bjyoon@ece.tamu.edu	Yoon, Byung-Jun/B-1466-2008	Yoon, Byung-Jun/0000-0001-9328-1101	National Science Foundation through NSF Award [CCF-1149544]; Division of Computing and Communication Foundations [1149544] Funding Source: National Science Foundation	National Science Foundation through NSF Award(National Science Foundation (NSF)); Division of Computing and Communication Foundations(National Science Foundation (NSF)NSF - Directorate for Computer & Information Science & Engineering (CISE))	This work was supported in part by the National Science Foundation through NSF Award CCF-1149544. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ali W, 2010, MOL BIOSYST, V6, P2296, DOI 10.1039/c004430j; Ali W, 2009, BIOINFORMATICS, V25, P3166, DOI 10.1093/bioinformatics/btp569; Altschul SF, 1996, METHOD ENZYMOL, V266, P460; Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389; ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1016/S0022-2836(05)80360-2; [Anonymous], 2004, PHYS REV E, DOI DOI 10.1103/PhysRevE.70.056131; [Anonymous], [No title captured]; Ashburner M, 2000, NAT GENET, V25, P25, DOI 10.1038/75556; Ay F, 2011, J COMPUT BIOL, V18, P219, DOI 10.1089/cmb.2010.0280; Bandyopadhyay S, 2006, GENOME RES, V16, P428, DOI 10.1101/gr.4526006; Barabasi AL, 2004, NAT REV GENET, V5, P101, DOI 10.1038/nrg1272; Barabasi AL, 1999, SCIENCE, V286, P509, DOI 10.1126/science.286.5439.509; Baudot A, 2004, GENOME BIOL, V5, DOI 10.1186/gb-2004-5-10-r76; Bayati M, 2009, IEEE DATA MINING, P705, DOI 10.1109/ICDM.2009.135; Bebek G, 2007, LECT NOTES COMPUT SC, V4023, P119; Beltrao P, 2007, PLOS COMPUT BIOL, V3, P258, DOI 10.1371/journal.pcbi.0030025; Berg J, 2004, BMC EVOL BIOL, V4, DOI 10.1186/1471-2148-4-51; Berg J, 2006, P NATL ACAD SCI USA, V103, P10967, DOI 10.1073/pnas.0602294103; Bhan A, 2002, BIOINFORMATICS, V18, P1486, DOI 10.1093/bioinformatics/18.11.1486; Bradde S, 2010, EPL-EUROPHYS LETT, V89, DOI 10.1209/0295-5075/89/37009; Bruckner S, 2010, J COMPUT BIOL, V17, P237, DOI 10.1089/cmb.2009.0170; Chindelevitch L, 2010, BIOCOMPUT-PAC SYM, P123; Colak R, 2009, PACIFIC SYMPOSIUM ON BIOCOMPUTING 2009, P178; Coolen ACC, 2011, HANDBOOK OF STATISTICAL SYSTEMS BIOLOGY, P309; Cowley MJ, 2012, NUCLEIC ACIDS RES, V40, pD862, DOI 10.1093/nar/gkr967; D'Antonio M, 2011, PLOS COMPUT BIOL, V7, DOI 10.1371/journal.pcbi.1002029; Deng MH, 2002, GENOME RES, V12, P1540, DOI 10.1101/gr.153002; Denielou YP, 2009, LECT NOTES COMPUT SC, V5577, P263, DOI 10.1007/978-3-642-02441-2_23; Dost B, 2008, J COMPUT BIOL, V15, P913, DOI 10.1089/cmb.2007.0172; Dutkowski J, 2007, BIOINFORMATICS, V23, pI149, DOI 10.1093/bioinformatics/btm194; Enright AJ, 1999, NATURE, V402, P86, DOI 10.1038/47056; Erten S, 2009, BMC BIOINFORMATICS, V10, DOI 10.1186/1471-2105-10-333; Evlampiev K, 2008, P NATL ACAD SCI USA, V105, P9863, DOI 10.1073/pnas.0804119105; Flannick J, 2006, GENOME RES, V16, P1169, DOI 10.1101/gr.5235706; Flannick J, 2009, J COMPUT BIOL, V16, P1001, DOI 10.1089/cmb.2009.0099; Ge H, 2000, Nucleic Acids Res, V28, pe3, DOI 10.1093/nar/28.2.e3; Goh KI, 2005, J KOREAN PHYS SOC, V46, P551; Guillaume JL, 2006, PHYSICA A, V371, P795, DOI 10.1016/j.physa.2006.04.047; Guo X, 2009, BIOINFORMATICS, V25, pI240, DOI 10.1093/bioinformatics/btp202; Ho Y, 2002, NATURE, V415, P180, DOI 10.1038/415180a; Hormozdiari F, 2007, PLOS COMPUT BIOL, V3, P1373, DOI 10.1371/journal.pcbi.0030118; Ispolatov I, 2005, PHYS REV E, V71, DOI 10.1103/PhysRevE.71.061911; Kalaev M, 2008, BIOINFORMATICS, V24, P594, DOI 10.1093/bioinformatics/btm630; Kanehisa M, 2000, NUCLEIC ACIDS RES, V28, P27, DOI 10.1093/nar/28.1.27; Kelley BP, 2004, NUCLEIC ACIDS RES, V32, pW83, DOI 10.1093/nar/gkh411; Kerrien S, 2012, NUCLEIC ACIDS RES, V40, pD841, DOI 10.1093/nar/gkr1088; Kim WK, 2008, PLOS COMPUT BIOL, V4, DOI 10.1371/journal.pcbi.1000232; Klau GW, 2009, BMC BIOINFORMATICS, V10, DOI 10.1186/1471-2105-10-S1-S59; Knuth D.E., 1997, FUNDAMENTAL ALGORITH, VI; Koyuturk M, 2006, J COMPUT BIOL, V13, P182, DOI 10.1089/cmb.2006.13.182; Kuchaiev O, 2011, BIOINFORMATICS, V27, P1390, DOI 10.1093/bioinformatics/btr127; Levy ED, 2008, CURR OPIN STRUC BIOL, V18, P349, DOI 10.1016/j.sbi.2008.03.003; Liao CS, 2009, BIOINFORMATICS, V25, pI253, DOI 10.1093/bioinformatics/btp203; Licata L, 2012, NUCLEIC ACIDS RES, V40, pD857, DOI 10.1093/nar/gkr930; LIPMAN DJ, 1985, SCIENCE, V227, P1435, DOI 10.1126/science.2983426; Matthews LR, 2001, GENOME RES, V11, P2120, DOI 10.1101/gr.205301; Mewes HW, 2006, NUCLEIC ACIDS RES, V34, pD169, DOI 10.1093/nar/gkj148; Middendorf M., 2005, P NATL ACAD SCI USA, V102, p3192 3197, DOI DOI 10.1073/pnas.0409515102; Navlakha S, 2011, PLOS COMPUT BIOL, V7, DOI 10.1371/journal.pcbi.1001119; Ohno S., 1970, EVOLUTION GENE DUPLI; Park D, 2011, NUCLEIC ACIDS RES, V39, pD295, DOI 10.1093/nar/gkq1234; Pastor-Satorras R, 2003, J THEOR BIOL, V222, P199, DOI 10.1016/S0022-5193(03)00028-6; Pellegrini M, 1999, P NATL ACAD SCI USA, V96, P4285, DOI 10.1073/pnas.96.8.4285; Pinter RY, 2005, BIOINFORMATICS, V21, P3401, DOI 10.1093/bioinformatics/bti554; Prasad TSK, 2009, NUCLEIC ACIDS RES, V37, pD767, DOI 10.1093/nar/gkn892; Prieto C, 2006, NUCLEIC ACIDS RES, V34, pW298, DOI 10.1093/nar/gkl128; Przulj N, 2010, BIOCOMPUT-PAC SYM, P178; Qian J, 2001, J MOL BIOL, V313, P673, DOI 10.1006/jmbi.2001.5079; Qian XN, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0008070; Qian XN, 2009, J COMPUT BIOL, V16, P145, DOI 10.1089/cmb.2008.02TT; Ratmann O, 2007, PLOS COMPUT BIOL, V3, P2266, DOI 10.1371/journal.pcbi.0030230; Rzhetsky A, 2001, BIOINFORMATICS, V17, P988, DOI 10.1093/bioinformatics/17.10.988; Sahraeian SME, 2012, BIOINFORMATICS, V28, P2129, DOI 10.1093/bioinformatics/bts341; Sahraeian SME, 2011, INT CONF ACOUST SPEE, P6008; Salwinski L, 2004, NUCLEIC ACIDS RES, V32, pD449, DOI 10.1093/nar/gkh086; Sharan R, 2005, P NATL ACAD SCI USA, V102, P1974, DOI 10.1073/pnas.0409522102; Sharan R, 2006, NAT BIOTECHNOL, V24, P427, DOI 10.1038/nbt1196; Singh R, 2008, P NATL ACAD SCI USA, V105, P12763, DOI 10.1073/pnas.0806627105; Smith E D, 2002, ADV COMPLEX SYST, V5, P43, DOI DOI 10.1142/S021952590200047X; Stark C, 2011, NUCLEIC ACIDS RES, V39, pD698, DOI 10.1093/nar/gkq1116; Uetz P, 2000, NATURE, V403, P623, DOI 10.1038/35001009; Vazquez A, 2004, P NATL ACAD SCI USA, V101, P17940, DOI 10.1073/pnas.0406024101; Vazquez Alexei, 2003, ComPlexUs, V1, P38, DOI 10.1159/000067642; Wagner A, 2003, P ROY SOC B-BIOL SCI, V270, P457, DOI 10.1098/rspb.2002.2269; Zaslavskiy M, 2009, BIOINFORMATICS, V25, pI259, DOI 10.1093/bioinformatics/btp196; Zhang A, 2009, PROTEIN INTERACTION NETWORKS: COMPUTATIONAL ANALYSIS, P1, DOI 10.1017/CBO9780511626593; Zhenping L, 2007, BIOINFORMATICS, V23, P1631, DOI 10.1093/bioinformatics/btm156	87	31	31	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 13	2012	7	8							e41474	10.1371/journal.pone.0041474	http://dx.doi.org/10.1371/journal.pone.0041474			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	988OJ	22912671	Green Published, gold, Green Submitted			2022-12-25	WOS:000307500100004
J	Szmaragd, C; Green, LE; Medley, GF; Browne, WJ				Szmaragd, Camille; Green, Laura E.; Medley, Graham F.; Browne, William J.			Impact of Imperfect Test Sensitivity on Determining Risk Factors: The Case of Bovine Tuberculosis	PLOS ONE			English	Article							CATTLE HERDS; DIAGNOSTIC-TESTS; ENGLAND; FRAMEWORK; FARMS	Background: Imperfect diagnostic testing reduces the power to detect significant predictors in classical cross-sectional studies. Assuming that the misclassification in diagnosis is random this can be dealt with by increasing the sample size of a study. However, the effects of imperfect tests in longitudinal data analyses are not as straightforward to anticipate, especially if the outcome of the test influences behaviour. The aim of this paper is to investigate the impact of imperfect test sensitivity on the determination of predictor variables in a longitudinal study. Methodology/Principal Findings: To deal with imperfect test sensitivity affecting the response variable, we transformed the observed response variable into a set of possible temporal patterns of true disease status, whose prior probability was a function of the test sensitivity. We fitted a Bayesian discrete time survival model using an MCMC algorithm that treats the true response patterns as unknown parameters in the model. We applied our approach to epidemiological data of bovine tuberculosis outbreaks in England and investigated the effect of reduced test sensitivity in the determination of risk factors for the disease. We found that reduced test sensitivity led to changes to the collection of risk factors associated with the probability of an outbreak that were chosen in the 'best' model and to an increase in the uncertainty surrounding the parameter estimates for a model with a fixed set of risk factors that were associated with the response variable. Conclusions/Significance: We propose a novel algorithm to fit discrete survival models for longitudinal data where values of the response variable are uncertain. When analysing longitudinal data, uncertainty surrounding the response variable will affect the significance of the predictors and should therefore be accounted for either at the design stage by increasing the sample size or at the post analysis stage by conducting appropriate sensitivity analyses.	[Szmaragd, Camille; Browne, William J.] Univ Bristol, Sch Vet Sci, Langford, Devon, England; [Green, Laura E.; Medley, Graham F.] Univ Warwick, Sch Life Sci, Coventry CV4 7AL, W Midlands, England	University of Bristol; University of Warwick	Szmaragd, C (corresponding author), Univ Bristol, Sch Vet Sci, Langford, Devon, England.	camille.szmaragd@bristol.ac.uk	Green, Laura/G-8345-2011; Medley, Graham/B-7289-2008; Browne, William J/A-8686-2010	Green, Laura/0000-0003-2957-8773; Medley, Graham/0000-0002-0030-7278; Browne, William J/0000-0002-6659-6885	Defra [SE3239]	Defra(Department for Environment, Food & Rural Affairs (DEFRA))	This work was funded by Defra (http:\\www.defra.gov.uk) under the Animal Health and Welfare call (project number SE3239). Defra had some input in the design of the initial field trial and in the collection and original analysis of the data. They did not actually have any input in the design and modelling/analysis of the data as presented in the paper. The authors provided with the data by AHVLA, came up with a new modelling approach (described in the paper), reformatting the data to the format required for the analysis, analysed and wrote the paper without any help by the funder. The authors sent Defra the draft manuscript prior to submission for comments as required by the term of their funding. The funders had no role in the data selection, preparation and analysis, decision to publish, or preparation of the manuscript.	Alvarez J, 2012, VET MICROBIOL, V155, P38, DOI 10.1016/j.vetmic.2011.07.034; Animal Health Defra, 2010, DEAL TB YOUR HERD; Cannon RM, 2001, PREV VET MED, V49, P141, DOI 10.1016/S0167-5877(01)00184-2; Carrique-Mas JJ, 2008, PREV VET MED, V84, P85, DOI 10.1016/j.prevetmed.2007.11.001; Christley RM, 2011, PREV VET MED, V100, P126, DOI 10.1016/j.prevetmed.2011.02.005; Clegg TA, 2011, VET MICROBIOL, V151, P68, DOI 10.1016/j.vetmic.2011.02.027; Cox D.R., 1996, MULTIVARIATE DEPENDE; de la Rua-Domenech R, 2006, RES VET SCI, V81, P190, DOI 10.1016/j.rvsc.2005.11.005; Defra, 2011, HIST OVERVIEW BOVINE; Diggle PJ, 2011, EPIDEMIOLOGY RES INT, V2011; Donnelly CA, 2006, NATURE, V439, P843, DOI 10.1038/nature04454; Gilbert M, 2005, NATURE, V435, P491, DOI 10.1038/nature03548; Gopal R, 2006, VET REC, V159, P265, DOI 10.1136/vr.159.9.265; Green LE, 2005, PREV VET MED, V70, P293, DOI 10.1016/j.prevetmed.2005.05.005; Griffin JM, 2005, PREV VET MED, V67, P237, DOI 10.1016/j.prevetmed.2004.10.009; Independent Scientific Group on Cattle TB, 2007, VELEST USERS GUIDE S; Independent Scientific Review Group, 1997, VELEST USERS GUIDE S; Lachish S, 2012, METHODS ECOL EVOL, V3, P339, DOI 10.1111/j.2041-210X.2011.00156.x; Lunn DJ, 2000, STAT COMPUT, V10, P325, DOI 10.1023/A:1008929526011; MONAGHAN ML, 1994, VET MICROBIOL, V40, P111, DOI 10.1016/0378-1135(94)90050-7; Ramirez-Villaescusa AM, 2010, PREV VET MED, V95, P224, DOI 10.1016/j.prevetmed.2010.03.009; Reilly LA, 2007, PREV VET MED, V80, P129, DOI 10.1016/j.prevetmed.2007.02.002; Steele F, 2008, J R STAT SOC A STAT, V171, P5; Thom A, 2004, VET IMMUNOL IMMUNOP, V102, P399, DOI 10.1016/j.vetimm.2004.08.005; Wolfe DM, 2009, PREV VET MED, V92, P99, DOI 10.1016/j.prevetmed.2009.07.012	25	5	5	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 13	2012	7	8							e43116	10.1371/journal.pone.0043116	http://dx.doi.org/10.1371/journal.pone.0043116			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	988OJ	22912804	Green Published, gold, Green Submitted			2022-12-25	WOS:000307500100063
J	Kelly, SD; Hansen, BC; Clark, DT				Kelly, Spencer D.; Hansen, Bruce C.; Clark, David T.			"Slight'' of Hand: The Processing of Visually Degraded Gestures with Speech	PLOS ONE			English	Article							REACTION-TIME; PERCEPTION; FACES; RECOGNITION; LATENCY; MODEL	Co-speech hand gestures influence language comprehension. The present experiment explored what part of the visual processing system is optimized for processing these gestures. Participants viewed short video clips of speech and gestures (e.g., a person saying "chop'' or "twist'' while making a chopping gesture) and had to determine whether the two modalities were congruent or incongruent. Gesture videos were designed to stimulate the parvocellular or magnocellular visual pathways by filtering out low or high spatial frequencies (HSF versus LSF) at two levels of degradation severity (moderate and severe). Participants were less accurate and slower at processing gesture and speech at severe versus moderate levels of degradation. In addition, they were slower for LSF versus HSF stimuli, and this difference was most pronounced in the severely degraded condition. However, exploratory item analyses showed that the HSF advantage was modulated by the range of motion and amount of motion energy in each video. The results suggest that hand gestures exploit a wide range of spatial frequencies, and depending on what frequencies carry the most motion energy, parvocellular or magnocellular visual pathways are maximized to quickly and optimally extract meaning.	[Kelly, Spencer D.; Hansen, Bruce C.; Clark, David T.] Colgate Univ, Dept Psychol, Hamilton, NY 13346 USA; [Kelly, Spencer D.; Hansen, Bruce C.; Clark, David T.] Colgate Univ, Neurosci Program, Hamilton, NY 13346 USA; [Kelly, Spencer D.] Colgate Univ, Ctr Language & Brain, Hamilton, NY 13346 USA	Colgate University; Colgate University; Colgate University	Kelly, SD (corresponding author), Colgate Univ, Dept Psychol, Hamilton, NY 13346 USA.	skelly@colgate.edu	Hansen, Bruce/E-8516-2010	Hansen, Bruce/0000-0002-8898-1688				ADELSON EH, 1985, J OPT SOC AM A, V2, P284, DOI 10.1364/JOSAA.2.000284; Bair W, 2002, J NEUROSCI, V22, P3189, DOI 10.1523/JNEUROSCI.22-08-03189.2002; Belardinelli A, 2009, LECT NOTES ARTIF INT, V5395, P112; Bosworth RG, 2006, J OPT SOC AM A, V23, P2085, DOI 10.1364/JOSAA.23.002085; BREITMEYER BG, 1975, VISION RES, V15, P1411, DOI 10.1016/0042-6989(75)90200-X; Bullier J, 2001, TRENDS COGN SCI, V5, P369, DOI 10.1016/S1364-6613(00)01730-7; Callan DE, 2004, J COGNITIVE NEUROSCI, V16, P805, DOI 10.1162/089892904970771; Calvert GA, 2001, CEREB CORTEX, V11, P1110, DOI 10.1093/cercor/11.12.1110; Carandini M, 2005, J NEUROSCI, V25, P10577, DOI 10.1523/JNEUROSCI.3726-05.2005; Cassagrande VA, 2003, VISUAL NEUROSCIENCES; Clark H.H., 1996, USING LANGUAGE; Goffaux V, 2006, J EXP PSYCHOL HUMAN, V32, P1023, DOI 10.1037/0096-1523.32.4.1023; Goffaux V, 2009, VISION RES, V49, P774, DOI 10.1016/j.visres.2009.02.009; Hansen BC, 2008, VISION RES, V48, P2523, DOI 10.1016/j.visres.2008.08.016; HARWERTH RS, 1978, VISION RES, V18, P1579, DOI 10.1016/0042-6989(78)90014-7; HEEGER DJ, 1987, J OPT SOC AM A, V4, P1455, DOI 10.1364/JOSAA.4.001455; Hickok G, 2007, NAT REV NEUROSCI, V8, P393, DOI 10.1038/nrn2113; Hostetter AB, 2011, PSYCHOL BULL, V137, P297, DOI 10.1037/a0022128; Hubbard AL, 2009, HUM BRAIN MAPP, V30, P1028, DOI 10.1002/hbm.20565; Kaplan E, 2004, VISUAL NEUROSCIENCES; Kelly SD, 2008, LANG LINGUIST COMPAS, V2, DOI 10.1111/j.1749-818x.2008.00067.x; Kelly SD, 2010, PSYCHOL SCI, V21, P260, DOI 10.1177/0956797609357327; Kelly SD, 2010, J COGNITIVE NEUROSCI, V22, P683, DOI 10.1162/jocn.2009.21254; Kendon A., 2004, GESTURE VISIBLE ACTI, DOI DOI 10.1017/CBO9780511807572; LIVINGSTONE M, 1988, SCIENCE, V240, P740, DOI 10.1126/science.3283936; McNeill D., 1992, HAND MIND WHAT GESTU; MERIGAN WH, 1993, ANNU REV NEUROSCI, V16, P369, DOI 10.1146/annurev.ne.16.030193.002101; Montgomery KJ, 2007, SOC COGN AFFECT NEUR, V2, P114, DOI 10.1093/scan/nsm004; Munhall KG, 2004, PERCEPT PSYCHOPHYS, V66, P574, DOI 10.3758/BF03194902; NOWAK LG, 1995, VISUAL NEUROSCI, V12, P371, DOI 10.1017/S095252380000804X; Obermeier C, 2012, CORTEX, V48, P857, DOI 10.1016/j.cortex.2011.02.007; PARKER DM, 1987, VISION RES, V27, P1279, DOI 10.1016/0042-6989(87)90204-5; Pilz KS, 2009, VIS COGN, V17, P716, DOI 10.1080/13506280802340588; RIEDL TR, 1988, J OPT SOC AM A, V5, P606, DOI 10.1364/JOSAA.5.000606; Rogers W.T., 1978, HUM COMMUN RES, V5, P54, DOI [10.1111/j.1468-2958.1978.tb00622.x, DOI 10.1111/J.1468-2958.1978.TB00622.X]; RYAN TA, 1959, PSYCHOL BULL, V56, P394, DOI 10.1037/h0041280; Schmolesky MT, 1998, J NEUROPHYSIOL, V79, P3272, DOI 10.1152/jn.1998.79.6.3272; Sekiyama K, 2003, NEUROSCI RES, V47, P277, DOI 10.1016/S0168-0102(03)00214-1; SHAPLEY R, 1986, TRENDS NEUROSCI, V9, P229, DOI 10.1016/0166-2236(86)90064-0; Vassilev A, 2002, VISION RES, V42, P851, DOI 10.1016/S0042-6989(01)00300-5; Vlamings PHJM, 2009, J VISION, V9, DOI 10.1167/9.5.12; WATSON AB, 1985, J OPT SOC AM A, V2, P322, DOI 10.1364/JOSAA.2.000322	42	4	4	1	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 9	2012	7	8							e42620	10.1371/journal.pone.0042620	http://dx.doi.org/10.1371/journal.pone.0042620			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	986WZ	22912715	Green Published, gold, Green Submitted			2022-12-25	WOS:000307378500021
J	Krysl, P; Hawkins, AD; Schilt, C; Cranford, TW				Krysl, Petr; Hawkins, Anthony D.; Schilt, Carl; Cranford, Ted W.			Angular Oscillation of Solid Scatterers in Response to Progressive Planar Acoustic Waves: Do Fish Otoliths Rock?	PLOS ONE			English	Article							DIRECTIONAL HEARING; COD; DISCRIMINATION; STIMULI; SOUND	Fish can sense a wide variety of sounds by means of the otolith organs of the inner ear. Among the incompletely understood components of this process are the patterns of movement of the otoliths vis-a-vis fish head or whole-body movement. How complex are the motions? How does the otolith organ respond to sounds from different directions and frequencies? In the present work we examine the responses of a dense rigid scatterer (representing the otolith) suspended in an acoustic fluid to low-frequency planar progressive acoustic waves. A simple mechanical model, which predicts both translational and angular oscillation, is formulated. The responses of simple shapes (sphere and hemisphere) are analyzed with an acoustic finite element model. The hemispherical scatterer is found to oscillate both in the direction of the propagation of the progressive waves and also in the plane of the wavefront as a result of angular motion. The models predict that this characteristic will be shared by other irregularly-shaped scatterers, including fish otoliths, which could provide the fish hearing mechanisms with an additional component of oscillation and therefore one more source of acoustical cues.	[Krysl, Petr] Univ Calif San Diego, La Jolla, CA 92093 USA; [Hawkins, Anthony D.] Loughine Ltd, Kincraig Blairs, Aberdeen, Scotland; [Schilt, Carl] Bigleaf Sci Serv, N Bonneville, WA USA; [Cranford, Ted W.] Quantitat Morphol Consulting Inc, San Diego, CA USA	University of California System; University of California San Diego	Krysl, P (corresponding author), Univ Calif San Diego, La Jolla, CA 92093 USA.	pkrysl@ucsd.edu		Krysl, Petr/0000-0003-1761-5047	Office of Naval research [N00014-09-1-0611]	Office of Naval research(Office of Naval Research)	The research was funded by the Office of Naval research, grant number N00014-09-1-0611. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Chapman C, 1974, COMP BIOCH PHYSL, P371; CHAPMAN CJ, 1974, J EXP BIOL, V61, P521; DeVRIES H., 1950, ACTA OTO LARYNGOL, V38, P262, DOI 10.3109/00016485009118384; DEVRIES H, 1956, PROG BIOPHYS MOL BIO, V6, P208, DOI 10.1016/S0096-4174(18)30108-2; Fan ZW, 2008, J ACOUST SOC AM, V124, P2727, DOI 10.1121/1.2977733; FLOCK A, 1965, ACTA OTO LARYNG ST S, V199, P1; Hawkins A.D., 1976, Developments Aquacult Fish Sci, V5, P149; HAWKINS AD, 1977, J COMP PHYSIOL, V122, P1, DOI 10.1007/BF00611244; Hearing Pumphrey R., 1950, S SOC EXP BIOL, P1; HICKLING R, 1966, J ACOUST SOC AM, V39, P276, DOI 10.1121/1.1909887; Howe M. S., 2006, HYDRODYNAMICS SOUND; HUDSPETH AJ, 1977, P NATL ACAD SCI USA, V74, P2407, DOI 10.1073/pnas.74.6.2407; Krysl P, 2008, INT J NUMER METH ENG, V74, P754, DOI 10.1002/nme.2192; Krysl P, 2011, THERMAL STRESS ANAL; OLSSON P, 1985, J ACOUST SOC AM, V78, P2132, DOI 10.1121/1.392673; Popper Arthur N., 2003, P3, DOI 10.1007/978-0-387-22628-6_1; Rodgers G, 2011, EXPT STUDY ACOUSTICA; SAND O, 1978, J COMP PHYSIOL, V123, P85, DOI 10.1007/BF00657346; Sand O, 2000, PHILOS T ROY SOC B, V355, P1295, DOI 10.1098/rstb.2000.0687; Sand O, 2008, J ACOUST SOC AM, V121; Sand Olav, 2008, V32, P183; Schilt C. R., 2011, J ACOUST SOC AM, V129, P2472; SCHUIJF A, 1983, NATURE, V302, P143, DOI 10.1038/302143a0; SCHUIJF A, 1972, Netherlands Journal of Zoology, V22, P81; SCHUIJF A, 1975, J COMP PHYSIOL, V98, P333, DOI 10.1007/BF00709804; SMITH WE, 1972, AUST J PHYS, V25, P275, DOI 10.1071/PH720275; Webb JF., 2008, FISH BIOACOUSTICS	27	16	16	1	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 9	2012	7	8							e42591	10.1371/journal.pone.0042591	http://dx.doi.org/10.1371/journal.pone.0042591			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	986WZ	22912710	Green Published, Green Submitted, gold			2022-12-25	WOS:000307378500020
J	Yan, J; Guo, XL; Jin, Z; Sun, JF; Shen, LW; Tong, SB				Yan, Jing; Guo, Xiaoli; Jin, Zheng; Sun, Junfeng; Shen, Liwei; Tong, Shanbao			Cognitive Alterations in Motor Imagery Process after Left Hemispheric Ischemic Stroke	PLOS ONE			English	Article							MENTAL ROTATION; PREMOTOR CORTEX; BRAIN POTENTIALS; LEFT PARIETAL; UPPER-LIMB; SYNCHRONIZATION; ACTIVATION; ATTENTION; MOVEMENT; TASK	Background: Motor imagery training is a promising rehabilitation strategy for stroke patients. However, few studies had focused on the neural mechanisms in time course of its cognitive process. This study investigated the cognitive alterations after left hemispheric ischemic stroke during motor imagery task. Methodology/Principal Findings: Eleven patients with ischemic stroke in left hemisphere and eleven age-matched control subjects participated in mental rotation task (MRT) of hand pictures. Behavior performance, event-related potential (ERP) and event-related (de)synchronization (ERD/ERS) in beta band were analyzed to investigate the cortical activation. We found that: (1) The response time increased with orientation angles in both groups, called "angle effect", however, stoke patients' responses were impaired with significantly longer response time and lower accuracy rate; (2) In early visual perceptual cognitive process, stroke patients showed hypo-activations in frontal and central brain areas in aspects of both P200 and ERD; (3) During mental rotation process, P300 amplitude in control subjects decreased while angle increased, called "amplitude modulation effect", which was not observed in stroke patients. Spatially, patients showed significant lateralization of P300 with activation only in contralesional (right) parietal cortex while control subjects showed P300 in both parietal lobes. Stroke patients also showed an overall cortical hypo-activation of ERD during this sub-stage; (4) In the response sub-stage, control subjects showed higher ERD values with more activated cortical areas particularly in the right hemisphere while angle increased, named "angle effect", which was not observed in stroke patients. In addition, stroke patients showed significant lower ERD for affected hand (right) response than that for unaffected hand. Conclusions/Significance: Cortical activation was altered differently in each cognitive sub-stage of motor imagery after left hemispheric ischemic stroke. These results will help to understand the underlying neural mechanisms of mental rotation following stroke and may shed light on rehabilitation based on motor imagery training.	[Yan, Jing; Guo, Xiaoli; Sun, Junfeng; Tong, Shanbao] Shanghai Jiao Tong Univ, Sch Biomed Engn, Shanghai 200030, Peoples R China; [Jin, Zheng; Shen, Liwei] Fifth Peoples Hosp Shanghai, Dept Neurol, Shanghai, Peoples R China; [Sun, Junfeng; Tong, Shanbao] Shanghai Jiao Tong Univ, Med X Res Inst, Shanghai 200030, Peoples R China	Shanghai Jiao Tong University; Shanghai Jiao Tong University	Yan, J (corresponding author), Shanghai Jiao Tong Univ, Sch Biomed Engn, Shanghai 200030, Peoples R China.	stong@sjtu.edu.cn	Sun, Junfeng/D-1590-2010	Sun, Junfeng/0000-0002-7614-7127; Jin, Zheng/0000-0002-9499-934X	National Natural Science Foundation of China [60901025, 61001015]; National Basic Research Program of China (973 Program) [2011CB013304]; International Science & Technology Cooperation Program of China [2011DFA10950]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); National Basic Research Program of China (973 Program)(National Basic Research Program of China); International Science & Technology Cooperation Program of China	This work was supported by National Natural Science Foundation of China (No. 60901025, 61001015), National Basic Research Program of China (973 Program) (No. 2011CB013304), and International Science & Technology Cooperation Program of China (No. 2011DFA10950). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alivisatos B, 1997, NEUROPSYCHOLOGIA, V35, P111, DOI 10.1016/S0028-3932(96)00083-8; Bajric J, 1999, PSYCHOPHYSIOLOGY, V36, P399, DOI 10.1017/S0048577299981647; Berthoz A, 1996, COGNITIVE BRAIN RES, V3, P101, DOI 10.1016/0926-6410(95)00035-6; Binkofski F, 2006, J PHYSIOL-PARIS, V99, P396, DOI 10.1016/j.jphysparis.2006.03.005; BONDA E, 1995, P NATL ACAD SCI USA, V92, P11180, DOI 10.1073/pnas.92.24.11180; Cisek P, 2005, NEURON, V45, P801, DOI 10.1016/j.neuron.2005.01.027; CORBALLIS MC, 1988, PSYCHOL REV, V95, P115, DOI 10.1037/0033-295X.95.1.115; Creem-Regehr SH, 2009, NEUROBIOL LEARN MEM, V91, P166, DOI 10.1016/j.nlm.2008.10.004; Crosbie JH, 2004, CLIN REHABIL, V18, P60, DOI 10.1191/0269215504cr702oa; DECETY J, 1989, BEHAV BRAIN RES, V34, P35, DOI 10.1016/S0166-4328(89)80088-9; Decety J, 1999, TRENDS COGN SCI, V3, P172, DOI 10.1016/S1364-6613(99)01312-1; Decety Jean, 1995, Behavioural Brain Research, V72, P127, DOI 10.1016/0166-4328(96)00141-6; Dijkerman HC, 2004, CLIN REHABIL, V18, P538, DOI 10.1191/0269215504cr769oa; DUNCOMBE ME, 1994, NEUROPSYCHOLOGIA, V32, P1383, DOI 10.1016/0028-3932(94)00071-9; Ganis G, 2000, CEREB CORTEX, V10, P175, DOI 10.1093/cercor/10.2.175; GEORGOPOULOS AP, 1989, SCIENCE, V243, P234, DOI 10.1126/science.2911737; Grezes J, 2001, HUM BRAIN MAPP, V12, P1, DOI 10.1002/1097-0193(200101)12:1<1::AID-HBM10>3.0.CO;2-V; HAALAND KY, 1994, BRAIN COGNITION, V24, P104, DOI 10.1006/brcg.1994.1006; Heil M, 2002, PSYCHOPHYSIOLOGY, V39, P414, DOI 10.1017/S0048577202001105; Heil M, 2002, PSYCHOPHYSIOLOGY, V39, P535, DOI 10.1017/S0048577202020449; Heil M, 1997, J EXP PSYCHOL HUMAN, V23, P681, DOI 10.1037/0096-1523.23.3.681; Heil M, 1998, ACTA PSYCHOL, V99, P217, DOI 10.1016/S0001-6918(98)00012-2; Hendricks HT, 2002, ARCH PHYS MED REHAB, V83, P1629, DOI 10.1053/apmr.2002.35473; Jackson PL, 2001, ARCH PHYS MED REHAB, V82, P1133, DOI 10.1053/apmr.2001.24286; JEANNEROD M, 1995, NEUROPSYCHOLOGIA, V33, P1419, DOI 10.1016/0028-3932(95)00073-C; Johnson SH, 2002, J COGNITIVE NEUROSCI, V14, P841, DOI 10.1162/089892902760191072; Jung TP, 2000, PSYCHOPHYSIOLOGY, V37, P163, DOI 10.1017/S0048577200980259; Kosslyn SM, 1998, PSYCHOPHYSIOLOGY, V35, P151, DOI 10.1017/S0048577298001516; KURATA K, 1994, BEHAV BRAIN RES, V61, P135, DOI 10.1016/0166-4328(94)90154-6; Lamm C, 2007, NEUROIMAGE, V36, P1374, DOI 10.1016/j.neuroimage.2007.04.012; Leocani L, 1997, EVOKED POTENTIAL, V104, P199, DOI 10.1016/S0168-5597(96)96051-7; Liesefeld HR, 2011, BRAIN COGNITION, V75, P101, DOI 10.1016/j.bandc.2010.10.012; Liu KP, 2004, ARCH PHYS MED REHAB, V85, P1403, DOI 10.1016/j.apmr.2003.12.035; Lu CF, 2011, CLIN NEUROPHYSIOL, V122, P1569, DOI 10.1016/j.clinph.2011.01.050; Nowak DA, 2009, NEUROREHAB NEURAL RE, V23, P641, DOI 10.1177/1545968309336661; Page S J, 2001, Top Stroke Rehabil, V8, P54; Page SJ, 2005, ARCH PHYS MED REHAB, V86, P399, DOI 10.1016/j.apmr.2004.10.002; Page SJ, 2001, CLIN REHABIL, V15, P233, DOI 10.1191/026921501672063235; PARSONS LM, 1994, J EXP PSYCHOL HUMAN, V20, P709, DOI 10.1037/0096-1523.20.4.709; PARSONS LM, 1995, NATURE, V375, P54, DOI 10.1038/375054a0; PERONNET F, 1989, BRAIN COGNITION, V9, P279, DOI 10.1016/0278-2626(89)90037-7; Petit LS, 2003, BRAIN COGNITION, V51, P95, DOI 10.1016/S0278-2626(02)00526-2; Pfurtscheller G, 2006, NEUROIMAGE, V31, P153, DOI 10.1016/j.neuroimage.2005.12.003; Pfurtscheller G, 1998, ELECTROMYOGR MOTOR C, V109, P154, DOI 10.1016/S0924-980X(97)00070-2; PFURTSCHELLER G, 1989, ELECTROEN CLIN NEURO, V72, P250, DOI 10.1016/0013-4694(89)90250-2; Pfurtscheller G, 1996, INT J PSYCHOPHYSIOL, V24, P39, DOI 10.1016/S0167-8760(96)00066-9; Pfurtscheller G, 1999, CLIN NEUROPHYSIOL, V110, P1842, DOI 10.1016/S1388-2457(99)00141-8; Pfurtscheller G, 1997, NEUROSCI LETT, V239, P65, DOI 10.1016/S0304-3940(97)00889-6; Porro CA, 1996, J NEUROSCI, V16, P7688; Porro CA, 2000, EUR J NEUROSCI, V12, P3059, DOI 10.1046/j.1460-9568.2000.00182.x; Rushworth MFS, 2003, NEUROIMAGE, V20, pS89, DOI 10.1016/j.neuroimage.2003.09.011; SAYERS BMA, 1974, NATURE, V247, P481, DOI 10.1038/247481a0; Serrien DJ, 2006, NAT REV NEUROSCI, V7, P160, DOI 10.1038/nrn1849; Sharma N, 2009, STROKE, V40, P1315, DOI 10.1161/STROKEAHA.108.525766; Sharma N, 2006, STROKE, V37, P1941, DOI 10.1161/01.STR.0000226902.43357.fc; Simon SR, 2002, J NEUROPHYSIOL, V88, P2047, DOI 10.1152/jn.2002.88.4.2047; Sirigu A, 1999, BRAIN, V122, P1867, DOI 10.1093/brain/122.10.1867; Sousa RM, 2009, LANCET, V374, P1821, DOI 10.1016/S0140-6736(09)61829-8; Tomasino B, 2005, NEUROREPORT, V16, P1795, DOI 10.1097/01.wnr.0000185957.65723.52; Vingerhoets G, 2002, NEUROIMAGE, V17, P1623, DOI 10.1006/nimg.2002.1290; WIJERS AA, 1989, PSYCHOPHYSIOLOGY, V26, P452, DOI 10.1111/j.1469-8986.1989.tb01951.x; Windischberger C, 2003, NEUROIMAGE, V20, P225, DOI 10.1016/S1053-8119(03)00235-0; Wraga M, 2003, BRAIN COGNITION, V52, P135, DOI 10.1016/S0278-2626(03)00033-2; Yoshino A, 2000, COGNITIVE BRAIN RES, V9, P121, DOI 10.1016/S0926-6410(99)00046-4	64	25	34	3	31	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 9	2012	7	8							e42922	10.1371/journal.pone.0042922	http://dx.doi.org/10.1371/journal.pone.0042922			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	986WZ	22912763	Green Submitted, Green Published, gold			2022-12-25	WOS:000307378500032
J	Cherrington, BD; Zhang, XS; McElwee, JL; Morency, E; Anguish, LJ; Coonrod, SA				Cherrington, Brian D.; Zhang, Xuesen; McElwee, John L.; Morency, Eric; Anguish, Lynne J.; Coonrod, Scott A.			Potential Role for PAD2 in Gene Regulation in Breast Cancer Cells	PLOS ONE			English	Article							PEPTIDYLARGININE DEIMINASE; ARGININE METHYLATION; HISTONE DEIMINATION; TRANSGENIC MICE; EXPRESSION; LOCALIZATION; DISEASE; ANGIOGENESIS; PLEIOTROPHIN; INVOLVEMENT	The peptidylarginine deiminase (PAD) family of enzymes post-translationally convert positively charged arginine residues in substrate proteins to the neutral, non-standard residue citrulline. PAD family members 1, 2, 3, and 6 have previously been localized to the cell cytoplasm and, thus, their potential to regulate gene activity has not been described. We recently demonstrated that PAD2 is expressed in the canine mammary gland epithelium and that levels of histone citrullination in this tissue correlate with PAD2 expression. Given these observations, we decided to test whether PAD2 might localize to the nuclear compartment of the human mammary epithelium and regulate gene activity in these cells. Here we show, for the first time, that PAD2 is specifically expressed in human mammary gland epithelial cells and that a portion of PAD2 associates with chromatin in MCF-7 breast cancer cells. We investigated a potential nuclear function for PAD2 by microarray, qPCR, and chromatin immunoprecipitation analysis. Results show that the expression of a unique subset of genes is disregulated following depletion of PAD2 from MCF-7 cells. Further, ChIP analysis of two of the most highly up-and down-regulated genes (PTN and MAGEA12, respectively) found that PAD2 binds directly to these gene promoters and that the likely mechanism by which PAD2 regulates expression of these genes is via citrullination of arginine residues 2-8-17 on histone H3 tails. Thus, our findings define a novel role for PAD2 in gene expression in human mammary epithelial cells.	[Cherrington, Brian D.] Univ Wyoming, Dept Zool & Physiol, Laramie, WY 82071 USA; [Zhang, Xuesen; McElwee, John L.; Morency, Eric; Anguish, Lynne J.; Coonrod, Scott A.] Cornell Univ, Coll Vet Med, James A Baker Inst Anim Hlth, Ithaca, NY 14853 USA	University of Wyoming; Cornell University	Cherrington, BD (corresponding author), Univ Wyoming, Dept Zool & Physiol, Laramie, WY 82071 USA.	sac269@cornell.edu		McElwee, John/0000-0003-1538-533X; Cherrington, Brian/0000-0001-5847-2295	DOD Era of Hope Scholar Award [W871XWH-07-1-0372]; Post Doctoral Fellowship from Susan G. Komen for the Cure [KG101303]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [T32HD052471] Funding Source: NIH RePORTER	DOD Era of Hope Scholar Award; Post Doctoral Fellowship from Susan G. Komen for the Cure; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD))	This work was supported by a DOD Era of Hope Scholar Award (grant W871XWH-07-1-0372) to SAC. XZ was supported by a Post Doctoral Fellowship from Susan G. Komen for the Cure, KG101303. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arita K, 2006, P NATL ACAD SCI USA, V103, P5291, DOI 10.1073/pnas.0509639103; Bezy O, 2007, MOL CELL BIOL, V27, P6818, DOI 10.1128/MCB.00375-07; Chang XT, 2006, MOL CARCINOGEN, V45, P183, DOI 10.1002/mc.20169; Cherrington BD, 2010, PLOS ONE, V5, DOI [10.1371/journal/pone.0011768, 10.1371/journal.pone.0011768]; Cuthbert GL, 2004, CELL, V118, P545, DOI 10.1016/j.cell.2004.08.020; Dardik R, 2006, EXP CELL RES, V312, P2973, DOI 10.1016/j.yexcr.2006.05.019; Denis H, 2009, MOL CELL BIOL, V29, P4982, DOI 10.1128/MCB.00285-09; Feng Y, 2011, PROTEIN CELL, V2, P7, DOI 10.1007/s13238-011-1002-9; Ishigami A, 2005, J NEUROSCI RES, V80, P120, DOI 10.1002/jnr.20431; Jang B, 2010, ACTA NEUROPATHOL, V119, P199, DOI 10.1007/s00401-009-0625-x; Krishnakumar R, 2008, SCIENCE, V319, P819, DOI 10.1126/science.1149250; Lee HJ, 2010, J BIOL CHEM; Li PX, 2008, MOL CELL BIOL, V28, P4745, DOI 10.1128/MCB.01747-07; Liu YL, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021314; Luo Y, 2006, J AM CHEM SOC, V128, P1092, DOI 10.1021/ja0576233; Massague J, 2005, GENE DEV, V19, P2783, DOI 10.1101/gad.1350705; Mastronardi FG, 1996, J CLIN INVEST, V97, P349, DOI 10.1172/JCI118422; Miranda EI, 2010, LEUKEMIA RES, V34, P1121, DOI 10.1016/j.leukres.2010.03.045; Musse AA, 2008, DIS MODEL MECH, V1, P229, DOI 10.1242/dmm.000729; Nakashima K, 2002, J BIOL CHEM, V277, P49562, DOI 10.1074/jbc.M208795200; Papadimitriou E, 2009, EUR CYTOKINE NETW, V20, P180, DOI 10.1684/ecn.2009.0172; Perez-Pinera P, 2007, CELL CYCLE, V6, P2877, DOI 10.4161/cc.6.23.5090; SENSHU T, 1989, ENDOCRINOLOGY, V124, P2666, DOI 10.1210/endo-124-6-2666; Simpson AJG, 2005, NAT REV CANCER, V5, P615, DOI 10.1038/nrc1669; Suzuki A, 2003, NAT GENET, V34, P395, DOI 10.1038/ng1206; TAKAHARA H, 1989, J BIOL CHEM, V264, P13361; TAKAHARA H, 1992, J BIOL CHEM, V267, P520; Vossenaar ER, 2003, BIOESSAYS, V25, P1106, DOI 10.1002/bies.10357; Vossenaar ER, 2004, ANN RHEUM DIS, V63, P373, DOI 10.1136/ard.2003.012211; Wang Y, 2004, SCIENCE, V306, P279, DOI 10.1126/science.1101400; Wood DD, 2008, LAB INVEST, V88, P354, DOI 10.1038/labinvest.3700748; Yang B, 2007, CANCER RES, V67, P9954, DOI 10.1158/0008-5472.CAN-07-1478; Yao HJ, 2008, J BIOL CHEM, V283, P20060, DOI 10.1074/jbc.M802940200; Yoon S, 2006, GROWTH FACTORS, V24, P21, DOI 10.1080/02699050500284218; Zhang XS, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1002112	35	61	62	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 24	2012	7	7							e41242	10.1371/journal.pone.0041242	http://dx.doi.org/10.1371/journal.pone.0041242			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	978NX	22911765	Green Published, gold, Green Submitted			2022-12-25	WOS:000306751300028
J	Vafia, K; Groth, S; Beckmann, T; Hirose, M; Dworschak, J; Recke, A; Ludwig, RJ; Hashimoto, T; Zillikens, D; Schmidt, E				Vafia, Katerina; Groth, Stephanie; Beckmann, Tina; Hirose, Misa; Dworschak, Jenny; Recke, Andreas; Ludwig, Ralf J.; Hashimoto, Takashi; Zillikens, Detlef; Schmidt, Enno			Pathogenicity of Autoantibodies in Anti-p200 Pemphigoid	PLOS ONE			English	Article							DERMAL-EPIDERMAL SEPARATION; EPIDERMOLYSIS-BULLOSA ACQUISITA; VII-COLLAGEN; PASSIVE TRANSFER; BASEMENT-MEMBRANE; XVII COLLAGEN; HUMAN SKIN; SUBEPIDERMAL BLISTERS; ANTIBODIES; ANTIGEN	Recently, the C-terminus of laminin gamma 1 has been identified as target antigen in anti-p200 pemphigoid and the disease was renamed as anti-laminin gamma 1 pemphigoid. However, the pathogenic relevance of these autoantibodies has not yet been demonstrated. Therefore, we employed an ex vivo model of autoantibody-mediated leukocyte-dependent neutrophil activation and dermal-epidermal separation (DES) using cryosections of human skin. We showed that anti-p200 pemphigoid sera (n = 7) induced DES in a time-dependent manner, in contrast to sera from healthy controls. Furthermore, laminin gamma 1-specific IgG and serum depleted from anti-laminin gamma 1 reactivity were generated using the recombinant C-terminus of laminin gamma 1 (LAMC1-term; amino acids 1364 to 1609). Interestingly, both fractions labeled the dermal-epidermal-junction (DEJ) by indirect immunofluorescence microscopy on human foreskin and recognized a 200 kDa protein by immunoblotting with dermal extract. Human and rabbit IgG against LAMC1-cterm failed to attract neutrophils at the DEJ and to induce DES. In contrast, patient serum depleted from LAMC1-cterm reactivity led to the same extent of DES as non-depleted IgG. Repeated injection of rabbit anti-murine LAMC1-cterm IgG into both neonatal and adult C57BL/6mice as well as repetitive immunization of various mouse strains with murine LAMC1-cterm failed to induce macro-and microscopic lesions. In all mice, circulating anti-LAMC1-cterm antibodies were present, but only in some mice, IgG deposits were seen at the DEJ. We conclude that autoantibodies in anti-p200 pemphigoid sera are pathogenic while pathogenicity is not mediated by autoantibodies against laminin gamma 1. Further studies are needed to identify the pathogenically relevant autoantigen in anti-p200 pemphigoid.	[Vafia, Katerina; Groth, Stephanie; Beckmann, Tina; Hirose, Misa; Dworschak, Jenny; Recke, Andreas; Ludwig, Ralf J.; Zillikens, Detlef; Schmidt, Enno] Med Univ Lubeck, Dept Dermatol, D-23538 Lubeck, Germany; [Hashimoto, Takashi] Kurume Univ, Sch Med, Dept Dermatol, Kurume, Fukuoka 830, Japan; [Schmidt, Enno] Med Univ Lubeck, Comprehens Ctr Inflammat Med, D-23538 Lubeck, Germany	University of Lubeck; Kurume University; University of Lubeck	Vafia, K (corresponding author), Med Univ Lubeck, Dept Dermatol, D-23538 Lubeck, Germany.	enno.schmidt@uk-sh.de	Ludwig, Ralf/F-3996-2018; Schmidt, Enno/C-4008-2009; Zillikens, Detlef/C-8572-2011; Ludwig, Ralf J/A-2629-2008; Hashimoto, Takashi/H-6947-2019; Goletz, Stephanie/K-1358-2014; Recke, Andreas/C-8963-2009; Hirose, Misa/A-2858-2014	Ludwig, Ralf/0000-0002-1394-1737; Schmidt, Enno/0000-0002-1206-8913; Ludwig, Ralf J/0000-0002-1394-1737; Hashimoto, Takashi/0000-0002-0144-3255; Recke, Andreas/0000-0002-7674-1804; 	Schleswig-Holstein Cluster of Excellence in Inflammation Research (DFG) [EXC 306/1]; Medical Faculty of the University of Luebeck [E24-2010]	Schleswig-Holstein Cluster of Excellence in Inflammation Research (DFG)(German Research Foundation (DFG)); Medical Faculty of the University of Luebeck	Support was granted by the Schleswig-Holstein Cluster of Excellence in Inflammation Research (DFG EXC 306/1) to ES, DZ and RL and the Medical Faculty of the University of Luebeck (E24-2010) to SG. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Chen KR, 1996, BRIT J DERMATOL, V134, P340; Dainichi T, 2010, J DERMATOL, V37, P231, DOI 10.1111/j.1346-8138.2009.00793.x; Dainichi T, 2009, P NATL ACAD SCI USA, V106, P2800, DOI 10.1073/pnas.0809230106; DIAZ LA, 1990, J CLIN INVEST, V86, P1088, DOI 10.1172/JCI114812; Dilling A, 2007, J DERMATOL, V34, P1, DOI 10.1111/j.1346-8138.2007.00208.x; GAMMON WR, 1982, J INVEST DERMATOL, V78, P285, DOI 10.1111/1523-1747.ep12507222; Groth S, 2011, BRIT J DERMATOL, V164, P76, DOI 10.1111/j.1365-2133.2010.10056.x; Hirose M, 2011, J IMMUNOL, V187, P1176, DOI 10.4049/jimmunol.1100596; Hofmann SC, 2008, J INVEST DERMATOL, V128, P87, DOI 10.1038/sj.jid.5700952; Iwata H, 2009, J INVEST DERMATOL, V129, P919, DOI 10.1038/jid.2008.305; LABIB RS, 1986, J IMMUNOL, V136, P1231; Lazarova Z, 2000, J INVEST DERMATOL, V114, P178, DOI 10.1046/j.1523-1747.2000.00829.x; Lazarova Z, 1996, J CLIN INVEST, V98, P1509, DOI 10.1172/JCI118942; LIU Z, 1993, J CLIN INVEST, V92, P2480, DOI 10.1172/JCI116856; Ludwig RJ, 2011, J INVEST DERMATOL, V131, P167, DOI 10.1038/jid.2010.248; Mihai S, 2007, J CELL MOL MED, V11, P1117, DOI 10.1111/j.1582-4934.2007.00081.x; MUELLER S, 1989, J INVEST DERMATOL, V92, P33, DOI 10.1111/1523-1747.ep13070476; Nishie W, 2007, NAT MED, V13, P378, DOI 10.1038/nm1496; Schmidt E, 2000, J INVEST DERMATOL, V115, P842, DOI 10.1046/j.1523-1747.2000.00141.x; Schmidt E, 2000, ARCH DERMATOL, V136, P174, DOI 10.1001/archderm.136.2.174; Shimanovich I, 2003, J INVEST DERMATOL, V121, P1402, DOI 10.1111/j.1523-1747.2003.12609.x; Sitaru C, 2005, J CLIN INVEST, V115, P870, DOI 10.1172/JCI200521386; Sitaru C, 2002, AM J PATHOL, V161, P301, DOI 10.1016/S0002-9440(10)64182-X; Sitaru C, 2002, J INVEST DERMATOL, V118, P664, DOI 10.1046/j.1523-1747.2002.01720.x; Sitaru C, 2006, J IMMUNOL, V177, P3461, DOI 10.4049/jimmunol.177.5.3461; STANLEY JR, 1981, CELL, V24, P897, DOI 10.1016/0092-8674(81)90115-X; Woodley DT, 2006, J INVEST DERMATOL, V126, P1323, DOI 10.1038/sj.jid.5700254; Woodley DT, 2005, J INVEST DERMATOL, V124, P958, DOI 10.1111/j.0022-202X.2005.23702.x; Yamamoto K, 2002, J INVEST DERMATOL, V118, P485, DOI 10.1046/j.0022-202x.2001.01683.x; Zillikens D, 1996, J INVEST DERMATOL, V106, P1332, DOI 10.1111/1523-1747.ep12349283; Zillikens D, 2000, BRIT J DERMATOL, V143, P1043, DOI 10.1046/j.1365-2133.2000.03841.x	31	31	33	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 24	2012	7	7							e41769	10.1371/journal.pone.0041769	http://dx.doi.org/10.1371/journal.pone.0041769			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	978NX	22911854	gold, Green Published, Green Submitted			2022-12-25	WOS:000306751300072
J	Shi, YY; Bai, YJ; Zou, YG; Cai, B; Liu, F; Fu, P; Wang, LL				Shi, Yunying; Bai, Yangjuan; Zou, Yuangao; Cai, Bei; Liu, Fei; Fu, Ping; Wang, Lanlan			The Value of Plasma Paraquat Concentration in Predicting Therapeutic Effects of Haemoperfusion in Patients with Acute Paraquat Poisoning	PLOS ONE			English	Article							TOXICITY	Objective: This study was aimed to analyze the scavenging effect of haemoperfusion on plasma paraquat (PQ) and to evaluate the clinical significance of PQ examination in the treatment of patients with acute paraquat poisoning. Methods: 85 patients with acute paraquat intoxication by oral ingestion were admitted in West China Hospital from Jun, 2010 to Mar, 2011. A standardized therapeutic regimen including emergency haemoperfusion was given on all subjects. A total of 91 whole blood samples were taken before (0h), underway (1h after haemoperfusion beginning) and at the end (2h) of the haemoperfusion therapy. The clearance rate was calculated and related factors were analyzed. Results: As heamoperfusion was going on, the plasma paraquat concentration of the patients kept falling down. After 1 hour of haemoperfusion, the average clearance rate (R-1) was 37.06 +/- 21.81%. After 2 hours of haemoperfusion, the average clearance rate (R-2) was 45.99 +/- 23.13%. The average of R-1/R-2 ratio was 76.61 +/- 22.80%. In the high paraquat concentration group (plasma paraquat concentration (C-0)>300 ng/mL), both the averages of R-1 and R-2 were significantly higher than those of the low paraquat concentration group (C-0 <= 200 ng/mL) (p<0.05), and there was no significant difference of R-1/R-2 between these two groups (p>0.05). Conclusions: The dynamic monitoring of plasma PQ concentration was not only critical in the clinical evaluation but also helpful in guiding the treatment of patients with acute PQ intoxication. Haemoperfusion can effectively eliminate paraquat from the plasma in patients with high initial plasma PQ concentration, while in patients with low initial plasma PQ concentration (<200 ng/ml), the clearance effect of harmoperfusion was very limited. Increasing HP time might improve the overall clearance rate of HP on plasma PQ yet decrease the elimination efficiency of HP, while repeated HP treatment was helpful against the rebound phenomena.	[Shi, Yunying; Liu, Fei; Fu, Ping] Sichuan Univ, W China Hosp, Dept Nephrol, Chengdu 610064, Peoples R China; [Bai, Yangjuan; Zou, Yuangao; Cai, Bei; Wang, Lanlan] Sichuan Univ, W China Hosp, Dept Lab Med, Chengdu 610064, Peoples R China	Sichuan University; Sichuan University	Shi, YY (corresponding author), Sichuan Univ, W China Hosp, Dept Nephrol, Chengdu 610064, Peoples R China.	wangll87@126.com	Shi, Yun Ying/GWZ-9476-2022	Shi, Yun Ying/0000-0002-4544-5439	National Natural Science Foundation of China [81072443, 81100536, 30772051, 30950010, 81001325]; Foundation of Education Ministry of China [20090181120099, 20090181110026]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Foundation of Education Ministry of China(Ministry of Education, China)	This research was sponsored by National Natural Science Foundation of China (Nos. 81072443, 81100536, 30772051, 30950010, 81001325) and Foundation of Education Ministry of China (20090181120099, 20090181110026). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Castro Rui, 2005, Acta Med Port, V18, P423; Chen Yan-jun, 2010, Zhonghua Lao Dong Wei Sheng Zhi Ye Bing Za Zhi, V28, P358; Gil HW, 2008, CLIN TOXICOL, V46, P515, DOI 10.1080/15563650701549403; HAMPSON ECGM, 1988, MED TOXICOL ADV DRUG, V3, P64, DOI 10.1007/BF03259932; Hong SY, 2003, TOXICOL IND HEALTH, V19, P17, DOI 10.1191/0748233703th171oa; Jones AL, 1999, QJM-MON J ASSOC PHYS, V92, P573, DOI 10.1093/qjmed/92.10.573; Jones GM, 2000, J TOXICOL-CLIN TOXIC, V38, P123, DOI 10.1081/CLT-100100926; Kang MS, 2009, J KOREAN MED SCI, V24, pS156, DOI 10.3346/jkms.2009.24.S1.S156; Lee EY, 2002, TOXICOL IND HEALTH, V18, P201, DOI 10.1191/0748233702th141oa; Lopez Lago A M, 2002, An Med Interna, V19, P310; Sabzghabaee AM, 2010, SINGAP MED J, V51, P496; Senarathna L, 2009, QJM-INT J MED, V102, P251, DOI 10.1093/qjmed/hcp006; Smith L L, 1978, Ciba Found Symp, P321; SMITH LL, 1985, PHILOS T R SOC B, V311, P647, DOI 10.1098/rstb.1985.0170; SMITH LL, 1987, HUM TOXICOL, V6, P31, DOI 10.1177/096032718700600105; SUZUKI K, 1993, HUM EXP TOXICOL, V12, P323, DOI 10.1177/096032719301200411; Yoon SCTW, 2002, KOREAN J NEPHROL, V21, P914; Yoon Sung-Chul, 2009, Korean J Intern Med, V24, P93, DOI 10.3904/kjim.2009.24.2.93; Zou YG, 2011, J CHROMATOGR B, V879, P1809, DOI 10.1016/j.jchromb.2011.05.004	19	28	43	0	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 20	2012	7	7							e40911	10.1371/journal.pone.0040911	http://dx.doi.org/10.1371/journal.pone.0040911			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	977GL	22911716	gold, Green Submitted, Green Published			2022-12-25	WOS:000306644600027
J	Wang, ZX; Wang, Y; Farhangfar, F; Zimmer, M; Zhang, YX				Wang, Zhenxiang; Wang, Ying; Farhangfar, Farhang; Zimmer, Monica; Zhang, Yongxin			Enhanced Keratinocyte Proliferation and Migration in Co-culture with Fibroblasts	PLOS ONE			English	Article							GROWTH-FACTOR EGF; IFN-GAMMA PRODUCTION; FACTOR HB-EGF; IN-VITRO; DERMAL FIBROBLASTS; CONNECTIVE-TISSUE; CELL-MIGRATION; SCRATCH ASSAY; FACTOR-ALPHA; EPIDERMAL-KERATINOCYTES	Wound healing is primarily controlled by the proliferation and migration of keratinocytes and fibroblasts as well as the complex interactions between these two cell types. To investigate the interactions between keratinocytes and fibroblasts and the effects of direct cell-to-cell contact on the proliferation and migration of keratinocytes, keratinocytes and fibroblasts were stained with different fluorescence dyes and co-cultured with or without transwells. During the early stage (first 5 days) of the culture, the keratinocytes in contact with fibroblasts proliferated significantly faster than those not in contact with fibroblasts, but in the late stage (11th to 15th day), keratinocyte growth slowed down in all cultures unless EGF was added. In addition, keratinocyte migration was enhanced in co-cultures with fibroblasts in direct contact, but not in the transwells. Furthermore, the effects of the fibroblasts on keratinocyte migration and growth at early culture stage correlated with heparin-binding EGF-like growth factor (HB-EGF), IL-1 alpha and TGF-beta 1 levels in the cultures where the cells were grown in direct contact. These effects were inhibited by anti-HB-EGF, anti-IL-1 alpha and anti-TGF-beta 1 antibodies and anti-HB-EGF showed the greatest inhibition. Co-culture of keratinocytes and IL-1 alpha and TGF-beta 1 siRNA-transfected fibroblasts exhibited a significant reduction in HB-EGF production and keratinocyte proliferation. These results suggest that contact with fibroblasts stimulates the migration and proliferation of keratinocytes during wound healing, and that HB-EGF plays a central role in this process and can be up-regulated by IL-1 alpha and TGF-beta 1, which also regulate keratinocyte proliferation differently during the early and late stage.	[Wang, Zhenxiang; Zimmer, Monica] Third Mil Med Univ, Southwest Hosp, Dept Plast & Aesthet Surg, Chongqing, Peoples R China; [Wang, Ying; Zhang, Yongxin] ZYX Biotech Co, Dept R&D, Carrollton, TX USA; [Farhangfar, Farhang] Regenetech Inc, Houston, TX USA	Army Medical University	Wang, ZX (corresponding author), Third Mil Med Univ, Southwest Hosp, Dept Plast & Aesthet Surg, Chongqing, Peoples R China.	zyx@zyxbiotech.com	Zhang, Yongxin/AAI-5646-2020		Zyxell Inc.; National Natural Science Foundation of China [81071563]	Zyxell Inc.; National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This study was supported by Zyxell Inc. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. Some experiments done for the manuscript revisions were supported by National Natural Science Foundation of China (81071563). No additional external funding was received for this study.	Abdullah KM, 1999, ENDOCRINE, V10, P35, DOI 10.1385/ENDO:10:1:35; ANFINOGENOV VA, 1992, TSITOLOGIYA+, V34, P60; Cha D, 1996, J INVEST DERMATOL, V106, P590, DOI 10.1111/1523-1747.ep12345083; CHEN JD, 1995, J INVEST DERMATOL, V104, P729, DOI 10.1111/1523-1747.ep12606970; Cribbs RK, 1998, J BURN CARE REHABIL, V19, P95, DOI 10.1097/00004630-199803000-00002; Decline F, 2003, CELL MOTIL CYTOSKEL, V54, P64, DOI 10.1002/cm.10086; DELAPORTE E, 1989, PATHOL BIOL, V37, P875; Ding Y, 2010, J BIOL CHEM, V285, P37909, DOI 10.1074/jbc.M109.093724; Evans RA, 2003, EXP CELL RES, V282, P90, DOI 10.1016/S0014-4827(02)00015-0; Fagot D, 2002, ARCH DERMATOL RES, V293, P576, DOI 10.1007/s00403-001-0271-1; [富建华 Fu Jianhua], 2011, [中国当代儿科杂志, Chinese Journal of Contemporary Pediatrics], V13, P36; Funayama Emi, 2002, Hokkaido Journal of Medical Science, V77, P533; Fusenig N E, 1994, J Dermatol Sci, V7 Suppl, pS142, DOI 10.1016/0923-1811(94)90045-0; GAIL MH, 1973, EXP CELL RES, V79, P386, DOI 10.1016/0014-4827(73)90458-8; GAIL MH, 1971, EXP CELL RES, V65, P221, DOI 10.1016/S0014-4827(71)80070-8; Garner WL, 1998, PLAST RECONSTR SURG, V102, P135, DOI 10.1097/00006534-199807000-00021; Garton AJ, 1999, J BIOL CHEM, V274, P3811, DOI 10.1074/jbc.274.6.3811; Goetsch KP, 2011, ANAL BIOCHEM, V411, P158, DOI 10.1016/j.ab.2010.12.012; GONUL B, 1992, EXP EYE RES, V54, P519, DOI 10.1016/0014-4835(92)90130-K; Goretsky MJ, 1996, J TRAUMA, V40, P894, DOI 10.1097/00005373-199606000-00006; Haber M, 2003, VET OPHTHALMOL, V6, P211, DOI 10.1046/j.1463-5224.2003.00296.x; Harrison CA, 2005, WOUND REPAIR REGEN, V13, P543, DOI 10.1111/j.1524-475X.2005.00076.x; HASHIMOTO K, 1994, J BIOL CHEM, V269, P20060; Hashimoto K, 2000, J DERMATOL SCI, V24, pS46, DOI 10.1016/S0923-1811(00)00141-9; Haverstock B D, 2001, Clin Podiatr Med Surg, V18, P147; HIGASHIYAMA S, 1991, SCIENCE, V251, P936, DOI 10.1126/science.1840698; HODARA ML, 1991, ARCH BIOCHEM BIOPHYS, V286, P85, DOI 10.1016/0003-9861(91)90011-7; Huang S, 2010, BIOMATERIALS, V31, P5520, DOI 10.1016/j.biomaterials.2010.03.060; Jeong HW, 2004, J CELL BIOCHEM, V92, P770, DOI 10.1002/jcb.20110; Kitano Y, 1976, Med J Osaka Univ, V26, P147; KIYOHARA Y, 1991, J PHARMACOBIO-DYNAM, V14, P47, DOI 10.1248/bpb1978.14.47; Koivisto L, 2006, EXP CELL RES, V312, P2791, DOI 10.1016/j.yexcr.2006.05.009; Konstantinova N V, 1996, Biull Eksp Biol Med, V121, P181; Laato M, 1990, Duodecim, V106, P860; Laco F, 2009, J DERMATOL SCI, V55, P150, DOI 10.1016/j.jdermsci.2009.05.009; LACROIX M, 1995, ARCH DERMATOL RES, V287, P659, DOI 10.1007/BF00371739; Liang CC, 2007, NAT PROTOC, V2, P329, DOI 10.1038/nprot.2007.30; Maas-Szabowski N, 2000, J INVEST DERMATOL, V114, P1075, DOI 10.1046/j.1523-1747.2000.00987.x; Marikovsky M, 1996, J INVEST DERMATOL, V106, P616, DOI 10.1111/1523-1747.ep12345413; MARIKOVSKY M, 1993, P NATL ACAD SCI USA, V90, P3889, DOI 10.1073/pnas.90.9.3889; McCawley LJ, 1997, ENDOCRINOLOGY, V138, P121, DOI 10.1210/en.138.1.121; Moon H, 2012, ARCH PHARM RES, V35, P383, DOI 10.1007/s12272-012-0220-x; Newby CS, 2000, J INVEST DERMATOL, V115, P292, DOI 10.1046/j.1523-1747.2000.00056.x; Nolte SV, 2008, CELLS TISSUES ORGANS, V187, P165, DOI 10.1159/000111805; Nowinski D, 2002, J INVEST DERMATOL, V119, P449, DOI 10.1046/j.1523-1747.2002.01841.x; O'Toole EA, 1997, J CLIN INVEST, V100, P2881, DOI 10.1172/JCI119837; OKUMURA K, 1990, PHARMACEUT RES, V7, P1289, DOI 10.1023/A:1015946123697; Parnigotto Pier Paolo, 1993, Italian Journal of Anatomy and Embryology, V98, P31; Pilcher BK, 1997, J CELL BIOL, V137, P1445, DOI 10.1083/jcb.137.6.1445; Rasanen K, 2010, EXP CELL RES, V316, P1739, DOI 10.1016/j.yexcr.2010.01.020; Rose MT, 2012, VET J; Sawicki G, 2005, MOL CELL BIOCHEM, V269, P209, DOI 10.1007/s11010-005-3178-x; SCHULTZ G, 1991, J CELL BIOCHEM, V45, P346, DOI 10.1002/jcb.240450407; Seomun Y, 2008, J CELL BIOCHEM, V104, P934, DOI 10.1002/jcb.21675; Shirakata Y, 2005, J CELL SCI, V118, P2363, DOI 10.1242/jcs.02346; Snyder R J, 2001, Ostomy Wound Manage, V47, P20; South AP, 2003, J CELL SCI, V116, P3303, DOI 10.1242/jcs.00636; Sugai J, 1998, J DERMATOL SCI, V17, P190, DOI 10.1016/S0923-1811(98)00006-1; Sun T, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002129; Szabowski A, 2000, CELL, V103, P745, DOI 10.1016/S0092-8674(00)00178-1; Tsuboi Ryoji, 1992, Journal of Dermatology (Tokyo), V19, P652; TUAN TL, 1994, J CELL SCI, V107, P2285; Uchino T, 2009, TOXICOL IN VITRO, V23, P333, DOI 10.1016/j.tiv.2008.12.003; Watanabe Takashi, 2006, Tanpakushitsu Kakusan Koso, V51, P715; Werner S, 2007, J INVEST DERMATOL, V127, P998, DOI 10.1038/sj.jid.5700786; WOODLEY DT, 1993, DERMATOL CLIN, V11, P641, DOI 10.1016/S0733-8635(18)30217-1; Yarrow JC, 2004, BMC BIOTECHNOL, V4, DOI 10.1186/1472-6750-4-21; Ye H, 2011, WOUND REPAIR REGEN, V19, P392, DOI 10.1111/j.1524-475X.2011.00680.x; Yoshioka R, 2010, INVEST OPHTH VIS SCI, V51, P5630, DOI 10.1167/iovs.10-5158; Zhang Y, 2002, CELL DEATH DIFFER, V9, P651, DOI 10.1038/sj.cdd.4401011; Zhang YX, 2000, J INTERF CYTOK RES, V20, P235, DOI 10.1089/107999000312658; Zhang YX, 2002, IMMUNOLOGY, V105, P286, DOI 10.1046/j.0019-2805.2001.01368.x; Zhang YX, 2002, EXP BIOL MED, V227, P133, DOI 10.1177/153537020222700208; Zhang YX, 2001, J INTERF CYTOK RES, V21, P843, DOI 10.1089/107999001753238097; Zhu Yao-Feng, 2008, Zhonghua Yi Xue Za Zhi, V88, P697	75	71	73	0	27	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 20	2012	7	7							e40951	10.1371/journal.pone.0040951	http://dx.doi.org/10.1371/journal.pone.0040951			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	977GL	22911722	Green Published, Green Submitted, gold			2022-12-25	WOS:000306644600031
J	Zielinski, R; Hassan, M; Lyakhov, I; Needle, D; Chernomordik, V; Garcia-Glaessner, A; Ardeshirpour, Y; Capala, J; Gandjbakhche, A				Zielinski, Rafal; Hassan, Moinuddin; Lyakhov, Ilya; Needle, Danielle; Chernomordik, Victor; Garcia-Glaessner, Alejandra; Ardeshirpour, Yasaman; Capala, Jacek; Gandjbakhche, Amir			Affibody-DyLight Conjugates for In Vivo Assessment of HER2 Expression by Near-Infrared Optical Imaging	PLOS ONE			English	Article							MALIGNANT-TUMORS; BREAST-CANCER; HER2-POSITIVE TUMORS; FLUORESCENT PROTEINS; BINDING-PROTEINS; MOLECULES; THERAPY; RECOMBINANT; TRACER; AGENT	Purpose: Amplification of the HER2/neu gene and/or overexpression of the corresponding protein have been identified in approximately 20% of invasive breast carcinomas. Assessment of HER2 expression in vivo would advance development of new HER2-targeted therapeutic agents and, potentially, facilitate choice of the proper treatment strategy offered to the individual patient. We present novel HER2-specific probes for in vivo evaluation of the receptor status by near-infrared (NIR) optical imaging. Experimental Design: Affibody molecules were expressed, purified, and labeled with NIR-fluorescent dyes. The binding affinity and specificity of the obtained probe were tested in vitro. For in vivo validation, the relationship of the measured NIR signal and HER2 expression was characterized in four breast cancer xenograft models, expressing different levels of HER2. Accumulation of Affibody molecules in tumor tissue was further confirmed by ex vivo analysis. Results: Affibody-DyLight conjugates showed high affinity to HER2 (K-D = 3.66 +/- 0.26). No acute toxicity resulted from injection of the probes (up to 0.5 mg/kg) into mice. Pharmacokinetic studies revealed a relatively short (37.53 +/- 2.8 min) half-life of the tracer in blood. Fluorescence accumulation in HER2-positive BT-474 xenografts was evident as soon as a few minutes post injection and reached its maximum at 90 minutes. On the other hand, no signal retention was observed in HER2-negative MDA-MB-468 xenografts. Immunostaining of extracted tumor tissue confirmed penetration of the tracer into tumor tissue. Conclusions: The results of our studies suggest that Affibody-DyLight-750 conjugate is a powerful tool to monitor HER2 status in a preclinical setting. Following clinical validation, it might provide complementary means for assessment of HER2 expression in breast cancer patients (assuming availability of proper NIR scanners) and/or be used to facilitate detection of HER2-positive metastatic lesions during NIR-assisted surgery.	[Zielinski, Rafal; Garcia-Glaessner, Alejandra; Capala, Jacek] NCI, Radiat Oncol Branch, Ctr Canc Res, NIH, Bethesda, MD 20892 USA; [Zielinski, Rafal] John Paul II Catholic Univ Lublin, Dept Mol Biol, Lublin, Poland; [Hassan, Moinuddin; Chernomordik, Victor; Ardeshirpour, Yasaman; Gandjbakhche, Amir] Eunice Kennedy Shriver Natl Inst Child Hlth & Hum, Sect Analyt & Funct Biophoton, Program Pediat Imaging & Tissue Sci, NIH, Bethesda, MD USA; [Lyakhov, Ilya] NCI, Prot Chem Lab, SAIC Frederick Inc, Frederick, MD 21701 USA; [Lyakhov, Ilya] VARNISS LLC, Frederick, MD USA; [Needle, Danielle] NCI, Ctr Canc Res, Nanobiol Program, Frederick, MD 21701 USA; [Needle, Danielle] NCI, Prot Engn Sect, Macromol Crystallog Lab, Frederick, MD 21701 USA	National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); Catholic University of Lublin; National Institutes of Health (NIH) - USA; NIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD); National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); Science Applications International Corporation (SAIC); SAIC-Frederick; National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI)	Zielinski, R (corresponding author), Univ Texas MD Anderson Canc Ctr, Dept Expt Therapeut, Houston, TX 77030 USA.	rjzielinski@mdanderson.org	Capala, Jacek/S-3553-2019	Garcia Glaessner, Alejandra/0000-0002-0766-9917	National Cancer Institute, NIH; Eunice Kennedy Shriver National Institute of Child Health and Human Development, NIH; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [ZIAHD000261] Funding Source: NIH RePORTER	National Cancer Institute, NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); Eunice Kennedy Shriver National Institute of Child Health and Human Development, NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD))	This research is supported by the Intramural Research Program of National Cancer Institute, NIH, and Intramural Research Program of the Eunice Kennedy Shriver National Institute of Child Health and Human Development, NIH. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allison M, 2010, NAT BIOTECHNOL, V28, P117, DOI 10.1038/nbt0210-117; Ardeshirpour Y, 2011, TECHNOL CANCER RES T, V10, P549, DOI 10.1177/153303461101000605; Chernomordik V, 2010, MOL IMAGING, V9, P192, DOI 10.2310/7290.2010.00018; Crawley MJ, 2005, STAT INTRO USING R, P327, DOI DOI 10.1002/9781119941750; Eigenbrot C, 2010, P NATL ACAD SCI USA, V107, P15039, DOI 10.1073/pnas.1005025107; Ekblad T, 2008, EUR J NUCL MED MOL I, V35, P2245, DOI 10.1007/s00259-008-0845-7; Hassan M, 2007, MOL IMAGING, V6, P229, DOI 10.2310/7290.2007.00019; Hassan M, 2012, MOL IMAGING, V11, P177, DOI 10.2310/7290.2011.00038; Hoffman RM, 2005, NAT REV CANCER, V5, P796, DOI 10.1038/nrc1717; Hofmann M, 2006, NEOPLASIA, V8, P89, DOI 10.1593/neo.05469; Kapust RB, 2001, PROTEIN ENG, V14, P993, DOI 10.1093/protein/14.12.993; Kramer-Marek G, EUR J NUCL MED MOL I; Kramer-Marek G, 2008, EUR J NUCL MED MOL I, V35, P1008, DOI 10.1007/s00259-007-0658-0; Lee SB, 2008, CLIN CANCER RES, V14, P3840, DOI 10.1158/1078-0432.CCR-07-4076; Lundberg E, 2007, J IMMUNOL METHODS, V319, P53, DOI 10.1016/j.jim.2006.10.013; Lyakhov I, 2010, CHEMBIOCHEM, V11, P345, DOI 10.1002/cbic.200900532; Menard S, 2003, ONCOGENE, V22, P6570, DOI 10.1038/sj.onc.1206779; Meric-Bernstam F, 2006, CLIN CANCER RES, V12, P6326, DOI 10.1158/1078-0432.CCR-06-1732; Nord K, 1997, NAT BIOTECHNOL, V15, P772, DOI 10.1038/nbt0897-772; Nordberg E, 2008, ONCOL REP, V19, P853; Nygren PA, 2008, FEBS J, V275, P2668, DOI 10.1111/j.1742-4658.2008.06438.x; Orlova A, 2007, CANCER RES, V67, P2178, DOI 10.1158/0008-5472.CAN-06-2887; Puri A, 2008, J LIPOSOME RES, V18, P293, DOI [10.1080/08982100802457377, 10.1080/08982100802457377 ]; Schuetz F, 2011, BREAST CARE, V6, P179, DOI 10.1159/000329336; Shaner NC, 2005, NAT METHODS, V2, P905, DOI 10.1038/NMETH819; SLAMON DJ, 1987, SCIENCE, V235, P177, DOI 10.1126/science.3798106; Smith B, J CONTROL RELEASE, V153, P187; Tolmachev V, 2006, J NUCL MED, V47, P846; Tolmachev V, 2009, J NUCL MED, V50, P274, DOI 10.2967/jnumed.108.055525; Tran T, 2007, BIOCONJUGATE CHEM, V18, P1956, DOI 10.1021/bc7002617; Tran TA, 2009, EUR J NUCL MED MOL I, V36, P1864, DOI 10.1007/s00259-009-1176-z; Urica N, 2008, EGFR HER2 TARGETING, P50; Witton CJ, 2003, J PATHOL, V200, P290, DOI 10.1002/path.1370; Zielinski R, 2011, CLIN CANCER RES, V17, P5071, DOI 10.1158/1078-0432.CCR-10-2887; Zielinski R, 2009, J IMMUNOTHER, V32, P817, DOI 10.1097/CJI.0b013e3181ad4d5d	35	17	19	2	22	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 20	2012	7	7							e41016	10.1371/journal.pone.0041016	http://dx.doi.org/10.1371/journal.pone.0041016			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	977GL	22911732	Green Published, Green Submitted, gold			2022-12-25	WOS:000306644600036
J	Cameron, EA; Maynard, MA; Smith, CJ; Smith, TJ; Koropatkin, NM; Martens, EC				Cameron, Elizabeth A.; Maynard, Mallory A.; Smith, Christopher J.; Smith, Thomas J.; Koropatkin, Nicole M.; Martens, Eric C.			Multidomain Carbohydrate-binding Proteins Involved in Bacteroides thetaiotaomicron Starch Metabolism	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							OUTER-MEMBRANE PROTEINS; HUMAN GUT SYMBIONT; ALPHA-AMYLASE; FUNCTIONAL-ANALYSIS; STRUCTURAL BASIS; I-TASSER; GLYCOGEN; DOMAIN; RECOGNITION; COMPLEX	Human colonic bacteria are necessary for the digestion of many dietary polysaccharides. The intestinal symbiont Bacteroides thetaiotaomicron uses five outer membrane proteins to bind and degrade starch. Here, we report the x-ray crystallographic structures of SusE and SusF, two outer membrane proteins composed of tandem starch specific carbohydrate-binding modules (CBMs) with no enzymatic activity. Examination of the two CBMs in SusE and three CBMs in SusF reveals subtle differences in the way each binds starch and is reflected in their K-d values for both high molecular weight starch and small maltooligosaccharides. Thus, each site seems to have a unique starch preference that may enable these proteins to interact with different regions of starch or its breakdown products. Proteins similar to SusE and SusF are encoded in many other polysaccharide utilization loci that are possessed by human gut bacteria in the phylum Bacteroidetes. Thus, these proteins are likely to play an important role in carbohydrate metabolism in these abundant symbiotic species. Understanding structural changes that diversify and adapt related proteins in the human gut microbial community will be critical to understanding the detailed mechanistic roles that they perform in the complex digestive ecosystem.	[Cameron, Elizabeth A.; Maynard, Mallory A.; Smith, Christopher J.; Koropatkin, Nicole M.; Martens, Eric C.] Univ Michigan, Sch Med, Dept Microbiol & Immunol, Ann Arbor, MI 48109 USA; [Smith, Thomas J.; Koropatkin, Nicole M.] Donald Danforth Plant Sci Ctr, St Louis, MO 63132 USA	University of Michigan System; University of Michigan; Donald Danforth Plant Science Center	Koropatkin, NM (corresponding author), Univ Michigan, Sch Med, Dept Microbiol & Immunol, Ann Arbor, MI 48109 USA.	nkoropat@umich.edu; emartens@umich.edu	Smith, Thomas J/K-9086-2013	Smith, Thomas J/0000-0003-3528-6793	National Institutes of Health [K01DK084214]; University of Michigan [GM07544]; University of Michigan Gastrointestinal Peptides Research Center; United States Department of Energy, Office of Science, Office of Basic Energy Sciences for use of the Advanced Photon Source [DE-AC02-06CH11357]; Michigan Economic Development Corporation; Michigan Technology Tri-Corridor program [085P1000817]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [K01DK084214] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); University of Michigan(University of Michigan System); University of Michigan Gastrointestinal Peptides Research Center; United States Department of Energy, Office of Science, Office of Basic Energy Sciences for use of the Advanced Photon Source(United States Department of Energy (DOE)); Michigan Economic Development Corporation; Michigan Technology Tri-Corridor program; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported, in whole or in part, by National Institutes of Health Grant K01DK084214 (to E. C. M), the University of Michigan Biological Sciences Scholars Program, and pilot/feasibility grants from the University of Michigan Gastrointestinal Peptides Research Center (to E. C. M. and N. M. K.).; Supported by University of Michigan Genetics Training Grant GM07544.; We thank the United States Department of Energy, Office of Science, Office of Basic Energy Sciences for use of the Advanced Photon Source under Contract DE-AC02-06CH11357. Use of the LS-CAT Sector 21 was supported by the Michigan Economic Development Corporation and Michigan Technology Tri-Corridor program Grant 085P1000817.	Adams PD, 2002, ACTA CRYSTALLOGR D, V58, P1948, DOI 10.1107/S0907444902016657; ANDERSON KL, 1989, J BACTERIOL, V171, P3199, DOI 10.1128/jb.171.6.3199-3204.1989; Bateman A, 2004, NUCLEIC ACIDS RES, V32, pD138, DOI [10.1093/nar/gkt1223, 10.1093/nar/gkp985, 10.1093/nar/gkr1065]; Boraston AB, 2006, J BIOL CHEM, V281, P587, DOI 10.1074/jbc.M509958200; Boraston AB, 2004, BIOCHEM J, V382, P769, DOI 10.1042/BJ20040892; Cantarel BL, 2009, NUCLEIC ACIDS RES, V37, pD233, DOI 10.1093/nar/gkn663; Chen VB, 2010, ACTA CRYSTALLOGR D, V66, P12, DOI 10.1107/S0907444909042073; Cho KH, 2001, J BACTERIOL, V183, P7224, DOI 10.1128/JB.183.24.7224-7230.2001; Ellrott K, 2010, PLOS COMPUT BIOL, V6, DOI 10.1371/journal.pcbi.1000798; Flint HJ, 2008, NAT REV MICROBIOL, V6, P121, DOI 10.1038/nrmicro1817; Guillen D, 2010, APPL MICROBIOL BIOT, V85, P1241, DOI 10.1007/s00253-009-2331-y; Holdeman L. V, 1977, ANAEROBE LAB MANUAL, V4th; HOLM L, 1995, TRENDS BIOCHEM SCI, V20, P478, DOI 10.1016/S0968-0004(00)89105-7; Janecek S, 2011, ENZYME MICROB TECH, V49, P429, DOI 10.1016/j.enzmictec.2011.07.002; Juge N, 2006, BBA-PROTEINS PROTEOM, V1764, P275, DOI 10.1016/j.bbapap.2005.11.008; Kitamura M, 2008, J BIOL CHEM, V283, P36328, DOI 10.1074/jbc.M806115200; Koropatkin NM, 2008, STRUCTURE, V16, P1105, DOI 10.1016/j.str.2008.03.017; Koropatkin NM, 2007, J BIOL CHEM, V282, P2606, DOI 10.1074/jbc.M610222200; Koropatkin NM, 2012, NAT REV MICROBIOL, V10, P323, DOI 10.1038/nrmicro2746; Koropatkin NM, 2010, STRUCTURE, V18, P200, DOI 10.1016/j.str.2009.12.010; Kovacs-Simon A, 2011, INFECT IMMUN, V79, P548, DOI 10.1128/IAI.00682-10; Latorre-Garcia L, 2005, J BIOTECHNOL, V118, P167, DOI 10.1016/j.jbiotec.2005.03.019; Ley RE, 2008, SCIENCE, V320, P1647, DOI 10.1126/science.1155725; Machovic M, 2006, CELL MOL LIFE SCI, V63, P2710, DOI 10.1007/s00018-006-6246-9; Martens EC, 2008, CELL HOST MICROBE, V4, P447, DOI 10.1016/j.chom.2008.09.007; Martens EC, 2011, PLOS BIOL, V9, DOI 10.1371/journal.pbio.1001221; Martens EC, 2009, J BIOL CHEM, V284, P24673, DOI 10.1074/jbc.R109.022848; Mccoy AJ, 2007, J APPL CRYSTALLOGR, V40, P658, DOI 10.1107/S0021889807021206; MCNEIL NI, 1984, AM J CLIN NUTR, V39, P338, DOI 10.1093/ajcn/39.2.338; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Penninga D, 1996, J BIOL CHEM, V271, P32777, DOI 10.1074/jbc.271.51.32777; Polekhina G, 2005, STRUCTURE, V13, P1453, DOI 10.1016/j.str.2005.07.008; Qin JJ, 2010, NATURE, V464, P59, DOI 10.1038/nature08821; Reeves AR, 1997, J BACTERIOL, V179, P643, DOI 10.1128/jb.179.3.643-649.1997; Roy A, 2010, NAT PROTOC, V5, P725, DOI 10.1038/nprot.2010.5; Shipman JA, 2000, J BACTERIOL, V182, P5365, DOI 10.1128/JB.182.19.5365-5372.2000; Sonnenburg ED, 2010, CELL, V141, P1241, DOI 10.1016/j.cell.2010.05.005; Sumitani J, 2000, BIOCHEM J, V350, P477, DOI 10.1042/0264-6021:3500477; Tan TC, 2008, J MOL BIOL, V378, P852, DOI 10.1016/j.jmb.2008.02.041; Turnbaugh PJ, 2006, NATURE, V444, P1027, DOI 10.1038/nature05414; van Bueren AL, 2007, NAT STRUCT MOL BIOL, V14, P76, DOI 10.1038/nsmb1187; van Bueren AL, 2011, STRUCTURE, V19, P640, DOI 10.1016/j.str.2011.03.001; VANDUYNE GD, 1993, J MOL BIOL, V229, P105, DOI 10.1006/jmbi.1993.1012; Xu J, 2003, SCIENCE, V299, P2074, DOI 10.1126/science.1080029; Zhang Y, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-40; Zwart Peter H., 2008, V426, P419, DOI 10.1007/978-1-60327-058-8_28	46	74	78	2	59	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 5	2012	287	41					34614	34625		10.1074/jbc.M112.397380	http://dx.doi.org/10.1074/jbc.M112.397380			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	018IS	22910908	Green Published, hybrid			2022-12-25	WOS:000309654200064
J	Haddad, D; Chen, CH; Carlin, S; Silberhumer, G; Chen, NG; Zhang, Q; Longo, V; Carpenter, SG; Mittra, A; Carson, J; Au, J; Gonen, M; Zanzonico, PB; Szalay, AA; Fong, YM				Haddad, Dana; Chen, Chun-Hao; Carlin, Sean; Silberhumer, Gerd; Chen, Nanhai G.; Zhang, Qian; Longo, Valerie; Carpenter, Susanne G.; Mittra, Arjun; Carson, Joshua; Au, Joyce; Gonen, Mithat; Zanzonico, Pat B.; Szalay, Aladar A.; Fong, Yuman			Imaging Characteristics, Tissue Distribution, and Spread of a Novel Oncolytic Vaccinia Virus Carrying the Human Sodium Iodide Symporter	PLOS ONE			English	Article							POSITRON-EMISSION-TOMOGRAPHY; ENGINEERED MEASLES-VIRUS; REPLICATING ADENOVIRUS; VIRAL THERAPY; GENE-THERAPY; NUDE-MICE; CANCER; RADIOVIROTHERAPY; MYELOMA; ERADICATION	Introduction: Oncolytic viruses show promise for treating cancer. However, to assess therapy and potential toxicity, a noninvasive imaging modality is needed. This study aims to determine the in vivo biodistribution, and imaging and timing characteristics of a vaccinia virus, GLV-1h153, encoding the human sodium iodide symporter (hNIS. Methods: GLV-1h153 was modified from GLV-1h68 to encode the hNIS gene. Timing of cellular uptake of radioiodide I-131 in human pancreatic carcinoma cells PANC-1 was assessed using radiouptake assays. Viral biodistribution was determined in nude mice bearing PANC-1 xenografts, and infection in tumors confirmed histologically and optically via Green Fluorescent Protein (GFP) and bioluminescence. Timing characteristics of enhanced radiouptake in xenografts were assessed via I-124-positron emission tomography (PET). Detection of systemic administration of virus was investigated with both I-124-PET and 99m-technecium gamma-scintigraphy. Results: GLV-1h153 successfully facilitated time-dependent intracellular uptake of I-131 in PANC-1 cells with a maximum uptake at 24 hours postinfection (P < 0.05). In vivo, biodistribution profiles revealed persistence of virus in tumors 5 weeks postinjection at 10(9) plaque-forming unit (PFU)/gm tissue, with the virus mainly cleared from all other major organs. Tumor infection by GLV-1h153 was confirmed via optical imaging and histology. GLV-1h153 facilitated imaging virus replication in tumors via PET even at 8 hours post radiotracer injection, with a mean % ID/gm of 3.82 +/- 60.46 (P < 0.05) 2 days after intratumoral administration of virus, confirmed via tissue radiouptake assays. One week post systemic administration, GLV1h153-infected tumors were detected via I-124-PET and 99m-technecium-scintigraphy. Conclusion: GLV-1h153 is a promising oncolytic agent against pancreatic cancer with a promising biosafety profile. GLV-1h153 facilitated time-dependent hNIS-specific radiouptake in pancreatic cancer cells, facilitating detection by PET with both intratumoral and systemic administration. Therefore, GLV-1h153 is a promising candidate for the noninvasive imaging of virotherapy and warrants further study into longterm monitoring of virotherapy and potential radiocombination therapies with this treatment and imaging modality.	[Haddad, Dana; Chen, Chun-Hao; Silberhumer, Gerd; Carpenter, Susanne G.; Mittra, Arjun; Carson, Joshua; Au, Joyce; Fong, Yuman] Mem Sloan Kettering Canc Ctr, Dept Surg, New York, NY 10021 USA; [Haddad, Dana; Szalay, Aladar A.] Univ Wurzburg, Dept Biochem, Wurzburg, Bavaria, Germany; [Carlin, Sean] Mem Sloan Kettering Canc Ctr, Dept Radiol, Radiopharmaceut Chem Serv, New York, NY 10021 USA; [Chen, Nanhai G.; Zhang, Qian; Szalay, Aladar A.] Genelux Corp, San Diego Sci Ctr, San Diego, CA USA; [Longo, Valerie; Zanzonico, Pat B.] Mem Sloan Kettering Canc Ctr, Dept Med Phys, New York, NY 10021 USA; [Gonen, Mithat] Mem Sloan Kettering Canc Ctr, Dept Epidemiol & Biostat, New York, NY 10021 USA; [Chen, Nanhai G.; Szalay, Aladar A.] Univ Calif San Diego, Dept Radiat Oncol, San Diego, CA 92103 USA	Memorial Sloan Kettering Cancer Center; University of Wurzburg; Memorial Sloan Kettering Cancer Center; Memorial Sloan Kettering Cancer Center; Memorial Sloan Kettering Cancer Center; University of California System; University of California San Diego	Haddad, D (corresponding author), Mem Sloan Kettering Canc Ctr, Dept Surg, 1275 York Ave, New York, NY 10021 USA.	aaszalay@genelux.com; fongy@mskcc.org	Gonen, Mithat/E-4826-2012	Gonen, Mithat/0000-0001-8683-8477; Haddad, Dana/0000-0002-8176-0102; Carlin, Sean/0000-0002-5401-0648	Genelux Corporation (Research & Development facility in San Diego, California, United States of America); University of Wuerzburg; Genelux Corporation and Memorial Sloan-Kettering Cancer Center	Genelux Corporation (Research & Development facility in San Diego, California, United States of America); University of Wuerzburg; Genelux Corporation and Memorial Sloan-Kettering Cancer Center	This work was supported by grants from Genelux Corporation (Research & Development facility in San Diego, California, United States of America). DH, visitor at Memorial Sloan-Kettering Cancer Center, is a graduate student in AAS's laboratory in the Department of Biochemistry and Graduate School of Life Sciences, University of Wurzburg, Germany, and is supported by a graduate stipend from The University of Wuerzburg as well as travel grants from Genelux Corporation and Memorial Sloan-Kettering Cancer Center. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adusumilli PS, 2007, ANN SURG ONCOL, V14, P258, DOI 10.1245/s10434-006-9127-4; Baker C. H., 2004, Current Drug Targets - Immune Endocrine and Metabolic Disorders, V4, P167, DOI 10.2174/1568008043339839; Barton KN, 2008, MOL THER, V16, P1761, DOI 10.1038/mt.2008.172; Blechacz B, 2006, HEPATOLOGY, V44, P1465, DOI 10.1002/hep.21437; Bruno R, 2004, J ENDOCRINOL INVEST, V27, P1010, DOI 10.1007/BF03345302; Carlson SK, 2009, AM J ROENTGENOL, V192, P279, DOI 10.2214/AJR.08.1205; CARRASCO N, 1993, BIOCHIM BIOPHYS ACTA, V1154, P65, DOI 10.1016/0304-4157(93)90017-I; Chen NH, 2009, MOL MED, V15, P144, DOI 10.2119/molmed.2009.00014; Chen NG, 2010, FUTURE VIROL, V5, P763, DOI 10.2217/FVL.10.58; Dingli D, 2004, BLOOD, V103, P1641, DOI 10.1182/blood-2003-07-2233; FENNER F, 1989, RES VIROLOGY, V140, P465, DOI 10.1016/S0923-2516(89)80126-8; Fenner F, 1989, RES VIROLOGY, V140, P487; Galasso D, 2010, EUR REV MED PHARMACO, V14, P375; Gentschev I, 2009, CANCER GENE THER, V16, P320, DOI 10.1038/cgt.2008.87; Gentschev I, 2010, J ONCOL, V2010, DOI 10.1155/2010/736907; Goel A, 2007, BLOOD, V110, P2342, DOI 10.1182/blood-2007-01-065573; Haddad D, 2011, J TRANSL MED, V9, DOI 10.1186/1479-5876-9-36; Hasegawa K, 2006, CLIN CANCER RES, V12, P1868, DOI 10.1158/1078-0432.CCR-05-1803; Hingorani M, 2010, CURR CANCER DRUG TAR, V10, P242, DOI 10.2174/156800910791054194; Jezek Z, 1988, HUMAN MONKEYPOX; Kelly KJ, 2008, HUM GENE THER, V19, P774, DOI 10.1089/hum.2008.036; Kelly KJ, 2009, INT J CANCER, V124, P911, DOI 10.1002/ijc.24037; Kuruppu D, 2007, CANCER RES, V67, P3295, DOI 10.1158/0008-5472.CAN-06-4062; Lin SF, 2007, SURGERY, V142, P976, DOI 10.1016/j.surg.2007.09.017; Lin SF, 2008, J CLIN ENDOCR METAB, V93, P4403, DOI 10.1210/jc.2008-0316; Liu CS, 2010, MOL THER, V18, P1155, DOI 10.1038/mt.2010.43; Merron A, 2007, GENE THER, V14, P1731, DOI 10.1038/sj.gt.3303043; Moss B., 2001, POXVIRIDAE VIRUSES T; Msaouel P, 2009, MOL THER, V17, P2041, DOI 10.1038/mt.2009.218; Peerlinck I, 2009, CLIN CANCER RES, V15, P6595, DOI 10.1158/1078-0432.CCR-09-0262; Penheiter AR, 2010, AM J ROENTGENOL, V195, P341, DOI 10.2214/AJR.09.3672; Schmidt FI, 2012, CURR OPIN VIROL, V2, P20, DOI 10.1016/j.coviro.2011.11.007; Serganova I, 2005, NUCL MED BIOL, V32, P763, DOI 10.1016/j.nucmedbio.2005.05.008; Serganova I, 2007, NUCL MED BIOL, V34, P791, DOI 10.1016/j.nucmedbio.2007.05.009; Squadroni M, 2010, EUR REV MED PHARMACO, V14, P386; Thorne SH, 2005, CURR OPIN MOL THER, V7, P359; Thorne SH, 2005, CURR GENE THER, V5, P429, DOI 10.2174/1566523054546215; Thorne SH, 2008, CURR OPIN MOL THER, V10, P387; Thorne Steve H., 2009, V542, P635, DOI 10.1007/978-1-59745-561-9_32; Trujillo MA, 2009, BREAST CANCER RES, V11, DOI 10.1186/bcr2342; Vaha-Koskela MJV, 2007, CANCER LETT, V254, P178, DOI 10.1016/j.canlet.2007.02.002; Westfall P.H., 1993, RESAMPLING BASED MUL, V279; Yu YA, 2009, MOL CANCER THER, V8, P141, DOI 10.1158/1535-7163.MCT-08-0533; Zanzonico P, 2004, SEMIN NUCL MED, V34, P87, DOI 10.1053/j.semnuclmed.2003.12.002; Zanzonico P, 1995, CLIN SPECT IMAGING, P7; Zanzonico PB, 2000, J NUCL MED, V41, P297; Zanzonico PB, 1995, PRINCIPLES NUCL MED, V2nd, P106; Zhang Q, 2007, CANCER RES, V67, P10038, DOI 10.1158/0008-5472.CAN-07-0146	48	21	27	0	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 17	2012	7	8							e41647	10.1371/journal.pone.0041647	http://dx.doi.org/10.1371/journal.pone.0041647			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	996DG	22912675	Green Published, Green Submitted, gold			2022-12-25	WOS:000308063700005
J	Kua, LF; Ross, S; Lee, SC; Mimura, K; Kono, K; Goh, BC; Yong, WP				Kua, Ley-Fang; Ross, Soo; Lee, Soo-Chin; Mimura, Kousaku; Kono, Koji; Goh, Boon-Cher; Yong, Wei-Peng			UGT1A6 Polymorphisms Modulated Lung Cancer Risk in a Chinese Population	PLOS ONE			English	Article							HARDY-WEINBERG EQUILIBRIUM; UDP-GLUCURONOSYLTRANSFERASE; CIGARETTE-SMOKING; GENETIC POLYMORPHISMS; 1A6 PHARMACOGENETICS; BRONCHIAL EPITHELIUM; TOTAL EXPOSURE; BREAST-CANCER; ASSOCIATION; UGT1A1-ASTERISK-28	Uridine diphosphoglucuronosyltransferases (UGTs) 1A6 is the only UGT1A isoform expressed in lung tissue. It is responsible for the detoxification of carcinogens such as benezo[a]pyrene from cigarette smoke. The purpose of this study was to evaluate the association of UGT1A6 polymorphisms and haplotypes with lung cancer risk and to evaluate the functional significance of UGT1A6 polymorphisms. Genomic DNA was isolated from leukocytes. Eight UGT1A6 polymorphisms were sequenced in a test set of 72 Chinese lung cancer patients and 62 healthy controls. Potential risk modifying alleles were validated in a separate set of 95 Chinese lung cancer patients and 100 healthy controls. UGT1A6 19T>G, 541A>G and 552A>C showed significant association with increased lung cancer risk, while UGT1A6 105C>T and IVS1+130G>T were significantly associated with reduced lung cancer risk. Multivariate logistic regression analysis demonstrated a significant association of lung cancer with UGT1A6 541A>G (OR: 3.582, 95% CI: 1.27-10.04, p = 0.015), 552A>C (OR: 5.364, 95% CI: 1.92-14.96, p = 0.001) and IVS1+130G>T (OR: 0.191, 95% CI: 0.09-0.36, p<0.001). Functional test demonstrated that UGT1A6 105C>T increased mRNA stability, providing a plausible explanation of its association with reduced lung cancer risk. Thus UGT1A6 polymorphisms may be used to identify people with increased risk of developing lung cancer.	[Kua, Ley-Fang; Ross, Soo; Lee, Soo-Chin; Goh, Boon-Cher; Yong, Wei-Peng] Natl Univ Singapore, Canc Inst Singapore, Dept Haematol Oncol, Singapore 117548, Singapore; [Ross, Soo; Lee, Soo-Chin; Kono, Koji; Goh, Boon-Cher; Yong, Wei-Peng] Natl Univ Singapore, Canc Sci Inst Singapore, Singapore 117548, Singapore; [Mimura, Kousaku; Kono, Koji] Natl Univ Singapore, Dept Sugery, Yong Loo Lin Sch Med, Singapore 117548, Singapore	National University of Singapore; National University of Singapore; National University of Singapore	Kua, LF (corresponding author), Natl Univ Singapore, Canc Inst Singapore, Dept Haematol Oncol, Singapore 117548, Singapore.	wei_peng_yong@nuhs.edu.sg	Lee, Soo Chin/S-9111-2016; Yong, Wei-Peng/Y-7260-2018	Lee, Soo Chin/0000-0002-5835-6419; Yong, Wei-Peng/0000-0003-4404-3777; Goh, Boon Cher/0000-0002-4107-102X	National Healthcare Group (Singapore) [NHG-SIG/06007]	National Healthcare Group (Singapore)	This work was supported by the National Healthcare Group (Singapore) small innovative grant [NHG-SIG/06007]. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Araki J, 2005, EUR J CANCER, V41, P2360, DOI 10.1016/j.ejca.2005.04.043; AUERBACH O, 1961, NEW ENGL J MED, V265, P253, DOI 10.1056/NEJM196108102650601; AUERBACH O, 1957, NEW ENGL J MED, V256, P97, DOI 10.1056/NEJM195701172560301; Chan AT, 2005, JNCI-J NATL CANCER I, V97, P457, DOI 10.1093/jnci/dji066; Ciotti M, 1997, PHARMACOGENETICS, V7, P485, DOI 10.1097/00008571-199712000-00007; Denissenko MF, 1996, SCIENCE, V274, P430, DOI 10.1126/science.274.5286.430; Fang JL, 2004, CANCER EPIDEM BIOMAR, V13, P102, DOI 10.1158/1055-9965.EPI-03-0070; Fang JL, 2002, CANCER RES, V62, P1978; Gallagher CJ, 2007, CANCER EPIDEM BIOMAR, V16, P823, DOI 10.1158/1055-9965.EPI-06-0823; GSCHAIDMEIER H, 1995, BIOCHEM PHARMACOL, V49, P1601, DOI 10.1016/0006-2952(95)00095-H; Guillemette C, 2000, CANCER RES, V60, P950; Guillemette C, 2001, CANCER EPIDEM BIOMAR, V10, P711; Hecht SS, 1999, JNCI-J NATL CANCER I, V91, P1194, DOI 10.1093/jnci/91.14.1194; HOFFMANN D, 1995, J NATL CANCER I, V87, P1862, DOI 10.1093/jnci/87.24.1862; HOFFMANN D, 1987, JNCI-J NATL CANCER I, V79, P1281; Hosking L, 2004, EUR J HUM GENET, V12, P395, DOI 10.1038/sj.ejhg.5201164; Izukawa T, 2009, DRUG METAB DISPOS, V37, P1759, DOI 10.1124/dmd.109.027227; JIN CJ, 1993, CARCINOGENESIS, V14, P2637, DOI 10.1093/carcin/14.12.2637; Kohle C, 2003, BIOCHEM PHARMACOL, V65, P1521, DOI 10.1016/S0006-2952(03)00074-1; Krishnaswamy S, 2005, J PHARMACOL EXP THER, V313, P1331, DOI 10.1124/jpet.104.081950; Krishnaswamy S, 2005, J PHARMACOL EXP THER, V313, P1340, DOI 10.1124/jpet.104.081968; Krishnaswamy S, 2004, DRUG METAB DISPOS, V32, P862, DOI 10.1124/dmd.32.8.862; Krishnaswamy S, 2003, DRUG METAB DISPOS, V31, P133, DOI 10.1124/dmd.31.1.133; Lampe JW, 1999, PHARMACOGENETICS, V9, P341, DOI 10.1097/00008571-199906000-00009; Lubin JH, 2007, EPIDEMIOLOGY, V18, P639, DOI 10.1097/EDE.0b013e31812717fe; Lubin JH, 2006, CANCER EPIDEM BIOMAR, V15, P517, DOI 10.1158/1055-9965.EPI-05-0863; MACKENZIE PI, 1993, CANCER RES, V53, P1529; Nagar S, 2004, PHARMACOGENETICS, V14, P487, DOI 10.1097/01.fpc.0000114771.78957.cb; Pacheco PR, 2009, MOL DIAGN THER, V13, P261, DOI 10.2165/11317170-000000000-00000; Richie JP, 1997, CANCER EPIDEM BIOMAR, V6, P783; Saeki M, 2006, PHARMACOGENOMICS J, V6, P63, DOI 10.1038/sj.tpj.6500335; Saeki Mayumi, 2005, Drug Metab Pharmacokinet, V20, P85, DOI 10.2133/dmpk.20.85; SHIELDS PG, 1993, CANCER RES, V53, P3486; Swauger JE, 2002, REGUL TOXICOL PHARM, V35, P142, DOI 10.1006/rtph.2001.1521; Xu JF, 2002, HUM GENET, V111, P573, DOI 10.1007/s00439-002-0819-y; Yea SS, 2008, THER DRUG MONIT, V30, P23, DOI 10.1097/FTD.0b013e3181633824; Zhang W, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000396; Zheng Z, 2001, JNCI-J NATL CANCER I, V93, P1411, DOI 10.1093/jnci/93.18.1411	38	15	17	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 17	2012	7	8							e42873	10.1371/journal.pone.0042873	http://dx.doi.org/10.1371/journal.pone.0042873			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	996DG	22912755	Green Submitted, gold, Green Published			2022-12-25	WOS:000308063700027
J	Oblessuc, PR; Borges, A; Chowdhury, B; Caldas, DGG; Tsai, SM; Camargo, LEA; Melotto, M				Oblessuc, Paula Rodrigues; Borges, Aline; Chowdhury, Bablu; Gomes Caldas, Danielle Gregorio; Tsai, Siu Mui; Aranha Camargo, Luis Eduardo; Melotto, Maeli			Dissecting Phaseolus vulgaris Innate Immune System against Colletotrichum lindemuthianum Infection	PLOS ONE			English	Article							PHENYLALANINE AMMONIA-LYASE; ANTHRACNOSE RESISTANCE; DISEASE RESISTANCE; DEFENSE RESPONSES; MESSENGER-RNA; HOST-DEFENSE; COMMON; GENE; PROTEINS; LOCUS	Background: The genus Colletotrichum is one of the most economically important plant pathogens, causing anthracnose on a wide range of crops including common beans (Phaseolus vulgaris L.). Crop yield can be dramatically decreased depending on the plant cultivar used and the environmental conditions. This study aimed to identify potential genetic components of the bean immune system to provide environmentally friendly control measures against this fungus. Methodology and Principal Findings: As the common bean is not amenable to reverse genetics to explore functionality and its genome is not fully curated, we used putative Arabidopsis orthologs of bean expressed sequence tag (EST) to perform bioinformatic analysis and experimental validation of gene expression to identify common bean genes regulated during the incompatible interaction with C. lindemuthianum. Similar to model pathosystems, Gene Ontology (GO) analysis indicated that hormone biosynthesis and signaling in common beans seem to be modulated by fungus infection. For instance, cytokinin and ethylene responses were up-regulated and jasmonic acid, gibberellin, and abscisic acid responses were down-regulated, indicating that these hormones may play a central role in this pathosystem. Importantly, we have identified putative bean gene orthologs of Arabidopsis genes involved in the plant immune system. Based on experimental validation of gene expression, we propose that hypersensitive reaction as part of effector-triggered immunity may operate, at least in part, by down-regulating genes, such as FLS2-like and MKK5-like, putative orthologs of the Arabidopsis genes involved in pathogen perception and downstream signaling. Conclusions/Significance: We have identified specific bean genes and uncovered metabolic processes and pathways that may be involved in the immune response against pathogens. Our transcriptome database is a rich resource for mining novel defense-related genes, which enabled us to develop a model of the molecular components of the bean innate immune system regulated upon pathogen attack.	[Oblessuc, Paula Rodrigues; Chowdhury, Bablu; Melotto, Maeli] Univ Texas Arlington, Dept Biol, Arlington, TX 76019 USA; [Borges, Aline; Gomes Caldas, Danielle Gregorio; Tsai, Siu Mui] Univ Sao Paulo, CENA, Piracicaba, SP, Brazil; [Aranha Camargo, Luis Eduardo] Univ Sao Paulo, ESALQ, Dept Fitopatol, Piracicaba, SP, Brazil	University of Texas System; University of Texas Arlington; Universidade de Sao Paulo; Universidade de Sao Paulo	Oblessuc, PR (corresponding author), Univ Texas Arlington, Dept Biol, Arlington, TX 76019 USA.	melotto@uta.edu	Camargo, Luis Eduardo Aranha/Y-9954-2019; Tsai, Siu Mui/C-2793-2012; Caldas, Danielle/D-5685-2012; Oblessuc, Paula Rodrigues/AAJ-7755-2020; Oblessuc, Paula R/M-1184-2016; Camargo, Luis Eduardo A/C-2735-2012	Camargo, Luis Eduardo Aranha/0000-0002-5650-5695; Tsai, Siu Mui/0000-0002-3733-6312; Oblessuc, Paula Rodrigues/0000-0002-4977-3317; Oblessuc, Paula R/0000-0002-4977-3317; Camargo, Luis Eduardo A/0000-0002-5650-5695; Melotto, Maeli/0000-0001-6021-9803	University of Texas at Arlington	University of Texas at Arlington	This study was supported in part by The University of Texas at Arlington startup funds to MM. No additional external funding received for this study. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abid G, 2011, PLANT CELL TISS ORG, V107, P341, DOI 10.1007/s11240-011-9986-7; Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389; Alvarado-Gutierrez A, 2008, PHYSIOL MOL PLANT P, V72, P111, DOI 10.1016/j.pmpp.2008.04.005; Aoki KF, 2005, CURR PROTOC BIOINFOR, V1, P1; Arnold DL, 2011, MOL PLANT PATHOL, V12, P617, DOI [10.1111/j.1364-3703.2010.00697.x, 10.1111/J.1364-3703.2010.00697.X]; Astier J, 2011, ANN PLANT REV NITROG, P147; Azaiez A, 2009, MOL PLANT MICROBE IN, V22, P190, DOI 10.1094/MPMI-22-2-0190; Bailey J. A., 1992, Colletotrichum: biology, pathology and control., P88; Balardin RS, 1998, J AM SOC HORTIC SCI, V123, P1038, DOI 10.21273/JASHS.123.6.1038; Blair MW, 2011, PLANT GENOME-US, V4, P204, DOI 10.3835/plantgenome2011.02.0093; Blair MW, 2011, BMC PLANT BIOL, V11, DOI 10.1186/1471-2229-11-171; Bolwell GP, 2002, J EXP BOT, V53, P1367, DOI 10.1093/jexbot/53.372.1367; BOLWELL GP, 1985, EUR J BIOCHEM, V149, P411, DOI 10.1111/j.1432-1033.1985.tb08941.x; Borges A, 2012, PLANT CELL REP, V31, P827, DOI 10.1007/s00299-011-1204-x; Boudart G, 1998, PLANTA, V206, P86, DOI 10.1007/s004250050377; Broughton WJ, 2003, PLANT SOIL, V252, P55, DOI 10.1023/A:1024146710611; Clough SJ, 2000, P NATL ACAD SCI USA, V97, P9323, DOI 10.1073/pnas.150005697; Conesa Ana, 2008, Int J Plant Genomics, V2008, P619832, DOI 10.1155/2008/619832; D'Ovidio R, 2004, PLANT PHYSIOL, V135, P2424, DOI 10.1104/pp.104.044644; David P, 2008, MOL GENET GENOMICS, V280, P521, DOI 10.1007/s00438-008-0384-8; David P, 2010, THEOR APPL GENET, V121, P87, DOI 10.1007/s00122-010-1293-x; Dean R, 2012, MOL PLANT PATHOL, V13, P414, DOI 10.1111/j.1364-3703.2011.00783.x; Dodds PN, 2010, NAT REV GENET, V11, P539, DOI 10.1038/nrg2812; Du Z, 2010, NUCLEIC ACIDS RES, V38, pW64, DOI 10.1093/nar/gkq310; Dufresne M, 2000, PLANT CELL, V12, P1579, DOI 10.1105/tpc.12.9.1579; EDWARDS K, 1985, P NATL ACAD SCI USA, V82, P6731, DOI 10.1073/pnas.82.20.6731; Eulgem T, 2005, TRENDS PLANT SCI, V10, P71, DOI 10.1016/j.tplants.2004.12.006; Ferreira RB, 2007, MOL PLANT PATHOL, V8, P677, DOI [10.1111/j.1364-3703.2007.00419.x, 10.1111/J.1364-3703.2007.00419.X]; Ferrier-Cana E, 2003, THEOR APPL GENET, V106, P251, DOI 10.1007/s00122-002-1032-z; Fisher Ronald A., 1973, STAT METHODS SCI INF; FLOR HH, 1971, ANNU REV PHYTOPATHOL, V9, P275, DOI 10.1146/annurev.py.09.090171.001423; Fraire-Velazquez S, 2003, PHYSIOL MOL PLANT P, V63, P79, DOI 10.1016/j.pmpp.2003.10.004; Garcia RAV, 2011, BMC GENET, V12, DOI 10.1186/1471-2156-12-41; Geffroy V, 1998, THEOR APPL GENET, V96, P494, DOI 10.1007/s001220050766; Geffroy V, 2008, THEOR APPL GENET, V116, P407, DOI 10.1007/s00122-007-0678-y; Geffroy V, 2009, GENETICS, V181, P405, DOI 10.1534/genetics.108.093583; Gibertia S, 2011, J PLANT PHYSL, V169, P249; Hanai LR, 2010, MOL BREEDING, V25, P25, DOI 10.1007/s11032-009-9306-7; Heath MC, 2000, PLANT MOL BIOL, V44, P321, DOI 10.1023/A:1026592509060; Hruz Tomas, 2008, Advances in Bioinformatics, V2008, P420747, DOI 10.1155/2008/420747; Huckelhoven R, 2007, ANNU REV PHYTOPATHOL, V45, P101, DOI 10.1146/annurev.phyto.45.062806.094325; Jones JDG, 2006, NATURE, V444, P323, DOI 10.1038/nature05286; Knogge W, 2009, MYCOTA, P337; LatundeDada AO, 1996, MYCOL RES, V100, P1133, DOI 10.1016/S0953-7562(96)80226-7; Laurie-Berry N, 2006, MOL PLANT MICROBE IN, V19, P789, DOI 10.1094/MPMI-19-0789; Lopes DB, 2001, PHYTOPATHOLOGY, V91, P212, DOI 10.1094/PHYTO.2001.91.2.212; Lopez CE, 2003, PHYTOPATHOLOGY, V93, P88, DOI 10.1094/PHYTO.2003.93.1.88; MAHE A, 1993, MOL PLANT MICROBE IN, V6, P423, DOI 10.1094/MPMI-6-423; Masoudi-Nejad A, 2007, PLANT PHYSIOL, V144, P857, DOI 10.1104/pp.106.095059; McConnell M, 2010, THEOR APPL GENET, V121, P1103, DOI 10.1007/s00122-010-1375-9; Melotto M, 2000, EUPHYTICA, V116, P143, DOI 10.1023/A:1004005001049; Melotto M, 2005, GENOME, V48, P562, DOI 10.1139/G05-010; Melotto M, 2004, THEOR APPL GENET, V109, P690, DOI 10.1007/s00122-004-1697-6; Melotto M, 2000, COLLETOTRICHUM, P346; Melotto M, 2001, THEOR APPL GENET, V103, P508, DOI 10.1007/s001220100609; Melotto M, 2012, PROKARYOTES IN PRESS; Membre N, 2000, PLANTA, V211, P345, DOI 10.1007/s004250000277; Mohammed Yesuf, 2007, Tropical Science, V47, P96, DOI 10.1002/ts.202; Mysore KS, 2002, PLANT J, V32, P299, DOI 10.1046/j.1365-313X.2002.01424.x; Nanda AK, 2010, J INTEGR PLANT BIOL, V52, P195, DOI 10.1111/j.1744-7909.2010.00933.x; Nomura K, 2005, CURR OPIN PLANT BIOL, V8, P361, DOI 10.1016/j.pbi.2005.05.005; Nuss L, 1996, PHYSIOL MOL PLANT P, V48, P83, DOI 10.1006/pmpp.1996.0008; OCONNELL RJ, 1985, PHYSIOL PLANT PATHOL, V27, P75, DOI 10.1016/0048-4059(85)90058-X; Park CJ, 2004, PLANTA, V219, P797, DOI 10.1007/s00425-004-1290-x; Pastor-Corrales M.A., 1989, BEAN PRODUCTION PROB, P77; Pfaffl MW, 2002, NUCLEIC ACIDS RES, V30, DOI 10.1093/nar/30.9.e36; Pinto JMA, 2012, PHYTOPATHOLOGY, V102, P490, DOI 10.1094/PHYTO-06-11-0179; Ramakers C, 2003, NEUROSCI LETT, V339, P62, DOI 10.1016/S0304-3940(02)01423-4; Ramirez M, 2005, PLANT PHYSIOL, V137, P1211, DOI 10.1104/pp.104.054999; Santner A, 2010, PLANT J, V61, P1029, DOI 10.1111/j.1365-313X.2010.04112.x; SKIPP RA, 1972, PHYSIOL PLANT PATHOL, V2, P357, DOI 10.1016/S0048-4059(72)80007-9; Tavernier V, 2007, J EXP BOT, V58, P3351, DOI 10.1093/jxb/erm182; Thibivilliers S, 2009, BMC PLANT BIOL, V9, DOI 10.1186/1471-2229-9-46; Thimm O, 2004, PLANT J, V37, P914, DOI 10.1111/j.1365-313X.2004.02016.x; Vallad G, 2001, THEOR APPL GENET, V103, P1046, DOI 10.1007/s001220100705; van Loon LC, 2006, ANNU REV PHYTOPATHOL, V44, P135, DOI 10.1146/annurev.phyto.44.070505.143425; Van Zhong G, 2003, PLANT MOL BIOL, V53, P117, DOI 10.1023/B:PLAN.0000009270.81977.ef; WALTER MH, 1990, MOL GEN GENET, V222, P353, DOI 10.1007/BF00633840; Woo EJ, 2000, NAT STRUCT BIOL, V7, P1036; Young RA, 1998, THEOR APPL GENET, V96, P87, DOI 10.1007/s001220050713; Zhao YF, 2003, PLANT J, V36, P485, DOI 10.1046/j.1365-313X.2003.01895.x; Zhou LC, 2012, OMICS, V16, P208, DOI 10.1089/omi.2011.0111	82	21	21	0	45	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 17	2012	7	8							e43161	10.1371/journal.pone.0043161	http://dx.doi.org/10.1371/journal.pone.0043161			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	996DG	22912818	Green Published, Green Submitted, gold			2022-12-25	WOS:000308063700054
J	Gu, LL; Musiienko, V; Bai, ZJ; Qin, AJ; Schneller, SW; Li, QJ				Gu, Linlin; Musiienko, Volodymyr; Bai, Zhijun; Qin, Aijian; Schneller, Stewart W.; Li, Qianjun			Novel Virostatic Agents against Bluetongue Virus	PLOS ONE			English	Article							SEROTYPE 8; INFECTIOUS-DISEASES; MEDITERRANEAN BASIN; MAMMALIAN-CELLS; AUTOPHAGY; REPLICATION; APOPTOSIS; MACHINERY; PROTEINS; EUROPE	Bluetongue virus (BTV), a member in the family Reoviridae, is a re-emerging animal disease infecting cattle and sheep. With its recent outbreaks in Europe, there is a pressing need for efficacious antivirals. We presented here the identification and characterization of a novel virostatic molecule against BTV, an aminothiophenecarboxylic acid derivative named compound 003 (C003). The virostatic efficacy of C003 could be improved via chemical modification, leading to a de novo synthesized compound 052 (C052). The 50% effective concentrations (EC50) of C003 and C052 were determined at 1.76 +/- 0.73 mu M and 0.27 +/- 0.12 mu M, respectively. The 50% cytotoxicity concentration (CC50) of C003 was over 100 mu M and the CC50 of C052 was at 82.69 mu M. Accordingly, the 50% selective index (SI50) of C003 and C052 against BTV was over 57 and 306, respectively. The inhibitory effect of C003/C052 on BTV-induced apoptosis was also confirmed via the inhibition of caspase-3/-7 activation post BTV infection. C003/C052 could inhibit BTV induced CPE even when added as late as 24 h.p.i., indicating that they might act at late stage of viral life-cycle. C003/C052 could reduce over two-logs of both the progeny virus production and the number of genomic viral RNA copies. Interestingly, both the activation of host autophagy and viral protein expression were inhibited post BTV infection when cells were treated with C003 and C052, suggesting that C003/C052 might act as virostatic agents via inhibiting host autophagy activation. Although further investigations might be needed to pin down the exact mechanism of C003/C052, our finding suggested that these compounds might be potent lead compounds with potential novel mechanism of action against BTV.	[Gu, Linlin; Qin, Aijian] Yangzhou Univ, Jiangsu Key Lab Prevent Vet Med, Yangzhou, Peoples R China; [Gu, Linlin; Bai, Zhijun; Li, Qianjun] Univ Alabama Birmingham, Dept Med, Div Infect Dis, Birmingham, AL 35294 USA; [Musiienko, Volodymyr; Schneller, Stewart W.] Auburn Univ, Dept Chem & Biochem, Molette Lab Drug Discovery, Auburn, AL 36849 USA; [Bai, Zhijun] Guangzhou Ctr Dis Control & Prevent, Guangzhou, Guangdong, Peoples R China	Yangzhou University; University of Alabama System; University of Alabama Birmingham; Auburn University System; Auburn University	Gu, LL (corresponding author), Yangzhou Univ, Jiangsu Key Lab Prevent Vet Med, Yangzhou, Peoples R China.	liq@uab.edu			NIH [1R03MH08127-01, 7R03MH08127-02]; IMPACT funds from Department of Medicine at University of Alabama	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); IMPACT funds from Department of Medicine at University of Alabama	This project was supported by grant 1R03MH08127-01 and 7R03MH08127-02 from NIH to Q. Li, and by the IMPACT funds from Department of Medicine at University of Alabama to Q. Li. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bartram DJ, 2011, VET J; Berkova Z, 2006, J VIROL, V80, P6061, DOI 10.1128/JVI.02167-05; Bhanuprakash V, 2009, EXPERT REV VACCINES, V8, P191, DOI 10.1586/14760584.8.2.191; Boyce M, 2008, J VIROL, V82, P8339, DOI 10.1128/JVI.00808-08; Boyce M, 2007, J VIROL, V81, P2179, DOI 10.1128/JVI.01819-06; Buchholz UJ, 1999, J VIROL, V73, P251, DOI 10.1128/JVI.73.1.251-259.1999; Celma CCP, 2009, J VIROL, V83, P6806, DOI 10.1128/JVI.00263-09; Cherra SJ, 2010, NEUROPATH APPL NEURO, V36, P125, DOI [10.1111/j.1365-2990.2009.01062.x, 10.1111/j.1365-2990.2010.01062.x]; Clarke TE, 2003, INT REV IMMUNOL, V22, P401, DOI 10.1080/08830180305215; De A, 2009, VET ITAL, V45, P339; Dreux M, CELL CYCLE, V9, P1295; Dreux M, 2009, AUTOPHAGY, V5, P1224, DOI 10.4161/auto.5.8.10219; Dreux M, 2009, P NATL ACAD SCI USA, V106, P14046, DOI 10.1073/pnas.0907344106; Dungu B, 2004, DEV BIOLOGICALS, V119, P463; El-Batta A, 2007, J ORG CHEM, V72, P5244, DOI 10.1021/jo070665k; Enserink M, 2006, SCIENCE, V313, P1218; Everett H, 1999, TRENDS MICROBIOL, V7, P160, DOI 10.1016/S0966-842X(99)01487-0; Fimia GM, 2009, CELL DEATH DIFFER, V16, P933, DOI 10.1038/cdd.2009.47; Forzan M, 2007, J VIROL, V81, P4819, DOI 10.1128/JVI.02284-06; Gougeon ML, 2009, APOPTOSIS, V14, P501, DOI 10.1007/s10495-009-0314-1; Hamers C, 2009, VET REC, V165, P369, DOI 10.1136/vr.165.13.369; Harty RN, 2009, ANTIVIR RES, V81, P189, DOI 10.1016/j.antiviral.2008.12.003; HAYDEN FG, 1980, ANTIMICROB AGENTS CH, V17, P865, DOI 10.1128/AAC.17.5.865; Heaton NS, 2010, CELL HOST MICROBE, V8, P422, DOI 10.1016/j.chom.2010.10.006; Hyser JM, J VIROL, V86, P4921; Jackson WT, 2005, PLOS BIOL, V3, P861, DOI 10.1371/journal.pbio.0030156; Jonsson CB, 2007, EUROPEAN PHARM REV, P4; Kar AK, 2003, J VIROL, V77, P11347, DOI 10.1128/JVI.77.21.11347-11356.2003; Khakpoor A, 2009, J GEN VIROL, V90, P1093, DOI 10.1099/vir.0.007914-0; Koyama A. Hajime, 1998, Journal of Medical Investigation, V45, P37; Landry ML, 2000, ANTIMICROB AGENTS CH, V44, P688, DOI 10.1128/AAC.44.3.688-692.2000; Larsen KE, 2002, HISTOL HISTOPATHOL, V17, P897, DOI 10.14670/HH-17.897; Law AHY, 2010, CELL MOL IMMUNOL, V7, P263, DOI 10.1038/cmi.2010.25; Lee YR, 2008, VIROLOGY, V374, P240, DOI 10.1016/j.virol.2008.02.016; Li Q, 2007, INSECT MOL BIOL, V16, P93, DOI 10.1111/j.1365-2583.2007.00705.x; Li QJ, 2009, ANTIVIR RES, V83, P267, DOI 10.1016/j.antiviral.2009.06.004; Maclachlan NJ, 2009, J COMP PATHOL, V141, P1, DOI 10.1016/j.jcpa.2009.04.003; MacLachlan NJ, 2000, ANIM REPROD SCI, V60, P643, DOI 10.1016/S0378-4320(00)00105-6; Matsuo E, 2009, J VIROL, V83, P8842, DOI 10.1128/JVI.00465-09; Mehlhorn H, 2008, PARASITOL RES, V103, pS79, DOI 10.1007/s00436-008-1100-7; Mehlhorn H, 2009, PARASITOL RES, V105, P313, DOI 10.1007/s00436-009-1416-y; Meiswinkel R, 2008, PREV VET MED, V87, P182, DOI 10.1016/j.prevetmed.2008.06.008; Mellor PS, 2008, PREV VET MED, V87, P4, DOI 10.1016/j.prevetmed.2008.06.002; Mellor PS, 2002, VET J, V164, P20, DOI 10.1053/tvjl.2002.0713; Meroc E, 2009, TRANSBOUND EMERG DIS, V56, P39, DOI 10.1111/j.1865-1682.2008.01063.x; Mertens P P C, 2004, Vet Ital, V40, P426; MERTENS PPC, 1987, VIROLOGY, V157, P375, DOI 10.1016/0042-6822(87)90280-7; Mortola E, 2004, J VIROL, V78, P2875, DOI 10.1128/JVI.78.6.2875-2883.2004; Mortola E, 2009, REV ARGENT MICROBIOL, V41, P134; Nagaleekar VK, 2007, ARCH VIROL, V152, P1751, DOI 10.1007/s00705-007-0988-z; Noah JW, 2007, ANTIVIR RES, V73, P50, DOI 10.1016/j.antiviral.2006.07.006; Orvedahl A, 2009, CELL DEATH DIFFER, V16, P57, DOI 10.1038/cdd.2008.130; Panyasrivanit M, 2009, J GEN VIROL, V90, P448, DOI 10.1099/vir.0.005355-0; Paweska JT, 2002, MED VET ENTOMOL, V16, P10, DOI 10.1046/j.1365-2915.2002.00334.x; Phillips T, 2011, J VIROL METHODS, V173, P182, DOI 10.1016/j.jviromet.2011.02.002; Prentice E, 2004, J BIOL CHEM, V279, P10136, DOI 10.1074/jbc.M306124200; Rossman JS, 2009, CELL HOST MICROBE, V6, P299, DOI 10.1016/j.chom.2009.09.009; Roy P, 2006, CURR TOP MICROBIOL, V309, P87; Roy P, 2005, ADV VIRUS RES, V64, P69, DOI 10.1016/S0065-3527(05)64004-3; Roy P, 2008, J GEN VIROL, V89, P1789, DOI 10.1099/vir.0.2008/002089-0; Roy P, 2008, CELL BIOCHEM BIOPHYS, V50, P143, DOI 10.1007/s12013-008-9009-4; Sabnis RW, 1999, J HETEROCYCLIC CHEM, V36, P333, DOI 10.1002/jhet.5570360203; Saegerman C, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009405; Santman-Berends IMGA, 2010, THERIOGENOLOGY, V74, P1377, DOI 10.1016/j.theriogenology.2010.06.008; Schwartz-Cornil I, 2008, VET RES, V39, DOI 10.1051/vetres:2008023; Singletary K, 2008, CANCER EPIDEM BIOMAR, V17, P1596, DOI 10.1158/1055-9965.EPI-07-2917; Stauber N, 1997, J VIROL, V71, P7220; Stewart ME, 2010, VIROL J, V7, DOI 10.1186/1743-422X-7-362; Szmaragd C, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009353; Touchard FP, 2004, TETRAHEDRON LETT, V45, P5519, DOI 10.1016/j.tetlet.2004.05.026; Toussaint JF, 2007, J VIROL METHODS, V140, P115, DOI 10.1016/j.jviromet.2006.11.007; Vandenbussche F, 2009, TRANSBOUND EMERG DIS, V56, P346, DOI 10.1111/j.1865-1682.2009.01093.x; Wackerlin R, 2010, VACCINE; Wileman T, 2006, SCIENCE, V312, P875, DOI 10.1126/science.1126766; Wilson AJ, 2009, PHILOS T R SOC B, V364, P2669, DOI 10.1098/rstb.2009.0091; Worwa G, 2008, SCHWEIZ ARCH TIERH, V150, P491, DOI 10.1024/0036-7281.150.10.491; Worwa G, 2010, VET MICROBIOL; Yorimitsu T, 2005, CELL DEATH DIFFER, V12, P1542, DOI 10.1038/sj.cdd.4401765; Zhou Z, 2009, AUTOPHAGY, V5, P321, DOI 10.4161/auto.5.3.7406	79	10	10	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 15	2012	7	8							e43341	10.1371/journal.pone.0043341	http://dx.doi.org/10.1371/journal.pone.0043341			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	993AG	22905259	Green Submitted, Green Published, gold			2022-12-25	WOS:000307823600070
J	Wang, LL; Wang, LL; Zhang, H; Zhou, Z; Siva, VS; Song, LS				Wang, Leilei; Wang, Lingling; Zhang, Huan; Zhou, Zhi; Siva, Vinu S.; Song, Linsheng			A C1q Domain Containing Protein from Scallop Chlamys farreri Serving as Pattern Recognition Receptor with Heat-Aggregated IgG Binding Activity	PLOS ONE			English	Article							C-TYPE LECTIN; CLASSICAL COMPLEMENT PATHWAY; OYSTER CRASSOSTREA-GIGAS; IMMUNE GENE REPERTOIRE; GLOBULAR HEAD; B-CHAIN; C1Q-DOMAIN-CONTAINING PROTEIN; INNATE IMMUNITY; HUMAN-MONOCYTES; A-CHAINS	Background: The C1q domain containing (C1qDC) proteins refer to a family of all proteins that contain the globular C1q (gC1q) domain, and participate in a series of immune responses depending on their gC1q domains to bind a variety of self and non-self binding ligands. Methodology: In the present study, the mRNA expression patterns, localization, and activities of a C1qDC protein from scallop Chlamys farreri (CfC1qDC) were investigated to understand its possible functions in innate immunity. The relative expression levels of CfC1qDC mRNA in hemocytes were all significantly up-regulated after four typical PAMPs (LPS, PGN, beta-glucan and polyl:C) stimulation. During the embryonic development of scallop, the mRNA transcripts of CfC1qDC were detected in all the stages, and the expression level was up-regulated from D-hinged larva and reached the highest at eyespot larva. The endogenous CfC1qDC was dominantly located in the hepatopancreas, gill, kidney and gonad of adult scallop through immunofluorescence. The recombinant protein of CfC1qDC (rCfC1qDC) could not only bind various PAMPs, such as LPS, PGN, beta-glucan as well as polyl: C, but also enhance the phagocytic activity of scallop hemocytes towards Escherichia coli. Meanwhile, rCfC1qDC could interact with human heat-aggregated IgG, and this interaction could be inhibited by LPS. Conclusions: All these results indicated that CfC1qDC in C. farreri not only served as a PRR involved in the PAMPs recognition, but also an opsonin participating in the clearance of invaders in innate immunity. Moreover, the ability of CfC1qDC to interact with immunoglobulins provided a clue to understand the evolution of classical pathway in complement system.	[Wang, Leilei; Wang, Lingling; Zhang, Huan; Zhou, Zhi; Siva, Vinu S.; Song, Linsheng] Chinese Acad Sci, Inst Oceanol, Key Lab Expt Marine Biol, Qingdao, Peoples R China; [Wang, Leilei; Siva, Vinu S.] Chinese Acad Sci, Grad Univ, Beijing, Peoples R China	Chinese Academy of Sciences; Institute of Oceanology, CAS; Chinese Academy of Sciences; University of Chinese Academy of Sciences, CAS	Wang, LL (corresponding author), Chinese Acad Sci, Inst Oceanol, Key Lab Expt Marine Biol, Qingdao, Peoples R China.	wanglingling@qdio.ac.cn; wanglingling@qdio.ac.cn; lshsong@ms.qdio.ac.cn	zhi, zhouzhi/J-8063-2013		National Natural Science Foundation of China (NSFC) [30925028, 40806064]; 973 program [2010CB126404]; Shandong Provincial Natural Science Foundation [JQ201110]; Knowledge Innovation Program of the Chinese Academy of Sciences [KZCX2-YW-QN206]	National Natural Science Foundation of China (NSFC)(National Natural Science Foundation of China (NSFC)); 973 program(National Basic Research Program of China); Shandong Provincial Natural Science Foundation(Natural Science Foundation of Shandong Province); Knowledge Innovation Program of the Chinese Academy of Sciences(Chinese Academy of SciencesKnowledge Innovation Program of the Chinese Academy of Sciences)	This research was supported by grants (Nos. 30925028 and 40806064) from the National Natural Science Foundation of China (NSFC) (http://www.nsfc.gov.cn/), the 973 program (No. 2010CB126404) (http://www.973.gov.cn/), the Shandong Provincial Natural Science Foundation (No. JQ201110) (http://www.sdnsf. gov.cn/), and the Knowledge Innovation Program of the Chinese Academy of Sciences (No. KZCX2-YW-QN206) (http://www.cas.cn/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adema CM, 2010, MOL IMMUNOL, V47, P849, DOI 10.1016/j.molimm.2009.10.019; Arnold K, 2006, BIOINFORMATICS, V22, P195, DOI 10.1093/bioinformatics/bti770; BOBAK DA, 1987, J IMMUNOL, V138, P1150; BOBAK DA, 1988, J IMMUNOL, V141, P592; Carland TM, 2010, DEV COMP IMMUNOL, V34, P785, DOI 10.1016/j.dci.2010.02.014; Cheng SF, 2006, J VIROL METHODS, V135, P173, DOI 10.1016/j.jviromet.2006.03.016; Dodds AW, 2007, IMMUNOBIOLOGY, V212, P233, DOI 10.1016/j.imbio.2006.11.009; Fujita T, 2002, NAT REV IMMUNOL, V2, P346, DOI 10.1038/nri800; Fujita T, 2004, IMMUNOL REV, V198, P185, DOI 10.1111/j.0105-2896.2004.0123.x; Gaboriaud C, 2003, J BIOL CHEM, V278, P46974, DOI 10.1074/jbc.M307764200; Gerdol M, 2011, DEV COMP IMMUNOLOGY; Gestal C, 2010, DEV COMP IMMUNOL, V34, P926, DOI 10.1016/j.dci.2010.02.012; Ghai R, 2007, IMMUNOBIOLOGY, V212, P253, DOI 10.1016/j.imbio.2006.11.001; Hibino T, 2006, DEV BIOL, V300, P349, DOI 10.1016/j.ydbio.2006.08.065; Huang SF, 2008, GENOME RES, V18, P1112, DOI 10.1101/gr.069674.107; Kiefer Florian, 2009, Nucleic Acids Res, V37, pD387, DOI 10.1093/nar/gkn750; Kishore U, 2000, IMMUNOPHARMACOLOGY, V49, P159, DOI 10.1016/S0162-3109(00)80301-X; Kishore U, 2004, TRENDS IMMUNOL, V25, P551, DOI 10.1016/j.it.2004.08.006; Kishore U, 2003, J IMMUNOL, V171, P812, DOI 10.4049/jimmunol.171.2.812; Kishore U, 2001, J IMMUNOL, V166, P559, DOI 10.4049/jimmunol.166.1.559; Kishore U, 1998, BIOCHEM J, V333, P27, DOI 10.1042/bj3330027; Kishore W, 2004, IMMUNOL LETT, V95, P113, DOI 10.1016/j.imlet.2004.06.015; Kojouharova MS, 2004, J IMMUNOL, V172, P4351, DOI 10.4049/jimmunol.172.7.4351; Kojouharova MS, 2003, BBA-PROTEINS PROTEOM, V1652, P64, DOI 10.1016/j.bbapap.2003.08.003; Kong PF, 2010, DEV COMP IMMUNOL, V34, P837, DOI 10.1016/j.dci.2010.03.006; Kumar S, 2004, BRIEF BIOINFORM, V5, P150, DOI 10.1093/bib/5.2.150; Liu WF, 2009, J PROTEOME RES, V8, P1198, DOI 10.1021/pr800840x; Matsushita M, 2004, P NATL ACAD SCI USA, V101, P10127, DOI 10.1073/pnas.0402180101; Nepomuceno RR, 1997, IMMUNITY, V6, P119, DOI 10.1016/S1074-7613(00)80419-7; OSTREIKO KK, 1987, IMMUNOL LETT, V15, P311, DOI 10.1016/0165-2478(87)90134-9; Perrigault M, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-377; Prado-Alvarez M, 2009, FISH SHELLFISH IMMUN, V26, P72, DOI 10.1016/j.fsi.2008.03.002; SELLAR GC, 1991, BIOCHEM J, V274, P481, DOI 10.1042/bj2740481; Sjowall C, 2007, BIOCHEM BIOPH RES CO, V352, P251, DOI 10.1016/j.bbrc.2006.11.013; Stuart LM, 2005, IMMUNITY, V22, P539, DOI 10.1016/j.immuni.2005.05.002; Tahtouh M, 2009, MOL IMMUNOL, V46, P523, DOI 10.1016/j.molimm.2008.07.026; Tang YT, 2005, GENOMICS, V86, P100, DOI 10.1016/j.ygeno.2005.03.001; Taris N, 2009, ANIM GENET, V40, P663, DOI 10.1111/j.1365-2052.2009.01894.x; Tirape A, 2007, DEV COMP IMMUNOL, V31, P859, DOI 10.1016/j.dci.2007.01.005; Vieira OV, 2002, BIOCHEM J, V366, P689, DOI 10.1042/BJ20020691; Wang L, 2011, DEV COMP IMMUNOLOGY; Wootton EC, 2003, FISH SHELLFISH IMMUN, V15, P195, DOI 10.1016/S1050-4648(02)00161-4; Yang JL, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017089; Yang JL, 2010, DEV COMP IMMUNOL, V34, P1274, DOI 10.1016/j.dci.2010.07.004; Yu YH, 2008, J IMMUNOL, V181, P7024, DOI 10.4049/jimmunol.181.10.7024; Yu YH, 2007, J IMMUNOL, V179, P8425, DOI 10.4049/jimmunol.179.12.8425; Zhang H, 2008, FISH SHELLFISH IMMUN, V25, P281, DOI 10.1016/j.fsi.2008.06.003; Zhang HA, 2011, FISH SHELLFISH IMMUN, V30, P17, DOI 10.1016/j.fsi.2009.12.019; Zhang H, 2009, DEV COMP IMMUNOL, V33, P780, DOI 10.1016/j.dci.2009.01.003; Zhou Z, 2012, FISH SHELLFISH IMMUN, V33, P67, DOI 10.1016/j.fsi.2012.04.002	50	14	19	2	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 15	2012	7	8							e43289	10.1371/journal.pone.0043289	http://dx.doi.org/10.1371/journal.pone.0043289			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	993AG	22905248	Green Submitted, Green Published, gold			2022-12-25	WOS:000307823600064
J	Badve, S; Goswami, C; Gokmen-Polar, Y; Nelson, RP; Henley, J; Miller, N; Zaheer, NA; Sledge, GW; Li, L; Kesler, KA; Loehrer, PJ				Badve, Sunil; Goswami, Chirayu; Goekmen-Polar, Yesim; Nelson, Robert P., Jr.; Henley, John; Miller, Nick; Zaheer, Narjis A.; Sledge, George W., Jr.; Li, Lang; Kesler, Kenneth A.; Loehrer, Patrick J., Sr.			Molecular Analysis of Thymoma	PLOS ONE			English	Article							GENETIC ABERRATIONS; EXPRESSION ANALYSIS; CANCER; MALIGNANCIES; CARCINOMAS; TUMORS; STAGE; RISK; B10	Histologic classification of thymomas has significant limitations with respect to both subtype definitions and consistency. In order to better understand the biology of the disease processes, we performed whole genome gene expression analysis. RNA was extracted from fresh frozen tumors from 34 patients with thymomas and followup data was available. Using the Illumina BeadStudio (R) platform and Human Ref-8 Beadchip, gene expression data was analyzed with Partek Genomics Suite (R), and Ingenuity Pathways Analysis (IPA). Unsupervised clustering of gene expression data, representing one of the largest series in literature, resulted in identification of four molecular clusters of tumors (C1-C4), which correlated with histology (P = 0.002). However, neither histology nor clusters correlated with clinical outcomes. Correlation of gene expression data with clinical data showed that a number of genes were associated with either advanced stage at diagnosis or development of recurrence or metastases. The top pathways associated with metastases were amino acid metabolisms, biosynthesis of steroids and glycosphingolipids, cell cycle checkpoint proteins and Notch signaling. The differential expression of some of the top genes related to both metastases and stage was confirmed by RT-PCR in all cases of metastases and matched nonmetastatic cases. A number of potential candidates for therapeutics were also identified.	[Badve, Sunil; Zaheer, Narjis A.; Sledge, George W., Jr.] Indiana Univ Sch Med, Dept Pathol & Lab Med, Indianapolis, IN USA; [Badve, Sunil; Goekmen-Polar, Yesim; Nelson, Robert P., Jr.; Miller, Nick; Sledge, George W., Jr.; Loehrer, Patrick J., Sr.] Indiana Univ Sch Med, Dept Med, Indianapolis, IN USA; [Goswami, Chirayu; Li, Lang] Indiana Univ Sch Med, Ctr Computat Biol & Bioinformat, Indianapolis, IN USA; [Kesler, Kenneth A.] Indiana Univ Sch Med, Dept Surg, Indianapolis, IN USA; [Badve, Sunil; Sledge, George W., Jr.; Loehrer, Patrick J., Sr.] Indiana Univ, Melvin & Bren Simon Canc Ctr, Indianapolis, IN 46204 USA; [Henley, John] Columbus Reg Hosp, Columbus, IN USA	Indiana University System; Indiana University Bloomington; Indiana University System; Indiana University Bloomington; Indiana University System; Indiana University Bloomington; Indiana University System; Indiana University Bloomington; Indiana University System; Indiana University-Purdue University Indianapolis	Badve, S (corresponding author), Indiana Univ Sch Med, Dept Pathol & Lab Med, Indianapolis, IN USA.	sbadve@iupui.edu	Gokmen-Polar, Yesim/AAX-4001-2021	Gokmen-Polar, Yesim/0000-0001-9927-4893; Badve, Sunil/0000-0001-8861-9980	Barbara P. Hochberg Foundation; William P. Loehrer Family Research Fund	Barbara P. Hochberg Foundation; William P. Loehrer Family Research Fund	This work was supported in part by the Barbara P. Hochberg Foundation and William P. Loehrer Family Research Fund. The funders had no role in study design data collection and analysis, decision to publish, or preparation of the manuscript.	Casey EM, 2008, HEMATOL ONCOL CLIN N, V22, P457, DOI 10.1016/j.hoc.2008.03.010; Chong IW, 2006, ONCOL REP, V16, P981; Chung YT, 2012, MOD PATHOL; DALCIN P, 1993, GENE CHROMOSOME CANC, V6, P243; Engels EA, 2003, INT J CANCER, V105, P546, DOI 10.1002/ijc.11099; FORNASIERO A, 1990, J CLIN ONCOL, V8, P1419, DOI 10.1200/JCO.1990.8.8.1419; Fukumoto S, 2005, CLIN CANCER RES, V11, P1776, DOI 10.1158/1078-0432.CCR-04-1238; Girard N, 2009, CLIN CANCER RES, V15, P6790, DOI 10.1158/1078-0432.CCR-09-0644; Granato F, 2012, HISTOPATHOLOGY, V60, P437, DOI 10.1111/j.1365-2559.2011.04111.x; Heringlake S, 2010, J HEPATOL, V52, P220, DOI 10.1016/j.jhep.2009.11.005; Inoue M, 2003, CANCER RES, V63, P3708; Jain RK, 2010, MODERN PATHOL, V23, P1641, DOI 10.1038/modpathol.2010.172; KRISTOFFERSSON U, 1989, CANCER GENET CYTOGEN, V41, P93, DOI 10.1016/0165-4608(89)90112-X; LATTES R, 1962, CANCER, V15, P1224, DOI 10.1002/1097-0142(196211/12)15:6<1224::AID-CNCR2820150621>3.0.CO;2-V; Lee GY, 2007, BMC GENOMICS, V8, DOI 10.1186/1471-2164-8-305; Liu JH, 2009, RECENT PAT ANTI-CANC, V4, P246, DOI 10.2174/157489209789206931; Ma J, 2008, J BIOL CHEM, V283, P3418, DOI 10.1074/jbc.M707650200; MASAOKA A, 1981, CANCER, V48, P2485, DOI 10.1002/1097-0142(19811201)48:11<2485::AID-CNCR2820481123>3.0.CO;2-R; Okereke IC, 2010, ANN THORAC SURG, V89, P1071, DOI 10.1016/j.athoracsur.2010.01.026; Rosai J., 1999, HISTOLOGICAL TYPING, V2nd; Sasaki H, 2002, INT J CANCER, V101, P342, DOI 10.1002/ijc.10624; Thomas CR, 1999, J CLIN ONCOL, V17, P2280, DOI 10.1200/JCO.1999.17.7.2280; Travis WD., 2004, TRAVIS WB WHO CLASSI; Wei JS, 2004, CANCER RES, V64, P6883, DOI 10.1158/0008-5472.CAN-04-0695; Yoshitake H, 2007, INT J GYNECOL CANCER, V17, P1300, DOI 10.1111/j.1525-1438.2007.00932.x	25	26	27	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 13	2012	7	8							e42669	10.1371/journal.pone.0042669	http://dx.doi.org/10.1371/journal.pone.0042669			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	988OJ	22912720	Green Published, Green Submitted, gold			2022-12-25	WOS:000307500100021
J	Comar, M; Zanotta, N; Croci, E; Murru, I; Marci, R; Pancaldi, C; Dolcet, O; Luppi, S; Martinelli, M; Giolo, E; Ricci, G; Tognon, M				Comar, Manola; Zanotta, Nunzia; Croci, Eleonora; Murru, Immacolata; Marci, Roberto; Pancaldi, Cecilia; Dolcet, Ornella; Luppi, Stefania; Martinelli, Monica; Giolo, Elena; Ricci, Giuseppe; Tognon, Mauro			Association between the JC Polyomavirus Infection and Male Infertility	PLOS ONE			English	Article							PROGRESSIVE MULTIFOCAL LEUKOENCEPHALOPATHY; HUMAN-PAPILLOMAVIRUS INFECTION; BK VIRUS; GENOTYPES; SEQUENCES; PROSTATE; SEMEN; EPIDEMIOLOGY; PREVALENCE; REGION	In recent years the incidence of male infertility has increased. Many risk factors have been taken into consideration, including viral infections. Investigations into viral agents and male infertility have mainly been focused on human papillomaviruses, while no reports have been published on polyomaviruses and male infertility. The aim of this study was to verify whether JC virus and BK virus are associated with male infertility. Matched semen and urine samples from 106 infertile males and 100 fertile males, as controls, were analyzed. Specific PCR analyses were carried out to detect and quantify large T (Tag) coding sequences of JCV and BKV. DNA sequencing, carried out in Tag JCV-positive samples, was addressed to viral protein 1 (VP1) coding sequences. The prevalence of JCV Tag sequences in semen and urine samples from infertile males was 34% (72/212), whereas the BKV prevalence was 0.94% (2/212). Specifically, JCV Tag sequences were detected in 24.5% (26/106) of semen and 43.4% (46/106) of urine samples from infertile men. In semen and urine samples from controls the prevalence was 11% and 28%, respectively. A statistically significant difference (p<0.05) in JCV prevalence was disclosed in semen and urine samples of cases vs. controls. A higher JC viral DNA load was detected in samples from infertile males than in controls. In samples from infertile males the JC virus type 2 strain, subtype 2b, was more prevalent than ubiquitous type 1. JCV type 2 strain infection has been found to be associated with male infertility. These data suggest that the JC virus should be taken into consideration as an infectious agent which is responsible for male infertility.	[Comar, Manola; Zanotta, Nunzia; Croci, Eleonora; Murru, Immacolata; Dolcet, Ornella; Luppi, Stefania; Martinelli, Monica; Giolo, Elena; Ricci, Giuseppe] Univ Trieste, Inst Maternal & Child Hlth, IRCCS Burlo Garofolo Trieste, Trieste, Italy; [Marci, Roberto] Univ Ferrara, Sch Med & Surg, Sect Obstet & Gynaecol, I-44100 Ferrara, Italy; [Pancaldi, Cecilia; Tognon, Mauro] Univ Ferrara, Sch Med & Surg, Sect Cell Biol & Mol Genet, I-44100 Ferrara, Italy	IRCCS Burlo Garofolo; University of Trieste; University of Ferrara; University of Ferrara	Comar, M (corresponding author), Univ Trieste, Inst Maternal & Child Hlth, IRCCS Burlo Garofolo Trieste, Trieste, Italy.	tgm@unife.it	Marci, Roberto/G-6927-2012; Zanotta, Nunzia/K-4539-2016; Comar, Manola/K-4613-2016; Ricci, Giuseppe/AAC-3332-2022; Luppi, Stefania/K-1810-2018; COMAR, Manola/K-4613-2016	Marci, Roberto/0000-0002-9230-6685; Zanotta, Nunzia/0000-0002-6458-1946; Comar, Manola/0000-0001-6310-3320; Ricci, Giuseppe/0000-0002-8031-1102; Martinelli, Monica/0000-0002-1277-1713; COMAR, Manola/0000-0002-9487-861X	Ricerca Corrente of the Istituto di Ricovero e Cura a Carattere Scientifico (IRCCS) Burlo-Garofalo Hospital, Trieste; Emilia-Romagna Region, Bologna; University of Trieste; University of Ferrara	Ricerca Corrente of the Istituto di Ricovero e Cura a Carattere Scientifico (IRCCS) Burlo-Garofalo Hospital, Trieste; Emilia-Romagna Region, Bologna(Regione Emilia Romagna); University of Trieste; University of Ferrara	This investigation was supported in part by grants from the Ricerca Corrente of the Istituto di Ricovero e Cura a Carattere Scientifico (IRCCS) Burlo-Garofalo Hospital, Trieste, the Emilia-Romagna Region, Bologna and the Universities of Trieste and Ferrara. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agostini H T, 1998, J Hum Virol, V1, P200; Agostini HT, 1997, P NATL ACAD SCI USA, V94, P14542, DOI 10.1073/pnas.94.26.14542; Agostini HT, 2001, J GEN VIROL, V82, P1221, DOI 10.1099/0022-1317-82-5-1221; Agostini HT, 2000, J NEUROVIROL, V6, pS101; [Anonymous], 1999, WHO LAB MAN EX HUM S; [Anonymous], 2010, WHO LAB MAN EX PROC; Barbanti-Brodano G, 2006, ADV EXP MED BIOL, V577, P319; Bezold G, 2007, FERTIL STERIL, V87, P1087, DOI 10.1016/j.fertnstert.2006.08.109; Bofill-Mas S, 2001, J VIROL, V75, P10290, DOI 10.1128/JVI.75.21.10290-10299.2001; Bofill-Mas S, 2000, APPL ENVIRON MICROB, V66, P238, DOI 10.1128/AEM.66.1.238-245.2000; Boldorini R, 2008, PATHOLOGY, V40, P72, DOI 10.1080/00313020701716458; Boldorini R, 2011, J GEN VIROL, V92, P1044, DOI 10.1099/vir.0.028571-0; Comar M, 2011, J MED VIROL, V83, P1770, DOI 10.1002/jmv.22184; Comar M, 2010, J MED VIROL, V82, P1236, DOI 10.1002/jmv.21786; Das D, 2004, ONCOGENE, V23, P7031, DOI 10.1038/sj.onc.1207920; Das D, 2008, J VIROL, V82, P2705, DOI 10.1128/JVI.02461-07; Delbue S, 2009, J NEUROVIROL, V15, P51, DOI 10.1080/13550280802425467; Dubois V, 2001, J INFECT DIS, V183, P213, DOI 10.1086/317927; Garolla A, 2011, CURR OPIN OBSTET GYN, V23, P232, DOI 10.1097/GCO.0b013e328348a3a4; Gorelik L, 2011, J INFECT DIS, V204, P103, DOI 10.1093/infdis/jir198; Gray-Swain MR, 2006, CURR OPIN OBSTET GYN, V18, P503, DOI 10.1097/01.gco.0000242952.87125.69; Haggerty CL, 2011, INFECT DIS OBSTET GY, V2011; Hermonat PL, 1997, VIRUS GENES, V14, P13; Jobes DV, 2001, ARCH VIROL, V146, P2097, DOI 10.1007/s007050170023; Kapranos N, 2003, FERTIL STERIL, V79, P1566, DOI 10.1016/S0015-0282(03)00370-4; Knowles WA, 2006, ADV EXP MED BIOL, V577, P19; Lai YM, 1997, FERTIL STERIL, V67, P1152, DOI 10.1016/S0015-0282(97)81454-9; Martini F, 2004, CANCER INVEST, V22, P697, DOI 10.1081/CNV-200032937; Martini F, 1996, CANCER RES, V56, P4820; MONINI P, 1995, VIROLOGY, V214, P273, DOI 10.1006/viro.1995.9928; Monini P, 1996, INT J CANCER, V66, P717, DOI 10.1002/(SICI)1097-0215(19960611)66:6<717::AID-IJC1>3.3.CO;2-N; Oger P, 2011, REPROD BIOMED ONLINE, V23, P207, DOI 10.1016/j.rbmo.2011.04.008; Pagani E, 2003, J NEUROVIROL, V9, P559, DOI 10.1080/13550280390241269; Pancaldi C, 2011, BLOOD, V117, P7099, DOI 10.1182/blood-2010-09-310557; Perino A, 2011, FERTIL STERIL, V95, P1845, DOI 10.1016/j.fertnstert.2010.11.047; Rohde V, 1999, FERTIL STERIL, V72, P814, DOI 10.1016/S0015-0282(99)00363-5; Rossi A, 2007, J MED VIROL, V79, P408, DOI 10.1002/jmv.20829; Sala M, 2001, J GEN VIROL, V82, P899, DOI 10.1099/0022-1317-82-4-899; Santulli P, 2011, FERTIL STERIL, V95, P507, DOI 10.1016/j.fertnstert.2010.09.018; Stephens Amanda J, 2011, Infect Dis Obstet Gynecol, V2011, P525182, DOI 10.1155/2011/525182; Zambrano A, 2002, PROSTATE, V53, P263, DOI 10.1002/pros.10157	41	17	17	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 13	2012	7	8							e42880	10.1371/journal.pone.0042880	http://dx.doi.org/10.1371/journal.pone.0042880			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	988OJ	22912758	Green Published, Green Submitted, gold			2022-12-25	WOS:000307500100041
J	Dang, BN; Westbrook, RA; Rodriguez-Barradas, MC; Giordano, TP				Dang, Bich N.; Westbrook, Robert A.; Rodriguez-Barradas, Maria C.; Giordano, Thomas P.			Identifying Drivers of Overall Satisfaction in Patients Receiving HIV Primary Care: A Cross-Sectional Study	PLOS ONE			English	Article							SCREENING-TEST; HOSPITAL-CARE; UNITED-STATES; ADHERENCE; QUESTION; PERFORMANCE; PHYSICIANS; PROVIDER; OUTCOMES; QUALITY	Objective: This study seeks to understand the drivers of overall patient satisfaction in a predominantly low-income, ethnic-minority population of HIV primary care patients. The study's primary aims were to determine 1) the component experiences which contribute to patients' evaluations of their overall satisfaction with care received, and 2) the relative contribution of each component experience in explaining patients' evaluation of overall satisfaction. Methods: We conducted a cross-sectional study of 489 adult patients receiving HIV primary care at two clinics in Houston, Texas, from January 13-April 21, 2011. The participation rate among eligible patients was 94%. The survey included 15 questions about various components of the care experience, 4 questions about the provider experience and 3 questions about overall care. To ensure that the survey was appropriately tailored to our clinic population and the list of component experiences reflected all aspects of the care experience salient to patients, we conducted in-depth interviews with key providers and clinic staff and pre-tested the survey instrument with patients. Results: Patients' evaluation of their provider correlated the strongest with their overall satisfaction (standardized beta = 0.445, p<0.001) and accounted for almost half of the explained variance. Access and availability, like clinic hours and ease of calling the clinic, also correlated with overall satisfaction, but less strongly. Wait time and parking, despite receiving low patient ratings, did not correlate with overall satisfaction. Conclusions: The patient-provider relationship far exceeds other component experiences of care in its association with overall satisfaction. Our study suggests that interventions to improve overall patient satisfaction should focus on improving patients' evaluation of their provider.	[Dang, Bich N.; Giordano, Thomas P.] Houston Vet Affairs Hlth Serv Res & Dev Ctr Excel, Houston, TX USA; [Dang, Bich N.; Rodriguez-Barradas, Maria C.; Giordano, Thomas P.] Michael E DeBakey VA Med Ctr, Houston, TX USA; [Dang, Bich N.; Rodriguez-Barradas, Maria C.; Giordano, Thomas P.] Baylor Coll Med, Dept Med, Houston, TX 77030 USA; [Dang, Bich N.; Giordano, Thomas P.] Harris Cty Hosp Dist, Houston, TX USA; [Westbrook, Robert A.] Rice Univ, Jesse H Jones Grad Sch Business, Houston, TX USA	Baylor College of Medicine; Baylor College of Medicine; Rice University	Dang, BN (corresponding author), Houston Vet Affairs Hlth Serv Res & Dev Ctr Excel, Houston, TX USA.	bndang@bcm.edu		Giordano, Thomas/0000-0002-9346-5530	Houston Veterans Affairs Health Services Research and Development Center of Excellence [HFP90-020]; Michael E. DeBakey Veterans Affairs Medical Center; Harris County Hospital District, Houston, Texas, United States of America	Houston Veterans Affairs Health Services Research and Development Center of Excellence; Michael E. DeBakey Veterans Affairs Medical Center; Harris County Hospital District, Houston, Texas, United States of America	This project was supported in part by the facilities and resources of the Houston Veterans Affairs Health Services Research and Development Center of Excellence (HFP90-020), Michael E. DeBakey Veterans Affairs Medical Center and the Harris County Hospital District, Houston, Texas, United States of America.	Abramowitz S, 1987, QRB Qual Rev Bull, V13, P122; ANDREWS FM, 1976, SOC INDIC RES, V3, P1, DOI 10.1007/BF00286161; Baker R, 1996, BRIT J GEN PRACT, V46, P601; Barbosa CD, 2012, PATIENT PREFER ADHER, V6, P39, DOI 10.2147/PPA.S24752; BARTLETT EE, 1984, J CHRON DIS, V37, P755, DOI 10.1016/0021-9681(84)90044-4; Beach MC, 2006, J GEN INTERN MED, V21, P661, DOI 10.1111/j.1525-1497.2006.00399.x; Boulding W, 2011, AM J MANAG CARE, V17, P41; Campsmith M. L., 2008, Morbidity and Mortality Weekly Report, V57, P1073; Cleary P D, 1989, QRB Qual Rev Bull, V15, P172; Crow R, 2002, Health Technol Assess, V6, P1; Davies AR, 1981, R2711HHS RAND CORP; DeSalvo KB, 2006, J GEN INTERN MED, V21, P267, DOI 10.1111/j.1525-1497.2005.00291.x; Dholakia UM, 2010, REV MARKET RES, V7, P145, DOI 10.1108/S1548-6435(2010)0000007009; Fan VS, 2005, J GEN INTERN MED, V20, P226, DOI 10.1111/j.1525-1497.2005.40135.x; Garman Andrew N, 2004, Qual Manag Health Care, V13, P75; Giordano LA, 2010, MED CARE RES REV, V67, P27, DOI 10.1177/1077558709341065; Gossey JT, 2008, HLTH LITERACY PATIEN; Hair J., 2010, MULTIVARIATE DATA AN, V7; HAZZARD A, 1990, J PEDIATR PSYCHOL, V15, P543, DOI 10.1093/jpepsy/15.4.543; HENNESSY CH, 1994, PUBLIC HEALTH REP, V109, P665; Huba GJ, 1996, MODULE 64 SELF EFFIC; Jha AK, 2008, NEW ENGL J MED, V359, P1921, DOI 10.1056/NEJMsa0804116; Kane RL, 2005, UNDERSTANDING HLTH C, P159; Li JZ, 2012, AIDS, V26, P185, DOI 10.1097/QAD.0b013e32834e9d7d; Liu W, 2011, J CONSUM RES, V38, P242, DOI 10.1086/658884; Mahajan AP, 2008, AIDS, V22, pS67, DOI 10.1097/01.aids.0000327438.13291.62; MARQUIS MS, 1983, MED CARE, V21, P821, DOI 10.1097/00005650-198308000-00006; Mittal V, 1998, J MARKETING, V62, P33, DOI 10.2307/1251801; Mittal V., 2010, MSI FAST FORWARD SER; MORRELL DC, 1986, BMJ-BRIT MED J, V292, P870, DOI 10.1136/bmj.292.6524.870; Oliver RL, 2010, SATISFACTION BEHAV P, DOI DOI 10.4324/9781315700892; PEARLIN LI, 1981, J HEALTH SOC BEHAV, V22, P337, DOI 10.2307/2136676; PEARLIN LI, 1978, J HEALTH SOC BEHAV, V19, P2, DOI 10.2307/2136319; Pilpel D, 1996, J GEN INTERN MED, V11, P312, DOI 10.1007/BF02598274; Roberts KJ, 2002, AIDS PATIENT CARE ST, V16, P43, DOI 10.1089/108729102753429398; Safran DG, 1998, J FAM PRACTICE, V47, P213; Safran DG, 2001, J FAM PRACTICE, V50, P130; Safran DG, 2006, J GEN INTERN MED, V21, P13, DOI 10.1111/j.1525-1497.2005.00311.x; Schneider J, 2004, J GEN INTERN MED, V19, P1096, DOI 10.1111/j.1525-1497.2004.30418.x; Sitzia J, 1997, SOC SCI MED, V45, P1829, DOI 10.1016/S0277-9536(97)00128-7; Smith P.C., 1969, MEASUREMENT SATISFAC; Smith PC, 2010, ARCH INTERN MED, V170, P1155, DOI 10.1001/archinternmed.2010.140; Smith PC, 2009, J GEN INTERN MED, V24, P783, DOI 10.1007/s11606-009-0928-6; Tull D.S., 1993, MARKETING RES MEASUR; Watkins CL, 2007, CLIN REHABIL, V21, P846, DOI 10.1177/0269215507079846; Weaver M, 1997, AM J MANAG CARE, V3, P579; WESTBROOK RA, 1981, J RETAILING, V57, P68; Willis GB, 2005, COGNITIVE INTERVIEWI; Wood E, 2004, JAIDS-J ACQ IMM DEF, V35, P261, DOI 10.1097/00126334-200403010-00006; Woodside A G, 1989, J Health Care Mark, V9, P5; Zikmund W., 2012, ESSENTIALS MARKETING	51	28	29	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 13	2012	7	8							e42980	10.1371/journal.pone.0042980	http://dx.doi.org/10.1371/journal.pone.0042980			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	988OJ	22912770	Green Published, gold, Green Submitted			2022-12-25	WOS:000307500100047
J	Lai, CY; Tsai, AC; Chen, MC; Chang, LH; Sun, HL; Chang, YL; Chen, CC; Teng, CM; Pan, SL				Lai, Chin-Yu; Tsai, An-Chi; Chen, Mei-Chuan; Chang, Li-Hsun; Sun, Hui-Lung; Chang, Ya-Ling; Chen, Chien-Chih; Teng, Che-Ming; Pan, Shiow-Lin			Aciculatin Induces p53-Dependent Apoptosis via MDM2 Depletion in Human Cancer Cells In Vitro and In Vivo	PLOS ONE			English	Article							WILD-TYPE P53; P73 FUNCTION; PROTEIN; ACTIVATION; DNA; THERAPY; PATHWAY; EXPRESSION; FLAVONOIDS; ONCOGENE	Aciculatin, a natural compound extracted from the medicinal herb Chrysopogon aciculatus, shows potent anti-cancer potency. This study is the first to prove that aciculatin induces cell death in human cancer cells and HCT116 mouse xenografts due to G1 arrest and subsequent apoptosis. The primary reason for cell cycle arrest and cell death was p53 accumulation followed by increased p21 level, dephosphorylation of Rb protein, PUMA expression, and induction of apoptotic signals such as cleavage of caspase-9, caspase-3, and PARP. We demonstrated that p53 allele-null (-/-) (p53-KO) HCT116 cells were more resistant to aciculatin than cells with wild-type p53 (+/+). The same result was achieved by knocking down p53 with siRNA in p53 wild-type cells, indicating that p53 plays a crucial role in aciculatin-induced apoptosis. Although DNA damage is the most common event leading to p53 activation, we found only weak evidence of DNA damage after aciculatin treatment. Interestingly, the aciculatin-induced downregulation of MDM2, an important negative regulator of p53, contributed to p53 accumulation. The anti-cancer activity and importance of p53 after aciculatin treatment were also confirmed in the HCT116 xenograft models. Collectively, these results indicate that aciculatin treatment induces cell cycle arrest and apoptosis via inhibition of MDM2 expression, thereby inducing p53 accumulation without significant DNA damage and genome toxicity.	[Lai, Chin-Yu; Chen, Mei-Chuan; Chang, Li-Hsun; Sun, Hui-Lung; Chang, Ya-Ling; Teng, Che-Ming] Natl Taiwan Univ, Inst Pharmacol, Coll Med, Taipei 10764, Taiwan; [Tsai, An-Chi; Pan, Shiow-Lin] Natl Hlth Res Inst, Inst Biotechnol & Pharmaceut Res, Zhunan Town, Taiwan; [Chen, Chien-Chih] Hungkuang Univ, Dept Biotechnol, Taichung, Taiwan	National Taiwan University; National Health Research Institutes - Taiwan; Hungkuang University	Lai, CY (corresponding author), Natl Taiwan Univ, Inst Pharmacol, Coll Med, Taipei 10764, Taiwan.	cmteng@ntu.edu.tw; apan0826@nhri.org.tw	Pan, Shiow-Lin/C-1372-2010; Huang, James/ADK-6342-2022	TENG, CHE-MING/0000-0002-9719-7334	National Science Council of the Republic of China [NSC 99-2628-B-002-024-MY3, NSC 99-2320-B-400-008-MY3]	National Science Council of the Republic of China(Ministry of Science and Technology, Taiwan)	This work was supported by the National Science Council of the Republic of China (NSC 99-2628-B-002-024-MY3 and NSC 99-2320-B-400-008-MY3)(http://web1.nsc.gov.tw/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Boyd MT, 2000, J BIOL CHEM, V275, P31883, DOI 10.1074/jbc.M004252200; CARTE BK, 1991, TETRAHEDRON, V47, P1815; Celeste A, 2003, NAT CELL BIOL, V5, P675, DOI 10.1038/ncb1004; Chang LH, 2011, J CELL PHYSIOL, V226, P1060, DOI 10.1002/jcp.22428; Chen MC, 2011, CANC SCI; Chen TH, 2008, CLIN CANCER RES, V14, P4250, DOI 10.1158/1078-0432.CCR-07-4578; Chene P, 2003, NAT REV CANCER, V3, P102, DOI 10.1038/nrc991; Cheok CF, 2010, CELL DEATH DIFFER, V17, P1486, DOI 10.1038/cdd.2010.18; Cheok CF, 2011, NAT REV CLIN ONCOL, V8, P25, DOI 10.1038/nrclinonc.2010.174; Gu HY, 2008, MOL CANCER THER, V7, P3298, DOI 10.1158/1535-7163.MCT-08-0212; Hsieh IN, 2011, J BIOMED SCI, V18, DOI 10.1186/1423-0127-18-28; Jin YT, 2003, EMBO J, V22, P6365, DOI 10.1093/emboj/cdg600; Kaeser MD, 2004, J BIOL CHEM, V279, P7598, DOI 10.1074/jbc.M311732200; Kanakis CD, 2007, CELL BIOCHEM BIOPHYS, V49, P29, DOI 10.1007/s12013-007-0037-2; KRAUSE JA, 1991, ACTA CRYSTALLOGR C, V47, P2595, DOI 10.1107/S0108270191006170; Kravchenko JE, 2008, P NATL ACAD SCI USA, V105, P6302, DOI 10.1073/pnas.0802091105; Lain S, 2003, EUR J CANCER, V39, P1053, DOI 10.1016/S0959-8049(03)00063-7; Lau LMS, 2008, ONCOGENE, V27, P997, DOI 10.1038/sj.onc.1210707; Lee DH, 2008, BIOCHEM PHARMACOL, V75, P2020, DOI 10.1016/j.bcp.2008.02.023; Li M, 2005, CANCER RES, V65, P8200, DOI 10.1158/0008-5472.CAN-05-1302; OLINER JD, 1992, NATURE, V358, P80, DOI 10.1038/358080a0; Piette J, 1997, ONCOGENE, V15, P1001, DOI 10.1038/sj.onc.1201432; Plaumann B, 1996, ONCOGENE, V13, P1605; Rong JJ, 2009, CANCER LETT, V284, P102, DOI 10.1016/j.canlet.2009.04.011; Stad R, 2001, EMBO REP, V2, P1029, DOI 10.1093/embo-reports/kve227; Thakur VS, 2010, CANCER LETT, V296, P225, DOI 10.1016/j.canlet.2010.04.012; Vazquez A, 2008, NAT REV DRUG DISCOV, V7, P979, DOI 10.1038/nrd2656; Vidal A, 2000, GENE, V247, P1, DOI 10.1016/S0378-1119(00)00092-5; Vousden KH, 2007, NAT REV MOL CELL BIO, V8, P275, DOI 10.1038/nrm2147; Xia M, 2011, ONCOGENE, V30, P346, DOI 10.1038/onc.2010.413; XIAO ZX, 1995, NATURE, V375, P694, DOI 10.1038/375694a0; Zeng XY, 1999, MOL CELL BIOL, V19, P3257; Zhang Z, 2005, ONCOGENE, V24, P7238, DOI 10.1038/sj.onc.1208814	33	23	25	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 13	2012	7	8							e42192	10.1371/journal.pone.0042192	http://dx.doi.org/10.1371/journal.pone.0042192			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	988OJ	22912688	Green Submitted, Green Published, gold			2022-12-25	WOS:000307500100008
J	Mutze, U; Beblo, S; Kortz, L; Matthies, C; Koletzko, B; Bruegel, M; Rohde, C; Thiery, J; Kiess, W; Ceglarek, U				Muetze, Ulrike; Beblo, Skadi; Kortz, Linda; Matthies, Claudia; Koletzko, Berthold; Bruegel, Mathias; Rohde, Carmen; Thiery, Joachim; Kiess, Wieland; Ceglarek, Uta			Metabolomics of Dietary Fatty Acid Restriction in Patients with Phenylketonuria	PLOS ONE			English	Article							RANDOMIZED CONTROLLED-TRIAL; FISH-OIL SUPPLEMENTATION; LIQUID-CHROMATOGRAPHY; DOCOSAHEXAENOIC ACID; MASS-SPECTROMETRY; ARACHIDONIC-ACID; PLATELET SIZE; TERM INFANTS; SERUM-LIPIDS; CHILDREN	Background: Patients with phenylketonuria (PKU) have to follow a lifelong phenylalanine restricted diet. This type of diet markedly reduces the intake of saturated and unsaturated fatty acids especially long chain polyunsaturated fatty acids (LC-PUFA). Long-chain saturated fatty acids are substrates of mitochondrial fatty acid oxidation for acetyl-Co Aproduction. LC-PUFA are discussed to affect inflammatory and haemostaseological processes in health and disease. The influence of the long term PKU diet on fatty acid metabolism with a special focus on platelet eicosanoid metabolism has been investigated in the study presented here. Methodology/Principal findings: 12 children with PKU under good metabolic control and 8 healthy controls were included. Activated fatty acids (acylcarnitines C6-C18) in dried blood and the cholesterol metabolism in serum were analyzed by liquid chromatographic tandem mass spectrometry (LC-MS/MS). Fatty acid composition of plasma glycerophospholipids was determined by gas chromatography. LC-PUFA metabolites were analyzed in supernatants by LC-MS/MS before and after platelet activation and aggregation using a standardized protocol. Patients with PKU had significantly lower free carnitine and lower activated fatty acids in dried blood compared to controls. Phytosterols as marker of cholesterol (re-) absorption were not influenced by the dietary fatty acid restriction. Fatty acid composition in glycerophospholipids was comparable to that of healthy controls. However, patients with PKU showed significantly increased concentrations of y-linolenic acid (C18:3n-6) a precursor of arachidonic acid. In the PKU patients significantly higher platelet counts were observed. After activation with collagen platelet aggregation and thromboxane B-2 and thromboxane B-3 release did not differ from that of healthy controls. Conclusion/Significance: Long-term dietary fatty acid restriction influenced the intermediates of mitochondrial beta-oxidation. No functional influence on unsaturated fatty acid metabolism and platelet aggregation in patients with PKU was detected.	[Muetze, Ulrike; Beblo, Skadi; Rohde, Carmen; Kiess, Wieland] Univ Leipzig, Dept Women & Child Hlth, Hosp Children & Adolescents, Univ Hosp, Leipzig, Germany; [Kortz, Linda; Thiery, Joachim; Ceglarek, Uta] Univ Leipzig, Univ Hosp, Inst Lab Med, Leipzig, Germany; [Kortz, Linda; Ceglarek, Uta] Univ Leipzig, LIFE Leipzig Res Ctr Civilizat Dis, Leipzig, Germany; [Matthies, Claudia; Koletzko, Berthold] Univ Munich, Dr von Hauner Childrens Hosp, Div Metab Dis & Nutr Med, Munich, Germany; [Bruegel, Mathias] Univ Munich, Inst Lab Med, Munich, Germany	Leipzig University; Leipzig University; Leipzig University; University of Munich; University of Munich	Mutze, U (corresponding author), Univ Leipzig, Dept Women & Child Hlth, Hosp Children & Adolescents, Univ Hosp, Leipzig, Germany.	Ulrike.Muetze@medizin.uni-leipzig.de	Ceglarek, Uta/GOE-5561-2022		Medical Faculty; University of Leipzig, Germany; LIFE - Leipzig Research Center for Civilization Diseases; Universitat Leipzig; European Social Fund and the Free State of Saxony; Commission of the European Communities; RTD Programme; NUTRIMENTHE [FP7-212652]	Medical Faculty; University of Leipzig, Germany; LIFE - Leipzig Research Center for Civilization Diseases; Universitat Leipzig; European Social Fund and the Free State of Saxony; Commission of the European Communities(European Commission); RTD Programme; NUTRIMENTHE	Junior research grant by the Medical Faculty, University of Leipzig, Germany. This publication is supported by LIFE - Leipzig Research Center for Civilization Diseases, Universitat Leipzig. This project was funded by means of the European Social Fund and the Free State of Saxony. Further support was received from the Commission of the European Communities, specific RTD Programme "Quality of Life and Management of Living Resources'', within the 7th Framework Programme NUTRIMENTHE, FP7-212652. This manuscript does not necessarily reflect the views of the Commission and in no way anticipates the future policy in this area. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ACOSTA PB, 1973, J AM DIET ASSOC, V63, P631; Agostoni C, 1997, PROSTAG LEUKOTR ESS, V56, P219, DOI 10.1016/S0952-3278(97)90538-X; [Anonymous], [No title captured]; [Anonymous], 2000, REF NARST; Bath PMW, 1996, BLOOD COAGUL FIBRIN, V7, P157, DOI 10.1097/00001721-199603000-00011; Beblo S, 2001, NEUROLOGY, V57, P1488, DOI 10.1212/WNL.57.8.1488; Beblo S, 2007, J PEDIATR-US, V150, P479, DOI 10.1016/j.jpeds.2006.12.011; Birch EE, 2000, DEV MED CHILD NEUROL, V42, P174, DOI 10.1017/S0012162200000311; Birch EE, 1998, PEDIATR RES, V44, P201, DOI 10.1203/00006450-199808000-00011; BOHLES H, 1991, EUR J PEDIATR, V150, P425, DOI 10.1007/BF02093725; Brauer R, 2011, METABOLOMICS, V7, P344, DOI 10.1007/s11306-010-0256-1; Calder PC, 2006, AM J CLIN NUTR, V83, p1505S, DOI 10.1093/ajcn/83.6.1505S; Calder PC, 2008, PROSTAG LEUKOTR ESS, V79, P101, DOI 10.1016/j.plefa.2008.09.016; CASTILLO M, 1988, NEUROCHEM RES, V13, P551, DOI 10.1007/BF00973296; Colome C, 2001, CLIN BIOCHEM, V34, P373, DOI 10.1016/S0009-9120(01)00249-1; Dame C, 2005, BRIT J HAEMATOL, V129, P165, DOI 10.1111/j.1365-2141.2004.05329.x; DECSI T, 1994, EUR J PEDIATR, V153, P520, DOI 10.1007/s004310050184; Deems R, 2007, METHOD ENZYMOL, V432, P59, DOI 10.1016/S0076-6879(07)32003-X; Fischer GM, 2000, BBA-MOL BASIS DIS, V1501, P200, DOI 10.1016/S0925-4439(00)00023-5; GALLI C, 1991, J PEDIATR-US, V119, P562, DOI 10.1016/S0022-3476(05)82405-9; Galluzzo CR, 1985, J INHERIT METAB D S2, V2, P129; Glaser C, 2010, J PEDIATR-US, V157, P826, DOI 10.1016/j.jpeds.2010.05.001; Glaser C, 2010, J LIPID RES, V51, P216, DOI 10.1194/jlr.D000547; Koletzko B, 1999, J MAMMARY GLAND BIOL, V4, P269, DOI 10.1023/A:1018749913421; Koletzko B, 2007, J INHERIT METAB DIS, V30, P326, DOI 10.1007/s10545-007-0491-4; Koletzko B, 1999, LIPIDS, V34, P215, DOI 10.1007/s11745-999-0356-x; Kortz L, 2009, LABORATORIUMSMEDIZIN, V33, P341, DOI 10.1515/JLM.2009.057; LAWSON JA, 1986, ANAL BIOCHEM, V155, P198, DOI 10.1016/0003-2697(86)90247-2; Lembcke J, 2005, J LIPID RES, V46, P21, DOI 10.1194/jlr.C400004-JLR200; Loeber JG, 2007, J INHERIT METAB DIS, V30, P430, DOI 10.1007/s10545-007-0644-5; MARTINEZ M, 1992, J PEDIATR-US, V120, pS129, DOI 10.1016/S0022-3476(05)81247-8; Mensink GBM, 2007, ERNAHRUNGSSTUDIE KIG, P100; Moseley K, 2002, J INHERIT METAB DIS, V25, P56, DOI 10.1023/A:1015142001578; NEEDLEMAN P, 1976, NATURE, V261, P558, DOI 10.1038/261558a0; Poge AP, 1998, J INHERIT METAB DIS, V21, P373, DOI 10.1023/A:1005350523826; Riediger ND, 2009, J AM DIET ASSOC, V109, P668, DOI 10.1016/j.jada.2008.12.022; Rohde C, 2012, EUR J CLIN NUTR; Russo GL, 2009, BIOCHEM PHARMACOL, V77, P937, DOI 10.1016/j.bcp.2008.10.020; Salem N, 2001, LIPIDS, V36, P945, DOI 10.1007/s11745-001-0805-6; SCHULPIS KH, 1990, ACTA PAEDIATR SCAND, V79, P930, DOI 10.1111/j.1651-2227.1990.tb11354.x; Schulpis KH, 2004, CLIN NUTR, V23, P401, DOI 10.1016/j.clnu.2003.09.006; Shefer S, 2000, J NEUROSCI RES, V61, P549, DOI 10.1002/1097-4547(20000901)61:5<549::AID-JNR10>3.0.CO;2-0; SUTOR AH, 1999, PEDIAT HEMATOLOGY, P455; THOMPSON CB, 1983, J LAB CLIN MED, V101, P205; VILASECA MA, 1993, J INHERIT METAB DIS, V16, P101, DOI 10.1007/BF00711322; Vizioli L, 2009, INT J CLIN PRACT, V63, P1509, DOI 10.1111/j.1742-1241.2009.02070.x; Weigel C, 2008, ANN NUTR METAB, V53, P91, DOI 10.1159/000165356	47	19	19	1	26	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 13	2012	7	8							e43021	10.1371/journal.pone.0043021	http://dx.doi.org/10.1371/journal.pone.0043021			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	988OJ	22912778	Green Published, gold, Green Submitted			2022-12-25	WOS:000307500100051
J	Onomoto, K; Jogi, M; Yoo, JS; Narita, R; Morimoto, S; Takemura, A; Sambhara, S; Kawaguchi, A; Osari, S; Nagata, K; Matsumiya, T; Namiki, H; Yoneyama, M; Fujita, T				Onomoto, Koji; Jogi, Michihiko; Yoo, Ji-Seung; Narita, Ryo; Morimoto, Shiho; Takemura, Azumi; Sambhara, Suryaprakash; Kawaguchi, Atushi; Osari, Suguru; Nagata, Kyosuke; Matsumiya, Tomoh; Namiki, Hideo; Yoneyama, Mitsutoshi; Fujita, Takashi			Critical Role of an Antiviral Stress Granule Containing RIG-I and PKR in Viral Detection and Innate Immunity	PLOS ONE			English	Article							DOUBLE-STRANDED-RNA; INDUCIBLE GENE-I; PROTEIN-KINASE-R; NF-KAPPA-B; VIRUS-INFECTION; NS1 PROTEIN; ADAPTER PROTEIN; INTERFERON; RECOGNITION; ACTIVATION	Retinoic acid inducible gene I (RIG-I)-like receptors (RLRs) function as cytoplasmic sensors for viral RNA to initiate antiviral responses including type I interferon (IFN) production. It has been unclear how RIG-I encounters and senses viral RNA. To address this issue, we examined intracellular localization of RIG-I in response to viral infection using newly generated anti-RIG-I antibody. Immunohistochemical analysis revealed that RLRs localized in virus-induced granules containing stress granule (SG) markers together with viral RNA and antiviral proteins. Because of similarity in morphology and components, we termed these aggregates antiviral stress granules (avSGs). Influenza A virus (IAV) deficient in non-structural protein 1 (NS1) efficiently generated avSGs as well as IFN, however IAV encoding NS1 produced little. Inhibition of avSGs formation by removal of either the SG component or double-stranded RNA (dsRNA)-dependent protein kinase (PKR) resulted in diminished IFN production and concomitant enhancement of viral replication. Furthermore, we observed that transfection of dsRNA resulted in IFN production in an avSGs-dependent manner. These results strongly suggest that the avSG is the locus for non-self RNA sensing and the orchestration of multiple proteins is critical in the triggering of antiviral responses.	[Onomoto, Koji; Jogi, Michihiko; Yoo, Ji-Seung; Narita, Ryo; Morimoto, Shiho; Takemura, Azumi; Fujita, Takashi] Kyoto Univ, Inst Virus Res, Mol Genet Lab, Kyoto 606, Japan; [Onomoto, Koji] Waseda Univ, Res Inst Sci & Engn, Tokyo, Japan; [Jogi, Michihiko; Yoo, Ji-Seung; Fujita, Takashi] Kyoto Univ, Mol Cell Biol Lab, Grad Sch Biostudies, Kyoto, Japan; [Onomoto, Koji; Jogi, Michihiko; Yoneyama, Mitsutoshi] Chiba Univ, Med Mycol Res Ctr, Div Mol Immunol, Chuo Ku, Chiba, Japan; [Sambhara, Suryaprakash] Ctr Dis Control & Prevent, Influenza Div, Atlanta, GA USA; [Kawaguchi, Atushi; Osari, Suguru; Nagata, Kyosuke] Univ Tsukuba, Dept Infect Biol, Fac Med, Tsukuba, Ibaraki, Japan; [Kawaguchi, Atushi; Osari, Suguru; Nagata, Kyosuke] Univ Tsukuba, Grad Sch Comprehens Human Sci, Tsukuba, Ibaraki, Japan; [Kawaguchi, Atushi] Kitasato Univ, Kitasato Inst Life Sci, Tokyo, Japan; [Matsumiya, Tomoh] Hirosaki Univ, Grad Sch Med, Dept Vasc Biol, Inst Brain Sci, Aomori, Japan; [Onomoto, Koji; Namiki, Hideo] Waseda Univ, Grad Sch Sci & Engn, Tokyo, Japan; [Yoneyama, Mitsutoshi] Japan Sci & Technol Agcy, PRESTO, Saitama, Japan	Kyoto University; Waseda University; Kyoto University; Chiba University; Centers for Disease Control & Prevention - USA; University of Tsukuba; University of Tsukuba; Kitasato University; Hirosaki University; Waseda University; Japan Science & Technology Agency (JST)	Onomoto, K (corresponding author), Chiba Univ, Med Mycol Res Ctr, Div Mol Immunol, Chuo Ku, Chiba, Japan.	myoneyam@faculty.chiba-u.jp; tfujita@virus.kyoto-u.ac.jp	Matsumiya, Tomoh/ABA-5861-2021; Sambhara, Suryaprakash/AAC-4428-2021; Yoneyama, Mitsutoshi/D-8244-2017; Yoo, Ji-Seung/P-9688-2019	Yoneyama, Mitsutoshi/0000-0001-9512-0408; Yoo, Ji-Seung/0000-0002-3708-8240; Kawaguchi, Atsushi/0000-0002-5485-1578	Ministry of Education, Culture, Sports, Science and Technology in Japan [20112009]; Ministry of Health, Labour and Welfare of Japan; PRESTO Japan Science and Technology Agency; Uehara Memorial Foundation; Mochida Memorial Foundation for Medical and Pharmaceutical Research; Takaeda Science Foundation; Naito Foundation; Nippon Boehringer Ingelheim; Grants-in-Aid for Scientific Research [23249023] Funding Source: KAKEN	Ministry of Education, Culture, Sports, Science and Technology in Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Ministry of Health, Labour and Welfare of Japan(Ministry of Health, Labour and Welfare, Japan); PRESTO Japan Science and Technology Agency(Japan Science & Technology Agency (JST)); Uehara Memorial Foundation(Uehara Memorial Foundation); Mochida Memorial Foundation for Medical and Pharmaceutical Research; Takaeda Science Foundation; Naito Foundation(Naito Memorial Foundation); Nippon Boehringer Ingelheim(Boehringer Ingelheim); Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	The Ministry of Education, Culture, Sports, Science and Technology in Japan (Innovative Areas "RNA regulation'' (No. 20112009), Scientific Research "A'', and Research Activity Start-up) (http://www.mext.go.jp/english/), the Ministry of Health, Labour and Welfare of Japan (http://www.mhlw.go.jp/english/index.html), the PRESTO Japan Science and Technology Agency (http://www.jst.go.jp/kisoken/presto/index_e.html), the Uehara Memorial Foundation (http://www.ueharazaidan.com/), the Mochida Memorial Foundation for Medical and Pharmaceutical Research (http://www.mochida.co.jp/zaidan/), the Takaeda Science Foundation (http://www.takeda-sci.or.jp/index.html), the Naito Foundation (http://www.naito-f.or.jp/), and Nippon Boehringer Ingelheim (http://www.boehringer-ingelheim.co.jp/com/Home/index.jsp). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Barry G, 2009, J GEN VIROL, V90, P1382, DOI 10.1099/vir.0.007336-0; Baum A, 2010, P NATL ACAD SCI USA, V107, P16303, DOI 10.1073/pnas.1005077107; Berlanga JJ, 2006, EMBO J, V25, P1730, DOI 10.1038/sj.emboj.7601073; Bridge AJ, 2003, NAT GENET, V34, P263, DOI 10.1038/ng1173; Brummelkamp TR, 2002, SCIENCE, V296, P550, DOI 10.1126/science.1068999; Buchan JR, 2009, MOL CELL, V36, P932, DOI 10.1016/j.molcel.2009.11.020; Carpentier PA, 2007, GLIA, V55, P239, DOI 10.1002/glia.20450; DALY C, 1993, MOL CELL BIOL, V13, P3756, DOI 10.1128/MCB.13.6.3756; Diebold SS, 2003, NATURE, V424, P324, DOI 10.1038/nature01783; Dixit E, 2010, CELL, V141, P668, DOI 10.1016/j.cell.2010.04.018; Gack MU, 2009, CELL HOST MICROBE, V5, P439, DOI 10.1016/j.chom.2009.04.006; Gale M, 1998, PHARMACOL THERAPEUT, V78, P29, DOI 10.1016/S0163-7258(97)00165-4; Gilfoy FD, 2007, J VIROL, V81, P11148, DOI 10.1128/JVI.00446-07; Guo Z, 2007, AM J RESP CELL MOL, V36, P263, DOI 10.1165/rcmb.2006-0283RC; Hale BG, 2008, J GEN VIROL, V89, P2359, DOI 10.1099/vir.0.2008/004606-0; Hornung V, 2006, SCIENCE, V314, P994, DOI 10.1126/science.1132505; Hou FJ, 2011, CELL, V146, P448, DOI 10.1016/j.cell.2011.06.041; Iseni F, 2002, EMBO J, V21, P5141, DOI 10.1093/emboj/cdf513; Iwamura T, 2001, GENES CELLS, V6, P375, DOI 10.1046/j.1365-2443.2001.00426.x; Jo S, 2010, MICROBES INFECT, V12, P1079, DOI 10.1016/j.micinf.2010.06.011; Kato H, 2006, NATURE, V441, P101, DOI 10.1038/nature04734; Kato H, 2008, J EXP MED, V205, P1601, DOI 10.1084/jem.20080091; Kawai T, 2005, NAT IMMUNOL, V6, P981, DOI 10.1038/ni1243; Kedersha N, 2007, METHOD ENZYMOL, V431, P61, DOI 10.1016/S0076-6879(07)31005-7; Khaperskyy DA, 2011, FASEB J; Li W, 2002, J VIROL, V76, P11989, DOI 10.1128/JVI.76.23.11989-12000.2002; Malathi K, 2007, NATURE, V448, P816, DOI 10.1038/nature06042; McAllister CS, 2009, J BIOL CHEM, V284, P1644, DOI 10.1074/jbc.M807888200; Meylan E, 2005, NATURE, V437, P1167, DOI 10.1038/nature04193; Mibayashi M, 2007, J VIROL, V81, P514, DOI 10.1128/JVI.01265-06; Min JY, 2007, VIROLOGY, V363, P236, DOI 10.1016/j.virol.2007.01.038; Momose F, 2007, MICROBES INFECT, V9, P1422, DOI 10.1016/j.micinf.2007.07.007; Naldini L, 1996, SCIENCE, V272, P263, DOI 10.1126/science.272.5259.263; Nallagatla SR, 2007, SCIENCE, V318, P1455, DOI 10.1126/science.1147347; Onoguchi K, 2007, J BIOL CHEM, V282, P7576, DOI 10.1074/jbc.M608618200; Onoguchi K, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1001012; Ouda R, 2011, J BIOL CHEM, V286, P26210, DOI 10.1074/jbc.M111.229856; Pichlmair A, 2006, SCIENCE, V314, P997, DOI 10.1126/science.1132998; Portela A, 2002, J GEN VIROL, V83, P723, DOI 10.1099/0022-1317-83-4-723; Rasmussen SB, 2009, J GEN VIROL, V90, P74, DOI 10.1099/vir.0.005389-0; Rehwinkel J, 2010, CELL, V140, P397, DOI 10.1016/j.cell.2010.01.020; RUBINSTEIN S, 1981, J VIROL, V37, P755, DOI 10.1128/JVI.37.2.755-758.1981; Saito T, 2007, P NATL ACAD SCI USA, V104, P582, DOI 10.1073/pnas.0606699104; Samanta M, 2006, EMBO J, V25, P4207, DOI 10.1038/sj.emboj.7601314; Samuel CE, 2001, CLIN MICROBIOL REV, V14, P778, DOI 10.1128/CMR.14.4.778-809.2001; Schulz O, 2010, CELL HOST MICROBE, V7, P354, DOI 10.1016/j.chom.2010.04.007; Seth RB, 2005, CELL, V122, P669, DOI 10.1016/j.cell.2005.08.012; Simpson-Holley M, 2011, J VIROL, V85, P1581, DOI 10.1128/JVI.02247-10; White JP, 2007, CELL HOST MICROBE, V2, P295, DOI 10.1016/j.chom.2007.08.006; Witte K, 2010, CYTOKINE GROWTH F R, V21, P237, DOI 10.1016/j.cytogfr.2010.04.002; Xu LG, 2005, MOL CELL, V19, P727, DOI 10.1016/j.molcel.2005.08.014; Yang YL, 1995, EMBO J, V14, P6095, DOI 10.1002/j.1460-2075.1995.tb00300.x; Yoneyama M, 1998, EMBO J, V17, P1087, DOI 10.1093/emboj/17.4.1087; Yoneyama M, 2005, J IMMUNOL, V175, P2851, DOI 10.4049/jimmunol.175.5.2851; Yoneyama M, 2004, NAT IMMUNOL, V5, P730, DOI 10.1038/ni1087; Yoneyama M, 2010, REV MED VIROL, V20, P4, DOI 10.1002/rmv.633; Zufferey R, 1997, NAT BIOTECHNOL, V15, P871, DOI 10.1038/nbt0997-871	57	237	245	0	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 13	2012	7	8							e43031	10.1371/journal.pone.0043031	http://dx.doi.org/10.1371/journal.pone.0043031			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	988OJ	22912779	Green Submitted, gold, Green Published			2022-12-25	WOS:000307500100053
J	Passmore, HA; Bruna, EM; Heredia, SM; Vasconcelos, HL				Passmore, Heather A.; Bruna, Emilio M.; Heredia, Sylvia M.; Vasconcelos, Heraldo L.			Resilient Networks of Ant-Plant Mutualists in Amazonian Forest Fragments	PLOS ONE			English	Article							POLLINATOR INTERACTIONS; WEB; SPECIALIZATION; DIVERSITY; CONNECTANCE; ASYMMETRIES; ROBUSTNESS; SPACE; WORLD; TIME	Background: The organization of networks of interacting species, such as plants and animals engaged in mutualisms, strongly influences the ecology and evolution of partner communities. Habitat fragmentation is a globally pervasive form of spatial heterogeneity that could profoundly impact the structure of mutualist networks. This is particularly true for biodiversity-rich tropical ecosystems, where the majority of plant species depend on mutualisms with animals and it is thought that changes in the structure of mutualist networks could lead to cascades of extinctions. Methodology/Principal Findings: We evaluated effects of fragmentation on mutualistic networks by calculating metrics of network structure for ant-plant networks in continuous Amazonian forests with those in forest fragments. We hypothesized that networks in fragments would have fewer species and higher connectance, but equal nestedness and resilience compared to forest networks. Only one of the nine metrics we compared differed between continuous forest and forest fragments, indicating that networks were resistant to the biotic and abiotic changes that accompany fragmentation. This is partially the result of the loss of only specialist species with one connection that were lost in forest fragments. Conclusions/Significance: We found that the networks of ant-plant mutualists in twenty-five year old fragments are similar to those in continuous forest, suggesting these interactions are resistant to the detrimental changes associated with habitat fragmentation, at least in landscapes that are a mosaic of fragments, regenerating forests, and pastures. However, ant-plant mutualistic networks may have several properties that may promote their persistence in fragmented landscapes. Proactive identification of key mutualist partners may be necessary to focus conservation efforts on the interactions that insure the integrity of network structure and the ecosystems services networks provide.	[Passmore, Heather A.; Bruna, Emilio M.] Univ Florida, Dept Wildlife Ecol & Conservat, Gainesville, FL 32610 USA; [Bruna, Emilio M.] Univ Florida, Ctr Latin Amer Studies, Gainesville, FL USA; [Heredia, Sylvia M.] Univ Calif Riverside, Dept Bot & Plant Sci, Riverside, CA 92521 USA; [Vasconcelos, Heraldo L.] Univ Fed Uberlandia, Inst Biol, BR-38400 Uberlandia, MG, Brazil; [Bruna, Emilio M.; Heredia, Sylvia M.; Vasconcelos, Heraldo L.] Inst Nacl de Pesquisas da Amazonia, Biol Dynam Forest Fragments Project, Manaus, Amazonas, Brazil; [Bruna, Emilio M.; Heredia, Sylvia M.; Vasconcelos, Heraldo L.] Smithsonian Trop Res Inst, Manaus, Amazonas, Brazil	State University System of Florida; University of Florida; State University System of Florida; University of Florida; University of California System; University of California Riverside; Universidade Federal de Uberlandia; Institute Nacional de Pesquisas da Amazonia; Smithsonian Institution; Smithsonian Tropical Research Institute	Passmore, HA (corresponding author), Univ Florida, Dept Wildlife Ecol & Conservat, Gainesville, FL 32610 USA.	embruna@ufl.edu	Bruna, Emilio M/H-2769-2012; Vasconcelos, Heraldo L/C-3353-2013	Bruna, Emilio M/0000-0003-3381-8477; Vasconcelos, Heraldo L/0000-0001-6969-7131	United States National Science Foundation [DEB-0453631, DEB-0309819]	United States National Science Foundation(National Science Foundation (NSF))	This research was supported by grants DEB-0453631 and DEB-0309819 from the United States National Science Foundation (http://nsf.gov). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ATMAR W, 1993, OECOLOGIA, V96, P373, DOI 10.1007/BF00317508; Banasek-Richter C, 2004, J THEOR BIOL, V226, P23, DOI 10.1016/S0022-5193(03)00305-9; Banasek-Richter C, 2009, ECOLOGY, V90, P1470, DOI 10.1890/08-2207.1; Bascompte J, 2003, P NATL ACAD SCI USA, V100, P9383, DOI 10.1073/pnas.1633576100; Bascompte J, 2007, ANNU REV ECOL EVOL S, V38, P567, DOI 10.1146/annurev.ecolsys.38.091206.095818; Bascompte J, 2009, SCIENCE, V325, P416, DOI 10.1126/science.1170749; Bascompte J, 2009, PHILOS T R SOC B, V364, P1781, DOI 10.1098/rstb.2008.0226; BAWA KS, 1990, ANNU REV ECOL SYST, V21, P399, DOI 10.1146/annurev.es.21.110190.002151; Bezerra ELS, 2009, J ANIM ECOL, V78, P1096, DOI 10.1111/j.1365-2656.2009.01567.x; BIERREGAARD RO, 2002, LESSONS AMAZONIA ECO; Bluthgen N, 2007, CURR BIOL, V17, P341, DOI 10.1016/j.cub.2006.12.039; Bronstein JL, 1998, BIOTROPICA, V30, P150, DOI 10.1111/j.1744-7429.1998.tb00050.x; BRONSTEIN JL, 1994, Q REV BIOL, V69, P31, DOI 10.1086/418432; Bruna EM, 2005, BIOL CONSERV, V124, P209, DOI 10.1016/j.biocon.2005.01.026; Bruna EM, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022937; Burgos E, 2007, J THEOR BIOL, V249, P307, DOI 10.1016/j.jtbi.2007.07.030; Burkle LA, 2011, AM J BOT, V98, P528, DOI 10.3732/ajb.1000391; Davies KF, 2004, ECOLOGY, V85, P265, DOI 10.1890/03-0110; Diaz-Castelazo C, 2010, ECOLOGY, V91, P793, DOI 10.1890/08-1883.1; Dormann C.F., 2008, R NEWS, V8, P8, DOI DOI 10.1159/000265935; Dormann C. F., 2009, OPEN ECOL J, V2, P7, DOI DOI 10.2174/1874213000902010007; FEARNSIDE PM, 2002, LESSONS AMAZONIA ECO, P291; Ferraz G, 2003, P NATL ACAD SCI USA, V100, P14069, DOI 10.1073/pnas.2336195100; FONSECA CR, 1994, J ECOL, V82, P833, DOI 10.2307/2261447; Fonseca CR, 1996, J ANIM ECOL, V65, P339, DOI 10.2307/5880; Fortuna MA, 2006, ECOL LETT, V9, P278, DOI 10.1111/j.1461-0248.2005.00868.x; Galeano J, 2009, ENVIRON MODELL SOFTW, V24, P1342, DOI 10.1016/j.envsoft.2009.05.014; Gilbert AJ, 2009, ECOL INDIC, V9, P72, DOI 10.1016/j.ecolind.2008.01.010; Girao LC, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000908; Gonzalez A, 2011, AM J BOT, V98, P503, DOI 10.3732/ajb.1000424; Guimaraes PR, 2007, CURR BIOL, V17, P1797, DOI 10.1016/j.cub.2007.09.059; Heil M, 2003, ANNU REV ECOL EVOL S, V34, P425, DOI 10.1146/annurev.ecolsys.34.011802.132410; Henle K, 2004, BIODIVERS CONSERV, V13, P207, DOI 10.1023/B:BIOC.0000004319.91643.9e; Ings TC, 2009, J ANIM ECOL, V78, P253, DOI 10.1111/j.1365-2656.2008.01460.x; JANZEN DH, 1974, NAT HIST, V83, P48; JANZEN DH, 1969, ECOLOGY, V50, P147, DOI 10.2307/1934677; JORDANO P, 1987, AM NAT, V129, P657, DOI 10.1086/284665; Kaartinen R, 2011, J ANIM ECOL, V80, P622, DOI 10.1111/j.1365-2656.2011.01811.x; Kiers ET, 2010, ECOL LETT, V13, P1459, DOI 10.1111/j.1461-0248.2010.01538.x; Laurance W. F., 2001, LESSONS AMAZONIA ECO, P158; Laurance WF, 2002, CONSERV BIOL, V16, P605, DOI 10.1046/j.1523-1739.2002.01025.x; Laurance WF, 2011, BIOL CONSERV, V144, P56, DOI 10.1016/j.biocon.2010.09.021; Memmott J, 2004, P ROY SOC B-BIOL SCI, V271, P2605, DOI 10.1098/rspb.2004.2909; Memmott J, 2007, ECOL LETT, V10, P710, DOI 10.1111/j.1461-0248.2007.01061.x; Morales JM, 2008, OIKOS, V117, P1362, DOI 10.1111/j.0030-1299.2008.16737.x; Morris RJ, 2010, PHILOS T R SOC B, V365, P3709, DOI 10.1098/rstb.2010.0273; Okuyama T, 2008, ECOL LETT, V11, P208, DOI 10.1111/j.1461-0248.2007.01137.x; Passmore HA, 2012, DRYAD DIGITAL REPOSI, DOI 105061/dryadpf2r0; Piazzon M, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019637; Ramos-Jiliberto R, 2009, OECOLOGIA, V160, P697, DOI 10.1007/s00442-009-1344-7; Sabatino M, 2010, ECOL APPL, V20, P1491, DOI 10.1890/09-1626.1; Sodhi NS, 2005, ANIM CONSERV, V8, P217, DOI 10.1017/S1367943005001927; Trager MD, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0014308; Tylianakis JM, 2008, ECOL LETT, V11, P1351, DOI 10.1111/j.1461-0248.2008.01250.x; Tylianakis JM, 2007, NATURE, V445, P202, DOI 10.1038/nature05429; Valladares G, 2012, OIKOS, V121, P299, DOI 10.1111/j.1600-0706.2011.19671.x; Vazquez DP, 2004, ECOLOGY, V85, P1251, DOI 10.1890/03-3112; Vazquez DP, 2002, AM NAT, V159, P606, DOI 10.1086/339991; Vermaat JE, 2009, ECOLOGY, V90, P278, DOI 10.1890/07-0978.1	59	25	25	0	72	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 9	2012	7	8							e40803	10.1371/journal.pone.0040803	http://dx.doi.org/10.1371/journal.pone.0040803			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	986WZ	22912666	Green Published, gold, Green Submitted			2022-12-25	WOS:000307378500003
J	Xu, JZ; Li, K; Smith, RA; Waterton, JC; Zhao, P; Chen, HD; Does, MD; Manning, HC; Gore, JC				Xu, Junzhong; Li, Ke; Smith, R. Adam; Waterton, John C.; Zhao, Ping; Chen, Heidi; Does, Mark D.; Manning, H. Charles; Gore, John C.			Characterizing Tumor Response to Chemotherapy at Various Length Scales Using Temporal Diffusion Spectroscopy	PLOS ONE			English	Article							BRAIN; GRADIENT; MRI; COEFFICIENT; CANCER; CELLULARITY; BIOMARKER; DENSITY; SYSTEMS; CELLS	Measurements of apparent diffusion coefficient (ADC) using magnetic resonance imaging (MRI) have been suggested as potential imaging biomarkers for monitoring tumor response to treatment. However, conventional pulsed-gradient spin echo (PGSE) methods incorporate relatively long diffusion times, and are usually sensitive to changes in cell density and necrosis. Diffusion temporal spectroscopy using the oscillating gradient spin echo (OGSE) sequence is capable of probing short length scales, and may detect significant intracellular microstructural changes independent of gross cell density changes following anti-cancer treatment. To test this hypothesis, SW620 xenografts were treated by barasertib (AZD1152), a selective inhibitor of Aurora B kinase which causes SW620 cancer cells to develop polyploidy and increase in size following treatment, ultimately leading to cell death through apoptosis. Following treatment, the ADC values obtained by both the PGSE and low frequency OGSE methods increased. However, the ADC values at high gradient frequency (i.e. short diffusion times) were significantly lower in treated tumors, consistent with increased intracellular restrictions/hindrances. This suggests that ADC values at long diffusion times are dominated by tumor microstructure at long length scales, and may not convey unambiguous information of subcellular space. While the diffusion temporal spectroscopy provides more comprehensive means to probe tumor microstructure at various length scales. This work is the first study to probe intracellular microstructural variations due to polyploidy following treatment using diffusion MRI in vivo. It is also the first observation of post-treatment ADC changes occurring in opposite directions at short and long diffusion times. The current study suggests that temporal diffusion spectroscopy potentially provides pharmacodynamic biomarkers of tumor early response which distinguish microstructural variations following treatment at both the subcellular and supracellular length scales.	[Xu, Junzhong; Li, Ke; Smith, R. Adam; Zhao, Ping; Does, Mark D.; Manning, H. Charles; Gore, John C.] Vanderbilt Univ, Inst Imaging Sci, Nashville, TN 37203 USA; [Xu, Junzhong; Li, Ke; Smith, R. Adam; Zhao, Ping; Does, Mark D.; Manning, H. Charles; Gore, John C.] Vanderbilt Univ, Dept Radiol & Radiol Sci, Nashville, TN USA; [Waterton, John C.] AstraZeneca, Alderley Pk, Cheshire, England; [Chen, Heidi] Vanderbilt Univ, Dept Biostat, Nashville, TN USA; [Does, Mark D.; Gore, John C.] Vanderbilt Univ, Dept Biomed Engn, Nashville, TN 37235 USA; [Gore, John C.] Vanderbilt Univ, Dept Mol Physiol & Biophys, Nashville, TN 37232 USA	Vanderbilt University; Vanderbilt University; AstraZeneca; Vanderbilt University; Vanderbilt University; Vanderbilt University	Xu, JZ (corresponding author), Vanderbilt Univ, Inst Imaging Sci, Nashville, TN 37203 USA.	junzhong.xu@vanderbilt.edu	Waterton, John Charles/A-8565-2008; Xu, junzhong/E-6731-2010	Waterton, John Charles/0000-0002-7734-2290; Xu, junzhong/0000-0001-7895-4232	National Institutes of Health [R01CA109106, R01CA140628, P50CA128323, U24CA126588]; AstraZeneca; In Vivo Cellular and Molecular Imaging Center (ICMIC) at Vanderbilt University; NATIONAL CANCER INSTITUTE [U24CA126588, R01CA109106, R01CA140628, P50CA128323] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); AstraZeneca(AstraZeneca); In Vivo Cellular and Molecular Imaging Center (ICMIC) at Vanderbilt University; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	The authors would like to acknowledge financial support from National Institutes of Health Grant #R01CA109106, #R01CA140628, #P50CA128323 and #U24CA126588. This work was also part-funded by AstraZeneca. JX was supported by a career development award from the In Vivo Cellular and Molecular Imaging Center (ICMIC) at Vanderbilt University. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aggarwal M, 2012, MAGN RESON MED, V67, P98, DOI 10.1002/mrm.22981; Aksel B, 2007, MAGN RESON MED, V58, P134, DOI 10.1002/mrm.21263; [Anonymous], 2009, NEOPLASIA, V11, P102, DOI 10.1593/neo.81328; Chenevert TL, 1997, CLIN CANCER RES, V3, P1457; Colvin DC, 2008, CANCER RES, V68, P5941, DOI 10.1158/0008-5472.CAN-08-0832; Colvin DC, 2011, MAGN RESON MED, V65, P796, DOI 10.1002/mrm.22666; Colvin DC, 2011, MAGN RESON IMAGING, V29, P315, DOI 10.1016/j.mri.2010.10.003; Does MD, 2003, MAGN RESON MED, V49, P206, DOI 10.1002/mrm.10385; Gautschi O, 2008, CLIN CANCER RES, V14, P1639, DOI 10.1158/1078-0432.CCR-07-2179; Gauvain KM, 2001, AM J ROENTGENOL, V177, P449, DOI 10.2214/ajr.177.2.1770449; Gore JC, 2010, NMR BIOMED, V23, P745, DOI 10.1002/nbm.1531; Guo Y, 2002, J MAGN RESON IMAGING, V16, P172, DOI 10.1002/jmri.10140; HONG XL, 1992, J MAGN RESON, V99, P561, DOI 10.1016/0022-2364(92)90210-X; Hosey TP, 2003, DIFFUSION TENSOR IMA, P2123; Lyng H, 2000, MAGNET RESON MED, V43, P828, DOI 10.1002/1522-2594(200006)43:6<828::AID-MRM8>3.0.CO;2-P; MAKI JH, 1991, MAGNET RESON MED, V17, P95, DOI 10.1002/mrm.1910170114; McHugh DJ, 2011, PROBING TISSUE MICRO, P1147; Moffat BA, 2005, P NATL ACAD SCI USA, V102, P5524, DOI 10.1073/pnas.0501532102; Moffat BA, 2006, NEOPLASIA, V8, P259, DOI 10.1593/neo.05844; Mori S, 1998, MAGNET RESON MED, V40, P511, DOI 10.1002/mrm.1910400403; Moroz MA, 2011, CLIN CANCER RES, V17, P1099, DOI 10.1158/1078-0432.CCR-10-1430; MOSELEY ME, 1990, MAGN RESON MED, V14, P330, DOI 10.1002/mrm.1910140218; NEEMAN M, 1991, MAGNET RESON MED, V21, P138, DOI 10.1002/mrm.1910210117; Parsons EC, 2006, MAGNET RESON MED, V55, P75, DOI 10.1002/mrm.20732; Parsons EC, 2002, NUCL MAGNETIC RESONA; RIGHINI A, 1994, MAGN RESON IMAGING, V12, P865, DOI 10.1016/0730-725X(94)92027-3; Ross BD, 2003, MOL CANCER THER, V2, P581; STEJSKAL EO, 1965, J CHEM PHYS, V42, P288, DOI 10.1063/1.1695690; STEPISNIK J, 1981, PHYSICA B & C, V104, P350, DOI 10.1016/0378-4363(81)90182-0; Storchova Z, 2004, NAT REV MOL CELL BIO, V5, P45, DOI 10.1038/nrm1276; Sugahara T, 1999, JMRI-J MAGN RESON IM, V9, P53, DOI 10.1002/(SICI)1522-2586(199901)9:1<53::AID-JMRI7>3.0.CO;2-2; TSURUDA JS, 1991, MAGNET RESON MED, V19, P316, DOI 10.1002/mrm.1910190221; Wilkinson RW, 2007, CLIN CANCER RES, V13, P3682, DOI 10.1158/1078-0432.CCR-06-2979; Xu JZ, 2011, MAGN RESON MED, V65, P920, DOI 10.1002/mrm.22704; Xu JZ, 2011, MAGN RESON IMAGING, V29, P380, DOI 10.1016/j.mri.2010.10.002; Xu J, 2009, MAGN RESON MED, V61, P828, DOI 10.1002/mrm.21793; Zhao M, 1996, BRIT J CANCER, V73, P61, DOI 10.1038/bjc.1996.11	37	35	36	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 24	2012	7	7							e41714	10.1371/journal.pone.0041714	http://dx.doi.org/10.1371/journal.pone.0041714			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	978NX	22911846	Green Published, gold, Green Submitted			2022-12-25	WOS:000306751300065
J	Anthony, KC; Kaur, J; Kak, I; Assi, J; MacMillan, C; Ralhan, R; Walfish, PG				Anthony, K. -C.; Kaur, Jatinder; Kak, Ipshita; Assi, Jasmeet; MacMillan, Christina; Ralhan, Ranju; Walfish, Paul G.			Biotinidase is a Novel Marker for Papillary Thyroid Cancer Aggressiveness	PLOS ONE			English	Article							FINE-NEEDLE-ASPIRATION; ENDOTHELIAL GROWTH-FACTOR; BRAF V600E MUTATION; CARCINOMAS; RECURRENCE; EXPRESSION; KINASE	Biotinidase was identified in secretome analysis of thyroid cancer cell lines using proteomics. The goal of the current study was to analyze the expression of biotinidase in thyroid cancer tissues and fine needle aspiration (FNA) samples to evaluate its diagnostic and prognostic potential in thyroid cancer. Immunohistochemical analysis of biotinidase was carried out in 129 papillary thyroid cancer (PTC, 34 benign thyroid tissues and 43 FNA samples and correlated with patients' prognosis. Overall biotinidase expression was decreased in PTC compared to benign nodules (p = 0.001). Comparison of aggressive and non-aggressive PTC showed decrease in overall biotinidase expression in the former (p = 0.001). Loss of overall biotinidase expression was associated with poor disease free survival (p = 0.019, Hazards ratio (HR) = 3.1). We examined the effect of subcellular compartmentalization of nuclear and cytoplasmic biotinidase on patient survival. Decreased nuclear expression of biotinidase was observed in PTC as compared to benign tissues (p, 0.001). Upon stratification within PTC, nuclear expression was reduced in aggressive as compared to non-aggressive tumors (p, 0.001). Kaplan-Meier survival analysis showed significant association of loss of nuclear biotinidase expression with reduced disease free survival (p = 0.014, HR = 5.4). Cytoplasmic biotinidase expression was reduced in aggressive thyroid cancers in comparison with non-aggressive tumors (p = 0.002, Odds ratio (OR) = 0.29) which was evident by its significant association with advanced T stage (p = 0.003, OR = 0.28), nodal metastasis (p<0.001, OR = 0.16), advanced TNM stage (p, 0.001, OR = 0.21) and extrathyroidal extension (p = 0.001, OR = 0.23). However, in multivariate analysis extrathyroidal extension emerged as the most significant prognostic marker for aggressive thyroid carcinomas (p = 0.015, HR = 12.8). In conclusion, loss of overall biotinidase expression is a novel marker for thyroid cancer aggressiveness.	[Anthony, K. -C.; Kaur, Jatinder; Kak, Ipshita; Assi, Jasmeet; Ralhan, Ranju; Walfish, Paul G.] Mt Sinai Hosp, Alex & Simona Shnaider Lab Mol Oncol, Dept Pathol & Lab Med, Joseph & Wolf Lebov Hlth Complex, Toronto, ON M5G 1X5, Canada; [Ralhan, Ranju; Walfish, Paul G.] Mt Sinai Hosp, Joseph & Mildred Sonshine Family Ctr Head & Neck, Toronto, ON M5G 1X5, Canada; [Ralhan, Ranju; Walfish, Paul G.] Mt Sinai Hosp, Dept Otolaryngol Head & Neck Surg, Toronto, ON M5G 1X5, Canada; [Ralhan, Ranju; Walfish, Paul G.] Univ Toronto, Dept Otolaryngol Head & Neck Surg, Toronto, ON, Canada	University of Toronto; University Toronto Affiliates; Sinai Health System Toronto; Lunenfeld Tanenbaum Research Institute; University of Toronto; University Toronto Affiliates; Sinai Health System Toronto; University of Toronto; University Toronto Affiliates; Sinai Health System Toronto; Lunenfeld Tanenbaum Research Institute; University of Toronto	Anthony, KC (corresponding author), Mt Sinai Hosp, Alex & Simona Shnaider Lab Mol Oncol, Dept Pathol & Lab Med, Joseph & Wolf Lebov Hlth Complex, Toronto, ON M5G 1X5, Canada.	rralhan@mtsinai.on.ca; pwalfish@mtsinai.on.ca	Bhurji, Jatinder K/B-6767-2013; Kak, Ipshita/AAK-8658-2021	Kaur, Jatinder/0000-0003-1650-0707	Mount Sinai Foundation of Toronto; Da Vinci Gala Fundraiser; Alex and Simona Shnaider Chair in Thyroid Cancer; Temmy Latner/Dynacare Foundation; Mount Sinai Hospital Department of Medicine Research Fund	Mount Sinai Foundation of Toronto; Da Vinci Gala Fundraiser; Alex and Simona Shnaider Chair in Thyroid Cancer; Temmy Latner/Dynacare Foundation; Mount Sinai Hospital Department of Medicine Research Fund	The financial support of this work from Mount Sinai Foundation of Toronto, Da Vinci Gala Fundraiser, Alex and Simona Shnaider Chair in Thyroid Cancer, The Temmy Latner/Dynacare Foundation, and the Mount Sinai Hospital Department of Medicine Research Fund is gratefully acknowledged. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Carpi A, 2008, CANCER LETT, V264, P163, DOI 10.1016/j.canlet.2008.02.056; Catalano MG, 2012, FRONTIERS IN ENDOCRI, P3; Ciampi R, 2005, ENDOCR PATHOL, V16, P163, DOI 10.1385/EP:16:3:163; Coorough N, 2011, J SURG RES, V170, P48, DOI 10.1016/j.jss.2011.02.048; Durante C, 2007, J CLIN ENDOCR METAB, V92, P2840, DOI 10.1210/jc.2006-2707; Fagin JA, 2004, J ENDOCRINOL, V183, P249, DOI 10.1677/joe.1.05895; Ghossein R, 2009, ARCH PATHOL LAB MED, V133, P683, DOI 10.1043/1543-2165-133.5.683; Guerra A, 2012, J CLIN ENDOCRINOL ME; Huang L, 2011, CANCER-AM CANCER SOC, V117, P3363, DOI 10.1002/cncr.25870; Jemal A, 2011, CA-CANCER J CLIN, V61, P134, DOI [10.3322/caac.20115, 10.3322/caac.20107]; Jo YS, 2006, J CLIN ENDOCR METAB, V91, P3667, DOI 10.1210/jc.2005-2836; Kang UB, 2010, BMC CANCER, V10, DOI 10.1186/1471-2407-10-114; Kashat L, 2010, J PROTEOME RES, V9, P5757, DOI 10.1021/pr100529t; Kazaure HS, 2011, ANN SURG ONCOL; Knauf JA, 2011, ONCOGENE, V30, P3153, DOI 10.1038/onc.2011.44; Lee JI, 2012, HEAD NECK; Lee ST, 2012, J CLIN ENDOCRINOL ME; Lennard CM, 2001, SURGERY, V129, P552, DOI 10.1067/msy.2001.112592; Lin JD, 2005, THYROID, V15, P708, DOI 10.1089/thy.2005.15.708; Nagaiah G, 2011, J ONCOL, V2011, DOI 10.1155/2011/542358; Nikiforov YE, 2009, J CLIN ENDOCR METAB, V94, P2092, DOI 10.1210/jc.2009-0247; Pelttari H, 2012, APMIS, V120, P380, DOI 10.1111/j.1600-0463.2011.02844.x; Ralhan R, 2010, BMC CANCER, V10, DOI 10.1186/1471-2407-10-331; Ricarte-Filho J, 2012, THYROID; Smallridge RC, 2009, ENDOCR-RELAT CANCER, V16, P17, DOI 10.1677/ERC-08-0154; Smith BR, 2006, THYROID, V16, P109, DOI 10.1089/thy.2006.16.109; Zempleni Janos, 2008, Expert Rev Endocrinol Metab, V3, P715, DOI 10.1586/17446651.3.6.715	27	4	4	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 23	2012	7	7							e40956	10.1371/journal.pone.0040956	http://dx.doi.org/10.1371/journal.pone.0040956			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	977TM	22911723	Green Published, gold, Green Submitted			2022-12-25	WOS:000306687700027
J	Buler, JJ; Randall, LA; Fleskes, JP; Barrow, WC; Bogart, T; Kluver, D				Buler, Jeffrey J.; Randall, Lori A.; Fleskes, Joseph P.; Barrow, Wylie C., Jr.; Bogart, Tianna; Kluver, Daria			Mapping Wintering Waterfowl Distributions Using Weather Surveillance Radar	PLOS ONE			English	Article							CALIFORNIA CENTRAL-VALLEY; FEMALE NORTHERN PINTAILS; BIRD MOVEMENTS; SATELLITE TELEMETRY; SPRING MIGRATION; VISIBILITY BIAS; AERIAL SURVEYS; GREAT-LAKES; PATTERNS; WSR-88D	The current network of weather surveillance radars within the United States readily detects flying birds and has proven to be a useful remote-sensing tool for ornithological study. Radar reflectivity measures serve as an index to bird density and have been used to quantitatively map landbird distributions during migratory stopover by sampling birds aloft at the onset of nocturnal migratory flights. Our objective was to further develop and validate a similar approach for mapping wintering waterfowl distributions using weather surveillance radar observations at the onset of evening flights. We evaluated data from the Sacramento, CA radar (KDAX) during winters 1998-1999 and 1999-2000. We determined an optimal sampling time by evaluating the accuracy and precision of radar observations at different times during the onset of evening flight relative to observed diurnal distributions of radio-marked birds on the ground. The mean time of evening flight initiation occurred 23 min after sunset with the strongest correlations between reflectivity and waterfowl density on the ground occurring almost immediately after flight initiation. Radar measures became more spatially homogeneous as evening flight progressed because birds dispersed from their departure locations. Radars effectively detected birds to a mean maximum range of 83 km during the first 20 min of evening flight. Using a sun elevation angle of -5 degrees (28 min after sunset) as our optimal sampling time, we validated our approach using KDAX data and additional data from the Beale Air Force Base, CA (KBBX) radar during winter 1998-1999. Bias-adjusted radar reflectivity of waterfowl aloft was positively related to the observed diurnal density of radio-marked waterfowl locations on the ground. Thus, weather radars provide accurate measures of relative wintering waterfowl density that can be used to comprehensively map their distributions over large spatial extents.	[Buler, Jeffrey J.] Univ Delaware, Dept Entomol & Wildlife Ecol, Newark, DE 19716 USA; [Randall, Lori A.; Barrow, Wylie C., Jr.] US Geol Survey, Natl Wetlands Res Ctr, Lafayette, LA USA; [Fleskes, Joseph P.] US Geol Survey, Western Ecol Res Ctr, Dixon, CA USA; [Bogart, Tianna; Kluver, Daria] Univ Delaware, Dept Geog, Newark, DE USA	University of Delaware; United States Department of the Interior; United States Geological Survey; United States Department of the Interior; United States Geological Survey; University of Delaware	Buler, JJ (corresponding author), Univ Delaware, Dept Entomol & Wildlife Ecol, Newark, DE 19716 USA.	jbuler@udel.edu	Buler, Jeffrey/H-3207-2019	Buler, Jeffrey/0000-0002-2696-847X; Bogart, Tianna/0000-0003-0296-8798	United States Department of Agriculture Natural Resources Conservation Service	United States Department of Agriculture Natural Resources Conservation Service	Financial support was provided by the United States Department of Agriculture Natural Resources Conservation Service. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akesson S, 1996, J AVIAN BIOL, V27, P95, DOI 10.2307/3677138; ANDRIEU H, 1995, J APPL METEOROL, V34, P225, DOI 10.1175/1520-0450(1995)034&lt;0225:IOVPOR&gt;2.0.CO;2; [Anonymous], 1993, DOPPLER RADAR WEATHE; BALDASSARRE GA, 1984, J WILDLIFE MANAGE, V48, P63, DOI 10.2307/3808453; Bech J, 2003, J ATMOS OCEAN TECH, V20, P845, DOI 10.1175/1520-0426(2003)020<0845:TSOSPW>2.0.CO;2; Black JE, 1999, WEATHER FORECAST, V14, P1039, DOI 10.1175/1520-0434(1999)014<1039:CODOBM>2.0.CO;2; Bonter DN, 2009, CONSERV BIOL, V23, P440, DOI 10.1111/j.1523-1739.2008.01085.x; Bruderer B, 2001, IBIS, V143, P178, DOI 10.1111/j.1474-919X.2001.tb04475.x; Buler JJ, 2011, J ORNITHOL, V152, P101, DOI 10.1007/s10336-010-0640-7; Buler JJ, 2009, IEEE T GEOSCI REMOTE, V47, P2741, DOI 10.1109/TGRS.2009.2014463; Chrisman J., 1995, WSR 88D CLUTTER SUPP; Cox RR, 1996, CONDOR, V98, P810, DOI 10.2307/1369861; Cressie N. A. C., 1993, STAT SPATIAL DATA WI; CRUM TD, 1993, B AM METEOROL SOC, V74, P1669, DOI 10.1175/1520-0477(1993)074<1669:TWATWO>2.0.CO;2; Diehl RH, 2003, AUK, V120, P278, DOI 10.1642/0004-8038(2003)120[0278:ROOBMO]2.0.CO;2; DIEHL RH, 2005, BIRD CONSERVATION IM, P876; ELY CR, 1992, CONDOR, V94, P857, DOI 10.2307/1369283; Fleskes J.P., 2005, WATERFOWL DISTRIBUTI; Fleskes JP, 2007, J WILDLIFE MANAGE, V71, P2238, DOI 10.2193/2005-634; Fleskes JP, 2002, J WILDLIFE MANAGE, V66, P138, DOI 10.2307/3802880; GAUTHREA.SA, 1971, AUK, V88, P343, DOI 10.2307/4083884; Gauthreaux SA, 2003, AVIAN MIGRATION, P335; Gauthreaux SA, 2003, AUK, V120, P266, DOI 10.1642/0004-8038(2003)120[0266:ROABC]2.0.CO;2; Gauthreaux SA, 1998, WEATHER FORECAST, V13, P453, DOI 10.1175/1520-0434(1998)013<0453:DOBMOT>2.0.CO;2; Gauthreaux SA, 1999, WEATHER FORECAST, V14, P1041, DOI 10.1175/1520-0434(1999)014<1041:R>2.0.CO;2; Haig SM, 1998, CONSERV BIOL, V12, P749, DOI 10.1046/j.1523-1739.1998.97102.x; HEBRARD J J, 1971, Ibis, V113, P8, DOI 10.1111/j.1474-919X.1971.tb05119.x; HEDENSTROM A, 1992, J EXP BIOL, V164, P19; JOHNSON FA, 1989, WILDLIFE SOC B, V17, P222; Kucera PA, 2004, J ATMOS OCEAN TECH, V21, P995, DOI 10.1175/1520-0426(2004)021<0995:RBOSUG>2.0.CO;2; Littlefield CD, 2000, CONSERVATION ASSESSM; MILLER M R, 1985, Wildfowl, V36, P53; Miller MR, 2005, WILSON BULL, V117, P364, DOI 10.1676/04-114.1; Miller MR, 2005, CAN J ZOOL, V83, P1314, DOI 10.1139/Z05-125; O'Neal BJ, 2010, J FIELD ORNITHOL, V81, P71, DOI 10.1111/j.1557-9263.2009.00263.x; ORIANS GH, 1961, ECOL MONOGR, V31, P285, DOI 10.2307/1948556; PAULUS S L, 1988, P135; POLLOCK KH, 1987, J WILDLIFE MANAGE, V51, P502, DOI 10.2307/3801040; Randall LA, 2011, J WILDLIFE MANAGE, V75, P1324, DOI 10.1002/jwmg.173; RAVELING DG, 1972, WILSON BULL, V84, P278; Russell KR, 1998, J FIELD ORNITHOL, V69, P316; Ruth JM, 2008, MANAGEMENT RES APPL; SEIBERT HENRI C., 1951, AUK, V68, P63; Shuford WD, 1998, CONDOR, V100, P227, DOI 10.2307/1370264; Silverman B.W., 1986, DENSITY ESTIMATION S; Stafford JD, 2010, WETLANDS, V30, P565, DOI 10.1007/s13157-010-0049-3; TAMISIER A, 1976, Wildfowl, V27, P19; Thompson WL, 2002, AUK, V119, P18, DOI 10.1642/0004-8038(2002)119[0018:TRBSAF]2.0.CO;2; U.S. Fish and Wildlife Service, 1978, CONC PLAN WAT WINT H; Warnock SE, 1995, AUK, V112, P920, DOI 10.2307/4089023	50	24	25	0	29	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 23	2012	7	7							e41571	10.1371/journal.pone.0041571	http://dx.doi.org/10.1371/journal.pone.0041571			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	977TM	22911816	Green Published, gold, Green Submitted			2022-12-25	WOS:000306687700114
J	Chen, T; Huang, Q; Li, ZL; Zhang, W; Lu, CP; Yao, HC				Chen, Tao; Huang, Qin; Li, Zhaolong; Zhang, Wei; Lu, Chengping; Yao, Huochun			Construction and Characterization of a Streptococcus suis Serotype 2 Recombinant Expressing Enhanced Green Fluorescent Protein	PLOS ONE			English	Article							FLOW-CYTOMETRY; VIRULENCE; BACTERIA; GFP; IDENTIFICATION; PHAGOCYTOSIS; PATHOGEN; TYPE-2; HEMOLYSIN; SUILYSIN	Streptococcus suis serotype 2 (S. suis 2) is an important pathogen, responsible for diverse diseases in swine and humans. To obtain a S. suis 2 strain that can be tracked in vitro and in vivo, we constructed the Egfp-HA9801 recombinant S. suis 2 strain with egfp and spc(r) genes inserted via homologous recombination. To assess the effects of the egfp and spc(r) genes in HA9801, the biochemical characteristics, growth features and virulence in Balb/C mice were compared between the recombinant and the parent HA9801 strain. We detected the EGFP expression from Egfp-HA9801 by epifluorescence microscopy. The results showed that the biochemical characterization and growth features of the Egfp-HA9801 recombinant were highly similar to that of the parent HA9801. We did not find significant differences in lethality (50% lethal dose), morbidity and mortality between the two strains. Furthermore, the bacterial counts in each various tissues of Egfp-HA9801-infected mice displayed similar dynamic compared with the HA9801-infected mice. Our results also showed that the Egfp-HA9801 cells grown at 37 degrees C for 36 h displayed greater green fluorescence signals than the cells grown at 28 degrees C for 36 h and 37 degrees C for 24 h. The fluorescence in the tissue cryosections of Egfp-HA9801-injected mice was also stronger than that of the HA9801 group. Together, these results indicate that the egfp and spc(r) insertions into the Egfp-HA9801 recombinant did not significantly change the virulence when compared with HA980, and this EGFP labeled strain can be used for future S. suis 2 pathogenesis research.	[Chen, Tao; Huang, Qin; Li, Zhaolong; Zhang, Wei; Lu, Chengping; Yao, Huochun] Nanjing Agr Univ, Minist Agr, Key Lab Anim Bacteriol, Nanjing, Jiangsu, Peoples R China	Ministry of Agriculture & Rural Affairs; Nanjing Agricultural University	Chen, T (corresponding author), Nanjing Agr Univ, Minist Agr, Key Lab Anim Bacteriol, Nanjing, Jiangsu, Peoples R China.	yaohch@njau.edu.cn			Foundation of National Natural Science Foundation of China [30671558]; Priority Academic Program Development of Jiangsu Higher Education Institutions	Foundation of National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Priority Academic Program Development of Jiangsu Higher Education Institutions	This work was supported by The Foundation of National Natural Science Foundation of China (No. 30671558), and The Priority Academic Program Development of Jiangsu Higher Education Institutions. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Berthelot-Herault F, 2000, VET RES, V31, P473, DOI 10.1051/vetres:2000133; CHANTER N, 1993, VET MICROBIOL, V36, P39, DOI 10.1016/0378-1135(93)90127-S; de Greeff A, 2002, INFECT IMMUN, V70, P1319, DOI 10.1128/IAI.70.3.1319-1325.2002; Dominguez-Punaro MC, 2007, J IMMUNOL, V179, P1842, DOI 10.4049/jimmunol.179.3.1842; Gottschalk Marcelo, 2007, Animal Health Research Reviews, V8, P29, DOI 10.1017/S1466252307001247; GOTTSCHALK MG, 1995, MICROBIOL-SGM, V141, P189, DOI 10.1099/00221287-141-1-189; Hansen MC, 2001, MICROBIOL-SGM, V147, P1383, DOI 10.1099/00221287-147-5-1383; Heinzelmann M, 1999, MICROBIOL IMMUNOL, V43, P505, DOI 10.1111/j.1348-0421.1999.tb02435.x; JACOBS AAC, 1994, INFECT IMMUN, V62, P1742, DOI 10.1128/IAI.62.5.1742-1748.1994; Jean PC, 1995, GENE, V164, P123; Jin Z, 2005, J BIOTECHNOL, V119, P368; Li L, 2008, MICROB PATHOGENESIS, V45, P192, DOI 10.1016/j.micpath.2008.05.008; Lun ZR, 2007, LANCET INFECT DIS, V7, P201, DOI 10.1016/S1473-3099(07)70001-4; Nicholas B, 2001, ANAL BIOCHEM, V291, P175; Normile D, 2005, SCIENCE, V309, P1308; Rodriguez ME, 2001, J IMMUNOL METHODS, V252, P33, DOI 10.1016/S0022-1759(01)00329-5; Schnell SA, 1999, J HISTOCHEM CYTOCHEM, V47, P719, DOI 10.1177/002215549904700601; Scott KP, 1998, FEMS MICROBIOL ECOL, V26, P219, DOI 10.1111/j.1574-6941.1998.tb00507.x; Shichun L, 2004, J MICROBIOLOGICAL ME, V56, P401; Smith HE, 1999, INFECT IMMUN, V67, P1750; Staats JJ, 1997, VET RES COMMUN, V21, P381, DOI 10.1023/A:1005870317757; Stretton S, 1998, APPL ENVIRON MICROB, V64, P2554; Suarez A, 1997, GENE, V196, P69, DOI 10.1016/S0378-1119(97)00197-2; Takamatsu D, 2001, PLASMID, V45, P101, DOI 10.1006/plas.2000.1510; Tombolini R, 1997, FEMS MICROBIOL ECOL, V22, P17, DOI 10.1111/j.1574-6941.1997.tb00352.x; Tsien RY, 1998, ANNU REV BIOCHEM, V67, P509, DOI 10.1146/annurev.biochem.67.1.509; Valdivia RH, 1996, GENE, V173, P47, DOI 10.1016/0378-1119(95)00706-7; Vanier G, 2009, MICROB PATHOGENESIS, V46, P13, DOI 10.1016/j.micpath.2008.10.003; VECHT U, 1991, INFECT IMMUN, V59, P3156, DOI 10.1128/IAI.59.9.3156-3162.1991; WILLIAMS AE, 1990, MICROB PATHOGENESIS, V8, P189, DOI 10.1016/0882-4010(90)90046-S; Yu HJ, 2006, EMERG INFECT DIS, V12, P914, DOI 10.3201/eid1206.051194; Zimmer M, 2002, CHEM REV, V102, P759, DOI 10.1021/cr010142r	32	2	3	0	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 20	2012	7	7							e39697	10.1371/journal.pone.0039697	http://dx.doi.org/10.1371/journal.pone.0039697			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	977GL	22911688	Green Published, gold, Green Submitted			2022-12-25	WOS:000306644600007
J	Jonsson, CB; Camp, JV; Wu, A; Zheng, HY; Kraenzle, JL; Biller, AE; Vanover, CD; Chu, YK; Ng, CK; Proctor, M; Sherwood, L; Steffen, MC; Mollura, DJ				Jonsson, Colleen B.; Camp, Jeremy V.; Wu, Albert; Zheng, Huaiyu; Kraenzle, Jennifer L.; Biller, Ashley E.; Vanover, Carol D.; Chu, Yong-Kyu; Ng, Chin K.; Proctor, Mary; Sherwood, Leslie; Steffen, Marlene C.; Mollura, Daniel J.			Molecular Imaging Reveals a Progressive Pulmonary Inflammation in Lower Airways in Ferrets Infected with 2009 H1N1 Pandemic Influenza Virus	PLOS ONE			English	Article							A H1N1; RECEPTOR SPECIFICITY; CELL TROPISM; HEMAGGLUTININ; D222G; SUBSTITUTION; PROFILES	Molecular imaging has gained attention as a possible approach for the study of the progression of inflammation and disease dynamics. Herein we used [F-18]-2-deoxy-2-fluoro-D-glucose ([F-18]-FDG) as a radiotracer for PET imaging coupled with CT (FDG-PET/CT) to gain insight into the spatiotemporal progression of the inflammatory response of ferrets infected with a clinical isolate of a pandemic influenza virus, H1N1 (H1N1pdm). The thoracic regions of mock-and H1N1pdm-infected ferrets were imaged prior to infection and at 1, 2, 3 and 6 days post-infection (DPI). On 1 DPI, FDG-PET/CT imaging revealed areas of consolidation in the right caudal lobe which corresponded with elevated [F-18]-FDG uptake (maximum standardized uptake values (SUVMax), 4.7-7.0). By days 2 and 3, consolidation (CT) and inflammation ([F-18]-FDG) appeared in the left caudal lobe. By 6 DPI, CT images showed extensive areas of patchy ground-glass opacities (GGO) and consolidations with the largest lesions having high SUVMax (6.0-7.6). Viral shedding and replication were detected in most nasal, throat and rectal swabs and nasal turbinates and lungs on 1, 2 and 3 DPI, but not on day 7, respectively. In conclusion, molecular imaging of infected ferrets revealed a progressive consolidation on CT with corresponding [F-18]-FDG uptake. Strong positive correlations were measured between SUVMax and bronchiolitis-related pathologic scoring (Spearman's rho = 0.75). Importantly, the extensive areas of patchy GGO and consolidation seen on CT in the ferret model at 6 DPI are similar to that reported for human H1N1pdm infections. In summary, these first molecular imaging studies of lower respiratory infection with H1N1pdm show that FDG-PET can give insight into the spatiotemporal progression of the inflammation in real-time.	[Jonsson, Colleen B.; Camp, Jeremy V.; Kraenzle, Jennifer L.; Biller, Ashley E.; Vanover, Carol D.; Chu, Yong-Kyu; Steffen, Marlene C.] Univ Louisville, Ctr Predict Med Biodef & Emerging Infect Dis, Louisville, KY 40292 USA; [Jonsson, Colleen B.] Univ Louisville, Dept Microbiol & Immunol, Louisville, KY 40292 USA; [Wu, Albert; Mollura, Daniel J.] NIH, Ctr Infect Dis Imaging, Dept Radiol & Imaging Sci, Bethesda, MD 20892 USA; [Zheng, Huaiyu; Ng, Chin K.] Univ Louisville, Dept Radiol, Louisville, KY 40292 USA; [Proctor, Mary; Sherwood, Leslie] Univ Louisville, Dept Res Resources Facil, Louisville, KY 40292 USA	University of Louisville; University of Louisville; National Institutes of Health (NIH) - USA; University of Louisville; University of Louisville	Jonsson, CB (corresponding author), Univ Louisville, Ctr Predict Med Biodef & Emerging Infect Dis, Louisville, KY 40292 USA.	cbjons01@louisville.edu	Jonsson, Colleen/X-2360-2019; Camp, Jeremy V./AAS-6184-2020; Jonsson, Colleen/GPC-4424-2022	Camp, Jeremy V./0000-0002-9040-5786; Jonsson, Colleen/0000-0002-2640-7672	Commonwealth of Kentucky as a Clinical and Translational Science Pilot Project Program at the University of Louisville; Clinical Research Training Program; United States National Institutes of Health (NIH); Pfizer Inc.; Center for Infectious Disease Imaging in the Intramural Research Program of the NIH	Commonwealth of Kentucky as a Clinical and Translational Science Pilot Project Program at the University of Louisville; Clinical Research Training Program; United States National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Pfizer Inc.(Pfizer); Center for Infectious Disease Imaging in the Intramural Research Program of the NIH	Financial support was provided in part by the Commonwealth of Kentucky as a Clinical and Translational Science Pilot Project Program at the University of Louisville to C.B.J., the Clinical Research Training Program (a public-private partnership supported jointly by the United States National Institutes of Health (NIH) and Pfizer Inc. via a grant to the Foundation for NIH from Pfizer Inc.), and the Center for Infectious Disease Imaging in the Intramural Research Program of the NIH. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agarwal PP, 2009, AM J ROENTGENOL, V193, P1488, DOI 10.2214/AJR.09.3599; Anton A, 2010, DIAGN MICR INFEC DIS, V67, P207, DOI 10.1016/j.diagmicrobio.2010.02.002; Barnard DL, 2009, ANTIVIR RES, V82, pA110, DOI 10.1016/j.antiviral.2008.12.014; Bellani G, 2010, INTENS CARE MED, V36, P717, DOI 10.1007/s00134-010-1756-1; Belser JA, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025091; Belser JA, 2011, DIS MODEL MECH, V4, P575, DOI 10.1242/dmm.007823; Bray M, 2011, J INFECT DIS, V203, P1348, DOI 10.1093/infdis/jir038; Centers for Disease Control and Prevention (CDC), 2009, MMWR Morb Mortal Wkly Rep, V58, P467; Chan MCW, 2010, AM J PATHOL, V176, P1828, DOI 10.2353/ajpath.2010.091087; Chen DL, 2006, J APPL PHYSIOL, V100, P1602, DOI 10.1152/japplphysiol.01429.2005; Chen DL, 2004, AM J PHYSIOL-LUNG C, V286, pL834, DOI 10.1152/ajplung.00339.2003; Childs RA, 2009, NAT BIOTECHNOL, V27, P797, DOI 10.1038/nbt0909-797; Chutinimitkul S, 2010, J VIROL, V84, P11802, DOI 10.1128/JVI.01136-10; Davis SL, 2009, ANTIMICROB AGENTS CH, V53, P4879, DOI 10.1128/AAC.00789-09; Davis SL, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006297; Donaldson LJ, 2009, BMJ-BRIT MED J, V339, DOI 10.1136/bmj.b5213; Fujisawa H, 2008, J VIROL, V82, P2772, DOI 10.1128/JVI.01210-07; Gill JR, 2010, ARCH PATHOL LAB MED, V134, P235, DOI 10.1043/1543-2165-134.2.235; Hansell DM, 2008, RADIOLOGY, V246, P697, DOI 10.1148/radiol.2462070712; Ibricevic A, 2006, J VIROL, V80, P7469, DOI 10.1128/JVI.02677-05; Jain S, 2009, NEW ENGL J MED, V361, P1935, DOI 10.1056/NEJMoa0906695; Jones HA, 1997, EUR RESPIR J, V10, P795; Jones HA, 1998, AM J RESP CRIT CARE, V158, P620, DOI 10.1164/ajrccm.158.2.9711075; Kilander A, 2010, EURO SURVEILL, V15; Kroeze EJBV, 2011, J GEN VIROL, V92, P1854, DOI 10.1099/vir.0.032805-0; Kuster SP, 2010, EUR J CLIN MICROBIOL, V29, P835, DOI 10.1007/s10096-010-0935-x; LEE EJ, 1982, LAB ANIM, V16, P133, DOI 10.1258/002367782781110241; Lee NLS, 2009, HONG KONG MED J, V15, P38; Libster R, 2010, NEW ENGL J MED, V362, P45, DOI 10.1056/NEJMoa0907673; Liu Y, 2010, J VIROL, V84, P12069, DOI 10.1128/JVI.01639-10; Louie JK, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018221; Lucker LM, 2011, SWISS MED WKLY, V141, DOI 10.4414/smw.2011.13177; Mak GC, 2010, EUROSURVEILLANCE, V15, P15; Mollura DJ, 2010, J AM COLL RADIOL, V7, P690, DOI 10.1016/j.jacr.2010.01.007; Neumann G, 2009, NATURE, V459, P931, DOI 10.1038/nature08157; Nicholls JM, 2007, RESP RES, V8, DOI 10.1186/1465-9921-8-73; O'Donnell CD, 2011, MICROBES INFECT, V13, P502, DOI 10.1016/j.micinf.2011.01.014; Patel M, 2010, BRIT J ANAESTH, V104, P128, DOI 10.1093/bja/aep375; Qureshi NR, 2006, J THORAC IMAG, V21, P259, DOI 10.1097/01.rti.0000213573.94032.53; REED L. J., 1938, AMER JOUR HYG, V27, P493; Rowe T, 2010, VIROLOGY, V401, P257, DOI 10.1016/j.virol.2010.02.020; Safronetz D, 2011, J VIROL, V85, P1214, DOI 10.1128/JVI.01848-10; Salem N, 2010, PLOS NEGLECT TROP D, V4, DOI 10.1371/journal.pntd.0000827; Shieh WJ, 2010, AM J PATHOL, V177, P166, DOI 10.2353/ajpath.2010.100115; Shim SS, 2011, CLIN RADIOL, V66, P118, DOI 10.1016/j.crad.2010.07.011; Shope RE, 1934, J EXP MED, V60, P49, DOI 10.1084/jem.60.1.49; Woo PCY, 2010, J INFECT DIS, V201, P346, DOI 10.1086/649785	47	26	26	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 20	2012	7	7							e40094	10.1371/journal.pone.0040094	http://dx.doi.org/10.1371/journal.pone.0040094			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	977GL	22911695	gold, Green Submitted, Green Published			2022-12-25	WOS:000306644600014
J	Pan, H; Cui, BL; Zhang, DG; Farrar, J; Law, F; Ba-Thein, W				Pan, Hui; Cui, Binglin; Zhang, Dangui; Farrar, Jeremy; Law, Frieda; Ba-Thein, William			Prior Knowledge, Older Age, and Higher Allowance Are Risk Factors for Self-Medication with Antibiotics among University Students in Southern China	PLOS ONE			English	Article							ANTIMICROBIAL DRUGS; RESISTANCE; CHILDREN; COMMUNITY; ANTIMALARIALS; POPULATION; NIGERIA; EUROPE	Background: Self-medication with antibiotics (SMA) has been reported among university students in many countries, but little research has been done on this issue in China. The objective of this study was to evaluate knowledge and behaviors of university students and risk factors concerning SMA. Methodology/Principal Findings: Using a novel questionnaire-based data collection instrument, an anonymous online survey was conducted with the students of Shantou University (STU), a university comprising 8 schools/colleges in eastern Guangdong, China. Of 1,300 respondents (13.8% of total eligible participants), 47.8% had self-treated with antibiotics. Logistic regression analysis identified prior knowledge of antibiotics (PKA), older age, and higher monthly allowance as independent risk factors for SMA. PKA significantly influenced students' knowledge about antibiotics, their uses, and common adverse reactions (all p, 0.05). Among self-medicated students, 61.7% used antibiotics at least twice in the previous year. Community pharmacies were the major source of self-prescribed antibiotics. Reported common indications for SMA were sore throat (59.7%), fever (38.2%), cough (37.4%), runny nose (29.3%), and nasal congestion (28.7%). While 74.1% of self-medication episodes were based on students' own experiences, only 31.1% of students claimed to understand the package insert. Alteration of antibiotics and dosage during the course of self-treatment was made by 63.8% and 55.6% of students, respectively. At least two kinds of antibiotics were simultaneously taken by 82.6% of students. The majority of self-medicated students failed to complete the course of antibiotics. Adverse reactions were reported by 16.3% of students. Amoxicillin was the most common antibiotic used for self-medication. Conclusions: High prevalence of SMA was noted among STU students. Presence of risk factors and risk-associated behaviors/attitudes in the study population calls for focused educational intervention and stricter governmental legislation and regulation of antibiotic use and sale in pharmacies.	[Pan, Hui; Cui, Binglin; Zhang, Dangui; Farrar, Jeremy; Ba-Thein, William] Shantou Univ, Shantou Oxford Clin Res Unit, Coll Med, Shantou, Guangdong, Peoples R China; [Farrar, Jeremy] Univ Oxford, Clin Res Unit, Hosp Trop Dis, Wellcome Trust Major Overseas Programme, Ho Chi Minh City, Vietnam; [Law, Frieda] Shantou Univ, Consultant Off, Coll Med, Shantou, Guangdong, Peoples R China; [Ba-Thein, William] Shantou Univ, Dept Microbiol & Immunol, Coll Med, Shantou, Guangdong, Peoples R China	Shantou University; University of Oxford; Shantou University; Shantou University	Pan, H (corresponding author), Shantou Univ, Shantou Oxford Clin Res Unit, Coll Med, Shantou, Guangdong, Peoples R China.	wbathein@stu.edu.cn	Farrar, Jeremy J./HGA-7610-2022; Zhang, Dangui/CAE-9930-2022	Farrar, Jeremy/0000-0002-2700-623X; Pan, Hui/0000-0001-6873-5749	Li Ka Shing Foundation; Shantou University Medical College; Li Ka Shing Foundation-University of Oxford Global Health Programme [B9RSRT0-14]	Li Ka Shing Foundation; Shantou University Medical College; Li Ka Shing Foundation-University of Oxford Global Health Programme	This study was supported by the Li Ka Shing Foundation, Shantou University Medical College, and the Li Ka Shing Foundation-University of Oxford Global Health Programme (grant no. B9RSRT0-14). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Al-Azzam Sayer I., 2007, International Journal of Occupational Medicine and Environmental Health, V20, P373, DOI 10.2478/v10001-007-0038-9; Awad A, 2005, J PHARM PHARM SCI, V8, P326; Awad AI, 2007, ANN PHARMACOTHER, V41, P1249, DOI 10.1345/aph.1K068; Bi P, 2000, SOC SCI MED, V50, P1445, DOI 10.1016/S0277-9536(99)00304-4; Buke AC, 2003, INT J ANTIMICROB AG, V21, P63, DOI 10.1016/S0924-8579(02)00272-8; Buke C, 2005, J INFECTION, V51, P135, DOI 10.1016/j.jinf.2004.12.001; Chen Q, 2008, J NW U NATL NATURAL, V29, P90; Chen Y, 2003, CHINESE RURAL HLTH S, V23, P52; Duong DV, 1997, TROP MED INT HEALTH, V2, P1133, DOI 10.1046/j.1365-3156.1997.d01-213.x; Esimone CO, 2007, PHARM WORLD SCI, V29, P655, DOI 10.1007/s11096-007-9124-0; Goossens H, 2005, LANCET, V365, P579, DOI 10.1016/S0140-6736(05)17907-0; Grigoryan L, 2006, EMERG INFECT DIS, V12, P452, DOI 10.3201/eid1203.050992; Hadi U, 2008, INT J INFECT DIS, V12, P622, DOI 10.1016/j.ijid.2008.01.002; Han F, 2011, J LIAONING U TCM, V13, P139; Harbarth S, 2005, EMERG INFECT DIS, V11, P794, DOI 10.3201/eid1106.050167; Kristiansson C, 2008, TROP MED INT HEALTH, V13, P434, DOI 10.1111/j.1365-3156.2008.02019.x; Kumarasamy KK, 2010, LANCET INFECT DIS, V10, P597, DOI 10.1016/S1473-3099(10)70143-2; Larsson M, 2000, TROP MED INT HEALTH, V5, P711, DOI 10.1046/j.1365-3156.2000.00630.x; Lewis K, 2009, CAN MED ASSOC J, V181, pE237, DOI 10.1503/cmaj.109-3070; Li J, 2008, CHINESE MED ETHICS, V21, P94; Li M, 2011, SOCIAL SCI J U SHANX, V23, P17; Liu M, 2009, J PEDIAT PHARM, V15, P34; McNulty CAM, 2006, EMERG INFECT DIS, V12, P1523, DOI 10.3201/eid1210.051471; Morgan DJ, 2011, LANCET INFECT DIS, V11, P692, DOI 10.1016/S1473-3099(11)70054-8; Mu S, 2001, CLIN FOCUS, V16, P540; Sapkota AR, 2010, BMC PUBLIC HEALTH, V10, DOI 10.1186/1471-2458-10-610; SCHORLING JB, 1991, INT J EPIDEMIOL, V20, P293, DOI 10.1093/ije/20.1.293; Skliros E, 2010, BMC FAM PRACT, V11, DOI 10.1186/1471-2296-11-58; Togoobaatar G, 2010, B WORLD HEALTH ORGAN, V88, P930, DOI 10.2471/BLT.10.079004; Xing Y, 2007, CHINESE J SCH DOCTOR, V21, P287; [徐京杭 XU Jinghang], 2007, [中国实用内科杂志, Chinese Journal of Practical Internal Medicine], V27, P1692; Ye L, 2005, CHINESE NURSING RES, V19, P2373; 杨永弘, 2002, [中国实用儿科杂志, Chinese Journal of Practical Pediatrics], V17, P148	33	83	85	3	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 20	2012	7	7							e41314	10.1371/journal.pone.0041314	http://dx.doi.org/10.1371/journal.pone.0041314			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	977GL	22911779	gold, Green Published, Green Submitted			2022-12-25	WOS:000306644600070
J	Popp, D; Narita, A; Lee, LJ; Larsson, M; Robinson, RC				Popp, David; Narita, Akihiro; Lee, Lin Jie; Larsson, Marten; Robinson, Robert C.			Microtubule-like Properties of the Bacterial Actin Homolog ParM-R1	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							DYNAMIC INSTABILITY; DNA SEGREGATION; ELECTRON-MICROSCOPY; MITOTIC SPINDLE; OSCILLATIONS; MECHANISM; PROTEIN; NUCLEATION; CYTOSKELETON; FILAMENTS	In preparation for mammalian cell division, microtubules repeatedly probe the cytoplasm to capture chromosomes and assemble the mitotic spindle. Critical features of this microtubule system are the formation of radial arrays centered at the centrosomes and dynamic instability, leading to persistent cycles of polymerization and depolymerization. Here, we show that actin homolog, ParM-R1 that drives segregation of the R1 multidrug resistance plasmid from Escherichia coli, can also self-organize in vitro into asters, which resemble astral microtubules. ParM-R1 asters grow from centrosome-like structures consisting of interconnected nodes related by a pseudo 8-fold symmetry. In addition, we show that ParM-R1 is able to perform persistent microtubule-like oscillations of assembly and disassembly. In vitro, a whole population of ParM-R1 filaments is synchronized between phases of growth and shrinkage, leading to prolonged synchronous oscillations even at physiological ParM-R1 concentrations. These results imply that the selection pressure to reliably segregate DNA during cell division has led to common mechanisms within diverse segregation machineries.	[Popp, David; Lee, Lin Jie; Larsson, Marten; Robinson, Robert C.] Proteos, Inst Mol & Cell Biol, Singapore 138673, Singapore; [Narita, Akihiro] Nagoya Univ, Grad Sch Sci, Struct Biol Res Ctr, Chikusa Ku, Nagoya, Aichi 4648601, Japan; [Narita, Akihiro] Nagoya Univ, Grad Sch Sci, Div Biol Sci, Chikusa Ku, Nagoya, Aichi 4648601, Japan; [Robinson, Robert C.] Natl Univ Singapore, Dept Biochem, Singapore 117597, Singapore; [Robinson, Robert C.] Nanyang Technol Univ, Sch Biol Sci, Singapore 637551, Singapore	Agency for Science Technology & Research (A*STAR); A*STAR - Institute of Molecular & Cell Biology (IMCB); Nagoya University; Nagoya University; National University of Singapore; Nanyang Technological University & National Institute of Education (NIE) Singapore; Nanyang Technological University	Popp, D (corresponding author), Proteos, David Popp Inst Mol & Cell Biol, 61 Biopolis Dr, Singapore 138673, Singapore.	dpopp@imcb.a-star.edu.sg	Robinson, Robert/G-9702-2011	Robinson, Robert/0000-0001-6367-6903; Larsson, Marten/0000-0002-7855-9539	Biomedical Research Council, A*STAR; Joint Council Office (JCO) [10/03/FG/06/04]; ERATO, JST; Grants-in-Aid for Scientific Research [20227008] Funding Source: KAKEN	Biomedical Research Council, A*STAR(Agency for Science Technology & Research (A*STAR)); Joint Council Office (JCO); ERATO, JST(Japan Science & Technology Agency (JST)); Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	D. P., L.J.L., M. L., and R. C. R. thank the Biomedical Research Council, A*STAR for support. This work was funded in part by Joint Council Office (JCO) Grant Project (10/03/FG/06/04 (D. P., R. C. R.)).; We thank ERATO, JST for support in the initial stage of this work and Y. Maeda for helpful discussions.	Azimzadeh J, 2010, CURR BIOL, V20, pR816, DOI 10.1016/j.cub.2010.08.010; BAYLEY PM, 1989, J CELL SCI, V93, P241; CAYLEY S, 1991, J MOL BIOL, V222, P281, DOI 10.1016/0022-2836(91)90212-O; Chumnarnsilpa S, 2009, P NATL ACAD SCI USA, V106, P13719, DOI 10.1073/pnas.0812383106; Dickinson M, 2005, NATURE, V433, P330, DOI 10.1038/nature03230; Drew KRP, 2011, P NATL ACAD SCI USA, V108, P11075, DOI 10.1073/pnas.1018724108; Erickson HP, 2010, MICROBIOL MOL BIOL R, V74, P504, DOI 10.1128/MMBR.00021-10; Gadde S, 2004, CURR BIOL, V14, pR797, DOI 10.1016/j.cub.2004.09.021; Garner EC, 2004, SCIENCE, V306, P1021, DOI 10.1126/science.1101313; HESS B, 1987, TRENDS BIOCHEM SCI, V12, P45, DOI 10.1016/0968-0004(87)90024-7; Hud NV, 2005, ANNU REV BIOPH BIOM, V34, P295, DOI 10.1146/annurev.biophys.34.040204.144500; Jensen RB, 1999, EMBO J, V18, P4076, DOI 10.1093/emboj/18.14.4076; Lange BMH, 2005, HISTOCHEM CELL BIOL, V124, P325, DOI 10.1007/s00418-005-0032-x; Lim GE, 2005, P NATL ACAD SCI USA, V102, P17658, DOI 10.1073/pnas.0507222102; Lin YC, 2007, MACROMOLECULES, V40, P7714, DOI 10.1021/ma070862l; Loose M, 2011, NAT STRUCT MOL BIOL, V18, P577, DOI 10.1038/nsmb.2037; Luders J, 2007, NAT REV MOL CELL BIO, V8, P161, DOI 10.1038/nrm2100; Lutkenhaus J, 1997, ANNU REV BIOCHEM, V66, P93, DOI 10.1146/annurev.biochem.66.1.93; MANDELKOW EM, 1991, J CELL BIOL, V114, P977, DOI 10.1083/jcb.114.5.977; MANDELKOW EM, 1992, CELL MOTIL CYTOSKEL, V22, P235, DOI 10.1002/cm.970220403; MARKUS M, 1984, P NATL ACAD SCI-BIOL, V81, P4394, DOI 10.1073/pnas.81.14.4394; Markus M., 1988, CHEM BIOL ORG; MARX A, 1994, EUR BIOPHYS J BIOPHY, V22, P405, DOI 10.1007/BF00180162; MELKI R, 1988, EMBO J, V7, P2653, DOI 10.1002/j.1460-2075.1988.tb03118.x; Moller-Jensen J, 2002, EMBO J, V21, P3119, DOI 10.1093/emboj/cdf320; Murayama Y, 2011, EMBO J, V30, P68, DOI 10.1038/emboj.2010.298; Nedelec FJ, 1997, NATURE, V389, P305, DOI 10.1038/38532; OBERMANN H, 1990, J BIOL CHEM, V265, P4382; Oosawa F., 1975, THERMODYNAMICS POLYM; Orlova A, 2007, NAT STRUCT MOL BIOL, V14, P921, DOI 10.1038/nsmb1300; Pogliano J, 2008, CURR OPIN CELL BIOL, V20, P19, DOI 10.1016/j.ceb.2007.12.006; Pollard TD, 2010, CURR OPIN CELL BIOL, V22, P50, DOI 10.1016/j.ceb.2009.11.010; Popp D, 2008, EMBO J, V27, P570, DOI 10.1038/sj.emboj.7601978; Popp D, 2007, BIOCHEM BIOPH RES CO, V353, P109, DOI 10.1016/j.bbrc.2006.11.130; Popp D, 2010, BIOCHEM BIOPH RES CO, V391, P1598, DOI 10.1016/j.bbrc.2009.12.078; Popp D, 2009, J MOL BIOL, V388, P209, DOI 10.1016/j.jmb.2009.02.057; Popp D, 2009, BIOPOLYMERS, V91, P340, DOI 10.1002/bip.21136; Salje J, 2009, SCIENCE, V323, P509, DOI 10.1126/science.1164346; Sasaki D, 2005, J MUSCLE RES CELL M, V26, P93, DOI 10.1007/s10974-005-0249-2; SAWIN KE, 1991, J CELL BIOL, V112, P925, DOI 10.1083/jcb.112.5.925; van den Ent F, 2002, EMBO J, V21, P6935, DOI 10.1093/emboj/cdf672; Yasunaga T, 1996, J STRUCT BIOL, V116, P155, DOI 10.1006/jsbi.1996.0025	42	2	2	2	16	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 26	2012	287	44					37078	37088		10.1074/jbc.M111.319491	http://dx.doi.org/10.1074/jbc.M111.319491			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	030RT	22908230	Green Published, hybrid			2022-12-25	WOS:000310588500042
J	Wang, YT; Tong, XM; Omoregie, ES; Liu, WJ; Meng, SD; Ye, X				Wang, Yetao; Tong, Xiaomei; Omoregie, Ehimwenma Sheena; Liu, Wenjun; Meng, Songdong; Ye, Xin			Tetraspanin 6 (TSPAN6) Negatively Regulates Retinoic Acid-inducible Gene I-like Receptor-mediated Immune Signaling in a Ubiquitination-dependent Manner	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							NF-KAPPA-B; ADAPTER PROTEIN; VIRUS; RNA; IDENTIFICATION; INDUCTION; LIGASE; CARDIF	The recognition between retinoic acid-inducible gene I-like receptors (RLRs) and viral RNA triggers an intracellular cascade of signaling to induce the expression of type I IFNs. Both positive and negative regulation of the RLR signaling pathway are important for the host antiviral immune response. Here, we demonstrate that the tetraspanin protein TSPAN6 inhibits RLR signaling by affecting the formation of the adaptor MAVS (mitochondrial antiviral signaling)-centered signalosome. We found that overexpression of TSPAN6 impaired RLR-mediated activation of IFN-stimulated response element, NF-kappa B, and IFN-beta promoters, whereas knockdown of TSPAN6 enhanced the RLR-mediated signaling pathway. Interestingly, as the RLR pathway was activated, TSPAN6 underwent Lys-63-linked ubiquitination, which promoted its association with MAVS. The interaction of TSPAN6 and MAVS interfered with the recruitment of RLR downstream molecules TRAF3, MITA, and IRF3 to MAVS. Further study revealed that the first transmembrane domain of TSPAN6 is critical for its ubiquitination and association with MAVS as well as its inhibitory effect on RLR signaling. We concluded that TSPAN6 functions as a negative regulator of the RLR pathway by interacting with MAVS in a ubiquitination-dependent manner.	[Wang, Yetao; Tong, Xiaomei; Liu, Wenjun; Meng, Songdong; Ye, Xin] Chinese Acad Sci, Inst Microbiol, CAS Key Lab Pathogen Microbiol & Immunol, Beijing 100101, Peoples R China; [Wang, Yetao] Chinese Acad Sci, Grad Univ, Beijing 100101, Peoples R China; [Omoregie, Ehimwenma Sheena] Univ Benin, Fac Life Sci, Dept Biochem, Benin, Nigeria	Chinese Academy of Sciences; Institute of Microbiology, CAS; Chinese Academy of Sciences; University of Chinese Academy of Sciences, CAS; University of Benin	Ye, X (corresponding author), Chinese Acad Sci, Inst Microbiol, CAS Key Lab Pathogen Microbiol & Immunol, 1 Beichen W Rd, Beijing 100101, Peoples R China.	yex@im.ac.cn	omoregie, Ehimwenma Sheena/AAE-1379-2022	Wang, Yetao/0000-0001-8101-5455	Ministry of Science and Technology of China [2012CB519003, 2011CB504802, 2011CB504705]; Chinese Academy of Sciences (CAS) [KSCX2-YW-R-198, KSCX2-EW-J-6]; Academy of Sciences for the Developing World (TWAS; Trieste, Italy); Innovative Research Group of the National Natural Science Foundation of China [81021003]	Ministry of Science and Technology of China(Ministry of Science and Technology, China); Chinese Academy of Sciences (CAS)(Chinese Academy of Sciences); Academy of Sciences for the Developing World (TWAS; Trieste, Italy); Innovative Research Group of the National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work was supported in part by Ministry of Science and Technology of China Grants 2012CB519003, 2011CB504802, and 2011CB504705; Chinese Academy of Sciences (CAS) Innovation Projects KSCX2-YW-R-198 and KSCX2-EW-J-6; and the Academy of Sciences for the Developing World (TWAS; Trieste, Italy).; Principal Investigator of the Innovative Research Group of the National Natural Science Foundation of China (supported by Grant 81021003). To whom correspondence should be addressed: CAS Key Laboratory of Pathogenic Microbiology and Immunology, Institute of Microbiology, Chinese Academy of Sciences, 1 Beichen West Rd., Chaoyang District, Beijing 100101, China. Tel.: 86-10-6480-7508; Fax: 86-10-6480-7513; E-mail: yex@im.ac.cn.	Arimoto KI, 2007, P NATL ACAD SCI USA, V104, P7500, DOI 10.1073/pnas.0611551104; Bhoj VG, 2009, NATURE, V458, P430, DOI 10.1038/nature07959; Ding SW, 2010, NAT REV IMMUNOL, V10, P632, DOI 10.1038/nri2824; Gack MU, 2007, NATURE, V446, P916, DOI 10.1038/nature05732; Hemler ME, 2005, NAT REV MOL CELL BIO, V6, P801, DOI 10.1038/nrm1736; Honda K, 2005, INT IMMUNOL, V17, P1367, DOI 10.1093/intimm/dxh318; Kawai T, 2005, NAT IMMUNOL, V6, P981, DOI 10.1038/ni1243; Leung KT, 2011, BLOOD, V117, P1840, DOI 10.1182/blood-2010-04-281329; Loo YM, 2011, IMMUNITY, V34, P680, DOI 10.1016/j.immuni.2011.05.003; Matsuda A, 2003, ONCOGENE, V22, P3307, DOI 10.1038/sj.onc.1206406; Meylan E, 2005, NATURE, V437, P1167, DOI 10.1038/nature04193; Rehwinkel J, 2010, CELL, V140, P397, DOI 10.1016/j.cell.2010.01.020; Saha SK, 2006, EMBO J, V25, P3257, DOI 10.1038/sj.emboj.7601220; Samuel CE, 2001, CLIN MICROBIOL REV, V14, P778, DOI 10.1128/CMR.14.4.778-809.2001; Seth RB, 2005, CELL, V122, P669, DOI 10.1016/j.cell.2005.08.012; Thali M, 2011, BIOCHEM SOC T, V39, P529, DOI 10.1042/BST0390529; Veenbergen S, 2011, IMMUNOL LETT, V138, P129, DOI 10.1016/j.imlet.2011.03.010; Wang YT, 2012, EUR J IMMUNOL, V42, P1304, DOI 10.1002/eji.201142125; Xu LG, 2005, MOL CELL, V19, P727, DOI 10.1016/j.molcel.2005.08.014; Yoneyama M, 2009, IMMUNOL REV, V227, P54, DOI 10.1111/j.1600-065X.2008.00727.x	20	24	24	1	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 5	2012	287	41					34626	34634		10.1074/jbc.M112.390401	http://dx.doi.org/10.1074/jbc.M112.390401			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	018IS	22908223	Green Published, hybrid			2022-12-25	WOS:000309654200065
J	Khare, S; Lawhon, SD; Drake, KL; Nunes, JES; Figueiredo, JF; Rossetti, CA; Gull, T; Everts, RE; Lewin, HA; Galindo, CL; Garner, HR; Adams, LG				Khare, Sangeeta; Lawhon, Sara D.; Drake, Kenneth L.; Nunes, Jairo E. S.; Figueiredo, Josely F.; Rossetti, Carlos A.; Gull, Tamara; Everts, Robin E.; Lewin, Harris A.; Galindo, Cristi L.; Garner, Harold R.; Adams, Leslie Garry			Systems Biology Analysis of Gene Expression during In Vivo Mycobacterium avium paratuberculosis Enteric Colonization Reveals Role for Immune Tolerance	PLOS ONE			English	Article							MONOCYTE-DERIVED MACROPHAGES; SUBSP-PARATUBERCULOSIS; JOHNES-DISEASE; GAMMA-INTERFERON; PEYERS-PATCHES; CROHNS-DISEASE; RECEPTOR GENES; M CELLS; INFECTION; TUBERCULOSIS	Survival and persistence of Mycobacterium avium subsp. paratuberculosis (MAP) in the intestinal mucosa is associated with host immune tolerance. However, the initial events during MAP interaction with its host that lead to pathogen survival, granulomatous inflammation, and clinical disease progression are poorly defined. We hypothesize that immune tolerance is initiated upon initial contact of MAP with the intestinal Peyer's patch. To test our hypothesis, ligated ileal loops in neonatal calves were infected with MAP. Intestinal tissue RNAs were collected (0.5, 1, 2, 4, 8 and 12 hrs post-infection), processed, and hybridized to bovine gene expression microarrays. By comparing the gene transcription responses of calves infected with the MAP, informative complex patterns of expression were clearly visible. To interpret these complex data, changes in the gene expression were further analyzed by dynamic Bayesian analysis, and genes were grouped into the specific pathways and gene ontology categories to create a holistic model. This model revealed three different phases of responses: i) early (30 min and 1 hr post-infection), ii) intermediate (2, 4 and 8 hrs post-infection), and iii) late (12 hrs post-infection). We describe here the data that include expression profiles for perturbed pathways, as well as, mechanistic genes (genes predicted to have regulatory influence) that are associated with immune tolerance. In the Early Phase of MAP infection, multiple pathways were initiated in response to MAP invasion via receptor mediated endocytosis and changes in intestinal permeability. During the Intermediate Phase, perturbed pathways involved the inflammatory responses, cytokine-cytokine receptor interaction, and cell-cell signaling. During the Late Phase of infection, gene responses associated with immune tolerance were initiated at the level of T-cell signaling. Our study provides evidence that MAP infection resulted in differentially regulated genes, perturbed pathways and specifically modified mechanistic genes contributing to the colonization of Peyer's patch.	[Khare, Sangeeta; Lawhon, Sara D.; Nunes, Jairo E. S.; Figueiredo, Josely F.; Rossetti, Carlos A.; Gull, Tamara; Adams, Leslie Garry] Texas A&M Univ, Coll Vet Med & Biomed Sci, Dept Vet Pathobiol, College Stn, TX USA; [Drake, Kenneth L.] Seralogix Ltd, Austin, TX USA; [Everts, Robin E.; Lewin, Harris A.] Univ Illinois, Dept Anim Sci, Urbana, IL 61801 USA; [Galindo, Cristi L.; Garner, Harold R.] Univ Texas SW Med Sch, Eugene McDermott Ctr Human Growth & Dev, Dallas, TX USA	Texas A&M University System; Texas A&M University College Station; University of Illinois System; University of Illinois Urbana-Champaign; University of Texas System; University of Texas Southwestern Medical Center Dallas	Khare, S (corresponding author), US FDA, Natl Ctr Toxicol Res, Jefferson, AR 72079 USA.	gadams@cvm.tamu.edu	LEWIN, HARRIS/HGC-6543-2022; Khare, SangeetA/Q-5470-2019; Lawhon, Sara D./G-5147-2011	LEWIN, HARRIS/0000-0002-1043-7287; Khare, SangeetA/0000-0002-9496-6636; Lawhon, Sara D./0000-0001-9154-8909	U.S. Department of Agriculture Cooperative State Research, Education and Extension Service-National Research Initiative-Coordinated Agricultural Project-Johne's Disease Integrated Program [2004-35605-14243, Q6286224133]; Texas AM University; Texas A&M University Life Sciences Task Force; National Institutes of Health (U.S.) NIH-NIAID [AI060933]; NIH NIAID SBIR [2R44AI058362-02, R43AI084223-01]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R43AI084223, R44AI058362, K08AI060933] Funding Source: NIH RePORTER	U.S. Department of Agriculture Cooperative State Research, Education and Extension Service-National Research Initiative-Coordinated Agricultural Project-Johne's Disease Integrated Program; Texas AM University; Texas A&M University Life Sciences Task Force; National Institutes of Health (U.S.) NIH-NIAID; NIH NIAID SBIR; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	The study was supported by funds to Sangeeta Khare from the U.S. Department of Agriculture Cooperative State Research, Education and Extension Service-National Research Initiative-Coordinated Agricultural Project-Johne's Disease Integrated Program (2004-35605-14243 sub-award Q6286224133) and Animal Health formula funds through Texas A&M University. This study was also supported by funds awarded to Leslie Garry Adams from the Texas A&M University Life Sciences Task Force. Sara D. Lawhon was supported by National Institutes of Health (U.S.) NIH-NIAID AI060933. The computational analysis work was supported in part by NIH NIAID SBIR grants 2R44AI058362-02 and R43AI084223-01 awarded to Kenneth L. Drake. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adams L Garry, 2011, BMC Proc, V5 Suppl 4, pS6, DOI 10.1186/1753-6561-5-S4-S6; Alzuherri HM, 1997, RES VET SCI, V63, P139, DOI 10.1016/S0034-5288(97)90007-2; ARMSTRONG JA, 1971, J EXP MED, V134, P713, DOI 10.1084/jem.134.3.713; Baldi P, 2001, BIOINFORMATICS, V17, P509, DOI 10.1093/bioinformatics/17.6.509; BARTHALAY Y, 1990, EMBO J, V9, P3603, DOI 10.1002/j.1460-2075.1990.tb07571.x; Baum J, 2003, INFECT IMMUN, V71, P1856, DOI 10.1128/IAI.71.4.1856-1863.2003; BENDIXEN PH, 1977, AM J VET RES, V38, P2027; Berger ST, 2006, IMMUNOL CELL BIOL, V84, P349, DOI 10.1111/j.1440-1711.2006.01431.x; Bermudez LE, 2010, INFECT IMMUN, V78, P3570, DOI 10.1128/IAI.01411-09; Boyce JA, 2003, J ALLERGY CLIN IMMUN, V111, P24, DOI 10.1067/mai.2003.60; BUERGELT CD, 1978, VET PATHOL, V15, P196, DOI 10.1177/030098587801500206; Chalupsky K, 2005, P NATL ACAD SCI USA, V102, P9056, DOI 10.1073/pnas.0409594102; Chamberlin WM, 2006, MED SCI MONITOR, V12, pRA27; CLEMENS DL, 1995, J EXP MED, V181, P257, DOI 10.1084/jem.181.1.257; Courtemanche C, 2004, J IMMUNOL, V173, P3186, DOI 10.4049/jimmunol.173.5.3186; Crawford GC, 2006, J WILDLIFE DIS, V42, P715, DOI 10.7589/0090-3558-42.4.715; CROWLE AJ, 1991, INFECT IMMUN, V59, P1823, DOI 10.1128/IAI.59.5.1823-1831.1991; de Chambrun GP, 2008, CURR OPIN GASTROEN, V24, P440, DOI 10.1097/MOG.0b013e3283023be5; Everts RE, 2005, VET IMMUNOL IMMUNOP, V105, P235, DOI 10.1016/j.vetimm.2005.02.003; Ferwerda G, 2007, J LEUKOCYTE BIOL, V82, P1011, DOI 10.1189/jlb.0307147; Fooksman DR, 2011, ANN REV IMMUNOLOGY; Fratti RA, 2003, P NATL ACAD SCI USA, V100, P5437, DOI 10.1073/pnas.0737613100; Furness JB, 2008, NEUROGASTROENT MOTIL, V20, P32, DOI 10.1111/j.1365-2982.2008.01094.x; Goldfine H, 2000, INFECT IMMUN, V68, P5735, DOI 10.1128/IAI.68.10.5735-5741.2000; Greenwell-Wild T, 2002, J IMMUNOL, V169, P6286, DOI 10.4049/jimmunol.169.11.6286; Gwozdz JM, 2001, J COMP PATHOL, V124, P317, DOI 10.1053/jcpa.2001.0468; Hines ME, 2007, VET MICROBIOL, V122, P197, DOI 10.1016/j.vetmic.2007.03.009; Hwang IY, 2010, GENES IMMUN, V11, P384, DOI 10.1038/gene.2010.27; Khare S, 2004, J CLIN MICROBIOL, V42, P1075, DOI 10.1128/JCM.42.3.1075-1081.2004; Khare S, 2009, VET PATHOL, V46, P717, DOI 10.1354/vp.08-VP-0187-G-FL; Kim M, 2009, NATURE, V459, P578, DOI 10.1038/nature07952; Kirkwood CD, 2009, INFLAMM BOWEL DIS, V15, P1643, DOI 10.1002/ibd.20967; Knosel T, 2009, PATHOL RES PRACT, V205, P223, DOI 10.1016/j.prp.2008.04.018; Krajinovic M, 2004, J IMMUNOL, V173, P3186; Kusner DJ, 1996, J EXP MED, V184, P585, DOI 10.1084/jem.184.2.585; LARSEN AB, 1975, AM J VET RES, V36, P255; Lawhon SD, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0026869; Legler DF, 1998, J EXP MED, V187, P655, DOI 10.1084/jem.187.4.655; Lei LY, 2007, VET IMMUNOL IMMUNOP, V120, P177, DOI 10.1016/j.vetimm.2007.06.031; Lidar M, 2009, ISR MED ASSOC J, V11, P558; Lin JE, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0031686; Long AD, 2001, J BIOL CHEM, V276, P19937, DOI 10.1074/jbc.M010192200; Loor JJ, 2007, PHYSIOL GENOMICS, V32, P105, DOI 10.1152/physiolgenomics.00188.2007; Man SM, 2011, NAT REV GASTRO HEPAT, V8, P152, DOI 10.1038/nrgastro.2011.3; McKenna HJ, 2000, BLOOD, V95, P3489, DOI 10.1182/blood.V95.11.3489; Meena LS, 2010, FEBS J, V277, P2416, DOI 10.1111/j.1742-4658.2010.07666.x; Missler M, 1998, J NEUROSCI, V18, P3630; Missler M, 1998, J NEUROCHEM, V71, P1339; Missler M, 1998, J BIOL CHEM, V273, P34716, DOI 10.1074/jbc.273.52.34716; MOMOTANI E, 1988, VET PATHOL, V25, P131, DOI 10.1177/030098588802500205; Murphy JT, 2006, PHYSIOL GENOMICS, V28, P67, DOI 10.1152/physiolgenomics.00098.2006; Nyhan WL, 2005, MOL GENET METAB, V86, P25, DOI 10.1016/j.ymgme.2005.07.027; Olsen I, 2005, INFECT IMMUN, V73, P5628, DOI 10.1128/IAI.73.9.5628-5635.2005; Pai RK, 2004, INFECT IMMUN, V72, P6603, DOI 10.1128/IAI.72.11.6603-6614.2004; Pierce ES, 2009, GUT PATHOG, V1, DOI 10.1186/1757-4749-1-17; Plattner BL, 2011, VET PATHOL, V48, P584, DOI 10.1177/0300985810383874; Polymeros D, 2006, GASTROENTEROLOGY, V131, P85, DOI 10.1053/j.gastro.2006.04.021; Purdie AC, 2012, COMP IMMUNOL MICROB, V35, P151, DOI 10.1016/j.cimid.2011.12.007; Rosales C., 2005, MOL MECH PHAGOCYTOSI; Rossetti CA, 2011, RES VET SCI, V91, P40, DOI 10.1016/j.rvsc.2010.09.002; Ruiz-Larranaga O, 2011, J DAIRY SCI, V94, P3635, DOI 10.3168/jds.2010-3788; Russell DG, 2010, CELL HOST MICROBE, V8, P68, DOI 10.1016/j.chom.2010.06.002; Russell DG, 2009, NAT IMMUNOL, V10, P943, DOI 10.1038/ni.1781; Sartor RB, 2005, GUT, V54, P896, DOI 10.1136/gut.2004.055889; Sartor RB, 2003, CURR OPIN GASTROEN, V19, P358, DOI 10.1097/00001574-200307000-00006; Scanu AM, 2007, J CLIN MICROBIOL, V45, P3883, DOI 10.1128/JCM.01371-07; Sechi LA, 2007, WORLD J GASTROENTERO, V13, P5731, DOI 10.3748/wjg.v13.i43.5731; Secott TE, 2004, INFECT IMMUN, V72, P3724, DOI 10.1128/IAI.72.7.3724-3732.2004; Sharbati J, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020258; Shi L, 2009, INFECT IMMUN, V77, P3227, DOI 10.1128/IAI.00063-09; Singh Udai P, 2008, BMC Immunol, V9, P25, DOI 10.1186/1471-2172-9-25; Smythies LE, 2005, J CLIN INVEST, V115, P66, DOI 10.1172/JCI200519229; Sommer S, 2009, VET IMMUNOL IMMUNOP, V128, P44, DOI 10.1016/j.vetimm.2008.10.294; Souza CD, 2007, MICROBES INFECT, V9, P1545, DOI 10.1016/j.micinf.2007.08.008; Souza CD, 2006, MICROB PATHOGENESIS, V41, P59, DOI 10.1016/j.micpath.2006.04.002; Taupin D, 2003, NAT REV MOL CELL BIO, V4, P721, DOI 10.1038/nrm1203; Taylor DL, 2008, VET IMMUNOL IMMUNOP, V124, P132, DOI 10.1016/j.vetimm.2008.02.021; Tiffany HL, 1997, J EXP MED, V186, P165, DOI 10.1084/jem.186.1.165; Tilg H, 2006, NAT REV IMMUNOL, V6, P772, DOI 10.1038/nri1937; van Leeuwen IMM, 2009, CELL PROLIFERAT, V42, P617, DOI 10.1111/j.1365-2184.2009.00627.x; Waddell LA, 2008, CAN J PUBLIC HEALTH, V99, P145, DOI 10.1007/BF03405464; Waters WR, 2003, INFECT IMMUN, V71, P5130, DOI 10.1128/IAI.71.9.5130-5138.2003; Weiss DJ, 2008, VET PATHOL, V45, P829, DOI 10.1354/vp.45-6-829; Weiss DJ, 2006, VET PATHOL, V43, P127, DOI 10.1354/vp.43-2-127; Weiss DJ, 2001, INFECT IMMUN, V69, P1002, DOI 10.1128/IAI.69.2.1002-1008.2001; Weiss DJ, 2008, J LEUKOCYTE BIOL, V83, P48, DOI 10.1189/jlb.0707490; Young LS, 1998, IMMUNOL TODAY, V19, P502, DOI 10.1016/S0167-5699(98)01340-1	87	36	37	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 17	2012	7	8							e42127	10.1371/journal.pone.0042127	http://dx.doi.org/10.1371/journal.pone.0042127			34	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	996DG	22912686	Green Published, Green Submitted, gold			2022-12-25	WOS:000308063700011
J	Morsello, C; Ruiz-Mallen, I; Diaz, MDM; Reyes-Garcia, V				Morsello, Carla; Ruiz-Mallen, Isabel; Montoya Diaz, Maria Dolores; Reyes-Garcia, Victoria			The Effects of Processing Non-Timber Forest Products and Trade Partnerships on People's Well-Being and Forest Conservation in Amazonian Societies	PLOS ONE			English	Article							TROPICAL FORESTS; AGRICULTURAL CHANGE; PROPENSITY SCORE; RAIN-FOREST; INCOME; MARKETS; LIVELIHOODS; MANAGEMENT; GENDER; COMMERCIALIZATION	This study evaluated whether processing non-timber forest products (NTFPs) and establishing trade partnerships between forest communities and companies enhance the outcomes of NTFP commercialization. In particular, we evaluated whether product processing, partnerships, or their combination was associated with a number of outcomes related to the well-being of forest inhabitants and forest conservation. We based our analyses on ethnographic and quantitative data (i.e., survey and systematic observations) gathered at seven communities from five societies of the Brazilian and Bolivian Amazon. Our results indicated that product processing and partnerships do not represent a silver bullet able to improve the results of NTFP commercialization in terms of well-being and conservation indicators. Compared with cases without interventions, households adopting partnerships but not product processing were most often associated with improved economic proxies of well-being (total income, NTFP income, food consumption and gender equality in income). In comparison, the combination of product processing and partnerships was associated with similar outcomes. Unexpectedly, product processing alone was associated with negative outcomes in the economic indicators of well-being. All of the investigated strategies were associated with less time spent in social and cultural activities. With respect to forest conservation, the strategies that included a partnership with or without processing produced similar results: while household deforestation tended to decrease, the hunting impact increased. Processing alone was also associated with higher levels of hunting, though it did not reduce deforestation. Our results indicate that establishing partnerships may enhance the outcomes of NTFP trade in terms of the financial outcomes of local communities, but practitioners need to use caution when adopting the processing strategy and they need to evaluate potential negative results for indicators of social and cultural activities. With respect to conservation, the three strategies are promising for reducing deforestation, but more pervasive impacts, such as hunting, might increase.	[Morsello, Carla] Univ Sao Paulo, EACH, Sao Paulo, Brazil; [Ruiz-Mallen, Isabel; Reyes-Garcia, Victoria] Univ Autonoma Barcelona, Inst Ciencia & Tecnol Ambientals, E-08193 Barcelona, Spain; [Montoya Diaz, Maria Dolores] Univ Sao Paulo, Fac Econ Adm & Contabilidade, Sao Paulo, Brazil; [Reyes-Garcia, Victoria] Univ Autonoma Barcelona, ICREA, E-08193 Barcelona, Spain	Universidade de Sao Paulo; Autonomous University of Barcelona; Universidade de Sao Paulo; Autonomous University of Barcelona; ICREA	Morsello, C (corresponding author), Univ Sao Paulo, EACH, Sao Paulo, Brazil.	morsello@usp.br	Diaz, Maria Dolores M./F-3198-2013; Morsello, Carla/D-7393-2012; Ruiz-Mallen, Isabel/E-9614-2018; Reyes-Garcia, Victoria/C-4552-2008	Diaz, Maria Dolores M./0000-0003-2385-2073; Morsello, Carla/0000-0001-7548-6541; Ruiz-Mallen, Isabel/0000-0002-9679-3329; Reyes-Garcia, Victoria/0000-0002-2914-8055	Rainforest Alliance (USA); Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (Brazil) [Fapesp 2005/01288-1, 2007/06844]; Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (Brazil) [CAPES AUX-PE-DGU 744/2010]; National Science Foundation-Anthropology (USA); Direccion General das Universidades Espanholas (Spain) [HBP2009-0014]; ICREA Funding Source: Custom	Rainforest Alliance (USA); Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (Brazil)(Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP)); Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (Brazil)(Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES)); National Science Foundation-Anthropology (USA); Direccion General das Universidades Espanholas (Spain); ICREA(ICREA)	Research in Brazil was financed by a Kleinhans Award from Rainforest Alliance (USA; see http://http://www.rainforest-alliance.org/fellowships) to Morsello, scholarships from Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (Brazil; Fapesp 2005/01288-1, 2007/06844; see http://www.fapesp.org) and scholarships and collaboration funding from Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (Brazil; CAPES AUX-PE-DGU 744/2010). In Bolivia, financing came through National Science Foundation-Anthropology (USA; see http://www.nsf.org) and a scholarship from Direccion General das Universidades Espanholas (Spain; HBP2009-0014; see http://www.micinn.es/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Angelsen A., 2003, EXPLORING FOREST POV, V40, P1; Arnold J. E. M., 1998, Incomes from the forest: methods for the development and conservation of forest products for local communities., P17; Arnold JEM, 2001, ECOL ECON, V39, P437, DOI 10.1016/S0921-8009(01)00236-1; BEHRENS CA, 1992, HUM ECOL, V20, P435, DOI 10.1007/BF00890429; Belcher B, 2005, WORLD DEV, V33, P1435, DOI 10.1016/j.worlddev.2004.10.007; Belcher B., 2004, FOREST PRODUCTS LIVE, V1, P1; Belcher BM, 2005, INT FOREST REV, V7, P82, DOI 10.1505/ifor.2005.7.2.82; Belcher B, 2007, DEV POLICY REV, V25, P355, DOI 10.1111/j.1467-7679.2007.00374.x; BLUMBERG RL, 1988, J FAM ISSUES, V9, P51, DOI 10.1177/019251388009001004; Bodmer RE, 1997, CONSERV BIOL, V11, P460, DOI 10.1046/j.1523-1739.1997.96022.x; Brites AD, 2010, THESIS U SAO PAULO S; Caliendo M, 2008, J ECON SURV, V22, P31, DOI 10.1111/j.1467-6419.2007.00527.x; Chandramohan B, 2008, 12 BIENN C INT ASS S; Clay J, 1992, CULTURAL SURVIVAL Q, V16, P31; Clay J, 1992, BUYING FORESTS NEW P, P400; Clement C.R., 1993, SELECTED SPECIES STR; Coad L, 2010, CONSERV BIOL, V24, P1510, DOI 10.1111/j.1523-1739.2010.01525.x; Coomes OT, 2004, ECOL ECON, V51, P47, DOI 10.1016/j.ecolecon.2004.04.004; Counsell Simon, 1992, RAINFOREST HARVEST; Demmer J, 2002, BIODIVERS CONSERV, V11, P1845, DOI 10.1023/A:1020305903156; Diener E, 2000, AM PSYCHOL, V55, P34, DOI 10.1037/0003-066X.55.1.34; Duchelle AE, 2012, FOREST ECOL MANAG, V268, P39, DOI 10.1016/j.foreco.2011.05.023; Faria RBMd, 2007, THESIS U SAO PAULO S; Ferraro PJ, 2011, CONSERV BIOL, V25, P1134, DOI 10.1111/j.1523-1739.2011.01791.x; Ferraro PJ, 2011, P NATL ACAD SCI USA, V108, P13913, DOI 10.1073/pnas.1011529108; Ferraro PJ, 2006, PLOS BIOL, V4, P482, DOI 10.1371/journal.pbio.0040105; Ferrer-i-Carbonell A, 2005, J PUBLIC ECON, V89, P997, DOI 10.1016/j.jpubeco.2004.06.003; Freese CH, 1997, HARVESTING WILD SPEC, P1; Godoy R, 2010, ANIM CONSERV, V13, P265, DOI 10.1111/j.1469-1795.2009.00330.x; Godoy R, 1997, CURR ANTHROPOL, V38, P875, DOI 10.1086/204676; Goldstein H., 2011, MULTILEVEL STAT MODE, V4th; Gubbi S, 2008, ORYX, V42, P222, DOI 10.1017/S0030605308071111; Guo S. Y., 2009, PROPENSITY SCORE ANA; HAMMOND DS, 1995, HUM ECOL, V23, P335, DOI 10.1007/BF01190136; Henrich J, 1997, HUM ECOL, V25, P319, DOI 10.1023/A:1021982324396; Hirano K., 2001, HLTH SERVICES OUTCOM, V2, P259, DOI [10.1023/A:1020371312283, DOI 10.1023/A:1020371312283]; Hox JJ, 2010, MULTILEVEL ANAL TECH, V2nd; Humphries S, 2012, ECOL ECON, V77, P62, DOI 10.1016/j.ecolecon.2011.10.018; Imbens GW, 2000, BIOMETRIKA, V87, P706, DOI 10.1093/biomet/87.3.706; Jerozolimski A, 2003, BIOL CONSERV, V111, P415, DOI 10.1016/S0006-3207(02)00310-5; KAINER KA, 1992, ECON BOT, V46, P408, DOI 10.1007/BF02866513; Kanmegne J, 2007, J FOOD AGRIC ENVIRON, V5, P243; Kusters K, 2006, ECOL SOC, V11; Marshall E., 2006, COMMERCIALIZATION NO; Mayers J, 2002, CO COMMUNITY FORESTR, P25; Mayers J., 2002, CO COMMUNITY FORESTR; Morsello C, 2006, FOREST POLICY ECON, V8, P485, DOI 10.1016/j.forpol.2005.08.010; Morsello C., 2007, PARTNERSHIPS SUSTAIN, P147, DOI [10.1163/ej.9789004153394.i-329.65, DOI 10.1163/EJ.9789004153394.I-329.65]; Neumann R.P., 2000, COMMERCIALISATION NO; Nugent Stephen, 1993, AMAZONIAN CABOCLO SO; Parry L, 2009, BIOL CONSERV, V142, P1777, DOI 10.1016/j.biocon.2009.03.018; Pattanayak SK., 2009, ROUGH GUIDE IMPACT E; PETERS CM, 1989, NATURE, V339, P655, DOI 10.1038/339655a0; Piperata BA, 2011, AM J PHYS ANTHROPOL, V146, P1, DOI 10.1002/ajpa.21459; Pokorny B, 2012, GEOFORUM, V43, P387, DOI 10.1016/j.geoforum.2010.08.002; Ravallion M, 2008, HBK ECON, V9, P3787, DOI 10.1016/S1573-4471(07)04059-4; Ribeiro FN, 2009, THESIS U SAO PAULO S; Rizek MB, HUM ECOL IN PRESS; Ros-Tonen M. A. F., 2005, Forests, Trees and Livelihoods, V15, P129; Ros-Tonen MA., 2007, PARTNERSHIPS SUSTAIN, P3; Ros-Tonen MAF, 2008, FOREST ECOL MANAG, V256, P1482, DOI 10.1016/j.foreco.2008.02.044; Russell Bernard, 1998, HDB METHODS CULTURAL, P301; Sahlins M., 1972, STONE AGE EC; Scherr S.J., 2003, NEW AGENDA FOREST CO; Shackleton C, 2004, S AFR J SCI, V100, P658; Shackleton CM, 2007, FOREST POLICY ECON, V9, P558, DOI 10.1016/j.forpol.2006.03.004; Shackleton S, 2002, DEVOLUTION COMMUNITY; Shepard Glenn Harvey, 2004, TERRAS INDIGENAS UNI, P129; Shively GE, 2001, LAND ECON, V77, P268, DOI 10.2307/3147094; Sills E, 2011, NON-TIMBER FOREST PRODUCTS IN THE GLOBAL CONTEXT, P23, DOI 10.1007/978-3-642-17983-9_2; Siren AH, 2006, ECOL SOC, V11; Stoner KE, 2007, BIOTROPICA, V39, P385, DOI 10.1111/j.1744-7429.2007.00291.x; Stuart EA, 2010, STAT SCI, V25, P1, DOI 10.1214/09-STS313; Sunderlin WD, 2005, WORLD DEV, V33, P1383, DOI 10.1016/j.worlddev.2004.10.004; Ticktin T, 2004, J APPL ECOL, V41, P11, DOI 10.1111/j.1365-2664.2004.00859.x; Tu D, 2004, FOREST PRODUCTS LIVE, P107; Vadez V, 2004, HUM ECOL, V32, P635, DOI 10.1007/s10745-004-6100-3; Vadez V., 2003, FIELD METHOD, V15, P289; Welch JR, 2009, HUM ECOL, V37, P13, DOI 10.1007/s10745-009-9216-7; Wilkie DS, 2001, CONSERV BIOL, V15, P761, DOI 10.1046/j.1523-1739.2001.015003761.x; Wong GY, 2003, WORLD DEV, V31, P1405, DOI 10.1016/S0305-750X(03)00099-8	81	17	18	2	71	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 17	2012	7	8							e43055	10.1371/journal.pone.0043055	http://dx.doi.org/10.1371/journal.pone.0043055			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	996DG	22912787	Green Published, Green Submitted, gold			2022-12-25	WOS:000308063700034
J	Torpey, K; Mandala, J; Kasonde, P; Bryan-Mofya, G; Bweupe, M; Mukundu, J; Zimba, C; Mwale, C; Lumano, H; Welsh, M				Torpey, Kwasi; Mandala, Justin; Kasonde, Prisca; Bryan-Mofya, Gail; Bweupe, Maximillian; Mukundu, Jonathan; Zimba, Chilunje; Mwale, Catherine; Lumano, Hilary; Welsh, Michael			Analysis of HIV Early Infant Diagnosis Data to Estimate Rates of Perinatal HIV Transmission in Zambia	PLOS ONE			English	Article							TO-CHILD TRANSMISSION; SINGLE-DOSE NEVIRAPINE; HUMAN-IMMUNODEFICIENCY-VIRUS; RANDOMIZED CONTROLLED-TRIAL; PREVENTION; ZIDOVUDINE; PROPHYLAXIS; PROGRAMS; INTRAPARTUM; LAMIVUDINE	Background: Mother-to-child transmission of HIV (MTCT) remains the most prevalent source of pediatric HIV infection. Most PMTCT (prevention of mother-to-child transmission of HIV) programs have concentrated monitoring and evaluation efforts on process rather than on outcome indicators. In this paper, we review service data from 28,320 children born to HIV-positive mothers to estimate MTCT rates. Method: This study analyzed DNA PCR results and PMTCT data from perinatally exposed children zero to 12 months of age from five Zambian provinces between September 2007 and July 2010. Results: The majority of children (58.6%) had a PCR test conducted between age six weeks and six months. Exclusive breastfeeding (56.8%) was the most frequent feeding method. An estimated 45.9% of mothers were below 30 years old and 93.3% had disclosed their HIV status. In terms of ARV regimen for PMTCT, 32.7% received AZT+single dose NVP (sdNVP), 30.9% received highly active antiretroviral treatment (HAART), 19.6% received sdNVP only and 12.9% received no ARVs. Transmission rates at six weeks when ARVs were received by both mother and baby, mother only, baby only, and none were 5.8%, 10.5%, 15.8% and 21.8% respectively. Transmission rates at six weeks where mother received HAART, AZT+sd NVP, sdNVP, and no intervention were 4.2%, 6.8%, 8.7% and 20.1% respectively. Based on adjusted analysis including ARV exposures and non ARV-related parameters, lower rates of positive PCR results were associated with 1) both mother and infant receiving prophylaxis, 2) children never breastfed and 3) mother being 30 years old or greater. Overall between September 2007 and July 2010, 12.2% of PCR results were HIV positive. Between September 2007 and January 2009, then between February 2009 and July 2010, proportions of positive PCR results were 15.1% and 11% respectively, a significant difference. Conclusion: The use of ARV drugs reduces vertical transmission of HIV in a program setting. Non-chemoprophylactic factors also play a significant role in HIV transmission. The overall change in the proportions of positive PCR results over time is more likely an indication of better PMTCT implementation. Determination of the outcomes of PMTCT in program settings is feasible but requires accurate documentation and analysis.	[Torpey, Kwasi; Mandala, Justin; Kasonde, Prisca; Mukundu, Jonathan; Zimba, Chilunje; Mwale, Catherine; Welsh, Michael] FHI 360, Durham, NC USA; [Bryan-Mofya, Gail; Lumano, Hilary] Management Sci Hlth, Cambridge, MA USA; [Bweupe, Maximillian] Minist Hlth Zambia, Lusaka, Zambia	FHI 360	Torpey, K (corresponding author), FHI 360, Durham, NC USA.	KTorpey@sidhas.org		Torpey, Kwasi/0000-0003-1628-2922	Family Health International/Zambia; U.S. President's Emergency Plan for AIDS Relief through U.S. Agency for International Development Cooperative Agreement [690-A-00-04-00319-00]	Family Health International/Zambia; U.S. President's Emergency Plan for AIDS Relief through U.S. Agency for International Development Cooperative Agreement(United States Agency for International Development (USAID)United States Department of Health & Human ServicesCenters for Disease Control & Prevention - USA)	Support for this paper was provided by Family Health International/Zambia with funding from the U.S. President's Emergency Plan for AIDS Relief through U.S. Agency for International Development Cooperative Agreement No. 690-A-00-04-00319-00. The funder played no role in design, data collection and analysis.	[Anonymous], 2011, WORLD AIDS DAY REP; Bedri A, 2008, LANCET, V372, P300, DOI 10.1016/S0140-6736(08)61114-9; Black RE, 2003, LANCET, V361, P2226, DOI 10.1016/S0140-6736(03)13779-8; Coetzee D, 2005, B WORLD HEALTH ORGAN, V83, P489; Creek T, 2008, PEDIATR INFECT DIS J, V27, P22, DOI 10.1097/INF.0b013e3181469050; Dabis F, 2005, AIDS, V19, P309; De Cock KM, 2000, JAMA-J AM MED ASSOC, V283, P1175, DOI 10.1001/jama.283.9.1175; Guay LA, 1999, LANCET, V354, P795, DOI 10.1016/S0140-6736(99)80008-7; Kumwenda NI, 2008, NEW ENGL J MED, V359, P119, DOI 10.1056/NEJMoa0801941; Malyuta R, 2006, EUR J PUBLIC HEALTH, V16, P123, DOI 10.1093/eurpub/cki150; Maru S, 2009, AIDS CARE, V21, P1114, DOI 10.1080/09540120802705842; Matovu A, 2008, East Afr Med J, V85, P162; Meda N, 2011, LANCET INFECT DIS, V11, P171, DOI 10.1016/S1473-3099(10)70288-7; Ministry of Health, 2010, NAT PROT GUID INT PR; Moodley D, 2003, J INFECT DIS, V187, P725, DOI 10.1086/367898; Msuya SE, 2008, AIDS CARE, V20, P700, DOI 10.1080/09540120701687059; Ostergaard Lise Rosendal, 2010, Afr J Reprod Health, V14, P213; Rollins N, 2007, AIDS, V21, P1341, DOI 10.1097/QAD.0b013e32814db7d4; Sherman GG, 2004, SAMJ S AFR MED J, V94, P289; Stringer EM, 2008, B WORLD HEALTH ORGAN, V86, P57, DOI 10.2471/BLT.07.043117; Thior I, 2006, JAMA-J AM MED ASSOC, V296, P794, DOI 10.1001/jama.296.7.794; Torpey K, 2011, J INT ASS PHYS AIDS, V11, P26; Torpey K, 2010, JAIDS-J ACQ IMM DEF, V54, P415, DOI 10.1097/QAI.0b013e3181e36616; UNICEF World Health Organization UNAIDS Vanderbilt University School of Medicine, 2009, CONS M EV IMP PREV M; WHO, 2012, US ANT DRUGS TREAT P; World Health Organization, 2010, GUID HIV INF FEED PR; World Health Organization, 2010, PMTCT STRAT VIS 2010; World Health Organization, 2021, ANT DRUGS TREAT PREG; World Health Organization, 2010, UN ACC SCAL PRIOR HI	29	34	35	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 17	2012	7	8							e42859	10.1371/journal.pone.0042859	http://dx.doi.org/10.1371/journal.pone.0042859			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	996DG	22912752	gold, Green Published, Green Submitted			2022-12-25	WOS:000308063700025
J	Morrison, NA; Stephens, AA; Osato, M; Polly, P; Tan, TC; Yamashita, N; Doecke, JD; Pasco, J; Fozzard, N; Jones, G; Ralston, SH; Sambrook, PN; Prince, RL; Nicholson, GC				Morrison, Nigel A.; Stephens, Alexandre A.; Osato, Motomi; Polly, Patsie; Tan, Timothy C.; Yamashita, Namiko; Doecke, James D.; Pasco, Julie; Fozzard, Nicolette; Jones, Graeme; Ralston, Stuart H.; Sambrook, Philip N.; Prince, Richard L.; Nicholson, Geoff C.			Glutamine Repeat Variants in Human RUNX2 Associated with Decreased Femoral Neck BMD, Broadband Ultrasound Attenuation and Target Gene Transactivation	PLOS ONE			English	Article							BONE; MUTATIONS; RECEPTOR; CBFA1; WOMEN; FRACTURE; ALLELES; LENGTH; PERIMENOPAUSAL; POLYMORPHISMS	RUNX2 is an essential transcription factor required for skeletal development and cartilage formation. Haploinsufficiency of RUNX2 leads to cleidocranial displaysia (CCD) a skeletal disorder characterised by gross dysgenesis of bones particularly those derived from intramembranous bone formation. A notable feature of the RUNX2 protein is the polyglutamine and polyalanine (23Q/17A) domain coded by a repeat sequence. Since none of the known mutations causing CCD characterised to date map in the glutamine repeat region, we hypothesised that Q-repeat mutations may be related to a more subtle bone phenotype. We screened subjects derived from four normal populations for Q-repeat variants. A total of 22 subjects were identified who were heterozygous for a wild type allele and a Q-repeat variant allele: (15Q, 16Q, 18Q and 30Q). Although not every subject had data for all measures, Q-repeat variants had a significant deficit in BMD with an average decrease of 0.7SD measured over 12 BMD-related parameters (p = 0.005). Femoral neck BMD was measured in all subjects (-0.6SD, p = 0.0007). The transactivation function of RUNX2 was determined for 16Q and 30Q alleles using a reporter gene assay. 16Q and 30Q alleles displayed significantly lower transactivation function compared to wild type (23Q). Our analysis has identified novel Q-repeat mutations that occur at a collective frequency of about 0.4%. These mutations significantly alter BMD and display impaired transactivation function, introducing a new class of functionally relevant RUNX2 mutants.	[Morrison, Nigel A.; Stephens, Alexandre A.; Doecke, James D.; Fozzard, Nicolette] Griffith Univ, Sch Med Sci, Southport, Qld 4215, Australia; [Osato, Motomi] Natl Univ Singapore, Inst Mol & Cell Biol, Singapore 117548, Singapore; [Polly, Patsie; Tan, Timothy C.] Univ New S Wales, Dept Pathol & Inflammat, Sch Med Sci, Sydney, NSW, Australia; [Polly, Patsie; Tan, Timothy C.] Univ New S Wales, Infect Res Ctr, Sch Med Sci, Sydney, NSW, Australia; [Yamashita, Namiko] Natl Univ Singapore, Canc Sci Inst Singapore, Singapore 117548, Singapore; [Pasco, Julie] Deakin Univ, Sch Med, Geelong, Vic 3217, Australia; [Jones, Graeme] Menzies Inst, Hobart, Tas, Australia; [Ralston, Stuart H.] Univ Edinburgh, Ctr Mol Med, Edinburgh, Midlothian, Scotland; [Sambrook, Philip N.] Univ Sydney, Royal N Shore Hosp, Sydney, NSW 2006, Australia; [Prince, Richard L.] Sir Charles Gairdner Hosp, Western Australian Inst Med Res, Perth, WA 6000, Australia; [Prince, Richard L.] Sir Charles Gairdner Hosp, Dept Endocrinol & Diabet, Perth, WA 6000, Australia; [Nicholson, Geoff C.] Univ Queensland, Rural Clin Sch, Sch Med, Toowoomba, Qld, Australia	Griffith University; Agency for Science Technology & Research (A*STAR); A*STAR - Institute of Molecular & Cell Biology (IMCB); National University of Singapore; University of New South Wales Sydney; University of New South Wales Sydney; National University of Singapore; Deakin University; University of Tasmania; Menzies Institute for Medical Research; University of Edinburgh; Royal North Shore Hospital; University of Sydney; University of Western Australia; University of Western Australia; University of Queensland	Morrison, NA (corresponding author), Griffith Univ, Sch Med Sci, Southport, Qld 4215, Australia.	N.Morrison@mailbox.gu.edu.au	Osato, Motomi/N-5056-2014; Stephens, Alexandre S/P-1396-2016; Morrison, Nigel A/F-4082-2012; Nicholson, Geoffrey C/F-1901-2010; Doecke, James D/A-5361-2009	Osato, Motomi/0000-0003-3982-9054; Stephens, Alexandre S/0000-0003-2465-8117; Morrison, Nigel A/0000-0003-4774-3808; Nicholson, Geoffrey C/0000-0002-0152-1153; Doecke, James D/0000-0003-2863-0293; Tan, Timothy/0000-0003-4449-1457	Griffith University	Griffith University(Griffith University)	Alex Stephens and James Doecke were supported by Griffith University postgraduate scholarships. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2012, ONL MEND INH MAN OMI; Atanesyan L, 2012, BIOL CHEM, V393, P63, DOI 10.1515/BC-2011-252; Bustamante M, 2007, CALCIFIED TISSUE INT, V81, P327, DOI 10.1007/s00223-007-9069-2; CHAMBERLAIN NL, 1994, NUCLEIC ACIDS RES, V22, P3181, DOI 10.1093/nar/22.15.3181; Chan MY, 2012, CALCIFIED TISSUE INT, V90, P128, DOI 10.1007/s00223-011-9556-3; Cohen MM, 2009, AM J MED GENET A, V149A, P2629, DOI 10.1002/ajmg.a.33021; Ding C, 2008, ANN RHEUM DIS, V67, P1256, DOI 10.1136/ard.2007.082651; Doecke JD, 2006, J BONE MINER RES, V21, P265, DOI 10.1359/JBMR; Ducy P, 1997, CELL, V89, P747, DOI 10.1016/S0092-8674(00)80257-3; Dyer BW, 2000, ANAL BIOCHEM, V282, P158, DOI 10.1006/abio.2000.4605; Enomoto H, 2000, J BIOL CHEM, V275, P8695, DOI 10.1074/jbc.275.12.8695; Ermakov S, 2008, ANN HUM GENET, V72, P510, DOI 10.1111/j.1469-1809.2008.00441.x; Finsterer J, 2010, J NEUROL SCI, V298, P1, DOI 10.1016/j.jns.2010.08.025; Fondon JW, 2004, P NATL ACAD SCI USA, V101, P18058, DOI 10.1073/pnas.0408118101; Green RE, 2010, SCIENCE, V328, P710, DOI 10.1126/science.1188021; Henry MJ, 2000, J CLIN DENSITOM, V3, P261, DOI 10.1385/JCD:3:3:261; Hood G.M., 2010, POPTOOLS VERSION 3 2; Kanatani N, 2006, DEV BIOL, V296, P48, DOI 10.1016/j.ydbio.2006.03.039; KANIS JA, 1994, J BONE MINER RES, V9, P1137, DOI 10.1002/jbmr.5650090802; Komori T, 1997, CELL, V89, P755, DOI 10.1016/S0092-8674(00)80258-5; Lee HJ, 2009, CALCIFIED TISSUE INT, V84, P439, DOI 10.1007/s00223-009-9246-6; Long FX, 2012, NAT REV MOL CELL BIO, V13, P27, DOI 10.1038/nrm3254; MacDonald HM, 2001, J BONE MINER RES, V16, P1634, DOI 10.1359/jbmr.2001.16.9.1634; Makovey J, 2007, J BONE MINER RES, V22, P1773, DOI 10.1359/JBMR.070708; McGuigan FEA, 2002, J BONE MINER RES, V17, P1273, DOI 10.1359/jbmr.2002.17.7.1273; McMurray CT, 2010, NAT REV GENET, V11, P786, DOI 10.1038/nrg2828; MIZUSHIMA S, 1990, NUCLEIC ACIDS RES, V18, P5322, DOI 10.1093/nar/18.17.5322; Morrison NA, 2005, PHARMACOGENET GENOM, V15, P127, DOI 10.1097/01213011-200502000-00008; Mundlos S, 1997, CELL, V89, P773, DOI 10.1016/S0092-8674(00)80260-3; Napierala D, 2005, MOL GENET METAB, V86, P257, DOI 10.1016/j.ymgme.2005.07.012; Ogawa H, 2008, COMPUT BIOL CHEM, V32, P102, DOI 10.1016/j.compbiolchem.2007.11.001; Otto F, 1997, CELL, V89, P765, DOI 10.1016/S0092-8674(00)80259-7; Paredes R, 2004, MOL CELL BIOL, V24, P8847, DOI 10.1128/MCB.24.20.8847-8861.2004; Pasco JA, 2006, OSTEOPOROSIS INT, V17, P1404, DOI 10.1007/s00198-006-0135-9; Perutz MF, 2002, P NATL ACAD SCI USA, V99, P5591, DOI 10.1073/pnas.042681399; Pineda B, 2010, J BONE MINER METAB, V28, P696, DOI 10.1007/s00774-010-0183-2; Polly P, 2000, FASEB J, V14, P1455, DOI 10.1096/fj.14.10.1455; Prince RL, 2006, ARCH INTERN MED, V166, P869, DOI 10.1001/archinte.166.8.869; Sanders KM, 1999, OSTEOPOROSIS INT, V10, P240, DOI 10.1007/s001980050222; Sears KE, 2007, EVOL DEV, V9, P555, DOI 10.1111/j.1525-142X.2007.00196.x; TILYARD MW, 1992, NEW ENGL J MED, V326, P357, DOI 10.1056/NEJM199202063260601; Vaughan T, 2004, BONE, V34, P1029, DOI 10.1016/j.bone.2004.02.004; Vaughan T, 2002, J BONE MINER RES, V17, P1527, DOI 10.1359/jbmr.2002.17.8.1527; Whan V, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-654; Xiao ZS, 2005, DEV BIOL, V283, P345, DOI 10.1016/j.ydbio.2005.04.028; Yoshida T, 2002, AM J HUM GENET, V71, P724, DOI 10.1086/342717; Zhang YW, 2000, P NATL ACAD SCI USA, V97, P10549, DOI 10.1073/pnas.180309597; Zhang YW, 2000, GENE, V244, P21, DOI 10.1016/S0378-1119(99)00558-2	48	17	17	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 13	2012	7	8							e42617	10.1371/journal.pone.0042617	http://dx.doi.org/10.1371/journal.pone.0042617			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	988OJ	22912713	Green Published, gold			2022-12-25	WOS:000307500100018
J	Huang, XY; Yuan, F; Liang, MH; Lo, HW; Shinohara, ML; Robertson, C; Zhong, P				Huang, Xiaoyi; Yuan, Fang; Liang, Meihua; Lo, Hui-Wen; Shinohara, Mari L.; Robertson, Cary; Zhong, Pei			M-HIFU Inhibits Tumor Growth, Suppresses STAT3 Activity and Enhances Tumor Specific Immunity in a Transplant Tumor Model of Prostate Cancer	PLOS ONE			English	Article							INTENSITY-FOCUSED ULTRASOUND; HUMAN HEPATOCELLULAR-CARCINOMA; MURINE MELANOMA MODEL; LONG-TERM MORTALITY; ANTITUMOR IMMUNITY; TARGETED DISRUPTION; BREAST-CANCER; CYCLIN D1; BCL-XL; DENDRITIC CELLS	Objective: In this study, we explored the use of mechanical high intensity focused ultrasound (M-HIFU) as a neo-adjuvant therapy prior to surgical resection of the primary tumor. We also investigated the role of signal transducer and activator of transcription 3 (STAT3) in M-HIFU elicited anti-tumor immune response using a transplant tumor model of prostate cancer. Methods: RM-9, a mouse prostate cancer cell line with constitutively activated STAT3, was inoculated subcutaneously in C57BL/6J mice. The tumor-bearing mice (with a maximum tumor diameter of 5 similar to 6 mm) were treated by M-HIFU or sham exposure two days before surgical resection of the primary tumor. Following recovery, if no tumor recurrence was observed in 30 days, tumor rechallenge was performed. The growth of the rechallenged tumor, survival rate and anti-tumor immune response of the animal were evaluated. Results: No tumor recurrence and distant metastasis were observed in both treatment groups employing M-HIFU + surgery and surgery alone. However, compared to surgery alone, M-HIFU combined with surgery were found to significantly inhibit the growth of rechallenged tumors, down-regulate intra-tumoral STAT3 activities, increase cytotoxic T cells in spleens and tumor draining lymph nodes (TDLNs), and improve the host survival. Furthermore, M-HIFU combined with surgery was found to significantly decrease the level of immunosuppression with concomitantly increased number and activities of dendritic cells, compared to surgery alone. Conclusion: Our results demonstrate that M-HIFU can inhibit STAT3 activities, and when combined synergistically with surgery, may provide a novel and promising strategy for the treatment of prostate cancers.	[Huang, Xiaoyi; Yuan, Fang; Zhong, Pei] Duke Univ, Dept Mech Engn & Mat Sci, Durham, NC 27706 USA; [Liang, Meihua; Lo, Hui-Wen] Duke Univ, Sch Med, Dept Surg, Div Surg Sci, Durham, NC USA; [Shinohara, Mari L.] Duke Univ, Med Ctr, Dept Immunol, Durham, NC USA; [Shinohara, Mari L.] Duke Univ, Med Ctr, Dept Mol Genet & Microbiol, Durham, NC USA; [Robertson, Cary; Zhong, Pei] Duke Univ, Med Ctr, Dept Surg, Div Urol, Durham, NC 27710 USA	Duke University; Duke University; Duke University; Duke University; Duke University	Huang, XY (corresponding author), Duke Univ, Dept Mech Engn & Mat Sci, Durham, NC 27706 USA.	huiwen.lo@duke.edu; mari.shinohara@duke.edu; pzhong@duke.edu		Lo, Hui-Wen/0000-0002-0681-7914; Huang, Xiaoyi/0000-0002-2355-5688; Shinohara, Mari/0000-0002-6808-9844	National Institutes of Health [5R21CA135221-02]; Duke Comprehensive Cancer Center; DoD [PC100266]; CONCERN Foundation; Morris Foundation; NATIONAL CANCER INSTITUTE [R21CA135221] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Duke Comprehensive Cancer Center; DoD(United States Department of Defense); CONCERN Foundation; Morris Foundation; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported in part by National Institutes of Health through grant #: 5R21CA135221-02 (http://www.nih.gov/), by a Prostate Cancer Pre-SPORE grant from the Duke Comprehensive Cancer Center, by a grant from DoD (PC100266), by a grant from the CONCERN Foundation, and by a grant from the Morris Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allen GW, 2007, CANCER-AM CANCER SOC, V110, P1405, DOI 10.1002/cncr.22940; Bai JR, 2005, CANCER RES, V65, P2344, DOI 10.1158/0008-5472.CAN-04-3502; Brayer J, 2010, IMMUNOL LETT, V131, P126, DOI 10.1016/j.imlet.2010.03.004; Chen LL, 1998, ULTRASOUND MED BIOL, V24, P1475, DOI 10.1016/S0301-5629(98)00134-3; Gabrilovich DI, 2009, NAT REV IMMUNOL, V9, P162, DOI 10.1038/nri2506; Gelet A, 2004, J UROLOGY, V171, P271, DOI 10.1016/S0022-5347(18)38264-8; Gelet A, 2001, EUR UROL, V40, P124, DOI 10.1159/000049761; Haura EB, 2005, NAT CLIN PRACT ONCOL, V2, P315, DOI 10.1038/ncponc0195; Hayakawa Y, 2011, P NATL ACAD SCI USA, V108, P780, DOI 10.1073/pnas.1011418108; Hu Z, 2007, J TRANSL MED, V5, DOI 10.1186/1479-5876-5-34; Hu ZL, 2005, BIOCHEM BIOPH RES CO, V335, P124, DOI 10.1016/j.bbrc.2005.07.071; Huang H, 2009, OLIGONUCLEOTIDES, V19, P151, DOI 10.1089/oli.2008.0174; JAIN RK, 1987, CANCER RES, V47, P3039; Jung KH, 2010, J CELL BIOCHEM, V110, P687, DOI 10.1002/jcb.22579; Kennedy JE, 2005, NAT REV CANCER, V5, P321, DOI 10.1038/nrc1591; Kim JK, 2009, INT J ONCOL, V35, P1257, DOI 10.3892/ijo_00000442; Kortylewski M, 2005, NAT MED, V11, P1314, DOI 10.1038/nm1325; Kortylewski M, 2008, CURR OPIN IMMUNOL, V20, P228, DOI 10.1016/j.coi.2008.03.010; Kujawski M, 2010, CANCER RES, V70, P9599, DOI 10.1158/0008-5472.CAN-10-1293; Lo HW, 2008, CLIN CANCER RES, V14, P6042, DOI 10.1158/1078-0432.CCR-07-4923; Lo HW, 2010, DISCOV MED, V10, P44; Lo HW, 2009, CANCER RES, V69, P6790, DOI 10.1158/0008-5472.CAN-09-0886; Martin SS, 2004, ONCOGENE, V23, P4641, DOI 10.1038/sj.onc.1207595; Meliilo JA, 2010, J IMMUNOL, V184, P2638, DOI 10.4049/jimmunol.0902960; Merglen A, 2007, ARCH INTERN MED, V167, P1944, DOI 10.1001/archinte.167.18.1944; Pallandre JR, 2007, J IMMUNOL, V179, P7593, DOI 10.4049/jimmunol.179.11.7593; PETERS G, 1994, J CELL SCI, P89; Pilon-Thomas S, 2006, J IMMUNOTHER, V29, P381, DOI 10.1097/01.cji.0000199199.20717.67; Roach M, 2008, ARCH INTERN MED, V168, P1351, DOI 10.1001/archinte.168.12.1351; Selvendiran K, 2010, CANCER BIOL THER, V10, P386, DOI 10.4161/cbt.10.4.12448; Shinohara ML, 2008, IMMUNITY, V29, P68, DOI 10.1016/j.immuni.2008.05.008; Shinohara ML, 2006, NAT IMMUNOL, V7, P498, DOI 10.1038/ni1327; Srinivasan A, 1998, J BIOL CHEM, V273, P4523, DOI 10.1074/jbc.273.8.4523; Tantivejkul K, 2005, J CELL BIOCHEM, V96, P641, DOI 10.1002/jcb.20533; TERHAAR G, 1995, ULTRASOUND MED BIOL, V21, P1089, DOI 10.1016/0301-5629(95)02010-1; Turkson J, 2004, EXPERT OPIN THER TAR, V8, P409, DOI 10.1517/14728222.8.5.409; van Delft MF, 2006, CELL RES, V16, P203, DOI 10.1038/sj.cr.7310028; Wang TH, 2004, NAT MED, V10, P48, DOI 10.1038/nm976; Wang X, 2002, CHINESE MED J-PEKING, V115, P1332; Wei DY, 2003, ONCOGENE, V22, P319, DOI 10.1038/sj.onc.1206122; Wu F, 2007, INT J HYPERTHER, V23, P165, DOI 10.1080/02656730701206638; Wu F, 2003, ULTRASOUND MED BIOL, V29, P1487, DOI 10.1016/S0301-5629(03)01034-2; Wu F, 2007, ANN SURG ONCOL, V14, P1237, DOI 10.1245/s10434-006-9275-6; Wu F, 2006, AM J SURG, V192, P179, DOI 10.1016/j.amjsurg.2006.03.014; Xing YF, 2008, BIOCHEM BIOPH RES CO, V375, P645, DOI 10.1016/j.bbrc.2008.08.072; YANG R, 1992, J PEDIATR SURG, V27, P246, DOI 10.1016/0022-3468(92)90321-W; Yu H, 2004, NAT REV CANCER, V4, P97, DOI 10.1038/nrc1275; Yu H, 2007, NAT REV IMMUNOL, V7, P41, DOI 10.1038/nri1995; Yu H, 2009, NAT REV CANCER, V9, P798, DOI 10.1038/nrc2734; Zhang T, 2011, CANCER RES, V71, P2066, DOI 10.1158/0008-5472.CAN-10-3200; Zhong P, 2011, AIP CONF PROC, V1359, P289, DOI 10.1063/1.3607920; Zhou YF, 2006, J ACOUST SOC AM, V120, P676, DOI 10.1121/1.2214131; Zhu H, 2010, CANCER LETT, V294, P101, DOI 10.1016/j.canlet.2010.01.028	53	36	37	2	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 24	2012	7	7							e41632	10.1371/journal.pone.0041632	http://dx.doi.org/10.1371/journal.pone.0041632			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	978NX	22911830	gold, Green Published, Green Submitted			2022-12-25	WOS:000306751300059
J	Shi, WF; Freitas, IT; Zhu, CD; Zheng, W; Hall, WW; Higgins, DG				Shi, Weifeng; Freitas, Ines T.; Zhu, Chaodong; Zheng, Wei; Hall, William W.; Higgins, Desmond G.			Recombination in Hepatitis C Virus: Identification of Four Novel Naturally Occurring Inter-Subtype Recombinants	PLOS ONE			English	Article							LARGE PHYLOGENETIC TREES; MAXIMUM-LIKELIHOOD; DETECTING RECOMBINATION; MITOCHONDRIAL-DNA; MOSAIC STRUCTURE; SEQUENCES; GENOTYPES; POPULATIONS; INFECTION; THERAPY	Recombination in Hepatitis C virus (HCV) is considered to be rare. In this study, we performed a phylogenetic analysis of 1278 full-length HCV genome sequences to identify potential recombination events. Nine inter-genotype recombinants were identified, all of which have been previously reported. This confirms the rarity of inter-genotype HCV recombinants. The analysis also identified five inter-subtype recombinants, four of which are documented for the first time (EU246930, EU246931, EU246932, and EU246937). Specifically, the latter represent four different novel recombination types (6a/6o, 6e/6o, 6e/6h, and 6n/6o), and this was well supported by seven independent methods embedded in RDP. The breakpoints of the four novel HCV recombinants are located within the NS5B coding region and were different from all previously reported breakpoints. While the locations of the breakpoints identified by RDP were not identical, they are very close. Our study suggests that while recombination in HCV is rare, this warrants further investigation.	[Shi, Weifeng; Freitas, Ines T.; Higgins, Desmond G.] Univ Coll Dublin, Conway Inst Biomol & Biomed Res, Dublin 2, Ireland; [Zhu, Chaodong; Zheng, Wei] Chinese Acad Sci, Inst Zool, Key Lab Zool Systemat & Evolut, Beijing, Peoples R China; [Zheng, Wei] Chinese Acad Sci, Shenzhen Inst Adv Technol, Shenzhen, Peoples R China; [Zheng, Wei] Chinese Acad Sci, Grad Univ, Beijing, Peoples R China; [Hall, William W.] Univ Coll Dublin, Natl Virus Reference Lab, Dublin 2, Ireland	University College Dublin; Chinese Academy of Sciences; Institute of Zoology, CAS; Chinese Academy of Sciences; Shenzhen Institute of Advanced Technology, CAS; Chinese Academy of Sciences; University of Chinese Academy of Sciences, CAS; University College Dublin	Shi, WF (corresponding author), Chinese Acad Sci, Guangzhou Inst Adv Technol, Guangzhou, Guangdong, Peoples R China.	wfshi.tsmc@gmail.com	ZHU, Chao-Dong/E-5961-2011; Higgins, des g/J-6314-2012	ZHU, Chao-Dong/0000-0002-9347-3178; Higgins, Des/0000-0002-3952-3285	Science Foundation Ireland (PI) [07/IN.1/B1783]; UK Wellcome Trust [097427/Z/11/Z]; National Science Foundation, China [31172048, J0930004]	Science Foundation Ireland (PI)(Science Foundation Ireland); UK Wellcome Trust(Wellcome Trust); National Science Foundation, China(National Natural Science Foundation of China (NSFC))	This study was supported by Science Foundation Ireland (PI grant 07/IN.1/B1783). I.T. Freitas was funded by the UK Wellcome Trust (097427/Z/11/Z). C. Zhu and W. Zheng were supported by the National Science Foundation, China (Grants Nos. 31172048, J0930004). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Asselah T, 2003, GUT, V52, P900, DOI 10.1136/gut.52.6.900; Boni MF, 2007, GENETICS, V176, P1035, DOI 10.1534/genetics.106.068874; Burke DS, 1997, EMERG INFECT DIS, V3, P253, DOI 10.3201/eid0303.970301; CHOO QL, 1989, SCIENCE, V244, P359, DOI 10.1126/science.2523562; Colina R, 2004, J GEN VIROL, V85, P31, DOI 10.1099/vir.0.19472-0; Demetriou VL, 2011, ADV VIROL, V2011, DOI 10.1155/2011/710438; Dubuisson J, 2007, WORLD J GASTROENTERO, V13, P2406, DOI 10.3748/wjg.v13.i17.2406; Giannini C, 1999, J LAB CLIN MED, V134, P68, DOI 10.1016/S0022-2143(99)90055-0; Gibbs MJ, 2000, BIOINFORMATICS, V16, P573, DOI 10.1093/bioinformatics/16.7.573; Gonzalez-Candelas F, 2011, VIRUSES-BASEL, V3, P2006, DOI 10.3390/v3102006; Guindon S, 2003, SYST BIOL, V52, P696, DOI 10.1080/10635150390235520; Hall T, 1999, NUCL ACIDS S SER, V41, P95, DOI DOI 10.1021/BK-1999-0734.CH008; HASEGAWA M, 1985, J MOL EVOL, V22, P160, DOI 10.1007/BF02101694; Huson DH, 2007, BMC BIOINFORMATICS, V8, DOI 10.1186/1471-2105-8-460; Kalinina O, 2002, J VIROL, V76, P4034, DOI 10.1128/JVI.76.8.4034-4043.2002; Kapoor A, 2011, P NATL ACAD SCI USA, V108, P11608, DOI 10.1073/pnas.1101794108; KISHINO H, 1989, J MOL EVOL, V29, P170, DOI 10.1007/BF02100115; Kurbanov F, 2008, HEPATOL RES, V38, P457, DOI 10.1111/j.1872-034X.2007.00293.x; Legrand-Abravanel F, 2007, J VIROL, V81, P4357, DOI 10.1128/JVI.02639-06; Lole KS, 1999, J VIROL, V73, P152, DOI 10.1128/JVI.73.1.152-160.1999; Martin D, 2000, BIOINFORMATICS, V16, P562, DOI 10.1093/bioinformatics/16.6.562; Martin DP, 2010, BIOINFORMATICS, V26, P2462, DOI 10.1093/bioinformatics/btq467; Martin DP, 2005, AIDS RES HUM RETROV, V21, P98, DOI 10.1089/aid.2005.21.98; Matsubara T, 1996, J PEDIATR GASTR NUTR, V22, P79, DOI 10.1097/00005176-199601000-00013; Moreau I, 2006, VIROL J, V3, DOI 10.1186/1743-422X-3-95; Morel V, 2011, J VIRAL HEPATITIS, V18, P77, DOI 10.1111/j.1365-2893.2010.01367.x; Moreno MP, 2006, VIROL J, V3, DOI 10.1186/1743-422X-3-87; Noppornpath S, 2008, J GEN VIROL, V89, P1276, DOI 10.1099/vir.0.83593-0; Padidam M, 1999, VIROLOGY, V265, P218, DOI 10.1006/viro.1999.0056; Posada D, 2002, MOL BIOL EVOL, V19, P708, DOI 10.1093/oxfordjournals.molbev.a004129; Posada D, 2001, P NATL ACAD SCI USA, V98, P13757, DOI 10.1073/pnas.241370698; Raghwani J, 2012, J VIROL, V86, P2212, DOI 10.1128/JVI.06184-11; Ross RS, 2008, EVOL BIOINFORM, V4, P249; Schijman A, 2004, CLIN DIAGN LAB IMMUN, V11, P433, DOI 10.1128/CDLI.11.2.433-435.2004; Schmidt HA, 2002, BIOINFORMATICS, V18, P502, DOI 10.1093/bioinformatics/18.3.502; Sentandreu V, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003239; Shi WF, 2012, VIROLOGY, V427, P51, DOI 10.1016/j.virol.2012.01.030; Sievers F, 2011, MOL SYST BIOL, V7, DOI 10.1038/msb.2011.75; Simmonds P, 2005, J VIROL, V79, P15467, DOI 10.1128/JVI.79.24.15467-15476.2005; Simmonds P, 2004, J GEN VIROL, V85, P3173, DOI 10.1099/vir.0.80401-0; Smith DB, 1997, J GEN VIROL, V78, P321, DOI 10.1099/0022-1317-78-2-321; SMITH JM, 1992, J MOL EVOL, V34, P126; Stamatakis A, 2005, BIOINFORMATICS, V21, P456, DOI 10.1093/bioinformatics/bti191; Stamatakis A, 2006, P 20 IEEE INT PAR DI, DOI DOI 10.1109/IPDPS.2006.1639535; Strimmer K, 1997, P NATL ACAD SCI USA, V94, P6815, DOI 10.1073/pnas.94.13.6815; Strimmer K, 2002, P ROY SOC B-BIOL SCI, V269, P137, DOI 10.1098/rspb.2001.1862; Tallo T, 2007, J MED VIROL, V79, P374, DOI 10.1002/jmv.20828; TAMURA K, 1993, MOL BIOL EVOL, V10, P512, DOI 10.1093/oxfordjournals.molbev.a040023; Tavare S., 1986, LECT MATH LIFE SCI, V17, P57, DOI DOI 10.1016/J.MARPOLBUL.2009.11.011; Toyoda H, 1998, CLIN INFECT DIS, V26, P440, DOI 10.1086/516332; Tscherne DM, 2007, J VIROL, V81, P3693, DOI 10.1128/JVI.01748-06; Yang J, 2006, J GEN VIROL, V87, P2203, DOI 10.1099/vir.0.81752-0; Yun AB, 1996, J MED VIROL, V49, P155, DOI 10.1002/(SICI)1096-9071(199607)49:3<155::AID-JMV1>3.0.CO;2-3	53	28	28	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 24	2012	7	7							e41997	10.1371/journal.pone.0041997	http://dx.doi.org/10.1371/journal.pone.0041997			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	978NX	22911872	Green Submitted, gold, Green Published			2022-12-25	WOS:000306751300088
J	Slotta-Huspenina, J; Berg, D; Bauer, K; Wolff, C; Malinowsky, K; Bauer, L; Drecoll, E; Bettstetter, M; Feith, M; Walch, A; Hofler, H; Becker, KF; Langer, R				Slotta-Huspenina, Julia; Berg, Daniela; Bauer, Karina; Wolff, Claudia; Malinowsky, Katharina; Bauer, Lukas; Drecoll, Enken; Bettstetter, Marcus; Feith, Marcus; Walch, Axel; Hoefler, Heinz; Becker, Karl-Friedrich; Langer, Rupert			Evidence of Prognostic Relevant Expression Profiles of Heat-Shock Proteins and Glucose-Regulated Proteins in Oesophageal Adenocarcinomas	PLOS ONE			English	Article							HISTOPATHOLOGICAL TUMOR-REGRESSION; NEOADJUVANT CHEMOTHERAPY; CANCER; HSP90; GRP78; ASSOCIATION; THERAPY; HSP70; HSP27; MICROARRAYS	A high percentage of oesophageal adenocarcinomas show an aggressive clinical behaviour with a significant resistance to chemotherapy. Heat-shock proteins (HSPs) and glucose-regulated proteins (GRPs) are molecular chaperones that play an important role in tumour biology. Recently, novel therapeutic approaches targeting HSP90/GRP94 have been introduced for treating cancer. We performed a comprehensive investigation of HSP and GRP expression including HSP27, phosphorylated (p)-HSP27((Ser15)), p-HSP27((Ser78)), p-HSP27((Ser82)), HSP60, HSP70, HSP90, GRP78 and GRP94 in 92 primary resected oesophageal adenocarcinomas by using reverse phase protein arrays (RPPA), immunohistochemistry (IHC) and real-time quantitative RTPCR (qPCR). Results were correlated with pathologic features and survival. HSP/GRP protein and mRNA expression was detected in all tumours at various levels. Unsupervised hierarchical clustering showed two distinct groups of tumours with specific protein expression patterns: The hallmark of the first group was a high expression of p-HSP27((Ser15, Ser78, Ser82)) and low expression of GRP78, GRP94 and HSP60. The second group showed the inverse pattern with low p-HSP27 and high GRP78, GRP94 and HSP60 expression. The clinical outcome for patients from the first group was significantly improved compared to patients from the second group, both in univariate analysis (p = 0.015) and multivariate analysis (p = 0.029). Interestingly, these two groups could not be distinguished by immunohistochemistry or qPCR analysis. In summary, two distinct and prognostic relevant HSP/GRP protein expression patterns in adenocarcinomas of the oesophagus were detected by RPPA. Our approach may be helpful for identifying candidates for specific HSP/GRP-targeted therapies.	[Slotta-Huspenina, Julia; Berg, Daniela; Bauer, Karina; Wolff, Claudia; Malinowsky, Katharina; Bauer, Lukas; Drecoll, Enken; Hoefler, Heinz; Becker, Karl-Friedrich; Langer, Rupert] Tech Univ Munich, Inst Pathol, Munich, Germany; [Feith, Marcus] Tech Univ Munich, Dept Surg, Munich, Germany; [Walch, Axel; Hoefler, Heinz] Helmholtz Zentrum Munchen, Inst Pathol, Oberschleissheim, Germany; [Langer, Rupert] Univ Bern, Inst Pathol, Bern, Switzerland; [Bettstetter, Marcus] Teilgemeinschaftspraxis Molekularpathol, Munich, Germany	Technical University of Munich; Technical University of Munich; Helmholtz Association; Helmholtz-Center Munich - German Research Center for Environmental Health; University of Bern	Slotta-Huspenina, J (corresponding author), Tech Univ Munich, Inst Pathol, Munich, Germany.	slotta.huspenina@lrz.tum.de	Langer, Rupert/AAU-1174-2021; Walch, Axel/B-4554-2012; Becker, Karl-Friedrich/D-3636-2015	Langer, Rupert/0000-0001-9491-3609; Walch, Axel/0000-0001-5578-4023; Becker, Karl-Friedrich/0000-0002-6801-4498	Deutsche Forschungsgemeinschaft (DFG) [LA 2706]; NGFN (Nationales Genomforschungsnetz) project of BMBF (Bundesministerium fur Bildung und Forschung) [01GR0805]	Deutsche Forschungsgemeinschaft (DFG)(German Research Foundation (DFG)); NGFN (Nationales Genomforschungsnetz) project of BMBF (Bundesministerium fur Bildung und Forschung)	This study was supported by the Deutsche Forschungsgemeinschaft (DFG, grant no. LA 2706) and the NGFN (Nationales Genomforschungsnetz) project of the BMBF (Bundesministerium fur Bildung und Forschung; grant no. 01GR0805. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akutsu Y, 2011, ANN SURG ONCOL, V18, P832, DOI 10.1245/s10434-010-1128-7; Banerji U, 2009, CLIN CANCER RES, V15, P9, DOI 10.1158/1078-0432.CCR-08-0132; Bauer K, 2012, CELL ONCOL DORDR; Becker KF, 2007, J PATHOL, V211, P370, DOI 10.1002/path.2107; Becker K, 2011, ANN SURG, V253, P934, DOI 10.1097/SLA.0b013e318216f449; Berg D, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023985; Berg D, 2011, METHODS MOL BIOL, V785, P109, DOI 10.1007/978-1-61779-286-1_8; Berg D, 2010, EUR J CANCER, V46, P47, DOI 10.1016/j.ejca.2009.10.016; Calderwood SK, 2006, TRENDS BIOCHEM SCI, V31, P164, DOI 10.1016/j.tibs.2006.01.006; Ciocca DR, 2005, CELL STRESS CHAPERON, V10, P86, DOI 10.1379/CSC-99r.1; Cunningham D, 2006, NEW ENGL J MED, V355, P11, DOI 10.1056/NEJMoa055531; DeMeester SR, 2006, ANN SURG ONCOL, V13, P12, DOI 10.1245/ASO.2005.12.025; Eisen MB, 1998, P NATL ACAD SCI USA, V95, P14863, DOI 10.1073/pnas.95.25.14863; Fu Y, 2006, CANCER BIOL THER, V5, P741, DOI 10.4161/cbt.5.7.2970; Fukuyo Y, 2010, CANCER LETT, V290, P24, DOI 10.1016/j.canlet.2009.07.010; Gonzalez-Angulo Ana M, 2011, Clin Proteomics, V8, P11, DOI 10.1186/1559-0275-8-11; Gulmann C, 2006, J PATHOL, V208, P595, DOI 10.1002/path.1958; Handschuh G, 1999, ONCOGENE, V18, P4301, DOI 10.1038/sj.onc.1202790; Jego G, 2010, CANC LETT; Jemal A, 2011, CA-CANCER J CLIN, V61, P134, DOI [10.3322/caac.20115, 10.3322/caac.20107]; Khalil AA, 2011, BBA-REV CANCER, V1816, P89, DOI 10.1016/j.bbcan.2011.05.001; Klopfleisch R, 2011, HISTOL HISTOPATHOL, V26, P797, DOI 10.14670/HH-26.797; Lagarde SM, 2006, J CLIN ONCOL, V24, P4347, DOI 10.1200/JCO.2005.04.9445; Langer R, 2009, MODERN PATHOL, V22, P1555, DOI 10.1038/modpathol.2009.123; Langer R, 2008, CLIN CANCER RES, V14, P8279, DOI 10.1158/1078-0432.CCR-08-0679; Langer R, 2008, BMC CANCER, V8, DOI 10.1186/1471-2407-8-70; Lee AS, 2007, CANCER RES, V67, P3496, DOI 10.1158/0008-5472.CAN-07-0325; Lim SO, 2005, WORLD J GASTROENTERO, V11, P2072, DOI 10.3748/wjg.v11.i14.2072; LINDQUIST S, 1988, ANNU REV GENET, V22, P631, DOI 10.1146/annurev.ge.22.120188.003215; Lordick F, 2004, BRIT J SURG, V91, P540, DOI 10.1002/bjs.4575; Moore HM, 2011, BIOPRESERV BIOBANK, V9, P57, DOI 10.1089/bio.2010.0036; Nanjundan M, 2010, J THORAC ONCOL, V5, P1894, DOI 10.1097/JTO.0b013e3181f2a266; O'Dwyer D, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027718; Paweletz CP, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0026459; Pfister K, 2007, CANCER-AM CANCER SOC, V110, P926, DOI 10.1002/cncr.22864; Powers MV, 2010, CELL CYCLE, V9, P1542, DOI 10.4161/cc.9.8.11204; Powers MV, 2009, CELL CYCLE, V8, P518, DOI 10.4161/cc.8.4.7583; Robb JA, 2008, JAMA-J AM MED ASSOC, V300, P650, DOI 10.1001/jama.300.6.650-c; Rogalla T, 1999, J BIOL CHEM, V274, P18947, DOI 10.1074/jbc.274.27.18947; Schneider PM, 2005, ANN SURG, V242, P684, DOI 10.1097/01.sla.0000186170.38348.7b; Sharma V, 2012, MOL CELL PROTEOMICS; Sinha A, 2007, LIFE SCI, V80, P1345, DOI 10.1016/j.lfs.2006.12.005; Specht K, 2001, AM J PATHOL, V158, P419, DOI 10.1016/S0002-9440(10)63985-5; Spurrier B, 2008, NAT PROTOC, V3, P1796, DOI 10.1038/nprot.2008.179; Tan SS, 2011, J PATHOL, V223, P81, DOI 10.1002/path.2795; Tibes R, 2006, MOL CANCER THER, V5, P2512, DOI 10.1158/1535-7163.MCT-06-0334; Tweedle EM, 2010, GUT, V59, P1501, DOI 10.1136/gut.2009.196626; Uckun FM, 2011, BRIT J HAEMATOL, V153, P741, DOI 10.1111/j.1365-2141.2011.08671.x; Usmani SZ, 2010, J HEMATOL ONCOL, V3, DOI 10.1186/1756-8722-3-40; Wang XP, 2010, CLIN DEV IMMUNOL, DOI 10.1155/2010/212537; Wolff C, 2010, J PATHOL; Wolff C, 2011, METHODS MOL BIOL, V785, P123, DOI 10.1007/978-1-61779-286-1_9; Wolff C, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016353; Wu X, 2009, BRIT J CANCER, V100, P334, DOI 10.1038/sj.bjc.6604855	54	22	23	1	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 24	2012	7	7							e41420	10.1371/journal.pone.0041420	http://dx.doi.org/10.1371/journal.pone.0041420			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	978NX	22911792	gold, Green Submitted, Green Published			2022-12-25	WOS:000306751300038
J	Zheng, L; Zhang, DM; Chen, XC; Yang, L; Wei, YQ; Zhao, X				Zheng, Lan; Zhang, Dongmei; Chen, Xiancheng; Yang, Li; Wei, Yuquan; Zhao, Xia			Antitumor Activities of Human Placenta-Derived Mesenchymal Stem Cells Expressing Endostatin on Ovarian Cancer	PLOS ONE			English	Article							CELLULAR VEHICLES; PROGENITOR CELLS; GENE-THERAPY; GROWTH; TRAFFICKING; INDUCTION; MIGRATION; CHEMOKINE; DELIVERY; FOCUS	Endostatin is an important endogenous inhibitor of neovascularization that has been widely used in anti-angiogenesis therapy for the treatment of cancer. However, its clinical application is largely hampered by its low efficacy. Human placenta-derived mesenchymal stem cells (hpMSCs) are particularly attractive cells for clinical use in cell-based therapies. In the present study, hpMSCs were isolated and characterized. We then evaluated the tumor targeting properties and antitumor effects of hpMSCs as gene delivery vehicles for ovarian cancer therapy. We efficiently engineered hpMSCs to deliver endostatin via adenoviral transduction mediated by Lipofectamine 2000. The tropism capacity of the engineered hpMSCs toward tumor cells was then confirmed by in vitro migration assays and in vivo by intraperitoneal injection of hpMSCs into nude mice. The hpMSCs expressing the human endostatin gene demonstrated preferential homing to the tumor site and significantly decreased the tumor volume without apparent systemic toxic effects. These observations were associated with significantly decreased blood sprouts and tumor cell proliferation as well as a dramatically increased tumor apoptosis index. These results suggested that hpMSCs are potentially an effective delivery vehicle for therapeutic genes for the treatment of ovarian cancer.	[Zheng, Lan; Zhao, Xia] Sichuan Univ, Dept Gynecol & Obstet, W China Hosp 2, Chengdu 610064, Sichuan, Peoples R China; [Zhang, Dongmei; Chen, Xiancheng; Yang, Li; Wei, Yuquan] W China Hosp, State Key Lab Biotherapy, Chengdu, Sichuan, Peoples R China; [Zhang, Dongmei; Chen, Xiancheng; Yang, Li; Wei, Yuquan] W China Hosp, Ctr Canc, Chengdu, Sichuan, Peoples R China	Sichuan University; Sichuan University; Sichuan University	Zheng, L (corresponding author), Sichuan Univ, Dept Gynecol & Obstet, W China Hosp 2, Chengdu 610064, Sichuan, Peoples R China.	xia-zhao@126.com			National 973 Program of China [2011CB910703]	National 973 Program of China(National Basic Research Program of China)	This work was supported by National 973 Program of China grants (2011CB910703). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Baksh D, 2004, J CELL MOL MED, V8, P301, DOI 10.1111/j.1582-4934.2004.tb00320.x; Ceradini DJ, 2004, NAT MED, V10, P858, DOI 10.1038/nm1075; Dkhissi F, 2003, HUM GENE THER, V14, P997, DOI 10.1089/104303403766682250; Eichna DM, 2008, CLIN J ONCOL NURS, V12, P108, DOI 10.1188/08.CJON.108-112; Fukuchi Y, 2004, STEM CELLS, V22, P649, DOI 10.1634/stemcells.22-5-649; Gasparini G, 1999, DRUGS, V58, P17, DOI 10.2165/00003495-199958010-00003; Hanahan D, 2000, CELL, V100, P57, DOI 10.1016/S0092-8674(00)81683-9; He TC, 1998, P NATL ACAD SCI USA, V95, P2509, DOI 10.1073/pnas.95.5.2509; Indraccolo S, 2002, GENE THER, V9, P867, DOI 10.1038/sj.gt.3301703; Kassem M, 2004, BASIC CLIN PHARMACOL, V95, P209, DOI 10.1111/j.1742-7843.2004.pto950502.x; Kleinman ME, 2007, ARTERIOSCL THROM VAS, V27, P2664, DOI 10.1161/ATVBAHA.107.150284; Komarova S, 2006, MOL CANCER THER, V5, P755, DOI 10.1158/1535-7163.MCT-05-0334; Li L, 2004, WORLD J GASTROENTERO, V10, P1867; Liang ZH, 2004, CHINESE MED J-PEKING, V117, P1809; Liu JY, 2003, BLOOD, V102, P1815, DOI 10.1182/blood-2002-12-3772; Ponte AL, 2007, STEM CELLS, V25, P1737, DOI 10.1634/stemcells.2007-0054; Luo X, 2005, TECHNOL CANCER RES T, V4, P193, DOI 10.1177/153303460500400208; Malecki M, 2005, GENE THER, V12, pS159, DOI 10.1038/sj.gt.3302621; Mareschi K, 2006, J CELL BIOCHEM, V97, P744, DOI 10.1002/jcb.20681; Miao ZN, 2006, CELL BIOL INT, V30, P681, DOI 10.1016/j.cellbi.2006.03.009; Nakamizo A, 2005, CANCER RES, V65, P3307, DOI 10.1158/0008-5472.CAN-04-1874; Ozols RF, 2004, CANCER CELL, V5, P19, DOI 10.1016/S1535-6108(04)00002-9; Pereboeva L, 2004, BIODRUGS, V18, P361, DOI 10.2165/00063030-200418060-00003; Pereboeva L, 2003, STEM CELLS, V21, P389, DOI 10.1634/stemcells.21-4-389; Pittenger MF, 1999, SCIENCE, V284, P143, DOI 10.1126/science.284.5411.143; Rosu-Myles M, 2005, J CELL SCI, V118, P4343, DOI 10.1242/jcs.02555; Semenov OV, 2010, AM J OBSTET GYNECOL, V202, DOI 10.1016/j.ajog.2009.10.869; Shan WW, 2009, CELL CYCLE, V8, P731, DOI 10.4161/cc.8.5.7848; Sordi V, 2005, BLOOD, V106, P419, DOI 10.1182/blood-2004-09-3507; Studeny M, 2002, CANCER RES, V62, P3603; Wang Lei, 2002, Hematology, V7, P113; Wang Li, 2009, Sichuan Da Xue Xue Bao Yi Xue Ban, V40, P190; Yamanaka R, 2001, CANCER GENE THER, V8, P796, DOI 10.1038/sj.cgt.7700367; Yang L, 2010, CANCER GENE THER, V17, P49, DOI 10.1038/cgt.2009.47	34	22	24	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 24	2012	7	7							e39119	10.1371/journal.pone.0039119	http://dx.doi.org/10.1371/journal.pone.0039119			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	978NX	22911684	Green Published, gold, Green Submitted			2022-12-25	WOS:000306751300004
J	Goropashnaya, AV; Fedorov, VB; Seifert, B; Pamilo, P				Goropashnaya, Anna V.; Fedorov, Vadim B.; Seifert, Bernhard; Pamilo, Pekka			Phylogenetic Relationships of Palaearctic Formica Species (Hymenoptera, Formicidae) Based on Mitochondrial Cytochrome b Sequences	PLOS ONE			English	Article							ANTS HYMENOPTERA; GENETIC DIFFERENTIATION; CHROMOSOME-NUMBERS; TAXONOMIC REVISION; WOOD ANTS; EVOLUTION; DNA; POPULATIONS; RUFA; DIVERSIFICATION	Ants of genus Formica demonstrate variation in social organization and represent model species for ecological, behavioral, evolutionary studies and testing theoretical implications of the kin selection theory. Subgeneric division of the Formica ants based on morphology has been questioned and remained unclear after an allozyme study on genetic differentiation between 13 species representing all subgenera was conducted. In the present study, the phylogenetic relationships within the genus were examined using mitochondrial DNA sequences of the cytochrome b and a part of the NADH dehydrogenase subunit 6. All 23 Formica species sampled in the Palaearctic clustered according to the subgeneric affiliation except F. uralensis that formed a separate phylogenetic group. Unlike Coptoformica and Formica s. str., the subgenus Serviformica did not form a tight cluster but more likely consisted of a few small clades. The genetic distances between the subgenera were around 10%, implying approximate divergence time of 5 Myr if we used the conventional insect divergence rate of 2% per Myr. Within-subgenus divergence estimates were 6.69% in Serviformica, 3.61% in Coptoformica, 1.18% in Formica s. str., which supported our previous results on relatively rapid speciation in the latter subgenus. The phylogeny inferred from DNA sequences provides a necessary framework against which the evolution of social traits can be compared. We discuss implications of inferred phylogeny for the evolution of social traits.	[Goropashnaya, Anna V.] Uppsala Univ, EBC, Dept Ecol & Genet, Uppsala, Sweden; [Goropashnaya, Anna V.; Fedorov, Vadim B.] Univ Alaska, Inst Arctic Biol, Fairbanks, AK 99775 USA; [Seifert, Bernhard] Senckenberg Museum Nat Hist, Gorlitz, Germany; [Pamilo, Pekka] Univ Helsinki, Dept Biosci, Helsinki, Finland	Uppsala University; University of Alaska System; University of Alaska Fairbanks; Senckenberg Gesellschaft fur Naturforschung (SGN); University of Helsinki	Goropashnaya, AV (corresponding author), Uppsala Univ, EBC, Dept Ecol & Genet, Uppsala, Sweden.	agoropashnaya@alaska.edu			Natural Science Research Councils of Sweden; Natural Science Research Councils of Finland; Sven and Lilly Lawski's Foundation; European Comission	Natural Science Research Councils of Sweden; Natural Science Research Councils of Finland; Sven and Lilly Lawski's Foundation; European Comission(European CommissionEuropean Commission Joint Research Centre)	The study has been supported by grants from the Natural Science Research Councils of Sweden and Finland, Sven and Lilly Lawski's Foundation, and from the European Comission. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 1995, NEW GEN CATALOGUE AN; Bernasconi C, 2011, MYRMECOL NEWS, V14, P37; Boomsma JJ, 1998, BEHAV ECOL SOCIOBIOL, V42, P85, DOI 10.1007/s002650050415; Brady SG, 2006, P NATL ACAD SCI USA, V103, P18172, DOI 10.1073/pnas.0605858103; Brady SG, 2003, P NATL ACAD SCI USA, V100, P6575, DOI 10.1073/pnas.1137809100; Chapuisat M, 1997, EVOLUTION, V51, P475, DOI 10.1111/j.1558-5646.1997.tb02435.x; CHERIX D, 1991, ETHOL ECOL EVOL, P61; DESALLE R, 1987, J MOL EVOL, V26, P157, DOI 10.1007/BF02111289; Dlussky GM, 2008, PALEONTOL J+, V42, P500, DOI 10.1134/S0031030108050055; Dlussky G.M., 1967, ANTS GENUS FORMICA H; FELSENSTEIN J, 1988, ANNU REV GENET, V22, P521, DOI 10.1146/annurev.ge.22.120188.002513; Goropashnaya AV, 2007, ANN ZOOL FENN, V44, P462; Goropashnaya AV, 2004, MOL PHYLOGENET EVOL, V32, P198, DOI 10.1016/j.ympev.2003.11.016; Goropashnaya AV, 2004, MOL ECOL, V13, P1849, DOI 10.1111/j.1365-294X.2004.02189.x; Goropashnaya AV, 2001, MOL ECOL, V10, P2807, DOI 10.1046/j.1365-294X.2001.t01-1-01410.x; Goropashnaya AV, 2003, THESIS UPPSALA U UPP; Gyllenstrand N, 2005, J EVOLUTION BIOL, V18, P978, DOI 10.1111/j.1420-9101.2005.00908.x; Gyllenstrand N, 2004, INSECT SOC, V51, P139, DOI 10.1007/s00040-003-0720-2; Hasegawa E, 2002, ANN ZOOL FENN, V39, P267; Helantera H, 2007, AM NAT, V170, pE14, DOI 10.1086/518185; Holldobler B., 1990, pi; JERMIIN LS, 1994, J MOL EVOL, V38, P282, DOI 10.1007/BF00176090; Johnson RN, 2003, MOL PHYLOGENET EVOL, V29, P317, DOI 10.1016/S1055-7903(03)00114-3; Keane TM, 2007, NUCLEIC ACIDS RES, V35, pW33, DOI 10.1093/nar/gkm359; Keane TM, 2006, BMC EVOL BIOL, V6, DOI 10.1186/1471-2148-6-29; Kulmuni J, 2010, P NATL ACAD SCI USA, V107, P7371, DOI 10.1073/pnas.0912409107; Kumar S, 2004, BRIEF BIOINFORM, V5, P150, DOI 10.1093/bib/5.2.150; Kutter H., 1977, Insecta Helvetica Catalogus, V6, P1; Liautard C, 2001, EVOLUTION, V55, P2484, DOI 10.1111/j.0014-3820.2001.tb00763.x; Lorite P, 2002, SOCIOBIOLOGY, V40, P331; Moreau CS, 2006, SCIENCE, V312, P101, DOI 10.1126/science.1124891; PAMILO P, 1984, BIOL J LINN SOC, V21, P331, DOI 10.1111/j.1095-8312.1984.tb00370.x; PAMILO P, 1992, INSECT SOC, V39, P15, DOI 10.1007/BF01240528; PAMILO P, 1979, ANN ENTOMOL FENN, V45, P65; Rich PV, 1997, FOSSIL BOOK RECORD P; ROSENGREN M, 1980, HEREDITAS, V92, P321; Rosengren Rainer, 1993, P308; ROSS KG, 1991, J EVOLUTION BIOL, V4, P117, DOI 10.1046/j.1420-9101.1991.4010117.x; Savolainen R, 2003, P NATL ACAD SCI USA, V100, P7169, DOI 10.1073/pnas.1036825100; Seifert B, 2004, ORG DIVERS EVOL, V4, P295, DOI 10.1016/j.ode.2004.04.005; Seifert B., 1991, Abhandlungen und Berichte des Naturkundemuseums Goerlitz, V65, P1; Seifert Bernhard, 2004, Myrmecologische Nachrichten, V6, P29; Seifert B, 2010, EVOL ECOL, V24, P1219, DOI 10.1007/s10682-010-9371-8; Seifert Bernhard, 2000, Zoosystema, V22, P517; Seifert B, 2009, MYRMECOL NEWS, V12, P255; Seifert B, 2009, MYRMECOL NEWS, V12, P67; Sundstrom L, 2003, EVOLUTION, V57, P1552, DOI 10.1111/j.0014-3820.2003.tb00363.x; Swofford D.L., 1999, PAUP PHYLOGENETIC AN; TINAUT A, 1989, EOS-Revista Espanola de Entomologia, V65, P280	49	24	27	4	43	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 23	2012	7	7							e41697	10.1371/journal.pone.0041697	http://dx.doi.org/10.1371/journal.pone.0041697			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	977TM	22911845	Green Published, Green Submitted, gold			2022-12-25	WOS:000306687700141
J	Gartner, S; Liu, YL; Natesan, S				Gartner, Suzanne; Liu, Yiling; Natesan, Senthilkumar			De novo Generation of Cells within Human Nurse Macrophages and Consequences following HIV-1 Infection	PLOS ONE			English	Article							HUMAN-IMMUNODEFICIENCY-VIRUS; CIRCULATING CD14(+) MONOCYTES; RECENT THYMIC EMIGRANTS; CD4(+) T-CELLS; ACTIVE ANTIRETROVIRAL THERAPY; CHRONIC LYMPHOCYTIC-LEUKEMIA; RECEPTOR EXCISION CIRCLES; STEM-CELLS; GASTROINTESTINAL-TRACT; HTLV-III/LAV	Nurse cells are defined as those that provide for the development of other cells. We report here, that in vitro, human monocyte-derived macrophages can behave as nurse cells with functional capabilities that include de novo generation of CD4+ T-lymphocytes and a previously unknown small cell with monocytoid characteristics. We named these novel cells "self-renewing monocytoid cells" (SRMC), because they could develop into nurse macrophages that produced another generation of SRMC. SRMC were not detectable in blood. Their transition to nurse behavior was characterized by expression of CD10, a marker of thymic epithelium and bone marrow stroma, typically absent on macrophages. Bromodeoxyuridine labeling and immunostaining for cdc6 expression confirmed DNA synthesis within nurse macrophages. T-cell excision circles were detected in macrophages, along with expression of pre-T-cell receptor alpha and recombination activating gene 1, suggesting that genetic recombination events associated with generation of the T-cell receptor were occurring in these cells. SRMC expressed CCR5, the coreceptor for R5 HIV-1 isolates, and were highly susceptible to HIV-1 entry leading to productive infection. While expressing HIV-1, SRMC could differentiate into nurse macrophages that produced another generation of HIV-1-expressing SRMC. The infected nurse macrophage/SRMC cycle could continue in vitro for multiple generations, suggesting it might represent a mechanism whereby HIV-1 can maintain persistence in vivo. HIV-1 infection of nurse macrophages led to a decline in CD4+ T-cell production. There was severe, preferential loss of the CCR5+ CD4+ T-cell subpopulation. Confocal microscopy revealed individual HIV-1-expressing nurse macrophages simultaneously producing both HIV-1-expressing SRMC and non-expressing CD3+ cells, suggesting that nurse macrophages might be a source of latently infected CD4+ T-cells. Real-time PCR experiments confirmed this by demonstrating 10-fold more HIV-1-genome-harboring T-cells, than virus-expressing ones. These phenomena have far-reaching implications, and elicit new perspectives regarding HIV pathogenesis and T-cell and hematopoietic cell development.	[Gartner, Suzanne; Liu, Yiling; Natesan, Senthilkumar] Johns Hopkins Univ, Sch Med, Dept Neurol, Baltimore, MD 21205 USA	Johns Hopkins University	Gartner, S (corresponding author), Univ Maryland, Sch Med, Inst Human Virol, Baltimore, MD 21201 USA.	sgartner@ihv.umaryland.edu			NIH/NIMH [R01 MH63039, R01 MH067831]; NIH/NIAID [R01 AI057007]; Dept. of Neurology at Johns Hopkins University School of Medicine; Johns Hopkins National Institute of Mental Health (NIMH) Center for Novel Therapeutics of HIV-associated Cognitive Disorders; NIMH [P30MH075673]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI057007] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH067831, R01MH063039, P30MH075673] Funding Source: NIH RePORTER	NIH/NIMH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NIH/NIAID(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); Dept. of Neurology at Johns Hopkins University School of Medicine; Johns Hopkins National Institute of Mental Health (NIMH) Center for Novel Therapeutics of HIV-associated Cognitive Disorders; NIMH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))	This work was supported by research grants from NIH/NIMH R01 MH63039 and R01 MH067831 and from NIH/NIAID R01 AI057007 (all to S. G.). Additional financial support came from the Dept. of Neurology at Johns Hopkins University School of Medicine and the Johns Hopkins National Institute of Mental Health (NIMH) Center for Novel Therapeutics of HIV-associated Cognitive Disorders, funded by NIMH Grant P30MH075673. Generous support was also provided by the Institute of Human Virology, University of Maryland School of Medicine. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AUSTERBERRY CF, 1984, P NATL ACAD SCI-BIOL, V81, P7383, DOI 10.1073/pnas.81.23.7383; Benz C, 2005, J EXP MED, V202, P21, DOI 10.1084/jem.20050146; Bleul CC, 1997, P NATL ACAD SCI USA, V94, P1925, DOI 10.1073/pnas.94.5.1925; Borghesi L, 2004, J EXP MED, V199, P491, DOI 10.1084/jem.20031800; Brenchley JM, 2004, J EXP MED, V200, P749, DOI 10.1084/jem.20040874; Brown A, 2005, J LEUKOCYTE BIOL, V78, P675, DOI 10.1189/jlb.0505237; Burger JA, 2000, BLOOD, V96, P2655; Chou CS, 1997, P NATL ACAD SCI USA, V94, P1361, DOI 10.1073/pnas.94.4.1361; Chun TW, 2008, J INFECT DIS, V197, P714, DOI 10.1086/527324; CHUN TW, 1995, NAT MED, V1, P1284, DOI 10.1038/nm1295-1284; Chun TW, 1997, NATURE, V387, P183, DOI 10.1038/387183a0; Corcoran L, 2003, J IMMUNOL, V170, P4926, DOI 10.4049/jimmunol.170.10.4926; Douek DC, 1998, NATURE, V396, P690, DOI 10.1038/25374; Douek DC, 2000, LANCET, V355, P1875, DOI 10.1016/S0140-6736(00)02293-5; Edgar BA, 2001, CELL, V105, P297, DOI 10.1016/S0092-8674(01)00334-8; GARTNER S, 1990, AIDS RES HUM RETROV, V6, P1017, DOI 10.1089/aid.1990.6.1017; GARTNER S, 1986, SCIENCE, V233, P215, DOI 10.1126/science.3014648; GARTNER S, 1986, JAMA-J AM MED ASSOC, V256, P2365, DOI 10.1001/jama.256.17.2365; GENDELMAN HE, 1988, J EXP MED, V167, P1428, DOI 10.1084/jem.167.4.1428; Guerin S, 1997, FASEB J, V11, P376, DOI 10.1096/fasebj.11.5.9141505; Guerin S, 1997, FASEB J, V11, P1003, DOI 10.1096/fasebj.11.12.9337153; Havlir DV, 2003, J VIROL, V77, P11212, DOI 10.1128/JVI.77.20.11212-11219.2003; Hazenberg MD, 2001, J MOL MED, V79, P631, DOI 10.1007/s001090100271; HOXIE JA, 1986, SCIENCE, V234, P1123, DOI 10.1126/science.3095925; Igarashi H, 2002, IMMUNITY, V17, P117, DOI 10.1016/S1074-7613(02)00366-7; Joos B, 2008, P NATL ACAD SCI USA, V105, P16725, DOI 10.1073/pnas.0804192105; Kieffer TL, 2004, J INFECT DIS, V189, P1452, DOI 10.1086/382488; Kodama H, 2006, IMMUNOL CELL BIOL, V84, P209, DOI 10.1111/j.1440-1711.2006.01424.x; Kodama H, 2005, STEM CELLS DEV, V14, P676, DOI 10.1089/scd.2005.14.676; Kong FK, 1999, P NATL ACAD SCI USA, V96, P1536, DOI 10.1073/pnas.96.4.1536; Kucia M, 2007, LEUKEMIA, V21, P297, DOI 10.1038/sj.leu.2404470; Kucia M, 2006, LEUKEMIA, V20, P857, DOI 10.1038/sj.leu.2404171; Kuwana M, 2003, J LEUKOCYTE BIOL, V74, P833, DOI 10.1189/jlb.0403170; Kuwana M, 2006, STEM CELLS, V24, P2733, DOI 10.1634/stemcells.2006-0026; Li QS, 2005, NATURE, V434, P1148, DOI 10.1038/nature03513; LI SL, 1991, RES VIROLOGY, V142, P173, DOI 10.1016/0923-2516(91)90054-7; Ling B, 2007, AIDS, V21, P2377, DOI 10.1097/QAD.0b013e3282f08b32; Maldarelli F, 2007, PLOS PATHOG, V3, P484, DOI 10.1371/journal.ppat.0030046; Manwani D, 2008, CURR TOP DEV BIOL, V82, P23, DOI 10.1016/S0070-2153(07)00002-6; Mattapallil JJ, 2005, NATURE, V434, P1093, DOI 10.1038/nature03501; Mehandru S, 2004, J EXP MED, V200, P761, DOI 10.1084/jem.20041196; Michael NL, 1997, NAT MED, V3, P338, DOI 10.1038/nm0397-338; Mochizuki K, 2010, WIRES RNA, V1, P376, DOI 10.1002/wrna.34; Nettles RE, 2005, JAMA-J AM MED ASSOC, V293, P817, DOI 10.1001/jama.293.7.817; NICHOLSON JKA, 1986, J IMMUNOL, V137, P323; Nottet HSLM, 2009, JAIDS-J ACQ IMM DEF, V50, P345, DOI 10.1097/QAI.0b013e318197eb04; Paczkowska E, 2009, STROKE, V40, P1237, DOI 10.1161/STROKEAHA.108.535062; Pandrea I, 2007, BLOOD, V109, P1069, DOI 10.1182/blood-2006-05-024364; Persaud D, 2004, J VIROL, V78, P968, DOI 10.1128/JVI.78.2.968-979.2004; Pierson T, 2000, ANNU REV IMMUNOL, V18, P665, DOI 10.1146/annurev.immunol.18.1.665; Pierson T, 2000, J VIROL, V74, P7824, DOI 10.1128/JVI.74.17.7824-7833.2000; Pujol BF, 2000, DIFFERENTIATION, V65, P287, DOI 10.1046/j.1432-0436.2000.6550287.x; RITTER MA, 1981, IMMUNOLOGY, V44, P439; Rodewald HR, 2008, ANNU REV IMMUNOL, V26, P355, DOI 10.1146/annurev.immunol.26.021607.090408; RODEWALD HR, 1993, J EXP MED, V177, P1079, DOI 10.1084/jem.177.4.1079; Rodewald HR, 2001, NATURE, V414, P763, DOI 10.1038/414763a; Rossi SW, 2006, NATURE, V441, P988, DOI 10.1038/nature04813; SAINTRUF C, 1994, SCIENCE, V266, P1208, DOI 10.1126/science.7973703; SANDOR M, 1994, P NATL ACAD SCI USA, V91, P12857, DOI 10.1073/pnas.91.26.12857; Schatz DG, 2011, NAT REV IMMUNOL, V11, P251, DOI 10.1038/nri2941; Shieh JTC, 2000, J VIROL, V74, P693, DOI 10.1128/JVI.74.2.693-701.2000; Six EM, 2007, J EXP MED, V204, P3085, DOI 10.1084/jem.20071003; SODROSKI J, 1986, NATURE, V322, P470, DOI 10.1038/322470a0; SOLARI F, 1995, J CELL SCI, V108, P3233; Spradling Allan C., 1993, P1; Touloumi G, 2004, AIDS RES HUM RETROV, V20, P47, DOI 10.1089/088922204322749495; Tsukada N, 2002, BLOOD, V99, P1030, DOI 10.1182/blood.V99.3.1030; TURK JL, 1982, IMMUNOBIOLOGY, V161, P274, DOI 10.1016/S0171-2985(82)80083-1; Veazey RS, 1998, SCIENCE, V280, P427, DOI 10.1126/science.280.5362.427; Veazey RS, 2000, J VIROL, V74, P11001, DOI 10.1128/JVI.74.23.11001-11007.2000; von Boehmer H, 2005, NAT REV IMMUNOL, V5, P571, DOI 10.1038/nri1636; WEKERLE H, 1980, J EXP MED, V151, P925, DOI 10.1084/jem.151.4.925; WEKERLE H, 1980, NATURE, V283, P402, DOI 10.1038/283402a0; Wojakowski W, 2009, J AM COLL CARDIOL, V53, P1, DOI 10.1016/j.jacc.2008.09.029; WU L, 1991, J EXP MED, V174, P1617, DOI 10.1084/jem.174.6.1617; WU L, 1991, NATURE, V349, P71, DOI 10.1038/349071a0; Yamanaka K, 2005, CLIN CANCER RES, V11, P5748, DOI 10.1158/1078-0432.CCR-04-2514; YAO M, 1974, CHROMOSOMA, V48, P1; YAO MC, 1984, CELL, V36, P433, DOI 10.1016/0092-8674(84)90236-8; ZACK JA, 1990, CELL, V61, P213, DOI 10.1016/0092-8674(90)90802-L; Zhang LQ, 1999, J EXP MED, V190, P725, DOI 10.1084/jem.190.5.725; Zhao Y, 2003, P NATL ACAD SCI USA, V100, P2426, DOI 10.1073/pnas.0536882100	82	7	7	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 18	2012	7	7							e40139	10.1371/journal.pone.0040139	http://dx.doi.org/10.1371/journal.pone.0040139			26	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	975YY	22911696	gold, Green Submitted, Green Published			2022-12-25	WOS:000306548900017
J	Bupha-Intr, T; Haizlip, KM; Janssen, PML				Bupha-Intr, Tepmanas; Haizlip, Kaylan M.; Janssen, Paul M. L.			Role of Endothelin in the Induction of Cardiac Hypertrophy In Vitro	PLOS ONE			English	Article							CA2+/CALMODULIN-DEPENDENT KINASE-II; SLOW FORCE RESPONSE; GENE-EXPRESSION; STRETCH; CARDIOMYOCYTES; CONTRACTION; CA2+; MYOCARDIUM; ATRIAL; HEART	Endothelin (ET-1) is a peptide hormone mediating a wide variety of biological processes and is associated with development of cardiac dysfunction. Generally, ET-1 is regarded as a molecular marker released only in correlation with the observation of a hypertrophic response or in conjunction with other hypertrophic stress. Although the cardiac hypertrophic effect of ET-1 is demonstrated, inotropic properties of cardiac muscle during chronic ET-1-induced hypertrophy remain largely unclear. Through the use of a novel in vitro multicellular culture system, changes in contractile force and kinetics of rabbit cardiac trabeculae in response to 1 nM ET-1 for 24 hours can be observed. Compared to the initial force at t = 0 hours, ET-1 treated muscles showed a similar to 2.5 fold increase in developed force after 24 hours without any effect on time to peak contraction or time to 90% relaxation. ET-1 increased muscle diameter by 12.5 +/- 3.2% from the initial size, due to increased cell width compared to non-ET-1 treated muscles. Using specific signaling antagonists, inhibition of NCX, CaMKII, MAPKK, and IP3 could attenuate the effect of ET-1 on increased developed force. However, among these inhibitions only IP3 receptor blocker could not prevent the increase muscle size by ET-1. Interestingly, though calcineurin-NFAT inhibition could not suppress the effect of ET-1 on force development, it did prevent muscle hypertrophy. These findings suggest that ET-1 provokes both inotropic and hypertrophic activations on myocardium in which both activations share the same signaling pathway through MAPK and CaMKII in associated with NCX activity.	[Bupha-Intr, Tepmanas] Ohio State Univ, Coll Med, Dept Physiol & Cell Biol, Columbus, OH 43210 USA; Ohio State Univ, Coll Med, D Davis Heart Lung Res Inst, Columbus, OH 43210 USA	Ohio State University; Ohio State University	Bupha-Intr, T (corresponding author), Ohio State Univ, Coll Med, Dept Physiol & Cell Biol, Columbus, OH 43210 USA.	janssen.10@osu.edu	Janssen, Paul ML/E-3307-2011	Janssen, Paul/0000-0002-9682-3014	American Heart Association	American Heart Association(American Heart Association)	Work supported by American Heart Association Established Investigator Award. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alvarez BV, 1999, CIRC RES, V85, P716, DOI 10.1161/01.RES.85.8.716; Backs J, 2006, J CLIN INVEST, V116, P1853, DOI 10.1172/JCI27438; Balke CW, 1998, CARDIOVASC RES, V37, P290, DOI 10.1016/S0008-6363(97)00272-1; Baudet S, 2001, CARDIOVASC RES, V50, P486, DOI 10.1016/S0008-6363(01)00225-5; Berra-Romani R, 2010, BIOCHEM BIOPH RES CO, V395, P126, DOI 10.1016/j.bbrc.2010.03.153; Bers DM, 2001, CIRC RES, V89, P373, DOI 10.1161/res.89.5.373; Bupha-Intr T, 2007, AM J PHYSIOL-HEART C, V293, pH3759, DOI 10.1152/ajpheart.01267.2006; Bupha-Intr T, 2009, AM J PHYSIOL-HEART C, V296, pH806, DOI 10.1152/ajpheart.01058.2008; Castillo SS, 2004, CANCER RES, V64, P2782, DOI 10.1158/0008-5472.CAN-03-1530; Chase A, 2010, J MOL CELL CARDIOL; Choukroun G, 1999, J CLIN INVEST, V104, P391, DOI 10.1172/JCI6350; Choukroun G, 1998, J CLIN INVEST, V102, P1311, DOI 10.1172/JCI3512; Domeier TL, 2008, AM J PHYSIOL-HEART C, V294, pH596, DOI 10.1152/ajpheart.01155.2007; Dulce RA, 2006, J MOL CELL CARDIOL, V41, P807, DOI 10.1016/j.yjmcc.2006.05.016; Frank D, 2008, HYPERTENSION, V51, P309, DOI 10.1161/HYPERTENSIONAHA.107.098046; Fujita S, 1996, J Card Fail, V2, pS45, DOI 10.1016/S1071-9164(96)80058-3; Guterl KA, 2007, AM J PHYSIOL-HEART C, V293, pH3707, DOI 10.1152/ajpheart.00296.2007; Haizlip KM, 2012, AM J PHYSIOL-HEART C, V302, pH2509, DOI 10.1152/ajpheart.00660.2011; Haworth RS, 2003, J BIOL CHEM, V278, P31676, DOI 10.1074/jbc.M304400200; Hidaka Ikuhiro, 2009, Hiroshima Journal of Medical Sciences, V58, P9; Ito N, 1997, J CLIN INVEST, V99, P125, DOI 10.1172/JCI119123; James AF, 2007, BRIT J PHARMACOL, V152, P417, DOI 10.1038/sj.bjp.0707438; Janssen PML, 2009, PHARMACOLOGY, V83, P141, DOI 10.1159/000187428; Janssen PML, 2010, AM J PHYSIOL-HEART C, V299, pH1092, DOI 10.1152/ajpheart.00417.2010; Janssen PML, 1998, AM J PHYSIOL-HEART C, V274, pH1481, DOI 10.1152/ajpheart.1998.274.5.H1481; Janssen PML, 1999, J MOL CELL CARDIOL, V31, P1419, DOI 10.1006/jmcc.1999.0978; Janssen PML, 2002, CARDIOVASC RES, V55, P300, DOI 10.1016/S0008-6363(02)00406-6; Janssen PML, 2002, AM J PHYSIOL-HEART C, V282, pH349, DOI 10.1152/ajpheart.00024.2001; Janssen PML, 2010, AM J PHYSL HEART CIR; JONES LG, 1992, AM J PHYSIOL, V263, pH1447, DOI 10.1152/ajpheart.1992.263.5.H1447; Kennedy RA, 2006, J MOL CELL CARDIOL, V41, P236, DOI 10.1016/j.yjmcc.2006.04.011; Kerkela R, 2011, AM J PHYSIOL-REG I, V300, pR140, DOI 10.1152/ajpregu.00853.2009; Kockskamper J, 2008, PROG BIOPHYS MOL BIO, V97, P250, DOI 10.1016/j.pbiomolbio.2008.02.026; Komukai K, 2010, AM J PHYSIOL-HEART C, V298, pH1902, DOI 10.1152/ajpheart.01141.2009; Lehnart SE, 2000, AM J PHYSIOL-HEART C, V279, pH986, DOI 10.1152/ajpheart.2000.279.3.H986; Liao P, 2002, CIRC RES, V90, P190, DOI 10.1161/hh0202.104220; Ling HY, 2009, J CLIN INVEST, V119, P1230, DOI 10.1172/JCI38022; Liu CQ, 2008, EUR J PHARMACOL, V590, P250, DOI 10.1016/j.ejphar.2008.05.009; MacDonnell SM, 2009, CIRC RES, V105, P316, DOI 10.1161/CIRCRESAHA.109.194035; Rohini A, 2009, PHARM RES, V61, P269; Schunkert H, 1999, J MOL MED-JMM, V77, P623, DOI 10.1007/s001099900035; Sugden Peter H., 2005, Current Vascular Pharmacology, V3, P343, DOI 10.2174/157016105774329390; Ueno M, 1999, AM J PHYSIOL-REG I, V277, pR1321, DOI 10.1152/ajpregu.1999.277.5.R1321; von Lewinski D, 2003, CARDIOVASC RES, V57, P1052, DOI 10.1016/S0008-6363(02)00830-1; Wang H, 2006, J MOL CELL CARDIOL, V41, P823, DOI 10.1016/j.yjmcc.2006.08.016; Xiao L, 2008, CIRC RES, V103, P733, DOI 10.1161/CIRCRESAHA.108.171157; Yamazaki T, 1996, J Card Fail, V2, pS7, DOI 10.1016/S1071-9164(96)80053-4; Zhu WD, 2000, J BIOL CHEM, V275, P15239, DOI 10.1074/jbc.275.20.15239; Zima AV, 2004, J PHYSIOL-LONDON, V555, P607, DOI 10.1113/jphysiol.2003.058529	49	31	31	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 17	2012	7	8							e43179	10.1371/journal.pone.0043179	http://dx.doi.org/10.1371/journal.pone.0043179			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	996DG	22912821	Green Published, gold, Green Submitted			2022-12-25	WOS:000308063700057
J	de Moura, MB; Vincent, G; Fayewicz, SL; Bateman, NW; Hood, BL; Sun, M; Suhan, J; Duensing, S; Yin, Y; Sander, C; Kirkwood, JM; Becker, D; Conrads, TP; Van Houten, B; Moschos, SJ				de Moura, Michelle Barbi; Vincent, Garret; Fayewicz, Shelley L.; Bateman, Nicholas W.; Hood, Brian L.; Sun, Mai; Suhan, Joseph; Duensing, Stefan; Yin, Yan; Sander, Cindy; Kirkwood, John M.; Becker, Dorothea; Conrads, Thomas P.; Van Houten, Bennett; Moschos, Stergios J.			Mitochondrial Respiration - An Important Therapeutic Target in Melanoma	PLOS ONE			English	Article							CELL LINES; METABOLISM; EXPRESSION; FLUX; LIPOGENESIS; SURVIVAL; GROWTH; OXYGEN	The importance of mitochondria as oxygen sensors as well as producers of ATP and reactive oxygen species (ROS) has recently become a focal point of cancer research. However, in the case of melanoma, little information is available to what extent cellular bioenergetics processes contribute to the progression of the disease and related to it, whether oxidative phosphorylation (OXPHOS) has a prominent role in advanced melanoma. In this study we demonstrate that compared to melanocytes, metastatic melanoma cells have elevated levels of OXPHOS. Furthermore, treating metastatic melanoma cells with the drug, Elesclomol, which induces cancer cell apoptosis through oxidative stress, we document by way of stable isotope labeling with amino acids in cell culture (SILAC) that proteins participating in OXPHOS are downregulated. We also provide evidence that melanoma cells with high levels of glycolysis are more resistant to Elesclomol. We further show that Elesclomol upregulates hypoxia inducible factor 1-alpha (HIF-1 alpha), and that prolonged exposure of melanoma cells to this drug leads to selection of melanoma cells with high levels of glycolysis. Taken together, our findings suggest that molecular targeting of OXPHOS may have efficacy for advanced melanoma.	[de Moura, Michelle Barbi; Bateman, Nicholas W.; Van Houten, Bennett] Univ Pittsburgh, Dept Pharmacol & Chem Biol, Pittsburgh, PA 15260 USA; [Vincent, Garret; Fayewicz, Shelley L.; Yin, Yan; Sander, Cindy; Kirkwood, John M.; Moschos, Stergios J.] Univ Pittsburgh, Dept Med, Pittsburgh, PA USA; [Hood, Brian L.; Conrads, Thomas P.] Inova Hlth Syst, Womens Hlth Integrated Res Ctr, Gynecol Canc Ctr Excellence, Annandale, VA USA; [Sun, Mai] Univ Pittsburgh, Dept Biostat, Pittsburgh, PA 15261 USA; [Suhan, Joseph] Carnegie Mellon Univ, Dept Biol Sci, Pittsburgh, PA 15213 USA; [Duensing, Stefan] Urol Univ Klin Heidelberg, Sekt Mol Uroonkol, Heidelberg, Germany; [Becker, Dorothea] Univ Pittsburgh, Dept Pathol, Pittsburgh, PA USA	Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Inova Health System; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Carnegie Mellon University; Ruprecht Karls University Heidelberg; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh	de Moura, MB (corresponding author), Univ Pittsburgh, Dept Pharmacol & Chem Biol, Pittsburgh, PA 15260 USA.	stergios_moschos@med.unc.edu	Van Houten, Bennett/K-2284-2019	Sun, Mai/0000-0003-0489-1616	Career Development Award of a SPORE in Skin Cancer [P50CA121973]; Pennsylvania Department of Health PA CURE award; NATIONAL CANCER INSTITUTE [P50CA121973] Funding Source: NIH RePORTER	Career Development Award of a SPORE in Skin Cancer; Pennsylvania Department of Health PA CURE award; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported by a Career Development Award of a SPORE in Skin Cancer (P50CA121973) to SJM, and a Pennsylvania Department of Health PA CURE award to BVH. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Berridge MV, 2010, REJUV RES, V13, P139, DOI 10.1089/rej.2009.0948; Birket MJ, 2011, J CELL SCI, V124, P348, DOI 10.1242/jcs.072272; Blackman RK, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0029798; Boisvert-Adamo K, 2009, MOL CANCER RES, V7, P549, DOI 10.1158/1541-7786.MCR-08-0358; Brand MD, 2010, EXP GERONTOL, V45, P466, DOI 10.1016/j.exger.2010.01.003; Buchet K, 1998, J BIOL CHEM, V273, P22983, DOI 10.1074/jbc.273.36.22983; Chapman PB, 2011, NEW ENGL J MED, V364, P2507, DOI 10.1056/NEJMoa1103782; de Moura MB, 2010, ENVIRON MOL MUTAGEN, V51, P391, DOI 10.1002/em.20575; Dykstra KM, 2010, MOL BIOL CELL, V21, P1556, DOI 10.1091/mbc.E09-12-1002; Eberle J, 2008, CURR GENOMICS, V9, P409, DOI 10.2174/138920208785699571; Farmer PJ, 2003, PIGM CELL RES, V16, P273, DOI 10.1034/j.1600-0749.2003.00046.x; Filipp FV, 2012, PIGM CELL MELANOMA R, V25, P375, DOI 10.1111/j.1755-148X.2012.00989.x; Flint MS, 2009, PSYCHONEUROENDOCRINO, V34, P1533, DOI 10.1016/j.psyneuen.2009.05.008; Foley KP, 2007, AACR NCI EORTC S MOL; Ganter B, 2008, CURR OPIN DRUG DISC, V11, P86; Gnaiger E, 1998, J EXP BIOL, V201, P1129; Hanahan D, 2011, CELL, V144, P646, DOI 10.1016/j.cell.2011.02.013; Hauschild A, 2009, ASCO ANN M ORL FL; Hersey P, 2009, CLIN CANCER RES, V15, P6490, DOI 10.1158/1078-0432.CCR-09-0251; Hill BG, 2009, BIOCHEM J, V424, P99, DOI 10.1042/BJ20090934; Hodi FS, 2010, NEW ENGL J MED, V363, P711, DOI 10.1056/NEJMoa1003466; Huttemann M, 2008, J BIOENERG BIOMEMBR, V40, P445, DOI 10.1007/s10863-008-9169-3; Jonas EA, 2004, P NATL ACAD SCI USA, V101, P13590, DOI 10.1073/pnas.0401372101; KALLINOWSKI F, 1989, CANCER RES, V49, P3759; Kirshner JR, 2008, MOL CANCER THER, V7, P2319, DOI 10.1158/1535-7163.MCT-08-0298; Kong Q, 2000, MED HYPOTHESES, V55, P29, DOI 10.1054/mehy.1999.0982; Kuphal S, 2010, EUR J CANCER, V46, P1159, DOI 10.1016/j.ejca.2010.01.031; Manola J, 2000, J CLIN ONCOL, V18, P3782, DOI 10.1200/JCO.2000.18.22.3782; MCCONNELL HM, 1992, SCIENCE, V257, P1906, DOI 10.1126/science.1329199; Metallo CM, 2012, NATURE, V481, P380, DOI 10.1038/nature10602; Meyskens FL, 2001, PIGM CELL RES, V14, P148, DOI 10.1034/j.1600-0749.2001.140303.x; Moschos SJ, 2009, CANCER BIOL THER, V8, P1815, DOI 10.4161/cbt.8.19.9435; Nakajima EC, 2012, MOL CARCINOG; O'Day S, 2009, J CLIN ONCOL, V27, P5452, DOI 10.1200/JCO.2008.17.1579; PARCE JW, 1989, SCIENCE, V246, P243, DOI 10.1126/science.2799384; Qian W, 2010, METHODS, V51, P452, DOI 10.1016/j.ymeth.2010.03.006; Scott DA, 2011, J BIOL CHEM, V286, P42626, DOI 10.1074/jbc.M111.282046; Semenza GL, 2010, CURR OPIN GENET DEV, V20, P51, DOI 10.1016/j.gde.2009.10.009; Silverthorn CF, 2010, MELANOMA RES, V20, P61, DOI 10.1097/CMR.0b013e328333d8c2; Sondergaard JN, 2010, J TRANSL MED, V8, DOI 10.1186/1479-5876-8-39; Sosman JA, 2012, NEW ENGL J MED, V366, P707, DOI 10.1056/NEJMoa1112302; Vander Heiden MG, 2011, NAT REV DRUG DISCOV, V10, P671, DOI 10.1038/nrd3504; Vlashi E, 2011, P NATL ACAD SCI USA, V108, P16062, DOI 10.1073/pnas.1106704108; Wang XH, 2011, CANCER RES, V71, P7410, DOI 10.1158/0008-5472.CAN-10-1134; WARBURG O, 1956, SCIENCE, V123, P309, DOI 10.1126/science.123.3191.309; Wu M, 2007, AM J PHYSIOL-CELL PH, V292, pC125, DOI 10.1152/ajpcell.00247.2006; Zhuang LQ, 2010, MODERN PATHOL, V23, P45, DOI 10.1038/modpathol.2009.129	47	77	77	1	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 17	2012	7	8							e40690	10.1371/journal.pone.0040690	http://dx.doi.org/10.1371/journal.pone.0040690			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	996DG	22912665	Green Submitted, Green Published, gold, Green Accepted			2022-12-25	WOS:000308063700001
J	Lang, M; Kojonazarov, B; Tian, X; Kalymbetov, A; Weissmann, N; Grimminger, F; Kretschmer, A; Stasch, JP; Seeger, W; Ghofrani, HA; Schermuly, RT				Lang, Michaela; Kojonazarov, Baktybek; Tian, Xia; Kalymbetov, Anuar; Weissmann, Norbert; Grimminger, Friedrich; Kretschmer, Axel; Stasch, Johannes-Peter; Seeger, Werner; Ghofrani, Hossein Ardeschir; Schermuly, Ralph Theo			The Soluble Guanylate Cyclase Stimulator Riociguat Ameliorates Pulmonary Hypertension Induced by Hypoxia and SU5416 in Rats	PLOS ONE			English	Article							ARTERIAL-HYPERTENSION; NITRIC-OXIDE; PHOSPHODIESTERASE TYPE-5; THERAPEUTIC-EFFICACY; INHIBITION; SILDENAFIL; CIRCULATION; ACTIVATION; EXPRESSION; DISCOVERY	Background: The nitric oxide (NO)-soluble guanylate cyclase (sGC)-cyclic guanosine monophosphate (cGMP) signal-transduction pathway is impaired in many cardiovascular diseases, including pulmonary arterial hypertension (PAH). Riociguat (BAY 63-2521) is a stimulator of sGC that works both in synergy with and independently of NO to increase levels of cGMP. The aims of this study were to investigate the role of NO-sGC-cGMP signaling in a model of severe PAH and to evaluate the effects of sGC stimulation by riociguat and PDE5 inhibition by sildenafil on pulmonary hemodynamics and vascular remodeling in severe experimental PAH. Methods and Results: Severe angioproliferative PAH was induced in rats by combined exposure to the vascular endothelial growth factor receptor antagonist SU5416 and hypoxia (SUHx). Twenty-one days thereafter rats were randomized to receive either riociguat (10 mg/kg/day), sildenafil (50 mg/kg/day) or vehicle by oral gavage, for 14 days until the day of the terminal hemodynamic measurements. Administration of riociguat or sildenafil significantly decreased right ventricular systolic pressure (RVSP). Riociguat significantly decreased RV hypertrophy (RVH) (0.55 +/- 0.02, p<0.05), increased cardiac output (60.8 +/-.8 mL/minute, p<0.05) and decreased total pulmonary resistance (4.03 +/- 0.3 mmHg min(-1) ml(-1) 100 g BW, p<0.05), compared with sildenafil and vehicle. Both compounds significantly decreased the RV collagen content and improved RV function, but the effects of riociguat on tricuspid annular plane systolic excursion and RV myocardial performance were significantly better than those of sildenafil (p<0.05). The proportion of occluded arteries was significantly lower in animals receiving riociguat than in those receiving vehicle (p<0.05); furthermore, the neointima/media ratio was significantly lower in those receiving riociguat than in those receiving sildenafil or vehicle (p<0.05). Conclusion: Riociguat and sildenafil significantly reduced RVSP and RVH, and improved RV function compared with vehicle. Riociguat had a greater effect on hemodynamics and RVH than sildenafil.	[Lang, Michaela; Kojonazarov, Baktybek; Tian, Xia; Kalymbetov, Anuar; Weissmann, Norbert; Grimminger, Friedrich; Seeger, Werner; Ghofrani, Hossein Ardeschir; Schermuly, Ralph Theo] Univ Giessen, Giessen, Germany; [Lang, Michaela; Kojonazarov, Baktybek; Tian, Xia; Kalymbetov, Anuar; Weissmann, Norbert; Grimminger, Friedrich; Seeger, Werner; Ghofrani, Hossein Ardeschir; Schermuly, Ralph Theo] Marburg Lung Ctr, Giessen, Germany; [Kretschmer, Axel; Stasch, Johannes-Peter] Bayer HealthCare, Wuppertal, Germany; [Seeger, Werner; Schermuly, Ralph Theo] Max Planck Inst Heart & Lung Res, Dept Lung Dev & Remodeling, Bad Nauheim, Germany	Justus Liebig University Giessen; Bayer AG; Bayer Healthcare Pharmaceuticals; Max Planck Society	Lang, M (corresponding author), Univ Giessen, Giessen, Germany.	ralph.schermuly@innere.med.uni-giessen.de	Ghofrani, Ardeschir/AAD-5293-2020; Ghofrani, Hossein Ardeschir/AAD-2856-2022; Kalymbetov, Anuar/AAT-7178-2021	Ghofrani, Ardeschir/0000-0002-2029-4419; Grimminger, Friedrich/0000-0001-8725-6276; Seeger, Werner/0000-0003-1946-0894; Schermuly, Ralph/0000-0002-5167-6970; Weissmann, Norbert/0000-0003-2675-3871	Deutsche Forschungsgemeinschaft [GR1081/7-1]; University of Giessen; University Marburg Lung Center within the LOEWE programme of the state of Hesse; Bayer Healthcare; Excellence Cluster Cardiopulmonary System; German Research Foundation; University of Giessen and Marburg Lung Center	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); University of Giessen; University Marburg Lung Center within the LOEWE programme of the state of Hesse; Bayer Healthcare(Bayer AGBayer Healthcare Pharmaceuticals); Excellence Cluster Cardiopulmonary System(German Research Foundation (DFG)); German Research Foundation(German Research Foundation (DFG)); University of Giessen and Marburg Lung Center	This work was supported by Deutsche Forschungsgemeinschaft, GR1081/7-1, the Universities of Giessen and Marburg Lung Center within the LOEWE programme of the state of Hesse and by an unrestricted research grant from Bayer Healthcare, who also provided study material. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; JPS is employee of Bayer HealthCare, who also provided an unrestricted research grant. RTS declares he has been a consultant for Bayer Healthcare and has received speakers bureau (honoraria) from Bayer Healthcare. RTS also declares he has received grant/research support from Bayer HealthCare, Excellence Cluster Cardiopulmonary System, German Research Foundation, and the University of Giessen and Marburg Lung Center. HAG declares he has been a consultant for Bayer Healthcare and has received speakers bureau (honoraria) from Bayer Healthcare. HAG also declares he has received unrestricted research grant from Bayer Healthcare (related to this study), supports/grants Excellence Cluster Cardiopulmonary System, German Research Foundation, and the University of Giessen and Marburg Lung Center. FG declares he has been a consultant for Bayer Healthcare and has received grant/research support from Excellence Cluster Cardiopulmonary System, German Research Foundation, and the University of Giessen and Marburg Lung Center. There are no patents, products in development or marketed products to declare. This does not alter the authors' adherence to all the PLoS ONE policies on sharing data and materials, as detailed online in the guide for authors. ML, BK, NW and WS have declared that no competing interests exist.	Abe K, 2010, CIRCULATION, V121, P2747, DOI 10.1161/CIRCULATIONAHA.109.927681; ARNOLD WP, 1977, P NATL ACAD SCI USA, V74, P3203, DOI 10.1073/pnas.74.8.3203; Bauer NR, 2007, AM J PHYSIOL-LUNG C, V293, pL580, DOI 10.1152/ajplung.00281.2007; Bhatia S, 2003, MAYO CLIN PROC, V78, P1207, DOI 10.4065/78.10.1207; Black SM, 2001, AM J PHYSIOL-LUNG C, V281, pL1051, DOI 10.1152/ajplung.2001.281.5.L1051; Bogaard HJ, 2012, AM J RESP CELL MOL, V46, P582, DOI 10.1165/rcmb.2011-0296OC; Chockalingam A, 2005, INT J CARDIOL, V99, P91, DOI 10.1016/j.ijcard.2003.12.023; Dahal BK, 2010, EUR RESPIR J, V36, P808, DOI 10.1183/09031936.00140309; DALONZO GE, 1991, ANN INTERN MED, V115, P343, DOI 10.7326/0003-4819-115-5-343; Dumitrascu R, 2006, CIRCULATION, V113, P286, DOI 10.1161/CIRCULATIONAHA.105.581405; Evgenov OV, 2004, CIRCULATION, V110, P2253, DOI 10.1161/01.CIR.0000144469.01521.8A; Fagan KA, 1999, AM J PHYSIOL-LUNG C, V277, pL472, DOI 10.1152/ajplung.1999.277.3.L472; Galie N, 2005, NEW ENGL J MED, V353, P2148, DOI 10.1056/NEJMoa050010; Geschka S, PLOS ONE, V6, pe21853; Ghofrani HA, 2010, EUR RESPIR J, V36, P792, DOI 10.1183/09031936.00182909; Ghofrani HA, 2004, J AM COLL CARDIOL, V43, p68S, DOI 10.1016/j.jacc.2004.02.031; Grimminger F, 2009, EUR RESPIR J, V33, P785, DOI 10.1183/09031936.00039808; KITABATAKE A, 1983, CIRCULATION, V68, P302, DOI 10.1161/01.CIR.68.2.302; Kosanovic D, 2011, RESP RES, V12, DOI 10.1186/1465-9921-12-87; Li DC, 1999, AM J PHYSIOL-LUNG C, V277, pL841, DOI 10.1152/ajplung.1999.277.4.L841; Li DC, 2001, AM J PHYSIOL-LUNG C, V281, pL369, DOI 10.1152/ajplung.2001.281.2.L369; MacLean MR, 1997, J PHARMACOL EXP THER, V283, P619; Michelakis ED, 2003, ADV EXP MED BIOL, V543, P293; Mittendorf J, 2009, CHEMMEDCHEM, V4, P853, DOI 10.1002/cmdc.200900014; Morrell NW, 2009, J AM COLL CARDIOL, V54, pS20, DOI 10.1016/j.jacc.2009.04.018; Nagendran J, 2007, CIRCULATION, V116, P238, DOI 10.1161/CIRCULATIONAHA.106.655266; Oka M, 2007, CIRC RES, V100, P923, DOI 10.1161/01.RES.0000261658.12024.18; Schermuly RT, 2008, EUR RESPIR J, V32, P881, DOI 10.1183/09031936.00114407; Schermuly RT, 2011, NAT REV CARDIOL, V8, P443, DOI 10.1038/nrcardio.2011.87; Schermuly RT, 2005, J CLIN INVEST, V115, P2811, DOI 10.1172/JCI24838; Schermuly RT, 2004, CIRC RES, V94, P1101, DOI 10.1161/01.RES.0000126050.41296.8E; Schermuly RT, 2004, AM J RESP CRIT CARE, V169, P39, DOI 10.1164/rccm.200302-282OC; Schymura Y, 2011, AM J RESP CRIT CARE, V183; Sharkovska Y, J HYPERTENS, V28, P1666; Stasch JP, 2006, J CLIN INVEST, V116, P2552, DOI 10.1172/JCI28371; Stasch Johannes-Peter, 2009, V191, P277, DOI 10.1007/978-3-540-68964-5_13; Stenmark KR, 2009, AM J PHYSIOL-LUNG C, V297, pL1013, DOI 10.1152/ajplung.00217.2009; Taraseviciene-Stewart L, 2001, FASEB J, V15, P427, DOI 10.1096/fj.00-0343com; Taraseviciene-Stewart L, 2006, AM J PHYSIOL-LUNG C, V291, pL668, DOI 10.1152/ajplung.00491.2005; Tei C, 1995, J Cardiol, V26, P357; Urboniene D, 2010, AM J PHYSIOL-LUNG C, V299, pL401, DOI 10.1152/ajplung.00114.2010; Wharton J, 2005, AM J RESP CRIT CARE, V172, P105, DOI 10.1164/rccm.200411-1587OC	42	96	101	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 17	2012	7	8							e43433	10.1371/journal.pone.0043433	http://dx.doi.org/10.1371/journal.pone.0043433			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	996DG	22912874	Green Published, gold			2022-12-25	WOS:000308063700102
J	Timm, S; Mielewczik, M; Florian, A; Frankenbach, S; Dreissen, A; Hocken, N; Fernie, AR; Walter, A; Bauwe, H				Timm, Stefan; Mielewczik, Michael; Florian, Alexandra; Frankenbach, Silja; Dreissen, Anne; Hocken, Nadine; Fernie, Alisdair R.; Walter, Achim; Bauwe, Hermann			High-to-Low CO2 Acclimation Reveals Plasticity of the Photorespiratory Pathway and Indicates Regulatory Links to Cellular Metabolism of Arabidopsis	PLOS ONE			English	Article							LEAF GROWTH; CHLOROPHYLL FLUORESCENCE; GENE-EXPRESSION; PHOTOSYSTEM-II; MUTANTS; GLYOXYLATE; DEFICIENT; CYCLE; HYDROXYPYRUVATE; THALIANA	Background: Photorespiratory carbon metabolism was long considered as an essentially closed and nonregulated pathway with little interaction to other metabolic routes except nitrogen metabolism and respiration. Most mutants of this pathway cannot survive in ambient air and require CO2-enriched air for normal growth. Several studies indicate that this CO2 requirement is very different for individual mutants, suggesting a higher plasticity and more interaction of photorespiratory metabolism as generally thought. To understand this better, we examined a variety of high-and low-level parameters at 1% CO2 and their alteration during acclimation of wild-type plants and selected photorespiratory mutants to ambient air. Methodology and Principal Findings: The wild type and four photorespiratory mutants of Arabidopsis thaliana (Arabidopsis) were grown to a defined stadium at 1% CO2 and then transferred to normal air (0.038% CO2). All other conditions remained unchanged. This approach allowed unbiased side-by-side monitoring of acclimation processes on several levels. For all lines, diel (24 h) leaf growth, photosynthetic gas exchange, and PSII fluorescence were monitored. Metabolite profiling was performed for the wild type and two mutants. During acclimation, considerable variation between the individual genotypes was detected in many of the examined parameters, which correlated with the position of the impaired reaction in the photorespiratory pathway. Conclusions: Photorespiratory carbon metabolism does not operate as a fully closed pathway. Acclimation from high to low CO2 was typically steady and consistent for a number of features over several days, but we also found unexpected short-term events, such as an intermittent very massive rise of glycine levels after transition of one particular mutant to ambient air. We conclude that photorespiration is possibly exposed to redox regulation beyond known substrate-level effects. Additionally, our data support the view that 2-phosphoglycolate could be a key regulator of photosynthetic-photorespiratory metabolism as a whole.	[Timm, Stefan; Frankenbach, Silja; Bauwe, Hermann] Univ Rostock, Dept Plant Physiol, Rostock, Germany; [Mielewczik, Michael; Walter, Achim] Swiss Fed Inst Technol, Inst Agr Sci, Zurich, Switzerland; [Mielewczik, Michael; Dreissen, Anne; Hocken, Nadine; Walter, Achim] Forschungszentrum Julich, Inst Bio & Geosci IBG 2, D-52425 Julich, Germany; [Florian, Alexandra; Fernie, Alisdair R.] Max Planck Inst Mol Plant Physiol, Potsdam, Germany	University of Rostock; Swiss Federal Institutes of Technology Domain; ETH Zurich; Helmholtz Association; Research Center Julich; Max Planck Society	Timm, S (corresponding author), Univ Rostock, Dept Plant Physiol, Rostock, Germany.	hermann.bauwe@uni-rostock.de	Walter, Achim/N-8392-2013; Timm, Stefan/HII-7311-2022; Mielewczik, Michael/H-6491-2015; Frankenbach, Silja/W-7020-2018	Timm, Stefan/0000-0003-3105-6296; Mielewczik, Michael/0000-0002-3796-4183; Frankenbach, Silja/0000-0001-7481-2325; Walter, Achim/0000-0001-7753-9643	Deutsche Forschungsgemeinschaft (Photorespiration Network PROMICS) [FOR 1186]	Deutsche Forschungsgemeinschaft (Photorespiration Network PROMICS)(German Research Foundation (DFG))	This work was supported by grants from the Deutsche Forschungsgemeinschaft (Photorespiration Network PROMICS, FOR 1186) to AW, ARF and HB). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allan WL, 2009, BIOCHEM J, V423, P15, DOI 10.1042/BJ20090826; Alonso JM, 2003, SCIENCE, V301, P653, DOI 10.1126/science.1086391; ANDERSON LE, 1971, BIOCHIM BIOPHYS ACTA, V235, P237, DOI 10.1016/0005-2744(71)90051-9; Araujo WL, 2011, TRENDS PLANT SCI, V16, P489, DOI 10.1016/j.tplants.2011.05.008; Barak S, 2001, PLANT MOL BIOL, V45, P399, DOI 10.1023/A:1010688804719; Bauwe H, 2010, TRENDS PLANT SCI, V15, P330, DOI 10.1016/j.tplants.2010.03.006; Biskup B, 2009, PLANT PHYSIOL, V149, P1452, DOI 10.1104/pp.108.134486; BLACKWELL RD, 1988, PHOTOSYNTH RES, V16, P155, DOI 10.1007/BF00039491; Blasing OE, 2005, PLANT CELL, V17, P3257, DOI 10.1105/tpc.105.035261; Boldt R, 2005, PLANT CELL, V17, P2413, DOI 10.1105/tpc.105.033993; Boyes DC, 2001, PLANT CELL, V13, P1499, DOI 10.1105/tpc.13.7.1499; Bykova NV, 2005, PLANTA, V222, P130, DOI 10.1007/s00425-005-1505-9; CHOLLET R, 1975, BOT REV, V41, P137, DOI 10.1007/BF02860828; Collakova E, 2008, PLANT CELL, V20, P1818, DOI 10.1105/tpc.108.058701; Cousins AB, 2008, PLANT PHYSIOL, V148, P786, DOI 10.1104/pp.108.122622; Dodd AN, 2005, SCIENCE, V309, P630, DOI 10.1126/science.1115581; DOUCE R, 1989, ANNU REV PLANT PHYS, V40, P371, DOI 10.1146/annurev.pp.40.060189.002103; Dutilleul C, 2003, PLANT PHYSIOL, V131, P264, DOI 10.1104/pp.011155; Eisenhut M, 2008, P NATL ACAD SCI USA, V105, P17199, DOI 10.1073/pnas.0807043105; Engel N, 2011, PLANT PHYSIOL, V157, P1711, DOI 10.1104/pp.111.184564; Fahnenstich H, 2008, PLANT PHYSIOL, V148, P719, DOI 10.1104/pp.108.126789; Fait A, 2008, TRENDS PLANT SCI, V13, P14, DOI 10.1016/j.tplants.2007.10.005; Fernie AR, 2009, PHYTOCHEMISTRY, V70, P828, DOI 10.1016/j.phytochem.2009.04.023; Foyer CH, 2011, PLANT PHYSIOL, V155, P2, DOI 10.1104/pp.110.167569; Foyer CH, 2009, ANNU REV PLANT BIOL, V60, P455, DOI 10.1146/annurev.arplant.043008.091948; GIVAN CV, 1992, PLANT PHYSIOL, V100, P552, DOI 10.1104/pp.100.2.552; Graf A, 2010, P NATL ACAD SCI USA, V107, P9458, DOI 10.1073/pnas.0914299107; HALL NP, 1987, PHOTOSYNTH RES, V11, P89, DOI 10.1007/BF00117676; Hausler RE, 1996, PLANTA, V200, P388, DOI 10.1007/BF00231394; Hetherington AM, 2003, NATURE, V424, P901, DOI 10.1038/nature01843; Ho CL, 2001, AMINO ACIDS, V20, P243, DOI 10.1007/s007260170042; HOFSTRA G, 1969, PLANTA, V85, P228, DOI 10.1007/BF00389400; Jansen M, 2009, FUNCT PLANT BIOL, V36, P902, DOI 10.1071/FP09095; JOHNSON LN, 1970, J MOL BIOL, V47, P93, DOI 10.1016/0022-2836(70)90404-3; JONES MGK, 1977, PLANT PHYSIOL, V60, P379, DOI 10.1104/pp.60.3.379; KELLY GJ, 1976, FEBS LETT, V68, P55, DOI 10.1016/0014-5793(76)80403-6; KEYS AJ, 1978, NATURE, V275, P741, DOI 10.1038/275741a0; KLECZKOWSKI LA, 1994, ANNU REV PLANT PHYS, V45, P339, DOI 10.1146/annurev.pp.45.060194.002011; Kofler H, 2000, MOL GEN GENET, V263, P978, DOI 10.1007/PL00008698; Lisec J, 2006, NAT PROTOC, V1, P387, DOI 10.1038/nprot.2006.59; Morison JIL, 1998, J EXP BOT, V49, P443, DOI 10.1093/jexbot/49.suppl_1.443; Munoz-Bertomeu J, 2009, PLANT PHYSIOL, V151, P541, DOI 10.1104/pp.109.143701; MURRAY AJS, 1989, PLANT PHYSIOL, V91, P395, DOI 10.1104/pp.91.1.395; Niittyla T, 2004, SCIENCE, V303, P87, DOI 10.1126/science.1091811; Noctor G, 2002, ANN BOT-LONDON, V89, P841, DOI 10.1093/aob/mcf096; Noctor G, 1999, J EXP BOT, V50, P1157, DOI 10.1093/jexbot/50.336.1157; Novitskaya L, 2002, PLANT CELL ENVIRON, V25, P821, DOI 10.1046/j.1365-3040.2002.00866.x; Nunes-Nesi A, 2011, PLANT PHYSIOL, V155, P101, DOI 10.1104/pp.110.163816; OBERHUBER W, 1993, PLANT PHYSIOL, V101, P507, DOI 10.1104/pp.101.2.507; Potters G, 2002, PLANT PHYSIOL BIOCH, V40, P537, DOI 10.1016/S0981-9428(02)01414-6; Pracharoenwattana I, 2010, PLANT MOL BIOL, V72, P101, DOI 10.1007/s11103-009-9554-2; Queval G, 2007, PLANT J, V52, P640, DOI 10.1111/j.1365-313X.2007.03263.x; Reumann S, 2006, BBA-MOL CELL RES, V1763, P1496, DOI 10.1016/j.bbamcr.2006.09.008; Rojas CM, 2012, PLANT CELL, V24, P336, DOI 10.1105/tpc.111.093245; Sage RF, 2000, STUD PLAN S, V7, P13; SCHREIBER U, 1986, PHOTOSYNTH RES, V10, P51, DOI 10.1007/BF00024185; Schwarte S, 2007, PLANT PHYSIOL, V144, P1580, DOI 10.1104/pp.107.099192; SOMERVILLE CR, 1981, PLANT PHYSIOL, V67, P666, DOI 10.1104/pp.67.4.666; SOMERVILLE CR, 1980, P NATL ACAD SCI-BIOL, V77, P2684, DOI 10.1073/pnas.77.5.2684; Somerville CR, 2001, PLANT PHYSIOL, V125, P20, DOI 10.1104/pp.125.1.20; SOMERVILLE CR, 1979, NATURE, V280, P833, DOI 10.1038/280833a0; SOMERVILLE CR, 1982, TRENDS BIOCHEM SCI, V7, P171, DOI 10.1016/0968-0004(82)90130-X; Sweetlove LJ, 2006, P NATL ACAD SCI USA, V103, P19587, DOI 10.1073/pnas.0607751103; Takahashi S, 2007, PLANT PHYSIOL, V144, P487, DOI 10.1104/pp.107.097253; Takahashi S, 2011, TRENDS PLANT SCI, V16, P53, DOI 10.1016/j.tplants.2010.10.001; Timm S, 2008, PLANT CELL, V20, P2848, DOI 10.1105/tpc.108.062265; Timm S, 2011, PLANT PHYSIOL, V155, P694, DOI 10.1104/pp.110.166538; Tolbert N. E., 1973, CURRENT TOPICS CELLU, P21; Tolbert NE, 1963, PHOTOSYNTHETIC MECHA, V1145, P648; TROUGHTON JH, 1969, AUST J BIOL SCI, V22, P815, DOI 10.1071/BI9690815; Voll LM, 2006, PLANT PHYSIOL, V140, P59, DOI 10.1104/pp.105.071399; Walter A, 2005, GLOBAL CHANGE BIOL, V11, P1207, DOI 10.1111/j.1365-2486.2005.00990.x; Weise SE, 2004, PLANTA, V218, P474, DOI 10.1007/s00425-003-1128-y; Wiese A, 2007, NEW PHYTOL, V174, P752, DOI 10.1111/j.1469-8137.2007.02053.x; Wingler A, 1999, PLANTA, V207, P518, DOI 10.1007/s004250050512; Zelitch I, 2009, PLANT PHYSIOL, V149, P195, DOI 10.1104/pp.108.128439	76	66	69	2	60	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 17	2012	7	8							e42809	10.1371/journal.pone.0042809	http://dx.doi.org/10.1371/journal.pone.0042809			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	996DG	22912743	Green Published, Green Submitted, gold			2022-12-25	WOS:000308063700024
J	Vargas, M; Karamsetty, R; Leppla, SH; Chaudry, GJ				Vargas, Micaela; Karamsetty, Raghavendra; Leppla, Stephen H.; Chaudry, G. Jilani			Broad Expression Analysis of Human ANTXR1/TEM8 Transcripts Reveals Differential Expression and Novel Splizce Variants	PLOS ONE			English	Article							ANTHRAX LETHAL FACTOR; PROTECTIVE ANTIGEN; CAPILLARY MORPHOGENESIS; FACTOR CLEAVES; KINASE-KINASE; TOXIN; RECEPTOR; BINDING; CELLS; APOPTOSIS	Tumor endothelial marker 8 (TEM8; ANTXR1) is one of two anthrax toxin receptors; the other is capillary morphogenesis gene 2 protein (CMG2; ANTXR2). TEM8 shows enhanced expression in certain tumor endothelia, and is thought to be a player in tumor vasculature formation. However, a comprehensive expression profile of individual TEM8 variants in normal or cancerous tissues is lacking. In this work we carried out an extensive analysis of all splice variants of human TEM8 in 12 digestive tissues, and 8 each fetal and adult tissues, 6 of them cognate pairs. Using variant-specific primers, we first ascertained the status of full-length transcripts by nested PCR. We then carried out quantitative analysis of each transcript by real-time PCR. Three splice variants of TEM8 were reported before, two single-pass integral membrane forms (V1 and V2) and one secreted (V3). Our analysis has revealed two new variants, one encoding a membrane-bound form of the receptor and the other secreted, which we have designated V4 and V5, respectively. All tissues had V1, V2, V3, and V4, but only prostate had V5. Real-time PCR revealed that all variants are present at different levels in various tissues. V3 appeared the most abundant of all. To ascertain its functionality for anthrax toxin, we expressed the newly identified form V4 in a receptor-negative host cell, and included V1 and V2 for comparison. Cytotoxicity, toxin binding, and internalization assays showed V4 to be as efficient a receptor as V1 and V2.	[Vargas, Micaela; Karamsetty, Raghavendra; Chaudry, G. Jilani] Univ Texas San Antonio, Dept Biol, Cell & Mol Biol Program, San Antonio, TX USA; [Leppla, Stephen H.] NIAID, Microbial Pathogenesis Sect, Parasit Dis Lab, NIH, Bethesda, MD 20892 USA	University of Texas System; University of Texas at San Antonio (UTSA); National Institutes of Health (NIH) - USA; NIH National Institute of Allergy & Infectious Diseases (NIAID)	Vargas, M (corresponding author), Univ Illinois, Coll Med, Dept Pharmacol, Chicago, IL 60680 USA.	jilani.chaudry@utsa.edu			University of Texas at San Antonio; San Antonio Area Foundation; National Institute of Allergy and Infectious Diseases/National Institute of General Medical Sciences [SC1AI081654]; Minority Biomedical Research Support-Research Initiative for Scientific Enhancement [GM60655]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [ZIAAI001032, SC1AI081654] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R25GM060655] Funding Source: NIH RePORTER	University of Texas at San Antonio; San Antonio Area Foundation; National Institute of Allergy and Infectious Diseases/National Institute of General Medical Sciences; Minority Biomedical Research Support-Research Initiative for Scientific Enhancement; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	Funding for this work was provided to GJC by The University of Texas at San Antonio, San Antonio Area Foundation, and National Institute of Allergy and Infectious Diseases/National Institute of General Medical Sciences grant SC1AI081654 (Minority Biomedical Research Support-Support of Competitive Research). MV was supported for her PhD by the Minority Biomedical Research Support-Research Initiative for Scientific Enhancement grant GM60655 to the University of Texas at San Antonio. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abrami L, 2006, J CELL BIOL, V172, P309, DOI 10.1083/jcb.200507067; Abrami L, 2003, J CELL BIOL, V160, P321, DOI 10.1083/jcb.200211018; Abrami L, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1000792; ARORA N, 1992, J BIOL CHEM, V267, P15542; Bell SE, 2001, J CELL SCI, V114, P2755; Bonuccelli G, 2005, AM J PHYSIOL-CELL PH, V288, pC1402, DOI 10.1152/ajpcell.00582.2004; Bradley KA, 2001, NATURE, V414, P225, DOI 10.1038/n35101999; Bradley KA, 2003, J BIOL CHEM, V278, P49342, DOI 10.1074/jbc.M307900200; Carson-Walter EB, 2001, CANCER RES, V61, P6649; Chaudry GJ, 2002, TRENDS MICROBIOL, V10, P58, DOI 10.1016/S0966-842X(01)02294-6; De Preter K, 2004, BMC GENOMICS, V5, DOI 10.1186/1471-2164-5-11; Duesbery NS, 1998, SCIENCE, V280, P734, DOI 10.1126/science.280.5364.734; FRIEDLANDER AM, 1986, J BIOL CHEM, V261, P7123; Go MY, 2009, INFECT IMMUN, V77, P52, DOI 10.1128/IAI.01073-08; GORDON VM, 1995, INFECT IMMUN, V63, P82, DOI 10.1128/IAI.63.1.82-87.1995; Hotchkiss KA, 2005, EXP CELL RES, V305, P133, DOI 10.1016/j.yexcr.2004.12.025; Kintzer AF, 2009, J MOL BIOL, V392, P614, DOI 10.1016/j.jmb.2009.07.037; Kirby JE, 2004, INFECT IMMUN, V72, P430, DOI 10.1128/IAI.72.1.430-439.2004; KLIMPEL KR, 1992, P NATL ACAD SCI USA, V89, P10277, DOI 10.1073/pnas.89.21.10277; KLIMPEL KR, 1994, MOL MICROBIOL, V13, P1093, DOI 10.1111/j.1365-2958.1994.tb00500.x; Koo HM, 2002, P NATL ACAD SCI USA, V99, P3052, DOI 10.1073/pnas.052707699; LEPPLA SH, 1982, P NATL ACAD SCI-BIOL, V79, P3162, DOI 10.1073/pnas.79.10.3162; Leppla SH, 2000, HANDB EXP PHARM, V145, P445; Liu SH, 2003, J BIOL CHEM, V278, P5227, DOI 10.1074/jbc.M210321200; Liu SQ, 2009, CHEM J CHINESE U, V30, P106; MILNE JC, 1994, J BIOL CHEM, V269, P20607; Mogridge J, 2002, P NATL ACAD SCI USA, V99, P7045, DOI 10.1073/pnas.052160199; Mogridge J, 2002, BIOCHEMISTRY-US, V41, P1079, DOI 10.1021/bi015860m; Nanda A, 2004, CANCER RES, V64, P817, DOI 10.1158/0008-5472.CAN-03-2408; Oberthuer A, 2005, GENE, V363, P41, DOI 10.1016/j.gene.2005.07.038; Park JM, 2002, SCIENCE, V297, P2048, DOI 10.1126/science.1073163; Pellizzari R, 1999, FEBS LETT, V462, P199, DOI 10.1016/S0014-5793(99)01502-1; Popov SG, 2002, BIOCHEM BIOPH RES CO, V293, P349, DOI 10.1016/S0006-291X(02)00227-9; Premanandan C, 2006, MICROB PATHOGENESIS, V41, P193, DOI 10.1016/j.micpath.2006.05.003; Reeves CV, 2010, ONCOGENE, V29, P789, DOI 10.1038/onc.2009.383; Rmali KA, 2005, BIOCHEM BIOPH RES CO, V334, P231, DOI 10.1016/j.bbrc.2005.06.085; Rmali KA, 2004, INT J MOL MED, V14, P75; Scobie HM, 2005, CURR OPIN MICROBIOL, V8, P106, DOI 10.1016/j.mib.2004.12.005; Scobie HM, 2003, P NATL ACAD SCI USA, V100, P5170, DOI 10.1073/pnas.0431098100; St Croix B, 2000, SCIENCE, V289, P1197; van der Goot G, 2009, MOL ASPECTS MED, V30, P406, DOI 10.1016/j.mam.2009.08.007; Vitale G, 1998, BIOCHEM BIOPH RES CO, V248, P706, DOI 10.1006/bbrc.1998.9040; Vitale G, 2000, BIOCHEM J, V352, P739, DOI 10.1042/0264-6021:3520739; Wei W, 2006, CELL, V124, P1141, DOI 10.1016/j.cell.2005.12.045; Yang MY, 2010, BIOCHIM BIOPHYS ACTA, V1813, P39; Young JAT, 2007, ANNU REV BIOCHEM, V76, P243, DOI 10.1146/annurev.biochem.75.103004.142728	46	9	11	1	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 17	2012	7	8							e43174	10.1371/journal.pone.0043174	http://dx.doi.org/10.1371/journal.pone.0043174			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	996DG	22912819	Green Published, gold			2022-12-25	WOS:000308063700055
J	Hill, MM; Daud, NH; Aung, CS; Loo, D; Martin, S; Murphy, S; Black, DM; Barry, R; Simpson, F; Liu, LB; Pilch, PF; Hancock, JF; Parat, MO; Parton, RG				Hill, Michelle M.; Daud, Noor Huda; Aung, Cho Sanda; Loo, Dorothy; Martin, Sally; Murphy, Samantha; Black, Debra M.; Barry, Rachael; Simpson, Fiona; Liu, Libin; Pilch, Paul F.; Hancock, John F.; Parat, Marie-Odile; Parton, Robert G.			Co-Regulation of Cell Polarization and Migration by Caveolar Proteins PTRF/Cavin-1 and Caveolin-1	PLOS ONE			English	Article							KINASE-C-ALPHA; BREAST-CANCER; ENDOTHELIAL-CELLS; POLYMERASE-I; LUNG-CANCER; LIPID RAFTS; EXPRESSION; OVEREXPRESSION; GROWTH; METASTASIS	Caveolin-1 and caveolae are differentially polarized in migrating cells in various models, and caveolin-1 expression has been shown to quantitatively modulate cell migration. PTRF/cavin-1 is a cytoplasmic protein now established to be also necessary for caveola formation. Here we tested the effect of PTRF expression on cell migration. Using fluorescence imaging, quantitative proteomics, and cell migration assays we show that PTRF/cavin-1 modulates cellular polarization, and the subcellular localization of Rac1 and caveolin-1 in migrating cells as well as PKC alpha caveola recruitment. PTRF/cavin-1 quantitatively reduced cell migration, and induced mesenchymal epithelial reversion. Similar to caveolin-1, the polarization of PTRF/cavin-1 was dependent on the migration mode. By selectively manipulating PTRF/cavin-1 and caveolin-1 expression (and therefore caveola formation) in multiple cell systems, we unveil caveola-independent functions for both proteins in cell migration.	[Hill, Michelle M.; Loo, Dorothy; Black, Debra M.; Barry, Rachael; Simpson, Fiona] Univ Queensland, Diamantina Inst, Brisbane, Qld, Australia; [Hill, Michelle M.; Martin, Sally; Murphy, Samantha; Hancock, John F.; Parton, Robert G.] Univ Queensland, Inst Mol Biosci, Brisbane, Qld, Australia; [Daud, Noor Huda; Aung, Cho Sanda; Parat, Marie-Odile] Univ Queensland, Sch Pharm, Brisbane, Qld, Australia; [Liu, Libin; Pilch, Paul F.] Boston Univ, Sch Med, Dept Biochem, Boston, MA 02118 USA; [Parton, Robert G.] Univ Queensland, Ctr Microscopy & Microanal, Brisbane, Qld, Australia	University of Queensland; University of Queensland; University of Queensland; Boston University; University of Queensland	Hill, MM (corresponding author), Univ Queensland, Diamantina Inst, Brisbane, Qld, Australia.	m.parat@uq.edu.au; r.parton@uq.edu.au	Parton, Robert G/C-5673-2009; Hill, Michelle Mei Chih/G-4417-2010; Parat, Marie-Odile/G-4410-2010; Simpson, Fiona/J-2721-2012; Martin, Sally/A-7150-2010; Liu, Libin/ABH-6019-2020; Simpson, Fiona/ABE-1276-2020	Parton, Robert G/0000-0002-7494-5248; Hill, Michelle Mei Chih/0000-0003-1134-0951; Parat, Marie-Odile/0000-0003-4895-7381; Simpson, Fiona/0000-0002-0271-781X; Martin, Sally/0000-0001-9294-5404; Simpson, Fiona/0000-0002-0271-781X; Pilch, Paul/0000-0003-1997-0499; Barry, Rachael/0000-0001-8168-3226; Hancock, John/0000-0003-0542-4710	National Health and Medical Research Council of Australia [569512, 546155, 51105]; Australian Cancer Research Fund; Prostate Cancer Foundation Australia; Heart Foundation Australia; Cancer Council Queensland	National Health and Medical Research Council of Australia(National Health and Medical Research Council (NHMRC) of Australia); Australian Cancer Research Fund; Prostate Cancer Foundation Australia; Heart Foundation Australia; Cancer Council Queensland(Cancer Council Queensland)	This study was supported by the National Health and Medical Research Council of Australia (MMH CDA no. 569512, FS CDA no. 546155, RGP Program Grant no. 51105), the Australian Cancer Research Fund and the Prostate Cancer Foundation Australia (MMH, RGP). MOP is supported by Heart Foundation Australia and Cancer Council Queensland. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aung CS, 2011, EUR J CELL BIOL, V90, P136, DOI 10.1016/j.ejcb.2010.06.004; Bastiani M, 2009, J CELL BIOL, V185, P1259, DOI 10.1083/jcb.200903053; Buitrago C, 2010, J STEROID BIOCHEM, V121, P169, DOI 10.1016/j.jsbmb.2010.03.002; Campbell L, 2003, BRIT J CANCER, V89, P1909, DOI 10.1038/sj.bjc.6601359; Engelman JA, 1997, J BIOL CHEM, V272, P16374, DOI 10.1074/jbc.272.26.16374; Fang K, 2007, CELL CYCLE, V6, P199, DOI 10.4161/cc.6.2.3740; Felicetti F, 2009, INT J CANCER, V125, P1514, DOI 10.1002/ijc.24451; Fiucci G, 2002, ONCOGENE, V21, P2365, DOI 10.1038/sj.onc.1205300; Galbiati F, 2001, MOL BIOL CELL, V12, P2229, DOI 10.1091/mbc.12.8.2229; Grande-Garcia A, 2007, J CELL BIOL, V177, P683, DOI 10.1083/jcb.200701006; Hansen CG, 2009, NAT CELL BIOL, V11, P807, DOI 10.1038/ncb1887; Hayashi YK, 2009, J CLIN INVEST, V119, P2623, DOI 10.1172/JCI38660; Hill MM, 2008, CELL, V132, P113, DOI 10.1016/j.cell.2007.11.042; Inder KL, 2012, MOL CELL PROTEOMICS, V11, DOI 10.1074/mcp.M111.012245; Ito Y, 2002, J SYN ORG CHEM JPN, V60, P1, DOI 10.5059/yukigoseikyokaishi.60.1; Kato K, 2002, CANCER, V94, P929, DOI 10.1002/cncr.10329.abs; Ko YG, 1998, J CELL BIOCHEM, V71, P524, DOI 10.1002/(SICI)1097-4644(19981215)71:4<524::AID-JCB7>3.3.CO;2-2; Lee H, 2002, AM J PATHOL, V161, P1357, DOI 10.1016/S0002-9440(10)64412-4; Lin CW, 2010, J CELL PHYSIOL, V225, P472, DOI 10.1002/jcp.22226; Liu J, 2001, AM J PHYSIOL-CELL PH, V280, pC823, DOI 10.1152/ajpcell.2001.280.4.C823; Liu LB, 2008, CELL METAB, V8, P310, DOI 10.1016/j.cmet.2008.07.008; Liu LB, 2008, J BIOL CHEM, V283, P4314, DOI 10.1074/jbc.M707890200; McMahon KA, 2009, EMBO J, V28, P1001, DOI 10.1038/emboj.2009.46; Mineo C, 1998, J CELL BIOL, V141, P601, DOI 10.1083/jcb.141.3.601; Nakashima H, 2007, CANCER SCI, V98, P512, DOI 10.1111/j.1349-7006.2007.00419.x; Parat MO, 2009, INT REV CEL MOL BIO, V273, P117, DOI 10.1016/S1937-6448(08)01804-2; Parat MO, 2003, MOL BIOL CELL, V14, P3156, DOI 10.1091/mbc.e02-11-0761; Parton RG, 2007, NAT REV MOL CELL BIO, V8, P185, DOI 10.1038/nrm2122; Prevostel C, 2000, J CELL SCI, V113, P2575; Rajab A, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1000874; Rajjayabun PH, 2001, UROLOGY, V58, P811, DOI 10.1016/S0090-4295(01)01337-1; Santilman Virginie, 2007, Angiogenesis, V10, P297, DOI 10.1007/s10456-007-9083-z; Santilman V, 2006, CELL MOTIL CYTOSKEL, V63, P673, DOI 10.1002/cm.20153; Shatz M, 2010, EXP CELL RES; SHENOYSCARIA AM, 1994, J CELL BIOL, V126, P353, DOI 10.1083/jcb.126.2.353; Silverman-Gavrila R, 2011, AM J PATHOL, V178, P895, DOI 10.1016/j.ajpath.2010.10.001; Sloan EK, 2004, ONCOGENE, V23, P7893, DOI 10.1038/sj.onc.1208062; SMART EJ, 1994, J CELL BIOL, V124, P307, DOI 10.1083/jcb.124.3.307; Song KS, 1997, CELL MOL BIOL, V43, P293; Sowa G, 2001, P NATL ACAD SCI USA, V98, P14072, DOI 10.1073/pnas.241409998; Sunaga N, 2004, CANCER RES, V64, P4277, DOI 10.1158/0008-5472.CAN-03-3941; Tanase CP, 2008, EXPERT REV MOL DIAGN, V8, P395, DOI 10.1586/14737159.8.4.395; Thomas NBP, 2010, BREAST CANCER RES TR, V119, P575, DOI 10.1007/s10549-009-0355-8; Thompson TC, 2010, PROSTATE CANCER P D, V13, P6, DOI 10.1038/pcan.2009.29; Verma P, 2010, MOL BIOL CELL, V21, P2226, DOI 10.1091/mbc.E09-05-0417; Williams TM, 2004, J BIOL CHEM, V279, P51630, DOI 10.1074/jbc.M409214200; Wu P, 2008, BIOCHEM BIOPH RES CO, V376, P215, DOI 10.1016/j.bbrc.2008.08.146; Yeh DM, 2009, ANAT REC, V292, P1584, DOI 10.1002/ar.20974; Zhang W, 2000, J BIOL CHEM, V275, P20717, DOI 10.1074/jbc.M909895199; Zhang ZB, 2009, PATHOL ONCOL RES, V15, P495, DOI 10.1007/s12253-008-9144-7; Zhu H, 2004, FEBS LETT, V576, P369, DOI 10.1016/j.febslet.2004.09.041	51	44	45	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 13	2012	7	8							e43041	10.1371/journal.pone.0043041	http://dx.doi.org/10.1371/journal.pone.0043041			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	988OJ	22912783	gold, Green Published, Green Submitted			2022-12-25	WOS:000307500100056
J	Krol, E; van Kessel, SP; van Bezouwen, LS; Kumar, N; Boekema, EJ; Scheffers, DJ				Krol, Ewa; van Kessel, Sebastiaan P.; van Bezouwen, Laura S.; Kumar, Neeraj; Boekema, Egbert J.; Scheffers, Dirk-Jan			Bacillus subtilis SepF Binds to the C-Terminus of FtsZ	PLOS ONE			English	Article							CELL-DIVISION PROTEIN; ESCHERICHIA-COLI FTSZ; CYTOSKELETAL PROTEIN; RING; ZIPA; MINC; SITE; POLYMERIZATION; PROTOFILAMENTS; LOCALIZATION	Bacterial cell division is mediated by a multi-protein machine known as the "divisome", which assembles at the site of cell division. Formation of the divisome starts with the polymerization of the tubulin-like protein FtsZ into a ring, the Z-ring. Z-ring formation is under tight control to ensure bacteria divide at the right time and place. Several proteins bind to the Z-ring to mediate its membrane association and persistence throughout the division process. A conserved stretch of amino acids at the C-terminus of FtsZ appears to be involved in many interactions with other proteins. Here, we describe a novel pull-down assay to look for binding partners of the FtsZ C-terminus, using a HaloTag affinity tag fused to the C-terminal 69 amino acids of B. subtilis FtsZ. Using lysates of Escherichia coli overexpressing several B. subtilis cell division proteins as prey we show that the FtsZ C-terminus specifically pulls down SepF, but not EzrA or MinC, and that the interaction depends on a conserved 16 amino acid stretch at the extreme C-terminus. In a reverse pull-down SepF binds to full-length FtsZ but not to a FtsZ Delta C16 truncate or FtsZ with a mutation of a conserved proline in the C-terminus. We show that the FtsZ C-terminus is required for the formation of tubules from FtsZ polymers by SepF rings. An alanine-scan of the conserved 16 amino acid stretch shows that many mutations affect SepF binding. Combined with the observation that SepF also interacts with the C-terminus of E. coli FtsZ, which is not an in vivo binding partner, we propose that the secondary and tertiary structure of the FtsZ C-terminus, rather than specific amino acids, are recognized by SepF.	[Krol, Ewa; van Kessel, Sebastiaan P.; Kumar, Neeraj; Scheffers, Dirk-Jan] Univ Groningen, Dept Mol Microbiol, Groningen Biomol Sci & Biotechnol Inst, Groningen, Netherlands; [van Bezouwen, Laura S.; Boekema, Egbert J.] Univ Groningen, Dept Electron Microscopy, Groningen Biomol Sci & Biotechnol Inst, Groningen, Netherlands	University of Groningen; University of Groningen	Krol, E (corresponding author), Univ Groningen, Dept Mol Microbiol, Groningen Biomol Sci & Biotechnol Inst, Groningen, Netherlands.	d.j.scheffers@rug.nl	Kumar, Neeraj/S-5654-2018; Cendrowicz, Ewa/AAT-9419-2021; Scheffers, Dirk-Jan/B-9475-2008	Kumar, Neeraj/0000-0001-6713-2129; Cendrowicz, Ewa/0000-0002-8854-228X; Scheffers, Dirk-Jan/0000-0002-9439-9168; van Kessel, Sebastiaan Pieter/0000-0002-9462-0141; Kumar, Neeraj/0000-0003-0769-1564	Netherlands Organisation for Scientific Research (NWO) [864.09.010]	Netherlands Organisation for Scientific Research (NWO)(Netherlands Organization for Scientific Research (NWO))	This work was funded by a VIDI grant (864.09.010) from the Netherlands Organisation for Scientific Research (NWO) (www.nwo.nl) to DJS. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adams DW, 2009, NAT REV MICROBIOL, V7, P642, DOI 10.1038/nrmicro2198; Bernhardt TG, 2005, MOL CELL, V18, P555, DOI 10.1016/j.molcel.2005.04.012; Buske PJ, 2012, J BIOL CHEM, V287, P10945, DOI 10.1074/jbc.M111.330324; Camberg JL, 2009, P NATL ACAD SCI USA, V106, P10614, DOI 10.1073/pnas.0904886106; Corbin BD, 2007, J BACTERIOL, V189, P3026, DOI 10.1128/JB.01581-06; Datta P, 2002, J BIOL CHEM, V277, P24983, DOI 10.1074/jbc.M203847200; de Boer PAJ, 2010, CURR OPIN MICROBIOL, V13, P730, DOI 10.1016/j.mib.2010.09.015; Durand-Heredia JM, 2011, J BACTERIOL, V193, P1405, DOI 10.1128/JB.01258-10; de Oliveira IFF, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012048; Gueiros FJ, 2002, GENE DEV, V16, P2544, DOI 10.1101/gad.1014102; Gundogdu ME, 2011, EMBO J, V30, P617, DOI 10.1038/emboj.2010.345; Hale CA, 1997, CELL, V88, P175, DOI 10.1016/S0092-8674(00)81838-3; Hale CA, 2011, J BACTERIOL, V193, P1393, DOI 10.1128/JB.01245-10; Handler AA, 2008, MOL MICROBIOL, V68, P588, DOI 10.1111/j.1365-2958.2008.06173.x; Haney SA, 2001, J BIOL CHEM, V276, P11980, DOI 10.1074/jbc.M009810200; Hu ZL, 1999, P NATL ACAD SCI USA, V96, P14819, DOI 10.1073/pnas.96.26.14819; Levin PA, 1999, P NATL ACAD SCI USA, V96, P9642, DOI 10.1073/pnas.96.17.9642; Los GV, 2008, ACS CHEM BIOL, V3, P373, DOI 10.1021/cb800025k; Lucet I, 2000, EMBO J, V19, P1467, DOI 10.1093/emboj/19.7.1467; Ma XL, 1999, J BACTERIOL, V181, P7531, DOI 10.1128/JB.181.24.7531-7544.1999; Marston AL, 1999, MOL MICROBIOL, V33, P84, DOI 10.1046/j.1365-2958.1999.01450.x; Mosyak L, 2000, EMBO J, V19, P3179, DOI 10.1093/emboj/19.13.3179; Scheffers DJ, 2008, FEBS LETT, V582, P2601, DOI 10.1016/j.febslet.2008.06.038; Shen B, 2009, MOL MICROBIOL, V72, P410, DOI 10.1111/j.1365-2958.2009.06651.x; Singh JK, 2008, J BIOL CHEM, V283, P31116, DOI 10.1074/jbc.M805910200; Singh JK, 2007, BIOCHEMISTRY-US, V46, P11013, DOI 10.1021/bi700710j; Szwedziak P, 2012, EMBO J, V31, P2249, DOI 10.1038/emboj.2012.76; Tonthat NK, 2011, EMBO J, V30, P154, DOI 10.1038/emboj.2010.288; van der Does C, 1998, BIOCHEMISTRY-US, V37, P201, DOI 10.1021/bi972105t; WANG XD, 1993, MOL MICROBIOL, V9, P435, DOI 10.1111/j.1365-2958.1993.tb01705.x; Weart RB, 2005, MOL MICROBIOL, V57, P238, DOI 10.1111/j.1365-2958.2005.04673.x; Weart RB, 2007, CELL, V130, P335, DOI 10.1016/j.cell.2007.05.043; Wu LJ, 2009, EMBO J, V28, P1940, DOI 10.1038/emboj.2009.144; Yang DC, 2011, P NATL ACAD SCI USA, V108, pE1052, DOI 10.1073/pnas.1107780108	34	38	38	1	36	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 13	2012	7	8							e43293	10.1371/journal.pone.0043293	http://dx.doi.org/10.1371/journal.pone.0043293			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	988OJ	22912848	Green Submitted, gold, Green Published			2022-12-25	WOS:000307500100076
J	Ozen, E; Gozukizil, A; Erdal, E; Uren, A; Bottaro, DP; Atabey, N				Ozen, Evin; Gozukizil, Aysim; Erdal, Esra; Uren, Aykut; Bottaro, Donald P.; Atabey, Nese			Heparin Inhibits Hepatocyte Growth Factor Induced Motility and Invasion of Hepatocellular Carcinoma Cells through Early Growth Response Protein 1	PLOS ONE			English	Article							TRANSCRIPTION FACTOR EGR-1; FACTOR SCATTER FACTOR; SIGNALING PATHWAY; IN-VIVO; MELANOMA-CELLS; UP-REGULATION; EXPRESSION; PTEN; GENE; CLASSIFICATION	The Hepatocyte Growth Factor (HGF)/c-Met signaling pathway regulates hepatocyte proliferation, and pathway aberrations are implicated in the invasive and metastatic behaviors of hepatocellular carcinoma (HCC). In addition to c-Met, heparin acts as a co-receptor to modulate pathway activity. Recently, anti-metastatic and anti-cancer effects of heparin have been reported. However, the role of heparin in the regulation of HGF signaling remains controversial and the effects of heparin on HGF-induced biological responses during hepatocarcinogenesis is not yet defined. In this study we determined the effects of heparin on HGF-induced activities of HCC cells and the underlying molecular mechanisms. Here, we report for the first time that heparin inhibits HGF-induced adhesion, motility and invasion of HCC cells. In addition, heparin reduced HGF-induced activation of c-Met and MAPK in a dose-dependent manner, as well as decreased transcriptional activation and expression of Early growth response factor 1 (Egr1). HGF-induced MMP-2 and MMP-9 activation, and MT1-MMP expression, also were inhibited by heparin. Stable knockdown of Egr1 caused a significant decrease in HGF-induced invasion, as well as the activation and expression of MMPs. Parallel to these findings, the overexpression of Egr1 increased the invasiveness of HCC cells. Our results suggest that Egr1 activates HGF-induced cell invasion through the regulation of MMPs in HCC cells and heparin inhibits HGF-induced cellular invasion via the downregulation of Egr1. Therefore, heparin treatment might be a therapeutic approach to inhibit invasion and metastasis of HCC, especially for patients with active HGF/c-Met signaling.	[Ozen, Evin; Gozukizil, Aysim; Erdal, Esra; Atabey, Nese] Dokuz Eylul Univ, Dept Med Biol & Genet, Sch Med, Izmir, Turkey; [Uren, Aykut] Georgetown Univ, Med Ctr, Lombardi Comprehens Canc Ctr, Washington, DC 20007 USA; [Bottaro, Donald P.] NCI, Urol Oncol Branch, Ctr Canc Res, NIH, Bethesda, MD 20892 USA	Dokuz Eylul University; Georgetown University; National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI)	Ozen, E (corresponding author), Dokuz Eylul Univ, Dept Med Biol & Genet, Sch Med, Izmir, Turkey.	nese.atabey@deu.edu.tr	Atabey, Nese/A-1853-2018; Bottaro, Donald P/AAF-3853-2020; Erdal, Esra/AAE-1339-2019; Erdal, Esra/T-9057-2018; Bottaro, Donald P/F-8550-2010	Atabey, Nese/0000-0003-4966-2980; Bottaro, Donald P/0000-0002-5057-5334; Erdal, Esra/0000-0001-7264-0574; Erdal, Esra/0000-0001-7264-0574; Bottaro, Donald P/0000-0002-5057-5334	Turkish Scientific and Technological Research Council (TUBITAK) [SBAG - 110S349]; Dokuz Eylul University Research Foundation [2008-KB-SAG-02]; Intramural Research Program of the NIH, National Cancer Institute, Center for Cancer Research; Cancer Center Support Grant from NIH/NCI [P30 CA051008]; NATIONAL CANCER INSTITUTE [ZIABC011124, P30CA051008] Funding Source: NIH RePORTER	Turkish Scientific and Technological Research Council (TUBITAK)(Turkiye Bilimsel ve Teknolojik Arastirma Kurumu (TUBITAK)); Dokuz Eylul University Research Foundation(Dokuz Eylul University); Intramural Research Program of the NIH, National Cancer Institute, Center for Cancer Research(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); Cancer Center Support Grant from NIH/NCI; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This project was funded by grants to Prof. Dr. Atabey from Turkish Scientific and Technological Research Council (TUBITAK, SBAG - 110S349) and Dokuz Eylul University Research Foundation (2008-KB-SAG-02). This work was also supported in part by the Intramural Research Program of the NIH, National Cancer Institute, Center for Cancer Research and by the Cancer Center Support Grant (P30 CA051008) from NIH/NCI for the use of Biacore Molecular Interaction Shared Resource. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akl EA, 2011, COCHRANE DB SYST REV, V11; Baron V, 2006, CANCER GENE THER, V13, P115, DOI 10.1038/sj.cgt.7700896; Boccaccio C, 2006, NAT REV CANCER, V6, P637, DOI 10.1038/nrc1912; Borsig L, 2010, THROMB RES, V125, pS66, DOI 10.1016/S0049-3848(10)70017-7; Bouchard F, 2010, BLOOD, V116, P759, DOI 10.1182/blood-2009-12-257030; Chalkiadaki G, 2011, CANCER LETT, V312, P235, DOI 10.1016/j.canlet.2011.08.016; Chen CC, 2004, J CELL BIOCHEM, V93, P1063, DOI 10.1002/jcb.20257; Cokakli M, 2009, BMC CANCER, V9, DOI 10.1186/1471-2407-9-65; Damm S, 2010, J INVEST DERMATOL, V130, P1893, DOI 10.1038/jid.2010.45; Deakin JA, 1999, J CELL SCI, V112, P1999; Dussmann P, 2011, BMC DEV BIOL, V11, DOI 10.1186/1471-213X-11-28; Ferlay J, 2010, INT J CANCER, V127, P2893, DOI 10.1002/ijc.25516; Gaggioli C, 2005, ONCOGENE, V24, P1423, DOI 10.1038/sj.onc.1208318; Gitenay D, 2009, FUTURE ONCOL, V5, P993, DOI 10.2217/FON.09.67; Grotegut S, 2006, EMBO J, V25, P3534, DOI 10.1038/sj.emboj.7601213; Hanahan D, 2011, CELL, V144, P646, DOI 10.1016/j.cell.2011.02.013; Hao MW, 2002, WORLD J GASTROENTERO, V8, P203; Heideman DAM, 2005, CANCER GENE THER, V12, P954, DOI 10.1038/sj.cgt.7700856; Henry JC, 2010, BIOCHEM BIOPH RES CO, V403, P120, DOI 10.1016/j.bbrc.2010.10.130; Hickok JR, 2011, J BIOL CHEM, V286, P41413, DOI 10.1074/jbc.M111.287052; Huang RP, 1997, INT J CANCER, V72, P102, DOI 10.1002/(SICI)1097-0215(19970703)72:1<102::AID-IJC15>3.0.CO;2-L; Kaposi-Novak P, 2006, J CLIN INVEST, V116, P1582, DOI 10.1172/JCI27236; Kawashita Y, 1999, HUM GENE THER, V10, P1509, DOI 10.1089/10430349950017842; Kragh M, 2005, ONCOL REP, V14, P99; Krones-Herzig A, 2005, CANCER RES, V65, P5133, DOI 10.1158/0008-5472.CAN-04-3742; Kudo M, 2011, DIGEST DIS, V29, P273, DOI 10.1159/000327558; Lai JP, 2004, ONCOGENE, V23, P1439, DOI 10.1038/sj.onc.1207258; Lee KH, 2009, CLIN EXP METASTAS, V26, P685, DOI 10.1007/s10585-009-9266-7; LEVIN WJ, 1995, ONCOGENE, V11, P1261; Li J, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021816; Livraghi T, 2011, SCAND J SURG, V100, P22, DOI 10.1177/145749691110000105; Lyon M, 2002, J BIOL CHEM, V277, P1040, DOI 10.1074/jbc.M107506200; Ma LX, 2012, INVEST NEW DRUG, V30, P508, DOI 10.1007/s10637-010-9578-0; Marx-Stoelting P, 2009, INT J CANCER, V124, P1767, DOI 10.1002/ijc.24167; Nagai T, 2011, MOL CANCER THER, V10, P169, DOI 10.1158/1535-7163.MCT-10-0544; Nagy Z, 2009, PATHOL ONCOL RES, V15, P689, DOI 10.1007/s12253-009-9204-7; Ogunwobi OO, 2011, CLIN EXP METASTAS, V28, P721, DOI 10.1007/s10585-011-9404-x; Ozaki I, 2003, HEPATOL RES, V27, P288, DOI 10.1016/S1386-6346(03)00268-7; Peng WX, 2010, ANAT REC, V293, P414, DOI 10.1002/ar.21086; Peruzzi B, 2006, CLIN CANCER RES, V12, P3657, DOI 10.1158/1078-0432.CCR-06-0818; Pignatelli M, 2003, BIOCHEM J, V373, P739, DOI 10.1042/BJ20021918; Quinones A, 2003, LIFE SCI, V72, P2975, DOI 10.1016/S0024-3205(03)00230-3; Recio JA, 2003, CANCER RES, V63, P1576; Ritchie JP, 2011, CLIN CANCER RES, V17, P1382, DOI 10.1158/1078-0432.CCR-10-2476; Rubin JS, 2001, J BIOL CHEM, V276, P32977, DOI 10.1074/jbc.M105486200; Sakata H, 1997, J BIOL CHEM, V272, P9457; Sayan AE, 2001, ONCOGENE, V20, P5111, DOI 10.1038/sj.onc.1204669; Severi T, 2010, ACTA PHARMACOL SIN, V31, P1409, DOI 10.1038/aps.2010.142; Shin SY, 2010, MOL CANCER RES, V8, P507, DOI 10.1158/1541-7786.MCR-09-0454; Steffan JJ, 2011, CURR PROTEIN PEPT SC, V12, P12; Ushio K, 2009, MOL CANCER RES, V7, P1179, DOI 10.1158/1541-7786.MCR-08-0289; van Doormaal FF, 2011, J CLIN ONCOL, V29, P2071, DOI 10.1200/JCO.2010.31.9293; van Malenstein H, 2011, EUR J CANCER, V47, P1789, DOI 10.1016/j.ejca.2011.04.027; Virolle T, 2001, NAT CELL BIOL, V3, P1124, DOI 10.1038/ncb1201-1124; Wang SW, 2007, CANCER LETT, V257, P87, DOI 10.1016/j.canlet.2007.07.002; Whittaker S, 2010, ONCOGENE, V29, P4989, DOI 10.1038/onc.2010.236; Worden B, 2005, CANCER RES, V65, P7071, DOI 10.1158/0008-5472.CAN-04-0989; Xu J, 2007, MOL CANCER RES, V5, P605, DOI 10.1158/1541-7786.MCR-06-0286; You HN, 2011, HEPATOLOGY, V54, P879, DOI 10.1002/hep.24450; Yu JX, 2009, EMBO J, V28, P21, DOI 10.1038/emboj.2008.238; Zhang ZM, 2011, WORLD J GASTROENTERO, V17, P1685, DOI 10.3748/wjg.v17.i13.1685	61	34	35	0	22	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 13	2012	7	8							e42717	10.1371/journal.pone.0042717	http://dx.doi.org/10.1371/journal.pone.0042717			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	988OJ	22912725	Green Published, Green Submitted, gold			2022-12-25	WOS:000307500100023
J	Ripoll, C; Rivals, I; Yahya-Graison, EA; Dauphinot, L; Paly, E; Mircher, C; Ravel, A; Grattau, Y; Blehaut, H; Megarbane, A; Dembour, G; de Freminville, B; Touraine, R; Creau, N; Potier, MC; Delabar, JM				Ripoll, Clementine; Rivals, Isabelle; Yahya-Graison, Emilie Ait; Dauphinot, Luce; Paly, Evelyne; Mircher, Clothilde; Ravel, Aime; Grattau, Yann; Blehaut, Henri; Megarbane, Andre; Dembour, Guy; de Freminville, Benedicte; Touraine, Renaud; Creau, Nicole; Potier, Marie Claude; Delabar, Jean Maurice			Molecular Signatures of Cardiac Defects in Down Syndrome Lymphoblastoid Cell Lines Suggest Altered Ciliome and Hedgehog Pathways	PLOS ONE			English	Article							CONGENITAL HEART-DEFECTS; DEVELOPMENTAL DEFECTS; SYNDROME PROJECT; PRIMARY CILIUM; HUMAN FETUSES; EXPRESSION; MOUSE; GENES; HUMAN-CHROMOSOME-21; ANOMALIES	Forty percent of people with Down syndrome exhibit heart defects, most often an atrioventricular septal defect (AVSD) and less frequently a ventricular septal defect (VSD) or atrial septal defect (ASD). Lymphoblastoid cell lines (LCLs) were established from lymphocytes of individuals with trisomy 21, the chromosomal abnormality causing Down syndrome. Gene expression profiles generated from DNA microarrays of LCLs from individuals without heart defects (CHD-; n = 22) were compared with those of LCLs from patients with cardiac malformations (CHD+; n = 21). After quantile normalization, principal component analysis revealed that AVSD carriers could be distinguished from a combined group of ASD or VSD (ASD+VSD) carriers. From 9,758 expressed genes, we identified 889 and 1,016 genes differentially expressed between CHD- and AVSD and CHD- and ASD+VSD, respectively, with only 119 genes in common. A specific chromosomal enrichment was found in each group of affected genes. Among the differentially expressed genes, more than 65% are expressed in human or mouse fetal heart tissues (GEO dataset). Additional LCLs from new groups of AVSD and ASD+VSD patients were analyzed by quantitative PCR; observed expression ratios were similar to microarray results. Analysis of GO categories revealed enrichment of genes from pathways regulating clathrin-mediated endocytosis in patients with AVSD and of genes involved in semaphorin-plexin-driven cardiogenesis and the formation of cytoplasmic microtubules in patients with ASD-VSD. A pathway-oriented search revealed enrichment in the ciliome for both groups and a specific enrichment in Hedgehog and Jak-stat pathways among ASD+VSD patients. These genes or related pathways are therefore potentially involved in normal cardiogenesis as well as in cardiac malformations observed in individuals with trisomy 21.	[Ripoll, Clementine; Yahya-Graison, Emilie Ait; Paly, Evelyne; Creau, Nicole; Delabar, Jean Maurice] Univ Paris Diderot, Unite Biol Fonct & Adaptat, EAC4413, CNRS, Paris, France; [Rivals, Isabelle] ESPCI ParisTech, Equipe Stat Appl, Paris, France; [Dauphinot, Luce; Potier, Marie Claude] UPMC Hop Pitie Salpetriere, CRICM, CNRS, UMR7225,INSERM,UMR975, Paris, France; [Paly, Evelyne; Ravel, Aime; Grattau, Yann; Blehaut, Henri; Megarbane, Andre] Inst Med Jerome Lejeune & Fdn Jerome, Paris, France; [Megarbane, Andre] Univ St Joseph, Unite Genet Med, Fac Med, Beirut, Lebanon; [Dembour, Guy] Clin Univ St Luc, B-1200 Brussels, Belgium; [de Freminville, Benedicte; Touraine, Renaud] Ctr Hosp Univ St Etienne, Serv Genet, St Etienne, France	Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Universite Paris Cite; UDICE-French Research Universities; PSL Research University Paris; Ecole Superieure de Physique et de Chimie Industrielles de la Ville de Paris (ESPCI); Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Sorbonne Universite; Saint Joseph University Beirut; Universite Catholique Louvain; Cliniques Universitaires Saint-Luc; CHU de St Etienne	Ripoll, C (corresponding author), Univ Paris Diderot, Unite Biol Fonct & Adaptat, EAC4413, CNRS, Sorbonne Paris Cite, Paris, France.	delabar@univ-paris-diderot.fr	Megarbane, Andre/ABD-5574-2021; Touraine, Renaud/AAV-1605-2020; Rivals, Isabelle/AAE-7971-2022	Rivals, Isabelle/0000-0002-8736-7010; Ait Yahya Graison, Emilie/0000-0002-7205-2649; Potier, Marie-Claude/0000-0003-2462-7150	European Union integrated AnEUploidy project [037627]	European Union integrated AnEUploidy project	This work was supported by the European Union integrated AnEUploidy project (contract no. 037627). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aanhaanen WTJ, 2011, BIRTH DEFECTS RES A, V91, P565, DOI 10.1002/bdra.20826; Anderson RH, 2003, HEART, V89, P949, DOI 10.1136/heart.89.8.949; Bean LJH, 2011, BIRTH DEFECTS RES A, V91, P885, DOI 10.1002/bdra.22848; Boyle J, 2011, EUR J HUM GENET, V19, P857, DOI 10.1038/ejhg.2011.59; Cao F, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003474; Clement CA, 2009, J CELL SCI, V122, P3070, DOI 10.1242/jcs.049676; Conti A, 2007, BMC GENOMICS, V8, DOI 10.1186/1471-2164-8-268; de Lange FJ, 2004, CIRC RES, V95, P645, DOI 10.1161/01.RES.0000141429.13560.cb; de Mooij YM, 2009, PRENATAL DIAG, V29, P840, DOI 10.1002/pd.2316; Delabar JM, 2006, THESCIENTIFICWORLDJO, V6, P1945, DOI 10.1100/tsw.2006.322; Deutsch S, 2005, HUM MOL GENET, V14, P3741, DOI 10.1093/hmg/ddi404; Dolk H, 2010, ADV EXP MED BIOL, V686, P349, DOI 10.1007/978-90-481-9485-8_20; Dunlevy L, 2010, CARDIOVASC RES, V88, P287, DOI 10.1093/cvr/cvq193; DURHAM NM, 1989, J MENT DEFIC RES, V33, P343; Dyer LA, 2009, DEV BIOL, V336, P137, DOI 10.1016/j.ydbio.2009.10.009; Fernandez B, 2009, J AM COLL CARDIOL, V54, P2312, DOI 10.1016/j.jacc.2009.07.044; Fredouille C, 2005, ARCH MAL COEUR VAISS, V98, P549; Freeman SB, 2008, GENET MED, V10, P173, DOI 10.1097/GIM.0b013e3181634867; Freeman SB, 1998, AM J MED GENET, V80, P213, DOI 10.1002/(SICI)1096-8628(19981116)80:3<213::AID-AJMG6>3.0.CO;2-8; Goddeeris MM, 2008, DEVELOPMENT, V135, P1887, DOI 10.1242/dev.016147; Goetz SC, 2010, NAT REV GENET, V11, P331, DOI 10.1038/nrg2774; Hills CB, 2011, PEDIATR CARDIOL, V32, P977, DOI 10.1007/s00246-011-0006-9; Hoffmann AD, 2009, DEVELOPMENT, V136, P1761, DOI 10.1242/dev.034157; Hyett J, 1997, AM J MED GENET, V69, P207, DOI 10.1002/(SICI)1096-8628(19970317)69:2<207::AID-AJMG18>3.0.CO;2-P; Iwamoto K, 2004, MOL PSYCHIATR, V9, P406, DOI 10.1038/sj.mp.4001437; Jang JW, 2011, BIOCHEM BIOPH RES CO, V410, P183, DOI 10.1016/j.bbrc.2011.05.011; Johnson AN, 2011, DEVELOPMENT, V138, P4627, DOI 10.1242/dev.071464; Kallen B, 1996, AM J MED GENET, V65, P160; LaFramboise WA, 2010, J PROTEOMICS, V73, P992, DOI 10.1016/j.jprot.2009.12.013; Laumonnier F, 2010, MOL PSYCHIATR, V15, P767, DOI 10.1038/mp.2009.14; Li CM, 2006, BMC MED GENET, V7, DOI 10.1186/1471-2350-7-24; Liu CH, 2011, HUM GENET, V130, P623, DOI 10.1007/s00439-011-0980-2; Locke AE, 2010, GENET EPIDEMIOL, V34, P613, DOI 10.1002/gepi.20518; Luna-Zurita L, 2010, J CLIN INVEST, V120, P3493, DOI 10.1172/JCI42666; Mao R, 2005, GENOME BIOL, V6, DOI 10.1186/gb-2005-6-13-r107; McClintock TS, 2008, PHYSIOL GENOMICS, V32, P198, DOI 10.1152/physiolgenomics.00128.2007; Moore CS, 2006, MAMM GENOME, V17, P1005, DOI 10.1007/s00335-006-0032-8; Moorman A, 2003, HEART, V89, P806, DOI 10.1136/heart.89.7.806; Nishimura Y, 2007, HUM MOL GENET, V16, P1682, DOI 10.1093/hmg/ddm116; O'Doherty A, 2005, SCIENCE, V309, P2033, DOI 10.1126/science.1114535; Obermann-Borst SA, 2011, EUR J CLIN INVEST, V41, P143, DOI 10.1111/j.1365-2362.2010.02388.x; Paladini D, 2000, ULTRASOUND OBST GYN, V15, P104, DOI 10.1046/j.1469-0705.2000.00027.x; Papavassiliou P, 2009, AM J MED GENET A, V149A, P573, DOI 10.1002/ajmg.a.32729; Parisot P, 2011, BIRTH DEFECTS RES A, V91, P477, DOI 10.1002/bdra.20803; Roper RJ, 2009, MECH DEVELOP, V126, P212, DOI 10.1016/j.mod.2008.11.002; Sato M, 2006, DEV BIOL, V298, P12, DOI 10.1016/j.ydbio.2006.05.033; Schule B, 2007, AM J HUM GENET, V81, P492, DOI 10.1086/520063; Shetty J, 2007, GENE, V396, P93, DOI 10.1016/j.gene.2007.02.031; Slough J, 2008, DEV DYNAM, V237, P2304, DOI 10.1002/dvdy.21669; Snider P, 2007, THESCIENTIFICWORLDJO, V7, P1090, DOI 10.1100/tsw.2007.189; Stoll C, 1998, ANN GENET-PARIS, V41, P44; Stranger BE, 2005, PLOS GENET, V1, P695, DOI 10.1371/journal.pgen.0010078; Torfs CP, 1999, EPIDEMIOLOGY, V10, P264, DOI 10.1097/00001648-199905000-00013; Torfs CP, 1998, AM J MED GENET, V77, P431, DOI 10.1002/(SICI)1096-8628(19980605)77:5<431::AID-AJMG15>3.0.CO;2-J; Torrioli MG, 2010, AM J MED GENET A, V152A, P1420, DOI 10.1002/ajmg.a.33484; Toyofuku T, 2004, NAT CELL BIOL, V6, P1204, DOI 10.1038/ncb1193; Venugopalan P, 2003, Indian Pediatr, V40, P398; Vida VL, 2005, CARDIOL YOUNG, V15, P286, DOI 10.1017/S1047951105000582; Williams AD, 2008, DEV DYNAM, V237, P426, DOI 10.1002/dvdy.21416; Xu HS, 2007, SEMIN CELL DEV BIOL, V18, P77, DOI 10.1016/j.semcdb.2006.11.011; Xu TH, 2010, J AM COLL CARDIOL, V55, P587, DOI 10.1016/j.jacc.2009.11.020; Yahya-Graison EA, 2007, AM J HUM GENET, V81, P475, DOI 10.1086/520000	62	20	20	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 9	2012	7	8							e41616	10.1371/journal.pone.0041616	http://dx.doi.org/10.1371/journal.pone.0041616			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	986WZ	22912673	Green Published, Green Submitted, gold			2022-12-25	WOS:000307378500006
J	Deng, BC; Zhang, SJ; Geng, YZ; Zhang, YZ; Wang, YC; Yao, WQ; Wen, Y; Cui, W; Zhou, Y; Gu, QH; Wang, W; Wang, Y; Shao, Z; Wang, YL; Li, CB; Wang, DL; Zhao, YT; Liu, P				Deng, Baocheng; Zhang, Shujun; Geng, Yingzhi; Zhang, Yuzhong; Wang, Yuncheng; Yao, Wenqing; Wen, Ying; Cui, Wei; Zhou, Ying; Gu, Qiuhong; Wang, Wen; Wang, Yu; Shao, Zhen; Wang, Yanli; Li, Chengbo; Wang, Donglei; Zhao, Yitong; Liu, Pei			Cytokine and Chemokine Levels in Patients with Severe Fever with Thrombocytopenia Syndrome Virus	PLOS ONE			English	Article							NECROSIS-FACTOR-ALPHA; IFN-GAMMA; HEMORRHAGIC-FEVER; INTERFERON-GAMMA; T-CELL; EXPRESSION; DENGUE; BUNYAVIRUS; INFECTION; CHINA	Background: Severe fever with thrombocytopenia syndrome virus (SFTSV), which can cause hemorrhagic fever-like illness, is a newly discovered bunyavirus in China. The pathogenesis of SFTSV infection is poorly understood. However, it has been suggested that immune mechanisms, including cytokines and chemokines, play an important role in disease pathogenesis. In the present study, we investigated host cytokine and chemokine profiles in serum samples of patients with SFTSV infection from Northeast China and explored a possible correlation between cytokine levels and disease severity. Methods and Principal Findings: Acute phase serum samples from 40 patients, diagnosed with SFTSV infection were included. Patients were divided into two groups - severe or non-severe - based on disease severity. Levels of tumor necrosis factor (TNF)-alpha, transforming growth factor (TGF)-beta, interleukin-6, interferon (IFN)-gamma, IFN-gamma-induced protein (IP)-10 and RANTES were measured in the serum samples with commercial ELISAs. Statistical analysis showed that increases in TNF-alpha, IP-10 and IFN-gamma were associated with disease severity. Conclusions: We suggest that a cytokine-mediated inflammatory response, characterized by cytokine and chemokine production imbalance, might be in part responsible for the disease progression of patients with SFTSV infection.	[Deng, Baocheng; Wen, Ying; Cui, Wei; Zhou, Ying; Gu, Qiuhong; Wang, Wen; Wang, Yu; Shao, Zhen; Wang, Yanli; Li, Chengbo; Wang, Donglei; Zhao, Yitong; Liu, Pei] China Med Univ, Affiliated Hosp 1, Dept Infect Dis, Shenyang, Liaoning Provin, Peoples R China; [Zhang, Shujun; Zhang, Yuzhong; Wang, Yuncheng] Kuandian Country Hosp, Dept Infect Dis, Dandong, Liaoning Provin, Peoples R China; [Geng, Yingzhi; Yao, Wenqing] Liaoning Prov Ctr Dis Control & Prevent, Shenyang, Liaoning Provin, Peoples R China	China Medical University	Liu, P (corresponding author), China Med Univ, Affiliated Hosp 1, Dept Infect Dis, Shenyang, Liaoning Provin, Peoples R China.	syliupei2003@yahoo.com.cn						Azeredo EL, 2006, MEM I OSWALDO CRUZ, V101, P437, DOI 10.1590/S0074-02762006000400016; Bao CJ, 2011, CLIN INFECT DIS, V53, P1208, DOI 10.1093/cid/cir732; Bernabei P, 2001, J LEUKOCYTE BIOL, V70, P950; Boehm U, 1997, ANNU REV IMMUNOL, V15, P749, DOI 10.1146/annurev.immunol.15.1.749; Bozza FA, 2008, BMC INFECT DIS, V8, DOI 10.1186/1471-2334-8-86; Chakravarti A, 2006, INDIAN J MED RES, V123, P25; de Jong MD, 2006, NAT MED, V12, P1203, DOI 10.1038/nm1477; Dufour JH, 2002, J IMMUNOL, V168, P3195, DOI 10.4049/jimmunol.168.7.3195; Green S, 1999, J INFECT DIS, V179, P755, DOI 10.1086/314680; Liu Y, 2011, VECTOR BORNE ZOONOTI; Marta RF, 1999, AM J TROP MED HYG, V60, P85, DOI 10.4269/ajtmh.1999.60.85; Miossec P, 2009, NEW ENGL J MED, V361, P888, DOI 10.1056/NEJMra0707449; Papa A, 2006, J CLIN VIROL, V36, P272, DOI 10.1016/j.jcv.2006.04.007; Peiris JSM, 2004, LANCET, V363, P617, DOI 10.1016/S0140-6736(04)15595-5; Proost P, 2003, EUR J IMMUNOL, V33, P3146, DOI 10.1002/eji.200324136; Rostami MN, 2010, PLOS NEGLECT TROP D, V4, DOI 10.1371/journal.pntd.0000845; Sadeghi M, 2011, BMC IMMUNOL, V12, DOI 10.1186/1471-2172-12-65; Saksida A, 2011, BMC INFECT DIS, V11, DOI 10.1186/1471-2334-11-142; Schnittler HJ, 2003, THROMB HAEMOSTASIS, V89, P967; Sobek V, 2002, EUR J IMMUNOL, V32, P2490, DOI 10.1002/1521-4141(200209)32:9<2490::AID-IMMU2490>3.0.CO;2-G; Sundstrom JB, 2001, J VIROL, V75, P6070, DOI 10.1128/JVI.75.13.6070-6085.2001; Villinger F, 1999, J INFECT DIS, V179, pS188, DOI 10.1086/514283; Vollmer-Conna U, 2008, CLIN INFECT DIS, V47, P1418, DOI 10.1086/592967; Wong CK, 2004, CLIN EXP IMMUNOL, V136, P95, DOI 10.1111/j.1365-2249.2004.02415.x; Yu X, 2011, PLOS ONE, V6, DOI [10.1371/journal.pone.0020575, 10.1371/journal.pone.0028680]; Yu XJ, 2011, NEW ENGL J MED, V364, P1523, DOI 10.1056/NEJMoa1010095; Zeng RH, 2011, CYTOKINE, V53, P1, DOI 10.1016/j.cyto.2010.09.011; Zhang YZ, 2012, CLIN INFECT DIS, V54, P527, DOI 10.1093/cid/cir804; Zhang YZ, 2011, CLIN INFECT DIS	29	87	98	2	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 24	2012	7	7							e41365	10.1371/journal.pone.0041365	http://dx.doi.org/10.1371/journal.pone.0041365			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	978NX	22911786	Green Published, gold, Green Submitted			2022-12-25	WOS:000306751300034
J	Ma, JY; Li, M; Ge, ZJ; Luo, YB; Ou, XH; Song, SH; Tian, DM; Yang, J; Zhang, B; Ou-Yang, YC; Hou, Y; Liu, ZH; Schatten, H; Sun, QY				Ma, Jun-Yu; Li, Mo; Ge, Zhao-Jia; Luo, Yibo; Ou, Xiang-Hong; Song, Shuhui; Tian, Dongmei; Yang, Jin; Zhang, Bing; Ou-Yang, Ying-Chun; Hou, Yi; Liu, Zhonghua; Schatten, Heide; Sun, Qing-Yuan			Whole Transcriptome Analysis of the Effects of Type I Diabetes on Mouse Oocytes	PLOS ONE			English	Article							TO-CELL COMMUNICATION; MOLECULAR-MECHANISMS; PATERNAL GENOME; MATURATION; OVULATION; EXPRESSION; STREPTOZOTOCIN; FERTILIZATION; DEMETHYLATION; MELLITUS	In mouse ovarian follicles, granulosa cells but not oocytes take up glucose to provide the oocyte with nourishments for energy metabolism. Diabetes-induced hyperglycemia or glucose absorption inefficiency consistently causes granulosa cell apoptosis and further exerts a series of negative impacts on oocytes including reduced meiosis resumption rate, low oocyte quality and preimplantation embryo degeneration. Here we compared the transcriptome of mouse oocytes from genetically derived NOD diabetic mice or chemically induced STZ diabetic mice with that of corresponding normal mice. Differentially expressed genes were extracted from the two diabetic models. Gene set enrichment analysis showed that genes associated with metabolic and developmental processes were differentially expressed in oocytes from both models of diabetes. In addition, NOD diabetes also affected the expression of genes associated with ovulation, cell cycle progression, and preimplantation embryo development. Notably, Dnmt1 expression was significantly down-regulated, but Mbd3 expression was up-regulated in diabetic mouse oocytes. Our data not only revealed the mechanisms by which diabetes affects oocyte quality and preimplantation embryo development, but also linked epigenetic hereditary factors with metabolic disorders in germ cells.	[Ma, Jun-Yu; Li, Mo; Ge, Zhao-Jia; Luo, Yibo; Ou, Xiang-Hong; Ou-Yang, Ying-Chun; Hou, Yi; Sun, Qing-Yuan] Chinese Acad Sci, Inst Zool, State Key Lab Reprod Biol, Beijing, Peoples R China; [Ma, Jun-Yu; Liu, Zhonghua] NE Agr Univ, Coll Life Sci, Harbin, Peoples R China; [Song, Shuhui; Tian, Dongmei; Yang, Jin; Zhang, Bing] Chinese Acad Sci, Beijing Inst Genom, CAS Key Lab Genome Sci & Informat, Beijing, Peoples R China; [Schatten, Heide] Univ Missouri, Dept Vet Pathobiol, Columbia, MO USA	Chinese Academy of Sciences; Institute of Zoology, CAS; Northeast Agricultural University - China; Chinese Academy of Sciences; Beijing Institute of Genomics, CAS; University of Missouri System; University of Missouri Columbia	Ma, JY (corresponding author), Chinese Acad Sci, Inst Zool, State Key Lab Reprod Biol, Beijing, Peoples R China.	sunqy@ioz.ac.cn	song, shuhui/D-6015-2014		National Basic Research Program of China [2012CB944404, 2011CB944501]; National Natural Science Foundation of China [30930065]	National Basic Research Program of China(National Basic Research Program of China); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This study was supported by the National Basic Research Program of China (2012CB944404, 2011CB944501) and National Natural Science Foundation of China (No. 30930065) to QYS. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BEEBE LFS, 1991, DIABETES, V40, P457, DOI 10.2337/diabetes.40.4.457; BONNEVIENIELSEN V, 1981, DIABETES, V30, P424, DOI 10.2337/diabetes.30.5.424; Chang AS, 2005, ENDOCRINOLOGY, V146, P2445, DOI 10.1210/en.2004-1472; DEKEL N, 1981, DEV BIOL, V86, P356, DOI 10.1016/0012-1606(81)90193-7; DIAMOND MP, 1989, J REPROD FERTIL, V86, P1; GILULA NB, 1978, J CELL BIOL, V78, P58, DOI 10.1083/jcb.78.1.58; Hara K, 2006, GENES CELLS, V11, P1281, DOI 10.1111/j.1365-2443.2006.01019.x; Heikinheimo O, 1998, MOL HUM REPROD, V4, P745, DOI 10.1093/molehr/4.8.745; Holt JE, 2011, DEVELOPMENT, V138, P905, DOI 10.1242/dev.059022; Homer H, 2009, SCIENCE, V326, P991, DOI 10.1126/science.1175326; Howell CY, 2001, CELL, V104, P829, DOI 10.1016/S0092-8674(01)00280-X; Iqbal K, 2011, P NATL ACAD SCI USA, V108, P3642, DOI 10.1073/pnas.1014033108; Jawerbaum A, 2010, ENDOCR REV, V31, P680, DOI 10.1210/er.2009-0038; JUNOD A, 1969, J CLIN INVEST, V48, P2129, DOI 10.1172/JCI106180; Kurimoto K, 2007, NAT PROTOC, V2, P739, DOI 10.1038/nprot.2007.79; LI E, 1992, CELL, V69, P915, DOI 10.1016/0092-8674(92)90611-F; Li L, 2010, DEVELOPMENT, V137, P859, DOI 10.1242/dev.039487; Manoli T, 2006, BIOINFORMATICS, V22, P2500, DOI 10.1093/bioinformatics/btl424; Mayer W, 2000, NATURE, V403, P501, DOI 10.1038/35000656; MOLEY KH, 1991, J REPROD FERTIL, V93, P325; Moore RK, 2004, TRENDS ENDOCRIN MET, V15, P356, DOI 10.1016/j.tem.2004.08.008; Oswald J, 2000, CURR BIOL, V10, P475, DOI 10.1016/S0960-9822(00)00448-6; Otsuka F, 2002, P NATL ACAD SCI USA, V99, P8060, DOI 10.1073/pnas.122066899; Ratchford AM, 2008, MOL ENDOCRINOL, V22, P2643, DOI 10.1210/me.2007-0495; Ratnam S, 2002, DEV BIOL, V245, P304, DOI 10.1006/dbio.2002.0628; Reese KJ, 2007, PLOS GENET, V3, P1407, DOI 10.1371/journal.pgen.0030137; Reik W, 2001, SCIENCE, V293, P1089, DOI 10.1126/science.1063443; Russell DL, 2007, HUM REPROD UPDATE, V13, P289, DOI 10.1093/humupd/dml062; Santos F, 2002, DEV BIOL, V241, P172, DOI 10.1006/dbio.2001.0501; Shaw JE, 2010, DIABETES RES CLIN PR, V87, P4, DOI 10.1016/j.diabres.2009.10.007; Subramanian A, 2005, P NATL ACAD SCI USA, V102, P15545, DOI 10.1073/pnas.0506580102; Sugiura K, 2007, DEVELOPMENT, V134, P2593, DOI 10.1242/dev.006882; Sutton-McDowall ML, 2010, REPRODUCTION, V139, P685, DOI 10.1530/REP-09-0345; Tanghe S, 2002, MOL REPROD DEV, V61, P414, DOI 10.1002/mrd.10102; Thomas HE, 2000, DIABETES-METAB RES, V16, P251, DOI 10.1002/1520-7560(200007/08)16:4<251::AID-DMRR126>3.3.CO;2-3; VANBLERKOM J, 1995, HUM REPROD, V10, P415, DOI 10.1093/oxfordjournals.humrep.a135954; Wang LK, 2010, BIOINFORMATICS, V26, P136, DOI 10.1093/bioinformatics/btp612; Wang Q, 2012, AM J PHYSL ENDOCRINO; Wang Q, 2012, ENDOCRINOLOGY, V153, P1984, DOI 10.1210/en.2011-1815; Wang QA, 2010, MITOCHONDRION, V10, P403, DOI 10.1016/j.mito.2010.03.002; Wang Q, 2009, MOL ENDOCRINOL, V23, P1603, DOI 10.1210/me.2009-0033; Wu XM, 2003, NAT GENET, V33, P187, DOI 10.1038/ng1079; Yoon JW, 2001, ANN NY ACAD SCI, V928, P200	43	11	13	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 24	2012	7	7							e41981	10.1371/journal.pone.0041981	http://dx.doi.org/10.1371/journal.pone.0041981			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	978NX	22911868	Green Submitted, Green Published, gold			2022-12-25	WOS:000306751300085
J	Mughal, SK; Myazin, AE; Zhavoronkov, LP; Rubanovich, AV; Dubrova, YE				Mughal, Safeer K.; Myazin, Andrey E.; Zhavoronkov, Leonid P.; Rubanovich, Alexander V.; Dubrova, Yuri E.			The Dose and Dose-Rate Effects of Paternal Irradiation on Transgenerational Instability in Mice: A Radiotherapy Connection	PLOS ONE			English	Article							REPEAT DNA LOCI; GENOMIC INSTABILITY; MUTATION-INDUCTION; GERM-LINE; ANTICANCER DRUGS; MOUSE GERMLINE; BONE-MARROW; NO EVIDENCE; RADIATION; EXPOSURE	The non-targeted effects of human exposure to ionising radiation, including transgenerational instability manifesting in the children of irradiated parents, remains poorly understood. Employing a mouse model, we have analysed whether low-dose acute or low-dose-rate chronic paternal c-irradiation can destabilise the genomes of their first-generation offspring. Using single-molecule PCR, the frequency of mutation at the mouse expanded simple tandem repeat (ESTR) locus Ms6-hm was established in DNA samples extracted from sperm of directly exposed BALB/c male mice, as well as from sperm and the brain of their first-generation offspring. For acute c-irradiation from 10-100 cGy a linear dose-response for ESTR mutation induction was found in the germ line of directly exposed mice, with a doubling dose of 57 cGy. The mutagenicity of acute exposure to 100 cGy was more pronounced than that for chronic low-dose-rate irradiation. The analysis of transgenerational effects of paternal irradiation revealed that ESTR mutation frequencies were equally elevated in the germ line (sperm) and brain of the offspring of fathers exposed to 50 and 100 cGy of acute c-rays. In contrast, neither paternal acute irradiation at lower doses (10-25 cGy), nor low-dose-rate exposure to 100 cGy affected stability of their offspring. Our data imply that the manifestation of transgenerational instability is triggered by a threshold dose of acute paternal irradiation. The results of our study also suggest that most doses of human exposure to ionising radiation, including radiotherapy regimens, may be unlikely to result in transgenerational instability in the offspring children of irradiated fathers.	[Mughal, Safeer K.; Dubrova, Yuri E.] Univ Leicester, Dept Genet, Leicester LE1 7RH, Leics, England; [Myazin, Andrey E.; Rubanovich, Alexander V.] Russian Acad Sci, Vavilov Inst Gen Genet, Moscow, Russia; [Zhavoronkov, Leonid P.] Russian Minist Hlth & Social Dev, Med Radiol Res Ctr, Obninsk, Russia	University of Leicester; Russian Academy of Sciences; Vavilov Institute of General Genetics; Ministry of Health of the Russian Federation	Mughal, SK (corresponding author), Univ Leicester, Dept Genet, Univ Rd, Leicester LE1 7RH, Leics, England.	yed2@le.ac.uk	Zhavoronkov, Leonid Petrovich/AAG-9214-2019; Dubrova, Yuri/ABA-7148-2020; Zhavoronkov, Leonid/W-4116-2017; Rubanovich, Alexander/B-4992-2017	Zhavoronkov, Leonid Petrovich/0000-0001-5100-9118; Zhavoronkov, Leonid/0000-0001-5100-9118; Dubrova, Yuri/0000-0001-5281-7539	European Commission [036465]; Cancer Research UK [C23612/A9483, C23912/A12262]; Wellcome Trust [091106/Z/10/Z]; Electromagnetic Field (EMF) Biological Research Trust [BRT 11/42]	European Commission(European CommissionEuropean Commission Joint Research Centre); Cancer Research UK(Cancer Research UK); Wellcome Trust(Wellcome TrustEuropean Commission); Electromagnetic Field (EMF) Biological Research Trust	This work was supported by a research grant from the European Commission (http://www.wellcome.ac.uk/; NOTE, contract number 036465; http://ec.europa.eu/research/fp6/). Y.E.D. work is also supported by research grants from Cancer Research UK (http://www.cancerresearchuk.org/; contract number C23612/A9483 and C23912/A12262), the Wellcome Trust (http://www.wellcome.ac.uk/; contract number 091106/Z/10/Z), and the Electromagnetic Field (EMF) Biological Research Trust (http://www.emfbrt.org/; contract number BRT 11/42). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aghajanyan A, 2011, ENVIRON MOL MUTAGEN, V52, P538, DOI 10.1002/em.20655; Ali HEA, 2012, MUTAT RES-FUND MOL M, V732, P21, DOI 10.1016/j.mrfmmm.2012.01.003; Barber R, 2002, P NATL ACAD SCI USA, V99, P6877, DOI 10.1073/pnas.102015399; Barber RC, 2006, ONCOGENE, V25, P7336, DOI 10.1038/sj.onc.1209723; Barber RC, 2009, MUTAT RES-FUND MOL M, V664, P6, DOI 10.1016/j.mrfmmm.2009.01.011; Ding LH, 2005, RADIAT RES, V164, P17, DOI 10.1667/RR3354; Dubrova YE, 2000, MUTAT RES-FUND MOL M, V453, P17, DOI 10.1016/S0027-5107(00)00068-3; Dubrova YE, 2005, RADIAT RES, V163, P200, DOI 10.1667/RR3296; Dubrova YE, 1998, P NATL ACAD SCI USA, V95, P6251, DOI 10.1073/pnas.95.11.6251; Dubrova YE, 2000, NATURE, V405, P37, DOI 10.1038/35011135; Dubrova YE, 2008, ENVIRON MOL MUTAGEN, V49, P308, DOI 10.1002/em.20385; FRANKENBERGSCHWAGER M, 1990, RADIAT ENVIRON BIOPH, V29, P273, DOI 10.1007/BF01210408; Glen CD, 2008, CANCER RES, V68, P3630, DOI 10.1158/0008-5472.CAN-08-0484; Glen CD, 2012, P NATL ACAD SCI USA, V109, P2984, DOI 10.1073/pnas.1119396109; Hatch T, 2007, ONCOGENE, V26, P4720, DOI 10.1038/sj.onc.1210253; LYON MF, 1972, MUTAT RES, V15, P185, DOI 10.1016/0027-5107(72)90031-0; Rithidech KN, 2012, DOSE-RESPONSE, V10, P11, DOI 10.2203/dose-response.11-002.Rithidech; RUSSELL WL, 1982, P NATL ACAD SCI-BIOL, V79, P542, DOI 10.1073/pnas.79.2.542; RUSSELL WL, 1982, P NATL ACAD SCI-BIOL, V79, P539, DOI 10.1073/pnas.79.2.539; SEARLE AG, 1974, ADV RADIAT BIOL, V4, P131; Shiraishi K, 2002, RADIAT RES, V157, P661, DOI 10.1667/0033-7587(2002)157[0661:PIOSRO]2.0.CO;2; Tawn EJ, 2005, MUTAT RES-GEN TOX EN, V583, P198, DOI 10.1016/j.mrgentox.2005.03.007; Tucker JD, 1998, MUTAT RES, V400, P231; UNSCEAR, 2000, SOURC EFF ION RAD UN, VI; UNSCEAR, 2001, UN SCI COMM EFF AT R; Vilarino-Guell C, 2003, MUTAT RES-FUND MOL M, V526, P63, DOI 10.1016/S0027-5107(03)00016-2; Zheng NJ, 2000, ENVIRON MOL MUTAGEN, V36, P134, DOI 10.1002/1098-2280(2000)36:2<134::AID-EM8>3.0.CO;2-D; Zyuzikov NA, 2011, RADIAT RES, V175, P322, DOI 10.1667/RR2386.1	28	26	28	0	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 24	2012	7	7							e41300	10.1371/journal.pone.0041300	http://dx.doi.org/10.1371/journal.pone.0041300			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	978NX	22911775	Green Submitted, Green Published, gold			2022-12-25	WOS:000306751300029
J	Lu, YC; Vaarhorst, A; Merry, AHH; Dolle, MET; Hovenier, R; Imholz, S; Schouten, LJ; Heijmans, BT; Muller, M; Slagboom, PE; van den Brandt, PA; Gorgels, APM; Boer, JMA; Feskens, EJM				Lu, Yingchang; Vaarhorst, Anika; Merry, Audrey H. H.; Dolle, Martijn E. T.; Hovenier, Robert; Imholz, Sandra; Schouten, Leo J.; Heijmans, Bastiaan T.; Mueller, Michael; Slagboom, P. Eline; van den Brandt, Piet A.; Gorgels, Anton P. M.; Boer, Jolanda M. A.; Feskens, Edith J. M.			Markers of Endogenous Desaturase Activity and Risk of Coronary Heart Disease in the CAREMA Cohort Study	PLOS ONE			English	Article							DIETARY ARACHIDONIC-ACID; GENOME-WIDE ASSOCIATION; N-6 FATTY-ACIDS; GENETIC-VARIATION; LOCI; METABOLISM; EXPRESSION; VARIANTS; DELTA-5; CLONING	Background: Intakes of n-3 polyunsaturated fatty acids (PUFAs), especially EPA (C20:5n-3) and DHA (C22:6n-3), are known to prevent fatal coronary heart disease (CHD). The effects of n-6 PUFAs including arachidonic acid (C20: 4n-6), however, remain unclear. delta-5 and delta-6 desaturases are rate-limiting enzymes for synthesizing long-chain n-3 and n-6 PUFAs. C20:4n-6 to C20:3n-6 and C18:3n-6 to C18:2n-6 ratios are markers of endogenous delta-5 and delta-6 desaturase activities, but have never been studied in relation to incident CHD. Therefore, the aim of this study was to investigate the relation between these ratios as well as genotypes of FADS1 rs174547 and CHD incidence. Methods: We applied a case-cohort design within the CAREMA cohort, a large prospective study among the general Dutch population followed up for a median of 12.1 years. Fatty acid profile in plasma cholesteryl esters and FADS1 genotype at baseline were measured in a random subcohort (n = 1323) and incident CHD cases (n = 537). Main outcome measures were hazard ratios (HRs) of incident CHD adjusted for major CHD risk factors. Results: The AA genotype of rs174547 was associated with increased plasma levels of C204n-6, C20:5n-3 and C22:6n-3 and increased delta-5 and delta-6 desaturase activities, but not with CHD risk. In multivariable adjusted models, high baseline delta-5 desaturase activity was associated with reduced CHD risk (P for trend = 0.02), especially among those carrying the high desaturase activity genotype (AA): HR (95% CI) = 0.35 (0.15-0.81) for comparing the extreme quintiles. High plasma DHA levels were also associated with reduced CHD risk. Conclusion: In this prospective cohort study, we observed a reduced CHD risk with an increased C20:4n-6 to C20:3n-6 ratio, suggesting that delta-5 desaturase activity plays a role in CHD etiology. This should be investigated further in other independent studies.	[Lu, Yingchang; Hovenier, Robert; Mueller, Michael; Feskens, Edith J. M.] Univ Wageningen & Res Ctr, Div Human Nutr, Wageningen, Netherlands; [Lu, Yingchang; Dolle, Martijn E. T.; Imholz, Sandra; Boer, Jolanda M. A.] Natl Inst Publ Hlth & Environm RIVM, Bilthoven, Netherlands; [Vaarhorst, Anika; Heijmans, Bastiaan T.; Slagboom, P. Eline] Leiden Univ, Med Ctr, Dept Mol Epidemiol, Leiden, Netherlands; [Merry, Audrey H. H.; van den Brandt, Piet A.] Maastricht Univ, CAPHRI Sch Publ Hlth & Primary Care, Dept Epidemiol, Maastricht, Netherlands; [Schouten, Leo J.; van den Brandt, Piet A.] Maastricht Univ, GROW Sch Oncol & Dev Biol, Dept Epidemiol, Maastricht, Netherlands; [Gorgels, Anton P. M.] Univ Hosp Maastricht, Dept Cardiol, Maastricht, Netherlands	Wageningen University & Research; Netherlands National Institute for Public Health & the Environment; Leiden University; Leiden University Medical Center (LUMC); Leiden University - Excl LUMC; Maastricht University; Maastricht University; Maastricht University; Maastricht University Medical Centre (MUMC)	Lu, YC (corresponding author), Univ Wageningen & Res Ctr, Div Human Nutr, Wageningen, Netherlands.	kevin.lu@wur.nl; edith.feskens@wur.nl	Muller, Michael/M-5724-2019; Slagboom, P. Eline/R-4790-2016; Schouten, Leo J/G-3713-2012; Schouten, Leo J/AAB-2275-2019; Muller, Michael/B-5795-2008; Feskens, Edith/ABI-1446-2020	Muller, Michael/0000-0002-5930-9905; Slagboom, P. Eline/0000-0002-2875-4723; Schouten, Leo J/0000-0003-3361-7560; Muller, Michael/0000-0002-5930-9905; Feskens, Edith/0000-0001-5819-2488; van den Brandt, Piet/0000-0001-8781-8099	Netherlands Heart Foundation [2006B195]; Ministry of Public Health, Welfare and Sports of the Netherlands	Netherlands Heart Foundation(Netherlands Heart Foundation); Ministry of Public Health, Welfare and Sports of the Netherlands	This study was supported by grant 2006B195 of the Netherlands Heart Foundation. The monitoring project on cardiovascular disease risk factors was financially supported by the Ministry of Public Health, Welfare and Sports of the Netherlands. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 1993, NETH J CARDIOL; Barlow WE, 1999, J CLIN EPIDEMIOL, V52, P1165, DOI 10.1016/S0895-4356(99)00102-X; Baylin A, 2006, CURR OPIN LIPIDOL, V17, P22, DOI 10.1097/01.mol.0000199814.46720.83; Bokor S, 2010, J LIPID RES, V51, P2325, DOI 10.1194/jlr.M006205; Burdge G, 2004, CURR OPIN CLIN NUTR, V7, P137, DOI 10.1097/00075197-200403000-00006; Cai JW, 2004, BIOMETRICS, V60, P1015, DOI 10.1111/j.0006-341X.2004.00257.x; Calder PC, 2007, BRIT J NUTR, V98, P451, DOI 10.1017/S0007114507761779; Calder PC, 2010, BRIT J NUTR, V104, P1575, DOI 10.1017/S0007114510004253; Cho HP, 1999, J BIOL CHEM, V274, P471, DOI 10.1074/jbc.274.1.471; Cho HP, 1999, J BIOL CHEM, V274, P37335, DOI 10.1074/jbc.274.52.37335; De Caterina R, 2011, NEW ENGL J MED, V364, P2439, DOI 10.1056/NEJMra1008153; Demirkan A, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1002490; Dixon AL, 2007, NAT GENET, V39, P1202, DOI 10.1038/ng2109; Dupuis J, 2010, NAT GENET, V42, P105, DOI 10.1038/ng.520; Eijgelsheim M, 2010, HUM MOL GENET, V19, P3885, DOI 10.1093/hmg/ddq303; Fairfax BP, 2012, NAT GENET, V44, P502, DOI 10.1038/ng.2205; Ferretti A, 1997, LIPIDS, V32, P435, DOI 10.1007/s11745-997-0057-5; Grundy SM, 2002, CIRCULATION, V106, P3143, DOI 10.1161/circ.106.25.3143; Harris WS, 2007, ATHEROSCLEROSIS, V193, P1, DOI 10.1016/j.atherosclerosis.2007.03.018; Harris WS, 2009, CIRCULATION, V119, P902, DOI 10.1161/CIRCULATIONAHA.108.191627; Joensen AM, 2011, CIRCULATION, V124, P1232, DOI 10.1161/CIRCULATIONAHA.110.987057; Kathiresan S, 2009, NAT GENET, V41, P56, DOI 10.1038/ng.291; KATTERMANN R, 1984, J CLIN CHEM CLIN BIO, V22, P245; Kelley DS, 1997, LIPIDS, V32, P449, DOI 10.1007/s11745-997-0059-3; Kroger J, 2011, AM J CLIN NUTR, V93, P127, DOI 10.3945/ajcn.110.005447; Kromhout D, 2010, NEW ENGL J MED, V363, P2015, DOI 10.1056/NEJMoa1003603; Kusumoto A, 2007, BRIT J NUTR, V98, P626, DOI 10.1017/S0007114507734566; Langholz B, 2007, COMPUT STAT DATA AN, V51, P3737, DOI 10.1016/j.csda.2006.12.028; Lemaitre RN, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1002193; Lu YC, 2010, AM J CLIN NUTR, V92, P258, DOI 10.3945/ajcn.2009.29130; Marquardt A, 2000, GENOMICS, V66, P175, DOI 10.1006/geno.2000.6196; Mathias RA, 2010, J LIPID RES, V51, P2766, DOI 10.1194/jlr.M008359; Merry AHH, 2009, EUR J EPIDEMIOL, V24, P237, DOI 10.1007/s10654-009-9335-x; MILLER SA, 1988, NUCLEIC ACIDS RES, V16, P1215, DOI 10.1093/nar/16.3.1215; Mozaffarian D, 2008, AM J CLIN NUTR, V87, p1991S, DOI 10.1093/ajcn/87.6.1991S; Mozaffarian D, 2010, PLOS MED, V7, DOI 10.1371/journal.pmed.1000252; Nakamura MT, 2004, ANNU REV NUTR, V24, P345, DOI 10.1146/annurev.nutr.24.121803.063211; Nelson GJ, 1997, LIPIDS, V32, P421, DOI 10.1007/s11745-997-0055-7; Nelson GJ, 1997, LIPIDS, V32, P427, DOI 10.1007/s11745-997-0056-6; Plaisier CL, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000642; Raatz SK, 2001, J NUTR, V131, P231; Rauch B, 2010, CIRCULATION, V122, P2152, DOI 10.1161/CIRCULATIONAHA.110.948562; Schadt EE, 2008, PLOS BIOL, V6, P1020, DOI 10.1371/journal.pbio.0060107; Schaeffer L, 2006, HUM MOL GENET, V15, P1745, DOI 10.1093/hmg/ddl117; Schmitz G, 2008, PROG LIPID RES, V47, P147, DOI 10.1016/j.plipres.2007.12.004; Schunkert H, 2011, NAT GENET, V43, P333, DOI [10.1038/ng.784, 10.1161/CIRCGENETICS.111.960443]; Serhan CN, 2008, NAT REV IMMUNOL, V8, P349, DOI 10.1038/nri2294; SEYBERTH HW, 1975, CLIN PHARMACOL THER, V18, P521; Simopoulos AP, 2006, BIOMED PHARMACOTHER, V60, P502, DOI 10.1016/j.biopha.2006.07.080; Stoffel W, 2008, EMBO J, V27, P2281, DOI 10.1038/emboj.2008.156; Suhre K, 2011, NATURE, V477, P54, DOI 10.1038/nature10354; Tanaka T, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000338; Teslovich TM, 2010, NATURE, V466, P707, DOI 10.1038/nature09270; Vaarhorst AAM, 2012, CIRC-CARDIOVASC GENE, V5, P202, DOI 10.1161/CIRCGENETICS.111.960708; Yokoyama M, 2007, LANCET, V369, P1090, DOI 10.1016/S0140-6736(07)60527-3	55	44	44	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 23	2012	7	7							e41681	10.1371/journal.pone.0041681	http://dx.doi.org/10.1371/journal.pone.0041681			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	977TM	22911844	gold, Green Published, Green Submitted			2022-12-25	WOS:000306687700140
J	Reyes, LM; Garcia, RG; Ruiz, SL; Camacho, PA; Ospina, MB; Aroca, G; Accini, JL; Lopez-Jaramillo, P				Reyes, Laura M.; Garcia, Ronald G.; Ruiz, Silvia L.; Camacho, Paul A.; Ospina, Maria B.; Aroca, Gustavo; Accini, Jose L.; Lopez-Jaramillo, Patricio			Risk Factors for Preeclampsia in Women from Colombia: A Case-Control Study	PLOS ONE			English	Article							PREGNANCY-INDUCED HYPERTENSION; C-REACTIVE PROTEIN; MATERNAL-FETAL OUTCOMES; BODY-MASS INDEX; LATIN-AMERICA; CARBOHYDRATE INTOLERANCE; REGIONAL DIFFERENCES; GLUCOSE-INTOLERANCE; INSULIN-RESISTANCE; FAMILY-HISTORY	Background: Preeclampsia (PE) is a multi-causal disease characterized by the development of hypertension and proteinuria in the second half of pregnancy. Multiple risk factors have been associated with the development of PE. Moreover, it is known that these risk factors vary between populations from developed and developing countries. The aim of this study is to identify which risk factors are associated with the development of preeclampsia (PE) among Colombian women. Methods: A multi-centre case-control study was conducted between September 2006 and July 2009 in six Colombian cities. Cases included women with PE (n = 201); controls were aged-matched pregnant women (n = 201) without cardiovascular or endocrine diseases for a case-control ratio of 1:1. A complete medical chart, physical examination and biochemical analysis were completed before delivery. Multivariable logistic regression was used to calculate odds ratios (OR) and 95% confidence intervals (CI) of potential risk factors associated with PE. Results: The presence of factors present in the metabolic syndrome cluster such as body mass index > 31 Kg/m2 (OR = 2.18; 1.14-4.14 95% CI), high-density lipoprotein < 1.24 mmol/L (OR = 2.42; 1.53-3.84 95% CI), triglycerides > 3.24 mmol/L (OR = 1.60; 1.04-2.48 95% CI) and glycemia > 4.9 mmol/L (OR = 2.66; 1.47-4.81 95% CI) as well as being primigravidae (OR = 1.71; 1.07-2.73 95% CI) were associated with the development of PE, after adjusting for other variables. Conclusion: Factors present in the cluster of metabolic syndrome and primigravidity were associated with a greater risk of PE among Colombian women. Understanding the role of this cluster of risk factors in the development of PE is of crucial importance to prevent PE and remains to be determined.	[Reyes, Laura M.; Garcia, Ronald G.; Ruiz, Silvia L.; Camacho, Paul A.] Fdn Cardiovasc Colombia, Dept Res, Floridablanca, Santander, Colombia; [Ospina, Maria B.] Univ Alberta, Sch Publ Hlth, Edmonton, AB, Canada; [Aroca, Gustavo] Clin Costa, Barranquilla, Atlantico, Colombia; [Accini, Jose L.] Hosp Univ Barranquilla, Barranquilla, Atlantico, Colombia; [Lopez-Jaramillo, Patricio] Univ Santander UDES, Fac Med, Dept Res, Bucaramanga, Santander, Colombia; [Lopez-Jaramillo, Patricio] Fdn Oftalmol Santander Clin Carlos Ardila Lulle F, Dept Res, Floridablanca, Santander, Colombia	University of Alberta; Universidad Industrial de Santander	Reyes, LM (corresponding author), Fdn Cardiovasc Colombia, Dept Res, Floridablanca, Santander, Colombia.	jplopezj@gmail.com	Aroca, Gustavo/P-9173-2016; Aroca Martinez, Gustavo/N-9133-2013; Reyes, Laura M./AAA-1581-2019; Garcia, Ronald G./AAU-8608-2020	Aroca, Gustavo/0000-0002-9222-3257; Aroca Martinez, Gustavo/0000-0002-9222-3257; Reyes, Laura M./0000-0003-4207-0480; Garcia, Ronald G./0000-0002-8325-9944; Ospina, Maria/0000-0002-1627-4781; Camacho, Paul Anthony/0000-0002-6233-9582; Ospina, Maria/0000-0001-9305-7521; Lopez-Jaramillo, Patricio/0000-0002-9122-8742	COLCIENCIAS (Departamento Administrativo de Ciencia, Tecnologia e Innovacion) [6566-04-18061]	COLCIENCIAS (Departamento Administrativo de Ciencia, Tecnologia e Innovacion)(Departamento Administrativo de Ciencia, Tecnologia e Innovacion Colciencias)	This work was supported by COLCIENCIAS (Departamento Administrativo de Ciencia, Tecnologia e Innovacion) Grant number: 6566-04-18061. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 1985, THEORETICAL EPIDEMIO; Bautista LE, 2001, J HYPERTENS, V19, P857, DOI 10.1097/00004872-200105000-00004; Belfort R, 2005, DIABETES, V54, P1640, DOI 10.2337/diabetes.54.6.1640; Bellamy L, 2007, BMJ-BRIT MED J, V335, P974, DOI 10.1136/bmj.39335.385301.BE; Bhagat K, 1997, CIRCULATION, V96, P3042, DOI 10.1161/01.CIR.96.9.3042; Cekmen MB, 2003, CLIN BIOCHEM, V36, P575, DOI 10.1016/S0009-9120(03)00099-7; Chavarro JE, 2009, EUR J CLIN NUTR, V63, P78, DOI 10.1038/sj.ejcn.1602904; Christiansen LR, 2006, AM J FOREN MED PATH, V27, P11, DOI 10.1097/01.paf.0000203154.50648.33; Crane JMG, 2009, J OBSTET GYNAECOL CA, V31, P28, DOI 10.1016/S1701-2163(16)34050-6; Dane B, 2009, ARCH GYNECOL OBSTET, V280, P921, DOI 10.1007/s00404-009-1029-9; Danesh J, 2004, NEW ENGL J MED, V350, P1387, DOI 10.1056/NEJMoa032804; Driul L, 2008, ARCH GYNECOL OBSTET, V278, P23, DOI 10.1007/s00404-007-0524-0; Druzin ML, 2008, CURR OPIN OBSTET GYN, V20, P91, DOI 10.1097/GCO.0b013e3282f7335a; Duckitt K, 2005, BRIT MED J, V330, P565, DOI 10.1136/bmj.38380.674340.E0; Garcia RG, 2007, AM J HYPERTENS, V20, P98, DOI 10.1016/j.amjhyper.2006.06.001; Gifford RW, 2000, AM J OBSTET GYNECOL, V183, pS1, DOI 10.1067/mob.2000.107928; Herrera JA, 2001, MED HYPOTHESES, V57, P393, DOI 10.1054/mehy.2001.1378; Joffe GM, 1998, AM J OBSTET GYNECOL, V179, P1032, DOI 10.1016/S0002-9378(98)70210-8; Kaaja R, 2008, Minerva Ginecol, V60, P421; Khan KS, 2006, LANCET, V367, P1066, DOI 10.1016/S0140-6736(06)68397-9; KUHL C, 1991, DIABETES, V40, P18, DOI 10.2337/diab.40.2.S18; Lopez-Jarami P, 2008, AM J HYPERTENS, V21, P527, DOI 10.1038/ajh.2007.86; Lopez-Jaramillo P, 2005, J HYPERTENS, V23, P1121, DOI 10.1097/01.hjh.0000170371.49010.4a; Lopez-Jaramillo P, 2008, J HYPERTENS, V26, P1886, DOI 10.1097/HJH.0b013e328308ba8d; Lopez-Jaramillo P, 2007, REV ESP CARDIOL, V60, P168, DOI 10.1157/13099463; Lopez-Jaramillo P, 2009, COLOMB MEDICA, V40, P226; Lopez-Jaramillo P, 2009, REV ESP CARDIOL, V62, P670, DOI 10.1016/S0300-8932(09)71334-X; Martin U, 1999, CLIN SCI, V96, P421, DOI 10.1042/CS19980326; Ness RB, 2003, OBSTET GYNECOL, V102, P1366, DOI 10.1016/j.obstetgynecol.2003.08.011; Nordin NM, 2006, J OBSTET GYNAECOL RE, V32, P107, DOI 10.1111/j.1447-0756.2006.00360.x; Osungbade KO, 2011, J PREGNANCY, V2011, DOI 10.1155/2011/481095; Qiu CF, 2003, HYPERTENSION, V41, P408, DOI 10.1161/01.HYP.0000056996.25503.F5; Ray JG, 2006, BJOG-INT J OBSTET GY, V113, P379, DOI 10.1111/j.1471-0528.2006.00889.x; Reyes LM, 2012, GROWTH FACTORS, V30, P158, DOI 10.3109/08977194.2012.674035; Reyes L, 2012, J OBSTET GYNAECOL RE, V38, P498, DOI 10.1111/j.1447-0756.2011.01763.x; Rost NS, 2001, STROKE, V32, P2575, DOI 10.1161/hs1101.098151; Rueda-Clausen CF, 2008, INT J CARDIOL, V125, P111, DOI 10.1016/j.ijcard.2006.12.092; Saldana TM, 2004, AM J CLIN NUTR, V79, P479; SERMER M, 1995, AM J OBSTET GYNECOL, V173, P146, DOI 10.1016/0002-9378(95)90183-3; Sibai BM, 2003, OBSTET GYNECOL, V102, P181, DOI 10.1016/S0029-7844(03)00475-7; Sierra-Laguado J, 2007, AM J HYPERTENS, V20, P437, DOI 10.1016/j.amjhyper.2006.10.009; Vambergue A, 2002, EUR J OBSTET GYN R B, V102, P31, DOI 10.1016/S0301-2115(01)00556-5; Walker JJ, 2000, LANCET, V356, P1260, DOI 10.1016/S0140-6736(00)02800-2; Wellen KE, 2003, J CLIN INVEST, V112, P1785, DOI 10.1172/JCI20514	44	25	27	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 23	2012	7	7							e41622	10.1371/journal.pone.0041622	http://dx.doi.org/10.1371/journal.pone.0041622			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	977TM	22911827	Green Submitted, gold, Green Published			2022-12-25	WOS:000306687700126
J	Wang, W; Fu, W; Wu, J; Ma, XC; Sun, XL; Huang, Y; Hashimoto, K; Gao, CG				Wang, Wei; Fu, Wei; Wu, Jin; Ma, Xian-cang; Sun, Xue-li; Huang, Yi; Hashimoto, Kenji; Gao, Cheng-ge			Prevalence of PTSD and Depression among Junior Middle School Students in a Rural Town Far from the Epicenter of the Wenchuan Earthquake in China	PLOS ONE			English	Article							POSTTRAUMATIC-STRESS-DISORDER; CHILDRENS REVISED IMPACT; TSUNAMI-AFFECTED AREAS; MENTAL-HEALTH PROBLEMS; EVENT SCALE; ADOLESCENTS; COMORBIDITY; SURVIVORS; SYMPTOMS; VALIDITY	Context: On May12th 2008, a devastating earthquake measuring 8.0 on the Richter scale, struck Wenchuan county and surrounding areas in China. The prevalence of mental illness among children and adolescents in a rural town far from the earthquake epicenter is unknown. Objective: To assess the prevalence of posttraumatic stress disorder (PTSD) and depression among junior middle school students in a rural town Ningqiang county, 327 km from the earthquake epicenter. Design, Setting, and Participants: A population-based mental health survey was conducted in March, 2009. Main Outcome Measure: Survey Self-designed General Condition Survey Scale, Children's Revised Impact of Event Scale (CRIES-13), and the Depression Self-rating Scale for Children (DSRSC) were used to sample 1,841 junior middle school students in Ningqiang county, ten months after the Wenchuan earthquake. Results: The prevalence rate of a high-risk for PTSD was 28.4%, with 32.7% among females, 23.8% among males (female vs. male, p < 0.001), 38.6% in the severe exposure group and 24.3% in the mild exposure group (severe vs. mild exposure, p < 0.001). For depressive symptoms, the overall prevalence was 19.5%, with 24.0% among females, 14.7% among males, 24.5% in the severe exposure group and 17.5% in the mild exposure group (female vs. male, p < 0.001; severe vs. mild exposure, p < 0.001, respectively). In multivariate analysis, factors such as "having felt despair", or "danger" and "having own house destroyed or damaged" were significantly associated with PTSD symptoms. Female gender and delayed evacuation in females, and earthquake related experiences in males were significantly associated with depression. Conclusion: Traumatic events experienced during the earthquake were significantly associated with symptoms of PTSD and depression in children and adolescents, ten months after the Wenchuan earthquake. These data highlight a need for mental health services for children and adolescents in rural areas, far from earthquake epicenters.	[Wang, Wei; Fu, Wei; Ma, Xian-cang; Gao, Cheng-ge] Xi An Jiao Tong Univ, Coll Med, Affiliated Hosp 1, Dept Psychiat, Xian 710049, Peoples R China; [Sun, Xue-li; Huang, Yi] Sichuan Univ, W China Hosp, Mental Hlth Ctr, Chengdu 610064, Peoples R China; [Wu, Jin; Hashimoto, Kenji] Chiba Univ, Ctr Forens Mental Hlth, Div Clin Neurosci, Chiba, Japan	Xi'an Jiaotong University; Sichuan University; Chiba University	Gao, CG (corresponding author), Xi An Jiao Tong Univ, Coll Med, Affiliated Hosp 1, Dept Psychiat, Xian 710049, Peoples R China.	hashimoto@faculty.chiba-u.jp; yaogaow@163.com	Hashimoto, Kenji/I-5800-2015	Hashimoto, Kenji/0000-0002-8892-0439				Ayub M, 2012, CHILD PSYCHIAT HUM D, V43, P323, DOI 10.1007/s10578-011-0267-9; BIRLESON P, 1981, J CHILD PSYCHOL PSYC, V22, P73, DOI 10.1111/j.1469-7610.1981.tb00533.x; Copeland WE, 2007, ARCH GEN PSYCHIAT, V64, P577, DOI 10.1001/archpsyc.64.5.577; Davidson J. R. T., 1993, POSTTRAUMATIC STRESS, P57; Davidson JRT, 2006, J CLIN PSYCHIAT, V67, P9; Davidson JRT, 2004, J NEUROPSYCH CLIN N, V16, P135, DOI 10.1176/appi.neuropsych.16.2.135; Eksi A, 2007, INT J PSYCHIAT CLIN, V11, P190, DOI 10.1080/13651500601017548; Eksi A, 2009, EUR CHILD ADOLES PSY, V18, P384, DOI 10.1007/s00787-009-0745-9; Fan F, 2011, J TRAUMA STRESS, V24, P44, DOI 10.1002/jts.20599; Galea S, 2005, EPIDEMIOL REV, V27, P78, DOI 10.1093/epirev/mxi003; Galea S, 2007, ARCH GEN PSYCHIAT, V64, P1427, DOI 10.1001/archpsyc.64.12.1427; GERSONS BPR, 1992, BRIT J PSYCHIAT, V161, P742, DOI 10.1192/bjp.161.6.742; Giannopoulou I, 2006, EUR PSYCHIAT, V21, P160, DOI 10.1016/j.eurpsy.2005.09.005; Goenjian AK, 2000, AM J PSYCHIAT, V157, P911, DOI 10.1176/appi.ajp.157.6.911; GOENJIAN AK, 1995, J AM ACAD CHILD PSY, V34, P1174, DOI 10.1097/00004583-199509000-00015; Goenjian AK, 2005, AM J PSYCHIAT, V162, P2302, DOI 10.1176/appi.ajp.162.12.2302; Goenjian AK, 2011, J AFFECT DISORDERS, V133, P509, DOI 10.1016/j.jad.2011.04.053; GREEN BL, 1991, J AM ACAD CHILD PSY, V30, P945, DOI 10.1097/00004583-199111000-00012; GREEN BL, 1990, AM J ORTHOPSYCHIAT, V60, P43, DOI 10.1037/h0079168; HAGSTROM R, 1995, J TRAUMA STRESS, V8, P391, DOI 10.1007/BF02102965; HOROWITZ M, 1979, PSYCHOSOM MED, V41, P209, DOI 10.1097/00006842-197905000-00004; Jaycox LH, 2010, J TRAUMA STRESS, V23, P223, DOI 10.1002/jts.20518; Jia ZB, 2010, QUAL LIFE RES, V19, P1381, DOI 10.1007/s11136-010-9703-8; KESSLER RC, 1995, ARCH GEN PSYCHIAT, V52, P1048, DOI 10.1001/archpsyc.1995.03950240066012; Kessler RC, 2003, ARCH GEN PSYCHIAT, V60, P1117, DOI 10.1001/archpsyc.60.11.1117; Kolaitis G, 2003, EUR CHILD ADOLES PSY, V12, P273, DOI 10.1007/s00787-003-0339-x; Li L, 2007, CHINA J HLTH PSYCHOL, V15, P526; Liu MX, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0014706; Liu ZY, 2010, BIOSCI TRENDS, V4, P96; Ma EYM, 2007, EXPLORATORY FACTOR A; Ma XH, 2011, PSYCHIAT RES, V189, P385, DOI [10.1016/j.psychres.2010.12.016, 10.1016/j.psychres.2011.02.016]; Papadatou D, 2012, J TRAUMA STRESS, V25, P57, DOI 10.1002/jts.21656; Perrin S, 2005, BEHAV COGN PSYCHOTH, V33, P487, DOI 10.1017/S1352465805002419; PYNOOS RS, 1993, BRIT J PSYCHIAT, V163, P239, DOI 10.1192/bjp.163.2.239; Quinn KM, 1995, POSTTRAUMATIC STRESS, P85; Smith P, 2003, PERS INDIV DIFFER, V34, P315, DOI 10.1016/S0191-8869(02)00047-8; [苏林雁 Sun Linyan], 2003, [中国心理卫生杂志, Chinese Mental Health Journal], V17, P547; Thienkrua W, 2006, JAMA-J AM MED ASSOC, V296, P549, DOI 10.1001/jama.296.5.549; Tucker P, 2000, J BEHAV HEALTH SER R, V27, P406, DOI 10.1007/BF02287822; Uemoto M, 2012, INT J BEHAV MED, V19, P243, DOI 10.1007/s12529-011-9184-3; van Griensven F, 2006, JAMA-J AM MED ASSOC, V296, P537, DOI 10.1001/jama.296.5.537; Zhang N, 2011, SCAND J PSYCHOL, V52, P236, DOI 10.1111/j.1467-9450.2010.00867.x; Zhang Z, 2011, PSYCHOL MED, V13, P1; Zheng YH, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0029404	44	51	54	0	40	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 23	2012	7	7							e41665	10.1371/journal.pone.0041665	http://dx.doi.org/10.1371/journal.pone.0041665			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	977TM	22911838	Green Published, gold			2022-12-25	WOS:000306687700135
J	Heskes, AM; Goodger, JQD; Tsegay, S; Quach, T; Williams, SJ; Woodrow, IE				Heskes, Allison M.; Goodger, Jason Q. D.; Tsegay, Sammi; Quach, Tim; Williams, Spencer J.; Woodrow, Ian E.			Localization of Oleuropeyl Glucose Esters and a Flavanone to Secretory Cavities of Myrtaceae	PLOS ONE			English	Article							EUCALYPTUS-GLOBULUS; FLAVONOL GLYCOSIDES; GLANDULAR TRICHOMES; PHENOLIC-COMPOUNDS; MASS-SPECTROMETRY; LEAVES; CHEMISTRY; ACID; CYPELLOCARPA; POLYBRACTEA	We report the widespread occurrence of structurally diverse oleuropeyl glucose esters, including the new diester eucaglobulin B, localized specifically to the essential oil secretory cavities of myrtaceous species. Clear taxonomic patterns in the composition of cavity extracts within the genus Eucalyptus are shown with species from subgenus Symphyomyrtus dominated by oleuropeyl glucose esters and species from subgenus Eucalyptus dominated instead by the flavanone, pinocembrin. We also examined the intra-species occurrence of oleuropeyl glucose esters by quantifying the abundant constituents cuniloside B and froggattiside A in trees from two populations of Eucalyptus polybractea R. T. Baker. All trees contained both compounds, which were positively correlated with total essential oil concentration. This apparent ubiquity of oleuropeyl glucose esters at both intra-and inter-specific levels in Eucalyptus is indicative of important physiological or ecological functions. The significance of their prevalence and the sequestration of these esters and also pinocembrin to the extracellular domain of secretory cavities is discussed in light of their potential biological activities and our findings that they are spatially segregated to the exterior of cavity lumina. The localization of oleuropeyl glucose esters to a specific and isolatable tissue type has the potential to aid in future elucidation of function and biosynthesis.	[Heskes, Allison M.; Goodger, Jason Q. D.; Woodrow, Ian E.] Univ Melbourne, Sch Bot, Melbourne, Vic 3010, Australia; [Tsegay, Sammi; Quach, Tim; Williams, Spencer J.] Univ Melbourne, Sch Chem, Melbourne, Vic 3010, Australia; [Tsegay, Sammi; Quach, Tim; Williams, Spencer J.] Univ Melbourne, Mol Sci & Biotechnol Inst Bio21, Melbourne, Vic 3010, Australia	University of Melbourne; University of Melbourne; University of Melbourne	Heskes, AM (corresponding author), Univ Melbourne, Sch Bot, Melbourne, Vic 3010, Australia.	a.heskes@student.unimelb.edu.au	Williams, Spencer/C-3545-2009; Goodger, Jason/B-2779-2013	Williams, Spencer/0000-0001-6341-4364; Goodger, Jason/0000-0001-7392-3891; Heskes, Allison/0000-0002-2732-5185	Holsworth Wildlife Research Endowment; Australian Research Council [DP1094530, LP110100138];  [DP1093356]	Holsworth Wildlife Research Endowment; Australian Research Council(Australian Research Council); 	Allison M. Heskes was supported by the Holsworth Wildlife Research Endowment (managed by ANZ Trustees). Jason Q. D. Goodger and Ian E. Woodrow were supported by the Australian Research Council (Project DP1094530 and LP110100138), and Spencer J. Williams, Sammi Tsegay and Tim Quach (Project DP1093356). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Almeras E, 2003, PLANT J, V34, P202, DOI 10.1046/j.1365-313X.2003.01718.x; BICK IRC, 1972, AUST J CHEM, V25, P449, DOI 10.1071/CH9720449; Boulekbache-Makhlouf L, 2010, J AGR FOOD CHEM, V58, P12615, DOI 10.1021/jf1029509; Brooker MIH, 2000, AUST SYST BOT, V13, P79, DOI 10.1071/SB98008; Cadahia E, 1997, PHYTOCHEM ANALYSIS, V8, P78; Close DC, 2001, AUST J PLANT PHYSIOL, V28, P269, DOI 10.1071/PP00112; Degabriel JL, 2009, ECOLOGY, V90, P711, DOI 10.1890/08-0940.1; Napal GND, 2009, BIORESOURCE TECHNOL, V100, P3669, DOI 10.1016/j.biortech.2009.02.050; Dinkova-Kostova AT, 2001, P NATL ACAD SCI USA, V98, P3404, DOI 10.1073/pnas.051632198; EDWARDS PB, 1993, OECOLOGIA, V95, P551, DOI 10.1007/BF00317440; Eyles A, 2004, TREES-STRUCT FUNCT, V18, P204, DOI 10.1007/s00468-003-0297-4; Eyles A, 2003, FOREST PATHOL, V33, P317, DOI 10.1046/j.1439-0329.2003.00332.x; FAHN A, 1988, NEW PHYTOL, V108, P229, DOI 10.1111/j.1469-8137.1988.tb04159.x; Ghisalberti EL, 1996, PHYTOCHEMISTRY, V41, P7, DOI 10.1016/0031-9422(95)00484-X; Gilles M, 2010, FOOD CHEM, V119, P731, DOI 10.1016/j.foodchem.2009.07.021; Gobbo-Neto L, 2008, RAPID COMMUN MASS SP, V22, P3802, DOI 10.1002/rcm.3802; Goodger JQD, 2007, FOREST ECOL MANAG, V250, P196, DOI 10.1016/j.foreco.2007.05.015; Goodger JQD, 2011, PHYTOCHEMISTRY, V72, P2259, DOI 10.1016/j.phytochem.2011.08.026; Goodger JQD, 2010, PLANT METHODS, V6, DOI 10.1186/1746-4811-6-20; Goodger JQD, 2009, PHYTOCHEMISTRY, V70, P1187, DOI 10.1016/j.phytochem.2009.06.004; Hakki Z, 2010, CARBOHYD RES, V345, P2079, DOI 10.1016/j.carres.2010.07.029; Hanawa F, 2001, PHYTOCHEMISTRY, V57, P223, DOI 10.1016/S0031-9422(00)00514-8; Hasegawa T, 2008, PHYTOCHEMISTRY, V69, P747, DOI 10.1016/j.phytochem.2007.08.030; Henery ML, 2007, NEW PHYTOL, V176, P82, DOI 10.1111/j.1469-8137.2007.02159.x; Heskes AM, 2012, J MICROSC-OXFORD, V247, P33, DOI 10.1111/j.1365-2818.2011.03593.x; Hou AJ, 2000, J ASIAN NAT PROD RES, V2, P205, DOI 10.1080/10286020008039912; HYODO S, 1992, BIOSCI BIOTECH BIOCH, V56, P138, DOI 10.1271/bbb.56.138; Ito H, 2000, J NAT PROD, V63, P1253, DOI 10.1021/np0001981; JUNG JH, 1990, PHYTOCHEMISTRY, V29, P1667, DOI 10.1016/0031-9422(90)80142-4; Kasajima N, 2005, CHEM PHARM BULL, V53, P1345, DOI 10.1248/cpb.53.1345; King DJ, 2004, FUNCT PLANT BIOL, V31, P451, DOI 10.1071/FP03217; Lawler IR, 1999, J CHEM ECOL, V25, P401, DOI 10.1023/A:1020863216892; MANNS D, 1994, PLANTA MED, V60, P467, DOI 10.1055/s-2006-959534; Matsuki M, 2011, J CHEM ECOL, V37, P286, DOI 10.1007/s10886-011-9916-5; Moore BD, 2004, J CHEM ECOL, V30, P1743, DOI 10.1023/B:JOEC.0000042399.06553.c6; Nakanishi T, 2005, CHEM PHARM BULL, V53, P783, DOI 10.1248/cpb.53.783; PROKSCH M, 1985, PHYTOCHEMISTRY, V24, P2889, DOI 10.1016/0031-9422(85)80021-2; RiceEvans CA, 1997, TRENDS PLANT SCI, V2, P152, DOI 10.1016/S1360-1385(97)01018-2; SCARPATI ML, 1966, TETRAHEDRON LETT, P5673; SHAIN L, 1982, PHYTOPATHOLOGY, V72, P877, DOI 10.1094/Phyto-72-877; Tian LW, 2009, J NAT PROD, V72, P1608, DOI 10.1021/np900290s; Turner GW, 2000, PLANT PHYSIOL, V124, P665, DOI 10.1104/pp.124.2.665; WOLLENWEBER E, 1982, PHYTOCHEMISTRY, V21, P1063, DOI 10.1016/S0031-9422(00)82416-4; Yao LH, 2004, J AGR FOOD CHEM, V52, P210, DOI 10.1021/jf034990u; Yuan Y, 2008, J ASIAN NAT PROD RES, V10, P999, DOI 10.1080/10286020802240418	45	25	25	1	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 20	2012	7	7							e40856	10.1371/journal.pone.0040856	http://dx.doi.org/10.1371/journal.pone.0040856			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	977GL	22911712	Green Submitted, Green Published, gold			2022-12-25	WOS:000306644600023
J	Hsu, PH; Miaw, SC; Chuang, CC; Chang, PY; Fu, SJ; Jow, GM; Chiu, MM; Jeng, CJ				Hsu, Po-Hao; Miaw, Shi-Chuen; Chuang, Chau-Ching; Chang, Pei-Yu; Fu, Ssu-Ju; Jow, Guey-Mei; Chiu, Mei-Miao; Jeng, Chung-Jiuan			14-3-3 theta is a Binding Partner of Rat Eag1 Potassium Channels	PLOS ONE			English	Article							PHOSPHORYLATION-INDEPENDENT INTERACTION; DIFFERENTIAL LOCALIZATION; FUNCTIONAL EXPRESSION; PAS DOMAINS; K+ CHANNELS; HUMAN ETHER; PROTEINS; FAMILY; DROSOPHILA; CAMKII	The ether-a-go-go (Eag) potassium (K+) channel belongs to the superfamily of voltage-gated K+ channel. In mammals, the expression of Eag channels is neuron-specific but their neurophysiological role remains obscure. We have applied the yeast two-hybrid screening system to identify rat Eag1 (rEag1)-interacting proteins from a rat brain cDNA library. One of the clones we identified was 14-3-3 theta, which belongs to a family of small acidic protein abundantly expressed in the brain. Data from in vitro yeast two-hybrid and GST pull-down assays suggested that the direct association with 14-3-3 theta was mediated by both the N- and the C-termini of rEag1. Co-precipitation of the two proteins was confirmed in both heterologous HEK293T cells and native hippocampal neurons. Electrophysiological studies showed that over-expression of 14-3-3 theta led to a sizable suppression of rEag1 K+ currents with no apparent alteration of the steady-state voltage dependence and gating kinetics. Furthermore, co-expression with 14-3-3 theta failed to affect the total protein level, membrane trafficking, and single channel conductance of rEag1, implying that 14-3-3 theta binding may render a fraction of the channel locked in a nonconducting state. Together these data suggest that 14-3-3 theta is a binding partner of rEag1 and may modulate the functional expression of the K+ channel in neurons.	[Hsu, Po-Hao; Chuang, Chau-Ching; Chang, Pei-Yu; Fu, Ssu-Ju; Chiu, Mei-Miao; Jeng, Chung-Jiuan] Natl Yang Ming Univ, Inst Anat & Cell Biol, Sch Med, Taipei 112, Taiwan; [Jeng, Chung-Jiuan] Natl Yang Ming Univ, Brain Res Ctr, Taipei 112, Taiwan; [Miaw, Shi-Chuen] Natl Taiwan Univ, Grad Inst Immunol, Coll Med, Taipei 10764, Taiwan; [Jow, Guey-Mei] Fu Jen Catholic Univ, Sch Med, New Taipei City, Taiwan	National Yang Ming Chiao Tung University; National Yang Ming Chiao Tung University; National Taiwan University; Fu Jen Catholic University	Hsu, PH (corresponding author), Natl Yang Ming Univ, Inst Anat & Cell Biol, Sch Med, Taipei 112, Taiwan.	cjjeng@ym.edu.tw		MIAW, SHI-CHUEN/0000-0003-1347-9367	National Science Council, Taiwan [NSC97-2320-B-010-020-MY3]; Aim for the Top University Plan, Ministry of Education, Taiwan	National Science Council, Taiwan(Ministry of Science and Technology, Taiwan); Aim for the Top University Plan, Ministry of Education, Taiwan	This work was supported by research grants from National Science Council, Taiwan (NSC97-2320-B-010-020-MY3) and from the Aim for the Top University Plan, Ministry of Education, Taiwan. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aitken A, 2006, SEMIN CANCER BIOL, V16, P162, DOI 10.1016/j.semcancer.2006.03.005; Alvarez O, 2002, ADV PHYSIOL EDUC, V26, P327, DOI 10.1152/advan.00006.2002; Angrand PO, 2006, MOL CELL PROTEOMICS, V5, P2211, DOI 10.1074/mcp.M600147-MCP200; Brelidze TI, 2012, NATURE, V481, P530, DOI 10.1038/nature10735; Brelidze TI, 2009, J BIOL CHEM, V284, P27989, DOI 10.1074/jbc.M109.016337; Bridges Dave, 2004, Sci STKE, V2004, pre10, DOI 10.1126/stke.2422004re10; Broadie K, 1997, NEURON, V19, P391, DOI 10.1016/S0896-6273(00)80948-4; Chen IH, 2011, J BIOL CHEM, V286, P27183, DOI 10.1074/jbc.M111.233825; Dougherty MK, 2004, J CELL SCI, V117, P1875, DOI 10.1242/jcs.01171; Fernandez E, 2009, MOL SYST BIOL, V5, DOI 10.1038/msb.2009.27; Fink CC, 2002, CURR OPIN NEUROBIOL, V12, P293, DOI 10.1016/S0959-4388(02)00327-6; Frings S, 1998, J GEN PHYSIOL, V111, P583, DOI 10.1085/jgp.111.4.583; Fu HA, 2000, ANNU REV PHARMACOL, V40, P617, DOI 10.1146/annurev.pharmtox.40.1.617; Fuglsang AT, 2003, J BIOL CHEM, V278, P42266, DOI 10.1074/jbc.M306707200; Heusser K, 2006, J CELL SCI, V119, P4353, DOI 10.1242/jcs.03196; Ichimura T, 2005, J BIOL CHEM, V280, P13187, DOI 10.1074/jbc.M412884200; Jagemann LR, 2008, J BIOL CHEM, V283, P17450, DOI 10.1074/jbc.M709185200; Jeng CJ, 2005, NEUROREPORT, V16, P229, DOI 10.1097/00001756-200502280-00005; Jow GM, 2008, NEUROSCI LETT, V431, P12, DOI 10.1016/j.neulet.2007.11.017; Kagan A, 2002, EMBO J, V21, P1889, DOI 10.1093/emboj/21.8.1889; Li Y, 2006, NEURON, V51, P755, DOI 10.1016/j.neuron.2006.08.014; Lisman J, 2002, NAT REV NEUROSCI, V3, P175, DOI 10.1038/nrn753; LIU D, 1995, NATURE, V376, P191, DOI 10.1038/376191a0; Lu CS, 2003, NEURON, V40, P1185, DOI 10.1016/S0896-6273(03)00786-4; Ludwig J, 2000, MOL CELL NEUROSCI, V16, P59, DOI 10.1006/mcne.2000.0851; MACKINNON R, 1991, NATURE, V350, P232, DOI 10.1038/350232a0; Marble DD, 2005, J NEUROSCI, V25, P4898, DOI 10.1523/JNEUROSCI.4566-04.2005; Masters SC, 2001, J BIOL CHEM, V276, P45193, DOI 10.1074/jbc.M105971200; McIntosh BE, 2010, ANNU REV PHYSIOL, V72, P625, DOI 10.1146/annurev-physiol-021909-135922; Naisbitt S, 1999, NEURON, V23, P569, DOI 10.1016/S0896-6273(00)80809-0; Ottmann C, 2007, EMBO J, V26, P902, DOI 10.1038/sj.emboj.7601530; Partch CL, 2010, J CELL PHYSIOL, V223, P553, DOI 10.1002/jcp.22067; Philip N, 2001, J NEUROSCI, V21, P8417, DOI 10.1523/JNEUROSCI.21-21-08417.2001; Piros ET, 1999, J BIOL CHEM, V274, P33677, DOI 10.1074/jbc.274.47.33677; Pulina MV, 2006, J BIOL CHEM, V281, P19645, DOI 10.1074/jbc.M602033200; Rajan S, 2002, J PHYSIOL-LONDON, V545, P13, DOI 10.1113/jphysiol.2002.027052; Saganich MJ, 1999, J NEUROSCI, V19, P10789, DOI 10.1523/JNEUROSCI.19-24-10789.1999; Saganich MJ, 2001, J NEUROSCI, V21, P4609, DOI 10.1523/JNEUROSCI.21-13-04609.2001; Schonherr R, 2000, EMBO J, V19, P3263, DOI 10.1093/emboj/19.13.3263; Stevens L, 2009, EUR BIOPHYS J BIOPHY, V38, P523, DOI 10.1007/s00249-009-0402-8; Sun XX, 2004, J BIOL CHEM, V279, P10206, DOI 10.1074/jbc.M310728200; Taylor BL, 1999, MICROBIOL MOL BIOL R, V63, P479, DOI 10.1128/MMBR.63.2.479-506.1999; Tu JC, 1999, NEURON, V23, P583, DOI 10.1016/S0896-6273(00)80810-7; Tzivion G, 2002, J BIOL CHEM, V277, P3061, DOI 10.1074/jbc.R100059200; van Heusden GPH, 2005, IUBMB LIFE, V57, P623, DOI 10.1080/15216540500252666; Wang Z, 2002, J BIOL CHEM, V277, P24022, DOI 10.1074/jbc.M201949200; WARMKE JW, 1994, P NATL ACAD SCI USA, V91, P3438, DOI 10.1073/pnas.91.8.3438; Xiao Bing, 1995, Nature (London), V376, P188, DOI 10.1038/376188a0; Zagotta WN, 2003, NATURE, V425, P200, DOI 10.1038/nature01922; Ziechner U, 2006, FEBS J, V273, P1074, DOI 10.1111/j.1742-4658.2006.05134.x	50	12	12	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 20	2012	7	7							e41203	10.1371/journal.pone.0041203	http://dx.doi.org/10.1371/journal.pone.0041203			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	977GL	22911758	Green Published, gold, Green Submitted			2022-12-25	WOS:000306644600054
J	Joseph, MS; Ying, Z; Zhuang, YM; Zhong, H; Wu, AG; Bhatia, HS; Cruz, R; Tillakaratne, NJK; Roy, RR; Edgerton, VR; Gomez-Pinilla, F				Joseph, M. Selvan; Ying, Zhe; Zhuang, Yumei; Zhong, Hui; Wu, Aiguo; Bhatia, Harsharan S.; Cruz, Rusvelda; Tillakaratne, Niranjala J. K.; Roy, Roland R.; Edgerton, V. Reggie; Gomez-Pinilla, Fernando			Effects of Diet and/or Exercise in Enhancing Spinal Cord Sensorimotor Learning	PLOS ONE			English	Article							TRAUMATIC BRAIN-INJURY; SATURATED-FAT DIET; DOCOSAHEXAENOIC ACID; SYNAPTIC PLASTICITY; NEUROTROPHIC FACTOR; OXIDATIVE STRESS; MEMBRANE HOMEOSTASIS; BDNF; RECOVERY; RATS	Given that the spinal cord is capable of learning sensorimotor tasks and that dietary interventions can influence learning involving supraspinal centers, we asked whether the presence of omega-3 fatty acid docosahexaenoic acid (DHA) and the curry spice curcumin (Cur) by themselves or in combination with voluntary exercise could affect spinal cord learning in adult spinal mice. Using an instrumental learning paradigm to assess spinal learning we observed that mice fed a diet containing DHA/Cur performed better in the spinal learning paradigm than mice fed a diet deficient in DHA/Cur. The enhanced performance was accompanied by increases in the mRNA levels of molecular markers of learning, i.e., BDNF, CREB, CaMKII, and syntaxin 3. Concurrent exposure to exercise was complementary to the dietary treatment effects on spinal learning. The diet containing DHA/Cur resulted in higher levels of DHA and lower levels of omega-6 fatty acid arachidonic acid (AA) in the spinal cord than the diet deficient in DHA/Cur. The level of spinal learning was inversely related to the ratio of AA: DHA. These results emphasize the capacity of select dietary factors and exercise to foster spinal cord learning. Given the non-invasiveness and safety of the modulation of diet and exercise, these interventions should be considered in light of their potential to enhance relearning of sensorimotor tasks during rehabilitative training paradigms after a spinal cord injury.	[Joseph, M. Selvan; Ying, Zhe; Wu, Aiguo; Bhatia, Harsharan S.; Cruz, Rusvelda; Tillakaratne, Niranjala J. K.; Roy, Roland R.; Edgerton, V. Reggie; Gomez-Pinilla, Fernando] Univ Calif Los Angeles, Dept Integrat Biol & Physiol, Los Angeles, CA 90095 USA; [Edgerton, V. Reggie] Univ Calif Los Angeles, Dept Neurobiol, Los Angeles, CA USA; [Zhuang, Yumei; Edgerton, V. Reggie; Gomez-Pinilla, Fernando] Univ Calif Los Angeles, Dept Neurosurg, Los Angeles, CA USA; [Gomez-Pinilla, Fernando] Univ Calif Los Angeles, UCLA Brain Injury Res Ctr, Los Angeles, CA USA; [Zhong, Hui; Tillakaratne, Niranjala J. K.; Roy, Roland R.; Edgerton, V. Reggie; Gomez-Pinilla, Fernando] Univ Calif Los Angeles, Brain Res Inst, Los Angeles, CA 90024 USA	University of California System; University of California Los Angeles; University of California System; University of California Los Angeles; University of California System; University of California Los Angeles; University of California System; University of California Los Angeles; University of California System; University of California Los Angeles	Joseph, MS (corresponding author), Univ Calif Los Angeles, Dept Integrat Biol & Physiol, Los Angeles, CA 90095 USA.	fgomezpi@ucla.edu	Bhatia, Harsharan singh/AAR-4628-2021	Bhatia, Harsharan Singh/0000-0001-9912-8263; Joseph, Michael Selvan/0000-0002-0620-9249	National Institutes of Health [R01 NS056413, NS056413, R01 NS050465]; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS050465, R01NS056413] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This research was supported by the National Institutes of Health R01 NS056413, Diversity Supplement NS056413, and R01 NS050465. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abe T, 2008, CURR OPIN PHARMACOL, V8, P57, DOI 10.1016/j.coph.2007.12.002; Adelson PD, 1997, J NEUROTRAUM, V14, P99, DOI 10.1089/neu.1997.14.99; Alberini CM, 1999, J EXP BIOL, V202, P2887; Ansari MA, 2008, FREE RADICAL BIO MED, V45, P443, DOI 10.1016/j.freeradbiomed.2008.04.038; ARAUJO DM, 1989, BRAIN RES, V484, P130, DOI 10.1016/0006-8993(89)90355-7; Baumbauer KM, 2009, J NEUROSCI, V29, P14383, DOI 10.1523/JNEUROSCI.3583-09.2009; Bhatia HS, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0028451; Blanquet PR, 2003, NEUROSCIENCE, V118, P477, DOI 10.1016/S0306-4522(02)00963-6; Chung WL, 2008, J NUTR, V138, P1165, DOI 10.1093/jn/138.6.1165; Chytrova G, 2010, BRAIN RES, V1341, P32, DOI 10.1016/j.brainres.2009.05.018; Cole Greg M., 2006, Nutrition and Health (Bicester), V18, P249; Cole GM, 2007, ADV EXP MED BIOL, V595, P197; Courtine G, 2008, NAT MED, V14, P69, DOI 10.1038/nm1682; Courtine G, 2009, NAT NEUROSCI, V12, P1333, DOI 10.1038/nn.2401; Curtis LB, 2008, J COMP NEUROL, V510, P550, DOI 10.1002/cne.21806; de Leon RD, 1998, J NEUROPHYSIOL, V79, P1329, DOI 10.1152/jn.1998.79.3.1329; de Leon RD, 1998, J NEUROPHYSIOL, V80, P83; DELEON R, 1994, BRAIN RES, V654, P241, DOI 10.1016/0006-8993(94)90485-5; Edgerton VE, 2009, ENCY NEUROSCIENCE, P629; Edgerton VR, 2001, J PHYSIOL-LONDON, V533, P15, DOI 10.1111/j.1469-7793.2001.0015b.x; Engesser-Cesar C, 2005, J NEUROTRAUM, V22, P157, DOI 10.1089/neu.2005.22.157; Engesser-Cesar C, 2007, EUR J NEUROSCI, V25, P1931, DOI 10.1111/j.1460-9568.2007.05469.x; Figueroa JD, 2012, J NEUROTRAUM, V29, P551, DOI 10.1089/neu.2011.2141; Finkbeiner S, 2000, NEURON, V25, P11, DOI 10.1016/S0896-6273(00)80866-1; FORSSBERG H, 1980, ACTA PHYSIOL SCAND, V108, P283, DOI 10.1111/j.1748-1716.1980.tb06534.x; FORSSBERG H, 1980, ACTA PHYSIOL SCAND, V108, P269, DOI 10.1111/j.1748-1716.1980.tb06533.x; Fujita S, 2001, BRIT J PHARMACOL, V132, P1417, DOI 10.1038/sj.bjp.0703970; Gomez-Pinilla F, 2007, NEUROSCIENCE, V148, P893, DOI 10.1016/j.neuroscience.2007.05.051; Gomez-Pinilla F, 2010, NEUROSCIENCE, V168, P130, DOI 10.1016/j.neuroscience.2010.02.070; Gomez-Pinilla F, 2008, NAT REV NEUROSCI, V9, P568, DOI 10.1038/nrn2421; Gomez-Pinilla F, 2011, PREV MED, V52, pS75, DOI 10.1016/j.ypmed.2011.01.023; Grau James W, 2006, Behav Cogn Neurosci Rev, V5, P191, DOI 10.1177/1534582306289738; Grau JW, 1998, BEHAV NEUROSCI, V112, P1366, DOI 10.1037/0735-7044.112.6.1366; Greiner RS, 1999, LIPIDS, V34, pS239, DOI 10.1007/BF02562305; Harkema S. J., 2011, ARCH PHYS MED REHABI; Harkema SJ, 1997, J NEUROPHYSIOL, V77, P797, DOI 10.1152/jn.1997.77.2.797; Hashimoto M, 2006, CLIN EXP PHARMACOL P, V33, P934, DOI 10.1111/j.1440-1681.2006.04467.x; HORRIDGE G. A., 1962, NATURE, V193, P697, DOI 10.1038/193697a0; Huang WL, 2007, BRAIN, V130, P3004, DOI 10.1093/brain/awm223; Huie JR, 2012, NEUROSCIENCE, V200, P74, DOI 10.1016/j.neuroscience.2011.10.028; Igarashi M, 2011, J NEUROCHEM; Igarashi M., 2011, BIOCH BIOPHYS ACTA; Jindrich DL, 2009, J NEUROSCI METH, V182, P250, DOI 10.1016/j.jneumeth.2009.06.001; Jump DB, 2002, CURR OPIN LIPIDOL, V13, P155, DOI 10.1097/00041433-200204000-00007; Kawakita E, 2006, NEUROSCIENCE, V139, P991, DOI 10.1016/j.neuroscience.2006.01.021; Keeler BE, 2012, BRAIN RES, V1438, P8, DOI 10.1016/j.brainres.2011.12.015; Kida S, 2002, NAT NEUROSCI, V5, P348, DOI 10.1038/nn819; King VR, 2006, J NEUROSCI, V26, P4672, DOI 10.1523/JNEUROSCI.5539-05.2006; Lim SY, 2001, J NUTR, V131, P319, DOI 10.1093/jn/131.2.319; Liu YB, 2008, J NEUROCHEM, V105, P1336, DOI 10.1111/j.1471-4159.2008.05236.x; Ma D, 2008, HIPPOCAMPUS, V18, P326, DOI 10.1002/hipo.20393; Ma DX, 2010, BRAIN RES, V1330, P1, DOI 10.1016/j.brainres.2010.03.002; Maher P, 2010, NEUROBIOL AGING, V31, P706, DOI 10.1016/j.neurobiolaging.2008.05.020; Marini AM, 2008, CNS NEUROL DISORD-DR, V7, P382, DOI 10.2174/187152708786441849; MCMAHON HT, 1995, J BIOL CHEM, V270, P2213, DOI 10.1074/jbc.270.5.2213; Mendell LM, 2001, J PHYSIOL-LONDON, V533, P91, DOI 10.1111/j.1469-7793.2001.0091b.x; Mizuno M, 2002, BEHAV BRAIN RES, V133, P135, DOI 10.1016/S0166-4328(01)00470-3; Molteni R, 2002, NEUROSCIENCE, V112, P803, DOI 10.1016/S0306-4522(02)00123-9; Patterson SL, 1996, NEURON, V16, P1137, DOI 10.1016/S0896-6273(00)80140-3; Pereira AC, 2007, P NATL ACAD SCI USA, V104, P5638, DOI 10.1073/pnas.0611721104; Rao JS, 2007, MOL PSYCHIATR, V12, P36, DOI 10.1038/sj.mp.4001888; Rodger J, 1998, J NEUROCHEM, V71, P666; Rongo C, 2002, BIOESSAYS, V24, P223, DOI 10.1002/bies.10057; ROY RR, 1992, LAB ANIM SCI, V42, P335; Salem N, 2001, LIPIDS, V36, P945, DOI 10.1007/s11745-001-0805-6; Shah Prithvi K, 2012, Eur J Neurosci, V36, P2054, DOI 10.1111/j.1460-9568.2012.08106.x; Sharma S, 2009, NEUROSCIENCE, V161, P1037, DOI 10.1016/j.neuroscience.2009.04.042; Sharma S, 2010, EXP NEUROL, V226, P191, DOI 10.1016/j.expneurol.2010.08.027; Silva AJ, 1998, ANNU REV NEUROSCI, V21, P127, DOI 10.1146/annurev.neuro.21.1.127; Skup M, 2002, EXP NEUROL, V176, P289, DOI 10.1006/exnr.2002.7943; Suganuma H, 2010, NEUROPATHOLOGY, V30, P597, DOI 10.1111/j.1440-1789.2010.01114.x; Tanaka JI, 2008, SCIENCE, V319, P1683, DOI 10.1126/science.1152864; Teague WE, 2002, CELL MOL BIOL LETT, V7, P262; Tillakaratne NJK, 2010, NEUROSCIENCE, V166, P23, DOI 10.1016/j.neuroscience.2009.12.010; van den Brand R, 2012, SCIENCE, V336, P1182, DOI 10.1126/science.1217416; Vaynman S, 2004, EUR J NEUROSCI, V20, P2580, DOI 10.1111/j.1460-9568.2004.03720.x; Wu A, 2008, NEUROSCIENCE, V155, P751, DOI 10.1016/j.neuroscience.2008.05.061; Wu A, 2004, J NEUROTRAUM, V21, P1457, DOI 10.1089/neu.2004.21.1457; Wu A, 2003, NEUROSCIENCE, V119, P365, DOI 10.1016/S0306-4522(03)00154-4; Wu AG, 2006, EXP NEUROL, V197, P309, DOI 10.1016/j.expneurol.2005.09.004; Wu AG, 2004, EUR J NEUROSCI, V19, P1699, DOI 10.1111/j.1460-9568.2004.03246.x; Wu AG, 2011, J NEUROTRAUM, V28, P2113, DOI 10.1089/neu.2011.1872; Wu AG, 2011, NEUROREHAB NEURAL RE, V25, P332, DOI 10.1177/1545968310397706; Yamashima T, 2008, PROG NEUROBIOL, V84, P105, DOI 10.1016/j.pneurobio.2007.11.002; Ying Z, 2008, NEUROSCIENCE, V155, P1070, DOI 10.1016/j.neuroscience.2008.06.057; Ying Z, 2003, BRAIN RES, V987, P93, DOI 10.1016/S0006-8993(03)03258-X; Zhong H, 2012, FRONT PHYSIOL, V3, DOI 10.3389/fphys.2012.00112	87	14	15	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 20	2012	7	7							e41288	10.1371/journal.pone.0041288	http://dx.doi.org/10.1371/journal.pone.0041288			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	977GL	22911773	Green Published, gold, Green Submitted			2022-12-25	WOS:000306644600067
J	Xu, PX; Garczynski, SF; Atungulu, E; Syed, Z; Choo, YM; Vidal, DM; Zitelli, CHL; Leal, WS				Xu, Pingxi; Garczynski, Stephen F.; Atungulu, Elizabeth; Syed, Zainulabeuddin; Choo, Young-Moo; Vidal, Diogo M.; Zitelli, Caio H. L.; Leal, Walter S.			Moth Sex Pheromone Receptors and Deceitful Parapheromones	PLOS ONE			English	Article							NAVEL ORANGEWORM LEPIDOPTERA; ANTHERAEA-PERNYI; IDENTIFICATION; HELIOTHIS; COMMUNICATION; COMPONENTS; SENSILLA; ANTENNAE	The insect's olfactory system is so selective that male moths, for example, can discriminate female-produced sex pheromones from compounds with minimal structural modifications. Yet, there is an exception for this "lock-and-key'' tight selectivity. Formate analogs can be used as replacement for less chemically stable, long-chain aldehyde pheromones, because male moths respond physiologically and behaviorally to these parapheromones. However, it remained hitherto unknown how formate analogs interact with aldehyde-sensitive odorant receptors (ORs). Neuronal responses to semiochemicals were investigated with single sensillum recordings. Odorant receptors (ORs) were cloned using degenerate primers, and tested with the Xenopus oocyte expression system. Quality, relative quantity, and purity of samples were evaluated by gas chromatography and gas chromatography-mass spectrometry. We identified olfactory receptor neurons (ORNs) housed in trichoid sensilla on the antennae of male navel orangeworm that responded equally to the main constituent of the sex pheromone, (11Z,13Z)-hexadecadienal (Z11Z13-16Ald), and its formate analog, (9Z,11Z)-tetradecen-1-yl formate (Z9Z11-14OFor). We cloned an odorant receptor co-receptor (Orco) and aldehyde-sensitive ORs from the navel orangeworm, one of which (AtraOR1) was expressed specifically in male antennae. AtraOR1 center dot AtraOrco-expressing oocytes responded mainly to Z11Z13-16Ald, with moderate sensitivity to another component of the sex pheromone, (11Z,13Z)-hexadecadien-1-ol. Surprisingly, this receptor was more sensitive to the related formate than to the natural sex pheromone. A pheromone receptor from Heliothis virescens, HR13 (=HvirOR13) showed a similar profile, with stronger responses elicited by a formate analog than to the natural sex pheromone, (11Z)-hexadecenal thus suggesting this might be a common feature of moth pheromone receptors.	[Xu, Pingxi; Atungulu, Elizabeth; Syed, Zainulabeuddin; Choo, Young-Moo; Vidal, Diogo M.; Zitelli, Caio H. L.; Leal, Walter S.] Univ Calif Davis, Honorary Maeda Duffey Lab, Davis, CA 95616 USA; [Garczynski, Stephen F.] USDA ARS, Yakima Agr Res Lab, Wapato, WA USA	University of California System; University of California Davis; United States Department of Agriculture (USDA)	Xu, PX (corresponding author), Univ Calif Davis, Honorary Maeda Duffey Lab, Davis, CA 95616 USA.	wsleal@ucdavis.edu	Vidal, Diogo M/G-4262-2011; Leal, Walter/ABC-6940-2021; Vidal, Diogo/P-5151-2019; syed, zainulabeuddin/L-4961-2016	Vidal, Diogo M/0000-0002-1157-4179; Vidal, Diogo/0000-0002-1157-4179; syed, zainulabeuddin/0000-0002-6235-7115; Leal Filho, Walter/0000-0002-1241-5225; Lopes Zitelli, Caio Henrique/0000-0002-5109-1470; Leal, Walter/0000-0002-6800-1240	National Science Foundation [0918177]; AFRI competitive from USDA-NIFA [2010-65105-20582]; National Institutes of Health [1R01AI095514-01A1]; NRI grant from USDA-NIFA [2008-35302-18839]; Washington Tree Fruit Commission; CAPES; Direct For Biological Sciences [0918177] Funding Source: National Science Foundation; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI095514] Funding Source: NIH RePORTER	National Science Foundation(National Science Foundation (NSF)); AFRI competitive from USDA-NIFA; National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NRI grant from USDA-NIFA; Washington Tree Fruit Commission; CAPES(Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES)); Direct For Biological Sciences(National Science Foundation (NSF)NSF - Directorate for Biological Sciences (BIO)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported in part by National Science Foundation grant 0918177, AFRI competitive grant 2010-65105-20582 from USDA-NIFA, and National Institutes of Health, 1R01AI095514-01A1 to W.S.L. S.F.G. was supported by NRI grant 2008-35302-18839 from USDA-NIFA and grants from the Washington Tree Fruit Commission. D.M.V. and C.H.L.Z. were supported by CAPES undergraduate scholarship. The funders played no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Baker TC, 2009, INTEGRATED PEST MANAGEMENT: CONCEPTS, TACTICS, STRATEGIES AND CASE STUDIES, P273; Boeckh J., 1960, Zoologische Jahrbuecher Jena Anatomie, V78, P559; Carde R. T., 2007, P122, DOI 10.1017/CBO9780511752353.006; COFFELT JA, 1979, J CHEM ECOL, V5, P955, DOI 10.1007/BF00990218; Forstner Maike, 2009, Int J Biol Sci, V5, P745; Garczynski SF, 2012, INSECT SCI, V19, P64, DOI 10.1111/j.1744-7917.2011.01423.x; GRANT AJ, 1989, J CHEM ECOL, V15, P2625, DOI 10.1007/BF01014721; Grosse-Wilde E, 2007, EUR J NEUROSCI, V25, P2364, DOI 10.1111/j.1460-9568.2007.05512.x; HUMMEL HE, 1973, SCIENCE, V181, P873, DOI 10.1126/science.181.4102.873; KAISSLIN.KE, 1970, NATURWISSENSCHAFTEN, V57, P23, DOI 10.1007/BF00593550; KAISSLING KE, 1987, WRIGHT LECT INSECT O; Kanno H, 2010, J CHEM ECOL, V36, P584, DOI 10.1007/s10886-010-9799-x; KEIL TA, 1984, ZOOMORPHOLOGY, V104, P147, DOI 10.1007/BF00312133; Kuenen LPS, 2010, J ECON ENTOMOL, V103, P314, DOI 10.1603/EC09177; LANDOLT PJ, 1982, J ECON ENTOMOL, V75, P547, DOI 10.1093/jee/75.3.547; Leal WS, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007235; Leal WS, 2005, P NATL ACAD SCI USA, V102, P5386, DOI 10.1073/pnas.0501447102; Leal WS, 2005, NATURWISSENSCHAFTEN, V92, P139, DOI 10.1007/s00114-004-0598-5; LIMAN ER, 1992, NEURON, V9, P861, DOI 10.1016/0896-6273(92)90239-A; McLaughlin JR, 1972, ENVIRON ENTOMOL, V62, P1520; MENG LZ, 1989, J COMP PHYSIOL A, V165, P139, DOI 10.1007/BF00619188; MITCHELL ER, 1975, ENVIRON ENTOMOL, V4, P577, DOI 10.1093/ee/4.4.577; Mitsuno H, 2008, EUR J NEUROSCI, V28, P893, DOI 10.1111/j.1460-9568.2008.06429.x; Renou M, 2000, ANNU REV ENTOMOL, V45, P605, DOI 10.1146/annurev.ento.45.1.605; SHOREY HH, 1974, J ECON ENTOMOL, V67, P347, DOI 10.1093/jee/67.3.347; Syed Z, 2011, JOVE-J VIS EXP, DOI 10.3791/2489; TODD JL, 1992, J CHEM ECOL, V18, P2331, DOI 10.1007/BF00984953; Vosshall LB, 2011, CHEM SENSES, V36, P497, DOI 10.1093/chemse/bjr022; Wang G, 2011, INSECT MOL BIOL, V20, P125, DOI 10.1111/j.1365-2583.2010.01045.x; Wanner KW, 2007, P NATL ACAD SCI USA, V104, P14383, DOI 10.1073/pnas.0705459104	30	29	33	0	38	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 20	2012	7	7							e41653	10.1371/journal.pone.0041653	http://dx.doi.org/10.1371/journal.pone.0041653			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	977GL	22911835	gold, Green Published			2022-12-25	WOS:000306644600088
J	Kim, SJ; Lee, Y; Kim, NY; Hwang, Y; Hwang, B; Min, JK; Koh, SS				Kim, S. J.; Lee, Y.; Kim, N. Y.; Hwang, Y.; Hwang, B.; Min, J-K; Koh, S. S.			Pancreatic adenocarcinoma upregulated factor, a novel endothelial activator, promotes angiogenesis and vascular permeability	ONCOGENE			English	Article						PAUF; angiogenesis; vascular permeability; CXCR4	GROWTH-FACTOR; HIGH EXPRESSION; POOR-PROGNOSIS; CANCER CELLS; VE-CADHERIN; IN-VITRO; METASTASIS; PAUF; CONSEQUENCES; JUNCTIONS	Pancreatic adenocarcinoma upregulated factor (PAUF) was recently reported to be a metastasis factor for pancreatic cancer cells. Here, we demonstrate a novel role for PAUF as a potent endothelial activator, promoting both angiogenesis and vascular permeability. Overexpression of PAUF in a mouse pancreatic cancer model resulted in increased tumor vascularity. Recombinant PAUF (rPAUF) enhanced proliferation, migration and capillary-like tube formation of human endothelial cells (ECs), consistently with increased neovascularization in vivo. rPAUF also increased endothelial permeability through the disruption of vascular endothelial-cadherin-facilitated cell-cell junctions in vitro and induced vascular leakage in mouse skin. These effects were attenuated upon treatment with an antibody against PAUF. Moreover, PAUF evoked a time-and dose-dependent activation of extracellular signal-regulated kinase (ERK) 1/2, AKT and endothelial NO synthase (eNOS) in ECs, which are closely linked to rPAUF-induced angiogenesis. Finally, rPAUF upregulated the expression of C-X-C chemokine receptor 4 (CXCR4) in ECs and potentiated the in vitro and in vivo EC angiogenic responses to stromal cell-derived factor-1 (SDF-1), a ligand for CXCR4. Taken together, these data demonstrate that PAUF has a novel function in promoting angiogenesis and vascular permeability. Our findings suggest new possibilities for PAUF's role in the pathogenesis of angiogenesis-dependent diseases.	[Kim, S. J.; Lee, Y.; Kim, N. Y.; Hwang, Y.; Hwang, B.; Min, J-K; Koh, S. S.] Korea Res Inst Biosci & Biotechnol, Immunotherapy Res Ctr, Taejon 305806, South Korea; [Kim, S. J.; Kim, N. Y.; Hwang, Y.; Koh, S. S.] Univ Sci & Technol, Dept Funct Genom, Taejon, South Korea; [Hwang, Y.; Hwang, B.] Univ Sci & Technol, Dept Biomol Sci, Taejon, South Korea	Korea Research Institute of Bioscience & Biotechnology (KRIBB)	Min, JK (corresponding author), Korea Res Inst Biosci & Biotechnol, Immunotherapy Res Ctr, 125 Gwahak Ro, Taejon 305806, South Korea.	jekmin@kribb.re.kr; sskoh@kribb.re.kr		Min, Jeong-Ki/0000-0003-4924-8739	National Research Foundation of Korea [2011-0015073, 2011-0016309]; Ministry of Education, Science and Technology; Inno-Project of the Korea Research Institute of Bioscience and Biotechnology; Korea Research Council of Fundamental Science and Technology (National Agenda Project)	National Research Foundation of Korea(National Research Foundation of Korea); Ministry of Education, Science and Technology(Ministry of Education, Science & Technology (MEST), Republic of Korea); Inno-Project of the Korea Research Institute of Bioscience and Biotechnology; Korea Research Council of Fundamental Science and Technology (National Agenda Project)	This work was supported by grants from the National Research Foundation of Korea (2011-0015073 and 2011-0016309), funded by the Ministry of Education, Science and Technology and a grant from the Inno-Project of the Korea Research Institute of Bioscience and Biotechnology and a grant from the Korea Research Council of Fundamental Science and Technology (National Agenda Project).	Akira S, 2004, NAT REV IMMUNOL, V4, P499, DOI 10.1038/nri1391; Alagappan VKT, 2005, CELL BIOCHEM BIOPHYS, V43, P119, DOI 10.1385/CBB:43:1:119; Bazzoni G, 2004, PHYSIOL REV, V84, P869, DOI 10.1152/physrev.00035.2003; Bergers G, 2003, NAT REV CANCER, V3, P401, DOI 10.1038/nrc1093; Carmeliet P, 2000, NATURE, V407, P249, DOI 10.1038/35025220; Cui K, 2011, J SURG RES, V171, P143, DOI 10.1016/j.jss.2010.03.001; Dejana E, 2008, J CELL SCI, V121, P2115, DOI 10.1242/jcs.017897; Dvorak HF, 2002, J CLIN ONCOL, V20, P4368, DOI 10.1200/JCO.2002.10.088; Esser S, 1998, J CELL SCI, V111, P1853; Ferrara N, 2005, NATURE, V438, P967, DOI 10.1038/nature04483; Fukumura D, 1997, AM J PATHOL, V150, P713; Grote K, 2010, BLOOD, V115, P2543, DOI 10.1182/blood-2009-05-224402; Hordijk PL, 1999, J CELL SCI, V112, P1915; Ikeda N, 1999, BRIT J CANCER, V79, P1553, DOI 10.1038/sj.bjc.6690248; Itakura J, 1997, CLIN CANCER RES, V3, P1309; Jia ZL, 2007, CANCER RES, V67, P4878, DOI 10.1158/0008-5472.CAN-06-3494; Kanagawa M, 2011, BIOCHEM BIOPH RES CO, V404, P201, DOI 10.1016/j.bbrc.2010.11.093; Kim SA, 2009, CANCER SCI, V100, P828, DOI 10.1111/j.1349-7006.2009.01106.x; Korc M, 1998, Surg Oncol Clin N Am, V7, P25; Korc M, 2003, MOL CANCER, V2, P1; Kryczek I, 2005, AM J REPROD IMMUNOL, V54, P270, DOI 10.1111/j.1600-0897.2005.00307.x; Lee Y, 2010, ONCOGENE, V29, P56, DOI 10.1038/onc.2009.298; Lee Y, 2011, EXP MOL MED, V43, P291, DOI 10.3858/emm.2011.43.5.030; Marin V, 2001, J IMMUNOL METHODS, V254, P183, DOI 10.1016/S0022-1759(01)00408-2; Mirshahi F, 2000, THROMB RES, V99, P587, DOI 10.1016/S0049-3848(00)00292-9; Nagy JA, 2007, ANNU REV PATHOL-MECH, V2, P251, DOI 10.1146/annurev.pathol.2.010506.134925; Niedergethmann M, 2002, PANCREAS, V25, P122, DOI 10.1097/00006676-200208000-00002; Park HD, 2011, ONCOGENE, V30, P201, DOI 10.1038/onc.2010.401; Petit I, 2007, TRENDS IMMUNOL, V28, P299, DOI 10.1016/j.it.2007.05.007; Pyun BJ, 2008, CANCER RES, V68, P227, DOI 10.1158/0008-5472.CAN-07-2799; Seo Y, 2000, CANCER, V88, P2239, DOI 10.1002/(SICI)1097-0142(20000515)88:10<2239::AID-CNCR6>3.0.CO;2-V; Steeg PS, 2006, NAT MED, V12, P895, DOI 10.1038/nm1469; Thurston G, 2000, NAT MED, V6, P460, DOI 10.1038/74725; Voronov E, 2003, P NATL ACAD SCI USA, V100, P2645, DOI 10.1073/pnas.0437939100; Wang Z, 2008, BRIT J CANCER, V99, P1695, DOI 10.1038/sj.bjc.6604745; Weis SM, 2005, NATURE, V437, P497, DOI 10.1038/nature03987; West XZ, 2010, NATURE, V467, P972, DOI 10.1038/nature09421; Whipple C, 2008, LANGENBECK ARCH SURG, V393, P901, DOI 10.1007/s00423-008-0280-z; Wong HH, 2009, NAT REV GASTRO HEPAT, V6, P412, DOI 10.1038/nrgastro.2009.89; Wright TJ, 2002, EXP CELL RES, V280, P159, DOI 10.1006/excr.2002.5636; Xie KP, 2006, CYTOKINE GROWTH F R, V17, P147, DOI 10.1016/j.cytogfr.2006.01.002; Zetter BR, 1998, ANNU REV MED, V49, P407, DOI 10.1146/annurev.med.49.1.407	42	31	33	0	4	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	AUG 1	2013	32	31					3638	3647		10.1038/onc.2012.366	http://dx.doi.org/10.1038/onc.2012.366			10	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	194MW	22907431				2022-12-25	WOS:000322638400008
J	Freeman, LR; Zhang, L; Dasuri, K; Fernandez-Kim, SO; Bruce-Keller, AJ; Keller, JN				Freeman, Linnea R.; Zhang, Le; Dasuri, Kalavathi; Fernandez-Kim, Sun-Ok; Bruce-Keller, Annadora J.; Keller, Jeffrey N.			Mutant Amyloid Precursor Protein Differentially Alters Adipose Biology under Obesogenic and Non-Obesogenic Conditions	PLOS ONE			English	Article							TRANSGENIC MOUSE MODEL; ALZHEIMERS-DISEASE; A-BETA; INSULIN-RESISTANCE; TRANSCRIPTIONAL REGULATION; METABOLIC SYNDROME; LEPTIN PROMOTER; SKELETAL-MUSCLE; GENE-EXPRESSION; ADIPOCYTE SIZE	Mutations in amyloid precursor protein (APP) have been most intensely studied in brain tissue for their link to Alzheimer's disease (AD) pathology. However, APP is highly expressed in a variety of tissues including adipose tissue, where APP is also known to exhibit increased expression in response to obesity. In our current study, we analyzed the effects of mutant APP (E693Q, D694N, K670N/M671L) expression toward multiple aspects of adipose tissue homeostasis. These data reveal significant hypoleptinemia, decreased adiposity, and reduced adipocyte size in response to mutant APP, and this was fully reversed upon high fat diet administration. Additionally, mutant APP was observed to significantly exacerbate insulin resistance, triglyceride elevations, and macrophage infiltration of adipose tissue in response to a high fat diet. Taken together, these data have significant implications for linking mutant APP expression to adipose tissue dysfunction and global changes in endocrine and metabolic function under both obesogenic and non-obesogenic conditions.	[Freeman, Linnea R.; Zhang, Le; Dasuri, Kalavathi; Fernandez-Kim, Sun-Ok; Bruce-Keller, Annadora J.; Keller, Jeffrey N.] Pennington Biomed Res Ctr LSU Syst, Baton Rouge, LA USA		Freeman, LR (corresponding author), Pennington Biomed Res Ctr LSU Syst, Baton Rouge, LA USA.	Jeffrey.Keller@pbrc.edu	DASURI, KALAVATHI/E-7381-2012; Bruce-Keller, Annadora/N-1954-2017; Keller, Jeffrey N/N-1975-2017	keller, jeffrey/0000-0002-9892-7423	COBRE (National Institutes of Health [NIH] [2P20-RR021945)]; NORC center grants from the NIH [NIH 2P30-DK072476]; Pennington Animal Metabolism and Behavior Core; Hibernia National Bank/Edward G Schleider Chair; NATIONAL CENTER FOR RESEARCH RESOURCES [P20RR021945] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P30DK072476] Funding Source: NIH RePORTER	COBRE (National Institutes of Health [NIH]; NORC center grants from the NIH; Pennington Animal Metabolism and Behavior Core; Hibernia National Bank/Edward G Schleider Chair; NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work utilized the facilities of the Cell Biology and Bioimaging Core that are supported in part by COBRE (National Institutes of Health [NIH] 2P20-RR021945) and NORC (NIH 2P30-DK072476) center grants from the NIH, the Pennington Animal Metabolism and Behavior Core, and funds from the Hibernia National Bank/Edward G Schleider Chair (JNK). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahima RS, 2006, OBESITY, V14, P242, DOI 10.1038/oby.2006.317; Garcia-Lara JMA, 2010, REV INVEST CLIN, V62, P343; BEER J, 1995, NEURODEGENERATION, V4, P51, DOI 10.1006/neur.1995.0006; Boncompagni S, 2012, J BIOL CHEM, V287, P20534, DOI 10.1074/jbc.M112.359588; Bradley JS, 2009, BIOFACTORS, V35, P258, DOI 10.1002/biof.41; Bullo M, 2007, PUBLIC HEALTH NUTR, V10, P1164, DOI 10.1017/S1368980007000663; Cahova M, 2007, PHYSIOL RES, V56, P1, DOI 10.33549/physiolres.930882; Chen WM, 2012, OCEAN ENG, V42, P7, DOI 10.1016/j.oceaneng.2011.12.019; Christensen MA, 2004, MOL CELL BIOL, V24, P865, DOI 10.1128/MCB.24.2.865-874.2004; Craft S, 2009, ARCH NEUROL-CHICAGO, V66, P300, DOI 10.1001/archneurol.2009.27; Davis J, 2004, J BIOL CHEM, V279, P20296, DOI 10.1074/jbc.M312946200; Fantuzzi G, 2005, J ALLERGY CLIN IMMUN, V115, P911, DOI 10.1016/j.jaci.2005.02.023; Farnier C, 2003, INT J OBESITY, V27, P1178, DOI 10.1038/sj.ijo.0802399; Fewlass DC, 2004, FASEB J, V18, P1870, DOI 10.1096/fj.04-2572com; Flegal KM, 2012, JAMA-J AM MED ASSOC, V307, P491, DOI 10.1001/jama.2012.39; Fox NW, 1997, BIOCHEM BIOPH RES CO, V240, P759, DOI 10.1006/bbrc.1997.7728; Greco SJ, 2010, J ALZHEIMERS DIS, V19, P1155, DOI 10.3233/JAD-2010-1308; Guo KY, 2004, AM J PHYSIOL-REG I, V287, pR112, DOI 10.1152/ajpregu.00028.2004; Guo QX, 2012, CELL RES, V22, P78, DOI 10.1038/cr.2011.116; Haass C, 2012, CSH PERSPECT MED, V2, DOI 10.1101/cshperspect.a006270; Harvey J, 2010, CLIN CHEM, V56, P696, DOI 10.1373/clinchem.2010.144006; Hosogai N, 2007, DIABETES, V56, P901, DOI 10.2337/db06-0911; Kumar-Singh S, 2008, GENES BRAIN BEHAV, V7, P67, DOI 10.1111/j.1601-183X.2007.00380.x; LaFerla FM, 2007, NAT REV NEUROSCI, V8, P499, DOI 10.1038/nrn2168; Lee EB, 2005, J CELL BIOL, V168, P291, DOI 10.1083/jcb.200407070; Lee YH, 2008, OBESITY, V16, P1493, DOI 10.1038/oby.2008.267; Levin-Allerhand J A, 2002, J Nutr Health Aging, V6, P315; Luchsinger JA, 2011, ALZ DIS ASSOC DIS, V26, P101; Luo Y, 2003, NEUROBIOL DIS, V14, P81, DOI 10.1016/S0969-9961(03)00104-9; Mason MM, 1998, ENDOCRINOLOGY, V139, P1013, DOI 10.1210/en.139.3.1013; Meakin PJ, 2012, BIOCHEM J, V441, P285, DOI 10.1042/BJ20110512; Meissner U, 2003, BIOCHEM BIOPH RES CO, V303, P707, DOI 10.1016/S0006-291X(03)00401-7; Moussa CEH, 2006, FASEB J, V20, P2165, DOI 10.1096/fj.06-5763fje; Mouton PR, 2009, NEUROSCI LETT, V464, P184, DOI 10.1016/j.neulet.2009.08.038; Nishimura Satoshi, 2009, Discov Med, V8, P55; Olefsky JM, 2010, ANNU REV PHYSIOL, V72, P219, DOI 10.1146/annurev-physiol-021909-135846; Profenno LA, 2010, BIOL PSYCHIAT, V67, P505, DOI 10.1016/j.biopsych.2009.02.013; Puig KL, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0030378; Richardson James A, 2002, ILAR J, V43, P89; Roder K, 1999, GENE, V234, P61, DOI 10.1016/S0378-1119(99)00180-8; Rosen ED, 2006, NATURE, V444, P847, DOI 10.1038/nature05483; Senechal Y, 2008, BEHAV BRAIN RES, V186, P126, DOI 10.1016/j.bbr.2007.08.003; Shoelson SE, 2006, J CLIN INVEST, V116, P1793, DOI 10.1172/JCI29069; Skurk T, 2007, J CLIN ENDOCR METAB, V92, P1023, DOI 10.1210/jc.2006-1055; Slawik M, 2007, GENES NUTR, V2, P41, DOI 10.1007/s12263-007-0014-9; Sommer G, 2009, J CELL BIOCHEM, V108, P1418, DOI 10.1002/jcb.22382; Sugarman MC, 2006, NEUROBIOL AGING, V27, P423, DOI 10.1016/j.neurobiolaging.2005.02.011; Sun X, 2006, P NATL ACAD SCI USA, V103, P18727, DOI 10.1073/pnas.0606298103; Thirumangalakudi L, 2008, J NEUROCHEM, V106, P475, DOI 10.1111/j.1471-4159.2008.05415.x; Timper K, 2006, BIOCHEM BIOPH RES CO, V341, P1135, DOI 10.1016/j.bbrc.2006.01.072; Trayhurn P, 2005, ACTA PHYSIOL SCAND, V184, P285, DOI 10.1111/j.1365-201X.2005.01468.x; Van Nostrand WE, 2000, MOL MED TODAY, V6, P373, DOI 10.1016/S1357-4310(00)01762-7; Van Nostrand WE, 2010, STROKE, V41, pS135, DOI 10.1161/STROKEAHA.110.595272; Van Vickle GD, 2008, AM J PATHOL, V173, P483, DOI 10.2353/ajpath.2008.071191; Villemagne VL, 2012, EUR J NUCL MED MOL I, V39, P209, DOI 10.1007/s00259-011-2045-0; Walsh DM, 2007, BIOCHEM SOC T, V35, P416, DOI 10.1042/BST0350416; Wang J, 2005, FASEB J, V19, P659, DOI 10.1096/fj.04-3182fje; Wang RS, 2006, FASEB J, V20, P1275, DOI 10.1096/fj.06-5839fje; Wang ZL, 2012, CURR ALZHEIMER RES, V9, P217, DOI 10.2174/156720512799361691; Wilcock DM, 2008, J NEUROSCI, V28, P1537, DOI 10.1523/JNEUROSCI.5066-07.2008; Zhang L, 2011, AM J PHYSIOL-ENDOC M, V301, pE599, DOI 10.1152/ajpendo.00059.2011; Zhang X, 2007, J BIOL CHEM, V282, P10873, DOI 10.1074/jbc.M608856200	62	11	11	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 17	2012	7	8							e43193	10.1371/journal.pone.0043193	http://dx.doi.org/10.1371/journal.pone.0043193			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	996DG	22912823	Green Published, Green Submitted, gold			2022-12-25	WOS:000308063700059
J	Aonuma, H; Watanabe, T				Aonuma, Hitoshi; Watanabe, Takayuki			Changes in the Content of Brain Biogenic Amine Associated with Early Colony Establishment in the Queen of the Ant, Formica japonica	PLOS ONE			English	Article							DIVISION-OF-LABOR; HONEY-BEE COLONIES; AGE-RELATED-CHANGES; JUVENILE-HORMONE; PHEIDOLE-DENTATA; APIS-MELLIFERA; DROSOPHILA-MELANOGASTER; NESTMATE RECOGNITION; TEMPORAL POLYETHISM; GRYLLUS-BIMACULATUS	We examined changes in the content of biogenic amines in the brains of ant queen associated with early colony establishment. In ants, including Formica japonica, winged virgin queens lose their wings following copulation, and then start establishing a colony. Significant changes in brain biogenic amine content in the queen are associated with transition from winged virgin queen to wingless mated queen. The levels of serotonin (5HT), octopamine (OA) and dopamine (DA) decreased significantly in the brain of the queen after starting a colony. On the other hand, tyramine (TA) increased significantly in the brain following colony establishment. Catabolized substances of the biogenic amines in the brain were also measured. The levels of N-acetyloctopamine (Nac-OA) and N-acetyltyramine (Nac-TA) in the brain did not show a significant change after the queen established a colony. However, the levels of N-acetylserotonin (Nac-5HT) in the brain were significantly higher in wingless mated queens than in winged virgin queens, whereas levels of N-acetyldopamine (Nac-DA) in the brain were significantly lower in wingless mated queens than winged virgin queens. These results suggest that serotonergic and octopaminergic systems in the brain of the queen change when the mated queen starts to establish a new colony.	[Aonuma, Hitoshi; Watanabe, Takayuki] Hokkaido Univ, Res Inst Elect Sci, Sapporo, Hokkaido, Japan	Hokkaido University	Aonuma, H (corresponding author), Hokkaido Univ, Res Inst Elect Sci, Sapporo, Hokkaido, Japan.	aon@es.hokudai.ac.jp	Aonuma, Hitoshi/D-6540-2012	Aonuma, Hitoshi/0000-0001-8380-1820; Watanabe, Takayuki/0000-0003-4211-0032	MEXT, Scientific Research on Priority Areas [454, 17075001]; JSPS [23300113]	MEXT, Scientific Research on Priority Areas(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI)); JSPS(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science)	This research was partly supported by grants-in-aid for Scientific Research (KAKENHI) from the MEXT, Scientific Research on Priority Areas (Area No. 454) to H. Aonuma (No. 17075001) and from the JSPS to H. Aonuma (No. 23300113). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALEXANDER RICHARD D., 1961, BEHAVIOUR, V17, P130, DOI 10.1163/156853961X00042; Aonuma H, 2012, ACTA BIOL HUNG, V63, P63, DOI 10.1556/ABiol.63.2012.Suppl.2.6; Barron AB, 2002, J COMP PHYSIOL A, V188, P603, DOI 10.1007/s00359-002-0335-5; Baumann A., 2003, ENCY INSECTS, P91; Beggs KT, 2007, P NATL ACAD SCI USA, V104, P2460, DOI 10.1073/pnas.0608224104; Beggs KT, 2009, CURR BIOL, V19, P1206, DOI 10.1016/j.cub.2009.05.051; Boulay R, 2001, BEHAV PROCESS, V55, P67, DOI 10.1016/S0376-6357(01)00163-2; Boulay R, 2000, J EXP BIOL, V203, P513; Boulay R, 2000, ANIM BEHAV, V59, P1127, DOI 10.1006/anbe.2000.1408; Buschinger A, 1974, SOZIALPOLYMORPHISMUS; Chen YL, 2008, ARCH INSECT BIOCHEM, V68, P241, DOI 10.1002/arch.20259; Dolezal AG, 2012, J EXP BIOL, V215, P454, DOI 10.1242/jeb.060822; Evans P.D., 1980, Advances in Insect Physiology, V15, P317, DOI 10.1016/S0065-2806(08)60143-5; FRANKS NR, 1994, ANIM BEHAV, V48, P470, DOI 10.1006/anbe.1994.1261; Gatellier L, 2004, J EXP BIOL, V207, P2487, DOI 10.1242/jeb.01035; Giray T, 2005, P NATL ACAD SCI USA, V102, P3330, DOI 10.1073/pnas.0409560102; Gordon DM, 1996, NATURE, V380, P121, DOI 10.1038/380121a0; Grozinger CM, 2003, P NATL ACAD SCI USA, V100, P14519, DOI 10.1073/pnas.2335884100; Gruntenko N, 2004, ARCH INSECT BIOCHEM, V55, P55, DOI 10.1002/arch.10123; HARRIS JW, 1992, J INSECT PHYSIOL, V38, P29, DOI 10.1016/0022-1910(92)90019-A; Hoyer SC, 2005, ARTHROPOD STRUCT DEV, V34, P429, DOI 10.1016/j.asd.2005.03.003; Hoyer SC, 2008, CURR BIOL, V18, P159, DOI 10.1016/j.cub.2007.12.052; Johnson O, 2009, NEUROSCIENCE, V158, P1292, DOI 10.1016/j.neuroscience.2008.10.055; KAATZ H, 1994, J INSECT PHYSIOL, V40, P865, DOI 10.1016/0022-1910(94)90020-5; KONDOH M, 1968, Japanese Journal of Ecology, V18, P124; KOSTOWSKI W, 1975, PHARMACOL BIOCHEM BE, V3, P717, DOI 10.1016/0091-3057(75)90200-2; Lehman HK, 2006, J EXP BIOL, V209, P2774, DOI 10.1242/jeb.02296; Leibowitz SF, 1998, BIOL PSYCHIAT, V44, P851, DOI 10.1016/S0006-3223(98)00186-3; LENT CM, 1985, BRAIN RES BULL, V14, P643, DOI 10.1016/0361-9230(85)90114-5; LONG TF, 1983, P NATL ACAD SCI-BIOL, V80, P4159, DOI 10.1073/pnas.80.13.4159; Masuko K, 1998, ZOOL SCI, V15, P409, DOI 10.2108/zsj.15.409; Meer RKV, 2008, NATURWISSENSCHAFTEN, V95, P1155, DOI 10.1007/s00114-008-0432-6; Menzel R, 1996, ANNU REV NEUROSCI, V19, P379, DOI 10.1146/annurev.ne.19.030196.002115; Mizunami M, 2009, BMC BIOL, V7, DOI 10.1186/1741-7007-7-46; Muscedere ML, 2012, J COMP PHYSIOL A, V198, P219, DOI 10.1007/s00359-011-0701-2; NAGAO T, 1991, J COMP PHYSIOL A, V168, P159, DOI 10.1007/BF00218408; Neckameyer WS, 1998, J NEUROGENET, V12, P101, DOI 10.3109/01677069809167259; Neckameyer WS, 2005, STRESS, V8, P117, DOI 10.1080/10253890500147381; Obara Y, 2011, NATURWISSENSCHAFTEN, V98, P989, DOI 10.1007/s00114-011-0847-3; Pophof B, 2000, J COMP PHYSIOL A, V186, P307, DOI 10.1007/s003590050431; Pophof B, 2002, J COMP PHYSIOL A, V188, P659, DOI 10.1007/s00359-002-0343-5; PUNZO F, 1994, COMP BIOCHEM PHYS C, V107, P387, DOI 10.1016/1367-8280(94)90066-3; RAUSCHENBACH IY, 1993, J INSECT PHYSIOL, V39, P761, DOI 10.1016/0022-1910(93)90051-R; Rillich J, 2011, P ROY SOC B-BIOL SCI, V278, P1873, DOI 10.1098/rspb.2010.2099; ROBINSON GE, 1994, ANIM BEHAV, V48, P467, DOI 10.1006/anbe.1994.1260; Robinson GE, 1999, NATURE, V399, P534, DOI 10.1038/21095; ROBINSON GE, 1987, BEHAV ECOL SOCIOBIOL, V20, P329, DOI 10.1007/BF00300679; Roeder T, 2003, ARCH INSECT BIOCHEM, V54, P1, DOI 10.1002/arch.10102; Roeder T, 2005, ANNU REV ENTOMOL, V50, P447, DOI 10.1146/annurev.ento.50.071803.130404; Sasaki K, 2001, J INSECT PHYSIOL, V47, P1205, DOI 10.1016/S0022-1910(01)00105-6; Sasaki K, 2007, J INSECT PHYSIOL, V53, P940, DOI 10.1016/j.jinsphys.2007.03.006; Saveer AM, 2012, P ROY SOC B-BIOL SCI, V279, P2314, DOI 10.1098/rspb.2011.2710; Scheiner R, 2006, CURR NEUROPHARMACOL, V4, P259, DOI 10.2174/157015906778520791; Schrempf A, 2005, CURR BIOL, V15, P267, DOI 10.1016/S0960-9822(05)00071-0; Schulz DJ, 1999, J COMP PHYSIOL A, V184, P481, DOI 10.1007/s003590050348; Schulz DJ, 2001, J COMP PHYSIOL A, V187, P53, DOI 10.1007/s003590000177; Seid MA, 2005, NATURWISSENSCHAFTEN, V92, P198, DOI 10.1007/s00114-005-0610-8; Seid MA, 2008, DEV NEUROBIOL, V68, P1325, DOI 10.1002/dneu.20663; Seid MA, 2006, BEHAV ECOL SOCIOBIOL, V60, P631, DOI 10.1007/s00265-006-0207-z; Sitaraman D, 2005, PNAS, V105, P5579; Stevenson PA, 2005, J NEUROSCI, V25, P1431, DOI 10.1523/JNEUROSCI.4258-04.2005; Wada-Katsumata A, 2011, J EXP BIOL, V214, P1707, DOI 10.1242/jeb.051565; Wagener-Hulme C, 1999, J COMP PHYSIOL A, V184, P471, DOI 10.1007/s003590050347; WILSON EO, 1983, BEHAV ECOL SOCIOBIOL, V14, P47, DOI 10.1007/BF00366655; WOODRING J, 1994, J INSECT PHYSIOL, V40, P797, DOI 10.1016/0022-1910(94)90009-4; WOODRING JP, 1988, J INSECT PHYSIOL, V34, P759, DOI 10.1016/0022-1910(88)90149-7	66	19	21	5	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 15	2012	7	8							e43377	10.1371/journal.pone.0043377	http://dx.doi.org/10.1371/journal.pone.0043377			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	993AG	22905265	Green Published, gold			2022-12-25	WOS:000307823600075
J	Buu, TN; van Soolingen, D; Huyen, MNT; Lan, NTN; Quy, HT; Tiemersma, EW; Kremer, K; Borgdorff, MW; Cobelens, FGJ				Buu, Tran N.; van Soolingen, Dick; Huyen, Mai N. T.; Lan, Nguyen T. N.; Quy, Hoang T.; Tiemersma, Edine W.; Kremer, Kristin; Borgdorff, Martien W.; Cobelens, Frank G. J.			Increased Transmission of Mycobacterium tuberculosis Beijing Genotype Strains Associated with Resistance to Streptomycin: A Population-Based Study	PLOS ONE			English	Article							DRUG-RESISTANCE; MOLECULAR EPIDEMIOLOGY; TREATMENT FAILURE; SOUTH; MUTATIONS; SPREAD; IDENTIFICATION; INFECTION; DIAGNOSIS; GENETICS	Background: Studies have shown that the Mycobacterium tuberculosis Beijing genotype is an emerging pathogen that is frequently associated with drug resistance. This suggests that drug resistant Beijing strains have a relatively high transmission fitness compared to other drug-resistant strains. Methods and Findings: We studied the relative transmission fitness of the Beijing genotype in relation to anti-tuberculosis drug resistance in a population-based study of smear-positive tuberculosis patients prospectively recruited and studied over a 4-year period in rural Vietnam. Transmission fitness was analyzed by clustering of cases on basis of three DNA typing methods. Of 2531 included patients, 2207 (87%) were eligible for analysis of whom 936 (42%) were in a DNA fingerprint cluster. The clustering rate varied by genotype with 292/786 (37%) for the Beijing genotype, 527/802 (67%) for the East-African Indian (EAI) genotype, and 117/619 (19%) for other genotypes. Clustering was associated with the EAI compared to the Beijing genotype (adjusted odds ratio (ORadj) 3.4: 95% CI 2.8-4.4). Patients infected with streptomycin-resistant strains were less frequently clustered than patients infected with streptomycin-susceptible strains when these were of the EAI genotype (ORadj 0.6, 95% CI 0.4-0.9), while this pattern was reversed for strains of the Beijing genotype (ORadj 1.3, 95% CI 1.0-1.8, p for difference 0.002). The strong association between Beijing and MDR-TB (ORadj 7.2; 95% CI 4.2-12.3) existed only if streptomycin resistance was present. Conclusions: Beijing genotype strains showed less overall transmissibility than EAI strains, but when comparisons were made within genotypes, Beijing strains showed increased transmission fitness when streptomycin-resistant, while the reverse was observed for EAI strains. The association between MDR-TB and Beijing genotype in this population was strongly dependent on resistance to streptomycin. Streptomycin resistance may provide Beijing strains with a fitness advantage over other genotypes and predispose to multidrug resistance in patients infected with Beijing strains.	[Buu, Tran N.] Pham Ngoc Thach Hosp, TB Control Dept, Ho Chi Minh City, Vietnam; [van Soolingen, Dick] Natl Inst Publ Hlth & Environm, Lab Infect Dis & Screening, NL-3720 BA Bilthoven, Netherlands; [Huyen, Mai N. T.; Lan, Nguyen T. N.] Pham Ngoc Thach Hosp, Dept Microbiol, Ho Chi Minh City, Vietnam; [van Soolingen, Dick] Radboud Univ Nijmegen Med Ctr, Dept Med Microbiol, Nijmegen, Netherlands; [Quy, Hoang T.] Pham Ngoc Thach Hosp, Dept Med, Ho Chi Minh City, Vietnam; [Tiemersma, Edine W.] KNCV TB Fdn, Asia Dept, The Hague, Netherlands; [Tiemersma, Edine W.; Cobelens, Frank G. J.] Amsterdam Inst Global Hlth & Dev, Amsterdam, Netherlands; [Kremer, Kristin] WHO, Reg Off Europe, Div Communicable Dis Hlth Secur & Environm, DK-2100 Copenhagen, Denmark; [Borgdorff, Martien W.] Amsterdam Municipal Hlth Serv, Amsterdam, Netherlands; [Cobelens, Frank G. J.] Univ Amsterdam, Acad Med Ctr, Dept Global Hlth, NL-1105 AZ Amsterdam, Netherlands	Netherlands National Institute for Public Health & the Environment; Radboud University Nijmegen; KNCV Tuberculosis Foundation; World Health Organization; University of Amsterdam; Academic Medical Center Amsterdam	Buu, TN (corresponding author), Pham Ngoc Thach Hosp, TB Control Dept, Ho Chi Minh City, Vietnam.	f.cobelens@aighd.org		Cobelens, Frank/0000-0002-4367-1133; Tran Ngoc, Buu/0000-0003-3554-1176	KNCV Tuberculosis Foundation; Medical Committee Netherlands-Vietnam; World Health Organization; TBadapt project [037919]	KNCV Tuberculosis Foundation; Medical Committee Netherlands-Vietnam; World Health Organization(World Health Organization); TBadapt project	Financial support for this study was provided by KNCV Tuberculosis Foundation, the Medical Committee Netherlands-Vietnam, the World Health Organization and the TBadapt project (037919). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anh DD, 2000, EMERG INFECT DIS, V6, P302; [Anonymous], 2009, GUID SURV DRUG RES T; [Anonymous], 2010, MULTIDRUG EXTENSIVEL; [Anonymous], 1994, GLOB TUB PROGR GLOB; [Anonymous], 2005, MINISTRY HLTH HIV AI; Baranov AA, 2009, INT J TUBERC LUNG D, V13, P1288; Bifani PJ, 1996, JAMA-J AM MED ASSOC, V275, P452, DOI 10.1001/jama.275.6.452; Braden CR, 1997, J INFECT DIS, V175, P1446, DOI 10.1086/516478; Braden CR, 2001, CLIN INFECT DIS, V33, pE42, DOI 10.1086/322635; Brudey K, 2006, BMC MICROBIOL, V6, DOI 10.1186/1471-2180-6-23; Buu TN, 2009, INT J TUBERC LUNG D, V13, P900; Buu TN, 2010, CLIN INFECT DIS, V51, P879, DOI 10.1086/656410; Caminero JA, 2001, AM J RESP CRIT CARE, V164, P1165, DOI 10.1164/ajrccm.164.7.2101031; Cowley D, 2008, CLIN INFECT DIS, V47, P1252, DOI 10.1086/592575; de Jong BC, 2008, J INFECT DIS, V198, P1037, DOI 10.1086/591504; DeRiemer K, 2007, AM J RESP CRIT CARE, V176, P936, DOI 10.1164/rccm.200603-440OC; Devaux I, 2009, EMERG INFECT DIS, V15, P1052, DOI 10.3201/eid1507.080994; Dou HY, 2008, BMC INFECT DIS, V8, DOI 10.1186/1471-2334-8-170; Gagneux S, 2006, PLOS PATHOG, V2, P603, DOI 10.1371/journal.ppat.0020061; Githui WA, 2004, INT J TUBERC LUNG D, V8, P352; Glynn JR, 1999, INT J TUBERC LUNG D, V3, P1055; Glynn JR, 2006, EMERG INFECT DIS, V12, P736, DOI 10.3201/eid1205.050400; Glynn JR, 2005, EMERG INFECT DIS, V11, P150, DOI 10.3201/eid1101.040869; Heersma HF, 1998, METHODS MOL BIOL, V101; Hillemann D, 2005, INT J TUBERC LUNG D, V9, P1161; Houben RMGJ, 2009, T ROY SOC TROP MED H, V103, P1187, DOI 10.1016/j.trstmh.2009.03.013; Huong NT, 2006, J INFECT DIS, V194, P1226, DOI 10.1086/507906; Huyen MNT, 2010, BMC INFECT DIS, V10, DOI 10.1186/1471-2334-10-149; Institute de Biologie, 2005, I BIOL I PASTCUR L M; Jou RW, 2005, J CLIN MICROBIOL, V43, P95, DOI 10.1128/JCM.43.1.95-100.2005; Kamerbeek J, 1997, J CLIN MICROBIOL, V35, P907, DOI 10.1128/JCM.35.4.907-914.1997; Kremer K, 2004, J CLIN MICROBIOL, V42, P4040, DOI 10.1128/JCM.42.9.4040-4049.2004; Kubica T, 2004, INT J TUBERC LUNG D, V8, P1107; Lan NTN, 2003, EMERG INFECT DIS, V9, P1633, DOI 10.3201/eid0912.030169; Mitchison DA, 1998, INT J TUBERC LUNG D, V2, P10; Quy HT, 2006, INT J TUBERC LUNG D, V10, P45; Rad ME, 2003, EMERG INFECT DIS, V9, P838, DOI 10.3201/eid0907.020803; Samper S, 2005, J CLIN MICROBIOL, V43, P1220, DOI 10.1128/JCM.43.3.1220-1227.2005; Sun YJ, 2010, CLIN MICROBIOL INFEC, V16, P287, DOI 10.1111/j.1469-0691.2009.02800.x; Toungoussova OS, 2002, J CLIN MICROBIOL, V40, P1930, DOI 10.1128/JCM.40.6.1930-1937.2002; van Soolingen D, 2000, J INFECT DIS, V182, P1788, DOI 10.1086/317598; van Soolingen D, 2001, Methods Mol Med, V54, P165, DOI 10.1385/1-59259-147-7:165; VANEMBDEN JDA, 1993, J CLIN MICROBIOL, V31, P406, DOI 10.1128/JCM.31.2.406-409.1993; VANSOOLINGEN D, 1995, J CLIN MICROBIOL, V33, P3234, DOI 10.1128/JCM.33.12.3234-3238.1995; Verver S, 2004, INT J EPIDEMIOL, V33, P351, DOI 10.1093/ije/dyh021; WHO, 2003, GLOB TUB PROGR TREAT; WHO, 2010, GLOB TUB CONTR 2010	47	43	44	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 13	2012	7	8							e42323	10.1371/journal.pone.0042323	http://dx.doi.org/10.1371/journal.pone.0042323			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	988OJ	22912700	Green Published, gold, Green Submitted			2022-12-25	WOS:000307500100012
J	Plaisier, MA; Smeets, JBJ				Plaisier, Myrthe A.; Smeets, Jeroen B. J.			Mass Is All That Matters in the Size-Weight Illusion	PLOS ONE			English	Article							PERCEPTION; CUES; OBJECTS	An object in outer space is weightless due to the absence of gravity, but astronauts can still judge whether one object is heavier than another one by accelerating the object. How heavy an object feels depends on the exploration mode: an object is perceived as heavier when holding it against the pull of gravity than when accelerating it. At the same time, perceiving an object's size influences the percept: small objects feel heavier than large objects with the same mass (size-weight illusion). Does this effect depend on perception of the pull of gravity? To answer this question, objects were suspended from a long wire and participants were asked to push an object and rate its heaviness. This way the contribution of gravitational forces on the percept was minimised. Our results show that weight is not at all necessary for the illusion because the size-weight illusion occurred without perception of weight. The magnitude of the illusion was independent of whether inertial or gravitational forces were perceived. We conclude that the size-weight illusion does not depend on prior knowledge about weights of object, but instead on a more general knowledge about the mass of objects, independent of the contribution of gravity. Consequently, the size-weight illusion will have the same magnitude on Earth as it should have on the Moon or even under conditions of weightlessness.	[Plaisier, Myrthe A.] Univ Bielefeld, Cognit Neurosci Dept, D-33615 Bielefeld, Germany; [Plaisier, Myrthe A.; Smeets, Jeroen B. J.] Vrije Univ Amsterdam, Fac Human Movement Sci, Amsterdam, Netherlands	University of Bielefeld; Vrije Universiteit Amsterdam	Plaisier, MA (corresponding author), Univ Bielefeld, Cognit Neurosci Dept, D-33615 Bielefeld, Germany.	myrthe.plaisier@uni-bielefeld.de	Smeets, Jeroen/B-4198-2008	Smeets, Jeroen/0000-0002-3794-0579	Netherlands Organization for Scientific Research [MaGW 453-08-004]; NWO in collaboration with the Marie Curie Cofund [MAGW 446-10-012]; Marie Curie Cofund [MAGW 446-10-012]	Netherlands Organization for Scientific Research(Netherlands Organization for Scientific Research (NWO)); NWO in collaboration with the Marie Curie Cofund; Marie Curie Cofund	Funding provided by VICI grant (MaGW 453-08-004) for JBJS from the Netherlands Organization for Scientific Research. Rubicon grant from NWO in collaboration with the Marie Curie Cofund (MAGW 446-10-012) for MAP. www.nwo.nl. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amazeen EL, 1996, J EXP PSYCHOL HUMAN, V22, P213, DOI 10.1037/0096-1523.22.1.213; Brayanov JB, 2010, J NEUROPHYSIOL, V103, P1518, DOI 10.1152/jn.00814.2009; Buckingham G, 2010, EXP BRAIN RES, V205, P283, DOI 10.1007/s00221-010-2353-9; Buckingham G, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009709; Buckingham G, 2009, J NEUROPHYSIOL, V102, P3111, DOI 10.1152/jn.00515.2009; Charpentier A., 1891, ARCHIVE PHYSIOLOGIE, V3, P122; Ellis RR, 1999, PERCEPT PSYCHOPHYS, V61, P1564, DOI 10.3758/BF03213118; ELLIS RR, 1993, PERCEPT PSYCHOPHYS, V53, P315, DOI 10.3758/BF03205186; Ernst MO, 2007, J VISION, V7, DOI 10.1167/7.5.7; Ernst MO, 2002, NATURE, V415, P429, DOI 10.1038/415429a; Flanagan JR, 2008, CURR BIOL, V18, P1742, DOI 10.1016/j.cub.2008.09.042; Flanagan JR, 2000, NAT NEUROSCI, V3, P737, DOI 10.1038/76701; GORDON AM, 1991, EXP BRAIN RES, V83, P477; Grandy MS, 2006, J NEUROPHYSIOL, V95, P3887, DOI 10.1152/jn.00851.2005; ROSS H, 1984, SCIENCE, V225, P219, DOI 10.1126/science.6729479; ROSS HE, 1987, Q J EXP PSYCHOL-A, V39, P77, DOI 10.1080/02724988743000042; Tiest WMB, 2010, ATTEN PERCEPT PSYCHO, V72, P1144, DOI 10.3758/APP.72.4.1144; Weiss Y, 2002, NAT NEUROSCI, V5, P598, DOI 10.1038/nn858; Zhu Q, 2011, EVOL HUM BEHAV, V32, P288, DOI 10.1016/j.evolhumbehav.2010.11.005; ZWISLOCKI JJ, 1980, PERCEPT PSYCHOPHYS, V28, P28, DOI 10.3758/BF03204312	20	23	23	2	22	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 9	2012	7	8							e42518	10.1371/journal.pone.0042518	http://dx.doi.org/10.1371/journal.pone.0042518			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	986WZ	22912704	gold, Green Published, Green Submitted			2022-12-25	WOS:000307378500017
J	Zhou, ZB; Meng, FG; Chae, SR; Huang, GC; Fu, WJ; Jia, XS; Li, SY; Chen, GH				Zhou, Zhongbo; Meng, Fangang; Chae, So-Ryong; Huang, Guocheng; Fu, Wenjie; Jia, Xiaoshan; Li, Shiyu; Chen, Guang-Hao			Microbial Transformation of Biomacromolecules in a Membrane Bioreactor: Implications for Membrane Fouling Investigation	PLOS ONE			English	Article							DISSOLVED ORGANIC-MATTER; EXTRACELLULAR POLYMERIC SUBSTANCES; EXCITATION-EMISSION MATRIX; PARALLEL FACTOR-ANALYSIS; FLUORESCENCE EXCITATION; WASTE-WATER; ACTIVATED-SLUDGE; BIODEGRADABILITY; DEGRADATION; PRODUCTS	Background: The complex characteristics and unclear biological fate of biomacromolecules (BMM), including colloidal and soluble microbial products (SMP), extracellular polymeric substances (EPS) and membrane surface foulants (MSF), are crucial factors that limit our understanding of membrane fouling in membrane bioreactors (MBRs). Findings: In this study, the microbial transformation of BMM was investigated in a lab-scale MBR by well-controlled bioassay tests. The results of experimental measurements and mathematical modeling show that SMP, EPS, and MSF had different biodegradation behaviors and kinetic models. Based on the multi-exponential G models, SMP were mainly composed of slowly biodegradable polysaccharides (PS), proteins (PN), and non-biodegradable humic substances (HS). In contrast, EPS contained a large number of readily biodegradable PN, slowly biodegradable PS and HS. MSF were dominated by slowly biodegradable PS, which had a degradation rate constant similar to that of SMP-PS, while degradation behaviors of MSF-PN and MSF-HS were much more similar to those of EPS-PN and EPS-HS, respectively. In addition, the large-molecular weight (MW) compounds (>100 kDa) in BMM were found to have a faster microbial transformation rate compared to the small-MW compounds (<5 kDa). The parallel factor (PARAFAC) modeling of three-dimensional fluorescence excitation-emission matrix (EEM) spectra showed that the tryptophan-like PN were one of the major fractions in the BMM and they were more readily biodegradable than the HS. Besides microbial mineralization, humification and hydrolysis could be viewed as two important biotransformation mechanisms of large-MW compounds during the biodegradation process. Significance: The results of this work can aid in tracking the origin of membrane foulants from the perspective of the biotransformation behaviors of SMP, EPS, and MSF.	[Zhou, Zhongbo; Meng, Fangang; Huang, Guocheng; Fu, Wenjie; Jia, Xiaoshan; Li, Shiyu; Chen, Guang-Hao] Sun Yat Sen Univ, SYSU HKUST Res Ctr Innovat Environm Technol SHRCI, Sch Environm Sci & Engn, Guangzhou 510275, Guangdong, Peoples R China; [Zhou, Zhongbo; Meng, Fangang; Huang, Guocheng; Fu, Wenjie; Jia, Xiaoshan; Li, Shiyu] Guangdong Prov Key Lab Environm Pollut Control &, Guangzhou, Guangdong, Peoples R China; [Chae, So-Ryong] Univ Sydney, Sch Chem & Biomol Engn, Sydney, NSW 2006, Australia; [Chen, Guang-Hao] Hong Kong Univ Sci & Technol, Dept Civil & Environm Engn, Hong Kong, Hong Kong, Peoples R China	Hong Kong University of Science & Technology; Sun Yat Sen University; University of Sydney; Hong Kong University of Science & Technology	Meng, FG (corresponding author), Sun Yat Sen Univ, SYSU HKUST Res Ctr Innovat Environm Technol SHRCI, Sch Environm Sci & Engn, Guangzhou 510275, Guangdong, Peoples R China.	fgmeng80@126.com	Zhou, Zhongbo/F-3365-2013; Chae, Soryong/A-3334-2013; Meng, Fangang/AAV-1870-2020; Chen, Guanghao/G-8980-2016; Zhou, Zhongbo/U-5358-2017	Meng, Fangang/0000-0002-7976-9722; Zhou, Zhongbo/0000-0001-5694-5319; Chen, G.H./0000-0002-1353-8585; Chae, Soryong/0000-0002-2382-4075	opening Laboratory Fund of Sun Yat-sen University [KF201013]; Specialized Research Fund for the Doctoral Program of Higher Education of China [20100171120014]; Fundamental Research Funds for the Central Universities [2010380003161541]; New Century Excellent Talents in University from the Ministry of Education of China [NCET-11-0537]	opening Laboratory Fund of Sun Yat-sen University; Specialized Research Fund for the Doctoral Program of Higher Education of China(Specialized Research Fund for the Doctoral Program of Higher Education (SRFDP)); Fundamental Research Funds for the Central Universities(Fundamental Research Funds for the Central Universities); New Century Excellent Talents in University from the Ministry of Education of China	The project was supported by the opening Laboratory Fund of Sun Yat-sen University (No. KF201013, http://soeasy.sysu.edu.cn/dela/), the Specialized Research Fund for the Doctoral Program of Higher Education of China (No. 20100171120014, http://www.dost.moe.edu.cn/), the financial support of the Fundamental Research Funds for the Central Universities (No. 2010380003161541, http://home3.sysu.edu.cn/kjc), and the New Century Excellent Talents in University from the Ministry of Education of China (NCET-11-0537, http://www.dost.moe.edu.cn/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Al-Halbouni D, 2009, WATER RES, V43, P97, DOI 10.1016/j.watres.2008.10.008; Al-Halbouni D, 2008, WATER RES, V42, P1475, DOI 10.1016/j.watres.2007.10.026; Amon RMW, 1996, LIMNOL OCEANOGR, V41, P41, DOI 10.4319/lo.1996.41.1.0041; Baghoth SA, 2011, WATER RES, V45, P797, DOI 10.1016/j.watres.2010.09.005; Barker DJ, 1999, WATER RES, V33, P2499, DOI 10.1016/S0043-1354(98)00489-8; Chen W, 2003, ENVIRON SCI TECHNOL, V37, P5701, DOI 10.1021/es034354c; Chinese-NEPA, 1997, WAT WAST MON METH; Coble PG, 1996, MAR CHEM, V51, P325, DOI 10.1016/0304-4203(95)00062-3; Drews A, 2007, WATER RES, V41, P3850, DOI 10.1016/j.watres.2007.05.046; DUBOIS M, 1956, ANAL CHEM, V28, P350, DOI 10.1021/ac60111a017; Gruenheid S, 2008, WATER SCI TECHNOL, V57, P987, DOI 10.2166/wst.2008.207; Harmon ME, 2009, GLOBAL CHANGE BIOL, V15, P1320, DOI 10.1111/j.1365-2486.2008.01837.x; Henderson RK, 2009, WATER RES, V43, P863, DOI 10.1016/j.watres.2008.11.027; Huang GC, 2011, APPL MICROBIOL BIOT, V90, P1795, DOI 10.1007/s00253-011-3251-1; Hudson N, 2007, RIVER RES APPL, V23, P631, DOI 10.1002/rra.1005; Hwang BK, 2008, ENVIRON SCI TECHNOL, V42, P3963, DOI 10.1021/es7029784; Jiang T, 2008, WATER RES, V42, P4955, DOI 10.1016/j.watres.2008.09.037; Kalbitz K, 2003, GEODERMA, V113, P273, DOI 10.1016/S0016-7061(02)00365-8; Laspidou CS, 2002, WATER RES, V36, P2711, DOI 10.1016/S0043-1354(01)00413-4; Li XY, 2007, WATER RES, V41, P1022, DOI 10.1016/j.watres.2006.06.037; Liang S, 2007, WATER RES, V41, P95, DOI 10.1016/j.watres.2006.10.008; LOWRY OH, 1951, J BIOL CHEM, V193, P265; Malamis S, 2009, BIORESOURCE TECHNOL, V100, P3350, DOI 10.1016/j.biortech.2009.01.053; Meng FG, 2013, AICHE J, V59, P46, DOI 10.1002/aic.13799; Meng FG, 2011, WATER RES, V45, P4661, DOI 10.1016/j.watres.2011.06.026; Meng FG, 2009, ENVIRON SCI TECHNOL, V43, P8821, DOI 10.1021/es9019996; Menniti A, 2010, WATER RES, V44, P5240, DOI 10.1016/j.watres.2010.06.040; Menniti A, 2009, WATER RES, V43, P4305, DOI 10.1016/j.watres.2009.06.052; Murphy KR, 2011, ENVIRON SCI TECHNOL, V45, P2909, DOI 10.1021/es103015e; Namour P, 1998, WATER RES, V32, P2224, DOI 10.1016/S0043-1354(97)00428-4; Ni BJ, 2010, WATER RES, V44, P2292, DOI 10.1016/j.watres.2009.12.025; Okamura D, 2010, ENVIRON SCI TECHNOL, V44, P8644, DOI 10.1021/es102321m; Stedmon CA, 2005, LIMNOL OCEANOGR, V50, P1415, DOI 10.4319/lo.2005.50.5.1415; Stedmon CA, 2003, MAR CHEM, V82, P239, DOI 10.1016/S0304-4203(03)00072-0; Stedmon CA, 2008, LIMNOL OCEANOGR-METH, V6, P572, DOI 10.4319/lom.2008.6.572; Vahatalo AV, 2010, BIOGEOCHEMISTRY, V100, P227, DOI 10.1007/s10533-010-9419-4; Wang ZW, 2007, APPL MICROBIOL BIOT, V74, P462, DOI 10.1007/s00253-006-0686-x; Wang ZW, 2009, WATER RES, V43, P2504, DOI 10.1016/j.watres.2009.02.026; Wu J, 2011, WATER RES, V45, P1711, DOI 10.1016/j.watres.2010.11.022; YAMAGIWA K, 1994, BIORESOURCE TECHNOL, V50, P131, DOI 10.1016/0960-8524(94)90065-5; Yamashita Y, 2008, ENVIRON SCI TECHNOL, V42, P7374, DOI 10.1021/es801357h; Yamashita Y, 2008, LIMNOL OCEANOGR, V53, P1900, DOI 10.4319/lo.2008.53.5.1900; Yavich AA, 2004, WATER RES, V38, P2839, DOI 10.1016/j.watres.2004.03.040; Yu GH, 2010, WATER RES, V44, P797, DOI 10.1016/j.watres.2009.10.021; Zhang XQ, 2003, CHEMOSPHERE, V50, P63, DOI 10.1016/S0045-6535(02)00319-3; Zhou ZB, 2012, RSC ADV, V2, P453, DOI 10.1039/c1ra00420d	46	20	22	1	84	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 9	2012	7	8							e42270	10.1371/journal.pone.0042270	http://dx.doi.org/10.1371/journal.pone.0042270			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	986WZ	22912694	Green Published, Green Submitted, gold			2022-12-25	WOS:000307378500014
J	Abdalla, H; Srinivasan, L; Shah, S; Mayer-Barber, KD; Sher, A; Sutterwala, FS; Briken, V				Abdalla, Hana; Srinivasan, Lalitha; Shah, Swati; Mayer-Barber, Katrin D.; Sher, Alan; Sutterwala, Fayyaz S.; Briken, Volker			Mycobacterium tuberculosis Infection of Dendritic Cells Leads to Partially Caspase-1/11-Independent IL-1 beta and IL-18 Secretion but Not to Pyroptosis	PLOS ONE			English	Article							INFLAMMASOME ACTIVATION; IN-VIVO; MACROPHAGE APOPTOSIS; ADAPTIVE IMMUNITY; INNATE IMMUNITY; CASPASE-1; DEATH; MICE; RECEPTOR; BINDING	Background: Interleukin-1 beta (IL-1 beta) is important for host resistance against Mycobacterium tuberculosis (Mtb) infections. The response of the dendritic cell inflammasome during Mtb infections has not been investigated in detail. Methodology/Principal Findings: Here we show that Mtb infection of bone marrow-derived dendritic cells (BMDCs) induces IL-1 beta secretion and that this induction is dependent upon the presence of functional ASC and NLRP3 but not NLRC4 or NOD2. The analysis of cell death induction in BMDCs derived from these knock-out mice revealed the important induction of host cell apoptosis but not necrosis, pyroptosis or pyronecrosis. Furthermore, NLRP3 inflammasome activation and apoptosis induction were both reduced in BMDCs infected with the esxA deletion mutant of Mtb demonstrating the importance of a functional ESX-1 secretion system. Surprisingly, caspase-1/11-deficient BMDCs still secreted residual levels of IL-1 beta and IL-18 upon Mtb infection which was abolished in cells infected with the esxA Mtb mutant. Conclusion: Altogether we demonstrate the partially caspase-1/11-independent, but NLRP3- and ASC-dependent IL-1 beta secretion in Mtb-infected BMDCs. These findings point towards a potential role of DCs in the host innate immune response to mycobacterial infections via their capacity to induce IL-1 beta and IL-18 secretion.	[Abdalla, Hana; Srinivasan, Lalitha; Shah, Swati; Briken, Volker] Univ Maryland, Dept Cell Biol & Mol Genet, College Pk, MD 20742 USA; [Abdalla, Hana; Srinivasan, Lalitha; Shah, Swati; Briken, Volker] Univ Maryland, Maryland Pathogen Res Inst, College Pk, MD 20742 USA; [Mayer-Barber, Katrin D.; Sher, Alan] NIAID, Parasit Dis Lab, NIH, Bethesda, MD 20892 USA; [Sutterwala, Fayyaz S.] Univ Iowa, Dept Internal Med, Inflammat Program, Iowa City, IA 52242 USA; [Sutterwala, Fayyaz S.] Vet Affairs Med Ctr, Iowa City, IA 52242 USA	University System of Maryland; University of Maryland College Park; University System of Maryland; University of Maryland College Park; National Institutes of Health (NIH) - USA; NIH National Institute of Allergy & Infectious Diseases (NIAID); University of Iowa; US Department of Veterans Affairs; Veterans Health Administration (VHA); Iowa City VA Health Care System	Abdalla, H (corresponding author), Univ Maryland, Dept Cell Biol & Mol Genet, College Pk, MD 20742 USA.	vbriken@umd.edu	Sutterwala, Fayyaz/AAH-5859-2021; Cassel, Suzanne/AAI-3947-2021	Cassel, Suzanne/0000-0003-2492-1923; Briken, Volker/0000-0001-5830-6107	National Institutes of Health [NIAID RO1 AI072584]; Heiser Program for Research in Leprosy and Tuberculosis postdoctoral fellowship of the New York Community Trust; Scholar Rescue Fund; NIAID, NIH; Veterans Administration [IBX000167A]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI072584] Funding Source: NIH RePORTER; Veterans Affairs [I01BX000167] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Heiser Program for Research in Leprosy and Tuberculosis postdoctoral fellowship of the New York Community Trust; Scholar Rescue Fund; NIAID, NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); Veterans Administration(US Department of Veterans Affairs); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); Veterans Affairs(US Department of Veterans Affairs)	The work was supported by the National Institutes of Health grant NIAID RO1 AI072584 (H. A., L. S., V. B.), the Heiser Program for Research in Leprosy and Tuberculosis postdoctoral fellowship of the New York Community Trust (to H. A.), the Scholar Rescue Fund (H. A.), the Intramural Research Program of the NIAID, NIH (K.D.M.-B. and A. S.) and a Veterans Administration Merit Review Grant IBX000167A (F. S. S.). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abdallah AM, 2007, NAT REV MICROBIOL, V5, P883, DOI 10.1038/nrmicro1773; Adachi O, 1998, IMMUNITY, V9, P143, DOI 10.1016/S1074-7613(00)80596-8; Beausejour A, 1998, INFECT IMMUN, V66, P676; Behar SM, 2010, NAT REV MICROBIOL, V8, P668, DOI 10.1038/nrmicro2387; Bergsbaken T, 2007, PLOS PATHOG, V3, P1570, DOI 10.1371/journal.ppat.0030161; Bergsbaken T, 2009, NAT REV MICROBIOL, V7, P99, DOI 10.1038/nrmicro2070; Blomgran R, 2012, CELL HOST MICROBE, V11, P81, DOI 10.1016/j.chom.2011.11.012; Bodnar KA, 2001, INFECT IMMUN, V69, P800, DOI 10.1128/IAI.69.2.800-809.2001; Briken V, 2008, FUTURE MICROBIOL, V3, P415, DOI 10.2217/17460913.3.4.415; Burguillos MA, 2011, NATURE, V472, P319, DOI 10.1038/nature09788; Carlsson F, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1000895; Chen YJ, 1996, EMBO J, V15, P3853, DOI 10.1002/j.1460-2075.1996.tb00759.x; Divangahi M, 2008, J IMMUNOL, V181, P7157, DOI 10.4049/jimmunol.181.10.7157; Dorhoi A, 2011, EUR J IMMUNOL; Dye C, 2010, SCIENCE, V328, P856, DOI 10.1126/science.1185449; Fink SL, 2008, P NATL ACAD SCI USA, V105, P4312, DOI 10.1073/pnas.0707370105; Fink SL, 2006, CELL MICROBIOL, V8, P1812, DOI 10.1111/j.1462-5822.2006.00751.x; Fremond CM, 2007, J IMMUNOL, V179, P1178, DOI 10.4049/jimmunol.179.2.1178; Gandotra S, 2007, INFECT IMMUN, V75, P5127, DOI 10.1128/IAI.00458-07; Hersh D, 1999, P NATL ACAD SCI USA, V96, P2396, DOI 10.1073/pnas.96.5.2396; Hickman SP, 2002, J IMMUNOL, V168, P4636, DOI 10.4049/jimmunol.168.9.4636; Hsu LC, 2008, P NATL ACAD SCI USA, V105, P7803, DOI 10.1073/pnas.0802726105; Hsu T, 2003, P NATL ACAD SCI USA, V100, P12420, DOI 10.1073/pnas.1635213100; Jiao XN, 2002, J IMMUNOL, V168, P1294, DOI 10.4049/jimmunol.168.3.1294; Kayagaki N, 2011, NATURE, V479, P117, DOI 10.1038/nature10558; Kleinnijenhuis J, 2009, EUR J IMMUNOL, V39, P1914, DOI 10.1002/eji.200839115; Koo IC, 2008, CELL MICROBIOL, V10, P1866, DOI 10.1111/j.1462-5822.2008.01177.x; Kuranaga E, 2012, GENES CELLS; Kurenuma T, 2009, INFECT IMMUN, V77, P3992, DOI 10.1128/IAI.00015-09; LI P, 1995, CELL, V80, P401, DOI 10.1016/0092-8674(95)90490-5; Majlessi L, 2005, J IMMUNOL, V174, P3570, DOI 10.4049/jimmunol.174.6.3570; Mantegazza AR, 2008, BLOOD, V112, P4712, DOI 10.1182/blood-2008-01-134791; Mariathasan S, 2004, NATURE, V430, P213, DOI 10.1038/nature02664; Mariathasan S, 2007, NAT REV IMMUNOL, V7, P31, DOI 10.1038/nri1997; Master SS, 2008, CELL HOST MICROBE, V3, P224, DOI 10.1016/j.chom.2008.03.003; Mayer-Barber KD, 2010, J IMMUNOL, V184, P3326, DOI 10.4049/jimmunol.0904189; Miggin SM, 2007, P NATL ACAD SCI USA, V104, P3372, DOI 10.1073/pnas.0608100104; Miller J, 2010, NY TIMES BK REV, P6; Mishra BB, 2010, CELL MICROBIOL, V12, P1046, DOI 10.1111/j.1462-5822.2010.01450.x; Netea MG, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1000661; Netea MG, 2009, BLOOD, V113, P2324, DOI 10.1182/blood-2008-03-146720; Pan H, 2005, NATURE, V434, P767, DOI 10.1038/nature03419; Pan QL, 2007, J LEUKOCYTE BIOL, V82, P177, DOI 10.1189/jlb.1006627; Pedra JHF, 2009, CURR OPIN IMMUNOL, V21, P10, DOI 10.1016/j.coi.2009.01.006; Philips JA, 2012, ANNU REV PATHOL-MECH, V7, P353, DOI 10.1146/annurev-pathol-011811-132458; Pieters J, 2008, CELL HOST MICROBE, V3, P399, DOI 10.1016/j.chom.2008.05.006; Russell DG, 2007, NAT REV MICROBIOL, V5, P39, DOI 10.1038/nrmicro1538; Schneider BE, 2010, EUR J IMMUNOL, V40, P396, DOI 10.1002/eji.200939583; Schroder K, 2010, CELL, V140, P821, DOI 10.1016/j.cell.2010.01.040; Simeone R, 2009, CURR OPIN MICROBIOL, V12, P4, DOI 10.1016/j.mib.2008.11.003; Stanley SA, 2003, P NATL ACAD SCI USA, V100, P13001, DOI 10.1073/pnas.2235593100; Steinman RM, 2010, IMMUNOL REV, V234, P5, DOI 10.1111/j.0105-2896.2009.00888.x; Sugawara I, 1999, INFECT IMMUN, V67, P2585, DOI 10.1128/IAI.67.5.2585-2589.1999; Sugawara I, 2001, MICROBIOL IMMUNOL, V45, P743, DOI 10.1111/j.1348-0421.2001.tb01310.x; Sutterwala FS, 2006, IMMUNITY, V24, P317, DOI 10.1016/j.immuni.2006.02.004; TeKippe EM, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012320; Tian T, 2005, J IMMUNOL, V175, P3268, DOI 10.4049/jimmunol.175.5.3268; Ting JPY, 2008, IMMUNITY, V28, P285, DOI 10.1016/j.immuni.2008.02.005; Ting JPY, 2008, NAT REV IMMUNOL, V8, P372, DOI 10.1038/nri2296; Urdahl KB, 2011, MUCOSAL IMMUNOL, V4, P288, DOI 10.1038/mi.2011.10; Walter K, 2010, IMMUNOBIOLOGY, V215, P804, DOI 10.1016/j.imbio.2010.05.015; Wolf AJ, 2007, J IMMUNOL, V179, P2509, DOI 10.4049/jimmunol.179.4.2509	62	38	39	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 24	2012	7	7							e40722	10.1371/journal.pone.0040722	http://dx.doi.org/10.1371/journal.pone.0040722			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	978NX	22911706	Green Submitted, gold, Green Published			2022-12-25	WOS:000306751300011
J	Chimalapati, S; Cohen, JM; Camberlein, E; MacDonald, N; Durmort, C; Vernet, T; Hermans, PWM; Mitchell, T; Brown, JS				Chimalapati, Suneeta; Cohen, Jonathan M.; Camberlein, Emilie; MacDonald, Nathanael; Durmort, Claire; Vernet, Thierry; Hermans, Peter W. M.; Mitchell, Timothy; Brown, Jeremy S.			Effects of Deletion of the Streptococcus pneumoniae Lipoprotein Diacylglyceryl Transferase Gene lgt on ABC Transporter Function and on Growth In Vivo	PLOS ONE			English	Article							SIGNAL PEPTIDASE II; ESCHERICHIA-COLI; STAPHYLOCOCCUS-AUREUS; IRON UPTAKE; LIPID MODIFICATION; PNEUMOCOCCAL PNEUMONIA; LISTERIA-MONOCYTOGENES; IMMUNE ACTIVATION; BACILLUS-SUBTILIS; VIRULENCE FACTORS	Lipoproteins are an important class of surface associated proteins that have diverse roles and frequently are involved in the virulence of bacterial pathogens. As prolipoproteins are attached to the cell membrane by a single enzyme, prolipoprotein diacylglyceryl transferase (Lgt), deletion of the corresponding gene potentially allows the characterisation of the overall importance of lipoproteins for specific bacterial functions. We have used a Delta lgt mutant strain of Streptococcus pneumoniae to investigate the effects of loss of lipoprotein attachment on cation acquisition, growth in media containing specific carbon sources, and virulence in different infection models. Immunoblots of triton X-114 extracts, flow cytometry and immunofluorescence microscopy confirmed the Delta lgt mutant had markedly reduced lipoprotein expression on the cell surface. The Delta lgt mutant had reduced growth in cation depleted medium, increased sensitivity to oxidative stress, reduced zinc uptake, and reduced intracellular levels of several cations. Doubling time of the Delta lgt mutant was also increased slightly when grown in medium with glucose, raffinose and maltotriose as sole carbon sources. These multiple defects in cation and sugar ABC transporter function for the Delta lgt mutant were associated with only slightly delayed growth in complete medium. However the Delta lgt mutant had significantly reduced growth in blood or bronchoalveolar lavage fluid and a marked impairment in virulence in mouse models of nasopharyngeal colonisation, sepsis and pneumonia. These data suggest that for S. pneumoniae loss of surface localisation of lipoproteins has widespread effects on ABC transporter functions that collectively prevent the Delta lgt mutant from establishing invasive infection.	[Chimalapati, Suneeta; Cohen, Jonathan M.; Camberlein, Emilie; MacDonald, Nathanael; Brown, Jeremy S.] Royal Free & Univ Coll Med Sch, Rayne Inst, Ctr Resp Res, Dept Med, London WC1E 6BT, England; [Cohen, Jonathan M.] UCL Inst Child Hlth, Infect Dis & Microbiol Unit, London, England; [Durmort, Claire; Vernet, Thierry] CEA, Inst Biol Struct Jean Pierre Ebel, Grenoble, France; [Durmort, Claire; Vernet, Thierry] CNRS, Inst Biol Struct Jean Pierre Ebel, Grenoble, France; [Durmort, Claire; Vernet, Thierry] Univ Grenoble 1, Inst Biol Struct Jean Pierre Ebel, Grenoble, France; [Hermans, Peter W. M.] Radboud Univ Nijmegen, Med Ctr, Lab Pediat Infect Dis, NL-6525 ED Nijmegen, Netherlands; [Mitchell, Timothy] Univ Glasgow, Div Infect & Immun, IBLS, Glasgow, Lanark, Scotland	University of London; King's College London; University College London; University of London; University College London; UDICE-French Research Universities; Communaute Universite Grenoble Alpes; Universite Grenoble Alpes (UGA); CEA; Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Communaute Universite Grenoble Alpes; Universite Grenoble Alpes (UGA); CEA; Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Communaute Universite Grenoble Alpes; Universite Grenoble Alpes (UGA); CEA; Centre National de la Recherche Scientifique (CNRS); Radboud University Nijmegen; University of Glasgow	Chimalapati, S (corresponding author), Royal Free & Univ Coll Med Sch, Rayne Inst, Ctr Resp Res, Dept Med, London WC1E 6BT, England.	jeremy.brown@ucl.ac.uk	Durmort, Claire/L-4380-2013; Cohen, Jonathan/C-4588-2008; Vernet, Thierry/G-1118-2012; Hermans, Peter W.M./H-8042-2014	Cohen, Jonathan/0000-0002-3966-3640; Brown, Jeremy/0000-0002-5650-5361; Cohen, Jonathan/0000-0003-1004-5598; Mitchell, Timothy/0000-0002-8309-5556	Department of Health's NIHR Biomedical Research Centre's funding scheme; UCL Charities funding; Wellcome Trust [076442]; Medical Research Council [G0700829, G0600410]; Region Rhone-Alpes; Academy of Medical Sciences (AMS) [AMS-SGCL5-Cohen] Funding Source: researchfish; National Institute for Health Research [CL-2009-18-010] Funding Source: researchfish; MRC [G0600410, G0700829] Funding Source: UKRI	Department of Health's NIHR Biomedical Research Centre's funding scheme(National Institute for Health Research (NIHR)); UCL Charities funding; Wellcome Trust(Wellcome Trust); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Region Rhone-Alpes(Region Auvergne-Rhone-Alpes); Academy of Medical Sciences (AMS)(Academy of Medical Sciences (AMS)); National Institute for Health Research(National Institute for Health Research (NIHR)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	This work was undertaken at UCLH/UCL, who received a proportion of funding from the Department of Health's NIHR Biomedical Research Centre's funding scheme, and was supported by the UCL Charities funding and grants from the Wellcome Trust (grant reference 076442) and the Medical Research Council (grants G0700829 and G0600410). Financial support from the Region Rhone-Alpes through the "Explo'ra pro 2010'' programme to CD is also acknowledged. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arimoto T, 2008, ORAL MICROBIOL IMMUN, V23, P515, DOI 10.1111/j.1399-302X.2008.00455.x; Banaiee N, 2006, J IMMUNOL, V176, P3019, DOI 10.4049/jimmunol.176.5.3019; Basavanna S, 2009, INFECT IMMUN, V77, P3412, DOI 10.1128/IAI.01543-08; Baumgartner M, 2007, J BACTERIOL, V189, P313, DOI 10.1128/JB.00976-06; Bayle L, 2011, MOL MICROBIOL, V82, P904, DOI 10.1111/j.1365-2958.2011.07862.x; Bergmann S, 2006, MICROBIOL-SGM, V152, P295, DOI 10.1099/mic.0.28610-0; Bidossi A, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0033320; BORDIER C, 1981, J BIOL CHEM, V256, P1604; Bray BA, 2009, MICROBIOL-SGM, V155, P1451, DOI 10.1099/mic.0.025213-0; Brightbill HD, 1999, SCIENCE, V285, P732, DOI 10.1126/science.285.5428.732; Brown JS, 2004, INFECT IMMUN, V72, P1587, DOI 10.1128/IAI.72.3.1587-1593.2004; Brown JS, 2002, INFECT IMMUN, V70, P4389, DOI 10.1128/IAI.70.8.4389-4398.2002; Brown JS, 2001, MOL MICROBIOL, V40, P572, DOI 10.1046/j.1365-2958.2001.02414.x; Brown JS, 2001, INFECT IMMUN, V69, P6702, DOI 10.1128/IAI.69.11.6702-6706.2001; BURNETTECURLEY D, 1995, INFECT IMMUN, V63, P4669, DOI 10.1128/IAI.63.12.4669-4674.1995; Chimalapati S, 2011, INFECT IMMUN, V79, P4965, DOI 10.1128/IAI.05923-11; Cockayne A, 1998, INFECT IMMUN, V66, P3767, DOI 10.1128/IAI.66.8.3767-3774.1998; Cohen JM, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025558; Das S, 2009, J BACTERIOL, V191, P4166, DOI 10.1128/JB.01739-08; Dawid S, 2007, INFECT IMMUN, V75, P443, DOI 10.1128/IAI.01775-05; Desrosiers DC, 2010, INFECT IMMUN, V78, P5163, DOI 10.1128/IAI.00732-10; Dintilhac A, 1997, MOL MICROBIOL, V25, P727, DOI 10.1046/j.1365-2958.1997.5111879.x; Echchannaoui H, 2002, J INFECT DIS, V186, P798, DOI 10.1086/342845; Eriksson EMY, 2007, CURR PROTEIN PEPT SC, V8, P412; Gabbianelli R, 2011, BMC MICROBIOL, V11, DOI 10.1186/1471-2180-11-36; GAN K, 1993, J BIOL CHEM, V268, P16544; Gee KR, 2002, CELL CALCIUM, V31, P245, DOI 10.1016/S0143-4160(02)00053-2; Hamilton A, 2006, INFECT IMMUN, V74, P6907, DOI 10.1128/IAI.01116-06; Hava D, 2002, MOL MICROBIOL, V45, P1389, DOI 10.1046/j.1365-2958.2002.t01-1-03106.x; HAVARSTEIN LS, 1995, P NATL ACAD SCI USA, V92, P11140, DOI 10.1073/pnas.92.24.11140; Henneke P, 2008, J IMMUNOL, V180, P6149, DOI 10.4049/jimmunol.180.9.6149; Hermans PWM, 2006, J BIOL CHEM, V281, P968, DOI 10.1074/jbc.M510014200; Hiron A, 2010, MOL MICROBIOL, V77, P1246, DOI 10.1111/j.1365-2958.2010.07287.x; Hyams C, 2010, INFECT IMMUN, V78, P704, DOI 10.1128/IAI.00881-09; INOUYE S, 1983, SCIENCE, V221, P59, DOI 10.1126/science.6344218; Jacobsen FE, 2011, METALLOMICS, V3, P38, DOI 10.1039/c0mt00050g; Janulczyk R, 1999, MOL MICROBIOL, V34, P596, DOI 10.1046/j.1365-2958.1999.01626.x; Jomaa M, 2005, INFECT IMMUN, V73, P6852, DOI 10.1128/IAI.73.10.6852-6859.2005; Jonsson IM, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0014209; Kadioglu A, 2008, NAT REV MICROBIOL, V6, P288, DOI 10.1038/nrmicro1871; Khandavilli S, 2008, MOL MICROBIOL, V67, P541, DOI 10.1111/j.1365-2958.2007.06065.x; Knapp S, 2004, J IMMUNOL, V172, P3132, DOI 10.4049/jimmunol.172.5.3132; Koedel U, 2003, J IMMUNOL, V170, P438, DOI 10.4049/jimmunol.170.1.438; Lacks SA, 2000, MOL MICROBIOL, V35, P1089, DOI 10.1046/j.1365-2958.2000.01777.x; Lau GW, 2001, MOL MICROBIOL, V40, P555, DOI 10.1046/j.1365-2958.2001.02335.x; Leskela S, 1999, MOL MICROBIOL, V31, P1075, DOI 10.1046/j.1365-2958.1999.01247.x; Link AJ, 1997, J BACTERIOL, V179, P6228, DOI 10.1128/jb.179.20.6228-6237.1997; Loisel E, 2008, J MOL BIOL, V381, P594, DOI 10.1016/j.jmb.2008.05.068; Loisel E, 2011, BIOCHEMISTRY-US, V50, P3551, DOI 10.1021/bi200012f; Machata S, 2008, J IMMUNOL, V181, P2028, DOI 10.4049/jimmunol.181.3.2028; Malley R, 2003, P NATL ACAD SCI USA, V100, P1966, DOI 10.1073/pnas.0435928100; Marion C, 2011, INFECT IMMUN, V79, P4193, DOI 10.1128/IAI.05290-11; Marra A, 2002, MICROBIOL-SGM, V148, P1483, DOI 10.1099/00221287-148-5-1483; Marriott HM, 2008, AM J RESP CRIT CARE, V177, P887, DOI 10.1164/rccm.200707-990OC; McAllister LJ, 2004, MOL MICROBIOL, V53, P889, DOI 10.1111/j.1365-2958.2004.04164.x; McCluskey J, 2004, MOL MICROBIOL, V51, P1661, DOI 10.1111/j.1365-2958.2003.03917.x; Molzen TE, 2011, INFECT IMMUN, V79, P288, DOI 10.1128/IAI.00631-10; Orihuela CJ, 2001, INFECT IMMUN, V69, P7565, DOI 10.1128/IAI.69.12.7565-7571.2001; Overweg K, 2000, INFECT IMMUN, V68, P4180, DOI 10.1128/IAI.68.7.4180-4188.2000; Petit CM, 2001, FEMS MICROBIOL LETT, V200, P229, DOI 10.1111/j.1574-6968.2001.tb10720.x; Petrarca P, 2010, J BACTERIOL, V192, P1553, DOI 10.1128/JB.01310-09; Pezza RJ, 2002, NUCLEIC ACIDS RES, V30, P4700, DOI 10.1093/nar/gkf606; Polissi A, 1998, INFECT IMMUN, V66, P5620, DOI 10.1128/IAI.66.12.5620-5629.1998; Richards L, 2010, IMMUNOBIOLOGY, V215, P251, DOI 10.1016/j.imbio.2009.12.004; Sambrook J., 1989, MOL CLONING LAB MANU, V2; Samen U, 2004, J BACTERIOL, V186, P1398, DOI 10.1128/JB.186.5.1398-1408.2004; SANKARAN K, 1994, J BIOL CHEM, V269, P19701; Schmaler M, 2009, J IMMUNOL, V182, P7110, DOI 10.4049/jimmunol.0804292; Schreur PJW, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022299; SEGAL AW, 1980, FEBS LETT, V110, P111, DOI 10.1016/0014-5793(80)80035-4; Standish AJ, 2009, J IMMUNOL, V183, P2602, DOI 10.4049/jimmunol.0900688; Stoll H, 2005, INFECT IMMUN, V73, P2411, DOI 10.1128/IAI.73.4.2411-2423.2005; Sutcliffe IC, 2002, MICROBIOL-SGM, V148, P2065, DOI 10.1099/00221287-148-7-2065; Tettelin H, 2001, SCIENCE, V293, P498, DOI 10.1126/science.1061217; Tjalsma H, 1999, J BIOL CHEM, V274, P1698, DOI 10.1074/jbc.274.3.1698; TOKUNAGA M, 1982, P NATL ACAD SCI-BIOL, V79, P2255, DOI 10.1073/pnas.79.7.2255; Tseng HJ, 2002, INFECT IMMUN, V70, P1635, DOI 10.1128/IAI.70.3.1635-1639.2002; van Rossum AMC, 2005, INFECT IMMUN, V73, P7718, DOI 10.1128/IAI.73.11.7718-7726.2005; Wardenburg JB, 2006, P NATL ACAD SCI USA, V103, P13831, DOI 10.1073/pnas.0603072103; Ware D, 2006, INFECT IMMUN, V74, P352, DOI 10.1128/IAI.74.1.352-361.2006; YAMAGATA H, 1983, MOL GEN GENET, V192, P10, DOI 10.1007/BF00327640; Yoshimura A, 1999, J IMMUNOL, V163, P1	82	28	28	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 24	2012	7	7							e41393	10.1371/journal.pone.0041393	http://dx.doi.org/10.1371/journal.pone.0041393			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	978NX	22911788	Green Published, gold, Green Accepted, Green Submitted			2022-12-25	WOS:000306751300036
J	Rajasekaran, S; Vaz, M; Reddy, SP				Rajasekaran, Subbiah; Vaz, Michelle; Reddy, Sekhar P.			Fra-1/AP-1 Transcription Factor Negatively Regulates Pulmonary Fibrosis In Vivo	PLOS ONE			English	Article							EPITHELIAL-MESENCHYMAL TRANSITION; TISSUE INHIBITOR; MATRIX METALLOPROTEINASES; TGF-BETA; EXPRESSION; MICE; CELLS; AP-1; ACTIVATION; PROMOTER	The Fra-1/AP-1 transcription factor plays a key role in tumor epithelial cell progression; however, its role in pathogenic lung fibrosis remains unclear. In the present study, using a genetic approach (Fra-1 deficient mice), we have demonstrated a novel regulatory (protective) role for Fra-1 in lung fibrosis. We found greater levels of progressive interstitial fibrosis, characterized by increased levels of inflammation, collagen accumulation, and profibrotic and fibrotic gene expression in the lungs of Fra-1(Delta/Delta) mice than in those of Fra-1(+/+) mice following bleomycin treatment. Fra-1 knockdown in human lung epithelial cells caused the upregulation of mesenchymal marker N-cadherin, concomitant with a downregulation of the epithelial phenotype marker E-cadherin, under basal conditions and in response to bleomycin and TGF-beta 1. Furthermore, Fra-1 knockdown caused an enhanced expression of type 1 collagen and the downregulation of collagenase (MMP-1 and MMP-13) gene expression in human lung epithelial cells. Collectively, our findings demonstrate that Fra-1 mediates anti-fibrotic effects in the lung through the modulation of proinflammatory, profibrotic and fibrotic gene expression, and suggests that the Fra-1 transcription factor may be a potential target for pulmonary fibrosis, a progressive disorder with poor prognosis and treatment.	[Rajasekaran, Subbiah; Reddy, Sekhar P.] Univ Illinois, Dept Pediat, Chicago, IL 60607 USA; [Rajasekaran, Subbiah; Vaz, Michelle; Reddy, Sekhar P.] Johns Hopkins Univ, Dept Environm Hlth Sci, Bloomberg Sch Publ Hlth, Baltimore, MD 21205 USA	University of Illinois System; University of Illinois Chicago; University of Illinois Chicago Hospital; Johns Hopkins University; Johns Hopkins Bloomberg School of Public Health	Rajasekaran, S (corresponding author), Univ Illinois, Dept Pediat, Chicago, IL 60607 USA.	sreddy03@uic.edu		Subbiah, Rajasekaran/0000-0003-2303-3246	National Institutes of Health (NIH) [RO1 ES11863, RO1 HL66109, R21 ES18998]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL066109] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [R21ES018998, R01ES011863] Funding Source: NIH RePORTER	National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS))	Funded by the National Institutes of Health (NIH) grants RO1 ES11863, RO1 HL66109, R21 ES18998 (to SPR). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adiseshaiah P, 2008, J CELL PHYSIOL, V216, P405, DOI 10.1002/jcp.21410; Andreolas C, 2008, INT J CANCER, V122, P1745, DOI 10.1002/ijc.23309; ANGEL P, 1988, CELL, V55, P875, DOI 10.1016/0092-8674(88)90143-2; Asano Y, 2006, CLIN EXP RHEUMATOL, V24, P394; Bonniaud P, 2005, AM J RESP CRIT CARE, V171, P889, DOI 10.1164/rccm.200405-612OC; BROEKELMANN TJ, 1991, P NATL ACAD SCI USA, V88, P6642, DOI 10.1073/pnas.88.15.6642; Cailes JB, 1996, EUR RESPIR J, V9, P992, DOI 10.1183/09031936.96.09050992; Chung KY, 1996, J BIOL CHEM, V271, P3272, DOI 10.1074/jbc.271.6.3272; Cobelens PM, 2010, CRIT CARE, V14, DOI 10.1186/cc9232; Cutroneo KR, 2003, J CELL BIOCHEM, V90, P1, DOI 10.1002/jcb.10599; Daniels CE, 2004, J CLIN INVEST, V114, P1308, DOI 10.1175/JCI200419603; Eferl R, 2003, NAT REV CANCER, V3, P859, DOI 10.1038/nrc1209; Eferl R, 2004, EMBO J, V23, P2789, DOI 10.1038/sj.emboj.7600282; Eferl R, 2008, P NATL ACAD SCI USA, V105, P10525, DOI 10.1073/pnas.0801414105; Eitzman DT, 1996, J CLIN INVEST, V97, P232, DOI 10.1172/JCI118396; Gharaee-Kermani M, 2005, AM J PATHOL, V166, P1593, DOI 10.1016/S0002-9440(10)62470-4; GRIGORIADIS AE, 1993, J CELL BIOL, V122, P685, DOI 10.1083/jcb.122.3.685; Ho HH, 2008, J IMMUNOL, V181, P5089, DOI 10.4049/jimmunol.181.7.5089; Izbicki G, 2002, INT J EXP PATHOL, V83, P111, DOI 10.1046/j.1365-2613.2002.00220.x; JANICKBUCKNER D, 1989, TOXICOL APPL PHARM, V100, P465, DOI 10.1016/0041-008X(89)90294-9; Jochum W, 2000, NAT MED, V6, P980, DOI 10.1038/79676; Jones HA, 1998, AM J RESP CRIT CARE, V158, P620, DOI 10.1164/ajrccm.158.2.9711075; Kalluri R, 2003, J CLIN INVEST, V112, P1776, DOI 10.1172/JCI200320530; Keane MP, 1999, J IMMUNOL, V162, P5511; Kim HT, 1997, BIOCHEM J, V324, P547, DOI 10.1042/bj3240547; Kireva T, 2011, HEPATOLOGY, V53, P1259, DOI 10.1002/hep.24175; Lawson WE, 2005, AM J PATHOL, V167, P1267, DOI 10.1016/S0002-9440(10)61214-X; Liu JY, 1998, AM J PATHOL, V153, P1839, DOI 10.1016/S0002-9440(10)65698-2; McKeown S, 2009, EUR RESPIR J, V33, P77, DOI 10.1183/09031936.00060708; Meixner A, 2004, EMBO J, V23, P1325, DOI 10.1038/sj.emboj.7600133; Mejlvang J, 2007, EXP CELL RES, V313, P380, DOI 10.1016/j.yexcr.2006.10.017; Mitsuhashi H, 1996, AM J RESP CRIT CARE, V153, P369, DOI 10.1164/ajrccm.153.1.8542145; Nagase H, 1999, J BIOL CHEM, V274, P21491, DOI 10.1074/jbc.274.31.21491; Ortiz LA, 2002, AM J PHYSIOL-LUNG C, V282, pL1209, DOI 10.1152/ajplung.00144.2001; Pardo A, 2003, AM J RESP CRIT CARE, V167, P925, DOI 10.1164/rccm.200209-1007OC; Pardo A, 2002, INT J BIOCHEM CELL B, V34, P1534, DOI 10.1016/S1357-2725(02)00091-2; PHAN SH, 1983, CHEST, V83, pS44; Piao CQ, 2005, CARCINOGENESIS, V26, P725, DOI 10.1093/carcin/bgi016; Ramos C, 2001, AM J RESP CELL MOL, V24, P591, DOI 10.1165/ajrcmb.24.5.4333; Schorpp M, 1996, NUCLEIC ACIDS RES, V24, P1787, DOI 10.1093/nar/24.9.1787; SCHRIER DJ, 1983, AM REV RESPIR DIS, V127, P63, DOI 10.1164/arrd.1983.127.1.63; Selman M, 2000, AM J PHYSIOL-LUNG C, V279, pL562, DOI 10.1152/ajplung.2000.279.3.L562; Sisson TH, 2010, AM J RESP CRIT CARE, V181, P254, DOI 10.1164/rccm.200810-1615OC; Smart DE, 2006, HEPATOLOGY, V44, P1432, DOI 10.1002/hep.21436; SMITH RE, 1994, J IMMUNOL, V153, P4704; Smith RE, 1998, J LEUKOCYTE BIOL, V64, P528, DOI 10.1002/jlb.64.4.528; Stinson S, 2011, SCI SIGNAL, V4, DOI 10.1126/scisignal.2001538; Swiderski RE, 1998, AM J PATHOL, V152, P821; Takada Y, 2011, ONCOGENE, V30, P3821, DOI 10.1038/onc.2011.101; Tallquist MD, 2000, GENESIS, V26, P113, DOI 10.1002/(SICI)1526-968X(200002)26:2<113::AID-GENE3>3.0.CO;2-2; Tan RJ, 2006, AM J RESP CELL MOL, V35, P289, DOI 10.1165/rcmb.2005-0471OC; Tower GB, 2003, EUR J BIOCHEM, V270, P4216, DOI 10.1046/j.1432-1033.2003.03821.x; Vaz M, 2012, AM J RESP CELL MOL, V46, P55, DOI 10.1165/rcmb.2011-0169OC; Vincenti MP, 2000, METH MOL B, V151, P121, DOI 10.1385/1-59259-046-2:121; Westermarck J, 1999, FASEB J, V13, P781, DOI 10.1096/fasebj.13.8.781; Willis BC, 2005, AM J PATHOL, V166, P1321, DOI 10.1016/S0002-9440(10)62351-6; Willis BC, 2007, AM J PHYSIOL-LUNG C, V293, pL525, DOI 10.1152/ajplung.00163.2007; Wu Z, 2007, RESP RES, V8, DOI 10.1186/1465-9921-8-1; Yamaguchi T, 2009, J BONE MINER RES, V24, P2056, DOI [10.1359/JBMR.090603, 10.1359/jbmr.090603]; Yan Sheng, 2005, Hepatobiliary Pancreat Dis Int, V4, P569; Yoshiji H, 2000, HEPATOLOGY, V32, P1248, DOI 10.1053/jhep.2000.20521; ZHANG K, 1995, AM J PATHOL, V147, P352	62	29	32	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 24	2012	7	7							e41611	10.1371/journal.pone.0041611	http://dx.doi.org/10.1371/journal.pone.0041611			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	978NX	22911824	gold, Green Published, Green Submitted			2022-12-25	WOS:000306751300058
J	Borobia, AM; Lubomirov, R; Ramirez, E; Lorenzo, A; Campos, A; Munoz-Romo, R; Fernandez-Capitan, C; Frias, J; Carcas, AJ				Borobia, Alberto M.; Lubomirov, Rubin; Ramirez, Elena; Lorenzo, Alicia; Campos, Armando; Munoz-Romo, Raul; Fernandez-Capitan, Carmen; Frias, Jesus; Carcas, Antonio J.			An Acenocoumarol Dosing Algorithm Using Clinical and Pharmacogenetic Data in Spanish Patients with Thromboembolic Disease	PLOS ONE			English	Article							ORAL ANTICOAGULANT-THERAPY; BLEEDING COMPLICATIONS; DOSE REQUIREMENTS; WARFARIN; CYP2C9; VKORC1; GENOTYPE; POLYMORPHISM; ASSOCIATION; TRIAL	Appropriate dosing of coumarins is difficult to establish, due to significant inter-individual variability in the dose required to obtain stable anticoagulation. Several genetic and other clinical factors have been associated with the coumarins dose, and some pharmacogenetic-guided dosing algorithms for warfarin and acenocoumarol have been developed for mixed populations. We recruited 147 patients with thromboembolic disease who were on stable doses and with an international normalized ratio (INR) between 2 and 3. We ascertained the influence of clinical and genetic variables on the stable acenocoumarol dose by multiple linear regression analysis in a derivation cohort (DC; n = 117) and developed an algorithm for dosing that included clinical factors (age, body mass index and concomitant drugs) and genetic variations of VKORC1, CYP2C9, CYP4F2 and APOE. For purposes of comparison, a model including only clinical data was created. The clinical factors explained 22% of the dose variability, which increased to 60.6% when pharmacogenetic information was included (p<0.001); CYP4F2 and APOE variants explained 4.9% of this variability. The mean absolute error of the predicted acenocoumarol dose (mg/week) obtained with the pharmacogenetic algorithm was 3.63 vs. 5.08 mg/week with the clinical algorithm (95% CI: 0.88 to 2.04). In the testing cohort (n = 30), clinical factors explained a mere 7% of the dose variability, compared to 39% explained by the pharmacogenetic algorithm. Considering a more clinically relevant parameter, the pharmacogenetic algorithm correctly predicted the real stable dose in 59.8% of the cases (DC) vs. only 37.6% predicted by the clinical algorithm (95% CI: 10 to 35). Therefore the number of patients needed to genotype to avoid one over-or underdosing was estimated to be 5.	[Borobia, Alberto M.; Ramirez, Elena; Frias, Jesus; Carcas, Antonio J.] Univ Autonoma Madrid, Clin Pharmacol Serv, La Paz Univ Hosp, Dept Pharmacol,Sch Med,IdiPAZ, Madrid, Spain; [Fernandez-Capitan, Carmen] Univ Autonoma Madrid, Dept Internal Med, La Paz Univ Hosp, Sch Med, Madrid, Spain	Autonomous University of Madrid; Hospital Universitario La Paz; Autonomous University of Madrid; Hospital Universitario La Paz	Borobia, AM (corresponding author), Univ Autonoma Madrid, Clin Pharmacol Serv, La Paz Univ Hosp, Dept Pharmacol,Sch Med,IdiPAZ, Madrid, Spain.	a.borobia@gmail.com; antonio.carcas@uam.es	Ramírez, Elena/AGX-8858-2022; Carcas, Antonio J/E-1149-2012; Ramírez, Elena/S-5600-2018; Iniesta, Jesus A Frias/L-2692-2013; Borobia, Alberto M./H-6887-2013	Ramírez, Elena/0000-0002-4052-8876; Carcas, Antonio J/0000-0003-1823-4174; Ramírez, Elena/0000-0002-4052-8876; Borobia, Alberto M./0000-0002-8584-3263	Instituto de Salud Carlos III [FIS PI070710]	Instituto de Salud Carlos III(Instituto de Salud Carlos IIIEuropean Commission)	This study was supported by a research grant from Instituto de Salud Carlos III (FIS PI070710). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anderson JL, 2007, CIRCULATION, V116, P2563, DOI 10.1161/CIRCULATIONAHA.107.737312; Ansell J, 2001, CHEST, V119, p22S, DOI 10.1378/chest.119.1_suppl.22S; Cadamuro J, 2010, EUR J CLIN PHARMACOL, V66, P253, DOI 10.1007/s00228-009-0768-7; Caldwell MD, 2008, BLOOD, V111, P4106, DOI 10.1182/blood-2007-11-122010; Caldwell MD, 2007, CLIN MED RES, V5, P8, DOI 10.3121/cmr.2007.724; Caraco Y, 2008, CLIN PHARMACOL THER, V83, P460, DOI 10.1038/sj.clpt.6100316; Cavallari LH, 2011, PHARMACOTHERAPY, V31, P785, DOI 10.1592/phco.31.8.785; COOK RJ, 1995, BRIT MED J, V310, P452, DOI 10.1136/bmj.310.6977.452; Gadisseur APA, 2002, BRIT J HAEMATOL, V117, P940, DOI 10.1046/j.1365-2141.2002.03493.x; Guijarro R, 2008, EUR J INTERN MED, V19, P443, DOI 10.1016/j.ejim.2007.06.026; Hirsh J, 2003, CIRCULATION, V107, P1692, DOI 10.1161/01.CIR.0000063575.17904.4E; HOFMAN A, 1991, EUR J EPIDEMIOL, V7, P403, DOI 10.1007/BF00145007; Klein TE, 2009, NEW ENGL J MED, V360, P753, DOI 10.1056/NEJMoa0809329; LANDEFELD CS, 1989, AM J MED, V87, P144; Lenzini P, 2010, CLIN PHARMACOL THER, V87, P572, DOI 10.1038/clpt.2010.13; Meijer K, 2011, THROMB HAEMOSTASIS, V105, P232, DOI 10.1160/TH10-05-0324; Millican EA, 2007, BLOOD, V110, P1511, DOI 10.1182/blood-2007-01-069609; Moreau C, 2011, J THROMB HAEMOST, V9, P711, DOI 10.1111/j.1538-7836.2011.04213.x; Palareti G, 1996, LANCET, V348, P423, DOI 10.1016/S0140-6736(96)01109-9; Perez-Andreu V, 2010, J THROMB HAEMOST, V8, P1012, DOI 10.1111/j.1538-7836.2010.03800.x; Perez-Andreu V, 2009, BLOOD, V113, P4977, DOI 10.1182/blood-2008-09-176222; Rathore SS, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0037844; Sagrieya H, 2010, PHARMACOGENET GENOM, V20, P407, DOI 10.1097/FPC.0b013e328338bac2; Schalekamp T, 2006, CLIN PHARMACOL THER, V80, P13, DOI 10.1016/j.clpt.2006.04.006; Sconce EA, 2005, BLOOD, V106, P2329, DOI 10.1182/blood-2005-03-1108; SHEINER LB, 1981, J PHARMACOKINET BIOP, V9, P503, DOI 10.1007/BF01060893; Spreafico M, 2008, PHARMACOGENOMICS, V9, P1237, DOI 10.2217/14622416.9.9.1237; Stehle S, 2008, CLIN PHARMACOKINET, V47, P565, DOI 10.2165/00003088-200847090-00002; Takahashi H, 2004, CLIN PHARMACOL THER, V75, P376, DOI 10.1016/j.clpt.2004.01.007; Teichert M, 2009, CLIN PHARMACOL THER, V85, P379, DOI 10.1038/clpt.2008.294; Teichert M, 2009, HUM MOL GENET, V18, P3758, DOI 10.1093/hmg/ddp309; van Schie RMF, 2011, EUR HEART J, V32, P1909, DOI 10.1093/eurheartj/ehr116; van Schie RMF, 2009, PHARMACOGENOMICS, V10, P1687, DOI [10.2217/pgs.09.125, 10.2217/PGS.09.125]; VANDERMEER FJM, 1993, ARCH INTERN MED, V153, P1557, DOI 10.1001/archinte.153.13.1557; Verde Z, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011210; Visser LE, 2005, PHARMACOGENET GENOM, V15, P69, DOI 10.1097/01213011-200502000-00002; Wu AHB, 2007, PHARMACOGENOMICS, V8, P851, DOI 10.2217/14622416.8.7.851; Zambon CF, 2011, PHARMACOGENOMICS, V12, P15, DOI [10.2217/pgs.10.162, 10.2217/PGS.10.162]	38	44	46	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 20	2012	7	7							e41360	10.1371/journal.pone.0041360	http://dx.doi.org/10.1371/journal.pone.0041360			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	977GL	22911785	Green Published, Green Submitted, gold			2022-12-25	WOS:000306644600075
J	Choo, YY; Hagen, T				Choo, Yin Yin; Hagen, Thilo			Mechanism of Cullin3 E3 Ubiquitin Ligase Dimerization	PLOS ONE			English	Article							RECOGNITION MODEL; MAMMALIAN-CELLS; DLG MOTIFS; C-ELEGANS; COMPLEX; PROTEIN; KEAP1; NRF2; DEGRADATION; ACTIVATION	Cullin E3 ligases are the largest family of ubiquitin ligases with diverse cellular functions. One of seven cullin proteins serves as a scaffold protein for the assembly of the multisubunit ubiquitin ligase complex. Cullin binds the RING domain protein Rbx1/Rbx2 via its C-terminus and a cullin-specific substrate adaptor protein via its N-terminus. In the Cul3 ubiquitin ligase complex, Cul3 substrate receptors contain a BTB/POZ domain. Several studies have established that Cul3-based E3 ubiquitin ligases exist in a dimeric state which is required for binding of a number of substrates and has been suggested to promote ubiquitin transfer. In two different models, Cul3 has been proposed to dimerize either via BTB/POZ domain dependent substrate receptor homodimerization or via direct interaction between two Cul3 proteins that is mediated by Nedd8 modification of one of the dimerization partners. In this study, we show that the majority of the Cul3 proteins in cells exist as dimers or multimers and that Cul3 self-association is mediated via the Cul3 N-terminus while the Cul3 C-terminus is not required. Furthermore, we show that Cul3 self-association is independent of its modification with Nedd8. Our results provide evidence for BTB substrate receptor dependent Cul3 dimerization which is likely to play an important role in promoting substrate ubiquitination.	[Choo, Yin Yin; Hagen, Thilo] Natl Univ Singapore, Yong Loo Lin Sch Med, Dept Biochem, Singapore 117595, Singapore	National University of Singapore	Choo, YY (corresponding author), Natl Univ Singapore, Yong Loo Lin Sch Med, Dept Biochem, Singapore 117595, Singapore.	bchth@nus.edu.sg			Singapore National Medical Research Council [EDG09May050]	Singapore National Medical Research Council(National Medical Research Council, Singapore)	This study was supported by a grant from the Singapore National Medical Research Council (grant number EDG09May050). The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahn J, 2011, BIOCHEMISTRY-US, V50, P1359, DOI 10.1021/bi101749s; Bosu DR, 2008, CELL DIV, V3, DOI 10.1186/1747-1028-3-7; Chen YZ, 2009, MOL CELL, V35, P841, DOI 10.1016/j.molcel.2009.09.004; Chew EH, 2007, J BIOL CHEM, V282, P17032, DOI 10.1074/jbc.M701153200; Chew EH, 2007, CELL SIGNAL, V19, P1071, DOI 10.1016/j.cellsig.2006.12.002; Choo YY, 2011, MOL BIOL CELL, V22, P4706, DOI 10.1091/mbc.E11-03-0251; Correale S, 2011, BIOCHIMIE, V93, P715, DOI 10.1016/j.biochi.2010.12.014; Culbert AA, 2001, FEBS LETT, V507, P288, DOI 10.1016/S0014-5793(01)02990-8; Cullinan SB, 2004, MOL CELL BIOL, V24, P8477, DOI 10.1128/MCB.24.19.8477-8486.2004; Duda DM, 2008, CELL, V134, P995, DOI 10.1016/j.cell.2008.07.022; Furukawa M, 2003, NAT CELL BIOL, V5, P1001, DOI 10.1038/ncb1056; Hernadez-Munoz I, 2005, P NATL ACAD SCI USA, V102, P7635, DOI 10.1073/pnas.0408918102; Kigoshi Y, 2011, J BIOL CHEM, V286, P33613, DOI 10.1074/jbc.M111.245126; Kobayashi A, 2004, MOL CELL BIOL, V24, P7130, DOI 10.1128/MCB.24.16.7130-7139.2004; Liew CW, 2010, BIOCHEM J, V431, P23, DOI 10.1042/BJ20100957; Liu J, 2009, SCIENCE, V323, P1218, DOI 10.1126/science.1157669; Lo SC, 2006, EMBO J, V25, P3605, DOI 10.1038/sj.emboj.7601243; Luke-Glaser S, 2007, J CELL SCI, V120, P3179, DOI 10.1242/jcs.015883; McMahon M, 2006, J BIOL CHEM, V281, P24756, DOI 10.1074/jbc.M601119200; Moreau D, 2011, DEV CELL, V21, P231, DOI 10.1016/j.devcel.2011.06.014; Nikolay R, 2004, J BIOL CHEM, V279, P2673, DOI 10.1074/jbc.M311112200; Petroski MD, 2005, NAT REV MOL CELL BIO, V6, P9, DOI 10.1038/nrm1547; Pintard L, 2004, EMBO J, V23, P1681, DOI 10.1038/sj.emboj.7600186; Pintard L, 2003, CURR BIOL, V13, P911, DOI 10.1016/S0960-9822(03)00336-1; Plechanovova A, 2011, NAT STRUCT MOL BIOL, V18, P1052, DOI 10.1038/nsmb.2108; Saha A, 2008, MOL CELL, V32, P21, DOI 10.1016/j.molcel.2008.08.021; Singer JD, 1999, GENE DEV, V13, P2375, DOI 10.1101/gad.13.18.2375; Small E, 2010, BIOCHEM BIOPH RES CO, V400, P471, DOI 10.1016/j.bbrc.2010.08.062; Stogios PJ, 2005, GENOME BIOL, V6, DOI 10.1186/gb-2005-6-10-r82; Tang X, 2007, CELL, V129, P1165, DOI 10.1016/j.cell.2007.04.042; Tong KI, 2006, MOL CELL BIOL, V26, P2887, DOI 10.1128/MCB.26.8.2887-2900.2006; Tong KI, 2007, MOL CELL BIOL, V27, P7511, DOI 10.1128/MCB.00753-07; Tong KI, 2006, BIOL CHEM, V387, P1311, DOI 10.1515/BC.2006.164; Wimuttisuk W, 2007, MOL BIOL CELL, V18, P899, DOI 10.1091/mbc.E06-06-0542; Xu LH, 2002, PLANT CELL, V14, P1919, DOI 10.1105/tpc.003368; Yamoah K, 2008, P NATL ACAD SCI USA, V105, P12230, DOI 10.1073/pnas.0806155105; Zhang DD, 2004, MOL CELL BIOL, V24, P10941, DOI 10.1128/MCB.24.24.10941-10953.2004; Zhang ZG, 2010, EMBO J, V29, P3733, DOI 10.1038/emboj.2010.247; Zheng N, 2002, NATURE, V416, P703, DOI 10.1038/416703a; Zhuang M, 2009, MOL CELL, V36, P39, DOI 10.1016/j.molcel.2009.09.022; Zipper LM, 2002, J BIOL CHEM, V277, P36544, DOI 10.1074/jbc.M206530200	41	14	14	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 20	2012	7	7							e41350	10.1371/journal.pone.0041350	http://dx.doi.org/10.1371/journal.pone.0041350			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	977GL	22911784	Green Published, Green Submitted, gold			2022-12-25	WOS:000306644600074
J	Rivero-Juarez, A; Morgaz, J; Camacho, A; Munoz-Rascon, P; Dominguez, JM; Sanchez-Cespedes, R; Torre-Cisneros, J; Rivero, A				Rivero-Juarez, Antonio; Morgaz, Juan; Camacho, Angela; Munoz-Rascon, Pilar; Manuel Dominguez, Juan; Sanchez-Cespedes, Raquel; Torre-Cisneros, Julian; Rivero, Antonio			Liver Stiffness Using Transient Elastography is Applicable to Canines for Hepatic Disease Models	PLOS ONE			English	Article							C VIRUS; FIBROSIS; DIAGNOSIS; KEY	Background: The objectives of this study were to evaluate the best position and best exploration probe for determining liver stiffness (LS) in dogs using transient liver elastography (TE). Thirteen dogs were used in the study. Methodology/Principal Findings: Morphometric measurements taken were thoracic circumference, weight and height. Elastographic measurements were taken in 4 anatomical positions using two different probes: medium (M) and small (S). The exploration was considered correct when the success rate was above 60% and the interquartile range of the measurements did not exceed 30%. The best measurements were obtained in the middle of the 6th-9th intercostal spaces, with the dog in the left lateral position and using probe M for preference in adults and probe S mandatory for animals <2 years. The correlation between probes was 99%. Intra-observer variability showed an intra-class correlation of 97.6%. Conclusions/Significance: TE is a technique that is reproducible in dogs.	[Rivero-Juarez, Antonio; Camacho, Angela; Torre-Cisneros, Julian; Rivero, Antonio] Univ Hosp Reina Sofia, Infect Dis Unit, Inst Maimonides Invest Biomed IMIBIC, Cordoba, Spain; [Morgaz, Juan; Munoz-Rascon, Pilar; Manuel Dominguez, Juan] Vet Sch Cordoba, Dept Anim Med & Surg, Cordoba, Spain; [Sanchez-Cespedes, Raquel] Vet Sch Cordoba, Dept Comparat Pathol, Cordoba, Spain		Rivero-Juarez, A (corresponding author), Univ Hosp Reina Sofia, Infect Dis Unit, Inst Maimonides Invest Biomed IMIBIC, Cordoba, Spain.	ariveror@gmail.com	Sánchez-Céspedes, Raquel/A-7467-2018; MORGAZ, JUAN/L-1056-2014; Rivero, Antonio/ABE-5294-2020; DE LA TORRE CISNEROS, JULIAN/AAL-5723-2021; Dominguez Perez, Juan Manuel/AGG-5203-2022; Espejo, Angela Camacho/AAM-9991-2021; Rivero-Juarez, Antonio/E-4528-2019	Sánchez-Céspedes, Raquel/0000-0003-3282-7187; MORGAZ, JUAN/0000-0002-5512-1622; Rivero-Juarez, Antonio/0000-0002-5813-6889; Rivero, Antonio/0000-0001-5005-8268; Rivero Roman, Antonio/0000-0002-8643-4250				Abenavoli L, 2008, INT J CLIN PRACT, V62, P1108, DOI 10.1111/j.1742-1241.2007.01680.x; Castera L, 2008, J HEPATOL, V48, P835, DOI 10.1016/j.jhep.2008.02.008; Ding CB, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022921; Dorner M, 2011, NATURE, V474, P208, DOI 10.1038/nature10168; Fraquelli M, 2007, GUT, V56, P968, DOI 10.1136/gut.2006.111302; Friedrich-Rust M, 2008, GASTROENTEROLOGY, V134, P960, DOI 10.1053/j.gastro.2008.01.034; Ghany MG, 2009, HEPATOLOGY, V49, P1335, DOI 10.1002/hep.22759; Hofmann WP, 2011, NAT REV GASTRO HEPAT, V8, P257, DOI 10.1038/nrgastro.2011.49; Ingiliz P, 2009, WORLD J GASTROENTERO, V15, P3398, DOI 10.3748/wjg.15.3398; Kapoor A, 2011, P NATL ACAD SCI USA, V108, P11608, DOI 10.1073/pnas.1101794108; Kim KM, 2007, J GASTROENTEROL, V42, P382, DOI 10.1007/s00535-007-2016-1; Laflamme D, 1997, CANINE PRACT, V22, P10; Lauer GM, 2001, NEW ENGL J MED, V345, P41, DOI 10.1056/NEJM200107053450107; Lavanchy D, 1999, J VIRAL HEPATITIS, V6, P35; Lucidarme D, 2007, HEPATOLOGY, V46, p318A; McGivern DR, 2011, GASTROENTEROLOGY, V141, P806, DOI 10.1053/j.gastro.2011.07.028; Neukam K, 2010, EUROPEAN J GASTROENT, V15, P93; Pietschmann T, 2009, NATURE, V457, P797, DOI 10.1038/457797a; Pineda JA, 2009, JAIDS-J ACQ IMM DEF, V51, P445, DOI 10.1097/QAI.0b013e3181acb675; Ploss A, 2009, EMBO REP, V10, P1220, DOI 10.1038/embor.2009.223; Ploss A, 2009, NATURE, V457, P882, DOI 10.1038/nature07684; Roulot D, 2008, J HEPATOL, V48, P606, DOI 10.1016/j.jhep.2007.11.020; Sandrin L, 2003, ULTRASOUND MED BIOL, V29, P1705, DOI 10.1016/j.ultrasmedbio.2003.07.001; Takeda T, 2006, WORLD J GASTROENTERO, V12, P7768, DOI 10.3748/wjg.v12.i48.7768; Vergara S, 2007, CLIN INFECT DIS, V45, P969, DOI 10.1086/521857; Verstrepen BE, 2011, J INFECT DIS, V204, P837, DOI 10.1093/infdis/jir423	26	6	6	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 20	2012	7	7							e41557	10.1371/journal.pone.0041557	http://dx.doi.org/10.1371/journal.pone.0041557			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	977GL	22911813	Green Published, gold, Green Submitted			2022-12-25	WOS:000306644600086
J	Takeda, E; Nakagawa, S; Nakaya, Y; Tanaka, A; Miyazawa, T; Yasuda, J				Takeda, Eri; Nakagawa, So; Nakaya, Yuki; Tanaka, Atsushi; Miyazawa, Takayuki; Yasuda, Jiro			Identification and Functional Analysis of Three Isoforms of Bovine BST-2	PLOS ONE			English	Article							CELL-SURFACE; IMMUNODEFICIENCY-VIRUS; MOLECULAR-CLONING; DOWN-REGULATION; HIV-1 RELEASE; TETHERIN; PROTEIN; BST-2/TETHERIN; RESTRICTION; ALIGNMENT	Human BST-2 (hBST-2) has been identified as a cellular antiviral factor that blocks the release of various enveloped viruses. Orthologues of BST-2 have been identified in several species, including human, monkeys, pig, mouse, cat and sheep. All have been reported to possess antiviral activity. Duplication of the BST-2 gene has been observed in sheep and the paralogues are referred to as ovine BST-2A and BST2-B, although only a single gene corresponding to BST-2 has been identified in most species. In this study, we identified three isoforms of bovine BST-2, named bBST-2A1, bBST-2A2 and bBST-2B, in bovine cells treated with type I interferon, but not in untreated cells. Both bBST-2A1 and bBST-2A2 are posttranslationally modified by N-linked glycosylation and a GPI-anchor as well as hBST-2, while bBST-2B has neither of these modifications. Exogenous expression of bBST-2A1 or bBST-2A2 markedly reduced the production of bovine leukemia virus and vesicular stomatitis virus from cells, while the antiviral activity of bBST-2B was much weaker than those of bBST-2A1 and bBST-2A2. Our data suggest that bBST-2A1 and bBST-2A2 function as part of IFN-induced innate immunity against virus infection. On the other hand, bBST-2B may have a different physiological function from bBST-2A1 and bBST-2A2.	[Takeda, Eri; Yasuda, Jiro] Nagasaki Univ, Dept Emerging Infect Dis, Inst Trop Med, Nagasaki 852, Japan; [Nakagawa, So] Natl Inst Genet, Ctr Informat Biol, Mishima, Shizuoka 411, Japan; [Nakagawa, So] Natl Inst Genet, DNA Data Bank Japan DDBJ, Mishima, Shizuoka 411, Japan; [Nakagawa, So] Japan Soc Promot Sci, Tokyo, Japan; [Nakaya, Yuki; Miyazawa, Takayuki] Kyoto Univ, Inst Virus Res, Lab Signal Transduct, Kyoto 606, Japan; [Tanaka, Atsushi] Gunma Univ, Dept Virol & Prevent Med, Grad Sch Med, Maebashi, Gunma 371, Japan	Nagasaki University; Research Organization of Information & Systems (ROIS); National Institute of Genetics (NIG) - Japan; Research Organization of Information & Systems (ROIS); National Institute of Genetics (NIG) - Japan; Japan Society for the Promotion of Science; Kyoto University; Gunma University	Takeda, E (corresponding author), Nagasaki Univ, Dept Emerging Infect Dis, Inst Trop Med, Nagasaki 852, Japan.	j-yasuda@nagasaki-u.ac.jp	Nakagawa, So/Q-2712-2015; Nakaya, Yuki/AAD-1553-2020	Nakagawa, So/0000-0003-1760-3839; Nakaya, Yuki/0000-0002-0888-204X; Miyazawa, Takayuki/0000-0003-1938-9661; Yasuda, Jiro/0000-0001-9928-5621	Program for Promotion of Basic and Applied Researches for Innovations in Bio-oriented Industry (BRAIN)	Program for Promotion of Basic and Applied Researches for Innovations in Bio-oriented Industry (BRAIN)	Funding for this study was provided by the Program for Promotion of Basic and Applied Researches for Innovations in Bio-oriented Industry (BRAIN). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abascal F, 2010, NUCLEIC ACIDS RES, V38, pW7, DOI 10.1093/nar/gkq291; Andrew AJ, 2009, RETROVIROLOGY, V6, DOI 10.1186/1742-4690-6-80; Arnaud F, 2010, J VIROL, V84, P4415, DOI 10.1128/JVI.00029-10; Blasius AL, 2006, J IMMUNOL, V177, P3260, DOI 10.4049/jimmunol.177.5.3260; Darriba D, 2011, BIOINFORMATICS, V27, P1164, DOI 10.1093/bioinformatics/btr088; DEVARE SG, 1976, SCIENCE, V194, P1428, DOI 10.1126/science.188129; Dietrich I, 2011, J VIROL, V85, P5840, DOI 10.1128/JVI.00071-11; Elsik CG, 2009, SCIENCE, V324, P522, DOI 10.1126/science.1169588; Erikson E, 2011, P NATL ACAD SCI USA, V108, P13688, DOI 10.1073/pnas.1101684108; Evans DT, 2010, TRENDS MICROBIOL, V18, P388, DOI 10.1016/j.tim.2010.06.010; Fukuma A, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018247; Goffinet C, 2010, J VIROL, V84, P11374, DOI 10.1128/JVI.01067-10; GOTTLINGER HG, 1993, P NATL ACAD SCI USA, V90, P7381, DOI 10.1073/pnas.90.15.7381; ISHIKAWA J, 1995, GENOMICS, V26, P527, DOI 10.1016/0888-7543(95)80171-H; Jia B, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000429; Jouvenet N, 2009, J VIROL, V83, P1837, DOI 10.1128/JVI.02211-08; Kaletsky RL, 2009, P NATL ACAD SCI USA, V106, P2886, DOI 10.1073/pnas.0811014106; Katoh K, 2005, NUCLEIC ACIDS RES, V33, P511, DOI 10.1093/nar/gki198; Kent WJ, 2002, GENOME RES, V12, P656, DOI 10.1101/gr.229202; Kupzig S, 2003, TRAFFIC, V4, P694, DOI 10.1034/j.1600-0854.2003.00129.x; Liberatore RA, 2011, P NATL ACAD SCI USA, V108, P18097, DOI 10.1073/pnas.1113694108; Liu J, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011904; Mansouri M, 2009, J VIROL, V83, P9672, DOI 10.1128/JVI.00597-09; Mattiuzzo G, 2010, J VIROL, V84, P2618, DOI 10.1128/JVI.01928-09; Neil SJD, 2008, NATURE, V451, P425, DOI 10.1038/nature06553; Ohtomo T, 1999, BIOCHEM BIOPH RES CO, V258, P583, DOI 10.1006/bbrc.1999.0683; Perez-Caballero D, 2009, CELL, V139, P499, DOI 10.1016/j.cell.2009.08.039; Sakuma T, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006934; Sakuma T, 2009, J VIROL, V83, P2382, DOI 10.1128/JVI.01607-08; Stamatakis A, 2006, BIOINFORMATICS, V22, P2688, DOI 10.1093/bioinformatics/btl446; Tellam RL, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-193; Tokarev AA, 2011, J VIROL, V85, P51, DOI 10.1128/JVI.01795-10; Urata S, 2006, J VIROL, V80, P4191, DOI 10.1128/JVI.80.8.4191-4195.2006; Van Damme N, 2008, CELL HOST MICROBE, V3, P245, DOI 10.1016/j.chom.2008.03.001; Weidner JM, 2010, J VIROL, V84, P12646, DOI 10.1128/JVI.01328-10; Xu FW, 2011, VIROL J, V8, DOI 10.1186/1743-422X-8-198; YASUDA J, 1993, ARCH VIROL, V133, P283, DOI 10.1007/BF01313769; YASUDA J, 1994, J VIROL, V68, P8141, DOI 10.1128/JVI.68.12.8141-8146.1994; Zhang FW, 2009, CELL HOST MICROBE, V6, P54, DOI 10.1016/j.chom.2009.05.008	39	13	13	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 20	2012	7	7							e41483	10.1371/journal.pone.0041483	http://dx.doi.org/10.1371/journal.pone.0041483			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	977GL	22911799	Green Published, gold, Green Submitted			2022-12-25	WOS:000306644600081
J	Zeeshan, M; Alam, MT; Vinayak, S; Bora, H; Tyagi, RK; Alam, MS; Choudhary, V; Mittra, P; Lumb, V; Bharti, PK; Udhayakumar, V; Singh, N; Jain, V; Singh, PP; Sharma, YD				Zeeshan, Mohammad; Alam, Mohammad Tauqeer; Vinayak, Sumiti; Bora, Hema; Tyagi, Rupesh Kumar; Alam, Mohd Shoeb; Choudhary, Vandana; Mittra, Pooja; Lumb, Vanshika; Bharti, Praveen Kumar; Udhayakumar, Venkatachalam; Singh, Neeru; Jain, Vidhan; Singh, Pushpendra Pal; Sharma, Yagya Dutta			Genetic Variation in the Plasmodium falciparum Circumsporozoite Protein in India and Its Relevance to RTS,S Malaria Vaccine	PLOS ONE			English	Article							CELL EPITOPE POLYMORPHISMS; PHASE 2A TRIAL; NATURAL-SELECTION; CANDIDATE ANTIGENS; EXPANDED-PROGRAM; NAIVE ADULTS; EFFICACY; SEQUENCE; SAFETY; IMMUNOGENICITY	RTS,S is the most advanced malaria vaccine candidate, currently under phase-III clinical trials in Africa. This Plasmodium falciparum vaccine contains part of the central repeat region and the complete C-terminal T cell epitope region (Th2R and Th3R) of the circumsporozoite protein (CSP). Since naturally occurring polymorphisms at the vaccine candidate loci are critical determinants of the protective efficacy of the vaccines, it is imperative to investigate these polymorphisms in field isolates. In this study we have investigated the genetic diversity at the central repeat, C-terminal T cell epitope (Th2R and Th3R) and N-terminal T cell epitope regions of the CSP, in P. falciparum isolates from Madhya Pradesh state of India. These isolates were collected through a 5-year prospective study aimed to develop a well-characterized field-site for the future evaluation of malaria vaccine in India. Our results revealed that the central repeat (63 haplotypes, n = 161) and C-terminal Th2R/Th3R epitope (24 haplotypes, n = 179) regions were highly polymorphic, whereas N-terminal non-repeat region was less polymorphic (5 haplotypes, n = 161) in this population. We did not find any evidence of the role of positive natural selection in maintaining the genetic diversity at the Th2R/Th3R regions of CSP. Comparative analysis of the Th2R/Th3R sequences from this study to the global isolates (n = 1160) retrieved from the GenBank database revealed two important points. First, the majority of the sequences (similar to 61%, n = 179) from this study were identical to the Dd2/Indochina type, which is also the predominant Th2R/Th3R haplotype in Asia (similar to 59%, n = 974). Second, the Th2R/Th3R sequences in Asia, South America and Africa are geographically distinct with little allele sharing between continents. In conclusion, this study provides an insight on the existing polymorphisms in the CSP in a parasite population from India that could potentially influence the efficacy of RTS, S vaccine in this region.	[Zeeshan, Mohammad; Alam, Mohammad Tauqeer; Vinayak, Sumiti; Bora, Hema; Tyagi, Rupesh Kumar; Alam, Mohd Shoeb; Choudhary, Vandana; Mittra, Pooja; Lumb, Vanshika; Sharma, Yagya Dutta] All India Inst Med Sci, Dept Biotechnol, New Delhi 110029, India; [Bharti, Praveen Kumar; Singh, Neeru; Jain, Vidhan; Singh, Pushpendra Pal] Reg Med Res Ctr Tribals, Jabalpur, Madhya Pradesh, India; [Udhayakumar, Venkatachalam] Ctr Dis Control & Prevent, Malaria Branch, Div Parasit Dis & Malaria, Ctr Global Hlth, Atlanta, GA USA	All India Institute of Medical Sciences (AIIMS) New Delhi; Indian Council of Medical Research (ICMR); ICMR - National Institute for Research in Tribal Health (NIRTH); Centers for Disease Control & Prevention - USA	Zeeshan, M (corresponding author), All India Inst Med Sci, Dept Biotechnol, New Delhi 110029, India.	ydsharma_aiims@yahoo.com	Singh, Puspendra/R-5135-2019; Singh, Puspendra/P-1772-2017; Vinayak, Sumiti/F-9395-2013; Singh, Pushpendra/T-4248-2018; Singh, Puspendra/F-5751-2012; Singh, Pushpendra P./P-6421-2018; alam, mohammed/GXH-3645-2022	Singh, Puspendra/0000-0003-2616-9309; Singh, Pushpendra/0000-0002-7277-115X; Singh, Pushpendra P./0000-0003-3813-4322; 	Biotechnology Information System (BTIS) of the Department of Biotechnology at the All India Institute of Medical Sciences; Indian Council of Medical Research	Biotechnology Information System (BTIS) of the Department of Biotechnology at the All India Institute of Medical Sciences; Indian Council of Medical Research(Indian Council of Medical Research (ICMR))	We are grateful to all patients who donated their blood samples for this study. We also acknowledge the supports provided by the Biotechnology Information System (BTIS) of the Department of Biotechnology at the All India Institute of Medical Sciences, and Mrs. Shalini Narang during the preparation of this manuscript.; Financial support was provided by the Indian Council of Medical Research. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agnandji ST, 2010, J INFECT DIS, V202, P1076, DOI 10.1086/656190; Agnandji ST, 2011, NEW ENGL J MED, V365, P1863, DOI 10.1056/NEJMoa1102287; Aide P, 2011, VACCINE, V29, P6059, DOI 10.1016/j.vaccine.2011.03.041; Aide P, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013838; ALEY SB, 1986, J EXP MED, V164, P1915, DOI 10.1084/jem.164.6.1915; Alloueche A, 2003, AM J TROP MED HYG, V68, P97, DOI 10.4269/ajtmh.2003.68.97; Alloueche A, 2000, MOL BIOCHEM PARASIT, V106, P273, DOI 10.1016/S0166-6851(99)00221-2; Ancsin JB, 2004, J BIOL CHEM, V279, P21824, DOI 10.1074/jbc.M401979200; Asante KP, 2011, LANCET INFECT DIS, V11, P741, DOI 10.1016/S1473-3099(11)70100-1; Barry AE, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0008497; Bongfen SE, 2009, VACCINE, V27, P328, DOI 10.1016/j.vaccine.2008.09.097; Casares S, 2010, VACCINE, V28, P4880, DOI 10.1016/j.vaccine.2010.05.033; Chenet SM, 2008, MALARIA J, V7, DOI 10.1186/1475-2875-7-93; Conway DJ, 1997, PARASITOL TODAY, V13, P26, DOI 10.1016/S0169-4758(96)10077-6; Crompton PD, 2010, J CLIN INVEST, V120, P4168, DOI 10.1172/JCI44423; de Stricker K, 2000, MOL BIOCHEM PARASIT, V111, P123, DOI 10.1016/S0166-6851(00)00304-2; DOOLAN DL, 1992, INFECT IMMUN, V60, P675, DOI 10.1128/IAI.60.2.675-682.1992; ENEA V, 1984, SCIENCE, V225, P628, DOI 10.1126/science.6204384; Enosse S, 2006, PLOS CLIN TRIALS, V1, DOI 10.1371/journal.pctr.0010005; Escalante AA, 1998, GENETICS, V149, P189; Escalante AA, 2002, MOL BIOCHEM PARASIT, V125, P83, DOI 10.1016/S0166-6851(02)00216-5; FU YX, 1993, GENETICS, V133, P693; Garg S, 2007, MALARIA J, V6, DOI 10.1186/1475-2875-6-154; GORDON DM, 1995, J INFECT DIS, V171, P1576, DOI 10.1093/infdis/171.6.1576; Hall T.A., 1999, NUCL ACIDS S SERIES, V41, P95, DOI [DOI 10.1021/BK-1999-0734.CH008, citeulike-article-id:691774, 10.12691/ajmr-6-4-3]; HILL AVS, 1992, NATURE, V360, P434, DOI 10.1038/360434a0; HUGHES AL, 1991, GENETICS, V127, P345; Jalloh A, 2006, J CLIN MICROBIOL, V44, P1229, DOI 10.1128/JCM.44.4.1229-1235.2006; Jalloh A, 2009, MALARIA J, V8, DOI 10.1186/1475-2875-8-120; JONGWUTIWES S, 1994, AM J TROP MED HYG, V51, P659, DOI 10.4269/ajtmh.1994.51.659; Jongwutiwes S, 2010, VACCINE; Kester KE, 2008, VACCINE, V26, P2191, DOI 10.1016/j.vaccine.2008.02.048; Kester KE, 2007, VACCINE, V25, P5359, DOI 10.1016/j.vaccine.2007.05.005; Kester KE, 2009, J INFECT DIS, V200, P337, DOI 10.1086/600120; Kumkhaek C, 2005, J IMMUNOL, V175, P3935, DOI 10.4049/jimmunol.175.6.3935; Leach A, 2011, MALARIA J, V10, DOI 10.1186/1475-2875-10-224; NEI M, 1986, MOL BIOL EVOL, V3, P418; Nicholas K.B., 1997, EMBNEW NEWS, V4, P14, DOI DOI 10.11118/ACTAUN201361041061; Olotu A, 2011, LANCET INFECT DIS, V11, P102, DOI 10.1016/S1473-3099(10)70262-0; Putaporntip C, 2008, GENE, V427, P51, DOI 10.1016/j.gene.2008.09.009; Putaporntip C, 2009, INFECT GENET EVOL, V9, P567, DOI 10.1016/j.meegid.2009.02.006; Rathore D, 2005, J BIOL CHEM, V280, P20524, DOI 10.1074/jbc.M414254200; Rathore D, 2002, J BIOL CHEM, V277, P7092, DOI 10.1074/jbc.M106862200; Roggero MA, 1995, MOL IMMUNOL, V32, P1301, DOI 10.1016/0161-5890(95)00136-0; Rozas J, 2003, BIOINFORMATICS, V19, P2496, DOI 10.1093/bioinformatics/btg359; SHI YP, 1993, INFECT IMMUN, V61, P2425, DOI 10.1128/IAI.61.6.2425-2433.1993; Stoute JA, 1997, NEW ENGL J MED, V336, P86, DOI 10.1056/NEJM199701093360202; TAJIMA F, 1989, GENETICS, V123, P585; Tamura K, 2007, MOL BIOL EVOL, V24, P1596, DOI 10.1093/molbev/msm092; Tanabe K, 2004, SCIENCE, V303, P493, DOI 10.1126/science.1092077; Udhayakumar V, 1997, EUR J IMMUNOL, V27, P1952, DOI 10.1002/eji.1830270819; Vinayak S, 2006, MOL BIOCHEM PARASIT, V147, P101, DOI 10.1016/j.molbiopara.2006.01.013; Waitumbi JN, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007849; Weedall GD, 2007, INT J PARASITOL, V37, P77, DOI 10.1016/j.ijpara.2006.09.001; WHO, 2010, WORLD MALARIA REPORT 2010, P1; YOSHIDA N, 1990, EXP PARASITOL, V71, P386, DOI 10.1016/0014-4894(90)90064-J; Zakeri S, 2007, AM J TROP MED HYG, V76, P1046, DOI 10.4269/ajtmh.2007.76.1046	57	40	44	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 17	2012	7	8							e43430	10.1371/journal.pone.0043430	http://dx.doi.org/10.1371/journal.pone.0043430			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	996DG	22912873	gold, Green Published, Green Submitted			2022-12-25	WOS:000308063700101
J	Akong-Moore, K; Chow, OA; von Kockritz-Blickwede, M; Nizet, V				Akong-Moore, Kathryn; Chow, Ohn A.; von Koeckritz-Blickwede, Maren; Nizet, Victor			Influences of Chloride and Hypochlorite on Neutrophil Extracellular Trap Formation	PLOS ONE			English	Article							MYELOPEROXIDASE; CHOLESTEROL; PROTEINS; KILL	Background: The release by neutrophils of DNA-based extracellular traps (NETs) is a recently recognized innate immune phenomenon that contributes significantly to control of bacterial pathogens at tissue foci of infection. NETs have also been implicated in the pathogenesis of non-infectious diseases such as small vessel vasculitis, lupus and cystic fibrosis lung disease. Reactive oxygen species (ROS) are important mediators of NET generation (NETosis). Neutrophils with reduced ROS production, such as those from patients with chronic granulomatous disease or myeloperoxidase (MPO) deficiency, produce fewer NETs in response to inflammatory stimuli. To better understand the roles of various ROS in NETosis, we explore the role of MPO, its substrates chloride ion (Cl-) and hydrogen peroxide (H2O2), and its product hypochlorite (HOCl) in NETosis. Findings: In human peripheral blood neutrophils, pharmacologic inhibition of MPO decreased NETosis. Absence of extracellular Cl-, a substrate for MPO, also reduced NETosis. While exogenous addition of H2O2 and HOCl stimulated NETosis, only exogenous HOCl could rescue NETosis in the setting of MPO inhibition. Neither pharmacological inhibition nor genetic deletion of MPO in murine neutrophils blocked NETosis, in contrast to findings in human neutrophils. Conclusions: Our results pinpoint HOCl as the key ROS involved in human NETosis. This finding has implications for understanding innate immune function in diseases in which Cl- homeostasis is disturbed, such as cystic fibrosis. Our results also reveal an example of significant species-specific differences in NET phenotypes, and the need for caution in extrapolation to humans from studies of murine NETosis.	[Akong-Moore, Kathryn; Chow, Ohn A.; von Koeckritz-Blickwede, Maren; Nizet, Victor] Univ Calif San Diego, Dept Pediat, La Jolla, CA 92093 USA; [Nizet, Victor] Univ Calif San Diego, Skaggs Sch Pharm & Pharmaceut Sci, La Jolla, CA 92093 USA; [Akong-Moore, Kathryn; Nizet, Victor] Rady Childrens Hosp, San Diego, CA USA	University of California System; University of California San Diego; University of California System; University of California San Diego; Rady Childrens Hospital San Diego	Akong-Moore, K (corresponding author), Univ Calif San Diego, Dept Pediat, La Jolla, CA 92093 USA.	vnizet@ucsd.edu	Nizet, Victor/AAF-3190-2019	Nizet, Victor/0000-0003-3847-0422	UCSD Pediatric Pulmonary Medicine Fellowship Program; NIH [AI077780, AI090863]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R56AI090863, R01AI077780] Funding Source: NIH RePORTER	UCSD Pediatric Pulmonary Medicine Fellowship Program; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	K.A.-M. received the support of the UCSD Pediatric Pulmonary Medicine Fellowship Program. Research was funded by NIH grants AI077780 and AI090863 (VN). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Berends ETM, 2010, J INNATE IMMUN, V2, P576, DOI 10.1159/000319909; Brennan ML, 2001, J CLIN INVEST, V107, P419, DOI 10.1172/JCI8797; Brinkmann V, 2004, SCIENCE, V303, P1532, DOI 10.1126/science.1092385; Brinkmann V, 2007, NAT REV MICROBIOL, V5, P577, DOI 10.1038/nrmicro1710; Carr AC, 1996, ARCH BIOCHEM BIOPHYS, V332, P63, DOI 10.1006/abbi.1996.0317; Dypbukt JM, 2005, FREE RADICAL BIO MED, V39, P1468, DOI 10.1016/j.freeradbiomed.2005.07.008; Hampton MB, 1998, BLOOD, V92, P3007, DOI 10.1182/blood.V92.9.3007.421k47_3007_3017; HEINECKE JW, 1994, BIOCHEMISTRY-US, V33, P10127, DOI 10.1021/bi00199a041; Kang JI, 2008, CHEM RES TOXICOL, V21, P1028, DOI 10.1021/tx7003486; KETTLE AJ, 1995, BIOCHEM J, V308, P559, DOI 10.1042/bj3080559; Li PX, 2010, J EXP MED, V207, P1853, DOI 10.1084/jem.20100239; Metzler KD, 2011, BLOOD, V117, P953, DOI 10.1182/blood-2010-06-290171; Nauseef WM, 2007, IMMUNOL REV, V219, P88, DOI 10.1111/j.1600-065X.2007.00550.x; Painter RG, 2008, J LEUKOCYTE BIOL, V83, P1345, DOI 10.1189/jlb.0907658; Papayannopoulos V, 2010, J CELL BIOL, V191, P677, DOI 10.1083/jcb.201006052; von Kockritz-Blickwede M, 2009, J MOL MED, V87, P775, DOI 10.1007/s00109-009-0481-0; Zavodnik IB, 2001, FREE RADICAL BIO MED, V30, P363, DOI 10.1016/S0891-5849(00)00479-2	17	87	94	1	22	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 13	2012	7	8							e42984	10.1371/journal.pone.0042984	http://dx.doi.org/10.1371/journal.pone.0042984			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	988OJ	22912772	Green Published, gold, Green Submitted			2022-12-25	WOS:000307500100048
J	Heber, S; Briskie, JV; Apiolaza, LA				Heber, Sol; Briskie, James V.; Apiolaza, Luis A.			A Test of the 'Genetic Rescue' Technique Using Bottlenecked Donor Populations of Drosophila melanogaster	PLOS ONE			English	Article							ADDERS VIPERA-BERUS; OUTBREEDING DEPRESSION; INBREEDING DEPRESSION; CONSERVATION BIOLOGY; FLORIDA PANTHER; EXTINCTION RISK; MEXICAN WOLVES; NEW-ZEALAND; MANAGEMENT; RESTORATION	We produced replicated experimental lines of inbred fruit flies Drosophila melanogaster to test the effects of crossing different bottlenecked populations as a method of 'genetic rescue' for endangered species lacking outbred donor populations. Two strains differing in the origin of the founders were maintained as isolated populations in a laboratory environment. After two generations of controlled full-sib matings, the resulting inbred fruit flies had significantly reduced breeding success and survival rates. However, crosses between the two bottlenecked strains reversed the effects of inbreeding and led to increases in breeding success and survival that persisted into the second generation of hybrid offspring. In contrast, crosses within each strain (but between different replicate lines) resulted in only slight improvements in some fitness components, and this positive trend was reversed in the second generation. This experiment highlights the potential value of translocations between different inbred populations of endangered species as a tool to mitigate the negative effects of inbreeding, but this benefit may depend upon the origin of the populations. Our results also confirm the importance of maintaining adequate levels of genetic variation within populations and that severely bottlenecked populations should not be discounted as possible donors in genetic rescue programs for endangered species.	[Heber, Sol; Briskie, James V.] Univ Canterbury, Sch Biol Sci, Christchurch 1, New Zealand; [Apiolaza, Luis A.] Univ Canterbury, Sch Forestry, Christchurch 1, New Zealand	University of Canterbury; University of Canterbury	Heber, S (corresponding author), Univ Canterbury, Sch Biol Sci, Christchurch 1, New Zealand.	sol.heber@pg.canterbury.ac.nz		Apiolaza, Luis/0000-0003-0958-3540	University of Canterbury; Brian Mason Science and Technical Trust	University of Canterbury; Brian Mason Science and Technical Trust	This project was funded by the University of Canterbury and the Brian Mason Science and Technical Trust (http://www.brianmasontrust.org/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ardern SL, 1997, MOL ECOL, V6, P21, DOI 10.1046/j.1365-294X.1997.00147.x; ARMSTRONG DP, 1995, BIOL CONSERV, V71, P281, DOI 10.1016/0006-3207(94)00038-R; Bijlsma R, 2010, CONSERV GENET, V11, P449, DOI 10.1007/s10592-010-0058-z; BRISCOE DA, 1992, CONSERV BIOL, V6, P416, DOI 10.1046/j.1523-1739.1992.06030416.x; Brook BW, 2002, CONSERV ECOL, V6; Bryant EH, 1999, CONSERV BIOL, V13, P1487, DOI 10.1046/j.1523-1739.1999.98440.x; Charlesworth B, 1999, GENET RES, V74, P329, DOI 10.1017/S0016672399004152; Edmands S, 1999, EVOLUTION, V53, P1757, DOI 10.1111/j.1558-5646.1999.tb04560.x; Edmands S, 2007, MOL ECOL, V16, P463, DOI 10.1111/j.1365-294X.2006.03148.x; England PR, 2003, CONSERV GENET, V4, P595, DOI 10.1023/A:1025639811865; Frankham R., 2010, INTRO CONSERVATION G, DOI DOI 10.1017/CBO9780511809002; Frankham R, 2011, CONSERV BIOL, V25, P465, DOI 10.1111/j.1523-1739.2011.01662.x; Frankham R, 1999, ANIM CONSERV, V2, P255, DOI 10.1111/j.1469-1795.1999.tb00071.x; Fredrickson RJ, 2007, P ROY SOC B-BIOL SCI, V274, P2365, DOI 10.1098/rspb.2007.0785; Goldberg TL, 2005, CONSERV BIOL, V19, P455, DOI 10.1111/j.1523-1739.2005.00091.x; Groombridge JJ, 2000, NATURE, V403, P616, DOI 10.1038/35001148; Hedrick PW, 2010, CONSERV GENET, V11, P615, DOI 10.1007/s10592-009-9999-5; Henderson C. R, 1984, APPL LINEAR MODELS A; Holand AM, 2011, 42001 NORW U SCI TEC; Hothorn T, 2008, BIOMETRICAL J, V50, P346, DOI 10.1002/bimj.200810425; Ingvarsson PK, 2002, NATURE, V420, P472, DOI 10.1038/420472a; Jamieson IG, 2006, CONSERV BIOL, V20, P38, DOI 10.1111/j.1523-1739.2005.00282.x; JIMENEZ JA, 1994, SCIENCE, V266, P271, DOI 10.1126/science.7939661; Johnson WE, 2010, SCIENCE, V329, P1641, DOI 10.1126/science.1192891; Kristensen TN, 2010, TRENDS ECOL EVOL, V25, P44, DOI 10.1016/j.tree.2009.06.014; LYNCH M, 1991, EVOLUTION, V45, P622, DOI [10.1111/j.1558-5646.1991.tb04333.x, 10.2307/2409915]; Madsen T, 1999, NATURE, V402, P34, DOI 10.1038/46941; Madsen T, 2004, BIOL CONSERV, V120, P145, DOI 10.1016/j.biocon.2004.01.022; Madsen T, 1996, BIOL CONSERV, V75, P113, DOI 10.1016/0006-3207(95)00067-4; Marr AB, 2002, EVOLUTION, V56, P131; Marshall TC, 2000, ANIM CONSERV, V3, P241, DOI 10.1111/j.1469-1795.2000.tb00109.x; MAYFIELD HAROLD, 1961, WILSON BULL, V73, P255; MOLINAFREANER F, 1993, EVOLUTION, V47, P1472, DOI 10.2307/2410161; Nakagawa S, 2004, BEHAV ECOL, V15, P1044, DOI 10.1093/beheco/arh107; Newman D, 1997, EVOLUTION, V51, P354, DOI [10.2307/2411107, 10.1111/j.1558-5646.1997.tb02422.x]; Newman D, 2001, CONSERV BIOL, V15, P1054, DOI 10.1046/j.1523-1739.2001.0150041054.x; O'Grady JJ, 2006, BIOL CONSERV, V133, P42, DOI 10.1016/j.biocon.2006.05.016; Pimm SL, 2006, ANIM CONSERV, V9, P115, DOI 10.1111/j.1469-1795.2005.00010.x; R DEVELOPMENT CORE TEAM, 2011, R LANG ENV STAT COMP; Rue H, 2009, J R STAT SOC B, V71, P319, DOI 10.1111/j.1467-9868.2008.00700.x; SPIELMAN D, 1992, ZOO BIOL, V11, P343, DOI 10.1002/zoo.1430110506; Tallmon DA, 2004, TRENDS ECOL EVOL, V19, P489, DOI 10.1016/j.tree.2004.07.003; Therneau T, 2011, SURVIVAL SURVIVAL AN; Weeks AR, 2011, EVOLUTIONARY APPL, P1; Westemeier RL, 1998, SCIENCE, V282, P1695, DOI 10.1126/science.282.5394.1695; Wisley SM, 2008, CONSERV GENET, V9, P389	46	8	8	2	67	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 13	2012	7	8							e43113	10.1371/journal.pone.0043113	http://dx.doi.org/10.1371/journal.pone.0043113			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	988OJ	22912802	Green Published, Green Submitted, gold			2022-12-25	WOS:000307500100062
J	Mei, F; Guo, S; He, YT; Wang, LY; Wang, HK; Niu, JQ; Kong, JM; Li, XM; Wu, YZ; Xiao, L				Mei, Feng; Guo, Sheng; He, Yangtao; Wang, Linyun; Wang, Hongkai; Niu, Jianqin; Kong, Jiming; Li, Xinmin; Wu, Yuzhang; Xiao, Lan			Quetiapine, an Atypical Antipsychotic, Is Protective against Autoimmune-Mediated Demyelination by Inhibiting Effector T Cell Proliferation	PLOS ONE			English	Article							EXPERIMENTAL ALLERGIC ENCEPHALOMYELITIS; MULTIPLE-SCLEROSIS; PROGENITOR CELLS; RECEPTOR; REMYELINATION; ACTIVATION; DIFFERENTIATION; ABNORMALITIES; INFLAMMATION; EXPRESSION	Quetiapine (Que), a commonly used atypical antipsychotic drug (APD), can prevent myelin from breakdown without immune attack. Multiple sclerosisis (MS), an autoimmune reactive inflammation demyelinating disease, is triggered by activated myelin-specific T lymphocytes (T cells). In this study, we investigated the potential efficacy of Que as an immune-modulating therapeutic agent for experimental autoimmune encephalomyelitis (EAE), a mouse model for MS. Que treatment was initiated on the onset of MOG(35-55) peptide induced EAE mice and the efficacy of Que on modulating the immune response was determined by Flow Cytometry through analyzing CD4(+)/CD8(+) populations and the proliferation of effector T cells (CD4(+) CD25(-)) in peripheral immune organs. Our results show that Que dramatically attenuates the severity of EAE symptoms. Que treatment decreases the extent of CD4(+)/CD8(+) T cell infiltration into the spinal cord and suppresses local glial activation, thereby diminishing the loss of mature oligodendrocytes and myelin breakdown in the spinal cord of EAE mice. Our results further demonstrate that Que treatment decreases the CD4(+)/CD8(+) T cell populations in lymph nodes and spleens of EAE mice and inhibits either MOG(35-55) or anti-CD3 induced proliferation as well as IL-2 production of effector T cells (CD4(+) CD25(-)) isolated from EAE mice spleen. Together, these findings suggest that Que displays an immune-modulating role during the course of EAE, and thus may be a promising candidate for treatment of MS.	[Mei, Feng; He, Yangtao; Wang, Linyun; Wang, Hongkai; Niu, Jianqin; Xiao, Lan] Third Mil Med Univ, Chongqing Key Lab Neurobiol, Dept Histol & Embryol, Chongqing, Peoples R China; [Guo, Sheng; Wu, Yuzhang] Third Mil Med Univ, Dept Immunol, Chongqing, Peoples R China; [Kong, Jiming] Univ Manitoba, Dept Human Anat & Cell Sci, Winnipeg, MB, Canada; [Li, Xinmin] Univ Manitoba, Dept Psychiat, Winnipeg, MB R3T 2N2, Canada	Army Medical University; Army Medical University; University of Manitoba; University of Manitoba	Mei, F (corresponding author), Third Mil Med Univ, Chongqing Key Lab Neurobiol, Dept Histol & Embryol, Chongqing, Peoples R China.	xiaolan35@hotmail.com		Mei, Feng/0000-0003-4125-1570; Kong, Jiming/0000-0002-2859-9831; Wu, Yuzhang/0000-0002-4049-0214	National Natural Science Foundation of China (NSCF) [81071084]; International Science & Technology Cooperation Program of China [2010DFB30820]; Natural Science Foundation Project of Chongqing (CQ CSTC) [2009BB5157, 2010BB5157]	National Natural Science Foundation of China (NSCF)(National Natural Science Foundation of China (NSFC)); International Science & Technology Cooperation Program of China; Natural Science Foundation Project of Chongqing (CQ CSTC)	This work is in part supported by the National Natural Science Foundation of China (NSCF, 81071084), International Science & Technology Cooperation Program of China (2010DFB30820) and Natural Science Foundation Project of Chongqing (CQ CSTC, 2009BB5157, 2010BB5157). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aharoni R, 2008, P NATL ACAD SCI USA, V105, P11358, DOI 10.1073/pnas.0804632105; Aston C, 2005, MOL PSYCHIATR, V10, P309, DOI 10.1038/sj.mp.4001565; Bian Q, 2008, PROG NEURO-PSYCHOPH, V32, P42, DOI 10.1016/j.pnpbp.2007.06.031; Bitsch A, 2000, BRAIN, V123, P1174, DOI 10.1093/brain/123.6.1174; CHANG JF, 1991, J IMMUNOL, V147, P860; Constantin G, 2009, STEM CELLS, V27, P2624, DOI 10.1002/stem.194; De SP, 2008, J IMMUNOL, V181, P338; Dutta R, 2011, ANN NEUROL, V69, P445, DOI 10.1002/ana.22337; Fletcher JM, 2010, CLIN EXP IMMUNOL, V162, P1, DOI 10.1111/j.1365-2249.2010.04143.x; Franco PG, 2008, EXP NEUROL, V212, P458, DOI 10.1016/j.expneurol.2008.04.039; Freire-Garabal M, 2003, NEUROSCI LETT, V342, P33, DOI 10.1016/S0304-3940(03)00215-5; Gordon D, 2010, J NEUROPATH EXP NEUR, V69, P1087, DOI 10.1097/NEN.0b013e3181f97392; Inoue M, 2011, INT IMMUNOPHARMACOL, V11, P67, DOI 10.1016/j.intimp.2010.10.007; Janardhan V, 2002, J NEUROL SCI, V205, P51, DOI 10.1016/S0022-510X(02)00312-X; Jones HM, 2000, AM J PSYCHIAT, V157, P148, DOI 10.1176/ajp.157.1.148; JONES RE, 1990, J NEUROIMMUNOL, V30, P61, DOI 10.1016/0165-5728(90)90053-P; Kanwar JR, 2004, BRAIN, V127, P1313, DOI 10.1093/brain/awh156; Kerns D, 2010, SCHIZOPHR RES, V120, P150, DOI 10.1016/j.schres.2010.04.012; Konradi C, 2012, NEUROBIOL DIS, V45, P37, DOI 10.1016/j.nbd.2011.01.025; Kuhlmann T, 2008, BRAIN, V131, P1749, DOI 10.1093/brain/awn096; Liu LP, 2010, J NEUROSCI, V30, P9074, DOI 10.1523/JNEUROSCI.1238-10.2010; Makar TK, 2008, J NEUROIMMUNOL, V196, P67, DOI 10.1016/j.jneuroim.2008.02.014; Maruo S, 1996, J IMMUNOL, V156, P1748; Mason JL, 2000, J NEUROSCI, V20, P5703, DOI 10.1523/JNEUROSCI.20-15-05703.2000; Mostert JP, 2008, J NEUROL NEUROSUR PS, V79, P1027, DOI 10.1136/jnnp.2007.139345; Nakane H, 2004, INFLAMM RES, V53, P324, DOI 10.1007/s00011-004-1264-2; Noubade R, 2007, J CLIN INVEST, V117, P3507, DOI 10.1172/JCI32792; Rasmussen S, 2011, ANN NEUROL, V69, P878, DOI 10.1002/ana.22299; Ray LA, 2010, DRUG ALCOHOL REV, V29, P568, DOI 10.1111/j.1465-3362.2010.00185.x; Stromnes IM, 2006, NAT PROTOC, V1, P1810, DOI 10.1038/nprot.2006.285; Trapp BD, 2008, ANNU REV NEUROSCI, V31, P247, DOI 10.1146/annurev.neuro.30.051606.094313; Wei ZL, 2003, J NEUROSCI RES, V74, P942, DOI 10.1002/jnr.10832; Xiao L, 2008, MOL PSYCHIATR, V13, P697, DOI 10.1038/sj.mp.4002064; Xu HY, 2008, FEBS J, V275, P3718, DOI 10.1111/j.1742-4658.2008.06519.x; Zhang YB, 2008, SCHIZOPHR RES, V106, P182, DOI 10.1016/j.schres.2008.09.013	35	35	38	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 13	2012	7	8							e42746	10.1371/journal.pone.0042746	http://dx.doi.org/10.1371/journal.pone.0042746			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	988OJ	22912731	Green Published, Green Submitted, gold			2022-12-25	WOS:000307500100026
J	Sanchez, CEG; Garcia, CAV; Saez, RGT				Garcia Sanchez, Carlos Eduardo; Vargas Garcia, Cesar Augusto; Torres Saez, Rodrigo Gonzalo			Predictive Potential of Flux Balance Analysis of Saccharomyces cerevisiae Using as Optimization Function Combinations of Cell Compartmental Objectives	PLOS ONE			English	Article							METABOLIC FLUXES; GROWTH; MODEL; IDENTIFICATION	Background: The main objective of flux balance analysis (FBA) is to obtain quantitative predictions of metabolic fluxes of an organism, and it is necessary to use an appropriate objective function to guarantee a good estimation of those fluxes. Methodology: In this study, the predictive performance of FBA was evaluated, using objective functions arising from the linear combination of different cellular objectives. This approach is most suitable for eukaryotic cells, owing to their multiplicity of cellular compartments. For this reason, Saccharomyces cerevisiae was used as model organism, and its metabolic network was represented using the genome-scale metabolic model iMM904. As the objective was to evaluate the predictive performance from the FBA using the kind of objective function previously described, substrate uptake and oxygen consumption were the only input data used for the FBA. Experimental information about microbial growth and exchange of metabolites with the environment was used to assess the quality of the predictions. Conclusions: The quality of the predictions obtained with the FBA depends greatly on the knowledge of the oxygen uptake rate. For the most of studied classifications, the best predictions were obtained with "maximization of growth'', and with some combinations that include this objective. However, in the case of exponential growth with unknown oxygen exchange flux, the objective function "maximization of growth, plus minimization of NADH production in cytosol, plus minimization of NAD(P)H consumption in mitochondrion'' gave much more accurate estimations of fluxes than the obtained with any other objective function explored in this study.	[Garcia Sanchez, Carlos Eduardo] Univ Ind Santander, Grp Invest Bioquim & Microbiol, Escuela Ingn Quim, Bucaramanga, Santander, Colombia; [Vargas Garcia, Cesar Augusto] Univ Ind Santander, Grp Invest Ingn Biomed, Escuela Ingn Sistemas & Informat, Bucaramanga, Santander, Colombia; [Torres Saez, Rodrigo Gonzalo] Univ Ind Santander, Grp Invest Bioquim & Microbiol, Escuela Quim, Bucaramanga, Santander, Colombia	Universidad Industrial de Santander; Universidad Industrial de Santander; Universidad Industrial de Santander	Sanchez, CEG (corresponding author), Univ Ind Santander, Grp Invest Bioquim & Microbiol, Escuela Ingn Quim, Bucaramanga, Santander, Colombia.	carlos.garcia6@correo.uis.edu.co	Vargas-Garcia, Cesar/J-8090-2017	Vargas-Garcia, Cesar/0000-0002-4286-8882; Torres, Rodrigo/0000-0003-1113-3020; Garcia Sanchez, Carlos Eduardo/0000-0003-1543-1498	Universidad Industrial de Santander; Grupo de Investigacion en Bioquimica y Microbiologia of the Universidad Industrial de Santander	Universidad Industrial de Santander; Grupo de Investigacion en Bioquimica y Microbiologia of the Universidad Industrial de Santander	CEGS and CAVG received funding from a scholarship of the Universidad Industrial de Santander. Development of the study was supported by the Grupo de Investigacion en Bioquimica y Microbiologia of the Universidad Industrial de Santander. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Albers E, 1996, APPL ENVIRON MICROB, V62, P3187, DOI 10.1128/AEM.62.9.3187-3195.1996; Bakker BM, 2001, FEMS MICROBIOL REV, V25, P15, DOI 10.1016/S0168-6445(00)00039-5; Burgard AP, 2003, BIOTECHNOL BIOENG, V82, P670, DOI 10.1002/bit.10617; Cakir T, 2007, BIOTECHNOL PROGR, V23, P320, DOI 10.1021/bp060272r; Daran-Lapujade P, 2004, J BIOL CHEM, V279, P9125, DOI 10.1074/jbc.M309578200; Edwards JS, 2000, P NATL ACAD SCI USA, V97, P5528, DOI 10.1073/pnas.97.10.5528; Edwards JS, 2001, NAT BIOTECHNOL, V19, P125, DOI 10.1038/84379; Feist AM, 2010, CURR OPIN MICROBIOL, V13, P344, DOI 10.1016/j.mib.2010.03.003; Forster J, 2003, GENOME RES, V13, P244, DOI 10.1101/gr.234503; Franzen CJ, 2003, YEAST, V20, P117, DOI 10.1002/yea.956; Frick O, 2005, MICROB CELL FACT, V4, DOI 10.1186/1475-2859-4-30; Gianchandani EP, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-43; Gombert AK, 2001, J BACTERIOL, V183, P1441, DOI 10.1128/JB.183.4.1441-1451.2001; Heyland J, 2009, MICROBIOL-SGM, V155, P3827, DOI 10.1099/mic.0.030213-0; Ibarra RU, 2002, NATURE, V420, P186, DOI 10.1038/nature01149; Jouhten P, 2008, BMC SYST BIOL, V2, DOI 10.1186/1752-0509-2-60; Kauffman KJ, 2003, CURR OPIN BIOTECH, V14, P491, DOI 10.1016/j.copbio.2003.08.001; Knorr AL, 2007, BIOINFORMATICS, V23, P351, DOI 10.1093/bioinformatics/btl619; Koffas M, 1999, ANNU REV BIOMED ENG, V1, P535, DOI 10.1146/annurev.bioeng.1.1.535; Llaneras F, 2008, J BIOSCI BIOENG, V105, P1, DOI 10.1263/jbb.105.1; Mo ML, 2009, BMC SYST BIOL, V3, DOI 10.1186/1752-0509-3-37; Nissen TL, 1997, MICROBIOL-UK, V143, P203, DOI 10.1099/00221287-143-1-203; Ostergaard S, 2000, MICROBIOL MOL BIOL R, V64, P34, DOI 10.1128/MMBR.64.1.34-50.2000; Ostergaard S, 2001, BIOTECHNOL BIOENG, V73, P412, DOI 10.1002/bit.1075; Papin JA, 2003, TRENDS BIOCHEM SCI, V28, P250, DOI 10.1016/S0968-0004(03)00064-1; Ramakrishna R, 2001, AM J PHYSIOL-REG I, V280, pR695, DOI 10.1152/ajpregu.2001.280.3.R695; Raman K, 2009, BRIEF BIOINFORM, V10, P435, DOI 10.1093/bib/bbp011; Schellenberger J, 2011, NAT PROTOC, V6, P1290, DOI 10.1038/nprot.2011.308; Schilling CH, 2002, J BACTERIOL, V184, P4582, DOI 10.1128/JB.184.16.4582-4593.2002; Schuetz R, 2007, MOL SYST BIOL, V3, DOI 10.1038/msb4100162; Van Hoek P, 1998, APPL ENVIRON MICROB, V64, P4226; van Winden WA, 2005, FEMS YEAST RES, V5, P559, DOI 10.1016/j.femsyr.2004.10.007; VARMA A, 1994, BIO-TECHNOL, V12, P994, DOI 10.1038/nbt1094-994; Wiebe MG, 2008, FEMS YEAST RES, V8, P140, DOI 10.1111/j.1567-1364.2007.00234.x; Wiechert W, 2002, J BIOTECHNOL, V94, P37, DOI 10.1016/S0168-1656(01)00418-7; Zomorrodi AR, 2010, BMC SYST BIOL, V4, DOI 10.1186/1752-0509-4-178	37	9	9	0	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 9	2012	7	8							e43006	10.1371/journal.pone.0043006	http://dx.doi.org/10.1371/journal.pone.0043006			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	986WZ	22912775	Green Published, gold			2022-12-25	WOS:000307378500036
J	Barat, S; Steeb, B; Maze, A; Bumann, D				Barat, Somedutta; Steeb, Benjamin; Maze, Alain; Bumann, Dirk			Extensive In Vivo Resilience of Persistent Salmonella	PLOS ONE			English	Article							MYCOBACTERIUM-TUBERCULOSIS PERSISTENCE; ESCHERICHIA-COLI; TYPHIMURIUM; VIRULENCE; REPLICATION; INFECTION; METABOLISM; DYNAMICS; MUTANTS; DUBLIN	Chronic infections caused by persistent pathogens represent an important health problem. Here, we establish a simple practical mouse Salmonella infection model for identifying bacterial maintenance functions that are essential for persistency. In this model, a substantial fraction of Salmonella survived even several days of treatment with a potent fluoroquinolone antibiotic indicating stringency of the model. Evaluation of twelve metabolic defects revealed dramatically different requirements for Salmonella during persistency as compared to acute infections. Disrupted synthesis of unsaturated/cyclopropane fatty acids was the only defect that resulted in rapid Salmonella clearance suggesting that this pathway might contain suitable targets for antimicrobial chemotherapy of chronic infection.	[Barat, Somedutta; Steeb, Benjamin; Maze, Alain; Bumann, Dirk] Univ Basel, Biozentrum, Focal Area Infect Biol, Basel, Switzerland	University of Basel	Barat, S (corresponding author), Univ Basel, Biozentrum, Focal Area Infect Biol, Basel, Switzerland.	Dirk.Bumann@unibas.ch		Maze, Alain/0000-0003-0873-3690	Deutsche Forschungsgemeinschaft (European Research Training Group) [1273]; Schweizerischer Nationalfonds [31003A-121834]	Deutsche Forschungsgemeinschaft (European Research Training Group); Schweizerischer Nationalfonds(Swiss National Science Foundation (SNSF))	This work was supported by Deutsche Forschungsgemeinschaft (European Research Training Group 1273) and Schweizerischer Nationalfonds (31003A-121834). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Baek SH, 2011, PLOS BIOL, V9, DOI 10.1371/journal.pbio.1001065; Becker D, 2006, NATURE, V440, P303, DOI 10.1038/nature04616; Becker SA, 2007, NAT PROTOC, V2, P727, DOI 10.1038/nprot.2007.99; Bhan MK, 2005, LANCET, V366, P749, DOI 10.1016/S0140-6736(05)67181-4; Bjur E, 2006, INFECT IMMUN, V74, P5140, DOI 10.1128/IAI.00449-06; Brinster S, 2009, NATURE, V458, P83, DOI 10.1038/nature07772; Bryk R, 2008, CELL HOST MICROBE, V3, P137, DOI 10.1016/j.chom.2008.02.003; BUCHMEIER NA, 1993, MOL MICROBIOL, V7, P933, DOI 10.1111/j.1365-2958.1993.tb01184.x; Clements MO, 2002, P NATL ACAD SCI USA, V99, P8784, DOI 10.1073/pnas.132047099; Datsenko KA, 2000, P NATL ACAD SCI USA, V97, P6640, DOI 10.1073/pnas.120163297; Dhar N, 2010, P NATL ACAD SCI USA, V107, P12275, DOI 10.1073/pnas.1003219107; Diacon AH, 2009, NEW ENGL J MED, V360, P2397, DOI 10.1056/NEJMoa0808427; Djaman O, 2004, J BIOL CHEM, V279, P44590, DOI 10.1074/jbc.M406487200; Dubois-Brissonnet F, 2011, APPL ENVIRON MICROB, V77, P906, DOI 10.1128/AEM.01480-10; ENG RHK, 1991, ANTIMICROB AGENTS CH, V35, P1824, DOI 10.1128/AAC.35.9.1824; Fang FC, 2005, INFECT IMMUN, V73, P2547, DOI 10.1128/IAI.73.4.2547-2549.2005; Fauvart M, 2011, J MED MICROBIOL, V60, P699, DOI 10.1099/jmm.0.030932-0; Gomez JE, 2004, TUBERCULOSIS, V84, P29, DOI 10.1016/j.tube.2003.08.003; Grant AJ, 2008, PLOS BIOL, V6, P757, DOI 10.1371/journal.pbio.0060074; Griffin A, 2009, J IMMUNOL, V183, P1263, DOI 10.4049/jimmunol.0900772; Griffin AJ, 2011, INFECT IMMUN, V79, P1479, DOI 10.1128/IAI.01033-10; Helaine S, 2010, P NATL ACAD SCI USA, V107, P3746, DOI 10.1073/pnas.1000041107; HOISETH SK, 1981, NATURE, V291, P238, DOI 10.1038/291238a0; Hurdle JG, 2011, NAT REV MICROBIOL, V9, P62, DOI 10.1038/nrmicro2474; Imlay JA, 2003, ANNU REV MICROBIOL, V57, P395, DOI 10.1146/annurev.micro.57.030502.090938; John AK, 2011, ANTIMICROB AGENTS CH, V55, P3510, DOI 10.1128/AAC.00172-11; Kulp A, 2010, ANNU REV MICROBIOL, V64, P163, DOI 10.1146/annurev.micro.091208.073413; Levin BR, 2006, NAT REV MICROBIOL, V4, P556, DOI 10.1038/nrmicro1445; Lewis K, 2010, ANNU REV MICROBIOL, V64, P357, DOI 10.1146/annurev.micro.112408.134306; Machutta CA, 2010, J BIOL CHEM, V285, P6161, DOI 10.1074/jbc.M109.077909; MCFARLAND WC, 1987, MICROB PATHOGENESIS, V3, P129, DOI 10.1016/0882-4010(87)90071-4; Meredith TC, 2005, J BACTERIOL, V187, P6936, DOI 10.1128/JB.187.20.6936-6942.2005; MIYAKAWA S, 1982, J ANTIBIOT, V35, P411, DOI 10.7164/antibiotics.35.411; Monack DM, 2004, J EXP MED, V199, P231, DOI 10.1084/jem.20031319; Monack DM, 2011, CURR OPIN MICROBIOL, V2011, P30; Munoz-Elias EJ, 2005, INFECT IMMUN, V73, P546, DOI 10.1128/IAI.73.1.546-551.2005; Nath G, 2010, J INFECT DEV COUNTR, V4, P259, DOI 10.3855/jidc.820; Oberhardt MA, 2009, MOL SYST BIOL, V5, DOI 10.1038/msb.2009.77; Rao SPS, 2008, P NATL ACAD SCI USA, V105, P11945, DOI 10.1073/pnas.0711697105; Stewart GR, 2003, NAT REV MICROBIOL, V1, P97, DOI 10.1038/nrmicro749; Thiele I, 2011, BMC SYST BIOL, V5, DOI 10.1186/1752-0509-5-8; Thierauf Anne, 2009, V501, P267, DOI 10.1007/978-1-60327-164-6_23; Tierrez A, 2005, CELL MICROBIOL, V7, P901, DOI 10.1111/j.1462-5822.2005.00540.x; Tischler AD, 2010, CURR OPIN MICROBIOL, V13, P93, DOI 10.1016/j.mib.2009.12.007; Turner AK, 2003, INFECT IMMUN, V71, P3392, DOI 10.1128/IAI.71.6.3392-3401.2003; VANCUTSEM PM, 1990, CORNELL VET, V80, P173; Wiegand I, 2008, NAT PROTOC, V3, P163, DOI 10.1038/nprot.2007.521	47	17	17	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 24	2012	7	7							e42007	10.1371/journal.pone.0042007	http://dx.doi.org/10.1371/journal.pone.0042007			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	978NX	22911873	Green Published, gold, Green Accepted			2022-12-25	WOS:000306751300089
J	Kanno, H; Nishihara, H; Narita, T; Yamaguchi, S; Kobayashi, H; Tanino, M; Kimura, T; Terasaka, S; Tanaka, S				Kanno, Hiromi; Nishihara, Hiroshi; Narita, Takuhito; Yamaguchi, Shigeru; Kobayashi, Hiroyuki; Tanino, Mishie; Kimura, Taichi; Terasaka, Shunsuke; Tanaka, Shinya			Prognostic Implication of Histological Oligodendroglial Tumor Component: Clinicopathological Analysis of 111 Cases of Malignant Gliomas	PLOS ONE			English	Article							ARMS 1P; SURVIVAL; GLIOBLASTOMAS; ASTROCYTOMAS; DIAGNOSIS; PATHOLOGY; OUTCOMES; GRADE; 19Q	The favorable prognosis of high-grade oligodendroglial tumor such as glioblastoma (GBM) with oligodendroglioma component (GBMO) has been suggested; however, the studies which examine the prognostic significance of oligodendroglial tumor were limited. In this study, we performed a histopathology-based reevaluation of 111 cases of high grade gliomas according to the latest World Health Organization (WHO), and compared the clinical outcomes between oligodendroglial tumors and pure astrocytic tumors. The survival analysis revealed that the patients with high grade oligodendroglial tumor including GBMO significantly indicated better prognosis compared to the patients with high grade pure astrocytic tumors (GBM and AA, anaplastic astrocytoma) as expected, and the obtained survival curves were almost identical to those from the patients with conventional Grade III or Grade IV tumors, respectively. Moreover, if the cases of oligodendroglial tumor were histopathologically excluded, the patients with AA exhibited extremely poor prognosis which was similar to that of GBM, suggesting that the histological identification of oligodendroglial tumor component, even partially, prescribe the prognosis of high grade glioma patients. This is the prominent report of retrospective clinicopathological analysis for high-grade gliomas throughout Grade III and IV, especially referring to the prognostic value of histological oligodendroglial tumor component; in addition, our results might offer an alternative aspect for the grading of high-grade astrocytic/oligodendroglial tumors.	[Kanno, Hiromi; Narita, Takuhito; Tanino, Mishie; Kimura, Taichi; Tanaka, Shinya] Hokkaido Univ, Sch Med, Dept Pathol, Canc Res Lab, Sapporo, Hokkaido 060, Japan; [Nishihara, Hiroshi] Hokkaido Univ, Sch Med, Lab Translat Pathol, Sapporo, Hokkaido 060, Japan; [Yamaguchi, Shigeru; Kobayashi, Hiroyuki; Terasaka, Shunsuke] Hokkaido Univ, Sch Med, Dept Neurosurg, Sapporo, Hokkaido 060, Japan	Hokkaido University; Hokkaido University; Hokkaido University	Kanno, H (corresponding author), Hokkaido Univ, Sch Med, Dept Pathol, Canc Res Lab, Sapporo, Hokkaido 060, Japan.	hnishihara@s5.dion.ne.jp	KOBAYASHI, Hiroyuki/G-8990-2012; Yamaguchi, Shigeru/G-5419-2012; Tanaka, Shinya/AAO-8771-2021; Tanaka, Shinya/D-3586-2011	Yamaguchi, Shigeru/0000-0003-3710-5888; Tanaka, Shinya/0000-0001-6470-3301; 				Aldape K, 2007, ARCH PATHOL LAB MED, V131, P242; Burger PC, 2001, MODERN PATHOL, V14, P842, DOI 10.1038/modpathol.3880400; Donahue B, 1997, INT J RADIAT ONCOL, V38, P911, DOI 10.1016/S0360-3016(97)00126-0; Fuller CE, 2003, J NEUROPATH EXP NEUR, V62, P1118, DOI 10.1093/jnen/62.11.1118; Hartmann C, 2004, J MOL MED, V82, P638, DOI 10.1007/s00109-004-0565-9; Hilton DA, 2004, HISTOPATHOLOGY, V44, P555, DOI 10.1111/j.1365-2559.2004.01887.x; Homma T, 2006, J NEUROPATH EXP NEUR, V65, P846, DOI 10.1097/01.jnen.0000235118.75182.94; Kraus JA, 2001, ACTA NEUROPATHOL, V101, P311; Laws ER, 2003, J NEUROSURG, V99, P467, DOI 10.3171/jns.2003.99.3.0467; McDonald JM, 2005, CANCER-AM CANCER SOC, V104, P1468, DOI 10.1002/cncr.21338; Miller CR, 2006, J CLIN ONCOL, V24, P5419, DOI 10.1200/JCO.2006.08.1497; Perry A, 2007, WHO CLASSIFICATION T, P164; Pinto LW, 2008, VIRCHOWS ARCH, V452, P481, DOI 10.1007/s00428-007-0562-9; Salminen E, 1996, EUR J CANCER, V32A, P1918, DOI 10.1016/0959-8049(96)00211-0; Salvati M, 2009, J NEURO-ONCOL, V94, P129, DOI 10.1007/s11060-009-9815-6; Shaw EG, 1997, J NEURO-ONCOL, V31, P273, DOI 10.1023/A:1005715703598; Smith JS, 2000, J CLIN ONCOL, V18, P636, DOI 10.1200/JCO.2000.18.3.636; Tortosa A, 2003, CANCER, V97, P1063, DOI 10.1002/cncr.11120; van den Bent MJ, 2006, J CLIN ONCOL, V24, P2715, DOI 10.1200/JCO.2005.04.6078; Wick W, 2009, J CLIN ONCOL, V27, P5874, DOI 10.1200/JCO.2009.23.6497	20	13	13	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 24	2012	7	7							e41669	10.1371/journal.pone.0041669	http://dx.doi.org/10.1371/journal.pone.0041669			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	978NX	22911839	Green Published, gold, Green Submitted			2022-12-25	WOS:000306751300062
J	Xie, JB; Tang, LS; Wang, ZY; Xu, GQ; Li, Y				Xie, Jiangbo; Tang, Lisong; Wang, Zhongyuan; Xu, Guiqing; Li, Yan			Distinguishing the Biomass Allocation Variance Resulting from Ontogenetic Drift or Acclimation to Soil Texture	PLOS ONE			English	Article							PHENOTYPIC PLASTICITY; RELATIVE GROWTH; WATER; ALLOMETRY; PLANTS; ROOT; LEAF; PATTERNS; LIGHT; PRODUCTIVITY	In resource-poor environments, adjustment in plant biomass allocation implies a complex interplay between environmental signals and plant development rather than a delay in plant development alone. To understand how environmental factors influence biomass allocation or the developing phenotype, it is necessary to distinguish the biomass allocations resulting from environmental gradients or ontogenetic drift. Here, we compared the development trajectories of cotton plants (Gossypium herbaceum L.), which were grown in two contrasting soil textures during a 60-d period. Those results distinguished the biomass allocation pattern resulting from ontogenetic drift and the response to soil texture. The soil texture significantly changed the biomass allocation to leaves and roots, but not to stems. Soil texture also significantly changed the development trajectories of leaf and root traits, but did not change the scaling relationship between basal stem diameter and plant height. Results of nested ANOVAs of consecutive plant-size categories in both soil textures showed that soil gradients explained an average of 63.64-70.49% of the variation of biomass allocation to leaves and roots. Ontogenetic drift explained 77.47% of the variation in biomass allocation to stems. The results suggested that the environmental factors governed the biomass allocation to roots and leaves, and ontogenetic drift governed the biomass allocation to stems. The results demonstrated that biomass allocation to metabolically active organs (e. g., roots and leaves) was mainly governed by environmental factors, and that biomass allocation to metabolically non-active organs (e. g., stems) was mainly governed by ontogenetic drift. We concluded that differentiating the causes of development trajectories of plant traits was important to the understanding of plant response to environmental gradients.	[Xie, Jiangbo; Tang, Lisong; Wang, Zhongyuan; Xu, Guiqing; Li, Yan] Chinese Acad Sci, Xinjiang Inst Ecol & Geog, State Key Lab Desert & Oasis Ecol, Urumqi, Xinjiang, Peoples R China; [Xie, Jiangbo; Wang, Zhongyuan] Chinese Acad Sci, Grad Sch, Beijing, Peoples R China	Chinese Academy of Sciences; Xinjiang Institute of Ecology & Geography, CAS; Chinese Academy of Sciences; University of Chinese Academy of Sciences, CAS	Xie, JB (corresponding author), Chinese Acad Sci, Xinjiang Inst Ecol & Geog, State Key Lab Desert & Oasis Ecol, Urumqi, Xinjiang, Peoples R China.	liyan@ms.xjb.ac.cn		wang, zhongyuan/0000-0001-6018-4647	National Natural Science Foundation of China [31000166, 40725002]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This research was funded by the National Natural Science Foundation of China (Grant no. 31000166 and 40725002). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ackerly D, 2004, ECOL MONOGR, V74, P25, DOI 10.1890/03-4022; Biondini M, 2008, J THEOR BIOL, V251, P35, DOI 10.1016/j.jtbi.2007.11.018; Bond BJ, 2000, TRENDS PLANT SCI, V5, P349, DOI 10.1016/S1360-1385(00)01691-5; BROUWER R., 1962, NETHERLANDS JOUR AGRIC SCI, V10, P361; BROUWER R, 1983, NETH J AGR SCI, V31, P335; BROUWER R., 1962, NETHERLANDS JOUR AGRIC SCI, V10, P399; Cambui CA, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019211; Canham CD, 1996, CAN J FOREST RES, V26, P1521, DOI 10.1139/x26-171; CHAPIN FS, 1993, AM NAT, V142, pS78, DOI 10.1086/285524; Chave J, 2009, ECOL LETT, V12, P351, DOI 10.1111/j.1461-0248.2009.01285.x; Chen SY, 2010, CHINESE SCI BULL, V55, P1135, DOI 10.1007/s11434-010-0107-5; Cheng DL, 2010, BIOL LETTERS, V6, P715, DOI 10.1098/rsbl.2010.0070; COLEMAN JS, 1994, TRENDS ECOL EVOL, V9, P187, DOI 10.1016/0169-5347(94)90087-6; Coleman MD, 2004, TREE PHYSIOL, V24, P1347, DOI 10.1093/treephys/24.12.1347; CONOVER WJ, 1981, AM STAT, V35, P124, DOI 10.2307/2683975; Deng JM, 2006, J ECOL, V94, P953, DOI 10.1111/j.1365-2745.2006.01141.x; Evans GC., 1972, QUANTITATIVE ANAL PL; Gedroc JJ, 1996, FUNCT ECOL, V10, P44, DOI 10.2307/2390260; Geng YP, 2007, BIOL INVASIONS, V9, P245, DOI 10.1007/s10530-006-9029-1; Gunn S, 1999, FUNCT ECOL, V13, P3, DOI 10.1046/j.1365-2435.1999.00002.x; Guo W, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027998; Hacke UG, 2000, OECOLOGIA, V124, P495, DOI 10.1007/PL00008875; Hermans C, 2006, TRENDS PLANT SCI, V11, P610, DOI 10.1016/j.tplants.2006.10.007; Huang YX, 2010, BOTANY, V88, P13, DOI 10.1139/B09-095; Huang YX, 2009, NORD J BOT, V27, P539, DOI 10.1111/j.1756-1051.2009.00382.x; Ichihashi R, 2010, PLANT ECOL, V211, P181, DOI 10.1007/s11258-010-9783-0; Knight H, 2001, TRENDS PLANT SCI, V6, P262, DOI 10.1016/S1360-1385(01)01946-X; LEDIG FT, 1970, BOT GAZ, V131, P349, DOI 10.1086/336552; Li Y, 2005, PLANT CELL ENVIRON, V28, P492, DOI 10.1111/j.1365-3040.2005.01291.x; Li Y, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0028601; Liu GF, 2010, NEW PHYTOL, V188, P543, DOI 10.1111/j.1469-8137.2010.03388.x; Marschner H., 1995, MINERAL NUTR HIGHER, V2nd ed.; McCarthy MC, 2007, FUNCT ECOL, V21, P713, DOI 10.1111/j.1365-2435.2007.01276.x; McConnaughay KDM, 1999, ECOLOGY, V80, P2581, DOI 10.1890/0012-9658(1999)080[2581:BAIPOO]2.0.CO;2; McKenna MF, 1999, ECOSCIENCE, V6, P286, DOI 10.1080/11956860.1999.11682529; Moriuchi KS, 2005, NEW PHYTOL, V166, P149, DOI 10.1111/j.1469-8137.2005.01346.x; Muller Ivo, 2000, Perspectives in Plant Ecology Evolution and Systematics, V3, P115, DOI 10.1078/1433-8319-00007; Niinemets U, 2004, NEW PHYTOL, V162, P683, DOI 10.1111/j.1469-8137.2004.01071.x; Niklas KJ, 2006, NEW PHYTOL, V171, P27, DOI 10.1111/j.1469-8137.2006.01760.x; Overman AR, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0028515; Poorter H, 2000, AUST J PLANT PHYSIOL, V27, P595, DOI 10.1071/PP99173; Price CA, 2007, P NATL ACAD SCI USA, V104, P13204, DOI 10.1073/pnas.0702242104; Shemesh H, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010824; Shipley B, 2002, FUNCT ECOL, V16, P326, DOI 10.1046/j.1365-2435.2002.00626.x; Sugiura D, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022236; Sultan SE, 2000, TRENDS PLANT SCI, V5, P537, DOI 10.1016/S1360-1385(00)01797-0; Taskinen S, 2011, BIOMETRICAL J, V53, P652, DOI 10.1002/bimj.201000018; Warton D, 2006, BIOL REV, V81, P1; Warton DI, 2002, BIOMETRICAL J, V44, P161, DOI 10.1002/1521-4036(200203)44:2<161::AID-BIMJ161>3.0.CO;2-N; Weigelt A, 2005, PLANT ECOL, V176, P57, DOI 10.1007/s11258-004-0016-2; Weiner J, 2004, PERSPECT PLANT ECOL, V6, P207, DOI 10.1078/1433-8319-00083; Weiner J, 2009, J ECOL, V97, P1220, DOI 10.1111/j.1365-2745.2009.01559.x; Wright IJ, 2000, FUNCT ECOL, V14, P97, DOI 10.1046/j.1365-2435.2000.00393.x; Wright Sarah D., 2002, Plant Species Biology, V17, P119, DOI 10.1046/j.1442-1984.2002.00082.x; Wu Rongling, 2004, BMC Ecology, V4, P14, DOI 10.1186/1472-6785-4-14; Xu H, 2007, PLANT CELL ENVIRON, V30, P399, DOI 10.1111/j.1365-3040.2006.001626.x	56	64	78	3	73	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 24	2012	7	7							e41502	10.1371/journal.pone.0041502	http://dx.doi.org/10.1371/journal.pone.0041502			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	978NX	22911802	Green Published, gold, Green Submitted			2022-12-25	WOS:000306751300049
J	de la Estrella, M; Mateo, RG; Wieringa, JJ; Mackinder, B; Munoz, J				de la Estrella, Manuel; Mateo, Ruben G.; Wieringa, Jan J.; Mackinder, Barbara; Munoz, Jesus			Legume Diversity Patterns in West Central Africa: Influence of Species Biology on Distribution Models	PLOS ONE			English	Article							EQUATORIAL-GUINEA ANNOBON; SAMPLE-SIZE; PLANT DIVERSITY; INDICATOR GROUPS; CLIMATE-CHANGE; BIODIVERSITY; LEGUMINOSAE; PERFORMANCE; NICHE; ACCURACY	Objectives: Species Distribution Models (SDMs) are used to produce predictions of potential Leguminosae diversity in West Central Africa. Those predictions are evaluated subsequently using expert opinion. The established methodology of combining all SDMs is refined to assess species diversity within five defined vegetation types. Potential species diversity is thus predicted for each vegetation type respectively. The primary aim of the new methodology is to define, in more detail, areas of species richness for conservation planning. Methodology: Using Maxent, SDMs based on a suite of 14 environmental predictors were generated for 185 West Central African Leguminosae species, each categorised according to one of five vegetation types: Afromontane, coastal, non-flooded forest, open formations, or riverine forest. The relative contribution of each environmental variable was compared between different vegetation types using a nonparametric Kruskal-Wallis analysis followed by a post-hoc Kruskal-Wallis Paired Comparison contrast. Legume species diversity patterns were explored initially using the typical method of stacking all SDMs. Subsequently, five different ensemble models were generated by partitioning SDMs according to vegetation category. Ecological modelers worked with legume specialists to improve data integrity and integrate expert opinion in the interpretation of individual species models and potential species richness predictions for different vegetation types. Results/Conclusions: Of the 14 environmental predictors used, five showed no difference in their relative contribution to the different vegetation models. Of the nine discriminating variables, the majority were related to temperature variation. The set of variables that played a major role in the Afromontane species diversity model differed significantly from the sets of variables of greatest relative important in other vegetation categories. The traditional approach of stacking all SDMs indicated overall centers of diversity in the region but the maps indicating potential species richness by vegetation type offered more detailed information on which conservation efforts can be focused.	[de la Estrella, Manuel] Univ Cordoba, Dept Bot Ecol & Fisiol Vegetal, Cordoba, Spain; [de la Estrella, Manuel] Univ Montreal, Inst Rech Biol Vegetale, Montreal, PQ H1X 2B2, Canada; [de la Estrella, Manuel] Univ Montreal, Dept Sci Biol, Montreal, PQ H3C 3J7, Canada; [Mateo, Ruben G.; Munoz, Jesus] Real Jardin Bot RJB CSIC, Madrid, Spain; [Mateo, Ruben G.] Univ Liege, Inst Bot, Liege, Belgium; [Wieringa, Jan J.] Wageningen Univ, Herbarium Vadense WAG, Netherlands Ctr Biodivers Naturalis, Sect NHN, Wageningen, Netherlands; [Munoz, Jesus] Univ Tecnol Indoamer, Ambato, Ecuador	Universidad de Cordoba; Universite de Montreal; Universite de Montreal; Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Real Jardin Botanico de Madrid; University of Liege; Wageningen University & Research	de la Estrella, M (corresponding author), Univ Cordoba, Dept Bot Ecol & Fisiol Vegetal, Cordoba, Spain.	rubeng.mateo@gmail.com	Wieringa, Jan J./D-9517-2015; de la Estrella, Manuel/I-4926-2013; Munoz, Jesus/B-7809-2008; Mateo, Rubén/M-3545-2015	Wieringa, Jan J./0000-0003-0566-372X; de la Estrella, Manuel/0000-0002-4484-3566; Mateo, Rubén/0000-0001-8577-001X; Munoz, Jesus/0000-0002-9266-2268	Spanish Juan de la Cierva grant [JCI-2009-05243]; Ministry of Science and Technology [CGL2011-28613-C03-02, CGL2009-07405-BOS]; Ministry of Science and Technology of Spain [CGL2009-09530-BOS]	Spanish Juan de la Cierva grant; Ministry of Science and Technology(Ministry of Science, ICT & Future Planning, Republic of Korea); Ministry of Science and Technology of Spain(Ministry of Science and Innovation, Spain (MICINN)Spanish Government)	ME was funded by a Spanish Juan de la Cierva grant JCI-2009-05243 and projects CGL2011-28613-C03-02 and CGL2009-07405-BOS of the Ministry of Science and Technology. Grant CGL2009-09530-BOS also of the Ministry of Science and Technology of Spain funded JM's research. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Araujo MB, 2005, GLOBAL CHANGE BIOL, V11, P1504, DOI 10.1111/j.1365-2486.2005.01000.x; Araujo MB, 2006, J BIOGEOGR, V33, P1677, DOI 10.1111/j.1365-2699.2006.01584.x; Baselga A, 2010, J BIOGEOGR, V37, P1842, DOI 10.1111/j.1365-2699.2010.02341.x; Bean WT, 2012, ECOGRAPHY, V35, P250, DOI 10.1111/j.1600-0587.2011.06545.x; Beentje H.J., 1994, CTR PLANT DIVERSITY, V1, P227; Botkin DB, 2007, BIOSCIENCE, V57, P227, DOI 10.1641/B570306; Bourg NA, 2005, ECOLOGY, V86, P2793, DOI 10.1890/04-1666; Breteler FJ, 1994, WAGENINGEN AGR U PAP, V94-4, P1; Breteler FJ., 1999, WAGENINGEN AGR U PAP, V99-3, P1; Breteler FJ, 2010, PLANT ECOL EVOL, V143, P70, DOI 10.5091/plecevo.2010.369; Burkill MH, 1995, USEFUL PLANTS W TR 3; Cable S, 1998, PLANTS MOUNT CAMEROO; Cayuela L, 2009, TROP CONSERV SCI, V2, P319, DOI 10.1177/194008290900200304; Cheek M., 2004, PLANTS KUPE MWANENGU; Cheek M, 2000, PLANTS MOUNT OKU IJI; Conover WJ., 1999, PRACTICAL NONPARAMET, V3rd; de la Estrella M, 2012, S AFR J BOT, V78, P257, DOI 10.1016/j.sajb.2011.04.006; De la Estrella M, 2006, BOT J LINN SOC, V151, P541, DOI 10.1111/j.1095-8339.2006.00538.x; de la Estrella M, 2010, SYST BOT, V35, P296, DOI 10.1600/036364410791638414; Edwards TC, 2006, ECOL MODEL, V199, P132, DOI 10.1016/j.ecolmodel.2006.05.016; Elith J, 2009, ECOGRAPHY, V32, P66, DOI 10.1111/j.1600-0587.2008.05505.x; Estrella M, 2005, BELG J BOT, V138, P11; Estrella M, 2012, NORD J BOT, V30, P136; Estrella M, 2010, FOLIA GEOBOT, V45, P1; EXELL A W, 1973, Garcia De Orta Serie de Botanica, V1, P3; Feria TP, 2002, DIVERS DISTRIB, V8, P49, DOI 10.1046/j.1472-4642.2002.00127.x; Ferrier S, 2006, J APPL ECOL, V43, P393, DOI 10.1111/j.1365-2664.2006.01149.x; Flather CH, 1997, ECOL APPL, V7, P531, DOI 10.1890/1051-0761(1997)007[0531:IGICNO]2.0.CO;2; Gelfand AE, 2005, J R STAT SOC C-APPL, V54, P1, DOI 10.1111/j.1467-9876.2005.00466.x; Graham CH, 2006, GLOBAL ECOL BIOGEOGR, V15, P578, DOI 10.1111/j.1466-8238.2006.00257.x; Guisan A, 2000, ECOL MODEL, V135, P147, DOI 10.1016/S0304-3800(00)00354-9; Guisan A, 2005, ECOL LETT, V8, P993, DOI 10.1111/j.1461-0248.2005.00792.x; Hampe A, 2004, GLOBAL ECOL BIOGEOGR, V13, P469, DOI 10.1111/j.1466-822X.2004.00090.x; Hernandez PA, 2006, ECOGRAPHY, V29, P773, DOI 10.1111/j.0906-7590.2006.04700.x; Hijmans RJ, 2005, INT J CLIMATOL, V25, P1965, DOI 10.1002/joc.1276; Holmgren M., 2004, Biodiversity of West African forests: an ecological atlas of woody plant species, P73, DOI 10.1079/9780851997346.0073; Hortal J, 2008, J BIOGEOGR, V35, P1335, DOI 10.1111/j.1365-2699.2008.01955.x; Hortal J, 2007, CONSERV BIOL, V21, P853, DOI 10.1111/j.1523-1739.2007.00686.x; Howard PC, 1998, NATURE, V394, P472, DOI 10.1038/28843; Jeschke JM, 2008, ANN NY ACAD SCI, V1134, P1, DOI 10.1196/annals.1439.002; Jimenez-Valverde A, 2012, GLOBAL ECOL BIOGEOGR, V21, P498, DOI 10.1111/j.1466-8238.2011.00683.x; Johnson CJ, 2005, ENVIRON CONSERV, V32, P117, DOI 10.1017/S0376892905002171; Kadmon R, 2003, ECOL APPL, V13, P853, DOI 10.1890/1051-0761(2003)013[0853:ASAOFA]2.0.CO;2; Kareiva P, 2003, AM SCI, V91, P344, DOI 10.1511/2003.26.869; Kearney M, 2004, ECOLOGY, V85, P3119, DOI 10.1890/03-0820; Kuper W, 2006, BOT J LINN SOC, V150, P355, DOI 10.1111/j.1095-8339.2006.00494.x; Lawler JJ, 2003, CONSERV BIOL, V17, P875, DOI 10.1046/j.1523-1739.2003.01638.x; Leathwick JR, 2006, ECOL MODEL, V199, P188, DOI 10.1016/j.ecolmodel.2006.05.022; Lebrun Jean-Pierre, 1998, Candollea, V53, P365; Lehmann A, 2002, BIODIVERS CONSERV, V11, P2217, DOI 10.1023/A:1021398729516; Lewis G, 2005, LEGUMES WORLD; Lobo Jorge M., 2008, Biodiversity Informatics, V5, P14; Loiselle BA, 2003, CONSERV BIOL, V17, P1591, DOI 10.1111/j.1523-1739.2003.00233.x; Loiselle BA, 2008, J BIOGEOGR, V35, P105, DOI 10.1111/j.1365-2699.2007.01779.x; Lughadha EN, 2005, PHILOS T ROY SOC B, V360, P359, DOI 10.1098/rstb.2004.1596; Mabberley D. J., 1997, PLANT BOOK PORTABLE; Mackinder B, 2010, KEW B, V65, P1; Mackinder B. A., 2010, Systematics and conservation of African plants. Proceedings of the 18th AETFAT Congress, Yaounde, Cameroun, 26 February to 2 March 2007, P43; Mackinder B. A., 2006, Edinburgh Journal of Botany, V63, P161, DOI 10.1017/S0960428606000631; Mackinder B.A., 2011, SYST BOT MONOGR, V91, P1; Maharjan SK, 2011, BIOTROPICA, V43, P552, DOI 10.1111/j.1744-7429.2010.00747.x; Margules CR, 2000, NATURE, V405, P243, DOI 10.1038/35012251; Mateo RG, 2008, MODELOS PREDICTIVOS; Mateo RG, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0032586; Mateo RG, 2011, REV CHIL HIST NAT, V84, P217, DOI 10.4067/S0716-078X2011000200008; Mateo RG, 2010, J VEG SCI, V21, P908, DOI 10.1111/j.1654-1103.2010.01198.x; Mateo RG, 2010, DIVERS DISTRIB, V16, P84, DOI 10.1111/j.1472-4642.2009.00617.x; Urbina-Cardona JN, 2010, CONSERV BIOL, V24, P1031, DOI 10.1111/j.1523-1739.2009.01432.x; Papes M, 2007, DIVERS DISTRIB, V13, P890, DOI 10.1111/j.1472-4642.2007.00392.x; Pearson RG, 2007, J BIOGEOGR, V34, P102, DOI 10.1111/j.1365-2699.2006.01594.x; PETERS D, 1998, NR002 COMM AUSTR PAR; Phillips SJ, 2006, ECOL MODEL, V190, P231, DOI 10.1016/j.ecolmodel.2005.03.026; Pickesgill B, 1996, ADV LEGUME SYSTEMA 8; Pineda E, 2009, J ANIM ECOL, V78, P182, DOI 10.1111/j.1365-2656.2008.01471.x; Polhill R. M., 1981, ADV LEGUME SYSTEMA 1; Pulliam HR, 2000, ECOL LETT, V3, P349, DOI 10.1046/j.1461-0248.2000.00143.x; RAVEN PH, 1992, SCIENCE, V258, P1099, DOI 10.1126/science.258.5085.1099; Raxworthy CJ, 2003, NATURE, V426, P837, DOI 10.1038/nature02205; Reddy S, 2003, J BIOGEOGR, V30, P1719, DOI 10.1046/j.1365-2699.2003.00946.x; Rowe RJ, 2005, J BIOGEOGR, V32, P1883, DOI 10.1111/j.1365-2699.2005.01346.x; Sarkar S, 2009, BIODIVERS CONSERV, V18, P1793, DOI 10.1007/s10531-008-9559-1; Soberon Jorge, 2005, Biodiversity Informatics, V2, P1; Sosef M.S.M., 2006, SCRIPTA BOT BELG, V35, P1; Sprent J.I., 2001, NODULATION LEGUMES; Stockwell DRB, 2002, ECOL MODEL, V148, P1, DOI 10.1016/S0304-3800(01)00388-X; Thomas CD, 2004, NATURE, V427, P145, DOI 10.1038/nature02121; Thuiller W, 2005, P NATL ACAD SCI USA, V102, P8245, DOI 10.1073/pnas.0409902102; Trotta-Moreu N, 2010, ENVIRON ENTOMOL, V39, P42, DOI 10.1603/EN08179; Valiela I, 2001, BIOSCIENCE, V51, P807, DOI 10.1641/0006-3568(2001)051[0807:MFOOTW]2.0.CO;2; van der Burgt Xander M., 2012, Kew Bulletin, V67, P51, DOI 10.1007/s12225-012-9345-9; Velayos M, 2010, FLORA GUINEA ECUATOR, VV, P529; Wieringa J.J., 1999, WAGENINGEN AGR U PAP, V99, P1; Wieringa JJ, 2012, NORD J BOT, V30, P144, DOI 10.1111/j.1756-1051.2011.01260.x; Williams JN, 2009, DIVERS DISTRIB, V15, P565, DOI 10.1111/j.1472-4642.2009.00567.x; Wisz MS, 2008, DIVERS DISTRIB, V14, P763, DOI 10.1111/j.1472-4642.2008.00482.x	95	24	25	1	38	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 23	2012	7	7							e41526	10.1371/journal.pone.0041526	http://dx.doi.org/10.1371/journal.pone.0041526			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	977TM	22911808	gold, Green Published, Green Submitted			2022-12-25	WOS:000306687700100
J	Reekie, J; Kowalska, JD; Karpov, I; Rockstroh, J; Karlsson, A; Rakhmanova, A; Horban, A; Kirk, O; Lundgren, JD; Mocroft, A				Reekie, Joanne; Kowalska, Justyna D.; Karpov, Igor; Rockstroh, Jurgen; Karlsson, Anders; Rakhmanova, Aza; Horban, Andrzej; Kirk, Ole; Lundgren, Jens D.; Mocroft, Amanda		EuroSIDA EuroCoord	Regional Differences in AIDS and Non-AIDS Related Mortality in HIV-Positive Individuals across Europe and Argentina: The EuroSIDA Study	PLOS ONE			English	Article							ACTIVE ANTIRETROVIRAL THERAPY; INFECTED PATIENTS; DEATH; ADHERENCE; HEPATITIS; PEOPLE; ADULTS	Background: Differences in access to care and treatment have been reported in Eastern Europe, a region with one of the fastest growing HIV epidemics, compared to the rest of Europe. This analysis aimed to establish whether there are regional differences in the mortality rate of HIV-positive individuals across Europe, and Argentina. Methods: 13,310 individuals under follow-up were included in the analysis. Poisson regression investigated factors associated with the risk of death. Findings: During 82,212 person years of follow-up (PYFU) 1,147 individuals died (mortality rate 14.0 per 1,000 PYFU (95% confidence interval [CI] 13.1-14.8). Significant differences between regions were seen in the rate of all-cause, AIDS and non-AIDS related mortality (global p < 0.0001 for all three endpoints). Compared to South Europe, after adjusting for baseline demographics, laboratory measurements and treatment, a higher rate of AIDS related mortality was observed in East Europe (IRR 2.90, 95% CI 1.97-4.28, p <.0001), and a higher rate of non-AIDS related mortality in North Europe (IRR 1.51, 95% CI 1.24-1.82, p <.0001). The differences observed in North Europe decreased over calendar-time, in 2009-2011, the higher rate of non-AIDS related mortality was no longer significantly different to South Europe (IRR 1.07, 95% CI 0.66-1.75, p = 0.77). However, in 2009-2011, there remained a higher rate of AIDS-related mortality (IRR 2.41, 95% CI 1.11-5.25, p = 0.02) in East Europe compared to South Europe in adjusted analysis. Interpretations: There are significant differences in the rate of all-cause mortality among HIV-positive individuals across different regions of Europe and Argentina. Individuals in Eastern Europe had an increased risk of mortality from AIDS related causes and individuals in North Europe had the highest rate of non-AIDS related mortality. These findings are important for understanding and reviewing HIV treatment strategies and policies across the European region.	[Reekie, Joanne; Mocroft, Amanda] UCL, Sch Med, London, England; [Kowalska, Justyna D.; Kirk, Ole; Lundgren, Jens D.] Univ Copenhagen, Copenhagen HIV Programme, Copenhagen, Denmark; [Karpov, Igor] Belarus State Med Univ, Minsk, BELARUS; [Rockstroh, Jurgen] Univ Bonn, Bonn, Germany; [Karlsson, Anders] Venhaelsan Sodersjukhuset, Stockholm, Sweden; [Rakhmanova, Aza] Med Acad Botkin Hosp, St Petersburg, Russia; [Horban, Andrzej] Warsaw Med Univ, Hosp Infect Dis, Warsaw, Poland; [Kirk, Ole; Lundgren, Jens D.] Rigshosp, Dept Infect Dis, DK-2100 Copenhagen, Denmark	University of London; University College London; UCL Medical School; University of Copenhagen; University of Bonn; Medical University of Warsaw; Rigshospitalet; University of Copenhagen	Reekie, J (corresponding author), UCL, Sch Med, London, England.	j.reekie@ucl.ac.uk	Kowalska, Justyna D./E-9423-2013; Castagna, Antonella/K-3280-2018; Mitsura, Viktar/G-2457-2017; kirk, ole/ABB-4746-2021; Lundgren, Jens/AAE-6876-2019; Ostergaard, Lars/AAA-3020-2020; Vandekerckhove, Linos/J-6420-2013; Begovac, Josip/AAI-5672-2021; Soriano, Vicente/O-5730-2018; Grzeszczuk, Anna/R-7844-2018; LAZZARIN, Adriano/K-3607-2018; Flisiak, Robert/S-5356-2018	Castagna, Antonella/0000-0002-8338-9714; Mitsura, Viktar/0000-0002-0449-5026; Ostergaard, Lars/0000-0003-2459-0511; Vandekerckhove, Linos/0000-0002-8600-1631; Begovac, Josip/0000-0003-2641-4327; Soriano, Vicente/0000-0002-4624-5199; Gianotti, Nicola/0000-0002-7182-5080; Grzeszczuk, Anna/0000-0002-6420-5545; Jevtovic, Dorde/0000-0003-1127-6072; Ristola, Matti/0000-0001-5115-2811; Lundgren, Jens/0000-0001-8901-7850; LAZZARIN, Adriano/0000-0003-2551-7754; Podlekareva, Daria/0000-0003-3187-0597; Flisiak, Robert/0000-0003-3394-1635; Anna, Vassilenko/0000-0003-1907-2322; Ostergaard, Lars/0000-0002-7619-605X; Leen, Clifford/0000-0001-8439-7719; Benfield, Thomas/0000-0003-0698-9385; Katzenstein, Terese L/0000-0002-2233-500X	European Commission [CT94-1637, CT97-2713, QLK2-2000-00773, LSHP-CT-2006-018632, 260694]; Swiss National Science Foundation [108787]	European Commission(European CommissionEuropean Commission Joint Research Centre); Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission)	This work was supported by the European Commission BIOMED 1 (CT94-1637), BIOMED 2 (CT97-2713), the 5th Framework (QLK2-2000-00773) and the 6th Framework (LSHP-CT-2006-018632), and the 7th Framework (FP7/2007-2013, EuroCoord no 260694) programmes. The participation of centres from Switzerland was supported by The Swiss National Science Foundation (Grant 108787). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Braitstein P, 2006, AIDS, V20, P323, DOI 10.1097/01.aids.0000198091.70325.f4; Chiesi A, 1999, AIDS, V13, P2281, DOI 10.1097/00002030-199911120-00010; Deeks SG, 2011, ANNU REV MED, V62, P141, DOI 10.1146/annurev-med-042909-093756; Deeks SG, 2009, BMJ-BRIT MED J, V338, DOI 10.1136/bmj.a3172; Friis-Moller N, 2003, NEW ENGL J MED, V349, P1993, DOI 10.1056/NEJMoa030218; Hamers FF, 2003, LANCET, V361, P1035, DOI 10.1016/S0140-6736(03)12831-0; Hogg R, 2008, LANCET, V372, P293, DOI 10.1016/S0140-6736(08)61113-7; Joint United Nations Programme on HIV/AIDS (UNAIDS), 2009, FACT SHEET N AM W CE; Kowalska JD, 2011, EPIDEMIOLOGY, V22, P516, DOI 10.1097/EDE.0b013e31821b5332; Kowalska JD, 2011, HIV CLIN TRIALS, V12, P109, DOI 10.1310/hct1202-109; Lewden C, 2005, INT J EPIDEMIOL, V34, P121, DOI 10.1093/ije/dyh307; Lewden C, 2008, JAIDS-J ACQ IMM DEF, V48, P590, DOI 10.1097/QAI.0b013e31817efb54; Mathers BM, 2010, LANCET, V375, P1014, DOI 10.1016/S0140-6736(10)60232-2; Mocroft A, 1999, AIDS, V13, P943, DOI 10.1097/00002030-199905280-00010; Mocroft A, 2008, HIV MED, V9, P261, DOI 10.1111/j.1468-1293.2008.00557.x; Mocroft A, 2003, LANCET, V362, P22, DOI 10.1016/S0140-6736(03)13802-0; Mocroft A, 2002, AIDS, V16, P1663, DOI 10.1097/00002030-200208160-00012; Murray M, 2012, HIV MED, V13, P89, DOI 10.1111/j.1468-1293.2011.00940.x; Podlekareva D, 2008, INDICATORS USE HEALT; Podlekareva Daria, 2008, Central European Journal of Public Health, V16, P99; Saranga A, 2008, INT J DRUG POLICY, V19, pS25, DOI 10.1016/j.drugpo.2007.11.008; Sofi F, 2008, BMJ-BRIT MED J, V337, DOI 10.1136/bmj.a1344; UNAIDS, 2009, ARG COUNT SIT 2009; UNAIDS, 2008, 08 REP GLOB AIDS EP; UNAIDS, 2009, FACT SHEETS E EUR CE; UNAIDS, 2010, GLOB REP UNAIDS REP; [UNAIDS World Health Organization], 2009, 09 AIDS EP UPD, P1; Van Asten LC, 2003, EUR J PUBLIC HEALTH, V13, P347, DOI 10.1093/eurpub/13.4.347; Vollset SE, 2010, SCAND J PUBLIC HEALT, V38, P127, DOI 10.1177/1403494810379893; Wood E, 2003, CAN MED ASSOC J, V169, P656	30	26	26	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 23	2012	7	7							e41673	10.1371/journal.pone.0041673	http://dx.doi.org/10.1371/journal.pone.0041673			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	977TM	22911841	Green Published, Green Submitted, Green Accepted, gold			2022-12-25	WOS:000306687700137
J	Domingues, MN; de Campos, BM; de Oliveira, MLP; de Mello, UQ; Benedetti, CE				Domingues, Mariane Noronha; de Campos, Bruna Medeia; Peixoto de Oliveira, Maria Luiza; de Mello, Uli Quirino; Benedetti, Celso Eduardo			TAL Effectors Target the C-Terminal Domain of RNA Polymerase II (CTD) by Inhibiting the Prolyl-Isomerase Activity of a CTD-Associated Cyclophilin	PLOS ONE			English	Article							PRE-MESSENGER-RNA; XANTHOMONAS-CITRI; TRANSCRIPTION TERMINATION; PATHOGENICITY GENE; UBIQUITIN LIGASE; DNA RECOGNITION; ESS1; PROTEINS; PTHA; UBIQUITYLATION	Transcriptional activator-like (TAL) effectors of plant pathogenic bacteria function as transcription factors in plant cells. However, how TAL effectors control transcription in the host is presently unknown. Previously, we showed that TAL effectors of the citrus canker pathogen Xanthomonas citri, named PthAs, targeted the citrus protein complex comprising the thioredoxin CsTdx, ubiquitin-conjugating enzymes CsUev/Ubc13 and cyclophilin CsCyp. Here we show that CsCyp complements the function of Cpr1 and Ess1, two yeast cyclophilins that regulate transcription by the isomerization of proline residues of the regulatory C-terminal domain (CTD) of RNA polymerase II. We also demonstrate that CsCyp, CsTdx, CsUev and four PthA variants interact with the citrus CTD and that CsCyp co-immunoprecipitate with the CTD in citrus cell extracts and with PthA2 transiently expressed in sweet orange epicotyls. The interactions of CsCyp with the CTD and PthA2 were inhibited by cyclosporin A (CsA), a cyclophilin inhibitor. Moreover, we present evidence that PthA2 inhibits the peptidyl-prolyl cis-trans isomerase (PPIase) activity of CsCyp in a similar fashion as CsA, and that silencing of CsCyp, as well as treatments with CsA, enhance canker lesions in X. citri-infected leaves. Given that CsCyp appears to function as a negative regulator of cell growth and that Ess1 negatively regulates transcription elongation in yeast, we propose that PthAs activate host transcription by inhibiting the PPIase activity of CsCyp on the CTD.	[Domingues, Mariane Noronha; de Campos, Bruna Medeia; Peixoto de Oliveira, Maria Luiza; de Mello, Uli Quirino; Benedetti, Celso Eduardo] Ctr Nacl Pesquisa Energia & Mat, Lab Nacl Biociencias, Campinas, SP, Brazil		Domingues, MN (corresponding author), Ctr Nacl Pesquisa Energia & Mat, Lab Nacl Biociencias, Campinas, SP, Brazil.	celso.benedetti@lnbio.org.br	Citros, Inct/I-2442-2013	Benedetti, Celso/0000-0002-4602-0256; Domingues, Mariane/0000-0003-0229-8261	Fundacao de Amparo a Pesquisa do Estado de Sao Paulo; Conselho Nacional de Desenvolvimento Cientifico e Tecnologico	Fundacao de Amparo a Pesquisa do Estado de Sao Paulo(Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP)); Conselho Nacional de Desenvolvimento Cientifico e Tecnologico(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ))	This work was supported by grants from Fundacao de Amparo a Pesquisa do Estado de Sao Paulo and Conselho Nacional de Desenvolvimento Cientifico e Tecnologico. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Al-Saadi A, 2007, MOL PLANT MICROBE IN, V20, P934, DOI 10.1094/MPMI-20-8-0934; Arevalo-Rodriguez M, 2000, EMBO J, V19, P3739, DOI 10.1093/emboj/19.14.3739; Arevalo-Rodriguez M, 2005, EUKARYOT CELL, V4, P17, DOI 10.1128/EC.4.1.17-29.2005; Boch J, 2009, SCIENCE, V326, P1509, DOI 10.1126/science.1178811; Braun P, 2011, SCIENCE, V333, P601, DOI 10.1126/science.1203877; Brunings AM, 2003, MOL PLANT PATHOL, V4, P141, DOI 10.1046/j.1364-3703.2003.00163.x; Buratowski S, 2009, MOL CELL, V36, P541, DOI 10.1016/j.molcel.2009.10.019; Camara Y, 2011, CELL METAB, V13, P527, DOI 10.1016/j.cmet.2011.04.002; Cernadas RA, 2008, MOL PLANT PATHOL, V9, P609, DOI 10.1111/J.1364-3703.2008.00486.X; Cernadas RA, 2009, PLANT SCI, V177, P190, DOI 10.1016/j.plantsci.2009.05.006; Chapman RD, 2004, NUCLEIC ACIDS RES, V32, P35, DOI 10.1093/nar/gkh172; Coaker G, 2005, SCIENCE, V308, P548, DOI 10.1126/science.1108633; Daulny A, 2009, DNA REPAIR, V8, P444, DOI 10.1016/j.dnarep.2009.01.017; de Souza TA, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0032305; Deng D, 2012, SCIENCE, V335, P720, DOI 10.1126/science.1215670; Domingues MN, 2010, MOL PLANT PATHOL, V11, P663, DOI [10.1111/J.1364-3703.2010.00636.X, 10.1111/j.1364-3703.2010.00636.x]; Duan YP, 1999, MOL PLANT MICROBE IN, V12, P556, DOI 10.1094/MPMI.1999.12.6.556; Fujimori F, 1999, BIOCHEM BIOPH RES CO, V265, P658, DOI 10.1006/bbrc.1999.1736; Gullerova M, 2006, RNA, V12, P631, DOI 10.1261/rna.2226106; HANES SD, 1989, YEAST, V5, P55, DOI 10.1002/yea.320050108; Hani J, 1999, J BIOL CHEM, V274, P108, DOI 10.1074/jbc.274.1.108; James P, 1996, GENETICS, V144, P1425; JEFFERSON RA, 1987, EMBO J, V6, P3901; Jeong SJ, 2005, J MICROBIOL, V43, P516; Jouvet N, 2010, BMC MOL BIOL, V11, DOI 10.1186/1471-2199-11-92; Kay S, 2009, CURR OPIN MICROBIOL, V12, P37, DOI 10.1016/j.mib.2008.12.006; Kay S, 2007, SCIENCE, V318, P648, DOI 10.1126/science.1144956; Kay S, 2009, PLANT J, V59, P859, DOI 10.1111/j.1365-313X.2009.03922.x; KOFRON JL, 1991, BIOCHEMISTRY-US, V30, P6127, DOI 10.1021/bi00239a007; Krishnamurthy S, 2009, MOL CELL BIOL, V29, P2925, DOI 10.1128/MCB.01655-08; Liou YC, 2002, P NATL ACAD SCI USA, V99, P1335, DOI 10.1073/pnas.032404099; Lunde BM, 2010, NAT STRUCT MOL BIOL, V17, P1195, DOI 10.1038/nsmb.1893; Mak ANS, 2012, SCIENCE, V335, P716, DOI 10.1126/science.1216211; Meinhart A, 2005, GENE DEV, V19, P1401, DOI 10.1101/gad.1318105; Morris DP, 1999, J BIOL CHEM, V274, P31583, DOI 10.1074/jbc.274.44.31583; Moscou MJ, 2009, SCIENCE, V326, P1501, DOI 10.1126/science.1178817; Murakami MT, 2010, PROTEINS, V78, P3386, DOI 10.1002/prot.22846; Palancade B, 2003, EUR J BIOCHEM, V270, P3859, DOI 10.1046/j.1432-1033.2003.03794.x; de Oliveira MLP, 2009, PLANT CELL REP, V28, P387, DOI 10.1007/s00299-008-0646-2; Roberti M, 2009, BBA-BIOENERGETICS, V1787, P303, DOI 10.1016/j.bbabio.2009.01.013; Romer P, 2007, SCIENCE, V318, P645, DOI 10.1126/science.1144958; Romer P, 2009, PLANT PHYSIOL, V150, P1697, DOI 10.1104/pp.109.139931; Singh N, 2009, MOL CELL, V36, P255, DOI 10.1016/j.molcel.2009.08.018; Somesh BP, 2007, CELL, V129, P57, DOI 10.1016/j.cell.2007.01.046; Somesh BP, 2005, CELL, V121, P913, DOI 10.1016/j.cell.2005.04.010; SWARUP S, 1992, MOL PLANT MICROBE IN, V5, P204, DOI 10.1094/MPMI-5-204; SWARUP S, 1991, PHYTOPATHOLOGY, V81, P802, DOI 10.1094/Phyto-81-802; Uetz P, 2000, NATURE, V403, P623, DOI 10.1038/35001009; Werner-Allen JW, 2011, J BIOL CHEM, V286, P5717, DOI 10.1074/jbc.M110.197129; Wesley SV, 2001, PLANT J, V27, P581, DOI 10.1046/j.1365-313X.2001.01105.x; Wu XY, 2000, EMBO J, V19, P3727, DOI 10.1093/emboj/19.14.3727; Wu XY, 2003, GENETICS, V165, P1687; Wu XY, 2001, CURR GENET, V40, P234, DOI 10.1007/s00294-001-0257-8; Xu YX, 2007, GENE DEV, V21, P2950, DOI 10.1101/gad.1592807; Zhang MH, 2005, MOL CELL, V20, P525, DOI 10.1016/j.molcel.2005.09.023	55	15	16	0	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 20	2012	7	7							e41553	10.1371/journal.pone.0041553	http://dx.doi.org/10.1371/journal.pone.0041553			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	977GL	22911812	Green Published, gold, Green Submitted			2022-12-25	WOS:000306644600085
J	Muthu, M; Richardson, KA; Sutherland-Smith, AJ				Muthu, Muralidharan; Richardson, Kylie A.; Sutherland-Smith, Andrew J.			The Crystal Structures of Dystrophin and Utrophin Spectrin Repeats: Implications for Domain Boundaries	PLOS ONE			English	Article							ALPHA-ACTININ ROD; MUSCULAR-DYSTROPHY; SKELETAL-MUSCLE; PLAKIN DOMAIN; MDX MICE; GLYCOPROTEIN COMPLEX; MOLECULAR-GRAPHICS; PROTEIN-STRUCTURE; NUCLEIC-ACIDS; F-ACTIN	Dystrophin and utrophin link the F-actin cytoskeleton to the cell membrane via an associated glycoprotein complex. This functionality results from their domain organization having an N-terminal actin-binding domain followed by multiple spectrin-repeat domains and then C-terminal protein-binding motifs. Therapeutic strategies to replace defective dystrophin with utrophin in patients with Duchenne muscular dystrophy require full-characterization of both these proteins to assess their degree of structural and functional equivalence. Here the high resolution structures of the first spectrin repeats (N-terminal repeat 1) from both dystrophin and utrophin have been determined by x-ray crystallography. The repeat structures both display a three-helix bundle fold very similar to one another and to homologous domains from spectrin, a-actinin and plectin. The utrophin and dystrophin repeat structures reveal the relationship between the structural domain and the canonical spectrin repeat domain sequence motif, showing the compact structural domain of spectrin repeat one to be extended at the C-terminus relative to its previously defined sequence repeat. These structures explain previous in vitro biochemical studies in which extending dystrophin spectrin repeat domain length leads to increased protein stability. Furthermore we show that the first dystrophin and utrophin spectrin repeats have no affinity for F-actin in the absence of other domains.	[Muthu, Muralidharan; Richardson, Kylie A.; Sutherland-Smith, Andrew J.] Massey Univ, Inst Mol BioSci, Palmerston North, New Zealand	Massey University	Muthu, M (corresponding author), Massey Univ, Inst Mol BioSci, Palmerston North, New Zealand.	A.J.Sutherland-Smith@massey.ac.nz	Sutherland-Smith, Andrew/F-1813-2011	Sutherland-Smith, Andrew/0000-0001-9485-1428	Massey University; Neurological Foundation of New Zealand; Palmerston North Medical Research Foundation	Massey University; Neurological Foundation of New Zealand; Palmerston North Medical Research Foundation	The authors acknowledge funding of a Massey University Doctoral Scholarship to MM and Neurological Foundation of New Zealand, Palmerston North Medical Research Foundation and Massey University Research Fund grants to AJSS. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adams PD, 2002, ACTA CRYSTALLOGR D, V58, P1948, DOI 10.1107/S0907444902016657; Altmann SM, 2002, STRUCTURE, V10, P1085, DOI 10.1016/S0969-2126(02)00808-0; Amann KJ, 1998, J BIOL CHEM, V273, P28419, DOI 10.1074/jbc.273.43.28419; Amann KJ, 1999, J BIOL CHEM, V274, P35375, DOI 10.1074/jbc.274.50.35375; Ashkenazy H, 2010, NUCLEIC ACIDS RES, V38, pW529, DOI 10.1093/nar/gkq399; Banatao DR, 2006, P NATL ACAD SCI USA, V103, P16230, DOI 10.1073/pnas.0607674103; Bhasin N, 2005, J MOL BIOL, V352, P795, DOI 10.1016/j.jmb.2005.07.064; Bhosle RC, 2006, BIOCHEM BIOPH RES CO, V346, P768, DOI 10.1016/j.bbrc.2006.05.192; Blake DJ, 2002, PHYSIOL REV, V82, P291, DOI 10.1152/physrev.00028.2001; BLOCH R J, 1992, Trends in Cell Biology, V2, P186, DOI 10.1016/0962-8924(92)90231-B; Bond CS, 2009, ACTA CRYSTALLOGR D, V65, P510, DOI 10.1107/S0907444909007835; Calvert R, 1996, BIOPHYS J, V71, P1605, DOI 10.1016/S0006-3495(96)79363-3; Choi HJ, 2011, J MOL BIOL, V409, P800, DOI 10.1016/j.jmb.2011.04.046; Clark AR, 2009, HUM MOL GENET, V18, P4791, DOI 10.1093/hmg/ddp442; CLERK A, 1993, HISTOCHEM J, V25, P554; Davis IW, 2004, NUCLEIC ACIDS RES, V32, pW615, DOI 10.1093/nar/gkh398; DeLano W.L., 2002, PYMOL MOL GRAPHICS S; Di Certo MG, 2010, HUM MOL GENET, V19, P752, DOI 10.1093/hmg/ddp539; Djinovic-Carugo K, 2002, FEBS LETT, V513, P119, DOI 10.1016/S0014-5793(01)03304-X; Djinovic-Carugo K, 1999, CELL, V98, P537, DOI 10.1016/S0092-8674(00)81981-9; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; ENGLAND SB, 1990, NATURE, V343, P180, DOI 10.1038/343180a0; ERVASTI JM, 1993, J CELL BIOL, V122, P809, DOI 10.1083/jcb.122.4.809; Grum VL, 1999, CELL, V98, P523, DOI 10.1016/S0092-8674(00)81980-7; Harper SQ, 2002, NAT MED, V8, P253, DOI 10.1038/nm0302-253; Henderson DM, 2011, HUM MOL GENET, V20, P2955, DOI 10.1093/hmg/ddr199; Holm L, 2008, BIOINFORMATICS, V24, P2780, DOI 10.1093/bioinformatics/btn507; Jefferson JJ, 2007, J MOL BIOL, V366, P244, DOI 10.1016/j.jmb.2006.11.036; KAHANA E, 1994, J MOL BIOL, V235, P1271, DOI 10.1006/jmbi.1994.1080; KAHANA E, 1995, BIOCHEMISTRY-US, V34, P8110, DOI 10.1021/bi00025a017; KOENIG M, 1990, J BIOL CHEM, V265, P4560; Krissinel E, 2007, J MOL BIOL, V372, P774, DOI 10.1016/j.jmb.2007.05.022; Kusunoki H, 2004, J MOL BIOL, V344, P495, DOI 10.1016/j.jmb.2004.09.019; Kusunoki H, 2004, STRUCTURE, V12, P645, DOI 10.1016/j.str.2004.02.022; Lai Y, 2009, J CLIN INVEST, V119, P624, DOI 10.1172/JCI36612; Larkin MA, 2007, BIOINFORMATICS, V23, P2947, DOI 10.1093/bioinformatics/btm404; Le Rumeur E, 2003, J BIOL CHEM, V278, P5993, DOI 10.1074/jbc.M207321200; Legardinier S, 2009, J BIOL CHEM, V284, P8822, DOI 10.1074/jbc.M805846200; Legardinier S, 2009, J MOL BIOL, V389, P546, DOI 10.1016/j.jmb.2009.04.025; LOVE DR, 1989, NATURE, V339, P55, DOI 10.1038/339055a0; Mccoy AJ, 2007, J APPL CRYSTALLOGR, V40, P658, DOI 10.1107/S0021889807021206; Menhart N, 2006, BBA-PROTEINS PROTEOM, V1764, P993, DOI 10.1016/j.bbapap.2006.03.017; Mirza A, 2010, BBA-PROTEINS PROTEOM, V1804, P1796, DOI 10.1016/j.bbapap.2010.03.009; Miura P, 2009, HUM MOL GENET, V18, P4640, DOI 10.1093/hmg/ddp431; Murshudov GN, 1997, ACTA CRYSTALLOGR D, V53, P240, DOI 10.1107/S0907444996012255; Nguyen T M, 1991, J Cell Biol, V115, P1695, DOI 10.1083/jcb.115.6.1695; Pantazatos DP, 1997, J BIOL CHEM, V272, P21052, DOI 10.1074/jbc.272.34.21052; PARRY DAD, 1992, BIOPHYS J, V61, P858, DOI 10.1016/S0006-3495(92)81893-3; Pascual J, 1997, J MOL BIOL, V273, P740, DOI 10.1006/jmbi.1997.1344; Potterton L, 2004, ACTA CRYSTALLOGR D, V60, P2288, DOI 10.1107/S0907444904023716; Prochniewicz E, 2009, P NATL ACAD SCI USA, V106, P7822, DOI 10.1073/pnas.0812007106; Roy A, 2010, NAT PROTOC, V5, P725, DOI 10.1038/nprot.2010.5; Rybakova IN, 2006, J BIOL CHEM, V281, P9996, DOI 10.1074/jbc.M513121200; Rybakova IN, 2005, J BIOL CHEM, V280, P23018, DOI 10.1074/jbc.M502530200; Rybakova IN, 1997, J BIOL CHEM, V272, P28771, DOI 10.1074/jbc.272.45.28771; Rybakova IN, 2000, J CELL BIOL, V150, P1209, DOI 10.1083/jcb.150.5.1209; Saadat L, 2006, BBA-PROTEINS PROTEOM, V1764, P943, DOI 10.1016/j.bbapap.2006.02.012; Sawyer GM, 2009, J MOL BIOL, V390, P1030, DOI 10.1016/j.jmb.2009.06.009; Sonnenberg A, 2007, J MOL BIOL, V368, P1379, DOI 10.1016/j.jmb.2007.02.090; Stone MR, 2005, MOL BIOL CELL, V16, P4280, DOI 10.1091/mbc.E05-02-0112; Sutherland-Smith AJ, 2003, J MOL BIOL, V329, P15, DOI 10.1016/S0022-2836(03)00422-4; Tinsley JM, 1996, NATURE, V384, P349, DOI 10.1038/384349a0; Wallace GQ, 2009, ANNU REV PHYSIOL, V71, P37, DOI 10.1146/annurev.physiol.010908.163216; WAY M, 1992, J CELL BIOL, V119, P835, DOI 10.1083/jcb.119.4.835; WINDER SJ, 1995, FEBS LETT, V369, P27, DOI 10.1016/0014-5793(95)00398-S; Winn MD, 2001, ACTA CRYSTALLOGR D, V57, P122, DOI 10.1107/S0907444900014736; Yamashita K, 2010, BIOCHEM BIOPH RES CO, V391, P812, DOI 10.1016/j.bbrc.2009.11.144; YAN Y, 1993, SCIENCE, V262, P2027, DOI 10.1126/science.8266097; Ylanne J, 2001, STRUCTURE, V9, P597, DOI 10.1016/S0969-2126(01)00619-0; Zuellig RA, 2000, J CELL BIOCHEM, V77, P418, DOI 10.1002/(SICI)1097-4644(20000601)77:3<418::AID-JCB7>3.0.CO;2-Z	70	32	32	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 20	2012	7	7							e40066	10.1371/journal.pone.0040066	http://dx.doi.org/10.1371/journal.pone.0040066			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	977GL	22911693	Green Published, gold, Green Submitted			2022-12-25	WOS:000306644600012
J	Tekedereli, I; Alpay, SN; Tavares, CDJ; Cobanoglu, ZE; Kaoud, TS; Sahin, I; Sood, AK; Lopez-Berestein, G; Dalby, KN; Ozpolat, B				Tekedereli, Ibrahim; Alpay, S. Neslihan; Tavares, Clint D. J.; Cobanoglu, Zehra E.; Kaoud, Tamer S.; Sahin, Ibrahim; Sood, Anil K.; Lopez-Berestein, Gabriel; Dalby, Kevin N.; Ozpolat, Bulent			Targeted Silencing of Elongation Factor 2 Kinase Suppresses Growth and Sensitizes Tumors to Doxorubicin in an Orthotopic Model of Breast Cancer	PLOS ONE			English	Article							MR 100,000 SUBSTRATE; HUMAN GLIOMA-CELLS; PROTEIN-SYNTHESIS; C-MYC; EUKARYOTIC ELONGATION-FACTOR-2; CYCLIN D1; SIGNAL-TRANSDUCTION; IN-SITU; CALMODULIN; SRC	Eukaryotic elongation factor 2 kinase (eEF-2K), through its phosphorylation of elongation factor 2 (eEF2), provides a mechanism by which cells can control the rate of the elongation phase of protein synthesis. The activity of eEF-2K is increased in rapidly proliferating malignant cells, is inhibited during mitosis, and may contribute to the promotion of autophagy in response to anti-cancer therapies. The purpose of this study was to examine the therapeutic potential of targeting eEF-2K in breast cancer tumors. Through the systemic administration of liposomal eEF-2K siRNA (twice a week, i.v. 150 mu g/kg), the expression of eEF-2K was down-regulated in vivo in an orthotopic xenograft mouse model of a highly aggressive triple negative MDA-MB-231 tumor. This targeting resulted in a substantial decrease in eEF2 phosphorylation in the tumors, and led to the inhibition of tumor growth, the induction of apoptosis and the sensitization of tumors to the chemotherapy agent doxorubicin. eEF-2K down-modulation in vitro resulted in a decrease in the expression of c-Myc and cyclin D1 with a concomitant increase in the expression of p27(Kip1). A decrease in the basal activity of c-Src (phospho-Tyr-416), focal adhesion kinase (phospho-Tyr-397), and Akt (phospho-Ser-473) was also detected following eEF-2K down-regulation in MDA-MB-231 cells, as determined by Western blotting. Where tested, similar results were seen in ER-positive MCF-7 cells. These effects were also accompanied by a decrease in the observed invasive phenotype of the MDA-MB-231 cells. These data support the notion that the disruption of eEF-2K expression in breast cancer cells results in the down-regulation of signaling pathways affecting growth, survival and resistance and has potential as a therapeutic approach for the treatment of breast cancer.	[Tekedereli, Ibrahim; Alpay, S. Neslihan; Cobanoglu, Zehra E.; Sahin, Ibrahim; Lopez-Berestein, Gabriel; Ozpolat, Bulent] Univ Texas MD Anderson Canc Ctr, Dept Expt Therapeut, Houston, TX 77030 USA; [Tavares, Clint D. J.; Dalby, Kevin N.] Univ Texas Austin, Grad Program Cell & Mol Biol, Austin, TX 78712 USA; [Kaoud, Tamer S.; Dalby, Kevin N.] Univ Texas Austin, Coll Pharm, Div Med Chem, Austin, TX 78712 USA; [Sood, Anil K.] Univ Texas MD Anderson Canc Ctr, Dept Gynecol Oncol, Houston, TX 77030 USA; [Sood, Anil K.; Lopez-Berestein, Gabriel] Univ Texas MD Anderson Canc Ctr, Dept Canc Biol, Houston, TX 77030 USA; [Sood, Anil K.; Lopez-Berestein, Gabriel; Ozpolat, Bulent] Univ Texas MD Anderson Canc Ctr, Ctr RNAi & Noncoding RNA, Houston, TX 77030 USA	University of Texas System; UTMD Anderson Cancer Center; University of Texas System; University of Texas Austin; University of Texas System; University of Texas Austin; University of Texas System; UTMD Anderson Cancer Center; University of Texas System; UTMD Anderson Cancer Center; University of Texas System; UTMD Anderson Cancer Center	Tekedereli, I (corresponding author), Univ Texas MD Anderson Canc Ctr, Dept Expt Therapeut, Houston, TX 77030 USA.	kinases@me.com; bozpolat@mdanderson.org	Dalby, Kevin N/A-1905-2013; Kaoud, Tamer S/C-3618-2019; Sahin, Ibrahim/AAO-1035-2020; Şahin, İbrahim/HHY-8303-2022	Dalby, Kevin N/0000-0001-9272-5129; Kaoud, Tamer S/0000-0003-1298-8725; 	Norman Hackerman Advanced Technology Research Program [003658-0069-2009]; Cancer Prevention and Research Institute of Texas [RP120406]; Welch Foundation [F-1390]; National Institutes of Health [GM59802]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM059802] Funding Source: NIH RePORTER	Norman Hackerman Advanced Technology Research Program; Cancer Prevention and Research Institute of Texas; Welch Foundation(The Welch Foundation); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This research was supported in part by grants from The Norman Hackerman Advanced Technology Research Program (003658-0069-2009), The Cancer Prevention and Research Institute of Texas (RP120406) to BO and KND, the Welch Foundation (F-1390) and the National Institutes of Health to KND (GM59802). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abe O, 1998, LANCET, V352, P930; Abramczyk O, 2011, PROTEIN EXPRES PURIF, V79, P237, DOI 10.1016/j.pep.2011.05.005; Akar U, 2008, AUTOPHAGY, V4, P669, DOI 10.4161/auto.6083; Akar U, 2010, MOL CANCER THER, V9, P1180, DOI 10.1158/1535-7163.MCT-09-1025; Alkarain A, 2004, J MAMMARY GLAND BIOL, V9, P67, DOI 10.1023/B:JOMG.0000023589.00994.5e; Arora S, 2005, CANCER RES, V65, P3806, DOI 10.1158/0008-5472.CAN-04-4036; BAGAGLIO DM, 1994, CELL GROWTH DIFFER, V5, P1403; Biscardi JS, 1998, MOL CARCINOGEN, V21, P261, DOI 10.1002/(SICI)1098-2744(199804)21:4<261::AID-MC5>3.0.CO;2-N; Boyce M, 2008, CELL DEATH DIFFER, V15, P589, DOI 10.1038/sj.cdd.4402296; Browne GJ, 2004, J BIOL CHEM, V279, P12220, DOI 10.1074/jbc.M309773200; CARLBERG U, 1991, BIOCHEM BIOPH RES CO, V180, P1372, DOI 10.1016/S0006-291X(05)81347-6; Casamayor A, 1999, BIOCHEM J, V342, P287, DOI 10.1042/0264-6021:3420287; CHAFOULEAS JG, 1981, P NATL ACAD SCI-BIOL, V78, P996, DOI 10.1073/pnas.78.2.996; Chen CY, 2011, CANCER SCI, V102, P1582, DOI 10.1111/j.1349-7006.2011.01975.x; Chen Z, 2011, J BIOL CHEM; Cheng Y, 2011, CANCER RES, V71, P2654, DOI 10.1158/0008-5472.CAN-10-2889; Cheng Y, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009715; Cobleigh MA, 2011, SEMIN ONCOL, V38, pS11, DOI 10.1053/j.seminoncol.2011.04.005; Connolly E, 2006, MOL CELL BIOL, V26, P3955, DOI 10.1128/MCB.26.10.3955-3965.2006; DAKSIS JI, 1994, ONCOGENE, V9, P3635; Dang CV, 2008, NAT REV CANCER, V8, P51, DOI 10.1038/nrc2274; Devkota AK, 2012, BIOCHEMISTRY; Devkota AK, 2012, BIOCHEMISTRY-US, V51, P2100, DOI 10.1021/bi201787p; ENGEL LW, 1978, CANCER RES, V38, P4327; Esteva FJ, 2002, J CLIN ONCOL, V20, P1800, DOI 10.1200/JCO.2002.07.058; Finn RS, 2008, ANN ONCOL, V19, P1379, DOI 10.1093/annonc/mdn291; GAVRIELI Y, 1992, J CELL BIOL, V119, P493, DOI 10.1083/jcb.119.3.493; Gildish I, 2012, LEARN MEMORY, V19, P116, DOI 10.1101/lm.023937.111; GILLETT C, 1994, CANCER RES, V54, P1812; Hait WN, 2006, AUTOPHAGY, V2, P294, DOI 10.4161/auto.2857; Hannon GJ, 2004, NATURE, V431, P371, DOI 10.1038/nature02870; Landen CN, 2005, CANCER RES, V65, P6910, DOI 10.1158/0008-5472.CAN-05-0530; Liao D. Joshua, 2007, Critical Reviews in Oncogenesis, V13, P93; Liao DJ, 2000, ENDOCR-RELAT CANCER, V7, P143, DOI 10.1677/erc.0.0070143; LUTTRELL DK, 1994, P NATL ACAD SCI USA, V91, P83, DOI 10.1073/pnas.91.1.83; Ma XJM, 2009, NAT REV MOL CELL BIO, V10, P307, DOI 10.1038/nrm2672; Mitra SK, 2006, CURR OPIN CELL BIOL, V18, P516, DOI 10.1016/j.ceb.2006.08.011; Moon DO, 2009, ARCH PHARM RES, V32, P1351, DOI 10.1007/s12272-009-2002-7; NAIRN AC, 1985, P NATL ACAD SCI USA, V82, P7939, DOI 10.1073/pnas.82.23.7939; NAIRN AC, 1987, J BIOL CHEM, V262, P17299; Nakamura J, 2009, INT J ONCOL, V34, P1181, DOI 10.3892/ijo_00000246; NILSSON A, 1995, BBA-MOL CELL RES, V1268, P263, DOI 10.1016/0167-4889(95)00084-6; Oltersdorf T, 2005, NATURE, V435, P677, DOI 10.1038/nature03579; Ozpolat B, 2010, J INTERN MED, V267, P44, DOI 10.1111/j.1365-2796.2009.02191.x; Ozpolat B, 2010, P AM ASS CANC RES AA; Ozpolat B, 2007, MOL CANCER RES, V5, P95, DOI 10.1158/1541-7786.MCR-06-0125; Park S, 2008, NEURON, V59, P70, DOI 10.1016/j.neuron.2008.05.023; PARKIN N, 1988, MOL CELL BIOL, V8, P2875, DOI 10.1128/MCB.8.7.2875; Parmer TG, 1999, BRIT J CANCER, V79, P59, DOI 10.1038/sj.bjc.6690012; Parmer TG, 1997, CELL GROWTH DIFFER, V8, P327; Plumb JA, 1999, METH MOLEC MED, V28, P17, DOI 10.1385/1-59259-687-8:17; Proud CG, 2007, BIOCHEM J, V403, P217, DOI 10.1042/BJ20070024; Rosenwald IB, 1995, CELL PROLIFERAT, V28, P631, DOI 10.1111/j.1365-2184.1995.tb00050.x; Roskoski R, 2004, BIOCHEM BIOPH RES CO, V324, P1155, DOI 10.1016/j.bbrc.2004.09.171; Ryazanov AG, 2002, FEBS LETT, V514, P26, DOI 10.1016/S0014-5793(02)02299-8; Sarbassov DD, 2005, SCIENCE, V307, P1098, DOI 10.1126/science.1106148; SCHALLER MD, 1994, MOL CELL BIOL, V14, P1680, DOI 10.1128/MCB.14.3.1680; Scheetz AJ, 2000, NAT NEUROSCI, V3, P211, DOI 10.1038/72915; Shahid R, 2010, BIOCHEMISTRY-US, V49, P8300, DOI 10.1021/bi100957h; Shaw Leslie M., 2004, V294, P97; Shi YJ, 2005, J BIOL CHEM, V280, P10964, DOI 10.1074/jbc.M407874200; Spagnou S, 2004, BIOCHEMISTRY-US, V43, P13348, DOI 10.1021/bi048950a; Summy JM, 2006, CLIN CANCER RES, V12, P1398, DOI 10.1158/1078-0432.CCR-05-2692; Tavares CDJ, 2012, BIOCHEMISTRY-US, V51, P2232, DOI 10.1021/bi201788e; Weatherill DB, 2011, J NEUROCHEM, V117, P841, DOI 10.1111/j.1471-4159.2011.07251.x; Wilson GR, 2006, BRIT J CANCER, V95, P1410, DOI 10.1038/sj.bjc.6603444; Wu H, 2006, CANCER RES, V66, P3015, DOI 10.1158/0008-5472.CAN-05-1554; Wu H, 2009, CANCER RES, V69, P2453, DOI 10.1158/0008-5472.CAN-08-2872; Yang J, 2001, CANCER RES, V61, P4010; Yang W, 2001, ONCOGENE, V20, P1688, DOI 10.1038/sj.onc.1204245; Zhang L, 2011, ACTA PHARMACOL SIN, V32, P361, DOI 10.1038/aps.2010.213; Zhang Y, 2011, BIOCHEM BIOPH RES CO, V414, P129, DOI 10.1016/j.bbrc.2011.09.038	72	86	90	0	25	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 20	2012	7	7							e41171	10.1371/journal.pone.0041171	http://dx.doi.org/10.1371/journal.pone.0041171			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	977GL	22911754	Green Submitted, gold, Green Published			2022-12-25	WOS:000306644600050
J	Thio, M; Kormelink, TG; Fischer, MJ; Blokhuis, BR; Nijkamp, FP; Redegeld, FA				Thio, Marco; Kormelink, Tom Groot; Fischer, Marcel J.; Blokhuis, Bart R.; Nijkamp, Frans P.; Redegeld, Frank A.			Antigen Binding Characteristics of Immunoglobulin Free Light Chains: Crosslinking by Antigen is Essential to Induce Allergic Inflammation	PLOS ONE			English	Article							STEM-CELL FACTOR; ANTIBODY-ACTIVITY; MAST-CELLS; RECEPTOR; HEAVY; DIMER; RECOGNITION	Beside the production of complete immunoglobulins IgG, IgE, IgA, IgM and IgD, consisting of tetrameric heterodimers of immunoglobulin heavy and light chains, B cells also secrete immunoglobulin free light chains (Ig-fLC). Previous studies showed that Ig-fLCs are able to induce immediate hypersensitivity reactions. It is apparent that recognition and binding of antigen are crucial steps in the onset of these inflammatory responses. In this study, the binding characteristics of Ig-fLC to antigen were further investigated using various biochemical approaches. In addition, we investigated whether antigen-mediated crosslinking of Ig-fLC is required to initiate allergic skin inflammation in vivo. Our study shows that binding of Ig-fLCs to antigen can be measured with different experimental setups. Surface plasmon resonance analysis showed real-time antigen binding characteristics. Specific antigen binding by Ig-fLCs was further detected using immunoblotting and ELISA. Using the ELISA-based assay, a binding affinity of 76.9 +/- 3.8 nM was determined for TNP-specific Ig-fLC. Antigen-induced ear swelling in mice passively sensitized with trinitrophenol-specific Ig-fLC was inhibited when multivalent antigen was combined with excess of monovalent antigen during challenge. We conclude that Ig-fLCs are able to interact with antigen, a prerequisite for antigen-specific cellular activation. In analogy to antigen-specific Fc receptor-induced mast cell activation, crosslinking of Ig-fLCs is necessary to initiate a local allergic response.	[Thio, Marco; Kormelink, Tom Groot; Blokhuis, Bart R.; Nijkamp, Frans P.; Redegeld, Frank A.] Univ Utrecht, Fac Sci, Dept Pharmaceut Sci, Div Pharmacol, Utrecht, Netherlands; [Fischer, Marcel J.] Univ Utrecht, Fac Sci, Dept Pharmaceut Sci, Div Med Chem, Utrecht, Netherlands	Utrecht University; Utrecht University	Thio, M (corresponding author), Univ Utrecht, Fac Sci, Dept Pharmaceut Sci, Div Pharmacol, Utrecht, Netherlands.	f.a.m.redegeld@uu.nl	Redegeld, Frank A/O-6534-2016	Redegeld, Frank A/0000-0001-8830-7960	Utrecht Institute for Pharmaceutical Sciences, Faculty of Science, Utrecht University	Utrecht Institute for Pharmaceutical Sciences, Faculty of Science, Utrecht University	This study has been financially supported by the Utrecht Institute for Pharmaceutical Sciences, Faculty of Science, Utrecht University. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Contini C, 2000, J NEUROIMMUNOL, V108, P221, DOI 10.1016/S0165-5728(00)00280-0; Holowka D, 2007, IMMUNOL REV, V217, P269, DOI 10.1111/j.1600-065X.2007.00517.x; Jokiranta TS, 1999, J IMMUNOL, V163, P4590; Kalesnikoff J, 2008, NAT IMMUNOL, V9, P1215, DOI 10.1038/ni.f.216; Karimi K, 2000, EXP HEMATOL, V28, P626, DOI 10.1016/S0301-472X(00)00161-2; Karimi K, 1999, EXP HEMATOL, V27, P654, DOI 10.1016/S0301-472X(98)00083-6; Kraneveld AD, 2005, P NATL ACAD SCI USA, V102, P1578, DOI 10.1073/pnas.0406808102; LEDBETTER JA, 1987, MOL IMMUNOL, V24, P1255, DOI 10.1016/0161-5890(87)90119-2; Lu JH, 2011, P NATL ACAD SCI USA, V108, P4974, DOI 10.1073/pnas.1018369108; MAHANA W, 1994, SCAND J IMMUNOL, V39, P107, DOI 10.1111/j.1365-3083.1994.tb03347.x; MASAT L, 1994, P NATL ACAD SCI USA, V91, P893, DOI 10.1073/pnas.91.3.893; Matsumori A, 2010, CIRC RES, V106, P1533, DOI 10.1161/CIRCRESAHA.110.218438; METZGER H, 1994, ADV EXP MED BIOL, V365, P175; Mittermann I, 2010, J ALLERGY CLIN IMMUN, V125, P1300, DOI 10.1016/j.jaci.2010.03.017; Mortaz E, 2005, BIOCHEM PHARMACOL, V69, P1049, DOI 10.1016/j.bcp.2004.12.018; Nakano T, 2006, CLIN BIOCHEM, V39, P955, DOI 10.1016/j.clinbiochem.2006.05.008; Nakano T, 2011, CLIN CHIM ACTA, V412, P843, DOI 10.1016/j.cca.2011.03.007; Nishimura Eisaku, 1999, Human Antibodies, V9, P111; Noel D, 1996, J IMMUNOL METHODS, V193, P177, DOI 10.1016/0022-1759(96)00043-9; PAINTER RG, 1972, BIOCHEMISTRY-US, V11, P1338, DOI 10.1021/bi00758a002; PAINTER RG, 1972, BIOCHEMISTRY-US, V11, P1327, DOI 10.1021/bi00758a001; Pomes A, 2002, EUR J BIOCHEM, V269, P3086, DOI 10.1046/j.1432-1033.2002.02990.x; Redegeld FA, 2002, NAT MED, V8, P694, DOI 10.1038/nm722; Rijnierse A, 2010, J IMMUNOL, V185, P653, DOI 10.4049/jimmunol.0901129; SCHECHTER I, 1976, BIOCHEMISTRY-US, V15, P2785, DOI 10.1021/bi00658a013; Schouten B, 2010, J ALLERGY CLIN IMMUN, V125, P1308, DOI 10.1016/j.jaci.2010.02.039; Song MK, 2000, BIOCHEM BIOPH RES CO, V268, P390, DOI 10.1006/bbrc.2000.2134; SUN M, 1994, J BIOL CHEM, V269, P734; Thio M, 2008, TRENDS PHARMACOL SCI, V29, P170, DOI 10.1016/j.tips.2008.01.004; VALENTA R, 1991, J ALLERGY CLIN IMMUN, V88, P889, DOI 10.1016/0091-6749(91)90245-J; YAMASHITA T, 1994, P NATL ACAD SCI USA, V91, P11251, DOI 10.1073/pnas.91.23.11251; YOO TJ, 1967, SCIENCE, V157, P707, DOI 10.1126/science.157.3789.707	32	15	17	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 20	2012	7	7							e40986	10.1371/journal.pone.0040986	http://dx.doi.org/10.1371/journal.pone.0040986			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	977GL	22911727	gold, Green Published, Green Submitted			2022-12-25	WOS:000306644600032
J	Gao, WL; Dang, SN; Yan, H; Wang, DL				Gao, Wenlong; Dang, Shaonong; Yan, Hong; Wang, Duolao			Care-Seeking Pattern for Diarrhea among Children under 36 Months Old in Rural Western China	PLOS ONE			English	Article							CHILDHOOD DIARRHEA; BEHAVIOR; MALARIA; MANAGEMENT; DISTANCE; SERVICES; ILLNESS; POLICY	Objective: To explore the caretakers' care-seeking pattern and its determinants among children under 36 months old with diarrhea in rural western China. Methods: The data of 14112 households was collected in 45 counties of 10 provinces of western China from June to August 2005. A generalized estimated equation (GEE) linear model was used to identify the determinants of the care-seeking. Results: Village-level and township-level care were sought for childhood diarrhea by 67.02% of the caretakers. GEE model analysis shows that compared with the caretakers of the children delivered at county-level or above hospitals, those of the children delivered at home seldom sought a higher level care (-0.23, 95% CI: -0.45,-0.01, p = 0.040); that the age of the children was negatively associated with seeking a higher level care (12 vs 36 months: 0.35, 95% CI: 0.16,0.55, p < 0.001; 24 vs 36 months: 0.26, 95% CI: 0.08, 0.44, p = 0.004); that the more danger signs of diarrhea the caretakers recognized, the higher level care they sought for their children with diarrhea (0.04, 95% CI: 0.00,0.07, p = 0.037); that the children with breastfeeding were given a higher level care than those without (0.15, 95% CI: 0.01,0.28, p = 0.035); that the mothers with a higher education sought the higher level care than those with only primary education (0.29, 95% CI: 0.03,0.56, p = 0.032); and that the farther the villages where these caretakers lived were from their townships, the lower level care for their children with diarrhea they sought (-0.09, 95% CI: -0.18,-0.01, p = 0.039). Conclusion: Village-level and township-level care were sought for childhood diarrhea by most of the caretakers. Birth settings, the distance from village to township, maternal education, caretakers' awareness of the danger signs of diarrhea, breastfeeding status and age of children affected the care-seeking. These findings may have some implications for the improvement of health care services and care-seeking intervention against childhood diarrhea in rural western China.	[Gao, Wenlong; Dang, Shaonong; Yan, Hong] Xi An Jiao Tong Univ, Sch Publ Hlth, Coll Med, Dept Epidemiol & Hlth Stat, Xian 710049, Shaanxi, Peoples R China; [Wang, Duolao] London Sch Hyg & Trop Med, Dept Med Stat, London WC1, England	Xi'an Jiaotong University; University of London; London School of Hygiene & Tropical Medicine	Gao, WL (corresponding author), Xi An Jiao Tong Univ, Sch Publ Hlth, Coll Med, Dept Epidemiol & Hlth Stat, Xian 710049, Shaanxi, Peoples R China.	xjtu_yh.paper@yahoo.com.cn	Gao, Wenlong/E-5687-2013; Shaonong, Dang/J-7421-2019	Shaonong, Dang/0000-0002-6980-8169	Chinese Ministry of Health; United Nations Children's Fund	Chinese Ministry of Health; United Nations Children's Fund	The study was supported financially by the Chinese Ministry of Health and the United Nations Children's Fund. Neither of the funding sources had any role in the study design, the collection, analysis, interpretation of data and the writing of the report, nor did in the decision to submit the paper for publication.	Awoyemi T. T., 2011, Journal of Human Ecology, V35, P1; Bryce J, 2005, LANCET, V365, P1147, DOI 10.1016/S0140-6736(05)71877-8; Danso-Appiah A, 2010, PLOS NEGLECT TROP D, V4, P1; Das A, 2010, MALARIA J, V9, DOI 10.1186/1475-2875-9-377; Dong LF, 2011, J PUBLIC HLTH, DOI [10.1093/pubmed/fdr019:1-6, DOI 10.1093/PUBMED/FDR019:1-6]; Dong LF, 2008, J ANTIMICROB CHEMOTH, V62, P410, DOI 10.1093/jac/dkn153; Dong LF, 2010, J EPIDEMIOL COMMUN H, V64, P549, DOI 10.1136/jech.2008.085415; Enzley S, 1997, GLOBAL REV DIARRHEAL; Granich R, 1999, SOC SCI MED, V48, P489, DOI 10.1016/S0277-9536(98)00356-6; Heuveline P, 2000, SOC SCI MED, V50, P345, DOI 10.1016/S0277-9536(99)00282-8; Jones G, 2003, LANCET, V362, P65, DOI 10.1016/S0140-6736(03)13811-1; Kalton G, 1983, SAGE U PAPER SERIES, p[07, 38]; LIANG KY, 1986, BIOMETRIKA, V73, P13, DOI 10.1093/biomet/73.1.13; Malik EM, 2006, MALARIA J, V5, DOI 10.1186/1475-2875-5-60; Mondal Md. Nazrul Islam, 2009, Journal of Human Ecology, V26, P31; Mongolia MoH, 2000, CAR PRACT YOUNG CHIL; Ogunlesi TA, 2010, J TROP PEDIATRICS, V56, P379, DOI 10.1093/tropej/fmq009; Omotade OO, 2000, J HEALTH POPUL NUTR, V18, P139; Rao KV, 1998, NATL FAMILY HLTH SUR; Rutstein SO, 2004, DHS COMP REPORTS, P8; Salako LA, 2001, J TROP PEDIATRICS, V47, P230, DOI 10.1093/tropej/47.4.230; Shaikh BT, 2005, J PUBLIC HEALTH-UK, V27, P49, DOI 10.1093/pubmed/fdh207; Sreeramareddy Chandrashekhar T, 2006, BMC Int Health Hum Rights, V6, P7, DOI 10.1186/1472-698X-6-7; STOCK R, 1983, SOC SCI MED, V17, P563, DOI 10.1016/0277-9536(83)90298-8; UNICEF/WHO, 2009, DIARRH WHY CHILDR AR; Wei XL, 2011, BMC PUBLIC HEALTH, V11, DOI 10.1186/1471-2458-11-103; Yadav SP, 2010, J VECTOR DIS, V47, P235; ZEGER SL, 1988, BIOMETRICS, V44, P1049, DOI 10.2307/2531734; Zhang Jing, 2008, Zhonghua Liu Xing Bing Xue Za Zhi, V29, P989	29	15	17	2	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 17	2012	7	8							e43103	10.1371/journal.pone.0043103	http://dx.doi.org/10.1371/journal.pone.0043103			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	996DG	22912799	Green Submitted, Green Published, gold			2022-12-25	WOS:000308063700042
J	Johnson, AJ; Hirson, GD; Ebeler, SE				Johnson, Arielle J.; Hirson, Gregory D.; Ebeler, Susan E.			Perceptual Characterization and Analysis of Aroma Mixtures Using Gas Chromatography Recomposition-Olfactometry	PLOS ONE			English	Article							EXTRACT DILUTION ANALYSIS; ODOR; REPRESENTATIVENESS; COMPONENTS; OMISSION; QUALITY; IMPACT; WINES; FOODS; L.	This paper describes the design of a new instrumental technique, Gas Chromatography Recomposition-Olfactometry (GC-R), that adapts the reconstitution technique used in flavor chemistry studies by extracting volatiles from a sample by headspace solid-phase microextraction (SPME), separating the extract on a capillary GC column, and recombining individual compounds selectively as they elute off of the column into a mixture for sensory analysis (Figure 1). Using the chromatogram of a mixture as a map, the GC-R instrument allows the operator to "cut apart" and recombine the components of the mixture at will, selecting compounds, peaks, or sections based on retention time to include or exclude in a reconstitution for sensory analysis. Selective recombination is accomplished with the installation of a Deans Switch directly in-line with the column, which directs compounds either to waste or to a cryotrap at the operator's discretion. This enables the creation of, for example, aroma reconstitutions incorporating all of the volatiles in a sample, including instrumentally undetectable compounds as well those present at concentrations below sensory thresholds, thus correcting for the "reconstitution discrepancy" sometimes noted in flavor chemistry studies. Using only flowering lavender (Lavandula angustifola 'Hidcote Blue') as a source for volatiles, we used the instrument to build mixtures of subsets of lavender volatiles in-instrument and characterized their aroma qualities with a sensory panel. We showed evidence of additive, masking, and synergistic effects in these mixtures and of "lavender' aroma character as an emergent property of specific mixtures. This was accomplished without the need for chemical standards, reductive aroma models, or calculation of Odor Activity Values, and is broadly applicable to any aroma or flavor.	[Johnson, Arielle J.; Hirson, Gregory D.; Ebeler, Susan E.] Univ Calif Davis, Dept Viticulture & Enol, Agr & Environm Chem Grad Grp, Davis, CA 95616 USA	University of California System; University of California Davis	Johnson, AJ (corresponding author), Univ Calif Davis, Dept Viticulture & Enol, Agr & Environm Chem Grad Grp, Davis, CA 95616 USA.	seebeler@ucdavis.edu		Johnson, Arielle/0000-0001-9216-558X; Ebeler, Susan/0000-0002-8394-6736	National Science Foundation [DGE-1148897]; Walter and Erika Jennings Graduate Fellowship	National Science Foundation(National Science Foundation (NSF)); Walter and Erika Jennings Graduate Fellowship	Jim McCurry of Agilent Technologies provided the auxiliary pressure controller used for the modified instrument design. Financial support for AJJ was partially provided by an National Science Foundation Graduate Research Fellowship, grant number DGE-1148897. GDH was partially supported by a Walter and Erika Jennings Graduate Fellowship. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. No additional external funding was received for this study.	ABBOTT N, 1993, J AGR FOOD CHEM, V41, P777, DOI 10.1021/jf00029a019; Acena L, 2010, J CHROMATOGR A, V1217, P7781, DOI 10.1016/j.chroma.2010.10.030; ACREE TE, 1984, FOOD CHEM, V14, P273, DOI 10.1016/0308-8146(84)90082-7; Aftel M., 2004, ESSENCE ALCHEMY NATU; An M, 2001, J CHROMATOGR A, V917, P245, DOI 10.1016/S0021-9673(01)00657-4; Axel R, 2004, SCENTS SENSIBILITY M, V2004, P234; Buck LB, 2004, UNRAVELING SENSE SME, V2004, P267; Bult JHF, 2001, CHEM SENSES, V26, P459, DOI 10.1093/chemse/26.5.459; Escudero A, 2004, J AGR FOOD CHEM, V52, P3516, DOI 10.1021/jf035341l; Etievant PX, 1993, DEV FOOD SCI, P179; Ferreira V, 2002, MOLEC METH PLAN ANAL, V21, P89; Grosch W, 2001, CHEM SENSES, V26, P533, DOI 10.1093/chemse/26.5.533; GROSCH W, 1993, TRENDS FOOD SCI TECH, V4, P68, DOI 10.1016/0924-2244(93)90187-F; GUADAGNI DG, 1966, J SCI FOOD AGR, V17, P142, DOI 10.1002/jsfa.2740170311; LAING DG, 1989, PHYSIOL BEHAV, V46, P809, DOI 10.1016/0031-9384(89)90041-3; Le Berre E, 2008, CHEM SENSES, V33, P389, DOI 10.1093/chemse/bjn006; Le Berre E, 2008, CHEM SENSES, V33, P193, DOI 10.1093/chemse/bjm080; Patton S., 1957, J FOOD RES, V22, P316, DOI DOI 10.1111/J.1365-2621.1957.TB17017.X; Perez-Silva A, 2006, FOOD CHEM, V99, P728, DOI 10.1016/j.foodchem.2005.08.050; Pineau B, 2007, J AGR FOOD CHEM, V55, P4103, DOI 10.1021/jf070120r; Plutowska B, 2008, FOOD CHEM, V107, P449, DOI 10.1016/j.foodchem.2007.08.058; Poinot P, 2007, FOOD RES INT, V40, P1170, DOI 10.1016/j.foodres.2007.06.011; Ryan D, 2008, TRENDS FOOD SCI TECH, V19, P383, DOI 10.1016/j.tifs.2008.01.007; San-Juan F, 2010, FOOD CHEM, V123, P188, DOI 10.1016/j.foodchem.2010.03.129; Shepherd GM, 2006, NATURE, V444, P316, DOI 10.1038/nature05405; Steinhaus M, 2009, J AGR FOOD CHEM, V57, P2882, DOI 10.1021/jf803728n; van Ruth SM, 2004, HDB FLAVOR CHARACTER, P303; Wilson D. A., 2006, LEARNING SMELL	28	19	19	2	66	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 17	2012	7	8							e42693	10.1371/journal.pone.0042693	http://dx.doi.org/10.1371/journal.pone.0042693			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	996DG	22912722	gold, Green Published, Green Submitted			2022-12-25	WOS:000308063700018
J	Blijdorp, K; van den Heuvel-Eibrink, MM; Pieters, R; Boot, AM; Delhanty, PJD; van der Lely, AJ; Neggers, SJCMM				Blijdorp, Karin; van den Heuvel-Eibrink, Marry M.; Pieters, Rob; Boot, Annemieke M.; Delhanty, Patric J. D.; van der Lely, Aart-Jan; Neggers, Sebastian J. C. M. M.			Obesity Is Underestimated Using Body Mass Index and Waist-Hip Ratio in Long-Term Adult Survivors of Childhood Cancer	PLOS ONE			English	Article							ACUTE LYMPHOBLASTIC-LEUKEMIA; BONE-MINERAL DENSITY; X-RAY ABSORPTIOMETRY; INSULIN-RESISTANCE; METABOLIC SYNDROME; FAT; GROWTH; FATNESS; RISK	Objective: Obesity, represented by high body mass index (BMI), is a major complication after treatment for childhood cancer. However, it has been shown that high total fat percentage and low lean body mass are more reliable predictors of cardiovascular morbidity. In this study longitudinal changes of BMI and body composition, as well as the value of BMI and waist-hip ratio representing obesity, were evaluated in adult childhood cancer survivors. Methods: Data from 410 survivors who had visited the late effects clinic twice were analyzed. Median follow-up time was 16 years (interquartile range 11-21) and time between visits was 3.2 years (2.9-3.6). BMI was measured and body composition was assessed by dual X-ray absorptiometry (DXA, Lunar Prodigy; available twice in 182 survivors). Data were compared with healthy Dutch references and calculated as standard deviation scores (SDS). BMI, waist-hip ratio and total fat percentage were evaluated cross-sectionally in 422 survivors, in who at least one DXA scan was assessed. Results: BMI was significantly higher in women, without significant change over time. In men BMI changed significantly with time (Delta SDS = 0.19, P<0.001). Percentage fat was significantly higher than references in all survivors, with the highest SDS after cranial radiotherapy (CRT) (mean SDS 1.73 in men, 1.48 in women, P<0.001). Only in men, increase in total fat percentage was significantly higher than references (Delta SDS = 0.22, P<0.001). Using total fat percentage as the gold standard, 65% of female and 42% of male survivors were misclassified as non-obese using BMI. Misclassification of obesity using waist-hip ratio was 40% in women and 24% in men. Conclusions: Sixteen years after treatment for childhood cancer, the increase in BMI and total fat percentage was significantly greater than expected, especially after CRT. This is important as we could show that obesity was grossly underestimated using BMI and waist-hip ratio.	[Blijdorp, Karin; van den Heuvel-Eibrink, Marry M.; Pieters, Rob; Neggers, Sebastian J. C. M. M.] Erasmus MC Sophia Childrens Hosp, Dept Pediat Oncol Hematol, Rotterdam, Netherlands; [Blijdorp, Karin; van der Lely, Aart-Jan; Neggers, Sebastian J. C. M. M.] Erasmus Univ, Dept Med, Endocrinol Sect, Med Ctr, Rotterdam, Netherlands; [Boot, Annemieke M.] Univ Groningen, Univ Med Ctr Groningen, Dept Pediat Endocrinol, NL-9713 AV Groningen, Netherlands	Erasmus University Rotterdam; Erasmus MC; Erasmus University Rotterdam; Erasmus MC; University of Groningen	Blijdorp, K (corresponding author), Erasmus MC Sophia Childrens Hosp, Dept Pediat Oncol Hematol, Rotterdam, Netherlands.	k.blijdorp@erasmusmc.nl						Attanasio A, 1998, J CLIN ENDOCR METAB, V83, P379; Bjorntorp P, 1997, NUTRITION, V13, P795, DOI 10.1016/S0899-9007(97)00191-3; Boot AM, 2010, BONE, V46, P336, DOI 10.1016/j.bone.2009.10.003; Brouwer CAJ, 2007, CRIT REV ONCOL HEMAT, V63, P32, DOI 10.1016/j.critrevonc.2007.01.007; Brouwer CA, 2011, SUPPORT CARE CANC; Elmlinger MW, 2004, CLIN CHEM LAB MED, V42, P654, DOI 10.1515/CCLM.2004.112; Fredriks AM, 2000, PEDIATR RES, V47, P316, DOI 10.1203/00006450-200003000-00006; Garmey EG, 2008, J CLIN ONCOL, V26, P4639, DOI 10.1200/JCO.2008.16.3527; Hazem A, 2012, EUR J ENDOCRINOL, V166, P13, DOI 10.1530/EJE-11-0558; Health BNIo, 2000, NIH PUBLICATION; Janiszewski PM, 2007, J CLIN ENDOCR METAB, V92, P3816, DOI 10.1210/jc.2006-2178; Jarfelt M, 2005, EUR J ENDOCRINOL, V153, P81, DOI 10.1530/eje.1.01931; LARSSON B, 1984, BRIT MED J, V288, P1401, DOI 10.1136/bmj.288.6428.1401; Marinovic D, 2005, PEDIATRICS, V116, pE102, DOI 10.1542/peds.2004-1838; Nysom K, 2003, MED PEDIATR ONCOL, V40, P239, DOI 10.1002/mpo.10260; Oeffinger KC, 2003, J CLIN ONCOL, V21, P1359, DOI 10.1200/JCO.2003.06.131; PAGANO L, 1994, INT J CLIN LAB RES, V24, P117, DOI 10.1007/BF02593912; Paradisi G, 1999, DIABETES CARE, V22, P1310, DOI 10.2337/diacare.22.8.1310; Ries L., 2005, SEER CANC STAT REV 1; Sardinha LB, 2000, METABOLISM, V49, P1379, DOI [10.1053/meta.2000.17716, 10.1053/meta.2000.7716]; Shah NR, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0033308; Simone J.V., 2003, CHILDHOOD CANC SURVI; van Beek RD, 2006, PEDIATR BLOOD CANCER, V46, P88, DOI 10.1002/pbc.20437; van der Sluis IM, 2000, MED PEDIATR ONCOL, V35, P415, DOI 10.1002/1096-911X(20001001)35:4<415::AID-MPO4>3.3.CO;2-0; van der Sluis IM, 2002, ARCH DIS CHILD, V87, P341, DOI 10.1136/adc.87.4.341; van Waas M, 2010, ANN ONCOL, V21, P1121, DOI 10.1093/annonc/mdp414; van Waas M, 2010, J PEDIAT HEMATOL ONC, V32, P171, DOI 10.1097/MPH.0b013e3181d419c3; VANDONGENMELMAN JEWM, 1995, PEDIATR RES, V38, P86, DOI 10.1203/00006450-199507000-00015; Warner JT, 1997, ARCH DIS CHILD, V76, P298, DOI 10.1136/adc.76.4.298	29	40	41	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 14	2012	7	8							e43269	10.1371/journal.pone.0043269	http://dx.doi.org/10.1371/journal.pone.0043269			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	988OQ	22905245	Green Published, Green Submitted, gold			2022-12-25	WOS:000307500800069
J	Francois, S; D'Orlando, C; Fatone, T; Touvier, T; Pessina, P; Meneveri, R; Brunelli, S				Francois, Stephanie; D'Orlando, Cristina; Fatone, Tiziana; Touvier, Thierry; Pessina, Patrizia; Meneveri, Raffaella; Brunelli, Silvia			Necdin Enhances Myoblasts Survival by Facilitating the Degradation of the Mediator of Apoptosis CCAR1/CARP1	PLOS ONE			English	Article							GROWTH SUPPRESSOR NECDIN; CELL-CYCLE; REGULATORY PROTEIN-1; SKELETAL-MUSCLE; NITRIC-OXIDE; TRANSCRIPTION; RING; INTERACTS; PAX7; MAGE	Regeneration of muscle fibers, lost during pathological muscle degeneration or after injuries, is sustained by the production of new myofibers by means of the satellite cells. Survival of the satellite cells is a critical requirement for efficient muscle reconstitution. Necdin, a member of the MAGE proteins family, is expressed in satellite cell-derived myogenic precursors during perinatal growth and in the adult upon activation during muscle regeneration, where it plays an important role both in myoblast differentiation and survival. We show here that necdin exerts its pro-survival activity by counteracting the action of the pro-apoptotic protein Cell Cycle Apoptosis Regulatory Protein (CCAR1/CARP1) that we have identified as a new molecular interactor of necdin by two-hybrid screening. Necdin is responsible for the maintenance of CCAR1 protein levels, by implementing its ubiquitination and degradation through the proteasome. Taken together, these data shed new light on the molecular mechanism of necdin anti-apoptotic activity in myogenesis.	[Francois, Stephanie; D'Orlando, Cristina; Fatone, Tiziana; Pessina, Patrizia; Meneveri, Raffaella; Brunelli, Silvia] Univ Milano Bicocca, Dept Expt Med, Monza, Italy; [Touvier, Thierry] E Medea Sci Inst, Lecce, Italy; [Brunelli, Silvia] Ist Sci San Raffaele, Div Regenerat Med Stem Cells & Gene Therapy, I-20132 Milan, Italy	University of Milano-Bicocca; IRCCS Eugenio Medea; Vita-Salute San Raffaele University; IRCCS Ospedale San Raffaele	Francois, S (corresponding author), Univ Milano Bicocca, Dept Expt Med, Monza, Italy.	silvia.brunelli@unimib.it	Touvier, Thierry/K-6194-2016; Brunelli, Silvia/P-3853-2019; Pessina, Patrizia/I-2093-2015; Brunelli, Silvia/J-3248-2014	Touvier, Thierry/0000-0002-9700-9911; Brunelli, Silvia/0000-0003-1753-5346; Pessina, Patrizia/0000-0002-4227-411X; Brunelli, Silvia/0000-0003-1753-5346	Italian Ministry of University and Research; European Community's Seventh Framework Programme in the project ENDOSTEM [241440]	Italian Ministry of University and Research(Ministry of Education, Universities and Research (MIUR)); European Community's Seventh Framework Programme in the project ENDOSTEM	This work has benefited from research funding from the Italian Ministry of University and Research (PRIN 2009, S.B.) and the European Community's Seventh Framework Programme in the project ENDOSTEM (Grant agreement number 241440, S.B.). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abou-Khalil R, 2009, CELL STEM CELL, V5, P298, DOI 10.1016/j.stem.2009.06.001; Barker PA, 2002, J NEUROSCI RES, V67, P705, DOI 10.1002/jnr.10160; Borycki AG, 1999, DEVELOPMENT, V126, P1665; Brunelli S, 2004, CIRC RES, V94, P1571, DOI 10.1161/01.RES.0000132747.12860.10; Brunelli S, 2008, PHARMACOL RES, V58, P117, DOI 10.1016/j.phrs.2008.06.008; Charge SBP, 2004, PHYSIOL REV, V84, P209, DOI 10.1152/physrev.00019.2003; Dellavalle A, 2007, NAT CELL BIOL, V9, P255, DOI 10.1038/ncb1542; Deponti D, 2007, J CELL BIOL, V179, P305, DOI 10.1083/jcb.200701027; Doyle JM, 2010, MOL CELL, V39, P963, DOI 10.1016/j.molcel.2010.08.029; Espantman KC, 2010, MOL CELL, V39, P835, DOI 10.1016/j.molcel.2010.09.006; Feng Y, 2011, PROTEIN CELL, V2, P7, DOI 10.1007/s13238-011-1002-9; Hasegawa K, 2008, J NEUROSCI, V28, P8772, DOI 10.1523/JNEUROSCI.3052-08.2008; Hirai H, 2010, J CELL BIOL, V191, P347, DOI 10.1083/jcb.201006025; Jiang Yan, 2010, J Mol Signal, V5, P7, DOI 10.1186/1750-2187-5-7; Kim JH, 2008, MOL CELL, V31, P510, DOI 10.1016/j.molcel.2008.08.001; Lee MH, 2006, SEMIN CANCER BIOL, V16, P225, DOI 10.1016/j.semcancer.2006.03.009; Lepper C, 2009, NATURE, V460, P627, DOI 10.1038/nature08209; Manfredi JJ, 2010, GENE DEV, V24, P1580, DOI 10.1101/gad.1941710; Marine JC, 2010, CELL DEATH DIFFER, V17, P93, DOI 10.1038/cdd.2009.68; Minasi MG, 2002, DEVELOPMENT, V129, P2773; Moon HE, 2005, FEBS LETT, V579, P3797, DOI 10.1016/j.febslet.2005.05.072; Ou C-Y, 2009, J BIOL CHEM, P1; Pani L, 2002, GENE DEV, V16, P676, DOI 10.1101/gad.969302; Pessina P, 2011, CELL DEATH DIFFER; Pisconti A, 2006, J CELL BIOL, V172, P233, DOI 10.1083/jcb.200507083; Puliyappadamba Vineshkumar Thidil, 2011, J Biol Chem, V286, P38000, DOI 10.1074/jbc.M111.222398; Relaix F, 2006, J CELL BIOL, V172, P91, DOI 10.1083/jcb.200508044; Rishi AK, 2006, J BIOL CHEM, V281, P13188, DOI 10.1074/jbc.M512279200; Rishi AK, 2003, J BIOL CHEM, V278, P33422, DOI 10.1074/jbc.M303173200; Sasaki A, 2002, J BIOL CHEM, V277, P22541, DOI 10.1074/jbc.M109728200; Sciorati C, 2006, J CELL SCI, V119, P5114, DOI 10.1242/jcs.03300; Sciorati C, 2009, J CELL SCI, V122, P1119, DOI 10.1242/jcs.041665; Seale P, 2000, CELL, V102, P777, DOI 10.1016/S0092-8674(00)00066-0; Shea KL, 2010, CELL STEM CELL, V6, P117, DOI 10.1016/j.stem.2009.12.015; Taniguchi N, 2000, J BIOL CHEM, V275, P31674, DOI 10.1074/jbc.M005103200; Taniura H, 1999, J BIOL CHEM, V274, P16242, DOI 10.1074/jbc.274.23.16242; Taniura H, 1998, J BIOL CHEM, V273, P720, DOI 10.1074/jbc.273.2.720; Taniura H, 2002, J CELL BIOCHEM, V84, P545, DOI 10.1002/jcb.10047.abs; Tidball JG, 2005, AM J PHYSIOL-REG I, V288, pR345, DOI 10.1152/ajpregu.00454.2004; Zhang LY, 2007, MOL CANCER THER, V6, P1661, DOI 10.1158/1535-7163.MCT-06-0653	40	12	14	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 14	2012	7	8							e43335	10.1371/journal.pone.0043335	http://dx.doi.org/10.1371/journal.pone.0043335			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	988OQ	22905258	gold, Green Published, Green Submitted			2022-12-25	WOS:000307500800078
J	Weinstein, S; Emmanuel, R; Jacobi, AM; Abraham, A; Behlke, MA; Sprague, AG; Novobrantseva, TI; Nagler, A; Peer, D				Weinstein, Shiri; Emmanuel, Rafi; Jacobi, Ashley M.; Abraham, Avigdor; Behlke, Mark A.; Sprague, Andrew G.; Novobrantseva, Tatiana I.; Nagler, Arnon; Peer, Dan			RNA Inhibition Highlights Cyclin D1 as a Potential Therapeutic Target for Mantle Cell Lymphoma	PLOS ONE			English	Article							IN-VITRO; CANCER; PATHOGENESIS; PATHWAYS; D2	Mantle cell lymphoma is characterized by a genetic translocation results in aberrant overexpression of the CCND1 gene, which encodes cyclin D1. This protein functions as a regulator of the cell cycle progression, hence is considered to play an important role in the pathogenesis of the disease. In this study, we used RNA interference strategies to examine whether cyclin D1 might serve as a therapeutic target for mantle cell lymphoma. Knocking down cyclin D1 resulted in significant growth retardation, cell cycle arrest, and most importantly, induction of apoptosis. These results mark cyclin D1 as a target for mantle cell lymphoma and emphasize the therapeutic potential hidden in its silencing.	[Weinstein, Shiri; Emmanuel, Rafi; Peer, Dan] Tel Aviv Univ, George S Wise Fac Life Sci, Dept Cell Res & Immunol, Lab NanoMed, IL-69978 Tel Aviv, Israel; [Weinstein, Shiri; Emmanuel, Rafi; Peer, Dan] Tel Aviv Univ, Ctr Nanosci & Nanotechnol, IL-69978 Tel Aviv, Israel; [Jacobi, Ashley M.; Behlke, Mark A.] Integrated DNA Technol Inc, Corvallis, IA USA; [Abraham, Avigdor; Nagler, Arnon] Chaim Sheba Med Ctr, Div Hematol, IL-52621 Tel Hashomer, Israel; [Sprague, Andrew G.; Novobrantseva, Tatiana I.] Alnylam Pharmaceut, Cambridge, MA USA	Tel Aviv University; Tel Aviv University; Chaim Sheba Medical Center	Weinstein, S (corresponding author), Tel Aviv Univ, George S Wise Fac Life Sci, Dept Cell Res & Immunol, Lab NanoMed, IL-69978 Tel Aviv, Israel.	peer@tauex.tau.ac.il	Peer, Dan/A-1785-2011	Peer, Dan/0000-0001-8238-0673; Behlke, Mark/0000-0002-4218-857X	Lewis Family Trust; Israel Science Foundation [181/10]	Lewis Family Trust; Israel Science Foundation(Israel Science Foundation)	This work was supported by grants from the Lewis Family Trust and Israel Science Foundation (www.isf.org.il) (Award #181/10) to DP. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amarzguioui M, 2006, NAT PROTOC, V1, P508, DOI 10.1038/nprot.2006.72; Beltran E, 2011, P NATL ACAD SCI USA, V108, P12461, DOI 10.1073/pnas.1018941108; Chen R, 2010, CANCER RES, V70, P6587, DOI 10.1158/0008-5472.CAN-09-3578; Fernadez V, 2005, J CLIN ONCOL, V23, P6364, DOI 10.1200/JCO.2005.05.019; Gershoni JM, 1988, METHODS BIOCH ANAL, V33, P1; HUNTER T, 1994, CELL, V79, P573, DOI 10.1016/0092-8674(94)90543-6; Jares P, 2007, NAT REV CANCER, V7, P750, DOI 10.1038/nrc2230; Kawamata N, 2007, BLOOD, V110, P2667, DOI 10.1182/blood-2005-11-026344; Klier M, 2008, LEUKEMIA, V22, P2097, DOI 10.1038/leu.2008.213; Liu Q, 2010, CLIN CANCER RES, V16, P3182, DOI 10.1158/1078-0432.CCR-09-2484; Rao DD, 2009, ADV DRUG DELIVER REV, V61, P746, DOI 10.1016/j.addr.2009.04.004; Sherr CJ, 2002, CANCER CELL, V2, P103, DOI 10.1016/S1535-6108(02)00102-2; Sherr CJ, 1996, SCIENCE, V274, P1672, DOI 10.1126/science.274.5293.1672; Tchakarska G, 2009, HAEMATOL-HEMATOL J, V94, P1781, DOI 10.3324/haematol.2009.011460; Tiemann K, 2011, LEUKEMIA LYMPHOMA, V52, P2148, DOI 10.3109/10428194.2011.593272; Venkataraman G, 2006, LEUKEMIA RES, V30, P1377, DOI 10.1016/j.leukres.2006.03.004	16	27	28	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 14	2012	7	8							e43343	10.1371/journal.pone.0043343	http://dx.doi.org/10.1371/journal.pone.0043343			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	988OQ	22905260	Green Published, gold			2022-12-25	WOS:000307500800079
J	Cadete, RM; Melo, MA; Dussan, KJ; Rodrigues, RCLB; Silva, SS; Zilli, JE; Vital, MJS; Gomes, FCO; Lachance, MA; Rosa, CA				Cadete, Raquel M.; Melo, Monaliza A.; Dussan, Kelly J.; Rodrigues, Rita C. L. B.; Silva, Silvio S.; Zilli, Jerri E.; Vital, Marcos J. S.; Gomes, Fatima C. O.; Lachance, Marc-Andre; Rosa, Carlos A.			Diversity and Physiological Characterization of D-Xylose-Fermenting Yeasts Isolated from the Brazilian Amazonian Forest	PLOS ONE			English	Article							SUGARCANE BAGASSE HYDROLYSATE; XYLITOL PRODUCTION; ETHANOL-PRODUCTION; ALCOHOLIC FERMENTATION; SP-NOV.; SACCHAROMYCES-CEREVISIAE; CANDIDA-TROPICALIS; BEETLES; WOOD; MIXTURES	Background: This study is the first to investigate the Brazilian Amazonian Forest to identify new D-xylose-fermenting yeasts that might potentially be used in the production of ethanol from sugarcane bagasse hemicellulosic hydrolysates. Methodology/Principal Findings: A total of 224 yeast strains were isolated from rotting wood samples collected in two Amazonian forest reserve sites. These samples were cultured in yeast nitrogen base (YNB)-D-xylose or YNB-xylan media. Candida tropicalis, Asterotremella humicola, Candida boidinii and Debaryomyces hansenii were the most frequently isolated yeasts. Among D-xylose-fermenting yeasts, six strains of Spathaspora passalidarum, two of Scheffersomyces stipitis, and representatives of five new species were identified. The new species included Candida amazonensis of the Scheffersomyces clade and Spathaspora sp. 1, Spathaspora sp. 2, Spathaspora sp. 3, and Candida sp. 1 of the Spathaspora clade. In fermentation assays using D-xylose (50 g/L) culture medium, S. passalidarum strains showed the highest ethanol yields (0.31 g/g to 0.37 g/g) and productivities (0.62 g/L.h to 0.75 g/L.h). Candida amazonensis exhibited a virtually complete D-xylose consumption and the highest xylitol yields (0.55 g/g to 0.59 g/g), with concentrations up to 25.2 g/L. The new Spathaspora species produced ethanol and/or xylitol in different concentrations as the main fermentation products. In sugarcane bagasse hemicellulosic fermentation assays, S. stipitis UFMG-XMD-15.2 generated the highest ethanol yield (0.34 g/g) and productivity (0.2 g/L.h), while the new species Spathaspora sp. 1 UFMG-XMD-16.2 and Spathaspora sp. 2 UFMG-XMD-23.2 were very good xylitol producers. Conclusions/Significance: This study demonstrates the promise of using new D-xylose-fermenting yeast strains from the Brazilian Amazonian Forest for ethanol or xylitol production from sugarcane bagasse hemicellulosic hydrolysates.	[Cadete, Raquel M.; Melo, Monaliza A.; Rosa, Carlos A.] Univ Fed Minas Gerais, Inst Ciencias Biol, Dept Microbiol, Belo Horizonte, MG, Brazil; [Dussan, Kelly J.; Rodrigues, Rita C. L. B.; Silva, Silvio S.] Univ Sao Paulo, Dept Biotecnol, Escola Engn Lorena, Sao Paulo, Brazil; [Zilli, Jerri E.] Embrapa Agrobiol, Rio De Janeiro, Brazil; [Vital, Marcos J. S.] Univ Fed Roraima, Dept Biol, Boa Vista, Brazil; [Gomes, Fatima C. O.] Ctr Fed Educ Tecnol Minas Gerais, Dept Quim, Belo Horizonte, MG, Brazil; [Lachance, Marc-Andre] Univ Western Ontario, Dept Biol, London, ON, Canada	Universidade Federal de Minas Gerais; Universidade de Sao Paulo; Empresa Brasileira de Pesquisa Agropecuaria (EMBRAPA); Universidade Federal de Roraima; Western University (University of Western Ontario)	Cadete, RM (corresponding author), Univ Fed Minas Gerais, Inst Ciencias Biol, Dept Microbiol, Belo Horizonte, MG, Brazil.	carlrosa@icb.ufmg.br	da Silva, Silvio Silvério/H-8960-2012; Medina, Kelly Johana Dussan/H-6956-2013; de Cássia Lacerda Brambilla Rodrigues, Rita/B-5201-2013	da Silva, Silvio Silvério/0000-0003-0669-2784; Medina, Kelly Johana Dussan/0000-0003-1810-5313; de Cássia Lacerda Brambilla Rodrigues, Rita/0000-0003-0387-5083	Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq - Brazil) [560715/2010-2]; Fundacao de Amparo a Pesquisa do Estado de Minas Gerais (FAPEMIG); Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP) [2008/57926-4]; Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES) [2280/2008]; Natural Science and Engineering Research Council of Canada	Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq - Brazil)(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); Fundacao de Amparo a Pesquisa do Estado de Minas Gerais (FAPEMIG)(Fundacao de Amparo a Pesquisa do Estado de Minas Gerais (FAPEMIG)); Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP)(Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP)); Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES)(Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES)); Natural Science and Engineering Research Council of Canada(Natural Sciences and Engineering Research Council of Canada (NSERC))	This work was funded by Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq - Brazil, process 560715/2010-2), Fundacao de Amparo a Pesquisa do Estado de Minas Gerais (FAPEMIG), Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP, process 2008/57926-4), Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES, Procad-NF, process 2280/2008) and the Natural Science and Engineering Research Council of Canada (M. A. L.). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agbogbo FK, 2008, BIOTECHNOL LETT, V30, P1515, DOI 10.1007/s10529-008-9728-z; Agbogbo FK, 2007, J IND MICROBIOL BIOT, V34, P723, DOI 10.1007/s10295-007-0247-z; Agbogbo FK, 2006, PROCESS BIOCHEM, V41, P2333, DOI 10.1016/j.procbio.2006.05.004; Alves LA, 1998, APPL BIOCHEM BIOTECH, V70-2, P89, DOI 10.1007/BF02920126; Aristidou A, 2000, CURR OPIN BIOTECH, V11, P187, DOI 10.1016/S0958-1669(00)00085-9; Bhadra B, 2008, CURR MICROBIOL, V56, P489, DOI 10.1007/s00284-008-9108-x; Branco RD, 2011, BIOMASS BIOENERG, V35, P3241, DOI 10.1016/j.biombioe.2011.02.014; BRUINENBERG PM, 1984, APPL MICROBIOL BIOT, V19, P256, DOI 10.1007/BF00251847; Cadete RM, 2012, INT J SYST EVOL MICR, V62, P1438, DOI 10.1099/ijs.0.036715-0; Cadete RM, 2009, FEMS YEAST RES, V9, P1338, DOI 10.1111/j.1567-1364.2009.00582.x; Carvalho W, 2002, APPL BIOCHEM BIOTECH, V98, P489, DOI 10.1385/ABAB:98-100:1-9:489; Chandel A.K., 2010, J COMMER BIOTECHNOL, V16, P239, DOI [10.1057/JCB.2010.5/TABLES/6, DOI 10.1057/JCB.2010.5/TABLES/6, DOI 10.1057/JCB.2010.5]; Chandel AK, 2011, BIOTECHNOL MOL BIOL, V6, P08; Chandel AK, 2007, BIORESOURCE TECHNOL, V98, P1947, DOI 10.1016/j.biortech.2006.07.047; da Cunha-Pereira F, 2011, BIORESOURCE TECHNOL, V102, P4218, DOI 10.1016/j.biortech.2010.12.060; Du Preez J, 2009, NEW BIOTECHNOL, V25, pS52, DOI 10.1016/j.nbt.2009.06.265; DUPREEZ JC, 1986, APPL MICROBIOL BIOT, V23, P228, DOI 10.1007/BF00261920; Ferreira AD, 2011, YEAST, V28, P547, DOI 10.1002/yea.1858; Fonseca C, 2007, APPL MICROBIOL BIOT, V75, P303, DOI 10.1007/s00253-006-0830-7; Hahn-Hagerdal B, 2004, APPL BIOCHEM BIOTECH, V113, P1207; Hou X, 2012, APPL MICROBIOL BIOT, V94, P205, DOI 10.1007/s00253-011-3694-4; JEFFRIES TW, 1985, TRENDS BIOTECHNOL, V3, P208, DOI 10.1016/0167-7799(85)90048-4; JEFFRIES TW, 1981, BIOTECHNOL LETT, V3, P213, DOI 10.1007/BF00154647; JEFFRIES TW, 1994, ENZYME MICROB TECH, V16, P922, DOI 10.1016/0141-0229(94)90001-9; Jindamorakot S, 2007, FEMS YEAST RES, V7, P1409, DOI 10.1111/j.1567-1364.2007.00305.x; Kim S, 2005, BIOMASS BIOENERG, V29, P426, DOI 10.1016/j.biombioe.2005.06.004; Kim TB, 2003, BIOTECHNOL LETT, V25, P2085, DOI 10.1023/B:BILE.0000007069.74876.0c; Kurtzman CP, 2011, YEASTS: A TAXONOMIC STUDY, VOLS 1-3, 5TH EDITION, P87, DOI 10.1016/B978-0-444-52149-1.00007-0; Kurtzman CP, 2011, YEASTS: A TAXONOMIC STUDY, VOLS 1-3, 5TH EDITION, P521, DOI 10.1016/B978-0-444-52149-1.00042-2; Kurtzman CP, 2011, YEASTS: A TAXONOMIC STUDY, VOLS 1-3, 5TH EDITION, P1; Lachance MA, 1999, CAN J MICROBIOL, V45, P172, DOI 10.1139/cjm-45-2-172; Lachance MA, 2011, YEASTS: A TAXONOMIC STUDY, VOLS 1-3, 5TH EDITION, P987, DOI 10.1016/B978-0-444-52149-1.00090-2; Liu YR, 2011, ANTON LEEUW INT J G, V99, P643, DOI 10.1007/s10482-010-9537-y; Lopes MDB, 1996, APPL ENVIRON MICROB, V62, P4514, DOI 10.1128/AEM.62.12.4514-4520.1996; MORAIS PB, 1995, J IND MICROBIOL, V14, P531, DOI 10.1007/BF01573969; MORAIS PB, 1995, APPL ENVIRON MICROB, V61, P4251, DOI 10.1128/AEM.61.12.4251-4257.1995; Nakamura N, 2008, ENZYME MICROB TECH, V43, P233, DOI 10.1016/j.enzmictec.2008.04.003; Nguyen NH, 2006, MYCOL RES, V110, P1232, DOI 10.1016/j.mycres.2006.07.002; NIGAM JN, 1985, APPL ENVIRON MICROB, V50, P1486, DOI 10.1128/AEM.50.6.1486-1489.1985; NIGAM P, 1995, PROCESS BIOCHEM, V30, P117, DOI 10.1016/0032-9592(95)95709-R; Peres CA, 2010, BIOL CONSERV, V143, P2314, DOI 10.1016/j.biocon.2010.01.021; Pires JM, 1972, THESIS USP BRAZIL; Pokhrel CP, 2008, SCI WORLD, V6, P19; Rao RS, 2008, LETT APPL MICROBIOL, V47, P19, DOI 10.1111/j.1472-765X.2008.02380.x; Rao RS, 2006, BIORESOURCE TECHNOL, V97, P1974, DOI 10.1016/j.biortech.2005.08.015; Rosa CA, 2007, INT J SYST EVOL MICR, V57, P161, DOI 10.1099/ijs.0.64624-0; Saha BC, 2003, J IND MICROBIOL BIOT, V30, P279, DOI 10.1007/s10295-003-0049-x; SALATI E, 1984, SCIENCE, V225, P129, DOI 10.1126/science.225.4658.129; Sanchez S, 2008, WORLD J MICROB BIOT, V24, P709, DOI 10.1007/s11274-007-9527-z; Santos R, 2011, ANTON LEEUW INT J G, V99, P635, DOI 10.1007/s10482-010-9536-z; Schmidell W, 2001, MODELADEM MATEMATICA, P123; Silva CJSM, 2001, LETT APPL MICROBIOL, V32, P248, DOI 10.1046/j.1472-765X.2001.00899.x; Silva SS, 1998, APPL BIOCHEM BIOTECH, V70-2, P331, DOI 10.1007/BF02920149; Smith MT, 2011, YEASTS: A TAXONOMIC STUDY, VOLS 1-3, 5TH EDITION, P959, DOI 10.1016/B978-0-444-52149-1.00087-2; Suh SO, 2003, MOL ECOL, V12, P3137, DOI 10.1046/j.1365-294X.2003.01973.x; Suzuki M, 2011, YEASTS: A TAXONOMIC STUDY, VOLS 1-3, 5TH EDITION, P785, DOI 10.1016/B978-0-444-52149-1.00067-7; Tamura K, 2011, MOL BIOL EVOL, V28, P2731, DOI 10.1093/molbev/msr121; TOIVOLA A, 1984, APPL ENVIRON MICROB, V47, P1221, DOI 10.1128/AEM.47.6.1221-1223.1984; van Maris AJA, 2006, ANTON LEEUW INT J G, V90, P391, DOI 10.1007/s10482-006-9085-7; Vital MJS, 2002, BRAZ J MICROBIOL, V33, P230, DOI 10.1590/S1517-83822002000300008; Wohlbach DJ, 2011, P NATL ACAD SCI USA, V108, P13212, DOI 10.1073/pnas.1103039108	61	79	80	0	40	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 13	2012	7	8							e43135	10.1371/journal.pone.0043135	http://dx.doi.org/10.1371/journal.pone.0043135			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	988OJ	22912807	Green Submitted, gold, Green Published			2022-12-25	WOS:000307500100065
J	Funston, G; Goh, W; Wei, SJ; Tng, QS; Brown, C; Tong, LJ; Verma, C; Lane, D; Ghadessy, F				Funston, Garth; Goh, Walter; Wei, Siau Jia; Tng, Quah Soo; Brown, Christopher; Tong, Loh Jiah; Verma, Chandra; Lane, David; Ghadessy, Farid			Binding of Translationally Controlled Tumour Protein to the N-Terminal Domain of HDM2 Is Inhibited by Nutlin-3	PLOS ONE			English	Article							HISTAMINE-RELEASING FACTOR; CANCER CELLS; ANTIAPOPTOTIC ACTIVITY; DNA-DAMAGE; IN-VIVO; TCTP; P53; MDM2; GROWTH; UBIQUITINATION	Translationally Controlled Tumour Protein (TCTP), a highly conserved protein present in all eukaryotic organisms, has a number of intracellular and extracellular functions including an anti-apoptotic role. TCTP was recently shown to interact with both p53 and HDM2, inhibiting auto-ubiquitination of the latter and thereby promoting p53 degradation. In this study, we further investigated the interaction between TCTP and HDM2, mapping the reciprocal binding sites of TCTP and HDM2. TCTP primarily interacts with the N-terminal, p53-binding region of HDM2 through its highly basic domain 2. Furthermore, we discovered that Nutlin-3, a small molecule known to promote apoptosis and cell cycle arrest by blocking binding between HDM2 and p53, has a similar inhibitory effect on the interaction of HDM2 and TCTP. This result may provide an additional explanation of how Nutlin-derived compounds currently in clinical trials function to promote apoptosis in cancer cells.	[Funston, Garth] Univ Cambridge, Addenbrookes Hosp, Sch Clin Med, Cambridge CB2 2QQ, England; [Goh, Walter; Wei, Siau Jia; Tng, Quah Soo; Brown, Christopher; Lane, David; Ghadessy, Farid] ASTAR, p53Lab, Singapore, Singapore; [Tong, Loh Jiah; Verma, Chandra] ASTAR, Bioinformat Inst, Singapore, Singapore; [Verma, Chandra] Nanyang Technol Univ, Sch Biol Sci, Singapore, Singapore; [Verma, Chandra] Natl Univ Singapore, Dept Biol Sci, Singapore 117548, Singapore	Cambridge University Hospitals NHS Foundation Trust; Addenbrooke's Hospital; University of Cambridge; Agency for Science Technology & Research (A*STAR); Agency for Science Technology & Research (A*STAR); A*STAR - Bioinformatics Institute (BII); Nanyang Technological University & National Institute of Education (NIE) Singapore; Nanyang Technological University; National University of Singapore	Funston, G (corresponding author), Univ Cambridge, Addenbrookes Hosp, Sch Clin Med, Cambridge CB2 2QQ, England.	fghadessy@p53Lab.a-star.edu.sg		Lane, David/0000-0003-0551-3545; Funston, Garth/0000-0002-4156-6401	Agency for Science, Technology and Research (Singapore)	Agency for Science, Technology and Research (Singapore)(Agency for Science Technology & Research (A*STAR))	This work was funded by the Agency for Science, Technology and Research (Singapore). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adriaenssens E, 2002, BIOCHEM PHARMACOL, V64, P797, DOI 10.1016/S0006-2952(02)01141-3; Amson R, 2012, NAT MED, V18, P91, DOI 10.1038/nm.2546; Arcuri F, 2004, PROSTATE, V60, P130, DOI 10.1002/pros.20054; Bheekha-Escura R, 2000, BLOOD, V96, P2191; Bommer UA, 2004, INT J BIOCHEM CELL B, V36, P379, DOI 10.1016/S1357-2725(03)00213-9; Brown CJ, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024122; Bunz F, 1998, SCIENCE, V282, P1497, DOI 10.1126/science.282.5393.1497; Chen YJ, 2011, J BIOL CHEM, V286, P32575, DOI 10.1074/jbc.M110.217836; Gachet Y, 1999, J CELL SCI, V112, P1257; Hsu YC, 2007, NATURE, V445, P785, DOI 10.1038/nature05528; Joseph TL, 2010, CELL CYCLE, V9, P1167, DOI 10.4161/cc.9.6.11067; Jung J, 2004, J BIOL CHEM, V279, P49868, DOI 10.1074/jbc.M400895200; Kim M, 2000, ARCH PHARM RES, V23, P633, DOI 10.1007/BF02975253; Kussie PH, 1996, SCIENCE, V274, P948, DOI 10.1126/science.274.5289.948; Liu H, 2005, MOL CELL BIOL, V25, P3117, DOI 10.1128/MCB.25.8.3117-3126.2005; Ma JH, 2006, BIOCHEMISTRY-US, V45, P9238, DOI 10.1021/bi060661u; MACDONALD SM, 1995, SCIENCE, V269, P688, DOI 10.1126/science.7542803; McCoy MA, 2003, P NATL ACAD SCI USA, V100, P1645, DOI 10.1073/pnas.0334477100; Rho SB, 2011, FEBS LETT, V585, P29, DOI 10.1016/j.febslet.2010.11.014; Shimizu H, 2002, J BIOL CHEM, V277, P28446, DOI 10.1074/jbc.M202296200; Susini L, 2008, CELL DEATH DIFFER, V15, P1211, DOI 10.1038/cdd.2008.18; TAKAHASHI T, 1992, CANCER RES, V52, P2340; Thaw P, 2001, NAT STRUCT BIOL, V8, P701, DOI 10.1038/90415; Tuynder M, 2002, P NATL ACAD SCI USA, V99, P14976, DOI 10.1073/pnas.222470799; Uhrinova S, 2005, J MOL BIOL, V350, P587, DOI 10.1016/j.jmb.2005.05.010; Vassilev LT, 2004, SCIENCE, V303, P844, DOI 10.1126/science.1092472; Vonakis BM, 2003, J IMMUNOL, V171, P3742, DOI 10.4049/jimmunol.171.7.3742; Wallace M, 2006, AM BOOK REV, V27, P3, DOI 10.1353/abr.2006.0081; Wawrzynow B, 2009, J BIOL CHEM, V284, P11517, DOI 10.1074/jbc.M809294200; Yang Y, 2005, ONCOGENE, V24, P4778, DOI 10.1038/sj.onc.1208666; Yarm FR, 2002, MOL CELL BIOL, V22, P6209, DOI 10.1128/MCB.22.17.6209-6221.2002; YENOFSKY R, 1983, MOL CELL BIOL, V3, P1197, DOI 10.1128/MCB.3.7.1197; Zhang J, 2012, P NATL ACAD SCI USA, V109, pE926, DOI 10.1073/pnas.1106300109; Zhu WL, 2008, ANTICANCER RES, V28, P1575	34	11	13	1	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 13	2012	7	8							e42642	10.1371/journal.pone.0042642	http://dx.doi.org/10.1371/journal.pone.0042642			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	988OJ	22912717	gold, Green Published			2022-12-25	WOS:000307500100020
J	Colomb, J; Reiter, L; Blaszkiewicz, J; Wessnitzer, J; Brembs, B				Colomb, Julien; Reiter, Lutz; Blaszkiewicz, Jedrzej; Wessnitzer, Jan; Brembs, Bjoern			Open Source Tracking and Analysis of Adult Drosophila Locomotion in Buridan's Paradigm with and without Visual Targets	PLOS ONE			English	Article							CENTRAL COMPLEX; MUSHROOM BODIES; MELANOGASTER; BEHAVIOR; MUTANT; BRAIN; ORIENTATION; DOPAMINE; FIXATION; PORTRAIT	Background: Insects have been among the most widely used model systems for studying the control of locomotion by nervous systems. In Drosophila, we implemented a simple test for locomotion: in Buridan's paradigm, flies walk back and forth between two inaccessible visual targets [1]. Until today, the lack of easily accessible tools for tracking the fly position and analyzing its trajectory has probably contributed to the slow acceptance of Buridan's paradigm. Methodology/Principal Findings: We present here a package of open source software designed to track a single animal walking in a homogenous environment (Buritrack) and to analyze its trajectory. The Centroid Trajectory Analysis (CeTrAn) software is coded in the open source statistics project R. It extracts eleven metrics and includes correlation analyses and a Principal Components Analysis (PCA). It was designed to be easily customized to personal requirements. In combination with inexpensive hardware, these tools can readily be used for teaching and research purposes. We demonstrate the capabilities of our package by measuring the locomotor behavior of adult Drosophila melanogaster (whose wings were clipped), either in the presence or in the absence of visual targets, and comparing the latter to different computer-generated data. The analysis of the trajectories confirms that flies are centrophobic and shows that inaccessible visual targets can alter the orientation of the flies without changing their overall patterns of activity. Conclusions/Significance: Using computer generated data, the analysis software was tested, and chance values for some metrics (as well as chance value for their correlation) were set. Our results prompt the hypothesis that fixation behavior is observed only if negative phototaxis can overcome the propensity of the flies to avoid the center of the platform. Together with our companion paper, we provide new tools to promote Open Science as well as the collection and analysis of digital behavioral data.	[Colomb, Julien; Reiter, Lutz; Blaszkiewicz, Jedrzej; Brembs, Bjoern] Free Univ Berlin, FB Biol, Inst Biol Neurobiol, Berlin, Germany; [Wessnitzer, Jan] Univ Edinburgh, Inst Percept Act & Behav, Sch Informat, Edinburgh, Midlothian, Scotland; [Brembs, Bjoern] Univ Leipzig, Dept Genet, Leipzig, Germany	Free University of Berlin; University of Edinburgh; Leipzig University	Colomb, J (corresponding author), Free Univ Berlin, FB Biol, Inst Biol Neurobiol, Berlin, Germany.	J.Cjulien.colomb@fu-berlin.de	Brembs, Björn/A-9970-2008	Brembs, Björn/0000-0001-7824-7650; Colomb, Julien/0000-0002-3127-5520	Swiss National Fund [PA00P3_124141]; Engineering and Physical Sciences Research Council [EP/F030673/1]; EPSRC [EP/F030673/1] Funding Source: UKRI	Swiss National Fund(Swiss National Science Foundation (SNSF)); Engineering and Physical Sciences Research Council(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC)); EPSRC(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC))	JC was supported by the Swiss National Fund for research grant PA00P3_124141, and JW by the Engineering and Physical Sciences Research Council EP/F030673/1. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bassler U, 1983, NEURAL BASIS ELEMENT; Besson M, 2005, J NEUROBIOL, V62, P386, DOI 10.1002/neu.20111; Branson K, 2009, NAT METHODS, V6, P451, DOI [10.1038/nmeth.1328, 10.1038/NMETH.1328]; BUELTHOFF H, 1982, Journal of Comparative Physiology A Sensory Neural and Behavioral Physiology, V148, P471; Calenge C, 2006, ECOL MODEL, V197, P516, DOI 10.1016/j.ecolmodel.2006.03.017; Calenge C, 2009, ECOL INFORM, V4, P34, DOI 10.1016/j.ecoinf.2008.10.002; Callaerts P, 2001, J NEUROBIOL, V46, P73, DOI 10.1002/1097-4695(20010205)46:2<73::AID-NEU10>3.0.CO;2-N; Gomez-Marin A, 2011, PLOS ONE; GOTZ KG, 1985, J COMP PHYSIOL A, V156, P329, DOI 10.1007/BF00610726; Gotz KG, 1980, DEV NEUROBIOLOGY DRO, P391; Hills T, 2004, J NEUROSCI, V24, P1217, DOI 10.1523/JNEUROSCI.1569-03.2004; Martin JR, 1999, J COMP PHYSIOL A, V184, P73, DOI 10.1007/s003590050307; Martin JR, 2004, BEHAV PROCESS, V67, P207, DOI 10.1016/j.beproc.2004.04.003; McEwen RS, 1918, J EXP ZOOL, V25, P49, DOI 10.1002/jez.1400250103; Mronz M, 2008, 2008 IEEE/RSJ INTERNATIONAL CONFERENCE ON ROBOTS AND INTELLIGENT SYSTEMS, VOLS 1-3, CONFERENCE PROCEEDINGS, P3559, DOI 10.1109/IROS.2008.4650587; Neuser K, 2008, NATURE, V453, P1244, DOI 10.1038/nature07003; OSORIO D, 1990, J EXP BIOL, V149, P281; Phillips AM, 2005, GENE, V351, P131, DOI 10.1016/j.gene.2005.03.013; Pielage J, 2002, DEV BIOL, V249, P283, DOI 10.1006/dbio.2002.0770; Poeck B, 2008, DEV NEUROBIOL, V68, P1046, DOI 10.1002/dneu.20643; Riemensperger T, 2011, P NATL ACAD SCI USA, V108, P834, DOI 10.1073/pnas.1010930108; Riley JR, 2005, NATURE, V435, P205, DOI 10.1038/nature03526; Robie AA, 2010, J EXP BIOL, V213, P2494, DOI 10.1242/jeb.041749; Romero-Pozuelo J, 2007, EUR J NEUROSCI, V26, P2428, DOI 10.1111/j.1460-9568.2007.05877.x; Serway CN, 2009, J NEUROGENET, V23, P173, DOI 10.1080/01677060802572895; Sorribes A, 2011, PLOS COMPUT BIOL, V7, DOI 10.1371/journal.pcbi.1002075; Strauss R, 2002, CURR OPIN NEUROBIOL, V12, P633, DOI 10.1016/S0959-4388(02)00385-9; STRAUSS R, 1992, J NEUROGENET, V8, P125, DOI 10.3109/01677069209083444; Strauss R, 2001, J COMP PHYSIOL A, V187, P617, DOI 10.1007/s003590100234; Strauss R, 1998, J COMP PHYSIOL A, V182, P411, DOI 10.1007/s003590050190; Valente D, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0001083; Venables W.N., 2002, MODERN APPL STAT S, V4th ed, DOI DOI 10.1007/978-0-387-21706-2; WEHNER R, 1972, J INSECT PHYSIOL, V18, P1531, DOI 10.1016/0022-1910(72)90232-6; Xiong Y, 2010, FLY, V4, P194, DOI 10.4161/fly.12668	34	55	55	0	25	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 9	2012	7	8							e42247	10.1371/journal.pone.0042247	http://dx.doi.org/10.1371/journal.pone.0042247			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	986WZ	22912692	Green Published, Green Submitted, gold			2022-12-25	WOS:000307378500013
J	Terradas, R; Grau, S; Blanch, J; Riu, M; Saballs, P; Castells, X; Horcajada, JP; Knobel, H				Terradas, Roser; Grau, Santiago; Blanch, Jordi; Riu, Marta; Saballs, Pere; Castells, Xavier; Pablo Horcajada, Juan; Knobel, Hernando			Eosinophil Count and Neutrophil-Lymphocyte Count Ratio as Prognostic Markers in Patients with Bacteremia: A Retrospective Cohort Study	PLOS ONE			English	Article							C-REACTIVE PROTEIN; BLOOD-STREAM INFECTIONS; CRITICALLY-ILL PATIENTS; ACUTE-INFLAMMATION; RELIABLE MARKER; CARE-UNIT; MORTALITY; SEPSIS; PROCALCITONIN; ASSOCIATION	Introduction: There is scarce evidence on the use of eosinophil count as a marker of outcome in patients with infection. The aim of this study was to evaluate whether changes in eosinophil count, as well as the neutrophil-lymphocyte count ratio (NLCR), could be used as clinical markers of outcome in patients with bacteremia. Methods: We performed a retrospective study of patients with a first episode of community-acquired or healthcare-related bacteremia during hospital admission between 2004 and 2009. A total of 2,311 patients were included. Cox regression was used to analyze the behaviour of eosinophil count and the NLCR in survivors and non-survivors. Results: In the adjusted analysis, the main independent risk factor for mortality was persistence of an eosinophil count below 0.0454.10(3)/ul (HR = 4.20; 95% CI 2.66-6.62). An NLCR value >7 was also an independent risk factor but was of lesser importance. The mean eosinophil count in survivors showed a tendency to increase rapidly and to achieve normal values between the second and third day. In these patients, the NLCR was <7 between the second and third day. Conclusion: Both sustained eosinopenia and persistence of an NLCR >7 were independent markers of mortality in patients with bacteremia.	[Terradas, Roser; Blanch, Jordi; Riu, Marta; Castells, Xavier] Hosp del Mar, Dept Epidemiol & Hlth Serv Evaluat, Barcelona, Spain; [Terradas, Roser] Univ Autonoma Barcelona, PhD Programme Med, E-08193 Barcelona, Spain; [Grau, Santiago] Hosp del Mar, Dept Pharm, Barcelona, Spain; [Blanch, Jordi; Riu, Marta; Castells, Xavier] CIBERESP, Barcelona, Spain; [Saballs, Pere; Pablo Horcajada, Juan; Knobel, Hernando] Hosp del Mar, Dept Internal Med & Infect Dis, Barcelona, Spain	Institut Hospital del Mar d'Investigacions Mediques (IMIM); Hospital del Mar; Autonomous University of Barcelona; Institut Hospital del Mar d'Investigacions Mediques (IMIM); Hospital del Mar; CIBER - Centro de Investigacion Biomedica en Red; CIBERESP; Institut Hospital del Mar d'Investigacions Mediques (IMIM); Hospital del Mar	Terradas, R (corresponding author), Hosp del Mar, Dept Epidemiol & Hlth Serv Evaluat, Barcelona, Spain.	MTerradas@hospitaldelmar.cat	Blanch, Jordi/K-1685-2017; Knobel, Hernando/AAD-3582-2020; Castells, Xavier/S-7798-2016; Horcajada, Juan P./AAU-7717-2021; Knobel, Hernando/B-5223-2016; Blanch, Jordi/U-1407-2019	Blanch, Jordi/0000-0001-8211-3292; Knobel, Hernando/0000-0003-3186-6416; Castells, Xavier/0000-0002-2528-0382; Horcajada, Juan P./0000-0001-9873-5459; Knobel, Hernando/0000-0003-3186-6416; Blanch, Jordi/0000-0001-8211-3292; Riu, Marta/0000-0003-4702-3472; Terradas-Robledo, Roser/0000-0002-7689-1183				Abidi K, 2008, CRIT CARE, V12, DOI 10.1186/cc6883; Abidi K, 2011, INTENS CARE MED, V37, P1136, DOI 10.1007/s00134-011-2170-z; Arendrup MC, 2011, J CLIN MICROBIOL, V49, P3300, DOI 10.1128/JCM.00179-11; BASS DA, 1975, J CLIN INVEST, V55, P1229, DOI 10.1172/JCI108041; BASS DA, 1980, J CLIN INVEST, V65, P1265, DOI 10.1172/JCI109789; Beyersmann J, 2008, J CLIN EPIDEMIOL, V61, P1216, DOI 10.1016/j.jclinepi.2008.02.008; Cohen AL, 2008, INFECT CONT HOSP EP, V29, P901, DOI 10.1086/591741; Cook Emily J, 2007, Int J Surg, V5, P27, DOI 10.1016/j.ijsu.2006.05.013; de Jager CPC, 2010, CRIT CARE, V14, DOI 10.1186/cc9309; Gil H, 2003, REV MED INTERNE, V24, P431, DOI 10.1016/S0248-8663(03)00138-3; Halazun KJ, 2009, ANN SURG, V250, P141, DOI 10.1097/SLA.0b013e3181a77e59; Ho KM, 2009, ANAESTH INTENS CARE, V37, P450, DOI 10.1177/0310057X0903700319; Holland M, 2010, RESPIROLOGY, V15, P165, DOI 10.1111/j.1440-1843.2009.01651.x; Horan TC, 2008, AM J INFECT CONTROL, V36, P309, DOI 10.1016/j.ajic.2008.03.002; Jensen US, 2011, CLIN MICROBIOL INFEC, V17, P1148, DOI 10.1111/j.1469-0691.2011.03587.x; Kim DY, 2011, CANCER RES TREAT, V43, P176, DOI 10.4143/crt.2011.43.3.176; Kleinbaum DG, 2005, SERIES STAT BIOL HLT; LIPKIN WI, 1979, ARCH INTERN MED, V139, P490, DOI 10.1001/archinte.139.4.490; Lodise TP, 2007, ANTIMICROB AGENTS CH, V51, P3510, DOI 10.1128/AAC.00338-07; Consuegra ILDM, 2010, MED INTENSIVA, V34, P246, DOI 10.1016/j.medin.2009.11.007; Moosig F, 1998, ARTHRITIS RHEUM, V41, P566, DOI 10.1002/1529-0131(199803)41:3<566::AID-ART30>3.0.CO;2-U; Quan HD, 2005, MED CARE, V43, P1130, DOI 10.1097/01.mlr.0000182534.19832.83; R DEVELOPMENT CORE TEAM, 2011, R LANG ENV STAT COMP; Sarraf KM, 2009, J THORAC CARDIOV SUR, V137, P425, DOI 10.1016/j.jtcvs.2008.05.046; Setterberg MJ, 2004, CLIN INFECT DIS, V38, P460, DOI 10.1086/380846; Shaaban H, 2010, J CRIT CARE, V25, P570, DOI 10.1016/j.jcrc.2010.03.002; Simon CE, 1922, MANUAL CLIN DIAGNOSI; Smithson A, 2009, CRIT CARE, V13, DOI 10.1186/cc7877; Tamhane UU, 2008, AM J CARDIOL, V102, P653, DOI 10.1016/j.amjcard.2008.05.006; Walsh Sr, 2005, J SURG ONCOL, V91, P181, DOI 10.1002/jso.20329; Weller PF, 1996, CLIN IMMUNOLOGY PRIN, P1022; Wibrow BA, 2011, ANAESTH INTENS CARE, V39, P224, DOI 10.1177/0310057X1103900211; Wyllie DH, 2004, J CLIN PATHOL, V57, P950, DOI 10.1136/jcp.2004.017335; Zhang Z, 2011, ANAESTH INTENS CARE, V39, P854, DOI 10.1177/0310057X1103900509	34	107	112	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 9	2012	7	8							e42860	10.1371/journal.pone.0042860	http://dx.doi.org/10.1371/journal.pone.0042860			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	986WZ	22912753	Green Published, gold, Green Submitted			2022-12-25	WOS:000307378500031
J	Vilar, S; Harpaz, R; Santana, L; Uriarte, E; Friedman, C				Vilar, Santiago; Harpaz, Rave; Santana, Lourdes; Uriarte, Eugenio; Friedman, Carol			Enhancing Adverse Drug Event Detection in Electronic Health Records Using Molecular Structure Similarity: Application to Pancreatitis	PLOS ONE			English	Article							PHARMACOVIGILANCE; ENTECAVIR; DATABASES; DIAGNOSIS; THERAPY; SAFETY	Background: Adverse drug events (ADEs) detection and assessment is at the center of pharmacovigilance. Data mining of systems, such as FDA's Adverse Event Reporting System (AERS) and more recently, Electronic Health Records (EHRs), can aid in the automatic detection and analysis of ADEs. Although different data mining approaches have been shown to be valuable, it is still crucial to improve the quality of the generated signals. Objective: To leverage structural similarity by developing molecular fingerprint-based models (MFBMs) to strengthen ADE signals generated from EHR data. Methods: A reference standard of drugs known to be causally associated with the adverse event pancreatitis was used to create a MFBM. Electronic Health Records (EHRs) from the New York Presbyterian Hospital were mined to generate structured data. Disproportionality Analysis (DPA) was applied to the data, and 278 possible signals related to the ADE pancreatitis were detected. Candidate drugs associated with these signals were then assessed using the MFBM to find the most promising candidates based on structural similarity. Results: The use of MFBM as a means to strengthen or prioritize signals generated from the EHR significantly improved the detection accuracy of ADEs related to pancreatitis. MFBM also highlights the etiology of the ADE by identifying structurally similar drugs, which could follow a similar mechanism of action. Conclusion: The method proposed in this paper provides evidence of being a promising adjunct to existing automated ADE detection and analysis approaches.	[Vilar, Santiago; Harpaz, Rave; Friedman, Carol] Columbia Univ, Med Ctr, Dept Biomed Informat, New York, NY 10027 USA; [Vilar, Santiago; Santana, Lourdes; Uriarte, Eugenio] Univ Santiago de Compostela, Dept Organ Chem, Fac Pharm, Santiago De Compostela, Spain	Columbia University; Universidade de Santiago de Compostela	Vilar, S (corresponding author), Columbia Univ, Med Ctr, Dept Biomed Informat, New York, NY 10027 USA.	sav7003@dbmi.columbia.edu	Santana, Lourdes/L-2981-2014; Uriarte, Eugenio EU/F-5691-2012	Santana, Lourdes/0000-0001-6056-8253; Uriarte, Eugenio EU/0000-0001-6218-2899; Vilar Varela, Santiago/0000-0003-2663-4370	National Library of Medicine, "Plan Galego de Investigacion, Innovacion e Crecemento (I2C)'' [R01 LM010016, R01 LM010016-0S1, R01 LM010016-0S2, R01 LM008635, T15 LM007079]; European Social Fund (ESF); Angeles Alvarino program from Xunta de Galicia (Spain); NATIONAL LIBRARY OF MEDICINE [T15LM007079, R01LM010016, R01LM008635] Funding Source: NIH RePORTER	National Library of Medicine, "Plan Galego de Investigacion, Innovacion e Crecemento (I2C)''; European Social Fund (ESF)(European Social Fund (ESF)); Angeles Alvarino program from Xunta de Galicia (Spain); NATIONAL LIBRARY OF MEDICINE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Library of Medicine (NLM))	This work was supported by grants R01 LM010016 (Dr. Friedman), R01 LM010016-0S1 (Dr. Friedman), R01 LM010016-0S2 (Dr. Friedman), R01 LM008635(Dr. Friedman), and T15 LM007079 (Dr. Harpaz) from the National Library of Medicine, "Plan Galego de Investigacion, Innovacion e Crecemento 2011-2015 (I2C)'', European Social Fund (ESF) and Angeles Alvarino program from Xunta de Galicia (Spain). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], MOE VERS 2011 10; Badalov N, 2007, CLIN GASTROENTEROL H, V5, P648, DOI 10.1016/j.cgh.2006.11.023; Catalan I, 1999, An Med Interna, V16, P47; De Waele JJ, 2003, CLIN INFECT DIS, V37, P208, DOI 10.1086/375603; Durant JL, 2002, J CHEM INF COMP SCI, V42, P1273, DOI 10.1021/ci010132r; Durval A, 2011, MINERVA ANESTESIOL, V77, P1018; Eltookhy A, 2006, CAN PHARM J, V139, P58, DOI 10.1177/171516350613900611; Epelde F, 1996, ANN PHARMACOTHER, V30, P1339, DOI 10.1177/106002809603001121; FDA U.S. Food and Drug Administration, US FOOD DRUG ADM ADV; Friedman C, 2004, J AM MED INFORM ASSN, V11, P392, DOI 10.1197/jamia.M1552; Harpaz R, 2011, CLIN PHARMACOL THER, V89, P243, DOI 10.1038/clpt.2010.285; Harpaz Rave, 2010, AMIA Annu Symp Proc, V2010, P281; Hauben M, 2003, DRUG SAFETY, V26, P159, DOI 10.2165/00002018-200326030-00003; Hauben Manfred, 2005, Expert Opin Drug Saf, V4, P929, DOI 10.1517/14740338.4.5.929; Holmes AB, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021132; Howaizi M, 2000, GASTROEN CLIN BIOL, V24, P589; Khanna V, 2009, BMC BIOINFORMATICS, V10, DOI 10.1186/1471-2105-10-S15-S10; Kim H, 2008, GUT LIVER, V2, P74, DOI 10.5009/gnl.2008.2.2.74; Kim S, 2011, J CHEMINFORMATICS, V3, DOI 10.1186/1758-2946-3-26; Koller EA, 2003, PHARMACOTHERAPY, V23, P1123, DOI 10.1592/phco.23.10.1123.32759; Lee HM, 2011, PANCREAS, V40, P780, DOI 10.1097/MPA.0b013e31821fa52f; LOTT JA, 1991, CLIN CHEM, V37, P361; Martin YC, 2002, J MED CHEM, V45, P4350, DOI 10.1021/jm020155c; Mehrotra T N, 1981, J Assoc Physicians India, V29, P489; MUNGALL IPF, 1975, POSTGRAD MED J, V51, P855, DOI 10.1136/pgmj.51.602.855; Munoz A, 2000, AM FAM PHYSICIAN, V62, P164; Nisius B, 2009, CHEMMEDCHEM, V4, P1859, DOI 10.1002/cmdc.200900243; Platt R, 2009, NEW ENGL J MED, V361, P645, DOI 10.1056/NEJMp0905338; Red Book Online, 2011, MICR HEALTHC SER; Reese JA, 2010, BLOOD, V116, P2127, DOI 10.1182/blood-2010-03-276691; Sato K, 2007, CLIN THER, V29, P1468, DOI 10.1016/j.clinthera.2007.07.012; Steffen A, 2009, J CHEM INF MODEL, V49, P338, DOI 10.1021/ci800326z; Stephenson WP, 2007, PHARMACOEPIDEM DR S, V16, P359, DOI 10.1002/pds.1323; Stuecklin-Utsch A, 2002, MYCOSES, V45, P170, DOI 10.1046/j.1439-0507.2002.00744.x; Vilar S, 2011, J AM MED INFORM ASSN, V18, pI73, DOI 10.1136/amiajnl-2011-000417; Wang XY, 2009, J AM MED INFORM ASSN, V16, P328, DOI 10.1197/jamia.M3028; Williams C, 2006, MOL DIVERS, V10, P311, DOI 10.1007/s11030-006-9039-z; Yao GB, 2007, HEPATOL INT, V1, P365, DOI 10.1007/s12072-007-9009-2	38	16	16	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 24	2012	7	7							e41471	10.1371/journal.pone.0041471	http://dx.doi.org/10.1371/journal.pone.0041471			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	978NX	22911794	Green Submitted, Green Published, gold			2022-12-25	WOS:000306751300045
J	Makino, K; Kawamura, K; Sato, W; Kawamura, N; Fujimoto, T; Terada, Y				Makino, Kenichi; Kawamura, Kazuhiro; Sato, Wataru; Kawamura, Nanami; Fujimoto, Toshio; Terada, Yukihiro			Inhibition of Uterine Sarcoma Cell Growth through Suppression of Endogenous Tyrosine Kinase B Signaling	PLOS ONE			English	Article							GYNECOLOGIC-ONCOLOGY-GROUP; PHASE-II TRIAL; PHOSPHATIDYLINOSITOL 3'-KINASE PATHWAY; PROTECTS NEUROBLASTOMA-CELLS; NEUROTROPHIC FACTOR; PREIMPLANTATION EMBRYOS; ADVANCED LEIOMYOSARCOMA; PROGNOSTIC-FACTORS; RECEPTOR TRKB; IN-VITRO	Uterine leiomyosarcoma is an aggressive tumor typically found at advanced stages due to difficulties with early diagnosis. Because uterine leiomyosarcoma is resistant to conventional radiation and chemotherapy, the development of more potent medical therapeutics is anticipated. Using quantitative real-time RT-PCR and immunostaining, we found the expression of brain-derived neurotrophic factor (BDNF) and neurotropin-4/5, together with their receptor, tyrosine kinase B (TrkB), in different uterine sarcoma cell lines and primary tumor samples from uterine leiomyosarcoma patients. We noted that levels of BDNF were more abundant than those of neurotropin-4/5. Moreover, the expression of TrkB and its ligands was elevated in a multidrug-resistant cell line and samples obtained from patients with leiomyosarcoma. In cultured uterine sarcoma cells, inhibition of endogenous TrkB signaling by treatment with either the soluble TrkB ectodomain or the Trk receptor inhibitor, K252a, suppressed cell proliferation and increased apoptosis based on cell viability and proliferation, in situ terminal deoxynucleotidyl transferase-mediated 2'-deoxyuridine 5'-triphosphate nick end-labeling and caspase-3/7 assays, whereas an inactive plasma membrane nonpermeable K252b was ineffective. Correspondingly, treatment with exogenous BDNF increased cell proliferation. In in vivo studies in athymic nude mice bearing multidrug-resistant uterine sarcoma cell tumors, we demonstrate suppression of tumor growth by treatment with K252a, but not K252b, as reflected by decreased cell proliferation and increased levels of apoptosis and caspase-3/7 activities without obvious side effects. Our findings indicated that endogenous signaling of the TrkB pathway contributed to uterine sarcoma cell growth, and inhibition of TrkB signaling in these tumors could provide a novel medical therapy for patients with uterine sarcomas.	[Makino, Kenichi; Kawamura, Kazuhiro; Sato, Wataru; Kawamura, Nanami; Fujimoto, Toshio; Terada, Yukihiro] Akita Univ, Sch Med, Dept Obstet & Gynecol, Akita 010, Japan	Akita University	Makino, K (corresponding author), Akita Univ, Sch Med, Dept Obstet & Gynecol, Akita 010, Japan.	kawamura@yf7.so-net.ne.jp		Fujimoto, Toshio/0000-0001-5678-0438	Terumo Life Science Foundation [21791539, 23013004]; Kanae Foundation for the Promotion of Medical Science; Naito Foundation; Novartis Foundation for the Promotion of Science; Mochida Memorial Foundation for Medical and Pharmaceutical Research; Uehara Memorial Foundation;  [21390447]	Terumo Life Science Foundation(Terumo Life Science Foundation); Kanae Foundation for the Promotion of Medical Science; Naito Foundation(Naito Memorial Foundation); Novartis Foundation for the Promotion of Science; Mochida Memorial Foundation for Medical and Pharmaceutical Research; Uehara Memorial Foundation(Uehara Memorial Foundation); 	This work was supported by grants from a Grant-In-Aid for Scientific Research (K. K.; Grant-In-Aid for Young Scientists B (grant numbers 21791539), Grant-In-Aid for Scientific Research on Priority Areas, THE GERMLINE: Its Developmental Cycle and Epigenome Network (grant numbers 23013004)) and research funds from the Terumo Life Science Foundation (K. K., http://www.terumozaidan.or.jp), the Kanae Foundation for the Promotion of Medical Science (K. K., http://www.kanae-zaidan.com/), the Naito Foundation (K. K., http://www.naito-f.or.jp), the Novartis Foundation for the Promotion of Science (K. K., http://novartisfound.or.jp/eng/index-e.html), and the Mochida Memorial Foundation for Medical and Pharmaceutical Research (K. K., http://www.mochida.co.jp/zaidan/), the Uehara Memorial Foundation (Y.T., http://www.ueharazaidan.com/), and Grant-In-Aid for Scientific Research B (Y.T., grant numbers 21390447). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akahira J, 2006, ONCOLOGY-BASEL, V71, P333, DOI 10.1159/000107107; Aoyama M, 2001, CANCER LETT, V164, P51, DOI 10.1016/S0304-3835(00)00715-1; BARBACID M, 1994, J NEUROBIOL, V25, P1386, DOI 10.1002/neu.480251107; Brodeur GM, 2009, CLIN CANCER RES, V15, P3244, DOI 10.1158/1078-0432.CCR-08-1815; Chen G, 1997, J BIOL CHEM, V272, P5974, DOI 10.1074/jbc.272.9.5974; Cimmino F, 2009, ONCOGENE, V28, P2015, DOI 10.1038/onc.2009.70; D'Adamo DR, 2005, J CLIN ONCOL, V23, P7135, DOI 10.1200/JCO.2005.16.139; Desmet CJ, 2006, CELL MOL LIFE SCI, V63, P755, DOI 10.1007/s00018-005-5490-8; Dinh TA, 2004, GYNECOL ONCOL, V92, P648, DOI 10.1016/j.ygyno.2003.10.044; Dusenbery KE, 2004, GYNECOL ONCOL, V94, P191, DOI 10.1016/j.ygyno.2004.04.001; Eggert A, 2001, J CLIN ONCOL, V19, P689, DOI 10.1200/JCO.2001.19.3.689; HARKER WG, 1985, CANCER RES, V45, P4091; Hensley ML, 2009, GYNECOL ONCOL, V115, P460, DOI 10.1016/j.ygyno.2009.09.011; Hensley ML, 2002, J CLIN ONCOL, V20, P2824, DOI 10.1200/JCO.2002.11.050; Ho R, 2002, CANCER RES, V62, P6462; ISHIWATA I, 1977, CANCER RES, V37, P658; Jaboin J, 2002, CANCER RES, V62, P6756; Kapp DS, 2008, CANCER-AM CANCER SOC, V112, P820, DOI 10.1002/cncr.23245; Kawamura K, 2005, BIOL REPROD, V73, P1094, DOI 10.1095/biolreprod.105.042754; Kawamura K, 2005, P NATL ACAD SCI USA, V102, P9206, DOI 10.1073/pnas.0502442102; Kawamura K, 2003, ENDOCRINOLOGY, V144, P2623, DOI 10.1210/en.2003-0033; Kawamura K, 2007, DEV BIOL, V311, P147, DOI 10.1016/j.ydbio.2007.08.026; Kawamura K, 2011, ENDOCRINOLOGY, V152, P1090, DOI 10.1210/en.2010-1124; Kawamura K, 2009, ENDOCRINOLOGY, V150, P3774, DOI 10.1210/en.2009-0213; Kawamura N, 2010, ENDOCRINOLOGY, V151, P3006, DOI 10.1210/en.2009-1378; Krause DS, 2005, NEW ENGL J MED, V353, P172, DOI 10.1056/NEJMra044389; LEIBSOHN S, 1990, AM J OBSTET GYNECOL, V162, P968, DOI 10.1016/0002-9378(90)91298-Q; Liu DY, 2004, J BIOL CHEM, V279, P48434, DOI 10.1074/jbc.M407190200; Liu FT, 2005, NAT REV CANCER, V5, P29, DOI 10.1038/nrc1527; MARTINZANCA D, 1986, NATURE, V319, P743, DOI 10.1038/319743a0; MATSUMOTO K, 1995, CANCER RES, V55, P1798; McMeekin DS, 2007, GYNECOL ONCOL, V106, P596, DOI 10.1016/j.ygyno.2007.05.013; NAKAGAWARA A, 1994, MOL CELL BIOL, V14, P759, DOI 10.1128/MCB.14.1.759; Nakaigawa N, 2006, CANCER RES, V66, P3699, DOI 10.1158/0008-5472.CAN-05-0617; OMURA GA, 1983, CANCER, V52, P626, DOI 10.1002/1097-0142(19830815)52:4<626::AID-CNCR2820520409>3.0.CO;2-E; Reed NS, 2008, EUR J CANCER, V44, P808, DOI 10.1016/j.ejca.2008.01.019; Remmelink M, 1999, J CANCER RES CLIN, V125, P275, DOI 10.1007/s004320050274; Ren WH, 2008, CLIN CANCER RES, V14, P5466, DOI 10.1158/1078-0432.CCR-08-0562; Rose PG, 1998, GYNECOL ONCOL, V70, P267, DOI 10.1006/gyno.1998.5080; ROSS AH, 1995, J NEUROCHEM, V65, P2748; Sagae S, 2004, ONCOLOGY-BASEL, V67, P33, DOI 10.1159/000080283; Scala S, 1996, CANCER RES, V56, P3737; Sclabas GM, 2005, CLIN CANCER RES, V11, P440; Seddon BM, 2011, EUR J RADIOL, V78, P30, DOI 10.1016/j.ejrad.2010.12.057; Smith HO, 2002, GYNECOL ONCOL, V84, P140, DOI 10.1006/gyno.2001.6482; SOPPET D, 1991, CELL, V65, P895, DOI 10.1016/0092-8674(91)90396-G; Sutton G, 1996, GYNECOL ONCOL, V62, P226, DOI 10.1006/gyno.1996.0220; SUTTON GP, 1992, AM J OBSTET GYNECOL, V166, P556, DOI 10.1016/0002-9378(92)91671-V; TAPLEY P, 1992, ONCOGENE, V7, P371; THIGPEN JT, 1991, J CLIN ONCOL, V9, P1962, DOI 10.1200/JCO.1991.9.11.1962; Vanhecke E, 2011, CLIN CANCER RES, V17, P1741, DOI 10.1158/1078-0432.CCR-10-1890; Weissenbacher T, 2011, ANTICANCER RES, V31, P451; Yoshii A, 2010, DEV NEUROBIOL, V70, P304, DOI 10.1002/dneu.20765	53	15	17	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 23	2012	7	7							e41049	10.1371/journal.pone.0041049	http://dx.doi.org/10.1371/journal.pone.0041049			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	977TM	22911740	Green Published, gold, Green Submitted			2022-12-25	WOS:000306687700037
J	Moilanen, AM; Rysa, J; Serpi, R; Mustonen, E; Szabo, Z; Aro, J; Napankangas, J; Tenhunen, O; Sutinen, M; Salo, T; Ruskoaho, H				Moilanen, Anne-Mari; Rysa, Jaana; Serpi, Raisa; Mustonen, Erja; Szabo, Zoltan; Aro, Jani; Napankangas, Juha; Tenhunen, Olli; Sutinen, Meeri; Salo, Tuula; Ruskoaho, Heikki			(Pro)renin Receptor Triggers Distinct Angiotensin II-Independent Extracellular Matrix Remodeling and Deterioration of Cardiac Function	PLOS ONE			English	Article							VACUOLAR H+-ATPASE; IN-VIVO; TRANSGENIC RATS; HEART-FAILURE; GENE-TRANSFER; RENIN/PRORENIN RECEPTOR; MYOCARDIAL-INFARCTION; NATRIURETIC-PEPTIDE; PRORENIN RECEPTOR; PROTEIN-KINASE	Background: Activation of the renin-angiotensin-system (RAS) plays a key pathophysiological role in heart failure in patients with hypertension and myocardial infarction. However, the function of (pro)renin receptor ((P)RR) is not yet solved. We determined here the direct functional and structural effects of (P)RR in the heart. Methodology/Principal Findings: (P)RR was overexpressed by using adenovirus-mediated gene delivery in normal adult rat hearts up to 2 weeks. (P)RR gene delivery into the anterior wall of the left ventricle decreased ejection fraction (P<0.01), fractional shortening (P<0.01), and intraventricular septum diastolic and systolic thickness, associated with approximately 2-fold increase in left ventricular (P)RR protein levels at 2 weeks. To test whether the worsening of cardiac function and structure by (P)RR gene overexpression was mediated by angiotensin II (Ang II), we infused an AT(1) receptor blocker losartan via osmotic minipumps. Remarkably, cardiac function deteriorated in losartan-treated (P)RR overexpressing animals as well. Intramyocardial (P)RR gene delivery also resulted in Ang II-independent activation of extracellular-signal-regulated kinase1/2 phosphorylation and myocardial fibrosis, and the expression of transforming growth factor-beta 1 and connective tissue growth factor genes. In contrast, activation of heat shock protein 27 phosphorylation and apoptotic cell death by (P)RR gene delivery was Ang II-dependent. Finally, (P)RR overexpression significantly increased direct protein-protein interaction between (P)RR and promyelocytic zinc-finger protein. Conclusions/Significance: These results indicate for the first time that (P)RR triggers distinct Ang II-independent myocardial fibrosis and deterioration of cardiac function in normal adult heart and identify (P)RR as a novel therapeutic target to optimize RAS blockade in failing hearts.	[Moilanen, Anne-Mari; Rysa, Jaana; Serpi, Raisa; Mustonen, Erja; Szabo, Zoltan; Aro, Jani; Tenhunen, Olli; Ruskoaho, Heikki] Univ Oulu, Dept Pharmacol & Toxicol, Inst Biomed, Oulu, Finland; [Napankangas, Juha] Univ Oulu, Dept Pathol, Inst Diagnost, Oulu, Finland; [Sutinen, Meeri; Salo, Tuula] Univ Oulu, Oulu Univ Hosp, Inst Dent, Dept Diagnost & Oral Med, Oulu, Finland; [Salo, Tuula] Univ Helsinki, Inst Dent, FIN-00014 Helsinki, Finland	University of Oulu; University of Oulu; University of Oulu; University of Helsinki	Moilanen, AM (corresponding author), Univ Oulu, Dept Pharmacol & Toxicol, Inst Biomed, Oulu, Finland.	heikki.ruskoaho@oulu.fi	, tuula/ABG-2051-2021	Napankangas, Juha/0000-0003-3088-5180; Serpi, Raisa/0000-0002-8207-4673; Szabo, Zoltan/0000-0003-0778-1113; Salo, Tuula/0000-0001-6039-0088; Rysa, Jaana/0000-0003-2205-6323	Academy of Finland (Center of Excellence); Sigrid Juselius Foundation; Finnish Foundation for Cardiovascular Research	Academy of Finland (Center of Excellence)(Academy of Finland); Sigrid Juselius Foundation(Sigrid Juselius Foundation); Finnish Foundation for Cardiovascular Research	This work was supported by the Academy of Finland (Center of Excellence; http://www.aka.fi/en-GB/A/), Sigrid Juselius Foundation(http://www.sigridjuselius.fi/foundation), and Finnish Foundation for Cardiovascular Research (http://www.sydantutkimussaatio.fi). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Advani A, 2009, HYPERTENSION, V54, P261, DOI 10.1161/HYPERTENSIONAHA.109.128645; Bader M, 2010, ANNU REV PHARMACOL, V50, P439, DOI 10.1146/annurev.pharmtox.010909.105610; Batenburg WW, 2011, HYPERTENSION, V58, P1111, DOI 10.1161/HYPERTENSIONAHA.111.180737; Brown RD, 2005, ANNU REV PHARMACOL, V45, P657, DOI 10.1146/annurev.pharmtox.45.120403.095802; Burckle CA, 2006, HYPERTENSION, V47, P552, DOI 10.1161/01.HYP.0000199912.47657.04; Burridge K, 2004, CELL, V116, P167, DOI 10.1016/S0092-8674(04)00003-0; Connelly KA, 2011, J HYPERTENS, V29, P1175, DOI 10.1097/HJH.0b013e3283462674; Cruciat CM, 2010, SCIENCE, V327, P459, DOI 10.1126/science.1179802; Detillieux KA, 2003, CARDIOVASC RES, V57, P8, DOI 10.1016/S0008-6363(02)00708-3; Dorn GW, 2005, J CLIN INVEST, V115, P527, DOI 10.1172/JCI200524178; Feldt S, 2008, J AM SOC NEPHROL, V19, P743, DOI 10.1681/ASN.2007091030; FRENCH BA, 1994, CIRCULATION, V90, P2414, DOI 10.1161/01.CIR.90.5.2414; Frey N, 2003, ANNU REV PHYSIOL, V65, P45, DOI 10.1146/annurev.physiol.65.092101.142243; GUZMAN RJ, 1993, CIRC RES, V73, P1202, DOI 10.1161/01.RES.73.6.1202; Hautala N, 2001, CIRCULATION, V103, P730; Heineke J, 2006, NAT REV MOL CELL BIO, V7, P589, DOI 10.1038/nrm1983; Hirose T, 2009, PEPTIDES, V30, P2316, DOI 10.1016/j.peptides.2009.09.015; Ichihara A, 2006, HYPERTENSION, V47, P894, DOI 10.1161/01.HYP.0000215838.48170.0b; Jessup M, 2003, NEW ENGL J MED, V348, P2007, DOI 10.1056/NEJMra021498; Kaneshiro Y, 2006, KIDNEY INT, V70, P641, DOI 10.1038/sj.ki.5001627; Kaneshiro Y, 2007, J AM SOC NEPHROL, V18, P1789, DOI 10.1681/ASN.2006091062; Kinouchi K, 2010, CIRC RES, V107, P30, DOI 10.1161/CIRCRESAHA.110.224667; Lako-Futo Z, 2003, CIRCULATION, V108, P2414, DOI 10.1161/01.CIR.0000093193.63314.D9; Lompre AM, 2010, CIRCULATION, V121, P822, DOI 10.1161/CIRCULATIONAHA.109.890954; Magga J, 1997, CIRC RES, V81, P694; Mahmud H, 2012, J CELL MOL MED, V16, P722, DOI 10.1111/j.1582-4934.2011.01377.x; Moilanen AM, 2011, CIRC-HEART FAIL, V4, P483, DOI 10.1161/CIRCHEARTFAILURE.110.958033; Nguyen G, 2002, J CLIN INVEST, V109, P1417, DOI 10.1172/JCI200214276; Nguyen G, 2011, CLIN SCI, V120, P169, DOI 10.1042/CS20100432; Nyberg P, 2003, J BIOL CHEM, V278, P22404, DOI 10.1074/jbc.M210325200; RUSKOAHO H, 1992, PHARMACOL REV, V44, P479; Rysa J, 2005, HYPERTENSION, V45, P927, DOI 10.1161/01.HYP.0000161873.27088.4c; Rysa J, 2010, CIRC-HEART FAIL, V3, P440, DOI 10.1161/CIRCHEARTFAILURE.109.889642; Schefe JH, 2006, CIRC RES, V99, P1355, DOI 10.1161/01.RES.0000251700.00994.0d; Serpi R, 2009, CTS-CLIN TRANSL SCI, V2, P422, DOI 10.1111/j.1752-8062.2009.00163.x; Soini Y, 1996, BRIT J CANCER, V73, P1025, DOI 10.1038/bjc.1996.199; Szatkowski ML, 2001, J CLIN INVEST, V107, P191, DOI 10.1172/JCI9862; Tenhunen O, 2004, J BIOL CHEM, V279, P24852, DOI 10.1074/jbc.M314317200; Tenhunen O, 2006, FASEB J, V20, P1907, DOI 10.1096/fj.05-5618fje; Tenhunen O, 2006, CIRC RES, V99, P485, DOI 10.1161/01.RES.0000238387.85144.92; van Esch JHM, 2011, HYPERTENSION, V57, P852, DOI 10.1161/HYPERTENSIONAHA.110.169060; Walsh K, 2007, J CLIN INVEST, V117, P3176, DOI 10.1172/JCI34126; Weig HJ, 2000, CIRCULATION, V101, P1578, DOI 10.1161/01.CIR.101.13.1578; Whelan RS, 2010, ANNU REV PHYSIOL, V72, P19, DOI 10.1146/annurev.physiol.010908.163111; Zhao TQ, 2010, MICROVASC RES, V80, P188, DOI 10.1016/j.mvr.2010.03.014	45	34	34	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 23	2012	7	7							e41404	10.1371/journal.pone.0041404	http://dx.doi.org/10.1371/journal.pone.0041404			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	977TM	22911790	Green Submitted, gold, Green Published			2022-12-25	WOS:000306687700085
J	Chevalier, SA; Durand, S; Dasgupta, A; Radonovich, M; Cimarelli, A; Brady, JN; Mahieux, R; Pise-Masison, CA				Chevalier, Sebastien A.; Durand, Stephanie; Dasgupta, Arindam; Radonovich, Michael; Cimarelli, Andrea; Brady, John N.; Mahieux, Renaud; Pise-Masison, Cynthia A.			The Transcription Profile of Tax-3 Is More Similar to Tax-1 than Tax-2: Insights into HTLV-3 Potential Leukemogenic Properties	PLOS ONE			English	Article							T-LYMPHOTROPIC-VIRUS; NF-KAPPA-B; I-ASSOCIATED MYELOPATHY; NUCLEAR EXPORT SIGNAL; DOMAIN-BINDING MOTIF; GENE-EXPRESSION; TYPE-1 HTLV-1; PDZ DOMAIN; TRANSFORMING ACTIVITY; INTERACTION NETWORKS	Human T-cell Lymphotropic Viruses type 1 (HTLV-1) is the etiological agent of Adult T-cell Leukemia/Lymphoma. Although associated with lymphocytosis, HTLV-2 infection is not associated with any malignant hematological disease. Similarly, no infection-related symptom has been detected in HTLV-3-infected individuals studied so far. Differences in individual Tax transcriptional activity might account for these distinct physiopathological outcomes. Tax-1 and Tax-3 possess a PDZ binding motif in their sequence. Interestingly, this motif, which is critical for Tax-1 transforming activity, is absent from Tax-2. We used the DNA microarray technology to analyze and compare the global gene expression profiles of different T- and non T-cell types expressing Tax-1, Tax-2 or Tax-3 viral transactivators. In a T-cell line, this analysis allowed us to identify 48 genes whose expression is commonly affected by all Tax proteins and are hence characteristic of the HTLV infection, independently of the virus type. Importantly, we also identified a subset of genes (n = 70) which are specifically up-regulated by Tax-1 and Tax-3, while Tax-1 and Tax-2 shared only 1 gene and Tax-2 and Tax-3 shared 8 genes. These results demonstrate that Tax-3 and Tax-1 are closely related in terms of cellular gene deregulation. Analysis of the molecular interactions existing between those Tax-1/Tax-3 deregulated genes then allowed us to highlight biological networks of genes characteristic of HTLV-1 and HTLV-3 infection. The majority of those up-regulated genes are functionally linked in biological processes characteristic of HTLV-1-infected T-cells expressing Tax such as regulation of transcription and apoptosis, activation of the NF-kappa B cascade, T-cell mediated immunity and induction of cell proliferation and differentiation. In conclusion, our results demonstrate for the first time that, in T-and non T-cells types, Tax-3 is a functional analogue of Tax-1 in terms of transcriptional activation and suggest that HTLV-3 might share pathogenic features with HTLV-1 in vivo.	[Chevalier, Sebastien A.; Dasgupta, Arindam; Radonovich, Michael; Brady, John N.; Pise-Masison, Cynthia A.] NCI, Virus Tumor Biol Sect, Cellular Oncol Lab, NIH, Bethesda, MD 20892 USA; [Chevalier, Sebastien A.; Mahieux, Renaud] Ecole Normale Super, INSERM, U758, Retroviral Oncogenesis Lab, Lyon, France; [Durand, Stephanie; Cimarelli, Andrea] Ecole Normale Super, INSERM, U758, Lab Primate Lentiviruses, Lyon, France	National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); Ecole Normale Superieure de Lyon (ENS de LYON); Institut National de la Sante et de la Recherche Medicale (Inserm); Ecole Normale Superieure de Lyon (ENS de LYON); Institut National de la Sante et de la Recherche Medicale (Inserm)	Chevalier, SA (corresponding author), NCI, Virus Tumor Biol Sect, Cellular Oncol Lab, NIH, Bethesda, MD 20892 USA.	sebastien.chevalier@ens-lyon.fr		DURAND, Stephanie/0000-0003-2434-9429; mahieux, renaud/0000-0002-5129-6804; CIMARELLI, Andrea/0000-0003-0892-0488	United States National Institutes of Health, National Cancer Institute; Center for Cancer Research; Fogerty fellowship; FRM (Fondation pour la Recherche Medicale); INCa (Institut National du Cancer); ANRS (Agence Nationale de Recherche sur le SIDA); SIDACTION; INSERM (Institut National de la Sante Et de la Recherche Medicale); ENS Lyon (Ecole Normale Superieure de Lyon)	United States National Institutes of Health, National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); Center for Cancer Research(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); Fogerty fellowship; FRM (Fondation pour la Recherche Medicale)(Fondation pour la Recherche Medicale); INCa (Institut National du Cancer)(Institut National du Cancer (INCA) France); ANRS (Agence Nationale de Recherche sur le SIDA)(ANRSFrench National Research Agency (ANR)); SIDACTION; INSERM (Institut National de la Sante Et de la Recherche Medicale)(Institut National de la Sante et de la Recherche Medicale (Inserm)); ENS Lyon (Ecole Normale Superieure de Lyon)	This work was supported by the United States National Institutes of Health, National Cancer Institute, and the Center for Cancer Research. SAC was supported by Fogerty fellowship and is now supported by FRM (Fondation pour la Recherche Medicale) and by INCa (Institut National du Cancer). SD and AC are supported by ANRS (Agence Nationale de Recherche sur le SIDA) and SIDACTION. RM is supported by INSERM (Institut National de la Sante Et de la Recherche Medicale) and ENS Lyon (Ecole Normale Superieure de Lyon).	Afonso PV, 2010, BLOOD, V116, P3802, DOI 10.1182/blood-2010-02-270751; Aldana-Masangkay GI, 2011, J BIOMED BIOTECHNOL, DOI 10.1155/2011/875824; Alefantis T, 2003, J BIOL CHEM, V278, P21814, DOI 10.1074/jbc.M211576200; [Anonymous], 1988, Int J Cancer, V41, P505, DOI 10.1002/ijc.2910410406; Araujo A, 2004, ANN NEUROL, V56, P10, DOI 10.1002/ana.20126; Arlt A, 2011, EUR J CELL BIOL, V90, P545, DOI 10.1016/j.ejcb.2010.10.002; Bader GD, 2003, BMC BIOINFORMATICS, V4, DOI 10.1186/1471-2105-4-2; Bartman MT, 2008, BLOOD, V112, P3995, DOI 10.1182/blood-2008-05-155960; Baydoun HH, 2010, MOL CANCER, V9, DOI 10.1186/1476-4598-9-302; Bellon M, 2010, BLOOD, V115, P2441, DOI 10.1182/blood-2009-08-241117; Bertazzoni U, 2011, VIRUSES-BASEL, V3, P541, DOI 10.3390/v3050541; Boumber YA, 2007, CANCER RES, V67, P1997, DOI 10.1158/0008-5472.CAN-06-3093; Calattini S, 2005, RETROVIROLOGY, V2, DOI 10.1186/1742-4690-2-30; Calattini S, 2006, J VIROL, V80, P9876, DOI 10.1128/JVI.00799-06; Calattini S, 2009, J INFECT DIS, V199, P561, DOI 10.1086/596206; Chevalier SA, 2006, ONCOGENE, V25, P4470, DOI 10.1038/sj.onc.1209472; Chevalier SA, 2005, RETROVIROLOGY, V2, DOI 10.1186/1742-4690-2-70; Cline MS, 2007, NAT PROTOC, V2, P2366, DOI 10.1038/nprot.2007.324; De la Fuente C, 2000, AIDS RES HUM RETROV, V16, P1695, DOI 10.1089/08892220050193164; Douceron E, 2012, J INFECT DIS, V205, P82, DOI 10.1093/infdis/jir708; Eisen MB, 1998, P NATL ACAD SCI USA, V95, P14863, DOI 10.1073/pnas.95.25.14863; Endo K, 2002, J VIROL, V76, P2648, DOI 10.1128/JVI.76.6.2648-2653.2002; Feuer G, 2005, ONCOGENE, V24, P5996, DOI 10.1038/sj.onc.1208971; Garcia O, 2007, BIOINFORMATICS, V23, P394, DOI 10.1093/bioinformatics/btl605; GESSAIN A, 1985, LANCET, V2, P407; Halin M, 2009, BLOOD, V114, P2427, DOI 10.1182/blood-2008-09-179879; Harhaj EW, 2011, CELL RES, V21, P22, DOI 10.1038/cr.2010.166; Harhaj EW, 1999, ONCOGENE, V18, P1341, DOI 10.1038/sj.onc.1202405; Harhaj NS, 2007, J BIOL CHEM, V282, P4185, DOI 10.1074/jbc.M611031200; Hasegawa H, 2006, NAT MED, V12, P466, DOI 10.1038/nm1389; Higuchi M, 2007, J VIROL, V81, P11900, DOI 10.1128/JVI.00532-07; Hirata A, 2004, VIROLOGY, V318, P327, DOI 10.1016/j.virol.2003.10.006; Huang DW, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-9-r183; Huang DW, 2007, NUCLEIC ACIDS RES, V35, pW169, DOI 10.1093/nar/gkm415; Huang DW, 2009, NAT PROTOC, V4, P44, DOI 10.1038/nprot.2008.211; Iqbal J, 2010, BLOOD, V115, P1026, DOI 10.1182/blood-2009-06-227579; JACOBSON S, 1993, ANN NEUROL, V33, P392, DOI 10.1002/ana.410330411; Journo C, 2009, FUTURE MICROBIOL, V4, P425, DOI 10.2217/FMB.09.13; Kadiu I, 2011, J PROTEOME RES, V10, P3225, DOI 10.1021/pr200262q; Kannian P, 2010, VIRUSES-BASEL, V2, P2037, DOI 10.3390/v2092037; Kfoury Y, 2008, ONCOGENE, V27, P1665, DOI 10.1038/sj.onc.1210804; Lamsoul I, 2005, MOL CELL BIOL, V25, P10391, DOI 10.1128/MCB.25.23.10391-10406.2005; Larocque E, 2011, J VIROL, V85, P12673, DOI 10.1128/JVI.05296-11; Maere S, 2005, BIOINFORMATICS, V21, P3448, DOI 10.1093/bioinformatics/bti551; Mahieux R, 2000, J VIROL, V74, P6866, DOI 10.1128/JVI.74.15.6866-6874.2000; Mahieux R, 2011, VIRUSES-BASEL, V3, P1074, DOI 10.3390/v3071074; Matsuoka M, 2011, ONCOGENE, V30, P1379, DOI 10.1038/onc.2010.537; Matsuoka M, 2007, NAT REV CANCER, V7, P270, DOI 10.1038/nrc2111; Mauclere P, 2011, J INFECT DIS, V203, P1316, DOI 10.1093/infdis/jir031; Meertens L, 2004, J BIOL CHEM, V279, P43307, DOI 10.1074/jbc.M400497200; Nejmeddine M, 2005, J BIOL CHEM, V280, P29653, DOI 10.1074/jbc.M502639200; Ng PWP, 2001, ONCOGENE, V20, P4484, DOI 10.1038/sj.onc.1204513; Nicot C, 2000, ONCOGENE, V19, P2155, DOI 10.1038/sj.onc.1203536; Oliere S, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1001177; OSAME M, 1986, LANCET, V1, P1031; Pise-Masison CA, 2002, CANCER RES, V62, P3562; Pise-Masison CA, 2009, BLOOD, V113, P4016, DOI 10.1182/blood-2008-08-175901; Ross TM, 1997, J VIROL, V71, P8912, DOI 10.1128/JVI.71.11.8912-8917.1997; Ross TM, 2000, J VIROL, V74, P2655, DOI 10.1128/JVI.74.6.2655-2662.2000; Rousset R, 1998, ONCOGENE, V16, P643, DOI 10.1038/sj.onc.1201567; Ruckes T, 2001, BLOOD, V98, P1150, DOI 10.1182/blood.V98.4.1150; Sasaki H, 2005, BLOOD, V105, P1204, DOI 10.1182/blood-2004-03-1222; Satou Y, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1001274; Semmes OJ, 1996, VIROLOGY, V217, P373, DOI 10.1006/viro.1996.0126; Shannon P, 2003, GENOME RES, V13, P2498, DOI 10.1101/gr.1239303; Sherman BT, 2007, BMC BIOINFORMATICS, V8, DOI 10.1186/1471-2105-8-426; Shoji T, 2009, RETROVIROLOGY, V6, DOI 10.1186/1742-4690-6-83; Smoot ME, 2011, BIOINFORMATICS, V27, P431, DOI 10.1093/bioinformatics/btq675; Szklarczyk D, 2011, NUCLEIC ACIDS RES, V39, pD561, DOI 10.1093/nar/gkq973; Takatsuki T., 1977, 16 INT C HEM AMST, P73; Tanaka Y, 1996, J VIROL, V70, P8508, DOI 10.1128/JVI.70.12.8508-8517.1996; Tattermusch S, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002480; Tripp A, 2003, J VIROL, V77, P12152, DOI 10.1128/JVI.77.22.12152-12164.2003; Turci M, 2006, GENE, V365, P119, DOI 10.1016/J.gene.2005.09.043; Turci M, 2009, VIROLOGY; Van Prooyen N, 2010, MOL ASPECTS MED, V31, P333, DOI 10.1016/j.mam.2010.07.001; Verdonck K, 2007, LANCET INFECT DIS, V7, P266, DOI 10.1016/S1473-3099(07)70081-6; von Mering C, 2005, NUCLEIC ACIDS RES, V33, pD433, DOI 10.1093/nar/gki005; Wolfe ND, 2005, P NATL ACAD SCI USA, V102, P7994, DOI 10.1073/pnas.0501734102; Wu XF, 2011, CELL BIOSCI, V1, DOI 10.1186/2045-3701-1-27; Wycuff DR, 2005, FRONT BIOSCI-LANDMRK, V10, P620, DOI 10.2741/1558; Xie L, 2006, BLOOD, V107, P1980, DOI 10.1182/blood-2005-03-1333; YAMAOKA S, 1992, ONCOGENE, V7, P433; Yan PR, 2009, BLOOD, V113, P4370, DOI 10.1182/blood-2008-10-185660; Zane L, 2010, VIROLOGY, V407, P341, DOI 10.1016/j.virol.2010.07.023; Zheng HQ, 2010, VIROLOGY, V401, P137, DOI 10.1016/j.virol.2010.03.010	87	26	26	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 20	2012	7	7							e41003	10.1371/journal.pone.0041003	http://dx.doi.org/10.1371/journal.pone.0041003			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	977GL	22911729	Green Submitted, Green Published, gold			2022-12-25	WOS:000306644600033
J	Dinh, HQ; Dubin, M; Sedlazeck, FJ; Lettner, N; Scheid, OM; von Haeseler, A				Dinh, Huy Q.; Dubin, Manu; Sedlazeck, Fritz J.; Lettner, Nicole; Scheid, Ortrun Mittelsten; von Haeseler, Arndt			Advanced Methylome Analysis after Bisulfite Deep Sequencing: An Example in Arabidopsis	PLOS ONE			English	Article							DNA METHYLATION	Deep sequencing after bisulfite conversion (BS-Seq) is the method of choice to generate whole genome maps of cytosine methylation at single base-pair resolution. Its application to genomic DNA of Arabidopsis flower bud tissue resulted in the first complete methylome, determining a methylation rate of 6.7% in this tissue. BS-Seq reads were mapped onto an in silico converted reference genome, applying the so-called 3-letter genome method. Here, we present BiSS (Bisufite Sequencing Scorer), a new method applying Smith-Waterman alignment to map bisulfite-converted reads to a reference genome. In addition, we introduce a comprehensive adaptive error estimate that accounts for sequencing errors, erroneous bisulfite conversion and also wrongly mapped reads. The re-analysis of the Arabidopsis methylome data with BiSS mapped substantially more reads to the genome. As a result, it determines the methylation status of an extra 10% of cytosines and estimates the methylation rate to be 7.7%. We validated the results by individual traditional bisulfite sequencing for selected genomic regions. In addition to predicting the methylation status of each cytosine, BiSS also provides an estimate of the methylation degree at each genomic site. Thus, BiSS explores BS-Seq data more extensively and provides more information for downstream analysis.	[Dinh, Huy Q.; Sedlazeck, Fritz J.; von Haeseler, Arndt] Univ Vienna, Max F Perutz Labs, Ctr Integrat Bioinformat Vienna, Vienna, Austria; [Dinh, Huy Q.; Sedlazeck, Fritz J.; von Haeseler, Arndt] Med Univ Vienna, Vienna, Austria; [Dinh, Huy Q.; Dubin, Manu; Lettner, Nicole; Scheid, Ortrun Mittelsten] Austrian Acad Sci, Gregor Mendel Inst Mol Plant Biol, A-1010 Vienna, Austria	Medical University of Vienna; University of Vienna; Vienna Biocenter (VBC); Max F. Perutz Laboratories (MFPL); Medical University of Vienna; Austrian Academy of Sciences; Vienna Biocenter (VBC); Gregor Mendel Institute of Molecular Plant Biology (GMI)	Dinh, HQ (corresponding author), Univ Vienna, Max F Perutz Labs, Ctr Integrat Bioinformat Vienna, Vienna, Austria.	ortrun.mittelsten_scheid@gmi.oeaw.ac.at; arndt.von.haeseler@univie.ac.at	Dinh, Huy/M-8646-2016; Sedlazeck, Fritz J/E-4548-2018; von Haeseler, Arndt/HCI-9958-2022	Dinh, Huy/0000-0002-3307-1126; Sedlazeck, Fritz J/0000-0001-6040-2691; von Haeseler, Arndt/0000-0002-3366-4458; Dubin, Manu/0000-0003-2374-2456; Mittelsten Scheid, Ortrun/0000-0002-7757-4809	Wiener Wissenschafts-, Forschungs- und Technologiefonds (WWTF); Austrian Science Fund [FWF M1369]	Wiener Wissenschafts-, Forschungs- und Technologiefonds (WWTF); Austrian Science Fund(Austrian Science Fund (FWF))	This work was supported by a grant from the Wiener Wissenschafts-, Forschungs- und Technologiefonds (WWTF) to AvH and the Austrian Science Fund (FWF M1369) to MD and OMS. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Chatterjee A, 2012, NUCLEIC ACIDS RES, V40, DOI 10.1093/nar/gks150; Chen PY, 2010, BMC BIOINFORMATICS, V11, DOI 10.1186/1471-2105-11-203; Coarfa C, 2010, BMC BIOINFORMATICS, V11, DOI 10.1186/1471-2105-11-572; Cokus SJ, 2008, NATURE, V452, P215, DOI 10.1038/nature06745; Foerster AM, 2010, METHODS MOL BIOL, V631, P1, DOI 10.1007/978-1-60761-646-7_1; FROMMER M, 1992, P NATL ACAD SCI USA, V89, P1827, DOI 10.1073/pnas.89.5.1827; Harris EY, 2010, BIOINFORMATICS, V26, P572, DOI 10.1093/bioinformatics/btp706; Harris RA, 2010, NAT BIOTECHNOL, V28, P1097, DOI 10.1038/nbt.1682; Kakutani T, 1999, GENETICS, V151, P831; Krueger F, 2011, BIOINFORMATICS, V27, P1571, DOI 10.1093/bioinformatics/btr167; LEUTWILER LS, 1984, MOL GEN GENET, V194, P15, DOI 10.1007/BF00383491; Li H, 2008, GENOME RES, V18, P1851, DOI 10.1101/gr.078212.108; Lister R, 2008, CELL, V133, P523, DOI 10.1016/j.cell.2008.03.029; Lister R, 2009, NATURE, V462, P315, DOI 10.1038/nature08514; Ning ZM, 2001, GENOME RES, V11, P1725, DOI 10.1101/gr.194201; Pedersen B, 2011, BIOINFORMATICS, V27, P2435, DOI 10.1093/bioinformatics/btr394; Rozhon W, 2008, ANAL BIOCHEM, V375, P354, DOI 10.1016/j.ab.2008.01.001; Smith AD, 2009, BIOINFORMATICS, V25, P2841, DOI 10.1093/bioinformatics/btp533; Xi YP, 2009, BMC BIOINFORMATICS, V10, DOI [10.1186/1471-2105-10-S1-S58, 10.1186/1471-2105-10-232]; Zemach A, 2010, SCIENCE, V328, P916, DOI 10.1126/science.1186366	21	13	14	0	28	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 20	2012	7	7							e41528	10.1371/journal.pone.0041528	http://dx.doi.org/10.1371/journal.pone.0041528			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	977GL	22911809	Green Submitted, Green Published, gold			2022-12-25	WOS:000306644600084
J	Kotze, DJ; O'Hara, RB; Lehvavirta, S				Kotze, D. Johan; O'Hara, Robert B.; Lehvavirta, Susanna			Dealing with Varying Detection Probability, Unequal Sample Sizes and Clumped Distributions in Count Data	PLOS ONE			English	Article							CARABID BEETLE; ACTIVITY-DENSITY; COLEOPTERA; ASSEMBLAGES; DISPERSION; DYNAMICS; PATTERNS	Temporal variation in the detectability of a species can bias estimates of relative abundance if not handled correctly. For example, when effort varies in space and/or time it becomes necessary to take variation in detectability into account when data are analyzed. We demonstrate the importance of incorporating seasonality into the analysis of data with unequal sample sizes due to lost traps at a particular density of a species. A case study of count data was simulated using a spring-active carabid beetle. Traps were 'lost' randomly during high beetle activity in high abundance sites and during low beetle activity in low abundance sites. Five different models were fitted to datasets with different levels of loss. If sample sizes were unequal and a seasonality variable was not included in models that assumed the number of individuals was log-normally distributed, the models severely under-or overestimated the true effect size. Results did not improve when seasonality and number of trapping days were included in these models as offset terms, but only performed well when the response variable was specified as following a negative binomial distribution. Finally, if seasonal variation of a species is unknown, which is often the case, seasonality can be added as a free factor, resulting in well-performing negative binomial models. Based on these results we recommend (a) add sampling effort (number of trapping days in our example) to the models as an offset term, (b) if precise information is available on seasonal variation in detectability of a study object, add seasonality to the models as an offset term; (c) if information on seasonal variation in detectability is inadequate, add seasonality as a free factor; and (d) specify the response variable of count data as following a negative binomial or over-dispersed Poisson distribution.	[Kotze, D. Johan; Lehvavirta, Susanna] Univ Helsinki, Dept Environm Sci, Helsinki, Finland; [O'Hara, Robert B.] Univ Helsinki, Dept Math & Stat, Helsinki, Finland; [O'Hara, Robert B.] Biodivers & Climate Res Ctr, Frankfurt, Germany; [Lehvavirta, Susanna] Univ Helsinki, Finnish Museum Nat Hist, Bot Garden, Helsinki, Finland	University of Helsinki; University of Helsinki; University of Helsinki	Kotze, DJ (corresponding author), Univ Helsinki, Dept Environm Sci, Helsinki, Finland.	johan.kotze@helsinki.fi	O'Hara, Bob/A-7499-2008; Kotze, David J/A-2834-2008; Lehvävirta, Susanna/L-3948-2014	O'Hara, Bob/0000-0001-9737-3724; Kotze, David J/0000-0003-4211-4420; Lehvävirta, Susanna/0000-0002-8148-9981	Academy of Finland [126915]; Helsinki University Centre for Environment (HENVI); Biodiversity and Climate Research Centre (BiK-F) of Hesse's Ministry of Higher Education, Research and the Arts	Academy of Finland(Academy of Finland); Helsinki University Centre for Environment (HENVI); Biodiversity and Climate Research Centre (BiK-F) of Hesse's Ministry of Higher Education, Research and the Arts	Funding for D.J. Kotze and S. Lehvavirta was provided by the Academy of Finland (http://www.aka.fi/en-GB/A/, project number: 126915) and Helsinki University Centre for Environment (HENVI, http://www.helsinki.fi/henvi/english/). Funding for R. B. O'Hara was provided by the Biodiversity and Climate Research Centre (BiK-F), which is part of the LOEWE programme "Landes-Offensive zur Entwicklung Wissenschaftlich-okonomischer Exzellenz" of Hesse's Ministry of Higher Education, Research and the Arts. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alaruikka D, 2002, J INSECT CONSERV, V6, P195, DOI 10.1023/A:1024432830064; [Anonymous], 1982, ESTIMATION ANIMAL AB; Bates D.M., 2009, LME4 LINEAR MIXED EF, VR package Ver. 0.999375-28; Buckland S.T., 2001, pi; Carmona DM, 1999, ENVIRON ENTOMOL, V28, P1145, DOI 10.1093/ee/28.6.1145; Cornelissen T, 2008, BASIC APPL ECOL, V9, P67, DOI 10.1016/j.baae.2006.08.007; Crawley MJ, 2003, STAT COMPUTING INTRO; Cuesta D, 2008, ENVIRON POLLUT, V152, P394, DOI 10.1016/j.envpol.2007.06.073; Dennis P, 1997, J APPL ECOL, V34, P433, DOI 10.2307/2404888; Firle S, 1998, ECOLOGY, V79, P2113, DOI 10.1890/0012-9658(1998)079[2113:TIOMAR]2.0.CO;2; Giles J, 2006, NATURE, V443, P379, DOI 10.1038/443379b; Grandchamp A.C., 2000, URBAN ECOSYST, V4, P321; Hoef JMV, 2007, ECOLOGY, V88, P2766, DOI 10.1890/07-0043.1; Koivula M, 2004, J INSECT CONSERV, V8, P297, DOI 10.1007/s10841-004-0296-9; Koivula MJ, 2005, ANN ZOOL FENN, V42, P615; Kotze DJ, 2002, J BIOGEOGR, V29, P375, DOI 10.1046/j.1365-2699.2002.00681.x; Lehvavirta Susanna, 2006, Urban Ecosystems, V9, P13, DOI 10.1007/s11252-006-5526-3; Lindroth C.H., 1985, CARABIDAE COLEOPTE 1; Lindroth C.H., 1986, CARABIDAE COLEOPTE 2; Liu ZM, 2008, AUST J ENTOMOL, V47, P243, DOI 10.1111/j.1440-6055.2008.00651.x; Lloyd-Smith JO, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000180; Martin TG, 2005, ECOL LETT, V8, P1235, DOI 10.1111/j.1461-0248.2005.00826.x; McCullagh P, 1989, GEN LINEAR MODELS; Niemela J, 2002, LANDSCAPE ECOL, V17, P387, DOI 10.1023/A:1021270121630; NIEMELA J, 1989, ANN ZOOL FENN, V26, P35; O'Hara RB, 2010, METHODS ECOL EVOL, V1, P118, DOI 10.1111/j.2041-210X.2010.00021.x; O'Hara RB, 2009, ANN ZOOL FENN, V46, P124, DOI 10.5735/086.046.0205; Onzo A, 2005, ENVIRON ENTOMOL, V34, P866, DOI 10.1603/0046-225X-34.4.866; Pawson SM, 2009, FOREST ECOL MANAG, V258, pS108, DOI 10.1016/j.foreco.2009.08.012; Pollock KH, 2002, ENVIRONMETRICS, V13, P105, DOI 10.1002/env.514; Quinn GP, 2003, EXPT DESIGN DATA ANA; R Core Team, 2022, R LANG ENV STAT COMP; SEBER GAF, 1986, BIOMETRICS, V42, P267, DOI 10.2307/2531049; Thomas CFG, 1998, OECOLOGIA, V116, P103, DOI 10.1007/s004420050568; Underwood AJ, 1997, EXPT ECOLOGY; Venables W.N., 2002, MODERN APPL STAT S, V4th ed, DOI DOI 10.1007/978-0-387-21706-2; Venn SJ, 2003, EUR J ENTOMOL, V100, P73, DOI 10.14411/eje.2003.015; WARD D, 1992, J ARACHNOL, V20, P73; Whelan CJ, 2005, FUNCT ECOL, V19, P529, DOI 10.1111/j.1365-2435.2005.00996.x; White GC, 1996, ECOLOGY, V77, P2549, DOI 10.2307/2265753; WOLDA H, 1978, AM NAT, V112, P1017, DOI 10.1086/283344; Woltmann S, 2005, ORNITOL NEOTROP, V16, P337; Yin ZY, 2005, PLANT ECOL, V178, P189, DOI 10.1007/s11258-004-3285-x	43	31	31	1	34	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 20	2012	7	7							e40923	10.1371/journal.pone.0040923	http://dx.doi.org/10.1371/journal.pone.0040923			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	977GL	22911719	Green Published, gold, Green Submitted			2022-12-25	WOS:000306644600029
J	Pasotti, L; Politi, N; Zucca, S; De Angelis, MGC; Magni, P				Pasotti, Lorenzo; Politi, Nicolo; Zucca, Susanna; De Angelis, Maria Gabriella Cusella; Magni, Paolo			Bottom-Up Engineering of Biological Systems through Standard Bricks: A Modularity Study on Basic Parts and Devices	PLOS ONE			English	Article							SYNTHETIC BIOLOGY; CONSTRUCTION; DESIGN; CELLS	Background: Modularity is a crucial issue in the engineering world, as it enables engineers to achieve predictable outcomes when different components are interconnected. Synthetic Biology aims to apply key concepts of engineering to design and construct new biological systems that exhibit a predictable behaviour. Even if physical and measurement standards have been recently proposed to facilitate the assembly and characterization of biological components, real modularity is still a major research issue. The success of the bottom-up approach strictly depends on the clear definition of the limits in which biological functions can be predictable. Results: The modularity of transcription-based biological components has been investigated in several conditions. First, the activity of a set of promoters was quantified in Escherichia coli via different measurement systems (i.e., different plasmids, reporter genes, ribosome binding sites) relative to an in vivo reference promoter. Second, promoter activity variation was measured when two independent gene expression cassettes were assembled in the same system. Third, the interchangeability of input modules (a set of constitutive promoters and two regulated promoters) connected to a fixed output device (a logic inverter) expressing GFP was evaluated. The three input modules provide tunable transcriptional signals that drive the output device. If modularity persists, identical transcriptional signals trigger identical GFP outputs. To verify this, all the input devices were individually characterized and then the input-output characteristic of the logic inverter was derived in the different configurations. Conclusions: Promoters activities (referred to a standard promoter) can vary when they are measured via different reporter devices (up to 22%), when they are used within a two-expression-cassette system (up to 35%) and when they drive another device in a functionally interconnected circuit (up to 44%). This paper provides a significant contribution to the study of modularity limitations in building biological systems by providing useful data on context-dependent variability of biological components.	[Pasotti, Lorenzo; Politi, Nicolo; Zucca, Susanna; Magni, Paolo] Univ Pavia, Dipartimento Ingn Ind & Informaz, I-27100 Pavia, Italy; [Pasotti, Lorenzo; Politi, Nicolo; Zucca, Susanna; De Angelis, Maria Gabriella Cusella; Magni, Paolo] Univ Pavia, Ctr Ingn Tissutale, I-27100 Pavia, Italy	University of Pavia; University of Pavia	Pasotti, L (corresponding author), Univ Pavia, Dipartimento Ingn Ind & Informaz, Via Palestro 3, I-27100 Pavia, Italy.	paolo.magni@unipv.it	Pasotti, Lorenzo/AAA-5215-2022; Zucca, Susanna/G-7087-2018	Pasotti, Lorenzo/0000-0002-5431-3083; Zucca, Susanna/0000-0001-8465-632X; Magni, Paolo/0000-0002-8931-4676; Cusella De Angelis, Maria Gabriella/0000-0003-2642-3346	Italian Ministero dell'Universita' e della Ricerca through the FIRB ITALBIONET project	Italian Ministero dell'Universita' e della Ricerca through the FIRB ITALBIONET project	This project was partially funded by the Italian Ministero dell'Universita' e della Ricerca through the FIRB ITALBIONET project. No additional external funding was received for this study. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anderson JC, 2007, MOL SYST BIOL, V3, DOI 10.1038/msb4100173; Anderson JC, 2006, J MOL BIOL, V355, P619, DOI 10.1016/j.jmb.2005.10.076; Anderson JC, 2010, J BIOL ENG, V4; Andrianantoandro E, 2006, MOL SYST BIOL, V2, DOI 10.1038/msb4100073; Canton B, 2008, NAT BIOTECHNOL, V26, P787, DOI 10.1038/nbt1413; Cox IIIRS, 2010, J BIOL ENG, V4; Davis JH, 2011, NUCLEIC ACIDS RES, V39, P1131, DOI 10.1093/nar/gkq810; Del Vecchio D, 2008, MOL SYST BIOL, V4, DOI 10.1038/msb4100204; Ellis T, 2009, NAT BIOTECHNOL, V27, P465, DOI 10.1038/nbt.1536; Elowitz MB, 2000, NATURE, V403, P335, DOI 10.1038/35002125; Endy D, 2005, NATURE, V438, P449, DOI 10.1038/nature04342; Foundation TB, BIOBRICKS STAND BIOL; French CE, 2009, J R SOC INTERFACE, V6, DOI 10.1098/rsif.2008.0527.focus; Hajimorad M, 2011, J BIOL ENG, V5, DOI 10.1186/1754-1611-5-3; Heinemann M, 2006, BIOINFORMATICS, V22, P2790, DOI 10.1093/bioinformatics/btl469; Kelly JR, 2008, THESIS MIT; Kim K.H., 2010, J BIOL ENG, V4; Knight TF, 2003, INERT1989 ROC; Kobayashi H, 2004, P NATL ACAD SCI USA, V101, P8414, DOI 10.1073/pnas.0402940101; Kwok R, 2010, NATURE, V463, P288, DOI 10.1038/463288a; Lee TS, 2011, J BIOL ENG, V5, DOI 10.1186/1754-1611-5-12; Lutz R, 1997, NUCLEIC ACIDS RES, V25, P1203, DOI 10.1093/nar/25.6.1203; Martin L, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007569; MIT, REG STAND BIOL PARTS; Pasotti L, 2011, BIOTECHNOL J, V6, P784, DOI 10.1002/biot.201100080; Pasotti L, 2011, J BIOL ENG, V5, DOI 10.1186/1754-1611-5-8; Ro DK, 2006, NATURE, V440, P940, DOI 10.1038/nature04640; Rubin AJ, 2009, J BIOL ENG, V3; Salis HM, 2009, NAT BIOTECHNOL, V27, P946, DOI 10.1038/nbt.1568; Sauro HM, 2008, MOL SYST BIOL, V4, DOI 10.1038/msb.2008.3; Savage DF, 2008, ACS CHEM BIOL, V3, P13, DOI 10.1021/cb700259j; Serrano L, 2007, MOL SYST BIOL, V3, DOI 10.1038/msb4100202; Wang BJ, 2011, NAT COMMUN, V2, DOI 10.1038/ncomms1516; Yokobayashi Y, 2002, P NATL ACAD SCI USA, V99, P16587, DOI 10.1073/pnas.252535999; Zucca S, 2012, BMC BIOINFORMATICS, V13, DOI 10.1186/1471-2105-13-S4-S11	35	25	25	0	22	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 20	2012	7	7							e39407	10.1371/journal.pone.0039407	http://dx.doi.org/10.1371/journal.pone.0039407			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	977GL	22911685	Green Published, gold			2022-12-25	WOS:000306644600005
J	Perney, NM; Braddick, L; Jurna, M; Garbacik, ET; Offerhaus, HL; Serpell, LC; Blanch, E; Holden-Dye, L; Brocklesby, WS; Melvin, T				Perney, Nicolas M.; Braddick, Lucy; Jurna, Martin; Garbacik, Erik T.; Offerhaus, Herman L.; Serpell, Louise C.; Blanch, Ewan; Holden-Dye, Lindy; Brocklesby, William S.; Melvin, Tracy			Polyglutamine Aggregate Structure In Vitro and In Vivo; New Avenues for Coherent Anti-Stokes Raman Scattering Microscopy	PLOS ONE			English	Article							CAENORHABDITIS-ELEGANS; HUNTINGTONS-DISEASE; OPTICAL-ACTIVITY; PROTEIN; SPECTROSCOPY; CELLS; CARS; CONFORMATION; PATHOGENESIS; THRESHOLD	Coherent anti-Stokes Raman scattering (CARS) microscopy is applied for the first time for the evaluation of the protein secondary structure of polyglutamine (polyQ) aggregates in vivo. Our approach demonstrates the potential for translating information about protein structure that has been obtained in vitro by X-ray diffraction into a microscopy technique that allows the same protein structure to be detected in vivo. For these studies, fibres of polyQ containing peptides (D(2)Q(15)K(2)) were assembled in vitro and examined by electron microscopy and X-ray diffraction methods; the fibril structure was shown to be cross beta-sheet. The same polyQ fibres were evaluated by Raman spectroscopy and this further confirmed the beta-sheet structure, but indicated that the structure is highly rigid, as indicated by the strong Amide I signal at 1659 cm(-1). CARS spectra were simulated using the Raman spectrum taking into account potential non-resonant contributions, providing evidence that the Amide I signal remains strong, but slightly shifted to lower wavenumbers. Combined CARS (1657 cm(-1)) and multi-photon fluorescence microscopy of chimeric fusions of yellow fluorescent protein (YFP) with polyQ (Q40) expressed in the body wall muscle cells of Caenorhabditis elegans nematodes (1 day old adult hermaphrodites) revealed diffuse and foci patterns of Q40-YFP that were both fluorescent and exhibited stronger CARS (1657 cm(-1)) signals than in surrounding tissues at the resonance for the cross beta-sheet polyQ in vitro.	[Perney, Nicolas M.; Braddick, Lucy; Brocklesby, William S.; Melvin, Tracy] Univ Southampton, Optoelect Res Ctr, Highfield, Hants, England; [Jurna, Martin; Garbacik, Erik T.; Offerhaus, Herman L.] Univ Twente, MESA Inst Nanotechnol, NL-7500 AE Enschede, Netherlands; [Serpell, Louise C.] Univ Sussex, Sch Life Sci, Falmer, Sussex, England; [Blanch, Ewan] Univ Manchester, Fac Life Sci, Manchester, Lancs, England; [Blanch, Ewan] Univ Manchester, Manchester Interdisciplinary Bioctr, Manchester, Lancs, England; [Holden-Dye, Lindy] Univ Southampton, Sch Biol Sci, Highfield, Hants, England	University of Southampton; University of Twente; University of Sussex; University of Manchester; University of Manchester; University of Southampton	Perney, NM (corresponding author), Univ Southampton, Optoelect Res Ctr, Highfield, Hants, England.	tm@orc.soton.ac.uk	Brocklesby, William S/D-4872-2011; Offerhaus, Herman/AAD-8742-2021; Offerhaus, Herman/D-4848-2014	Brocklesby, William S/0000-0002-2123-6712; Offerhaus, Herman/0000-0003-3697-5750; Offerhaus, Herman/0000-0003-3697-5750; Holden-Dye, Lindy/0000-0002-9704-1217; Serpell, Louise/0000-0001-9335-7751; Blanch, Ewan/0000-0002-0781-4926	EPSRC [EP/J019623/1] Funding Source: UKRI; Engineering and Physical Sciences Research Council [EP/J019623/1] Funding Source: researchfish	EPSRC(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC)); Engineering and Physical Sciences Research Council(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC))		Bell AF, 2000, BIOCHEMISTRY-US, V39, P4423, DOI 10.1021/bi992675o; Blanch EW, 2000, J MOL BIOL, V301, P553, DOI 10.1006/jmbi.2000.3981; BRENNER S, 1974, GENETICS, V77, P71; Brignull HR, 2006, METHOD ENZYMOL, V412, P256, DOI 10.1016/S0076-6879(06)12016-9; Brignull HR, 2006, J NEUROSCI, V26, P7597, DOI 10.1523/JNEUROSCI.0990-06.2006; Cheng JX, 2002, BIOPHYS J, V83, P502, DOI 10.1016/S0006-3495(02)75186-2; Cheng JX, 2002, J OPT SOC AM B, V19, P1363, DOI 10.1364/JOSAB.19.001363; Cheng JX, 2001, OPT LETT, V26, P1341, DOI 10.1364/OL.26.001341; CHIKISHEV AY, 1992, BIOPHYS J, V63, P976, DOI 10.1016/S0006-3495(92)81691-0; Choi W, 2007, NAT METHODS, V4, P717, DOI 10.1038/NMETH1078; Evans CL, 2005, P NATL ACAD SCI USA, V102, P16807, DOI 10.1073/pnas.0508282102; Freudiger CW, 2008, SCIENCE, V322, P1857, DOI 10.1126/science.1165758; Fujita K, 2008, MOL CELLS, V26, P530; Gidalevitz T, 2006, SCIENCE, V311, P1471, DOI 10.1126/science.1124514; Heiser V, 2002, P NATL ACAD SCI USA, V99, P16400, DOI 10.1073/pnas.182426599; Hellerer T, 2004, APPL PHYS LETT, V85, P25, DOI 10.1063/1.1768312; Hellerer T, 2007, P NATL ACAD SCI USA, V104, P14658, DOI 10.1073/pnas.0703594104; Jahn TR, 2010, J MOL BIOL, V395, P717, DOI 10.1016/j.jmb.2009.09.039; Jurna M, 2009, PHYS REV LETT, V103, DOI 10.1103/PhysRevLett.103.043905; Kim S, 2002, NAT CELL BIOL, V4, P826, DOI 10.1038/ncb863; Kirstein-Miles J, 2010, DEV DYNAM, V239, P1529, DOI 10.1002/dvdy.22292; Kneipp K, 1999, CHEM REV, V99, P2957, DOI 10.1021/cr980133r; Kobayashi Y, 2000, J BIOL CHEM, V275, P8772, DOI 10.1074/jbc.275.12.8772; Konorov SO, 2007, ANAL CHEM, V79, P7221, DOI 10.1021/ac070544k; Kopito RR, 2000, TRENDS CELL BIOL, V10, P524, DOI 10.1016/S0962-8924(00)01852-3; Kruglik SG, 2002, J AM CHEM SOC, V124, P10992, DOI 10.1021/ja0260824; Landles C, 2004, EMBO REP, V5, P958, DOI 10.1038/sj.embor.7400250; Le TT, 2010, J LIPID RES, V51, P3091, DOI 10.1194/jlr.R008730; Le TT, 2010, J LIPID RES, V51, P672, DOI 10.1194/jlr.D000638; Makin OS, 2007, J APPL CRYSTALLOGR, V40, P966, DOI 10.1107/S0021889807034681; McColl IH, 2004, J AM CHEM SOC, V126, P5076, DOI 10.1021/ja049271q; Morley JF, 2002, P NATL ACAD SCI USA, V99, P10417, DOI 10.1073/pnas.152161099; Perutz MF, 2002, P NATL ACAD SCI USA, V99, P5591, DOI 10.1073/pnas.042681399; Petry R, 2003, CHEMPHYSCHEM, V4, P14, DOI 10.1002/cphc.200390004; Satyal SH, 2000, P NATL ACAD SCI USA, V97, P5750, DOI 10.1073/pnas.100107297; Scherzinger E, 1999, P NATL ACAD SCI USA, V96, P4604, DOI 10.1073/pnas.96.8.4604; Sharma D, 1999, FEBS LETT, V456, P181, DOI 10.1016/S0014-5793(99)00933-3; Sikorski P, 2005, BIOMACROMOLECULES, V6, P425, DOI 10.1021/bm0494388; Vartiainen EM, 2006, OPT EXPRESS, V14, P3622, DOI 10.1364/OE.14.003622; Wacker JL, 2004, NAT STRUCT MOL BIOL, V11, P1215, DOI 10.1038/nsmb860; Wyttenbach A, 2004, J MOL NEUROSCI, V23, P69, DOI 10.1385/JMN:23:1-2:069; Xie XS, 2006, SCIENCE, V312, P228, DOI 10.1126/science.1127566	42	9	10	1	46	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 20	2012	7	7							e40536	10.1371/journal.pone.0040536	http://dx.doi.org/10.1371/journal.pone.0040536			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	977GL	22911702	Green Published, gold, Green Accepted, Green Submitted			2022-12-25	WOS:000306644600020
J	Cattaruzza, M; Nogoy, N; Wojtowicz, A; Hecker, M				Cattaruzza, Marco; Nogoy, Nicole; Wojtowicz, Agnieszka; Hecker, Markus			Zinc finger motif-1 antagonizes PDGF-BB-induced growth and dedifferentiation of vascular smooth muscle cells	FASEB JOURNAL			English	Article						proliferation; cellular phenotype control; early growth response-1; Egr-1	RNA-POLYMERASE-II; TRANSCRIPTION FACTOR; GENE-EXPRESSION; FACTOR RECEPTOR; PROLIFERATION; ACTIVATION; EWS; METASTASIS; HTAF(II)68; PROTEIN-1	Zinc finger motif-1 (ZFM1) represses proinflammatory gene expression in vascular smooth muscle cells (SMCs) at a global level and thus may also be involved in the attenuation of growth factor-induced phenotype changes in these cells. Using human primary cultured thymus vein SMCs, we have investigated the molecular mechanism by which a potent SMC mitogen, platelet-derived growth factor-BB (PDGF-BB), causes a rapid decrease in ZFM1 expression in a concentration-dependent manner and consequences thereof. Reporter gene analyses and chromatin immunoprecipitation showed that PDGF-BB-induced ZFM1 repression occurs at the level of transcription through replacement of the activating transcription factor Sp1 by Egr-1. The subsequent drop in ZFM1 abundance disinhibits SMC proliferation, migration, and synthetic gene expression in a concerted manner. Stabilizing ZFM1 levels in a PDGF-BB-independent way with a GFP-ZFM1 expression construct or by using Egr-1-specific decoy oligonucleotides abrogates all PDGF-BB effects. Conversely, siRNA-mediated knockdown of ZFM1 alone not only increases the sensitivity of SMCs for PDGF-BB, but even mimics PDGF-BB-induced proliferation and gene expression. Our findings suggest that ZFM1 is an important factor for the stabilization of a contractile SMC phenotype under basal or mildly activating conditions and that, as a prerequisite for efficient action, PDGF-BB must repress ZFM1 expression to alter the SMC phenotype.-Cattaruzza, M., Nogoy, N., Wojtowicz, A., Hecker, M. Zinc finger motif-1 antagonizes PDGF-BB-induced growth and dedifferentiation of vascular smooth muscle cells. FASEB J. 26, 4864-4875 (2012). www.fasebj.org	[Cattaruzza, Marco; Nogoy, Nicole; Wojtowicz, Agnieszka; Hecker, Markus] Heidelberg Univ, Div Cardiovasc Physiol, Inst Physiol & Pathophysiol, D-69120 Heidelberg, Germany	Ruprecht Karls University Heidelberg	Cattaruzza, M (corresponding author), Heidelberg Univ, Div Cardiovasc Physiol, Inst Physiol & Pathophysiol, Neuenheimer Feld 326, D-69120 Heidelberg, Germany.	cattaruzza@physiologie.uni-heidelberg.de		Nogoy, Nicole/0000-0002-5192-9835	Deutsche Forschungsgemeinschaft [GRK 335]; European Commission (Marie Curie ITN SmArt)	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); European Commission (Marie Curie ITN SmArt)	The authors thank Renate Cattaruzza for expert technical assistance. This project was supported by the Deutsche Forschungsgemeinschaft (GRK 335), the European Commission (Marie Curie ITN SmArt), and intramural funding. M.C. planned and performed experiments and wrote the manuscript, N.N. planned and performed experiments, A. W. performed luciferin reporter gene assays, and M. H. planned experiments and participated in the writing of the manuscript. The authors declare no conflicts of interest.	Bell B, 2001, MOL CELL, V8, P591, DOI 10.1016/S1097-2765(01)00325-2; Bertolotti A, 1996, EMBO J, V15, P5022, DOI 10.1002/j.1460-2075.1996.tb00882.x; Bertolotti A, 1998, MOL CELL BIOL, V18, P1489, DOI 10.1128/MCB.18.3.1489; Buchwald AB, 2002, J AM COLL CARDIOL, V39, P732, DOI 10.1016/S0735-1097(01)01797-1; Cartharius K, 2005, BIOINFORMATICS, V21, P2933, DOI 10.1093/bioinformatics/bti473; Cattaruzza M, 2000, FASEB J, V14, P991, DOI 10.1096/fasebj.14.7.991; Cattaruzza M, 2002, J BIOL CHEM, V277, P6582, DOI 10.1074/jbc.M108283200; Chang HJ, 2006, INT J ONCOL, V28, P135; Chen CN, 2006, P NATL ACAD SCI USA, V103, P2665, DOI 10.1073/pnas.0510973103; Christopher P., 2001, ARTERIOSCLER THROMB, V31, P1495; Grazul-Bilska AT, 2003, DRUG TODAY, V39, P787, DOI 10.1358/dot.2003.39.10.799472; Guth S, 2000, J BIOL CHEM, V275, P38059, DOI 10.1074/jbc.M001483200; HOLYCROSS BJ, 1992, CIRC RES, V71, P1525, DOI 10.1161/01.RES.71.6.1525; Hummerich L, 2006, ONCOGENE, V25, P111, DOI 10.1038/sj.onc.1209016; Kamimura M, 2004, HYPERTENSION, V44, P944, DOI 10.1161/01.HYP.0000146908.75091.99; Kaplan-Albuquerque N, 2005, CIRC RES, V97, P427, DOI 10.1161/01.RES.0000179776.40216.a9; Kitadai Y, 2006, AM J PATHOL, V169, P2054, DOI 10.2353/ajpath.2006.060653; Kono SA, 2012, CURR CANCER DRUG TAR, V12, P107; Long XC, 2008, ARTERIOSCL THROM VAS, V28, P1505, DOI 10.1161/ATVBAHA.108.166066; Maehara K, 2001, FASEB J, V15, P2025, DOI 10.1096/fj.00-0909fje; MARMUR JD, 1992, CIRCULATION, V86, P53; Marumo T, 1997, CIRCULATION, V96, P2361; Morishita R, 1998, CIRC RES, V82, P1023, DOI 10.1161/01.RES.82.10.1023; Myllarniemi M, 1997, FASEB J, V11, P1119, DOI 10.1096/fasebj.11.13.9367346; Nissen LJ, 2007, J CLIN INVEST, V117, P2766, DOI 10.1172/JCI32479; Shitashige M, 2007, CANCER SCI, V98, P1862, DOI 10.1111/j.1349-7006.2007.00629.x; Thomas MC, 2006, CRIT REV BIOCHEM MOL, V41, P105, DOI 10.1080/10409230600648736; Wada H, 2002, J CELL BIOL, V156, P983, DOI 10.1083/jcb.200106057; Wagner S, 2003, J IMMUNOL, V170, P1462, DOI 10.4049/jimmunol.170.3.1462; Wang ZG, 2003, P NATL ACAD SCI USA, V100, P7129, DOI 10.1073/pnas.1232341100; Wojtowicz A, 2010, CIRC RES, V107, P898, DOI 10.1161/CIRCRESAHA.110.227850; Xue Y, 2012, NAT MED, V18, P100, DOI 10.1038/nm.2575; Yamamoto H, 1996, EXP CELL RES, V222, P125, DOI 10.1006/excr.1996.0016; Zhang D, 1998, J BIOL CHEM, V273, P6868, DOI 10.1074/jbc.273.12.6868; Zhang D, 1998, J BIOL CHEM, V273, P18086, DOI 10.1074/jbc.273.29.18086	35	6	8	0	4	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	DEC	2012	26	12					4864	4875		10.1096/fj.12-210302	http://dx.doi.org/10.1096/fj.12-210302			12	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	047KD	22906951				2022-12-25	WOS:000311838300010
J	Tokutake, T; Kasuga, K; Yajima, R; Sekine, Y; Tezuka, T; Nishizawa, M; Ikeuchi, T				Tokutake, Takayoshi; Kasuga, Kensaku; Yajima, Ryuji; Sekine, Yumi; Tezuka, Toshiyuki; Nishizawa, Masatoyo; Ikeuchi, Takeshi			Hyperphosphorylation of Tau Induced by Naturally Secreted Amyloid-beta at Nanomolar Concentrations Is Modulated by Insulin-dependent Akt-GSK3 beta Signaling Pathway	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MILD COGNITIVE IMPAIRMENT; GROWTH-FACTOR-I; ALZHEIMERS-DISEASE; HIPPOCAMPAL-NEURONS; GAMMA-SECRETASE; MOUSE MODEL; PHOSPHORYLATION; OLIGOMERS; BRAIN; PROTEIN	Alzheimer disease (AD) is neuropathologically characterized by the formation of senile plaques from amyloid-beta (A beta) and neurofibrillary tangles composed of phosphorylated Tau. Although there is growing evidence for the pathogenic role of soluble A beta species in AD, the major question of how A beta induces hyperphosphorylation of Tau remains unanswered. To address this question, we here developed a novel cell coculture system to assess the effect of extracellular A beta at physiologically relevant levels naturally secreted from donor cells on the phosphorylation of Tau in recipient cells. Using this assay, we demonstrated that physiologically relevant levels of secreted A beta are sufficient to cause hyperphosphorylation of Tau in recipient N2a cells expressing human Tau and in primary culture neurons. This hyperphosphorylation of Tau is inhibited by blocking A beta production in donor cells. The expression of familial AD-linked PSEN1 mutants and APP Delta E693 mutant that induce the production of oligomeric A beta in donor cells results in a similar hyperphosphorylation of Tau in recipient cells. The mechanism underlying the A beta-induced Tau hyperphosphorylation is mediated by the impaired insulin signal transduction because we demonstrated that the phosphorylation of Akt and GSK3 beta upon insulin stimulation is less activated under this condition. Treating cells with the insulin-sensitizing drug rosiglitazone, a peroxisome proliferator-activated receptor gamma agonist, attenuates the A beta-dependent hyperphosphorylation of Tau. These findings suggest that the disturbed insulin signaling cascade may be implicated in the pathways through which soluble A beta induces Tau phosphorylation and further support the notion that correcting insulin signal dysregulation in AD may offer a potential therapeutic approach.	[Tokutake, Takayoshi; Kasuga, Kensaku; Yajima, Ryuji; Sekine, Yumi; Tezuka, Toshiyuki; Nishizawa, Masatoyo; Ikeuchi, Takeshi] Niigata Univ, Brain Res Inst, Dept Neurol, Niigata 9518585, Japan; [Ikeuchi, Takeshi] Niigata Univ, Ctr Transdisciplinary Res, Niigata 9518585, Japan	Niigata University; Niigata University	Ikeuchi, T (corresponding author), Niigata Univ, Brain Res Inst, Dept Neurol, 1-757 Asahimachi, Niigata 9518585, Japan.	ikeuchi@bri.niigata-u.ac.jp	Tokutake, Takayoshi/AAY-3873-2020; Kasuga, Kensaku/AAQ-6627-2020	Tokutake, Takayoshi/0000-0002-4808-0471; Kasuga, Kensaku/0000-0002-2178-0769	Ministry of Education and Science/Japan Society for the Promotion of Science (JSPS) [20590990, 23591234]; Suzuken Memorial Foundation; JSPS [21890078]; Tsubaki Memorial Foundation	Ministry of Education and Science/Japan Society for the Promotion of Science (JSPS); Suzuken Memorial Foundation; JSPS(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); Tsubaki Memorial Foundation	This work was supported in part by Grants-in-aid for Scientific Research (C) 20590990 and 23591234 from the Ministry of Education and Science/Japan Society for the Promotion of Science (JSPS) (to T. I.), a grant from the Suzuken Memorial Foundation (to T. I.), Grant-in-Aid for Young Scientists 21890078 from JSPS (to K. K.), and a grant from the Tsubaki Memorial Foundation (to T. T.).	Biessels GJ, 2006, LANCET NEUROL, V5, P64, DOI 10.1016/S1474-4422(05)70284-2; Craft S, 2012, ARCH NEUROL-CHICAGO, V69, P29, DOI 10.1001/archneurol.2011.233; De Felice FG, 2009, P NATL ACAD SCI USA, V106, P1971, DOI 10.1073/pnas.0809158106; Glabe CG, 2008, J BIOL CHEM, V283, P29639, DOI 10.1074/jbc.R800016200; Gold M, 2010, DEMENT GERIATR COGN, V30, P131, DOI 10.1159/000318845; Gong CX, 2005, J NEURAL TRANSM, V112, P813, DOI 10.1007/s00702-004-0221-0; Gong YS, 2003, P NATL ACAD SCI USA, V100, P10417, DOI 10.1073/pnas.1834302100; HILL JM, 1986, NEUROSCIENCE, V17, P1127, DOI 10.1016/0306-4522(86)90082-5; Hong M, 1997, J BIOL CHEM, V272, P19547, DOI 10.1074/jbc.272.31.19547; Hooper C, 2008, J NEUROCHEM, V104, P1433, DOI 10.1111/j.1471-4159.2007.05194.x; Ikeuchi T, 2003, J BIOL CHEM, V278, P7010, DOI 10.1074/jbc.M209252200; Inestrosa NC, 2005, EXP CELL RES, V304, P91, DOI 10.1016/j.yexcr.2004.09.032; Israel MA, 2012, NATURE, V482, P216, DOI 10.1038/nature10821; Jin M, 2011, P NATL ACAD SCI USA, V108, P5819, DOI 10.1073/pnas.1017033108; Kaneko H, 2007, J NEUROSCI, V27, P13092, DOI 10.1523/JNEUROSCI.4244-07.2007; Kasuga K, 2007, BIOCHEM BIOPH RES CO, V360, P90, DOI 10.1016/j.bbrc.2007.06.022; Kasuga K, 2009, J NEUROL, V256, P1351, DOI 10.1007/s00415-009-5096-4; Klyubin I, 2005, NAT MED, V11, P556, DOI 10.1038/nm1234; Lee HK, 2009, MOL BIOL CELL, V20, P1533, DOI 10.1091/mbc.E08-07-0777; Lesort M, 2000, NEUROSCIENCE, V99, P305, DOI 10.1016/S0306-4522(00)00200-1; Liu Y, 2011, J PATHOL, V225, P54, DOI 10.1002/path.2912; Ma QL, 2009, J NEUROSCI, V29, P9078, DOI 10.1523/JNEUROSCI.1071-09.2009; MORISHIMAKAWASHIMA M, 1995, J BIOL CHEM, V270, P823, DOI 10.1074/jbc.270.2.823; Ohara T, 2011, NEUROLOGY, V77, P1126, DOI 10.1212/WNL.0b013e31822f0435; Pedersen WA, 2006, EXP NEUROL, V199, P265, DOI 10.1016/j.expneurol.2006.01.018; Profenno LA, 2010, BIOL PSYCHIAT, V67, P505, DOI 10.1016/j.biopsych.2009.02.013; Roychaudhuri R, 2009, J BIOL CHEM, V284, P4749, DOI 10.1074/jbc.R800036200; Saltiel AR, 2001, NATURE, V414, P799, DOI 10.1038/414799a; Sato Naoyuki, 2011, Curr Aging Sci, V4, P118; Sato T, 2011, NEUROBIOL AGING, V32, P1626, DOI 10.1016/j.neurobiolaging.2009.10.009; Schrijvers EMC, 2010, NEUROLOGY, V75, P1982, DOI 10.1212/WNL.0b013e3181ffe4f6; Schubert M, 2003, J NEUROSCI, V23, P7084, DOI 10.1523/JNEUROSCI.23-18-07084.2003; Shankar GM, 2007, J NEUROSCI, V27, P2866, DOI 10.1523/JNEUROSCI.4970-06.2007; Sheu WHH, 2011, J PHARMACEUT BIOMED, V54, P759, DOI 10.1016/j.jpba.2010.10.008; Steen E, 2005, J ALZHEIMERS DIS, V7, P63, DOI 10.3233/jad-2005-7107; Takashima A, 1996, NEUROSCI LETT, V203, P33, DOI 10.1016/0304-3940(95)12257-5; Takeda S, 2010, P NATL ACAD SCI USA, V107, P7036, DOI 10.1073/pnas.1000645107; Tomiyama T, 2008, ANN NEUROL, V63, P377, DOI 10.1002/ana.21321; Tomiyama T, 2010, J NEUROSCI, V30, P4845, DOI 10.1523/JNEUROSCI.5825-09.2010; Townsend M, 2007, J BIOL CHEM, V282, P33305, DOI 10.1074/jbc.M610390200; Watson GS, 2005, AM J GERIAT PSYCHIAT, V13, P950, DOI 10.1176/appi.ajgp.13.11.950; Xia WM, 2009, ARCH NEUROL-CHICAGO, V66, P190, DOI 10.1001/archneurol.2008.565; Zempel H, 2010, J NEUROSCI, V30, P11938, DOI 10.1523/JNEUROSCI.2357-10.2010; Zhao WQ, 2008, FASEB J, V22, P246, DOI 10.1096/fj.06-7703com; Zhao WQ, 1999, J BIOL CHEM, V274, P34893, DOI 10.1074/jbc.274.49.34893	45	81	85	0	22	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 12	2012	287	42					35222	35233		10.1074/jbc.M112.348300	http://dx.doi.org/10.1074/jbc.M112.348300			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	022OF	22910909	Green Published, hybrid			2022-12-25	WOS:000309968000032
J	Zhao, LL; Pence, MG; Christov, PP; Wawrzak, Z; Choi, JY; Rizzo, CJ; Egli, M; Guengerich, FP				Zhao, Linlin; Pence, Matthew G.; Christov, Plamen P.; Wawrzak, Zdzislaw; Choi, Jeong-Yun; Rizzo, Carmelo J.; Egli, Martin; Guengerich, F. Peter			Basis of Miscoding of the DNA Adduct N-2,3-Ethenoguanine by Human Y-family DNA Polymerases	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							TRANSLESION SYNTHESIS; CRYSTAL-STRUCTURES; STRUCTURAL BASIS; N2,3-ETHENOGUANINE; BYPASS; DAMAGE; REPLICATION; EFFICIENT; PROGRAM; LESIONS	N-2,3-Ethenoguanine (N-2,3-epsilon G)is one of the exocyclic DNA adducts produced by endogenous processes (e. g. lipid peroxidation) and exposure to bioactivated vinyl monomers such as vinyl chloride, which is a known human carcinogen. Existing studies exploring the miscoding potential of this lesion are quite indirect because of the lability of the glycosidic bond. We utilized a 2'-fluoro isostere approach to stabilize this lesion and synthesized oligonucleotides containing 2'-fluoro-N-2,3-epsilon-2'-deoxyarabinoguanosine to investigate the miscoding potential of N-2,3-epsilon G by Y-family human DNA polymerases (pols). In primer extension assays, pol eta and pol kappa replicated through N-2,3-epsilon G, whereas pol iota and REV1 yielded only 1-base incorporation. Steady-state kinetics revealed that dCTP incorporation is preferred opposite N-2,3-epsilon G with relative efficiencies in the order of pol kappa > REV1> pol eta approximate to pol iota, and dTTP misincorporation is the major miscoding event by all four Y-family human DNA pols. Pol iota had the highest dTTP misincorporation frequency (0.71) followed by pol eta (0.63). REV1 misincorporated dTTP and dGTP with much lower frequencies. Crystal structures of pol iota with N-2,3-epsilon G paired to dCTP and dTTP revealed Hoogsteen-like base pairing mechanisms. Two hydrogen bonds were observed in the N-2,3-epsilon G: dCTP base pair, whereas only one appears to be present in the case of the N-2,3-epsilon G: dTTP pair. Base pairing mechanisms derived from the crystal structures explain the slightly favored dCTP insertion for pol iota in steady-state kinetic analysis. Taken together, these results provide a basis for the mutagenic potential of N-2,3-epsilon G.	[Zhao, Linlin; Pence, Matthew G.; Egli, Martin; Guengerich, F. Peter] Vanderbilt Univ, Sch Med, Dept Biochem, Nashville, TN 37232 USA; [Christov, Plamen P.; Rizzo, Carmelo J.] Vanderbilt Univ, Sch Med, Dept Chem, Nashville, TN 37232 USA; [Zhao, Linlin; Pence, Matthew G.; Christov, Plamen P.; Rizzo, Carmelo J.; Egli, Martin; Guengerich, F. Peter] Vanderbilt Univ, Sch Med, Ctr Mol Toxicol, Nashville, TN 37232 USA; [Wawrzak, Zdzislaw] Northwestern Univ, Synchrotron Res Ctr, Life Sci Collaborat Access Team, Argonne, IL 60439 USA; [Choi, Jeong-Yun] Sungkyunkwan Univ, Samsung Biomed Res Inst, Sch Med, Div Pharmacol,Dept Mol Cell Biol, Gyeonggi Do 440746, South Korea	Vanderbilt University; Vanderbilt University; Vanderbilt University; Northwestern University; Sungkyunkwan University (SKKU)	Guengerich, FP (corresponding author), Vanderbilt Univ, Sch Med, Dept Biochem, 638B Robinson Res Bldg,2200 Pierce Ave, Nashville, TN 37232 USA.	f.guengerich@vanderbilt.edu	Zhao, Linlin/H-1652-2013; Pence, Matthew/J-1379-2012	Zhao, Linlin/0000-0002-8821-4198; Pence, Matthew/0000-0003-2271-789X	United States Department of Energy [DE-AC02-06CH11357]; Michigan Economic Development Corporation; Michigan Technology Tri-Corridor Grant [085P1000817]; National Institutes of Health from the United States Public Health Service [R01 ES010546, R01 ES010375, P01 ES05355, T32 ES007028, P30 ES000267]; National Research Foundation from the Ministry of Education, Science and Technology Korea [2010-0006538]; NATIONAL CANCER INSTITUTE [P01CA160032] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [R01ES010375, T32ES007028, P01ES005355, P30ES000267, R01ES010546] Funding Source: NIH RePORTER	United States Department of Energy(United States Department of Energy (DOE)); Michigan Economic Development Corporation; Michigan Technology Tri-Corridor Grant; National Institutes of Health from the United States Public Health Service; National Research Foundation from the Ministry of Education, Science and Technology Korea; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS))	The use of the Advanced Photon Source and Life Sciences Collaborative Access Team Sector 21 was supported by United States Department of Energy Grant DE-AC02-06CH11357 and Michigan Economic Development Corporation and the Michigan Technology Tri-Corridor Grant 085P1000817.; This work was supported, in whole or in part, by National Institutes of Health Grants R01 ES010546 (to F. P. G.), R01 ES010375 (to F. P. G. and M. E.), P01 ES05355 (to M. E. and C. J. R.), T32 ES007028 (to F. P. G. and M. G. P.), and P30 ES000267 (to M. E., F. P. G., and C. J. R.) from the United States Public Health Service. This work was also supported by National Research Foundation Grant 2010-0006538 from the Ministry of Education, Science and Technology Korea (to J.-Y. C.).	Akasaka S, 1999, CHEM RES TOXICOL, V12, P501, DOI 10.1021/tx980259j; Anzahaee MY, 2011, J AM CHEM SOC, V133, P728, DOI 10.1021/ja109817p; Asensio JL, 1998, J MOL BIOL, V275, P811, DOI 10.1006/jmbi.1997.1520; BAILEY S, 1994, ACTA CRYSTALLOGR D, V50, P760, DOI 10.1107/s0907444994003112; BASU AK, 1993, BIOCHEMISTRY-US, V32, P12793, DOI 10.1021/bi00210a031; Bebenek K, 2004, ADV PROTEIN CHEM, V69, P137; Berger I, 1998, NUCLEIC ACIDS RES, V26, P2473, DOI 10.1093/nar/26.10.2473; CHENG KC, 1991, P NATL ACAD SCI USA, V88, P9974, DOI 10.1073/pnas.88.22.9974; Choi JY, 2008, J BIOL CHEM, V283, P23645, DOI 10.1074/jbc.M801686200; Choi JY, 2006, CHEM RES TOXICOL, V19, P879, DOI 10.1021/tx060051v; Choi JY, 2005, J MOL BIOL, V352, P72, DOI 10.1016/j.jmb.2005.06.079; DeLano W.L., 2002, PYMOL MOL GRAPHICS S; DOSANJH MK, 1994, P NATL ACAD SCI USA, V91, P1024, DOI 10.1073/pnas.91.3.1024; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; FEDTKE N, 1990, CARCINOGENESIS, V11, P1287, DOI 10.1093/carcin/11.8.1287; Fukuda H, 2009, J BIOL CHEM, V284, P25585, DOI 10.1074/jbc.M109.037259; Gonzalez-Reche LM, 2002, TOXICOL LETT, V134, P71, DOI 10.1016/S0378-4274(02)00165-0; Hang B, 2003, MUTAT RES-FUND MOL M, V531, P191, DOI 10.1016/j.mrfmmm.2003.07.006; Hubscher U, 2002, ANNU REV BIOCHEM, V71, P133, DOI 10.1146/annurev.biochem.71.090501.150041; Johnson RE, 2000, J BIOL CHEM, V275, P7447, DOI 10.1074/jbc.275.11.7447; KOCHETKOV NK, 1971, TETRAHEDRON LETT, P1993; Lange SS, 2011, NAT REV CANCER, V11, P96, DOI 10.1038/nrc2998; Lee SH, 2005, CHEM RES TOXICOL, V18, P780, DOI 10.1021/tx0497088; LEONARD NJ, 1993, CHEMTRACTS BIOCH MOL, V4, P251; Levine RL, 2001, J BIOL CHEM, V276, P18717, DOI 10.1074/jbc.M102158200; Li F, 2006, BIOCHEMISTRY-US, V45, P4141, DOI 10.1021/bi052322r; Lord CJ, 2012, NATURE, V481, P287, DOI 10.1038/nature10760; Marion MJ, 1996, INT ARCH OCC ENV HEA, V68, P394; Minko IG, 2008, J BIOL CHEM, V283, P17075, DOI 10.1074/jbc.M801238200; MORIYA M, 1994, P NATL ACAD SCI USA, V91, P11899, DOI 10.1073/pnas.91.25.11899; Nair Deepak T, 2006, Nat Struct Mol Biol, V13, P619, DOI 10.1038/nsmb1118; Nair DT, 2006, STRUCTURE, V14, P749, DOI 10.1016/j.str.2006.01.010; Nair DT, 2005, STRUCTURE, V13, P1569, DOI 10.1016/j.str.2005.08.010; Nair DT, 2004, NATURE, V430, P377, DOI 10.1038/nature02692; Nair U, 2007, FREE RADICAL BIO MED, V43, P1109, DOI 10.1016/j.freeradbiomed.2007.07.012; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Pence MG, 2010, J BIOL CHEM, V285, P40666, DOI 10.1074/jbc.M110.183665; Pence MG, 2009, J BIOL CHEM, V284, P1732, DOI 10.1074/jbc.M807296200; PLUM GE, 1995, J MOL BIOL, V248, P679; Rozenski J, 2002, J AM SOC MASS SPECTR, V13, P200, DOI 10.1016/S1044-0305(01)00354-3; SAGRIPANTI JL, 1989, J BIOL CHEM, V264, P1729; Sale JE, 2012, NAT REV MOL CELL BIO, V13, P141, DOI 10.1038/nrm3289; SATTSANGI PD, 1977, J ORG CHEM, V42, P3292, DOI 10.1021/jo00440a020; SECRIST JA, 1972, BIOCHEMISTRY-US, V11, P3499, DOI 10.1021/bi00769a001; Shibutani S, 1996, BIOCHEMISTRY-US, V35, P14992, DOI 10.1021/bi961446o; Silverstein TD, 2010, NATURE, V465, P1039, DOI 10.1038/nature09104; Singer B, 2002, BIOCHEMISTRY-US, V41, P1778, DOI 10.1021/bi0119114; SINGER B, 1991, CARCINOGENESIS, V12, P745, DOI 10.1093/carcin/12.4.745; SINGER B, 1987, CARCINOGENESIS, V8, P745, DOI 10.1093/carcin/8.5.745; Srinivasadesikan V, 2011, J PHYS CHEM B, V115, P10537, DOI 10.1021/jp202738v; Swan MK, 2009, J MOL BIOL, V390, P699, DOI 10.1016/j.jmb.2009.05.026; Swenberg JA, 2011, TOXICOL SCI, V120, pS130, DOI 10.1093/toxsci/kfq371; Vagin A, 1997, J APPL CRYSTALLOGR, V30, P1022, DOI 10.1107/S0021889897006766; Winn MD, 2003, METHOD ENZYMOL, V374, P300, DOI 10.1016/S0076-6879(03)74014-2; Winn MD, 2001, ACTA CRYSTALLOGR D, V57, P122, DOI 10.1107/S0907444900014736; Yang W, 2007, P NATL ACAD SCI USA, V104, P15591, DOI 10.1073/pnas.0704219104; Yang W, 2011, PROTEIN SCI, V20, P1781, DOI 10.1002/pro.723; Zang H, 2005, J BIOL CHEM, V280, P29750, DOI 10.1074/jbc.M504756200; Zhao LL, 2012, ANGEW CHEM INT EDIT, V51, P5466, DOI 10.1002/anie.201109004	59	21	21	0	12	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 12	2012	287	42					35516	35526		10.1074/jbc.M112.403253	http://dx.doi.org/10.1074/jbc.M112.403253			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	022OF	22910910	Green Published, hybrid			2022-12-25	WOS:000309968000060
J	Han, X; Fang, XF; Lou, XY; Hua, DS; Ding, WC; Foltz, G; Hood, L; Yuan, Y; Lin, BY				Han, Xu; Fang, Xuefeng; Lou, Xiaoyan; Hua, Dasong; Ding, Wenchao; Foltz, Gregory; Hood, Leroy; Yuan, Ying; Lin, Biaoyang			Silencing SOX2 Induced Mesenchymal-Epithelial Transition and Its Expression Predicts Liver and Lymph Node Metastasis of CRC Patients	PLOS ONE			English	Article							TRANSCRIPTION FACTOR SNAIL; BETA-CATENIN; STEM-CELLS; COLORECTAL-CANCER; BREAST-CANCER; E-CADHERIN; MATRIX METALLOPROTEINASES; TUMOR-METASTASIS; DOWN-REGULATION; CHIP-SEQ	SOX2 is an important stem cell marker and plays important roles in development and carcinogenesis. However, the role of SOX2 in Epithelial-Mesenchymal Transition has not been investigated. We demonstrated, for the first time, that SOX2 is involved in the Epithelial-Mesenchymal Transition (EMT) process as knock downof SOX2 in colorectal cancer (CRC) SW620 cells induced a Mesenchymal-Epithelial Transition (MET) process with recognized changes in the expression of key genes involved in the EMT process including E-cadherin and vimentin. In addition, we provided a link between SOX2 activity and the WNT pathway by showing that knock down of SOX2 reduced the WNT pathway activity in colorectal cancer (CRC) cells. We further demonstrated that SOX2 is involved in cell migration and invasion in vitro and in metastasis in vivo for CRC cells, and that the process might be mediated through the MMP2 activity. Finally, an IHC analysis of 44 cases of colorectal cancer patients suggested that SOX2 is a prognosis marker for metastasis of colorectal cancers.	[Han, Xu; Lou, Xiaoyan; Hua, Dasong; Ding, Wenchao; Lin, Biaoyang] Zhejiang Univ, Zhejiang California Int Nanosyst Inst, Syst Biol Div, Hangzhou 310003, Zhejiang, Peoples R China; [Foltz, Gregory; Lin, Biaoyang] Swedish Med Ctr, Swedish Neurosci Inst, Seattle, WA USA; [Hood, Leroy] Inst Syst Biol, Seattle, WA USA; [Fang, Xuefeng; Yuan, Ying] Zhejiang Univ, Hosp 2, Coll Med, Dept Med Oncol, Hangzhou 310003, Zhejiang, Peoples R China; [Lin, Biaoyang] Univ Washington, Dept Urol, Seattle, WA 98195 USA	Zhejiang University; Swedish Medical Center; Institute for Systems Biology (ISB); Zhejiang University; University of Washington; University of Washington Seattle	Yuan, Y (corresponding author), Zhejiang Univ, Hosp 2, Coll Med, Dept Med Oncol, Hangzhou 310003, Zhejiang, Peoples R China.	yuanying1999@zju.edu.cn; biaoylin@gmail.com	Lin, Biaoyang/AAA-1258-2020	Lin, Biaoyang/0000-0002-2189-0407	Ministry of Science and Technology of China [2006AA02A303, 2006AA02Z4A2, 2006DFA32950, 2007DFC30360]; National Natural Science Foundation of China [81101580]	Ministry of Science and Technology of China(Ministry of Science and Technology, China); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	Supported by grants to BL from the Ministry of Science and Technology of China [grant 2006AA02A303, 2006AA02Z4A2, 2006DFA32950 and 2007DFC30360], and grant to XF from the National Natural Science Foundation of China (No. 81101580). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alonso MM, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0026740; Avilion AA, 2003, GENE DEV, V17, P126, DOI 10.1101/gad.224503; Basu-Roy U, 2012, ONCOGENE, V31, P2270, DOI 10.1038/onc.2011.405; Bates RC, 2005, CANCER BIOL THER, V4, P365; Batlle E, 2000, NAT CELL BIOL, V2, P84, DOI 10.1038/35000034; Bienz M, 2000, CELL, V103, P311, DOI 10.1016/S0092-8674(00)00122-7; Brabletz T, 2005, CELLS TISSUES ORGANS, V179, P56, DOI 10.1159/000084509; Burbridge TJ, 2008, NEUROSCIENCE, V152, P723, DOI 10.1016/j.neuroscience.2008.01.020; Cano A, 2000, NAT CELL BIOL, V2, P76, DOI 10.1038/35000025; Chen YP, 2008, J BIOL CHEM, V283, P17969, DOI 10.1074/jbc.M802917200; Christiansen JJ, 2006, CANCER RES, V66, P8319, DOI 10.1158/0008-5472.CAN-06-0410; Deryugina EI, 2006, CANCER METAST REV, V25, P9, DOI 10.1007/s10555-006-7886-9; Fang XF, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-11; Fang XF, 2010, OMICS, V14, P369, DOI 10.1089/omi.2010.0053; Floor S, 2011, ONCOGENE, V30, P4609, DOI 10.1038/onc.2011.184; Gottardi CJ, 2001, CURR BIOL, V11, pR792, DOI 10.1016/S0960-9822(01)00473-0; Hajra KM, 2002, CANCER RES, V62, P1613; Jia XP, 2011, J MOL CELL BIOL, V3, P230, DOI 10.1093/jmcb/mjr002; Kikuchi A, 2000, BIOCHEM BIOPH RES CO, V268, P243, DOI 10.1006/bbrc.1999.1860; Kim K, 2002, CELL BIOL INT, V26, P463, DOI 10.1006/cbir.2002.0901; Kolligs FT, 2002, DIGESTION, V66, P131, DOI 10.1159/000066755; Larue L, 2005, ONCOGENE, V24, P7443, DOI 10.1038/sj.onc.1209091; Lee JM, 2006, J CELL BIOL, V172, P973, DOI 10.1083/jcb.200601018; LEIBOVITZ A, 1976, CANCER RES, V36, P4562; Leis O, 2012, ONCOGENE, V31, P1354, DOI 10.1038/onc.2011.338; Li XL, 2004, INT J ONCOL, V24, P257; Mani SA, 2008, CELL, V133, P704, DOI 10.1016/j.cell.2008.03.027; Mann B, 1999, P NATL ACAD SCI USA, V96, P1603, DOI 10.1073/pnas.96.4.1603; Mariadason JM, 2001, CANCER RES, V61, P3465; Micalizzi DS, 2009, FUTURE ONCOL, V5, P1129, DOI 10.2217/FON.09.94; Nelson WJ, 2004, SCIENCE, V303, P1483, DOI 10.1126/science.1094291; Park KS, 2011, J GASTROEN HEPATOL, V26, P391, DOI 10.1111/j.1440-1746.2010.06504.x; Park SB, 2012, CELL DEATH DIFFER, V19, P534, DOI 10.1038/cdd.2011.137; Picanco-Castro V, 2011, STEM CELLS DEV, V20, P169, DOI 10.1089/scd.2009.0424; Polette M, 2007, CELLS TISSUES ORGANS, V185, P61, DOI 10.1159/000101304; Rodriguez-Pinilla SM, 2007, MODERN PATHOL, V20, P474, DOI 10.1038/modpathol.3800760; Sanada Y, 2006, PANCREAS, V32, P164, DOI 10.1097/01.mpa.0000202947.80117.a0; Savore C, 2005, CLIN EXP METASTAS, V22, P377, DOI 10.1007/s10585-005-2339-3; Snoek-van Beurden PAM, 2005, BIOTECHNIQUES, V38, P73, DOI 10.2144/05381RV01; Subbarayan V, 2000, J CLIN INVEST, V105, P387, DOI 10.1172/JCI8150; Takahashi K, 2007, CELL, V131, P861, DOI 10.1016/j.cell.2007.11.019; Takahashi K, 2006, CELL, V126, P663, DOI 10.1016/j.cell.2006.07.024; Thiery JP, 2009, CELL, V139, P871, DOI 10.1016/j.cell.2009.11.007; Thiery JP, 2002, NAT REV CANCER, V2, P442, DOI 10.1038/nrc822; Wiese AH, 2007, CANCER DETECT PREV, V31, P282, DOI 10.1016/j.cdp.2007.07.003; Xiang R, 2011, BRIT J CANCER, V104, P1410, DOI 10.1038/bjc.2011.94; Yang J, 2008, DEV CELL, V14, P818, DOI 10.1016/j.devcel.2008.05.009; Zhang C, 2003, DEVELOPMENT, V130, P5609, DOI 10.1242/dev.00798; Zorn AM, 1999, MOL CELL, V4, P487, DOI 10.1016/S1097-2765(00)80200-2	49	111	116	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 17	2012	7	8							e41335	10.1371/journal.pone.0041335	http://dx.doi.org/10.1371/journal.pone.0041335			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	996DG	22912670	gold, Green Published, Green Submitted			2022-12-25	WOS:000308063700004
J	Herwig, JN; Depczynski, M; Roberts, JD; Semmens, JM; Gagliano, M; Heyward, AJ				Herwig, Jade N.; Depczynski, Martial; Roberts, John D.; Semmens, Jayson M.; Gagliano, Monica; Heyward, Andrew J.			Using Age-Based Life History Data to Investigate the Life Cycle and Vulnerability of Octopus cyanea	PLOS ONE			English	Article							GROWTH; MOLLUSCA; VULGARIS; SOUTH; GRAY; CEPHALOPODA; TEMPERATURE; STYLETS; BORDERS; WATERS	Octopus cyanea is taken as an unregulated, recreationally fished species from the intertidal reefs of Ningaloo, Western Australia. Yet despite its exploitation and importance in many artisanal fisheries throughout the world, little is known about its life history, ecology and vulnerability. We used stylet increment analysis to age a wild O. cyanea population for the first time and gonad histology to examine their reproductive characteristics. O. cyanea conforms to many cephalopod life history generalisations having rapid, non-asymptotic growth, a short life-span and high levels of mortality. Males were found to mature at much younger ages and sizes than females with reproductive activity concentrated in the spring and summer months. The female dominated sex-ratios in association with female brooding behaviours also suggest that larger conspicuous females may be more prone to capture and suggests that this intertidal octopus population has the potential to be negatively impacted in an unregulated fishery. Size at age and maturity comparisons between our temperate bordering population and lower latitude Tanzanian and Hawaiian populations indicated stark differences in growth rates that correlate with water temperatures. The variability in life history traits between global populations suggests that management of O. cyanea populations should be tailored to each unique set of life history characteristics and that stylet increment analysis may provide the integrity needed to accurately assess this.	[Herwig, Jade N.; Depczynski, Martial; Heyward, Andrew J.] Univ Western Australia, Oceans Inst, Australian Inst Marine Sci, Perth, WA 6009, Australia; [Roberts, John D.; Gagliano, Monica] Univ Western Australia, Sch Anim Biol, Ctr Evolutionary Biol, Perth, WA 6009, Australia; [Semmens, Jayson M.] Univ Tasmania, Inst Marine & Antarctic Res, Fisheries Aquaculture & Coasts Ctr, Hobart, Tas, Australia; [Gagliano, Monica] Univ Western Australia, Ctr Microscopy Characterisat & Anal, Perth, WA 6009, Australia	Australian Institute of Marine Science; University of Western Australia; University of Western Australia; University of Tasmania; University of Western Australia	Herwig, JN (corresponding author), Univ Western Australia, Oceans Inst, Australian Inst Marine Sci, Perth, WA 6009, Australia.	m.depczynski@aims.gov.au	Gagliano, Monica/A-3129-2012; depczynski, martial/B-7689-2008	Gagliano, Monica/0000-0002-2414-6990; depczynski, martial/0000-0001-8723-0076; Semmens, Jayson/0000-0003-1742-6692	West Australian Marine Science Institute (WAMSI) via the Australian Institute of Marine Science (WA); University of Western Australia	West Australian Marine Science Institute (WAMSI) via the Australian Institute of Marine Science (WA); University of Western Australia	Funding for this research was provided by the West Australian Marine Science Institute (WAMSI) via the Australian Institute of Marine Science (WA) and the University of Western Australia. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andre J, 2009, MAR ECOL PROG SER, V374, P167, DOI 10.3354/meps07736; Araujo R, 2011, J PHYCOL, V47, P451, DOI 10.1111/j.1529-8817.2011.00986.x; Arendt JD, 1997, Q REV BIOL, V72, P149, DOI 10.1086/419764; Avila-Poveda OH, 2009, BIOL BULL-US, V216, P94, DOI 10.1086/BBLv216n1p94; Barratt IM, 2010, ICES J MAR SCI, V67, P1452, DOI 10.1093/icesjms/fsq047; Boyle PR, 1991, UFAW HDB CARE MANAGE; Brown JH, 2004, ECOLOGY, V85, P1771, DOI 10.1890/03-9000; Diamantidis AD, 2008, J APPL ENTOMOL, V132, P695, DOI 10.1111/j.1439-0418.2008.01325.x; Doubleday Z, 2006, J EXP MAR BIOL ECOL, V338, P35, DOI 10.1016/j.jembe.2006.06.027; Doubleday ZA, 2011, ICES J MAR SCI, V68, P2059, DOI 10.1093/icesjms/fsr135; Fischer P, 1999, J FISH BIOL, V54, P1231, DOI 10.1006/jfbi.1999.0956; Forsythe John W., 1993, P133; Forsythe JW, 1997, J EXP MAR BIOL ECOL, V209, P15, DOI 10.1016/S0022-0981(96)00057-3; Gray J. E., 1849, CATALOGUE MOLLUSCA C, p[i, 1]; Guard M, 2002, AMBIO, V31, P528, DOI 10.1639/0044-7447(2002)031[0528:TAFFOC]2.0.CO;2; Guard M, 2003, THESIS U ABERDEEN SC; Hanlon RT, 2008, MAR FRESHW BEHAV PHY, V41, P19, DOI 10.1080/10236240701661123; Harrison HB, 2012, CURR BIOL, V22, P1023, DOI 10.1016/j.cub.2012.04.008; HARTWICK EB, 1984, MAR BEHAV PHYSIOL, V11, P95, DOI 10.1080/10236248409387038; Hermosilla CA, 2010, ICES J MAR SCI, V67, P1458, DOI 10.1093/icesjms/fsq054; Hernaman V, 2005, MAR ECOL PROG SER, V290, P207, DOI 10.3354/meps290207; Hewit DA, 2007, T AM FISH SOC, V136, P1030, DOI 10.1577/T06-078.1; HOENIG JM, 1983, FISH B-NOAA, V81, P898; HOFFMANN AA, 1994, TRENDS ECOL EVOL, V9, P223, DOI 10.1016/0169-5347(94)90248-8; Humber F., 2006, SEASONAL CLOSURES NO; IRIBARNE OO, 1991, J ZOOL, V223, P549, DOI 10.1111/j.1469-7998.1991.tb04387.x; Jones T, 2009, NINGALOO COAST REGIO; King M, 1995, FISHERIES BIOL ASSES; Leporati SC, 2008, MAR ECOL PROG SER, V367, P213, DOI 10.3354/meps07558; Leporati SC, 2007, MAR BIOL, V151, P1375, DOI 10.1007/s00227-006-0575-y; MAGINNIS.LA, 1969, J EXP BIOL, V51, P607; Mather JA, 2004, J ZOOL, V263, P89, DOI 10.1017/S0952836904004911; NORMAN MD, 1991, B MAR SCI, V49, P20; Norman MD, 2000, CEPHALOPODS WORLD GU; PAPINI MR, 1991, J COMP PSYCHOL, V105, P107, DOI 10.1037/0735-7036.105.2.107; Planes S, 2009, P NATL ACAD SCI USA, V106, P5693, DOI 10.1073/pnas.0808007106; Reis CS, 2002, B MAR SCI, V71, P1099; Rodriguez-Rua A, 2005, MAR BIOL, V147, P927, DOI 10.1007/s00227-005-1621-x; Sauer WHH, 2011, AFR J MAR SCI, V33, P181, DOI 10.2989/1814232X.2011.572386; Semmens JM, 2004, MAR FRESHWATER RES, V55, P367, DOI 10.1071/MF03155; SMALE MJ, 1981, MAR BIOL, V65, P1, DOI 10.1007/BF00397061; Stearns S.C., 1992, pi; Thomson D.P., 2009, STOCK ASSESSMENT TAR; Van Heukelem WF, 1966, THESIS U HAWAII US; VANHEUKE.WF, 1973, J ZOOL, V169, P299; VANHEUKELEM WF, 1976, THESIS U HAWAII HAWA; WELLS MJ, 1970, J ZOOL, V161, P65, DOI 10.1111/j.1469-7998.1970.tb02170.x; Wood JB, 2000, MAR BIOL, V136, P91, DOI 10.1007/s002270050012; YARNALL JL, 1969, ANIM BEHAV, V17, P747, DOI 10.1016/S0003-3472(69)80022-9	49	18	21	0	41	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 17	2012	7	8							e43679	10.1371/journal.pone.0043679	http://dx.doi.org/10.1371/journal.pone.0043679			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	996DG	22912898	Green Submitted, Green Published, gold			2022-12-25	WOS:000308063700126
J	Keane, E; Layte, R; Harrington, J; Kearney, PM; Perry, IJ				Keane, Eimear; Layte, Richard; Harrington, Janas; Kearney, Patricia M.; Perry, Ivan J.			Measured Parental Weight Status and Familial Socio-Economic Status Correlates with Childhood Overweight and Obesity at Age 9	PLOS ONE			English	Article							BODY-MASS INDEX; PREDICTING OBESITY; ENERGY-INTAKE; CHILDREN; FOOD; ASSOCIATIONS; ENVIRONMENT; PREVALENCE; ADULTHOOD; BMI	Background: Parental obesity is a predominant risk factor for childhood obesity. Family factors including socio-economic status (SES) play a role in determining parent weight. It is essential to unpick how shared family factors impact on child weight. This study aims to investigate the association between measured parent weight status, familial socio-economic factors and the risk of childhood obesity at age 9. Methodology/Principal Findings: Cross sectional analysis of the first wave (2008) of the Growing Up in Ireland (GUI) study. GUI is a nationally representative study of 9-year-old children (N = 8,568). Schools were selected from the national total (response rate 82%) and age eligible children (response rate 57%) were invited to participate. Children and their parents had height and weight measurements taken using standard methods. Data were reweighted to account for the sampling design. Childhood overweight and obesity prevalence were calculated using International Obesity Taskforce definitions. Multinomial logistic regression examined the association between parent weight status, indicators of SES and child weight. Overall, 25% of children were either overweight (19.3%) or obese (6.6%). Parental obesity was a significant predictor of child obesity. Of children with normal weight parents, 14.4% were overweight or obese whereas 46.2% of children with obese parents were overweight or obese. Maternal education and household class were more consistently associated with a child being in a higher body mass index category than household income. Adjusted regression indicated that female gender, one parent family type, lower maternal education, lower household class and a heavier parent weight status significantly increased the odds of childhood obesity. Conclusions/Significance: Parental weight appears to be the most influential factor driving the childhood obesity epidemic in Ireland and is an independent predictor of child obesity across SES groups. Due to the high prevalence of obesity in parents and children, population based interventions are required.	[Keane, Eimear; Harrington, Janas; Kearney, Patricia M.; Perry, Ivan J.] Natl Univ Ireland Univ Coll Cork, Dept Epidemiol & Publ Hlth, Cork, Ireland; [Layte, Richard] Sir John Rogersons Quay, Econ & Social Res Inst, Dublin, Ireland	University College Cork; Economic & Social Research Institute (ESRI)	Keane, E (corresponding author), Natl Univ Ireland Univ Coll Cork, Dept Epidemiol & Publ Hlth, Cork, Ireland.	eimear.keane@ucc.ie	Harrington, Janas/AAV-8123-2021	Harrington, Janas/0000-0002-6238-7031; Kearney, Patricia/0000-0001-9599-3540; Layte, Richard/0000-0002-3170-767X; Perry, Ivan/0000-0002-4965-9792	Government of Ireland through the Department of Children and Youth Affairs; Department of Social Protection; Central Statistics Office; National Children's Research Centre, Crumlin, Dublin	Government of Ireland through the Department of Children and Youth Affairs; Department of Social Protection; Central Statistics Office; National Children's Research Centre, Crumlin, Dublin	The Growing Up in Ireland study is funded by the Government of Ireland through the Department of Children and Youth Affairs in association with the Department of Social Protection and the Central Statistics Office. This present research is funded by the National Children's Research Centre, Crumlin, Dublin (http://www.nationalchildrensresearchcentre.ie/project/view/35). The funders of this present research had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bauer F, 2009, AM J CLIN NUTR, V90, P951, DOI 10.3945/ajcn.2009.27781; Booth KM, 2005, J AM DIET ASSOC, V105, pS110, DOI 10.1016/j.jada.2005.02.045; Burke V, 2001, INT J OBESITY, V25, P147, DOI 10.1038/sj.ijo.0801538; Cecil JE, 2008, NEW ENGL J MED, V359, P2558, DOI 10.1056/NEJMoa0803839; Cole TJ, 2000, BMJ-BRIT MED J, V320, P1240, DOI 10.1136/bmj.320.7244.1240; Danielzik S, 2002, EUR J NUTR, V41, P132, DOI 10.1007/s00394-002-0367-1; GARN SM, 1989, AM J CLIN NUTR, V50, P1308, DOI 10.1093/ajcn/50.6.1308; Gibson LY, 2007, MED J AUSTRALIA, V186, P591, DOI 10.5694/j.1326-5377.2007.tb01061.x; Gluckman PD, 2010, J DEV ORIG HLTH DIS, V1, P6, DOI 10.1017/S2040174409990171; Grunert KG, 2012, TRENDS FOOD IN PRESS; Hannon PA, 2003, APPETITE, V40, P77, DOI 10.1016/S0195-6663(02)00140-X; Harrington J, 2011, PUBLIC HEALTH NUTR, V1, P1; Hesketh K, 2007, INT J PEDIATR OBES, V2, P86, DOI 10.1080/17477160601148554; Hesketh K, 2009, INT J PEDIATR OBES, V4, P45, DOI 10.1080/17477160802191122; Irish Social Sciences Data Archive, 2010, SAMPL DES RESP WAV 1; Juliusson PB, 2010, ACTA PAEDIATR, V99, P900, DOI 10.1111/j.1651-2227.2010.01730.x; Knai C, 2012, INT J ENV RES PUB HE, V9, P1472, DOI 10.3390/ijerph9041472; Lake JK, 1997, ARCH DIS CHILD, V77, P376, DOI 10.1136/adc.77.5.376; Lawlor DA, 2007, AM J EPIDEMIOL, V165, P418, DOI 10.1093/aje/kwk030; Layte R, 2011, J EPIDEMIOL COMMUN H, V65, P881, DOI 10.1136/jech.2010.116749; Lazzeri G, 2011, NUTR J, V10, DOI 10.1186/1475-2891-10-76; Lioret S, 2009, OBESITY, V17, P1092, DOI 10.1038/oby.2008.619; Maes HHM, 1997, BEHAV GENET, V27, P325, DOI 10.1023/A:1025635913927; Magarey AM, 2003, INT J OBESITY, V27, P505, DOI 10.1038/sj.ijo.0802251; Moschonis G, 2010, PUBLIC HEALTH NUTR, V13, P1693, DOI 10.1017/S1368980010002247; Murray A, 2011, GROWING IRELAND DESI; Ochoa MC, 2009, REV ESP OBES, V7, P395; Parsons TJ, 1999, INT J OBESITY, V23, pS1; Rosenkranz RR, 2008, NUTR REV, V66, P123, DOI 10.1111/j.1753-4887.2008.00017.x; Semmler C, 2009, OBESITY, V17, P814, DOI 10.1038/oby.2008.621; Shrewsbury V, 2008, OBESITY, V16, P275, DOI 10.1038/oby.2007.35; SOBAL J, 1989, PSYCHOL BULL, V105, P260, DOI 10.1037/0033-2909.105.2.260; Sonestedt E, 2009, AM J CLIN NUTR, V90, P1418, DOI 10.3945/ajcn.2009.27958; Wake M, 2007, INT J OBESITY, V31, P1044, DOI 10.1038/sj.ijo.0803503; Wardle J, 2001, INT J OBESITY, V25, P971, DOI 10.1038/sj.ijo.0801661; Wells JCK, 2011, EUR J CLIN NUTR, V65, P1173, DOI 10.1038/ejcn.2011.132; Whelton H, 2007, BMC PUBLIC HEALTH, V7, DOI 10.1186/1471-2458-7-187; Whitaker KL, 2010, AM J CLIN NUTR, V91, P1560, DOI 10.3945/ajcn.2009.28838; Whitaker RC, 1997, NEW ENGL J MED, V337, P869, DOI 10.1056/NEJM199709253371301; Whitaker RC, 1998, J PEDIATR-US, V132, P768, DOI 10.1016/S0022-3476(98)70302-6; WHO, 2000, OB PREV MAN GLOB EP; Williams J, 2009, 1 OFF MIN CHILDR YOU	42	58	62	1	29	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 17	2012	7	8							e43503	10.1371/journal.pone.0043503	http://dx.doi.org/10.1371/journal.pone.0043503			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	996DG	22912886	Green Published, Green Submitted, gold			2022-12-25	WOS:000308063700114
J	Fekete, N; Rojewski, MT; Furst, D; Kreja, L; Ignatius, A; Dausend, J; Schrezenmeier, H				Fekete, Natalie; Rojewski, Markus T.; Fuerst, Daniel; Kreja, Ludwika; Ignatius, Anita; Dausend, Julia; Schrezenmeier, Hubert			GMP-Compliant Isolation and Large-Scale Expansion of Bone Marrow-Derived MSC	PLOS ONE			English	Article							MESENCHYMAL STEM-CELLS; STROMAL CELLS; PHENOTYPIC CHARACTERIZATION; DONOR VARIATION; HUMAN PLACENTA; DIFFERENTIATION; BLOOD	Background: Mesenchymal stromal cells (MSC) have gained importance in tissue repair, tissue engineering and in immunosupressive therapy during the last years. Due to the limited availability of MSC in the bone marrow, ex vivo amplification prior to clinical application is requisite to obtain therapeutic applicable cell doses. Translation of preclinical into clinical-grade large-scale MSC expansion necessitates precise definition and standardization of all procedural parameters including cell seeding density, culture medium and cultivation devices. While xenogeneic additives such as fetal calf serum are still widely used for cell culture, its use in the clinical context is associated with many risks, such as prion and viral transmission or adverse immunological reactions against xenogeneic components. Methods and Findings: We established animal-free expansion protocols using platelet lysate as medium supplement and thereby could confirm its safety and feasibility for large-scale MSC isolation and expansion. Five different GMP-compliant standardized protocols designed for the safe, reliable, efficient and economical isolation and expansion of MSC was performed and MSC obtained were analyzed for differentiation capacity by qPCR and histochemistry. Expression of standard MSC markers as defined by the International Society for Cellular Therapy as well as expression of additional MSC markers and of various chemokine and cytokine receptors was analysed by flow cytometry. Changes of metabolic markers and cytokines in the medium were addressed using the LUMINEX platform. Conclusions: The five different systems for isolation and expansion of MSC described in this study are all suitable to produce at least 100 millions of MSC, which is commonly regarded as a single clinical dose. Final products are equal according to the minimal criteria for MSC defined by the ISCT. We showed that chemokine and integrin receptors analyzed had the same expression pattern, suggesting that MSC from either of the systems show equal characteristics of homing and adhesion.	[Fekete, Natalie; Rojewski, Markus T.; Dausend, Julia; Schrezenmeier, Hubert] Univ Ulm Klinikum, Inst Transfus Med, Ulm, Germany; [Fekete, Natalie; Rojewski, Markus T.; Fuerst, Daniel; Dausend, Julia; Schrezenmeier, Hubert] Inst Klin Transfus Med & Immungenet, Ulm, Germany; [Kreja, Ludwika; Ignatius, Anita] Inst Unfallchirurg Forsch & Biomech, Ulm, Germany	Ulm University	Fekete, N (corresponding author), Univ Ulm Klinikum, Inst Transfus Med, Ulm, Germany.	markus.rojewski@uni-ulm.de	Fekete, Natalie/W-9220-2019; Ignatius, Anita/M-6012-2013	Ignatius, Anita/0000-0002-4782-1979; Rojewski, Markus/0000-0003-4265-0442; Fekete, Natalie/0000-0003-4856-9338	European Commission: CASCADE (Cultivated Adult Stem Cells as Alternative for Damaged Tissue) [223236, HEALTH-F5-2009-223236]; European Commission: REBORNE (Regenerating BOne defects using New biomedical Engineering approaches) [HEALTH- 2009-1.4.2-241879]; University Centre of Musculoskelettal Research, Ulm, Germany)	European Commission: CASCADE (Cultivated Adult Stem Cells as Alternative for Damaged Tissue); European Commission: REBORNE (Regenerating BOne defects using New biomedical Engineering approaches); University Centre of Musculoskelettal Research, Ulm, Germany)	This work was supported by grants from the 7th Framework Program of the European Commission: CASCADE (Cultivated Adult Stem Cells as Alternative for Damaged Tissue) (number 223236; HEALTH-F5-2009-223236) and REBORNE (Regenerating BOne defects using New biomedical Engineering approaches) (number HEALTH- 2009-1.4.2-241879), and the University Centre of Musculoskelettal Research, Ulm, Germany). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andrews PW, 2009, STEM CELL REV REP, V5, P301, DOI 10.1007/s12015-009-9085-x; Antunes M., 2007, J EUR UNION, V324, P121; Arpornmaeklong P, 2004, INT J ORAL MAX SURG, V33, P60, DOI 10.1054/ijom.2003.0492; Battula VL, 2008, DIFFERENTIATION, V76, P326, DOI 10.1111/j.1432-0436.2007.00225.x; Bernardo ME, 2011, BEST PRACT RES CL HA, V24, P73, DOI 10.1016/j.beha.2010.11.002; Bieback K, 2009, STEM CELLS, V27, P2331, DOI 10.1002/stem.139; Buhring HJ, 2009, ANN NY ACAD SCI, V1176, P124, DOI 10.1111/j.1749-6632.2009.04564.x; Bundes_aerztekammer, 2010, RICHTL GEW BLUT BLUT; CAPLAN AI, 1994, CLIN PLAST SURG, V21, P429; Dominici M, 2006, CYTOTHERAPY, V8, P315, DOI 10.1080/14653240600855905; European Commission, 2003, OJ L, V262, P1422; EuropeanCommission, 2002, OFFICIAL J EUROPEA L, V45, P30; FDA, 2011, GUID IND CURR GOOD T; Fekete N, 2012, CYTOTHERAPY, V14, P540, DOI 10.3109/14653249.2012.655420; Henschler R, 2008, TRANSFUS MED HEMOTH, V35, P306, DOI 10.1159/000143110; Horwitz EM, 2008, CYTOTHERAPY, V10, P771, DOI 10.1080/14653240802618085; Hwang JH, 2009, J KOREAN MED SCI, V24, P547, DOI 10.3346/jkms.2009.24.4.547; Phinney DG, 1999, J CELL BIOCHEM, V75, P424, DOI 10.1002/(SICI)1097-4644(19991201)75:3<424::AID-JCB8>3.0.CO;2-8; Rojewski MT, 2008, TRANSFUS MED HEMOTH, V35, P168, DOI 10.1159/000129013; Sensebe L, 2010, VOX SANG, V98, P93, DOI 10.1111/j.1423-0410.2009.01227.x; Siddappa R, 2007, J ORTHOP RES, V25, P1029, DOI 10.1002/jor.20402; Spaeth EL, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004992; Subbanna PKT, 2007, MED HYPOTHESES, V69, P469, DOI 10.1016/j.mehy.2006.12.016; Tarte K, 2010, BLOOD, V115, P1549, DOI 10.1182/blood-2009-05-219907; Tautzenberger A, 2010, BIOMATERIALS, V31, P2064, DOI 10.1016/j.biomaterials.2009.11.099; Tolar J, 2010, STEM CELLS, V28, P1446, DOI 10.1002/stem.459; Vogel JP, 2006, PLATELETS, V17, P462, DOI 10.1080/09537100600758867; Wagner W, 2008, TRANSFUS MED HEMOTH, V35, P185, DOI 10.1159/000128956; Xia WJ, 2011, CELL BIOL INT, V35, P639, DOI 10.1042/CBI20100361; Zhukareva V, 2010, CYTOKINE, V50, P317, DOI 10.1016/j.cyto.2010.01.004	30	131	135	3	37	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 14	2012	7	8							e43255	10.1371/journal.pone.0043255	http://dx.doi.org/10.1371/journal.pone.0043255			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	988OQ	22905242	Green Published, Green Submitted, gold			2022-12-25	WOS:000307500800067
J	Costessi, A; Mahrour, N; Sharma, V; Stunnenberg, R; Stoel, MA; Tijchon, E; Conaway, JW; Conaway, RC; Stunnenberg, HG				Costessi, Adalberto; Mahrour, Nawel; Sharma, Vikram; Stunnenberg, Rieka; Stoel, Marieke A.; Tijchon, Esther; Conaway, Joan W.; Conaway, Ronald C.; Stunnenberg, Hendrik G.			The Human EKC/KEOPS Complex Is Recruited to Cullin2 Ubiquitin Ligases by the Human Tumour Antigen PRAME	PLOS ONE			English	Article							PREFERENTIALLY EXPRESSED ANTIGEN; MYELOID-LEUKEMIA; MELANOMA PRAME; BREAST-CANCER; KEOPS COMPLEX; PROTEIN; PRPK; IDENTIFICATION; PROGRESSION; RELEVANCE	The human tumour antigen PRAME (preferentially expressed antigen in melanoma) is frequently overexpressed during oncogenesis, and high PRAME levels are associated with poor clinical outcome in a variety of cancers. However, the molecular pathways in which PRAME is implicated are not well understood. We recently characterized PRAME as a BC-box subunit of a Cullin2-based E3 ubiquitin ligase. In this study, we mined the PRAME interactome to a deeper level and identified specific interactions with OSGEP and LAGE3, which are human orthologues of the ancient EKC/KEOPS complex. By characterizing biochemically the human EKC complex and its interactions with PRAME, we show that PRAME recruits a Cul2 ubiquitin ligase to EKC. Moreover, EKC subunits associate with PRAME target sites on chromatin. Our data reveal a novel link between the oncoprotein PRAME and the conserved EKC complex and support a role for both complexes in the same pathways.	[Costessi, Adalberto; Sharma, Vikram; Stunnenberg, Rieka; Stoel, Marieke A.; Tijchon, Esther; Stunnenberg, Hendrik G.] Radboud Univ Nijmegen, Dept Mol Biol, Nijmegen Ctr Mol Life Sci, NL-6525 ED Nijmegen, Netherlands; [Mahrour, Nawel; Conaway, Joan W.; Conaway, Ronald C.] Stowers Inst Med Res, Kansas City, MO USA; [Conaway, Joan W.; Conaway, Ronald C.] Univ Kansas, Med Ctr, Dept Biochem & Mol Biol, Kansas City, KS 66103 USA	Radboud University Nijmegen; Stowers Institute for Medical Research; University of Kansas; University of Kansas Medical Center	Costessi, A (corresponding author), Radboud Univ Nijmegen, Dept Mol Biol, Nijmegen Ctr Mol Life Sci, NL-6525 ED Nijmegen, Netherlands.	H.Stunnenberg@ncmls.ru.nl	Stunnenberg, Hendrik G./D-6875-2012; Tijchon, Esther/A-1679-2016	Stunnenberg, Hendrik G./0000-0002-0066-1576; Conaway, Joan/0000-0002-2786-0663	Dutch Cancer Society KWF; National Institute of General Medical Sciences [GM41628]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R37GM041628, R01GM041628] Funding Source: NIH RePORTER	Dutch Cancer Society KWF(KWF Kankerbestrijding); National Institute of General Medical Sciences(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	Work in the authors' laboratories was funded by Dutch Cancer Society KWF (to HGS) and by Grant GM41628 from the National Institute of General Medical Sciences (to RCC and JWC). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abe Y, 2001, J BIOL CHEM, V276, P44003, DOI 10.1074/jbc.M105669200; Allander SV, 2002, AM J PATHOL, V161, P1587, DOI 10.1016/S0002-9440(10)64437-9; Alpen B, 2002, GENE, V297, P141, DOI 10.1016/S0378-1119(02)00879-X; Costessi A, 2011, EMBO J, V30, P3786, DOI 10.1038/emboj.2011.262; Daugeron MC, 2011, NUCLEIC ACIDS RES, V39, P6148, DOI 10.1093/nar/gkr178; Doolan P, 2008, BREAST CANCER RES TR, V109, P359, DOI 10.1007/s10549-007-9643-3; Downey M, 2006, CELL, V124, P1155, DOI 10.1016/j.cell.2005.12.044; El Yacoubi B, 2011, EMBO J, V30, P882, DOI 10.1038/emboj.2010.363; Epping MT, 2008, BRIT J CANCER, V99, P398, DOI 10.1038/sj.bjc.6604494; Epping MT, 2005, CELL, V122, P835, DOI 10.1016/j.cell.2005.07.003; Facchin S, 2007, CELL MOL LIFE SCI, V64, P2680, DOI 10.1007/s00018-007-7179-7; Facchin S, 2003, FEBS LETT, V549, P63, DOI 10.1016/S0014-5793(03)00770-1; Galperin MY, 2008, ENVIRON MICROBIOL, V10, P281, DOI 10.1111/j.1462-2920.2007.01552.x; Haqq C, 2005, P NATL ACAD SCI USA, V102, P6092, DOI 10.1073/pnas.0501564102; Hecker A, 2008, EMBO J, V27, P2340, DOI 10.1038/emboj.2008.157; Ikeda H, 1997, IMMUNITY, V6, P199, DOI 10.1016/S1074-7613(00)80426-4; Ikeda S, 2002, BIOCHEM BIOPH RES CO, V296, P785, DOI 10.1016/S0006-291X(02)00939-7; Kilpinen S, 2008, GENOME BIOL, V9, DOI 10.1186/gb-2008-9-9-r139; Kisseleva-Romanova E, 2006, EMBO J, V25, P3576, DOI 10.1038/sj.emboj.7601235; Mahrour N, 2008, J BIOL CHEM, V283, P8005, DOI 10.1074/jbc.M706987200; Mao DYL, 2008, MOL CELL, V32, P259, DOI 10.1016/j.molcel.2008.10.002; Mariappan M, 2010, NATURE, V466, P1120, DOI 10.1038/nature09296; Miyoshi A, 2003, BIOCHEM BIOPH RES CO, V303, P399, DOI 10.1016/S0006-291X(03)00333-4; Oberthuer A, 2004, CLIN CANC RES; Partheen K, 2008, INT J CANCER, V123, P2130, DOI 10.1002/ijc.23758; Radich JP, 2006, P NATL ACAD SCI USA, V103, P2794, DOI 10.1073/pnas.0510423103; Reinders J, 2006, J PROTEOME RES, V5, P1543, DOI 10.1021/pr050477f; Santamaria C, 2008, HAEMATOL-HEMATOL J, V93, P1797, DOI 10.3324/haematol.13214; Srinivasan M, 2011, EMBO J, V30, P873, DOI 10.1038/emboj.2010.343; Steinbach D, 2007, CANCER GENET CYTOGEN, V177, P51, DOI 10.1016/j.cancergencyto.2007.05.011; Tajeddine N, 2005, CANCER RES, V65, P7348, DOI 10.1158/0008-5472.CAN-04-4011; Tanaka N, 2011, LEUKEMIA RES, V35, P1219, DOI 10.1016/j.leukres.2011.04.005; Wang QY, 2011, MOL CELL, V42, P758, DOI 10.1016/j.molcel.2011.05.010; Xu Z, 2008, NAT STRUCT MOL BIOL, V15, P1309, DOI 10.1038/nsmb.1518; Yarian C, 2002, J BIOL CHEM, V277, P16391, DOI 10.1074/jbc.M200253200	35	35	40	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 13	2012	7	8							e42822	10.1371/journal.pone.0042822	http://dx.doi.org/10.1371/journal.pone.0042822			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	988OJ	22912744	Green Submitted, gold, Green Published			2022-12-25	WOS:000307500100034
J	Fradet, S; Pierredon, S; Ribaux, P; Epiney, M; Ya, KS; Irion, O; Cohen, M				Fradet, Sarah; Pierredon, Sandra; Ribaux, Pascale; Epiney, Manuella; Ya, Kazuo Shin; Irion, Olivier; Cohen, Marie			Involvement of Membrane GRP78 in Trophoblastic Cell Fusion	PLOS ONE			English	Article							PLACENTAL BEWO CELLS; INTERCELLULAR FUSION; DIFFERENTIATION; PROTEIN; SYNCYTIN; CYTOTROPHOBLAST; PREECLAMPSIA; APOPTOSIS; CANCER; SYNCYTIALISATION	Background: Glucose-regulated protein 78 (GRP78) is highly expressed in first trimester cytrophoblastic cells (CTBs), especially in syncytiotrophoblast (STB). However, the role of GRP78 in these cells has never been investigated. Methodology/Principal Findings: In this study, we have examined the role of GRP78 in trophoblast fusion using the Bewo choriocarcinoma cell line as a model of cytotrophoblast fusion. Down regulation of GRP78 by siRNA or chemical inhibitors and use of antibodies against GRP78 in culture medium significantly decreased forskolin-induced fusion capacity of Bewo cells suggesting the involvement of membrane GRP78 in trophoblast fusion. GRP78 expression was also studied in preeclamptic (PE) CTBs which are known to have lower fusion capacity compared to control CTBs. Interestingly, despite the increase of GRP78 mRNA in PE CTBs, membrane GRP78 is significantly decreased in PE CTBs compared to control CTBs, suggesting that relocation of GRP78 from the endoplasmic reticulum to cell surface is probably altered in PE CTBs. Conclusions: Our results imply that membrane GRP78 could play an important role in syncytialisation. They also suggest that deregulation of GRP78 expression or relocation at cell surface might be involved in pregnancy complication associated with defective syncytialisation, such as preeclampsia.	[Fradet, Sarah; Pierredon, Sandra; Ribaux, Pascale; Epiney, Manuella; Irion, Olivier; Cohen, Marie] Fac Med, Dept Gynecol, Geneva, Switzerland; [Ya, Kazuo Shin] Natl Inst Adv Ind Sci & Technol, Biomed Informat Res Ctr, Tokyo, Japan	University of Geneva; National Institute of Advanced Industrial Science & Technology (AIST)	Fradet, S (corresponding author), Fac Med, Dept Gynecol, Geneva, Switzerland.	marie.cohen@hcuge.ch	Shin-ya, Kazuo/L-9613-2018	Shin-ya, Kazuo/0000-0002-4702-0661; cohen, marie/0000-0003-4621-5464	Swiss National Funds [31003A-127392]; HUG [PRD 10-I-11]	Swiss National Funds(Swiss National Science Foundation (SNSF)); HUG	This work was supported by the Swiss National Funds (31003A-127392; www.snf.ch) and HUG (PRD 10-I-11). The funders had no role in study design, data collection, and analysis, decision to publish, or preparation of the manuscript.	ADLER RR, 1995, BIOL REPROD, V53, P905, DOI 10.1095/biolreprod53.4.905; Al-Nasiry S, 2006, HUM REPROD, V21, P193, DOI 10.1093/humrep/dei272; ALEXANDRE S, 1991, MOL ENDOCRINOL, V5, P1862, DOI 10.1210/mend-5-12-1862; Arnaudeau S, 2009, PROTEOMICS, V9, P5316, DOI 10.1002/pmic.200800865; Bischof P, 1995, Early Pregnancy, V1, P263; Bischof P, 2005, INT J BIOCHEM CELL B, V37, P1, DOI 10.1016/j.biocel.2004.05.014; Burikhanov R, 2009, CELL, V138, P377, DOI 10.1016/j.cell.2009.05.022; Daoud G, 2005, J PHYSIOL-LONDON, V566, P409, DOI 10.1113/jphysiol.2005.089326; Das M, 2004, PLACENTA, V25, P396, DOI 10.1016/j.placenta.2003.11.004; Delidaki M, 2011, MOL CELL ENDOCRINOL, V332, P213, DOI 10.1016/j.mce.2010.10.013; Dudek J, 2009, CELL MOL LIFE SCI, V66, P1556, DOI 10.1007/s00018-009-8745-y; Ferretti C, 2007, HUM REPROD UPDATE, V13, P121, DOI 10.1093/humupd/dml048; Fu Y, 2006, CANCER BIOL THER, V5, P741, DOI 10.4161/cbt.5.7.2970; Gonzalez-Gronow M, 2009, ANTIOXID REDOX SIGN, V11, P2299, DOI [10.1089/ars.2009.2568, 10.1089/ARS.2009.2568]; Handwerger S, 2010, MOL CELL ENDOCRINOL, V323, P94, DOI 10.1016/j.mce.2009.12.015; Keryer G, 1998, J BIOL CHEM, V273, P34594, DOI 10.1074/jbc.273.51.34594; Kudo Y, 2003, BBA-MOL BASIS DIS, V1638, P63, DOI 10.1016/S0925-4439(03)00043-7; Kudo Y, 2003, BBA-MOL CELL RES, V1640, P25, DOI 10.1016/S0167-4889(03)00004-1; Langbein M, 2008, MOL REPROD DEV, V75, P175, DOI 10.1002/mrd.20729; Laverriere A, 2009, MOL HUM REPROD, V15, P569, DOI 10.1093/molehr/gap037; Lee AS, 2009, CANCER BIOL THER, V8, P2103, DOI 10.4161/cbt.8.22.10140; Li JZ, 2006, CURR MOL MED, V6, P45, DOI 10.2174/156652406775574523; Matthiesen L, 2005, CHEM IMMUNOL ALLERGY, V89, P49, DOI 10.1159/000087912; Mi S, 2000, NATURE, V403, P785, DOI 10.1038/35001608; Misra UK, 2005, J IMMUNOL, V174, P2092, DOI 10.4049/jimmunol.174.4.2092; Ni M, 2011, BIOCHEM J, V434, P181, DOI 10.1042/BJ20101569; Park HR, 2004, JNCI-J NATL CANCER I, V96, P1300, DOI 10.1093/jnci/djh243; Pfaffenbach KT, 2011, CURR OPIN CELL BIOL, V23, P150, DOI 10.1016/j.ceb.2010.09.007; Pollheimer J, 2005, PLACENTA, V26, pS21, DOI 10.1016/j.placenta.2004.11.013; Potgens AJG, 2004, HUM REPROD UPDATE, V10, P487, DOI 10.1093/humupd/dmh039; SHI QJ, 1993, ENDOCRINOLOGY, V132, P1387, DOI 10.1210/en.132.3.1387; Vaillancourt C, 2009, MINI-REV MED CHEM, V9, P962, DOI 10.2174/138955709788681663; Vargas A, 2011, REPROD SCI; WICE B, 1990, EXP CELL RES, V186, P306, DOI 10.1016/0014-4827(90)90310-7; Yoshie M, 2010, HUM REPROD, V25, P2229, DOI 10.1093/humrep/deq190; Zhang Y, 2010, J BIOL CHEM, V285, P15065, DOI 10.1074/jbc.M109.087445	36	26	27	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 9	2012	7	8							e40596	10.1371/journal.pone.0040596	http://dx.doi.org/10.1371/journal.pone.0040596			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	986WZ	22912664	Green Submitted, Green Published, gold			2022-12-25	WOS:000307378500002
J	Picard, M; Wright, KJ; Ritchie, D; Thomas, MM; Hepple, RT				Picard, Martin; Wright, Kathryn J.; Ritchie, Darmyn; Thomas, Melissa M.; Hepple, Russell T.			Mitochondrial Function in Permeabilized Cardiomyocytes Is Largely Preserved in the Senescent Rat Myocardium	PLOS ONE			English	Article							LEFT-VENTRICULAR MASS; CYTOCHROME-C RELEASE; CALORIC RESTRICTION; BROWN-NORWAY; AGING HEART; INTERFIBRILLAR MITOCHONDRIA; OXIDATIVE DAMAGE; SKELETAL-MUSCLE; FISCHER-344; CARDIOMYOPATHY	The aging heart is characterized by a progressive decline in contractile function and diastolic relaxation. Amongst the factors implicated in these changes is a progressive replacement fibrosis secondary to cardiomyoctye death, oxidative damage, and energetic deficit, each of which may be secondary to impaired mitochondrial function. Here, we performed an in-depth examination of mitochondrial function in saponin-permeabilized cardiomyocyte bundles, a preparation where all mitochondria are represented and their structure intact, from young adult (YA) and senescent (SEN) rats (n = 8 per group). When accounting for increased fibrosis (+19%, P<0.01) and proportional decrease in citrate synthase activity in the SEN myocardium (-23%, P<0.05), mitochondrial respiration and reactive oxygen species (H2O2) emission across a range of energized states was similar between age groups. Accordingly, the abundance of electron transport chain proteins was also unchanged. Likewise, except for CuZnSOD (-37%, P<0.05), the activity of antioxidant enzymes was unaltered with aging. Although time to mitochondrial permeability transition pore (mPTP) opening was decreased (-25%, P<0.05) in the SEN heart, suggesting sensitization to apoptotic stimuli, this was not associated with a difference in apoptotic index measured by ELISA. Collectively, our results suggest that the function of existing cardiac ventricular mitochondria is relatively preserved in SEN rat heart when measured in permeabilized cells.	[Picard, Martin; Hepple, Russell T.] McGill Univ, Dept Med, Dept Kinesiol, Montreal, PQ, Canada; [Wright, Kathryn J.; Ritchie, Darmyn; Thomas, Melissa M.] Univ Calgary, Fac Kinesiol, Muscle & Aging Lab, Calgary, AB, Canada	McGill University; University of Calgary	Picard, M (corresponding author), Univ Penn, Childrens Hosp Philadelphia, Ctr Mitochondrial & Epigen Med, Philadelphia, PA 19104 USA.	russell.hepple@mcgill.ca		Jacob, Kathryn/0000-0001-8373-5915; Picard, Martin/0000-0003-2835-0478; Hepple, Russell/0000-0003-3640-486X	Canadian Institutes for Health Research [MOP 57808, IAO 84673]; Natural Sciences and Engineering Research Council (NSERC)	Canadian Institutes for Health Research(Canadian Institutes of Health Research (CIHR)); Natural Sciences and Engineering Research Council (NSERC)(Natural Sciences and Engineering Research Council of Canada (NSERC))	This work was supported by operating grants from the Canadian Institutes for Health Research (MOP 57808 and IAO 84673 to Dr. Hepple). Dr. Picard is a CIHR fellow in Systems Biology and in Psychosocial Oncology and is supported by a scholarship from the Natural Sciences and Engineering Research Council (NSERC). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anderson EJ, 2006, AM J PHYSIOL-CELL PH, V290, pC844, DOI 10.1152/ajpcell.00402.2005; ANVERSA P, 1990, CIRC RES, V67, P871, DOI 10.1161/01.RES.67.4.871; Bancroft J.D., 1996, THEORY PRACTICE HIST, VVolume 6; Betik AC, 2009, AM J PHYSIOL-REG I, V297, pR744, DOI 10.1152/ajpregu.90959.2008; Boyle AJ, 2011, EXP GERONTOL, V46, P549, DOI 10.1016/j.exger.2011.02.010; Bratic I, 2010, BBA-BIOENERGETICS, V1797, P961, DOI 10.1016/j.bbabio.2010.01.004; Corsetti G, 2008, AM J CARDIOL, V101, p26E, DOI 10.1016/j.amjcard.2008.02.078; Dai DF, 2010, AGING CELL, V9, P536, DOI 10.1111/j.1474-9726.2010.00581.x; Dai DF, 2009, CIRCULATION, V119, P2789, DOI 10.1161/CIRCULATIONAHA.108.822403; Fannin SW, 1999, ARCH BIOCHEM BIOPHYS, V372, P399, DOI 10.1006/abbi.1999.1508; FROLKIS VV, 1988, GERONTOLOGY, V34, P64, DOI 10.1159/000212932; Gredilla R, 2001, FASEB J, V15, P1589, DOI 10.1096/fj.00-0764fje; Hacker TA, 2006, AM J PHYSIOL-HEART C, V290, pH304, DOI 10.1152/ajpheart.00290.2005; Hagen TM, 2002, ANN NY ACAD SCI, V959, P491, DOI 10.1111/j.1749-6632.2002.tb02119.x; Hansford RG, 1997, J BIOENERG BIOMEMBR, V29, P89, DOI 10.1023/A:1022420007908; Hofer T, 2009, MECH AGEING DEV, V130, P297, DOI 10.1016/j.mad.2009.01.004; Hood DA, 2001, J APPL PHYSIOL, V90, P1137, DOI 10.1152/jappl.2001.90.3.1137; Hua YN, 2011, BASIC RES CARDIOL, V106, P1173, DOI 10.1007/s00395-011-0222-8; Judge S, 2005, FASEB J, V19, P419, DOI 10.1096/fj.04-2622fje; Kajstura J, 1996, AM J PHYSIOL-HEART C, V271, pH1215, DOI 10.1152/ajpheart.1996.271.3.H1215; Kajstura J, 2010, CIRC RES, V107, P1374, DOI 10.1161/CIRCRESAHA.110.231498; Kakarla SK, 2010, J GERONTOL A-BIOL, V65, P147, DOI 10.1093/gerona/glp203; Kwak HB, 2006, FASEB J, V20, P791, DOI 10.1096/fj.05-5116fje; Lakatta EG, 2003, CIRCULATION, V107, P139, DOI 10.1161/01.CIR.0000048892.83521.58; Lemieux H, 2010, J GERONTOL A-BIOL, DOI [DOI 10.1093/GERONA/GLQ1141, 10.1093/gerona/glq1141]; Lesnefsky EJ, 2006, AGEING RES REV, V5, P402, DOI 10.1016/j.arr.2006.04.001; Lesnefsky EJ, 2001, J MOL CELL CARDIOL, V33, P37, DOI 10.1006/jmcc.2000.1273; LEVY D, 1990, NEW ENGL J MED, V322, P1561, DOI 10.1056/NEJM199005313222203; LEVY D, 1989, ANN INTERN MED, V110, P101, DOI 10.7326/0003-4819-110-2-101; Lipman RD, 1996, J GERONTOL A-BIOL, V51, pB54, DOI 10.1093/gerona/51A.1.B54; Ljubicic V, 2010, MECH AGEING DEV, V131, P79, DOI 10.1016/j.mad.2009.12.004; Mansouri A, 2006, MECH AGEING DEV, V127, P298, DOI 10.1016/j.mad.2005.11.004; MANZELMANN MS, 1987, MECH AGEING DEV, V39, P281, DOI 10.1016/0047-6374(87)90067-4; Miro O, 2000, CARDIOVASC RES, V47, P624, DOI 10.1016/S0008-6363(00)00122-X; Niemann B, 2010, CARDIOVASC RES, V88, P267, DOI 10.1093/cvr/cvq273; OLIVETTI G, 1991, CIRC RES, V68, P1560, DOI 10.1161/01.RES.68.6.1560; Ong SB, 2010, CARDIOVASC RES, V88, P16, DOI 10.1093/cvr/cvq237; Petrosillo G, 2010, J PINEAL RES, V48, P340, DOI 10.1111/j.1600-079X.2010.00758.x; Phaneuf S, 2002, AM J PHYSIOL-REG I, V282, pR423, DOI 10.1152/ajpregu.00296.2001; Picard M, 2011, J AGING RES, V2011; Picard M, 2008, AM J PHYSIOL-REG I, V295, pR659, DOI 10.1152/ajpregu.90357.2008; Picard M, 2011, J PHYSIOL-LONDON, V589, P4413, DOI 10.1113/jphysiol.2011.212712; Picard M, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018317; Picard Martin, 2010, Aging Cell, V9, P1032, DOI 10.1111/j.1474-9726.2010.00628.x; Sahin E, 2010, NATURE, V464, P520, DOI 10.1038/nature08982; Saks VA, 1998, MOL CELL BIOCHEM, V184, P81, DOI 10.1023/A:1006834912257; Seo AY, 2010, J CELL SCI, V123, P2533, DOI 10.1242/jcs.070490; Shinmura K, 2011, J MOL CELL CARDIOL, V50, P117, DOI 10.1016/j.yjmcc.2010.10.018; Skulachev VP, 2001, TRENDS BIOCHEM SCI, V26, P23, DOI 10.1016/S0968-0004(00)01735-7; St-Pierre J, 2006, CELL, V127, P397, DOI 10.1016/j.cell.2006.09.024; Tweedie C, 2011, AM J PHYSIOL-REG I, V300, pR544, DOI 10.1152/ajpregu.00250.2010; Twig G, 2008, EMBO J, V27, P433, DOI 10.1038/sj.emboj.7601963; VEKSLER VI, 1987, BIOCHIM BIOPHYS ACTA, V892, P191, DOI 10.1016/0005-2728(87)90174-5; Wallace DC, 2005, ANNU REV GENET, V39, P359, DOI 10.1146/annurev.genet.39.110304.095751; Wanagat J, 2002, J MOL CELL CARDIOL, V34, P17, DOI 10.1006/jmcc.2001.1483; Wohlgemuth SE, 2007, REJUV RES, V10, P281, DOI 10.1089/rej.2006.0535; Zhang D, 2005, CARDIOVASC PATHOL, V14, P61, DOI 10.1016/j.carpath.2005.01.006	57	23	23	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 9	2012	7	8							e43003	10.1371/journal.pone.0043003	http://dx.doi.org/10.1371/journal.pone.0043003			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	986WZ	22912774	Green Submitted, Green Published, gold			2022-12-25	WOS:000307378500035
J	Ratzka, C; Forster, F; Liang, CG; Kupper, M; Dandekar, T; Feldhaar, H; Gross, R				Ratzka, Carolin; Foerster, Frank; Liang, Chunguang; Kupper, Maria; Dandekar, Thomas; Feldhaar, Heike; Gross, Roy			Molecular Characterization of Antimicrobial Peptide Genes of the Carpenter Ant Camponotus floridanus	PLOS ONE			English	Article							HONEYBEE APIS-MELLIFERA; INSECT DEFENSIN; DROSOPHILA-MELANOGASTER; SEQUENCE ALIGNMENT; IMMUNE-RESPONSE; DRAFT GENOME; ALPHA-FACTOR; EVOLUTION; BLOCHMANNIA; TREE	The production of antimicrobial peptides (AMPs) is a major defense mechanism against pathogen infestation and of particular importance for insects relying exclusively on an innate immune system. Here, we report on the characterization of three AMPs from the carpenter ant Camponotus floridanus. Due to sequence similarities and amino acid composition these peptides can be classified into the cysteine-rich (e.g. defensin) and glycine-rich (e.g. hymenoptaecin) AMP groups, respectively. The gene and cDNA sequences of these AMPs were established and their expression was shown to be induced by microbial challenge. We characterized two different defensin genes. The defensin-2 gene has a single intron, whereas the defensin-1 gene has two introns. The deduced amino acid sequence of the C. floridanus defensins is very similar to other known ant defensins with the exception of a short C-terminal extension of defensin-1. The hymenoptaecin gene has a single intron and a very peculiar domain structure. The corresponding precursor protein consists of a signal- and a pro-sequence followed by a hymenoptaecin-like domain and six directly repeated hymenoptaecin domains. Each of the hymenoptaecin domains is flanked by an EAEP-spacer sequence and a RR-site known to be a proteolytic processing site. Thus, proteolytic processing of the multipeptide precursor may generate several mature AMPs leading to an amplification of the immune response. Bioinformatical analyses revealed the presence of hymenoptaecin genes with similar multipeptide precursor structure in genomes of other ant species suggesting an evolutionary conserved important role of this gene in ant immunity.	[Ratzka, Carolin; Kupper, Maria; Gross, Roy] Univ Wurzburg, Dept Microbiol, Bioctr, Wurzburg, Germany; [Foerster, Frank; Liang, Chunguang; Dandekar, Thomas] Univ Wurzburg, Dept Bioinformat, Bioctr, Wurzburg, Germany; [Feldhaar, Heike] Univ Bayreuth, Dept Anim Ecol 1, Bayreuth, Germany	University of Wurzburg; University of Wurzburg; University of Bayreuth	Ratzka, C (corresponding author), Univ Wurzburg, Dept Microbiol, Bioctr, Wurzburg, Germany.	carolin.ratzka@biozentrum.uni-wuerzburg.de	Dandekar, Thomas/A-4431-2017; Gross, Roy/I-3360-2014; Feldhaar, Heike/AAB-8678-2020; Förster, Frank/A-2181-2010	Dandekar, Thomas/0000-0003-1886-7625; Förster, Frank/0000-0003-4166-5423; Gross, Roy/0000-0002-5878-873X; Feldhaar, Heike/0000-0001-6797-5126	Deutsche Forschungsgemeinschaft (DFG) [GR1243/8-1]; EU COST (European Cooperation in Science and Technology) [FA0701]; Chancengleichheit fur Frauen in Forschung und Lehre; "Open Access Publishing'' program of the DFG; University of Wurzburg;  [SFB567/C2]	Deutsche Forschungsgemeinschaft (DFG)(German Research Foundation (DFG)); EU COST (European Cooperation in Science and Technology); Chancengleichheit fur Frauen in Forschung und Lehre; "Open Access Publishing'' program of the DFG; University of Wurzburg; 	This work was funded by the priority program SFB567/C2 and the grant GR1243/8-1 of the Deutsche Forschungsgemeinschaft (DFG), and by the EU COST (European Cooperation in Science and Technology) action FA0701 "Arthropod symbioses: from fundamental studies to pest management''. C. Ratzka was kindly supported by the program "Chancengleichheit fur Frauen in Forschung und Lehre''. The publication of this manuscript was funded by the "Open Access Publishing'' program of the DFG and the University of Wurzburg. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abascal F, 2010, NUCLEIC ACIDS RES, V38, pW7, DOI 10.1093/nar/gkq291; Bonasio R, 2010, SCIENCE, V329, P1068, DOI 10.1126/science.1192428; Brady SG, 2006, P NATL ACAD SCI USA, V103, P18172, DOI 10.1073/pnas.0605858103; Bulet P, 2004, IMMUNOL REV, V198, P169, DOI 10.1111/j.0105-2896.2004.0124.x; Cantarel BL, 2008, GENOME RES, V18, P188, DOI 10.1101/gr.6743907; CASTEELS P, 1993, J BIOL CHEM, V268, P7044; CASTEELSJOSSON K, 1994, J BIOL CHEM, V269, P28569; CASTEELSJOSSON K, 1993, EMBO J, V12, P1569, DOI 10.1002/j.1460-2075.1993.tb05801.x; Choi YS, 2008, COMP BIOCHEM PHYS B, V150, P141, DOI 10.1016/j.cbpb.2008.02.007; CORNET B, 1995, STRUCTURE, V3, P435, DOI 10.1016/S0969-2126(01)00177-0; Cremer S, 2007, CURR BIOL, V17, pR693, DOI 10.1016/j.cub.2007.06.008; DIMARCQ JL, 1994, EUR J BIOCHEM, V221, P201, DOI 10.1111/j.1432-1033.1994.tb18730.x; DMOCHOWSKA A, 1987, CELL, V50, P573, DOI 10.1016/0092-8674(87)90030-4; Duckert P, 2004, PROTEIN ENG DES SEL, V17, P107, DOI 10.1093/protein/gzh013; Durand D, 2006, J COMPUT BIOL, V13, P320, DOI 10.1089/cmb.2006.13.320; Edgar RC, 2004, NUCLEIC ACIDS RES, V32, P1792, DOI 10.1093/nar/gkh340; Evans JD, 2006, INSECT MOL BIOL, V15, P645, DOI 10.1111/j.1365-2583.2006.00682.x; Feldhaar H, 2008, MICROBES INFECT, V10, P1082, DOI 10.1016/j.micinf.2008.07.010; Feldhaar H, 2007, BMC BIOL, V5, DOI 10.1186/1741-7007-5-48; Froy O, 2003, TRENDS GENET, V19, P684, DOI 10.1016/j.tig.2003.10.010; FULLER RS, 1989, P NATL ACAD SCI USA, V86, P1434, DOI 10.1073/pnas.86.5.1434; Gadau J, 2012, TRENDS GENET, V28, P14, DOI 10.1016/j.tig.2011.08.005; Ganesan S, 2011, CURR TOP MICROBIOL, V349, P25, DOI 10.1007/82_2010_107; Gao B, 2010, PROCESS BIOCHEM, V45, P139, DOI 10.1016/j.procbio.2009.08.017; Gascuel O, 1997, MOL BIOL EVOL, V14, P685, DOI 10.1093/oxfordjournals.molbev.a025808; Gouy M, 2010, MOL BIOL EVOL, V27, P221, DOI 10.1093/molbev/msp259; Gruber CW, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0032559; Guindon S, 2010, SYST BIOL, V59, P307, DOI 10.1093/sysbio/syq010; Haine ER, 2008, SCIENCE, V322, P1257, DOI 10.1126/science.1165265; HEINZE J, 1994, NATURWISSENSCHAFTEN, V81, P34; JULIUS D, 1983, CELL, V32, P839, DOI 10.1016/0092-8674(83)90070-3; Klaudiny J, 2005, INSECT BIOCHEM MOLEC, V35, P11, DOI 10.1016/j.ibmb.2004.09.007; Lemaitre B, 2007, ANNU REV IMMUNOL, V25, P697, DOI 10.1146/annurev.immunol.25.022106.141615; Letunic I, 2007, BIOINFORMATICS, V23, P127, DOI 10.1093/bioinformatics/btl529; MagetDana R, 1997, BIOPHYS J, V73, P2527, DOI 10.1016/S0006-3495(97)78281-X; MASCHWITZ U, 1970, J INSECT PHYSIOL, V16, P387, DOI 10.1016/0022-1910(70)90180-0; MONNER DA, 1971, J BACTERIOL, V107, P420, DOI 10.1128/JB.107.2.420-432.1971; Nygaard S, 2011, GENOME RES, V21, P1339, DOI 10.1101/gr.121392.111; Ratzka C, 2011, INSECT BIOCHEM MOLEC, V41, P529, DOI 10.1016/j.ibmb.2011.03.002; Reddy KVR, 2004, INT J ANTIMICROB AG, V24, P536, DOI 10.1016/j.ijantimicag.2004.09.005; Sauer C, 2002, APPL ENVIRON MICROB, V68, P4187, DOI 10.1128/AEM.68.9.4187-4193.2002; Schluns H, 2009, MYRMECOL NEWS, V12, P237; Smith CR, 2011, P NATL ACAD SCI USA, V108, P5667, DOI 10.1073/pnas.1007901108; Smith CD, 2011, P NATL ACAD SCI USA, V108, P5673, DOI 10.1073/pnas.1008617108; Stanke M, 2008, BIOINFORMATICS, V24, P637, DOI 10.1093/bioinformatics/btn013; STEINER H, 1981, NATURE, V292, P246, DOI 10.1038/292246a0; Strand Michael R., 2008, Insect Science, V15, P1, DOI 10.1111/j.1744-7917.2008.00183.x; Street TO, 2006, J MOL BIOL, V360, P258, DOI 10.1016/j.jmb.2006.05.024; Suen G, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1002007; Talavera G, 2007, SYST BIOL, V56, P564, DOI 10.1080/10635150701472164; Tian CH, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-187; Vernot B, 2008, J COMPUT BIOL, V15, P981, DOI 10.1089/cmb.2008.0092; Viljakainen L, 2005, INSECT MOL BIOL, V14, P335, DOI 10.1111/j.1365-2583.2005.00564.x; Viljakainen L, 2008, J MOL EVOL, V67, P643, DOI 10.1007/s00239-008-9173-6; Wernegreen JJ, 2009, BMC EVOL BIOL, V9, DOI 10.1186/1471-2148-9-292; Xu P, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004239	56	17	18	1	27	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 9	2012	7	8							e43036	10.1371/journal.pone.0043036	http://dx.doi.org/10.1371/journal.pone.0043036			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	986WZ	22912782	Green Published, gold, Green Submitted			2022-12-25	WOS:000307378500037
J	Arias-Gonzalez, JR				Ricardo Arias-Gonzalez, J.			Entropy Involved in Fidelity of DNA Replication	PLOS ONE			English	Article							NONEQUILIBRIUM FLUCTUATIONS; POLYMERASE FIDELITY; SINGLE-MOLECULE; THERMODYNAMICS; INFORMATION; COMPUTATION; MODEL; DISSIPATION; MECHANISM; DYNAMICS	Information has an entropic character which can be analyzed within the framework of the Statistical Theory in molecular systems. R. Landauer and C. H. Bennett showed that a logical copy can be carried out in the limit of no dissipation if the computation is performed sufficiently slowly. Structural and recent single-molecule assays have provided dynamic details of polymerase machinery with insight into information processing. Here, we introduce a rigorous characterization of Shannon Information in biomolecular systems and apply it to DNA replication in the limit of no dissipation. Specifically, we devise an equilibrium pathway in DNA replication to determine the entropy generated in copying the information from a DNA template in the absence of friction. Both the initial state, the free nucleotides randomly distributed in certain concentrations, and the final state, a polymerized strand, are mesoscopic equilibrium states for the nucleotide distribution. We use empirical stacking free energies to calculate the probabilities of incorporation of the nucleotides. The copied strand is, to first order of approximation, a state of independent and non-indentically distributed random variables for which the nucleotide that is incorporated by the polymerase at each step is dictated by the template strand, and to second order of approximation, a state of non-uniformly distributed random variables with nearest-neighbor interactions for which the recognition of secondary structure by the polymerase in the resultant double-stranded polymer determines the entropy of the replicated strand. Two incorporation mechanisms arise naturally and their biological meanings are explained. It is known that replication occurs far from equilibrium and therefore the Shannon entropy here derived represents an upper bound for replication to take place. Likewise, this entropy sets a universal lower bound for the copying fidelity in replication.	[Ricardo Arias-Gonzalez, J.] Inst Madrileno Estudios Avanzados Nanociencia, Madrid, Spain; [Ricardo Arias-Gonzalez, J.] Ctr Nacl Biotecnol, Dept Macromol Struct, Madrid, Spain; [Ricardo Arias-Gonzalez, J.] Ctr Nacl Biotecnol, Inst Madrileno Estudios Avanzados Nanociencia, Associated Unit, Unidad Nanobiotecnol, Madrid, Spain	Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Centro Nacional de Biotecnologia (CNB); Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Centro Nacional de Biotecnologia (CNB)	Arias-Gonzalez, JR (corresponding author), Inst Madrileno Estudios Avanzados Nanociencia, Madrid, Spain.	ricardo.arias@imdea.org	Arias-Gonzalez, J. Ricardo/L-8538-2014	Arias-Gonzalez, J. Ricardo/0000-0001-6802-0874	Spanish Ministry of Science and Innovation [2007-01765]	Spanish Ministry of Science and Innovation(Ministry of Science and Innovation, Spain (MICINN)Spanish Government)	This work was funded by the Spanish Ministry of Science and Innovation (www.micinn.es) under the "Ramon y Cajal" program (Grant No. RYC- 2007-01765). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allawi HT, 1998, BIOCHEMISTRY-US, V37, P9435, DOI 10.1021/bi9803729; Andrieux D, 2008, P NATL ACAD SCI USA, V105, P9516, DOI 10.1073/pnas.0802049105; Andrieux D, 2009, J CHEM PHYS, V130, DOI 10.1063/1.3050099; BENNETT CH, 1979, BIOSYSTEMS, V11, P85, DOI 10.1016/0303-2647(79)90003-0; BENNETT CH, 1982, INT J THEOR PHYS, V21, P905, DOI 10.1007/BF02084158; BENNETT CH, 1973, IBM J RES DEV, V17, P525, DOI 10.1147/rd.176.0525; Berut A, 2012, NATURE, V483, P187, DOI 10.1038/nature10872; Cover TM, 1991, ELEMENTS OF INFORMAT; DAVIS BK, 1965, NATURE, V206, P183, DOI 10.1038/206183a0; Gaspard P, 2007, CR PHYS, V8, P598, DOI 10.1016/j.crhy.2007.05.002; Guajardo R, 1997, J MOL BIOL, V265, P8, DOI 10.1006/jmbi.1996.0707; HOPFIELD JJ, 1974, P NATL ACAD SCI USA, V71, P4135, DOI 10.1073/pnas.71.10.4135; Hormeno S, 2006, BIOL CELL, V98, P679, DOI 10.1042/BC20060036; Hormeno S, 2012, BIOPOLYMERS, V97, P199, DOI 10.1002/bip.21728; Huguet JM, 2010, P NATL ACAD SCI USA, V107, P15431, DOI 10.1073/pnas.1001454107; Ibarra B, 2009, EMBO J, V28, P2794, DOI 10.1038/emboj.2009.219; Johnson SJ, 2004, CELL, V116, P803, DOI 10.1016/S0092-8674(04)00252-1; Julicher F, 1998, BIOPHYS J, V74, P1169, DOI 10.1016/S0006-3495(98)77833-6; Kamtekar S, 2004, MOL CELL, V16, P609, DOI 10.1016/j.molcel.2004.10.019; Klump H. H., 2009, Transactions of the Royal Society of South Africa, V64, P73; Korzheva N, 2003, MOL MOTORS, P153; LANDAUER R, 1988, NATURE, V335, P779, DOI 10.1038/335779a0; Landauer R, 1961, ADV CHEM PHYS, V5, P183; Lee HR, 2006, J BIOL CHEM, V281, P36236, DOI 10.1074/jbc.M607964200; LOEB LA, 1982, ANNU REV BIOCHEM, V51, P429, DOI 10.1146/annurev.bi.51.070182.002241; Maxwell JC, 1871, THEORY OF HEAT; Morin JA, 2012, P NATL ACAD SCI USA, V109, P8115, DOI 10.1073/pnas.1204759109; Parrondo JMR, 2002, APPL PHYS A-MATER, V75, P179, DOI 10.1007/s003390201332; PETRUSKA J, 1986, P NATL ACAD SCI USA, V83, P1559, DOI 10.1073/pnas.83.6.1559; PETRUSKA J, 1988, P NATL ACAD SCI USA, V85, P6252, DOI 10.1073/pnas.85.17.6252; Ritort F, 2008, ADV CHEM PHYS, V137, P31; SantaLucia J, 2004, ANNU REV BIOPH BIOM, V33, P415, DOI 10.1146/annurev.biophys.32.110601.141800; SVOBODA K, 1994, CELL, V77, P773, DOI 10.1016/0092-8674(94)90060-4; Szilard L, 1929, Z PHYS, V53, P840, DOI 10.1007/BF01341281; VOLKENST.MV, 1961, DOKL AKAD NAUK SSSR+, V136, P1216; Wuite GJL, 2000, NATURE, V404, P103, DOI 10.1038/35003614; YIN H, 1995, SCIENCE, V270, P1653, DOI 10.1126/science.270.5242.1653	37	15	16	0	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 9	2012	7	8							e42272	10.1371/journal.pone.0042272	http://dx.doi.org/10.1371/journal.pone.0042272			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	986WZ	22912695	Green Published, gold, Green Submitted			2022-12-25	WOS:000307378500015
J	Zhang, WP; Yie, SM; Yue, BS; Zhou, JL; An, RX; Yang, JD; Chen, WL; Wang, CD; Zhang, L; Shen, FJ; Yang, GY; Hou, R; Zhang, ZH				Zhang, Wenping; Yie, Shangmian; Yue, Bisong; Zhou, Jielong; An, Renxiong; Yang, Jiangdong; Chen, Wangli; Wang, Chengdong; Zhang, Liang; Shen, Fujun; Yang, Guangyou; Hou, Rong; Zhang, Zhihe			Determination of Baylisascaris schroederi Infection in Wild Giant Pandas by an Accurate and Sensitive PCR/CESSCP Method	PLOS ONE			English	Article							CAPILLARY-ELECTROPHORESIS; QUANTIFICATION; POPULATION; FECES; PARASITES; BEAR; DNA	It has been recognized that other than habitat loss, degradation and fragmentation, the infection of the roundworm Baylisascaris schroederi (B. schroederi) is one of the major causes of death in wild giant pandas. However, the prevalence and intensity of the parasite infection has been inconsistently reported through a method that uses sedimentation-floatation followed by a microscope examination. This method fails to accurately determine infection because there are many bamboo residues and/or few B. schroederi eggs in the examined fecal samples. In the present study, we adopted a method that uses PCR and capillary electrophoresis combined with a single-strand conformation polymorphism analysis (PCR/CE-SSCP) to detect B. schroederi infection in wild giant pandas at a nature reserve, and compared it to the traditional microscope approach. The PCR specifically amplified a single band of 279-bp from both fecal samples and positive controls, which was confirmed by sequence analysis to correspond to the mitochondrial COII gene of B. schroederi. Moreover, it was demonstrated that the amount of genomic DNA was linearly correlated with the peak area of the CE-SSCP analysis. Thus, our adopted method can reliably detect the infectious prevalence and intensity of B. schroederi in wild giant pandas. The prevalence of B. schroederi was found to be 54% in the 91 fecal samples examined, and 48% in the fecal samples of 31 identified individual giant pandas. Infectious intensities of the 91 fecal samples were detected to range from 2.8 to 959.2 units/gram, and from 4.8 to 959.2 units/gram in the fecal samples of the 31 identified giant pandas. For comparison, by using the traditional microscope method, the prevalence of B. schroederi was found to be only 33% in the 91 fecal samples, 32% in the fecal samples of the 31 identified giant pandas, and no reliable infectious intensity was observed.	[Zhang, Wenping; Yie, Shangmian; An, Renxiong; Wang, Chengdong; Zhang, Liang; Shen, Fujun; Hou, Rong; Zhang, Zhihe] Chengdu Res Base Giant Panda Breeding, Sichuan Key Lab Conservat Biol Endangered Wildlif, Chengdu, Sichuan, Peoples R China; [Yue, Bisong] Sichuan Univ, Coll Life Sci, Sichuan Key Lab Conservat Biol Endangered Wildlif, Chengdu 610064, Peoples R China; [Zhou, Jielong] SW Forestry Univ, Coll Life Sci, Kunming, Peoples R China; [Yang, Jiangdong; Yang, Guangyou] Sichuan Agr Univ, Coll Anim Sci, Yaan, Peoples R China; [Chen, Wangli] Tangjiahe Natl Nat Reserve, Guangyuan, Peoples R China	Sichuan University; Sichuan Agricultural University	Zhang, WP (corresponding author), Chengdu Res Base Giant Panda Breeding, Sichuan Key Lab Conservat Biol Endangered Wildlif, Chengdu, Sichuan, Peoples R China.	bsyue@yahoo.com; zhang_zoology@163.com			Sichuan Youth Science and Technology Foundation [09ZQ026-042]; National Basic Research Program of China (973 Project) [2009CB426311]; National Science and Technology Supporting Program [2012BAC01B06]	Sichuan Youth Science and Technology Foundation; National Basic Research Program of China (973 Project)(National Basic Research Program of China); National Science and Technology Supporting Program	This research was funded by Sichuan Youth Science and Technology Foundation (09ZQ026-042), National Basic Research Program of China (973 Project: 2009CB426311), and National Science and Technology Supporting Program (2012BAC01B06). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allen BL, 2011, CURR ZOOL, V57, P568, DOI 10.1093/czoolo/57.5.568; Carlsgart J, 2009, PARASITOL RES, V104, P939, DOI 10.1007/s00436-008-1307-7; DIERENFELD ES, 1982, J NUTR, V112, P636, DOI 10.1093/jn/112.4.636; Hu JC, 2001, RES GIANT PANDA; Lai Conglong, 1993, Chinese Journal of Veterinary Medicine, V19, P10; McINTOSH ALLEN, 1939, ZOOLOGICA [NEW YORK], V24, P355; Nielsen MK, 2010, VET PARASITOL, V174, P77, DOI 10.1016/j.vetpar.2010.08.007; Nielsen MK, 2008, INT J PARASITOL, V38, P443, DOI 10.1016/j.ijpara.2007.07.014; Park YS, 2006, ELECTROPHORESIS, V27, P3836, DOI 10.1002/elps.200600225; Rosalino LM, 2006, EUR J WILDLIFE RES, V52, P202, DOI 10.1007/s10344-006-0033-7; Rozsa L, 2000, J PARASITOL, V86, P228, DOI 10.1645/0022-3395(2000)086[0228:QPISOH]2.0.CO;2; Sambrook J., 2002, MOL CLONING LAB MANU; Schaller GB, 1984, GIANT PANDAS WOLONG; Shin GW, 2008, ANAL BIOCHEM, V383, P31, DOI 10.1016/j.ab.2008.08.021; Shin GW, 2010, BIOTECHNOL BIOENG, V106, P167, DOI 10.1002/bit.22646; Solberg KH, 2006, BIOL CONSERV, V128, P158, DOI 10.1016/j.biocon.2005.09.025; Tang YW, 1997, CLIN CHEM, V43, P2021; Valiere N, 2002, MOL ECOL NOTES, V2, P377, DOI 10.1046/j.1471-8286.2002.00228.x; Wu J, 1987, CHINESE J VET MED, V07, P9; WU J, 1985, VET SCI CHINA, V6, P21; Xie Y, 2011, GENE, V482, P59, DOI 10.1016/j.gene.2011.05.004; Xue KM, 1987, PAPERS DIS GIANT PAN; Yang JD, 2011, CURR ZOOL, V57, P717, DOI 10.1093/czoolo/57.6.717; Zhan XJ, 2006, CURR BIOL, V16, pR451, DOI 10.1016/j.cub.2006.05.042; Zhang JS, 2008, ECOHEALTH, V5, P6, DOI 10.1007/s10393-007-0139-8; Zhang L, 2011, J WILDLIFE DIS, V47, P164, DOI 10.7589/0090-3558-47.1.164; Zhang WP, 2009, ZOO BIOL, V28, P49, DOI 10.1002/zoo.20227; Zhang Z, 2006, GIANT PANDA EX SITU; Zhang Ze-Jun, 2002, Acta Ecologica Sinica, V22, P990	29	12	13	0	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 27	2012	7	7							e41995	10.1371/journal.pone.0041995	http://dx.doi.org/10.1371/journal.pone.0041995			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	981ER	22911871	Green Published, Green Submitted, gold			2022-12-25	WOS:000306950200144
J	Bohmann, F; Mirceska, A; Pfeilschifter, J; Lindhoff-Last, E; Steinmetz, H; Foerch, C; Pfeilschifter, W				Bohmann, Ferdinand; Mirceska, Ana; Pfeilschifter, Josef; Lindhoff-Last, Edelgard; Steinmetz, Helmuth; Foerch, Christian; Pfeilschifter, Waltraud			No Influence of Dabigatran Anticoagulation on Hemorrhagic Transformation in an Experimental Model of Ischemic Stroke	PLOS ONE			English	Article							DIRECT THROMBIN INHIBITOR; NONVALVULAR ATRIAL-FIBRILLATION; RE-LY TRIAL; TISSUE-PLASMINOGEN ACTIVATOR; INTRACEREBRAL HEMORRHAGE; ETEXILATE; WARFARIN; THERAPY; PHARMACOKINETICS; PHARMACODYNAMICS	Background: Dabigatran etexilate (DE) is a new oral direct thrombin inhibitor. Clinical trials point towards a favourable risk-to-benefit profile of DE compared to warfarin. In this study, we evaluated whether hemorrhagic transformation (HT) occurs after experimental stroke under DE treatment as we have shown for warfarin. Methods: 44 male C57BL/6 mice were pretreated orally with 37.5 mg/kg DE, 75 mg/kg DE or saline and diluted thrombin time (dTT) and DE plasma concentrations were monitored. Ischemic stroke was induced by transient middle cerebral artery occlusion (tMCAO) for 1 h or 3 h. We assessed functional outcome and HT blood volume 24 h and 72 h after tMCAO. Results: After 1 h tMCAO, HT blood volume did not differ significantly between mice pretreated with DE 37.5 mg/kg and controls (1.5 +/- 0.5 mu l vs. 1.8 +/- 0.5 mu l, p > 0.05). After 3 h tMCAO, DE-anticoagulated mice did also not show an increase in HT, neither at the dose of 37.5 mg/kg equivalent to anticoagulant treatment in the therapeutic range (1.3 +/- 0.9 mu l vs. control 2.3 +/- 0.5 mu l, p > 0.05) nor at 75 mg/kg, clearly representing supratherapeutic anticoagulation (1.8 +/- 0.8 mu l, p>0.05). Furthermore, no significant increase in HT under continued anticoagulation with DE 75 mg/kg could be found at 72 h after tMCAO for 1 h (1.7 +/- 0.9 mu l vs. control 1.6 +/- 0.4 mu l, p>0.05). Conclusion: Our experimental data suggest that DE does not significantly increase hemorrhagic transformation after transient focal cerebral ischemia in mice. From a translational viewpoint, this indicates that a continuation of DE anticoagulation in case of an ischemic stroke might be safe, but clearly, clinical data on this question are warranted.	[Bohmann, Ferdinand; Steinmetz, Helmuth; Foerch, Christian; Pfeilschifter, Waltraud] Goethe Univ Frankfurt, Dept Neurol, Univ Hosp, Frankfurt, Germany; [Mirceska, Ana; Pfeilschifter, Josef] Goethe Univ Frankfurt, Dept Gen Pharmacol & Toxicol, Univ Hosp, Frankfurt, Germany; [Lindhoff-Last, Edelgard] Goethe Univ Frankfurt, Dept Internal Med, Div Vasc Med, Univ Hosp, Frankfurt, Germany	Goethe University Frankfurt; Goethe University Frankfurt Hospital; Goethe University Frankfurt; Goethe University Frankfurt Hospital; Goethe University Frankfurt; Goethe University Frankfurt Hospital	Bohmann, F (corresponding author), Goethe Univ Frankfurt, Dept Neurol, Univ Hosp, Frankfurt, Germany.	w.pfeilschifter@med.uni-frankfurt.de	Pfeilschifter, Waltraud/K-6134-2012	Pfeilschifter, Waltraud/0000-0001-6935-8842				Britz, 2007, RQUBE VERSION 1 00 8; Brouns R, 2009, CLIN NEUROL NEUROSUR, V111, P483, DOI 10.1016/j.clineuro.2009.04.001; Chen JL, 2001, STROKE, V32, P2682, DOI 10.1161/hs1101.098367; Connolly SJ, 2009, NEW ENGL J MED, V361, P1139, DOI 10.1056/NEJMoa0905561; Demchuk AM, 1999, STROKE, V30, P34, DOI 10.1161/01.STR.30.1.34; Di Nisio M, 2005, NEW ENGL J MED, V353, P1028, DOI 10.1056/NEJMra044440; Dirnagl Ulrich Group Members of the MCAO-SOP, 2009, STANDARD OPERATING P; Eikelboom JW, 2011, CIRCULATION, V123, P2363, DOI 10.1161/CIRCULATIONAHA.110.004747; Ezekowitz MD, 2007, AM J CARDIOL, V100, P1419, DOI 10.1016/j.amjcard.2007.06.034; Hart RG, 2007, ANN INTERN MED, V146, P857, DOI 10.7326/0003-4819-146-12-200706190-00007; Kilkenny C, 2010, PLOS BIOL, V8, DOI 10.1371/journal.pbio.1000412; Kleinschnitz C, 2007, CIRCULATION, V115, P2323, DOI 10.1161/CIRCULATIONAHA.107.691279; Lauer A, 2011, CIRCULATION, V124, P1654, DOI 10.1161/CIRCULATIONAHA.111.035972; Lee CJ, 2011, BRIT J CLIN PHARMACO, V72, P581, DOI 10.1111/j.1365-2125.2011.03916.x; Liesenfeld KH, 2011, J THROMB HAEMOST, V9, P2168, DOI 10.1111/j.1538-7836.2011.04498.x; Mosesson MW, 2004, BIOPHYS CHEM, V110, P93, DOI 10.1016/j.bpc.2004.01.007; Nielsen VG, 2005, ACTA ANAESTH SCAND, V49, P222, DOI 10.1111/j.1399-6576.2005.00602.x; Oldgren J, 2011, ANN INTERN MED, V155, P660, DOI 10.7326/0003-4819-155-10-201111150-00004; Pfeilschifter W, 2011, STROKE, V42, P1116, DOI 10.1161/STROKEAHA.110.604652; Selim M, 2002, STROKE, V33, P2047, DOI 10.1161/01.STR.0000023577.65990.4E; Stangier J, 2008, CLIN PHARMACOKINET, V47, P285, DOI 10.2165/00003088-200847050-00001; Stangier J, 2007, BRIT J CLIN PHARMACO, V64, P292, DOI 10.1111/j.1365-2125.2007.02899.x; Tsakiris DA, 1999, THROMB HAEMOSTASIS, V81, P177, DOI 10.1055/s-0037-1614439; van Ryn J, 2010, THROMB HAEMOSTASIS, V103, P1116, DOI 10.1160/TH09-11-0758; Wienen W, 2007, THROMB HAEMOSTASIS, V98, P333, DOI 10.1160/TH07-02-0113; WOLF PA, 1991, STROKE, V22, P983, DOI 10.1161/01.STR.22.8.983	26	31	31	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 24	2012	7	7							e40804	10.1371/journal.pone.0040804	http://dx.doi.org/10.1371/journal.pone.0040804			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	978NX	22911709	Green Submitted, Green Published, gold			2022-12-25	WOS:000306751300015
J	Zhang, D; Li, XH; Chen, CC; Li, YY; Zhao, L; Jing, YY; Liu, W; Wang, XY; Zhang, Y; Xia, HF; Chang, YN; Gao, X; Yan, J; Ying, H				Zhang, Duo; Li, Xihua; Chen, Chuchu; Li, Yuyin; Zhao, Lei; Jing, Yanyan; Liu, Wei; Wang, Xiaoyun; Zhang, Ying; Xia, Hongfeng; Chang, Yaning; Gao, Xiang; Yan, Jun; Ying, Hao			Attenuation of p38-Mediated miR-1/133 Expression Facilitates Myoblast Proliferation during the Early Stage of Muscle Regeneration	PLOS ONE			English	Article							FIBROBLAST-GROWTH-FACTOR; SKELETAL-MUSCLE; CELL-PROLIFERATION; SATELLITE CELLS; SMALL RNAS; EXTRACELLULAR-MATRIX; MUSCULAR-DYSTROPHY; STEM-CELLS; DIFFERENTIATION; MICRORNAS	Myoblast proliferation following myotrauma is regulated by multiple factors including growth factors, signal pathways, transcription factors, and miRNAs. However, the molecular mechanisms underlying the orchestration of these regulatory factors remain unclear. Here we show that p38 signaling is required for miR-1/133a clusters transcription and both p38 activity and miR-1/133 expression are attenuated during the early stage of muscle regeneration in various animal models. Additionally, we show that both miR-1 and miR-133 reduce Cyclin D1 expression and repress myoblast proliferation by inducing G1 phase arrest. Furthermore, we demonstrate that miR-133 inhibits mitotic progression by targeting Sp1, which mediates Cyclin D1 transcription, while miR-1 suppresses G1/S phase transition by targeting Cyclin D1. Finally, we reveal that proproliferative FGF2, which is elevated during muscle regeneration, attenuates p38 signaling and miR-1/133 expression. Taken together, our results suggest that downregulation of p38-mediated miR-1/133 expression by FGF2 and subsequent upregulation of Sp1/Cyclin D1 contribute to the increased myoblast proliferation during the early stage of muscle regeneration.	[Zhang, Duo; Li, Yuyin; Jing, Yanyan; Liu, Wei; Wang, Xiaoyun; Zhang, Ying; Xia, Hongfeng; Ying, Hao] Chinese Acad Sci, Key Lab Nutr & Metab, Inst Nutr Sci, Shanghai Inst Biol Sci,Grad Sch, Shanghai, Peoples R China; [Li, Xihua; Zhao, Lei] Fudan Univ, Childrens Hosp, Dept Neuromuscular Dis, Shanghai 200433, Peoples R China; [Chen, Chuchu; Chang, Yaning] E China Univ Sci & Technol, Sch Biotechnol, Shanghai 200237, Peoples R China; [Gao, Xiang; Yan, Jun] Nanjing Univ, Model Anim Res Ctr, Nanjing, Jiangsu, Peoples R China; [Gao, Xiang; Yan, Jun] Nanjing Univ, MOE Key Lab Model Anim Dis Study, Nanjing, Jiangsu, Peoples R China; [Yan, Jun] Wenzhou Med Coll, Sch Life Sci, Zhejiang Prov Key Lab Technol & Applicat Model Or, Wenzhou, Peoples R China	Chinese Academy of Sciences; Shanghai Institutes for Biological Sciences, CAS; Fudan University; East China University of Science & Technology; Nanjing University; Nanjing University; Wenzhou Medical University	Zhang, D (corresponding author), Chinese Acad Sci, Key Lab Nutr & Metab, Inst Nutr Sci, Shanghai Inst Biol Sci,Grad Sch, Shanghai, Peoples R China.	yinghao@sibs.ac.cn	Zhang, Duo/U-6203-2019; Zhang, Duo/GYU-8678-2022; Yan, Jun/Q-3031-2017; Zhang, Duo/S-2034-2016	Yan, Jun/0000-0002-1303-1952; Wang, Xiaoyun/0000-0002-9900-740X; Zhang, Duo/0000-0003-0361-4174	Chinese Academy of Sciences [KSCX2-EW-R-09]; Ministry of Science and Technology of China [2009CB919000, 2010CB912500, 2010CB945100]; National Natural Science Foundation [30970587, 31070679]; Science and Technology Commission of Shanghai Municipality [10ZR1435000]; Fundamental Research Funds for the Central Universities; Shanghai Charity Foundation	Chinese Academy of Sciences(Chinese Academy of Sciences); Ministry of Science and Technology of China(Ministry of Science and Technology, China); National Natural Science Foundation(National Natural Science Foundation of China (NSFC)); Science and Technology Commission of Shanghai Municipality(Science & Technology Commission of Shanghai Municipality (STCSM)); Fundamental Research Funds for the Central Universities(Fundamental Research Funds for the Central Universities); Shanghai Charity Foundation	This work was supported by grants from the One Hundred Talents Program of the Chinese Academy of Sciences, the Ministry of Science and Technology of China (973 Program 2009CB919000, 2010CB912500, 2010CB945100), the National Natural Science Foundation (30970587, 31070679), the Science and Technology Commission of Shanghai Municipality (10ZR1435000), Knowledge Innovation Program of the Chinese Academy of Sciences (KSCX2-EW-R-09), the Fundamental Research Funds for the Central Universities (Jun Yan), and Shanghai Charity Foundation (The Special Fund for DMD). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ANDERSON JE, 1995, EXP CELL RES, V216, P325, DOI 10.1006/excr.1995.1041; Cacchiarelli D, 2010, CELL METAB, V12, P341, DOI 10.1016/j.cmet.2010.07.008; Calguner E, 2003, ANAT HISTOL EMBRYOL, V32, P54, DOI 10.1046/j.1439-0264.2003.00439.x; Care A, 2007, NAT MED, V13, P613, DOI 10.1038/nm1582; Chen CZ, 2004, SCIENCE, V303, P83, DOI 10.1126/science.1091903; Chen JF, 2006, NAT GENET, V38, P228, DOI 10.1038/ng1725; Chen JF, 2010, J CELL BIOL, V190, P867, DOI 10.1083/jcb.200911036; CLARKE MSF, 1993, J CELL SCI, V106, P121; Dhawan J, 2005, TRENDS CELL BIOL, V15, P666, DOI 10.1016/j.tcb.2005.10.007; DIMARIO J, 1989, SCIENCE, V244, P688, DOI 10.1126/science.2717945; Ebert MS, 2007, NAT METHODS, V4, P721, DOI 10.1038/NMETH1079; Eisenberg I, 2007, P NATL ACAD SCI USA, V104, P17016, DOI 10.1073/pnas.0708115104; Greco S, 2009, FASEB J, V23, P3335, DOI 10.1096/fj.08-128579; Guller I, 2010, J PHYSIOL-LONDON, V588, P4075, DOI 10.1113/jphysiol.2010.194175; HAUGK KL, 1995, J ANIM SCI, V73, P1972; Hawke TJ, 2001, J APPL PHYSIOL, V91, P534, DOI 10.1152/jappl.2001.91.2.534; Hui LJ, 2007, NAT GENET, V39, P741, DOI 10.1038/ng2033; Jiang SA, 2010, CANCER RES, V70, P3119, DOI 10.1158/0008-5472.CAN-09-4250; JOHNSON SE, 1995, EXP CELL RES, V219, P449, DOI 10.1006/excr.1995.1251; Lee RC, 2001, SCIENCE, V294, P862, DOI 10.1126/science.1065329; Lefaucheur JP, 1995, NEUROSCI LETT, V202, P121, DOI 10.1016/0304-3940(95)12223-0; Lemischka I, 1999, P NATL ACAD SCI USA, V96, P14193, DOI 10.1073/pnas.96.25.14193; Liu N, 2008, GENE DEV, V22, P3242, DOI 10.1101/gad.1738708; MALEY MAL, 1995, EXP CELL RES, V219, P169, DOI 10.1006/excr.1995.1217; Milasincic DJ, 1996, MOL CELL BIOL, V16, P5964; Perdiguero E, 2007, CELL CYCLE, V6, P1298, DOI 10.4161/cc.6.11.4315; Perdiguero E, 2007, EMBO J, V26, P1245, DOI 10.1038/sj.emboj.7601587; Qiu BY, 2010, DIABETES, V59, P256, DOI 10.2337/db09-0223; Ro S, 2006, BIOCHEM BIOPH RES CO, V351, P756, DOI 10.1016/j.bbrc.2006.10.105; Ruiz-Bonilla V, 2008, CELL CYCLE, V7, P2208, DOI 10.4161/cc.7.14.6273; Stefani G, 2008, NAT REV MOL CELL BIO, V9, P219, DOI 10.1038/nrm2347; Sun YT, 2010, J CELL BIOL, V189, P1157, DOI 10.1083/jcb.200912093; Sweetman D, 2008, DEV BIOL, V321, P491, DOI 10.1016/j.ydbio.2008.06.019; Townley-Tilson WHD, 2010, INT J BIOCHEM CELL B, V42, P1252, DOI 10.1016/j.biocel.2009.03.002; Warren GL, 2002, FASEB J, V16, P1630, DOI 10.1096/fj.02-0187fje; Xiao F, 2011, CELL RES, V21, P350, DOI 10.1038/cr.2010.144; Yablonka-Reuveni Z, 1999, J HISTOCHEM CYTOCHEM, V47, P23, DOI 10.1177/002215549904700104; Ying H, 2006, J CLIN INVEST, V116, P2972, DOI 10.1172/JCI28598; Yuasa K, 2008, CELL STRUCT FUNCT, V33, P163, DOI 10.1247/csf.08022; Zhang Y, 2010, CELL PHYSIOL BIOCHEM, V26, P991, DOI 10.1159/000324012	40	79	84	0	27	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 24	2012	7	7							e41478	10.1371/journal.pone.0041478	http://dx.doi.org/10.1371/journal.pone.0041478			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	978NX	22911796	Green Published, Green Submitted, gold			2022-12-25	WOS:000306751300046
J	Hillebrand, A; Post, JJ; Wurbs, D; Wahler, D; Lenders, M; Krzyzanek, V; Prufer, D; Gronover, CS				Hillebrand, Andrea; Post, Janina J.; Wurbs, David; Wahler, Daniela; Lenders, Malte; Krzyzanek, Vladislav; Pruefer, Dirk; Gronover, Christian Schulze			Down-Regulation of Small Rubber Particle Protein Expression Affects Integrity of Rubber Particles and Rubber Content in Taraxacum brevicorniculatum	PLOS ONE			English	Article							HEVEA-BRASILIENSIS; ELONGATION-FACTOR; PARTHENIUM-ARGENTATUM; SILENCING AFFECTS; LATEX; PRENYLTRANSFERASE; STABILITY; CDNA	The biosynthesis of rubber is thought to take place on the surface of rubber particles in laticifers, highly specialized cells that are present in more than 40 plant families. The small rubber particle protein (SRPP) has been supposed to be involved in rubber biosynthesis, and recently five SRPPs (TbSRPP1-5) were identified in the rubber-producing dandelion species Taraxacum brevicorniculatum. Here, we demonstrate by immunogold labeling that TbSRPPs are localized to rubber particles, and that rubber particles mainly consist of TbSRPP3, 4 and 5 as shown by high-resolution two-dimensional gel electrophoresis and mass spectrometric analysis. We also carried out an RNA-interference approach in transgenic plants to address the function of TbSRPPs in rubber biosynthesis as well as rubber particle morphology and stability. TbSRPP-RNAi transgenic T. brevicorniculatum plants showed a 40-50% reduction in the dry rubber content, but neither the rubber weight average molecular mass nor the polydispersity of the rubber were affected. Although no phenotypical differences to wildtype particles could be observed in vivo, rubber particles from the TbSRPP-RNAi transgenic lines were less stable and tend to rapidly aggregate in expelling latex after wounding of laticifers. Our results prove that TbSRPPs are very crucial for rubber production in T. brevicorniculatum, probably by contributing to a most favourable and stable rubber particle architecture for efficient rubber biosynthesis and eventually storage.	[Hillebrand, Andrea; Post, Janina J.; Wurbs, David; Wahler, Daniela; Lenders, Malte; Pruefer, Dirk] Univ Munster, Inst Plant Biol & Biotechnol, Munster, Germany; [Krzyzanek, Vladislav] Univ Munster, Inst Med Phys & Biophys, Munster, Germany; [Hillebrand, Andrea; Pruefer, Dirk; Gronover, Christian Schulze] Fraunhofer Inst Mol Biol & Appl Ecol, Aachen, Germany; [Krzyzanek, Vladislav] Acad Sci Czech Republ, Inst Sci Instruments, Vvi, CS-61264 Brno, Czech Republic	University of Munster; University of Munster; Fraunhofer Gesellschaft; Czech Academy of Sciences; Institute of Scientific Instruments of the Czech Academy of Sciences	Hillebrand, A (corresponding author), Univ Munster, Inst Plant Biol & Biotechnol, Munster, Germany.	christian.schulze.gronover@ime.fraunhofer.de	Krzyzanek, Vladislav/C-6275-2008	Krzyzanek, Vladislav/0000-0002-7996-2979; Kanel, Andrea/0000-0002-1653-562X; Schulze Gronover, Christian/0000-0001-6398-2265	European Union Framework Program 7 [212827]; Deutsche Bundesstiftung Umwelt [AZ13255]; Ministry of Science and Education of Germany [FKZ 0315971C]	European Union Framework Program 7; Deutsche Bundesstiftung Umwelt; Ministry of Science and Education of Germany	This work was supported by a grant from the European Union Framework Program 7 (project no. 212827, EU-PEARLS), the Deutsche Bundesstiftung Umwelt (AZ13255) and the Ministry of Science and Education of Germany (grant no. FKZ 0315971C). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ARCHER BL, 1963, BIOCHEM J, V89, P565, DOI 10.1042/bj0890565; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; CORNISH K, 1990, PHYTOCHEMISTRY, V29, P3809, DOI 10.1016/0031-9422(90)85337-F; Cornish K, 1999, PLANTA, V210, P85, DOI 10.1007/s004250050657; Cornish K, 2001, PHYTOCHEMISTRY, V57, P1123, DOI 10.1016/S0031-9422(01)00097-8; DENNIS MS, 1989, J BIOL CHEM, V264, P18618; DENNIS MS, 1989, J BIOL CHEM, V264, P18608; Freitas AM, 2001, J COLLOID INTERF SCI, V233, P73, DOI 10.1006/jcis.2000.7218; Geer LY, 2004, J PROTEOME RES, V3, P958, DOI 10.1021/pr0499491; Genovese DB, 2001, FOOD HYDROCOLLOID, V15, P1, DOI 10.1016/S0268-005X(00)00053-9; Giasson S, 1998, LANGMUIR, V14, P891, DOI 10.1021/la960747w; GOMEZ J B, 1989, Journal of Natural Rubber Research, V4, P204; Grasso D., 2002, Re/Views in Environmental Science and Bio/Technology, V1, P17, DOI 10.1023/A:1015146710500; HELLER W, 1960, J POLYM SCI, V47, P203, DOI 10.1002/pol.1960.1204714918; HO CC, 1989, COLLOID POLYM SCI, V267, P643, DOI 10.1007/BF01410442; Jucker BA, 1998, ENVIRON SCI TECHNOL, V32, P2909, DOI 10.1021/es980211s; Kharel Y, 2003, NAT PROD REP, V20, P111, DOI 10.1039/b108934j; Kim IJ, 2004, J EXP BOT, V55, P377, DOI 10.1093/jxb/erh039; Kirschner J, 2013, GENET RESOUR CROP EV, V60, P455, DOI 10.1007/s10722-012-9848-0; Naumann B, 2005, J BIOL CHEM, V280, P20431, DOI 10.1074/jbc.M414486200; Oh SK, 1999, J BIOL CHEM, V274, P17132, DOI 10.1074/jbc.274.24.17132; Peng CC, 2003, BIOTECHNOL PROGR, V19, P1623, DOI 10.1021/bp034129z; Pfaffl MW, 2002, NUCLEIC ACIDS RES, V30, DOI 10.1093/nar/30.9.e36; Post J, 2012, PLANT PHYSIOL, V158, P1406, DOI 10.1104/pp.111.187880; POULTER CD, 1978, ACCOUNTS CHEM RES, V11, P307, DOI 10.1021/ar50128a004; POULTER CD, 1976, BIOCHEMISTRY-US, V15, P1079, DOI 10.1021/bi00650a019; Priya P, 2007, PLANT CELL REP, V26, P1833, DOI 10.1007/s00299-007-0402-z; Riddick T. M., 1968, ZETA METER MANUAL; Sando T, 2009, PLANTA, V230, P215, DOI 10.1007/s00425-009-0936-0; Sansatsadeekul J, 2011, J BIOSCI BIOENG, V111, P628, DOI 10.1016/j.jbiosc.2011.01.013; Schmidt T, 2010, BMC BIOCHEM, V11, DOI 10.1186/1471-2091-11-11; Schmidt T, 2010, PLANT MOL BIOL REP, V28, P277, DOI 10.1007/s11105-009-0145-9; Shevchenko A, 2006, NAT PROTOC, V1, P2856, DOI 10.1038/nprot.2006.468; Siler DJ, 1997, PLANT PHYSIOL BIOCH, V35, P881; SILER DJ, 1993, PHYTOCHEMISTRY, V32, P1097, DOI 10.1016/S0031-9422(00)95072-6; Singh AP, 2003, J EXP BOT, V54, P985, DOI 10.1093/jxb/erg107; TZEN JTC, 1992, J CELL BIOL, V117, P327, DOI 10.1083/jcb.117.2.327; VERWEY EJW, 1947, J PHYS COLLOID CHEM, V51, P631, DOI 10.1021/j150453a001; Wahler D, 2012, PROTEOMICS, V12, P901, DOI 10.1002/pmic.201000778; Wahler D, 2009, PLANT PHYSIOL, V151, P334, DOI 10.1104/pp.109.138743; Wood DF, 2000, INT J PLANT SCI, V161, P435, DOI 10.1086/314269	41	60	71	1	43	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 23	2012	7	7							e41874	10.1371/journal.pone.0041874	http://dx.doi.org/10.1371/journal.pone.0041874			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	977TM	22911861	Green Published, Green Submitted, gold			2022-12-25	WOS:000306687700161
J	De Conto, F; Di Lonardo, E; Arcangeletti, MC; Chezzi, C; Medici, MC; Calderaro, A				De Conto, Flora; Di Lonardo, Enrica; Arcangeletti, Maria Cristina; Chezzi, Carlo; Medici, Maria Cristina; Calderaro, Adriana			Highly Dynamic Microtubules Improve the Effectiveness of Early Stages of Human Influenza A/NWS/33 Virus Infection in LLC-MK2 Cells	PLOS ONE			English	Article							SWINE-FEVER VIRUS; VIRAL INTERACTIONS; EPITHELIAL-CELLS; TUBULIN; CYTOSKELETON; PROTEIN; TRANSPORT; ACTIN; ACETYLATION; AUTOPHAGY	Background: This study aims to investigate the role of microtubule dynamics in the initiation of NWS/33 human influenza A (NWS) virus infection in MDCK and LLC-MK2 mammalian kidney cells. We previously demonstrated a host-dependent role of the actin cytoskeleton in inducing restriction during the early phases of NWS infection. Furthermore, we showed the differential infectious entry of NWS virus in the above mentioned cell models. Methodology/Principal Findings: By first employing a panel of microtubule-modulators, we evidenced that microtubule-stabilization negatively interferes with NWS replication in LLC-MK2 but not in MDCK cells. Conversely, microtubule-depolymerization improves NWS growth in LLC-MK2 but not in the MDCK model. By using immunofluorescence labelling and Western blotting analyses upon NWS infection in mammalian kidney cells, it was observed that the occurrence of alpha-tubulin hyperacetylation - a post-translational modified form suggestive of stable microtubules - was significantly delayed in LLC-MK2 when compared to MDCK cells. Furthermore, mock-infected LLC-MK2 cells were shown to have higher levels of both acetylated alpha-tubulin and microtubule-associated protein 4 (MAP4), the latter being essential for the maintenance of normal microtubule polymer levels in interphase epithelial cells. Finally, to obtain highly dynamic microtubules in LLC-MK2 cells, we knocked down the expression of MAP4 by using a RNA-mediated RNA interference approach. The results evidenced that MAP4 silencing improves NWS growth in LLC-MK2 cells. Conclusion: By evidencing the cell type-dependent regulatory role of microtubule dynamics on NWS replication in mammalian kidney cells, we demonstrated that microtubule-stabilization represents a restriction factor for the initiation of NWS infection in LLC-MK2 but not in MDCK cells.	[De Conto, Flora; Di Lonardo, Enrica; Arcangeletti, Maria Cristina; Chezzi, Carlo; Medici, Maria Cristina; Calderaro, Adriana] Univ Parma, Microbiol Sect, Dept Pathol & Lab Med, I-43100 Parma, Italy	University of Parma; University Hospital of Parma	De Conto, F (corresponding author), Univ Parma, Microbiol Sect, Dept Pathol & Lab Med, I-43100 Parma, Italy.	flora.deconto@unipr.it	De Conto, Flora/H-9760-2019	De Conto, Flora/0000-0002-0493-2353	Ministry of University and Scientific Research FIL (Parma); Italian Scientific Research Fund PRIN	Ministry of University and Scientific Research FIL (Parma); Italian Scientific Research Fund PRIN	This work was supported by grants from Ministry of University and Scientific Research FIL 2009 (Parma) and the Italian Scientific Research Fund PRIN 2008. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alonso C, 2001, J VIROL, V75, P9819, DOI 10.1128/JVI.75.20.9819-9827.2001; Amorim MJ, 2011, J VIROL, V85, P4143, DOI 10.1128/JVI.02606-10; Andersen SSL, 2000, TRENDS CELL BIOL, V10, P261, DOI 10.1016/S0962-8924(00)01786-4; Apodaca G, 2001, TRAFFIC, V2, P149, DOI 10.1034/j.1600-0854.2001.020301.x; Aprea S, 2006, J NEUROSCI, V26, P4054, DOI 10.1523/JNEUROSCI.0603-06.2006; Arcangeletti MC, 2008, ARCH VIROL, V153, P1209, DOI 10.1007/s00705-008-0103-0; Balasubramani M, 2011, MUTAT RES-GEN TOX EN, V722, P154, DOI 10.1016/j.mrgentox.2010.08.019; Bulinski JC, 1997, J CELL SCI, V110, P3055; BULINSKI JC, 1980, J CELL BIOL, V87, P802, DOI 10.1083/jcb.87.3.802; Cai DW, 2009, PLOS BIOL, V7, DOI 10.1371/journal.pbio.1000216; Cantin R, 2005, J VIROL, V79, P6577, DOI 10.1128/JVI.79.11.6577-6587.2005; Chang YC, 2008, MOL BIOL CELL, V19, P2147, DOI 10.1091/mbc.E07-12-1269; De Conto F, 2011, VIRUS RES, V155, P221, DOI 10.1016/j.virusres.2010.10.008; Dohner K, 2005, TRENDS MICROBIOL, V13, P320, DOI 10.1016/j.tim.2005.05.010; Downing KH, 2000, ANNU REV CELL DEV BI, V16, P89, DOI 10.1146/annurev.cellbio.16.1.89; Drewes G, 1998, TRENDS BIOCHEM SCI, V23, P307, DOI 10.1016/S0968-0004(98)01245-6; Fislova T, 2010, J VIROL, V84, P8691, DOI 10.1128/JVI.00813-10; Frampton AR, 2010, VET MICROBIOL, V141, P12, DOI 10.1016/j.vetmic.2009.07.035; Gao YS, 2007, MOL CELL BIOL, V27, P8637, DOI 10.1128/MCB.00393-07; Gao YS, 2010, J BIOL CHEM, V285, P11219, DOI 10.1074/jbc.M109.042754; Gilbert JM, 2003, J VIROL, V77, P2615, DOI 10.1128/JVI.77.4.2615-2622.2003; Glotzer JB, 2001, J VIROL, V75, P2421, DOI 10.1128/JVI.75.5.2421-2434.2001; Gross SP, 2007, CURR BIOL, V17, pR478, DOI 10.1016/j.cub.2007.04.025; Hait William N, 2006, Trans Am Clin Climatol Assoc, V117, P85; Hammond JW, 2008, CURR OPIN CELL BIOL, V20, P71, DOI 10.1016/j.ceb.2007.11.010; Holmfeldt P, 2002, CURR BIOL, V12, P1034, DOI 10.1016/S0960-9822(02)00897-7; Howell B, 1999, MOL BIOL CELL, V10, P105, DOI 10.1091/mbc.10.1.105; HUNZIKER W, 1990, EMBO J, V9, P3515, DOI 10.1002/j.1460-2075.1990.tb07560.x; Husain M, 2011, FEBS LETT, V585, P128, DOI 10.1016/j.febslet.2010.11.023; JOACHIMS M, 1995, VIROLOGY, V211, P451, DOI 10.1006/viro.1995.1427; Johannsen E, 2004, P NATL ACAD SCI USA, V101, P16286, DOI 10.1073/pnas.0407320101; Joseph RA, 2008, HEPATOLOGY, V47, P1745, DOI 10.1002/hep.22014; Jouvenet N, 2004, J VIROL, V78, P7990, DOI 10.1128/JVI.78.15.7990-8001.2004; Kannan H, 2009, J VIROL, V83, P6375, DOI 10.1128/JVI.02571-08; Lakadamyali M, 2003, P NATL ACAD SCI USA, V100, P9280, DOI 10.1073/pnas.0832269100; MANDELKOW E, 1995, CURR OPIN CELL BIOL, V7, P72, DOI 10.1016/0955-0674(95)80047-6; Matsuyama A, 2002, EMBO J, V21, P6820, DOI 10.1093/emboj/cdf682; Momose F, 2007, MICROBES INFECT, V9, P1422, DOI 10.1016/j.micinf.2007.07.007; Momose F, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021123; Naranatt PP, 2005, J VIROL, V79, P1191, DOI 10.1128/JVI.79.2.1191-1206.2005; Noda T, 2009, CELL DEATH DIFFER, V16, P984, DOI 10.1038/cdd.2009.54; Parker JSL, 2002, J VIROL, V76, P4483, DOI 10.1128/JVI.76.9.4483-4496.2002; PARYSEK LM, 1984, J CELL BIOL, V99, P2287, DOI 10.1083/jcb.99.6.2287; Perdiz D, 2011, CELL SIGNAL, V23, P763, DOI 10.1016/j.cellsig.2010.10.014; Quinones GB, 2011, MOL BIOL CELL, V22, P1045, DOI 10.1091/mbc.E10-06-0519; Radtke K, 2006, CELL MICROBIOL, V8, P387, DOI 10.1111/j.1462-5822.2005.00679.x; Reed NA, 2006, CURR BIOL, V16, P2166, DOI 10.1016/j.cub.2006.09.014; Seisenberger G, 2001, SCIENCE, V294, P1929, DOI 10.1126/science.1064103; Shaw ML, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.1000085; Smith GA, 2002, ANNU REV CELL DEV BI, V18, P135, DOI 10.1146/annurev.cellbio.18.012502.105920; Suikkanen S, 2003, J VIROL, V77, P10270, DOI 10.1128/JVI.77.19.10270-10279.2003; VANZEIJL MJAH, 1990, CELL REGUL, V1, P921, DOI 10.1091/mbc.1.12.921; Vaughan JC, 2009, BIOPHYS J, V97, P1647, DOI 10.1016/j.bpj.2009.07.011; Wade RH, 2009, MOL BIOTECHNOL, V43, P177, DOI 10.1007/s12033-009-9193-5; Wang QJ, 2006, J NEUROSCI, V26, P8057, DOI 10.1523/JNEUROSCI.2261-06.2006; Wang XM, 1996, J CELL BIOL, V132, P345, DOI 10.1083/jcb.132.3.345; Warren JC, 2007, CELL MOTIL CYTOSKEL, V64, P675, DOI 10.1002/cm.20215; Welte MA, 2010, CURR BIOL, V20, pR410, DOI 10.1016/j.cub.2010.03.018; Westermann S, 2003, NAT REV MOL CELL BIO, V4, P938, DOI 10.1038/nrm1260; Xie R, 2011, J BIOL CHEM, V286, P10367, DOI 10.1074/jbc.M110.206532; Xie R, 2010, BMC CELL BIOL, V11, DOI 10.1186/1471-2121-11-89; Yamauchi Y, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002316; Yedowitz JC, 2005, J VIROL, V79, P4730, DOI 10.1128/JVI.79.8.4730-4743.2005; Yoder A, 2011, J VIROL, V85, P3020, DOI 10.1128/JVI.02462-10; Zhou Z, 2009, AUTOPHAGY, V5, P321, DOI 10.4161/auto.5.3.7406	65	11	11	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 20	2012	7	7							e41207	10.1371/journal.pone.0041207	http://dx.doi.org/10.1371/journal.pone.0041207			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	977GL	22911759	Green Published, gold, Green Submitted			2022-12-25	WOS:000306644600055
J	Liu, XY; Yue, CX; Xu, Z; Shu, H; Pu, MJ; Yu, H; Shi, YM; Zhuang, LY; Xu, XH; Zhang, ZJ				Liu, Xiaoyan; Yue, Chunxian; Xu, Zhi; Shu, Hao; Pu, Mengjia; Yu, Hui; Shi, Yongmei; Zhuang, Liying; Xu, Xiaohui; Zhang, Zhijun			Association Study of Candidate Gene Polymorphisms with Amnestic Mild Cognitive Impairment in a Chinese Population	PLOS ONE			English	Article							ONSET ALZHEIMERS-DISEASE; SYNDROME CRITICAL REGION; LINKAGE DISEQUILIBRIUM; PLASMINOGEN-ACTIVATOR; PRECURSOR PROTEIN; TAU; BACE2; HOMOLOG; PLAU; MAPS	To investigate the relationship between amnestic mild cognitive impairment (aMCI) and candidate gene polymorphisms in a Chinese population, 116 aMCI patients and 93 normal controls were recruited. Multi-dimensional neuropsychological tests were used to extensively assess the cognitive functions of the subjects. MassARRAY and iPLEX systems were used to measure candidate single nucleotide polymorohisms (SNPs) and analyse allelic, genotypic or haplotypic distributions. The scores of the neuropsychological tests were significantly lower for the aMCI patients than for the normal controls. The distributions of SNPs relating to the amyloid cascade hypothesis (TOMM40 rs157581 G and TOMM40 rs2075650 G), to the cholesterol metabolism hypothesis (ApoE rs429358 C, LDLR rs11668477 G and CH25H rs7091822 T and PLAU rs2227564 CT) and to the tau hypothesis (MAPT/STH rs242562 GG) in aMCI were significantly different than those in normal controls. Interactions were also found in aMCI amongst SNPs in LDLR rs11668477, PLAU rs2227564, and TOMM40 rs157581, between SNPs in TOMM40 rs157580 and BACE2 rs9975138. The study suggests that aMCI is characterised by memory impairment and associated with SNPs in three systems relating to the pathogenesis of AD-those of the amyloid cascade, tau and cholesterol metabolism pathways. Interactions were also observed between genes in the amyloid pathway and between the amyloid and cholesterol pathways.	[Liu, Xiaoyan; Yue, Chunxian; Shu, Hao; Pu, Mengjia; Yu, Hui; Shi, Yongmei; Zhuang, Liying; Xu, Xiaohui; Zhang, Zhijun] Southeast Univ, Sch Clin Med, Nanjing, Peoples R China; [Liu, Xiaoyan; Yue, Chunxian; Xu, Zhi; Shu, Hao; Pu, Mengjia; Shi, Yongmei; Zhuang, Liying; Xu, Xiaohui; Zhang, Zhijun] Southeast Univ, Dept Neurol, Affiliated ZhongDa Hosp, Nanjing, Peoples R China	Southeast University - China; Southeast University - China	Liu, XY (corresponding author), Southeast Univ, Sch Clin Med, Nanjing, Peoples R China.	zhijunzhang@seu.edu.cn			National Nature Science Foundation of China for the Excellent Young Scientist [30825014]; National Natural Science Foundation of China [81171021]	National Nature Science Foundation of China for the Excellent Young Scientist(National Natural Science Foundation of China (NSFC)); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This research was supported by the National Nature Science Foundation of China for the Excellent Young Scientist (No. 30825014 Zhijun Zhang) and National Natural Science Foundation of China (No. 81171021 Yongmei Shi). The funders had a role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Acquati F, 2000, FEBS LETT, V468, P59, DOI 10.1016/S0014-5793(00)01192-3; Akiyama H, 2000, NEUROBIOL AGING, V21, P383, DOI 10.1016/S0197-4580(00)00124-X; Benarroch EE, 2008, NEUROLOGY, V71, P1368, DOI 10.1212/01.wnl.0000333215.93440.36; Cheon MS, 2008, AMINO ACIDS, V35, P339, DOI 10.1007/s00726-007-0618-9; Ehehalt R, 2003, J CELL BIOL, V160, P113, DOI 10.1083/jcb.200207113; Farzan M, 2000, P NATL ACAD SCI USA, V97, P9712, DOI 10.1073/pnas.160115697; Finckh U, 2003, NEUROGENETICS, V4, P213, DOI 10.1007/s10048-003-0157-9; Gauthier S, 2006, LANCET, V367, P1262, DOI 10.1016/S0140-6736(06)68542-5; GLENNER GG, 1984, BIOCHEM BIOPH RES CO, V120, P885, DOI 10.1016/S0006-291X(84)80190-4; Gotz J, 2001, SCIENCE, V293, P1491, DOI 10.1126/science.1062097; Han MR, 2010, BMC NEUROL, V10, DOI 10.1186/1471-2377-10-90; Kimura R, 2007, HUM MOL GENET, V16, P15, DOI 10.1093/hmg/ddl437; Kivipelto M, 2002, ANN INTERN MED, V137, P149, DOI 10.7326/0003-4819-137-3-200208060-00006; Lamsa R, 2008, NEUROBIOL AGING, V29, P848, DOI 10.1016/j.neurobiolaging.2006.12.009; Lehmann DJ, 1997, HUM MOL GENET, V6, P1933, DOI 10.1093/hmg/6.11.1933; Park K, 2010, J LEUKOCYTE BIOL, V88, P1081, DOI 10.1189/jlb.0610318; PERRY EK, 1986, BRIT MED BULL, V42, P63, DOI 10.1093/oxfordjournals.bmb.a072100; Petersen RC, 1999, ARCH NEUROL-CHICAGO, V56, P303, DOI 10.1001/archneur.56.3.303; Rapoport M, 2002, P NATL ACAD SCI USA, V99, P6364, DOI 10.1073/pnas.092136199; Riemenschneider M, 2006, HUM MOL GENET, V15, P2446, DOI 10.1093/hmg/ddl167; Roses AD, 2010, PHARMACOGENOMICS J, V10, P375, DOI 10.1038/tpj.2009.69; Skipper L, 2004, AM J HUM GENET, V75, P669, DOI 10.1086/424492; Song WJ, 1996, GENOMICS, V38, P331, DOI 10.1006/geno.1996.0636; Wang JZ, 2007, EUR J NEUROSCI, V25, P59, DOI 10.1111/j.1460-9568.2006.05226.x; Wijsman EM, 2004, AM J HUM GENET, V75, P398, DOI 10.1086/423393; Yu CE, 2007, GENOMICS, V89, P655, DOI 10.1016/j.ygeno.2007.02.002	26	13	13	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 20	2012	7	7							e41198	10.1371/journal.pone.0041198	http://dx.doi.org/10.1371/journal.pone.0041198			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	977GL	22911757	gold, Green Published, Green Submitted			2022-12-25	WOS:000306644600053
J	Malmstrom, S; Larsson, SB; Hannoun, C; Lindh, M				Malmstrom, Sebastian; Larsson, Simon B.; Hannoun, Charles; Lindh, Magnus			Hepatitis B Viral DNA Decline at Loss of HBeAg Is Mainly Explained by Reduced cccDNA Load - Down-Regulated Transcription of PgRNA Has Limited Impact	PLOS ONE			English	Article							BASAL CORE PROMOTER; VIRUS-REPLICATION; PRECORE MUTATIONS; SURFACE-ANTIGEN; INHIBITION; INFECTION	Background: Quantification of hepatitis B virus (HBV) DNA and surface antigen (HBsAg) serum levels have become increasingly important for the assessment of clinical stage and response to treatment for chronic hepatitis B. Effective immune clearance results in reduction of viremia by 4-5 log units and HBsAg levels by 2 log, but these processes are not well understood. Thus, it is uncertain to what extent mechanisms that inhibit transcription of the pregenomic RNA (pgRNA), an RNA intermediate, contribute to suppression of viremia. Likewise, it is unclear if transcriptional regulation is important for the excessive production of surface antigen (HBsAg) that is a hallmark of HBV infection. Methods: HBV RNA and cccDNA were quantified in 19 liver biopsies from patients with chronic HBV infection, as well as in transfected Huh7.5 cells and in PLC/PRF/5 cells carrying integrated HBV genome. Results: Patients negative for HBeAg had 2.15 log lower levels of cccDNA in liver tissue, 4.84 log lower serum levels of HBV DNA and 1.45 log lower serum levels of HBsAg, than HBeAg-positive patients. The pgRNA in liver tissue correlated strongly with cccDNA (R-2 = 0.87, p<0.0001) and HBV DNA levels in serum (R-2 = 0.81, p<0.0001), whereas S-RNA correlated strongly with cccDNA (R-2 = 0.65, p<0.0001) and HBsAg levels (R-2 = 0.57, p = 0.0003). The S-RNA/pgRNA ratio was higher in HBeAg-negative patients (ratio 40 vs. 3, p = 0.01) and in PLC/PRF/5 cells, and was in transfected Huh7.5 cells not influenced by mutations in the HBV core promoter. Conclusion: The reduction of viremia that is observed after loss of HBeAg was mainly explained by reduced cccDNA load in the liver, whereas the contribution of down-regulation of pgRNA transcription was relatively small. Enhanced transcription of S-RNA does not explain excessive production of HBsAg.	[Malmstrom, Sebastian; Larsson, Simon B.; Hannoun, Charles; Lindh, Magnus] Univ Gothenburg, Dept Infect Dis, Gothenburg, Sweden	University of Gothenburg	Malmstrom, S (corresponding author), Univ Gothenburg, Dept Infect Dis, Gothenburg, Sweden.	magnus.lindh@microbio.gu.se	Larsson, Simon/AAA-8822-2020	Larsson, Simon/0000-0002-0964-6137	ALF-LUA [ALFGBG-146611]; Swedish Research Council [B0060901]	ALF-LUA; Swedish Research Council(Swedish Research CouncilEuropean Commission)	The project was funded by grants from ALF-LUA (grant ALFGBG-146611) and the Swedish Research Council (grant B0060901). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BRUSS V, 1991, P NATL ACAD SCI USA, V88, P1059, DOI 10.1073/pnas.88.3.1059; Chan HLY, 2011, J HEPATOL, V55, P1121, DOI 10.1016/j.jhep.2011.06.006; Chen CJ, 2006, JAMA-J AM MED ASSOC, V295, P65, DOI 10.1001/jama.295.1.65; Chou YC, 2007, HEPATOLOGY, V46, P672, DOI 10.1002/hep.21726; Dandri M, 2008, HEPATOLOGY, V48, P1079, DOI 10.1002/hep.22469; Gordien E, 2001, J VIROL, V75, P2684, DOI 10.1128/JVI.75.6.2684-2691.2001; GUIDOTTI LG, 1994, P NATL ACAD SCI USA, V91, P3764, DOI 10.1073/pnas.91.9.3764; GUNTHER S, 1995, J VIROL, V69, P5437; Jammeh S, 2008, J GEN VIROL, V89, P901, DOI 10.1099/vir.0.83468-0; Laras A, 2002, VIROLOGY, V295, P86, DOI 10.1006/viro.2001.1352; Laras A, 2006, HEPATOLOGY, V44, P694, DOI 10.1002/hep.21299; Lee WM, 1997, NEW ENGL J MED, V337, P1733, DOI 10.1056/NEJM199712113372406; Levrero M, 2009, J HEPATOL, V51, P581, DOI 10.1016/j.jhep.2009.05.022; Lindh M, 2000, J VIRAL HEPATITIS, V7, P258; MACNAB GM, 1976, BRIT J CANCER, V34, P509, DOI 10.1038/bjc.1976.205; Nguyen T, 2010, J HEPATOL, V52, P508, DOI 10.1016/j.jhep.2010.01.007; Pollicino T, 2006, GASTROENTEROLOGY, V130, P823, DOI 10.1053/j.gastro.2006.01.001; Qin YL, 2011, J VIROL, V85, P10167, DOI 10.1128/JVI.00819-11; Shepard CW, 2006, EPIDEMIOL REV, V28, P112, DOI 10.1093/epirev/mxj009; Suri D, 2001, J HEPATOL, V35, P790, DOI 10.1016/S0168-8278(01)00215-X; Tacke F, 2004, J VIROL, V78, P8524, DOI 10.1128/JVI.78.16.8524-8535.2004; Thompson AJV, 2010, HEPATOLOGY, V51, P1933, DOI 10.1002/hep.23571; Tong Shuping, 2005, Int J Med Sci, V2, P2; Volz T, 2007, GASTROENTEROLOGY, V133, P843, DOI 10.1053/j.gastro.2007.06.057; Werle-Lapostolle B, 2004, GASTROENTEROLOGY, V126, P1750, DOI 10.1053/j.gastro.2004.03.018; Wursthorn K, 2006, HEPATOLOGY, V44, P675, DOI 10.1002/hep.21282	26	34	38	1	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 20	2012	7	7							e36349	10.1371/journal.pone.0036349	http://dx.doi.org/10.1371/journal.pone.0036349			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	977GL	22911677	Green Published, gold, Green Submitted			2022-12-25	WOS:000306644600001
J	Panneerdoss, S; Chang, YF; Buddavarapu, KC; Chen, HIH; Shetty, G; Wang, HZ; Chen, YD; Kumar, TR; Rao, MK				Panneerdoss, Subbarayalu; Chang, Yao-Fu; Buddavarapu, Kalyan C.; Chen, Hung-I Harry; Shetty, Gunapala; Wang, Huizhen; Chen, Yidong; Kumar, T. Rajendra; Rao, Manjeet K.			Androgen-Responsive MicroRNAs in Mouse Sertoli Cells	PLOS ONE			English	Article							TESTIS BARRIER DYNAMICS; PROTEIN-KINASE; GENE-EXPRESSION; HOMEOBOX GENE; SPERMATOGENESIS; RECEPTOR; BIOGENESIS; TRANSCRIPTION; KNOCKOUT; SUBUNIT	Although decades of research have established that androgen is essential for spermatogenesis, androgen's mechanism of action remains elusive. This is in part because only a few androgen-responsive genes have been definitively identified in the testis. Here, we propose that microRNAs - small, non-coding RNAs - are one class of androgen-regulated trans-acting factors in the testis. Specifically, by using androgen suppression and androgen replacement in mice, we show that androgen regulates the expression of several microRNAs in Sertoli cells. Our results reveal that several of these microRNAs are preferentially expressed in the testis and regulate genes that are highly expressed in Sertoli cells. Because androgen receptor-mediated signaling is essential for the pre- and post-meiotic germ cell development, we propose that androgen controls these events by regulating Sertoli/germ cell-specific gene expression in a microRNA-dependent manner.	[Panneerdoss, Subbarayalu; Chang, Yao-Fu; Buddavarapu, Kalyan C.; Chen, Hung-I Harry; Chen, Yidong; Rao, Manjeet K.] Univ Texas Hlth Sci Ctr San Antonio, Greehey Childrens Canc Res Inst, San Antonio, TX 78229 USA; [Shetty, Gunapala] Univ Texas MD Anderson Canc Ctr, Dept Expt Radiat Oncol, Houston, TX 77030 USA; [Wang, Huizhen; Kumar, T. Rajendra] Univ Kansas, Med Ctr, Dept Mol & Integrat Physiol, Kansas City, KS 66103 USA; [Rao, Manjeet K.] Univ Texas Hlth Sci Ctr San Antonio, Dept Cellular & Struct Biol, San Antonio, TX 78229 USA	University of Texas System; University of Texas Health San Antonio; University of Texas System; UTMD Anderson Cancer Center; University of Kansas; University of Kansas Medical Center; University of Texas System; University of Texas Health San Antonio	Panneerdoss, S (corresponding author), Univ Texas Hlth Sci Ctr San Antonio, Greehey Childrens Canc Res Inst, San Antonio, TX 78229 USA.	raom@uthscsa.edu		Shetty, Gunapala/0000-0001-5786-0667	National Institutes of Health (NIH) [R01, HD057118, P20 RR016475, R03 HD043945]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [R03HD043945, R01HD057118] Funding Source: NIH RePORTER; NATIONAL CENTER FOR RESEARCH RESOURCES [P20RR016475] Funding Source: NIH RePORTER	National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR))	MKR was supported by National Institutes of Health (NIH) R01 grant HD057118, and work in the TRK laboratory is supported in part by NIH grants P20 RR016475 and R03 HD043945. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amir AL, 2003, J BIOL CHEM, V278, P30828, DOI 10.1074/jbc.M301208200; Anway MD, 2003, BIOL REPROD, V68, P996, DOI 10.1095/biolreprod.102.008045; Bartel DP, 2004, CELL, V116, P281, DOI 10.1016/S0092-8674(04)00045-5; Bhardwaj A, 2008, MOL CELL BIOL, V28, P2138, DOI 10.1128/MCB.01170-07; Braun RE, 1998, SEMIN CELL DEV BIOL, V9, P483, DOI 10.1006/scdb.1998.0226; Chang YF, 2012, P NATL ACAD SCI USA, V109, P5750, DOI 10.1073/pnas.1117837109; Chang YF, 2011, BIOTECHNIQUES, V51, P341, DOI 10.2144/000113764; Chung SSW, 2004, DEV DYNAM, V230, P754, DOI 10.1002/dvdy.20083; Dahle MK, 2002, J BIOL CHEM, V277, P22902, DOI 10.1074/jbc.M200131200; Dean DM, 1996, MOL ENDOCRINOL, V10, P1489, DOI 10.1210/me.10.12.1489; Denolet E, 2006, MOL ENDOCRINOL, V20, P321, DOI 10.1210/me.2005-0113; Fix C, 2004, P NATL ACAD SCI USA, V101, P10919, DOI 10.1073/pnas.0404278101; Gregory CW, 2001, J ANDROL, V22, P537; Gye MC, 2003, ARCH ANDROLOGY, V49, P271, DOI [10.1080/713828170, 10.1080/01485010390204913]; Hayashi K, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001738; Imam JS, 2010, ONCOGENE IN PRESS, P223; King IA, 1996, J INVEST DERMATOL, V107, P531, DOI 10.1111/1523-1747.ep12582790; Krol J, 2010, NAT REV GENET, V11, P597, DOI 10.1038/nrg2843; Lewis BP, 2003, CELL, V115, P787, DOI 10.1016/S0092-8674(03)01018-3; Lie PPY, 2010, INT J BIOCHEM CELL B, V42, P975, DOI 10.1016/j.biocel.2010.02.010; Lu J, 2005, NATURE, V435, P834, DOI 10.1038/nature03702; Ma XP, 2004, P NATL ACAD SCI USA, V101, P17294, DOI 10.1073/pnas.0404743101; MacLean JA, 2005, CURR TOP DEV BIOL, V71, P131, DOI 10.1016/S0070-2153(05)71005-X; Nicholls PK, 2011, ENDOCRINOLOGY, V152, P1670, DOI 10.1210/en.2010-1341; Papaioannou MD, 2009, DEV BIOL, V326, P250, DOI 10.1016/j.ydbio.2008.11.011; Rao MK, 2003, MOL ENDOCRINOL, V17, P223, DOI 10.1210/me.2002-0232; Ro S, 2007, DEV BIOL, V311, P592, DOI 10.1016/j.ydbio.2007.09.009; Sassone-Corsi P, 2002, SCIENCE, V296, P2176, DOI 10.1126/science.1070963; Scobey MJ, 2001, ENDOCRINOLOGY, V142, P948, DOI 10.1210/en.142.2.948; Shetty G, 2000, ENDOCRINOLOGY, V141, P1735, DOI 10.1210/en.141.5.1735; Wang RS, 2006, ENDOCRINOLOGY, V147, P5624, DOI 10.1210/en.2006-0138; Wang RS, 2009, ENDOCR REV, V30, P119, DOI 10.1210/er.2008-0025; Wong CH, 2005, ENDOCRINOLOGY, V146, P1893, DOI 10.1210/en.2004-1464; Yu ZR, 2005, BIOL REPROD, V73, P427, DOI 10.1095/biolreprod.105.040998; Zhou Q, 2005, BIOL REPROD, V72, P1010, DOI 10.1095/biolreprod.104.035915	35	40	43	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 20	2012	7	7							e41146	10.1371/journal.pone.0041146	http://dx.doi.org/10.1371/journal.pone.0041146			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	977GL	22911753	Green Published, Green Submitted, gold			2022-12-25	WOS:000306644600049
J	Kim, W; Kim, SY; Kim, T; Kim, M; Bae, DJ; Choi, HI; Kim, IS; Jho, E				Kim, W.; Kim, S. Y.; Kim, T.; Kim, M.; Bae, D-J; Choi, H-I; Kim, I-S; Jho, E.			ADP-ribosylation factors 1 and 6 regulate Wnt/beta-catenin signaling via control of LRP6 phosphorylation	ONCOGENE			English	Article						ADP-ribosylation factor (Arf); Wnt; signal transduction; phosphatidylinositol 4,5 bisphosphate (PtdIns (4,5)P-2); LRP6	NUCLEOTIDE-EXCHANGE FACTORS; BETA-CATENIN; ARF FAMILY; ACTIVATION; MEMBRANE; PROTEINS; PATHWAY; COMPLEX; ENDOCYTOSIS; MECHANISM	It has been shown that inhibition of GTPase-activating protein of ADP-ribosylation factor (Arf), ArfGAP, with a small molecule (QS11) results in synergistic activation of Wnt/beta-catenin signaling. However, the role of Arf in Wnt/b-catenin signaling has not yet been elucidated. Here, we show that activation of Arf is essential for Wnt/beta-catenin signaling. The level of the active form of Arf (Arf-GTP) transiently increased in the presence of Wnt, and this induction event was abrogated by blocking the interaction between Wnt and Frizzled (Fzd). In addition, knockdown of Fzds, Dvls or LRP6 blocked the Wnt-mediated activation of Arf. Consistently, depletion of Arf led to inhibition of Wnt-mediated membrane PtdIns (4,5)P-2 (phosphatidylinositol 4,5-bisphosphate) synthesis and LRP6 phosphorylation. Overall, our data suggest that transient activation of Arf modulates LRP6 phosphorylation for the transduction of Wnt/beta-catenin signaling.	[Kim, W.; Kim, T.; Kim, M.; Jho, E.] Univ Seoul, Dept Life Sci, Seoul, South Korea; [Kim, S. Y.; Bae, D-J; Choi, H-I; Kim, I-S] Kyungpook Natl Univ, Sch Med, Dept Biochem & Cell Biol, Cell & Matrix Res Inst, Taegu 700422, South Korea; [Kim, I-S] Korea Inst Sci & Technol, Biomed Res Inst, Seoul, South Korea	University of Seoul; Kyungpook National University; Korea Institute of Science & Technology (KIST)	Kim, IS (corresponding author), Kyungpook Natl Univ, Sch Med, Dept Biochem & Cell Biol, Cell & Matrix Res Inst, 101 Dongin 2Ga, Taegu 700422, South Korea.	iskim@knu.ac.kr; ej70@uos.ac.kr	김, 인산/I-8988-2014	Jho, Eek-hoon/0000-0003-2414-6234; Choi, Hee-Jung/0000-0002-1167-1526	National Research Foundation of Korea; Ministry of Education, Science and Technology [2006-2004046, 2012R1A2A2A01012472, 2010-0029206, 2011-0003980]; Brain Korea 21 program	National Research Foundation of Korea(National Research Foundation of Korea); Ministry of Education, Science and Technology(Ministry of Education, Science & Technology (MEST), Republic of Korea); Brain Korea 21 program(Ministry of Education & Human Resources Development (MOEHRD), Republic of Korea)	This work was supported by grants from the National Research Foundation of Korea funded by the Ministry of Education, Science and Technology (2006-2004046 and 2012R1A2A2A01012472 to E-HJ; 2010-0029206 to I-SK; 2011-0003980 to S-YK). WK, TK, and MK were supported by the Brain Korea 21 program.	Bilic J, 2007, SCIENCE, V316, P1619, DOI 10.1126/science.1137065; Brummelkamp TR, 2002, SCIENCE, V296, P550, DOI 10.1126/science.1068999; Clevers H, 2006, CELL, V127, P469, DOI 10.1016/j.cell.2006.10.018; D'Souza-Schorey C, 2006, NAT REV MOL CELL BIO, V7, P347, DOI 10.1038/nrm1910; Davidson G, 2005, NATURE, V438, P867, DOI 10.1038/nature04170; Gagliardi M, 2008, TRAFFIC, V9, P1, DOI 10.1111/j.1600-0854.2007.00662.x; Giguere P, 2006, CELL SIGNAL, V18, P1988, DOI 10.1016/j.cellsig.2006.03.003; Gillingham AK, 2007, ANNU REV CELL DEV BI, V23, P579, DOI 10.1146/annurev.cellbio.23.090506.123209; Godi A, 1999, NAT CELL BIOL, V1, P280, DOI 10.1038/12993; Hall B, 2008, ANAL BIOCHEM, V374, P243, DOI 10.1016/j.ab.2007.11.032; He X, 2004, DEVELOPMENT, V131, P1663, DOI 10.1242/dev.01117; Heo WD, 2006, SCIENCE, V314, P1458, DOI 10.1126/science.1134389; Honda A, 1999, CELL, V99, P521, DOI 10.1016/S0092-8674(00)81540-8; Hsieh JC, 1999, P NATL ACAD SCI USA, V96, P3546, DOI 10.1073/pnas.96.7.3546; Jackson CL, 2000, TRENDS CELL BIOL, V10, P60, DOI 10.1016/S0962-8924(99)01699-2; Kahn RA, 2006, J CELL BIOL, V172, P645, DOI 10.1083/jcb.200512057; Kumari S, 2008, NAT CELL BIOL, V10, P30, DOI 10.1038/ncb1666; Li VSW, 2012, CELL, V149, P1245, DOI 10.1016/j.cell.2012.05.002; Liu XX, 2005, CURR BIOL, V15, P1989, DOI 10.1016/j.cub.2005.10.050; Logan CY, 2004, ANNU REV CELL DEV BI, V20, P781, DOI 10.1146/annurev.cellbio.20.010403.113126; MacDonald BT, 2008, J BIOL CHEM, V283, P16115, DOI 10.1074/jbc.M800327200; MacDonald BT, 2009, DEV CELL, V17, P9, DOI 10.1016/j.devcel.2009.06.016; Naslavsky N, 2004, MOL BIOL CELL, V15, P3542, DOI 10.1091/mbc.E04-02-0151; Nishida K, 2011, J IMMUNOL, V187, P932, DOI 10.4049/jimmunol.1100360; Nishioka T, 2008, MOL BIOL CELL, V19, P4213, DOI 10.1091/mbc.E08-03-0315; Pan WJ, 2008, SCIENCE, V321, P1350, DOI 10.1126/science.1160741; Perez-Mansilla B, 2006, BBA-MOL CELL BIOL L, V1761, P1429, DOI 10.1016/j.bbalip.2006.09.006; Sakane H, 2010, J CELL SCI, V123, P360, DOI 10.1242/jcs.058008; Santy LC, 2001, J CELL BIOL, V154, P599, DOI 10.1083/jcb.200104019; Sawano A, 2000, Nucleic Acids Res, V28, pE78, DOI 10.1093/nar/28.16.e78; Shin HW, 2004, J BIOCHEM, V136, P761, DOI 10.1093/jb/mvh185; Suzuki T, 2006, MOL CELL BIOL, V26, P6149, DOI 10.1128/MCB.00298-06; Tamai K, 2004, MOL CELL, V13, P149, DOI 10.1016/S1097-2765(03)00484-2; Tiscornia G, 2003, P NATL ACAD SCI USA, V100, P1844, DOI 10.1073/pnas.0437912100; Willert K, 1999, GENE DEV, V13, P1768, DOI 10.1101/gad.13.14.1768; Wong HC, 2003, MOL CELL, V12, P1251, DOI 10.1016/S1097-2765(03)00427-1; Wu XM, 2008, CELL, V133, P340, DOI 10.1016/j.cell.2008.01.052; Yamamoto H, 2006, DEV CELL, V11, P213, DOI 10.1016/j.devcel.2006.07.003; Zeng X, 2005, NATURE, V438, P873, DOI 10.1038/nature04185; Zhang QS, 2007, P NATL ACAD SCI USA, V104, P7444, DOI 10.1073/pnas.0702136104	40	20	20	0	11	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232			ONCOGENE	Oncogene	JUL 11	2013	32	28					3390	3396		10.1038/onc.2012.373	http://dx.doi.org/10.1038/onc.2012.373			7	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	180TM	22907437				2022-12-25	WOS:000321620200009
J	Geng, H; Liu, Q; Xue, CH; David, LL; Beer, TM; Thomas, GV; Dai, MS; Qian, DZ				Geng, Hao; Liu, Qiong; Xue, Changhui; David, Larry L.; Beer, Tomasz M.; Thomas, George V.; Dai, Mu-Shui; Qian, David Z.			HIF1 alpha Protein Stability Is Increased by Acetylation at Lysine 709	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							HYPOXIA-INDUCIBLE FACTOR-1-ALPHA; TRANSCRIPTIONAL ACTIVITY; PROLINE HYDROXYLATION; HISTONE DEACETYLASES; FACTOR 1-ALPHA; TUMOR-GROWTH; HIF-1-ALPHA; DEGRADATION; VHL; PATHWAY	Lysine acetylation regulates protein stability and function. p300 is a component of the HIF-1 transcriptional complex and positively regulates the transactivation of HIF-1. Here, we show a novel molecular mechanism by which p300 facilitates HIF-1 activity. p300 increases HIF-1 alpha (HIF1 alpha) protein acetylation and stability. The regulation can be opposed by HDAC1, but not by HDAC3, and is abrogated by disrupting HIF1 alpha-p300 interaction. Mechanistically, p300 specifically acetylates HIF1 alpha at Lys-709, which increases the protein stability and decreases polyubiquitination in both normoxia and hypoxia. Compared with the wild-type protein, a HIF1 alpha K709A mutant protein is more stable, less polyubiquitinated, and less dependent on p300. Overexpression of the HIF1 alpha wild-type or K709A mutant in cancer cells lacking the endogenous HIF1 alpha shows that the K709A mutant is transcriptionally more active toward the HIF-1 reporter and some endogenous target genes. Cancer cells containing the K709A mutant are less sensitive to hypoxia-induced growth arrest than the cells containing the HIF1 alpha wildtype. Taken together, these data demonstrate a novel biological consequence upon HIF1 alpha-p300 interaction, in which HIF1 alpha can be stabilized by p300 via Lys-709 acetylation.	[Geng, Hao; Liu, Qiong; Xue, Changhui; David, Larry L.; Beer, Tomasz M.; Thomas, George V.; Dai, Mu-Shui; Qian, David Z.] Oregon Hlth & Sci Univ, Oregon Hlth & Sci Univ Knight Canc Inst, Portland, OR 97239 USA	Oregon Health & Science University	Qian, DZ (corresponding author), OHSU, Oregon Hlth & Sci Univ Knight Canc Inst, 3303 SW Bond Ave,CH14R, Portland, OR 97239 USA.	qianzh@ohsu.edu	Qian, David Z/AAL-3441-2021; Liu, Qiong/G-8666-2014	Liu, Qiong/0000-0003-4114-5540; Thomas, George V/0000-0001-7416-8840	U. S. Public Health Service Grant from the National Cancer Institute, National Institutes of Health [R01CA149253]; NATIONAL CANCER INSTITUTE [R01CA149253, R01CA160474] Funding Source: NIH RePORTER	U. S. Public Health Service Grant from the National Cancer Institute, National Institutes of Health; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported by U. S. Public Health Service Grant R01CA149253 from the National Cancer Institute, National Institutes of Health.	Arany Z, 1996, P NATL ACAD SCI USA, V93, P12969, DOI 10.1073/pnas.93.23.12969; Chan HM, 2001, J CELL SCI, V114, P2363; Chen LF, 2002, EMBO J, V21, P6539, DOI 10.1093/emboj/cdf660; Dann CE, 2002, P NATL ACAD SCI USA, V99, P15351, DOI 10.1073/pnas.202614999; Ellis L, 2009, CANCER LETT, V280, P145, DOI 10.1016/j.canlet.2008.11.012; Finley LWS, 2011, CANCER CELL, V19, P416, DOI 10.1016/j.ccr.2011.02.014; Geng H, 2011, J BIOL CHEM, V286, P38095, DOI 10.1074/jbc.M111.257055; Geng H, 2010, CANCER RES, V70, P3239, DOI 10.1158/0008-5472.CAN-09-3186; Harten SK, 2009, ADV ENZYME REGUL, V49, P43, DOI 10.1016/j.advenzreg.2008.12.005; Isaacs JS, 2002, J BIOL CHEM, V277, P29936, DOI 10.1074/jbc.M204733200; Ivan M, 2001, SCIENCE, V292, P464, DOI 10.1126/science.1059817; Jeong JW, 2002, CELL, V111, P709, DOI 10.1016/S0092-8674(02)01085-1; Kato H, 2004, J BIOL CHEM, V279, P41966, DOI 10.1074/jbc.M406320200; Kim SH, 2007, ONCOL REP, V17, P647; Kim W, 2011, MOL CELL, V44, P325, DOI 10.1016/j.molcel.2011.08.025; Koh MY, 2008, MOL CELL BIOL, V28, P7081, DOI 10.1128/MCB.00773-08; Kung AL, 2004, CANCER CELL, V6, P33, DOI 10.1016/j.ccr.2004.06.009; Kung AL, 2000, NAT MED, V6, P1335, DOI 10.1038/82146; Laemmle A, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0033433; Lim JH, 2010, MOL CELL, V38, P864, DOI 10.1016/j.molcel.2010.05.023; Liu YV, 2007, CELL CYCLE, V6, P656, DOI 10.4161/cc.6.6.3981; Liu YV, 2007, MOL CELL, V25, P207, DOI 10.1016/j.molcel.2007.01.001; Luo WB, 2011, CELL, V145, P732, DOI 10.1016/j.cell.2011.03.054; Luo WB, 2010, J BIOL CHEM, V285, P3651, DOI 10.1074/jbc.M109.068577; Mahon PC, 2001, GENE DEV, V15, P2675, DOI 10.1101/gad.924501; Qian DZ, 2006, CANCER RES, V66, P8814, DOI 10.1158/0008-5472.CAN-05-4598; Sadoul K, 2008, BIOCHIMIE, V90, P306, DOI 10.1016/j.biochi.2007.06.009; Semenza G.L., 2007, SCI STKE, V2007, pcm8; Semenza GL, 2004, CANCER CELL, V5, P405, DOI 10.1016/S1535-6108(04)00118-7; Semenza GL, 2012, TRENDS PHARMACOL SCI, V33, P207, DOI 10.1016/j.tips.2012.01.005; Semenza GL, 2012, CELL, V148, P399, DOI 10.1016/j.cell.2012.01.021; Yu F, 2001, P NATL ACAD SCI USA, V98, P9630, DOI 10.1073/pnas.181341498; Zhang HF, 2008, P NATL ACAD SCI USA, V105, P19579, DOI 10.1073/pnas.0809763105	33	94	95	0	15	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 12	2012	287	42					35496	35505		10.1074/jbc.M112.400697	http://dx.doi.org/10.1074/jbc.M112.400697			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	022OF	22908229	Green Published, hybrid			2022-12-25	WOS:000309968000058
J	Bartels, P; Hirsch, PE; Svanback, R; Eklov, P				Bartels, Pia; Hirsch, Philipp E.; Svanback, Richard; Eklov, Peter			Water Transparency Drives Intra-Population Divergence in Eurasian Perch (Perca fluviatilis)	PLOS ONE			English	Article							ROACH RUTILUS-RUTILUS; DISSOLVED ORGANIC-CARBON; DREISSENA-POLYMORPHA; VISUAL CONDITIONS; GENETIC-EVIDENCE; STABLE ISOTOPES; SPECIES PAIR; CICHLID FISH; SAGINAW BAY; LAKE-HURON	Trait combinations that lead to a higher efficiency in resource utilization are important drivers of divergent natural selection and adaptive radiation. However, variation in environmental features might constrain foraging in complex ways and therefore impede the exploitation of critical resources. We tested the effect of water transparency on intra-population divergence in morphology of Eurasian perch (Perca fluviatilis) across seven lakes in central Sweden. Morphological divergence between near-shore littoral and open-water pelagic perch substantially increased with increasing water transparency. Reliance on littoral resources increased strongly with increasing water transparency in littoral populations, whereas littoral reliance was not affected by water transparency in pelagic populations. Despite the similar reliance on pelagic resources in pelagic populations along the water transparency gradient, the utilization of particular pelagic prey items differed with variation in water transparency in pelagic populations. Pelagic perch utilized cladocerans in lakes with high water transparency and copepods in lakes with low water transparency. We suggest that under impaired visual conditions low utilization of littoral resources by littoral perch and utilization of evasive copepods by pelagic perch may lead to changes in morphology. Our findings indicate that visual conditions can affect population divergence in predator populations through their effects on resource utilization.	[Bartels, Pia; Hirsch, Philipp E.; Svanback, Richard; Eklov, Peter] Uppsala Univ, Dept Ecol & Genet, Uppsala, Sweden	Uppsala University	Bartels, P (corresponding author), Umea Univ, Dept Ecol & Environm Sci, Umea, Sweden.	pia.bartels@emg.umu.se	Hirsch, Philipp/F-4895-2012	Hirsch, Philipp Emanuel/0000-0002-6927-2368	Swedish Research Council for Environment, Agricultural Sciences, and Spatial Planning (FORMAS); Swedish Research Council (VR); Uppsala Graduate School; Malmens Foundation	Swedish Research Council for Environment, Agricultural Sciences, and Spatial Planning (FORMAS)(Swedish Research Council Formas); Swedish Research Council (VR)(Swedish Research Council); Uppsala Graduate School; Malmens Foundation	This study was financed by grants from the Swedish Research Council for Environment, Agricultural Sciences, and Spatial Planning (FORMAS) to PB and PE, the Swedish Research Council (VR) to PE and RS, the Uppsala Graduate School to PEH, and the Malmens Foundation to PB and PEH. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aberle N, 2006, ARCH HYDROBIOL, V167, P447, DOI 10.1127/0003-9136/2006/0167-0447; Baumgartner D, 2003, INT REV HYDROBIOL, V88, P453, DOI 10.1002/iroh.200310632; Bohman IM, 2006, HYDROBIOLOGIA, V556, P99, DOI 10.1007/s10750-005-1052-1; Bonsdorff E, 1997, OCEANOL ACTA, V20, P319; Borkman DG, 1998, ICES J MAR SCI, V55, P668, DOI 10.1006/jmsc.1998.0380; BOTRELL HH, 1976, NORW J ZOOL, V24, P419; Burnham K.P., 2002, MODEL SELECTION MULT, DOI 10.1007/b97636; Carter MW, 2010, T AM FISH SOC, V139, P353, DOI 10.1577/T08-159.1; DAVIESCOLLEY RJ, 1987, LIMNOL OCEANOGR, V32, P416, DOI 10.4319/lo.1987.32.2.0416; DRENNER RW, 1978, J FISH RES BOARD CAN, V35, P1370, DOI 10.1139/f78-215; EHLINGER TJ, 1988, P NATL ACAD SCI USA, V85, P1878, DOI 10.1073/pnas.85.6.1878; Eriksson L., 2006, MULTI AND MEGAVARIAT; Estlander S, 2010, J FISH BIOL, V77, P241, DOI 10.1111/j.1095-8649.2010.02682.x; Fahnenstiel GL, 1995, J GREAT LAKES RES, V21, P465, DOI 10.1016/S0380-1330(95)71059-0; GREGORY RS, 1993, CAN J FISH AQUAT SCI, V50, P233, DOI 10.1139/f93-026; Harvey BC, 2008, T AM FISH SOC, V137, P1756, DOI 10.1577/T08-039.1; Heubel KU, 2006, J FISH BIOL, V68, P555, DOI 10.1111/j.0022-1112.2006.00941.x; Hongve D, 2004, AQUAT SCI, V66, P231, DOI 10.1007/s00027-004-0708-7; HURVICH CM, 1991, BIOMETRIKA, V78, P499; Jarvenpaa M, 2004, P ROY SOC B-BIOL SCI, V271, P2361, DOI 10.1098/rspb.2004.2870; Johnston TA, 1999, FRESHWATER BIOL, V41, P653, DOI 10.1046/j.1365-2427.1999.00400.x; Jonsson M, 2011, J FISH BIOL, V79, P290, DOI 10.1111/j.1095-8649.2011.03004.x; Jonsson M, 2012, ECOL FRESHW FISH, V21, P461, DOI 10.1111/j.1600-0633.2012.00565.x; Karlsson J, 2009, NATURE, V460, P506, DOI 10.1038/nature08179; KENT C, 1982, CAN J FISH AQUAT SCI, V39, P847, DOI 10.1139/f82-115; KIRK JTO, 1977, AUST J MAR FRESH RES, V28, P497, DOI 10.1071/MF9770497; Lind Owen T., 2003, Archiv fuer Hydrobiologie Supplement, V139, P327; Ljunggren L, 2007, J FISH BIOL, V70, P1319, DOI 10.1111/j.1095-8649.2007.01412.x; Lowe RL, 1995, J GREAT LAKES RES, V21, P558, DOI 10.1016/S0380-1330(95)71066-8; Lythgoe J.N., 1979, ECOLOGY VISION; McArdle BH, 2001, ECOLOGY, V82, P290, DOI 10.1890/0012-9658(2001)082[0290:fmmtcd]2.0.co;2; MCPHAIL JD, 1984, CAN J ZOOL, V62, P1402, DOI 10.1139/z84-201; MEYER A, 1989, OECOLOGIA, V80, P431, DOI 10.1007/BF00379047; Monteith DT, 2007, NATURE, V450, P537, DOI 10.1038/nature06316; Morris DP, 1995, LIMNOL OCEANOGR, V40, P1381, DOI 10.4319/lo.1995.40.8.1381; O'Keefe TC, 1998, J PLANKTON RES, V20, P973; PERSSON L, 1990, ECOLOGY, V71, P44, DOI 10.2307/1940246; PERSSON L, 1987, OECOLOGIA, V73, P170, DOI 10.1007/BF00377504; Phillips DL, 2001, OECOLOGIA, V127, P171, DOI 10.1007/s004420000578; Pinnegar JK, 1999, FUNCT ECOL, V13, P225, DOI 10.1046/j.1365-2435.1999.00301.x; Post DM, 2007, OECOLOGIA, V152, P179, DOI 10.1007/s00442-006-0630-x; Post DM, 2002, ECOLOGY, V83, P703, DOI 10.1890/0012-9658(2002)083[0703:USITET]2.0.CO;2; Quevedo M, 2009, ECOLOGY, V90, P2263, DOI 10.1890/07-1580.1; Rohlf F. J., 2005, TPSRELW RELATIVE WAR; SCHLUTER D, 1984, AM NAT, V123, P175, DOI 10.1086/284196; SCHOENER TW, 1970, ECOLOGY, V51, P408, DOI 10.2307/1935376; Seehausen O, 1997, SCIENCE, V277, P1808, DOI 10.1126/science.277.5333.1808; Smith TB, 1996, ANNU REV ECOL SYST, V27, P111, DOI 10.1146/annurev.ecolsys.27.1.111; SMOCK LA, 1980, FRESHWATER BIOL, V10, P375, DOI 10.1111/j.1365-2427.1980.tb01211.x; Sondergaard M, 2007, J APPL ECOL, V44, P1095, DOI 10.1111/j.1365-2664.2007.01363.x; SUGIURA N, 1978, COMMUN STAT A-THEOR, V7, P13, DOI 10.1080/03610927808827599; Svanback R, 2004, FUNCT ECOL, V18, P503, DOI 10.1111/j.0269-8463.2004.00858.x; Svanback R, 2003, OIKOS, V102, P273, DOI 10.1034/j.1600-0706.2003.12657.x; Svanback R, 2008, OIKOS, V117, P114, DOI 10.1111/j.2007.0030-1299.16267.x; Taylor EB, 2006, MOL ECOL, V15, P343, DOI 10.1111/j.1365-294X.2005.02794.x; UIBLEIN F, 1992, ENVIRON BIOL FISH, V33, P47, DOI 10.1007/BF00002552; Utne-Palm AC, 2002, MAR FRESHW BEHAV PHY, V35, P111, DOI 10.1080/10236240290025644; Vadeboncoeur Y, 2003, LIMNOL OCEANOGR, V48, P1408, DOI 10.4319/lo.2003.48.4.1408; WALLACE RK, 1981, T AM FISH SOC, V110, P72, DOI 10.1577/1548-8659(1981)110&lt;72:AAODI&gt;2.0.CO;2; Zelditch M.L., 2004, GEOMETRIC MORPHOMETR, DOI DOI 10.1016/B978-0-12-778460-1.X5000-5; [No title captured]	61	30	30	0	72	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 17	2012	7	8							e43641	10.1371/journal.pone.0043641	http://dx.doi.org/10.1371/journal.pone.0043641			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	996DG	22912895	gold, Green Published, Green Submitted			2022-12-25	WOS:000308063700123
J	Ku, BJ; Kim, TH; Lee, JH; Buras, ED; White, LD; Stevens, RD; Ilkayeva, OR; Bain, JR; Newgard, CB; DeMayo, FJ; Jeong, JW				Ku, Bon Jeong; Kim, Tae Hoon; Lee, Jae Hee; Buras, Eric D.; White, Lisa D.; Stevens, Robert D.; Ilkayeva, Olga R.; Bain, James R.; Newgard, Christopher B.; DeMayo, Francesco J.; Jeong, Jae-Wook			Mig-6 Plays a Critical Role in the Regulation of Cholesterol Homeostasis and Bile Acid Synthesis	PLOS ONE			English	Article							GENE-EXPRESSION; LIVER; METABOLISM; INDUCTION; IDENTIFICATION; DEFICIENCY; RECEPTORS; GLUCOSE; CDC42	The disruption of cholesterol homeostasis leads to an increase in cholesterol levels which results in the development of cardiovascular disease. Mitogen Inducible Gene 6 (Mig-6) is an immediate early response gene that can be induced by various mitogens, stresses, and hormones. To identify the metabolic role of Mig-6 in the liver, we conditionally ablated Mig-6 in the liver using the Albumin-Cre mouse model (Alb(cre/+) Mig-6(f/f); Mig-6(d/d)). Mig-6(d/d) mice exhibit hepatomegaly and fatty liver. Serum levels of total, LDL, and HDL cholesterol and hepatic lipid were significantly increased in the Mig-6(d/d) mice. The daily excretion of fecal bile acids was significantly decreased in the Mig-6(d/d) mice. DNA microarray analysis of mRNA isolated from the livers of these mice showed alterations in genes that regulate lipid metabolism, bile acid, and cholesterol synthesis, while the expression of genes that regulate biliary excretion of bile acid and triglyceride synthesis showed no difference in the Mig-6(d/d) mice compared to Mig-6(f/f) controls. These results indicate that Mig-6 plays an important role in cholesterol homeostasis and bile acid synthesis. Mice with liver specific conditional ablation of Mig-6 develop hepatomegaly and increased intrahepatic lipid and provide a novel model system to investigate the genetic and molecular events involved in the regulation of cholesterol homeostasis and bile acid synthesis. Defining the molecular mechanisms by which Mig-6 regulates cholesterol homeostasis will provide new insights into the development of more effective ways for the treatment and prevention of cardiovascular disease.	[Ku, Bon Jeong; Buras, Eric D.; DeMayo, Francesco J.] Baylor Coll Med, Dept Mol & Cellular Biol, Houston, TX 77030 USA; [Ku, Bon Jeong] Chungnam Natl Univ, Dept Internal Med, Sch Med, Taejon, South Korea; [Kim, Tae Hoon; Lee, Jae Hee; Jeong, Jae-Wook] Michigan State Univ, Dept Obstet Gynecol & Reprod Biol, Grand Rapids, MI USA; [White, Lisa D.] Baylor Coll Med, Microarray Core Facil, Dept Mol & Human Genet, Houston, TX 77030 USA; [Stevens, Robert D.; Ilkayeva, Olga R.; Bain, James R.; Newgard, Christopher B.] Duke Univ, Med Ctr, Sarah W Stedman Nutr & Metab Ctr, Dept Pharmacol & Canc Biol, Durham, NC USA; [Stevens, Robert D.; Ilkayeva, Olga R.; Bain, James R.; Newgard, Christopher B.] Duke Univ, Med Ctr, Dept Med, Durham, NC 27710 USA	Baylor College of Medicine; Chungnam National University; Michigan State University; Baylor College of Medicine; Duke University; Duke University	Ku, BJ (corresponding author), Baylor Coll Med, Dept Mol & Cellular Biol, Houston, TX 77030 USA.	JaeWook.Jeong@hc.msu.edu	DeMayo, Francesco/C-6255-2019	DeMayo, Francesco/0000-0002-9480-7336; Ku, Bon Jeong/0000-0002-3414-8949; Bain, James R./0000-0002-8917-9187	National Institutes of Health (NIH) [P01DK59820, R01HD057873, U19-DK62434]; Korean Diabetes Association Research Grant; Korea Healthcare Technology Research & Development Project, Ministry for Health, Welfare Family Affairs [A100588]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [R01HD057873] Funding Source: NIH RePORTER; NATIONAL CANCER INSTITUTE [P50CA098258] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P01DK059820, U19DK062434] Funding Source: NIH RePORTER	National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Korean Diabetes Association Research Grant; Korea Healthcare Technology Research & Development Project, Ministry for Health, Welfare Family Affairs; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported by National Institutes of Health (NIH) Grant P01DK59820 (to FJD), NIH Grant R01HD057873 (to JWJ), NIH Grant U19-DK62434 (CBN), and 2009 Korean Diabetes Association Research Grant and The Korea Healthcare Technology Research & Development Project, Ministry for Health, Welfare & Family Affairs A100588 (to BJK). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adams SH, 2009, J NUTR, V139, P1073, DOI 10.3945/jn.108.103754; Amatschek S, 2004, CANCER RES, V64, P844, DOI 10.1158/0008-5472.CAN-03-2361; An J, 2004, NAT MED, V10, P268, DOI 10.1038/nm995; Anastasi S, 2005, ONCOGENE, V24, P4540, DOI 10.1038/sj.onc.1208658; Bouche C, 2004, ENDOCR REV, V25, P807, DOI 10.1210/er.2003-0026; Bradbury MW, 2006, AM J PHYSIOL-GASTR L, V290, pG194, DOI 10.1152/ajpgi.00413.2005; BURBELO PD, 1995, J BIOL CHEM, V270, P29071, DOI 10.1074/jbc.270.49.29071; CADILLA C, 1992, GENE, V118, P223, DOI 10.1016/0378-1119(92)90192-R; CHACE DH, 1995, CLIN CHEM, V41, P62; Charlton-Menys V, 2008, EXP PHYSIOL, V93, P27, DOI 10.1113/expphysiol.2007.035147; Chiang JYL, 2009, J LIPID RES, V50, P1955, DOI 10.1194/jlr.R900010-JLR200; Chiang JYL, 2002, ENDOCR REV, V23, P443, DOI 10.1210/er.2000-0035; Cleeman JI, 2001, JAMA-J AM MED ASSOC, V285, P2486, DOI 10.1001/jama.285.19.2486; Dennis G, 2003, GENOME BIOL, V4, DOI 10.1186/gb-2003-4-9-r60; Durrington P, 2003, LANCET, V362, P717, DOI 10.1016/S0140-6736(03)14234-1; Erickson SK, 2003, J LIPID RES, V44, P1001, DOI 10.1194/jlr.M200489-JLR200; Ferby I, 2006, NAT MED, V12, P568, DOI 10.1038/nm1401; Fuchs M, 2003, AM J PHYSIOL-GASTR L, V284, pG551, DOI 10.1152/ajpgi.00468.2002; Goodwin B, 2000, MOL CELL, V6, P517, DOI 10.1016/S1097-2765(00)00051-4; Hofmann AF, 1999, ARCH INTERN MED, V159, P2647, DOI 10.1001/archinte.159.22.2647; Huang DW, 2009, NAT PROTOC, V4, P44, DOI 10.1038/nprot.2008.211; Ikonen E, 2006, PHYSIOL REV, V86, P1237, DOI 10.1152/physrev.00022.2005; Jeong JW, 2009, P NATL ACAD SCI USA, V106, P8677, DOI 10.1073/pnas.0903632106; Jeong JW, 2005, ENDOCRINOLOGY, V146, P3490, DOI 10.1210/en.2005-0016; Jin N, 2007, GENESIS, V45, P716, DOI 10.1002/dvg.20348; Keeton AB, 2004, BBA-GENE STRUCT EXPR, V1679, P248, DOI 10.1016/j.bbaexp.2004.07.002; KENT TA, 1994, ENDOCRINOLOGY, V134, P2237, DOI 10.1210/en.134.5.2237; Kim TH, 2010, ONCOGENE, V29, P3770, DOI 10.1038/onc.2010.126; Kim TH, 2010, J ONCOL, V2010, DOI 10.1155/2010/139087; Lefebvre P, 2009, PHYSIOL REV, V89, P147, DOI 10.1152/physrev.00010.2008; Li C, 2001, P NATL ACAD SCI USA, V98, P31, DOI 10.1073/pnas.011404098; Li T, HEPTAOLOGY, V52, P678; Mahgoub MA, 1998, MOL CELL BIOCHEM, V180, P59, DOI 10.1023/A:1006834922035; Makkinje A, 2000, J BIOL CHEM, V275, P17838, DOI 10.1074/jbc.M909735199; MILLINGTON DS, 1990, J INHERIT METAB DIS, V13, P321, DOI 10.1007/BF01799385; MOHN KL, 1990, J BIOL CHEM, V265, P21914; Nabel EG, 2003, NEW ENGL J MED, V349, P60, DOI 10.1056/NEJMra035098; PACKARD CJ, 1982, J LIPID RES, V23, P1081; Pirone DM, 2001, TRENDS GENET, V17, P370, DOI 10.1016/S0168-9525(01)02311-3; Postic C, 1999, J BIOL CHEM, V274, P305, DOI 10.1074/jbc.274.1.305; Pullingr CR, 2002, J CLIN INVEST, V110, P109, DOI 10.1172/JCI200215387; Saarikoski ST, 2002, FEBS LETT, V530, P186, DOI 10.1016/S0014-5793(02)03475-0; Stamler J, 2000, JAMA-J AM MED ASSOC, V284, P311, DOI 10.1001/jama.284.3.311; Tseng RC, 2005, INT J CANCER, V117, P241, DOI 10.1002/ijc.21178; van Laar T, 2001, MOL CARCINOGEN, V31, P63, DOI 10.1002/mc.1040; WICK M, 1995, EXP CELL RES, V219, P527, DOI 10.1006/excr.1995.1261; Wu JY, 2004, J CLIN INVEST, V113, P434, DOI 10.1172/JCI200419574; Yusuf S, 2004, LANCET, V364, P937, DOI 10.1016/S0140-6736(04)17018-9; Zhang YW, 2007, ONCOGENE, V26, P269, DOI 10.1038/sj.onc.1209790; Zhang YW, 2007, CELL CYCLE, V6, P507, DOI 10.4161/cc.6.5.3928; Zhang YW, 2005, P NATL ACAD SCI USA, V102, P11740, DOI 10.1073/pnas.0505171102	51	19	20	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 17	2012	7	8							e42915	10.1371/journal.pone.0042915	http://dx.doi.org/10.1371/journal.pone.0042915			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	996DG	22912762	Green Submitted, Green Published, gold			2022-12-25	WOS:000308063700030
J	Ma, DL; Chan, DSH; Fu, WC; He, HZ; Yang, H; Yan, SC; Leung, CH				Ma, Dik-Lung; Chan, Daniel Shiu-Hin; Fu, Wai-Chung; He, Hong-Zhang; Yang, Hui; Yan, Siu-Cheong; Leung, Chung-Hang			Discovery of a Natural Product-Like c-myc G-Quadruplex DNA Groove-Binder by Molecular Docking	PLOS ONE			English	Article							PROMOTER REGION; DOWN-REGULATION; LIGAND; RECOGNITION; IDENTIFICATION; STABILIZATION; TARGET	The natural product-like carbamide (1) has been identified as a stabilizer of the c-myc G-quadruplex through high-throughput virtual screening. NMR and molecular modeling experiments revealed a groove-binding mode for 1. The biological activity of 1 against the c-myc G-quadruplex was confirmed by its ability to inhibit Taq polymerase-mediated DNA extension and c-myc expression in vitro, demonstrating that 1 is able to control c-myc gene expression at the transcriptional level presumably through the stabilization of the c-myc promoter G-quadruplex. Furthermore, the interaction between carbamide analogues and the c-myc G-quadruplex was also investigated by in vitro experiments in order to generate a brief structure-activity relationship (SAR) for the observed potency of carbamide 1.	[Ma, Dik-Lung; Chan, Daniel Shiu-Hin; Fu, Wai-Chung; He, Hong-Zhang; Yang, Hui] Hong Kong Baptist Univ, Dept Chem, Kowloon Tong, Hong Kong, Peoples R China; [Yan, Siu-Cheong] Hong Kong Polytech Univ, Dept Appl Biol & Chem Technol, Hong Kong, Hong Kong, Peoples R China; [Leung, Chung-Hang] Univ Macau, Inst Chinese Med Sci, Taipa, Peoples R China; [Leung, Chung-Hang] Univ Macau, State Key Lab Qual Res Chinese Med, Taipa, Peoples R China	Hong Kong Baptist University; Hong Kong Polytechnic University; University of Macau; University of Macau	Ma, DL (corresponding author), Hong Kong Baptist Univ, Dept Chem, Kowloon Tong, Hong Kong, Peoples R China.	edmondma@hkbu.edu.hk; DuncanLeung@umac.mo	Fu, Wai-Chung/C-4487-2013; Fu, Wai Chung/HGC-1135-2022	Fu, Wai-Chung/0000-0002-7181-0057; Fu, Wai Chung/0000-0002-7181-0057; Yan, Siu-cheoong/0000-0001-7486-3069; Ma, Dik-Lung/0000-0002-9515-340X	Hong Kong Baptist University [FRG2/10-11/008, FRG2/11-12/009]; Environment and Conservation Fund (ECF) [3/2010]; Centre for Cancer and Inflammation Research, School of Chinese Medicine (CCIR-SCM, HKBU); Research Fund for the Control of Infectious Diseases [RFCID/11101212]; Research Grants Council [HKBU/201811]; University of Macau [MYRG091(Y1-L2)-ICMS12-LCH, MYRG121(Y1-L3)-ICMS12-LCH]	Hong Kong Baptist University; Environment and Conservation Fund (ECF); Centre for Cancer and Inflammation Research, School of Chinese Medicine (CCIR-SCM, HKBU); Research Fund for the Control of Infectious Diseases; Research Grants Council(Hong Kong Research Grants Council); University of Macau	This work is supported by Hong Kong Baptist University (FRG2/10-11/008 and FRG2/11-12/009), Environment and Conservation Fund (ECF Project 3/2010), Centre for Cancer and Inflammation Research, School of Chinese Medicine (CCIR-SCM, HKBU), the Research Fund for the Control of Infectious Diseases (RFCID/11101212) and the Research Grants Council (HKBU/201811), the University of Macau (Start-up Research Grant to C.-H. Leung), MYRG091(Y1-L2)-ICMS12-LCH and MYRG121(Y1-L3)-ICMS12-LCH. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Blay G, 2000, STUD NAT PROD CHEM, V24, P53, DOI DOI 10.1016/S1572-5995(00)80044-7; Butler MS, 2008, NAT PROD REP, V25, P475, DOI 10.1039/b514294f; Chen Q, 1996, P NATL ACAD SCI USA, V93, P2635, DOI 10.1073/pnas.93.7.2635; Cheng JY, 1998, J PHYS CHEM B, V102, P5542, DOI 10.1021/jp9820424; Dang CV, 2006, SEMIN CANCER BIOL, V16, P253, DOI 10.1016/j.semcancer.2006.07.014; Dash J, 2008, J AM CHEM SOC, V130, P15950, DOI 10.1021/ja8046552; Franke L, 2007, J MED CHEM, V50, P2640, DOI 10.1021/jm060655w; Hwang SH, 2011, J MED CHEM, V54, P3037, DOI 10.1021/jm2001376; Lee HM, 2010, CHEM COMMUN, V46, P4680, DOI 10.1039/b926359d; Lipps HJ, 2009, TRENDS CELL BIOL, V19, P414, DOI 10.1016/j.tcb.2009.05.002; Ma DL, 2008, CHEMMEDCHEM, V3, P881, DOI 10.1002/cmdc.200700342; Maiti S, 2003, BIOCHEM BIOPH RES CO, V310, P505, DOI 10.1016/j.bbrc.2003.09.052; Mergny JL, 1998, NAT MED, V4, P1366, DOI 10.1038/3949; Monchaud D, 2008, ORG BIOMOL CHEM, V6, P627, DOI 10.1039/b714772b; Ou TM, 2007, J MED CHEM, V50, P1465, DOI 10.1021/jm0610088; Parkinson GN, 2002, NATURE, V417, P876, DOI 10.1038/nature755; Phan AT, 2005, NAT CHEM BIOL, V1, P167, DOI 10.1038/nchembio723; Phan AT, 2004, J AM CHEM SOC, V126, P8710, DOI 10.1021/ja048805k; POSTEL EH, 1989, MOL CELL BIOL, V9, P5123, DOI 10.1128/MCB.9.11.5123; Siddiqui-Jain A, 2002, P NATL ACAD SCI USA, V99, P11593, DOI 10.1073/pnas.182256799; Totrov M, 1997, PROTEINS, P215; Trotta R, 2011, BIOCHIMIE, V93, P1280, DOI 10.1016/j.biochi.2011.05.021; White EW, 2007, BIOPHYS CHEM, V126, P140, DOI 10.1016/j.bpc.2006.06.006; Wu P, 2009, CHEM-EUR J, V15, P13008, DOI 10.1002/chem.200901943	24	39	39	1	27	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 17	2012	7	8							e43278	10.1371/journal.pone.0043278	http://dx.doi.org/10.1371/journal.pone.0043278			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	996DG	22912844	Green Published, gold, Green Submitted			2022-12-25	WOS:000308063700073
J	Zhao, JM; Huang, X; Ouyang, XH; Chen, WL; Du, AP; Zhu, L; Wang, SG; Deng, XW; Li, SG				Zhao, Junming; Huang, Xi; Ouyang, Xinhao; Chen, Weilan; Du, Anping; Zhu, Ling; Wang, Shiguang; Deng, Xing Wang; Li, Shigui			OsELF3-1, an Ortholog of Arabidopsis EARLY FLOWERING 3, Regulates Rice Circadian Rhythm and Photoperiodic Flowering	PLOS ONE			English	Article							ARABIDOPSIS-THALIANA; AMBIENT-TEMPERATURE; RESPONSE REGULATOR; NATURAL VARIATION; ORYZA-SATIVA; CLOCK; GENE; PROTEIN; ELF3; TIME	Arabidopsis thaliana EARLY FLOWERING 3 (ELF3) as a zeitnehmer (time taker) is responsible for generation of circadian rhythm and regulation of photoperiodic flowering. There are two orthologs (OsELF3-1 and OsELF3-2) of ELF3 in rice (Oryza sativa), but their roles have not yet been fully identified. Here, we performed a functional characterization of OsELF3-1 and revealed it plays a more predominant role than OsELF3-2 in rice heading. Our results suggest OsELF3-1 can affect rice circadian systems via positive regulation of OsLHY expression and negative regulation of OsPRR1, OsPRR37, OsPRR73 and OsPRR95 expression. In addition, OsELF3-1 is involved in blue light signaling by activating EARLY HEADING DATE 1 (Ehd1) expression to promote rice flowering under short-day (SD) conditions. Moreover, OsELF3-1 suppresses a flowering repressor GRAIN NUMBER, PLANT HEIGHT AND HEADING DATE 7 (Ghd7) to indirectly accelerate flowering under long-day (LD) conditions. Taken together, our results indicate OsELF3-1 is essential for circadian regulation and photoperiodic flowering in rice.	[Zhao, Junming; Ouyang, Xinhao; Chen, Weilan; Du, Anping; Zhu, Ling; Wang, Shiguang; Li, Shigui] Sichuan Agr Univ, Rice Res Inst, Chengdu, Sichuan, Peoples R China; [Zhao, Junming; Ouyang, Xinhao; Chen, Weilan; Du, Anping; Zhu, Ling; Wang, Shiguang; Li, Shigui] Sichuan Agr Univ, State Key Lab Hybrid Rice, Chengdu, Sichuan, Peoples R China; [Huang, Xi] Beijing Normal Univ, Coll Life Sci, Beijing 100875, Peoples R China; [Huang, Xi; Ouyang, Xinhao; Deng, Xing Wang] Peking Univ, Coll Life Sci, Natl Lab Prot Engn & Plant Genet Engn, Peking Yale Joint Ctr Plant Mol Genet & Agrobiote, Beijing 100871, Peoples R China	Sichuan Agricultural University; Sichuan Agricultural University; Beijing Normal University; Peking University	Zhao, JM (corresponding author), Sichuan Agr Univ, Rice Res Inst, Chengdu, Sichuan, Peoples R China.	oyxh1983@126.com; lishigui@sicau.edu.cn	du, anping/AAK-3544-2020; Deng, Xing Wang/ABF-4107-2020		China Postdoctoral Science Foundation Grant [2012M510266]; Postdoctoral Fellowship at Center for Life Sciences; National Natural Science Foundation of China [30971763, 31025017]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R37GM047850] Funding Source: NIH RePORTER	China Postdoctoral Science Foundation Grant(China Postdoctoral Science Foundation); Postdoctoral Fellowship at Center for Life Sciences; National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	China Postdoctoral Science Foundation Grant (2012M510266) and The Postdoctoral Fellowship at Center for Life Sciences to XO (http://www.chinapostdoctor.org.cn/V3/Program/Main.aspx) (http://www.cls.edu.cn/). and National Natural Science Foundation of China (30971763 and 31025017) to SL (http://www.nsfc.gov.cn/Portal0/default152.htm). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Corbesier L, 2007, SCIENCE, V316, P1030, DOI 10.1126/science.1141752; Covington MF, 2001, PLANT CELL, V13, P1305, DOI 10.1105/tpc.13.6.1305; Dixon LE, 2011, CURR BIOL, V21, P120, DOI 10.1016/j.cub.2010.12.013; Doi K, 2004, GENE DEV, V18, P926, DOI 10.1101/gad.1189604; Fu C, 2009, PLANT BIOLOGY, V11, P751, DOI 10.1111/j.1438-8677.2008.00156.x; Gendron JM, 2012, P NATL ACAD SCI USA, V109, P3167, DOI 10.1073/pnas.1200355109; Harmer SL, 2009, ANNU REV PLANT BIOL, V60, P357, DOI 10.1146/annurev.arplant.043008.092054; Hayama R, 2004, PLANT PHYSIOL, V135, P677, DOI 10.1104/pp.104.042614; Hayama R, 2003, NATURE, V422, P719, DOI 10.1038/nature01549; Hazen SP, 2005, P NATL ACAD SCI USA, V102, P10387, DOI 10.1073/pnas.0503029102; He CK, 2009, PLANT BIOTECHNOL J, V7, P227, DOI 10.1111/j.1467-7652.2008.00393.x; Helfer A, 2011, CURR BIOL, V21, P126, DOI 10.1016/j.cub.2010.12.021; Herrero E., 2012, PLANT CELL; Herrero E, 2012, MOL PLANT, V5, P554, DOI 10.1093/mp/sss010; Hicks KA, 1996, SCIENCE, V274, P790, DOI 10.1126/science.274.5288.790; Hicks KA, 2001, PLANT CELL, V13, P1281, DOI 10.1105/tpc.13.6.1281; HIEI Y, 1994, PLANT J, V6, P271, DOI 10.1046/j.1365-313X.1994.6020271.x; Huang W, 2012, SCIENCE, V336, P75, DOI 10.1126/science.1219075; Ishikawa R, 2005, PLANT CELL, V17, P3326, DOI 10.1105/tpc.105.037028; Itoh H, 2010, NAT GENET, V42, P635, DOI 10.1038/ng.606; Izawa T, 2002, GENE DEV, V16, P2006, DOI 10.1101/gad.999202; Izawa T, 2007, J EXP BOT, V58, P3091, DOI 10.1093/jxb/erm159; Izawa T, 2007, INT REV CYTOL, V256, P191, DOI 10.1016/S0074-7696(07)56006-7; Jeong DH, 2006, PLANT J, V45, P123, DOI 10.1111/j.1365-313X.2005.02610.x; Jiao YL, 2005, PLANT CELL, V17, P3239, DOI 10.1105/tpc.105.035840; Kardailsky I, 1999, SCIENCE, V286, P1962, DOI 10.1126/science.286.5446.1962; Kojima S, 2002, PLANT CELL PHYSIOL, V43, P1096, DOI 10.1093/pcp/pcf156; Kolmos E, 2011, PLANT CELL, V23, P3230, DOI 10.1105/tpc.111.088195; Komiya R, 2008, DEVELOPMENT, V135, P767, DOI 10.1242/dev.008631; Komiya R, 2009, DEVELOPMENT, V136, P3443, DOI 10.1242/dev.040170; Lee J, 2010, J EXP BOT, V61, P2247, DOI 10.1093/jxb/erq098; Lee SY, 2004, PLANT J, V38, P754, DOI 10.1111/j.1365-313X.2004.02082.x; Liu XL, 2001, PLANT CELL, V13, P1293, DOI 10.1105/tpc.13.6.1293; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Matsubara K, 2008, PLANT PHYSIOL, V148, P1425, DOI 10.1104/pp.108.125542; Matsubara K, 2012, PLANT CELL PHYSIOL, V53, P709, DOI 10.1093/pcp/pcs028; Matsubara K, 2011, PLANT J, V66, P603, DOI 10.1111/j.1365-313X.2011.04517.x; McWatters HG, 2000, NATURE, V408, P716, DOI 10.1038/35047079; Murakami M, 2003, PLANT CELL PHYSIOL, V44, P1229, DOI 10.1093/pcp/pcg135; Murakami M, 2007, PLANT CELL PHYSIOL, V48, P110, DOI 10.1093/pcp/pcl043; Nusinow DA, 2011, NATURE, V475, P398, DOI 10.1038/nature10182; Osugi A, 2011, PLANT PHYSIOL, V157, P1128, DOI 10.1104/pp.111.181792; Park DH, 1999, SCIENCE, V285, P1579, DOI 10.1126/science.285.5433.1579; Pruneda-Paz JL, 2009, SCIENCE, V323, P1481, DOI 10.1126/science.1167206; Reed JW, 2000, PLANT PHYSIOL, V122, P1149, DOI 10.1104/pp.122.4.1149; Ryu CH, 2009, PLANT CELL ENVIRON, V32, P1412, DOI 10.1111/j.1365-3040.2009.02008.x; Saito H, 2012, PLANT CELL PHYSIOL, V53, P717, DOI 10.1093/pcp/pcs029; Samach A, 2000, SCIENCE, V288, P1613, DOI 10.1126/science.288.5471.1613; Schaffer R, 1998, CELL, V93, P1219, DOI 10.1016/S0092-8674(00)81465-8; Seo E, 2009, PLANT CELL, V21, P3185, DOI 10.1105/tpc.108.063883; Somers DE, 1998, DEVELOPMENT, V125, P485; Strasser B, 2009, PLANT J, V58, P629, DOI 10.1111/j.1365-313X.2009.03811.x; Strayer C, 2000, SCIENCE, V289, P768, DOI 10.1126/science.289.5480.768; Suarez-Lopez P, 2001, NATURE, V410, P1116, DOI 10.1038/35074138; Tamaki S, 2007, SCIENCE, V316, P1033, DOI 10.1126/science.1141753; Thines B, 2010, P NATL ACAD SCI USA, V107, P3257, DOI 10.1073/pnas.0911006107; Tsuji H, 2011, CURR OPIN PLANT BIOL, V14, P45, DOI 10.1016/j.pbi.2010.08.016; Wang ZY, 1998, CELL, V93, P1207, DOI 10.1016/S0092-8674(00)81464-6; Xue WY, 2008, NAT GENET, V40, P761, DOI 10.1038/ng.143; Yano M, 2000, PLANT CELL, V12, P2473, DOI 10.1105/tpc.12.12.2473; Yu JW, 2008, MOL CELL, V32, P617, DOI 10.1016/j.molcel.2008.09.026; Zagotta MT, 1996, PLANT J, V10, P691, DOI 10.1046/j.1365-313X.1996.10040691.x; Zeevaart JAD, 2008, CURR OPIN PLANT BIOL, V11, P541, DOI 10.1016/j.pbi.2008.06.009; Zust T, 2011, PLANT CELL, V23, P3230	64	73	91	7	70	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 17	2012	7	8							e43705	10.1371/journal.pone.0043705	http://dx.doi.org/10.1371/journal.pone.0043705			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	996DG	22912900	gold, Green Published, Green Submitted			2022-12-25	WOS:000308063700128
J	Dorman, SE; Chihota, VN; Lewis, JJ; Shah, M; Clark, D; Grant, AD; Churchyard, GJ; Fielding, KL				Dorman, Susan E.; Chihota, Violet N.; Lewis, James J.; Shah, Maunank; Clark, David; Grant, Alison D.; Churchyard, Gavin J.; Fielding, Katherine L.			Performance Characteristics of the Cepheid Xpert MTB/RIF Test in a Tuberculosis Prevalence Survey	PLOS ONE			English	Article							MYCOBACTERIUM-TUBERCULOSIS; PULMONARY TUBERCULOSIS; RIFAMPIN RESISTANCE; RANDOMIZED-TRIAL; DIAGNOSIS; HIV; ASSAY; ERA	Background: Xpert MTB/RIF ("Xpert'') is a molecular test for detection of Mycobacterium tuberculosis (MTB) in sputum. Performance characteristics have been established for its use during passive tuberculosis (TB) case detection in symptomatic TB suspects, but Xpert performance has not been assessed in other settings. Objectives were to determine Xpert performance and costs in the context of a TB prevalence survey. Methodology/Principal Findings: This was a diagnostic sub-study of a TB prevalence survey conducted in gold mining companies in South Africa. Sputa (one per participant) were tested using smear microscopy, liquid culture (reference comparator), and Xpert. Costs were collected using an ingredients approach and analyzed using a public health program perspective. 6893 participants provided a sputum specimen. 187/6893 (2.7%) were positive for MTB in culture, 144/6893 (2.1%) were positive for MTB by Xpert, and 91/6893 (1.3%) were positive for acid fast bacilli by microsocopy. Sensitivity, specificity, positive predictive value, and negative predictive value for detection of MTB by Xpert were 62.6% (95% confidence interval [CI] 55.2, 69.5), 99.6% (99.4, 99.7), 81.3% (73.9, 87.3), and 98.9 (98.6, 98.8); agreement between Xpert and culture was 98.5% (98.2, 98.8). Sensitivity of microscopy was 17.6% (12.5, 23.9). When individuals with a history of TB treatment were excluded from the analysis, Xpert specificity was 99.8 (99.7, 99.9) and PPV was 90.6 (83.3, 95.4) for detection of MTB. For the testing scenario of 7000 specimens with 2.7% of specimens culture positive for MTB, costs were $165,690 for Xpert and $115,360 for the package of microscopy plus culture. Conclusion: In the context of a TB prevalence survey, the Xpert diagnostic yield was substantially higher than that of microscopy yet lower than that of liquid culture. Xpert may be useful as a sole test for TB case detection in prevalence surveys, particularly in settings lacking capacity for liquid culture.	[Dorman, Susan E.; Shah, Maunank] Johns Hopkins Univ, Sch Med, Baltimore, MD 21218 USA; [Chihota, Violet N.; Lewis, James J.; Clark, David; Churchyard, Gavin J.] Aurum Inst Hlth Res, Johannesburg, South Africa; [Lewis, James J.; Grant, Alison D.; Churchyard, Gavin J.; Fielding, Katherine L.] Univ London London Sch Hyg & Trop Med, London WC1E 7HT, England; [Churchyard, Gavin J.] Univ Witwatersrand, Sch Publ Hlth, Johannesburg, South Africa	Johns Hopkins University; University of London; London School of Hygiene & Tropical Medicine; University of Witwatersrand	Dorman, SE (corresponding author), Johns Hopkins Univ, Sch Med, Baltimore, MD 21218 USA.	dsusan1@jhmi.edu	Lewis, James/F-6333-2013; Chihota, Violet/DWH-9372-2022	Chihota, Violet/0000-0003-1444-9266; Lewis, James/0000-0002-8603-2761; Churchyard, Gavin/0000-0002-4269-3699	U.S. National Institutes of Health [RO1 AI51528, 5U2RTW007370, 5U2RTW007373]; Bill and Melinda Gates Foundation; Biostatistics core of the Consortium to Respond Effectively to the AIDS and TB Epidemics (CREATE); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [K23AI089259, K23AI051528] Funding Source: NIH RePORTER; Medical Research Council [G0700837, MR/K007467/1] Funding Source: researchfish; National Institute for Health Research [PHCS/03/01] Funding Source: researchfish; MRC [G0700837, MR/K007467/1] Funding Source: UKRI	U.S. National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Bill and Melinda Gates Foundation(Bill & Melinda Gates Foundation); Biostatistics core of the Consortium to Respond Effectively to the AIDS and TB Epidemics (CREATE); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); National Institute for Health Research(National Institute for Health Research (NIHR)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	This work was supported by grants from the U.S. National Institutes of Health (RO1 AI51528, 5U2RTW007370, and 5U2RTW007373) and the Bill and Melinda Gates Foundation. Katherine Fielding was partially funded and James Lewis fully funded by the Biostatistics core of the Consortium to Respond Effectively to the AIDS and TB Epidemics (CREATE) with a grant from the Bill and Melinda Gates Foundation. The Foundation for Innovative New Diagnostics provided Xpert MTB/RIF cartridges at a reduced concessionary price. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ayles H, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005602; Ayles HM, 2008, TRIALS, V9, DOI 10.1186/1745-6215-9-63; Banada PP, 2010, J CLIN MICROBIOL, V48, P3551, DOI 10.1128/JCM.01053-10; Blakemore R, 2010, J CLIN MICROBIOL, V48, P2495, DOI 10.1128/JCM.00128-10; Boehme CC, 2011, LANCET, V377, P1495, DOI 10.1016/S0140-6736(11)60438-8; Boehme CC, 2010, NEW ENGL J MED, V363, P1005, DOI 10.1056/NEJMoa0907847; Burman WJ, 2000, CLIN INFECT DIS, V31, P1390, DOI 10.1086/317504; Corbett EL, 2010, LANCET, V376, P1244, DOI 10.1016/S0140-6736(10)61425-0; Dye C, 2008, LANCET INFECT DIS, V8, P233, DOI 10.1016/S1473-3099(07)70291-8; Fielding KL, 2011, CONTEMP CLIN TRIALS, V32, P382, DOI 10.1016/j.cct.2010.12.008; Glaziou P, 2008, INT J TUBERC LUNG D, V12, P1003; Global TB Programme World Health Organization, WHOTB98258; Helb D, 2010, J CLIN MICROBIOL, V48, P229, DOI 10.1128/JCM.01463-09; Kent PT, 1985, GUIDE LEVEL 3 LAB; Lawn SD, 2011, PLOS MED, V8, DOI 10.1371/journal.pmed.1001067; Marlowe EM, 2011, J CLIN MICROBIOL, V49, P1621, DOI 10.1128/JCM.02214-10; Perkins MD, 2007, J INFECT DIS, V196, pS15, DOI 10.1086/518656; Steingart K, 2006, LANCET INFECT DIS, V6, P570, DOI 10.1016/S1473-3099(06)70578-3; Siddiqi K, 2003, LANCET INFECT DIS, V3, P288, DOI 10.1016/S1473-3099(03)00609-1; Theron G, 2011, AM J RESP CRIT CARE, V184, P132, DOI 10.1164/rccm.201101-0056OC; van der Werf MJ, 2008, INT J TUBERC LUNG D, V12, P1255; Van Rie A, 2012, INT J TUBERC LUNG D, V16, P206, DOI 10.5588/ijtld.11.0395; Vassall A, 2011, PLOS MED, V8, DOI 10.1371/journal.pmed.1001120; World Health Organization, 2011, WHOHTMTB20112; World Health Organization, 2010, WHOHTMTB201017	25	47	48	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 15	2012	7	8							e43307	10.1371/journal.pone.0043307	http://dx.doi.org/10.1371/journal.pone.0043307			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	993AG	22905254	Green Published, gold, Green Submitted			2022-12-25	WOS:000307823600067
J	Munoz, C; Saxena, A; Pakladok, T; Bogatikov, E; Wilmes, J; Seebohm, G; Foller, M; Lang, F				Munoz, Carlos; Saxena, Ambrish; Pakladok, Tatsiana; Bogatikov, Evgenii; Wilmes, Jan; Seebohm, Guiscard; Foeller, Michael; Lang, Florian			Stimulation of HERG Channel Activity by beta-catenin	PLOS ONE			English	Article							CARDIAC-HYPERTROPHY; THERAPEUTIC TARGET; SIGNALING PATHWAYS; POTASSIUM CHANNELS; UP-REGULATION; WNT; EXPRESSION; APOPTOSIS; CADHERIN; ALPHA	The multifunctional protein beta-catenin governs as transcription factor the expression of a wide variety of genes relevant for cell proliferation and cell survival. In addition, beta-catenin is localized at the cell membrane and may influence the function of channels. The present study explored the possibility that beta-catenin participates in the regulation of the HERG K+ channel. To this end, HERG was expressed in Xenopus oocytes with or without beta-catenin and the voltage-gated current determined utilizing the dual electrode voltage clamp. As a result, expression of beta-catenin markedly upregulated HERG channel activity, an effect not sensitive to inhibition of transcription with actinomycin D (10 mu M). According to chemiluminescence, beta-catenin may increase HERG channel abundance within the oocyte cell membrane. Following inhibition of channel insertion into the cell membrane by brefeldin A (5 mu M) the decay of current was similar in oocytes expressing HERG together with beta-catenin to oocytes expressing HERG alone. The experiments uncover a novel function of APC/beta-catenin, i.e. the regulation of HERG channels.	[Munoz, Carlos; Saxena, Ambrish; Pakladok, Tatsiana; Bogatikov, Evgenii; Wilmes, Jan; Foeller, Michael; Lang, Florian] Univ Tubingen, Dept Physiol, Tubingen, Germany; [Seebohm, Guiscard] Ruhr Univ Bochum, Bochum, Germany; [Foeller, Michael] Univ Hlth Network, Ontario Canc Inst, Campbell Family Inst Breast Canc Res, Toronto, ON, Canada	Eberhard Karls University of Tubingen; Ruhr University Bochum; University of Toronto; University Toronto Affiliates; University Health Network Toronto	Munoz, C (corresponding author), Univ Tubingen, Dept Physiol, Tubingen, Germany.	florian.lang@uni-tuebingen.de	Saxena, Ambrish/AAQ-5984-2020		Deutsche Forschungsgemeinschaft [GRK 1302/1, SE 1077/3, SFB 773]	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG))	The work was supported by the Deutsche Forschungsgemeinschaft (GRK 1302/1, SE 1077/3 and SFB 773). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ai ZW, 2000, J CLIN INVEST, V105, P161, DOI 10.1172/JCI7798; Alesutan IS, 2010, CELL PHYSIOL BIOCHEM, V25, P187, DOI 10.1159/000276569; Arcangeli Annarosa, 2005, V266, P225; Asher V, 2010, WORLD J SURG ONCOL, V8, DOI 10.1186/1477-7819-8-113; Bergmann MW, 2010, CIRC RES, V107, P1198, DOI 10.1161/CIRCRESAHA.110.223768; Blankesteijn WM, 2008, TRENDS PHARMACOL SCI, V29, P175, DOI 10.1016/j.tips.2008.01.003; Cadigan KM, 2006, J CELL SCI, V119, P395, DOI 10.1242/jcs.02826; Coussen F, 2002, J NEUROSCI, V22, P6426, DOI 10.1523/jneurosci.22-15-06426.2002; Covey TM, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013545; Croce Jenifer C., 2008, V469, P3, DOI 10.1007/978-1-60327-469-2_1; Dehner M, 2008, J BIOL CHEM, V283, P19201, DOI 10.1074/jbc.M710366200; Dermaku-Sopjani M, 2011, CELL PHYSIOL BIOCHEM, V28, P251, DOI 10.1159/000331737; Es-Salah-Lamoureux Z, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010876; Fagotto F, 1996, J CELL BIOL, V132, P1105, DOI 10.1083/jcb.132.6.1105; Flaherty MP, 2008, TRENDS CARDIOVAS MED, V18, P260, DOI 10.1016/j.tcm.2008.12.001; Grigoryan T, 2008, GENE DEV, V22, P2308, DOI 10.1101/gad.1686208; He TC, 1998, SCIENCE, V281, P1509, DOI 10.1126/science.281.5382.1509; Heallen T, 2011, SCIENCE, V332, P458, DOI 10.1126/science.1199010; Hirotani S, 2007, CIRC RES, V101, P1164, DOI 10.1161/CIRCRESAHA.107.160614; Hirschy A, 2010, BASIC RES CARDIOL, V105, P597, DOI 10.1007/s00395-010-0101-8; Hosseinzadeh Z, 2011, CELL PHYSIOL BIOCHEM, V28, P693, DOI 10.1159/000335763; Hu CJ, 2011, AM J MED SCI, V341, P119, DOI 10.1097/MAJ.0b013e3181f73f81; Jin TR, 2008, CELL SIGNAL, V20, P1697, DOI 10.1016/j.cellsig.2008.04.014; Koutsouki E, 2007, BIOCHEM BIOPH RES CO, V363, P18, DOI 10.1016/j.bbrc.2007.07.181; Kuwabara M, 2007, FEBS LETT, V581, P4821, DOI 10.1016/j.febslet.2007.09.007; Lesage F, 2004, P NATL ACAD SCI USA, V101, P671, DOI 10.1073/pnas.0307681100; Maier G, 2006, CELL PHYSIOL BIOCHEM, V18, P177, DOI 10.1159/000097666; Masuelli L, 2003, CARDIOVASC RES, V60, P376, DOI 10.1016/j.cardiores.2003.08.005; Munoz C, 2012, BIOCHEM BIOPH RES CO, V417, P692, DOI 10.1016/j.bbrc.2011.11.156; Naishiro Y, 2005, ONCOGENE, V24, P3141, DOI 10.1038/sj.onc.1208517; Nebenfuhr A, 2002, PLANT PHYSIOL, V130, P1102, DOI 10.1104/pp.011569; Rao TP, 2010, CIRC RES, V106, P1798, DOI 10.1161/CIRCRESAHA.110.219840; Rochais F, 2009, CIRC RES, V104, P933, DOI 10.1161/CIRCRESAHA.109.194464; Sanguinetti MC, 1999, ANN NY ACAD SCI, V868, P406, DOI 10.1111/j.1749-6632.1999.tb11302.x; Schroen B, 2007, J EXP MED, V204, P1227, DOI 10.1084/jem.20070145; Schumann H, 2000, CARDIOVASC RES, V45, P720, DOI 10.1016/S0008-6363(99)00376-4; Sopjani M, 2010, BIOCHEM BIOPH RES CO, V402, P467, DOI 10.1016/j.bbrc.2010.10.049; Strutz-Seebohm N, 2011, CELL PHYSIOL BIOCHEM, V27, P443, DOI 10.1159/000329965; ter Horst P, 2012, ACTA PHYSIOL, V204, P110, DOI 10.1111/j.1748-1716.2011.02309.x; Tetsu O, 1999, NATURE, V398, P422, DOI 10.1038/18884; Vallon V, 2006, J MOL MED, V84, P396, DOI 10.1007/s00109-005-0027-z; Vallorosi CJ, 2000, J BIOL CHEM, V275, P3328, DOI 10.1074/jbc.275.5.3328; van Noort M, 2002, J BIOL CHEM, V277, P17901, DOI 10.1074/jbc.M111635200; Vincent GM, 1998, ANNU REV MED, V49, P263; Wang JX, 2004, J BIOL CHEM, V279, P13289, DOI 10.1074/jbc.C400025200; Wang YH, 2008, BRIT J PHARMACOL, V154, P429, DOI 10.1038/bjp.2008.95; Wilmes J, 2012, MOL MEMBR BIOL, V29, P87, DOI 10.3109/09687688.2012.678017; Yao H, 2011, EXPERT OPIN THER TAR, V15, P873, DOI 10.1517/14728222.2011.577418	48	3	3	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 15	2012	7	8							e43353	10.1371/journal.pone.0043353	http://dx.doi.org/10.1371/journal.pone.0043353			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	993AG	22905262	Green Submitted, gold, Green Published			2022-12-25	WOS:000307823600071
J	Iglesias, DM; El-Kares, R; Taranta, A; Bellomo, F; Emma, F; Besouw, M; Levtchenko, E; Toelen, J; van den Heuvel, L; Chu, LL; Zhao, J; Young, YK; Eliopoulos, N; Goodyer, P				Iglesias, Diana M.; El-Kares, Reyhan; Taranta, Anna; Bellomo, Francesco; Emma, Francesco; Besouw, Martine; Levtchenko, Elena; Toelen, Jaan; van den Heuvel, Lambertus; Chu, LeeLee; Zhao, Jing; Young, Yoon Kow; Eliopoulos, Nicoletta; Goodyer, Paul			Stem Cell Microvesicles Transfer Cystinosin to Human Cystinotic Cells and Reduce Cystine Accumulation In Vitro	PLOS ONE			English	Article							NEPHROPATHIC CYSTINOSIS; DIMETHYL ESTER; KIDNEY INJURY; LEUKOCYTES; TRANSPLANTATION; IDENTIFICATION; COMMUNICATION; FIBROBLASTS; CYSTEAMINE; MEDIATORS	Cystinosis is a rare disease caused by homozygous mutations of the CTNS gene, encoding a cystine efflux channel in the lysosomal membrane. In Ctns knockout mice, the pathologic intralysosomal accumulation of cystine that drives progressive organ damage can be reversed by infusion of wildtype bone marrow-derived stem cells, but the mechanism involved is unclear since the exogeneous stem cells are rarely integrated into renal tubules. Here we show that human mesenchymal stem cells, from amniotic fluid or bone marrow, reduce pathologic cystine accumulation in co-cultured CTNS mutant fibroblasts or proximal tubular cells from cystinosis patients. This paracrine effect is associated with release into the culture medium of stem cell microvesicles (100-400 nm diameter) containing wildtype cystinosin protein and CTNS mRNA. Isolated stem cell microvesicles reduce target cell cystine accumulation in a dose-dependent, Annexin V-sensitive manner. Microvesicles from stem cells expressing CTNSRed transfer tagged CTNS protein to the lysosome/endosome compartment of cystinotic fibroblasts. Our observations suggest that exogenous stem cells may reprogram the biology of mutant tissues by direct microvesicle transfer of membrane-associated wildtype molecules.	[Iglesias, Diana M.; El-Kares, Reyhan; Chu, LeeLee; Goodyer, Paul] McGill Univ, Montreal Childrens Hosp, Dept Pediat, Montreal, PQ H3H 1P3, Canada; [Taranta, Anna; Bellomo, Francesco; Emma, Francesco] Osped Pediat Bambino Gesu, UOC Nefrol & Dialisi, Rome, Italy; [Besouw, Martine; Levtchenko, Elena; Toelen, Jaan; van den Heuvel, Lambertus] Katholieke Univ Leuven, Pediat Lab, Univ Hosp, Dept Pediat Nephrol, Louvain, Belgium; [Zhao, Jing; Young, Yoon Kow; Eliopoulos, Nicoletta] McGill Univ, Jewish Gen Hosp, Lady Davis Inst Med Res, Montreal, PQ H3T 1E2, Canada; [Eliopoulos, Nicoletta] McGill Univ, Dept Surg, Div Surg Res, Montreal, PQ H3A 2T5, Canada; [Eliopoulos, Nicoletta] McGill Univ, Dept Oncol, Montreal, PQ, Canada	McGill University; IRCCS Bambino Gesu; KU Leuven; Lady Davis Institute; McGill University; McGill University; McGill University	Iglesias, DM (corresponding author), McGill Univ, Montreal Childrens Hosp, Dept Pediat, Montreal, PQ H3H 1P3, Canada.	paul.goodyer@mcgill.ca	van den Heuvel, Lambertus/AAM-1772-2021; Emma, Francesco/H-2116-2012; Taranta, Anna/AAA-6113-2020; Bellomo, Francesco/K-2142-2012; Levtchenko, Elena/AAO-7125-2020; van den Heuvel, L.P.W.J./H-8044-2014	van den Heuvel, Lambertus/0000-0003-3917-6727; Emma, Francesco/0000-0002-0383-3468; Bellomo, Francesco/0000-0003-2912-8764; van den Heuvel, L.P.W.J./0000-0003-3917-6727; Taranta, Anna/0000-0002-7606-9085	Cystinosis Research Foundation; Genome Quebec; Ministere du Developpement Economique, de l'Innovation et de l'Exportation du Quebec [PSR-SIIRI-450]; Cystinosis Awareness and Research Effort; James McGill Research Chair	Cystinosis Research Foundation; Genome Quebec; Ministere du Developpement Economique, de l'Innovation et de l'Exportation du Quebec; Cystinosis Awareness and Research Effort; James McGill Research Chair	This work was supported by the Cystinosis Research Foundation (http://www.natalieswish.org/); Genome Quebec (http://www.genomequebec.com/); Ministere du Developpement Economique, de l'Innovation et de l'Exportation du Quebec (Grant PSR-SIIRI-450; http://www.mdeie.gouv.qc.ca/); and Cystinosis Awareness and Research Effort (http://www.cystinosis.ca/). Dr. P. Goodyer is the recipient of a James McGill Research Chair. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Al-Nedawi K, 2008, NAT CELL BIOL, V10, P619, DOI 10.1038/ncb1725; Al-Nedawi K, 2009, CELL CYCLE, V8, P2014, DOI 10.4161/cc.8.13.8988; Al-Nedawi K, 2009, P NATL ACAD SCI USA, V106, P3794, DOI 10.1073/pnas.0804543106; Anikster Y, 1999, MOL GENET METAB, V66, P111, DOI 10.1006/mgme.1998.2790; Asanuma H, 2010, J UROLOGY, V184, P26, DOI 10.1016/j.juro.2010.03.050; Bruno S, 2009, J AM SOC NEPHROL, V20, P1053, DOI 10.1681/ASN.2008070798; Camussi G, 2010, KIDNEY INT, V78, P838, DOI 10.1038/ki.2010.278; Choi DS, 2011, PROTEOMICS, V11, P2745, DOI 10.1002/pmic.201100022; Collino F, 2011, VITAM HORM, V87, P291, DOI 10.1016/B978-0-12-386015-6.00033-0; Eliopoulos N, 2010, AM J PHYSIOL-RENAL, V299, pF1288, DOI 10.1152/ajprenal.00671.2009; FRATANTONI JC, 1968, SCIENCE, V162, P570, DOI 10.1126/science.162.3853.570; GAHL WA, 1982, J BIOL CHEM, V257, P9570; GAHL WA, 1982, SCIENCE, V217, P1263, DOI 10.1126/science.7112129; Gahl WA, 2007, ANN INTERN MED, V147, P242, DOI 10.7326/0003-4819-147-4-200708210-00006; Geraerts M, 2006, BMC BIOTECHNOL, V6, DOI 10.1186/1472-6750-6-34; Gilfix BM, 1997, CLIN CHEM, V43, P687; Hauser PV, 2010, AM J PATHOL, V177, P2011, DOI 10.2353/ajpath.2010.091245; Kalatzis V, 2001, EMBO J, V20, P5940, DOI 10.1093/emboj/20.21.5940; Lee TH, 2011, SEMIN IMMUNOPATHOL, V33, P455, DOI 10.1007/s00281-011-0250-3; Mahoney CP, 2000, PEDIATR NEPHROL, V15, P50, DOI 10.1007/PL00013448; MARKELLO TC, 1993, NEW ENGL J MED, V328, P1157, DOI 10.1056/NEJM199304223281604; Nesterova G, 2008, PEDIATR NEPHROL, V23, P863, DOI 10.1007/s00467-007-0650-8; Park MA, 2006, J AM SOC NEPHROL, V17, P3167, DOI 10.1681/ASN.2006050474; Prasad VK, 2008, BLOOD, V112, P2979, DOI 10.1182/blood-2008-03-140830; SCHNEIDE.JA, 1968, PEDIATR RES, V2, P441, DOI 10.1203/00006450-196811000-00001; SCHNEIDER JA, 1967, SCIENCE, V157, P1321, DOI 10.1126/science.157.3794.1321; STEINHERZ R, 1982, P NATL ACAD SCI-BIOL, V79, P4446, DOI 10.1073/pnas.79.14.4446; STEINHERZ R, 1982, NEW ENGL J MED, V306, P1468, DOI 10.1056/NEJM198206173062407; Syres K, 2009, BLOOD, V114, P2542, DOI 10.1182/blood-2009-03-213934; Taranta A, 2008, AM J PHYSIOL-RENAL, V294, pF1101, DOI 10.1152/ajprenal.00413.2007; Wilmer MJ, 2011, BBA-MOL BASIS DIS, V1812, P643, DOI 10.1016/j.bbadis.2011.02.010; Yeagy BA, 2011, KIDNEY INT, V79, P1198, DOI 10.1038/ki.2010.537	32	56	57	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 13	2012	7	8							e42840	10.1371/journal.pone.0042840	http://dx.doi.org/10.1371/journal.pone.0042840			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	988OJ	22912749	Green Published, gold, Green Submitted			2022-12-25	WOS:000307500100037
J	Petersen, H; Matrosovich, M; Pleschka, S; Rautenschlein, S				Petersen, Henning; Matrosovich, Mikhail; Pleschka, Stephan; Rautenschlein, Silke			Replication and Adaptive Mutations of Low Pathogenic Avian Influenza Viruses in Tracheal Organ Cultures of Different Avian Species	PLOS ONE			English	Article							A VIRUSES; RECEPTOR-BINDING; HONG-KONG; HOST-RANGE; H9N2; HEMAGGLUTININ; PIGEONS; INFECTION; CHICKENS; SUSCEPTIBILITY	Transmission of avian influenza viruses (AIV) between different avian species may require genome mutations that allow efficient virus replication in a new species and could increase virulence. To study the role of domestic poultry in the evolution of AIV we compared replication of low pathogenic (LP) AIV of subtypes H9N2, H7N7 and H6N8 in tracheal organ cultures (TOC) and primary embryo fibroblast cultures of chicken, turkey, Pekin duck and homing pigeon. Virus strain-dependent and avian species-related differences between LPAIV were observed in growth kinetics and induction of ciliostasis in TOC. In particular, our data demonstrate high susceptibility to LPAIV of turkey TOC contrasted with low susceptibility of homing pigeon TOC. Serial virus passages in the cells of heterologous host species resulted in adaptive mutations in the AIV genome, especially in the receptor-binding site and protease cleavage site of the hemagglutinin. Our data highlight differences in susceptibility of different birds to AIV viruses and emphasizes potential role of poultry in the emergence of new virus variants.	[Petersen, Henning; Rautenschlein, Silke] Univ Vet Med Hannover, Clin Poultry, Hannover, Germany; [Matrosovich, Mikhail] Univ Marburg, Inst Virol, D-3550 Marburg, Germany; [Pleschka, Stephan] Univ Giessen, Inst Med Virol, Giessen, Germany	University of Veterinary Medicine Hannover, Foundation; Philipps University Marburg; Justus Liebig University Giessen	Petersen, H (corresponding author), Univ Vet Med Hannover, Clin Poultry, Hannover, Germany.	Silke.Rautenschlein@tiho-hannover.de	Pleschka, Stephan/HGU-9354-2022	Matrosovich, Mikhail/0000-0003-1618-2083; Pleschka, Stephan/0000-0002-7372-7089	FluResearchNet - Molecular Signatures Determining Pathogenicity and Species Transmission of Influenza A Viruses; Federal Ministry of Education and Research [01KI07133, 01KI07136]; European Commission FP7 project FLUPIG	FluResearchNet - Molecular Signatures Determining Pathogenicity and Species Transmission of Influenza A Viruses; Federal Ministry of Education and Research(Federal Ministry of Education & Research (BMBF)); European Commission FP7 project FLUPIG	This work was supported by the FluResearchNet - Molecular Signatures Determining Pathogenicity and Species Transmission of Influenza A Viruses, funded by the Federal Ministry of Education and Research (01KI07133 to S. Rautenschlein and 01KI07136 to S. Pleschka) and European Commission FP7 project FLUPIG (to M. Matrosovich). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abolnik C, 2007, VIRUS GENES, V34, P37, DOI 10.1007/s11262-006-0007-6; Alexander DJ, 2007, AVIAN DIS, V51, P161, DOI 10.1637/7602-041306R.1; Baigent SJ, 2001, VIRUS RES, V79, P177, DOI 10.1016/S0168-1702(01)00272-6; Barber MRW, 2010, P NATL ACAD SCI USA, V107, P5913, DOI 10.1073/pnas.1001755107; Bi JM, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013063; BLASKOVIC P, 1972, ARCH GES VIRUSFORSCH, V37, P104, DOI 10.1007/BF01241156; Brown IH, 2010, AVIAN DIS, V54, P187, DOI 10.1637/8949-053109-Reg.1; Brown IH, 2006, DEV BIOLOGICALS, V124, P45; Brown JD, 2009, J VET DIAGN INVEST, V21, P437, DOI 10.1177/104063870902100404; Butt KM, 2005, J CLIN MICROBIOL, V43, P5760, DOI 10.1128/JCM.43.11.5760-5767.2005; Capua I, 2003, AVIAN DIS, V47, P839, DOI 10.1637/0005-2086-47.s3.839; Chen J, 1998, CELL, V95, P409, DOI 10.1016/S0092-8674(00)81771-7; Fang TH, 2006, AVIAN DIS, V50, P269, DOI 10.1637/7437-090905R.1; Fouchier RAM, 2009, REV SCI TECH OIE, V28, P49, DOI 10.20506/rst.28.1.1863; Gabriel G, 2005, P NATL ACAD SCI USA, V102, P18590, DOI 10.1073/pnas.0507415102; Garten Wolfgang, 2008, V27, P156; Gronesova P, 2009, ACTA VIROL, V53, P213, DOI 10.4149/av_2009_03_213; Guan Y, 2000, J VIROL, V74, P9372, DOI 10.1128/JVI.74.20.9372-9380.2000; Hale BG, 2008, J GEN VIROL, V89, P2359, DOI 10.1099/vir.0.2008/004606-0; Hoffmann E, 2001, ARCH VIROL, V146, P2275, DOI 10.1007/s007050170002; Hossain MJ, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003170; Kaleta EF, 2005, DEUT TIERARZTL WOCH, V112, P448; Kaleta EF, 2004, DEUT TIERARZTL WOCH, V111, P467; Klopfleisch R, 2006, VET PATHOL, V43, P463, DOI 10.1354/vp.43-4-463; Ladman BS, 2008, AVIAN DIS, V52, P623, DOI 10.1637/8282-031208-Reg.1; Li JL, 2010, VIRUS RES, V147, P40, DOI 10.1016/j.virusres.2009.10.002; Li OTW, 2007, J VIROL METHODS, V142, P218, DOI 10.1016/j.jviromet.2007.01.015; Liu M, 2003, AVIAN DIS, V47, P849, DOI 10.1637/0005-2086-47.s3.849; LIU YP, 2007, J JISHOU UNIV, V28, P1; Liu YH, 2009, AVIAN PATHOL, V38, P263, DOI 10.1080/03079450903055363; Ludwig S, 2006, CELL MICROBIOL, V8, P375, DOI 10.1111/j.1462-5822.2005.00678.x; Matrosovich M, 2009, REV SCI TECH OIE, V28, P203, DOI 10.20506/rst.28.1.1870; Matrosovich M, 2006, VIROL J, V3, DOI 10.1186/1743-422X-3-63; Matrosovich Mikhail N., 2008, V27, P134; Matrosovich MN, 2001, VIROLOGY, V281, P156, DOI 10.1006/viro.2000.0799; Moresco KA, 2010, AVIAN DIS, V54, P622, DOI 10.1637/8837-040309-Reg.1; Neumann G, 2006, EMERG INFECT DIS, V12, P881, DOI 10.3201/eid1206.051336; NOBUSAWA E, 1991, VIROLOGY, V182, P475, DOI 10.1016/0042-6822(91)90588-3; Olsen B, 2006, SCIENCE, V312, P384, DOI 10.1126/science.1122438; Panigrahy B, 1996, AVIAN DIS, V40, P600, DOI 10.2307/1592270; Penski N, 2011, J VIROL, V85, P7730, DOI 10.1128/JVI.00063-11; Perk S, 2006, DEV BIOLOGICALS, V124, P201; Perkins LEL, 2002, AVIAN DIS, V46, P53, DOI 10.1637/0005-2086(2002)046[0053:POAHKO]2.0.CO;2; Pillai SPS, 2010, AVIAN DIS, V54, P522, DOI 10.1637/8770-033109-Review.1; Pillai SPS, 2010, VIROL J, V7, DOI 10.1186/1743-422X-7-5; Reemers SS, 2009, VET IMMUNOL IMMUNOP, V132, P91, DOI 10.1016/j.vetimm.2009.04.021; Reperant LA, 2012, VACCINE; Saito T, 2001, VACCINE, V20, P125, DOI 10.1016/S0264-410X(01)00279-1; SCHMIDT RC, 1974, J INFECT DIS, V129, P28, DOI 10.1093/infdis/129.1.28; SEKELLICK MJ, 1986, METHOD ENZYMOL, V119, P115; Skehel JJ, 2000, ANNU REV BIOCHEM, V69, P531, DOI 10.1146/annurev.biochem.69.1.531; Suarez DL, 2004, EMERG INFECT DIS, V10, P693, DOI 10.3201/eid1004.030396; Suarez DL, 2000, VET MICROBIOL, V74, P15, DOI 10.1016/S0378-1135(00)00161-9; Swayne D.E., 2008, DIS POULTRY, P153; Tumpey TM, 2004, AVIAN DIS, V48, P167, DOI 10.1637/7103; Wan HQ, 2006, VIROLOGY, V346, P278, DOI 10.1016/j.virol.2005.10.035; Wang WJ, 2010, J VIROL, V84, P6570, DOI 10.1128/JVI.00221-10; Wang ZF, 2010, J VIROL, V84, P11323, DOI 10.1128/JVI.01034-10; WEBSTER RG, 1992, MICROBIOL REV, V56, P152, DOI 10.1128/MMBR.56.1.152-179.1992; Winter C, 2008, MICROBES INFECT, V10, P367, DOI 10.1016/j.micinf.2007.12.009; WOfAH OIE, 2009, MAN DIAGN TESTS VACC; Xing Z, 2011, AM J RESP CELL MOL, V44, P24, DOI 10.1165/rcmb.2009-0120OC; Yassine Hadi M., 2010, Animal Health Research Reviews, V11, P53, DOI 10.1017/S1466252310000137; Yu H, 2008, VET MICROBIOL, V131, P82, DOI 10.1016/j.vetmic.2008.02.024	64	30	32	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 13	2012	7	8							e42260	10.1371/journal.pone.0042260	http://dx.doi.org/10.1371/journal.pone.0042260			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	988OJ	22912693	Green Published, gold, Green Submitted			2022-12-25	WOS:000307500100009
J	Yan, G; Zhang, YC; Yu, JL; Yu, Y; Zhang, F; Zhang, ZZ; Wu, AM; Yan, XH; Zhou, Y; Wang, FD				Yan, Guang; Zhang, Yuchao; Yu, Junlei; Yu, Yu; Zhang, Fan; Zhang, Zhuzhen; Wu, Aimin; Yan, Xianghua; Zhou, Yi; Wang, Fudi			Slc39a7/zip7 Plays a Critical Role in Development and Zinc Homeostasis in Zebrafish	PLOS ONE			English	Article							X-RAY-FLUORESCENCE; ACRODERMATITIS-ENTEROPATHICA; SIGNALING PATHWAYS; LIV-1 SUBFAMILY; TRANSPORTER; CELLS; GENE; EXPRESSION; MOUSE; PROTEINS	Background: Slc39a7/Zip7, also known as Ke4, is a member of solute carrier family 39 (Slc39a) and plays a critical role in regulating cell growth and death. Because the function of Zip7 in vivo was unclear, the present study investigated the function of zip7 in vertebrate development and zinc metabolism using zebrafish as a model organism. Principal Finding: Using real-time PCR to determine the gene expression pattern of zip7 during zebrafish development, we found that zip7 mRNA is expressed throughout embryonic development and into maturity. Interestingly, whole mount in situ hybridization revealed that while zip7 mRNA is ubiquitously expressed until 12 hours post-fertilization (hpf); at 24 hpf and beyond, zip7 mRNA was specifically detected only in eyes. Morpholino-antisense (MO) gene knockdown assay revealed that downregulation of zip7 expression resulted in several morphological defects in zebrafish including decreased head size, smaller eyes, shorter palates, and shorter and curved spinal cords. Analysis by synchrotron radiation X-ray fluorescence (SR-XRF) showed reduced concentrations of zinc in brain, eyes, and gills of zip7-MO-injected embryos. Furthermore, incubation of the zip7 knockdown embryos in a zinc-supplemented solution was able to rescue the MO-induced morphological defects. Significance: Our data suggest that zip7 is required for eye, brain, and skeleton formation during early embryonic development in zebrafish. Moreover, zinc supplementation can partially rescue defects resulting from zip7 gene knockdown. Taken together, our data provide critical insight into a novel function of zip7 in development and zinc homeostasis in vivo in zebrafish.	[Yan, Guang; Zhang, Yuchao; Yu, Junlei; Yu, Yu; Zhang, Fan; Zhang, Zhuzhen; Wu, Aimin; Wang, Fudi] Chinese Acad Sci, Shanghai Inst Biol Sci, Inst Nutr Sci, Grp Biomet Metab,Key Lab Nutr & Metab,Grad Sch, Shanghai, Peoples R China; [Zhang, Yuchao; Yan, Xianghua] Huazhong Agr Univ, Minist Agr, Key Lab Swine Genet & Breeding, Coll Anim Sci & Technol, Wuhan, Peoples R China; [Yu, Junlei] Nanchang Univ, Sch Life Engn, Nanchang, Peoples R China; [Yu, Junlei] Nanchang Univ, Sch Food Engn, Nanchang, Peoples R China; [Zhou, Yi] Harvard Univ, Sch Med, Childrens Hosp Boston, Stem Cell Program, Boston, MA USA; [Zhou, Yi] Harvard Univ, Sch Med, Childrens Hosp Boston, Div Hematol Oncol, Boston, MA USA; [Zhou, Yi] Harvard Univ, Sch Med, Dana Farber Canc Inst, Harvard Stem Cell Inst, Boston, MA 02115 USA	Chinese Academy of Sciences; Shanghai Institutes for Biological Sciences, CAS; Huazhong Agricultural University; Ministry of Agriculture & Rural Affairs; Nanchang University; Nanchang University; Harvard University; Boston Children's Hospital; Harvard Medical School; Harvard University; Boston Children's Hospital; Harvard Medical School; Harvard University; Dana-Farber Cancer Institute; Harvard Medical School	Yan, G (corresponding author), Chinese Acad Sci, Shanghai Inst Biol Sci, Inst Nutr Sci, Grp Biomet Metab,Key Lab Nutr & Metab,Grad Sch, Shanghai, Peoples R China.	wangfd@sibs.ac.cn	Wang, Fudi/L-7888-2018	Wang, Fudi/0000-0001-8730-0003; Zhang, Zhuzhen/0000-0001-6787-3920; Yan, Guang/0000-0001-6784-0010	Ministry of Science and Technology of China (973 Program) [2009CB941400, 2011CB966200]; National Natural Science Foundation of China [10979071, 30970665, 31030039, 30901193]; Science & Technology Commission of Shanghai Municipality grant [10JC1416800]; Chinese Academy of Sciences Hundred Talents Program [KSCX2-YW-R-141]	Ministry of Science and Technology of China (973 Program)(Ministry of Science and Technology, ChinaNational Basic Research Program of China); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Science & Technology Commission of Shanghai Municipality grant(Science & Technology Commission of Shanghai Municipality (STCSM)); Chinese Academy of Sciences Hundred Talents Program(Chinese Academy of Sciences)	This work was supported by research grants from the Ministry of Science and Technology of China (973 Program) (grant numbers 2009CB941400, 2011CB966200 to FW); the National Natural Science Foundation of China (grant numbers 10979071, 30970665, 31030039 to FW, 30901193 to YY); Science & Technology Commission of Shanghai Municipality grant (grant number 10JC1416800 to FW) and Chinese Academy of Sciences Hundred Talents Program (grant number KSCX2-YW-R-141 to FW). FW is a scholar of the Hundred Talents Program of the Chinese Academy of Sciences. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ando A, 1996, GENOMICS, V35, P600, DOI 10.1006/geno.1996.0405; Andreini C, 2006, J PROTEOME RES, V5, P196, DOI 10.1021/pr050361j; Andreini C, 2011, J INORG BIOCH; Bill BR, 2009, ZEBRAFISH, V6, P69, DOI 10.1089/zeb.2008.0555; Chowanadisai W, 2008, BRAIN RES, V1199, P10, DOI 10.1016/j.brainres.2008.01.015; Chowanadisai W, 2006, J BIOL CHEM, V281, P39699, DOI 10.1074/jbc.M605821200; Colvin RA, 2008, AM J PHYSIOL-CELL PH, V294, pC726, DOI 10.1152/ajpcell.00541.2007; Doerr TD, 1998, NUTRITION, V14, P489, DOI 10.1016/S0899-9007(98)00036-7; Dufner-Beattie J, 2003, J BIOL CHEM, V278, P33474, DOI 10.1074/jbc.M305000200; Eide DJ, 2006, BBA-MOL CELL RES, V1763, P711, DOI 10.1016/j.bbamcr.2006.03.005; Eide DJ, 2004, PFLUG ARCH EUR J PHY, V447, P796, DOI 10.1007/s00424-003-1074-3; Feeney GP, 2005, BBA-GENE STRUCT EXPR, V1732, P88, DOI 10.1016/j.bbaexp.2005.12.002; Fukada T, 2011, J BIOL INORG CHEM, V16, P1123, DOI 10.1007/s00775-011-0797-4; Fukada T, 2011, METALLOMICS, V3, P662, DOI 10.1039/c1mt00011j; Fukunaka A, 2009, J BIOL CHEM, V284, P30798, DOI 10.1074/jbc.M109.026435; Guo L, 2010, P NATL ACAD SCI USA, V107, P2818, DOI 10.1073/pnas.0914941107; Haase H, 2009, ANNU REV NUTR, V29, P133, DOI 10.1146/annurev-nutr-080508-141119; Heldin CH, 1997, NATURE, V390, P465, DOI 10.1038/37284; Hirano T, 2008, ADV IMMUNOL, V97, P149, DOI 10.1016/S0065-2776(08)00003-5; Ho E, 2012, COMP BIOCHEM PHYS C, V155, P26, DOI 10.1016/j.cbpc.2011.05.002; Hogstrand C, 2009, TRENDS MOL MED, V15, P101, DOI 10.1016/j.molmed.2009.01.004; Huang LP, 2005, J BIOL CHEM, V280, P15456, DOI 10.1074/jbc.M412188200; Huang LP, 1997, NAT GENET, V17, P292, DOI 10.1038/ng1197-292; Inoue K, 2002, HUM MOL GENET, V11, P1775, DOI 10.1093/hmg/11.15.1775; Kawasaki E, 2012, ENDOCR J; Kim BE, 2004, J BIOL CHEM, V279, P4523, DOI 10.1074/jbc.M310799200; KIMMEL CB, 1995, DEV DYNAM, V203, P253, DOI 10.1002/aja.1002030302; LAI F, 1994, GENOMICS, V23, P338, DOI 10.1006/geno.1994.1509; Lasswell J, 2000, PLANT CELL, V12, P2395, DOI 10.1105/tpc.12.12.2395; Lichten LA, 2009, ANNU REV NUTR, V29, P153, DOI 10.1146/annurev-nutr-033009-083312; Liuzzi JP, 2003, J NUTR, V133, P342, DOI 10.1093/jn/133.2.342; Ohana E, 2009, J BIOL CHEM, V284, P17677, DOI 10.1074/jbc.M109.007203; Palmiter RD, 2004, PFLUG ARCH EUR J PHY, V447, P744, DOI 10.1007/s00424-003-1070-7; Prasad AS, 2009, CURR OPIN CLIN NUTR, V12, P646, DOI 10.1097/MCO.0b013e3283312956; Prasad AS, 2001, NUTRITION, V17, P67, DOI 10.1016/S0899-9007(00)00469-X; PRASAD AS, 1995, NUTRITION, V11, P93; Punshon T, 2009, ANN BOT-LONDON, V103, P665, DOI 10.1093/aob/mcn264; Qian LX, 2009, AM J PHYSIOL-CELL PH, V297, pC369, DOI 10.1152/ajpcell.00589.2008; Rungby J, 2010, DIABETOLOGIA, V53, P1549, DOI 10.1007/s00125-010-1793-x; Sehgal VN, 2000, CLIN DERMATOL, V18, P745, DOI 10.1016/S0738-081X(00)00150-4; Stathakis DG, 1999, GENETICS, V153, P361; Sun Yan, 2008, Chinese Journal of Pathology, V37, P660; Suzuki T, 2005, J BIOL CHEM, V280, P30956, DOI 10.1074/jbc.M506902200; Taylor KM, 2008, ENDOCRINOLOGY, V149, P4912, DOI 10.1210/en.2008-0351; Taylor KM, 2012, SCI SIGNAL, V5, DOI 10.1126/scisignal.2002585; Taylor KM, 2004, BIOCHEM J, V377, P131, DOI 10.1042/BJ20031183; Taylor KM, 2003, BBA-BIOMEMBRANES, V1611, P16, DOI 10.1016/S0005-2736(03)00048-8; Urbanczyk A, 2011, BIOCHEM J, V433, P43, DOI 10.1042/BJ20101111; VALLEE BL, 1993, PHYSIOL REV, V73, P79, DOI 10.2466/pr0.1993.73.1.79; Wang DW, 2007, P NATL ACAD SCI USA, V104, P12428, DOI 10.1073/pnas.0705502104; Wang FD, 2004, J BIOL CHEM, V279, P51433, DOI 10.1074/jbc.M408361200; Wang FD, 2004, HUM MOL GENET, V13, P563, DOI 10.1093/hmg/ddh049; Wang HAO, 2011, ANAL CHEM, V83, P6259, DOI 10.1021/ac200899x; Weaver BP, 2007, BIOL CHEM, V388, P1301, DOI 10.1515/BC.2007.149; Yamashita S, 2004, NATURE, V429, P298, DOI 10.1038/nature02545; Yamashita S, 2002, DEV CELL, V2, P363, DOI 10.1016/S1534-5807(02)00126-0	56	36	37	2	22	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 13	2012	7	8							e42939	10.1371/journal.pone.0042939	http://dx.doi.org/10.1371/journal.pone.0042939			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	988OJ	22912764	Green Submitted, Green Published, gold			2022-12-25	WOS:000307500100043
J	Ye, JH; Rong, XM; Xiang, YQ; Xing, YG; Tang, YM				Ye, Jianhong; Rong, Xiaoming; Xiang, Yanqun; Xing, Yigang; Tang, Yamei			A Study of Radiation-Induced Cerebral Vascular Injury in Nasopharyngeal Carcinoma Patients with Radiation-Induced Temporal Lobe Necrosis	PLOS ONE			English	Article							CAROTID-ARTERY STENOSIS; RADIOTHERAPY; IRRADIATION	Purpose: To investigate radiation-induced carotid and cerebral vascular injury and its relationship with radiation-induced temporal lobe necrosis in nasopharyngeal carcinoma (NPC) patients. Methods and Materials: Fifty eight NPC patients with radiation-induced temporal lobe necrosis (TLN) were recruited in the study. Duplex ultrasonography was used to scan bilateral carotid arterials to evaluate the intima-media thickness (IMT) and occurrence of plaque formation. Flow velocities of bilateral middle cerebral arteries (MCAs), internal carotid arteries (ICAs) and basal artery (BA) were estimated through Transcranial Color Doppler (TCD). The results were compared with data from 33 patients who were free from radiation-induced temporal lobe necrosis after radiotherapy and 29 healthy individuals. Results: Significant differences in IMT, occurrence of plaques of ICAs and flow velocities of both MCAs and ICAs were found between patients after radiotherapy and healthy individuals (p<.05). IMT had positive correlation with post radiation interval (p = 0.049). Compared with results from patients without radiation-induced TLN, the mean IMT was significantly thicker in patients with TLN (p<0.001). Plaques were more common in patients with TLN than patients without TLN (p = 0.038). In addition, flow velocities of MCAs and ICAs in patients with TLN were much faster (p<0.001, p<0.001). Among patients with unilateral TLN, flow velocity of MCAs was significantly different between ipsilateral and contralateral sides to the lesion (p = 0.001). Conclusion: Thickening of IMT, occurrence of plaque formation and hemodynamic abnormality are more common in patients after radiotherapy, especially in those with TLN, compared with healthy individuals.	[Ye, Jianhong; Rong, Xiaoming; Xing, Yigang; Tang, Yamei] Sun Yat Sen Univ, Dept Neurol, Sun Yat Sen Mem Hosp, Guangzhou 510275, Guangdong, Peoples R China; [Rong, Xiaoming; Tang, Yamei] Sun Yat Sen Univ, Guangdong Higher Educ Inst, Key Lab Malignant Tumor Gene Regulat & Target The, Guangzhou 510275, Guangdong, Peoples R China; [Xiang, Yanqun] Sun Yat Sen Univ, Ctr Canc, Dept Nasopharyngeal Carcinoma, Guangzhou 510275, Guangdong, Peoples R China	Sun Yat Sen University; Sun Yat Sen University; Sun Yat Sen University	Ye, JH (corresponding author), Sun Yat Sen Univ, Dept Neurol, Sun Yat Sen Mem Hosp, Guangzhou 510275, Guangdong, Peoples R China.	yameitang@hotmail.com		Tang, Yamei/0000-0002-6353-6107	National Natural Science Foundation of China [81072242]; Natural Science Foundation of Guangdong Province [S2011010004708]; Fundamental Research Funds for the Central Universities; Funds for Pearl River Science & Technology Star of Guangzhou City	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Natural Science Foundation of Guangdong Province(National Natural Science Foundation of Guangdong Province); Fundamental Research Funds for the Central Universities(Fundamental Research Funds for the Central Universities); Funds for Pearl River Science & Technology Star of Guangzhou City	This work was supported by National Natural Science Foundation of China (No. 81072242), the Natural Science Foundation of Guangdong Province (No. S2011010004708), the Fundamental Research Funds for the Central Universities and Funds for Pearl River Science & Technology Star of Guangzhou City to Yamei Tang. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abayomi OK, 2004, ORAL ONCOL, V40, P872, DOI 10.1016/j.oraloncology.2003.12.005; Chang YJ, 2009, J VASC SURG, V50, P280, DOI 10.1016/j.jvs.2009.01.033; Chaturvedi S, 2005, NEUROLOGY, V65, P794, DOI 10.1212/01.wnl.0000176036.07558.82; Cheng SWK, 2000, ARCH OTOLARYNGOL, V126, P517, DOI 10.1001/archotol.126.4.517; Dorresteijn LDA, 2005, EUR J CANCER, V41, P1026, DOI 10.1016/j.ejca.2005.01.020; Favre JP, 2008, J VASC SURG, V48, P852, DOI 10.1016/j.jvs.2008.05.069; Gianicolo ME, 2010, CARDIOVASC ULTRASOUN, V8, DOI 10.1186/1476-7120-8-8; Kablak-Ziembicka A, 2005, KARDIOL POL, V63, P390; Kablak-Ziembicka Anna, 2005, Kardiol Pol, V63, P381; Lam WMM, 2001, CANCER, V92, P2357, DOI 10.1002/1097-0142(20011101)92:9<2357::AID-CNCR1583>3.0.CO;2-K; Lam WWM, 2003, J ULTRAS MED, V22, P1055, DOI 10.7863/jum.2003.22.10.1055; Lawrence YR, 2010, INT J RADIAT ONCOL, V76, pS20, DOI 10.1016/j.ijrobp.2009.02.091; LEE AWM, 1988, CANCER-AM CANCER SOC, V61, P1535, DOI 10.1002/1097-0142(19880415)61:8<1535::AID-CNCR2820610809>3.0.CO;2-E; Li CS, 2010, CLIN NEUROL NEUROSUR, V112, P682, DOI 10.1016/j.clineuro.2010.05.007; Lyubimova N, 2004, BRIT J RADIOL, V77, P488, DOI 10.1259/bjr/15169876; Man BL, 2009, STROKE, V40, P3211, DOI 10.1161/STROKEAHA.109.557041; Marcel M, 2005, NEUROLOGY, V65, P959, DOI 10.1212/01.wnl.0000176033.64896.c6; Muzaffar K, 2000, LARYNGOSCOPE, V110, P1811, DOI 10.1097/00005537-200011000-00007; Lima MNP, 2011, RADIOTHER ONCOL, V101, P449, DOI 10.1016/j.radonc.2010.03.026; Shichita T, 2009, ANGIOLOGY, V60, P276, DOI 10.1177/0003319709335905; Tang YM, 2010, J NEURO-OPHTHALMOL, V30, P315, DOI 10.1097/WNO.0b013e3181dee914; Thomas GN, 2008, CEREBROVASC DIS, V25, P261, DOI 10.1159/000116303	22	18	24	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 13	2012	7	8							e42890	10.1371/journal.pone.0042890	http://dx.doi.org/10.1371/journal.pone.0042890			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	988OJ	22912759	Green Published, gold, Green Submitted			2022-12-25	WOS:000307500100042
J	Choi, JN; Kim, J; Kim, J; Jung, WH; Lee, CH				Choi, Jung Nam; Kim, Jeongmi; Kim, Jiyoung; Jung, Won Hee; Lee, Choong Hwan			Influence of Iron Regulation on the Metabolome of Cryptococcus neoformans	PLOS ONE			English	Article							CENTRAL-NERVOUS-SYSTEM; CEREBROSPINAL-FLUID; CANDIDA-ALBICANS; INOSITOL; MYOINOSITOL; SPECTROMETRY; PATHOGENESIS; ASSOCIATION; DEGRADATION; DEFICIENCY	Iron is an essential nutrient for virtually all organisms and acts as a cofactor for many key enzymes of major metabolic pathways. Furthermore, iron plays a critical role in pathogen-host interactions. In this study, we analyzed metabolomic changes associated with iron availability and the iron regulatory protein Cir1 in a human fungal pathogen Cryptococcus neoformans. Our metabolite analysis revealed that Cir1 influences the glycolytic pathway, ergosterol biosynthesis and inositol metabolism, which require numerous iron-dependent enzymes and play important roles in pathogenesis and antifungal sensitivity of the fungus. Moreover, we demonstrated that increased cellular iron content and altered gene expression in the cir1 mutant contributed to metabolite changes. Our study provides a new insight into iron regulation and the role of Cir1 in metabolome of C. neoformans.	[Choi, Jung Nam; Kim, Jiyoung; Lee, Choong Hwan] Konkuk Univ, Dept Biosci & Biotechnol, Seoul, South Korea; [Kim, Jeongmi; Jung, Won Hee] Chung Ang Univ, Dept Biotechnol, Anseong, Gyeonggi Do, South Korea	Konkuk University; Chung Ang University	Choi, JN (corresponding author), Konkuk Univ, Dept Biosci & Biotechnol, Seoul, South Korea.	chlee123@konkuk.ac.kr			National Research Foundation of Korea; Ministry of Education, Science and Technology [2010-0027204, MEST 2010-0019306, 20110005810]	National Research Foundation of Korea(National Research Foundation of Korea); Ministry of Education, Science and Technology(Ministry of Education, Science & Technology (MEST), Republic of Korea)	This work was supported by awards from the National Research Foundation of Korea funded by the Ministry of Education, Science and Technology 2010-0027204 and MEST 2010-0019306 (CHL), and the National Research Foundation of Korea funded by the Ministry of Education, Science and Technology 20110005810 (WHJ). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Chen YL, 2008, INFECT IMMUN, V76, P2793, DOI 10.1128/IAI.01514-07; Choi YH, 2004, J NAT PROD, V67, P953, DOI 10.1021/np049919c; Dunn WB, 2011, NAT PROTOC, V6, P1060, DOI 10.1038/nprot.2011.335; Gao XF, 2009, ANAL BIOCHEM, V393, P163, DOI 10.1016/j.ab.2009.06.036; Ghannoum MA, 2000, CLIN MICROBIOL REV, V13, P122, DOI 10.1128/CMR.13.1.122-143.2000; Ghannoum MA, 1999, CLIN MICROBIOL REV, V12, P501, DOI 10.1128/CMR.12.4.501; HITCHCOCK CA, 1987, J MED VET MYCOL, V25, P29; Holmes E, 2008, NATURE, V453, P396, DOI 10.1038/nature06882; Jung WH, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.0040045; Jung WH, 2006, PLOS BIOL, V4, P2282, DOI 10.1371/journal.pbio.0040410; Jung WH, 2009, EUKARYOT CELL, V8, P1511, DOI 10.1128/EC.00166-09; Katajamaa M, 2005, BMC BIOINFORMATICS, V6, DOI 10.1186/1471-2105-6-179; Kim DH, 2010, ANALYST, V135, P1235, DOI 10.1039/b923046g; Kouskoumvekaki I, 2011, J BIOMED BIOTECHNOL, DOI 10.1155/2011/525497; Kusano M, 2007, BMC SYST BIOL, V1, DOI 10.1186/1752-0509-1-53; Luberto C, 2001, GENE DEV, V15, P201, DOI 10.1101/gad.856001; Nohturfft A, 2009, ANNU REV CELL DEV BI, V25, P539, DOI 10.1146/annurev.cellbio.24.110707.175344; Philpott C.C., 2012, BIOCH BIOPHYS ACTA; Philpott CC, 2006, BBA-MOL CELL RES, V1763, P636, DOI 10.1016/j.bbamcr.2006.05.008; Puig S, 2005, CELL, V120, P99, DOI 10.1016/j.cell.2004.11.032; Reynolds TB, 2009, MICROBIOL-SGM, V155, P1386, DOI 10.1099/mic.0.025718-0; Schaible ME, 2004, NAT REV MICROBIOL, V2, P946, DOI 10.1038/nrmicro1046; Scherling C, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012569; Shakoury-Elizeh M, 2010, J BIOL CHEM, V285, P14823, DOI 10.1074/jbc.M109.091710; Shea JM, 2006, INFECT IMMUN, V74, P5977, DOI 10.1128/IAI.00768-06; Shetty HU, 1996, CLIN CHEM, V42, P298; SPECTOR R, 1975, AM J PHYSIOL, V228, P1510, DOI 10.1152/ajplegacy.1975.228.5.1510; SPECTOR R, 1975, J NEUROCHEM, V25, P353, DOI 10.1111/j.1471-4159.1975.tb06980.x; Tikunov Y, 2005, PLANT PHYSIOL, V139, P1125, DOI 10.1104/pp.105.068130; Villas-Boas SG, 2006, ANAL BIOCHEM, V349, P297, DOI 10.1016/j.ab.2005.11.019; Wang YN, 2011, EUKARYOT CELL, V10, P618, DOI 10.1128/EC.00327-10; Xue CY, 2007, CELL HOST MICROBE, V1, P263, DOI 10.1016/j.chom.2007.05.005; Xue CY, 2010, MBIO, V1, DOI 10.1128/mBio.00084-10	33	52	53	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 23	2012	7	7							e41654	10.1371/journal.pone.0041654	http://dx.doi.org/10.1371/journal.pone.0041654			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	977TM	22911836	Green Published, gold			2022-12-25	WOS:000306687700133
J	Cote, GJ; Zhu, W; Thomas, A; Martin, E; Murad, F; Sharina, IG				Cote, Gilbert J.; Zhu, Wen; Thomas, Anthony; Martin, Emil; Murad, Ferid; Sharina, Iraida G.			Hydrogen Peroxide Alters Splicing of Soluble Guanylyl Cyclase and Selectively Modulates Expression of Splicing Regulators in Human Cancer Cells	PLOS ONE			English	Article							TRACT-BINDING-PROTEIN; IRES-MEDIATED TRANSLATION; MESSENGER-RNA BINDING; OXIDATIVE STRESS; NITRIC-OXIDE; CYSTEINE OXIDATION; EXON INCLUSION; MECHANISMS; ATHEROSCLEROSIS; PROLIFERATION	Background: Soluble guanylyl cyclase (sGC) plays a central role in nitric oxide (NO)-mediated signal transduction in the cardiovascular, nervous and gastrointestinal systems. Alternative RNA splicing has emerged as a potential mechanism to modulate sGC expression and activity. C-alpha 1 sGC is an alternative splice form that is resistant to oxidation-induced protein degradation and demonstrates preferential subcellular distribution to the oxidized environment of endoplasmic reticulum (ER). Methodology/Principal Findings: Here we report that splicing of C-alpha 1 sGC can be modulated by H2O2 treatment in BE2 neuroblastoma and MDA-MD-468 adenocarcinoma human cells. In addition, we show that the H2O2 treatment of MDA-MD-468 cells selectively decreases protein levels of PTBP1 and hnRNP A2/B1 splice factors identified as potential alpha 1 gene splicing regulators by in silico analysis. We further demonstrate that down-regulation of PTBP1 by H2O2 occurs at the protein level with variable regulation observed in different breast cancer cells. Conclusions/Significance: Our data demonstrate that H2O2 regulates RNA splicing to induce expression of the oxidation-resistant C-alpha 1 sGC subunit. We also report that H2O2 treatment selectively alters the expression of key splicing regulators. This process might play an important role in regulation of cellular adaptation to conditions of oxidative stress.	[Cote, Gilbert J.; Zhu, Wen] Univ Texas MD Anderson Canc Ctr, Dept Endocrine Neoplasia & Hormonal Disorders, Houston, TX 77030 USA; [Thomas, Anthony; Martin, Emil; Sharina, Iraida G.] Univ Texas Med Sch, UTHealth, Dept Internal Med Cardiol, Houston, TX USA; [Murad, Ferid] George Washington Univ, Dept Biochem & Mol Biol, Washington, DC USA	University of Texas System; UTMD Anderson Cancer Center; University of Texas System; University of Texas Health Science Center Houston; George Washington University	Cote, GJ (corresponding author), Univ Texas MD Anderson Canc Ctr, Dept Endocrine Neoplasia & Hormonal Disorders, Houston, TX 77030 USA.	Iraida.G.Sharina@uth.tmc.edu	Sharina, Iraida/C-9888-2014	Martin, Emil/0000-0002-9094-4165	NIH [RO1 HL088128, 3R01HL088128]; AHA South Central Affiliate [09GRNT2060182]; NATIONAL CENTER FOR RESEARCH RESOURCES [UL1RR024148] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL088128] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); AHA South Central Affiliate; NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported by NIH grants RO1 HL088128 and 3R01HL088128 and AHA South Central Affiliate Grant-in-Aid 09GRNT2060182 to E. M. and departmental start-up funds to I. S. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ardanaz N, 2006, EXP BIOL MED, V231, P237; Ashibe B, 2007, J BIOL CHEM, V282, P20763, DOI 10.1074/jbc.M611853200; Back SH, 2002, J BIOL CHEM, V277, P27200, DOI 10.1074/jbc.M203887200; Baralle D, 2009, EMBO REP, V10, P810, DOI 10.1038/embor.2009.170; Caceres JF, 2002, TRENDS GENET, V18, P186, DOI 10.1016/S0168-9525(01)02626-9; Cheung HC, 2009, BRAIN, V132, P2277, DOI 10.1093/brain/awp153; Clower CV, 2010, P NATL ACAD SCI USA, V107, P1894, DOI 10.1073/pnas.0914845107; Desmet FO, 2009, NUCLEIC ACIDS RES, V37, DOI 10.1093/nar/gkp215; Galban S, 2008, MOL CELL BIOL, V28, P93, DOI 10.1128/MCB.00973-07; Grover R, 2008, CELL CYCLE, V7, P2189, DOI 10.4161/cc.7.14.6271; Gulden M, 2010, FREE RADICAL BIO MED, V49, P1298, DOI 10.1016/j.freeradbiomed.2010.07.015; Hang XY, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-126; He X, 2007, ONCOGENE, V26, P4961, DOI 10.1038/sj.onc.1210307; Hirschfeld M, 2009, CANCER RES, V69, P2082, DOI 10.1158/0008-5472.CAN-08-1997; Irani K, 1997, SCIENCE, V275, P1649, DOI 10.1126/science.275.5306.1649; Jin W, 2000, CANCER RES, V60, P1221; Jin W, 2003, CANCER RES, V63, P6154; Kattapuram T, 2005, J BIOL CHEM, V280, P15340, DOI 10.1074/jbc.M500214200; Keene JD, 2007, NAT REV GENET, V8, P533, DOI 10.1038/nrg2111; Kent WJ, 2002, GENOME RES, V12, P996, DOI 10.1101/gr.229102; Klein JA, 2003, J CLIN INVEST, V111, P785, DOI 10.1172/JCI200318182; Koscielny G, 2009, GENOMICS, V93, P213, DOI 10.1016/j.ygeno.2008.11.003; Kraehling JR, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025772; Marengo B, 2008, FREE RADICAL BIO MED, V44, P474, DOI 10.1016/j.freeradbiomed.2007.10.031; MATSUO N, 1995, J BIOL CHEM, V270, P28216, DOI 10.1074/jbc.270.47.28216; Meurer S, 2009, CIRC RES, V105, P33, DOI 10.1161/CIRCRESAHA.109.198234; Monie TP, 2005, RNA, V11, P1803, DOI 10.1261/rna.2214405; Murad F, 2006, NEW ENGL J MED, V355, P2003, DOI 10.1056/NEJMsa063904; Nienhuis HLA, 2009, AUTOIMMUNITY, V42, P302, DOI 10.1080/08916930902831746; Panchenko MP, 2009, CARDIOVASC PATHOL, V18, P167, DOI 10.1016/j.carpath.2008.03.008; PIERCE GB, 1991, DIFFERENTIATION, V46, P181, DOI 10.1111/j.1432-0436.1991.tb00880.x; Pleiss JA, 2007, MOL CELL, V27, P928, DOI 10.1016/j.molcel.2007.07.018; Poole LB, 2008, CURR OPIN CHEM BIOL, V12, P18, DOI 10.1016/j.cbpa.2008.01.021; Reddie KG, 2008, CURR OPIN CHEM BIOL, V12, P746, DOI 10.1016/j.cbpa.2008.07.028; Sawicka K, 2008, BIOCHEM SOC T, V36, P641, DOI 10.1042/BST0360641; Schepens B, 2005, NUCLEIC ACIDS RES, V33, P6884, DOI 10.1093/nar/gki1000; Sharin VG, 2010, STEM CELLS DEV; SHARINA IG, 2011, NITRIC OXIDE; Sharina IG, 2008, J BIOL CHEM, V283, P15104, DOI 10.1074/jbc.M710269200; Shi Y, 2007, MOL CELL, V28, P79, DOI 10.1016/j.molcel.2007.08.028; Shibayama M, 2009, FEBS J, V276, P6658, DOI 10.1111/j.1742-4658.2009.07380.x; Shin C, 2004, NAT REV MOL CELL BIO, V5, P727, DOI 10.1038/nrm1467; Stasch JP, 2006, J CLIN INVEST, V116, P2552, DOI 10.1172/JCI28371; Stone JR, 2006, ANTIOXID REDOX SIGN, V8, P243, DOI 10.1089/ars.2006.8.243; Sugamura K, 2011, FREE RADICAL BIO MED, V51, P978, DOI 10.1016/j.freeradbiomed.2011.05.004; Takeo K, 2009, AM J PHYSIOL-CELL PH, V297, pC330, DOI 10.1152/ajpcell.00009.2009; Vafa O, 2002, MOL CELL, V9, P1031, DOI 10.1016/S1097-2765(02)00520-8; Wang C, 2008, J BIOL CHEM, V283, P20277, DOI 10.1074/jbc.M803682200; Witten JT, 2011, TRENDS GENET, V27, P89, DOI 10.1016/j.tig.2010.12.001; Xue YC, 2009, MOL CELL, V36, P996, DOI 10.1016/j.molcel.2009.12.003; Zhang J, 2009, CELL DEATH DIFFER, V16, P1460, DOI 10.1038/cdd.2009.87	51	18	21	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 20	2012	7	7							e41099	10.1371/journal.pone.0041099	http://dx.doi.org/10.1371/journal.pone.0041099			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	977GL	22911749	gold, Green Published, Green Submitted			2022-12-25	WOS:000306644600048
J	Gismondi, E; Beisel, JN; Cossu-Leguille, C				Gismondi, Eric; Beisel, Jean-Nicolas; Cossu-Leguille, Carole			Polymorphus Minutus Affects Antitoxic Responses of Gammarus Roeseli Exposed to Cadmium	PLOS ONE			English	Article							PARASITE POMPHORHYNCHUS-LAEVIS; ACANTHOCEPHALAN PARASITES; MICROSPORIDIA PARASITES; VERTICAL TRANSMISSION; BIOLOGICAL INVASION; CAROTENOID-PIGMENTS; ENZYME-ACTIVITIES; FIELD EVIDENCE; DAPHNIA-MAGNA; SEX-RATIO	The acanthocephalan parasite Polymorphus minutus is a manipulator of its intermediate host Gammarus roeseli, which favours its transmission to the final host, a water bird. In contaminated environments, G. roeseli have to cope with two stresses, i.e. P. minutus infection and pollutants. As P. minutus survival relies on its host's survival, we investigated the influence of P. minutus on the antitoxic defence capacities and the energy reserves of G. roeseli females after cadmium exposure. In parallel, malondialdehyde, a toxic effect biomarker, was measured in G. roeseli females and in P. minutus. The results revealed that infected females displayed higher cell damage than uninfected ones, despite an apparent increase in reduced glutathione and metallothionein production. In fact, the increase of these antitoxic systems could be counterbalanced by carotenoid intake by the parasite, so that the overall defence system seemed less efficient in infected females than in uninfected ones. In addition, we demonstrated that cadmium induced cell damage in P. minutus, probably linked with cadmium accumulation in the parasite. Altogether, we observed a paradoxical pattern of responses suggesting that P. minutus increases cadmium toxicity in G. roeseli females although (i) it tends to increase several host antitoxic defence capacities and (ii) it bears part of the pollutant, as reflected by cell damage in the parasite.	[Gismondi, Eric; Beisel, Jean-Nicolas; Cossu-Leguille, Carole] Univ Lorraine, CNRS UMR 7146, LIEBE, Metz, France	Centre National de la Recherche Scientifique (CNRS); Universite de Lorraine	Gismondi, E (corresponding author), Univ Lorraine, CNRS UMR 7146, LIEBE, Metz, France.	eric.gismondi@hotmail.fr	Beisel, Jean-Nicolas/H-4392-2011; Gismondi, Eric/ABC-4356-2020	Beisel, Jean-Nicolas/0000-0002-1935-7689; Cossu-Leguille, Carole/0000-0002-6284-4415; Gismondi, Eric/0000-0003-3102-3443	French Ministry of Education and Research (Ministere de 458 l'Enseignement Superieur et de la Recherche)	French Ministry of Education and Research (Ministere de 458 l'Enseignement Superieur et de la Recherche)	This study was supported by the French Ministry of Education and Research (Ministere de 458 l'Enseignement Superieur et de la Recherche), which the authors sincerely thank here. The present work is part of the research program EC2CO. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alhama J, 2006, J CHROMATOGR A, V1107, P52, DOI 10.1016/j.chroma.2005.11.057; Amiard JC, 2006, AQUAT TOXICOL, V76, P160, DOI 10.1016/j.aquatox.2005.08.015; Babin A, 2010, AM NAT, V176, P234, DOI 10.1086/653670; Barata C, 2005, COMP BIOCHEM PHYS C, V140, P175, DOI 10.1016/j.cca.2005.01.013; BARRETT J, 1968, COMP BIOCHEM PHYSIOL, V27, P575, DOI 10.1016/0010-406X(68)90254-5; Baudrimont M, 2006, MAR POLLUT BULL, V52, P494, DOI 10.1016/j.marpolbul.2005.09.035; BEHRENS WA, 1991, LIPIDS, V26, P232, DOI 10.1007/BF02543977; Bigot A, 2011, ENVIRON TOXICOL, V26, P623, DOI 10.1002/tox.20599; Bollache L, 2002, J INVERTEBR PATHOL, V79, P102, DOI 10.1016/S0022-2011(02)00027-7; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; CARGILL AS, 1985, FRESHWATER BIOL, V15, P455, DOI 10.1111/j.1365-2427.1985.tb00215.x; Cezilly F, 2005, BEHAV PROCESS, V68, P223, DOI 10.1016/j.beproc.2004.08.013; Cornet S, 2010, PARASITOLOGY, V137, P137, DOI 10.1017/S0031182009991077; Cornet S, 2009, INT J PARASITOL, V39, P221, DOI 10.1016/j.ijpara.2008.06.007; ELENDT BP, 1990, WATER RES, V24, P1157, DOI 10.1016/0043-1354(90)90180-E; Forrow DM, 2000, ENVIRON TOXICOL CHEM, V19, P2100, DOI 10.1002/etc.5620190820; Gaillard M, 2004, COMP BIOCHEM PHYS B, V139, P129, DOI 10.1016/j.cbpc.2004.07.001; GILCHRIST BM, 1972, COMP BIOCHEM PHYSIOL, V42, P263, DOI 10.1016/0305-0491(72)90273-8; Gismondi E, 2012, PARASITOLOGY, V139, P1054, DOI 10.1017/S0031182012000315; Gismondi E, 2012, ECOTOXICOLOGY, V21, P1188, DOI 10.1007/s10646-012-0873-8; Gismondi E, 2012, ENVIRON POLLUT, V160, P17, DOI 10.1016/j.envpol.2011.09.021; Haine ER, 2007, PARASITOLOGY, V134, P1363, DOI 10.1017/S0031182007002715; Haine ER, 2004, INT J PARASITOL, V34, P1137, DOI 10.1016/j.ijpara.2004.06.006; Kennedy CR, 2006, ECOLOGY OF THE ACANTHOCEPHALA, P1, DOI 10.2277/ 0521850088; Lagrue C, 2007, ECOLOGY, V88, P2839, DOI 10.1890/06-2105.1; Langston W.J., 1998, METAL METABOLISM AQU; LEE WY, 1981, WATER AIR SOIL POLL, V15, P185, DOI 10.1007/BF00161252; LEROY P, 1993, CHROMATOGRAPHIA, V36, P130, DOI 10.1007/BF02263849; Marcogliese DJ, 2005, DIS AQUAT ORGAN, V63, P77, DOI 10.3354/dao063077; Medoc V, 2006, INT J PARASITOL, V36, P1351, DOI 10.1016/j.ijpara.2006.07.001; Medoc V, 2011, OIKOS, V120, P1452, DOI 10.1111/j.1600-0706.2011.19585.x; Medoc V, 2009, NATURWISSENSCHAFTEN, V96, P513, DOI 10.1007/s00114-008-0503-8; Minguez L, 2011, ECOTOXICOLOGY; Minguez L, 2009, ENVIRON RES, V109, P843, DOI 10.1016/j.envres.2009.07.012; Negre-Sadargues G, 2000, COMP BIOCHEM PHYS A, V127, P293, DOI 10.1016/S1095-6433(00)00258-0; PALOZZA P, 1992, METHOD ENZYMOL, V213, P403; Parmentier C, 1998, J CHROMATOGR B, V719, P37, DOI 10.1016/S0378-4347(98)00414-9; Paul-Pont I, 2010, ENVIRON POLLUT, V158, P3401, DOI 10.1016/j.envpol.2010.07.028; Plaistow SJ, 2001, INT J PARASITOL, V31, P346, DOI 10.1016/S0020-7519(01)00115-1; Rauque CA, 2009, J INVERTEBR PATHOL, V100, P35, DOI 10.1016/j.jip.2008.10.001; Rigaud T, 2003, PARASITOLOGY, V127, P571, DOI 10.1017/S0031182003004050; ROESIJADI G, 1992, AQUAT TOXICOL, V22, P81, DOI 10.1016/0166-445X(92)90026-J; Siddall R, 1998, PARASITOL RES, V84, P573, DOI 10.1007/s004360050451; Sparkes TC, 1996, OECOLOGIA, V106, P166, DOI 10.1007/BF00328595; Sroda S, 2011, ECOTOXICOLOGY, V20, P264, DOI 10.1007/s10646-010-0578-9; STILLMAN MJ, 1995, COORDIN CHEM REV, V144, P461, DOI 10.1016/0010-8545(95)01173-M; Sures B, 2007, J HELMINTHOL, V81, P191, DOI 10.1017/S0022149X07751465; SURES B, 1995, PARASITOL RES, V81, P494, DOI 10.1007/BF00931792; Sures B, 1999, PARASITOL TODAY, V15, P16, DOI 10.1016/S0169-4758(98)01358-1; Sures B, 2005, ENVIRON RES, V98, P83, DOI 10.1016/j.envres.2004.05.010; Sures B, 2004, TRENDS PARASITOL, V20, P170, DOI 10.1016/j.pt.2004.01.014; Sures B, 2002, ENVIRON POLLUT, V119, P333, DOI 10.1016/S0269-7491(01)00340-2; Taraschewski H, 2000, ADV PARASIT, V46, P1, DOI 10.1016/S0065-308X(00)46008-2; Terry RS, 2004, P ROY SOC B-BIOL SCI, V271, P1783, DOI 10.1098/rspb.2004.2793; Thomas F, 2000, J PARASITOL, V86, P650, DOI 10.1645/0022-3395(2000)086[0650:DPTEIG]2.0.CO;2; THOMAS F, 1995, OECOLOGIA, V104, P259, DOI 10.1007/BF00328591; Vasseur P, 2004, ENVIRON TOXICOL, V19, P433, DOI 10.1002/tox.20024	57	14	14	0	34	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 20	2012	7	7							e41475	10.1371/journal.pone.0041475	http://dx.doi.org/10.1371/journal.pone.0041475			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	977GL	22911795	gold, Green Published			2022-12-25	WOS:000306644600079
J	Stark, RJ; Aghakasiri, N; Rumbaut, RE				Stark, Ryan J.; Aghakasiri, Niloufar; Rumbaut, Rolando E.			Platelet-Derived Toll-Like Receptor 4 (Tlr-4) Is Sufficient to Promote Microvascular Thrombosis in Endotoxemia	PLOS ONE			English	Article							DISSEMINATED INTRAVASCULAR COAGULATION; MOUSE CREMASTER VENULES; P-SELECTIN; TISSUE FACTOR; IN-VIVO; LIPOPOLYSACCHARIDE; ACTIVATION; MICE; MICROPARTICLES; AGGREGATION	Endotoxin (lipopolysaccharide, LPS) produced by gram-negative bacteria initiates a host of pro-inflammatory effects through Toll-like receptor 4 (TLR-4). We reported previously that LPS enhances microvascular thrombosis in cremaster venules of wild-type mice, but had no effect in mice deficient in TLR-4. Since TLR-4 is expressed on various cell types, the cellular origin of TLR-4 responsible for the LPS-enhanced thrombosis remains undetermined. Platelets are known to express functional TLR-4. Platelet-derived TLR-4 has been suggested to mediate various inflammatory responses in endotoxemia, including production of tumor necrosis factor alpha (TNF-alpha) and interleukin-1 beta (IL-1 beta), two cytokines reported to enhance microvascular thrombosis. We determined whether platelet-derived TLR-4 was sufficient to mediate the enhanced thrombosis induced by endotoxin and whether these responses were accompanied by systemic increases in TNF-alpha and IL-1 beta. We isolated platelets from wild-type mice and transfused them into either of two strains of TLR-4-deficient mice (C57BL/10ScN and B6.B10ScN-TLR-4(lps-del)/Jth). The mice were then injected with LPS or saline, and the kinetics of thrombosis were studied 4 hours later. Transfusion of wild-type platelets restored responsiveness to LPS in TLR-4-deficient mice with regards to microvascular thrombosis but not to plasma levels of TNF-alpha or IL-1 beta. The accelerated rates of microvascular thrombosis induced by platelet transfusions were specific to TLR-4, since isolation and transfusion of platelets derived from TLR-4-deficient donors did not restore responsiveness to LPS. These studies demonstrate that platelet-derived TLR-4 is sufficient to promote microvascular thrombosis in endotoxemia, independent of systemic increases in TNF-alpha or IL-1 beta.	[Stark, Ryan J.; Rumbaut, Rolando E.] Baylor Coll Med, Dept Pediat, Houston, TX 77030 USA; [Aghakasiri, Niloufar; Rumbaut, Rolando E.] Baylor Coll Med, Dept Med, Houston, TX 77030 USA; [Rumbaut, Rolando E.] Michael E DeBakey VA Med Ctr, Houston, TX USA	Baylor College of Medicine; Baylor College of Medicine; Baylor College of Medicine	Stark, RJ (corresponding author), Baylor Coll Med, Dept Pediat, Houston, TX 77030 USA.	rrumbaut@bcm.edu	Stark, Ryan/O-1862-2019; Stark, Ryan/GZL-7445-2022	Stark, Ryan/0000-0001-6142-5502; Stark, Ryan/0000-0001-6142-5502; Rumbaut, Rolando/0000-0002-8486-1013	National Institutes of Health [HL-079368]; Department of Veterans Affairs, Veterans Health Administration, Office of Research and Development, Biomedical Laboratory Research and Development; NIH [T32-HL007939]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL079368, T32HL007939] Funding Source: NIH RePORTER; Veterans Affairs [I01BX000550] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Department of Veterans Affairs, Veterans Health Administration, Office of Research and Development, Biomedical Laboratory Research and Development(US Department of Veterans Affairs); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); Veterans Affairs(US Department of Veterans Affairs)	This study was supported in part by National Institutes of Health grant HL-079368, and by the Department of Veterans Affairs, Veterans Health Administration, Office of Research and Development, Biomedical Laboratory Research and Development. The contents of this manuscript are solely the responsibility of the authors and do not necessarily represent the views of the Department of Veterans Affairs or the United States Government. R.J. Stark was supported by NIH Grant T32-HL007939. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andonegui G, 2003, J CLIN INVEST, V111, P1011, DOI 10.1172/JCI200316510; Andonegui G, 2005, BLOOD, V106, P2417, DOI 10.1182/blood-2005-03-0916; Andonegui G, 2009, J CLIN INVEST, V119, P1921, DOI 10.1172/JCI36411; Aslam R, 2006, BLOOD, V107, P637, DOI 10.1182/blood-2005-06-2202; Brown GT, 2011, J IMMUNOL, V186, P5489, DOI 10.4049/jimmunol.1001623; Cerwinka WH, 2003, AM J PHYSIOL-HEART C, V284, pH535, DOI 10.1152/ajpheart.00311.2002; Chou J, 2004, BLOOD, V104, P3190, DOI 10.1182/blood-2004-03-0935; Clark SR, 2007, NAT MED, V13, P463, DOI 10.1038/nm1565; Cribbs SK, 2007, CRIT CARE MED, V35, P2646, DOI 10.1097/01.CCM.0000288082.99980.90; Dasgupta SK, 2009, BLOOD, V113, P1332, DOI 10.1182/blood-2008-07-167148; DAVIS MJ, 1987, MICROVASC RES, V34, P223, DOI 10.1016/0026-2862(87)90055-0; Falati S, 2003, J EXP MED, V197, P1585, DOI 10.1084/jem.20021868; Gando S, 1996, THROMB HAEMOSTASIS, V75, P224; Gawaz M, 1997, INTENS CARE MED, V23, P379, DOI 10.1007/s001340050344; Hashimoto K, 2009, J CARDIOVASC PHARM, V54, P57, DOI 10.1097/FJC.0b013e3181ab373d; Hoshino K, 1999, J IMMUNOL, V162, P3749; Hrachovinova I, 2003, NAT MED, V9, P1020, DOI 10.1038/nm899; Jayachandran M, 2007, J APPL PHYSIOL, V102, P429, DOI 10.1152/japplphysiol.01576.2005; Kornerup KN, 2010, J APPL PHYSIOL, V109, P758, DOI 10.1152/japplphysiol.01086.2009; Li ZJ, 2006, INVEST OPHTH VIS SCI, V47, P4794, DOI 10.1167/iovs.06-0381; Li ZJ, 2011, AM J PATHOL, V178, P1106, DOI 10.1016/j.ajpath.2010.12.001; MAYADAS TN, 1993, CELL, V74, P541, DOI 10.1016/0092-8674(93)80055-J; McCuskey RS, 1996, CARDIOVASC RES, V32, P752, DOI 10.1016/S0008-6363(96)00113-7; Medzhitov R, 1997, NATURE, V388, P394, DOI 10.1038/41131; Qureshi ST, 1999, J EXP MED, V189, P615, DOI 10.1084/jem.189.4.615; Rumbaut RE, 2006, AM J PHYSIOL-HEART C, V290, pH1671, DOI 10.1152/ajpheart.00305.2005; Rumbaut RE, 2004, MICROCIRCULATION, V11, P239, DOI 10.1080/10739680490425949; Sabroe I, 2002, J IMMUNOL, V168, P4701, DOI 10.4049/jimmunol.168.9.4701; Semeraro F, 2011, BLOOD, V118, P1952, DOI 10.1182/blood-2011-03-343061; Shashkin PN, 2008, J IMMUNOL, V181, P3495, DOI 10.4049/jimmunol.181.5.3495; Stahl AL, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006990; SUFFREDINI AF, 1989, NEW ENGL J MED, V321, P280, DOI 10.1056/NEJM198908033210503; Taylor FB, 2001, THROMB HAEMOSTASIS, V86, P1327, DOI 10.1055/s-0037-1616068; Yoshida H, 2011, INFLAMM BOWEL DIS, V17, P2217, DOI 10.1002/ibd.21593; Yoshida H, 2010, AM J PATHOL, V177, P2774, DOI 10.2353/ajpath.2010.100205; Zhang GY, 2009, J IMMUNOL, V182, P7997, DOI 10.4049/jimmunol.0802884	36	59	64	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 20	2012	7	7							e41254	10.1371/journal.pone.0041254	http://dx.doi.org/10.1371/journal.pone.0041254			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	977GL	22911769	gold, Green Published, Green Submitted			2022-12-25	WOS:000306644600063
J	Yang, Y; Zhou, L; Lu, L; Wang, L; Li, X; Jiang, P; Chan, LKY; Zhang, T; Yu, J; Kwong, J; Cheung, T; Chung, T; Mak, K; Sun, H; Wang, H				Yang, Y.; Zhou, L.; Lu, L.; Wang, L.; Li, X.; Jiang, P.; Chan, L. K. Y.; Zhang, T.; Yu, J.; Kwong, J.; Cheung, T. H.; Chung, T.; Mak, K.; Sun, H.; Wang, H.			A novel miR-193a-5p-YY1-APC regulatory axis in human endometrioid endometrial adenocarcinoma	ONCOGENE			English	Article						YY1; EEC; APC; EZH2; H3K27me3; microRNA	YIN YANG 1; SKELETAL MYOGENESIS; TUMOR-SUPPRESSOR; CATENIN PATHWAY; DNA METHYLATION; CANCER; MICRORNAS; PATHOGENESIS; DISEASE; BIOLOGY	Aberrant expression and altered function of transcription factors (TFs) have vital roles in many aspects of tumor development and progression. In this study, we investigated the functional significance of a TF, Yin Yang1 (YY1) in tumorigenesis of endometrioid endometrial carcinoma (EEC). We demonstrated that YY1 is upregulated in EEC cell lines and primary tumors; and its expression is associated with tumor stages. Depletion of YY1 inhibits EEC cell proliferation and migration both in vitro and in vivo, whereas overexpression of YY1 promotes EEC cell growth. These results suggest that YY1 functions as an oncogenic factor in EEC. Transcriptome analysis revealed a significant effect of YY1 on critical aspects of EEC tumorigenesis through inhibition of APC expression. Further mechanistic investigation uncovered a new epigenetic silencing mode of APC by YY1 through recruitment of EZH2 and trimethylation of histone 3 lysine 27 on its promoter region. Moreover, YY1 overexpression was found to be a consequence of miR-193a-5p downregulation through direct miR-193a-5p-YY1 interplay. Our results therefore establish a novel miR-193a-5p-YY1-APC axis, which contributes to EEC development, and may serve as future intervention target.	[Yang, Y.; Zhou, L.; Wang, L.; Chan, L. K. Y.; Zhang, T.; Kwong, J.; Cheung, T. H.; Chung, T.; Wang, H.] Chinese Univ Hong Kong, Dept Obstet & Gynaecol, Hong Kong, Hong Kong, Peoples R China; [Yang, Y.; Zhou, L.; Lu, L.; Wang, L.; Li, X.; Jiang, P.; Chan, L. K. Y.; Zhang, T.; Yu, J.; Kwong, J.; Sun, H.; Wang, H.] Chinese Univ Hong Kong, Prince Wales Hosp, Li Ka Shing Inst Hlth Sci, Hong Kong, Hong Kong, Peoples R China; [Lu, L.; Jiang, P.; Sun, H.] Chinese Univ Hong Kong, Dept Chem Pathol, Hong Kong, Hong Kong, Peoples R China; [Li, X.; Yu, J.] Chinese Univ Hong Kong, Inst Digest Dis, Hong Kong, Hong Kong, Peoples R China; [Li, X.; Yu, J.] Chinese Univ Hong Kong, Dept Med & Therapeut, Hong Kong, Hong Kong, Peoples R China; [Mak, K.] Chinese Univ Hong Kong, Sch Biomed Sci, Hong Kong, Hong Kong, Peoples R China	Chinese University of Hong Kong; Chinese University of Hong Kong; Prince of Wales Hospital; Chinese University of Hong Kong; Chinese University of Hong Kong; Chinese University of Hong Kong; Chinese University of Hong Kong	Wang, H (corresponding author), Chinese Univ Hong Kong, Prince Wales Hosp, Li Ka Shing Inst Hlth Sci 507A, Hong Kong, Hong Kong, Peoples R China.	huating.wang@cuhk.edu.hk	Sun, Hao/J-9964-2013; sun, hao/GRS-7732-2022; JIANG, Peiyong/AAZ-9898-2020; Li, Xiao-xing/B-9114-2008; Sun, Hao/T-5576-2019; Zhou, Liang/P-4174-2015; Zhang, Tao/ADM-1606-2022; Wang, Huating/C-6719-2014; Kwong, Joseph/H-2368-2013; Yu, Jun/D-8569-2015	Sun, Hao/0000-0002-5547-9501; Li, Xiao-xing/0000-0001-8791-7505; Sun, Hao/0000-0002-5547-9501; Zhou, Liang/0000-0001-5973-7873; Zhang, Tao/0000-0002-8644-8468; Wang, Huating/0000-0001-5474-2905; Kwong, Joseph/0000-0002-3380-6882; Yu, Jun/0000-0001-5008-2153; Jiang, Peiyong/0000-0003-4523-3476; CHUNG, Tony/0000-0002-6362-8546; Mak, Kingston King-Lun/0000-0002-4733-9146	Research Grants Council (RGC) of the Hong Kong Special Administrative Region, China [CUHK476309, CUHK476310, CUHK473211]; CUHK direct grants [2041474, 2041492, 2041662]	Research Grants Council (RGC) of the Hong Kong Special Administrative Region, China(Hong Kong Research Grants Council); CUHK direct grants	The work described in this paper was substantially supported by three General Research Funds (GRFs) from Research Grants Council (RGC) of the Hong Kong Special Administrative Region, China (CUHK476309 and CUHK476310 to HW, and CUHK473211 to HS), and three CUHK direct grants (2041474 to HS and 2041492 and 2041662 to HW).	Aguilera Oscar, 2007, Endocrine Metabolic & Immune Disorders-Drug Targets, V7, P13; Andl CD, 2010, J ONCOL, V2010, DOI 10.1155/2010/174715; Bansal N, 2009, CANCER CONTROL, V16, P8, DOI 10.1177/107327480901600102; Bartel DP, 2004, CELL, V116, P281, DOI 10.1016/S0092-8674(04)00045-5; Boren T, 2008, GYNECOL ONCOL, V110, P206, DOI 10.1016/j.ygyno.2008.03.023; Castellano G, 2009, CELL CYCLE, V8, P1367, DOI 10.4161/cc.8.9.8314; Cedar H, 2009, NAT REV GENET, V10, P295, DOI 10.1038/nrg2540; Chase A, 2011, CLIN CANCER RES, V17, P2613, DOI 10.1158/1078-0432.CCR-10-2156; Chung TKH, 2009, INT J CANCER, V124, P1358, DOI 10.1002/ijc.24071; DAWE CJ, 1964, JNCI-J NATL CANCER I, V33, P441; Fullgrabe J, 2011, ONCOGENE, V30, P3391, DOI 10.1038/onc.2011.121; Gordon S, 2006, ONCOGENE, V25, P1125, DOI 10.1038/sj.onc.1209080; Hatziapostolou M, 2011, CELL MOL LIFE SCI, V68, P1681, DOI 10.1007/s00018-010-0624-z; Huang YW, 2009, CANCER RES, V69, P9038, DOI 10.1158/0008-5472.CAN-09-1499; Knuutila S, 1998, AM J PATHOL, V152, P1107; Ko CY, 2008, J BIOL CHEM, V283, P30919, DOI 10.1074/jbc.M804029200; Lu LN, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0027596; Moreno-Bueno G, 2002, ONCOGENE, V21, P7981, DOI 10.1038/sj.onc.1205924; Nebert DW, 2002, TOXICOLOGY, V181, P131, DOI 10.1016/S0300-483X(02)00269-X; Pan Q, 2008, SEMIN REPROD MED, V26, P479, DOI 10.1055/s-0028-1096128; RICHARDSON GS, 1984, GYNECOL ONCOL, V17, P213, DOI 10.1016/0090-8258(84)90080-5; SUI G, 2009, MOL CELL PHARM, V1, P157, DOI DOI 10.4255/MCPHARMACOL.09.20; Takeshita F, 2010, MOL THER, V18, P181, DOI 10.1038/mt.2009.207; Wang H, 2008, CANCER CELL, V14, P369, DOI 10.1016/j.ccr.2008.10.006; Wang HT, 2007, MOL CELL BIOL, V27, P4374, DOI 10.1128/MCB.02020-06; Wang H, 2009, CELL CYCLE, V8, P1833, DOI 10.4161/cc.8.12.8851; Wang LJ, 2012, MOL THER, V20, P1222, DOI 10.1038/mt.2012.35; Wiggins JF, 2010, CANCER RES, V70, P5923, DOI 10.1158/0008-5472.CAN-10-0655; Yang HJ, 2006, BMC CANCER, V6, DOI 10.1186/1471-2407-6-212; Yu J, 2009, GASTROENTEROLOGY, V136, P640, DOI 10.1053/j.gastro.2008.10.050; Zaravinos A, 2010, CELL CYCLE, V9, P512, DOI 10.4161/cc.9.3.10588; Zysman M, 2002, CANCER RES, V62, P3663	32	60	66	0	13	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232			ONCOGENE	Oncogene	JUL 18	2013	32	29					3432	3442		10.1038/onc.2012.360	http://dx.doi.org/10.1038/onc.2012.360			11	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	186AZ	22907428				2022-12-25	WOS:000322014900004
J	Kim, KJ; Moon, SM; Kim, SA; Kang, KW; Yoon, JH; Ahn, SG				Kim, K-J; Moon, S-M; Kim, S-A; Kang, K-W; Yoon, J-H; Ahn, S-G			Transcriptional regulation of MDR-1 by HOXC6 in multidrug-resistant cells	ONCOGENE			English	Article						HOXC6; MDR-1; multidrug resistance (MDR); apoptosis	CANCER-CELLS; GENE-EXPRESSION; PROSTATE-CANCER; HOMEOBOX B3; MORPHOGENESIS; GROWTH; PHENOTYPE; BINDING; TISSUE; GLAND	Resistance to chemotherapeutic drugs is a significant clinical problem in the treatment of cancer and this resistance has been linked to the cellular expression of multidrug-efflux transporters. The aim of this study was to explore the role of HOXC6 in the regulation of multidrug resistance (MDR) to chemotherapeutic drugs. The HOXC6 gene was identified as being overexpressed in drug-resistant cells compared with parental cell lines. Transfection assays demonstrated that HOXC6 activated MDR-1 promoter activity. A series of MDR-1 promoter deletion mutants was examined and the minimal HOXC6-responsive region was identified to be in the TAAT motif (-2243 bp) of the MDR-1 promoter. Interestingly, overexpression of HOXC6 in the parental cell lines resulted in the upregulation of MDR-1 expression. The inhibition of HOXC6 using small interfering RNA led to the repression of MDR-1. We determined that knockdown of HOXC6 expression in MDR cells increased their sensitivity to paclitaxel. Flow cytometry analysis suggested that siHOXC6 could induce paclitaxel-induced apoptosis and that this was accompanied by an increased accumulation and a decreased release of paclitaxel. Taken together, our findings suggest that HOXC6 expression is an important mechanism of chemotherapeutic drug resistance via its regulation of MDR-1.	[Kim, K-J; Moon, S-M; Ahn, S-G] Chosun Univ, Dept Pathol, Sch Dent, Kwangju 501759, South Korea; [Kim, S-A] Dongguk Univ, Dept Biochem, Gyeongju, South Korea; [Kang, K-W] Seoul Natl Univ, Coll Pharm, Seoul, South Korea; [Yoon, J-H] Wonkwang Univ, Daejeon Dent Hosp, Dept Oral Pathol, Taejon, South Korea	Chosun University; Dongguk University; Seoul National University (SNU); Wonkwang University	Ahn, SG (corresponding author), Chosun Univ, Dept Pathol, Sch Dent, 375 Seosuk Dong, Kwangju 501759, South Korea.	ahnsg@chosun.ac.kr		Kim, Soo-A/0000-0001-6777-739X	National Research Foundation of Korea (NRF); Ministry of Education, Science and Technology [R13-2008-010-00000-0, 2011-0029091]	National Research Foundation of Korea (NRF)(National Research Foundation of Korea); Ministry of Education, Science and Technology(Ministry of Education, Science & Technology (MEST), Republic of Korea)	This research was supported by National Research Foundation of Korea (NRF) funded by the Ministry of Education, Science and Technology (No. R13-2008-010-00000-0; No. 2011-0029091).	Abate-Shen C, 2002, NAT REV CANCER, V2, P777, DOI 10.1038/nrc907; Bodey B, 2000, ANTICANCER RES, V20, P3281; Bodey B, 2000, ANTICANCER RES, V20, P2717; CASTRONOVO V, 1994, BIOCHEM PHARMACOL, V47, P137, DOI 10.1016/0006-2952(94)90447-2; Chen HX, 2003, CANCER BIOL THER, V2, P524, DOI 10.4161/cbt.2.5.525; Cho S, 2011, P NATL ACAD SCI USA, V108, P20778, DOI 10.1073/pnas.1019452108; Deeley RG, 2006, FEBS LETT, V580, P1103, DOI 10.1016/j.febslet.2005.12.036; DEVITA G, 1993, EUR J CANCER, V29A, P887, DOI 10.1016/S0959-8049(05)80432-0; Ernst T, 2002, AM J PATHOL, V160, P2169, DOI 10.1016/S0002-9440(10)61165-0; FRIEDMANN Y, 1994, CANCER RES, V54, P5981; Fujiki K, 2008, GASTROENTEROLOGY, V135, P907, DOI 10.1053/j.gastro.2008.06.034; Garcia-Gasca A, 2000, DEV DYNAM, V219, P261, DOI 10.1002/1097-0177(2000)9999:9999<::AID-DVDY1048>3.0.CO;2-3; Gottesman MM, 2002, NAT REV CANCER, V2, P48, DOI 10.1038/nrc706; Grishina IB, 2005, DEV BIOL, V288, P334, DOI 10.1016/j.ydbio.2005.08.018; Guo CC, 2005, INT J CANCER, V116, P155, DOI 10.1002/ijc.20919; Haimeur A, 2004, CURR DRUG METAB, V5, P21, DOI 10.2174/1389200043489199; JONES FS, 1993, P NATL ACAD SCI USA, V90, P6557, DOI 10.1073/pnas.90.14.6557; Kim SA, 2012, J CELL PHYSIOL, V227, P1, DOI 10.1002/jcp.22948; Lin YS, 2007, DEVELOPMENT, V134, P723, DOI 10.1242/dev.02765; Litman T, 2001, CELL MOL LIFE SCI, V58, P931, DOI 10.1007/PL00000912; McCabe CD, 2008, CANCER RES, V68, P1988, DOI 10.1158/0008-5472.CAN-07-5843; Miller GJ, 2003, CANCER RES, V63, P5879; Ramachandran S, 2005, ONCOGENE, V24, P188, DOI 10.1038/sj.onc.1207906; Ricort JM, 2002, J BIOL CHEM, V277, P19448, DOI 10.1074/jbc.M200439200; Svingen T, 2006, HEREDITY, V97, P88, DOI 10.1038/sj.hdy.6800847; Szakacs G, 2004, CANCER CELL, V6, P129, DOI 10.1016/j.ccr.2004.06.026; TIBERIO C, 1994, INT J CANCER, V58, P608, DOI 10.1002/ijc.2910580426; VANDERGEER P, 1994, ANNU REV CELL BIOL, V10, P251, DOI 10.1146/annurev.cellbio.10.1.251; Veraksa A, 2000, MOL GENET METAB, V69, P85, DOI 10.1006/mgme.2000.2963	29	20	20	0	7	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232			ONCOGENE	Oncogene	JUL 11	2013	32	28					3339	3349		10.1038/onc.2012.354	http://dx.doi.org/10.1038/onc.2012.354			11	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	180TM	22907429				2022-12-25	WOS:000321620200004
J	Lim, U; Turner, SD; Franke, AA; Cooney, RV; Wilkens, LR; Ernst, T; Albright, CL; Novotny, R; Chang, LD; Kolonel, LN; Murphy, SP; Le Marchand, L				Lim, Unhee; Turner, Stephen D.; Franke, Adrian A.; Cooney, Robert V.; Wilkens, Lynne R.; Ernst, Thomas; Albright, Cheryl L.; Novotny, Rachel; Chang, Linda; Kolonel, Laurence N.; Murphy, Suzanne P.; Le Marchand, Loic			Predicting Total, Abdominal, Visceral and Hepatic Adiposity with Circulating Biomarkers in Caucasian and Japanese American Women	PLOS ONE			English	Article							BODY-FAT DISTRIBUTION; MAGNETIC-RESONANCE-SPECTROSCOPY; INSULIN-RESISTANCE; METABOLIC SYNDROME; LIVER FAT; WAIST CIRCUMFERENCE; SUBCUTANEOUS FAT; MEASUREMENT SITE; RISK-FACTOR; OBESITY	Background: Characterization of abdominal and intra-abdominal fat requires imaging, and thus is not feasible in large epidemiologic studies. Objective: We investigated whether biomarkers may complement anthropometry (body mass index [BMI], waist circumference [WC], and waist-hip ratio [WHR]) in predicting the size of the body fat compartments by analyzing blood biomarkers, including adipocytokines, insulin resistance markers, sex steroid hormones, lipids, liver enzymes and gastro-neuropeptides. Methods: Fasting levels of 58 blood markers were analyzed in 60 healthy, Caucasian or Japanese American postmenopausal women who underwent anthropometric measurements, dual energy X-ray absorptiometry (DXA), and abdominal magnetic resonance imaging. Total, abdominal, visceral and hepatic adiposity were predicted based on anthropometry and the biomarkers using Random Forest models. Results: Total body fat was well predicted by anthropometry alone (R-2 = 0.85), by the 5 best predictors from the biomarker model alone (leptin, leptin-adiponectin ratio [LAR], free estradiol, plasminogen activator inhibitor-1 [PAI1], alanine transaminase [ALT]; R-2 = 0.69), or by combining these 5 biomarkers with anthropometry (R-2 = 0.91). Abdominal adiposity (DXA trunk-to-periphery fat ratio) was better predicted by combining the two types of predictors (R-2 = 0.58) than by anthropometry alone (R-2 = 0.53) or the 5 best biomarkers alone (25(OH)-vitamin D-3, insulin-like growth factor binding protein-1 [IGFBP1], uric acid, soluble leptin receptor [sLEPR], Coenzyme Q10; R-2 = 0.35). Similarly, visceral fat was slightly better predicted by combining the predictors (R-2 = 0.68) than by anthropometry alone (R-2 = 0.65) or the 5 best biomarker predictors alone (leptin, C-reactive protein [CRP], LAR, lycopene, vitamin D-3; R-2 = 0.58). Percent liver fat was predicted better by the 5 best biomarker predictors (insulin, sex hormone binding globulin [SHBG], LAR, alpha-tocopherol, PAI1; R-2 = 0.42) or by combining the predictors (R-2 = 0.44) than by anthropometry alone (R-2 = 0.29). Conclusion: The predictive ability of anthropometry for body fat distribution may be enhanced by measuring a small number of biomarkers. Studies to replicate these data in men and other ethnic groups are warranted.	[Lim, Unhee; Wilkens, Lynne R.; Novotny, Rachel; Kolonel, Laurence N.; Murphy, Suzanne P.; Le Marchand, Loic] Univ Hawaii, Ctr Canc, Program Epidemiol, Honolulu, HI 96822 USA; [Turner, Stephen D.] Univ Virginia, Sch Med, Bioinformat Core, Charlottesville, VA 22908 USA; [Franke, Adrian A.] Univ Hawaii, Ctr Canc, Canc Biol Program, Honolulu, HI 96822 USA; [Cooney, Robert V.] Univ Hawaii, John A Burns Sch Med, Off Publ Hlth Studies, Honolulu, HI 96822 USA; [Ernst, Thomas; Chang, Linda] Univ Hawaii, John A Burns Sch Med, Div Neurol, Honolulu, HI 96822 USA; [Albright, Cheryl L.] Univ Hawaii, Ctr Canc, Prevent & Control Program, Honolulu, HI 96822 USA; [Albright, Cheryl L.] Univ Hawaii, Sch Nursing, Honolulu, HI 96822 USA	Cancer Research Center of Hawaii; University of Hawaii System; University of Virginia; Cancer Research Center of Hawaii; University of Hawaii System; University of Hawaii System; University of Hawaii System; Cancer Research Center of Hawaii; University of Hawaii System; University of Hawaii System	Lim, U (corresponding author), Univ Hawaii, Ctr Canc, Program Epidemiol, Honolulu, HI 96822 USA.	ulim@cc.hawaii.edu	Turner, Stephen/GXM-4654-2022; Lim, Unhee/AEA-8591-2022	Lim, Unhee/0000-0001-6221-7190	University of Hawaii Cancer Center; National Cancer Institute [R37 CA54281, P30 CA71789]; National Institutes of Health [5P20-RR11091, G12-RR003061]; National Institutes of Health - National Center for Research Resources [P20 RR11091]; NATIONAL CANCER INSTITUTE [P30CA071789, R37CA054281] Funding Source: NIH RePORTER; NATIONAL CENTER FOR RESEARCH RESOURCES [G12RR003061, P20RR011091] Funding Source: NIH RePORTER	University of Hawaii Cancer Center; National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Institutes of Health - National Center for Research Resources(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR))	Funding for this study was provided in part by the University of Hawaii Cancer Center (SPM, RN, LLM) and individual research funds (UL, LLM), as well as by the National Cancer Institute for the Multiethnic Cohort (R37 CA54281: LNK) and for the University of Hawaii Cancer Center's Shared Resources (P30 CA71789), the National Institutes of Health for the University of Hawaii-Queen's Medical Center MR Research Center (5P20-RR11091 and G12-RR003061: TE and LC), and the National Institutes of Health - National Center for Research Resources for the University of Hawaii Clinical Research Center (P20 RR11091). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Balkau B, 2010, BMC GASTROENTEROL, V10, DOI 10.1186/1471-230X-10-56; Bea JW, 2011, CLIN CHEM LAB MED, V49, P817, DOI 10.1515/CCLM.2011.122; Beasley LE, 2009, OBESITY, V17, P1062, DOI 10.1038/oby.2008.627; Bergman RN, 2006, OBESITY, V14, p16S, DOI 10.1038/oby.2006.277; Bosy-Westphal A, 2010, J NUTR, V140, P954, DOI 10.3945/jn.109.118737; Boyko EJ, 2000, DIABETES CARE, V23, P465, DOI 10.2337/diacare.23.4.465; Breiman L., 2001, Machine Learning, V45, P5, DOI 10.1023/A:1010933404324; Camhi SM, 2011, OBESITY, V19, P402, DOI 10.1038/oby.2010.248; Carr DB, 2004, DIABETES, V53, P2087, DOI 10.2337/diabetes.53.8.2087; Carroll JF, 2009, OBESITY, V17, P1420, DOI 10.1038/oby.2008.657; Cnop M, 2003, DIABETOLOGIA, V46, P459, DOI 10.1007/s00125-003-1074-z; Cohen J, 2003, APPL MULTIPLE REGRES, V3rd, DOI DOI 10.4324/9780203774441; Fierbinteanu-Braticevici C, 2010, WORLD J GASTROENTERO, V16, P4784, DOI 10.3748/wjg.v16.i38.4784; Friedman J., 2001, ELEMENTS STAT LEARNI, DOI DOI 10.1007/978-0-387-84858-7; Goodpaster BH, 2005, ARCH INTERN MED, V165, P777, DOI 10.1001/archinte.165.7.777; Guiu B, 2009, EUR RADIOL, V19, P1786, DOI 10.1007/s00330-009-1330-9; Harrell FE, 2001, REGRESSION MODELING; Indulekha K, 2011, CLIN BIOCHEM, V44, P281, DOI 10.1016/j.clinbiochem.2010.12.015; Ishii M, 2005, TOHOKU J EXP MED, V206, P23, DOI 10.1620/tjem.206.23; Ix JH, 2009, J CLIN ENDOCR METAB, V94, P4492, DOI 10.1210/jc.2009-0916; Kabir M, 2005, AM J PHYSIOL-ENDOC M, V288, pE454, DOI 10.1152/ajpendo.00203.2004; Kim BK, 2009, BREAST CANCER RES, V11, DOI 10.1186/bcr2247; Koh SJ, 2008, CLIN CHIM ACTA, V389, P45, DOI 10.1016/j.cca.2007.11.017; Kolonel LN, 2000, AM J EPIDEMIOL, V151, P346, DOI 10.1093/oxfordjournals.aje.a010213; Koster A, 2010, OBESITY, V18, P2354, DOI 10.1038/oby.2010.86; Kotronen A, 2010, OBESITY, V18, P937, DOI 10.1038/oby.2009.326; Kuk JL, 2006, DIABETES CARE, V29, P679, DOI 10.2337/diacare.29.03.06.dc05-1500; Kumagai S, 2005, METAB SYNDR RELAT D, V3, P85, DOI 10.1089/met.2005.3.85; Lee CG, 2009, J CLIN ENDOCR METAB, V94, P1104, DOI 10.1210/jc.2008-0701; Lemieux S, 1996, AM J CLIN NUTR, V64, P685, DOI 10.1093/ajcn/64.5.685; Li CY, 2009, AM J CLIN NUTR, V90, P1457, DOI 10.3945/ajcn.2009.28141; Lim U, 2011, NUTR DIABETES, V1, DOI 10.1038/nutd.2011.2; Lim U, 2012, J ACAD NUTR IN PRESS; Loomba R, 2010, GASTROENTEROLOGY, V139, P836, DOI 10.1053/j.gastro.2010.06.009; Ludescher B, 2009, INVEST RADIOL, V44, P712, DOI 10.1097/RLI.0b013e3181afbb1e; Miyazaki Y, 2009, CARDIOVASC DIABETOL, V8, DOI 10.1186/1475-2840-8-44; Montagne CT, 2000, DIABETES, V49, P883, DOI 10.2337/diabetes.49.6.883; Nakamura Y, 2009, OBESITY, V17, P1269, DOI 10.1038/oby.2009.3; Nielsen TL, 2007, J CLIN ENDOCR METAB, V92, P2696, DOI 10.1210/jc.2006-1847; Nobili V, 2006, EUR J ENDOCRINOL, V155, P735, DOI 10.1530/eje.1.02288; Oh TH, 2008, J GASTROEN HEPATOL, V23, P411, DOI 10.1111/j.1440-1746.2007.05125.x; Rodenburg W, 2008, PHYSIOL GENOMICS, V33, P78, DOI 10.1152/physiolgenomics.00167.2007; Rose DP, 2007, ENDOCR REV, V28, P763, DOI 10.1210/er.2006-0019; Snijder MB, 2005, DIABETOLOGIA, V48, P301, DOI 10.1007/s00125-004-1637-7; Sorensen HT, 2003, J CLIN GASTROENTEROL, V36, P356, DOI 10.1097/00004836-200304000-00015; Stefan N, 2007, DIABETES CARE, V30, P1173, DOI 10.2337/dc06-2342; Sun Q, 2010, AM J EPIDEMIOL, V172, P1442, DOI 10.1093/aje/kwq306; Svetnik V, 2003, J CHEM INF COMP SCI, V43, P1947, DOI 10.1021/ci034160g; Szczepaniak LS, 2005, AM J PHYSIOL-ENDOC M, V288, pE462, DOI 10.1152/ajpendo.00064.2004; Tanko LB, 2004, CIRCULATION, V110, P2246, DOI 10.1161/01.CIR.0000144470.55149.E5; Targher G, 2007, NUTR METAB CARDIOVAS, V17, P517, DOI 10.1016/j.numecd.2006.04.002; Tonjes A, 2010, CURR PHARM DESIGN, V16, P1921, DOI 10.2174/138161210791208938; Turer AT, 2012, J CLIN ENDOCRINOL ME; van Dijk SJ, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0014422; Vohl MC, 2004, OBES RES, V12, P1217, DOI 10.1038/oby.2004.153; Wajchenberg BL, 2002, HORM METAB RES, V34, P616, DOI 10.1055/s-2002-38256; Wang S, 2009, INT J OBESITY, V33, P481, DOI 10.1038/ijo.2008.277; Young KA, 2009, J CLIN ENDOCR METAB, V94, P3306, DOI 10.1210/jc.2009-0079	58	39	39	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 17	2012	7	8							e43502	10.1371/journal.pone.0043502	http://dx.doi.org/10.1371/journal.pone.0043502			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	996DG	22912885	Green Published, gold, Green Submitted			2022-12-25	WOS:000308063700113
J	Pais, R; Bhowmick, S; Chattopadhyay, S; Lemire, Y; Sharafieh, R; Yadav, R; O'Rourke, J; Cone, RE				Pais, Roshan; Bhowmick, Sourojit; Chattopadhyay, Subhasis; Lemire, Yen; Sharafieh, Roshanak; Yadav, Rajwahrdan; O'Rourke, James; Cone, Robert E.			An Intracameral Injection of Antigen Induces In Situ Chemokines and Cytokines Required for the Generation of Circulating Immunoregulatory Monocytes	PLOS ONE			English	Article							NECROSIS-FACTOR-ALPHA; GROWTH-FACTOR-BETA; IMMUNE DEVIATION ACAID; ANTERIOR-CHAMBER; TGF-BETA; T-CELLS; DIVERGENT ROLES; BONE-MARROW; INFLAMMATORY MONOCYTES; PRESENTING CELLS	Anterior Chamber-Associated Immune Deviation (ACAID) induced by an intracameral injection of antigen generates antigen-specific regulatory splenic T cells that suppress specifically cell-mediated immunity specific for the injected antigen. Circulating F4/80(+) cells recovered from mice receiving an intracameral injection of antigen are thought to be ocular in origin and induce the development of thymic and splenic regulatory T cells. We have shown previously that after the intracameral injection of antigen there is a CCR2/CCL2-dependent infiltration of circulating F4/80(+) cells into the anterior chamber associated with the generation of circulating, ACAID-inducing F4/80(+) monocytes. Here we tested the hypothesis that the intracameral injection of antigen induces events in the anterior chamber that are associated with the induction of circulating immunoregulatory monocytes that induce the suppression of cell-mediated immunity. The intracameral injection of antigen resulted in aqueous humor (i) a time-dependent increase of CCL2 and CCL7, (ii) a transient increase in TNF-alpha, and (iii) an infiltration of CD11b(hi), Gr1(hi) and F4/80(+) as well as F4/80(-) and Gr1(hi) peripheral blood cells into the anterior chamber. Further characterization of these F4/80(+) cells revealed that they are Ly 6C(hi), LY6G(lo) or negative, 7/4 (LY6B)(hi), CD115(+), CD45(+), CD49B(+), and CD62 L+. Antibody-mediated neutralization of TGF-beta in situ in the anterior chamber prevented the induction of circulating, ACAID-inducing monocytes and ACAID. These cells did not increase in the irides of ACAID-refractory CCR2-/- and CCL2-/- mice that received an intracameral injection of antigen. Our results extend our suggestion that ACAID is initiated as the result of a mild proinflammatory response to intracameral injection that results in the infiltration of a CCR2(+) subset of monocytes into the anterior chamber where there is a TGF-beta-dependent induction of an immunosuppressive phenotype in the infiltrated monocytes that recirculate to induce antigen-specific regulatory T cells.	[Pais, Roshan; Bhowmick, Sourojit; Chattopadhyay, Subhasis; Lemire, Yen; Sharafieh, Roshanak; Yadav, Rajwahrdan; O'Rourke, James; Cone, Robert E.] Univ Connecticut, Ctr Hlth, Dept Immunol, Farmington, CT USA	University of Connecticut	Pais, R (corresponding author), Morehouse Sch Med, Dept Microbiol Biochem & Immunol, Atlanta, GA 30310 USA.	Cone@UCHC.EDU	Pais, Roshan/AAV-3585-2021		United States Public Health Service/National Eye Institute [EY017289, EY017537]; Connecticut Lions Eye Research Foundation; NATIONAL EYE INSTITUTE [R01EY017537, R01EY017289] Funding Source: NIH RePORTER	United States Public Health Service/National Eye Institute; Connecticut Lions Eye Research Foundation; NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI))	Work in this laboratory is supported by United States Public Health Service/National Eye Institute grants EY017289, EY017537 (p://www.nei.nih.gov) and the Connecticut Lions Eye Research Foundation. The funders had no role in study design, data collection and analysis, decision to publish or preparation of the manuscript.	Armant M, 1999, J EXP MED, V190, P1175, DOI 10.1084/jem.190.8.1175; Ashour HM, 2006, J IMMUNOL, V177, P8331, DOI 10.4049/jimmunol.177.12.8331; Augier S, 2010, J IMMUNOL, V185, P7165, DOI 10.4049/jimmunol.0902583; Baeck C, 2012, GUT, V61, P416, DOI 10.1136/gutjnl-2011-300304; Bhowmick S, 2011, INT IMMUNOL, V23, P119, DOI 10.1093/intimm/dxq461; Bian ZM, 2004, INVEST OPHTH VIS SCI, V45, P1887, DOI 10.1167/iovs.03-0608; Biswas SK, 2010, NAT IMMUNOL, V11, P889, DOI 10.1038/ni.1937; Camelo S, 2003, INVEST OPHTH VIS SCI, V44, P5212, DOI 10.1167/iovs.03-0181; Cone RE, 2009, OPHTHALMOLOGY EYE DI, V2009, P133; Cone RE, 2010, OPHTHALMOL EYE DIS, V2, P57, DOI 10.4137/OED.S6113; Cone Robert E., 2008, V94, P138, DOI 10.1159/000154998; DIAMOND MS, 1990, J CELL BIOL, V111, P3129, DOI 10.1083/jcb.111.6.3129; Dullforce PA, 2004, J IMMUNOL, V172, P6701, DOI 10.4049/jimmunol.172.11.6701; FERGUSON TA, 1994, INVEST OPHTH VIS SCI, V35, P2643; Ferguson TA, 1994, INVEST OPHTH VIS SCI, V35, P085; FLEMING TJ, 1993, J IMMUNOL, V151, P2399; Fukao T, 2003, TRENDS IMMUNOL, V24, P358, DOI 10.1016/S1471-4906(03)00139-X; Gautier EL, 2009, ARTERIOSCL THROM VAS, V29, P1412, DOI 10.1161/ATVBAHA.108.180505; Geissmann F, 2003, IMMUNITY, V19, P71, DOI 10.1016/S1074-7613(03)00174-2; Gelman AE, 2010, AM J TRANSPLANT, V10, P1189, DOI 10.1111/j.1600-6143.2010.03101.x; Hamid T, 2009, CIRCULATION, V119, P1386, DOI 10.1161/CIRCULATIONAHA.108.802918; HARA Y, 1993, J IMMUNOL, V151, P5162; Holt MP, 2008, J LEUKOCYTE BIOL, V84, P1410, DOI 10.1189/jlb.0308173; Jia T, 2008, J IMMUNOL, V180, P6846, DOI 10.4049/jimmunol.180.10.6846; Jimenez-Sainz MC, 2003, MOL PHARMACOL, V64, P773, DOI 10.1124/mol.64.3.773; Kanamori H, 2007, BIOCHEM BIOPH RES CO, V360, P772, DOI 10.1016/j.bbrc.2007.06.148; Karlmark KR, 2009, HEPATOLOGY, V50, P261, DOI 10.1002/hep.22950; Kezuka T, 2004, OCUL IMMUNOL INFLAMM, V12, P17, DOI 10.1076/ocii.12.1.17.28066; Kezuka T, 2000, INVEST OPHTH VIS SCI, V41, P1803; Khera TK, 2010, PROG RETIN EYE RES, V29, P610, DOI 10.1016/j.preteyeres.2010.08.003; Kriegel MA, 2012, P NATL ACAD SCI USA, V109, P3457, DOI 10.1073/pnas.1115308109; Kruger Bernd, 2008, Transplant Rev (Orlando), V22, P131, DOI 10.1016/j.trre.2007.12.002; Kuziel WA, 1997, P NATL ACAD SCI USA, V94, P12053, DOI 10.1073/pnas.94.22.12053; Lai JJ, 2009, J CLIN INVEST, V119, P3739, DOI 10.1172/JCI39335; Li X, 2006, IMMUNOLOGY, V117, P566, DOI 10.1111/j.1365-2567.2006.02333.x; Liss C, 2001, INT J CANCER, V93, P781, DOI 10.1002/ijc.1407; Liu Y, 2012, J IMMUNOL, V188, P5500, DOI 10.4049/jimmunol.1103505; Lu B, 1998, J EXP MED, V187, P601, DOI 10.1084/jem.187.4.601; Lu HY, 2011, FASEB J, V25, P3344, DOI 10.1096/fj.10-178939; Ma HL, 2010, ARTHRITIS RHEUM-US, V62, P430, DOI 10.1002/art.27203; MACKAY F, 1993, J EXP MED, V177, P1277, DOI 10.1084/jem.177.5.1277; Martinez CO, 2010, AM J PHYSIOL-REG I, V299, pR832, DOI 10.1152/ajpregu.00797.2009; Masli S, 2006, INT IMMUNOL, V18, P689, DOI 10.1093/intimm/dxl006; Masli S, 2009, IMMUNOLOGY, V127, P62, DOI 10.1111/j.1365-2567.2008.02933.x; Mitchell C, 2009, AM J PATHOL, V174, P1766, DOI 10.2353/ajpath.2009.080632; Niederkorn JY, 2002, CRIT REV IMMUNOL, V22, P13; Ohta K, 2000, INVEST OPHTH VIS SCI, V41, P2591; Peschon JJ, 1998, J IMMUNOL, V160, P943; Qian BZ, 2011, NATURE, V475, P222, DOI 10.1038/nature10138; Sakamoto T, 2000, GENE THER, V7, P1915, DOI 10.1038/sj.gt.3301320; Schilling M, 2009, BRAIN RES, V1289, P79, DOI 10.1016/j.brainres.2009.06.054; Semple BD, 2010, J CEREBR BLOOD F MET, V30, P769, DOI 10.1038/jcbfm.2009.262; Semple BD, 2010, J CEREBR BLOOD F MET, V30, P459, DOI 10.1038/jcbfm.2009.240; Seo SU, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1001304; Serbina NV, 2008, ANNU REV IMMUNOL, V26, P421, DOI 10.1146/annurev.immunol.26.021607.090326; Shi C, 2011, J IMMUNOL, V187, P5293, DOI 10.4049/jimmunol.1101721; Sriram K, 2007, J NEUROIMMUNE PHARM, V2, P140, DOI 10.1007/s11481-007-9070-6; Stout RD, 2004, J LEUKOCYTE BIOL, V76, P509, DOI 10.1189/jlb.0504272; Stout RD, 2009, J LEUKOCYTE BIOL, V86, P1105, DOI 10.1189/jlb.0209073; Suvannavejh GC, 2000, CELL IMMUNOL, V205, P24, DOI 10.1006/cimm.2000.1706; Tacke F, 2006, J EXP MED, V203, P583, DOI 10.1084/jem.20052119; Tsou CL, 2007, J CLIN INVEST, V117, P902, DOI 10.1172/JCI29919; Turner SJ, 1998, J BIOL CHEM, V273, P25987, DOI 10.1074/jbc.273.40.25987; Vega JL, 2009, AM J PATHOL, V175, P1218, DOI 10.2353/ajpath.2009.090264; Wang YF, 2001, J LEUKOCYTE BIOL, V69, P741; WILBANKS GA, 1992, EUR J IMMUNOL, V22, P165, DOI 10.1002/eji.1830220125; WILBANKS GA, 1991, J IMMUNOL, V146, P3018; Wilbanks GA, 1992, EUR J IMMUNOL, V22, P031; Xing ZQ, 2010, DIS MODEL MECH, V3, P451, DOI 10.1242/dmm.003186; Xu YY, 2008, BRIT J HAEMATOL, V142, P192, DOI 10.1111/j.1365-2141.2008.07130.x; Yamagami S, 2004, INVEST OPHTH VIS SCI, V45, P515, DOI 10.1167/iovs.03-0912; Yi JY, 2005, J BIOL CHEM, V280, P10870, DOI 10.1074/jbc.M413223200; Yona S, 2010, CURR OPIN HEMATOL, V17, P53, DOI 10.1097/MOH.0b013e3283324f80; Zamiri P, 2007, OCUL IMMUNOL INFLAMM, V15, P279, DOI 10.1080/09273940701382432	74	2	2	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 17	2012	7	8							e43182	10.1371/journal.pone.0043182	http://dx.doi.org/10.1371/journal.pone.0043182			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	996DG	22912822	Green Published, gold, Green Submitted			2022-12-25	WOS:000308063700058
J	Zhou, WJ; Chen, LG; Paul, J; Yang, SF; Li, FZ; Sampson, K; Woodgett, JR; Beaulieu, JM; Gamble, KL; Li, XH				Zhou, Wenjun; Chen, Ligong; Paul, Jodi; Yang, Sufen; Li, Fuzeng; Sampson, Karen; Woodgett, Jim R.; Beaulieu, Jean Martin; Gamble, Karen L.; Li, Xiaohua			The Effects of Glycogen Synthase Kinase-3beta in Serotonin Neurons	PLOS ONE			English	Article							LOCOMOTOR-ACTIVITY; 5-HT1B RECEPTORS; IN-VIVO; AGGRESSIVE-BEHAVIOR; SIGNAL-TRANSDUCTION; ADENYLATE-CYCLASE; FRONTAL-CORTEX; CELL-SURVIVAL; ANXIETY-LIKE; OPEN-FIELD	Glycogen synthase kinase-3 (GSK3) is a constitutively active protein kinase in brain. Increasing evidence has shown that GSK3 acts as a modulator in the serotonin neurotransmission system, including direct interaction with serotonin 1B (5-HT1B) receptors in a highly selective manner and prominent modulating effect on 5-HT1B receptor activity. In this study, we utilized the serotonin neuron-selective GSK3 beta knockout (snGSK3 beta-KO) mice to test if GSK3 beta in serotonin neurons selectively modulates 5-HT1B autoreceptor activity and function. The snGSK3 beta-KO mice were generated by crossbreeding GSK3 beta-floxed mice and ePet1-Cre mice. These mice had normal growth and physiological characteristics, similar numbers of tryptophan hydroxylase-2 (TpH2)-expressing serotonin neurons, and the same brain serotonin content as in littermate wild type mice. However, the expression of GSK3 beta in snGSK3 beta-KO mice was diminished in TpH2-expressing serotonin neurons. Compared to littermate wild type mice, snGSK3 beta-KO mice had a reduced response to the 5-HT1B receptor agonist anpirtoline in the regulation of serotonergic neuron firing, cAMP production, and serotonin release, whereas these animals displayed a normal response to the 5-HT1A receptor agonist 8-OH-DPAT. The effect of anpirtoline on the horizontal, center, and vertical activities in the open field test was differentially affected by GSK3 beta depletion in serotonin neurons, wherein vertical activity, but not horizontal activity, was significantly altered in snGSK3 beta-KO mice. In addition, there was an enhanced anti-immobility response to anpirtoline in the tail suspension test in snGSK3 beta-KO mice. Therefore, results of this study demonstrated a serotonin neuron-targeting function of GSK3 beta by regulating 5-HT1B autoreceptors, which impacts serotonergic neuron firing, serotonin release, and serotonin-regulated behaviors.	[Zhou, Wenjun; Chen, Ligong; Paul, Jodi; Yang, Sufen; Li, Fuzeng; Gamble, Karen L.; Li, Xiaohua] Univ Alabama Birmingham, Dept Psychiat & Behav Neurobiol, Birmingham, AL 35294 USA; [Sampson, Karen] Univ Laval, Dept Phys, Fac Sci & Engn, Quebec City, PQ G1K 7P4, Canada; [Woodgett, Jim R.] Mt Sinai Hosp, Samuel Lunenfeld Res Inst, Toronto, ON M5G 1X5, Canada; [Beaulieu, Jean Martin] Univ Laval, Fac Med, Dept Psychiat & Neurosci, Quebec City, PQ G1K 7P4, Canada	University of Alabama System; University of Alabama Birmingham; Laval University; University of Toronto; University Toronto Affiliates; Sinai Health System Toronto; Lunenfeld Tanenbaum Research Institute; Laval University	Zhou, WJ (corresponding author), Univ Alabama Birmingham, Dept Psychiat & Behav Neurobiol, Birmingham, AL 35294 USA.	xiaohua.li@stvhs.com	Woodgett, Jim/F-1087-2010; Beaulieu, Jean-Martin/A-7598-2008; Zhou, Wenjun/H-2824-2016	Woodgett, Jim/0000-0003-3731-5797; Beaulieu, Jean-Martin/0000-0002-0446-7447; Zhou, Wenjun/0000-0003-4042-4329; Zhou, wenjun/0000-0002-8268-0251; Gamble, Karen/0000-0003-3813-8577	National Institutes of Health (NIH) [MH86622]; Canadian Institutes of Health Research (CIHR) [MOP74711]; CIHR [NSA93798]; NIH [GM086683]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R00GM086683, K99GM086683] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [K02MH086622] Funding Source: NIH RePORTER	National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Canadian Institutes of Health Research (CIHR)(Canadian Institutes of Health Research (CIHR)); CIHR(Canadian Institutes of Health Research (CIHR)); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))	This work was supported by National Institutes of Health (NIH) grant MH86622 (XL), Canadian Institutes of Health Research (CIHR) grant MOP74711 (JRW), CIHR grant NSA93798 (JMB), and NIH grant GM086683 (KLG). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alimohamad H, 2005, BIOL PSYCHIAT, V57, P533, DOI 10.1016/j.biopsych.2004.11.036; Beaulieu JM, 2008, P NATL ACAD SCI USA, V105, P1333, DOI 10.1073/pnas.0711496105; Beaulieu JM, 2008, CELL, V132, P125, DOI 10.1016/j.cell.2007.11.041; Blier P, 1998, ANN NY ACAD SCI, V861, P204, DOI 10.1111/j.1749-6632.1998.tb10192.x; Bockaert J, 2006, CELL TISSUE RES, V326, P553, DOI 10.1007/s00441-006-0286-1; BOUHELAL R, 1988, EUR J PHARMACOL, V151, P189, DOI 10.1016/0014-2999(88)90799-6; CADE JFJ, 1949, MED J AUSTRALIA, V2, P349, DOI 10.5694/j.1326-5377.1949.tb36912.x; Chaouloff F, 1999, PSYCHOPHARMACOLOGY, V141, P326, DOI 10.1007/s002130050841; CHEETHAM SC, 1993, BRIT J PHARMACOL, V110, P1621, DOI 10.1111/j.1476-5381.1993.tb14010.x; Chen L, 2011, MOL PHARMACOL, V79, P974, DOI 10.1124/mol.111.071092; Chen LG, 2009, MOL PHARMACOL, V76, P1150, DOI 10.1124/mol.109.056994; Chenu F, 2008, J PSYCHIATR NEUROSCI, V33, P541; Clark M S, 2001, Psychopharmacol Bull, V35, P170; Doble BW, 2003, J CELL SCI, V116, P1175, DOI 10.1242/jcs.00384; Drago A, 2010, EUR J CLIN PHARMACOL, V66, P5, DOI 10.1007/s00228-009-0724-6; EMBI N, 1980, EUR J BIOCHEM, V107, P519, DOI 10.1111/j.1432-1033.1980.tb06059.x; Evans AK, 2008, EUR J PHARMACOL, V590, P136, DOI 10.1016/j.ejphar.2008.06.014; Freland L, 2012, FRONT MOL NEUROSCI, V5, DOI 10.3389/fnmol.2012.00014; Gainetdinov RR, 2004, ANNU REV NEUROSCI, V27, P107, DOI 10.1146/annurev.neuro.27.070203.144206; Hendricks T, 1999, J NEUROSCI, V19, P10348; Hendricks TJ, 2003, NEURON, V37, P233, DOI 10.1016/S0896-6273(02)01167-4; Hoeflich KP, 2000, NATURE, V406, P86, DOI 10.1038/35017574; Hoyer D, 1997, NEUROPHARMACOLOGY, V36, P419, DOI 10.1016/S0028-3908(97)00036-1; Johnson-Farley NN, 2006, J PHARMACOL EXP THER, V316, P1062, DOI 10.1124/jpet.105.094433; JONES BJ, 1968, J PHARM PHARMACOL, V20, P302, DOI 10.1111/j.2042-7158.1968.tb09743.x; Jope RS, 2004, TRENDS BIOCHEM SCI, V29, P95, DOI 10.1016/j.tibs.2003.12.004; Kearn C.S., 2004, IMMUNOFLUORESCENT MA; Klein PS, 1996, P NATL ACAD SCI USA, V93, P8455, DOI 10.1073/pnas.93.16.8455; Li XH, 2004, NEUROPSYCHOPHARMACOL, V29, P1426, DOI 10.1038/sj.npp.1300439; Li XH, 2007, INT J NEUROPSYCHOPH, V10, P7, DOI 10.1017/S1461145706006547; Li XH, 2010, NEUROPSYCHOPHARMACOL, V35, P2143, DOI 10.1038/npp.2010.105; Liang MH, 2007, J BIOL CHEM, V282, P3904, DOI 10.1074/jbc.M605178200; Liang MH, 2006, J BIOL CHEM, V281, P30479, DOI 10.1074/jbc.M607468200; Lione AM, 2000, J NEUROCHEM, V75, P934, DOI 10.1046/j.1471-4159.2000.0750934.x; Lundkvist GB, 2005, J NEUROSCI, V25, P7682, DOI 10.1523/JNEUROSCI.2211-05.2005; Mai L, 2002, J NEUROCHEM, V82, P75, DOI 10.1046/j.1471-4159.2002.00939.x; Massot O, 1999, NEUROPSYCHOPHARMACOL, V21, P530, DOI 10.1016/S0893-133X(99)00042-1; Miczek KA, 2004, ANN NY ACAD SCI, V1036, P336, DOI 10.1196/annals.1330.021; Nunemaker Craig S., 2003, Biological Procedures Online, V5, P53, DOI 10.1251/bpo46; O'Brien WT, 2011, J CLIN INVEST, V121, P3756, DOI 10.1172/JCI45194; ONeill MF, 1996, PHARMACOL BIOCHEM BE, V53, P535, DOI 10.1016/0091-3057(95)02047-0; Pap M, 1998, J BIOL CHEM, V273, P19929, DOI 10.1074/jbc.273.32.19929; Patel S, 2008, MOL CELL BIOL, V28, P6314, DOI 10.1128/MCB.00763-08; Paxinos G., 2001, MOUSE BRAIN STEREOTA; Phiel CJ, 2003, NATURE, V423, P435, DOI 10.1038/nature01640; Polter A, 2010, NEUROPSYCHOPHARMACOL, V35, P1761, DOI 10.1038/npp.2010.43; Polter AM, 2012, CELL SIGNAL, V24, P265, DOI 10.1016/j.cellsig.2011.09.009; Polter AM, 2011, FRONT MOL NEUROSCI, V4, DOI 10.3389/fnmol.2011.00031; PRANZATELLI MR, 1987, PHARMACOL BIOCHEM BE, V27, P497, DOI 10.1016/0091-3057(87)90354-6; Prut L, 2003, EUR J PHARMACOL, V463, P3, DOI 10.1016/S0014-2999(03)01272-X; Rao R, 2010, J AM SOC NEPHROL, V21, P428, DOI 10.1681/ASN.2009060672; Raymond JR, 2001, PHARMACOL THERAPEUT, V92, P179, DOI 10.1016/S0163-7258(01)00169-3; Riad N, 2000, J COMP NEUROL, V417, P181, DOI 10.1002/(SICI)1096-9861(20000207)417:2<181::AID-CNE4>3.0.CO;2-A; Rogers DC, 1997, MAMM GENOME, V8, P711, DOI 10.1007/s003359900551; Roh MS, 2007, EXP MOL MED, V39, P353, DOI 10.1038/emm.2007.39; Ruf BM, 2009, CURR DRUG TARGETS, V10, P1118, DOI 10.2174/138945009789735192; Sari Y, 2004, NEUROSCI BIOBEHAV R, V28, P565, DOI 10.1016/j.neubiorev.2004.08.008; Scott MM, 2005, P NATL ACAD SCI USA, V102, P16472, DOI 10.1073/pnas.0504510102; Stambolic V, 1996, CURR BIOL, V6, P1664, DOI 10.1016/S0960-9822(02)70790-2; Thompson BJ, 2011, P NATL ACAD SCI USA, V108, P3785, DOI 10.1073/pnas.1011920108; Trillat AC, 1997, J NEUROCHEM, V69, P2019; Valvezan AJ, 2012, FRONT MOL NEUROSCI, V5, DOI 10.3389/fnmol.2012.00001; WALSH RN, 1976, PSYCHOL BULL, V83, P482, DOI 10.1037/0033-2909.83.3.482; WANG QM, 1994, BIOCHEMISTRY-US, V33, P143, DOI 10.1021/bi00167a018; Woodgett J R, 2001, Sci STKE, V2001, pre12, DOI 10.1126/stke.2001.100.re12; WOODGETT JR, 1990, EMBO J, V9, P2431, DOI 10.1002/j.1460-2075.1990.tb07419.x; Yao HB, 2002, J CHEM NEUROANAT, V23, P291, DOI 10.1016/S0891-0618(02)00014-5	67	20	20	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 17	2012	7	8							e43262	10.1371/journal.pone.0043262	http://dx.doi.org/10.1371/journal.pone.0043262			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	996DG	22912839	Green Published, gold			2022-12-25	WOS:000308063700069
J	Ono, M; Hamada, Y; Horiuchi, Y; Matsuo-Takasaki, M; Imoto, Y; Satomi, K; Arinami, T; Hasegawa, M; Fujioka, T; Nakamura, Y; Noguchi, E				Ono, Mizuho; Hamada, Yuko; Horiuchi, Yasue; Matsuo-Takasaki, Mami; Imoto, Yoshimasa; Satomi, Kaishi; Arinami, Tadao; Hasegawa, Mamoru; Fujioka, Tsuyoshi; Nakamura, Yukio; Noguchi, Emiko			Generation of Induced Pluripotent Stem Cells from Human Nasal Epithelial Cells Using a Sendai Virus Vector	PLOS ONE			English	Article							INDUCTION; DERIVATION	The generation of induced pluripotent stem cells (iPSCs) by introducing reprogramming factors into somatic cells is a promising method for stem cell therapy in regenerative medicine. Therefore, it is desirable to develop a minimally invasive simple method to create iPSCs. In this study, we generated human nasal epithelial cells (HNECs)-derived iPSCs by gene transduction with Sendai virus (SeV) vectors. HNECs can be obtained from subjects in a noninvasive manner, without anesthesia or biopsy. In addition, SeV carries no risk of altering the host genome, which provides an additional level of safety during generation of human iPSCs. The multiplicity of SeV infection ranged from 3 to 4, and the reprogramming efficiency of HNECs was 0.08-0.10%. iPSCs derived from HNECs had global gene expression profiles and epigenetic states consistent with those of human embryonic stem cells. The ease with which HNECs can be obtained, together with their robust reprogramming characteristics, will provide opportunities to investigate disease pathogenesis and molecular mechanisms in vitro, using cells with particular genotypes.	[Ono, Mizuho; Hamada, Yuko; Arinami, Tadao; Noguchi, Emiko] Univ Tsukuba, Fac Med, Dept Med Genet, Tsukuba, Ibaraki, Japan; [Horiuchi, Yasue] Johns Hopkins Univ, Sch Med, Dept Psychiat & Behav Sci, Baltimore, MD 21205 USA; [Matsuo-Takasaki, Mami] Univ Tsukuba, Dept Regenerat Med & Stem Cell Biol, Fac Med, Tsukuba, Ibaraki, Japan; [Imoto, Yoshimasa] Univ Fukui, Fac Med Sci, Dept Otorhinolaryngol Head & Neck Surg, Fukui 910, Japan; [Satomi, Kaishi] Univ Tsukuba, Dept Diagnost Pathol, Fac Med, Tsukuba, Ibaraki, Japan; [Hasegawa, Mamoru] DNAVEC Res Inc, Tsukuba, Ibaraki, Japan; [Fujioka, Tsuyoshi; Nakamura, Yukio] RIKEN, BioResource Ctr, Cell Engn Div, Tsukuba, Ibaraki, Japan; [Noguchi, Emiko] Japan Sci & Technol Agcy, Chiyoda Ku, Tokyo 1028666, Japan	University of Tsukuba; Johns Hopkins University; University of Tsukuba; University of Fukui; University of Tsukuba; DNAVEC Corporation; RIKEN; Japan Science & Technology Agency (JST)	Ono, M (corresponding author), Univ Tsukuba, Fac Med, Dept Med Genet, Tsukuba, Ibaraki, Japan.	enoguchi@md.tsukuba.ac.jp	Nakamura, Yukio/A-5263-2016; Horiuchi, Yasue/ABC-6248-2021	Nakamura, Yukio/0000-0001-8056-4946; Horiuchi, Yasue/0000-0003-0597-2514	Japan Science and Technology Agency, Japan	Japan Science and Technology Agency, Japan(Japan Science & Technology Agency (JST))	This study was supported by research grants from the Japan Science and Technology Agency, Japan. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ban H, 2011, P NATL ACAD SCI USA, V108, P14234, DOI 10.1073/pnas.1103509108; Chou BK, 2011, CELL RES, V21, P518, DOI 10.1038/cr.2011.12; Du P, 2008, BIOINFORMATICS, V24, P1547, DOI 10.1093/bioinformatics/btn224; Freberg CT, 2007, MOL BIOL CELL, V18, P1543, DOI 10.1091/mbc.E07-01-0029; Hanna J, 2008, CELL, V133, P250, DOI 10.1016/j.cell.2008.03.028; Liu T, 2012, STEM CELLS DEV; Loh YH, 2010, CELL STEM CELL, V7, P15, DOI 10.1016/j.stem.2010.06.004; Mack AA, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027956; Miyoshi K, 2010, J BIOSCI BIOENG, V110, P345, DOI 10.1016/j.jbiosc.2010.03.004; Park IH, 2008, CELL, V134, P877, DOI 10.1016/j.cell.2008.07.041; Seki T, 2010, CELL STEM CELL, V7, P11, DOI 10.1016/j.stem.2010.06.003; Sun N, 2009, P NATL ACAD SCI USA, V106, P15720, DOI 10.1073/pnas.0908450106; Takahashi K, 2007, NAT PROTOC, V2, P3081, DOI 10.1038/nprot.2007.418; Takahashi K, 2007, CELL, V131, P861, DOI 10.1016/j.cell.2007.11.019; Takenaka C, 2010, EXP HEMATOL, V38, P154, DOI 10.1016/j.exphem.2009.11.003; Tamaoki N, 2010, J DENT RES, V89, P773, DOI 10.1177/0022034510366846; Yonemitsu Y, 2000, NAT BIOTECHNOL, V18, P970, DOI 10.1038/79463; Yu JY, 2007, SCIENCE, V318, P1917, DOI 10.1126/science.1151526; Yusa K, 2011, NATURE, V478, P391, DOI 10.1038/nature10424; Zaehres H, 2007, CELL, V131, P834, DOI 10.1016/j.cell.2007.11.020	20	33	34	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 13	2012	7	8							e42855	10.1371/journal.pone.0042855	http://dx.doi.org/10.1371/journal.pone.0042855			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	988OJ	22912751	Green Published, gold			2022-12-25	WOS:000307500100038
J	Webber, L; Kilpi, F; Marsh, T; Rtveladze, K; Brown, M; McPherson, K				Webber, Laura; Kilpi, Fanny; Marsh, Tim; Rtveladze, Ketevan; Brown, Martin; McPherson, Klim			High Rates of Obesity and Non-Communicable Diseases Predicted across Latin America	PLOS ONE			English	Article							NUTRITION TRANSITION; ECONOMIC BURDEN; WORLDWIDE; TRENDS; CHILE; RISK	Non-communicable diseases (NCDs) such as cardiovascular disease and stroke are a major public health concern across Latin America. A key modifiable risk factor for NCDs is overweight and obesity highlighting the need for policy to reduce prevalence rates and ameliorate rising levels of NCDs. A cross-sectional regression analysis was used to project BMI and related disease trends to 2050. We tested the extent to which interventions that decrease body mass index (BMI) have an effect upon the number of incidence cases avoided for each disease. Without intervention obesity trends will continue to rise across much of Latin America. Effective interventions are necessary if rates of obesity and related diseases are to be reduced.	[Webber, Laura; Kilpi, Fanny; Marsh, Tim; Rtveladze, Ketevan; Brown, Martin] Natl Heart Forum, London, England; [McPherson, Klim] Univ Oxford, New Coll, Oxford, England	University of Oxford	Webber, L (corresponding author), Natl Heart Forum, London, England.	laura.webber@heartforum.org.uk		Kilpi, Fanny/0000-0002-3551-2829	GlaxoSmithKline [27875780]	GlaxoSmithKline(GlaxoSmithKline)	This research was funded by a non-discretionary educational grant from GlaxoSmithKline (number 27875780). The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Albala C, 2002, PUBLIC HEALTH NUTR, V5, P123, DOI 10.1079/PHN2001283; Ares Valdes Yolanda, 2009, Arch Esp Urol, V62, P201; Barcelo A, 2003, B WORLD HEALTH ORGAN, V81, P19; Brundenius C, 2009, LAT AM PERSPECT, V36, P31, DOI 10.1177/0094582X09331968; Coleman MP, 2008, LANCET ONCOL, V9, P730, DOI 10.1016/S1470-2045(08)70179-7; Fenger RV, 2012, CLIN EXP ALLERGY, V42, P1237, DOI 10.1111/j.1365-2222.2012.03972.x; Finucane MM, 2011, LANCET, V377, P557, DOI 10.1016/S0140-6736(10)62037-5; Frenk J, 1991, Health Transit Rev, V1, P21; Gami AS, 2007, J AM COLL CARDIOL, V49, P565, DOI 10.1016/j.jacc.2006.08.060; Guh DP, 2009, BMC PUBLIC HEALTH, V9, DOI 10.1186/1471-2458-9-88; Kopelman P, 2007, OBES REV, V8, pVI; McPherson K, 2007, TACKLING OBESITIES F; National Cancer Institute, SEER CANC STAT REV 1; OMRAN AR, 1983, J TROP PEDIATRICS, V29, P305, DOI 10.1093/tropej/29.6.305; Ortiz-Barboza A, 2011, IARC Sci Publ, P85; PAHO website, PAHO PREV CONTR CHRO; Pena M, 2010, OBESITY POVERTY NEW; Porrata C, 2000, OBESIDAD POBREZA NUE, P57; Pratt M, 2011, FOOD NUTR BULL, V25, P183; Secretaria de Salud, HEART DIS STROK STAT; Uauy R, 2001, J NUTR, V131, p893S, DOI 10.1093/jn/131.3.893S; Viani GA, 2006, RADIAT ONCOL, V1, DOI 10.1186/1748-717X-1-24; Vio F, 2008, PUBLIC HEALTH NUTR, V11, P405, DOI 10.1017/S136898000700050X; Vio F, 2000, PUBLIC HEALTH NUTR, V3, P49, DOI 10.1017/S1368980000000070; Wang YC, 2011, LANCET, V378, P815, DOI 10.1016/S0140-6736(11)60814-3; Wild S, 2004, DIABETES CARE, V27, P1047, DOI 10.2337/diacare.27.5.1047; Withrow D, 2011, OBES REV, V12, P131, DOI 10.1111/j.1467-789X.2009.00712.x; World Health Organization, WHO GLOB INF; Yusuf E, 2012, ARTHRITIS RES THER, V14, DOI 10.1186/ar3894	29	67	69	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 13	2012	7	8							e39589	10.1371/journal.pone.0039589	http://dx.doi.org/10.1371/journal.pone.0039589			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	988OJ	22912663	Green Published, gold, Green Submitted			2022-12-25	WOS:000307500100003
J	Lynch, AG; Chin, SF; Dunning, MJ; Caldas, C; Tavare, S; Curtis, C				Lynch, Andy G.; Chin, Suet-Feung; Dunning, Mark J.; Caldas, Carlos; Tavare, Simon; Curtis, Christina			Calling Sample Mix-Ups in Cancer Population Studies	PLOS ONE			English	Article							COPY NUMBER; POLYMORPHISMS; PROBES; SYSTEM	Sample tracking errors have been and always will be a part of the practical implementation of large experiments. It has recently been proposed that expression quantitative trait loci (eQTLs) and their associated effects could be used to identify sample mix-ups and this approach has been applied to a number of large population genomics studies to illustrate the prevalence of the problem. We had adopted a similar approach, termed 'BADGER', in the METABRIC project. METABRIC is a large breast cancer study that may have been the first in which eQTL-based detection of mismatches was used during the study, rather than after the event, to aid quality assurance. We report here on the particular issues associated with large cancer studies performed using historical samples, which complicate the interpretation of such approaches. In particular we identify the complications of using tumour samples, of considering cellularity and RNA quality, of distinct subgroups existing in the study population (including family structures), and of choosing eQTLs to use. We also present some results regarding the design of experiments given consideration of these matters. The eQTL-based approach to identifying sample tracking errors is seen to be of value to these studies, but requiring care in its implementation.	[Lynch, Andy G.; Chin, Suet-Feung; Caldas, Carlos; Tavare, Simon] Univ Cambridge, Dept Oncol, Cambridge, England; [Lynch, Andy G.; Chin, Suet-Feung; Dunning, Mark J.; Caldas, Carlos; Tavare, Simon] Canc Res UK, Cambridge Res Inst, Cambridge, England; [Curtis, Christina] Univ So Calif, Dept Prevent Med, Los Angeles, CA 90089 USA	University of Cambridge; Cancer Research UK; CRUK Cambridge Institute; University of Cambridge; University of Southern California	Lynch, AG (corresponding author), Univ Cambridge, Dept Oncol, Cambridge, England.	andy.lynch@cancer.org.uk	Caldas, Carlos/A-7543-2008; Caldas, Carlos/U-7250-2019	Caldas, Carlos/0000-0003-3547-1489; chin, suet-feung/0000-0001-5697-1082; Curtis, Christina/0000-0003-0166-3802; Lynch, Andy/0000-0002-7876-7338; Dunning, Mark/0000-0002-8853-9435	University of Cambridge [C14303/A10825]; Hutchison Whampoa Limited; Cancer Research UK; Cancer Research UK [19556] Funding Source: researchfish; National Institute for Health Research [NF-SI-0611-10154] Funding Source: researchfish	University of Cambridge(University of Cambridge); Hutchison Whampoa Limited; Cancer Research UK(Cancer Research UK); Cancer Research UK(Cancer Research UK); National Institute for Health Research(National Institute for Health Research (NIHR))	This research was supported by The University of Cambridge, Cancer Research UK grant C14303/A10825, www.cancerresearchuk.org, and Hutchison Whampoa Limited. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alberts R, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000622; Altshuler D, 2005, NATURE, V437, P1299, DOI 10.1038/nature04226; Baggerly KA, 2009, ANN APPL STAT, V3, P1309, DOI 10.1214/09-AOAS291; Baker SC, 2005, NAT METHODS, V2, P731, DOI 10.1038/nmeth1005-731; Barbosa-Morais NL, 2010, NUCLEIC ACIDS RES, V38, DOI 10.1093/nar/gkp942; Benovoy D, 2008, NUCLEIC ACIDS RES, V36, P4417, DOI 10.1093/nar/gkn409; Burton PR, 2007, NATURE, V447, P661, DOI 10.1038/nature05911; Connelly JJ, 2006, PLOS GENET, V2, P1265, DOI 10.1371/journal.pgen.0020139; Cookson W, 2009, NAT REV GENET, V10, P184, DOI 10.1038/nrg2537; Curtis C, 2012, NATURE, V486, P346, DOI 10.1038/nature10983; da Silva CC, 2009, GENET MOL BIOL, V32, P354, DOI 10.1590/S1415-47572009000200023; Duan SW, 2008, BIOINFORMATION, V2, P469, DOI 10.6026/97320630002469; Leisch F, 2002, COMPSTAT 2002: PROCEEDINGS IN COMPUTATIONAL STATISTICS, P575; Morley M, 2004, NATURE, V430, P743, DOI 10.1038/nature02797; Nica AC, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1002003; R DEVELOPMENT CORE TEAM, 2011, R LANG ENV STAT COMP; Ritchie ME, 2011, PLOS COMPUT BIOL, V7, DOI 10.1371/journal.pcbi.1002276; Schadt EE, 2012, NAT GENET, V44, P603, DOI 10.1038/ng.2248; Shalon D, 1996, GENOME RES, V6, P639, DOI 10.1101/gr.6.7.639; Stears RL, 2003, NAT MED, V9, P140, DOI 10.1038/nm0103-140; Stranger BE, 2007, SCIENCE, V315, P848, DOI 10.1126/science.1136678; Stranger BE, 2012, PLOS GENET, V8, P272, DOI 10.1371/journal.pgen.1002639; Walter M, 2010, BIOTECHNIQUES, V48, P371, DOI 10.2144/000113421; Wang Y, 2009, BMC MED GENOMICS, V2, DOI 10.1186/1755-8794-2-8; Westra HJ, 2011, BIOINFORMATICS, V27, P2104, DOI 10.1093/bioinformatics/btr323; Zeller T, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010693; Zhang W, 2009, HUM GENET, V125, P81, DOI 10.1007/s00439-008-0601-x	27	5	5	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 9	2012	7	8							e41815	10.1371/journal.pone.0041815	http://dx.doi.org/10.1371/journal.pone.0041815			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	986WZ	22912679	gold, Green Published, Green Submitted			2022-12-25	WOS:000307378500009
J	Savas, S; Hyde, A; Stuckless, SN; Parfrey, P; Younghusband, HB; Green, R				Savas, Sevtap; Hyde, Angela; Stuckless, Susan N.; Parfrey, Patrick; Younghusband, H. Banfield; Green, Roger			Serotonin Transporter Gene (SLC6A4) Variations Are Associated with Poor Survival in Colorectal Cancer Patients	PLOS ONE			English	Article							DUAL ROLES; DEPRESSION; VASOPRESSIN; ANXIETY; LIFE; NEWFOUNDLAND; INFLAMMATION; RECEPTOR; WOMEN; BDNF	Prognosis in colorectal cancer patients is quite variable, even after adjustment for clinical parameters such as disease stage and microsatellite instability status. It is possible that the psychological distress experienced by patients, including anxiety and depression, may be correlated with poor prognosis. In the present study, we hypothesize that genetic variations within three genes biologically linked to the stress response, namely serotonin transporter (SLC6A4), brain-derived neurotrophic factor (BDNF), and arginine vasopressin receptor (AVPR1B) genes are associated with prognosis in colorectal cancer patients. We used a population-based cohort of 280 patients who were followed for up to 12.5 years after diagnosis. Our multivariate analysis showed that a tagSNP in the SLC6A4 gene (rs12150214) was a predictor of shorter overall survival (HR: 1.572, 95% CI: 1.142-2.164, p = 0.005) independent of stage, age, grade and MSI status. Additionally, a multivariate analysis using the combined genotypes of three polymorphisms in this gene demonstrated that the presence of any of the minor alleles at these polymorphic loci was an independent predictor of both shorter overall survival (HR: 1.631, 95% CI: 1.190-2.236, p = 0.002) and shorter disease specific survival (HR: 1.691, 95% CI: 1.138-2.512, p = 0.009). The 5-HTT protein coded by the SLC6A4 gene has also been implicated in inflammation. While our results remain to be replicated in other patient cohorts, we suggest that the genetic variations in the SLC6A4 gene contribute to poor survival in colorectal cancer patients.	[Savas, Sevtap; Hyde, Angela; Younghusband, H. Banfield; Green, Roger] Mem Univ Newfoundland, Fac Med, Discipline Genet, St John, NF, Canada; [Savas, Sevtap] Mem Univ Newfoundland, Fac Med, Discipline Oncol, St John, NF, Canada; [Stuckless, Susan N.; Parfrey, Patrick] Mem Univ Newfoundland, Clin Epidemiol Unit, Fac Med, St John, NF, Canada	Memorial University Newfoundland; Memorial University Newfoundland; Memorial University Newfoundland	Savas, S (corresponding author), Mem Univ Newfoundland, Fac Med, Discipline Genet, St John, NF, Canada.	savas@mun.ca		Savas, Sevtap/0000-0002-7324-938X	Canadian Institute of Health Research Institute of Genetics; Canadian Gene Cure Foundation; Memorial University of Newfoundland; Research and Development Corporation (RDC) of Newfoundland; CIHR; Atlantic Innovation Fund	Canadian Institute of Health Research Institute of Genetics(Canadian Institutes of Health Research (CIHR)); Canadian Gene Cure Foundation; Memorial University of Newfoundland; Research and Development Corporation (RDC) of Newfoundland; CIHR(Canadian Institutes of Health Research (CIHR)); Atlantic Innovation Fund	This work was supported by the Canadian Institute of Health Research Institute of Genetics and the Canadian Gene Cure Foundation, Memorial University of Newfoundland, Research and Development Corporation (RDC) of Newfoundland, Interdisciplinary Team in Colorectal Cancer funded by CIHR, and Interdisciplinary Team in Human Genetics funded by the Atlantic Innovation Fund. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akaike H., 1973, P 2 INT S INF THEOR, VI, P610, DOI DOI 10.1007/978-1-4612-1694-0_15; Anisman H, 2009, J PSYCHIATR NEUROSCI, V34, P4; Barrett JC, 2005, BIOINFORMATICS, V21, P263, DOI 10.1093/bioinformatics/bth457; Becker C, 2005, CELL CYCLE, V4, P217; *CAN CANC SOC STEE, 2010, CAN CANC STAT 2010; Caspi A, 2010, AM J PSYCHIAT, V167, P509, DOI 10.1176/appi.ajp.2010.09101452; Chourbaji S, 2011, NEUROSCI BIOBEHAV R, V35, P599, DOI 10.1016/j.neubiorev.2010.07.003; Dempster EL, 2007, ARCH GEN PSYCHIAT, V64, P1189, DOI 10.1001/archpsyc.64.10.1189; DUPONT WD, 1990, CONTROL CLIN TRIALS, V11, P116, DOI 10.1016/0197-2456(90)90005-M; Ferrone C, 2010, J CLIN ONCOL, V28, P4045, DOI 10.1200/JCO.2010.27.9992; Green RC, 2007, FAM CANCER, V6, P53, DOI 10.1007/s10689-006-9104-x; Griebel G, 2003, CNS NEUROL DISORD-DR, V2, P191, DOI 10.2174/1568007033482850; Gripp S, 2007, J CLIN ONCOL, V25, P3313, DOI 10.1200/JCO.2006.10.5411; Hansel A, 2010, NEUROSCI BIOBEHAV R, V35, P115, DOI 10.1016/j.neubiorev.2009.12.012; Hamer M, 2009, J PSYCHOSOM RES, V66, P255, DOI 10.1016/j.jpsychores.2008.11.002; Haub S, 2010, NEUROGASTROENT MOTIL, V22, DOI 10.1111/j.1365-2982.2010.01479.x; Haub S, 2010, NEUROGASTROENT MOTIL, V22, pe229; Johansson M, 2011, BMC CANCER, V11, DOI 10.1186/1471-2407-11-283; Kirstein M, 2002, CELL MOL LIFE SCI, V59, P1787, DOI 10.1007/PL00012506; Kuechler T, 2007, J CLIN ONCOL, V25, P2702, DOI 10.1200/JCO.2006.08.2883; Landgraf Rainer, 2006, CNS & Neurological Disorders-Drug Targets, V5, P167, DOI 10.2174/187152706776359664; Lazary J, 2008, BIOL PSYCHIAT, V64, P498, DOI 10.1016/j.biopsych.2008.03.030; Martinowich K, 2008, NEUROPSYCHOPHARMACOL, V33, P73, DOI 10.1038/sj.npp.1301571; Morikawa T, 2011, JAMA-J AM MED ASSOC, V305, P1685, DOI 10.1001/jama.2011.513; Murphy DL, 2011, CURR OPIN PHARMACOL, V11, P3, DOI 10.1016/j.coph.2011.02.008; Okayama A, 2007, ASIAN PAC J CANCER P, V8, P191; Parkin DM, 2005, CA-CANCER J CLIN, V55, P74, DOI 10.3322/canjclin.55.2.74; Phillips KA, 2008, J CLIN ONCOL, V26, P4666, DOI 10.1200/JCO.2007.14.8718; Pucci S, 2009, CELL CYCLE, V8, P473, DOI 10.4161/cc.8.3.7652; Rodriguez S, 2009, AM J EPIDEMIOL, V169, P505, DOI 10.1093/aje/kwn359; Savas S, 2009, HUM MUTAT, V30, P1369, DOI 10.1002/humu.21078; Sharma A, 2007, ANN SURG ONCOL, V14, P3435, DOI 10.1245/s10434-007-9554-x; Sharp T, 2011, CURR OPIN PHARMACOL, V11, P45, DOI 10.1016/j.coph.2011.02.003; Sherry ST, 2001, NUCLEIC ACIDS RES, V29, P308, DOI 10.1093/nar/29.1.308; Spiller R, 2008, NEUROPHARMACOLOGY, V55, P1072, DOI 10.1016/j.neuropharm.2008.07.016; Su SY, 2009, CIRC-CARDIOVASC GENE, V2, P614, DOI 10.1161/CIRCGENETICS.109.870386; Surget A, 2008, EUR J PHARMACOL, V583, P340, DOI 10.1016/j.ejphar.2007.11.065; Ugnat AM, 2005, EUR J CANCER PREV, V14, P91, DOI 10.1097/00008469-200504000-00004; Wein S, 2010, CANCER J, V16, P493, DOI 10.1097/PPO.0b013e3181f28b64; Weinberger T, 2010, PSYCHIAT CLIN N AM, V33, P409, DOI 10.1016/j.psc.2010.01.005; Woods MO, 2005, CLIN CANCER RES, V11, P6853, DOI 10.1158/1078-0432.CCR-05-0726; Zamarron BF, 2011, INT J BIOL SCI, V7, P651, DOI 10.7150/ijbs.7.651	42	20	24	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 24	2012	7	7							e38953	10.1371/journal.pone.0038953	http://dx.doi.org/10.1371/journal.pone.0038953			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	978NX	22911682	Green Published, Green Submitted, gold			2022-12-25	WOS:000306751300002
J	Jeseta, M; Marin, M; Tichovska, H; Melicharova, P; Cailliau-Maggio, K; Martoriati, A; Lescuyer-Rousseau, A; Beaujois, R; Petr, J; Sedmikova, M; Bodart, JF				Jeseta, Michal; Marin, Matthieu; Tichovska, Hana; Melicharova, Petra; Cailliau-Maggio, Katia; Martoriati, Alain; Lescuyer-Rousseau, Arlette; Beaujois, Remy; Petr, Jaroslav; Sedmikova, Marketa; Bodart, Jean-Francois			Nitric Oxide-Donor SNAP Induces Xenopus Eggs Activation	PLOS ONE			English	Article							CA2+ SIGNALING DIFFERENTIATION; SEA-URCHIN EGGS; OOCYTE MATURATION; PORCINE OOCYTES; SODIUM-NITROPRUSSIDE; LAEVIS EGGS; PIG OOCYTES; INOSITOL TRISPHOSPHATE; CALCIUM MICRODOMAINS; RYANODINE RECEPTORS	Nitric oxide (NO) is identified as a signaling molecule involved in many cellular or physiological functions including meiotic maturation and parthenogenetic activation of mammalian oocytes. We observed that nitric oxide donor SNAP was potent to induce parthenogenetic activation in Xenopus eggs. NO-scavenger CPTIO impaired the effects of SNAP, providing evidence for the effects of the latter to be specific upon NO release. In Xenopus eggs, SNAP treatment induced pigment rearrangement, pronucleus formation and exocytosis of cortical granules. At a biochemical level, SNAP exposure lead to MAPK and Rsk inactivation within 30 minutes whereas MPF remained active, in contrast to calcium ionophore control where MPF activity dropped rapidly. MAPK inactivation could be correlated to pronuclear envelope reformation observed. In SNAP-treated eggs, a strong increase in intracellular calcium level was observed. NO effects were impaired in calcium-free or calcium limited medium, suggesting that that parthenogenetic activation of Xenopus oocytes with a NO donor was mainly calcium-dependent.	[Jeseta, Michal] Vet Res Inst, Dept Genet & Reprod, CS-62132 Brno, Czech Republic; [Tichovska, Hana; Melicharova, Petra; Sedmikova, Marketa] Czech Univ Life Sci, Dept Vet Sci, Prague, Czech Republic; [Marin, Matthieu; Cailliau-Maggio, Katia; Martoriati, Alain; Lescuyer-Rousseau, Arlette; Beaujois, Remy; Bodart, Jean-Francois] Univ Lille 1, Lab Regulat Signaux Div EA 4479, F-59655 Villeneuve Dascq, France; [Marin, Matthieu; Beaujois, Remy; Bodart, Jean-Francois] Interdisciplinary Res Inst USR 3078 CNRS, Villeneuve Dascq, France; [Petr, Jaroslav] Res Inst Anim Prod, Prague, Czech Republic	Czech Veterinary Research Institute; Czech University of Life Sciences Prague; Universite de Lille - ISITE; Universite de Lille; Universite de Lille - ISITE; Universite de Lille; Czech Research Institute of Animal Science	Jeseta, M (corresponding author), Vet Res Inst, Dept Genet & Reprod, CS-62132 Brno, Czech Republic.	jeseta@vri.cz	Sedmíková, Markéta/B-5768-2018; Jeseta, Michal/A-3159-2013; Bodart, Jean-François Laurent/AAZ-2075-2021	Sedmíková, Markéta/0000-0003-0947-4256; Jeseta, Michal/0000-0003-1778-3454; Bodart, Jean-François Laurent/0000-0002-6113-7700; Cailliau, Katia/0000-0001-7993-8437; cailliau, katia/0000-0003-1772-1034; Martoriati, Alain/0000-0002-5684-1728	Czech Science Fundation [GACR 523/08/H064]; ministry of education youth and sports of Czech Republic [MSM 6046070901]; Czech ministry of agriculture [MZe 0002716202]; Econet [18857PA]	Czech Science Fundation; ministry of education youth and sports of Czech Republic(Ministry of Education, Youth & Sports - Czech Republic); Czech ministry of agriculture(Ministry of Agriculture, Czech Republic); Econet	This work was supported by a grant from the Czech Science Fundation (GACR 523/08/H064), the ministry of education youth and sports of Czech Republic (MSM 6046070901), the Czech ministry of agriculture (MZe 0002716202) and Econet grant 18857PA. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ajmat MT, 2011, ZYGOTE, V19, P171, DOI 10.1017/S0967199410000444; Amano T, 2005, THERIOGENOLOGY, V64, P261, DOI 10.1016/j.theriogenology.2004.12.001; BATES JN, 1991, BIOCHEM PHARMACOL, V42, pS157, DOI 10.1016/0006-2952(91)90406-U; Berridge MJ, 2006, CELL CALCIUM, V40, P405, DOI 10.1016/j.ceca.2006.09.002; Berridge MJ, 2000, NAT REV MOL CELL BIO, V1, P11, DOI 10.1038/35036035; Berridge MJ, 1996, CELL CALCIUM, V20, P95, DOI 10.1016/S0143-4160(96)90098-6; Betts DH, 2008, MOL HUM REPROD, V14, P445, DOI 10.1093/molehr/gan035; Bian K, 2003, FRONT BIOSCI-LANDMRK, V8, pD264, DOI 10.2741/997; Biswas S, 1998, J REPROD FERTIL, V114, P157, DOI 10.1530/jrf.0.1140157; Bodart JF, 2002, MOL REPROD DEV, V61, P570, DOI 10.1002/mrd.10112; Bodart JF, 1999, EXP CELL RES, V253, P413, DOI 10.1006/excr.1999.4662; Bodart JFL, 2005, DEV BIOL, V283, P373, DOI 10.1016/j.ydbio.2005.04.031; Bu S, 2007, MOL CELL ENDOCRINOL, V207, P21; BUSA WB, 1985, J CELL BIOL, V100, P1325, DOI 10.1083/jcb.100.4.1325; BUSA WB, 1985, J CELL BIOL, V101, P677, DOI 10.1083/jcb.101.2.677; BUTLER AR, 1987, CHEM SOC REV, V16, P361, DOI 10.1039/cs9871600361; Castro A, 2001, MOL BIOL CELL, V12, P2660, DOI 10.1091/mbc.12.9.2660; Chesnel F, 2006, CELL CYCLE, V5, P1687, DOI 10.4161/cc.5.15.3123; Chmelikova E, 2009, CZECH J ANIM SCI, V54, P137, DOI 10.17221/1742-CJAS; Chmelikova E, 2010, ZYGOTE, V18, P235, DOI 10.1017/S0967199409990268; CLAPHAM DE, 1995, CELL, V80, P259, DOI 10.1016/0092-8674(95)90408-5; Doran SA, 2003, AM J PHYSIOL-REG I, V285, pR348, DOI 10.1152/ajpregu.00634.2002; El-Jouni W, 2005, DEV BIOL, V288, P514, DOI 10.1016/j.ydbio.2005.10.034; Erickson ES, 2004, BIOPHYS CHEM, V112, P1, DOI 10.1016/j.bpc.2004.06.010; Fan HY, 2003, BIOL REPROD, V68, P968, DOI 10.1095/biolreprod.102.008839; Fattaey A, 1997, Prog Cell Cycle Res, V3, P233; Flament S, 2000, ZYGOTE, V8, P3, DOI 10.1017/S0967199400000770; Gundersen CB, 2002, J CELL SCI, V115, P1313; Hattori MA, 2000, J MOL ENDOCRINOL, V24, P65, DOI 10.1677/jme.0.0240065; Hyslop LA, 2001, DEV BIOL, V234, P216, DOI 10.1006/dbio.2001.0252; Inoue D, 2007, NATURE, V446, P1100, DOI 10.1038/nature05688; JablonkaShariff A, 1997, ENDOCRINOLOGY, V138, P460, DOI 10.1210/en.138.1.460; Kumar S, 2010, FREE RADICAL BIO MED, V48, P851, DOI 10.1016/j.freeradbiomed.2010.01.004; Kuo RK, 2000, NATURE, V406, P633, DOI 10.1038/35020577; LAMAS S, 1992, P NATL ACAD SCI USA, V89, P6348, DOI 10.1073/pnas.89.14.6348; Leckie C, 2003, J BIOL CHEM, V278, P12247, DOI 10.1074/jbc.M210770200; LORCA T, 1991, MOL CELL BIOL, V11, P1171, DOI 10.1128/MCB.11.2.1171; Machaca K, 2000, J BIOL CHEM, V275, P38710, DOI 10.1074/jbc.M007887200; Machaca K, 2007, J CELL PHYSIOL, V213, P331, DOI 10.1002/jcp.21194; Marin M, 2012, ADV EXPT ME IN PRESS, V740, P875; Marin M, 2010, J MEMBRANE BIOL, V236, P233, DOI 10.1007/s00232-010-9290-1; MARKS GS, 1995, DRUG METAB DISPOS, V23, P1248; Megson IL, 2000, DRUG FUTURE, V25, P701, DOI 10.1358/dof.2000.025.07.858691; MEHTA JL, 1995, J LAB CLIN MED, V125, P370; MONCADA S, 1991, PHARMACOL REV, V43, P109; NATHAN C, 1992, FASEB J, V6, P3051, DOI 10.1096/fasebj.6.12.1381691; Nishikimi A, 2001, REPRODUCTION, V122, P957, DOI 10.1530/reprod/122.6.957; Nishiyama T, 2007, NATURE, V446, P1096, DOI 10.1038/nature05696; NORBURY C, 1990, CIBA F SYMP, V150, P168; Petr J, 2005, MOL CELL ENDOCRINOL, V242, P16, DOI 10.1016/j.mce.2005.05.004; Petr J, 2005, MOL REPROD DEV, V71, P115, DOI 10.1002/mrd.20248; Peunova N, 2001, J NEUROSCI, V21, P8809, DOI 10.1523/JNEUROSCI.21-22-08809.2001; Pires PRL, 2009, ANIM REPROD SCI, V116, P233, DOI 10.1016/j.anireprosci.2009.02.019; Reyes R, 2004, ARCH ANDROLOGY, V50, P303, DOI 10.1080/01485010490448471; Rolfe M, 1997, J MOL MED-JMM, V75, P5, DOI 10.1007/s001090050081; Sengoku K, 2001, MOL REPROD DEV, V58, P262, DOI 10.1002/1098-2795(200103)58:3&lt;262::AID-MRD3&gt;3.0.CO;2-8; Song T, 2008, BIOCHEM J, V412, P223, DOI 10.1042/BJ20071195; STEINHAR.RA, 1974, P NATL ACAD SCI USA, V71, P1915, DOI 10.1073/pnas.71.5.1915; Stricker SA, 1999, DEV BIOL, V211, P157, DOI 10.1006/dbio.1999.9340; Stricker SA, 2011, REPRODUCTION, V142, P29, DOI 10.1530/REP-10-0509; Sun L, 2008, BIOL REPROD, V78, P726, DOI 10.1095/biolreprod.107.063693; Suzuki T, 2010, DEVELOPMENT, V137, P3281, DOI 10.1242/dev.052480; Takata T, 2011, NITRIC OXIDE-BIOL CH, V25, P145, DOI 10.1016/j.niox.2011.01.004; Tatemoto H, 2001, ZYGOTE, V9, P15, DOI 10.1017/S0967199401001034; Tichovska H, 2011, ANIMAL, V5, P1398, DOI 10.1017/S1751731111000565; Ullah G, 2007, CELL CALCIUM, V42, P556, DOI 10.1016/j.ceca.2007.01.010; Viana KS, 2007, ANIM REPROD SCI, V102, P217, DOI 10.1016/j.anireprosci.2006.11.004; Whitaker M, 2006, CELL CALCIUM, V40, P585, DOI 10.1016/j.ceca.2006.08.018; Wu JQ, 2008, J CELL SCI, V121, P3509, DOI 10.1242/jcs.036855; XIE QW, 1992, SCIENCE, V256, P225, DOI 10.1126/science.1373522; Yamamoto T, 2000, P SOC EXP BIOL MED, V225, P200, DOI 10.1046/j.1525-1373.2000.22525.x; Yanagimachi R., 1988, PHYSL REPROD, P230; Yang JZ, 2005, CELL BIOL INT, V29, P785, DOI 10.1016/j.cellbi.2005.05.005; Zini A, 1996, BIOL REPROD, V55, P935, DOI 10.1095/biolreprod55.5.935	74	7	8	0	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 23	2012	7	7							e41509	10.1371/journal.pone.0041509	http://dx.doi.org/10.1371/journal.pone.0041509			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	977TM	22911804	Green Published, gold, Green Submitted			2022-12-25	WOS:000306687700096
J	Kumar, M; Liu, HB; Rice, AP				Kumar, Manish; Liu, Hongbing; Rice, Andrew P.			Regulation of Interferon-beta by MAGI-1 and Its Interaction with Influenza A Virus NS1 Protein with ESEV PBM	PLOS ONE			English	Article							ANTIVIRAL SIGNALING PROTEIN; PRE-MESSENGER-RNAS; PDZ-BINDING MOTIF; X-RAY-STRUCTURE; NF-KAPPA-B; RIG-I; INNATE IMMUNITY; UBIQUITIN LIGASE; EFFECTOR DOMAIN; ADAPTER PROTEIN	The NS1 protein from avian influenza A viruses contains a PDZ binding motif (PBM) at its carboxyl terminus with the consensus sequence ESEV. The ESEV PBM confers binding to several cellular PDZ proteins, including Dlg1, MAGI-1 and Scribble. The interaction between NS1 and Scribble protects infected cells from apoptosis, while the interaction between NS1 and both Dlg1 and Scribble disrupts tight junctions. In this study, we examined the MAGI-1 protein. We made the unexpected observation that siRNA depletion of MAGI-1 activates IRF3 and induces the IFN-beta promoter. We found that the ESEV NS1 protein sequesters MAGI-1 away from the plasma membrane in infected cells. Using plasmid vectors to express NS1 proteins, we observed that the ESEV PBM elicits an IFN-beta induction signal as indicated by activation of IRF3 and a relative deficiency in NS1 inhibition of induction of the IFN-beta promoter by dsRNA or RIG-I. Taken together, our data suggest that disruption of MAGI-1 by the ESEV PBM activates an IFN-beta induction signal. During viral infection, however, induction of the IFN-beta gene does not occur presumably because other anti-IFN functions dominate over the IFN-activation activity of the ESEV PBM. We postulate that the ESEV PBM's broad binding activity for PDZ proteins may allow NS1 to bind to some PDZ proteins such as MAGI-1 that confer no benefit or may even be detrimental to viral replication. However, the advantage of binding to key PDZ proteins such as Dlg1 and Scribble may dominate and therefore provide an overall benefit for the virus to encode the ESEV PBM.	[Kumar, Manish; Liu, Hongbing; Rice, Andrew P.] Baylor Coll Med, Dept Mol Virol & Microbiol, Houston, TX 77030 USA	Baylor College of Medicine	Kumar, M (corresponding author), Baylor Coll Med, Dept Mol Virol & Microbiol, Houston, TX 77030 USA.	arice@bcm.edu	Kumar, Manish/F-2497-2012	Kumar, Manish/0000-0003-2209-7547; Rice, Andrew/0000-0002-1237-4769	National Institutes of Health [R21AI083396]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R21AI083396] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was funded by a grant from National Institutes of Health (R21AI083396). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Blonska M, 2011, CELL RES, V21, P55, DOI 10.1038/cr.2010.182; Bonjardim CA, 2009, IMMUNOL LETT, V122, P1, DOI 10.1016/j.imlet.2008.11.002; Bornholdt ZA, 2006, NAT STRUCT MOL BIOL, V13, P559, DOI 10.1038/nsmb1099; Bornholdt ZA, 2008, NATURE, V456, P985, DOI 10.1038/nature07444; Chastre E, 2009, FASEB J, V23, P916, DOI 10.1096/fj.08-106344; Das K, 2008, P NATL ACAD SCI USA, V105, P13093, DOI 10.1073/pnas.0805213105; Ehrhardt C, 2010, MICROBES INFECT, V12, P81, DOI 10.1016/j.micinf.2009.09.007; Fodor E, 1999, J VIROL, V73, P9679, DOI 10.1128/JVI.73.11.9679-9682.1999; Gack MU, 2007, NATURE, V446, P916, DOI 10.1038/nature05732; Gack MU, 2009, CELL HOST MICROBE, V5, P439, DOI 10.1016/j.chom.2009.04.006; Gardiol D, 1998, J GEN VIROL, V79, P1963, DOI 10.1099/0022-1317-79-8-1963; GIARD DJ, 1973, J NATL CANCER I, V51, P1417, DOI 10.1093/jnci/51.5.1417; Glaunsinger BA, 2000, ONCOGENE, V19, P5270, DOI 10.1038/sj.onc.1203906; Golebiewski L, 2011, J VIROL, V85, P10639, DOI 10.1128/JVI.05070-11; Graef KM, 2010, J VIROL, V84, P8433, DOI 10.1128/JVI.00879-10; Hale BG, 2008, J GEN VIROL, V89, P2359, DOI 10.1099/vir.0.2008/004606-0; Hale BG, 2008, VIROLOGY, V378, P1, DOI 10.1016/j.virol.2008.05.026; Hale BG, 2006, P NATL ACAD SCI USA, V103, P14194, DOI 10.1073/pnas.0606109103; Javier RT, 2011, J VIROL, V85, P11544, DOI 10.1128/JVI.05410-11; Kawai T, 2005, NAT IMMUNOL, V6, P981, DOI 10.1038/ni1243; Kim EJ, 2004, NAT REV NEUROSCI, V5, P771, DOI 10.1038/nrn1517; Kranjec C, 2011, J VIROL, V85, P1757, DOI 10.1128/JVI.01756-10; Kuo RL, 2010, VIROLOGY, V408, P146, DOI 10.1016/j.virol.2010.09.012; Laura RP, 2002, EXP CELL RES, V275, P155, DOI 10.1006/excr.2002.5475; Liu HB, 2010, J VIROL, V84, P11164, DOI 10.1128/JVI.01278-10; Liu JS, 1997, NAT STRUCT BIOL, V4, P896, DOI 10.1038/nsb1197-896; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Meylan E, 2005, NATURE, V437, P1167, DOI 10.1038/nature04193; Mibayashi M, 2007, J VIROL, V81, P514, DOI 10.1128/JVI.01265-06; Nakagawa S, 2000, MOL CELL BIOL, V20, P8244, DOI 10.1128/MCB.20.21.8244-8253.2000; Nemeroff ME, 1998, MOL CELL, V1, P991, DOI 10.1016/S1097-2765(00)80099-4; Noah DL, 2003, VIROLOGY, V307, P386, DOI 10.1016/S0042-6822(02)00127-7; Nourry Claire, 2003, Sci STKE, V2003, pRE7; Obenauer JC, 2006, SCIENCE, V311, P1576, DOI 10.1126/science.1121586; Ridgway LD, 2009, AM J PHYSIOL-CELL PH, V297, pC55, DOI 10.1152/ajpcell.00073.2009; Sakurai A, 2006, MOL BIOL CELL, V17, P966, DOI 10.1091/mbc.E05-07-0647; Seth RB, 2005, CELL, V122, P669, DOI 10.1016/j.cell.2005.08.012; Seth RB, 2006, CELL RES, V16, P141, DOI 10.1038/sj.cr.7310019; Takeuchi O, 2007, IMMUNOL REV, V220, P214, DOI 10.1111/j.1600-065X.2007.00562.x; Takeuchi O, 2009, IMMUNOL REV, V227, P75, DOI 10.1111/j.1600-065X.2008.00737.x; Thomas M, 2011, VIROL J, V8, DOI 10.1186/1743-422X-8-25; Varga ZT, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002067; Werme K, 2008, CELL MICROBIOL, V10, P696, DOI 10.1111/j.1462-5822.2007.01076.x; Xu LG, 2005, MOL CELL, V19, P727, DOI 10.1016/j.molcel.2005.08.014; Yu J, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019511; Zaric J, 2011, ONCOGENE; Zhang H, 2011, VIROL J, V8, DOI 10.1186/1743-422X-8-298; Zielecki F, 2010, J VIROL, V84, P10708, DOI 10.1128/JVI.00610-10	48	16	18	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 20	2012	7	7							e41251	10.1371/journal.pone.0041251	http://dx.doi.org/10.1371/journal.pone.0041251			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	977GL	22911767	Green Published, gold, Green Submitted			2022-12-25	WOS:000306644600061
J	Seixas, E; Ramalho, JS; Mota, LJ; Barral, DC; Seabra, MC				Seixas, Elsa; Ramalho, Jose S.; Mota, Luis J.; Barral, Duarte C.; Seabra, Miguel C.			Bacteria and Protozoa Differentially Modulate the Expression of Rab Proteins	PLOS ONE			English	Article							PHAGOSOME MATURATION; GTPASES; TRANSLOCATION; TRAFFICKING; FUSION; KISS; GUT	Phagocytic cells represent an important line of innate defense against microorganisms. Uptake of microorganisms by these cells involves the formation of a phagosome that matures by fusing with endocytic compartments, resulting in killing of the enclosed microbe. Small GTPases of the Rab family are key regulators of vesicular trafficking in the endocytic pathway. Intracellular pathogens can interfere with the function of these proteins in order to subvert host immune responses. However, it is unknown if this subversion can be achieved through the modulation of Rab gene expression. We compared the expression level of 23 distinct Rab GTPases in mouse macrophages after infection with the protozoan Plasmodium berghei, and the bacteria Escherichia coli and Salmonella enterica. We found that P. berghei induces an increase in the expression of a different set of Rab genes than E. coli and S. enterica, which behaved similarly. Strikingly, when one of the Rab proteins whose expression was increased by P. berghei, namely Rab14, was silenced, we observed a significant increase in the phagocytosis of P. berghei, whereas Rab14 overexpression led to a decrease in phagocytosis. This suggests that the parasite might induce the increase of Rab14 expression for its own advantage. Similarly, when Rab9a, whose expression was increased by E. coli and S. enterica, was silenced, we observed an increase in the phagocytosis of both bacterial species, whereas Rab9a overexpression caused a reduction in phagocytosis. This further suggests that the modulation of Rab gene expression could represent a mechanism of immune evasion. Thus, our study analyzes the modulation of Rab gene expression induced by bacteria and protozoa and suggests that this modulation could be necessary for the success of microbial infection.	[Seixas, Elsa; Ramalho, Jose S.; Barral, Duarte C.; Seabra, Miguel C.] Univ Nova Lisboa, Fac Ciencias Med, CEDOC, P-1200 Lisbon, Portugal; [Seixas, Elsa; Seabra, Miguel C.] Inst Gulbenkian Ciencias, Oeiras, Portugal; [Mota, Luis J.] Univ Nova Lisboa, Inst Tecnol Quim & Biol, Oeiras, Portugal	Universidade Nova de Lisboa; Instituto Gulbenkian de Ciencia; Universidade Nova de Lisboa	Seixas, E (corresponding author), Univ Nova Lisboa, Fac Ciencias Med, CEDOC, P-1200 Lisbon, Portugal.	duarte.barral@fcm.unl.pt; miguel.seabra@fcm.unl.pt	Seabra, Miguel C/M-3280-2013; Seabra, Miguel/AAC-3099-2019; Ramalho, Jose/M-6415-2015; Mota, Luis/B-9497-2008; Barral, Duarte/E-7548-2013	Seabra, Miguel C/0000-0002-6404-4892; Ramalho, Jose/0000-0002-1927-164X; Mota, Luis/0000-0002-5592-8397; Barral, Duarte/0000-0001-8867-2407; Seixas, Elsa/0000-0003-2819-2051	Fundacao para a Ciencia e a Tecnologia, Portugal [PEst-OE/EQB/LA0004/2011, PTDC/SAU-MII/104622/2008, SFRH/BPD/34094/2006]; Marie Curie International Reintegration Grant [PIRGOS-GA-2009-247726]	Fundacao para a Ciencia e a Tecnologia, Portugal(Portuguese Foundation for Science and Technology); Marie Curie International Reintegration Grant(European Commission)	This work was supported by Fundacao para a Ciencia e a Tecnologia, Portugal through Grants PEst-OE/EQB/LA0004/2011 (to L.J.M.); PTDC/SAU-MII/104622/2008 (to M. C. S.); SFRH/BPD/34094/2006 (to E. S.); and Marie Curie International Reintegration Grant, PIRGOS-GA-2009-247726 (to D. C. B.). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BERON W, 1995, TRENDS CELL BIOL, V5, P100, DOI 10.1016/S0962-8924(00)88958-8; Brurnell JH, 2007, MICROBIOL MOL BIOL R, V71, P636, DOI 10.1128/MMBR.00023-07; Capmany A, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0014084; DESJARDINS M, 1995, TRENDS CELL BIOL, V5, P183, DOI 10.1016/S0962-8924(00)88989-8; Diekmann Y, 2011, PLOS COMPUT BIOL, V7, DOI 10.1371/journal.pcbi.1002217; Drecktrah D, 2007, TRAFFIC, V8, P212, DOI 10.1111/j.1600-0854.2006.00529.x; Duclos S, 2000, J CELL SCI, V113, P3531; Kinchen JM, 2008, NAT REV MOL CELL BIO, V9, P781, DOI 10.1038/nrm2515; Kohler CD, 2011, INT J MED MICROBIOL, V301, P642, DOI 10.1016/j.ijmm.2011.09.006; Kyei GB, 2006, EMBO J, V25, P5250, DOI 10.1038/sj.emboj.7601407; Lichtman SM, 2001, J PEDIATR GASTR NUTR, V33, P1, DOI 10.1097/00005176-200107000-00001; Lopes VS, 2007, TRAFFIC, V8, P486, DOI 10.1111/j.1600-0854.2007.00548.x; MacFie J, 1999, GUT, V45, P223, DOI 10.1136/gut.45.2.223; Nieuwenhuijzen GAP, 1996, EUR J SURG, V162, P259; Novick P, 1997, CURR OPIN CELL BIOL, V9, P496, DOI 10.1016/S0955-0674(97)80025-7; Reddy BS, 2007, CLIN NUTR, V26, P208, DOI 10.1016/j.clnu.2006.10.006; Rogers LD, 2007, P NATL ACAD SCI USA, V104, P18520, DOI 10.1073/pnas.0705801104; Sacks D, 2002, NAT IMMUNOL, V3, P1041, DOI 10.1038/ni1102-1041; Schwartz SL, 2007, J CELL SCI, V120, P3905, DOI 10.1242/jcs.015909; Scianimanico S, 1999, CELL MICROBIOL, V1, P19, DOI 10.1046/j.1462-5822.1999.00002.x; Seabra MC, 2002, TRENDS MOL MED, V8, P23, DOI 10.1016/S1471-4914(01)02227-4; Seixas E, 2009, EUR J IMMUNOL, V39, P1850, DOI 10.1002/eji.200838403; SHEAR HL, 1989, J IMMUNOL, V143, P2038; Smith AC, 2007, J CELL BIOL, V176, P263, DOI 10.1083/jcb.200611056; Sorensen M, 2003, FEBS LETT, V552, P110, DOI 10.1016/S0014-5793(03)00856-1; Stenmark H, 2001, GENOME BIOL, V2; Stuart LM, 2007, NATURE, V445, P95, DOI 10.1038/nature05380; Stuart LM, 2005, IMMUNITY, V22, P539, DOI 10.1016/j.immuni.2005.05.002; URQUHART AD, 1994, CLIN INFECT DIS, V19, P117, DOI 10.1093/clinids/19.1.117; Via LE, 1997, J BIOL CHEM, V272, P13326, DOI 10.1074/jbc.272.20.13326; Vieira OV, 2002, BIOCHEM J, V366, P689, DOI 10.1042/BJ20020691	31	12	13	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 20	2012	7	7							e39858	10.1371/journal.pone.0039858	http://dx.doi.org/10.1371/journal.pone.0039858			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	977GL	22911692	Green Published, Green Submitted, gold			2022-12-25	WOS:000306644600011
J	Van Rooij, P; Martel, A; D'Herde, K; Brutyn, M; Croubels, S; Ducatelle, R; Haesebrouck, F; Pasmans, F				Van Rooij, Pascale; Martel, An; D'Herde, Katharina; Brutyn, Melanie; Croubels, Siska; Ducatelle, Richard; Haesebrouck, Freddy; Pasmans, Frank			Germ Tube Mediated Invasion of Batrachochytrium dendrobatidis in Amphibian Skin Is Host Dependent	PLOS ONE			English	Article							FROGS LITORIA-CAERULEA; AFRICAN CLAWED FROG; CHYTRID FUNGUS; XENOPUS-LAEVIS; PEPTIDE DEFENSES; SP-NOV; CHYTRIDIOMYCOSIS; PATHOGENESIS; DECLINES; POPULATIONS	Batrachochytrium dendrobatidis (Bd) is the causative agent of chytridiomycosis, a fungal skin disease in amphibians and driver of worldwide amphibian declines. We focussed on the early stages of infection by Bd in 3 amphibian species with a differential susceptibility to chytridiomycosis. Skin explants of Alytes muletensis, Litoria caerulea and Xenopus leavis were exposed to Bd in an Ussing chamber for 3 to 5 days. Early interactions of Bd with amphibian skin were observed using light microscopy and transmission electron microscopy. To validate the observations in vitro, comparison was made with skin from experimentally infected frogs. Additional in vitro experiments were performed to elucidate the process of intracellular colonization in L. caerulea. Early interactions of Bd with amphibian skin are: attachment of zoospores to host skin, zoospore germination, germ tube development, penetration into skin cells, invasive growth in the host skin, resulting in the loss of host cell cytoplasm. Inoculation of A. muletensis and L. caerulea skin was followed within 24 h by endobiotic development, with sporangia located intracellularly in the skin. Evidence is provided of how intracellular colonization is established and how colonization by Bd proceeds to deeper skin layers. Older thalli develop rhizoid-like structures that spread to deeper skin layers, form a swelling inside the host cell to finally give rise to a new thallus. In X. laevis, interaction of Bd with skin was limited to an epibiotic state, with sporangia developing upon the skin. Only the superficial epidermis was affected. Epidermal cells seemed to be used as a nutrient source without development of intracellular thalli. The in vitro data agreed with the results obtained after experimental infection of the studied frog species. These data suggest that the colonization strategy of B. dendrobatidis is host dependent, with the extent of colonization most likely determined by inherent characteristics of the host epidermis.	[Van Rooij, Pascale; Martel, An; Brutyn, Melanie; Ducatelle, Richard; Haesebrouck, Freddy; Pasmans, Frank] Univ Ghent, Fac Vet Med, Dept Pathol Bacteriol & Avian Dis, Merelbeke, Belgium; [D'Herde, Katharina] Univ Ghent, Fac Med & Hlth Sci, Dept Basic Med Sci, B-9000 Ghent, Belgium; [Croubels, Siska] Univ Ghent, Fac Vet Med, Dept Pharmacol Toxicol & Biochem, Merelbeke, Belgium	Ghent University; Ghent University; Ghent University	Van Rooij, P (corresponding author), Univ Ghent, Fac Vet Med, Dept Pathol Bacteriol & Avian Dis, Merelbeke, Belgium.	pascale.vanrooij@ugent.be	Haesebrouck, Freddy/M-3857-2014; D'Herde, Katharina/AAM-4570-2020; Martel, An/D-3713-2014; Pasmans, Frank/D-3667-2014	Haesebrouck, Freddy/0000-0002-1709-933X; D'Herde, Katharina/0000-0001-6591-0476; Croubels, Siska/0000-0001-6357-3517	PVR by research grant from Ghent University [BOF08/24J/004]	PVR by research grant from Ghent University	Funding for this work was provided to PVR by research grant BOF08/24J/004 from Ghent University. No additional external funding was received for this study. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Barr DJS, 2001, MYCOTA, V7, P93; Becker MH, 2009, APPL ENVIRON MICROB, V75, P6635, DOI 10.1128/AEM.01294-09; Berger L, 2005, DIS AQUAT ORGAN, V68, P65, DOI 10.3354/dao068065; Berger L, 2005, DIS AQUAT ORGAN, V68, P51, DOI 10.3354/dao068051; Berger L, 1998, P NATL ACAD SCI USA, V95, P9031, DOI 10.1073/pnas.95.15.9031; Berger L, 2009, RES VET SCI, V87, P106, DOI 10.1016/j.rvsc.2008.11.005; Boyle DG, 2004, DIS AQUAT ORGAN, V60, P141, DOI 10.3354/dao060141; Campbell CR, 2012, INT J BIOCHEM CELL B, V44, P431, DOI 10.1016/j.biocel.2011.12.002; Carver S, 2010, COPEIA, P487, DOI 10.1643/CH-09-128; Crawford AJ, 2010, P NATL ACAD SCI USA, V107, P13777, DOI 10.1073/pnas.0914115107; Farrer RA, 2011, P NATL ACAD SCI USA, V108, P18732, DOI 10.1073/pnas.1111915108; Fisher MC, 2009, MOL ECOL, V18, P4731, DOI 10.1111/j.1365-294X.2009.04385.x; Fisher MC, 2009, MOL ECOL, V18, P415, DOI 10.1111/j.1365-294X.2008.04041.x; Garner TWJ, 2006, BIOL LETTERS, V2, P455, DOI 10.1098/rsbl.2006.0494; Green DE, 2007, HERPETOL CONSERV BIO, V2, P43; Hill WA, 2010, J AM ASSOC LAB ANIM, V49, P215; IUCN, 2011, 2011 1 IUCN RED LIST; Kielgast J, 2010, ANIM CONSERV, V13, P36, DOI 10.1111/j.1469-1795.2009.00297.x; Lotters S, 2009, ECOHEALTH, V6, P358, DOI 10.1007/s10393-010-0281-6; Longcore JE, 1999, MYCOLOGIA, V91, P219, DOI 10.2307/3761366; LONGCORE JE, 1995, MYCOLOGIA, V87, P25, DOI 10.2307/3760942; Marantelli Gerry, 2004, Pacific Conservation Biology, V10, P173; Marcum RD, 2010, DIS AQUAT ORGAN, V91, P17, DOI 10.3354/dao02235; Martel A, 2011, MED MYCOL, V49, P143, DOI 10.3109/13693786.2010.508185; Moss AS, 2010, DIS AQUAT ORGAN, V92, P149, DOI 10.3354/dao02223; Moss AS, 2008, MYCOLOGIA, V100, P1, DOI 10.3852/mycologia.100.1.1; Naglik JR, 2003, MICROBIOL MOL BIOL R, V67, P400, DOI 10.1128/MMBR.67.3.400-428.2003; NISHIKAWA A, 1990, IN VITRO CELL DEV B, V26, P1128; Pessier AP, 1999, J VET DIAGN INVEST, V11, P194, DOI 10.1177/104063879901100219; Ramsey JP, 2010, INFECT IMMUN, V78, P3981, DOI 10.1128/IAI.00402-10; Rollins-Smith LA, 2005, DEV COMP IMMUNOL, V29, P589, DOI 10.1016/j.dci.2004.11.004; Rollins-Smith LA, 2009, BBA-BIOMEMBRANES, V1788, P1593, DOI 10.1016/j.bbamem.2009.03.008; Rosenblum EB, 2008, P NATL ACAD SCI USA, V105, P17034, DOI 10.1073/pnas.0804173105; Schneider DS, 2008, NAT REV IMMUNOL, V8, P889, DOI 10.1038/nri2432; Shin W, 2001, CAN J BOT, V79, P1083, DOI 10.1139/b01-086; Solis R, 2010, BIOL INVASIONS, V12, P1641, DOI 10.1007/s10530-009-9577-2; Stuart SN, 2004, SCIENCE, V306, P1783, DOI 10.1126/science.1103538; Van Rooij P, 2010, ATLA-ALTERN LAB ANIM, V38, P519, DOI 10.1177/026119291003800614; Vermout S, 2008, MYCOPATHOLOGIA, V166, P267, DOI 10.1007/s11046-008-9104-5; Voyles J, 2007, DIS AQUAT ORGAN, V77, P113, DOI 10.3354/dao01838; Voyles J, 2011, MICROBES INFECT, V13, P25, DOI 10.1016/j.micinf.2010.09.015; Voyles J, 2009, SCIENCE, V326, P582, DOI 10.1126/science.1176765; Wake DB, 2008, P NATL ACAD SCI USA, V105, P11466, DOI 10.1073/pnas.0801921105; Walker SF, 2008, CURR BIOL, V18, pR853, DOI 10.1016/j.cub.2008.07.033; Weldon C, 2004, EMERG INFECT DIS, V10, P2100, DOI 10.3201/eid1012.030804; Woodhams DC, 2007, ANIM CONSERV, V10, P409, DOI 10.1111/j.1469-1795.2007.00130.x	46	45	46	0	59	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 20	2012	7	7							e41481	10.1371/journal.pone.0041481	http://dx.doi.org/10.1371/journal.pone.0041481			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	977GL	22911798	Green Published, Green Submitted, gold			2022-12-25	WOS:000306644600080
J	Wei, WJ; Sun, HY; Ting, KY; Zhang, LH; Lee, HC; Li, GR; Yue, JB				Wei, Wen-Jie; Sun, Hai-Ying; Ting, Kai Yiu; Zhang, Li-He; Lee, Hon-Cheung; Li, Gui-Rong; Yue, Jianbo			Inhibition of Cardiomyocytes Differentiation of Mouse Embryonic Stem Cells by CD38/cADPR/Ca2+ Signaling Pathway	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CYCLIC ADP-RIBOSE; RECEPTOR; CARDIOGENESIS; CALRETICULIN; ACTIVATION; TRANSIENT; CHANNELS; MYOCYTES; MICE; BMP	Cyclic adenosine diphosphoribose ( cADPR) is an endogenous Ca2+ mobilizing messenger that is formed by ADP-ribosyl cyclases from nicotinamide adenine dinucleotide (NAD). The main ADP-ribosyl cyclase in mammals is CD38, a multi-functional enzyme and a type II membrane protein. Here we explored the role of CD38-cADPR-Ca2+ in the cardiomyogenesis of mouse embryonic stem (ES) cells. We found that the mouse ES cells are responsive to cADPR and possess the key components of the cADPR signaling pathway. In vitro cardiomyocyte (CM) differentiation of mouse ES cells was initiated by embryoid body (EB) formation. Interestingly, beating cells appeared earlier and were more abundant in CD38 knockdown EBs than in control EBs. Real-time RT-PCR and Western blot analyses further showed that the expression of several cardiac markers, including GATA4, MEF2C, NKX2.5, and alpha-MLC, were increased markedly in CD38 knockdown EBs than those in control EBs. Similarly, FACS analysis showed that more cardiac Troponin T-positive CMs existed in CD38 knockdown or 8-Br-cADPR, a cADPR antagonist, treated EBs compared with that in control EBs. On the other hand, overexpression of CD38 in mouse ES cells significantly inhibited CM differentiation. Moreover, CD38 knockdown ES cell-derived CMs possess the functional properties characteristic of normal ES cell-derived CMs. Last, we showed that the CD38-cADPR pathway negatively modulated the FGF4-Erks1/2 cascade during CM differentiation of ES cells, and transiently inhibition of Erk1/2 blocked the enhanced effects of CD38 knockdown on the differentiation of CM from ES cells. Taken together, our data indicate that the CD38-cADPR-Ca2+ signaling pathway antagonizes the CM differentiation of mouse ES cells.	[Wei, Wen-Jie; Sun, Hai-Ying; Ting, Kai Yiu; Lee, Hon-Cheung; Li, Gui-Rong; Yue, Jianbo] Univ Hong Kong, Dept Physiol, Hong Kong, Hong Kong, Peoples R China; [Zhang, Li-He] Peking Univ, Sch Pharmaceut Sci, State Key Lab Nat & Biomimet Drugs, Beijing 100191, Peoples R China	University of Hong Kong; Peking University	Yue, JB (corresponding author), Univ Hong Kong, Dept Physiol, Hong Kong, Hong Kong, Peoples R China.	jyue@hku.hk	, 李贵荣（沧海一粟）/AAZ-4335-2020; Li, Gui-Rong/C-4341-2009; Lee, Hon Cheung/C-4329-2009; Yue, Jianbo/AAC-4588-2019; Yue, Jianbo/K-8002-2015	, 李贵荣（沧海一粟）/0000-0002-9437-2280; Yue, Jianbo/0000-0001-6384-5447	Research Grant Council (RGC) [HKU 784710M, HKU 782709M, HKU 785911M]; National Natural Science Foundation of China (NSFC)/RGC Grant from Hong Kong [N_HKU 737/09]; Leukemia and Lymphoma Society of America	Research Grant Council (RGC)(Hong Kong Research Grants Council); National Natural Science Foundation of China (NSFC)/RGC Grant from Hong Kong; Leukemia and Lymphoma Society of America(Leukemia and Lymphoma Society)	This work was supported by Research Grant Council (RGC) Grants HKU 784710M, HKU 782709M, HKU 785911M, a National Natural Science Foundation of China (NSFC)/RGC Grant from Hong Kong (N_HKU 737/09) and a Special Fellow Award from the Leukemia and Lymphoma Society of America (to J. Y.).	Apati A, 2012, MOL CELL ENDOCRINOL, V353, P57, DOI 10.1016/j.mce.2011.08.038; Barron M, 2000, DEV DYNAM, V218, P383, DOI 10.1002/(SICI)1097-0177(200006)218:2<383::AID-DVDY11>3.0.CO;2-P; Caspi O, 2007, J AM COLL CARDIOL, V50, P1884, DOI 10.1016/j.jacc.2007.07.054; Christoforou N, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011536; Churamani D, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000797; Creton R, 2000, DEV BIOL, V217, P375, DOI 10.1006/dbio.1999.9542; Farokhpour M, 2009, TOXICOL IN VITRO, V23, P1422, DOI 10.1016/j.tiv.2009.07.008; Galione A, 2000, Sci STKE, V2000, ppe1; Galione Antony, 1998, Cell Biochemistry and Biophysics, V28, P19, DOI 10.1007/BF02738307; Graeff R, 2002, BIOCHEM J, V361, P379, DOI 10.1042/bj3610379; Gu XF, 2004, J MED CHEM, V47, P5674, DOI 10.1021/jm040092t; Guse AH, 2004, CURR MED CHEM, V11, P847, DOI 10.2174/0929867043455602; Itzhaki I, 2006, ANN NY ACAD SCI, V1080, P207, DOI 10.1196/annals.1380.017; Janowski E, 2006, ANN NY ACAD SCI, V1080, P154, DOI 10.1196/annals.1380.014; Jude Joseph A, 2008, Proc Am Thorac Soc, V5, P15, DOI 10.1513/pats.200704-047VS; Kapur N, 2007, J PHYSIOL-LONDON, V581, P1113, DOI 10.1113/jphysiol.2006.125955; Kleger A, 2010, CIRCULATION, V122, P1823, DOI 10.1161/CIRCULATIONAHA.110.971721; KUEMMERLE JF, 1995, J BIOL CHEM, V270, P25488, DOI 10.1074/jbc.270.43.25488; Kume S, 1997, SCIENCE, V278, P1940, DOI 10.1126/science.278.5345.1940; Kupperman E, 2000, NATURE, V406, P192, DOI 10.1038/35018092; Kwong AKY, 2012, BIOCHEMISTRY-US, V51, P555, DOI 10.1021/bi201509f; Laflamme MA, 2007, NAT BIOTECHNOL, V25, P1015, DOI 10.1038/nbt1327; Li PL, 1997, ADV EXP MED BIOL, V419, P437; Li S, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0031905; Lickteig K, 1996, MOL REPROD DEV, V44, P146, DOI 10.1002/(SICI)1098-2795(199606)44:2<146::AID-MRD2>3.0.CO;2-N; Lough J, 1996, DEV BIOL, V178, P198, DOI 10.1006/dbio.1996.0211; Malavasi F, 2008, PHYSIOL REV, V88, P841, DOI 10.1152/physrev.00035.2007; MALTSEV VA, 1994, CIRC RES, V75, P233, DOI 10.1161/01.RES.75.2.233; Mesaeli N, 1999, J CELL BIOL, V144, P857, DOI 10.1083/jcb.144.5.857; Mikoshiba K, 2011, CELL CALCIUM, V49, P331, DOI 10.1016/j.ceca.2010.12.006; Moorman AFM, 2004, ANN NY ACAD SCI, V1015, P171, DOI 10.1196/annals.1302.014; Munoz-Chapuli R, 2010, J CARDIOVASC TRANSL, V3, P37, DOI 10.1007/s12265-009-9146-1; MURTHY KS, 1995, AM J PHYSIOL-GASTR L, V269, pG93, DOI 10.1152/ajpgi.1995.269.1.G93; Onizuka T, 2012, J MOL CELL CARDIOL, V52, P650, DOI 10.1016/j.yjmcc.2011.11.010; Pandur P, 2005, BIOL CELL, V97, P197; Papp S, 2009, STEM CELLS, V27, P1507, DOI 10.1002/stem.85; Puceat M, 2005, CELL CALCIUM, V38, P383, DOI 10.1016/j.ceca.2005.06.016; Quattrocelli M, 2011, J CELL BIOCHEM, V112, P2006, DOI 10.1002/jcb.23118; Rakovic S, 1996, CURR BIOL, V6, P989, DOI 10.1016/S0960-9822(02)00643-7; Sarkar Prasenjit, 2009, Critical Reviews in Biomedical Engineering, V37, P283, DOI 10.1615/CritRevBiomedEng.v37.i4-5.10; Satin J, 2004, J PHYSIOL-LONDON, V559, P479, DOI 10.1113/jphysiol.2004.068213; Satin J, 2008, STEM CELLS, V26, P1961, DOI 10.1634/stemcells.2007-0591; Shimoji K, 2010, CELL STEM CELL, V6, P227, DOI 10.1016/j.stem.2010.01.002; Takahashi J, 2003, BIOCHEM BIOPH RES CO, V312, P434, DOI 10.1016/j.bbrc.2003.10.143; Thai TL, 2009, AM J PHYSIOL-RENAL, V297, pF169, DOI 10.1152/ajprenal.00079.2009; Willems E, 2009, PEDIATR CARDIOL, V30, P635, DOI 10.1007/s00246-009-9409-2; Wobus A M, 2002, Methods Mol Biol, V185, P127; Yanagi K, 2007, STEM CELLS, V25, P2712, DOI 10.1634/stemcells.2006-0388; Yang HT, 2002, P NATL ACAD SCI USA, V99, P9225, DOI 10.1073/pnas.142651999; Ying QL, 2003, NAT BIOTECHNOL, V21, P183, DOI 10.1038/nbt780; Yu PL, 2012, J BIOL CHEM, V287, P24774, DOI 10.1074/jbc.M111.329854; Yuasa S, 2005, NAT BIOTECHNOL, V23, P607, DOI 10.1038/nbt1093; Yue JB, 2006, MOL CELL BIOL, V26, P5300, DOI 10.1128/MCB.00273-06; Yue JB, 2009, J BIOL CHEM, V284, P29335, DOI 10.1074/jbc.M109.049767; Zeevi-Levin N, 2010, CRIT REV EUKAR GENE, V20, P51, DOI 10.1615/CritRevEukarGeneExpr.v20.i1.40; Zhang F, 2008, CELL SIGNAL, V20, P637, DOI 10.1016/j.cellsig.2007.11.013; Zhang G, 2006, AM J PHYSIOL-HEART C, V290, pH1172, DOI 10.1152/ajpheart.00441.2005; Zhang JH, 2009, CIRC RES, V104, pE30, DOI 10.1161/CIRCRESAHA.108.192237; Zhu XL, 1996, DEV DYNAM, V207, P429, DOI 10.1002/(SICI)1097-0177(199612)207:4<429::AID-AJA7>3.0.CO;2-J	59	27	27	0	16	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 12	2012	287	42					35599	35611		10.1074/jbc.M112.392530	http://dx.doi.org/10.1074/jbc.M112.392530			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	022OF	22908234	hybrid, Green Published			2022-12-25	WOS:000309968000072
J	Neukamm, SS; Toth, R; Morrice, N; Campbell, DG; MacKintosh, C; Lehmann, R; Haering, HU; Schleicher, ED; Weigert, C				Neukamm, Sabine S.; Toth, Rachel; Morrice, Nick; Campbell, David G.; MacKintosh, Carol; Lehmann, Rainer; Haering, Hans-Ulrich; Schleicher, Erwin D.; Weigert, Cora			Identification of the Amino Acids 300-600 of IRS-2 as 14-3-3 Binding Region with the Importance of IGF-1/Insulin-Regulated Phosphorylation of Ser-573	PLOS ONE			English	Article							INSULIN-RECEPTOR SUBSTRATE-1; CRYSTAL-STRUCTURE; STRUCTURAL BASIS; IN-VIVO; PROTEIN; RESISTANCE; ISOFORM; DOMAIN; SITES; ASSOCIATION	Phosphorylation of insulin receptor substrate (IRS)-2 on tyrosine residues is a key event in IGF-1/insulin signaling and leads to activation of the PI 3-kinase and the Ras/MAPK pathway. Furthermore, phosphorylated serine/threonine residues on IRS-2 can induce 14-3-3 binding. In this study we searched IRS-2 for novel phosphorylation sites and investigated the interaction between IRS-2 and 14-3-3. Mass spectrometry identified a total of 24 serine/threonine residues on IRS-2 with 12 sites unique for IRS-2 while the other residues are conserved in IRS-1 and IRS-2. IGF-1 stimulation led to increased binding of 14-3-3 to IRS-2 in transfected HEK293 cells and this binding was prevented by inhibition of the PI 3-kinase pathway and an Akt/PKB inhibitor. Insulin-stimulated interaction between endogenous IRS-2 and 14-3-3 was observed in rat hepatoma cells and in mice liver after an acute insulin stimulus and refeeding. Using different IRS-2 fragments enabled localization of the IGF-1-dependent 14-3-3 binding region spanning amino acids 300-600. The 24 identified residues on IRS-2 included several 14-3-3 binding candidates in the region 300-600. Single alanine mutants of these candidates led to the identification of serine 573 as 14-3-3 binding site. A phospho-site specific antibody was generated to further characterize serine 573. IGF-1-dependent phosphorylation of serine 573 was reduced by inhibition of PI 3-kinase and Akt/PKB. A negative role of this phosphorylation site was implicated by the alanine mutant of serine 573 which led to enhanced phosphorylation of Akt/PKB in an IGF-1 time course experiment. To conclude, our data suggest a physiologically relevant role for IGF-1/insulin-dependent 14-3-3 binding to IRS-2 involving serine 573.	[Neukamm, Sabine S.; Lehmann, Rainer; Schleicher, Erwin D.; Weigert, Cora] Univ Tubingen Hosp, Dept Internal Med 4, Div Clin Chem & Pathobiochem, Tubingen, Germany; [Neukamm, Sabine S.; Lehmann, Rainer; Haering, Hans-Ulrich; Schleicher, Erwin D.; Weigert, Cora] Univ Tubingen, Helmholtz Ctr Munich, Inst Diabet Res & Metab Dis, Paul Langerhans Inst Tuebingen, Tubingen, Germany; [Toth, Rachel] Univ Dundee, Coll Life Sci, Div Signal Transduct & Therapy, Dundee, Scotland; [Morrice, Nick] Univ Glasgow, Beatson Inst Canc Res, Glasgow, Lanark, Scotland; [Campbell, David G.; MacKintosh, Carol] Univ Dundee, Coll Life Sci, MRC Prot Phosphorylat Unit, Dundee, Scotland; [Haering, Hans-Ulrich] Univ Tubingen Hosp, Dept Internal Med 4, Div Endocrinol Diabetol Vasc Med Nephrol & Clin C, Tubingen, Germany	Eberhard Karls University of Tubingen; Eberhard Karls University Hospital; Eberhard Karls University of Tubingen; Helmholtz Association; Helmholtz-Center Munich - German Research Center for Environmental Health; University of Dundee; Beatson Institute; University of Glasgow; University of Dundee; Eberhard Karls University of Tubingen; Eberhard Karls University Hospital	Neukamm, SS (corresponding author), Univ Tubingen Hosp, Dept Internal Med 4, Div Clin Chem & Pathobiochem, Tubingen, Germany.	Cora.Weigert@med.uni-tuebingen.de	Campbell, David G/K-1874-2015; MacKintosh, Carol/B-8210-2011; Lehmann, Rainer/AAF-4281-2019	Campbell, David G/0000-0003-2278-2149; MacKintosh, Carol/0000-0001-9166-589X; Lehmann, Rainer/0000-0003-1218-6810	Deutsche Forschungsgemeinschaft [GRK 1302/1, 1302/2]; German Federal Ministry of Education and Research; MRC [G1100713, MC_EX_G0801767, MC_U127084354] Funding Source: UKRI; Medical Research Council [MC_EX_G0801767, MC_U127084354, G1100713] Funding Source: researchfish	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); German Federal Ministry of Education and Research(Federal Ministry of Education & Research (BMBF)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	This study was supported by grants from the Deutsche Forschungsgemeinschaft to HUH, ES and CW [GRK 1302/1 and 1302/2]. This study was supported in part by a grant from the German Federal Ministry of Education and Research to the German Centre for Diabetes Research (DZD e.V.). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aitken A, 2011, SEMIN CELL DEV BIOL, V22, P673, DOI 10.1016/j.semcdb.2011.08.003; Benzing T, 2002, J BIOL CHEM, V277, P32954, DOI 10.1074/jbc.M200859200; CHEN C, 1987, MOL CELL BIOL, V7, P2745, DOI 10.1128/MCB.7.8.2745; Cullere X, 1998, J VIROL, V72, P558; Danielsson A, 2005, J BIOL CHEM, V280, P34389, DOI 10.1074/jbc.C500230200; Datta SR, 2000, MOL CELL, V6, P41, DOI 10.1016/S1097-2765(00)00006-X; Du XP, 1996, J BIOL CHEM, V271, P7362, DOI 10.1074/jbc.271.13.7362; Dubois F, 2009, MOL CELL PROTEOMICS, V8, P2487, DOI 10.1074/mcp.M800544-MCP200; Ewing RM, 2007, MOL SYST BIOL, V3, DOI 10.1038/msb4100134; Fritsche L, 2008, CURR MED CHEM, V15, P1316, DOI 10.2174/092986708784534956; Fritsche L, 2011, AM J PHYSIOL-ENDOC M, V300, pE824, DOI 10.1152/ajpendo.00409.2010; Geraghty KM, 2007, BIOCHEM J, V407, P231, DOI 10.1042/BJ20070649; Giraud J, 2004, J BIOL CHEM, V279, P3447, DOI 10.1074/jbc.M308631200; Giraud J, 2007, MOL ENDOCRINOL, V21, P2294, DOI 10.1210/me.2007-0159; Graves PR, 2001, ONCOGENE, V20, P1839, DOI 10.1038/sj.onc.1204259; Greene MW, 2002, BIOCHEMISTRY-US, V41, P7082, DOI 10.1021/bi015992f; Hanke S, 2009, MOL CELL PROTEOMICS, V8, P519, DOI 10.1074/mcp.M800407-MCP200; Harlow E., 1988, ANTIBODIES LAB MANUA; Herschkovitz A, 2007, J BIOL CHEM, V282, P18018, DOI 10.1074/jbc.M610949200; Jin J, 2004, CURR BIOL, V14, P1436, DOI 10.1016/j.cub.2004.07.051; Johnson C, 2010, BIOCHEM J, V427, P69, DOI 10.1042/BJ20091834; Kosaki A, 1998, J BIOL CHEM, V273, P940, DOI 10.1074/jbc.273.2.940; Lee S, 2008, ENDOCRINOLOGY, V149, P2451, DOI 10.1210/en.2007-1595; LIU D, 1995, NATURE, V376, P191, DOI 10.1038/376191a0; Masters SC, 1999, BIOCHEMISTRY-US, V38, P5216, DOI 10.1021/bi982492m; Meek SEM, 2004, J BIOL CHEM, V279, P32046, DOI 10.1074/jbc.M403044200; Morino K, 2006, DIABETES, V55, pS9, DOI 10.2337/db06-S002; Mothe I, 1996, J BIOL CHEM, V271, P11222, DOI 10.1074/jbc.271.19.11222; Muslin AJ, 1996, CELL, V84, P889, DOI 10.1016/S0092-8674(00)81067-3; MYERS MG, 1992, P NATL ACAD SCI USA, V89, P10350, DOI 10.1073/pnas.89.21.10350; O'Kelly I, 2002, CELL, V111, P577, DOI 10.1016/S0092-8674(02)01040-1; Obsil T, 2003, BIOCHEMISTRY-US, V42, P15264, DOI 10.1021/bi0352724; Obsil T, 2001, CELL, V105, P257, DOI 10.1016/S0092-8674(01)00316-6; Ogihara T, 1997, J BIOL CHEM, V272, P25267, DOI 10.1074/jbc.272.40.25267; Oriente F, 2005, J BIOL CHEM, V280, P40642, DOI 10.1074/jbc.M508570200; Peng CY, 1997, SCIENCE, V277, P1501, DOI 10.1126/science.277.5331.1501; Rubio MP, 2004, BIOCHEM J, V379, P395, DOI 10.1042/bj20031797; Rui LY, 2001, J CLIN INVEST, V107, P181, DOI 10.1172/JCI10934; Sharfi H, 2008, AM J PHYSIOL-ENDOC M, V294, pE307, DOI 10.1152/ajpendo.00534.2007; Shen YH, 2003, MOL BIOL CELL, V14, P4721, DOI 10.1091/mbc.E02-12-0821; SUN XJ, 1995, NATURE, V377, P173, DOI 10.1038/377173a0; Taniguchi CM, 2006, NAT REV MOL CELL BIO, V7, P85, DOI 10.1038/nrm1837; Vincenz C, 1996, J BIOL CHEM, V271, P20029, DOI 10.1074/jbc.271.33.20029; Weigert C, 2005, J BIOL CHEM, V280, P37393, DOI 10.1074/jbc.M506134200; Weigert C, 2004, J BIOL CHEM, V279, P23942, DOI 10.1074/jbc.M312692200; Weigert C, 2008, MOL ENDOCRINOL, V22, P2729, DOI 10.1210/me.2008-0102; Werner ED, 2004, J BIOL CHEM, V279, P35298, DOI 10.1074/jbc.M405203200; Wilker EW, 2005, J BIOL CHEM, V280, P18891, DOI 10.1074/jbc.M500982200; Williamson BL, 2006, MOL CELL PROTEOMICS, V5, P337, DOI 10.1074/mcp.M500210-MCP200; Xiang XQ, 2002, MOL ENDOCRINOL, V16, P552, DOI 10.1210/me.16.3.552; Yaffe MB, 2002, FEBS LETT, V513, P53, DOI 10.1016/S0014-5793(01)03288-4; Yaffe MB, 1997, CELL, V91, P961, DOI 10.1016/S0092-8674(00)80487-0; Yi ZP, 2007, DIABETES, V56, P1508, DOI 10.2337/db06-1355; Zhang J, 2008, J BIOL CHEM, V283, P35375, DOI 10.1074/jbc.M806480200; Zick Yehiel, 2005, Sci STKE, V2005, ppe4, DOI 10.1126/stke.2682005pe4	55	6	7	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 17	2012	7	8							e43296	10.1371/journal.pone.0043296	http://dx.doi.org/10.1371/journal.pone.0043296			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	996DG	22912850	Green Published, Green Accepted, gold, Green Submitted			2022-12-25	WOS:000308063700078
J	Wang, N; Li, QG; Zhang, L; Lin, HL; Hu, J; Li, DG; Shi, SZ; Cui, SY; Zhou, JH; Ji, JY; Wan, JJ; Cai, GY; Chen, XM				Wang, Nan; Li, Qinggang; Zhang, Li; Lin, Hongli; Hu, Jie; Li, Diangeng; Shi, Suozhu; Cui, Shaoyuan; Zhou, Jianhui; Ji, Jiayao; Wan, Jiajia; Cai, Guangyan; Chen, Xiangmei			Mesenchymal Stem Cells Attenuate Peritoneal Injury through Secretion of TSG-6	PLOS ONE			English	Article							IN-VITRO; ADHESION; HYALURONAN; PROTEIN; MEMBRANE; HEART; MODEL; TRANSPLANTATION; INTERFERENCE; PROGRESSION	Background: Mesothelial cell injury plays an important role in peritoneal fibrosis. Present clinical therapies aimed at alleviating peritoneal fibrosis have been largely inadequate. Mesenchymal stem cells (MSCs) are efficient for repairing injuries and reducing fibrosis. This study was designed to investigate the effects of MSCs on injured mesothelial cells and peritoneal fibrosis. Methodology/Principal Findings: Rat bone marrow-derived MSCs (5x10(6)) were injected into Sprague-Dawley (SD) rats via tail vein 24 h after peritoneal scraping. Distinct reductions in adhesion formation; infiltration of neutrophils, macrophage cells; number of fibroblasts; and level of transforming growth factor (TGF)-beta 1 were found in MSCs-treated rats. The proliferation and repair of peritoneal mesothelial cells in MSCs-treated rats were stimulated. Mechanically injured mesothelial cells co-cultured with MSCs in transwells showed distinct increases in migration and proliferation. In vivo imaging showed that MSCs injected intravenously mainly accumulated in the lungs which persisted for at least seven days. No apparent MSCs were observed in the injured peritoneum even when MSCs were injected intraperitoneally. The injection of serum-starved MSCs-conditioned medium (CM) intravenously reduced adhesions similar to MSCs. Antibody based protein array of MSCs-CM showed that the releasing of TNF alpha-stimulating gene (TSG)-6 increased most dramatically. Promotion of mesothelial cell repair and reduction of peritoneal adhesion were produced by the administration of recombinant mouse (rm) TSG-6, and were weakened by TSG-6-RNA interfering. Conclusions/Significance: Collectively, these results indicate that MSCs may attenuate peritoneal injury by repairing mesothelial cells, reducing inflammation and fibrosis. Rather than the engraftment, the secretion of TSG-6 by MSCs makes a major contribution to the therapeutic benefits of MSCs.	[Wang, Nan; Li, Qinggang; Zhang, Li; Hu, Jie; Li, Diangeng; Shi, Suozhu; Cui, Shaoyuan; Zhou, Jianhui; Ji, Jiayao; Wan, Jiajia; Cai, Guangyan; Chen, Xiangmei] Peoples Liberat Army Gen Hosp, Dept Nephrol, State Key Lab Kidney Dis, Beijing, Peoples R China; [Wang, Nan; Li, Qinggang; Zhang, Li; Hu, Jie; Li, Diangeng; Shi, Suozhu; Cui, Shaoyuan; Zhou, Jianhui; Ji, Jiayao; Wan, Jiajia; Cai, Guangyan; Chen, Xiangmei] Mil Med Postgrad Coll, Beijing, Peoples R China; [Wang, Nan; Ji, Jiayao; Wan, Jiajia] Nankai Univ, Coll Med, Tianjin 300071, Peoples R China; [Lin, Hongli] Dalian Med Univ, Affiliated Hosp 1, Dept Nephrol, Liaoning, Peoples R China	Chinese People's Liberation Army General Hospital; Nankai University; Dalian Medical University	Wang, N (corresponding author), Peoples Liberat Army Gen Hosp, Dept Nephrol, State Key Lab Kidney Dis, Beijing, Peoples R China.	caiguangyan@sina.com; xmchen301@126.com			National High Technology Research and Development Program [2011AA020115]; National Basic Research Program of China [2011CB964904]; National key Technology RD Program [2011BA110B08]; Health Industry Scientific Research Special Project [201002010]	National High Technology Research and Development Program(National High Technology Research and Development Program of China); National Basic Research Program of China(National Basic Research Program of China); National key Technology RD Program(National Key Technology R&D Program); Health Industry Scientific Research Special Project	This research was supported by a grant (2011AA020115; http://www.863.gov.cn) from the National High Technology Research and Development Program and a grant (2011CB964904; http://www.973.gov.cn) from the National Basic Research Program of China, a grant (2011BA110B08; http://kjzc.jhgl.org) from the National key Technology R&D Program, and a grant (201002010; http://www.moh.gov.cn) from the Health Industry Scientific Research Special Project. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Al'Qteishat A, 2006, BRAIN, V129, P2158, DOI 10.1093/brain/awl139; Aroeira LS, 2007, J AM SOC NEPHROL, V18, P2004, DOI 10.1681/ASN.2006111292; Bruno S, 2009, J AM SOC NEPHROL, V20, P1053, DOI 10.1681/ASN.2008070798; Cahill RA, 2008, WORLD J GASTROENTERO, V14, P4861, DOI 10.3748/wjg.14.4861; Choi H, 2011, BLOOD, V118, P330, DOI 10.1182/blood-2010-12-327353; Evanko SP, 2007, ADV DRUG DELIVER REV, V59, P1351, DOI 10.1016/j.addr.2007.08.008; Fang CC, 2010, WORLD J SURG, V34, P721, DOI 10.1007/s00268-009-0378-7; Fischer UM, 2009, STEM CELLS DEV, V18, P683, DOI 10.1089/scd.2008.0253; Gnecchi M, 2005, NAT MED, V11, P367, DOI 10.1038/nm0405-367; Gnecchi M, 2008, CIRC RES, V103, P1204, DOI 10.1161/CIRCRESAHA.108.176826; Gnecchi M, 2009, STEM CELLS, V27, P971, DOI 10.1002/stem.12; Guo H, 2009, BRIT J SURG, V96, P1323, DOI 10.1002/bjs.6722; Guo Q, 2008, BRIT J SURG, V95, P252, DOI 10.1002/bjs.5890; Herrick SE, 2004, INT J BIOCHEM CELL B, V36, P621, DOI 10.1016/j.biocel.2003.11.002; Hoshino A, 2007, J IMMUNOL, V178, P5296, DOI 10.4049/jimmunol.178.8.5296; Kamel RM, 2010, EUR J OBSTET GYN R B, V150, P111, DOI 10.1016/j.ejogrb.2010.02.003; Kanazawa H, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019195; Lauder CIW, 2011, J SURG RES, V171, P877, DOI 10.1016/j.jss.2010.06.028; Lee RH, 2009, CELL STEM CELL, V5, P54, DOI 10.1016/j.stem.2009.05.003; Lee RH, 2009, BLOOD, V113, P816, DOI 10.1182/blood-2007-12-128702; Lesley J, 2004, J BIOL CHEM, V279, P25745, DOI 10.1074/jbc.M313319200; Li LL, 2008, TRANSPL INT, V21, P1181, DOI 10.1111/j.1432-2277.2008.00742.x; Liu HJ, 2006, SURGERY, V140, P441, DOI 10.1016/j.surg.2005.12.014; Lozito TP, 2011, J CELL PHYSIOL, V226, P385, DOI 10.1002/jcp.22344; Meirelles LD, 2009, CYTOKINE GROWTH F R, V20, P419, DOI 10.1016/j.cytogfr.2009.10.002; Mias C, 2009, STEM CELLS, V27, P2734, DOI 10.1002/stem.169; Mindrescu C, 2005, BIOCHEM BIOPH RES CO, V330, P737, DOI 10.1016/j.bbrc.2005.03.040; Munoz JR, 2005, P NATL ACAD SCI USA, V102, P18171, DOI 10.1073/pnas.0508945102; Nagaya N, 2005, CIRCULATION, V112, P1128, DOI 10.1161/CIRCULATIONAHA.104.500447; Nie J, 2007, KIDNEY INT, V72, P1336, DOI 10.1038/sj.ki.5002533; Ninichuk V, 2006, KIDNEY INT, V70, P121, DOI 10.1038/sj.ki.5001521; Oh JY, 2010, P NATL ACAD SCI USA, V107, P16875, DOI 10.1073/pnas.1012451107; Ortiz LA, 2003, P NATL ACAD SCI USA, V100, P8407, DOI 10.1073/pnas.1432929100; Oyagi S, 2006, J HEPATOL, V44, P742, DOI 10.1016/j.jhep.2005.10.026; Parekkadan B, 2010, ANNU REV BIOMED ENG, V12, P87, DOI 10.1146/annurev-bioeng-070909-105309; Pittenger MF, 1999, SCIENCE, V284, P143, DOI 10.1126/science.284.5411.143; SAVANI RC, 1995, J CLIN INVEST, V95, P1158, DOI 10.1172/JCI117764; Saxena R, 2008, PEDIATR NEPHROL, V23, P695, DOI 10.1007/s00467-007-0580-5; Segura T, 2007, J SURG RES, V141, P162, DOI 10.1016/j.jss.2006.07.045; Selbi W, 2006, J AM SOC NEPHROL, V17, P1553, DOI 10.1681/ASN.2005080879; Song H, 2010, STEM CELLS, V28, P555, DOI 10.1002/stem.302; Szanto S, 2004, ARTHRITIS RHEUM-US, V50, P3012, DOI 10.1002/art.20655; Takahashi M, 2005, CIRCULATION, V112, pU321; van Poll D, 2008, HEPATOLOGY, V47, P1634, DOI 10.1002/hep.22236; Whang SH, 2011, J SURG RES, V167, P245, DOI 10.1016/j.jss.2009.06.020; Williams JD, 2002, J AM SOC NEPHROL, V13, P470, DOI 10.1681/ASN.V132470; Williams JD, 2003, KIDNEY INT, V64, pS43, DOI 10.1046/j.1523-1755.2003.08805.x; Yew TL, 2011, CELL TRANSPLANT, V20, P693, DOI 10.3727/096368910X550198; Yoon BS, 2010, STEM CELLS DEV, V19, P887, DOI 10.1089/scd.2009.0138; Yung S, 1998, KIDNEY INT, V54, P2160, DOI 10.1046/j.1523-1755.1998.00177.x; Zangi L, 2009, STEM CELLS, V27, P2865, DOI 10.1002/stem.217	51	84	91	0	23	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 17	2012	7	8							e43768	10.1371/journal.pone.0043768	http://dx.doi.org/10.1371/journal.pone.0043768			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	996DG	22912904	Green Published, Green Submitted, gold			2022-12-25	WOS:000308063700132
J	Duong, T; Jourdain, G; Ngo-Giang-Huong, N; Le Coeur, S; Kantipong, P; Buranabanjasatean, S; Leenasirimakul, P; Ariyadej, S; Tansuphasawasdikul, S; Thongpaen, S; Lallemant, M				Trinh Duong; Jourdain, Gonzague; Ngo-Giang-Huong, Nicole; Le Coeur, Sophie; Kantipong, Pacharee; Buranabanjasatean, Sudanee; Leenasirimakul, Prattana; Ariyadej, Sriprapar; Tansuphasawasdikul, Somboon; Thongpaen, Suchart; Lallemant, Marc		Program HIV Prevention Treatment P	Laboratory and Clinical Predictors of Disease Progression following Initiation of Combination Therapy in HIV-Infected Adults in Thailand	PLOS ONE			English	Article							ACTIVE ANTIRETROVIRAL THERAPY; TO-CHILD TRANSMISSION; CD4 CELL COUNT; HIV-1-INFECTED PATIENTS; PROGNOSTIC IMPORTANCE; TREATMENT PROGRAMS; EARLY MORTALITY; SEVERE ANEMIA; CARE PROGRAM; SOUTH-AFRICA	Background: Data on determinants of long-term disease progression in HIV-infected patients on antiretroviral therapy (ART) are limited in low and middle-income settings. Methods: Effects of current CD4 count, viral load and haemoglobin and diagnosis of AIDS-defining events (ADEs) after start of combination ART (cART) on death and new ADEs were assessed using Poisson regression, in patient aged >= 18 years within a multi-centre cohort in Thailand. Results: Among 1,572 patients, median follow-up from cART initiation was 4.4 (IQR 3.6-6.3) years. The analysis of death was based on 60 events during 6,573 person-years; 30/50 (60%) deaths with underlying cause ascertained were attributable to infections. Analysis of new ADE included 192 events during 5,865 person-years; TB and Pneumocystis jiroveci pneumonia were the most commonly presented first new ADE (35% and 20% of cases, respectively). In multivariable analyses, low current CD4 count after starting cART was the strongest predictor of death and of new ADE. Even at CD4 above 200 cells/mm 3, survival improved steadily with CD4, with mortality rare at >= 500 cells/mm 3 (rate 1.1 per 1,000 person-years). Haemoglobin had a strong independent effect, while viral load was weakly predictive with poorer prognosis only observed at >= 100,000 copies/ml. Mortality risk increased following diagnosis of ADEs during cART. The decline in mortality rate with duration on cART (from 21.3 per 1,000 person-years within first 6 months to 4.7 per 1,000 person-years at >= 36 months) was accounted for by current CD4 count. Conclusions: Patients with low CD4 count or haemoglobin require more intensive diagnostic and treatment of underlying causes. Maintaining CD4 >= 500 cells/mm(3) minimizes mortality. However, patient monitoring could potentially be relaxed at high CD4 count if resources are limited. Optimal ART monitoring strategies in low-income settings remain a research priority. Better understanding of the aetiology of anaemia in patients on ART could guide prevention and treatment.	[Trinh Duong; Jourdain, Gonzague; Ngo-Giang-Huong, Nicole; Le Coeur, Sophie; Lallemant, Marc] Inst Rech Dev IRD, UMI 174, Paris, France; [Trinh Duong] Univ London London Sch Hyg & Trop Med, MRC Trop Epidemiol Grp, London WC1E 7HT, England; [Jourdain, Gonzague; Ngo-Giang-Huong, Nicole; Le Coeur, Sophie; Lallemant, Marc] Chiang Mai Univ, Fac Associated Med Sci, Chiang Mai 50000, Thailand; [Jourdain, Gonzague; Ngo-Giang-Huong, Nicole; Le Coeur, Sophie; Lallemant, Marc] Harvard Univ, Sch Publ Hlth, Boston, MA 02115 USA; [Le Coeur, Sophie] Univ Paris Descartes INED IRD, Inst Rech Dev, CEPED, UMR 196, Paris, France; [Kantipong, Pacharee] Chiang Rai Prachanukroh Hosp, Chiang Rai, Thailand; [Buranabanjasatean, Sudanee] Mae Chan Hosp, Chiang Rai, Thailand; [Leenasirimakul, Prattana] Nakornping Hosp, Chiang Mai, Thailand; [Ariyadej, Sriprapar] Rayong Hosp, Rayong, Thailand; [Tansuphasawasdikul, Somboon] Buddhachinaraj Hosp, Phitsanulok, Thailand; [Thongpaen, Suchart] Mahasarakam Hosp, Mahasarakam, Thailand	Institut de Recherche pour le Developpement (IRD); University of London; London School of Hygiene & Tropical Medicine; Chiang Mai University; Harvard University; Harvard T.H. Chan School of Public Health; UDICE-French Research Universities; Universite Paris Cite; Institut de Recherche pour le Developpement (IRD)	Duong, T (corresponding author), Inst Rech Dev IRD, UMI 174, Paris, France.	gonzague.jourdain@phpt.org	Jourdain, Gonzague/F-9117-2017; Ngo-Giang-Huong, Nicole/G-2860-2017	Jourdain, Gonzague/0000-0002-3365-7020; Ngo-Giang-Huong, Nicole/0000-0001-8950-3234	The Global Fund to fight AIDS, Tuberculosis and Malaria Thailand [PR-A-N-008]; Ministry of Public Health, Thailand; Oxfam Great Britain, Thailand; Institut de Recherche pour le Developpement (IRD), France; Institut National d'Etudes Demographiques, France; The Thai International Development Cooperation Agency (TICA), Thailand; Paediatric European Network for the Treatment of AIDS (PENTA)	The Global Fund to fight AIDS, Tuberculosis and Malaria Thailand; Ministry of Public Health, Thailand; Oxfam Great Britain, Thailand; Institut de Recherche pour le Developpement (IRD), France; Institut National d'Etudes Demographiques, France; The Thai International Development Cooperation Agency (TICA), Thailand; Paediatric European Network for the Treatment of AIDS (PENTA)	The treatment, laboratory monitoring and follow up for the patients and data collection are supported by: The Global Fund to fight AIDS, Tuberculosis and Malaria Thailand Grant Round 1 sub recipient PR-A-N-008; Ministry of Public Health, Thailand; Oxfam Great Britain, Thailand; Institut de Recherche pour le Developpement (IRD), France; Institut National d'Etudes Demographiques, France; The Thai International Development Cooperation Agency (TICA), Thailand. TD was funded by the Paediatric European Network for the Treatment of AIDS (PENTA) for this work. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Babiker AG, 2012, CLIN TRIALS IN PRESS; Berhane K, 2004, JAIDS-J ACQ IMM DEF, V37, P1245, DOI 10.1097/01.qai.0000134759.01684.27; Braitstein P, 2006, LANCET, V367, P817, DOI 10.1016/S0140-6736(06)68337-2; Chene G, 2003, LANCET, V362, P679, DOI 10.1016/S0140-6736(03)14229-8; DURRLEMAN S, 1989, STAT MED, V8, P551, DOI 10.1002/sim.4780080504; Falster K, 2009, AIDS, V23, P2323, DOI 10.1097/QAD.0b013e328331910c; Fregonese F, 2012, JAIDS-J ACQ IMM DEF, V60, P91, DOI 10.1097/QAI.0b013e31824bd33f; Greub G, 2000, LANCET, V356, P1800, DOI 10.1016/S0140-6736(00)03232-3; Harris RJ, 2008, ANTIVIR THER, V13, P959; Hoffmann CJ, 2011, JAIDS-J ACQ IMM DEF, V58, P269, DOI 10.1097/QAI.0b013e31823219d1; Kelley CF, 2009, CLIN INFECT DIS, V48, P787, DOI 10.1086/597093; Kiragga AN, 2010, J INT AIDS SOC, V13, DOI 10.1186/1758-2652-13-42; Koenig SP, 2012, JAIDS-J ACQ IMM DEF, V59, pE60, DOI 10.1097/QAI.0b013e318245d3c1; Lallemant M, 2000, NEW ENGL J MED, V343, P982, DOI 10.1056/NEJM200010053431401; Lallemant M, 2004, NEW ENGL J MED, V351, P217, DOI 10.1056/NEJMoa033500; Lanoy E, 2009, AIDS, V23, P2199, DOI 10.1097/QAD.0b013e3283305a00; Lawn SD, 2008, AIDS, V22, P1897, DOI 10.1097/QAD.0b013e32830007cd; Lawn SD, 2009, AIDS, V23, P335, DOI 10.1097/QAD.0b013e328321823f; Lewden C, 2007, JAIDS-J ACQ IMM DEF, V46, P72; Lewis DK, 2005, T ROY SOC TROP MED H, V99, P561, DOI 10.1016/j.trstmh.2005.01.002; Lundgren JD, 2002, J INFECT DIS, V185, P178, DOI 10.1086/338267; Maman D, 2012, 17 INT AIDS C MEX CI, V26, P1393; Mills EJ, 2012, 17 INT AIDS C MEX CI; Mocroft A, 2007, AIDS, V21, P1867, DOI 10.1097/QAD.0b013e328270b877; Mocroft A, 2009, CLIN INFECT DIS, V48, P1138, DOI 10.1086/597468; Moh R, 2007, AIDS, V21, P2483, DOI 10.1097/QAD.0b013e3282f09876; Moore DM, 2011, JAIDS-J ACQ IMM DEF, V58, P289, DOI 10.1097/QAI.0b013e3182303716; Phillips A, 2010, LANCET, V375, P96, DOI 10.1016/S0140-6736(09)62103-6; Royston P, 2004, STATA J, V4, P227, DOI 10.1177/1536867X0400400301; Russell EC, 2010, BMC PUBLIC HEALTH, V10, DOI 10.1186/1471-2458-10-433; Shah S, 2007, HIV MED, V8, P38, DOI 10.1111/j.1468-1293.2007.00434.x; Tarwater PM, 2004, AIDS, V18, P2419; Thai S, 2009, TROP MED INT HEALTH, V14, P1048, DOI 10.1111/j.1365-3156.2009.02334.x; Walker AS, 2011, CURR OPIN INFECT DIS, V24, P27, DOI 10.1097/QCO.0b013e3283423e0e; Wandeler G, 2012, JAIDS-J ACQ IMM DEF, V59, pE9, DOI 10.1097/QAI.0b013e31823edb6a; Weigel R, 2012, AIDS, V26, P365, DOI 10.1097/QAD.0b013e32834ed814; WHO, 2010, ANT THER HIV INF AD; WHO, 2002, SCAL ANT THER RES LI	38	9	9	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 15	2012	7	8							e43375	10.1371/journal.pone.0043375	http://dx.doi.org/10.1371/journal.pone.0043375			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	993AG	22905264	Green Published, Green Submitted, gold			2022-12-25	WOS:000307823600074
J	Li, W; Xu, YP; Zhang, ZX; Cao, WY; Li, F; Zhou, XP; Chen, GY; Cai, XZ				Li, Wen; Xu, You-Ping; Zhang, Zhi-Xin; Cao, Wen-Yuan; Li, Fei; Zhou, Xueping; Chen, Gong-You; Cai, Xin-Zhong			Identification of Genes Required for Nonhost Resistance to Xanthomonas oryzae pv. oryzae Reveals Novel Signaling Components	PLOS ONE			English	Article							HYPERSENSITIVE REACTION; PATHOGEN XANTHOMONAS; NEGATIVE REGULATOR; EFFECTOR PROTEINS; DEFENSE; DISEASE; CALRETICULIN; CALCIUM; PLANTS; INDUCTION	Background: Nonhost resistance is a generalized, durable, broad-spectrum resistance exhibited by plant species to a wide variety of microbial pathogens. Although nonhost resistance is an attractive breeding strategy, the molecular basis of this form of resistance remains unclear for many plant-microbe pathosystems, including interactions with the bacterial pathogen of rice, Xanthomonas oryzae pv. oryzae (Xoo). Methods and Findings: Virus-induced gene silencing (VIGS) and an assay to detect the hypersensitive response (HR) were used to screen for genes required for nonhost resistance to Xoo in N. benthamiana. When infiltrated with Xoo strain YN-1, N. benthamiana plants exhibited a strong necrosis within 24 h and produced a large amount of H2O2 in the infiltrated area. Expression of HR-and defense-related genes was induced, whereas bacterial numbers dramatically decreased during necrosis. VIGS of 45 ACE (Avr/Cf-elicited) genes revealed identified seven genes required for nonhost resistance to Xoo in N. benthamiana. The seven genes encoded a calreticulin protein (ACE35), an ERF transcriptional factor (ACE43), a novel Solanaceous protein (ACE80), a hydrolase (ACE117), a peroxidase (ACE175) and two proteins with unknown function (ACE95 and ACE112). The results indicate that oxidative burst and calcium-dependent signaling pathways play an important role in nonhost resistance to Xoo. VIGS analysis further revealed that ACE35, ACE80, ACE95 and ACE175, but not the other three ACE genes, interfered with the Cf-4/Avr4-dependent HR. Conclusions/Significance: N. benthamiana plants inoculated with Xoo respond by rapidly eliciting an HR and nonhost resistance. The oxidative burst and other signaling pathways are pivotal in Xoo-N. benthamiana nonhost resistance, and genes involved in this response partially overlap with those involved in Cf/Avr4-dependent HR. The seven genes required for N. benthamiana-mediated resistance to Xoo provide a basis for further dissecting the molecular mechanism of nonhost resistance.	[Li, Wen; Zhang, Zhi-Xin; Cao, Wen-Yuan; Li, Fei; Zhou, Xueping; Cai, Xin-Zhong] Zhejiang Univ, Coll Agr & Biotechnol, Inst Biotechnol, Hangzhou 310027, Peoples R China; [Xu, You-Ping] Zhejiang Univ, Ctr Anal & Measurement, Hangzhou 310027, Peoples R China; [Zhou, Xueping; Cai, Xin-Zhong] Zhejiang Univ, State Key Lab Rice Biol, Hangzhou 310027, Peoples R China; [Chen, Gong-You] Shanghai Jiao Tong Univ, Sch Agr & Biol, Key Lab Urban S, Minist Agr, Shanghai 200030, Peoples R China	Zhejiang University; Zhejiang University; Zhejiang University; Ministry of Agriculture & Rural Affairs; Shanghai Jiao Tong University	Li, W (corresponding author), Zhejiang Univ, Coll Agr & Biotechnol, Inst Biotechnol, Hangzhou 310027, Peoples R China.	gyouchen@sjtu.edu.cn; xzhcai@zju.edu.cn	CHEN, Gongyou/AAA-9694-2019	CHEN, Gongyou/0000-0003-1979-2880	Program for Changjiang Scholars and Innovative Research Team in University [IRT0943]; National Basic Research Program of China [2009CB119000]; Fundamental Research Funds for the Central Universities [2011XZZX006]; Zhejiang Provincial Natural Science Foundation of China [LZ12C14002]; Program for New Century Excellent Talents in University [NCET-08-0485];  [2009ZX08009-044B]	Program for Changjiang Scholars and Innovative Research Team in University(Program for Changjiang Scholars & Innovative Research Team in University (PCSIRT)); National Basic Research Program of China(National Basic Research Program of China); Fundamental Research Funds for the Central Universities(Fundamental Research Funds for the Central Universities); Zhejiang Provincial Natural Science Foundation of China(Natural Science Foundation of Zhejiang Province); Program for New Century Excellent Talents in University(Program for New Century Excellent Talents in University (NCET)); 	This work was financially supported by grants from the Program for Changjiang Scholars and Innovative Research Team in University (no. IRT0943), the genetically modified organisms breeding major projects (no. 2009ZX08009-044B), the National Basic Research Program of China (no. 2009CB119000), the Fundamental Research Funds for the Central Universities (no. 2011XZZX006), the Zhejiang Provincial Natural Science Foundation of China (no. LZ12C14002) and the Program for New Century Excellent Talents in University (no. NCET-08-0485). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alfano JR, 2004, ANNU REV PHYTOPATHOL, V42, P385, DOI 10.1146/annurev.phyto.42.040103.110731; Bogdanove AJ, 2010, CURR OPIN PLANT BIOL, V13, P394, DOI 10.1016/j.pbi.2010.04.010; Buttner D, 2010, FEMS MICROBIOL REV, V34, P107, DOI 10.1111/j.1574-6976.2009.00192.x; Burch-Smith TM, 2004, PLANT J, V39, P734, DOI 10.1111/j.1365-313X.2004.02158.x; Chen MH, 2005, PLANT PHYSIOL, V138, P1866, DOI 10.1104/pp.105.064386; Chen XW, 2010, P NATL ACAD SCI USA, V107, P8029, DOI 10.1073/pnas.0912311107; Crofts AJ, 1998, TRENDS PLANT SCI, V3, P396, DOI 10.1016/S1360-1385(98)01312-0; DENECKE J, 1995, PLANT CELL, V7, P391, DOI 10.1105/tpc.7.4.391; Droillard MJ, 1997, PLANTA, V202, P341, DOI 10.1007/s004250050136; Fujimoto SY, 2000, PLANT CELL, V12, P393, DOI 10.1105/tpc.12.3.393; Gonzalez C, 2007, MOL PLANT MICROBE IN, V20, P534, DOI 10.1094/MPMI-20-5-0534; Gurlebeck D, 2006, J PLANT PHYSIOL, V163, P233, DOI 10.1016/j.jplph.2005.11.011; Gutterson N, 2004, CURR OPIN PLANT BIOL, V7, P465, DOI 10.1016/j.pbi.2004.04.007; Han SW, 2011, CURR OPIN MICROBIOL, V14, P62, DOI 10.1016/j.mib.2010.12.006; Heath MC, 2000, CURR OPIN PLANT BIOL, V3, P315, DOI 10.1016/S1369-5266(00)00087-X; Hiraga S, 2001, PLANT CELL PHYSIOL, V42, P462, DOI 10.1093/pcp/pce061; Holub EB, 2004, TRENDS PLANT SCI, V9, P211, DOI 10.1016/j.tplants.2004.03.002; Hong W, 2007, MOL PLANT PATHOL, V8, P515, DOI 10.1111/J.1364-3703.2007.00412.X; Katagiri Fumiaki, 2002, Arabidopsis Book, V1, pe0039, DOI 10.1199/tab.0039; Kawano T, 2003, PLANT CELL REP, V21, P829, DOI 10.1007/s00299-003-0591-z; KLEMENT Z, 1967, ANNU REV PHYTOPATHOL, V5, P17, DOI 10.1146/annurev.py.05.090167.000313; KLEMENT Z, 1964, PHYTOPATHOLOGY, V54, P474; Kobayashi M, 2007, PLANT CELL, V19, P1065, DOI 10.1105/tpc.106.048884; Kudla J, 2010, PLANT CELL, V22, P541, DOI 10.1105/tpc.109.072686; Lacy G. H., 1982, PHYTOPATHOGENIC PROK, V2, P149; Lee SW, 2006, P NATL ACAD SCI USA, V103, P18395, DOI 10.1073/pnas.0605508103; Lee SW, 2009, SCIENCE, V326, P850, DOI 10.1126/science.1173438; Lenk A, 2009, ADV BOT RES, V51, P91, DOI 10.1016/S0065-2296(09)51003-8; Li YR, 2011, MOL PLANT MICROBE IN, V24, P1086, DOI 10.1094/MPMI-09-10-0205; Lipka U, 2008, CURR OPIN PLANT BIOL, V11, P404, DOI 10.1016/j.pbi.2008.04.004; Ma W, 2007, CELL MICROBIOL, V9, P2571, DOI 10.1111/j.1462-5822.2007.01031.x; Mysore KS, 2004, TRENDS PLANT SCI, V9, P97, DOI 10.1016/j.tplants.2003.12.005; Niks RE, 2009, NEW PHYTOL, V182, P817, DOI 10.1111/j.1469-8137.2009.02849.x; Nino-Liu DO, 2006, MOL PLANT PATHOL, V7, P303, DOI 10.1111/j.1364-3703.2006.00344.x; Nurnberger T, 2005, MOL PLANT PATHOL, V6, P335, DOI 10.1111/j.1364-3703.2005.00279.x; Park CJ, 2010, CELL MICROBIOL, V12, P1017, DOI 10.1111/j.1462-5822.2010.01489.x; Park CJ, 2008, PLOS BIOL, V6, P1910, DOI 10.1371/journal.pbio.0060231; Peng Y, 2008, MOL PLANT, V1, P446, DOI 10.1093/mp/ssn024; Persson S, 2001, PLANT PHYSIOL, V126, P1092, DOI 10.1104/pp.126.3.1092; Rojas CM, 2012, PLANT CELL, V24, P336, DOI 10.1105/tpc.111.093245; Romeis T, 1999, PLANT CELL, V11, P273, DOI 10.1105/tpc.11.2.273; Romeis T, 2001, EUR MOL BIOL ORG J, V20, P556; Schulze-Lefert P, 2011, TRENDS PLANT SCI, V16, P117, DOI 10.1016/j.tplants.2011.01.001; Schweizer P, 2007, PHYSIOL MOL PLANT P, V70, P3, DOI 10.1016/j.pmpp.2007.07.004; SONG WY, 1995, SCIENCE, V270, P1804, DOI 10.1126/science.270.5243.1804; Thordal-Christensen H, 2003, CURR OPIN PLANT BIOL, V6, P351, DOI 10.1016/S1369-5266(03)00063-3; van Loon LC, 2006, ANNU REV PHYTOPATHOL, V44, P135, DOI 10.1146/annurev.phyto.44.070505.143425; Wang CC, 2006, FUNCT PLANT BIOL, V33, P347, DOI 10.1071/FP05096; Wang XE, 2009, MOL PLANT MICROBE IN, V22, P1227, DOI 10.1094/MPMI-22-10-1227; Wang YS, 2006, PLANT CELL, V18, P3635, DOI 10.1105/tpc.106.046730; White FF, 2009, MOL PLANT PATHOL, V10, P749, DOI 10.1111/j.1364-3703.2009.00590.x; White FF, 2009, PLANT PHYSIOL, V150, P1677, DOI 10.1104/pp.109.139360; Xu YP, 2007, J INTEGR PLANT BIOL, V49, P1726, DOI 10.1111/j.1744-7909.2007.00569.x; Xu YouPing, 2008, Journal of Zhejiang University (Agriculture and Life Sciences), V34, P119; Zhao BY, 2005, P NATL ACAD SCI USA, V102, P15383, DOI 10.1073/pnas.0503023102; Zhao BY, 2004, MOL PLANT MICROBE IN, V17, P771, DOI 10.1094/MPMI.2004.17.7.771; Zhu JW, 2008, EUR J PLANT PATHOL, V122, P307, DOI 10.1007/s10658-008-9294-1	57	39	41	0	34	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 13	2012	7	8							e42796	10.1371/journal.pone.0042796	http://dx.doi.org/10.1371/journal.pone.0042796			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	988OJ	22912739	Green Published, gold, Green Submitted			2022-12-25	WOS:000307500100031
J	Eckstein, RL; Ruch, D; Otte, A; Donath, TW				Eckstein, R. Lutz; Ruch, Diana; Otte, Annette; Donath, Tobias W.			Invasibility of a Nutrient-Poor Pasture through Resident and Non-Resident Herbs Is Controlled by Litter, Gap Size and Propagule Pressure	PLOS ONE			English	Article							SEEDLING ESTABLISHMENT; PLANT LITTER; ECOLOGICAL RESISTANCE; WATER AVAILABILITY; SOIL RESOURCES; INVASION; VEGETATION; COMMUNITIES; DISTURBANCE; REMOVAL	Since inference concerning the relative effects of propagule pressure, biotic interactions, site conditions and species traits on the invasibility of plant communities is limited, we carried out a field experiment to study the role of these factors for absolute and relative seedling emergence in three resident and three non-resident confamilial herb species on a nutrient-poor temperate pasture. We set up a factorial field experiment with two levels each of the factors litter cover (0 and 400 g m(-2)), gap size (0.01 and 0.1 m(2)) and propagule pressure (5 and 50 seeds) and documented soil temperature, soil water content and relative light availability. Recruitment was recorded in spring and autumn 2010 and in spring 2011 to cover initial seedling emergence, establishment after summer drought and final establishment after the first winter. Litter alleviated temperature and moisture conditions and had positive effects on proportional and absolute seedling emergence during all phases of recruitment. Large gaps presented competition-free space with high light availability but showed higher temperature amplitudes and lower soil moisture. Proportional and absolute seedling recruitment was significantly higher in large than in small gaps. In contrast, propagule pressure facilitated absolute seedling emergence but had no effects on proportional emergence or the chance for successful colonisation. Despite significantly higher initial seedling emergence of resident than non-resident species, seed mass and other species-specific traits may be better predictors for idiosyncratic variation in seedling establishment than status. Our data support the fluctuating resource hypothesis and demonstrate that the reserve effect of seeds may facilitate seedling emergence. The direct comparison of propagule pressure with other environmental factors showed that propagule pressure affects absolute seedling abundance, which may be crucial for species that depend on other individuals for sexual reproduction. However, propagule batch size did not significantly affect the chance for successful colonisation of disturbed plots.	[Eckstein, R. Lutz; Ruch, Diana; Otte, Annette; Donath, Tobias W.] Univ Giessen, Inst Landscape Ecol & Resource Management, Res Ctr BioSyst Land Use & Nutr IFZ, Giessen, Germany	Justus Liebig University Giessen	Eckstein, RL (corresponding author), Univ Giessen, Inst Landscape Ecol & Resource Management, Res Ctr BioSyst Land Use & Nutr IFZ, Giessen, Germany.	lutz.eckstein@umwelt.uni-giessen.de	Eckstein, Lutz/A-9241-2012; Donath, Tobias W./B-2856-2012	Donath, Tobias W./0000-0003-1874-1096				AGUILERA MO, 1993, J ECOL, V81, P253, DOI 10.2307/2261495; Boeken B, 2001, J VEG SCI, V12, P825, DOI 10.2307/3236870; Bradley BA, 2010, TRENDS ECOL EVOL, V25, P310, DOI 10.1016/j.tree.2009.12.003; Bullock J. M., 2000, Seeds: the ecology of regeneration in plant communities, P375, DOI 10.1079/9780851994321.0375; BULLOCK JM, 1995, OIKOS, V72, P273, DOI 10.2307/3546229; Burke MJW, 1996, ECOLOGY, V77, P776, DOI 10.2307/2265501; Colautti RI, 2006, BIOL INVASIONS, V8, P1023, DOI 10.1007/s10530-005-3735-y; Davis MA, 2005, ECOGRAPHY, V28, P696, DOI 10.1111/j.2005.0906-7590.04205.x; Davis MA, 2000, J ECOL, V88, P528, DOI 10.1046/j.1365-2745.2000.00473.x; Davis MA, 2001, ECOL LETT, V4, P421, DOI 10.1046/j.1461-0248.2001.00246.x; Dierschke H., 2002, KULTURGRASLAND; Donath TW, 2008, J ECOL, V96, P272, DOI 10.1111/j.1365-2745.2007.01338.x; Donath TW, 2006, BIOL CONSERV, V130, P315, DOI 10.1016/j.biocon.2005.12.022; Donath TW, 2010, PLANT ECOL, V207, P257, DOI 10.1007/s11258-009-9670-8; Donath TW, 2004, AGR ECOSYST ENVIRON, V104, P439, DOI 10.1016/j.agee.2004.01.039; Eckstein RL, 2011, ANN BOT-LONDON, V108, P177, DOI 10.1093/aob/mcr097; Eckstein RL, 2005, J ECOL, V93, P807, DOI 10.1111/j.1365-2745.2005.01015.x; Eckstein RL, 2005, NEW PHYTOL, V166, P525, DOI 10.1111/j.1469-8137.2005.01336.x; Ellenberg H., 1992, SCRIPTA GEOBOT, V18, P1; Foster BL, 2004, ECOLOGY, V85, P1541, DOI 10.1890/03-3165; GOLDBERG DE, 1983, OECOLOGIA, V60, P149, DOI 10.1007/BF00379516; Grime J. P., 1979, Plant strategies and vegetation processes.; Gross KL, 2005, ECOLOGY, V86, P476, DOI 10.1890/04-0122; GROSS KL, 1984, J ECOL, V72, P369, DOI 10.2307/2260053; HLUG (Hessisches Landesamt fu r Umwelt und Geologie), 2011, UMW HESS KLIM; HOBBS RJ, 1988, AUST J ECOL, V13, P171, DOI 10.1111/j.1442-9993.1988.tb00966.x; HUENNEKE LF, 1990, ECOLOGY, V71, P478, DOI 10.2307/1940302; Jensen K, 2003, BASIC APPL ECOL, V4, P579, DOI 10.1078/1439-1791-00179; Kaligaric M, 2011, PLANT BIOSYST, V145, P688, DOI 10.1080/11263504.2011.601338; Leishman M. R., 2000, Seeds: the ecology of regeneration in plant communities, P31, DOI 10.1079/9780851994321.0031; Loydi A, 2009, PLANT ECOL, V201, P471, DOI 10.1007/s11258-008-9468-0; Milbau A, 2003, NEW PHYTOL, V159, P657, DOI 10.1046/j.1469-8137.2003.00833.x; Moles AT, 2004, J ECOL, V92, P372, DOI 10.1111/j.0022-0477.2004.00884.x; Morgan JW, 1997, J APPL ECOL, V34, P566, DOI 10.2307/2404907; Quinn GP, 2003, EXPT DESIGN DATA ANA; Rasran L, 2007, FOLIA GEOBOT, V42, P271, DOI 10.1007/BF02806467; Renne IJ, 2006, ECOLOGY, V87, P2264, DOI 10.1890/0012-9658(2006)87[2264:SIGIEO]2.0.CO;2; Rotundo JL, 2005, J ECOL, V93, P829, DOI 10.1111/j.1365-2745.2005.01022.x; Ruprecht E, 2010, J VEG SCI, V21, P1069, DOI 10.1111/j.1654-1103.2010.01206.x; Ruprecht E, 2010, BIOL CONSERV, V143, P449, DOI 10.1016/j.biocon.2009.11.012; RYSER P, 1993, J VEG SCI, V4, P195, DOI 10.2307/3236105; Simberloff D, 2009, ANNU REV ECOL EVOL S, V40, P81, DOI 10.1146/annurev.ecolsys.110308.120304; Skorka P, 2010, BIOL CONSERV, V143, P856, DOI 10.1016/j.biocon.2009.12.030; Spackova I, 2004, FOLIA GEOBOT, V39, P41, DOI 10.1007/BF02803263; StatSoft Inc, 2011, STATISTICA WIND SOFT; Thiele J, 2006, PHYTOCOENOLOGIA, V36, P281, DOI 10.1127/0340-269X/2006/0036-0281; Thompson K, 2001, J ECOL, V89, P1054, DOI 10.1111/j.1365-2745.2001.00627.x; Thomsen MA, 2006, ECOL LETT, V9, P160, DOI 10.1111/j.1461-0248.2005.00857.x; Thuiller W, 2006, ECOLOGY, V87, P1755, DOI 10.1890/0012-9658(2006)87[1755:IBESTA]2.0.CO;2; Turnbull LA, 2000, OIKOS, V88, P225, DOI 10.1034/j.1600-0706.2000.880201.x; Von Holle B, 2005, ECOLOGY, V86, P3212, DOI 10.1890/05-0427; Voss N, 2011, J VEG SCI, V22, P726, DOI 10.1111/j.1654-1103.2011.01284.x; Westoby M, 1996, PHILOS T R SOC B, V351, P1309, DOI 10.1098/rstb.1996.0114; Xiong SJ, 1999, J ECOL, V87, P984, DOI 10.1046/j.1365-2745.1999.00414.x	54	16	18	0	44	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 24	2012	7	7							e41887	10.1371/journal.pone.0041887	http://dx.doi.org/10.1371/journal.pone.0041887			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	978NX	22911863	Green Published, gold, Green Submitted			2022-12-25	WOS:000306751300080
J	Fu, SM; Feng, CL; Guo, SC; Luo, YJ; Parasuraman, R				Fu, Shimin; Feng, Chunliang; Guo, Shichun; Luo, Yuejia; Parasuraman, Raja			Neural Adaptation Provides Evidence for Categorical Differences in Processing of Faces and Chinese Characters: An ERP Study of the N170	PLOS ONE			English	Article							UNFAMILIAR FACES; DOMAIN SPECIFICITY; TEMPORAL DYNAMICS; HUMAN BRAIN; EXPERTISE; INVERSION; PERCEPTION; OBJECT; ACTIVATION; REPETITION	Whether face perception involves domain-specific or domain-general processing is an extensively debated issue. Relative to non-face objects and alphabetical scripts, Chinese characters provide a good contrast to faces because of their structural configuration, requirement for high level of visual expertise to literate Chinese people, and unique appearance and identity for each individual stimulus. To examine potential categorical differences in their neural processing, event-related potentials (ERPs) were recorded to blocked face and Chinese character stimuli. Fast adaptation method was applied to better control for the low-level stimulus difference between faces and Chinese characters. Participants were required to respond to the color of the outer frame in which these stimuli were presented, at either a fast (ISI 650 ms) or slow (ISI 1300 ms) rate, and with an orientation that was either the same or alternated between upright and inverted. Faces elicited a larger and later N170 relative to characters, but the N170 was more left-lateralized for characters relative to the faces. Adaptation-by-rate and adaptation-by-orientation effects were observed on the amplitude of N170, and both were more pronounced for faces relative to characters. Inverted stimuli elicited a later N170 relative to upright stimuli, without amplitude change, and this inversion effect was more pronounced for faces relative to characters. Moreover, faces elicited a larger and later P1 and a larger adaptation-by-rate effect on P1 relative to characters. The adaptation-by-orientation effect was illustrated by a larger P1 under the same relative to the alternated orientation condition. Therefore, evidence from the amplitude and the lateralization of N170, the stimulus inversion effect on N170 latency, and the neural adaptation between faces and Chinese characters on P1 and N170 components support the notion that the processing of faces and Chinese characters involve categorically different neural mechanisms.	[Fu, Shimin; Guo, Shichun] Tsinghua Univ, Dept Psychol, Beijing 100084, Peoples R China; [Feng, Chunliang; Luo, Yuejia] Beijing Normal Univ, State Key Lab Cognit Neurosci & Learning, Beijing 100875, Peoples R China; [Parasuraman, Raja] George Mason Univ, Dept Psychol, Fairfax, VA 22030 USA	Tsinghua University; Beijing Normal University; George Mason University	Fu, SM (corresponding author), Tsinghua Univ, Dept Psychol, Beijing 100084, Peoples R China.	sfu@tsinghua.edu.cn; luoyj@bnu.edu.cn	Fu, Shimin/ABD-7806-2021; Fu, Shimin/A-6438-2008		Tsinghua University, China [20111081107]; Scientific Research Foundation for the Returned Overseas Chinese Scholars, State Education Ministry [20111021085]; Ministry of Sci & Tech (973 Program) [2011CB711000]; NSF China [30930031, 91132704]; Global Research Initiative Program; United States National Institute of Health [1R01TW007897]; FOGARTY INTERNATIONAL CENTER [R01TW007897] Funding Source: NIH RePORTER	Tsinghua University, China; Scientific Research Foundation for the Returned Overseas Chinese Scholars, State Education Ministry(Scientific Research Foundation for the Returned Overseas Chinese Scholars); Ministry of Sci & Tech (973 Program); NSF China(National Natural Science Foundation of China (NSFC)); Global Research Initiative Program; United States National Institute of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); FOGARTY INTERNATIONAL CENTER(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Fogarty International Center (FIC))	This research is supported by the Initiative Scientific Research Program, Tsinghua University, China (20111081107) and the Scientific Research Foundation for the Returned Overseas Chinese Scholars, State Education Ministry (20111021085) to SF, and the Ministry of Sci & Tech (973 Program, 2011CB711000), NSF China (30930031, 91132704), Global Research Initiative Program, and the United States National Institute of Health grants (1R01TW007897) to YL.; This research is supported by the Initiative Scientific Research Program, Tsinghua University, China (20111081107) and the Scientific Research Foundation for the Returned Overseas Chinese Scholars, State Education Ministry to SF, and the Ministry of Sci & Tech (973 Program, 2011CB711000), NSF China (30930031, 91132704), Global Research Initiative Program, and the United States National Institutes of Health grants (1R01TW007897) to YL. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bentin S, 1996, J COGNITIVE NEUROSCI, V8, P551, DOI 10.1162/jocn.1996.8.6.551; Bentin S, 1999, J COGNITIVE NEUROSCI, V11, P235, DOI 10.1162/089892999563373; Bolger DJ, 2005, HUM BRAIN MAPP, V25, P92, DOI 10.1002/hbm.20124; Busey TA, 2005, VISION RES, V45, P431, DOI 10.1016/j.visres.2004.08.021; Caharel S, 2009, NEUROPSYCHOLOGIA, V47, P639, DOI 10.1016/j.neuropsychologia.2008.11.016; Campanella S, 2002, J COGNITIVE NEUROSCI, V14, P210, DOI 10.1162/089892902317236858; Carmel D, 2002, COGNITION, V83, P1, DOI 10.1016/S0010-0277(01)00162-7; Chen YP, 2002, J COGNITIVE NEUROSCI, V14, P1088, DOI 10.1162/089892902320474535; Dalrymple KA, 2011, NEUROPSYCHOLOGIA, V49, P2553, DOI 10.1016/j.neuropsychologia.2011.05.003; Deffke I, 2007, NEUROIMAGE, V35, P1495, DOI 10.1016/j.neuroimage.2007.01.034; Eimer M, 2000, COGNITIVE BRAIN RES, V10, P145, DOI 10.1016/S0926-6410(00)00038-0; Eimer M, 2011, BRAIN RES, V1376, P76, DOI 10.1016/j.brainres.2010.12.046; Fu SM, 2010, BIOL PSYCHOL, V85, P171, DOI 10.1016/j.biopsycho.2010.06.008; Fu SM, 2002, NEUROIMAGE, V17, P1538, DOI 10.1006/nimg.2002.1155; Gauthier I, 2003, NAT NEUROSCI, V6, P428, DOI 10.1038/nn1029; Gauthier I, 2000, NAT NEUROSCI, V3, P191, DOI 10.1038/72140; Gauthier I, 1999, NAT NEUROSCI, V2, P568, DOI 10.1038/9224; Ge LZ, 2006, PSYCHOL SCI, V17, P12, DOI 10.1111/j.1467-9280.2005.01658.x; Harris A, 2008, CEREB CORTEX, V18, P467; Harris A, 2007, CEREB CORTEX, V17, P63, DOI 10.1093/cercor/bhj124; Haxby JV, 2000, TRENDS COGN SCI, V4, P223, DOI 10.1016/S1364-6613(00)01482-0; Heisz JJ, 2006, VISION RES, V46, P47, DOI 10.1016/j.visres.2005.09.028; Hillyard SA, 1998, CURR OPIN NEUROBIOL, V8, P202, DOI 10.1016/S0959-4388(98)80141-4; Itier RJ, 2006, NEUROIMAGE, V29, P667, DOI 10.1016/j.neuroimage.2005.07.041; Itier RJ, 2002, NEUROIMAGE, V15, P353, DOI 10.1006/nimg.2001.0982; Itier RJ, 2004, CEREB CORTEX, V14, P132, DOI 10.1093/cercor/bhg111; Itier RJ, 2007, J COGNITIVE NEUROSCI, V19, P1815, DOI 10.1162/jocn.2007.19.11.1815; Kanwisher N, 2000, NAT NEUROSCI, V3, P759, DOI 10.1038/77664; Kikutani M, 2010, PSYCHOL SCI, V21, P865, DOI 10.1177/0956797610371964; Kim KH, 2004, NEUROREPORT, V15, P1099, DOI 10.1097/00001756-200405190-00003; Kovacs G, 2006, CEREB CORTEX, V16, P742, DOI 10.1093/cercor/bhj020; Liu JG, 2009, NEUROREPORT, V20, P273, DOI 10.1097/WNR.0b013e32832000f8; Maurer U, 2008, J COGNITIVE NEUROSCI, V20, P1878, DOI 10.1162/jocn.2008.20125; Maurer U, 2008, FRONT HUM NEUROSCI, V2, DOI 10.3389/neuro.09.018.2008; Mercure E, 2008, J COGNITIVE NEUROSCI, V20, P2070, DOI 10.1162/jocn.2008.20137; Mercure E, 2011, FRONT HUM NEUROSCI, V5, DOI [10.3389/fnhum.2011.00006, 10.3389/fnhum.2011.00062]; Noguchi Y, 2004, J NEUROSCI, V24, P6283, DOI 10.1523/JNEUROSCI.0655-04.2004; PARASURAMAN R, 1980, BIOL PSYCHOL, V11, P217, DOI 10.1016/0301-0511(80)90057-5; Prieto E, 2011, FRONTIERS HUMAN NEUR; Rossion B, 1999, BIOL PSYCHOL, V50, P173, DOI 10.1016/S0301-0511(99)00013-7; Rossion B, 2003, NEUROIMAGE, V20, P1609, DOI 10.1016/j.neuroimage.2003.07.010; Rossion B, 2008, NEUROIMAGE, V39, P1959, DOI 10.1016/j.neuroimage.2007.10.011; Rossion B, 2007, J COGNITIVE NEUROSCI, V19, P543, DOI 10.1162/jocn.2007.19.3.543; Sadeh B, 2010, NEUROIMAGE, V53, P782, DOI 10.1016/j.neuroimage.2010.06.029; Schweinberger SR, 2002, COGNITIVE BRAIN RES, V14, P398, DOI 10.1016/S0926-6410(02)00142-8; Schweinberger SR, 2002, NEUROPSYCHOLOGIA, V40, P2057, DOI 10.1016/S0028-3932(02)00050-7; Tan LH, 2005, HUM BRAIN MAPP, V25, P83, DOI 10.1002/hbm.20134; Tanaka JW, 2001, PSYCHOL SCI, V12, P43, DOI 10.1111/1467-9280.00308; Thierry G, 2007, NAT NEUROSCI, V10, P505, DOI 10.1038/nn1864; Tsao DY, 2006, SCIENCE, V311, P670, DOI 10.1126/science.1119983; Webster MA, 2004, NATURE, V428, P557, DOI 10.1038/nature02420; Wong ACN, 2005, COGN AFFECT BEHAV NE, V5, P306, DOI 10.3758/CABN.5.3.306; YIN RK, 1969, J EXP PSYCHOL, V81, P141, DOI 10.1037/h0027474; Zhang JX, 2004, NEUROIMAGE, V23, P975, DOI 10.1016/j.neuroimage.2004.07.008; Zhao JZ, 2010, NEUROSCI LETT, V478, P107, DOI 10.1016/j.neulet.2010.04.075	55	24	25	2	38	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 24	2012	7	7							e41103	10.1371/journal.pone.0041103	http://dx.doi.org/10.1371/journal.pone.0041103			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	978NX	22911750	Green Published, gold, Green Submitted			2022-12-25	WOS:000306751300023
J	Rocca, RA; Magoon, G; Reynolds, DF; Krahn, T; Tilroe, VO; Boots, PMO; Grierson, AJ				Rocca, Richard A.; Magoon, Gregory; Reynolds, David F.; Krahn, Thomas; Tilroe, Vincent O.; Boots, Peter M. Op den Velde; Grierson, Andrew J.			Discovery of Western European R1b1a2 Y Chromosome Variants in 1000 Genomes Project Data: An Online Community Approach	PLOS ONE			English	Article							POPULATIONS; DIVERSITY; IBERIA	The authors have used an online community approach, and tools that were readily available via the Internet, to discover genealogically and therefore phylogenetically relevant Y-chromosome polymorphisms within core haplogroup R1b1a2-L11/S127 (rs9786076). Presented here is the analysis of 135 unrelated L11 derived samples from the 1000 Genomes Project. We were able to discover new variants and build a much more complex phylogenetic relationship for L11 sub-clades. Many of the variants were further validated using PCR amplification and Sanger sequencing. The identification of these new variants will help further the understanding of population history including patrilineal migrations in Western and Central Europe where R1b1a2 is the most frequent haplogroup. The fine-grained phylogenetic tree we present here will also help to refine historical genetic dating studies. Our findings demonstrate the power of citizen science for analysis of whole genome sequence data.	[Krahn, Thomas] FamilyTreeDNA Genom Res Ctr, Houston, TX USA; [Grierson, Andrew J.] Univ Sheffield, Sheffield Inst Translat Neurosci, Sheffield, S Yorkshire, England	University of Sheffield		rrocca@live.com	Grierson, Andy/A-5067-2009	Grierson, Andy/0000-0001-7039-6731				Adams SM, 2008, AM J HUM GENET, V83, P725, DOI 10.1016/j.ajhg.2008.11.007; Alonso S, 2005, EUR J HUM GENET, V13, P1293, DOI 10.1038/sj.ejhg.5201482; Altshuler D, 2010, NATURE, V467, P1061, DOI 10.1038/nature09534; Balaresque P, 2010, PLOS BIOL, V8, DOI 10.1371/journal.pbio.1000285; Bryc K, 2010, P NATL ACAD SCI USA, V107, P8954, DOI 10.1073/pnas.0914618107; Busby GBJ, 2012, P ROY SOC B-BIOL SCI, V279, P884, DOI 10.1098/rspb.2011.1044; Cruciani F, 2011, FORENSIC SCI INT-GEN, V5, pE49, DOI 10.1016/j.fsigen.2010.07.006; DeFrancesco L, 2012, NAT BIOTECHNOL, V30, P126, DOI 10.1038/nbt0212-126a; Donnelly P, 2011, SCIENCE, V331, P1024, DOI 10.1126/science.1204089; Ellis N, 2002, GENOME RES, V12, P339; He M, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004684; Hurles ME, 1999, AM J HUM GENET, V65, P1437, DOI 10.1086/302617; Koch J., 2009, PALAEOHISPANICA, V9, P339; Koch John T., 2006, CELTIC CULTURE HIST; Lacan M, 2011, P NATL ACAD SCI USA, V108, P18255, DOI 10.1073/pnas.1113061108; Lacan M, 2011, P NATL ACAD SCI USA, V108, P9788, DOI 10.1073/pnas.1100723108; Lappalainen T, 2006, GENE, V376, P207, DOI 10.1016/j.gene.2006.03.004; Larmuseau MHD, 2011, FORENSIC SCI INT-GEN, V5, P95, DOI 10.1016/j.fsigen.2010.08.020; Lee E. J., 2012, AM J PHYS ANTHR; Li H, 2009, BIOINFORMATICS, V25, P2078, DOI 10.1093/bioinformatics/btp352; Lopez-Parra AM, 2009, ANN HUM GENET, V73, P42, DOI 10.1111/j.1469-1809.2008.00478.x; Mallory Joseph P., 1997, ENCY INDOEUROPEAN CU; Myres NM, 2011, EUR J HUM GENET, V19, P95, DOI 10.1038/ejhg.2010.146; Pollack Andrew, 2011, NEW YORK TIMES, pB1; Rozen S, 2000, Methods Mol Biol, V132, P365; Russo E, 2001, NATURE, V413, P4; Tong P, 2010, GENOME BIOL, V11, DOI 10.1186/gb-2010-11-9-r91; Underhill PA, 2000, NAT GENET, V26, P358, DOI 10.1038/81685; Zhivotovsky LA, 2006, MOL BIOL EVOL, V23, P2268, DOI 10.1093/molbev/msl105	29	27	27	0	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 24	2012	7	7							e41634	10.1371/journal.pone.0041634	http://dx.doi.org/10.1371/journal.pone.0041634			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	978NX	22911832	Green Published, Green Accepted, gold			2022-12-25	WOS:000306751300060
J	Wang, E; Zhao, YD; Monaco, A; Uccellini, L; Kirkwood, JM; Spyropoulou-Vlachou, M; Panelli, MC; Marincola, FM; Gogas, H				Wang, Ena; Zhao, Yingdong; Monaco, Alessandro; Uccellini, Lorenzo; Kirkwood, John M.; Spyropoulou-Vlachou, Maria; Panelli, Monica C.; Marincola, Francesco M.; Gogas, Helen			A Multi-Factorial Genetic Model for Prognostic Assessment of High Risk Melanoma Patients Receiving Adjuvant Interferon	PLOS ONE			English	Article							TUMOR-INFILTRATING LYMPHOCYTES; HLA CLASS-I; IMMUNOLOGICAL CONSTANT; CTLA4 GENE; SURVIVAL; POLYMORPHISM; CANCER; SUSCEPTIBILITY; AUTOIMMUNITY; ASSOCIATION	Purpose: IFNa was the first cytokine to demonstrate anti-tumor activity in advanced melanoma. Despite the ability of high-dose IFNa reducing relapse and mortality by up to 33%, large majority of patients experience side effects and toxicity which outweigh the benefits. The current study attempts to identify genetic markers likely to be associated with benefit from IFNa-2b treatment and predictive for survival. Experimental design: We tested the association of variants in FOXP3 microsatellites, CTLA4 SNPs and HLA genotype in 284 melanoma patients and their association with prognosis and survival of melanoma patients who received IFNa adjuvant therapy. Results: Univariate survival analysis suggested that patients bearing either the DRB1*15 or HLA-Cw7 allele suffered worse OS while patients bearing either HLA-Cw6 or HLA-B44 enjoyed better OS. DRB1*15 positive patients suffered also worse RFS and conversely HLA-Cw6 positive patients had better RFS. Multivariate analysis revealed that a five-marker genotyping signature was prognostic of OS independent of disease stage. In the multivariate Cox regression model, HLA-B38 (p = 0.021), HLA-C15 (p = 0.025), HLA-C3 (p = 0.014), DRB1*15 (p = 0.005) and CT60*G/G (0.081) were significantly associated with OS with risk ratio of 0.097 (95% CI, 0.013-0.709), 0.387 (95% CI, 0.169-0.889), 0.449 (95% CI, 0.237-0.851), 1.948 (95% CI, 1.221-3.109) and 1.484 (95% IC, 0.953-2.312) respectively. Conclusion: These results suggest that gene polymorphisms relevant to a biological occurrence are more likely to be informative when studied in concert to address potential redundant or conflicting functions that may limit each gene individual contribution. The five markers identified here exemplify this concept though prospective validation in independent cohorts is needed.	[Wang, Ena; Monaco, Alessandro; Uccellini, Lorenzo; Marincola, Francesco M.] NIH, Dept Transfus Med, Ctr Clin, Bethesda, MD 20892 USA; [Wang, Ena; Monaco, Alessandro; Uccellini, Lorenzo; Marincola, Francesco M.] NIH, Trans NIH Ctr Human Immunol, Bethesda, MD 20892 USA; [Zhao, Yingdong] NCI, Div Canc Treatment & Diag, NIH, Bethesda, MD 20892 USA; [Kirkwood, John M.; Panelli, Monica C.] Univ Pittsburgh, Inst Canc, Hillman Canc Ctr, Pittsburgh, PA USA; [Spyropoulou-Vlachou, Maria] Gen Hosp, Natl Tissue Typing Ctr, Dept Immunol, Athens, Greece; [Gogas, Helen] Univ Athens, Sch Med, Dept Med 1, GR-11527 Athens, Greece	National Institutes of Health (NIH) - USA; NIH Clinical Center (CC); National Institutes of Health (NIH) - USA; National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Athens Medical School; National & Kapodistrian University of Athens	Wang, E (corresponding author), NIH, Dept Transfus Med, Ctr Clin, Bethesda, MD 20892 USA.	hgogas@hol.gr	Monaco, Alessandro/O-5338-2015; Monaco, Alessandro/ABH-3887-2020	Monaco, Alessandro/0000-0002-9941-7003; Monaco, Alessandro/0000-0002-9941-7003	CLINICAL CENTER [ZIACL002118] Funding Source: NIH RePORTER	CLINICAL CENTER		American Academy of Dermatology, 2011, MEL FACT SHEET; American Cancer Society, 2010, CANC FACTS FIG 2010; Amundsen SS, 2004, TISSUE ANTIGENS, V64, P593, DOI 10.1111/j.1399-0039.2004.00312.x; Ascierto ML, 2011, J TRANSL MED, V9, DOI 10.1186/1479-5876-9-146; Ascierto PA, 2008, J TRANSL MED, V6, DOI 10.1186/1479-5876-6-62; Balch CM, 2009, J CLIN ONCOL, V27, P6199, DOI 10.1200/JCO.2009.23.4799; Banwell B, 2011, LANCET NEUROL, V10, P436, DOI 10.1016/S1474-4422(11)70045-X; Benhatchi K, 2011, CLIN RHEUMATOL, V30, P1319, DOI 10.1007/s10067-011-1752-z; Bouwhuis MG, 2010, CANCER IMMUNOL IMMUN, V59, P303, DOI 10.1007/s00262-009-0751-2; Breunis WB, 2008, J IMMUNOTHER, V31, P586, DOI 10.1097/CJI.0b013e31817fd8f3; Briggs FBS, 2011, GENES IMMUN, V12, P615, DOI 10.1038/gene.2011.34; Casula M, 2010, ANN ONCOL, V21, P1379, DOI 10.1093/annonc/mdq056; Cheng XL, 2011, HEPATO-GASTROENTEROL, V58, P432; Clemente CG, 1996, CANCER, V77, P1303, DOI 10.1002/(SICI)1097-0142(19960401)77:7<1303::AID-CNCR12>3.3.CO;2-0; COLOVAI AI, 1994, TISSUE ANTIGENS, V44, P65, DOI 10.1111/j.1399-0039.1994.tb02361.x; COX DR, 1972, J R STAT SOC B, V34, P187; Deschoolmeester V, 2010, BMC IMMUNOL, V11, DOI 10.1186/1471-2172-11-19; Gambineri E, 2003, CURR OPIN RHEUMATOL, V15, P430, DOI 10.1097/00002281-200307000-00010; Garbe C, 2011, ONCOLOGIST, V16, P5, DOI 10.1634/theoncologist.2010-0190; Gogas H, 2010, J TRANSL MED, V8, DOI 10.1186/1479-5876-8-108; Gogas H, 2010, CANCER-AM CANCER SOC, V116, P4326, DOI 10.1002/cncr.25211; Gooden MJM, 2011, BRIT J CANCER, V105, P93, DOI 10.1038/bjc.2011.189; Gough SCL, 2005, IMMUNOL REV, V204, P102, DOI 10.1111/j.0105-2896.2005.00249.x; Heagerty PJ, 2000, BIOMETRICS, V56, P337, DOI 10.1111/j.0006-341X.2000.00337.x; Hoon DSB, 1998, J CLIN ONCOL, V16, P1430, DOI 10.1200/JCO.1998.16.4.1430; Huang CL, 2005, CANC SKIN, P265; Kirkwood JM, 2001, J CLIN ONCOL, V19, P2370, DOI 10.1200/JCO.2001.19.9.2370; Kirkwood JM, 2002, CANCER-AM CANCER SOC, V95, P1101, DOI 10.1002/cncr.10775; Kohaar I, 2009, HUM IMMUNOL, V70, P222, DOI 10.1016/j.humimm.2009.01.003; Kristiansen OP, 2000, GENES IMMUN, V1, P170, DOI 10.1038/sj.gene.6363655; Li YF, 2011, CLIN CANCER RES, V17, P3830, DOI 10.1158/1078-0432.CCR-10-2877; Lin ZH, 2010, BMC GASTROENTEROL, V10, DOI 10.1186/1471-230X-10-145; Liu DX, 2005, CLIN CANCER RES, V11, P1237; Liu Y, 2011, DNA CELL BIOL, V30, P1051, DOI 10.1089/dna.2011.1269; Mahmoud SMA, 2011, J CLIN ONCOL, V29, P1949, DOI 10.1200/JCO.2010.30.5037; Marsh SGE, 2002, EUR J IMMUNOGENET, V29, P463, DOI 10.1046/j.1365-2370.2002.00359.x; Muto M, 2011, J DERMATOL SCI, V62, P70, DOI 10.1016/j.jdermsci.2010.10.012; Nestle FO, 2009, NEW ENGL J MED, V361, P496, DOI 10.1056/NEJMra0804595; Niu JZ, 2011, CANCER IMMUNOL IMMUN, V60, P1109, DOI 10.1007/s00262-011-1025-3; OLERUP O, 1992, TISSUE ANTIGENS, V39, P225, DOI 10.1111/j.1399-0039.1992.tb01940.x; Ozdilli K, 2010, J INT MED RES, V38, P1835, DOI 10.1177/147323001003800531; Pectasides D, 2009, J CLIN ONCOL, V27, P939, DOI 10.1200/JCO.2008.16.3121; Rizza P, 2011, EXPERT REV VACCINES, V10, P487, DOI [10.1586/erv.11.9, 10.1586/ERV.11.9]; SAIKI RK, 1989, P NATL ACAD SCI USA, V86, P6230, DOI 10.1073/pnas.86.16.6230; Sakaguchi S, 2011, METHODS MOL BIOL, V707, P3, DOI 10.1007/978-1-61737-979-6_1; Sanderson K, 2005, J CLIN ONCOL, V23, P741, DOI 10.1200/JCO.2005.01.128; Schwartzentruber DJ, 2011, NEW ENGL J MED, V364, P2119, DOI 10.1056/NEJMoa1012863; Simon RM, 2011, BRIEF BIOINFORM, V12, P203, DOI 10.1093/bib/bbr001; Sosman JA, 2002, J CLIN ONCOL, V20, P2067, DOI 10.1200/JCO.2002.08.072; Spivey TL, 2011, J TRANSL MED, V9, DOI 10.1186/1479-5876-9-174; Thompson CB, 1997, IMMUNITY, V7, P445, DOI 10.1016/S1074-7613(00)80366-0; Ueda H, 2003, NATURE, V423, P506, DOI 10.1038/nature01621; Ugurel S, 2008, CANCER IMMUNOL IMMUN, V57, P685, DOI 10.1007/s00262-007-0407-z; Wang E, 2008, TRENDS IMMUNOL, V29, P256, DOI 10.1016/j.it.2008.03.002; Yurkovetsky ZR, 2007, CLIN CANCER RES, V13, P2422, DOI 10.1158/1078-0432.CCR-06-1805; Zhang YG, 2011, CANCER-AM CANCER SOC, V117, P4312, DOI 10.1002/cncr.25979	58	14	14	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 24	2012	7	7							e40805	10.1371/journal.pone.0040805	http://dx.doi.org/10.1371/journal.pone.0040805			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	978NX	22911710	Green Accepted, Green Published, gold, Green Submitted			2022-12-25	WOS:000306751300016
J	Feng, J; Liu, B; Zhang, ZQ; Ren, Y; Li, Y; Gan, F; Huang, YP; Chen, XD; Shen, P; Wang, L; Tang, B; Tang, XF				Feng, Jie; Liu, Bin; Zhang, Ziqian; Ren, Yan; Li, Yang; Gan, Fei; Huang, Yuping; Chen, Xiangdong; Shen, Ping; Wang, Lei; Tang, Bing; Tang, Xiao-Feng			The Complete Genome Sequence of Natrinema sp J7-2, a Haloarchaeon Capable of Growth on Synthetic Media without Amino Acid Supplements	PLOS ONE			English	Article							EXTREMELY HALOPHILIC ARCHAEON; ARGININE TRANSLOCATION PATHWAY; HALOFERAX-VOLCANII; SP-NOV.; SALT-LAKE; PHYLOGENETIC NETWORKS; HALOARCULA-HISPANICA; NUCLEOTIDE-SEQUENCE; ESCHERICHIA-COLI; GEN. NOV.	Natrinema sp. J7-2 is an extreme haloarchaeon capable of growing on synthetic media without amino acid supplements. Here we report the complete genome sequence of Natrinema sp. J7-2 which is composed of a 3,697,626-bp chromosome and a 95,989-bp plasmid pJ7-I. This is the first complete genome sequence of a member of the genus Natrinema. We demonstrate that Natrinema sp. J7-2 can use gluconate, glycerol, or acetate as the sole carbon source and that its genome encodes complete metabolic pathways for assimilating these substrates. The biosynthetic pathways for all 20 amino acids have been reconstructed, and we discuss a possible evolutionary relationship between the haloarchaeal arginine synthetic pathway and the bacterial lysine synthetic pathway. The genome harbors the genes for assimilation of ammonium and nitrite, but not nitrate, and has a denitrification pathway to reduce nitrite to N2O. Comparative genomic analysis suggests that most sequenced haloarchaea employ the TrkAH system, rather than the Kdp system, to actively uptake potassium. The genomic analysis also reveals that one of the three CRISPR loci in the Natrinema sp. J7-2 chromosome is located in an integrative genetic element and is probably propagated via horizontal gene transfer (HGT). Finally, our phylogenetic analysis of haloarchaeal genomes provides clues about evolutionary relationships of haloarchaea.	[Feng, Jie; Zhang, Ziqian; Gan, Fei; Huang, Yuping; Chen, Xiangdong; Shen, Ping; Tang, Bing; Tang, Xiao-Feng] Wuhan Univ, Coll Life Sci, Wuhan 430072, Hubei, Peoples R China; [Liu, Bin; Ren, Yan; Li, Yang; Wang, Lei] Nankai Univ, TEDA Sch Biol Sci & Biotechnol, Tianjin 300071, Peoples R China; [Wang, Lei] Minist Educ, Key Lab Mol Microbiol & Technol, Tianjin, Peoples R China	Wuhan University; Nankai University	Feng, J (corresponding author), Wuhan Univ, Coll Life Sci, Wuhan 430072, Hubei, Peoples R China.	tangb@whu.edu.cn; tangxf@whu.edu.cn	Gan, Fei/I-8599-2017; Feng, Jie/AAZ-1723-2021; Wang, Lei/C-5176-2009	Feng, Jie/0000-0001-8358-5654; Wang, Lei/0000-0003-4427-0881	National Natural Science Foundation of China [30870063, 30970071]; Program of Introducing Talents of Discipline to Universities of China [B06018]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Program of Introducing Talents of Discipline to Universities of China(Ministry of Education, China - 111 Project)	This work was supported in part by the National Natural Science Foundation of China (30870063, 30970071) and the Program of Introducing Talents of Discipline to Universities of China (B06018). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allers T, 2004, APPL ENVIRON MICROB, V70, P943, DOI 10.1128/AEM.70.2.943-953.2004; Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389; Anderson I, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020237; Anderson I, 2009, STAND GENOMIC SCI, V1, P218, DOI 10.4056/sigs.31864; Badger JH, 1999, MOL BIOL EVOL, V16, P512, DOI 10.1093/oxfordjournals.molbev.a026133; Baliga NS, 2004, GENOME RES, V14, P2221, DOI 10.1101/gr.2700304; BAUM BR, 1992, TAXON, V41, P3, DOI 10.2307/1222480; Bolhuis A, 2002, MICROBIOL-SGM, V148, P3335, DOI 10.1099/00221287-148-11-3335; Bolhuis H, 2006, BMC GENOMICS, V7, DOI 10.1186/1471-2164-7-169; Bonete Maria Jose, 2008, Saline Syst, V4, P9, DOI 10.1186/1746-1448-4-9; Bryant D, 2004, MOL BIOL EVOL, V21, P255, DOI 10.1093/molbev/msh018; Cabello P, 2004, MICROBIOL-SGM, V150, P3527, DOI 10.1099/mic.0.27303-0; Castillo AM, 2006, INT J SYST EVOL MICR, V56, P2683, DOI 10.1099/ijs.0.64421-0; CHIARIOTTI L, 1986, MOL GEN GENET, V202, P42, DOI 10.1007/BF00330514; Creevey CJ, 2005, BIOINFORMATICS, V21, P390, DOI 10.1093/bioinformatics/bti020; Creevey CJ, 2004, P ROY SOC B-BIOL SCI, V271, P2551, DOI 10.1098/rspb.2004.2864; Delcher AL, 1999, NUCLEIC ACIDS RES, V27, P4636, DOI 10.1093/nar/27.23.4636; Dilks M, 2005, J BACTERIOL, V187, P8104, DOI 10.1128/JB.187.23.8104-8113.2005; EISENBERG H, 1992, ADV PROTEIN CHEM, V43, P1, DOI 10.1016/S0065-3233(08)60553-7; Euzeby JP, 1997, INT J SYST BACTERIOL, V47, P590, DOI 10.1099/00207713-47-2-590; Falb M, 2005, GENOME RES, V15, P1336, DOI 10.1101/gr.3952905; Falb M, 2008, EXTREMOPHILES, V12, P177, DOI 10.1007/s00792-008-0138-x; Finn RD, 2006, NUCLEIC ACIDS RES, V34, pD247, DOI 10.1093/nar/gkj149; Fitch WM, 1997, J MOL EVOL S1, pS65; Godde JS, 2006, J MOL EVOL, V62, P718, DOI 10.1007/s00239-005-0223-z; Gonzalez O, 2010, PLOS COMPUT BIOL, V6, DOI 10.1371/journal.pcbi.1000799; Grissa I, 2007, BMC BIOINFORMATICS, V8, DOI 10.1186/1471-2105-8-172; Guindon S, 2003, SYST BIOL, V52, P696, DOI 10.1080/10635150390235520; Hartman AL, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009605; Hochuli M, 1999, J BACTERIOL, V181, P3226, DOI 10.1128/JB.181.10.3226-3237.1999; Horie A, 2009, NAT CHEM BIOL, V5, P673, DOI 10.1038/nchembio.198; Horvath P, 2010, SCIENCE, V327, P167, DOI 10.1126/science.1179555; Hulo N, 2006, NUCLEIC ACIDS RES, V34, pD227, DOI 10.1093/nar/gkj063; Huson DH, 2006, MOL BIOL EVOL, V23, P254, DOI 10.1093/molbev/msj030; KAMEKURA M, 1992, J BACTERIOL, V174, P736, DOI 10.1128/jb.174.3.736-742.1992; Katoh K, 2010, BIOINFORMATICS, V26, P1899, DOI 10.1093/bioinformatics/btq224; KAURI T, 1990, SYST APPL MICROBIOL, V13, P14, DOI 10.1016/S0723-2020(11)80174-8; Khomyakova M, 2011, SCIENCE, V331, P334, DOI 10.1126/science.1196544; LANYI JK, 1974, BACTERIOL REV, V38, P272, DOI 10.1128/MMBR.38.3.272-290.1974; Letunic I, 2006, NUCLEIC ACIDS RES, V34, pD257, DOI 10.1093/nar/gkj079; Li L, 2003, GENOME RES, V13, P2178, DOI 10.1101/gr.1224503; Liolios K, 2010, NUCLEIC ACIDS RES, V38, pD346, DOI 10.1093/nar/gkp848; Liu HL, 2011, J BACTERIOL, V193, P6086, DOI 10.1128/JB.05953-11; Lledo B, 2005, GENE, V361, P80, DOI 10.1016/j.gene.2005.07.011; Lowe TM, 1997, NUCLEIC ACIDS RES, V25, P955, DOI 10.1093/nar/25.5.955; Malfatti S, 2009, STAND GENOMIC SCI, V1, P150, DOI 10.4056/sigs.23264; McGenity TJ, 1998, INT J SYST BACTERIOL, V48, P1187, DOI 10.1099/00207713-48-4-1187; MEVARECH M, 1985, J BACTERIOL, V162, P461, DOI 10.1128/JB.162.1.461-462.1985; Mojica FJM, 2005, J MOL EVOL, V60, P174, DOI 10.1007/s00239-004-0046-3; Moriya Y, 2007, NUCLEIC ACIDS RES, V35, pW182, DOI 10.1093/nar/gkm321; Ng WV, 2000, P NATL ACAD SCI USA, V97, P12176, DOI 10.1073/pnas.190337797; OREN A, 1995, FEMS MICROBIOL ECOL, V18, P75, DOI 10.1016/0168-6496(95)00044-B; Oren Aharon, 2008, Saline Syst, V4, P2, DOI 10.1186/1746-1448-4-2; Pfeiffer F, 2008, GENOMICS, V91, P335, DOI 10.1016/j.ygeno.2008.01.001; RAGAN MA, 1992, BIOSYSTEMS, V28, P47, DOI 10.1016/0303-2647(92)90007-L; Rawls KS, 2011, J BACTERIOL, V193, P4469, DOI 10.1128/JB.00276-11; Roh SW, 2010, J BACTERIOL, V192, P4528, DOI 10.1128/JB.00663-10; Rose RW, 2002, MOL MICROBIOL, V45, P943, DOI 10.1046/j.1365-2958.2002.03090.x; Rutherford K, 2000, BIOINFORMATICS, V16, P944, DOI 10.1093/bioinformatics/16.10.944; SAITOU N, 1987, MOL BIOL EVOL, V4, P406, DOI 10.1093/oxfordjournals.molbev.a040454; Saunders E, 2010, STAND GENOMIC SCI, V2, P107, DOI 10.4056/sigs.681272; Shen P, 1994, CHINESE J GENET, V21, P409; Shi WL, 2006, EXTREMOPHILES, V10, P599, DOI 10.1007/s00792-006-0003-8; Shukla Hem D., 2006, Astrobiology, V6, P249; Siguier P, 2006, NUCLEIC ACIDS RES, V34, pD32, DOI 10.1093/nar/gkj014; SOLIMAN GSH, 1982, ZBL BAKT MIK HYG I C, V3, P318, DOI 10.1016/S0721-9571(82)80045-8; Sorek R, 2008, NAT REV MICROBIOL, V6, P181, DOI 10.1038/nrmicro1793; Strahl H, 2008, EXTREMOPHILES, V12, P741, DOI 10.1007/s00792-008-0177-3; Tanner JJ, 2008, AMINO ACIDS, V35, P719, DOI 10.1007/s00726-008-0062-5; Tapingkae W, 2008, INT J SYST EVOL MICR, V58, P2378, DOI 10.1099/ijs.0.65644-0; Thomas JR, 2006, FEMS MICROBIOL LETT, V256, P44, DOI 10.1111/j.1574-6968.2006.00107.x; Tindall BJ, 2009, STAND GENOMIC SCI, V1, P270, DOI 10.4056/sigs.42644; TOMLINSON GA, 1986, INT J SYST BACTERIOL, V36, P66, DOI 10.1099/00207713-36-1-66; Waino M, 2000, INT J SYST EVOL MICR, V50, P183, DOI 10.1099/00207713-50-1-183; Wanner C, 1999, GENETICS, V152, P1417; White RH, 2006, BIOCHEMISTRY-US, V45, P12366, DOI 10.1021/bi061018a; Xin HW, 2000, INT J SYST EVOL MICR, V50, P1297, DOI 10.1099/00207713-50-3-1297; Xu XW, 2005, INT J SYST EVOL MICR, V55, P1311, DOI 10.1099/ijs.0.63622-0; Xu ZS, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023562; Ye XC, 2003, FEMS MICROBIOL LETT, V221, P53, DOI 10.1016/S0378-1097(03)00175-7; Zhang Fan, 2009, Weishengwu Xuebao, V49, P1445; Zhang H, 2007, FEMS MICROBIOL LETT, V275, P168, DOI 10.1111/j.1574-6968.2007.00881.x; Zhang H, 2009, EXTREMOPHILES, V13, P669, DOI 10.1007/s00792-009-0251-5	83	21	21	2	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 23	2012	7	7							e41621	10.1371/journal.pone.0041621	http://dx.doi.org/10.1371/journal.pone.0041621			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	977TM	22911826	gold, Green Submitted, Green Published			2022-12-25	WOS:000306687700125
J	Mercado, N; Hakim, A; Kobayashi, Y; Meah, S; Usmani, OS; Chung, KF; Barnes, PJ; Ito, K				Mercado, Nicolas; Hakim, Amir; Kobayashi, Yoshiki; Meah, Sally; Usmani, Omar S.; Chung, Kian Fan; Barnes, Peter J.; Ito, Kazuhiro			Restoration of Corticosteroid Sensitivity by p38 Mitogen Activated Protein Kinase Inhibition in Peripheral Blood Mononuclear Cells from Severe Asthma	PLOS ONE			English	Article							FACTOR-KAPPA-B; INSENSITIVE ASTHMA; GENE-EXPRESSION; DOUBLE-BLIND; RHEUMATOID-ARTHRITIS; RESISTANT ASTHMA; MAPK INHIBITOR; T-CELLS; RECEPTOR; INFLAMMATION	Background: Severe asthma accounts for a small number of asthmatics but represents a disproportionate cost to health care systems. The underlying mechanism in severe asthma remains unknown but several mechanisms are likely to be involved because of a very heterogeneous profile. We investigated the effects of a p38MAPK inhibitor in corticosteroid sensitivity in peripheral blood mononuclear cells (PBMCs) from severe asthmatics and the profile of its responders. Methodology/Principal Findings: Corticosteroid sensitivity was determined by measuring dexamethasone inhibition of CD3/28 and TNF-alpha induced IL-8 production in PBMCs by using ELISA. PBMCs from severe asthmatics were relatively less sensitive to dexamethasone (Dex) as compared to those of non-severe asthmatics and healthy volunteers. The IC50 values of Dex negatively correlated with decreased glucocorticoid receptor (GR) nuclear translocation assessed using immunocytochemistry (r = -0.65; p<0.0005) and with decreased FEV1 (% predicted) (r = 0.6; p<0.0005). A p38 alpha/beta inhibitor (SB203580) restored Dex-sensitivity in a subpopulation of severe asthma that was characterized by a defective GR nuclear translocation, clinically by lower FEV1 and higher use of oral prednisolone. We also found that SB203580 partially inhibited GR phosphorylation at serine 226, resulting in increased GR nuclear translocation in IL-2/IL-4 treated corticosteroid insensitive U937s. Conclusions/Significance: p38MAPK alpha/beta is involved in defective GR nuclear translocation due to phosphorylation at Ser226 and this will be a useful biomarker to identify responders to p38MAPK alpha/beta inhibitor in the future.	[Mercado, Nicolas; Hakim, Amir; Kobayashi, Yoshiki; Meah, Sally; Usmani, Omar S.; Chung, Kian Fan; Barnes, Peter J.; Ito, Kazuhiro] Univ London Imperial Coll Sci Technol & Med, Airway Dis Sect, Natl Heart & Lung Inst, London, England; [Hakim, Amir; Meah, Sally; Usmani, Omar S.; Chung, Kian Fan] Royal Brompton Hosp, Biomed Res Unit, London SW3 6LY, England	Imperial College London; Royal Brompton Hospital	Mercado, N (corresponding author), Univ London Imperial Coll Sci Technol & Med, Airway Dis Sect, Natl Heart & Lung Inst, London, England.	k.ito@imperial.ac.uk	Chung, Kian Fan/I-8456-2019; Ito, Kazuhiro/AAF-5994-2019; Chung, Kian Fan/B-1872-2012	Chung, Kian Fan/0000-0001-7101-1426; Chung, Kian Fan/0000-0001-7101-1426; hakim, amir/0000-0002-4884-3141; Barnes, Peter/0000-0002-5122-4018; mercado, nicolas/0000-0002-8728-0994	Asthma UK [04-56]; Medical Research Council (MRC) [G0700900]; NIHR Respiratory Disease Biomedical Research Unit at the Royal Brompton NHS Trust at Imperial College London; MRC [G0700900] Funding Source: UKRI; Medical Research Council [G0700900, G0801056B] Funding Source: researchfish; National Institute for Health Research [NF-SI-0611-10148, CDF-2011-04-053] Funding Source: researchfish	Asthma UK; Medical Research Council (MRC)(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); NIHR Respiratory Disease Biomedical Research Unit at the Royal Brompton NHS Trust at Imperial College London; MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); National Institute for Health Research(National Institute for Health Research (NIHR))	This work was funded by grants from Asthma UK [04-56] and from the Medical Research Council (MRC) [G0700900]. The study was supported by the NIHR Respiratory Disease Biomedical Research Unit at the Royal Brompton NHS Trust at Imperial College London. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adcock IM, 2003, J ENDOCRINOL, V178, P347, DOI 10.1677/joe.0.1780347; Barnes Peter J, 2004, Proc Am Thorac Soc, V1, P264, DOI 10.1513/pats.200402-014MS; Barnes PJ, 2006, TRENDS MOL MED, V12, P515, DOI 10.1016/j.molmed.2006.09.006; Bergmann MW, 2004, IMMUNOLOGY, V111, P430, DOI 10.1111/j.0019-2805.2004.01833.x; Bhavsar P, 2010, EUR RESPIR J, V35, P750, DOI 10.1183/09031936.00071309; Bhavsar P, 2008, THORAX; Bhavsar PK, 2010, RESP RES, V11, DOI 10.1186/1465-9921-11-71; Chanez P, 2007, J ALLERGY CLIN IMMUN, V119, P1337, DOI 10.1016/j.jaci.2006.11.702; Chung KF, 1999, EUR RESPIR J, V13, P1198; Chung KF, 2011, CHEST, V139, P1470, DOI 10.1378/chest.10-1914; Clark AR, 2003, FEBS LETT, V546, P37, DOI 10.1016/S0014-5793(03)00439-3; Cohen SB, 2009, ARTHRITIS RHEUM, V60, P335, DOI 10.1002/art.24266; Damjanov N, 2009, ARTHRITIS RHEUM-US, V60, P1232, DOI 10.1002/art.24485; Dente FL, 2006, ANN ALLERG ASTHMA IM, V97, P312, DOI 10.1016/S1081-1206(10)60795-8; Gagliardo R, 2003, AM J RESP CRIT CARE, V168, P1190, DOI 10.1164/rccm.200205-479OC; GINA, 2011, GLOB IN ASTHM GUID; Goleva E, 2006, AM J RESP CRIT CARE, V173, P607, DOI 10.1164/rccm.200507-1046OC; Goleva E, 2009, AM J RESP CELL MOL, V40, P223, DOI 10.1165/rcmb.2007-0327OC; Hamilton LM, 2003, CLIN EXP ALLERGY, V33, P233, DOI 10.1046/j.1365-2222.2003.01593.x; Hew M, 2006, AM J RESP CRIT CARE, V174, P134, DOI 10.1164/rccm.200512-1930OC; Irusen E, 2002, J ALLERGY CLIN IMMUN, V109, P649, DOI 10.1067/mai.2002.122465; Ito K, 2007, PHARMACOL THERAPEUT, V116, P249, DOI 10.1016/j.pharmthera.2007.06.009; KAM JC, 1993, J IMMUNOL, V151, P3460; Kobayashi Y, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027627; LEUNG DYM, 1995, J EXP MED, V181, P33, DOI 10.1084/jem.181.1.33; Li LB, 2007, BLOOD, V110, P1570, DOI 10.1182/blood-2007-01-070755; Little SA, 2002, AM J MED, V112, P446, DOI 10.1016/S0002-9343(02)01047-1; Livingston E, 2007, EUR RESPIR J, V29, P64, DOI 10.1183/09031936.06.00120505; Mann BS, 2006, RESP RES, V7, DOI 10.1186/1465-9921-7-59; Matthews JG, 2004, J ALLERGY CLIN IMMUN, V113, P1100, DOI 10.1016/j.jaci.2004.03.018; Mercado N, 2011, MOL PHARMACOL, V80, P1128, DOI 10.1124/mol.111.071993; Polosa R, 2007, INTERN MED J; Roebuck KA, 1999, J INTERF CYTOK RES, V19, P429, DOI 10.1089/107999099313866; Rogatsky I, 1998, P NATL ACAD SCI USA, V95, P2050, DOI 10.1073/pnas.95.5.2050; Rossios C, 2012, BRIT J PHARMACOL, V167, P775, DOI 10.1111/j.1476-5381.2012.01864.x; Saatian B, 2006, BIOCHEM J, V393, P657, DOI 10.1042/BJ20050791; Saccani S, 2002, NAT IMMUNOL, V3, P69, DOI 10.1038/ni748; Saha SK, 2008, J ALLERGY CLIN IMMUN, V121, P685, DOI 10.1016/j.jaci.2008.01.005; Schafer PH, 1999, J IMMUNOL, V162, P7110; Schreiber S, 2006, CLIN GASTROENTEROL H, V4, P325, DOI 10.1016/j.cgh.2005.11.013; Shaw DE, 2007, CHEST, V132, P1871, DOI 10.1378/chest.07-1047; Silvestri M, 2006, CLIN EXP ALLERGY, V36, P1373, DOI 10.1111/j.1365-2222.2006.02502.x; Singh D, 2010, J CLIN PHARMACOL, V50, P94, DOI 10.1177/0091270009347873; Sorkness RL, 2007, J APPL PHYSL; To Y, 2010, AM J RESP CRIT CARE, V182, P897, DOI 10.1164/rccm.200906-0937OC; Wang Z, 2002, J BIOL CHEM, V277, P26573, DOI 10.1074/jbc.M110530200	46	83	91	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 23	2012	7	7							e41582	10.1371/journal.pone.0041582	http://dx.doi.org/10.1371/journal.pone.0041582			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	977TM	22911818	Green Submitted, Green Published, gold			2022-12-25	WOS:000306687700118
J	Benedusi, V; Martorana, F; Brambilla, L; Maggi, A; Rossi, D				Benedusi, Valeria; Martorana, Francesca; Brambilla, Liliana; Maggi, Adriana; Rossi, Daniela			The Peroxisome Proliferator-activated Receptor gamma (PPAR gamma) Controls Natural Protective Mechanisms against Lipid Peroxidation in Amyotrophic Lateral Sclerosis	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MOTOR-NEURON DEGENERATION; TRANSGENIC MOUSE MODEL; SKELETAL-MUSCLE; OXIDATIVE STRESS; MOLECULAR-MECHANISMS; SPINAL-CORDS; ANIMAL-MODEL; SURVIVAL; DISEASE; CELLS	Recent evidence highlights the peroxisome proliferator-activated receptors (PPARs) as critical neuroprotective factors in several neurodegenerative diseases, including amyotrophic lateral sclerosis (ALS). To gain new mechanistic insights into the role of these receptors in the context of ALS, here we investigated how PPAR transcriptional activity varies in hSOD1(G93A) ALS transgenic mice. We demonstrate that PPAR gamma-driven transcription selectively increases in the spinal cord of symptomatic hSOD1(G93A) mice. This phenomenon correlates with the up-regulation of target genes, such as lipoprotein lipase and glutathione S-transferase alpha-2, which are implicated in scavenging lipid peroxidation by-products. Such events are associated with enhanced PPAR gamma immunoreactivity within motor neuronal nuclei. This observation, and the fact that PPAR gamma displays increased responsiveness in cultured hSOD1(G93A) motor neurons, points to a role for this receptor in neutralizing deleterious lipoperoxidation derivatives within the motor cells. Consistently, in both motor neuron-like cultures and animal models, we report that PPAR gamma is activated by lipid peroxidation end products, such as 4-hydroxynonenal, whose levels are elevated in the cerebrospinal fluid and spinal cord from ALS patients. We propose that the accumulation of critical concentrations of lipid peroxidation adducts during ALS progression leads to the activation of PPAR gamma in motor neurons. This in turn triggers self-protective mechanisms that involve the up-regulation of lipid detoxification enzymes, such as lipoprotein lipase and glutathione S-transferase alpha-2. Our findings indicate that anticipating natural protective reactions by pharmacologically modulating PPAR gamma transcriptional activity may attenuate neurodegeneration by limiting the damage induced by lipid peroxidation derivatives.	[Martorana, Francesca; Brambilla, Liliana; Rossi, Daniela] IRCCS Fdn Salvatore Maugeri, Lab Res Neurodegenerat Disorders, I-27100 Pavia, Italy; [Benedusi, Valeria; Maggi, Adriana] Univ Milan, Dept Pharmacol & Biomol Sci, I-20133 Milan, Italy; [Benedusi, Valeria; Maggi, Adriana] Univ Milan, Ctr Excellence Neurodegenerat Dis, I-20133 Milan, Italy	Istituti Clinici Scientifici Maugeri IRCCS; University of Milan; University of Milan	Rossi, D (corresponding author), IRCCS Fdn Salvatore Maugeri, Lab Res Neurodegenerat Disorders, I-27100 Pavia, Italy.	daniela.rossi@fsm.it	Brambilla, Liliana/AAA-3303-2021; Rossi, Daniela Maria/AAA-3401-2021	Brambilla, Liliana/0000-0001-5714-3625; Rossi, Daniela Maria/0000-0002-3346-1327; Maggi, Adriana/0000-0001-5700-5273; MARTORANA, FRANCESCA/0000-0003-4091-8134; Benedusi, Valeria/0000-0003-4791-4806	Telethon Foundation [GGP05244]; Italian Ministry of Health; European Union [NoE DIMI LSHBCT-2005-512146, 278850]	Telethon Foundation(Fondazione Telethon); Italian Ministry of Health(Ministry of Health, Italy); European Union(European Commission)	This work was supported by Telethon Foundation Grant GGP05244 (to D. R.), the Italian Ministry of Health, European Union's Sixth Framework Programme under grant agreement NoE DIMI LSHBCT-2005-512146 (Diagnostic Molecular Imaging - DiMI) (to A. M.), and Seventh Framework Programme (FP7/2007-2013) under grant agreement no. 278850 (Imaging of Neuroinflammation in Neurodegenerative Diseases - INMiND) (to A. M.).	Adibhatla RM, 2010, ANTIOXID REDOX SIGN, V12, P125, DOI [10.1089/ars.2009.2668, 10.1089/ARS.2009.2668]; Allen S, 2003, J BIOL CHEM, V278, P6371, DOI 10.1074/jbc.M209915200; Amin RH, 2010, AM J PHYSIOL-ENDOC M, V298, pE28, DOI 10.1152/ajpendo.00446.2009; Barber SC, 2010, FREE RADICAL BIO MED, V48, P629, DOI 10.1016/j.freeradbiomed.2009.11.018; Basu-Modak S, 1999, J BIOL CHEM, V274, P35881, DOI 10.1074/jbc.274.50.35881; Benedusi V, 2012, ENDOCRINOLOGY, V153, P2777, DOI 10.1210/en.2011-1925; BENSIMON G, 1994, NEW ENGL J MED, V330, P585, DOI 10.1056/NEJM199403033300901; BLASI E, 1990, J NEUROIMMUNOL, V27, P229, DOI 10.1016/0165-5728(90)90073-V; BLAU HM, 1985, SCIENCE, V230, P758, DOI 10.1126/science.2414846; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; Brewer GJ, 2007, NAT PROTOC, V2, P1490, DOI 10.1038/nprot.2007.207; Bruijn LI, 1997, NEURON, V18, P327, DOI 10.1016/S0896-6273(00)80272-X; CASHMAN NR, 1992, DEV DYNAM, V194, P209, DOI 10.1002/aja.1001940306; Chai RJ, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0028090; Chen HF, 2010, BRAIN RES, V1340, P52, DOI 10.1016/j.brainres.2010.03.075; Chio A, 2009, NEUROLOGY, V73, P1681, DOI 10.1212/WNL.0b013e3181c1df1e; Ciana P, 2007, MOL ENDOCRINOL, V21, P388, DOI 10.1210/me.2006-0152; Cullingford TE, 2002, NEUROPHARMACOLOGY, V42, P724, DOI 10.1016/S0028-3908(02)00014-X; Cutler RG, 2002, ANN NEUROL, V52, P448, DOI 10.1002/ana.10312; Da Cruz S, 2012, CELL METAB, V15, P778, DOI 10.1016/j.cmet.2012.03.019; Dobrowolny G, 2008, CELL METAB, V8, P425, DOI 10.1016/j.cmet.2008.09.002; Dorst J, 2011, J NEUROL, V258, P613, DOI 10.1007/s00415-010-5805-z; Dupuis L, 2008, NEUROLOGY, V70, P1004, DOI 10.1212/01.wnl.0000285080.70324.27; Dupuis L, 2004, P NATL ACAD SCI USA, V101, P11159, DOI 10.1073/pnas.0402026101; ESTERBAUER H, 1991, FREE RADICAL BIO MED, V11, P81, DOI 10.1016/0891-5849(91)90192-6; Fergani A, 2007, J LIPID RES, V48, P1571, DOI 10.1194/jlr.M700017-JLR200; FRISA PS, 1994, J NEUROSCI RES, V39, P47, DOI 10.1002/jnr.490390107; GUNTINASLICHIUS O, 1993, J MICROSC-OXFORD, V172, P177, DOI 10.1111/j.1365-2818.1993.tb03409.x; GURNEY ME, 1994, SCIENCE, V264, P1772, DOI 10.1126/science.8209258; Heiman-Patterson TD, 2005, J NEUROL SCI, V236, P1, DOI 10.1016/j.jns.2005.02.006; Heneka MT, 2007, BBA-MOL CELL BIOL L, V1771, P1031, DOI 10.1016/j.bbalip.2007.04.016; Heneka MT, 2007, NAT CLIN PRACT NEURO, V3, P496, DOI 10.1038/ncpneuro0586; Ilieva H, 2009, J CELL BIOL, V187, P761, DOI 10.1083/jcb.200908164; Itoh T, 2008, NAT STRUCT MOL BIOL, V15, P924, DOI 10.1038/nsmb.1474; Jang YC, 2012, AGING CELL, V11, P770, DOI 10.1111/j.1474-9726.2012.00843.x; Jang YC, 2010, FASEB J, V24, P1376, DOI 10.1096/fj.09-146308; Miana-Mena FJ, 2011, J NEUROL, V258, P762, DOI 10.1007/s00415-010-5825-8; Kageyama H, 2003, BIOCHEM BIOPH RES CO, V305, P22, DOI 10.1016/S0006-291X(03)00663-6; Kiaei M, 2005, EXP NEUROL, V191, P331, DOI 10.1016/j.expneurol.2004.10.007; Kim SM, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017985; Lever TE, 2009, DYSPHAGIA, V24, P180, DOI 10.1007/s00455-008-9190-z; Liang HY, 2011, MUSCLE NERVE, V44, P947, DOI 10.1002/mus.22217; Muller FL, 2007, AM J PHYSIOL-REG I, V293, pR1159, DOI 10.1152/ajpregu.00767.2006; Norris AW, 2003, J CLIN INVEST, V112, P608, DOI 10.1172/JCI200317305; Paradis E, 2003, J BIOL CHEM, V278, P9698, DOI 10.1074/jbc.M208452200; Pedersen WA, 1998, ANN NEUROL, V44, P819, DOI 10.1002/ana.410440518; Pedersen WA, 1999, EXP NEUROL, V155, P1, DOI 10.1006/exnr.1998.6890; Riahi Y, 2010, DIABETES, V59, P808, DOI 10.2337/db09-1207; Ricote M, 2007, BBA-MOL CELL BIOL L, V1771, P926, DOI 10.1016/j.bbalip.2007.02.013; ROSEN DR, 1993, NATURE, V362, P59, DOI 10.1038/362059a0; Rossi D, 2008, CELL DEATH DIFFER, V15, P1691, DOI 10.1038/cdd.2008.99; Rossi D, 2005, J BIOL CHEM, V280, P42088, DOI 10.1074/jbc.M504124200; Schutz B, 2005, J NEUROSCI, V25, P7805, DOI 10.1523/JNEUROSCI.2038-05.2005; Shibata N, 2004, BRAIN RES, V1019, P170, DOI 10.1016/j.brainres.2004.05.110; Simpson EP, 2004, NEUROLOGY, V62, P1758, DOI 10.1212/WNL.62.10.1758; Simpson EP, 2003, CURR OPIN RHEUMATOL, V15, P730, DOI 10.1097/00002281-200311000-00008; Smith RG, 1998, ANN NEUROL, V44, P696, DOI 10.1002/ana.410440419; Song WJ, 2013, NEUROBIOL DIS, V51, P72, DOI 10.1016/j.nbd.2012.07.004; Turner BJ, 2008, PROG NEUROBIOL, V85, P94, DOI 10.1016/j.pneurobio.2008.01.001; Uchida K, 2003, PROG LIPID RES, V42, P318, DOI 10.1016/S0163-7827(03)00014-6; Valdez G, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0034640; Victor NA, 2006, EUR J NEUROSCI, V24, P1653, DOI 10.1111/j.1460-9568.2006.05037.x; Vigh L, 2005, ACTA NEUROPATHOL, V109, P567, DOI 10.1007/s00401-004-0977-1; Wong M, 2010, HUM MOL GENET, V19, P2284, DOI 10.1093/hmg/ddq106; WONG PC, 1995, NEURON, V14, P1105, DOI 10.1016/0896-6273(95)90259-7; YAFFE D, 1977, NATURE, V270, P725, DOI 10.1038/270725a0; Yang Y, 2001, J BIOL CHEM, V276, P19220, DOI 10.1074/jbc.M100551200; Zhao W, 2011, MOL NEURODEGENER, V6, DOI 10.1186/1750-1326-6-51; Zhao XR, 2009, J NEUROSCI, V29, P6186, DOI 10.1523/JNEUROSCI.5857-08.2009	69	46	48	0	15	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 19	2012	287	43					35899	35911		10.1074/jbc.M112.366419	http://dx.doi.org/10.1074/jbc.M112.366419			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	027PA	22910911	hybrid, Green Published			2022-12-25	WOS:000310364000012
J	Fujikawa, M; Kobayashi, K; Kozawa, T				Fujikawa, Mayu; Kobayashi, Kazuo; Kozawa, Takahiro			Direct Oxidation of the [2Fe-2S] Cluster in SoxR Protein by Superoxide DISTINCT DIFFERENTIAL SENSITIVITY TO SUPEROXIDE-MEDIATED SIGNAL TRANSDUCTION	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							STRESS SENSOR SOXR; ESCHERICHIA-COLI; PULSE-RADIOLYSIS; PSEUDOMONAS-AERUGINOSA; RESPONSE REGULON; TRANSCRIPTION FACTOR; CRYSTAL-STRUCTURE; GENE-EXPRESSION; IN-VIVO; DNA	The [2Fe-2S] transcription factor SoxR is activated by reversible one-electron oxidation of its [2Fe-2S] cluster, leading to enhanced production of various antioxidant proteins through induction of the soxRS regulon in Escherichia coli. Recently, there has been considerable debate about whether superoxide (O (center dot) over bar (2).) activates SoxR directly. To elucidate the underlying activation mechanism, we investigated SoxR interaction with O (center dot) over bar (2). using pulse radiolysis. Radiolytically generated hydrated electrons reduced the oxidized form of the [2Fe-2S] cluster of SoxR within 2 mu s. A subsequent increase in absorption in the visible region corresponding to reoxidation of the [2Fe-2S] cluster was observed on a time scale of milliseconds. Addition of human copper/zinc superoxide dismutase inhibited this delayed oxidation in a concentration-dependent fashion (I-50 = 1.0 mu M), indicating that O (center dot) over bar (2). oxidized the reduced form of SoxR directly. The second-order rate constant of this process was estimated to be 5 x 10(8) M-1 s(-1). A similar result was observed after pulse radiolysis of Pseudomonas aeruginosa SoxR. However, superoxide dismutase inhibited the oxidation of reduced SoxR much more effectively in P. aeruginosa, even at a lower concentration (I-50 = 80 nM), indicating that the soxRS response is much more sensitive to O (center dot) over bar2. in E. coli than in P. aeruginosa. These results suggest that SoxR proteins play a distinct regulatory role in the activation of O (center dot) over bar2.	[Fujikawa, Mayu; Kobayashi, Kazuo; Kozawa, Takahiro] Osaka Univ, Inst Sci & Ind Res, Ibaraki, Osaka 5670047, Japan	Osaka University	Kobayashi, K (corresponding author), Osaka Univ, Inst Sci & Ind Res, Mihogaoka 8-1, Ibaraki, Osaka 5670047, Japan.	kobayasi@sanken.osaka-u.ac.jp	Kobayashi, Kazuo/H-9279-2012	Kobayashi, Kazuo/0000-0002-5586-9112	Ministry of Education, Science, Sports, and Culture of Japan	Ministry of Education, Science, Sports, and Culture of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT))	This work was supported in part by a grant-in-aid for scientific research (C) from the Ministry of Education, Science, Sports, and Culture of Japan (to K.K.).	ANSARI AZ, 1995, NATURE, V374, P371; BIELSKI BHJ, 1978, PHOTOCHEM PHOTOBIOL, V28, P645, DOI 10.1111/j.1751-1097.1978.tb06986.x; Blanchard JL, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0001186; Bonnot F, 2012, J AM CHEM SOC, V134, P5120, DOI 10.1021/ja209297n; BULL C, 1985, J AM CHEM SOC, V107, P3295, DOI 10.1021/ja00297a040; Changela A, 2003, SCIENCE, V301, P1383, DOI 10.1126/science.1085950; Coulter ED, 2000, J AM CHEM SOC, V122, P11555, DOI 10.1021/ja005583r; De Nicola GM, 2011, NATURE, V475, P106, DOI 10.1038/nature10189; Dietrich LEP, 2008, SCIENCE, V321, P1203, DOI 10.1126/science.1160619; Dietrich LEP, 2006, MOL MICROBIOL, V61, P1308, DOI 10.1111/j.1365-2958.2006.05306.x; Ding HG, 1997, P NATL ACAD SCI USA, V94, P8445, DOI 10.1073/pnas.94.16.8445; Ding HG, 1996, J BIOL CHEM, V271, P33173, DOI 10.1074/jbc.271.52.33173; GARDNER PR, 1991, J BIOL CHEM, V266, P19328; GARDNER PR, 1991, J BIOL CHEM, V266, P1478; Gaudu P, 1996, P NATL ACAD SCI USA, V93, P10094, DOI 10.1073/pnas.93.19.10094; Gaudu P, 1997, J BIOL CHEM, V272, P5082, DOI 10.1074/jbc.272.8.5082; Gorodetsky AA, 2008, P NATL ACAD SCI USA, V105, P3684, DOI 10.1073/pnas.0800093105; Green J, 2004, NAT REV MICROBIOL, V2, P954, DOI 10.1038/nrmicro1022; Gu MZ, 2011, MOL MICROBIOL, V79, P1136, DOI 10.1111/j.1365-2958.2010.07520.x; HASE T, 1977, J BIOCHEM-TOKYO, V82, P267, DOI 10.1093/oxfordjournals.jbchem.a131679; Heldwein EEZ, 2001, NATURE, V409, P378, DOI 10.1038/35053138; Hidalgo E, 1997, EMBO J, V16, P1056, DOI 10.1093/emboj/16.5.1056; Hidalgo Elena, 1996, P435; IMLAY JA, 1991, J BIOL CHEM, V266, P6957; Imlay JA, 2008, ANNU REV BIOCHEM, V77, P755, DOI 10.1146/annurev.biochem.77.061606.161055; Kahmann JD, 2003, EMBO J, V22, P1824, DOI 10.1093/emboj/cdg181; KLUG D, 1972, J BIOL CHEM, V247, P4839; Kobayashi K, 2004, J BIOCHEM, V136, P607, DOI 10.1093/jb/mvh168; Kobayashi K, 1999, FEBS LETT, V451, P227, DOI 10.1016/S0014-5793(99)00565-7; KOBAYASHI K, 1989, J BIOL CHEM, V264, P15280; KOBAYASHI K, 1995, J CHEM SOC DALTON, P2885, DOI 10.1039/dt9950002885; Kobayashi K, 2011, BIOCHEMISTRY-US, V50, P9468, DOI 10.1021/bi201526y; Koo MS, 2003, EMBO J, V22, P2614, DOI 10.1093/emboj/cdg252; Kovacs JA, 2007, ACCOUNTS CHEM RES, V40, P501, DOI 10.1021/ar600059h; Krapp AR, 2011, MICROBIOL-SGM, V157, P957, DOI 10.1099/mic.0.039461-0; KUO CF, 1987, J BIOL CHEM, V262, P4724; LIOCHEV SI, 1991, J BIOL CHEM, V266, P8747; LIOCHEV SI, 1993, ARCH BIOCHEM BIOPHYS, V301, P379, DOI 10.1006/abbi.1993.1159; LIOCHEV SI, 1992, P NATL ACAD SCI USA, V89, P5892, DOI 10.1073/pnas.89.13.5892; Liochev SI, 2011, FREE RADICAL BIO MED, V50, P1813, DOI 10.1016/j.freeradbiomed.2011.03.029; Mathe C, 2005, J AM CHEM SOC, V127, P16436, DOI 10.1021/ja053808y; MUIRWOOD P, 1974, FEBS LETT, V44, P22, DOI 10.1016/0014-5793(74)80297-8; Mustafa G, 2008, J BIOL CHEM, V283, P22215, DOI 10.1074/jbc.M800911200; Nakamura M, 1999, J BIOCHEM, V126, P10, DOI 10.1093/oxfordjournals.jbchem.a022409; Newberry KJ, 2004, J BIOL CHEM, V279, P20356, DOI 10.1074/jbc.M400960200; Nguyen T, 2009, J BIOL CHEM, V284, P13291, DOI 10.1074/jbc.R900010200; NUNOSHIBA T, 1992, J BACTERIOL, V174, P6054, DOI 10.1128/JB.174.19.6054-6060.1992; Outten CE, 1999, J BIOL CHEM, V274, P37517, DOI 10.1074/jbc.274.53.37517; Palma M, 2005, INFECT IMMUN, V73, P2958, DOI 10.1128/IAI.73.5.2958-2966.2005; Park W, 2006, BIOCHEM BIOPH RES CO, V341, P51, DOI 10.1016/j.bbrc.2005.12.142; PICK M, 1974, J AM CHEM SOC, V96, P7329, DOI 10.1021/ja00830a026; Pomposiello PJ, 2001, TRENDS BIOTECHNOL, V19, P109, DOI 10.1016/S0167-7799(00)01542-0; Pomposiello PJ, 2001, J BACTERIOL, V183, P3890, DOI 10.1128/JB.183.13.3890-3902.2001; Price-Whelan A, 2007, J BACTERIOL, V189, P6372, DOI 10.1128/JB.00505-07; SAWADA Y, 1975, BIOCHEMISTRY-US, V14, P3761, DOI 10.1021/bi00688a007; Storz G, 1999, CURR OPIN MICROBIOL, V2, P188, DOI 10.1016/S1369-5274(99)80033-2; Sutton VR, 2004, BIOCHEMISTRY-US, V43, P791, DOI 10.1021/bi0357053; TSANEVA IR, 1990, J BACTERIOL, V172, P4197, DOI 10.1128/jb.172.8.4197-4205.1990; Watanabe S, 2008, P NATL ACAD SCI USA, V105, P4121, DOI 10.1073/pnas.0709188105; Watanabe S, 2006, ACTA CRYSTALLOGR F, V62, P1275, DOI 10.1107/S1744309106048482; WU J, 1992, J BACTERIOL, V174, P3915, DOI 10.1128/jb.174.12.3915-3920.1992; WU J, 1995, J BIOL CHEM, V270, P10323, DOI 10.1074/jbc.270.17.10323	62	39	40	0	20	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 12	2012	287	42					35702	35708		10.1074/jbc.M112.395079	http://dx.doi.org/10.1074/jbc.M112.395079			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	022OF	22908228	hybrid, Green Published			2022-12-25	WOS:000309968000081
J	Zhang, DY; Li, JX; Zhang, M; Gao, GX; Zuo, ZH; Yu, YH; Zhu, LD; Gao, JM; Huang, CS				Zhang, Dongyun; Li, Jingxia; Zhang, Min; Gao, Guangxun; Zuo, Zhenghong; Yu, Yonghui; Zhu, Linda; Gao, Jimin; Huang, Chuanshu			The Requirement of c-Jun N-terminal Kinase 2 in Regulation of Hypoxia-inducing Factor-1 alpha mRNA Stability	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							NATURAL ANTISENSE TRANSCRIPTS; NICKEL-INDUCED TRANSFORMATION; PHOSPHATIDYLINOSITOL 3-KINASE; NUCLEOLIN; PROTEIN; HIF-1-ALPHA; JNK; EXPRESSION; INDUCTION; TRISTETRAPROLIN	The mRNAof hif-1 alpha is considered as being constitutively and ubiquitously expressed, regardless of the level of oxygen tension. However many recent reports have showed that hif-1 alpha mRNA could be regulated by natural antisense transcripts, potential microRNAs, and low O-2. In this study, it was found that a deficiency of JNK2 expression reduced HIF-1 alpha protein induction in response to nickel treatment resulting from the impaired expression of hif-1 alpha mRNA. Both the promoter luciferase assay and mRNA degradation assay clearly showed that depletion of JNK2 affected stability of hif-1 alpha mRNA, rather than regulated its transcription. In addition, nucleolin, a classic histone chaperone, was demonstrated to physically bind to hif-1 alpha mRNA and maintain its stability. Further investigation indicated that JNK2 regulated nucleolin expression and might in turn stabilize hif-1 alpha mRNA. Collectively, we provided one more piece of evidence for the oncogenic role of JNK2 and nucleolin in regulating the cancer microenvironments by controlling HIF-1 alpha expression.	[Zhang, Dongyun; Li, Jingxia; Gao, Guangxun; Zuo, Zhenghong; Yu, Yonghui; Zhu, Linda; Huang, Chuanshu] NYU, Sch Med, Nelson Inst Environm Med, Tuxedo Pk, NY 10987 USA; [Zhang, Min; Gao, Jimin] Wenzhou Med Coll, Sch Life Sci, Zhejiang Prov Key Lab Med Genet, Wenzhou 325035, Zhejiang, Peoples R China	New York University; Wenzhou Medical University	Huang, CS (corresponding author), NYU, Sch Med, Nelson Inst Environm Med, 57 Old Forge Rd, Tuxedo Pk, NY 10987 USA.	chuanshu@env.med.nyu.edu	Zuo, Zhenghong/G-4615-2010; Yu, Yonghui/AAZ-4093-2021	Huang, Chuanshu/0000-0003-4133-5096	NIH/NCI [CA112557]; NIH/NIEHS [ES000260, ES010344];  [NSFC81229002];  [NSFC 30971516]; NATIONAL CANCER INSTITUTE [R01CA112557] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [P42ES010344, P30ES000260] Funding Source: NIH RePORTER	NIH/NCI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NIH/NIEHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); ; ; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS))	This work was supported, in whole or in part, by National Institutes of Health Grants CA112557 from NIH/NCI and ES000260 and ES010344 from NIH/NIEHS as well as NSFC81229002 and NSFC 30971516.	Bardos JI, 2005, BBA-REV CANCER, V1755, P107, DOI 10.1016/j.bbcan.2005.05.001; BEACH LR, 1978, J BIOL CHEM, V253, P2628; Bode AM, 2007, MOL CARCINOGEN, V46, P591, DOI 10.1002/mc.20348; Campalans A, 2004, PLANT CELL, V16, P1047, DOI 10.1105/tpc.019406; Cao HP, 2003, ARCH BIOCHEM BIOPHYS, V412, P106, DOI 10.1016/S0003-9861(03)00012-2; Caudle WM, 2009, NEUROSCI LETT, V459, P11, DOI 10.1016/j.neulet.2009.04.060; Chen CY, 2000, GENE DEV, V14, P1236; Chen NY, 2001, CANCER RES, V61, P3908; Dean JLE, 2004, CELL SIGNAL, V16, P1113, DOI 10.1016/j.cellsig.2004.04.006; Ding J, 2006, J BIOL CHEM, V281, P9093, DOI 10.1074/jbc.M510537200; Dolt KS, 2007, GENE, V386, P73, DOI 10.1016/j.gene.2006.08.004; Dranovsky A, 2001, NEUROBIOL AGING, V22, P517, DOI 10.1016/S0197-4580(00)00248-7; FURST A, 1984, IARC SCI PUBL, P245; Ginisty H, 1999, J CELL SCI, V112, P761; Gonzalez V, 2009, J BIOL CHEM, V284, P23622, DOI 10.1074/jbc.M109.018028; Gordan JD, 2007, CURR OPIN GENET DEV, V17, P71, DOI 10.1016/j.gde.2006.12.006; GRANDJEAN P, 1984, IARC SCI PUBL, P469; Greasley PJ, 2000, NUCLEIC ACIDS RES, V28, P446, DOI 10.1093/nar/28.2.446; Greco A, 2009, REV MED VIROL, V19, P201, DOI 10.1002/rmv.614; Guo W, 2011, CELL MOL LIFE SCI, V68, P475, DOI 10.1007/s00018-010-0459-7; Huang CS, 1996, J BIOL CHEM, V271, P31262, DOI 10.1074/jbc.271.49.31262; Huang CS, 1996, MOL CELL BIOL, V16, P6427; Huang CS, 1996, INT J ONCOL, V8, P389; Jiang BH, 2001, CELL GROWTH DIFFER, V12, P363; Johnson GL, 2002, SCIENCE, V298, P1911, DOI 10.1126/science.1072682; Karin M, 2005, IUBMB LIFE, V57, P283, DOI 10.1080/15216540500097111; Ke QD, 2006, MOL PHARMACOL, V70, P1469, DOI 10.1124/mol.106.027029; Lin NY, 2008, BIOCHEM BIOPH RES CO, V365, P69, DOI 10.1016/j.bbrc.2007.10.119; Lu HT, 2005, MOL CELL BIOCHEM, V279, P45, DOI 10.1007/s11010-005-8215-2; Maxwell PH, 2001, EXP NEPHROL, V9, P235; Minet E, 1999, BIOCHEM BIOPH RES CO, V261, P534, DOI 10.1006/bbrc.1999.0995; Richard DE, 1999, J BIOL CHEM, V274, P32631, DOI 10.1074/jbc.274.46.32631; Rossignol F, 2004, GENE, V339, P121, DOI 10.1016/j.gene.2004.06.029; Rossignol F, 2002, GENE, V299, P135, DOI 10.1016/S0378-1119(02)01049-1; Sabapathy K, 2004, MOL CELL, V15, P713, DOI 10.1016/j.molcel.2004.08.028; Sabapathy K, 1999, CURR BIOL, V9, P116, DOI 10.1016/S0960-9822(99)80065-7; Salnikow K, 1999, CARCINOGENESIS, V20, P1819, DOI 10.1093/carcin/20.9.1819; Salnikow K, 2008, CHEM RES TOXICOL, V21, P28, DOI 10.1021/tx700198a; Seko Y, 2006, AUTOIMMUN REV, V5, P299, DOI 10.1016/j.autrev.2005.10.013; Semenza GL., 2007, SCI STKE, V2007, pCM8, DOI [DOI 10.1126/STKE.4072007CM8, 10.1126/stke.4072007cm8]; She QB, 2002, CANCER RES, V62, P1343; Sirri V, 1997, CYTOMETRY, V28, P147, DOI 10.1002/(SICI)1097-0320(19970601)28:2<147::AID-CYTO8>3.3.CO;2-G; Song L, 2007, MOL CELL BIOL, V27, P2713, DOI 10.1128/MCB.00657-06; Soundararajan S, 2008, CANCER RES, V68, P2358, DOI 10.1158/0008-5472.CAN-07-5723; Storck Sebastien, 2007, Subcell Biochem, V41, P125; Taguchi A, 2008, CANCER RES, V68, P5540, DOI 10.1158/0008-5472.CAN-07-6460; Takagi M, 2005, CELL, V123, P49, DOI 10.1016/j.cell.2005.07.034; Tang GL, 2001, NATURE, V414, P313, DOI 10.1038/35104568; Taylor GA, 1996, IMMUNITY, V4, P445, DOI 10.1016/S1074-7613(00)80411-2; Terova G, 2008, AQUACULTURE, V279, P150, DOI 10.1016/j.aquaculture.2008.03.041; Uribe DJ, 2011, BIOCHEMISTRY-US, V50, P3796, DOI 10.1021/bi101633b; Vlaminck B, 2007, FEBS J, V274, P5533, DOI 10.1111/j.1742-4658.2007.06072.x; Wan J, 2004, MOL CELL BIOL, V24, P192, DOI 10.1128/MCB.24.1.192-199.2004; Zhang DY, 2007, CARCINOGENESIS, V28, P883, DOI 10.1093/carcin/bgl186; Zhang DY, 2006, J BIOL CHEM, V281, P34113, DOI 10.1074/jbc.M602821200; Zhang DY, 2010, CANCER RES, V70, P813, DOI 10.1158/0008-5472.CAN-09-0448; Zhang J, 2008, CANCER RES, V68, P1046, DOI 10.1158/0008-5472.CAN-07-1927; Zhang QW, 2003, TOXICOL APPL PHARM, V192, P201, DOI 10.1016/S0041-008X(03)00280-1; Zou AP, 2001, PHYSIOL GENOMICS, V6, P159, DOI 10.1152/physiolgenomics.2001.6.3.159	59	17	17	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 5	2012	287	41					34361	34371		10.1074/jbc.M112.365882	http://dx.doi.org/10.1074/jbc.M112.365882			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	018IS	22910906	Green Published, hybrid			2022-12-25	WOS:000309654200039
J	Zou, LY; Zhu-Mauldin, X; Marchase, RB; Paterson, AJ; Liu, J; Yang, QL; Chatham, JC				Zou, Luyun; Zhu-Mauldin, Xiaoyuan; Marchase, Richard B.; Paterson, Andrew J.; Liu, Jian; Yang, Qinglin; Chatham, John C.			Glucose Deprivation-induced Increase in Protein O-GlcNAcylation in Cardiomyocytes Is Calcium-dependent	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							LINKED N-ACETYLGLUCOSAMINE; ISCHEMIA-REPERFUSION INJURY; GLCNAC MODIFICATION; NEONATAL CARDIOMYOCYTES; UP-REGULATION; POSTTRANSLATIONAL MODIFICATION; HEXOSAMINE PATHWAY; INSULIN-RESISTANCE; MAMMALIAN-CELLS; KINASE-BETA	The posttranslational modification of nuclear and cytosolic proteins by O-linked beta-N-acetylglucosamine (O-GlcNAc) has been shown to play an important role in cellular response to stress. Although increases in O-GlcNAc levels have typically been thought to be substrate-driven, studies in several transformed cell lines reported that glucose deprivation increased O-GlcNAc levels by a number of different mechanisms. A major goal of this study therefore was to determine whether in primary cells, such as neonatal cardiomyocytes, glucose deprivation increases O-GlcNAc levels and if so by what mechanism. Glucose deprivation significantly increased cardiomyocyte O-GlcNAc levels in a time-dependent manner and was associated with decreased O-GlcNAcase (OGA) but not O-GlcNAc transferase (OGT) protein. This response was unaffected by either the addition of pyruvate as an alternative energy source or by the p38 MAPK inhibitor SB203580. However, the response to glucose deprivation was blocked completely by glucosamine, but not by inhibition of OGA with 2-acetamido-2-deoxy-D-glucopyranosylidene)amino-N-phenylcarbamate. Interestingly, the CaMKII inhibitor KN93 also significantly reduced the response to glucose deprivation. Lowering extracellular Ca2+ with EGTA or blocking store operatedCa(2+) entry with SKF96365 also attenuated the glucose deprivation-induced increase in O-GlcNAc. In C2C12 and HEK293 cells both glucose deprivation and heat shock increased O-GlcNAc levels, and CaMKII inhibitor KN93 attenuated the response to both stresses. These results suggest that increased intracellular calcium and subsequent activation of CaMKII play a key role in regulating the stress-induced increase in cellular O-GlcNAc levels.	[Zou, Luyun; Zhu-Mauldin, Xiaoyuan; Chatham, John C.] Univ Alabama Birmingham, Dept Pathol, Div Mol & Cellular Pathol, Birmingham, AL 35294 USA; [Marchase, Richard B.] Univ Alabama Birmingham, Dept Cell Biol, Birmingham, AL 35294 USA; [Paterson, Andrew J.] Univ Alabama Birmingham, Div Endocrinol Diabet & Metab, Dept Med, Birmingham, AL 35294 USA; [Liu, Jian; Yang, Qinglin] Univ Alabama Birmingham, Dept Nutr Sci, Birmingham, AL 35294 USA	University of Alabama System; University of Alabama Birmingham; University of Alabama System; University of Alabama Birmingham; University of Alabama System; University of Alabama Birmingham; University of Alabama System; University of Alabama Birmingham	Chatham, JC (corresponding author), Univ Alabama Birmingham, Dept Pathol, Div Mol & Cellular Pathol, 1670 Univ Blvd,Volker Hall G001, Birmingham, AL 35294 USA.	jchatham@uab.edu			National Institutes of Health [HL101192, HL079364]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL079364, R01HL101192, R01HL085499, R01HL084456] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work supported, in whole or in part, by National Institutes of Health Grants HL101192 and HL079364 (to J. C. C.).	Bain J, 2007, BIOCHEM J, V408, P297, DOI 10.1042/BJ20070797; Boglarka L, 2010, AM J PHYSIOL-HEART C, V299, pH1715, DOI 10.1152/ajpheart.00337.2010; BRAUN AP, 1995, ANNU REV PHYSIOL, V57, P417, DOI 10.1146/annurev.ph.57.030195.002221; Buse MG, 2006, AM J PHYSIOL-ENDOC M, V290, pE1, DOI 10.1152/ajpendo.00329.2005; Carling D, 2008, INT J OBESITY, V32, pS55, DOI 10.1038/ijo.2008.124; Champattanachai V, 2008, AM J PHYSIOL-CELL PH, V294, pC1509, DOI 10.1152/ajpcell.00456.2007; Champattanachai V, 2007, AM J PHYSIOL-CELL PH, V292, pC178, DOI 10.1152/ajpcell.00162.2006; Cheung WD, 2008, J BIOL CHEM, V283, P13009, DOI 10.1074/jbc.M801222200; CHOU TY, 1995, J BIOL CHEM, V270, P18961, DOI 10.1074/jbc.270.32.18961; Copeland RJ, 2008, AM J PHYSIOL-ENDOC M, V295, pE17, DOI 10.1152/ajpendo.90281.2008; Dias WB, 2007, MOL BIOSYST, V3, P766, DOI 10.1039/b704905f; Dias WB, 2009, J BIOL CHEM, V284, P21327, DOI 10.1074/jbc.M109.007310; Donadio AC, 2008, J CELL BIOCHEM, V103, P800, DOI 10.1002/jcb.21449; Duk M, 1997, ANAL BIOCHEM, V253, P98, DOI 10.1006/abio.1997.9994; Durgan DJ, 2011, J BIOL CHEM, V286, P44606, DOI 10.1074/jbc.M111.278903; Faust AC, 2011, CRIT CARE NURSE, V31, pE9, DOI 10.4037/ccn2011188; Fulop N, 2008, BIOGERONTOLOGY, V9, P139, DOI 10.1007/s10522-007-9123-5; Fulop N, 2007, AM J PHYSIOL-CELL PH, V292, pC1370, DOI 10.1152/ajpcell.00422.2006; HALTIWANGER RS, 1990, J BIOL CHEM, V265, P2563; Hanover JA, 2001, FASEB J, V15, P1865, DOI 10.1096/fj.01-0094rev; Hanover JA, 2010, BBA-GEN SUBJECTS, V1800, P80, DOI 10.1016/j.bbagen.2009.07.017; Hardie DG, 2008, FEBS LETT, V582, P81, DOI 10.1016/j.febslet.2007.11.018; Hart GW, 2011, ANNU REV BIOCHEM, V80, P825, DOI 10.1146/annurev-biochem-060608-102511; Hawley SA, 2005, CELL METAB, V2, P9, DOI 10.1016/j.cmet.2005.05.009; Horman S, 2008, J BIOL CHEM, V283, P18505, DOI 10.1074/jbc.M802053200; Hu Y, 2005, CIRC RES, V96, P1006, DOI 10.1161/01.RES.0000165478.06813.58; Hunton DL, 2004, AM J PHYSIOL-HEART C, V286, pH1124, DOI 10.1152/ajpheart.00162.2003; Hunton DL, 2002, J BIOL CHEM, V277, P14266, DOI 10.1074/jbc.M107167200; Isono T, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018959; Jones SP, 2008, CIRCULATION, V117, P1172, DOI 10.1161/CIRCULATIONAHA.107.730515; Kang JG, 2009, J BIOL CHEM, V284, P34777, DOI 10.1074/jbc.M109.026351; Kazemi Z, 2010, J BIOL CHEM, V285, P39096, DOI 10.1074/jbc.M110.131102; Kreppel LK, 1999, J BIOL CHEM, V274, P32015, DOI 10.1074/jbc.274.45.32015; Laczy B, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018417; Liu J, 2007, AM J PHYSIOL-HEART C, V293, pH1391, DOI 10.1152/ajpheart.00285.2007; Love Dona C, 2005, Sci STKE, V2005, pre13, DOI 10.1126/stke.3122005re13; Macauley MS, 2005, J BIOL CHEM, V280, P25313, DOI 10.1074/jbc.M413819200; McClain DA, 2002, J DIABETES COMPLICAT, V16, P72, DOI 10.1016/S1056-8727(01)00188-X; Ngoh GA, 2008, J MOL CELL CARDIOL, V45, P313, DOI 10.1016/j.yjmcc.2008.04.009; Ngoh GA, 2009, CIRC RES, V104, P41, DOI 10.1161/CIRCRESAHA.108.189431; Pang Y, 2002, DIABETES, V51, P3461, DOI 10.2337/diabetes.51.12.3461; Rex-Mathes M, 2001, BIOCHIMIE, V83, P583, DOI 10.1016/S0300-9084(01)01305-0; Shaw P, 1996, ONCOGENE, V12, P921; Soderling TR, 2001, CHEM REV, V101, P2341, DOI 10.1021/cr0002386; Song M, 2008, CELL SIGNAL, V20, P94, DOI 10.1016/j.cellsig.2007.09.002; Takeda K, 2004, J MOL CELL CARDIOL, V36, P821, DOI 10.1016/j.yjmcc.2004.03.008; Taylor RP, 2008, J BIOL CHEM, V283, P6050, DOI 10.1074/jbc.M707328200; Taylor RP, 2009, J BIOL CHEM, V284, P3425, DOI 10.1074/jbc.M803198200; Toleman C, 2006, BBA-GEN SUBJECTS, V1760, P829, DOI 10.1016/j.bbagen.2006.01.017; Watson LJ, 2010, P NATL ACAD SCI USA, V107, P17797, DOI 10.1073/pnas.1001907107; Wellen KE, 2010, GENE DEV, V24, P2784, DOI 10.1101/gad.1985910; Wells L, 2003, BIOCHEM BIOPH RES CO, V302, P435, DOI 10.1016/S0006-291X(03)00175-X; Woods A, 2005, CELL METAB, V2, P21, DOI 10.1016/j.cmet.2005.06.005; Yan H, 2012, J CELL MOL MED, V16, P2049, DOI 10.1111/j.1582-4934.2011.01500.x; Zachara N. E., 2011, CURR PROTOC PROTEIN, V95, P1761; Zachara NE, 2011, AMINO ACIDS, V40, P793, DOI 10.1007/s00726-010-0695-z; Zachara NE, 2004, J BIOL CHEM, V279, P30133, DOI 10.1074/jbc.M403773200; Zhang T, 2004, RECENT PROG HORM RES, V59, P141, DOI 10.1210/rp.59.1.141; Zoungas S, 2010, NEW ENGL J MED, V363, P1410, DOI 10.1056/NEJMoa1003795	59	42	42	1	20	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 5	2012	287	41					34419	34431		10.1074/jbc.M112.393207	http://dx.doi.org/10.1074/jbc.M112.393207			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	018IS	22908225	Green Published, hybrid			2022-12-25	WOS:000309654200044
J	Bhushan, V; Saha, G; Lindsen, J; Shimojo, S; Bhattacharya, J				Bhushan, Vidya; Saha, Goutam; Lindsen, Job; Shimojo, Shinsuke; Bhattacharya, Joydeep			How We Choose One over Another: Predicting Trial-by-Trial Preference Decision	PLOS ONE			English	Article							GENERALIZED SYNCHRONIZATION; STIMULI; EEG; RECOGNITION; COMPETENCE; LIKELIHOOD; TIME	Preference formation is a complex problem as it is subjective, involves emotion, is led by implicit processes, and changes depending on the context even within the same individual. Thus, scientific attempts to predict preference are challenging, yet quite important for basic understanding of human decision making mechanisms, but prediction in a group-average sense has only a limited significance. In this study, we predicted preferential decisions on a trial by trial basis based on brain responses occurring before the individuals made their decisions explicit. Participants made a binary preference decision of approachability based on faces while their electrophysiological responses were recorded. An artificial neural network based pattern-classifier was used with time-frequency resolved patterns of a functional connectivity measure as features for the classifier. We were able to predict preference decisions with a mean accuracy of 74.3 +/- 2.79% at participant-independent level and of 91.4 +/- 3.8% at participant-dependent level. Further, we revealed a causal role of the first impression on final decision and demonstrated the temporal trajectory of preference decision formation.	[Bhushan, Vidya; Saha, Goutam] Indian Inst Technol, Dept Elect & Elect Commun Engn, Kharagpur 721302, W Bengal, India; [Lindsen, Job; Bhattacharya, Joydeep] Univ London, Dept Psychol, London, England; [Shimojo, Shinsuke] CALTECH, Div Biol, Pasadena, CA 91125 USA	Indian Institute of Technology System (IIT System); Indian Institute of Technology (IIT) - Kharagpur; University of London; California Institute of Technology	Bhushan, V (corresponding author), Indian Inst Technol, Dept Elect & Elect Commun Engn, Kharagpur 721302, W Bengal, India.	j.bhattacharya@gold.ac.uk	Saha, Goutam/AAH-6281-2020	Saha, Goutam/0000-0001-6187-1684	JST.ERATO; DST, Government of India; JST.CREST; MEXT.gCOE	JST.ERATO(Japan Science & Technology Agency (JST)); DST, Government of India(Department of Science & Technology (India)); JST.CREST(Japan Science & Technology Agency (JST)Core Research for Evolutional Science and Technology (CREST)); MEXT.gCOE	The research has been partially supported by JST.ERATO (SS, JB) and DST, Government of India (JB, GS). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; We thank Rhiannon Jones for data collection. We also thank Dr. Sam Gilbert for raising the issue of motor responses. SS is supported by JST.CREST and MEXT.gCOE.	Abarbanel HDI, 1996, PHYS REV E, V53, P4528, DOI 10.1103/PhysRevE.53.4528; Adolphs R, 1998, NATURE, V393, P470, DOI 10.1038/30982; [Anonymous], 2008, 1 IMPRESSIONS; Ariely D, 2010, NAT REV NEUROSCI, V11, P284, DOI 10.1038/nrn2795; Bhattacharya J, 2005, HUM BRAIN MAPP, V26, P1, DOI 10.1002/hbm.20104; Bishop CM, 2006, PATTERN RECOGN, Vxx; Campbell DW, 2009, DEPRESS ANXIETY, V26, P419, DOI 10.1002/da.20474; Campbell DW, 2011, J PERS, V79, P335, DOI 10.1111/j.1467-6494.2010.00687.x; Chapman KW, 2010, J SENS STUD, V25, P35, DOI 10.1111/j.1745-459X.2010.00294.x; Chau T, 2009, J NEURAL ENG, V6, P1; Clithero JA, 2011, NEUROIMAGE, V56, P699, DOI 10.1016/j.neuroimage.2010.03.057; Cohen MX, 2009, J COGNITIVE NEUROSCI, V21, P390, DOI 10.1162/jocn.2008.21020; COLES MGH, 1989, PSYCHOPHYSIOLOGY, V26, P251, DOI 10.1111/j.1469-8986.1989.tb01916.x; DEECKE L, 1987, CIBA F SYMP, V132, P231; Deiber MP, 1996, J NEUROPHYSIOL, V75, P233, DOI 10.1152/jn.1996.75.1.233; Delorme A, 2004, J NEUROSCI METH, V134, P9, DOI 10.1016/j.jneumeth.2003.10.009; Dominguez LG, 2009, J NEURAL ENG, V6, DOI 10.1088/1741-2560/6/5/058001; Hampton AN, 2007, P NATL ACAD SCI USA, V104, P1377, DOI 10.1073/pnas.0606297104; Harrison SA, 2009, NATURE, V458, P632, DOI 10.1038/nature07832; Haykin SS, 1999, NEURAL NETWORKS COMP, Vxxi; Haynes JD, 2005, NAT NEUROSCI, V8, P686, DOI 10.1038/nn1445; Haynes JD, 2007, CURR BIOL, V17, P323, DOI 10.1016/j.cub.2006.11.072; Hogarth RM, 1980, JUDGMENT CHOICE PSYC, Vxi; Jain AK, 2000, IEEE T PATTERN ANAL, V22, P4, DOI 10.1109/34.824819; Kamitani Y, 2005, NAT NEUROSCI, V8, P679, DOI 10.1038/nn1444; Kay KN, 2008, NATURE, V452, P352, DOI 10.1038/nature06713; Kim H, 2007, P NATL ACAD SCI USA, V104, P18253, DOI 10.1073/pnas.0703101104; Leclerc D, 2004, INT J INTERCULT REL, V28, P181, DOI 10.1016/j.ijintrel.2004.06.006; Leocani L, 1997, EVOKED POTENTIAL, V104, P199, DOI 10.1016/S0168-5597(96)96051-7; Leotti LA, 2010, TRENDS COGN SCI, V14, P457, DOI 10.1016/j.tics.2010.08.001; LIBET B, 1983, BRAIN, V106, P623, DOI 10.1093/brain/106.3.623; Luu S, 2009, J NEURAL ENG, V6, DOI 10.1088/1741-2560/6/1/016003; Marchisano C, 2003, J SENS STUD, V18, P487, DOI 10.1111/j.1745-459X.2003.tb00402.x; Meyer K, 2010, NAT NEUROSCI, V13, P667, DOI 10.1038/nn.2533; Montez T, 2006, NEUROIMAGE, V33, P1117, DOI 10.1016/j.neuroimage.2006.06.066; Oosterhof NN, 2008, P NATL ACAD SCI USA, V105, P11087, DOI 10.1073/pnas.0805664105; Pochon JB, 2008, J NEUROSCI, V28, P3468, DOI 10.1523/JNEUROSCI.4195-07.2008; Pockett S, 2009, CLIN NEUROPHYSIOL, V120, P695, DOI 10.1016/j.clinph.2008.12.044; PRUZANSKY S, 1964, J ACOUST SOC AM, V36, P2041, DOI 10.1121/1.1919320; Santos IM, 2011, Q J EXP PSYCHOL, V64, P751, DOI 10.1080/17470218.2010.519779; Stam CJ, 2002, PHYSICA D, V163, P236, DOI 10.1016/S0167-2789(01)00386-4; Thornhill R, 1999, TRENDS COGN SCI, V3, P452, DOI 10.1016/S1364-6613(99)01403-5; Todorov A, 2005, SCIENCE, V308, P1623, DOI 10.1126/science.1110589	44	7	7	0	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 17	2012	7	8							e43351	10.1371/journal.pone.0043351	http://dx.doi.org/10.1371/journal.pone.0043351			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	996DG	22912859	Green Published, Green Accepted, gold			2022-12-25	WOS:000308063700087
J	Tewson, P; Westenberg, M; Zhao, YX; Campbell, RE; Quinn, AM; Hughes, TE				Tewson, Paul; Westenberg, Mara; Zhao, Yongxin; Campbell, Robert E.; Quinn, Anne Marie; Hughes, Thomas E.			Simultaneous Detection of Ca2+ and Diacylglycerol Signaling in Living Cells	PLOS ONE			English	Article							PROTEIN-KINASE-C; GREEN FLUORESCENT PROTEIN; REPORTER; DOMAIN	Phospholipase C produces two second messengers - diacylglycerol (DAG), which remains in the membrane, and inositol triphosphate (IP3), which triggers the release of calcium ions (Ca2+) from intracellular stores. Genetically encoded sensors based on a single circularly permuted fluorescent protein (FP) are robust tools for studying intracellular Ca2+ dynamics. We have developed a robust sensor for DAG based on a circularly permuted green FP that can be co-imaged with the red fluorescent Ca2+ sensor R-GECO for simultaneous measurement of both second messengers.	[Tewson, Paul; Westenberg, Mara; Quinn, Anne Marie; Hughes, Thomas E.] Montana Mol, Bozeman, MT USA; [Hughes, Thomas E.] Montana State Univ, Dept Cell Biol & Neurosci, Bozeman, MT 59717 USA; [Zhao, Yongxin; Campbell, Robert E.] Univ Alberta, Dept Chem, Edmonton, AB, Canada	Montana State University System; Montana State University Bozeman; University of Alberta	Tewson, P (corresponding author), Montana Mol, Bozeman, MT USA.	thughesgfp@mac.com	Zhao, Yongxin/AAE-3708-2020; Zhao, Yongxin/F-1874-2015	Zhao, Yongxin/0000-0003-4188-5725; Zhao, Yongxin/0000-0003-4188-5725; Campbell, Robert E./0000-0003-0604-092X; Hughes, Thomas/0000-0002-8430-070X	NIMH - National Institue of Mental Health [1R43MH096670-01A1]; Montana Board of Research and Commercialization [11-37]; Alberta Innovates; Canadian Institutes of Health Research; Natural Sciences and Engineering Research Council of Canada; NATIONAL INSTITUTE OF MENTAL HEALTH [R43MH096670] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R44NS082222] Funding Source: NIH RePORTER	NIMH - National Institue of Mental Health; Montana Board of Research and Commercialization; Alberta Innovates; Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR)); Natural Sciences and Engineering Research Council of Canada(Natural Sciences and Engineering Research Council of Canada (NSERC)CGIAR); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This work was supported by the NIMH - National Institue of Mental Health (1R43MH096670-01A1), and The Montana Board of Research and Commercialization #11-37 to A. M. Q., and by Alberta Innovates (Y.Z.), Canadian Institutes of Health Research (R. E. C), and Natural Sciences and Engineering Research Council of Canada (R. E. C.). R. E. C. holds a Tier II Canada Research Chair in Bioanalytical Chemistry.	Akerboom J, 2009, J BIOL CHEM, V284, P6455, DOI 10.1074/jbc.M807657200; Dries DR, 2007, J BIOL CHEM, V282, P826, DOI 10.1074/jbc.C600268200; Erion DM, 2010, NAT MED, V16, P400, DOI 10.1038/nm0410-400; Falkenburger BH, 2010, J GEN PHYSIOL, V135, P81, DOI 10.1085/jgp.200910344; Gallegos LL, 2006, J BIOL CHEM, V281, P30947, DOI 10.1074/jbc.M603741200; Giorgione JR, 2006, J BIOL CHEM, V281, P1660, DOI 10.1074/jbc.M510251200; Nakai J, 2001, NAT BIOTECHNOL, V19, P137, DOI 10.1038/84397; Nausch LWM, 2008, P NATL ACAD SCI USA, V105, P365, DOI 10.1073/pnas.0710387105; Newton AC, 2010, AM J PHYSIOL-ENDOC M, V298, pE395, DOI 10.1152/ajpendo.00477.2009; Oancea E, 1998, CELL, V95, P307, DOI 10.1016/S0092-8674(00)81763-8; Oancea E, 1998, J CELL BIOL, V140, P485, DOI 10.1083/jcb.140.3.485; Sato M, 2006, NAT METHODS, V3, P797, DOI 10.1038/nmeth930; Shaner NC, 2004, NAT BIOTECHNOL, V22, P1567, DOI 10.1038/nbt1037; Szymczak AL, 2004, NAT BIOTECHNOL, V22, P589, DOI 10.1038/nbt957; Violin JD, 2003, J CELL BIOL, V161, P899, DOI 10.1083/jcb.200302125; Zhao Y, 2011, AIDS RES HUM RETRO S, DOI [10.1126/science.1208592, DOI 10.1126/SCIENCE.1208592]	16	43	45	1	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 17	2012	7	8							e42791	10.1371/journal.pone.0042791	http://dx.doi.org/10.1371/journal.pone.0042791			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	996DG	22912738	gold, Green Published, Green Submitted			2022-12-25	WOS:000308063700023
J	Trainor, C; Butterworth, KT; McGarry, CK; McMahon, SJ; O'Sullivan, JM; Hounsell, AR; Prise, KM				Trainor, Colman; Butterworth, Karl T.; McGarry, Conor K.; McMahon, Stephen J.; O'Sullivan, Joe M.; Hounsell, Alan R.; Prise, Kevin M.			DNA Damage Responses following Exposure to Modulated Radiation Fields	PLOS ONE			English	Article							DOUBLE-STRAND BREAKS; PRIMARY HUMAN FIBROBLASTS; IRRADIATED GLIOMA-CELLS; BYSTANDER RESPONSES; NITRIC-OXIDE; CELLULAR-RESPONSE; TUMOR-CELLS; SURVIVAL; INDUCE; 53BP1	During the delivery of advanced radiotherapy treatment techniques modulated beams are utilised to increase dose conformity across the target volume. Recent investigations have highlighted differential cellular responses to modulated radiation fields particularly in areas outside the primary treatment field that cannot be accounted for by scattered dose alone. In the present study, we determined the DNA damage response within the normal human fibroblast AG0-1522B and the prostate cancer cell line DU-145 utilising the DNA damage assay. Cells plated in slide flasks were exposed to 1 Gy uniform or modulated radiation fields. Modulated fields were delivered by shielding 25%, 50% or 75% of the flask during irradiation. The average number of 53BP1 or gamma H2AX foci was measured in 2 mm intervals across the slide area. Following 30 minutes after modulated radiation field exposure an increase in the average number of foci out-of-field was observed when compared to non-irradiated controls. In-field, a non-uniform response was observed with a significant decrease in the average number of foci compared to uniformly irradiated cells. Following 24 hrs after exposure there is evidence for two populations of responding cells to bystander signals in-and out-of-field. There was no significant difference in DNA damage response between 25%, 50% or 75% modulated fields. The response was dependent on cellular secreted intercellular signalling as physical inhibition of intercellular communication abrogated the observed response. Elevated residual DNA damage observed within out-of-field regions decreased following addition of an inducible nitric oxide synthase inhibitor (Aminoguanidine). These data show, for the first time, differential DNA damage responses in-and out-of-field following modulated radiation field delivery. This study provides further evidence for a role of intercellular communication in mediating cellular radiobiological response to modulated radiation fields and may inform the refinement of existing radiobiological models for the optimization of advanced radiotherapy treatment plans.	[Trainor, Colman; Butterworth, Karl T.; McGarry, Conor K.; McMahon, Stephen J.; O'Sullivan, Joe M.; Hounsell, Alan R.; Prise, Kevin M.] Queens Univ Belfast, Ctr Canc Res & Cell Biol, Belfast, Antrim, North Ireland; [McGarry, Conor K.; O'Sullivan, Joe M.; Hounsell, Alan R.] Belfast Hlth & Social Care Trust, No Ireland Canc Ctr, Belfast, Antrim, North Ireland	Queens University Belfast	Trainor, C (corresponding author), Queens Univ Belfast, Ctr Canc Res & Cell Biol, Belfast, Antrim, North Ireland.	ctrainor14@qub.ac.uk	Butterworth, Karl/I-7476-2019; Prise, Kevin/N-7872-2015	Butterworth, Karl/0000-0001-7170-6789; Prise, Kevin/0000-0001-6134-7946; McGarry, Conor/0000-0001-6396-2184; McMahon, Stephen/0000-0001-5980-6728; O'Sullivan, Joe/0000-0001-6999-2739	Cancer Research UK [C1513/A7047, C212/A11342]; Health and Social care Research and Development Office of the Northern Ireland; Northern Ireland Department of Education and Learning; Public Health Agency [EAT/3977/08] Funding Source: researchfish	Cancer Research UK(Cancer Research UK); Health and Social care Research and Development Office of the Northern Ireland; Northern Ireland Department of Education and Learning; Public Health Agency	Cancer Research UK grant C1513/A7047 to KMP. Cancer Research UK grant C212/A11342 to ARH. Health and Social care Research and Development Office of the Northern Ireland a Fellowship Award to CMcG Northern Ireland Department of Education and Learning for a studentship to CT. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Burdak-Rothkamm S, 2007, ONCOGENE, V26, P993, DOI 10.1038/sj.onc.1209863; Burdak-Rothkamm S, 2008, CANCER RES, V68, P7059, DOI 10.1158/0008-5472.CAN-08-0545; Butterworth KT, 2011, INT J RADIAT ONCOL, V79, P1516, DOI 10.1016/j.ijrobp.2010.11.034; Butterworth KT, 2010, PHYS MED BIOL, V55, P1607, DOI 10.1088/0031-9155/55/6/005; Hall EJ, 2006, RADIOBIOLOGY RADIOLO, V6th; Han W, 2007, BRIT J RADIOL, V80, pS7, DOI 10.1259/bjr/44550200; Hu BR, 2006, CARCINOGENESIS, V27, P245, DOI 10.1093/carcin/bgi224; Mackonis EC, 2007, PHYS MED BIOL, V52, P5469, DOI 10.1088/0031-9155/52/18/001; Mothersill C, 1997, INT J RADIAT BIOL, V71, P421, DOI 10.1080/095530097144030; Mothersill C, 1998, RADIAT RES, V149, P256, DOI 10.2307/3579958; Prise KM, 2009, NAT REV CANCER, V9, P351, DOI 10.1038/nrc2603; Prise KM, 2005, LANCET ONCOL, V6, P520, DOI 10.1016/S1470-2045(05)70246-1; PRISE KM, 1994, INT J RADIAT BIOL, V66, P537, DOI 10.1080/09553009414551581; Rogakou EP, 1998, J BIOL CHEM, V273, P5858, DOI 10.1074/jbc.273.10.5858; Ryan LA, 2008, RADIAT RES, V169, P188, DOI 10.1667/RR1141.1; Schultz LB, 2000, J CELL BIOL, V151, P1381, DOI 10.1083/jcb.151.7.1381; Shao C, 2008, ONCOGENE, V27, P434, DOI 10.1038/sj.onc.1210653; Shao C, 2003, CANCER RES, V63, P8437; Shao C, 2002, INT J RADIAT BIOL, V78, P837, DOI 10.1080/09553000210149786; Shao C, 2008, MUTAT RES-FUND MOL M, V638, P139, DOI 10.1016/j.mrfmmm.2007.09.007; Smilenov LB, 2006, RADIAT PROT DOSIM, V122, P256, DOI 10.1093/rpd/ncl461; Sokolov MV, 2005, ONCOGENE, V24, P7257, DOI 10.1038/sj.onc.1208886; Suchowerska N, 2005, PHYS MED BIOL, V50, P3041, DOI 10.1088/0031-9155/50/13/005; Syme A, 2009, PHYS MED BIOL, V54, P6623, DOI 10.1088/0031-9155/54/21/012; Tartier L, 2007, CANCER RES, V67, P5872, DOI 10.1158/0008-5472.CAN-07-0188; Tomita M, 2010, RADIAT RES, V173, P380, DOI 10.1667/RR1995.1; Trainor C, 2012, RADIAT RES, V177, P44, DOI 10.1667/RR2656.1; Yang HY, 2007, RADIAT RES, V168, P292, DOI 10.1667/RR0864.1; Yang HY, 2005, ONCOGENE, V24, P2096, DOI 10.1038/sj.onc.1208439	29	39	39	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 17	2012	7	8							e43326	10.1371/journal.pone.0043326	http://dx.doi.org/10.1371/journal.pone.0043326			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	996DG	22912853	Green Published, Green Submitted, gold			2022-12-25	WOS:000308063700081
J	Yamada, T; Ohta, H; Watanabe, H; Kanai, C; Tani, M; Ohno, T; Takayama, Y; Iwanami, A; Kato, N; Hashimoto, R				Yamada, Takashi; Ohta, Haruhisa; Watanabe, Hiromi; Kanai, Chieko; Tani, Masayuki; Ohno, Taisei; Takayama, Yuko; Iwanami, Akira; Kato, Nobumasa; Hashimoto, Ryuichiro			Functional Alterations in Neural Substrates of Geometric Reasoning in Adults with High-Functioning Autism	PLOS ONE			English	Article							WORKING-MEMORY; NEUROCOGNITIVE DEVELOPMENT; FLUID INTELLIGENCE; CORPUS-CALLOSUM; VISUAL-SEARCH; FMRI; PERFORMANCE; TASK; SCHIZOPHRENIA; CONNECTIVITY	Individuals with autism spectrum condition (ASC) are known to excel in some perceptual cognitive tasks, but such developed functions have been often regarded as "islets of abilities" that do not significantly contribute to broader intellectual capacities. However, recent behavioral studies have reported that individuals with ASC have advantages for performing Raven's (Standard) Progressive Matrices (RPM/RSPM), a standard neuropsychological test for general fluid intelligence, raising the possibility that ASC's cognitive strength can be utilized for more general purposes like novel problem solving. Here, the brain activity of 25 adults with high-functioning ASC and 26 matched normal controls (NC) was measured using functional magnetic resonance imaging (fMRI) to examine neural substrates of geometric reasoning during the engagement of a modified version of the RSPM test. Among the frontal and parietal brain regions involved in fluid intelligence, ASC showed larger activation in the left lateral occipitotemporal cortex (LOTC) during an analytic condition with moderate difficulty than NC. Activation in the left LOTC and ventrolateral prefrontal cortex (VLPFC) increased with task difficulty in NC, whereas such modulation of activity was absent in ASC. Furthermore, functional connectivity analysis revealed a significant reduction of activation coupling between the left inferior parietal cortex and the right anterior prefrontal cortex during both figural and analytic conditions in ASC. These results indicate altered pattern of functional specialization and integration in the neural system for geometric reasoning in ASC, which may explain its atypical cognitive pattern, including performance on the Raven's Matrices test.	[Yamada, Takashi; Ohta, Haruhisa; Watanabe, Hiromi; Kanai, Chieko; Tani, Masayuki; Ohno, Taisei; Takayama, Yuko; Iwanami, Akira; Kato, Nobumasa; Hashimoto, Ryuichiro] Showa Univ, Sch Med, Dept Psychiat, Tokyo 142, Japan; [Kanai, Chieko; Kato, Nobumasa; Hashimoto, Ryuichiro] Japan Sci & Technol Agcy, CREST, Tokyo, Japan	Showa University; Japan Science & Technology Agency (JST)	Yamada, T (corresponding author), Showa Univ, Sch Med, Dept Psychiat, Tokyo 142, Japan.	dbridges50@gmail.com		Hashimoto, Ryu-ichiro/0000-0002-9661-3412	CREST of Japanese Science and Technology (JST); Kakenhi	CREST of Japanese Science and Technology (JST); Kakenhi(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was supported by CREST of Japanese Science and Technology (JST) to NK and Grant-in-Aid for Research Activity Start-up (Kakenhi) to RH. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alexander AL, 2007, NEUROIMAGE, V34, P61, DOI 10.1016/j.neuroimage.2006.08.032; Anderson JS, 2011, CEREB CORTEX, V21, P1134, DOI 10.1093/cercor/bhq190; Barttfeld P, 2011, NEUROPSYCHOLOGIA, V49, P254, DOI 10.1016/j.neuropsychologia.2010.11.024; Bolte S, 2009, J AUTISM DEV DISORD, V39, P678, DOI 10.1007/s10803-008-0667-2; Bracci S, 2012, J NEUROPHYSIOL, V107, P1443, DOI 10.1152/jn.00619.2011; Casanova MF, 2009, PHILOS T R SOC B, V364, P1433, DOI 10.1098/rstb.2008.0331; Crone EA, 2006, P NATL ACAD SCI USA, V103, P9315, DOI 10.1073/pnas.0510088103; Crone EA, 2009, DEVELOPMENTAL SCI, V12, P55, DOI 10.1111/j.1467-7687.2008.00743.x; Dawson M, 2007, PSYCHOL SCI, V18, P657, DOI 10.1111/j.1467-9280.2007.01954.x; Desco M, 2011, NEUROIMAGE, V57, P281, DOI 10.1016/j.neuroimage.2011.03.063; Dosenbach NUF, 2010, SCIENCE, V329, P1358, DOI 10.1126/science.1194144; Fox MD, 2005, NEUROIMAGE, V25, P771, DOI 10.1016/j.neuroimage.2004.12.025; Geake JG, 2005, NEUROIMAGE, V26, P555, DOI 10.1016/j.neuroimage.2005.01.035; Geake JG, 2010, NEUROIMAGE, V49, P3489, DOI 10.1016/j.neuroimage.2009.09.008; Geschwind DH, 2007, CURR OPIN NEUROBIOL, V17, P103, DOI 10.1016/j.conb.2007.01.009; Gray JR, 2003, NAT NEUROSCI, V6, P316, DOI 10.1038/nn1014; Grill-Spector K, 2003, CURR OPIN NEUROBIOL, V13, P159, DOI 10.1016/S0959-4388(03)00040-0; Hampshire A, 2011, CEREB CORTEX, V21, P1, DOI 10.1093/cercor/bhq085; Hayashi M, 2008, BRAIN COGNITION, V66, P306, DOI 10.1016/j.bandc.2007.09.008; Johnson MR, 2006, BIOL PSYCHIAT, V60, P11, DOI 10.1016/j.biopsych.2005.11.012; Jung RE, 2007, BEHAV BRAIN SCI, V30, P135, DOI 10.1017/S0140525X07001185; Kanai C, 2012, RES AUTISM SPECT DIS, V6, P7; Keary CJ, 2009, J AUTISM DEV DISORD, V39, P834, DOI 10.1007/s10803-009-0689-4; Koch K, 2012, NEUROPSYCHOLOGIA, V50, P958, DOI 10.1016/j.neuropsychologia.2012.02.002; Konishi S, 2001, NEUROIMAGE, V13, P364, DOI 10.1006/nimg.2000.0691; Koshino H, 2005, NEUROIMAGE, V24, P810, DOI 10.1016/j.neuroimage.2004.09.028; Lynn R, 2004, WESCHLER ADULT INTEL, V32; Manoach DS, 2003, SCHIZOPHR RES, V60, P285, DOI 10.1016/S0920-9964(02)00294-3; Matsuoka K, 2006, PSYCHIAT CLIN NEUROS, V60, P332, DOI 10.1111/j.1440-1819.2006.01510.x; Mottron L, 2006, J AUTISM DEV DISORD, V36, P27, DOI 10.1007/s10803-005-0040-7; O'Riordan MA, 2001, J EXP PSYCHOL HUMAN, V27, P719, DOI 10.1037//0096-1523.27.3.719; OLDFIELD RC, 1971, NEUROPSYCHOLOGIA, V9, P97, DOI 10.1016/0028-3932(71)90067-4; Plaisted K, 1998, J CHILD PSYCHOL PSYC, V39, P777, DOI 10.1017/S0021963098002613; Prabhakaran V, 2000, NAT NEUROSCI, V3, P85, DOI 10.1038/71156; Prabhakaran V, 1997, COGNITIVE PSYCHOL, V33, P43, DOI 10.1006/cogp.1997.0659; Preusse F, 2011, FRONT HUM NEUROSCI, V5, DOI 10.3389/fnhum.2011.00022; Price CJ, 2006, J MAGN RESON IMAGING, V23, P816, DOI 10.1002/jmri.20580; Price CJ, 1999, HUM BRAIN MAPP, V8, P102, DOI 10.1002/(SICI)1097-0193(1999)8:2/3<102::AID-HBM6>3.0.CO;2-J; Ring HA, 1999, BRAIN, V122, P1305, DOI 10.1093/brain/122.7.1305; Sahyoun CP, 2010, NEUROPSYCHOLOGIA, V48, P86, DOI 10.1016/j.neuropsychologia.2009.08.013; SHAH A, 1983, J CHILD PSYCHOL PSYC, V24, P613, DOI 10.1111/j.1469-7610.1983.tb00137.x; SHAH A, 1993, J CHILD PSYCHOL PSYC, V34, P1351, DOI 10.1111/j.1469-7610.1993.tb02095.x; Soulieres I, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025372; Soulieres I, 2009, HUM BRAIN MAPP, V30, P4082, DOI 10.1002/hbm.20831; van der Ven AHGS, 2000, PERSONALITY INDIVIDU, V29; Vincent JL, 2006, J NEUROPHYSIOL, V96, P3517, DOI 10.1152/jn.00048.2006; Wakabayashi A, 2006, J AUTISM DEV DISORD, V36, P263, DOI 10.1007/s10803-005-0061-2	47	14	15	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 17	2012	7	8							e43220	10.1371/journal.pone.0043220	http://dx.doi.org/10.1371/journal.pone.0043220			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	996DG	22912831	Green Published, gold, Green Submitted			2022-12-25	WOS:000308063700063
J	Aragao, AZB; Belloni, M; Simabuco, FM; Zanetti, MR; Yokoo, S; Domingues, RR; Kawahara, R; Pauletti, BA; Goncalves, A; Agostini, M; Graner, E; Coletta, RD; Fox, JW; Leme, AFP				Aragao, Annelize Z. B.; Belloni, Marilia; Simabuco, Fernando M.; Zanetti, Mariana R.; Yokoo, Sami; Domingues, Romenia R.; Kawahara, Rebeca; Pauletti, Bianca A.; Goncalves, Anderson; Agostini, Michelle; Graner, Edgard; Coletta, Ricardo D.; Fox, Jay W.; Paes Leme, Adriana F.			Novel Processed Form of Syndecan-1 Shed from SCC-9 Cells Plays a Role in Cell Migration	PLOS ONE			English	Article							PROTEOMIC ANALYSIS; INTRACELLULAR DOMAIN; CLEAVAGE; EXPRESSION; REDUCTION; CARCINOMA; RELEASE	The extracellular milieu is comprised in part by products of cellular secretion and cell surface shedding. The presence of such molecules of the sheddome and secretome in the context of the extracellular milieu may have important clinical implications. In cancer they have been hypothesized to play a role in tumor growth and metastasis. The objective of this study was to evaluate whether the sheddome/secretome from two cell lines could be correlated with their potential for tumor development. Two epithelial cell lines, HaCaT and SCC-9, were chosen based on their differing abilities to form tumors in animal models of tumorigenesis. These cell lines when stimulated with phorbol-ester (PMA) showed different characteristics as assessed by cell migration, adhesion and higher gelatinase activity. Proteomic analysis of the media from these treated cells identified interesting, functionally relevant differences in their sheddome/secretome. Among the shed proteins, soluble syndecan-1 was found only in media from stimulated tumorigenic cells (SCC-9) and its fragments were observed in higher amount in the stimulated tumorigenic cells than stimulated non-tumorigenic cells (HaCaT). The increase in soluble syndecan-1 was associated with a decrease in membrane-bound syndecan-1 of SCC-9 cells after PMA stimuli. To support a functional role for soluble syndecan-1 fragments we demonstrated that the synthetic syndecan-1 peptide was able to induce cell migration in both cell lines. Taken together, these results suggested that PMA stimulation alters the sheddome/secretome of the tumorigenic cell line SCC-9 and one such component, the syndecan-1 peptide identified in this study, was revealed to promote migration in these epithelial cell lines.	[Aragao, Annelize Z. B.; Belloni, Marilia; Simabuco, Fernando M.; Zanetti, Mariana R.; Yokoo, Sami; Domingues, Romenia R.; Kawahara, Rebeca; Pauletti, Bianca A.; Goncalves, Anderson; Paes Leme, Adriana F.] Brazilian Biosci Natl Lab CNPEM, Mass Spectrometry Lab, Campinas, SP, Brazil; [Agostini, Michelle; Graner, Edgard; Coletta, Ricardo D.] Univ Estadual Campinas, Piracicaba Sch Dent, Piracicaba, Brazil; [Fox, Jay W.] Univ Virginia, Sch Med, Charlottesville, VA 22908 USA	Universidade Estadual de Campinas; University of Virginia	Aragao, AZB (corresponding author), Brazilian Biosci Natl Lab CNPEM, Mass Spectrometry Lab, Campinas, SP, Brazil.	adriana.paesleme@lnbio.org.br	Leme, Adriana F Paes/C-9679-2012; Simabuco, Fernando M/GQA-4176-2022; Simabuco, Fernando M/G-8421-2017; Graner, Edgard/K-4411-2012; Coletta, Ricardo D./B-4909-2015; Agostini, Michelle/AAD-6610-2022; Agostini, Michelle/I-1275-2012; Graner, Edgard/P-4651-2019; Aragão, Annelize Z B/I-6535-2012; Kawahara, Rebeca/B-1532-2015	Leme, Adriana F Paes/0000-0001-7959-147X; Simabuco, Fernando M/0000-0002-1672-9686; Simabuco, Fernando M/0000-0002-1672-9686; Graner, Edgard/0000-0002-4737-7935; Coletta, Ricardo D./0000-0001-5285-3046; Agostini, Michelle/0000-0002-3648-337X; Yokoo, Sami/0000-0003-4658-9319; Kawahara, Rebeca/0000-0002-0292-2637; Rodrigues Zanetti, Mariana/0000-0001-8335-1575	Conselho Nacional de Desenvolvimento Cientifico e Tecnologico [470567/2009-0]; Fundacao de Amparo a Pesquisa do Estado de Sao Paulo [2009/52833-0, 2009/18301-1, 2010/09642-7, 2010/19278-0]	Conselho Nacional de Desenvolvimento Cientifico e Tecnologico(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); Fundacao de Amparo a Pesquisa do Estado de Sao Paulo(Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP))	This study was supported by grants from Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (470567/2009-0) and grants and fellowships from Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (2009/52833-0; 2009/18301-1; 2010/09642-7; 2010/19278-0). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Beauvais DM, 2003, EXP CELL RES, V286, P219, DOI 10.1016/S0014-4827(03)00126-5; Berti DA, 2009, J BIOL CHEM, V284, P14105, DOI 10.1074/jbc.M807916200; BOUKAMP P, 1988, J CELL BIOL, V106, P761, DOI 10.1083/jcb.106.3.761; Brou C, 2000, MOL CELL, V5, P207, DOI 10.1016/S1097-2765(00)80417-7; Caescu CI, 2009, BIOCHEM J, V424, P79, DOI 10.1042/BJ20090549; Cauwe B, 2007, CRIT REV BIOCHEM MOL, V42, P113, DOI 10.1080/10409230701340019; Chen P, 2009, MMP7 SHEDDING SYNDEC; Demidova-Rice TN, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0032146; Doucet A, 2008, MOL CELL PROTEOMICS, V7, P1925, DOI 10.1074/mcp.R800012-MCP200; Eming SA, 2010, J PROTEOME RES, V9, P4758, DOI 10.1021/pr100456d; Endo K, 2003, J BIOL CHEM, V278, P40764, DOI 10.1074/jbc.M306736200; Escalante T, 2009, J PROTEOME RES, V8, P5120, DOI 10.1021/pr900489m; Faca VM, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002425; Hartmann D, 2002, HUM MOL GENET, V11, P2615, DOI 10.1093/hmg/11.21.2615; Heinz A, 2010, FEBS J, V277, P1939, DOI 10.1111/j.1742-4658.2010.07616.x; Humphries M J, 2001, Curr Protoc Cell Biol, VChapter 9, DOI 10.1002/0471143030.cb0901s00; Jacobs JM, 2008, J PROTEOME RES, V7, P558, DOI 10.1021/pr0704377; Jemal A, 2009, CA-CANCER J CLIN, V59, P225, DOI 10.3322/caac.20006; Karagiannis GS, 2010, MOL ONCOL, V4, P496, DOI 10.1016/j.molonc.2010.09.001; Kurokawa H, 2006, J ORAL PATHOL MED, V35, P301, DOI 10.1111/j.1600-0714.2006.00412.x; Liang CC, 2007, NAT PROTOC, V2, P329, DOI 10.1038/nprot.2007.30; Liu HB, 2004, ANAL CHEM, V76, P4193, DOI 10.1021/ac0498563; Manon-Jensen T, 2010, FEBS J, V277, P3876, DOI 10.1111/j.1742-4658.2010.07798.x; Marambaud P, 2002, EMBO J, V21, P1948, DOI 10.1093/emboj/21.8.1948; Martinez A, 2009, J ORAL PATHOL MED, V38, P580, DOI 10.1111/j.1600-0714.2009.00761.x; McQuade KJ, 2006, J CELL SCI, V119, P2445, DOI 10.1242/jcs.02970; Nikolova V, 2009, CARCINOGENESIS, V30, P397, DOI 10.1093/carcin/bgp001; Okamoto I, 2001, J CELL BIOL, V155, P755, DOI 10.1083/jcb.200108159; Leme AFP, 2012, J PROTEOME RES, V11, P279, DOI 10.1021/pr2006439; Leme AFP, 2009, PROTEOMICS, V9, P733, DOI 10.1002/pmic.200800484; Ramani VC, 2012, J BIOL CHEM, V287, P9952, DOI 10.1074/jbc.M111.330803; Ro Y, 2006, INT J ORAL MAX SURG, V35, P252, DOI 10.1016/j.ijom.2005.06.020; Villen J, 2008, NAT PROTOC, V3, P1630, DOI 10.1038/nprot.2008.150; Wu CC, 2010, MOL CELL PROTEOMICS, V9, P1100, DOI 10.1074/mcp.M900398-MCP200; Yang Y, 2002, BLOOD, V100, P610, DOI 10.1182/blood.V100.2.610; Yao L, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024684; Zong F, 2011, SPECIFIC SYNDECAN 1	37	38	39	1	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 15	2012	7	8							e43521	10.1371/journal.pone.0043521	http://dx.doi.org/10.1371/journal.pone.0043521			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	993AG	22905270	gold, Green Published, Green Submitted			2022-12-25	WOS:000307823600079
J	Boudou-Rouquette, P; Narjoz, C; Golmard, JL; Thomas-Schoemann, A; Mir, O; Taieb, F; Durand, JP; Coriat, R; Dauphin, A; Vidal, M; Tod, M; Loriot, MA; Goldwasser, F; Blanchet, B				Boudou-Rouquette, Pascaline; Narjoz, Celine; Golmard, Jean Louis; Thomas-Schoemann, Audrey; Mir, Olivier; Taieb, Fabrice; Durand, Jean-Philippe; Coriat, Romain; Dauphin, Alain; Vidal, Michel; Tod, Michel; Loriot, Marie-Anne; Goldwasser, Francois; Blanchet, Benoit			Early Sorafenib-Induced Toxicity Is Associated with Drug Exposure and UGTIA9 Genetic Polymorphism in Patients with Solid Tumors: A Preliminary Study	PLOS ONE			English	Article							CANCER RESISTANCE PROTEIN; BODY-COMPOSITION; PHARMACOKINETICS; ERLOTINIB; ABCG2; KINASE; IMPACT; QUANTIFICATION; METABOLITE; INHIBITOR	Background: Identifying predictive biomarkers of drug response is of key importance to improve therapy management and drug selection in cancer therapy. To date, the influence of drug exposure and pharmacogenetic variants on sorafenib-induced toxicity remains poorly documented. The aim of this pharmacokinetic/pharmacodynamic (PK/PD) study was to investigate the relationship between early toxicity and drug exposure or pharmacogenetic variants in unselected adult outpatients treated with single-agent sorafenib for advanced solid tumors. Methods: Toxicity was recorded in 54 patients on days 15 and 30 after treatment initiation and sorafenib exposure was assessed in 51 patients. The influence of polymorphisms in CYP3A5, UGT1A9, ABCB1 and ABCG2 was examined in relation to sorafenib exposure and toxicity. Clinical characteristics, drug exposure and pharmacogenetic variants were tested univariately for association with toxicities. Candidate variables with p<0.1 were analyzed in a multivariate analysis. Results: Gender was the sole parameter independently associated with sorafenib exposure (p = 0.0008). Multivariate analysis showed that increased cumulated sorafenib (AUC(cum)) was independently associated with any grade >= 3 toxicity (p = 0.037); UGT1A9 polymorphism (rs17868320) with grade >= 2 diarrhea (p = 0.015) and female gender with grade >= 2 hand-foot skin reaction (p = 0.018). Using ROC curve, the threshold AUCcum value of 3,161 mg/L. h was associated with the highest risk to develop any grade >= 3 toxicity (p = 0.018). Conclusion: In this preliminary study, increased cumulated drug exposure and UGT1A9 polymorphism (rs17868320) identified patients at high risk for early sorafenib-induced severe toxicity. Further PK/PD studies on larger population are warranted to confirm these preliminary results.	[Boudou-Rouquette, Pascaline; Thomas-Schoemann, Audrey; Mir, Olivier; Durand, Jean-Philippe; Coriat, Romain; Goldwasser, Francois; Blanchet, Benoit] Ctr Etud & Recours Inhibiteurs Angiogenese, Paris, France; [Boudou-Rouquette, Pascaline; Mir, Olivier; Durand, Jean-Philippe; Coriat, Romain; Goldwasser, Francois] Hop Cochin, AP HP, Unite Cancerol Med, F-75674 Paris, France; [Narjoz, Celine; Loriot, Marie-Anne] Hop Europeen Georges Pompidou, AP HP, Serv Biochim, Unite Fonct Pharmacogenet & Oncol Mol, Paris, France; [Narjoz, Celine; Loriot, Marie-Anne] Univ Paris 05, INSERM, UMR S 775, Paris, France; [Golmard, Jean Louis] Hop La Pitie Salpetriere, AP HP, Dept Biostat, Paris, France; [Thomas-Schoemann, Audrey; Taieb, Fabrice; Dauphin, Alain; Vidal, Michel; Blanchet, Benoit] Hop Cochin, AP HP, Unite Fonct Pharmacocinet & Pharmacochim, F-75674 Paris, France; [Thomas-Schoemann, Audrey; Vidal, Michel] Univ Paris 05, UFR Pharm, CNRS, UMR8638, Paris, France; [Tod, Michel] Hop Croix Rousse, Hosp Civils Lyon, F-69317 Lyon, France; [Tod, Michel] Univ Lyon, EMR3738, Lyon, France	Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Cochin - APHP; UDICE-French Research Universities; Universite Paris Cite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Europeen Georges-Pompidou - APHP; UDICE-French Research Universities; Universite Paris Cite; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Pitie-Salpetriere - APHP; UDICE-French Research Universities; Sorbonne Universite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Cochin - APHP; UDICE-French Research Universities; Universite Paris Cite; Centre National de la Recherche Scientifique (CNRS); CNRS - Institute of Chemistry (INC); UDICE-French Research Universities; Universite Paris Cite; CHU Lyon	Boudou-Rouquette, P (corresponding author), Ctr Etud & Recours Inhibiteurs Angiogenese, Paris, France.	benoit.blanchet@cch.aphp.fr	Goldwasser, François/P-4861-2017; Vidal, Michel/ABA-3396-2020; /ABG-4006-2020; Coriat, Romain/O-7902-2017; /AFP-4402-2022; Mir, Olivier/GNP-7828-2022	/0000-0002-4860-305X; /0000-0002-4860-305X; Mir, Olivier/0000-0002-6761-4002; Vidal, Michel/0000-0002-4858-1591; Loriot, Marie-Anne/0000-0001-9102-2667; NARJOZ, Celine/0000-0001-6959-3527				Agarwal S, 2011, J PHARMACOL EXP THER, V336, P223, DOI 10.1124/jpet.110.175034; Azad NS, 2009, CLIN CANCER RES, V15, P1411, DOI 10.1158/1078-0432.CCR-08-1141; Blanchet B, 2009, J PHARMACEUT BIOMED, V49, P1109, DOI 10.1016/j.jpba.2009.02.008; Blanchet B, 2010, EXPERT OPIN DRUG SAF, V9, P275, DOI 10.1517/14740330903510608; Cusatis G, 2006, J NATL CANCER I, V98, P1739, DOI 10.1093/jnci/djj469; Delbaldo C, 2006, CLIN CANCER RES, V12, P6073, DOI 10.1158/1078-0432.CCR-05-2596; Dranitsaris G, 2012, ANN ONCOLOGY; Garcia-Donas J, 2011, LANCET ONCOL, V12, P1143, DOI 10.1016/S1470-2045(11)70266-2; Gnoth MJ, 2010, DRUG METAB DISPOS, V38, P1341, DOI 10.1124/dmd.110.032052; Gomo C, 2011, INVEST NEW DRUG, V29, P1511, DOI 10.1007/s10637-010-9514-3; Hornecker M, 2011, INVEST NEW DRUGS; Houk BE, 2010, CANCER CHEMOTH PHARM, V66, P357, DOI 10.1007/s00280-009-1170-y; Iyer R, 2010, EXPERT OPIN PHARMACO, V11, P1943, DOI 10.1517/14656566.2010.496453; Jain L, 2011, BRIT J CLIN PHARMACO, V72, P294, DOI 10.1111/j.1365-2125.2011.03963.x; Janmahasatian S, 2005, CLIN PHARMACOKINET, V44, P1051, DOI 10.2165/00003088-200544100-00004; Kuypers DRJ, 2005, CLIN PHARMACOL THER, V78, P351, DOI 10.1016/j.clpt.2005.06.007; Lagas JS, 2010, MOL CANCER THER, V9, P319, DOI 10.1158/1535-7163.MCT-09-0663; Lemos C, 2011, PHARMACOGENOMICS, V12, P159, DOI [10.2217/pgs.10.172, 10.2217/PGS.10.172]; Levey AS, 2007, CLIN CHEM, V53, P766, DOI 10.1373/clinchem.2006.077180; Li J, 2007, CANCER BIOL THER, V6, P432, DOI 10.4161/cbt.6.3.3763; Lu JF, 2006, CLIN PHARMACOL THER, V80, P136, DOI 10.1016/j.clpt.2006.04.007; Mathijssen RHJ, 2009, CLIN PHARMACOL THER, V85, P23, DOI 10.1038/sj.clpt.6100511; Morimoto M, 2011, HEPATOL RES, V41, P296, DOI 10.1111/j.1872-034X.2011.00778.x; Mourtzakis M, 2008, APPL PHYSIOL NUTR ME, V33, P997, DOI 10.1139/H08-075; National Cancer Institute, 2009, COMM TERM CRIT ADV E; National Cancer Institute, 2006, COMM TERM CRIT ADV E; Porta C, 2007, CLIN EXP MED, V7, P127, DOI 10.1007/s10238-007-0145-8; Prado CMM, 2011, CANCER CHEMOTH PHARM, V67, P93, DOI 10.1007/s00280-010-1288-y; Rudin CM, 2008, J CLIN ONCOL, V26, P1119, DOI 10.1200/JCO.2007.13.1128; Strumberg D, 2005, J CLIN ONCOL, V23, P965, DOI 10.1200/JCO.2005.06.124; Strumberg D, 2007, ONCOLOGIST, V12, P426, DOI 10.1634/theoncologist.12-4-426; Thomas F, 2009, EUR J CANCER, V45, P2316, DOI 10.1016/j.ejca.2009.05.007; Tod M, 2011, PHARM RES-DORDR, V28, P3199, DOI 10.1007/s11095-011-0499-1; Treinen-Moslen M, 2006, PHARMACOL THERAPEUT, V112, P649, DOI 10.1016/j.pharmthera.2006.05.007; van Erp NP, 2009, CANCER TREAT REV, V35, P692, DOI 10.1016/j.ctrv.2009.08.004; van Erp NP, 2009, J CLIN ONCOL, V27, P4406, DOI 10.1200/JCO.2008.21.7679; Villeneuve L, 2003, J PHARMACOL EXP THER, V307, P117, DOI 10.1124/jpet.103.054072; White-Koning M, 2011, CLIN CANCER RES, V17, P4862, DOI 10.1158/1078-0432.CCR-10-3278; Wilhelm SM, 2008, MOL CANCER THER, V7, P3129, DOI 10.1158/1535-7163.MCT-08-0013	39	79	80	0	46	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 13	2012	7	8							e42875	10.1371/journal.pone.0042875	http://dx.doi.org/10.1371/journal.pone.0042875			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	988OJ	22912756	Green Published, Green Submitted, gold			2022-12-25	WOS:000307500100039
J	Zhang, LJ; Qi, RF; Zhong, JH; Xu, Q; Zheng, G; Lu, GM				Zhang, Long Jiang; Qi, Rongfeng; Zhong, Jianhui; Xu, Qiang; Zheng, Gang; Lu, Guang Ming			The Effect of Hepatic Encephalopathy, Hepatic Failure, and Portosystemic Shunt on Brain Volume of Cirrhotic Patients: A Voxel-Based Morphometry Study	PLOS ONE			English	Article							MAGNETIC-RESONANCE-SPECTROSCOPY; DEFAULT-MODE; ABNORMALITIES; IMPAIRMENT; MATTER	Purpose: To evaluate the effect of hepatic encephalopathy (HE), hepatic failure, and portosystemic shunt (PS) on the brain volume alteration in cirrhotic patients with MRI voxel-based morphometry (VBM). Methods: Sixty cirrhotic patients (overt HE [OHE], n = 11; minimal HE [MHE], n = 19; non HE [nHE], n = 30) including 12 with pre- and post-transjugular intrahepatic portosystemic shunt (TIPS) scanning and 40 healthy controls were recruited. Neuropsychological and laboratory tests were performed in all patients. VBM was analyzed with ANOVA test among 4 groups, and t-tests for patients with different hepatic function, PS scores, and TIPS. Multiple linear regression was performed to investigate the effect of venous blood ammonia levels, Child-Pugh scores, and PS on the brain volumes in all patients. Results: Cirrhotic patients exhibited decreased volume in many areas of gray matter (GM), increased volume in thalamus, and increased whiter matter (WM) volume, with the extent of affected brain volume greater in HE patients than nHE patients. Hepatic failure also resulted in decreased GM volume. Patients with high PS scores and TIPS displayed decreased GM and increased WM volume in some regions. Post-TIPS patients displayed increased GM volume in the thalamus. Multiple covariate regression results suggested that Child-Pugh score was a major factor to affect GM volume, while PS mainly affected WM volume. Conclusion: Brain structure abnormalities appeared bilaterally symmetrical in cirrhotic patients, and the impairment was more extensive in HE patients than those without HE. Increased thalamus volume was not associated with HE progression. Hepatic failure and PS altered cirrhotic patients' brain structure.	[Zhang, Long Jiang; Qi, Rongfeng; Zheng, Gang; Lu, Guang Ming] Nanjing Univ, Coll Med, Sch Clin, Dept Med Imaging,Jinling Hosp, Nanjing, Jiangsu, Peoples R China; [Zhong, Jianhui] Univ Rochester, Sch Med & Dent, Dept Imaging Sci, Rochester, NY USA; [Xu, Qiang] Univ Elect Sci & Technol China, Sch Life Sci & Technol, Minist Educ, Key Lab NeuroInformat, Chengdu 610054, Peoples R China	Nanjing University; University of Rochester; University of Electronic Science & Technology of China	Zhang, LJ (corresponding author), Nanjing Univ, Coll Med, Sch Clin, Dept Med Imaging,Jinling Hosp, Nanjing, Jiangsu, Peoples R China.	kevinzhanglongjiang@yahoo.com.cn; cjr.luguangming@vip.163.com	Zhong, Jianhui/AAE-6061-2020	Xu, Qiang/0000-0002-7739-7515	Natural Scientific Foundation of China [30700194, 81101039]; Natural Scientific Foundation of Jiangsu province, China [BK2007572]; China Postdoctoral Science Foundation of Jiangsu Province [100283C]	Natural Scientific Foundation of China(National Natural Science Foundation of China (NSFC)); Natural Scientific Foundation of Jiangsu province, China; China Postdoctoral Science Foundation of Jiangsu Province(China Postdoctoral Science Foundation)	This work was supported by the grants from the Natural Scientific Foundation of China [Grant No. 30700194 for Long Jiang Zhang; Grant No. 81101039 fro Gang Zheng], the Natural Scientific Foundation of Jiangsu province, China [Grant No. BK2007572 for Long Jiang Zhang], and China Postdoctoral Science Foundation of Jiangsu Province (Grant No. 100283C for Gang Zheng). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Brancatelli G, 2001, RADIOLOGY, V220, P321, DOI 10.1148/radiology.220.2.r01au23321; Bryce TJ, 2003, AM J ROENTGENOL, V181, P1629, DOI 10.2214/ajr.181.6.1811629; Butterworth RF, 2011, HEPATOLOGY, V53, P1372, DOI 10.1002/hep.24228; Chen HJ, 2011, EUR J RADIOL; Cordoba J, 2011, J HEPATOL, V54, P1030, DOI 10.1016/j.jhep.2010.11.015; DeLong M, 2009, PARKINSONISM RELAT D, V15, pS237, DOI 10.1016/S1353-8020(09)70822-3; Ferenci P, 2002, HEPATOLOGY, V35, P716, DOI 10.1053/jhep.2002.31250; Fox MD, 2005, P NATL ACAD SCI USA, V102, P9673, DOI 10.1073/pnas.0504136102; Greicius MD, 2004, P NATL ACAD SCI USA, V101, P4637, DOI 10.1073/pnas.0308627101; Guevara M, 2011, J HEPATOL, V55, P564, DOI 10.1016/j.jhep.2010.12.008; Gupta RK, 2010, METAB BRAIN DIS, V25, P355, DOI 10.1007/s11011-010-9206-x; Hsu TW, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0035266; Kerns JG, 2004, SCIENCE, V303, P1023, DOI 10.1126/science.1089910; Krieger S, 1997, J HEPATOL, V27, P121, DOI 10.1016/S0168-8278(97)80290-5; Mantini D, 2007, P NATL ACAD SCI USA, V104, P13170, DOI 10.1073/pnas.0700668104; Matsusue E, 2005, AM J NEURORADIOL, V26, P347; Mechtcheriakov S, 2005, NEURORADIOLOGY, V47, P27, DOI 10.1007/s00234-004-1298-8; PUGH RNH, 1973, BRIT J SURG, V60, P646, DOI 10.1002/bjs.1800600817; Raichle ME, 2001, P NATL ACAD SCI USA, V98, P676, DOI 10.1073/pnas.98.2.676; Rodrigo R, 2010, GASTROENTEROLOGY, V139, P675, DOI 10.1053/j.gastro.2010.03.040; ROSS BD, 1994, RADIOLOGY, V193, P457, DOI 10.1148/radiology.193.2.7972763; Rovira A, 2008, AM J NEURORADIOL, V29, P1612, DOI 10.3174/ajnr.A1139; TARTER RE, 1986, LANCET, V2, P893; Weissenborn K, 2007, GUT, V56, P1736, DOI 10.1136/gut.2006.110569; Wu XJ, 2010, J HEPATO-BIL-PAN SCI, V17, P701, DOI 10.1007/s00534-010-0270-8; Yoshikawa T, 2011, MAGN RESON MED SCI, V10, P21, DOI 10.2463/mrms.10.21; ZENEROLI ML, 1987, J HEPATOL, V4, P283, DOI 10.1016/S0168-8278(87)80536-6; Zhang LJ, 2007, ACTA RADIOL, V48, P781, DOI 10.1080/02841850701422161; Zhang LJ, 2007, ACTA RADIOL, V48, P577, DOI 10.1080/02841850701308378; Zhang LJ, 2010, HEPATOL RES, V40, P777, DOI 10.1111/j.1872-034X.2010.00681.x; Zhang LJ, 2012, HUM BRAIN MAPP, V33, P1384, DOI 10.1002/hbm.21295	31	31	35	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 13	2012	7	8							e42824	10.1371/journal.pone.0042824	http://dx.doi.org/10.1371/journal.pone.0042824			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	988OJ	22912746	Green Published, Green Submitted, gold			2022-12-25	WOS:000307500100036
J	Tran, PT; Sharifi, MN; Poddar, S; Dent, RM; Niyogi, KK				Tran, Phoi T.; Sharifi, Marina N.; Poddar, Subhajit; Dent, Rachel M.; Niyogi, Krishna K.			Intragenic Enhancers and Suppressors of Phytoene Desaturase Mutations in Chlamydomonas reinhardtii	PLOS ONE			English	Article							SYNTHASE GENE FAMILY; CAROTENOID BIOSYNTHESIS; ZETA-CAROTENE; HAEMATOCOCCUS-PLUVIALIS; ARABIDOPSIS-THALIANA; FUNCTIONAL-ANALYSIS; TERMINAL OXIDASE; CAPSICUM-ANNUUM; BINDING SITES; ABSCISIC-ACID	Photosynthetic organisms synthesize carotenoids for harvesting light energy, photoprotection, and maintaining the structure and function of photosynthetic membranes. A light-sensitive, phytoene-accumulating mutant, pds1-1, was isolated in Chlamydomonas reinhardtii and found to be genetically linked to the phytoene desaturase (PDS) gene. PDS catalyzes the second step in carotenoid biosynthesis-the conversion of phytoene to zeta-carotene. Decreased accumulation of downstream colored carotenoids suggested that the pds1-1 mutant is leaky for PDS activity. A screen for enhancers of the pds1-1 mutation yielded the pds1-2 allele, which completely lacks PDS activity. A second independent null mutant (pds1-3) was identified using DNA insertional mutagenesis. Both null mutants accumulate only phytoene and no other carotenoids. All three phytoene-accumulating mutants exhibited slower growth rates and reduced plating efficiency compared to wildtype cells and white phytoene synthase mutants. Insight into amino acid residues important for PDS activity was obtained through the characterization of intragenic suppressors of pds1-2. The suppressor mutants fell into three classes: revertants of the pds1-1 point mutation, mutations that changed PDS amino acid residue Pro64 to Phe, and mutations that converted PDS residue Lys90 to Met. Characterization of pds1-2 intragenic suppressors coupled with computational structure prediction of PDS suggest that amino acids at positions 90 and 143 are in close contact in the active PDS enzyme and have important roles in its structural stability and/or activity.	[Tran, Phoi T.; Sharifi, Marina N.; Poddar, Subhajit; Dent, Rachel M.; Niyogi, Krishna K.] Univ Calif Berkeley, Dept Plant & Microbial Biol, Howard Hughes Med Inst, Phys Biosci Div,Lawrence Berkeley Natl Lab, Berkeley, CA 94720 USA	Howard Hughes Medical Institute; United States Department of Energy (DOE); Lawrence Berkeley National Laboratory; University of California System; University of California Berkeley	Tran, PT (corresponding author), Univ Calif Berkeley, Dept Plant & Microbial Biol, Howard Hughes Med Inst, Phys Biosci Div,Lawrence Berkeley Natl Lab, Berkeley, CA 94720 USA.	niyogi@berkeley.edu	Tran, Phoi/G-4594-2013	Poddar, Subhajit/0000-0002-9764-3242; Sharifi, Marina/0000-0003-0128-3033	National Institute of General Medical Sciences [R01GM058799]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM058799] Funding Source: NIH RePORTER	National Institute of General Medical Sciences(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by award number R01GM058799 from the National Institute of General Medical Sciences (to KKN). The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institute of General Medical Sciences or the National Institutes of Health. The funder had no role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AlBabili S, 1996, PLANT J, V9, P601, DOI 10.1046/j.1365-313X.1996.9050601.x; Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389; Aluru MR, 2009, PLANT PHYSIOL, V150, P904, DOI 10.1104/pp.109.135780; ARMSTRONG GA, 1989, MOL GEN GENET, V216, P254, DOI 10.1007/BF00334364; Baroli I, 2003, PLANT CELL, V15, P992, DOI 10.1105/tpc.010405; BASSI R, 1993, EUR J BIOCHEM, V212, P297, DOI 10.1111/j.1432-1033.1993.tb17662.x; Bohne F, 2002, BBA-GENE STRUCT EXPR, V1579, P26, DOI 10.1016/S0167-4781(02)00500-6; Breitenbach J, 2001, J AGR FOOD CHEM, V49, P5270, DOI 10.1021/jf0106751; Busch M, 2002, PLANT PHYSIOL, V128, P439, DOI [10.1104/pp.128.2.439, 10.1104/pp.010573]; Calucci L, 2004, J AGR FOOD CHEM, V52, P4274, DOI 10.1021/jf0353741; Campisi L, 2006, PLANT GROWTH REGUL, V48, P79, DOI 10.1007/s10725-005-4831-9; Carol P, 1999, PLANT CELL, V11, P57, DOI 10.1105/tpc.11.1.57; Carol P, 2001, TRENDS PLANT SCI, V6, P31, DOI 10.1016/S1360-1385(00)01811-2; CHAMOVITZ D, 1993, J BIOL CHEM, V268, P17348; Conti A, 2004, PLANT CELL PHYSIOL, V45, P445, DOI 10.1093/pcp/pch052; Croce R, 1999, J BIOL CHEM, V274, P29613, DOI 10.1074/jbc.274.42.29613; Cunningham FX, 1998, ANNU REV PLANT PHYS, V49, P557, DOI 10.1146/annurev.arplant.49.1.557; DAVIES JP, 1992, NUCLEIC ACIDS RES, V20, P2959, DOI 10.1093/nar/20.12.2959; DEMMIGADAMS B, 1992, ANNU REV PLANT PHYS, V43, P599, DOI 10.1146/annurev.pp.43.060192.003123; Dent RM, 2005, PLANT PHYSIOL, V137, P545, DOI 10.1104/pp.104.055244; Diretto G, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000350; Emanuelsson O, 1999, PROTEIN SCI, V8, P978, DOI 10.1110/ps.8.5.978; Fang J, 2008, PLANT J, V54, P177, DOI 10.1111/j.1365-313X.2008.03411.x; Farre G, 2010, PLANT SCI, V179, P28, DOI 10.1016/j.plantsci.2010.03.009; Frank HA, 1996, PHOTOCHEM PHOTOBIOL, V63, P257, DOI 10.1111/j.1751-1097.1996.tb03022.x; FRASER PD, 1993, BIOCHEM J, V291, P687, DOI 10.1042/bj2910687; Fraser PD, 2004, PROG LIPID RES, V43, P228, DOI 10.1016/j.plipres.2003.10.002; Giovannucci E, 1999, JNCI-J NATL CANCER I, V91, P317, DOI 10.1093/jnci/91.4.317; GIULIANO G, 1993, PLANT CELL, V5, P379, DOI 10.1105/tpc.5.4.379; Gonzalez-Ballester D, 2005, ANAL BIOCHEM, V340, P330, DOI 10.1016/j.ab.2005.01.031; GROSS CH, 1988, CURR GENET, V13, P503, DOI 10.1007/BF02427756; Grunewald K, 2000, PLANT PHYSIOL, V122, P1261, DOI 10.1104/pp.122.4.1261; Hable WE, 1998, MOL GEN GENET, V257, P167; Harris E. H., 1989, CHLAMYDOMONAS SOURCE; Havaux M, 1998, TRENDS PLANT SCI, V3, P147, DOI 10.1016/S1360-1385(98)01200-X; HERRIN DL, 1992, J BIOL CHEM, V267, P8260; Holt NE, 2005, SCIENCE, V307, P433, DOI 10.1126/science.1105833; Howitt CA, 2006, PLANT CELL ENVIRON, V29, P435, DOI 10.1111/j.1365-3040.2005.01492.x; Li FQ, 2008, PLANT PHYSIOL, V147, P1334, DOI 10.1104/pp.108.122119; Li FQ, 2008, PLANT PHYSIOL, V146, P1333, DOI 10.1104/pp.107.111120; Li FQ, 2009, PLANT SIGNAL BEHAV, V4, P208, DOI 10.4161/psb.4.3.7798; LINDEN H, 1993, PHYSIOL PLANTARUM, V88, P229, DOI 10.1111/j.1399-3054.1993.tb05493.x; Maluf MP, 1997, J EXP BOT, V48, P1259, DOI 10.1093/jxb/48.6.1259; MAYER MP, 1989, PESTIC BIOCHEM PHYS, V34, P111, DOI 10.1016/0048-3575(89)90148-X; McCarthy SS, 2004, GENETICS, V168, P1249, DOI 10.1534/genetics.104.030635; Merchant SS, 2007, SCIENCE, V318, P245, DOI 10.1126/science.1143609; Miki D, 2004, PLANT CELL PHYSIOL, V45, P490, DOI 10.1093/pcp/pch048; Niyogi KK, 1997, P NATL ACAD SCI USA, V94, P14162, DOI 10.1073/pnas.94.25.14162; Niyogi KK, 1999, ANNU REV PLANT PHYS, V50, P333, DOI 10.1146/annurev.arplant.50.1.333; Norris SR, 1995, PLANT CELL, V7, P2139, DOI 10.1105/tpc.7.12.2139; Page JE, 2004, PLANT PHYSIOL, V134, P1401, DOI 10.1104/pp.103.038133; PECKER I, 1992, P NATL ACAD SCI USA, V89, P4962, DOI 10.1073/pnas.89.11.4962; Pruitt KD, 2007, NUCLEIC ACIDS RES, V35, pD61, DOI 10.1093/nar/gkl842; Qin GJ, 2007, CELL RES, V17, P471, DOI 10.1038/cr.2007.40; ROCK CD, 1991, P NATL ACAD SCI USA, V88, P7496, DOI 10.1073/pnas.88.17.7496; Rozen S, 2000, Methods Mol Biol, V132, P365; Schafer L, 2006, PLANT CELL ENVIRON, V29, P1349, DOI 10.1111/j.1365-3040.2006.01515.x; Schwartz SH, 1997, SCIENCE, V276, P1872, DOI 10.1126/science.276.5320.1872; Simkin AJ, 2003, J PLANT PHYSIOL, V160, P439, DOI 10.1078/0176-1617-00871; Simkin AJ, 2000, J AGR FOOD CHEM, V48, P4676, DOI 10.1021/jf0006426; Steinbrenner J, 2006, APPL ENVIRON MICROB, V72, P7477, DOI 10.1128/AEM.01461-06; Stolbova A. V., 1999, Genetika, V35, P111; TAYLOR HF, 1967, NATURE, V215, P1513, DOI 10.1038/2151513a0; THOMPSON JD, 1994, NUCLEIC ACIDS RES, V22, P4673, DOI 10.1093/nar/22.22.4673; Vila M, 2008, PROCESS BIOCHEM, V43, P1147, DOI 10.1016/j.procbio.2008.06.014; vonLintig J, 1997, PLANT J, V12, P625, DOI 10.1046/j.1365-313X.1997.00625.x; Wang T, 2005, NEW PHYTOL, V167, P751, DOI 10.1111/j.1469-8137.2005.01454.x; Wass MN, 2009, PROTEINS, V77, P147, DOI 10.1002/prot.22513; Welsch R, 2000, PLANTA, V211, P846, DOI 10.1007/s004250000352; Werner R, 1998, PLANT MOL BIOL REP, V16, P295, DOI 10.1023/A:1007583508766; Wetzel CM, 1998, PLANT MOL BIOL, V37, P1045, DOI 10.1023/A:1006021522259; Wurtzel ET, 2001, J EXP BOT, V52, P161, DOI 10.1093/jexbot/52.354.161; Yamamoto H.Y., 2004, OXYGENIC PHOTOSYNTHE, P539	73	21	21	0	22	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 10	2012	7	8							e42196	10.1371/journal.pone.0042196	http://dx.doi.org/10.1371/journal.pone.0042196			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	986XO	22912689	Green Submitted, gold, Green Published			2022-12-25	WOS:000307380900024
J	ten Berge, HFM; van der Meer, HG; Steenhuizen, JW; Goedhart, PW; Knops, P; Verhagen, J				ten Berge, Hein F. M.; van der Meer, Hugo G.; Steenhuizen, Johan W.; Goedhart, Paul W.; Knops, Pol; Verhagen, Jan			Olivine Weathering in Soil, and Its Effects on Growth and Nutrient Uptake in Ryegrass (Lolium perenne L.): A Pot Experiment	PLOS ONE			English	Article							PLANT; BIOAVAILABILITY; PHYTOTOXICITY; SERPENTINE; NICKEL; SEQUESTRATION; ROCK; TOOL; CO2; NI	Mineral carbonation of basic silicate minerals regulates atmospheric CO2 on geological time scales by locking up carbon. Mining and spreading onto the earth's surface of fast-weathering silicates, such as olivine, has been proposed to speed up this natural CO2 sequestration ('enhanced weathering'). While agriculture may offer an existing infrastructure, weathering rate and impacts on soil and plant are largely unknown. Our objectives were to assess weathering of olivine in soil, and its effects on plant growth and nutrient uptake. In a pot experiment with perennial ryegrass (Lolium perenne L.), weathering during 32 weeks was inferred from bioavailability of magnesium (Mg) in soil and plant. Olivine doses were equivalent to 1630 (OLIV1), 8150, 40700 and 204000 (OLIV4) kg ha(-1). Alternatively, the soluble Mg salt kieserite was applied for reference. Olivine increased plant growth (+ 15.6%) and plant K concentration (+ 16.5%) in OLIV4. At all doses, olivine increased bioavailability of Mg and Ni in soil, as well as uptake of Mg, Si and Ni in plants. Olivine suppressed Ca uptake. Weathering estimated from a Mg balance was equivalent to 240 kg ha(-1) (14.8% of dose, OLIV1) to 2240 kg ha(-1) (1.1%, OLIV4). This corresponds to gross CO2 sequestration of 290 to 2690 kg ha(-1) (29 10(3) to 269 10(3) kg km(-2).) Alternatively, weathering estimated from similarity with kieserite treatments ranged from 13% to 58% for OLIV1. The Olsen model for olivine carbonation predicted 4.0% to 9.0% weathering for our case, independent of olivine dose. Our % values observed at high doses were smaller than this, suggesting negative feedbacks in soil. Yet, weathering appears fast enough to support the 'enhanced weathering' concept. In agriculture, olivine doses must remain within limits to avoid imbalances in plant nutrition, notably at low Ca availability; and to avoid Ni accumulation in soil and crop.	[ten Berge, Hein F. M.; van der Meer, Hugo G.; Steenhuizen, Johan W.; Verhagen, Jan] WUR Plant Res Int, Wageningen, Netherlands; [Goedhart, Paul W.] WUR Biometris, Wageningen, Netherlands; [Knops, Pol] Innovat Concepts BV, Gorinchem, Netherlands		ten Berge, HFM (corresponding author), WUR Plant Res Int, Wageningen, Netherlands.	hein.tenberge@wur.nl	Goedhart, Paul/F-7836-2013	Goedhart, Paul/0000-0002-9586-9862; Verhagen, Jan/0000-0001-8408-0543	Strategic Knowledge Development Programme of Wageningen UR on Climate Change (Netherlands Ministry of Economic Affairs, Agriculture and Innovation); OCI Nitrogen	Strategic Knowledge Development Programme of Wageningen UR on Climate Change (Netherlands Ministry of Economic Affairs, Agriculture and Innovation); OCI Nitrogen	This study was financed by the Strategic Knowledge Development Programme of Wageningen UR on Climate Change (Netherlands Ministry of Economic Affairs, Agriculture and Innovation); and by OCI Nitrogen (www.ocinitrogen.com). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2001, TRACE METALS SOILS P; Asemaneh T, 2007, PLANT SOIL, V293, P49, DOI 10.1007/s11104-006-9147-7; Bearat H, 2006, ENVIRON SCI TECHNOL, V40, P4802, DOI 10.1021/es0523340; CIPEC, 2005, BENCHM EN CONS CAN O, P56; Cochran W.G., 1967, STAT METHODS; Dahlin D. C., 2005, DOEARCTR04002; Dessert C, 2001, EARTH PLANET SC LETT, V188, P459, DOI 10.1016/S0012-821X(01)00317-X; DIJKSHOORN W, 1979, NETH J AGR SCI, V27, P241; DUNSMORE HE, 1992, ENERG CONVERS MANAGE, V33, P565, DOI 10.1016/0196-8904(92)90057-4; Fernandez S, 1999, COMMUN SOIL SCI PLAN, V30, P1867, DOI 10.1080/00103629909370338; Gregg SJ, 1982, ADSORPTION SURFACE A; Hangx SJT, 2009, INT J GREENH GAS CON, V3, P757, DOI 10.1016/j.ijggc.2009.07.001; Hartmann J, 2008, NATURWISSENSCHAFTEN, V95, P1159, DOI 10.1007/s00114-008-0434-4; Hartmann J, 2009, CHEM GEOL, V265, P237, DOI 10.1016/j.chemgeo.2009.03.024; Kohler P, 2010, P NATL ACAD SCI USA, V107, P20228, DOI 10.1073/pnas.1000545107; Kwon S, 2011, J ENVIRON SCI-CHINA, V23, P1233, DOI 10.1016/S1001-0742(10)60555-4; Lal R, 2008, PHILOS T R SOC B, V363, P815, DOI 10.1098/rstb.2007.2185; LASAGA AC, 1998, PR S GEOCH, P3; Lazarus BE, 2011, PLANT SOIL, V342, P327, DOI 10.1007/s11104-010-0698-2; Le Quere C, 2009, NAT GEOSCI, V2, P831, DOI 10.1038/ngeo689; MACINTIRE WH, 1959, J AGR FOOD CHEM, V7, P566, DOI 10.1021/jf60102a007; Miranda M, 2009, J TRACE ELEM MED BIO, V23, P231, DOI 10.1016/j.jtemb.2009.03.004; Mora A, 2010, GEOCHEM GEOPHY GEOSY, V11, DOI 10.1029/2010GC003209; Nagy L, 1997, NEW PHYTOL, V137, P267, DOI 10.1046/j.1469-8137.1997.00799.x; Neel C, 2007, APPL GEOCHEM, V22, P724, DOI 10.1016/j.apgeochem.2006.11.008; Olsen AA, 2007, THESIS VIRGINIA POLY; Olsen AA, 2007, AM MINERAL, V92, P598, DOI 10.2138/am.2007.2462; Rooney CP, 2007, ENVIRON POLLUT, V145, P596, DOI 10.1016/j.envpol.2006.04.008; Samecka-Cymerman A, 2009, ENVIRON GEOL, V58, P509, DOI 10.1007/s00254-008-1524-5; Schuiling RD, 2006, CLIMATIC CHANGE, V74, P349, DOI 10.1007/s10584-005-3485-y; Smith P, 2008, PHILOS T R SOC B, V363, P789, DOI 10.1098/rstb.2007.2184; Smolders E, 2009, ENVIRON TOXICOL CHEM, V28, P1633, DOI 10.1897/08-592.1; Suchet PA, 2003, GLOBAL BIOGEOCHEM CY, V17, DOI 10.1029/2002GB001891; TNO, 2008, TNO U R 0776 B DESK; UNFCCC, 1992, FCCCINFORMAL84 UNFCC; Weng LP, 2004, ENVIRON SCI TECHNOL, V38, P156, DOI 10.1021/es030053r; Wilson SA, 2009, ECON GEOL, V104, P95, DOI 10.2113/gsecongeo.104.1.95	37	41	41	14	98	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 9	2012	7	8							e42098	10.1371/journal.pone.0042098	http://dx.doi.org/10.1371/journal.pone.0042098			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	986WZ	22912685	Green Submitted, gold, Green Published			2022-12-25	WOS:000307378500011
J	Cai, BH; Hsu, PC; Hsin, IL; Chao, CF; Lu, MH; Lin, HC; Chiou, SH; Tao, PL; Chen, JY				Cai, Bi-He; Hsu, Pei-Ching; Hsin, I-Lun; Chao, Chung-Faye; Lu, Mei-Hua; Lin, Hwang-Chi; Chiou, Shih-Hwa; Tao, Pao-Luh; Chen, Jang-Yi			p53 Acts as a Co-Repressor to Regulate Keratin 14 Expression during Epidermal Cell Differentiation	PLOS ONE			English	Article							TUMOR-SUPPRESSOR P53; TRANSCRIPTIONAL REPRESSION; DNA-BINDING; KERATINOCYTE DIFFERENTIATION; SP1-DEPENDENT REPRESSOR; NEGATIVE REGULATION; PIFITHRIN-ALPHA; GENE-EXPRESSION; MUTANT P53; IN-VIVO	During epidermal cell differentiation, keratin 14 (K14) expression is down-regulated, p53 expression varies, and the expression of the p53 target genes, p21 and 14-3-3s, increases. These trends suggest that the relative transcriptional activity of p53 is increased during epidermal cell differentiation. To determine the relationship between K14 and p53, we constructed K14 promoters of various sizes and found that wild-type p53 could repress the promoter activity of all of the K14 promoter constructs in H1299 cells. K14-p160 contains an SP1 binding site mutation that prevents p53 from repressing K14 expression. Using a DNA affinity precipitation assay, we confirmed that p53 forms a complex with SP1 at the SP1 binding site between nucleotides -48 and -43 on the K14 promoter. Thus, our data indicate that p53 acts as a co-repressor to down-regulate K14 expression by binding to SP1. Next, we used a 12-O-tetradecanoylphorbol-13-acetate (TPA)-induced epidermal cell differentiation model to examine the inhibition of K14 expression caused by increased p53 activity. Human ovarian teratocarcinoma C9 cells were treated with TPA to induce differentiation. Over-expression of the dominant negative p53 mutant Delta TAp53, which inhibits p53 activity, prevented the TPA-induced K14 down-regulation in C9 cells. Furthermore, treatment of normal primary human foreskin keratinocytes (PHFK) with the p53 inhibitor pifithrin-alpha (PFT-alpha) showed that the inhibition of p53 activity relieves K14 repression during epidermal cell differentiation. Finally, we found that TPA induces the phosphorylation of p53 at residue 378, which enhances the affinity of p53 to bind to Sp1 and repress K14 expression.	[Cai, Bi-He; Hsu, Pei-Ching; Hsin, I-Lun; Chao, Chung-Faye; Lu, Mei-Hua; Chen, Jang-Yi] Natl Def Med Ctr, Dept Biol & Anat, Taipei, Taiwan; [Lin, Hwang-Chi] Shin Kong Wu Ho Su Mem Hosp, Div Plast Surg, Taipei, Taiwan; [Cai, Bi-He; Chiou, Shih-Hwa] Taipei Vet Gen Hosp, Dept Med Res & Educ, Taipei, Taiwan; [Tao, Pao-Luh] Natl Hlth Res Inst, Inst Populat Hlth Sci, Div Mental Hlth & Addict Med, Miaoli, Taiwan; [Cai, Bi-He; Hsu, Pei-Ching] Acad Sinica, Inst Biomed Sci, Taipei, Taiwan; [Hsin, I-Lun] Chung Shan Med Univ, Inst Med & Mol Toxicol, Taichung, Taiwan	National Defense Medical Center; Shin Kong Wu Ho Su Memorial Hospital; Taipei Veterans General Hospital; National Health Research Institutes - Taiwan; Academia Sinica - Taiwan; Chung Shan Medical University	Cai, BH (corresponding author), Natl Def Med Ctr, Dept Biol & Anat, Taipei, Taiwan.	jychen01@ndmctsgh.edu.tw	Cai, Bi-He/AAB-2965-2020; Cai, Bi-He/V-5756-2019; Tao, Pao-Luh/F-6085-2010	Cai, Bi-He/0000-0003-4226-6096; Hsin, I-Lun/0000-0003-4711-3582	Shin Kong Wu Ho-Su Memorial Hospital [SKH-8302-97-DR-11]; National Science Council, Republic of China [NSC97-2320-B-016-005 -MY3]	Shin Kong Wu Ho-Su Memorial Hospital; National Science Council, Republic of China(Ministry of Science and Technology, Taiwan)	This work was supported by the Shin Kong Wu Ho-Su Memorial Hospital [SKH-8302-97-DR-11 to CFC and HCL] and the National Science Council, Republic of China [NSC97-2320-B-016-005 -MY3 to PLT]. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AGOFF SN, 1993, SCIENCE, V259, P84, DOI 10.1126/science.8418500; Banerjee T, 2009, NUCLEIC ACIDS RES, V37, P2688, DOI 10.1093/nar/gkp110; Baran W, 2005, ACTA DERMATOVEN ALP, V14, P79; Beitzinger M, 2006, ONCOGENE, V25, P813, DOI 10.1038/sj.onc.1209125; BERNERD F, 1992, J INVEST DERMATOL, V98, P902, DOI 10.1111/1523-1747.ep12460344; BOEHNCKE WH, 1994, ARCH DERMATOL RES, V287, P68, DOI 10.1007/BF00370721; Cai BH, 2012, J BIOCHEM, V152, P99, DOI 10.1093/jb/mvs053; Cai BH, 2009, NUCLEIC ACIDS RES, V37, P1984, DOI 10.1093/nar/gkp033; Candi E, 2006, CELL DEATH DIFFER, V13, P1037, DOI 10.1038/sj.cdd.4401926; Chan WM, 2004, MOL CELL BIOL, V24, P3536, DOI 10.1128/MCB.24.8.3536-3551.2004; Chua CC, 2006, AM J PHYSIOL-HEART C, V290, pH2606, DOI 10.1152/ajpheart.01138.2005; Codelia VA, 2010, MOL HUM REPROD, V16, P734, DOI 10.1093/molehr/gaq045; Eckert RL, 1997, PHYSIOL REV, V77, P397, DOI 10.1152/physrev.1997.77.2.397; ELDEIRY WS, 1993, CELL, V75, P817, DOI 10.1016/0092-8674(93)90500-P; Farmer G, 1996, NUCLEIC ACIDS RES, V24, P4281, DOI 10.1093/nar/24.21.4281; Harmes DC, 2003, ONCOGENE, V22, P7607, DOI 10.1038/sj.onc.1207129; Hermeking H, 1997, MOL CELL, V1, P3, DOI 10.1016/S1097-2765(00)80002-7; HERSKOWITZ I, 1987, NATURE, V329, P219, DOI 10.1038/329219a0; Ho J, 2003, CELL DEATH DIFFER, V10, P404, DOI 10.1038/sj.cdd.4401191; Ichikawa T, 2008, ONCOGENE, V27, P409, DOI 10.1038/sj.onc.1210658; Imbriano C, 2005, MOL CELL BIOL, V25, P3737, DOI 10.1128/MCB.25.9.3737-3751.2005; Innocente SA, 2005, FEBS LETT, V579, P1001, DOI 10.1016/j.febslet.2004.12.073; Innocente SA, 2005, BIOCHEM BIOPH RES CO, V329, P713, DOI 10.1016/j.bbrc.2005.02.028; JAKEN S, 1988, CARCINOGENESIS, V9, P1033, DOI 10.1093/carcin/9.6.1033; Komarov PG, 1999, SCIENCE, V285, P1733, DOI 10.1126/science.285.5434.1733; Koster MI, 2004, GENE DEV, V18, P126, DOI 10.1101/gad.1165104; Koster MI, 2006, DEV BIOL, V289, P253, DOI 10.1016/j.ydbio.2005.10.041; Koutsodontis G, 2005, BIOCHEM J, V389, P443, DOI 10.1042/BJ20041980; Lee KC, 1999, MOL CELL BIOL, V19, P1279; Li BQ, 2001, J BIOL CHEM, V276, P29729, DOI 10.1074/jbc.M101167200; Lin HC, 2008, PIGM CELL MELANOMA R, V21, P559, DOI 10.1111/j.1755-148X.2008.00487.x; Lu Mei-Hua, 2000, Proceedings of the National Science Council Republic of China Part B Life Sciences, V24, P169; MACK DH, 1993, NATURE, V363, P281, DOI 10.1038/363281a0; Maeda Y, 2006, BIOCHEM J, V400, P303, DOI 10.1042/BJ20060614; Mangiulli M, 2009, NUCLEIC ACIDS RES, V37, P6092, DOI 10.1093/nar/gkp674; Menendez D, 2009, NAT REV CANCER, V9, P724, DOI 10.1038/nrc2730; Mills AA, 1999, NATURE, V398, P708, DOI 10.1038/19531; MILNER J, 1991, CELL, V65, P765, DOI 10.1016/0092-8674(91)90384-B; Murphy M, 1999, GENE DEV, V13, P2490, DOI 10.1101/gad.13.19.2490; Murphy PJM, 2004, J BIOL CHEM, V279, P30195, DOI 10.1074/jbc.M403539200; Nguyen BC, 2006, GENE DEV, V20, P1028, DOI 10.1101/gad.1406006; Nicolas M, 2003, NAT GENET, V33, P416, DOI 10.1038/ng1099; Ou YH, 2005, MOL BIOL CELL, V16, P1684, DOI 10.1091/mbc.E04-08-0689; Pal S, 2001, CANCER RES, V61, P6952; Paramio JM, 2000, MOL CARCINOGEN, V29, P251, DOI 10.1002/1098-2744(200012)29:4<251::AID-MC1007>3.0.CO;2-O; Pellegrini G, 2001, P NATL ACAD SCI USA, V98, P3156, DOI 10.1073/pnas.061032098; Qin JZ, 2002, ONCOGENE, V21, P2991, DOI 10.1038/sj.onc.1205404; Rajagopalan S, 2008, NUCLEIC ACIDS RES, V36, P5983, DOI 10.1093/nar/gkn598; Rajagopalan S, 2010, NUCLEIC ACIDS RES, V38, P893, DOI 10.1093/nar/gkp1041; Romano RA, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005623; Sauer M, 2008, NUCLEIC ACIDS RES, V36, P1900, DOI 10.1093/nar/gkn044; Schavinsky-Khrapunsky Y, 2003, ONCOGENE, V22, P5315, DOI 10.1038/sj.onc.1206782; Sengupta S, 2005, ONCOGENE, V24, P1738, DOI 10.1038/sj.onc.1208380; Sherman L, 2002, VIROLOGY, V292, P309, DOI 10.1006/viro.2001.1263; Sun RL, 2011, J BIOL CHEM, V286, DOI 10.1074/jbc.M110.178798; Truong AB, 2006, GENE DEV, V20, P3185, DOI 10.1101/gad.1463206; Waterman MJF, 1998, NAT GENET, V19, P175, DOI 10.1038/542; Westfall MD, 2003, MOL CELL BIOL, V23, P2264, DOI 10.1128/MCB.23.7.2264-2276.2003; Wu GJ, 2005, CANCER RES, V65, P758; Wu YL, 2001, ONCOGENE, V20, P240, DOI 10.1038/sj.onc.1204067; Yang A, 1999, NATURE, V398, P714, DOI 10.1038/19539; Yang AN, 1998, MOL CELL, V2, P305, DOI 10.1016/S1097-2765(00)80275-0; Yugawa T, 2007, MOL CELL BIOL, V27, P3732, DOI 10.1128/MCB.02119-06	63	19	20	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 24	2012	7	7							e41742	10.1371/journal.pone.0041742	http://dx.doi.org/10.1371/journal.pone.0041742			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	978NX	22911849	gold, Green Submitted, Green Published			2022-12-25	WOS:000306751300068
J	Mei, HX; Cheng, L; Tang, J; Fu, ZY; Wang, X; Jen, PHS; Chen, QC				Mei, Hui-Xian; Cheng, Liang; Tang, Jia; Fu, Zi-Ying; Wang, Xin; Jen, Philip H. -S.; Chen, Qi-Cai			Bilateral Collicular Interaction: Modulation of Auditory Signal Processing in Amplitude Domain	PLOS ONE			English	Article							BIG BROWN BAT; INFERIOR COLLICULUS; EPTESICUS-FUSCUS; CORTICOFUGAL MODULATION; CENTRAL NUCLEUS; DESCENDING PROJECTIONS; MERIONES-UNGUICULATUS; NEURONS; FREQUENCY; MIDBRAIN	In the ascending auditory pathway, the inferior colliculus (IC) receives and integrates excitatory and inhibitory inputs from many lower auditory nuclei, intrinsic projections within the IC, contralateral IC through the commissure of the IC and from the auditory cortex. All these connections make the IC a major center for subcortical temporal and spectral integration of auditory information. In this study, we examine bilateral collicular interaction in modulating amplitude-domain signal processing using electrophysiological recording, acoustic and focal electrical stimulation. Focal electrical stimulation of one (ipsilateral) IC produces widespread inhibition (61.6%) and focused facilitation (9.1%) of responses of neurons in the other (contralateral) IC, while 29.3% of the neurons were not affected. Bilateral collicular interaction produces a decrease in the response magnitude and an increase in the response latency of inhibited IC neurons but produces opposite effects on the response of facilitated IC neurons. These two groups of neurons are not separately located and are tonotopically organized within the IC. The modulation effect is most effective at low sound level and is dependent upon the interval between the acoustic and electric stimuli. The focal electrical stimulation of the ipsilateral IC compresses or expands the rate-level functions of contralateral IC neurons. The focal electrical stimulation also produces a shift in the minimum threshold and dynamic range of contralateral IC neurons for as long as 150 minutes. The degree of bilateral collicular interaction is dependent upon the difference in the best frequency between the electrically stimulated IC neurons and modulated IC neurons. These data suggest that bilateral collicular interaction mainly changes the ratio between excitation and inhibition during signal processing so as to sharpen the amplitude sensitivity of IC neurons. Bilateral interaction may be also involved in acoustic-experience-dependent plasticity in the IC. Three possible neural pathways underlying the bilateral collicular interaction are discussed.	[Mei, Hui-Xian; Cheng, Liang; Tang, Jia; Fu, Zi-Ying; Wang, Xin; Chen, Qi-Cai] Cent China Normal Univ, Coll Life Sci, Wuhan, Hubei, Peoples R China; [Mei, Hui-Xian; Cheng, Liang; Tang, Jia; Fu, Zi-Ying; Wang, Xin; Chen, Qi-Cai] Cent China Normal Univ, Hubei Key Lab Genet Regulat & Integrat Biol, Wuhan, Hubei, Peoples R China; [Jen, Philip H. -S.] Univ Missouri, Div Biol Sci, Columbia, MO 65211 USA	Central China Normal University; Central China Normal University; University of Missouri System; University of Missouri Columbia	Mei, HX (corresponding author), Cent China Normal Univ, Coll Life Sci, Wuhan, Hubei, Peoples R China.	Jenp@missouri.edu; qcchen2003@yahoo.com.cn	Fu, Ziying/N-7127-2013	Fu, Ziying/0000-0002-0065-8297	National Science Foundation of China [31070971, 30970972, 31000959]; Division of Biological Sciences University of Missouri-Columbia, United States of America	National Science Foundation of China(National Natural Science Foundation of China (NSFC)); Division of Biological Sciences University of Missouri-Columbia, United States of America	This work was supported by the grants (#31070971, #30970972, #31000959) from the National Science Foundation of China and a fund from the Division of Biological Sciences University of Missouri-Columbia, United States of America, respectively. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ADAMS JC, 1979, J COMP NEUROL, V183, P519, DOI 10.1002/cne.901830305; AITKIN LM, 1984, J COMP NEUROL, V228, P210, DOI 10.1002/cne.902280207; Bajo VM, 2005, J COMP NEUROL, V486, P101, DOI 10.1002/cne.20542; Cant NB, 2006, J COMP NEUROL, V495, P511, DOI 10.1002/cne.20888; Casseday JH, 2002, SPR HDB AUD, V15, P238; HERBERT H, 1991, J COMP NEUROL, V304, P103, DOI 10.1002/cne.903040108; Hernandez O, 2006, NEUROREPORT, V17, P1611, DOI 10.1097/01.wnr.0000236857.70715.be; Jen PHS, 1999, J COMP PHYSIOL A, V184, P185, DOI 10.1007/s003590050317; Jen PHS, 2003, HEARING RES, V184, P91, DOI 10.1016/S0378-5955(03)00237-5; Jen PHS, 1998, J COMP PHYSIOL A, V183, P683, DOI 10.1007/s003590050291; Jen PHS, 2002, HEARING RES, V168, P196, DOI 10.1016/S0378-5955(02)00358-1; Jen PHS, 2002, HEARING RES, V168, P139, DOI 10.1016/S0378-5955(02)00369-6; Jen PHS, 2001, EXP BRAIN RES, V137, P292; JEN PHS, 1982, J COMP PHYSIOL, V147, P351, DOI 10.1007/BF00609669; Ji WQ, 2001, J NEUROPHYSIOL, V86, P211, DOI 10.1152/jn.2001.86.1.211; Jia T, 2007, CHINESE J PHYSIOL, V50, P187; KLUG A, 1995, J NEUROPHYSIOL, V74, P1701, DOI 10.1152/jn.1995.74.4.1701; Koch U, 1998, J NEUROPHYSIOL, V80, P71, DOI 10.1152/jn.1998.80.1.71; Lu Y, 2001, EXP BRAIN RES, V141, P331, DOI 10.1007/s002210100885; Malmierca MS, 2009, J COMP NEUROL, V514, P226, DOI 10.1002/cne.21997; Malmierca MS, 2005, NEUROSCIENCE, V136, P883, DOI 10.1016/j.neuroscience.2005.04.040; Malmierca MS, 2005, EUR J NEUROSCI, V21, P2701, DOI 10.1111/j.1460-9568.2005.04103.x; Malmierca MS, 2003, EXP BRAIN RES, V153, P522, DOI 10.1007/s00221-003-1615-1; MALMIERCA MS, 1995, J COMP NEUROL, V357, P124, DOI 10.1002/cne.903570112; Moore DR, 1998, J NEUROPHYSIOL, V80, P2229, DOI 10.1152/jn.1998.80.5.2229; PINHEIRO AD, 1991, J COMP PHYSIOL A, V169, P69; POON PWF, 1990, EXP BRAIN RES, V79, P83; Popelar J, 2003, PHYSIOL RES, V52, P615; SALDANA E, 1992, J COMP NEUROL, V319, P417, DOI 10.1002/cne.903190308; Saldana E, 1996, J COMP NEUROL, V371, P15, DOI 10.1002/(SICI)1096-9861(19960715)371:1<15::AID-CNE2>3.0.CO;2-O; SHNEIDERMAN A, 1989, J COMP NEUROL, V286, P28, DOI 10.1002/cne.902860103; Suga N, 2002, NEURON, V36, P9, DOI 10.1016/S0896-6273(02)00933-9; Suga N, 1997, ENCY ACOUSTICS, P1409; Suga N, 2010, AUDITORY VESTIBULAR, P313; Suga N, 2008, J COMP PHYSIOL A, V194, P169, DOI 10.1007/s00359-007-0274-2; SUN X, 1989, BRAIN RES, V495, P1, DOI 10.1016/0006-8993(89)91212-2; Sun XD, 1996, NEUROSCI LETT, V212, P131, DOI 10.1016/0304-3940(96)12788-9; Wang X, 2007, BRAIN RES, V1167, P80, DOI 10.1016/j.brainres.2007.07.002; Winer JA, 2006, HEARING RES, V212, P1, DOI 10.1016/j.heares.2005.06.014; Winer JA, 1998, J COMP NEUROL, V400, P147; Wu FJ, 2008, CHINESE J PHYSIOL, V51, P13; WU FJ, 2009, CHIN J PHYSL, V52, P1; Wu M, 1991, Chin J Physiol, V34, P145; Xiao ZJ, 2002, NAT NEUROSCI, V5, P57, DOI 10.1038/nn786; Yan J, 2001, NEUROREPORT, V12, P3313, DOI 10.1097/00001756-200110290-00033; Yan J, 2002, EUR J NEUROSCI, V16, P119, DOI 10.1046/j.1460-9568.2002.02046.x; Yan J, 2005, J NEUROPHYSIOL, V93, P71, DOI 10.1152/jn.00348.2004; Yan J, 1996, SCIENCE, V273, P1100, DOI 10.1126/science.273.5278.1100; Zhang YF, 2000, J NEUROPHYSIOL, V84, P325, DOI 10.1152/jn.2000.84.1.325; Zhang YK, 2005, J NEUROPHYSIOL, V94, P2676, DOI 10.1152/jn.00549.2005; Zhou XM, 2007, J NEUROPHYSIOL, V98, P2509, DOI 10.1152/jn.00613.2007	51	11	15	1	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 24	2012	7	7							e41311	10.1371/journal.pone.0041311	http://dx.doi.org/10.1371/journal.pone.0041311			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	978NX	22911778	Green Submitted, Green Published, gold			2022-12-25	WOS:000306751300030
J	Nannyonga, B; Sumpter, DJT; Mugisha, JYT; Luboobi, LS				Nannyonga, Betty; Sumpter, David J. T.; Mugisha, Joseph Y. T.; Luboobi, Livingstone S.			The Dynamics, Causes and Possible Prevention of Hepatitis E Outbreaks	PLOS ONE			English	Article							TRANSMISSION DYNAMICS; DISEASES; MALARIA; PERSISTENCE; INFECTION; EVOLUTION; ECOLOGY	Rapidly spreading infectious diseases are a serious risk to public health. The dynamics and the factors causing outbreaks of these diseases can be better understood using mathematical models, which are fit to data. Here we investigate the dynamics of a Hepatitis E outbreak in the Kitgum region of northern Uganda during 2007 to 2009. First, we use the data to determine that R-0 is approximately 2.25 for the outbreak. Secondly, we use a model to estimate that the critical level of latrine and bore hole coverages needed to eradicate the epidemic is at least 16% and 17% respectively. Lastly, we further investigate the relationship between the co-infection factor for malaria and Hepatitis E on the value of R0 for Hepatitis E. Taken together, these results provide us with a better understanding of the dynamics and possible causes of Hepatitis E outbreaks.	[Nannyonga, Betty; Mugisha, Joseph Y. T.; Luboobi, Livingstone S.] Makerere Univ, Dept Math, Kampala, Uganda; [Sumpter, David J. T.] Uppsala Univ, Dept Math, S-75238 Uppsala, Sweden	Makerere University; Uppsala University	Nannyonga, B (corresponding author), Makerere Univ, Dept Math, Kampala, Uganda.	bnk@math.mak.ac.ug		Luboobi, Livingstone Serwada/0000-0003-0438-9845	International Science Program - ISP; Mathematics Institute of Uppsala University, Sweden	International Science Program - ISP; Mathematics Institute of Uppsala University, Sweden	BN acknowledges the International Science Program - ISP for the funding of this study and the Mathematics Institute of Uppsala University, Sweden. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abu-Raddad LJ, 2006, SCIENCE, V314, P1603, DOI 10.1126/science.1132338; ANDERSON R M, 1991; Andrade BB, 2001, PLOS ONE, V6; [Anonymous], 2009, WHO REP; [Anonymous], 2009, MIN HLTH UG WEEKL RE; [Anonymous], 1996, GLOBAL BURDEN DIS CO; Barcus MJ, 2002, AM J TROP MED HYG, V66, P140, DOI 10.4269/ajtmh.2002.66.140; Castillo-Chavez C., 2002, MATH APPROACHES EMER, V1; Centers for disease control and prevention, 2009, HEP E INF HLTH PROF; Cyranoski D, 2001, NATURE, V412, P261, DOI 10.1038/35085715; Earn DJD, 2002, TRENDS ECOL EVOL, V17, P334, DOI 10.1016/S0169-5347(02)02502-8; Edelstein-Keshet L., 2005, SIAM CLASSICS APPL M, V46; Enserink M, 2004, SCIENCE, V303, P1605, DOI 10.1126/science.303.5664.1605; Ferguson N, 1999, P NATL ACAD SCI USA, V96, P790, DOI 10.1073/pnas.96.2.790; Gold MR, 1996, COST EFFECTIVENESS H; Gubler DJ, 2002, ARCH MED RES, V33, P330, DOI 10.1016/S0188-4409(02)00378-8; GUPTA S, 1994, P ROY SOC B-BIOL SCI, V256, P231, DOI 10.1098/rspb.1994.0075; Gupta S, 1998, SCIENCE, V280, P912, DOI 10.1126/science.280.5365.912; Keeling, 2008, MODELLING INFECT DIS; Kermack WO, 1927, P R SOC LOND A-CONTA, V115, P700, DOI 10.1098/rspa.1927.0118; King AA, 2008, NATURE, V454, P877, DOI 10.1038/nature07084; Klouwenberg PK, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021013; Koelle K, 2005, NATURE, V436, P696, DOI 10.1038/nature03820; Lipsitch M, 2003, SCIENCE, V300, P1966, DOI 10.1126/science.1086616; Macdonald G., 1957, EPIDEMIOLOGY CONTROL; Maiwald T, 2008, BIOINFORMATICS, V24, P2037, DOI 10.1093/bioinformatics/btn350; Pasquetto V, 2002, J EXP MED, V192, P529; Read AF, 2001, SCIENCE, V292, P1099, DOI 10.1126/science.1059410; Rohani P, 2000, LANCET, V355, P285, DOI 10.1016/S0140-6736(99)04482-7; THURSZ MR, 1995, NAT MED, V1, P374, DOI 10.1038/nm0495-374; van den Driessche P, 2002, MATH BIOSCI, V180, P29, DOI 10.1016/S0025-5564(02)00108-6; Vasco DA, 2007, J THEOR BIOL, V245, P9, DOI 10.1016/j.jtbi.2006.08.015	32	10	10	1	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 24	2012	7	7							e41135	10.1371/journal.pone.0041135	http://dx.doi.org/10.1371/journal.pone.0041135			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	978NX	22911752	Green Published, gold, Green Submitted			2022-12-25	WOS:000306751300025
J	Wang, T; Su, YJ; Li, Y				Wang, Ting; Su, Yingjuan; Li, Yuan			Population Genetic Variation in the Tree Fern Alsophila spinulosa (Cyatheaceae): Effects of Reproductive Strategy	PLOS ONE			English	Article							BREEDING SYSTEMS; DIVERSITY; VARIABILITY; EVOLUTION; BIOLOGY; MARKERS; OPHIOGLOSSACEAE; DIFFERENTIATION; RECOMBINATION; PTERIDOPHYTA	Background: Essentially all ferns can perform both sexual and asexual reproduction. Their populations represent suitable study objects to test the population genetic effects of different reproductive systems. Using the diploid homosporous fern Alsophila spinulosa as an example species, the main purpose of this study was to assess the relative impact of sexual and asexual reproduction on the level and structure of population genetic variation. Methodology/Principal Findings: Inter-simple sequence repeats analysis was conducted on 140 individuals collected from seven populations (HSG, LCH, BPC, MPG, GX, LD, and ZHG) in China. Seventy-four polymorphic bands discriminated a total of 127 multilocus genotypes. Character compatibility analysis revealed that 50.0 to 70.0% of the genotypes had to be deleted in order to obtain a tree-like structure in the data set from populations HSG, LCH, MPG, BPC, GX, and LD; and there was a gradual decrease of conflict in the data set when genotypes with the highest incompatibility counts were successively deleted. In contrast, in population ZHG, only 33.3% of genotypes had to be removed to achieve complete compatibility in the data set, which showed a sharp decline in incompatibility upon the deletion of those genotypes. All populations examined possessed similar levels of genetic variation. Population ZHG was not found to be more differentiated than the other populations. Conclusions/Significance: Sexual recombination is the predominant source of genetic variation in most of the examined populations of A. spinulosa. However, somatic mutation contributes most to the genetic variation in population ZHG. This change of the primary mode of reproduction does not cause a significant difference in the population genetic composition. Character compatibility analysis represents an effective approach to separate the role of sexual and asexual components in shaping the genetic pattern of fern populations.	[Wang, Ting] Chinese Acad Sci, Wuhan Bot Garden, CAS Key Lab Plant Germplasm Enhancement & Special, Wuhan, Hubei, Peoples R China; [Su, Yingjuan; Li, Yuan] Sun Yat Sen Univ, Sch Life Sci, State Key Lab Biocontrol, Guangzhou 510275, Guangdong, Peoples R China	Chinese Academy of Sciences; Wuhan Botanical Garden, CAS; Sun Yat Sen University	Wang, T (corresponding author), Chinese Acad Sci, Wuhan Bot Garden, CAS Key Lab Plant Germplasm Enhancement & Special, Wuhan, Hubei, Peoples R China.	suyj@mail.sysu.edu.cn			National Natural Science Foundation of China [30771763, 30970290, 31070594]; Innovative Program of Chinese Academy of Sciences [KSCX2-YW-Z-0940]; Natural Science Foundation of Hubei Province, China [O631061H01]; Opening Fund of Laboratory Sun Yat-sen University; Guangdong Key Laboratory of Plant Resources [plant01k13]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Innovative Program of Chinese Academy of Sciences(Knowledge Innovation Program of the Chinese Academy of Sciences); Natural Science Foundation of Hubei Province, China(Natural Science Foundation of Hubei Province); Opening Fund of Laboratory Sun Yat-sen University; Guangdong Key Laboratory of Plant Resources	This work was supported by the National Natural Science Foundation of China (Grant No. 30771763, 30970290, and 31070594), the Innovative Program of Chinese Academy of Sciences (KSCX2-YW-Z-0940), the Outstanding Young Scientist Project" of the Natural Science Foundation of Hubei Province, China (Grant No. O631061H01), and the Opening Fund of Laboratory Sun Yat-sen University (2010), and Guangdong Key Laboratory of Plant Resources (plant01k13). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 1992, FERNS FERN ALLIES JA; Asker S. E., 1992, APOMIXIS PLANTS; Camacho FJ, 2001, AM J BOT, V88, P1065, DOI 10.2307/2657089; Ceplitis A, 2001, EVOLUTION, V55, P1581, DOI 10.1111/j.0014-3820.2001.tb00677.x; Chapman H, 2004, HEREDITY, V92, P182, DOI 10.1038/sj.hdy.6800392; Chen YY, 2010, BIOCHEM SYST ECOL, V38, P1129, DOI 10.1016/j.bse.2010.12.016; Chiou WL, 2003, PTERIDOLOGY IN THE NEW MILLENNIUM, P485; Dong SY, 2009, ANN BOT FENN, V46, P381, DOI 10.5735/085.046.0502; Eicchorn S., 2003, BIOL PLANTS; Fu L.G., 1992, CHINA PLANT RED DATA, V1; Grant V., 1981, PLANT SPECIATION, Vsecond; Hamrick JL, 1996, PHILOS T ROY SOC B, V351, P1291, DOI 10.1098/rstb.1996.0112; Hassel K, 2005, AM J BOT, V92, P1684, DOI 10.3732/ajb.92.10.1684; HAUFLER CH, 1987, AM J BOT, V74, P953, DOI 10.2307/2443877; Haufler CH, 2002, BIOSCIENCE, V52, P1081, DOI 10.1641/0006-3568(2002)052[1081:HAOOPI]2.0.CO;2; Haufler Christopher H., 1992, P145; Hock Z, 2009, PLANT ECOL, V202, P123, DOI 10.1007/s11258-008-9541-8; Holsinger KE, 2002, MOL ECOL, V11, P1157, DOI 10.1046/j.1365-294X.2002.01512.x; Hooper EA, 1997, AM J BOT, V84, P1664, DOI 10.2307/2446464; Houliston GJ, 2004, AM J BOT, V91, P37, DOI 10.3732/ajb.91.1.37; Jimenez A, 2010, ANN BOT-LONDON, V106, P149, DOI 10.1093/aob/mcq094; Johns RJ, 1991, CURTISS BOT MAG, V8, P107; Kameyama Y, 2006, J PLANT RES, V119, P357, DOI 10.1007/s10265-006-0282-2; Kjolner S, 2006, BOT J LINN SOC, V152, P209, DOI 10.1111/j.1095-8339.2006.00545.x; Klekowski E.J., 1969, BOT J LINN SOC, V62, P361, DOI [DOI 10.1111/J.1095-8339.1969.TB01973.X, 10.1007/978-3-642-18475-8, DOI 10.1007/978-3-642-18475-8]; Klekowski EJ, 1979, EXPT BIOL FERNS, P133; Korpelainen H, 1996, AM J BOT, V83, P58, DOI 10.2307/2445954; Lewontin R.C., 1972, EVOLUTIONARY BIOL, V14, P381, DOI DOI 10.1007/978-1-4684-9063-3_14; Li ZH, 2005, COURSE STAT ANAL SPS; LLOYD RM, 1974, ANN MO BOT GARD, V61, P318, DOI 10.2307/2395060; LOVELESS MD, 1984, ANNU REV ECOL SYST, V15, P65, DOI 10.1146/annurev.es.15.110184.000433; Maki M, 1998, HEREDITY, V80, P604; McVeigh I, 1937, BOT REV, V3, P457; Mes THM, 1998, MOL ECOL, V7, P1719, DOI 10.1046/j.1365-294x.1998.00508.x; NEI M, 1973, P NATL ACAD SCI USA, V70, P3321, DOI 10.1073/pnas.70.12.3321; RANKER TA, 1992, HEREDITY, V69, P175, DOI 10.1038/hdy.1992.111; Ranker TA, 2008, BIOLOGY AND EVOLUTION OF FERNS AND LYCOPHYTES, P107, DOI 10.1017/CBO9780511541827.005; Richards AJ, 1996, FOLIA GEOBOT PHYTOTX, V31, P405, DOI 10.1007/BF02815385; Rumsey FJ, 1999, BIOL J LINN SOC, V66, P333, DOI 10.1111/j.1095-8312.1999.tb01894.x; Sokal RR, 2003, BIOMETRY; SOLTIS DE, 1986, AM J BOT, V73, P588, DOI 10.2307/2444264; SOLTIS DE, 1987, AM NAT, V130, P219, DOI 10.1086/284706; Su YJ, 2005, MOL PHYLOGENET EVOL, V34, P323, DOI 10.1016/j.ympev.2004.10.016; Suter M, 2000, INT J PLANT SCI, V161, P233, DOI 10.1086/314258; Tryon R. M., 1982, FERNS ALLIED PLANTS; van der Hulst RGM, 2000, MOL ECOL, V9, P1, DOI 10.1046/j.1365-294x.2000.00704.x; Van der Hulst RGM, 2003, HEREDITY, V90, P326, DOI 10.1038/sj.hdy.6800248; Wang JH, 1996, GUIHAIA, V16, P283; WHITE RA, 1969, B TORREY BOT CLUB, V96, P10, DOI 10.2307/2484004; Wilkinson M, 1995, PICA95 SOFTWARE DOCU; WILKINSON M, 2001, PICA SOFTWARE DOCUME; Willis K. J., 2002, EVOLUTION PLANTS; WRIGHT S, 1951, ANN EUGENIC, V15, P323; Yeh F.C., 1999, MICROSOFT WINDOWS BA; Zhang XC, 2004, FLORA REIPUBLICAE PO, P249; Zhou ZQ, 2004, J GUIZHOU NORMAL U N, V22, P100; [No title captured]	57	4	5	2	42	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 24	2012	7	7							e41780	10.1371/journal.pone.0041780	http://dx.doi.org/10.1371/journal.pone.0041780			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	978NX	22911855	Green Submitted, Green Published, gold			2022-12-25	WOS:000306751300074
J	Wang, ZH; Ma, N; Riley, J; Armstead, WM; Liu, RY				Wang, Zhenhong; Ma, Nan; Riley, John; Armstead, William M.; Liu, Renyu			Salvinorin A Administration after Global Cerebral Hypoxia/Ischemia Preserves Cerebrovascular Autoregulation via Kappa Opioid Receptor in Piglets	PLOS ONE			English	Article							SIGNAL-REGULATED-KINASE; ACUTE ISCHEMIC-STROKE; MEK1 PROTEIN-KINASE; HALLUCINOGEN SALVINORIN; NITRIC-OXIDE; RAT MODEL; IN-VIVO; NEUROPROTECTION; AGONIST; ACTIVATION	Background: Cerebral hypoxia/ischemia (HI) is not uncommon during the perinatal period. If occurring, it can result in severe neurologic disabilities that persist throughout life. Salvinorin A, a non-opioid Kappa opioid receptors (KOR) selective agonist, has the potential to address this devastating situation. We have demonstrated that salvinorin A administration before HI, preserves pial artery autoregulative function through both the KOR and extracellular signal-regulated kinases (ERK) pathways. In the present study, we tested the hypothesis that administration of salvinorin A after HI could preserve cerebral autoregulation via KOR and ERK pathway. Methodology/Principal Findings: The response of the pial artery to hypercapnia, hypotension and isoproterenol were monitored before and 1 hour after HI in piglets equipped with a cranial window. Four groups of drug administration were performed after HI. The control group had DMSO (1 mu l/kg, i.v.) administrated immediately after HI. Two salvinorin A treated groups had salvinorin A (10 mu g/kg, i.v.) administrated 0 and 30 min after HI, respectively. The 4th group had salvinorin A and the KOR antagonist norbinaltorphimine (Nor-BIN, 1 mu M topical) co-administrated 0 min after HI (n = 5). The dilation responses of the pial artery to hypercapnia and hypotension were impaired after global HI and were preserved with salvinorin A administration immediately or 30 min after HI. The preservation of autoregulation was abolished when nor-BIN was administered. Levels of phosphor-ERK(pERK)/ERK in the cerebrospinal fluid (CSF) were measured before and 1 hour after HI. After HI, the pERK/ERK levels significantly increased in both DMSO control group and salvinorin A and nor-BIN co-administration group. The elevated levels of pERK/ERK were not observed with salvinorin A only groups. Conclusions: Salvinorin A administration 0 and 30 min after HI preserves autoregulation of pial artery to hypercapnia and hypotension via kappa opioid receptor and ERK pathway.	[Wang, Zhenhong; Ma, Nan; Riley, John; Armstead, William M.; Liu, Renyu] Hosp Univ Penn, Dept Anesthesiol & Crit Care, Philadelphia, PA 19104 USA; [Wang, Zhenhong] Shanghai Jiao Tong Univ, Renji Hosp, Sch Med, Dept Anesthesiol, Shanghai 200030, Peoples R China	University of Pennsylvania; Pennsylvania Medicine; Shanghai Jiao Tong University	Wang, ZH (corresponding author), Hosp Univ Penn, Dept Anesthesiol & Crit Care, 3400 Spruce St, Philadelphia, PA 19104 USA.	William.Armstead@uphs.upenn.edu; liur@uphs.upenn.edu	Ma, Nan/L-1282-2013	Ma, Nan/0000-0003-4006-1003; Riley, John/0000-0002-7932-8935	National Institutes of Health [K08-GM-093115-01, NS53410]; Department of Anesthesiology and Critical Care at the Perelman School of Medicine at the University of Pennsylvania; McCabe foundation; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [K08GM093115] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS053410] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Department of Anesthesiology and Critical Care at the Perelman School of Medicine at the University of Pennsylvania; McCabe foundation; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This research was supported by National Institutes of Health grant number K08-GM-093115-01(PI, RL) and NS53410 (PI, WA). It is also supported by the Department of Anesthesiology and Critical Care at the Perelman School of Medicine at the University of Pennsylvania (PI, RL); McCabe foundation (PI, RL). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alessandrini A, 1999, P NATL ACAD SCI USA, V96, P12866, DOI 10.1073/pnas.96.22.12866; Armstead WM, 2008, BRAIN RES, V1231, P121, DOI 10.1016/j.brainres.2008.06.115; Armstead WM, 2011, BRAIN RES, V1376, P88, DOI 10.1016/j.brainres.2010.12.052; BASKIN DS, 1984, NATURE, V312, P551, DOI 10.1038/312551a0; Blom I, 2003, DEV MED CHILD NEUROL, V45, P233, DOI 10.1017/S001216220300046X; Braida D, 2009, BRIT J PHARMACOL, V157, P844, DOI 10.1111/j.1476-5381.2009.00230.x; Butelman ER, 2009, J PHARMACOL EXP THER, V328, P588, DOI 10.1124/jpet.108.145342; Chabrier S, 2011, THROMB RES, V127, P13, DOI 10.1016/j.thromres.2010.10.003; Charron C, 2008, PHYSIOL BEHAV, V93, P502, DOI 10.1016/j.physbeh.2007.10.015; Chen TY, 2004, STROKE, V35, P1180, DOI 10.1161/01.STR.0000125011.93188.c6; Choi JS, 2006, NEUROSCI LETT, V409, P187, DOI 10.1016/j.neulet.2006.09.053; Dawson SL, 2003, CEREBROVASC DIS, V16, P69, DOI 10.1159/000070118; Eames PJ, 2002, J NEUROL NEUROSUR PS, V72, P467; Feng Y, 2004, LIFE SCI, V75, P2615, DOI 10.1016/j.lfs.2004.07.008; Goyagi T, 2003, STROKE, V34, P1533, DOI 10.1161/01.STR.0000072512.30658.E7; HALL ED, 1988, STROKE, V19, P1008, DOI 10.1161/01.STR.19.8.1008; HAYWARD NJ, 1993, EUR J NEUROSCI, V5, P961, DOI 10.1111/j.1460-9568.1993.tb00947.x; Hooker JM, 2008, NEUROIMAGE, V41, P1044, DOI 10.1016/j.neuroimage.2008.03.003; Hurvitz Edward, 2004, Top Stroke Rehabil, V11, P51; Jeong S, 2012, J NEUROSURG ANESTH, V24, P51, DOI 10.1097/ANA.0b013e3182368d70; Liebelt B, 2010, NEUROSCIENCE, V166, P1091, DOI 10.1016/j.neuroscience.2009.12.067; Maddahi A, 2011, J CEREBR BLOOD F MET, V31, P144, DOI 10.1038/jcbfm.2010.62; MAYHAN WG, 1988, AM J PHYSIOL, V255, pH879, DOI 10.1152/ajpheart.1988.255.4.H879; Melief EJ, 2011, MOL PHARMACOL, V80, P920, DOI 10.1124/mol.111.074195; Mowry M, 2003, J PSYCHOACTIVE DRUGS, V35, P379, DOI 10.1080/02791072.2003.10400021; Nicole O, 2001, NAT MED, V7, P59, DOI 10.1038/83358; Park EM, 2004, NEUROSCIENCE, V123, P147, DOI 10.1016/j.neuroscience.2003.08.023; Reinhard M, 2012, ACTA NEUROL SCAND, V125, P156, DOI 10.1111/j.1600-0404.2011.01515.x; Roth BL, 2002, P NATL ACAD SCI USA, V99, P11934, DOI 10.1073/pnas.182234399; Sanders RD, 2010, ANESTHESIOLOGY, V113, P233, DOI 10.1097/ALN.0b013e3181dc1b84; Su DS, 2007, NEUROSCI LETT, V423, P113, DOI 10.1016/j.neulet.2007.06.044; Su DAS, 2012, ANESTH ANALG, V114, P200, DOI 10.1213/ANE.0b013e31823a5d36; Su DS, 2011, ANESTHESIOLOGY, V114, P374, DOI 10.1097/ALN.0b013e318204e029; Teksin ZS, 2009, EUR J PHARM BIOPHARM, V72, P471, DOI 10.1016/j.ejpb.2009.01.002; Vortherms TA, 2006, MOL INTERV, V6, P257, DOI 10.1124/mi.6.5.7; Wang XK, 2003, J PHARMACOL EXP THER, V304, P172, DOI 10.1124/jpet.102.040246; Wu DC, 2000, J CEREBR BLOOD F MET, V20, P1320, DOI 10.1097/00004647-200009000-00007; Yang L, 2011, BRAIN RES, V1383, P307, DOI 10.1016/j.brainres.2011.01.083; Zeynalov E, 2006, J CEREBR BLOOD F MET, V26, P414, DOI 10.1038/sj.jcbfm.9600196; Zhang ZA, 2003, ANESTH ANALG, V97, P1776, DOI 10.1213/01.ANE.0000087800.56290.2E; Zhao P, 2006, J NEUROPATH EXP NEUR, V65, P945, DOI 10.1097/01.jnen.0000235123.05677.4b	41	13	17	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 24	2012	7	7							e41724	10.1371/journal.pone.0041724	http://dx.doi.org/10.1371/journal.pone.0041724			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	978NX	22911847	Green Submitted, Green Published, gold			2022-12-25	WOS:000306751300066
J	Zhou, AM; Lu, YY; Zeng, L; Xu, YJ; Liang, GW				Zhou, Aiming; Lu, Yongyue; Zeng, Ling; Xu, Yijuan; Liang, Guangwen			Does Mutualism Drive the Invasion of Two Alien Species? The Case of Solenopsis invicta and Phenacoccus solenopsis	PLOS ONE			English	Article							IMPORTED FIRE ANT; ARGENTINE ANTS; BIOLOGICAL INVASIONS; LABORATORY COLONIES; RAIN-FOREST; APHID; HYMENOPTERA; HONEYDEW; COTTON; FORMICIDAE	Although mutualism between ants and honeydew-producing hemipterans has been extensively recognized in ecosystem biology, however few attempts to test the hypothesis that mutualism between two alien species leads to the facilitation of the invasion process. To address this problem, we focus on the conditional mutualism between S. invicta and P. solenopsis by field investigations and indoor experiments. In the laboratory, ant colony growth increased significantly when ants had access to P. solenopsis and animal-based food. Honeydew produced by P. solenopsis also improved the survival of ant workers. In the field, colony density of P. solenopsis was significantly greater on plots with ants than on plots without ants. The number of mealybug mummies on plants without fire ants was almost three times that of plants with fire ants, indicating a strong effect of fire ants on mealybug survival. In addition, the presence of S. invicta successfully contributed to the spread of P. solenopsis. The quantity of honeydew consumption by S. invicta was significantly greater than that of a presumptive native ant, Tapinoma melanocephalum. When compared with the case without ant tending, mealybugs tended by ants matured earlier and their lifespan and reproduction increased. T. melanocephalum workers arrived at honeydew more quickly than S. invicta workers, while the number of foraging S. invicta workers on plants steadily increased, eventually exceeding that number of T. melanocephalum foragers. Overall, these results suggest that the conditional mutualism between S. invicta and P. solenopsis facilitates population growth and fitness of both species. S. invicta tends to acquire much more honeydew and drive away native ants, promoting their predominance. These results suggest that the higher foraging tempo of S. invicta may provide more effective protection of P. solenopsis than native ants. Thus mutualism between these two alien species may facilitate the invasion success of both species.	[Zhou, Aiming; Lu, Yongyue; Zeng, Ling; Xu, Yijuan; Liang, Guangwen] S China Agr Univ, Red Imported Fire Ant Res Ctr, Guangzhou, Guangdong, Peoples R China	South China Agricultural University	Zhou, AM (corresponding author), S China Agr Univ, Red Imported Fire Ant Res Ctr, Guangzhou, Guangdong, Peoples R China.	xuyijuan@yahoo.com; gwliang@scau.edu.cn			National Natural Science Foundation of China [31101498]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This study was supported by the National Natural Science Foundation of China (No. 31101498). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abbott KL, 2007, OIKOS, V116, P1238, DOI 10.1111/j.0030-1299.2007.15629.x; Akintola A. J., 2008, Agricultural Journal, V3, P1, DOI 10.3923/ijar.2008.1.26; BANKS CJ, 1958, J EXP BIOL, V35, P703; Beattie A. J., 1985, EVOLUTIONARY ECOLOGY; Bluthgen N, 2000, OECOLOGIA, V125, P229, DOI 10.1007/s004420000449; Brightwell RJ, 2010, BIOL INVASIONS, V12, P2051, DOI 10.1007/s10530-009-9607-0; Bruno JF, 2003, TRENDS ECOL EVOL, V18, P119, DOI 10.1016/S0169-5347(02)00045-9; BUCKLEY R, 1987, ADV ECOL RES, V16, P53; BUCKLEY RC, 1987, ANNU REV ECOL SYST, V18, P111, DOI 10.1146/annurev.es.18.110187.000551; Carter W., 1973, INSECTS RELATION PLA; Coppler LB, 2007, FLA ENTOMOL, V90, P419, DOI 10.1653/0015-4040(2007)90[419:RIFAHF]2.0.CO;2; Culik MP, 2005, ZOOTAXA, P1; Daane KM, 2007, ECOL ENTOMOL, V32, P583, DOI 10.1111/j.1365-2311.2007.00910.x; Daane KM, 2006, CROP PROT, V25, P592, DOI 10.1016/j.cropro.2005.08.015; Davidson DW, 2004, OECOLOGIA, V139, P255, DOI 10.1007/s00442-004-1508-4; Dejean A, 2003, REV MOSAICS DOMINAT; Delabie Jacques H. C., 2001, Neotropical Entomology, V30, P501, DOI 10.1590/S1519-566X2001000400001; Diaz D, 2004, J ECON ENTOMOL, V97, P222, DOI 10.1603/0022-0493-97.2.222; DOUGLAS AE, 1993, ECOL ENTOMOL, V18, P31, DOI 10.1111/j.1365-2311.1993.tb01076.x; Eisner T., 1957, BULL MUS COMP ZOOL, V116, P429; Flatt T, 2000, ECOLOGY, V81, P3522, DOI 10.1890/0012-9658(2000)081[3522:TEOMAO]2.0.CO;2; FUCHS TW, 1991, SOUTHWEST ENTOMOL, V16, P215; GLANCEY BM, 1981, INSECT SOC, V28, P395, DOI 10.1007/BF02224196; Helms KR, 2008, ENVIRON ENTOMOL, V37, P487, DOI 10.1603/0046-225X(2008)37[487:PRACGI]2.0.CO;2; Helms KR, 2002, ECOLOGY, V83, P2425, DOI 10.1890/0012-9658(2002)083[2425:WAOTIA]2.0.CO;2; Hodgson C, 2008, ZOOTAXA, P1; Holland J. Nathaniel, 2005, P17; Holldobler B., 1990, pi; Holway DA, 2002, ANNU REV ECOL SYST, V33, P181, DOI 10.1146/annurev.ecolsys.33.010802.150444; Kaplan I, 2002, ENVIRON ENTOMOL, V31, P1175, DOI 10.1603/0046-225X-31.6.1175; Kaplan I, 2005, ECOLOGY, V86, P1640, DOI 10.1890/04-0016; Lach L, 2003, ANN MO BOT GARD, V90, P91, DOI 10.2307/3298529; Li J, 2008, PLANT QUARANTINE, V22, P19; Liu SS, 2007, SCIENCE, V318, P1769, DOI 10.1126/science.1149887; Lu M, 2010, NEW PHYTOL, V187, P859, DOI 10.1111/j.1469-8137.2010.03316.x; Lu M, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0001302; [陆永跃 LU Yong-Yue], 2008, [环境昆虫学报, Journal of Environmental Entomology], V30, P386; Mittler T. E., 1958, Proceedings of the Royal Entomological Society of London (A), V33, P49; Moller H, 1996, BIOL CONSERV, V78, P125, DOI 10.1016/0006-3207(96)00022-5; Ness JH, 2004, BIOL INVASIONS, V6, P445, DOI 10.1023/B:BINV.0000041556.88920.dd; Nixon G.E.J., 1951, ASS ANTS APHIDS COCC; Phillips P. A., 1991, California Agriculture, V45, P26; PORTER SD, 1990, ECOLOGY, V71, P2095, DOI 10.2307/1938623; PORTER SD, 1989, J KANSAS ENTOMOL SOC, V62, P288; Richardson David M., 2000, Diversity and Distributions, V6, P93, DOI 10.1046/j.1472-4642.2000.00083.x; Simberloff Daniel, 1999, Biological Invasions, V1, P21, DOI 10.1023/A:1010086329619; SORENSEN AA, 1981, INSECT SOC, V28, P129, DOI 10.1007/BF02223701; Stadler B, 2002, ECOL LETT, V5, P216, DOI 10.1046/j.1461-0248.2002.00300.x; Stradling D, 1978, FOOD FEEDING HABITS, P81; Tobin John E., 1994, P279; Traveset A, 2006, TRENDS ECOL EVOL, V21, P208, DOI 10.1016/j.tree.2006.01.006; Tschinkel WR., 2006, FIRE ANTS; Vermeij GJ, 1996, BIOL CONSERV, V78, P3, DOI 10.1016/0006-3207(96)00013-4; Vitousek PM, 1996, AM SCI, V84, P468; WAY MJ, 1963, ANNU REV ENTOMOL, V8, P307, DOI 10.1146/annurev.en.08.010163.001515; Wheeler W.M., 1960, ANTS THEIR STRUCTURE; Whittaker J, 1991, EFFECTS ANTS TEMPERA, P67; Williams D. J., 1992, Mealybugs of Central and South America.; WILLIAMS DF, 1987, ARCH INSECT BIOCHEM, V4, P251, DOI 10.1002/arch.940040403; WILLIAMS DF, 1980, J ECON ENTOMOL, V73, P176, DOI 10.1093/jee/73.1.176; Yao I, 2000, OIKOS, V89, P3, DOI 10.1034/j.1600-0706.2000.890101.x; [曾玲 Zeng Ling], 2005, [昆虫知识, Entomological  Knowledge], V42, P144; Zhou AM, 2012, SOCIOBIOLOGY, V59, P71	63	34	41	2	64	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 23	2012	7	7							e41856	10.1371/journal.pone.0041856	http://dx.doi.org/10.1371/journal.pone.0041856			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	977TM	22911859	Green Submitted, gold, Green Published			2022-12-25	WOS:000306687700159
J	Jarni, K; De Cuyper, B; Brus, R				Jarni, Kristjan; De Cuyper, Bart; Brus, Robert			Genetic Variability of Wild Cherry (Prunus avium L.) Seed Stands in Slovenia as Revealed by Nuclear Microsatellite Loci	PLOS ONE			English	Article							FRAXINUS-EXCELSIOR-L.; HETEROZYGOTE-EXCESS; POPULATIONS; DIFFERENTIATION; SOFTWARE; DISTANCE; TRIALS; DNA	Microsatellite markers were used to describe the genetic variability of four seed stands of wild cherry (Prunus avium L.). One hundred and thirty one individuals were genotyped at ten nuclear microsatellite loci. Total genetic diversity was high (H-E = 0.704), while differences between stands were small but significant (F-ST = 0.053, G(ST)' = 0.234). There was a significant amount of clonal reproduction in one stand, with only 11 genotypes identified among 36 trees. One stand showed a significant excess (F-IS = -0.044) of heterozygosity, and one showed a deficit (F-IS = 0.044). Our results demonstrate the importance of taking into account the biological and genetic characteristics of species in forest management, especially when determining a new seed stand. The small genetic differences found between seed stands indicate that a large number of stands are not required. However, they should be carefully selected and should possess adequate genetic variability to ensure low relatedness between seed trees.	[Jarni, Kristjan; Brus, Robert] Univ Ljubljana, Dept Forestry & Renewable Forest Resources, Biotech Fac, Ljubljana, Slovenia; [De Cuyper, Bart] Res Inst Nat & Forest, Dept Management & Sustainable Use, Geraardsbergen, Belgium	University of Ljubljana; Research Institute for Nature & Forest	Jarni, K (corresponding author), Univ Ljubljana, Dept Forestry & Renewable Forest Resources, Biotech Fac, Ljubljana, Slovenia.	kristjan.jarni@bf.uni-lj.si	Jarni, Kristjan/A-1264-2011		Slovenian Research Agency [L4-4091]; Pahernik Fundation; COST action [2474 EUR]	Slovenian Research Agency(Slovenian Research Agency - Slovenia); Pahernik Fundation; COST action(European Cooperation in Science and Technology (COST))	This research was supported by the Slovenian Research Agency (project L4-4091) and the Pahernik Fundation. The authors thank the COST action E42 for its contribution to this work through financing the Short Term Scientific Mission of Kristjan Jarni. Slovenian Research Agency (project L4-4091) (3000 EUR) http://www.arrs.gov.si/en/, COST Action E42 (2474 EUR) http://www.cost.esf.org/domains_actions/fps/Actions/E42, Pahernik Fundation (1000 EUR) http://www.pahernikova-ustanova.si/. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], OFFICIAL J EUROPEAN, V11, P17; Balloux F, 2004, EVOLUTION, V58, P1891; BARTON NH, 1986, HEREDITY, V56, P409, DOI 10.1038/hdy.1986.63; Clarke JB, 2003, MOL ECOL NOTES, V3, P578, DOI 10.1046/j.1471-8286.2003.00517.x; Derory J, 2002, ANN FOREST SCI, V59, P699, DOI 10.1051/forest:2002058; Ducci F, 1997, CAN J FOREST RES, V27, P1998, DOI 10.1139/cjfr-27-12-1998; Excoffier L, 2005, EVOL BIOINFORM, V1, P47, DOI 10.1177/117693430500100003; Guarino C, 2009, GENOME, V52, P320, DOI [10.1139/G09-007, 10.1139/g09-007]; Hedrick PW, 2005, EVOLUTION, V59, P1633, DOI 10.1111/j.0014-3820.2005.tb01814.x; Heuertz M, 2004, EVOLUTION, V58, P976; Hoebee SE, 2006, FOREST ECOL MANAG, V226, P1, DOI 10.1016/j.foreco.2005.12.024; Jensen JS, 2000, SCAND J FOREST RES, V15, P297, DOI 10.1080/028275800447922; Kobliha J., 2002, Journal of Forest Science (Prague), V48, P202; Lacis G, 2009, SCI HORTIC-AMSTERDAM, V121, P451, DOI 10.1016/j.scienta.2009.03.016; MAGGIONI L, 2006, 6 M 20 21 JUN 2003 B; MCPFE, 1993, 2 MIN C PROT FOR EUR; Mohanty A, 2001, HEREDITY, V87, P421, DOI 10.1046/j.1365-2540.2001.00922.x; Muranty H, 1998, SILVAE GENET, V47, P249; NEI M, 1978, GENETICS, V89, P583; Nepveu G, 1993, ANN SCI FOR S1, V50, P388; Nocetti M, 2010, WOOD SCI TECHNOL, V44, P621, DOI 10.1007/s00226-009-0294-x; Pravilnik o dolocitvi proveniencnih obmocij, 2003, PRAV DOL PROV OBM; Rousset F, 1997, GENETICS, V145, P1219; Rousset F, 2008, MOL ECOL RESOUR, V8, P103, DOI 10.1111/j.1471-8286.2007.01931.x; RUSSELL K, 2003, EUFORGEN TECHNICAL G; Santi F, 2010, SILVAE GENET, V59, P137, DOI 10.1515/sg-2010-0016; Schueler S, 2006, MOL ECOL, V15, P3231, DOI 10.1111/j.1365-294X.2006.03029.x; Stoeckel S, 2006, MOL ECOL, V15, P2109, DOI 10.1111/j.1365-294X.2006.02926.x; Vaughan SP, 2007, HEREDITY, V98, P274, DOI 10.1038/sj.hdy.6800935; Vaughan SP, 2004, MOL ECOL NOTES, V4, P429, DOI 10.1111/j.1471-8286.2004.00673.x; Vekemans X, 2004, MOL ECOL, V13, P921, DOI 10.1046/j.1365-294X.2004.02076.x; Westergren M, 2012, SUMAR LIST, V136, P263	32	10	12	0	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 20	2012	7	7							e41231	10.1371/journal.pone.0041231	http://dx.doi.org/10.1371/journal.pone.0041231			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	977GL	22911762	Green Published, Green Submitted, gold			2022-12-25	WOS:000306644600057
J	Mannowetz, N; Wandernoth, PM; Wennemuth, G				Mannowetz, Nadja; Wandernoth, Petra M.; Wennemuth, Gunther			Glucose is a pH-Dependent Motor for Sperm Beat Frequency during Early Activation	PLOS ONE			English	Article							PROTEIN-TYROSINE PHOSPHORYLATION; MITOCHONDRIAL PYRUVATE CARRIER; SOLUBLE ADENYLYL-CYCLASE; MOUSE SPERMATOZOA; DICARBOXYLATE COTRANSPORTER; MAMMALIAN SPERMATOZOA; TYPE-1 HEXOKINASE; CYSTIC-FIBROSIS; TRANSPORT; CAPACITATION	To reach the egg in the ampulla, sperm have to travel along the female genital tract, thereby being dependent on external energy sources and substances to maintain and raise the flagellar beat. The vaginal fluid is rich in lactate, whereas in the uterine fluid glucose is the predominant substrate. This evokes changes in the lactate content of sperm as well as in the intracellular pH (pH(i)) since sperm possess lactate/proton co-transporters. It is well documented that glycolysis yields ATP and that HCO3- is a potent factor in the increase of beat frequency. We here show for the first time a pathway that connects both parts. We demonstrate a doubling of beat frequency in the mere presence of glucose. This effect can reversibly be blocked by 2-deoxy-D-glucose, dichloroacetate and aminooxyacetate, strongly suggesting that it requires both glycolysis and mitochondrial oxidation of glycolytic end products. We show that the glucose-mediated acceleration of flagellar beat and ATP production are hastened by a pH(i) >= 7.1, whereas a pH(i) <= 7.1 leaves both parameters unchanged. Since we observed a diminished rise in beat frequency in the presence of specific inhibitors against carbonic anhydrases, soluble adenylyl cyclase and protein kinase, we suggest that the glucose-mediated effect is linked to CO2 hydration and thus the production of HCO3- by intracellular CA isoforms. In summary, we propose that, in sperm, glycolysis is an additional pH(i)-dependent way to produce HCO3-, thus enhancing sperm beat frequency and contributing to fertility.	[Mannowetz, Nadja; Wandernoth, Petra M.; Wennemuth, Gunther] Univ Saarland, Dept Anat & Cell Biol, D-6650 Homburg, Germany	Saarland University	Mannowetz, N (corresponding author), Univ Saarland, Dept Anat & Cell Biol, D-6650 Homburg, Germany.	gunther.wennemuth@uks.eu		Wennemuth, Gunther/0000-0003-3313-2475				Aft RL, 2002, BRIT J CANCER, V87, P805, DOI 10.1038/sj.bjc.6600547; Bajpai M, 2006, BIOL REPROD, V74, P109, DOI 10.1095/biolreprod.105.043588; Buck J, 1999, P NATL ACAD SCI USA, V96, P79, DOI 10.1073/pnas.96.1.79; BURCKHARDT G, 1984, PFLUG ARCH EUR J PHY, V401, P254, DOI 10.1007/BF00582592; BURGOS C, 1995, BIOL REPROD, V53, P84, DOI 10.1095/biolreprod53.1.84; Carlson AE, 2007, DEV BIOL, V312, P183, DOI 10.1016/j.ydbio.2007.09.017; Chen XZ, 1998, J BIOL CHEM, V273, P20972, DOI 10.1074/jbc.273.33.20972; Chen YQ, 2000, SCIENCE, V289, P625, DOI 10.1126/science.289.5479.625; Demarco IA, 2003, J BIOL CHEM, V278, P7001, DOI 10.1074/jbc.M206284200; Eddy EM, 2003, MICROSC RES TECHNIQ, V61, P103, DOI 10.1002/jemt.10320; Edwards AS, 2000, CURR OPIN CELL BIOL, V12, P217, DOI 10.1016/S0955-0674(99)00085-X; Feiden S, 2008, REPROD FERT DEVELOP, V20, P713, DOI 10.1071/RD08004; Florman HM, 2007, P NATL ACAD SCI USA, V104, P11123, DOI 10.1073/pnas.0703626104; Ford WCL, 2006, HUM REPROD UPDATE, V12, P269, DOI 10.1093/humupd/dmi053; FRASER LR, 1990, J REPROD FERTIL, P9; GARDNER DK, 1990, J REPROD FERTIL, V88, P361, DOI 10.1530/jrf.0.0880361; Gawlik V, 2008, MOL MEMBR BIOL, V25, P224, DOI 10.1080/09687680701855405; Gomez O, 2006, REPRODUCTION, V131, P63, DOI 10.1530/rep.1.00750; HALESTRAP AP, 1975, BIOCHEM J, V148, P85, DOI 10.1042/bj1480085; HALESTRAP AP, 1978, BIOCHEM J, V172, P377, DOI 10.1042/bj1720377; HALESTRAP AP, 1980, INT J BIOCHEM, V11, P97, DOI 10.1016/0020-711X(80)90241-4; HALPERIN ML, 1969, J BIOL CHEM, V244, P384; Hertz L, 2005, J NEUROSCI RES, V79, P11, DOI 10.1002/jnr.20294; Hess KC, 2005, DEV CELL, V9, P249, DOI 10.1016/j.devcel.2005.06.007; HIIPAKKA RA, 1978, BIOL REPROD, V19, P368, DOI 10.1095/biolreprod19.2.368; Hildyard JCW, 2003, BIOCHEM J, V374, P607, DOI 10.1042/BJ20030995; HYNE RV, 1985, J REPROD FERTIL, V73, P59, DOI 10.1530/jrf.0.0730059; KAUPPINEN RA, 1987, BIOCHIM BIOPHYS ACTA, V930, P173, DOI 10.1016/0167-4889(87)90029-2; Kim ST, 2007, REPROD SCI, V14, P445, DOI 10.1177/1933719107306226; Kirichok Y, 2011, MOL HUM REPROD, V17, P478, DOI 10.1093/molehr/gar044; Lishko PV, 2010, CELL, V140, P327, DOI 10.1016/j.cell.2009.12.053; Mannowetz N, 2010, INT J ANDROL; Markovich D, 2004, PFLUG ARCH EUR J PHY, V447, P594, DOI 10.1007/s00424-003-1128-6; Miki Kiyoshi, 2007, Soc Reprod Fertil Suppl, V65, P309; MINAKAMI S, 1966, J BIOCHEM, V59, P145, DOI 10.1093/oxfordjournals.jbchem.a128275; MONTAMAT EE, 1988, BIOCHEM J, V255, P1053, DOI 10.1042/bj2551053; Mukai C, 2004, BIOL REPROD, V71, P540, DOI 10.1095/biolreprod.103.026054; Mycielska ME, 2009, BIOESSAYS, V31, P10, DOI 10.1002/bies.080137; Nakamura N, 2008, BIOL REPROD, V79, P537, DOI 10.1095/biolreprod.108.067561; Nakamura N, 2008, MOL REPROD DEV, V75, P632, DOI 10.1002/mrd.20791; Pajor AM, 2000, AM J PHYSIOL-RENAL, V279, pF482, DOI 10.1152/ajprenal.2000.279.3.F482; Palmieri F, 2004, PFLUG ARCH EUR J PHY, V447, P689, DOI 10.1007/s00424-003-1099-7; PAPA S, 1974, EUR J BIOCHEM, V49, P265, DOI 10.1111/j.1432-1033.1974.tb03831.x; PARKKILA S, 1991, HISTOCHEMISTRY, V95, P477, DOI 10.1007/BF00315743; STACPOOLE PW, 1989, METABOLISM, V38, P1124, DOI 10.1016/0026-0495(89)90051-6; Storey BT, 2008, INT J DEV BIOL, V52, P427, DOI 10.1387/ijdb.072522bs; UI M, 1966, BIOCHIM BIOPHYS ACTA, V124, P310, DOI 10.1016/0304-4165(66)90194-2; VISCONTI PE, 1995, DEVELOPMENT, V121, P1139; VISCONTI PE, 1995, DEVELOPMENT, V121, P1129; Wandernoth PM, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015061; Wang D, 2003, NAT CELL BIOL, V5, P1117, DOI 10.1038/ncb1072; Welch JE, 2000, J ANDROL, V21, P328; Wennemuth G, 2003, DEVELOPMENT, V130, P1317, DOI 10.1242/dev.00353; WICK AN, 1957, J BIOL CHEM, V224, P963; Xu WM, 2007, P NATL ACAD SCI USA, V104, P9816, DOI 10.1073/pnas.0609253104; Yao XZ, 2002, BIOCHEMISTRY-US, V41, P1083, DOI 10.1021/bi0156761; Zeng Y, 1996, DEV BIOL, V173, P510, DOI 10.1006/dbio.1996.0044	57	25	25	1	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 20	2012	7	7							e41030	10.1371/journal.pone.0041030	http://dx.doi.org/10.1371/journal.pone.0041030			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	977GL	22911736	Green Published, gold, Green Submitted			2022-12-25	WOS:000306644600040
J	Schwartze, VU; Hoffmann, K; Nyilasi, I; Papp, T; Vagvolgyi, C; de Hoog, S; Voigt, K; Jacobsen, ID				Schwartze, Volker U.; Hoffmann, Kerstin; Nyilasi, Ildiko; Papp, Tamas; Vagvoelgyi, Csaba; de Hoog, Sybren; Voigt, Kerstin; Jacobsen, Ilse D.			Lichtheimia Species Exhibit Differences in Virulence Potential	PLOS ONE			English	Article							MULTIPLE SEQUENCE ALIGNMENT; ALTERNATIVE INFECTION MODEL; CRYPTOCOCCUS-NEOFORMANS; MUCORMYCOSIS; SUSCEPTIBILITY; EPIDEMIOLOGY; TEMPERATURE; RHIZOPUS; SURVIVAL; DNA	Although the number of mucormycosis cases has increased during the last decades, little is known about the pathogenic potential of most mucoralean fungi. Lichtheimia species represent the second and third most common cause of mucormycosis in Europe and worldwide, respectively. To date only three of the five species of the genus have been found to be involved in mucormycosis, namely L. corymbifera, L. ramosa and L. ornata. However, it is not clear whether the clinical situation reflects differences in virulence between the species of Lichtheimia or whether other factors are responsible. In this study the virulence of 46 strains of all five species of Lichtheimia was investigated in chicken embryos. Additionally, strains of the closest-related genus Dichotomocladium were tested. Full virulence was restricted to the clinically relevant species while all strains of L. hyalospora, L. sphaerocystis and Dichotomocladium species were attenuated. Although virulence differences were present in the clinically relevant species, no connection between origin (environmental vs clinical) or phylogenetic position within the species was observed. Physiological studies revealed no clear connection of stress resistance and carbon source utilization with the virulence of the strains. Slower growth at 37 degrees C might explain low virulence of L. hyalospora, L. spaherocystis and Dichotomocladium; however, similarly slow growing strains of L. ornata were fully virulent. Thus, additional factors or a complex interplay of factors determines the virulence of strains. Our data suggest that the clinical situation in fact reflects different virulence potentials in the Lichtheimiaceae.	[Schwartze, Volker U.; Jacobsen, Ilse D.] Hans Knoell Inst, Leibniz Inst Nat Prod Res & Infect Biol, Dept Microbial Pathogen Mech, Jena, Germany; [Schwartze, Volker U.; Hoffmann, Kerstin; Voigt, Kerstin] Univ Jena, Inst Microbiol, Dept Microbiol & Mol Biol, Jena, Germany; [Nyilasi, Ildiko; Papp, Tamas; Vagvoelgyi, Csaba] Univ Szeged, Fac Sci & Informat, Dept Microbiol, Szeged, Hungary; [de Hoog, Sybren] CBS KNAW Fungal Biodivers Ctr, Utrecht, Netherlands	Hans Knoll Institute (HKI); Friedrich Schiller University of Jena; Szeged University; Royal Netherlands Academy of Arts & Sciences; Westerdijk Fungal Biodiversity Institute (KNAW)	Schwartze, VU (corresponding author), Hans Knoell Inst, Leibniz Inst Nat Prod Res & Infect Biol, Dept Microbial Pathogen Mech, Jena, Germany.	Ilse.jacobsen@hki-jena.de	Tamás, Papp/L-8272-2018; Vagvolgyi, Csaba/L-8497-2018; Voigt, Kerstin/AAA-9021-2019; Nyilasi, Ildikó/L-8288-2018; Jacobsen, Ilse/B-3155-2011	Vagvolgyi, Csaba/0000-0003-0009-7773; Nyilasi, Ildikó/0000-0001-7457-067X; Jacobsen, Ilse/0000-0002-6033-9984; Schwartze, Volker U./0000-0003-4429-6360; Papp, Tamas/0000-0001-8211-5431	University of Jena; Leibniz Institute for Natural Product Research and Infection Biology (Hans Knoll Institute)	University of Jena; Leibniz Institute for Natural Product Research and Infection Biology (Hans Knoll Institute)	This study was financially supported by the University of Jena and the Leibniz Institute for Natural Product Research and Infection Biology (Hans Knoll Institute). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alastruey-Izquierdo A, 2010, J CLIN MICROBIOL, V48, P2154, DOI 10.1128/JCM.01744-09; [Anonymous], 2007, MICROBE; Aufauvre-Brown A, 1998, EUR J CLIN MICROBIOL, V17, P778, DOI 10.1007/s100960050184; Bates S, 2006, J BIOL CHEM, V281, P90, DOI 10.1074/jbc.M510360200; Brock M, 2009, CURR OPIN MICROBIOL, V12, P371, DOI 10.1016/j.mib.2009.05.004; CENIS JL, 1992, NUCLEIC ACIDS RES, V20, P2380, DOI 10.1093/nar/20.9.2380; Champion OL, 2009, MICROBIOL-SGM, V155, P1516, DOI 10.1099/mic.0.026823-0; Cooney NM, 2008, CURR OPIN MICROBIOL, V11, P511, DOI 10.1016/j.mib.2008.09.018; Cymborowski B, 2000, ACTA BIOCHIM POL, V47, P215, DOI 10.18388/abp.2000_4080; Delgado ACN, 2005, MYCOPATHOLOGIA, V159, P7, DOI 10.1007/s11046-004-9618-4; DETILLEUX PG, 1988, VET PATHOL, V25, P138, DOI 10.1177/030098588802500206; Duran R, 2010, TOXINS, V2, P367, DOI 10.3390/toxins2040367; Ewbank JJ, 2011, DIS MODEL MECH, V4, P300, DOI 10.1242/dmm.006684; Fairley C, 2000, OPHTHALMOLOGY, V107, P555, DOI 10.1016/S0161-6420(99)00142-6; FROMTLING RA, 1989, MYCOPATHOLOGIA, V106, P163, DOI 10.1007/BF00443057; Garcia-Hermoso D, 2009, J CLIN MICROBIOL, V47, P3862, DOI 10.1128/JCM.02094-08; Gomes MZR, 2011, CLIN MICROBIOL REV, V24, P411, DOI 10.1128/CMR.00056-10; Hall T, 1999, NUCL ACIDS S SER, V41, P95, DOI DOI 10.1021/BK-1999-0734.CH008; HARTL A, 1995, ARZNEIMITTEL-FORSCH, V45-2, P926; Hoffmann K, 2007, MYCOL RES, V111, P1169, DOI 10.1016/j.mycres.2007.07.002; HUSSAIN S, 1995, EUR J RADIOL, V20, P151, DOI 10.1016/0720-048X(95)00644-6; Ibrahim AS, 2005, INFECT IMMUN, V73, P778, DOI 10.1128/IAI.73.2.778-783.2005; Jacobsen ID, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019741; Jacobsen ID, 2010, INFECT IMMUN, V78, P2995, DOI 10.1128/IAI.00268-10; Katoh K, 2002, NUCLEIC ACIDS RES, V30, P3059, DOI 10.1093/nar/gkf436; Lamaris GA, 2009, J INFECT DIS, V199, P1399, DOI 10.1086/597615; Lanternier F, 2012, CLIN INFECT DIS, V54, pS35, DOI 10.1093/cid/cir880; Liang KP, 2006, J CLIN MICROBIOL, V44, P892, DOI 10.1128/JCM.44.3.892-898.2006; Liu MF, 2010, J CLIN INVEST, V120, P1914, DOI 10.1172/JCI42164; McCormick A, 2010, CELL MICROBIOL, V12, P1535, DOI 10.1111/j.1462-5822.2010.01517.x; MICHENER CD, 1957, EVOLUTION, V11, P130, DOI 10.2307/2406046; Nakagawa Y, 2003, MICROBIOL IMMUNOL, V47, P395, DOI 10.1111/j.1348-0421.2003.tb03376.x; O'Donnell K, 1998, MYCOLOGIA, V90, P624, DOI 10.2307/3761222; ODONNELL K, 1993, FUNGAL HOLOMORPH : MITOTIC, MEIOTIC AND PLEOMORPHIC SPECIATION IN FUNGAL SYSTEMATICS, P225; Olias P, 2011, VET MICROBIOL, V148, P348, DOI 10.1016/j.vetmic.2010.08.029; Ribes JA, 2000, CLIN MICROBIOL REV, V13, P236, DOI 10.1128/CMR.13.2.236-301.2000; Roden MM, 2005, CLIN INFECT DIS, V41, P634, DOI 10.1086/432579; SAITOU N, 1987, MOL BIOL EVOL, V4, P406, DOI 10.1093/oxfordjournals.molbev.a040454; Skiada A, 2011, CLIN MICROBIOL INFEC, V17, P1859, DOI 10.1111/j.1469-0691.2010.03456.x; SUGAR AM, 1992, CLIN INFECT DIS, V14, pS126, DOI 10.1093/clinids/14.Supplement_1.S126; Swofford D.L., 2002, PAUP PHYLOGENETIC AN; THOMPSON JD, 1994, NUCLEIC ACIDS RES, V22, P4673, DOI 10.1093/nar/22.22.4673; TIEFFENBERG J, 1978, INFECT IMMUN, V19, P481, DOI 10.1128/IAI.19.2.481-485.1978; Tsung Lilian L. Y., 2010, Hong Kong Medical Journal, V16, P137; VOGELSTEIN B, 1979, P NATL ACAD SCI USA, V76, P615, DOI 10.1073/pnas.76.2.615; White T.J., 1990, PCR PROTOCOLS GUIDE, P315, DOI DOI 10.1016/B978-0-12-372180-8.50042-1; WOSTEMEYER J, 1985, EUR J BIOCHEM, V146, P443, DOI 10.1111/j.1432-1033.1985.tb08671.x	47	30	30	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 20	2012	7	7							e40908	10.1371/journal.pone.0040908	http://dx.doi.org/10.1371/journal.pone.0040908			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	977GL	22911715	gold, Green Published, Green Submitted			2022-12-25	WOS:000306644600026
J	Ling, H; Jolicoeur, P				Ling, H.; Jolicoeur, P.			Notch-1 signaling promotes the cyclinD1-dependent generation of mammary tumor-initiating cells that can revert to bi-potential progenitors from which they arise	ONCOGENE			English	Article						mammary tumors; Notch1; Cyclin D1 addiction; tumor-initiating cells	CANCER STEM-CELLS; BREAST-CANCER; STEM/PROGENITOR CELLS; GLAND DEVELOPMENT; HETEROGENEITY; FATE; IDENTIFICATION; TUMORIGENESIS; POPULATION; PHENOTYPE	In a previous work, we reported that young transgenic (Tg) mice expressing the intracellular domain of Notch1 (N1(IC)) showed expansion of lin(-) CD24(+) CD29(high) mammary cells enriched for stem cells and later developed mammary tumors. Mammary tumor formation was abolished or greatly reduced in cyclin D1(-/-) or cyclin D1(+/-) N1(IC) Tg mice, respectively. Here, we studied the epithelial cell subsets present in N1(IC)-induced tumors. CD24(-) CD29(int) and CD24(+) CD29(high) cells were found to be present at low numbers in tumors. The latter had the same properties as those expanded in young Tg females, and neither cell population showed tumor-initiating potential nor were they required for maintenance of tumors after transplantation. CD24(int) CD29(int) cells were identified as tumor-initiating and mammosphere-forming cells and represent a large percentage tumor cells in this model. Their number was significantly lower in tumors from cyclin D1(+/-) N1(IC) Tg mice. Using cyclin D1 shRNA knockdown, we also show that N1(IC)-induced tumor cells remain addicted to cyclin D1 for growth and survival. Interestingly, at lower levels of cyclin D1 or after transplantation in the presence of normal mammary cells, these N1(IC)-expressing tumor cells reverted to a state of low malignancy and differentiate into duct-like structures. They seem to adopt the fate of bi-potential stem/progenitor cells similar to that of the expanded CD24(+) CD29(high) stem/progenitor cells from which they are likely to be derived. Our data indicate that decreasing cyclin D1 levels would be an efficient treatment for tumors induced by N1 signaling.	[Ling, H.; Jolicoeur, P.] Clin Res Inst Montreal, Mol Biol Lab, Montreal, PQ H2W 1R7, Canada; [Jolicoeur, P.] McGill Univ, Div Expt Med, Montreal, PQ, Canada; [Jolicoeur, P.] Univ Montreal, Dept Microbiol & Immunol, Montreal, PQ H3C 3J7, Canada	Institut de Recherche Clinique de Montreal (IRCM); Universite de Montreal; McGill University; Universite de Montreal	Jolicoeur, P (corresponding author), Clin Res Inst Montreal, Mol Biol Lab, 110 Pine Ave W, Montreal, PQ H2W 1R7, Canada.	Paul.Jolicoeur@ircm.qc.ca			Canadian Institute of Health Research (CIHR); Canada Research Chair	Canadian Institute of Health Research (CIHR)(Canadian Institutes of Health Research (CIHR)); Canada Research Chair(Natural Resources CanadaCanadian Forest ServiceCanada Research Chairs)	This work was supported by grant to PJ from the Canadian Institute of Health Research (CIHR). PJ is a recipient of a Canada Research Chair. We thank Jean-Rene Sylvestre for excellent animal care. We are grateful to Annie Lavallee as well as to Eric Massicotte and Julie Lord for their excellent assistance with tissue sections and flow cytometry, respectively.	Baker M, 2008, NATURE, V454, P556, DOI [10.1038/454556a, 10.1038/456553a]; Booth BW, 2011, ONCOGENE, V30, P679, DOI 10.1038/onc.2010.439; Bouras T, 2008, CELL STEM CELL, V3, P429, DOI 10.1016/j.stem.2008.08.001; Bussard KM, 2010, CANCER RES, V70, P6336, DOI 10.1158/0008-5472.CAN-10-0591; Callahan R, 2004, J MAMMARY GLAND BIOL, V9, P145, DOI 10.1023/B:JOMG.0000037159.63644.81; Cho RW, 2008, STEM CELLS, V26, P364, DOI 10.1634/stemcells.2007-0440; Clarke MF, 2006, CELL, V124, P1111, DOI 10.1016/j.cell.2006.03.011; Clevers H, 2011, NAT MED, V17, P313, DOI 10.1038/nm.2304; DEOME KB, 1959, CANCER RES, V19, P515; Dirks PB, 2006, NATURE, V444, P687, DOI 10.1038/444687a; Dontu G, 2005, J MAMMARY GLAND BIOL, V10, P75, DOI 10.1007/s10911-005-2542-5; Dontu G, 2004, BREAST CANCER RES, V6, pR605, DOI 10.1186/bcr920; Dontu G, 2004, TRENDS ENDOCRIN MET, V15, P193, DOI 10.1016/j.tem.2004.05.011; Grimshaw MJ, 2008, BREAST CANCER RES, V10, DOI 10.1186/bcr2106; Gupta PB, 2009, NAT MED, V15, P1010, DOI 10.1038/nm0909-1010; HEPPNER GH, 1984, CANCER RES, V44, P2259; Hill RP, 2006, CANCER RES, V66, P1891, DOI 10.1158/0008-5472.CAN-05-3450; Hu CY, 2006, AM J PATHOL, V168, P973, DOI 10.2353/ajpath.2006.050416; Hu YF, 2009, J IMMUNOL METHODS, V347, P70, DOI 10.1016/j.jim.2009.06.008; ILLMENSEE K, 1976, P NATL ACAD SCI USA, V73, P549, DOI 10.1073/pnas.73.2.549; Ishizawa K, 2010, CELL STEM CELL, V7, P279, DOI 10.1016/j.stem.2010.08.009; Jordan CT, 2006, NEW ENGL J MED, V355, P1253, DOI 10.1056/NEJMra061808; Kelly PN, 2007, SCIENCE, V317, P337, DOI 10.1126/science.1142596; Kordon EC, 1998, DEVELOPMENT, V125, P1921; Li Y, 2003, P NATL ACAD SCI USA, V100, P15853, DOI 10.1073/pnas.2136825100; Li Z, 2007, CANCER CELL, V12, P542, DOI 10.1016/j.ccr.2007.11.012; Lim E, 2009, NAT MED, V15, P907, DOI 10.1038/nm.2000; Ling H, 2010, ONCOGENE, V29, P4543, DOI 10.1038/onc.2010.186; Liu BY, 2004, P NATL ACAD SCI USA, V101, P4158, DOI 10.1073/pnas.0400699101; Liu JC, 2007, CANCER RES, V67, P8671, DOI 10.1158/0008-5472.CAN-07-1486; Molyneux G, 2010, CELL STEM CELL, V7, P403, DOI 10.1016/j.stem.2010.07.010; Pece S, 2010, CELL, V140, P62, DOI 10.1016/j.cell.2009.12.007; Polyak K, 2006, NAT MED, V12, P296, DOI 10.1038/nm1379; Proia TA, 2011, CELL STEM CELL, V8, P149, DOI 10.1016/j.stem.2010.12.007; Quintana E, 2008, NATURE, V456, P593, DOI 10.1038/nature07567; Reya T, 2001, NATURE, V414, P105, DOI 10.1038/35102167; Robinson DR, 2011, NAT MED, V17, P1646, DOI 10.1038/nm.2580; Rosen JM, 2009, SCIENCE, V324, P1670, DOI 10.1126/science.1171837; Sansone P, 2007, J CLIN INVEST, V117, P3988, DOI 10.1172/JCI32533; Shackleton M, 2006, NATURE, V439, P84, DOI 10.1038/nature04372; Shackleton M, 2009, CELL, V138, P822, DOI 10.1016/j.cell.2009.08.017; Smith GH, 2001, MICROSC RES TECHNIQ, V52, P190, DOI 10.1002/1097-0029(20010115)52:2<190::AID-JEMT1005>3.0.CO;2-O; Smith GH, 2008, BREAST CANCER RES, V10, DOI 10.1186/bcr1856; Stingl J, 2006, NATURE, V439, P993, DOI 10.1038/nature04496; Vaillant F, 2008, CANCER RES, V68, P7711, DOI 10.1158/0008-5472.CAN-08-1949; Van Keymeulen A, 2011, NATURE, V479, P189, DOI 10.1038/nature10573; Visvader JE, 2009, GENE DEV, V23, P2563, DOI 10.1101/gad.1849509; Zhang M, 2008, CANCER RES, V68, P4674, DOI 10.1158/0008-5472.CAN-07-6353; Zheng XS, 2007, CANCER RES, V67, P3691, DOI 10.1158/0008-5472.CAN-06-3912	49	18	19	0	11	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	JUL 18	2013	32	29					3410	3419		10.1038/onc.2012.341	http://dx.doi.org/10.1038/onc.2012.341			10	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	186AZ	22907433	Green Accepted			2022-12-25	WOS:000322014900002
J	Razandi, M; Pedram, A; Jordan, VC; Fuqua, S; Levin, ER				Razandi, M.; Pedram, A.; Jordan, V. C.; Fuqua, S.; Levin, E. R.			Tamoxifen regulates cell fate through mitochondrial estrogen receptor beta in breast cancer	ONCOGENE			English	Article						estrogen receptor; mitochondria; apoptosis; tamoxifen resistance	MANGANESE-SUPEROXIDE-DISMUTASE; KINASE-C-DELTA; REACTIVE OXYGEN; INDUCED APOPTOSIS; EPITHELIAL-CELLS; RESPIRATORY-CHAIN; PLASMA-MEMBRANE; CYTOCHROME-C; STRESS; ALPHA	Tamoxifen (TAM) has both cytostatic and cytotoxic properties for breast cancer. TAM engaged mitochondrial estrogen receptor beta (ER beta) as an antagonist in MCF7-BK cells, increasing reactive oxygen species (ROS) concentrations from the mitochondria that were required for cytotoxicity. In part, this derived from TAM downregulating manganese superoxide dismutase (MnSOD) activity by causing the nitrosylation of tyrosine 34, thereby increasing ROS. ROS-activated protein kinase C delta and c-jun N-terminal kinases, resulting in the mitochondrial translocation of Bax and cytochrome C release. Interestingly, TAM failed to cause high ROS levels or induce cell death in MCF7-BK-TR cells due to stimulation of MnSOD activity through agonistic effects at mitochondrial ER beta. In several mouse xenograft models, lentiviral shRNA-induced knockdown of MnSOD caused tumors that grew in the presence of TAM to undergo substantial apoptosis. Tumor MnSOD and mitochondrial ER beta are therefore targets for therapeutic intervention to reverse TAM resistance and enhance a cell death response.	[Razandi, M.; Pedram, A.; Levin, E. R.] Vet Affairs Med Ctr, Div Endocrinol, Med Serv 111 1, Long Beach, CA 90822 USA; [Razandi, M.; Pedram, A.; Levin, E. R.] Univ Calif Irvine, Dept Med, Irvine, CA 92717 USA; [Razandi, M.; Pedram, A.; Levin, E. R.] Univ Calif Irvine, Dept Biochem, Irvine, CA 92717 USA; [Jordan, V. C.] Georgetown Univ, Lombardi Canc Ctr, Washington, DC USA; [Fuqua, S.] Baylor Coll Med, Houston, TX 77030 USA	US Department of Veterans Affairs; Veterans Health Administration (VHA); VA Long Beach Healthcare System; University of California System; University of California Irvine; University of California System; University of California Irvine; Georgetown University; Baylor College of Medicine	Levin, ER (corresponding author), Vet Affairs Med Ctr, Div Endocrinol, Med Serv 111 1, 5901 E,7th St, Long Beach, CA 90822 USA.	ellis.levin@va.gov	JORDAN, V.Craig/AAX-3562-2020; Jordan, V. Craig/H-4491-2011; Levin, Ellis/J-5402-2013		Research Service of the Department of Veteran's Affairs; NIH [CA-10036]; SPORE in Breast Cancer [P50CA89018]; Department of Defense Center of Excellence Grant [W81XWH-06-1-0590]; Georgetown Lombardi Comprehensive Cancer Spore Grant [P30CA051008]; NATIONAL CANCER INSTITUTE [R01CA100366, P30CA062203, P30CA051008, R01CA072038] Funding Source: NIH RePORTER	Research Service of the Department of Veteran's Affairs(US Department of Veterans Affairs); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); SPORE in Breast Cancer(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); Department of Defense Center of Excellence Grant; Georgetown Lombardi Comprehensive Cancer Spore Grant; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	The work was supported by grants from the Research Service of the Department of Veteran's Affairs, and NIH CA-10036 to ERL and SPORE in Breast Cancer (#P50CA89018), Department of Defense Center of Excellence Grant (#W81XWH-06-1-0590) (VCJ) and Georgetown Lombardi Comprehensive Cancer Spore Grant (#P30CA051008).	Arpino G, 2008, ENDOCR REV, V29, P217, DOI 10.1210/er.2006-0045; Aslan M, 2003, ANTIOXID REDOX SIGN, V5, P781, DOI 10.1089/152308603770380089; Barone I, 2011, JNCI-J NATL CANCER I, V103, P538, DOI 10.1093/jnci/djr058; Benhar M, 2002, EMBO REP, V3, P420, DOI 10.1093/embo-reports/kvf094; Brodie C, 2003, APOPTOSIS, V8, P19, DOI 10.1023/A:1021640817208; Chalut KJ, 2009, CANCER RES, V69, P1199, DOI 10.1158/0008-5472.CAN-08-3079; Chapman KE, 2005, AM J PHYSIOL-LUNG C, V289, pL834, DOI 10.1152/ajplung.00069.2005; Chen JQ, 2004, AM J PHYSIOL-ENDOC M, V286, pE1011, DOI 10.1152/ajpendo.00508.2003; Chua PJ, 2009, EXP BIOL MED, V234, P1086, DOI 10.3181/0903-RM-98; Clarke M, 1998, LANCET, V351, P1451; Dejean LM, 2005, MOL BIOL CELL, V16, P2424, DOI 10.1091/mbc.E04-12-1111; Di X, 2009, BIOCHEM PHARMACOL, V77, P1139, DOI 10.1016/j.bcp.2008.12.016; Diehn M, 2009, NATURE, V458, P780, DOI 10.1038/nature07733; Fan P, 2007, CANCER RES, V67, P1352, DOI 10.1158/0008-5472.CAN-06-1020; Felty Q, 2005, ONCOGENE, V24, P4883, DOI 10.1038/sj.onc.1208667; Flynn JM, 2008, AM J PHYSIOL-ENDOC M, V295, pE637, DOI 10.1152/ajpendo.90407.2008; Fuqua SAW, 2004, BREAST CANCER RES TR, V87, pS3; Gross A, 1998, EMBO J, V17, P3878, DOI 10.1093/emboj/17.14.3878; Halliwell B, 1999, FREE RADICAL RES, V31, P261, DOI 10.1080/10715769900300841; Han P, 2009, BIOCHEM BIOPH RES CO, V385, P251, DOI 10.1016/j.bbrc.2009.05.059; Harrington WR, 2003, MOL CELL ENDOCRINOL, V206, P13, DOI 10.1016/S0303-7207(03)00255-7; Hsieh YC, 2006, J MOL CELL CARDIOL, V41, P511, DOI 10.1016/j.yjmcc.2006.06.001; Huang CC, 2009, TOXICOLOGY, V255, P58, DOI 10.1016/j.tox.2008.10.001; Huang P, 2000, NATURE, V407, P390, DOI 10.1038/35030140; Hurtado A, 2008, NATURE, V456, P663, DOI 10.1038/nature07483; Ishikawa K, 2008, SCIENCE, V320, P661, DOI 10.1126/science.1156906; James AM, 2005, J BIOL CHEM, V280, P21295, DOI 10.1074/jbc.M501527200; Jurgensmeier JM, 1998, P NATL ACAD SCI USA, V95, P4997, DOI 10.1073/pnas.95.9.4997; Kim HS, 2010, CANCER CELL, V17, P41, DOI 10.1016/j.ccr.2009.11.023; Lebovitz RM, 1996, P NATL ACAD SCI USA, V93, P9782, DOI 10.1073/pnas.93.18.9782; LI YB, 1995, NAT GENET, V11, P376, DOI 10.1038/ng1295-376; Luce A, 2009, CARCINOGENESIS, V30, P432, DOI 10.1093/carcin/bgp008; MacMillan-Crow LA, 1998, BIOCHEMISTRY-US, V37, P1613, DOI 10.1021/bi971894b; Majumder PK, 2001, CELL GROWTH DIFFER, V12, P465; Mandlekar S, 2001, APOPTOSIS, V6, P469, DOI 10.1023/A:1012437607881; Milanesi L, 2009, STEROIDS, V74, P489, DOI 10.1016/j.steroids.2009.01.005; Mingo-Sion AM, 2004, ONCOGENE, V23, P596, DOI 10.1038/sj.onc.1207147; Moriai R, 2009, BREAST CANCER RES TR, V117, P261, DOI 10.1007/s10549-008-0164-5; Osborne CK, 2003, J NATL CANCER I, V95, P353, DOI 10.1093/jnci/95.5.353; Park WC, 2005, INT J ONCOL, V27, P1459; Pedram A, 2006, MOL BIOL CELL, V17, P2125, DOI 10.1091/mbc.E05-11-1013; Pedram A, 2006, MOL ENDOCRINOL, V20, P1996, DOI 10.1210/me.2005-0525; Pedram A, 2010, MOL ENDOCRINOL, V24, P2152, DOI 10.1210/me.2010-0154; Petros JA, 2005, P NATL ACAD SCI USA, V102, P719, DOI 10.1073/pnas.0408894102; Poyton RO, 2009, TRENDS ENDOCRIN MET, V20, P332, DOI 10.1016/j.tem.2009.04.001; Razandi M, 2000, MOL ENDOCRINOL, V14, P1434, DOI 10.1210/me.14.9.1434; Speirs V, 2008, BREAST CANCER RES, V10, DOI 10.1186/bcr2140; Tao RD, 2010, MOL CELL, V40, P893, DOI 10.1016/j.molcel.2010.12.013; Trounce I A, 1996, Methods Enzymol, V264, P484, DOI 10.1016/S0076-6879(96)64044-0; van de Vijver MJ, 2002, NEW ENGL J MED, V347, P1999, DOI 10.1056/NEJMoa021967; Xiao D, 2008, J BIOL CHEM, V283, P30151, DOI 10.1074/jbc.M802529200; Yamakura F, 1998, J BIOL CHEM, V273, P14085, DOI 10.1074/jbc.273.23.14085; Yang SH, 2004, P NATL ACAD SCI USA, V101, P4130, DOI 10.1073/pnas.0306948101	53	55	57	0	23	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232			ONCOGENE	Oncogene	JUL 4	2013	32	27					3274	3285		10.1038/onc.2012.335	http://dx.doi.org/10.1038/onc.2012.335			12	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	176JZ	22907432	Green Accepted, Green Submitted			2022-12-25	WOS:000321301600007
J	Aljakna, A; Choi, S; Savage, H; Blair, RH; Gu, TJ; Svenson, KL; Churchill, GA; Hibbs, M; Korstanje, R				Aljakna, Aleksandra; Choi, Seungbum; Savage, Holly; Blair, Rachael Hageman; Gu, Tongjun; Svenson, Karen L.; Churchill, Gary A.; Hibbs, Matt; Korstanje, Ron			Pla2g12b and Hpn Are Genes Identified by Mouse ENU Mutagenesis That Affect HDL Cholesterol	PLOS ONE			English	Article							HEPATOCYTE GROWTH-FACTOR; TRANSMEMBRANE SERINE-PROTEASE; CARDIOVASCULAR-DISEASE; MICE DEFICIENT; HEPSIN; METABOLISM; PHYSIOLOGY; EXPRESSION; VARIANCE; LIVER	Despite considerable progress understanding genes that affect the HDL particle, its function, and cholesterol content, genes identified to date explain only a small percentage of the genetic variation. We used N-ethyl-N-nitrosourea mutagenesis in mice to discover novel genes that affect HDL cholesterol levels. Two mutant lines (Hlb218 and Hlb320) with low HDL cholesterol levels were established. Causal mutations in these lines were mapped using linkage analysis: for line Hlb218 within a 12 Mbp region on Chr 10; and for line Hlb320 within a 21 Mbp region on Chr 7. High-throughput sequencing of Hlb218 liver RNA identified a mutation in Pla2g12b. The transition of G to A leads to a cysteine to tyrosine change and most likely causes a loss of a disulfide bridge. Microarray analysis of Hlb320 liver RNA showed a 7-fold downregulation of Hpn; sequencing identified a mutation in the 3' splice site of exon 8. Northern blot confirmed lower mRNA expression level in Hlb320 and did not show a difference in splicing, suggesting that the mutation only affects the splicing rate. In addition to affecting HDL cholesterol, the mutated genes also lead to reduction in serum non-HDL cholesterol and triglyceride levels. Despite low HDL cholesterol levels, the mice from both mutant lines show similar atherosclerotic lesion sizes compared to control mice. These new mutant mouse models are valuable tools to further study the role of these genes, their affect on HDL cholesterol levels, and metabolism.	[Aljakna, Aleksandra; Choi, Seungbum; Savage, Holly; Blair, Rachael Hageman; Gu, Tongjun; Svenson, Karen L.; Churchill, Gary A.; Hibbs, Matt; Korstanje, Ron] Jackson Lab, Bar Harbor, ME 04609 USA	Jackson Laboratory	Aljakna, A (corresponding author), Jackson Lab, 600 Main St, Bar Harbor, ME 04609 USA.	ron.korstanje@jax.org	Khan, Aleksandra Aljakna/AAJ-5913-2021; Churchill, Gary/AAY-7496-2020; Gu, Tongjun/AAE-4801-2020	Khan, Aleksandra Aljakna/0000-0002-9652-740X; Churchill, Gary/0000-0001-9190-9284; 	National Institute of General Medical Sciences [GM076468]; National Heart, Lung, and Blood Institute [HL095668]; American Recovery and Reinvestment Act (ARRA); National Research Service Award (NSRA) fellowship [1F32 HL095240]; National Cancer Institute [CA034196]; NATIONAL CANCER INSTITUTE [P30CA034196] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [F32HL095240, R01HL095668] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P50GM076468] Funding Source: NIH RePORTER	National Institute of General Medical Sciences(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); National Heart, Lung, and Blood Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); American Recovery and Reinvestment Act (ARRA); National Research Service Award (NSRA) fellowship(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by the National Institute of General Medical Sciences (grant GM076468 to AA, RK and GC); the National Heart, Lung, and Blood Institute (grant HL095668 and an American Recovery and Reinvestment Act (ARRA) supplement to RK and a National Research Service Award (NSRA) fellowship 1F32 HL095240 to RHB); and by the National Cancer Institute Cancer Core (grant CA034196 to the Jackson Laboratory). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AEBI M, 1987, CELL, V50, P237, DOI 10.1016/0092-8674(87)90219-4; Anderson N, 2008, PHARMACOL REV, V60, P311, DOI 10.1124/pr.108.00001; Bartlett K, 2004, EUR J BIOCHEM, V271, P462, DOI 10.1046/j.1432-1033.2003.03947.x; Bolstad BM, 2003, BIOINFORMATICS, V19, P185, DOI 10.1093/bioinformatics/19.2.185; Brolinson A, 2008, ENDOCRINOLOGY, V149, P3158, DOI 10.1210/en.2007-1402; Broman KW, 2009, STAT BIOL HEALTH, P1, DOI 10.1007/978-0-387-92125-9_1; Broman KW, 2003, BIOINFORMATICS, V19, P889, DOI 10.1093/bioinformatics/btg112; Bugge TH, 2009, J BIOL CHEM, V284, P23177, DOI 10.1074/jbc.R109.021006; Chen MQ, 2010, MOL CELL BIOCHEM, V337, P259, DOI 10.1007/s11010-009-0307-y; CHOMCZYNSKI P, 1992, ANAL BIOCHEM, V201, P134, DOI 10.1016/0003-2697(92)90185-A; Cohen JC, 2011, SCIENCE, V332, P1519, DOI 10.1126/science.1204265; Cui XG, 2005, BIOSTATISTICS, V6, P59, DOI 10.1093/biostatistics/kxh018; Dunning MJ, 2007, BIOINFORMATICS, V23, P2183, DOI 10.1093/bioinformatics/btm311; Fafalios A, 2011, NAT MED, V17, P1577, DOI 10.1038/nm.2531; Farmer JA, 2011, CURR ATHEROSCLER REP, V13, P107, DOI 10.1007/s11883-011-0166-3; Ferre F, 2005, BIOINFORMATICS, V21, P2336, DOI 10.1093/bioinformatics/bti328; Friedman JR, 2006, CELL MOL LIFE SCI, V63, P2317, DOI 10.1007/s00018-006-6095-6; Ganesan R, 2011, MOL CANCER RES, V9, P1175, DOI 10.1158/1541-7786.MCR-11-0004; Gentleman RC, 2004, GENOME BIOL, V5, DOI 10.1186/gb-2004-5-10-r80; Grano M, 1996, P NATL ACAD SCI USA, V93, P7644, DOI 10.1073/pnas.93.15.7644; Gross DA, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010796; Guan M, 2011, HEPATOLOGY, V53, P458, DOI 10.1002/hep.24066; Guipponi M, 2007, AM J PATHOL, V171, P608, DOI 10.2353/ajpath.2007.070068; Hebbard L, 2011, NAT REV GASTRO HEPAT, V8, P34, DOI 10.1038/nrgastro.2010.191; Hooper AJ, 2011, J LIPID RES, V52, P593, DOI 10.1194/jlr.R008896; Hunt MC, 2002, J BIOL CHEM, V277, P1128, DOI 10.1074/jbc.M106458200; Ikonen E, 2008, NAT REV MOL CELL BIO, V9, P125, DOI 10.1038/nrm2336; Kataoka H, 2010, FEBS J, V277, P2230, DOI 10.1111/j.1742-4658.2010.07640.x; Kerr MK, 2000, J COMPUT BIOL, V7, P819, DOI 10.1089/10665270050514954; King VL, 2011, CURR OPIN LIPIDOL, V22, P302, DOI 10.1097/MOL.0b013e3283488c39; KURACHI K, 1994, METHOD ENZYMOL, V244, P100; Laffel L, 1999, DIABETES-METAB RES, V15, P412, DOI 10.1002/(SICI)1520-7560(199911/12)15:6<412::AID-DMRR72>3.0.CO;2-8; Langmead B, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-3-r25; LEHNINGER AL, 1960, J BIOL CHEM, V235, P2450; LEYTUS SP, 1988, BIOCHEMISTRY-US, V27, P1067, DOI 10.1021/bi00403a032; Liden M, 2003, MOL ASPECTS MED, V24, P403, DOI 10.1016/S0098-2997(03)00036-0; Lloyd-Jones D, 2010, CIRCULATION, V121, P948, DOI 10.1161/CIRCULATIONAHA.109.192666; Lopez AD, 2006, LANCET, V367, P1747, DOI 10.1016/S0140-6736(06)68770-9; Mandl J, 2009, BRIT J PHARMACOL, V157, P1097, DOI 10.1111/j.1476-5381.2009.00282.x; Massa ML, 2011, IUBMB LIFE, V63, P1, DOI 10.1002/iub.411; Mathers CD, 2006, PLOS MED, V3, DOI 10.1371/journal.pmed.0030442; Mead JR, 2002, J MOL MED, V80, P753, DOI 10.1007/s00109-002-0384-9; Miziorko HM, 2011, ARCH BIOCHEM BIOPHYS, V505, P131, DOI 10.1016/j.abb.2010.09.028; Movva R, 2009, ANN BIOL CLIN-PARIS, V67, P7, DOI [10.1373/clinchem.2007.101923, 10.1684/abc.2008.0284]; Murakami M, 2011, J BIOCHEM, V150, P233, DOI 10.1093/jb/mvr088; Nadeau JH, 2000, NAT GENET, V25, P381, DOI 10.1038/78051; Nakamura T, 2011, J GASTROEN HEPATOL, V26, P188, DOI 10.1111/j.1440-1746.2010.06549.x; NISHINA PM, 1990, J LIPID RES, V31, P859; PAIGEN B, 1987, ATHEROSCLEROSIS, V68, P231, DOI 10.1016/0021-9150(87)90202-4; Ragbir S, 2010, CURR ATHEROSCLER REP, V12, P343, DOI 10.1007/s11883-010-0091-x; Ralph SJ, 2010, MOL ASPECTS MED, V31, P29, DOI 10.1016/j.mam.2009.12.006; Rouault M, 2003, BIOCHEMISTRY-US, V42, P11494, DOI 10.1021/bi0349930; Schultz JM, 2009, AM J HUM GENET, V85, P25, DOI 10.1016/j.ajhg.2009.06.003; Somoza JR, 2003, STRUCTURE, V11, P1123, DOI 10.1016/S0969-2126(03)00148-5; Strong A, 2010, CURR CARDIOVASC RISK, V4, P461, DOI 10.1007/s12170-010-0131-7; Sundaram M, 2010, NUTR METAB, V7, DOI 10.1186/1743-7075-7-35; Svenson KL, 2003, J APPL PHYSIOL, V94, P1650, DOI 10.1152/japplphysiol.01029.2003; Teslovich TM, 2010, NATURE, V466, P707, DOI 10.1038/nature09270; TORRESROSADO A, 1993, P NATL ACAD SCI USA, V90, P7181, DOI 10.1073/pnas.90.15.7181; Toth Peter P, 2007, Curr Atheroscler Rep, V9, P81, DOI 10.1007/BF02693933; TSUJI A, 1991, J BIOL CHEM, V266, P16948; Wang Chun, 2010, Front Biosci (Schol Ed), V2, P515; Ward JR, 2009, CLIN EXP IMMUNOL, V156, P386, DOI 10.1111/j.1365-2249.2009.03886.x; Weiner ID, 2011, AM J PHYSIOL-RENAL, V300, pF11, DOI 10.1152/ajprenal.00554.2010; Wu H., 2003, ANAL GENE EXPRESSION, P313, DOI DOI 10.1007/0-387-21679-0_14; Wu QY, 1998, J CLIN INVEST, V101, P321, DOI 10.1172/JCI1617	66	13	14	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 17	2012	7	8							e43139	10.1371/journal.pone.0043139	http://dx.doi.org/10.1371/journal.pone.0043139			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	996DG	22912808	Green Published, Green Submitted, gold			2022-12-25	WOS:000308063700047
J	Fatouros, NE; Lucas-Barbosa, D; Weldegergis, BT; Pashalidou, FG; van Loon, JJA; Dicke, M; Harvey, JA; Gols, R; Huigens, ME				Fatouros, Nina E.; Lucas-Barbosa, Dani; Weldegergis, Berhane T.; Pashalidou, Foteini G.; van Loon, Joop J. A.; Dicke, Marcel; Harvey, Jeffrey A.; Gols, Rieta; Huigens, Martinus E.			Plant Volatiles Induced by Herbivore Egg Deposition Affect Insects of Different Trophic Levels	PLOS ONE			English	Article							ELM LEAF BEETLE; WHITEBACKED PLANTHOPPER; COTESIA-GLOMERATA; PIERIS-BRASSICAE; RICE PLANTS; OVIPOSITION; DEFENSE; RESPONSES; CUES; PARASITOIDS	Plants release volatiles induced by herbivore feeding that may affect the diversity and composition of plant-associated arthropod communities. However, the specificity and role of plant volatiles induced during the early phase of attack, i.e. egg deposition by herbivorous insects, and their consequences on insects of different trophic levels remain poorly explored. In olfactometer and wind tunnel set-ups, we investigated behavioural responses of a specialist cabbage butterfly (Pieris brassicae) and two of its parasitic wasps (Trichogramma brassicae and Cotesia glomerata) to volatiles of a wild crucifer (Brassica nigra) induced by oviposition of the specialist butterfly and an additional generalist moth (Mamestra brassicae). Gravid butterflies were repelled by volatiles from plants induced by cabbage white butterfly eggs, probably as a means of avoiding competition, whereas both parasitic wasp species were attracted. In contrast, volatiles from plants induced by eggs of the generalist moth did neither repel nor attract any of the tested community members. Analysis of the plant's volatile metabolomic profile by gas chromatography-mass spectrometry and the structure of the plant-egg interface by scanning electron microscopy confirmed that the plant responds differently to egg deposition by the two lepidopteran species. Our findings imply that prior to actual feeding damage, egg deposition can induce specific plant responses that significantly influence various members of higher trophic levels.	[Fatouros, Nina E.; Lucas-Barbosa, Dani; Weldegergis, Berhane T.; Pashalidou, Foteini G.; van Loon, Joop J. A.; Dicke, Marcel; Gols, Rieta; Huigens, Martinus E.] Wageningen Univ, Entomol Lab, Res Ctr, Wageningen, Netherlands; [Harvey, Jeffrey A.] Netherlands Inst Ecol NIOO KNAW, Dept Terr Ecol, Wageningen, Netherlands; [Huigens, Martinus E.] Dutch Butterfly Conservat, Wageningen, Netherlands	Wageningen University & Research; Royal Netherlands Academy of Arts & Sciences; Netherlands Institute of Ecology (NIOO-KNAW)	Fatouros, NE (corresponding author), Wageningen Univ, Entomol Lab, Res Ctr, Wageningen, Netherlands.	nina.fatouros@wur.nl	Pashalidou, Foteini/Y-3913-2019; gols, rieta/H-7291-2019; Weldegergis, Berhane/F-6961-2012; Lucas-Barbosa, Dani/AAD-8133-2020; Harvey, Jeffrey A/B-7439-2008; Fatouros, Nina/AAO-9698-2020; Dicke, Marcel/B-2300-2010; KNAW, NIOO-KNAW/A-4320-2012; van Loon, Joop J.A./B-3744-2009	Harvey, Jeffrey A/0000-0002-4227-7935; Fatouros, Nina/0000-0003-0841-3144; Dicke, Marcel/0000-0001-8565-8896; Weldegergis, Berhane T./0000-0001-8838-7876; Gols, Rieta/0000-0002-6839-8225; KNAW, NIOO-KNAW/0000-0002-3835-159X; Paschalidou, Foteini/0000-0001-5746-8227; van Loon, Joop J.A./0000-0002-4260-0501	Netherlands Organisation for Scientific Research (NWO/ALW VENI) [863.05.020, 863.09.002]	Netherlands Organisation for Scientific Research (NWO/ALW VENI)(Netherlands Organization for Scientific Research (NWO))	The Netherlands Organisation for Scientific Research (NWO/ALW VENI grants 863.05.020 to Dr. Huigens and 863.09.002 to Dr. Fatouros) is acknowledged for funding. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Balbyshev NF, 1997, J ECON ENTOMOL, V90, P652, DOI 10.1093/jee/90.2.652; BEAMENT J. W. L., 1957, BULL ENT RES, V48, P109, DOI 10.1017/S0007485300054134; Beyaert I., 2011, P ROY SOC LOND B BIO, V279, P101; Blenn B, 2012, J CHEM ECOL, DOI [10.1007/s10886-10012-10132-10888, DOI 10.1007/S10886-10012-10132-10888]; Bruce TJA, 2010, BIOL LETTERS, V6, P314, DOI 10.1098/rsbl.2009.0953; Bruessow F, 2010, PLANT J, V62, P876, DOI 10.1111/j.1365-313X.2010.04200.x; Bruessow F, 2007, PLANT SIGNAL BEHAV, V2, P165, DOI 10.4161/psb.2.3.3690; Colazza S, 2004, J CHEM ECOL, V30, P945, DOI 10.1023/B:JOEC.0000028460.70584.d1; Colazza S, 2004, J EXP BIOL, V207, P47, DOI 10.1242/jeb.00732; Colazza S, 2010, PROG BIOL CONTROL, V9, P97, DOI 10.1007/978-1-4020-9110-0_4; Conti E, 2010, J EXP BIOL, V213, P3911, DOI 10.1242/jeb.045922; Conti E, 2008, EUR J ENTOMOL, V105, P839, DOI 10.14411/eje.2008.111; De Moraes CM, 2001, NATURE, V410, P577, DOI 10.1038/35069058; Desurmont GA, 2011, ECOL ENTOMOL, V36, P335, DOI 10.1111/j.1365-2311.2011.01277.x; Dicke M, 2010, TRENDS PLANT SCI, V15, P167, DOI 10.1016/j.tplants.2009.12.002; Dicke M, 2009, PLANT CELL ENVIRON, V32, P654, DOI 10.1111/j.1365-3040.2008.01913.x; Doss RP, 2000, P NATL ACAD SCI USA, V97, P6218, DOI 10.1073/pnas.110054697; DOSS RP, 1995, J CHEM ECOL, V21, P97, DOI 10.1007/BF02033665; Dudareva N, 2006, CRIT REV PLANT SCI, V25, P417, DOI 10.1080/07352680600899973; Eriksson L, 2006, MULTI AND MEGAVARI 1; Fatouros NE, 2005, ENTOMOL EXP APPL, V115, P207, DOI 10.1111/j.1570-7458.2005.00245.x; Fatouros NE, 2008, P NATL ACAD SCI USA, V105, P10033, DOI 10.1073/pnas.0707809105; Fatouros NE, 2009, J CHEM ECOL, V35, P1373, DOI 10.1007/s10886-009-9714-5; Penaflor MFGV, 2011, PLANTA, V234, P207, DOI 10.1007/s00425-011-1409-9; Figueroa IA, 2010, ATTRACTION TRICHOGRA; GEERVLIET JBF, 1994, ENTOMOL EXP APPL, V73, P289, DOI 10.1007/BF02382480; Geervliet JBF, 1996, J INSECT BEHAV, V9, P525, DOI 10.1007/BF02213877; Gols R, 2008, ECOLOGY, V89, P1616, DOI 10.1890/07-0873.1; Gols R, 2009, PHYTOCHEM REV, V8, P187, DOI 10.1007/s11101-008-9104-6; Gols R, 2009, OIKOS, V118, P733, DOI 10.1111/j.1600-0706.2008.17231.x; Gorb S., 2001, ATTACHMENT DEVICES I; Hare JD, 2011, ANNU REV ENTOMOL, V56, P161, DOI 10.1146/annurev-ento-120709-144753; Harvey JA, 2000, ECOL ENTOMOL, V25, P267, DOI 10.1046/j.1365-2311.2000.00265.x; Harvey JA, 2011, J CHEM ECOL, V37, P1081, DOI 10.1007/s10886-011-0024-3; Harvey JA, 2011, POPUL ECOL, V53, P587, DOI 10.1007/s10144-011-0267-4; Heil M, 2008, NEW PHYTOL, V178, P41, DOI 10.1111/j.1469-8137.2007.02330.x; Hilker M, 2002, J EXP BIOL, V205, P455; Hilker M, 2011, PHYTOCHEMISTRY, V72, P1612, DOI 10.1016/j.phytochem.2011.02.018; Hilker M, 2010, BIOL REV, V85, P267, DOI 10.1111/j.1469-185X.2009.00100.x; Hilker M, 2006, J CHEM ECOL, V32, P1379, DOI 10.1007/s10886-006-9057-4; Karban R., 1997, INDUCED RESPONSES HE, DOI 10.7208/chicago/9780226424972.001.0001; Kessler A, 2001, SCIENCE, V291, P2141, DOI 10.1126/science.291.5511.2141; Kessler A, 2007, CURR OPIN PLANT BIOL, V10, P409, DOI 10.1016/j.pbi.2007.06.001; Kessler A, 2011, FUNCT ECOL, V25, P348, DOI 10.1111/j.1365-2435.2010.01818.x; Kim J, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0037420; Little D, 2007, PLANT PHYSIOL, V143, P784, DOI 10.1104/pp.106.090837; Lucas-Barbosa D, 2012, FUNCT ECOL IN PRESS; MATTIACCI L, 1995, J INSECT BEHAV, V8, P485, DOI 10.1007/BF01995321; Meiners T, 2005, ENTOMOL EXP APPL, V115, P171, DOI 10.1111/j.1570-7458.2005.00280.x; Meiners T, 1997, OECOLOGIA, V112, P87, DOI 10.1007/s004420050287; Meiners T, 2000, J CHEM ECOL, V26, P221, DOI 10.1023/A:1005453830961; Mumm R, 2005, ENTOMOL EXP APPL, V115, P217, DOI 10.1111/j.1570-7458.2005.00262.x; Mumm R, 2010, CAN J ZOOL, V88, P628, DOI 10.1139/Z10-032; NOLDUS LPJJ, 1991, PHYSIOL ENTOMOL, V16, P329, DOI 10.1111/j.1365-3032.1991.tb00571.x; Pare PW, 1999, PLANT PHYSIOL, V121, P325, DOI 10.1104/pp.121.2.325; Pashalidou FG, 2010, ECOL ENTOMOL, V35, P748, DOI 10.1111/j.1365-2311.2010.01235.x; Petzold-Maxwell J, 2011, ECOL ENTOMOL, V36, P700, DOI 10.1111/j.1365-2311.2011.01315.x; PIMM SL, 1991, NATURE, V350, P669, DOI 10.1038/350669a0; Poelman EH, 2008, TRENDS PLANT SCI, V13, P534, DOI 10.1016/j.tplants.2008.08.003; Poelman EH, 2008, ENTOMOL EXP APPL, V127, P218, DOI 10.1111/j.1570-7458.2008.00700.x; Polaszek A, 2010, PROG BIOL CONTROL, V9, P237, DOI 10.1007/978-1-4020-9110-0_9; Schoonhoven L. M., 2005, Insect-plant biology; Schroder R, 2005, PLANT PHYSIOL, V138, P470, DOI 10.1104/pp.105.059915; Seino Y, 1996, APPL ENTOMOL ZOOL, V31, P467, DOI 10.1303/aez.31.467; SHAPIRO AM, 1987, OECOLOGIA, V71, P631, DOI 10.1007/BF00379310; Smallegange RC, 2007, J CHEM ECOL, V33, P1831, DOI 10.1007/s10886-007-9350-x; Suzuki Y, 1996, APPL ENTOMOL ZOOL, V31, P111, DOI 10.1303/aez.31.111; Tamiru A, 2012, J CHEM ECOL, V38, P231, DOI 10.1007/s10886-012-0082-1; Tamiru A, 2011, ECOL LETT, V14, P1075, DOI 10.1111/j.1461-0248.2011.01674.x; Turlings TCJ, 2004, PHYSIOL ENTOMOL, V29, P45, DOI 10.1111/j.1365-3032.2004.0362.x; Unsicker SB, 2009, CURR OPIN PLANT BIOL, V12, P479, DOI 10.1016/j.pbi.2009.04.001; Van der Putten WH, 2001, TRENDS ECOL EVOL, V16, P547, DOI 10.1016/S0169-5347(01)02265-0; Velikova V, 2010, J CHEM ECOL, V36, P629, DOI 10.1007/s10886-010-9801-7	73	110	116	0	168	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 17	2012	7	8							e43607	10.1371/journal.pone.0043607	http://dx.doi.org/10.1371/journal.pone.0043607			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	996DG	22912893	Green Published, Green Submitted, gold			2022-12-25	WOS:000308063700121
J	Franck, P; Siegwart, M; Olivares, J; Toubon, JF; Lavigne, C				Franck, Pierre; Siegwart, Myriam; Olivares, Jerome; Toubon, Jean-Francois; Lavigne, Claire			Multiple Origins of the Sodium Channel kdr Mutations in Codling Moth Populations	PLOS ONE			English	Article							INSECTICIDE RESISTANCE MECHANISMS; CYDIA-POMONELLA LEPIDOPTERA; AZINPHOS-METHYL RESISTANCE; IN-HOUSE FLIES; PYRETHROID RESISTANCE; KNOCKDOWN RESISTANCE; DELTAMETHRIN RESISTANCE; EVOLUTIONARY GENETICS; L. LEPIDOPTERA; TORTRICIDAE	Resistance to insecticides is one interesting example of a rapid current evolutionary change. DNA variability in the voltage-gated sodium channel gene (trans-membrane segments 5 and 6 in domain II) was investigated in order to estimate resistance evolution to pyrethroid in codling moth populations at the World level. DNA variation among 38 sequences revealed a unique kdr mutation (L1014F) involved in pyrethroid resistance in this gene region, which likely resulted from several convergent substitutions. The analysis of codling moth samples from 52 apple orchards in 19 countries using a simple PCR-RFLP confirmed that this kdr mutation is almost worldwide distributed. The proportions of kdr mutation were negatively correlated with the annual temperatures in the sampled regions. Homozygous kdr genotypes in the French apple orchards showed lower P450 cytochrome oxidase activities than other genotypes. The most plausible interpretation of the geographic distribution of kdr in codling moth populations is that it has both multiple independent origins and a spreading limited by low temperature and negative interaction with the presence of alternative resistance mechanisms to pyrethroid in the populations.	[Franck, Pierre; Siegwart, Myriam; Olivares, Jerome; Toubon, Jean-Francois; Lavigne, Claire] INRA, Plantes & Syst Culture Hort UR1115, Avignon, France	INRAE	Franck, P (corresponding author), INRA, Plantes & Syst Culture Hort UR1115, Avignon, France.	Pierre.Franck@avignon.inra.fr		Lavigne, Claire/0000-0003-2869-5177; Franck, Pierre/0000-0002-1904-8325	French program ECOGER "Ecco des vergers"	French program ECOGER "Ecco des vergers"	This study was partially funded by the French program ECOGER "Ecco des vergers". The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. No additional external funding was received for this study.	Alon M, 2006, INSECT BIOCHEM MOLEC, V36, P71, DOI 10.1016/j.ibmb.2005.10.007; Anstead JA, 2005, INSECT BIOCHEM MOLEC, V35, P249, DOI 10.1016/j.ibmb.2004.12.004; Berticat C, 2008, BMC EVOL BIOL, V8, DOI 10.1186/1471-2148-8-104; Boivin T, 2001, ENTOMOL EXP APPL, V99, P381, DOI 10.1023/A:1019232611880; Bouvier JC, 1998, ARCH INSECT BIOCHEM, V39, P55, DOI 10.1002/(SICI)1520-6327(1998)39:2&lt;55::AID-ARCH2&gt;3.0.CO;2-1; Bouvier JC, 2001, HEREDITY, V87, P456, DOI 10.1046/j.1365-2540.2001.00928.x; Brooke BD, 2008, T ROY SOC TROP MED H, V102, P524, DOI 10.1016/j.trstmh.2008.01.001; Brun-Barale A, 2005, PEST MANAG SCI, V61, P549, DOI 10.1002/ps.1002; Cao XM, 2006, ENVIRON ENTOMOL, V35, P1, DOI 10.1603/0046-225X-35.1.1; Davies TGE, 2008, PEST MANAG SCI, V64, P1126, DOI 10.1002/ps.1617; Denholm I, 2002, SCIENCE, V297, P2222, DOI 10.1126/science.1077266; DESOUSA G, 1995, ANAL BIOCHEM, V229, P86, DOI 10.1006/abio.1995.1382; Foster SP, 2003, HEREDITY, V91, P98, DOI 10.1038/sj.hdy.6800285; Franck P, 2010, J APPL ENTOMOL, V134, P191, DOI 10.1111/j.1439-0418.2009.01426.x; Fuentes-Contreras E, 2007, J ECON ENTOMOL, V100, P551, DOI 10.1603/0022-0493(2007)100[551:EOARAA]2.0.CO;2; Gibbs MJ, 2000, BIOINFORMATICS, V16, P573, DOI 10.1093/bioinformatics/16.7.573; Guerrero FD, 2002, J MED ENTOMOL, V39, P747, DOI 10.1603/0022-2585-39.5.747; Guillemaud T, 1996, HEREDITY, V77, P535, DOI 10.1038/hdy.1996.181; Hall T.A., 1999, NUCL ACIDS S SERIES, V41, P95, DOI [DOI 10.1021/BK-1999-0734.CH008, citeulike-article-id:691774, 10.12691/ajmr-6-4-3]; Heath L, 2006, J VIROL, V80, P11827, DOI 10.1128/JVI.01100-06; Jamroz RC, 1998, INSECT BIOCHEM MOLEC, V28, P1031, DOI 10.1016/S0965-1748(98)00094-0; Joly E, 1996, Methods Mol Biol, V58, P237; Kwon DH, 2004, PESTIC BIOCHEM PHYS, V80, P21, DOI 10.1016/j.pestbp.2004.06.001; Labbe P, 2005, J EVOLUTION BIOL, V18, P1471, DOI 10.1111/j.1420-9101.2005.00938.x; Lynd A, 2010, MOL BIOL EVOL, V27, P1117, DOI 10.1093/molbev/msq002; Martin D, 2000, BIOINFORMATICS, V16, P562, DOI 10.1093/bioinformatics/16.6.562; Martin DP, 2005, AIDS RES HUM RETROV, V21, P98, DOI 10.1089/aid.2005.21.98; Martinez-Torres D, 1999, PESTIC SCI, V55, P1012, DOI 10.1002/(SICI)1096-9063(199910)55:10&lt;1012::AID-PS39&gt;3.0.CO;2-5; Martinez-Torres D, 1998, INSECT MOL BIOL, V7, P179, DOI 10.1046/j.1365-2583.1998.72062.x; Meraner A, 2008, MOL PHYLOGENET EVOL, V48, P825, DOI 10.1016/j.ympev.2008.05.026; O'Reilly AO, 2006, BIOCHEM J, V396, P255, DOI 10.1042/BJ20051925; Padidam M, 1999, VIROLOGY, V265, P218, DOI 10.1006/viro.1999.0056; Park Y, 1997, INSECT BIOCHEM MOLEC, V27, P9, DOI 10.1016/S0965-1748(96)00077-X; Pinto J, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0001243; Posada D, 2001, P NATL ACAD SCI USA, V98, P13757, DOI 10.1073/pnas.241370698; Ranson H, 2000, INSECT MOL BIOL, V9, P491, DOI 10.1046/j.1365-2583.2000.00209.x; Reuveny H, 2004, ARCH INSECT BIOCHEM, V57, P92, DOI 10.1002/arch.20016; Reyes M, 2009, B ENTOMOL RES, V99, P359, DOI 10.1017/S0007485308006366; Reyes M, 2007, PEST MANAG SCI, V63, P890, DOI 10.1002/ps.1421; Reyes PFM, 2007, MOL ECOL, V16, P3554, DOI 10.1111/j.1365-294X.2007.03410.x; Ricci B, 2009, LANDSCAPE ECOL, V24, P337, DOI 10.1007/s10980-008-9308-6; Rinkevich FD, 2006, INSECT MOL BIOL, V15, P157, DOI 10.1111/j.1365-2583.2006.00620.x; Rinkevich FD, 2007, INSECT BIOCHEM MOLEC, V37, P550, DOI 10.1016/j.ibmb.2007.02.013; Rousset F, 2008, MOL ECOL RESOUR, V8, P103, DOI 10.1111/j.1471-8286.2007.01931.x; Sauphanor B, 1998, ENTOMOL EXP APPL, V88, P247, DOI 10.1023/A:1003452216629; Sauphanor B, 1998, J ECON ENTOMOL, V91, P1225, DOI 10.1093/jee/91.6.1225; Sauphanor B, 2000, PEST MANAG SCI, V56, P74, DOI 10.1002/(SICI)1526-4998(200001)56:1<74::AID-PS96>3.0.CO;2-C; ShelDeshova G. G., 1967, ENTOMOL REV, V46, P349; SMITH JM, 1992, J MOL EVOL, V34, P126; SMITH L. C., 1955, Journal of the Department of Agriculture of South Australia, V59, P12; Soderlund DM, 2003, INSECT BIOCHEM MOLEC, V33, P563, DOI 10.1016/S0965-1748(03)00023-7; Soleno J, 2008, PEST MANAG SCI, V64, P964, DOI 10.1002/ps.1582; Tamura K, 2007, MOL BIOL EVOL, V24, P1596, DOI 10.1093/molbev/msm092; THWAITE WG, 1993, PEST CONTROL & SUSTAINABLE AGRICULTURE, P166; Vais H, 2001, PEST MANAG SCI, V57, P877, DOI 10.1002/ps.392; VARELA LG, 1993, J ECON ENTOMOL, V86, P1, DOI 10.1093/jee/86.1.1; Voudouris CC, 2011, PESTIC BIOCHEM PHYS, V100, P229, DOI 10.1016/j.pestbp.2011.04.006; WALSH PS, 1991, BIOTECHNIQUES, V10, P506, DOI 10.2144/000114018; Williamson MS, 1996, MOL GENETICS EVOLUTI, P53; Zlotkin E, 1999, ANNU REV ENTOMOL, V44, P429, DOI 10.1146/annurev.ento.44.1.429	60	14	14	2	43	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 17	2012	7	8							e43543	10.1371/journal.pone.0043543	http://dx.doi.org/10.1371/journal.pone.0043543			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	996DG	22912889	Green Published, Green Submitted, gold			2022-12-25	WOS:000308063700117
J	Higuchi, T; Sakamoto, S; Kakinuma, Y; Kai, S; Yagyu, K; Todaka, H; Chi, E; Okada, S; Ujihara, T; Morisawa, K; Ono, M; Sugiyama, Y; Ishida, W; Fukushima, A; Tsuda, M; Agata, Y; Taniguchi, T				Higuchi, Takuma; Sakamoto, Shuji; Kakinuma, Yoshihiko; Kai, Shoko; Yagyu, Ken-ichi; Todaka, Hiroshi; Chi, Eunsup; Okada, Shoshiro; Ujihara, Takako; Morisawa, Keiko; Ono, Masafumi; Sugiyama, Yasunori; Ishida, Waka; Fukushima, Atsuki; Tsuda, Masayuki; Agata, Yasutoshi; Taniguchi, Taketoshi			High Expression of Nuclear Factor 90 (NF90) Leads to Mitochondrial Degradation in Skeletal and Cardiac Muscles	PLOS ONE			English	Article							MESSENGER-RNA STABILIZATION; ACTIVATED T-CELLS; BINDING-PROTEIN; NEGATIVE REGULATOR; IN-VIVO; KINASE; GENE; AUTOPHAGOSOME; BIOGENESIS; NF45	While NF90 has been known to participate in transcription, translation and microRNA biogenesis, physiological functions of this protein still remain unclear. To uncover this, we generated transgenic (Tg) mice using NF90 cDNA under the control of beta-actin promoter. The NF90 Tg mice exhibited a reduction in body weight compared with wild-type mice, and a robust expression of NF90 was detected in skeletal muscle, heart and eye of the Tg mice. To evaluate the NF90 overexpression-induced physiological changes in the tissues, we performed a number of analyses including CT-analysis and hemodynamic test, revealing that the NF90 Tg mice developed skeletal muscular atrophy and heart failure. To explore causes of the abnormalities in the NF90 Tg mice, we performed histological and biochemical analyses for the skeletal and cardiac muscles of the Tg mice. Surprisingly, these analyses demonstrated that mitochondria in those muscular tissues of the Tg mice were degenerated by autophagy. To gain further insight into the cause for the mitochondrial degeneration, we identified NF90-associated factors by peptide mass fingerprinting. Of note, approximately half of the NF90-associated complexes were ribosome-related proteins. Interestingly, protein synthesis rate was significantly suppressed by high-expression of NF90. These observations suggest that NF90 would negatively regulate the function of ribosome via its interaction with the factors involved in the ribosome function. Furthermore, we found that the translations or protein stabilities of PGC-1 and NRF-1, which are critical transcription factors for expression of mitochondrial genes, were significantly depressed in the skeletal muscles of the NF90 Tg mice. Taken together, these findings suggest that the mitochondrial degeneration engaged in the skeletal muscle atrophy and the heart failure in the NF90 Tg mice may be caused by NF90-induced posttranscriptional repression of transcription factors such as PGC-1 and NRF-1 for regulating nuclear-encoded genes relevant to mitochondrial function.	[Higuchi, Takuma; Sakamoto, Shuji; Kai, Shoko; Yagyu, Ken-ichi; Todaka, Hiroshi; Chi, Eunsup; Morisawa, Keiko; Sugiyama, Yasunori; Taniguchi, Taketoshi] Kochi Med Sch, Ctr Sci Res, Mol Biol Lab, Kochi, Japan; [Kakinuma, Yoshihiko] Kochi Med Sch, Dept Cardiovasc Control, Kochi, Japan; [Okada, Shoshiro] Aichi Med Univ, Sch Med, Dept Pharmacol, Aichi, Japan; [Ujihara, Takako] Kochi Med Sch, Ctr Sci Res, Facil Radioisotope Res, Kochi, Japan; [Ono, Masafumi] Kochi Med Sch, Dept Gastroenterol & Hepatol, Kochi, Japan; [Ishida, Waka; Fukushima, Atsuki] Kochi Med Sch, Dept Ophthalmol, Kochi, Japan; [Tsuda, Masayuki] Kochi Med Sch, Ctr Sci Res, Div Lab Anim Sci, Kochi, Japan; [Agata, Yasutoshi] Kyoto Univ, Grad Sch Med, Dept Immunol & Cell Biol, Kyoto, Japan	Kochi University; Kochi University; Aichi Medical University; Kochi University; Kochi University; Kochi University; Kochi University; Kyoto University	Higuchi, T (corresponding author), Kochi Med Sch, Ctr Sci Res, Mol Biol Lab, Kochi, Japan.	sshuji@kochi-u.ac.jp		Kakinuma, Yoshihiko/0000-0001-5470-9128; Agata, Yasutoshi/0000-0001-9642-6994	Ministry of Education, Culture, Sports, Science and Technology (MEXT) of Japan [21790280]; Kochi University Presidenta's Discretionary Grant	Ministry of Education, Culture, Sports, Science and Technology (MEXT) of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Kochi University Presidenta's Discretionary Grant	This work was supported by a Grant-in-Aid for Young Scientists (B) from The Ministry of Education, Culture, Sports, Science and Technology (MEXT) of Japan (grant numbers: 21790280. URL:http://kaken.nii.ac.jp/en/p/21790280) and The Kochi University Presidenta's Discretionary Grant. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Gwizdek C, 2004, J BIOL CHEM, V279, P884, DOI 10.1074/jbc.M306808200; He H, 2003, J BIOL CHEM, V278, P29278, DOI 10.1074/jbc.M303800200; Jin Y, 2005, ELECTROPHORESIS, V26, P1019, DOI 10.1002/elps.200410187; Kabeya Y, 2000, EMBO J, V19, P5720, DOI 10.1093/emboj/19.21.5720; KAO PN, 1994, J BIOL CHEM, V269, P20691; Kiesler P, 2010, J BIOL CHEM, V285, P8256, DOI 10.1074/jbc.M109.041004; KISSANE JM, 1958, J BIOL CHEM, V233, P184; Krol J, 2010, NAT REV GENET, V11, P597, DOI 10.1038/nrg2843; Kuwano Y, 2008, MOL CELL BIOL, V28, P4562, DOI 10.1128/MCB.00165-08; Kuwano Y, 2010, NUCLEIC ACIDS RES, V38, P225, DOI 10.1093/nar/gkp861; Mizushima N, 2004, MOL BIOL CELL, V15, P1101, DOI 10.1091/mbc.E03-09-0704; NIWA H, 1991, GENE, V108, P193, DOI 10.1016/0378-1119(91)90434-D; Patel RC, 1999, J BIOL CHEM, V274, P20432, DOI 10.1074/jbc.274.29.20432; Pfeifer I, 2008, P NATL ACAD SCI USA, V105, P4173, DOI 10.1073/pnas.0711222105; Puigserver P, 1998, CELL, V92, P829, DOI 10.1016/S0092-8674(00)81410-5; RANDO TA, 1994, J CELL BIOL, V125, P1275, DOI 10.1083/jcb.125.6.1275; Reichman TW, 2002, MOL CELL BIOL, V22, P343, DOI 10.1128/MCB.22.1.343-356.2002; Ryter JM, 1998, EMBO J, V17, P7505, DOI 10.1093/emboj/17.24.7505; Sakamoto S, 2001, J BIOL CHEM, V276, P37237, DOI 10.1074/jbc.M105543200; Sakamoto S, 1999, BIOCHEMISTRY-US, V38, P3355, DOI 10.1021/bi982099g; Sakamoto S, 2009, MOL CELL BIOL, V29, P3754, DOI 10.1128/MCB.01836-08; Saunders LR, 2003, FASEB J, V17, P961, DOI 10.1096/fj.02-0958rev; Schreiber SN, 2004, P NATL ACAD SCI USA, V101, P6472, DOI 10.1073/pnas.0308686101; Shi LF, 2005, J BIOL CHEM, V280, P18981, DOI 10.1074/jbc.M411034200; Shi LF, 2007, NUCLEIC ACIDS RES, V35, P2302, DOI 10.1093/nar/gkm117; Shim J, 2002, MOL CELL, V10, P1331, DOI 10.1016/S1097-2765(02)00730-X; STJOHNSTON D, 1992, P NATL ACAD SCI USA, V89, P10979, DOI 10.1073/pnas.89.22.10979; Tang J, 2000, J BIOL CHEM, V275, P19866, DOI 10.1074/jbc.M000023200; Tian B, 2001, J BIOL CHEM, V276, P9936, DOI 10.1074/jbc.M007328200; Ting NSY, 1998, J BIOL CHEM, V273, P2136, DOI 10.1074/jbc.273.4.2136; Wang P, 2009, J VIROL, V83, P7850, DOI 10.1128/JVI.00735-09; Wu JX, 2006, BIOCHEM BIOPH RES CO, V339, P437, DOI 10.1016/j.bbrc.2005.10.211; Wu ZD, 1999, CELL, V98, P115, DOI 10.1016/S0092-8674(00)80611-X; Zhou ZL, 2002, NATURE, V419, P182, DOI 10.1038/nature01031; Zhu P, 2010, J IMMUNOL, V185, P5140, DOI 10.4049/jimmunol.1000849	35	6	6	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 17	2012	7	8							e43340	10.1371/journal.pone.0043340	http://dx.doi.org/10.1371/journal.pone.0043340			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	996DG	22912857	Green Published, gold			2022-12-25	WOS:000308063700085
J	Keller, C; Kroening, S; Zuehlke, J; Kunath, F; Krueger, B; Goppelt-Struebe, M				Keller, Christof; Kroening, Sven; Zuehlke, Jonathan; Kunath, Frank; Krueger, Bettina; Goppelt-Struebe, Margarete			Distinct Mesenchymal Alterations in N-Cadherin and E-Cadherin Positive Primary Renal Epithelial Cells	PLOS ONE			English	Article							CHRONIC KIDNEY-DISEASE; RHO-KINASE INHIBITOR; TISSUE GROWTH-FACTOR; MUSCLE ACTIN EXPRESSION; TGF-BETA; DIABETIC-NEPHROPATHY; MYOFIBROBLAST TRANSDIFFERENTIATION; TRANSCRIPTION FACTORS; FEEDBACK LOOP; CANCER-CELLS	Background: Renal tubular epithelial cells of proximal and distal origin differ markedly in their physiological functions. Therefore, we hypothesized that they also differ in their capacity to undergo epithelial to mesenchymal alterations. Results: We used cultures of freshly isolated primary human tubular cells. To distinguish cells of different tubular origin we took advantage of the fact that human proximal epithelial cells uniquely express N-cadherin instead of E-cadherin as major cell-cell adhesion molecule. To provoke mesenchymal alteration we treated these cocultures with TGF-beta for up to 6 days. Within this time period, the morphology of distal tubular cells was barely altered. In contrast to tubular cell lines, E-cadherin was not down-regulated by TGF-beta, even though TGF-beta signal transduction was initiated as demonstrated by nuclear localization of Smad2/3. Analysis of transcription factors and miRNAs possibly involved in E-cadherin regulation revealed high levels of miRNAs of the miR200-family, which may contribute to the stability of E-cadherin expression in human distal tubular epithelial cells. By contrast, proximal tubular epithelial cells altered their phenotype when treated with TGF-beta. They became elongated and formed three-dimensional structures. Rho-kinases were identified as modulators of TGF-beta-induced morphological alterations. Non-specific inhibition of Rho-kinases resulted in stabilization of the epithelial phenotype, while partial effects were observed upon downregulation of Rho-kinase isoforms ROCK1 and ROCK2. The distinct reactivity of proximal and distal cells was retained when the cells were cultured as polarized cells. Conclusions: Interference with Rho-kinase signaling provides a target to counteract TGF-beta-mediated mesenchymal alterations of epithelial cells, particularly in proximal tubular epithelial cells. Furthermore, primary distal tubular cells differed from cell lines by their high phenotypic stability which included constant expression of E-cadherin. Our cell culture system of primary epithelial cells is thus suitable to understand and modulate cellular remodeling processes of distinct tubular cells relevant for human renal disease.	[Keller, Christof; Kroening, Sven; Zuehlke, Jonathan; Goppelt-Struebe, Margarete] Univ Erlangen Nurnberg, Dept Hypertens & Nephrol, D-91054 Erlangen, Germany; [Kunath, Frank] Univ Erlangen Nurnberg, Dept Urol, D-91054 Erlangen, Germany; [Krueger, Bettina] Univ Erlangen Nurnberg, Dept Cellular & Mol Physiol, D-91054 Erlangen, Germany	University of Erlangen Nuremberg; University of Erlangen Nuremberg; University of Erlangen Nuremberg	Keller, C (corresponding author), Univ Erlangen Nurnberg, Dept Hypertens & Nephrol, D-91054 Erlangen, Germany.	margarete.goppelt-struebe@uk-erlangen.de	Kunath, Frank/AAF-9389-2019	Kunath, Frank/0000-0003-3951-6058	Marohn Stiftung of the University of Erlangen-Nuremberg; Deutsche Forschungsgemeinschaft [SFB423]	Marohn Stiftung of the University of Erlangen-Nuremberg; Deutsche Forschungsgemeinschaft(German Research Foundation (DFG))	This study was supported by the Marohn Stiftung of the University of Erlangen-Nuremberg. CK and JZ were recipients of fellowships from the Deutsche Forschungsgemeinschaft, SFB423. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bhatt K, 2011, AM J PHYSIOL-RENAL, V300, pF602, DOI 10.1152/ajprenal.00727.2010; Bhowmick NA, 2001, MOL BIOL CELL, V12, P27, DOI 10.1091/mbc.12.1.27; Bishop AL, 2000, BIOCHEM J, V348, P241, DOI 10.1042/0264-6021:3480241; Bonventre JV, 1998, AM J PHYSIOL-RENAL, V275, pF623, DOI 10.1152/ajprenal.1998.275.5.F623; Brabletz S, 2011, EMBO J, V30, P770, DOI 10.1038/emboj.2010.349; Bracken CP, 2008, CANCER RES, V68, P7846, DOI 10.1158/0008-5472.CAN-08-1942; Das S, 2009, BMC CELL BIOL, V10, DOI 10.1186/1471-2121-10-94; Elberg G, 2008, AM J PHYSIOL-RENAL, V294, pF1116, DOI 10.1152/ajprenal.00142.2007; Forino M, 2006, INT J EXP PATHOL, V87, P197, DOI 10.1111/j.1365-2613.2006.00479.x; Fragiadaki M, 2011, INT J EXP PATHOL, V92, P143, DOI 10.1111/j.1365-2613.2011.00775.x; Fu P, 2006, J AM SOC NEPHROL, V17, P3105, DOI 10.1681/ASN.2005121366; Fukumoto Y, 2005, HEART, V91, P391, DOI 10.1136/hrt.2003.029470; Garcia-Sanchez O, 2010, KIDNEY INT, V77, P950, DOI 10.1038/ki.2010.88; Geiger TR, 2009, BBA-REV CANCER, V1796, P293, DOI 10.1016/j.bbcan.2009.07.006; Gregory PA, 2011, MOL BIOL CELL, V22, P1686, DOI 10.1091/mbc.E11-02-0103; Hahmann C, 2010, CELL MOL LIFE SCI, V67, P171, DOI 10.1007/s00018-009-0189-x; Haudek SB, 2009, CARDIOVASC RES, V83, P511, DOI 10.1093/cvr/cvp135; Hills CE, 2011, CYTOKINE GROWTH F R, V22, P131, DOI 10.1016/j.cytogfr.2011.06.002; Hills CE, 2009, AM J PHYSIOL-RENAL, V296, pF614, DOI 10.1152/ajprenal.90500.2008; Hugo HJ, 2011, CELLS TISSUES ORGANS, V193, P23, DOI 10.1159/000320174; Hutchison N, 2009, CELL SIGNAL, V21, P1522, DOI 10.1016/j.cellsig.2009.05.012; Ikenoya M, 2002, J NEUROCHEM, V81, P9, DOI 10.1046/j.1471-4159.2002.00801.x; Ivanova L, 2008, AM J PHYSIOL-RENAL, V294, pF1238, DOI 10.1152/ajprenal.00326.2007; Jiang J, 2004, TOXICOL SCI, V80, P170, DOI 10.1093/toxsci/kfh143; Koesters R, 2010, AM J PATHOL, V177, P632, DOI 10.2353/ajpath.2010.091012; Komers R, 2011, CURR OPIN NEPHROL HY, V20, P77, DOI 10.1097/MNH.0b013e32834131f8; Kriz W, 2011, J CLIN INVEST, V121, P468, DOI 10.1172/JCI44595; Kroening S, 2010, J CELL PHYSIOL, V223, P703, DOI 10.1002/jcp.22079; Kroening S, 2010, AM J PHYSIOL-RENAL, V298, pF796, DOI 10.1152/ajprenal.00528.2009; Kroening S, 2009, NEPHROL DIAL TRANSPL, V24, P3319, DOI 10.1093/ndt/gfp305; Liao DK, 2007, J CARDIOVASC PHARM, V50, P17, DOI 10.1097/FJC.0b013e318070d1bd; Lock FE, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0008190; Lorenzen JM, 2011, NAT REV NEPHROL, V7, P286, DOI 10.1038/nrneph.2011.26; Masszi A, 2003, AM J PHYSIOL-RENAL, V284, pF911, DOI 10.1152/ajprenal.00183.2002; Masumoto A, 2001, HYPERTENSION, V38, P1307, DOI 10.1161/hy1201.096541; Medici D, 2006, MOL BIOL CELL, V17, P1871, DOI 10.1091/mbc.E05-08-0767; Morita T, 2007, J CELL BIOL, V179, P1027, DOI 10.1083/jcb.200708174; Nishikimi T, 2006, J PHARMACOL SCI, V100, P22, DOI 10.1254/jphs.FMJ05003X5; NOUWEN EJ, 1993, KIDNEY INT, V44, P147, DOI 10.1038/ki.1993.225; Panorchan P, 2006, J CELL SCI, V119, P66, DOI 10.1242/jcs.02719; Park JW, 2011, J PHARMACOL EXP THER, V338, P271, DOI 10.1124/jpet.111.179457; Peinado H, 2003, J BIOL CHEM, V278, P21113, DOI 10.1074/jbc.M211304200; Prozialeck Walter C, 2004, BMC Physiol, V4, P10, DOI 10.1186/1472-6793-4-10; Ruperez M, 2005, KIDNEY INT, V68, P39; Sahai E, 2002, NAT CELL BIOL, V4, P408, DOI 10.1038/ncb796; Samarakoon R, 2010, CELL SIGNAL, V22, P1413, DOI 10.1016/j.cellsig.2010.03.020; Satoh S, 2002, EUR J PHARMACOL, V455, P169, DOI 10.1016/S0014-2999(02)02619-5; Schnaper HW, 2009, FRONT BIOSCI-LANDMRK, V14, P2448, DOI 10.2741/3389; Seidel B, 2004, ONCOGENE, V23, P5532, DOI 10.1038/sj.onc.1207718; Shimazui T, 2006, ONCOL REP, V15, P1181; Thiery JP, 2009, CELL, V139, P871, DOI 10.1016/j.cell.2009.11.007; Tian YC, 2003, AM J PHYSIOL-RENAL, V285, pF130, DOI 10.1152/ajprenal.00408.2002; Valcourt U, 2005, MOL BIOL CELL, V16, P1987, DOI 10.1091/mbc.e04-08-0658; Wang B, 2012, J AM SOC NEPHROL, V23, P252, DOI 10.1681/ASN.2011010055; Wang YP, 2009, CIRC RES, V104, P531, DOI 10.1161/CIRCRESAHA.108.188524; Xiong MX, 2012, AM J PHYSIOL-RENAL, V302, pF369, DOI 10.1152/ajprenal.00268.2011; Yoneda A, 2005, J CELL BIOL, V170, P443, DOI 10.1083/jcb.200412043; Zhang C, 2004, LIFE SCI, V75, P367, DOI 10.1016/j.lfs.2004.02.005; Zhang YE, 2009, CELL RES, V19, P128, DOI 10.1038/cr.2008.328; Zhang YM, 2006, FASEB J, V20, P916, DOI 10.1096/fj.05-5129com	60	30	30	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 17	2012	7	8							e43584	10.1371/journal.pone.0043584	http://dx.doi.org/10.1371/journal.pone.0043584			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	996DG	22912891	Green Submitted, gold, Green Published			2022-12-25	WOS:000308063700119
J	Lu, D; Davis, MPA; Abreu-Goodger, C; Wang, W; Campos, LS; Siede, J; Vigorito, E; Skarnes, WC; Dunham, I; Enright, AJ; Liu, PT				Lu, Dong; Davis, Matthew P. A.; Abreu-Goodger, Cei; Wang, Wei; Campos, Lia S.; Siede, Julia; Vigorito, Elena; Skarnes, William C.; Dunham, Ian; Enright, Anton J.; Liu, Pentao			MiR-25 Regulates Wwp2 and Fbxw7 and Promotes Reprogramming of Mouse Fibroblast Cells to iPSCs	PLOS ONE			English	Article							PLURIPOTENT STEM-CELLS; HUMAN SOMATIC-CELLS; TUMOR-SUPPRESSOR; SELF-RENEWAL; MICRORNA BIOGENESIS; RNA INTERFERENCE; UBIQUITIN LIGASE; GENERATION; EXPRESSION; ADULT	Background: miRNAs are a class of small non-coding RNAs that regulate gene expression and have critical functions in various biological processes. Hundreds of miRNAs have been identified in mammalian genomes but only a small number of them have been functionally characterized. Recent studies also demonstrate that some miRNAs have important roles in reprogramming somatic cells to induced pluripotent stem cells (iPSCs). Methods: We screened 52 miRNAs cloned in a piggybac (PB) vector for their roles in reprogramming of mouse embryonic fibroblast cells to iPSCs. To identify targets of miRNAs, we made Dgcr8-deficient embryonic stem (ES) cells and introduced miRNA mimics to these cells, which lack miRNA biogenesis. The direct target genes of miRNA were identified through global gene expression analysis and target validation. Results and conclusion: We found that over-expressing miR-25 or introducing miR-25 mimics enhanced production of iPSCs. We identified a number of miR-25 candidate gene targets. Of particular interest were two ubiquitin ligases, Wwp2 and Fbxw7, which have been proposed to regulate Oct4, c-Myc and Klf5, respectively. Our findings thus highlight the complex interplay between miRNAs and transcription factors involved in reprogramming, stem cell self-renewal and maintenance of pluripotency.	[Lu, Dong; Davis, Matthew P. A.; Wang, Wei; Campos, Lia S.; Skarnes, William C.; Liu, Pentao] Wellcome Trust Sanger Inst, Cambridge, England; [Davis, Matthew P. A.; Abreu-Goodger, Cei; Dunham, Ian; Enright, Anton J.] European Bioinformat Inst, Cambridge, England; [Siede, Julia; Vigorito, Elena] Babraham Inst, Lab Lymphocyte Signalling & Dev, Cambridge, England	Wellcome Trust Sanger Institute; European Molecular Biology Laboratory (EMBL); UK Research & Innovation (UKRI); Biotechnology and Biological Sciences Research Council (BBSRC); Babraham Institute	Lu, D (corresponding author), Wellcome Trust Sanger Inst, Wellcome Trust Genome Campus, Cambridge, England.	pl2@sanger.ac.uk	Enright, Anton/F-3094-2011; Abreu-Goodger, Cei/A-1268-2010	Enright, Anton/0000-0002-6090-3100; Abreu-Goodger, Cei/0000-0001-8302-9893; Dunham, Ian/0000-0003-2525-5598; Davis, Matthew/0000-0002-9909-3651	Wellcome Trust [077186/Z/05/Z]; MRC [G1001781, G0700287] Funding Source: UKRI; Medical Research Council [G1001781, G0700287] Funding Source: researchfish	Wellcome Trust(Wellcome TrustEuropean Commission); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	Funding provided by The Wellcome Trust (077186/Z/05/Z; www.wellcome.ac.uk/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aasen T, 2008, NAT BIOTECHNOL, V26, P1276, DOI 10.1038/nbt.1503; Anokye-Danso F, 2011, CELL STEM CELL, V8, P376, DOI 10.1016/j.stem.2011.03.001; Anton R, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0026257; Aoi T, 2008, SCIENCE, V321, P699, DOI 10.1126/science.1154884; Barroso-delJesus A, 2008, MOL CELL BIOL, V28, P6609, DOI 10.1128/MCB.00398-08; Bartel DP, 2009, CELL, V136, P215, DOI 10.1016/j.cell.2009.01.002; Brett JO, 2011, AGING-US, V3, P108, DOI 10.18632/aging.100285; Denli AM, 2004, NATURE, V432, P231, DOI 10.1038/nature03049; Du P, 2008, BIOINFORMATICS, V24, P1547, DOI 10.1093/bioinformatics/btn224; Feng B, 2009, NAT CELL BIOL, V11, P197, DOI 10.1038/ncb1827; Gentleman RC, 2004, GENOME BIOL, V5, DOI 10.1186/gb-2004-5-10-r80; Gregory RI, 2004, NATURE, V432, P235, DOI 10.1038/nature03120; Grishok A, 2001, CELL, V106, P23, DOI 10.1016/S0092-8674(01)00431-7; Gu P, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002548; Han JY, 2010, NATURE, V463, P1096, DOI 10.1038/nature08735; Han JJ, 2006, CELL, V125, P887, DOI 10.1016/j.cell.2006.03.043; Hanna J, 2008, CELL, V133, P250, DOI 10.1016/j.cell.2008.03.028; Hayashi K, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001738; Heng JCD, 2010, CELL STEM CELL, V6, P167, DOI 10.1016/j.stem.2009.12.009; Hong H, 2009, NATURE, V460, P1132, DOI 10.1038/nature08235; Houbaviy HB, 2003, DEV CELL, V5, P351, DOI 10.1016/S1534-5807(03)00227-2; Huangfu DW, 2008, NAT BIOTECHNOL, V26, P795, DOI 10.1038/nbt1418; Jiang JM, 2008, NAT CELL BIOL, V10, P353, DOI 10.1038/ncb1698; Judson RL, 2009, NAT BIOTECHNOL, V27, P459, DOI 10.1038/nbt.1535; Kanellopoulou C, 2005, GENE DEV, V19, P489, DOI 10.1101/gad.1248505; Kawamura T, 2009, NATURE, V460, P1140, DOI 10.1038/nature08311; Ketting RF, 2001, GENE DEV, V15, P2654, DOI 10.1101/gad.927801; Kim JB, 2008, NATURE, V454, P646, DOI 10.1038/nature07061; Koepp DM, 2001, SCIENCE, V294, P173, DOI 10.1126/science.1065203; Kumar M, 2011, ONCOGENE, V30, P843, DOI 10.1038/onc.2010.457; Lee Y, 2003, NATURE, V425, P415, DOI 10.1038/nature01957; Li H, 2009, NATURE, V460, P1136, DOI 10.1038/nature08290; Li RH, 2010, CELL STEM CELL, V7, P51, DOI 10.1016/j.stem.2010.04.014; Li ZH, 2011, EMBO J, V30, P823, DOI 10.1038/emboj.2011.2; Lin SL, 2008, RNA, V14, P2115, DOI 10.1261/rna.1162708; Lin SM, 2008, NUCLEIC ACIDS RES, V36, DOI 10.1093/nar/gkm1075; Liu N, 2010, J BIOL CHEM; Lowry WE, 2008, P NATL ACAD SCI USA, V105, P2883, DOI 10.1073/pnas.0711983105; Lu J, 2005, NATURE, V435, P834, DOI 10.1038/nature03702; Mali P, 2008, STEM CELLS, V26, P1998, DOI 10.1634/stemcells.2008-0346; Marson A, 2008, CELL, V134, P521, DOI 10.1016/j.cell.2008.07.020; Marson A, 2008, CELL STEM CELL, V3, P132, DOI 10.1016/j.stem.2008.06.019; Melton C, 2010, NATURE, V463, P621, DOI 10.1038/nature08725; Mi SL, 2007, P NATL ACAD SCI USA, V104, P19971, DOI 10.1073/pnas.0709313104; Minella AC, 2005, CELL CYCLE, V4, P1356, DOI 10.4161/cc.4.10.2058; Miyoshi N, 2011, CELL STEM CELL, V8, P633, DOI 10.1016/j.stem.2011.05.001; Murchison EP, 2005, P NATL ACAD SCI USA, V102, P12135, DOI 10.1073/pnas.0505479102; Niwa H, 2000, NAT GENET, V24, P372, DOI 10.1038/74199; Okita K, 2008, SCIENCE, V322, P949, DOI 10.1126/science.1164270; Okita K, 2007, NATURE, V448, P313, DOI 10.1038/nature05934; Park IH, 2008, NATURE, V451, P141, DOI [10.1038/nature06534, 10.1038/natureO6534]; Peltier HJ, 2008, RNA, V14, P844, DOI 10.1261/rna.939908; Razumilava N, 2012, HEPATOLOGY, V55, P465, DOI 10.1002/hep.24698; Rosenfeld N, 2008, NAT BIOTECHNOL, V26, P462, DOI 10.1038/nbt1392; Shen J, 2008, CARCINOGENESIS, V29, P1963, DOI 10.1093/carcin/bgn172; Shi Y, 2008, CELL STEM CELL, V2, P525, DOI 10.1016/j.stem.2008.05.011; Silva J, 2008, PLOS BIOL, V6, P2237, DOI 10.1371/journal.pbio.0060253; Smyth G.K., 2004, STAT APPL GENET MOL, V3, DOI DOI 10.2202/1544-6115.1027; Stadtfeld M, 2008, SCIENCE, V322, P945, DOI 10.1126/science.1162494; Stadtfeld M, 2008, CURR BIOL, V18, P890, DOI 10.1016/j.cub.2008.05.010; Takahashi K, 2007, CELL, V131, P861, DOI 10.1016/j.cell.2007.11.019; Takahashi K, 2006, CELL, V126, P663, DOI 10.1016/j.cell.2006.07.024; Tang FC, 2006, NUCLEIC ACIDS RES, V34, DOI 10.1093/nar/gnj009; Utikal J, 2009, NATURE, V460, P1145, DOI 10.1038/nature08285; van Dongen S, 2008, NAT METHODS, V5, P1023, DOI 10.1038/nmeth.1267; Wang W, 2008, P NATL ACAD SCI USA, V105, P9290, DOI 10.1073/pnas.0801017105; Wang W, 2011, P NATL ACAD SCI USA, V108, P18283, DOI 10.1073/pnas.1100893108; Wang YM, 2007, NAT GENET, V39, P380, DOI 10.1038/ng1969; Wang Y, 2008, NAT GENET, V40, P1478, DOI 10.1038/ng.250; Welcker M, 2008, NAT REV CANCER, V8, P83, DOI 10.1038/nrc2290; Wernig M, 2007, NATURE, V448, P318, DOI 10.1038/nature05944; Wilming LG, 2008, NUCLEIC ACIDS RES, V36, pD753, DOI 10.1093/nar/gkm987; Woltjen K, 2009, NATURE, V458, P766, DOI 10.1038/nature07863; Xu HM, 2004, J BIOL CHEM, V279, P23495, DOI 10.1074/jbc.M400516200; Xu HM, 2009, CELL RES, V19, P561, DOI 10.1038/cr.2009.31; Yada M, 2004, EMBO J, V23, P2116, DOI 10.1038/sj.emboj.7600217; Yanaihara N, 2006, CANCER CELL, V9, P189, DOI 10.1016/j.ccr.2006.01.025; Ying QL, 2008, NATURE, V453, P519, DOI 10.1038/nature06968; Yu JY, 2007, SCIENCE, V318, P1917, DOI 10.1126/science.1151526; Yu JY, 2009, SCIENCE, V324, P797, DOI 10.1126/science.1172482; Yusa K, 2009, NAT METHODS, V6, P363, DOI [10.1038/NMETH.1323, 10.1038/nmeth.1323]; Zhang HY, 2012, ONCOL REP, V27, P594, DOI 10.3892/or.2011.1530; Zhang L, 2006, P NATL ACAD SCI USA, V103, P9136, DOI 10.1073/pnas.0508889103; Zhao Y, 2008, CELL STEM CELL, V3, P475, DOI 10.1016/j.stem.2008.10.002	84	53	60	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 17	2012	7	8							e40938	10.1371/journal.pone.0040938	http://dx.doi.org/10.1371/journal.pone.0040938			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	996DG	22912667	Green Published, Green Submitted, gold			2022-12-25	WOS:000308063700002
J	Scalley-Kim, ML; Hess, BW; Kelly, RL; Krostag, ARF; Lustig, KH; Marken, JS; Ovendale, PJ; Posey, AR; Smolak, PJ; Taylor, JDL; Wood, CL; Bienvenue, DL; Probst, P; Salmon, RA; Allison, DS; Foy, TM; Raport, CJ				Scalley-Kim, Michelle L.; Hess, Bruce W.; Kelly, Ryan L.; Krostag, Anne-Rachel F.; Lustig, Kurt H.; Marken, John S.; Ovendale, Pamela J.; Posey, Aaron R.; Smolak, Pamela J.; Taylor, Janelle D. L.; Wood, C. L.; Bienvenue, David L.; Probst, Peter; Salmon, Ruth A.; Allison, Daniel S.; Foy, Teresa M.; Raport, Carol J.			Novel Highly Potent Therapeutic Antibody Neutralizes Multiple Human Chemokines and Mimics Viral Immune Modulation	PLOS ONE			English	Article							EXPERIMENTAL AUTOIMMUNE ENCEPHALOMYELITIS; COLLAGEN-INDUCED ARTHRITIS; CENTRAL-NERVOUS-SYSTEM; CCR5 D32 POLYMORPHISM; RHEUMATOID-ARTHRITIS; RECEPTOR CCR5; NEGATIVE ASSOCIATION; IN-VIVO; SCLEROSIS LESIONS; PERIPHERAL-BLOOD	Chemokines play a key role in leukocyte recruitment during inflammation and are implicated in the pathogenesis of a number of autoimmune diseases. As such, inhibiting chemokine signaling has been of keen interest for the development of therapeutic agents. This endeavor, however, has been hampered due to complexities in the chemokine system. Many chemokines have been shown to signal through multiple receptors and, conversely, most chemokine receptors bind to more than one chemokine. One approach to overcoming this complexity is to develop a single therapeutic agent that binds and inactivates multiple chemokines, similar to an immune evasion strategy utilized by a number of viruses. Here, we describe the development and characterization of a novel therapeutic antibody that targets a subset of human CC chemokines, specifically CCL3, CCL4, and CCL5, involved in chronic inflammatory diseases. Using a sequential immunization approach, followed by humanization and phage display affinity maturation, a therapeutic antibody was developed that displays high binding affinity towards the three targeted chemokines. In vitro, this antibody potently inhibits chemotaxis and chemokine-mediated signaling through CCR1 and CCR5, primary chemokine receptors for the targeted chemokines. Furthermore, we have demonstrated in vivo efficacy of the antibody in a SCID-hu mouse model of skin leukocyte migration, thus confirming its potential as a novel therapeutic chemokine antagonist. We anticipate that this antibody will have broad therapeutic utility in the treatment of a number of autoimmune diseases due to its ability to simultaneously neutralize multiple chemokines implicated in disease pathogenesis.	[Scalley-Kim, Michelle L.; Krostag, Anne-Rachel F.; Marken, John S.; Smolak, Pamela J.; Taylor, Janelle D. L.; Wood, C. L.; Allison, Daniel S.] VLST Corp, Dept Prot Engn, Seattle, WA USA; [Hess, Bruce W.; Lustig, Kurt H.; Ovendale, Pamela J.; Posey, Aaron R.; Probst, Peter; Salmon, Ruth A.; Foy, Teresa M.; Raport, Carol J.] VLST Corp, Dept Immunol & Preclin Pharmacol, Seattle, WA USA; [Kelly, Ryan L.; Bienvenue, David L.] VLST Corp, Dept Prot Sci, Seattle, WA USA		Scalley-Kim, ML (corresponding author), VLST Corp, Dept Prot Engn, Seattle, WA USA.	tfoy@vlstcorp.com			VLST Corporation	VLST Corporation	VLST Corporation funded the work in this manuscript. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alcami A, 2003, NAT REV IMMUNOL, V3, P36, DOI 10.1038/nri980; Amat M, 2006, BRIT J PHARMACOL, V149, P666, DOI 10.1038/sj.bjp.0706912; Armour KL, 1999, EUR J IMMUNOL, V29, P2613, DOI 10.1002/(SICI)1521-4141(199908)29:08<2613::AID-IMMU2613>3.0.CO;2-J; Balashov KE, 1999, P NATL ACAD SCI USA, V96, P6873, DOI 10.1073/pnas.96.12.6873; Barcellos LF, 2000, IMMUNOGENETICS, V51, P281, DOI 10.1007/s002510050621; Barnes DA, 1998, J CLIN INVEST, V101, P2910, DOI 10.1172/JCI2172; Berahovich RD, 2005, J IMMUNOL, V174, P7341, DOI 10.4049/jimmunol.174.11.7341; Buatois V, 2010, J IMMUNOL, V185, P2544, DOI 10.4049/jimmunol.1000182; Burns JM, 2002, J BIOL CHEM, V277, P2785, DOI 10.1074/jbc.M109884200; Carballido JM, 2003, J IMMUNOL METHODS, V273, P125, DOI 10.1016/S0022-1759(02)00422-2; CARTER P, 1992, P NATL ACAD SCI USA, V89, P4285, DOI 10.1073/pnas.89.10.4285; Carter PJ, 2006, NAT REV IMMUNOL, V6, P343, DOI 10.1038/nri1837; CHOTHIA C, 1989, NATURE, V342, P877, DOI 10.1038/342877a0; Conklyn MJ, 1996, CYTOKINE, V8, P762, DOI 10.1006/cyto.1996.0101; Coyle PK, 2010, AM J MANAG CARE, V16, pS164; Czaplewski LG, 1999, J BIOL CHEM, V274, P16077, DOI 10.1074/jbc.274.23.16077; Dahl ME, 2008, J PHARMACOL EXP THER, V327, P926, DOI 10.1124/jpet.108.142695; Deer JR, 2004, BIOTECHNOL PROGR, V20, P880, DOI 10.1021/bp034383r; Didier PJ, 1999, INFLAMMATION, V23, P75, DOI 10.1023/A:1020243701890; Dogan RNE, 2004, FRONT BIOSCI-LANDMRK, V9, P1500, DOI 10.2741/1284; Fagete S, 2009, MABS-AUSTIN, V1, P288, DOI 10.4161/mabs.1.3.8527; Firestein GS, 2003, NATURE, V423, P356, DOI 10.1038/nature01661; Fleishaker DL, 2012, ARTHRITIS RES THER, V14, DOI 10.1186/ar3685; Gade-Andavolu R, 2004, GENET MED, V6, P126, DOI 10.1097/01.GIM.0000127274.45301.54; Guan E, 2002, J BIOL CHEM, V277, P32348, DOI 10.1074/jbc.M203077200; Haringman JJ, 2006, ANN RHEUM DIS, V65, P294, DOI 10.1136/ard.2005.037176; HAWKINS RE, 1992, J MOL BIOL, V226, P889, DOI 10.1016/0022-2836(92)90639-2; Horuk R, 2009, NAT REV DRUG DISCOV, V8, P23, DOI 10.1038/nrd2734; Inoki I, 2001, FASEB J, V15, P219, DOI 10.1096/fj.01-0332fje; Jones JM, 2008, CYTOKINE, V43, P220, DOI 10.1016/j.cyto.2008.05.016; JONES ST, 1991, BIO-TECHNOL, V9, P579; Kabat EA, 1991, SEQUENCES PROTEINS I; KASAMA T, 1995, J CLIN INVEST, V95, P2868, DOI 10.1172/JCI117993; Katschke KJ, 2001, ARTHRITIS RHEUM, V44, P1022, DOI 10.1002/1529-0131(200105)44:5<1022::AID-ANR181>3.3.CO;2-E; Kohem C, 2007, SCAND J RHEUMATOL, V36, P359, DOI 10.1080/03009740701393999; KUNKEL TA, 1987, METHOD ENZYMOL, V154, P367; Labrijn AF, 2009, NAT BIOTECHNOL, V27, P767, DOI 10.1038/nbt.1553; Mahad DJ, 2004, J NEUROPATH EXP NEUR, V63, P262, DOI 10.1093/jnen/63.3.262; Matsui M, 2002, J NEUROIMMUNOL, V128, P16, DOI 10.1016/S0165-5728(02)00121-2; Mueller A, 2006, BIOCHEM PHARMACOL, V72, P739, DOI 10.1016/j.bcp.2006.06.001; PlaterZyberk C, 1997, IMMUNOL LETT, V57, P117, DOI 10.1016/S0165-2478(97)00075-8; Pokorny V, 2005, ANN RHEUM DIS, V64, P487, DOI 10.1136/ard.2004.023333; Prahalad S, 2006, GENES IMMUN, V7, P264, DOI 10.1038/sj.gene.6364298; Reid C, 2006, PROTEIN ENG DES SEL, V19, P317, DOI 10.1093/protein/gzl015; Rossi D, 2000, ANNU REV IMMUNOL, V18, P217, DOI 10.1146/annurev.immunol.18.1.217; Rossol M, 2009, ARTHRITIS RES THER, V11, DOI 10.1186/ar2733; Rottman JB, 2000, EUR J IMMUNOL, V30, P2372, DOI 10.1002/1521-4141(2000)30:8<2372::AID-IMMU2372>3.0.CO;2-D; Russo RC, 2010, CURR OPIN DRUG DISC, V13, P414; Sallusto F, 2008, NAT IMMUNOL, V9, P949, DOI 10.1038/ni.f.214; Sapir Y, 2010, J IMMUNOL, V185, P2589, DOI 10.4049/jimmunol.1000666; Schall TJ, 2011, NAT REV IMMUNOL, V11, P355, DOI 10.1038/nri2972; Schier Robert, 1996, Human Antibodies and Hybridomas, V7, P97; Seet BT, 2003, ANNU REV IMMUNOL, V21, P377, DOI 10.1146/annurev.immunol.21.120601.141049; Sellebjerg F, 2000, J NEUROIMMUNOL, V102, P98, DOI 10.1016/S0165-5728(99)00166-6; Sidhu SS, 2000, METHOD ENZYMOL, V328, P333, DOI 10.1016/S0076-6879(00)28406-1; Silversides JA, 2004, MULT SCLER J, V10, P149, DOI 10.1191/1352458504ms994oa; Simpson JE, 1998, J NEUROIMMUNOL, V84, P238, DOI 10.1016/S0165-5728(97)00208-7; Smith CA, 1997, VIROLOGY, V236, P316, DOI 10.1006/viro.1997.8730; Sorensen TL, 1999, J CLIN INVEST, V103, P807, DOI 10.1172/JCI5150; Sorensen TL, 1998, SEMIN NEUROL, V18, P287, DOI 10.1055/s-2008-1040879; Tak P.P., 2012, ANN RHEUM DIS; Tran EH, 2000, EUR J IMMUNOL, V30, P1410, DOI 10.1002/(SICI)1521-4141(200005)30:5<1410::AID-IMMU1410>3.0.CO;2-L; Trebst C, 2001, AM J PATHOL, V159, P1701, DOI 10.1016/S0002-9440(10)63017-9; Volin MV, 1998, CLIN IMMUNOL IMMUNOP, V89, P44, DOI 10.1006/clin.1998.4590; Yang YF, 2002, EUR J IMMUNOL, V32, P2124, DOI 10.1002/1521-4141(200208)32:8<2124::AID-IMMU2124>3.0.CO;2-S; Zapico I, 2000, GENES IMMUN, V1, P288, DOI 10.1038/sj.gene.6363673	66	7	9	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 17	2012	7	8							e43332	10.1371/journal.pone.0043332	http://dx.doi.org/10.1371/journal.pone.0043332			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	996DG	22912856	Green Published, gold, Green Submitted			2022-12-25	WOS:000308063700084
J	Galluzzi, L; De Santi, M; Crinelli, R; De Marco, C; Zaffaroni, N; Duranti, A; Brandi, G; Magnani, M				Galluzzi, Luca; De Santi, Mauro; Crinelli, Rita; De Marco, Cinzia; Zaffaroni, Nadia; Duranti, Andrea; Brandi, Giorgio; Magnani, Mauro			Induction of Endoplasmic Reticulum Stress Response by the Indole-3-Carbinol Cyclic Tetrameric Derivative CTet in Human Breast Cancer Cell Lines	PLOS ONE			English	Article							ANTICANCER AGENT; ER STRESS; APOPTOSIS; AUTOPHAGY; PATHWAY; DEATH; XBP1; ACTIVATION; PROTEINS; CAPACITY	Background: Indole-3-carbinol and its metabolic products are considered promising chemopreventive and anticancer agents. Previously we have shown that the indole-3-carbinol cyclic tetrameric derivative CTet induces autophagy and inhibits cell proliferation via inhibition of Akt activity and overexpression of p21/CDKN1A and GADD45A, in both estrogen receptor-positive (MCF-7) and triple negative (MDA-MB-231) breast cancer cell lines. In the present study, we further characterize the autophagic response and investigate the mechanism through which CTet regulates these events. Methodology/Principal Findings: Analysis of gene expression microarray data and subsequent confirmation by quantitative real-time PCR, showed that CTet is able to induce up-regulation of key signaling molecules involved in endoplasmic reticulum (ER) stress response (e. g. DDIT3/CHOP, CHAC1, ATF3, HSPA5/BiP/GRP78, CEBPB, ASNS) and autophagy (e. g. MAP1LC3B), in both MCF-7 and MDA-MB-231 cell lines. Moreover, the monitoring of Xbp-1 splicing confirmed the activation of IRE1/Xbp-1 ER stress response branch after CTet treatment. The role of autophagic processes (known to be induced by ER stress) was investigated further through ATG5 gene silencing and pharmacological inhibition of AVOs formation. CTet was shown to induce an autophagy-related cell death. Moreover, CTet-treated cells stained with Hoechst/PI revealed the presence of necrotic processes without evidence of apoptosis. Conclusions/Significance: The ER stress response was identified as the main upstream molecular mechanism through which CTet acts in both hormone-responsive and triple-negative breast cancer cells. Because of its important role in cancer development, ER stress is a potential target in cancer therapy. The abiltiy of CTet to induce ER stress response and subsequently activate a death program in tumor cells confirms this molecule as a promising anticancer agent.	[Galluzzi, Luca] Univ Urbino Carlo Bo, Dept Biomol Sci, Fano, PU, Italy; [De Santi, Mauro; Crinelli, Rita; Brandi, Giorgio; Magnani, Mauro] Univ Urbino Carlo Bo, Dept Biomol Sci, Urbino, PU, Italy; [De Marco, Cinzia; Zaffaroni, Nadia] Ist Nazl Tumori, Fdn IRCCS, Dept Expt Oncol & Mol Med, I-20133 Milan, Italy; [Duranti, Andrea] Univ Urbino Carlo Bo, Med Chem & Technol Unit, Dept Biomol Sci, Urbino, PU, Italy	University of Urbino; University of Urbino; Fondazione IRCCS Istituto Nazionale Tumori Milan; University of Urbino	Galluzzi, L (corresponding author), Univ Urbino Carlo Bo, Dept Biomol Sci, Fano, PU, Italy.	luca.galluzzi@uniurb.it	Magnani, Mauro/A-1919-2008; Zaffaroni, Nadia/J-8178-2016; De Marco, Cinzia/Y-7377-2018; Galluzzi, Luca/G-3969-2012; De Santi, Mauro/F-5401-2013	Zaffaroni, Nadia/0000-0002-4669-0890; De Marco, Cinzia/0000-0003-1153-270X; Galluzzi, Luca/0000-0002-1747-526X; De Santi, Mauro/0000-0003-2983-8344; Magnani, Mauro/0000-0001-6456-6626; Crinelli, Rita/0000-0002-1235-8910; Brandi, Giorgio/0000-0003-1380-6137	Italian Association for Cancer Research (AIRC)	Italian Association for Cancer Research (AIRC)(Fondazione AIRC per la ricerca sul cancro)	This work was supported in part by the Italian Association for Cancer Research (AIRC). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. No additional external funding received for this study.	Calfon M, 2002, NATURE, V415, P92, DOI 10.1038/415092a; Chen DZ, 2001, J NUTR, V131, P3294, DOI 10.1093/jn/131.12.3294; Coopman PJ, 1998, CLIN CANCER RES, V4, P507; Corradetti MN, 2005, J BIOL CHEM, V280, P9769, DOI 10.1074/jbc.C400557200; Cullinan SB, 2006, INT J BIOCHEM CELL B, V38, P317, DOI 10.1016/j.biocel.2005.09.018; De Santi M, 2011, BREAST CANCER RES, V13, DOI 10.1186/bcr2855; Du KY, 2003, SCIENCE, V300, P1574, DOI 10.1126/science.1079817; Gotoh T, 2011, INT J INFLAMM, V2011, DOI 10.4061/2011/259462; Guidarelli A, 2010, ANTIOXID REDOX SIGN, V13, P745, DOI 10.1089/ars.2009.2845; Healy SJM, 2009, EUR J PHARMACOL, V625, P234, DOI 10.1016/j.ejphar.2009.06.064; Hotamisligil GS, 2010, CELL, V140, P900, DOI 10.1016/j.cell.2010.02.034; Huang JX, 2009, BIOCHEM SOC T, V37, P217, DOI 10.1042/BST0370217; Huang J, 2011, ANTIOXID REDOX SIGN, V14, P2215, DOI 10.1089/ars.2010.3554; Kagawa S, 2001, CLIN CANCER RES, V7, P1474; Kanemoto S, 2005, BIOCHEM BIOPH RES CO, V331, P1146, DOI 10.1016/j.bbrc.2005.04.039; Li YW, 1999, ONCOGENE, V18, P3166, DOI 10.1038/sj.onc.1202650; LOWRY OH, 1951, J BIOL CHEM, V193, P265; Lucarini S, 2011, TETRAHEDRON LETT, V52, P2812, DOI 10.1016/j.tetlet.2011.03.117; Lucarini S, 2010, MOLECULES, V15, P4085, DOI 10.3390/molecules15064085; Menendez-Benito V, 2005, HUM MOL GENET, V14, P2787, DOI 10.1093/hmg/ddi312; Nishitoh H, 2002, GENE DEV, V16, P1345, DOI 10.1101/gad.992302; Paglin S, 2001, CANCER RES, V61, P439; Rao RV, 2004, CELL DEATH DIFFER, V11, P372, DOI 10.1038/sj.cdd.4401378; Rouschop KMA, 2010, J CLIN INVEST, V120, P127, DOI 10.1172/JCI40027; Samali A., 2010, INT J CELL BIOL, DOI [DOI 10.1155/2010/830307, DOI 10.1109/IJCNN.2010.5596663]; Schroder M, 2008, CELL MOL LIFE SCI, V65, P862, DOI 10.1007/s00018-007-7383-5; Shaw RJ, 2006, NATURE, V441, P424, DOI 10.1038/nature04869; Sun SS, 2004, CELL STRESS CHAPERON, V9, P76; TOWBIN H, 1979, P NATL ACAD SCI USA, V76, P4350, DOI 10.1073/pnas.76.9.4350; Ullman E, 2008, CELL DEATH DIFFER, V15, P422, DOI 10.1038/sj.cdd.4402234; Weng JR, 2008, CANCER LETT, V262, P153, DOI 10.1016/j.canlet.2008.01.033; Yamamoto K, 2004, J BIOCHEM, V136, P343, DOI 10.1093/jb/mvh122; Yamamoto K, 2008, J BIOCHEM, V144, P477, DOI 10.1093/jb/mvn091; Yorimitsu T, 2007, AUTOPHAGY, V3, P160, DOI 10.4161/auto.3653; Zhang JY, 2011, BMC MOL BIOL, V12, DOI 10.1186/1471-2199-12-25	35	42	45	1	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 14	2012	7	8							e43249	10.1371/journal.pone.0043249	http://dx.doi.org/10.1371/journal.pone.0043249			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	988OQ	22905241	Green Published, gold, Green Submitted			2022-12-25	WOS:000307500800066
J	Banerjee, S; Mujumdar, N; Dudeja, V; Mackenzie, T; Krosch, TK; Sangwan, V; Vickers, SM; Saluja, AK				Banerjee, Sulagna; Mujumdar, Nameeta; Dudeja, Vikas; Mackenzie, Tiffany; Krosch, Tara K.; Sangwan, Veena; Vickers, Selwyn M.; Saluja, Ashok K.			MUC1c Regulates Cell Survival in Pancreatic Cancer by Preventing Lysosomal Permeabilization	PLOS ONE			English	Article							GROWTH-FACTOR RECEPTOR; MULTIPLE-MYELOMA CELLS; HEAT-SHOCK-PROTEIN-70 FAMILY; METASTATIC PROPERTIES; ONCOPROTEIN FUNCTIONS; INDUCED APOPTOSIS; CYTOPLASMIC TAIL; MUCIN 1; HSP70; ADENOCARCINOMA	Background: MUC1 is a type I transmembrane glycoprotein aberrantly overexpressed in various cancer cells including pancreatic cancer. The cytosolic end of MUC1 (MUC1-c) is extensively involved in a number of signaling pathways. MUC1-c is reported to inhibit apoptosis in a number of cancer cells, but the mechanism of inhibition is unclear. Method: Expression of MUC1-c was studied in the pancreatic cancer cell line MIAPaCa-2 at the RNA level by using qRTPCR and at the protein level by Western blotting. MUC1-c expression was inhibited either by siRNA or by a specific peptide inhibitor, GO-201. Effect of MUC1-c inhibition on viability and proliferation and lysosomal permeabilization were studied. Association of MUC1-c with HSP70 was detected by co-immunoprecipitation of MUC1-c and HSP70. Localization of MUC1-c in cellular organelles was monitored by immunofluorescence and with immuno-blotting by MUC1-c antibody after subcellular fractionation. Results: Inhibition of MUC1-c by an inhibitor (GO-201) or siRNA resulted in reduced viability and reduced proliferation of pancreatic cancer cells. Furthermore, GO-201, the peptide inhibitor of MUC1-c, was effective in reducing tumor burden in pancreatic cancer mouse model. MUC1-c was also found to be associated with HSP70 in the cytosol, although a significant amount of MUC1 was also seen to be present in the lysosomes. Inhibition of MUC1 expression or activity showed an enhanced Cathepsin B activity in the cytosol, indicating lysosomal permeabilization. Therefore this study indicates that MUC1-c interacted with HSP70 in the cytosol of pancreatic cancer cells and localized to the lysosomes in these cells. Further, our results showed that MUC1-c protects pancreatic cancer cells from cell death by stabilizing lysosomes and preventing release of Cathepsin B in the cytosol.	[Banerjee, Sulagna; Mujumdar, Nameeta; Dudeja, Vikas; Mackenzie, Tiffany; Krosch, Tara K.; Sangwan, Veena; Vickers, Selwyn M.; Saluja, Ashok K.] Univ Minnesota, Dept Surg, Div Basic & Translat Res, Minneapolis, MN 55455 USA; [Mackenzie, Tiffany] Univ Minnesota, Dept Pharmacol, Minneapolis, MN 55455 USA; [Vickers, Selwyn M.; Saluja, Ashok K.] Univ Minnesota, Masonic Canc Ctr, Minneapolis, MN USA	University of Minnesota System; University of Minnesota Twin Cities; University of Minnesota System; University of Minnesota Twin Cities; University of Minnesota System; University of Minnesota Twin Cities	Banerjee, S (corresponding author), Univ Minnesota, Dept Surg, Div Basic & Translat Res, Box 242 UMHC, Minneapolis, MN 55455 USA.	asaluja@umn.edu			National Institutes of Health [R21 5R21CA131663-02, R01 5R01CA124723-05]; Catherine and Robert Goodale foundation; NATIONAL CANCER INSTITUTE [R01CA124723, P50CA101955, R21CA131663] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Catherine and Robert Goodale foundation; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This project was funded by the National Institutes of Health R21 5R21CA131663-02, R01 5R01CA124723-05 and Catherine and Robert Goodale foundation to AKS. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agata N, 2008, CANCER RES, V68, P6136, DOI 10.1158/0008-5472.CAN-08-0464; Aghdassi A, 2007, CANCER RES, V67, P616, DOI 10.1158/0008-5472.CAN-06-1567; Ahmad R, 2007, NAT CELL BIOL, V9, P1419, DOI 10.1038/ncb1661; Ahmad R, 2011, SCI SIGNAL, V4, DOI 10.1126/scisignal.2001426; Ahmad R, 2009, CANCER RES, V69, P7013, DOI 10.1158/0008-5472.CAN-09-0523; Baldus SE, 2004, CRIT REV CL LAB SCI, V41, P189, DOI 10.1080/10408360490452040; Besmer DM, 2011, CANCER RES, V71, P4432, DOI 10.1158/0008-5472.CAN-10-4439; Bivik C, 2007, CARCINOGENESIS, V28, P537, DOI 10.1093/carcin/bgl152; Boya P, 2008, ONCOGENE, V27, P6434, DOI 10.1038/onc.2008.310; Burdick MD, 1997, J BIOL CHEM, V272, P24198, DOI 10.1074/jbc.272.39.24198; CHEN WH, 1982, IN VITRO CELL DEV B, V18, P24; Creagh EM, 2000, EXP CELL RES, V257, P58, DOI 10.1006/excr.2000.4856; Croce MV, 2003, J HISTOCHEM CYTOCHEM, V51, P781, DOI 10.1177/002215540305100609; Daugaard M, 2007, FEBS LETT, V581, P3702, DOI 10.1016/j.febsiet.2007.05.039; Daugaard M, 2007, CANCER RES, V67, P2559, DOI 10.1158/0008-5472.CAN-06-4121; Dudeja V, 2009, GASTROENTEROLOGY, V136, P1772, DOI 10.1053/j.gastro.2009.01.070; Ferri KF, 2001, NAT CELL BIOL, V3, pE255, DOI 10.1038/ncb1101-e255; Garrido C, 2006, CELL CYCLE, V5, P2592, DOI 10.4161/cc.5.22.3448; Huang L, 2005, CANCER RES, V65, P10413, DOI 10.1158/0008-5472.CAN-05-2474; Jemal A, 2011, CA-CANCER J CLIN, V61, P133, DOI [10.3322/caac.20105, 10.3322/caac.20073]; Joshi MD, 2009, MOL CANCER THER, V8, P3056, DOI 10.1158/1535-7163.MCT-09-0646; Kawano T, 2007, CANCER RES, V67, P11576, DOI 10.1158/0008-5472.CAN-07-2756; Khodarev N, 2010, ONCOGENE, V29, P920, DOI 10.1038/onc.2009.391; Kohlgraf KG, 2003, CANCER RES, V63, P5011; Kufe D, 2010, ONCOGENE, V29, P5663, DOI 10.1038/onc.2010.334; Kufe DW, 2009, NAT REV CANCER, V9, P874, DOI 10.1038/nrc2761; Lee KM, 2003, BIOCHEM BIOPH RES CO, V301, P1038, DOI 10.1016/S0006-291X(03)00086-X; Leng YM, 2007, J BIOL CHEM, V282, P19321, DOI 10.1074/jbc.M703222200; Li Y, 2003, CANCER BIOL THER, V2, P187, DOI 10.4161/cbt.2.2.282; LIGTENBERG MJL, 1992, CANCER RES, V52, P2318; Luzio JP, 2007, NAT REV MOL CELL BIO, V8, P622, DOI 10.1038/nrm2217; Macao B, 2006, NAT STRUCT MOL BIOL, V13, P71, DOI 10.1038/nsmb1035; MCDONALD JK, 1975, LIFE SCI, V17, P1269; Nylandsted J, 2004, J EXP MED, V200, P425, DOI 10.1084/jem.20040531; Petersen NHT, 2010, CELL CYCLE, V9, P2305, DOI 10.4161/cc.9.12.12052; Phillips PA, 2007, CANCER RES, V67, P9407, DOI 10.1158/0008-5472.CAN-07-1077; Raina D, 2004, J BIOL CHEM, V279, P20607, DOI 10.1074/jbc.M310538200; Raina D, 2006, EMBO J, V25, P3774, DOI 10.1038/sj.emboj.7601263; Raina D, 2009, CANCER RES, V69, P5133, DOI 10.1158/0008-5472.CAN-09-0854; Ren CY, 2004, J CANCER RES CLIN, V130, P245, DOI 10.1007/s00432-003-0537-4; Ren J, 2004, CANCER CELL, V5, P163, DOI 10.1016/S1535-6108(04)00020-0; Ren J, 2006, ONCOGENE, V25, P20, DOI 10.1038/sj.onc.1209012; Ren J, 2006, MOL CANCER RES, V4, P873, DOI 10.1158/1541-7786.MCR-06-0204; Riedl SJ, 2007, NAT REV MOL CELL BIO, V8, P405, DOI 10.1038/nrm2153; Rohde M, 2005, GENE DEV, V19, P570, DOI 10.1101/gad.305405; Roy LD, 2011, ONCOGENE, V30, P1449, DOI 10.1038/onc.2010.526; Saluja A, 2008, J GASTROEN HEPATOL, V23, pS42, DOI 10.1111/j.1440-1746.2007.05272.x; Satoh S, 2000, INT J CANCER, V88, P507, DOI 10.1002/1097-0215(20001115)88:4<507::AID-IJC1>3.0.CO;2-0; Schroeder JA, 2004, ONCOGENE, V23, P5739, DOI 10.1038/sj.onc.1207713; Schroeder JA, 2001, J BIOL CHEM, V276, P13057, DOI 10.1074/jbc.M011248200; Singh PK, 2007, CANCER RES, V67, P5201, DOI 10.1158/0008-5472.CAN-06-4647; Stankiewicz AR, 2005, J BIOL CHEM, V280, P38729, DOI 10.1074/jbc.M509497200; TANIGUCHI S, 1992, CLIN EXP METASTAS, V10, P259; Traven A, 2004, CANCER CELL, V5, P107, DOI 10.1016/S1535-6108(04)00029-7; Tsutsumida H, 2006, CLIN CANCER RES, V12, P2976, DOI 10.1158/1078-0432.CCR-05-1197; Voos W, 2003, MOL CELL, V11, P1, DOI 10.1016/S1097-2765(03)00002-9; Wei XL, 2005, CANCER CELL, V7, P167, DOI 10.1016/j.ccr.2005.01.008; Yamamoto M, 1997, J BIOL CHEM, V272, P12492, DOI 10.1074/jbc.272.19.12492; Yin L, 2010, CANCER BIOL THER, V10, DOI 10.4161/cbt.10.5.12584; Yin L, 2010, MOL PHARMACOL, V78, P166, DOI 10.1124/mol.110.065011; Yin L, 2009, INT J ONCOL, V34, P1691, DOI 10.3892/ijo_00000300; Young JC, 2003, CELL, V112, P41, DOI 10.1016/S0092-8674(02)01250-3	62	14	15	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 13	2012	7	8							e43020	10.1371/journal.pone.0043020	http://dx.doi.org/10.1371/journal.pone.0043020			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	988OJ	22912777	Green Submitted, Green Published, gold			2022-12-25	WOS:000307500100050
J	Gao, MS; Coggin, A; Yagnik, K; Teplitski, M				Gao, Mengsheng; Coggin, Andrew; Yagnik, Kruti; Teplitski, Max			Role of Specific Quorum-Sensing Signals in the Regulation of Exopolysaccharide II Production within Sinorhizobium meliloti Spreading Colonies	PLOS ONE			English	Article							RHIZOBIUM-LEGUME SYMBIOSIS; ACYL HOMOSERINE LACTONES; PSEUDOMONAS-AERUGINOSA; GALACTOGLUCAN BIOSYNTHESIS; SWARMING MOTILITY; BIOFILM FORMATION; NODULE INVASION; GENE-EXPRESSION; EPS II; INFECTION	Background: Quorum sensing (QS) in Sinorhizobium meliloti involves at least half a dozen different N-acyl homoserine lactone (AHL) signals. These signals are produced by SinI, the sole AHL synthase in S. meliloti Rm8530. The sinI gene is regulated by two LuxR-type transcriptional regulators, SinR and ExpR. Mutations in sinI, sinR and expR abolish the production of exopolysaccharide II (EPS II). Methodology/Principal Findings: This study investigated a new type of coordinated surface spreading of Rm8530 that can be categorized as swarming. Motility assays on semi-solid surfaces revealed that both flagella and EPS II are required for this type of motility. The production of EPS II depends on AHLs produced by SinI. Of these AHLs, only C-16:1- and 3-oxo-C-16:1- homoserine lactones (HSLs) stimulated swarming in an ExpR-dependent manner. These two AHLs induced the strongest response in the wggR reporter fusions. WggR is a positive regulator of the EPS II biosynthesis gene expression. The levels of the wggR activation correlated with the extent of swarming. Furthermore, swarming of S. meliloti required the presence of the high molecular weight (HMW) fraction of EPS II. Within swarming colonies, a recombinase-based RIVET reporter in the wggR gene was resolved in 30% of the cells, indicating an enhanced regulation of EPS II production in the subpopulation of cells, which was sufficient to support swarming of the entire colony. Conclusions/Significance: Swarming behavior of S. meliloti Rm8530 on semi-solid surfaces is found to be dependent on the functional QS regulatory cascades. Even though multiple AHL signals are produced by the bacterium, only two AHLs species, C-16:1- and 3-oxo-C-16:1-HSLs, affected swarming by up-regulating the expression of wggR. While EPS II is produced by Rm8530 as high and low molecular weight fractions, only the HMW EPS II facilitated initial stages of swarming, thus, suggesting a function for this polymer.	[Gao, Mengsheng; Coggin, Andrew; Yagnik, Kruti; Teplitski, Max] Univ Florida, Inst Food & Agr Sci, Soil & Water Sci Dept, Gainesville, FL 32611 USA	State University System of Florida; University of Florida	Gao, MS (corresponding author), Univ Florida, Inst Food & Agr Sci, Soil & Water Sci Dept, Gainesville, FL 32611 USA.	msgao@ufl.edu		Yagnik, Kruti/0000-0001-6494-2142	United States Department of Agriculture National Research Initiative [2007-35319-18158]; CRIS project [FLA-SWS-004631]; Current Research Information System [FLA-SWS-004984]; University of Florida Research Innovation Grant program; University of Florida Institute of Food and Agricultural Sciences; University of Florida	United States Department of Agriculture National Research Initiative(United States Department of Agriculture (USDA)); CRIS project; Current Research Information System(United States Department of Agriculture (USDA)); University of Florida Research Innovation Grant program; University of Florida Institute of Food and Agricultural Sciences(University of Florida); University of Florida(University of Florida)	This work was supported by United States Department of Agriculture National Research Initiative 2007-35319-18158 (CRIS project # FLA-SWS-004631) in cooperation with The Current Research Information System # FLA-SWS-004984. Additional funding was provided by University of Florida Research Innovation Grant program. Research contribution of KY was funded by University of Florida Institute of Food and Agricultural Sciences Dean for Summer Research Internship Program. Publication of this article was funded in part by the University of Florida Open-Access Publishing Fund. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bahlawane C, 2008, MOL PLANT MICROBE IN, V21, P1498, DOI 10.1094/MPMI-21-11-1498; Bahlawane C, 2008, J BACTERIOL, V190, P3456, DOI 10.1128/JB.00062-08; Baumgarth B, 2005, MICROBIOL-SGM, V151, P259, DOI 10.1099/mic.0.27442-0; Becker A, 1997, J BACTERIOL, V179, P1375, DOI 10.1128/jb.179.4.1375-1384.1997; BERINGER JE, 1974, J GEN MICROBIOL, V84, P188; Bittner AN, 2006, J BACTERIOL, V188, P3507, DOI 10.1128/JB.188.10.3507-3515.2006; Camilli A, 1995, MOL MICROBIOL, V18, P671, DOI 10.1111/j.1365-2958.1995.mmi_18040671.x; Crespi BJ, 2001, TRENDS ECOL EVOL, V16, P178, DOI 10.1016/S0169-5347(01)02115-2; Daniels R, 2006, P NATL ACAD SCI USA, V103, P14965, DOI 10.1073/pnas.0511037103; Downie JA, 2010, FEMS MICROBIOL REV, V34, P150, DOI 10.1111/j.1574-6976.2009.00205.x; Driscoll BT, 1997, MICROBIOL-SGM, V143, P489, DOI 10.1099/00221287-143-2-489; FINAN TM, 1995, GENE, V152, P65, DOI 10.1016/0378-1119(94)00643-7; FINAN TM, 1986, J BACTERIOL, V167, P66, DOI 10.1128/jb.167.1.66-72.1986; Fujishige NA, 2006, FEMS MICROBIOL ECOL, V56, P195, DOI 10.1111/j.1574-6941.2005.00044.x; Gage DJ, 2002, J BACTERIOL, V184, P7042, DOI 10.1128/JB.184.24.7042-7046.2002; Galibert F, 2001, SCIENCE, V293, P668, DOI 10.1126/science.1060966; Gao MS, 2008, MOL PLANT MICROBE IN, V21, P162, DOI 10.1094/MPMI-21-2-0162; Gao MS, 2010, MOL PLANT MICROBE IN, V23, P355, DOI 10.1094/MPMI-23-4-0355; Gao MS, 2005, J BACTERIOL, V187, P7931, DOI 10.1128/JB.187.23.7931-7944.2005; Gibson KE, 2008, ANNU REV GENET, V42, P413, DOI 10.1146/annurev.genet.42.110807.091427; GLAZEBROOK J, 1989, CELL, V56, P661, DOI 10.1016/0092-8674(89)90588-6; GLAZEBROOK J, 1991, METHOD ENZYMOL, V204, P398; Gonzalez JE, 1996, P NATL ACAD SCI USA, V93, P8636, DOI 10.1073/pnas.93.16.8636; GOTZ R, 1987, J BACTERIOL, V169, P3146; Gurich N, 2009, J BACTERIOL, V191, P4372, DOI 10.1128/JB.00376-09; Harshey RM, 2003, ANNU REV MICROBIOL, V57, P249, DOI 10.1146/annurev.micro.57.030502.091014; Janczarek M, 2011, INT J MOL SCI, V12, P7898, DOI 10.3390/ijms12117898; Kearns DB, 2010, NAT REV MICROBIOL, V8, P634, DOI 10.1038/nrmicro2405; KELLER M, 1995, MOL PLANT MICROBE IN, V8, P267, DOI 10.1094/MPMI-8-0267; Khan SR, 2008, APPL ENVIRON MICROB, V74, P5053, DOI 10.1128/AEM.01098-08; KOVACH ME, 1995, GENE, V166, P175, DOI 10.1016/0378-1119(95)00584-1; Lindum PW, 1998, J BACTERIOL, V180, P6384; Llamas I, 2004, APPL ENVIRON MICROB, V70, P3715, DOI [10.1128/AEM.70.6.3715-3723.2004, 10.1128/aem.70.6.3715-3723.2004]; Long SR, 2001, PLANT PHYSIOL, V125, P69, DOI 10.1104/pp.125.1.69; Marketon MM, 2002, J BACTERIOL, V184, P5686, DOI 10.1128/JB.184.20.5686-5695.2002; Marketon MM, 2003, J BACTERIOL, V185, P325, DOI 10.1128/JB.185.1.325-331.2003; Mathesius U, 2003, P NATL ACAD SCI USA, V100, P1444, DOI 10.1073/pnas.262672599; McIntosh M, 2009, MOL MICROBIOL, V74, P1238, DOI 10.1111/j.1365-2958.2009.06930.x; McIntosh M, 2008, J BACTERIOL, V190, P5308, DOI 10.1128/JB.00063-08; Mueller K, 2011, J BACTERIOL, V193, P485, DOI 10.1128/JB.01129-10; MULLER P, 1993, MOL PLANT MICROBE IN, V6, P55, DOI 10.1094/MPMI-6-055; Nadell CD, 2010, PLOS COMPUT BIOL, V6, DOI 10.1371/journal.pcbi.1000716; Nogales J, 2012, J BACTERIOL; OCHSNER UA, 1995, P NATL ACAD SCI USA, V92, P6424, DOI 10.1073/pnas.92.14.6424; Oke V, 1999, MOL MICROBIOL, V32, P837, DOI 10.1046/j.1365-2958.1999.01402.x; Pellock BJ, 2002, J BACTERIOL, V184, P5067, DOI 10.1128/JB.184.18.5067-5076.2002; QUANDT J, 1993, GENE, V127, P15, DOI 10.1016/0378-1119(93)90611-6; Rinaudi LV, 2009, J BACTERIOL, V191, P7216, DOI 10.1128/JB.01063-09; SHI WY, 1993, P NATL ACAD SCI USA, V90, P3378, DOI 10.1073/pnas.90.8.3378; Sorroche FG, 2010, CURR MICROBIOL, V61, P465, DOI 10.1007/s00284-010-9639-9; Soto MJ, 2002, MOL MICROBIOL, V43, P371, DOI 10.1046/j.1365-2958.2002.02749.x; Sule S, 2009, LETT APPL MICROBIOL, V49, P596, DOI 10.1111/j.1472-765X.2009.02716.x; Tian CF, 2012, P NATL ACAD SCI USA, V109, P6751, DOI 10.1073/pnas.1120260109; Venturi V, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009998; Verstraeten N, 2008, TRENDS MICROBIOL, V16, P496, DOI 10.1016/j.tim.2008.07.004; Wang QF, 2004, MOL MICROBIOL, V52, P169, DOI 10.1111/j.1365-2958.2003.03977.x; Xavier JB, 2011, MOL MICROBIOL, V79, P166, DOI 10.1111/j.1365-2958.2010.07436.x; ZHAN HJ, 1989, P NATL ACAD SCI USA, V86, P3055, DOI 10.1073/pnas.86.9.3055	58	35	36	3	32	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 13	2012	7	8							e42611	10.1371/journal.pone.0042611	http://dx.doi.org/10.1371/journal.pone.0042611			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	988OJ	22912712	Green Published, gold, Green Submitted			2022-12-25	WOS:000307500100017
J	Kamphuis, W; Mamber, C; Moeton, M; Kooijman, L; Sluijs, JA; Jansen, AHP; Verveer, M; de Groot, LR; Smith, VD; Rangarajan, S; Rodriguez, JJ; Orre, M; Hol, EM				Kamphuis, Willem; Mamber, Carlyn; Moeton, Martina; Kooijman, Lieneke; Sluijs, Jacqueline A.; Jansen, Anne H. P.; Verveer, Monique; de Groot, Lody R.; Smith, Vanessa D.; Rangarajan, Sindhoo; Rodriguez, Jose J.; Orre, Marie; Hol, Elly M.			GFAP Isoforms in Adult Mouse Brain with a Focus on Neurogenic Astrocytes and Reactive Astrogliosis in Mouse Models of Alzheimer Disease	PLOS ONE			English	Article							FIBRILLARY ACIDIC PROTEIN; TRIPLE-TRANSGENIC MODEL; INTERMEDIATE-FILAMENTS; SENILE PLAQUES; IMMUNOHISTOCHEMICAL CHARACTERIZATION; SUBVENTRICULAR ZONE; BETA; EXPRESSION; IDENTIFICATION; PATHOLOGY	Glial fibrillary acidic protein (GFAP) is the main astrocytic intermediate filament (IF). GFAP splice isoforms show differential expression patterns in the human brain. GFAP delta is preferentially expressed by neurogenic astrocytes in the subventricular zone (SVZ), whereas GFAP(+1) is found in a subset of astrocytes throughout the brain. In addition, the expression of these isoforms in human brain material of epilepsy, Alzheimer and glioma patients has been reported. Here, for the first time, we present a comprehensive study of GFAP isoform expression in both wild-type and Alzheimer Disease (AD) mouse models. In cortex, cerebellum, and striatum of wild-type mice, transcripts for Gfap-alpha, Gfap-beta, Gfap-gamma, Gfap-delta, Gfap-kappa, and a newly identified isoform Gfap-zeta, were detected. Their relative expression levels were similar in all regions studied. GFAP alpha showed a widespread expression whilst GFAP delta distribution was prominent in the SVZ, rostral migratory stream (RMS), neurogenic astrocytes of the subgranular zone (SGZ), and subpial astrocytes. In contrast to the human SVZ, we could not establish an unambiguous GFAP delta localization in proliferating cells of the mouse SVZ. In APPswePS1dE9 and 3xTgAD mice, plaque-associated reactive astrocytes had increased transcript levels of all detectable GFAP isoforms and low levels of a new GFAP isoform, Gfap-Delta Ex7. Reactive astrocytes in AD mice showed enhanced GFAP alpha and GFAP delta immunolabeling, less frequently increased vimentin and nestin, but no GFAP kappa or GFAP(+1) staining. In conclusion, GFAP delta protein is present in SVZ, RMS, and neurogenic astrocytes of the SGZ, but also outside neurogenic niches. Furthermore, differential GFAP isoform expression is not linked with aging or reactive gliosis. This evidence points to the conclusion that differential regulation of GFAP isoforms is not involved in the reorganization of the IF network in reactive gliosis or in neurogenesis in the mouse brain.	[Kamphuis, Willem; Mamber, Carlyn; Moeton, Martina; Kooijman, Lieneke; Sluijs, Jacqueline A.; Jansen, Anne H. P.; Verveer, Monique; de Groot, Lody R.; Smith, Vanessa D.; Rangarajan, Sindhoo; Orre, Marie; Hol, Elly M.] Royal Netherlands Acad Arts & Sci KNAW, Netherlands Inst Neurosci, Dept Astrocyte Biol & Neurodegenerat, Amsterdam, Netherlands; [Hol, Elly M.] Univ Amsterdam, Ctr Neurosci, Swammerdam Inst Life Sci, Amsterdam, Netherlands; [Smith, Vanessa D.] Mayo Clin, Coll Med, Rochester, MN USA; [Rodriguez, Jose J.] Univ Basque Country UPV EHU, Dept Neurosci, Leioa, Spain; [Rodriguez, Jose J.] Basque Fdn Sci, IKERBASQUE, Bilbao, Spain	Royal Netherlands Academy of Arts & Sciences; Netherlands Institute for Neuroscience (NIN-KNAW); University of Amsterdam; Mayo Clinic; University of Basque Country; Basque Foundation for Science	Kamphuis, W (corresponding author), Royal Netherlands Acad Arts & Sci KNAW, Netherlands Inst Neurosci, Dept Astrocyte Biol & Neurodegenerat, Amsterdam, Netherlands.	w.kamphuis@nin.knaw.nl	Hol, Elly/J-2025-2019; Hol, Elly M/F-1891-2013	Hol, Elly/0000-0001-5604-2603; Hol, Elly M/0000-0001-5604-2603	Internationale Stichting Alzheimer Onderzoek (ISAO) [08504]; Netherlands Organization for Scientific Research (NWO) [865.09.003]	Internationale Stichting Alzheimer Onderzoek (ISAO); Netherlands Organization for Scientific Research (NWO)(Netherlands Organization for Scientific Research (NWO))	This work was supported by the Internationale Stichting Alzheimer Onderzoek (ISAO; M.O. [#08504]) and the Netherlands Organization for Scientific Research (NWO; VICI grant to E. M. H. [865.09.003]). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allaman I, 2011, TRENDS NEUROSCI, V34, P76, DOI 10.1016/j.tins.2010.12.001; Allaman I, 2010, J NEUROSCI, V30, P3326, DOI 10.1523/JNEUROSCI.5098-09.2010; Andreiuolo F, 2008, NEUROPATHOLOGY; Arnold SE, 1996, ACTA NEUROPATHOL, V91, P269, DOI 10.1007/s004010050425; Bandyopadhyay U, 2010, MOL CELL, V39, P535, DOI 10.1016/j.molcel.2010.08.004; Blechingberg J, 2007, GLIA, V55, P497, DOI 10.1002/glia.20475; Boer K, 2010, EPILEPSY RES, V90, P99, DOI 10.1016/j.eplepsyres.2010.03.014; Buffo A, 2010, BIOCHEM PHARMACOL, V79, P77, DOI 10.1016/j.bcp.2009.09.014; Bugiani M, 2011, J NEUROPATH EXP NEUR, V70, P69, DOI 10.1097/NEN.0b013e318203ae74; Cahoy JD, 2008, J NEUROSCI, V28, P264, DOI 10.1523/JNEUROSCI.4178-07.2008; Choi KC, 2009, NEUROSCI LETT, V463, P182, DOI 10.1016/j.neulet.2009.07.076; Condorelli DF, 1999, J NEUROSCI RES, V56, P219, DOI 10.1002/(SICI)1097-4547(19990501)56:3<219::AID-JNR1>3.0.CO;2-2; Condorelli DF, 1999, NEUROCHEM RES, V24, P709, DOI 10.1023/A:1021016828704; Dijk F, 2004, INVEST OPHTH VIS SCI, V45, P330, DOI 10.1167/iovs.03-0285; Doetsch F, 1999, CELL, V97, P703, DOI 10.1016/S0092-8674(00)80783-7; ENG LF, 1992, PROG BRAIN RES, V94, P353; FEINSTEIN DL, 1992, J NEUROSCI RES, V32, P1, DOI 10.1002/jnr.490320102; Fuller S, 2009, EXPERT REV NEUROTHER, V9, P1585, DOI 10.1586/ERN.09.111; Glickman MH, 2002, PHYSIOL REV, V82, P373, DOI 10.1152/physrev.00027.2001; Halassa MM, 2010, ANNU REV PHYSIOL, V72, P335, DOI 10.1146/annurev-physiol-021909-135843; Hanzel DK, 1999, NAT BIOTECHNOL, V17, P53, DOI 10.1038/5225; Heo DH, 2012, J NEURO-ONCOL, V108, P45, DOI 10.1007/s11060-012-0801-z; Hol EM, 2003, MOL PSYCHIATR, V8, P786, DOI 10.1038/sj.mp.4001379; Hyder CL, 2011, J CELL SCI, V124, P1363, DOI 10.1242/jcs.041244; Jankowsky JL, 2004, HUM MOL GENET, V13, P159, DOI 10.1093/hmg/ddh019; Kamphuis W, 2012, GLIA, V60, P615, DOI 10.1002/glia.22295; Kashon ML, 2004, J ALZHEIMERS DIS, V6, P595; Kato S, 1998, PATHOL INT, V48, P332, DOI 10.1111/j.1440-1827.1998.tb03915.x; Kim S, 2010, NAT REV MOL CELL BIO, V11, P75, DOI 10.1038/nrm2818; Kuchibhotla KV, 2009, SCIENCE, V323, P1211, DOI 10.1126/science.1169096; Lepekhin EA, 2001, J NEUROCHEM, V79, P617, DOI 10.1046/j.1471-4159.2001.00595.x; Liem RKH, 2009, J CLIN INVEST, V119, P1814, DOI 10.1172/JCI38003; LIN RCS, 1995, NEUROBIOL DIS, V2, P79, DOI 10.1006/nbdi.1995.0008; Marti-Fabregas J, 2010, NEUROLOGY, V74, P357, DOI 10.1212/WNL.0b013e3181cbccec; Mastrangelo MA, 2008, BMC NEUROSCI, V9, DOI 10.1186/1471-2202-9-81; Mei X, 2010, NEUROSCIENCE, V171, P92, DOI 10.1016/j.neuroscience.2010.08.001; Middeldorp J, 2011, PROG NEUROBIOL, V93, P421, DOI 10.1016/j.pneurobio.2011.01.005; Middeldorp J, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007663; Middeldorp J, 2009, FASEB J, V23, P2710, DOI 10.1096/fj.08-127696; Muramori F, 1998, PSYCHIAT CLIN NEUROS, V52, P593, DOI 10.1111/j.1440-1819.1998.tb02706.x; Nawashiro H, 1998, NEUROREPORT, V9, P1691, DOI 10.1097/00001756-199806010-00004; Nawashiro H, 2000, J CEREBR BLOOD F MET, V20, P1040, DOI 10.1097/00004647-200007000-00003; Nielsen AL, 2004, J BIOL CHEM, V279, P41537, DOI 10.1074/jbc.M406601200; Nielsen AL, 2002, J BIOL CHEM, V277, P29983, DOI 10.1074/jbc.M112121200; Nielsen HM, 2009, GLIA, V57, P978, DOI 10.1002/glia.20822; NOPPE M, 1986, CLIN CHIM ACTA, V155, P143, DOI 10.1016/0009-8981(86)90275-5; Oberheim NA, 2012, METHODS MOL BIOL, V814, P23, DOI 10.1007/978-1-61779-452-0_3; Oddo S, 2003, NEURON, V39, P409, DOI 10.1016/S0896-6273(03)00434-3; Oddo S, 2003, NEUROBIOL AGING, V24, P1063, DOI 10.1016/j.neurobiolaging.2003.08.012; Olabarria M, 2010, GLIA, V58, P831, DOI 10.1002/glia.20967; Otani N, 2006, J CLIN NEUROSCI, V13, P934, DOI 10.1016/j.jocn.2005.10.018; PEKNY M, 1995, EMBO J, V14, P1590, DOI 10.1002/j.1460-2075.1995.tb07147.x; Perng MD, 2008, MOL BIOL CELL, V19, P4521, DOI 10.1091/mbc.E08-03-0284; Peters O, 2009, J ALZHEIMERS DIS, V18, P177, DOI 10.3233/JAD-2009-1140; Ridet JL, 1997, TRENDS NEUROSCI, V20, P570, DOI 10.1016/S0166-2236(97)01139-9; Rodriguez JJ, 2009, CELL DEATH DIFFER, V16, P378, DOI 10.1038/cdd.2008.172; Roelofs RF, 2005, GLIA, V52, P289, DOI 10.1002/glia.20243; Rutka JT, 1999, INT J DEV NEUROSCI, V17, P503, DOI 10.1016/S0736-5748(99)00049-0; Salmina AB, 2009, J ALZHEIMERS DIS, V16, P485, DOI 10.3233/JAD-2009-0988; SARRIA AJ, 1994, J CELL SCI, V107, P1593; Schwartz AL, 2009, ANNU REV PHARMACOL, V49, P73, DOI 10.1146/annurev.pharmtox.051208.165340; Seri B, 2004, J COMP NEUROL, V478, P359, DOI 10.1002/cne.20288; Seth P, 2008, J BIOSCIENCES, V33, P405, DOI 10.1007/s12038-008-0060-5; Simpson JE, 2010, NEUROBIOL AGING, V31, P578, DOI 10.1016/j.neurobiolaging.2008.05.015; Sofroniew MV, 2010, ACTA NEUROPATHOL, V119, P7, DOI 10.1007/s00401-009-0619-8; Sofroniew MV, 2009, TRENDS NEUROSCI, V32, P638, DOI 10.1016/j.tins.2009.08.002; Tanaka H, 2002, J NEUROSCI RES, V67, P11, DOI 10.1002/jnr.10004.abs; van den Berge SA, 2010, AGING CELL, V9, P313, DOI 10.1111/j.1474-9726.2010.00556.x; Vehmas AK, 2003, NEUROBIOL AGING, V24, P321, DOI 10.1016/S0197-4580(02)00090-8; Vincent AJ, 2010, J ALZHEIMERS DIS, V22, P699, DOI 10.3233/JAD-2010-101089; WESTERMARK B, 1973, ACTA PATH MICRO IM A, VA 81, P791; Westphal M, 2011, NAT REV NEUROSCI, V12, P495, DOI 10.1038/nrn3060; Wharton SB, 2009, DEMENT GERIATR COGN, V27, P465, DOI 10.1159/000217729; Wong E, 2010, CSH PERSPECT BIOL, V2, DOI 10.1101/cshperspect.a006734; Wyss-Coray T, 2003, NAT MED, V9, P453, DOI 10.1038/nm838; Xu KX, 1999, GLIA, V25, P390, DOI 10.1002/(SICI)1098-1136(19990215)25:4<390::AID-GLIA8>3.0.CO;2-7; Xue ZG, 2004, EXP CELL RES, V298, P431, DOI 10.1016/j.yexcr.2004.04.023; YAMADA T, 1992, ACTA NEUROPATHOL, V84, P157, DOI 10.1007/BF00311389; Yoshida T, 2007, J HUM GENET, V52, P362, DOI 10.1007/s10038-007-0124-7; ZELENIKA D, 1995, MOL BRAIN RES, V30, P251, DOI 10.1016/0169-328X(95)00010-P	80	183	193	1	30	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 13	2012	7	8							e42823	10.1371/journal.pone.0042823	http://dx.doi.org/10.1371/journal.pone.0042823			24	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	988OJ	22912745	gold, Green Published			2022-12-25	WOS:000307500100035
J	Lopez-del Hoyo, N; Fazioli, L; Lopez-Begines, S; Fernandez-Sanchez, L; Cuenca, N; Llorens, J; de la Villa, P; Mendez, A				Lopez-del Hoyo, Natalia; Fazioli, Lucrezia; Lopez-Begines, Santiago; Fernandez-Sanchez, Laura; Cuenca, Nicolas; Llorens, Jordi; de la Villa, Pedro; Mendez, Ana			Overexpression of Guanylate Cyclase Activating Protein 2 in Rod Photoreceptors In Vivo Leads to Morphological Changes at the Synaptic Ribbon	PLOS ONE			English	Article							MOUSE RETINA; LOCALIZATION; EXPRESSION; SYNAPSES; CLONING; TRANSMISSION; DYNAMICS; MUTATION; REVEALS; BASSOON	Guanylate cyclase activating proteins are EF-hand containing proteins that confer calcium sensitivity to retinal guanylate cyclase at the outer segment discs of photoreceptor cells. By making the rate of cGMP synthesis dependent on the free intracellular calcium levels set by illumination, GCAPs play a fundamental role in the recovery of the light response and light adaptation. The main isoforms GCAP1 and GCAP2 also localize to the synaptic terminal, where their function is not known. Based on the reported interaction of GCAP2 with Ribeye, the major component of synaptic ribbons, it was proposed that GCAP2 could mediate the synaptic ribbon dynamic changes that happen in response to light. We here present a thorough ultrastructural analysis of rod synaptic terminals in loss-of-function (GCAP1/GCAP2 double knockout) and gain-of-function (transgenic overexpression) mouse models of GCAP2. Rod synaptic ribbons in GCAPs-/- mice did not differ from wildtype ribbons when mice were raised in constant darkness, indicating that GCAPs are not required for ribbon early assembly or maturation. Transgenic overexpression of GCAP2 in rods led to a shortening of synaptic ribbons, and to a higher than normal percentage of club-shaped and spherical ribbon morphologies. Restoration of GCAP2 expression in the GCAPs-/- background (GCAP2 expression in the absence of endogenous GCAP1) had the striking result of shortening ribbon length to a much higher degree than overexpression of GCAP2 in the wildtype background, as well as reducing the thickness of the outer plexiform layer without affecting the number of rod photoreceptor cells. These results indicate that preservation of the GCAP1 to GCAP2 relative levels is relevant for maintaining the integrity of the synaptic terminal. Our demonstration of GCAP2 immunolocalization at synaptic ribbons at the ultrastructural level would support a role of GCAPs at mediating the effect of light on morphological remodeling changes of synaptic ribbons.	[Lopez-del Hoyo, Natalia; Fazioli, Lucrezia; Lopez-Begines, Santiago; Llorens, Jordi; Mendez, Ana] Bellvitge Biomed Res Inst IDIBELL, Barcelona, Spain; [Fernandez-Sanchez, Laura; Cuenca, Nicolas] Univ Alicante, Dept Physiol Genet & Microbiol, E-03080 Alicante, Spain; [Llorens, Jordi] Univ Barcelona, Dept Physiol Sci 2, Barcelona, Spain; [de la Villa, Pedro] Univ Alcala de Henares, Dept Physiol, Madrid, Spain; [Mendez, Ana] Univ Barcelona, Dept Pathol & Expt Therapeut, Barcelona, Spain	Institut d'Investigacio Biomedica de Bellvitge (IDIBELL); Universitat d'Alacant; University of Barcelona; Universidad de Alcala; University of Barcelona	Lopez-del Hoyo, N (corresponding author), Bellvitge Biomed Res Inst IDIBELL, Barcelona, Spain.	mendezzu@idibell.cat	Lopez del Hoyo, Natalia/K-7816-2013; Méndez, Ana/F-9729-2016; Llorens, Jordi/A-6959-2008; Cuenca, Nicolas/I-2007-2015; López, Santiago/AAZ-3824-2021; Fernandez-Sanchez, Laura/AAB-5663-2019; de la Villa, Pedro/G-2322-2016	Lopez del Hoyo, Natalia/0000-0001-9333-8235; Méndez, Ana/0000-0001-6393-1644; Llorens, Jordi/0000-0002-3894-9401; Cuenca, Nicolas/0000-0002-6767-5710; López, Santiago/0000-0001-8809-8919; Fernandez-Sanchez, Laura/0000-0002-3629-0156; de la Villa, Pedro/0000-0001-9856-6616	Spanish Ministry of Science and Innovation [BFU2008-04199/BFI, BFU2011-26519/BFI, BFU2009-06945, SAF2010-21879, RETICS RD07/0062/0008, BFU2009-07793/BFI, RETICS RD07/0062/0012]; European Community [210042/RODCELL]; Bellvitge Biomedical Research Institute (IDIBELL) [10IDB012]	Spanish Ministry of Science and Innovation(Ministry of Science and Innovation, Spain (MICINN)Spanish Government); European Community(European Commission); Bellvitge Biomedical Research Institute (IDIBELL)	This work was supported by grants from the Spanish Ministry of Science and Innovation to A. M. (BFU2008-04199/BFI and BFU2011-26519/BFI), to J.Ll. (BFU2009-06945), to P.dlV. (SAF2010-21879 and RETICS RD07/0062/0008), to N.C. (BFU2009-07793/BFI and RETICS RD07/0062/0012); from the European Community to A. M. (Marie-Curie Reintegration grant 210042/RODCELL) and from The Bellvitge Biomedical Research Institute (IDIBELL) to A. M. (10IDB012). N.L.-H. was the recipient of an Bellvitge Biomedical Research Institute (IDIBELL) PhD fellowship. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adly MA, 1999, INVEST OPHTH VIS SCI, V40, P2165; Arshavsky VY, 2012, J BIOL CHEM, V287, P1620, DOI 10.1074/jbc.R111.305243; Balkema GW, 2001, VISUAL NEUROSCI, V18, P789, DOI 10.1017/S0952523801185123; Ball SL, 2002, INVEST OPHTH VIS SCI, V43, P1595; Biehlmaier O, 2007, NEUROCHEM INT, V50, P189, DOI 10.1016/j.neuint.2006.08.001; Burns ME, 2002, NEURON, V36, P81, DOI 10.1016/S0896-6273(02)00911-X; Chang B, 2006, VISUAL NEUROSCI, V23, P11, DOI 10.1017/S095252380623102X; Cuenca N, 1998, INVEST OPHTH VIS SCI, V39, P1243; Dick O, 2003, NEURON, V37, P775, DOI 10.1016/S0896-6273(03)00086-2; Dieck ST, 2005, J CELL BIOL, V168, P825, DOI 10.1083/jcb.200408157; Dieck ST, 2006, CELL TISSUE RES, V326, P339, DOI 10.1007/s00441-006-0234-0; DIZHOOR AM, 1995, J BIOL CHEM, V270, P25200, DOI 10.1074/jbc.270.42.25200; Frins S, 1996, J BIOL CHEM, V271, P8022, DOI 10.1074/jbc.271.14.8022; Fuchs M, 2012, J COMP NEUR IN PRESS; GORCZYCA WA, 1994, P NATL ACAD SCI USA, V91, P4014, DOI 10.1073/pnas.91.9.4014; Grossman GH, 2009, INVEST OPHTH VIS SCI, V50, P3074, DOI 10.1167/iovs.08-3190; Haeseleer F, 2004, NAT NEUROSCI, V7, P1079, DOI 10.1038/nn1320; Hagstrom SA, 1999, INVEST OPHTH VIS SCI, V40, P2795; Howes K, 1998, INVEST OPHTH VIS SCI, V39, P867; Kachi S, 1999, EXP EYE RES, V68, P465, DOI 10.1006/exer.1998.0629; Libby RT, 2004, J CELL SCI, V117, P4509, DOI 10.1242/jcs.01316; LoGiudice L, 2009, NEUROSCIENTIST, V15, P380, DOI 10.1177/1073858408331373; Mansergh F, 2005, HUM MOL GENET, V14, P3035, DOI 10.1093/hmg/ddi336; Mendez A, 2001, P NATL ACAD SCI USA, V98, P9948, DOI 10.1073/pnas.171308998; OttoBruc A, 1997, P NATL ACAD SCI USA, V94, P4727, DOI 10.1073/pnas.94.9.4727; PALCZEWSKI K, 1994, NEURON, V13, P395, DOI 10.1016/0896-6273(94)90355-7; Parsons TD, 2003, NEURON, V37, P379, DOI 10.1016/S0896-6273(03)00062-X; Peshenko IV, 2011, BIOCHEMISTRY-US, V50, P5590, DOI 10.1021/bi200491b; Peshenko IV, 2004, J BIOL CHEM, V279, P16903, DOI 10.1074/jbc.C400065200; Prescott ED, 2005, CURR OPIN NEUROBIOL, V15, P431, DOI 10.1016/j.conb.2005.07.005; Regus-Leidig H, 2010, MOL VIS, V16, P2690; Regus-Leidig H, 2009, J COMP NEUROL, V512, P814, DOI 10.1002/cne.21915; Reim K, 2005, J CELL BIOL, V169, P669, DOI 10.1083/jcb.200502115; Schmitz F, 2006, P NATL ACAD SCI USA, V103, P2926, DOI 10.1073/pnas.0510060103; Schmitz F, 2009, NEUROSCIENTIST, V15, P611, DOI 10.1177/1073858409340253; Sharma M, 2011, NAT CELL BIOL, V13, P30, DOI 10.1038/ncb2131; Snellman J, 2011, NAT NEUROSCI, V14, P1135, DOI 10.1038/nn.2870; Spiwoks-Becker I, 2004, EUR J NEUROSCI, V19, P1559, DOI 10.1111/j.1460-9568.2004.03198.x; Thoreson WB, 2007, MOL NEUROBIOL, V36, P205, DOI 10.1007/s12035-007-0019-9; Van Epps HA, 2004, J NEUROSCI, V24, P8641, DOI 10.1523/JNEUROSCI.2892-04.2004; Venkatesan JK, 2010, J NEUROSCI, V30, P6559, DOI 10.1523/JNEUROSCI.3701-09.2010; Vollrath L, 1996, MICROSC RES TECHNIQ, V35, P472, DOI 10.1002/(SICI)1097-0029(19961215)35:6<472::AID-JEMT6>3.0.CO;2-K; Vollrath L, 2001, MARC MALPIG SYMP SER, V7, P499; von Gersdorff H, 2001, NEURON, V29, P7, DOI 10.1016/S0896-6273(01)00175-1; Werblin FS, 2011, J PHYSIOL-LONDON, V589, P3691, DOI 10.1113/jphysiol.2011.210617; Zampighi GA, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016944; Zenisek D, 2004, J NEUROSCI, V24, P9752, DOI 10.1523/JNEUROSCI.2886-04.2004	49	12	12	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 13	2012	7	8							e42994	10.1371/journal.pone.0042994	http://dx.doi.org/10.1371/journal.pone.0042994			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	988OJ	22912773	Green Published, gold			2022-12-25	WOS:000307500100049
J	Niedringhaus, M; Chen, X; Dzakpasu, R; Conant, K				Niedringhaus, Mark; Chen, Xin; Dzakpasu, Rhonda; Conant, Katherine			MMPs and Soluble ICAM-5 Increase Neuronal Excitability within In Vitro Networks of Hippocampal Neurons	PLOS ONE			English	Article							CELL-ADHESION MOLECULES; LONG-TERM POTENTIATION; MATRIX METALLOPROTEINASES; EXTRACELLULAR-MATRIX; NMDA RECEPTOR; SPINE ENLARGEMENT; SILENT SYNAPSES; PLASTICITY; MATRIX-METALLOPROTEINASE-9; MECHANISMS	Matrix metalloproteinases (MMPs) are zinc-dependent endopeptidases that are released from neurons in an activity dependent manner. Published studies suggest their activity is important to varied forms of learning and memory. At least one MMP can stimulate an increase in the size of dendritic spines, structures which represent the post synaptic component for a large number of glutamatergic synapses. This change may be associated with increased synaptic glutamate receptor incorporation, and an increased amplitude and/or frequency of alpha-amino-3-hydroxyl-5-methyl-4-isoxazole-propionate (AMPA) mini excitatory post-synaptic currents (EPSCs). An associated increase in the probability of action potential occurrence would be expected. While the mechanism(s) by which MMPs may influence synaptic structure and function are not completely understood, MMP dependent shedding of specific cell adhesion molecules (CAMs) could play an important role. CAMs are ideally positioned to be cleaved by synaptically released MMPs, and shed N terminal domains could potentially interact with previously unengaged integrins to stimulate dendritic actin polymerization with spine expansion. In the present study, we have used multielectrode arrays (MEAs) to investigate MMP and soluble CAM dependent changes in neuronal activity recorded from hippocampal cultures. We have focused on intercellular adhesion molecule-5 (ICAM-5) in particular, as this CAM is expressed on glutamatergic dendrites and shed in an MMP dependent manner. We show that chemical long-term potentiation (cLTP) evoked changes in recorded activity, and the dynamics of action potential bursts in particular, are altered by MMP inhibition. A blocking antibody to beta(1) integrins has a similar effect. We also show that the ectodomain of ICAM-5 can stimulate beta(1) integrin dependent increases in spike counts and burst number. These results support a growing body of literature suggesting that MMPs have important effects on neuronal excitability. They also support the possibility that MMP dependent shedding of specific synaptic CAMs can contribute to these effects.	[Niedringhaus, Mark; Dzakpasu, Rhonda; Conant, Katherine] Georgetown Univ, Med Ctr, Interdisciplinary Program Neurosci, Washington, DC 20007 USA; [Chen, Xin; Dzakpasu, Rhonda] Georgetown Univ, Dept Phys, Washington, DC 20057 USA; [Dzakpasu, Rhonda] Georgetown Univ, Med Ctr, Dept Physiol & Pharmacol, Washington, DC 20007 USA; [Conant, Katherine] Georgetown Univ, Med Ctr, Dept Neurosci, Washington, DC 20007 USA	Georgetown University; Georgetown University; Georgetown University; Georgetown University	Niedringhaus, M (corresponding author), Georgetown Univ, Med Ctr, Interdisciplinary Program Neurosci, Washington, DC 20007 USA.	dzakpasu@physics.georgetown.edu; kec84@georgetown.edu	Dzakpasu, Rhonda/F-8060-2019	Dzakpasu, Rhonda/0000-0002-7223-4602	Luce Foundation; National Institutes of Health, National Institute on Aging [029806]; Division Of Physics [1205919] Funding Source: National Science Foundation	Luce Foundation; National Institutes of Health, National Institute on Aging(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); Division Of Physics(National Science Foundation (NSF)NSF - Directorate for Mathematical & Physical Sciences (MPS))	Dr. Niedringhaus, Dr. Chen, and Dr. Dzakpasu were supported by the Luce Foundation. Dr. Conant was supported by a grant from the National Institutes of Health, National Institute on Aging (grant No. 029806). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ben-Ari Y, 2001, TRENDS NEUROSCI, V24, P353, DOI 10.1016/S0166-2236(00)01813-0; Bernard-Trifilo JA, 2005, J NEUROCHEM, V93, P834, DOI 10.1111/j.1471-4159.2005.03062.x; Bi GQ, 1998, J NEUROSCI, V18, P10464, DOI 10.1523/jneurosci.18-24-10464.1998; Blankenship AG, 2010, NAT REV NEUROSCI, V11, P18, DOI 10.1038/nrn2759; Bologna LL, 2010, NEUROSCIENCE, V165, P692, DOI 10.1016/j.neuroscience.2009.11.018; Brown TE, 2008, SYNAPSE, V62, P886, DOI 10.1002/syn.20562; Brown Travis E, 2007, Learn Mem, V14, P214, DOI 10.1101/lm.476207; Chen X, 2010, PHYS REV E, V82, DOI 10.1103/PhysRevE.82.031907; Chiappalone M, 2008, EUR J NEUROSCI, V28, P221, DOI 10.1111/j.1460-9568.2008.06259.x; Clifford MA, 2011, NEURAL DEV, V6, DOI 10.1186/1749-8104-6-21; Cohen D, 2011, J NEUROPHYSIOL, V106, P2314, DOI 10.1152/jn.00969.2010; Conant K, 2010, NEUROSCIENCE, V166, P508, DOI 10.1016/j.neuroscience.2009.12.061; Conant K, 2011, J NEUROCHEM, V118, P521, DOI 10.1111/j.1471-4159.2010.07153.x; Docherty SJ, 2010, GENES BRAIN BEHAV, V9, P234, DOI 10.1111/j.1601-183X.2009.00553.x; Fragkouli A, 2012, J NEUROCHEM, V121, P239, DOI 10.1111/j.1471-4159.2011.07637.x; Furutani Y, 2007, J NEUROSCI, V27, P8866, DOI 10.1523/JNEUROSCI.1047-07.2007; Gillies MJ, 2002, J PHYSIOL-LONDON, V543, P779, DOI 10.1113/jphysiol.2002.024588; Harris KD, 2001, NEURON, V32, P141, DOI 10.1016/S0896-6273(01)00447-0; Hinkle CL, 2006, J NEUROBIOL, V66, P1378, DOI 10.1002/neu.20257; Hoffman KB, 1998, BRAIN RES, V811, P29, DOI 10.1016/S0006-8993(98)00906-8; HUERTA PT, 1993, NATURE, V364, P723, DOI 10.1038/364723a0; ISAAC JTR, 1995, NEURON, V15, P427, DOI 10.1016/0896-6273(95)90046-2; Israel JM, 2008, J NEUROSCI, V28, P385, DOI 10.1523/JNEUROSCI.5198-07.2008; Kean MJ, 2009, J CELL SCI, V122, P4089, DOI 10.1242/jcs.052761; Kerchner GA, 2008, NAT REV NEUROSCI, V9, P813, DOI 10.1038/nrn2501; Kessels HW, 2009, NEURON, V61, P340, DOI 10.1016/j.neuron.2009.01.015; Kim J, 2011, J BIOL CHEM, V285, P22919; Kopec CD, 2006, J NEUROSCI, V26, P2000, DOI 10.1523/JNEUROSCI.3918-05.2006; Kramar EA, 2006, P NATL ACAD SCI USA, V103, P5579, DOI 10.1073/pnas.0601354103; Kudrimoti HS, 1999, J NEUROSCI, V19, P4090; LARSON J, 1986, SCIENCE, V232, P985, DOI 10.1126/science.3704635; Leonardo CC, 2008, J NEUROINFLAMM, V5, DOI 10.1186/1742-2094-5-34; Lim ST, 2012, J NEUROCHEM, V120, P741, DOI 10.1111/j.1471-4159.2011.07592.x; LOUGHLIN SE, 1986, NEUROSCIENCE, V18, P307, DOI 10.1016/0306-4522(86)90156-9; Madhavan R, 2007, THESIS GEORGIA I TEC; Malinow R, 2002, ANNU REV NEUROSCI, V25, P103, DOI 10.1146/annurev.neuro.25.112701.142758; Matsuno H, 2006, J NEUROSCI, V26, P1776, DOI 10.1523/JNEUROSCI.2651-05.2006; McCawley LJ, 2001, CURR OPIN CELL BIOL, V13, P534, DOI 10.1016/S0955-0674(00)00248-9; Meighan PC, 2007, J NEUROCHEM, V102, P2085, DOI 10.1111/j.1471-4159.2007.04682.x; Meighan SE, 2006, J NEUROCHEM, V96, P1227, DOI 10.1111/j.1471-4159.2005.03565.x; Michaluk P, 2007, J BIOL CHEM, V282, P16036, DOI 10.1074/jbc.M700641200; Milward EA, 2007, J NEUROIMMUNOL, V187, P9, DOI 10.1016/j.jneuroim.2007.04.010; Mizoguchi H, 2007, J NEUROCHEM, V100, P1579, DOI 10.1111/j.1471-4159.2006.04288.x; Nagy V, 2006, J NEUROSCI, V26, P1923, DOI 10.1523/JNEUROSCI.4359-05.2006; Nagy V, 2007, LEARN MEMORY, V14, P655, DOI 10.1101/lm.678307; Ogita H, 2008, J MICROSC-OXFORD, V231, P455, DOI 10.1111/j.1365-2818.2008.02058.x; Otto T, 1991, Hippocampus, V1, P181, DOI 10.1002/hipo.450010206; Pak DTS, 2001, NEURON, V31, P289, DOI 10.1016/S0896-6273(01)00355-5; Pasterkamp RJ, 2003, NATURE, V424, P398, DOI 10.1038/nature01790; Pauly T, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002681; Pennartz CMA, 2002, PROG BRAIN RES, V138, P143, DOI 10.1016/S0079-6123(02)38076-2; Perouansky M, 2010, ANESTHESIOLOGY, V113, P1299, DOI 10.1097/ALN.0b013e3181f90ccc; Popescu IR, 2010, J PHYSIOL-LONDON, V588, P939, DOI 10.1113/jphysiol.2009.181461; Potter SM, 2001, J NEUROSCI METH, V110, P17, DOI 10.1016/S0165-0270(01)00412-5; Rivera S, 2010, J NEUROSCI, V30, P15337, DOI 10.1523/JNEUROSCI.3467-10.2010; Samochowiec A, 2010, BRAIN RES, V1327, P103, DOI 10.1016/j.brainres.2010.02.072; Savtchouk I, 2011, J NEUROSCI, V31, P501, DOI 10.1523/JNEUROSCI.2608-10.2011; Sbai O, 2008, MOL CELL NEUROSCI, V39, P549, DOI 10.1016/j.mcn.2008.08.004; Sfakianos MK, 2007, J NEUROSCI, V27, P10982, DOI 10.1523/JNEUROSCI.0793-07.2007; Shi Y, 2006, J NEUROSCI, V26, P1813, DOI 10.1523/JNEUROSCI.4091-05.2006; Snyder K, 2012, NEUROPSYCHOPHARMACOL, V37, P520, DOI 10.1038/npp.2011.218; Stegenga J, 2010, BIOPHYS J, V98, P2452, DOI 10.1016/j.bpj.2010.02.026; SWANSON LW, 1975, J COMP NEUROL, V163, P467, DOI 10.1002/cne.901630406; Tada T, 2006, CURR OPIN NEUROBIOL, V16, P95, DOI 10.1016/j.conb.2005.12.001; Tanaka Y, 2002, BIOCHEM BIOPH RES CO, V299, P472, DOI 10.1016/S0006-291X(02)02681-5; Thelen K, 2002, J NEUROSCI, V22, P4918, DOI 10.1523/JNEUROSCI.22-12-04918.2002; Tian L, 2007, J CELL BIOL, V178, P687, DOI 10.1083/jcb.200612097; Traub RD, 2004, ANNU REV NEUROSCI, V27, P247, DOI 10.1146/annurev.neuro.27.070203.144303; Uhl GR, 2008, ARCH GEN PSYCHIAT, V65, P345, DOI 10.1001/archpsyc.65.3.345; Wagenaar DA, 2006, BMC NEUROSCI, V7, DOI 10.1186/1471-2202-7-11; Wagenaar DA, 2006, PHYS REV E, V73, DOI 10.1103/PhysRevE.73.051907; Wang XB, 2008, P NATL ACAD SCI USA, V105, P19520, DOI 10.1073/pnas.0807248105; Weinhberger O, 2009, ANN M SOC NEUR, V322, pD16; Wright John W., 2007, Neural Plasticity, V2007, DOI 10.1155/2007/73813; Yong VW, 2007, J NEUROL SCI, V259, P79, DOI 10.1016/j.jns.2006.11.021	75	38	40	1	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 13	2012	7	8							e42631	10.1371/journal.pone.0042631	http://dx.doi.org/10.1371/journal.pone.0042631			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	988OJ	22912716	gold, Green Submitted, Green Published			2022-12-25	WOS:000307500100019
J	Fernandez-Mercado, M; Yip, BH; Pellagatti, A; Davies, C; Larrayoz, MJ; Kondo, T; Perez, C; Killick, S; McDonald, EJ; Odero, MD; Agirre, X; Prosper, F; Calasanz, MJ; Wainscoat, JS; Boultwood, J				Fernandez-Mercado, Marta; Yip, Bon Ham; Pellagatti, Andrea; Davies, Carwyn; Jose Larrayoz, Maria; Kondo, Toshinori; Perez, Cristina; Killick, Sally; McDonald, Emma-Jane; Dolores Odero, Maria; Agirre, Xabier; Prosper, Felipe; Jose Calasanz, Maria; Wainscoat, James S.; Boultwood, Jacqueline			Mutation Patterns of 16 Genes in Primary and Secondary Acute Myeloid Leukemia (AML) with Normal Cytogenetics	PLOS ONE			English	Article							DNMT3A MUTATIONS; MYELODYSPLASTIC SYNDROMES; PROGNOSTIC IMPACT; ASXL1; TET2; EVENTS; RUNX1; IDH2; NPM1; JAK2	Acute myeloid leukemia patients with normal cytogenetics (CN-AML) account for almost half of AML cases. We aimed to study the frequency and relationship of a wide range of genes previously reported as mutated in AML (ASXL1, NPM1, FLT3, TET2, IDH1/2, RUNX1, DNMT3A, NRAS, JAK2, WT1, CBL, SF3B1, TP53, KRAS and MPL) in a series of 84 CN-AML cases. The most frequently mutated genes in primary cases were NPM1 (60.8%) and FLT3 (50.0%), and in secondary cases ASXL1 (48.5%) and TET2 (30.3%). We showed that 85% of CN-AML patients have mutations in at least one of ASXL1, NPM1, FLT3, TET2, IDH1/2 and/or RUNX1. Serial samples from 19 MDS/CMML cases that progressed to AML were analyzed for ASXL1/TET2/IDH1/2 mutations; seventeen cases presented mutations of at least one of these genes. However, there was no consistent pattern in mutation acquisition during disease progression. This report concerns the analysis of the largest number of gene mutations in CN-AML studied to date, and provides insight into the mutational profile of CN-AML.	[Fernandez-Mercado, Marta; Yip, Bon Ham; Pellagatti, Andrea; Davies, Carwyn; Wainscoat, James S.; Boultwood, Jacqueline] John Radcliffe Hosp, LLR Mol Haematol Unit, NDCLS, Oxford OX3 9DU, England; [Pellagatti, Andrea; Dolores Odero, Maria; Jose Calasanz, Maria] Univ Navarra, Dept Genet, E-31080 Pamplona, Spain; [Kondo, Toshinori] Kawasaki Med Sch, Div Hematol, Okayama, Japan; [Perez, Cristina] Univ Navarra, Lab Myeloproliferat Syndromes, Oncol Area, Fdn Appl Med Res,Clin Univ, E-31080 Pamplona, Spain; [Killick, Sally; McDonald, Emma-Jane] Royal Bournemouth Hosp, Dept Haematol, Bournemouth, Dorset, England; [Dolores Odero, Maria] Univ Navarra, Div Oncol, Ctr Appl Med Res, E-31080 Pamplona, Spain; [Agirre, Xabier; Prosper, Felipe] Univ Navarra, Div Canc, E-31080 Pamplona, Spain; [Agirre, Xabier; Prosper, Felipe] Univ Navarra, Area Cell Therapy, E-31080 Pamplona, Spain; [Agirre, Xabier; Prosper, Felipe] Univ Navarra, Hematol Serv, E-31080 Pamplona, Spain	University of Oxford; University of Navarra; Kawasaki Medical School; University of Navarra; University of Navarra; University of Navarra; University of Navarra; University of Navarra	Fernandez-Mercado, M (corresponding author), John Radcliffe Hosp, LLR Mol Haematol Unit, NDCLS, Oxford OX3 9DU, England.	jacqueline.boultwood@ndcls.ox.ac.uk	, Bon Ham Yip/E-4925-2019; Prosper, Felipe/H-6859-2017; Calasanz, MJ/R-5813-2016; Agirre, Xabier/ABE-4110-2020; Odero/ABG-9860-2020	, Bon Ham Yip/0000-0002-2105-3254; Prosper, Felipe/0000-0001-6115-8790; Calasanz, MJ/0000-0002-0374-3008; Odero/0000-0002-8858-2054; Boultwood, Jacqueline/0000-0002-4330-2928; Pellagatti, Andrea/0000-0002-6122-0221; Fernandez-Mercado, Marta/0000-0003-3458-9231	Leukaemia and Lymphoma Research; Kay Kendall Leukaemia Fund of the United Kingdom	Leukaemia and Lymphoma Research; Kay Kendall Leukaemia Fund of the United Kingdom	This work was supported by Leukaemia and Lymphoma Research and the Kay Kendall Leukaemia Fund of the United Kingdom. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abbas S, 2008, HAEMATOL-HEMATOL J, V93, P1595, DOI 10.3324/haematol.13187; Abdel-Wahab O, 2010, CANCER RES, V70, P447, DOI 10.1158/0008-5472.CAN-09-3783; Beer PA, 2010, BLOOD, V115, P2891, DOI 10.1182/blood-2009-08-236596; Boultwood J, 2010, LEUKEMIA, V24, P1062, DOI 10.1038/leu.2010.20; Carbuccia N, 2010, LEUKEMIA, V24, P469, DOI 10.1038/leu.2009.218; Chou WC, 2010, BLOOD, V116, P4086, DOI 10.1182/blood-2010-05-283291; Couronne L, 2010, LEUKEMIA, V24, P201, DOI 10.1038/leu.2009.169; Dicker F, 2010, LEUKEMIA, V24, P1528, DOI 10.1038/leu.2010.124; Figueroa ME, 2010, CANCER CELL, V18, P553, DOI 10.1016/j.ccr.2010.11.015; Flach J, 2011, LEUKEMIA, V25, P713, DOI 10.1038/leu.2010.304; Ishikawa Y, 2009, EUR J HAEMATOL, V83, P90, DOI 10.1111/j.1600-0609.2009.01261.x; Jankowska AM, 2011, BLOOD, V118, P3932, DOI 10.1182/blood-2010-10-311019; Ley TJ, 2010, NEW ENGL J MED, V363, P2424, DOI 10.1056/NEJMoa1005143; Marcucci G, 2012, J CLIN ONCOL, V30, P742, DOI 10.1200/JCO.2011.39.2092; Metzeler KH, 2011, BLOOD, V118, P6920, DOI 10.1182/blood-2011-08-368225; Metzeler KH, 2011, J CLIN ONCOL, V29, P1373, DOI 10.1200/JCO.2010.32.7742; Mrozek K, 2007, BLOOD, V109, P431, DOI 10.1182/blood-2006-06-001149; Pratcorona M, 2011, HAEMATOLOGICA; Renneville A, 2012, LEUKEMIA; Rocquain J, 2010, BMC CANCER, V10, DOI 10.1186/1471-2407-10-401; Schlenk RF, 2008, NEW ENGL J MED, V358, P1909, DOI 10.1056/NEJMoa074306; Shen Y, 2011, BLOOD, V118, P5593, DOI 10.1182/blood-2011-03-343988; Thol F, 2011, J CLIN ONCOL, V29, P2889, DOI 10.1200/JCO.2011.35.4894	23	50	58	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 9	2012	7	8							e42334	10.1371/journal.pone.0042334	http://dx.doi.org/10.1371/journal.pone.0042334			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	986WZ	22912701	Green Submitted, Green Published, gold			2022-12-25	WOS:000307378500016
J	Wu, J; Shekhar, N; Lele, PP; Lele, TP				Wu, Jun; Shekhar, Nandini; Lele, Pushkar P.; Lele, Tanmay P.			FRAP Analysis: Accounting for Bleaching during Image Capture	PLOS ONE			English	Article							ESTROGEN-RECEPTOR-ALPHA; FLUORESCENCE RECOVERY; IN-VIVO; DIFFUSION MEASUREMENTS; RATE CONSTANTS; BINDING; DYNAMICS; REVEALS; PARAMETERS; TRANSPORT	The analysis of Fluorescence Recovery After Photobleaching (FRAP) experiments involves mathematical modeling of the fluorescence recovery process. An important feature of FRAP experiments that tends to be ignored in the modeling is that there can be a significant loss of fluorescence due to bleaching during image capture. In this paper, we explicitly include the effects of bleaching during image capture in the model for the recovery process, instead of correcting for the effects of bleaching using reference measurements. Using experimental examples, we demonstrate the usefulness of such an approach in FRAP analysis.	[Wu, Jun; Shekhar, Nandini; Lele, Tanmay P.] Univ Florida, Dept Chem Engn, Gainesville, FL 32611 USA; [Lele, Pushkar P.] Harvard Univ, Dept Mol & Cellular Biol, Cambridge, MA 02138 USA	State University System of Florida; University of Florida; Harvard University	Wu, J (corresponding author), Univ Florida, Dept Chem Engn, Gainesville, FL 32611 USA.	tlele@che.ufl.edu	Wu, Jun/Q-7143-2018	Wu, Jun/0000-0002-4457-5485; Lele, Pushkar/0000-0002-2894-3487	National Science Foundation [CMMI 0954302, CMMI 0927945]	National Science Foundation(National Science Foundation (NSF))	This work was supported by the National Science Foundation under awards CMMI 0954302 (TPL) and CMMI 0927945 (TPL). http://www.nsf.gov/awards/award_visualization_noscript.jsp?org = CMMI (R) ion = US-FL&instId = 0015354000. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BENSON DM, 1985, J CELL BIOL, V100, P1309, DOI 10.1083/jcb.100.4.1309; Braeckmans K, 2007, BIOPHYS J, V92, P2172, DOI 10.1529/biophysj.106.099838; Bulinski JC, 2001, J CELL SCI, V114, P3885; Deschout H, 2010, OPT EXPRESS, V18, P22886, DOI 10.1364/OE.18.022886; Dragestein KA, 2008, J CELL BIOL, V180, P729, DOI 10.1083/jcb.200707203; Kang M, 2008, BIOPHYS J, V95, pL13, DOI 10.1529/biophysj.108.135913; Kang MC, 2010, BIOPHYS J, V99, P2737, DOI 10.1016/j.bpj.2010.09.013; Kang M, 2009, BIOPHYS J, V97, P1501, DOI 10.1016/j.bpj.2009.06.017; KAUFMAN EN, 1990, BIOPHYS J, V58, P873, DOI 10.1016/S0006-3495(90)82432-2; KAUFMAN EN, 1991, BIOPHYS J, V60, P596, DOI 10.1016/S0006-3495(91)82089-6; Lele TP, 2008, BIOCHEM BIOPH RES CO, V369, P929, DOI 10.1016/j.bbrc.2008.02.137; Lele TP, 2006, BIOPHYS CHEM, V120, P32, DOI 10.1016/j.bpc.2005.10.007; Lele TP, 2006, J CELL PHYSIOL, V207, P187, DOI 10.1002/jcp.20550; Mueller F, 2012, METHODS MOL BIOL, V833, P153, DOI 10.1007/978-1-61779-477-3_11; Mueller F, 2010, CURR OPIN CELL BIOL, V22, P403, DOI 10.1016/j.ceb.2010.03.002; Phair RD, 2004, METHOD ENZYMOL, V375, P393; Phair RD, 2001, NAT REV MOL CELL BIO, V2, P898, DOI 10.1038/35103000; Sharp ZD, 2006, J CELL SCI, V119, P4101, DOI 10.1242/jcs.03161; Smisdom N, 2011, J BIOMED OPT, V16, DOI 10.1117/1.3569620; Sprague BL, 2005, TRENDS CELL BIOL, V15, P84, DOI 10.1016/j.tcb.2004.12.001; Sprague BL, 2004, BIOPHYS J, V86, P3473, DOI 10.1529/biophysj.103.026765; Stasevich TJ, 2010, BIOPHYS J, V99, P3093, DOI 10.1016/j.bpj.2010.08.059; Stenoien DL, 2001, NAT CELL BIOL, V3, P15, DOI 10.1038/35050515; van Royen Martin E., 2008, V464, P363, DOI 10.1007/978-1-60327-461-6_20; Wagner S, 2004, J CELL BIOL, V164, P843, DOI 10.1083/jcb.200307002	25	13	13	2	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 9	2012	7	8							e42854	10.1371/journal.pone.0042854	http://dx.doi.org/10.1371/journal.pone.0042854			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	986WZ	22912750	Green Published, gold, Green Submitted			2022-12-25	WOS:000307378500030
J	Pozo-Rodriguez, F; Lopez-Campos, JL; Alvarez-Martinez, CJ; Castro-Acosta, A; Aguero, R; Hueto, J; Hernandez-Hernandez, J; Barron, M; Abraira, V; Forte, A; Nieto, JMS; Lopez-Gabaldon, E; Cosio, BG; Agusti, A				Pozo-Rodriguez, Francisco; Luis Lopez-Campos, Jose; Alvarez-Martinez, Carlos J.; Castro-Acosta, Ady; Agueero, Ramon; Hueto, Javier; Hernandez-Hernandez, Jesus; Barron, Manuel; Abraira, Victor; Forte, Anabel; Sanchez Nieto, Juan Miguel; Lopez-Gabaldon, Encarnacion; Cosio, Borja G.; Agusti, Alvar		AUDIPOC Study Grp	Clinical Audit of COPD Patients Requiring Hospital Admissions in Spain: AUDIPOC Study	PLOS ONE			English	Article							OBSTRUCTIVE PULMONARY-DISEASE; QUALITY-OF-CARE; ACUTE EXACERBATIONS; IMPACT	Backgrounds: AUDIPOC is a nationwide clinical audit that describes the characteristics, interventions and outcomes of patients admitted to Spanish hospitals because of an exacerbation of chronic obstructive pulmonary disease (ECOPD), assessing the compliance of these parameters with current international guidelines. The present study describes hospital resources, hospital factors related to case recruitment variability, patients' characteristics, and adherence to guidelines. Methodology/Principal Findings: An organisational database was completed by all participant hospitals recording resources and organisation. Over an 8-week period 11,564 consecutive ECOPD admissions to 129 Spanish hospitals covering 70% of the Spanish population were prospectively identified. At hospital discharge, 5,178 patients (45% of eligible) were finally included, and thus constituted the audited population. Audited patients were reassessed 90 days after admission for survival and readmission rates. A wide variability was observed in relation to most variables, hospital adherence to guidelines, and readmissions and death. Median inpatient mortality was 5% (across-hospital range 0-35%). Among discharged patients, 37% required readmission (0-62%) and 6.5% died (0-35%). The overall mortality rate was 11.6% (0-50%). Hospital size and complexity and aspects related to hospital COPD awareness were significantly associated with case recruitment. Clinical management most often complied with diagnosis and treatment recommendations but rarely (<50%) addressed guidance on healthy life-styles. Conclusions/Significance: The AUDIPOC study highlights the large across-hospital variability in resources and organization of hospitals, patient characteristics, process of care, and outcomes. The study also identifies resources and organizational characteristics associated with the admission of COPD cases, as well as aspects of daily clinical care amenable to improvement.	[Pozo-Rodriguez, Francisco; Alvarez-Martinez, Carlos J.; Castro-Acosta, Ady] Hosp 12 Octubre, Inst Invest, E-28041 Madrid, Spain; [Pozo-Rodriguez, Francisco; Luis Lopez-Campos, Jose; Castro-Acosta, Ady; Cosio, Borja G.; Agusti, Alvar] Inst Salud Carlos III, Ctr Biomed Res Resp Dis CIBERES, Madrid, Spain; [Luis Lopez-Campos, Jose] Hosp Univ Virgen del Rocio, IBiS, Seville, Spain; [Agueero, Ramon] Hosp Univ Marques de Valdecilla, Santander, Spain; [Hueto, Javier] Complejo Hosp Navarra, Pamplona, Spain; [Hernandez-Hernandez, Jesus] Hosp Nuestra Sra Sonsoles, Avila, Spain; [Barron, Manuel] Complejo Hosp San Millan, Logrono, Spain; [Abraira, Victor] Hosp Univ Ramon y Cajal, IRYCIS, Madrid, Spain; [Abraira, Victor] Inst Salud Carlos III, Ctr Biomed Res Epidemiol & Publ Hlth CIBERESP, Madrid, Spain; [Forte, Anabel] Univ Castellon, Dept Stat & Operat Res, Castellon de La Plana, Spain; [Sanchez Nieto, Juan Miguel] Hosp Univ Morales Meseguer, Murcia, Spain; [Lopez-Gabaldon, Encarnacion] Hosp Virgen Salud, Toledo, Spain; [Cosio, Borja G.] Hosp Univ Son Espases, Balearic Isl, Spain; [Agusti, Alvar] Hosp Clin Barcelona, Inst Torax, Barcelona, Spain	Hospital Universitario 12 de Octubre; CIBER - Centro de Investigacion Biomedica en Red; CIBERES; Instituto de Salud Carlos III; Consejo Superior de Investigaciones Cientificas (CSIC); University of Sevilla; CSIC-JA-USE - Instituto de Biomedicina de Sevilla (IBIS); Virgen del Rocio University Hospital; Hospital Universitario Marques de Valdecilla (HUMV); Servicio Navarro de Salud - Osasunbidea; Hospital Universitario Ramon y Cajal; CIBER - Centro de Investigacion Biomedica en Red; CIBERESP; Instituto de Salud Carlos III; Universitat Jaume I; Meseguer General University Hospital Morales; Complejo Hospitalario de Toledo; Hospital Universitari Son Espases; University of Barcelona; Hospital Clinic de Barcelona	Pozo-Rodriguez, F (corresponding author), Hosp 12 Octubre, Inst Invest, E-28041 Madrid, Spain.	fpozo@h12o.es	Alfageme, Inmaculada/K-2092-2014; Barbé, Ferran/A-5988-2010; Alcázar-Navarrete, Bernardino/X-8947-2018; Forte, Anabel/Q-1512-2015; Valle-Falcones, Manuel/AAB-5557-2019; Represas-Represas, Cristina/AAA-7143-2019; Forte, Anabel/GLT-9488-2022; Andújar-Espinosa, Rubén/ABD-6716-2020; López-Quílez, Antonio/H-5945-2011; Ussetti, Piedad/B-3853-2014; Marcos, Pedro J/K-9965-2015; Garcia-Navarro, Alvar Agusti/F-4474-2015; Clemente, Marta Garcia/P-6628-2016; Castro-Acosta, Ady Angelica/H-4163-2011; Perez, Nicolas/A-7850-2015; G.Cosio, Borja/P-4963-2017; Fernandez, Virginia Leiro/B-9679-2018; FERNANDEZ, DANIEL LOPEZ/H-8651-2015; Guardia, Sergi Pascual/L-7652-2014; Lopez-Campos Bodineau, Jose Luis/Q-1637-2018	Alfageme, Inmaculada/0000-0002-5106-1669; Barbé, Ferran/0000-0002-2340-8928; Alcázar-Navarrete, Bernardino/0000-0003-2356-9366; Forte, Anabel/0000-0001-9534-1817; Valle-Falcones, Manuel/0000-0002-0900-146X; Represas-Represas, Cristina/0000-0002-5908-6684; Forte, Anabel/0000-0001-9534-1817; Andújar-Espinosa, Rubén/0000-0002-6714-9438; López-Quílez, Antonio/0000-0002-7022-9260; Ussetti, Piedad/0000-0002-3439-5536; Marcos, Pedro J/0000-0001-9600-3537; Garcia-Navarro, Alvar Agusti/0000-0003-3271-3788; Clemente, Marta Garcia/0000-0003-0463-5946; Castro-Acosta, Ady Angelica/0000-0001-7591-6011; Perez, Nicolas/0000-0002-1192-5901; G.Cosio, Borja/0000-0002-6388-8209; Fernandez, Virginia Leiro/0000-0001-9613-430X; FERNANDEZ, DANIEL LOPEZ/0000-0003-2131-9515; Guardia, Sergi Pascual/0000-0002-6567-0916; Canon-Barroso, Lourdes/0000-0002-9164-8915; AYERBE GARCIA, RUTH/0000-0001-8459-5037; ESTEBAN, CRISTOBAL/0000-0001-9878-7806; Ordonez Gomez, Paola Lisseth/0000-0001-8463-7057; Hernandez Hernandez, Jesus R./0000-0002-7526-1120; Abraira, Victor/0000-0002-4615-8503; Lopez-Campos Bodineau, Jose Luis/0000-0003-1703-1367; Pajares, Virginia/0000-0002-0916-527X; FERNANDEZ-VILLAR, ALBERTO/0000-0001-7407-5249; Ruiz Albi, Tomas/0000-0003-4785-7151; Abascal-Bolado, Beatriz/0000-0001-6712-9923; Domenech del Rio, Adolfo/0000-0002-3127-9150; Villanueva, Manuel Angel/0000-0003-3256-9579; Boukichou Abdelkader, Nisa/0000-0002-7427-531X; Gullon, Jose Antonio/0000-0002-3007-0873; CORBACHO, DOLORES/0000-0003-1239-5276; Cascante, Jose Antonio/0000-0003-2830-9272; Borderias, Luis/0000-0003-3296-9644; Rio, Maria Teresa/0000-0003-2958-1067	Fondo de Investigacion Sanitaria (FIS); Instituto de Salud Carlos III; Ministerio de Ciencia e Innovacion [PI 08/90129, PI 90486, PI08/90578, PI 07/90503, PI 08/90251, PI 07/90516, PI 08/90529, PI 07/90309, PI 08/90457, PI 07/90721, PI 08/90550, PI08/90447, PI07/90403, PI 08/90486]; Spanish Respiratory Society (SEPAR); CIBER de Enfermedades Respiratorias (CIBERES)	Fondo de Investigacion Sanitaria (FIS)(Instituto de Salud Carlos III); Instituto de Salud Carlos III(Instituto de Salud Carlos IIIEuropean Commission); Ministerio de Ciencia e Innovacion(Ministry of Science and Innovation, Spain (MICINN)Instituto de Salud Carlos IIISpanish Government); Spanish Respiratory Society (SEPAR); CIBER de Enfermedades Respiratorias (CIBERES)	This work was supported by Fondo de Investigacion Sanitaria (FIS), Instituto de Salud Carlos III, Ministerio de Ciencia e Innovacion (PI 08/90129, PI 90486, PI08/90578, PI 07/90503, PI 08/90251, PI 07/90516, PI 08/90529, PI 07/90309, PI 08/90457, PI 08/90129, PI 07/90721, PI 08/90550, PI08/90447, PI07/90403, PI 08/90486), Spanish Respiratory Society (SEPAR) and CIBER de Enfermedades Respiratorias (CIBERES). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agabiti N, 2010, EUR RESPIR J, V35, P1031, DOI 10.1183/09031936.00056209; Agusti A, 2010, RESP RES, V11, DOI 10.1186/1465-9921-11-122; [Anonymous], 2011, NICE CLIN GUIDELINE; [Anonymous], 2010, GUIA PRACT CLIN DIAG; Barba R, 2012, EUR RESPIR J, V39, P46, DOI 10.1183/09031936.00013211; Berger Z, 2010, J EVAL CLIN PRACT, V16, P1045, DOI 10.1111/j.1365-2753.2009.01247.x; Calderon-Larranaga A, 2011, THORAX, V66, P191, DOI 10.1136/thx.2010.147058; Cody Ron, 2005, CODYS DATA CLEANING; Gutierrez PC, 2010, MED CLIN-BARCELONA, V134, P505, DOI 10.1016/j.medcli.2009.12.002; Davidoff F, 1999, ANN INTERN MED, V130, P1019, DOI 10.7326/0003-4819-130-12-199906150-00022; Donaldson GC, 2006, THORAX, V61, P164, DOI 10.1136/thx.2005.041806; Eddy D M, 1984, Health Aff (Millwood), V3, P74, DOI 10.1377/hlthaff.3.2.74; Flottorp SA, 2010, USING AUDIT FEEDBACK; GUYATT G, 1992, JAMA-J AM MED ASSOC, V268, P2420, DOI 10.1001/jama.1992.03490170092032; Hernandez-Garcia I, 2011, REV CLIN ESP, V211, P219, DOI 10.1016/j.rce.2010.10.009; Holt JB, 2011, INT J CHRONIC OBSTR, V6, P321, DOI 10.2147/COPD.S19945; Hurst JR, 2009, AM J RESP CRIT CARE, V179, P369, DOI 10.1164/rccm.200807-1067OC; Instituto Nacional de Estadistica, 2011, INEBASE; Liaaen ED, 2010, RESP MED, V104, P1304, DOI 10.1016/j.rmed.2010.03.007; Lindenauer PK, 2006, ANN INTERN MED, V144, P894, DOI 10.7326/0003-4819-144-12-200606200-00006; Lynch SM, 2007, STAT SOC BEHAV SC, P1, DOI 10.1007/978-0-387-71265-9; Mathers CD, 2006, PLOS MED, V3, DOI 10.1371/journal.pmed.0030442; NICE and the Healthcare Commission, 2002, PRINC BEST PRACT CLI; Pozo-Rodriguez F, 2010, ARCH BRONCONEUMOL, V46, P349, DOI 10.1016/j.arbres.2010.04.004; Pretto JJ, INTERN MED IN PRESS; Price LC, 2006, THORAX, V61, P837, DOI 10.1136/thx.2005.049940; [Royal College of Physicians of London British Thoracic Society British Lung Foundation], 2011, REP NAT CHRON OBSTR; Soriano JB, 2010, EUR RESPIR J, V36, P758, DOI 10.1183/09031936.00138409; Spiegelhalter DJ, 2003, STAT MED, V22, P3687, DOI 10.1002/sim.1586	29	66	66	0	48	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 31	2012	7	7							e42156	10.1371/journal.pone.0042156	http://dx.doi.org/10.1371/journal.pone.0042156			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	982LS	22911875	Green Published, Green Submitted, gold			2022-12-25	WOS:000307045600061
J	Burke, DP; Kelly, DJ				Burke, Darren Paul; Kelly, Daniel John			Substrate Stiffness and Oxygen as Regulators of Stem Cell Differentiation during Skeletal Tissue Regeneration: A Mechanobiological Model	PLOS ONE			English	Article							ENDOTHELIAL GROWTH-FACTOR; MECHANO-REGULATION MODEL; BONE REGENERATION; DISTRACTION OSTEOGENESIS; BIOPHYSICAL STIMULI; GAP SIZE; IN-VIVO; CARTILAGE; TENSION; ANGIOGENESIS	Extrinsic mechanical signals have been implicated as key regulators of mesenchymal stem cell (MSC) differentiation. It has been possible to test different hypotheses for mechano-regulated MSC differentiation by attempting to simulate regenerative events such as bone fracture repair, where repeatable spatial and temporal patterns of tissue differentiation occur. More recently, in vitro studies have identified other environmental cues such as substrate stiffness and oxygen tension as key regulators of MSC differentiation; however it remains unclear if and how such cues determine stem cell fate in vivo. As part of this study, a computational model was developed to test the hypothesis that substrate stiffness and oxygen tension regulate stem cell differentiation during fracture healing. Rather than assuming mechanical signals act directly on stem cells to determine their differentiation pathway, it is postulated that they act indirectly to regulate angiogenesis and hence partially determine the local oxygen environment within a regenerating tissue. Chondrogenesis of MSCs was hypothesized to occur in low oxygen regions, while in well vascularised regions of the regenerating tissue a soft local substrate was hypothesised to facilitate adipogenesis while a stiff substrate facilitated osteogenesis. Predictions from the model were compared to both experimental data and to predictions of a well established computational mechanobiological model where tissue differentiation is assumed to be regulated directly by the local mechanical environment. The model predicted all the major events of fracture repair, including cartilaginous bridging, endosteal and periosteal bony bridging and bone remodelling. It therefore provides support for the hypothesis that substrate stiffness and oxygen play a key role in regulating MSC fate during regenerative events such as fracture healing.	[Burke, Darren Paul; Kelly, Daniel John] Trinity Coll Dublin, Trinity Biomed Sci Inst, Trinity Ctr Bioengn, Dublin, Ireland; [Burke, Darren Paul; Kelly, Daniel John] Trinity Coll Dublin, Dept Mech & Mfg Engn, Sch Engn, Dublin, Ireland	Trinity College Dublin; Trinity College Dublin	Burke, DP (corresponding author), Trinity Coll Dublin, Trinity Biomed Sci Inst, Trinity Ctr Bioengn, Dublin, Ireland.	kellyd9@tcd.ie		Kelly, Daniel/0000-0003-4091-0992	Science Foundation Ireland [08/Y15/B1336]; Trinity College Dublin Research Studentship Award	Science Foundation Ireland(Science Foundation IrelandEuropean Commission); Trinity College Dublin Research Studentship Award	This study was funded by Science Foundation Ireland under the President of Ireland Young Researcher Award (08/Y15/B1336) and through a Trinity College Dublin Research Studentship Award. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ARMSTRONG CG, 1982, J BONE JOINT SURG AM, V64, P88, DOI 10.2106/00004623-198264010-00013; Bailon-Plaza A, 2001, J THEOR BIOL, V212, P191, DOI 10.1006/jtbi.2001.2372; Bian LM, 2012, TISSUE ENG PT A, V18, P715, DOI [10.1089/ten.tea.2011.0455, 10.1089/ten.TEA.2011.0455]; Boccaccio A, 2008, MED BIOL ENG COMPUT, V46, P283, DOI 10.1007/s11517-007-0247-1; Boccaccio A, 2007, ANN BIOMED ENG, V35, P1940, DOI 10.1007/s10439-007-9367-x; Boccaccio A, 2011, J ORTHOP RES, V29, P433, DOI 10.1002/jor.21231; Boerckel JD, 2011, P NATL ACAD SCI USA, V108, pE674, DOI 10.1073/pnas.1107019108; BRUETON RN, 1990, CLIN ORTHOP RELAT R, P286; Buckley CT, 2010, OSTEOARTHR CARTILAGE, V18, P1345, DOI 10.1016/j.joca.2010.07.004; Byrne DP, 2011, J ORTHOP RES; Cao Y, 2007, J CLIN INVEST, V117, P2362, DOI 10.1172/JCI32239; CARTER DR, 1988, J ORTHOP RES, V6, P736, DOI 10.1002/jor.1100060517; Carter DR, 1998, CLIN ORTHOP RELAT R, pS41; Checa S, 2009, ANN BIOMED ENG, V37, P129, DOI 10.1007/s10439-008-9594-9; Chen G, 2009, J BIOMECH, V42, P2575, DOI 10.1016/j.jbiomech.2009.07.010; Claes L, 2002, J ORTHOP RES, V20, P1099, DOI 10.1016/S0736-0266(02)00044-X; Claes LE, 1999, J BIOMECH, V32, P255, DOI 10.1016/S0021-9290(98)00153-5; Cowin SC, 1999, J BIOMECH, V32, P217, DOI 10.1016/S0021-9290(98)00161-4; Engler AJ, 2006, CELL, V126, P677, DOI 10.1016/j.cell.2006.06.044; Epari DR, 2008, BONE, V43, P734, DOI 10.1016/j.bone.2008.06.007; Fehrer C, 2007, AGING CELL, V6, P745, DOI 10.1111/j.1474-9726.2007.00336.x; FROST HM, 1990, ANAT REC, V226, P403, DOI 10.1002/ar.1092260402; Garcia P, 2012, J BONE JOINT SURG AM, V94A, P49, DOI 10.2106/JBJS.J.00795; Garcia-Aznar JM, 2007, J BIOMECH, V40, P1467, DOI 10.1016/j.jbiomech.2006.06.013; Geris L, 2008, J THEOR BIOL, V251, P137, DOI 10.1016/j.jtbi.2007.11.008; Geris L, 2010, TISSUE ENG PT A, V16, P3353, DOI [10.1089/ten.tea.2010.0130, 10.1089/ten.TEA.2010.0130]; Geris L, 2010, PLOS COMPUT BIOL, V6, DOI 10.1371/journal.pcbi.1000915; Gerstenfeld LC, 2003, J CELL BIOCHEM, V88, P873, DOI 10.1002/jcb.10435; Gomez-Benito MJ, 2005, J THEOR BIOL, V235, P105, DOI 10.1016/j.jtbi.2004.12.023; Gomillion CT, 2006, BIOMATERIALS, V27, P6052, DOI 10.1016/j.biomaterials.2006.07.033; Hausman GJ, 2004, J ANIM SCI, V82, P925; Hausman MR, 2001, BONE, V29, P560, DOI 10.1016/S8756-3282(01)00608-1; Hayward LN, 2009, BIOMECH MODEL MECHAN; HERSHEY D, 1968, AICHE J, V14, P969, DOI 10.1002/aic.690140628; Hirao M, 2006, J BIOL CHEM, V281, P31079, DOI 10.1074/jbc.M602296200; Holzwarth C, 2010, BMC CELL BIOL, V11, DOI 10.1186/1471-2121-11-11; HORI RY, 1982, J BIOMED MATER RES, V16, P911, DOI 10.1002/jbm.820160615; Isaksson H, 2007, J BIOMECH, V40, P2002, DOI 10.1016/j.jbiomech.2006.09.028; Isaksson H, 2006, J BIOMECH, V39, P1507, DOI 10.1016/j.jbiomech.2005.01.037; Kanichai M, 2008, J CELL PHYSIOL, V216, P708, DOI 10.1002/jcp.21446; Kelly DJ, 2006, TISSUE ENG, V12, P2509, DOI 10.1089/ten.2006.12.2509; Kelly DJ, 2010, BIRTH DEFECTS RES C, V90, P75, DOI 10.1002/bdrc.20173; Kelly DJ, 2005, J BIOMECH, V38, P1413, DOI 10.1016/j.jbiomech.2004.06.026; Khayyeri H, 2009, J ORTHOP RES, V27, P1659, DOI 10.1002/jor.20926; Krinner A, 2009, CELL PROLIFERAT, V42, P471, DOI 10.1111/j.1365-2184.2009.00621.x; Kronenberg HM, 2003, NATURE, V423, P332, DOI 10.1038/nature01657; Lacroix D, 2002, J BIOMECH, V35, P1163, DOI 10.1016/S0021-9290(02)00086-6; Lacroix D, 2002, MED BIOL ENG COMPUT, V40, P14, DOI 10.1007/BF02347690; Lacroix D, 2000, SIMULATION TISSUE DI; Lienau J, 2005, J ORTHOP RES, V23, P639, DOI 10.1016/j.orthres.2004.09.006; Ma T, 2009, BIOTECHNOL PROGR, V25, P32, DOI 10.1002/btpr.128; Mackie EJ, 2008, INT J BIOCHEM CELL B, V40, P46, DOI 10.1016/j.biocel.2007.06.009; MENTE PL, 1994, J ORTHOP RES, V12, P637, DOI 10.1002/jor.1100120506; Merceron C, 2010, AM J PHYSIOL-CELL PH, V298, pC355, DOI 10.1152/ajpcell.00398.2009; Meyer EG, 2010, J BIOMECH, V43, P2516, DOI 10.1016/j.jbiomech.2010.05.020; Nagel T, 2010, BIOMECH MODEL MECHAN, V9, P359, DOI 10.1007/s10237-009-0182-1; OCHOA JA, 1992, T 38 ORS, P162; Park JS, 2011, BIOMATERIALS, V32, P3921, DOI 10.1016/j.biomaterials.2011.02.019; Pattappa G, 2010, J CELL PHYSL; PAUWELS F, 1960, Z Anat Entwicklungsgesch, V121, P478, DOI 10.1007/BF00523401; Peiffer V, 2011, BIOMECH MODEL MECHAN, V10, P383, DOI 10.1007/s10237-010-0241-7; Pek YS, 2010, BIOMATERIALS, V31, P385, DOI 10.1016/j.biomaterials.2009.09.057; Prendergast PJ, 1997, CLIN BIOMECH, V12, P343, DOI 10.1016/S0268-0033(97)00018-1; Prendergast PJ, 1997, J BIOMECH, V30, P539, DOI 10.1016/S0021-9290(96)00140-6; ROACH HI, 1995, J CELL BIOL, V131, P483, DOI 10.1083/jcb.131.2.483; RUBIN CT, 1985, CALCIFIED TISSUE INT, V37, P411, DOI 10.1007/BF02553711; Savarino L, 2005, J BONE JOINT SURG BR, V87B, P571, DOI 10.1302/0301-620X.87B4.15316; SCHAFFLER MB, 1988, J BIOMECH, V21, P13, DOI 10.1016/0021-9290(88)90186-8; Sheehy EJ, 2012, BIOCHEM BIOPH RES CO, V417, P305, DOI 10.1016/j.bbrc.2011.11.105; Simon U, 2011, COMPUT METHOD BIOMEC, V14, P79, DOI 10.1080/10255842.2010.499865; Steward AJ, 2012, ACTA BIOMATER, V8, P2153, DOI 10.1016/j.actbio.2012.03.016; Street J, 2002, P NATL ACAD SCI USA, V99, P9656, DOI 10.1073/pnas.152324099; Taylor DK, 2009, J BONE MINER RES, V24, P1043, DOI [10.1359/jbmr.090101, 10.1359/JBMR.090101]; Vetter A, 2011, BIOMECH MODEL MECHAN; Vetter A, 2010, J ORTHOP RES, V28, P1440, DOI 10.1002/jor.21175; Vinardell T, 2012, EUR CELLS MATER, V23, P121, DOI 10.22203/eCM.v023a09; Yin M, 2002, J BONE MINER RES, V17, P56, DOI 10.1359/jbmr.2002.17.1.56; Yun Z, 2002, DEV CELL, V2, P331, DOI 10.1016/S1534-5807(02)00131-4	78	63	64	2	48	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 24	2012	7	7							e40737	10.1371/journal.pone.0040737	http://dx.doi.org/10.1371/journal.pone.0040737			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	978NX	22911707	Green Published, Green Submitted, gold			2022-12-25	WOS:000306751300012
J	Farmer, C; Cox, JJ; Fletcher, EV; Woods, CG; Wood, JN; Schorge, S				Farmer, Clare; Cox, James J.; Fletcher, E. V.; Woods, C. Geoffrey; Wood, John N.; Schorge, Stephanie			Splice Variants of Na(V)1.7 Sodium Channels Have Distinct beta Subunit-Dependent Biophysical Properties	PLOS ONE			English	Article							ALPHA-SUBUNIT; MESSENGER-RNAS; DIFFERENTIAL EXPRESSION; RAT-BRAIN; PAIN; TARGETS; SCN9A; ERYTHROMELALGIA; ERYTHERMALGIA; INACTIVATION	Genes encoding the alpha subunits of neuronal sodium channels have evolutionarily conserved sites of alternative splicing but no functional differences have been attributed to the splice variants. Here, using Na(V)1.7 as an exemplar, we show that the sodium channel isoforms are functionally distinct when co-expressed with beta subunits. The gene, SCN9A, encodes the alpha subunit of the Na(V)1.7 channel, and contains both sites of alternative splicing that are highly conserved. In conditions where the intrinsic properties of the Na(V)1.7 splice variants were similar when expressed alone, co-expression of beta 1 subunits had different effects on channel availability that were determined by splicing at either site in the alpha subunit. While the identity of exon 5 determined the degree to which beta 1 subunits altered voltage-dependence of activation (P = 0.027), the length of exon 11 regulated how far beta 1 subunits depolarised voltage-dependence of inactivation (P = 0.00012). The results could have a significant impact on channel availability, for example with the long version of exon 11, the co-expression of beta 1 subunits could lead to nearly twice as large an increase in channel availability compared to channels containing the short version. Our data suggest that splicing can change the way that Na-V channels interact with beta subunits. Because splicing is conserved, its unexpected role in regulating the functional impact of beta subunits may apply to multiple voltage-gated sodium channels, and the full repertoire of beta subunit function may depend on splicing in alpha subunits.	[Farmer, Clare; Fletcher, E. V.; Schorge, Stephanie] UCL Inst Neurol, London, England; [Cox, James J.; Wood, John N.] UCL Wolfson Inst Biomed Res, London, England; [Woods, C. Geoffrey] Addenbrookes Hosp, Cambridge Inst Med Res, Dept Med Genet, Cambridge, England	University of London; University College London; University of London; University College London; Cambridge University Hospitals NHS Foundation Trust; Addenbrooke's Hospital; University of Cambridge	Farmer, C (corresponding author), UCL Inst Neurol, Queen Sq, London, England.	s.schorge@ucl.ac.uk	Schorge, Stephanie/C-8515-2009; Fletcher, Emily V/AAN-9916-2020; Cox, James/R-1910-2016	Schorge, Stephanie/0000-0003-1541-5148; Fletcher, Emily V/0000-0002-9786-4221; 	Royal Society; MRC; BBSRC; Wellcome Trust; World University Program [R31-2008-000-10103-0]; Pfizer; Medical Research Council [G0601440, G1100340, G0901905] Funding Source: researchfish; MRC [MR/J012742/1, G0601440, G0901905, G1100340] Funding Source: UKRI	Royal Society(Royal Society of London); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Wellcome Trust(Wellcome Trust); World University Program; Pfizer(Pfizer); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	SS holds a University Research Fellowship from the Royal Society. This work was funded by the MRC (CF, JJC, JNW, SS), BBSRC (JJC, JNW), and Wellcome Trust (JJC, CGW, JNW, SS), and World University Program grant R31-2008-000-10103-0 (JNW). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; The authors have read the journal's policy and have the following conflicts: Funding was received from Pfizer (JJC, CGW). This does not alter the authors' adherence to all the PLoS ONE policies on sharing data and materials.	Blackburn-Munro G, 1999, NEUROSCIENCE, V90, P153, DOI 10.1016/S0306-4522(98)00415-1; Brackenbury WJ, 2011, FRONT PHARMACOL, V2, DOI 10.3389/fphar.2011.00053; Chatelier A, 2008, J NEUROPHYSIOL, V99, P2241, DOI 10.1152/jn.01350.2007; Choi JS, 2006, NEUROLOGY, V67, P1563, DOI 10.1212/01.wnl.0000231514.33603.1e; Choi JS, 2010, BRAIN, V133, P1823, DOI 10.1093/brain/awq114; Copley RR, 2004, TRENDS GENET, V20, P171, DOI 10.1016/j.tig.2004.02.001; Cox JJ, 2006, NATURE, V444, P894, DOI 10.1038/nature05413; Cummins TR, 1998, J NEUROSCI, V18, P9607; Cummins TR, 2004, J NEUROSCI, V24, P8232, DOI 10.1523/JNEUROSCI.2695-04.2004; Dib-Hajj SD, 2009, PAIN MED, V10, P1260, DOI 10.1111/j.1526-4637.2009.00719.x; Dib-Hajj SD, 2008, ADV GENET, V63, P85, DOI 10.1016/S0065-2660(08)01004-3; Ellerkmann RK, 2003, NEUROSCIENCE, V119, P323, DOI 10.1016/S0306-4522(03)00168-4; Fertleman CR, 2006, NEURON, V52, P767, DOI 10.1016/j.neuron.2006.10.006; Fischer TZ, 2009, ANN NEUROL, V65, P733, DOI 10.1002/ana.21678; Fletcher EV, 2011, J BIOL CHEM, V286, P36700, DOI 10.1074/jbc.M111.250225; Gazina EV, 2010, NEUROSCIENCE, V166, P195, DOI 10.1016/j.neuroscience.2009.12.011; Gorter JA, 2006, J NEUROSCI, V26, P11083, DOI 10.1523/JNEUROSCI.2766-06.2006; GUSTAFSON TA, 1993, J BIOL CHEM, V268, P18648; Jarecki BW, 2009, CHANNELS, V3, P259; Lopez-Santiago LF, 2011, J BIOL CHEM, V286, P22913, DOI 10.1074/jbc.M111.242370; Momin A, 2008, CURR OPIN NEUROBIOL, V18, P383, DOI 10.1016/j.conb.2008.08.017; Patino GA, 2010, NEUROSCI LETT; Raymond CK, 2004, J BIOL CHEM, V279, P46234, DOI 10.1074/jbc.M406387200; SARAO R, 1991, NUCLEIC ACIDS RES, V19, P5673, DOI 10.1093/nar/19.20.5673; SCHEINMAN RI, 1989, J BIOL CHEM, V264, P10660; Thun J, 2009, BRAIN RES, V1269, P11, DOI 10.1016/j.brainres.2009.02.044; Yang Y, 2004, J MED GENET, V41, P171, DOI 10.1136/jmg.2003.012153	27	13	15	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 24	2012	7	7							e41750	10.1371/journal.pone.0041750	http://dx.doi.org/10.1371/journal.pone.0041750			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	978NX	22911851	Green Published, gold, Green Submitted			2022-12-25	WOS:000306751300069
J	Sorochkina, AI; Plotnikov, EY; Rokitskaya, TI; Kovalchuk, SI; Kotova, EA; Sychev, SV; Zorov, DB; Antonenko, YN				Sorochkina, Alexandra I.; Plotnikov, Egor Y.; Rokitskaya, Tatyana I.; Kovalchuk, Sergei I.; Kotova, Elena A.; Sychev, Sergei V.; Zorov, Dmitry B.; Antonenko, Yuri N.			N-Terminally Glutamate-Substituted Analogue of Gramicidin A as Protonophore and Selective Mitochondrial Uncoupler	PLOS ONE			English	Article							BIOMEMBRANE-PRODUCED ENERGY; OXIDATIVE-PHOSPHORYLATION; LIPID-BILAYERS; ELECTROCHEMICAL GRADIENT; TRANSMEMBRANE CHANNEL; PHOSPHOLIPID-VESICLES; ACETYL GRAMICIDIN; FLUORESCENT-PROBE; ELECTRIC FORM; MEMBRANE	Limited uncoupling of oxidative phosphorylation could be beneficial for cells by preventing excessive generation of reactive oxygen species. Typical uncouplers are weak organic acids capable of permeating across membranes with a narrow gap between efficacy and toxicity. Aimed at designing a nontoxic uncoupler, the protonatable amino acid residue Glu was substituted for Val at the N-terminus of the pentadecapeptide gramicidin A (gA). The modified peptide [Glu1]gA exhibited high uncoupling activity in isolated mitochondria, in particular, abolishing membrane potential at the inner mitochondrial membrane with the same or even larger efficacy as gA. With mitochondria in cell culture, the depolarizing activity of [Glu1]gA was observed at concentrations by an order of magnitude lower than those of gA. On the contrary, [Glu1]gA was much less potent in forming proton channels in planar lipid bilayers than gA. Remarkably, at uncoupling concentrations, [Glu1]gA did not alter cell morphology and was nontoxic in MTT test, in contrast to gA showing high toxicity. The difference in the behavior of [Glu1]gA and gA in natural and artificial membranes could be ascribed to increased capability of [Glu1]gA to permeate through membranes and/or redistribute between different membranes. Based on the protective role of mild uncoupling, [Glu1]gA and some other proton-conducting gA analogues may be considered as prototypes of prospective therapeutic agents.	[Sorochkina, Alexandra I.; Plotnikov, Egor Y.; Rokitskaya, Tatyana I.; Kotova, Elena A.; Zorov, Dmitry B.; Antonenko, Yuri N.] Moscow MV Lomonosov State Univ, Belozersky Inst Physicochem Biol, Moscow, Russia; [Kovalchuk, Sergei I.; Sychev, Sergei V.] Russian Acad Sci, Shemyakin & Ovchinnikov Inst Bioorgan Chem, Moscow, Russia	Lomonosov Moscow State University; Russian Academy of Sciences; Pushchino Scientific Center for Biological Research (PSCBI) of the Russian Academy of Sciences; Institute of Bioorganic Chemistry of the Russian Academy of Sciences	Sorochkina, AI (corresponding author), Moscow MV Lomonosov State Univ, Belozersky Inst Physicochem Biol, Moscow, Russia.	yuriantonenko@yahoo.com	Kovalchuk, Sergey I/J-3247-2014; Plotnikov, Egor Y/F-8592-2019; Antonenko, Yuri N/K-1323-2013; Kotova, Elena/A-6214-2012; Zorov, Dmitry B./AAB-1738-2019; Rokitskaya, Tatyana/J-3541-2013	Kovalchuk, Sergey I/0000-0001-5273-3431; Plotnikov, Egor Y/0000-0003-2838-3704; Zorov, Dmitry B./0000-0003-0863-8490; Rokitskaya, Tatyana/0000-0002-7719-1875	Russian Foundation for Basic Research [12-04-00199, 11-04-00771, 11-04-01307]	Russian Foundation for Basic Research(Russian Foundation for Basic Research (RFBR))	This work was supported in part by the Russian Foundation for Basic Research grants 12-04-00199, 11-04-00771 and 11-04-01307. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AKERMAN KEO, 1976, FEBS LETT, V68, P191, DOI 10.1016/0014-5793(76)80434-6; Andersen O S, 1999, Methods Enzymol, V294, P208; Antonenko YN, 2011, J BIOL CHEM, V286, P17831, DOI 10.1074/jbc.M110.212837; AZZONE GF, 1978, BIOCHIM BIOPHYS ACTA, V501, P296, DOI 10.1016/0005-2728(78)90035-X; BAKEEVA LE, 1970, BIOCHIM BIOPHYS ACTA, V216, P13, DOI 10.1016/0005-2728(70)90154-4; BAMBERG E, 1979, J MEMBRANE BIOL, V50, P257, DOI 10.1007/BF01868892; BAMBERG E, 1977, P NATL ACAD SCI USA, V74, P2402, DOI 10.1073/pnas.74.6.2402; BEZRUKOV SM, 1984, BIOL MEMBRANY, V1, P659; Chen Y, 1999, J BIOL CHEM, V274, P18364, DOI 10.1074/jbc.274.26.18364; Chernyshev A, 2003, BIOPHYS J, V84, P238, DOI 10.1016/S0006-3495(03)74845-0; CLEMENT NR, 1981, BIOCHEMISTRY-US, V20, P1534, DOI 10.1021/bi00509a019; CLEMENT NR, 1981, BIOCHEMISTRY-US, V20, P1544, DOI 10.1021/bi00509a021; Cukierman S, 1997, BIOPHYS J, V73, P2489, DOI 10.1016/S0006-3495(97)78277-8; Cunha FM, 2011, CURR DRUG TARGETS, V12, P783; DEAMER DW, 1987, J BIOENERG BIOMEMBR, V19, P457; Decoursey TE, 2003, PHYSIOL REV, V83, P475, DOI 10.1152/physrev.00028.2002; DENIZOT F, 1986, J IMMUNOL METHODS, V89, P271, DOI 10.1016/0022-1759(86)90368-6; Doebler JA, 1999, CELL BIOL TOXICOL, V15, P279, DOI 10.1023/A:1007651417519; GOODALL MC, 1971, ARCH BIOCHEM BIOPHYS, V147, P129, DOI 10.1016/0003-9861(71)90318-3; Gowen JA, 2002, BIOPHYS J, V83, P880, DOI 10.1016/S0006-3495(02)75215-6; Greathouse D V, 1999, Methods Enzymol, V294, P525; GRINIUS LL, 1970, BIOCHIM BIOPHYS ACTA, V216, P1, DOI 10.1016/0005-2728(70)90153-2; Grundlingh J, 2011, J MED TOXICOL, V7, P205, DOI 10.1007/s13181-011-0162-6; Harper J A, 2001, Obes Rev, V2, P255, DOI 10.1046/j.1467-789X.2001.00043.x; Heytler P G, 1979, Methods Enzymol, V55, P462; HLADKY SB, 1984, CURR TOP MEMBR TRANS, V21, P327; Johnson  D., 1967, METHOD ENZYMOL, V10, P94, DOI DOI 10.1016/0076-6879(67)10018-9; Koeppe RE, 1996, ANNU REV BIOPH BIOM, V25, P231; Korshunov SS, 1997, FEBS LETT, V416, P15, DOI 10.1016/S0014-5793(97)01159-9; KRISHNAMOORTHY G, 1986, BIOCHEMISTRY-US, V25, P6666, DOI 10.1021/bi00369a051; LARIS PC, 1975, BIOCHIM BIOPHYS ACTA, V376, P415, DOI 10.1016/0005-2728(75)90163-2; LEUNG J, 1973, BIOCHIM BIOPHYS ACTA, V298, P718, DOI 10.1016/0005-2736(73)90088-6; LIBERMAN EA, 1969, NATURE, V222, P1076, DOI 10.1038/2221076a0; MATTICE GL, 1995, BIOCHEMISTRY-US, V34, P6827, DOI 10.1021/bi00020a029; MITCHELL P, 1966, BIOL REV, V41, P445, DOI 10.1111/j.1469-185X.1966.tb01501.x; MITCHELL P, 1967, BIOCHEM J, V105, P1147, DOI 10.1042/bj1051147; Mobashery N, 1997, FEBS LETT, V412, P15, DOI 10.1016/S0014-5793(97)00709-6; MORROW JS, 1979, J MOL BIOL, V132, P733, DOI 10.1016/0022-2836(79)90386-3; MUELLER P, 1963, J PHYS CHEM-US, V67, P534, DOI 10.1021/j100796a529; Nicholls DG, 2006, J BIOL CHEM, V281, P14864, DOI 10.1074/jbc.M510916200; NICOLAY K, 1994, J BIOENERG BIOMEMBR, V26, P327, DOI 10.1007/BF00763104; PADAN E, 1973, EUR J BIOCHEM, V40, P431, DOI 10.1111/j.1432-1033.1973.tb03212.x; Pandya JD, 2009, EXP NEUROL, V218, P381, DOI 10.1016/j.expneurol.2009.05.023; Perevoshchikova IV, 2009, BIOCHEMISTRY-MOSCOW+, V74, P663, DOI 10.1134/S000629790906011X; PODLESKI T, 1969, NATURE, V221, P541, DOI 10.1038/221541a0; Robinson HJ, 1942, J PHARMACOL EXP THER, V74, P75; Rokitskaya TI, 2012, EUR BIOPHYS J BIOPHY, V41, P129, DOI 10.1007/s00249-011-0764-6; Rokitskaya TI, 2002, BIOPHYS J, V82, P865, DOI 10.1016/S0006-3495(02)75448-9; Rostovtseva TK, 1998, BIOPHYS J, V75, P1783, DOI 10.1016/S0006-3495(98)77620-9; ROTTENBERG H, 1989, BIOCHEMISTRY-US, V28, P4355, DOI 10.1021/bi00436a035; Saparov SM, 2000, BIOPHYS J, V79, P2526, DOI 10.1016/S0006-3495(00)76493-9; SEOH SA, 1993, BIOPHYS J, V65, P1817, DOI 10.1016/S0006-3495(93)81239-6; Skulachev VP, 1998, BBA-BIOENERGETICS, V1363, P100, DOI 10.1016/S0005-2728(97)00091-1; Skulachev VP, 1996, Q REV BIOPHYS, V29, P169, DOI 10.1017/S0033583500005795; SMITH PK, 1985, ANAL BIOCHEM, V150, P76, DOI 10.1016/0003-2697(85)90442-7; Starkov AA, 1997, BIOSCIENCE REP, V17, P273, DOI 10.1023/A:1027380527769; Starkov AA, 2003, J NEUROCHEM, V86, P1101, DOI 10.1046/j.1471-4159.2003.01908.x; Stuart JA, 1999, J BIOENERG BIOMEMBR, V31, P517, DOI 10.1023/A:1005456725549; Sychev SV, 1996, J PEPT SCI, V2, P141, DOI 10.1002/psc.59; SZABO G, 1979, SCIENCE, V203, P55, DOI 10.1126/science.83000; TERADA H, 1990, ENVIRON HEALTH PERSP, V87, P213, DOI 10.2307/3431027; URRY DW, 1971, P NATL ACAD SCI USA, V68, P672, DOI 10.1073/pnas.68.3.672; VANDERMEULEN DL, 1976, BIOCHIM BIOPHYS ACTA, V449, P340, DOI 10.1016/0005-2728(76)90146-8; Wallace KB, 2000, ANNU REV PHARMACOL, V40, P353, DOI 10.1146/annurev.pharmtox.40.1.353	64	20	20	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 24	2012	7	7							e41919	10.1371/journal.pone.0041919	http://dx.doi.org/10.1371/journal.pone.0041919			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	978NX	22911866	gold, Green Submitted, Green Published			2022-12-25	WOS:000306751300083
J	Choy, HA				Choy, Henry A.			Multiple Activities of LigB Potentiate Virulence of Leptospira interrogans: Inhibition of Alternative and Classical Pathways of Complement	PLOS ONE			English	Article							IMMUNOGLOBULIN-LIKE PROTEINS; FACTOR-H; IMMUNE EVASION; STAPHYLOCOCCUS-AUREUS; BORRELIA-BURGDORFERI; SURFACE PROTEIN; ANTILEPTOSPIRAL ACTIVITY; HUMAN PLASMINOGEN; BINDING PROTEIN; CLUMPING FACTOR	Microbial pathogens acquire the immediate imperative to avoid or counteract the formidable defense of innate immunity as soon as they overcome the initial physical barriers of the host. Many have adopted the strategy of directly disrupting the complement system through the capture of its components, using proteins on the pathogen's surface. In leptospirosis, pathogenic Leptospira spp. are resistant to complement-mediated killing, in contrast to the highly vulnerable non-pathogenic strains. Pathogenic L. interrogans uses LenA/LfhA and LcpA to respectively sequester and commandeer the function of two regulators, factor H and C4BP, which in turn bind C3b or C4b to interrupt the alternative or classical pathways of complement activation. LigB, another surface-proximal protein originally characterized as an adhesin binding multiple host proteins, has other activities suggesting its importance early in infection, including binding extracellular matrix, plasma, and cutaneous repair proteins and inhibiting hemostasis. In this study, we used a recent model of ectopic expression of LigB in the saprophyte, L. biflexa, to test the hypothesis that LigB also interacts with complement proteins C3b and C4b to promote the virulence of L. interrogans. The surface expression of LigB partially rescued the non-pathogen from killing by 5% normal human serum, showing 1.3- to 48-fold greater survival 4 to 6 d following exposure to complement than cultures of the non-expressing parental strain. Recombinant LigB7'-12 comprising the LigB-specific immunoglobulin repeats binds directly to human complement proteins, C3b and C4b, with respective K(d)s of 43 +/- 26 nM and 69 +/- 18 nM. Repeats 9 to 11, previously shown to contain the binding domain for fibronectin and fibrinogen, are also important in LigB-complement interactions, which interfere with the alternative and classical pathways measured by complement-mediated hemolysis of erythrocytes. Thus, LigB is an adaptable interface for L. interrogans to efficiently counteract the multiple homeostatic processes of the host.	[Choy, Henry A.] Univ Calif Los Angeles, David Geffen Sch Med, Dept Med, Los Angeles, CA 90095 USA; [Choy, Henry A.] HACme Lab Serv, Los Angeles, CA USA	University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA	Choy, HA (corresponding author), Univ Calif Los Angeles, David Geffen Sch Med, Dept Med, Los Angeles, CA 90095 USA.	hachoy@ucla.edu			National Institutes of Health [AI-034431]; VA Medical Research Funds; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI034431, R29AI034431, R21AI034431] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); VA Medical Research Funds(US Department of Veterans Affairs); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	The study was supported by the National Institutes of Health (AI-034431) and VA Medical Research Funds to David A. Haake. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alitalo A, 2001, INFECT IMMUN, V69, P3685, DOI 10.1128/IAI.69.6.3685-3691.2001; BANFI E, 1982, J GEN MICROBIOL, V128, P813; Barbosa AS, 2006, INFECT IMMUN, V74, P6356, DOI 10.1128/IAI.00460-06; Barbosa AS, 2010, INFECT IMMUN, V78, P3207, DOI 10.1128/IAI.00279-10; Barbosa AS, 2009, INFECT IMMUN, V77, P1137, DOI 10.1128/IAI.01310-08; Barthel D, 2012, J IMMUNOL, V188, P379, DOI 10.4049/jimmunol.1101927; Beckmann C, 2002, INFECT IMMUN, V70, P2869, DOI 10.1128/IAI.70.6.2869-2876.2002; Bharti AR, 2003, LANCET INFECT DIS, V3, P757, DOI 10.1016/S1473-3099(03)00830-2; Brooks CS, 2005, J IMMUNOL, V175, P3299, DOI 10.4049/jimmunol.175.5.3299; Bykowski T, 2007, INFECT IMMUN, V75, P4227, DOI 10.1128/IAI.00604-07; Castiblanco-Valencia MM, 2012, J INFECT DIS, V205, P995, DOI 10.1093/infdis/jir875; Chen H, 2010, P NATL ACAD SCI USA, V107, P17621, DOI 10.1073/pnas.1003750107; Choy HA, 2007, INFECT IMMUN, V75, P2441, DOI 10.1128/IAI.01635-06; Choy HA, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016879; Chung MC, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018119; Cinco M, 2010, NEW MICROBIOL, V33, P283; Croda J, 2007, J CLIN MICROBIOL, V45, P1528, DOI 10.1128/JCM.02344-06; Figueira CP, 2011, BMC MICROBIOL, V11, DOI 10.1186/1471-2180-11-129; Foster TJ, 2009, VET DERMATOL, V20, P456, DOI 10.1111/j.1365-3164.2009.00825.x; Fraga TR, 2011, SCAND J IMMUNOL, V73, P408, DOI 10.1111/j.1365-3083.2010.02505.x; Goris MGA, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018279; Grosskinsky S, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004858; Haake DA, 2002, CLIN INFECT DIS, V34, pE40, DOI 10.1086/339942; Hair PS, 2008, J INFECT DIS, V198, P125, DOI 10.1086/588825; Hair PS, 2010, INFECT IMMUN, V78, P1717, DOI 10.1128/IAI.01065-09; Hammel M, 2007, J BIOL CHEM, V282, P30051, DOI 10.1074/jbc.M704247200; Hammel M, 2007, NAT IMMUNOL, V8, P430, DOI 10.1038/ni1450; Hellwage J, 2001, J BIOL CHEM, V276, P8427, DOI 10.1074/jbc.M007994200; JOHNSON RC, 1966, J BACTERIOL, V91, P1403, DOI 10.1128/JB.91.4.1403-1409.1966; JOHNSON RC, 1967, J BACTERIOL, V93, P513, DOI 10.1128/JB.93.2.513-519.1967; Jongerius I, 2007, J EXP MED, V204, P2461, DOI 10.1084/jem.20070818; Jongerius I, 2010, J BIOL CHEM, V285, P14973, DOI 10.1074/jbc.M109.091975; Kenedy MR, 2009, INFECT IMMUN, V77, P2773, DOI 10.1128/IAI.00318-09; Kirkitadze MD, 2001, IMMUNOL REV, V180, P146, DOI 10.1034/j.1600-065X.2001.1800113.x; Ko AI, 1999, LANCET, V354, P820, DOI 10.1016/S0140-6736(99)80012-9; Kraiczy P, 2006, MOL IMMUNOL, V43, P31, DOI 10.1016/j.molimm.2005.06.016; Lambris JD, 2008, NAT REV MICROBIOL, V6, P132, DOI 10.1038/nrmicro1824; Lee LYL, 2004, J INFECT DIS, V190, P571, DOI 10.1086/422259; Levett PN, 2001, CLIN MICROBIOL REV, V14, P296, DOI 10.1128/CMR.14.2.296-326.2001; Lin YP, 2007, BIOCHEM BIOPH RES CO, V362, P443, DOI 10.1016/j.bbrc.2007.07.196; Lin YP, 2011, MOL MICROBIOL, V79, P1063, DOI 10.1111/j.1365-2958.2010.07510.x; Lin YP, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011301; Luo SS, 2011, J BIOL CHEM, V286, P8021, DOI 10.1074/jbc.M110.130138; Matsunaga J, 2005, INFECT IMMUN, V73, P70, DOI 10.1128/IAI.73.1.70-78.2005; Matsunaga J, 2007, INFECT IMMUN, V75, P2864, DOI 10.1128/IAI.01619-06; McBride AJA, 2005, CURR OPIN INFECT DIS, V18, P376, DOI 10.1097/01.qco.0000178824.05715.2c; Mendes RS, 2011, INFECT IMMUN, V79, P4657, DOI 10.1128/IAI.05583-11; Meri T, 2005, MICROB PATHOGENESIS, V39, P139, DOI 10.1016/j.micpath.2005.07.003; Meri T, 2004, INFECT IMMUN, V72, P6633, DOI 10.1128/IAI.72.11.6633-6641.2004; Monahan AM, 2009, J APPL MICROBIOL, V107, P707, DOI 10.1111/j.1365-2672.2009.04220.x; Narita M, 2005, AM J TROP MED HYG, V73, P652, DOI 10.4269/ajtmh.2005.73.652; Palaniappan RUM, 2007, CURR OPIN INFECT DIS, V20, P284, DOI 10.1097/QCO.0b013e32814a5729; Papasergi S, 2010, J BIOL CHEM, V285, P7517, DOI 10.1074/jbc.M109.062075; Pietikainen J, 2010, MOL IMMUNOL, V47, P1299, DOI 10.1016/j.molimm.2009.11.028; Ricklin D, 2009, J IMMUNOL, V183, P2565, DOI 10.4049/jimmunol.0901443; Rooijakkers SHM, 2005, NAT IMMUNOL, V6, P920, DOI 10.1038/ni1235; Stevenson B, 2002, INFECT IMMUN, V70, P491, DOI 10.1128/IAI.70.2.491-497.2002; Stevenson B, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0001188; Verma A, 2006, INFECT IMMUN, V74, P2659, DOI 10.1128/IAI.74.5.2659-2666.2006; Verma A, 2010, INFECT IMMUN, V78, P2053, DOI 10.1128/IAI.01282-09; Vieira ML, 2011, MICROB PATHOGENESIS, V51, P360, DOI 10.1016/j.micpath.2011.06.008; Vieira ML, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011259	62	36	36	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 23	2012	7	7							e41566	10.1371/journal.pone.0041566	http://dx.doi.org/10.1371/journal.pone.0041566			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	977TM	22911815	Green Published, gold, Green Submitted			2022-12-25	WOS:000306687700112
J	Jung, K; Wang, QH; Kim, Y; Scheuer, K; Zhang, ZW; Shen, Q; Chang, KO; Saif, LJ				Jung, Kwonil; Wang, Qiuhong; Kim, Yunjeong; Scheuer, Kelly; Zhang, Zhenwen; Shen, Quan; Chang, Kyeong-Ok; Saif, Linda J.			The Effects of Simvastatin or Interferon-alpha on Infectivity of Human Norovirus Using a Gnotobiotic Pig Model for the Study of Antivirals	PLOS ONE			English	Article							PORCINE RESPIRATORY CORONAVIRUS; GENE-EXPRESSION; UNITED-STATES; DISEASE; STATINS; GASTROENTERITIS; MODULATION; ROTAVIRUS; PARTICLES; RESPONSES	The lack of an animal model for human norovirus (HuNoV) has hindered the development of therapeutic strategies. This study demonstrated that a commonly used cholesterol-lowering statin medication, simvastatin, which increases HuNoV replication in an in vitro replicon system, also enhances HuNoV infectivity in the gnotobiotic (Gn) pig model. In contrast, oral treatment with interferon (IFN)-alpha reduces HuNoV infectivity. Young piglets, all with A or H1 histo-blood group antigens on enterocytes, were treated orally with 8 mg/kg/day of simvastatin; 5 days later, the pigs were inoculated orally with a GII.4 HuNoV (HS194/2009/US strain) and then treated with simvastatin for 5 more days. Simvastatin induced significantly earlier onset and longer duration of HuNoV fecal shedding in treated pigs, frequently with higher fecal viral titers. Simvastatin impaired poly (I:C)-induced IFN-alpha expression in macrophages or dendritic cells, possibly due to lowered toll-like receptor (TLR) 3 expression; however, the mechanisms were not related to interferon regulatory factor 3 or nuclear factor kappa B signaling pathway. Thus, the enhanced, earlier infectivity of HuNoV in simvastatin-treated pigs coincided with the inhibitory effect of simvastatin on innate immunity. In contrast to the increased HuNoV shedding that simvastatin induced, viral shedding during the treatment period was reduced or curtailed in the HuNoV-inoculated pigs pre-treated/treated with human IFN-alpha. Our findings are the first to indicate that IFN-alpha has potential as antiviral therapy against HuNoV. Based on these intriguing and novel findings using the Gn pig model, we confirmed that HuNoV infectivity is altered by treatment with simvastatin or IFN-alpha. Collectively, these findings indicate that Gn pigs are a useful model to test immunomodulators or efficacy of antivirals against HuNoV.	[Jung, Kwonil; Wang, Qiuhong; Scheuer, Kelly; Zhang, Zhenwen; Shen, Quan; Saif, Linda J.] Ohio State Univ, Ohio Agr Res & Dev Ctr, Dept Vet Prevent Med, Food Anim Hlth Res Program, Wooster, OH 44691 USA; [Kim, Yunjeong; Chang, Kyeong-Ok] Kansas State Univ, Coll Vet Med, Manhattan, KS 66506 USA	University System of Ohio; Ohio State University; Kansas State University	Jung, K (corresponding author), Ohio State Univ, Ohio Agr Res & Dev Ctr, Dept Vet Prevent Med, Food Anim Hlth Res Program, Wooster, OH 44691 USA.	saif.2@osu.edu	Saif, Linda/E-4005-2011	Kim, Yunjeong/0000-0002-2977-4400	National Institute of Allergy and Infectious Diseases, National Institutes of Health [U01 AI08001, R01 AI056351]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI056351] Funding Source: NIH RePORTER	National Institute of Allergy and Infectious Diseases, National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported by two grants (co-PI, Dr. Linda Saif) from the National Institute of Allergy and Infectious Diseases, National Institutes of Health, Grant U01 AI08001 (Dr. K.O. Chang, PI) and Grant R01 AI056351 (Dr. R. Baric, PI). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bauhofer O, 2007, J VIROL, V81, P3087, DOI 10.1128/JVI.02032-06; Bok K, 2011, P NATL ACAD SCI USA, V108, P325, DOI 10.1073/pnas.1014577107; Bull RA, 2011, TRENDS MICROBIOL, V19, P233, DOI 10.1016/j.tim.2011.01.002; Bull RA, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1000831; Chang KO, 2009, J VIROL, V83, P8587, DOI 10.1128/JVI.00005-09; Charlton-Menys V, 2008, EXP PHYSIOL, V93, P27, DOI 10.1113/expphysiol.2007.035147; Cheetham S, 2007, J VIROL, V81, P3535, DOI 10.1128/JVI.01306-06; Cheetham S, 2006, J VIROL, V80, P10372, DOI 10.1128/JVI.00809-06; Cummins JM, 2005, AM J VET RES, V66, P164, DOI 10.2460/ajvr.2005.66.164; CUMMINS JM, 1995, VET IMMUNOL IMMUNOP, V45, P355, DOI 10.1016/0165-2427(94)05351-R; Darwish I, 2011, EXPERT REV ANTI-INFE, V9, P807, DOI [10.1586/ERI.11.56, 10.1586/eri.11.56]; Delang L, 2009, HEPATOLOGY, V50, P6, DOI 10.1002/hep.22916; Esseili MA, 2012, APPL ENVIRON MICROB, V78, P786, DOI 10.1128/AEM.07081-11; Feld JJ, 2005, NATURE, V436, P967, DOI 10.1038/nature04082; FORTI RL, 1985, J CLIN MICROBIOL, V21, P689, DOI 10.1128/JCM.21.5.689-693.1985; Glass RI, 2009, NEW ENGL J MED, V361, P1776, DOI 10.1056/NEJMra0804575; Gonzalez AM, 2010, IMMUNOLOGY, V131, P242, DOI 10.1111/j.1365-2567.2010.03298.x; HaslerRapacz J, 1996, ARTERIOSCL THROM VAS, V16, P137, DOI 10.1161/01.ATV.16.1.137; Hodgkinson CP, 2008, PHARMACOGENET GENOM, V18, P803, DOI 10.1097/FPC.0b013e3283050aff; Hutson AM, 2002, J INFECT DIS, V185, P1335, DOI 10.1086/339883; Jung K, 2006, RES VET SCI, V81, P310, DOI 10.1016/j.rvsc.2006.03.005; Jung K, 2010, VET IMMUNOL IMMUNOP, V136, P335, DOI 10.1016/j.vetimm.2010.03.022; Jung K, 2009, J GEN VIROL, V90, P2713, DOI 10.1099/vir.0.014001-0; Kageyama T, 2003, J CLIN MICROBIOL, V41, P1548, DOI 10.1128/JCM.41.4.1548-1557.2003; Kim YC, 2010, IMMUNOLOGY, V130, P484, DOI 10.1111/j.1365-2567.2010.03269.x; LECCE J G, 1990, Molecular Biotherapy, V2, P211; Li GM, 2007, MICROBES INFECT, V9, P96, DOI 10.1016/j.micinf.2006.10.015; Lindesmith L, 2005, J VIROL, V79, P2900, DOI 10.1128/JVI.79.5.2900-2909.2005; Lindesmith LC, 2011, J VIROL, V85, P231, DOI 10.1128/JVI.01364-10; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Meng SS, 2011, J INTERF CYTOK RES, V31, P533, DOI 10.1089/jir.2010.0123; Miller LC, 2009, CLIN VACCINE IMMUNOL, V16, P360, DOI 10.1128/CVI.00269-08; Ming Tan, 2007, Expert Reviews in Molecular Medicine, V9, P1, DOI 10.1017/S1462399407000348; Morillo SG, 2011, REV ASSOC MED BRAS, V57, P462, DOI 10.1590/S0104-42302011000400023; Mumphrey SM, 2007, J VIROL, V81, P3251, DOI 10.1128/JVI.02096-06; Namangala B, 2006, J INTERF CYTOK RES, V26, P675, DOI 10.1089/jir.2006.26.675; Nygard AB, 2007, BMC MOL BIOL, V8, DOI 10.1186/1471-2199-8-67; Perry JW, 2010, J VIROL, V84, P6163, DOI 10.1128/JVI.00331-10; Rondy M, 2011, EPIDEMIOL INFECT, V139, P453, DOI 10.1017/S0950268810000993; Roos-Weil D, 2011, TRANSPLANTATION; Ross JW, 2010, REPROD BIOL ENDOCRIN, V8, DOI 10.1186/1477-7827-8-39; Scallan E, 2011, EMERG INFECT DIS, V17, P16, DOI [10.3201/eid1701.P21101, 10.3201/eid1701.091101p2]; Schwartz S, 2011, BLOOD; Sen GC, 2005, CYTOKINE GROWTH F R, V16, P1, DOI 10.1016/j.cytogfr.2005.01.006; Somasekharan S, 2008, J MEMBRANE BIOL, V222, P17, DOI 10.1007/s00232-008-9099-3; Souza M, 2007, J VIROL, V81, P9183, DOI 10.1128/JVI.00558-07; Takanashi S, 2011, 30 AM SOC VIR, P298; Takanashi S, 2011, J CLIN MICROBIOL, V49, P3234, DOI 10.1128/JCM.00305-11; Tan M, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1000983; Troeger H, 2009, GUT, V58, P1070, DOI 10.1136/gut.2008.160150; Watanuki H, 2009, VET IMMUNOL IMMUNOP, V131, P273, DOI 10.1016/j.vetimm.2009.04.005; Wobus CE, 2006, J VIROL, V80, P5104, DOI 10.1128/JVI.02346-05; Youssef S, 2002, NATURE, V420, P78, DOI 10.1038/nature01158; Zhang SW, 2011, J MED VIROL, V83, P1476, DOI 10.1002/jmv.22108	54	58	59	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 23	2012	7	7							e41619	10.1371/journal.pone.0041619	http://dx.doi.org/10.1371/journal.pone.0041619			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	977TM	22911825	Green Published, Green Submitted, gold			2022-12-25	WOS:000306687700124
J	Udekwu, KI; Levin, BR				Udekwu, Klas I.; Levin, Bruce R.			Staphylococcus aureus in Continuous Culture: A Tool for the Rational Design of Antibiotic Treatment Protocols	PLOS ONE			English	Article							BACTERIAL-CELL DENSITY; IN-VITRO; FUNCTIONAL-RELATIONSHIP; PHARMACODYNAMIC MODEL; ANTIMICROBIAL THERAPY; ESCHERICHIA-COLI; PERSISTER CELLS; GROWTH-RATE; PHARMACOKINETICS; RESISTANCE	In vitro measures of the pharmacodynamics of antibiotics that account for the factors anticipated for bacteria in infected patients are central to the rational design of antibiotic treatment protocols. We consider whether or not continuous culture devices are a way to obtain these measures. Staphylococcus aureus PS80 in high-density continuous cultures were exposed to oxacillin, ciprofloxacin, vancomycin, gentamicin, daptomycin and linezolid. Contrary to results from low density retentostats as well as to predictions of traditional PK/MIC ratios, daily dosing with up to 100x MIC did not clear these cultures. The densities of S. aureus in these cultures oscillated with constant amplitude and never fell below 10(5) CFU per ml. Save for daptomycin "treated" populations, the densities of bacteria in these cultures remained significantly below that of similar antibiotic-free cultures. Although these antibiotics varied in their pharmacodynamic properties there were only modest differences in their mean densities. Mathematical models and experiments suggest that the dominant factor preventing clearance was wall-adhering subpopulations reseeding the planktonic population which can be estimated and corrected for. Continuous cultures provide a way to evaluate the potential efficacy of antibiotic treatment regimes in vitro under conditions that are more clinically realistic and comprehensive than traditional in vitro PK/PD indices.	[Udekwu, Klas I.; Levin, Bruce R.] Emory Univ, Dept Biol, Atlanta, GA 30322 USA	Emory University	Udekwu, KI (corresponding author), Swedish Med Nanosci Ctr, Dept Neurosci, Stockholm, Sweden.	klas.udekwu@ki.se	Udekwu, Klas/I-4764-2012		United States National Institutes of Health [GM091875]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM091875] Funding Source: NIH RePORTER	United States National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by a grant from the United States National Institutes of Health (GM091875 to BRL). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allison KR, 2011, NATURE, V473, P216, DOI 10.1038/nature10069; Ambrose PG, 2007, CLIN INFECT DIS, V44, P79, DOI 10.1086/510079; Amsterdam D., 2005, ANTIBIOTICS LAB MED, P61; Andes D, 2004, CLIN LAB MED, V24, P477, DOI 10.1016/j.cll.2004.03.009; Andes D, 2009, ANTIMICROB AGENTS CH, V53, P3003, DOI 10.1128/AAC.01584-08; ANDREW JH, 1987, J ANTIMICROB CHEMOTH, V20, P213, DOI 10.1093/jac/20.2.213; ANWAR H, 1992, CAN J MICROBIOL, V38, P618, DOI 10.1139/m92-102; ANWAR H, 1989, J ANTIMICROB CHEMOTH, V24, P647, DOI 10.1093/jac/24.5.647; Balaban NQ, 2004, SCIENCE, V305, P1622, DOI 10.1126/science.1099390; Baudoux P, 2007, J ANTIMICROB CHEMOTH, V59, P246, DOI 10.1093/jac/dkl489; Bigger J, 1944, LANCET, P2497; BILELLO JA, 1994, ANTIMICROB AGENTS CH, V38, P1386, DOI 10.1128/AAC.38.6.1386; Bonapace CR, 2002, ANTIMICROB AGENTS CH, V46, P3574, DOI 10.1128/AAC.46.11.3574-3579.2002; BROWN MRW, 1990, ANTIMICROB AGENTS CH, V34, P1623, DOI 10.1128/AAC.34.9.1623; Craig WA, 1996, PEDIATR INFECT DIS J, V15, P255, DOI 10.1097/00006454-199603000-00015; CRAIG WA, 1993, J ANTIMICROB CHEMOTH, V31, P149, DOI 10.1093/jac/31.suppl_D.149; DAVEY PG, 1987, J ANTIMICROB CHEMOTH, V20, P639, DOI 10.1093/jac/20.5.639; Drusano GL, 2007, CLIN INFECT DIS, V45, pS89, DOI 10.1086/518137; EUCAST, 2000, CLIN MICROBIOL INFEC, V6, P570; FORREST A, 1993, ANTIMICROB AGENTS CH, V37, P1073, DOI 10.1128/AAC.37.5.1073; Fux CA, 2005, TRENDS MICROBIOL, V13, P34, DOI 10.1016/j.tim.2004.11.010; GILBERT P, 1989, APPL ENVIRON MICROB, V55, P1308, DOI 10.1128/AEM.55.5.1308-1311.1989; Gillespie Effie L, 2005, Expert Opin Drug Metab Toxicol, V1, P351, DOI 10.1517/17425255.1.3.351; Institute CaLS, 2005, PERF STAND ANT SUS S; Keren I, 2004, J BACTERIOL, V186, P8172, DOI 10.1128/JB.186.24.8172-8180.2004; Kolodkin-Gal I, 2010, SCIENCE, V328, P627, DOI 10.1126/science.1188628; Leuthner KD, 2006, J ANTIMICROB CHEMOTH, V58, P338, DOI 10.1093/jac/dkl235; Levin BR, 2010, ANTIMICROB AGENTS CH, V54, P3414, DOI 10.1128/AAC.00381-10; Lewis K, 2000, MICROBIOL MOL BIOL R, V64, P503, DOI 10.1128/MMBR.64.3.503-514.2000; Lewis K, 2007, NAT REV MICROBIOL, V5, P48, DOI 10.1038/nrmicro1557; Lopez D, 2010, GENE DEV, V24, P1893, DOI 10.1101/gad.1945010; Louie A, 1998, ANTIMICROB AGENTS CH, V42, P1105, DOI 10.1128/AAC.42.5.1105; Lowdin E, 1998, ANTIMICROB AGENTS CH, V42, P2739, DOI 10.1128/AAC.42.10.2739; MACKENZIE FM, 1993, J ANTIMICROB CHEMOTH, V32, P519, DOI 10.1093/jac/32.4.519; Mouton JW, 2002, INT J ANTIMICROB AG, V19, P323, DOI 10.1016/S0924-8579(02)00028-6; Mouton JW, 2001, J ANTIMICROB CHEMOTH, V47, P500, DOI 10.1093/jac/47.4.500; Odenholt I, 2003, CLIN MICROBIOL INFEC, V9, P930, DOI 10.1046/j.1469-0691.2003.00692.x; Odenholt I, 2000, J ANTIMICROB CHEMOTH, V46, P35, DOI 10.1093/jac/46.1.35; Odenholt I, 2007, ANTIMICROB AGENTS CH, V51, P3311, DOI 10.1128/AAC.01470-06; Patel R, 2005, CLIN ORTHOP RELAT R, P41, DOI 10.1097/01.blo.0000175714.68624.74; Rang C, 2001, CAN J MICROBIOL, V47, P86, DOI 10.1139/cjm-47-1-86; Regoes RR, 2004, ANTIMICROB AGENTS CH, V48, P3670, DOI 10.1128/AAC.48.10.3670-3676.2004; Safdar N, 2004, ANTIMICROB AGENTS CH, V48, P63, DOI 10.1128/AAC.48.1.63-68.2004; Sakoulas G, 2009, CLIN THER, V31, P1936, DOI 10.1016/j.clinthera.2009.09.012; Sillankorva S, 2008, J APPL MICROBIOL, V105, P196, DOI 10.1111/j.1365-2672.2008.03743.x; Skiest DJ, 2006, J CLIN MICROBIOL, V44, P655, DOI 10.1128/JCM.44.2.655-656.2006; SORIANO F, 1990, J ANTIMICROB CHEMOTH, V25, P621, DOI 10.1093/jac/25.4.621; Soriano F, 2009, J ANTIMICROB CHEMOTH, V63, P1301, DOI 10.1093/jac/dkp112; Stewart PS, 2002, INT J MED MICROBIOL, V292, P107, DOI 10.1078/1438-4221-00196; Thwaites GE, 2011, NAT REV MICROBIOL, V9, P215, DOI 10.1038/nrmicro2508; TUOMANEN E, 1986, J GEN MICROBIOL, V132, P1297; Udekwu KI, 2009, J ANTIMICROB CHEMOTH, V63, P745, DOI 10.1093/jac/dkn554; Wiuff C, 2005, ANTIMICROB AGENTS CH, V49, P1483, DOI 10.1128/AAC.49.4.1483-1494.2005	53	8	9	0	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 20	2012	7	7							e38866	10.1371/journal.pone.0038866	http://dx.doi.org/10.1371/journal.pone.0038866			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	977GL	22911681	Green Published, gold, Green Submitted			2022-12-25	WOS:000306644600004
J	Zheng, WY; Zhang, WY; Hu, W; Zhang, C; Yang, Y				Zheng, Wenyun; Zhang, Wenyao; Hu, Wei; Zhang, Chao; Yang, Yi			Exploring the Smallest Active Fragment of HsQSOX1b and Finding a Highly Efficient Oxidative Engine	PLOS ONE			English	Article							QUIESCIN-SULFHYDRYL OXIDASE; EGG-WHITE; QSOX; THIOREDOXIN; PROTEINS; SHUTTLE	Human quiescin-sulfhydryl oxidase 1 isoform b (HsQSOX1b) is a highly efficient, multiple-domain enzyme that directly inserts disulfide bonds into client protein. However, previous studies have focused mainly on the catalytic activity of the whole protein rather than its domain structure. In this research, we dissected the structure and function of HsQSOX1b and explored its mechanism as a highly efficient sulfhydryl oxidase by analyzing the truncated variants. The results showed that the first HsQSOX1b thioredoxin domain was essential for thiol oxidase activity. The smallest active fragment (SAQ) was identified to consist of a helix-rich region (HRR) and an essential for respiration and viability/augmenter of liver regeneration (ERV/ALR) domain, which remained highly active to oxidize an artificial non-thiol substrate but not small molecular and protein thiols. Our study clearly demonstrated that SAQ is a highly efficient oxidative engine, which shows high efficiency in the de novo disulfide formation and oxygen reduction and that this more efficient oxidative engine is necessary for the highly efficient catalysis of QSOXs compared to Erv1 and Erv2. This study will help address the roles of different HsQSOX1b domains in de novo disulfide formation and encourage the engineering of more efficient QSOX variants for the in vitro folding of disulfide-containing proteins.	[Zheng, Wenyun; Zhang, Wenyao; Hu, Wei; Zhang, Chao; Yang, Yi] E China Univ Sci & Technol, Sch Pharm, State Key Lab Bioreactor Engn, Synthet Biol & Biotechnol Lab, Shanghai 200237, Peoples R China	East China University of Science & Technology	Zheng, WY (corresponding author), E China Univ Sci & Technol, Sch Pharm, State Key Lab Bioreactor Engn, Synthet Biol & Biotechnol Lab, Shanghai 200237, Peoples R China.	yiyang@ecust.edu.cn	Yang, Yi/C-1297-2013	Yang, Yi/0000-0001-7896-1184	863 Program [2006AA02Z160]; NSFC (National Nature Science Foundation of China) [90713026, 31071260, 31170815]; Fok Ying Tung Education Foundation [111022]; Program for Professor of Special Appointment (Eastern Scholar) at Shanghai Institutions of Higher Learning; Dawn Program of Shanghai Education Commission [11SG31]; 111 Project [B07023]; Fundamental Research Funds for the Central Universities	863 Program(National High Technology Research and Development Program of China); NSFC (National Nature Science Foundation of China)(National Natural Science Foundation of China (NSFC)); Fok Ying Tung Education Foundation(Fok Ying Tung Education Foundation); Program for Professor of Special Appointment (Eastern Scholar) at Shanghai Institutions of Higher Learning; Dawn Program of Shanghai Education Commission; 111 Project(Ministry of Education, China - 111 Project); Fundamental Research Funds for the Central Universities(Fundamental Research Funds for the Central Universities)	This work was supported by the 863 Program (Grant No. 2006AA02Z160), NSFC (National Nature Science Foundation of China) (Grant Nos. 90713026, 31071260 and 31170815), the Fok Ying Tung Education Foundation (Grant No. 111022), the Program for Professor of Special Appointment (Eastern Scholar) at Shanghai Institutions of Higher Learning, Dawn Program of Shanghai Education Commission (Grant No. 11SG31), the 111 Project (Grant No. B07023), and the Fundamental Research Funds for the Central Universities. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alon A, 2010, FEBS LETT, V584, P1521, DOI 10.1016/j.febslet.2010.03.001; Coppock DL, 1998, GENOMICS, V54, P460, DOI 10.1006/geno.1998.5605; Coppock DL, 2006, ANTIOXID REDOX SIGN, V8, P300, DOI 10.1089/ars.2006.8.300; Faccio G, 2011, APPL MICROBIOL BIOT, V91, P957, DOI 10.1007/s00253-011-3440-y; Gross E, 2002, NAT STRUCT BIOL, V9, P61, DOI 10.1038/nsb740; Heckler EJ, 2008, BBA-MOL CELL RES, V1783, P567, DOI 10.1016/j.bbamcr.2007.10.002; Heckler EJ, 2008, BIOCHEMISTRY-US, V47, P4955, DOI 10.1021/bi702522q; Hoober KL, 1999, J BIOL CHEM, V274, P31759, DOI 10.1074/jbc.274.45.31759; Hoober KL, 1999, J BIOL CHEM, V274, P22147, DOI 10.1074/jbc.274.32.22147; Hoober KL, 1996, J BIOL CHEM, V271, P30510, DOI 10.1074/jbc.271.48.30510; Inaba K, 2010, GENES CELLS, V15, P935, DOI 10.1111/j.1365-2443.2010.01434.x; KIRLEY TL, 1989, ANAL BIOCHEM, V180, P231, DOI 10.1016/0003-2697(89)90422-3; Kodali VK, 2010, BIOCHEMISTRY-US, V49, P2075, DOI 10.1021/bi902222s; Mairet-Coello G, 2004, J COMP NEUROL, V473, P334, DOI 10.1002/cne.20126; Margittai E, 2011, TRAFFIC, V12, P1, DOI 10.1111/j.1600-0854.2010.01108.x; Morel C, 2007, EXP CELL RES, V313, P3971, DOI 10.1016/j.yexcr.2007.09.003; Raje S, 2002, ANAL BIOCHEM, V307, P266, DOI 10.1016/S0003-2697(02)00050-7; Sevier CS, 2012, ANTIOXID REDOX SIGN, V16, P800, DOI 10.1089/ars.2011.4450; Tury A, 2004, J ENDOCRINOL, V183, P353, DOI 10.1677/joe.1.05842; Vitu E, 2006, J MOL BIOL, V362, P89, DOI 10.1016/j.jmb.2006.06.070; YANG JT, 1986, METHOD ENZYMOL, V130, P208; Zheng WY, 2011, J BIOCHEM, V149, P293, DOI 10.1093/jb/mvq143	22	5	6	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 20	2012	7	7							e40935	10.1371/journal.pone.0040935	http://dx.doi.org/10.1371/journal.pone.0040935			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	977GL	22911720	Green Published, gold, Green Submitted			2022-12-25	WOS:000306644600030
J	Magnusson, LU; Lundqvist, A; Karlsson, MN; Skalen, K; Levin, M; Wiklund, O; Boren, J; Hulten, LM				Magnusson, Lisa U.; Lundqvist, Annika; Karlsson, Merja Nurkkala; Skalen, Kristina; Levin, Max; Wiklund, Olov; Boren, Jan; Hulten, Lillemor Mattsson			Arachidonate 15-Lipoxygenase Type B Knockdown Leads to Reduced Lipid Accumulation and Inflammation in Atherosclerosis	PLOS ONE			English	Article							OXIDATIVE MODIFICATION; EXPRESSION; LDL; 8S-LIPOXYGENASE; IDENTIFICATION; INTERLEUKIN-2; ANGIOGENESIS; MACROPHAGES; PRODUCTS; INCREASE	Inflammation in the vascular wall is important for development of atherosclerosis. We have shown previously that arachidonate 15-lipoxygenase type B (ALOX15B) is more highly expressed in human atherosclerotic lesions than in healthy arteries. This enzyme oxidizes fatty acids to substances that promote local inflammation and is expressed in lipid-loaded macrophages (foam cells) present in the atherosclerotic lesions. Here, we investigated the role of ALOX15B in foam cell formation in human primary macrophages and found that silencing of human ALOX15B decreased cellular lipid accumulation as well as proinflammatory cytokine secretion from macrophages. To investigate the role of ALOX15B in promoting the development of atherosclerosis in vivo, we used lentiviral shRNA silencing and bone marrow transplantation to knockdown mouse Alox15b gene expression in LDL-receptor-deficient (Ldlr(-/-)) mice. Knockdown of mouse Alox15b in vivo decreased plaque lipid content and markers of inflammation. In summary, we have shown that ALOX15B influences progression of atherosclerosis, indicating that this enzyme has an active proatherogenic role.	[Magnusson, Lisa U.; Lundqvist, Annika; Karlsson, Merja Nurkkala; Skalen, Kristina; Levin, Max; Wiklund, Olov; Boren, Jan; Hulten, Lillemor Mattsson] Univ Gothenburg, Sahlgrenska Ctr Cardiovasc & Metab Res, Dept Mol & Clin Med, Wallenberg Lab,Inst Med,Sahlgrenska Acad, Gothenburg, Sweden	University of Gothenburg	Magnusson, LU (corresponding author), Univ Gothenburg, Sahlgrenska Ctr Cardiovasc & Metab Res, Dept Mol & Clin Med, Wallenberg Lab,Inst Med,Sahlgrenska Acad, Gothenburg, Sweden.	lisa.magnusson@gu.se			Swedish Research Council; Swedish Heart-Lung Foundation; Swedish Foundation for Strategic Research; Sahlgrenska University Hospital ALF; Novo Nordisk Fonden [NNF11OC1014864] Funding Source: researchfish	Swedish Research Council(Swedish Research CouncilEuropean Commission); Swedish Heart-Lung Foundation(Swedish Heart-Lung Foundation); Swedish Foundation for Strategic Research(Swedish Foundation for Strategic Research); Sahlgrenska University Hospital ALF; Novo Nordisk Fonden(Novo Nordisk Foundation)	Swedish Research Council, the Swedish Heart-Lung Foundation, the Swedish Foundation for Strategic Research and the Sahlgrenska University Hospital ALF research grants. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andersson L, 2006, J CELL SCI, V119, P2246, DOI 10.1242/jcs.02941; Bae J, 2008, J MICROBIOL BIOTECHN, V18, P377; Danielsson KN, 2008, ATHEROSCLEROSIS, V199, P34, DOI 10.1016/j.atherosclerosis.2007.10.027; Eefting D, 2009, J VASC SURG, V50, P152, DOI 10.1016/j.jvs.2009.03.027; EZAKI M, 1995, J LIPID RES, V36, P1996; FROST SC, 1985, J BIOL CHEM, V260, P2646; Funk CD, 2001, TRENDS CARDIOVAS MED, V11, P116; Furstenberger G, 2002, PROSTAG OTH LIPID M, V68-9, P235, DOI 10.1016/S0090-6980(02)00033-3; Gertow K, 2011, ATHEROSCLEROSIS, V215, P411, DOI 10.1016/j.atherosclerosis.2011.01.015; Hansson GK, 2002, CIRC RES, V91, P281, DOI 10.1161/01.RES.0000029784.15893.10; Hansson GK, 2006, NAT REV IMMUNOL, V6, P508, DOI 10.1038/nri1882; Harats D, 2000, ARTERIOSCL THROM VAS, V20, P2100, DOI 10.1161/01.ATV.20.9.2100; Hedrick CC, 1999, ADV EXP MED BIOL, V469, P455; Hulten LM, 2010, EUR J CLIN INVEST, V40, P11, DOI 10.1111/j.1365-2362.2009.02223.x; Jisaka M, 1997, J BIOL CHEM, V272, P24410, DOI 10.1074/jbc.272.39.24410; Jisaka M, 2000, J BIOL CHEM, V275, P1287, DOI 10.1074/jbc.275.2.1287; Kuhn H, 2006, PROG LIPID RES, V45, P334, DOI 10.1016/j.plipres.2006.02.003; KUHN H, 1994, J LIPID RES, V35, P1749; Libby P, 2010, CIRC J, V74, P213, DOI 10.1253/circj.CJ-09-0706; McLaren JE, 2011, PROG LIPID RES, V50, P331, DOI 10.1016/j.plipres.2011.04.002; Paoletti R, 2004, CIRCULATION, V109, P20, DOI 10.1161/01.CIR.0000131514.71167.2e; Ribatti D, 2008, ANN MED, V40, P606, DOI 10.1080/07853890802186913; Ross R, 1999, NEW ENGL J MED, V340, P115, DOI 10.1056/NEJM199901143400207; Schweiger D, 2007, J LIPID RES, V48, P553, DOI 10.1194/jlr.M600311-JLR200; Shen JH, 1996, J CLIN INVEST, V98, P2201, DOI 10.1172/JCI119029; Upadhya S, 2004, ANGIOLOGY, V55, P289, DOI 10.1177/000331970405500308; Waddington E, 2001, ANAL BIOCHEM, V292, P234, DOI 10.1006/abio.2001.5075; YLAHERTTUALA S, 1995, J CLIN INVEST, V95, P2692, DOI 10.1172/JCI117971; Zhao L, 2004, TRENDS CARDIOVAS MED, V14, P191, DOI 10.1016/j.tcm.2004.04.003	29	25	27	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 17	2012	7	8							e43142	10.1371/journal.pone.0043142	http://dx.doi.org/10.1371/journal.pone.0043142			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	996DG	22912809	Green Published, gold, Green Submitted			2022-12-25	WOS:000308063700048
J	Qiu, XH; Yan, X; Liu, MX; Han, RC				Qiu, Xuehong; Yan, Xun; Liu, Mingxing; Han, Richou			Genetic and Proteomic Characterization of rpoB Mutations and Their Effect on Nematicidal Activity in Photorhabdus luminescens LN2	PLOS ONE			English	Article							INSECT PATHOGENIC NEMATODES; III SECRETION SYSTEM; MYCOBACTERIUM-TUBERCULOSIS; ENTOMOPATHOGENIC NEMATODES; XENORHABDUS-NEMATOPHILA; RIFAMPIN RESISTANCE; MOLECULAR ANALYSIS; BACILLUS-SUBTILIS; OXIDATIVE STRESS; DRUG-RESISTANCE	Rifampin resistant (Rif(R)) mutants of the insect pathogenic bacterium Photorhabdus luminescens LN2 from entomopathogenic nematode Heterorhabditis indica LN2 were genetically and proteomically characterized. The Rif(R) mutants showed typical phase one characters of Photorhabdus bacteria, and insecticidal activity against Galleria mellonella larvae, but surprisingly influenced their nematicidal activity against axenic infective juveniles (IJs) of H. bacteriophora H06, an incompatible nematode host. 13 out of 34 Rif(R) mutants lost their nematicidal activity against H06 IJs but supported the reproduction of H06 nematodes. 7 nematicidal-producing and 7 non-nematicidal-producing Rif(R) mutants were respectively selected for rpoB sequence analysis. rpoB mutations were found in all 14 Rif(R) mutants. The rpoB (P564L) mutation was found in all 7 mutants which produced nematicidal activity against H06 nematodes, but not in the mutants which supported H06 nematode production. Allelic exchange assays confirmed that the Rif-resistance and the impact on nematicidal activity of LN2 bacteria were conferred by rpoB mutation(s). The non-nematicidal-producing Rif(R) mutant was unable to colonize in the intestines of H06 IJs, but able to colonize in the intestines of its indigenous LN2 IJs. Proteomic analysis revealed different protein expression between wild-type strain and Rif(R) mutants, or between nematicidal-producing and non nematicidal-producing mutants. At least 7 putative proteins including DsbA, HlpA, RhlE, RplC, NamB (a protein from T3SS), and 2 hypothetical proteins (similar to unknown protein YgdH and YggE of Escherichia coli respectively) were probably involved in the nematicidal activity of LN2 bacteria against H06 nematodes. This hypothesis was further confirmed by creating insertion-deletion mutants of three selected corresponding genes (the downregulated rhlE and namB, and upregualted dsbA). These results indicate that the rpoB mutations greatly influence the symbiotic association between the symbionts and their entomopathogenic nematode hosts.	[Qiu, Xuehong; Yan, Xun; Liu, Mingxing; Han, Richou] Guangdong Entomol Inst, Guangzhou, Guangdong, Peoples R China	Guangdong Academy of Sciences; Institute of Zoology, Guangdong Academy of Sciences	Qiu, XH (corresponding author), Guangdong Entomol Inst, Guangzhou, Guangdong, Peoples R China.	richou-han@163.net			National Natural Science Foundation of China [31010103912, 31000879, 31101494]; Natural Science Foundation of Guangdong Province, China [10151026001000010]; Guangzhou Science & Technology Project [2011J2200032]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Natural Science Foundation of Guangdong Province, China(National Natural Science Foundation of Guangdong Province); Guangzhou Science & Technology Project	This work was supported by National Natural Science Foundation of China (No: 31010103912, No: 31000879 and No: 31101494), Natural Science Foundation of Guangdong Province, China (No: 10151026001000010) and Guangzhou Science & Technology Project (No: 2011J2200032). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akhurst R. J., 1990, Entomopathogenic nematodes in biological control., P75; AKHURST RJ, 1982, J GEN MICROBIOL, V128, P3061; AKHURST RJ, 1980, J GEN MICROBIOL, V121, P303; AKHURST RJ, 1983, EXP PARASITOL, V55, P258, DOI 10.1016/0014-4894(83)90020-6; An RS, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013154; Bowen D, 1998, SCIENCE, V280, P2129, DOI 10.1126/science.280.5372.2129; Bowen DJ, 1998, APPL ENVIRON MICROB, V64, P3029; Brugirard-Ricaud K, 2005, CELL MICROBIOL, V7, P363, DOI 10.1111/j.1462-5822.2004.00466.x; Campbell EA, 2001, CELL, V104, P901, DOI 10.1016/S0092-8674(01)00286-0; Carata E, 2009, MICROB CELL FACT, V8, DOI 10.1186/1475-2859-8-18; Cartier G, 2010, BIOCHEMISTRY-US, V49, P2636, DOI 10.1021/bi902082d; Castaneda-Garcia A, 2011, J ANTIMICROB CHEMOTH, V66, P1489, DOI 10.1093/jac/dkr165; Chalabaev S, 2007, PROTEOMICS, V7, P4499, DOI 10.1002/pmic.200700609; Ciche TA, 2006, BIOL CONTROL, V38, P22, DOI 10.1016/j.biocontrol.2005.11.016; Cowles CE, 2004, MOL MICROBIOL, V54, P464, DOI 10.1111/j.1365-2958.2004.04271.x; Cui LZ, 2010, ANTIMICROB AGENTS CH, V54, P5222, DOI 10.1128/AAC.00437-10; Duchaud E, 2003, NAT BIOTECHNOL, V21, P1307, DOI 10.1038/nbt886; EHLERS R-U, 1990, Revue de Nematologie, V13, P417; Ensign JC, 2002, PCT Patent, Patent No. [US6379946 B1, 6379946]; ffrench-Constant RH, 2007, TOXICON, V49, P436, DOI 10.1016/j.toxicon.2006.11.019; Gentry DR, 2007, ANTIMICROB AGENTS CH, V51, P2048, DOI 10.1128/AAC.01066-06; Georgis R, 2006, BIOL CONTROL, V38, P103, DOI 10.1016/j.biocontrol.2005.11.005; GERRITSEN LJM, 1993, FUND APPL NEMATOL, V16, P367; Gerritsen LJM, 1997, FUND APPL NEMATOL, V20, P317; Goodrich-Blair H, 2007, MOL MICROBIOL, V64, P260, DOI 10.1111/j.1365-2958.2007.05671.x; GORG A, 1988, ELECTROPHORESIS, V9, P681, DOI 10.1002/elps.1150091103; HAN R, 1990, Revue de Nematologie, V13, P411; Han RC, 2001, FEMS MICROBIOL ECOL, V35, P239, DOI 10.1111/j.1574-6941.2001.tb00809.x; Han RC, 1998, NEMATOLOGICA, V44, P425, DOI 10.1163/005525998X00089; Han RC, 1999, NEMATOLOGY, V1, P687, DOI 10.1163/156854199508711; HAN RH, 1991, J INVERTEBR PATHOL, V58, P27, DOI 10.1016/0022-2011(91)90158-M; Herrera L, 2003, INT J ANTIMICROB AG, V21, P403, DOI 10.1016/S0924-8579(03)00036-0; HERRERO M, 1990, J BACTERIOL, V172, P6557, DOI 10.1128/jb.172.11.6557-6567.1990; Heungens K, 2002, MOL MICROBIOL, V45, P1337, DOI 10.1046/j.1365-2958.2002.03100.x; Hu K., 1995, Journal of Nematology, V27, P502; HUBNER P, 1993, MOL MICROBIOL, V10, P123, DOI 10.1111/j.1365-2958.1993.tb00909.x; Jain C, 2008, RNA, V14, P381, DOI 10.1261/rna.800308; Jiang QY, 1990, CHINESE SCI BULL, V35, P302; JIN DJ, 1989, J BACTERIOL, V171, P5229, DOI 10.1128/jb.171.9.5229-5231.1989; JIN DJ, 1988, J MOL BIOL, V202, P45, DOI 10.1016/0022-2836(88)90517-7; Joyce SA, 2003, MOL MICROBIOL, V47, P1445, DOI 10.1046/j.1365-2958.2003.03389.x; KANIGA K, 1991, GENE, V109, P137, DOI 10.1016/0378-1119(91)90599-7; Kim S, 2005, APPL ENVIRON MICROB, V71, P2762, DOI 10.1128/AEM.71.5.2762-2765.2005; Lai CX, 2002, MICROBIOL-SGM, V148, P3365, DOI 10.1099/00221287-148-11-3365; Martens EC, 2005, CELL MICROBIOL, V7, P1723, DOI 10.1111/j.1462-5822.2005.00585.x; Maughan H, 2004, J BACTERIOL, V186, P2481, DOI 10.1128/JB.186.8.2481-2486.2004; MILLER N, 1994, J CLIN MICROBIOL, V32, P393, DOI 10.1128/JCM.32.2.393-397.1994; Mitchinson G.A., 1985, B INT UNION TUBERC, V65, P30; MUSSER JM, 1995, CLIN MICROBIOL REV, V8, P496, DOI 10.1128/CMR.8.4.496; Perkins AE, 2008, J BACTERIOL, V190, P807, DOI 10.1128/JB.00901-07; POINER GO, 1966, PARASITOLOGY, V56, P385, DOI 10.1017/S0031182000070980; Qiu XH, 2009, APPL ENVIRON MICROB, V75, P4221, DOI 10.1128/AEM.02967-08; Ramaswamy S., 1998, Tubercle and Lung Disease, V79, P3, DOI 10.1054/tuld.1998.0002; Riska PF, 2000, INT J TUBERC LUNG D, V4, pS4; Sambrook J, 2001, MOL CLONING LAB MANU; Schmidt MA, 2012, BMC MICROBIOL, V12, DOI 10.1186/1471-2180-12-98; Shouldice SR, 2011, ANTIOXID REDOX SIGN, V14, P1729, DOI 10.1089/ars.2010.3344; Sicard M, 2004, J EVOLUTION BIOL, V17, P985, DOI 10.1111/j.1420-9101.2004.00748.x; Sicard M, 2007, ENVIRON MICROBIOL, V9, P12, DOI 10.1111/j.1462-2920.2006.01099.x; SIMON R, 1983, BIO-TECHNOL, V1, P784, DOI 10.1038/nbt1183-784; Stinson MW, 1998, INFECT IMMUN, V66, P259, DOI 10.1128/IAI.66.1.259-265.1998; TELENTI A, 1993, LANCET, V341, P647, DOI 10.1016/0140-6736(93)90417-F; Wang QZ, 2007, J PROTEOME RES, V6, P4564, DOI 10.1021/pr070242z; Watanabe Y, 2011, J CLIN MICROBIOL, V49, P2680, DOI 10.1128/JCM.02144-10; WOODLEY CL, 1972, ANTIMICROB AGENTS CH, V2, P245, DOI 10.1128/AAC.2.4.245; Yang G, 2006, J BACTERIOL, V188, P2254, DOI 10.1128/JB.188.6.2254-2261.2006; Yuen LKW, 1999, J CLIN MICROBIOL, V37, P3844, DOI 10.1128/JCM.37.12.3844-3850.1999; Zhang GY, 1999, CELL, V98, P811, DOI 10.1016/S0092-8674(00)81515-9; Zhang Y, 2009, INT J TUBERC LUNG D, V13, P1320; Zhang Y, 2000, MOLECULAR GENETICS OF MYCOBACTERIA, P235; Zhou YN, 1998, P NATL ACAD SCI USA, V95, P2908, DOI 10.1073/pnas.95.6.2908	71	10	10	0	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 17	2012	7	8							e43114	10.1371/journal.pone.0043114	http://dx.doi.org/10.1371/journal.pone.0043114			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	996DG	22912803	Green Published, Green Submitted, gold			2022-12-25	WOS:000308063700045
J	Tajiri, N; Acosta, S; Glover, LE; Bickford, PC; Simancas, AJ; Yasuhara, T; Date, I; Solomita, MA; Antonucci, I; Stuppia, L; Kaneko, Y; Borlongan, CV				Tajiri, Naoki; Acosta, Sandra; Glover, Loren E.; Bickford, Paula C.; Jacotte Simancas, Alejandra; Yasuhara, Takao; Date, Isao; Solomita, Marianna A.; Antonucci, Ivana; Stuppia, Liborio; Kaneko, Yuji; Borlongan, Cesar V.			Intravenous Grafts Of Amniotic Fluid-Derived Stem Cells Induce Endogenous Cell Proliferation and Attenuate Behavioral Deficits in Ischemic Stroke Rats	PLOS ONE			English	Article							TISSUE-PLASMINOGEN ACTIVATOR; SPATIAL MEMORY PERFORMANCE; FOCAL CEREBRAL-ISCHEMIA; LONG-TERM POTENTIATION; MORRIS WATER MAZE; SYNAPTIC PLASTICITY; RECOGNITION MEMORY; DORSAL HIPPOCAMPUS; BRAIN-INJURY; NEUROGENESIS	We recently reported isolation of viable rat amniotic fluid-derived stem (AFS) cells [1]. Here, we tested the therapeutic benefits of AFS cells in a rodent model of ischemic stroke. Adult male Sprague-Dawley rats received a 60-minute middle cerebral artery occlusion (MCAo). Thirty-five days later, animals exhibiting significant motor deficits received intravenous transplants of rat AFS cells or vehicle. At days 60-63 post-MCAo, significant recovery of motor and cognitive function was seen in stroke animals transplanted with AFS cells compared to vehicle-infused stroke animals. Infarct volume, as revealed by hematoxylin and eosin (H&E) staining, was significantly reduced, coupled with significant increments in the cell proliferation marker, Ki67, and the neuronal marker, MAP2, in the dentate gyrus (DG) [2] and the subventricular zone (SVZ) of AFS cell-transplanted stroke animals compared to vehicle-infused stroke animals. A significantly higher number of double-labeled Ki67/MAP2-positive cells and a similar trend towards increased Ki67/MAP2 double-labeling were observed in the DG and SVZ of AFS cell-transplanted stroke animals, respectively, compared to vehicle-infused stroke animals. This study reports the therapeutic potential of AFS cell transplantation in stroke animals, possibly via enhancement of endogenous repair mechanisms.	[Tajiri, Naoki; Acosta, Sandra; Glover, Loren E.; Bickford, Paula C.; Solomita, Marianna A.; Kaneko, Yuji; Borlongan, Cesar V.] Univ S Florida, Morsani Coll Med, Dept Neurosurg & Brain Repair, Ctr Excellence Aging & Brain Repair, Tampa, FL 33620 USA; [Jacotte Simancas, Alejandra] Univ Autonoma Barcelona, Dept Psicobiol & Metodol Ciencias Salud, E-08193 Barcelona, Spain; [Yasuhara, Takao; Date, Isao] Okayama Univ, Dept Neurol Surg, Grad Sch Med Dent & Pharmaceut Sci, Okayama, Japan; [Solomita, Marianna A.; Antonucci, Ivana; Stuppia, Liborio] Univ G DAnnunzio, Dept Biomed Sci, Chieti, Italy; [Solomita, Marianna A.; Antonucci, Ivana; Stuppia, Liborio] Univ G dAnnunzio, Sch Adv Studies G dAnnunzio, Dept Neurosci & Imaging, Chieti, Italy; [Solomita, Marianna A.; Antonucci, Ivana; Stuppia, Liborio] Aging Res Ctr, Stem TeCh Grp, Chieti, Italy	State University System of Florida; University of South Florida; Autonomous University of Barcelona; Okayama University; G d'Annunzio University of Chieti-Pescara; G d'Annunzio University of Chieti-Pescara	Tajiri, N (corresponding author), Univ S Florida, Morsani Coll Med, Dept Neurosurg & Brain Repair, Ctr Excellence Aging & Brain Repair, Tampa, FL 33620 USA.	cborlong@health.usf.edu	Tajiri, Naoki/K-1230-2012; Bickford, Paula C/J-5970-2012; Yasuhara, Takao/AEU-1075-2022; Kaneko, Yuji/J-6447-2012; Borlongan, Cesar/I-5696-2012	Tajiri, Naoki/0000-0003-2189-662X; Bickford, Paula C/0000-0001-9657-7725; Borlongan, Cesar/0000-0002-2966-9782; Stuppia, Liborio/0000-0002-6232-0996	SanBio Inc.; Celgene Cellular Therapeutics; KMPHC; NeuralStem Inc.	SanBio Inc.; Celgene Cellular Therapeutics(Bristol-Myers SquibbCelgene Corporation); KMPHC; NeuralStem Inc.	CVB is supported in part by SanBio Inc., Celgene Cellular Therapeutics, KMPHC and NeuralStem Inc. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Acosta S, 2010, REJUV RES, V13, P581, DOI 10.1089/rej.2009.1011; Anisman H, 2002, J NEUROSCI, V22, P7809; Antonucci I, 2011, CELL TRANSPLANT, V20, P789, DOI 10.3727/096368910X539074; Bergado JA, 2011, NEUROSCIENCE, V172, P256, DOI 10.1016/j.neuroscience.2010.10.064; BLISS TVP, 1993, NATURE, V361, P31, DOI 10.1038/361031a0; Borlongan CV, 2009, STROKE, V40, pS146, DOI 10.1161/STROKEAHA.108.533091; Borlongan CV, 2004, STROKE, V35, P2385, DOI 10.1161/01.STR.0000141680.49960.d7; BORLONGAN CV, 1995, J NEUROSCI, V15, P5372; Borlongan CV, 2005, BRAIN RES, V1048, P116, DOI 10.1016/j.brainres.2005.04.087; Broadbent NJ, 2004, P NATL ACAD SCI USA, V101, P14515, DOI 10.1073/pnas.0406344101; Burns TC, 2009, J COMP NEUROL, V515, P125, DOI 10.1002/cne.22038; Chopp M, 2009, CELL TRANSPLANT, V18, P691, DOI 10.3727/096368909X470883; Clark RE, 2007, J NEUROSCI, V27, P6647, DOI 10.1523/JNEUROSCI.0913-07.2007; Clarke MSF, 1999, LEARN MEMORY, V6, P634, DOI 10.1101/lm.6.6.634; Clavel C, 2008, CURR OPIN ORGAN TRAN, V13, P36, DOI 10.1097/MOT.0b013e3282f428d1; De Coppi P, 2007, NAT BIOTECHNOL, V25, P100, DOI 10.1038/nbt1274; Drapeau E, 2008, AGING CELL, V7, P569, DOI 10.1111/j.1474-9726.2008.00369.x; Dupret D, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001959; Duva CA, 1997, BEHAV NEUROSCI, V111, P1184, DOI 10.1037/0735-7044.111.6.1184; EBRAHIMI A, 1992, NEUROSCI RES, V14, P39, DOI 10.1016/S0168-0102(05)80005-7; Ekdahl CT, 2009, NEUROSCIENCE, V158, P1021, DOI 10.1016/j.neuroscience.2008.06.052; Encinas JM, 2011, CELL STEM CELL, V8, P566, DOI 10.1016/j.stem.2011.03.010; Fauza D, 2004, BEST PRACT RES CL OB, V18, P877, DOI 10.1016/j.bpobgyn.2004.07.001; Freret T, 2009, BEHAV NEUROSCI, V123, P224, DOI 10.1037/a0014157; Fukunaga A, 2003, ACTA NEUROCHIR, V145, P473, DOI 10.1007/s00701-003-0038-x; Fukunaga A, 1999, CELL TRANSPLANT, V8, P435, DOI 10.1177/096368979900800415; GALLAGHER M, 1993, BEHAV NEUROSCI, V107, P618, DOI 10.1037/0735-7044.107.4.618; Ghionzoli M, 2010, PEDIATR SURG INT, V26, P79, DOI 10.1007/s00383-009-2504-x; Gillani RL, 2010, BEHAV BRAIN RES, V208, P415, DOI 10.1016/j.bbr.2009.12.015; Graham GD, 2003, STROKE, V34, P2847, DOI 10.1161/01.STR.0000101752.23813.C3; Grefkes C, 2008, ANN NEUROL, V63, P236, DOI 10.1002/ana.21228; Gusev PA, 2001, J NEUROPHYSIOL, V86, P881, DOI 10.1152/jn.2001.86.2.881; Health USNIo, 2012, CLIN TRIALS; Hematti P, 2004, PLOS BIOL, V2, P2183, DOI 10.1371/journal.pbio.0020423; in 'tAnker PS, 2003, BLOOD, V102, P1548, DOI 10.1182/blood-2003-04-1291; Jezierski A, 2010, STEM CELL REV REP, V6, P199, DOI 10.1007/s12015-010-9116-7; Jurgens HA, 2012, J NEUROSCI, V32, P3958, DOI 10.1523/JNEUROSCI.6389-11.2012; Kalogiannidis I, 2011, CLIN EXP OBSTET GYN, V38, P239; Kaneko Y, 2011, J PINEAL RES, V50, P272, DOI 10.1111/j.1600-079X.2010.00837.x; Lin MS, 2011, STROKE, V42, P2850, DOI 10.1161/STROKEAHA.111.613133; Liu TJ, 2008, SHOCK, V29, P603, DOI 10.1097/SHK.0b013e318157e845; Manuelpillai U, 2011, PLACENTA, V32, pS320, DOI 10.1016/j.placenta.2011.04.010; Mauro A, 2010, VET RES COMMUN, V34, pS25, DOI 10.1007/s11259-010-9393-2; McDonald HY, 2005, NEUROSCI LETT, V385, P70, DOI 10.1016/j.neulet.2005.05.022; McLaughlin D, 2006, J NEUROSCI RES, V83, P1190, DOI 10.1002/jnr.20828; Mimura T, 2005, J NEUROPATH EXP NEUR, V64, P1108, DOI 10.1097/01.jnen.0000190068.03009.b5; Miyoshi E, 2012, BEHAV BRAIN RES, V226, P171, DOI 10.1016/j.bbr.2011.09.011; NISHINO H, 1993, BRAIN RES BULL, V32, P517, DOI 10.1016/0361-9230(93)90300-Z; Norris CM, 1999, NEUROBIOL LEARN MEM, V71, P194, DOI 10.1006/nlme.1998.3864; Ou YL, 2010, BRAIN RES, V1366, P217, DOI 10.1016/j.brainres.2010.09.098; Paxinos G., 2007, RAT BRAIN STEREOTAXI, V6th ed.; Pisani A, 2005, MOVEMENT DISORD, V20, P395, DOI 10.1002/mds.20394; Pisu MG, 2011, BEHAV BRAIN RES, V222, P73, DOI 10.1016/j.bbr.2011.03.021; Prasongchean W, 2012, STEM CELLS DEV, V21, P675, DOI 10.1089/scd.2011.0281; Prusa Andrea-Romana, 2002, Med Sci Monit, V8, pRA253; Prusa AR, 2003, HUM REPROD, V18, P1489, DOI 10.1093/humrep/deg279; Rehni AK, 2007, BEHAV BRAIN RES, V183, P95, DOI 10.1016/j.bbr.2007.05.028; Richardson DP, 2002, EUR J NEUROSCI, V16, P1593, DOI 10.1046/j.1460-9568.2002.02214.x; Roger VL, 2012, CIRCULATION, V125, P188, DOI 10.1161/CIR.0b013e3182456d46; Roubelakis MG, 2007, STEM CELLS DEV, V16, P931, DOI 10.1089/scd.2007.0036; Rush BK, 2010, J STROKE CEREBROVASC, V19, P326, DOI 10.1016/j.jstrokecerebrovasdis.2009.09.009; Saxe MD, 2006, P NATL ACAD SCI USA, V103, P17501, DOI 10.1073/pnas.0607207103; SCOVILLE WB, 1957, J NEUROL NEUROSUR PS, V20, P11, DOI 10.1136/jnnp.20.1.11; Shors TJ, 2002, HIPPOCAMPUS, V12, P578, DOI 10.1002/hipo.10103; Tabuse M, 2010, J CLIN NEUROSCI, V17, P1412, DOI 10.1016/j.jocn.2010.01.056; Takahashi K, 2008, BRAIN RES, V1234, P172, DOI 10.1016/j.brainres.2008.07.086; Tsai MS, 2006, BIOL REPROD, V74, P545, DOI 10.1095/biolreprod.105.046029; Tsai MS, 2004, HUM REPROD, V19, P1450, DOI 10.1093/humrep/deh279; Vorhees CV, 2006, NAT PROTOC, V1, P848, DOI 10.1038/nprot.2006.116; Wattanathorn J, 2011, EVID-BASED COMPL ALT, V2011, P1, DOI 10.1155/2011/429505; Wechsler L, 2009, STROKE, V40, P510, DOI 10.1161/STROKEAHA.108.526863; Xu J, 2012, NEUROPHARMACOLOGY, V62, P2424, DOI 10.1016/j.neuropharm.2012.02.014; Yasuhara T, 2006, FRONT BIOSCI-LANDMRK, V11, P760, DOI 10.2741/1834; Yip TR, 2007, STROKE, V38, P1952, DOI 10.1161/STROKEAHA.106.479477; Yu SJ, 2009, CELL TRANSPLANT, V18, P111, DOI 10.3727/096368909788341243; Zhang CL, 2010, J NEUROSCI RES, V88, P3275, DOI 10.1002/jnr.22495; Zvejniece L, 2012, J NEUROSCI METH, V208, P197, DOI 10.1016/j.jneumeth.2012.05.018	78	64	67	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 17	2012	7	8							e43779	10.1371/journal.pone.0043779	http://dx.doi.org/10.1371/journal.pone.0043779			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	996DG	22912905	Green Submitted, Green Published, gold			2022-12-25	WOS:000308063700133
J	Tokarska-Schlattner, M; Epand, RF; Meiler, F; Zandomeneghi, G; Neumann, D; Widmer, HR; Meier, BH; Epand, RM; Saks, V; Wallimann, T; Schlattner, U				Tokarska-Schlattner, Malgorzata; Epand, Raquel F.; Meiler, Flurina; Zandomeneghi, Giorgia; Neumann, Dietbert; Widmer, Hans R.; Meier, Beat H.; Epand, Richard M.; Saks, Valdur; Wallimann, Theo; Schlattner, Uwe			Phosphocreatine Interacts with Phospholipids, Affects Membrane Properties and Exerts Membrane-Protective Effects	PLOS ONE			English	Article							MITOCHONDRIAL CREATINE-KINASE; ACTIVATED PROTEIN-KINASE; SKELETAL-MUSCLE; OXIDATIVE STRESS; EXOGENOUS PHOSPHOCREATINE; CYCLOCREATINE PHOSPHATE; PERMEABILITY TRANSITION; ISCHEMIC MYOCARDIUM; MAGNETIC-RESONANCE; MOLECULAR-DYNAMICS	A broad spectrum of beneficial effects has been ascribed to creatine (Cr), phosphocreatine (PCr) and their cyclic analogues cyclo-(cCr) and phospho-cyclocreatine (PcCr). Cr is widely used as nutritional supplement in sports and increasingly also as adjuvant treatment for pathologies such as myopathies and a plethora of neurodegenerative diseases. Additionally, Cr and its cyclic analogues have been proposed for anti-cancer treatment. The mechanisms involved in these pleiotropic effects are still controversial and far from being understood. The reversible conversion of Cr and ATP into PCr and ADP by creatine kinase, generating highly diffusible PCr energy reserves, is certainly an important element. However, some protective effects of Cr and analogues cannot be satisfactorily explained solely by effects on the cellular energy state. Here we used mainly liposome model systems to provide evidence for interaction of PCr and PcCr with different zwitterionic phospholipids by applying four independent, complementary biochemical and biophysical assays: (i) chemical binding assay, (ii) surface plasmon resonance spectroscopy (SPR), (iii) solid-state P-31-NMR, and (iv) differential scanning calorimetry (DSC). SPR revealed low affinity PCr/phospholipid interaction that additionally induced changes in liposome shape as indicated by NMR and SPR. Additionally, DSC revealed evidence for membrane packing effects by PCr, as seen by altered lipid phase transition. Finally, PCr efficiently protected against membrane permeabilization in two different model systems: liposome-permeabilization by the membrane-active peptide melittin, and erythrocyte hemolysis by the oxidative drug doxorubicin, hypoosmotic stress or the mild detergent saponin. These findings suggest a new molecular basis for non-energy related functions of PCr and its cyclic analogue. PCr/phospholipid interaction and alteration of membrane structure may not only protect cellular membranes against various insults, but could have more general implications for many physiological membrane-related functions that are relevant for health and disease.	[Tokarska-Schlattner, Malgorzata; Saks, Valdur; Schlattner, Uwe] Univ Grenoble 1, LBFA, Grenoble, France; [Tokarska-Schlattner, Malgorzata; Saks, Valdur; Schlattner, Uwe] INSERM, U1055, Grenoble, France; [Epand, Raquel F.; Epand, Richard M.] McMaster Univ, Dept Biochem & Biomed Sci, Hamilton, ON, Canada; [Meiler, Flurina; Neumann, Dietbert; Wallimann, Theo] Swiss Fed Inst Technol, Inst Cell Biol, Zurich, Switzerland; [Zandomeneghi, Giorgia; Meier, Beat H.] Swiss Fed Inst Technol, Inst Phys Chem, Zurich, Switzerland; [Widmer, Hans R.] Univ Bern, Inselspital, Dept Neurosurg, CH-3010 Bern, Switzerland	UDICE-French Research Universities; Communaute Universite Grenoble Alpes; Universite Grenoble Alpes (UGA); Institut National de la Sante et de la Recherche Medicale (Inserm); McMaster University; Swiss Federal Institutes of Technology Domain; ETH Zurich; Swiss Federal Institutes of Technology Domain; ETH Zurich; University of Bern; University Hospital of Bern	Tokarska-Schlattner, M (corresponding author), Univ Grenoble 1, LBFA, Grenoble, France.	malgorzata.tokarska-schlattner@ujf-grenoble.fr	Widmer, Hans Rudolf/O-5172-2017; Widmer, Hans R./AAC-8948-2022; , Richard/R-2316-2019; Schlattner, Uwe/D-1267-2009; Wallimann, Theo/C-6047-2008; Zandomeneghi, Giorgia/J-8124-2016	Widmer, Hans Rudolf/0000-0003-3378-8765; , Richard/0000-0002-9602-9558; Schlattner, Uwe/0000-0003-1159-5911; Wallimann, Theo/0000-0003-4957-5836; Zandomeneghi, Giorgia/0000-0001-9452-8751; Tokarska-Schlattner, Malgorzata/0000-0003-4401-7050; Neumann, Dietbert/0000-0002-4316-684X	European Community [EIF ANTHRAWES 41870, ERG ANTHRAPLUS 249202]; Agence Nationale de la Recherche; Swiss Heart Foundation; Wolfermann-Nageli-Stiftung; Heart and Stroke Foundation of Ontario [T6915]	European Community(European Commission); Agence Nationale de la Recherche(French National Research Agency (ANR)); Swiss Heart Foundation; Wolfermann-Nageli-Stiftung; Heart and Stroke Foundation of Ontario(Heart & Stroke Foundation of Ontario)	This work was supported by a Marie Curie Intraeuropean Fellowship (EIF ANTHRAWES 41870) and a European Reintegration Grant (ERG ANTHRAPLUS 249202) of the European Community (to M.T.S.), the Agence Nationale de la Recherche (chaire d'excellence to U.S.), as well as the Swiss Heart Foundation, the Wolfermann-Nageli-Stiftung (to U.S.) and the Heart and Stroke Foundation of Ontario Grant T6915 (to R.M.E.). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andres RH, 2008, BRAIN RES BULL, V76, P329, DOI 10.1016/j.brainresbull.2008.02.035; ANNESLEY TM, 1977, BIOCHEM BIOPH RES CO, V74, P185, DOI 10.1016/0006-291X(77)91392-4; ANYUKHOVSKY EP, 1986, BIOCHEM MED METAB B, V35, P327, DOI 10.1016/0885-4505(86)90090-3; Beal MF, 2002, FREE RADICAL BIO MED, V32, P797, DOI 10.1016/S0891-5849(02)00780-3; Blomgren K, 2006, FREE RADICAL BIO MED, V40, P388, DOI 10.1016/j.freeradbiomed.2005.08.040; Braegger Christian P, 2003, J Cyst Fibros, V2, P177, DOI 10.1016/S1569-1993(03)00089-4; Brosnan JT, 2007, ANNU REV NUTR, V27, P241, DOI 10.1146/annurev.nutr.27.061406.093621; BRUMM T, 1992, BIOPHYS J, V61, P1018, DOI 10.1016/S0006-3495(92)81909-4; Butterfield DA, 2002, FREE RADICAL BIO MED, V32, P1050, DOI 10.1016/S0891-5849(02)00794-3; Ceddia RB, 2004, J PHYSIOL-LONDON, V555, P409, DOI 10.1113/jphysiol.2003.056291; Chen JCH, 2008, INT J TECHNOL MANAGE, V43, P1; Deldicque L, 2008, J APPL PHYSIOL, V104, P371, DOI 10.1152/japplphysiol.00873.2007; Deldicque L, 2007, AM J PHYSIOL-CELL PH, V293, pC1263, DOI 10.1152/ajpcell.00162.2007; Dolder M, 2003, J BIOL CHEM, V278, P17760, DOI 10.1074/jbc.M208705200; Dubinnyi MA, 2006, SOLID STATE NUCL MAG, V29, P305, DOI 10.1016/j.ssnmr.2005.10.009; Fimognari C, 2009, MUTAT RES-FUND MOL M, V670, P59, DOI 10.1016/j.mrfmmm.2009.07.005; GREENHAFF PL, 1993, CLIN SCI, V84, P565, DOI 10.1042/cs0840565; Guidi C, 2008, BBA-GEN SUBJECTS, V1780, P16, DOI 10.1016/j.bbagen.2007.09.018; HARRIS RC, 1992, CLIN SCI, V83, P367, DOI 10.1042/cs0830367; Hass CJ, 2007, NEUROREHAB NEURAL RE, V21, P107, DOI 10.1177/1545968306293449; HELLER H, 1993, J PHYS CHEM-US, V97, P8343, DOI 10.1021/j100133a034; HESPEL P, 1990, J PHYSIOL-LONDON, V427, P347, DOI 10.1113/jphysiol.1990.sp018175; Hespel P, 2001, CAN J APPL PHYSIOL, V26, pS79, DOI 10.1139/h2001-045; Hespel Peter, 2007, V46, P245; Hosamani R, 2010, NEUROCHEM RES, V35, P1402, DOI 10.1007/s11064-010-0198-z; Ingwall JS, 2002, J MOL CELL CARDIOL, V34, P1111, DOI 10.1006/jmcc.2002.2062; Klivenyi P, 1999, NAT MED, V5, P347, DOI 10.1038/6568; Klivenyi P, 2004, NEUROBIOL DIS, V15, P610, DOI 10.1016/j.nbd.2003.12.014; KONOREV E A, 1991, Biokhimiya, V56, P1701; Kornacker M, 2001, INT J CANCER, V94, P513, DOI 10.1002/ijc.1502; Kristensen CA, 1999, BRIT J CANCER, V79, P278, DOI 10.1038/sj.bjc.6690045; Kurosawa Y, 2012, J CLIN INVE IN PRESS; Lawler JM, 2002, BIOCHEM BIOPH RES CO, V290, P47, DOI 10.1006/bbrc.2001.6164; Lee SK, 1997, J TOXICOL ENV HEALTH, V51, P557, DOI 10.1080/009841097159836; Lenz H, 2007, MOL CELL BIOCHEM, V306, P153, DOI 10.1007/s11010-007-9565-8; LI PK, 1982, CLIN CHEM, V28, P92; LILLIE JW, 1993, CANCER RES, V53, P3172; LOMBARDINI JB, 1983, EXP EYE RES, V37, P239, DOI 10.1016/0014-4835(83)90158-6; MARTIN KJ, 1994, CANCER RES, V54, P5160; Matthews RT, 1999, EXP NEUROL, V157, P142, DOI 10.1006/exnr.1999.7049; Meyer LE, 2006, J BIOL CHEM, V281, P37361, DOI 10.1074/jbc.M604123200; MILLER EE, 1993, P NATL ACAD SCI USA, V90, P3304, DOI 10.1073/pnas.90.8.3304; MILLER K, 1993, AM J PHYSIOL, V265, pC1544, DOI 10.1152/ajpcell.1993.265.6.C1544; Nabuurs C, 2010, J BIOL CHEM, V285, P39588, DOI 10.1074/jbc.M110.164665; OGorman E, 1997, FEBS LETT, V414, P253, DOI 10.1016/S0014-5793(97)01045-4; Pacher P, 2005, TRENDS PHARMACOL SCI, V26, P302, DOI 10.1016/j.tips.2005.04.003; Ponticos M, 1998, EMBO J, V17, P1688, DOI 10.1093/emboj/17.6.1688; QIU XX, 1993, BIOCHIM BIOPHYS ACTA, V1147, P59, DOI 10.1016/0005-2736(93)90316-R; Ravina B, 2006, NEUROLOGY, V66, P664; Rayburn JR, 1995, FOOD CHEM TOXICOL, V33, P1021, DOI 10.1016/0278-6915(95)00080-1; Rodriguez M, 2005, J MOL CELL CARDIOL, V38, P723, DOI 10.1016/j.yjmcc.2005.02.019; Ronca G, 1989, CARDIOPROTECTION PHO, P61; RUDA MY, 1988, AM HEART J, V116, P393, DOI 10.1016/0002-8703(88)90611-4; SAKS VA, 1993, CURR THER RES CLIN E, V53, P565, DOI 10.1016/S0011-393X(05)80663-0; Saks V, 2010, BBA-BIOENERGETICS, V1797, P678, DOI 10.1016/j.bbabio.2010.01.011; SANDERS CR, 1994, PROG NUCL MAG RES SP, V26, P421, DOI 10.1016/0079-6565(94)80012-X; Schimmel L, 1996, ANTICANCER RES, V16, P375; Schlattner U, 2000, J BIOENERG BIOMEMBR, V32, P123, DOI 10.1023/A:1005576831968; Schlattner U, 2006, BBA-MOL BASIS DIS, V1762, P164, DOI 10.1016/j.bbadis.2005.09.004; Schlattner U, 2000, J BIOL CHEM, V275, P17314, DOI 10.1074/jbc.M001919200; Schlattner U, 2004, J BIOL CHEM, V279, P24334, DOI 10.1074/jbc.M314158200; Schlattner U, 2003, RECENT RES DEV BIOL, V1, P93; Schroder L, 2004, J MAGN RESON, V171, P213, DOI 10.1016/j.jmr.2004.08.015; SEBRING LA, 1986, BIOCHIM BIOPHYS ACTA, V884, P559, DOI 10.1016/0304-4165(86)90208-4; Sestili P, 2006, FREE RADICAL BIO MED, V40, P837, DOI 10.1016/j.freeradbiomed.2005.10.035; SHAROV VG, 1986, BIOCHEM MED METAB B, V35, P101, DOI 10.1016/0885-4505(86)90064-2; SHAROV VG, 1987, J THORAC CARDIOV SUR, V94, P749; Simonian NA, 1996, ANNU REV PHARMACOL, V36, P83, DOI 10.1146/annurev.pa.36.040196.000503; Speer O, 2004, MOL CELL BIOCHEM, V256, P407, DOI 10.1023/B:MCBI.0000009886.98508.e7; Suter M, 2006, J BIOL CHEM, V281, P32207, DOI 10.1074/jbc.M606357200; Tokarska-Schlattner M, 2008, J BIOL CHEM, V283, P26198, DOI 10.1074/jbc.M803132200; Tokarska-Schlattner M, 2007, BBA-BIOENERGETICS, V1767, P1276, DOI 10.1016/j.bbabio.2007.08.006; van Meer G, 2005, EMBO J, V24, P3159, DOI 10.1038/sj.emboj.7600798; Van Schaftingen E, 2002, BIOCHEM J, V362, P513, DOI 10.1042/0264-6021:3620513; WALLIMAN.T, 1973, EUR J BIOCHEM, V38, P180, DOI 10.1111/j.1432-1033.1973.tb03048.x; Wallimann T, 2007, MOL SYSTEM BIOENERGE, P195, DOI [10.1002/9783527621095.ch7, DOI 10.1002/9783527621095.CH7, DOI 10.1002/9783527621095]; Wallimann T, 2011, AMINO ACIDS, V40, P1271, DOI 10.1007/s00726-011-0877-3; Wallimann Theo, 2007, V46, P1; Wyss M, 2000, PHYSIOL REV, V80, P1107, DOI 10.1152/physrev.2000.80.3.1107; Wyss Markus, 2007, V46, P309; Young JF, 2010, J INT SOC SPORT NUTR, V7, DOI 10.1186/1550-2783-7-9; ZUCCHI R, 1989, J MOL CELL CARDIOL, V21, P67, DOI 10.1016/0022-2828(89)91494-6	82	50	51	0	32	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 17	2012	7	8							e43178	10.1371/journal.pone.0043178	http://dx.doi.org/10.1371/journal.pone.0043178			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	996DG	22912820	Green Published, gold			2022-12-25	WOS:000308063700056
J	Hou, J; Riise, J; Pakkenberg, B				Hou, Jack; Riise, Jesper; Pakkenberg, Bente			Application of Immunohistochemistry in Stereology for Quantitative Assessment of Neural Cell Populations Illustrated in the Gottingen Minipig	PLOS ONE			English	Article							TOTAL NUMBER; GLIAL-CELLS; NEURONS; VALIDATION; ACTIVATION; GROWTH; LAYER; NEUN	Background: Stereology is the study of estimating geometric quantities. When successfully applied, the combination of immunohistochemistry (IHC) and stereology eliminates intra- and interobserver variability for cell type identification. Methodology/Principal Findings: We propose a method to validate existing antibody based cell type markers for stereological application. Comparison was made on the 100-days-old Gottingen minipig (G-mini) neocortex between estimates of total neuron number derived from Giemsa staining using morphological criteria and immunohistochemistry-based cell counting with NeuN. The mean total neuron numbers estimated by the two staining methods were not significantly different. Estimated quantities, including glial cell number, neocortical volume, cell densities and glial-to-neuron ratio were also presented. Additionally, we assessed other commonly used glial markers and discussed how to evaluate the advantages and disadvantages of these markers for stereological estimation of cell number. Conclusion/Significance: The concordance in quantitative estimates of total neuron number derived from NeuN- and Giemsa-stained sections provides evidence for the sensitivity and specificity of NeuN as a neuronal marker in the G-mini. Although time-consuming, quantitative validation of IHC should always be considered in stereological studies if there is doubt of the sensitivity, specificity, or reproducibility of cell type markers. Inaccurate staining may cause both over- and underestimation of the total cell number and inflict considerable limitation when analyzing the results.	[Hou, Jack; Riise, Jesper; Pakkenberg, Bente] Copenhagen Univ Hosp, Res Lab Stereol & Neurosci, Bispebjerg, Denmark	University of Copenhagen	Hou, J (corresponding author), Copenhagen Univ Hosp, Res Lab Stereol & Neurosci, Bispebjerg, Denmark.	forsklab@bbh.regionh.dk		pakkenberg, bente/0000-0003-3851-6494				Andersen K, 2012, NEUROBIOL AGING, V33, DOI 10.1016/j.neurobiolaging.2010.06.013; Bjarkam C R, 2008, Br J Neurosurg, V22 Suppl 1, pS9, DOI 10.1080/02688690802448285; Bjarkam CR, 2008, J NEUROSCI METH, V168, P151, DOI 10.1016/j.jneumeth.2007.09.008; Bordeaux J, 2010, BIOTECHNIQUES, V48, P197, DOI 10.2144/000113382; Boyce RW, 2010, TOXICOL PATHOL, V38, P1011, DOI 10.1177/0192623310385140; Chadi G, 2001, INT J NEUROSCI, V111, P137, DOI 10.3109/00207450108994227; DOBBING J, 1973, ARCH DIS CHILD, V48, P757, DOI 10.1136/adc.48.10.757; Dorph-Petersen KA, 2001, J MICROSC-OXFORD, V204, P232, DOI 10.1046/j.1365-2818.2001.00958.x; Fjord-Larsen L, 2010, MOL THER, V18, P2164, DOI 10.1038/mt.2010.154; GUNDERSEN HJG, 1986, J MICROSC-OXFORD, V143, P3, DOI 10.1111/j.1365-2818.1986.tb02764.x; Hedreen JC, 1998, ANAT REC, V250, P366; Jelsing J, 2006, J EXP BIOL, V209, P1454, DOI 10.1242/jeb.02141; Kragh PM, 2009, TRANSGENIC RES, V18, P545, DOI 10.1007/s11248-009-9245-4; Larsen CC, 2006, NEUROSCIENCE, V139, P999, DOI 10.1016/j.neuroscience.2006.01.005; Larsen M, 2004, ANAT EMBRYOL, V208, P239, DOI 10.1007/s00429-004-0395-0; Loesch A, 2010, CELL TISSUE RES, V341, P223, DOI 10.1007/s00441-010-1002-8; Lyck L, 2006, J NEUROSCI METH, V152, P229, DOI 10.1016/j.jneumeth.2005.09.009; Mack AF, 2004, INVEST OPHTH VIS SCI, V45, P3749, DOI 10.1167/iovs.04-0190; Melvin NR, 2010, J HISTOCHEM CYTOCHEM, V58, P577, DOI 10.1369/jhc.2009.954164; Miki Takanori, 2005, Anatomical Science International, V80, P153, DOI 10.1111/j.1447-073x.2005.00121.x; Mikkelsen M, 1999, NEUROTOXICOL TERATOL, V21, P169, DOI 10.1016/S0892-0362(98)00037-3; Mouton PR, 2002, BRAIN RES, V956, P30, DOI 10.1016/S0006-8993(02)03475-3; MULLEN RJ, 1992, DEVELOPMENT, V116, P201; Olaussen KA, 2010, CANCER RES, V70, P3851, DOI 10.1158/0008-5472.CAN-09-4352; Opriessnig T, 2010, J VET DIAGN INVEST, V22, P86, DOI 10.1177/104063871002200116; Pakkenberg B, 1997, J COMP NEUROL, V384, P312, DOI 10.1002/(SICI)1096-9861(19970728)384:2<312::AID-CNE10>3.0.CO;2-K; Papageorgiou IE, 2011, GLIA, V59, P1706, DOI 10.1002/glia.21217; Pelvig DP, 2003, DEMENT GERIATR COGN, V16, P212, DOI 10.1159/000072805; Pilegaard K, 1996, ANAL QUANT CYTOL, V18, P279; Prasad K, 2010, EXP NEUROL, V225, P328, DOI 10.1016/j.expneurol.2010.07.004; Samuelsen GB, 2003, CEREB CORTEX, V13, P115, DOI 10.1093/cercor/13.2.115; Stewart W, 2003, NEUROSCIENCE, V119, P121, DOI 10.1016/S0306-4522(03)00116-7; West MJ, 2004, NEUROBIOL AGING, V25, P1205, DOI 10.1016/j.neurobiolaging.2003.12.005; West MJ, 2002, PROG BRAIN RES, V135, P43; WEST MJ, 1993, NEUROBIOL AGING, V14, P275, DOI 10.1016/0197-4580(93)90112-O; WEST MJ, 1990, J COMP NEUROL, V296, P1, DOI 10.1002/cne.902960102; Widdows K, 2009, PLACENTA, V30, P735, DOI 10.1016/j.placenta.2009.05.007; Wolf HK, 1996, J HISTOCHEM CYTOCHEM, V44, P1167, DOI 10.1177/44.10.8813082; Zhang XM, 2010, J NEUROINFLAMM, V7, DOI 10.1186/1742-2094-7-26	39	12	12	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 15	2012	7	8							e43556	10.1371/journal.pone.0043556	http://dx.doi.org/10.1371/journal.pone.0043556			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	993AG	22905271	gold, Green Published, Green Submitted			2022-12-25	WOS:000307823600080
J	Renner, M; Schweizer, C; Bannai, H; Triller, A; Levi, S				Renner, Marianne; Schweizer, Claude; Bannai, Hiroko; Triller, Antoine; Levi, Sabine			Diffusion Barriers Constrain Receptors at Synapses	PLOS ONE			English	Article							SINGLE-PARTICLE TRACKING; GABA(A) RECEPTORS; GLYCINE RECEPTORS; EXTRASYNAPTIC MEMBRANES; INHIBITORY SYNAPSES; LATERAL MOBILITY; GEPHYRIN; SUBUNIT; MOLECULE; TRANSMISSION	The flux of neurotransmitter receptors in and out of synapses depends on receptor interaction with scaffolding molecules. However, the crowd of transmembrane proteins and the rich cytoskeletal environment may constitute obstacles to the diffusion of receptors within the synapse. To address this question, we studied the membrane diffusion of the gamma-aminobutyric acid type A receptor (GABA(A)R) subunits clustered (gamma 2) or not (alpha 5) at inhibitory synapses in rat hippocampal dissociated neurons. Relative to the extrasynaptic region, gamma 2 and alpha 5 showed reduced diffusion and increased confinement at both inhibitory and excitatory synapses but they dwelled for a short time at excitatory synapses. In contrast, gamma 2 was similar to 3-fold more confined and dwelled similar to 3-fold longer in inhibitory synapses than alpha 5, indicating faster synaptic escape of alpha 5. Furthermore, using a gephyrin dominant-negative approach, we showed that the increased residency time of gamma 2 at inhibitory synapses was due to receptor-scaffold interactions. As shown for GABA(A)R, the excitatory glutamate receptor 2 subunit ( GluA2) of the alpha-amino-3-hydroxy-5-methyl-4-isoxazolepropionic acid receptor (AMPAR) had lower mobility in both excitatory and inhibitory synapses but a higher residency time at excitatory synapses. Therefore barriers impose significant diffusion constraints onto receptors at synapses where they accumulate or not. Our data further reveal that the confinement and the dwell time but not the diffusion coefficient report on the synapse specific sorting, trapping and accumulation of receptors.	[Renner, Marianne; Schweizer, Claude; Bannai, Hiroko; Triller, Antoine; Levi, Sabine] CNRS, UMR8197, INSERM, U1024,IBENS, Paris, France	Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); Institut National de la Sante et de la Recherche Medicale (Inserm)	Renner, M (corresponding author), CNRS, UMR8197, INSERM, U1024,IBENS, Paris, France.	antoine.triller@ens.fr; sabine.levi@inserm.fr	Bannai, Hiroko/I-7130-2014; LEVI, SABINE/AAX-5607-2020; Renner, Marianne/H-5315-2011	Bannai, Hiroko/0000-0002-0951-488X; Levi, Sabine/0000-0002-9927-0945; TRILLER, Antoine/0000-0002-7530-1233; Renner, Marianne/0000-0002-8727-6581	INSERM; Association Francaise contre les Myopathies (AFM); Agence Nationale de la Recherche (ANR) [Neur-043-02]; Toyobo Biotechnology Foundation; Japan Society for the Promotion of Science [06J06775]	INSERM(Institut National de la Sante et de la Recherche Medicale (Inserm)European Commission); Association Francaise contre les Myopathies (AFM)(Association Francaise contre les Myopathies); Agence Nationale de la Recherche (ANR)(French National Research Agency (ANR)); Toyobo Biotechnology Foundation; Japan Society for the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science)	This work was supported by INSERM and Association Francaise contre les Myopathies (AFM). CS was supported by INSERM, MR by Agence Nationale de la Recherche (ANR) grant Neur-043-02 and HB by the Toyobo Biotechnology Foundation and the Japan Society for the Promotion of Science (06J06775). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alivisatos AP, 2005, ANNU REV BIOMED ENG, V7, P55, DOI 10.1146/annurev.bioeng.7.060804.100432; Anderson RGW, 2002, SCIENCE, V296, P1821, DOI 10.1126/science.1068886; Bannai H, 2006, NAT PROTOC, V1, P2628, DOI 10.1038/nprot.2006.429; Bannai H, 2009, NEURON, V62, P670, DOI 10.1016/j.neuron.2009.04.023; Bats C, 2007, NEURON, V53, P719, DOI 10.1016/j.neuron.2007.01.030; Biederer T, 2002, SCIENCE, V297, P1525, DOI 10.1126/science.1072356; Bogdanov Y, 2006, EMBO J, V25, P4381, DOI 10.1038/sj.emboj.7601309; Bonneau S, 2005, IEEE T IMAGE PROCESS, V14, P1384, DOI 10.1109/TIP.2005.852794; Bouthour W, 2011, CEREB CORTEX; Brunig I, 2002, J COMP NEUROL, V443, P43, DOI 10.1002/cne.10102; BUSSELL SJ, 1995, BIOPHYS J, V68, P1836, DOI 10.1016/S0006-3495(95)80360-7; Calamai M, 2009, J NEUROSCI, V29, P7639, DOI 10.1523/JNEUROSCI.5711-08.2009; Choquet D, 2003, NAT REV NEUROSCI, V4, P251, DOI 10.1038/nrn1077; Christie SB, 2002, PROG BRAIN RES, V136, P157; Crestani F, 2002, NEUROPHARMACOLOGY, V43, P679, DOI 10.1016/S0028-3908(02)00159-4; Dahan M, 2003, SCIENCE, V302, P442, DOI 10.1126/science.1088525; Danglot L, 2003, MOL CELL NEUROSCI, V23, P264, DOI 10.1016/S1044-7431(03)00069-1; Dietrich C, 2002, BIOPHYS J, V82, P274, DOI 10.1016/S0006-3495(02)75393-9; Ehrensperger MV, 2007, BIOPHYS J, V92, P3706, DOI 10.1529/biophysj.106.095596; Essrich C, 1998, NAT NEUROSCI, V1, P563, DOI 10.1038/2798; Fannon AM, 1996, NEURON, V17, P423, DOI 10.1016/S0896-6273(00)80175-0; Fischer F, 2000, J COMP NEUROL, V427, P634, DOI 10.1002/1096-9861(20001127)427:4<634::AID-CNE10>3.0.CO;2-X; Fritschy JM, 2008, TRENDS NEUROSCI, V31, P257, DOI 10.1016/j.tins.2008.02.006; FRITSCHY JM, 1995, J COMP NEUROL, V359, P154, DOI 10.1002/cne.903590111; Goslin K., 1998, RAT HIPPOCAMPAL NEUR, P339; Groc L, 2006, P NATL ACAD SCI USA, V103, P18769, DOI 10.1073/pnas.0605238103; Hanus C, 2006, J NEUROSCI, V26, P4586, DOI 10.1523/JNEUROSCI.5123-05.2006; Hedstrom KL, 2008, J CELL BIOL, V183, P635, DOI 10.1083/jcb.200806112; Husi H, 2000, NAT NEUROSCI, V3, P661, DOI 10.1038/76615; Jacob TC, 2005, J NEUROSCI, V25, P10469, DOI 10.1523/JNEUROSCI.2267-05.2005; Kneussel M, 1999, J NEUROSCI, V19, P9289, DOI 10.1523/jneurosci.19-21-09289.1999; Kusumi A, 2005, ANNU REV BIOPH BIOM, V34, P351, DOI 10.1146/annurev.biophys.34.040204.144637; Levi S, 2004, J NEUROSCI, V24, P207, DOI 10.1523/JNEUROSCI.1661-03.2004; Levi S, 2008, NEURON, V59, P261, DOI 10.1016/j.neuron.2008.05.030; Machado P, 2011, J NEUROSCI, V31, P3, DOI 10.1523/JNEUROSCI.2533-10.2011; Meier J, 2001, NAT NEUROSCI, V4, P253, DOI 10.1038/85099; Michalet X, 2010, PHYS REV E, V82, DOI 10.1103/PhysRevE.82.041914; Miesenbock G, 1998, NATURE, V394, P192, DOI 10.1038/28190; Muir J, 2010, P NATL ACAD SCI USA, V107, P16679, DOI 10.1073/pnas.1000589107; Mukherjee J, 2011, J NEUROSCI, V31, P14677, DOI 10.1523/JNEUROSCI.2001-11.2011; Nusser Z, 1998, J NEUROSCI, V18, P1693; Nusser Z, 1996, J NEUROSCI, V16, P103; Qian H, 1991, BIOPHYS J, V60, P910, DOI 10.1016/S0006-3495(91)82125-7; Renner M, 2009, J NEUROSCI, V29, P2926, DOI 10.1523/JNEUROSCI.4445-08.2009; Renner ML, 2009, NEUROPHARMACOLOGY, V56, P30, DOI 10.1016/j.neuropharm.2008.07.022; Rossi DJ, 1998, NEURON, V20, P783, DOI 10.1016/S0896-6273(00)81016-8; Saxton MJ, 1997, ANNU REV BIOPH BIOM, V26, P373, DOI 10.1146/annurev.biophys.26.1.373; Scheiffele P, 2000, CELL, V101, P657, DOI 10.1016/S0092-8674(00)80877-6; Serge A, 2002, J NEUROSCI, V22, P3910, DOI 10.1523/JNEUROSCI.22-10-03910.2002; Serwanski DR, 2006, J COMP NEUROL, V499, P458, DOI 10.1002/cne.21115; Swanwick CC, 2006, J COMP NEUROL, V495, P497, DOI 10.1002/cne.20897; Tada T, 2007, CURR BIOL, V17, P1752, DOI 10.1016/j.cub.2007.09.039; Tardin C, 2003, EMBO J, V22, P4656, DOI 10.1093/emboj/cdg463; Thomas P, 2005, NAT NEUROSCI, V8, P889, DOI 10.1038/nn1483; Triller A, 2005, TRENDS NEUROSCI, V28, P133, DOI 10.1016/j.tins.2005.01.001; Triller A, 2008, NEURON, V59, P359, DOI 10.1016/j.neuron.2008.06.022; Tsuriel S, 2006, PLOS BIOL, V4, P1572, DOI 10.1371/journal.pbio.0040271; Uchida N, 1996, J CELL BIOL, V135, P767, DOI 10.1083/jcb.135.3.767; Yamagata M, 2002, CELL, V110, P649, DOI 10.1016/S0092-8674(02)00910-8	59	35	35	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 13	2012	7	8							e43032	10.1371/journal.pone.0043032	http://dx.doi.org/10.1371/journal.pone.0043032			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	988OJ	22912780	Green Published, Green Submitted, gold			2022-12-25	WOS:000307500100054
J	Shi, LH; Ko, ML; Abbott, LC; Ko, GYP				Shi, Liheng; Ko, Michael L.; Abbott, Louise C.; Ko, Gladys Y. -P.			Identification of Peptide Lv, a Novel Putative Neuropeptide That Regulates the Expression of L-Type Voltage-Gated Calcium Channels in Photoreceptors	PLOS ONE			English	Article							CA2+ CHANNELS; SYNAPTIC PLASTICITY; TERMINAL MITOSIS; MEMORY; PROTEINS; CELLS; PROTEOME; HORMONES; CA(V)1.2; GENOME	Neuropeptides are small protein-like signaling molecules with diverse roles in regulating neural functions such as sleep/wake cycles, pain modulation, synaptic plasticity, and learning and memory. Numerous drugs designed to target neuropeptides, their receptors, or relevant pathways have been developed in the past few decades. Hence, the discovery and characterization of new neuropeptides and their functions have received considerable attention from scientific research. Computational bioinformatics coupled with functional assays are powerful tools to address the difficulties in discovering new bioactive peptides. In this study, a new bioinformatic strategy was designed to screen full length human and mouse cDNA databases to search for novel peptides. One was discovered and named peptide Lv because of its ability to enhance L-type voltage-gated calcium channel (L-VGCC) currents in retinal photoreceptors. Using matrix-assisted laser desorption/ionization-time of flight mass spectrometry (MALDI-TOF MS), peptide Lv was detected in the culture media, which indicated that it was secreted from 661W cells transfected with the gene. In vitro treatments with either glutathione S-transferase (GST) fusion peptide Lv or synthesized peptide Lv enhanced L-VGCC channel activities in cone photoreceptors. At the molecular level, peptide Lv stimulated cAMP production, enhanced phosphorylation of extracellular signal-regulated kinase (ERK), and increased the protein expression of L-VGCC alpha 1 subunits in cone photoreceptors. Therefore, the biological activities of peptide Lv may be very important in the modulation of L-VGCC dependent neural plasticity.	[Shi, Liheng; Ko, Michael L.; Abbott, Louise C.; Ko, Gladys Y. -P.] Texas A&M Univ, Coll Vet Med & Biomed Sci, Dept Vet Integrat Biosci, College Stn, TX 77843 USA	Texas A&M University System; Texas A&M University College Station	Shi, LH (corresponding author), Texas A&M Univ, Coll Vet Med & Biomed Sci, Dept Vet Integrat Biosci, College Stn, TX 77843 USA.	gko@cvm.tamu.edu	Abbott, Louise C/AAC-4392-2022		National Institutes of Health [RO1 EY017452]; College of Veterinary Medicine and Biomedical Sciences at Texas AM University; NATIONAL EYE INSTITUTE [R01EY017452] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); College of Veterinary Medicine and Biomedical Sciences at Texas AM University; NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI))	This work was supported by National Institutes of Health RO1 EY017452 to GK and a postdoctoral research award from the College of Veterinary Medicine and Biomedical Sciences at Texas A&M University to LS. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adams JP, 2002, ANNU REV PHARMACOL, V42, P135, DOI 10.1146/annurev.pharmtox.42.082701.145401; ADLER R, 1989, SCIENCE, V243, P391, DOI 10.1126/science.2911751; ADLER R, 1984, J CELL BIOL, V99, P1173, DOI 10.1083/jcb.99.3.1173; ALUBAIDI MR, 1992, J CELL BIOL, V119, P1681, DOI 10.1083/jcb.119.6.1681; Barnes S, 2002, ADV EXP MED BIOL, V514, P465; BeleckyAdams T, 1996, DEV BIOL, V178, P304, DOI 10.1006/dbio.1996.0220; BLISS TVP, 1993, NATURE, V361, P31, DOI 10.1038/361031a0; Carpio Y, 2006, PEPTIDES, V27, P710, DOI 10.1016/j.peptides.2005.08.013; Catterall WA, 2008, NEURON, V59, P882, DOI 10.1016/j.neuron.2008.09.005; Chiu PCN, 2008, HUM REPROD, V23, P1385, DOI 10.1093/humrep/den047; Choo KH, 2005, BMC BIOINFORMATICS, V6, DOI 10.1186/1471-2105-6-249; Couceyro PR, 2003, PROTEIN EXPRES PURIF, V32, P185, DOI 10.1016/j.pep.2003.08.015; Davare MA, 2001, SCIENCE, V293, P98, DOI 10.1126/science.293.5527.98; Dolphin AC, 2009, CURR OPIN NEUROBIOL, V19, P237, DOI 10.1016/j.conb.2009.06.006; Eisenhaber B, 2010, METHODS MOL BIOL, V609, P365, DOI 10.1007/978-1-60327-241-4_21; Emanuelsson O, 2007, NAT PROTOC, V2, P953, DOI 10.1038/nprot.2007.131; Fourcaudot E, 2009, NAT NEUROSCI, V12, P1093, DOI 10.1038/nn.2378; Gao TY, 1997, NEURON, V19, P185, DOI 10.1016/S0896-6273(00)80358-X; GLEASON E, 1992, VISUAL NEUROSCI, V8, P315, DOI 10.1017/S0952523800005058; Hewes RS, 2001, GENOME RES, V11, P1126, DOI 10.1101/gr.169901; Hummon AB, 2006, SCIENCE, V314, P647, DOI 10.1126/science.1124128; Kamp TJ, 2000, CIRC RES, V87, P1095, DOI 10.1161/01.RES.87.12.1095; KANDEL E, 1995, SCIENCE, V268, P825, DOI 10.1126/science.7754367; Kawai J, 2001, NATURE, V409, P685, DOI 10.1038/35055500; Ko ML, 2007, J NEUROCHEM, V103, P784, DOI 10.1111/j.1471-4159.2007.04816.x; KOLODKIN AL, 1993, CELL, V75, P1389, DOI 10.1016/0092-8674(93)90625-Z; Li B, 2008, GENOME RES, V18, P113, DOI 10.1101/gr.6714008; Lovejoy DA, 2009, ANN NY ACAD SCI, V1163, P215, DOI 10.1111/j.1749-6632.2008.03629.x; Mirabeau O, 2007, GENOME RES, V17, P320, DOI 10.1101/gr.5755407; Moosmang S, 2005, J NEUROSCI, V25, P9883, DOI 10.1523/JNEUROSCI.1531-05.2005; Murakami S, 2003, J PERIODONTAL RES, V38, P97, DOI 10.1034/j.1600-0765.2003.00640.x; Ota T, 2004, NAT GENET, V36, P40, DOI 10.1038/ng1285; Palop JJ, 2010, NAT NEUROSCI, V13, P812, DOI 10.1038/nn.2583; Rosenberg D, 2002, ANN NY ACAD SCI, V968, P65, DOI 10.1111/j.1749-6632.2002.tb04327.x; Rotzinger S, 2010, PEPTIDES, V31, P736, DOI 10.1016/j.peptides.2009.12.015; Sakurai T, 2010, ANN NY ACAD SCI, V1200, P149, DOI 10.1111/j.1749-6632.2010.05513.x; Schiller MR, 1996, FEBS LETT, V382, P6, DOI 10.1016/0014-5793(96)00083-X; Singh A, 2006, NAT NEUROSCI, V9, P1108, DOI 10.1038/nn1751; Steiner DF, 1998, CURR OPIN CHEM BIOL, V2, P31, DOI 10.1016/S1367-5931(98)80033-1; Vassilatis DK, 2003, P NATL ACAD SCI USA, V100, P4903, DOI 10.1073/pnas.0230374100; Waltereit R, 2003, MOL NEUROBIOL, V27, P99, DOI 10.1385/MN:27:1:99; Wettschureck N, 2005, PHYSIOL REV, V85, P1159, DOI 10.1152/physrev.00003.2005; Wilding John P. H., 2001, Current Opinion in Pharmacology, V1, P656, DOI 10.1016/S1471-4892(01)00111-4; Zuhlke RD, 1999, NATURE, V399, P159, DOI 10.1038/20200	44	6	8	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 13	2012	7	8							e43091	10.1371/journal.pone.0043091	http://dx.doi.org/10.1371/journal.pone.0043091			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	988OJ	22912796	Green Submitted, gold, Green Published			2022-12-25	WOS:000307500100061
J	Shimizu, K; Takahama, S; Endo, Y; Sawasaki, T				Shimizu, Kouhei; Takahama, Shoukichi; Endo, Yaeta; Sawasaki, Tatsuya			Stress-Inducible Caspase Substrate TRB3 Promotes Nuclear Translocation of Procaspase-3	PLOS ONE			English	Article							ENDOPLASMIC-RETICULUM STRESS; TRANSCRIPTIONAL ACTIVITY; CELL-DEATH; ER STRESS; ADIPOCYTE DIFFERENTIATION; INDUCED APOPTOSIS; ACTIVATION; PATHWAY; TRIBBLES; ATF4	Pseudokinase TRB3 is a stress-inducible nuclear protein, which has recently been shown to be involved in ER stress-induced apoptosis. However, it remains unclear how TRB3 contributes to the process. We recently demonstrated that TRB3 was cleaved by caspase-3 (CASP3) in vitro and also in apoptosis-induced cells. Thus, we investigate the role of TRB3 cleavage in the apoptotic process to address the above question. Overexpression studies revealed that the cleavage of TRB3 promoted CASP3/7 activation and apoptosis. In contrast, the anti-apoptotic effects were found under TRB3 non-cleavable conditions, such as ER stress, and also when the CASP3/7 activation was enhanced by knockdown of endogenous TRB3 expression. Interestingly, nuclear translocation of procaspase-3 (proCASP3) was observed in cells either overexpressing TRB3 or under tunicamycin-induced ER stress. Although forced cytoplasmic expression of proCASP3 enhanced apoptosis significantly, its nuclear expression did not produce any pro-apoptotic effect, suggesting that nuclear distribution of proCASP3 is not critical for the execution of apoptosis. Thus, TRB3 might prevent cytoplasmic activation of CASP3 by promoting proCASP3 entry into the nucleus, and thereby inhibit apoptosis. Taken together, our results suggest that TRB3, through its own cleavage, functions as a molecular switch between the cell survival and apoptotic pathways under stressful conditions.	[Shimizu, Kouhei; Endo, Yaeta; Sawasaki, Tatsuya] Ehime Univ, Cell Free Sci & Technol Res Ctr, Matsuyama, Ehime, Japan; [Takahama, Shoukichi; Endo, Yaeta; Sawasaki, Tatsuya] Ehime Univ, Venture Business Lab, Matsuyama, Ehime, Japan; [Endo, Yaeta; Sawasaki, Tatsuya] Ehime Univ, Proteomed Res Ctr, Toon, Japan; [Endo, Yaeta; Sawasaki, Tatsuya] RIKEN Syst & Struct Biol Ctr, Yokohama, Kanagawa, Japan	Ehime University; Ehime University; Ehime University; RIKEN	Shimizu, K (corresponding author), Ehime Univ, Cell Free Sci & Technol Res Ctr, Matsuyama, Ehime, Japan.	sawasaki@ehime-u.ac.jp		Sawasaki, Tatsuya/0000-0002-7952-0556; Shimizu, Kouhei/0000-0001-9523-4296	Japan Society for the Promotion of Science; Ministry of Education, Culture, Sports, Science, and Technology in Japan; Grants-in-Aid for Scientific Research [22310127] Funding Source: KAKEN	Japan Society for the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); Ministry of Education, Culture, Sports, Science, and Technology in Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was partly supported by a Grant-in-Aid for Scientific Research (B) (Dr. Sawasaki) and a Grant-in-Aid for JSPS Fellows (Dr. Shimizu) from Japan Society for the Promotion of Science, and a Grant-in-Aid for Scientific Research on Innovative Areas (Dr. Sawasaki) from the Ministry of Education, Culture, Sports, Science, and Technology in Japan. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bezy O, 2007, MOL CELL BIOL, V27, P6818, DOI 10.1128/MCB.00375-07; Bowers AJ, 2003, ONCOGENE, V22, P2823, DOI 10.1038/sj.onc.1206367; Cheung HH, 2006, EXP CELL RES, V312, P2347, DOI 10.1016/j.yexcr.2006.03.027; Colussi PA, 1998, J BIOL CHEM, V273, P24535, DOI 10.1074/jbc.273.38.24535; Corcoran CA, 2005, CANCER BIOL THER, V4, P1063, DOI 10.4161/cbt.4.10.2205; Du KY, 2003, SCIENCE, V300, P1574, DOI 10.1126/science.1079817; Galehdar Z, 2010, J NEUROSCI, V30, P16938, DOI 10.1523/JNEUROSCI.1598-10.2010; Giri K, 2003, FEBS LETT, V555, P380, DOI 10.1016/S0014-5793(03)01294-8; Humphrey RK, 2010, J BIOL CHEM, V285, P22426, DOI 10.1074/jbc.M110.123786; Inoue S, 2009, CELL DEATH DIFFER, V16, P1053, DOI 10.1038/cdd.2009.29; Jousse C, 2007, J BIOL CHEM, V282, P15851, DOI 10.1074/jbc.M611723200; Kamada S, 2005, J BIOL CHEM, V280, P857, DOI 10.1074/jbc.C400538200; Kato S, 2007, BIOCHEM BIOPH RES CO, V353, P933, DOI 10.1016/j.bbrc.2006.12.161; Kiss-Toth E, 2004, J BIOL CHEM, V279, P42703, DOI 10.1074/jbc.M407732200; Launay S, 2005, ONCOGENE, V24, P5137, DOI 10.1038/sj.onc.1208524; Li F, 2010, CELL STEM CELL, V7, P508, DOI 10.1016/j.stem.2010.09.003; Mancini M, 1998, J CELL BIOL, V140, P1485, DOI 10.1083/jcb.140.6.1485; Mancini M, 2000, J CELL BIOL, V149, P603, DOI 10.1083/jcb.149.3.603; Manns J, 2011, FASEB J, V25, P3250, DOI 10.1096/fj.10-177527; Misiti F, 2005, NEUROCHEM INT, V46, P575, DOI 10.1016/j.neuint.2005.01.001; Nakanishi K, 2007, FASEB J, V21, P2994, DOI 10.1096/fj.06-6408com; Ord D, 2007, EXP CELL RES, V313, P3556, DOI 10.1016/j.yexcr.2007.07.017; Ohoka N, 2005, EMBO J, V24, P1243, DOI 10.1038/sj.emboj.7600596; Ohoka N, 2010, BIOCHEM BIOPH RES CO, V392, P289, DOI 10.1016/j.bbrc.2009.12.175; Ord D, 2003, EXP CELL RES, V286, P308, DOI 10.1016/S0014-4827(03)00070-3; Puthalakath H, 2007, CELL, V129, P1337, DOI 10.1016/j.cell.2007.04.027; Qi L, 2006, SCIENCE, V312, P1763, DOI 10.1126/science.1123374; Schwarzer R, 2006, CELL SIGNAL, V18, P899, DOI 10.1016/j.cellsig.2005.08.002; Shikama Y, 2001, EXP CELL RES, V264, P315, DOI 10.1006/excr.2000.5153; Szegezdi E, 2006, EMBO REP, V7, P880, DOI 10.1038/sj.embor.7400779; Tadokoro D, 2010, CELL DEATH DIS, V1, DOI 10.1038/cddis.2010.65; Takahashi Y, 2008, J LIPID RES, V49, P880, DOI 10.1194/jlr.M700545-JLR200; Takemoto K, 2003, J CELL BIOL, V160, P235, DOI 10.1083/jcb.200207111; Upton JP, 2008, MOL CELL BIOL, V28, P3943, DOI 10.1128/MCB.00013-08; Wali VB, 2009, APOPTOSIS, V14, P1366, DOI 10.1007/s10495-009-0406-y; Woehlbier U, 2011, TRENDS BIOCHEM SCI, V36, P329, DOI 10.1016/j.tibs.2011.03.001; Wurstle ML, 2010, J BIOL CHEM, V285, P33209, DOI 10.1074/jbc.M110.113860; Xu CY, 2005, J CLIN INVEST, V115, P2656, DOI 10.1172/JCI26373; Yoshida H, 2007, FEBS J, V274, P630, DOI 10.1111/j.1742-4658.2007.05639.x; Zhivotovsky B, 1999, CELL DEATH DIFFER, V6, P644, DOI 10.1038/sj.cdd.4400536; Zou CG, 2009, ENDOCRINOLOGY, V150, P277, DOI 10.1210/en.2008-0794	41	19	21	1	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 9	2012	7	8							e42721	10.1371/journal.pone.0042721	http://dx.doi.org/10.1371/journal.pone.0042721			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	986WZ	22912727	Green Submitted, Green Published, gold			2022-12-25	WOS:000307378500025
J	Mitin, N; Rossman, KL; Der, CJ				Mitin, Natalia; Rossman, Kent L.; Der, Channing J.			Identification of a Novel Actin-Binding Domain within the Rho Guanine Nucleotide Exchange Factor TEM4	PLOS ONE			English	Article							PLECKSTRIN HOMOLOGY DOMAIN; ARP2/3 COMPLEX; CRYSTAL-STRUCTURE; F-ACTIN; CELL-MIGRATION; PDZ-RHOGEF; ATP-ACTIN; ADP-ACTIN; PROTEIN; GTPASES	Spatio-temporal activation of Rho GTPases is essential for their function in a variety of biological processes and is achieved in part by regulating the localization of their activators, the Rho guanine nucleotide exchange factors (RhoGEFs). In this study, we provide the first characterization of the full-length protein encoded by RhoGEF TEM4 and delineate its domain structure, catalytic activity, and subcellular localization. First, we determined that TEM4 can stimulate guanine nucleotide exchange on RhoA and the related RhoB and RhoC isoforms. Second, we determined that TEM4, like other Dbl RhoGEFs, contains a functional pleckstrin homology (PH) domain immediately C-terminal to the catalytic Dbl homology (DH) domain. Third, using immunofluorescence analysis, we showed that TEM4 localizes to the actin cytoskeleton through sequences in the N-terminus of TEM4 independently of the DH/PH domains. Using site-directed mutagenesis and deletion analysis, we identified a minimal region between residues 81 and 135 that binds directly to F-actin and has an similar to 90-fold higher affinity for ATP-loaded F-actin. Finally, we demonstrated that a single point mutation (R130D) within full-length TEM4 abolishes actin binding and localization of TEM4 to the actin cytoskeleton, as well as dampens the in vivo activity of TEM4 towards RhoC. Taken together, our data demonstrate that TEM4 contains a novel actin binding domain and binding to actin is essential for TEM4 subcellular localization and activity. The unique subcellular localization of TEM4 suggests a spatially-restricted activity and expands the diversity of mechanisms by which RhoGEF function can be regulated.	[Mitin, Natalia] Univ N Carolina, Lineberger Comprehens Canc Ctr, Chapel Hill, NC 27599 USA; Univ N Carolina, Dept Pharmacol, Chapel Hill, NC USA	University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina; University of North Carolina Chapel Hill	Mitin, N (corresponding author), Univ N Carolina, Lineberger Comprehens Canc Ctr, Chapel Hill, NC 27599 USA.	nmitin@med.unc.edu		Der, Channing/0000-0002-7751-2747	NIH GI SPORE Developmental Research [CA106991]; NIH grant [CA129610]; NATIONAL CANCER INSTITUTE [R01CA129610, P50CA106991] Funding Source: NIH RePORTER	NIH GI SPORE Developmental Research; NIH grant(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported by NIH GI SPORE Developmental Research grant to N.M. and K.L.R. (CA106991) and NIH grant CA129610 to C.J.D. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aktories K, 2005, CURR TOP MICROBIOL, V291, P113; Banerjee J, 2004, MOL BIOL CELL, V15, P1760, DOI 10.1091/mbc.E03-07-0527; Banerjee J, 2009, BIOCHEMISTRY-US, V48, P8032, DOI 10.1021/bi9010013; Banuelos S, 1998, STRUCTURE, V6, P1419, DOI 10.1016/S0969-2126(98)00141-5; Baumeister MA, 2006, BIOCHEM J, V400, P563, DOI 10.1042/BJ20061020; Blanchoin L, 2000, CURR BIOL, V10, P1273, DOI 10.1016/S0960-9822(00)00749-1; Blanchoin L, 2002, BIOCHEMISTRY-US, V41, P597, DOI 10.1021/bi011214b; Bravo-Cordero JJ, 2011, CURR BIOL, V21, P635, DOI 10.1016/j.cub.2011.03.039; Bryce NS, 2005, CURR BIOL, V15, P1276, DOI 10.1016/j.cub.2005.06.043; Buchsbaum RJ, 2002, MOL CELL BIOL, V22, P4073, DOI 10.1128/MCB.22.12.4073-4085.2002; Cai L, 2008, CELL, V134, P828, DOI 10.1016/j.cell.2008.06.054; Cai L, 2007, J CELL SCI, V120, P1779, DOI 10.1242/jcs.007641; Cai L, 2007, CELL, V128, P915, DOI 10.1016/j.cell.2007.01.031; Carugo KD, 1997, NAT STRUCT BIOL, V4, P175, DOI 10.1038/nsb0397-175; Chang YC, 2008, MOL BIOL CELL, V19, P2147, DOI 10.1091/mbc.E07-12-1269; Chen CKM, 2011, TRENDS BIOCHEM SCI, V36, P553, DOI 10.1016/j.tibs.2011.07.004; Connolly BA, 2005, MOL CELL BIOL, V25, P4602, DOI 10.1128/MCB.25.11.4602-4614.2005; COUE M, 1987, FEBS LETT, V213, P316, DOI 10.1016/0014-5793(87)81513-2; De Toledo M, 2000, FEBS LETT, V480, P287, DOI 10.1016/S0014-5793(00)01953-0; Fields AP, 2010, ADV ENZYME REGUL, V50, P190, DOI 10.1016/j.advenzreg.2009.10.010; FRIEDERICH E, 1992, CELL, V70, P81, DOI 10.1016/0092-8674(92)90535-K; Fuentes EJ, 2003, J BIOL CHEM, V278, P21188, DOI 10.1074/jbc.M211792200; Gibrat JF, 1996, CURR OPIN STRUC BIOL, V6, P377, DOI 10.1016/S0959-440X(96)80058-3; Gimona M, 2002, FEBS LETT, V513, P98, DOI 10.1016/S0014-5793(01)03240-9; Hakem A, 2005, GENE DEV, V19, P1974, DOI 10.1101/gad.1310805; Hall A, 2000, PHILOS T R SOC B, V355, P965, DOI 10.1098/rstb.2000.0632; Ito M, 1999, MOL CELL BIOL, V19, P7539; Kelkar N, 2000, MOL CELL BIOL, V20, P1030, DOI 10.1128/MCB.20.3.1030-1043.2000; Kelley LA, 2009, NAT PROTOC, V4, P363, DOI 10.1038/nprot.2009.2; Kovar DR, 2006, CELL, V124, P423, DOI 10.1016/j.cell.2005.11.038; Krendel M, 2002, NAT CELL BIOL, V4, P294, DOI 10.1038/ncb773; Lemmon MA, 2008, NAT REV MOL CELL BIO, V9, P99, DOI 10.1038/nrm2328; Mitin N, 2007, NAT STRUCT MOL BIOL, V14, P814, DOI 10.1038/nsmb1290; Mohl M, 2006, N-S ARCH PHARMACOL, V373, P333, DOI 10.1007/s00210-006-0083-0; Nalbant P, 2009, MOL BIOL CELL, V20, P4070, DOI 10.1091/mbc.E09-01-0041; Narumiya S, 2009, CANCER METAST REV, V28, P65, DOI 10.1007/s10555-008-9170-7; Obaishi H, 1998, J BIOL CHEM, V273, P18697, DOI 10.1074/jbc.273.30.18697; Pollard TD, 2003, CELL, V112, P453, DOI 10.1016/S0092-8674(03)00120-X; Pollard TD, 2000, ANNU REV BIOPH BIOM, V29, P545, DOI 10.1146/annurev.biophys.29.1.545; POLLARD TD, 1986, J CELL BIOL, V103, P2747, DOI 10.1083/jcb.103.6.2747; Raftopoulou M, 2004, DEV BIOL, V265, P23, DOI 10.1016/j.ydbio.2003.06.003; Ridley AJ, 2001, TRENDS CELL BIOL, V11, P471, DOI 10.1016/S0962-8924(01)02153-5; Ridley AJ, 2003, SCIENCE, V302, P1704, DOI 10.1126/science.1092053; Ridley AJ, 2006, TRENDS CELL BIOL, V16, P522, DOI 10.1016/j.tcb.2006.08.006; Riedl J, 2008, NAT METHODS, V5, P605, DOI 10.1038/nmeth.1220; Roberts PJ, 2008, J BIOL CHEM, V283, P25150, DOI 10.1074/jbc.M800882200; Rossman KL, 2005, NAT REV MOL CELL BIO, V6, P167, DOI 10.1038/nrm1587; Rost B, 2004, NUCLEIC ACIDS RES, V32, pW321, DOI 10.1093/nar/gkh377; Rumenapp U, 2002, BIOCHEM J, V366, P721, DOI 10.1042/BJ20020654; Ruskamo S, 2009, ACTA CRYSTALLOGR D, V65, P1217, DOI 10.1107/S0907444909037330; Schmidt A, 2002, GENE DEV, V16, P1587, DOI 10.1101/gad.1003302; Schultz J, 2000, NUCLEIC ACIDS RES, V28, P231, DOI 10.1093/nar/28.1.231; Simpson KJ, 2004, CANCER RES, V64, P8694, DOI 10.1158/0008-5472.CAN-04-2247; Skowronek KR, 2004, J BIOL CHEM, V279, P37895, DOI 10.1074/jbc.M312677200; Sondek J, 1996, NATURE, V379, P369, DOI 10.1038/379369a0; St Croix B, 2000, SCIENCE, V289, P1197; Svitkina TM, 1999, J CELL BIOL, V145, P1009, DOI 10.1083/jcb.145.5.1009; Tatsumoto T, 1999, J CELL BIOL, V147, P921, DOI 10.1083/jcb.147.5.921; Vega FM, 2007, CELL, V129, P1430, DOI 10.1016/j.cell.2007.06.021; Vetter IR, 2001, SCIENCE, V294, P1299, DOI 10.1126/science.1062023; Weed SA, 2000, J CELL BIOL, V151, P29, DOI 10.1083/jcb.151.1.29; Welch HCE, 2002, CELL, V108, P809, DOI 10.1016/S0092-8674(02)00663-3; Winkler S, 2005, BIOCHEM BIOPH RES CO, V335, P1280, DOI 10.1016/j.bbrc.2005.08.025; Wolfe BA, 2009, PLOS BIOL, V7, DOI 10.1371/journal.pbio.1000110; Worthylake DK, 2000, NATURE, V408, P682, DOI 10.1038/35047014; Zheng J, 1997, J BIOL CHEM, V272, P30340, DOI 10.1074/jbc.272.48.30340	66	21	21	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 24	2012	7	7							e41876	10.1371/journal.pone.0041876	http://dx.doi.org/10.1371/journal.pone.0041876			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	978NX	22911862	gold, Green Published, Green Submitted			2022-12-25	WOS:000306751300079
J	Porritt, MJ; Andersson, HC; Hou, L; Nilsson, A; Pekna, M; Pekny, M; Nilsson, M				Porritt, Michelle J.; Andersson, Helene C.; Hou, Linda; Nilsson, Asa; Pekna, Marcela; Pekny, Milos; Nilsson, Michael			Photothrombosis-Induced Infarction of the Mouse Cerebral Cortex Is Not Affected by the Nrf2-Activator Sulforaphane	PLOS ONE			English	Article							TRANSCRIPTION FACTOR NRF2; ACUTE ISCHEMIC-STROKE; GENE-EXPRESSION; RAT; INJURY; BRAIN; PROTECTION; DAMAGE; INDUCTION; OXIDOREDUCTASE-1	Sulforaphane-induced activation of the transcription factor NF-E2 related factor 2 (Nrf2 or the gene Nfe2l2) and subsequent induction of the phase II antioxidant system has previously been shown to exert neuroprotective action in a transient model of focal cerebral ischemia. However, its ability to attenuate functional and cellular deficits after permanent focal cerebral ischemia is not clear. We assessed the neuroprotective effects of sulforaphane in the photothrombotic model of permanent focal cerebral ischemia. Sulforaphane was administered (5 or 50 mg/kg, i.p.) after ischemic onset either as a single dose or as daily doses for 3 days. Sulforaphane increased transcription of Nrf2, Hmox1, GCLC and GSTA4 mRNA in the brain confirming activation of the Nrf2 system. Single or repeated administration of sulforaphane had no effect on the infarct volume, nor did it reduce the number of activated glial cells or proliferating cells when analyzed 24 and 72 h after stroke. Motor-function as assessed by beam-walking, cylinder-test, and adhesive test, did not improve after sulforaphane treatment. The results show that sulforaphane treatment initiated after photothrombosis-induced permanent cerebral ischemia does not interfere with key cellular mechanisms underlying tissue damage.	[Porritt, Michelle J.; Andersson, Helene C.; Hou, Linda; Pekna, Marcela; Pekny, Milos; Nilsson, Michael] Univ Gothenburg, Ctr Brain Repair & Rehabil CBR, Inst Neurosci & Physiol, Sahlgrenska Acad, Gothenburg, Sweden; [Nilsson, Asa] Sahlgrens Univ Hosp, Gothenburg, Sweden	University of Gothenburg; Sahlgrenska University Hospital	Porritt, MJ (corresponding author), Univ Gothenburg, Ctr Brain Repair & Rehabil CBR, Inst Neurosci & Physiol, Sahlgrenska Acad, Gothenburg, Sweden.	michael.nilsson@vgregion.se	Pekna, Marcela/AAM-3249-2021; NILSSON, MICHAEL/ABE-7821-2020; Pekna, Marcela/AAM-3261-2021	Pekna, Marcela/0000-0003-2734-8237; NILSSON, MICHAEL/0000-0002-8826-1621; Pekna, Marcela/0000-0003-2734-8237	STENA research foundation; AFA research foundation; ALF Goteborg; Edit Jacobsson Foundation; Rune and Ulla Amlovs Foundation; Swedish Medical Research Council [11548, 20116]; EduGlia ITN EU grant; Free Mason Foundation; Torsten and Ragnar Soderbergs Foundation	STENA research foundation; AFA research foundation; ALF Goteborg; Edit Jacobsson Foundation; Rune and Ulla Amlovs Foundation; Swedish Medical Research Council(Swedish Medical Research Council (SMRC)); EduGlia ITN EU grant; Free Mason Foundation; Torsten and Ragnar Soderbergs Foundation	Supported by research grants from the STENA and AFA research foundations (to MN, M. Pekny and M. Pekna), by ALF Goteborg (to MN, M. Pekny and M. Pekna), the Edit Jacobsson Foundation (to MN, MJP, M. Pekna and M. Pekny), the Rune and Ulla Amlovs Foundation (MN, M. Pekna and M. Pekny), by the Swedish Medical Research Council (project 11548 to M. Pekny and 20116 to M. Pekna), EduGlia ITN EU grant (to M. Pekny, MN and M. Pekna), the Free Mason Foundation (M. Pekny) and the Torsten and Ragnar Soderbergs Foundation (M. Pekny, MN and M. Pekna). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bergstrom P, 2011, NEUROPHARMACOLOGY, V60, P343, DOI 10.1016/j.neuropharm.2010.09.023; Calkins MJ, 2005, P NATL ACAD SCI USA, V102, P244, DOI 10.1073/pnas.0408487101; Chang YY, 1999, NEUROSCI LETT, V277, P61, DOI 10.1016/S0304-3940(99)00799-5; Chen G, 2011, J NEUROSCI RES, V89, P515, DOI 10.1002/jnr.22577; Crack PJ, 2003, J CEREBR BLOOD F MET, V23, P19, DOI 10.1097/01.WCB.0000035181.38851.71; Cullinan SB, 2004, J BIOL CHEM, V279, P20108, DOI 10.1074/jbc.M314219200; Demougeot C, 2003, J CEREBR BLOOD F MET, V23, P482, DOI 10.1097/01.WCB.0000050066.57184.60; DeRyck M, 1996, J PHARMACOL EXP THER, V279, P748; Dinkova-Kostova AT, 2010, ARCH BIOCHEM BIOPHYS, V501, P116, DOI 10.1016/j.abb.2010.03.019; Fisher M, 2009, STROKE, V40, P2244, DOI 10.1161/STROKEAHA.108.541128; GROME JJ, 1988, J CEREBR BLOOD F MET, V8, P89, DOI 10.1038/jcbfm.1988.11; Hacke W, 2008, NEW ENGL J MED, V359, P1317, DOI 10.1056/NEJMoa0804656; Haupt C, 2007, MOL CELL NEUROSCI, V35, P89, DOI 10.1016/j.mcn.2007.02.005; Hoehn B, 2003, STROKE, V34, P2489, DOI 10.1161/01.STR.0000091268.25816.19; Hubbs AF, 2007, AM J PATHOL, V170, P2068, DOI 10.2353/ajpath.2007.060898; JANDER S, 1995, J CEREBR BLOOD F MET, V15, P42, DOI 10.1038/jcbfm.1995.5; Kang KW, 2002, NITRIC OXIDE-BIOL CH, V7, P244, DOI 10.1016/S1089-8603(02)00117-9; Kernie SG, 2001, J NEUROSCI RES, V66, P317, DOI 10.1002/jnr.10013; KHARLAMOV A, 1993, J NEUROSCI, V13, P2483, DOI 10.1523/JNEUROSCI.13-06-02483.1993; Kuroda S, 1997, CLIN NEUROSCI, V4, P199; Lee JK, 2007, SURG NEUROL, V67, P620, DOI 10.1016/j.surneu.2006.08.077; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Lu SC, 2009, MOL ASPECTS MED, V30, P42, DOI 10.1016/j.mam.2008.05.005; Mattson MP, 2008, CRIT REV TOXICOL, V38, P633, DOI 10.1080/10408440802026406; Nioi P, 2004, MUTAT RES-FUND MOL M, V555, P149, DOI 10.1016/j.mrfmmm.2004.05.023; Nowicka D, 2008, ACTA NEUROBIOL EXP, V68, P155; Paxinos G., 2007, RAT BRAIN STEREOTAXI, V6th ed.; Ping Z, 2010, BRAIN RES, V1343, P178, DOI 10.1016/j.brainres.2010.04.036; Schallert T, 2000, NEUROPHARMACOLOGY, V39, P777, DOI 10.1016/S0028-3908(00)00005-8; Schallert Timothy, 2006, NeuroRx, V3, P497, DOI 10.1016/j.nurx.2006.08.001; SCHROETER M, 1994, J NEUROIMMUNOL, V55, P195, DOI 10.1016/0165-5728(94)90010-8; Shah ZA, 2011, NEUROSCIENCE, V180, P248, DOI 10.1016/j.neuroscience.2011.02.031; SNAPE MF, 1993, NEUROSCIENCE, V53, P837, DOI 10.1016/0306-4522(93)90628-S; So HS, 2006, CELL DEATH DIFFER, V13, P1763, DOI 10.1038/sj.cdd.4401863; Son TG, 2009, J NEUROCHEM; Stankowski JN, 2011, ANTIOXID REDOX SIGN, V14, P1841, DOI 10.1089/ars.2010.3292; Talalay P, 2004, METHOD ENZYMOL, V382, P355; van der Worp HB, 2010, PLOS MED, V7, DOI 10.1371/journal.pmed.1000245; WATSON BD, 1985, ANN NEUROL, V17, P497, DOI 10.1002/ana.410170513; Yu SS, 2011, NEUROCHEM RES, V36, P339, DOI 10.1007/s11064-010-0335-8; Zhao J, 2006, NEUROSCI LETT, V393, P108, DOI 10.1016/j.neulet.2005.09.065; Zhao J, 2005, J NEUROSCI RES, V82, P499, DOI 10.1002/jnr.20649; Zhao XR, 2007, STROKE, V38, P3280, DOI 10.1161/STROKEAHA.107.486506	43	36	36	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 23	2012	7	7							e41090	10.1371/journal.pone.0041090	http://dx.doi.org/10.1371/journal.pone.0041090			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	977TM	22911746	Green Published, Green Submitted, gold			2022-12-25	WOS:000306687700040
J	Zhang, HF; Ni, B; Zhao, X; Dadzie, I; Du, H; Wang, Q; Xu, HX; Huang, XX				Zhang, Haifang; Ni, Bin; Zhao, Xin; Dadzie, Isaac; Du, Hong; Wang, Qiang; Xu, Huaxi; Huang, Xinxiang			Fis Is Essential for the Stability of Linear Plasmid pBSSB1 and Affects the Motility of Salmonella enterica Serovar Typhi	PLOS ONE			English	Article							ESCHERICHIA-COLI; TERMINAL PROTEINS; DNA-REPLICATION; STREPTOMYCES; CHROMOSOMES; INSTABILITY; BINDING; GENES; CYCLE	pBSSB1 is a 27 kb non-bacteriophage-related linear plasmid first found in Salmonella enterica serovar Typhi (S. Typhi), but the mechanism underlying the replication of pBSSB1 is currently unknown. Previous reports showed that the factor for inversion stimulation (Fis) encoded by fis can affect the replication, transcription and other processes through binding DNA. Here, a fis deletion mutant of S. Typhi (Delta fis) was prepared through the homologous recombination mediated by suicide plasmid and the loss of pBSSB1 in Delta fis was observed surprisingly by pulsed field gel electrophoresis (PFGE). Subsequently, the loss of pBSSB1 was verified by PCR and Southern blot. In addition, the motility of Delta fis was deficient and the flagellin of Dfis could not be detected by 2-dimensional polyacrylamide gel electrophoresis. All these results show that Fis is essential for the stability of pBSSB1 and affects the motility of S. Typhi.	[Zhang, Haifang; Ni, Bin; Zhao, Xin; Dadzie, Isaac; Du, Hong; Xu, Huaxi; Huang, Xinxiang] Jiangsu Univ, Sch Med Technol, Dept Biochem & Mol Biol, Zhenjiang, Jiangsu, Peoples R China; [Wang, Qiang] Nanjing Univ, Dept Biol, State Key Lab Pharmaceut Biotechnol, Nanjing, Jiangsu, Peoples R China	Jiangsu University; Nanjing University	Zhang, HF (corresponding author), Jiangsu Univ, Sch Med Technol, Dept Biochem & Mol Biol, Zhenjiang, Jiangsu, Peoples R China.	huxinx@yahoo.com.hk	Dadzie, Isaac/AAA-6026-2019	Dadzie, Isaac/0000-0002-2146-6796	National Natural Science Foundation of China [31000076]; Natural Science Foundation for colleges and universities in Jiangsu Province [10KJB310001]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Natural Science Foundation for colleges and universities in Jiangsu Province	This work was supported by National Natural Science Foundation of China (31000076) and Natural Science Foundation for colleges and universities in Jiangsu Province (10KJB310001). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Baker S, 2007, PLOS PATHOG, V3, P605, DOI 10.1371/journal.ppat.0030059; Baker S, 2007, MOL MICROBIOL, V66, P1207, DOI 10.1111/j.1365-2958.2007.05995.x; Balding C, 2006, PLASMID, V56, P68, DOI 10.1016/j.plasmid.2005.12.001; Blaby IK, 2009, MICROBIOL-SGM, V155, P2676, DOI 10.1099/mic.0.029777-0; Browning DF, 2010, CURR OPIN MICROBIOL, V13, P773, DOI 10.1016/j.mib.2010.09.013; Cameron ADS, 2011, MOL MICROBIOL, V80, P85, DOI 10.1111/j.1365-2958.2011.07560.x; Datsenko KA, 2000, P NATL ACAD SCI USA, V97, P6640, DOI 10.1073/pnas.120163297; Froelich JM, 1996, J BACTERIOL, V178, P6006, DOI 10.1128/jb.178.20.6006-6012.1996; GILLE H, 1991, NUCLEIC ACIDS RES, V19, P4167, DOI 10.1093/nar/19.15.4167; HAYAKAWA T, 1979, J ANTIBIOT, V32, P1348, DOI 10.7164/antibiotics.32.1348; Huang XX, 2004, FEMS MICROBIOL LETT, V234, P239, DOI 10.1016/j.femsle.2004.03.030; KADO CI, 1981, J BACTERIOL, V145, P1365, DOI 10.1128/JB.145.3.1365-1373.1981; Kelly A, 2004, MICROBIOL-SGM, V150, P2037, DOI 10.1099/mic.0.27209-0; Lobry JR, 2003, CURR OPIN MICROBIOL, V6, P101, DOI 10.1016/S1369-5274(03)00024-9; Picardeau M, 2000, GENOME RES, V10, P1594, DOI 10.1101/gr.124000; PLASTERK RHA, 1985, NATURE, V318, P257, DOI 10.1038/318257a0; Ryan VT, 2004, MOL MICROBIOL, V51, P1347, DOI 10.1046/j.1365-2958.2003.03906.x; SUMMERS DK, 1984, CELL, V36, P1097, DOI 10.1016/0092-8674(84)90060-6; SUMMERS DK, 1993, MOL MICROBIOL, V8, P1031, DOI 10.1111/j.1365-2958.1993.tb01648.x; Tsai HH, 2011, NUCLEIC ACIDS RES, V39, P2165, DOI 10.1093/nar/gkq1204; Wold S, 1996, NUCLEIC ACIDS RES, V24, P3527, DOI 10.1093/nar/24.18.3527; Yang CC, 2002, MOL MICROBIOL, V43, P297, DOI 10.1046/j.1365-2958.2002.02760.x; YUAN HS, 1991, P NATL ACAD SCI USA, V88, P9558, DOI 10.1073/pnas.88.21.9558; Zhong L, 2010, J BACTERIOL, V192, P3747, DOI 10.1128/JB.00123-10; Zou X, 2009, MICROBIOL IMMUNOL, V53, P191, DOI 10.1111/j.1348-0421.2009.00106.x	25	10	14	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 23	2012	7	7							e37462	10.1371/journal.pone.0037462	http://dx.doi.org/10.1371/journal.pone.0037462			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	977TM	22911678	Green Published, gold, Green Submitted			2022-12-25	WOS:000306687700001
J	Bin, JM; Leong, SY; Bull, SJ; Antel, JP; Kennedy, TE				Bin, Jenea M.; Leong, Soo Yuen; Bull, Sarah-Jane; Antel, Jack P.; Kennedy, Timothy E.			Oligodendrocyte Precursor Cell Transplantation into Organotypic Cerebellar Shiverer Slices: A Model to Study Myelination and Myelin Maintenance	PLOS ONE			English	Article							IN-VITRO; CULTURES; DIFFERENTIATION; REMYELINATION	Current in vitro models to investigate the consequence of oligodendrocyte-specific loss-of-function mutations on myelination are primarily limited to co-culture experiments, which do not accurately recapitulate the complex in vivo environment. Here, we describe the development of an in vitro model of myelination and myelin maintenance in which oligodendrocyte precursor cells are transplanted into organotypic cerebellar slice cultures derived from dysmyelinated shiverer mice. Compared to neuron-oligodendrocyte co-cultures, organotypic slices more closely mimic the environment in vivo, while utilizing a genetic background that allows for straight-forward identification of myelin generated by transplanted cells. We show at the ultrastructural level that the myelin generated by wild-type transplanted oligodendrocytes is compact and terminates in cytoplasmic loops that form paranodal junctions with the axon. This myelination results in the appropriate sequestering of axonal proteins into specialized domains surrounding the nodes of Ranvier. We also demonstrate the applicability of this approach for xenograft transplantation of oligodendrocyte precursor cells derived from rat or human sources. This method provides a time-efficient and cost-effective adjunct to conditional knockout mouse lines or in vivo transplantation models to study oligodendrocyte-specific loss-of-function mutations. Furthermore, the approach can be readily used to assess the effect of pharmacological manipulations on myelin, providing a tool to better understand myelination and develop effective therapeutic strategies to treat myelin-related diseases.	[Bin, Jenea M.; Leong, Soo Yuen; Bull, Sarah-Jane; Antel, Jack P.; Kennedy, Timothy E.] McGill Univ, Montreal Neurol Inst, Dept Neurol & Neurosurg, Montreal, PQ H3A 2B4, Canada	McGill University	Bin, JM (corresponding author), McGill Univ, Montreal Neurol Inst, Dept Neurol & Neurosurg, Montreal, PQ H3A 2B4, Canada.	timothy.kennedy@mcgill.ca		antel, jack/0000-0002-5148-0636	Multiple Sclerosis Society of Canada; Vanier Canada Graduate Scholarship; Fonds de la Recherche en Sante du Quebec	Multiple Sclerosis Society of Canada; Vanier Canada Graduate Scholarship; Fonds de la Recherche en Sante du Quebec(Fonds de la Recherche en Sante du Quebec)	This project was supported by operating grants from Multiple Sclerosis Society of Canada (http://mssociety.ca/en/research/default.htm). JMB is supported by a Vanier Canada Graduate Scholarship and SJB is supported by a Multiple Sclerosis Society of Canada Studentship. TEK is a Killam Foundation Scholar and holds a Chercheur National award from the Fonds de la Recherche en Sante du Quebec. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Armstrong RC, 1998, METHODS, V16, P282, DOI 10.1006/meth.1998.0685; BILLINGSGAGLIARDI S, 1984, P NATL ACAD SCI-BIOL, V81, P2558, DOI 10.1073/pnas.81.8.2558; BLAKEMORE WF, 1974, NATURE, V249, P577, DOI 10.1038/249577a0; CAMPAGNONI AT, 1988, MOL NEUROBIOL, V2, P41, DOI 10.1007/BF02935632; Chen Y, 2007, NAT PROTOC, V2, P1044, DOI 10.1038/nprot.2007.149; Duncan ID, 2011, NEUROTHERAPEUTICS, V8, P607, DOI 10.1007/s13311-011-0080-y; Gahwiler BH, 1997, TRENDS NEUROSCI, V20, P471, DOI 10.1016/S0166-2236(97)01122-3; Izrael M, 2007, MOL CELL NEUROSCI, V34, P310, DOI 10.1016/j.mcn.2006.11.008; Jarjour AA, 2008, J NEUROSCI, V28, P11003, DOI 10.1523/JNEUROSCI.3285-08.2008; Jarjour AA, 2012, GLIA, V60, P1, DOI 10.1002/glia.21231; NOTTERPEK LM, 1993, J NEUROSCI RES, V36, P621, DOI 10.1002/jnr.490360603; O'Meara RW, 2011, JOVE-J VIS EXP, DOI 10.3791/3324; Poliak S, 2003, NAT REV NEUROSCI, V4, P968, DOI 10.1038/nrn1253; READHEAD C, 1990, BEHAV GENET, V20, P213, DOI 10.1007/BF01067791; Windrem MS, 2004, NAT MED, V10, P93, DOI 10.1038/nm974; Zhang H, 2011, EXP NEUROL, V230, P138, DOI 10.1016/j.expneurol.2011.04.009; Zhang PL, 2006, MOL CELL NEUROSCI, V31, P387, DOI 10.1016/j.mcn.2005.10.014	17	15	17	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 20	2012	7	7							e41237	10.1371/journal.pone.0041237	http://dx.doi.org/10.1371/journal.pone.0041237			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	977GL	22911763	Green Published, gold, Green Submitted			2022-12-25	WOS:000306644600058
J	Estella, C; Herrer, I; Moreno-Moya, JM; Quinonero, A; Martinez, S; Pellicer, A; Simon, C				Estella, Carlos; Herrer, Isabel; Manuel Moreno-Moya, Juan; Quinonero, Alicia; Martinez, Sebastian; Pellicer, Antonio; Simon, Carlos			miRNA Signature and Dicer Requirement during Human Endometrial Stromal Decidualization In Vitro	PLOS ONE			English	Article							BINDING PROTEIN-BETA; TRANSCRIPTION FACTOR; GENE-EXPRESSION; CYCLIC-AMP; C/EBP-BETA; CROSS-TALK; KINASE-A; MICRORNAS; CELLS; HOXA10	Decidualization is a morphological and biochemical transformation of endometrial stromal fibroblast into differentiated decidual cells, which is critical for embryo implantation and pregnancy establishment. The complex regulatory networks have been elucidated at both the transcriptome and the proteome levels, however very little is known about the post-transcriptional regulation of this process. miRNAs regulate multiple physiological pathways and their de-regulation is associated with human disorders including gynaecological conditions such as endometriosis and preeclampsia. In this study we profile the miRNAs expression throughout human endometrial stromal (hESCs) decidualization and analyze the requirement of the miRNA biogenesis enzyme Dicer during this process. A total of 26 miRNAs were upregulated and 17 miRNAs downregulated in decidualized hESCs compared to non-decidualized hESCs. Three miRNAs families, miR-181, miR-183 and miR-200, are down-regulated during the decidualization process. Using miRNAs target prediction algorithms we have identified the potential targets and pathways regulated by these miRNAs. The knockdown of Dicer has a minor effect on hESCs during in vitro decidualization. We have analyzed a battery of decidualization markers such as cell morphology, Prolactin, IGFBP-1, MPIF-1 and TIMP-3 secretion as well as HOXA10, COX2, SP1, C/EBP beta and FOXO1 expression in decidualized hESCs with decreased Dicer function. We found decreased levels of HOXA10 and altered intracellular organization of actin filaments in Dicer knockdown decidualized hESCs compared to control. Our results provide the miRNA signature of hESC during the decidualization process in vitro. We also provide the first functional characterization of Dicer during human endometrial decidualization although surprisingly we found that Dicer plays a minor role regulating this process suggesting that alternative biogenesis miRNAs pathways must be involved in human endometrial decidualization.	[Estella, Carlos; Herrer, Isabel; Manuel Moreno-Moya, Juan; Quinonero, Alicia; Martinez, Sebastian; Pellicer, Antonio; Simon, Carlos] Univ Valencia, Inst Univ IVI INCLIVA, FIVI, Valencia, Spain; [Estella, Carlos] UAM, CSIC, Ctr Biol Mol Severo Ochoa, Dept Mol Biol, Madrid, Spain	University of Valencia; Autonomous University of Madrid; Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Centro de Biologia Molecular Severo Ochoa (CBM)	Estella, C (corresponding author), Univ Valencia, Inst Univ IVI INCLIVA, FIVI, Valencia, Spain.	carlos.simon@ivi.es	Estella, Carlos/L-2097-2014; MARTINEZ, ANTONIO PELLICER/C-4832-2015; Pellicer, Antonio/AAA-6005-2020; Simon, Carlos/G-2186-2014	Estella, Carlos/0000-0003-1551-2327; Pellicer, Antonio/0000-0002-8254-863X; Simon, Carlos/0000-0003-0902-9531				Babiarz JE, 2011, RNA, V17, P1489, DOI 10.1261/rna.2442211; Bartel DP, 2009, CELL, V136, P215, DOI 10.1016/j.cell.2009.01.002; Benson GV, 1996, DEVELOPMENT, V122, P2687; Brar AK, 2001, PHYSIOL GENOMICS, V7, P135, DOI 10.1152/physiolgenomics.00061.2001; Brar AK, 1997, ENDOCRINE, V6, P301, DOI 10.1007/BF02820507; BRUNER KL, 1995, P NATL ACAD SCI USA, V92, P7362, DOI 10.1073/pnas.92.16.7362; Burney RO, 2009, MOL HUM REPROD, V15, P625, DOI 10.1093/molehr/gap068; Chakraborty I, 1996, J MOL ENDOCRINOL, V16, P107, DOI 10.1677/jme.0.0160107; Christian M, 2002, J BIOL CHEM, V277, P20825, DOI 10.1074/jbc.M201018200; Christian Mark, 2002, Reprod Biomed Online, V4 Suppl 3, P24; CHRIVIA JC, 1993, NATURE, V365, P855, DOI 10.1038/365855a0; Cullen BR, 2004, MOL CELL, V16, P861, DOI 10.1016/j.molcel.2004.12.002; Dunn Carolyn L, 2003, Reprod Biomed Online, V7, P151; Garrido-Gomez T, 2010, J CLIN ENDOCRINOL ME; Gellersen B, 2003, J ENDOCRINOL, V178, P357, DOI 10.1677/joe.0.1780357; Gellersen B, 2007, SEMIN REPROD MED, V25, P445, DOI 10.1055/s-2007-991042; Gonzalez G, 2009, MOL REPROD DEV, V76, P678, DOI 10.1002/mrd.21010; Grewal S, 2008, P NATL ACAD SCI USA, V105, P16189, DOI 10.1073/pnas.0806219105; Harfe BD, 2005, P NATL ACAD SCI USA, V102, P10898, DOI 10.1073/pnas.0504834102; Harris KS, 2006, P NATL ACAD SCI USA, V103, P2208, DOI 10.1073/pnas.0510839103; He L, 2004, NAT REV GENET, V5, P522, DOI 10.1038/nrg1379; HIGUCHI T, 1995, ENDOCRINOLOGY, V136, P4973, DOI 10.1210/en.136.11.4973; Hong XM, 2008, ENDOCRINOLOGY, V149, P6207, DOI 10.1210/en.2008-0294; Ihnatovych I, 2009, BIOL REPROD, V81, P222, DOI 10.1095/biolreprod.108.074666; Kim JJ, 2007, MOL HUM REPROD, V13, P323, DOI 10.1093/molehr/gam005; Kim JJ, 2003, BIOL REPROD, V68, P24, DOI 10.1095/biolreprod.102.009316; Kim VN, 2005, NAT REV MOL CELL BIO, V6, P376, DOI 10.1038/nrm1644; Krikun G, 2000, MOL ENDOCRINOL, V14, P393, DOI 10.1210/me.14.3.393; Lam EW, 2011, J ENDOCRINOL; Lim H, 1997, CELL, V91, P197, DOI 10.1016/S0092-8674(00)80402-X; Lu Z, 2008, MOL HUM REPROD, V14, P357, DOI 10.1093/molehr/gan023; Luo XP, 2003, J CLIN ENDOCR METAB, V88, P4967, DOI 10.1210/jc.2003-030276; Mak IYH, 2002, J CLIN ENDOCR METAB, V87, P2581, DOI 10.1210/jc.87.6.2581; Mantena SR, 2006, P NATL ACAD SCI USA, V103, P1870, DOI 10.1073/pnas.0507261103; Myatt SS, 2010, CANCER RES, V70, P367, DOI 10.1158/0008-5472.CAN-09-1891; Nagaraja AK, 2008, MOL ENDOCRINOL, V22, P2336, DOI 10.1210/me.2008-0142; Pan Q, 2007, MOL HUM REPROD, V13, P797, DOI 10.1093/molehr/gam063; Papadopoulos GL, 2009, BIOINFORMATICS, V25, P1991, DOI 10.1093/bioinformatics/btp299; Paria BC, 2002, SCIENCE, V296, P2185, DOI 10.1126/science.1071601; Petracco R, 2011, J CLIN ENDOCRINOL ME; Piccinni MP, 2010, J REPROD IMMUNOL, V85, P71, DOI 10.1016/j.jri.2010.01.006; Pineles BL, 2007, AM J OBSTET GYNECOL, V196, P261, DOI 10.1016/j.ajog.2007.01.008; Popovici RM, 2000, ENDOCRINOLOGY, V141, P3510, DOI 10.1210/en.141.9.3510; Popovici RM, 1999, J CLIN ENDOCR METAB, V84, P2245, DOI 10.1210/jc.84.6.2245; Qian K, 2009, ENDOCRINOLOGY, V150, P4734, DOI 10.1210/en.2008-1629; Ramathal C, 2011, J BIOL CHEM, V286, P19860, DOI 10.1074/jbc.M110.191759; Ramathal CY, 2010, SEMIN REPROD MED, V28, P17, DOI 10.1055/s-0029-1242989; SATOKATA I, 1995, NATURE, V374, P460, DOI 10.1038/374460a0; Sibai B, 2005, LANCET, V365, P785, DOI 10.1016/S0140-6736(05)71003-5; SIMON C, 1994, J CLIN ENDOCR METAB, V78, P675, DOI 10.1210/jc.78.3.675; Singh M, 2008, MODERN PATHOL, V21, P912, DOI 10.1038/modpathol.2008.82; Snowdon J, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022828; Spoelstra NS, 2006, CANCER RES, V66, P3893, DOI 10.1158/0008-5472.CAN-05-2881; Stoikos CJ, 2008, HUM REPROD, V23, P1447, DOI 10.1093/humrep/den110; Taylor HS, 1998, J CLIN INVEST, V101, P1379, DOI 10.1172/JCI1057; Teague EMCO, 2010, HUM REPROD UPDATE, V16, P142, DOI 10.1093/humupd/dmp034; Teague EMCO, 2009, MOL ENDOCRINOL, V23, P265, DOI 10.1210/me.2008-0387; Telgmann R, 1997, ENDOCRINOLOGY, V138, P929, DOI 10.1210/en.138.3.929; Tierney EP, 2003, PHYSIOL GENOMICS, V16, P47, DOI 10.1152/physiolgenomics.00066.2003; Wang B, 2010, ONCOGENE, V29, P1787, DOI 10.1038/onc.2009.468; Yang JS, 2011, MOL CELL, V43, P892, DOI 10.1016/j.molcel.2011.07.024; Zhang YQ, 2010, AM J OBSTET GYNECOL, V202, DOI 10.1016/j.ajog.2010.01.057; Zhu XM, 2009, AM J OBSTET GYNECOL, V200, DOI 10.1016/j.ajog.2008.12.045	63	75	79	1	23	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 20	2012	7	7							e41080	10.1371/journal.pone.0041080	http://dx.doi.org/10.1371/journal.pone.0041080			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	977GL	22911744	Green Published, gold			2022-12-25	WOS:000306644600044
J	Koga, T; Ishida, T; Takeda, T; Ishii, Y; Uchi, H; Tsukimori, K; Yamamoto, M; Himeno, M; Furue, M; Yamada, H				Koga, Takayuki; Ishida, Takumi; Takeda, Tomoki; Ishii, Yuji; Uchi, Hiroshi; Tsukimori, Kiyomi; Yamamoto, Midori; Himeno, Masaru; Furue, Masutaka; Yamada, Hideyuki			Restoration of Dioxin-Induced Damage to Fetal Steroidogenesis and Gonadotropin Formation by Maternal Co-Treatment with alpha-Lipoic Acid	PLOS ONE			English	Article							LIPID-PEROXIDATION; ESTROGEN-RECEPTOR; ARYL-HYDROCARBON; VITAMIN-E; N-ACETYLASPARTATE; OXIDATIVE STRESS; EXPRESSION; 2,3,7,8-TETRACHLORODIBENZO-P-DIOXIN; TOXICITY; TCDD	2,3,7,8-Tetrachlorodibenzo-p-dioxin (TCDD), an endocrine disruptor, causes reproductive and developmental toxic effects in pups following maternal exposure in a number of animal models. Our previous studies have demonstrated that TCDD imprints sexual immaturity by suppressing the expression of fetal pituitary gonadotropins, the regulators of gonadal steroidogenesis. In the present study, we discovered that all TCDD-produced damage to fetal production of pituitary gonadotropins as well as testicular steroidogenesis can be repaired by co-treating pregnant rats with alpha-lipoic acid (LA), an obligate co-factor for intermediary metabolism including energy production. While LA also acts as an anti-oxidant, other anti-oxidants; i.e., ascorbic acid, butylated hydroxyanisole and edaravone, failed to exhibit any beneficial effects. Neither wasting syndrome nor CYP1A1 induction in the fetal brain caused through the activation of aryl hydrocarbon receptor (AhR) could be attenuated by LA. These lines of evidence suggest that oxidative stress makes only a minor contribution to the TCDD-induced disorder of fetal steroidogenesis, and LA has a restorative effect by targeting on mechanism(s) other than AhR activation. Following a metabolomic analysis, it was found that TCDD caused a more marked change in the hypothalamus, a pituitary regulator, than in the pituitary itself. Although the components of the tricarboxylic acid cycle and the ATP content of the fetal hypothalamus were significantly changed by TCDD, all these changes were again rectified by exogenous LA. We also provided evidence that the fetal hypothalamic content of endogenous LA is significantly reduced following maternal exposure to TCDD. Thus, the data obtained strongly suggest that TCDD reduces the expression of fetal pituitary gonadotropins to imprint sexual immaturity or disturb development by suppressing the level of LA, one of the key players serving energy production.	[Koga, Takayuki; Ishida, Takumi; Takeda, Tomoki; Ishii, Yuji; Yamada, Hideyuki] Kyushu Univ, Grad Sch Pharmaceut Sci, Fukuoka 812, Japan; [Ishida, Takumi] Sojo Univ, Fac Pharmaceut Sci, Kumamoto, Japan; [Uchi, Hiroshi] Kyushu Univ Hosp, Res & Clin Ctr Yusho & Dioxin, Fukuoka 812, Japan; [Tsukimori, Kiyomi] Fukuoka Childrens Hosp, Dept Obstet, Fukuoka, Japan; [Yamamoto, Midori; Himeno, Masaru] Nagasaki Int Univ, Fac Pharmaceut Sci, Sasebo, Japan; [Furue, Masutaka] Kyushu Univ, Grad Sch Med Sci, Fukuoka 812, Japan	Kyushu University; Sojo University; Kyushu University; Nagasaki International University; Kyushu University	Koga, T (corresponding author), Kyushu Univ, Grad Sch Pharmaceut Sci, Fukuoka 812, Japan.	hyamada@phar.kyushu-u.ac.jp	Ishii, Yuji/AAU-3300-2021; Tsukimori, Kiyomi/L-6228-2019	Tsukimori, Kiyomi/0000-0002-5196-2678; Koga, Takayuki/0000-0001-9782-6746	Ministry of Health, Labour and Welfare, Japan [H21-Kagaku-Ippan-005, H21-Shokuhin-Ippan-014]	Ministry of Health, Labour and Welfare, Japan(Ministry of Health, Labour and Welfare, Japan)	This study was upported by grants from the Ministry of Health, Labour and Welfare, Japan: Research on Risk of Chemical Substances [project No: H21-Kagaku-Ippan-005] and Research on Food Safety [project No: H21-Shokuhin-Ippan-014]. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AHMED AE, 1991, FUND APPL TOXICOL, V16, P356, DOI 10.1016/0272-0590(91)90120-S; ALBAYATI ZAF, 1987, ARCH ENVIRON CON TOX, V16, P159, DOI 10.1007/BF01055797; Badawi AF, 2000, CARCINOGENESIS, V21, P1593, DOI 10.1093/carcin/21.8.1593; Burger LL, 2004, J MOL ENDOCRINOL, V33, P559, DOI 10.1677/jme.1.01600; BURKE MD, 1975, DRUG METAB DISPOS, V3, P245; Chng HT, 2009, BRAIN RES, V1251, P80, DOI 10.1016/j.brainres.2008.11.025; COUTURE LA, 1990, TERATOLOGY, V42, P619, DOI 10.1002/tera.1420420606; Coyral-Castel S, 2008, J NEUROENDOCRINOL, V20, P335, DOI 10.1111/j.1365-2826.2007.01643.x; Dungan HM, 2006, ENDOCRINOLOGY, V147, P1154, DOI 10.1210/en.2005-1282; FernandezSalguero PM, 1996, TOXICOL APPL PHARM, V140, P173, DOI 10.1006/taap.1996.0210; Funato H, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018950; Hassoun EA, 1997, TOXICOLOGY, V124, P27, DOI 10.1016/S0300-483X(97)00127-3; Higashi Y, 2009, EXPERT OPIN PHARMACO, V10, P323, DOI [10.1517/14656560802636888 , 10.1517/14656560802636888]; Ishida T, 2005, J DERMATOL SCI, pS105, DOI 10.1016/j.descs.2005.03.011; Ishida T, 2005, TOXICOL APPL PHARM, V205, P89, DOI 10.1016/j.taap.2004.09.014; Kharat I, 1996, J BIOL CHEM, V271, P10533, DOI 10.1074/jbc.271.18.10533; Kim MS, 2004, NAT MED, V10, P727, DOI 10.1038/nm1061; Kobayashi M, 2006, ADV ENZYME REGUL, V46, P113, DOI 10.1016/j.advenzreg.2006.01.007; Kokura S, 2005, CANCER LETT, V229, P223, DOI 10.1016/j.canlet.2005.06.039; Komatsu T, 1996, YAKUBUTSUDOHTAI, V11, P492; Larsen JC, 2006, MOL NUTR FOOD RES, V50, P885, DOI 10.1002/mnfr.200500247; Latchoumycandane C, 2002, ARCH TOXICOL, V76, P113; Latchoumycandane C, 2002, J APPL TOXICOL, V22, P345, DOI 10.1002/jat.866; Madhavarao CN, 2003, J NEUROCHEM, V86, P824, DOI 10.1046/j.1471-4159.2003.01905.x; MARTIN GR, 1961, ARCH BIOCHEM BIOPHYS, V93, P110, DOI 10.1016/0003-9861(61)90321-6; Mimura J, 2003, BBA-GEN SUBJECTS, V1619, P263, DOI 10.1016/S0304-4165(02)00485-3; Moffett JR, 2007, PROG NEUROBIOL, V81, P89, DOI 10.1016/j.pneurobio.2006.12.003; Murugesan P, 2005, FREE RADICAL RES, V39, P1259, DOI 10.1080/10715760500308154; Mutoh J, 2006, ENDOCRINOLOGY, V147, P927, DOI 10.1210/en.2005-1125; Ogborne RM, 2005, ARTERIOSCL THROM VAS, V25, P2100, DOI 10.1161/01.ATV.0000183745.37161.6e; OHKAWA H, 1979, ANAL BIOCHEM, V95, P351, DOI 10.1016/0003-2697(79)90738-3; Ohtake F, 2003, NATURE, V423, P545, DOI 10.1038/nature01606; Ohtake F, 2007, NATURE, V446, P562, DOI 10.1038/nature05683; Packer L, 1997, Adv Pharmacol, V38, P79; PACKER L, 1995, FREE RADICAL BIO MED, V19, P227, DOI 10.1016/0891-5849(95)00017-R; PETERSON RE, 1993, CRIT REV TOXICOL, V23, P283, DOI 10.3109/10408449309105013; POLAND A, 1982, ANNU REV PHARMACOL, V22, P517, DOI 10.1146/annurev.pa.22.040182.002505; Puga A, 2009, BIOCHEM PHARMACOL, V77, P713, DOI 10.1016/j.bcp.2008.08.031; Schneider JE, 2004, PHYSIOL BEHAV, V81, P289, DOI 10.1016/j.physbeh.2004.02.007; Schupke H, 2001, DRUG METAB DISPOS, V29, P855; Schwarz JM, 2008, J STEROID BIOCHEM, V109, P300, DOI 10.1016/j.jsbmb.2008.03.012; Shay KP, 2009, BBA-GEN SUBJECTS, V1790, P1149, DOI 10.1016/j.bbagen.2009.07.026; Siman CM, 1997, DIABETOLOGIA, V40, P1416, DOI 10.1007/s001250050844; STOHS SJ, 1983, BIOCHEM BIOPH RES CO, V111, P854, DOI 10.1016/0006-291X(83)91377-3; STOHS SJ, 1984, XENOBIOTICA, V14, P533, DOI 10.3109/00498258409151443; Takeda T, 2012, J BIOL CHEM, V287, P18440, DOI 10.1074/jbc.M111.335158; Takeda T, 2009, J PHARMACOL EXP THER, V329, P1091, DOI 10.1124/jpet.109.151282; Taketoh J, 2007, LIFE SCI, V80, P1259, DOI 10.1016/j.lfs.2006.12.029; TAYLOR MJ, 1984, AGENTS ACTIONS, V15, P454, DOI 10.1007/BF01972387; Terasawa E, 2010, J NEUROENDOCRINOL, V22, P630, DOI 10.1111/j.1365-2826.2010.02027.x; Tian Y, 1998, J STEROID BIOCHEM, V67, P17, DOI 10.1016/S0960-0760(98)00067-3; Wang SJ, 2007, NEUROCHEM INT, V50, P51, DOI 10.1016/j.neuint.2006.06.011; WEBER LWD, 1991, TOXICOLOGY, V66, P133, DOI 10.1016/0300-483X(91)90214-L; Yi XW, 2005, MOL CELL BIOL, V25, P8387, DOI 10.1128/MCB.25.18.8387-8392.2005	54	32	35	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 20	2012	7	7							e40322	10.1371/journal.pone.0040322	http://dx.doi.org/10.1371/journal.pone.0040322			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	977GL	22911699	Green Published, gold, Green Submitted			2022-12-25	WOS:000306644600017
J	Wu, TS; Chiu, CH; Yang, CH; Leu, HS; Huang, CT; Chen, YC; Wu, TL; Chang, PY; Su, LH; Kuo, AJ; Chia, JH; Lu, CC; Lai, HC				Wu, Ting-Shu; Chiu, Cheng-Hsun; Yang, Chih-Hsun; Leu, Hsieh-Shong; Huang, Ching-Tai; Chen, Yi-Chieh; Wu, Tsu-Lan; Chang, Pi-Yueh; Su, Lin-Hui; Kuo, An-Jing; Chia, Ju-Hsin; Lu, Chia-Chen; Lai, Hsin-Chih			Fish Tank Granuloma Caused by Mycobacterium marinum	PLOS ONE			English	Article							INFECTIONS; SUSCEPTIBILITY; DIAGNOSIS; SKIN	Introduction: Mycobacterium marinum causes skin and soft tissue, bone and joint, and rare disseminated infections. In this study, we aimed to investigate the relationship between treatment outcome and antimicrobial susceptibility patterns. A total of 27 patients with M. marinum infections were enrolled. Methods: Data on clinical characteristics and therapeutic methods were collected and analyzed. We also determined the minimum inhibitory concentrations of 7 antibiotics against 30 isolates from these patients. Results: Twenty-seven patients received antimycobacterial agents with or without surgical debridement. Eighteen patients were cured, 8 failed to respond to treatment, and one was lost to follow-up. The duration of clarithromycin (147 vs. 28; p = 0.0297), and rifampicin (201 vs. 91; p = 0.0266) treatment in the cured patients was longer than that in the others. Surgical debridement was performed in 10 out of the 18 cured patients, and in 1 of another group (p = 0.0417). All the 30 isolates were susceptible to clarithromycin, amikacin, and linezolid; 29 (96.7%) were susceptible to ethambutol; 28 (93.3%) were susceptible to sulfamethoxazole; and 26 (86.7%) were susceptible to rifampicin. However, only 1 (3.3%) isolate was susceptible to doxycycline. Discussion: Early diagnosis of the infection and appropriate antimicrobial therapy with surgical debridement are the mainstays of successful treatment. Clarithromycin and rifampin are supposed to be more effective agents.	[Wu, Ting-Shu; Leu, Hsieh-Shong; Huang, Ching-Tai] Chang Gung Univ, Div Infect Dis, Dept Internal Med, Chang Gung Mem Hosp,Coll Med, Tao Yuan, Taiwan; [Wu, Ting-Shu] Chang Gung Univ, Grad Inst Clin Med Sci, Tao Yuan, Taiwan; [Chiu, Cheng-Hsun] Chang Gung Univ, Div Infect Dis, Dept Pediat,Coll Med, Chang Gung Childrens Hosp,Chang Gung Mem Hosp, Tao Yuan, Taiwan; [Yang, Chih-Hsun] Chang Gung Mem Hosp, Dept Dermatol, Tao Yuan, Taiwan; [Chen, Yi-Chieh] Chang Gung Univ, Dept Plast & Reconstruct Surg, Chang Gung Mem Hosp, Coll Med, Tao Yuan, Taiwan; [Wu, Tsu-Lan; Chang, Pi-Yueh; Su, Lin-Hui; Kuo, An-Jing; Chia, Ju-Hsin] Chang Gung Univ, Dept Lab Med, Chang Gung Mem Hosp, Coll Med, Tao Yuan, Taiwan; [Wu, Tsu-Lan; Chang, Pi-Yueh; Su, Lin-Hui; Kuo, An-Jing; Chia, Ju-Hsin; Lai, Hsin-Chih] Chang Gung Univ, Dept Med Biotechnol & Lab Sci, Tao Yuan, Taiwan; [Chang, Pi-Yueh; Chia, Ju-Hsin; Lai, Hsin-Chih] Chang Gung Univ, Grad Inst Med Biotechnol & Lab Sci, Tao Yuan, Taiwan; [Lu, Chia-Chen] Fu Jen Catholic Univ, Dept Resp Therapy, New Taipei, Taiwan; [Lai, Hsin-Chih] Chang Gung Univ, Res Ctr Pathogen Bacteria, Tao Yuan, Taiwan	Chang Gung Memorial Hospital; Chang Gung University; Chang Gung University; Chang Gung Memorial Hospital; Chang Gung University; Chang Gung Memorial Hospital; Chang Gung Memorial Hospital; Chang Gung University; Chang Gung Memorial Hospital; Chang Gung University; Chang Gung University; Chang Gung University; Fu Jen Catholic University; Chang Gung University	Wu, TS (corresponding author), Chang Gung Univ, Div Infect Dis, Dept Internal Med, Chang Gung Mem Hosp,Coll Med, Tao Yuan, Taiwan.	hclai@mail.cgu.edu.tw		LAI, HSIN-CHIH/0000-0002-0605-5040	National Science Council [NSC99-2321-B-002-022-MY3]; Chang Gung Memorial Hospital [CMRPG381391]	National Science Council(Ministry of Science and Technology, Taiwan); Chang Gung Memorial Hospital(Chang Gung Memorial Hospital)	This work was supported by the National Science Council (grant NSC99-2321-B-002-022-MY3), and Chang Gung Memorial Hospital (grant CMRPG381391). The funders had no role in study design, data collection and analysis, decision to publish or preparation of the manuscript.	ADAMS RM, 1970, J AMER MED ASSOC, V211, P457, DOI 10.1001/jama.211.3.457; Aubry A, 2002, ARCH INTERN MED, V162, P1746, DOI 10.1001/archinte.162.15.1746; BROWN BA, 1992, ANTIMICROB AGENTS CH, V36, P1987, DOI 10.1128/AAC.36.9.1987; Cheung Jason Pui-yin, 2010, J Orthop Surg (Hong Kong), V18, P98; CLSI/NCCLS, 2003, SUSCEPTIBILITY TESTI; COLLINS CH, 1985, J HYG-CAMBRIDGE, V94, P135, DOI 10.1017/S0022172400061349; Cummins DL, 2005, INT J DERMATOL, V44, P518, DOI 10.1111/j.1365-4632.2005.02204.x; DONTA ST, 1986, ARCH INTERN MED, V146, P902, DOI 10.1001/archinte.146.5.902; Dryden MS, 2011, J ANTIMICROB CHEMOTH, V66, pIV7, DOI 10.1093/jac/dkr072; Feddersen A, 1996, INFECTION, V24, P47, DOI 10.1007/BF01780651; Griffith DE, 2007, AM J RESP CRIT CARE, V175, P367, DOI 10.1164/rccm.200604-571ST; Holmes GF, 1999, J CLIN MICROBIOL, V37, P3059, DOI 10.1128/JCM.37.9.3059-3061.1999; Kent PT, 1985, GUIDE LEVEL 3 LAB; Lai CC, 2005, CLIN INFECT DIS, V40, P206, DOI 10.1086/426693; Lewis FMT, 2003, CLIN INFECT DIS, V37, P390, DOI 10.1086/376628; LJUNGBERG B, 1987, SCAND J INFECT DIS, V19, P539, DOI 10.3109/00365548709032420; Madan V, 2007, J EUR ACAD DERMATOL, V21, P572, DOI 10.1111/j.1468-3083.2006.01969.x; Osorio Filipa, 2010, Dermatol Online J, V16, P7; Pang HN, 2007, J INFECTION, V54, P584, DOI 10.1016/j.jinf.2006.11.014; PATEL S, 1995, J RHEUMATOL, V22, P1607; Rallis E, 2007, EXPERT OPIN PHARMACO, V8, P2965, DOI 10.1517/14656566.8.17.2965; Rodriguez JC, 2002, INT J ANTIMICROB AG, V20, P464, DOI 10.1016/S0924-8579(02)00239-X; RUNYON EH, 1981, REV INFECT DIS, V3, P819; Schwendiman Mark N, 2009, Dermatol Online J, V15, P11; Sivan M, 2008, JOINT BONE SPINE, V75, P600, DOI 10.1016/j.jbspin.2007.08.011; SWIFT S, 1962, NEW ENGL J MED, V267, P1244, DOI 10.1056/NEJM196212132672408; TELENTI A, 1993, J CLIN MICROBIOL, V31, P175, DOI 10.1128/JCM.31.2.175-178.1993; VINCENT V, 2003, MANUAL CLIN MICROBIO, P560; WALLACE RJ, 1986, J CLIN MICROBIOL, V24, P976, DOI 10.1128/JCM.24.6.976-981.1986; Wu Ting-Shu, 2002, Journal of Microbiology Immunology and Infection, V35, P42	30	30	30	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 20	2012	7	7							e41296	10.1371/journal.pone.0041296	http://dx.doi.org/10.1371/journal.pone.0041296			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	977GL	22911774	Green Published, Green Submitted			2022-12-25	WOS:000306644600068
J	Calao, M; Sekyere, EO; Cui, HJ; Cheung, BB; Thomas, WD; Keating, J; Chen, JB; Raif, A; Jankowski, K; Davies, NP; Bekkum, MV; Chen, B; Tan, O; Ellis, T; Norris, MD; Haber, M; Kim, ES; Shohet, JM; Trahair, TN; Liu, T; Wainwright, BJ; Ding, HF; Marshall, GM				Calao, M.; Sekyere, E. O.; Cui, H. J.; Cheung, B. B.; Thomas, W. D.; Keating, J.; Chen, J. B.; Raif, A.; Jankowski, K.; Davies, N. P.; Bekkum, M. V.; Chen, B.; Tan, O.; Ellis, T.; Norris, M. D.; Haber, M.; Kim, E. S.; Shohet, J. M.; Trahair, T. N.; Liu, T.; Wainwright, B. J.; Ding, H. F.; Marshall, G. M.			Direct effects of Bmi1 on p53 protein stability inactivates oncoprotein stress responses in embryonal cancer precursor cells at tumor initiation	ONCOGENE			English	Article						Bmi1; p53; MYCN; neuroblastoma; medulloblastoma; apoptosis	MYC TRANSGENIC MICE; STEM-CELLS; IN-VIVO; NEUROBLASTOMA; MEDULLOBLASTOMA; LINES; AMPLIFICATION; EXPRESSION; MECHANISM; APOPTOSIS	Embryonal cancer can arise from postnatally persistent embryonal remnant or rest cells, which are uniquely characterized by the absence of p53 mutations. Perinatal overexpression of the MycN oncoprotein in embryonal cancer precursor cells causes postnatal rests, and later tumor formation through unknown mechanisms. However, overexpression of Myc in adult tissues normally activates apoptosis and/or senescence signals as an organismal defense mechanism against cancer. Here, we show that perinatal neuroblastoma precursor cells exhibited a transiently diminished p53 response to MycN oncoprotein stress and resistance to trophic factor withdrawal, compared with their adult counterpart cells from the TH-MYCN-/- transgenic mouse model of neuroblastoma. The adult stem cell maintenance factor and Polycomb group protein, Bmi1 (B-cell-specific Moloney murine leukemia virus integration site), had a critical role at neuroblastoma initiation in the model, by repressing p53 responses in precursor cells. We further show in neuroblastoma tumor cells that Bmi1 could directly bind p53 in a complex with other Polycomb complex proteins, Ring1A or Ring1B, leading to increased p53 ubiquitination and degradation. Repressed p53 signal responses were also seen in precursor cells for other embryonal cancer types, medulloblastoma and acute lymphoblastic leukemia. Collectively, these date indicate a general mechanism for p53 inactivation in some embryonal cell types and consequent susceptibility to MycN oncogenesis at the point of embryonal tumor initiation.	[Calao, M.; Sekyere, E. O.; Cheung, B. B.; Thomas, W. D.; Keating, J.; Chen, J. B.; Raif, A.; Jankowski, K.; Davies, N. P.; Bekkum, M. V.; Chen, B.; Tan, O.; Norris, M. D.; Haber, M.; Trahair, T. N.; Liu, T.; Marshall, G. M.] Univ New S Wales, Lowy Canc Res Ctr, Childrens Canc Inst Australia Med Res, Sydney, NSW 2031, Australia; [Cui, H. J.] Southwest Univ, Inst Sericulture & Syst Biol, State Key Lab Silkworm Funct Genome Biol, Chongqing, Peoples R China; [Ellis, T.; Wainwright, B. J.] Univ Queensland, Inst Mol Biosci, Brisbane, Qld, Australia; [Kim, E. S.; Shohet, J. M.] Texas Childrens Hosp, Houston, TX 77030 USA; [Trahair, T. N.; Marshall, G. M.] Sydney Childrens Hosp, Sydney, NSW, Australia; [Ding, H. F.] Med Coll Georgia, Augusta, GA 30912 USA	Children's Cancer Institute; Children's Medical Research Institute - Australia; University of New South Wales Sydney; Southwest University - China; University of Queensland; Baylor College of Medicine; University of Sydney; University System of Georgia; Augusta University	Marshall, GM (corresponding author), Univ New S Wales, Lowy Canc Res Ctr, Childrens Canc Inst Australia Med Res, Sydney, NSW 2031, Australia.	g.marshall@ccia.unsw.edu.au	Chen, Jinbiao/J-5868-2013; Liu, Tao/A-3922-2015; Chen, Jinbiao/N-9905-2019	Chen, Jinbiao/0000-0003-0339-5880; Chen, Jinbiao/0000-0003-0339-5880; Cheung, Belamy/0000-0001-8784-860X; Ding, Han-Fei/0000-0001-5702-3439; Kim, Eugene/0000-0001-7959-5614; Liu, Tao/0000-0001-6244-7316; Haber, Michelle/0000-0003-2036-8817; Trahair, Toby/0000-0002-3295-228X; Tan, Owen/0000-0002-0303-7138; Wainwright, Brandon/0000-0003-0406-2092	National Health & Medical Research Council of Australia; Cancer Institute New South Wales; Cure for Life Foundation; Cancer Council New South Wales	National Health & Medical Research Council of Australia(National Health and Medical Research Council (NHMRC) of Australia); Cancer Institute New South Wales; Cure for Life Foundation; Cancer Council New South Wales(Cancer Council New South Wales)	We thank W Weiss for the TH-MYCN mice, and D Kaplan for the adenoviral vector MYCN constructs. This work was supported by the National Health & Medical Research Council of Australia, Cancer Institute New South Wales, Cure for Life Foundation and the Cancer Council New South Wales.	Alajez NM, 2009, CELL DEATH DIFFER, V16, P1469, DOI 10.1038/cdd.2009.85; Alchanati I, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0008104; BECKWITH JB, 1963, AM J PATHOL, V43, P1089; Brodeur GM, 2003, NAT REV CANCER, V3, P203, DOI 10.1038/nrc1014; Buchwald G, 2006, EMBO J, V25, P2465, DOI 10.1038/sj.emboj.7601144; Carr J, 2006, CANCER RES, V66, P2138, DOI 10.1158/0008-5472.CAN-05-2623; Chen LD, 2010, CANCER RES, V70, P1377, DOI 10.1158/0008-5472.CAN-09-2598; Chen ZW, 2009, NEOPLASIA, V11, P753, DOI 10.1593/neo.09466; Cheng AJ, 2007, EUR J CANCER, V43, P1467, DOI 10.1016/j.ejca.2007.03.008; Chesler L, 2008, NEOPLASIA, V10, P1268, DOI 10.1593/neo.08778; CICCARONE V, 1989, CANCER RES, V49, P219; Cohnheim J., 1889, LECT GEN PATHOLOGY; Cui HJ, 2007, AM J PATHOL, V170, P1370, DOI 10.2353/ajpath.2007.060754; Durante F., 1874, ARCH MEMOR OBSERV CH, V11, P217; Ellis T, 2003, GENESIS, V36, P158, DOI 10.1002/gene.10208; Fasano CA, 2007, CELL STEM CELL, V1, P87, DOI 10.1016/j.stem.2007.04.001; Gilbertson RJ, 2004, LANCET ONCOL, V5, P209, DOI 10.1016/S1470-2045(04)01424-X; Grossman SR, 2003, SCIENCE, V300, P342, DOI 10.1126/science.1080386; Gurova KV, 2005, P NATL ACAD SCI USA, V102, P17448, DOI 10.1073/pnas.0508888102; Hansford LM, 2004, P NATL ACAD SCI USA, V101, P12664, DOI 10.1073/pnas.0401083101; HAUPT Y, 1991, CELL, V65, P753, DOI 10.1016/0092-8674(91)90383-A; Hogarty MD, 2003, CANCER LETT, V197, P173, DOI 10.1016/S0304-3835(03)00103-4; Jasty R, 2001, NEOPLASIA, V3, P304, DOI 10.1038/sj.neo.7900171; Jiang LL, 2009, ACTA BIOCH BIOPH SIN, V41, P527, DOI 10.1093/abbs/gmp040; Johnsen J, 2009, APOPTOSIS, V14, P424, DOI 10.1007/s10495-009-0325-y; Kang MK, 2010, CELL CYCLE, V9, P2704, DOI 10.4161/cc.9.14.12322; Lai ZH, 2001, J BIOL CHEM, V276, P31357, DOI 10.1074/jbc.M011517200; Leung C, 2004, NATURE, V428, P337, DOI 10.1038/nature02385; Lossi L, 2003, PROG NEUROBIOL, V69, P287, DOI 10.1016/S0301-0082(03)00051-0; Momand J, 1998, NUCLEIC ACIDS RES, V26, P3453, DOI 10.1093/nar/26.15.3453; Ochiai H, 2010, ONCOGENE, V29, P2681, DOI 10.1038/onc.2010.22; Peirce SK, 2010, CELL HEALTH CYTOSKEL, V2, P49; ROLINK A, 1991, EMBO J, V10, P327, DOI 10.1002/j.1460-2075.1991.tb07953.x; ROSS RA, 1995, CELL GROWTH DIFFER, V6, P449; Scotting PJ, 2005, NAT REV CANCER, V5, P481, DOI 10.1038/nrc1633; Sherr CJ, 2006, NAT REV CANCER, V6, P663, DOI 10.1038/nrc1954; Taub JW, 2002, BLOOD, V99, P2992, DOI 10.1182/blood.V99.8.2992; Thomas WD, 2009, ONCOGENE, V28, P1605, DOI 10.1038/onc.2009.3; Thomas WD, 2004, INT J BIOCHEM CELL B, V36, P771, DOI 10.1016/S1357-2725(03)00254-1; VANDERLUGT NMT, 1994, GENE DEV, V8, P757, DOI 10.1101/gad.8.7.757; VANLOHUIZEN M, 1991, CELL, V65, P737, DOI 10.1016/0092-8674(91)90382-9; Wartiovaara K, 2002, J NEUROSCI, V22, P815, DOI 10.1523/JNEUROSCI.22-03-00815.2002; Weiss WA, 1997, EMBO J, V16, P2985, DOI 10.1093/emboj/16.11.2985; Wetmore C, 2001, CANCER RES, V61, P513; WHITLOCK CA, 1987, METHOD ENZYMOL, V150, P275; Woods WG, 1996, LANCET, V348, P1682, DOI 10.1016/S0140-6736(96)06020-5; Yang ZJ, 2008, CANCER CELL, V14, P135, DOI 10.1016/j.ccr.2008.07.003	47	46	46	0	16	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	AUG 1	2013	32	31					3616	3626		10.1038/onc.2012.368	http://dx.doi.org/10.1038/onc.2012.368			11	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	194MW	22907436	hybrid			2022-12-25	WOS:000322638400006
J	Du, W; Wang, S; Zhou, Q; Li, X; Chu, J; Chang, Z; Tao, Q; Ng, EKW; Fang, J; Sung, JJY; Yu, J				Du, W.; Wang, S.; Zhou, Q.; Li, X.; Chu, J.; Chang, Z.; Tao, Q.; Ng, E. K. W.; Fang, J.; Sung, J. J. Y.; Yu, J.			ADAMTS9 is a functional tumor suppressor through inhibiting AKT/mTOR pathway and associated with poor survival in gastric cancer	ONCOGENE			English	Article						ADAMTS9; tumor suppressor; AKT/mTOR pathway; gastric cancer; prognosis	NASOPHARYNGEAL CARCINOMA; GENE; MTOR; METHYLATION; EXPRESSION; ESOPHAGEAL; APOPTOSIS; THERAPY; CELLS; AKT	Using genome-wide promoter methylation analysis, we identified a disintegrin-like and metalloprotease with thrombospondin type 1 motif 9 (ADAMTS9) is methylated in cancer. We aim to clarify its epigenetic inactivation, biological function and clinical implication in gastric cancer. ADAMTS9 was silenced in 6 out of 8 gastric cancer cell lines. The loss of ADAMTS9 expression was regulated by promoter hypermethylation and could be restored by demethylation agent. Ectopic expression of ADAMTS9 in gastric cancer cell lines (AGS, BGC823) inhibited cell growth curve in both the cell lines (P<0.0001), suppressed colony formation (P<0.01) and induced apoptosis (P<0.001 in AGS, P<0.01 in BGC823). Moreover, conditioned culture medium from ADAMTS9-transfected cell lines significantly disrupted the human umbilical vein endothelial cell tube formation capacity on Matrigel (P<0.01 in AGS, P<0.001 in BGC823). The in vivo growth of ADAMTS9 cells in nude mice was also markedly diminished after stable expression of ADAMTS9 (P<0.001). On the other hand, ADAMTS9 knockdown promoted cell proliferation (P<0.001). We further revealed that ADAMTS9 inhibited tumor growth by blocking activation of Akt and its downstream target the mammalian target of rapamycin (mTOR). ADAMTS9 also reduced phosphorylation of mTOR downstream targets p70 ribosomal S6 kinase, eIF4E-binding protein and downregulated hypoxia-inducible factor-1 alpha. Therefore, this is the first demonstration that ADAMTS9 is a critical tumor suppressor of gastric cancer progression at least in part through suppression of oncogenic AKT/mTOR signaling. Moreover, promoter methylation of ADAMTS9 was detected in 29.2% (21/72) of primary gastric tumors. Multivariate analysis showed that patients with ADAMTS9 methylation had a poorer overall survival (relative risk (RR) = 2.788; 95% confidence interval, 1.474-5.274; P = 0.002). Kaplan-Meier survival curves showed that ADAMTS9 methylation was significantly associated with shortened survival in gastric cancer patients (P = 0.001, log-rank test). In conclusion, ADAMTS9 acts as a functional tumor suppressor in gastric cancer through inhibiting oncogenic AKT/mTOR signaling pathway. Methylation of ADAMTS9 is an independent prognostic factor of gastric cancer.	[Du, W.; Wang, S.; Li, X.; Sung, J. J. Y.; Yu, J.] Chinese Univ Hong Kong, Prince Wales Hosp, Inst Digest Dis, Shatin, Hong Kong, Peoples R China; [Du, W.; Wang, S.; Li, X.; Sung, J. J. Y.; Yu, J.] Chinese Univ Hong Kong, Prince Wales Hosp, Dept Med & Therapeut, Li Ka Shing Inst Hlth Sci, Shatin, Hong Kong, Peoples R China; [Du, W.; Fang, J.] Shanghai Jiao Tong Univ, Div Gastroenterol, Sch Med,Minist Hlth,State Key Lab Oncogene & Rela, Renji Hosp,Shanghai Inst Digest Disease,Key Lab G, Shanghai 200030, Peoples R China; [Zhou, Q.; Tao, Q.] Chinese Univ Hong Kong, Dept Clin Oncol, Shatin, Hong Kong, Peoples R China; [Chu, J.] Hong Kong Baptist Univ, Sch Chinese Med, Ctr Canc & Inflammat Res, Kowloon, Hong Kong, Peoples R China; [Chang, Z.] Tsinghua Univ, Sch Med, Dept Biol Sci & Biotechnol, State Key Lab Biomembrane & Membrane Biotechnol, Beijing 100084, Peoples R China; [Ng, E. K. W.] Chinese Univ Hong Kong, Dept Surg, Shatin, Hong Kong, Peoples R China	Chinese University of Hong Kong; Prince of Wales Hospital; Chinese University of Hong Kong; Prince of Wales Hospital; Shanghai Jiao Tong University; Chinese University of Hong Kong; Hong Kong Baptist University; Tsinghua University; Chinese University of Hong Kong	Yu, J (corresponding author), Chinese Univ Hong Kong, Prince Wales Hosp, Inst Digest Dis, Shatin, Hong Kong, Peoples R China.	jingyuanfang@yahoo.com; junyu@cuhk.edu.hk	Ng, Enders K.O./F-2787-2010; Li, Xiao-xing/B-9114-2008; Tao, Qian/T-4743-2018; Ng, Enders/T-3881-2019; Sung, Joseph J. Y./R-3203-2018; Yu, Jun/D-8569-2015; Ng, Enders Kwok Wai/E-8276-2016; Chang, Zhijie/AAH-8109-2019	Ng, Enders K.O./0000-0002-6955-0030; Li, Xiao-xing/0000-0001-8791-7505; Tao, Qian/0000-0001-5383-4808; Ng, Enders/0000-0002-6955-0030; Sung, Joseph J. Y./0000-0003-3125-5199; Yu, Jun/0000-0001-5008-2153; Ng, Enders Kai-on/0000-0002-5293-3529	National Basic Research Program of China (973 Program) [2010CB529305]; Shenzhen Basic Research Program [JC20110520111A]; Research Grants Council RGC CERG CUHK [473008]; Group Research Scheme CUHK [3110043]; CUHK Focused Investment Gant [1903026]; RFCID [10090942, 11100022]	National Basic Research Program of China (973 Program)(National Basic Research Program of China); Shenzhen Basic Research Program; Research Grants Council RGC CERG CUHK; Group Research Scheme CUHK; CUHK Focused Investment Gant; RFCID	This project was supported by National Basic Research Program of China (973 Program, 2010CB529305); Shenzhen Basic Research Program (JC20110520111A); Research Grants Council RGC CERG CUHK (473008); Group Research Scheme CUHK (3110043); CUHK Focused Investment Gant (1903026), and RFCID (10090942, 11100022).	Adams JM, 2007, ONCOGENE, V26, P1324, DOI 10.1038/sj.onc.1210220; Asnaghi L, 2004, ONCOGENE, V23, P5781, DOI 10.1038/sj.onc.1207698; Averous J, 2008, ONCOGENE, V27, P1106, DOI 10.1038/sj.onc.1210715; Cheung KF, 2012, CANCER-AM CANCER SOC, V118, P947, DOI 10.1002/cncr.26189; Cicenas J, 2011, J CANCER RES CLIN, V137, P1409, DOI 10.1007/s00432-011-1039-4; Clark ME, 2000, GENOMICS, V67, P343, DOI 10.1006/geno.2000.6246; Fingar DC, 2004, MOL CELL BIOL, V24, P200, DOI 10.1128/MCB.24.1.200-216.2004; Jin ZY, 2005, CANCER BIOL THER, V4, P139, DOI 10.4161/cbt.4.2.1508; Jungers KA, 2005, GENE EXPR PATTERNS, V5, P609, DOI 10.1016/j.modgep.2005.03.004; Kern CB, 2010, MATRIX BIOL, V29, P304, DOI 10.1016/j.matbio.2010.01.005; Koo BH, 2006, J BIOL CHEM, V281, P12485, DOI 10.1074/jbc.M511083200; Koo BH, 2010, AM J PATHOL, V176, P1494, DOI 10.2353/ajpath.2010.090655; Laughner E, 2001, MOL CELL BIOL, V21, P3995, DOI 10.1128/MCB.21.12.3995-4004.2001; Leung WK, 2006, CLIN CANCER RES, V12, P3216, DOI 10.1158/1078-0432.CCR-05-2442; Liu WL, 2011, HEPATOLOGY, V53, P843, DOI 10.1002/hep.24124; Liu YJ, 2006, ONCOGENE, V25, P2452, DOI 10.1038/sj.onc.1209287; Lo PHY, 2007, ONCOGENE, V26, P148, DOI 10.1038/sj.onc.1209767; Lo PHY, 2010, CANCER RES, V70, P5567, DOI 10.1158/0008-5472.CAN-09-4510; Lung HL, 2008, INT J CANCER, V123, P401, DOI 10.1002/ijc.23528; Luo J, 2003, CANCER CELL, V4, P257, DOI 10.1016/S1535-6108(03)00248-4; Ma XJM, 2009, NAT REV MOL CELL BIO, V10, P307, DOI 10.1038/nrm2672; Majumder PK, 2004, NAT MED, V10, P594, DOI 10.1038/nm1052; Musgrove EA, 2011, NAT REV CANCER, V11, P558, DOI 10.1038/nrc3090; Sepulveda AR, 2010, GASTROENTEROLOGY, V138, P1836, DOI 10.1053/j.gastro.2009.12.042; Somerville RPT, 2003, J BIOL CHEM, V278, P9503, DOI 10.1074/jbc.M211009200; Tee AR, 2003, CURR BIOL, V13, P1259, DOI 10.1016/S0960-9822(03)00506-2; Troiano L, 2007, NAT PROTOC, V2, P2719, DOI 10.1038/nprot.2007.405; Vivanco I, 2002, NAT REV CANCER, V2, P489, DOI 10.1038/nrc839; Yecies JL, 2011, J MOL MED, V89, P221, DOI 10.1007/s00109-011-0726-6; Ying JM, 2005, CLIN CANCER RES, V11, P6442, DOI 10.1158/1078-0432.CCR-05-0267; Yu J, 2009, CANCER-AM CANCER SOC, V115, P49, DOI 10.1002/cncr.23989; Yu J, 2009, GASTROENTEROLOGY, V136, P640, DOI 10.1053/j.gastro.2008.10.050; Zoncu R, 2011, NAT REV MOL CELL BIO, V12, P21, DOI 10.1038/nrm3025	33	83	90	0	33	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232			ONCOGENE	Oncogene	JUL 11	2013	32	28					3319	3328		10.1038/onc.2012.359	http://dx.doi.org/10.1038/onc.2012.359			10	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	180TM	22907434				2022-12-25	WOS:000321620200002
J	Yang, WW; Lu, Y; Xu, YC; Xu, LZ; Zheng, W; Wu, YY; Li, L; Shen, PP				Yang, Weiwei; Lu, Yan; Xu, Yichen; Xu, Lizhi; Zheng, Wei; Wu, Yuanyuan; Li, Long; Shen, Pingping			Estrogen Represses Hepatocellular Carcinoma (HCC) Growth via Inhibiting Alternative Activation of Tumor-associated Macrophages (TAMs)	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							RECEPTOR-BETA; LIVER-CANCER; MAMMARY-TUMORS; PROGRESSION; GENE; METASTASIS; MICE; HEPATOCARCINOGENESIS; EXPRESSION; INVASION	Hepatocarcinoma cancer (HCC), one of the most malignant cancers, occurs significantly more often in men than in women; however, little is known about its underlying molecular mechanisms. Here we identified that 17 beta-estradiol (E2) could suppress tumor growth via regulating the polarization of macrophages. We showed that E2 re-administration reduced tumor growth in orthotopic and ectopic mice HCC models. E2 functioned as a suppressor for macrophage alternative activation and tumor progression by keeping estrogen receptor beta (ER beta) away from interacting with ATP5J (also known as ATPase-coupling factor 6), a part of ATPase, thus inhibiting the JAK1-STAT6 signaling pathway. These studies introduce a novel mechanism for suppressing male-predominant HCC.	[Yang, Weiwei; Lu, Yan; Xu, Yichen; Zheng, Wei; Wu, Yuanyuan; Li, Long; Shen, Pingping] Nanjing Univ, State Key Lab Pharmaceut Biotechnol, Nanjing 210093, Jiangsu, Peoples R China; [Yang, Weiwei; Lu, Yan; Xu, Yichen; Zheng, Wei; Wu, Yuanyuan; Li, Long; Shen, Pingping] Nanjing Univ, Model Anim Res Ctr, Nanjing 210093, Jiangsu, Peoples R China; [Xu, Lizhi] Nanjing Univ, Sch Med, Jiangsu Key Lab Mol Med, Nanjing 210093, Jiangsu, Peoples R China	Nanjing University; Nanjing University; Nanjing University	Shen, PP (corresponding author), Nanjing Univ, State Key Lab Pharmaceut Biotechnol, Nanjing 210093, Jiangsu, Peoples R China.	ppshen@nju.edu.cn			National Natural Science Foundation of China [31070764, 91013015, 81121062]; National Key Basic Research Program of China [2010CB912203]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); National Key Basic Research Program of China(National Basic Research Program of China)	This work was supported by National Natural Science Foundation of China Projects 31070764, 91013015, and 81121062 and National Key Basic Research Program of China Project 2010CB912203.	Albini A, 2010, Q J NUCL MED MOL IM, V54, P244; Bao XF, 2007, J MOL MED, V85, P85, DOI 10.1007/s00109-006-0113-x; Barajas M, 2001, HEPATOLOGY, V33, P52, DOI 10.1053/jhep.2001.20796; Bingle L, 2002, J PATHOL, V196, P254, DOI 10.1002/path.1027; Biswas SK, 2006, BLOOD, V107, P2112, DOI 10.1182/blood-2005-01-0428; Bosch FX, 2004, GASTROENTEROLOGY, V127, pS5, DOI 10.1053/j.gastro.2004.09.011; Condeelis J, 2006, CELL, V124, P263, DOI 10.1016/j.cell.2006.01.007; de Visser KE, 2006, NAT REV CANCER, V6, P24, DOI 10.1038/nrc1782; DeNardo DG, 2009, CANCER CELL, V16, P91, DOI 10.1016/j.ccr.2009.06.018; Dickensheets H, 2007, GENES IMMUN, V8, P21, DOI 10.1038/sj.gene.6364352; Ding T, 2009, HUM PATHOL, V40, P381, DOI 10.1016/j.humpath.2008.08.011; El-Serag HB, 2001, HEPATOLOGY, V33, P62, DOI 10.1053/jhep.2001.21041; Gallo C, 1998, LANCET, V352, P17; Ghebranious N, 1998, HEPATOLOGY, V27, P383, DOI 10.1002/hep.510270211; Gocheva V, 2010, GENE DEV, V24, P241, DOI 10.1101/gad.1874010; Goswami S, 2005, CANCER RES, V65, P5278, DOI 10.1158/0008-5472.CAN-04-1853; Hoenerhoff MJ, 2011, TOXICOL PATHOL, V39, P678, DOI 10.1177/0192623311407213; Lin EY, 2001, J EXP MED, V193, P727, DOI 10.1084/jem.193.6.727; Lin EY, 2002, J MAMMARY GLAND BIOL, V7, P147, DOI 10.1023/A:1020399802795; Liu CL, 2000, AM J GASTROENTEROL, V95, P218; Lu XQ, 2008, BLOOD, V112, P4098, DOI 10.1182/blood-2008-03-148726; Lu YS, 2007, HEPATOLOGY, V46, P1119, DOI 10.1002/hep.21804; Maeda S, 2005, CELL, V121, P977, DOI 10.1016/j.cell.2005.04.014; Mantovani A, 2002, TRENDS IMMUNOL, V23, P549, DOI 10.1016/S1471-4906(02)02302-5; MANTOVANI A, 2006, DRUG DISCOV TODAY TH, V3, P361, DOI DOI 10.1016/J.DDSTR.2006.07.001; Mantovani A, 2010, CURR OPIN IMMUNOL, V22, P231, DOI 10.1016/j.coi.2010.01.009; Myers MP, 2001, J BIOL CHEM, V276, P47771, DOI 10.1074/jbc.C100583200; Nakatani T, 2001, JPN J CANCER RES, V92, P249, DOI 10.1111/j.1349-7006.2001.tb01089.x; Naugler WE, 2007, SCIENCE, V317, P121, DOI 10.1126/science.1140485; Ohmori Y, 1998, J BIOL CHEM, V273, P29202, DOI 10.1074/jbc.273.44.29202; Ojalvo LS, 2009, AM J PATHOL, V174, P1048, DOI 10.2353/ajpath.2009.080676; Okuno D, 2011, J BIOCHEM, V149, P655, DOI 10.1093/jb/mvr049; Pettersson K, 2001, ANNU REV PHYSIOL, V63, P165, DOI 10.1146/annurev.physiol.63.1.165; Pollard JW, 2009, NAT REV IMMUNOL, V9, P259, DOI 10.1038/nri2528; Pollard JW, 2004, NAT REV CANCER, V4, P71, DOI 10.1038/nrc1256; Pucci F, 2009, BLOOD, V114, P901, DOI 10.1182/blood-2009-01-200931; Qian BZ, 2010, CELL, V141, P39, DOI 10.1016/j.cell.2010.03.014; Rogers AB, 2007, CANCER RES, V67, P11536, DOI 10.1158/0008-5472.CAN-07-1479; Rolny C, 2011, CANCER CELL, V19, P31, DOI 10.1016/j.ccr.2010.11.009; Thomas MB, 2010, J CLIN ONCOL, V28, P3994, DOI 10.1200/JCO.2010.28.7805; Vivar OI, 2010, J BIOL CHEM, V285, P22059, DOI 10.1074/jbc.M110.114116; Xu HW, 2012, J PATHOL, V228, P216, DOI 10.1002/path.4009; Yang SH, 2009, J BIOL CHEM, V284, P9540, DOI 10.1074/jbc.M808246200; Yao XM, 2003, CLIN CANCER RES, V9, P2719; Zeisberger SM, 2006, BRIT J CANCER, V95, P272, DOI 10.1038/sj.bjc.6603240	45	83	88	0	30	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 23	2012	287	48					40140	40149		10.1074/jbc.M112.348763	http://dx.doi.org/10.1074/jbc.M112.348763			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	042CM	22908233	Green Published, hybrid			2022-12-25	WOS:000311448800005
J	Chatterjee, N; Banerjee, T; Datta, S				Chatterjee, Nilanjana; Banerjee, Tanmay; Datta, Santanu			Accurate Estimation of Nucleic Acids by Amplification Efficiency Dependent PCR	PLOS ONE			English	Article							REAL-TIME PCR; ISOCITRATE DEHYDROGENASE; BRANCH POINT; ACETATE METABOLISM; MATHEMATICAL-MODEL; QUANTITATIVE PCR; RT-PCR; PHOSPHORYLATION; QUANTIFICATION; EXPRESSION	Accurate estimation of template - DNA or RNA by real time PCR is dependent on the amplification efficiency (F) of the reaction. The analytical equation describing the kinetics of PCR that is influenced by template re-annealing is formulated. It predicts the gradual reduction of F - from its initial value of 2, leading to template saturation. From an experimental standpoint, due to the exponential nature of the reaction a minute change in F can lead to a large error in the estimation of the initial template concentration. On the basis of individual variation in the amplification efficiency we have formulated a simple mathematical model and an MS Excel based data analysis software that allows accurate and automated quantification of initial template concentration. This method which does not require any normalisation with housekeeping genes was validated by transcript profiling of the genes in the TCA/glyoxylate cycle of E. coli. Consistent with published reports, we observed a precise and specific induction of the glyoxylate shunt genes when the bacteria was shifted from a six carbon glucose media to a two carbon source like acetate.	[Chatterjee, Nilanjana; Banerjee, Tanmay; Datta, Santanu] AstraZeneca India Private Ltd, Mol Biol Sect, Bangalore, Karnataka, India	AstraZeneca	Chatterjee, N (corresponding author), So Illinois Univ, Sch Med, Dept Biochem & Mol Biol, Carbondale, IL 62901 USA.	santanu.datta@gmail.com						Batsch A, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-95; Bernstein JA, 2002, P NATL ACAD SCI USA, V99, P9697, DOI 10.1073/pnas.112318199; Boggy GJ, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012355; Bustin SA, 2000, J MOL ENDOCRINOL, V25, P169, DOI 10.1677/jme.0.0250169; COBB BD, 1994, NUCLEIC ACIDS RES, V22, P3801, DOI 10.1093/nar/22.18.3801; Cozzone AJ, 1998, ANNU REV MICROBIOL, V52, P127, DOI 10.1146/annurev.micro.52.1.127; Foster Russell G, 2007, Methods Mol Biol, V362, P3; Freeman WM, 1999, BIOTECHNIQUES, V26, P112, DOI 10.2144/99261rv01; Gevertz JL, 2005, BIOTECHNOL BIOENG, V92, P346, DOI 10.1002/bit.20617; Giulietti A, 2001, METHODS, V25, P386, DOI 10.1006/meth.2001.1261; Goss PJE, 1998, P NATL ACAD SCI USA, V95, P6750, DOI 10.1073/pnas.95.12.6750; Guescini M, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-326; Heid CA, 1996, GENOME RES, V6, P986, DOI 10.1101/gr.6.10.986; HIGUCHI R, 1993, BIO-TECHNOL, V11, P1026, DOI 10.1038/nbt0993-1026; Holms H, 1996, FEMS MICROBIOL REV, V19, P85, DOI 10.1111/j.1574-6976.1996.tb00255.x; Kainz P, 2000, BBA-GENE STRUCT EXPR, V1494, P23, DOI 10.1016/S0167-4781(00)00200-1; LAKSHMI TM, 1978, CAN J MICROBIOL, V24, P149, DOI 10.1139/m78-027; Lalam N, 2004, ADV APPL PROBAB, V36, P602, DOI 10.1239/aap/1086957587; LAPORTE DC, 1984, J BIOL CHEM, V259, P4068; LAPORTE DC, 1985, J BIOL CHEM, V260, P563; Lievens A, 2012, NUCLEIC ACIDS RES, V40, DOI 10.1093/nar/gkr775; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; LOWRY OH, 1971, J BIOL CHEM, V246, P6511; Mhlanga MM, 2001, METHODS, V25, P463, DOI 10.1006/meth.2001.1269; Niesters HGM, 2001, METHODS, V25, P419, DOI 10.1006/meth.2001.1264; Oh MK, 2002, J BIOL CHEM, V277, P13175, DOI 10.1074/jbc.M110809200; Pfaffl MW, 2001, NUCLEIC ACIDS RES, V29, DOI 10.1093/nar/29.9.e45; Platts AE, 2008, ANAL BIOCHEM, V380, P315, DOI 10.1016/j.ab.2008.05.048; Ramakers C, 2003, NEUROSCI LETT, V339, P62, DOI 10.1016/S0304-3940(02)01423-4; Rutledge RG, 2004, NUCLEIC ACIDS RES, V32, DOI 10.1093/nar/gnh177; Sevall JS, 2001, METHODS, V25, P452, DOI 10.1006/meth.2001.1267; Spiess AN, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-221; STUELAND CS, 1988, J BIOL CHEM, V263, P19475; Swillens S, 2008, ANAL BIOCHEM, V373, P370, DOI 10.1016/j.ab.2007.10.019; Thellin O, 1999, J BIOTECHNOL, V75, P291, DOI 10.1016/S0168-1656(99)00163-7; Tichopad A, 2003, NUCLEIC ACIDS RES, V31, DOI 10.1093/nar/gng122; WALSH K, 1984, J BIOL CHEM, V259, P9646; WALSH K, 1985, J BIOL CHEM, V260, P8430; WETMUR JG, 1968, J MOL BIOL, V31, P349, DOI 10.1016/0022-2836(68)90414-2; Yin JL, 2001, IMMUNOL CELL BIOL, V79, P213, DOI 10.1046/j.1440-1711.2001.01002.x; Yuan JS, 2007, BMC BIOINFORMATICS, V8, DOI 10.1186/1471-2105-8-S7-S6; Yuan Joshua S., 2008, Biotechnology Journal, V3, P112, DOI 10.1002/biot.200700169; Zhao S, 2005, J COMPUT BIOL, V12, P1047, DOI 10.1089/cmb.2005.12.1047	43	6	6	1	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 17	2012	7	8							e42063	10.1371/journal.pone.0042063	http://dx.doi.org/10.1371/journal.pone.0042063			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	996DG	22912684	Green Published, gold, Green Submitted			2022-12-25	WOS:000308063700010
J	Tagliamonte, M; Marasco, D; Ruggiero, A; De Stradis, A; Tornesello, ML; Totrov, M; Buonaguro, FM; Buonaguro, L				Tagliamonte, Maria; Marasco, Daniela; Ruggiero, Alessia; De Stradis, Angelo; Tornesello, Maria Lina; Totrov, Maxim; Buonaguro, Franco Maria; Buonaguro, Luigi			HIV p24 as Scaffold for Presenting Conformational HIV Env Antigens	PLOS ONE			English	Article							VIRUS-LIKE PARTICLES; HUMAN MONOCLONAL-ANTIBODY; NEUTRALIZING ACTIVITY; ASSEMBLY PROPERTIES; DENDRITIC CELLS; V3 LOOP; EPITOPE; PROTEINS; DESIGN; ENVELOPE	Heterologous protein scaffolds engrafted with structurally defined HIV Env epitopes recognized by broadly neutralizing monoclonal antibodies (MAbs) represent a promising strategy to elicit broad neutralizing antibodies. In such regards, a protein scaffold based on the HIV p24 CA protein is a highly attractive approach, providing also Gag epitopes for eliciting HIV non-neutralizing protective antibodies and specific CD4(+) and CD8(+) T cell responses. In the present study, computational techniques were employed to verify the presence of acceptor sites for conformational HIV Env epitopes and, as proof of concept, the analysis of HIV p24 CA-based scaffolds using a complete V3 loop in a MAb-bound conformation is presented. The V3-p24 epitope-scaffold proteins show the formation of capsomers made of hexamers similarly to the p24 wild type protein. Moreover, the conformational V3 loop presented on p24 scaffold is recognized by a panel of anti-V3 MAbs. The results suggest that HIV p24 CA protein has suitable acceptor sites for engrafting foreign epitopes, without disrupting the formation of capsomer hexamer structures, and that the V3 epitope does retain its antibody-bound conformation. This strongly support the feasibility of developing a scaffolding strategy based on p24 CA proteins displaying conformational minimal structural, antigenic HIV Env epitopes.	[Tagliamonte, Maria; Tornesello, Maria Lina; Buonaguro, Franco Maria; Buonaguro, Luigi] Ist Nazl Tumori Fond G Pascale, AIDS Reference Ctr, Lab Mol Biol & Viral Oncogenesis, Naples, Italy; [Marasco, Daniela] Univ Naples Federico II, Sch Biotechnol Sci, Dept Biol Sci, Naples, Italy; [Marasco, Daniela; Ruggiero, Alessia] Natl Resource Council, Inst Biostruct & Bioimaging, Naples, Italy; [De Stradis, Angelo] Natl Resource Council, Inst Plant Virol, Bari, Italy; [Totrov, Maxim] Molsoft LLC, La Jolla, CA USA	IRCCS Fondazione Pascale; University of Naples Federico II; Consiglio Nazionale delle Ricerche (CNR); Istituto di Biostrutture e Bioimmagini (IBB-CNR)	Tagliamonte, M (corresponding author), Ist Nazl Tumori Fond G Pascale, AIDS Reference Ctr, Lab Mol Biol & Viral Oncogenesis, Naples, Italy.	irccsvir@unina.it	DE STRADIS, ANGELO/B-2969-2013; Maria, Buonaguro Franco/AAF-4888-2019; Tagliamonte, Maria/I-2423-2016; Ruggiero, Alessia/GRJ-9538-2022; Marasco, Daniela/H-4848-2015; Buonaguro, Luigi/AAV-5655-2020; Buonaguro, Franco M./T-6028-2019; Tornesello, Maria Lina/A-1964-2008	DE STRADIS, ANGELO/0000-0003-1624-2365; Ruggiero, Alessia/0000-0002-3508-385X; Marasco, Daniela/0000-0002-6618-2949; Buonaguro, Franco M./0000-0002-7491-7220; Tornesello, Maria Lina/0000-0002-3523-3264; Buonaguro, Luigi/0000-0002-6380-7114; totrov, maxim/0000-0001-8594-274X; Tagliamonte, Maria/0000-0002-7167-4817	European Community [201433]; NGIN Programme	European Community(European Commission); NGIN Programme	The study was supported by the European Community's Seventh Framework Programme "Next Generation HIV-1 Immunogens inducing broadly reactive Neutralising antibodies - NGIN" (FP7/2007-2013) under grant agreement no 201433. Dr. Tagliamonte is funded by the NGIN Programme. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ABAGYAN R, 1994, J COMPUT CHEM, V15, P488, DOI 10.1002/jcc.540150503; Bachmann MF, 1995, EUR J IMMUNOL, V25, P3445, DOI 10.1002/eji.1830251236; Bachmann MF, 1996, EUR J IMMUNOL, V26, P2595, DOI 10.1002/eji.1830261109; Bell CH, 2008, J MOL BIOL, V375, P969, DOI 10.1016/j.jmb.2007.11.013; Boutwell CL, 2010, J INFECT DIS, V202, pS309, DOI 10.1086/655653; Brunel FM, 2006, J VIROL, V80, P1680, DOI 10.1128/JVI.80.4.1680-1687.2006; Buonaguro L, 2001, ANTIVIR RES, V49, P35, DOI 10.1016/S0166-3542(00)00136-4; Buonaguro L, 2011, CLIN VACCINE IMMUNOL, V18, P2003, DOI 10.1128/CVI.05326-11; Buonaguro L, 2010, CURR HIV RES, V8, P299, DOI 10.2174/157016210791208659; BURTON DR, 1994, SCIENCE, V266, P1024, DOI 10.1126/science.7973652; Cardoso RMF, 2005, IMMUNITY, V22, P163, DOI 10.1016/j.immuni.2004.12.011; Chakraborty K, 2006, BIOCHEM J, V399, P483, DOI 10.1042/BJ20060588; CHENGMAYER C, 1988, P NATL ACAD SCI USA, V85, P2815, DOI 10.1073/pnas.85.8.2815; Corti D, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0008805; Crooks ET, 2007, VIROLOGY, V366, P245, DOI 10.1016/j.virol.2007.04.033; Dhillon AK, 2007, J VIROL, V81, P6548, DOI 10.1128/JVI.02749-06; Doria-Rose NA, 2010, J VIROL, V84, P1631, DOI 10.1128/JVI.01482-09; EHRLICH LS, 1992, J VIROL, V66, P4874, DOI 10.1128/JVI.66.8.4874-4883.1992; Ganser-Pornillos BK, 2008, CURR OPIN STRUC BIOL, V18, P203, DOI 10.1016/j.sbi.2008.02.001; Ganser-Pornillos BK, 2004, J VIROL, V78, P2545, DOI 10.1128/JVI.78.5.2545-2552.2004; Gorny MK, 2006, J VIROL, V80, P6865, DOI 10.1128/JVI.02202-05; GORNY MK, 1992, J VIROL, V66, P7538, DOI 10.1128/JVI.66.12.7538-7542.1992; Gross I, 1997, EUR J BIOCHEM, V249, P592, DOI 10.1111/j.1432-1033.1997.t01-1-00592.x; Guenaga J, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016074; Hinton HJ, 2008, CURR TOP MICROBIOL, V319, P1; Huang CC, 2005, SCIENCE, V310, P1025, DOI 10.1126/science.1118398; JOHNSSON B, 1991, ANAL BIOCHEM, V198, P268, DOI 10.1016/0003-2697(91)90424-R; Martelli G.P., 1984, METHOD VIROL, V8, P143, DOI DOI 10.1016/B978-0-12-470208-0.50011-6; MUSTER T, 1993, J VIROL, V67, P6642, DOI 10.1128/JVI.67.11.6642-6647.1993; Nardin EH, 2004, INFECT IMMUN, V72, P6519, DOI 10.1128/IAI.72.11.6519-6527.2004; Netter HJ, 2001, J VIROL, V75, P2130, DOI 10.1128/JVI.75.5.2130-2141.2001; Ofek G, 2004, J VIROL, V78, P10724, DOI 10.1128/JVI.78.19.10724-10737.2004; Ofek G, 2010, P NATL ACAD SCI USA, V107, P17880, DOI 10.1073/pnas.1004728107; Pantophlet R, 2008, VIROLOGY, V381, P251, DOI 10.1016/j.virol.2008.08.032; Pornillos O, 2009, CELL, V137, P1282, DOI 10.1016/j.cell.2009.04.063; Ross AL, 2010, LANCET INFECT DIS, V10, P305, DOI 10.1016/S1473-3099(10)70069-4; Ruedl C, 2002, EUR J IMMUNOL, V32, P818, DOI 10.1002/1521-4141(200203)32:3<818::AID-IMMU818>3.0.CO;2-U; Sather DN, 2010, VACCINE, V28, pB8, DOI 10.1016/j.vaccine.2009.07.085; Schellenbacher C, 2009, J VIROL, V83, P10085, DOI 10.1128/JVI.01088-09; Stanfield RL, 2004, STRUCTURE, V12, P193, DOI 10.1016/j.str.2004.01.003; Stiegler G, 2001, AIDS RES HUM RETROV, V17, P1757, DOI 10.1089/08892220152741450; Totrov M, 2010, VIROLOGY, V405, P513, DOI 10.1016/j.virol.2010.06.027; Trkola A, 1996, J VIROL, V70, P1100, DOI 10.1128/JVI.70.2.1100-1108.1996; Vietheer PT, 2007, ANTIVIR THER, V12, P477; von Schwedler UK, 1998, EMBO J, V17, P1555, DOI 10.1093/emboj/17.6.1555; Vos Q, 2000, IMMUNOL REV, V176, P154; Walker LM, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1001028; Walker LM, 2009, SCIENCE, V326, P285, DOI 10.1126/science.1178746; Wang BZ, 2007, J VIROL, V81, P10869, DOI 10.1128/JVI.00542-07; Wu XL, 2010, SCIENCE, V329, P856, DOI 10.1126/science.1187659; Zhou TQ, 2007, NATURE, V445, P732, DOI 10.1038/nature05580; Zinkernagel RM, 2001, ADV IMMUNOL, V79, P1, DOI 10.1016/S0065-2776(01)79001-3	52	5	5	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 17	2012	7	8							e43318	10.1371/journal.pone.0043318	http://dx.doi.org/10.1371/journal.pone.0043318			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	996DG	22912852	Green Published, gold, Green Submitted			2022-12-25	WOS:000308063700080
J	Thun, GA; Ferrarotti, I; Imboden, M; Rochat, T; Gerbase, M; Kronenberg, F; Bridevaux, PO; Zemp, E; Zorzetto, M; Ottaviani, S; Russi, EW; Luisetti, M; Probst-Hensch, NM				Thun, Gian-Andri; Ferrarotti, Ilaria; Imboden, Medea; Rochat, Thierry; Gerbase, Margaret; Kronenberg, Florian; Bridevaux, Pierre-Olivier; Zemp, Elisabeth; Zorzetto, Michele; Ottaviani, Stefania; Russi, Erich W.; Luisetti, Maurizio; Probst-Hensch, Nicole M.			SERPINA1 PiZ and PiS Heterozygotes and Lung Function Decline in the SAPALDIA Cohort	PLOS ONE			English	Article							OBSTRUCTIVE PULMONARY-DISEASE; GENOME-WIDE ASSOCIATION; SYSTEMIC INFLAMMATION; ALPHA(1)-ANTITRYPSIN DEFICIENCY; GENERAL-POPULATION; FOLLOW-UP; ALPHA-1-ANTITRYPSIN DEFICIENCY; MZ HETEROZYGOTES; AIR-POLLUTION; BODY-WEIGHT	Background: Severe alpha1-antitrypsin (AAT) deficiency is a strong risk factor for COPD. But the impact of gene variants resulting in mild or intermediate AAT deficiency on the longitudinal course of respiratory health remains controversial. There is indication from experimental studies that pro-inflammatory agents like cigarette smoke can interact with these variants and thus increase the risk of adverse respiratory health effects. Therefore, we tested the effect of the presence of a protease inhibitor (Pi) S or Z allele (PiMS and PiMZ) on the change in lung function in different inflammation-exposed subgroups of a large, population-based cohort study. Methodology and Principal Findings: The SAPALDIA population includes over 4600 subjects from whom SERPINA1 genotypes for S and Z alleles, spirometry and respiratory symptoms at baseline and after 11 years follow-up, as well as proxies for inflammatory conditions, such as detailed smoking history, obesity and high sensitivity C-reactive protein (hs-CRP), were available. All analyses were performed by applying multivariate regression models. There was no overall unfavourable effect of PiMS or PiMZ genotype on lung function change. We found indication that PiZ heterozygosity interacted with inflammatory stimuli leading to an accelerated decline in measures in use as indices for assessing mild airway obstruction. Obese individuals with genotype PiMM had an average annual decline in the forced mid expiratory flow (Delta FEF25-75%) of 58.4 ml whereas in obese individuals with PiMZ it amounted to 92.2 ml (p = 0.03). Corresponding numbers for persistent smokers differed even more strongly (66.8 ml (PiMM) vs. 108.2 ml (PiMZ), p = 0.005). Equivalent, but less strong associations were observed for the change in the FEV1/FVC ratio. Conclusions: We suggest that, in addition to the well established impact of the rare PiZZ genotype, one Z allele may be sufficient to accelerate lung function decline in population subgroups characterized by elevated levels of low grade inflammation.	[Thun, Gian-Andri; Imboden, Medea; Zemp, Elisabeth; Probst-Hensch, Nicole M.] Swiss Trop & Publ Hlth Inst, Basel, Switzerland; [Thun, Gian-Andri; Imboden, Medea; Zemp, Elisabeth; Probst-Hensch, Nicole M.] Univ Basel, Basel, Switzerland; [Ferrarotti, Ilaria; Zorzetto, Michele; Ottaviani, Stefania; Luisetti, Maurizio] Univ Pavia, Ctr Diag Inherited Antitrypsin Deficiency Alpha1, Inst Resp Dis, IRCCS San Matteo Hosp Fdn, I-27100 Pavia, Italy; [Rochat, Thierry; Gerbase, Margaret; Bridevaux, Pierre-Olivier] Univ Hosp Geneva, Div Pulm Med, Geneva, Switzerland; [Kronenberg, Florian] Innsbruck Med Univ, Div Genet Epidemiol, Dept Med Genet Mol & Clin Pharmacol, Innsbruck, Austria; [Russi, Erich W.] Univ Zurich Hosp, Div Pulm, CH-8091 Zurich, Switzerland	University of Basel; Swiss Tropical & Public Health Institute; University of Basel; IRCCS Fondazione San Matteo; University of Pavia; University of Geneva; Medical University of Innsbruck; University of Zurich; University Zurich Hospital	Thun, GA (corresponding author), Swiss Trop & Publ Hlth Inst, Basel, Switzerland.	Nicole.Probst@unibas.ch	Kronenberg, Florian/B-1736-2008; Ottaviani, Stefania/AAD-4644-2022; Ferrarotti, Ilaria/AEX-4579-2022; Zorzetto, Michele/K-2281-2015; Russi, Erich/AGN-8387-2022; Bridevaux, Pierre-Olivier/AAN-8046-2021; Ottaviani, Stefania/K-6356-2016	Kronenberg, Florian/0000-0003-2229-1120; Ottaviani, Stefania/0000-0002-2039-230X; Zorzetto, Michele/0000-0002-7826-3666; Ottaviani, Stefania/0000-0002-2039-230X; Thun, Gian Andri/0000-0003-4436-3455; ferrarotti, ilaria/0000-0003-4892-4192	Swiss National Science Foundation [33CS30_134276/1, 33CSCO-108796, 3247BO-104283, 3247BO-104288, 3247BO-104284, 3247-065896, 3100-059302, 3200-052720, 3200-042532, 4026-028099, 3233-054996, PDFMP3-123171]; Federal Office for Forest, Environment and Landscape; Federal Office of Public Health; Federal Office of Roads and Transport; canton's government of Aargau; canton's government of Basel-Stadt; canton's government of Basel-Land; canton's government of Geneva; canton's government of Luzern; canton's government of Ticino; canton's government of Valais; canton's government of Zurich; Swiss Lung League; canton's Lung League of Basel Stadt/ Basel Landschaft; canton's Lung League of Geneva; canton's Lung League of Ticino; canton's Lung League of Valais; canton's Lung League of Zurich; Schweizerische Unfallversicherungsanstalt (SUVA); Freiwillige Akademische Gesellschaft; UBS Wealth Foundation; Talecris Biotherapeutics GmbH; Abbott Diagnostics; Kedrion S.p.A.; IRCCS (Istituto di ricovero e cura a carattere scientific) Foundation San Matteo Hospital; Cariplo Foundation; Talecris GmbH; eALTA Award; Grifols International S.A.	Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission); Federal Office for Forest, Environment and Landscape; Federal Office of Public Health; Federal Office of Roads and Transport; canton's government of Aargau; canton's government of Basel-Stadt; canton's government of Basel-Land; canton's government of Geneva; canton's government of Luzern; canton's government of Ticino; canton's government of Valais; canton's government of Zurich; Swiss Lung League; canton's Lung League of Basel Stadt/ Basel Landschaft; canton's Lung League of Geneva; canton's Lung League of Ticino; canton's Lung League of Valais; canton's Lung League of Zurich; Schweizerische Unfallversicherungsanstalt (SUVA); Freiwillige Akademische Gesellschaft; UBS Wealth Foundation; Talecris Biotherapeutics GmbH; Abbott Diagnostics(Abbott Laboratories); Kedrion S.p.A.; IRCCS (Istituto di ricovero e cura a carattere scientific) Foundation San Matteo Hospital; Cariplo Foundation(Fondazione Cariplo); Talecris GmbH; eALTA Award; Grifols International S.A.	The Swiss Study on Air Pollution and Lung and Heart Diseases in Adults (SAPALDIA) was supported by the Swiss National Science Foundation (grants no 33CS30_134276/1, 33CSCO-108796, 3247BO-104283, 3247BO-104288, 3247BO-104284, 3247-065896, 3100-059302, 3200-052720, 3200-042532, 4026-028099, 3233-054996, PDFMP3-123171), the Federal Office for Forest, Environment and Landscape, the Federal Office of Public Health, the Federal Office of Roads and Transport, the canton's government of Aargau, Basel-Stadt, Basel-Land, Geneva, Luzern, Ticino, Valais, Zurich, the Swiss Lung League, the canton's Lung League of Basel Stadt/ Basel Landschaft, Geneva, Ticino, Valais and Zurich, Schweizerische Unfallversicherungsanstalt (SUVA), Freiwillige Akademische Gesellschaft, UBS Wealth Foundation, Talecris Biotherapeutics GmbH and Abbott Diagnostics. The Center for Diagnosis of Inherited Alpha1-antitrypsin Deficiency in Pavia is supported by grants from Talecris Biotherapeutics GmbH, Kedrion S.p.A., IRCCS (Istituto di ricovero e cura a carattere scientific) Foundation San Matteo Hospital, and Cariplo Foundation 2006 projects. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; This study was funded by SUVA, Talecris Biotherapeutics GmbH, Abbott Diagnostics and Kedrion S.p.A. The Center for Diagnosis of Inherited Alpha1-antitrypsin Deficiency in Pavia is supported by grants from Talecris Biotherapeutics GmbH and Kedrion S.p.A. NPH has received an unrestricted research grant from Talecris GmbH. The grant money was applied to covering part of the salary costs for GAT. IF has received educational and consultancy fees, research grant (eALTA Award), and travel support from Talecris Biotherapeutics GmbH and Kedrion S.p.A. TR has received fees for consulting once in 2011 by Talecris Biotherapeutics GmbH. SO has received travel support from Grifols International S.A. and consultancy fees by Kedrion S.p.A. ML travels to European Respiratory Society and American Thoracic Society congresses have been funded by Talecris Biotherapeutics GmbH, has performed paid lectures for Kedrion S.p.A., has obtained research funds by Talecris Biotherapeutics GmbH, as well as funds for staff members. None of the companies was involved in defining specific aims, conduct of data analysis, data interpretation or decision to publish. There are no patents, products in development or marketed products to declare. This does not alter the authors' adherence to all the PLoS ONE policies on sharing data and materials, as detailed online in the guide for authors.	Ackermann-Liebrich U, 2005, SOZ PRAVENTIV MED, V50, P245, DOI 10.1007/s00038-005-4075-5; Alam S, 2011, AM J RESP CELL MOL, V45, P261, DOI 10.1165/rcmb.2010-0328OC; Banauch GI, 2010, CHEST, V138, P1116, DOI 10.1378/chest.10-0187; Bridevaux PO, 2009, EUR RESPIR J, V34, P332, DOI 10.1183/09031936.00162608; Bullo M, 2003, OBES RES, V11, P525, DOI 10.1038/oby.2003.74; Cho MH, 2012, HUM MOL GENET, V21, P947, DOI 10.1093/hmg/ddr524; COCHRANE GM, 1974, THORAX, V29, P389, DOI 10.1136/thx.29.4.389; Curjuric I, 2010, EUR RESPIR J, V35, P505, DOI 10.1183/09031936.00044309; Dahl M, 2005, EUR RESPIR J, V26, P67, DOI 10.1183/09031936.05.00135704; Dahl M, 2002, ANN INTERN MED, V136, P270, DOI 10.7326/0003-4819-136-4-200202190-00006; Dahl M, 2011, THORAX, V66, P197, DOI 10.1136/thx.2009.131193; DeMeo DL, 2004, THORAX, V59, P396, DOI 10.1136/thx.2003.012856; Downs SH, 2007, NEW ENGL J MED, V357, P2338, DOI 10.1056/NEJMoa073625; ERIKSSON S, 1985, EUR J RESPIR DIS, V67, P279; Ferrarotti I., 2012, THORAX; Gan WQ, 2004, THORAX, V59, P574, DOI 10.1136/thx.2003.019588; Hall IP, 2010, THORAX, V65, P760, DOI 10.1136/thx.2010.147173; Hersh CP, 2004, THORAX, V59, P843, DOI 10.1136/thx.2004.022541; Imboden M, 2012, J ALLERGY CLIN IMMUN, V129, P1218, DOI 10.1016/j.jaci.2012.01.074; Imboden M, 2009, ENVIRON HEALTH PERSP, V117, P1420, DOI 10.1289/ehp.0800430; JANUS ED, 1985, LANCET, V1, P152; JOHNSON D, 1979, J BIOL CHEM, V254, P4022; Kabesch M, 2004, THORAX, V59, P569, DOI 10.1136/thx.2003.016667; Kunzli N, 2005, SWISS MED WKLY, V135, P503; Luisetti M, 2004, THORAX, V59, P164, DOI 10.1136/thorax.2003.006494; Malerba M, 2006, THORAX, V61, P129, DOI 10.1136/thx.2005.043471; Margretardottir OB, 2009, COPD, V6, P250, DOI 10.1080/15412550903049157; Martin BW, 1997, SOZ PRAVENTIV MED, V42, P67, DOI 10.1007/BF01318136; McKeever T, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021593; Miller MR, 2005, EUR RESPIR J, V26, P319, DOI 10.1183/09031936.05.00034805; Mulgrew AT, 2004, CHEST, V125, P1952, DOI 10.1378/chest.125.5.1952; Obeidat M, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019382; Probst-Hensch NM, 2010, THORAX, V65, P150, DOI 10.1136/thx.2009.115063; Roytblat L, 2000, OBES RES, V8, P673, DOI 10.1038/oby.2000.86; Salome CM, 2010, J APPL PHYSIOL, V108, P206, DOI 10.1152/japplphysiol.00694.2009; Sandford AJ, 2001, AM J RESP CRIT CARE, V163, P469, DOI 10.1164/ajrccm.163.2.2006158; Senn O, 2005, EUR RESPIR J, V26, P909, DOI 10.1183/09031936.05.00021605; Senn O, 2008, RESP RES, V9, DOI 10.1186/1465-9921-9-35; Silva GE, 2003, CHEST, V123, P1435, DOI 10.1378/chest.123.5.1435; Simon MR, 2010, J ALLERGY CLIN IMMUN, V126, P527, DOI 10.1016/j.jaci.2010.05.016; Soler Artigas M, 2011, NAT GENET, V43, P1082, DOI 10.1038/ng.941; Sorheim IC, 2010, CHEST, V138, P1125, DOI 10.1378/chest.10-0746; Sunyer J, 2008, EUR RESPIR J, V32, P92, DOI 10.1183/09031936.00052507; Thomason MJ, 2000, THORAX, V55, P785, DOI 10.1136/thorax.55.9.785; von Ehrenstein OS, 2002, EUR RESPIR J, V19, P1099, DOI 10.1183/09031936.02.00104302; Vonk JM, 2003, THORAX, V58, P322, DOI 10.1136/thorax.58.4.322; Wadsworth MEJ, 2004, AM J RESP CELL MOL, V31, P559, DOI 10.1165/rcmb.2004-0027OC; Zorzetto M, 2008, CLIN CHEM, V54, P1331, DOI 10.1373/clinchem.2007.102798	48	26	27	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 13	2012	7	8							e42728	10.1371/journal.pone.0042728	http://dx.doi.org/10.1371/journal.pone.0042728			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	988OJ	22912729	Green Published, Green Accepted, gold, Green Submitted			2022-12-25	WOS:000307500100025
J	Downey, RV; Griffiths, HJ; Linse, K; Janussen, D				Downey, Rachel V.; Griffiths, Huw J.; Linse, Katrin; Janussen, Dorte			Diversity and Distribution Patterns in High Southern Latitude Sponges	PLOS ONE			English	Article							WEDDELL SEA; SHETLAND ISLANDS; MARINE SPONGES; BIODIVERSITY; BIOGEOGRAPHY; PORIFERA; OCEAN; DEMOSPONGIAE; ECOLOGY; FAUNA	Sponges play a key role in Antarctic marine benthic community structure and dynamics and are often a dominant component of many Southern Ocean benthic communities. Understanding the drivers of sponge distribution in Antarctica enables us to understand many of general benthic biodiversity patterns in the region. The sponges of the Antarctic and neighbouring oceanographic regions were assessed for species richness and biogeographic patterns using over 8,800 distribution records. Species-rich regions include the Antarctic Peninsula, South Shetland Islands, South Georgia, Eastern Weddell Sea, Kerguelen Plateau, Falkland Islands and north New Zealand. Sampling intensity varied greatly within the study area, with sampling hotspots found at the Antarctic Peninsula, South Georgia, north New Zealand and Tierra del Fuego, with limited sampling in the Bellingshausen and Amundsen seas in the Southern Ocean. In contrast to previous studies we found that eurybathy and circumpolar distributions are important but not dominant characteristics in Antarctic sponges. Overall Antarctic sponge species endemism is similar to 43%, with a higher level for the class Hexactinellida (68%). Endemism levels are lower than previous estimates, but still indicate the importance of the Polar Front in isolating the Southern Ocean fauna. Nineteen distinct sponge distribution patterns were found, ranging from regional endemics to cosmopolitan species. A single, distinct Antarctic demosponge fauna is found to encompass all areas within the Polar Front, and the sub-Antarctic regions of the Kerguelen Plateau and Macquarie Island. Biogeographical analyses indicate stronger faunal links between Antarctica and South America, with little evidence of links between Antarctica and South Africa, Southern Australia or New Zealand. We conclude that the biogeographic and species distribution patterns observed are largely driven by the Antarctic Circumpolar Current and the timing of past continent connectivity.	[Downey, Rachel V.; Griffiths, Huw J.; Linse, Katrin] British Antarctic Survey, Nat Environm Res Council, Cambridge CB3 0ET, England; [Janussen, Dorte] Forschungsinst & Nat Museum Senckenberg, Sekt Marine Evertebraten 1, Frankfurt, Germany	UK Research & Innovation (UKRI); Natural Environment Research Council (NERC); NERC British Antarctic Survey; Senckenberg Gesellschaft fur Naturforschung (SGN)	Downey, RV (corresponding author), British Antarctic Survey, Nat Environm Res Council, Cambridge CB3 0ET, England.	hjg@bas.ac.uk	Downey, Rachel/Q-4156-2019; Griffiths, Huw J/D-4234-2009	Griffiths, Huw J/0000-0003-1764-223X; Linse, Katrin/0000-0003-3477-3047; Downey, Rachel/0000-0001-9275-8879	Scientific Committee on Antarctic Research Marine Biodiversity Information Network (SCAR-MarBIN); TOTAL Foundation; German Research Foundation [JA 1063/14-1, JA 1063/14-2]; NERC [bas0100026] Funding Source: UKRI; Natural Environment Research Council [bas0100026] Funding Source: researchfish	Scientific Committee on Antarctic Research Marine Biodiversity Information Network (SCAR-MarBIN); TOTAL Foundation(Total SA); German Research Foundation(German Research Foundation (DFG)); NERC(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC)); Natural Environment Research Council(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC))	The authors thank the Scientific Committee on Antarctic Research Marine Biodiversity Information Network (SCAR-MarBIN) and the TOTAL Foundation for providing the funding to create the database. This paper is a contribution to the British Antarctic Survey core project, Environmental Change and Evolution. DJ would like to thank the German Research Foundation which finances projects JA 1063/14-1, 2. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allcock AL, 2011, DEEP-SEA RES PT II, V58, P242, DOI 10.1016/j.dsr2.2010.05.016; Amsler MO, 2009, ANTARCT SCI, V21, P579, DOI 10.1017/S0954102009990356; Arntz Wolf E., 1997, P3; Avila C, 2000, J EXP MAR BIOL ECOL, V252, P27, DOI 10.1016/S0022-0981(00)00227-6; AYLING AL, 1980, BIOL BULL, V158, P271, DOI 10.2307/1540854; Barnes DKA, 2008, CLIM RES, V37, P149, DOI 10.3354/cr00760; Barnes DKA, 2008, GLOBAL ECOL BIOGEOGR, V17, P84, DOI 10.1111/j.1466-8238.2007.00342.x; Barnes DKA, 2009, MAR ECOL PROG SER, V393, P13, DOI 10.3354/meps08246; Barnes DKA, 2000, VIE MILIEU, V50, P261; Barthel D, 1997, POLAR BIOL, V17, P91, DOI 10.1007/s003000050110; BARTHEL D, 1992, ANTARCT SCI, V4, P137, DOI 10.1017/S0954102092000221; Barthel D, 1994, ANTARCTIC HEXACTINEL, V6; Barthel D, 1989, DEEP SEA NEWSLETTER, V16, P8; BELIAEV GM, 1957, AM I BIOL SCI, V112, P116; BERGQUIST P R, 1978, P268; Brandt A, 2007, NATURE, V447, P307, DOI 10.1038/nature05827; BRAY JR, 1957, ECOL MONOGR, V27, P326, DOI 10.2307/1942268; Brey T, 1996, ANTARCT SCI, V8, P3, DOI 10.1017/S0954102096000028; Burton M., 1934, Great Barrier Reef Expedition 1928-9, V4, P513; Campos M, 2007, REV BRAS ZOOL, V24, P742, DOI 10.1590/S0101-81752007000300027; Campos M, 2007, REV BRAS ZOOL, V24, P687, DOI 10.1590/S0101-81752007000300021; Cattaneo-Vietti R., 2000, P539; Cerrano C, 2000, POLAR BIOL, V23, P441, DOI 10.1007/s003000050466; Clarke A, 2003, OCEANOGR MAR BIOL, V41, P47; Clarke A, 2007, DIVERS DISTRIB, V13, P620, DOI 10.1111/j.1472-4642.2007.00380.x; Clarke A, 2009, J GEOPHYS RES-BIOGEO, V114, DOI 10.1029/2008JG000886; Clarke KR, 2001, MAR ECOL PROG SER, V216, P265, DOI 10.3354/meps216265; Convey P, BIOGEOGRAPH IN PRESS, P471; DAYTON PK, 1974, ECOL MONOGR, V44, P105, DOI 10.2307/1942321; De Broyer C., 1996, B MUS CIV ST NAT VER, V20, P547; De Broyer C, 2011, SCAR MARBIN REGISTER; De Broyer C, 2011, DEEP-SEA RES PT II, V58, P5, DOI 10.1016/j.dsr2.2010.10.007; DELL RK, 1972, ADV MAR BIOL, V10, P1, DOI 10.1016/S0065-2881(08)60416-2; Eastman JT, 1999, ANTARCT SCI, V11, P293, DOI 10.1017/S0954102099000383; GendronBadou A, 1997, CR ACAD SCI II A, V325, P343, DOI 10.1016/S1251-8050(97)81382-1; Gotelli NJ, 2001, ECOL LETT, V4, P379, DOI 10.1046/j.1461-0248.2001.00230.x; Griffiths HJ, 2011, DEEP-SEA RES PT II, V58, P18, DOI 10.1016/j.dsr2.2010.10.008; Griffiths HJ, 2011, ECOGRAPHY, V34, P616, DOI 10.1111/j.1600-0587.2010.06612.x; Griffiths HJ, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011683; Griffiths HJ, 2009, J BIOGEOGR, V36, P162, DOI 10.1111/j.1365-2699.2008.01979.x; Gutt J, 1998, ANTARCT SCI, V10, P398, DOI 10.1017/S0954102098000480; Gutt J, 2003, MAR ECOL PROG SER, V253, P77, DOI 10.3354/meps253077; GUTT J, 1995, ANTARCT SCI, V7, P227, DOI 10.1017/S0954102095000320; Hedgpeth J.W., 1969, Antarctic Map fo Ser, V11, P1; Held C, 2003, ANTARCTIC BIOLOGY IN A GLOBAL CONTEXT, PROCEEDINGS, P135; HELMUTH B, 1994, MAR BIOL, V120, P421, DOI 10.1007/BF00680216; Hillenbrand CD, 2003, MAR GEOL, V193, P253, DOI 10.1016/S0025-3227(02)00659-X; Hogg MM, 2010, DEEP SEA SPONGE GROU; Hogg OT, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019795; Hommersand MH, 2009, BOT MAR, V52, P509, DOI 10.1515/BOT.2009.081; HOOPER JNA, 1994, SPONGES IN TIME AND SPACE, P191; Hooper JNA, 2002, SYSTEMA PORIFERA GUI; Janussen D, 2007, DEEP-SEA RES PT II, V54, P1864, DOI 10.1016/j.dsr2.2007.07.012; Janussen D, 2009, ZOOTAXA, P1; Knowlton N, 2000, HYDROBIOLOGIA, V420, P73, DOI 10.1023/A:1003933603879; Koltun V. M., 1970, Symp. zool. Soc. Lond., VNo. 25, P285; Koltun VM, 1969, ANTARCTIC MAP FOLIO, V11, P13; Leys SP, 2004, MAR ECOL PROG SER, V283, P133, DOI 10.3354/meps283133; Linse K, 2004, DEEP-SEA RES PT II, V51, P1827, DOI 10.1016/j.dsr2.2004.07.016; Linse K, 2007, POLAR BIOL, V30, P1059, DOI 10.1007/s00300-007-0265-3; Linse K, 2006, DEEP-SEA RES PT II, V53, P985, DOI 10.1016/j.dsr2.2006.05.003; Lockhart S.J., 2009, WGEMM0932 CCAMLR; Lorz AN, 2009, ZOOKEYS, P91, DOI 10.3897/zookeys.18.103; Maldonado Manuel, 2002, P21; McClintock JB, 2005, INTEGR COMP BIOL, V45, P359, DOI 10.1093/icb/45.2.359; MCCLINTOCK JB, 1994, J CHEM ECOL, V20, P859, DOI 10.1007/BF02059583; Moore JK, 1999, J GEOPHYS RES-OCEANS, V104, P3059, DOI 10.1029/1998JC900032; Munilla T, 2009, ANTARCT SCI, V21, P99, DOI 10.1017/S095410200800151X; NELSON DM, 1982, GEOCHIM COSMOCHIM AC, V46, P491, DOI 10.1016/0016-7037(82)90153-3; Pansini M, 1999, SCI MAR, V63, P203, DOI 10.3989/scimar.1999.63s1203; PEARSE JS, 1991, AM ZOOL, V31, P65; Primo C, 2007, ANTARCT SCI, V19, P321, DOI 10.1017/S0954102007000521; Rapp HT, 2011, DEEP-SEA RES PT II, V58, P58, DOI 10.1016/j.dsr2.2010.05.022; Rex MA, 1997, MARINE BIODIVERSITY-BOOK, P94, DOI 10.1017/CBO9780511752360.006; Rogers AD, 2007, PHILOS T R SOC B, V362, P2191, DOI 10.1098/rstb.2006.1948; SARA M, 1992, POLAR BIOL, V12, P559; Simpson T., 1984, CELL BIOL SPONGES; TABACHNICK KR, 1994, SPONGES IN TIME AND SPACE, P225; Teixido N, 2006, DEEP-SEA RES PT II, V53, P972, DOI 10.1016/j.dsr2.2006.02.008; THORPE JP, 1994, ZOOL SCR, V23, P3, DOI 10.1111/j.1463-6409.1994.tb00368.x; Thrush S, 2006, DEEP-SEA RES PT II, V53, P959, DOI 10.1016/j.dsr2.2006.02.006; Usher KM, 2004, MAR ECOL PROG SER, V270, P117, DOI 10.3354/meps270117; Van Soest RWM, 2011, WORLD PORIFERA DATAB; VANSOEST RWM, 1994, SPONGES IN TIME AND SPACE, P213; Worheide G, 2005, INTEGR COMP BIOL, V45, P377, DOI 10.1093/icb/45.2.377; WULFF JL, 1991, J EXP MAR BIOL ECOL, V149, P227, DOI 10.1016/0022-0981(91)90047-Z	86	69	73	2	39	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 24	2012	7	7							e41672	10.1371/journal.pone.0041672	http://dx.doi.org/10.1371/journal.pone.0041672			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	978NX	22911840	Green Published, Green Accepted, Green Submitted, gold			2022-12-25	WOS:000306751300063
J	Lin, CE; Chen, SU; Lin, CC; Chang, CH; Lin, YC; Tai, YL; Shen, TL; Lee, H				Lin, Chuan-En; Chen, Shee-Uan; Lin, Chu-Cheng; Chang, Chi-Hao; Lin, Yueh-Chien; Tai, Yu-Ling; Shen, Tang-Long; Lee, Hsinyu			Lysophosphatidic Acid Enhances Vascular Endothelial Growth Factor-C Expression in Human Prostate Cancer PC-3 Cells	PLOS ONE			English	Article							LYMPH-NODE METASTASIS; VEGF-C; MAMMARY TUMORIGENESIS; ACTIVATION; AUTOTAXIN; RECEPTOR; AXIS; PROGRESSION; INVASION; LPA(1)	Clinical evidence suggests that lymphangiogenesis and lymphatic metastasis are important processes during the progression of prostate cancer. Vascular endothelial growth factor (VEGF)-C was shown to be a key regulator in these processes. Our previous studies demonstrated that lysophosphatidic acid (LPA), a low-molecular-weight lipid growth factor, enhances VEGF-C expression in human endothelial cells. We previously demonstrated that the LPA receptor plays an important role in lymphatic development in zebrafish embryos. However, the effects of LPA on VEGF-C expression in prostate cancer are not known. Herein, we demonstrate that LPA up-regulated VEGF-C expression in three different human prostate cancer cell lines. In PC-3 human prostate cancer cells, the enhancing effects of LPA were mediated through both LPA1 and LPA3. In addition, reactive oxygen species (ROS) production and lens epithelium-derived growth factor (LEDGF) expression were involved in LPA(1/3)-dependent VEGF-C expression. Furthermore, autotaxin (ATX), an enzyme responsible for LPA synthesis, also participates in regulating VEGF-C expression. By interrupting LPA(1/3) of PC-3, conditioned medium (CM) induced human umbilical vein endothelial cell (HUVEC) lymphatic markers expression was also blocked. In summary, we found that LPA enhances VEGF-C expression through activating LPA(1/3)(-), ROS-, and LEDGF-dependent pathways. These novel findings could potentially shed light on developing new strategies for preventing lymphatic metastasis of prostate cancer.	[Lin, Chuan-En; Chang, Chi-Hao; Lin, Yueh-Chien; Lee, Hsinyu] Natl Taiwan Univ, Inst Zool, Taipei 10764, Taiwan; [Chen, Shee-Uan] Natl Taiwan Univ, Dept Obstet & Gynecol, Taipei 10764, Taiwan; [Lin, Chu-Cheng; Lee, Hsinyu] Natl Taiwan Univ, Dept Life Sci, Taipei 10764, Taiwan; [Tai, Yu-Ling; Shen, Tang-Long] Natl Taiwan Univ, Dept Plant Pathol & Microbiol, Taipei 10764, Taiwan; [Shen, Tang-Long; Lee, Hsinyu] Natl Taiwan Univ, Ctr Biotechnol, Taipei 10764, Taiwan; [Lee, Hsinyu] Natl Taiwan Univ, Angiogenesis Res Ctr, Taipei 10764, Taiwan	Academia Sinica - Taiwan; National Taiwan University; National Taiwan University; National Taiwan University; National Taiwan University; National Taiwan University; National Taiwan University	Lin, CE (corresponding author), Natl Taiwan Univ, Inst Zool, Taipei 10764, Taiwan.	hsinyu@ntu.edu.tw	Lin, Yueh-Chien/CAA-9333-2022	Lin, Yueh-Chien/0000-0002-8997-2708; Lee, Hsinyu/0000-0002-1477-0183; CHEN, SHEE-UAN/0000-0001-7592-3238; Shen, Tang-Long/0000-0001-6264-3608	National Science Council [NSC97-2311-B-002-002-MY3, NSC 99-2120-M-002-004, NHRI 101-EX101-10130BI]; National Health Research Institutes of the Republic of China	National Science Council(Ministry of Science and Technology, Taiwan); National Health Research Institutes of the Republic of China(National Health Research Institutes - Taiwan)	The research was supported by grants (NSC97-2311-B-002-002-MY3, NSC 99-2120-M-002-004 and NHRI 101-EX101-10130BI) from the National Science Council and National Health Research Institutes of the Republic of China. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arya M, 2006, SURG ONCOL, V15, P117, DOI 10.1016/j.suronc.2006.10.002; Aziziyeh AI, 2009, CELL SIGNAL, V21, P1207, DOI 10.1016/j.cellsig.2009.03.011; Brakenhielm E, 2007, INT J CANCER, V121, P2153, DOI 10.1002/ijc.22900; Burton JB, 2008, CANCER RES, V68, P7828, DOI 10.1158/0008-5472.CAN-08-1488; Choi JW, 2010, ANNU REV PHARMACOL, V50, P157, DOI 10.1146/annurev.pharmtox.010909.105753; Cohen B, 2009, NEOPLASIA, V11, P921, DOI 10.1593/neo.09636; Daniels T, 2005, PROSTATE, V62, P14, DOI 10.1002/pros.20112; Enholm B, 1997, ONCOGENE, V14, P2475, DOI 10.1038/sj.onc.1201090; Ferry G, 2008, J PHARMACOL EXP THER, V327, P809, DOI 10.1124/jpet.108.141911; Hama K, 2004, J BIOL CHEM, V279, P17634, DOI 10.1074/jbc.M313927200; Hao F, 2007, BBA-MOL CELL BIOL L, V1771, P883, DOI 10.1016/j.bbalip.2007.04.010; Hwang YS, 2006, MOL CARCINOGEN, V45, P518, DOI 10.1002/mc.20183; Jonkers J, 2009, CANCER CELL, V15, P457, DOI 10.1016/j.ccr.2009.05.003; Kishi Y, 2006, J BIOL CHEM, V281, P17492, DOI 10.1074/jbc.M601803200; Lee SJ, 2008, FASEB J, V22, P3706, DOI 10.1096/fj.08-106088; Li JP, 2005, ONCOGENE, V24, P5510, DOI 10.1038/sj.onc.1208693; Lin CI, 2008, CELL MOL LIFE SCI, V65, P2740, DOI 10.1007/s00018-008-8314-9; Lin CI, 2008, CELL SIGNAL, V20, P1804, DOI 10.1016/j.cellsig.2008.06.008; Lin JM, 2005, CANCER RES, V65, P6901, DOI 10.1158/0008-5472.CAN-05-0408; Liu SY, 2009, CELL CYCLE, V8, P3695, DOI 10.4161/cc.8.22.9937; Liu SY, 2009, CANCER CELL, V15, P539, DOI 10.1016/j.ccr.2009.03.027; Mediavilla-Varela M, 2009, MOL CANCER, V8, DOI 10.1186/1476-4598-8-68; Noguchi K, 2009, CURR OPIN PHARMACOL, V9, P15, DOI 10.1016/j.coph.2008.11.010; Nouh MAAM, 2009, CANCER SCI, V100, P1631, DOI 10.1111/j.1349-7006.2009.01234.x; Panupinthu N, 2010, BRIT J CANCER, V102, P941, DOI 10.1038/sj.bjc.6605588; Park JJ, 2012, PROSTATE; Park SY, 2007, CANCER LETT, V258, P63, DOI 10.1016/j.canlet.2007.08.011; Reinmuth N, 2007, INT J ONCOL, V31, P621; Rhim JH, 2008, J CANCER RES CLIN, V134, P45, DOI 10.1007/s00432-007-0243-8; Rinaldo F, 2007, ONCOGENE, V26, P1731, DOI 10.1038/sj.onc.1209971; Sapoznik S, 2009, CANCER RES, V69, P9306, DOI 10.1158/0008-5472.CAN-09-1213; Sharma P, 2000, BIOCHEM BIOPH RES CO, V276, P1320, DOI 10.1006/bbrc.2000.3606; Shinohara T, 2002, PROG RETIN EYE RES, V21, P341, DOI 10.1016/S1350-9462(02)00007-1; Su JL, 2007, BRIT J CANCER, V96, P541, DOI 10.1038/sj.bjc.6603487; van Meeteren LA, 2007, PROG LIPID RES, V46, P145, DOI 10.1016/j.plipres.2007.02.001; Ward Y, 2011, CANCER RES, V71, P7301, DOI 10.1158/0008-5472.CAN-11-2381; Xie YH, 2004, CELL SIGNAL, V16, P975, DOI 10.1016/j.cellsig.2004.03.005; Xie YH, 2002, J BIOL CHEM, V277, P32516, DOI 10.1074/jbc.M203864200; Zeng YP, 2006, CANCER RES, V66, P9566, DOI 10.1158/0008-5472.CAN-06-1488; Zeng YP, 2004, CLIN CANCER RES, V10, P5137, DOI 10.1158/1078-0432.CCR-03-0434; Zeng YP, 2005, PROSTATE, V65, P222, DOI 10.1002/pros.20288; Zeng Y, 2009, PROSTATE, V69, P283, DOI 10.1002/pros.20879	42	19	19	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 20	2012	7	7							e41096	10.1371/journal.pone.0041096	http://dx.doi.org/10.1371/journal.pone.0041096			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	977GL	22911748	Green Submitted, Green Published, gold			2022-12-25	WOS:000306644600047
J	Li, ZM; Huang, JJ; Xia, Y; Sun, J; Huang, Y; Wang, Y; Zhu, YJ; Li, YJ; Zhao, W; Wei, WX; Lin, TY; Huang, HQ; Jiang, WQ				Li, Zhi-Ming; Huang, Jia-Jia; Xia, Yi; Sun, Jian; Huang, Ying; Wang, Yu; Zhu, Ying-Jie; Li, Ya-Jun; Zhao, Wei; Wei, Wen-Xiao; Lin, Tong-Yu; Huang, Hui-Qiang; Jiang, Wen-Qi			Blood Lymphocyte-to-Monocyte Ratio Identifies High-Risk Patients in Diffuse Large B-Cell Lymphoma Treated with R-CHOP	PLOS ONE			English	Article							NON-HODGKIN-LYMPHOMA; ABSOLUTE MONOCYTE; RESPONSE CRITERIA; PROGNOSTIC-FACTOR; SURVIVAL; LYMPHOPENIA; EXPRESSION; COUNT; TUMOR; CHEMOTHERAPY	Background: Recent research has shown a correlation between immune microenvironment and lymphoma biology. This study aims to investigate the prognostic significance of the immunologically relevant lymphocyte-to-monocyte ratio (LMR), in diffuse large B-cell lymphoma (DLBCL) in the rituximab era. Methodology/Principal Findings: We analyzed retrospective data from 438 newly diagnosed DLBCL patients treated with rituximab plus cyclophosphamide, doxorubicin, vincristine, and prednisone (R-CHOP) therapy. We randomly selected 200 patients (training set) to generate a cutoff value for LMR by receiver operating characteristic (ROC) curve analysis. LMR was then analyzed in a testing set (n = 238) and in all patients (n = 438) for validation. The LMR cutoff value for survival analysis determined by ROC curve in the training set was 2.6. Patients with low LMR tended to have more adverse clinical characteristics. Low LMR at diagnosis was associated with worse survival in DLBCL, and could also identify high-risk patients in the low-risk IPI category. Multivariate analysis identified LMR as an independent prognostic factor of survival in the testing set and in all patients. Conclusions/Significance: Baseline LMR, a surrogate biomarker of the immune microenvironment, is an effective prognostic factor in DLBCL patients treated with R-CHOP therapy. Future prospective studies are required to confirm our findings.	[Li, Zhi-Ming; Huang, Jia-Jia; Xia, Yi; Sun, Jian; Huang, Ying; Wang, Yu; Zhu, Ying-Jie; Li, Ya-Jun; Zhao, Wei; Wei, Wen-Xiao; Lin, Tong-Yu; Huang, Hui-Qiang; Jiang, Wen-Qi] State Key Lab Oncol S China, Guangzhou, Guangdong, Peoples R China; [Li, Zhi-Ming; Huang, Jia-Jia; Xia, Yi; Wang, Yu; Zhu, Ying-Jie; Li, Ya-Jun; Zhao, Wei; Wei, Wen-Xiao; Lin, Tong-Yu; Huang, Hui-Qiang; Jiang, Wen-Qi] Sun Yat Sen Univ, Ctr Canc, Dept Med Oncol, Guangzhou 510275, Guangdong, Peoples R China; [Sun, Jian] Sun Yat Sen Univ, Ctr Canc, Dept Clin Trial Ctr, Guangzhou 510275, Guangdong, Peoples R China; [Huang, Ying] Sun Yat Sen Univ, Ctr Canc, Dept Radiat Oncol, Guangzhou 510275, Guangdong, Peoples R China	Sun Yat Sen University; Sun Yat Sen University; Sun Yat Sen University	Li, ZM (corresponding author), State Key Lab Oncol S China, Guangzhou, Guangdong, Peoples R China.	lzmlzmlzm@yahoo.com	jiang, wen/GYI-9662-2022; Wu, William K.K./A-3277-2009	Wu, William K.K./0000-0002-5662-5240; Qiu, Guixing/0000-0002-4597-9350	National Natural Science Foundation of China [81071950]; Fundamental Research Funds for the Central Universities [10ykpy36]; National-Eleventh Five Technology Major Project [2008ZX09312-002, 2012ZX09301]; Research Award Funds for Outstanding Young Researchers in Sun Yat-Sen Cancer Center	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Fundamental Research Funds for the Central Universities(Fundamental Research Funds for the Central Universities); National-Eleventh Five Technology Major Project; Research Award Funds for Outstanding Young Researchers in Sun Yat-Sen Cancer Center	This work was supported by National Natural Science Foundation of China (NO. 81071950), Fundamental Research Funds for the Central Universities (NO. 10ykpy36), National-Eleventh Five Technology Major Project (NO. 2008ZX09312-002, 2012ZX09301), and Research Award Funds for Outstanding Young Researchers in Sun Yat-Sen Cancer Center. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abid Muhammad Bilal, 2005, Asian Pac J Cancer Prev, V6, P531; Alizadeh AA, 2011, BLOOD, V118, P1350, DOI 10.1182/blood-2011-03-345272; Ansell SM, 2001, J CLIN ONCOL, V19, P720, DOI 10.1200/JCO.2001.19.3.720; Bari A, 2010, ANN ONCOL, V21, P1486, DOI 10.1093/annonc/mdp531; Bhaskaran K, 2004, AIDS, V18, P673, DOI [10.1097/01.aids.0000111464.61782.64, 10.1097/00002030-200403050-00012]; Borg C, 2004, CANCER-AM CANCER SOC, V101, P2675, DOI 10.1002/cncr.20688; Challa-Malladi M, 2011, CANCER CELL, V20, P728, DOI 10.1016/j.ccr.2011.11.006; Cheson BD, 1999, J CLIN ONCOL, V17, P1244, DOI 10.1200/JCO.1999.17.4.1244; Cheson BD, 2007, J CLIN ONCOL, V25, P579, DOI 10.1200/JCO.2006.09.2403; Coiffier B, 2007, ONCOGENE, V26, P3603, DOI 10.1038/sj.onc.1210376; Dave SS, 2004, NEW ENGL J MED, V351, P2159, DOI 10.1056/NEJMoa041869; Dworacki G, 2001, CLIN CANCER RES, V7, p947S; Huang JJ, 2011, ANN ONCOL, V22, P149, DOI 10.1093/annonc/mdq314; Huang JJ, 2011, HUM PATHOL, V42, P1459, DOI 10.1016/j.humpath.2010.12.014; Ishii H, 2012, INT J CANCER, V130, P48, DOI 10.1002/ijc.25969; Kim DH, 2007, LEUKEMIA, V21, P2227, DOI 10.1038/sj.leu.2404780; Kim YR, 2011, J HEMATOL ONCOL, V4, DOI 10.1186/1756-8722-4-34; Lenz G, 2008, NEW ENGL J MED, V359, P2313, DOI 10.1056/NEJMoa0802885; Lin Y, 2011, BLOOD, V117, P872, DOI 10.1182/blood-2010-05-283820; Morton LM, 2008, BLOOD, V112, P5150, DOI 10.1182/blood-2008-01-133587; Moskowitz C, 2012, BEST PRACT RES CL HA, V25, P41, DOI 10.1016/j.beha.2012.01.008; Pileri SA, 2011, SEMIN DIAGN PATHOL, V28, P113, DOI 10.1053/j.semdp.2011.02.001; Porrata LF, 2007, LEUKEMIA, V21, P2554, DOI 10.1038/sj.leu.2404819; Porrata LF, 2004, CLIN EXP MED, V4, P78, DOI 10.1007/s10238-004-0041-4; Porrata LF, 2012, BRIT J HAEMATOL, V157, P321, DOI 10.1111/j.1365-2141.2012.09067.x; Porrata LF, 2012, HAEMATOL-HEMATOL J, V97, P262, DOI 10.3324/haematol.2011.050138; Ray-Coquard I, 2009, CANCER RES, V69, P5383, DOI 10.1158/0008-5472.CAN-08-3845; Sehn LH, 2007, BLOOD, V109, P1857, DOI 10.1182/blood-2006-08-038257; Steidl C, 2010, NEW ENGL J MED, V362, P875, DOI 10.1056/NEJMoa0905680; Vegso G, 2011, PATHOL ONCOL RES, V17, P443, DOI 10.1007/s12253-010-9329-8; Wada N, 2012, HISTOPATHOLOGY, V60, P924, DOI 10.1111/j.1365-2559.2011.04161.x; Wada N, 2012, HISTOPATHOLOGY, V60, P313, DOI 10.1111/j.1365-2559.2011.04096.x; Wilcox RA, 2011, LEUKEMIA, V25, P1502, DOI 10.1038/leu.2011.112; Wilcox RA, 2012, LEUKEMIA LYMPHOMA, V53, P575, DOI 10.3109/10428194.2011.637211; Wilcox RA, 2009, BLOOD, V114, P2936, DOI 10.1182/blood-2009-05-220111	35	221	232	2	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 23	2012	7	7							e41658	10.1371/journal.pone.0041658	http://dx.doi.org/10.1371/journal.pone.0041658			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	977TM	23300886	Green Published, Green Submitted, gold			2022-12-25	WOS:000306687700134
J	Wang, Y; Guo, LH; Cai, SP; Dai, MZ; Yang, QN; Yu, WH; Yan, NH; Zhou, XM; Fu, J; Guo, XW; Han, PF; Wang, J; Liu, XY				Wang, Yun; Guo, Liheng; Cai, Su-Ping; Dai, Meizhi; Yang, Qiaona; Yu, Wenhan; Yan, Naihong; Zhou, Xiaomin; Fu, Jin; Guo, Xinwu; Han, Pengfei; Wang, Jun; Liu, Xuyang			Exome Sequencing Identifies Compound Heterozygous Mutations in CYP4V2 in a Pedigree with Retinitis Pigmentosa	PLOS ONE			English	Article							CORNEO-RETINAL DYSTROPHY; FATTY-ACID; CRYSTALLINE DYSTROPHY; DOCOSAHEXAENOIC ACID; CLINICAL-TRIAL; METABOLISM; GENE; DEFICIENCY; CAPTURE	Retinitis pigmentosa (RP) is a heterogeneous group of progressive retinal degenerations characterized by pigmentation and atrophy in the mid-periphery of the retina. Twenty two subjects from a four-generation Chinese family with RP and thin cornea, congenital cataract and high myopia is reported in this study. All family members underwent complete ophthalmologic examinations. Patients of the family presented with bone spicule-shaped pigment deposits in retina, retinal vascular attenuation, retinal and choroidal dystrophy, as well as punctate opacity of the lens, reduced cornea thickness and high myopia. Peripheral venous blood was obtained from all patients and their family members for genetic analysis. After mutation analysis in a few known RP candidate genes, exome sequencing was used to analyze the exomes of 3 patients III2, III4, III6 and the unaffected mother II2. A total of 34,693 variations shared by 3 patients were subjected to several filtering steps against existing variation databases. Identified variations were verified in the rest family members by PCR and Sanger sequencing. Compound heterozygous c. 802-8_810del17insGC and c. 1091-2A>G mutations of the CYP4V2 gene, known as genetic defects for Bietti crystalline corneoretinal dystrophy, were identified as causative mutations for RP of this family.	[Wang, Yun; Guo, Liheng; Yang, Qiaona; Yu, Wenhan; Yan, Naihong; Zhou, Xiaomin] W China Hosp, Translat Neurosci Ctr, State Key Lab Biotherapy, Ophthalm Labs, Chengdu, Sichuan Provinc, Peoples R China; [Wang, Yun; Guo, Liheng; Yang, Qiaona; Yu, Wenhan; Yan, Naihong; Zhou, Xiaomin] W China Hosp, Translat Neurosci Ctr, State Key Lab Biotherapy, Dept Ophthalmol, Chengdu, Sichuan Provinc, Peoples R China; [Cai, Su-Ping; Liu, Xuyang] Jinan Univ, Shenzhen Eye Hosp, Shenzhen, Peoples R China; [Dai, Meizhi; Fu, Jin; Guo, Xinwu; Han, Pengfei; Wang, Jun] BGI Shenzhen, Shenzhen, Guangdong, Peoples R China	Sichuan University; Sichuan University; Jinan University; Beijing Genomics Institute (BGI)	Wang, Y (corresponding author), W China Hosp, Translat Neurosci Ctr, State Key Lab Biotherapy, Ophthalm Labs, Chengdu, Sichuan Provinc, Peoples R China.	wangj@genomics.org.cn; xliu1213@yahoo.com.cn	Wang, Jun/A-7261-2013; Cai, Shanqing/F-6880-2013; Wang, Jun/C-8434-2016; Wang, Jun/B-9503-2016	Beal, Deryk S./0000-0001-9488-4326; Yu, Wenhan/0000-0002-0125-4358; Wang, Jun/0000-0002-8540-8931; Wang, Jun/0000-0002-2113-5874; Ghosh, Satrajit/0000-0002-5312-6729	National Natural Science Foundation of China (NSFC) [81000370]; National Basic Research Program of China (973 Program) [2011CB510201]	National Natural Science Foundation of China (NSFC)(National Natural Science Foundation of China (NSFC)); National Basic Research Program of China (973 Program)(National Basic Research Program of China)	This work was supported by grants from the National Natural Science Foundation of China (NSFC 81000370) and the National Basic Research Program of China (973 Program, 2011CB510201). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ANDERSON RE, 1987, EXP EYE RES, V44, P155, DOI 10.1016/S0014-4835(87)80034-9; Berson EL, 2004, ARCH OPHTHALMOL-CHIC, V122, P1297, DOI 10.1001/archopht.122.9.1297; Choi M, 2009, P NATL ACAD SCI USA, V106, P19096, DOI 10.1073/pnas.0910672106; CONVERSE CA, 1983, T OPHTHAL SOC UK, V103, P508; Giusto NM, 2000, PROG LIPID RES, V39, P315, DOI 10.1016/S0163-7827(00)00009-6; GONG JX, 1992, INVEST OPHTH VIS SCI, V33, P2596; Hartong DT, 2006, LANCET, V368, P1795, DOI 10.1016/S0140-6736(06)69740-7; Hoffman DR, 2004, AM J OPHTHALMOL, V137, P704, DOI 10.1016/j.ajo.2003.10.045; HOFFMAN DR, 1995, EXP EYE RES, V60, P279, DOI 10.1016/S0014-4835(05)80110-1; HOFFMAN DR, 1993, EXP EYE RES, V57, P359, DOI 10.1006/exer.1993.1135; HUMPHRIES P, 1992, SCIENCE, V256, P804, DOI 10.1126/science.1589761; Innis SM, 2003, J PEDIATR-US, V143, pS1, DOI 10.1067/S0022-3476(03)00396-2; Jin ZB, 2006, JPN J OPHTHALMOL, V50, P426, DOI 10.1007/s10384-006-0350-0; KAISERKUPFER MI, 1994, AM J OPHTHALMOL, V118, P569, DOI 10.1016/S0002-9394(14)76572-9; Kelly EJ, 2011, MOL INTERV, V11, P124, DOI 10.1124/mi.11.2.10; Lai TYY, 2007, INVEST OPHTH VIS SCI, V48, P5212, DOI 10.1167/iovs.07-0660; Lalonde E, 2010, HUM MUTAT, V31, P918, DOI 10.1002/humu.21293; Lee J, 1998, MOL GENET METAB, V65, P143, DOI 10.1006/mgme.1998.2723; Lee J, 2001, INVEST OPHTH VIS SCI, V42, P1707; Lee KYC, 2005, INVEST OPHTH VIS SCI, V46, P3812, DOI 10.1167/iovs.05-0378; Li AR, 2004, AM J HUM GENET, V74, P817, DOI 10.1086/383228; Li GQ, 2009, NUCLEIC ACIDS RES, V37, pD1025, DOI 10.1093/nar/gkn966; Li RQ, 2009, GENOME RES, V19, P1124, DOI 10.1101/gr.088013.108; Lin J, 2005, J MED GENET, V42, DOI 10.1136/jmg.2004.029066; NEURINGER M, 1986, P NATL ACAD SCI USA, V83, P4021, DOI 10.1073/pnas.83.11.4021; NEURINGER M, 1984, J CLIN INVEST, V73, P272, DOI 10.1172/JCI111202; Ng SB, 2009, NATURE, V461, P272, DOI 10.1038/nature08250; Rivolta C, 2002, HUM MOL GENET, V11, P1219, DOI 10.1093/hmg/11.10.1219; Shan MG, 2005, MOL VIS, V11, P738	29	42	45	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 31	2012	7	5							e33673	10.1371/journal.pone.0033673	http://dx.doi.org/10.1371/journal.pone.0033673			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959TY	22911857	Green Published, gold, Green Submitted			2022-12-25	WOS:000305338500004
J	IJssennagger, N; de Wit, N; Muller, M; van der Meer, R				IJssennagger, Noortje; de Wit, Nicole; Muller, Michael; van der Meer, Roelof			Dietary Heme-Mediated PPAR alpha Activation Does Not Affect the Heme-Induced Epithelial Hyperproliferation and Hyperplasia in Mouse Colon	PLOS ONE			English	Article							ACID-BINDING PROTEIN; RED MEAT; OXIDATIVE STRESS; CANCER; GENE; MICE; CARCINOGENESIS; EXPRESSION; RISK; NRF1	Red meat consumption is associated with an increased colon cancer risk. Heme, present in red meat, injures the colon surface epithelium by luminal cytotoxicity and reactive oxygen species. This surface injury is overcompensated by hyperproliferation and hyperplasia of crypt cells. Transcriptome analysis of mucosa of heme-fed mice showed, besides stress-and proliferation-related genes, many upregulated lipid metabolism-related PPAR alpha target genes. The aim of this study was to investigate the role of PPAR alpha in heme-induced hyperproliferation and hyperplasia. Male PPAR alpha KO and WT mice received a purified diet with or without heme. As PPAR alpha is proposed to protect against oxidative stress and lipid peroxidation, we hypothesized that the absence of PPAR alpha leads to more surface injury and crypt hyperproliferation in the colon upon heme-feeding. Heme induced luminal cytotoxicity and lipid peroxidation and colonic hyperproliferation and hyperplasia to the same extent in WT and KO mice. Transcriptome analysis of colonic mucosa confirmed similar heme-induced hyperproliferation in WT and KO mice. Stainings for alkaline phosphatase activity and expression levels of Vanin-1 and Nrf2-targets indicated a compromised antioxidant defense in heme-fed KO mice. Our results suggest that the protective role of PPAR alpha in antioxidant defense involves the Nrf2-inhibitor Fosl1, which is upregulated by heme in PPAR alpha KO mice. We conclude that PPAR alpha plays a protective role in colon against oxidative stress, but PPAR alpha does not mediate heme-induced hyperproliferation. This implies that oxidative stress of surface cells is not the main determinant of heme-induced hyperproliferation and hyperplasia.	[IJssennagger, Noortje; de Wit, Nicole; Muller, Michael; van der Meer, Roelof] Top Inst Food & Nutr, Wageningen, Netherlands; [IJssennagger, Noortje; Muller, Michael; van der Meer, Roelof] Wageningen Univ, Div Human Nutr, Nutr Metab & Genom Grp, Wageningen, Netherlands; [de Wit, Nicole; Muller, Michael] Netherlands Nutrigen Ctr, Wageningen, Netherlands	Top Institute Food & Nutrition; Wageningen University & Research	IJssennagger, N (corresponding author), Top Inst Food & Nutr, Wageningen, Netherlands.	noortje.ijssennagger@wur.nl	Muller, Michael/M-5724-2019; Muller, Michael/B-5795-2008; Kleerebezem, Michiel/AAT-2078-2021; Derrien, Muriel/AAS-6845-2021	Muller, Michael/0000-0002-5930-9905; Muller, Michael/0000-0002-5930-9905; Derrien, Muriel/0000-0001-8841-9153; Kleerebezem, Michiel/0000-0001-8552-2235	program council of TIFN [A-1001]	program council of TIFN	This study was funded by the program council of TIFN (grant A-1001). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abdelmegeed MA, 2009, FREE RADICAL BIO MED, V47, P767, DOI 10.1016/j.freeradbiomed.2009.06.017; Andrews GK, 2000, BIOCHEM PHARMACOL, V59, P95, DOI 10.1016/S0006-2952(99)00301-9; Anton PM, 2002, DIGEST DIS SCI, V47, P1308, DOI 10.1023/A:1015322514547; Bastide NM, 2011, CANCER PREV RES, V4, P177, DOI 10.1158/1940-6207.CAPR-10-0113; Berruyer C, 2004, MOL CELL BIOL, V24, P7214, DOI 10.1128/MCB.24.16.7214-7224.2004; Bolstad BM, 2003, BIOINFORMATICS, V19, P185, DOI 10.1093/bioinformatics/19.2.185; Bunger M, 2007, PHYSIOL GENOMICS, V30, P192, DOI 10.1152/physiolgenomics.00198.2006; Dai MH, 2005, NUCLEIC ACIDS RES, V33, DOI 10.1093/nar/gni179; de Vogel J, 2005, CARCINOGENESIS, V26, P387, DOI 10.1093/carcin/bgh331; de Vogel J, 2008, CARCINOGENESIS, V29, P398, DOI 10.1093/carcin/bgm278; Gentleman RC, 2004, GENOME BIOL, V5, DOI 10.1186/gb-2004-5-10-r80; GIOVANNUCCI E, 1994, CANCER RES, V54, P2390; Harada T, 2003, AM J PHYSIOL-GASTR L, V284, pG255, DOI 10.1152/ajpgi.00244.2002; IJssennagger N, 2012, GUT, V61, P1041, DOI 10.1136/gutjnl-2011-300239; Irizarry RA, 2003, NUCLEIC ACIDS RES, V31, DOI 10.1093/nar/gng015; Jemal A, 2011, CA-CANCER J CLIN, V61, P133, DOI [10.3322/caac.20105, 10.3322/caac.20073]; Kinzler KW, 1996, CELL, V87, P159, DOI 10.1016/S0092-8674(00)81333-1; Larsson SC, 2005, INT J CANCER, V113, P829, DOI 10.1002/ijc.20658; Lee SJ, 2010, TOXICOL APPL PHARM, V242, P191, DOI 10.1016/j.taap.2009.10.007; LEE SST, 1995, MOL CELL BIOL, V15, P3012; Lin K, 2011, J INTEGR BIOINFORMAT, V8, DOI 10.2390/biecoll-jib-2011-160; Muoio DM, 2002, J BIOL CHEM, V277, P26089, DOI 10.1074/jbc.M203997200; Nguyen T, 2009, J BIOL CHEM, V284, P13291, DOI 10.1074/jbc.R900010200; OHKAWA H, 1979, ANAL BIOCHEM, V95, P351, DOI 10.1016/0003-2697(79)90738-3; Patsouris D, 2006, ENDOCRINOLOGY, V147, P1508, DOI 10.1210/en.2005-1132; Pialoux V, 2009, FREE RADICAL BIO MED, V46, P321, DOI 10.1016/j.freeradbiomed.2008.10.047; Pierre F, 2003, CARCINOGENESIS, V24, P1683, DOI 10.1093/carcin/bgg130; Pouyet L, 2010, INFLAMM BOWEL DIS, V16, P96, DOI 10.1002/ibd.21031; Rakhshandehroo M, 2010, PPAR RES, V2010, DOI 10.1155/2010/612089; Reddy SPM, 2002, AM J PHYSIOL-LUNG C, V283, pL1161, DOI 10.1152/ajplung.00140.2002; Sesink ALA, 1999, CANCER RES, V59, P5704; Thompson J, 1999, MOL CELL BIOCHEM, V192, P9, DOI 10.1023/A:1006806616963; Venugopal R, 1996, P NATL ACAD SCI USA, V93, P14960, DOI 10.1073/pnas.93.25.14960; Wang GQ, 2005, HEPATOLOGY, V42, P871, DOI 10.1002/hep.20857; World Cancer Research Fund and American Institute for Cancer Research, 2007, FOOD NUTR PHYS ACT P; Yamamoto T, 2007, J AM SOC NEPHROL, V18, P2894, DOI 10.1681/ASN.2007010097; Yang HP, 2005, MOL CELL BIOL, V25, P5933, DOI 10.1128/MCB.25.14.5933-5946.2005; Vincent ZA, 2007, BBA-MOL CELL BIOL L, V1771, P915, DOI 10.1016/j.bbalip.2007.01.007	38	74	75	2	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 14	2012	7	8							e43260	10.1371/journal.pone.0043260	http://dx.doi.org/10.1371/journal.pone.0043260			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	988OQ	23239972	gold, Green Submitted, Green Published			2022-12-25	WOS:000307500800068
J	Sun, P; Mantri, N; Lou, HQ; Hu, Y; Sun, D; Zhu, YQ; Dong, TT; Lu, HF				Sun, Peng; Mantri, Nitin; Lou, Heqiang; Hu, Ya; Sun, Dan; Zhu, Yueqing; Dong, Tingting; Lu, Hongfei			Effects of Elevated CO2 and Temperature on Yield and Fruit Quality of Strawberry (Fragaria x ananassa Duch.) at Two Levels of Nitrogen Application	PLOS ONE			English	Article							CARBON-DIOXIDE; ANTIOXIDANT ACTIVITY; LEAF SENESCENCE; ARABIDOPSIS-THALIANA; PHENOLIC METABOLISM; HARVEST INDEX; SEED-SET; GROWTH; STRESS; WHEAT	We investigated if elevated CO2 could alleviate the negative effect of high temperature on fruit yield of strawberry (Fragaria x ananassa Duch. cv. Toyonoka) at different levels of nitrogen and also tested the combined effects of CO2, temperature and nitrogen on fruit quality of plants cultivated in controlled growth chambers. Results show that elevated CO2 and high temperature caused a further 12% and 35% decrease in fruit yield at low and high nitrogen, respectively. The fewer inflorescences and smaller umbel size during flower induction caused the reduction of fruit yield at elevated CO2 and high temperature. Interestingly, nitrogen application has no beneficial effect on fruit yield, and this may be because of decreased sucrose export to the shoot apical meristem at floral transition. Moreover, elevated CO2 increased the levels of dry matter-content, fructose, glucose, total sugar and sweetness index per dry matter, but decreased fruit nitrogen content, total antioxidant capacity and all antioxidant compounds per dry matter in strawberry fruit. The reduction of fruit nitrogen content and antioxidant activity was mainly caused by the dilution effect of accumulated non-structural carbohydrates sourced from the increased net photosynthetic rate at elevated CO2. Thus, the quality of strawberry fruit would increase because of the increased sweetness and the similar amount of fruit nitrogen content, antioxidant activity per fresh matter at elevated CO2. Overall, we found that elevated CO2 improved the production of strawberry (including yield and quality) at low temperature, but decreased it at high temperature. The dramatic fluctuation in strawberry yield between low and high temperature at elevated CO2 implies that more attention should be paid to the process of flower induction under climate change, especially in fruits that require winter chilling for reproductive growth.	[Sun, Peng; Lou, Heqiang; Hu, Ya; Sun, Dan; Zhu, Yueqing; Dong, Tingting; Lu, Hongfei] Zhejiang Normal Univ, Coll Chem & Life Sci, Jinhua, Peoples R China; [Mantri, Nitin] RMIT Univ, Hlth Innovat Res Inst, Sch Appl Sci, Melbourne, Vic, Australia	Zhejiang Normal University; Royal Melbourne Institute of Technology (RMIT)	Sun, P (corresponding author), Zhejiang Normal Univ, Coll Chem & Life Sci, Jinhua, Peoples R China.	luhongfei63@yahoo.com.cn	Lu, Hongfei/F-9526-2013	Lu, Hongfei/0000-0001-9732-0833; Lan, Ruiting/0000-0001-9834-5258; Mantri, Nitin/0000-0002-7621-035X	Project of Scientific and Technological Research Plan of Jinhua [2010-3-078, 2010-3-079]	Project of Scientific and Technological Research Plan of Jinhua	This research was funded by the Project of Scientific and Technological Research Plan of Jinhua (2010-3-078, 2010-3-079). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aerts R, 2000, ADV ECOL RES, V30, P1, DOI 10.1016/S0065-2504(08)60016-1; AHMED FE, 1993, PLANT CELL ENVIRON, V16, P835, DOI 10.1111/j.1365-3040.1993.tb00505.x; American Society for Testing Materials, 2002, STAND TEST METH TOT; AVIGDORIAVIDOV H, 1977, ANN BOT-LONDON, V41, P927, DOI 10.1093/oxfordjournals.aob.a085389; BAKER JT, 1989, CROP SCI, V29, P98, DOI 10.2135/cropsci1989.0011183X002900010024x; Baldocchi D, 2008, CLIMATIC CHANGE, V87, pS153, DOI 10.1007/s10584-007-9367-8; Bernier G, 2005, PLANT BIOTECHNOL J, V3, P3, DOI 10.1111/j.1467-7652.2004.00114.x; Bernier G., 1981, PHYSL FLOWERING, VI; Buchanan-Wollaston V, 2003, PLANT BIOTECHNOL J, V1, P3, DOI 10.1046/j.1467-7652.2003.00004.x; Caldwell CR, 2005, J AGR FOOD CHEM, V53, P1125, DOI 10.1021/jf0355351; CASANO LM, 1994, PLANT PHYSIOL, V106, P1033, DOI 10.1104/pp.106.3.1033; Chen K, 1997, J APPL BOT-ANGEW BOT, V71, P195; Chen K, 1997, J APPL BOT-ANGEW BOT, V71, P183; Corbesier L, 2007, SCIENCE, V316, P1030, DOI 10.1126/science.1141752; Datta R, 2001, SEX PLANT REPROD, V14, P127, DOI 10.1007/s00497-001-0105-5; Deng X, 1998, ANN BOT-LONDON, V81, P67, DOI 10.1006/anbo.1997.0535; DIXON RA, 1994, ANNU REV PHYTOPATHOL, V32, P479, DOI 10.1146/annurev.py.32.090194.002403; Franzaring J, 2011, ENVIRON EXP BOT, V72, P284, DOI 10.1016/j.envexpbot.2011.04.003; Giorgi A, 2009, FOOD CHEM, V114, P204, DOI 10.1016/j.foodchem.2008.09.039; Goncalves B, 2009, J AGR FOOD CHEM, V57, P265, DOI 10.1021/jf8020199; Grindal G, 1998, J PLANT GROWTH REGUL, V17, P161, DOI 10.1007/PL00007030; Grossman A, 2001, ANNU REV PLANT PHYS, V52, P163, DOI 10.1146/annurev.arplant.52.1.163; Heinonen IM, 1998, J AGR FOOD CHEM, V46, P4107, DOI 10.1021/jf980181c; HERMS DA, 1992, Q REV BIOL, V67, P283, DOI 10.1086/417659; Hikosaka K, 2011, J EXP BOT, V62, P1523, DOI 10.1093/jxb/erq401; IPCC, 2007, CLIMATE CHANGE 2007, DOI DOI 10.1260/095830507781076194; Jablonski LM, 2002, NEW PHYTOL, V156, P9, DOI 10.1046/j.1469-8137.2002.00494.x; Keutgen A, 2007, FOOD CHEM, V105, P1487, DOI 10.1016/j.foodchem.2007.05.033; Konsin M, 2001, J HORTIC SCI BIOTECH, V76, P77, DOI 10.1080/14620316.2001.11511330; Kovacik J, 2007, PLANT SOIL, V297, P255, DOI 10.1007/s11104-007-9346-x; Kumakura H, 1995, JARQ-JPN AGR RES Q, V29, P241; Ledesma NA, 2008, SCI HORTIC-AMSTERDAM, V116, P186, DOI 10.1016/j.scienta.2007.12.010; Levine LH, 2009, ADV SPACE RES, V44, P887, DOI 10.1016/j.asr.2009.06.017; Li WL, 2007, AGR WATER MANAGE, V87, P106, DOI 10.1016/j.agwat.2006.06.027; Lieten F, 1997, ACTA HORTIC, P583, DOI 10.17660/ActaHortic.1997.439.97; Lin YL, 2011, PLANT GROWTH REGUL, V64, P263, DOI 10.1007/s10725-011-9567-0; Lu HF, 2011, J FOOD ENG, V104, P149, DOI 10.1016/j.jfoodeng.2010.12.007; Lu HF, 2010, J AGR FOOD CHEM, V58, P2995, DOI 10.1021/jf903655a; Matsui T, 1997, FIELD CROP RES, V51, P213, DOI 10.1016/S0378-4290(96)03451-X; McConnaughay KDM, 1996, GLOB CHANGE BIOL, V2, P25, DOI 10.1111/j.1365-2486.1996.tb00046.x; MORISHITA M, 1993, J JPN SOC HORTIC SCI, V61, P857, DOI 10.2503/jjshs.61.857; Neill S, 2002, CURR OPIN PLANT BIOL, V5, P388, DOI 10.1016/S1369-5266(02)00282-0; NITSCH J. P., 1952, QUART REV BIOL, V27, P33, DOI 10.1086/398643; Porch TG, 2001, PLANT CELL ENVIRON, V24, P723, DOI 10.1046/j.1365-3040.2001.00716.x; Prasad PVV, 2006, AGR FOREST METEOROL, V139, P237, DOI 10.1016/j.agrformet.2006.07.003; Prasad PVV, 2006, FIELD CROP RES, V95, P398, DOI 10.1016/j.fcr.2005.04.008; Prasad PVV, 2003, GLOBAL CHANGE BIOL, V9, P1775, DOI [10.1046/j.1365-2486.2003.00708.x, 10.1046/j.1529-8817.2003.00708.x]; Prasad PVV, 2002, GLOBAL CHANGE BIOL, V8, P710, DOI 10.1046/j.1365-2486.2002.00508.x; Pressman E, 2002, ANN BOT-LONDON, V90, P631, DOI 10.1093/aob/mcf240; Quesada MA, 2009, PLANT PHYSIOL, V150, P1022, DOI 10.1104/pp.109.138297; Re R, 1999, FREE RADICAL BIO MED, V26, P1231, DOI 10.1016/S0891-5849(98)00315-3; Reddy KR, 2000, CLIMATE CHANGE AND GLOBAL CROP PRODUCTIVITY, P161, DOI 10.1079/9780851994390.0161; SAINI HS, 1982, ANN BOT-LONDON, V49, P835, DOI 10.1093/oxfordjournals.aob.a086310; Santos BM, 2009, INT J FRUIT SCI, V9, P126, DOI 10.1080/15538360902991337; Sato S, 2000, PLANT CELL ENVIRON, V23, P719, DOI 10.1046/j.1365-3040.2000.00589.x; Su WR, 2001, PLANT PHYSIOL BIOCH, V39, P45, DOI 10.1016/S0981-9428(00)01218-3; Sung SB, 2004, NATURE, V427, P159, DOI 10.1038/nature02195; Suzuki K, 2001, J AM SOC HORTIC SCI, V126, P571, DOI 10.21273/JASHS.126.5.571; Taub DR, 2008, J INTEGR PLANT BIOL, V50, P1365, DOI 10.1111/j.1744-7909.2008.00754.x; TAYLOR DR, 1994, PLANT GROWTH REGUL, V15, P235, DOI 10.1007/BF00029896; vanTienderen PH, 1996, AM J BOT, V83, P169, DOI 10.2307/2445934; Wang SY, 2004, J SCI FOOD AGR, V84, P1464, DOI 10.1002/jsfa.1824; Wang SY, 2003, J AGR FOOD CHEM, V51, P4315, DOI 10.1021/jf021172d; Wheeler TR, 1996, J AGR SCI, V127, P37, DOI 10.1017/S0021859600077352; Xiao G., 2009, ACTA ECOL SIN, V29, P205, DOI [10.1016/j.chnaes.2009.08.002, DOI 10.1016/J.CHNAES.2009.08.002]; Xiong W, 2007, CLIMATIC CHANGE, V81, P205, DOI 10.1007/s10584-006-9123-5; Yamasaki A, 2000, J JPN SOC HORTIC SCI, V69, P40, DOI 10.2503/jjshs.69.40; Yoshida H, 2011, FIELD CROP RES, V124, P433, DOI 10.1016/j.fcr.2011.07.016; Zheng H, 2011, J AGR FOOD CHEM, V59, P592, DOI 10.1021/jf1032476; Zheng H, 2010, J FOOD ENG, V101, P402, DOI 10.1016/j.jfoodeng.2010.07.028; Zhu CW, 2009, FUNCT PLANT BIOL, V36, P291, DOI 10.1071/FP08269	71	61	62	2	95	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 24	2012	7	7							e41000	10.1371/journal.pone.0041000	http://dx.doi.org/10.1371/journal.pone.0041000			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	978NX	23049947	Green Published, Green Submitted, gold			2022-12-25	WOS:000306751300020
J	Jin, XM; Ishii, H; Bai, ZB; Itokazu, T; Yamashita, T				Jin, Xuemei; Ishii, Hiroshi; Bai, Zhongbin; Itokazu, Takahide; Yamashita, Toshihide			Temporal Changes in Cell Marker Expression and Cellular Infiltration in a Controlled Cortical Impact Model in Adult Male C57BL/6 Mice	PLOS ONE			English	Article							TRAUMATIC BRAIN-INJURY; SPINAL-CORD-INJURY; CERVICAL LYMPH-NODES; FUNCTIONAL RECOVERY; IMMUNE-RESPONSE; T-CELLS; INFLAMMATION; MICROGLIA; SYSTEM; CNS	Background: Traumatic injury to the central nervous system (CNS) triggers a robust inflammatory response that leads to axonal damage and secondary degeneration of spared tissue. In contrast, some immune responses have neuroprotective effects. However, detailed information regarding the dynamics of immune responses after traumatic CNS injury is still unavailable. Methods: In the present study, changes in the immune cells present in the injured brain, spleen, and cervical lymph nodes (CLNs), which are draining lymphatic organs from the CNS, were analyzed after controlled cortical impact (CCI) by flow cytometry and immunohistochemistry. Results: The number of neutrophils and macrophages that infiltrated the injured brain immediately increased 1 d post-injury and declined rapidly thereafter. In the injured brain, resident microglia showed a bimodal increase during the first week and in the chronic phase (>= 3 weeks) after injury. Increase in the Iba-1(+) microglia/macrophages was observed around the injured site. Morphologic analysis showed that Iba-1(+) cells were round at 1 week, whereas those at 3 weeks were more ramified. Furthermore, CD86(+)/CD11b(+) M1-like microglia increased at 4 weeks after CCI, whereas CD206(+)/CD11b(+) M2-like microglia increased at 1 week. These results suggest that different subsets of microglia increased in the acute and chronic phases after CCI. Dendritic cells and T cells increased transiently within 1 week in the injured brain. In the CLNs and the spleen, T cells showed dynamic changes after CCI. In particular, the alteration in the number of T cells in the CLNs showed a similar pattern, with a 1-week delay, to that of microglia in the injured brain. Conclusion: The data from this study provide useful information on the dynamics of immune cells in CNS injuries.	[Jin, Xuemei; Ishii, Hiroshi; Itokazu, Takahide; Yamashita, Toshihide] Osaka Univ, Grad Sch Med, Dept Mol Neurosci, Suita, Osaka, Japan; [Jin, Xuemei; Ishii, Hiroshi; Itokazu, Takahide; Yamashita, Toshihide] Japan Sci & Technol Agcy JST, CREST, Chiyoda Ku, Tokyo, Japan; [Bai, Zhongbin] Yunnan Agr Univ, Key Lab Puer Tea Sci, Minist Educ, Kunming, Peoples R China	Osaka University; Japan Science & Technology Agency (JST); Yunnan Agricultural University	Jin, XM (corresponding author), Osaka Univ, Grad Sch Med, Dept Mol Neurosci, Suita, Osaka, Japan.	yamashita@molneu.med.osaka-u.ac.jp	Schierup, Mikkel Heide/F-1675-2010; Wang, Jun/C-8434-2016; FANG, Xiaodong/K-6743-2018; Wang, Jun/B-9503-2016; Zhang, Guojie/J-7273-2019	Schierup, Mikkel Heide/0000-0002-5028-1790; Meng, Yuhuan/0000-0001-7464-3103; He, Mingze/0000-0002-8164-2480; Wang, Jun/0000-0002-8540-8931; FANG, Xiaodong/0000-0001-7061-3337; Mailund, Thomas/0000-0001-6206-9239; Hvilsom, Christina/0000-0001-7870-6888; Jin, Xin/0000-0001-7554-4975; Yamashita, Toshihide/0000-0003-4559-7018; Itokazu, Takahide/0000-0003-2977-7190; Wang, Jun/0000-0002-2113-5874; Zhang, Guojie/0000-0001-6860-1521	Core Research for Evolutional Science and Technology (CREST); Japan Science and Technology Agency (JST)	Core Research for Evolutional Science and Technology (CREST)(Core Research for Evolutional Science and Technology (CREST)); Japan Science and Technology Agency (JST)(Japan Science & Technology Agency (JST))	This work was supported by Core Research for Evolutional Science and Technology (CREST), Japan Science and Technology Agency (JST). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aloisi F, 2001, GLIA, V36, P165, DOI 10.1002/glia.1106; Arneth BM, 2010, J NEUROIMMUNOL, V219, P123, DOI 10.1016/j.jneuroim.2009.12.011; Bechmann I, 2007, TRENDS IMMUNOL, V28, P5, DOI 10.1016/j.it.2006.11.007; Beck KD, 2010, BRAIN, V133, P433, DOI 10.1093/brain/awp322; Campanella M, 2002, STROKE, V33, P586, DOI 10.1161/hs0202.103399; Carson MJ, 2006, CLIN NEUROSCI RES, V6, P237, DOI 10.1016/j.cnr.2006.09.004; CLARK RSB, 1994, J NEUROTRAUM, V11, P499, DOI 10.1089/neu.1994.11.499; Clausen F, 2007, J NEUROTRAUM, V24, P1295, DOI 10.1089/neu.2006.0258; CSERR HF, 1992, IMMUNOL TODAY, V13, P507, DOI 10.1016/0167-5699(92)90027-5; Dardiotis E, 2012, BRAIN INJURY PATHOGE; De Haas AH, 2007, GLIA, V55, P1374, DOI 10.1002/glia.20554; de Vos AF, 2002, J IMMUNOL, V169, P5415, DOI 10.4049/jimmunol.169.10.5415; Derecki NC, 2010, J EXP MED, V207, P1067, DOI 10.1084/jem.20091419; Donnelly DJ, 2008, EXP NEUROL, V209, P378, DOI 10.1016/j.expneurol.2007.06.009; Foley LM, 2009, J NEUROTRAUM, V26, P1509, DOI 10.1089/neu.2008.0747; FORD AL, 1995, J IMMUNOL, V154, P4309; Galea I, 2007, TRENDS IMMUNOL, V28, P12, DOI 10.1016/j.it.2006.11.004; Gensel JC, 2011, EXPERT OPIN THER TAR, V15, P505, DOI 10.1517/14728222.2011.553605; Ghirnikar RS, 1998, NEUROCHEM RES, V23, P329, DOI 10.1023/A:1022453332560; Greter M, 2005, NAT MED, V11, P328, DOI 10.1038/nm1197; Hatterer E, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003321; Hawkins BT, 2005, PHARMACOL REV, V57, P173, DOI 10.1124/pr.57.2.4; Herz J, 2010, EXP NEUROL, V225, P9, DOI 10.1016/j.expneurol.2009.11.019; Kenne E, 2012, J NEUROINFLAMM, V9, DOI 10.1186/1742-2094-9-17; Kettenmann H, 2011, PHYSIOL REV, V91, P461, DOI 10.1152/physrev.00011.2010; Kigerl KA, 2009, J NEUROSCI, V29, P13435, DOI 10.1523/JNEUROSCI.3257-09.2009; Klemann C, 2009, AM J PATHOL, V174, P2234, DOI 10.2353/ajpath.2009.081084; Loane DJ, 2010, NEUROTHERAPEUTICS, V7, P366, DOI 10.1016/j.nurt.2010.07.002; Mantovani A, 2004, TRENDS IMMUNOL, V25, P677, DOI 10.1016/j.it.2004.09.015; Morganti-Kossmann MC, 2007, INJURY, V38, P1392, DOI 10.1016/j.injury.2007.10.005; Morganti-Kossmann MC, 2001, SHOCK, V16, P165, DOI 10.1097/00024382-200116030-00001; Nguyen HX, 2011, JOVE-J VIS EXP, DOI 10.3791/2698; Omoto S, 2010, J NEUROSCI, V30, P13045, DOI 10.1523/JNEUROSCI.3228-10.2010; Ransohoff RM, 2003, NAT REV IMMUNOL, V3, P569, DOI 10.1038/nri1130; Rhodes J, 2011, CURR OPIN CRIT CARE, V17, P122, DOI 10.1097/MCC.0b013e3283447948; Rivest S, 2009, NAT REV IMMUNOL, V9, P429, DOI 10.1038/nri2565; Sagar D, 2012, J NEUROIMMUNE PHARM, V7, P74, DOI 10.1007/s11481-011-9302-7; Saunders NR, 1999, CLIN EXP PHARMACOL P, V26, P11, DOI 10.1046/j.1440-1681.1999.02986.x; Schroeter M, 2005, NEUROMOL MED, V7, P183, DOI 10.1385/NMM:7:3:183; Schwartz M, 2005, ACTA NEUROCHIR SUPPL, V93, P147; Shichita T, 2009, NAT MED, V15, P946, DOI 10.1038/nm.1999; Soares HD, 1995, J NEUROSCI, V15, P8223; Veenith Tonny, 2009, World J Emerg Surg, V4, P7, DOI 10.1186/1749-7922-4-7; WIDNER H, 1988, SCAND J IMMUNOL, V28, P563, DOI 10.1111/j.1365-3083.1988.tb01488.x; Wilson EH, 2010, J CLIN INVEST, V120, P1368, DOI 10.1172/JCI41911; YAMADA S, 1991, AM J PHYSIOL, V261, pH1197, DOI 10.1152/ajpheart.1991.261.4.H1197; Ziebell JM, 2010, NEUROTHERAPEUTICS, V7, P22, DOI 10.1016/j.nurt.2009.10.016; Zindler E, 2010, BEST PRACT RES-CLIN, V24, P551, DOI 10.1016/j.bpa.2010.11.001	48	135	140	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 24	2012	7	7							e41892	10.1371/journal.pone.0041892	http://dx.doi.org/10.1371/journal.pone.0041892			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	978NX	22848389	Green Published, gold, Green Submitted			2022-12-25	WOS:000306751300081
J	Yueh, MF; Li, T; Evans, RM; Hammock, B; Tukey, RH				Yueh, Mei-Fei; Li, Tao; Evans, Ronald M.; Hammock, Bruce; Tukey, Robert H.			Triclocarban Mediates Induction of Xenobiotic Metabolism through Activation of the Constitutive Androstane Receptor and the Estrogen Receptor Alpha	PLOS ONE			English	Article							WASTE-WATER TREATMENT; UDP-GLUCURONOSYLTRANSFERASE-1 UGT1 LOCUS; INHIBITORY CROSS-TALK; NUCLEAR RECEPTOR; IN-VITRO; ANTIMICROBIAL TRICLOCARBAN; SIGNALING PATHWAY; GENE-EXPRESSION; TRANSGENIC MICE; HUMAN LIVER	Triclocarban (3,4,4'-trichlorocarbanilide, TCC) is used as a broad-based antimicrobial agent that is commonly added to personal hygiene products. Because of its extensive use in the health care industry and resistance to degradation in sewage treatment processes, TCC has become a significant waste product that is found in numerous environmental compartments where humans and wildlife can be exposed. While TCC has been linked to a range of health and environmental effects, few studies have been conducted linking exposure to TCC and induction of xenobiotic metabolism through regulation by environmental sensors such as the nuclear xenobiotic receptors (XenoRs). To identify the ability of TCC to activate xenobiotic sensors, we monitored XenoR activities in response to TCC treatment using luciferase-based reporter assays. Among the XenoRs in the reporter screening assay, TCC promotes both constitutive androstane receptor (CAR) and estrogen receptor alpha (ER alpha) activities. TCC treatment to hUGT1 mice resulted in induction of the UGT1A genes in liver. This induction was dependent upon the constitutive active/androstane receptor (CAR) because no induction occurred in hUGT1Car(-/-) mice. Induction of the UGT1A genes by TCC corresponded with induction of Cyp2b10, another CAR target gene. TCC was demonstrated to be a phenobarbital-like activator of CAR in receptor-based assays. While it has been suggested that TCC be classified as an endocrine disruptor, it activates ER alpha leading to induction of Cyp1b1 in female ovaries as well as in promoter activity. Activation of ER alpha by TCC in receptor-based assays also promotes induction of human CYP2B6. These observations demonstrate that TCC activates nuclear xenobiotic receptors CAR and ER alpha both in vivo and in vitro and might have the potential to alter normal physiological homeostasis. Activation of these xenobiotic-sensing receptors amplifies gene expression profiles that might represent a mechanistic base for potential human health effects from exposure to TCC.	[Tukey, Robert H.] Salk Inst Biol Studies, Howard Hughes Med Inst, Dept Chem, Lab Environm Toxicol, La Jolla, CA 92037 USA; [Li, Tao; Evans, Ronald M.] Salk Inst Biol Studies, Howard Hughes Med Inst, Gene Express Lab, La Jolla, CA 92037 USA; [Hammock, Bruce] Univ Calif Davis, Ctr Canc, Dept Entomol, Davis, CA 95616 USA; [Tukey, Robert H.] Salk Inst Biol Studies, Howard Hughes Med Inst, Dept Biochem, Lab Environm Toxicol, La Jolla, CA 92037 USA; [Yueh, Mei-Fei; Tukey, Robert H.] Salk Inst Biol Studies, Howard Hughes Med Inst, Dept Pharmacol, Lab Environm Toxicol, La Jolla, CA 92037 USA	Howard Hughes Medical Institute; Salk Institute; Howard Hughes Medical Institute; Salk Institute; University of California System; University of California Davis; Howard Hughes Medical Institute; Salk Institute; Howard Hughes Medical Institute; Salk Institute	Yueh, MF (corresponding author), Salk Inst Biol Studies, Howard Hughes Med Inst, Dept Pharmacol, Lab Environm Toxicol, 10010 N Torrey Pines Rd, La Jolla, CA 92037 USA.	rtukey@ucsd.edu	Evans, Ronald/AAF-4001-2019	Evans, Ronald/0000-0002-9986-5965; Evans, Richard/0000-0002-8651-6889	United States Public Health Service [P42ES010337]; ARRA Supplement [P42ES010337, P42ES004699, GM086713]; NATIONAL CANCER INSTITUTE [P30CA014195] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [P42ES004699, P42ES010337] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM100481, R01GM086713] Funding Source: NIH RePORTER	United States Public Health Service(United States Department of Health & Human ServicesUnited States Public Health Service); ARRA Supplement; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	Funding for this work was provided by United States Public Health Service Grants P42ES010337 (RE and RHT), a 2009 ARRA Supplement to Superfund grant P42ES010337 (RHT and MFY) and P42ES004699 (BDH), and GM086713 (RHT). BDH is a George and Judy Marcus Senior Fellow of the American Asthma Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahn KC, 2008, ENVIRON HEALTH PERSP, V116, P1203, DOI 10.1289/ehp.11200; Cai HL, 2010, DRUG METAB DISPOS, V38, P879, DOI 10.1124/dmd.109.030130; Carthew P, 1998, TOXICOL SCI, V44, P46, DOI 10.1093/toxsci/44.1.46; Chen F, 2011, ENVIRON POLLUT, V159, P1490, DOI 10.1016/j.envpol.2011.03.016; Chen JG, 2008, ENDOCRINOLOGY, V149, P1173, DOI 10.1210/en.2007-1057; Chen SJ, 2005, J BIOL CHEM, V280, P37547, DOI 10.1074/jbc.M506683200; Chen XS, 2011, LAB INVEST, V91, P1136, DOI 10.1038/labinvest.2011.68; Christen V, 2010, CHEMOSPHERE, V81, P1245, DOI 10.1016/j.chemosphere.2010.09.031; Downes M, 2003, MOL CELL, V11, P1079, DOI 10.1016/S1097-2765(03)00104-7; Forman BM, 1998, NATURE, V395, P612, DOI 10.1038/26996; Fujiwara R, 2010, P NATL ACAD SCI USA, V107, P5024, DOI 10.1073/pnas.0913290107; Giudice BD, 2010, ENVIRON TOXICOL CHEM, V29, P966, DOI 10.1002/etc.105; Halden RU, 2005, ENVIRON SCI TECHNOL, V39, P1420, DOI 10.1021/es049071e; Heidler J, 2008, ENVIRON SCI TECHNOL, V42, P6324, DOI 10.1021/es703008y; Heidler J, 2006, ENVIRON SCI TECHNOL, V40, P3634, DOI 10.1021/es052245n; Higgins CP, 2009, ENVIRON TOXICOL CHEM, V28, P2580, DOI 10.1897/09-013.1; HILES RA, 1978, DRUG METAB DISPOS, V6, P177; Kawamoto T, 2000, MOL ENDOCRINOL, V14, P1897, DOI 10.1210/me.14.11.1897; Kumar KS, 2010, ARCH ENVIRON CON TOX, V58, P275, DOI 10.1007/s00244-009-9383-y; Lee AJ, 2003, ENDOCRINOLOGY, V144, P3382, DOI 10.1210/en.2003-0192; Liu JY, 2011, TOXICOL APPL PHARM, V255, P200, DOI 10.1016/j.taap.2011.06.017; Lo R, 2010, BBA-GENE REGUL MECH, V1799, P469, DOI 10.1016/j.bbagrm.2010.01.005; Maglich JM, 2003, J BIOL CHEM, V278, P17277, DOI 10.1074/jbc.M300138200; Makishima M, 2002, SCIENCE, V296, P1313, DOI 10.1126/science.1070477; MANGELSDORF DJ, 1995, CELL, V83, P841, DOI 10.1016/0092-8674(95)90200-7; Miao J, 2006, J BIOL CHEM, V281, P14537, DOI 10.1074/jbc.M510713200; Min GS, 2002, J BIOL CHEM, V277, P34626, DOI 10.1074/jbc.M205239200; Nguyen N, 2008, J BIOL CHEM, V283, P7901, DOI 10.1074/jbc.M709244200; Perencevich EN, 2001, AM J INFECT CONTROL, V29, P281, DOI 10.1067/mic.2001.115469; Saez E, 2004, GENE DEV, V18, P528, DOI 10.1101/gad.1167804; Schebb NH, 2011, ENVIRON SCI TECHNOL, V45, P3109, DOI 10.1021/es103650m; Scientific Commitee on Consumer Products (2005) SCCP, 2005, SCCP085104; Senekeo-Effenberger K, 2007, DRUG METAB DISPOS, V35, P419, DOI 10.1124/dmd.106.013243d; Strassburg CP, 1997, MOL PHARMACOL, V52, P212, DOI 10.1124/mol.52.2.212; Strassburg CP, 1998, MOL PHARMACOL, V54, P647; Strassburg CP, 1997, CANCER RES, V57, P2979; Sueyoshi T, 1999, J BIOL CHEM, V274, P6043, DOI 10.1074/jbc.274.10.6043; Tsuchiya Y, 2004, CANCER RES, V64, P3119, DOI 10.1158/0008-5472.CAN-04-0166; Tukey RH, 2001, MOL PHARMACOL, V59, P405, DOI 10.1124/mol.59.3.405; Ueda A, 2002, MOL PHARMACOL, V61, P1, DOI 10.1124/mol.61.1.1; UMESONO K, 1988, NATURE, V336, P262, DOI 10.1038/336262a0; UMESONO K, 1989, CELL, V57, P1139, DOI 10.1016/0092-8674(89)90051-2; Walsh SE, 2003, J APPL MICROBIOL, V94, P240, DOI 10.1046/j.1365-2672.2003.01825.x; Wang HB, 2008, CURR DRUG METAB, V9, P598, DOI 10.2174/138920008785821710; WILLY PJ, 1995, GENE DEV, V9, P1033, DOI 10.1101/gad.9.9.1033; Xie W, 2000, NATURE, V406, P435, DOI 10.1038/35019116; Xie W, 2003, P NATL ACAD SCI USA, V100, P4150, DOI 10.1073/pnas.0438010100; Xie W, 2000, GENE DEV, V14, P3014, DOI 10.1101/gad.846800; Yamamoto Y, 2004, CANCER RES, V64, P7197, DOI 10.1158/0008-5472.CAN-04-1459; Yueh MF, 2011, MOL PHARMACOL, V79, P1053, DOI 10.1124/mol.110.070649; Yueh MF, 2007, J BIOL CHEM, V282, P8749, DOI 10.1074/jbc.M610790200	51	59	61	0	28	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 15	2012	7	6							e37705	10.1371/journal.pone.0037705	http://dx.doi.org/10.1371/journal.pone.0037705			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959WX	22912892	Green Published, gold			2022-12-25	WOS:000305350000007
J	IJssennagger, N; Derrien, M; van Doorn, GM; Rijnierse, A; van den Bogert, B; Muller, M; Dekker, J; Kleerebezem, M; van der Meer, R				IJssennagger, Noortje; Derrien, Muriel; van Doorn, Gerdien M.; Rijnierse, Anneke; van den Bogert, Bartholomeus; Muller, Michael; Dekker, Jan; Kleerebezem, Michiel; van der Meer, Roelof			Dietary Heme Alters Microbiota and Mucosa of Mouse Colon without Functional Changes in Host-Microbe Cross-Talk	PLOS ONE			English	Article							ALKALINE-PHOSPHATASE; RED MEAT; COLORECTAL-CANCER; HYDROGEN-SULFIDE; RISK; GUT; INHIBITOR; SHOCK; CONSUMPTION; MODULATION	Colon cancer is a major cause of cancer deaths in Western countries and is associated with diets high in red meat. Heme, the iron-porphyrin pigment of red meat, induces cytotoxicity of gut contents which injures surface cells leading to compensatory hyperproliferation of crypt cells. This hyperproliferation results in epithelial hyperplasia which increases the risk of colon cancer. In humans, a high red-meat diet increases Bacteroides spp in feces. Therefore, we simultaneously investigated the effects of dietary heme on colonic microbiota and on the host mucosa of mice. Whole genome microarrays showed that heme injured the colonic surface epithelium and induced hyperproliferation by changing the surface to crypt signaling. Using 16S rRNA phylogenetic microarrays, we investigated whether bacteria play a role in this changed signaling. Heme increased Bacteroidetes and decreased Firmicutes in colonic contents. This shift was most likely caused by a selective susceptibility of Gram-positive bacteria to heme cytotoxic fecal water, which is not observed for Gram-negative bacteria, allowing expansion of the Gram-negative community. The increased amount of Gram-negative bacteria most probably increased LPS exposure to colonocytes, however, there is no appreciable immune response detected in the heme-fed mice. There was no functional change in the sensing of the bacteria by the mucosa, as changes in inflammation pathways and Toll-like receptor signaling were not detected. This unaltered host-microbe cross-talk indicates that the changes in microbiota did not play a causal role in the observed hyperproliferation and hyperplasia.	[IJssennagger, Noortje; Derrien, Muriel; van Doorn, Gerdien M.; Rijnierse, Anneke; van den Bogert, Bartholomeus; Muller, Michael; Dekker, Jan; Kleerebezem, Michiel; van der Meer, Roelof] Top Inst Food & Nutr, Wageningen, Netherlands; [IJssennagger, Noortje; Rijnierse, Anneke; Muller, Michael; van der Meer, Roelof] Wageningen Univ, Div Human Nutr, Nutr Metab & Genom Grp, Wageningen, Netherlands; [Derrien, Muriel; van Doorn, Gerdien M.; van den Bogert, Bartholomeus; Kleerebezem, Michiel] Wageningen Univ, Microbiol Lab, Wageningen, Netherlands; [Kleerebezem, Michiel] NIZO Food Res, Ede, Netherlands	Top Institute Food & Nutrition; Wageningen University & Research; Wageningen University & Research; NIZO Food Research	Muller, M (corresponding author), Top Inst Food & Nutr, Wageningen, Netherlands.	michiel.kleerebezem@nizo.nl	Muller, Michael/M-5724-2019; Muller, Michael/B-5795-2008; Kleerebezem, Michiel/AAT-2078-2021; Derrien, Muriel/AAS-6845-2021	Muller, Michael/0000-0002-5930-9905; Muller, Michael/0000-0002-5930-9905; Derrien, Muriel/0000-0001-8841-9153; Kleerebezem, Michiel/0000-0001-8552-2235	program council of Top Institute Food and Nutrition (TIFN), Wageningen, the Netherlands [A-1001]	program council of Top Institute Food and Nutrition (TIFN), Wageningen, the Netherlands	This study was funded only by the program council of Top Institute Food and Nutrition (TIFN), Wageningen, the Netherlands (grant A-1001). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aderem A, 2000, NATURE, V406, P782, DOI 10.1038/35021228; ALJALILI TAR, 1988, CURR MICROBIOL, V17, P13, DOI 10.1007/BF01568812; Attene-Ramos MS, 2010, ENVIRON MOL MUTAGEN, V51, P304, DOI 10.1002/em.20546; Balder HF, 2006, CANCER EPIDEM BIOMAR, V15, P717, DOI 10.1158/1055-9965.EPI-05-0772; Bates JM, 2007, CELL HOST MICROBE, V2, P371, DOI 10.1016/j.chom.2007.10.010; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Bernstein H, 2005, MUTAT RES-REV MUTAT, V589, P47, DOI 10.1016/j.mrrev.2004.08.001; Bovee-Oudenhoven IM, 1999, J NUTR, V129, P607, DOI 10.1093/jn/129.3.607; CARTER RL, 1989, PSYCHOMETRIKA, V54, P9, DOI 10.1007/BF02294446; Collins D, 2011, LANCET ONCOL, V12, P504, DOI 10.1016/S1470-2045(10)70186-8; Dai MH, 2005, NUCLEIC ACIDS RES, V33, DOI 10.1093/nar/gni179; de Vogel J, 2005, CARCINOGENESIS, V26, P387, DOI 10.1093/carcin/bgh331; de Vogel J, 2008, CARCINOGENESIS, V29, P398, DOI 10.1093/carcin/bgm278; Fund WCR Research AIfC, 2007, FOOD NUTR PHYS ACT P, V1; Geurts L, 2011, FRONT MICROBIOL, V2, DOI 10.3389/fmicb.2011.00149; GIOVANNUCCI E, 1994, CANCER RES, V54, P2390; Harada T, 2003, AM J PHYSIOL-GASTR L, V284, pG255, DOI 10.1152/ajpgi.00244.2002; Huycke MM, 2004, EXP BIOL MED, V229, P586, DOI 10.1177/153537020422900702; IJssennagger N, 2011, GUT; Irizarry RA, 2003, BIOSTATISTICS, V4, P249, DOI 10.1093/biostatistics/4.2.249; Irizarry RA, 2003, NUCLEIC ACIDS RES, V31, DOI 10.1093/nar/gng015; Jemal A, 2008, CA-CANCER J CLIN, V58, P71, DOI 10.3322/CA.2007.0010; Johansson MEV, 2008, P NATL ACAD SCI USA, V105, P15064, DOI 10.1073/pnas.0803124105; Kleerebezem M, 2003, P NATL ACAD SCI USA, V100, P1990, DOI 10.1073/pnas.0337704100; Lalles JP, 2010, NUTR REV, V68, P323, DOI 10.1111/j.1753-4887.2010.00292.x; LAPRE JA, 1992, AM J PHYSIOL, V263, pG333, DOI 10.1152/ajpgi.1992.263.3.G333; Larsson SC, 2005, INT J CANCER, V113, P829, DOI 10.1002/ijc.20658; Lee DH, 2004, JNCI-J NATL CANCER I, V96, P403, DOI 10.1093/jnci/djh047; Levitt MD, 1999, J CLIN INVEST, V104, P1107, DOI 10.1172/JCI7712; Lewin MH, 2006, CANCER RES, V66, P1859, DOI 10.1158/0008-5472.CAN-05-2237; Lin K, 2011, J INTEGR BIOINFORMAT, V8, DOI 10.2390/biecoll-jib-2011-160; MAIER BR, 1974, AM J CLIN NUTR, V27, P1470, DOI 10.1093/ajcn/27.12.1470; Marchiando AM, 2011, GASTROENTEROLOGY, V140, P1208, DOI 10.1053/j.gastro.2011.01.004; McGarr SE, 2005, J CLIN GASTROENTEROL, V39, P98; McGuckin MA, 2011, NAT REV MICROBIOL, V9, P265, DOI 10.1038/nrmicro2538; Meijerink M, 2010, BENEF MICROBES, V1, P317, DOI 10.3920/BM2010.0029; Nakamura A, 2003, J EXP MED, V197, P669, DOI 10.1084/jem.20021824; NITZAN Y, 1994, CURR MICROBIOL, V29, P125, DOI 10.1007/BF01570752; Nobles CL, 2011, METALLOMICS, V3, P788, DOI 10.1039/c1mt00047k; O'Keefe SJD, 2008, CURR OPIN GASTROEN, V24, P51, DOI 10.1097/MOG.0b013e3282f323f3; Parham NJ, 2000, FEMS MICROBIOL ECOL, V31, P21, DOI 10.1111/j.1574-6941.2000.tb00667.x; Pierre F, 2003, CARCINOGENESIS, V24, P1683, DOI 10.1093/carcin/bgg130; Poelstra K, 1997, AM J PATHOL, V151, P1163; Rajilic-Stojanovic M, 2009, ENVIRON MICROBIOL, V11, P1736, DOI 10.1111/j.1462-2920.2009.01900.x; Ridlon JM, 2006, J LIPID RES, V47, P241, DOI 10.1194/jlr.R500013-JLR200; Salonen A, 2010, J MICROBIOL METH, V81, P127, DOI 10.1016/j.mimet.2010.02.007; Schepens MAA, 2011, NUTRITION, V27, P590, DOI 10.1016/j.nut.2010.05.002; SCHWARTZ S, 1985, GASTROENTEROLOGY, V89, P19, DOI 10.1016/0016-5085(85)90740-1; Sesink ALA, 1999, CANCER RES, V59, P5704; Si-Tahar M, 2000, GASTROENTEROLOGY, V118, P1061, DOI 10.1016/S0016-5085(00)70359-3; Vaishnava S, 2007, CELL HOST MICROBE, V2, P365, DOI 10.1016/j.chom.2007.11.004; Vandenabeele P, 2010, SCI SIGNAL, V3, DOI 10.1126/scisignal.3115re4; Williams SE, 2006, CLIN SCI, V110, P21, DOI 10.1042/CS20050115; Xu WF, 2007, NAT IMMUNOL, V8, P294, DOI 10.1038/ni1434; YOUNG GP, 1989, J GASTROEN HEPATOL, V4, P537, DOI 10.1111/j.1440-1746.1989.tb00858.x; Zhang XH, 2011, CANCER CAUSE CONTROL, V22, P1627, DOI 10.1007/s10552-011-9839-z; Zimmer J, 2012, EUR J CLIN NUTR, V66, P53, DOI 10.1038/ejcn.2011.141	57	74	75	2	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 11	2012	7	12							e49868	10.1371/journal.pone.0049868	http://dx.doi.org/10.1371/journal.pone.0049868			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	053RN	23239972	Green Published, gold, Green Submitted			2022-12-25	WOS:000312290800010
J	Wang, XM; Mao, XO; Xie, L; Sun, F; Greenberg, DA; Jin, KL				Wang, Xiaomei; Mao, XiaoOu; Xie, Lin; Sun, Fen; Greenberg, David A.; Jin, Kunlin			Conditional Depletion of Neurogenesis Inhibits Long-Term Recovery after Experimental Stroke in Mice	PLOS ONE			English	Article							FOCAL CEREBRAL-ISCHEMIA; SUBVENTRICULAR ZONE; FOREBRAIN NEUROGENESIS; BRAIN; CELLS; REPLACEMENT; PRECURSORS; MIGRATION; NEURONS	We reported previously that ablation of doublecortin (DCX)-immunopositive newborn neurons in mice worsens anatomical and functional outcome measured 1 day after experimental stroke, but whether this effect persists is unknown. We generated transgenic mice that express herpes simplex virus thymidine kinase under control of the DCX promoter (DCX-TK transgenic mice). DCX-expressing and recently divided cells in the rostral subventricular zone (SVZ) and hippocampus of DCX-TK transgenic mice, but not wild-type mice, were specifically depleted after ganciclovir (GCV) treatment for 14 days. Focal cerebral ischemia was induced by permanent distal middle cerebral artery occlusion (MCAO) on day 14 of vehicle or GCV treatment, and mice were killed 12 weeks after MCAO. Infarct volume was significantly increased and neurologic deficits were more severe in GCV- compared to vehicle-treated DCX-TK transgenic mice at first 8 weeks, after depletion of DCX- and bromodeoxyuridine-immunoreactive cells in the SVZ and dentate gyrus following focal ischemia. Our results indicate that endogenous neurogenesis in a critical period following experimental stroke influences the course of long-term recovery.	[Wang, Xiaomei; Mao, XiaoOu; Xie, Lin; Sun, Fen; Greenberg, David A.; Jin, Kunlin] Buck Inst Res Aging, Novato, CA USA; [Jin, Kunlin] Univ N Texas Hlth Sci Ctr Ft Worth, Dept Pharmacol & Neurosci, Ft Worth, TX USA; [Jin, Kunlin] Univ N Texas Hlth Sci Ctr Ft Worth, Inst Aging & Alzheimers Dis Res, Ft Worth, TX USA	Buck Institute for Research on Aging; University of North Texas System; University of North Texas Health Science Center; University of North Texas System; University of North Texas Health Science Center	Wang, XM (corresponding author), Buck Inst Res Aging, Novato, CA USA.	kunlin.jin@unthsc.edu	Sun, Fen/I-8516-2016; Pausch, Hubert/U-5934-2019; Lizier, Joseph/B-8093-2008; Wang, Xuelong/GQB-3574-2022; Wang, X. Rosalind/B-7097-2008; Zeng, Maomao/M-1422-2013; Prokopenko, Mikhail/A-3995-2008	Pausch, Hubert/0000-0002-0501-6760; Yu, Zhuowei/0000-0002-9152-6491; Lizier, Joseph/0000-0002-9910-8972; Tetens, Jens/0000-0001-5352-464X; Wang, Xuelong/0000-0003-4616-1531; SUN, FEN/0000-0003-2094-9494; Kou, Xiaoxing/0000-0001-9680-0077; Tang, Hailiang/0000-0003-1852-3128; Fries, Ruedi/0000-0002-4657-1787; Wang, X. Rosalind/0000-0001-5454-6197; Yan, Jizhou/0000-0001-7482-7842; Zeng, Maomao/0000-0001-9259-1992; Mao, Ying/0000-0001-8055-115X; Prokopenko, Mikhail/0000-0002-4215-0344; Wurmser, Christine/0000-0003-0649-6206; Miller, Jennifer/0000-0003-2110-3693	United States Public Health Service Grant [NS57186, AG21980, NS44921, NS62414]	United States Public Health Service Grant(United States Department of Health & Human ServicesUnited States Public Health Service)	This work was supported by United States Public Health Service Grants NS57186 and AG21980 (to KJ) and NS44921 and NS62414 (to DAG). The URL of any funder's website is www.nih.gov/. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ameh EA, 2009, SURG INFECT, V10, P105, DOI 10.1089/sur.2007.082; Arvidsson A, 2002, NAT MED, V8, P963, DOI 10.1038/nm747; Encarnacion A, 2011, J NEUROSCI METH, V196, P247, DOI 10.1016/j.jneumeth.2011.01.010; Eriksson PS, 1998, NAT MED, V4, P1313, DOI 10.1038/3305; Gu WG, 2000, J CEREBR BLOOD F MET, V20, P1166, DOI 10.1097/00004647-200008000-00002; Jin K, 2003, MOL CELL NEUROSCI, V24, P171, DOI 10.1016/S1044-7431(03)00159-3; Jin KL, 2001, P NATL ACAD SCI USA, V98, P4710, DOI 10.1073/pnas.081011098; Jin KL, 2010, AGING CELL, V9, P1076, DOI 10.1111/j.1474-9726.2010.00638.x; Jin KL, 2010, P NATL ACAD SCI USA, V107, P7993, DOI 10.1073/pnas.1000154107; Jorgensen H S, 1999, Phys Med Rehabil Clin N Am, V10, P887; Kernie SG, 2010, NEUROBIOL DIS, V37, P267, DOI 10.1016/j.nbd.2009.11.002; Lai B, 2008, NEUROSCI LETT, V442, P305, DOI 10.1016/j.neulet.2008.07.032; Liu JL, 1998, J NEUROSCI, V18, P7768; Mayo NE, 1999, DISABIL REHABIL, V21, P258; MCDERMOTT KW, 1991, J ANAT, V178, P45; Nakatomi H, 2002, CELL, V110, P429, DOI 10.1016/S0092-8674(02)00862-0; OHLSSON AL, 1995, STROKE, V26, P644, DOI 10.1161/01.STR.26.4.644; Parent JM, 2002, ANN NEUROL, V52, P802, DOI 10.1002/ana.10393; Raber J, 2004, ANN NEUROL, V55, P381, DOI 10.1002/ana.10853; REARDON JE, 1989, J BIOL CHEM, V264, P19039; SWANSON RA, 1990, J CEREBR BLOOD F MET, V10, P290, DOI 10.1038/jcbfm.1990.47; Yamashita T, 2006, J NEUROSCI, V26, P6627, DOI 10.1523/JNEUROSCI.0149-06.2006; Yoshimura S, 2001, P NATL ACAD SCI USA, V98, P5874, DOI 10.1073/pnas.101034998; Zhang L, 2002, J NEUROSCI METH, V117, P207, DOI 10.1016/S0165-0270(02)00114-0; Zhang RL, 2004, J CEREBR BLOOD F MET, V24, P441, DOI 10.1097/00004647-200404000-00009; Zhu CL, 2009, J NEUROCHEM, V111, P1447, DOI 10.1111/j.1471-4159.2009.06413.x	26	658	680	35	86	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 19	2012	7	6							e38932	10.1371/journal.pone.0038932	http://dx.doi.org/10.1371/journal.pone.0038932			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	963VI	23029330	Green Published, gold, Green Submitted			2022-12-25	WOS:000305652700041
J	Wang, XJ; Wei, DL; Song, ZG; Jiao, HC; Lin, H				Wang, Xiao Juan; Wei, Dai Lin; Song, Zhi Gang; Jiao, Hong Chao; Lin, Hai			Effects of Fatty Acid Treatments on the Dexamethasone-Induced Intramuscular Lipid Accumulation in Chickens	PLOS ONE			English	Article							ACTIVATED PROTEIN-KINASE; SKELETAL-MUSCLE CELLS; INDUCED INSULIN-RESISTANCE; MAMMALIAN TARGET; GENE-EXPRESSION; DOWN-REGULATION; PPAR-ALPHA; RAT; RECEPTOR; LIVER	Background: Glucocorticoid has an important effect on lipid metabolism in muscles, and the type of fatty acid likely affects mitochondrial utilization. Therefore, we hypothesize that the different fatty acid types treatment may affect the glucocorticoid induction of intramuscular lipid accumulation. Methodology/Principal Findings: The effect of dexamethasone (DEX) on fatty acid metabolism and storage in skeletal muscle of broiler chickens (Gallus gallus domesticus) was investigated with and without fatty acid treatments. Male Arbor Acres chickens (31 d old) were treated with either palmitic acid (PA) or oleic acid (OA) for 7 days, followed by DEX administration for 3 days (35-37 d old). The DEX-induced lipid uptake and oxidation imbalance, which was estimated by increased fatty acid transport protein 1 (FATP1) expression and decreased carnitine palmitoyl transferase 1 activity, contributed to skeletal muscle lipid accumulation. More sensitive than glycolytic muscle, the oxidative muscle in DEX-treated chickens showed a decrease in the AMP to ATP ratio, a decrease in AMP-activated protein kinase (AMPK) alpha phosphorylation and its activity, as well as an increase in the phosphorylation of mammalian target of rapamycin (mTOR) and ribosomal p70S6 kinase, without Akt activation. DEX-stimulated lipid deposition was augmented by PA, but alleviated by OA, in response to pathways that were regulated differently, including AMPK, mTOR and FATP1. Conclusions: DEX-induced intramuscular lipid accumulation was aggravated by SFA but alleviated by unsaturated fatty acid. The suppressed AMPK and augmented mTOR signaling pathways were involved in glucocortcoid-mediated enhanced intramuscular fat accumulation.	[Wang, Xiao Juan; Song, Zhi Gang; Jiao, Hong Chao; Lin, Hai] Shandong Agr Univ, Dept Anim Sci, Tai An, Shandong, Peoples R China; [Wei, Dai Lin] Taian Cent Hosp, Dept Endocrine, Tai An, Shandong, Peoples R China	Shandong Agricultural University	Wang, XJ (corresponding author), Shandong Agr Univ, Dept Anim Sci, Tai An, Shandong, Peoples R China.	hailin@sdau.edu.cn	Sun, Fen/I-8516-2016; Pausch, Hubert/U-5934-2019; Lizier, Joseph/B-8093-2008; Wang, Xuelong/GQB-3574-2022; Wang, X. Rosalind/B-7097-2008; Zeng, Maomao/M-1422-2013; Prokopenko, Mikhail/A-3995-2008	Pausch, Hubert/0000-0002-0501-6760; Yu, Zhuowei/0000-0002-9152-6491; Lizier, Joseph/0000-0002-9910-8972; Tetens, Jens/0000-0001-5352-464X; Wang, Xuelong/0000-0003-4616-1531; SUN, FEN/0000-0003-2094-9494; Kou, Xiaoxing/0000-0001-9680-0077; Tang, Hailiang/0000-0003-1852-3128; Fries, Ruedi/0000-0002-4657-1787; Wang, X. Rosalind/0000-0001-5454-6197; Yan, Jizhou/0000-0001-7482-7842; Zeng, Maomao/0000-0001-9259-1992; Mao, Ying/0000-0001-8055-115X; Prokopenko, Mikhail/0000-0002-4215-0344; Wurmser, Christine/0000-0003-0649-6206; Miller, Jennifer/0000-0003-2110-3693	Shandong Science Fund for Distinguished Youth Scholars; National Basic Research Program of China [2004CB117507]; National Natural Science Foundation of China [30771573]; Research Fund for the Doctoral Program of Higher Education of China	Shandong Science Fund for Distinguished Youth Scholars; National Basic Research Program of China(National Basic Research Program of China); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Research Fund for the Doctoral Program of Higher Education of China(Research Fund for the Doctoral Program of Higher Education of China (RFDP)Specialized Research Fund for the Doctoral Program of Higher Education (SRFDP))	This work was supported by grants from the Shandong Science Fund for Distinguished Youth Scholars, the National Basic Research Program of China (2004CB117507), the National Natural Science Foundation of China (No.30771573), and Research Fund for the Doctoral Program of Higher Education of China. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. The contents of this article are solely the responsibility of the authors and do not necessarily represent the official views of the sponsoring agencies.	Andrews RC, 1999, CLIN SCI, V96, P513, DOI 10.1042/cs0960513; Aoki M, 2001, P NATL ACAD SCI USA, V98, P136, DOI 10.1073/pnas.011528498; Berthiaume M, 2007, AM J PHYSIOL-ENDOC M, V293, pE1045, DOI 10.1152/ajpendo.00276.2007; BIEBER LL, 1972, ANAL BIOCHEM, V50, P509, DOI 10.1016/0003-2697(72)90061-9; Boden G, 1997, DIABETES, V46, P3, DOI 10.2337/diabetes.46.1.3; Bowes SB, 1996, J ENDOCRINOL, V148, P501, DOI 10.1677/joe.0.1480501; Braun EJ, 2008, COMP BIOCHEM PHYS B, V151, P1, DOI 10.1016/j.cbpb.2008.05.007; Cai YL, 2009, COMP BIOCHEM PHYS C, V150, P164, DOI 10.1016/j.cbpc.2009.04.005; Caton PW, 2011, BIOCHEM J, V437, P521, DOI 10.1042/BJ20110702; Christ-Crain M, 2008, FASEB J, V22, P1672, DOI 10.1096/fj.07-094144; Chuang JC, 2010, J LIPID RES, V51, P1344, DOI 10.1194/jlr.M002196; Clark H, 2004, EUR J BIOCHEM, V271, P2215, DOI 10.1111/j.1432-1033.2004.04151.x; Close B, 1997, LAB ANIM-UK, V31, P1, DOI 10.1258/002367797780600297; Coll T, 2006, DIABETES, V55, P2779, DOI 10.2337/db05-1494; Cota D, 2009, OBESITY, V17, P1641, DOI 10.1038/oby.2009.84; DAVIES SP, 1989, EUR J BIOCHEM, V186, P123, DOI 10.1111/j.1432-1033.1989.tb15185.x; de Oliveira C, 2011, LIPIDS HEALTH DIS, V10, DOI 10.1186/1476-511X-10-11; Duchene S, 2008, DOMEST ANIM ENDOCRIN, V34, P1, DOI 10.1016/j.domaniend.2006.09.002; Dupont J, 1999, J ENDOCRINOL, V162, P67, DOI 10.1677/joe.0.1620067; Dupont JL, 2004, DOMEST ANIM ENDOCRIN, V26, P127, DOI 10.1016/j.domaniend.2003.09.004; Dupont J, 2008, J ENDOCRINOL, V197, P531, DOI 10.1677/JOE-08-0055; Fingar DC, 2004, MOL CELL BIOL, V24, P200, DOI 10.1128/MCB.24.1.200-216.2004; Foucaud L, 1998, BBA-LIPID LIPID MET, V1391, P204, DOI 10.1016/S0005-2760(97)00213-0; Gao D, 2009, BRIT J NUTR, V102, P1557, DOI 10.1017/S0007114509990948; Gaster M, 2005, DIABETES, V54, P648, DOI 10.2337/diabetes.54.3.648; GRIFFIN HD, 1982, BRIT POULTRY SCI, V23, P307, DOI 10.1080/00071688208447962; Halevy O, 2000, J NUTR, V130, P858, DOI 10.1093/jn/130.4.858; Hardie DG, 2007, ANNU REV PHARMACOL, V47, P185, DOI 10.1146/annurev.pharmtox.47.120505.105304; Hayat MA, 1973, PRINCIPLES TECHNIQUE, V3, P237; Hickson-Bick DLM, 2000, J MOL CELL CARDIOL, V32, P511, DOI 10.1006/jmcc.1999.1098; Holland WL, 2007, CELL METAB, V5, P167, DOI 10.1016/j.cmet.2007.01.002; Hu ZY, 2009, J CLIN INVEST, V119, P3059, DOI 10.1172/JCI38770; HUNNICUTT JW, 1994, DIABETES, V43, P540, DOI 10.2337/diabetes.43.4.540; Inoki K, 2003, CELL, V115, P577, DOI 10.1016/S0092-8674(03)00929-2; Kamara K, 1998, PHYSIOL BEHAV, V64, P1, DOI 10.1016/S0031-9384(97)00534-9; Khamzina L, 2005, ENDOCRINOLOGY, V146, P1473, DOI 10.1210/en.2004-0921; Koh EH, 2003, DIABETES, V52, P2331, DOI 10.2337/diabetes.52.9.2331; Korach-Andre M, 2005, AM J PHYSIOL-ENDOC M, V288, pE106, DOI 10.1152/ajpendo.00089.2004; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; Lee WJ, 2006, BIOCHEM BIOPH RES CO, V340, P291, DOI 10.1016/j.bbrc.2005.12.011; Lillie RD, 1976, HISTOPATHOLOGIC TECH, Vfourth, P559; Lin H, 2004, COMP BIOCHEM PHYS B, V139, P737, DOI 10.1016/j.cbpc.2004.09.013; Liu ZQ, 2004, AM J PHYSIOL-ENDOC M, V287, pE275, DOI 10.1152/ajpendo.00457.2003; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Mordier S, 2007, BIOCHEM BIOPH RES CO, V362, P206, DOI 10.1016/j.bbrc.2007.08.004; Nader N, 2010, MOL ENDOCRINOL, V24, P1748, DOI 10.1210/me.2010-0192; Nakken GN, 2010, J APPL PHYSIOL, V108, P298, DOI 10.1152/japplphysiol.00906.2009; Porstmann T, 2008, CELL METAB, V8, P224, DOI 10.1016/j.cmet.2008.07.007; Prasad SSSV, 2010, LIPIDS HEALTH DIS, V9, DOI 10.1186/1476-511X-9-111; Proszkowiec-Weglarz M, 2006, COMP BIOCHEM PHYS B, V143, P92, DOI 10.1016/j.cbpb.2005.10.009; Qi D, 2004, DIABETES, V53, P1790, DOI 10.2337/diabetes.53.7.1790; Qi D, 2006, AM J PHYSIOL-ENDOC M, V291, P420; Rivas DA, 2009, J ENDOCRINOL, V202, P441, DOI 10.1677/JOE-09-0202; Ruddock MW, 2008, J BIOCHEM, V144, P599, DOI 10.1093/jb/mvn105; Ruderman NB, 2006, OBESITY, V14, p25S, DOI 10.1038/oby.2006.279; Rutter GA, 2003, BIOCHEM J, V375, P1, DOI 10.1042/BJ20030048; RYDER JM, 1985, J AGR FOOD CHEM, V33, P678, DOI 10.1021/jf00064a027; Saha AK, 2003, MOL CELL BIOCHEM, V253, P65, DOI 10.1023/A:1026053302036; Schwartz GJ, 2008, CELL METAB, V8, P281, DOI 10.1016/j.cmet.2008.08.005; Sekulic A, 2000, CANCER RES, V60, P3504; Shah OJ, 2000, AM J PHYSIOL, V279, P74; SIMON J, 1974, ENDOCRINOLOGY, V95, P1439, DOI 10.1210/endo-95-5-1439; Sipula IJ, 2006, METABOLISM, V55, P1637, DOI 10.1016/j.metabol.2006.08.002; SMOLENSKI RT, 1993, BIOMED CHROMATOGR, V7, P189, DOI 10.1002/bmc.1130070404; Staiger H, 2005, DIABETOLOGIA, V48, P2115, DOI 10.1007/s00125-005-1895-z; Stuart M, 2010, END ABSTR, V21, P180; Tremblay F, 2007, P NATL ACAD SCI USA, V104, P14056, DOI 10.1073/pnas.0706517104; Um SH, 2004, NATURE, V431, P200, DOI 10.1038/nature02866; Wang XJ, 2012, STRESS, V15, P443, DOI 10.3109/10253890.2011.639413; Wang XJ, 2010, COMP BIOCHEM PHYS C, V151, P447, DOI 10.1016/j.cbpc.2010.01.010; Watt MJ, 2006, J PHYSIOL-LONDON, V574, P139, DOI 10.1113/jphysiol.2006.107318; Winder WW, 1996, AM J PHYSIOL-ENDOC M, V270, pE299, DOI 10.1152/ajpendo.1996.270.2.E299; Wu QW, 2006, MOL CELL BIOL, V26, P3455, DOI 10.1128/MCB.26.9.3455-3467.2006; Zhang JL, 2004, AM J PHYSIOL-ENDOC M, V286, pE168, DOI 10.1152/ajpendo.00232.2003; Zhao JP, 2009, COMP BIOCHEM PHYS C, V149, P448, DOI 10.1016/j.cbpc.2008.10.106	75	658	680	35	86	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 18	2012	7	5							e36663	10.1371/journal.pone.0036663	http://dx.doi.org/10.1371/journal.pone.0036663			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959VG	23029330	gold, Green Submitted, Green Published			2022-12-25	WOS:000305343500022
J	Wang, XL; Wurmser, C; Pausch, H; Jung, S; Reinhardt, F; Tetens, J; Thaller, G; Fries, R				Wang, Xiaolong; Wurmser, Christine; Pausch, Hubert; Jung, Simone; Reinhardt, Friedrich; Tetens, Jens; Thaller, Georg; Fries, Ruedi			Identification and Dissection of Four Major QTL Affecting Milk Fat Content in the German Holstein-Friesian Population	PLOS ONE			English	Article							QUANTITATIVE TRAIT LOCUS; GROWTH-HORMONE RECEPTOR; MISSENSE MUTATION; GENE; DGAT1; AGPAT6; YIELD; TRANSCRIPTION; EXPRESSION; TISSUE	Milk composition traits exhibit a complex genetic architecture with a small number of major quantitative trait loci (QTL) explaining a large fraction of the genetic variation and numerous QTL with minor effects. In order to identify QTL for milk fat percentage (FP) in the German Holstein-Friesian (HF) population, a genome-wide association study (GWAS) was performed. The study population consisted of 2327 progeny-tested bulls. Genotypes were available for 44,280 SNPs. Phenotypes in the form of estimated breeding values (EBVs) for FP were used as highly heritable traits. A variance components-based approach was used to account for population stratification. The GWAS identified four major QTL regions explaining 46.18% of the FP EBV variance. Besides two previously known FP QTL on BTA14 (P = 8.91x10-(198)) and BTA20 (P = 7.03x10(-12)) within DGAT1 and GHR, respectively, we uncovered two additional QTL regions on BTA5 (P = 2.00x10(-13)) and BTA27 (P = 9.83x10(-5)) encompassing EPS8 and GPAT4, respectively. EPS8 and GPAT4 are involved in lipid metabolism in mammals. Re-sequencing of EPS8 and GPAT4 revealed 50 polymorphisms. Genotypes for five of them were inferred for the entire study population. Two polymorphisms affecting potential transcription factor binding sites of EPS8 (P = 1.40x10(-12)) and GPAT4 (P = 5.18x10(-5)), respectively, were highly significantly associated with the FP EBV. Our results provide evidence that alteration of regulatory sites is an important aspect of genetic variation of complex traits in cattle.	[Wang, Xiaolong; Wurmser, Christine; Pausch, Hubert; Jung, Simone; Fries, Ruedi] Tech Univ Muenchen, Chair Anim Breeding, Freising Weihenstephan, Germany; [Reinhardt, Friedrich] Vereinigte Informat Syst Tierhaltung wV, Verden, Germany; [Tetens, Jens; Thaller, Georg] Univ Kiel, Inst Anim Breeding & Husb, Kiel, Germany	Technical University of Munich; University of Kiel	Wang, XL (corresponding author), Tech Univ Muenchen, Chair Anim Breeding, Freising Weihenstephan, Germany.	xiaolong.wang@tierzucht.tum.de	Sun, Fen/I-8516-2016; Pausch, Hubert/U-5934-2019; Lizier, Joseph/B-8093-2008; Wang, Xuelong/GQB-3574-2022; Wang, X. Rosalind/B-7097-2008; Zeng, Maomao/M-1422-2013; Prokopenko, Mikhail/A-3995-2008	Pausch, Hubert/0000-0002-0501-6760; Yu, Zhuowei/0000-0002-9152-6491; Lizier, Joseph/0000-0002-9910-8972; Tetens, Jens/0000-0001-5352-464X; Wang, Xuelong/0000-0003-4616-1531; SUN, FEN/0000-0003-2094-9494; Kou, Xiaoxing/0000-0001-9680-0077; Tang, Hailiang/0000-0003-1852-3128; Fries, Ruedi/0000-0002-4657-1787; Wang, X. Rosalind/0000-0001-5454-6197; Yan, Jizhou/0000-0001-7482-7842; Zeng, Maomao/0000-0001-9259-1992; Mao, Ying/0000-0001-8055-115X; Prokopenko, Mikhail/0000-0002-4215-0344; Wurmser, Christine/0000-0003-0649-6206; Miller, Jennifer/0000-0003-2110-3693	German Ministry of Education and Research, BMBF [0315134A, 0315134D, 0315131A]; Forderverein Biotechnologieforschung e.V. (FBF), Bonn; Lohmann Tierzucht GmbH, Cuxhaven; China Scholarship Council (CSC)	German Ministry of Education and Research, BMBF(Federal Ministry of Education & Research (BMBF)); Forderverein Biotechnologieforschung e.V. (FBF), Bonn; Lohmann Tierzucht GmbH, Cuxhaven; China Scholarship Council (CSC)(China Scholarship Council)	This study is part of the projects FUGATO-plus GenoTrack and FUGATO-plus MeGA-M and was financially supported by the German Ministry of Education and Research, BMBF (grants 0315134A, 0315134D and 0315131A), the Forderverein Biotechnologieforschung e.V. (FBF), Bonn, and Lohmann Tierzucht GmbH, Cuxhaven. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; The authors acknowledge the vit w.V. Verden for providing phenotype data and the China Scholarship Council (CSC) for supporting X. Wang by a grant.	Beigneux AP, 2006, J LIPID RES, V47, P734, DOI 10.1194/jlr.M500556-JLR200; Bionaz M, 2008, J NUTR, V138, P1019, DOI 10.1093/jn/138.6.1019; Blott S, 2003, GENETICS, V163, P253; Bouwman AC, 2011, BMC GENET, V12, DOI 10.1186/1471-2156-12-43; Browning BL, 2009, AM J HUM GENET, V84, P210, DOI 10.1016/j.ajhg.2009.01.005; Buttchereit N, 2010, J DAIRY SCI, V93, P1702, DOI 10.3168/jds.2009-2198; Cartharius K, 2005, BIOINFORMATICS, V21, P2933, DOI 10.1093/bioinformatics/bti473; Chakravarty K, 2005, CRIT REV BIOCHEM MOL, V40, P129, DOI 10.1080/10409230590935479; Chatterjee S, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005197; Cohen-Zinder M, 2005, GENOME RES, V15, P936, DOI 10.1101/gr.3806705; Ed L, 2009, BIOINFORMATICS, V25, P1836, DOI 10.1093/bioinformatics/btp314; FAZIOLI F, 1993, EMBO J, V12, P3799, DOI 10.1002/j.1460-2075.1993.tb06058.x; Gordon D, 1998, GENOME RES, V8, P195, DOI 10.1101/gr.8.3.195; Gremme G, 2005, INFORM SOFTWARE TECH, V47, P965, DOI 10.1016/j.infsof.2005.09.005; Grisart B, 2002, GENOME RES, V12, P222, DOI 10.1101/gr.224202; Guo DL, 2009, SCI SIGNAL, V2, DOI 10.1126/scisignal.2000446; Hamza MS, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004907; Hayes BJ, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1001139; Jiang L, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013661; Kang HM, 2010, NAT GENET, V42, P348, DOI 10.1038/ng.548; Loor JJ, 2005, PHYSIOL GENOMICS, V23, P217, DOI 10.1152/physiolgenomics.00132.2005; Nickerson DA, 1997, NUCLEIC ACIDS RES, V25, P2745, DOI 10.1093/nar/25.14.2745; Portales-Casamar E, 2009, JASPAR 2010 GREATLY; Quackenbush J, 2001, NUCLEIC ACIDS RES, V29, P159, DOI 10.1093/nar/29.1.159; Schennink A, 2007, ANIM GENET, V38, P467, DOI 10.1111/j.1365-2052.2007.01635.x; Schennink A, 2009, ANIM GENET, V40, P909, DOI 10.1111/j.1365-2052.2009.01940.x; Schug Jonathan, 2008, Curr Protoc Bioinformatics, VChapter 2, DOI 10.1002/0471250953.bi0206s21; Signorelli F, 2009, LIVEST SCI, V125, P74, DOI 10.1016/j.livsci.2009.02.014; Thaller G, 2003, J ANIM SCI, V81, P1911; VanRaden PM, 2008, J DAIRY SCI, V91, P4414, DOI 10.3168/jds.2007-0980; Vergnes L, 2006, J LIPID RES, V47, P745, DOI 10.1194/jlr.M500553-JLR200; Viitala S, 2006, GENETICS, V173, P2151, DOI 10.1534/genetics.105.046730; Winter A, 2002, P NATL ACAD SCI USA, V99, P9300, DOI 10.1073/pnas.142293799; Yang JA, 2011, AM J HUM GENET, V88, P76, DOI 10.1016/j.ajhg.2010.11.011; Zimin AV, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-4-r42	35	658	680	35	86	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 11	2012	7	7							e40711	10.1371/journal.pone.0040711	http://dx.doi.org/10.1371/journal.pone.0040711			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	973LU	23029330	Green Submitted, Green Published, gold			2022-12-25	WOS:000306362400093
